data_5jtr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jtr _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.815 -1.18 . . . . 72.13 107.815 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -100.86 118.43 36.9 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.97 -0.752 . . . . 74.13 108.97 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -141.29 123.51 15.65 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.436 0.46 . . . . 75.53 110.908 -174.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.47 128.9 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.66 -1.237 . . . . 74.52 107.66 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -97.29 -28.91 13.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.472 -0.775 . . . . 75.42 111.341 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -175.85 127.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 123.428 0.455 . . . . 74.14 111.182 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.772 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 65.1 mt -107.74 133.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.359 -0.978 . . . . 74.24 108.359 168.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.429 ' HE1' HG13 ' A' ' 83' ' ' ILE . 17.0 p90 -165.26 154.43 12.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.034 0.934 . . . . 75.22 110.139 -174.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -81.14 121.15 25.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.316 -0.624 . . . . 73.35 109.316 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.2 mtpt -88.45 -24.57 22.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.623 0.369 . . . . 74.41 111.146 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 13.8 t70 -153.52 143.71 22.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.424 0.631 . . . . 71.42 109.955 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.402 HG21 HG21 ' B' ' 21' ' ' ILE . 65.9 mt -138.08 131.66 41.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 106.325 -1.731 . . . . 74.33 106.325 174.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.0 t -146.27 114.14 6.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.488 . . . . 71.33 109.684 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 88.8 t80 -116.11 120.33 38.7 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.242 -1.392 . . . . 74.53 107.242 172.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -119.95 130.8 54.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.365 -0.606 . . . . 75.31 109.365 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.84 76.03 23.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.844 -1.169 . . . . 73.03 107.844 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 -20.43 21.74 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.639 2.226 . . . . 72.12 112.028 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -110.63 25.24 11.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.981 0.912 . . . . 73.13 109.179 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.69 89.96 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.536 0.734 . . . . 72.1 112.882 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 30.7 Cg_endo -68.8 -22.6 36.6 Favored 'Trans proline' 0 C--N 1.387 2.566 0 CA-C-N 121.293 1.498 . . . . 63.04 112.287 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -81.63 -20.54 39.47 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.971 1.309 . . . . 74.23 111.293 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 p -64.52 -29.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.708 0.803 . . . . 74.02 111.592 -174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -62.7 -32.47 73.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.302 1.041 . . . . 74.44 111.597 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -72.26 -35.46 68.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.003 -0.999 . . . . 74.45 110.365 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 1.5 mmmp? -83.95 153.15 24.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.929 0.891 . . . . 74.01 110.808 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.06 144.69 32.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.383 0.673 . . . . 75.42 109.99 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.419 ' CE3' HD21 ' A' ' 68' ' ' LEU . 57.7 t-105 -86.77 86.39 7.32 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.83 0.824 . . . . 74.41 110.247 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -131.96 82.63 59.02 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.951 -1.5 . . . . 74.32 106.951 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.62 127.42 7.21 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.635 2.223 . . . . 73.52 113.368 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 106.02 18.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.945 -1.502 . . . . 71.32 106.945 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.4 130.21 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 116.23 -0.441 . . . . 75.32 111.183 -171.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 59.9 mtpt -109.26 144.96 36.7 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 74.14 110.504 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.439 HD22 HD21 ' A' ' 128' ' ' LEU . 7.9 mp -126.01 112.27 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.691 -1.595 . . . . 75.23 107.603 171.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.65 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.1 m-20 -104.09 110.1 22.15 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.209 -1.404 . . . . 73.52 107.209 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -96.52 127.32 42.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.185 -0.672 . . . . 74.33 109.185 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.63 162.09 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.191 0.596 . . . . 73.2 109.815 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -149.51 164.59 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.962 0.905 . . . . 71.23 110.261 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' HB1' ' NH2' ' A' ' 61' ' ' ARG . . . -148.68 154.13 39.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.634 1.174 . . . . 75.21 108.96 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 50.8 m -125.33 152.08 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.821 0.448 . . . . 74.1 110.264 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -150.14 138.59 20.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.953 0.901 . . . . 64.02 109.147 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -97.32 113.42 25.05 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.577 -0.527 . . . . 64.31 109.577 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.441 HD12 HG22 ' A' ' 83' ' ' ILE . 46.9 mt -89.19 -32.03 17.65 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.815 -0.629 . . . . 71.35 110.538 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.61 -173.86 3.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.671 0.788 . . . . 73.32 110.549 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.71 115.8 5.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.52 0.728 . . . . 74.51 109.285 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 71.69 -6.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.103 1.361 . . . . 71.01 112.613 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.4 t -99.11 112.48 31.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 70.22 108.055 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -122.62 167.31 13.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.227 -0.897 . . . . 73.23 110.27 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 48' ' ' SER . 35.4 tt0 -131.67 125.65 32.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.894 -1.503 . . . . 72.24 108.004 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.8 113.88 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.586 -1.264 . . . . 65.0 107.586 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.519 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -100.35 127.3 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.403 0.681 . . . . 74.21 109.836 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -96.49 118.55 33.24 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.944 -1.132 . . . . 73.2 107.944 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.547 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -96.39 101.85 13.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.002 -0.74 . . . . 72.51 109.002 170.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 18.3 t -95.64 128.66 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 107.387 -1.338 . . . . 74.22 107.387 169.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.8 m -117.84 132.03 56.48 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.844 -0.798 . . . . 73.31 108.844 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 114' ' ' ILE . 54.9 t -126.83 109.52 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.689 1.196 . . . . 73.14 108.308 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 2.6 m -115.79 132.91 56.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.349 -0.611 . . . . 61.15 109.349 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.4 105.04 12.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.103 -1.444 . . . . 73.32 107.103 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -109.56 123.52 49.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.84 -0.43 . . . . 75.51 109.84 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.419 HD21 ' CE3' ' A' ' 36' ' ' TRP . 33.7 mt -89.94 75.12 7.25 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.017 -1.105 . . . . 74.03 108.017 173.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.74 -105.52 1.96 Allowed Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.922 -0.871 . . . . 65.43 110.922 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.58 13.48 25.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.579 0.752 . . . . 73.44 110.693 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -120.31 114.08 21.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.533 -0.746 . . . . 72.45 109.76 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -73.46 132.09 42.54 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.46 1.027 . . . . 75.24 110.726 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.63 -54.14 4.73 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.318 1.047 . . . . 71.0 108.942 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -157.3 173.34 17.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.593 -1.185 . . . . 73.23 111.233 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -142.79 142.94 31.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.678 1.591 . . . . 63.22 107.555 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 34.1 m -143.74 99.56 3.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.158 0.583 . . . . 74.53 109.838 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 40.3 tt0 -109.14 121.47 45.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.077 0.551 . . . . 75.2 109.98 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 t -122.69 119.29 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.935 0.894 . . . . 64.45 109.355 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 46.0 mt-30 -85.58 91.91 8.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.523 -0.762 . . . . 74.34 109.125 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.11 97.5 10.35 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.207 -1.034 . . . . 75.11 108.207 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.74 144.16 18.06 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 112.173 -0.371 . . . . 72.45 112.173 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.547 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.62 125.43 3.0 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.281 -0.728 . . . . 74.31 111.281 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 51' ' ' LEU . 47.2 mt -80.36 129.71 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.625 -0.88 . . . . 75.42 108.625 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.7 120.85 27.26 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.268 -1.012 . . . . 74.02 108.268 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 t -105.39 94.22 5.1 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.437 -0.949 . . . . 74.13 108.437 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.5 pp -134.93 165.06 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.381 1.073 . . . . 73.5 108.4 -170.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.36 178.85 8.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.191 0.596 . . . . 72.04 111.073 170.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.86 67.66 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.739 -0.664 . . . . 71.23 114.522 170.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -113.6 147.71 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.203 0.601 . . . . 75.11 111.624 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -157.79 -170.25 3.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.98 1.312 . . . . 73.52 110.573 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 73.86 -149.41 41.31 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.996 0.808 . . . . 74.01 114.722 175.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.9 p -83.31 -23.43 32.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.577 1.151 . . . . 74.34 111.261 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -71.39 -35.45 71.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.488 1.115 . . . . 74.24 110.648 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 27.7 ptm -62.24 -39.6 93.37 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.199 0.312 . . . . 73.41 110.3 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.5 94.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.48 0.712 . . . . 71.44 110.569 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -57.99 -45.67 86.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.923 0.889 . . . . 73.4 111.488 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.43 -54.27 7.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.315 -0.402 . . . . 74.25 111.334 -173.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.0 -23.97 65.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.513 0.597 . . . . 74.11 111.449 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.85 -21.1 48.08 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-O 119.596 -0.558 . . . . 62.31 113.827 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -136.56 -54.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.654 0.727 . . . . 74.24 112.746 -173.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -72.81 -48.94 33.69 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.727 0.811 . . . . 73.45 112.475 -167.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.91 -46.8 75.13 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.258 1.023 . . . . 70.41 112.072 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.58 -20.82 40.51 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.588 1.525 . . . . 75.1 113.119 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 40.4 t-20 -67.85 -36.06 79.64 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.871 0.469 . . . . 73.11 109.829 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.0 mm -56.26 -43.18 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.677 0.791 . . . . 74.41 110.393 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.547 HD22 ' HA3' ' A' ' 82' ' ' GLY . 53.3 mt -81.46 -21.85 38.49 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.995 -1.002 . . . . 64.33 111.527 -172.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 29.3 t80 -66.14 -39.43 28.56 Favored Pre-proline 0 CA--C 1.56 1.35 0 N-CA-C 114.696 1.369 . . . . 73.01 114.696 -167.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 107' ' ' PHE . 12.2 Cg_endo -57.13 -40.05 86.14 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 121.878 1.718 . . . . 73.04 112.525 172.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.43 -35.38 63.37 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.552 0.741 . . . . 73.24 110.957 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.81 64.67 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.119 0.568 . . . . 75.4 110.153 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.482 ' NH1' HD13 ' C' ' 105' ' ' ILE . 34.8 ttm105 -51.41 -51.4 55.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.787 1.235 . . . . 71.44 110.333 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.82 -48.41 80.73 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.456 1.097 . . . . 75.22 111.362 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.413 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.1 t -54.18 -45.78 72.21 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.375 1.047 . . . . 72.5 110.698 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 64' ' ' VAL . 9.0 mt -64.29 -53.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.051 -0.977 . . . . 63.01 110.901 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.411 HG21 ' HG3' ' A' ' 125' ' ' GLN . 66.1 m -53.22 -39.57 63.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 72.42 111.371 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -71.4 -42.11 68.77 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.192 -0.913 . . . . 75.54 109.807 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.552 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 21.9 mtp -57.79 -41.94 83.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.826 0.85 . . . . 73.0 111.215 175.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.02 -50.19 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.415 1.086 . . . . 74.34 110.387 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 82.2 p -72.1 -27.18 62.48 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.734 -0.666 . . . . 75.32 111.784 -175.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.509 HH12 ' HG3' ' B' ' 112' ' ' GLU . 76.8 mtt-85 -73.11 -24.74 60.66 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.442 0.697 . . . . 73.14 110.335 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.41 14.83 48.94 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-O 119.833 -0.426 . . . . 72.24 113.133 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.8 t 62.83 15.21 8.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 127.331 2.252 . . . . 73.42 113.42 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -91.91 157.75 40.86 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.319 0.648 . . . . 71.03 109.855 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.22 151.99 76.35 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.68 2.253 . . . . 75.44 111.977 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' HG3' HG21 ' A' ' 115' ' ' THR . 28.1 tt0 -57.46 137.21 56.47 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.487 0.492 . . . . 61.43 110.818 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.4 tp -117.07 112.61 21.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.027 -0.988 . . . . 63.21 108.667 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.71 102.37 14.11 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.125 -1.065 . . . . 73.24 108.125 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.439 HD21 HD22 ' A' ' 42' ' ' LEU . 61.1 mt -71.35 117.98 13.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.05 -0.722 . . . . 75.45 109.05 177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.48 128.84 94.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.285 0.366 . . . . 71.13 110.605 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HB3' HH22 ' A' ' 111' ' ' ARG . 57.9 Cg_endo -72.9 136.97 26.04 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 121.833 1.688 . . . . 72.33 110.584 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.88 113.7 33.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.23 -1.396 . . . . 75.21 107.23 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.89 63.94 8.35 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.887 1.327 . . . . 73.13 109.215 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 113.822 -1.536 . . . . 75.31 110.064 179.354 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.248 0.991 0 N-CA-C 109.566 -0.531 . . . . 72.52 109.566 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.417 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 41.3 t80 -137.33 153.92 50.16 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.735 0.814 . . . . 63.02 108.916 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.587 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.424 0.69 . . . . 71.23 111.381 170.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tp -86.95 133.77 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.019 0.528 . . . . 72.33 109.699 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -101.64 -37.85 8.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.869 0.468 . . . . 72.14 109.841 170.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -167.36 137.51 2.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.678 0.391 . . . . 74.02 111.006 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.81 141.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.653 -1.61 . . . . 71.01 106.653 169.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -172.06 144.17 1.64 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.961 0.41 . . . . 74.45 111.701 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.526 HG23 HD13 ' B' ' 21' ' ' ILE . 16.4 m -76.07 128.18 34.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.534 -0.913 . . . . 75.13 108.534 170.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.467 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 42.1 mtpt -98.4 -40.99 8.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.502 0.721 . . . . 74.02 109.564 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 30.7 t70 -138.77 143.27 38.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.34 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.633 HD13 ' SG ' ' B' ' 113' ' ' CYS . 34.7 mm -131.32 142.88 42.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 125.309 1.443 . . . . 74.45 107.758 170.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.7 m -144.4 129.09 18.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.825 -1.08 . . . . 61.01 108.798 168.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 75.0 t80 -138.79 106.7 5.67 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.125 -2.176 . . . . 75.41 105.125 164.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -119.64 108.55 14.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.205 -1.406 . . . . 75.11 107.205 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.04 89.26 6.44 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.561 1.144 . . . . 75.53 108.461 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.75 -44.2 6.14 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.714 2.276 . . . . 75.21 111.695 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 41.0 m-80 -105.98 32.17 4.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.349 1.059 . . . . 60.12 109.414 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.19 -46.42 55.69 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 125.022 1.329 . . . . 74.23 113.929 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 38.4 Cg_endo -69.89 -23.15 30.53 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 121.56 1.507 . . . . 73.24 113.32 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 0.3 OUTLIER -78.63 -2.77 40.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.408 0.683 . . . . 74.05 111.415 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.82 -20.96 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.115 0.566 . . . . 74.23 110.593 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -84.36 -21.48 30.88 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.709 0.803 . . . . 71.3 110.422 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -87.83 -22.84 24.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.408 0.683 . . . . 75.42 111.659 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -107.04 99.88 9.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.976 0.91 . . . . 75.1 111.09 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.02 76.55 8.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.579 0.752 . . . . 74.12 109.359 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 t90 179.88 159.04 0.75 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.106 0.962 . . . . 72.4 109.667 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.56 137.81 85.98 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.081 0.953 . . . . 74.23 112.066 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.68 141.0 48.56 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.376 1.384 . . . . 73.42 110.271 163.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 44.6 mm-40 -75.21 99.24 3.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.247 -1.02 . . . . 75.25 108.247 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.413 ' HB ' ' HG ' ' B' ' 126' ' ' LEU . 14.1 t -97.57 118.21 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.763 -1.199 . . . . 72.11 107.763 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 134.29 46.41 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.666 -1.235 . . . . 72.3 107.666 -165.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.525 HD22 HD22 ' B' ' 128' ' ' LEU . 1.8 pp -86.67 162.49 17.89 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.086 0.773 . . . . 71.33 113.086 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.478 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.0 m-20 -146.94 131.75 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.002 -1.481 . . . . 73.34 107.002 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.13 142.83 34.22 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.229 -1.026 . . . . 55.23 108.229 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -145.11 140.31 27.94 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.305 -0.628 . . . . 73.31 109.305 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 48.3 m -108.93 111.43 23.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.512 0.725 . . . . 71.44 109.886 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.48 128.65 47.27 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 107.813 -1.181 . . . . 72.12 107.813 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.8 m -142.7 165.37 27.56 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.853 -0.529 . . . . 74.52 110.075 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.3 p -152.61 159.52 43.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 72.04 109.499 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -106.54 121.27 43.97 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.688 0.795 . . . . 75.31 109.5 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 85.5 mt -82.99 -43.1 16.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.251 0.62 . . . . 60.31 110.095 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.53 -177.07 6.27 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.381 -0.827 . . . . 74.43 111.019 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.23 112.54 5.87 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 113.76 -1.564 . . . . 72.35 109.096 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 73.61 8.26 5.02 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.924 1.29 . . . . 52.4 112.584 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -119.34 96.08 4.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.988 0.915 . . . . 72.21 108.635 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -99.21 169.61 9.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.713 0.768 . . . . 72.22 110.964 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.437 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.5 tm-20 -142.7 96.77 2.99 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.581 -1.637 . . . . 74.1 106.581 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 79.1 t -94.86 122.58 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.194 -0.669 . . . . 75.13 109.194 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 32.5 t -103.44 118.91 51.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.309 -0.86 . . . . 75.31 109.226 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.03 112.33 24.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.263 -1.384 . . . . 74.13 107.263 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -104.17 111.79 24.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.463 -0.79 . . . . 73.15 109.655 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.533 ' HB ' HD11 ' B' ' 114' ' ' ILE . 67.1 t -105.4 112.42 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.941 -1.133 . . . . 74.41 107.941 170.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 8.8 m -98.44 152.08 19.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.801 -0.815 . . . . 73.55 108.801 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.555 HG22 HG21 ' B' ' 114' ' ' ILE . 84.9 t -141.6 126.49 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.422 1.089 . . . . 71.03 108.326 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -114.26 135.32 54.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.666 0.786 . . . . 75.51 109.388 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.28 146.18 44.39 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.081 0.552 . . . . 73.32 110.231 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -149.87 129.87 13.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.27 0.557 . . . . 74.1 112.255 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.593 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 65.7 mt -95.15 104.84 16.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.727 1.211 . . . . 74.31 109.605 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.05 -110.1 3.28 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.702 0.626 . . . . 74.43 113.047 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.7 3.57 37.16 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.106 1.362 . . . . 71.21 109.62 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.29 154.24 39.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.125 0.97 . . . . 61.32 109.879 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -73.53 137.88 44.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.13 0.572 . . . . 70.5 109.931 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.593 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -92.73 -61.98 1.48 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.784 0.834 . . . . 72.54 108.869 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.26 166.78 32.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.984 -1.462 . . . . 74.41 109.501 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.13 111.12 6.31 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.846 -1.539 . . . . 75.32 106.846 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -116.7 158.69 23.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.043 -0.725 . . . . 73.42 109.043 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -166.26 127.63 1.8 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.092 -1.077 . . . . 75.01 108.092 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.74 142.6 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.782 -0.451 . . . . 75.31 109.782 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -120.38 95.99 4.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.126 -0.943 . . . . 75.21 109.361 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -86.59 103.67 15.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.097 -0.956 . . . . 73.32 109.251 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.13 159.48 28.83 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 111.598 -0.601 . . . . 74.33 111.598 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.17 127.42 1.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.75 -0.94 . . . . 73.31 110.75 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.423 HG22 HD12 ' B' ' 51' ' ' LEU . 50.4 mt -85.41 113.2 23.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.609 -0.886 . . . . 73.43 108.609 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -118.82 133.74 55.63 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.177 -0.675 . . . . 75.24 109.177 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -93.49 110.29 21.87 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.108 -1.071 . . . . 71.12 108.108 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.613 ' HB ' HD13 ' B' ' 89' ' ' ILE . 2.8 pp -121.19 134.68 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.306 0.642 . . . . 75.41 109.74 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.87 33.68 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.152 0.981 . . . . 74.1 108.986 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.31 -44.98 3.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 122.863 0.268 . . . . 65.34 113.261 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.613 HD13 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.1 136.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.918 0.887 . . . . 73.34 111.655 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 10.8 pt-20 -151.67 146.97 26.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.744 0.418 . . . . 74.2 110.561 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.23 -105.83 0.79 Allowed Glycine 0 C--N 1.35 1.334 0 O-C-N 124.037 0.835 . . . . 74.21 113.469 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.1 m -79.65 -31.72 41.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.923 0.889 . . . . 72.13 110.846 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 21.1 mt-30 -60.88 -48.74 80.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.315 0.646 . . . . 70.32 110.107 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.437 ' HA ' ' SG ' ' B' ' 97' ' ' CYS . 10.3 ptm -72.82 -36.85 67.61 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.158 -0.928 . . . . 75.42 110.137 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.73 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.066 0.546 . . . . 72.53 111.286 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -75.27 -35.84 61.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.096 0.958 . . . . 72.53 111.139 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' B' ' 94' ' ' MET . 27.3 p -78.66 -56.91 4.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 110.466 -0.198 . . . . 75.21 110.466 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.6 -22.75 64.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.249 0.62 . . . . 74.31 111.49 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.38 -0.39 40.6 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.246 -0.752 . . . . 62.32 114.584 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.95 -49.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.384 1.092 . . . . 75.2 112.319 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -72.22 -58.5 3.36 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.69 0.396 . . . . 75.45 111.193 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.06 -45.97 99.72 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 124.009 0.923 . . . . 73.2 111.956 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.72 -54.89 4.69 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.145 1.897 . . . . 73.24 112.349 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -63.56 -14.78 54.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.803 1.038 . . . . 60.12 113.803 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 75.4 mt -78.65 -48.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.738 -0.467 . . . . 65.43 109.738 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.01 -20.7 48.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.215 1.006 . . . . 65.53 111.785 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.87 -44.78 80.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.503 1.521 . . . . 72.32 112.517 -171.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.465 ' HA ' HH11 ' B' ' 111' ' ' ARG . 35.1 Cg_exo -56.69 -39.78 88.97 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 121.984 1.789 . . . . 74.41 112.94 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.431 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.8 m-85 -69.21 -41.62 76.84 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.138 0.575 . . . . 74.22 110.94 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.6 87.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.783 0.433 . . . . 71.33 110.121 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.465 HH11 ' HA ' ' B' ' 108' ' ' PRO . 28.9 mtp-105 -52.84 -63.41 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.778 1.231 . . . . 73.14 110.743 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.509 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.7 tp10 -55.28 -37.42 67.29 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.728 1.211 . . . . 63.32 111.493 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.633 ' SG ' HD13 ' B' ' 21' ' ' ILE . 2.0 t -72.57 -46.4 54.58 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 119.642 -0.218 . . . . 70.23 110.965 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.555 HG21 HG22 ' B' ' 64' ' ' VAL . 83.4 mt -60.02 -57.27 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.625 0.77 . . . . 63.33 110.668 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.412 HG23 ' H ' ' B' ' 126' ' ' LEU . 5.9 m -60.24 -28.19 67.82 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.123 0.889 . . . . 73.13 110.744 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.9 t -68.69 -53.12 24.13 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.476 0.711 . . . . 65.55 110.821 171.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.5 mmt -61.85 -37.69 85.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.004 0.522 . . . . 72.5 111.318 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.14 -49.46 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.859 1.264 . . . . 75.21 110.438 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' C' ' 126' ' ' LEU . 87.4 p -73.69 -22.99 59.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 74.12 112.258 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.8 mtt-85 -65.21 -32.37 74.01 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.472 0.709 . . . . 73.15 110.523 175.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 17.23 35.09 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.569 -0.741 . . . . 50.34 112.474 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 60.93 35.96 18.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.452 1.901 . . . . 73.51 112.648 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.32 159.37 29.52 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 124.24 1.016 . . . . 75.11 109.555 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.81 -175.06 2.49 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.948 2.432 . . . . 75.21 115.408 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.497 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 1.0 OUTLIER -65.58 133.43 51.16 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.971 1.308 . . . . 62.01 112.743 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.413 ' HG ' ' HB ' ' B' ' 40' ' ' VAL . 0.2 OUTLIER -153.72 86.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.199 -1.037 . . . . 64.34 108.199 163.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -102.62 136.89 41.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.643 -1.243 . . . . 73.53 107.643 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.525 HD22 HD22 ' B' ' 42' ' ' LEU . 10.8 mt -74.9 125.07 28.06 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.679 -0.489 . . . . 75.42 109.679 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -71.01 137.58 84.88 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.054 0.542 . . . . 73.11 110.7 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.683 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 12.8 Cg_exo -72.42 143.48 38.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.591 2.861 . . . . 74.1 113.138 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.53 128.35 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.259 0.624 . . . . 75.24 109.464 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.518 HD22 HG13 ' D' ' 105' ' ' ILE . 5.2 m-20 -83.62 81.59 8.68 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.167 0.587 . . . . 73.54 109.82 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 N--CA 1.471 0.583 0 CA-C-N 115.192 -0.913 . . . . 74.43 111.322 175.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.245 0.854 0 N-CA-C 107.455 -1.313 . . . . 74.11 107.455 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.524 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.3 t80 -98.64 127.1 44.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.797 -0.816 . . . . 74.23 108.797 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -138.2 126.57 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.618 -0.512 . . . . 72.21 109.618 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.491 HD13 HD11 ' C' ' 16' ' ' ILE . 16.4 tt -80.75 140.31 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.047 0.939 . . . . 74.52 109.004 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.475 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -111.55 -51.44 2.86 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.913 0.387 . . . . 71.42 110.218 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.413 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 50.2 ttt180 -167.88 140.53 3.16 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.536 -0.756 . . . . 74.22 109.445 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.491 HD11 HD13 ' C' ' 13' ' ' ILE . 50.3 mt -122.27 146.95 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.316 -0.994 . . . . 63.05 108.316 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 24.5 p90 -175.65 158.27 2.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.275 0.559 . . . . 73.43 111.284 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -77.16 118.54 19.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.2 -0.909 . . . . 74.34 109.153 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -77.46 -47.72 18.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.423 -0.955 . . . . 72.3 108.423 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -137.3 137.33 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.207 -1.361 . . . . 73.42 109.054 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.7 mt -134.68 145.45 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.969 -1.493 . . . . 74.03 106.969 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -159.37 150.23 19.64 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.223 0.535 . . . . 73.54 109.918 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -139.47 122.67 16.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.875 -1.157 . . . . 71.21 107.875 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.62 111.07 18.69 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.818 0.847 . . . . 71.05 109.182 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.44 84.06 60.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.201 -1.407 . . . . 64.2 107.201 167.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.49 -31.8 60.53 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.927 2.418 . . . . 71.22 111.892 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.456 ' O ' HG12 ' C' ' 31' ' ' VAL . 66.7 m-20 -96.89 24.96 5.66 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.342 1.057 . . . . 53.11 110.456 -176.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.74 97.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 115.26 1.578 . . . . 72.11 115.26 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -68.41 -41.97 5.95 Favored 'Trans proline' 0 C--N 1.384 2.44 0 CA-C-N 121.478 1.563 . . . . 73.31 112.082 169.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -64.02 -23.04 67.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.615 1.566 . . . . 73.03 113.131 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' C' ' 34' ' ' LYS . 15.8 m -57.63 -17.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.6 0.963 . . . . 73.51 113.6 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -59.66 -22.81 62.44 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.503 1.121 . . . . 71.52 112.436 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.6 22.53 5.92 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.428 0.529 . . . . 73.21 112.428 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -88.21 172.71 9.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.87 0.843 . . . . 74.33 111.337 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.45 ' O ' HD23 ' C' ' 68' ' ' LEU . 34.8 t70 -91.59 134.74 34.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.148 -1.387 . . . . 75.42 109.535 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -89.31 81.93 6.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.216 0.607 . . . . 73.32 111.33 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -159.1 69.66 3.4 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.133 0.573 . . . . 72.55 109.896 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' O ' ' C' ' 67' ' ' SER . 42.1 Cg_endo -91.45 157.58 3.65 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.729 2.286 . . . . 75.32 113.368 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.92 76.77 7.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.078 -1.419 . . . . 74.45 108.798 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 m -73.39 96.35 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 122.141 0.972 . . . . 72.12 110.091 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 14.5 ptmm? -128.71 137.86 51.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.382 -1.281 . . . . 60.31 110.458 -173.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.92 139.47 36.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.833 0.853 . . . . 74.35 109.896 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -120.25 106.65 12.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.377 0.671 . . . . 72.13 109.77 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.94 108.96 19.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.402 0.681 . . . . 71.43 109.503 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -113.74 129.48 56.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.004 1.322 . . . . 74.11 108.116 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 36.3 m -111.38 116.92 31.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.988 0.515 . . . . 71.03 110.712 -167.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.11 162.85 27.88 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.336 1.054 . . . . 70.21 109.423 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.0 m -148.56 165.8 30.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.133 0.973 . . . . 63.11 109.641 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -154.65 131.92 11.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.518 0.727 . . . . 74.31 109.511 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.34 120.03 19.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.149 0.579 . . . . 75.13 110.271 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' C' ' 57' ' ' GLU . 57.0 mt -94.2 -37.18 11.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.132 0.573 . . . . 73.2 109.508 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.07 -171.42 2.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.102 -0.954 . . . . 71.35 110.277 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.43 123.31 25.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.662 -0.699 . . . . 75.41 109.129 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 68.18 1.26 2.75 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.791 1.236 . . . . 74.35 112.906 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.98 112.71 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.067 -1.086 . . . . 74.53 108.067 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.37 133.9 43.04 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.91 -0.774 . . . . 74.31 108.91 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.7 tt0 -93.26 117.64 30.31 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.768 0.827 . . . . 70.43 109.77 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.37 118.27 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.144 -1.058 . . . . 73.43 108.144 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.35 106.44 20.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.165 -1.05 . . . . 71.54 108.165 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -99.67 109.69 22.15 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.096 -1.076 . . . . 75.33 108.096 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 31.1 ttm180 -81.24 110.2 16.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.889 0.875 . . . . 72.34 108.952 174.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 t -100.02 130.08 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.41 -1.33 . . . . 74.52 107.41 169.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -129.16 117.07 20.18 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.414 -0.587 . . . . 74.31 109.414 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.461 HG22 HD12 ' C' ' 114' ' ' ILE . 60.0 t -101.09 112.07 32.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.427 -0.953 . . . . 74.0 108.427 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -99.4 146.62 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.363 -0.835 . . . . 64.23 109.039 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.89 110.93 6.28 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.288 -1.004 . . . . 74.11 108.288 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 22.3 m -135.41 140.05 44.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.913 0.485 . . . . 64.45 110.438 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.725 HD12 ' HG3' ' C' ' 71' ' ' GLU . 6.5 mt -111.02 14.07 21.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.657 1.183 . . . . 72.1 110.667 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.86 -104.54 0.93 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.598 -1.001 . . . . 72.23 110.598 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -93.06 -33.01 14.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.437 0.695 . . . . 73.44 109.316 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.725 ' HG3' HD12 ' C' ' 68' ' ' LEU . 3.8 tp10 -76.84 119.75 21.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.199 1.4 . . . . 74.23 109.137 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -86.29 134.1 33.77 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.029 -0.73 . . . . 73.44 109.029 174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -75.08 -58.24 3.4 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.485 -0.561 . . . . 74.14 109.485 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.84 175.27 3.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.137 -0.938 . . . . 72.13 110.652 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.77 143.11 33.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.732 -1.581 . . . . 74.43 106.732 171.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.8 t -145.72 143.18 29.6 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.451 -0.944 . . . . 72.55 108.451 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -150.99 130.4 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.81 0.444 . . . . 75.2 109.979 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.98 115.07 23.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.291 1.036 . . . . 71.02 108.527 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 62.4 mt-30 -90.98 92.34 8.71 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.161 -1.051 . . . . 63.31 108.161 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -81.38 110.96 17.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.737 -1.12 . . . . 73.23 110.004 -176.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.6 146.08 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.782 -0.527 . . . . 61.3 111.782 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -142.62 120.42 1.57 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.889 -0.885 . . . . 64.53 110.889 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' D' ' 29' ' ' PRO . 11.0 mm -81.28 122.06 35.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.25 -1.018 . . . . 73.13 108.25 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -132.16 120.92 22.92 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.597 -0.89 . . . . 73.02 108.597 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.8 t -89.67 109.55 20.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.398 -0.964 . . . . 65.1 108.398 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.418 HG23 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -131.49 148.09 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.455 0.702 . . . . 75.34 111.036 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.8 152.75 9.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.796 1.238 . . . . 74.0 108.818 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.95 -16.38 58.65 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.967 -0.352 . . . . 74.33 113.176 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 42.4 pt . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 123.95 0.9 . . . . 73.3 110.325 178.321 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.943 -0.075 . . . . 72.13 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.42 ' HG3' ' N ' ' C' ' 95' ' ' ALA . 10.4 ptp -64.36 -48.02 77.11 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.295 0.372 . . . . 74.33 110.259 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' C' ' 94' ' ' MET . . . -71.29 -25.15 62.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.63 0.772 . . . . 61.4 111.195 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -79.22 -29.79 42.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 73.14 110.108 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -80.51 -66.77 0.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 116.577 -0.283 . . . . 74.53 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -3.78 58.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.766 -0.584 . . . . 74.22 112.259 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.81 9.28 25.6 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.894 -0.392 . . . . 53.04 113.791 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.29 -59.45 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.06 0.544 . . . . 64.53 110.207 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -66.55 -54.53 22.63 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.721 0.808 . . . . 74.13 112.565 -171.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.524 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 20.7 m -62.76 -45.84 88.03 Favored Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 123.594 0.758 . . . . 54.25 111.505 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.6 Cg_exo -57.64 -32.07 93.56 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.067 1.844 . . . . 73.31 113.752 168.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.83 -23.55 58.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.544 0.738 . . . . 73.52 110.822 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.482 HD13 ' NH1' ' A' ' 111' ' ' ARG . 46.0 mm -69.96 -33.26 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.196 0.598 . . . . 73.55 109.41 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.455 HD22 ' HA3' ' C' ' 82' ' ' GLY . 80.5 mt -88.26 -23.66 23.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.132 0.973 . . . . 71.24 111.951 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.55 -49.39 91.3 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.455 1.102 . . . . 73.33 113.339 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -65.69 -38.57 23.84 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.979 1.786 . . . . 73.42 112.152 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -61.76 -49.5 76.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.777 0.831 . . . . 74.02 111.197 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.84 -42.41 94.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.031 -0.986 . . . . 74.52 110.607 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.494 HH12 ' HG3' ' C' ' 130' ' ' PRO . 57.0 ttp180 -61.56 -42.44 98.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.554 1.142 . . . . 75.12 109.953 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.55 -35.89 65.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.721 0.809 . . . . 74.52 109.929 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 40.7 t -69.19 -29.85 67.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.637 0.375 . . . . 71.25 111.174 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.461 HD12 HG22 ' C' ' 64' ' ' VAL . 66.3 mt -72.28 -47.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 72.31 109.539 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -56.73 -31.99 65.1 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.382 1.073 . . . . 71.45 111.283 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -64.82 -56.5 13.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.578 1.151 . . . . 53.42 109.662 174.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.658 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.81 -38.07 77.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.603 1.161 . . . . 73.13 112.581 -177.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -69.83 -40.02 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.176 0.591 . . . . 74.53 110.252 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.559 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 34.1 t -62.93 -38.12 89.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.452 0.644 . . . . 73.41 110.628 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.466 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 51.0 mtt-85 -67.07 -37.51 84.13 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 114.534 -1.212 . . . . 72.1 110.404 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 7.2 57.2 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 123.637 0.586 . . . . 72.33 113.248 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.408 HG22 ' HB3' ' D' ' 17' ' ' TYR . 50.7 p 60.57 26.78 16.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 126.38 1.872 . . . . 60.43 113.168 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -97.73 156.02 36.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 123.283 0.633 . . . . 72.24 109.632 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.85 78.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.747 2.965 . . . . 74.42 114.405 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.559 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 0.0 OUTLIER -65.63 155.16 36.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.518 1.127 . . . . 73.23 112.497 173.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.514 ' HA ' ' HB2' ' B' ' 119' ' ' SER . 2.0 pt? -168.13 162.16 12.86 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.111 -1.404 . . . . 75.21 108.934 165.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -88.22 100.79 13.25 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.455 -1.683 . . . . 74.52 106.455 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.04 149.81 35.73 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 124.48 1.112 . . . . 70.41 111.124 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.73 122.48 16.54 Favored Pre-proline 0 CA--C 1.551 1.014 0 O-C-N 124.841 1.338 . . . . 71.24 111.853 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.772 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 71.9 Cg_exo -52.68 120.6 7.78 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.552 2.835 . . . . 74.14 112.846 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.5 m -77.48 91.42 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.037 0.922 . . . . 74.33 109.712 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -77.01 82.61 3.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.176 -0.92 . . . . 72.42 110.693 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 t80 . . . . . 0 N--CA 1.476 0.851 0 CA-C-N 115.034 -0.985 . . . . 71.41 111.054 178.855 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.241 0.614 0 N-CA-C 108.503 -0.925 . . . . 64.14 108.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -154.61 98.12 2.05 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 77.5 mt-30 -112.56 143.05 44.37 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.476 -0.935 . . . . 73.24 108.476 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.7 tt -104.38 101.47 12.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.994 -1.113 . . . . 75.44 107.994 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.54 -46.6 31.13 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.894 -0.593 . . . . 75.12 111.808 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.47 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 32.4 ttt180 -170.68 126.68 0.74 Allowed 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.167 0.292 . . . . 72.31 111.067 -167.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.95 123.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.581 0.752 . . . . 74.04 109.002 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.47 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 15.8 p90 -147.29 160.69 42.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.675 0.79 . . . . 74.11 111.724 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -91.53 122.42 34.1 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.12 -0.946 . . . . 71.45 108.828 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -86.46 -45.56 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.636 -0.876 . . . . 74.05 108.636 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -130.75 133.84 46.37 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 113.692 -1.594 . . . . 74.12 109.082 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.658 HG23 ' HE1' ' C' ' 117' ' ' MET . 83.0 mt -134.29 145.55 32.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.603 -1.258 . . . . 74.3 107.603 170.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -148.84 144.64 27.06 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.715 0.806 . . . . 75.12 109.393 171.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -146.04 132.2 19.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.146 -1.798 . . . . 74.44 106.146 170.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.49 134.18 43.16 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.055 -1.091 . . . . 75.24 108.055 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' D' ' 28' ' ' ALA . . . -128.63 89.6 48.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.738 -1.208 . . . . 74.42 107.738 174.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.39 -51.92 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.053 2.502 . . . . 72.11 112.974 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -96.7 38.91 1.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.494 -0.928 . . . . 73.13 108.494 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.42 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.84 -52.58 63.44 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 115.329 1.603 . . . . 72.41 115.329 -164.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.534 ' HB3' HD11 ' C' ' 83' ' ' ILE . 98.0 Cg_endo -82.98 -15.8 7.86 Favored 'Trans proline' 0 C--N 1.388 2.607 0 CA-C-N 121.302 1.501 . . . . 73.23 113.534 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -69.56 -38.96 77.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.659 1.183 . . . . 73.15 109.119 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 t -68.97 -29.57 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 125.426 1.491 . . . . 74.41 110.836 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.413 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 49.8 t80 -63.16 -36.02 82.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.137 0.575 . . . . 75.14 110.84 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.47 -1.83 56.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.984 0.914 . . . . 74.03 111.566 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.575 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 78.3 tttt -119.8 78.4 1.32 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.953 0.901 . . . . 71.3 109.407 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.81 85.93 6.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.154 0.582 . . . . 74.42 112.388 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -139.85 177.34 8.03 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.371 1.069 . . . . 74.25 108.759 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -87.18 119.11 70.8 Favored Pre-proline 0 CA--C 1.554 1.128 0 O-C-N 121.985 -0.447 . . . . 72.52 110.16 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.27 113.4 2.85 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.854 2.369 . . . . 64.14 112.255 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.19 114.03 12.07 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.835 -0.802 . . . . 74.13 108.835 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' D' ' 66' ' ' ALA . 31.5 m -99.76 134.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.834 0.854 . . . . 73.52 110.934 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 39.5 mmtm -97.12 110.8 23.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.453 -0.944 . . . . 72.21 108.453 171.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.567 ' HG ' HD13 ' D' ' 128' ' ' LEU . 1.8 mm? -97.14 115.43 27.52 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.041 -1.096 . . . . 74.43 108.041 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.809 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -107.24 119.53 39.65 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.434 -0.95 . . . . 71.02 108.434 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.9 129.45 41.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.041 -0.725 . . . . 73.12 109.041 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.9 t70 -152.44 151.11 30.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 64.3 108.595 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -133.22 163.03 30.2 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.51 0.724 . . . . 70.42 110.047 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.57 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -150.2 166.97 28.27 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 74.04 109.652 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -152.2 154.25 35.43 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.105 0.562 . . . . 71.14 110.444 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -157.22 119.03 3.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.193 0.997 . . . . 73.2 108.859 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -70.85 128.22 35.26 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.688 0.395 . . . . 63.04 110.211 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.5 mt -103.57 -29.1 11.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.318 0.647 . . . . 74.04 110.166 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.498 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -165.8 -176.63 3.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.297 1.039 . . . . 72.55 110.017 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.54 121.02 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.579 -0.897 . . . . 63.34 108.579 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 63.89 16.82 10.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.4 1.08 . . . . 71.15 112.756 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 79.6 t -131.2 128.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.283 1.033 . . . . 72.21 108.765 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.436 ' CE1' HG12 ' D' ' 86' ' ' ILE . 0.0 OUTLIER -151.41 161.67 42.3 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 72.53 110.674 176.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.442 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -103.01 120.55 40.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 124.531 1.132 . . . . 70.34 108.848 173.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.65 123.09 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.403 -1.332 . . . . 62.42 107.403 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 29.7 t -102.75 133.93 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.883 -0.784 . . . . 64.24 108.883 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.24 111.08 22.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.219 -1.03 . . . . 74.11 108.219 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.0 ttm-85 -86.84 110.53 20.02 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 109.144 -0.688 . . . . 75.23 109.144 171.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -108.56 103.83 16.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.87 -1.159 . . . . 73.02 107.87 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.809 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -96.04 146.5 24.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.957 -0.757 . . . . 71.42 108.957 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 81.2 t -138.21 123.18 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.818 1.247 . . . . 74.42 108.368 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 60.6 m -125.63 97.78 5.3 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 71.44 108.644 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.479 ' HB3' HG12 ' D' ' 40' ' ' VAL . . . -94.16 137.62 33.14 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.49 0.716 . . . . 74.3 109.385 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.8 m -137.06 149.53 47.47 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.142 0.577 . . . . 74.25 110.694 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -132.58 117.42 17.93 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.047 1.339 . . . . 75.11 107.999 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.26 -112.43 4.68 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.695 -0.562 . . . . 74.43 111.695 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 4.48 13.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.768 0.827 . . . . 75.02 110.815 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.575 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.6 pt-20 -118.62 170.9 8.58 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.308 0.643 . . . . 74.33 110.511 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -79.95 138.04 37.0 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.851 -0.613 . . . . 72.44 109.986 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.05 -56.74 2.96 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.704 0.802 . . . . 75.14 109.069 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -163.59 163.6 24.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.878 -1.055 . . . . 74.2 109.828 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.1 mt -118.82 153.04 35.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.048 1.339 . . . . 74.45 108.25 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.533 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 44.3 t -159.31 144.96 16.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.115 0.566 . . . . 64.04 109.988 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -156.83 139.71 15.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.61 . . . . 64.31 109.382 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.61 119.89 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 123.653 0.781 . . . . 75.03 108.936 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.2 mt-30 -97.47 87.84 4.22 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.768 0.827 . . . . 75.15 108.956 173.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -80.64 97.75 7.37 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.819 -1.537 . . . . 72.45 109.588 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.53 141.59 16.73 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.578 -0.609 . . . . 72.01 111.578 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.3 131.42 4.86 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.847 -0.501 . . . . 72.24 111.847 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -90.04 125.35 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.956 -0.757 . . . . 75.5 108.956 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -129.6 128.8 43.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.255 1.022 . . . . 74.45 109.493 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.403 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 6.0 m -88.29 95.18 10.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.054 0.942 . . . . 73.51 108.682 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' D' ' 56' ' ' TYR . 2.7 pp -109.42 140.23 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.66 0.384 . . . . 75.45 110.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.32 165.41 19.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.003 0.921 . . . . 74.03 109.113 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.36 23.83 76.45 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 121.529 0.516 . . . . 74.44 112.262 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.439 HD11 ' SD ' ' D' ' 94' ' ' MET . 2.3 pp -109.18 147.16 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.967 1.307 . . . . 74.32 110.238 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -168.58 150.46 4.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.923 0.489 . . . . 73.21 111.332 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.05 -139.75 48.25 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.015 0.822 . . . . 72.4 114.959 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.6 p -68.54 -18.69 64.41 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.544 0.738 . . . . 72.23 111.739 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -47.85 61.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.518 0.727 . . . . 73.21 109.573 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.439 ' SD ' HD11 ' D' ' 89' ' ' ILE . 9.3 tpt -58.34 -53.06 62.6 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.94 0.775 . . . . 62.52 110.553 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.17 86.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.956 0.785 . . . . 74.24 111.424 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -70.86 -47.09 61.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.409 0.683 . . . . 52.22 111.526 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.155 0.582 . . . . 72.41 110.589 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.03 -48.39 18.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.137 0.975 . . . . 75.05 110.34 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.45 -14.31 60.22 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.772 -0.649 . . . . 72.0 114.231 -169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.15 -60.97 1.32 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.025 0.53 . . . . 62.42 110.99 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -64.56 -47.45 78.69 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.818 0.673 . . . . 75.44 112.818 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.426 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 94.9 m -62.29 -50.17 80.84 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 118.8 -0.619 . . . . 74.12 111.246 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.459 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 60.1 Cg_exo -58.77 -31.0 94.19 Favored 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 122.542 2.161 . . . . 73.41 113.94 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.04 -32.9 74.65 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.09 0.556 . . . . 74.03 110.419 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.518 HG13 HD22 ' B' ' 132' ' ' ASN . 47.7 mm -69.9 -43.22 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.516 0.726 . . . . 71.05 110.21 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -73.36 -19.5 60.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.183 -0.917 . . . . 75.13 111.772 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -69.09 -44.33 27.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 N-CA-C 113.887 1.069 . . . . 75.23 113.887 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.03 -34.52 87.38 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 121.927 1.752 . . . . 74.31 113.237 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.683 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 97.0 m-85 -81.2 -33.87 32.66 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 75.42 111.441 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.33 66.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.16 0.584 . . . . 73.44 109.71 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -58.82 -49.31 78.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.089 1.356 . . . . 73.23 110.596 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.45 -43.41 94.37 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.172 0.92 . . . . 75.15 110.881 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.466 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.3 t -56.09 -41.59 75.42 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.628 0.58 . . . . 72.13 110.737 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.47 HG23 HG21 ' D' ' 64' ' ' VAL . 78.8 mt -70.91 -44.59 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.153 -0.931 . . . . 75.03 110.782 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.484 HG22 ' HG3' ' D' ' 125' ' ' GLN . 74.2 m -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.015 0.926 . . . . 75.33 110.598 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.31 -48.08 71.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.511 -1.222 . . . . 64.01 110.305 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.526 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.6 mtm -64.44 -32.76 74.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.008 0.523 . . . . 75.02 112.126 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' D' ' 123' ' ' PHE . 72.3 t -67.42 -45.73 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.566 -0.743 . . . . 73.33 109.531 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.8 p -71.76 -23.17 61.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.625 0.37 . . . . 74.55 111.548 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.484 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.4 mtt-85 -77.6 -34.35 53.48 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.094 0.958 . . . . 75.23 109.85 175.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -0.01 79.93 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.587 -0.733 . . . . 71.44 111.926 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p 61.5 42.31 11.52 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.313 1.845 . . . . 72.44 111.552 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.413 ' HB2' HG13 ' D' ' 118' ' ' VAL . 37.1 m-85 -111.56 167.82 8.52 Favored Pre-proline 0 CA--C 1.56 1.347 0 CA-C-N 113.078 -1.874 . . . . 75.2 107.878 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.17 140.37 24.91 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.996 1.797 . . . . 75.44 112.053 -171.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.484 ' HG3' HG22 ' D' ' 115' ' ' THR . 25.6 tt0 -45.61 123.78 4.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.502 1.121 . . . . 75.51 112.338 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.479 HD12 HG22 ' D' ' 40' ' ' VAL . 42.1 tp -108.56 93.02 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.524 -0.762 . . . . 74.32 109.021 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -115.53 106.0 13.44 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.03 0.932 . . . . 63.31 109.039 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.567 HD13 ' HG ' ' D' ' 42' ' ' LEU . 3.6 mm? -62.44 125.51 24.16 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.337 -0.847 . . . . 74.33 110.135 174.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.501 ' HB1' HE22 ' B' ' 12' ' ' GLN . . . -55.7 128.46 69.33 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 124.538 1.149 . . . . 60.45 110.562 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -73.59 95.23 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.307 2.671 . . . . 74.34 112.335 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 91.2 t -102.12 118.74 49.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.508 -1.293 . . . . 73.43 107.508 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 121.752 0.787 . . . . 62.42 109.215 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.245 0.841 0 N-CA-C 109.552 -0.536 . . . . 74.34 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.74 135.78 48.12 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.663 0.785 . . . . 74.45 108.956 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -160.52 141.17 11.7 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.647 0.592 . . . . 72.14 112.582 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.36 117.71 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 107.867 -1.16 . . . . 63.51 107.867 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 2.1 mp0 -84.69 -30.6 24.67 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.128 -0.463 . . . . 64.33 110.053 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -175.9 146.91 0.74 Allowed 'General case' 0 C--N 1.371 1.535 0 O-C-N 123.851 0.72 . . . . 71.04 111.046 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.838 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 96.5 mt -129.65 128.23 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.497 -1.297 . . . . 74.44 107.497 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -156.81 166.43 33.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.178 0.991 . . . . 75.13 110.656 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -92.26 119.0 31.44 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.921 -0.77 . . . . 72.44 108.921 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -82.62 -26.28 32.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.002 -0.37 . . . . 74.14 110.002 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.6 t70 -152.94 143.0 22.32 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.261 -0.881 . . . . 75.33 110.35 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.436 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 85.7 mt -138.39 140.88 39.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 C-N-CA 125.536 1.534 . . . . 72.32 106.926 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -149.15 126.68 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.753 0.658 . . . . 74.11 109.624 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.531 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 90.1 t80 -130.9 131.97 44.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.405 -1.332 . . . . 73.55 107.405 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.6 131.86 41.9 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.39 87.84 51.69 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.61 -1.256 . . . . 74.41 107.61 170.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.77 -22.76 42.74 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.672 2.248 . . . . 73.13 112.925 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -120.42 38.78 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.615 0.766 . . . . 73.24 109.448 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.412 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -59.41 -48.24 96.32 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.125 0.97 . . . . 64.23 113.055 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 10.1 Cg_exo -73.53 -42.04 0.99 Allowed 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.085 1.857 . . . . 72.03 112.266 168.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -62.8 -19.89 64.48 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.055 1.342 . . . . 73.24 112.792 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.66 -24.12 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.279 0.631 . . . . 73.1 111.814 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -54.98 -32.24 61.44 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.971 0.908 . . . . 73.32 112.698 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -86.21 -48.53 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.965 0.906 . . . . 74.22 110.359 -175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -78.91 128.56 33.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.802 -1.09 . . . . 64.44 112.038 -169.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.56 134.75 57.31 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.482 1.113 . . . . 72.22 111.246 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.548 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 46.6 t-105 -84.49 80.46 9.22 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.906 0.754 . . . . 74.34 111.231 -173.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.92 75.92 74.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.675 -1.231 . . . . 74.05 107.675 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.01 155.96 11.33 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.745 2.296 . . . . 72.3 113.336 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.27 105.76 17.94 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.317 -1.364 . . . . 70.05 107.317 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 65' ' ' THR . 36.0 t -87.24 98.78 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.878 -0.416 . . . . 71.13 109.878 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 85.0 tttt -81.72 130.86 35.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.446 0.698 . . . . 75.12 109.897 175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 HD21 HD22 ' A' ' 128' ' ' LEU . 5.7 mp -114.67 110.87 20.43 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.754 -0.832 . . . . 74.21 108.754 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.592 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.9 t70 -112.92 130.96 55.93 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.984 -1.117 . . . . 63.5 107.984 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.9 tp -117.54 131.27 56.72 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 74.42 109.307 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.68 146.74 40.03 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.945 -0.761 . . . . 71.42 108.945 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -147.55 143.13 27.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.283 -0.636 . . . . 64.44 109.283 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.54 134.11 15.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.63 0.772 . . . . 75.12 109.116 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.479 ' HG ' HG21 ' A' ' 58' ' ' VAL . 20.7 m -88.73 162.66 16.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.133 0.573 . . . . 75.22 110.556 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -149.86 141.15 23.19 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.536 1.134 . . . . 71.3 108.004 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -91.66 133.43 35.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.886 -0.413 . . . . 73.13 109.886 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 57' ' ' GLU . 42.5 mt -118.43 -35.32 3.8 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.803 0.841 . . . . 74.42 109.144 171.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -147.04 179.57 7.52 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.599 -1.182 . . . . 62.43 109.848 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.11 122.89 21.74 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.27 -1.011 . . . . 72.42 108.27 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 70.77 -6.38 1.26 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.699 1.199 . . . . 75.32 112.925 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.596 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 59.5 t -105.3 111.07 33.14 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 N-CA-C 108.088 -1.078 . . . . 70.3 108.088 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -119.11 128.12 54.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 74.04 109.796 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.698 ' HB2' HD12 ' A' ' 51' ' ' LEU . 13.1 tt0 -82.66 112.22 19.34 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.326 -1.361 . . . . 72.15 107.326 166.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.479 HG21 ' HG ' ' A' ' 48' ' ' SER . 61.0 t -100.7 115.62 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.854 -1.535 . . . . 75.21 106.854 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.654 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.7 t -96.29 129.44 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.388 -0.597 . . . . 74.41 109.388 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 111.39 23.67 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.112 -1.44 . . . . 74.51 107.112 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -100.49 102.75 14.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.665 -0.865 . . . . 71.32 108.665 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.4 128.53 46.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.101 -1.074 . . . . 75.13 108.101 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.8 m -113.94 135.99 53.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.848 -0.797 . . . . 75.51 108.848 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -132.49 136.95 55.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 125.568 1.547 . . . . 62.35 107.135 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.7 m -141.63 138.3 32.46 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.99 127.56 45.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.676 -1.601 . . . . 73.34 106.676 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -139.95 131.97 27.85 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.349 0.595 . . . . 63.54 111.688 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.3 mt -89.62 78.19 7.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.577 -1.268 . . . . 73.23 107.577 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -117.04 4.36 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.081 -0.963 . . . . 65.44 111.184 -173.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -87.87 -25.22 23.39 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.522 0.729 . . . . 75.12 110.297 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -79.93 106.8 12.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.078 0.951 . . . . 70.14 109.371 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -65.62 129.92 41.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.238 0.542 . . . . 75.34 111.139 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.28 -52.94 7.11 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.592 1.157 . . . . 74.33 109.004 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -158.25 155.26 28.61 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.464 -0.789 . . . . 73.5 111.396 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.413 HD11 ' H ' ' A' ' 76' ' ' CYS . 34.7 tp -117.94 146.35 44.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.972 1.309 . . . . 75.42 108.422 170.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.574 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 80.9 m -144.93 131.12 19.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.563 1.145 . . . . 53.41 108.85 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.74 128.6 14.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.191 -0.67 . . . . 73.52 109.191 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -130.29 110.4 19.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.437 -0.949 . . . . 73.44 108.437 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.7 mt-30 -86.34 81.01 8.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.7 -0.852 . . . . 72.4 108.7 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.87 93.58 3.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.2 -1.364 . . . . 73.31 109.046 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.16 143.7 16.77 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.766 -0.534 . . . . 74.33 111.766 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.516 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -141.51 131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.044 -0.823 . . . . 74.41 111.044 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 17.3 mt -81.14 128.8 38.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 74.03 108.849 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -136.21 131.0 34.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.086 0.554 . . . . 71.34 110.699 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -83.5 119.67 24.97 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.052 -1.092 . . . . 74.02 108.052 168.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.32 122.48 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 75.23 110.096 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.17 162.95 28.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.632 0.773 . . . . 75.12 109.961 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.05 81.54 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.132 -0.485 . . . . 51.2 112.948 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.46 137.2 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.187 0.995 . . . . 61.1 109.808 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.527 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 20.2 tt0 -137.07 -179.11 5.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 73.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.527 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 48.95 -124.24 12.3 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 124.02 0.819 . . . . 63.31 114.94 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -79.11 -16.61 56.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.543 0.737 . . . . 60.14 111.608 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.69 -39.88 61.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.679 0.392 . . . . 74.42 110.369 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.05 36.61 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.299 0.24 . . . . 73.14 110.838 175.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.7 -30.01 67.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.501 . . . . 74.2 110.072 171.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.48 -44.11 45.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.86 0.864 . . . . 73.13 110.319 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.17 -63.91 1.08 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.259 0.623 . . . . 70.1 111.566 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 tt -71.12 -46.2 62.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.511 0.724 . . . . 73.53 111.031 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.69 -18.25 79.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.742 0.657 . . . . 52.5 114.742 -169.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.56 -51.78 0.69 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.578 0.689 . . . . 74.11 112.205 -172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.24 -37.29 71.98 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.328 0.651 . . . . 74.01 112.441 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.31 -45.79 13.81 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-O 118.355 -0.831 . . . . 54.01 113.028 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.78 -22.66 68.88 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 121.531 1.487 . . . . 73.14 112.578 168.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -79.38 -22.43 44.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.038 0.535 . . . . 71.25 111.79 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.72 -36.97 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.627 -0.879 . . . . 71.31 108.627 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD22 ' HA3' ' A' ' 82' ' ' GLY . 44.1 mt -85.8 -18.31 33.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.115 . . . . 73.14 112.568 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -66.25 -42.62 50.57 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-O 117.709 -1.139 . . . . 75.42 114.013 -171.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.21 -35.27 86.25 Favored 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 121.951 1.733 . . . . 74.51 112.745 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -74.07 -40.8 62.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.654 0.781 . . . . 72.55 111.343 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.22 75.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.332 0.653 . . . . 52.51 109.8 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.442 ' NH1' HG22 ' C' ' 105' ' ' ILE . 34.5 ttm180 -52.11 -55.21 22.27 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.65 1.218 . . . . 74.55 109.893 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.46 -40.65 97.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.204 0.94 . . . . 74.44 111.3 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.601 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -61.87 -35.69 79.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.983 0.513 . . . . 74.45 111.207 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 95.6 mt -72.62 -51.02 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 75.31 109.644 173.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 125' ' ' GLN . 97.9 m -53.41 -37.17 62.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.318 1.447 . . . . 74.0 111.227 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.7 t -69.47 -49.65 52.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.927 -1.033 . . . . 65.54 110.118 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 60.7 mtm -57.83 -44.84 86.71 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.346 0.658 . . . . 74.31 110.984 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.73 -48.84 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.386 -1.279 . . . . 75.51 110.608 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -68.78 -29.53 67.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.744 -0.662 . . . . 73.52 111.544 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -73.93 -28.59 61.6 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.64 0.776 . . . . 73.33 110.529 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.89 10.67 51.36 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.954 0.784 . . . . 71.54 112.801 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.416 HG23 ' HB3' ' D' ' 125' ' ' GLN . 3.7 m 66.34 26.05 10.32 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.794 1.238 . . . . 75.34 110.467 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -103.33 157.73 33.23 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.019 -0.991 . . . . 75.41 108.852 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.548 ' HG3' ' HE1' ' A' ' 36' ' ' TRP . 73.1 Cg_endo -68.8 147.54 69.22 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.093 1.862 . . . . 73.22 111.744 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.483 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.4 tt0 -58.13 128.88 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 123.949 0.78 . . . . 70.35 110.878 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -108.98 101.32 10.42 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.895 -0.78 . . . . 74.3 108.895 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.428 ' HB3' HD13 ' C' ' 13' ' ' ILE . 92.4 m-20 -98.41 105.18 17.29 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.901 -0.777 . . . . 74.43 108.901 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.517 HD22 HD21 ' A' ' 42' ' ' LEU . 46.0 mt -72.96 139.12 46.51 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.537 -0.756 . . . . 74.23 109.218 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.03 138.03 90.97 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.667 0.604 . . . . 45.52 110.433 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.645 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 16.1 Cg_endo -76.57 96.93 1.1 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 121.611 1.541 . . . . 73.03 109.143 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 m -97.94 112.07 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.977 -1.01 . . . . 75.44 108.37 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -103.91 109.98 21.94 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.797 -1.092 . . . . 65.32 108.325 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.4 t80 . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.53 0.732 . . . . 74.12 111.281 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 108.568 -0.901 . . . . 74.24 108.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.411 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 46.5 t80 -142.84 131.31 22.34 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 74.43 107.5 165.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -160.55 139.97 10.79 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.991 0.807 . . . . 75.11 110.021 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.596 HD13 HG13 ' B' ' 16' ' ' ILE . 16.9 tt -95.93 145.23 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.377 1.071 . . . . 74.32 109.836 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.18 -35.07 8.16 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 119.658 -0.21 . . . . 62.23 111.037 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -173.53 144.76 1.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.502 0.321 . . . . 75.24 111.565 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.596 HG13 HD13 ' B' ' 13' ' ' ILE . 60.9 mt -118.94 138.11 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.182 -1.414 . . . . 74.14 107.182 165.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -167.3 142.12 3.89 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.341 1.026 . . . . 75.31 109.339 -170.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.4 m -75.16 118.8 18.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.476 -0.935 . . . . 74.33 108.476 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -85.14 -34.64 22.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.824 -0.625 . . . . 72.54 110.832 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.03 145.92 15.54 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.407 0.442 . . . . 74.01 110.924 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.631 HD12 ' SG ' ' B' ' 113' ' ' CYS . 40.5 mm -135.63 142.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.431 1.092 . . . . 73.31 109.877 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -136.61 127.93 28.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.921 1.289 . . . . 72.12 108.569 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -144.38 109.5 5.07 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.873 -1.528 . . . . 73.22 106.873 165.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -123.42 113.35 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.469 -0.937 . . . . 72.05 108.469 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.33 90.02 5.36 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.662 1.185 . . . . 74.31 108.965 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.86 -25.18 53.01 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.285 1.99 . . . . 71.34 111.759 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 92.4 m-20 -121.28 31.46 6.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.441 1.097 . . . . 72.21 110.064 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.409 ' O ' HG12 ' B' ' 31' ' ' VAL . . . -46.87 -48.52 51.32 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 125.399 1.48 . . . . 71.51 113.476 172.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.05 -17.83 17.02 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.855 1.703 . . . . 74.31 113.396 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 2.0 m-70 -82.6 -1.24 50.25 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.206 0.817 . . . . 75.11 113.206 -171.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.409 HG12 ' O ' ' B' ' 28' ' ' ALA . 7.2 p -79.84 -25.99 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.239 0.542 . . . . 75.13 109.812 166.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -78.96 -32.01 45.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.489 -0.56 . . . . 75.53 109.489 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.505 ' HA ' HE21 ' B' ' 33' ' ' GLN . 0.0 OUTLIER -71.43 -45.0 63.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.146 -0.479 . . . . 75.52 110.716 177.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -108.08 110.46 22.14 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.234 1.014 . . . . 72.41 109.252 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -74.12 79.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.136 0.575 . . . . 71.23 111.487 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -162.15 151.09 15.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.194 -1.41 . . . . 75.55 107.194 169.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -92.23 133.17 30.53 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.08 0.952 . . . . 72.51 109.443 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 158.26 35.6 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.023 2.482 . . . . 74.54 113.818 -169.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.27 107.95 12.41 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.917 -0.771 . . . . 71.42 108.917 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.453 HG13 HD21 ' B' ' 126' ' ' LEU . 17.7 t -95.28 123.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.576 0.751 . . . . 75.14 109.12 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -136.85 145.31 44.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.624 0.77 . . . . 74.5 110.845 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.666 HD21 HD21 ' B' ' 128' ' ' LEU . 2.4 pt? -116.8 166.54 12.02 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.365 0.666 . . . . 74.41 111.572 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -150.14 154.35 37.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.225 1.41 . . . . 74.3 108.142 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -94.54 148.99 21.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.166 0.586 . . . . 75.32 111.106 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -141.79 154.59 45.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.855 1.262 . . . . 72.44 108.943 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 72.0 p -122.92 134.8 54.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.547 . . . . 74.51 110.468 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.34 32.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.241 -1.022 . . . . 72.1 108.241 170.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.2 p -147.93 167.7 24.18 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.801 0.334 . . . . 72.44 111.367 172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.1 p -151.32 136.55 17.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.378 1.071 . . . . 73.34 108.69 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.84 129.69 35.12 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.471 -0.566 . . . . 63.21 109.471 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.555 HD12 HG22 ' B' ' 83' ' ' ILE . 26.9 mt -95.58 -47.21 6.32 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.442 -0.577 . . . . 75.02 109.442 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.26 -172.93 4.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.984 0.913 . . . . 74.53 110.179 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 103.07 0.3 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.09 -0.959 . . . . 74.43 110.148 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 4.9 m-20 65.38 12.82 8.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.917 1.287 . . . . 74.55 113.094 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -104.59 86.51 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 105.999 -1.852 . . . . 62.24 105.999 166.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.444 ' HH ' HG22 ' B' ' 86' ' ' ILE . 17.1 p90 -109.39 141.6 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.877 0.846 . . . . 75.23 109.762 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -103.54 115.84 31.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.058 -1.428 . . . . 73.44 107.994 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.98 127.73 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.881 0.472 . . . . 73.35 109.784 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -102.03 115.97 44.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.168 0.987 . . . . 72.33 108.612 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' B' ' 106' ' ' LEU . 0.5 OUTLIER -92.14 109.6 20.96 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.8 -1.185 . . . . 75.04 107.8 178.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -99.99 126.03 46.11 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.738 -0.468 . . . . 74.41 109.738 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.4 t -118.25 126.83 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.153 -1.055 . . . . 74.35 108.153 171.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 29.1 m -97.13 149.64 21.75 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.548 0.739 . . . . 73.14 109.147 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.512 HG22 HG21 ' B' ' 114' ' ' ILE . 55.6 t -135.33 132.73 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.266 1.026 . . . . 73.23 109.358 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -124.16 139.22 54.14 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.444 -0.947 . . . . 74.45 108.444 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.38 149.63 36.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.797 0.839 . . . . 64.44 109.072 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.7 p -144.95 132.65 21.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.367 0.877 . . . . 74.1 113.367 -174.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.6 104.73 16.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.151 1.38 . . . . 74.21 108.495 173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.75 -103.38 1.11 Allowed Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.042 -1.075 . . . . 72.44 111.18 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.18 3.55 11.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.47 1.508 . . . . 65.32 111.799 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.405 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 23.7 pt-20 -116.29 161.49 18.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.978 0.511 . . . . 63.43 111.15 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -77.65 113.28 15.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.066 0.547 . . . . 75.03 110.554 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -68.25 -59.39 3.24 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.872 -0.788 . . . . 73.33 108.872 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.02 168.47 27.15 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.117 -0.947 . . . . 73.44 111.425 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -130.39 113.28 14.14 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.743 -1.577 . . . . 64.33 106.743 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -118.11 153.14 34.27 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.893 -0.78 . . . . 74.12 108.893 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.82 132.8 3.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.88 144.07 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.709 0.803 . . . . 75.12 109.065 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -121.75 84.35 2.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.509 -0.923 . . . . 63.52 108.509 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.26 99.88 9.57 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 114.716 -1.129 . . . . 74.52 108.835 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.69 159.75 26.05 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.809 -0.517 . . . . 65.41 111.809 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.62 129.27 2.02 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.09 -0.804 . . . . 74.23 111.09 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.555 HG22 HD12 ' B' ' 51' ' ' LEU . 39.3 mt -86.64 130.71 36.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 N-CA-C 109.381 -0.6 . . . . 74.2 109.381 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -131.37 146.19 52.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.23 0.538 . . . . 73.21 110.205 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -127.92 112.83 15.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.883 1.273 . . . . 72.21 108.354 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 5.1 tt -139.48 140.54 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.638 0.775 . . . . 73.43 110.476 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 173.52 16.87 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.745 0.418 . . . . 74.31 111.532 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.59 -69.59 1.03 Allowed Glycine 0 C--N 1.351 1.392 0 C-N-CA 124.023 0.82 . . . . 71.23 112.886 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.437 HD11 HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -74.51 169.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.627 0.771 . . . . 75.25 111.559 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.88 -171.93 2.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.178 0.591 . . . . 73.05 111.552 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.47 -105.81 1.62 Allowed Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.13 -0.941 . . . . 75.04 112.837 172.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -77.73 -33.07 53.09 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 75.03 110.828 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -75.74 -38.85 58.11 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.184 0.593 . . . . 71.02 111.321 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptm -67.91 -34.43 76.62 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 120.871 0.367 . . . . 74.45 110.323 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.13 80.23 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.825 0.85 . . . . 75.53 110.899 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -71.32 -30.22 65.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.041 -0.981 . . . . 74.22 110.93 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' B' ' 102' ' ' CYS . 45.7 t -65.62 -69.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.169 0.293 . . . . 72.13 110.935 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.86 -19.78 60.62 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 111.928 0.344 . . . . 74.33 111.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.95 -25.65 44.32 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.574 0.546 . . . . 64.22 114.033 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -47.16 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.165 0.802 . . . . 75.31 113.165 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.03 -49.14 20.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.067 0.547 . . . . 74.25 111.955 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 80.4 m -60.45 -46.97 97.48 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.964 0.905 . . . . 75.2 111.91 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.76 -30.9 49.65 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 121.229 1.286 . . . . 70.53 112.951 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.83 -27.7 68.44 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.747 0.703 . . . . 75.21 111.22 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.51 -43.61 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 71.11 110.192 171.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HB2' HD13 ' B' ' 60' ' ' LEU . 41.0 mt -84.76 -14.54 47.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.09 0.956 . . . . 75.44 111.784 -174.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.565 ' HZ ' HD13 ' B' ' 128' ' ' LEU . 33.7 t80 -60.19 -47.26 97.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.063 1.345 . . . . 75.23 113.192 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' D' ' 112' ' ' GLU . 18.6 Cg_endo -58.06 -35.97 98.34 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.06 1.84 . . . . 74.4 113.706 174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 65.4 m-85 -69.7 -46.14 66.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 75.51 110.802 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.693 0.797 . . . . 71.21 110.345 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.452 HH11 ' HA ' ' B' ' 108' ' ' PRO . 33.4 mtp180 -50.48 -54.94 18.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.43 1.092 . . . . 75.33 110.789 173.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.8 -33.85 76.53 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.982 -1.008 . . . . 70.11 110.681 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.631 ' SG ' HD12 ' B' ' 21' ' ' ILE . 5.6 t -72.88 -41.15 65.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.098 0.559 . . . . 64.14 111.259 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' B' ' 62' ' ' VAL . 52.7 mt -65.6 -48.14 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.869 . . . . 74.23 108.652 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -51.51 -35.97 42.63 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 124.536 1.148 . . . . 63.01 111.177 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.9 t -69.24 -55.03 11.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.626 0.77 . . . . 62.21 110.826 175.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.474 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 18.0 mmt -65.67 -33.37 75.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.016 0.526 . . . . 72.32 111.901 -172.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.53 -41.42 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.055 0.942 . . . . 75.41 110.374 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.481 ' HB3' HE22 ' C' ' 125' ' ' GLN . 90.0 p -70.1 -26.05 63.79 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.27 0.557 . . . . 73.51 112.149 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.601 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 80.1 mtt-85 -68.6 -34.01 75.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.365 -0.834 . . . . 70.44 110.441 175.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.6 13.09 54.11 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.847 0.717 . . . . 72.43 112.738 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.25 42.21 12.32 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.554 1.942 . . . . 71.22 112.497 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.591 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 71.3 m-85 -120.32 172.78 4.27 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 114.167 -1.378 . . . . 75.1 109.333 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 85.3 Cg_endo -73.08 -167.55 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.965 2.444 . . . . 74.41 116.107 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -66.89 155.58 38.02 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.758 -1.564 . . . . 73.3 111.054 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' B' ' 42' ' ' LEU . 3.4 tm? -135.23 84.91 2.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.974 -2.232 . . . . 74.32 104.974 163.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -123.58 95.4 4.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.287 -1.375 . . . . 74.25 107.287 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.666 HD21 HD21 ' B' ' 42' ' ' LEU . 2.7 tm? -64.29 145.38 56.11 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.17 -0.923 . . . . 73.52 109.863 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.46 110.6 2.12 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 124.633 1.208 . . . . 74.22 110.426 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.643 ' HB2' HD12 ' D' ' 16' ' ' ILE . 10.3 Cg_exo -65.61 132.67 31.64 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.152 1.901 . . . . 73.24 110.319 -173.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.63 137.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.061 -0.348 . . . . 75.43 110.061 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -87.07 117.73 25.99 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.801 0.841 . . . . 71.21 109.015 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 47.3 t80 . . . . . 0 N--CA 1.485 1.292 0 C-N-CA 124.531 1.132 . . . . 73.21 113.1 -174.138 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.743 -0.466 . . . . 71.42 109.743 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.506 ' CE1' ' SG ' ' C' ' 102' ' ' CYS . 0.5 OUTLIER -120.91 163.53 18.08 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 116.04 -0.527 . . . . 73.42 109.79 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -136.12 129.76 32.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.005 -0.998 . . . . 74.53 108.993 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 127' ' ' ASN . 17.7 tt -66.19 137.79 24.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.253 1.021 . . . . 72.24 110.178 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.524 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 92.0 mm-40 -111.79 -45.45 3.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.202 -0.454 . . . . 64.15 110.101 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -174.98 142.02 0.62 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.604 0.565 . . . . 75.22 110.974 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.22 138.21 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.771 -1.196 . . . . 74.51 107.771 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.413 ' HE2' ' HB2' ' D' ' 28' ' ' ALA . 30.6 p90 -171.46 161.51 6.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.318 0.58 . . . . 71.34 110.95 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -86.36 105.0 16.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.03 -0.986 . . . . 74.32 109.01 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -67.46 -46.64 72.43 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.754 0.787 . . . . 74.32 109.426 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.4 t70 -136.12 145.25 45.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.224 -1.353 . . . . 53.11 109.441 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.7 mt -140.3 144.31 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.292 -1.373 . . . . 73.02 107.292 175.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.4 t -152.71 145.73 24.54 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.337 0.589 . . . . 72.01 110.198 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -149.15 120.79 8.03 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.373 -1.343 . . . . 71.14 107.373 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -126.01 124.11 39.98 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.482 -0.932 . . . . 71.55 108.482 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.39 89.72 10.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.172 -1.047 . . . . 72.33 108.172 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.88 -31.41 93.75 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.473 2.782 . . . . 62.43 112.926 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 87.2 m-20 -119.04 36.03 4.61 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 114.53 -1.214 . . . . 73.45 109.668 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.79 -48.6 77.0 Favored Pre-proline 0 CA--C 1.572 1.82 0 N-CA-C 114.213 1.19 . . . . 75.15 114.213 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.37 -29.54 1.46 Allowed 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.782 1.655 . . . . 53.35 113.069 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.444 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 41.3 t60 -69.59 -31.36 69.47 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.803 1.241 . . . . 72.22 112.328 -171.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.573 HG21 HD11 ' C' ' 68' ' ' LEU . 12.8 p -79.66 -19.3 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.836 1.254 . . . . 74.13 112.074 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.34 -39.24 69.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.01 0.924 . . . . 75.12 112.518 -171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -113.41 45.95 1.33 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.941 0.877 . . . . 72.21 109.389 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.418 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.9 OUTLIER -121.6 167.71 12.58 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.298 -0.631 . . . . 73.05 109.298 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.15 116.97 4.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.911 -0.774 . . . . 74.2 108.911 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -84.8 68.9 10.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.788 0.68 . . . . 74.05 111.428 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -140.59 79.33 20.11 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.508 0.723 . . . . 74.1 109.512 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.45 135.81 12.07 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.437 2.091 . . . . 73.43 109.963 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.56 118.74 24.01 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.003 -1.11 . . . . 64.14 108.003 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.617 HG13 HD22 ' C' ' 128' ' ' LEU . 24.7 t -65.46 95.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.095 1.497 . . . . 72.1 108.822 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 0.5 OUTLIER -110.95 116.13 30.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.241 -1.022 . . . . 74.02 108.241 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.62 137.54 54.87 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.107 -1.071 . . . . 75.54 108.107 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -147.81 145.44 28.75 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.328 0.651 . . . . 73.11 109.398 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.7 tp -113.6 132.56 55.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 64.32 110.275 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.685 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 4.3 m-20 -114.65 134.77 54.81 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 106.869 -1.53 . . . . 73.23 106.869 171.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -114.2 132.12 56.22 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.943 0.402 . . . . 73.34 110.391 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.06 147.15 45.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.984 0.914 . . . . 64.14 108.982 173.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -139.6 144.01 37.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.473 0.709 . . . . 74.11 109.805 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -146.23 134.26 21.48 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.832 0.853 . . . . 74.11 109.407 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -74.94 147.5 40.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.468 -0.938 . . . . 74.4 108.468 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.48 HD13 HD13 ' C' ' 83' ' ' ILE . 86.5 mt -118.25 -37.57 3.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.849 0.86 . . . . 74.43 110.401 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.39 -168.8 1.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.155 0.582 . . . . 73.13 110.858 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.47 116.26 5.41 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.197 -0.91 . . . . 73.41 109.419 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 62.09 18.11 9.71 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 124.549 1.14 . . . . 71.11 112.324 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' C' ' 51' ' ' LEU . 67.8 t -120.86 107.47 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.567 0.747 . . . . 71.23 109.299 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.89 161.53 14.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.847 0.832 . . . . 73.13 110.757 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.82 126.1 41.03 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.412 -1.722 . . . . 74.33 107.673 169.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 123.38 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.332 -0.618 . . . . 74.24 109.332 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.67 111.44 34.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.36 1.064 . . . . 73.52 108.668 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.99 100.01 12.3 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.055 -0.72 . . . . 74.02 109.055 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 41.2 ttm180 -82.33 100.09 9.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.85 -1.537 . . . . 74.14 106.85 171.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.5 t -103.16 113.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.495 -1.298 . . . . 71.43 107.495 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.8 m -118.71 131.52 56.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.883 -0.598 . . . . 72.43 110.106 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.576 HG21 HG21 ' C' ' 114' ' ' ILE . 55.2 t -114.89 131.39 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.668 1.187 . . . . 72.23 110.242 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 9.4 m -110.22 146.58 35.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 164.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 110.74 8.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.677 -1.231 . . . . 74.33 107.677 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -135.19 133.34 38.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.364 0.602 . . . . 74.02 111.449 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.573 HD11 HG21 ' C' ' 31' ' ' VAL . 4.0 mt -85.5 14.58 5.37 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 125.195 1.398 . . . . 75.41 110.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.75 -96.28 0.48 Allowed Glycine 0 C--N 1.35 1.357 0 N-CA-C 110.505 -1.038 . . . . 74.15 110.505 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.32 -25.77 15.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.23 1.012 . . . . 73.11 109.55 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.418 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.4 tp10 -87.71 116.94 26.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.211 1.004 . . . . 75.43 108.523 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -86.31 129.36 34.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.477 0.581 . . . . 73.21 110.256 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.66 -52.78 9.01 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.76 0.824 . . . . 74.12 109.843 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -163.39 175.13 11.11 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.553 0.692 . . . . 75.15 111.391 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.47 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -133.1 146.77 51.94 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.503 -1.666 . . . . 74.32 106.503 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.472 ' SG ' HG22 ' C' ' 114' ' ' ILE . 46.5 t -150.99 150.82 31.23 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.312 -0.625 . . . . 75.02 109.312 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.27 140.45 10.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.952 0.501 . . . . 62.4 109.929 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -135.35 134.05 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.344 -0.984 . . . . 73.41 108.344 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -109.63 92.68 4.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.088 -0.708 . . . . 75.04 109.088 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -81.21 107.32 13.9 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.556 -1.202 . . . . 74.13 109.934 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.63 145.35 18.3 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.449 -0.661 . . . . 70.52 111.449 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.22 117.24 0.98 Allowed Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.069 -0.812 . . . . 71.35 111.069 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 6.7 mm -86.53 126.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 N-CA-C 108.843 -0.799 . . . . 74.25 108.843 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -136.68 122.6 20.1 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.442 -0.947 . . . . 75.34 108.442 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -76.74 96.58 4.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.753 -0.832 . . . . 71.35 108.753 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.493 HD11 ' HE2' ' C' ' 94' ' ' MET . 2.7 pp -96.45 136.02 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.327 1.051 . . . . 73.41 111.131 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.42 -169.35 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.64 0.776 . . . . 74.31 110.018 172.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.39 -60.11 0.69 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.93 -0.468 . . . . 72.21 111.93 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.554 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.337 1.055 . . . . 64.22 112.356 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 108.413 -0.958 . . . . 71.24 108.413 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' C' ' 98' ' ' LEU . 34.7 tpp -71.14 -44.81 64.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.175 -0.92 . . . . 73.13 110.064 169.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.16 -29.19 70.18 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.223 0.609 . . . . 73.03 112.21 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -83.01 -45.29 14.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.29 0.636 . . . . 74.33 110.309 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -66.55 -60.4 2.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.487 -0.779 . . . . 74.55 110.18 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.541 ' HB2' ' SD ' ' C' ' 94' ' ' MET . 14.6 tp -64.84 -21.42 66.79 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.605 1.162 . . . . 74.12 111.329 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.87 -29.54 38.21 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.99 -0.55 . . . . 75.42 114.379 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.6 -42.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.765 0.782 . . . . 73.24 112.767 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.645 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 63.9 t80 -71.21 -49.39 43.95 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.177 0.591 . . . . 73.4 112.13 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.521 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 22.0 m -61.96 -47.97 89.84 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 123.053 0.541 . . . . 73.11 110.782 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 79.6 Cg_exo -56.11 -37.25 96.7 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 122.1 1.867 . . . . 72.13 114.429 169.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.47 -27.79 69.22 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.841 0.456 . . . . 72.44 111.254 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.442 HG22 ' NH1' ' A' ' 111' ' ' ARG . 43.6 mm -65.39 -46.55 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.722 -0.672 . . . . 75.22 109.831 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.465 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.6 mt -79.89 -24.18 41.35 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.088 -0.96 . . . . 73.42 112.351 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.57 -50.57 86.15 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-O 117.592 -1.195 . . . . 74.15 113.608 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.65 -32.6 93.43 Favored 'Trans proline' 0 C--N 1.384 2.422 0 CA-C-N 121.589 1.603 . . . . 73.31 112.96 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -65.54 -47.63 75.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.12 0.568 . . . . 75.51 110.519 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.67 96.58 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.895 0.878 . . . . 74.43 111.166 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -62.89 -52.64 62.29 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.464 1.506 . . . . 74.0 110.123 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -68.98 -27.49 65.76 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.673 0.608 . . . . 72.11 110.441 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -64.42 -51.18 64.48 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.941 -0.392 . . . . 74.42 109.941 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.576 HG21 HG21 ' C' ' 64' ' ' VAL . 63.5 mt -61.54 -49.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 123.431 0.457 . . . . 75.34 110.104 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -43.81 -45.07 7.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.121 1.369 . . . . 75.34 111.493 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -68.14 -51.69 43.19 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 113.561 -1.654 . . . . 53.42 110.703 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.573 ' HE1' HD12 ' D' ' 21' ' ' ILE . 13.8 mmm -57.49 -40.35 78.44 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.951 0.9 . . . . 72.52 112.245 -173.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' C' ' 126' ' ' LEU . 98.9 t -64.78 -44.73 96.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.128 -0.942 . . . . 71.22 110.782 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.3 t -66.16 -26.56 67.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.059 -0.973 . . . . 73.35 111.021 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.1 mtt-85 -68.41 -32.74 72.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.769 0.828 . . . . 71.04 110.541 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 9.75 67.49 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 115.856 -0.611 . . . . 53.33 113.014 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.446 HG22 ' HB3' ' D' ' 17' ' ' TYR . 6.3 p 61.93 24.31 14.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.449 1.9 . . . . 73.44 113.122 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.89 158.7 32.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 109.208 -0.664 . . . . 75.35 109.208 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.75 115.98 2.9 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.331 2.021 . . . . 72.54 110.556 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.481 HE22 ' HB3' ' B' ' 119' ' ' SER . 3.4 pt20 -45.91 147.29 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.705 1.253 . . . . 70.35 112.591 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -98.32 76.23 2.3 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.513 -0.921 . . . . 72.44 108.513 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -110.52 89.43 3.03 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.701 -1.222 . . . . 71.14 107.701 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.617 HD22 HG13 ' C' ' 40' ' ' VAL . 30.4 mt -84.68 151.94 24.11 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.656 0.741 . . . . 72.32 110.248 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.59 156.02 46.26 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 112.858 -1.974 . . . . 63.21 113.071 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.838 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 38.3 Cg_endo -60.52 125.1 16.5 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 124.138 3.225 . . . . 75.44 113.956 -173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.03 111.69 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.304 0.642 . . . . 64.32 110.364 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -115.73 108.43 16.35 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.501 1.121 . . . . 72.21 109.162 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 123.784 0.834 . . . . 74.11 112.488 179.674 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.236 0.354 0 N-CA-C 108.143 -1.058 . . . . 72.43 108.143 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.406 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 48.3 t80 -157.9 99.08 1.67 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.698 -1.223 . . . . 73.2 107.698 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.46 157.58 46.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.248 -1.019 . . . . 64.34 108.248 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.691 HG12 HD11 ' D' ' 16' ' ' ILE . 6.7 tp -98.18 140.5 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 123.197 0.599 . . . . 72.54 110.439 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -106.9 -33.04 7.65 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.579 0.752 . . . . 75.33 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -173.07 142.78 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 119.418 -0.325 . . . . 73.43 110.819 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.691 HD11 HG12 ' D' ' 13' ' ' ILE . 3.6 mp -121.11 130.12 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.291 -1.374 . . . . 74.44 107.291 171.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.446 ' HB3' HG22 ' C' ' 122' ' ' THR . 10.3 p90 -155.75 160.63 40.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.598 0.759 . . . . 72.53 110.679 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' THR . . . . . 0.423 HG22 HD11 ' D' ' 21' ' ' ILE . 60.9 p -86.43 118.31 25.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 71.31 109.567 172.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -86.88 -31.12 20.92 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.3 -0.409 . . . . 75.44 110.397 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.6 t70 -149.79 135.08 18.16 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.173 -0.921 . . . . 65.34 108.956 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.573 HD12 ' HE1' ' C' ' 117' ' ' MET . 84.3 mt -135.53 139.06 47.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.912 -1.144 . . . . 53.15 107.912 175.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -142.66 131.5 22.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.823 0.849 . . . . 71.23 108.755 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.8 t80 -134.4 117.52 16.41 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.162 -1.792 . . . . 74.42 106.162 167.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.4 122.95 32.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.311 0.644 . . . . 64.31 109.753 -170.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.05 88.81 18.11 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.595 -0.891 . . . . 71.15 108.595 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.67 -37.14 12.86 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.869 2.379 . . . . 72.32 113.243 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -112.4 35.03 3.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.935 -0.765 . . . . 73.54 108.935 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.413 ' HB2' ' HE2' ' C' ' 17' ' ' TYR . . . -44.83 -64.36 0.88 Allowed Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.973 1.471 . . . . 64.41 114.973 -163.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 83' ' ' ILE . 81.6 Cg_endo -78.15 -9.43 16.54 Favored 'Trans proline' 0 C--N 1.381 2.279 0 CA-C-N 122.3 1.857 . . . . 75.22 113.14 -176.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -84.45 -38.68 19.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 74.32 110.599 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.667 HG23 ' HA ' ' D' ' 73' ' ' ALA . 8.3 p -81.66 -12.29 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.979 0.418 . . . . 63.41 111.414 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.84 -7.57 53.86 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.257 0.465 . . . . 73.03 112.257 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.39 -20.8 59.93 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.513 0.725 . . . . 75.41 110.653 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.94 76.01 10.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.853 1.261 . . . . 71.05 110.083 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -84.96 67.89 10.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.152 0.977 . . . . 63.03 111.578 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -147.4 -179.43 6.84 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.634 1.174 . . . . 74.44 108.553 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -66.65 122.1 80.46 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.673 0.389 . . . . 70.55 111.444 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.474 ' HG3' HD22 ' D' ' 68' ' ' LEU . 7.7 Cg_exo -75.75 133.75 15.84 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.281 2.654 . . . . 72.25 111.631 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -88.66 132.39 34.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.704 -0.48 . . . . 73.31 109.704 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.89 140.07 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.785 0.834 . . . . 74.12 110.004 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.493 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 75.2 mmtt -116.0 112.92 22.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.49 1.116 . . . . 64.04 108.033 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.721 HD23 HD21 ' D' ' 128' ' ' LEU . 10.0 mp -95.79 119.79 34.92 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.478 -0.564 . . . . 73.05 109.478 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -113.17 141.75 46.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.236 -1.024 . . . . 74.13 108.236 173.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -118.61 130.96 56.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.473 0.709 . . . . 73.33 110.142 -171.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.6 t70 -139.23 146.14 40.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.079 0.952 . . . . 65.14 108.687 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 49.0 m -141.86 143.98 33.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.63 -0.878 . . . . 75.04 108.63 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.97 162.96 38.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.065 0.946 . . . . 64.24 108.806 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -151.87 155.65 38.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.492 0.317 . . . . 51.4 111.535 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.0 p -155.37 126.92 7.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.63 1.172 . . . . 63.41 109.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.51 123.55 24.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.622 0.769 . . . . 70.34 111.121 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' D' ' 57' ' ' GLU . 60.6 mt -90.63 -33.52 15.81 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.328 0.393 . . . . 74.23 110.588 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.17 -170.11 0.94 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.06 0.544 . . . . 74.24 111.82 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.22 121.99 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.825 0.85 . . . . 74.14 110.043 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 64.42 4.33 2.18 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.346 1.458 . . . . 74.44 112.212 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.04 124.82 67.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.93 0.892 . . . . 64.22 108.833 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.74 128.98 23.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.735 -1.209 . . . . 74.53 107.735 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' D' ' 51' ' ' LEU . 16.8 tt0 -92.54 129.99 38.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.171 -1.048 . . . . 70.23 108.171 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.77 124.85 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.179 -1.045 . . . . 75.31 108.179 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.597 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -100.53 142.14 16.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.373 0.669 . . . . 74.45 109.594 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.44 120.91 39.58 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.932 -1.136 . . . . 74.4 107.932 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.4 ttm-85 -104.25 101.02 10.75 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.629 -0.878 . . . . 74.51 108.629 174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -92.29 107.35 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.167 -1.049 . . . . 73.15 108.167 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 35.4 m -97.23 137.21 36.59 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.597 -0.728 . . . . 73.45 109.228 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 67.5 t -128.94 127.37 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.857 -1.164 . . . . 73.13 107.857 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 86.7 m -125.96 105.72 9.11 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.395 -0.965 . . . . 75.41 108.395 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.51 142.15 35.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.419 -0.809 . . . . 74.43 108.973 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.6 m -145.25 132.78 20.83 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.659 0.599 . . . . 64.44 111.229 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.474 HD22 ' HG3' ' D' ' 38' ' ' PRO . 13.8 mt -106.24 112.67 25.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.466 -1.243 . . . . 74.25 109.458 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.94 -113.57 4.61 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.263 -0.426 . . . . 71.25 112.085 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 3.99 18.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.169 0.587 . . . . 74.43 111.452 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -121.36 161.69 21.66 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.732 0.413 . . . . 73.31 110.124 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -78.12 125.11 28.87 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.206 0.603 . . . . 73.11 110.624 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -75.09 -64.14 1.12 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.822 0.849 . . . . 61.32 109.124 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -155.42 164.35 38.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.596 -0.729 . . . . 65.44 111.435 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.22 110.08 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.978 -1.489 . . . . 73.32 106.978 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.541 ' SG ' HG22 ' D' ' 114' ' ' ILE . 45.2 t -122.12 116.37 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.241 -0.651 . . . . 70.42 109.241 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -144.07 125.88 15.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.201 0.6 . . . . 73.25 109.82 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.75 116.22 42.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.742 0.817 . . . . 72.43 109.569 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.685 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.5 mt-30 -89.52 86.71 6.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.896 0.855 . . . . 74.32 109.232 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -80.25 100.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.056 -1.429 . . . . 74.23 109.56 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.79 144.36 17.13 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.922 -0.471 . . . . 73.01 111.922 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.16 139.28 9.12 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.711 -0.556 . . . . 75.43 111.711 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.81 127.71 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.161 -1.052 . . . . 75.11 108.161 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.17 153.33 41.7 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.844 0.857 . . . . 74.32 110.09 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -107.44 94.1 4.91 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.973 -1.121 . . . . 73.44 107.973 169.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tt -116.31 137.33 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.97 0.908 . . . . 72.54 110.079 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.17 155.76 11.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.051 0.94 . . . . 74.52 110.305 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.47 22.36 73.08 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 116.602 1.401 . . . . 75.31 116.602 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' D' ' 94' ' ' MET . 0.9 OUTLIER -121.16 152.22 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.281 0.632 . . . . 63.24 110.704 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -161.65 164.79 29.03 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 114.854 -1.066 . . . . 75.41 109.699 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.38 -129.2 36.86 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.443 -0.799 . . . . 74.13 113.362 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -70.96 -31.51 68.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.244 1.018 . . . . 73.32 111.635 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -70.73 -34.7 72.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 74.22 110.437 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.468 ' HG2' HD11 ' D' ' 89' ' ' ILE . 1.1 tmt? -74.57 -29.58 61.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.025 0.53 . . . . 73.31 110.22 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -38.89 91.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.285 0.634 . . . . 75.1 110.782 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.4 -29.07 41.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.247 -0.888 . . . . 75.33 111.313 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -78.6 -53.12 7.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.636 0.375 . . . . 65.12 111.027 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.566 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 52.8 tp -92.11 -48.28 6.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.109 0.564 . . . . 74.44 110.89 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.53 -14.13 82.3 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.403 0.44 . . . . 71.02 113.875 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.83 -55.88 1.06 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.877 0.471 . . . . 70.22 111.589 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -75.68 -37.03 59.9 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.908 0.707 . . . . 72.22 112.908 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 73.6 m -59.08 -52.9 71.47 Favored Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 118.851 -0.595 . . . . 73.4 111.441 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.65 -23.41 49.26 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.81 1.673 . . . . 73.51 113.221 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.59 -37.81 85.69 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.745 0.418 . . . . 74.44 110.785 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -61.31 -43.02 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.596 0.758 . . . . 75.21 110.177 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.91 -17.46 53.03 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.03 -0.986 . . . . 75.14 112.031 -172.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -66.77 -43.65 50.13 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.139 1.163 . . . . 74.12 114.139 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.51 -33.78 79.54 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 121.951 1.768 . . . . 61.2 112.932 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -88.62 -26.24 22.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.709 -1.132 . . . . 73.14 111.03 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.34 72.36 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.903 0.859 . . . . 72.51 109.102 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -61.41 -41.33 96.97 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 113.4 -1.727 . . . . 75.25 110.709 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 108' ' ' PRO . 9.6 tt0 -43.73 -54.64 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.779 1.232 . . . . 65.23 111.874 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.425 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 42.6 t -70.05 -48.31 58.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.604 -1.18 . . . . 63.43 111.083 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.541 HG22 ' SG ' ' D' ' 76' ' ' CYS . 45.5 mt -56.44 -58.73 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.812 0.845 . . . . 71.13 110.901 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -52.0 -42.87 63.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.8 1.24 . . . . 71.01 112.295 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.2 -41.55 66.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.193 -0.912 . . . . 71.51 110.923 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.529 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 57.8 mtm -68.46 -32.14 71.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.811 0.444 . . . . 75.22 111.424 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -61.84 -45.55 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 123.804 0.69 . . . . 74.23 109.896 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.4 -29.14 62.4 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.938 -0.574 . . . . 73.12 111.11 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -71.54 -33.05 68.82 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.697 0.799 . . . . 75.0 110.723 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.32 3.75 80.14 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.667 -0.697 . . . . 61.03 112.213 173.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 64.81 26.16 12.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.801 2.04 . . . . 74.11 112.933 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -91.94 161.9 32.28 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 114.556 -1.202 . . . . 71.21 108.818 167.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.64 126.97 17.01 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 122.287 1.991 . . . . 72.1 111.519 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.416 ' HB3' HG23 ' A' ' 122' ' ' THR . 51.5 tt0 -53.38 128.03 27.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.364 1.066 . . . . 74.11 111.827 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.7 tp -115.01 97.86 6.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.643 -0.708 . . . . 70.31 110.203 -166.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.487 ' OD1' ' HB ' ' B' ' 16' ' ' ILE . 46.6 m-80 -99.42 99.05 9.92 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.998 -0.742 . . . . 74.34 108.998 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.721 HD21 HD23 ' D' ' 42' ' ' LEU . 48.2 mt -66.85 120.99 14.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.039 0.936 . . . . 73.43 111.146 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.83 137.66 96.86 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.367 0.667 . . . . 74.5 111.978 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.411 ' HG2' ' HE2' ' B' ' 11' ' ' PHE . 3.2 Cg_exo -73.91 122.34 7.62 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.557 2.171 . . . . 74.43 110.446 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.86 120.52 59.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.25 0.62 . . . . 70.24 109.473 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 . . . . . 0 CA--C 1.542 0.64 0 CA-C-N 115.076 -0.965 . . . . 74.35 108.413 177.086 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.24 0.592 0 N-CA-C 109.488 -0.56 . . . . 75.23 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.403 ' HD1' HD11 ' A' ' 86' ' ' ILE . 67.2 t80 -129.05 140.01 51.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.742 -1.207 . . . . 71.5 107.742 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.564 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 27.3 tp60 -149.79 130.51 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.685 0.394 . . . . 74.13 110.162 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.79 112.83 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.549 -1.278 . . . . 73.33 107.549 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 85' ' ' SER . 8.0 mm-40 -87.88 -38.03 15.98 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.104 0.252 . . . . 70.34 110.94 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -171.95 124.32 0.53 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.954 0.502 . . . . 74.43 110.798 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 80.4 mt -108.6 135.78 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 74.3 108.767 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' HB3' HG21 ' B' ' 122' ' ' THR . 16.9 p90 -170.5 176.35 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.915 0.759 . . . . 74.52 111.489 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -98.78 128.95 45.16 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.114 -0.698 . . . . 72.15 109.114 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -92.5 -38.04 12.17 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.207 -0.664 . . . . 75.52 109.207 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.673 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -135.86 136.53 40.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.601 -1.181 . . . . 75.44 109.502 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.2 mt -135.97 139.52 45.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.949 -1.5 . . . . 63.21 106.949 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 t -149.28 122.78 9.11 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 123.474 0.484 . . . . 65.23 110.222 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.3 t80 -119.9 114.54 22.23 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.522 -1.658 . . . . 75.34 106.522 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.35 117.62 29.02 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.402 -0.592 . . . . 73.11 109.402 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.67 81.56 67.21 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 108.145 -1.057 . . . . 74.2 108.145 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.32 -35.03 42.15 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.563 2.175 . . . . 73.12 111.628 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.0 m-20 -104.98 31.54 4.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.26 -0.882 . . . . 74.43 109.62 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.41 99.66 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.299 1.039 . . . . 73.41 112.684 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.01 -26.24 11.08 Favored 'Trans proline' 0 C--N 1.38 2.23 0 CA-C-N 121.277 1.492 . . . . 63.4 113.721 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -70.7 -23.01 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.38 0.672 . . . . 74.43 112.357 -173.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.616 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.6 p -61.19 -20.39 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.15 0.58 . . . . 74.01 111.27 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.6 -39.57 91.69 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.246 1.018 . . . . 74.42 111.693 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.91 -28.27 17.38 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.679 0.392 . . . . 74.41 110.961 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.63 149.86 28.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.061 0.544 . . . . 71.34 111.204 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.5 147.36 41.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.443 0.697 . . . . 73.15 110.337 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.7 t-105 -93.81 76.96 4.23 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.605 0.717 . . . . 72.51 110.183 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -121.75 82.45 41.84 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 106.309 -1.737 . . . . 71.55 106.309 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.12 136.99 9.36 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.691 2.261 . . . . 52.41 113.082 -170.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.34 84.32 3.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.456 -1.683 . . . . 73.51 106.456 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.9 t -79.25 101.06 4.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 114.193 -1.367 . . . . 75.53 108.971 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -79.32 114.55 18.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.534 -0.913 . . . . 73.2 108.534 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.7 116.48 28.93 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.187 -1.412 . . . . 75.34 107.187 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.1 t70 -126.25 138.9 53.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.824 -0.806 . . . . 74.03 108.824 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.3 tp -130.38 120.03 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.995 -0.743 . . . . 72.44 108.995 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -135.65 157.15 47.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.676 0.79 . . . . 73.13 109.522 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -127.75 159.63 34.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.691 0.796 . . . . 74.31 109.662 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.39 136.06 21.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.694 1.198 . . . . 74.31 107.97 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.6 m -107.86 160.11 16.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 54.13 110.312 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -157.74 150.28 22.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.962 0.905 . . . . 65.15 109.385 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.01 140.25 47.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.239 -1.023 . . . . 75.51 108.239 170.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 83' ' ' ILE . 82.3 mt -115.59 -37.68 3.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.567 0.747 . . . . 74.45 110.569 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.15 -179.28 7.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.912 0.885 . . . . 74.2 110.318 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.28 114.52 3.22 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.633 -0.712 . . . . 65.33 109.262 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 69.15 0.99 3.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.893 1.277 . . . . 72.41 113.402 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -106.73 108.62 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.885 -1.154 . . . . 64.32 107.885 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 160.64 26.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.059 -0.719 . . . . 72.45 109.059 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.87 134.69 47.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.77 0.828 . . . . 74.15 108.948 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.5 t -118.13 122.23 69.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.321 -1.363 . . . . 64.31 107.321 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -98.69 134.74 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.727 0.811 . . . . 74.24 109.429 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.05 114.15 28.02 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.889 -1.152 . . . . 74.34 107.889 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.18 100.47 10.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.146 -0.687 . . . . 74.52 109.146 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 t -99.66 141.7 16.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.461 -0.94 . . . . 74.14 108.461 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 19.5 m -130.99 133.7 46.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.111 0.481 . . . . 65.41 110.533 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.5 t -130.62 109.48 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.341 1.457 . . . . 75.11 107.741 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.0 m -112.11 128.42 56.21 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.117 -0.697 . . . . 72.04 109.117 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.67 13.91 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.792 -0.818 . . . . 73.42 108.792 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 30.9 m -114.93 126.61 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.001 0.52 . . . . 74.22 110.051 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 HD21 ' CE3' ' A' ' 36' ' ' TRP . 25.7 mt -89.73 65.27 6.77 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.855 -1.165 . . . . 64.43 107.855 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 -101.8 1.23 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.101 -0.954 . . . . 75.03 110.999 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -88.36 -27.4 21.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.428 1.091 . . . . 75.32 110.126 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -98.05 94.79 7.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 74.43 110.08 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 92.6 m -67.41 125.58 26.58 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.839 0.745 . . . . 75.2 111.03 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.35 -56.85 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.83 0.852 . . . . 74.52 109.769 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -161.07 174.84 13.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.493 -1.23 . . . . 71.32 111.781 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -139.11 130.53 27.04 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.955 -1.498 . . . . 71.21 106.955 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.48 ' HB3' HG21 ' A' ' 114' ' ' ILE . 74.8 m -130.27 101.77 5.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.463 1.105 . . . . 64.44 109.761 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.44 121.56 29.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.836 -0.801 . . . . 74.21 108.836 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.4 t -129.49 129.62 66.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 123.458 0.703 . . . . 73.54 109.391 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.673 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.9 mt-30 -102.51 90.65 3.93 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.497 -0.774 . . . . 73.41 109.49 171.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.2 tp-100 -77.08 95.46 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.39 -1.277 . . . . 70.01 108.614 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.97 143.18 19.57 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 112.138 -0.385 . . . . 74.31 112.138 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.48 122.35 1.94 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 111.598 -0.601 . . . . 72.33 111.598 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 51' ' ' LEU . 43.9 mt -80.89 125.56 39.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.083 -1.08 . . . . 71.34 108.083 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -132.1 132.45 43.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.593 0.757 . . . . 74.23 110.582 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 33.4 t -80.24 122.79 27.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.451 -0.944 . . . . 72.54 108.451 166.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.403 HD11 ' HD1' ' A' ' 11' ' ' PHE . 5.8 tp -129.44 146.52 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.141 -0.688 . . . . 74.01 109.141 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.88 162.14 7.33 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.048 0.939 . . . . 74.12 110.978 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.61 88.35 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 115.688 1.035 . . . . 65.34 115.688 168.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 141.13 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.818 0.809 . . . . 73.24 109.864 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -146.25 170.31 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.874 0.47 . . . . 73.41 110.345 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 -115.8 4.99 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.18 0.925 . . . . 73.13 114.22 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.2 p -68.3 -34.16 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.363 1.065 . . . . 72.2 111.653 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -57.97 -44.38 87.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.956 0.902 . . . . 74.25 110.839 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.462 ' HE1' HD21 ' A' ' 98' ' ' LEU . 12.0 tpt -76.61 -40.68 48.69 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.869 -0.605 . . . . 73.55 111.022 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.44 71.89 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.322 0.582 . . . . 72.54 111.066 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -79.25 -41.82 27.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.104 0.962 . . . . 74.34 111.097 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 23.3 t -74.24 -63.6 1.19 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.772 0.429 . . . . 71.32 110.233 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.462 HD21 ' HE1' ' A' ' 94' ' ' MET . 50.6 tp -62.06 -33.34 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.928 0.891 . . . . 75.22 111.57 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.78 -10.46 63.04 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 115.239 0.855 . . . . 63.14 115.239 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.15 -55.47 0.32 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.971 0.886 . . . . 74.32 111.799 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.24 -60.07 2.9 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.53 0.567 . . . . 73.22 112.53 -168.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 30.5 m -55.88 -48.24 97.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.573 0.749 . . . . 71.43 112.865 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.459 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.2 Cg_endo -67.82 -28.95 35.89 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 120.702 1.287 . . . . 60.13 113.809 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.79 -19.9 51.08 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.295 0.952 . . . . 65.24 111.807 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.54 -38.57 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.216 1.007 . . . . 75.03 109.497 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' A' ' 82' ' ' GLY . 51.7 mt -75.94 -18.97 59.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.017 -1.447 . . . . 74.04 112.124 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.444 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 38.9 t80 -65.87 -40.53 39.55 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.462 1.282 . . . . 75.42 114.462 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.91 -39.65 83.8 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.154 1.903 . . . . 71.32 113.444 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -80.68 -33.84 35.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.389 -0.823 . . . . 75.42 111.546 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.85 81.5 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.02 -0.733 . . . . 72.23 109.02 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -52.15 -53.93 36.96 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.624 -1.171 . . . . 73.21 110.566 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.6 tm-20 -61.14 -41.19 96.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.044 0.84 . . . . 75.14 111.315 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.79 -47.63 84.28 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.892 -0.595 . . . . 71.42 110.714 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.48 HG21 ' HB3' ' A' ' 76' ' ' CYS . 97.8 mt -63.11 -47.71 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.133 0.973 . . . . 74.31 110.717 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.529 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.7 m -60.68 -41.88 95.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.523 1.129 . . . . 54.11 111.56 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.01 -43.39 78.95 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.684 -0.689 . . . . 75.1 110.602 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -55.65 -43.84 76.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.617 0.767 . . . . 72.42 111.453 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.41 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.938 0.895 . . . . 74.31 111.113 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -70.36 -26.97 63.97 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.292 -0.413 . . . . 44.33 111.294 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -73.93 -32.1 63.36 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.712 0.805 . . . . 71.05 109.952 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.51 -1.62 71.57 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.958 0.786 . . . . 72.24 112.875 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.8 m 67.81 40.28 2.44 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.87 1.319 . . . . 63.34 110.071 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.616 ' HE1' HG11 ' A' ' 31' ' ' VAL . 43.9 m-85 -116.72 152.31 48.27 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 114.524 -1.217 . . . . 74.35 109.579 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 135.69 60.96 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.114 2.543 . . . . 74.41 113.459 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.529 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.5 tt0 -58.74 139.5 56.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 74.34 112.304 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 tp -117.08 115.08 24.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.136 -0.69 . . . . 74.41 109.136 176.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -100.3 93.65 5.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.683 -0.858 . . . . 74.3 108.683 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.444 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -65.89 135.33 54.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.45 0.7 . . . . 75.32 109.9 -176.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.79 131.07 91.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 122.957 0.503 . . . . 74.01 111.897 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.39 110.77 2.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.596 2.197 . . . . 74.41 111.709 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.14 110.78 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.248 -1.019 . . . . 71.53 108.248 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -110.82 72.22 0.77 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.231 1.012 . . . . 74.22 112.749 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 73.02 110.732 169.068 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.244 0.788 0 N-CA-C 109.313 -0.625 . . . . 75.2 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.22 131.6 30.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.014 0.925 . . . . 75.11 108.9 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 24.4 tm0? -142.47 134.36 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.728 -1.212 . . . . 74.23 107.728 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -97.3 118.37 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 74.32 109.874 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.18 -53.56 4.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.692 0.282 . . . . 74.33 110.973 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 43.8 ttt180 -161.17 141.04 10.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.412 -0.358 . . . . 75.11 110.57 -169.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -115.8 143.64 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 107.96 -1.126 . . . . 74.45 107.96 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.425 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.9 p90 -168.9 158.22 8.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.356 0.598 . . . . 75.45 111.553 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -83.89 127.82 34.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.248 -0.887 . . . . 75.1 108.648 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -96.09 -41.2 8.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.165 0.586 . . . . 75.22 109.713 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.7 t70 -147.42 139.29 24.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.851 -0.613 . . . . 71.01 110.597 -168.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 mm -138.07 137.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.81 1.244 . . . . 74.2 108.811 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -138.8 125.09 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.05 -1.092 . . . . 72.21 108.05 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.6 t80 -137.59 108.05 6.52 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.17 -1.419 . . . . 72.23 107.17 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.81 117.83 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.438 -0.949 . . . . 75.4 108.438 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.543 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -112.82 87.89 10.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.796 0.838 . . . . 75.0 109.504 -176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 -38.24 10.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.075 2.517 . . . . 74.54 112.736 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 66.1 m-20 -111.74 29.07 8.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.445 0.698 . . . . 74.21 109.622 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.543 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -48.12 -54.58 23.66 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.787 1.235 . . . . 74.53 113.107 172.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 5.6 Cg_exo -76.22 -19.17 15.63 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.036 1.824 . . . . 74.53 111.754 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.426 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 80.7 m-70 -85.43 3.03 41.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.312 1.045 . . . . 71.15 111.408 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.45 -14.94 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 CA-C-O 121.419 0.628 . . . . 71.43 109.736 163.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -70.58 -28.77 65.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.754 0.821 . . . . 72.21 109.832 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.62 -39.7 18.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.314 0.646 . . . . 74.53 109.609 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.479 ' HZ2' ' HA3' ' B' ' 69' ' ' GLY . 27.3 mmtp -102.51 75.23 1.44 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.292 1.037 . . . . 72.13 109.955 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.49 76.44 5.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.824 0.849 . . . . 73.43 110.648 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -163.7 160.32 22.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.762 0.825 . . . . 75.1 109.403 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -69.84 118.61 64.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.208 1.003 . . . . 74.22 109.518 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.76 152.0 82.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.176 1.918 . . . . 63.14 113.026 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.24 119.06 13.87 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.473 -0.785 . . . . 74.23 109.033 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 t -85.01 119.66 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.466 -1.309 . . . . 73.21 107.466 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -134.73 138.59 44.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.643 ' HG ' ' HG ' ' B' ' 128' ' ' LEU . 0.0 OUTLIER -128.57 166.42 18.87 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.783 0.833 . . . . 75.43 111.542 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 121.24 1.55 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.423 -0.954 . . . . 71.12 108.423 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.1 163.74 21.81 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.361 0.6 . . . . 73.21 110.724 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -161.06 135.89 7.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.477 1.111 . . . . 75.41 108.447 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -108.65 119.68 40.24 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.843 0.354 . . . . 75.04 110.376 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.48 159.26 22.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.141 0.976 . . . . 73.01 108.711 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.498 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 73.9 m -144.39 162.69 35.84 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.178 -0.326 . . . . 71.22 111.464 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.1 t -157.12 137.9 13.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.078 0.951 . . . . 71.4 109.62 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -105.51 131.07 53.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.338 -0.616 . . . . 72.43 109.338 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.555 HD12 HG22 ' B' ' 83' ' ' ILE . 39.3 mt -98.36 -41.75 7.68 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.455 0.645 . . . . 73.44 109.472 175.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.84 10.87 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.596 -1.184 . . . . 63.53 109.358 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -76.57 134.17 39.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 72.34 108.414 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.3 -3.63 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.934 1.294 . . . . 62.45 111.811 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.54 95.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.298 1.039 . . . . 71.35 108.354 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.498 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 8.4 t80 -113.83 139.54 49.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.012 0.434 . . . . 72.32 110.623 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -121.85 108.4 13.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.873 0.869 . . . . 75.14 109.488 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.1 132.86 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.033 0.533 . . . . 71.22 110.093 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 40.8 t -104.14 116.94 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.308 0.643 . . . . 74.54 109.838 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 0.1 OUTLIER -94.1 115.77 28.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.876 -0.787 . . . . 73.34 108.876 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -102.16 123.75 46.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.955 0.407 . . . . 74.11 110.419 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 75.0 t -117.07 108.3 24.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.686 -1.227 . . . . 75.1 107.686 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.5 m -97.84 146.54 25.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.326 -0.62 . . . . 74.21 109.326 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 72.5 t -132.58 136.34 56.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 124.464 1.106 . . . . 73.1 109.578 -171.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.39 149.5 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.426 1.09 . . . . 53.32 109.012 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.46 161.76 37.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.214 0.606 . . . . 72.41 110.359 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.4 p -148.48 147.42 29.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.595 0.591 . . . . 72.22 112.595 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 44.5 mt -124.19 107.06 10.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.689 -1.597 . . . . 75.34 106.689 172.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.479 ' HA3' ' HZ2' ' B' ' 34' ' ' LYS . . . 73.42 -111.39 3.46 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.285 -0.731 . . . . 71.45 111.347 -171.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.18 3.24 12.66 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.901 0.85 . . . . 74.33 111.665 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.419 ' CD ' ' HZ3' ' B' ' 34' ' ' LYS . 12.8 pm0 -114.25 167.19 10.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.708 0.403 . . . . 74.44 110.402 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -64.88 144.03 57.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.324 0.65 . . . . 65.13 110.467 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.69 -58.77 1.83 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.374 -0.973 . . . . 71.44 108.374 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -150.92 166.38 30.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 113.833 -1.53 . . . . 75.12 109.276 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -134.91 140.37 45.7 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.428 -1.323 . . . . 72.22 107.428 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.483 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.1 t -140.82 159.96 41.08 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.575 0.75 . . . . 75.44 109.146 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.33 137.45 4.21 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.942 0.897 . . . . 72.01 108.601 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.64 141.03 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.45 0.7 . . . . 73.03 109.179 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -124.63 91.61 3.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 72.5 108.992 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -89.15 102.17 14.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.875 -1.057 . . . . 73.51 108.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.477 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.57 142.82 16.36 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.775 -0.53 . . . . 51.24 111.775 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.74 128.43 4.44 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.407 -0.677 . . . . 54.04 111.407 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.555 HG22 HD12 ' B' ' 51' ' ' LEU . 44.7 mt -83.29 126.89 40.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.72 -0.844 . . . . 74.53 108.72 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -135.18 135.48 41.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.249 0.619 . . . . 74.55 109.623 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.585 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 20.2 m -87.43 100.46 12.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.033 -1.099 . . . . 61.2 108.033 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.6 122.34 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.709 0.804 . . . . 74.12 109.63 -170.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.22 172.33 18.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.13 0.972 . . . . 62.33 111.097 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -28.12 6.65 Favored Glycine 0 C--N 1.357 1.708 0 CA-C-N 116.046 -0.525 . . . . 75.01 112.832 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.93 157.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.039 1.336 . . . . 74.33 113.451 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -161.32 143.15 11.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.535 -0.757 . . . . 72.32 109.866 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.49 -93.42 0.03 OUTLIER Glycine 0 C--N 1.362 1.979 0 O-C-N 124.324 1.015 . . . . 62.2 113.912 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.2 m -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.369 1.068 . . . . 73.53 110.604 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -67.55 -29.17 68.49 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.443 0.697 . . . . 71.23 111.505 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 52.8 tpp -67.02 -50.08 63.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.745 0.418 . . . . 73.42 110.495 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.31 -30.47 64.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.6 0.76 . . . . 74.35 111.834 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.69 -55.17 5.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.72 0.408 . . . . 73.33 110.024 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.475 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 42.8 t -69.35 -66.73 0.55 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.647 0.592 . . . . 75.42 110.819 -172.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.3 -26.74 62.98 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.751 0.421 . . . . 71.24 110.277 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.01 -39.06 13.65 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 114.976 0.751 . . . . 72.12 114.976 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.62 -46.88 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.718 0.759 . . . . 72.05 112.059 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.475 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 88.2 t80 -64.61 -54.35 33.32 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.554 0.741 . . . . 71.02 112.607 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.3 m -61.6 -46.82 93.87 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.476 0.71 . . . . 72.52 111.424 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.2 Cg_exo -58.04 -36.98 97.61 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 121.843 1.696 . . . . 74.44 113.873 167.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -72.16 -21.18 61.48 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 122.872 0.469 . . . . 75.43 111.463 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.447 HG22 ' NH2' ' D' ' 111' ' ' ARG . 56.9 mt -64.2 -45.0 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.641 0.776 . . . . 74.42 109.901 167.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 28.2 mt -84.4 -11.02 57.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.319 -1.31 . . . . 75.3 111.37 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.481 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 63.4 t80 -63.26 -45.49 85.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.023 1.329 . . . . 74.45 113.934 -172.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.27 -36.05 81.64 Favored 'Trans proline' 0 C--N 1.374 1.878 0 CA-C-N 121.226 1.473 . . . . 64.35 112.657 173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.425 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.2 m-85 -65.6 -40.5 92.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.969 0.508 . . . . 74.13 110.764 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -47.94 72.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.847 0.459 . . . . 72.52 110.266 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -51.35 -49.21 61.89 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.67 1.188 . . . . 73.12 111.369 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -38.97 79.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.632 -1.167 . . . . 74.42 109.898 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.497 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -71.28 -34.18 70.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.91 -0.586 . . . . 74.01 111.33 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.459 HG22 HG22 ' B' ' 64' ' ' VAL . 73.2 mt -67.54 -52.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.854 0.462 . . . . 75.34 109.766 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -53.36 -33.11 52.35 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 123.941 0.775 . . . . 74.54 111.401 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.0 t -65.8 -62.74 1.33 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.308 0.643 . . . . 71.14 110.648 172.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.527 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.8 mmt -61.25 -33.3 73.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.346 0.658 . . . . 65.31 112.449 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -76.96 -39.85 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.604 0.762 . . . . 74.44 110.693 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.473 ' HB3' HE22 ' C' ' 125' ' ' GLN . 91.3 p -66.39 -28.94 69.03 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.474 0.654 . . . . 53.51 111.15 176.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.527 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 84.2 mtt-85 -61.86 -31.78 72.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.523 -0.762 . . . . 74.24 110.205 174.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.58 12.85 58.04 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 119.425 -0.653 . . . . 73.5 114.145 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.612 HG21 ' HB3' ' A' ' 17' ' ' TYR . 15.0 p 61.63 21.27 11.99 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.01 1.724 . . . . 64.33 111.965 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -105.08 159.66 28.63 Favored Pre-proline 0 CA--C 1.567 1.624 0 C-N-CA 123.801 0.84 . . . . 73.51 110.738 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.71 156.85 64.38 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 123.814 3.009 . . . . 63.51 115.541 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.571 ' HB3' ' HB3' ' C' ' 125' ' ' GLN . 5.1 pm0 -63.06 156.81 23.75 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.741 0.816 . . . . 73.25 112.709 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.8 96.8 6.49 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.334 -0.987 . . . . 75.15 108.334 163.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -89.08 93.55 9.63 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.196 -2.15 . . . . 73.3 105.196 165.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.643 ' HG ' ' HG ' ' B' ' 42' ' ' LEU . 1.8 tt -81.44 135.79 35.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.101 -0.703 . . . . 73.44 109.101 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 132.86 89.1 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 124.067 0.855 . . . . 74.43 111.512 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.99 81.19 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.498 2.132 . . . . 75.2 111.471 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -78.21 75.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.279 -0.873 . . . . 74.35 110.34 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.11 84.84 1.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.482 -0.781 . . . . 73.14 109.013 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 CA--C 1.546 0.808 0 CA-C-N 115.478 -0.783 . . . . 63.42 111.063 -175.229 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 108.843 -0.799 . . . . 74.2 108.843 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -124.64 135.42 53.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.408 1.083 . . . . 70.53 108.352 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.573 ' HB3' ' HB3' ' C' ' 85' ' ' SER . 46.2 tt0 -146.35 105.28 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.09 0.556 . . . . 75.45 110.243 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.613 HD13 HD11 ' C' ' 16' ' ' ILE . 14.5 tt -72.14 129.91 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.43 0.692 . . . . 74.43 109.623 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.406 ' NE2' HE21 ' C' ' 12' ' ' GLN . 22.9 mm-40 -115.9 -49.16 2.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.919 0.487 . . . . 72.1 111.878 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -162.13 133.18 5.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.493 -0.558 . . . . 73.32 109.493 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.613 HD11 HD13 ' C' ' 13' ' ' ILE . 64.0 mt -123.14 138.35 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.583 -0.895 . . . . 74.41 108.583 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.461 ' HH ' HD11 ' C' ' 83' ' ' ILE . 26.3 p90 -174.73 162.75 3.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.806 0.336 . . . . 74.43 111.612 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -81.52 125.76 30.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.483 0.713 . . . . 74.55 110.064 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -75.57 -49.1 19.62 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.184 -1.043 . . . . 73.15 108.184 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.0 t70 -136.81 147.15 46.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.24 -1.345 . . . . 74.2 110.428 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.5 mt -143.44 145.47 22.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 126.19 1.796 . . . . 74.03 106.622 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -161.03 149.25 15.9 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.256 0.551 . . . . 74.14 110.465 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -149.41 118.25 6.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.327 -1.36 . . . . 73.03 107.327 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.19 122.61 44.52 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.06 -0.719 . . . . 72.0 109.06 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.44 80.86 46.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.054 -1.091 . . . . 75.13 108.054 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.6 -26.43 16.5 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.207 1.938 . . . . 74.2 110.525 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.22 16.16 6.6 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.587 1.155 . . . . 74.02 110.759 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.11 99.99 Favored Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 113.649 0.981 . . . . 65.03 113.649 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.44 -26.5 3.99 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 121.79 1.66 . . . . 73.45 112.699 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -70.18 -33.47 71.78 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.383 1.073 . . . . 75.44 111.841 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 p -79.69 -18.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.447 1.099 . . . . 72.12 111.401 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.85 -28.44 66.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.293 1.037 . . . . 74.21 112.154 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -127.79 44.43 2.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 54.23 109.86 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -121.26 159.75 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.665 0.786 . . . . 73.54 110.389 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.16 120.32 11.25 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.709 0.63 . . . . 75.25 110.236 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -85.28 97.43 9.94 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.072 0.939 . . . . 75.24 109.905 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -140.56 62.57 19.05 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.417 -0.957 . . . . 74.55 108.417 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.47 97.98 0.64 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.858 1.705 . . . . 64.44 112.282 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.89 77.6 9.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.57 -1.65 . . . . 75.4 107.494 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.574 ' HB ' HD13 ' C' ' 126' ' ' LEU . 19.6 m -89.84 110.73 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 113.687 -1.597 . . . . 72.11 110.36 -170.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -133.09 147.07 52.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 74.31 110.948 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.515 ' HG ' HD11 ' C' ' 128' ' ' LEU . 1.5 pp -105.38 165.73 10.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.356 0.598 . . . . 71.41 112.103 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -140.91 130.78 24.4 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.262 1.425 . . . . 71.44 107.531 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.95 118.43 36.95 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.247 0.619 . . . . 75.33 110.265 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 35.7 t70 -115.14 155.97 26.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.304 -0.999 . . . . 64.44 108.304 166.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -134.49 140.72 46.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.438 0.695 . . . . 75.02 110.29 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.3 38.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.29 1.036 . . . . 74.25 109.253 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -155.3 148.88 25.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.49 0.716 . . . . 74.35 109.274 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 38.3 t -144.86 128.29 16.93 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.635 0.774 . . . . 75.33 109.153 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -82.75 117.11 22.43 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.992 -0.744 . . . . 74.51 108.992 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' C' ' 57' ' ' GLU . 79.6 mt -92.48 -32.61 14.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.464 0.706 . . . . 72.23 110.368 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.34 -179.82 8.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.134 -0.939 . . . . 74.12 109.229 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.17 127.29 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 71.25 108.996 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.97 18.29 10.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.477 1.111 . . . . 74.01 112.461 -174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.28 115.16 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.568 -0.901 . . . . 73.15 108.568 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -116.16 169.57 9.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.055 0.931 . . . . 75.3 110.844 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD12 ' C' ' 51' ' ' LEU . 33.9 tt0 -127.45 133.24 49.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.924 -1.944 . . . . 73.22 107.99 173.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.42 127.89 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.101 -1.444 . . . . 73.12 107.101 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.52 HG23 ' HA2' ' C' ' 81' ' ' GLY . 61.7 t -126.46 114.23 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.234 -0.654 . . . . 74.2 109.234 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' C' ' 103' ' ' PRO . 18.6 mt -86.6 130.53 34.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.585 -0.524 . . . . 74.23 109.585 172.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.605 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 49.1 mtp180 -101.45 104.27 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.197 -1.038 . . . . 74.34 108.197 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.59 110.42 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.475 -1.305 . . . . 74.54 107.475 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -110.85 145.65 37.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.842 -0.799 . . . . 74.03 108.842 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.753 HG11 ' HG ' ' C' ' 126' ' ' LEU . 53.3 t -128.58 135.26 62.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.899 0.88 . . . . 74.22 109.224 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -117.92 138.11 52.37 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.989 -1.115 . . . . 73.52 107.989 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.99 132.79 55.13 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.269 -1.012 . . . . 71.34 108.269 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -132.96 164.21 27.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.833 0.708 . . . . 72.1 109.262 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 mt -124.04 29.08 6.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 106.926 -1.509 . . . . 74.33 106.926 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.82 -100.76 1.73 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.082 -0.963 . . . . 74.54 110.85 -169.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -89.67 -32.51 17.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.392 0.677 . . . . 71.24 110.107 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.65 120.84 32.05 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.616 0.766 . . . . 73.43 109.454 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -67.65 140.47 56.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.89 0.476 . . . . 74.34 111.026 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.43 -51.41 4.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.803 0.441 . . . . 64.21 109.931 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -168.5 177.27 5.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.944 0.898 . . . . 75.25 111.299 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.462 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -137.04 147.34 46.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.086 1.354 . . . . 73.14 107.391 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.462 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.0 t -148.99 153.48 37.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.349 0.66 . . . . 74.25 109.395 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -158.82 140.96 13.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.458 0.703 . . . . 71.25 109.905 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.98 119.26 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.714 0.806 . . . . 74.52 109.531 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.605 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 47.8 mt-30 -91.14 98.4 11.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.052 0.941 . . . . 64.33 109.623 172.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.447 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.2 tp-100 -88.78 107.82 19.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.617 0.767 . . . . 74.32 110.615 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.52 ' HA2' HG23 ' C' ' 59' ' ' VAL . . . -84.07 158.72 35.02 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.77 0.669 . . . . 75.4 113.041 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.64 117.29 0.77 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.481 -0.648 . . . . 73.31 111.481 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.461 HD11 ' HH ' ' C' ' 17' ' ' TYR . 15.0 mm -81.81 122.47 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.34 -0.615 . . . . 75.21 109.34 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -135.71 119.23 16.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.682 0.793 . . . . 75.23 109.149 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' C' ' 12' ' ' GLN . 41.1 t -77.08 128.0 33.68 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.765 -0.828 . . . . 72.14 108.765 170.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.47 HD12 HD13 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -145.99 126.9 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.501 0.72 . . . . 75.14 110.433 -166.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.85 176.19 11.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.591 1.157 . . . . 72.22 110.176 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -50.96 4.0 Favored Glycine 0 N--CA 1.48 1.626 0 CA-C-O 121.295 0.386 . . . . 64.32 113.257 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.602 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 125.448 1.499 . . . . 73.25 113.76 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 47.2 mt-30 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 111.587 0.217 . . . . 71.5 111.587 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.602 ' HB3' HG12 ' C' ' 89' ' ' ILE . 19.7 ptm -68.95 -37.22 78.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.053 0.221 . . . . 74.35 111.454 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -33.74 75.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.286 0.634 . . . . 65.2 111.185 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -75.8 -33.56 60.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.75 -0.659 . . . . 74.51 109.97 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.47 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 18.8 t -66.77 -60.97 2.21 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 123.559 0.744 . . . . 75.01 111.279 -173.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.22 -18.43 57.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.173 -0.33 . . . . 71.23 111.275 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -25.83 61.13 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.115 -0.493 . . . . 54.24 113.892 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.03 -43.2 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.518 0.933 . . . . 63.2 113.518 -172.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.71 -65.27 0.7 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.26 0.624 . . . . 74.11 111.751 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.47 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 15.1 m -60.53 -43.1 91.65 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.827 0.851 . . . . 75.11 112.259 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.519 ' HB3' HD22 ' C' ' 60' ' ' LEU . 98.0 Cg_exo -51.02 -47.24 26.6 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.597 2.198 . . . . 74.24 114.771 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.05 -21.98 64.06 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 122.579 0.352 . . . . 74.4 111.485 -173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.5 mm -60.58 -45.53 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.563 0.745 . . . . 73.52 109.855 168.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 40.7 mt -85.8 -22.73 27.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.828 -1.078 . . . . 71.14 112.456 -170.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.88 -52.34 65.82 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.016 -0.992 . . . . 74.24 113.465 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.51 -31.88 70.93 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 121.599 1.532 . . . . 73.0 113.55 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -65.79 -47.88 73.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.04 0.536 . . . . 75.33 110.606 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.39 -41.9 96.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.444 0.698 . . . . 63.33 111.057 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.04 -50.13 75.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.687 1.195 . . . . 74.14 110.664 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.5 -33.96 76.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.517 0.727 . . . . 72.3 110.289 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.13 -36.21 74.63 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 122.688 0.395 . . . . 73.01 111.654 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.52 HG23 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -69.81 -43.36 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.578 -0.527 . . . . 75.54 109.578 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.795 HG23 ' HB2' ' C' ' 125' ' ' GLN . 52.8 m -55.22 -38.62 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.255 1.022 . . . . 75.21 110.715 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -67.77 -53.65 25.52 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.638 -1.165 . . . . 51.45 110.272 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.73 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -49.79 -45.4 49.79 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.845 1.258 . . . . 73.54 112.921 -177.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.444 HG11 ' O ' ' C' ' 124' ' ' PRO . 92.7 t -72.01 -40.66 67.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.748 -0.66 . . . . 74.5 111.346 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -61.83 -31.88 72.16 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.365 -0.834 . . . . 65.22 111.208 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.53 -34.99 79.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.866 0.866 . . . . 74.14 110.25 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.52 11.8 37.09 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 123.744 0.652 . . . . 75.33 113.687 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 44.7 p 59.81 27.58 16.91 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.949 1.699 . . . . 74.44 112.617 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -109.05 167.85 8.55 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.246 1.018 . . . . 73.15 110.704 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.444 ' O ' HG11 ' C' ' 118' ' ' VAL . 43.7 Cg_exo -56.78 118.12 4.92 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.255 2.637 . . . . 75.31 112.551 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.795 ' HB2' HG23 ' C' ' 115' ' ' THR . 3.6 pt20 -51.59 143.57 12.17 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.051 0.844 . . . . 74.54 111.709 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.753 ' HG ' HG11 ' C' ' 64' ' ' VAL . 2.5 mm? -97.58 59.66 1.53 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.726 1.25 . . . . 71.13 110.453 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' B' ' 122' ' ' THR . 32.1 t30 -95.61 83.85 3.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 112.927 -1.942 . . . . 75.44 107.414 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.515 HD11 ' HG ' ' C' ' 42' ' ' LEU . 21.7 mt -90.73 154.41 19.56 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.198 -0.91 . . . . 75.33 110.241 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -35.71 135.36 0.5 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 126.201 1.8 . . . . 73.45 115.107 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.77 93.73 0.44 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.636 2.224 . . . . 72.04 111.504 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.89 106.7 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.955 0.883 . . . . 70.21 111.759 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.48 71.69 0.75 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.773 0.829 . . . . 74.04 109.63 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 115.974 -0.557 . . . . 71.53 111.085 176.251 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.1 m . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.158 -0.682 . . . . 74.21 109.158 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.403 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 40.5 t80 -152.28 97.82 2.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 106.477 -1.675 . . . . 64.42 106.477 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 75.8 mt-30 -112.25 118.32 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.746 0.419 . . . . 72.35 110.814 -173.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.5 103.14 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 107.926 -1.139 . . . . 72.21 107.926 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.96 -50.06 8.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.581 0.173 . . . . 73.21 111.405 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -170.8 134.04 0.99 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.767 0.427 . . . . 75.43 110.479 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.23 130.66 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -149.3 149.97 31.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.358 0.663 . . . . 75.14 111.895 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.6 p -77.71 114.66 16.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.669 -0.696 . . . . 75.21 109.75 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -86.06 -20.25 29.06 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.915 0.486 . . . . 73.05 110.059 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.8 t70 -153.55 140.24 18.96 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.72 -1.127 . . . . 61.32 109.594 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.73 HG21 ' HE1' ' C' ' 117' ' ' MET . 96.3 mt -136.67 144.72 31.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 125.189 1.396 . . . . 73.23 107.554 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -154.76 133.62 12.22 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.959 0.787 . . . . 73.33 109.507 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.5 t80 -132.48 126.8 33.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.283 -1.747 . . . . 74.41 106.283 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -121.63 142.75 49.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.03 -1.1 . . . . 74.21 108.03 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -138.42 76.71 36.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 106.374 -1.713 . . . . 75.33 106.374 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.19 -34.15 28.83 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.822 2.348 . . . . 65.44 112.783 -169.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.423 ' O ' HG21 ' D' ' 31' ' ' VAL . 41.2 m-20 -116.13 23.3 12.28 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.091 0.956 . . . . 74.24 110.294 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -46.28 -50.47 38.55 Favored Pre-proline 0 CA--C 1.567 1.631 0 N-CA-C 116.462 2.023 . . . . 64.44 116.462 -167.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.86 -15.98 10.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 CA-C-N 122.137 1.799 . . . . 74.23 113.319 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -75.16 -26.87 59.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.668 1.187 . . . . 75.21 109.782 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.423 HG21 ' O ' ' D' ' 27' ' ' ASN . 70.4 t -80.02 -13.27 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.919 0.888 . . . . 71.15 110.648 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.46 -25.41 67.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.561 0.345 . . . . 71.32 110.543 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.12 -7.48 55.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 72.12 111.411 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -110.89 92.0 3.88 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.077 0.951 . . . . 75.53 109.478 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -97.41 77.76 2.65 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.097 0.559 . . . . 71.4 109.885 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -165.01 172.37 12.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.886 0.474 . . . . 73.45 110.141 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -60.19 116.09 16.02 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.512 1.125 . . . . 74.24 110.965 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.75 123.94 12.43 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.026 1.817 . . . . 60.12 110.884 172.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -57.85 110.94 1.0 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.15 105.87 19.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.397 -0.819 . . . . 72.03 109.139 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.9 115.42 29.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.524 -1.658 . . . . 74.53 106.524 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.22 155.88 16.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.161 0.584 . . . . 73.54 109.972 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -149.47 132.28 16.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.131 0.572 . . . . 72.32 109.726 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -112.06 137.04 50.64 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.834 0.854 . . . . 74.32 109.655 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 3.8 t70 -133.57 154.84 50.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.931 1.292 . . . . 63.24 108.06 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.3 m -137.19 146.33 44.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.161 0.585 . . . . 75.23 110.294 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 167.03 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.389 1.075 . . . . 62.42 108.891 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -164.71 155.75 14.9 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.968 0.507 . . . . 75.33 110.844 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.1 p -158.75 132.99 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 65.23 109.323 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.44 133.8 48.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.391 0.676 . . . . 73.43 110.541 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' D' ' 57' ' ' GLU . 38.6 mt -102.16 -40.52 6.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.43 0.692 . . . . 75.4 110.31 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.98 -169.48 2.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.257 0.623 . . . . 71.44 111.222 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.71 111.48 1.64 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.241 -0.89 . . . . 61.44 110.648 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 75.89 5.29 3.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.485 1.514 . . . . 72.31 110.739 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.422 HG23 ' HG ' ' D' ' 85' ' ' SER . 67.4 t -108.57 121.19 61.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.216 0.606 . . . . 75.12 110.299 -175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.39 130.22 53.48 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.707 -1.22 . . . . 75.14 107.707 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.49 ' HB2' HD11 ' D' ' 51' ' ' LEU . 5.4 tm-20 -88.48 131.48 34.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.104 -1.813 . . . . 73.44 106.104 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.69 129.86 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.416 -0.957 . . . . 65.44 108.416 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.481 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -108.97 135.11 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.409 0.684 . . . . 74.34 110.604 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -115.74 124.08 49.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.789 -1.56 . . . . 74.13 106.789 171.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.622 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -106.77 99.6 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.72 -0.844 . . . . 74.42 108.72 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.87 122.52 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 74.43 108.136 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -121.43 134.37 55.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.357 -0.838 . . . . 63.14 109.635 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.557 HG23 HD11 ' D' ' 114' ' ' ILE . 86.2 t -124.58 102.77 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.79 0.836 . . . . 73.21 109.275 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -101.47 108.02 19.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.513 -0.921 . . . . 61.31 108.513 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.94 139.05 44.33 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.999 0.919 . . . . 75.23 109.131 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 79.2 p -143.39 138.93 29.74 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.077 0.551 . . . . 73.21 110.338 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -115.72 111.27 20.32 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.203 1.001 . . . . 74.25 109.656 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.03 10.94 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.517 0.511 . . . . 64.35 112.626 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 4.05 49.39 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.88 0.872 . . . . 75.51 110.95 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -131.32 147.87 52.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.513 0.725 . . . . 71.23 110.591 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -64.72 138.06 58.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.25 1.02 . . . . 63.42 111.277 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.11 -59.55 2.07 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.556 -0.905 . . . . 71.32 108.556 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -164.24 153.85 14.1 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.807 -1.088 . . . . 73.23 109.951 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 53.3 mt -113.41 154.47 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.019 . . . . 72.2 108.982 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG22 ' D' ' 114' ' ' ILE . 47.2 t -158.58 147.05 18.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.526 0.33 . . . . 74.44 110.436 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.52 121.31 5.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.896 0.878 . . . . 74.35 109.042 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.49 116.07 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 122.987 0.515 . . . . 75.53 109.846 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.717 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -90.11 87.85 7.04 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.638 0.732 . . . . 75.2 109.282 170.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.28 100.39 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.138 -1.392 . . . . 75.32 109.178 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.42 169.87 38.18 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.158 -0.377 . . . . 74.34 112.158 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.65 137.6 4.7 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 112.558 -0.217 . . . . 72.31 112.558 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.27 125.31 42.29 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.676 0.79 . . . . 73.22 109.653 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.07 142.63 50.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.654 0.782 . . . . 75.24 110.299 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 31.0 m -105.93 99.34 8.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.801 0.84 . . . . 63.21 108.796 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.69 138.4 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.423 1.089 . . . . 74.24 109.386 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.25 162.3 12.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.049 0.54 . . . . 63.51 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.51 85.06 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.979 -0.555 . . . . 72.4 113.665 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.74 169.04 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.501 0.72 . . . . 74.21 110.83 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -160.59 162.12 32.74 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.992 0.917 . . . . 74.1 109.54 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.67 -140.73 48.04 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.831 0.707 . . . . 74.54 114.035 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -62.22 -24.25 67.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.194 0.998 . . . . 73.3 111.909 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -61.47 -50.77 71.41 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.258 -0.645 . . . . 73.34 109.258 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.421 ' HE1' ' HB2' ' D' ' 94' ' ' MET . 5.3 ptm -66.4 -34.53 78.16 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.487 0.492 . . . . 75.44 110.507 -176.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.47 75.0 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.38 0.61 . . . . 75.4 111.294 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -69.32 -49.94 51.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 74.1 110.658 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -73.93 -38.39 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.848 -0.614 . . . . 74.41 111.672 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.522 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.6 tp -84.93 -29.67 24.96 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.353 0.661 . . . . 63.14 110.454 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.58 39.4 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.855 -0.611 . . . . 74.51 113.346 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -61.17 1.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.102 0.451 . . . . 74.14 111.705 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.33 -40.86 97.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.056 0.761 . . . . 74.54 113.056 -173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 74.1 m -68.35 -47.4 37.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 CA-C-O 118.95 -0.547 . . . . 65.45 112.104 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.513 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.9 Cg_exo -59.45 -32.91 97.18 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 121.844 1.696 . . . . 63.33 113.267 168.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -64.38 -24.93 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.122 0.569 . . . . 73.04 111.717 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.41 -44.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.44 -0.578 . . . . 75.43 109.44 171.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' D' ' 60' ' ' LEU . 51.4 mt -70.86 -26.06 63.09 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.33 -0.85 . . . . 74.22 111.528 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.03 -44.9 91.06 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 115.076 1.51 . . . . 75.54 115.076 -166.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.72 -35.01 95.93 Favored 'Trans proline' 0 C--N 1.381 2.282 0 CA-C-N 122.039 1.764 . . . . 74.41 113.032 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -76.44 -35.38 58.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.708 0.803 . . . . 74.51 110.482 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -48.38 71.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.585 0.754 . . . . 63.22 110.025 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.447 ' NH2' HG22 ' B' ' 105' ' ' ILE . 36.9 ttp180 -56.52 -50.33 72.13 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 113.97 -1.468 . . . . 75.33 110.869 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.27 -45.44 94.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.085 0.866 . . . . 74.43 111.091 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.471 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.9 t -57.17 -39.83 76.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 73.2 111.05 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.563 HG22 ' SG ' ' D' ' 76' ' ' CYS . 76.6 mt -68.72 -56.98 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.465 0.706 . . . . 74.51 109.847 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.415 HG21 ' HG3' ' D' ' 125' ' ' GLN . 88.2 m -49.46 -45.27 46.52 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.921 1.289 . . . . 73.32 111.923 -173.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 46.4 t -64.56 -45.52 86.74 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.893 -1.049 . . . . 75.52 110.258 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.6 mtm -63.22 -36.8 84.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.428 0.691 . . . . 70.15 111.801 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.403 HG22 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -66.88 -45.16 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 75.33 109.784 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -71.29 -27.23 63.27 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.69 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -69.98 -30.95 68.42 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.79 0.836 . . . . 74.33 109.643 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 8.74 63.95 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.818 0.698 . . . . 73.44 113.165 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.4 p 54.12 39.77 31.0 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.838 1.655 . . . . 74.3 112.313 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.531 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 38.9 m-85 -110.65 167.95 8.31 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.605 1.162 . . . . 74.53 108.861 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.21 155.84 62.91 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.392 2.061 . . . . 62.23 112.564 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.415 ' HG3' HG21 ' D' ' 115' ' ' THR . 34.7 tt0 -72.78 123.24 22.95 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.226 -0.657 . . . . 74.32 109.226 172.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.18 105.83 16.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.489 -0.93 . . . . 74.35 108.489 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 91.4 m-20 -97.6 88.86 4.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.915 -1.143 . . . . 73.02 107.915 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 26.3 tp -71.19 119.87 15.95 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.431 -0.804 . . . . 73.51 109.664 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.99 88.12 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.085 0.954 . . . . 72.42 112.288 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.32 106.8 1.18 Allowed 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.157 1.905 . . . . 65.0 110.796 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.06 109.95 30.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.371 -0.974 . . . . 74.54 108.371 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 108.415 -0.957 . . . . 73.03 108.415 175.349 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.551 1.002 0 N-CA-C 108.796 -0.816 . . . . 72.35 108.796 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.452 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 55.9 t80 -131.88 147.85 52.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.444 0.697 . . . . 74.02 110.436 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.632 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 58.5 tp60 -145.44 134.05 22.14 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 123.67 0.606 . . . . 74.44 111.022 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.45 HD12 HG13 ' A' ' 16' ' ' ILE . 4.5 tp -92.76 128.93 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.011 0.924 . . . . 75.44 108.541 167.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -106.54 -41.87 5.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.463 0.305 . . . . 74.2 110.996 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -169.75 133.34 1.24 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 119.747 -0.168 . . . . 74.34 111.212 -171.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.811 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 67.9 mt -113.1 139.08 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.206 1.003 . . . . 72.34 109.017 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 29.9 p90 -165.3 175.53 9.12 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.008 0.818 . . . . 71.42 111.664 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -100.71 118.99 37.94 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.37 -0.974 . . . . 75.23 108.37 170.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 25.0 mtpt -74.1 -34.37 63.92 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.011 -0.737 . . . . 75.34 109.011 171.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 29.8 t70 -145.03 141.87 29.27 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.257 -1.338 . . . . 71.11 110.241 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.38 142.2 44.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 106.772 -1.566 . . . . 63.32 106.772 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 138.28 21.06 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.395 0.678 . . . . 75.33 109.46 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.594 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.5 t80 -143.33 128.43 18.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.824 -1.547 . . . . 64.44 106.824 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -129.95 131.71 46.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.305 -0.628 . . . . 72.03 109.305 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.6 77.96 22.1 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 107.486 -1.301 . . . . 72.04 107.486 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.0 -35.57 33.87 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.798 2.332 . . . . 75.4 111.023 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 31' ' ' VAL . 87.9 m-20 -95.25 25.71 4.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.17 0.988 . . . . 74.21 110.889 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.06 99.86 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.032 0.933 . . . . 74.12 112.221 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.83 -31.18 32.34 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 121.675 1.583 . . . . 72.43 112.106 173.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.6 m-70 -65.38 -30.97 71.85 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.707 0.803 . . . . 74.43 111.405 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 27' ' ' ASN . 48.1 t -58.54 -26.43 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 122.929 0.492 . . . . 72.22 111.376 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.95 -39.63 95.22 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.059 0.544 . . . . 75.13 110.431 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -74.28 -37.09 63.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.219 1.008 . . . . 75.51 110.336 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -82.34 160.07 22.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.208 -0.905 . . . . 73.41 111.28 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.42 141.54 35.2 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 108.266 -1.013 . . . . 72.24 108.266 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -79.93 82.69 5.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.203 0.525 . . . . 73.32 109.681 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -132.73 72.91 76.91 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.161 -1.052 . . . . 71.12 108.161 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -83.05 157.77 15.33 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.563 2.175 . . . . 74.31 111.583 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -123.38 108.29 12.56 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.141 -1.059 . . . . 73.35 108.141 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.647 HG21 HD21 ' A' ' 128' ' ' LEU . 7.3 p -65.87 135.14 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 123.706 0.629 . . . . 72.42 111.64 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 47.6 mtpt -104.51 145.25 30.56 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.009 0.924 . . . . 74.3 108.731 167.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mp -123.28 105.86 10.22 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.788 -1.19 . . . . 65.01 107.788 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.573 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.1 m-20 -115.88 102.76 9.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.766 -1.198 . . . . 74.13 107.766 173.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.96 122.65 43.19 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.84 -1.541 . . . . 63.44 106.84 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.11 154.12 49.79 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.742 -0.836 . . . . 70.03 108.742 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -106.83 157.68 17.56 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.502 0.668 . . . . 74.11 110.55 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.686 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . . . -149.98 143.94 25.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.681 -1.229 . . . . 65.11 107.681 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 54.3 m -130.1 152.09 49.92 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.95 0.5 . . . . 72.33 110.025 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -158.27 121.09 3.79 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.272 0.629 . . . . 73.0 109.62 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.65 109.26 15.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.458 -0.942 . . . . 75.24 108.458 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.406 HD12 HG22 ' A' ' 83' ' ' ILE . 74.4 mt -86.11 -41.11 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.113 0.565 . . . . 72.41 111.128 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.434 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -154.43 -172.11 4.09 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.689 0.796 . . . . 71.21 110.266 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.71 110.58 4.36 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.341 0.656 . . . . 71.13 109.455 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.58 0.43 2.95 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.226 1.41 . . . . 73.2 112.636 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.434 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 85.0 t -98.94 113.14 32.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.549 -1.278 . . . . 72.14 107.549 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.453 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 0.2 OUTLIER -116.96 169.74 9.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -129.99 121.98 27.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.552 -0.907 . . . . 74.54 108.552 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.17 120.95 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.536 -1.653 . . . . 73.42 106.536 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 41.6 t -108.36 132.24 56.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.736 -0.839 . . . . 72.42 108.736 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.96 111.21 23.44 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.205 -1.406 . . . . 74.01 107.205 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.86 98.4 8.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.864 -1.161 . . . . 74.53 107.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.96 142.08 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.255 -1.017 . . . . 64.43 108.255 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.7 m -135.62 127.03 28.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.467 -0.938 . . . . 75.25 108.467 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.615 HG13 HG22 ' A' ' 40' ' ' VAL . 55.2 t -125.24 107.75 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.723 1.209 . . . . 75.34 109.275 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 m -107.34 137.27 45.7 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.798 0.439 . . . . 75.42 109.943 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.03 122.36 39.93 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.931 -0.766 . . . . 74.43 108.931 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 67.2 m -118.81 130.78 55.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.0 0.52 . . . . 64.13 110.574 173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.436 ' HG ' ' HB1' ' A' ' 73' ' ' ALA . 11.6 mt -87.79 69.58 9.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.432 1.493 . . . . 75.11 107.884 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -94.14 1.32 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 114.95 -1.023 . . . . 73.43 111.23 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.58 -25.98 14.24 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.726 0.81 . . . . 73.22 111.966 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -111.81 128.19 56.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.115 0.566 . . . . 64.45 110.691 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -67.38 133.26 49.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.21 0.604 . . . . 72.34 111.294 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.436 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -83.25 -56.64 3.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.613 1.165 . . . . 62.02 109.669 177.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -148.75 172.41 14.66 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.599 -1.182 . . . . 74.41 111.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -141.7 140.07 33.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.296 1.438 . . . . 72.41 107.733 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.615 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 29.9 m -128.04 140.59 51.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.988 -1.116 . . . . 71.52 107.988 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -148.85 118.31 6.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.255 -0.646 . . . . 73.32 109.255 168.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.14 110.6 23.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 123.752 0.821 . . . . 64.44 109.322 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.5 mt-30 -86.15 81.06 8.58 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.717 -0.846 . . . . 75.21 108.717 172.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.15 94.91 4.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.031 -0.986 . . . . 61.35 108.419 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -105.13 146.6 16.1 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 112.179 -0.368 . . . . 73.05 112.179 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.39 141.99 12.92 Favored Glycine 0 C--O 1.24 0.522 0 N-CA-C 111.433 -0.667 . . . . 75.53 111.433 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.416 HG13 ' HE1' ' A' ' 17' ' ' TYR . 50.6 mt -81.55 123.88 38.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.434 -0.95 . . . . 74.54 108.434 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -134.6 120.28 19.4 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.17 0.588 . . . . 75.0 109.743 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.632 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 24.0 m -83.6 103.25 12.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.881 -0.785 . . . . 72.41 108.881 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 HD13 ' A' ' 89' ' ' ILE . 45.2 pt -109.14 138.97 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.559 0.744 . . . . 71.41 110.709 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.5 153.79 33.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.206 -0.907 . . . . 73.42 109.344 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.66 85.98 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 121.305 -0.474 . . . . 74.55 114.239 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 2.2 pp -107.37 130.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.513 -1.291 . . . . 65.23 107.513 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.49 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 43.7 mt-10 -153.34 168.29 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.699 -1.223 . . . . 75.01 107.699 -174.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.97 -117.85 2.41 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 114.73 0.652 . . . . 75.14 114.73 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -81.82 -27.22 33.74 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 63.01 111.159 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -64.65 -36.11 83.2 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.808 0.843 . . . . 75.22 110.091 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.49 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 59.0 ttm -69.05 -45.94 69.13 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.305 -0.861 . . . . 74.03 109.403 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.23 -26.79 68.95 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.286 -0.87 . . . . 72.24 112.228 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -70.53 -43.85 68.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.775 0.43 . . . . 75.53 110.315 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -70.46 -64.25 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.856 0.722 . . . . 65.01 110.981 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.95 -19.76 60.57 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.149 0.425 . . . . 73.23 112.149 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.35 -35.15 8.16 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 114.23 0.452 . . . . 65.35 114.23 -170.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 133' ' ' PHE . . . -137.03 -48.01 0.6 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.793 0.294 . . . . 74.05 111.793 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.452 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.8 t80 -62.94 -61.44 2.39 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.407 0.683 . . . . 72.11 111.868 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.502 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.6 m -67.09 -37.45 13.57 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.72 0.808 . . . . 73.4 112.937 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.06 -44.05 48.4 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.149 1.9 . . . . 73.43 113.269 162.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -69.84 -23.43 63.3 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 75.22 111.664 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 102' ' ' CYS . 32.3 mm -65.77 -40.89 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.944 -0.762 . . . . 72.04 108.944 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.31 -23.06 26.41 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.364 1.066 . . . . 74.14 112.768 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -66.08 -42.84 53.86 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 114.249 1.203 . . . . 73.13 114.249 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.99 -34.56 99.2 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 121.938 1.758 . . . . 61.12 112.694 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -77.85 -39.0 44.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.761 0.825 . . . . 75.45 111.353 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.81 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.358 0.663 . . . . 75.13 109.548 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.478 ' NH1' HD13 ' C' ' 105' ' ' ILE . 34.6 ttm180 -48.59 -55.8 10.17 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.89 1.369 . . . . 75.54 110.717 176.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.438 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.0 tm-20 -66.07 -38.94 89.57 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.247 0.967 . . . . 74.21 111.18 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.573 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.2 t -62.37 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.221 0.608 . . . . 75.23 111.45 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.451 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 96.9 mt -76.6 -46.49 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.152 0.981 . . . . 65.34 110.534 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.2 m -57.04 -43.98 82.48 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.949 1.299 . . . . 72.11 111.373 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 29.0 t -68.68 -32.12 71.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.43 -0.805 . . . . 74.45 111.686 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 70.7 mtm -69.97 -38.28 76.04 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.581 0.352 . . . . 72.41 110.604 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -65.78 -48.51 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.559 0.743 . . . . 74.41 110.885 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.68 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 77.6 p -63.37 -35.61 80.96 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.516 0.674 . . . . 74.52 111.219 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -72.71 -20.5 61.21 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.3 -1.318 . . . . 74.45 110.656 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 16.39 37.87 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 119.413 -0.659 . . . . 75.13 113.295 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.456 HG22 ' HE ' ' B' ' 15' ' ' ARG . 0.5 OUTLIER 78.65 8.07 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 127.088 2.155 . . . . 75.43 112.082 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 119' ' ' SER . 19.0 m-85 -99.48 162.82 19.99 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.395 0.678 . . . . 74.45 110.127 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.98 125.93 13.18 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.857 1.704 . . . . 73.55 109.548 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.68 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 9.9 pt20 -61.72 147.54 45.77 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 123.554 0.534 . . . . 72.5 111.058 -173.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -121.77 113.0 19.07 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.984 -0.553 . . . . 75.3 110.118 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -110.72 111.68 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.388 -0.967 . . . . 74.32 108.388 174.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.647 HD21 HG21 ' A' ' 40' ' ' VAL . 86.7 mt -73.18 144.84 46.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.038 0.535 . . . . 71.33 110.284 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 153.64 75.36 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.788 0.835 . . . . 70.22 111.701 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.47 138.58 12.35 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 121.922 1.748 . . . . 71.15 111.847 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 m -103.45 112.44 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.485 -0.931 . . . . 64.41 108.485 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.71 69.9 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.466 0.651 . . . . 71.3 110.472 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.511 ' HD2' ' HB1' ' A' ' 100' ' ' ALA . 39.9 t80 . . . . . 0 C--O 1.218 -0.582 0 CA-C-N 115.687 -0.688 . . . . 72.55 110.007 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 108.567 -0.901 . . . . 74.35 108.567 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.44 123.45 13.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 73.52 109.82 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -127.5 141.77 51.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.647 1.179 . . . . 73.31 109.83 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.599 HG13 ' HD3' ' D' ' 130' ' ' PRO . 61.4 mt -93.04 129.56 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.018 -1.104 . . . . 73.44 108.018 166.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -89.39 -40.92 12.42 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.581 0.55 . . . . 74.45 110.69 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.456 ' HE ' HG22 ' A' ' 122' ' ' THR . 68.8 ttt180 -167.55 150.46 6.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.774 0.43 . . . . 73.15 110.546 -170.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.11 145.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.998 -1.482 . . . . 75.04 106.998 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.452 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.1 p90 -170.62 162.21 7.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.685 0.394 . . . . 73.44 111.198 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 84.8 m -90.19 124.71 35.07 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.107 -0.701 . . . . 74.53 109.107 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.08 -45.19 11.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.899 -0.591 . . . . 75.4 109.505 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.481 ' HB3' HE21 ' B' ' 79' ' ' GLN . 19.4 t70 -148.92 146.05 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.889 -0.596 . . . . 74.34 111.807 -165.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.758 HD12 ' SG ' ' B' ' 113' ' ' CYS . 42.9 mm -138.35 150.01 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.463 1.505 . . . . 71.41 109.068 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -150.32 150.89 32.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.722 -0.672 . . . . 70.2 110.146 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 66.8 t80 -157.42 111.82 2.67 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.891 -1.522 . . . . 62.42 106.891 168.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -125.56 114.59 18.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 73.13 109.471 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' B' ' 74' ' ' PHE . . . -107.05 91.54 6.62 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.445 0.698 . . . . 72.44 109.503 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.84 -29.81 88.9 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.008 2.472 . . . . 75.1 112.62 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.45 31.27 6.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.873 0.869 . . . . 73.35 110.349 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.28 -55.59 13.31 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 125.115 1.366 . . . . 75.52 114.341 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.36 -13.91 10.82 Favored 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 121.751 1.634 . . . . 74.43 112.834 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -85.51 0.53 52.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.986 0.914 . . . . 75.02 111.841 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.47 -18.08 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 124.387 1.075 . . . . 74.12 111.008 170.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.55 -37.16 86.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.79 0.836 . . . . 64.44 110.825 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -85.85 -43.87 12.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.479 -0.782 . . . . 70.35 110.539 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -78.08 89.9 4.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.059 0.544 . . . . 75.32 109.989 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -86.61 76.88 9.48 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.304 -0.862 . . . . 75.51 112.146 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -173.1 161.85 4.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.572 -0.74 . . . . 64.32 110.281 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -75.24 117.29 61.92 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.519 0.728 . . . . 73.02 109.329 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.4 151.5 79.09 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.7 2.267 . . . . 75.1 113.333 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.28 102.82 8.81 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.032 -0.985 . . . . 75.23 108.391 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 13.6 t -86.75 121.78 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.807 -0.812 . . . . 73.01 108.807 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -130.52 133.84 46.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.095 0.958 . . . . 74.42 108.724 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.35 149.24 31.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.393 -0.595 . . . . 74.21 109.393 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -135.51 135.96 40.84 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.016 0.926 . . . . 64.05 109.313 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.29 146.76 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.813 0.845 . . . . 73.53 109.892 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.52 152.34 34.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.349 1.059 . . . . 71.34 108.275 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -137.27 137.93 39.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.184 0.594 . . . . 75.01 109.408 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.82 151.89 51.37 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.828 1.251 . . . . 61.13 107.961 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.0 m -132.11 161.89 32.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.096 0.558 . . . . 53.11 110.246 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -163.44 155.8 17.99 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.681 1.192 . . . . 65.31 108.399 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.5 tt0 -124.4 132.72 53.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.567 -0.531 . . . . 74.33 109.567 171.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.1 mt -100.7 -31.73 11.07 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.602 0.761 . . . . 75.44 111.342 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -162.31 -172.08 3.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.654 0.781 . . . . 64.12 111.326 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.36 107.19 1.56 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.034 -0.984 . . . . 72.44 111.119 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.0 16.41 7.0 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.651 1.181 . . . . 75.23 112.386 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 91.7 t -115.68 116.59 52.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.157 -1.423 . . . . 74.2 107.157 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.536 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 11.0 p90 -123.92 179.12 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.321 0.649 . . . . 65.52 109.894 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -142.44 134.18 26.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.556 -0.905 . . . . 74.13 108.556 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.72 125.91 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.142 -1.059 . . . . 73.0 108.142 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.08 113.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.594 -0.891 . . . . 74.34 108.594 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 0.4 OUTLIER -93.57 118.46 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.755 -0.831 . . . . 74.11 108.755 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 35.1 ttm180 -105.12 120.77 42.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.157 0.583 . . . . 75.52 109.83 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.464 HG21 HD23 ' B' ' 60' ' ' LEU . 48.4 t -116.53 110.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.734 -1.21 . . . . 74.21 107.734 167.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -106.65 128.39 54.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.02 0.528 . . . . 74.23 109.796 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.572 HG22 HG22 ' B' ' 114' ' ' ILE . 97.2 t -115.39 128.84 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.216 1.006 . . . . 65.34 109.696 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -121.94 142.5 50.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.263 1.025 . . . . 71.53 109.562 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.07 163.87 28.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.176 0.991 . . . . 65.25 109.564 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.5 p -146.71 138.49 24.56 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.462 0.541 . . . . 73.35 112.462 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 mt -110.47 106.09 15.28 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.029 1.332 . . . . 74.24 107.982 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.46 -106.27 2.21 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.329 -0.462 . . . . 75.4 112.485 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.46 5.89 11.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.156 0.983 . . . . 61.14 110.732 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -127.22 171.47 11.42 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.091 0.956 . . . . 74.43 109.424 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 59.6 m -76.7 142.78 40.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.085 0.554 . . . . 75.03 111.31 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.56 -64.08 1.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.527 0.731 . . . . 70.33 109.33 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 32.7 p90 -147.5 162.02 39.9 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.005 -0.998 . . . . 75.12 110.6 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -130.0 154.09 47.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.239 1.416 . . . . 72.14 107.567 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.477 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.4 t -154.75 159.49 40.7 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.059 0.944 . . . . 63.21 108.675 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -164.67 141.04 5.99 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.655 0.782 . . . . 75.41 109.253 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.497 HG21 ' SG ' ' B' ' 113' ' ' CYS . 69.9 t -129.13 140.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.755 0.822 . . . . 75.34 108.948 171.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.481 HE21 ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -126.89 92.77 3.6 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.849 0.718 . . . . 74.32 109.164 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -89.86 101.82 14.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.272 -1.331 . . . . 73.44 109.048 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.11 15.46 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.896 -0.882 . . . . 72.42 110.896 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.75 125.95 2.87 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.167 -0.773 . . . . 72.31 111.167 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.91 126.43 40.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.719 0.808 . . . . 74.32 109.252 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -132.9 161.57 33.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.665 1.186 . . . . 74.43 109.293 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -134.03 127.38 32.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.492 1.117 . . . . 73.32 108.504 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.509 HG12 HD12 ' B' ' 89' ' ' ILE . 8.5 tt -139.1 135.98 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.512 -0.551 . . . . 74.02 109.512 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.33 158.57 36.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.716 0.806 . . . . 74.4 109.999 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.31 -30.3 10.69 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 111.797 -0.521 . . . . 73.41 111.797 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' B' ' 93' ' ' GLN . 0.1 OUTLIER -83.31 169.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.967 1.307 . . . . 73.13 111.087 175.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -152.16 143.68 23.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.992 0.917 . . . . 75.3 109.718 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -99.8 0.16 Allowed Glycine 0 C--N 1.35 1.331 0 O-C-N 123.917 0.761 . . . . 74.1 114.715 170.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 86.1 m -64.27 -42.75 96.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 74.45 112.349 -170.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.627 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 1.4 mp0 -62.13 -45.07 95.08 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.229 0.612 . . . . 74.42 110.093 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -39.97 65.93 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.233 -0.894 . . . . 73.24 110.164 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.56 69.13 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.252 0.621 . . . . 74.35 111.855 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -76.02 -40.58 53.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 74.54 110.501 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.524 ' SG ' ' SG ' ' B' ' 102' ' ' CYS . 49.6 t -66.2 -47.56 73.49 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.419 0.688 . . . . 75.44 109.674 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.65 -35.26 80.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.637 1.175 . . . . 74.51 110.837 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.69 2.14 87.78 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.375 -0.83 . . . . 63.15 114.172 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.99 -63.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.885 0.843 . . . . 63.4 112.732 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.8 -50.08 39.53 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.629 0.974 . . . . 72.43 113.629 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.524 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 61.4 m -58.44 -47.61 98.46 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.503 0.721 . . . . 63.23 112.081 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.03 -27.56 29.81 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 121.363 1.375 . . . . 73.51 112.898 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -64.84 -29.91 70.89 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.758 0.708 . . . . 73.1 110.515 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.523 HG22 ' NH2' ' D' ' 111' ' ' ARG . 63.7 mt -62.29 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.768 0.827 . . . . 62.51 110.372 172.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.424 ' HB2' HD13 ' B' ' 60' ' ' LEU . 39.2 mt -83.68 -11.85 56.66 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.882 -1.054 . . . . 75.22 111.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.539 ' HZ ' HD21 ' B' ' 128' ' ' LEU . 32.3 t80 -63.46 -46.8 84.28 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.298 1.439 . . . . 64.44 112.994 -170.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.419 ' HB3' ' HD2' ' D' ' 109' ' ' TYR . 29.1 Cg_endo -60.95 -36.93 80.71 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.64 1.56 . . . . 71.33 112.764 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.22 -42.25 99.13 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.247 0.619 . . . . 72.33 110.587 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -41.47 73.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.358 0.663 . . . . 65.2 111.357 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -56.53 -58.92 5.98 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.571 1.149 . . . . 74.42 111.275 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.39 -35.79 81.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.397 -0.819 . . . . 74.33 110.387 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.758 ' SG ' HD12 ' B' ' 21' ' ' ILE . 36.8 t -64.64 -37.14 86.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.476 0.547 . . . . 73.43 112.476 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.572 HG22 HG22 ' B' ' 64' ' ' VAL . 79.3 mt -70.76 -47.9 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.918 0.487 . . . . 73.42 110.131 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.6 m -62.49 -23.75 67.1 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.533 -0.758 . . . . 71.43 110.833 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -73.27 -54.71 7.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.567 1.147 . . . . 72.44 109.985 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.513 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -64.93 -33.74 76.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.982 0.913 . . . . 71.11 113.163 -172.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.91 -30.15 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 122.901 0.48 . . . . 75.24 110.175 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.51 ' HB3' ' HG2' ' B' ' 125' ' ' GLN . 54.5 p -72.14 -32.18 66.67 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.481 0.658 . . . . 65.53 110.478 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.573 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 67.7 mtt-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.722 -1.127 . . . . 73.01 109.814 171.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.37 15.79 52.34 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.097 -0.835 . . . . 71.44 113.342 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t 56.69 14.07 1.63 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 126.97 2.108 . . . . 74.05 113.884 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -106.14 160.15 27.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.698 0.799 . . . . 74.41 111.309 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -52.77 101.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.782 2.988 . . . . 74.32 114.49 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.547 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 0.1 OUTLIER -68.86 155.45 40.21 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 113.356 -1.747 . . . . 72.4 110.293 176.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tt -152.3 126.28 9.1 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.741 -0.837 . . . . 61.04 108.741 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.495 ' HB2' ' HG ' ' C' ' 119' ' ' SER . 24.9 t-20 -93.66 127.96 39.61 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.997 0.919 . . . . 62.42 108.661 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.539 HD21 ' HZ ' ' B' ' 107' ' ' PHE . 1.7 tt -70.54 130.89 43.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.617 -0.512 . . . . 75.31 109.617 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.64 144.67 98.73 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.563 0.745 . . . . 60.21 111.042 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.465 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 57.8 Cg_endo -65.22 92.02 0.22 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.39 2.726 . . . . 75.03 113.431 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -84.95 108.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.953 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.444 ' HB3' HG21 ' D' ' 13' ' ' ILE . 52.5 t30 -109.84 105.93 15.32 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.188 0.595 . . . . 70.23 110.177 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 t80 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 123.803 0.841 . . . . 74.45 111.368 176.421 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 80.5 m . . . . . 0 CA--C 1.528 0.134 0 N-CA-C 107.393 -1.336 . . . . 75.02 107.393 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -122.83 123.7 41.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.343 -1.355 . . . . 74.45 107.343 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.429 ' HB3' ' HG ' ' C' ' 85' ' ' SER . 6.5 tp-100 -154.79 138.41 16.05 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.399 0.437 . . . . 72.33 110.733 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.17 142.35 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.869 0.867 . . . . 72.32 109.075 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 30.9 mm-40 -111.39 -35.73 5.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.416 0.686 . . . . 72.25 110.663 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 42.4 ttt180 -173.33 136.49 0.62 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.114 0.566 . . . . 74.44 109.654 -171.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -123.18 143.85 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.407 -1.331 . . . . 72.22 107.407 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -177.71 168.85 2.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 75.54 110.72 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -87.56 111.86 21.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.372 -0.831 . . . . 63.03 109.323 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.38 -43.92 89.22 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.2 -0.667 . . . . 75.33 109.2 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -147.34 147.1 29.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.222 -1.354 . . . . 75.45 110.078 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.88 144.57 29.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 125.782 1.633 . . . . 73.42 106.729 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -153.33 151.02 29.5 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.31 0.576 . . . . 63.23 110.644 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -155.08 134.04 12.23 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.573 -1.194 . . . . 74.14 108.077 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.8 147.28 52.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.439 1.096 . . . . 75.01 108.268 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 84.87 6.32 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.544 0.737 . . . . 74.44 109.785 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.38 -27.97 46.97 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.989 2.459 . . . . 74.21 111.302 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.804 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 6.8 m-80 -95.25 18.56 12.15 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.797 -1.092 . . . . 74.13 111.551 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.423 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -57.67 -50.29 88.98 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 118.613 0.642 . . . . 73.13 111.19 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 46.0 Cg_endo -94.18 -26.33 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.743 1.629 . . . . 74.34 113.571 164.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.804 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 61.2 t60 -69.05 -24.41 64.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.734 1.213 . . . . 74.41 113.312 -170.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' C' ' 27' ' ' ASN . 8.8 p -74.99 -12.01 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 122.825 0.45 . . . . 73.53 111.854 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.67 -41.34 81.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.402 0.681 . . . . 74.14 112.189 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -112.12 48.11 1.01 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.071 0.939 . . . . 64.54 108.949 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.594 ' HG2' HD11 ' C' ' 68' ' ' LEU . 1.9 tppp? -124.33 164.05 20.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.455 -0.793 . . . . 74.22 109.481 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.42 105.79 8.78 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.859 -1.164 . . . . 70.53 107.859 166.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.4 ' HA ' HD23 ' C' ' 68' ' ' LEU . 1.4 p90 -84.0 73.35 10.37 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.917 0.887 . . . . 74.32 111.466 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -124.93 77.62 66.17 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.048 -0.723 . . . . 73.01 109.048 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.779 ' HG2' ' HG3' ' C' ' 124' ' ' PRO . 1.3 Cg_endo -86.51 137.4 4.95 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.366 2.711 . . . . 74.14 111.794 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.63 117.02 24.27 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.61 -1.256 . . . . 75.34 107.61 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.31 79.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 115.236 -0.893 . . . . 74.13 109.406 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.07 141.56 35.63 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.209 0.604 . . . . 63.32 110.847 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.1 165.91 14.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.785 0.834 . . . . 73.33 110.846 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -145.83 148.4 32.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.914 1.286 . . . . 71.01 107.594 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 15.6 tp -116.47 148.91 40.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.213 0.461 . . . . 75.41 111.042 -172.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.665 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 12.9 m-20 -141.15 137.97 33.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.37 1.068 . . . . 73.42 109.17 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -113.97 126.22 54.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.502 -0.925 . . . . 73.23 108.502 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.96 165.29 25.04 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.38 1.072 . . . . 73.43 108.54 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 m -145.09 168.31 20.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.319 0.648 . . . . 73.52 110.441 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.19 128.0 4.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.729 1.211 . . . . 73.3 108.025 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -90.31 126.2 35.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.979 -0.749 . . . . 71.33 108.979 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.447 HD13 HD13 ' C' ' 83' ' ' ILE . 61.8 mt -97.93 -36.42 10.16 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.836 0.854 . . . . 72.34 110.18 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.99 -178.05 5.41 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.493 -0.776 . . . . 75.31 109.96 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -68.04 123.47 20.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.137 -1.061 . . . . 73.33 108.137 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' C' ' 85' ' ' SER . 21.6 m-20 73.06 -4.33 2.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.701 1.2 . . . . 73.32 112.823 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 98.01 6.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.91 0.884 . . . . 75.23 108.74 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.11 116.39 26.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.716 0.806 . . . . 75.21 110.481 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -82.83 121.92 27.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.985 -1.007 . . . . 75.32 109.484 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.85 124.56 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.98 -1.118 . . . . 74.23 107.98 170.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.06 103.41 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.016 -1.105 . . . . 73.24 108.016 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.01 110.07 21.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.193 0.997 . . . . 65.45 108.365 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.665 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 47.5 ttp180 -103.34 137.33 41.6 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.035 0.534 . . . . 75.24 109.893 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.3 130.17 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.324 -1.362 . . . . 70.21 107.324 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -120.23 121.04 37.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.849 -0.797 . . . . 73.31 108.849 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.627 HG13 ' HG ' ' C' ' 126' ' ' LEU . 25.6 t -98.73 138.5 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.966 0.907 . . . . 73.51 109.319 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -123.35 138.75 54.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.153 -1.385 . . . . 73.2 107.486 171.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.946 -1.501 . . . . 62.54 106.946 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -134.49 128.85 34.22 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 123.643 0.589 . . . . 72.33 110.68 -176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.594 HD11 ' HG2' ' C' ' 34' ' ' LYS . 17.1 mt -84.65 47.55 1.39 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.482 1.513 . . . . 73.31 108.811 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.27 -82.82 0.49 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.847 -0.901 . . . . 75.33 110.847 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.98 -31.78 3.59 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.674 1.19 . . . . 73.34 108.829 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.55 ' HG2' ' HZ2' ' C' ' 34' ' ' LYS . 7.9 tp10 -62.49 121.84 14.27 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.902 0.881 . . . . 73.21 109.874 170.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -74.59 122.0 22.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.749 0.704 . . . . 73.34 109.62 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' C' ' 27' ' ' ASN . . . -72.35 -51.32 21.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.064 0.946 . . . . 61.41 109.92 177.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -167.17 176.68 6.64 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.916 -0.583 . . . . 75.4 110.443 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -131.02 142.89 50.37 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.59 -1.263 . . . . 75.14 107.59 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' C' ' 114' ' ' ILE . 47.2 t -144.63 147.73 33.45 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.373 -0.973 . . . . 73.43 108.373 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.99 141.47 14.07 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.714 0.406 . . . . 73.01 110.389 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.86 115.47 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.313 1.045 . . . . 74.34 108.922 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 45.6 mt-30 -91.51 95.3 9.87 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.557 -0.905 . . . . 74.53 108.557 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.96 111.49 20.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.775 0.83 . . . . 71.51 109.905 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 145.18 17.6 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 112.389 -0.284 . . . . 71.11 112.389 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.13 124.03 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.268 -1.133 . . . . 74.33 110.268 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.1 mm -81.87 121.5 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.193 -1.04 . . . . 75.02 108.193 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.42 118.86 28.42 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.291 -0.633 . . . . 71.11 109.291 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.429 ' HG ' ' HB3' ' C' ' 12' ' ' GLN . 23.5 p -85.43 100.44 11.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.833 -0.803 . . . . 61.32 108.833 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.37 146.49 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.594 0.758 . . . . 72.22 111.251 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.414 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -164.93 151.05 10.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.17 0.988 . . . . 73.41 109.959 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 -38.75 3.14 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 114.042 0.377 . . . . 72.04 114.042 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 124.455 1.102 . . . . 74.34 111.082 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.978 -0.379 . . . . 74.33 109.978 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 52.5 ttm -62.95 -47.35 83.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.916 -0.583 . . . . 72.23 109.958 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.47 72.67 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.86 0.725 . . . . 73.53 111.732 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -73.42 -31.89 64.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.663 0.785 . . . . 70.11 110.027 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.14 -35.62 48.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 72.24 110.989 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.998 0.919 . . . . 74.42 110.303 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 11.11 62.44 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 115.914 -0.585 . . . . 71.4 114.18 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.01 -61.58 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.488 0.644 . . . . 71.35 111.34 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -73.77 -46.53 45.06 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.898 0.703 . . . . 74.43 112.898 -172.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.464 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 82.8 m -60.9 -48.73 91.9 Favored Pre-proline 0 CA--C 1.563 1.47 0 CA-C-O 118.977 -0.535 . . . . 74.21 110.75 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 71.9 Cg_exo -57.04 -33.67 96.17 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.439 2.093 . . . . 72.44 114.081 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.46 -34.87 79.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.313 0.645 . . . . 62.4 111.193 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.478 HD13 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -64.92 -41.57 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.229 0.612 . . . . 74.04 110.331 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.2 mt -81.49 -22.28 38.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.216 -0.902 . . . . 73.23 112.088 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.72 -48.51 95.06 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 117.723 -1.132 . . . . 75.32 113.55 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.03 -39.54 84.92 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.195 1.93 . . . . 71.22 112.607 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -62.88 -52.31 63.58 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.845 -1.07 . . . . 74.44 111.952 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.18 -34.81 73.44 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.319 -0.4 . . . . 71.53 111.397 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.83 -51.03 67.13 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.257 1.423 . . . . 75.31 110.473 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.98 -36.44 69.81 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.507 -0.77 . . . . 74.23 110.195 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.16 -30.96 71.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.09 0.556 . . . . 72.22 111.378 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.601 HG23 HG21 ' C' ' 64' ' ' VAL . 98.1 mt -72.3 -45.49 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.0 -0.546 . . . . 75.23 109.871 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -56.76 -37.32 70.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.801 0.688 . . . . 75.42 110.423 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.7 t -59.76 -56.95 15.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.923 1.289 . . . . 64.14 110.45 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.742 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.17 -41.91 89.53 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.586 1.154 . . . . 74.0 112.917 -176.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' C' ' 126' ' ' LEU . 69.2 t -66.29 -41.59 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.424 0.689 . . . . 72.33 110.747 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.575 ' HB2' HE22 ' C' ' 125' ' ' GLN . 45.5 t -63.31 -35.96 82.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.145 -0.934 . . . . 75.11 110.993 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.508 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.5 mtt-85 -66.89 -37.92 85.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.979 -1.01 . . . . 73.24 110.122 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.15 0.84 82.7 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.283 -0.732 . . . . 74.34 113.328 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p 57.09 50.94 11.1 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.523 1.529 . . . . 74.43 111.492 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 26.9 m-85 -121.65 169.74 8.75 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.474 1.11 . . . . 74.53 110.693 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.779 ' HG3' ' HG2' ' C' ' 38' ' ' PRO . 26.9 Cg_endo -57.8 126.71 22.6 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.732 2.288 . . . . 71.24 110.905 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.575 HE22 ' HB2' ' C' ' 119' ' ' SER . 15.5 mm100 -58.99 132.44 54.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.148 0.979 . . . . 75.11 112.486 -168.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.656 ' HB2' HG22 ' C' ' 118' ' ' VAL . 1.7 mm? -108.02 72.18 0.84 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.779 -0.646 . . . . 74.52 109.968 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -126.53 89.02 2.93 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.035 -1.468 . . . . 65.02 107.035 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 31.9 mt -84.27 151.16 24.96 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.552 -1.203 . . . . 75.14 108.785 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.58 147.53 39.3 Favored Pre-proline 0 CA--C 1.546 0.791 0 O-C-N 124.281 0.988 . . . . 62.14 113.295 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.811 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 88.0 Cg_exo -50.36 115.2 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.545 2.83 . . . . 75.32 112.583 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.16 78.91 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-O 121.632 0.729 . . . . 71.53 109.128 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.64 93.46 8.4 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.189 -0.914 . . . . 73.23 109.978 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 33.4 p90 . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 114.389 -1.278 . . . . 72.24 111.443 179.663 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m . . . . . 0 C--O 1.244 0.797 0 N-CA-C 109.813 -0.44 . . . . 74.23 109.813 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 91.3 t80 -156.6 102.56 2.06 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.333 -1.358 . . . . 74.31 107.333 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 76.3 mt-30 -113.03 113.55 25.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.844 -0.799 . . . . 74.52 108.844 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' B' ' 132' ' ' ASN . 7.5 tt -91.43 98.31 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.581 -1.266 . . . . 64.35 107.581 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.53 -33.21 14.56 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.35 0.5 . . . . 75.22 112.35 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.434 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 75.2 ttt180 -170.53 122.42 0.63 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.059 -0.348 . . . . 74.42 110.059 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.407 HG12 ' HG3' ' B' ' 130' ' ' PRO . 35.4 mm -115.57 132.67 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.146 -1.057 . . . . 61.33 108.146 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.434 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 4.8 p90 -154.57 169.0 24.87 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.381 0.672 . . . . 73.12 112.024 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -97.7 119.59 36.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.016 -0.993 . . . . 73.4 108.815 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.02 -22.31 31.36 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.331 0.653 . . . . 74.13 110.2 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.3 t70 -160.85 139.5 10.07 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.102 0.961 . . . . 74.13 109.381 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.742 HG21 ' HE1' ' C' ' 117' ' ' MET . 67.3 mt -142.25 143.73 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.479 1.112 . . . . 72.32 108.258 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 60.7 m -141.98 136.76 30.64 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.228 1.011 . . . . 43.34 109.187 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.524 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.9 t80 -143.22 110.99 5.93 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 106.445 -1.687 . . . . 74.35 106.445 165.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -122.31 115.12 21.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.353 -0.61 . . . . 75.44 109.353 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' D' ' 28' ' ' ALA . . . -116.66 80.44 10.58 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.476 -0.935 . . . . 74.51 108.476 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . 0.403 ' HG2' ' ND2' ' D' ' 27' ' ' ASN . 58.2 Cg_endo -69.76 -29.83 23.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.669 2.246 . . . . 71.55 112.266 -174.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.403 ' ND2' ' HG2' ' D' ' 26' ' ' PRO . 3.2 m-80 -111.49 18.03 19.51 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.721 -0.672 . . . . 64.54 109.661 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' D' ' 25' ' ' ALA . . . -39.4 -54.35 3.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 115.586 1.699 . . . . 64.34 115.586 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.471 ' HB3' HD11 ' C' ' 83' ' ' ILE . 44.4 Cg_endo -81.67 -13.55 10.64 Favored 'Trans proline' 0 C--N 1.382 2.32 0 CA-C-N 121.307 1.503 . . . . 73.23 113.439 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -76.44 -36.83 57.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.687 1.195 . . . . 73.42 109.462 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.576 HG13 HD12 ' D' ' 68' ' ' LEU . 35.7 t -65.56 -23.96 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 124.877 1.271 . . . . 75.01 111.324 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.42 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 74.3 t80 -45.9 -36.64 5.55 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.335 1.454 . . . . 70.35 113.47 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -79.1 -6.54 56.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.637 0.775 . . . . 73.1 112.518 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -109.57 112.69 24.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.787 0.835 . . . . 64.52 110.029 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.2 60.3 1.41 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.927 0.891 . . . . 53.44 110.932 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.569 ' HB2' HD21 ' D' ' 68' ' ' LEU . 20.1 m95 -124.89 158.12 34.28 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.484 -0.561 . . . . 75.01 109.484 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -71.47 112.49 14.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.79 114.42 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.671 0 C-N-CA 122.783 2.322 . . . . 75.25 112.663 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.25 109.94 3.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.146 -1.057 . . . . 74.44 108.146 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 m -108.33 106.6 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.031 0.919 . . . . 63.22 109.142 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -94.28 115.97 28.29 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.248 -1.39 . . . . 74.22 107.248 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.05 136.08 34.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.498 -0.927 . . . . 73.32 108.498 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.731 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.7 m-20 -107.69 153.8 22.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.152 0.981 . . . . 73.0 108.562 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 tp -126.97 132.47 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.157 -0.683 . . . . 75.22 109.157 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t70 -140.62 141.18 35.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.018 -1.105 . . . . 72.23 108.018 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.1 m -118.53 143.64 46.6 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.979 -0.749 . . . . 71.22 108.979 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.9 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.323 1.049 . . . . 70.23 108.317 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.5 p -170.57 157.66 5.93 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.988 0.515 . . . . 72.22 110.894 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -149.57 140.44 22.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.911 -0.774 . . . . 72.42 108.911 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.2 119.93 25.16 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 109.405 -0.591 . . . . 72.13 109.405 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.6 mt -95.02 -34.92 12.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.18 0.592 . . . . 75.32 109.853 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.33 -177.43 6.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.207 -0.906 . . . . 52.53 110.392 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -66.91 129.97 41.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.81 -1.086 . . . . 64.3 109.254 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 58.31 17.84 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.669 1.187 . . . . 72.44 113.125 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.18 125.59 72.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 123.603 0.761 . . . . 75.31 109.144 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -123.64 135.23 53.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.815 -0.809 . . . . 74.12 108.815 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.9 tt0 -86.36 111.61 20.66 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.129 -1.804 . . . . 53.1 106.129 161.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -100.37 120.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 108.079 -1.082 . . . . 73.13 108.079 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 54.4 t -101.64 130.3 51.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.923 -1.035 . . . . 64.14 109.726 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.38 126.02 51.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.463 -1.31 . . . . 75.4 107.463 172.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -112.54 100.9 9.1 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.563 -0.903 . . . . 73.01 108.563 173.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.86 127.97 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.894 -1.15 . . . . 73.24 107.894 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.731 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -116.94 148.48 41.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.467 -0.938 . . . . 70.1 108.467 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.66 131.11 71.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.108 0.963 . . . . 72.42 108.875 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -117.09 95.81 5.16 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.246 -1.39 . . . . 74.35 107.246 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.57 129.44 43.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.061 -0.718 . . . . 74.34 109.061 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.453 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 36.9 m -143.6 137.27 28.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.369 0.604 . . . . 73.55 110.83 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.576 HD12 HG13 ' D' ' 31' ' ' VAL . 38.2 mt -104.16 97.34 7.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.593 1.157 . . . . 74.12 109.077 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.85 -119.79 19.6 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.162 0.914 . . . . 75.2 113.114 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.65 25.17 3.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.443 0.697 . . . . 71.5 111.882 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -141.2 146.57 37.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.54 0.336 . . . . 75.03 110.572 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.9 m -71.78 121.59 19.2 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.89 0.744 . . . . 73.35 109.818 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -77.7 -59.86 2.61 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.484 -0.932 . . . . 75.23 108.484 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -160.95 163.03 32.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.901 -1.045 . . . . 74.01 110.494 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.48 150.32 41.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.639 -1.245 . . . . 74.32 107.639 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.557 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.6 t -157.21 144.0 18.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.788 0.435 . . . . 64.32 110.153 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.05 130.69 9.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.284 0.633 . . . . 62.34 110.253 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.86 118.38 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 71.25 110.006 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.9 mt-30 -89.87 85.94 6.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.515 0.726 . . . . 73.23 109.358 168.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.29 93.74 5.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.259 -0.882 . . . . 64.45 108.859 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.34 144.08 17.04 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.619 -0.593 . . . . 74.14 111.619 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.59 139.34 9.63 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 112.213 -0.355 . . . . 61.1 112.213 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.9 mt -88.89 122.82 40.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.646 0.778 . . . . 71.31 108.916 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' D' ' 12' ' ' GLN . 59.5 m-85 -130.44 125.84 35.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.301 0.641 . . . . 74.1 110.145 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.0 m -92.71 105.04 17.25 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.73 -1.211 . . . . 65.43 107.73 169.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.68 140.16 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.357 0.663 . . . . 74.14 109.458 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.44 169.42 15.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.756 0.823 . . . . 75.53 110.612 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.64 22.16 77.6 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-N 116.655 -0.248 . . . . 72.04 113.466 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -132.01 161.79 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.493 1.117 . . . . 73.51 109.877 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 149.23 26.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.96 0.504 . . . . 73.14 111.127 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.6 -107.72 0.41 Allowed Glycine 0 C--N 1.35 1.356 0 O-C-N 124.541 1.151 . . . . 74.01 115.552 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -71.84 -42.86 66.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.031 0.933 . . . . 72.24 111.362 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -65.13 -35.06 79.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.012 0.525 . . . . 75.4 110.571 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 40.4 ttm -61.29 -53.56 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.852 -1.067 . . . . 72.33 110.539 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.85 -19.42 61.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.453 0.701 . . . . 61.35 111.748 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.05 -43.92 61.36 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.35 1.06 . . . . 74.02 110.163 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.12 -51.98 6.26 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.965 -0.561 . . . . 63.22 111.141 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.635 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.0 tp -80.51 -30.2 37.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.594 0.358 . . . . 60.25 111.514 -171.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.71 -29.92 41.42 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.821 -0.433 . . . . 71.35 113.554 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.25 -44.37 1.58 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.434 0.617 . . . . 74.33 112.371 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -73.4 -40.96 63.9 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 111.905 0.335 . . . . 74.14 111.905 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 82.8 m -67.23 -43.13 43.45 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-O 118.827 -0.606 . . . . 71.13 112.519 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -65.72 -27.07 52.67 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 121.334 1.356 . . . . 72.11 112.905 166.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -68.57 -27.42 66.06 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.422 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 19.7 mm -67.55 -45.91 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.422 0.689 . . . . 74.21 109.619 169.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.52 -22.36 61.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.732 -0.667 . . . . 74.25 111.961 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.72 -41.14 20.16 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.023 1.119 . . . . 72.32 114.023 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' B' ' 105' ' ' ILE . 72.2 Cg_exo -55.11 -41.94 73.77 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.959 1.772 . . . . 62.24 113.053 169.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.419 ' HD2' ' HB3' ' B' ' 108' ' ' PRO . 69.8 m-85 -71.05 -38.18 72.53 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.419 -0.809 . . . . 71.33 111.021 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.24 -43.7 70.03 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.741 0.816 . . . . 71.32 110.598 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.523 ' NH2' HG22 ' B' ' 105' ' ' ILE . 25.6 ttp180 -57.17 -53.2 60.81 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.781 -1.1 . . . . 74.1 109.72 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.56 -41.27 89.77 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.322 1.014 . . . . 75.33 111.451 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.403 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 37.0 t -57.61 -43.95 85.1 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.567 0.542 . . . . 72.32 110.732 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.557 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -66.08 -49.53 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.651 0.78 . . . . 74.34 110.114 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -56.02 -43.92 78.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 73.45 111.744 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.7 t -67.25 -42.06 84.57 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.038 -0.983 . . . . 54.51 110.3 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.1 mtm -66.72 -34.04 76.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.959 0.504 . . . . 74.43 111.46 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.494 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.2 t -62.23 -47.96 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 123.759 0.662 . . . . 74.45 109.736 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.3 p -72.21 -30.87 65.35 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.915 -0.584 . . . . 64.22 111.262 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -69.02 -30.5 68.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.798 0.839 . . . . 74.12 110.237 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.75 12.21 60.0 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.782 0.676 . . . . 64.25 112.982 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.469 HG23 ' HG2' ' A' ' 125' ' ' GLN . 30.2 p 59.58 28.69 18.16 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.956 1.702 . . . . 74.53 112.839 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.21 160.35 26.45 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.389 1.076 . . . . 73.2 108.928 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 126.54 16.65 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.719 2.28 . . . . 75.24 112.044 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.46 HE21 ' ND2' ' D' ' 127' ' ' ASN . 30.6 tt0 -50.83 121.81 6.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.315 1.046 . . . . 71.03 111.678 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.16 96.8 6.62 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.573 0.749 . . . . 72.44 110.144 -170.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.46 ' ND2' HE21 ' D' ' 125' ' ' GLN . 1.9 p30 -116.94 84.75 2.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.409 1.084 . . . . 74.32 109.975 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.84 157.29 35.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.698 -1.137 . . . . 73.42 111.636 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.64 156.62 88.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.968 0.907 . . . . 62.43 110.593 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.599 ' HD3' HG13 ' B' ' 13' ' ' ILE . 1.0 OUTLIER -80.4 147.36 17.94 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.115 1.876 . . . . 74.13 110.379 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.46 108.11 24.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.699 0.761 . . . . 73.52 109.332 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 . . . . . 0 C--O 1.242 0.68 0 N-CA-C 107.804 -1.184 . . . . 61.54 107.804 175.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.633 -0.506 . . . . 73.31 109.633 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -106.25 141.32 37.78 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.587 -0.894 . . . . 73.52 108.587 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 7.4 tp-100 -149.16 139.74 22.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.043 0.537 . . . . 71.53 110.854 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 tp -94.81 127.2 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.803 0.841 . . . . 64.53 109.396 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.541 ' NE2' HG21 ' A' ' 83' ' ' ILE . 27.7 tt0 -103.09 -28.15 12.13 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 118.585 -0.721 . . . . 65.11 111.239 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -178.27 127.62 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.777 0.717 . . . . 74.55 111.154 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.52 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 64.2 mt -107.93 133.58 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.557 -0.905 . . . . 73.22 108.557 168.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -170.16 164.66 9.2 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.511 0.724 . . . . 74.21 110.664 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -85.97 117.69 24.98 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.77 -0.826 . . . . 63.32 108.77 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.6 mtpt -80.08 -29.95 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.345 -0.388 . . . . 70.21 110.145 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -153.97 148.12 25.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.54 0.525 . . . . 71.03 109.864 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.6 mt -138.74 145.4 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.969 1.307 . . . . 74.44 107.875 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 t -150.06 139.87 21.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.332 0.653 . . . . 64.32 109.761 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.7 t80 -145.22 112.26 6.01 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.415 -1.698 . . . . 74.53 106.415 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -123.02 109.99 14.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.243 -0.651 . . . . 65.11 109.243 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.28 86.49 9.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.79 -1.189 . . . . 74.24 107.79 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.02 -17.16 19.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.475 2.117 . . . . 72.13 111.343 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.99 31.12 6.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.269 1.027 . . . . 74.15 109.369 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' HG13 ' A' ' 31' ' ' VAL . . . -59.54 -45.63 98.76 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-N 115.165 -0.925 . . . . 74.42 112.82 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.44 -25.05 48.84 Favored 'Trans proline' 0 C--N 1.398 3.161 0 CA-C-N 121.517 1.577 . . . . 74.41 112.456 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -71.02 -26.32 63.06 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.128 0.571 . . . . 75.43 111.006 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 28' ' ' ALA . 7.2 p -65.67 -12.69 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 118.455 0.571 . . . . 74.23 111.904 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.15 -39.29 75.44 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.87 0.468 . . . . 72.43 110.668 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.455 ' HG3' ' HG2' ' A' ' 34' ' ' LYS . 9.1 pt20 -89.56 -38.71 13.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.308 0.643 . . . . 73.42 110.667 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 2.0 mmmp? -82.73 128.73 34.65 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.049 0.94 . . . . 74.11 109.219 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.03 153.21 32.54 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.127 -0.323 . . . . 75.32 110.127 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 -81.59 78.99 8.27 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.998 0.428 . . . . 64.14 110.654 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -124.64 82.34 59.63 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 107.459 -1.312 . . . . 74.15 107.459 168.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.8 158.58 11.98 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.324 2.016 . . . . 73.44 112.466 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.3 103.38 11.51 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.654 -1.98 . . . . 74.12 105.654 159.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.38 135.28 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 70.33 109.704 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 87.6 tttt -110.89 129.77 55.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.458 0.703 . . . . 74.11 109.114 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.9 tp -97.2 109.74 22.43 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.149 -1.426 . . . . 74.02 107.149 166.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 25.5 t70 -105.74 139.76 39.83 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.068 -1.086 . . . . 74.31 108.068 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.13 128.08 41.1 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.689 -1.226 . . . . 74.23 107.689 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 28.0 t70 -140.7 159.23 42.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.224 1.01 . . . . 72.42 108.644 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 t -133.95 159.32 41.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.425 0.631 . . . . 73.24 111.063 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -141.51 150.14 41.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.224 1.409 . . . . 71.32 107.727 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -132.15 149.76 52.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.02 -0.363 . . . . 71.03 110.02 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -158.36 118.89 3.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.81 0.844 . . . . 64.12 108.729 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.27 117.09 21.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.327 -0.62 . . . . 74.41 109.327 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 83' ' ' ILE . 81.7 mt -86.35 -43.29 12.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.86 0.464 . . . . 62.32 110.715 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.82 -174.1 4.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.72 0.808 . . . . 72.25 110.163 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.9 121.5 18.21 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.25 -7.25 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.176 1.79 . . . . 74.35 111.807 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.78 120.67 55.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 124.433 1.093 . . . . 75.41 108.712 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -135.34 170.51 15.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.218 -1.03 . . . . 75.15 108.218 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -131.23 136.8 48.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.28 -0.637 . . . . 72.3 109.28 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 75.4 t -114.42 121.29 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.62 -0.881 . . . . 71.33 108.62 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.8 t -100.5 125.99 54.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.982 -0.748 . . . . 72.25 108.982 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 114.93 26.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.343 -1.354 . . . . 74.24 107.343 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -92.39 99.56 12.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.633 -1.247 . . . . 74.12 107.633 170.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.551 HG21 ' HB1' ' A' ' 110' ' ' ALA . 11.9 t -94.62 135.12 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.83 -1.544 . . . . 73.0 106.83 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 31.8 m -134.09 123.34 24.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.538 0.685 . . . . 74.24 110.73 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.629 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.1 t -109.18 107.76 23.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.902 1.281 . . . . 65.51 108.779 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -108.23 112.79 25.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.623 -0.88 . . . . 71.31 108.623 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.74 116.85 28.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.417 -1.327 . . . . 72.12 107.417 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -123.31 132.12 53.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.018 0.437 . . . . 74.24 110.867 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 62.0 mt -87.24 84.25 7.26 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.879 1.271 . . . . 71.35 109.217 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -91.02 1.1 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.935 -1.03 . . . . 65.3 111.525 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.38 -29.94 7.6 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.426 0.69 . . . . 74.23 110.681 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.13 133.33 35.44 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.305 0.642 . . . . 74.43 109.673 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -69.85 135.97 50.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.802 0.441 . . . . 74.1 110.954 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.451 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -78.4 -56.4 4.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.762 -0.829 . . . . 74.14 108.762 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -164.36 174.62 10.85 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 113.97 -1.468 . . . . 74.31 110.26 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -138.58 116.6 11.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.752 -1.113 . . . . 75.51 108.741 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.629 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.5 m -103.56 139.65 38.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.514 -0.921 . . . . 73.2 108.514 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -146.88 117.88 7.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.616 -0.883 . . . . 75.11 108.616 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.04 113.84 39.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 123.766 0.827 . . . . 75.54 109.413 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 16.0 mp0 -84.6 85.28 7.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.491 -1.232 . . . . 74.32 108.352 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -83.79 92.38 7.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.109 -1.441 . . . . 74.33 107.109 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.87 142.83 18.67 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.409 -0.676 . . . . 75.13 111.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.32 122.03 2.2 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 110.759 -0.936 . . . . 73.35 110.759 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.541 HG21 ' NE2' ' A' ' 14' ' ' GLN . 39.4 mt -81.89 125.89 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 107.789 -1.189 . . . . 73.51 107.789 172.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -128.59 164.58 22.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.36 0.664 . . . . 73.03 109.932 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 20.4 t -120.26 121.23 38.23 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.553 1.141 . . . . 75.43 109.212 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -138.55 150.1 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 123.378 0.671 . . . . 73.3 109.766 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.93 173.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.21 1.404 . . . . 50.34 110.211 167.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.96 88.67 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.952 0.783 . . . . 75.15 113.598 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -117.36 172.34 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.213 1.405 . . . . 73.11 109.427 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.6 tt0 -169.45 -177.63 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.814 0.846 . . . . 75.32 109.238 172.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.474 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.78 -142.81 42.62 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 123.44 0.543 . . . . 70.11 113.808 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -68.91 -18.95 64.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.835 0.854 . . . . 75.32 111.527 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -48.76 53.71 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.071 0.548 . . . . 74.55 109.586 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.416 ' HG3' ' N ' ' A' ' 95' ' ' ALA . 9.2 ptm -69.55 -36.67 76.57 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.691 0.281 . . . . 73.13 110.316 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 94' ' ' MET . . . -71.06 -28.52 64.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.651 0.78 . . . . 71.21 111.221 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.27 -37.75 13.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.38 -0.373 . . . . 74.12 110.942 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.8 t -66.02 -52.98 44.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.905 0.482 . . . . 74.43 110.39 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 tt -76.33 -39.38 54.16 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.605 0.762 . . . . 72.52 109.853 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.99 -24.16 58.24 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.031 0.772 . . . . 74.53 115.031 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -42.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.927 0.864 . . . . 70.4 112.306 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 59.4 t80 -78.73 -36.75 42.84 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 122.966 0.506 . . . . 74.14 112.339 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -72.52 -41.05 7.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-O 118.551 -0.738 . . . . 74.24 111.446 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.88 -21.93 63.69 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 121.485 1.457 . . . . 72.01 113.129 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -67.07 -37.29 83.76 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 122.795 0.438 . . . . 75.1 109.977 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -57.93 -41.8 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 65.5 110.064 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.558 HD22 ' HA3' ' A' ' 82' ' ' GLY . 60.4 mt -80.12 -24.65 40.35 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.486 -1.233 . . . . 70.3 111.651 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.56 -39.49 48.76 Favored Pre-proline 0 CA--C 1.575 1.915 0 N-CA-C 114.782 1.401 . . . . 54.23 114.782 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.17 -40.11 72.64 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 122.273 1.982 . . . . 74.43 112.58 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.41 ' CD2' ' HG3' ' C' ' 108' ' ' PRO . 90.8 m-85 -77.13 -32.44 56.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.03 -0.986 . . . . 73.23 110.833 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -68.62 -43.44 76.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 71.25 109.77 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.469 HH22 ' HG3' ' A' ' 130' ' ' PRO . 36.8 ttm180 -55.32 -54.26 45.85 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.629 1.205 . . . . 74.13 110.054 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.99 -40.58 98.2 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.347 1.029 . . . . 74.33 111.432 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.1 t -59.82 -37.01 77.96 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.919 0.762 . . . . 61.44 111.023 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.477 HG21 HG23 ' A' ' 64' ' ' VAL . 78.6 mt -72.52 -54.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.638 0.775 . . . . 64.41 110.147 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 125' ' ' GLN . 98.6 m -52.13 -37.04 53.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.797 1.639 . . . . 74.44 111.607 -174.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.09 -45.65 59.82 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.073 -0.967 . . . . 74.22 110.629 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.517 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.4 mtm -59.56 -41.47 90.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.107 0.48 . . . . 74.52 110.899 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.97 -46.97 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.828 1.251 . . . . 73.13 110.848 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -72.15 -30.66 65.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.699 0.4 . . . . 71.23 111.353 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.0 -26.94 63.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 75.33 110.418 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 7.77 57.72 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.897 -0.592 . . . . 73.05 113.342 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.7 m 66.98 30.85 7.34 Favored 'General case' 0 C--N 1.364 1.236 0 C-N-CA 124.671 1.188 . . . . 73.14 110.455 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -107.92 139.31 20.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.058 -1.089 . . . . 75.41 108.058 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 140.21 61.73 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.559 2.173 . . . . 73.41 112.609 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.475 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.0 tt0 -53.07 140.96 23.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.58 1.152 . . . . 72.05 112.163 -176.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.0 109.59 10.63 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.91 -1.145 . . . . 75.22 107.91 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -103.84 104.89 14.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.603 0.761 . . . . 74.31 108.96 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 66.3 mt -72.48 116.95 13.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.294 -0.632 . . . . 71.13 109.294 172.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.66 149.27 52.8 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.522 1.129 . . . . 61.3 111.922 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.469 ' HG3' HH22 ' A' ' 111' ' ' ARG . 5.4 Cg_exo -71.01 -176.75 1.95 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.573 2.182 . . . . 73.23 112.435 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -133.26 126.22 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.598 -0.89 . . . . 61.41 108.598 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -80.27 74.49 7.1 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.78 -0.822 . . . . 72.43 108.78 173.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 123.674 0.79 . . . . 75.51 111.714 -174.671 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 108.824 -0.806 . . . . 75.43 108.824 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.409 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 67.8 t80 -128.82 150.6 50.25 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.284 0.564 . . . . 75.41 111.899 -166.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.459 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 33.4 tp60 -142.54 123.63 14.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.054 1.342 . . . . 71.23 108.184 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.14 143.83 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.134 0.573 . . . . 75.33 109.984 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -116.94 -51.61 2.55 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.776 0.43 . . . . 74.32 110.841 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -162.53 143.65 10.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.405 0.282 . . . . 74.15 110.256 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -115.29 143.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.381 -1.34 . . . . 70.32 107.381 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -170.71 144.08 2.25 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.565 0.62 . . . . 73.31 111.716 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.3 m -75.25 121.72 22.59 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.976 -0.75 . . . . 71.4 108.976 172.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -88.73 -37.96 15.09 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.12 0.568 . . . . 75.41 110.312 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.6 t70 -152.89 144.08 23.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.283 -0.417 . . . . 72.5 112.071 -168.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.776 HD12 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -137.99 147.34 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.472 1.509 . . . . 65.55 108.492 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -150.58 150.69 31.52 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 73.23 108.78 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.9 t80 -160.19 114.7 2.24 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 106.625 -1.621 . . . . 72.31 106.625 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.78 113.91 20.34 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.408 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -106.96 89.23 4.24 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.649 -0.871 . . . . 71.04 108.649 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.46 -27.11 33.85 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.409 2.073 . . . . 74.44 112.035 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -123.3 30.59 6.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.372 1.069 . . . . 74.21 109.661 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -42.47 -52.07 10.74 Favored Pre-proline 0 CA--C 1.568 1.659 0 C-N-CA 125.525 1.53 . . . . 62.43 114.431 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.16 -17.61 27.8 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.359 2.04 . . . . 72.1 112.802 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.43 2.97 56.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.491 1.116 . . . . 73.23 111.244 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.02 -27.95 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.807 0.443 . . . . 74.23 111.327 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -64.74 -41.03 96.23 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.247 0.619 . . . . 75.35 109.996 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -65.0 -29.6 70.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.562 1.145 . . . . 75.44 110.799 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.459 ' HB2' HD12 ' B' ' 68' ' ' LEU . 33.0 mmtp -108.85 96.72 6.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.317 1.047 . . . . 74.45 110.637 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.37 78.02 7.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.048 0.539 . . . . 74.54 111.287 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.6 170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.238 1.015 . . . . 64.2 109.727 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 48.9 tt0 -67.29 119.04 62.03 Favored Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 123.789 0.681 . . . . 74.53 109.653 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.53 140.58 89.85 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.129 1.886 . . . . 74.34 110.842 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.464 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 36.3 mt-10 -67.04 100.45 0.75 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.708 -0.849 . . . . 74.2 108.708 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.09 120.84 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.758 -1.571 . . . . 72.32 106.758 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -144.08 126.68 16.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.577 -0.898 . . . . 75.33 108.577 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.485 HD11 HD11 ' B' ' 126' ' ' LEU . 1.8 pt? -129.29 159.02 37.45 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.982 0.513 . . . . 74.52 111.125 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -143.45 150.38 38.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.251 0.62 . . . . 74.11 110.77 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.13 144.03 29.29 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.726 1.21 . . . . 73.42 110.729 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.91 146.04 21.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 75.21 107.787 167.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.3 m -145.78 139.71 26.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.108 0.563 . . . . 73.42 110.004 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.31 134.76 18.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.101 0.96 . . . . 71.31 108.848 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.42 ' HG ' HD11 ' B' ' 98' ' ' LEU . 88.8 p -132.62 166.09 22.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.326 0.65 . . . . 73.4 110.343 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.1 p -153.09 137.19 16.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.645 0.778 . . . . 75.12 109.454 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -80.85 120.38 24.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.331 0.652 . . . . 75.44 110.539 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' B' ' 57' ' ' GLU . 38.4 mt -82.23 -50.03 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.754 0.822 . . . . 74.43 109.995 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.54 -171.11 3.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.272 1.029 . . . . 72.3 110.174 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.58 113.06 3.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.448 0.699 . . . . 73.22 110.56 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.4 m-20 71.06 -5.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.021 1.728 . . . . 73.41 112.694 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.68 116.62 46.72 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 108.15 -1.056 . . . . 71.4 108.15 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 155.33 50.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.172 -0.677 . . . . 75.25 109.172 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.443 ' HB2' HD13 ' B' ' 51' ' ' LEU . 6.9 tm-20 -111.68 112.28 23.87 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.342 -1.355 . . . . 75.42 107.342 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.95 127.21 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.964 0.905 . . . . 63.5 110.031 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -108.36 128.22 64.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.714 0.805 . . . . 73.25 109.282 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -105.44 109.11 20.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.794 -1.188 . . . . 75.24 107.794 175.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -93.41 119.25 32.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.838 0.455 . . . . 75.11 110.489 170.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 43.6 t -113.1 105.69 19.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.658 -1.238 . . . . 72.31 107.658 167.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -99.18 133.26 43.73 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.459 -0.571 . . . . 71.42 109.459 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 21.7 t -119.62 126.92 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.261 1.425 . . . . 71.03 109.069 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -114.72 149.13 37.31 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.426 1.09 . . . . 54.13 108.27 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.33 153.01 50.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.136 0.575 . . . . 63.13 109.736 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 33.5 p -146.13 141.23 27.31 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.606 0.566 . . . . 72.51 111.152 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' B' ' 34' ' ' LYS . 22.2 mt -130.17 99.82 5.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.253 1.421 . . . . 65.12 108.68 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -109.15 2.78 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.339 -0.391 . . . . 55.3 112.411 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -118.09 23.6 11.52 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.387 1.075 . . . . 74.22 110.555 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.86 160.72 42.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.116 0.566 . . . . 73.21 110.301 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -72.61 134.25 45.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.763 -0.653 . . . . 65.11 110.249 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.11 -58.07 2.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 73.23 109.271 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -153.19 173.54 15.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.787 -1.097 . . . . 72.5 109.779 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 73.2 mt -138.89 155.85 47.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.251 1.821 . . . . 74.21 106.473 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.561 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.4 t -160.49 159.59 30.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.81 0.844 . . . . 73.41 108.817 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.21 140.52 6.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.505 -0.924 . . . . 72.4 108.505 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' B' ' 110' ' ' ALA . 72.7 t -129.82 142.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.932 -1.136 . . . . 73.32 107.932 171.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -124.98 87.76 2.77 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.207 -1.035 . . . . 74.02 108.207 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -81.94 100.87 9.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.455 -1.248 . . . . 71.33 109.129 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.43 175.22 35.8 Favored Glycine 0 C--O 1.241 0.534 0 N-CA-C 111.954 -0.458 . . . . 73.53 111.954 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.97 137.16 3.73 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.932 -0.467 . . . . 64.44 111.932 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 127.01 40.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.775 -0.824 . . . . 71.5 108.775 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -138.64 161.24 37.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.405 1.082 . . . . 72.44 109.581 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.0 m -132.39 133.6 44.13 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.777 1.231 . . . . 73.1 108.982 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.566 HG23 ' SG ' ' B' ' 97' ' ' CYS . 2.7 pp -139.18 147.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 122.876 0.47 . . . . 70.32 111.868 -171.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.92 170.58 16.32 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.986 0.915 . . . . 75.15 109.749 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.12 16.31 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.426 -0.352 . . . . 70.23 113.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.14 142.54 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.385 1.074 . . . . 70.31 112.848 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.661 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 14.1 pt-20 -160.73 142.07 12.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.324 1.05 . . . . 65.5 109.026 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.08 -106.15 0.76 Allowed Glycine 0 C--N 1.354 1.564 0 C-N-CA 123.081 0.372 . . . . 40.24 113.928 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.2 m -77.21 -30.27 54.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.768 1.227 . . . . 73.44 111.796 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.661 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 1.5 mp0 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.421 0.689 . . . . 74.42 110.793 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 41.9 mtp -70.44 -39.79 74.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.607 0.763 . . . . 73.34 110.057 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.53 64.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 73.02 111.397 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.52 -39.23 92.88 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.334 0.654 . . . . 75.23 110.934 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.566 ' SG ' HG23 ' B' ' 86' ' ' ILE . 44.9 t -61.12 -61.56 2.48 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.109 -0.95 . . . . 75.13 111.635 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.42 HD11 ' HG ' ' B' ' 48' ' ' SER . 1.9 pt? -90.77 -18.4 25.0 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.575 0.583 . . . . 71.2 112.575 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.68 -26.72 11.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.232 0.333 . . . . 75.1 113.673 -173.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -55.96 1.86 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.371 0.508 . . . . 54.33 112.371 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -73.76 -60.06 2.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.524 0.33 . . . . 73.4 110.793 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.409 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 85.8 m -58.49 -46.18 99.63 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.196 -0.907 . . . . 72.51 112.225 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.418 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.9 Cg_exo -58.9 -36.52 96.78 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.039 1.826 . . . . 64.4 113.759 172.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -66.87 -29.83 69.84 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 118.625 0.648 . . . . 74.02 110.849 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -63.04 -50.25 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.03 0.532 . . . . 75.14 109.877 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -79.34 -10.42 59.81 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.162 -1.381 . . . . 75.35 111.883 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.403 ' HE1' HD13 ' B' ' 128' ' ' LEU . 24.1 t80 -65.55 -49.67 60.77 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.654 1.181 . . . . 75.54 113.109 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' B' ' 112' ' ' GLU . 25.1 Cg_exo -62.31 -35.72 71.8 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 121.494 1.463 . . . . 73.42 111.353 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -64.17 -48.6 75.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.069 0.947 . . . . 74.52 110.793 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.459 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -63.66 -49.08 74.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.127 0.971 . . . . 61.42 110.734 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -67.46 -43.31 81.36 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.95 0.781 . . . . 74.35 110.381 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' B' ' 108' ' ' PRO . 0.4 OUTLIER -69.26 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.131 0.972 . . . . 74.42 111.609 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' B' ' 21' ' ' ILE . 7.7 t -74.16 -39.05 63.5 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.8 -0.445 . . . . 71.42 109.8 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.48 HG21 HG22 ' B' ' 64' ' ' VAL . 94.2 mt -62.82 -46.76 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.604 0.762 . . . . 71.52 110.078 173.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.445 HG23 ' OE1' ' C' ' 125' ' ' GLN . 44.1 m -50.41 -39.52 47.45 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.958 1.303 . . . . 75.41 110.701 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.8 t -66.34 -56.15 12.51 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 113.957 -1.474 . . . . 72.34 110.552 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.7 mmt -64.26 -38.13 89.95 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.659 0.615 . . . . 73.54 112.659 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.28 -46.41 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.421 1.088 . . . . 74.32 110.409 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.556 ' HB3' ' NE2' ' C' ' 125' ' ' GLN . 81.9 p -71.71 -25.28 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.568 -0.742 . . . . 75.24 111.465 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.1 mtt-85 -65.47 -39.44 91.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.158 0.583 . . . . 73.21 110.091 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.11 3.85 50.06 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.631 -0.713 . . . . 74.42 113.15 172.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p 59.72 48.98 8.65 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 126.512 1.925 . . . . 75.42 111.27 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -115.69 161.61 29.5 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-N 113.867 -1.515 . . . . 74.32 110.585 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.524 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 89.0 Cg_exo -53.2 177.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 125.031 3.82 . . . . 74.41 118.509 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.65 147.48 52.9 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 113.824 -1.534 . . . . 74.42 113.688 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.485 HD11 HD11 ' B' ' 42' ' ' LEU . 3.5 tm? -149.97 106.73 3.54 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.166 -1.379 . . . . 74.35 107.626 173.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -137.72 118.82 14.43 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.679 -1.23 . . . . 60.43 107.679 163.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.451 HD22 ' N ' ' B' ' 129' ' ' ALA . 2.2 tt -79.91 135.3 36.39 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.241 -0.652 . . . . 74.21 109.241 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.451 ' N ' HD22 ' B' ' 128' ' ' LEU . . . -57.19 141.95 76.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.406 1.482 . . . . 71.13 113.078 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.487 ' HG3' ' H ' ' D' ' 16' ' ' ILE . 61.4 Cg_endo -71.97 99.26 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.673 2.249 . . . . 73.14 111.818 171.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.28 105.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 109.24 -0.652 . . . . 72.35 109.24 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -70.1 117.66 11.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.391 0.677 . . . . 73.23 110.719 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 19.2 p90 . . . . . 0 CA--C 1.555 1.173 0 C-N-CA 123.574 0.75 . . . . 74.35 112.911 177.793 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.0 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.404 -0.591 . . . . 72.04 109.404 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -107.83 163.74 12.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.635 1.174 . . . . 73.13 111.317 -169.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.023 0.929 . . . . 73.12 109.213 161.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.494 HD13 HG13 ' C' ' 16' ' ' ILE . 5.5 tp -78.55 133.62 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.03 -0.73 . . . . 72.21 109.03 167.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -103.7 -47.93 4.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.552 0.741 . . . . 73.22 110.388 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -169.65 134.31 1.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.637 -0.256 . . . . 74.32 110.435 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.494 HG13 HD13 ' C' ' 13' ' ' ILE . 92.3 mt -122.34 135.25 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.451 -0.944 . . . . 75.33 108.451 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.473 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 10.3 p90 -171.63 157.1 4.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.244 0.545 . . . . 71.34 111.821 -172.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -82.02 118.43 22.99 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.289 -0.869 . . . . 73.45 109.813 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -69.76 -45.96 66.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.661 0.743 . . . . 74.35 109.216 172.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -146.29 146.41 30.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 113.882 -1.508 . . . . 74.51 108.956 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.3 mt -138.99 140.16 39.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.99 -1.485 . . . . 73.14 106.99 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -152.52 148.63 27.61 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.273 0.558 . . . . 74.24 110.213 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -154.36 107.83 2.91 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.376 -1.342 . . . . 74.14 107.376 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.43 112.09 20.19 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.415 -0.958 . . . . 74.53 108.415 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.22 95.93 32.74 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.403 1.081 . . . . 75.25 109.355 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.5 -39.88 33.85 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.793 2.328 . . . . 73.5 111.977 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -96.25 29.4 2.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.931 -1.031 . . . . 75.55 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.43 -48.34 97.13 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.684 -0.674 . . . . 51.45 112.412 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.58 -31.14 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 121.455 1.437 . . . . 72.22 113.387 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -71.13 -25.11 62.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.383 0.673 . . . . 71.4 112.415 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.93 -22.08 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.531 0.732 . . . . 74.44 111.546 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.44 -36.81 71.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.269 1.027 . . . . 74.15 111.12 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.86 45.94 1.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.996 0.903 . . . . 73.43 109.012 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.806 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -123.49 155.1 38.17 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.931 0.892 . . . . 73.4 110.859 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.41 115.38 8.61 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.363 -0.977 . . . . 71.33 108.363 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -80.46 71.18 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.092 0.957 . . . . 71.43 111.887 -173.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' C' ' 68' ' ' LEU . 25.8 tt0 -122.66 78.18 47.7 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.897 0.879 . . . . 75.31 109.821 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.06 128.58 15.02 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.262 1.975 . . . . 74.32 111.152 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -87.7 107.36 18.6 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 74.5 106.785 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.31 113.65 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 124.113 0.883 . . . . 75.41 109.913 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.07 115.43 23.09 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.457 -1.312 . . . . 73.4 107.457 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.445 ' H ' HD21 ' C' ' 42' ' ' LEU . 2.7 pt? -110.47 143.97 39.99 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.341 -0.985 . . . . 71.24 108.341 169.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.26 144.08 26.28 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.968 -0.752 . . . . 63.3 108.968 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.89 123.94 51.0 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.588 0.555 . . . . 72.01 109.948 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -113.07 145.04 41.59 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.883 -1.525 . . . . 64.4 106.883 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -125.15 154.58 41.27 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.059 0.544 . . . . 64.34 110.001 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.6 161.51 39.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.499 1.119 . . . . 65.02 108.605 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.3 p -158.88 152.75 23.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.88 0.472 . . . . 62.32 110.978 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -156.84 130.28 8.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.721 0.808 . . . . 72.53 109.937 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -74.76 121.5 21.84 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.086 -0.709 . . . . 75.1 109.086 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.69 HD12 ' HB2' ' C' ' 57' ' ' GLU . 39.6 mt -94.98 -50.38 5.13 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.62 0.724 . . . . 74.45 110.864 -173.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -149.3 -172.19 4.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.749 -1.114 . . . . 74.25 109.945 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -69.96 113.89 7.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.852 0.461 . . . . 74.42 109.769 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 70.66 -0.38 2.97 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.674 1.589 . . . . 73.54 112.303 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 61.2 t -109.92 122.1 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 60.42 108.483 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.489 ' HH ' ' HB3' ' C' ' 98' ' ' LEU . 47.2 p90 -134.66 176.58 8.51 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.679 0.752 . . . . 74.42 109.711 174.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.69 ' HB2' HD12 ' C' ' 51' ' ' LEU . 36.7 tt0 -125.39 141.41 52.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.444 -1.253 . . . . 72.11 108.159 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.85 140.18 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.09 -1.078 . . . . 75.12 108.09 164.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.2 t -126.38 116.5 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.99 0.916 . . . . 74.53 109.465 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -87.8 104.88 16.99 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 122.761 0.424 . . . . 63.53 110.261 174.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -86.81 101.46 13.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.107 -1.071 . . . . 74.44 108.107 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.575 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.1 t -99.84 132.0 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.645 -1.243 . . . . 74.43 107.645 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -122.92 123.12 40.23 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.502 -0.555 . . . . 73.42 109.502 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.586 HG23 HG21 ' C' ' 114' ' ' ILE . 92.7 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.369 1.067 . . . . 73.33 108.858 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -98.57 139.46 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.004 -1.11 . . . . 74.23 108.004 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.43 114.21 8.04 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.633 -0.877 . . . . 70.41 108.633 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.8 m -123.73 135.35 53.8 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.941 0.497 . . . . 73.33 111.015 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.806 HD12 ' HG2' ' C' ' 34' ' ' LYS . 13.3 mt -85.53 55.17 3.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.032 1.333 . . . . 75.55 109.148 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -110.18 3.81 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.943 -1.263 . . . . 74.55 109.943 -172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.7 -23.72 17.45 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.876 . . . . 75.22 110.244 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -91.47 108.63 20.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.4 1.08 . . . . 73.25 110.027 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 59.0 m -70.19 122.65 19.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.304 0.642 . . . . 75.01 112.43 -171.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.57 ' HB3' ' HG ' ' C' ' 68' ' ' LEU . . . -67.77 -58.47 4.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.607 1.163 . . . . 74.03 110.254 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -154.53 176.2 12.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.587 -1.188 . . . . 74.23 111.05 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.79 109.75 5.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.578 -1.638 . . . . 75.33 106.578 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.517 ' SG ' HG22 ' C' ' 114' ' ' ILE . 43.6 t -107.45 146.25 31.97 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.528 -0.916 . . . . 74.52 108.528 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -158.24 129.77 6.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.807 -0.442 . . . . 73.31 109.807 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.24 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.309 1.044 . . . . 73.14 108.592 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.4 mt-30 -114.5 98.68 7.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 74.21 108.753 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -91.33 105.24 17.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.938 0.895 . . . . 75.15 110.26 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.78 151.45 22.33 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.311 0.382 . . . . 52.52 112.274 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.503 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.54 121.34 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.448 -0.661 . . . . 75.0 111.448 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.481 HD13 ' HB3' ' D' ' 29' ' ' PRO . 23.9 mm -82.69 127.8 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.747 -0.834 . . . . 75.43 108.747 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -136.23 126.03 25.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.335 0.654 . . . . 74.35 110.051 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.1 p -101.43 106.54 17.69 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.662 -0.866 . . . . 75.01 108.662 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.435 HD11 ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER -148.42 143.94 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.622 0.725 . . . . 72.32 111.369 -177.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.62 179.38 7.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.293 1.437 . . . . 71.03 109.716 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.72 52.74 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 114.618 0.607 . . . . 64.03 114.618 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 123.331 0.653 . . . . 73.24 111.865 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.722 -0.473 . . . . 74.31 109.722 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.8 ttm -63.89 -47.31 81.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 75.25 111.053 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.295 -0.866 . . . . 74.45 110.854 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -74.68 -24.91 58.86 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.98 -0.554 . . . . 74.5 111.731 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' C' ' 86' ' ' ILE . 42.7 t -72.06 -62.71 1.33 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.84 0.456 . . . . 74.43 111.503 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.489 ' HB3' ' HH ' ' C' ' 56' ' ' TYR . 0.0 OUTLIER -100.84 -6.86 24.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.764 -0.585 . . . . 72.12 112.433 -176.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.64 2.61 49.3 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.669 -0.517 . . . . 70.31 113.286 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.56 -58.55 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.267 0.533 . . . . 75.31 111.858 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -65.4 -67.9 0.4 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.36 1.064 . . . . 74.44 112.212 -168.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -57.84 -43.98 99.05 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.299 1.039 . . . . 62.2 112.813 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.35 -34.18 55.89 Favored 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 121.638 1.559 . . . . 75.14 113.575 170.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -72.0 -19.14 61.91 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 118.76 0.709 . . . . 73.1 110.866 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.419 HD13 HH12 ' A' ' 111' ' ' ARG . 40.5 mm -66.08 -41.75 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.515 0.726 . . . . 75.52 109.551 167.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.503 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.1 mt -79.13 -28.1 42.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.26 -0.882 . . . . 63.15 112.053 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -53.74 -45.97 98.56 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.364 -1.303 . . . . 73.42 113.271 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 109' ' ' TYR . 47.4 Cg_exo -53.96 -40.54 80.56 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 122.329 2.019 . . . . 72.11 113.274 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -69.21 -43.57 73.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.445 0.698 . . . . 72.33 110.651 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.82 98.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 73.41 110.718 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -57.94 -48.54 79.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.81 1.644 . . . . 73.54 110.751 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -72.35 -33.94 67.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.771 0.828 . . . . 73.45 110.541 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -65.03 -43.34 92.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.71 0.804 . . . . 74.33 110.466 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.586 HG21 HG23 ' C' ' 64' ' ' VAL . 87.9 mt -66.52 -50.03 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.212 0.605 . . . . 73.55 110.23 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.481 HG23 ' HB2' ' C' ' 125' ' ' GLN . 58.8 m -50.15 -44.28 52.5 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 124.555 1.16 . . . . 75.31 111.055 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.4 t -68.77 -46.82 67.76 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.484 -1.234 . . . . 75.4 110.012 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.566 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.75 -43.89 63.1 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.013 0.925 . . . . 71.43 112.229 178.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.1 t -66.1 -45.38 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.489 0.716 . . . . 71.5 110.668 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -70.47 -26.51 63.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.926 -0.579 . . . . 62.02 111.229 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.3 mtt-85 -65.99 -38.59 88.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.784 0.833 . . . . 74.23 110.413 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.69 3.7 63.09 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.755 -0.657 . . . . 71.43 112.826 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.447 HG21 ' HB3' ' D' ' 17' ' ' TYR . 25.5 p 63.32 33.42 14.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.349 1.86 . . . . 74.21 112.152 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.43 168.09 9.02 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.721 1.208 . . . . 71.12 109.609 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.48 106.51 0.6 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 122.386 2.058 . . . . 74.32 110.984 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.556 ' NE2' ' HB3' ' B' ' 119' ' ' SER . 18.7 pt20 -54.45 135.53 45.4 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.04 . . . . 72.22 111.842 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.01 89.67 3.71 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.402 0.62 . . . . 71.24 109.969 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -111.5 86.42 2.33 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.603 -1.629 . . . . 61.41 106.603 167.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 76.4 mt -87.52 153.8 21.13 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.261 -1.336 . . . . 75.41 109.985 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.25 127.84 5.85 Favored Pre-proline 0 CA--C 1.556 1.193 0 O-C-N 124.599 1.187 . . . . 52.01 112.817 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.52 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 37.0 Cg_endo -61.08 104.16 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.558 2.839 . . . . 73.12 113.054 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.68 91.66 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-O 121.955 0.883 . . . . 64.41 111.076 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -88.54 102.39 14.88 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.241 -1.022 . . . . 72.11 108.241 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 64.8 t80 . . . . . 0 CA--C 1.547 0.865 0 C-N-CA 123.877 0.871 . . . . 74.5 112.325 -173.509 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.779 -0.823 . . . . 73.42 108.779 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -156.57 111.1 2.78 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.691 -1.226 . . . . 64.43 107.691 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 79.2 mt-30 -117.66 116.63 27.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.565 0.746 . . . . 71.52 110.312 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.91 104.87 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.928 -1.508 . . . . 62.12 106.928 168.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.458 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 76.3 mt-30 -80.79 -41.9 22.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 119.106 -0.473 . . . . 75.13 110.759 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 177.96 144.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.686 0.616 . . . . 75.42 111.722 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.487 ' H ' ' HG3' ' B' ' 130' ' ' PRO . 2.0 mp -105.48 132.14 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 107.316 -1.364 . . . . 72.35 107.316 170.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.447 ' HB3' HG21 ' C' ' 122' ' ' THR . 32.9 p90 -158.28 159.8 36.35 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.321 1.049 . . . . 74.53 109.628 -174.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -92.37 118.13 30.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 72.14 109.812 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -89.07 -32.75 17.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.758 -0.655 . . . . 72.43 109.827 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.8 t70 -146.06 134.02 21.4 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.118 -0.946 . . . . 63.43 108.902 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.566 HG23 ' HE1' ' C' ' 117' ' ' MET . 68.3 mt -130.44 140.49 48.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.578 -1.268 . . . . 60.34 107.578 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -142.19 136.15 29.65 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.101 0.96 . . . . 73.34 108.837 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -144.31 119.83 10.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.558 -2.016 . . . . 73.33 105.558 166.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.69 134.29 54.96 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 108.973 -0.751 . . . . 72.42 108.973 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.53 82.22 47.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.758 -1.571 . . . . 74.31 106.758 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -65.91 -30.22 48.9 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.61 2.207 . . . . 71.44 112.043 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.7 24.9 12.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.726 -1.125 . . . . 54.31 109.898 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -41.22 -60.97 1.49 Allowed Pre-proline 0 CA--C 1.584 2.253 0 N-CA-C 116.018 1.859 . . . . 73.01 116.018 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.481 ' HB3' HD13 ' C' ' 83' ' ' ILE . 94.4 Cg_endo -79.6 -17.06 11.43 Favored 'Trans proline' 0 C--N 1.399 3.214 0 CA-C-N 122.923 2.08 . . . . 74.34 113.293 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -73.41 -39.22 65.23 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.989 1.316 . . . . 73.44 110.295 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.732 HG23 ' HA ' ' D' ' 73' ' ' ALA . 4.5 p -86.24 -7.86 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 124.296 1.038 . . . . 74.31 111.156 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.52 -25.34 59.71 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.363 1.065 . . . . 74.31 111.176 169.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.54 -14.21 62.85 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.232 1.013 . . . . 74.23 112.259 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.472 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 0.1 OUTLIER -96.92 106.28 18.57 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.854 0.862 . . . . 72.25 109.394 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.7 50.08 0.89 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.579 1.152 . . . . 74.11 110.604 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -146.59 177.51 9.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 75.42 110.509 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -62.05 113.98 10.16 Favored Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.058 0.943 . . . . 74.22 111.345 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HG3' HD22 ' D' ' 68' ' ' LEU . 15.4 Cg_exo -71.31 144.84 46.94 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.024 2.483 . . . . 71.34 113.037 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.87 142.69 47.94 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.489 -0.778 . . . . 75.4 109.053 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.433 HG22 HD11 ' D' ' 126' ' ' LEU . 95.7 t -124.95 118.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.21 108.385 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -112.67 118.26 34.55 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.24 -0.652 . . . . 75.33 109.24 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.624 HD23 HD23 ' D' ' 128' ' ' LEU . 5.7 mp -96.88 125.45 41.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.475 0.71 . . . . 75.32 109.696 -174.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.795 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.1 m-20 -107.06 126.86 52.9 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.459 -0.941 . . . . 73.01 108.459 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.58 132.23 40.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.258 0.623 . . . . 75.32 109.89 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.1 t70 -157.62 156.18 31.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 170.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -136.51 165.89 24.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.6 0.76 . . . . 74.03 109.794 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.99 177.57 10.03 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.889 1.275 . . . . 71.3 108.473 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -165.36 166.63 18.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.847 0.459 . . . . 73.43 111.249 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.6 p -154.24 131.69 11.28 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.292 1.037 . . . . 74.13 108.328 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.4 117.85 20.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.941 -0.762 . . . . 73.04 108.941 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.3 mt -92.27 -33.4 14.66 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.708 -0.478 . . . . 75.23 109.708 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.39 -177.04 5.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.538 0.735 . . . . 73.4 111.064 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -65.92 124.55 22.8 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.02 -0.991 . . . . 65.22 109.005 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 16.6 m-20 65.7 19.27 11.38 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.183 0.993 . . . . 64.34 111.821 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.24 119.93 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.735 0.814 . . . . 71.33 109.643 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -134.03 130.84 38.12 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.023 0.929 . . . . 71.12 108.668 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.443 ' HB2' HD11 ' D' ' 51' ' ' LEU . 4.2 tt0 -86.78 119.6 27.18 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.512 -1.292 . . . . 74.35 107.512 169.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -100.16 129.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.635 -1.246 . . . . 73.24 107.635 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.3 t -104.79 138.66 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 71.31 108.944 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -106.4 124.32 49.41 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.43 -1.322 . . . . 74.31 107.43 174.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.7 ttm-85 -99.5 98.99 9.82 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.544 -1.28 . . . . 72.11 107.544 173.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.597 HG23 ' HB1' ' D' ' 110' ' ' ALA . 9.3 t -100.51 112.72 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.397 -0.964 . . . . 75.24 108.397 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.795 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -114.5 145.76 41.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.791 -0.448 . . . . 72.32 109.791 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 39.3 t -133.95 105.17 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.889 1.276 . . . . 65.04 109.101 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -98.07 96.47 8.15 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.085 -1.08 . . . . 70.25 108.085 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.98 147.71 24.22 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.972 0.509 . . . . 70.11 110.131 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -137.23 133.49 35.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.346 0.593 . . . . 74.14 111.939 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.463 HD22 ' HG3' ' D' ' 38' ' ' PRO . 9.4 mt -119.69 108.87 14.97 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.008 1.323 . . . . 75.01 108.402 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.2 -118.41 4.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.724 -0.551 . . . . 75.01 111.724 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.75 4.72 15.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.534 0.734 . . . . 72.2 110.707 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.472 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 13.0 pt-20 -122.48 171.75 8.86 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.484 0.714 . . . . 71.45 110.549 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.8 m -68.18 123.76 21.6 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.938 -1.028 . . . . 74.11 110.734 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -73.35 -65.41 0.82 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.422 -0.955 . . . . 73.21 108.422 170.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -156.76 157.05 34.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.843 -1.072 . . . . 73.11 109.83 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.05 152.11 29.91 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.124 1.37 . . . . 70.34 108.608 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 39.3 t -157.85 143.39 17.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.487 0.715 . . . . 73.44 109.092 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.23 128.99 7.82 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.557 -0.535 . . . . 73.14 109.557 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.18 115.29 42.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.013 -0.736 . . . . 74.33 109.013 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.704 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.69 85.63 6.83 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.189 0.995 . . . . 63.25 108.627 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.04 96.9 6.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 113.324 -1.762 . . . . 75.2 108.241 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -97.72 144.14 17.11 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 112.061 -0.416 . . . . 70.55 112.061 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.61 137.64 7.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.366 -0.694 . . . . 50.13 111.366 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 62.0 mt -88.08 125.45 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.901 -0.777 . . . . 73.43 108.901 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -130.79 123.87 30.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.643 0.777 . . . . 74.55 109.62 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 66.5 m -80.77 106.23 12.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.611 -0.885 . . . . 72.15 108.611 170.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -108.23 103.55 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.998 0.904 . . . . 74.25 110.007 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' D' ' 54' ' ' ASP . . . -140.96 150.92 43.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.985 0.914 . . . . 71.54 109.711 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.6 14.83 75.22 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.093 0.246 . . . . 74.12 113.192 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.667 HD13 ' HG2' ' D' ' 94' ' ' MET . 24.7 pt -98.59 125.63 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.365 1.066 . . . . 74.22 108.708 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -140.67 172.83 12.15 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.228 0.537 . . . . 64.13 112.01 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.23 -143.9 47.92 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.31 -1.314 . . . . 74.34 113.684 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -85.32 -20.21 30.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.106 0.962 . . . . 63.14 110.724 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.82 -35.87 79.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.472 0.709 . . . . 73.13 110.627 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.667 ' HG2' HD13 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -58.33 -49.26 77.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.527 0.731 . . . . 71.35 110.69 175.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.01 94.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.309 -0.86 . . . . 74.42 111.047 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.25 -30.88 66.85 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.64 -0.709 . . . . 64.14 111.261 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.67 -48.35 64.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.822 0.449 . . . . 73.11 110.411 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.57 -36.5 65.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.141 0.576 . . . . 75.43 110.212 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.55 6.5 77.63 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.221 -0.766 . . . . 72.45 114.785 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.75 -57.92 0.14 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.364 1.082 . . . . 74.12 112.341 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -64.75 -51.7 60.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.183 0.593 . . . . 72.11 111.49 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.497 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 27.9 m -60.73 -47.93 94.5 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 118.498 -0.763 . . . . 75.44 111.357 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.536 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.2 Cg_exo -59.29 -31.38 94.98 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.418 2.078 . . . . 74.25 113.968 168.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.7 -31.29 70.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.861 0.465 . . . . 75.2 110.706 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.3 -33.82 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.505 0.722 . . . . 72.52 110.281 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' D' ' 60' ' ' LEU . 86.0 mt -76.95 -25.61 53.05 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.049 0.939 . . . . 73.4 111.731 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -63.74 -41.99 68.51 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 114.94 1.459 . . . . 74.1 114.94 -168.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.53 -41.85 71.71 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.106 1.87 . . . . 71.11 113.234 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.15 -30.74 38.95 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.134 -0.939 . . . . 73.14 110.365 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -63.89 -44.91 91.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.722 0.809 . . . . 72.42 110.179 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.0 -51.29 70.28 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 124.629 1.206 . . . . 74.34 110.515 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.2 -41.92 99.23 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.143 0.902 . . . . 73.43 110.559 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' D' ' 21' ' ' ILE . 47.1 t -56.51 -45.21 81.2 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 123.808 0.693 . . . . 71.14 110.356 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.445 HG12 ' SG ' ' D' ' 76' ' ' CYS . 77.4 mt -63.9 -54.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.024 0.828 . . . . 74.52 110.375 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m -51.38 -46.74 62.89 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.152 1.381 . . . . 75.12 111.893 -171.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.7 t -65.53 -44.5 86.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.6 -1.182 . . . . 71.43 110.271 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.7 mtm -65.74 -32.71 74.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.03 0.532 . . . . 71.32 111.692 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -63.93 -48.26 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.77 0.828 . . . . 73.04 109.982 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -72.25 -28.63 63.27 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.983 -0.553 . . . . 72.33 110.937 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.7 mtt-85 -69.81 -34.23 73.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.624 0.77 . . . . 74.44 110.041 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 8.65 64.16 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.982 -0.554 . . . . 64.32 113.001 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.8 p 61.27 30.62 19.26 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.956 1.702 . . . . 74.31 113.119 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -100.9 163.43 18.05 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 124.708 1.203 . . . . 75.22 108.697 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.12 143.21 43.78 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.212 1.942 . . . . 71.44 111.55 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -52.13 132.97 33.77 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.792 0.682 . . . . 75.11 111.384 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.433 HD11 HG22 ' D' ' 40' ' ' VAL . 29.4 tp -108.89 108.23 18.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.148 0.979 . . . . 74.12 109.715 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -102.12 102.75 13.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.395 0.678 . . . . 74.22 109.603 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.624 HD23 HD23 ' D' ' 42' ' ' LEU . 38.5 mt -72.75 118.47 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.125 -0.694 . . . . 75.45 109.125 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 125.09 79.25 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.341 0.656 . . . . 62.25 111.25 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -67.64 103.34 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.136 1.891 . . . . 72.34 110.605 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.84 110.12 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.107 0.956 . . . . 72.33 109.915 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 CA--C 1.539 0.527 0 CA-C-N 114.413 -1.267 . . . . 73.45 108.098 173.876 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 121.183 0.516 . . . . 74.24 110.484 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -133.53 127.47 33.24 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 106.61 -1.626 . . . . 71.33 106.61 158.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -141.06 136.65 32.22 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.089 0.243 . . . . 74.53 110.681 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.64 104.03 15.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 107.491 -1.299 . . . . 74.43 107.491 174.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.407 ' NE2' HG21 ' A' ' 83' ' ' ILE . 21.8 tt0 -81.28 -25.94 36.13 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 118.709 -0.662 . . . . 70.32 110.986 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -176.82 135.61 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.315 0.646 . . . . 65.35 110.711 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.5 136.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 123.765 0.826 . . . . 62.22 109.013 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' HE2' ' HG2' ' A' ' 19' ' ' LYS . 33.6 p90 -170.77 167.6 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.755 0.822 . . . . 75.2 110.863 -174.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -90.91 124.28 35.07 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 167.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -81.15 -33.34 33.2 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.352 -0.61 . . . . 72.0 109.352 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.5 t70 -148.23 140.84 24.49 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.797 -1.092 . . . . 74.33 109.911 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.1 mt -132.32 141.4 45.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.018 1.327 . . . . 73.32 107.442 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -149.65 130.85 14.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.127 -0.694 . . . . 75.3 109.127 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.7 t80 -132.46 135.85 46.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.7 -1.593 . . . . 74.0 106.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.11 152.63 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 75.43 108.29 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.84 79.35 46.02 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 106.541 -1.651 . . . . 73.24 106.541 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.9 -45.86 12.13 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.876 2.384 . . . . 73.34 112.094 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 28.2 m-80 -107.38 45.63 0.98 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.405 -0.816 . . . . 73.11 108.972 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -61.0 -50.16 85.95 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.187 0.995 . . . . 73.44 113.036 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -68.38 -7.99 21.73 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.823 1.682 . . . . 72.11 113.887 170.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.1 m80 -99.12 -13.4 19.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.766 0.826 . . . . 74.32 112.278 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -64.58 -23.02 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.896 0.316 . . . . 71.42 110.77 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.53 -34.92 74.83 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.078 0.951 . . . . 74.33 111.739 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -63.02 -54.71 34.0 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.555 0.742 . . . . 74.43 110.322 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -85.12 127.32 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.594 -1.185 . . . . 70.2 110.712 -172.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -66.8 136.36 55.33 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.785 -1.191 . . . . 74.12 107.785 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -60.05 100.78 0.1 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.453 1.095 . . . . 75.42 112.389 -163.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -127.35 76.51 76.52 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.633 1.173 . . . . 75.42 108.063 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.69 101.39 1.18 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.108 1.872 . . . . 74.53 111.642 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.01 94.67 9.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.674 -1.602 . . . . 64.05 106.674 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.8 m -84.37 129.76 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.832 -1.076 . . . . 75.11 111.666 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 3.0 mptp? -105.3 124.02 48.83 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.347 1.059 . . . . 75.4 108.577 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 128' ' ' LEU . 5.7 mp -97.52 120.96 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.574 1.15 . . . . 73.41 108.603 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.743 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 20.5 m-20 -117.57 111.27 18.99 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.279 -1.008 . . . . 75.24 108.279 167.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.7 tp -97.28 135.55 39.03 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.295 -1.002 . . . . 72.23 108.295 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 14.3 t70 -143.33 136.29 27.77 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -122.96 137.9 54.82 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.089 0.556 . . . . 75.42 109.643 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . . . -134.43 153.17 52.06 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.444 1.098 . . . . 53.3 108.902 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.8 m -134.11 157.35 46.39 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.717 0.407 . . . . 70.51 110.69 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -149.82 119.45 6.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.981 0.912 . . . . 75.14 108.827 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -74.38 122.76 23.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.877 0.471 . . . . 75.22 109.986 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.77 -43.72 7.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.179 0.592 . . . . 73.31 110.154 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -150.81 -169.54 3.41 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 123.703 0.801 . . . . 74.22 109.991 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.64 126.25 30.64 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.757 -0.831 . . . . 71.22 108.757 169.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 69.44 -3.03 1.71 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.737 1.615 . . . . 75.43 112.653 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 41.1 t -115.4 120.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 N-CA-C 107.924 -1.139 . . . . 74.53 107.924 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.57 170.38 15.82 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.915 -1.143 . . . . 75.4 107.915 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 9.0 tm-20 -127.3 132.17 50.35 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.666 -1.235 . . . . 72.13 107.666 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.76 120.79 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.47 -0.937 . . . . 72.54 108.47 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 43.7 t -95.24 130.92 43.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 123.64 0.776 . . . . 75.22 109.047 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.09 107.54 18.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.896 -1.52 . . . . 74.41 106.896 170.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 24.3 ttp180 -100.06 100.79 11.71 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.39 -0.967 . . . . 74.32 108.39 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' A' ' 114' ' ' ILE . 7.9 t -94.74 137.57 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.834 -1.173 . . . . 75.14 107.834 174.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.743 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.9 m -128.66 126.79 40.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.505 -0.554 . . . . 61.43 109.505 173.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.1 t -122.06 109.5 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.675 1.19 . . . . 75.14 109.537 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 80.0 m -101.41 141.97 33.5 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.429 -0.952 . . . . 62.14 108.429 173.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.07 109.58 14.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.266 -1.013 . . . . 75.12 108.266 173.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 39.8 m -107.46 127.23 53.42 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.343 -0.614 . . . . 64.41 109.343 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.3 mt -90.75 81.93 5.76 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.518 -1.66 . . . . 73.34 106.518 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.15 -86.4 1.1 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.16 -0.927 . . . . 75.42 110.881 -168.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.1 -19.25 4.4 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 70.12 110.452 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.08 108.02 18.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.855 0.862 . . . . 71.35 110.247 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.1 m -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.293 0.568 . . . . 75.43 111.442 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -54.09 7.69 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.92 1.288 . . . . 73.42 109.455 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -148.92 165.26 32.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.389 -1.278 . . . . 75.45 110.82 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.5 tp -130.89 145.2 51.94 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.666 -1.235 . . . . 73.54 107.666 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -134.54 140.39 46.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.77 0.828 . . . . 72.41 109.268 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.85 117.1 6.43 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.89 -0.781 . . . . 74.02 108.89 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.91 111.34 28.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.773 0.829 . . . . 73.31 109.038 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.6 mt-30 -88.42 82.57 6.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.118 -0.946 . . . . 73.11 109.119 173.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -75.95 93.6 3.26 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.154 -0.93 . . . . 75.04 108.842 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.39 148.9 19.54 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 116.179 -0.464 . . . . 70.43 112.06 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.06 123.97 1.73 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.74 -0.944 . . . . 61.22 110.74 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.4 mt -79.08 127.85 38.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.981 -1.118 . . . . 74.13 107.981 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.89 143.42 50.8 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.398 -0.593 . . . . 74.14 109.398 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 t -112.54 112.98 24.9 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.088 -1.078 . . . . 74.44 108.088 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -129.01 143.42 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.089 0.555 . . . . 72.54 110.011 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.06 175.39 2.29 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.208 1.003 . . . . 74.43 111.215 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 5.16 88.42 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.392 -0.822 . . . . 74.23 114.478 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.31 -179.62 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.337 1.055 . . . . 73.52 109.422 -176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.9 tt0 -168.37 177.2 5.47 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.085 0.554 . . . . 72.33 110.139 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.86 -121.28 22.74 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 114.969 0.748 . . . . 74.21 114.969 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.6 p -64.67 -30.92 71.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.899 0.88 . . . . 75.23 111.593 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.54 -42.1 71.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.549 0.739 . . . . 75.13 111.041 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -76.55 -30.24 57.0 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.507 -0.315 . . . . 71.33 110.701 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.76 63.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.147 0.579 . . . . 75.31 110.74 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -67.61 -48.56 66.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.174 0.99 . . . . 75.32 110.234 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 20.2 t -74.59 -63.0 1.34 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.544 -0.753 . . . . 73.01 111.001 -172.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 tt -62.36 -38.34 89.16 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.164 0.586 . . . . 75.35 110.698 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.15 -31.1 32.42 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 115.26 0.864 . . . . 72.14 115.26 -168.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -48.37 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.342 1.071 . . . . 71.44 112.569 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 86.4 t80 -66.66 -50.08 64.09 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.615 0.766 . . . . 75.2 112.697 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.6 m -72.16 -37.6 4.94 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.554 0.742 . . . . 75.52 112.634 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.65 -40.89 82.16 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.18 1.92 . . . . 71.22 112.478 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.27 -29.4 68.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.553 0.741 . . . . 72.32 111.419 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.689 HD11 HD22 ' C' ' 132' ' ' ASN . 40.1 mm -60.66 -44.52 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.998 0.904 . . . . 73.45 109.855 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 82' ' ' GLY . 79.2 mt -77.21 -18.77 57.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.166 -1.379 . . . . 73.35 112.176 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -68.42 -41.86 25.62 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.444 1.276 . . . . 72.21 114.444 -168.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.81 -39.03 90.39 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 121.966 1.777 . . . . 72.41 112.906 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -75.1 -36.74 61.67 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.491 0.717 . . . . 75.22 111.608 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.93 -46.83 76.79 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.576 -0.527 . . . . 74.41 109.576 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttm105 -55.22 -47.09 75.81 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 124.552 1.158 . . . . 73.31 110.52 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 6.7 tm-20 -59.42 -48.69 80.68 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.136 0.897 . . . . 74.43 111.061 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 51.1 t -57.73 -46.49 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.067 -0.97 . . . . 74.14 111.213 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 118' ' ' VAL . 89.5 mt -64.3 -53.19 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.525 0.73 . . . . 74.14 110.612 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.537 HG21 ' HG3' ' A' ' 125' ' ' GLN . 60.7 m -53.46 -44.39 68.89 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.799 1.24 . . . . 74.03 112.009 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 43.3 t -72.46 -32.65 66.43 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.298 -0.865 . . . . 61.42 111.166 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -64.29 -43.3 95.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.483 0.713 . . . . 74.22 110.851 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 114' ' ' ILE . 61.5 t -62.99 -49.27 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.627 1.171 . . . . 63.05 110.465 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.1 p -67.48 -26.04 66.17 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.846 -0.616 . . . . 62.44 111.6 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.527 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 26.4 ttm-85 -76.93 -26.06 53.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.272 1.029 . . . . 74.25 110.133 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 10.9 61.11 Favored Glycine 0 C--N 1.358 1.803 0 CA-C-N 115.887 -0.597 . . . . 74.14 112.618 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 67.66 36.49 3.63 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.815 1.293 . . . . 74.45 110.472 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -115.57 144.71 32.99 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 114.75 -1.114 . . . . 75.15 108.936 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.28 146.07 52.36 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.01 2.474 . . . . 72.01 113.275 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.537 ' HG3' HG21 ' A' ' 115' ' ' THR . 3.6 tt0 -59.07 140.92 55.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.135 0.974 . . . . 74.42 112.689 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.1 tp -124.86 114.16 18.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.935 0.894 . . . . 75.12 109.402 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -112.05 102.08 10.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.385 0.674 . . . . 71.15 109.505 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.75 127.11 31.54 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.867 -0.79 . . . . 72.13 108.867 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.4 132.03 95.24 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.784 0.834 . . . . 72.41 112.325 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -83.62 140.44 9.37 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.641 2.227 . . . . 72.14 112.153 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.67 125.3 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.96 0.904 . . . . 72.2 109.831 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -92.03 63.81 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 122.218 1.009 . . . . 74.22 110.536 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 75.33 110.188 176.305 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.238 0.475 0 N-CA-C 108.255 -1.017 . . . . 72.45 108.255 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.91 120.67 21.78 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.538 -0.912 . . . . 65.34 108.538 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.56 138.3 29.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.722 0.296 . . . . 72.42 110.243 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.471 HD11 HG13 ' B' ' 16' ' ' ILE . 16.1 tt -82.56 144.48 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.263 1.025 . . . . 63.51 110.031 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -109.28 -49.16 3.15 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.192 0.597 . . . . 72.53 110.035 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -171.38 146.27 2.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.172 0.589 . . . . 74.43 110.458 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.471 HG13 HD11 ' B' ' 13' ' ' ILE . 51.1 mt -116.47 145.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.191 -1.04 . . . . 75.41 108.191 169.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -168.71 145.47 3.73 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.759 0.423 . . . . 72.4 110.305 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.527 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 94.9 m -74.06 122.16 22.24 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.872 -0.788 . . . . 64.44 108.872 172.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -91.49 -37.45 13.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.619 -0.719 . . . . 75.41 110.341 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.1 t70 -154.3 146.28 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.666 0.27 . . . . 71.52 111.622 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.715 HD12 ' SG ' ' B' ' 113' ' ' CYS . 43.4 mm -138.56 143.73 31.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 125.378 1.471 . . . . 73.43 109.158 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.4 t -141.1 129.21 22.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.862 1.265 . . . . 74.2 108.424 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -143.2 131.9 22.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.096 -1.446 . . . . 74.41 107.096 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -136.01 140.15 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.674 -1.232 . . . . 74.5 107.674 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.557 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -134.85 85.09 36.37 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 107.904 -1.147 . . . . 74.02 107.904 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.95 -29.48 57.64 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.88 2.387 . . . . 74.12 111.99 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.81 28.91 8.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.945 0.898 . . . . 72.3 109.961 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.557 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -47.2 -52.75 32.86 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 125.429 1.491 . . . . 72.42 113.509 168.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.1 Cg_exo -81.63 -11.74 11.46 Favored 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 122.547 2.165 . . . . 75.41 112.876 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -89.17 3.07 53.14 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.214 1.006 . . . . 72.52 111.576 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.1 -21.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.247 0.619 . . . . 74.23 111.266 169.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -64.76 -40.54 95.44 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.706 0.802 . . . . 74.31 110.16 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.29 -30.03 30.82 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.061 -0.972 . . . . 74.41 111.135 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.79 90.33 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.261 1.025 . . . . 73.05 109.729 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.49 77.35 9.44 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.8 0.84 . . . . 73.42 110.567 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -172.01 156.36 4.04 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.853 0.861 . . . . 74.22 109.419 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.447 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 28.1 tt0 -66.25 125.52 90.4 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.536 1.135 . . . . 61.43 110.778 169.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.25 129.16 20.94 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.129 1.886 . . . . 71.44 110.691 169.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 134.04 48.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 120.933 0.396 . . . . 72.44 109.94 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 124' ' ' PRO . 18.9 t -114.99 127.37 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.9 0.48 . . . . 74.34 111.282 -166.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -134.78 134.28 40.75 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.406 -0.961 . . . . 75.23 108.406 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.492 HD21 ' H ' ' B' ' 42' ' ' LEU . 1.2 pt? -119.5 140.43 50.49 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.962 -1.125 . . . . 74.23 107.962 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -136.81 142.64 42.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.432 0.693 . . . . 61.21 109.389 -167.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 tt -94.77 138.91 31.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.353 0.661 . . . . 74.34 110.391 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.74 135.83 31.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.564 1.145 . . . . 64.41 108.553 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.0 m -109.65 124.78 51.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.854 0.462 . . . . 73.1 110.646 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.05 156.37 38.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.197 0.999 . . . . 70.45 108.336 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 45.5 p -144.88 170.8 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.8 0.44 . . . . 74.24 110.684 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -150.49 143.66 24.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.614 0.766 . . . . 75.24 109.011 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -94.57 114.98 27.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.406 0.683 . . . . 75.51 110.025 173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.2 -35.14 21.82 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.343 -0.614 . . . . 71.24 109.343 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.81 3.85 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.922 -1.036 . . . . 74.32 110.104 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.71 126.37 27.37 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.621 -1.172 . . . . 75.4 108.899 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 69.96 -4.36 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.592 1.157 . . . . 52.03 112.987 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.26 103.95 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.524 -0.917 . . . . 72.41 108.524 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.99 137.78 54.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.2 0.524 . . . . 74.13 110.164 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -114.44 105.86 13.62 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.081 -1.451 . . . . 64.22 107.081 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 83.9 t -92.82 125.75 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.309 0.644 . . . . 62.1 109.541 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.446 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.2 t -103.04 117.42 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.599 0.76 . . . . 74.03 109.746 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 0.0 OUTLIER -93.87 112.11 23.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.144 -0.687 . . . . 73.15 109.144 -177.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 41.9 ttm180 -94.7 114.24 26.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.953 0.501 . . . . 74.41 109.907 171.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.546 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.4 t -114.02 122.26 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.947 -1.131 . . . . 70.12 107.947 169.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -115.71 147.9 40.36 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.171 0.589 . . . . 54.35 110.378 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.553 HG22 HG21 ' B' ' 114' ' ' ILE . 44.5 t -127.3 127.14 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 75.35 109.582 -172.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.5 m -105.0 140.09 38.71 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.808 0.843 . . . . 71.44 109.281 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.4 22.62 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.097 0.959 . . . . 73.34 108.732 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 73.6 p -146.27 141.08 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.115 0.483 . . . . 71.45 111.529 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.465 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 65.6 mt -102.72 109.39 20.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.938 1.295 . . . . 75.15 108.678 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -111.88 3.5 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.02 -0.432 . . . . 74.02 112.02 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.17 10.21 18.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.044 0.938 . . . . 74.13 110.494 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -132.07 144.69 50.91 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.24 0.616 . . . . 74.14 109.821 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -66.91 134.77 52.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.203 0.601 . . . . 75.52 111.49 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -88.71 -58.86 2.4 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.679 -0.86 . . . . 62.31 108.679 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 158.81 39.36 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.318 -1.31 . . . . 74.44 109.925 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -136.37 124.0 22.34 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.18 1.392 . . . . 75.13 107.759 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.34 159.94 23.21 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.458 -0.571 . . . . 74.33 109.458 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -164.81 139.38 5.24 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.209 -1.034 . . . . 73.13 108.209 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 67.4 t -129.03 145.69 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 123.887 0.875 . . . . 75.3 108.722 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.9 mt-30 -124.43 85.9 2.48 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.545 -0.909 . . . . 73.11 108.545 174.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -82.67 101.63 10.96 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 114.432 -1.258 . . . . 74.24 109.877 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.65 161.22 29.53 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 121.181 -0.533 . . . . 72.25 112.018 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.11 126.45 1.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.361 -0.696 . . . . 70.11 111.361 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.89 128.12 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.956 -0.757 . . . . 71.35 108.956 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -132.85 163.46 29.04 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.685 1.194 . . . . 74.54 107.945 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 71.6 m -126.75 121.28 31.54 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.199 -1.037 . . . . 63.2 108.199 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.513 HD12 HD13 ' B' ' 89' ' ' ILE . 2.9 pp -128.28 147.03 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 73.24 110.263 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.04 162.63 40.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.547 0.739 . . . . 75.23 109.979 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.28 -28.98 8.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.261 0.464 . . . . 53.23 114.261 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.513 HD13 HD12 ' B' ' 86' ' ' ILE . 44.7 pt -67.83 162.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 61.31 112.865 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -165.35 159.68 17.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.1 -0.955 . . . . 73.3 111.596 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -130.32 50.11 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 124.014 0.821 . . . . 74.0 114.14 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.5 m -70.72 -25.31 62.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.933 0.893 . . . . 71.15 111.087 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.76 -26.91 67.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 75.1 110.623 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.495 ' HG3' HD12 ' B' ' 89' ' ' ILE . 18.1 ttt -72.67 -46.04 55.89 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.12 0.568 . . . . 74.03 110.522 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.84 67.14 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.438 -0.801 . . . . 74.1 111.192 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.17 -36.1 35.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.306 0.642 . . . . 75.24 110.716 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -74.74 -67.45 0.63 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.961 0.504 . . . . 73.21 111.914 -173.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.544 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.2 pp -94.27 -20.51 19.74 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.156 0.428 . . . . 75.33 112.156 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.68 -15.44 59.82 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.913 -0.382 . . . . 64.4 113.293 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.96 -52.53 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.206 0.503 . . . . 61.21 112.0 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -76.76 -37.28 56.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.963 0.357 . . . . 75.43 111.963 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 97.9 m -63.43 -51.44 67.58 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.607 -0.711 . . . . 74.45 111.566 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.451 ' HD3' HG13 ' B' ' 58' ' ' VAL . 36.5 Cg_endo -65.48 -17.53 57.65 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 121.763 1.642 . . . . 75.34 113.524 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.34 -42.04 75.83 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 122.864 0.466 . . . . 74.54 110.562 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 69.6 mt -58.92 -41.95 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.068 0.947 . . . . 72.11 110.194 173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -84.71 -12.94 52.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.546 -1.206 . . . . 74.21 111.969 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -63.49 -45.14 83.46 Favored Pre-proline 0 C--N 1.359 0.984 0 CA-C-O 117.576 -1.202 . . . . 74.44 112.706 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.13 -42.83 61.96 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.305 2.004 . . . . 63.25 113.177 172.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -70.55 -45.22 65.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.147 -0.933 . . . . 73.32 111.027 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.06 82.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.632 0.773 . . . . 74.21 111.096 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.69 -60.86 3.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.751 1.22 . . . . 72.54 109.236 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.87 -34.53 74.77 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.076 0.86 . . . . 65.43 110.413 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.715 ' SG ' HD12 ' B' ' 21' ' ' ILE . 14.7 t -60.33 -51.05 71.19 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.203 0.601 . . . . 74.12 111.46 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.553 HG21 HG22 ' B' ' 64' ' ' VAL . 80.8 mt -58.64 -52.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.441 0.696 . . . . 72.44 109.962 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.661 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 2.0 m -64.29 -21.0 66.45 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.903 -1.499 . . . . 75.04 111.236 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -83.55 -40.3 19.3 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.706 1.202 . . . . 64.52 112.061 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.9 mmt -69.12 -39.49 78.87 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.287 0.494 . . . . 63.22 111.926 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.53 -26.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.127 0.571 . . . . 74.35 110.436 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.3 t -64.93 -30.99 72.01 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 74.42 110.321 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.507 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 66.6 mtt-85 -72.81 -33.66 66.36 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.527 0.731 . . . . 71.23 110.129 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.83 -2.56 81.99 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-N 115.753 -0.658 . . . . 55.43 112.833 171.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 17' ' ' TYR . 5.4 t 55.41 34.3 22.68 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.77 2.028 . . . . 75.3 112.694 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.91 157.67 35.47 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.075 0.95 . . . . 71.21 110.851 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.447 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.4 Cg_exo -71.84 87.82 0.82 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.302 2.668 . . . . 74.14 113.771 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.661 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 0.0 OUTLIER -71.78 159.78 33.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.329 0.652 . . . . 72.45 112.225 171.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 33.1 tp -129.69 123.84 32.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.21 1.804 . . . . 75.02 107.542 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' C' ' 122' ' ' THR . 18.7 p-10 -91.5 110.24 21.55 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.09 -0.708 . . . . 71.31 109.09 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.5 137.74 54.64 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 74.03 110.621 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.24 141.78 97.78 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.057 0.943 . . . . 72.33 111.503 176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.6 106.96 0.79 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.923 2.415 . . . . 51.43 112.74 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -73.89 106.71 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.986 -0.552 . . . . 64.34 110.025 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -79.08 94.75 5.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.263 0.554 . . . . 75.35 109.647 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 23.6 p90 . . . . . 0 CA--C 1.546 0.809 0 CA-C-N 115.161 -0.927 . . . . 71.24 111.25 177.63 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.102 -0.703 . . . . 72.03 109.102 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.511 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.9 t80 -117.17 127.46 54.14 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.428 -0.952 . . . . 74.42 108.428 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -138.11 135.04 35.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.427 -0.953 . . . . 74.11 108.427 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.511 HD13 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -93.68 114.67 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.377 0.608 . . . . 72.51 109.779 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.484 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.0 mm-40 -82.04 -49.26 10.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 75.41 109.906 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -173.55 145.63 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.7 -0.682 . . . . 74.33 109.988 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.511 HG13 HD13 ' C' ' 13' ' ' ILE . 87.0 mt -128.12 144.63 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.503 -1.295 . . . . 63.44 107.503 171.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.551 ' HB3' HG21 ' D' ' 122' ' ' THR . 21.0 p90 -174.71 166.57 3.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.452 0.644 . . . . 72.32 110.77 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -88.16 105.91 17.83 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.003 -0.999 . . . . 61.03 109.44 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -65.68 -36.28 83.19 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.547 0.689 . . . . 73.33 109.487 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.5 t70 -149.13 142.94 25.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.542 -1.208 . . . . 70.13 109.63 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -136.91 139.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.358 -1.719 . . . . 74.21 106.358 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.46 143.49 22.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.376 -0.602 . . . . 73.52 109.376 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -143.65 113.93 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.558 -1.275 . . . . 74.23 107.558 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -116.57 119.77 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.669 -0.864 . . . . 73.24 108.669 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.77 82.21 67.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.673 -1.232 . . . . 74.24 107.673 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.11 -37.29 33.2 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.572 2.181 . . . . 75.2 111.574 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.68 31.3 3.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.28 -1.327 . . . . 72.1 110.474 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 86.26 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 113.956 1.095 . . . . 75.31 113.956 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.18 -19.73 6.59 Favored 'Trans proline' 0 C--N 1.385 2.457 0 CA-C-N 121.298 1.499 . . . . 71.4 112.818 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.84 -33.53 70.76 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.189 0.996 . . . . 73.1 112.271 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.461 HG23 HD13 ' C' ' 68' ' ' LEU . 12.4 p -78.61 -10.63 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.064 0.946 . . . . 73.32 111.943 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -57.51 -40.63 79.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.852 0.861 . . . . 74.44 112.207 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -105.79 41.91 1.32 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.967 0.889 . . . . 71.41 109.248 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.724 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.3 tppp? -125.38 155.94 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.42 0.688 . . . . 71.33 110.443 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.56 127.11 31.57 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.332 0.653 . . . . 74.15 109.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.46 95.49 9.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.585 -0.734 . . . . 74.14 110.815 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.07 68.7 81.28 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.335 -0.987 . . . . 61.51 108.335 167.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.71 111.46 3.33 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.363 2.042 . . . . 75.41 110.57 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -85.09 92.82 8.47 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.649 -1.241 . . . . 74.42 107.649 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.411 HG22 HD23 ' C' ' 126' ' ' LEU . 40.1 t -81.58 86.16 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.225 -1.352 . . . . 72.12 110.633 -168.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -91.26 105.28 17.68 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.372 -1.344 . . . . 75.13 107.372 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.454 HD22 HD12 ' C' ' 128' ' ' LEU . 0.5 OUTLIER -87.85 160.71 17.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.367 0.603 . . . . 71.41 111.209 177.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -137.05 144.18 43.06 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.737 1.215 . . . . 64.01 108.775 175.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 46.4 tp -131.45 105.34 7.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.489 -0.93 . . . . 73.45 108.489 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 20.0 t70 -113.33 140.15 48.26 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 74.12 109.26 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -114.4 134.08 55.25 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.18 0.592 . . . . 72.24 109.959 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.96 151.66 46.71 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.335 1.054 . . . . 72.23 108.407 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 73.8 m -138.42 149.21 45.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.261 0.625 . . . . 75.24 110.556 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -150.21 158.87 44.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.396 1.079 . . . . 71.13 109.503 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -102.51 138.91 38.8 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.198 -1.038 . . . . 72.51 108.198 168.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.418 HD13 HD13 ' C' ' 83' ' ' ILE . 89.3 mt -109.86 -37.03 5.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.523 0.729 . . . . 72.05 110.226 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 -167.51 1.71 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.228 0.611 . . . . 75.41 110.744 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.81 109.41 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.825 -1.079 . . . . 62.32 111.484 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.49 9.59 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.847 1.259 . . . . 72.24 111.968 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.28 118.78 54.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.535 1.134 . . . . 72.23 109.279 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.87 162.35 14.9 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.165 0.986 . . . . 74.14 110.322 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -127.22 116.66 20.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.9 -1.045 . . . . 74.32 108.453 165.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -106.64 124.74 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.716 -1.216 . . . . 74.13 107.716 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.44 119.15 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.778 0.831 . . . . 75.31 109.341 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' C' ' 103' ' ' PRO . 38.5 mt -88.41 118.44 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.091 0.556 . . . . 74.45 110.683 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 33.4 mtm105 -82.65 105.23 13.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.687 -1.227 . . . . 75.41 107.687 164.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -109.12 117.23 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.878 -1.156 . . . . 65.21 107.878 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -123.12 126.01 46.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.858 0.463 . . . . 74.35 109.91 -171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.616 HG21 HD12 ' C' ' 114' ' ' ILE . 54.5 t -107.65 113.69 44.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.484 0.714 . . . . 60.34 109.109 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.4 HG21 HD23 ' C' ' 75' ' ' LEU . 5.8 m -99.48 140.37 33.76 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.311 -0.996 . . . . 70.31 108.311 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.8 108.66 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.925 -0.768 . . . . 63.04 108.925 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.2 m -130.17 140.65 50.74 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.202 0.525 . . . . 71.1 110.255 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' C' ' 34' ' ' LYS . 12.3 mt -93.39 40.75 1.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.337 1.455 . . . . 75.04 109.159 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.07 -112.36 4.12 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.125 -1.59 . . . . 73.33 109.125 -163.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.2 -27.53 19.48 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.336 0.655 . . . . 71.5 110.117 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.724 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 9.7 tp10 -72.86 92.28 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.628 1.171 . . . . 73.45 110.393 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 117.97 12.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.387 0.613 . . . . 74.43 110.164 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.99 25.92 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.363 -1.289 . . . . 74.45 109.75 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -163.62 172.98 13.55 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.628 -0.715 . . . . 75.34 111.849 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.4 HD23 HG21 ' C' ' 65' ' ' THR . 2.5 tm? -144.38 116.89 8.59 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.102 -1.444 . . . . 73.43 107.102 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.523 ' SG ' HG22 ' C' ' 114' ' ' ILE . 42.0 t -115.68 145.74 42.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.639 0.775 . . . . 72.41 109.492 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.11 135.6 20.64 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.703 0.401 . . . . 63.12 110.031 171.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.71 118.2 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.486 1.115 . . . . 71.15 108.798 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.9 mt-30 -90.14 93.71 9.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.83 -0.804 . . . . 70.14 108.83 172.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -83.2 107.87 16.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.445 -0.798 . . . . 74.24 109.921 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.56 146.33 18.11 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.165 -0.47 . . . . 65.25 112.21 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.45 126.3 3.13 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 111.129 -0.789 . . . . 63.0 111.129 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.0 mm -91.04 124.93 43.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.26 -1.015 . . . . 72.04 108.26 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.42 119.52 21.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.289 0.636 . . . . 75.13 109.468 -175.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -87.6 100.02 12.48 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.28 -1.378 . . . . 65.51 107.28 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.459 HG13 ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -143.8 133.79 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.469 0.652 . . . . 75.0 110.904 -170.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.03 -177.22 5.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.074 1.35 . . . . 73.13 109.132 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -18.81 36.32 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 114.712 0.645 . . . . 61.32 114.712 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.015 0.926 . . . . 64.33 111.819 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 111.854 0.316 . . . . 65.35 111.854 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 38.1 ttm -58.67 -62.89 1.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.796 0.838 . . . . 73.44 111.417 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -27.4 63.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.623 -0.717 . . . . 61.34 111.708 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -77.3 -22.99 51.13 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 71.5 110.314 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 44.7 t -71.96 -64.03 1.02 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.329 0.252 . . . . 73.31 110.44 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.24 -16.44 56.47 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 122.259 -0.275 . . . . 75.11 110.986 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.21 -26.05 27.05 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.691 0.636 . . . . 72.12 114.691 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.06 -40.2 0.25 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.489 0.922 . . . . 70.41 113.489 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 87.1 t80 -74.56 -48.64 25.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.048 0.539 . . . . 73.52 111.234 -174.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.511 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 56.0 m -66.13 -45.1 61.85 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.313 0.645 . . . . 65.2 110.184 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.652 ' HB3' HD23 ' C' ' 60' ' ' LEU . 76.2 Cg_exo -52.38 -38.59 73.78 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.417 2.078 . . . . 75.33 115.01 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -63.66 -30.6 71.69 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 123.252 0.621 . . . . 74.32 111.209 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -65.62 -39.28 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.744 0.817 . . . . 75.22 110.489 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -88.94 -21.57 23.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.744 0.818 . . . . 73.33 112.353 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.77 -46.4 99.74 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.131 0.972 . . . . 73.24 113.039 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.55 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 23.7 Cg_exo -60.96 -40.14 55.04 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.872 1.714 . . . . 71.44 112.526 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -63.81 -46.15 86.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.571 0.748 . . . . 74.41 111.459 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.65 -43.46 93.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.369 0.668 . . . . 60.33 110.87 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -56.87 -50.88 71.14 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.011 1.324 . . . . 73.41 110.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.2 -41.41 85.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.785 0.834 . . . . 63.34 110.54 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.4 t -66.52 -30.87 71.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.539 0.735 . . . . 73.4 111.987 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.616 HD12 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -72.58 -50.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.837 0.455 . . . . 75.11 110.086 173.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.528 HG23 ' NE2' ' C' ' 125' ' ' GLN . 10.3 m -61.99 -27.81 69.12 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.106 0.562 . . . . 74.14 110.67 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.3 t -60.73 -51.76 67.99 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.161 0.984 . . . . 73.42 110.076 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.86 -38.96 83.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.582 1.153 . . . . 70.43 112.618 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.63 -39.73 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.271 0.628 . . . . 73.33 110.25 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -60.23 -42.96 96.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.66 0.784 . . . . 74.12 110.89 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' C' ' 116' ' ' SER . 89.2 mtt-85 -63.12 -34.0 76.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.723 -0.671 . . . . 71.12 111.38 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.46 12.51 58.64 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.156 -0.802 . . . . 73.21 113.536 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.448 ' HA ' HD22 ' B' ' 127' ' ' ASN . 70.3 p 55.23 42.81 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.421 1.488 . . . . 75.43 112.277 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.6 154.27 44.74 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 107.972 -1.122 . . . . 75.14 107.972 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.72 148.15 36.27 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.322 2.015 . . . . 75.0 112.225 -171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.528 ' NE2' HG23 ' C' ' 115' ' ' THR . 12.8 mm100 -62.76 110.43 1.74 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.667 0.988 . . . . 74.23 113.667 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.411 HD23 HG22 ' C' ' 40' ' ' VAL . 65.1 mt -92.21 76.13 5.33 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.416 0.686 . . . . 72.31 109.884 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -92.31 89.41 6.83 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.01 -0.995 . . . . 63.25 109.356 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.454 HD12 HD22 ' C' ' 42' ' ' LEU . 12.7 mt -86.74 153.04 22.01 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.415 -1.266 . . . . 74.42 109.841 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.19 120.11 2.34 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 125.633 1.573 . . . . 74.22 113.633 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.62 94.48 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.666 2.244 . . . . 71.55 111.145 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.56 98.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-N 114.965 -1.016 . . . . 74.25 111.383 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.689 HD22 HD11 ' A' ' 105' ' ' ILE . 57.3 t-20 -75.76 87.15 2.78 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.197 -0.91 . . . . 71.51 108.952 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.6 t80 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 71.32 112.631 -176.577 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.238 0.464 0 N-CA-C 109.067 -0.716 . . . . 65.41 109.067 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -154.37 105.68 2.69 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.862 -1.162 . . . . 75.14 107.862 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 74.9 mt-30 -117.34 115.94 26.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.992 0.517 . . . . 73.33 110.188 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -87.01 126.19 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.455 -0.943 . . . . 71.02 108.455 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.1 mt-30 -109.26 -47.53 3.39 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.114 0.413 . . . . 75.34 112.114 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -165.45 121.81 1.4 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.06 128.14 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.773 0.829 . . . . 74.11 109.057 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -161.99 174.58 12.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.95 0.881 . . . . 74.22 111.52 -171.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.51 120.68 40.67 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.72 -1.127 . . . . 71.13 108.985 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -84.77 -37.59 20.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.541 -0.54 . . . . 55.53 109.541 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.8 137.96 24.13 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.078 -0.965 . . . . 75.34 109.088 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.549 HG23 ' HE1' ' C' ' 117' ' ' MET . 74.9 mt -131.44 139.68 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 73.33 108.08 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.97 134.36 33.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.139 0.975 . . . . 70.1 108.812 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -146.94 116.18 6.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.614 -1.625 . . . . 72.31 106.614 170.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -122.23 144.35 49.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 73.14 109.499 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' D' ' 28' ' ' ALA . . . -134.25 75.2 65.68 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.896 -1.15 . . . . 62.05 107.896 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.96 -27.18 10.32 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.748 2.299 . . . . 63.41 113.081 -170.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.21 27.08 9.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.449 0.699 . . . . 71.2 109.978 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' D' ' 25' ' ' ALA . . . -54.95 -56.15 30.98 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 115.272 1.582 . . . . 62.04 115.272 -167.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.96 -6.23 13.14 Favored 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-N 121.474 1.562 . . . . 73.22 112.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -81.75 -44.46 17.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.642 1.177 . . . . 64.32 110.094 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.18 2.42 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.061 0.545 . . . . 74.34 111.202 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.25 -33.82 69.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.137 0.975 . . . . 73.13 110.34 165.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.59 -23.46 58.74 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.622 -1.172 . . . . 75.12 111.004 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -88.62 79.03 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 72.13 110.419 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -87.17 57.49 4.5 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.199 1.0 . . . . 73.03 110.894 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -125.86 175.87 7.35 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.884 1.274 . . . . 72.33 108.425 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -72.44 112.79 16.24 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 119.194 -0.431 . . . . 72.43 109.969 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.08 113.73 2.15 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.524 2.149 . . . . 61.13 111.889 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.77 112.42 6.21 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.09 0.869 . . . . 73.43 109.655 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 m -99.65 122.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 73.25 110.045 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -104.56 112.57 25.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 74.44 108.498 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.497 HD21 HD22 ' D' ' 128' ' ' LEU . 6.8 mp -95.22 142.25 27.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.345 0.658 . . . . 74.35 110.093 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.2 t70 -132.61 137.09 46.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.633 -0.877 . . . . 71.42 108.633 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 22.6 tp -115.12 129.59 56.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.295 -0.631 . . . . 73.53 109.295 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.98 148.02 44.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.289 1.035 . . . . 73.4 108.389 172.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 88.6 m -128.97 150.59 50.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.166 0.987 . . . . 71.42 108.718 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.556 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -148.94 164.15 35.39 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.039 0.936 . . . . 74.34 109.755 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 96.5 p -167.43 155.33 9.12 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.5 0.72 . . . . 70.2 111.089 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -156.42 130.91 8.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.886 0.874 . . . . 70.51 109.031 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.74 126.13 27.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.836 0.454 . . . . 73.42 110.244 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.1 mt -98.69 -35.99 10.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.052 0.541 . . . . 75.21 110.183 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -159.25 -171.28 3.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.333 0.653 . . . . 72.43 111.186 -176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.12 110.81 3.11 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.257 -0.883 . . . . 75.01 109.797 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 67.73 1.71 2.74 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.247 1.419 . . . . 71.43 112.707 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 52.2 t -110.24 134.16 53.3 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 123.87 0.868 . . . . 62.32 108.999 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -151.68 174.67 13.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.862 0.865 . . . . 71.03 109.08 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.0 tt0 -120.11 132.75 55.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.651 0.78 . . . . 73.41 109.127 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' D' ' 102' ' ' CYS . 58.5 t -100.24 132.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 108.045 -1.094 . . . . 65.1 108.045 168.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.556 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 47.0 t -111.12 136.15 48.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.48 -0.933 . . . . 73.2 108.48 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.87 127.49 56.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.138 -1.06 . . . . 74.43 108.138 179.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.58 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 35.3 ttm-85 -109.86 106.98 16.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.976 -0.749 . . . . 75.33 108.976 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -105.95 106.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 107.756 -1.201 . . . . 75.44 107.756 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 7.6 m -106.09 129.6 54.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.707 0.403 . . . . 70.33 110.183 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.451 HG21 HD12 ' D' ' 114' ' ' ILE . 63.4 t -119.64 102.89 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.719 1.208 . . . . 62.14 109.218 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -96.6 95.94 8.3 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.445 -0.946 . . . . 74.24 108.445 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 147.58 23.67 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.171 0.589 . . . . 63.35 110.495 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.515 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.4 p -155.8 129.16 8.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.564 0.697 . . . . 65.53 111.829 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 13.2 mt -92.51 98.33 11.39 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.695 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.04 -123.88 10.96 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.827 0.704 . . . . 73.43 112.133 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.92 5.98 37.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.17 0.588 . . . . 70.33 111.28 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -129.37 143.93 51.04 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.225 0.61 . . . . 71.11 110.8 -169.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.2 m -70.45 127.85 34.16 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.378 0.671 . . . . 73.43 110.982 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.515 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.67 -66.13 0.93 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.139 -1.059 . . . . 63.24 108.139 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.49 152.08 36.26 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.019 -0.991 . . . . 71.24 110.167 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.5 mt -104.93 147.11 28.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.573 -1.269 . . . . 75.15 107.573 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.406 ' SG ' HG21 ' D' ' 114' ' ' ILE . 45.5 t -156.92 143.4 18.26 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.87 -0.418 . . . . 65.23 109.87 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -157.15 141.23 16.26 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.505 -0.924 . . . . 71.41 108.505 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -135.51 116.64 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 74.22 109.555 175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -89.88 84.04 6.2 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.876 0.845 . . . . 73.54 108.889 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.88 100.33 7.98 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.208 -1.36 . . . . 64.35 109.292 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.58 143.87 16.47 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 111.683 -0.567 . . . . 54.52 111.683 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.97 139.26 6.82 Favored Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.279 -0.729 . . . . 72.2 111.279 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 49.0 mt -88.72 127.54 41.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 122.962 0.505 . . . . 70.12 109.91 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.68 146.27 52.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 72.22 109.49 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.5 m -116.32 105.14 12.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.356 0.663 . . . . 70.5 109.489 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.524 ' HB ' HD13 ' D' ' 89' ' ' ILE . 18.3 pt -109.33 142.4 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.413 0.551 . . . . 63.51 109.983 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.26 145.14 19.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.188 -0.915 . . . . 72.53 109.449 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.03 -10.05 61.79 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.108 0.403 . . . . 72.41 114.108 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.524 HD13 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -124.76 130.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.424 0.69 . . . . 73.41 110.368 -172.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.73 167.74 18.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.985 0.514 . . . . 73.13 111.173 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.43 -134.89 42.07 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.139 0.899 . . . . 53.31 113.208 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -66.39 -23.72 66.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.241 0.616 . . . . 71.31 111.608 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -66.52 -34.17 77.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.331 0.652 . . . . 71.53 110.912 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.498 ' HB3' HG12 ' D' ' 89' ' ' ILE . 3.2 ppp? -88.16 -27.76 21.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.433 0.293 . . . . 64.51 111.054 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.59 65.2 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.977 0.511 . . . . 71.3 111.879 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -84.56 -10.74 57.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.696 0.799 . . . . 71.43 110.338 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.03 -45.61 9.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.348 0.659 . . . . 74.23 109.543 170.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.93 -39.29 72.76 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.015 0.926 . . . . 74.0 111.432 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.16 12.44 67.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.068 -0.515 . . . . 61.32 113.018 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.54 -75.88 0.17 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.988 0.515 . . . . 61.01 111.716 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -72.74 -44.69 61.34 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.948 0.721 . . . . 75.4 112.948 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.468 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 61.7 m -61.52 -48.44 90.48 Favored Pre-proline 0 CA--C 1.567 1.626 0 CA-C-O 118.771 -0.633 . . . . 62.04 112.162 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.515 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 10.0 Cg_exo -72.76 -18.89 24.59 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.036 1.824 . . . . 75.53 112.977 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.31 -28.73 64.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.795 0.438 . . . . 71.42 110.563 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.11 -41.78 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-O 121.598 0.713 . . . . 71.42 109.413 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.72 -20.91 59.65 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.863 -1.062 . . . . 72.24 111.722 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.16 -41.42 14.29 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.252 1.205 . . . . 73.14 114.252 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -56.14 -36.04 95.91 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 121.762 1.641 . . . . 55.43 112.881 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.13 -32.82 33.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.81 0.844 . . . . 73.34 111.552 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.6 -50.74 63.94 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.584 -0.524 . . . . 74.54 109.584 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -58.31 -50.27 74.23 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.031 -1.441 . . . . 75.1 110.51 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -63.06 -42.43 99.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.46 0.704 . . . . 72.41 111.643 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' D' ' 21' ' ' ILE . 49.2 t -59.47 -44.86 92.92 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.767 0.667 . . . . 73.54 110.944 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.451 HD12 HG21 ' D' ' 64' ' ' VAL . 74.3 mt -62.41 -57.24 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.612 0.765 . . . . 75.34 110.092 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.499 HG23 ' HG3' ' D' ' 125' ' ' GLN . 83.8 m -50.12 -43.83 51.93 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.533 1.533 . . . . 70.14 112.477 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.99 -44.66 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 70.34 110.486 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -64.48 -33.78 76.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.909 0.484 . . . . 74.14 111.43 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.416 HG22 ' O ' ' D' ' 114' ' ' ILE . 79.4 t -64.61 -45.8 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.108 0.963 . . . . 72.42 110.049 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.03 -27.98 63.07 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.683 0.278 . . . . 71.32 111.085 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -71.68 -30.59 65.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.6 0.76 . . . . 75.11 110.138 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 6.64 80.11 Favored Glycine 0 C--N 1.358 1.781 0 O-C-N 123.66 0.6 . . . . 75.02 112.731 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.551 HG21 ' HB3' ' C' ' 17' ' ' TYR . 51.0 p 65.41 21.28 11.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.309 1.844 . . . . 71.51 113.09 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.26 164.89 18.01 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 124.82 1.248 . . . . 72.34 109.314 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.07 140.34 22.52 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.394 2.063 . . . . 63.42 112.266 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.499 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.8 tt0 -55.75 126.65 26.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 75.23 111.013 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.93 105.65 15.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.411 0.684 . . . . 75.13 109.209 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -98.48 92.81 5.83 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.718 -0.845 . . . . 73.12 108.718 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.497 HD22 HD21 ' D' ' 42' ' ' LEU . 76.3 mt -69.89 123.33 21.2 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.098 0.559 . . . . 75.14 109.555 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.21 133.05 75.33 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.254 0.621 . . . . 55.01 111.145 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.65 108.66 2.3 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 121.877 1.718 . . . . 75.12 110.17 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.7 107.25 22.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.809 -1.182 . . . . 73.41 107.809 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 . . . . . 0 C--O 1.241 0.649 0 CA-C-N 115.141 -0.936 . . . . 75.23 108.682 178.035 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.239 0.52 0 N-CA-C 109.328 -0.619 . . . . 74.41 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 45.3 t80 -127.38 141.68 51.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.204 1.002 . . . . 73.22 108.878 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 60.0 tp60 -152.66 137.35 16.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.999 0.52 . . . . 70.22 110.296 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.99 117.05 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.754 -1.202 . . . . 71.43 107.754 173.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -90.08 -40.73 12.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.443 0.297 . . . . 75.13 110.539 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -172.77 125.02 0.46 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.704 0.401 . . . . 75.24 110.693 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.87 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 71.6 mt -106.67 136.34 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.504 -0.925 . . . . 74.51 108.504 171.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 31.7 p90 -167.14 171.0 11.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.888 0.875 . . . . 72.54 110.101 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -92.38 130.29 38.1 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.498 -0.927 . . . . 75.54 108.498 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -92.35 -42.94 9.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.61 -0.885 . . . . 75.3 108.61 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.4 t70 -135.09 135.03 40.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.921 -1.036 . . . . 64.21 110.083 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.445 HG22 ' SD ' ' A' ' 117' ' ' MET . 82.5 mt -131.65 136.98 56.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.24 -1.393 . . . . 75.2 107.24 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -145.66 128.32 16.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.872 -0.418 . . . . 72.32 109.872 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 80.8 t80 -134.11 114.86 13.59 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.741 -1.578 . . . . 74.23 106.741 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 46.5 mt-10 -121.61 117.46 26.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.464 -0.569 . . . . 74.25 109.464 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.52 91.95 6.53 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 109.015 -0.735 . . . . 73.53 109.015 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 19.0 Cg_exo -67.39 -50.35 0.99 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.005 2.47 . . . . 71.4 111.854 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 40.1 m-80 -99.56 42.5 1.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.86 0.864 . . . . 73.34 109.86 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -48.39 96.45 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.76 1.224 . . . . 74.02 114.144 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 5.8 Cg_exo -78.88 -17.89 11.92 Favored 'Trans proline' 0 C--N 1.386 2.503 0 CA-C-N 121.168 1.453 . . . . 65.44 111.909 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -74.02 -38.79 63.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.14 111.546 -173.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.76 -14.15 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.758 0.823 . . . . 74.32 111.747 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.82 -39.63 89.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.487 0.715 . . . . 75.44 111.186 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -100.55 -30.28 11.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.604 0.762 . . . . 74.34 110.956 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.8 tmtp? -76.49 139.71 40.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.844 0.858 . . . . 73.32 108.95 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.1 m-20 -57.78 116.39 3.42 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.881 0.738 . . . . 72.43 109.793 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -79.17 80.45 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.191 0.996 . . . . 73.55 109.014 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -114.5 83.86 9.16 Favored Pre-proline 0 C--O 1.245 0.851 0 N-CA-C 107.404 -1.332 . . . . 64.24 107.404 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HB2' HG13 ' A' ' 40' ' ' VAL . 73.2 Cg_endo -73.76 122.16 7.56 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.921 1.747 . . . . 74.44 112.125 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -94.93 85.31 4.34 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 105.857 -1.905 . . . . 71.43 105.857 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 38' ' ' PRO . 14.0 m -75.25 93.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.703 -1.589 . . . . 74.4 110.744 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -77.78 144.7 36.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.268 -1.787 . . . . 74.54 108.891 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.37 147.7 38.46 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.711 -1.131 . . . . 75.1 108.866 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.4 132.04 18.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.425 -0.954 . . . . 64.24 108.425 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 tp -99.46 119.24 37.68 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.695 -0.854 . . . . 74.42 108.695 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.78 155.66 50.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.775 -0.454 . . . . 72.12 109.775 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -118.15 162.89 17.47 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.374 0.67 . . . . 73.43 109.443 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.02 116.12 6.92 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.618 -1.253 . . . . 63.42 107.618 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 p -98.88 150.27 22.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.321 -0.251 . . . . 72.31 110.321 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -159.34 121.07 3.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.449 0.7 . . . . 74.32 109.458 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.72 131.17 35.82 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.962 -0.755 . . . . 61.52 108.962 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 83' ' ' ILE . 82.8 mt -104.45 -38.32 6.85 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.313 0.645 . . . . 64.24 110.454 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -154.23 -177.61 6.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.098 0.959 . . . . 73.22 109.776 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.26 128.11 34.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.336 -0.987 . . . . 72.44 108.336 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 69.96 2.73 4.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.151 0.981 . . . . 72.34 111.935 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 54.5 t -120.31 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 107.01 -1.478 . . . . 74.21 107.01 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.38 128.67 44.95 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 74.35 108.95 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.25 115.09 28.34 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.861 -1.063 . . . . 72.43 109.168 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.42 119.73 53.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.047 0 N-CA-C 106.087 -1.82 . . . . 73.54 106.087 169.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -97.3 132.14 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.847 0.859 . . . . 75.12 108.938 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 115.37 27.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.726 -1.213 . . . . 74.45 107.726 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -105.3 100.74 10.31 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.03 -0.73 . . . . 73.11 109.03 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 114' ' ' ILE . 32.7 t -99.92 127.32 52.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.152 -1.055 . . . . 71.24 108.152 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -122.73 132.83 54.42 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.612 -0.514 . . . . 64.45 109.612 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 51.2 t -133.15 126.22 52.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 125.351 1.46 . . . . 72.41 108.569 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -118.66 137.03 53.58 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.44 109.437 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.66 111.8 23.49 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.049 -1.093 . . . . 72.31 108.049 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.9 m -108.46 131.29 54.94 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.973 0.416 . . . . 64.42 110.323 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.493 HD13 ' HB1' ' A' ' 73' ' ' ALA . 28.6 mt -105.14 43.1 1.14 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.699 -1.223 . . . . 74.04 107.699 173.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.98 -115.01 4.93 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.946 -1.261 . . . . 70.33 109.946 -168.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.41 -25.95 18.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.217 0.607 . . . . 73.44 110.411 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.64 99.6 5.85 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.84 -0.618 . . . . 74.45 110.015 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.9 m -68.75 127.45 33.11 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.206 -0.664 . . . . 74.41 109.206 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -78.83 -52.05 8.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.881 0.873 . . . . 72.0 109.101 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.46 159.74 43.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.163 -1.38 . . . . 74.33 110.328 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -130.55 132.37 45.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.049 -1.463 . . . . 61.45 107.049 173.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.9 m -122.09 135.21 54.78 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.145 0.978 . . . . 73.34 108.792 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -148.27 116.49 6.5 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.003 -1.11 . . . . 74.15 108.003 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.413 HG11 ' SG ' ' A' ' 113' ' ' CYS . 94.6 t -123.92 118.71 54.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.87 -0.789 . . . . 71.35 108.87 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.1 mt-30 -97.15 88.23 4.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.904 -1.044 . . . . 74.24 108.451 172.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.2 tp-100 -75.7 98.94 4.21 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 114.541 -1.209 . . . . 75.0 107.936 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.01 143.74 18.34 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 112.042 -0.423 . . . . 64.11 112.042 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.27 120.83 1.96 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.878 -0.889 . . . . 71.45 110.878 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' B' ' 29' ' ' PRO . 50.2 mt -81.71 126.73 39.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.304 -1.369 . . . . 70.14 107.304 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 64.8 m-85 -134.8 128.83 33.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.552 -0.536 . . . . 73.33 109.552 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 12' ' ' GLN . 9.3 p -84.08 96.62 8.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.58 -0.896 . . . . 74.45 108.58 170.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -129.03 133.72 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 74.01 109.378 -169.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 175.61 4.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.594 0.757 . . . . 64.03 111.161 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.46 -22.86 31.54 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.433 -0.803 . . . . 70.12 113.314 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -110.25 150.84 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 73.42 110.152 -176.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -140.88 174.87 10.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.596 0.358 . . . . 75.35 110.834 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.6 -134.46 35.54 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.384 -0.371 . . . . 75.12 113.391 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -68.07 -21.79 64.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.814 0.846 . . . . 71.31 111.745 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -65.46 -35.76 81.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.676 0.79 . . . . 71.15 110.685 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 62.0 tpp -69.22 -39.89 78.29 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 116.201 -0.454 . . . . 72.2 109.972 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -28.59 69.67 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.937 0.495 . . . . 74.14 111.31 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -72.36 -61.76 1.68 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.408 0.683 . . . . 63.32 111.017 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 9.1 t -68.39 -43.3 77.6 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 62.12 110.773 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 tt -84.56 -41.2 16.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.023 0.929 . . . . 75.25 110.618 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.14 -36.19 28.33 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 114.822 0.689 . . . . 75.52 114.822 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.8 -44.44 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.939 0.496 . . . . 72.04 112.107 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -74.18 -53.62 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.909 0.883 . . . . 74.31 112.669 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.12 -40.79 30.72 Favored Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 113.206 0.817 . . . . 73.52 113.206 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.8 Cg_endo -66.7 -22.14 50.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 CA-C-N 121.05 1.411 . . . . 73.21 113.295 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.89 -31.17 68.83 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 118.269 0.486 . . . . 72.04 110.461 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.25 -33.07 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.786 0.803 . . . . 75.14 110.364 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 103' ' ' PRO . 86.5 mt -82.67 -23.64 34.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.866 1.266 . . . . 75.43 113.123 -174.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -62.3 -40.7 69.08 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.609 1.337 . . . . 74.1 114.609 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.52 -38.54 83.57 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 121.982 1.788 . . . . 62.43 112.992 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -82.56 -34.09 27.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.086 0.954 . . . . 74.42 111.515 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.06 78.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.063 0.545 . . . . 72.52 109.544 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.427 HH22 ' HB3' ' A' ' 130' ' ' PRO . 39.6 ttm180 -52.04 -52.7 49.23 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.709 1.256 . . . . 74.23 110.655 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.45 -45.74 92.99 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.403 1.064 . . . . 72.35 111.244 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.413 ' SG ' HG11 ' A' ' 78' ' ' VAL . 49.3 t -58.76 -45.35 89.95 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.771 0.669 . . . . 75.53 111.154 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 62' ' ' VAL . 86.7 mt -62.52 -51.58 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.903 0.752 . . . . 73.23 109.793 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -56.14 -41.28 75.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.267 1.027 . . . . 53.21 111.805 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.9 t -66.21 -47.88 72.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.345 0.658 . . . . 73.53 110.006 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.445 ' SD ' HG22 ' A' ' 21' ' ' ILE . 13.5 mtp -55.59 -46.77 77.21 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.988 0.915 . . . . 71.41 111.048 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -60.1 -44.15 94.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.726 1.21 . . . . 73.11 111.17 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.4 t -68.38 -31.82 71.46 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.816 -0.629 . . . . 64.42 111.322 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.493 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 94.1 mtt-85 -74.16 -20.38 60.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.735 0.814 . . . . 74.24 110.844 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.04 11.55 57.03 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.511 0.507 . . . . 71.55 112.983 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.3 m 66.71 35.51 5.14 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.495 1.14 . . . . 63.34 110.323 177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.31 149.68 50.11 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.162 -0.926 . . . . 74.53 109.54 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.21 157.78 47.85 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.718 2.278 . . . . 64.22 112.564 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.83 141.74 58.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.637 -1.165 . . . . 73.53 112.628 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -123.48 107.06 11.16 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.156 -1.424 . . . . 71.43 107.156 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.55 99.97 8.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.148 0.979 . . . . 71.41 109.387 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.91 148.32 40.21 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.699 0.8 . . . . 71.33 110.421 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.62 147.45 98.69 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.634 0.774 . . . . 63.24 111.817 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HB3' HH22 ' A' ' 111' ' ' ARG . 71.7 Cg_endo -83.73 165.76 13.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.75 2.3 . . . . 75.44 112.801 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.41 114.68 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.744 -0.835 . . . . 75.04 108.744 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -99.98 63.82 1.2 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.948 -1.13 . . . . 72.33 107.948 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.479 0.991 0 CA-C-N 114.503 -1.226 . . . . 73.15 110.608 -176.512 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.424 -1.324 . . . . 74.34 107.424 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.9 140.95 38.54 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.813 -0.81 . . . . 71.13 108.813 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.6 140.26 18.93 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.631 0.582 . . . . 74.41 109.906 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 tt -95.09 133.03 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.939 0.896 . . . . 74.21 109.46 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -104.7 -50.55 3.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.814 0.446 . . . . 74.1 110.872 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -158.57 140.36 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.657 0.383 . . . . 75.14 110.8 -173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -117.83 142.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.015 -1.105 . . . . 72.4 108.015 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -162.86 169.63 19.5 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.823 0.702 . . . . 73.32 110.69 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.8 m -99.2 123.23 43.32 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.065 -0.716 . . . . 72.33 109.065 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.44 ' HZ1' ' HG3' ' A' ' 29' ' ' PRO . 40.5 mttp -77.21 -52.7 8.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.926 -0.579 . . . . 73.42 110.402 170.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -140.79 140.93 34.82 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.111 0.481 . . . . 71.32 111.919 -165.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.8 HD12 ' SG ' ' B' ' 113' ' ' CYS . 46.4 mm -132.81 138.14 52.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.933 1.293 . . . . 73.43 108.396 174.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -143.1 135.98 27.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.063 -0.971 . . . . 74.44 108.509 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -153.35 111.85 3.67 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.851 -1.166 . . . . 74.11 107.851 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -119.83 118.66 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.594 -0.891 . . . . 72.21 108.594 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -115.89 86.88 17.11 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.721 0.808 . . . . 75.24 109.643 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.9 -50.57 2.16 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.868 2.379 . . . . 64.52 112.695 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 88.8 m-20 -101.56 20.6 15.79 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.561 0.744 . . . . 72.24 111.435 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -48.6 -52.73 42.17 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 124.898 1.279 . . . . 54.0 112.932 168.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.461 ' HA ' HD11 ' A' ' 83' ' ' ILE . 43.8 Cg_endo -74.62 -12.02 22.31 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 121.692 1.595 . . . . 71.33 113.207 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.457 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 82.8 m-70 -96.01 1.12 52.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.759 0.824 . . . . 72.12 110.915 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.01 -22.92 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.817 1.247 . . . . 64.22 112.936 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.84 -42.05 78.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.915 0.886 . . . . 72.45 110.937 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -83.46 -12.47 56.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.5 1.12 . . . . 74.41 111.136 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -100.54 75.3 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.031 0.932 . . . . 74.24 109.284 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.12 76.04 9.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 71.54 110.899 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.48 158.51 1.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.89 1.276 . . . . 74.31 109.885 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.457 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 63.8 tt0 -83.93 130.89 53.3 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 74.32 108.729 173.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.415 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 50.3 Cg_endo -65.6 153.39 78.4 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.51 2.14 . . . . 75.5 112.746 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 42.8 mt-10 -69.76 100.82 1.57 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.944 . . . . 73.03 108.453 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' B' ' 126' ' ' LEU . 33.1 t -90.24 121.23 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 107.871 -1.159 . . . . 73.42 107.871 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -148.76 139.78 23.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.468 -1.308 . . . . 64.32 107.468 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.444 HD22 HD12 ' B' ' 126' ' ' LEU . 0.8 OUTLIER -128.11 163.03 25.52 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.711 0.767 . . . . 75.3 112.475 -171.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -126.9 154.15 44.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.049 -1.432 . . . . 74.52 108.555 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 tt -134.94 116.17 14.4 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.792 -1.559 . . . . 72.24 106.792 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -126.46 155.28 42.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.754 0.822 . . . . 75.43 110.044 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 29.2 m -111.4 136.69 50.18 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 72.51 110.394 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.15 154.06 36.7 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.688 1.195 . . . . 73.42 108.177 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 m -141.68 160.69 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.006 0.431 . . . . 54.34 111.338 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -162.99 163.38 26.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.108 1.363 . . . . 73.54 108.332 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -123.02 137.24 55.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.056 0.943 . . . . 74.44 109.193 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.421 HD13 HG23 ' B' ' 83' ' ' ILE . 46.7 mt -101.15 -35.11 9.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.177 0.591 . . . . 73.53 111.117 176.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.46 -174.25 2.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.346 1.058 . . . . 74.15 110.316 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.05 119.09 14.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.347 -0.842 . . . . 71.1 109.823 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 67.02 12.46 8.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.659 1.184 . . . . 74.34 112.138 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -128.27 110.62 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.779 -1.193 . . . . 63.22 107.779 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -122.31 163.96 18.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.137 -0.69 . . . . 75.2 109.137 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -137.93 110.46 7.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.681 -1.229 . . . . 73.43 107.681 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' B' ' 98' ' ' LEU . 24.4 m -107.77 150.66 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.211 0.529 . . . . 74.5 110.364 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 18.0 t -116.61 136.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 115.272 -0.876 . . . . 75.3 108.648 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -102.02 116.15 32.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.962 -1.125 . . . . 74.22 107.962 178.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -97.44 125.16 41.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.016 0.526 . . . . 63.43 109.98 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 12.7 t -125.7 116.86 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.486 -0.931 . . . . 74.4 108.486 166.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 38.0 m -99.08 152.13 20.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.452 1.101 . . . . 73.14 109.216 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.78 111.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.936 0.894 . . . . 71.03 109.242 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.2 m -92.31 138.41 31.54 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.514 0.725 . . . . 74.44 109.047 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.05 142.21 28.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.127 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 35.3 p -140.7 128.65 21.95 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.747 0.654 . . . . 73.53 111.824 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.8 99.04 11.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.951 -1.129 . . . . 74.41 107.951 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -112.81 3.79 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.341 -0.845 . . . . 54.21 111.467 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -108.26 1.32 21.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.091 0.956 . . . . 73.3 111.131 -176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.0 155.6 41.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.481 0.712 . . . . 74.34 110.213 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 130.72 44.17 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.034 0.534 . . . . 75.12 111.97 -173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.68 -58.85 2.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 64.3 108.72 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -161.55 162.93 30.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 113.536 -1.665 . . . . 71.34 109.352 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.4 mt -136.32 111.63 9.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.935 -1.506 . . . . 73.33 106.935 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -117.87 158.17 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.702 0.801 . . . . 74.24 109.068 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -165.68 146.69 7.0 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.003 -0.74 . . . . 75.12 109.003 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' B' ' 110' ' ' ALA . 74.8 t -129.15 144.5 37.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.566 -1.197 . . . . 73.23 108.353 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.527 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.1 mt-30 -127.36 93.46 3.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.547 -0.908 . . . . 74.42 108.547 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -86.08 102.66 14.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.95 -1.023 . . . . 70.34 109.449 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.57 148.87 20.76 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.759 -0.536 . . . . 71.44 111.759 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.25 126.09 2.16 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 117.27 0.535 . . . . 72.11 112.416 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.421 HG23 HD13 ' B' ' 51' ' ' LEU . 57.0 mt -85.98 127.2 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.535 0.734 . . . . 71.31 109.079 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -139.72 170.18 16.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 71.31 109.041 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -133.68 131.72 39.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 74.34 108.874 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.68 HD12 ' SG ' ' B' ' 97' ' ' CYS . 7.1 tt -140.32 145.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.417 0.287 . . . . 71.1 110.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.3 39.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.767 0.827 . . . . 72.24 110.078 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.05 -31.6 4.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.18 -0.464 . . . . 73.23 114.149 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' B' ' 94' ' ' MET . 0.1 OUTLIER -71.54 170.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.13 0.972 . . . . 75.4 112.679 -177.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 93' ' ' GLN . 13.8 pt-20 -164.12 160.25 21.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.326 0.65 . . . . 75.32 110.388 173.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.55 -128.74 47.57 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.469 0.48 . . . . 73.1 113.693 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 38.0 m -68.47 -21.88 64.59 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.367 0.667 . . . . 65.02 111.382 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' B' ' 90' ' ' GLU . 25.0 mt-30 -64.97 -31.7 73.06 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.907 0.483 . . . . 75.32 110.806 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.574 ' HE1' HD21 ' B' ' 98' ' ' LEU . 13.1 tpt -85.86 -46.3 10.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.457 -0.338 . . . . 73.23 110.574 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.67 66.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.781 0.833 . . . . 75.31 111.872 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.1 -38.67 75.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.638 0.775 . . . . 72.43 111.16 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.68 ' SG ' HD12 ' B' ' 86' ' ' ILE . 53.4 t -64.98 -68.37 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.882 0.31 . . . . 73.5 111.547 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' B' ' 58' ' ' VAL . 2.6 pt? -75.46 -18.02 59.98 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.785 0.266 . . . . 74.5 111.517 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.64 3.64 42.61 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-O 118.984 -0.898 . . . . 74.0 114.373 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.96 -50.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.076 0.938 . . . . 44.33 112.409 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -72.84 -46.57 52.27 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.557 0.743 . . . . 71.11 111.55 -170.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.0 -44.8 40.91 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 118.457 -0.782 . . . . 73.31 110.717 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.13 -45.35 21.8 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.033 1.822 . . . . 75.31 112.841 163.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -60.74 -36.52 79.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.509 0.724 . . . . 73.23 111.782 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.01 -48.37 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.358 0.663 . . . . 74.41 110.77 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.457 ' HB2' HD13 ' B' ' 60' ' ' LEU . 44.2 mt -83.0 -11.48 58.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.911 -1.04 . . . . 72.25 111.575 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -62.22 -48.42 87.77 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 117.904 -1.046 . . . . 72.43 113.724 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.17 -36.07 98.17 Favored 'Trans proline' 0 C--N 1.373 1.851 0 CA-C-N 121.04 1.407 . . . . 74.35 112.267 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.401 ' HE2' HG23 ' D' ' 115' ' ' THR . 91.0 m-85 -66.28 -51.37 58.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 74.33 111.261 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.429 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -60.84 -45.38 94.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.941 0.897 . . . . 64.32 110.832 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.424 ' NH2' HG22 ' C' ' 122' ' ' THR . 37.3 ttt180 -56.58 -50.34 72.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.204 1.401 . . . . 75.41 111.292 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.5 -35.75 81.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.236 0.614 . . . . 71.33 110.374 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.8 ' SG ' HD12 ' B' ' 21' ' ' ILE . 7.5 t -72.22 -37.96 69.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.152 -0.476 . . . . 62.22 111.065 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' B' ' 62' ' ' VAL . 54.0 mt -60.59 -50.22 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.352 0.661 . . . . 72.53 109.222 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 72.5 m -48.2 -46.49 35.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.842 1.339 . . . . 73.12 110.532 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.1 t -61.89 -56.51 18.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.446 -1.252 . . . . 62.02 110.882 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 20.0 mmt -67.6 -38.36 83.86 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.752 0.821 . . . . 75.12 112.389 -170.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.91 -44.45 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.424 0.631 . . . . 75.52 109.944 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.3 t -67.34 -25.16 65.85 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.648 -1.16 . . . . 72.0 112.222 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -70.94 -36.4 72.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.194 0.597 . . . . 64.23 109.933 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 6.75 56.59 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.662 0.601 . . . . 74.34 112.49 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.0 p 57.22 42.01 26.02 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.368 1.867 . . . . 75.42 111.457 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.462 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 48.3 m-85 -114.85 159.42 37.49 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.533 -1.212 . . . . 75.42 110.698 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.507 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 39.6 Cg_exo -60.53 104.56 0.26 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.58 2.853 . . . . 72.41 114.684 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.494 ' HG3' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -65.0 161.53 18.5 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.156 1.382 . . . . 61.21 111.447 171.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.46 ' HB2' HG13 ' B' ' 40' ' ' VAL . 1.1 tm? -132.29 117.99 18.89 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.395 -0.965 . . . . 72.3 108.395 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.41 94.85 10.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.132 -1.062 . . . . 62.11 108.132 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.452 HD21 ' N ' ' B' ' 129' ' ' ALA . 1.8 tt -58.4 138.99 56.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.681 -1.145 . . . . 72.12 110.565 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.452 ' N ' HD21 ' B' ' 128' ' ' LEU . . . -51.51 148.98 8.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 70.33 112.228 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.473 ' HG3' HG12 ' D' ' 16' ' ' ILE . 80.1 Cg_endo -72.07 78.81 1.78 Allowed 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.331 2.021 . . . . 74.22 111.451 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.7 m -74.07 83.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.239 1.019 . . . . 75.12 110.691 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.58 111.33 7.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.807 -1.088 . . . . 72.11 108.891 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.8 t80 . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.258 0.623 . . . . 74.41 110.91 -177.454 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.001 -0.74 . . . . 63.41 109.001 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -124.35 119.07 28.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -146.66 130.17 16.83 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.459 -0.941 . . . . 74.21 108.459 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 tp -78.81 137.89 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 109.477 -0.564 . . . . 75.44 109.477 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.51 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.9 mm-40 -98.96 -47.33 5.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.273 0.629 . . . . 72.41 109.881 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.41 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 66.4 ttt180 -170.77 124.99 0.68 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.581 0.551 . . . . 74.44 110.48 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -109.35 141.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.665 -1.235 . . . . 74.22 107.665 169.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.444 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 6.8 p90 -179.39 164.94 1.38 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.438 0.695 . . . . 71.35 110.029 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -88.7 122.87 32.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 122.971 0.508 . . . . 71.25 109.913 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.604 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.8 mmtp -74.54 -50.56 17.6 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.069 0.938 . . . . 74.34 108.686 170.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.99 141.52 40.45 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.003 -1.453 . . . . 73.34 109.004 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 94.2 mt -137.28 139.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.808 -1.553 . . . . 72.13 106.808 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -149.85 146.3 27.04 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.557 -0.534 . . . . 74.33 109.557 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -152.48 108.84 3.41 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.162 -1.422 . . . . 75.24 107.162 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -116.47 118.68 33.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.91 -0.774 . . . . 63.04 108.91 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.49 86.94 5.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.28 -1.748 . . . . 74.13 106.28 167.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.55 -38.61 61.24 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 122.67 2.247 . . . . 61.12 110.989 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -99.9 44.79 1.01 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.394 -1.275 . . . . 73.32 109.064 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.415 ' O ' HG13 ' C' ' 31' ' ' VAL . . . -59.26 -64.3 3.13 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.903 1.281 . . . . 73.31 112.694 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.5 -12.47 22.62 Favored 'Trans proline' 0 C--N 1.382 2.319 0 CA-C-N 121.876 1.706 . . . . 61.43 112.203 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.503 ' CD2' ' HD3' ' C' ' 34' ' ' LYS . 3.5 t-160 -67.7 -30.41 69.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.214 1.006 . . . . 74.41 109.907 174.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.801 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 2.9 p -69.51 -26.66 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 111.835 0.309 . . . . 72.12 111.835 -173.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.92 -40.15 72.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.651 1.18 . . . . 75.32 112.515 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -122.87 39.0 4.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.642 0.777 . . . . 65.34 109.889 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.801 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 31.7 ttpt -114.19 153.14 30.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 74.32 111.463 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.2 116.56 10.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.246 1.018 . . . . 54.14 110.539 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -87.2 101.7 13.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.378 1.071 . . . . 74.24 111.93 -173.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' C' ' 68' ' ' LEU . 0.1 OUTLIER -150.38 63.07 5.83 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 124.037 0.935 . . . . 75.32 109.683 168.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.26 122.09 6.87 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.099 2.532 . . . . 71.24 111.529 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.07 88.27 7.45 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.62 -1.252 . . . . 75.31 107.62 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.82 119.06 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.072 -1.422 . . . . 71.1 110.903 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -130.9 146.54 52.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.716 0.807 . . . . 71.12 110.396 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.4 ' HB2' HD13 ' C' ' 128' ' ' LEU . 56.1 tp -116.15 124.23 49.8 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.11 0.964 . . . . 73.33 109.201 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -119.21 116.84 27.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.843 0.857 . . . . 74.12 109.664 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.2 126.96 47.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.317 -0.994 . . . . 75.54 108.317 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -134.4 151.46 51.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.294 1.038 . . . . 74.13 108.863 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 24.5 m -112.17 115.83 29.48 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.108 0.563 . . . . 74.01 110.311 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.67 147.76 44.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.246 -1.02 . . . . 75.52 108.246 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -163.08 145.15 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.744 0.418 . . . . 70.22 110.649 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.2 t -145.35 125.98 14.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.214 1.005 . . . . 64.02 108.413 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.01 126.09 30.35 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.843 -0.428 . . . . 72.15 109.843 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.498 HD13 HD13 ' C' ' 83' ' ' ILE . 87.3 mt -91.34 -52.2 4.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.401 0.681 . . . . 75.02 110.675 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.83 -170.77 3.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.921 0.888 . . . . 75.23 110.646 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.13 117.89 7.76 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.184 -0.673 . . . . 71.24 109.184 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 64.76 12.19 7.46 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 124.232 0.958 . . . . 73.42 112.186 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.4 t -121.74 122.93 68.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.621 -1.252 . . . . 75.12 107.621 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.418 ' OH ' ' HB3' ' C' ' 98' ' ' LEU . 0.1 OUTLIER -138.99 157.91 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 175.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -105.02 116.29 31.7 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.575 -1.193 . . . . 74.42 108.563 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.98 132.03 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.911 -1.144 . . . . 72.23 107.911 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.5 t -128.0 111.25 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.205 -1.406 . . . . 64.33 107.205 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.417 HD23 HG21 ' C' ' 62' ' ' VAL . 0.3 OUTLIER -85.76 108.9 18.29 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.922 -1.51 . . . . 75.15 106.922 178.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -81.22 104.81 11.94 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.909 -1.145 . . . . 75.44 107.909 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.417 HG21 HD23 ' C' ' 60' ' ' LEU . 43.9 t -111.68 107.42 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.218 -0.66 . . . . 72.35 109.218 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -104.0 145.91 29.47 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.352 0.661 . . . . 74.04 109.285 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.654 HG21 HG23 ' C' ' 114' ' ' ILE . 38.9 t -140.54 117.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 124.706 1.202 . . . . 74.24 108.081 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -111.98 141.62 45.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.833 0.349 . . . . 63.25 110.097 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.37 103.17 6.29 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 107.155 -1.424 . . . . 64.42 107.155 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.1 m -125.55 137.9 53.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.163 0.506 . . . . 71.34 110.591 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.44 ' HB3' HE22 ' C' ' 37' ' ' GLN . 10.9 mt -89.51 37.55 0.87 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.859 1.264 . . . . 73.31 109.308 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.67 -115.47 5.11 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.213 -1.155 . . . . 72.34 110.213 -166.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.37 -31.48 16.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.582 0.753 . . . . 74.14 110.107 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.86 105.76 3.93 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.054 0.942 . . . . 64.04 108.922 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.06 135.61 37.76 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 122.27 -0.269 . . . . 74.13 110.95 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.55 -56.46 4.29 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.807 -0.812 . . . . 62.01 108.807 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -161.2 173.4 15.14 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.516 -0.765 . . . . 72.5 111.46 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.3 tm? -136.82 141.16 42.87 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.146 -1.428 . . . . 73.42 107.146 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.513 ' SG ' HG21 ' C' ' 114' ' ' ILE . 35.4 t -141.68 139.57 33.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.768 -1.197 . . . . 62.22 107.768 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.49 116.25 3.86 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.141 -0.689 . . . . 75.53 109.141 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -120.9 140.11 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.836 0.854 . . . . 74.51 109.623 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -107.7 109.02 20.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.941 0.896 . . . . 73.41 109.123 168.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -89.4 107.74 19.24 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.119 -0.697 . . . . 72.04 109.119 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.4 22.15 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.61 0.569 . . . . 53.03 112.033 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.524 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.43 116.83 0.77 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.694 -0.962 . . . . 73.32 110.694 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 13.7 mm -88.7 119.12 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.56 -0.904 . . . . 75.32 108.56 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 135.65 54.81 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.413 0.685 . . . . 75.0 109.725 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -103.47 99.66 9.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.845 -1.168 . . . . 60.34 107.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.82 156.23 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.096 0.558 . . . . 75.02 110.202 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.08 157.36 2.29 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.723 1.209 . . . . 71.23 108.949 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -18.27 54.26 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 120.333 -0.148 . . . . 73.44 113.178 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.708 HD11 ' HA ' ' C' ' 94' ' ' MET . 46.1 pt . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 123.126 0.57 . . . . 72.41 111.301 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 119.657 -0.211 . . . . 75.15 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.708 ' HA ' HD11 ' C' ' 89' ' ' ILE . 25.6 tpp -59.29 -55.37 35.65 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.536 0.523 . . . . 75.43 110.101 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.96 -34.6 78.47 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.644 -0.707 . . . . 74.41 112.229 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -77.78 -34.08 52.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.671 0.388 . . . . 75.23 111.772 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -68.8 -60.66 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.775 0.43 . . . . 70.24 110.755 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.707 HD22 ' SD ' ' C' ' 94' ' ' MET . 1.5 pp -94.43 -19.14 20.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.891 0.7 . . . . 75.22 112.891 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 6.73 73.76 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.785 -0.453 . . . . 71.5 113.326 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.69 -56.53 0.07 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.668 0.387 . . . . 72.25 111.873 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.53 -53.82 9.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.957 0.725 . . . . 71.25 112.957 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.35 -43.41 79.54 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 123.685 0.794 . . . . 72.4 112.456 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.04 -30.44 66.25 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 121.308 1.339 . . . . 75.04 112.706 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -66.64 -32.7 74.18 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.217 0.462 . . . . 72.31 110.315 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.422 HD13 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -60.22 -44.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.291 0.567 . . . . 72.14 109.903 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.524 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.8 mt -78.68 -21.12 48.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.9 -1.046 . . . . 74.55 111.926 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -56.69 -55.36 43.97 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 117.434 -1.27 . . . . 73.52 113.631 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.91 -30.7 84.15 Favored 'Trans proline' 0 C--N 1.377 2.03 0 CA-C-N 121.571 1.597 . . . . 74.51 112.732 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -63.39 -50.85 68.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.626 0.77 . . . . 75.01 110.83 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.33 98.73 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.229 1.012 . . . . 70.32 111.225 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -61.12 -44.17 97.76 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.405 1.882 . . . . 74.23 110.521 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.2 -35.11 63.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.347 0.659 . . . . 64.11 110.3 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.5 t -64.1 -34.43 78.03 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.504 0.722 . . . . 73.34 111.357 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.654 HG23 HG21 ' C' ' 64' ' ' VAL . 97.3 mt -73.28 -45.01 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.805 0.842 . . . . 75.33 111.349 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.4 m -57.83 -35.39 70.83 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.803 0.441 . . . . 75.42 111.787 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.1 -48.66 70.16 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.29 -0.633 . . . . 71.43 109.29 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.596 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.34 -39.46 70.03 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.872 1.269 . . . . 73.12 113.144 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' C' ' 126' ' ' LEU . 94.2 t -62.09 -48.23 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.218 0.532 . . . . 74.3 110.399 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.9 t -66.52 -28.66 68.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.079 -0.964 . . . . 70.31 111.843 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.596 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 84.6 mtt-85 -67.16 -40.62 86.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.068 -0.715 . . . . 75.41 109.068 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.65 5.04 66.13 Favored Glycine 0 C--N 1.358 1.789 0 O-C-N 124.038 0.836 . . . . 71.34 112.912 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.549 HG21 ' HB3' ' D' ' 17' ' ' TYR . 29.9 p 56.1 53.66 8.8 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.063 1.745 . . . . 72.12 111.939 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.507 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 56.4 m-85 -113.22 172.57 3.44 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 114.516 -1.22 . . . . 74.22 109.492 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 18.3 Cg_endo -56.59 171.49 0.96 Allowed 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.639 2.226 . . . . 70.14 113.327 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.507 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 9.0 tm0? -60.53 140.7 57.21 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.377 -0.972 . . . . 73.42 108.377 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.407 ' HB3' HG22 ' C' ' 118' ' ' VAL . 9.5 tp -151.03 83.34 1.33 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.975 0.893 . . . . 73.31 110.363 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.99 98.42 3.75 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.812 -1.54 . . . . 73.51 107.092 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' C' ' 42' ' ' LEU . 49.8 mt -78.5 149.26 33.17 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.636 -0.505 . . . . 75.25 109.636 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.86 155.5 82.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.926 0.89 . . . . 61.1 112.749 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.87 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 76.6 Cg_exo -54.74 132.5 52.09 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.926 3.084 . . . . 73.01 113.949 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -111.37 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.798 -1.186 . . . . 63.34 107.798 174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -87.59 68.75 9.63 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.543 0.687 . . . . 71.43 110.0 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.155 -0.929 . . . . 74.22 110.929 177.687 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.469 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 79.7 m . . . . . 0 C--O 1.244 0.792 0 N-CA-C 109.507 -0.553 . . . . 71.45 109.507 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.7 t80 -156.31 104.72 2.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.212 -1.403 . . . . 75.0 107.212 172.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -110.35 112.08 23.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.926 -1.138 . . . . 74.01 107.926 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 tt -80.36 98.63 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.102 -1.444 . . . . 75.3 107.102 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.66 -50.04 7.51 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.6 -167.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -162.3 119.08 2.03 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.663 -0.495 . . . . 74.55 109.663 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' B' ' 130' ' ' PRO . 28.3 mm -111.49 118.21 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.897 -1.149 . . . . 74.35 107.897 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.549 ' HB3' HG21 ' C' ' 122' ' ' THR . 1.5 p90 -148.5 146.59 28.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.28 0.632 . . . . 75.11 111.232 -171.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 50.0 p -75.98 113.04 13.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.021 -0.99 . . . . 72.11 109.938 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -80.92 -36.03 31.59 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.415 -0.587 . . . . 75.44 109.415 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -144.77 137.59 26.56 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.081 -0.963 . . . . 72.54 109.617 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.58 HG23 ' HE1' ' C' ' 117' ' ' MET . 78.2 mt -137.55 139.63 43.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.872 -1.159 . . . . 65.31 107.872 174.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -142.09 140.72 32.61 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -151.8 120.95 6.72 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.625 -1.621 . . . . 72.21 106.625 173.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.04 112.95 11.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 64.15 109.778 -175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -110.45 84.18 3.75 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.682 0.793 . . . . 64.13 109.581 177.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 -26.97 11.44 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.051 2.5 . . . . 73.33 113.183 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -114.82 25.35 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.922 0.889 . . . . 74.51 109.847 -174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.426 ' HB2' ' HE2' ' C' ' 17' ' ' TYR . . . -58.72 -57.42 26.86 Favored Pre-proline 0 CA--C 1.564 1.497 0 N-CA-C 115.038 1.496 . . . . 74.12 115.038 -164.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.604 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 86.6 Cg_endo -78.42 -15.07 14.25 Favored 'Trans proline' 0 C--N 1.38 2.217 0 CA-C-N 122.06 1.771 . . . . 75.22 112.799 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.42 -44.24 68.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.041 0.936 . . . . 74.12 109.543 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.519 HG23 ' HD2' ' D' ' 34' ' ' LYS . 2.1 p -84.38 0.77 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.61 0.764 . . . . 75.35 110.981 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 84.2 t80 -63.36 -17.33 62.49 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.464 1.106 . . . . 73.4 111.169 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -81.32 -1.31 44.77 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.69 0.796 . . . . 75.21 112.104 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.547 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 96.5 mttt -121.8 113.27 19.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.877 0.871 . . . . 74.15 112.446 -167.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.98 79.84 2.24 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.222 1.011 . . . . 73.13 111.228 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -127.04 171.38 11.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.508 -0.745 . . . . 75.24 110.572 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.482 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 29.4 tp60 -85.04 120.55 73.68 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.605 -1.257 . . . . 75.2 107.605 164.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.482 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 31.8 Cg_exo -57.4 114.5 1.97 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.977 1.784 . . . . 75.33 110.972 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -65.8 112.39 3.71 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 106.71 -1.589 . . . . 74.12 106.71 167.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.675 HG13 HG13 ' D' ' 64' ' ' VAL . 71.2 t -116.34 111.66 36.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 123.188 0.595 . . . . 73.12 109.591 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -87.21 133.67 33.63 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.961 -1.125 . . . . 75.21 107.961 169.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.15 127.41 53.79 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.706 -1.22 . . . . 75.43 107.706 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.2 t70 -112.76 125.18 54.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.228 -0.656 . . . . 70.44 109.228 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 62.0 tp -97.05 131.6 43.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.114 0.965 . . . . 73.4 109.758 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.0 t70 -147.59 155.45 41.84 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.631 -0.877 . . . . 71.21 108.631 168.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -146.28 151.36 37.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.384 0.674 . . . . 63.14 109.759 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.04 172.6 14.98 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.177 0.991 . . . . 74.14 108.853 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.2 p -163.76 163.68 23.97 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.729 0.412 . . . . 64.44 110.73 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 54.9 p -154.04 139.59 17.84 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.401 0.68 . . . . 74.41 109.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.15 122.98 25.1 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 110.207 -0.294 . . . . 71.23 110.207 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.0 mt -94.64 -35.99 11.96 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.631 0.582 . . . . 73.43 109.639 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.83 -176.6 5.34 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.038 0.935 . . . . 53.23 110.008 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.76 128.13 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.79 -0.641 . . . . 74.02 109.314 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 61.08 26.42 16.35 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.933 0.893 . . . . 63.42 110.854 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -139.68 122.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 C-N-CA 124.105 0.962 . . . . 72.32 109.717 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -136.07 137.37 41.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 73.32 108.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' D' ' 51' ' ' LEU . 20.5 tt0 -88.29 118.6 28.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.235 -1.024 . . . . 72.53 108.235 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.44 140.29 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.128 -1.064 . . . . 75.52 108.128 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.2 t -121.87 143.06 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.437 1.095 . . . . 72.42 108.997 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -119.74 126.83 52.03 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.511 -1.292 . . . . 72.25 107.511 174.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.3 ttm-85 -106.66 104.44 14.12 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.339 -0.986 . . . . 73.23 108.339 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 128.19 48.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.799 -1.186 . . . . 73.3 107.799 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.4 m -120.9 129.0 53.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.987 -0.375 . . . . 72.35 109.987 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.675 HG13 HG13 ' D' ' 40' ' ' VAL . 71.7 t -111.95 109.1 27.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 125.365 1.466 . . . . 71.11 109.318 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -102.17 93.75 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.397 -1.334 . . . . 74.13 107.397 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.92 144.01 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.586 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.407 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 18.5 m -142.87 135.72 27.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.451 0.469 . . . . 75.23 112.196 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' D' ' 73' ' ' ALA . 52.0 mt -116.65 125.44 51.77 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.87 0.868 . . . . 73.42 109.176 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.48 -113.09 4.11 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.143 -0.383 . . . . 42.01 112.143 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 7.01 10.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.273 0.629 . . . . 71.5 110.865 -176.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.547 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 15.2 pt-20 -129.42 174.62 9.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.37 0.668 . . . . 73.22 110.212 -175.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -72.62 132.85 44.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.541 -0.754 . . . . 73.22 110.91 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.517 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . . . -82.04 -57.98 3.17 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.62 -0.882 . . . . 72.34 108.62 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -164.8 165.53 20.52 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 113.623 -1.626 . . . . 74.11 108.921 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -122.77 153.45 39.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.452 -1.314 . . . . 74.24 107.452 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.562 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 40.1 t -158.7 146.91 18.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.742 0.417 . . . . 75.13 110.098 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.67 128.92 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.181 -0.674 . . . . 75.44 109.181 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.44 114.18 32.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.214 -0.662 . . . . 65.14 109.214 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.726 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.8 mt-30 -89.46 86.24 6.73 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.56 104.44 10.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 113.868 -1.515 . . . . 74.51 108.729 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.35 164.74 28.41 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 111.848 -0.501 . . . . 61.22 111.848 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.65 131.82 2.56 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.774 -0.531 . . . . 73.54 111.774 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.45 HG22 HD13 ' D' ' 51' ' ' LEU . 59.1 mt -87.88 132.24 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.957 -0.757 . . . . 72.23 108.957 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.38 145.49 47.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.54 0.736 . . . . 73.32 110.075 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 67.0 m -96.34 136.91 36.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.019 -0.734 . . . . 71.25 109.019 167.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.35 126.49 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.401 1.081 . . . . 74.14 110.134 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -167.93 156.03 8.84 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.733 0.813 . . . . 64.41 110.066 175.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.18 -20.68 28.37 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 120.147 -0.252 . . . . 74.44 112.951 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.431 ' H ' HD11 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -116.83 157.94 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.12 0.968 . . . . 75.2 109.295 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.85 175.0 13.04 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.03 0.381 . . . . 75.23 112.03 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -133.45 46.79 Favored Glycine 0 C--N 1.355 1.596 0 O-C-N 124.153 0.908 . . . . 73.4 114.073 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.853 0.861 . . . . 74.51 111.398 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -58.77 -45.28 90.14 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.056 0.943 . . . . 74.22 110.074 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.72 ' SD ' HD22 ' D' ' 98' ' ' LEU . 1.7 tmt? -81.85 -30.74 31.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.097 -0.956 . . . . 73.21 110.982 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.27 75.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.133 0.573 . . . . 71.03 110.93 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -73.52 -38.42 65.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.92 -0.582 . . . . 74.21 109.957 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.1 t -62.5 -49.2 76.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.055 0.542 . . . . 73.54 111.575 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.72 HD22 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -69.03 -29.59 67.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.21 0.604 . . . . 74.34 111.973 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.19 -18.05 37.97 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.684 0.615 . . . . 63.02 113.342 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -65.17 1.13 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.859 0.464 . . . . 73.34 111.396 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -67.66 -49.72 61.42 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.556 0.576 . . . . 73.35 112.556 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.465 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.4 m -61.85 -47.42 91.69 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.521 0.728 . . . . 31.25 111.837 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.545 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -61.25 -34.96 87.21 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.48 2.12 . . . . 73.41 112.854 169.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -64.73 -29.54 70.52 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.049 0.54 . . . . 62.41 110.718 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.95 -42.81 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.401 0.681 . . . . 73.25 110.388 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' D' ' 60' ' ' LEU . 63.9 mt -72.46 -23.74 61.1 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.201 -0.909 . . . . 71.22 111.222 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -64.91 -42.5 63.04 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.609 1.337 . . . . 72.12 114.609 -170.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.35 -41.4 59.34 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.115 1.876 . . . . 75.41 113.552 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -77.99 -36.83 48.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.81 0.844 . . . . 75.41 111.303 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.54 82.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.312 0.645 . . . . 72.21 109.895 176.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -54.59 -54.64 38.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.84 1.256 . . . . 74.41 110.467 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.1 -40.33 94.4 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.301 1.001 . . . . 74.22 111.381 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.411 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.4 t -57.41 -44.7 84.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.388 0.43 . . . . 75.43 110.406 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.498 HG12 ' SG ' ' D' ' 76' ' ' CYS . 86.7 mt -63.09 -55.15 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.164 -0.925 . . . . 75.34 110.238 173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.52 HG21 ' HG3' ' D' ' 125' ' ' GLN . 95.7 m -50.09 -48.48 53.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.306 1.442 . . . . 72.23 111.882 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.7 t -65.1 -41.91 94.51 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.76 -1.109 . . . . 71.42 109.932 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.409 ' HG2' HD11 ' C' ' 21' ' ' ILE . 74.1 mtm -65.51 -36.84 85.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.154 0.581 . . . . 72.23 111.251 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -62.36 -49.54 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.461 -0.791 . . . . 74.15 109.91 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -71.32 -27.63 63.53 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.167 0.587 . . . . 72.04 111.403 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -73.47 -31.07 63.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.846 0.859 . . . . 75.42 110.178 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.42 5.41 68.31 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.675 0.61 . . . . 53.31 112.16 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.0 p 60.94 27.57 17.42 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 126.554 1.942 . . . . 75.33 112.663 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -93.32 162.47 27.96 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.826 1.251 . . . . 74.14 109.728 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.56 134.85 36.93 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.979 2.453 . . . . 74.01 111.485 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.52 ' HG3' HG21 ' D' ' 115' ' ' THR . 47.6 tt0 -55.59 134.21 50.85 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 124.314 1.009 . . . . 70.31 111.988 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 tp -106.58 96.5 6.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.129 -0.693 . . . . 74.22 109.129 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -99.55 84.74 3.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.368 -0.604 . . . . 72.31 109.368 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.76 129.24 39.31 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.726 -0.67 . . . . 73.32 110.631 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.26 140.46 92.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 123.243 0.617 . . . . 65.31 111.613 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -82.38 122.36 3.63 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.25 1.967 . . . . 74.41 109.689 171.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.2 m -107.47 134.82 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.188 0.518 . . . . 73.23 110.088 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 121.892 0.853 . . . . 71.44 109.716 176.112 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.365 -0.606 . . . . 71.4 109.365 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -115.83 126.93 54.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.957 -1.497 . . . . 74.35 106.957 165.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 4.1 tp60 -143.56 124.65 14.46 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.082 0.239 . . . . 64.54 110.632 -166.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.62 98.61 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.576 -0.898 . . . . 75.05 108.576 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -82.41 -30.64 30.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.915 -0.564 . . . . 75.44 111.535 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 179.22 121.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.458 0.703 . . . . 74.12 110.084 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.542 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 86.8 mt -105.84 130.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.846 -1.168 . . . . 72.25 107.846 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.69 ' HE2' ' HB3' ' B' ' 28' ' ' ALA . 22.6 p90 -171.95 152.44 2.96 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 124.193 0.933 . . . . 71.34 110.561 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -75.64 119.38 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.215 -0.661 . . . . 74.04 109.215 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 46.2 mtpt -78.69 -46.28 19.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.136 -0.69 . . . . 72.12 109.136 174.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.46 136.73 41.53 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.889 -1.05 . . . . 71.3 109.383 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -129.06 140.72 48.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.354 -1.35 . . . . 74.13 107.354 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -142.96 128.72 19.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.452 0.701 . . . . 74.32 109.436 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 81.8 t80 -139.19 115.86 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.841 -1.541 . . . . 74.13 106.841 171.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -115.89 144.97 43.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.335 -0.987 . . . . 72.33 108.335 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.34 74.29 11.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.248 -1.39 . . . . 50.24 107.248 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.09 -23.34 24.93 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.543 2.162 . . . . 71.33 111.437 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 80.0 m-20 -110.4 33.54 4.44 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.858 -1.065 . . . . 72.41 109.79 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.42 95.92 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.28 1.032 . . . . 75.22 113.126 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -69.63 -27.83 26.63 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.715 1.61 . . . . 74.43 113.023 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.6 m170 -72.6 -37.17 68.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.082 0.553 . . . . 72.44 111.077 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 68' ' ' LEU . 13.6 p -68.3 -23.11 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.903 0.881 . . . . 75.33 112.317 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.568 ' HD1' HH11 ' B' ' 15' ' ' ARG . 78.5 t80 -70.39 -35.65 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.882 0.373 . . . . 73.31 110.393 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.73 -46.04 63.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.451 -0.795 . . . . 74.54 109.658 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 3.7 mmmp? -73.17 151.92 41.32 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.425 -1.261 . . . . 73.34 111.201 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.72 136.1 47.06 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.583 -0.735 . . . . 70.42 109.421 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -75.41 84.68 2.53 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.736 0.779 . . . . 71.14 109.261 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -118.23 76.79 12.47 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.882 -1.053 . . . . 64.31 108.434 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.17 125.64 9.91 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.914 1.742 . . . . 75.4 111.627 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -97.26 89.98 4.95 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.706 -1.59 . . . . 75.41 106.706 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.72 92.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.529 -0.76 . . . . 75.13 110.5 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.39 115.29 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.452 -0.944 . . . . 73.21 108.452 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.49 151.54 19.9 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.771 -0.826 . . . . 61.03 108.771 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.5 t70 -143.37 147.78 35.2 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.357 -0.979 . . . . 65.03 108.357 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp -134.96 126.31 28.35 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.453 -0.943 . . . . 71.53 108.453 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -143.47 156.66 44.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.609 -0.886 . . . . 42.42 108.609 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -140.3 151.56 45.17 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.095 0.558 . . . . 74.32 110.149 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.7 153.58 49.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.999 1.32 . . . . 70.31 108.088 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.6 m -131.82 157.43 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.867 0.365 . . . . 74.22 110.663 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -148.24 120.69 8.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.657 -0.868 . . . . 75.32 108.657 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -81.99 105.22 12.92 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.772 -0.825 . . . . 74.44 108.772 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.502 HD12 HG22 ' A' ' 83' ' ' ILE . 30.4 mt -84.18 -33.08 24.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.181 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.35 179.8 8.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.028 0.931 . . . . 73.04 109.736 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -70.35 125.03 25.62 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.843 -1.169 . . . . 65.45 107.843 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 75.11 -8.19 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.688 1.595 . . . . 73.54 112.785 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -107.45 110.6 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.683 -0.858 . . . . 71.32 108.683 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -133.65 123.67 25.44 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.271 -0.64 . . . . 74.5 109.271 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 28.0 tt0 -86.62 116.15 24.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.771 -0.649 . . . . 71.33 109.271 175.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.51 115.6 42.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 N-CA-C 107.233 -1.395 . . . . 63.24 107.233 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.565 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.3 t -98.78 136.6 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.694 0.798 . . . . 74.25 109.037 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.45 111.67 23.34 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.562 -1.273 . . . . 75.24 107.562 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.01 101.95 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.399 -0.963 . . . . 72.14 108.399 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.29 135.8 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.601 -1.259 . . . . 75.23 107.601 175.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 11.8 m -128.73 144.16 51.1 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.768 -0.456 . . . . 74.42 109.768 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 10.0 t -140.77 125.67 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.672 1.589 . . . . 75.33 107.793 -171.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -129.36 131.92 46.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.698 -0.482 . . . . 74.24 109.698 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.34 108.53 18.64 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.663 -0.866 . . . . 70.24 108.663 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.4 m -108.85 139.32 43.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.001 0.52 . . . . 74.11 110.17 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 31' ' ' VAL . 6.2 mt -113.65 78.48 1.15 Allowed 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.273 -1.01 . . . . 71.25 108.273 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.54 -86.13 1.24 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.97 -0.852 . . . . 44.32 110.97 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -131.05 -8.09 3.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.423 1.089 . . . . 71.32 111.303 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -99.71 110.35 22.75 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.264 -0.643 . . . . 71.41 109.264 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.0 m -70.76 132.12 44.87 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 110.056 -0.349 . . . . 73.32 110.056 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -77.21 -60.53 2.33 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.07 0.948 . . . . 74.23 109.367 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -151.99 172.18 16.67 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 114.613 -1.176 . . . . 74.33 111.075 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 HD11 ' H ' ' A' ' 76' ' ' CYS . 38.7 tp -132.57 147.43 52.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.903 1.281 . . . . 71.1 108.521 172.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -135.66 136.15 40.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.499 1.12 . . . . 72.41 109.145 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -147.37 129.28 15.34 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.489 -0.93 . . . . 75.54 108.489 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.21 109.56 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.959 -0.756 . . . . 72.32 108.959 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.57 82.84 8.09 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.186 -1.042 . . . . 74.13 108.186 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.0 tp-100 -75.69 92.26 2.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.553 -1.203 . . . . 71.5 108.403 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.68 144.23 21.17 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.315 -0.714 . . . . 63.44 111.315 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.89 118.26 1.22 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 110.11 -1.196 . . . . 63.24 110.11 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.4 mt -81.25 124.12 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.581 -1.266 . . . . 72.31 107.581 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 49.4 m-85 -133.35 121.05 21.78 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.411 -0.588 . . . . 73.42 109.411 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 22.4 t -79.36 96.67 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.026 -1.101 . . . . 71.03 108.026 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.531 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -121.2 128.07 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.067 -0.97 . . . . 75.14 109.418 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -174.15 178.15 2.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.535 1.134 . . . . 72.45 110.43 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.69 4.38 85.29 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.928 -0.578 . . . . 72.31 113.951 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -114.21 153.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.983 0.913 . . . . 63.42 109.546 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -144.33 168.94 18.9 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 109.27 -0.641 . . . . 71.44 109.27 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.77 -127.29 40.24 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.727 0.642 . . . . 74.13 114.688 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.6 p -62.25 -26.36 68.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.43 1.092 . . . . 72.11 112.077 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -64.07 -36.41 83.92 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.903 0.881 . . . . 75.32 111.074 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 77.7 mtp -67.27 -45.38 76.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.622 0.769 . . . . 74.15 110.2 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.85 71.98 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.884 -1.053 . . . . 72.53 111.255 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -66.96 -44.32 80.82 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.966 0.906 . . . . 73.12 110.362 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.57 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 14.3 t -71.81 -63.24 1.17 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.624 0.577 . . . . 73.33 110.791 -171.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.2 tp -68.75 -38.39 80.08 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 120.555 0.217 . . . . 72.43 111.525 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.15 -9.33 84.21 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.347 -0.696 . . . . 64.21 114.715 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.32 -53.68 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.904 0.852 . . . . 75.44 112.743 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.57 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 89.9 t80 -72.99 -60.97 1.98 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.72 0.808 . . . . 72.41 113.156 -164.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 72.0 m -61.22 -39.72 66.16 Favored Pre-proline 0 CA--C 1.557 1.23 0 N-CA-C 113.761 1.023 . . . . 64.05 113.761 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.47 -33.56 68.4 Favored 'Trans proline' 0 C--N 1.382 2.341 0 CA-C-N 120.976 1.384 . . . . 75.34 112.87 167.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -72.87 -23.62 60.76 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 117.903 0.319 . . . . 60.44 111.212 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.12 -42.31 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.952 0.882 . . . . 54.05 109.305 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.407 HD23 ' HG3' ' A' ' 80' ' ' GLN . 64.5 mt -80.1 -24.47 40.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.143 -1.39 . . . . 64.12 112.348 -174.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.39 -41.91 86.15 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.923 1.082 . . . . 75.04 113.923 -171.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.89 -39.33 91.79 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.421 2.081 . . . . 65.35 113.313 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -76.27 -41.69 48.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.308 -0.86 . . . . 65.23 111.387 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.86 85.93 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 74.32 109.984 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -49.86 -59.08 4.19 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 124.897 1.373 . . . . 73.32 109.683 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 4.4 tm-20 -58.32 -40.97 83.5 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.428 1.08 . . . . 73.04 112.251 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.482 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.0 t -62.07 -47.6 83.94 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.503 0.502 . . . . 63.21 110.91 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.47 -43.96 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.76 0.824 . . . . 74.21 110.464 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.741 HG23 ' HB2' ' A' ' 125' ' ' GLN . 74.0 m -58.26 -42.75 87.12 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.909 1.284 . . . . 70.33 111.586 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -72.93 -41.5 64.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.314 -0.857 . . . . 70.34 110.888 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.0 mtm -58.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.653 0.381 . . . . 71.22 111.324 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.9 -42.99 96.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.974 0.796 . . . . 75.44 111.47 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.4 p -67.56 -29.0 68.26 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.106 0.479 . . . . 73.43 110.958 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.8 -31.55 64.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.713 0.805 . . . . 74.14 109.943 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 29.53 4.56 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.972 0.796 . . . . 74.32 113.623 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.54 HG23 ' NE ' ' B' ' 15' ' ' ARG . 14.3 t 60.98 16.8 7.31 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.725 2.01 . . . . 74.51 114.994 169.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.18 159.36 52.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.618 -0.676 . . . . 72.42 111.962 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.18 139.76 90.91 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.82 2.346 . . . . 75.15 111.674 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.741 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.0 pt20 -55.44 151.64 9.9 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.576 1.173 . . . . 74.2 112.138 -173.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HG ' HG12 ' A' ' 64' ' ' VAL . 1.6 tm? -120.02 97.46 5.62 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 71.31 108.997 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -124.6 101.82 7.31 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.522 1.129 . . . . 73.24 109.406 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.78 159.11 32.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.882 0.873 . . . . 74.42 112.006 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 152.37 95.98 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.895 0.878 . . . . 62.41 111.731 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HG3' ' HH ' ' C' ' 101' ' ' TYR . 35.3 Cg_endo -91.71 111.26 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.284 2.656 . . . . 74.42 112.191 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.6 t -100.84 111.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.961 -1.126 . . . . 75.4 107.961 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -96.14 73.06 2.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.079 0.942 . . . . 73.1 109.258 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 CA--C 1.547 0.828 0 CA-C-N 114.069 -1.423 . . . . 73.43 110.25 176.62 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 C--O 1.238 0.45 0 N-CA-C 107.432 -1.322 . . . . 75.02 107.432 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.418 ' HA ' HG22 ' B' ' 86' ' ' ILE . 16.9 t80 -127.87 139.24 52.74 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -149.66 141.05 23.26 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.23 0.612 . . . . 72.42 109.789 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.432 HD11 HG13 ' B' ' 16' ' ' ILE . 7.2 tp -93.18 136.21 25.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 109.018 -0.734 . . . . 74.42 109.018 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.592 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.9 mm100 -104.95 -51.14 3.1 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.33 -0.619 . . . . 73.11 109.33 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.568 HH11 ' HD1' ' A' ' 32' ' ' PHE . 52.2 ttt180 -173.26 138.83 0.75 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.055 0.542 . . . . 75.23 110.543 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.432 HG13 HD11 ' B' ' 13' ' ' ILE . 55.8 mt -114.71 141.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.075 -1.083 . . . . 73.11 108.075 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.42 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 26.0 p90 -167.5 156.45 9.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.112 0.482 . . . . 75.43 111.957 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.9 m -81.57 125.83 31.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.31 -0.859 . . . . 74.33 108.685 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.36 -34.91 10.48 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.159 0.584 . . . . 74.13 111.301 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.655 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.6 t70 -153.95 132.82 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.743 -0.662 . . . . 65.23 109.942 -165.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.9 mm -135.94 138.31 47.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 124.102 0.961 . . . . 70.32 109.462 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.2 m -138.33 121.29 16.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.413 -1.267 . . . . 72.31 108.674 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.525 ' HZ ' ' HD2' ' B' ' 123' ' ' PHE . 83.3 t80 -130.65 108.59 10.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.652 -1.61 . . . . 72.24 106.652 163.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -122.45 114.67 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 71.33 108.746 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.21 87.15 3.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 74.14 108.867 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 35.7 Cg_endo -61.75 -41.12 40.52 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.173 2.582 . . . . 73.23 112.901 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -110.52 30.95 6.33 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.109 0.964 . . . . 72.33 109.912 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.69 ' HB3' ' HE2' ' A' ' 17' ' ' TYR . . . -47.66 -50.32 51.87 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 125.875 1.67 . . . . 62.03 115.057 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.89 -19.21 16.25 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.008 1.805 . . . . 73.41 112.445 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.04 5.01 53.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.923 1.289 . . . . 71.34 110.863 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.95 -28.85 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.548 0.739 . . . . 72.05 111.698 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -73.69 -33.51 64.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.38 0.672 . . . . 74.11 111.314 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.54 -20.38 63.69 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.135 0.974 . . . . 73.43 110.476 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -104.68 112.07 25.01 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.5 1.52 . . . . 72.21 111.379 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -93.54 77.97 4.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.229 0.612 . . . . 74.13 111.65 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 170.96 152.48 0.05 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 126.384 1.874 . . . . 74.13 109.307 161.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.439 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 0.6 OUTLIER -80.56 128.65 71.61 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 108.994 -0.743 . . . . 74.52 108.994 -177.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 10.6 Cg_endo -52.74 129.7 33.78 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.56 2.84 . . . . 73.11 114.048 -168.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.9 pt-20 -53.75 123.02 11.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.33 1.019 . . . . 64.45 110.358 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.41 124.1 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 107.973 -1.121 . . . . 74.31 107.973 -174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -147.95 142.91 26.93 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.381 0.673 . . . . 75.11 109.598 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.55 164.59 21.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.67 0.788 . . . . 74.15 111.012 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.0 m-20 -140.25 144.26 36.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.166 1.386 . . . . 73.52 108.375 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tt -129.2 96.28 4.27 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.027 -1.101 . . . . 74.22 108.027 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.85 158.3 39.86 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.147 0.979 . . . . 74.42 109.156 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -139.63 137.4 35.26 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.02 0.438 . . . . 74.2 110.901 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.69 161.46 21.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.627 1.171 . . . . 70.35 108.377 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 p -146.14 167.44 23.43 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.278 0.231 . . . . 74.11 111.107 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -153.12 135.59 15.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.061 0.944 . . . . 72.11 109.192 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -84.89 132.88 34.33 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.71 0.804 . . . . 71.23 109.408 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -99.13 -41.9 7.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.125 0.57 . . . . 73.05 110.262 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -169.34 3.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.266 0.627 . . . . 73.1 110.871 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.39 119.05 19.73 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.322 -0.854 . . . . 73.34 110.22 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 59.99 21.98 11.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.85 1.26 . . . . 62.21 112.41 -172.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.04 117.28 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.477 1.111 . . . . 75.42 108.376 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.624 ' HE2' ' HE1' ' B' ' 94' ' ' MET . 1.9 p90 -125.52 -177.79 4.02 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.339 0.59 . . . . 75.1 109.914 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -141.94 117.3 10.18 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.114 -1.81 . . . . 71.44 106.114 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.03 131.41 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 110.013 -0.366 . . . . 75.42 110.013 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -103.37 125.82 57.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.447 1.099 . . . . 74.53 109.253 176.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.17 122.25 34.47 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.244 -1.391 . . . . 74.14 107.244 169.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -108.22 106.63 16.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.718 0.807 . . . . 74.03 108.849 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 t -106.53 122.39 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.806 -0.813 . . . . 63.33 108.806 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.2 m -114.59 152.44 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.354 0.409 . . . . 74.41 109.943 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 39.3 t -129.47 126.11 62.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.818 1.247 . . . . 73.12 107.947 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -109.55 136.1 49.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.766 -1.198 . . . . 72.22 107.766 170.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.483 -0.932 . . . . 72.12 108.483 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -138.69 136.2 35.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.244 0.545 . . . . 63.33 112.201 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 46.5 mt -95.05 99.05 11.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.742 1.217 . . . . 74.51 108.019 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -129.8 15.58 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 120.016 -0.325 . . . . 45.31 112.517 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -98.86 36.92 1.59 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.973 0.892 . . . . 71.41 108.838 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -153.98 142.95 21.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.656 -0.702 . . . . 73.52 109.396 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -66.07 136.91 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.154 0.582 . . . . 75.34 111.562 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.527 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -92.83 -60.62 1.77 Allowed 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.105 0.962 . . . . 75.05 109.227 177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.425 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 26.3 p90 -157.6 160.58 38.24 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 113.361 -1.745 . . . . 74.32 108.863 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.6 mt -134.56 115.69 14.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.926 -1.509 . . . . 74.35 106.926 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -115.54 153.78 30.56 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.216 -1.031 . . . . 72.14 108.216 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.45 131.66 3.19 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.556 -0.905 . . . . 75.02 108.556 -174.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -122.63 142.66 38.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.485 -0.932 . . . . 74.11 108.485 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.655 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.4 mt-30 -125.29 90.22 3.19 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.462 -0.94 . . . . 71.13 108.462 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -83.79 106.48 15.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.151 -1.386 . . . . 64.53 109.12 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.62 164.28 26.55 Favored Glycine 0 C--O 1.24 0.487 0 O-C-N 123.44 0.463 . . . . 75.13 112.838 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.85 126.86 1.6 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.828 -0.909 . . . . 62.21 110.828 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 20.1 mt -86.05 129.7 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.607 -0.886 . . . . 75.24 108.607 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -134.34 141.76 47.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.953 0.901 . . . . 74.42 108.9 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -116.92 114.04 23.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.645 0.778 . . . . 72.42 109.227 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.51 HD11 HD11 ' B' ' 89' ' ' ILE . 2.7 pp -135.93 149.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.957 0.903 . . . . 71.53 110.645 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.78 172.14 18.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.593 0.757 . . . . 70.14 110.119 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.11 -48.69 0.92 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.962 -0.354 . . . . 73.41 113.98 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.51 HD11 HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -73.23 162.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 117.21 0.505 . . . . 73.11 111.679 -177.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -152.3 153.65 34.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.28 0.632 . . . . 75.04 110.163 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.04 -136.56 25.53 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 123.888 0.756 . . . . 74.35 113.93 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -77.87 -16.98 57.85 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.249 1.02 . . . . 63.42 111.508 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.84 -39.69 59.25 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.682 0.793 . . . . 74.32 111.163 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.624 ' HE1' ' HE2' ' B' ' 56' ' ' TYR . 14.8 tpt -69.97 -33.66 72.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.79 -1.095 . . . . 74.34 111.746 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.99 70.95 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.985 0.514 . . . . 71.43 111.527 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -73.44 -30.87 63.48 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.769 0.828 . . . . 64.32 111.385 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -79.22 -64.29 1.22 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.2 0.6 . . . . 63.13 110.817 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.64 -43.67 92.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 55.32 110.418 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.93 -2.13 86.47 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 118.788 -1.007 . . . . 74.11 114.992 -170.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.79 -52.38 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.642 1.221 . . . . 74.12 112.299 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -70.76 -44.11 67.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.419 0.287 . . . . 73.44 111.564 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -60.87 -47.89 94.37 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-O 118.765 -0.636 . . . . 74.12 111.593 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -47.48 -50.35 11.54 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.442 2.094 . . . . 75.42 113.967 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.9 -32.21 69.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.264 0.626 . . . . 72.33 112.507 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.7 -48.1 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.484 0.714 . . . . 75.4 110.881 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.03 -9.32 56.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.044 0.938 . . . . 75.32 111.35 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.458 ' HZ ' HD21 ' B' ' 128' ' ' LEU . 20.5 t80 -60.56 -48.56 93.13 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.255 1.422 . . . . 74.34 113.207 -172.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -38.14 54.79 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 121.732 1.622 . . . . 61.0 113.271 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 90.2 m-85 -61.62 -45.83 92.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.102 0.561 . . . . 74.31 110.602 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.99 94.2 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.095 0.958 . . . . 72.55 111.219 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.477 1.111 . . . . 73.43 111.431 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -37.35 83.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.259 -0.882 . . . . 73.21 110.015 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.492 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.8 t -66.16 -39.12 89.55 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.811 -0.631 . . . . 55.32 111.279 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.13 -51.98 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.738 0.415 . . . . 74.42 110.301 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.444 HG23 ' HB2' ' B' ' 125' ' ' GLN . 41.8 m -57.95 -27.36 63.34 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 123.899 0.749 . . . . 64.23 111.269 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -71.24 -62.28 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.35 0.66 . . . . 70.12 110.462 172.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.9 mmt -61.06 -39.97 91.89 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.488 0.715 . . . . 73.24 112.391 -170.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.406 HG11 ' O ' ' B' ' 124' ' ' PRO . 78.5 t -65.82 -43.04 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.611 -0.722 . . . . 73.2 111.144 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 63.2 p -69.65 -25.64 64.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.341 0.4 . . . . 73.34 111.394 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.482 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.1 mtt-85 -65.56 -36.89 85.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.564 -0.744 . . . . 73.42 110.023 174.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -81.13 7.17 60.84 Favored Glycine 0 C--N 1.356 1.69 0 O-C-N 124.04 0.838 . . . . 74.14 112.897 172.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.9 p 54.96 47.64 21.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.562 1.945 . . . . 61.32 111.504 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.525 ' HD2' ' HZ ' ' B' ' 23' ' ' PHE . 29.1 m-85 -120.36 166.62 14.77 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 114.016 -1.447 . . . . 75.55 110.781 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 36.7 Cg_endo -61.44 137.03 67.23 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.915 3.077 . . . . 74.33 115.334 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' C' ' 124' ' ' PRO . 13.6 pm0 -59.78 154.56 17.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.487 1.115 . . . . 75.1 112.648 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.44 95.96 4.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.079 -1.082 . . . . 74.31 108.079 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.407 HD21 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -92.58 90.62 7.21 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.973 -1.862 . . . . 74.04 105.973 172.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.458 HD21 ' HZ ' ' B' ' 107' ' ' PHE . 1.2 tt -67.88 133.98 50.06 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.414 -0.958 . . . . 75.1 108.414 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.69 107.55 0.85 Allowed Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 124.602 1.189 . . . . 72.41 111.269 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.14 88.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.946 2.431 . . . . 74.23 112.494 -170.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.74 149.5 12.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.981 -1.009 . . . . 71.24 110.425 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -111.45 116.25 30.59 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.009 -1.108 . . . . 64.12 108.009 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 123.907 0.883 . . . . 72.53 111.975 -174.595 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.24 0.605 0 N-CA-C 108.538 -0.912 . . . . 64.44 108.538 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.439 ' CD1' ' SG ' ' C' ' 97' ' ' CYS . 2.3 t80 -102.51 127.97 49.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.062 -1.426 . . . . 75.43 108.732 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -141.3 131.09 24.26 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.25 -1.389 . . . . 73.35 107.25 167.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.666 HD13 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -68.61 117.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 106.621 -1.622 . . . . 72.2 106.621 168.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.56 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -83.99 -50.6 7.86 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.007 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -176.13 133.71 0.25 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.77 0.669 . . . . 74.23 110.37 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.666 HG13 HD13 ' C' ' 13' ' ' ILE . 96.2 mt -115.48 140.06 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.098 -1.075 . . . . 72.04 108.098 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.564 ' HH ' HD11 ' C' ' 83' ' ' ILE . 30.5 p90 -177.91 147.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.703 0.401 . . . . 75.32 110.61 -173.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -72.89 121.67 20.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.388 -0.824 . . . . 75.33 109.896 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -76.18 -50.5 14.37 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.949 0.881 . . . . 74.23 108.667 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -135.0 136.96 42.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.763 -1.562 . . . . 73.4 108.952 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.8 mt -131.14 142.16 44.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.258 -1.756 . . . . 75.02 106.258 174.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -151.65 144.51 24.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.643 -0.503 . . . . 64.35 109.643 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -148.69 107.75 3.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.34 -1.356 . . . . 73.31 107.34 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.32 110.69 18.38 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.001 -0.74 . . . . 64.13 109.001 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.04 89.82 14.64 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.369 -0.974 . . . . 54.13 108.369 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.14 -39.67 22.73 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.554 2.169 . . . . 73.0 110.902 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -93.95 30.66 1.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.275 -1.33 . . . . 73.35 111.009 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.2 -48.26 97.68 Favored Pre-proline 0 CA--C 1.563 1.46 0 C-N-CA 123.388 0.675 . . . . 71.11 112.461 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -88.42 -22.68 1.23 Allowed 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 122.034 1.823 . . . . 75.2 112.601 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -69.63 -25.48 63.95 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.573 1.149 . . . . 71.33 111.682 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.15 -13.65 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.729 0.811 . . . . 73.32 111.388 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -58.32 -40.55 82.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.213 0.605 . . . . 70.5 111.636 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -102.14 38.9 1.57 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.114 0.566 . . . . 75.43 110.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.639 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.4 OUTLIER -126.65 162.27 26.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.563 0.745 . . . . 75.14 109.9 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.19 120.94 18.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.694 -0.854 . . . . 74.04 108.694 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -84.37 82.96 8.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.806 0.843 . . . . 73.2 110.943 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -139.67 70.48 37.59 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.854 -0.795 . . . . 75.05 108.854 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.423 ' HB2' HG12 ' C' ' 40' ' ' VAL . 3.2 Cg_exo -77.37 133.67 13.39 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.978 2.452 . . . . 75.45 112.231 -172.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.95 79.54 8.72 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.939 -1.504 . . . . 71.4 106.939 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.602 HG11 ' HG2' ' C' ' 124' ' ' PRO . 13.8 m -76.02 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.16 -1.382 . . . . 71.3 111.441 -170.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -97.0 136.13 38.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.17 -0.923 . . . . 75.01 110.25 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.517 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -114.43 140.99 48.25 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.656 -0.868 . . . . 61.31 108.656 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.08 119.65 33.96 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.718 0.807 . . . . 55.02 109.207 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.682 ' HG ' HD21 ' C' ' 60' ' ' LEU . 7.7 tt -85.9 114.14 22.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.779 -0.822 . . . . 72.33 108.779 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.449 ' O ' HD22 ' C' ' 60' ' ' LEU . 21.1 t70 -126.65 138.93 53.49 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.251 -1.018 . . . . 73.52 108.251 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -111.93 143.69 42.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.351 0.596 . . . . 75.24 110.541 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.94 150.38 50.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.542 1.137 . . . . 71.33 108.743 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -149.24 151.87 34.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.858 0.463 . . . . 72.22 110.048 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.1 t -160.58 140.42 11.09 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.376 -0.972 . . . . 65.22 108.376 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -86.96 137.55 32.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.916 0.388 . . . . 62.21 110.191 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.548 HD13 HD13 ' C' ' 83' ' ' ILE . 76.9 mt -101.38 -58.56 1.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.99 0.916 . . . . 73.51 109.348 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.74 -174.25 3.78 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.816 -1.084 . . . . 74.32 110.075 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -69.06 126.25 29.22 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.846 -1.07 . . . . 75.01 109.209 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.427 ' HB3' ' HB1' ' C' ' 87' ' ' ALA . 15.1 m-20 64.15 14.64 8.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.713 1.205 . . . . 75.54 111.898 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.77 104.48 11.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 124.447 1.099 . . . . 74.3 108.9 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.57 165.72 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.011 0.91 . . . . 75.34 110.203 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.02 119.22 27.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.844 -1.525 . . . . 75.14 107.416 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.02 120.03 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.881 -1.155 . . . . 74.01 107.881 172.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.0 t -106.65 113.49 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.297 -1.001 . . . . 74.52 108.297 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.682 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -84.29 102.79 12.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.337 -1.357 . . . . 74.25 107.337 176.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 3.1 tmm_? -84.31 104.53 14.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.337 -0.986 . . . . 75.31 108.337 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.0 t -101.09 130.07 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.257 -1.016 . . . . 73.12 108.257 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 39.5 m -120.39 126.47 50.56 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.695 -0.854 . . . . 74.23 108.695 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.625 HG23 HG21 ' C' ' 114' ' ' ILE . 40.1 t -99.79 124.28 53.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.333 1.053 . . . . 73.12 109.868 177.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -100.51 143.97 30.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.483 -1.303 . . . . 72.15 107.483 167.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.55 120.93 18.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.469 -1.308 . . . . 75.24 107.469 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.7 m -128.47 156.63 42.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.714 0.769 . . . . 54.31 110.627 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' C' ' 71' ' ' GLU . 22.8 mt -116.94 34.18 5.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.206 -1.405 . . . . 71.22 107.206 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.38 -82.94 0.32 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.924 -1.271 . . . . 70.52 109.924 -169.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.65 -24.77 4.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.873 0.869 . . . . 73.11 109.989 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.639 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.8 tp10 -67.65 120.5 14.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.93 0.892 . . . . 71.11 110.103 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -74.38 123.17 24.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.711 -0.478 . . . . 72.25 109.711 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.29 -49.54 22.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.502 0.721 . . . . 65.24 109.229 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -166.85 173.37 9.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.891 -1.05 . . . . 72.43 110.183 172.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.43 HD11 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -130.24 143.11 50.58 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 106.595 -1.631 . . . . 74.35 106.595 170.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.486 ' HB3' ' HB ' ' C' ' 64' ' ' VAL . 43.0 t -144.32 155.28 43.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.552 -0.907 . . . . 63.13 108.552 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -157.41 129.87 7.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.86 0.464 . . . . 74.24 110.165 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.53 115.66 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 62.8 mt-30 -88.6 91.17 8.7 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.614 -1.254 . . . . 70.44 107.614 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -78.07 107.04 10.35 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.546 -0.752 . . . . 75.52 109.725 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.04 152.44 31.35 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.874 -0.491 . . . . 54.4 111.874 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.17 118.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.601 -0.999 . . . . 72.31 110.601 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.564 HD11 ' HH ' ' C' ' 17' ' ' TYR . 10.0 mm -84.55 128.91 38.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.462 -0.94 . . . . 65.43 108.462 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.13 128.49 28.18 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.443 -0.577 . . . . 71.14 109.443 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.3 p -79.38 119.24 22.12 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.573 -0.899 . . . . 73.4 108.573 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.66 120.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.718 0.807 . . . . 74.42 109.761 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.427 ' HB1' ' HB3' ' C' ' 54' ' ' ASP . . . -167.32 157.57 11.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.004 0.922 . . . . 74.31 110.711 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.96 -18.7 42.57 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 123.129 0.268 . . . . 72.12 113.709 172.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.534 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.486 1.114 . . . . 74.55 110.625 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.818 -0.438 . . . . 63.42 109.818 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.529 ' HA ' ' HB3' ' C' ' 97' ' ' CYS . 11.2 ptm -78.3 -28.11 47.43 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.979 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.34 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.202 0.525 . . . . 72.24 110.407 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.79 -30.78 51.52 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.426 -0.807 . . . . 75.32 110.681 172.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.529 ' HB3' ' HA ' ' C' ' 94' ' ' MET . 48.7 t -81.53 -21.84 38.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.817 1.247 . . . . 73.33 113.521 -169.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.567 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.0 OUTLIER -139.04 -23.73 0.91 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 119.064 0.847 . . . . 71.24 111.997 172.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.51 -30.64 53.05 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 120.141 -0.255 . . . . 73.32 112.897 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.16 -42.11 2.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.017 0.527 . . . . 75.32 110.815 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.514 ' CE1' HG13 ' C' ' 105' ' ' ILE . 10.6 t80 -50.8 -71.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.927 0.891 . . . . 75.45 110.87 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 60.3 m -55.34 -45.81 99.8 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 113.558 -1.656 . . . . 74.3 113.71 -168.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HB3' HD22 ' C' ' 44' ' ' LEU . 74.2 Cg_exo -55.78 -45.94 35.27 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.446 1.431 . . . . 73.14 113.313 168.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.81 -25.56 66.51 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.519 0.728 . . . . 55.1 112.649 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.514 HG13 ' CE1' ' C' ' 101' ' ' TYR . 29.3 mm -85.55 -43.29 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.621 0.768 . . . . 74.51 110.611 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.22 -14.32 57.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.935 -0.575 . . . . 62.12 111.032 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.435 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 91.8 t80 -56.53 -54.35 54.39 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 117.705 -1.14 . . . . 72.11 111.761 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' C' ' 105' ' ' ILE . 32.5 Cg_exo -56.37 -40.33 85.36 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.338 2.025 . . . . 64.54 113.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -63.55 -52.35 61.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.045 0.938 . . . . 74.5 111.944 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.63 96.51 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 74.51 110.34 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -54.47 -47.85 72.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.973 1.709 . . . . 71.42 111.403 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.436 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -76.93 -37.58 55.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.964 0.505 . . . . 75.41 110.604 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 25.6 t -65.85 -32.58 74.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.042 0.537 . . . . 72.43 111.494 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.625 HG21 HG23 ' C' ' 64' ' ' VAL . 96.6 mt -72.31 -51.07 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.716 -0.675 . . . . 72.12 109.545 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m -51.12 -34.75 32.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.614 0.766 . . . . 74.32 111.562 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.9 t -59.4 -61.25 2.76 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.714 -1.13 . . . . 75.34 109.489 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.575 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.28 -45.24 54.27 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.514 1.526 . . . . 74.34 113.148 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.43 -46.71 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 72.2 110.43 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.988 -1.005 . . . . 73.44 111.43 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' C' ' 116' ' ' SER . 81.0 mtt-85 -69.1 -37.26 78.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.205 0.602 . . . . 72.33 109.861 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 6.7 72.57 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.884 0.74 . . . . 71.31 112.835 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.0 p 65.0 37.89 6.58 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.993 1.717 . . . . 60.43 111.982 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.564 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 60.0 m-85 -107.35 172.65 3.63 Favored Pre-proline 0 CA--C 1.572 1.821 0 C-N-CA 124.897 1.279 . . . . 70.15 109.803 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.602 ' HG2' HG11 ' C' ' 40' ' ' VAL . 73.8 Cg_endo -70.77 179.64 4.09 Favored 'Trans proline' 0 C--N 1.403 3.429 0 C-N-CA 122.49 2.126 . . . . 75.1 114.368 -171.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 125' ' ' GLN . 28.2 mm-40 -60.37 125.73 24.78 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.609 -0.723 . . . . 75.03 112.025 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.41 2.61 36.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.408 0.683 . . . . 63.11 110.346 170.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.429 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 43.2 t-20 -88.46 82.8 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.719 -1.586 . . . . 72.34 106.719 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 73.1 mt -89.86 158.27 17.53 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 112.555 -2.111 . . . . 74.4 110.33 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -34.62 130.89 0.45 Allowed Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.854 1.661 . . . . 74.03 114.583 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.542 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 74.1 Cg_endo -71.77 109.01 2.55 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.164 2.576 . . . . 75.04 112.664 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.88 104.73 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 75.43 109.123 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 103.4 15.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.41 0.684 . . . . 72.43 109.902 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 122.614 0.366 . . . . 72.42 111.349 175.565 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.241 0.612 0 N-CA-C 109.273 -0.64 . . . . 74.32 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -149.02 100.13 3.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.029 -1.471 . . . . 72.53 107.029 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -121.58 150.97 40.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.356 -0.979 . . . . 75.43 108.356 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 tp -102.81 137.16 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.156 -0.683 . . . . 75.04 109.156 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -99.3 -45.47 5.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.549 0.74 . . . . 74.35 109.507 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -168.43 147.26 4.35 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.942 0.497 . . . . 73.12 111.104 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.45 HD12 HD23 ' D' ' 106' ' ' LEU . 48.0 mm -115.81 122.76 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 105.958 -1.867 . . . . 74.15 105.958 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.69 156.27 34.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.098 0.951 . . . . 74.51 111.027 -169.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.3 p -91.86 116.99 29.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.945 -1.48 . . . . 72.23 109.152 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -85.84 -29.52 23.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.493 -0.776 . . . . 75.33 109.419 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.65 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.3 t70 -149.76 135.96 18.92 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.803 -1.09 . . . . 75.31 109.574 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.575 HG23 ' HE1' ' C' ' 117' ' ' MET . 60.6 mt -139.37 143.32 31.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.853 -1.165 . . . . 74.32 107.853 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -144.75 144.6 31.27 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.071 0.948 . . . . 71.51 108.861 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.626 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.4 t80 -145.6 129.63 17.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.53 -2.026 . . . . 73.0 105.53 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.3 mt-10 -133.07 136.03 45.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 73.43 108.498 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.432 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -131.0 75.27 78.81 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.032 -1.099 . . . . 74.34 108.032 174.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.0 -28.89 18.72 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.776 2.317 . . . . 74.23 112.571 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -114.37 32.76 5.72 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 123.726 0.811 . . . . 73.1 108.959 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -57.65 -58.31 19.23 Favored Pre-proline 0 N--CA 1.483 1.203 0 N-CA-C 114.543 1.312 . . . . 72.34 114.543 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.12 -4.08 13.59 Favored 'Trans proline' 0 C--N 1.381 2.256 0 CA-C-N 121.918 1.721 . . . . 74.3 112.637 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -84.25 -32.36 24.49 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.415 1.486 . . . . 74.1 109.107 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.57 -27.66 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.227 1.411 . . . . 74.42 111.952 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -62.43 -14.71 43.61 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 112.717 0.636 . . . . 74.34 112.717 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.908 0.883 . . . . 75.34 110.932 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.443 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 32.1 mmtp -84.26 104.28 14.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.715 1.206 . . . . 60.4 109.904 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.34 75.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 74.35 111.763 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -170.05 179.69 3.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.006 0.923 . . . . 73.32 109.924 171.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.554 HE21 ' HD2' ' D' ' 38' ' ' PRO . 37.8 tp60 -78.38 123.83 85.68 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.774 0.829 . . . . 72.35 108.787 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.554 ' HD2' HE21 ' D' ' 37' ' ' GLN . 39.7 Cg_exo -56.28 142.13 88.01 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.815 2.343 . . . . 72.23 115.006 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.16 112.24 2.3 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.652 -0.87 . . . . 74.34 108.652 167.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 22.5 m -103.33 117.29 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.579 0.704 . . . . 72.05 109.983 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -108.41 116.81 32.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.118 0.967 . . . . 74.41 108.756 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' D' ' 63' ' ' THR . 6.6 mp -104.64 135.72 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.283 0.364 . . . . 74.05 110.361 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.48 135.28 50.74 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.411 -0.813 . . . . 71.12 108.87 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 tt -96.55 127.15 42.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.893 -1.151 . . . . 73.43 107.893 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.2 t70 -150.05 155.73 40.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.432 -0.951 . . . . 63.02 108.432 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.4 t -139.6 160.92 38.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.347 0.594 . . . . 75.51 110.167 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.69 176.74 10.1 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.019 1.328 . . . . 74.3 107.79 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.458 ' HB2' ' CE1' ' D' ' 56' ' ' TYR . 78.2 p -172.98 165.94 5.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.526 0.565 . . . . 74.13 112.526 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 4.4 m -152.11 140.72 20.77 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.017 0.927 . . . . 75.43 109.484 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -83.53 118.24 23.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.315 -0.995 . . . . 73.31 108.315 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' D' ' 57' ' ' GLU . 22.0 mt -99.79 -29.3 12.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.906 0.482 . . . . 73.4 110.177 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.13 -172.75 2.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.589 0.756 . . . . 63.13 111.029 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -71.41 120.24 16.71 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.979 -1.009 . . . . 64.1 109.082 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 62.28 18.08 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.47 1.108 . . . . 71.52 111.276 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 74.0 t -121.22 121.65 65.4 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 107.009 -1.478 . . . . 75.35 107.009 174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.458 ' CE1' ' HB2' ' D' ' 48' ' ' SER . 12.4 t80 -144.64 128.27 17.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.909 -0.775 . . . . 73.5 108.909 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.4 tt0 -88.11 131.27 34.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.625 -0.88 . . . . 63.32 108.625 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.06 123.61 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.096 -1.446 . . . . 75.23 107.096 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.609 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 27.1 t -100.67 139.61 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 73.14 109.178 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -111.98 126.54 55.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.976 -1.12 . . . . 74.15 107.976 175.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.5 ttm-85 -102.92 101.62 11.65 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.715 -0.846 . . . . 73.34 108.715 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.9 t -102.91 121.85 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.706 -0.85 . . . . 74.41 108.706 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 23.7 m -125.7 130.92 52.51 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.397 0.679 . . . . 74.41 109.636 -171.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.534 HG22 HG21 ' D' ' 114' ' ' ILE . 32.1 t -120.8 103.66 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.677 1.191 . . . . 72.44 109.324 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -100.54 96.52 7.43 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.375 -0.972 . . . . 71.52 108.375 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 143.11 27.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.46 -0.791 . . . . 71.2 109.328 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.6 p -151.46 130.47 12.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.403 0.439 . . . . 51.02 111.867 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 21.3 mt -107.06 108.6 20.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.037 0.935 . . . . 73.14 110.283 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.12 -115.15 4.14 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.562 -0.615 . . . . 74.21 111.562 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 4.51 15.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.909 0.884 . . . . 73.33 110.598 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.6 pt-20 -116.14 161.89 18.26 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.786 -0.45 . . . . 54.05 109.786 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.5 m -71.54 133.86 46.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.537 -0.756 . . . . 63.44 110.572 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.427 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.88 -64.91 1.07 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.441 -0.948 . . . . 62.13 108.441 173.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -156.15 147.7 22.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.4 -0.818 . . . . 75.41 109.971 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.1 mt -100.39 153.94 18.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.853 0.861 . . . . 74.11 108.952 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.6 t -159.31 143.72 15.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.284 0.633 . . . . 73.13 109.651 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.39 128.54 7.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.108 0.563 . . . . 65.14 109.845 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.46 114.66 37.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 123.98 0.912 . . . . 73.33 109.017 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.65 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.6 mt-30 -89.54 86.36 6.73 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.838 0.828 . . . . 70.35 108.879 170.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.42 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.8 tp-100 -79.73 98.9 7.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.969 -1.468 . . . . 74.11 108.66 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.5 154.91 23.71 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.822 -0.511 . . . . 73.13 111.822 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.436 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -149.18 131.16 3.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.695 -0.962 . . . . 65.21 110.695 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.458 HG22 HD13 ' D' ' 51' ' ' LEU . 59.3 mt -94.97 109.02 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.398 -0.594 . . . . 73.55 109.398 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -110.53 126.64 54.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.484 0.714 . . . . 72.22 110.385 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -79.56 97.19 6.37 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.735 -0.839 . . . . 75.24 108.735 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.68 130.24 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.224 0.61 . . . . 75.25 110.803 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.76 153.63 14.93 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.779 0.832 . . . . 70.11 109.945 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 5.39 86.19 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.393 -0.367 . . . . 74.02 113.302 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -119.32 126.33 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.898 0.879 . . . . 70.42 109.465 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 174.38 10.68 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 122.046 -0.409 . . . . 73.15 111.215 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -139.79 39.53 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.934 0.772 . . . . 71.23 113.358 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.9 p -69.27 -32.33 71.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.641 0.776 . . . . 73.53 111.464 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.22 -40.99 96.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.745 . . . . 74.31 110.619 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.6 -55.86 10.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 74.53 110.754 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.64 69.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.453 0.701 . . . . 72.54 112.089 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -85.59 -35.36 21.07 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.466 0.707 . . . . 73.43 110.655 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -66.29 -41.83 89.22 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.662 0.268 . . . . 75.05 110.29 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 tt -78.06 -35.18 49.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.207 0.603 . . . . 74.43 110.065 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.42 -3.32 81.7 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.353 -0.693 . . . . 50.31 114.448 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -57.28 0.43 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 117.974 0.887 . . . . 73.23 111.818 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -72.37 -41.77 66.0 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 112.288 0.477 . . . . 71.44 112.288 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 69.8 m -66.76 -44.97 55.11 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.109 0.564 . . . . 75.41 111.088 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.547 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.9 Cg_exo -55.73 -35.55 93.5 Favored 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.491 2.127 . . . . 64.51 113.402 165.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.48 -29.96 70.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.911 0.484 . . . . 54.41 111.161 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -68.35 -38.49 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.087 0.555 . . . . 71.24 109.619 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.45 HD23 HD12 ' D' ' 16' ' ' ILE . 94.3 mt -79.14 -22.9 44.44 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.311 1.045 . . . . 62.15 112.589 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -66.21 -40.8 38.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.161 1.171 . . . . 75.4 114.161 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.74 -39.23 92.36 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.054 1.836 . . . . 53.45 113.296 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -79.44 -33.17 42.72 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.895 0.878 . . . . 75.23 110.799 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.85 68.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.562 0.745 . . . . 75.33 109.899 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -52.39 -54.27 34.07 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.226 -1.352 . . . . 74.2 110.553 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.34 -45.45 93.4 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.472 1.107 . . . . 75.33 111.687 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.7 t -54.82 -44.74 74.13 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.016 0.822 . . . . 74.11 110.961 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.534 HG21 HG22 ' D' ' 64' ' ' VAL . 77.0 mt -66.33 -53.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.203 -0.908 . . . . 74.31 110.885 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 54.0 m -53.85 -41.5 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.67 1.188 . . . . 74.35 111.567 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.3 t -67.57 -44.7 77.59 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 114.712 -1.131 . . . . 73.12 110.08 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.58 -32.58 74.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.977 0.511 . . . . 74.01 111.808 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.4 t -64.14 -46.51 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.298 0.639 . . . . 72.33 109.474 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -73.61 -27.78 61.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.704 -0.68 . . . . 64.21 111.35 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' D' ' 116' ' ' SER . 93.0 mtt-85 -72.24 -28.79 63.38 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.542 0.737 . . . . 75.41 110.118 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.04 10.06 70.0 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 123.83 0.706 . . . . 74.43 112.302 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.7 p 58.46 18.87 5.99 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.624 1.97 . . . . 75.32 113.691 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -86.58 152.07 54.0 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.889 -0.782 . . . . 74.4 108.889 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.05 133.02 55.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.732 2.288 . . . . 74.04 112.667 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -49.82 139.15 13.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.611 1.195 . . . . 75.42 112.376 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -120.35 102.4 8.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.822 . . . . 62.54 108.904 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -99.21 100.83 11.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.777 -0.823 . . . . 73.23 108.777 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 55.4 mt -72.02 136.0 46.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.616 0.572 . . . . 75.13 110.137 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.01 81.79 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.262 0.625 . . . . 64.24 110.998 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.39 96.79 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.407 2.071 . . . . 72.32 110.259 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -108.15 124.83 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.279 0.561 . . . . 75.52 110.153 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 108.375 -0.972 . . . . 73.21 108.375 174.554 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 109.344 -0.613 . . . . 73.34 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.484 ' HD2' HG21 ' A' ' 86' ' ' ILE . 36.2 t80 -121.32 130.01 53.41 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.767 -1.197 . . . . 75.12 107.767 166.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -144.52 123.39 12.7 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.997 0.186 . . . . 64.45 111.37 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 tp -68.7 130.95 34.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.956 -0.757 . . . . 73.32 108.956 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.458 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 28.1 mm-40 -110.62 -39.97 4.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.928 -0.578 . . . . 74.5 109.919 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.582 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 27.1 ttt180 -173.58 144.29 1.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 119.871 -0.109 . . . . 74.21 110.755 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.541 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 71.7 mt -123.01 132.31 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.535 -1.283 . . . . 64.44 107.535 170.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.582 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 15.4 p90 -156.73 155.45 31.68 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.416 0.686 . . . . 73.5 110.633 -174.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -88.52 109.39 20.02 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.851 -0.613 . . . . 74.13 109.697 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -72.4 -32.53 66.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.165 0.507 . . . . 74.44 109.985 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.72 142.84 27.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.961 -1.018 . . . . 72.23 109.537 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.47 137.88 53.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.665 -1.605 . . . . 75.2 106.665 169.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -144.41 136.54 26.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.925 -0.769 . . . . 74.14 108.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.5 t80 -142.32 112.19 6.86 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 106.939 -1.504 . . . . 74.13 106.939 175.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -118.67 108.45 14.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.98 -0.748 . . . . 63.22 108.98 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.95 81.95 2.87 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.479 -1.304 . . . . 72.44 107.479 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.31 -19.07 20.04 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.153 1.902 . . . . 71.44 111.694 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 45.7 m-80 -120.65 38.5 4.0 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.014 0.925 . . . . 74.42 109.181 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.66 -44.47 99.5 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.073 -0.967 . . . . 74.11 112.632 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.85 -28.96 67.61 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.394 1.533 . . . . 73.54 112.856 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.1 m170 -82.19 -26.31 33.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.543 0.737 . . . . 64.41 112.158 -169.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG22 HD13 ' A' ' 68' ' ' LEU . 7.3 p -63.9 -19.2 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.202 0.525 . . . . 74.12 111.807 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -83.29 -39.78 20.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.725 0.81 . . . . 75.03 110.998 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.79 -28.22 58.29 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.92 0.488 . . . . 75.21 110.724 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.68 160.87 22.31 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.284 0.634 . . . . 74.55 110.099 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.32 144.88 26.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.245 -0.65 . . . . 61.43 109.245 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.413 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.2 t-105 -75.77 89.01 2.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.66 0.784 . . . . 74.35 110.557 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -122.36 77.09 44.31 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 107.718 -1.215 . . . . 72.2 107.718 169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -84.97 145.89 10.09 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.486 2.124 . . . . 70.45 113.174 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -98.86 104.61 16.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.19 -1.411 . . . . 65.14 107.19 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 t -80.64 116.14 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.802 0.841 . . . . 74.43 108.881 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 59.2 tttm -120.35 113.99 21.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.713 0.805 . . . . 75.22 109.391 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.626 HD22 HD21 ' A' ' 128' ' ' LEU . 10.5 mp -104.87 125.74 51.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.968 -0.752 . . . . 72.35 108.968 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.663 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.3 m-20 -117.05 128.57 55.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.175 -1.046 . . . . 72.42 108.175 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -115.2 121.02 41.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.263 0.625 . . . . 71.52 109.69 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -138.86 154.57 48.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.208 1.003 . . . . 74.43 109.037 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -140.05 153.2 46.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.487 0.715 . . . . 72.52 109.484 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.38 113.28 6.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.015 -0.735 . . . . 74.03 109.015 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.2 p -90.07 165.58 13.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.711 0.404 . . . . 74.45 110.33 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 47.8 t -166.46 157.34 12.64 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.227 1.011 . . . . 61.32 108.568 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.63 132.8 55.62 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.899 -0.778 . . . . 74.23 108.899 169.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 57' ' ' GLU . 70.3 mt -105.52 -37.45 6.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.885 0.874 . . . . 74.44 110.405 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.49 -175.14 5.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.727 0.811 . . . . 71.0 109.82 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.31 104.71 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.046 0.538 . . . . 62.31 110.398 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 70.82 10.11 6.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.742 1.617 . . . . 71.41 112.432 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.07 112.42 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.0 -1.482 . . . . 73.52 107.0 170.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -117.74 150.18 39.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.502 0.721 . . . . 74.01 109.403 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 33.2 tt0 -111.11 118.31 35.66 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.48 -0.933 . . . . 71.13 108.48 171.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.8 115.57 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.916 -1.142 . . . . 74.23 107.916 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 53.7 t -98.01 137.52 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.387 0.675 . . . . 75.45 109.323 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.96 110.1 21.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.053 -1.462 . . . . 72.31 107.053 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -101.39 101.62 12.28 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.806 -0.813 . . . . 72.2 108.806 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -94.6 140.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.746 -1.205 . . . . 74.33 107.746 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 m -128.33 144.49 51.14 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.666 -0.864 . . . . 74.43 108.666 171.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 35.1 t -142.06 109.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.489 1.116 . . . . 71.34 108.543 -171.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -109.63 137.94 46.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.538 -0.541 . . . . 70.22 109.538 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.36 120.48 34.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.625 -1.25 . . . . 71.14 107.625 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -130.52 131.7 45.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.611 . . . . 74.44 110.866 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 HG22 ' A' ' 31' ' ' VAL . 49.6 mt -87.12 83.64 7.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.02 1.328 . . . . 74.23 107.852 177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.93 -89.47 0.77 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.768 -0.651 . . . . 53.51 111.88 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.41 -28.67 9.24 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.771 0.828 . . . . 74.11 110.866 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.17 117.15 29.38 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.907 0.483 . . . . 74.25 111.144 -171.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -66.95 110.38 3.32 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.117 0.484 . . . . 74.33 112.021 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.73 -57.01 14.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.796 1.239 . . . . 74.13 110.221 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.21 173.6 16.73 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.732 0.777 . . . . 71.42 111.986 175.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.1 tp -141.25 144.04 34.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.504 1.522 . . . . 74.45 107.837 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.568 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -140.61 125.04 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.36 1.064 . . . . 63.44 108.769 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.99 116.52 8.09 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.929 0.491 . . . . 72.25 109.725 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.78 111.76 26.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.105 0.962 . . . . 72.23 109.021 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.05 79.66 9.55 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.027 -1.101 . . . . 73.23 108.027 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.44 90.29 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.931 1.292 . . . . 73.5 108.699 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.55 144.23 19.65 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 116.064 -0.516 . . . . 75.43 112.119 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.83 130.26 4.81 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 111.791 -0.524 . . . . 75.45 111.791 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 39.2 mt -82.14 125.27 39.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.53 -0.915 . . . . 74.3 108.53 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 21.0 m-85 -131.51 119.45 21.56 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.895 -1.15 . . . . 65.52 107.895 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -79.03 99.83 7.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.977 -0.749 . . . . 73.22 108.977 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.484 HG21 ' HD2' ' A' ' 11' ' ' PHE . 2.7 pp -112.61 153.48 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.354 0.662 . . . . 74.44 110.408 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.88 158.05 7.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.85 0.86 . . . . 73.14 110.231 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.1 -10.36 60.93 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 114.929 0.732 . . . . 75.41 114.929 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.534 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.32 138.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.244 0.618 . . . . 75.12 109.469 -179.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 12.8 tt0 -148.21 175.7 10.84 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.535 -0.913 . . . . 73.55 108.535 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 63.45 -133.61 41.88 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.098 0.249 . . . . 72.14 112.953 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -73.43 -21.7 60.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.976 0.511 . . . . 53.31 111.113 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -71.14 -41.19 70.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 74.41 110.169 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.7 ttt -74.01 -38.8 63.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.681 -0.69 . . . . 73.42 109.936 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.21 69.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.648 -0.705 . . . . 75.52 111.545 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -77.12 -38.51 52.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.408 0.683 . . . . 72.3 109.964 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.4 -66.83 0.53 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.502 0.502 . . . . 72.02 110.649 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -82.24 -10.96 58.94 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.017 0.747 . . . . 72.14 113.017 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.97 2.99 25.69 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 118.947 -0.919 . . . . 74.3 114.469 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.23 -58.47 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.583 1.191 . . . . 73.34 112.051 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.463 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.9 t80 -67.06 -51.51 53.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.988 0.915 . . . . 75.5 111.737 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.0 m -71.73 -37.69 5.5 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.249 -0.882 . . . . 64.12 112.084 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.3 -39.57 72.27 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.911 1.741 . . . . 74.15 113.002 161.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.06 -24.27 61.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.619 0.768 . . . . 74.42 111.132 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.79 -43.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 109.149 -0.686 . . . . 72.11 109.149 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.546 HD22 ' HA3' ' A' ' 82' ' ' GLY . 47.3 mt -75.8 -25.48 56.42 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.988 -1.006 . . . . 64.34 111.769 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -64.41 -40.35 50.23 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 114.381 1.252 . . . . 73.44 114.381 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.55 -31.57 86.97 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 121.873 1.716 . . . . 74.3 113.502 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -87.64 -29.91 20.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.549 0.74 . . . . 73.24 111.001 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.9 86.06 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.725 -0.843 . . . . 74.44 108.725 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -62.45 -44.44 96.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.362 1.065 . . . . 73.3 110.029 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.431 ' HG2' HH12 ' B' ' 120' ' ' ARG . 10.4 tt0 -49.66 -54.28 19.53 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.278 1.031 . . . . 71.04 110.927 176.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.14 -42.95 88.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.566 -1.197 . . . . 63.11 111.561 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.533 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 97.2 mt -67.01 -62.58 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.911 0.485 . . . . 72.54 110.415 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.457 HG23 ' HG3' ' A' ' 125' ' ' GLN . 57.9 m -48.96 -35.37 14.97 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.004 1.322 . . . . 75.41 111.986 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.5 t -71.13 -49.65 41.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.027 -0.511 . . . . 72.42 110.875 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 58.5 mtm -56.33 -42.89 78.41 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.06 0.457 . . . . 74.52 110.847 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.12 -49.16 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.912 1.285 . . . . 72.14 110.633 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.7 -30.96 68.73 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.615 0.366 . . . . 64.44 111.385 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.481 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.5 mtt-85 -71.08 -30.76 66.96 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.928 0.891 . . . . 72.53 110.532 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.0 6.34 49.47 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.021 -0.536 . . . . 53.12 113.507 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.412 HG22 ' HE ' ' B' ' 15' ' ' ARG . 37.8 m 74.06 7.84 4.76 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 125.413 1.485 . . . . 73.24 111.054 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 31' ' ' VAL . 89.0 m-85 -81.71 159.02 67.39 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 123.493 0.717 . . . . 64.53 109.163 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.06 161.57 45.3 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.475 2.117 . . . . 74.22 111.614 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.457 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.5 tt0 -67.54 132.68 48.03 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.854 0.359 . . . . 74.33 110.551 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -111.69 106.62 15.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.93 0.892 . . . . 74.33 109.134 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.97 90.79 4.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.546 . . . . 63.51 110.335 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.626 HD21 HD22 ' A' ' 42' ' ' LEU . 48.4 mt -74.57 116.51 15.34 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.586 -0.894 . . . . 75.33 108.586 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 141.58 97.29 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 122.068 0.147 . . . . 62.1 111.242 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.12 121.23 8.63 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.193 1.928 . . . . 71.4 110.341 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.14 109.06 23.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.803 -1.184 . . . . 62.22 107.803 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.5 91.71 6.76 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.657 -1.156 . . . . 72.24 108.238 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.477 0.875 0 CA-C-N 114.945 -1.025 . . . . 73.54 110.814 -178.648 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.176 -0.305 . . . . 72.15 110.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -139.44 134.0 31.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.273 -1.01 . . . . 74.52 108.273 171.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -149.62 108.35 3.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.251 -0.648 . . . . 74.12 109.251 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -78.47 133.97 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.524 0.73 . . . . 74.41 109.309 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -105.6 -50.09 3.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.674 0.39 . . . . 65.21 110.925 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 122' ' ' THR . 45.9 ttt180 -159.99 146.34 15.86 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.456 0.17 . . . . 71.51 110.963 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.1 143.02 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.067 -1.457 . . . . 72.24 107.067 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.412 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.1 p90 -171.29 141.87 1.65 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 118.741 0.701 . . . . 73.13 111.198 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.6 m -74.15 118.55 17.24 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.739 -0.837 . . . . 74.14 108.739 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -86.71 -33.05 20.14 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.997 0.519 . . . . 74.05 110.524 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -158.21 143.46 16.63 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.867 0.321 . . . . 75.05 111.867 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.736 HD12 ' SG ' ' B' ' 113' ' ' CYS . 44.3 mm -131.88 142.35 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.823 1.249 . . . . 75.02 108.977 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.99 134.86 28.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.397 -0.964 . . . . 74.32 108.397 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -148.7 127.86 12.87 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 107.047 -1.464 . . . . 75.45 107.047 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.7 112.25 9.98 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.081 -1.081 . . . . 71.2 108.081 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.75 89.54 7.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.787 0.835 . . . . 75.32 108.954 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.7 -27.56 38.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.092 1.861 . . . . 75.54 111.696 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -113.82 29.44 8.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.626 0.77 . . . . 64.12 110.463 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.3 -48.45 55.85 Favored Pre-proline 0 CA--C 1.574 1.896 0 C-N-CA 124.905 1.282 . . . . 74.45 113.008 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.42 -25.48 3.8 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.044 1.83 . . . . 74.34 113.396 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.54 1.7 44.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.411 0.684 . . . . 74.54 111.923 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.47 -14.18 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.471 1.108 . . . . 73.13 111.237 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.09 -42.12 93.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.916 0.886 . . . . 73.23 110.408 169.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -75.56 -40.67 56.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.306 1.042 . . . . 74.14 110.289 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 32.1 mmtp -108.37 67.96 0.68 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.392 -1.276 . . . . 74.23 109.521 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.37 75.64 7.65 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.116 -0.947 . . . . 72.51 111.078 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -169.61 170.95 7.82 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 126.098 1.759 . . . . 75.33 109.637 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.495 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 54.1 tt0 -67.57 122.06 81.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 123.318 0.647 . . . . 73.25 110.404 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.31 151.41 80.76 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.92 2.413 . . . . 74.22 113.377 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.41 106.63 6.11 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.836 -0.802 . . . . 74.33 108.836 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.77 131.94 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.242 1.017 . . . . 75.05 110.803 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -124.43 143.1 50.82 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.992 -0.744 . . . . 75.14 108.992 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.596 HD23 HD12 ' B' ' 126' ' ' LEU . 1.0 OUTLIER -129.3 140.99 51.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.881 0.372 . . . . 71.53 110.829 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.49 145.13 49.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.372 1.069 . . . . 75.15 109.558 -168.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 31.0 tp -93.96 131.82 39.04 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.4 0.68 . . . . 74.21 109.719 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.48 124.38 28.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.971 0.908 . . . . 75.44 108.695 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.4 m -112.55 113.95 26.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.758 0.423 . . . . 73.44 110.169 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.95 149.03 39.42 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.774 -1.195 . . . . 74.24 107.774 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -143.15 173.03 11.93 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.84 0.352 . . . . 74.12 110.544 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.3 p -157.32 173.99 16.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.383 1.073 . . . . 70.31 108.948 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -124.58 121.72 35.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.674 0.39 . . . . 73.24 110.566 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 70.8 mt -80.57 -44.35 19.16 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.158 0.583 . . . . 72.35 111.126 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 -173.2 4.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.917 0.887 . . . . 74.13 109.746 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -61.72 112.77 2.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.433 -0.803 . . . . 74.31 110.277 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.52 0.28 3.19 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.922 1.689 . . . . 63.13 112.745 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.66 92.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 N-CA-C 107.543 -1.28 . . . . 74.22 107.543 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.26 171.05 8.96 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.29 0.636 . . . . 65.23 109.837 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.486 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 5.0 tm-20 -143.72 101.2 3.72 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.281 -1.377 . . . . 74.02 107.281 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.3 122.57 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.5 0.72 . . . . 70.32 110.304 -174.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 41.2 t -102.38 114.52 42.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.508 0.723 . . . . 73.54 109.532 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.16 106.87 18.79 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.714 -1.217 . . . . 71.44 107.714 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -95.18 116.41 28.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.252 -0.647 . . . . 65.23 109.252 170.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.432 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.0 t -105.43 120.88 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.292 -1.374 . . . . 72.14 107.292 164.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -96.51 146.84 24.44 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 71.11 109.0 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.51 HG22 HG21 ' B' ' 114' ' ' ILE . 41.6 t -134.7 128.66 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.816 0.846 . . . . 75.3 109.461 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.5 m -123.61 138.78 54.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.111 -0.949 . . . . 73.51 108.543 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.71 149.82 37.75 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.498 0.719 . . . . 53.21 109.205 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.1 p -143.94 137.74 28.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.708 0.63 . . . . 73.02 110.25 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 38.8 mt -90.9 98.73 11.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.077 -1.823 . . . . 74.23 106.077 170.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.63 -129.68 14.09 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.538 -0.755 . . . . 65.15 111.686 -169.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -92.75 2.83 56.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.054 0.941 . . . . 74.42 111.021 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -115.65 138.09 51.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.244 1.018 . . . . 74.24 109.02 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 132.7 49.85 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.317 0.58 . . . . 73.43 111.846 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.403 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -92.87 -58.65 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.376 1.071 . . . . 73.24 109.073 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -157.82 157.03 32.53 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.275 -1.329 . . . . 74.1 110.544 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.3 mt -135.18 110.71 9.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 106.673 -1.603 . . . . 72.55 106.673 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.95 157.86 25.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.357 -0.608 . . . . 50.44 109.357 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -164.6 135.08 4.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.979 -0.749 . . . . 71.21 108.979 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.425 HG11 ' HA ' ' B' ' 110' ' ' ALA . 68.9 t -123.92 139.83 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.546 -0.752 . . . . 71.24 109.086 173.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -122.66 89.13 3.06 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.489 -0.93 . . . . 74.54 108.489 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.36 101.23 12.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.2 -1.037 . . . . 64.41 108.2 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.5 159.32 28.27 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.24 -0.744 . . . . 74.12 111.24 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.92 129.36 2.38 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 112.002 -0.439 . . . . 33.0 112.002 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.412 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.2 mt -85.15 124.13 39.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.578 -0.897 . . . . 75.24 108.578 174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -136.33 158.11 45.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.162 0.985 . . . . 75.32 108.883 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -130.93 114.8 15.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.344 -0.613 . . . . 71.2 109.344 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.411 ' HB ' HD12 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -125.72 143.02 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.384 0.673 . . . . 74.12 110.003 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.03 167.86 29.19 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.98 0.912 . . . . 73.51 109.099 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.47 -70.19 1.22 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.847 -0.501 . . . . 74.15 111.847 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.411 HD12 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -57.62 141.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.823 0.449 . . . . 71.14 110.623 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -151.4 154.24 36.26 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.93 0.332 . . . . 75.52 110.593 -175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.21 -124.33 13.52 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.389 0.431 . . . . 73.53 112.7 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.6 m -65.76 -32.33 73.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.61 0.764 . . . . 75.34 110.121 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -69.38 -36.45 76.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.804 0.842 . . . . 73.11 110.512 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.684 ' HE3' HD23 ' B' ' 98' ' ' LEU . 18.0 ttt -72.6 -45.6 58.28 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.96 -0.385 . . . . 75.0 109.96 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.92 66.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.87 0.468 . . . . 71.34 112.057 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -73.36 -33.2 64.94 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.686 0.794 . . . . 75.42 110.806 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -86.26 -67.42 0.81 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.284 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.684 HD23 ' HE3' ' B' ' 94' ' ' MET . 16.8 tp -61.15 -32.36 72.08 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.597 1.159 . . . . 74.24 112.709 -175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.73 1.97 52.56 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.354 -0.692 . . . . 73.25 114.663 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.96 -52.2 0.33 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.904 0.852 . . . . 72.42 111.492 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -73.63 -46.8 44.62 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.017 0.527 . . . . 63.02 111.993 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 78.8 m -63.41 -44.16 81.36 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 118.814 -0.612 . . . . 75.53 111.207 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.96 -36.53 89.69 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.893 1.729 . . . . 73.34 113.396 164.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.7 -31.04 71.16 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 122.835 0.454 . . . . 72.41 111.432 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.403 HG22 ' NH2' ' D' ' 111' ' ' ARG . 94.7 mt -61.41 -50.76 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.913 0.885 . . . . 75.42 109.964 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 46.4 mt -77.58 -11.51 59.87 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.487 1.115 . . . . 73.12 112.135 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -69.24 -44.06 26.02 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.883 1.273 . . . . 73.13 113.621 -165.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.64 -34.47 51.46 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 121.568 1.512 . . . . 75.21 112.344 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -63.71 -41.67 98.06 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.715 0.634 . . . . 75.44 110.136 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -69.03 -42.76 75.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.447 -0.797 . . . . 73.43 110.325 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -57.24 -54.71 43.7 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.643 1.177 . . . . 73.13 111.776 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.08 -38.81 91.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.176 0.99 . . . . 73.32 110.395 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' B' ' 21' ' ' ILE . 8.7 t -67.65 -32.91 73.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.6 -0.727 . . . . 74.53 111.78 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.51 HG21 HG22 ' B' ' 64' ' ' VAL . 74.5 mt -65.52 -55.64 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.466 -0.568 . . . . 73.24 109.466 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 5.0 m -56.93 -32.17 65.71 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.277 0.986 . . . . 62.44 110.983 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.62 -53.2 51.42 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.484 -1.235 . . . . 70.42 110.747 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.1 mmt -67.68 -32.01 72.38 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.663 0.385 . . . . 74.51 111.703 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.13 -42.75 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.237 1.015 . . . . 73.4 110.688 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.03 -25.32 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.94 0.496 . . . . 74.52 111.739 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' B' ' 116' ' ' SER . 80.8 mtt-85 -66.85 -38.58 86.63 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.799 0.439 . . . . 75.51 109.848 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.41 4.21 56.37 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.263 -0.88 . . . . 75.32 113.148 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 66.8 p 59.44 50.73 7.25 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.921 1.688 . . . . 73.02 112.035 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -120.41 158.53 50.92 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.684 1.194 . . . . 72.25 109.795 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.495 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.2 Cg_exo -72.37 -174.65 1.49 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.57 2.847 . . . . 72.24 115.435 -166.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -58.85 130.66 48.05 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.839 -1.528 . . . . 74.23 112.118 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.596 HD12 HD23 ' B' ' 42' ' ' LEU . 59.0 tp -138.64 83.83 1.98 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.669 -1.234 . . . . 75.41 107.669 171.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.663 -1.236 . . . . 75.44 107.663 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 tt -87.0 130.62 34.38 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.581 -0.896 . . . . 75.0 108.581 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.43 34.76 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.236 0.615 . . . . 73.44 110.466 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.06 131.86 26.45 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.192 1.928 . . . . 74.33 110.984 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.89 143.79 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 122.957 0.503 . . . . 71.54 110.384 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -86.99 111.83 21.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.735 0.814 . . . . 62.14 109.24 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 123.95 0.9 . . . . 72.14 111.43 -177.395 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 107.711 -1.218 . . . . 75.3 107.711 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.582 ' HA ' HG21 ' C' ' 86' ' ' ILE . 41.5 t80 -125.99 120.1 29.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.11 0.564 . . . . 75.23 109.841 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -139.02 128.94 25.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.64 0.376 . . . . 71.11 110.066 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 tp -80.99 136.83 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.388 -0.597 . . . . 72.44 109.388 170.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.65 -49.7 3.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.46 0.704 . . . . 73.21 110.17 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -160.73 136.47 8.16 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.144 -0.48 . . . . 74.32 110.313 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.83 143.52 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.338 -1.356 . . . . 73.54 107.338 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -171.5 162.66 6.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.33 0.586 . . . . 72.21 110.754 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -83.8 113.64 21.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.456 -0.793 . . . . 64.32 109.137 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.4 ' HZ1' ' HD3' ' D' ' 29' ' ' PRO . 57.7 mmtt -64.76 -46.9 80.23 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 167.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -142.8 141.61 31.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.42 -1.718 . . . . 75.54 109.791 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -140.73 143.43 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.388 -1.708 . . . . 71.33 106.388 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -155.69 151.6 27.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.745 0.418 . . . . 61.04 110.117 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -155.62 121.49 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.769 -1.197 . . . . 52.31 107.769 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.36 136.61 54.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.374 0.67 . . . . 71.35 109.804 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.59 77.93 8.56 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.843 -1.169 . . . . 64.31 107.843 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.53 -9.75 23.09 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.371 2.047 . . . . 74.03 111.943 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -109.38 19.43 19.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.716 1.206 . . . . 73.33 110.213 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.72 -49.8 81.13 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 124.903 1.281 . . . . 74.43 113.475 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.95 -30.12 1.43 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.421 1.414 . . . . 73.45 113.31 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -69.41 -28.06 65.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.524 0.729 . . . . 73.04 111.955 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.87 -12.29 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.217 0.607 . . . . 74.0 111.411 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.88 -31.67 72.74 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.888 0.875 . . . . 74.25 111.261 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.7 20.83 17.96 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.4 0.68 . . . . 73.54 110.146 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.734 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -100.83 158.27 16.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.095 0.558 . . . . 74.0 109.887 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -77.44 121.32 23.67 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.281 -1.007 . . . . 74.25 108.281 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -85.0 91.15 8.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.598 0.713 . . . . 74.23 110.434 -172.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -131.32 69.66 82.0 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.559 -1.2 . . . . 72.04 108.239 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.56 104.65 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.655 2.236 . . . . 72.13 111.933 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -86.99 118.01 26.08 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.753 -0.832 . . . . 64.34 108.753 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.434 HG12 HD21 ' C' ' 126' ' ' LEU . 48.2 t -80.2 128.29 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 74.33 111.448 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.36 104.31 7.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.688 1.195 . . . . 73.32 107.865 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.468 HD21 HD11 ' C' ' 128' ' ' LEU . 0.3 OUTLIER -86.65 165.83 15.83 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.838 0.352 . . . . 75.44 110.407 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -138.35 146.25 42.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.384 -1.339 . . . . 75.53 107.384 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.7 tp -138.2 102.26 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.921 -0.77 . . . . 72.3 108.921 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.72 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 7.1 m-20 -120.09 142.32 48.99 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.427 0.691 . . . . 73.12 109.758 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -114.88 117.56 31.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.137 -0.69 . . . . 63.03 109.137 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.92 153.9 24.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.718 -1.216 . . . . 73.13 107.718 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.3 p -164.34 154.17 14.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.934 0.397 . . . . 70.12 111.328 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 15.5 p -170.34 138.92 1.63 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.248 1.019 . . . . 73.24 109.174 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -80.32 135.99 36.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.955 0.502 . . . . 72.31 109.817 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' C' ' 57' ' ' GLU . 63.7 mt -104.57 -26.56 12.3 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.83 0.852 . . . . 74.54 111.591 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.23 -172.99 1.39 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.383 0.673 . . . . 64.4 110.955 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.28 105.92 0.67 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 123.985 0.803 . . . . 72.33 110.919 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.53 10.04 5.52 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.254 1.422 . . . . 72.31 112.519 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.41 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 108.234 -1.024 . . . . 75.33 108.234 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -108.31 158.67 17.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.124 0.97 . . . . 73.45 108.75 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.575 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.4 tt0 -126.07 127.78 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.281 -1.007 . . . . 74.41 108.281 172.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 81.1 t -117.93 129.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.939 -1.134 . . . . 63.03 107.939 170.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.09 107.48 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.336 -0.987 . . . . 71.42 108.336 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.415 HD23 HG21 ' C' ' 62' ' ' VAL . 0.9 OUTLIER -86.19 106.21 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.069 -1.086 . . . . 75.04 108.069 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.72 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 57.4 ttt180 -82.12 105.38 13.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.415 HG21 HD23 ' C' ' 60' ' ' LEU . 13.6 t -105.42 130.99 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.213 -1.032 . . . . 75.13 108.213 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 21.9 m -129.7 146.29 51.48 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.02 -0.733 . . . . 74.41 109.02 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.485 HG22 HD12 ' C' ' 114' ' ' ILE . 50.8 t -131.07 127.94 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.948 0.899 . . . . 72.5 108.655 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.485 HG23 HD22 ' C' ' 75' ' ' LEU . 4.2 m -123.2 109.16 13.64 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.657 -1.238 . . . . 72.42 107.657 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.67 121.14 41.14 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.056 -1.09 . . . . 54.31 108.056 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -129.8 133.05 46.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.282 0.563 . . . . 71.31 110.593 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.734 HD12 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -87.1 33.88 0.68 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 125.726 1.61 . . . . 74.34 110.085 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.77 -103.1 2.17 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.176 -0.769 . . . . 60.02 111.176 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.35 -31.61 17.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.427 0.691 . . . . 75.32 110.16 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 4.0 tp10 -79.21 120.22 23.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 75.32 109.2 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -77.56 122.36 25.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.15 -0.685 . . . . 74.52 109.15 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.15 -50.29 34.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 63.31 109.598 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -160.84 170.66 20.23 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.422 -1.263 . . . . 74.31 110.98 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.485 HD22 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -136.35 147.23 47.27 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.996 -1.483 . . . . 73.33 106.996 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.4 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -147.81 149.21 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.478 -0.934 . . . . 75.44 108.478 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -157.61 118.81 3.58 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.848 0.459 . . . . 75.33 109.884 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -121.64 112.47 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.517 0.727 . . . . 73.01 109.364 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 49.7 mt-30 -94.82 99.64 11.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.704 -0.85 . . . . 74.54 108.704 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.584 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.1 tp-100 -85.07 104.93 15.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 71.43 110.542 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.06 145.67 22.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.47 -0.332 . . . . 71.11 112.326 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.456 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.92 127.85 2.72 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.057 -0.417 . . . . 62.53 112.057 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' D' ' 29' ' ' PRO . 12.6 mm -91.19 125.03 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.606 0.762 . . . . 64.44 109.124 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -133.69 118.31 17.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.864 -0.791 . . . . 74.22 108.864 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.1 p -85.69 97.37 10.09 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.817 -1.179 . . . . 74.23 107.817 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.582 HG21 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -125.22 135.48 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-O 121.531 0.682 . . . . 70.42 111.235 -174.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.95 -178.54 5.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.191 1.396 . . . . 74.54 107.905 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.74 -30.56 4.18 Favored Glycine 0 N--CA 1.477 1.419 0 C-N-CA 121.391 -0.433 . . . . 71.4 113.642 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 CA--C 1.549 0.918 0 C-N-CA 124.098 0.959 . . . . 74.42 111.764 179.558 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.345 0.117 . . . . 74.22 111.105 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.1 tpt -55.07 -36.93 66.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.892 0.877 . . . . 53.04 111.054 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.49 -47.44 11.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.636 0.774 . . . . 74.23 111.523 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -73.7 -34.61 64.93 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.482 0.713 . . . . 73.45 112.656 -167.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -63.6 -55.97 19.54 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.614 0.571 . . . . 75.14 111.233 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.413 HD12 ' N ' ' C' ' 99' ' ' GLY . 1.0 OUTLIER -92.83 -16.69 25.01 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.198 0.599 . . . . 74.05 112.528 -175.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . 0.413 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.95 -14.87 38.24 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.395 -0.67 . . . . 73.34 113.8 -172.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.08 -46.25 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.46 0.63 . . . . 70.35 111.979 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -74.7 -44.25 51.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.119 0.567 . . . . 72.43 111.972 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.513 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 73.2 m -67.63 -45.48 45.94 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.464 -0.779 . . . . 73.05 111.331 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.11 -36.65 96.63 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.249 1.966 . . . . 75.12 112.734 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -61.91 -33.44 74.24 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.546 0.738 . . . . 64.43 111.712 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -68.37 -39.31 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.165 0.586 . . . . 73.12 110.413 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.456 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.7 mt -80.84 -32.73 34.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.274 -0.876 . . . . 74.02 112.483 -171.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -54.19 -48.72 93.49 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 117.288 -1.339 . . . . 75.44 113.182 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -45.04 -43.19 15.86 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.974 2.449 . . . . 64.11 114.544 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -70.45 -45.32 66.01 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.285 0.634 . . . . 74.01 111.052 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -67.9 -37.01 81.19 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.117 0.567 . . . . 72.42 110.959 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -54.12 -51.08 65.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.341 1.456 . . . . 73.05 110.517 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.24 -32.03 66.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.224 -0.898 . . . . 64.53 110.92 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -74.6 -30.84 61.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.896 0.478 . . . . 73.51 111.609 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.485 HD12 HG22 ' C' ' 64' ' ' VAL . 94.3 mt -71.7 -46.31 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.572 -0.529 . . . . 73.42 109.572 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.587 HG23 ' HB2' ' C' ' 125' ' ' GLN . 54.2 m -51.28 -42.54 61.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 71.35 110.834 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -63.68 -52.56 60.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.811 -1.541 . . . . 75.22 110.219 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.636 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.93 -40.96 81.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.362 1.065 . . . . 73.31 113.162 -176.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.44 -46.44 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.283 0.633 . . . . 75.21 110.151 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -64.83 -27.69 69.05 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.001 -1.0 . . . . 71.03 111.648 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.6 mtt-85 -70.06 -37.26 75.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.616 0.767 . . . . 72.31 110.286 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.92 8.55 56.54 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.172 -0.793 . . . . 72.41 113.135 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 42.8 p 61.28 26.99 16.75 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 125.933 1.693 . . . . 74.14 112.664 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 51.5 m-85 -100.15 167.73 10.52 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.385 1.074 . . . . 73.14 109.606 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 45.0 Cg_endo -66.06 111.65 2.05 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 122.051 1.834 . . . . 62.42 111.682 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' C' ' 115' ' ' THR . 0.0 OUTLIER -47.47 143.32 3.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.569 1.147 . . . . 71.42 112.048 -173.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.434 HD21 HG12 ' C' ' 40' ' ' VAL . 1.2 tm? -111.13 91.25 3.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.21 0.529 . . . . 75.45 110.13 -173.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -129.95 92.33 3.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.866 -1.161 . . . . 64.1 107.866 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.468 HD11 HD21 ' C' ' 42' ' ' LEU . 61.6 mt -87.36 154.25 20.82 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.104 0.962 . . . . 73.43 111.442 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.72 136.27 13.28 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 124.42 1.075 . . . . 75.11 112.143 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 40.8 Cg_endo -63.85 108.4 0.9 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.989 2.46 . . . . 75.24 112.537 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.33 87.75 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.375 0.67 . . . . 71.12 109.492 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.77 101.59 8.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.945 -0.761 . . . . 61.1 108.945 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.3 t80 . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 124.07 0.948 . . . . 74.05 111.096 179.433 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 109.11 -0.7 . . . . 73.1 109.11 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -150.47 94.05 2.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.26 -1.385 . . . . 74.32 107.26 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.447 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 80.9 mt-30 -112.11 131.89 55.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.644 0.778 . . . . 62.51 108.967 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 138.68 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.231 -1.026 . . . . 75.13 108.231 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.417 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 52.8 mt-30 -106.04 -48.95 3.48 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 110.282 -0.266 . . . . 75.24 110.282 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 ttt85 -176.23 130.26 0.22 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.071 0.232 . . . . 74.4 111.618 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.408 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.1 mp -117.71 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.199 -1.037 . . . . 71.24 108.199 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -150.21 165.02 34.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.396 1.079 . . . . 73.51 110.546 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -90.85 113.55 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.289 -0.634 . . . . 74.34 109.289 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -78.95 -31.64 45.16 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.133 0.492 . . . . 74.45 109.964 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -150.37 142.29 23.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.053 -0.976 . . . . 73.3 109.3 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.636 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.1 mt -141.34 144.33 26.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.51 -1.293 . . . . 75.45 107.51 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -147.53 142.62 27.1 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.65 -0.87 . . . . 71.31 108.65 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.5 t80 -147.36 125.51 12.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.672 -1.603 . . . . 73.01 106.672 170.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.7 147.01 51.45 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.92 0.888 . . . . 75.44 108.707 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 78.43 37.08 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 107.498 -1.297 . . . . 74.24 107.498 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.21 -29.52 47.02 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.429 2.086 . . . . 74.03 112.275 -174.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -114.4 27.95 9.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.892 0.877 . . . . 64.31 110.139 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.12 -57.22 6.5 Favored Pre-proline 0 CA--C 1.576 1.974 0 N-CA-C 116.24 1.941 . . . . 64.13 116.24 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' C' ' 83' ' ' ILE . 24.1 Cg_endo -87.97 -5.17 6.91 Favored 'Trans proline' 0 C--N 1.384 2.404 0 CA-C-N 122.321 1.865 . . . . 74.24 112.955 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -79.0 -30.95 44.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.11 1.364 . . . . 74.45 108.751 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.449 HG12 ' CE1' ' D' ' 123' ' ' PHE . 3.1 t -68.13 -28.59 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.81 1.244 . . . . 61.45 110.82 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -53.65 -23.41 11.18 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.44 0.696 . . . . 74.11 112.605 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -86.56 -0.03 55.31 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.644 0.778 . . . . 64.14 112.704 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.674 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 95.6 mttt -126.96 113.12 16.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.234 1.013 . . . . 74.53 110.764 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.69 64.62 1.51 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.189 0.995 . . . . 65.12 110.874 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.421 ' HB2' HD21 ' D' ' 68' ' ' LEU . 14.5 m95 -126.18 173.79 8.99 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.858 0.863 . . . . 75.24 109.508 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -89.49 125.62 60.92 Favored Pre-proline 0 N--CA 1.476 0.842 0 N-CA-C 108.259 -1.015 . . . . 74.02 108.259 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.06 127.44 21.25 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.852 1.701 . . . . 75.1 111.588 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.4 OUTLIER -65.41 111.16 2.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.678 -1.23 . . . . 74.03 107.678 172.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.652 HG12 HG13 ' D' ' 64' ' ' VAL . 59.6 t -104.35 114.42 43.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 122.864 0.465 . . . . 73.34 110.36 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.404 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 4.7 tppp? -87.45 120.27 28.58 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.569 -0.741 . . . . 74.24 109.325 169.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.466 HD22 HD21 ' D' ' 128' ' ' LEU . 7.4 mp -96.27 111.72 23.7 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.486 -1.302 . . . . 64.03 107.486 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.6 t70 -109.47 119.6 39.95 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.227 -1.027 . . . . 64.44 108.227 175.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -96.58 131.12 43.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.298 0.639 . . . . 71.0 109.987 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.9 t70 -139.42 151.71 46.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.096 0.958 . . . . 74.23 108.528 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 155.98 44.76 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.401 0.68 . . . . 75.32 109.598 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.86 163.72 37.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.908 0.883 . . . . 74.12 109.096 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -150.12 153.17 35.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.113 0.565 . . . . 75.14 110.006 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.6 p -154.26 123.38 6.41 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.849 0.86 . . . . 55.34 109.005 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.99 121.07 22.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.891 0.476 . . . . 75.52 110.083 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.2 mt -89.38 -38.63 13.98 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.502 0.668 . . . . 74.35 109.393 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.16 -176.69 5.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.38 -1.282 . . . . 71.53 109.504 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 122.43 15.69 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.799 -0.637 . . . . 75.14 110.918 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 71.04 1.71 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.519 1.528 . . . . 71.34 112.55 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -110.04 123.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 124.198 0.999 . . . . 75.04 109.871 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.59 129.94 33.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.106 0.563 . . . . 64.45 109.998 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' D' ' 51' ' ' LEU . 9.3 tt0 -95.16 120.38 35.28 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.828 -1.175 . . . . 72.24 107.828 167.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.07 134.62 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.028 -0.731 . . . . 74.32 109.028 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.9 t -108.92 129.21 63.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.037 0.535 . . . . 73.05 110.029 -175.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -101.49 123.04 44.88 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.562 -1.273 . . . . 74.22 107.562 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.7 ttm-85 -108.8 102.84 11.84 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.876 -0.787 . . . . 74.43 108.876 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.82 107.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.114 -1.069 . . . . 73.3 108.114 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 45.6 m -97.68 136.1 38.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.922 -0.581 . . . . 63.12 109.603 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.652 HG13 HG12 ' D' ' 40' ' ' VAL . 53.4 t -126.67 103.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.825 1.25 . . . . 74.35 108.742 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 29.2 m -104.62 94.52 5.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.917 -1.142 . . . . 74.24 107.917 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.06 140.64 30.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.851 -0.613 . . . . 75.22 110.115 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.485 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.5 m -148.43 126.12 11.81 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.158 0.504 . . . . 70.23 111.577 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' D' ' 36' ' ' TRP . 26.2 mt -94.72 109.25 21.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.704 0.802 . . . . 71.41 109.634 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.25 -111.52 3.28 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.366 0.417 . . . . 61.03 112.283 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.57 7.96 12.78 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.367 0.667 . . . . 75.15 110.745 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.674 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 11.3 pt-20 -125.12 165.46 18.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.835 0.854 . . . . 74.32 109.302 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -75.8 136.37 40.24 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.278 0.631 . . . . 72.03 111.217 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.485 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.93 -1.137 . . . . 71.21 107.93 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.04 151.3 30.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.984 -1.007 . . . . 75.34 110.333 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.37 146.15 29.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.929 -1.137 . . . . 71.3 107.929 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.549 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 47.1 t -159.36 138.68 11.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.568 -0.53 . . . . 61.2 109.568 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.35 133.87 9.86 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.027 0.376 . . . . 74.24 110.602 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.8 118.13 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.175 0.59 . . . . 73.2 110.071 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.6 mt-30 -90.25 86.03 6.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.703 0.801 . . . . 72.24 109.24 170.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.16 95.16 6.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.661 1.185 . . . . 75.15 109.604 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.27 143.29 18.63 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 111.88 -0.488 . . . . 73.3 111.88 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.419 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -144.14 130.88 4.16 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.969 -0.453 . . . . 74.34 111.969 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 35.9 mt -90.47 133.6 31.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.693 0.797 . . . . 72.43 109.534 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -136.7 134.61 37.39 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.319 0.648 . . . . 75.2 110.176 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 40.0 m -82.46 104.36 12.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.984 -0.747 . . . . 75.14 108.984 166.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 134.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.282 1.033 . . . . 74.02 109.432 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.98 167.11 12.93 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.644 0.778 . . . . 73.01 111.39 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.13 -2.07 77.56 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 115.993 1.157 . . . . 73.52 115.993 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -123.18 169.99 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.353 1.061 . . . . 72.52 109.469 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -164.18 -173.37 3.11 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.568 0.581 . . . . 75.1 112.568 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 -145.14 31.16 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 123.932 0.777 . . . . 63.02 114.171 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.0 m -69.43 -27.19 65.05 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.363 0.665 . . . . 75.24 110.251 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -60.79 -43.41 98.16 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 110.223 -0.288 . . . . 74.12 110.223 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 50.3 ttm -68.08 -49.29 62.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.935 0.494 . . . . 74.32 111.118 176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.22 96.52 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.5 0.72 . . . . 74.04 112.228 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -87.63 -25.02 23.76 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.558 -0.746 . . . . 73.14 110.744 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.3 tp -65.51 -42.79 91.67 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.151 -0.931 . . . . 72.3 111.05 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.54 -7.15 76.15 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.753 -0.658 . . . . 75.11 114.615 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.7 -62.75 0.55 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 117.672 0.736 . . . . 64.52 112.077 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -64.88 -47.01 79.4 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.562 0.579 . . . . 74.32 112.562 -167.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -65.25 -45.55 71.24 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.662 -0.685 . . . . 74.34 110.809 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.402 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 83.9 Cg_exo -52.71 -38.86 77.61 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.266 1.978 . . . . 73.43 113.995 163.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -65.46 -27.73 68.72 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 122.852 0.461 . . . . 73.11 111.603 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.25 -44.88 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.266 -0.642 . . . . 75.31 109.266 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.419 HD22 ' HA3' ' D' ' 82' ' ' GLY . 65.0 mt -76.17 -20.26 57.71 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.829 -1.078 . . . . 75.04 111.732 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -68.25 -40.22 19.89 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 117.436 -1.269 . . . . 74.31 113.989 -168.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.95 -42.2 59.49 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.722 1.651 . . . . 62.43 112.771 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -76.73 -34.94 58.08 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.186 0.994 . . . . 73.41 110.982 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.91 51.91 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.465 0.706 . . . . 70.01 110.016 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -56.22 -47.73 77.87 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.818 1.324 . . . . 74.4 110.851 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.74 -46.78 88.16 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.236 0.96 . . . . 73.24 111.727 -175.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.452 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.6 t -55.73 -41.17 73.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.301 1.001 . . . . 75.11 110.349 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.476 HG22 ' SG ' ' D' ' 76' ' ' CYS . 67.8 mt -66.73 -53.75 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.347 1.029 . . . . 73.52 110.935 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.2 m -55.82 -39.2 71.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.555 1.142 . . . . 74.52 111.148 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.69 -46.23 76.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.573 -1.194 . . . . 72.41 110.261 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.549 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.1 mtm -66.23 -30.72 71.23 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.811 0.445 . . . . 72.52 112.097 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.8 t -64.37 -45.06 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 64.21 109.394 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -74.93 -24.32 58.47 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.258 -0.428 . . . . 63.33 111.458 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -74.16 -33.11 63.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.449 0.7 . . . . 74.41 109.938 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.11 4.58 85.81 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.976 -0.556 . . . . 63.13 112.531 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p 61.44 29.6 18.51 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.168 1.787 . . . . 74.43 113.349 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.449 ' CE1' HG12 ' D' ' 31' ' ' VAL . 97.3 m-85 -87.91 168.67 16.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.001 1.32 . . . . 72.34 109.451 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.56 140.1 38.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.792 2.328 . . . . 70.11 111.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.77 130.37 32.61 Favored 'General case' 0 C--O 1.243 0.763 0 O-C-N 124.057 0.848 . . . . 72.43 111.804 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -119.32 96.43 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.24 1.016 . . . . 73.42 109.401 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.73 98.34 9.18 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.672 -0.862 . . . . 72.41 108.672 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.466 HD21 HD22 ' D' ' 42' ' ' LEU . 75.5 mt -69.23 115.33 8.38 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.213 0.605 . . . . 75.31 109.692 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.84 135.77 87.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.264 0.625 . . . . 60.34 111.828 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.53 101.13 1.37 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.972 1.781 . . . . 71.22 110.029 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 114.27 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.058 0.943 . . . . 74.4 109.656 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 121.661 0.743 . . . . 60.55 109.588 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 73.4 m . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 107.921 -1.141 . . . . 74.14 107.921 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -136.57 144.0 43.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.143 -0.688 . . . . 73.01 109.143 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.76 137.24 11.98 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.499 0.5 . . . . 74.44 110.999 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.39 119.86 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 N-CA-C 109.374 -0.602 . . . . 73.25 109.374 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -97.93 -37.23 9.88 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.401 0.681 . . . . 74.1 110.393 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt85 -172.95 141.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.806 0.442 . . . . 74.23 111.3 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.6 mt -116.61 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 108.352 -0.981 . . . . 71.22 108.352 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -166.24 155.53 11.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.713 0.805 . . . . 72.41 111.226 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.416 HG23 ' HB3' ' B' ' 120' ' ' ARG . 60.0 p -87.04 114.64 23.82 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.973 -0.751 . . . . 74.54 108.973 169.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -76.72 -27.03 55.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.768 0.427 . . . . 74.34 109.986 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.9 t70 -154.59 140.75 18.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.414 -0.812 . . . . 65.53 109.466 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.8 mt -136.72 140.09 43.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.317 -1.364 . . . . 72.41 107.317 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.6 t -145.53 128.99 16.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.03 -0.729 . . . . 61.02 109.03 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 91.8 t80 -137.92 112.86 9.06 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.296 -1.742 . . . . 74.42 106.296 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -118.22 134.94 54.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.549 -0.537 . . . . 73.51 109.549 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.88 78.5 69.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 106.045 -1.835 . . . . 74.1 106.045 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.5 -24.49 26.21 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.186 1.924 . . . . 64.5 111.177 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -110.52 29.33 7.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.518 -1.219 . . . . 73.21 109.232 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.11 -43.64 97.51 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.283 1.033 . . . . 73.31 112.407 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.44 -25.57 70.67 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.231 1.475 . . . . 63.12 113.253 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -82.87 -13.77 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.022 0.529 . . . . 64.41 112.188 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.25 -18.17 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.468 0.577 . . . . 74.42 111.994 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.67 -40.26 20.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.921 0.888 . . . . 65.13 110.521 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.98 -25.82 31.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.987 0.515 . . . . 72.2 110.751 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.25 146.67 28.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.392 0.677 . . . . 74.15 111.184 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.65 122.04 18.33 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.547 -1.206 . . . . 74.35 108.602 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.471 ' CE3' HD21 ' A' ' 68' ' ' LEU . 74.4 t-105 -82.03 86.71 6.52 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.494 0.664 . . . . 71.11 110.165 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -124.45 83.42 57.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.487 -1.301 . . . . 74.01 107.487 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.65 119.29 5.13 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.519 2.146 . . . . 72.44 112.337 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.45 112.03 24.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.012 -1.107 . . . . 70.14 108.012 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.23 111.29 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.27 1.028 . . . . 72.4 110.729 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -101.82 140.35 36.22 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.836 -0.802 . . . . 74.42 108.836 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.402 HD21 HD21 ' A' ' 128' ' ' LEU . 6.0 mp -111.54 131.52 55.18 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.425 -0.954 . . . . 75.53 108.425 171.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.677 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -117.9 128.95 55.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.047 -1.094 . . . . 72.5 108.047 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.8 tp -98.15 128.9 44.9 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.215 -0.661 . . . . 74.24 109.215 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -134.09 151.65 51.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.67 -0.863 . . . . 74.32 108.67 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.1 m -141.49 147.96 38.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.075 0.95 . . . . 73.44 108.493 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.452 ' HB1' ' HB ' ' A' ' 59' ' ' VAL . . . -132.34 142.95 49.53 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.493 -0.929 . . . . 72.03 108.493 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.7 m -132.67 150.15 52.2 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.209 -0.293 . . . . 74.24 110.209 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -159.79 151.43 20.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.999 0.919 . . . . 65.04 109.128 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -95.53 114.08 25.8 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.838 -0.801 . . . . 70.43 108.838 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.49 HD12 HG22 ' A' ' 83' ' ' ILE . 83.8 mt -84.09 -43.59 14.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.723 0.409 . . . . 74.31 110.198 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.6 -178.16 6.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.027 0.931 . . . . 71.43 109.277 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.98 122.88 18.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.967 -0.753 . . . . 63.22 108.967 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 66.67 13.66 9.44 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.81 1.244 . . . . 72.13 112.133 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.33 125.54 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.494 -0.928 . . . . 75.35 108.494 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -130.87 168.32 17.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.277 0.56 . . . . 73.31 110.212 176.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HB2' HD13 ' A' ' 51' ' ' LEU . 31.2 tt0 -127.34 121.78 31.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.159 -1.052 . . . . 75.15 108.159 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.51 119.02 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.778 -1.193 . . . . 74.2 107.778 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.615 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -99.16 135.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.79 0.836 . . . . 70.43 108.983 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.37 112.01 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.9 -1.518 . . . . 75.11 106.9 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 79' ' ' GLN . 12.2 ttp180 -108.42 104.33 13.67 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.387 -0.597 . . . . 75.25 109.387 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.99 132.42 39.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.237 -1.023 . . . . 64.42 108.237 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.677 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.1 m -114.02 138.2 50.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.823 -0.806 . . . . 73.03 108.823 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 39.9 t -133.71 108.58 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 125.104 1.361 . . . . 75.24 108.382 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -106.02 140.48 38.94 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.568 -0.53 . . . . 74.44 109.568 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.9 117.27 27.67 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.172 -1.047 . . . . 73.34 108.172 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 m -113.88 127.56 56.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.189 0.596 . . . . 74.3 110.367 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.4 mt -93.41 53.46 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.292 1.437 . . . . 72.32 109.642 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.6 -84.93 0.97 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.119 -0.491 . . . . 74.25 112.147 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.04 -28.41 16.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.666 0.786 . . . . 73.44 111.724 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -123.39 133.69 54.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.714 0.806 . . . . 73.55 109.893 -169.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -71.34 136.89 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 120.916 0.388 . . . . 74.33 110.459 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -61.8 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.19 0.996 . . . . 61.44 109.214 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.83 167.64 26.85 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.34 -1.3 . . . . 72.11 110.297 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -134.43 140.36 46.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.806 1.242 . . . . 74.51 108.178 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.4 m -131.0 135.87 48.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.272 1.029 . . . . 74.15 108.973 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.17 123.45 8.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.602 0.361 . . . . 75.44 110.123 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 39.3 t -130.41 113.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.974 0.91 . . . . 74.21 109.749 -174.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 mt-30 -85.6 81.09 8.8 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.641 0.776 . . . . 73.51 108.916 172.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.74 90.53 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.154 0.982 . . . . 72.52 108.572 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.99 144.84 18.28 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 116.087 -0.506 . . . . 61.43 112.325 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.12 130.83 5.0 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 111.983 -0.447 . . . . 72.44 111.983 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.49 HG22 HD12 ' A' ' 51' ' ' LEU . 40.8 mt -81.29 131.34 34.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 107.426 -1.324 . . . . 74.13 107.426 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . 37.7 m-85 -131.79 155.43 47.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.725 -0.843 . . . . 74.23 108.725 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -111.49 114.22 27.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.603 1.161 . . . . 72.52 108.035 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 tt -139.08 152.92 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 118.086 0.403 . . . . 75.52 111.033 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.82 169.34 13.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.374 1.069 . . . . 72.0 110.352 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.45 5.76 86.04 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 123.901 0.751 . . . . 73.21 114.701 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.407 ' H ' HD11 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.05 153.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.154 0.981 . . . . 74.42 109.606 -177.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.23 170.48 22.38 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.165 0.586 . . . . 75.03 109.444 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.73 -125.3 34.59 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 123.701 0.667 . . . . 73.32 113.889 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.4 p -75.49 -21.39 58.08 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.731 0.812 . . . . 73.42 111.422 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.55 -40.16 92.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.004 0.522 . . . . 71.24 109.797 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -47.44 24.47 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.311 -0.859 . . . . 75.12 109.92 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -34.05 77.09 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.106 -0.952 . . . . 72.52 112.636 -172.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -78.89 -20.81 48.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.194 0.598 . . . . 72.04 110.855 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 49.4 t -80.42 -64.39 1.2 Allowed 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.413 0.285 . . . . 71.53 110.242 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.19 -37.12 84.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.961 0.504 . . . . 64.51 111.786 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.46 -15.11 64.62 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 114.92 0.728 . . . . 75.22 114.92 -172.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.88 -51.19 0.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.637 0.718 . . . . 74.54 112.656 -171.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.5 t80 -77.71 -51.69 10.17 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.216 0.607 . . . . 75.41 112.55 -168.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 67.7 m -70.84 -38.9 8.03 Favored Pre-proline 0 CA--C 1.569 1.688 0 C-N-CA 123.935 0.894 . . . . 74.22 113.112 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.37 -22.01 46.4 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.709 1.606 . . . . 62.23 112.434 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -71.42 -30.36 65.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.872 0.469 . . . . 73.22 110.492 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.03 -40.08 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.375 -0.602 . . . . 74.45 109.375 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.468 HD22 ' HA3' ' A' ' 82' ' ' GLY . 36.1 mt -82.1 -21.85 36.54 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.077 -0.965 . . . . 74.3 112.253 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -65.53 -39.31 32.26 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.697 1.369 . . . . 74.33 114.697 -170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.65 -34.76 99.11 Favored 'Trans proline' 0 C--N 1.393 2.899 0 CA-C-N 122.153 1.805 . . . . 75.21 112.51 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -80.76 -36.66 31.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.815 0.846 . . . . 73.3 110.459 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.87 79.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.09 0.556 . . . . 72.31 109.927 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -52.0 -57.77 8.49 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.593 1.183 . . . . 74.13 109.286 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.77 -43.64 97.77 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.592 1.183 . . . . 71.31 111.793 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.62 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.8 t -57.64 -47.64 81.69 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.945 0.898 . . . . 71.44 110.832 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.569 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 89.2 mt -64.34 -53.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.041 0.838 . . . . 74.31 110.463 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.3 m -50.25 -41.83 50.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.394 1.478 . . . . 74.01 111.505 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -72.78 -42.76 63.61 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.825 -1.08 . . . . 72.52 110.926 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.569 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 50.3 mtm -58.35 -42.61 87.25 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 74.1 110.86 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.8 t -60.12 -49.01 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.241 -1.345 . . . . 72.3 111.27 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.6 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 80.9 p -66.89 -31.41 71.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.887 0.475 . . . . 74.42 111.507 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.424 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.9 mtt-85 -68.7 -27.12 65.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.827 0.851 . . . . 72.34 111.358 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 13.06 53.24 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.628 -0.54 . . . . 71.01 113.545 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m 63.91 27.29 14.41 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.8 1.24 . . . . 72.24 110.871 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.36 150.0 37.97 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.555 -0.905 . . . . 71.11 108.555 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.77 120.56 7.17 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.882 1.721 . . . . 75.42 109.674 176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.6 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 10.8 pt20 -61.69 150.89 35.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.338 0.655 . . . . 63.42 111.719 -171.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.42 108.71 20.18 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.746 -0.835 . . . . 74.13 108.746 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -96.69 96.14 8.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.84 -1.17 . . . . 74.23 107.84 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.402 HD21 HD21 ' A' ' 42' ' ' LEU . 91.5 mt -65.72 148.63 51.44 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.473 -0.785 . . . . 72.23 110.58 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.84 60.83 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.013 0.525 . . . . 74.4 110.72 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.34 164.0 26.92 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.134 1.889 . . . . 64.44 111.924 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.01 114.13 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.997 0.919 . . . . 73.02 109.797 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.84 85.61 6.06 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.454 0.701 . . . . 72.31 109.476 173.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 124.544 1.138 . . . . 74.33 111.869 173.945 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.244 0.77 0 N-CA-C 108.756 -0.831 . . . . 70.11 108.756 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -133.44 144.67 49.64 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.21 0.604 . . . . 74.12 109.826 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -147.77 136.42 21.8 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.962 -1.017 . . . . 75.12 109.114 169.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.24 144.06 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.614 -0.884 . . . . 74.13 108.614 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.49 -49.36 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.412 0.285 . . . . 72.42 110.836 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -162.53 139.49 7.92 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.584 -0.154 . . . . 73.34 110.584 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.401 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 93.9 mt -115.28 137.83 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 106.744 -1.576 . . . . 71.24 106.744 170.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.467 ' HE1' HG13 ' B' ' 83' ' ' ILE . 16.2 p90 -165.65 144.91 6.34 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.66 0.6 . . . . 72.42 111.654 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.6 m -76.31 119.38 20.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.314 -0.857 . . . . 73.41 108.934 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -93.8 -26.96 16.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.383 0.673 . . . . 74.24 111.238 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.9 t70 -160.78 143.13 12.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.165 0.291 . . . . 72.0 110.78 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.3 mm -137.78 138.3 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.991 1.316 . . . . 72.14 108.992 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 7.9 t -137.91 138.76 39.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.22 -1.4 . . . . 75.31 107.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.466 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.8 t80 -160.62 114.53 2.11 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 107.753 -1.203 . . . . 73.21 107.753 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.8 147.89 42.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.811 -1.181 . . . . 74.22 107.811 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.85 81.92 61.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 106.911 -1.514 . . . . 72.53 106.911 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.55 -21.34 52.85 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.803 2.335 . . . . 73.22 113.094 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.33 30.47 6.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.917 0.887 . . . . 60.4 109.938 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.64 -50.54 59.12 Favored Pre-proline 0 CA--C 1.569 1.71 0 C-N-CA 124.752 1.221 . . . . 65.44 114.164 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.3 -16.77 6.9 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.87 1.713 . . . . 74.1 112.769 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.63 0.86 55.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.657 0.783 . . . . 64.34 110.817 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.24 -15.35 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 124.268 1.027 . . . . 61.32 111.385 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.81 -42.59 89.53 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.437 0.695 . . . . 74.54 110.607 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.68 -43.41 96.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.74 0.816 . . . . 73.52 110.85 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -103.2 76.42 1.44 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.631 -1.168 . . . . 75.4 109.989 -171.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.28 76.71 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.557 -1.656 . . . . 74.24 110.368 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.414 ' HZ2' ' H ' ' B' ' 69' ' ' GLY . 2.4 p-90 -157.65 176.59 12.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.831 -1.077 . . . . 74.32 109.5 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.83 99.46 0.99 Allowed Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.878 0.871 . . . . 74.11 108.832 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.505 ' HB3' HD22 ' B' ' 68' ' ' LEU . 55.9 Cg_endo -67.15 161.36 43.2 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.234 1.956 . . . . 73.03 112.94 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -75.18 102.18 4.88 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.903 -1.044 . . . . 74.25 108.964 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' B' ' 124' ' ' PRO . 8.0 t -92.21 119.03 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 N-CA-C 107.547 -1.279 . . . . 74.55 107.547 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -146.84 145.77 29.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.032 0.933 . . . . 72.44 108.992 -170.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.609 HD23 HD21 ' B' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 170.01 12.87 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.828 0.851 . . . . 74.53 111.003 -176.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.16 139.59 41.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.584 1.153 . . . . 75.2 109.335 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 129.73 36.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.838 . . . . 72.02 109.535 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -139.97 149.51 43.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.741 0.817 . . . . 75.13 109.601 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -145.22 134.31 22.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.166 0.587 . . . . 61.15 110.02 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.88 149.27 43.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.747 1.219 . . . . 74.14 107.738 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -143.89 160.97 39.87 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.343 0.657 . . . . 72.05 110.678 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.3 p -163.12 140.15 7.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.694 0.797 . . . . 73.24 109.352 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.8 tt0 -82.64 134.43 35.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 74.05 109.871 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -92.87 -55.2 3.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.297 0.639 . . . . 71.01 110.028 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.59 -165.13 1.97 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.577 -0.738 . . . . 63.3 110.942 -170.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.06 109.89 4.22 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.547 -0.752 . . . . 71.44 110.206 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.53 4.43 4.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.028 1.331 . . . . 64.53 111.908 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.94 114.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 124.734 1.214 . . . . 75.34 109.121 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 15.5 p90 -117.46 174.39 6.17 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.817 . . . . 75.22 109.224 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.17 117.66 8.55 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.469 -0.937 . . . . 73.44 108.469 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.13 127.47 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 71.5 109.585 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.7 t -101.38 113.77 38.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.989 0.915 . . . . 73.1 108.826 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.05 110.1 21.58 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.005 -1.48 . . . . 73.31 107.005 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.92 121.89 42.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.906 -0.405 . . . . 75.33 109.906 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.2 t -112.65 126.67 70.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.541 -1.281 . . . . 64.34 107.541 167.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.507 HG22 ' HB2' ' B' ' 77' ' ' GLU . 5.1 m -121.43 127.06 50.76 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 110.062 -0.347 . . . . 63.32 110.062 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 42' ' ' LEU . 38.6 t -99.04 127.9 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.995 . . . . 75.14 109.995 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -107.61 131.87 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.583 -1.189 . . . . 75.43 108.648 164.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.26 152.33 50.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.024 -0.732 . . . . 75.14 109.024 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.0 p -145.4 135.39 23.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.047 0.758 . . . . 75.32 113.047 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' B' ' 38' ' ' PRO . 75.9 mt -95.29 97.08 9.59 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.752 -1.567 . . . . 74.11 108.003 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HZ2' ' B' ' 36' ' ' TRP . . . 71.86 -117.04 6.29 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.482 -0.647 . . . . 71.32 111.482 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -105.43 9.33 33.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.494 1.118 . . . . 74.52 110.427 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.71 151.09 34.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.045 1.338 . . . . 72.55 108.414 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.88 133.83 43.17 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.164 0.438 . . . . 71.53 110.726 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.4 -63.3 1.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.89 0.876 . . . . 74.44 108.952 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.456 ' CE1' HG13 ' B' ' 64' ' ' VAL . 50.1 p90 -157.27 160.36 38.52 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.639 -1.164 . . . . 73.3 109.392 176.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.87 113.86 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.963 -1.125 . . . . 72.0 107.963 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.478 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.9 t -115.41 161.11 19.01 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.526 -0.916 . . . . 74.31 108.526 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.626 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.76 135.62 3.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.416 -0.587 . . . . 72.13 109.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.4 t -126.62 144.04 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.819 . . . . 73.12 108.79 171.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -122.97 91.8 3.57 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.784 -0.821 . . . . 54.55 108.784 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.474 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -84.61 100.68 11.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.419 -0.81 . . . . 74.32 109.161 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.2 158.41 23.78 Favored Glycine 0 C--O 1.24 0.521 0 N-CA-C 111.459 -0.656 . . . . 73.35 111.459 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.37 128.9 2.38 Favored Glycine 0 C--O 1.237 0.297 0 N-CA-C 112.011 -0.436 . . . . 74.13 112.011 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.467 HG13 ' HE1' ' B' ' 17' ' ' TYR . 55.2 mt -85.32 125.64 40.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.516 -0.92 . . . . 74.41 108.516 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.405 ' HB2' ' CZ ' ' B' ' 56' ' ' TYR . 29.7 m-85 -137.89 170.3 16.29 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.196 0.999 . . . . 54.4 108.574 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 43.5 m -135.14 132.63 38.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.93 0.892 . . . . 74.42 110.327 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.434 HD12 HG12 ' B' ' 89' ' ' ILE . 2.8 pp -136.25 146.19 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 123.541 0.736 . . . . 75.13 111.02 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.91 28.24 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.126 1.37 . . . . 74.45 108.245 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.76 -27.83 4.69 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-O 119.931 -0.372 . . . . 71.13 113.811 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.434 HG12 HD12 ' B' ' 86' ' ' ILE . 1.6 pp -53.24 142.99 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.626 1.17 . . . . 72.52 113.057 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -150.57 148.66 28.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.163 0.985 . . . . 73.35 110.434 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -136.09 49.94 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 124.387 1.054 . . . . 70.15 114.481 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -84.39 -19.21 33.92 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.746 0.818 . . . . 75.02 110.646 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.24 -21.73 63.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.101 0.56 . . . . 74.54 110.875 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.3 -42.49 93.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.375 0.67 . . . . 75.24 110.515 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -21.15 65.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 72.32 112.367 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.11 -42.02 89.76 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.257 0.623 . . . . 65.11 110.483 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' B' ' 86' ' ' ILE . 46.4 t -67.52 -57.06 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.096 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.36 -31.12 66.97 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.766 -0.652 . . . . 73.11 112.542 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.59 58.78 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.37 -0.683 . . . . 74.33 114.627 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.68 -48.1 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 117.636 0.718 . . . . 73.03 112.576 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -69.49 -48.44 60.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.657 0.383 . . . . 74.45 111.457 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -62.18 -48.91 86.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 118.216 -0.897 . . . . 74.15 110.793 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -50.58 -44.7 38.75 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.416 2.077 . . . . 75.24 113.515 166.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.13 -34.86 75.66 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.299 1.039 . . . . 74.11 112.178 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.21 -49.28 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.355 0.662 . . . . 64.33 110.176 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -76.55 -14.77 59.99 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.481 -1.236 . . . . 74.4 111.856 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.4 ' CE1' HD11 ' B' ' 128' ' ' LEU . 27.3 t80 -62.06 -52.64 65.99 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.271 1.428 . . . . 75.11 113.249 -167.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.57 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 36.9 Cg_endo -62.23 -32.55 82.41 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.022 1.815 . . . . 62.12 113.17 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.474 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.2 m-85 -64.36 -46.29 84.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.153 0.581 . . . . 74.23 110.057 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.2 90.16 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.959 0.903 . . . . 73.01 110.468 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 31.9 mtp180 -52.3 -56.11 16.98 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.586 1.155 . . . . 75.42 111.871 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -32.51 64.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.284 -0.871 . . . . 74.11 110.676 -173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -69.69 -34.6 74.16 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.831 0.452 . . . . 70.21 111.008 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.443 HD11 ' HB ' ' B' ' 62' ' ' VAL . 58.2 mt -62.69 -58.95 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.773 -0.825 . . . . 73.33 108.773 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -51.69 -32.65 30.79 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 124.86 1.35 . . . . 75.03 112.263 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -64.47 -50.33 67.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.076 0.95 . . . . 72.21 110.345 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.477 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 13.4 mmt -71.14 -30.86 67.01 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.105 0.479 . . . . 75.15 111.43 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.9 t -70.48 -37.8 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.18 0.992 . . . . 75.42 110.978 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 96.2 p -67.35 -33.04 74.41 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.169 0.509 . . . . 75.35 110.955 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.62 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 58.6 mtt-85 -64.64 -35.26 80.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.399 -0.819 . . . . 75.52 110.292 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.31 10.45 71.26 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.971 -0.905 . . . . 54.42 113.817 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.462 ' HA ' ' OD1' ' C' ' 127' ' ' ASN . 62.8 p 59.23 34.92 23.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.569 1.548 . . . . 65.43 113.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 23.7 m-85 -117.86 164.84 17.97 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 124.211 1.004 . . . . 75.35 110.631 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.591 ' HB2' HG22 ' B' ' 40' ' ' VAL . 7.3 Cg_exo -75.45 137.72 21.11 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 123.693 2.929 . . . . 71.12 115.257 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.577 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.9 OUTLIER -66.81 159.0 29.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.517 1.527 . . . . 72.42 113.282 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -126.3 117.47 23.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.106 -1.072 . . . . 73.4 108.106 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' C' ' 122' ' ' THR . 3.8 m120 -92.11 97.51 10.97 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.042 -1.466 . . . . 72.33 107.042 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.609 HD21 HD23 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -66.18 148.19 52.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.258 0.481 . . . . 73.11 110.961 -170.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.605 ' H ' HD22 ' B' ' 128' ' ' LEU . . . -41.11 107.0 0.45 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 127.335 2.254 . . . . 60.11 113.783 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.08 54.33 4.57 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.726 2.284 . . . . 70.24 111.774 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.502 HG21 ' HB1' ' B' ' 129' ' ' ALA . 67.0 t -87.35 113.63 25.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 124.782 1.233 . . . . 73.42 109.034 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -69.8 98.47 1.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.045 -1.095 . . . . 73.23 108.045 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 115.157 -0.929 . . . . 73.33 110.993 -175.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.2 m . . . . . 0 C--O 1.237 0.414 0 N-CA-C 107.017 -1.475 . . . . 74.32 107.017 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -95.17 116.64 29.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.341 -1.726 . . . . 75.32 106.341 168.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -143.69 141.87 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.722 -0.844 . . . . 71.32 108.722 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.0 133.5 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 123.71 0.631 . . . . 62.35 109.435 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -113.29 -28.96 7.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.58 0.752 . . . . 71.34 110.107 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.442 ' NH2' ' HB ' ' D' ' 122' ' ' THR . 16.1 ttt85 -179.65 144.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 122.976 0.511 . . . . 72.45 110.605 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 51.7 mt -124.39 134.17 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.407 -1.331 . . . . 73.32 107.407 168.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.584 ' HH ' HD11 ' C' ' 83' ' ' ILE . 21.5 p90 -176.94 155.01 1.17 Allowed 'General case' 0 C--O 1.227 -0.122 0 O-C-N 123.997 0.81 . . . . 70.12 110.421 -174.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.23 120.94 22.19 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.629 0.772 . . . . 73.01 109.664 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.458 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 28.9 mmtp -70.55 -49.09 51.72 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 107.974 -1.121 . . . . 75.12 107.974 167.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -138.51 142.68 39.34 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.803 -1.544 . . . . 75.22 109.498 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.24 144.8 28.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.936 -1.505 . . . . 75.31 106.936 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.2 t -155.21 148.3 24.71 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.254 0.55 . . . . 71.11 110.593 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.4 t80 -147.8 125.96 12.18 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 114.694 -1.139 . . . . 74.52 107.926 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.36 139.25 51.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.361 1.064 . . . . 70.41 108.321 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 76.26 36.24 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 105.954 -1.869 . . . . 74.41 105.954 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.25 -19.68 29.03 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.369 2.046 . . . . 74.53 111.071 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.75 11.4 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.679 -1.146 . . . . 74.32 110.376 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.05 -61.73 3.07 Favored Pre-proline 0 CA--C 1.573 1.85 0 N-CA-C 114.064 1.135 . . . . 73.14 114.064 -165.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.9 Cg_exo -76.05 -23.49 12.09 Favored 'Trans proline' 0 C--N 1.387 2.594 0 CA-C-N 121.746 1.659 . . . . 71.23 112.28 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -71.09 -38.16 72.4 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.797 1.239 . . . . 74.2 111.894 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.36 -10.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.377 1.071 . . . . 74.11 111.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.09 -40.52 70.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.759 0.824 . . . . 75.4 111.7 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.514 ' HA ' HE21 ' C' ' 33' ' ' GLN . 0.0 OUTLIER -116.52 38.78 3.33 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.997 0.903 . . . . 72.24 109.811 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.719 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -99.98 152.23 20.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.68 -0.638 . . . . 73.12 110.945 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.62 108.57 4.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.633 -1.247 . . . . 52.33 107.633 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -70.99 104.58 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.927 0.891 . . . . 74.24 110.68 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -134.47 49.88 4.38 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 124.174 0.99 . . . . 74.31 110.724 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 112.62 3.42 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.182 1.922 . . . . 73.42 112.302 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -86.0 95.08 9.39 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.579 -1.267 . . . . 72.34 107.579 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 76.0 t -80.7 89.63 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.095 -0.957 . . . . 74.13 110.118 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.88 139.14 31.24 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.837 -0.801 . . . . 75.45 108.837 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.593 ' HB3' HG23 ' C' ' 64' ' ' VAL . 0.6 OUTLIER -129.12 144.98 51.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.379 0.671 . . . . 54.34 109.633 172.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.46 139.19 53.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.796 1.239 . . . . 55.25 108.836 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.685 ' HG ' HD21 ' C' ' 60' ' ' LEU . 8.9 tt -114.21 135.7 53.76 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.629 0.772 . . . . 74.52 109.16 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -155.63 149.95 25.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.229 1.011 . . . . 75.34 108.835 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -112.16 152.11 28.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.466 0.65 . . . . 73.44 109.895 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.0 158.39 41.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.5 1.12 . . . . 75.43 108.173 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.4 t -153.26 148.84 27.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.899 0.38 . . . . 74.34 110.675 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -157.74 128.09 6.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.62 1.168 . . . . 74.12 108.917 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -81.41 131.22 35.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.312 -0.625 . . . . 73.32 109.312 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.507 HD13 HD13 ' C' ' 83' ' ' ILE . 84.2 mt -98.01 -40.1 8.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.542 0.737 . . . . 75.22 110.34 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.36 179.48 9.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.221 -0.899 . . . . 65.32 109.526 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.14 126.04 28.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.661 -0.866 . . . . 75.42 108.661 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.402 ' HA ' HG22 ' C' ' 86' ' ' ILE . 3.0 m-20 67.11 13.83 9.58 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.625 1.17 . . . . 64.54 112.606 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.68 117.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.405 1.082 . . . . 64.4 108.587 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 165.76 23.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.66 0.743 . . . . 72.5 109.547 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -126.57 136.63 52.8 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.328 1.051 . . . . 74.24 108.474 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.0 t -123.37 127.43 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.179 -1.415 . . . . 73.22 107.179 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.507 HG23 ' HA2' ' C' ' 81' ' ' GLY . 90.2 t -120.44 117.4 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.798 -0.815 . . . . 72.23 108.798 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.685 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -86.53 113.05 22.13 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.786 -0.82 . . . . 65.41 108.786 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -90.92 106.76 18.74 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.307 -0.998 . . . . 74.43 108.307 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.5 t -107.19 135.47 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.152 -1.055 . . . . 61.34 108.152 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -127.39 124.99 39.85 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.951 -0.388 . . . . 72.23 109.951 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.602 HG21 HG23 ' C' ' 114' ' ' ILE . 43.3 t -102.71 115.86 45.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 74.31 110.612 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -99.4 134.76 41.79 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.178 -1.045 . . . . 65.25 108.178 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.26 129.92 45.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.32 -0.993 . . . . 73.12 108.32 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 70.2 m -146.88 135.63 22.18 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.626 0.579 . . . . 72.2 111.146 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.719 HD12 ' HG2' ' C' ' 34' ' ' LYS . 5.9 mt -86.83 40.74 0.92 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.319 1.848 . . . . 74.22 109.413 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.42 -109.71 3.29 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.724 -0.95 . . . . 73.33 110.724 -168.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.25 -24.47 22.08 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.519 0.728 . . . . 75.52 110.136 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 6.9 tp10 -76.94 120.45 22.08 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.389 1.075 . . . . 75.11 110.027 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.1 m -66.65 125.36 25.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.958 0.799 . . . . 74.54 109.404 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.06 -51.9 8.46 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.842 -0.799 . . . . 72.52 108.842 174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -164.81 175.29 9.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.777 -1.101 . . . . 74.12 109.863 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -134.33 144.81 48.5 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.677 -1.601 . . . . 73.55 106.677 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' C' ' 114' ' ' ILE . 42.1 t -143.83 148.33 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.21 -1.033 . . . . 72.1 108.21 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.62 134.85 9.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.922 -0.77 . . . . 60.25 108.922 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.73 139.24 52.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.364 1.066 . . . . 75.54 108.521 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -116.4 90.34 3.31 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.116 -1.068 . . . . 75.42 108.116 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -79.56 106.6 11.7 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.675 -1.148 . . . . 75.25 109.991 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.507 ' HA2' HG23 ' C' ' 59' ' ' VAL . . . -82.72 148.41 26.05 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.371 0.419 . . . . 74.1 112.166 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.74 116.19 0.77 Allowed Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 110.795 -0.922 . . . . 74.33 110.795 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.584 HD11 ' HH ' ' C' ' 17' ' ' TYR . 10.9 mm -87.6 125.23 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.245 -1.02 . . . . 63.34 108.245 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -130.56 156.59 44.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.498 -0.927 . . . . 74.02 108.498 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -91.75 137.22 32.54 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.933 -0.766 . . . . 72.34 108.933 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.402 HG22 ' HA ' ' C' ' 54' ' ' ASP . 0.0 OUTLIER -108.52 134.67 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.655 -0.868 . . . . 73.11 108.655 172.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -178.39 153.56 0.75 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.574 0.75 . . . . 71.03 110.992 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.85 -36.53 3.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.652 1.021 . . . . 53.41 115.652 163.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.621 HD11 ' HE3' ' C' ' 94' ' ' MET . 1.6 pp . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 123.99 0.916 . . . . 73.42 112.282 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.537 0.208 . . . . 73.44 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.621 ' HE3' HD11 ' C' ' 89' ' ' ILE . 15.9 ptp -72.47 -27.37 62.25 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.298 -0.41 . . . . 72.13 111.816 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.94 76.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.491 0.716 . . . . 71.33 111.826 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -72.46 -24.57 61.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.063 0.545 . . . . 73.42 111.222 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 32.3 t -62.96 -63.46 1.2 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.537 0.523 . . . . 61.24 111.089 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.52 -23.92 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.49 0.586 . . . . 74.14 110.516 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.85 -24.44 76.63 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.486 -0.779 . . . . 64.15 113.521 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.61 -38.01 0.06 Allowed 'General case' 0 C--N 1.358 0.967 0 N-CA-C 113.723 1.009 . . . . 71.52 113.723 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.21 -39.01 82.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.517 0.727 . . . . 70.03 112.057 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.82 -50.28 4.22 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.46 -0.781 . . . . 72.23 111.301 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.49 -23.16 64.84 Favored 'Trans proline' 0 C--N 1.398 3.183 0 C-N-CA 121.637 1.558 . . . . 75.55 113.306 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -65.37 -36.13 83.05 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 122.984 0.514 . . . . 71.13 110.394 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.27 -41.52 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.895 0.878 . . . . 72.4 110.165 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 57.5 mt -86.64 -15.95 38.13 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.591 -1.186 . . . . 72.44 112.07 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -59.63 -51.58 80.03 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 117.617 -1.182 . . . . 72.41 113.182 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.94 -34.39 99.1 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 121.927 1.751 . . . . 74.45 112.596 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.64 -46.68 75.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.506 0.722 . . . . 73.3 110.864 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.59 94.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 42.33 110.402 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.19 -45.67 93.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.421 1.488 . . . . 72.23 110.716 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.59 -30.19 59.53 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.004 0.921 . . . . 63.11 110.324 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.1 t -68.67 -39.82 80.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.1 0.56 . . . . 75.01 110.481 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.602 HG23 HG21 ' C' ' 64' ' ' VAL . 86.4 mt -68.31 -45.06 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.064 0.546 . . . . 65.42 109.932 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.2 m -55.01 -38.87 68.46 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.634 0.774 . . . . 74.21 111.184 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -59.8 -60.6 3.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.187 -0.915 . . . . 71.42 109.716 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.809 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -48.2 -47.63 35.26 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.474 1.51 . . . . 73.22 113.349 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.547 HG11 HD21 ' C' ' 126' ' ' LEU . 53.5 t -70.69 -43.89 77.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.12 0.968 . . . . 75.24 111.796 -173.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.5 t -64.72 -30.57 71.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.889 -0.596 . . . . 64.51 110.793 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.455 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 75.2 mtt-85 -66.02 -32.53 74.06 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.816 -0.629 . . . . 73.5 110.564 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.28 12.3 60.9 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.526 0.516 . . . . 73.35 113.557 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.576 HG22 ' HB3' ' D' ' 17' ' ' TYR . 46.5 p 58.79 35.93 24.54 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.793 1.637 . . . . 75.41 112.922 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 41.5 m-85 -110.21 163.94 16.0 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.171 0.988 . . . . 74.5 110.504 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 32.7 Cg_endo -59.48 173.35 1.54 Allowed 'Trans proline' 0 C--N 1.402 3.361 0 C-N-CA 123.631 2.888 . . . . 73.34 114.905 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.577 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 5.7 mm-40 -60.68 136.26 58.01 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.393 -0.821 . . . . 73.42 111.732 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.547 HD21 HG11 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -112.32 24.81 12.15 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.278 -0.874 . . . . 74.52 111.683 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 7.1 p30 -92.56 84.0 5.01 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.523 1.63 . . . . 74.22 108.207 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.91 157.03 17.06 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.915 -1.038 . . . . 75.1 112.63 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -33.58 135.91 0.31 Allowed Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 126.542 1.937 . . . . 74.31 115.101 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.75 109.99 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.851 2.367 . . . . 74.42 111.609 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.05 30.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.428 0.691 . . . . 74.42 111.381 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -71.2 103.8 2.9 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 115.119 -0.946 . . . . 75.22 111.988 -175.418 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.433 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 47.7 m . . . . . 0 C--O 1.237 0.397 0 N-CA-C 108.633 -0.877 . . . . 75.24 108.633 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -153.49 99.53 2.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.378 -0.971 . . . . 75.51 108.378 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -123.58 114.4 19.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.77 0.828 . . . . 75.14 108.774 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.464 HD11 HD11 ' D' ' 16' ' ' ILE . 1.1 pp -78.75 127.05 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 107.157 -1.424 . . . . 75.22 107.157 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -85.09 -35.37 21.86 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.271 -0.27 . . . . 71.41 110.271 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.448 ' HB3' ' HE1' ' D' ' 17' ' ' TYR . 1.6 tpt180 -172.74 157.29 3.71 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.852 0.461 . . . . 71.32 110.514 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.464 HD11 HD11 ' D' ' 13' ' ' ILE . 19.7 mt -144.31 124.19 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.514 1.126 . . . . 75.53 108.038 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.576 ' HB3' HG22 ' C' ' 122' ' ' THR . 23.9 p90 -168.96 162.91 11.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.758 1.223 . . . . 73.4 109.996 -168.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.8 p -80.94 122.17 26.92 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.314 -0.857 . . . . 62.3 109.912 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 45.7 mtpt -86.09 -44.42 12.27 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 107.98 -1.118 . . . . 74.54 107.98 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.76 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.9 t70 -131.59 141.88 49.77 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.963 -1.017 . . . . 75.11 109.848 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.809 HG21 ' HE1' ' C' ' 117' ' ' MET . 55.4 mt -137.7 146.33 27.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.375 1.47 . . . . 74.14 107.778 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.1 140.5 17.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.498 0.666 . . . . 62.41 111.101 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.9 t80 -140.8 137.89 33.66 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.514 -1.662 . . . . 73.04 106.514 168.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.5 mt-10 -138.09 136.94 37.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.291 1.036 . . . . 73.15 108.489 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.463 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -148.11 74.17 10.97 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.959 -0.756 . . . . 71.23 108.959 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.71 -26.72 13.37 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.697 2.265 . . . . 73.33 112.407 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -99.46 -0.44 40.78 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.05 -0.977 . . . . 73.14 111.508 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -42.39 -57.87 4.13 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 116.071 1.878 . . . . 65.32 116.071 -163.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.458 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 67.1 Cg_endo -77.44 -25.18 8.47 Favored 'Trans proline' 0 C--N 1.387 2.59 0 CA-C-N 121.101 1.429 . . . . 75.44 113.221 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -87.14 -24.17 24.59 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.702 0.287 . . . . 74.12 110.585 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -8.93 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 123.495 0.718 . . . . 65.25 110.12 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -65.98 -38.17 87.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.774 0.829 . . . . 72.23 110.614 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -75.9 -2.1 28.6 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.81 0.338 . . . . 75.34 111.363 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.451 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 77.2 tttt -105.68 76.87 1.22 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.635 1.174 . . . . 74.02 107.975 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.62 95.19 8.27 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.015 -0.993 . . . . 73.12 112.325 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -150.05 176.13 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.401 -0.592 . . . . 75.23 109.401 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -73.3 114.12 28.45 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.139 0.976 . . . . 74.44 109.231 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.51 111.16 0.86 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.111 1.874 . . . . 74.1 110.421 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.66 111.17 2.28 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.862 -1.162 . . . . 73.53 107.862 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -98.35 121.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.352 0.661 . . . . 72.04 109.385 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.538 ' HZ2' ' HB2' ' D' ' 43' ' ' ASP . 13.9 tmtt? -109.06 114.26 27.83 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.568 -1.271 . . . . 75.1 107.568 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -96.61 116.27 28.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.852 0.861 . . . . 74.54 108.968 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.538 ' HB2' ' HZ2' ' D' ' 41' ' ' LYS . 15.7 t70 -108.41 125.87 52.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.712 -0.847 . . . . 71.44 108.712 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.71 129.82 42.8 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.423 -0.584 . . . . 73.43 109.423 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.5 t70 -144.55 152.82 41.11 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.147 -1.057 . . . . 73.3 108.147 172.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -145.19 157.31 44.11 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.326 0.651 . . . . 74.32 109.506 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.93 166.85 28.37 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.811 1.245 . . . . 71.23 107.793 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 68.9 p -168.1 166.01 13.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.828 0.451 . . . . 55.05 110.813 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.1 p -156.65 132.63 9.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.26 -0.882 . . . . 63.02 109.12 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -70.3 126.99 31.23 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.53 -0.544 . . . . 61.43 109.53 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.3 mt -91.45 -40.89 11.16 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.263 0.554 . . . . 74.01 109.824 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.22 -173.26 3.94 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.117 -0.947 . . . . 75.55 110.172 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.97 123.06 19.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.657 -0.701 . . . . 74.34 110.014 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 64.56 17.39 10.85 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.551 1.157 . . . . 75.31 112.242 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.12 123.47 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.563 0.745 . . . . 73.23 110.16 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.29 166.33 16.72 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.902 1.281 . . . . 71.14 108.419 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.475 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.5 tm-20 -130.6 126.93 37.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.737 -1.949 . . . . 71.23 105.737 168.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.86 133.23 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.189 0.996 . . . . 63.43 108.552 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.13 135.91 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.367 1.067 . . . . 70.43 110.079 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.46 126.6 52.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.212 -1.403 . . . . 73.31 107.212 171.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.533 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -104.51 102.95 12.57 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.883 -0.784 . . . . 74.12 108.883 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.5 t -95.18 119.39 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.373 -0.973 . . . . 73.41 108.373 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 32.0 m -115.76 136.92 52.58 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.677 -0.692 . . . . 74.12 110.164 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.577 HG22 HG23 ' D' ' 114' ' ' ILE . 76.4 t -126.76 102.3 9.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.897 1.279 . . . . 64.15 108.167 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -97.84 92.53 5.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.091 -1.448 . . . . 73.23 107.091 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.3 137.35 37.15 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.453 -0.943 . . . . 74.14 108.453 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.414 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.2 p -148.78 130.26 14.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.321 0.581 . . . . 75.44 111.782 -170.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' D' ' 73' ' ' ALA . 59.5 mt -98.31 107.67 20.18 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.694 1.198 . . . . 73.15 108.316 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.9 -134.58 22.05 Favored Glycine 0 C--N 1.343 0.932 0 O-C-N 123.536 0.523 . . . . 64.33 112.272 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.32 4.54 38.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.669 0.787 . . . . 63.45 111.943 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.451 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 13.7 pt-20 -132.08 162.73 30.1 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.836 0.454 . . . . 75.42 110.608 -172.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.0 m -66.83 136.4 55.36 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.148 -0.933 . . . . 71.33 111.552 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.437 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . . . -90.12 -56.44 3.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.931 -1.137 . . . . 73.51 107.931 169.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -162.62 144.42 10.47 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.201 -1.363 . . . . 71.34 109.802 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -110.53 111.52 22.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.832 0.853 . . . . 74.43 108.785 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.604 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 20.2 t -127.09 127.71 45.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.012 0.525 . . . . 75.23 109.936 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -148.38 139.77 23.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.431 0.692 . . . . 75.53 109.74 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' D' ' 113' ' ' CYS . 99.1 t -132.87 124.67 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.435 0.694 . . . . 70.21 109.678 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.76 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.8 mt-30 -91.74 88.32 6.64 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.751 -0.833 . . . . 74.43 108.751 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -80.05 109.71 14.75 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 114.401 -1.272 . . . . 75.05 108.353 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.07 166.8 21.33 Favored Glycine 0 C--O 1.241 0.545 0 N-CA-C 111.946 -0.462 . . . . 70.24 111.946 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.15 140.24 6.11 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.002 -0.839 . . . . 73.22 111.002 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -88.71 126.25 41.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.81 -0.811 . . . . 71.13 108.81 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -124.61 124.71 42.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.104 0.561 . . . . 74.3 109.965 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -93.28 111.34 22.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.052 0.941 . . . . 72.2 108.809 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 42.2 pt -116.68 142.98 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.237 0.615 . . . . 75.31 111.431 -172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.433 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -157.93 160.64 37.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.858 1.263 . . . . 65.21 108.585 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.75 22.4 78.12 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 123.062 0.226 . . . . 74.23 113.404 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' D' ' 94' ' ' MET . 1.2 pp -113.1 148.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.311 1.044 . . . . 75.21 109.959 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.27 146.41 32.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.34 0.656 . . . . 74.34 111.152 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 35.45 -97.65 0.01 OUTLIER Glycine 0 C--N 1.359 1.828 0 N-CA-C 116.494 1.357 . . . . 62.04 116.494 169.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -64.25 -53.82 43.15 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.722 1.209 . . . . 64.31 110.934 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.46 -31.06 71.94 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.94 -1.027 . . . . 64.03 110.876 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.608 ' HG2' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -71.96 -54.71 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.421 1.088 . . . . 61.23 109.915 -178.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.72 -25.79 68.36 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.835 -1.075 . . . . 65.14 111.563 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.67 -44.89 18.08 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.969 0.508 . . . . 70.12 111.01 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.9 -43.27 96.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.032 0.533 . . . . 73.14 111.033 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 tt -92.77 -33.39 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 73.34 110.682 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -20.73 57.36 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.401 0.52 . . . . 64.3 114.401 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.24 -49.86 1.1 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.577 0.689 . . . . 63.43 111.851 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -73.4 -45.01 57.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.868 0.467 . . . . 73.0 111.473 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 93.2 m -61.5 -48.04 91.64 Favored Pre-proline 0 CA--C 1.567 1.6 0 CA-C-O 118.286 -0.864 . . . . 64.44 111.637 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.8 Cg_exo -56.9 -38.17 96.55 Favored 'Trans proline' 0 C--N 1.399 3.228 0 C-N-CA 122.353 2.035 . . . . 64.52 113.366 168.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.91 -32.35 73.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.365 0.666 . . . . 70.53 111.251 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.65 -41.5 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.55 0.74 . . . . 62.51 110.259 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 61.7 mt -75.14 -23.52 57.83 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.152 -0.931 . . . . 74.04 111.607 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.405 ' HZ ' HD11 ' D' ' 128' ' ' LEU . 66.4 t80 -60.64 -45.39 97.07 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.733 1.382 . . . . 73.33 114.733 -169.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.12 -42.63 58.15 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 122.118 1.879 . . . . 72.23 112.816 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -76.49 -35.65 58.25 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.921 -1.036 . . . . 71.31 110.724 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.57 78.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.896 0.878 . . . . 62.31 110.905 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.401 HH12 ' HB3' ' D' ' 130' ' ' PRO . 28.8 ttp180 -58.87 -55.09 39.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.448 1.093 . . . . 75.52 109.956 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.56 -40.32 86.9 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.273 0.983 . . . . 75.51 111.895 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.496 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -59.28 -42.71 91.86 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.02 0.825 . . . . 53.34 110.333 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.577 HG23 HG22 ' D' ' 64' ' ' VAL . 66.5 mt -63.65 -52.02 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.018 0.927 . . . . 75.42 110.364 172.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.8 m -53.66 -43.61 68.96 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.361 1.464 . . . . 70.43 112.099 -172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -68.48 -43.05 77.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.011 -0.995 . . . . 71.02 110.377 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.604 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.7 mtm -66.35 -30.92 71.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.868 0.467 . . . . 75.23 111.964 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.426 HG22 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -71.02 -42.39 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.391 0.676 . . . . 75.12 110.397 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -71.06 -29.95 65.97 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 116.553 -0.294 . . . . 74.24 110.442 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -69.74 -28.67 65.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.762 0.825 . . . . 75.43 110.148 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 11.09 62.91 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.717 0.636 . . . . 74.1 112.922 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.539 HG22 ' HB3' ' C' ' 17' ' ' TYR . 75.1 p 56.06 25.12 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.292 1.837 . . . . 75.52 113.46 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.454 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 28.2 m-85 -103.34 166.22 12.18 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 125.055 1.342 . . . . 72.41 109.687 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 34.2 Cg_endo -59.23 124.71 16.19 Favored 'Trans proline' 0 C--N 1.394 2.933 0 C-N-CA 123.052 2.501 . . . . 75.23 112.791 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -55.16 119.64 5.8 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 123.883 0.74 . . . . 73.31 109.869 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.01 98.41 8.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.327 0.584 . . . . 73.1 109.831 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 79.6 m-20 -99.13 86.3 3.41 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.006 -1.109 . . . . 74.41 108.006 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.405 HD11 ' HZ ' ' D' ' 107' ' ' PHE . 1.0 OUTLIER -72.59 138.16 46.64 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.934 -1.03 . . . . 74.22 109.896 -173.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 131.5 95.21 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.993 0.517 . . . . 73.42 111.891 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HB3' HH12 ' D' ' 111' ' ' ARG . 58.4 Cg_endo -78.3 119.44 4.58 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.906 1.737 . . . . 72.4 110.072 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.75 120.22 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.63 0.728 . . . . 72.53 110.031 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 108.316 -0.994 . . . . 72.14 108.316 176.43 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.674 -0.862 . . . . 75.11 108.674 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -126.59 116.57 21.24 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.07 -1.085 . . . . 75.51 108.07 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -137.55 110.66 7.79 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.701 0.8 . . . . 64.04 108.997 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.91 125.29 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 171.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -88.55 -33.4 17.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.152 -0.685 . . . . 62.44 109.152 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -172.61 145.31 1.54 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.34 0.4 . . . . 74.42 110.901 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -121.81 129.96 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.912 -1.144 . . . . 74.51 107.912 168.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 38.9 p90 -163.6 159.13 21.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.607 0.763 . . . . 74.43 110.751 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -84.92 118.53 24.58 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.354 -0.61 . . . . 74.04 109.354 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.62 ' HZ3' ' HB1' ' B' ' 28' ' ' ALA . 23.6 mtpp -78.7 -40.64 33.2 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.752 -0.833 . . . . 75.12 108.752 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -136.42 142.17 43.65 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.985 -1.007 . . . . 75.01 110.234 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.534 HG21 ' SD ' ' B' ' 117' ' ' MET . 74.7 mt -139.84 140.72 35.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.56 1.544 . . . . 73.33 107.271 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -154.05 116.18 4.3 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 75.25 109.289 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 69.8 t80 -111.24 122.62 48.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.523 -1.658 . . . . 74.11 106.523 166.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.58 130.85 56.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.645 -0.872 . . . . 72.23 108.645 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.53 79.14 73.86 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.102 -1.814 . . . . 74.51 106.102 165.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.6 -27.25 45.81 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.439 2.093 . . . . 75.12 111.149 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -111.33 31.89 5.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.338 -1.301 . . . . 71.33 109.12 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.76 99.85 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.681 0.993 . . . . 71.21 113.681 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.52 -22.94 17.77 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 121.905 1.737 . . . . 71.24 113.415 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.45 -39.52 70.92 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.188 0.595 . . . . 75.15 111.011 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 73' ' ' ALA . 28.2 m -73.3 -15.64 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.352 0.661 . . . . 73.21 112.045 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.457 ' HD1' ' HD2' ' B' ' 15' ' ' ARG . 79.3 t80 -61.94 -38.92 90.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.784 0.834 . . . . 72.43 110.849 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -100.75 -13.26 18.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.239 0.616 . . . . 70.41 112.016 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.7 mmtp -83.29 150.71 25.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 117.977 0.353 . . . . 75.21 111.724 175.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.49 132.19 45.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.099 0.96 . . . . 74.42 109.895 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.504 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -77.63 93.44 4.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.216 0.531 . . . . 74.14 110.162 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' H ' HD23 ' A' ' 68' ' ' LEU . 8.5 tt0 -125.13 82.82 61.4 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.183 1.393 . . . . 75.34 107.745 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.4 114.32 3.77 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.537 2.158 . . . . 71.35 112.852 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -94.74 90.5 6.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.238 -1.764 . . . . 74.03 106.238 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.39 130.53 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.327 -0.851 . . . . 73.2 110.499 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.0 tttm -119.59 115.04 23.18 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.722 -1.214 . . . . 71.13 107.722 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.31 123.95 45.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.829 0.851 . . . . 73.11 109.222 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.486 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -118.84 109.21 15.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.989 0.916 . . . . 71.02 109.569 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.77 120.53 40.23 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.604 -0.887 . . . . 71.53 108.604 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -154.46 162.46 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.395 -0.594 . . . . 71.41 109.395 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -134.25 164.05 28.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.158 0.583 . . . . 72.35 110.842 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.79 108.27 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.826 -1.176 . . . . 73.24 107.826 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.8 m -109.9 152.44 25.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.135 0.574 . . . . 72.2 110.339 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.9 t -157.11 142.86 17.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.48 0.712 . . . . 65.43 110.062 -172.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -90.68 118.96 30.53 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.938 -0.764 . . . . 74.42 108.938 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 57' ' ' GLU . 71.3 mt -90.14 -39.64 12.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.086 0.555 . . . . 73.33 110.569 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.96 -174.09 3.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.789 0.836 . . . . 75.31 110.415 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.04 120.2 13.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.34 -0.985 . . . . 74.1 108.34 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 69.25 3.48 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.59 1.156 . . . . 54.23 112.811 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.32 114.59 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.821 -1.177 . . . . 72.34 107.821 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -142.58 133.05 25.02 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.488 -0.93 . . . . 74.15 108.488 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 51' ' ' LEU . 75.4 tt0 -114.09 120.14 39.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.737 0.415 . . . . 73.54 110.55 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -100.69 121.81 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.114 -1.81 . . . . 73.42 106.114 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -106.18 134.97 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.975 -0.75 . . . . 72.2 108.975 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.53 114.89 26.59 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.254 -1.017 . . . . 75.25 108.254 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -101.77 99.94 10.23 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.824 -0.806 . . . . 74.42 108.824 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.84 137.69 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 107.795 -1.187 . . . . 73.54 107.795 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.9 m -129.55 124.63 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.624 -0.88 . . . . 74.02 108.624 171.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.37 130.62 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 107.828 -1.175 . . . . 74.53 107.828 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 7.3 m -121.98 148.15 45.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.763 -1.569 . . . . 75.45 106.763 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.07 124.29 14.57 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.967 -1.123 . . . . 72.45 107.967 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 48.5 m -122.4 141.45 51.58 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 123.205 0.602 . . . . 73.11 110.298 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.504 HD21 ' CE3' ' A' ' 36' ' ' TRP . 51.1 mt -90.68 52.6 2.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.335 1.054 . . . . 75.3 109.791 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.14 -85.46 0.91 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.217 -0.901 . . . . 74.12 111.825 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -88.29 -31.09 19.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.443 0.697 . . . . 73.13 111.309 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.96 124.49 46.08 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 118.79 -0.624 . . . . 75.23 109.687 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.6 m -65.97 132.53 48.82 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.274 0.359 . . . . 65.24 110.797 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -75.51 -53.87 7.93 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.0 0.813 . . . . 75.01 109.697 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -164.06 169.77 17.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.583 -1.19 . . . . 74.23 111.304 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 tp -130.21 148.17 52.01 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.985 -1.461 . . . . 74.14 107.444 167.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.431 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -142.35 134.55 27.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.127 -1.064 . . . . 70.44 108.127 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -145.93 119.9 9.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.313 -0.995 . . . . 73.04 108.313 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.43 126.76 64.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.082 0.953 . . . . 75.32 109.635 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -104.99 90.15 3.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.044 -0.98 . . . . 74.01 108.781 172.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' O ' HD11 ' A' ' 106' ' ' LEU . 8.0 tp-100 -76.83 97.64 4.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.929 -1.137 . . . . 74.31 107.929 173.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.82 143.52 20.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.122 -0.791 . . . . 71.25 111.122 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.429 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.61 120.87 1.74 Allowed Glycine 0 CA--C 1.495 -1.163 0 N-CA-C 110.304 -1.118 . . . . 73.24 110.304 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -83.96 125.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.791 -1.189 . . . . 75.52 107.791 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.57 118.03 23.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.197 0.999 . . . . 73.53 108.331 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -87.5 100.11 12.53 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.161 -1.422 . . . . 75.22 107.161 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.6 HG21 HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -134.07 118.39 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.706 -0.679 . . . . 72.21 110.128 -168.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.8 177.67 11.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.727 1.211 . . . . 75.42 109.85 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.58 74.09 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 120.883 0.157 . . . . 43.02 112.958 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 94' ' ' MET . 1.1 pp -129.45 161.35 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.311 1.444 . . . . 72.31 110.169 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.69 171.18 14.46 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.542 0.737 . . . . 73.24 109.965 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.13 -120.0 2.11 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.387 1.315 . . . . 73.01 116.387 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -76.21 -15.97 59.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.994 0.918 . . . . 63.32 112.695 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.53 -50.86 69.67 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.583 -0.525 . . . . 75.2 109.583 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.607 ' HE2' HD11 ' A' ' 98' ' ' LEU . 14.4 ttt -74.22 -32.71 63.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.114 -0.948 . . . . 73.54 110.756 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.74 92.31 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.123 0.487 . . . . 60.31 111.137 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.01 -37.99 78.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.778 0.831 . . . . 74.34 110.668 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.82 -63.38 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.514 -0.766 . . . . 72.34 110.198 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.607 HD11 ' HE2' ' A' ' 94' ' ' MET . 53.8 mt -71.23 -22.78 61.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.251 0.62 . . . . 75.52 111.967 -176.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.6 -28.57 46.89 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.435 0.46 . . . . 71.03 113.887 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.93 -52.38 0.62 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.347 0.573 . . . . 72.24 112.397 -173.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -64.26 -54.42 33.58 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.328 0.651 . . . . 75.54 112.602 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.415 ' SG ' HD21 ' A' ' 98' ' ' LEU . 52.9 m -65.91 -46.45 64.86 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 123.839 0.856 . . . . 71.23 112.645 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.3 Cg_endo -66.32 -24.36 50.53 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 121.587 1.525 . . . . 72.44 112.852 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -74.32 -28.76 61.3 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.107 0.412 . . . . 73.34 111.032 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.42 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 19.6 mt -60.75 -43.07 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 121.369 0.604 . . . . 73.04 109.539 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.429 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.3 mt -70.53 -19.14 62.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.533 -1.212 . . . . 75.01 112.193 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -70.46 -42.49 15.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-O 117.563 -1.208 . . . . 74.44 113.6 -169.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 99.0 Cg_exo -49.43 -35.1 35.06 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.045 1.83 . . . . 72.44 114.022 168.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -84.74 -37.49 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.296 0.638 . . . . 72.43 111.439 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.33 -42.6 79.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.158 0.504 . . . . 71.44 109.984 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -53.37 -57.26 11.22 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.497 1.519 . . . . 75.44 109.909 171.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.35 -36.58 84.61 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.393 1.058 . . . . 64.24 111.671 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.23 -48.79 80.25 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.183 0.593 . . . . 71.34 110.026 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.89 -44.8 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 115.049 -0.978 . . . . 73.51 110.793 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 125' ' ' GLN . 60.2 m -57.55 -40.73 79.54 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.924 0.889 . . . . 74.45 111.116 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 t -69.0 -46.64 67.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.164 -0.925 . . . . 74.21 110.412 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.6 mtp -56.82 -40.69 76.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.764 0.825 . . . . 65.23 111.81 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.5 t -65.19 -46.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.506 1.123 . . . . 71.22 110.719 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -71.34 -26.49 62.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.598 0.359 . . . . 71.01 111.621 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.7 mtt-85 -73.2 -32.57 64.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.73 0.812 . . . . 73.24 110.082 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 4.4 60.25 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.999 -0.546 . . . . 74.42 112.901 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 m 68.07 44.19 1.5 Allowed 'General case' 0 C--N 1.36 1.052 0 CA-C-O 122.721 1.248 . . . . 72.34 110.268 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.9 149.13 50.22 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 114.769 -1.105 . . . . 74.14 108.955 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.29 141.58 93.34 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.087 1.858 . . . . 63.5 110.633 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -61.41 159.74 12.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.286 1.034 . . . . 73.53 112.448 -168.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.55 102.25 6.29 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 74.33 108.348 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -98.17 94.24 6.69 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.173 -0.676 . . . . 74.33 109.173 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 134.99 57.52 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.63 0.772 . . . . 72.14 110.906 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 139.45 91.74 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.162 0.585 . . . . 72.24 112.176 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.86 97.55 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.461 2.107 . . . . 72.33 109.991 177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.13 112.76 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.647 -0.872 . . . . 72.02 108.647 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.57 87.84 3.47 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.806 -0.634 . . . . 75.4 110.434 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.475 0.813 0 CA-C-N 115.611 -0.722 . . . . 72.14 109.259 169.499 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 110.018 -0.364 . . . . 70.33 110.018 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -131.96 113.58 13.58 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.622 -1.251 . . . . 63.13 107.622 172.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 21.2 tp60 -127.87 98.66 5.23 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.388 0.613 . . . . 72.52 109.983 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 tt -78.61 119.68 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 115.393 -0.821 . . . . 75.15 109.733 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.85 -48.35 7.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.049 0.54 . . . . 75.42 110.562 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.457 ' HD2' ' HD1' ' A' ' 32' ' ' PHE . 55.2 ttt180 -165.26 142.91 5.99 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.484 -0.325 . . . . 75.23 110.563 -172.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.2 mt -114.5 142.93 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.449 -1.315 . . . . 72.13 107.449 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -164.83 158.44 17.4 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.031 0.443 . . . . 74.34 110.567 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.512 HG21 HD13 ' B' ' 21' ' ' ILE . 89.5 m -85.62 123.36 30.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.158 -0.682 . . . . 72.44 109.158 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.425 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 30.9 mtpt -88.09 -35.87 17.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.453 -0.794 . . . . 72.21 111.183 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -161.92 147.89 13.49 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.999 0.428 . . . . 63.14 111.013 -173.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.512 HD13 HG21 ' B' ' 18' ' ' THR . 38.7 mm -142.33 145.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.101 1.76 . . . . 73.12 108.093 -175.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -154.44 148.43 25.69 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.676 0.61 . . . . 73.22 110.217 170.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 88.2 t80 -156.12 107.22 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.166 -1.42 . . . . 74.02 107.166 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.71 118.58 28.41 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.446 0.699 . . . . 72.41 109.793 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.12 87.89 9.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.429 1.092 . . . . 70.11 109.821 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 37.5 Cg_endo -63.67 -41.55 24.42 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.65 2.233 . . . . 75.52 113.072 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -106.27 31.51 5.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.58 0.752 . . . . 72.12 110.036 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.62 ' HB1' ' HZ3' ' A' ' 19' ' ' LYS . . . -48.59 -48.11 69.17 Favored Pre-proline 0 CA--C 1.573 1.855 0 C-N-CA 125.217 1.407 . . . . 75.42 114.698 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HG3' ' HZ1' ' A' ' 19' ' ' LYS . 89.9 Cg_endo -92.66 -5.34 3.27 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.086 1.857 . . . . 65.12 113.087 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -98.4 -0.47 43.58 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.689 0.796 . . . . 70.31 110.814 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.99 -28.02 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.39 1.076 . . . . 71.13 111.089 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -71.23 -18.25 62.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.878 0.871 . . . . 74.25 112.519 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.33 -41.01 79.18 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.396 0.617 . . . . 74.14 109.887 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.515 ' HB2' HD11 ' B' ' 68' ' ' LEU . 81.4 mttt -108.73 106.74 16.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.58 -1.191 . . . . 72.42 108.465 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.44 79.28 1.91 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.74 0.781 . . . . 73.11 110.13 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -153.52 151.37 29.73 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.996 -1.483 . . . . 71.52 106.996 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -90.64 114.93 62.97 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.507 -1.664 . . . . 72.11 106.507 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.53 131.36 37.72 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.305 2.004 . . . . 71.0 111.978 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 120.41 14.05 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.914 0.759 . . . . 73.53 109.107 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.804 HG11 HD21 ' B' ' 126' ' ' LEU . 2.1 t -86.02 118.74 33.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 106.503 -1.666 . . . . 75.52 106.503 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -138.46 134.92 34.64 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.496 -0.557 . . . . 71.44 109.496 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' B' ' 128' ' ' LEU . 0.7 OUTLIER -128.96 156.63 43.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.248 0.619 . . . . 73.02 112.393 -169.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.19 141.32 48.03 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.932 1.293 . . . . 65.54 108.622 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.2 tp -85.61 136.57 33.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.655 0.782 . . . . 75.11 110.99 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.9 m-20 -129.77 144.27 51.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.988 -1.116 . . . . 74.45 107.988 172.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.9 m -130.18 125.64 35.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.296 0.638 . . . . 72.32 109.968 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.418 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -132.23 159.07 40.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.169 0.988 . . . . 63.25 109.11 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 62.1 m -143.01 168.91 18.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.071 0.549 . . . . 73.01 109.98 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.5 t -151.45 164.35 36.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.515 1.126 . . . . 75.41 108.408 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -124.05 124.11 41.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.082 0.553 . . . . 72.43 109.54 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.518 HD12 HG22 ' B' ' 83' ' ' ILE . 85.7 mt -93.41 -28.55 16.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.342 0.657 . . . . 74.13 110.783 176.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.93 -171.48 0.75 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 71.04 111.223 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.48 113.14 4.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.615 -1.175 . . . . 74.21 110.152 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 75.93 -5.15 2.23 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.773 2.029 . . . . 73.05 112.09 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 51.1 t -104.86 99.73 9.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 108.106 -1.072 . . . . 74.24 108.106 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.91 168.48 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.513 0.673 . . . . 75.43 110.062 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -138.41 100.06 4.01 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.402 -1.703 . . . . 63.31 106.402 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.46 128.82 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.197 0.599 . . . . 64.22 109.739 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' B' ' 47' ' ' ALA . 47.1 t -105.37 145.07 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.006 0.922 . . . . 73.41 109.815 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 112.96 18.99 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.443 -1.688 . . . . 75.04 106.443 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 34.0 ttm180 -102.83 130.84 49.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.06 -0.718 . . . . 72.35 109.06 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.458 HG12 HD13 ' B' ' 42' ' ' LEU . 50.7 t -121.14 108.83 23.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 107.218 -1.401 . . . . 73.24 107.218 169.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -98.28 136.79 37.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.167 0.508 . . . . 74.1 109.93 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 89.8 t -122.97 137.98 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.195 1.398 . . . . 71.14 110.705 -169.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 57.4 m -123.9 151.38 43.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.873 1.269 . . . . 73.23 109.038 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.04 146.87 31.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.686 0.795 . . . . 41.53 108.913 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 67.3 p -153.68 158.72 41.47 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 75.04 111.554 -171.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' B' ' 34' ' ' LYS . 72.6 mt -128.27 107.0 9.41 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.581 -1.266 . . . . 74.42 107.581 169.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.8 -110.6 3.21 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 123.422 0.451 . . . . 73.13 112.322 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -110.0 0.25 18.42 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.54 0.736 . . . . 75.24 111.517 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.61 159.19 28.36 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.504 -0.747 . . . . 65.24 111.358 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -73.9 139.08 44.72 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.434 -0.803 . . . . 52.23 110.488 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.96 -53.67 3.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.149 -1.056 . . . . 53.24 108.149 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.509 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 46.0 p90 -156.44 170.16 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.724 -1.125 . . . . 73.1 110.415 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.65 155.14 48.54 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.68 1.592 . . . . 65.22 107.939 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.56 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 54.1 t -152.91 158.67 42.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.125 -0.694 . . . . 73.45 109.125 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -155.76 137.94 14.69 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.723 -1.214 . . . . 74.01 107.723 171.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.0 146.38 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.303 0.641 . . . . 72.22 109.277 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -129.65 99.24 5.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.783 0.833 . . . . 64.12 108.969 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -91.42 106.47 18.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.42 -0.809 . . . . 70.43 109.394 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.92 168.11 21.15 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.839 -0.505 . . . . 62.24 111.839 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.45 129.86 2.11 Favored Glycine 0 C--O 1.236 0.28 0 N-CA-C 111.005 -0.838 . . . . 63.22 111.005 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.518 HG22 HD12 ' B' ' 51' ' ' LEU . 45.0 mt -85.15 115.65 27.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.604 -0.887 . . . . 74.43 108.604 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.89 131.76 52.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.526 -0.916 . . . . 75.21 108.526 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -107.71 106.9 17.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.329 -0.989 . . . . 73.21 108.329 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -128.35 144.8 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.797 0.839 . . . . 75.42 111.277 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.73 171.92 19.43 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.348 1.059 . . . . 74.53 109.183 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.68 -48.33 2.06 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.368 -0.378 . . . . 74.24 112.733 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 163.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.533 0.733 . . . . 70.22 110.177 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 158.11 21.19 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.732 0.413 . . . . 72.22 111.529 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -113.72 5.45 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.858 0.724 . . . . 63.51 114.298 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.4 m -66.08 -38.29 87.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.318 1.047 . . . . 75.43 110.471 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.66 -31.32 66.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.674 -1.148 . . . . 75.12 110.002 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.5 tpt -70.39 -43.19 70.6 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.942 0.897 . . . . 70.25 109.945 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.63 67.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.196 -0.911 . . . . 72.32 111.278 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -83.51 -29.19 28.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.802 0.841 . . . . 73.42 110.561 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -68.98 -61.96 1.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.285 0.634 . . . . 72.24 110.789 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.73 -12.66 25.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.828 0.677 . . . . 73.23 112.828 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.68 1.42 42.19 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-O 119.92 -0.378 . . . . 75.21 113.66 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.1 -58.27 0.31 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.173 0.486 . . . . 73.23 111.114 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.409 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 52.7 t80 -74.66 -45.32 45.47 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.106 -0.497 . . . . 75.03 111.798 -172.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.537 ' HA ' HD12 ' B' ' 105' ' ' ILE . 99.8 m -63.64 -46.26 82.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.422 -0.799 . . . . 74.42 111.734 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.58 -39.19 92.47 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.777 1.651 . . . . 75.53 113.226 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.22 -30.54 71.66 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 123.014 0.525 . . . . 74.11 111.83 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' B' ' 102' ' ' CYS . 96.7 mt -64.43 -47.46 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.389 1.076 . . . . 75.31 110.41 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 mt -81.6 -12.62 58.67 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.345 -1.298 . . . . 65.12 111.384 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.452 ' HE2' ' HA ' ' B' ' 130' ' ' PRO . 26.1 t80 -63.29 -49.94 77.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.944 1.298 . . . . 72.2 113.084 -170.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.2 -33.25 95.0 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.867 1.711 . . . . 74.43 113.073 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.467 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 81.7 m-85 -66.11 -48.26 71.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.023 0.529 . . . . 74.42 110.837 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -40.88 97.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.954 0.902 . . . . 72.51 110.961 177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -55.57 -52.61 63.17 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.317 1.047 . . . . 73.22 110.454 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.31 -39.83 92.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.197 -0.91 . . . . 65.41 111.33 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.501 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.6 t -70.74 -43.43 68.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.871 -0.604 . . . . 75.21 111.559 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.447 HG22 HG22 ' B' ' 64' ' ' VAL . 95.5 mt -63.11 -46.78 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 122.815 0.446 . . . . 74.22 110.474 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.402 HG23 ' CB ' ' C' ' 119' ' ' SER . 22.6 m -52.24 -41.18 62.57 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.81 0.693 . . . . 74.24 111.092 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.9 t -62.7 -53.92 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.927 -0.578 . . . . 71.52 110.383 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 21' ' ' ILE . 36.8 mmt -59.49 -44.58 93.04 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.208 0.603 . . . . 62.44 111.76 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.04 -40.47 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.513 1.125 . . . . 74.22 111.235 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 94.3 p -70.52 -31.91 69.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.422 -0.354 . . . . 53.31 110.834 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.1 mtt-85 -63.12 -27.73 69.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.321 0.648 . . . . 72.21 111.063 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.13 10.55 63.02 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 123.632 0.582 . . . . 72.31 113.059 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 17' ' ' TYR . 30.2 p 64.62 44.06 4.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.749 2.019 . . . . 75.21 112.377 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.54 161.87 35.32 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.385 0.674 . . . . 73.34 110.908 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.433 ' HA ' ' OE1' ' C' ' 125' ' ' GLN . 32.1 Cg_exo -62.25 172.89 3.73 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.496 2.797 . . . . 65.13 114.326 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.681 ' HB3' ' HG3' ' C' ' 125' ' ' GLN . 12.9 pm0 -64.57 154.99 34.55 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 115.28 -0.873 . . . . 74.53 111.841 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.804 HD21 HG11 ' B' ' 40' ' ' VAL . 23.0 tp -142.48 83.98 1.84 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.477 -0.935 . . . . 63.51 108.477 165.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.84 106.31 13.69 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.037 -1.468 . . . . 74.24 107.037 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' B' ' 42' ' ' LEU . 4.0 tt -55.26 136.53 48.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.724 -1.125 . . . . 75.21 109.336 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.93 140.17 21.07 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 124.034 0.834 . . . . 52.34 110.985 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.496 ' HG2' ' HB ' ' D' ' 16' ' ' ILE . 25.8 Cg_exo -65.13 71.62 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.15 2.567 . . . . 74.53 113.242 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.62 85.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.298 -1.001 . . . . 71.15 108.298 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.428 ' ND2' HG22 ' D' ' 105' ' ' ILE . 2.1 m-20 -78.38 113.11 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.541 -0.911 . . . . 75.04 108.541 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 123.963 0.905 . . . . 75.54 110.709 175.018 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m . . . . . 0 C--O 1.239 0.545 0 N-CA-C 109.109 -0.7 . . . . 75.34 109.109 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 72.8 t80 -96.36 131.94 42.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.611 -0.885 . . . . 75.11 108.611 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -139.83 124.4 18.19 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.147 0.579 . . . . 71.43 109.878 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -93.35 133.24 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.535 0.734 . . . . 73.01 109.262 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -105.17 -45.96 4.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.618 0.767 . . . . 73.43 110.371 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -167.81 124.35 1.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.999 -0.371 . . . . 75.53 109.999 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.22 135.45 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.552 -0.907 . . . . 75.11 108.552 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.42 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 27.3 p90 -173.45 163.13 4.39 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.176 0.59 . . . . 71.35 109.804 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -85.78 124.28 32.1 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.812 0.445 . . . . 73.21 110.374 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.598 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.2 mmtp -78.1 -49.95 12.94 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.869 0.842 . . . . 70.11 108.977 170.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -135.41 142.47 45.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.989 -1.459 . . . . 72.51 109.38 -169.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.4 mt -143.99 146.13 21.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.714 -1.587 . . . . 74.52 106.714 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -159.7 149.75 18.65 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.266 0.555 . . . . 73.02 110.42 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -142.65 116.5 9.3 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.614 -1.254 . . . . 75.55 107.614 171.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.57 126.21 52.97 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.847 0.859 . . . . 75.14 109.725 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 81.32 70.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 107.998 -1.112 . . . . 70.23 107.998 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.22 -25.74 42.75 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.131 2.554 . . . . 73.31 112.194 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.25 26.72 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.985 0.914 . . . . 72.15 110.44 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.16 -53.5 22.09 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.161 1.171 . . . . 74.35 114.161 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -81.33 -18.74 8.29 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 121.566 1.511 . . . . 74.52 113.824 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.57 -49.26 42.24 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.303 0.641 . . . . 64.41 111.472 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -77.83 -13.37 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.802 1.241 . . . . 74.51 111.4 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.554 ' HE2' ' HD3' ' D' ' 15' ' ' ARG . 79.3 t80 -53.93 -43.06 69.46 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.322 1.049 . . . . 75.23 112.24 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -103.94 27.59 7.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.637 0.732 . . . . 74.32 110.046 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.11 165.18 11.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.404 0.682 . . . . 75.43 109.411 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.35 120.55 24.54 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.99 -0.744 . . . . 64.22 108.99 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -85.56 88.96 7.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.585 0.754 . . . . 71.24 110.688 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.417 ' H ' HD23 ' C' ' 68' ' ' LEU . 35.0 tt0 -128.75 74.32 80.69 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 107.768 -1.197 . . . . 75.24 107.768 169.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.82 143.21 4.18 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.503 2.802 . . . . 75.04 113.404 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.89 115.38 25.31 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.251 -1.018 . . . . 74.33 108.251 167.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.468 HG11 HD21 ' C' ' 128' ' ' LEU . 26.1 t -83.32 85.42 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.05 -0.722 . . . . 73.55 109.05 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -93.87 100.94 13.02 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.746 -1.205 . . . . 70.24 107.746 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.27 154.53 19.65 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.144 -0.688 . . . . 74.54 109.144 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.488 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -120.9 145.33 47.77 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.437 1.095 . . . . 74.44 108.19 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.5 tp -117.73 134.45 54.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.749 0.82 . . . . 70.23 108.861 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.15 150.08 27.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.222 -1.029 . . . . 74.24 108.222 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 91.6 m -137.95 123.97 20.23 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.096 -0.705 . . . . 75.41 109.096 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.98 23.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.287 1.035 . . . . 63.42 108.497 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 p -145.27 144.37 30.74 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.748 0.419 . . . . 72.0 110.455 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -145.1 129.77 18.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.919 0.888 . . . . 72.11 109.109 -176.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -76.95 131.86 38.73 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.527 -0.546 . . . . 74.42 109.527 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.552 HD12 HD13 ' C' ' 83' ' ' ILE . 35.4 mt -106.46 -42.71 4.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.681 . . . . 74.05 109.568 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.78 -177.11 5.41 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.45 -1.25 . . . . 73.24 109.138 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.99 109.08 6.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.053 -0.522 . . . . 73.24 109.935 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.86 18.04 11.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.039 1.336 . . . . 75.21 112.222 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.93 114.48 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.66 -1.608 . . . . 74.11 106.66 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.424 ' HE2' HG12 ' C' ' 86' ' ' ILE . 43.6 p90 -134.64 -178.74 5.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.656 0.741 . . . . 64.34 110.95 -174.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' C' ' 51' ' ' LEU . 23.9 tt0 -126.34 113.24 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.877 -1.511 . . . . 74.13 108.904 -170.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.9 129.52 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.219 -1.03 . . . . 75.31 108.219 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.1 106.36 16.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.486 -1.302 . . . . 64.53 107.486 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.1 OUTLIER -86.13 103.09 14.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.066 -1.087 . . . . 71.23 108.066 -177.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -84.83 106.11 16.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.768 0.827 . . . . 74.04 109.349 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.84 130.73 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 5.8 m -116.8 148.31 41.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.041 -1.096 . . . . 64.43 108.041 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.674 HG23 HG21 ' C' ' 114' ' ' ILE . 46.1 t -132.91 110.43 15.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.872 -1.159 . . . . 73.55 107.872 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m -102.57 139.02 38.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.0 -0.741 . . . . 74.4 109.0 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.53 112.75 15.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.513 -1.291 . . . . 65.1 107.513 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -129.82 130.03 44.78 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.346 0.404 . . . . 72.52 110.256 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.417 HD23 ' H ' ' C' ' 37' ' ' GLN . 41.7 mt -87.29 27.88 1.01 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.961 1.304 . . . . 75.54 110.906 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.22 -103.1 1.92 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.933 -0.867 . . . . 70.12 110.933 -171.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.69 -29.37 18.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.979 0.512 . . . . 74.2 110.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.82 121.12 22.92 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.977 0.911 . . . . 74.22 110.146 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.2 m -80.81 124.76 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.789 -0.819 . . . . 74.24 108.789 166.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.69 -51.16 9.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.405 -0.816 . . . . 73.22 109.973 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -166.53 176.45 7.31 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.263 -0.881 . . . . 74.12 110.729 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -143.4 141.4 30.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.906 -1.516 . . . . 73.53 106.906 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.493 ' SG ' HG22 ' C' ' 114' ' ' ILE . 42.0 t -147.4 125.4 12.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.864 0.465 . . . . 73.35 109.896 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -129.66 133.55 47.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.878 0.471 . . . . 64.33 110.122 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.51 137.83 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.024 0.93 . . . . 74.42 108.56 168.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.685 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -112.15 102.09 10.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.294 1.037 . . . . 74.42 108.665 171.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -86.93 108.98 19.04 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.452 -0.794 . . . . 75.02 110.251 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 150.21 25.76 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 123.232 0.332 . . . . 52.34 112.305 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.443 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.36 119.33 0.93 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.31 -0.716 . . . . 75.2 111.31 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.552 HD13 HD12 ' C' ' 51' ' ' LEU . 11.7 mm -84.82 124.66 40.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.52 -0.918 . . . . 74.21 108.52 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -132.12 126.35 33.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.656 0.782 . . . . 75.25 110.014 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -96.08 134.98 38.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.912 -1.144 . . . . 72.14 107.912 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.462 HD11 HG12 ' C' ' 89' ' ' ILE . 2.7 pp -131.87 162.65 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.536 0.684 . . . . 73.34 111.911 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.92 29.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.29 -1.323 . . . . 51.04 108.096 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.36 49.17 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.528 -1.151 . . . . 72.41 114.991 173.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.462 HG12 HD11 ' C' ' 86' ' ' ILE . 36.5 pt . . . . . 0 C--N 1.366 1.321 0 CA-C-N 118.489 1.144 . . . . 73.45 110.753 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 112.652 0.612 . . . . 65.23 112.652 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.5 ptm -82.74 5.88 19.94 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.307 0.643 . . . . 73.25 112.149 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.15 -21.38 2.64 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 72.32 110.929 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.549 1.14 . . . . 64.04 110.207 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.18 -60.46 2.22 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.224 0.61 . . . . 74.25 111.008 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.455 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.3 pp -75.01 -14.47 60.61 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.003 0.521 . . . . 72.24 112.392 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.63 6.96 68.02 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.933 -0.37 . . . . 63.45 113.246 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.16 -63.54 0.11 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.082 0.441 . . . . 74.34 111.607 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -69.75 -50.79 40.04 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.984 0.913 . . . . 74.31 112.639 -169.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.456 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -59.7 -47.14 98.22 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 118.7 -0.667 . . . . 64.42 112.314 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.47 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 33.2 Cg_exo -63.56 -34.73 63.1 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.858 1.705 . . . . 74.52 113.28 171.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -69.69 -22.07 63.45 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.718 0.407 . . . . 72.04 111.314 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -69.35 -41.43 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.215 0.606 . . . . 75.03 109.965 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.443 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.1 mt -78.2 -20.15 52.43 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.911 -1.041 . . . . 73.4 111.366 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -57.79 -51.56 80.84 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 113.855 1.057 . . . . 74.44 113.855 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.48 -34.94 99.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.851 1.7 . . . . 75.11 112.606 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.45 -43.32 77.3 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.32 0.648 . . . . 74.2 111.243 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.65 91.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.634 0.773 . . . . 70.45 110.48 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.22 -58.98 6.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.843 1.657 . . . . 75.24 110.615 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -33.2 73.88 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.392 0.433 . . . . 74.2 110.65 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -63.05 -33.34 75.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.147 0.579 . . . . 74.5 111.559 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.674 HG21 HG23 ' C' ' 64' ' ' VAL . 91.4 mt -75.04 -47.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 75.13 109.98 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.4 HG22 ' HB2' ' C' ' 125' ' ' GLN . 21.5 m -59.58 -28.5 67.2 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 115.252 -0.885 . . . . 54.24 111.183 -174.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.1 t -70.74 -50.43 36.27 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.321 -0.854 . . . . 73.11 110.155 170.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.559 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.98 -38.47 73.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.112 0.965 . . . . 71.22 113.323 -175.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.92 -36.27 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.337 -0.392 . . . . 73.54 110.604 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.402 ' CB ' HG23 ' B' ' 115' ' ' THR . 39.6 p -76.36 -22.08 55.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.797 0.439 . . . . 71.12 111.298 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 82.8 mtt-85 -68.39 -36.39 79.09 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 75.42 109.512 171.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.8 3.51 49.84 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.084 -0.962 . . . . 54.31 112.604 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.9 p 56.22 21.36 5.22 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 126.765 2.026 . . . . 72.41 112.321 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -97.84 161.24 26.36 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.516 1.126 . . . . 74.45 108.865 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.05 107.99 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.674 2.25 . . . . 72.42 111.734 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.681 ' HG3' ' HB3' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.62 155.97 17.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.846 0.716 . . . . 75.13 112.067 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -117.11 91.94 3.72 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.394 -0.965 . . . . 74.42 108.394 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -90.73 88.98 7.3 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.995 -1.483 . . . . 72.51 106.995 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.468 HD21 HG11 ' C' ' 40' ' ' VAL . 48.7 mt -79.55 142.66 35.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.52 -1.218 . . . . 73.32 112.093 -164.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.43 96.72 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.924 -1.034 . . . . 74.41 111.116 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.579 ' HG3' HD11 ' A' ' 16' ' ' ILE . 86.2 Cg_endo -75.26 -171.9 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.81 2.34 . . . . 73.33 113.875 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.72 117.15 7.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 114.185 -1.371 . . . . 72.43 107.412 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.41 65.72 9.33 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.246 0.546 . . . . 71.41 109.656 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.215 -0.758 0 N-CA-C 108.565 -0.902 . . . . 71.32 108.565 179.09 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.685 -0.487 . . . . 75.01 109.685 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.418 ' HD2' HG23 ' D' ' 86' ' ' ILE . 71.1 t80 -158.81 91.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.443 -1.317 . . . . 72.24 107.443 170.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.4 mt-30 -111.89 136.22 51.48 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.263 0.625 . . . . 75.51 109.707 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.3 131.92 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.02 -1.104 . . . . 71.54 108.02 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -106.29 -49.0 3.44 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.718 0.407 . . . . 62.3 111.456 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.554 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 62.2 ttt180 -178.46 134.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 122.262 0.225 . . . . 73.53 111.282 -174.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.496 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 3.0 mp -123.23 130.07 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.742 -1.207 . . . . 73.4 107.742 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -156.31 163.63 39.29 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 123.728 0.643 . . . . 75.2 111.842 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.02 110.11 10.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.736 -1.12 . . . . 74.13 109.634 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' D' ' 19' ' ' LYS . 46.0 mtpt -77.57 -32.81 54.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.86 -0.609 . . . . 73.24 109.734 172.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.737 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -146.4 138.41 24.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.79 -1.095 . . . . 53.15 109.718 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.559 HG21 ' HE1' ' C' ' 117' ' ' MET . 60.2 mt -137.15 147.75 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.528 1.131 . . . . 74.03 108.411 171.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -147.63 143.75 27.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.878 0.871 . . . . 63.4 108.668 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.504 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.3 t80 -147.54 124.98 11.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.919 -1.882 . . . . 74.41 105.919 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.61 142.01 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.735 0.814 . . . . 75.12 108.817 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.456 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -135.46 77.65 52.75 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 107.431 -1.322 . . . . 71.13 107.431 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.38 -28.89 17.54 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.748 2.299 . . . . 64.21 112.36 -172.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 50.8 m-20 -114.46 28.66 8.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.424 1.089 . . . . 65.13 109.338 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -60.25 -47.96 95.32 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.714 1.746 . . . . 75.5 115.714 -170.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.598 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 61.1 Cg_endo -80.94 -15.47 10.54 Favored 'Trans proline' 0 C--N 1.379 2.149 0 CA-C-N 122.021 1.757 . . . . 72.33 112.138 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.8 t-160 -68.41 -32.07 71.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.93 0.892 . . . . 70.41 108.918 167.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.466 HG21 HD12 ' D' ' 68' ' ' LEU . 12.9 t -68.08 -23.33 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.265 1.026 . . . . 75.53 111.499 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -55.66 -32.92 63.63 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 122.677 0.391 . . . . 75.13 111.67 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.85 -27.56 61.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.572 0.749 . . . . 74.13 111.42 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.499 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 66.1 mttt -97.12 111.21 23.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.839 0.856 . . . . 75.44 111.704 -174.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -108.02 52.32 0.72 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.947 1.299 . . . . 71.43 111.148 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -126.01 165.34 18.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.713 0.805 . . . . 65.52 108.94 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -81.61 122.05 80.27 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.641 -0.503 . . . . 75.43 109.641 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.58 126.21 18.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.691 2.261 . . . . 74.21 112.013 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.85 119.71 12.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.411 0.684 . . . . 74.54 109.206 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.8 107.19 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.22 0.608 . . . . 74.3 109.669 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 46.9 mmtm -98.82 114.46 27.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.425 0.69 . . . . 74.24 109.28 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.72 131.59 43.26 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.215 -0.661 . . . . 72.45 109.215 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.3 t70 -120.63 123.18 42.18 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.626 -1.25 . . . . 61.34 107.626 171.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -95.42 130.24 42.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.038 0.535 . . . . 61.52 109.893 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.8 t70 -138.35 150.43 46.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.433 -1.321 . . . . 64.41 107.433 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -145.31 157.11 44.12 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.271 -0.64 . . . . 73.5 109.271 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.01 167.57 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.062 0.945 . . . . 70.12 108.835 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.2 p -164.92 155.91 14.57 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.058 0.543 . . . . 73.13 110.571 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 19.5 p -164.55 132.29 3.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.04 0.936 . . . . 70.21 109.4 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.46 131.59 45.54 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.078 0.551 . . . . 73.31 111.309 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' D' ' 57' ' ' GLU . 64.7 mt -103.65 -37.72 7.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.632 0.773 . . . . 74.33 110.93 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -158.43 -167.54 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.356 0.662 . . . . 72.13 110.929 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -70.87 112.93 7.43 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.25 -0.887 . . . . 61.21 110.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 70.76 -2.62 2.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.579 1.552 . . . . 71.41 112.313 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 82.5 t -109.88 133.43 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.204 1.002 . . . . 74.41 109.434 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.03 154.08 36.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 74.31 109.306 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.647 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.1 tt0 -92.2 134.87 34.47 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.801 0.841 . . . . 73.43 109.346 176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.86 124.3 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.832 -1.173 . . . . 64.21 107.832 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.7 t -105.82 138.55 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.201 0.601 . . . . 65.22 109.448 175.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HB2' HD12 ' D' ' 106' ' ' LEU . 0.0 OUTLIER -113.11 123.85 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.948 -1.13 . . . . 74.11 107.948 176.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.6 ttm-85 -106.64 103.65 13.15 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.813 -0.81 . . . . 75.4 108.813 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.02 123.07 52.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.756 -0.831 . . . . 71.24 108.756 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.2 m -114.6 139.14 49.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.538 0.735 . . . . 71.22 109.599 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.548 HG22 HG23 ' D' ' 114' ' ' ILE . 50.8 t -131.67 100.6 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.804 1.242 . . . . 75.15 108.376 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.7 m -95.02 94.05 7.75 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.16 -1.422 . . . . 73.23 107.16 170.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.06 134.2 40.72 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.577 -0.897 . . . . 64.41 108.577 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 16.6 p -148.57 129.88 14.69 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.074 0.464 . . . . 62.22 111.524 -170.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.466 HD12 HG21 ' D' ' 31' ' ' VAL . 41.5 mt -95.16 104.71 16.6 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.569 1.147 . . . . 74.14 110.867 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.15 -110.91 3.6 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.556 0.535 . . . . 74.21 112.523 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.22 7.26 35.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 70.13 111.632 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.499 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 10.0 tp10 -126.38 150.15 48.77 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.212 0.605 . . . . 54.33 110.326 -175.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -73.22 132.55 43.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.27 0.628 . . . . 73.1 110.362 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.431 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -86.98 -57.68 2.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.547 0.739 . . . . 70.14 109.192 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.81 152.89 14.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.801 -1.091 . . . . 74.25 110.245 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -117.52 120.4 37.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.282 1.033 . . . . 72.33 108.788 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 48.5 t -133.07 142.0 48.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.415 0.686 . . . . 72.31 110.004 -175.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -156.5 129.65 7.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.916 0.486 . . . . 63.42 110.257 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . 0.45 HG21 HG22 ' D' ' 21' ' ' ILE . 84.8 t -128.37 122.72 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.989 0.916 . . . . 71.52 110.051 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -93.01 87.55 5.8 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.673 0.749 . . . . 74.51 109.531 169.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.27 96.62 6.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.19 -1.368 . . . . 62.33 108.954 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.92 157.76 29.92 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.812 -0.515 . . . . 70.31 111.812 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 138.44 5.45 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.946 -0.462 . . . . 74.23 111.946 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.435 HG22 HD13 ' D' ' 51' ' ' LEU . 54.0 mt -91.85 132.97 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 123.762 0.825 . . . . 73.21 109.941 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.1 150.1 52.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.499 0.72 . . . . 75.34 110.602 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.7 m -116.55 101.34 8.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.315 1.046 . . . . 63.53 109.248 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.452 ' HB ' HD13 ' D' ' 89' ' ' ILE . 39.2 pt -109.33 132.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.031 0.443 . . . . 74.33 110.747 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.98 165.77 26.97 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.971 0.909 . . . . 61.02 109.469 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.78 -21.6 6.45 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 114.198 0.439 . . . . 71.45 114.198 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -107.01 169.37 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.272 1.029 . . . . 75.35 109.308 175.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -170.78 -168.63 0.69 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 73.5 110.895 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.65 -141.9 29.2 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.243 -0.435 . . . . 63.25 113.837 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.9 m -82.68 -25.67 32.79 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.383 0.673 . . . . 74.44 111.339 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -63.46 -48.88 75.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.011 0.524 . . . . 73.24 109.788 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.41 ' HE3' HD11 ' D' ' 98' ' ' LEU . 2.9 ppp? -66.06 -31.77 72.84 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.426 0.454 . . . . 74.22 110.95 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.77 98.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.202 0.601 . . . . 74.15 111.212 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -79.22 -37.71 37.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.432 -0.349 . . . . 74.45 110.224 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.87 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.322 0.649 . . . . 70.04 111.481 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.41 HD11 ' HE3' ' D' ' 94' ' ' MET . 5.2 tt -75.78 -50.68 14.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.763 0.825 . . . . 74.03 109.042 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.01 14.1 65.08 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.868 -0.605 . . . . 61.02 114.398 -170.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -56.67 0.2 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.548 0.674 . . . . 75.33 111.618 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -72.09 -43.24 65.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.695 0.628 . . . . 72.53 112.695 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 98.8 m -63.37 -46.41 84.71 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 118.747 -0.644 . . . . 51.45 111.084 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.534 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.0 Cg_exo -58.82 -31.52 95.39 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 122.608 2.205 . . . . 74.13 114.013 166.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -65.86 -34.94 79.3 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.149 0.58 . . . . 74.21 110.757 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.428 HG22 ' ND2' ' B' ' 132' ' ' ASN . 37.3 mm -63.48 -39.76 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.382 0.673 . . . . 73.53 110.29 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' D' ' 60' ' ' LEU . 84.5 mt -74.24 -21.24 59.86 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.374 -0.83 . . . . 75.23 111.672 -175.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -67.9 -40.72 24.64 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 114.584 1.327 . . . . 72.11 114.584 -168.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.451 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 98.2 Cg_exo -49.72 -38.54 46.57 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 121.982 1.788 . . . . 71.25 113.586 170.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -83.87 -29.81 26.93 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.74 -1.118 . . . . 71.13 110.834 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.79 -49.73 64.9 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.31 0.644 . . . . 74.11 110.346 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.521 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.1 ttp-105 -50.98 -56.61 11.62 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.809 1.318 . . . . 72.4 110.273 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.97 -44.39 94.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.619 1.2 . . . . 72.05 111.595 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.459 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 40.8 t -56.3 -44.03 79.48 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.88 0.738 . . . . 63.42 111.075 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.548 HG23 HG22 ' D' ' 64' ' ' VAL . 74.2 mt -67.85 -53.28 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.883 . . . . 74.14 110.382 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -51.56 -43.64 62.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.071 1.348 . . . . 65.43 112.265 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.9 t -69.71 -41.56 75.2 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.149 -0.932 . . . . 74.5 110.525 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.509 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.5 mtm -64.36 -35.1 79.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.028 0.531 . . . . 73.43 111.534 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.3 t -61.53 -48.15 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.221 -0.9 . . . . 72.14 110.319 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.7 p -73.98 -23.02 59.41 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.079 -0.51 . . . . 70.12 111.604 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -73.97 -36.28 64.55 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.726 0.81 . . . . 74.25 110.235 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 2.48 71.66 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.714 0.634 . . . . 71.4 112.07 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 62.29 30.76 17.56 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.85 2.06 . . . . 71.31 112.45 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -88.92 168.64 15.07 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 125.232 1.413 . . . . 75.34 108.077 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.36 153.89 27.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.706 1.604 . . . . 75.53 110.884 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.48 132.31 47.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.174 0.19 . . . . 71.41 110.816 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.76 113.03 22.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.735 -0.839 . . . . 75.42 108.735 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.35 88.85 4.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.795 -1.187 . . . . 74.23 107.795 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.521 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 75.9 mt -63.56 114.56 4.01 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.568 -0.742 . . . . 73.01 109.425 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.55 137.92 89.45 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.215 0.82 . . . . 75.33 113.215 -168.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.409 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 60.0 Cg_endo -80.3 104.87 1.68 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.618 2.212 . . . . 71.24 110.55 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.43 111.32 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.954 -1.021 . . . . 73.42 110.542 -169.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--O 1.242 0.66 0 CA-C-O 122.405 1.098 . . . . 72.25 108.267 177.328 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.238 0.497 0 CA-C-O 121.018 0.437 . . . . 75.14 109.947 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 52.4 t80 -135.96 129.17 31.72 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.596 -1.261 . . . . 74.24 107.596 170.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -148.82 123.41 9.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.266 0.469 . . . . 71.3 112.266 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.571 HD13 HG13 ' A' ' 16' ' ' ILE . 3.4 tp -75.19 118.26 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.949 -1.023 . . . . 63.52 109.056 168.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.9 -20.75 13.34 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.292 0.637 . . . . 71.34 111.048 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -178.41 127.16 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.249 0.477 . . . . 74.31 111.157 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.571 HG13 HD13 ' A' ' 13' ' ' ILE . 48.3 mt -106.48 132.22 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.761 -0.829 . . . . 74.15 108.761 169.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -148.45 171.84 15.42 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.27 1.428 . . . . 75.22 109.931 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -102.15 123.49 46.09 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.959 -0.756 . . . . 74.11 108.959 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -81.53 -32.19 32.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.387 0.675 . . . . 75.42 110.556 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.7 t70 -150.1 144.34 25.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.13 110.083 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.441 HG23 ' SD ' ' A' ' 117' ' ' MET . 61.6 mt -137.38 130.3 43.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.852 -1.536 . . . . 71.14 106.852 171.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -140.33 116.17 10.3 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.113 -1.069 . . . . 71.14 108.113 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.4 t80 -126.68 109.2 11.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 106.667 -1.605 . . . . 71.22 106.667 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.97 108.91 15.85 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.403 -0.962 . . . . 75.54 108.403 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . . . -106.76 89.48 4.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.335 -0.987 . . . . 61.32 108.335 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.59 -43.45 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.446 2.098 . . . . 63.23 112.794 -172.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.6 m-80 -101.42 29.27 4.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.24 0.616 . . . . 73.25 109.891 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -50.79 -48.65 82.99 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 124.359 1.064 . . . . 74.54 113.163 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 21.8 Cg_exo -67.84 -26.39 38.37 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 121.688 1.592 . . . . 62.21 112.517 176.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.52 -28.4 60.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.625 -0.716 . . . . 73.12 110.857 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.724 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 41.4 t -58.79 -20.34 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 123.667 0.787 . . . . 72.13 111.645 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.77 -41.4 90.98 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.262 1.025 . . . . 75.24 111.776 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -101.27 -22.21 14.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.246 0.618 . . . . 70.51 111.436 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.9 mmmt -69.88 134.72 48.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.269 0.627 . . . . 72.24 110.001 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.42 131.94 44.84 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.339 -0.846 . . . . 65.25 109.087 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.432 ' HA ' HD23 ' A' ' 68' ' ' LEU . 75.4 t-105 -80.79 90.6 5.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.479 0.656 . . . . 75.44 110.006 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -121.22 83.97 39.85 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 106.866 -1.531 . . . . 74.2 106.866 165.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.05 132.24 16.51 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.295 1.996 . . . . 43.43 111.389 -171.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -94.49 91.51 6.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.097 -1.446 . . . . 74.13 107.097 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.34 98.59 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 124.612 1.195 . . . . 62.05 111.586 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 20.2 tptm -100.42 130.52 46.52 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.428 -1.26 . . . . 72.21 108.763 175.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -131.67 114.08 14.37 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.41 0.684 . . . . 72.51 109.367 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.512 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -108.08 137.56 45.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.394 1.078 . . . . 73.21 108.535 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.8 tp -119.0 118.9 32.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.747 -0.835 . . . . 70.3 108.747 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -128.58 149.99 50.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.012 0.925 . . . . 71.04 108.953 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -140.63 151.25 44.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.378 0.671 . . . . 74.43 109.858 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -142.53 155.29 45.0 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.226 1.01 . . . . 71.05 109.38 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 p -125.6 159.81 31.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.602 0.761 . . . . 64.24 110.329 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -159.12 122.43 3.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.683 0.793 . . . . 74.01 109.68 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -79.84 111.9 16.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.755 0.422 . . . . 74.54 109.869 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 57' ' ' GLU . 52.5 mt -88.52 -34.16 17.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.124 0.569 . . . . 75.34 110.667 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.58 -172.38 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.437 1.095 . . . . 71.51 109.937 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.19 107.41 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 72.12 109.522 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 68.56 3.66 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.219 1.408 . . . . 70.21 112.87 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.64 115.04 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.351 -1.351 . . . . 75.45 107.351 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -123.2 167.04 14.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.67 0.747 . . . . 74.34 110.745 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' HB2' HD13 ' A' ' 51' ' ' LEU . 19.3 tt0 -128.59 126.26 39.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.043 -1.435 . . . . 65.31 107.143 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -106.48 122.05 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.464 -1.31 . . . . 75.45 107.464 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.506 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.5 t -97.51 139.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 124.313 1.045 . . . . 74.4 108.291 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.12 112.77 19.1 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.434 -1.321 . . . . 74.53 107.434 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -109.75 103.03 11.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.658 0.742 . . . . 74.22 109.752 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.49 136.12 28.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.703 -1.135 . . . . 75.22 108.414 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.8 m -123.5 128.97 50.53 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.039 0.447 . . . . 73.2 110.276 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.5 t -125.33 110.5 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 74.41 109.394 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -107.73 138.59 43.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.19 0.45 . . . . 74.24 109.827 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.48 105.85 12.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.286 -1.376 . . . . 74.54 107.286 168.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 47.6 m -106.42 126.52 52.35 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.552 -0.536 . . . . 72.31 109.552 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 36' ' ' TRP . 17.0 mt -93.27 80.84 4.44 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.137 -1.431 . . . . 72.2 107.137 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -89.24 0.86 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.951 -1.022 . . . . 54.42 111.285 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -121.5 -15.06 8.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.167 0.987 . . . . 71.04 110.477 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -97.16 101.74 13.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.404 1.082 . . . . 73.24 109.83 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.4 m -66.17 127.19 31.19 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.263 0.554 . . . . 64.54 111.192 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -74.28 -55.06 6.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.738 1.215 . . . . 73.23 108.986 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 42.5 p90 -151.22 164.87 35.6 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.749 -1.114 . . . . 64.33 111.125 175.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.21 143.38 50.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.3 1.44 . . . . 71.02 107.224 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.8 m -130.11 136.05 48.9 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 123.712 0.805 . . . . 73.41 108.855 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -148.57 115.72 6.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.582 -0.896 . . . . 73.24 108.582 173.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.89 112.84 30.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.652 0.781 . . . . 74.34 109.518 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -86.67 84.49 7.38 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.751 -0.833 . . . . 65.32 108.751 172.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.53 93.3 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.588 -0.893 . . . . 74.54 108.588 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.37 148.44 20.08 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.413 -0.675 . . . . 73.12 111.413 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 131.92 4.03 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.865 -0.894 . . . . 64.13 110.865 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.78 121.33 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.662 -0.866 . . . . 73.42 108.662 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' CE2' HD11 ' A' ' 13' ' ' ILE . 34.5 m-85 -130.87 117.33 19.14 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.723 -1.214 . . . . 74.52 107.723 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 p -79.15 115.8 19.03 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.416 -0.957 . . . . 75.43 108.416 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HB ' HD12 ' A' ' 89' ' ' ILE . 44.4 pt -118.37 142.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.481 0.712 . . . . 72.4 110.594 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.81 155.74 17.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.099 0.96 . . . . 54.45 109.628 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 9.48 85.54 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.616 0.606 . . . . 75.44 114.616 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.453 HD12 ' HB ' ' A' ' 86' ' ' ILE . 1.3 pp -119.61 132.58 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 117.409 0.604 . . . . 74.24 110.678 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -151.76 173.39 14.79 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.373 1.069 . . . . 64.41 110.217 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.19 -136.26 51.13 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.602 0.564 . . . . 63.32 113.896 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -70.34 -25.95 63.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.759 0.824 . . . . 73.22 111.371 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -65.29 -43.35 91.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 73.34 110.492 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 28.0 ttt -76.11 -38.17 57.21 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.874 -0.603 . . . . 65.21 110.64 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.26 67.83 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.797 0.439 . . . . 70.04 111.489 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -71.72 -39.44 70.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.949 0.9 . . . . 75.04 110.473 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.606 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 t -77.36 -65.87 0.9 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.65 -0.704 . . . . 74.35 110.222 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.54 -17.95 61.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.745 0.818 . . . . 75.5 112.365 -176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.29 -16.91 54.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.852 -0.416 . . . . 61.23 113.964 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -55.7 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.403 0.601 . . . . 62.22 111.75 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 92.1 t80 -66.79 -61.05 2.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.904 0.882 . . . . 70.42 113.361 -168.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.606 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 79.1 m -62.78 -40.91 68.33 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.157 -0.925 . . . . 70.4 113.372 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -63.79 -32.53 67.29 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 121.098 1.428 . . . . 73.3 112.868 168.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -72.02 -24.64 61.59 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 117.945 0.339 . . . . 65.43 111.204 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -57.74 -43.26 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.638 0.733 . . . . 74.33 109.406 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 mt -77.49 -21.84 52.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.146 -1.388 . . . . 74.44 112.27 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -64.61 -41.35 57.04 Favored Pre-proline 0 CA--C 1.562 1.424 0 CA-C-O 117.475 -1.25 . . . . 75.53 114.116 -168.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.69 -31.26 91.54 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.119 1.879 . . . . 74.31 113.26 172.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.95 -41.07 21.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.616 0.766 . . . . 74.5 110.924 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.53 87.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.947 0.499 . . . . 73.11 110.061 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.483 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.9 ttm180 -50.51 -58.79 4.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.867 1.267 . . . . 64.43 110.154 173.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.19 -40.55 96.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.516 1.135 . . . . 74.52 111.754 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.407 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 49.6 t -57.59 -48.43 79.42 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 123.854 0.721 . . . . 74.31 110.1 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.467 HG21 HG22 ' A' ' 64' ' ' VAL . 95.1 mt -62.16 -51.16 75.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 O-C-N 124.306 1.004 . . . . 65.3 110.203 175.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.8 m -53.0 -42.72 65.87 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.81 1.244 . . . . 73.41 111.621 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 32.1 t -68.91 -47.01 66.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.969 -1.014 . . . . 62.24 109.985 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.441 ' SD ' HG23 ' A' ' 21' ' ' ILE . 15.6 mtp -53.45 -45.61 69.57 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.856 0.862 . . . . 72.45 111.394 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.09 -49.11 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.076 1.351 . . . . 74.24 111.046 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -68.48 -28.84 67.39 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.899 0.479 . . . . 74.34 111.454 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 116' ' ' SER . 90.5 mtt-85 -70.3 -27.59 64.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.694 0.798 . . . . 75.12 110.976 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.96 11.96 58.83 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 119.498 -0.612 . . . . 71.41 113.776 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.413 ' HB ' HH21 ' B' ' 15' ' ' ARG . 11.9 m 65.18 32.53 10.04 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.351 1.072 . . . . 75.41 110.316 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.413 ' HE1' HG11 ' A' ' 31' ' ' VAL . 65.2 m-85 -109.4 152.69 42.83 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 115.106 -0.952 . . . . 74.12 109.101 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 149.57 80.23 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.103 1.868 . . . . 71.23 111.319 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.53 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.7 tt0 -56.7 142.29 40.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.699 0.8 . . . . 73.33 111.313 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp -133.8 101.79 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.57 0.748 . . . . 74.1 109.434 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -98.63 100.7 11.95 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.61 117.85 6.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 75.14 109.928 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.94 150.36 50.03 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.345 0.658 . . . . 75.23 111.859 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.71 160.86 7.75 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.378 2.052 . . . . 73.31 112.763 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.89 114.3 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.806 -1.183 . . . . 72.03 107.806 165.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -98.8 63.41 1.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.648 0.737 . . . . 71.43 109.945 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 t80 . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 115.24 -0.891 . . . . 73.52 109.035 173.323 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.089 -0.708 . . . . 75.01 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -139.97 117.17 11.22 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.834 -0.802 . . . . 72.15 108.834 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -128.03 103.5 7.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.191 0.596 . . . . 75.43 109.797 176.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.473 HG21 ' HA ' ' D' ' 129' ' ' ALA . 12.5 tt -67.92 121.63 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 108.819 -0.808 . . . . 74.44 108.819 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -101.1 -47.38 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.86 0.464 . . . . 71.32 110.715 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.413 HH21 ' HB ' ' A' ' 122' ' ' THR . 66.9 ttt180 -163.25 135.59 5.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.098 -171.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.15 138.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 106.805 -1.554 . . . . 73.1 106.805 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.492 ' HE1' HG13 ' B' ' 83' ' ' ILE . 15.1 p90 -164.78 146.35 8.02 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 123.711 0.632 . . . . 72.21 111.178 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -74.64 116.84 15.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.864 -0.791 . . . . 75.4 108.864 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -89.48 -30.18 18.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.26 0.624 . . . . 73.23 111.158 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.5 t70 -158.25 142.89 16.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.091 -0.504 . . . . 60.32 110.376 -171.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.9 mm -138.29 141.46 37.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 125.336 1.455 . . . . 75.05 108.071 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -140.49 133.17 28.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.73 -1.123 . . . . 75.35 108.073 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.1 t80 -142.43 127.43 18.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.447 -1.686 . . . . 73.22 106.447 164.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.57 147.05 49.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.446 -1.316 . . . . 64.35 107.446 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.31 81.74 15.26 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 105.829 -1.915 . . . . 54.22 105.829 172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.87 -29.08 76.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.574 2.183 . . . . 74.42 111.13 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.25 30.7 6.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.66 -1.155 . . . . 54.33 110.435 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.45 -52.45 29.63 Favored Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 124.734 1.214 . . . . 71.24 111.972 169.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.25 -16.84 9.43 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.007 1.804 . . . . 74.31 113.072 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -87.59 3.15 48.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.339 0.656 . . . . 71.21 111.419 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.486 HG13 HD11 ' B' ' 68' ' ' LEU . 22.0 m -67.04 -17.12 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.644 0.778 . . . . 74.1 110.766 166.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -71.33 -31.28 67.21 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.403 1.081 . . . . 74.41 110.123 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.18 -42.65 15.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.351 0.66 . . . . 72.12 109.383 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -91.45 78.52 5.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.076 0.95 . . . . 72.51 109.377 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -83.11 74.87 9.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.42 -1.264 . . . . 75.44 110.471 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -179.46 171.64 1.24 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.199 1.0 . . . . 74.1 109.471 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -71.15 135.57 84.79 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.181 0.992 . . . . 70.45 111.276 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.54 157.41 48.89 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.135 1.89 . . . . 73.0 111.742 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 52.5 mt-10 -70.2 102.19 2.04 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.826 -1.176 . . . . 61.33 107.826 167.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.5 136.6 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.436 -0.95 . . . . 74.44 108.436 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -136.68 141.45 43.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.62 0.768 . . . . 74.31 109.23 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.557 ' HB3' HD12 ' B' ' 126' ' ' LEU . 2.8 pp -104.83 142.23 35.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.475 0.71 . . . . 74.33 109.366 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.512 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.2 m-20 -139.6 155.71 47.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.687 1.595 . . . . 70.42 106.916 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 165.09 36.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.944 0.402 . . . . 74.32 110.327 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.53 141.51 13.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.346 1.058 . . . . 75.22 109.057 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' THR . . . . . 0.56 HG23 ' HA2' ' B' ' 99' ' ' GLY . 88.8 m -108.57 120.06 41.34 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.251 0.621 . . . . 73.14 109.361 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.33 153.82 32.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.765 1.226 . . . . 64.14 108.539 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -142.99 163.41 32.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.096 0.558 . . . . 75.14 110.889 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -154.03 170.59 20.75 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.05 1.34 . . . . 75.04 109.222 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 64.0 tt0 -125.79 135.36 51.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.786 0.834 . . . . 72.55 109.818 169.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 59.3 mt -100.62 -44.75 5.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.677 0.791 . . . . 74.35 110.767 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -147.8 179.23 7.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.944 -1.025 . . . . 74.44 109.733 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.11 119.29 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.526 -0.761 . . . . 65.1 109.851 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' B' ' 85' ' ' SER . 16.6 m-20 70.76 -6.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.144 1.778 . . . . 75.12 112.674 -174.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.0 t -104.58 94.95 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.131 -1.062 . . . . 73.51 108.131 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 8.0 m-85 -94.93 169.39 10.16 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.435 0.694 . . . . 73.31 109.517 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.519 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 6.8 tm-20 -142.89 101.72 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.518 -1.289 . . . . 71.43 107.518 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.87 125.12 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.446 -0.576 . . . . 73.3 109.446 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.451 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.8 t -102.98 111.58 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.569 0.748 . . . . 74.02 109.605 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.37 112.09 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.381 -0.97 . . . . 74.42 108.381 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -96.44 131.45 43.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.592 -1.186 . . . . 74.34 109.708 173.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -126.89 120.29 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.579 -1.267 . . . . 72.53 107.579 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.4 m -109.48 153.97 23.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.494 1.117 . . . . 73.2 109.805 -174.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 85.1 t -133.33 126.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.631 1.172 . . . . 74.25 108.766 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 43.2 m -112.8 143.22 44.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.679 0.792 . . . . 75.44 109.335 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.7 151.37 34.79 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.56 0.344 . . . . 73.33 110.81 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.4 p -144.37 133.39 22.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.099 0.56 . . . . 75.05 111.203 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.486 HD11 HG13 ' B' ' 31' ' ' VAL . 41.8 mt -100.87 99.67 10.2 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 74.13 108.365 171.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.68 -120.01 6.73 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.018 -0.833 . . . . 41.33 111.018 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.17 6.0 35.37 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.803 0.841 . . . . 75.51 112.191 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -115.19 165.57 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.44 0.696 . . . . 64.43 109.793 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -77.82 133.14 38.26 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.121 0.568 . . . . 73.25 111.111 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.46 -60.2 2.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.64 0.776 . . . . 74.11 109.291 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.5 150.98 21.91 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.533 -1.212 . . . . 72.23 110.041 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.45 114.22 15.87 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.215 1.006 . . . . 74.41 108.729 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.539 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 51.4 t -115.38 157.94 23.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.766 -0.827 . . . . 74.0 108.766 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.88 135.97 2.85 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.451 -0.944 . . . . 71.1 108.451 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.74 143.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.51 -0.922 . . . . 73.25 108.51 172.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -127.15 89.25 2.94 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.68 -0.859 . . . . 73.14 108.68 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -83.45 104.71 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.939 -1.028 . . . . 74.23 108.506 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.21 162.52 29.71 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.574 -0.61 . . . . 72.52 111.574 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.09 128.81 2.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.519 -0.632 . . . . 64.12 111.519 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.498 HG22 HD12 ' B' ' 51' ' ' LEU . 37.8 mt -85.72 118.39 32.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.748 -0.834 . . . . 71.14 108.748 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.69 134.71 43.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.773 0.829 . . . . 75.13 109.375 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.568 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 43.2 m -97.58 113.85 25.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.268 0.627 . . . . 74.34 109.993 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 137.47 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.772 0.829 . . . . 73.14 111.608 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.41 173.09 17.17 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.698 1.199 . . . . 72.52 108.782 165.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.53 -44.29 3.32 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-O 120.279 -0.179 . . . . 75.21 112.771 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.91 152.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.876 0.87 . . . . 74.44 110.654 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -155.93 144.25 20.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 120.406 0.146 . . . . 71.13 110.64 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.39 -114.36 6.12 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.707 0.67 . . . . 73.43 114.034 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -67.01 -31.13 71.48 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.867 0.867 . . . . 74.13 110.996 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.34 0.656 . . . . 73.54 110.475 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.2 ttt -73.11 -37.86 66.53 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.767 -0.651 . . . . 64.42 110.681 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.84 -24.85 67.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 71.01 111.121 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -88.75 -23.38 22.92 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.048 0.939 . . . . 73.23 110.985 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.64 -67.66 0.64 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.716 0.406 . . . . 74.21 109.926 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.59 -18.4 58.66 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.034 0.383 . . . . 73.1 112.034 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.56 ' HA2' HG23 ' B' ' 46' ' ' THR . . . -90.11 -20.19 43.49 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.769 -0.462 . . . . 73.42 114.043 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.42 -52.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.766 0.654 . . . . 75.21 112.766 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -67.22 -50.17 61.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.104 0.561 . . . . 74.34 111.401 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.68 -47.41 82.17 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 118.236 -0.888 . . . . 65.33 110.42 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.8 -43.03 36.04 Favored 'Trans proline' 0 C--N 1.404 3.495 0 C-N-CA 122.296 1.998 . . . . 72.53 114.463 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -31.42 72.31 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.257 0.623 . . . . 73.21 111.867 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.9 -45.69 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.547 0.739 . . . . 74.03 110.372 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.24 -16.38 33.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.009 -0.996 . . . . 73.24 111.786 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.14 -44.17 95.73 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 125.773 1.629 . . . . 75.51 113.757 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.59 -40.32 74.93 Favored 'Trans proline' 0 C--N 1.4 3.286 0 C-N-CA 121.873 1.715 . . . . 74.05 112.494 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.8 m-85 -63.79 -44.09 94.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.17 0.588 . . . . 74.44 110.33 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.445 0.698 . . . . 70.41 111.045 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.52 -47.2 87.21 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.966 1.307 . . . . 74.1 111.063 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.82 -40.41 75.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.643 0.777 . . . . 73.32 110.0 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.492 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.7 t -67.45 -35.24 78.82 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 115.797 -0.638 . . . . 72.34 111.218 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.431 HG21 HG22 ' B' ' 64' ' ' VAL . 52.1 mt -62.81 -57.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.167 0.587 . . . . 74.51 109.548 174.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 90.1 m -59.84 -26.43 65.8 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.328 1.018 . . . . 70.53 111.183 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.6 t -66.03 -58.79 4.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.528 0.731 . . . . 75.33 109.852 171.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.2 mmt -62.79 -39.05 93.03 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.99 0.516 . . . . 61.25 112.267 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.0 -41.82 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.498 1.119 . . . . 63.3 110.631 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -72.69 -25.64 61.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.661 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.9 mtt-85 -65.32 -38.63 90.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.509 -0.552 . . . . 73.04 109.509 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 1.55 62.86 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.908 -0.587 . . . . 73.23 113.191 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.9 p 63.25 39.99 9.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 73.12 111.816 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -112.74 159.26 35.01 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.937 1.295 . . . . 72.3 111.207 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.41 141.46 95.64 Favored 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 123.745 2.964 . . . . 74.2 115.181 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' C' ' 124' ' ' PRO . 0.9 OUTLIER -65.61 160.39 22.66 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 126.322 1.849 . . . . 64.12 113.701 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' B' ' 42' ' ' LEU . 24.3 mt -127.54 102.46 6.87 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.254 -0.885 . . . . 74.01 110.004 163.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -91.05 100.24 13.13 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.542 -1.281 . . . . 74.24 107.542 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.87 136.33 33.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.112 0.565 . . . . 71.55 112.236 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.54 142.26 74.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.708 0.803 . . . . 72.42 110.324 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.417 ' HG2' HG21 ' D' ' 13' ' ' ILE . 29.0 Cg_endo -64.24 100.4 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.156 1.904 . . . . 75.44 111.396 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 m -75.5 71.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.024 0.916 . . . . 74.2 109.189 168.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.1 93.2 1.77 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.962 -1.125 . . . . 75.32 107.962 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.6 t80 . . . . . 0 CA--C 1.546 0.804 0 CA-C-N 114.031 -1.44 . . . . 74.12 111.886 -172.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.24 0.587 0 N-CA-C 109.571 -0.529 . . . . 75.14 109.571 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -117.65 125.16 50.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.504 1.122 . . . . 74.32 108.159 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -137.14 112.16 9.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.054 0.542 . . . . 74.22 109.601 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.448 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -64.47 130.87 30.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-N 115.862 -0.608 . . . . 75.02 109.926 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.574 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -103.75 -51.51 3.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.085 -0.709 . . . . 74.31 109.085 174.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -166.53 155.96 11.28 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.439 0.162 . . . . 71.52 111.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.448 HG13 HD11 ' C' ' 13' ' ' ILE . 93.9 mt -138.19 137.48 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.608 1.163 . . . . 74.32 108.128 173.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.505 ' HB3' HG22 ' D' ' 122' ' ' THR . 23.5 p90 -171.84 155.04 3.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.524 0.678 . . . . 74.44 111.786 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -78.72 117.99 20.37 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.67 -1.15 . . . . 74.33 108.461 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 17.4 mtmt -92.61 -38.57 11.81 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.903 -0.777 . . . . 74.4 108.903 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.9 t70 -133.9 134.89 43.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.683 -1.144 . . . . 74.21 108.729 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -138.82 141.02 37.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.078 -1.453 . . . . 75.24 107.078 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -151.95 150.22 29.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.394 0.616 . . . . 54.44 109.823 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -150.83 113.33 4.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.889 -1.523 . . . . 74.21 106.889 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -115.16 111.15 20.57 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.883 -0.784 . . . . 73.31 108.883 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.02 75.69 53.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.09 0.956 . . . . 72.24 108.711 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.54 -24.35 30.77 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.092 1.862 . . . . 73.25 110.465 168.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -92.23 19.12 7.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.18 0.992 . . . . 75.21 110.731 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.2 94.76 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.908 0.883 . . . . 75.24 113.353 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.63 -25.92 7.52 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 121.46 1.44 . . . . 75.31 112.06 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -69.48 -32.98 72.21 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.088 1.355 . . . . 74.24 111.29 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' C' ' 123' ' ' PHE . 12.6 p -72.05 -24.24 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.809 0.844 . . . . 74.42 111.689 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.31 -39.15 93.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.199 0.6 . . . . 75.12 111.139 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -100.74 39.9 1.33 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.752 0.821 . . . . 62.33 109.858 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.649 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -124.72 173.86 8.27 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.36 0.664 . . . . 72.54 110.459 -176.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.27 115.42 25.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.041 -1.096 . . . . 74.24 108.041 167.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.13 68.02 10.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.832 0.853 . . . . 75.11 111.839 -167.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -125.73 79.26 68.28 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.251 -1.018 . . . . 73.25 108.251 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.472 ' HB2' HG12 ' C' ' 40' ' ' VAL . 18.8 Cg_endo -89.42 137.57 3.02 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.472 2.115 . . . . 73.11 111.285 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.25 79.8 9.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.37 -1.344 . . . . 72.32 107.37 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.55 ' HB ' HD13 ' C' ' 126' ' ' LEU . 17.2 m -84.21 111.29 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.314 -1.766 . . . . 53.34 110.166 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -136.83 140.27 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.608 0.363 . . . . 74.3 110.104 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.477 ' HA ' HG22 ' C' ' 64' ' ' VAL . 3.4 pp -88.47 155.36 19.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.964 0.506 . . . . 74.41 109.796 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -144.31 125.27 14.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.689 -0.486 . . . . 51.52 109.689 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.11 120.2 32.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.112 0.965 . . . . 73.44 110.229 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.428 ' O ' HD22 ' C' ' 60' ' ' LEU . 30.4 t70 -117.32 146.8 43.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.707 1.203 . . . . 64.34 109.27 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.8 m -112.83 118.25 34.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.393 0.677 . . . . 75.3 110.592 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.87 160.29 29.14 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.88 1.272 . . . . 73.3 108.352 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -161.34 154.13 20.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.835 0.854 . . . . 74.34 110.077 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.1 p -147.75 143.45 27.56 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.592 1.157 . . . . 63.43 109.379 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -85.28 136.4 33.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.351 0.66 . . . . 75.02 110.351 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.507 HD13 HD13 ' C' ' 83' ' ' ILE . 85.8 mt -107.24 -39.66 5.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.871 0.868 . . . . 74.54 109.731 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.58 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -160.1 -178.54 7.06 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.587 -1.188 . . . . 73.01 109.752 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -73.33 119.99 18.33 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.678 -1.146 . . . . 73.02 108.462 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 66.22 19.66 11.08 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.81 1.244 . . . . 75.43 111.256 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 48.4 t -135.14 105.79 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 107.314 -1.365 . . . . 73.34 107.314 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.09 166.57 14.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.456 0.703 . . . . 74.44 110.78 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.86 110.71 13.98 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.261 -1.336 . . . . 72.21 108.537 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.449 HG12 ' HD3' ' C' ' 103' ' ' PRO . 59.9 t -96.08 136.1 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.435 -1.32 . . . . 72.5 107.435 174.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.8 t -128.41 107.01 15.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.096 0.959 . . . . 74.35 108.92 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.479 HD13 ' O ' ' C' ' 103' ' ' PRO . 0.4 OUTLIER -87.35 108.09 18.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.951 -1.129 . . . . 72.31 107.951 176.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -89.64 104.94 17.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.121 -0.696 . . . . 75.02 109.121 173.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.25 -1.019 . . . . 72.11 108.25 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -103.39 121.91 43.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.161 0.584 . . . . 72.43 109.503 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.59 HG23 HG23 ' C' ' 114' ' ' ILE . 88.5 t -102.34 136.44 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.762 1.225 . . . . 72.43 109.984 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 54.8 m -122.79 140.42 52.93 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.819 0.848 . . . . 74.25 109.044 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 117.87 17.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.036 -1.098 . . . . 71.32 108.036 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -135.0 131.78 37.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.481 0.658 . . . . 75.15 110.76 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.649 HD12 ' HG2' ' C' ' 34' ' ' LYS . 14.3 mt -89.61 41.97 1.07 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.423 1.889 . . . . 71.01 109.479 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.26 -109.11 3.29 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.529 -1.028 . . . . 75.43 110.529 -169.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -91.83 -31.4 15.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.622 0.769 . . . . 75.44 110.584 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -75.53 119.43 19.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.683 1.193 . . . . 72.52 109.074 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -75.79 124.96 28.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.772 -0.455 . . . . 71.11 109.772 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.6 -51.99 13.01 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.078 -0.712 . . . . 74.14 109.078 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -166.69 174.87 8.32 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 115.174 -0.921 . . . . 73.44 110.351 173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.465 HD11 ' N ' ' C' ' 76' ' ' CYS . 1.6 tm? -133.14 146.79 51.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.329 -1.73 . . . . 74.15 106.329 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.551 ' SG ' HG21 ' C' ' 114' ' ' ILE . 44.7 t -145.53 146.4 31.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.447 -0.946 . . . . 63.13 108.447 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.28 130.32 6.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.072 0.396 . . . . 72.24 110.698 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.87 134.55 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.232 1.013 . . . . 64.41 109.236 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.682 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.6 mt-30 -107.18 97.73 7.46 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.648 1.179 . . . . 70.52 108.361 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.417 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.8 tp-100 -82.71 101.24 10.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.526 -0.761 . . . . 74.44 109.027 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.02 145.38 20.67 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.948 -0.861 . . . . 64.13 110.948 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.26 122.65 1.54 Allowed Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.508 -1.037 . . . . 72.42 110.508 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 7.7 mm -84.02 128.15 39.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.246 -1.02 . . . . 75.14 108.246 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -134.69 120.92 20.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.653 0.781 . . . . 73.11 109.412 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -78.85 116.74 19.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.631 -1.248 . . . . 73.4 107.631 168.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.595 HG12 HD11 ' C' ' 89' ' ' ILE . 1.5 tt -133.58 114.46 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 C-N-CA 123.937 0.895 . . . . 74.5 109.743 -170.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.23 41.88 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.582 0.753 . . . . 62.51 110.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.7 -19.02 35.28 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 114.217 0.447 . . . . 72.25 114.217 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.595 HD11 HG12 ' C' ' 86' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 125.053 1.341 . . . . 70.51 111.283 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 119.273 -0.394 . . . . 61.21 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.3 ptp -71.38 -32.8 68.9 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.776 0.262 . . . . 74.33 110.652 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.9 94.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.933 0.893 . . . . 74.12 111.705 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -83.4 -30.92 26.98 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.046 -0.525 . . . . 71.52 111.031 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.16 -58.16 8.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.424 0.289 . . . . 63.45 110.575 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -82.31 -38.39 24.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.784 0.434 . . . . 75.14 110.517 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.74 10.23 75.07 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.001 -0.888 . . . . 73.54 115.029 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.92 -49.03 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.365 1.083 . . . . 74.02 112.452 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -76.14 -49.26 17.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.314 0.646 . . . . 73.44 111.079 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 99.4 m -59.35 -48.03 96.87 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.218 -0.896 . . . . 72.0 111.639 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.479 ' O ' HD13 ' C' ' 60' ' ' LEU . 39.5 Cg_endo -66.75 -27.29 44.68 Favored 'Trans proline' 0 C--N 1.399 3.234 0 C-N-CA 121.487 1.458 . . . . 74.4 112.781 172.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.91 -35.58 81.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.224 0.465 . . . . 71.43 110.974 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.483 HD13 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -65.01 -36.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.507 0.723 . . . . 74.44 110.092 174.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.47 -19.68 30.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.165 0.986 . . . . 74.4 112.455 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.9 -53.0 70.32 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.256 -1.354 . . . . 64.23 112.68 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.85 -33.85 97.52 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 121.94 1.76 . . . . 74.34 112.273 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.416 ' HE2' HG22 ' A' ' 115' ' ' THR . 89.6 m-85 -67.81 -50.48 56.6 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.005 0.922 . . . . 73.33 111.187 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -62.3 -41.4 98.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 64.35 110.392 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -57.76 -48.13 80.51 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.988 1.715 . . . . 73.1 110.902 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.435 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -74.89 -33.06 61.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.249 0.62 . . . . 73.21 110.581 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.1 t -63.85 -33.78 76.46 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.322 0.649 . . . . 74.34 110.824 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.59 HG23 HG23 ' C' ' 64' ' ' VAL . 96.8 mt -75.98 -46.35 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.096 -0.957 . . . . 73.33 110.507 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -55.92 -35.99 67.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.524 0.73 . . . . 62.33 110.851 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 44.6 t -60.62 -57.56 12.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.26 -1.336 . . . . 75.23 109.89 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.598 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.62 -39.39 70.76 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.907 1.283 . . . . 72.51 113.538 -177.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.33 -44.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.09 0.956 . . . . 75.44 110.439 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.3 t -63.03 -34.99 78.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.272 -0.876 . . . . 73.01 111.086 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 67.0 mtt-85 -64.83 -45.13 87.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.07 -0.968 . . . . 74.21 109.925 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.47 69.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.402 -0.817 . . . . 71.51 113.447 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 65.91 34.46 7.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.867 1.667 . . . . 65.44 113.23 170.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.505 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 87.1 m-85 -97.9 169.98 7.75 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 124.417 1.087 . . . . 62.13 109.802 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 72.1 Cg_endo -70.71 175.32 9.05 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.6 2.2 . . . . 73.42 112.803 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -60.23 130.64 47.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.859 0.464 . . . . 63.3 112.121 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.55 HD13 ' HB ' ' C' ' 40' ' ' VAL . 1.5 mm? -122.81 18.48 10.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.42 1.088 . . . . 74.4 110.857 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -90.44 81.15 6.0 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.001 -1.481 . . . . 63.25 107.001 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.71 101.71 14.11 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.196 -1.366 . . . . 71.2 111.088 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . 54.03 175.63 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 115.399 1.629 . . . . 74.22 115.399 162.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -91.58 -172.33 0.44 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.449 2.099 . . . . 75.54 113.334 165.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.48 122.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.765 0.826 . . . . 74.42 109.81 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -114.9 102.78 10.29 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.937 0.895 . . . . 72.14 109.276 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 t80 . . . . . 0 N--CA 1.479 1.023 0 C-N-CA 122.819 0.448 . . . . 74.42 111.77 177.587 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 C--O 1.24 0.567 0 N-CA-C 109.783 -0.451 . . . . 63.52 109.783 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' D' ' 85' ' ' SER . 73.5 t80 -156.73 93.06 1.34 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.968 1.307 . . . . 71.45 107.651 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.82 146.75 45.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.811 -0.631 . . . . 75.3 110.149 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.417 HG21 ' HG2' ' B' ' 130' ' ' PRO . 2.2 mp -83.12 125.83 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 72.12 108.688 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.0 -46.42 4.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.059 0.544 . . . . 75.11 111.403 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -166.45 122.44 1.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.919 -0.562 . . . . 73.52 110.938 -169.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.27 124.1 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.627 -1.249 . . . . 74.22 107.627 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -158.98 152.77 23.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 73.12 111.895 -168.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -86.49 117.8 25.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.162 -0.926 . . . . 72.11 109.087 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -88.67 -23.28 23.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.759 -0.655 . . . . 73.23 110.183 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.5 t70 -158.53 133.92 8.69 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.258 -0.883 . . . . 72.11 109.416 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.598 HG23 ' HE1' ' C' ' 117' ' ' MET . 76.7 mt -137.61 143.68 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.347 1.059 . . . . 71.42 108.386 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -142.12 143.96 33.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.958 1.303 . . . . 74.53 108.023 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.57 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.9 t80 -151.49 110.82 3.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.511 -2.033 . . . . 74.4 105.511 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -128.12 108.22 10.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.164 -0.68 . . . . 73.31 109.164 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.46 91.15 4.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 106.896 -1.52 . . . . 73.43 106.896 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 -24.96 11.95 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.426 2.084 . . . . 60.41 112.24 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -112.7 36.03 3.62 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 124.186 0.994 . . . . 72.23 108.419 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.443 ' HB2' ' HD2' ' C' ' 19' ' ' LYS . . . -59.96 -50.18 87.69 Favored Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.974 1.472 . . . . 61.53 114.974 -166.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.528 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.8 Cg_endo -83.98 -4.84 10.52 Favored 'Trans proline' 0 C--N 1.392 2.854 0 CA-C-N 121.803 1.68 . . . . 75.14 113.076 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -83.52 -37.04 23.58 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.288 1.035 . . . . 72.35 109.231 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' D' ' 73' ' ' ALA . 33.1 m -83.63 -4.24 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.864 0.865 . . . . 72.04 111.534 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.94 -25.73 67.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.671 0.788 . . . . 73.53 109.965 165.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -83.19 0.07 47.03 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.135 0.974 . . . . 71.32 111.447 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -116.94 86.23 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.536 1.134 . . . . 72.23 109.641 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.81 51.53 2.17 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.805 0.812 . . . . 75.13 110.186 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -130.15 -175.95 3.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.934 0.894 . . . . 74.11 109.222 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.463 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 33.9 tp60 -79.68 116.88 64.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 122.968 0.507 . . . . 70.22 110.293 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 13.9 Cg_exo -67.52 87.92 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.999 1.799 . . . . 74.23 109.375 169.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.88 120.66 14.53 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.539 -0.755 . . . . 63.33 110.548 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.626 HG11 HG13 ' D' ' 64' ' ' VAL . 84.8 t -95.83 117.65 40.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 114.991 -1.004 . . . . 75.14 110.291 -167.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.514 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.3 mmtt -89.58 115.2 26.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.712 -1.218 . . . . 74.31 107.712 171.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.51 124.53 37.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.218 -1.03 . . . . 73.14 108.218 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.466 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.8 t70 -116.59 125.39 51.76 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.388 -0.967 . . . . 64.11 108.388 174.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.61 132.3 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.749 0.82 . . . . 75.32 109.744 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.0 t70 -143.04 118.31 10.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.252 -1.388 . . . . 65.14 107.252 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -120.02 145.02 47.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.046 0.538 . . . . 63.1 110.27 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.29 43.94 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.17 0.988 . . . . 72.11 109.087 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -147.65 156.06 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.778 0.831 . . . . 65.23 109.521 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 63.4 p -151.77 127.27 10.04 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.329 0.651 . . . . 60.25 109.985 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -69.49 119.58 13.96 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.666 -0.494 . . . . 72.25 109.666 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' D' ' 57' ' ' GLU . 52.7 mt -92.35 -34.02 14.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.009 0.523 . . . . 75.33 110.348 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.84 -171.68 3.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.152 0.981 . . . . 75.22 109.856 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.12 109.59 1.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.036 0.534 . . . . 62.23 109.837 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.85 11.16 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.067 1.347 . . . . 73.12 113.193 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.89 133.27 58.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.386 . . . . 74.11 107.259 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.66 174.35 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.322 0.582 . . . . 71.14 109.822 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.484 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.8 tt0 -124.86 147.83 48.57 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 124.251 1.02 . . . . 74.11 108.511 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -120.15 125.57 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.521 -1.289 . . . . 73.15 107.521 167.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 82.4 t -103.54 126.81 57.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.019 0.928 . . . . 64.35 108.691 174.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.2 122.08 46.79 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.712 -1.218 . . . . 74.43 107.712 178.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.8 ttm-85 -109.47 99.97 9.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.298 -1.001 . . . . 73.23 108.298 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.08 126.68 44.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.19 -1.411 . . . . 75.35 107.19 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.0 m -120.44 127.22 52.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.585 0.707 . . . . 63.21 110.351 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.626 HG13 HG11 ' D' ' 40' ' ' VAL . 17.3 t -112.43 107.29 22.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 126.151 1.78 . . . . 75.2 109.144 -175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 22.6 m -107.6 93.07 4.34 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.7 -1.222 . . . . 61.21 107.7 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.5 137.59 34.34 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.151 -0.685 . . . . 71.32 109.151 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 43.4 m -137.68 134.4 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 74.43 111.48 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.412 HD12 ' HB ' ' D' ' 31' ' ' VAL . 21.7 mt -108.08 107.05 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.004 1.322 . . . . 75.21 110.397 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.55 -112.29 3.67 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.936 -0.466 . . . . 74.12 111.936 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.86 6.3 17.87 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.089 0.955 . . . . 74.12 111.002 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -124.17 168.32 13.07 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.659 0.784 . . . . 74.22 110.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -81.31 126.6 31.77 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.312 0.645 . . . . 74.32 110.283 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.709 ' HA ' HG13 ' D' ' 31' ' ' VAL . . . -78.05 -67.17 0.76 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.783 0.833 . . . . 53.31 109.243 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.08 153.68 32.31 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 115.169 -0.923 . . . . 74.41 110.117 173.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.5 mt -109.66 152.75 25.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.623 -1.251 . . . . 72.41 107.623 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 42.0 t -158.9 146.73 17.86 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.528 0.731 . . . . 71.25 109.095 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -156.1 128.95 7.9 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.302 -0.629 . . . . 75.41 109.302 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.78 115.58 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.03 0.532 . . . . 72.3 109.708 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.9 mt-30 -90.36 89.1 7.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.571 0.749 . . . . 74.24 109.817 170.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -81.31 100.39 9.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.684 -1.144 . . . . 75.04 108.838 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -95.6 144.62 17.35 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.491 -0.644 . . . . 63.32 111.491 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.82 130.52 3.93 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.317 -0.713 . . . . 62.31 111.317 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.6 mt -89.73 124.86 42.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 124.249 1.02 . . . . 72.43 109.011 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.91 168.77 16.76 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.047 1.339 . . . . 73.44 108.973 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.6 m -114.07 137.0 52.31 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.765 0.826 . . . . 75.15 109.637 171.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.44 125.44 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.296 0.638 . . . . 74.32 109.939 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.32 164.64 27.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.343 0.657 . . . . 73.43 110.602 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.04 -20.63 19.63 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 123.837 0.71 . . . . 73.42 114.788 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.49 163.3 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.993 0.917 . . . . 65.33 110.555 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -143.95 -176.12 4.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.08 0.952 . . . . 72.11 110.414 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.33 -133.54 20.05 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.347 -0.842 . . . . 74.2 113.565 171.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.1 m -59.3 -39.7 83.87 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.463 1.105 . . . . 73.23 111.812 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -58.62 -45.29 89.51 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.038 0.935 . . . . 73.11 111.604 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 3.4 ppp? -81.64 -39.26 24.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.547 0.339 . . . . 62.31 111.513 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.471 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.5 -40.3 92.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 73.52 111.272 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -78.96 -26.37 43.48 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.288 -0.869 . . . . 73.13 110.735 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.3 t -68.73 -52.5 30.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.437 0.295 . . . . 75.44 110.861 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' D' ' 94' ' ' MET . 1.7 pp -76.82 -18.34 58.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.096 0.406 . . . . 70.3 112.096 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.16 0.03 68.49 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.241 -0.755 . . . . 52.04 113.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.53 -61.56 0.17 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.081 0.94 . . . . 74.32 112.421 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -67.05 -48.88 66.95 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.533 0.733 . . . . 75.52 112.631 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 23.4 m -66.05 -42.7 53.19 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.384 0.674 . . . . 73.22 112.264 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.417 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 49.4 Cg_exo -59.15 -35.62 97.39 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.168 1.912 . . . . 72.15 112.762 166.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.85 -28.69 69.17 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.126 0.571 . . . . 73.02 111.356 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -65.97 -40.96 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.231 0.612 . . . . 75.53 110.011 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.57 -23.01 56.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.021 -0.99 . . . . 75.32 111.762 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -64.14 -40.9 57.5 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 117.495 -1.241 . . . . 74.33 113.904 -171.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.46 -41.9 42.85 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.224 1.949 . . . . 74.34 113.719 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -78.09 -38.69 43.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.749 0.82 . . . . 73.14 111.422 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.04 95.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.152 0.581 . . . . 74.2 109.913 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -57.14 -56.82 16.81 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 124.875 1.27 . . . . 72.54 109.732 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.11 -39.62 90.67 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.325 1.016 . . . . 70.53 111.837 -172.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -45.36 88.35 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.743 0.652 . . . . 74.01 110.408 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.503 HG12 ' SG ' ' D' ' 76' ' ' CYS . 84.2 mt -64.51 -53.66 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.124 0.97 . . . . 74.44 110.155 174.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.0 m -52.4 -41.18 62.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.99 1.716 . . . . 74.4 111.546 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -69.7 -44.9 69.46 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.685 -1.143 . . . . 61.21 110.105 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.72 -30.21 70.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.963 0.505 . . . . 72.15 112.007 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.5 t -65.57 -47.37 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.805 0.842 . . . . 73.53 109.75 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -72.18 -29.08 63.66 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.047 -0.524 . . . . 72.55 110.744 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -70.18 -30.91 68.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.651 0.78 . . . . 75.35 110.166 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 10.46 63.99 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 115.788 -0.642 . . . . 65.41 112.797 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.505 HG22 ' HB3' ' C' ' 17' ' ' TYR . 40.7 p 64.01 18.53 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.663 1.985 . . . . 74.11 113.841 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.442 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 88.0 m-85 -88.28 164.71 31.93 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.036 0.934 . . . . 74.25 108.875 171.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.42 140.89 71.89 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.707 2.271 . . . . 73.32 111.012 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.5 118.18 7.2 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 109.521 -0.548 . . . . 74.43 109.521 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.3 101.76 11.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.377 0.671 . . . . 64.23 109.689 -171.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -98.8 96.12 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.508 -0.923 . . . . 63.25 108.508 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 129.63 40.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.939 0.896 . . . . 74.23 110.758 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -57.44 132.07 81.57 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.717 0.807 . . . . 75.23 111.121 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.44 114.25 3.87 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 121.962 1.775 . . . . 73.34 110.656 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.8 t -106.03 107.09 21.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.033 -1.099 . . . . 72.45 108.033 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 107.722 -1.214 . . . . 74.53 107.722 177.014 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.3 m . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.638 -0.875 . . . . 62.14 108.638 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.463 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.2 t80 -109.2 149.99 28.58 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.748 -0.834 . . . . 74.54 108.748 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 51.0 tp60 -148.68 114.77 5.79 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.289 -0.263 . . . . 75.25 110.289 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.419 HD11 HG13 ' A' ' 16' ' ' ILE . 2.3 tp -72.1 90.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.907 -1.516 . . . . 75.34 106.907 164.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -82.98 -22.69 33.61 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.698 -1.137 . . . . 75.1 110.611 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -176.88 145.23 0.49 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.07 0.395 . . . . 72.44 111.297 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.575 HD13 ' HG3' ' C' ' 130' ' ' PRO . 95.3 mt -106.12 139.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.606 -1.627 . . . . 73.22 106.606 162.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.545 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.0 p90 -169.03 135.9 1.8 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.951 0.9 . . . . 63.52 109.712 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.492 HG23 ' HB3' ' B' ' 120' ' ' ARG . 46.7 p -77.71 118.02 19.67 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.141 -0.482 . . . . 63.24 109.799 174.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -84.15 -27.05 28.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.764 -0.653 . . . . 75.21 110.114 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -151.8 138.0 18.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.026 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.9 mt -132.69 139.23 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.981 -1.489 . . . . 75.3 106.981 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -152.34 110.53 3.7 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.076 0.465 . . . . 75.53 110.501 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.624 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 72.6 t80 -109.71 120.49 42.64 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 106.397 -1.705 . . . . 73.44 106.397 169.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -119.14 130.71 55.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.36 -0.978 . . . . 75.41 108.36 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.65 19.49 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.529 -1.286 . . . . 72.14 107.529 172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.31 -15.94 28.12 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.648 2.232 . . . . 74.03 112.129 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -113.44 28.49 8.74 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 124.188 0.995 . . . . 73.34 109.544 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -45.68 99.67 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 113.962 1.097 . . . . 73.31 113.962 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.79 -32.75 8.85 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 121.538 1.492 . . . . 71.53 112.333 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -74.27 -20.36 60.17 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.75 1.22 . . . . 75.41 111.678 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 p -75.32 -20.53 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.366 0.666 . . . . 75.02 112.097 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.65 -29.85 65.08 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.019 -0.537 . . . . 75.45 110.224 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -71.14 -28.83 64.57 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.148 0.979 . . . . 74.12 110.72 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -72.98 142.65 47.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 73.23 111.484 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -73.08 115.31 12.25 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.489 -1.301 . . . . 71.42 107.489 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -84.43 96.48 9.1 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.431 0.634 . . . . 74.55 110.867 -170.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -137.25 80.0 35.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 106.515 -1.661 . . . . 62.24 106.515 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.31 148.54 16.63 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.393 2.062 . . . . 73.3 112.544 -170.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.37 92.82 5.87 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.25 -1.389 . . . . 75.31 107.25 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -65.32 124.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.062 -0.972 . . . . 72.55 109.207 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -124.06 117.62 25.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.778 0.831 . . . . 74.43 109.321 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.4 tp -97.21 129.38 44.56 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.753 -0.832 . . . . 72.23 108.753 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.748 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.7 m-20 -115.19 134.35 55.23 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.273 1.029 . . . . 73.1 108.567 172.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -113.3 125.23 54.06 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.755 0.822 . . . . 74.01 109.246 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.27 145.52 37.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.334 0.653 . . . . 64.23 109.596 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.3 m -135.63 133.11 37.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 75.14 109.313 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 117.04 17.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.213 1.005 . . . . 74.5 109.439 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.3 p -118.47 153.27 34.42 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.46 0.704 . . . . 75.2 111.964 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -168.02 153.1 6.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.786 1.234 . . . . 73.53 109.523 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.4 138.6 32.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.887 -0.412 . . . . 74.42 109.887 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 55' ' ' VAL . 98.1 mt -107.5 -39.56 5.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.851 0.86 . . . . 75.41 111.134 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -157.95 -170.7 3.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.268 0.627 . . . . 64.3 110.305 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.96 113.18 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.248 1.019 . . . . 75.43 110.444 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 66.87 -4.29 0.81 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.488 1.515 . . . . 72.01 113.571 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 72.6 t -97.59 117.45 42.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.087 0.955 . . . . 71.34 108.439 -172.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -119.66 168.76 10.73 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.117 0.967 . . . . 74.32 109.367 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -130.67 130.84 44.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.541 -1.209 . . . . 70.43 108.459 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 111.94 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.477 -1.675 . . . . 72.02 106.477 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.2 t -98.35 131.57 45.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.898 -0.778 . . . . 65.22 108.898 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -101.28 108.57 20.25 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.073 -1.454 . . . . 74.03 107.073 177.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.02 101.47 12.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.356 -0.979 . . . . 75.41 108.356 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.517 HG21 ' HB1' ' A' ' 110' ' ' ALA . 9.9 t -98.62 145.06 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.677 -1.147 . . . . 71.15 108.286 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.748 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 42.5 m -133.11 137.52 46.34 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.735 -0.469 . . . . 72.4 109.735 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.12 107.74 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.675 1.19 . . . . 75.23 107.998 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 24.6 m -103.13 138.48 39.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.777 -0.823 . . . . 71.44 108.777 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.09 102.81 9.32 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.603 -1.629 . . . . 63.31 106.603 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 52.5 m -108.45 124.0 49.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.339 0.59 . . . . 74.14 109.677 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.554 HD13 ' HB1' ' A' ' 73' ' ' ALA . 14.7 mt -90.02 80.46 6.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.105 -1.443 . . . . 75.42 107.105 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -89.27 0.84 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.177 -0.919 . . . . 63.2 111.442 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -114.8 -26.39 7.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.451 0.7 . . . . 73.31 110.759 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -99.58 124.48 44.82 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.976 -0.379 . . . . 65.0 109.976 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 74.6 m -76.4 137.7 39.91 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.406 0.682 . . . . 73.31 111.437 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.554 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -78.87 -62.56 1.66 Allowed 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.815 1.246 . . . . 71.33 109.615 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -144.04 151.68 39.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.442 -1.254 . . . . 74.15 109.61 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.8 tp -126.09 115.56 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.038 1.335 . . . . 72.51 108.409 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.1 m -103.99 139.33 39.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.792 0.837 . . . . 75.12 108.94 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HG3' ' HG1' ' A' ' 63' ' ' THR . 23.5 tt0 -145.1 133.21 21.47 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.887 -1.524 . . . . 74.13 106.887 167.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.454 HG11 ' SG ' ' A' ' 113' ' ' CYS . 76.8 t -135.71 120.92 28.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.781 -0.822 . . . . 73.43 108.781 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.34 79.5 5.0 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.745 -1.205 . . . . 65.42 107.745 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.435 ' O ' HD12 ' A' ' 106' ' ' LEU . 7.0 tp-100 -76.65 93.93 3.7 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 106.917 -1.512 . . . . 73.42 106.917 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.07 160.07 19.39 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.746 -0.264 . . . . 72.51 113.0 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.59 138.86 6.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 112.197 -0.361 . . . . 73.51 112.197 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.545 HG13 ' HE1' ' A' ' 17' ' ' TYR . 74.8 mt -81.76 125.47 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.892 -1.151 . . . . 73.42 107.892 169.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 57.3 m-85 -131.26 117.84 19.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.897 -1.149 . . . . 63.4 107.897 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 18.9 m -81.37 114.34 20.07 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.171 -1.048 . . . . 71.13 108.171 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.7 140.12 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.403 0.681 . . . . 74.31 110.971 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -178.75 168.53 1.69 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.679 1.592 . . . . 71.03 108.924 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.08 -27.51 7.02 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-N 116.161 -0.472 . . . . 74.23 112.889 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.54 179.85 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.907 1.283 . . . . 72.11 110.114 -170.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.63 174.12 15.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.012 0.525 . . . . 74.34 110.068 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.91 -128.12 28.55 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.819 -0.628 . . . . 75.32 113.753 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 p -67.5 -29.82 69.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.263 1.025 . . . . 75.32 111.516 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.65 -36.64 70.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.608 0.568 . . . . 62.43 110.934 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.2 ttt -74.1 -37.31 64.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.003 -0.369 . . . . 74.03 110.003 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.21 68.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.007 0.523 . . . . 53.21 111.016 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -74.92 -52.19 11.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.667 0.787 . . . . 74.45 110.282 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.1 t -65.21 -62.19 1.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.957 0.785 . . . . 65.11 110.553 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -65.66 -38.77 90.27 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.971 0.908 . . . . 63.13 111.957 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.78 -28.52 38.14 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 115.238 0.855 . . . . 74.24 115.238 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 -40.61 0.6 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.165 0.983 . . . . 72.54 112.423 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 56.1 t80 -74.89 -39.44 61.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.582 0.753 . . . . 71.14 112.296 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -79.58 -39.8 1.37 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 123.235 0.614 . . . . 74.42 111.752 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.511 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 53.1 Cg_exo -54.91 -30.15 67.36 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.372 2.048 . . . . 75.34 112.98 164.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.81 -24.26 66.15 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.755 0.822 . . . . 75.21 111.553 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 mm -67.55 -42.5 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.913 0.864 . . . . 73.3 109.757 172.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 80' ' ' GLN . 44.3 mt -86.99 -15.98 37.13 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.272 -1.331 . . . . 74.52 112.25 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.36 -41.31 17.15 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-O 118.054 -0.974 . . . . 74.33 113.418 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.78 -35.28 80.02 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.81 1.673 . . . . 74.34 112.007 171.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.472 ' CE1' ' HD3' ' C' ' 111' ' ' ARG . 41.6 m-85 -77.0 -29.68 55.57 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.641 0.776 . . . . 72.51 112.213 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.517 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -72.36 -47.02 52.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.786 -0.82 . . . . 74.11 108.786 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.419 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.0 ttm180 -49.51 -50.13 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.048 1.467 . . . . 73.43 110.561 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.66 -40.47 73.0 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.36 1.038 . . . . 73.14 111.596 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.577 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.5 t -62.83 -41.83 99.49 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.483 0.489 . . . . 73.31 110.598 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -65.97 -51.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.259 -0.882 . . . . 74.43 109.658 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.1 m -55.36 -39.75 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.077 0.951 . . . . 75.34 111.259 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.1 t -66.73 -45.22 79.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 123.776 0.673 . . . . 73.15 110.342 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 34.1 mtm -63.13 -40.32 97.24 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.73 0.412 . . . . 70.21 111.146 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.1 -50.29 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.499 1.12 . . . . 74.45 110.149 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 94.8 p -70.98 -25.92 62.91 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.796 -0.638 . . . . 71.24 111.633 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 116' ' ' SER . 37.7 ttm-85 -79.04 -28.9 43.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.35 1.06 . . . . 75.53 109.461 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.21 9.77 56.38 Favored Glycine 0 C--N 1.356 1.672 0 CA-C-N 115.196 -0.911 . . . . 73.21 112.825 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.417 HG21 ' NH2' ' B' ' 15' ' ' ARG . 31.1 m 69.22 33.65 3.22 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 123.476 1.607 . . . . 73.14 111.122 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 119' ' ' SER . 75.7 m-85 -101.89 158.2 32.23 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 113.994 -1.457 . . . . 74.33 107.135 161.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.84 -174.1 0.56 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.974 1.783 . . . . 75.15 112.004 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -76.01 141.59 42.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.893 0.477 . . . . 75.43 112.135 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.08 94.13 3.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.455 -1.313 . . . . 63.34 107.455 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.11 110.86 22.63 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.331 0.652 . . . . 74.21 110.242 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.4 mt -74.15 145.37 44.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.378 -0.828 . . . . 75.14 110.949 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.12 146.39 98.98 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.096 0.559 . . . . 75.41 111.396 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.48 141.0 45.12 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.284 1.989 . . . . 73.15 111.721 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.23 108.74 22.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 108.457 -0.942 . . . . 74.02 108.457 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -109.18 74.75 0.92 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 72.31 109.06 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 115.667 -0.697 . . . . 74.42 110.641 177.263 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.245 0.841 0 N-CA-C 109.201 -0.666 . . . . 73.4 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -148.75 125.21 10.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.407 -1.331 . . . . 75.34 107.407 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -144.96 140.76 28.45 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.312 -0.625 . . . . 71.52 109.312 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.525 HD12 HG13 ' B' ' 16' ' ' ILE . 10.8 tt -90.75 144.07 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.521 0.728 . . . . 72.42 109.459 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.66 -44.59 3.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.959 0.504 . . . . 74.4 109.772 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.417 ' NH2' HG21 ' A' ' 122' ' ' THR . 19.7 ttt180 -169.6 146.22 3.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.3 0.24 . . . . 74.51 110.76 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.525 HG13 HD12 ' B' ' 13' ' ' ILE . 94.2 mt -120.42 144.49 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.378 -1.342 . . . . 73.45 107.378 173.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -169.37 158.98 8.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.69 0.677 . . . . 75.01 112.176 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.8 m -83.54 127.67 33.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.191 -0.913 . . . . 64.52 108.835 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -96.37 -36.62 10.79 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.666 0.786 . . . . 74.44 110.885 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -161.74 145.3 12.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.352 -0.385 . . . . 73.21 110.375 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.412 HD13 ' SG ' ' B' ' 113' ' ' CYS . 37.3 mm -137.2 138.93 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.682 1.193 . . . . 74.01 109.8 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 74.0 m -134.81 125.52 27.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.144 1.378 . . . . 75.45 108.492 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -142.78 108.2 5.04 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.54 -1.282 . . . . 75.11 107.54 167.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -119.2 122.99 43.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 45.2 108.462 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.11 89.43 14.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.991 0.917 . . . . 70.12 109.278 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.3 -32.04 73.11 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.194 2.596 . . . . 72.21 113.136 -172.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -117.96 32.09 6.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.911 0.884 . . . . 72.13 110.122 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.424 ' HB1' ' CE2' ' A' ' 17' ' ' TYR . . . -45.91 -54.76 15.16 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 125.646 1.578 . . . . 53.4 113.829 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.77 -24.36 34.63 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 122.511 2.141 . . . . 74.32 112.881 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -89.19 1.79 55.15 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.777 -1.101 . . . . 64.33 111.786 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.31 -23.88 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.927 0.491 . . . . 71.03 110.462 170.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -63.62 -38.85 92.69 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.543 0.737 . . . . 74.53 110.416 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -82.88 -41.75 18.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.927 0.891 . . . . 74.32 110.296 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -85.38 70.66 10.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.686 1.194 . . . . 75.21 109.032 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.53 74.58 9.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.263 1.03 . . . . 61.13 110.798 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -167.08 154.07 8.7 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.235 -1.394 . . . . 75.3 107.235 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.07 127.74 92.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.049 0.54 . . . . 74.45 110.226 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.69 151.79 81.72 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.257 1.972 . . . . 72.53 112.164 167.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 2.8 pt-20 -61.01 102.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.035 -0.984 . . . . 70.21 109.303 169.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.0 t -88.46 116.51 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.896 -1.15 . . . . 72.11 107.896 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -138.96 138.27 37.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.308 0.643 . . . . 75.34 109.275 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.434 ' HG ' HD23 ' B' ' 128' ' ' LEU . 0.8 OUTLIER -118.71 147.35 43.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 74.15 110.14 -168.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.26 149.5 52.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.214 1.406 . . . . 75.4 108.054 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.67 135.41 51.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.437 -0.579 . . . . 75.42 109.437 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -136.57 154.19 50.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.158 1.383 . . . . 75.24 108.363 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -132.03 139.94 48.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.986 0.514 . . . . 65.25 110.508 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.7 160.8 37.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 74.24 108.551 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -142.32 162.85 34.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.082 0.553 . . . . 72.25 110.588 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -153.35 168.2 26.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.821 1.248 . . . . 74.25 108.526 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -123.3 130.73 53.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.262 0.625 . . . . 64.23 111.134 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.54 HD12 HG22 ' B' ' 83' ' ' ILE . 65.7 mt -97.81 -49.86 4.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.469 0.708 . . . . 70.33 110.183 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.51 -170.89 3.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.501 -0.772 . . . . 71.02 110.387 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -65.71 116.19 6.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.702 -1.136 . . . . 73.33 109.704 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 72.62 2.78 4.48 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.817 1.647 . . . . 65.04 111.605 177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 95.51 3.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 124.291 1.036 . . . . 73.11 108.33 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.462 ' HB2' HD12 ' B' ' 86' ' ' ILE . 0.1 OUTLIER -94.58 139.02 31.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.842 177.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.458 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.2 tm-20 -103.65 95.99 6.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 106.622 -1.622 . . . . 64.43 106.622 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.29 123.1 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.267 -0.642 . . . . 72.42 109.267 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.6 t -102.31 123.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.568 0.747 . . . . 73.44 109.482 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -93.13 126.67 38.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.259 -1.386 . . . . 72.44 107.259 173.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.401 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 29.3 ttt180 -119.41 104.36 10.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.19 -0.67 . . . . 74.11 109.19 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.5 120.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.571 -0.9 . . . . 73.4 108.571 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -109.39 150.5 27.97 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.065 -0.717 . . . . 63.02 109.065 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.613 HG21 HG23 ' B' ' 114' ' ' ILE . 90.3 t -139.32 122.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.865 0.866 . . . . 75.13 109.279 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 79.8 m -113.76 138.78 49.78 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.638 0.775 . . . . 75.01 109.27 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.3 147.03 28.85 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.887 -1.052 . . . . 70.1 109.071 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 9.2 m -143.77 135.27 26.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.497 0.554 . . . . 64.23 112.497 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 50.0 mt -88.47 101.39 13.87 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.69 -1.596 . . . . 64.5 106.69 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -111.25 3.22 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.053 -0.819 . . . . 52.3 111.053 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.85 4.88 12.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.319 1.048 . . . . 75.22 110.734 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.75 139.07 50.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.578 1.151 . . . . 75.54 108.098 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -61.98 133.49 55.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.11 0.564 . . . . 71.53 112.141 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.433 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -86.95 -61.19 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.5 1.12 . . . . 74.01 109.176 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.02 167.1 28.7 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.456 -1.702 . . . . 72.24 109.618 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.69 118.86 11.35 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.661 1.585 . . . . 72.53 106.726 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -119.4 153.42 35.23 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.436 -0.579 . . . . 74.25 109.436 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.23 134.85 7.6 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.161 -1.052 . . . . 60.42 108.161 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.431 HG22 HG13 ' B' ' 114' ' ' ILE . 69.6 t -123.39 143.02 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 123.604 0.762 . . . . 74.33 109.738 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.401 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.4 mt-30 -118.15 90.93 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.653 -0.869 . . . . 74.02 108.653 171.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -89.88 100.8 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.339 -0.985 . . . . 72.24 108.339 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.68 163.69 29.85 Favored Glycine 0 C--O 1.242 0.643 0 N-CA-C 111.75 -0.54 . . . . 71.22 111.75 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.97 130.8 2.84 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.597 -0.601 . . . . 51.1 111.597 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.54 HG22 HD12 ' B' ' 51' ' ' LEU . 42.7 mt -86.39 116.31 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.725 0.81 . . . . 74.11 109.195 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -133.87 134.59 42.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.212 1.005 . . . . 73.2 109.183 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 41.8 m -95.34 110.86 22.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.768 0.827 . . . . 61.4 110.028 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -118.69 138.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.146 0.978 . . . . 71.24 110.606 -177.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.98 167.64 27.47 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.598 0.759 . . . . 64.23 109.744 167.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.25 -41.65 3.01 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 123.549 0.53 . . . . 51.21 113.045 176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.42 156.14 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.308 1.043 . . . . 74.52 110.872 169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.06 154.98 7.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.146 0.578 . . . . 72.1 109.732 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.75 -113.33 5.77 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.25 0.452 . . . . 75.42 113.444 170.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 -36.94 74.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.599 0.76 . . . . 70.42 110.643 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.48 -46.39 86.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.782 0.433 . . . . 72.31 110.731 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ttt -68.47 -40.87 80.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.017 -0.538 . . . . 71.41 110.326 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.65 70.34 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.324 0.649 . . . . 73.21 111.434 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -74.11 -36.33 64.2 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.585 0.754 . . . . 74.05 109.513 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.06 -68.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.791 -0.64 . . . . 62.43 110.446 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.76 -20.32 61.9 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.138 0.421 . . . . 72.42 112.138 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.46 -6.7 52.78 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.144 -0.809 . . . . 73.41 114.528 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.62 -42.54 0.14 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.255 1.028 . . . . 50.53 112.716 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -79.9 -53.04 7.13 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.932 0.333 . . . . 74.12 111.538 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.69 -45.56 99.82 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.648 0.779 . . . . 63.53 110.991 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -50.14 -46.93 26.03 Favored 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.512 2.142 . . . . 74.5 113.582 164.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.4 -35.6 70.24 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.624 0.769 . . . . 74.42 112.098 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.444 HG22 ' NH2' ' D' ' 111' ' ' ARG . 82.6 mt -65.13 -49.11 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.637 0.775 . . . . 71.13 110.332 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.44 ' HB2' HD12 ' B' ' 60' ' ' LEU . 50.8 mt -78.92 -12.65 60.04 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.684 -1.144 . . . . 74.55 111.966 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -67.77 -46.11 44.59 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.06 1.344 . . . . 71.12 113.451 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.47 -33.67 78.34 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.554 1.503 . . . . 75.43 112.203 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -65.8 -45.2 83.23 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.088 0.555 . . . . 71.01 110.531 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.79 77.79 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.318 0.647 . . . . 72.24 110.912 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -57.57 -53.41 58.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.04 0.936 . . . . 73.22 110.275 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.434 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.7 tm-20 -68.0 -29.79 68.89 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.046 0.842 . . . . 75.31 110.387 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 117' ' ' MET . 33.7 t -68.22 -45.63 72.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.158 0.583 . . . . 64.12 111.182 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.613 HG23 HG21 ' B' ' 64' ' ' VAL . 95.0 mt -63.11 -44.25 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 71.05 109.847 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.575 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . 32.6 m -66.34 -23.29 66.33 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.829 -1.078 . . . . 74.43 111.534 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.2 t -75.59 -40.87 55.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 75.1 110.627 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.4 mmt -79.29 -38.46 35.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.849 0.685 . . . . 74.3 112.849 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.786 ' HB ' ' HG3' ' B' ' 125' ' ' GLN . 95.5 t -75.62 -27.14 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.326 0.65 . . . . 62.42 110.77 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.9 p -66.72 -37.67 85.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.027 0.441 . . . . 63.33 110.248 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.577 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 60.5 mtt-85 -63.57 -40.3 96.62 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.147 -0.933 . . . . 74.24 110.508 175.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.94 80.93 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.716 0.635 . . . . 64.0 113.199 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p 62.38 33.45 16.32 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.548 1.939 . . . . 72.02 112.874 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.37 -177.17 0.58 Allowed Pre-proline 0 CA--C 1.568 1.635 0 CA-C-N 114.284 -1.325 . . . . 71.33 109.024 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.562 ' HB2' HG21 ' B' ' 40' ' ' VAL . 3.9 Cg_exo -81.87 116.72 2.86 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.853 2.369 . . . . 74.13 112.964 169.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.786 ' HG3' ' HB ' ' B' ' 118' ' ' VAL . 0.5 OUTLIER -72.02 164.01 26.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.908 0.883 . . . . 73.04 111.324 164.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.426 ' HB3' HD22 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -137.26 127.16 25.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.205 -1.035 . . . . 70.33 108.205 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -91.71 102.81 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.816 -1.179 . . . . 73.31 107.816 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.434 HD23 ' HG ' ' B' ' 42' ' ' LEU . 0.3 OUTLIER -66.08 139.34 58.17 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 110.361 -0.237 . . . . 70.41 110.361 -170.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.66 148.23 98.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.768 0.827 . . . . 70.2 111.118 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.405 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 93.4 Cg_endo -74.33 97.07 1.0 Allowed 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.22 1.946 . . . . 75.31 111.239 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.91 110.95 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.263 -0.643 . . . . 71.54 109.263 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -72.68 97.07 2.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.23 0.612 . . . . 74.01 109.452 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.636 0.774 . . . . 75.32 112.17 -175.728 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.236 0.356 0 N-CA-C 109.596 -0.52 . . . . 75.31 109.596 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.533 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 48.4 t80 -92.84 119.76 32.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.676 -1.231 . . . . 72.41 107.676 169.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -137.1 117.95 14.15 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 109.255 -0.646 . . . . 73.5 109.255 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 tp -70.53 131.44 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 109.437 -0.579 . . . . 72.41 109.437 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.507 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.9 mm-40 -96.15 -48.69 5.55 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.37 -0.832 . . . . 75.4 108.989 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.452 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 61.9 ttt180 -176.37 133.95 0.24 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.387 -0.824 . . . . 72.4 109.787 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -108.64 150.32 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.767 -1.197 . . . . 75.32 107.767 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.586 ' HH ' HD11 ' C' ' 83' ' ' ILE . 28.9 p90 -179.62 154.29 0.6 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.74 . . . . 74.4 109.471 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -74.87 118.4 17.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.763 -0.828 . . . . 74.31 108.763 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.619 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -69.92 -43.3 71.96 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.315 -0.994 . . . . 63.13 108.315 176.085 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.6 t70 -154.02 138.89 17.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.425 -1.716 . . . . 75.04 108.928 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.8 mt -129.3 145.72 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.714 -1.217 . . . . 64.31 107.714 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -153.23 150.06 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.527 0.679 . . . . 74.32 110.0 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -143.91 127.19 16.71 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.815 -1.55 . . . . 73.4 106.815 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 48.5 mt-10 -116.47 125.12 51.52 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.118 -0.697 . . . . 73.14 109.118 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.68 74.91 38.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.626 1.17 . . . . 74.12 108.189 171.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.98 -28.57 49.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.306 2.004 . . . . 74.45 110.452 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 93.1 m-20 -97.9 24.83 6.51 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.768 -1.106 . . . . 74.41 111.094 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.451 ' HA ' ' HZ ' ' C' ' 123' ' ' PHE . . . -57.09 -48.28 97.68 Favored Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.454 0.701 . . . . 64.2 111.74 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' C' ' 32' ' ' PHE . 56.4 Cg_endo -86.82 -25.46 1.16 Allowed 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.164 1.909 . . . . 75.41 113.27 168.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.407 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 83.0 t60 -70.01 -23.39 63.12 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.64 0.776 . . . . 74.43 112.627 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.602 HG11 ' HE1' ' C' ' 123' ' ' PHE . 9.9 p -78.03 1.3 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 124.278 1.031 . . . . 74.04 112.189 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' C' ' 29' ' ' PRO . 36.5 t80 -49.34 -43.45 43.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.72 1.608 . . . . 72.14 113.913 -171.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -128.65 48.81 2.27 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.364 -0.976 . . . . 72.33 108.364 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.89 155.31 19.46 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.834 -0.621 . . . . 75.52 109.63 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.27 118.39 12.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.776 . . . . 73.22 109.97 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -78.48 94.57 4.97 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.72 0.808 . . . . 74.03 110.755 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.33 54.06 2.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 114.986 -1.006 . . . . 71.4 110.082 171.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.32 97.88 0.17 Allowed 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.09 1.86 . . . . 75.45 111.715 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.24 108.83 17.33 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.401 -1.703 . . . . 75.43 106.401 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' C' ' 126' ' ' LEU . 46.4 t -94.02 102.64 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 113.897 -1.501 . . . . 63.15 110.218 -166.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.532 ' HB2' ' HZ1' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -92.87 112.52 24.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.3 0.64 . . . . 70.31 110.442 178.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.665 HD13 HD13 ' C' ' 128' ' ' LEU . 7.0 mp -91.24 141.01 29.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.733 -0.84 . . . . 74.53 108.733 172.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -143.18 138.48 29.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.899 0.88 . . . . 63.25 109.476 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.79 127.23 54.52 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.321 -0.622 . . . . 63.43 109.321 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.73 145.36 48.47 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.353 1.461 . . . . 74.04 108.276 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.2 t -123.67 139.45 53.98 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.275 0.559 . . . . 72.33 109.66 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.47 147.61 34.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.997 1.319 . . . . 75.31 107.682 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -145.75 155.43 42.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.937 0.398 . . . . 74.51 111.346 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.0 m -142.62 136.42 29.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.266 1.027 . . . . 63.41 108.527 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -84.66 116.76 23.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.554 -0.906 . . . . 71.45 108.554 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.483 HD13 HD13 ' C' ' 83' ' ' ILE . 76.4 mt -91.0 -34.4 15.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.752 -0.658 . . . . 75.15 109.579 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.75 -174.19 2.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.101 -0.954 . . . . 54.41 110.004 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.25 122.49 22.04 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.38 -0.827 . . . . 74.2 109.256 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 65.4 11.4 7.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.09 1.356 . . . . 74.3 112.406 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.23 110.67 30.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 108.18 -1.044 . . . . 71.34 108.18 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -127.03 129.82 48.8 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.631 -0.713 . . . . 75.22 109.623 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.27 109.92 16.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.241 -1.345 . . . . 74.45 108.462 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 64.8 t -97.68 114.7 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.102 -1.073 . . . . 73.21 108.102 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.8 105.34 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.676 -0.861 . . . . 63.12 108.676 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -96.7 104.4 16.39 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.754 -1.202 . . . . 73.15 107.754 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -85.8 116.48 24.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.627 0.771 . . . . 74.33 109.957 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.45 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.8 t -101.54 127.92 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.71 -1.218 . . . . 74.04 107.71 168.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.8 m -124.61 124.23 41.77 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.087 -0.709 . . . . 74.1 109.087 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.573 HG21 HG23 ' C' ' 114' ' ' ILE . 38.3 t -110.58 131.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 73.02 109.447 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 25.9 m -116.52 149.69 39.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.233 -1.395 . . . . 73.51 107.233 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.52 130.94 41.05 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.768 -1.197 . . . . 75.04 107.768 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.6 m -133.54 161.64 34.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.485 0.66 . . . . 74.32 110.693 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 mt -128.45 28.5 5.44 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.647 1.579 . . . . 75.54 108.016 -173.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.41 -113.85 2.62 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.349 -1.9 . . . . 75.3 108.349 -165.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.5 -27.12 19.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.204 0.601 . . . . 62.43 109.717 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.6 117.98 9.54 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 124.658 1.183 . . . . 75.41 110.214 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -79.17 126.43 30.73 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.523 -0.547 . . . . 74.13 109.523 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.03 -52.13 11.85 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.593 0.757 . . . . 55.34 109.011 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.413 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 43.1 p90 -164.18 172.68 13.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.535 -1.211 . . . . 74.41 110.129 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -137.72 145.13 42.14 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.754 -1.573 . . . . 74.4 106.754 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.433 ' N ' HD12 ' C' ' 75' ' ' LEU . 53.6 t -144.18 144.54 31.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.572 -0.899 . . . . 74.53 108.572 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.05 125.68 9.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.404 -0.591 . . . . 75.21 109.404 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' C' ' 110' ' ' ALA . 75.0 t -126.66 114.66 38.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.263 1.025 . . . . 72.52 108.424 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -96.81 87.51 4.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.62 -0.881 . . . . 75.53 108.62 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -85.14 119.81 25.95 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.075 -0.966 . . . . 70.12 109.542 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.619 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -114.05 153.77 17.38 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 123.453 0.471 . . . . 62.54 112.507 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -147.31 130.98 3.74 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.969 -1.252 . . . . 72.51 109.969 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.586 HD11 ' HH ' ' C' ' 17' ' ' TYR . 18.6 mm -88.56 119.01 35.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.764 -1.199 . . . . 71.35 107.764 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.58 122.88 39.3 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.39 -0.967 . . . . 71.14 108.39 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -90.19 100.4 13.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.886 -1.524 . . . . 73.2 106.886 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.504 HD11 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -122.72 133.45 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.697 0.799 . . . . 72.43 110.818 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.33 177.39 11.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.547 -0.751 . . . . 72.54 110.921 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.08 -63.69 2.07 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.641 -0.709 . . . . 62.15 112.731 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.5 2.032 0 C-N-CA 125.161 1.384 . . . . 65.11 112.787 176.06 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 118.851 -0.595 . . . . 73.53 111.944 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.6 tpt -45.77 -54.13 8.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.941 0.719 . . . . 62.23 112.941 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.26 -34.32 18.98 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.622 0.369 . . . . 74.01 111.378 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -74.6 -20.05 60.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.127 0.788 . . . . 72.21 113.127 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -68.02 -62.19 1.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.136 0.425 . . . . 74.01 110.696 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.401 ' H ' HD23 ' C' ' 98' ' ' LEU . 2.7 pt? -79.89 -20.3 46.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.239 -0.437 . . . . 73.24 111.294 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.67 -30.22 30.25 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.369 0.507 . . . . 70.42 114.369 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.2 -35.29 0.18 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.223 0.823 . . . . 60.14 113.223 -173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -73.38 -56.83 4.54 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.17 0.588 . . . . 73.11 111.169 -169.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.533 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 36.9 m -61.63 -46.36 93.61 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 123.73 0.812 . . . . 71.55 111.226 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 84.2 Cg_exo -53.44 -34.39 71.45 Favored 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 122.798 2.332 . . . . 72.53 114.61 167.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.6 -30.36 69.08 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.821 0.849 . . . . 71.24 111.365 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.419 HG23 ' NH1' ' A' ' 111' ' ' ARG . 46.2 mm -68.05 -29.88 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 123.199 0.6 . . . . 73.01 110.206 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.463 HD22 ' HA3' ' C' ' 82' ' ' GLY . 70.9 mt -93.05 -29.71 15.67 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.304 1.042 . . . . 73.42 112.567 -173.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -56.96 -38.32 67.38 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.79 -1.1 . . . . 73.24 113.956 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.17 -50.9 12.37 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.079 2.519 . . . . 75.01 113.897 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -62.05 -36.7 82.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.989 -1.005 . . . . 75.45 110.873 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.538 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -76.44 -40.0 51.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.459 -0.791 . . . . 74.34 111.2 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.472 ' HD3' ' CE1' ' A' ' 109' ' ' TYR . 29.1 ttt180 -58.15 -36.95 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.782 0.833 . . . . 75.12 111.142 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -44.96 25.18 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.197 0.599 . . . . 64.14 110.872 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.05 -30.17 71.11 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.325 0.65 . . . . 70.44 112.597 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.573 HG23 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -67.33 -49.91 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.339 0.655 . . . . 74.12 109.98 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.533 HG23 ' HB2' ' C' ' 125' ' ' GLN . 90.5 m -54.0 -42.74 69.36 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.253 0.971 . . . . 62.02 110.951 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.6 t -62.34 -49.26 76.3 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.168 -1.378 . . . . 73.33 110.754 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.575 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.19 -39.49 94.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.883 0.873 . . . . 72.32 112.373 -177.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.03 -41.85 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.152 0.581 . . . . 60.35 110.886 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 28.2 t -59.8 -35.74 75.3 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.439 -1.255 . . . . 73.53 111.851 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.573 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 73.6 mtt-85 -68.91 -38.6 79.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.313 -0.858 . . . . 72.44 110.895 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.22 4.66 66.25 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.699 -0.682 . . . . 75.25 112.85 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.46 HG22 ' O ' ' D' ' 16' ' ' ILE . 71.0 p 60.51 38.31 19.11 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.829 1.652 . . . . 63.44 112.207 172.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.602 ' HE1' HG11 ' C' ' 31' ' ' VAL . 43.9 m-85 -106.57 163.53 16.79 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.206 -1.361 . . . . 60.25 109.821 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.34 104.45 0.3 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.263 1.975 . . . . 75.34 111.181 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.775 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -56.07 150.77 13.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.237 1.415 . . . . 74.24 112.746 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' C' ' 40' ' ' VAL . 1.9 mm? -129.45 99.87 5.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.807 0.443 . . . . 74.24 110.737 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -109.32 84.63 1.96 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.37 -1.715 . . . . 74.21 106.37 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.665 HD13 HD13 ' C' ' 42' ' ' LEU . 55.4 mt -90.02 156.68 18.24 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.337 -1.301 . . . . 71.54 111.848 -172.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -34.62 121.98 0.55 Allowed Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.218 1.807 . . . . 73.34 113.65 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.575 ' HG3' HD13 ' A' ' 16' ' ' ILE . 74.4 Cg_endo -71.29 110.24 2.79 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.73 2.287 . . . . 63.42 111.559 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 86.0 t -76.0 94.32 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.94 -0.763 . . . . 71.4 108.94 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.56 104.67 3.37 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 CA--C 1.549 0.934 0 O-C-N 125.075 1.484 . . . . 74.23 112.761 -170.241 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.237 0.396 0 CA-C-O 121.007 0.432 . . . . 73.14 109.946 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -145.97 94.5 2.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 106.431 -1.692 . . . . 74.01 106.431 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -129.47 139.45 51.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.306 0.642 . . . . 71.34 109.468 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.48 142.81 12.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.152 0.581 . . . . 74.23 109.738 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 56.9 mt-30 -103.36 -43.93 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.15 0.58 . . . . 70.23 110.683 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.547 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 55.6 ttt180 -170.13 148.72 3.4 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 111.784 0.29 . . . . 75.44 111.784 -169.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.46 ' O ' HG22 ' C' ' 122' ' ' THR . 1.1 mp -120.68 144.2 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 106.205 -1.776 . . . . 74.02 106.205 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.547 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 16.3 p90 -165.9 151.07 8.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.478 0.656 . . . . 75.43 111.226 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -86.95 113.05 22.39 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.033 -0.985 . . . . 53.15 109.082 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -81.06 -28.84 35.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.978 -0.555 . . . . 73.32 110.289 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -151.82 136.44 17.0 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.788 -1.096 . . . . 73.11 109.131 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.575 HG23 ' HE1' ' C' ' 117' ' ' MET . 96.7 mt -130.81 138.3 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.694 -1.224 . . . . 71.15 107.694 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -141.59 137.11 31.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.138 0.975 . . . . 73.2 109.053 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.2 t80 -145.52 114.23 6.82 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.263 -1.755 . . . . 73.33 106.263 170.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 38.3 mt-10 -122.26 111.09 16.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.228 0.611 . . . . 75.44 109.707 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -108.91 88.99 5.97 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.331 -0.989 . . . . 74.41 108.331 174.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.48 -33.94 1.64 Allowed 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 122.634 2.223 . . . . 73.02 113.295 -173.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -101.26 28.25 5.55 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.944 0.897 . . . . 73.5 109.317 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' D' ' 25' ' ' ALA . . . -51.58 -55.22 31.43 Favored Pre-proline 0 CA--C 1.574 1.893 0 N-CA-C 116.149 1.907 . . . . 64.32 116.149 -165.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.2 -16.24 11.09 Favored 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 122.049 1.768 . . . . 73.25 113.43 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -72.64 -44.78 61.46 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.066 0.946 . . . . 73.35 109.81 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.693 HG23 ' HA ' ' D' ' 73' ' ' ALA . 5.3 p -82.93 -0.27 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.818 -172.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.452 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 80.2 t80 -57.82 -29.84 65.26 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.1 0.96 . . . . 75.45 111.098 164.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -78.95 4.36 14.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.705 0.802 . . . . 74.12 111.543 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -108.3 110.24 21.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.285 1.034 . . . . 74.41 108.717 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -112.59 48.83 0.97 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.343 1.057 . . . . 74.24 111.793 -164.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -154.29 -174.55 5.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.533 0.733 . . . . 73.22 110.403 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -72.24 126.8 90.97 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.147 0.579 . . . . 71.24 110.893 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.06 134.13 30.92 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.548 2.165 . . . . 74.21 111.898 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 38.1 mt-10 -60.14 115.08 3.21 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.218 0.949 . . . . 74.31 108.95 170.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.12 107.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.099 -1.075 . . . . 75.41 108.099 -176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' D' ' 65' ' ' THR . 0.2 OUTLIER -88.07 119.23 28.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.569 -1.271 . . . . 71.25 107.569 171.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.19 141.86 29.05 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.448 -0.945 . . . . 62.33 108.448 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -144.44 130.43 19.42 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.503 -0.925 . . . . 75.52 108.503 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.3 135.53 52.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.511 0.725 . . . . 74.34 109.958 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -144.67 156.96 44.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.505 1.122 . . . . 64.43 108.894 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -139.04 164.53 29.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 75.54 109.55 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 174.21 14.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.44 1.096 . . . . 73.52 108.594 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 95.8 p -164.14 157.57 18.25 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.006 0.432 . . . . 74.01 110.82 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.3 p -151.29 129.99 12.33 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.155 -0.93 . . . . 74.44 108.948 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.5 116.81 15.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.635 -0.505 . . . . 75.44 109.635 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' D' ' 57' ' ' GLU . 81.7 mt -92.64 -35.28 13.6 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.359 0.664 . . . . 74.43 109.709 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.545 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -154.99 -177.47 6.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.279 -0.873 . . . . 72.23 110.133 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.08 125.16 27.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.162 -1.051 . . . . 75.23 108.162 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.42 16.43 10.19 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.267 1.027 . . . . 75.31 112.271 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 65.2 t -136.72 127.19 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.569 1.147 . . . . 75.52 108.089 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.29 152.62 34.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.194 0.521 . . . . 74.4 110.102 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.6 tt0 -88.58 131.48 34.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.989 -1.005 . . . . 71.33 109.109 175.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.65 131.68 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.618 -1.253 . . . . 74.34 107.618 167.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.503 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 58.4 t -106.29 133.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.953 -0.758 . . . . 72.33 108.953 173.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -104.58 125.34 50.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.645 -1.613 . . . . 64.12 106.645 172.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.9 ttm-85 -106.97 100.2 9.72 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.211 -1.033 . . . . 71.14 108.211 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.79 121.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.298 -1.371 . . . . 74.53 107.298 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.0 m -124.84 128.99 49.54 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.454 0.645 . . . . 74.2 109.965 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.2 t -120.84 132.18 71.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.223 1.409 . . . . 75.11 109.171 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' D' ' 41' ' ' LYS . 89.0 m -128.65 98.75 5.11 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.649 -1.241 . . . . 74.44 107.649 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.13 141.95 28.9 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.869 -0.605 . . . . 72.33 109.599 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.445 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.7 p -143.14 129.13 19.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.41 0.443 . . . . 75.34 111.227 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 mt -108.99 99.76 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 73.13 108.751 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.87 -132.05 10.81 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.476 0.485 . . . . 60.03 111.972 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.94 5.03 52.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.463 0.705 . . . . 73.22 111.569 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -123.68 167.46 13.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.77 . . . . 71.4 110.557 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.9 m -77.68 132.01 37.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.2 -0.909 . . . . 74.54 110.293 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.693 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -82.53 -65.8 0.97 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.815 0.846 . . . . 74.52 108.73 176.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -154.75 170.39 21.71 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.202 -0.908 . . . . 75.12 110.116 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.0 mt -128.12 153.46 46.83 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.42 -1.326 . . . . 74.15 107.42 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.505 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.0 t -158.58 144.1 16.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.841 0.456 . . . . 71.43 110.253 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.34 124.44 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.244 -0.65 . . . . 75.11 109.244 170.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -125.75 116.2 45.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.47 0.708 . . . . 73.32 109.862 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.61 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -91.85 86.89 6.04 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.705 0.764 . . . . 74.14 109.809 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.72 98.36 7.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.112 1.365 . . . . 74.54 109.736 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.99 158.99 26.25 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.117 -0.393 . . . . 74.41 112.117 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.65 140.31 6.85 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.842 -0.503 . . . . 52.3 111.842 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.9 mt -91.55 120.89 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.518 0.727 . . . . 75.11 109.786 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -118.77 126.42 51.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 74.31 110.407 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 75.2 m -91.31 101.53 14.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.487 1.115 . . . . 71.33 109.541 171.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.87 141.76 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.072 0.549 . . . . 75.04 110.814 -177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.5 162.74 14.61 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.632 1.173 . . . . 73.22 109.129 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.79 77.52 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.356 0.41 . . . . 64.42 113.233 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.579 HG12 ' HB2' ' D' ' 94' ' ' MET . 0.1 OUTLIER -123.26 130.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 124.097 0.959 . . . . 73.15 109.462 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.89 170.77 15.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.894 0.878 . . . . 74.45 110.357 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.15 -141.98 33.6 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.211 -0.904 . . . . 71.42 113.569 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -75.32 -16.06 60.44 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.716 0.807 . . . . 62.32 111.948 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -60.85 -48.29 82.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.345 0.658 . . . . 75.33 109.992 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.662 ' HG3' HD23 ' D' ' 98' ' ' LEU . 11.2 tpt -80.97 -41.16 23.26 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.38 -0.827 . . . . 73.23 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.92 78.6 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 64.32 112.143 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.431 ' O ' ' HB1' ' D' ' 100' ' ' ALA . 80.4 t60 -76.84 -27.07 54.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.625 0.77 . . . . 72.25 110.69 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 37.3 t -75.33 -51.51 13.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.448 0.299 . . . . 73.51 111.273 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.662 HD23 ' HG3' ' D' ' 94' ' ' MET . 4.1 pp -67.38 -32.72 73.82 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.573 0.749 . . . . 74.41 112.217 -172.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.67 13.56 42.37 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.543 -0.587 . . . . 75.24 113.877 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' D' ' 96' ' ' HIS . . . -156.55 -59.86 0.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.35 0.575 . . . . 71.43 111.946 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.439 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 70.3 t80 -73.69 -42.29 61.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.888 0.699 . . . . 75.01 112.888 -168.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.04 -44.8 51.56 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.92 -0.562 . . . . 73.13 111.18 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.489 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.3 Cg_exo -56.74 -32.62 91.86 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.127 1.885 . . . . 72.54 113.663 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.18 -35.96 82.49 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.435 0.694 . . . . 75.44 111.272 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.87 -41.78 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.387 0.675 . . . . 71.33 110.208 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.8 mt -75.06 -21.22 59.13 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.955 -1.021 . . . . 74.23 111.757 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -64.9 -44.61 72.76 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.784 1.402 . . . . 62.22 114.784 -167.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.37 -39.53 86.89 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.244 1.963 . . . . 73.1 113.279 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -78.0 -37.69 46.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.014 -0.993 . . . . 71.23 110.932 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.41 90.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 72.02 110.694 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.444 ' NH2' HG22 ' B' ' 105' ' ' ILE . 40.1 ttp180 -57.47 -49.89 74.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.113 1.365 . . . . 74.44 111.009 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.17 -41.5 99.23 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.277 0.986 . . . . 75.02 111.648 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.465 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 45.0 t -56.58 -40.17 74.76 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.926 0.766 . . . . 75.24 110.896 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.505 HG23 ' SG ' ' D' ' 76' ' ' CYS . 39.8 mt -69.14 -50.36 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.088 -0.96 . . . . 72.14 110.087 175.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.431 HG22 ' HG3' ' D' ' 125' ' ' GLN . 20.2 m -52.05 -42.43 63.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.678 1.191 . . . . 72.15 111.981 -175.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -70.54 -43.45 69.52 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.894 -1.048 . . . . 73.42 110.948 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.62 -30.32 71.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.694 0.398 . . . . 61.03 111.615 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.4 t -66.17 -47.9 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.862 0.726 . . . . 73.44 110.346 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.3 p -71.43 -27.67 63.45 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.656 0.383 . . . . 73.15 111.061 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -75.9 -32.77 59.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.791 0.837 . . . . 73.24 109.795 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.64 -4.88 89.45 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 115.718 -0.674 . . . . 61.42 112.119 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 67.88 33.13 4.86 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.496 1.918 . . . . 70.52 113.117 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -102.6 166.22 12.37 Favored Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.806 1.242 . . . . 72.15 109.949 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.01 140.15 91.28 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 123.278 2.652 . . . . 73.32 112.889 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' D' ' 115' ' ' THR . 29.4 tt0 -52.18 140.06 22.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.087 0.867 . . . . 74.41 111.897 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.1 tp -128.3 106.12 8.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.634 -0.712 . . . . 74.25 109.519 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.0 106.29 8.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.832 0.853 . . . . 74.11 109.021 173.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.26 151.23 45.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 73.42 110.72 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.83 136.63 95.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.462 0.705 . . . . 71.13 111.16 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -69.5 113.11 3.22 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.005 1.804 . . . . 73.13 109.461 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.52 104.43 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.174 0.987 . . . . 72.44 109.663 -171.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 105.913 -1.884 . . . . 74.01 105.913 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.898 0.38 . . . . 73.01 110.282 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.407 ' CE2' ' SG ' ' A' ' 102' ' ' CYS . 58.1 t80 -98.54 139.82 33.69 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.098 -0.955 . . . . 74.34 108.513 162.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.603 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -156.39 137.37 13.55 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 112.329 0.492 . . . . 74.1 112.329 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 83' ' ' ILE . 7.9 tp -80.02 134.63 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.531 0.732 . . . . 74.13 110.149 169.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -101.77 -40.25 7.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.957 -0.757 . . . . 73.51 108.957 174.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -173.75 127.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.999 -0.524 . . . . 74.34 110.948 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.05 133.75 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.614 -0.884 . . . . 72.42 108.614 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 34.0 p90 -169.04 170.34 8.94 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.899 0.88 . . . . 74.34 110.578 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.8 p -93.39 120.08 33.26 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.32 -0.992 . . . . 73.45 108.32 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.7 mtpt -86.94 -42.94 12.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.204 -0.665 . . . . 75.5 109.204 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 12.0 t70 -135.16 128.51 32.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.145 -0.934 . . . . 70.54 108.499 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -122.95 143.28 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.952 -1.129 . . . . 73.41 107.952 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -143.5 125.91 15.73 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.798 -0.816 . . . . 70.23 108.798 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.564 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 89.9 t80 -131.1 129.87 42.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.586 -1.635 . . . . 74.11 106.586 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.91 138.83 47.09 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.313 -0.625 . . . . 72.11 109.313 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 76.18 11.39 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.385 -1.339 . . . . 72.03 107.385 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.53 -24.07 16.53 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.296 1.998 . . . . 73.32 111.202 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.03 25.76 7.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.078 0.951 . . . . 73.13 109.104 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' B' ' 17' ' ' TYR . . . -59.2 -47.64 97.93 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 124.389 1.075 . . . . 72.02 112.317 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.17 -27.99 84.68 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.982 1.788 . . . . 70.02 113.738 171.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -76.07 -48.79 19.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.7 0.8 . . . . 72.01 112.134 -173.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG21 HD11 ' A' ' 68' ' ' LEU . 7.4 p -57.11 -27.21 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.975 0.91 . . . . 75.43 112.362 -175.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.45 -36.32 75.73 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.381 1.072 . . . . 73.44 112.328 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.72 -12.39 20.02 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.063 0.545 . . . . 71.25 111.363 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.694 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 4.6 mmmp? -83.51 143.23 30.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.729 0.812 . . . . 74.54 111.972 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.47 143.59 57.69 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 124.324 1.015 . . . . 74.41 110.578 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.428 ' CE3' HD21 ' A' ' 68' ' ' LEU . 65.9 t-105 -93.0 86.69 5.5 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.758 0.79 . . . . 75.24 110.326 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -125.55 79.8 66.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 107.058 -1.46 . . . . 73.42 107.058 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 142.38 11.86 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.326 2.017 . . . . 72.31 112.928 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.55 86.04 3.49 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.257 -1.757 . . . . 74.41 106.257 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.49 93.76 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.02 -0.991 . . . . 74.31 108.966 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.3 tttt -79.22 124.42 28.35 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.55 -0.75 . . . . 75.3 109.096 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HG ' HD23 ' A' ' 128' ' ' LEU . 2.4 mm? -107.38 112.25 24.97 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.01 -1.107 . . . . 71.33 108.01 170.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 28.9 t70 -105.17 129.86 53.47 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.647 -0.872 . . . . 75.22 108.647 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.1 tp -106.04 131.93 52.73 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.174 -0.676 . . . . 75.43 109.174 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -143.0 152.61 42.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.131 -1.063 . . . . 74.32 108.131 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -138.01 156.59 47.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.929 0.892 . . . . 71.31 109.313 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 153.75 34.42 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.139 0.975 . . . . 75.34 108.797 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.46 152.43 51.52 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.896 0.478 . . . . 74.51 110.754 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -149.94 121.19 7.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.998 0.919 . . . . 63.12 109.046 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.37 -0.604 . . . . 74.13 109.37 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HG23 ' A' ' 83' ' ' ILE . 68.7 mt -88.58 -43.38 11.42 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.581 -0.736 . . . . 75.01 111.048 -175.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 -174.87 4.7 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.411 -0.813 . . . . 74.34 110.577 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -75.53 123.33 25.28 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.359 -0.837 . . . . 73.13 108.825 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.33 14.78 5.38 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.304 1.442 . . . . 73.21 111.77 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.26 114.13 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.771 0.828 . . . . 74.42 110.381 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -124.26 126.14 45.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.742 0.817 . . . . 72.23 108.992 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 33.8 tt0 -90.34 120.43 31.46 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.406 1.082 . . . . 60.15 109.152 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.499 HG21 ' HG ' ' A' ' 98' ' ' LEU . 21.5 t -102.61 116.71 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.73 -1.211 . . . . 53.2 107.73 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.0 t -99.23 126.28 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.038 -0.727 . . . . 74.11 109.038 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.27 115.67 31.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.349 -1.352 . . . . 75.01 107.349 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -108.83 105.38 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.42 0.628 . . . . 74.11 109.742 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -101.99 133.51 45.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.778 -1.101 . . . . 74.34 108.152 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.2 m -121.69 118.23 28.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.372 0.606 . . . . 73.34 110.528 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.7 t -105.6 107.08 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.701 -1.136 . . . . 75.45 108.931 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 12.4 m -106.51 131.78 53.28 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.625 -0.88 . . . . 75.34 108.625 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.78 107.78 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.073 -1.084 . . . . 72.24 108.073 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 44.8 m -115.24 126.98 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.643 0.377 . . . . 63.1 110.392 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.546 HD11 HG21 ' A' ' 31' ' ' VAL . 18.9 mt -88.97 58.95 4.8 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.093 -1.077 . . . . 75.54 108.093 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.36 -89.0 0.71 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-N 114.999 -1.001 . . . . 72.22 112.136 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -92.92 -28.1 16.67 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.049 0.94 . . . . 74.21 110.709 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.694 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -107.54 103.53 12.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.592 0.757 . . . . 75.5 109.631 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 91.8 m -66.03 130.34 42.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.638 0.654 . . . . 74.4 109.576 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.25 -56.3 4.57 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.806 0.843 . . . . 75.4 109.831 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.5 172.92 16.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.83 -1.077 . . . . 73.42 111.36 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -132.09 144.42 50.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.138 -1.392 . . . . 73.53 108.276 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -136.82 139.82 42.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.895 0.878 . . . . 72.14 108.665 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.453 ' HG2' ' OE1' ' A' ' 79' ' ' GLN . 43.6 tt0 -149.77 120.22 7.41 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.465 -0.568 . . . . 73.35 109.465 173.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.65 113.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.457 0.703 . . . . 71.21 110.485 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.453 ' OE1' ' HG2' ' A' ' 77' ' ' GLU . 1.7 mp0 -89.0 80.48 7.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.388 1.475 . . . . 74.24 108.36 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.36 94.27 3.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.713 -1.13 . . . . 73.14 108.879 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.88 140.74 19.65 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.409 -0.677 . . . . 64.41 111.409 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.619 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -142.89 122.22 1.88 Allowed Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.417 -1.073 . . . . 73.21 110.417 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.0 mt -83.74 125.91 40.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.685 -0.857 . . . . 72.4 108.685 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -128.36 120.47 27.06 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.079 -0.711 . . . . 64.24 109.079 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.3 t -81.27 102.17 10.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.504 0.722 . . . . 61.12 109.295 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 149.84 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.375 0.67 . . . . 73.23 110.402 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.07 177.06 2.01 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.708 1.203 . . . . 73.04 109.58 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.36 -34.35 4.19 Favored Glycine 0 N--CA 1.473 1.122 0 CA-C-N 116.126 -0.488 . . . . 73.44 114.076 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.55 150.85 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.97 0.908 . . . . 71.24 108.772 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.37 176.94 8.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.121 0.568 . . . . 74.51 112.065 -171.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.41 -126.71 40.52 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.118 -0.947 . . . . 74.25 113.089 172.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 40.9 p -71.45 -15.06 62.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.689 0.796 . . . . 71.35 112.568 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -72.15 -45.65 59.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.475 0.71 . . . . 63.4 110.584 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.97 -28.99 29.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.443 0.697 . . . . 74.43 109.981 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -72.93 -22.99 60.64 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.195 0.598 . . . . 62.51 111.177 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -65.89 -46.55 77.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.906 0.882 . . . . 74.43 109.616 169.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.598 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.4 m -60.55 -64.72 0.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.711 -1.131 . . . . 70.22 110.318 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.499 ' HG ' HG21 ' A' ' 58' ' ' VAL . 9.7 mp -73.8 -9.91 59.14 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.898 0.703 . . . . 73.54 112.898 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.89 -29.4 13.1 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.795 -0.447 . . . . 61.13 113.747 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.33 -44.47 0.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.876 0.695 . . . . 72.42 112.876 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.9 t80 -78.32 -60.44 2.37 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.246 0.618 . . . . 53.42 112.318 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 97' ' ' CYS . 59.1 m -66.64 -37.9 16.99 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 114.325 1.231 . . . . 64.21 114.325 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.51 -27.05 69.97 Favored 'Trans proline' 0 C--N 1.391 2.767 0 CA-C-N 121.391 1.533 . . . . 74.42 112.664 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -73.0 -26.5 61.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.974 0.509 . . . . 75.02 110.149 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -64.78 -43.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.311 0.576 . . . . 70.44 109.568 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.619 HD22 ' HA3' ' A' ' 82' ' ' GLY . 92.4 mt -76.85 -26.45 54.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.093 -0.958 . . . . 71.23 112.031 -175.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -64.32 -36.67 20.12 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.52 1.304 . . . . 62.44 114.52 -168.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 -34.37 95.03 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.074 1.849 . . . . 53.14 113.292 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -85.65 -36.29 20.39 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.667 0.787 . . . . 74.54 111.149 -174.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.89 85.03 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.377 -0.601 . . . . 65.42 109.377 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -53.16 -56.48 16.05 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.798 1.311 . . . . 63.51 109.492 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.8 -41.84 87.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.156 0.982 . . . . 74.02 111.8 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.479 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 48.3 t -62.5 -50.5 71.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.357 0.663 . . . . 74.44 110.674 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.531 HG21 HG22 ' A' ' 64' ' ' VAL . 89.7 mt -61.83 -51.22 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.92 0.763 . . . . 75.23 110.451 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.6 m -51.57 -45.16 63.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.923 1.289 . . . . 74.25 111.4 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -73.41 -41.49 63.23 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.841 -1.072 . . . . 64.31 110.833 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.564 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 21.5 mtp -55.13 -43.47 74.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.652 0.781 . . . . 75.11 111.424 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.08 -45.81 93.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.523 -1.217 . . . . 51.3 111.103 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.677 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.2 p -69.18 -32.52 71.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.383 0.273 . . . . 60.33 111.595 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.54 -28.43 67.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.614 0.766 . . . . 74.52 110.829 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.96 67.14 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.475 0.484 . . . . 63.11 113.496 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.413 ' HB ' HH21 ' B' ' 15' ' ' ARG . 9.5 m 64.07 43.24 5.2 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.74 1.216 . . . . 71.31 110.525 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.4 156.63 50.82 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 114.908 -1.042 . . . . 73.11 108.918 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.27 115.56 3.39 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.98 1.787 . . . . 72.43 110.395 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.677 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 8.5 pt20 -62.92 143.18 57.92 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.422 0.451 . . . . 65.33 110.222 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.84 122.16 46.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.88 -0.785 . . . . 73.55 108.88 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -97.11 94.15 6.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.429 HD23 ' HG ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -68.05 126.18 28.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.274 -0.875 . . . . 75.41 109.893 -172.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.08 128.13 93.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 O-C-N 123.466 0.479 . . . . 74.22 110.537 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.19 123.74 5.71 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.615 2.21 . . . . 74.34 111.567 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.4 112.43 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.129 -1.063 . . . . 73.11 108.129 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -90.91 72.26 6.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.082 -1.081 . . . . 72.32 108.082 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.032 -0.985 . . . . 71.43 111.103 -178.164 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.2 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.423 -1.325 . . . . 74.12 107.423 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -143.18 132.22 22.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.485 -0.932 . . . . 74.33 108.485 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -154.12 140.93 19.12 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.396 0.435 . . . . 53.13 111.702 173.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.562 HD12 HD11 ' B' ' 16' ' ' ILE . 58.8 mt -84.66 115.04 25.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.45 -0.944 . . . . 74.33 108.45 168.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -87.9 -35.07 17.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.604 0.565 . . . . 73.23 110.039 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.413 HH21 ' HB ' ' A' ' 122' ' ' THR . 70.8 ttt180 -167.27 137.73 2.98 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.045 -177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.562 HD11 HD12 ' B' ' 13' ' ' ILE . 98.0 mt -116.98 135.95 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.934 -1.506 . . . . 73.11 106.934 169.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 28' ' ' ALA . 16.2 p90 -168.99 152.04 5.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.274 0.559 . . . . 72.43 111.479 -170.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.2 m -83.04 121.48 27.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.343 -0.984 . . . . 75.34 108.343 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -92.24 -32.88 14.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.102 0.561 . . . . 73.34 110.773 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 25.7 t70 -155.95 142.42 18.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.981 -0.554 . . . . 75.45 110.851 -168.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 34.4 mm -138.87 142.08 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 62.51 108.881 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 41.4 t -141.36 133.76 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.451 -1.25 . . . . 52.33 107.856 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.0 t80 -147.34 107.54 4.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.493 -1.299 . . . . 74.45 107.493 171.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.45 120.97 39.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.127 0.971 . . . . 70.53 108.656 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.23 87.19 34.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.959 0.904 . . . . 70.15 109.857 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 -48.83 4.66 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.904 2.403 . . . . 64.14 112.672 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.494 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 28.1 m-80 -104.11 28.57 6.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.204 0.602 . . . . 73.33 110.66 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.522 ' HA ' ' HZ ' ' B' ' 123' ' ' PHE . . . -49.99 -51.66 59.58 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.885 1.274 . . . . 70.34 113.411 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 97.2 Cg_endo -86.98 -13.06 4.73 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.435 2.09 . . . . 62.42 113.394 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.494 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 88.3 m-70 -89.27 2.97 53.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.378 0.671 . . . . 73.24 111.078 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -62.66 -16.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.973 1.309 . . . . 72.22 111.942 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.893 0.877 . . . . 75.25 111.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.14 -45.91 72.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.775 -0.648 . . . . 62.13 110.806 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.644 ' HZ2' ' HB3' ' B' ' 71' ' ' GLU . 89.4 mttt -109.07 81.61 1.47 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.721 0.809 . . . . 74.03 109.511 -176.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -80.24 74.11 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.114 0.959 . . . . 70.43 111.41 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -159.29 174.28 15.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.997 1.319 . . . . 75.33 109.745 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.74 129.97 80.09 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 115.284 -0.871 . . . . 75.2 109.757 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.15 153.41 69.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.341 2.028 . . . . 72.4 111.723 167.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.3 mt-10 -65.65 99.79 0.47 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.05 -1.092 . . . . 73.13 108.05 172.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' B' ' 126' ' ' LEU . 21.7 t -87.18 117.43 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.413 -1.328 . . . . 74.13 107.413 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -151.67 132.86 14.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.066 -0.716 . . . . 74.24 109.066 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.615 ' HB3' HG21 ' B' ' 64' ' ' VAL . 1.5 pt? -128.92 164.55 22.89 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.032 0.444 . . . . 74.42 111.877 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -149.49 149.93 31.54 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.963 -1.017 . . . . 72.41 109.556 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.9 tt -107.14 136.69 46.56 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 74.5 111.121 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.697 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 1.2 m-20 -123.61 150.92 43.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.223 1.409 . . . . 73.14 107.574 172.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -136.41 134.19 37.5 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.77 147.38 27.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.348 1.059 . . . . 72.42 108.237 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -142.65 162.54 35.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.843 0.457 . . . . 74.12 110.555 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -154.33 166.4 33.33 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.566 1.146 . . . . 73.45 109.064 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -115.05 132.67 56.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.858 0.463 . . . . 73.41 110.373 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.93 -48.19 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.859 0.864 . . . . 74.25 110.063 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.86 -175.81 5.48 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.797 -1.092 . . . . 75.55 109.779 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -61.43 122.05 14.19 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.241 -0.89 . . . . 74.42 109.455 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 71.69 -5.29 1.69 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.23 1.412 . . . . 75.41 111.882 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -109.64 100.21 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.301 1.04 . . . . 75.13 108.715 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.49 172.44 6.97 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.623 0.769 . . . . 71.03 110.814 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -144.04 115.45 8.05 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.903 -1.517 . . . . 75.35 106.903 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' B' ' 98' ' ' LEU . 43.3 t -117.33 125.6 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.54 0.736 . . . . 74.13 109.805 -173.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.6 t -106.29 121.16 58.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.993 0.917 . . . . 73.2 110.319 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -93.81 114.47 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 107.653 -1.24 . . . . 72.52 107.653 170.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.697 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.0 ttm180 -100.64 112.56 24.96 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.11 118.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.11 -1.071 . . . . 74.41 108.11 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.2 m -115.9 137.08 52.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.616 0.766 . . . . 72.35 109.812 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' B' ' 42' ' ' LEU . 94.1 t -111.85 119.99 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.842 1.257 . . . . 74.22 110.453 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 67.5 m -89.67 140.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.896 -1.15 . . . . 63.41 107.896 165.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.54 143.61 26.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.013 -0.366 . . . . 71.02 110.013 175.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.6 p -156.03 135.2 12.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.687 0.625 . . . . 75.33 112.687 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -92.88 99.1 11.82 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.548 -1.279 . . . . 64.32 107.548 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.44 -130.93 41.13 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.65 0.594 . . . . 65.31 112.494 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -90.89 44.92 1.22 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.025 0.93 . . . . 74.22 110.091 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.644 ' HB3' ' HZ2' ' B' ' 34' ' ' LYS . 10.4 tp10 -158.06 139.02 13.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.455 0.702 . . . . 72.13 109.42 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.0 m -72.85 133.12 44.3 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.021 0.529 . . . . 71.43 110.466 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 -56.18 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.839 0.856 . . . . 71.43 109.281 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -152.85 165.93 33.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.301 -1.318 . . . . 72.12 109.83 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -140.73 121.07 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.419 -1.697 . . . . 73.3 106.419 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.549 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.4 t -116.31 158.96 22.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.319 -0.993 . . . . 74.41 108.319 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.3 tt0 -165.88 130.36 2.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.131 -0.692 . . . . 74.21 109.131 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -124.33 142.93 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.229 -1.026 . . . . 65.01 108.229 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -122.05 87.22 2.71 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.126 -1.065 . . . . 72.24 108.126 172.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -80.59 101.05 8.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.235 -1.348 . . . . 64.23 108.539 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.66 171.13 37.53 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.404 -0.678 . . . . 75.33 111.404 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.92 131.61 2.46 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.2 -0.76 . . . . 75.42 111.2 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.12 122.87 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.376 -1.342 . . . . 70.41 107.376 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -129.85 129.73 44.34 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.653 -1.24 . . . . 75.22 107.653 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -97.41 102.65 14.47 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.216 -0.661 . . . . 64.41 109.216 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.36 138.41 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.177 0.991 . . . . 74.03 110.901 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.8 172.06 19.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.449 1.099 . . . . 75.32 109.585 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -43.28 2.99 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-N 116.173 -0.467 . . . . 62.21 112.859 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 163.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.934 0.894 . . . . 75.33 111.019 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.37 143.82 15.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.005 0.522 . . . . 74.33 110.873 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.11 -104.36 0.45 Allowed Glycine 0 C--N 1.353 1.515 0 O-C-N 124.226 0.954 . . . . 44.12 114.121 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.3 m -65.88 -41.35 91.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.231 1.012 . . . . 65.03 110.258 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -61.33 -40.56 94.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.475 -0.784 . . . . 75.3 111.035 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.636 ' HE3' HD22 ' B' ' 98' ' ' LEU . 20.2 ttt -71.52 -40.7 69.93 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.509 0.505 . . . . 72.11 110.676 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.3 66.96 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.466 -0.788 . . . . 73.13 111.692 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -93.73 -21.22 19.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.973 0.909 . . . . 74.33 110.648 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -79.17 -67.2 0.78 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.563 -0.532 . . . . 75.14 109.563 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.636 HD22 ' HE3' ' B' ' 94' ' ' MET . 2.2 pp -95.34 -4.85 44.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.177 0.806 . . . . 71.01 113.177 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -3.21 56.59 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 120.04 -0.311 . . . . 73.53 112.665 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.05 -56.51 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.013 0.375 . . . . 74.13 112.013 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -74.78 -41.26 60.35 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.106 0.41 . . . . 75.51 112.106 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 85.6 m -68.9 -45.72 31.68 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.698 -0.668 . . . . 73.35 110.532 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.495 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.6 Cg_exo -55.69 -31.54 80.28 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.132 1.888 . . . . 73.52 113.895 165.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.409 HD21 ' HE1' ' B' ' 133' ' ' PHE . 54.6 t-20 -66.97 -40.79 87.53 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 122.886 0.474 . . . . 72.42 110.173 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.492 HG22 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -58.57 -49.17 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.66 0.784 . . . . 74.51 109.871 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.71 -9.64 59.67 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.781 -1.1 . . . . 74.43 112.005 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.502 ' HZ ' HD11 ' B' ' 128' ' ' LEU . 76.9 t80 -64.94 -51.06 59.18 Favored Pre-proline 0 N--CA 1.484 1.256 0 CA-C-O 117.991 -1.004 . . . . 74.12 113.402 -172.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.79 -35.8 87.14 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.788 1.658 . . . . 74.25 112.174 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.431 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.7 m-85 -64.17 -47.87 78.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.745 0.818 . . . . 74.34 110.858 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.61 91.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.379 -0.828 . . . . 54.14 110.467 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -65.1 -45.0 86.99 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.375 1.07 . . . . 75.31 109.948 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.08 -37.82 69.52 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.148 -0.933 . . . . 72.11 110.132 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 10.0 t -64.97 -35.69 82.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.945 0.498 . . . . 75.3 110.993 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.7 -53.31 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.22 0.608 . . . . 72.01 109.778 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -56.74 -31.55 64.68 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.139 0.899 . . . . 73.13 110.892 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -64.38 -53.26 51.42 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 114.805 -1.089 . . . . 74.51 110.111 172.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.4 mmt -66.53 -33.84 76.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.065 0.394 . . . . 72.02 112.065 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.25 -40.86 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.731 0.812 . . . . 71.32 109.906 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.6 p -73.03 -29.31 62.89 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.022 -0.535 . . . . 75.35 111.642 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.479 ' NH1' ' HA ' ' A' ' 113' ' ' CYS . 72.5 mtt-85 -65.73 -36.9 84.92 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.46 -0.791 . . . . 75.43 109.484 172.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.98 3.61 69.88 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 124.024 0.827 . . . . 75.31 113.5 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.4 p 59.56 29.67 19.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.824 1.65 . . . . 73.11 112.748 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.522 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 63.7 m-85 -102.24 155.51 36.39 Favored Pre-proline 0 N--CA 1.488 1.461 0 C-N-CA 124.206 1.003 . . . . 73.42 111.278 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.65 178.85 0.83 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.731 2.954 . . . . 74.04 115.662 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -64.93 152.85 42.13 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.56 -1.655 . . . . 73.31 114.573 -162.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.573 HD22 HD12 ' B' ' 42' ' ' LEU . 26.6 tp -149.32 106.08 3.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.003 -1.453 . . . . 75.22 108.861 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.52 92.36 2.9 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.588 -1.264 . . . . 73.24 107.588 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.524 HD12 HD11 ' B' ' 42' ' ' LEU . 2.4 tt -58.95 141.45 53.68 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.745 -1.116 . . . . 75.45 109.649 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.452 ' N ' HD21 ' B' ' 128' ' ' LEU . . . -57.46 106.48 0.69 Allowed Pre-proline 0 N--CA 1.477 0.912 0 O-C-N 124.359 1.037 . . . . 65.33 110.831 173.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.642 ' HB2' ' HB ' ' D' ' 16' ' ' ILE . 6.1 Cg_exo -79.3 123.16 5.42 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.662 2.241 . . . . 72.21 109.739 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' D' ' 13' ' ' ILE . 10.0 p -155.44 155.34 5.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 123.694 0.621 . . . . 74.54 109.732 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.496 ' H ' HD12 ' D' ' 13' ' ' ILE . 32.6 t30 -69.09 114.47 7.39 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 107.784 -1.191 . . . . 75.41 107.784 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.409 ' HE1' HD21 ' B' ' 104' ' ' ASN . 46.3 p90 . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 124.507 1.123 . . . . 74.12 112.015 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 38.9 m . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 107.553 -1.277 . . . . 52.24 107.553 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -120.94 119.01 31.35 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.133 -1.432 . . . . 72.44 107.133 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -146.13 136.3 23.71 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 171.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.429 HD13 ' O ' ' C' ' 83' ' ' ILE . 5.5 tp -80.47 132.17 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.369 -0.832 . . . . 73.23 108.79 169.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.462 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 76.2 mm-40 -99.59 -45.61 5.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.263 -0.881 . . . . 71.23 109.866 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -165.41 122.03 1.44 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.512 -0.767 . . . . 72.41 109.174 -170.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 56.1 mt -112.95 134.53 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.319 -1.363 . . . . 74.04 107.319 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.507 ' HH ' HD11 ' C' ' 83' ' ' ILE . 18.9 p90 -173.71 168.86 4.32 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 123.816 0.698 . . . . 73.04 110.636 -173.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -91.3 128.29 37.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.26 -0.882 . . . . 74.52 109.615 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.469 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 30.0 mmtp -80.01 -52.79 7.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.577 0.703 . . . . 75.11 109.413 170.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 28.9 t70 -135.75 115.09 12.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.6 -1.182 . . . . 75.21 109.267 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 54.8 mt -111.27 139.46 35.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.515 -1.661 . . . . 74.32 106.515 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -152.74 142.51 22.01 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.276 0.56 . . . . 43.32 109.819 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -132.48 133.77 44.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.322 -1.362 . . . . 74.54 107.322 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -125.89 127.55 46.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.954 -1.128 . . . . 74.31 107.954 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.7 76.61 12.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.867 -1.16 . . . . 63.01 107.867 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.62 -27.57 22.2 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.486 2.124 . . . . 63.44 110.785 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -106.56 29.12 7.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.484 1.113 . . . . 61.43 109.558 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -58.59 -50.67 86.76 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.072 1.138 . . . . 72.45 114.072 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 86.4 Cg_endo -86.21 -15.99 4.28 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.367 1.378 . . . . 73.44 112.356 171.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -72.12 -29.65 64.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.429 1.092 . . . . 73.52 111.548 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.616 HG23 HD12 ' C' ' 68' ' ' LEU . 14.7 p -79.03 -18.15 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.69 0.796 . . . . 74.0 111.842 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -53.99 -41.65 68.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.487 1.115 . . . . 72.33 112.201 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 52.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.509 -0.922 . . . . 71.3 108.509 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' C' ' 71' ' ' GLU . 0.1 OUTLIER -125.56 164.92 19.48 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.816 -0.552 . . . . 73.43 110.337 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.34 104.06 1.77 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.542 -0.91 . . . . 63.22 108.542 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.93 88.46 7.44 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.252 1.025 . . . . 74.22 112.616 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -133.1 71.43 77.46 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.62 1.168 . . . . 74.13 108.611 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.33 127.26 12.44 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.473 2.115 . . . . 73.13 111.638 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -87.09 112.91 22.37 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 72.22 108.525 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.454 HG11 HD23 ' C' ' 126' ' ' LEU . 21.8 t -79.88 80.49 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.141 -0.936 . . . . 71.42 108.691 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.509 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 25.5 tptp -90.95 102.03 14.79 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.585 -0.894 . . . . 65.32 108.585 -175.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.91 152.54 22.0 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.605 -0.725 . . . . 72.11 109.817 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 4.6 m-20 -139.75 136.36 34.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.075 0.95 . . . . 74.21 109.336 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 42.0 tp -112.8 108.88 18.04 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.768 0.827 . . . . 71.51 109.283 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 14.4 t70 -113.77 148.05 37.22 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.64 -1.245 . . . . 72.31 107.64 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 63.2 m -126.97 126.38 43.1 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.934 0.494 . . . . 62.14 109.884 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.13 146.32 45.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.11 -1.07 . . . . 75.14 108.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -149.37 143.66 25.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.77 0.828 . . . . 73.32 109.049 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 34.8 p -154.66 129.28 9.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.369 0.667 . . . . 73.03 110.45 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.29 133.95 42.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 110.037 -0.357 . . . . 75.13 110.037 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 83' ' ' ILE . 47.8 mt -98.66 -52.92 3.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.96 0.904 . . . . 71.24 110.417 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.92 -170.78 3.55 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.304 -0.862 . . . . 74.4 110.581 -170.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.44 109.64 3.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.135 0.974 . . . . 55.12 110.1 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 67.74 -4.02 1.04 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.911 1.285 . . . . 72.52 112.762 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.9 t -92.93 111.96 25.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 N-CA-C 108.308 -0.997 . . . . 72.4 108.308 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -119.04 157.88 26.93 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.197 0.999 . . . . 71.1 108.433 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.62 139.44 53.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.578 -0.897 . . . . 72.3 108.578 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.57 116.84 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.307 -1.368 . . . . 74.12 107.307 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.81 105.54 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.523 -0.917 . . . . 64.51 108.523 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.11 122.16 29.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.841 -1.17 . . . . 74.33 107.841 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 60.0 mtp180 -105.44 114.04 27.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.834 0.854 . . . . 75.13 110.036 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.518 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.9 t -106.91 128.24 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.1 -0.704 . . . . 72.45 109.1 172.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 14.3 m -111.59 138.14 48.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.473 -0.936 . . . . 65.42 108.473 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.701 HG23 HG21 ' C' ' 114' ' ' ILE . 97.5 t -123.19 112.22 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.957 -1.127 . . . . 73.44 107.957 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.75 142.57 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.86 -0.793 . . . . 72.52 108.86 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.17 102.9 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.758 -1.571 . . . . 74.22 106.758 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -136.77 142.82 42.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.38 0.61 . . . . 72.15 111.275 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.616 HD12 HG23 ' C' ' 31' ' ' VAL . 17.6 mt -94.02 30.62 1.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.405 1.482 . . . . 74.31 109.369 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.93 -110.58 2.81 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 109.773 -1.331 . . . . 63.51 109.773 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 -22.45 19.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.071 0.548 . . . . 74.42 110.513 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' C' ' 34' ' ' LYS . 11.4 tp10 -79.58 90.1 5.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.03 0.932 . . . . 74.13 109.706 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -73.04 123.25 23.16 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 120.953 0.406 . . . . 75.12 110.987 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.24 26.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.68 1.192 . . . . 74.42 109.779 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.08 168.57 24.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.223 -0.899 . . . . 71.35 110.896 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -136.44 136.52 39.58 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.311 -1.737 . . . . 64.25 106.311 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -146.8 113.05 5.87 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.097 0.408 . . . . 71.1 109.989 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -118.43 133.21 56.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.546 -0.538 . . . . 72.03 109.546 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.9 t -119.3 143.36 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.508 -0.923 . . . . 75.31 108.508 169.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -119.57 94.44 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.246 -1.02 . . . . 75.05 108.246 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -81.77 106.49 13.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.783 0.833 . . . . 73.02 110.822 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.01 146.8 23.27 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.201 -0.454 . . . . 74.32 112.542 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.436 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.16 120.72 1.29 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.23 -0.748 . . . . 74.03 111.23 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 51' ' ' LEU . 14.8 mm -90.97 115.51 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.18 -0.674 . . . . 70.35 109.18 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -120.9 117.37 27.19 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.642 -0.873 . . . . 73.0 108.642 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -88.46 104.75 17.09 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.608 -1.256 . . . . 71.35 107.608 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' C' ' 10' ' ' THR . 1.8 pp -130.97 138.25 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.296 0.638 . . . . 75.23 112.038 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.74 163.02 18.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.813 1.245 . . . . 55.14 109.83 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 -26.2 7.88 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.293 -0.412 . . . . 63.1 113.287 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.47 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.443 1.097 . . . . 74.42 110.213 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.839 -0.43 . . . . 74.21 109.839 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.47 ' HB3' HG12 ' C' ' 89' ' ' ILE . 14.3 ptp -77.58 -28.19 51.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.847 0.459 . . . . 73.14 111.897 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.53 -45.48 75.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.34 0.656 . . . . 74.34 110.802 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -78.76 -33.98 46.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.073 -0.512 . . . . 73.54 110.259 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 38.8 t -63.82 -59.99 3.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.96 0.504 . . . . 72.33 111.047 -177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 tt -71.63 -35.84 70.54 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.521 -0.548 . . . . 74.14 109.521 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.66 -4.68 90.22 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.163 -0.798 . . . . 70.04 114.882 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -155.08 -60.47 0.11 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.396 1.098 . . . . 72.12 112.143 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -60.68 -60.54 3.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.006 0.923 . . . . 73.43 113.26 -165.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 64.7 m -59.72 -47.71 96.87 Favored Pre-proline 0 CA--C 1.564 1.512 0 N-CA-C 113.181 0.808 . . . . 75.31 113.181 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.24 -32.05 42.95 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 120.982 1.386 . . . . 75.42 113.014 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -67.78 -27.88 67.13 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.958 0.503 . . . . 62.22 110.625 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.83 -42.61 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 65.12 110.15 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.436 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -78.87 -21.63 47.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.427 -0.806 . . . . 73.53 112.342 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -55.64 -51.98 75.73 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 117.799 -1.096 . . . . 73.14 113.881 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.28 -33.97 92.57 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.026 1.817 . . . . 70.44 113.508 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.89 -45.92 66.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 75.4 110.807 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.02 90.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.446 0.698 . . . . 74.41 110.382 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -54.47 -53.23 57.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.742 1.617 . . . . 75.4 111.127 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.4 -34.34 75.85 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.618 0.767 . . . . 72.42 110.65 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.6 t -70.45 -33.88 71.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.381 0.673 . . . . 74.21 112.107 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.701 HG21 HG23 ' C' ' 64' ' ' VAL . 92.5 mt -72.58 -49.08 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.014 0.526 . . . . 73.32 109.742 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.6 HG22 ' HB2' ' C' ' 125' ' ' GLN . 99.3 m -57.12 -33.98 67.9 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.158 0.911 . . . . 75.33 111.321 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.5 t -58.66 -57.36 13.33 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.57 -1.195 . . . . 73.32 109.743 170.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.617 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.22 -42.53 86.45 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.159 1.384 . . . . 75.21 113.914 -175.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.19 -47.33 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 123.635 0.584 . . . . 72.24 109.836 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -72.29 -22.56 61.18 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.888 -1.051 . . . . 74.25 111.777 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 86.0 mtt-85 -71.06 -39.26 72.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.118 0.567 . . . . 71.34 109.863 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' D' ' 17' ' ' TYR . . . -79.95 5.26 62.77 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.893 0.746 . . . . 63.42 112.591 171.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.658 ' HB ' HH21 ' D' ' 15' ' ' ARG . 43.0 p 58.04 38.71 26.7 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 74.23 112.143 174.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -102.32 164.15 16.28 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.046 1.338 . . . . 74.23 108.792 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.49 102.54 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.08 1.853 . . . . 74.5 112.336 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.6 ' HB2' HG22 ' C' ' 115' ' ' THR . 0.0 OUTLIER -60.63 140.87 57.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.154 0.582 . . . . 74.13 110.267 177.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.454 HD23 HG11 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -112.2 144.2 41.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.237 0.615 . . . . 74.23 110.912 -173.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -118.21 93.3 4.08 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.948 -1.13 . . . . 65.13 107.948 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.87 133.04 40.67 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.684 -1.144 . . . . 74.42 107.95 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.29 146.99 77.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 124.293 0.996 . . . . 74.51 111.09 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.21 100.63 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.117 2.545 . . . . 74.2 112.728 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.28 82.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.378 -0.828 . . . . 64.23 109.635 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.86 105.49 17.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.49 -1.3 . . . . 64.44 107.49 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 t80 . . . . . 0 N--CA 1.488 1.474 0 C-N-CA 123.424 0.69 . . . . 73.44 112.176 -176.995 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.241 0.65 0 N-CA-C 109.238 -0.653 . . . . 74.21 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 63.9 t80 -162.58 89.26 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.354 -2.091 . . . . 75.23 105.354 174.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -131.13 144.83 51.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.908 -1.145 . . . . 71.11 107.908 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.496 HD12 ' H ' ' B' ' 132' ' ' ASN . 47.8 mt -104.12 120.17 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 117.676 0.216 . . . . 64.2 111.452 -170.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.34 -28.47 34.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.593 0.757 . . . . 73.13 111.39 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.658 HH21 ' HB ' ' C' ' 122' ' ' THR . 14.1 tpt180 177.89 156.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.691 0.396 . . . . 74.24 110.242 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' B' ' 130' ' ' PRO . 17.8 mt -141.14 127.52 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 106.439 -1.689 . . . . 75.22 106.439 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.436 ' HB2' ' HA2' ' C' ' 121' ' ' GLY . 47.3 p90 -165.71 173.35 10.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.053 0.93 . . . . 74.52 110.906 -172.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.084 -1.417 . . . . 74.33 109.606 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -82.25 -17.95 44.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.104 -0.702 . . . . 74.35 109.104 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -158.17 135.92 10.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.117 1.367 . . . . 75.43 109.03 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.617 HG21 ' HE1' ' C' ' 117' ' ' MET . 21.1 mt -137.61 145.27 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.877 -1.157 . . . . 63.04 107.877 170.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -144.02 141.29 30.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.391 0.676 . . . . 73.44 110.224 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.1 t80 -147.53 122.61 10.13 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 105.842 -1.91 . . . . 74.11 105.842 169.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.16 123.47 28.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.118 -1.438 . . . . 64.44 107.118 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.04 78.33 41.91 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.545 -0.909 . . . . 64.33 108.545 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.24 -41.81 6.54 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.116 2.544 . . . . 73.43 112.963 -165.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 58.0 m-20 -106.47 17.9 22.7 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 123.884 0.873 . . . . 75.15 110.231 -175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -42.61 -51.29 11.94 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 116.369 1.988 . . . . 72.34 116.369 -164.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 14.9 Cg_endo -88.05 -14.38 3.45 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.807 1.671 . . . . 64.15 113.92 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -75.72 -40.57 55.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.417 1.087 . . . . 72.54 109.034 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.02 -1.07 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 114.702 -1.135 . . . . 75.21 110.257 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.17 -34.95 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.918 1.287 . . . . 74.11 110.578 164.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.95 -12.76 61.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.806 1.243 . . . . 72.44 112.156 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -89.94 101.93 14.63 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.097 0.959 . . . . 62.34 109.188 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -99.37 52.56 0.95 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.145 0.978 . . . . 71.55 111.234 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.45 -169.46 3.22 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.489 -0.778 . . . . 72.33 109.246 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -78.07 118.27 71.14 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.243 1.017 . . . . 74.23 111.528 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.47 97.39 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.304 2.003 . . . . 73.33 109.682 167.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.63 115.51 4.79 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 124.337 1.023 . . . . 74.43 109.847 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -97.09 113.31 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.908 0.861 . . . . 74.12 109.555 -174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.548 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.8 tmtt? -88.3 118.56 27.99 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.175 -1.417 . . . . 75.11 107.175 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.45 HD21 HD23 ' D' ' 128' ' ' LEU . 10.2 mp -94.27 144.33 25.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.623 -0.88 . . . . 72.31 108.623 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 24.6 t70 -145.27 118.66 9.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.142 -0.936 . . . . 64.21 108.839 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.79 130.39 44.05 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.342 0.657 . . . . 73.11 109.869 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -147.09 157.43 43.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.144 -1.058 . . . . 61.21 108.144 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -146.41 166.28 26.86 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.939 0.495 . . . . 72.33 110.479 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 166.72 31.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.457 1.103 . . . . 65.14 109.484 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -149.12 153.85 38.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.268 0.627 . . . . 61.11 109.743 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.5 126.83 9.26 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.502 0.721 . . . . 72.22 109.138 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' D' ' 55' ' ' VAL . 52.2 tt0 -71.84 119.27 15.78 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.536 -0.542 . . . . 75.12 109.536 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.15 -38.1 12.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.2 0.524 . . . . 72.13 110.12 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.08 174.4 11.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.803 -1.09 . . . . 61.31 109.561 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.67 133.25 45.54 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.245 -0.889 . . . . 74.01 109.534 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.88 15.4 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.797 1.239 . . . . 74.04 112.057 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' D' ' 50' ' ' GLN . 87.6 t -130.54 129.6 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.221 0.608 . . . . 74.12 110.784 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.14 129.36 41.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.016 0.926 . . . . 75.23 109.066 171.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -95.48 111.58 23.46 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.709 -0.848 . . . . 75.42 108.709 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 41.5 t -100.52 124.37 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.27 -1.011 . . . . 75.23 108.27 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.517 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.9 t -101.06 135.27 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.754 0.822 . . . . 71.42 109.282 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.65 43.66 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.897 -1.149 . . . . 73.32 107.897 175.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -98.75 108.37 21.04 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.708 HG23 ' HB1' ' D' ' 110' ' ' ALA . 48.1 t -105.35 116.66 49.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.966 -1.124 . . . . 71.54 107.966 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.588 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.6 m -111.81 137.1 50.22 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.156 0.503 . . . . 72.4 109.892 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.431 HG22 HG23 ' D' ' 114' ' ' ILE . 37.7 t -132.48 100.01 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.129 1.372 . . . . 74.43 107.885 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 40.3 m -96.51 94.59 7.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.409 -1.33 . . . . 71.54 107.409 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.83 141.23 30.28 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.577 -0.527 . . . . 72.4 109.577 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.437 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.88 137.46 18.79 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.502 0.501 . . . . 72.53 111.798 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 12.1 mt -110.53 107.85 17.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.919 1.288 . . . . 74.0 109.059 172.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -143.55 37.27 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.553 0.533 . . . . 75.2 112.183 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 8.24 15.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.629 0.772 . . . . 74.52 111.866 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.431 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.7 pt-20 -121.78 157.13 31.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.371 0.668 . . . . 63.34 109.894 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.3 m -73.05 141.02 47.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.67 -0.695 . . . . 73.42 110.534 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.56 -58.36 2.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.873 -1.158 . . . . 73.54 107.873 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -160.45 143.19 13.2 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 115.405 -0.816 . . . . 74.12 110.902 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.09 111.03 23.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.159 0.984 . . . . 74.12 109.209 171.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.552 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 42.5 t -125.06 133.72 52.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.427 0.691 . . . . 73.35 109.509 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -154.99 135.25 13.18 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.275 -0.639 . . . . 75.31 109.275 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . 0.541 HG21 HG22 ' D' ' 21' ' ' ILE . 97.6 t -127.23 142.32 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.686 0.795 . . . . 73.51 109.191 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.609 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 16.2 mt-30 -115.25 91.42 3.6 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.757 0.823 . . . . 75.14 109.078 171.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.61 93.04 6.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.899 -1.501 . . . . 65.54 108.861 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.32 141.26 18.94 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.282 -0.727 . . . . 74.35 111.282 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.53 130.57 4.63 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.558 -1.017 . . . . 73.34 110.558 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.63 121.01 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.069 -1.085 . . . . 71.32 108.069 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.5 122.6 35.64 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.584 0.754 . . . . 74.33 109.591 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -75.87 103.1 5.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.118 -0.697 . . . . 73.44 109.118 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.82 136.78 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.406 0.683 . . . . 74.24 110.546 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.88 160.95 12.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.215 1.006 . . . . 62.23 109.062 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.5 14.14 74.6 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 121.807 -0.235 . . . . 73.14 113.61 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.575 HD11 ' SD ' ' D' ' 94' ' ' MET . 1.8 pp -114.34 143.17 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 75.54 110.248 -174.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.13 177.4 4.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.719 0.807 . . . . 73.24 110.084 175.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.84 -137.87 39.29 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.561 0.538 . . . . 75.23 112.709 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.8 m -68.63 -30.73 69.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.384 1.074 . . . . 72.44 111.692 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.48 -49.3 75.95 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.49 0.716 . . . . 74.31 110.559 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.575 ' SD ' HD11 ' D' ' 89' ' ' ILE . 10.0 tpt -76.5 -33.53 58.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.1 0.56 . . . . 73.24 111.245 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.48 80.42 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.677 0.751 . . . . 73.32 110.633 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -80.15 -38.65 30.99 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.382 -1.281 . . . . 73.22 110.738 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 43.5 t -63.4 -45.11 92.55 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.082 0.553 . . . . 75.52 111.486 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.01 -54.11 6.35 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.743 0.817 . . . . 74.34 110.73 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.11 -4.7 83.94 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 115.005 0.762 . . . . 74.41 115.005 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.44 -49.74 0.41 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.992 0.896 . . . . 71.14 112.126 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 56.9 t80 -76.04 -37.39 58.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.795 0.438 . . . . 75.21 111.582 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 72.1 m -65.06 -50.07 63.66 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.539 -0.743 . . . . 45.44 110.386 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -51.22 -36.02 54.82 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.299 1.999 . . . . 72.02 114.254 167.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.37 -40.15 93.18 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.488 0.715 . . . . 70.31 111.022 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.81 -43.28 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.674 0.79 . . . . 74.52 110.348 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.2 -20.41 59.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.122 -0.944 . . . . 71.2 111.867 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -66.34 -41.4 41.69 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.469 1.285 . . . . 74.44 114.469 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.44 -45.18 41.52 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.937 1.758 . . . . 74.12 112.846 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -75.06 -35.83 61.85 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.892 0.877 . . . . 73.24 111.219 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.708 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -64.04 -52.44 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.094 0.957 . . . . 74.02 110.243 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.492 ' NH2' HG22 ' B' ' 105' ' ' ILE . 33.9 ttp180 -57.37 -49.84 74.87 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.231 -1.35 . . . . 75.41 109.993 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.47 -41.5 89.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.501 1.126 . . . . 75.23 111.775 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.46 ' SG ' HD11 ' D' ' 21' ' ' ILE . 36.6 t -57.96 -44.05 86.79 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.899 0.749 . . . . 55.24 110.689 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' D' ' 118' ' ' VAL . 71.1 mt -67.81 -49.16 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.68 0.792 . . . . 74.13 110.498 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.42 HG23 ' HG3' ' D' ' 125' ' ' GLN . 91.1 m -52.42 -48.11 65.92 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.379 1.472 . . . . 74.32 112.095 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -67.91 -41.24 82.96 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.369 -1.287 . . . . 73.25 110.533 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.552 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.1 mtm -65.15 -34.79 79.23 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.818 0.447 . . . . 73.45 111.964 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.3 t -66.4 -44.18 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 123.718 0.637 . . . . 75.41 110.295 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -71.8 -31.59 66.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.353 -0.385 . . . . 72.12 110.783 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -69.02 -27.65 65.87 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.747 0.819 . . . . 75.45 110.06 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.24 11.26 68.14 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.873 0.733 . . . . 64.54 112.901 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.497 HG22 ' HB3' ' C' ' 17' ' ' TYR . 42.2 p 56.02 33.8 22.51 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.829 1.651 . . . . 72.13 113.08 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.457 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 39.1 m-85 -110.98 166.37 10.89 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 125.141 1.376 . . . . 73.41 109.725 175.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 41.5 Cg_endo -61.42 123.46 12.82 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.046 2.497 . . . . 73.03 112.167 -176.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.42 ' HG3' HG23 ' D' ' 115' ' ' THR . 50.6 tt0 -52.06 122.21 8.09 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.051 0.844 . . . . 71.23 110.397 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 36.8 tp -103.9 93.91 5.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.391 0.615 . . . . 71.2 109.658 -166.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.53 82.44 2.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.01 -0.996 . . . . 72.12 108.481 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.45 HD23 HD21 ' D' ' 42' ' ' LEU . 95.9 mt -67.4 139.54 57.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.16 -0.927 . . . . 73.23 110.669 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 143.83 98.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.426 0.691 . . . . 64.41 110.779 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.36 142.18 14.74 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.059 1.839 . . . . 73.24 110.233 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.76 108.78 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 107.967 -1.124 . . . . 72.21 107.967 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 . . . . . 0 C--O 1.239 0.549 0 N-CA-C 107.223 -1.399 . . . . 75.54 107.223 174.843 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.24 0.601 0 N-CA-C 108.29 -1.004 . . . . 71.54 108.29 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.44 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 72.1 t80 -95.38 142.39 27.82 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.658 -0.867 . . . . 72.51 108.658 168.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -162.14 137.26 7.15 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.678 0.611 . . . . 72.01 112.501 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.406 HD11 ' CE2' ' A' ' 84' ' ' PHE . 3.8 tp -75.96 121.6 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.516 1.126 . . . . 74.22 109.16 170.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -107.09 -13.8 15.08 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-O 117.781 -1.105 . . . . 72.5 112.163 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 178.38 126.58 0.05 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 119.193 0.906 . . . . 74.1 110.691 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.453 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 77.2 mt -106.44 131.62 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.015 -1.105 . . . . 70.42 108.015 172.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 11.7 p90 -158.67 170.06 23.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.6 0.714 . . . . 75.11 111.136 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -99.5 114.31 27.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.795 -1.093 . . . . 72.43 108.71 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -77.65 -38.77 47.08 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.552 -0.536 . . . . 74.34 109.552 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.84 136.13 32.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.592 -1.186 . . . . 73.31 109.343 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.1 mt -129.95 130.34 66.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.107 -1.442 . . . . 75.21 107.107 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -136.32 106.1 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.523 -0.917 . . . . 73.54 108.523 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.1 t80 -120.65 110.09 16.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.178 -1.786 . . . . 70.24 106.178 167.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -119.43 127.11 52.79 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.278 0.631 . . . . 74.41 109.379 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.24 79.4 70.07 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.648 -1.241 . . . . 74.42 107.648 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.07 -22.07 23.21 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.889 2.393 . . . . 74.21 112.372 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -119.07 33.12 5.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.179 0.992 . . . . 72.24 109.048 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.16 -44.69 99.83 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.773 1.229 . . . . 71.23 113.331 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.47 -29.68 71.38 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.463 1.442 . . . . 70.34 112.555 173.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -76.62 -28.73 56.21 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.516 -0.766 . . . . 73.11 111.828 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.6 p -61.74 -23.08 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 118.193 0.451 . . . . 73.35 112.143 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.61 -39.65 67.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.176 0.99 . . . . 75.3 110.869 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -88.39 -19.59 26.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 71.41 110.744 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.38 148.83 33.53 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.419 0.688 . . . . 74.02 110.289 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.36 127.47 32.78 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 74.24 108.327 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.445 ' CE3' HD21 ' A' ' 68' ' ' LEU . 25.3 t-105 -86.26 84.94 7.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.578 0.704 . . . . 75.11 110.182 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 80.32 68.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.283 -1.377 . . . . 71.32 107.283 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.67 153.26 17.58 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.929 2.419 . . . . 74.42 113.154 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -96.06 90.72 5.64 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.001 -1.111 . . . . 71.1 108.001 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 m -69.98 93.18 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.381 1.086 . . . . 71.31 109.532 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -103.34 121.0 41.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.751 -1.113 . . . . 75.23 109.951 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.34 132.33 43.17 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.044 0.937 . . . . 71.51 109.348 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.747 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.4 m-20 -126.56 132.45 51.32 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.025 0.93 . . . . 74.33 108.754 176.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.746 -0.835 . . . . 74.4 108.746 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -134.29 145.42 49.07 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.679 -0.489 . . . . 70.24 109.679 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 m -109.42 121.38 45.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.865 0.866 . . . . 72.11 108.864 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.97 123.37 27.23 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 107.412 -1.329 . . . . 72.33 107.412 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.6 m -133.16 152.63 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.661 0.384 . . . . 74.35 110.704 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -149.96 130.84 14.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.838 0.855 . . . . 63.05 109.311 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -87.79 117.82 26.89 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.866 -0.791 . . . . 74.4 108.866 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 57' ' ' GLU . 54.9 mt -84.63 -44.57 13.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.543 0.737 . . . . 73.14 110.696 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.47 -171.94 4.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.692 0.797 . . . . 63.13 109.923 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -59.96 102.75 0.17 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.375 0.67 . . . . 74.02 110.39 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 65.3 12.11 7.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.823 1.249 . . . . 74.41 112.997 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.83 113.82 36.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.859 -1.534 . . . . 74.13 106.859 171.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -108.82 165.91 11.21 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.199 1.0 . . . . 74.13 111.3 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HB2' HD13 ' A' ' 51' ' ' LEU . 28.0 tt0 -131.26 118.59 20.6 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 112.574 -2.103 . . . . 74.34 106.862 164.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.61 117.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.344 -1.724 . . . . 71.42 106.344 170.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.536 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.4 t -97.9 127.99 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.114 -0.698 . . . . 71.3 109.114 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 109.85 21.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.427 -1.323 . . . . 75.45 107.427 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -106.01 106.74 17.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.019 -0.991 . . . . 73.2 109.559 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.95 133.47 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 114.95 -1.023 . . . . 75.4 108.553 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.747 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.8 m -117.69 131.71 56.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.912 -0.773 . . . . 75.14 108.912 173.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 37.1 t -126.21 111.42 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.869 1.268 . . . . 75.42 108.263 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 m -102.26 145.1 29.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.578 -0.527 . . . . 72.54 109.578 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.43 109.94 7.98 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.233 -1.025 . . . . 73.32 108.233 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.7 m -126.81 145.69 50.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.275 0.559 . . . . 75.15 110.363 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.445 HD21 ' CE3' ' A' ' 36' ' ' TRP . 49.1 mt -107.84 51.56 0.74 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.542 1.537 . . . . 73.15 108.031 -175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.93 -85.44 0.89 Allowed Glycine 0 C--N 1.349 1.282 0 CA-C-N 114.569 -1.196 . . . . 51.0 111.483 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -89.92 -24.73 21.25 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.131 0.973 . . . . 75.12 111.846 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -118.15 107.03 13.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.086 0.554 . . . . 75.4 110.392 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.2 123.44 20.72 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 118.525 0.602 . . . . 72.54 109.889 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.39 -54.73 6.33 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.852 -1.067 . . . . 70.44 109.648 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.5 172.48 17.14 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.467 -1.242 . . . . 74.41 110.912 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.6 141.31 33.46 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.114 -1.403 . . . . 72.03 107.364 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.542 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 54.9 m -140.16 99.78 3.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.285 -0.635 . . . . 74.41 109.285 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -121.58 122.86 40.61 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.508 -0.923 . . . . 64.53 108.508 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.47 131.13 70.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.511 0.725 . . . . 74.41 109.293 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -104.59 93.44 4.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.931 -1.031 . . . . 72.02 109.434 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -81.67 92.88 6.66 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.112 -1.069 . . . . 74.33 108.112 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.12 143.7 20.51 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.242 -0.743 . . . . 54.13 111.242 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.82 129.92 4.49 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.491 -0.644 . . . . 72.21 111.491 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -78.53 129.5 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 107.648 -1.242 . . . . 65.22 107.648 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 13' ' ' ILE . 49.5 m-85 -133.49 121.72 22.59 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.134 -0.691 . . . . 73.35 109.134 174.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.9 t -74.3 115.27 13.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.591 -1.262 . . . . 73.45 107.591 169.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -137.78 119.06 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.682 0.793 . . . . 75.0 109.729 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.01 161.6 28.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.931 0.893 . . . . 72.42 109.849 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.3 5.24 87.48 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.646 0.591 . . . . 63.31 114.399 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.34 166.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.753 . . . . 72.2 108.972 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -172.74 175.97 3.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.343 -0.614 . . . . 75.31 109.343 -168.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.42 -126.01 38.04 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.813 0.695 . . . . 75.21 114.437 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.3 p -82.47 -20.39 36.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.689 0.796 . . . . 73.34 110.98 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.96 -43.45 98.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.012 0.925 . . . . 74.43 111.006 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -49.48 67.07 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.879 0.737 . . . . 74.35 110.352 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.95 71.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.354 0.662 . . . . 71.42 111.534 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -71.56 -41.8 68.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.732 0.813 . . . . 64.4 110.528 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.67 -65.25 0.81 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.029 0.532 . . . . 64.24 110.489 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.62 -40.58 84.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.222 0.609 . . . . 74.22 111.046 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.78 -38.81 49.28 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.601 0.563 . . . . 72.15 113.793 -168.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.507 ' HB3' ' HB2' ' A' ' 133' ' ' PHE . . . -126.55 -53.53 1.46 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.124 0.462 . . . . 51.03 112.149 -171.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.44 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 82.9 t80 -63.7 -42.27 97.99 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.011 0.924 . . . . 74.4 112.862 -171.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 11' ' ' PHE . 73.7 m -77.62 -41.43 2.26 Favored Pre-proline 0 CA--C 1.557 1.243 0 N-CA-C 113.048 0.758 . . . . 72.41 113.048 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.76 -23.64 55.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 CA-C-N 121.139 1.442 . . . . 65.01 112.544 166.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -70.8 -24.92 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.966 0.506 . . . . 73.31 111.463 172.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.73 -42.82 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.968 0.89 . . . . 75.13 109.299 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.479 HD22 ' HA3' ' A' ' 82' ' ' GLY . 25.1 mt -84.06 -27.72 28.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.421 -1.263 . . . . 74.34 112.444 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -61.92 -40.74 71.6 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 114.504 1.298 . . . . 74.02 114.504 -171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.89 -36.22 82.57 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.963 1.775 . . . . 74.24 113.057 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' C' ' 108' ' ' PRO . 87.5 m-85 -81.56 -35.33 30.39 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.181 -0.918 . . . . 75.42 111.352 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.49 80.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.886 0.474 . . . . 64.45 110.566 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttm105 -56.46 -54.83 41.14 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 114.796 -1.093 . . . . 75.24 109.216 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.27 -41.33 88.61 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.393 1.058 . . . . 71.41 111.564 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.0 t -57.78 -50.98 71.42 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.742 0.651 . . . . 73.12 110.102 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.57 -42.72 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.937 0.895 . . . . 73.44 111.306 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 125' ' ' GLN . 90.7 m -57.35 -45.19 84.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.243 1.017 . . . . 73.4 110.616 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -70.93 -41.41 71.22 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.702 -1.135 . . . . 73.44 110.054 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.53 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 19.4 mtp -57.66 -46.14 84.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.864 0.866 . . . . 75.41 111.67 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.05 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.961 0.904 . . . . 73.42 110.67 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 82.5 p -69.66 -33.07 72.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.406 0.282 . . . . 61.34 111.62 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.59 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.7 mtt-85 -68.65 -27.31 65.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.48 0.712 . . . . 72.33 110.789 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.75 9.88 58.21 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.502 0.501 . . . . 64.13 113.2 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m 69.31 42.17 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.869 1.319 . . . . 65.54 110.584 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' SER . 90.5 m-85 -120.66 156.48 55.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.837 -1.074 . . . . 64.22 109.523 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.19 124.65 16.07 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.565 1.51 . . . . 73.24 109.789 166.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 19.7 pt20 -60.69 146.38 45.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.827 0.451 . . . . 73.12 111.34 -174.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -114.22 105.8 13.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.008 -0.542 . . . . 73.4 110.19 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -118.28 93.22 4.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 74.44 109.742 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.02 160.66 31.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.697 -1.138 . . . . 74.51 110.824 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.478 ' HA ' HG23 ' C' ' 13' ' ' ILE . . . -68.84 145.3 96.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.279 0.632 . . . . 54.51 112.441 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.25 114.5 4.01 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.118 1.879 . . . . 75.02 110.818 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 109.19 23.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.797 -1.557 . . . . 74.23 106.797 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -104.53 92.03 4.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.982 0.913 . . . . 72.53 110.358 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 100' ' ' ALA . 93.2 m-85 . . . . . 0 N--CA 1.481 1.094 0 CA-C-N 114.988 -1.005 . . . . 74.51 111.67 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.245 0.829 0 N-CA-C 109.017 -0.735 . . . . 64.55 109.017 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.02 156.43 39.96 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.382 -0.372 . . . . 75.12 111.177 162.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -122.78 111.37 16.62 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.75 -1.204 . . . . 73.52 107.75 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 tt -61.34 101.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.914 -1.494 . . . . 72.12 109.318 170.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -78.4 -33.25 48.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.677 -0.692 . . . . 75.53 109.672 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -173.19 141.36 0.94 Allowed 'General case' 0 C--N 1.361 1.089 0 O-C-N 123.354 0.409 . . . . 74.22 110.761 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.36 136.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 106.545 -1.65 . . . . 63.22 106.545 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -166.04 148.65 7.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.099 0.476 . . . . 74.14 111.069 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.526 HG21 HD13 ' B' ' 21' ' ' ILE . 86.3 m -76.92 117.42 18.5 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.712 -0.847 . . . . 73.43 108.712 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -88.38 -25.61 22.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.152 0.581 . . . . 74.25 110.633 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 15.8 t70 -158.55 143.54 16.24 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.347 0.594 . . . . 75.43 111.845 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.597 HD13 ' SG ' ' B' ' 113' ' ' CYS . 39.9 mm -134.18 138.59 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 C-N-CA 125.897 1.679 . . . . 72.32 106.867 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -146.62 133.4 20.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.606 -0.887 . . . . 74.04 108.606 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.2 115.59 6.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.395 -1.335 . . . . 74.33 107.395 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.06 127.16 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.51 86.95 48.98 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 108.383 -0.969 . . . . 73.11 108.383 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.28 -19.2 50.36 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.916 2.41 . . . . 64.45 111.928 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -126.6 30.58 5.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.021 0.928 . . . . 70.41 110.739 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.416 ' HB1' ' CE2' ' A' ' 17' ' ' TYR . . . -47.05 -49.51 50.23 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 124.55 1.14 . . . . 74.45 112.894 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.64 -24.46 1.86 Allowed 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 121.8 1.666 . . . . 73.14 113.699 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -76.56 -5.36 47.34 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.354 0.662 . . . . 72.32 112.356 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.14 -13.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.849 0.86 . . . . 72.43 110.653 170.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.2 -41.95 80.36 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.223 1.009 . . . . 75.41 110.78 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -75.75 -37.99 58.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.933 -1.031 . . . . 73.44 110.714 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -107.93 89.03 2.87 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.462 -0.79 . . . . 72.33 109.71 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.75 76.21 10.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.846 1.258 . . . . 73.14 112.025 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -172.93 156.23 3.3 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.357 0.663 . . . . 73.25 110.468 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -58.29 119.21 33.56 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.537 1.135 . . . . 70.41 111.473 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 37.8 Cg_endo -65.92 163.64 30.24 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.906 2.404 . . . . 73.3 112.018 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -76.08 100.92 5.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.724 -1.213 . . . . 73.32 107.724 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.473 HG13 HD11 ' B' ' 126' ' ' LEU . 16.8 t -88.6 120.6 37.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.361 -1.348 . . . . 75.45 107.361 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -145.31 144.6 30.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.017 0.527 . . . . 64.32 110.276 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.472 HD23 ' HG ' ' B' ' 128' ' ' LEU . 1.9 pt? -115.81 160.24 20.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 73.44 110.065 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.24 138.18 44.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.455 1.102 . . . . 71.11 108.721 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -90.96 134.34 34.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.248 0.619 . . . . 75.12 109.574 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.32 150.05 34.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.973 0.909 . . . . 74.31 108.609 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.3 m -142.92 113.42 7.37 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.105 -0.702 . . . . 75.01 109.105 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.75 120.81 32.84 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.384 -1.339 . . . . 70.11 107.384 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -132.92 172.26 12.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.941 0.496 . . . . 74.31 111.368 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.3 p -152.77 179.08 8.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.864 0.866 . . . . 74.25 109.999 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -122.13 121.74 37.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.629 0.771 . . . . 71.25 110.083 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.451 HD12 HG22 ' B' ' 83' ' ' ILE . 81.4 mt -79.03 -44.8 21.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.619 0.767 . . . . 74.05 110.642 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.18 -172.01 3.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.56 -0.745 . . . . 63.13 110.911 -172.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.87 111.95 1.66 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.767 -1.106 . . . . 75.31 110.265 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 70.43 -5.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.047 1.739 . . . . 60.44 112.932 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.85 93.17 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.054 -1.091 . . . . 74.43 108.054 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.13 141.07 30.7 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.898 -1.046 . . . . 73.31 110.005 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.637 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.7 tm-20 -105.2 100.15 9.74 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.888 -1.523 . . . . 64.4 106.888 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.64 117.68 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.25 0.62 . . . . 74.44 109.822 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.94 121.1 55.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 109.286 -0.635 . . . . 73.44 109.286 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.6 OUTLIER -93.06 118.08 30.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.05 -1.463 . . . . 75.03 107.05 172.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -106.45 116.45 31.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.494 0.717 . . . . 74.32 109.355 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.3 t -109.7 119.04 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.145 -1.057 . . . . 74.42 108.145 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -116.32 125.82 52.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.988 0.515 . . . . 71.3 110.21 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.633 HG23 HG23 ' B' ' 114' ' ' ILE . 77.8 t -107.72 137.43 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.729 1.212 . . . . 71.13 110.898 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.3 m -124.41 146.85 48.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.212 1.005 . . . . 74.21 109.923 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 156.26 42.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.066 0.946 . . . . 73.21 109.402 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.7 p -153.1 142.61 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.655 0.613 . . . . 75.22 112.655 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.1 mt -118.56 98.18 6.12 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.629 -0.878 . . . . 73.11 108.629 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.87 -110.44 2.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 122.954 0.311 . . . . 52.0 113.05 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -88.48 4.97 44.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.843 0.857 . . . . 75.21 110.285 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' B' ' 68' ' ' LEU . 1.2 mp0 -114.4 153.07 30.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.79 1.236 . . . . 65.41 109.998 -167.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -87.43 129.24 35.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.064 -1.088 . . . . 75.12 108.064 162.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.17 -55.8 4.14 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.849 -0.797 . . . . 75.21 108.849 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.1 150.29 20.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.804 -1.089 . . . . 71.44 110.694 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -124.88 113.87 18.44 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.505 1.522 . . . . 53.41 107.643 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.7 t -116.29 160.1 20.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.407 -0.961 . . . . 72.33 108.407 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.02 131.84 3.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.628 -0.878 . . . . 73.41 108.628 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.52 142.78 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.715 -0.846 . . . . 75.3 108.715 172.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.5 mt-30 -120.73 97.91 5.77 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.183 -0.917 . . . . 74.41 109.071 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -87.77 101.29 13.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.12 154.49 24.47 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 111.16 -0.776 . . . . 71.45 111.16 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.73 126.16 2.01 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.673 -1.371 . . . . 55.4 109.673 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.637 HG12 ' HG2' ' B' ' 57' ' ' GLU . 27.9 mt -85.25 115.89 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.114 -1.069 . . . . 73.33 108.114 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -124.93 132.47 53.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.798 -1.556 . . . . 74.25 106.798 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -88.97 88.63 7.66 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.025 -1.102 . . . . 73.23 108.025 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.68 129.83 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.935 0.494 . . . . 74.02 110.626 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.28 170.99 20.67 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.966 -1.015 . . . . 64.21 110.249 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.52 -49.35 2.62 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 75.21 112.219 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.524 ' H ' HD12 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -72.12 152.28 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.871 0.468 . . . . 74.51 111.316 174.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -160.4 172.48 17.2 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.848 -1.069 . . . . 65.01 108.97 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.93 -125.42 38.97 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.616 0.572 . . . . 61.12 113.747 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.0 m -74.57 -27.51 60.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.744 0.818 . . . . 62.34 111.109 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -68.9 -40.19 79.28 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.682 0.793 . . . . 71.33 109.881 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -41.91 59.92 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.045 -0.525 . . . . 72.23 110.116 176.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.73 62.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.149 0.98 . . . . 75.11 111.649 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -93.34 -13.1 28.52 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.061 -0.972 . . . . 74.44 111.191 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.31 -64.32 1.01 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.623 0.369 . . . . 70.24 110.195 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -15.83 60.93 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.146 0.178 . . . . 62.43 111.167 -176.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 -6.08 53.67 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.227 -0.763 . . . . 74.52 114.198 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.5 -47.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.399 1.1 . . . . 74.41 112.875 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -73.21 -54.02 9.48 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.052 0.541 . . . . 74.3 111.254 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 68.1 m -63.01 -45.3 86.65 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.529 0.732 . . . . 75.54 111.335 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -50.78 -45.0 38.05 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.416 2.077 . . . . 73.02 113.893 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 123.176 0.591 . . . . 74.13 112.057 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.514 HG22 ' NH2' ' D' ' 111' ' ' ARG . 79.5 mt -71.57 -47.98 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.659 0.784 . . . . 73.41 110.863 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.403 ' HB2' HD12 ' B' ' 60' ' ' LEU . 87.4 mt -80.3 -20.88 43.33 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.233 -0.894 . . . . 75.51 112.298 -172.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.42 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 64.5 t80 -64.71 -45.78 75.82 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.653 -1.165 . . . . 64.24 113.387 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 19.1 Cg_endo -56.72 -37.64 97.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 CA-C-N 121.581 1.6 . . . . 73.31 113.076 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.81 -49.6 65.29 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.31 0.644 . . . . 75.14 110.973 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.99 -42.39 98.34 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.717 0.807 . . . . 64.24 111.181 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.447 ' NH2' HG23 ' C' ' 122' ' ' THR . 50.1 ttt180 -58.87 -55.22 37.92 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.681 1.593 . . . . 71.31 110.96 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -38.5 90.88 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.487 0.715 . . . . 74.33 109.918 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.597 ' SG ' HD13 ' B' ' 21' ' ' ILE . 7.8 t -67.69 -42.08 82.64 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.745 -0.662 . . . . 73.52 112.103 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.633 HG23 HG23 ' B' ' 64' ' ' VAL . 96.8 mt -62.52 -50.61 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.696 -0.483 . . . . 74.43 109.696 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.497 HG23 HE21 ' C' ' 125' ' ' GLN . 86.7 m -55.59 -31.52 62.3 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.092 0.87 . . . . 75.53 111.183 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.9 t -66.05 -52.56 47.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.572 0.749 . . . . 72.35 110.403 172.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.6 mmt -67.36 -36.14 80.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.55 0.574 . . . . 73.34 112.55 -172.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.94 -42.02 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.639 0.776 . . . . 74.02 110.475 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.735 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 90.3 p -71.73 -30.31 65.47 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.469 -0.787 . . . . 71.1 111.872 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -63.44 -33.7 76.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 74.05 110.368 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.77 9.0 58.05 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.839 0.712 . . . . 74.21 113.329 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.9 p 56.15 27.97 12.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.892 1.677 . . . . 74.54 112.466 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.86 158.66 32.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.249 -0.887 . . . . 73.34 110.578 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.565 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 38.8 Cg_exo -61.98 179.73 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.484 2.789 . . . . 73.31 115.999 -171.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.668 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -62.84 150.21 42.29 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 113.894 -1.503 . . . . 71.13 114.347 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.473 HD11 HG13 ' B' ' 40' ' ' VAL . 53.3 tp -141.61 86.04 1.98 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.008 -1.478 . . . . 63.02 107.008 167.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' C' ' 119' ' ' SER . 7.1 m120 -116.11 90.62 3.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.485 -1.302 . . . . 75.04 107.485 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.472 ' HG ' HD23 ' B' ' 42' ' ' LEU . 1.9 tm? -84.88 138.01 32.79 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.512 -0.922 . . . . 75.34 108.512 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.409 ' HB2' ' NH1' ' D' ' 15' ' ' ARG . . . -67.62 107.24 1.64 Allowed Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 124.357 1.035 . . . . 75.51 109.913 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 129.71 25.28 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.09 1.86 . . . . 74.3 110.925 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' D' ' 13' ' ' ILE . 30.2 m -118.36 140.52 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.277 0.631 . . . . 75.44 110.522 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.714 ' H ' HG21 ' D' ' 13' ' ' ILE . 15.6 m-20 -69.76 104.97 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.256 -0.883 . . . . 73.42 109.093 170.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 CA--C 1.554 1.104 0 CA-C-O 120.858 0.361 . . . . 74.14 110.427 172.843 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 108.054 -1.091 . . . . 74.35 108.054 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -100.28 119.67 38.75 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.104 -0.702 . . . . 61.12 109.104 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -141.25 119.25 11.93 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.948 -0.76 . . . . 75.43 108.948 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.668 HD13 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -74.28 127.35 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 108.682 -0.859 . . . . 73.11 108.682 171.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.518 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 77.1 mm-40 -96.36 -49.52 5.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.096 0.558 . . . . 74.11 110.36 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.401 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 76.4 ttt180 -162.65 123.29 2.44 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.971 -0.381 . . . . 72.23 109.971 -171.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.668 HG13 HD13 ' C' ' 13' ' ' ILE . 76.6 mt -113.69 135.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.038 -1.097 . . . . 72.11 108.038 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.44 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.9 p90 -174.5 158.29 2.79 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 124.132 0.895 . . . . 75.12 110.866 -172.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -80.3 136.71 36.48 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.376 -0.829 . . . . 70.34 109.487 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -89.55 -51.39 5.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.27 1.033 . . . . 75.02 108.846 171.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 25.9 t70 -134.91 132.91 39.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.134 -1.848 . . . . 70.31 108.2 -171.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.4 mt -129.29 140.52 48.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.728 -1.582 . . . . 73.11 106.728 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -148.71 145.02 27.48 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.402 -0.592 . . . . 74.43 109.402 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.72 111.64 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.032 -1.47 . . . . 75.35 107.032 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.06 117.87 31.79 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.832 -1.173 . . . . 62.11 107.832 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.36 87.84 8.16 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 108.112 -1.07 . . . . 71.32 108.112 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.3 3.41 7.49 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.05 2.5 . . . . 74.31 111.709 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.3 12.56 8.21 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 124.246 1.019 . . . . 73.34 109.936 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.39 -49.43 82.18 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.737 1.014 . . . . 75.25 113.737 -171.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.53 -27.87 0.54 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.666 1.578 . . . . 62.02 113.449 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -70.12 -25.74 63.63 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.205 1.002 . . . . 63.11 112.905 -173.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.57 -6.86 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.328 1.051 . . . . 73.12 111.564 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -56.95 -41.7 78.75 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.357 1.063 . . . . 74.01 112.638 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -100.42 4.24 43.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.702 0.801 . . . . 70.25 110.606 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.418 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.5 OUTLIER -87.68 168.21 13.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.058 0.543 . . . . 74.52 111.76 -168.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.08 113.53 10.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.008 -0.738 . . . . 75.13 109.008 167.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -86.78 65.21 8.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.497 0.719 . . . . 65.03 110.157 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -135.57 78.98 48.74 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.414 -0.958 . . . . 73.21 108.414 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.96 167.57 26.77 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.826 2.351 . . . . 64.24 112.448 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -122.83 109.25 13.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 171.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.509 HG13 HD12 ' C' ' 126' ' ' LEU . 97.6 t -78.45 103.11 5.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.829 -0.804 . . . . 74.33 108.829 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -91.66 116.33 28.79 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.522 -1.288 . . . . 73.42 107.522 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.407 HD13 HG12 ' C' ' 40' ' ' VAL . 9.2 mp -85.93 149.1 25.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.974 0.51 . . . . 73.42 109.84 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.35 142.29 25.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.847 0.859 . . . . 74.21 108.976 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -135.17 136.02 41.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.897 -0.779 . . . . 75.12 108.897 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 28.0 t70 -141.18 145.9 36.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.991 -1.114 . . . . 75.32 107.991 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -114.2 137.5 51.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.096 0.558 . . . . 75.21 110.472 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.28 47.13 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.444 1.097 . . . . 60.14 108.589 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 70.2 p -160.22 150.53 18.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.741 0.416 . . . . 74.41 110.95 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.3 t -149.43 133.24 16.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.554 0.742 . . . . 75.03 109.511 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -77.98 139.03 39.14 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.602 -0.518 . . . . 74.23 109.602 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.461 HD12 HD13 ' C' ' 83' ' ' ILE . 53.1 mt -114.65 -30.52 6.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.773 0.829 . . . . 74.13 110.893 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.545 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -162.33 -175.07 4.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.25 1.02 . . . . 74.34 110.142 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.39 100.16 0.34 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.445 -0.798 . . . . 53.44 110.223 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.75 9.25 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.273 1.429 . . . . 75.31 113.843 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 89.9 t -100.41 117.95 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.635 -1.617 . . . . 62.42 106.635 164.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -137.06 -178.1 5.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.852 -0.796 . . . . 73.35 108.852 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -128.51 138.9 52.49 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.336 1.055 . . . . 63.43 109.829 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.69 127.72 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.767 -1.197 . . . . 72.22 107.767 168.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 111.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.913 0.885 . . . . 75.44 109.123 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' C' ' 103' ' ' PRO . 54.4 mt -87.53 109.06 19.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.077 0.551 . . . . 71.35 110.316 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 79.6 ttt180 -85.38 102.03 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.308 -0.997 . . . . 75.44 108.308 172.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.46 124.13 55.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.913 -1.143 . . . . 73.33 107.913 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -124.99 142.34 51.55 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.407 0.622 . . . . 72.04 109.769 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.51 HG11 HD23 ' C' ' 126' ' ' LEU . 70.6 t -135.52 130.22 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.442 1.097 . . . . 65.53 108.93 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.6 m -112.35 141.41 46.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.112 -1.07 . . . . 75.03 108.112 172.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.54 125.52 45.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.475 -1.306 . . . . 74.13 107.475 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -135.58 131.31 35.74 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.102 0.477 . . . . 74.34 110.5 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.418 HD12 ' HG2' ' C' ' 34' ' ' LYS . 11.7 mt -86.6 35.13 0.66 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.602 1.561 . . . . 74.53 109.321 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.57 -112.01 3.57 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 110.743 -0.943 . . . . 63.42 110.743 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.56 -31.52 18.6 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.632 0.773 . . . . 74.01 109.67 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -70.03 121.98 18.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.807 1.243 . . . . 74.41 110.363 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.5 m -80.05 131.66 35.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.765 0.257 . . . . 73.34 110.33 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.23 -53.89 4.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.112 0.565 . . . . 70.4 110.005 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -162.28 176.7 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.568 0.747 . . . . 73.01 111.07 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.467 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -136.73 143.96 43.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.656 -1.609 . . . . 75.11 106.656 171.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.467 ' N ' HD13 ' C' ' 75' ' ' LEU . 39.1 t -144.69 141.49 29.35 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.394 -0.965 . . . . 64.44 108.394 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.22 131.66 10.41 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.677 -0.49 . . . . 70.41 109.677 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.76 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.401 1.08 . . . . 74.11 108.305 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -121.1 96.84 5.26 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.232 1.013 . . . . 73.53 108.335 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.28 105.13 15.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.272 0.629 . . . . 74.21 110.556 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.45 150.57 25.86 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 123.668 0.605 . . . . 63.25 112.566 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -155.72 117.74 0.8 Allowed Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 111.47 -0.652 . . . . 64.21 111.47 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' D' ' 29' ' ' PRO . 9.5 mm -80.99 128.63 38.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 N-CA-C 108.733 -0.84 . . . . 62.13 108.733 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -135.11 131.17 36.57 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.193 0.597 . . . . 73.41 110.101 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -92.0 122.42 34.49 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.389 -1.337 . . . . 53.31 107.389 164.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 40.8 pt -113.71 -142.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 118.379 -0.819 . . . . 74.2 109.175 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 97.78 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.896 2.079 . . . . 74.34 110.596 176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -39.56 3.1 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.316 -0.714 . . . . 64.45 111.316 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp . . . . . 0 CA--C 1.551 1.018 0 C-N-CA 124.366 1.066 . . . . 75.32 111.166 169.314 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.684 0.278 . . . . 70.33 110.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.1 ttt -69.98 -41.94 73.76 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.676 -0.693 . . . . 74.44 110.957 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.1 76.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.976 0.51 . . . . 71.2 110.908 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -84.31 -21.48 30.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.672 0.789 . . . . 73.23 112.148 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 97.9 m -73.88 -59.75 2.57 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.701 0.401 . . . . 74.42 109.997 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.69 -26.3 68.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.179 0.991 . . . . 74.14 111.827 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 -22.44 42.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.375 -0.68 . . . . 75.02 114.295 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.84 -50.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.077 0.938 . . . . 64.5 113.428 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.441 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 85.4 t80 -69.87 -55.64 9.21 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 112.482 0.549 . . . . 74.25 112.482 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.426 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 32.0 m -60.9 -45.11 96.64 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.544 0.738 . . . . 74.34 111.277 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.472 ' HB3' HD21 ' C' ' 60' ' ' LEU . 91.5 Cg_exo -53.08 -40.37 76.96 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.591 2.194 . . . . 74.32 114.912 167.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.341 0.656 . . . . 72.01 111.511 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.4 mm -62.87 -42.4 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.471 -0.786 . . . . 72.22 110.554 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.478 HD21 ' HA3' ' C' ' 82' ' ' GLY . 73.8 mt -82.79 -25.43 32.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.988 0.915 . . . . 73.32 112.544 -171.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.16 -51.49 74.7 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.753 1.02 . . . . 73.11 113.753 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 109' ' ' TYR . 19.5 Cg_endo -58.32 -33.95 98.19 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.837 1.691 . . . . 74.01 113.665 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -67.65 -47.73 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.436 0.694 . . . . 75.43 110.812 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.84 92.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.762 0.825 . . . . 71.02 110.677 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.47 -53.26 59.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.678 1.591 . . . . 74.22 110.726 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.43 -30.94 70.81 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.699 0.799 . . . . 73.01 110.513 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.77 -38.04 87.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 74.21 110.655 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 61.0 mt -73.24 -42.07 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.021 -0.536 . . . . 73.12 110.385 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -55.94 -44.24 78.21 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.496 0.719 . . . . 62.42 110.928 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 85.6 p -70.58 -47.41 60.36 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.248 -0.887 . . . . 73.41 110.462 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.589 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -54.22 -45.77 72.34 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.319 1.048 . . . . 75.23 112.768 -177.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 -42.86 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.673 0.608 . . . . 74.42 110.509 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.434 ' HA ' ' ND2' ' B' ' 127' ' ' ASN . 37.6 t -67.82 -27.78 67.01 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.318 -0.855 . . . . 71.33 112.373 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.5 mtt-85 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.245 0.618 . . . . 74.31 109.575 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.96 7.96 64.78 Favored Glycine 0 C--N 1.36 1.895 0 O-C-N 123.794 0.684 . . . . 71.13 112.951 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.447 HG23 ' NH2' ' B' ' 111' ' ' ARG . 17.3 p 63.37 16.18 9.31 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 127.369 2.268 . . . . 74.21 113.586 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.91 153.38 63.73 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 107.894 -1.15 . . . . 71.54 107.894 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -51.98 118.56 4.63 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.969 2.446 . . . . 63.42 112.088 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.668 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 3.5 pt20 -44.77 146.89 0.7 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 124.906 1.282 . . . . 63.52 112.434 -172.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.51 HD23 HG11 ' C' ' 64' ' ' VAL . 14.7 tp -109.59 79.83 1.25 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.71 0.767 . . . . 74.42 112.845 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 6.9 p-10 -97.47 90.3 5.0 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.572 -1.195 . . . . 72.12 109.564 172.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 66.9 mt -74.83 146.0 42.37 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.478 -1.237 . . . . 74.2 109.465 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.03 130.03 92.83 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.339 0.399 . . . . 71.32 110.334 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.453 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 42.6 Cg_endo -65.61 101.31 0.44 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.955 2.437 . . . . 60.2 112.27 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 m -84.66 130.01 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.504 -0.771 . . . . 73.42 111.153 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -97.32 105.28 17.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.659 -1.238 . . . . 73.05 107.659 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.3 t80 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 124.575 1.15 . . . . 72.34 113.529 -176.14 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 C--O 1.242 0.679 0 N-CA-C 108.535 -0.913 . . . . 74.44 108.535 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.453 ' CZ ' ' SG ' ' D' ' 102' ' ' CYS . 43.4 t80 -157.31 126.48 5.92 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.417 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.7 mt-30 -140.08 158.11 44.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.143 0.577 . . . . 74.04 110.205 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.714 HG21 ' H ' ' B' ' 132' ' ' ASN . 10.5 tt -104.39 144.18 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.25 1.02 . . . . 74.52 110.191 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.44 -45.88 3.0 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.382 0.273 . . . . 73.22 111.624 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.409 ' NH1' ' HB2' ' B' ' 129' ' ' ALA . 12.7 tpt180 -169.79 130.75 1.04 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 119.33 -0.367 . . . . 73.22 110.923 -171.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.509 HG12 HD13 ' D' ' 13' ' ' ILE . 32.9 mm -116.73 130.37 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.206 -0.664 . . . . 73.31 109.206 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.442 ' HB3' HG22 ' C' ' 122' ' ' THR . 5.1 p90 -155.09 158.79 39.59 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.741 0.817 . . . . 75.25 111.731 -173.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -88.09 116.35 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.358 -0.608 . . . . 74.54 109.358 172.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.17 -29.13 26.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.109 175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.2 t70 -149.99 137.58 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.114 -0.948 . . . . 71.35 109.746 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.589 HG23 ' HE1' ' C' ' 117' ' ' MET . 63.7 mt -133.57 139.54 48.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.333 -1.358 . . . . 61.34 107.333 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -147.94 112.0 5.17 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.502 0.501 . . . . 71.44 110.012 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.6 t80 -109.73 122.22 46.99 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 105.674 -1.973 . . . . 71.21 105.674 167.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -132.97 109.28 9.46 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.598 -0.89 . . . . 71.22 108.598 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.73 83.45 4.57 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.75 -0.834 . . . . 72.22 108.75 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.75 -27.61 31.46 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.494 2.129 . . . . 62.31 112.074 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -114.14 35.59 4.09 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 124.588 1.155 . . . . 72.51 109.238 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.44 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.57 -58.76 16.74 Favored Pre-proline 0 CA--C 1.576 1.963 0 N-CA-C 114.947 1.462 . . . . 75.13 114.947 -164.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.533 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.2 Cg_endo -81.68 -14.31 10.24 Favored 'Trans proline' 0 C--N 1.389 2.708 0 CA-C-N 122.384 1.887 . . . . 74.33 113.027 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -68.67 -42.27 78.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.824 0.85 . . . . 73.44 109.934 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' D' ' 73' ' ' ALA . 1.0 OUTLIER -85.76 -2.37 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.082 -0.963 . . . . 63.52 110.226 -172.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.401 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 86.1 t80 -56.4 -35.37 67.7 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 73.41 111.005 164.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -65.42 -29.06 69.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 71.5 111.146 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -91.74 74.19 5.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.228 1.011 . . . . 75.01 110.189 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -87.42 79.46 8.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.079 0.942 . . . . 73.35 109.001 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -134.17 178.16 7.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.139 1.376 . . . . 72.04 108.168 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -75.68 118.38 70.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 118.547 0.612 . . . . 73.32 109.446 170.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.26 109.52 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.225 1.95 . . . . 55.12 111.182 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.49 113.64 3.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.135 -1.061 . . . . 73.14 108.135 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.56 HG12 HG13 ' D' ' 64' ' ' VAL . 97.5 t -95.76 106.2 17.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.616 -0.883 . . . . 75.24 108.616 -172.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.477 ' HZ2' ' HB2' ' D' ' 43' ' ' ASP . 14.0 tmtt? -87.78 110.35 20.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.124 -1.806 . . . . 74.42 106.124 169.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -94.66 157.22 16.06 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.04 -1.096 . . . . 72.24 108.04 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 11.4 t70 -146.18 132.37 19.42 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.899 -0.408 . . . . 62.13 109.899 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -102.31 130.5 49.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.168 0.987 . . . . 74.21 109.036 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -147.44 150.19 34.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.846 . . . . 75.3 108.914 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.6 t -126.42 159.33 33.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.256 0.622 . . . . 72.13 110.4 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.13 161.64 42.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 75.11 108.958 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 67.5 p -162.31 153.4 17.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.977 0.511 . . . . 71.43 110.936 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -155.47 147.81 23.8 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.717 0.807 . . . . 74.04 109.644 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -82.35 118.08 22.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.274 -0.639 . . . . 74.53 109.274 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.678 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.0 mt -92.66 -33.49 14.35 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.074 -0.343 . . . . 75.24 110.074 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.52 -177.96 2.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.282 1.033 . . . . 75.25 109.809 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.03 124.44 21.6 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.407 0.683 . . . . 65.42 109.977 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 65.0 14.25 9.22 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.036 1.334 . . . . 74.53 112.487 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -119.22 128.9 75.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.624 0.77 . . . . 74.15 109.404 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.35 149.78 50.37 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.848 0.859 . . . . 75.4 109.733 174.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.678 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.9 tt0 -109.38 117.47 34.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.299 -1.371 . . . . 73.42 107.299 163.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.27 129.75 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.528 -1.286 . . . . 74.15 107.528 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 40.7 t -113.19 132.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.67 -0.863 . . . . 71.22 108.67 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -108.62 126.05 52.53 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.949 -1.13 . . . . 73.2 107.949 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 40.7 ttm-85 -101.01 105.06 16.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.211 -1.033 . . . . 72.02 108.211 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.13 120.78 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.586 -1.264 . . . . 72.24 107.586 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.5 m -117.73 147.02 43.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.258 0.623 . . . . 75.52 109.452 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.56 HG13 HG12 ' D' ' 40' ' ' VAL . 69.2 t -133.87 100.57 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.014 1.326 . . . . 73.14 107.822 176.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -91.97 89.96 7.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.594 -2.002 . . . . 75.23 105.594 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.416 ' HB1' ' CE1' ' D' ' 74' ' ' PHE . . . -100.0 132.6 45.26 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.895 -1.048 . . . . 60.33 108.389 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 71.5 m -141.15 137.36 32.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 122.113 0.959 . . . . 73.41 111.814 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 54.8 mt -100.19 100.53 11.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.363 -1.744 . . . . 64.42 109.669 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.1 -123.6 10.68 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.835 -0.621 . . . . 71.22 111.957 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.92 4.21 53.46 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.353 0.661 . . . . 75.14 110.941 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.71 144.74 46.04 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.195 0.598 . . . . 72.1 110.026 -171.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -72.03 128.94 37.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.482 0.488 . . . . 70.33 110.208 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.559 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -78.33 -61.09 2.12 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.587 -0.894 . . . . 73.23 108.587 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.474 ' CZ ' HG21 ' D' ' 118' ' ' VAL . 0.5 OUTLIER -159.59 177.62 10.71 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 113.859 -1.519 . . . . 74.12 108.329 171.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -134.34 107.47 7.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 73.5 106.447 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' D' ' 114' ' ' ILE . 1.9 t -113.77 146.29 40.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.836 0.454 . . . . 74.14 111.763 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.32 136.53 11.88 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.26 1.024 . . . . 75.12 109.158 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.36 116.26 24.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.998 -0.742 . . . . 72.31 108.998 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.573 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -91.89 88.21 6.53 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.703 0.764 . . . . 74.14 109.518 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -82.09 104.19 12.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.239 -1.346 . . . . 74.15 109.034 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.95 155.36 23.03 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.444 -0.662 . . . . 62.11 111.444 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.421 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -159.08 132.03 2.93 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.574 -0.61 . . . . 50.33 111.574 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.45 HG22 HD13 ' D' ' 51' ' ' LEU . 34.3 mt -88.51 134.15 28.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 109.141 -0.689 . . . . 73.44 109.141 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.37 148.5 46.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 72.01 110.06 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 30.7 m -90.58 135.54 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.92 0.888 . . . . 65.2 109.138 170.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 5.0 tt -138.08 117.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 123.87 0.868 . . . . 75.34 110.166 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.27 146.29 5.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 70.33 110.103 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.81 0.27 59.04 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 113.737 0.255 . . . . 63.24 113.737 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 1.8 pp -103.06 164.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.098 0.959 . . . . 75.54 110.831 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.54 164.21 5.5 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.132 0.895 . . . . 75.51 110.31 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.58 -127.09 38.86 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 115.566 -0.743 . . . . 65.45 113.986 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.6 p -77.1 -27.31 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.777 0.831 . . . . 63.31 111.54 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -48.01 82.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.938 0.895 . . . . 71.22 110.846 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.455 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 25.3 ptm -68.73 -41.27 79.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.0 -0.545 . . . . 73.21 111.714 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.15 72.25 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.484 0.714 . . . . 73.21 111.104 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -81.16 -37.47 28.72 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.348 -0.842 . . . . 72.0 110.453 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -66.0 -49.79 66.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.166 0.586 . . . . 74.14 111.879 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.763 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.5 pp -83.82 -26.32 29.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.541 0.336 . . . . 74.22 111.23 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.31 -27.75 29.63 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.304 0.378 . . . . 70.52 113.447 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.76 -60.06 1.92 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.155 0.582 . . . . 75.34 110.469 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.403 ' O ' HG12 ' D' ' 105' ' ' ILE . 86.4 t80 -63.54 -49.61 72.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.733 0.413 . . . . 73.2 111.995 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.763 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 60.9 m -58.24 -51.58 80.74 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-O 118.642 -0.694 . . . . 72.23 112.494 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 39.3 Cg_exo -64.91 -32.79 54.26 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 121.66 1.574 . . . . 72.34 112.827 173.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.58 -32.17 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.971 0.508 . . . . 71.52 111.148 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.403 HG12 ' O ' ' D' ' 101' ' ' TYR . 38.2 mm -71.37 -35.68 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.756 0.822 . . . . 75.43 110.997 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.421 HD22 ' HA3' ' D' ' 82' ' ' GLY . 66.7 mt -75.04 -19.84 59.84 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.399 -0.819 . . . . 72.31 110.827 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -68.32 -42.5 29.35 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.294 1.22 . . . . 73.43 114.294 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -56.15 -40.42 84.96 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.069 1.846 . . . . 73.05 113.401 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -77.96 -35.0 50.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.052 0.941 . . . . 72.44 111.25 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.59 -42.87 77.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.467 0.707 . . . . 74.34 109.841 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.514 ' NH2' HG22 ' B' ' 105' ' ' ILE . 36.7 ttp180 -62.43 -46.62 87.7 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.438 -1.255 . . . . 74.14 109.888 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.92 -46.8 89.23 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.963 0.79 . . . . 71.51 110.743 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.431 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.8 t -59.23 -40.98 87.6 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.587 0.555 . . . . 72.21 110.678 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.586 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.8 mt -59.92 -57.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.915 0.486 . . . . 72.21 109.87 171.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 55.9 m -52.53 -44.49 65.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.36 1.464 . . . . 72.41 111.709 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.45 -44.55 78.39 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.528 -1.215 . . . . 71.22 110.07 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.7 mtm -66.01 -38.47 88.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.74 0.416 . . . . 71.32 111.411 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' D' ' 74' ' ' PHE . 98.6 t -62.53 -45.27 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 O-C-N 124.141 0.901 . . . . 72.44 109.795 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -71.45 -32.8 68.75 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.933 0.493 . . . . 74.33 111.03 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -70.08 -27.15 64.38 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.577 0.751 . . . . 75.54 109.949 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.17 11.89 70.8 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.918 0.761 . . . . 53.32 112.83 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 55.8 p 58.26 32.08 21.61 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.863 1.665 . . . . 61.34 113.356 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.43 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 84.9 m-85 -101.92 165.06 14.61 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.233 1.013 . . . . 73.13 108.296 168.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 57.3 Cg_endo -67.41 149.72 80.6 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.487 2.124 . . . . 61.34 112.423 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -59.19 126.92 29.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.294 0.637 . . . . 64.44 111.091 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.455 HD13 HG21 ' D' ' 40' ' ' VAL . 60.4 tp -107.79 96.48 6.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.529 0.732 . . . . 72.22 110.458 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -103.89 95.04 5.75 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.478 -0.564 . . . . 73.12 109.478 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.96 134.28 43.1 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.227 -0.657 . . . . 74.53 109.227 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.86 138.53 87.07 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.812 0.845 . . . . 65.42 111.569 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -83.6 103.8 1.1 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.306 2.004 . . . . 71.43 110.889 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -107.71 110.92 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.708 0.766 . . . . 70.25 110.415 -171.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.243 0.711 0 CA-C-N 115.045 -0.98 . . . . 71.53 109.648 175.191 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 109.618 -0.512 . . . . 73.51 109.618 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.425 ' CD1' ' HE2' ' A' ' 101' ' ' TYR . 50.5 t80 -136.32 136.96 40.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 75.1 108.72 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -151.18 125.88 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.864 -0.153 . . . . 73.4 110.965 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -76.26 132.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 75.03 108.385 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 79.6 mm-40 -103.85 -38.61 6.96 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 123.88 0.737 . . . . 74.45 109.906 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -168.94 141.84 2.78 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 112.074 0.398 . . . . 75.22 112.074 -171.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.721 HD13 ' HB3' ' C' ' 130' ' ' PRO . 74.4 mt -106.71 142.47 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 124.932 1.293 . . . . 74.3 107.516 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HH ' ' HB3' ' B' ' 29' ' ' PRO . 15.3 p90 -166.21 146.22 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.723 0.773 . . . . 75.43 111.003 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 p -88.46 105.06 17.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.845 -1.07 . . . . 73.11 109.321 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.49 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.1 mtpt -76.06 -28.21 57.54 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.857 -0.423 . . . . 74.13 109.857 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.3 t70 -148.77 130.77 15.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.87 -1.059 . . . . 73.12 109.67 174.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -122.84 136.36 59.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 105.983 -1.858 . . . . 74.13 105.983 167.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.82 108.26 3.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.831 0.348 . . . . 72.35 110.649 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.7 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.9 t80 -109.83 131.0 55.46 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.035 -1.468 . . . . 73.42 107.035 171.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.62 131.6 41.58 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.441 -0.948 . . . . 65.14 108.441 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.8 72.67 12.51 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.913 -0.773 . . . . 64.2 108.913 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.44 -13.22 25.2 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.509 2.139 . . . . 73.24 111.853 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -118.04 25.53 10.28 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.762 0.825 . . . . 74.23 109.296 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.47 99.8 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.166 0.987 . . . . 72.14 112.898 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.03 -18.08 18.96 Favored 'Trans proline' 0 C--N 1.391 2.812 0 CA-C-N 120.933 1.369 . . . . 72.41 113.208 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.95 -18.99 61.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.249 0.62 . . . . 73.42 111.938 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 8.6 p -64.69 -18.39 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 112.783 0.66 . . . . 70.33 112.783 -176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -71.45 -40.32 70.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.965 0.506 . . . . 74.5 110.604 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -86.68 -19.54 29.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.658 -0.701 . . . . 74.3 110.713 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 29.8 mmmt -81.97 151.0 27.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.12 0.568 . . . . 75.35 111.29 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.5 124.01 28.57 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.931 -1.031 . . . . 54.43 108.714 168.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.4 t-105 -76.13 87.42 3.01 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.115 0.483 . . . . 75.15 110.54 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.86 80.66 70.63 Favored Pre-proline 0 C--O 1.245 0.837 0 C-N-CA 124.505 1.122 . . . . 74.24 108.035 169.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.45 129.41 8.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.269 1.979 . . . . 75.23 111.804 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.79 84.17 3.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 105.626 -1.99 . . . . 74.35 105.626 172.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -77.19 93.85 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.344 -1.298 . . . . 74.43 109.854 -172.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.88 116.11 23.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 113.976 -1.466 . . . . 75.34 110.867 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 128' ' ' LEU . 6.6 mp -97.38 106.94 19.34 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.45 -1.25 . . . . 70.42 107.882 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.2 t70 -107.47 147.26 30.7 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.793 1.237 . . . . 73.31 109.364 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -129.8 137.61 50.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.013 0.925 . . . . 73.14 109.528 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -144.41 145.8 32.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.31 0.644 . . . . 72.33 109.485 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.8 m -107.19 125.93 51.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.619 0.768 . . . . 72.13 110.032 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.78 138.32 45.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.999 0.92 . . . . 70.01 108.825 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -135.65 162.46 32.67 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.434 0.693 . . . . 74.43 110.341 172.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 t -161.34 123.27 2.97 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.047 0.939 . . . . 72.01 108.661 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.08 146.26 39.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.812 -0.44 . . . . 73.33 109.812 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' A' ' 57' ' ' GLU . 49.9 mt -117.35 -34.92 4.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.507 0.723 . . . . 74.31 111.355 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -159.1 -175.28 5.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.987 0.915 . . . . 75.51 109.441 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.09 121.13 17.72 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.735 -0.839 . . . . 75.41 108.735 173.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.94 9.86 7.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.388 1.475 . . . . 70.51 113.013 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.562 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 71.1 t -124.12 122.24 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.152 -1.055 . . . . 73.21 108.152 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -140.84 170.47 15.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.998 -0.741 . . . . 75.34 108.998 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.504 ' HB2' HD13 ' A' ' 51' ' ' LEU . 23.0 tt0 -126.51 140.08 52.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.174 0.99 . . . . 74.31 108.75 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -117.48 124.86 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 107.138 -1.43 . . . . 74.54 107.138 164.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -98.29 127.04 51.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 172.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.86 109.47 21.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.843 -1.54 . . . . 74.44 106.843 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -98.52 100.33 11.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.267 -1.012 . . . . 74.44 108.267 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.81 117.14 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.582 -1.19 . . . . 74.4 108.756 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.1 m -112.74 128.01 56.3 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.55 -0.537 . . . . 71.12 109.55 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.28 107.54 21.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 107.948 -1.13 . . . . 72.14 107.948 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.0 m -102.16 141.35 35.14 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.318 -0.993 . . . . 71.22 108.318 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.19 106.88 10.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.068 -1.086 . . . . 63.21 108.068 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -108.97 125.96 52.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.049 0.54 . . . . 63.22 110.467 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 HD21 ' CE3' ' A' ' 36' ' ' TRP . 46.7 mt -88.46 62.33 6.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.47 -1.307 . . . . 73.55 107.47 171.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.39 1.32 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.57 -1.196 . . . . 74.24 111.371 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.01 -20.26 27.47 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.969 0.908 . . . . 75.14 111.161 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -109.2 118.86 37.82 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.351 -0.611 . . . . 75.3 109.351 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -73.18 130.17 39.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.559 0.618 . . . . 73.4 110.129 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -78.56 -56.75 4.19 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.78 -0.822 . . . . 71.01 108.78 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.19 168.6 26.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.167 -1.379 . . . . 75.51 110.558 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.4 116.91 11.36 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.545 1.138 . . . . 75.31 108.733 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 84.4 m -104.31 138.82 40.19 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 124.319 1.048 . . . . 75.35 108.893 172.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -148.04 117.33 6.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.255 -1.017 . . . . 74.3 108.255 171.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -122.81 111.48 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 109.316 -0.624 . . . . 75.42 109.316 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.0 mt-30 -86.42 82.19 8.05 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.89 -1.05 . . . . 74.44 108.732 170.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -77.96 95.63 4.85 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.358 -1.292 . . . . 71.11 109.405 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.14 154.53 29.02 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 112.057 -0.417 . . . . 72.33 112.057 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.57 131.8 3.0 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 112.136 -0.385 . . . . 52.11 112.136 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 37.0 mt -81.6 128.28 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.446 -0.946 . . . . 74.13 108.446 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.38 154.32 48.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.819 -0.808 . . . . 75.14 108.819 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -119.26 119.44 34.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.649 1.18 . . . . 72.53 108.051 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.446 HD12 HD13 ' A' ' 89' ' ' ILE . 2.9 pp -122.17 158.79 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.019 0.438 . . . . 74.02 111.098 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 151.91 8.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.591 -1.186 . . . . 74.44 109.094 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.23 83.82 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 115.26 0.864 . . . . 73.45 115.26 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.446 HD13 HD12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -115.88 136.58 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.538 0.669 . . . . 75.55 110.357 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -144.75 172.37 13.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.836 0.455 . . . . 65.4 111.54 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -120.67 23.77 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.899 -0.591 . . . . 71.11 113.31 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.7 p -79.58 -16.38 55.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.779 0.832 . . . . 71.0 111.832 -174.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.75 -42.43 90.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.767 0.827 . . . . 74.21 109.263 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 43.5 tpp -67.1 -38.37 85.55 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.976 -1.011 . . . . 75.24 110.509 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.44 81.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.704 0.802 . . . . 70.54 111.969 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -84.17 -36.67 22.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.766 0.426 . . . . 72.32 111.095 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -71.95 -64.73 0.88 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.703 0.401 . . . . 72.43 110.669 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.42 -34.54 76.18 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 72.43 110.324 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -5.59 78.19 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 119.077 -0.846 . . . . 72.11 114.968 -172.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.84 -55.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.534 1.167 . . . . 71.11 112.742 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.425 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 81.1 t80 -68.9 -45.74 70.14 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.882 0.697 . . . . 74.42 112.882 -169.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -73.58 -37.42 3.53 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.05 0.54 . . . . 72.41 112.315 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -48.84 -33.68 26.05 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.503 2.136 . . . . 72.54 113.901 162.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.19 -16.55 64.03 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.576 0.75 . . . . 75.43 111.991 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.63 -44.3 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 122.002 0.906 . . . . 74.11 109.639 171.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.74 -19.26 31.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.164 -1.38 . . . . 73.54 112.33 -172.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.44 -44.24 25.04 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.215 -0.898 . . . . 73.35 112.483 -173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.37 -35.26 98.87 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 121.996 1.797 . . . . 74.31 113.062 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.402 ' CE1' ' HD3' ' C' ' 111' ' ' ARG . 27.7 m-85 -82.77 -31.81 28.1 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.107 0.78 . . . . 71.5 113.107 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 -47.84 61.28 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.515 -0.92 . . . . 72.44 108.515 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.403 HH12 HD13 ' C' ' 105' ' ' ILE . 29.9 ttm180 -46.74 -59.7 2.87 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 125.331 1.644 . . . . 74.24 109.559 172.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.24 -38.35 90.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.433 1.083 . . . . 73.23 111.895 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 117' ' ' MET . 44.8 t -62.12 -46.43 89.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.659 0.384 . . . . 71.12 110.471 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 118' ' ' VAL . 34.1 mt -62.33 -47.19 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.882 0.873 . . . . 74.12 110.13 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 125' ' ' GLN . 67.5 m -55.68 -42.77 75.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.097 1.359 . . . . 65.13 110.71 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -68.87 -39.18 79.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.583 -1.189 . . . . 71.43 110.321 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -66.79 -35.56 80.36 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.425 0.29 . . . . 74.22 111.299 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -66.37 -40.09 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.478 0.711 . . . . 72.24 110.292 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.534 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.6 p -73.47 -34.3 65.28 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.36 -0.382 . . . . 64.03 111.259 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.12 -23.98 63.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.512 0.725 . . . . 71.22 110.261 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 31.04 3.55 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 123.743 0.687 . . . . 63.23 113.522 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.488 HG23 ' NE ' ' B' ' 15' ' ' ARG . 14.7 t 58.68 15.96 4.06 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.943 2.097 . . . . 72.01 114.683 173.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' SER . 42.0 m-85 -123.49 159.82 53.5 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.174 0.589 . . . . 74.4 111.066 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.61 135.63 57.91 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.447 2.098 . . . . 75.32 110.141 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.575 ' HB2' HG21 ' A' ' 115' ' ' THR . 12.7 pt20 -57.84 153.27 14.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.064 0.946 . . . . 75.44 111.709 -174.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.18 112.17 24.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.162 -1.051 . . . . 72.42 108.162 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' C' ' 16' ' ' ILE . 76.6 m-20 -97.31 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.316 -0.994 . . . . 70.44 108.316 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 42' ' ' LEU . 5.8 mp -69.0 142.12 54.72 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.744 -0.662 . . . . 75.1 109.622 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.1 74.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 122.704 0.401 . . . . 72.24 110.453 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.457 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 16.8 Cg_exo -68.05 124.78 12.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.459 2.106 . . . . 75.23 109.995 170.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.0 m -97.12 111.9 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 122.077 0.942 . . . . 75.43 108.951 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 86.46 2.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.167 -1.378 . . . . 65.24 109.396 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.489 1.497 0 C-N-CA 125.148 1.379 . . . . 73.24 112.951 -171.498 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--O 1.241 0.649 0 N-CA-C 107.982 -1.118 . . . . 74.43 107.982 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' B' ' 85' ' ' SER . 31.5 t80 -122.07 134.82 54.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.69 -0.855 . . . . 75.45 108.69 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -165.87 141.45 4.93 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.79 0.681 . . . . 74.21 109.248 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.6 HD12 HD12 ' B' ' 16' ' ' ILE . 78.4 mt -86.22 121.05 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.93 0.492 . . . . 72.51 110.326 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -80.65 -36.72 32.14 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.662 0.601 . . . . 73.04 111.249 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.488 ' NE ' HG23 ' A' ' 122' ' ' THR . 38.6 ttt180 -171.32 142.44 1.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.994 0.518 . . . . 70.51 109.949 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.6 HD12 HD12 ' B' ' 13' ' ' ILE . 90.1 mt -121.26 140.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.911 -1.144 . . . . 74.33 107.911 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.408 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 31.5 p90 -165.53 152.23 10.07 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.896 0.747 . . . . 74.21 111.079 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -75.42 123.98 26.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.262 -1.014 . . . . 72.34 108.262 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -92.54 -37.11 12.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.988 0.515 . . . . 75.43 109.679 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.0 t70 -148.84 147.96 29.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.531 -0.759 . . . . 75.54 110.712 -170.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.564 HD13 ' SG ' ' B' ' 113' ' ' CYS . 36.7 mm -143.11 143.41 24.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.504 1.521 . . . . 75.33 107.79 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 55.6 m -149.09 131.73 15.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.203 -0.908 . . . . 63.34 108.706 168.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -140.08 106.95 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.228 -1.768 . . . . 74.33 106.228 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.52 110.6 15.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.665 -0.865 . . . . 75.44 108.665 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.42 88.56 5.11 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.499 1.12 . . . . 73.41 109.205 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.68 -30.21 59.94 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.084 2.523 . . . . 74.13 112.374 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -118.45 31.39 6.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 71.22 110.22 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.63 -52.24 32.11 Favored Pre-proline 0 CA--C 1.572 1.799 0 C-N-CA 125.327 1.451 . . . . 75.14 113.648 173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 96.0 Cg_endo -77.7 -12.57 16.57 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.814 1.676 . . . . 71.4 113.142 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -86.98 1.12 53.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.897 0.879 . . . . 74.52 111.803 -175.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.13 -14.03 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 123.653 0.781 . . . . 73.53 110.334 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -65.76 -41.27 92.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.798 0.439 . . . . 73.03 110.266 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -47.27 12.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.327 -0.62 . . . . 73.54 109.327 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.38 67.82 9.57 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.12 -1.067 . . . . 75.41 108.12 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.21 75.56 9.13 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.432 -1.258 . . . . 74.53 111.442 -168.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -177.27 172.44 1.89 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.255 -1.339 . . . . 75.42 108.216 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.635 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 3.9 pt20 -71.05 134.84 85.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.322 0.649 . . . . 65.51 111.731 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.88 156.12 60.04 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.549 2.166 . . . . 73.35 112.461 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 27.2 mt-10 -70.31 98.86 1.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.372 -0.973 . . . . 73.22 108.372 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.574 ' HB ' HD12 ' B' ' 126' ' ' LEU . 16.4 m -87.67 122.55 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 74.52 109.445 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -153.22 130.31 11.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.476 1.11 . . . . 72.33 109.645 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.691 HD22 HD11 ' B' ' 126' ' ' LEU . 1.4 pt? -130.81 164.98 23.97 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.993 0.738 . . . . 65.21 112.993 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.96 141.19 38.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.188 1.395 . . . . 72.34 109.79 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -94.68 124.85 38.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 75.03 108.988 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -124.36 156.14 37.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.862 1.265 . . . . 72.0 108.427 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.2 t -129.4 140.85 51.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.616 0.722 . . . . 72.32 111.518 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 161.6 32.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.738 1.615 . . . . 64.03 107.981 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -143.12 165.77 26.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.46 0.648 . . . . 71.34 111.525 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.7 t -152.09 157.83 42.15 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.149 1.38 . . . . 74.41 108.379 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -123.66 129.01 50.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.17 -39.48 12.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.319 0.648 . . . . 71.01 110.125 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 179.96 8.1 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.517 1.127 . . . . 70.25 109.826 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.29 121.25 9.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.342 0.657 . . . . 71.45 109.517 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 66.17 -5.74 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 126.04 1.736 . . . . 64.51 113.712 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.71 86.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.945 -1.502 . . . . 72.22 106.945 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -95.82 168.71 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.609 . . . . 74.33 110.183 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -145.38 97.64 3.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.833 -1.544 . . . . 64.13 106.833 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.34 130.24 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.946 -0.761 . . . . 73.43 108.946 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.1 t -106.89 124.03 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.645 0.778 . . . . 72.41 109.734 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 1.0 OUTLIER -93.68 121.41 35.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.11 -1.07 . . . . 74.13 108.11 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -113.11 113.46 25.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.221 0.608 . . . . 75.02 109.821 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.557 ' HB ' HD11 ' B' ' 114' ' ' ILE . 47.9 t -104.93 125.48 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 63.02 108.546 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -98.64 137.66 36.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.784 -0.821 . . . . 73.13 108.784 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 50.6 t -128.67 123.76 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.774 -0.825 . . . . 65.24 108.774 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.7 m -108.07 139.07 43.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.023 0.929 . . . . 74.33 109.637 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.33 143.28 30.9 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.438 0.695 . . . . 70.32 109.216 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -151.46 134.13 15.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.462 0.541 . . . . 73.34 112.462 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -107.41 104.23 13.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.943 1.297 . . . . 63.03 108.758 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.96 -113.88 5.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.813 -0.437 . . . . 74.34 112.523 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -97.94 2.76 49.4 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.325 0.65 . . . . 71.34 111.502 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -130.81 157.68 42.21 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.556 0.342 . . . . 70.44 111.864 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.2 m -76.04 133.69 40.29 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.786 -0.643 . . . . 74.14 110.669 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.34 -55.77 3.29 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.533 0.733 . . . . 74.31 109.701 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -154.01 162.34 41.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.26 -0.882 . . . . 74.33 109.956 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.7 mt -142.25 116.05 9.24 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.075 1.35 . . . . 75.44 107.453 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -117.79 120.49 38.09 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.528 -0.545 . . . . 63.42 109.528 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -123.37 124.2 42.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.434 -0.95 . . . . 71.03 108.434 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.547 HG12 HD11 ' B' ' 21' ' ' ILE . 55.3 t -121.47 146.0 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.314 -0.995 . . . . 71.2 108.314 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.8 mt-30 -127.06 99.28 5.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.14 109.255 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.513 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -92.41 104.22 16.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.144 -1.389 . . . . 74.44 108.751 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.44 159.27 25.99 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 112.142 -0.383 . . . . 74.33 112.142 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.19 127.98 2.12 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.837 -0.905 . . . . 60.34 110.837 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.84 125.0 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.608 -0.886 . . . . 74.53 108.608 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.88 136.73 47.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.298 1.039 . . . . 74.13 109.979 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 5.7 m -90.22 110.48 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.043 -1.095 . . . . 73.4 108.043 172.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 38.3 pt -126.68 109.19 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.824 0.821 . . . . 72.43 110.553 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.5 170.71 20.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.645 -1.162 . . . . 72.53 109.441 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.53 -49.14 1.21 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 111.413 -0.675 . . . . 65.22 111.413 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 165.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.755 0.822 . . . . 71.1 111.387 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -163.7 144.87 9.03 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.89 0.744 . . . . 73.22 110.561 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.51 -110.44 3.13 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.555 -0.748 . . . . 73.51 113.031 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 m -65.26 -44.92 86.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 65.4 112.309 -170.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.9 -22.4 61.5 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.573 -0.74 . . . . 75.34 112.126 -167.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.413 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 17.4 ttt -72.15 -38.73 69.13 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.405 -0.22 . . . . 75.44 110.405 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.53 74.26 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.945 0.498 . . . . 55.34 110.845 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB1' ' B' ' 100' ' ' ALA . 59.2 t-80 -74.45 -20.51 60.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.687 0.795 . . . . 74.14 110.848 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -86.92 -67.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.131 0.573 . . . . 72.3 111.289 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.444 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.5 pp -74.19 -24.26 59.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.126 0.57 . . . . 72.23 112.301 -172.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.37 72.94 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.905 -0.386 . . . . 52.24 113.35 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' B' ' 96' ' ' HIS . . . -145.37 -69.92 0.28 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.502 0.556 . . . . 72.55 112.502 -173.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -74.03 -39.53 63.49 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.318 0.386 . . . . 72.32 111.562 -168.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 61.0 m -61.98 -50.33 81.34 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.865 -0.588 . . . . 53.53 111.522 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.64 -25.82 28.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.427 1.418 . . . . 71.54 113.415 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.83 -33.03 74.78 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.281 0.562 . . . . 74.35 110.962 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.423 HD12 HD11 ' B' ' 13' ' ' ILE . 59.6 mt -65.67 -44.9 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.257 1.023 . . . . 74.5 110.89 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.9 mt -81.33 -12.9 58.89 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.126 -0.943 . . . . 64.42 111.017 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -60.01 -49.94 88.75 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.755 -1.117 . . . . 72.2 112.093 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.49 -41.38 77.51 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.887 1.725 . . . . 72.34 113.011 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.513 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.2 m-85 -65.99 -50.22 65.06 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.483 0.713 . . . . 74.11 112.204 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.73 81.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.759 0.824 . . . . 70.12 110.847 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.402 HH22 HG23 ' C' ' 122' ' ' THR . 41.9 ttt180 -56.09 -48.6 75.81 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.379 1.472 . . . . 74.21 110.299 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.63 -36.36 80.66 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.399 0.68 . . . . 70.25 110.428 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.564 ' SG ' HD13 ' B' ' 21' ' ' ILE . 8.0 t -68.51 -45.02 73.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.752 0.421 . . . . 72.31 111.82 -174.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' B' ' 62' ' ' VAL . 92.1 mt -59.22 -50.77 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.955 0.902 . . . . 75.31 110.429 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.427 HG22 ' OG ' ' C' ' 119' ' ' SER . 86.9 m -58.26 -33.06 68.98 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 124.481 1.113 . . . . 65.25 111.175 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.7 t -69.75 -35.18 74.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.219 1.008 . . . . 74.44 111.357 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -79.24 -33.21 43.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.862 0.465 . . . . 72.04 111.481 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.56 -31.9 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.675 0.79 . . . . 74.14 110.748 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.504 ' HB3' HG21 ' C' ' 115' ' ' THR . 80.7 p -68.48 -33.45 74.18 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 116.03 -0.532 . . . . 64.03 112.068 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.451 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 83.7 mtt-85 -65.55 -36.96 85.34 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.011 -0.995 . . . . 74.45 110.96 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.89 9.09 63.9 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.508 -0.769 . . . . 71.21 113.85 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p 63.84 12.66 6.92 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.436 1.894 . . . . 75.21 113.192 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.477 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 58.3 m-85 -77.99 170.98 13.74 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.915 0.886 . . . . 74.3 110.269 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' B' ' 37' ' ' GLN . 62.5 Cg_endo -77.18 -169.11 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.101 1.867 . . . . 64.05 114.718 -170.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.426 ' HA ' ' CG ' ' C' ' 125' ' ' GLN . 17.7 pt20 -64.92 142.11 58.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.945 -1.48 . . . . 73.14 112.434 177.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.691 HD11 HD22 ' B' ' 42' ' ' LEU . 32.5 tp -151.57 98.34 2.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.334 -0.848 . . . . 74.2 108.895 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -134.65 126.04 28.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.644 . . . . 75.22 109.769 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.01 151.17 35.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.875 0.87 . . . . 73.34 111.807 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.69 106.54 15.77 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.981 -0.748 . . . . 64.14 108.981 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.452 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 21.6 Cg_endo -60.2 113.47 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.026 2.484 . . . . 75.22 112.938 -175.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.23 153.84 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.52 0.728 . . . . 75.33 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.404 ' HB2' HD12 ' D' ' 13' ' ' ILE . 50.2 t-20 -110.55 115.83 30.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.635 0.774 . . . . 70.22 110.562 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.48 1.055 0 C-N-CA 122.973 0.509 . . . . 75.0 111.201 175.188 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.3 m . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.484 -0.561 . . . . 75.53 109.484 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -104.34 140.3 38.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.702 0.801 . . . . 71.11 108.892 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -150.02 140.09 22.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.869 0.366 . . . . 74.04 111.305 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -93.34 141.49 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.232 1.013 . . . . 74.24 109.578 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.517 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.7 mm-40 -108.49 -49.11 3.22 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.37 0.668 . . . . 74.3 110.087 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.549 HH11 ' HD1' ' D' ' 32' ' ' PHE . 63.5 ttt180 -170.57 125.39 0.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.608 0.363 . . . . 74.25 110.354 -173.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.477 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 73.0 mt -109.6 141.73 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.344 -1.354 . . . . 75.34 107.344 176.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.542 ' HH ' HD11 ' C' ' 83' ' ' ILE . 40.6 p90 -176.94 156.69 1.36 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.037 0.836 . . . . 74.52 110.768 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -78.73 123.34 27.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.428 -0.806 . . . . 72.34 109.954 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.604 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -81.16 -44.87 17.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.007 -0.738 . . . . 72.1 109.007 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -149.87 134.19 17.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.41 -1.268 . . . . 70.42 109.606 -171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.549 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.0 mt -134.15 145.07 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.519 1.128 . . . . 74.12 108.499 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -156.24 151.99 27.22 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.223 0.535 . . . . 73.21 111.154 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -152.94 108.52 3.29 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.152 -1.425 . . . . 73.34 107.152 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.18 114.88 25.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.449 0.7 . . . . 70.03 110.298 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.72 83.44 62.3 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.609 1.163 . . . . 75.54 109.333 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.29 -23.15 24.5 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.412 2.074 . . . . 73.42 111.46 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -93.54 15.28 16.43 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.25 1.42 . . . . 70.44 109.535 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -56.95 -49.0 96.48 Favored Pre-proline 0 CA--C 1.567 1.616 0 N-CA-C 113.991 1.108 . . . . 51.21 113.991 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.98 -29.57 6.62 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.041 1.407 . . . . 73.31 113.132 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -70.25 -39.84 74.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.198 0.599 . . . . 75.2 111.739 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.424 HG22 HD11 ' C' ' 68' ' ' LEU . 10.5 p -71.18 -12.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.672 0.789 . . . . 74.52 111.16 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.97 -41.0 77.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 110.562 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -100.57 48.54 0.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.033 0.92 . . . . 74.32 109.842 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.575 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -125.52 158.75 33.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.803 0.841 . . . . 75.22 110.12 177.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.85 107.2 9.0 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 106.766 -1.568 . . . . 63.41 106.766 164.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.01 90.01 3.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.824 -0.625 . . . . 74.21 111.962 -164.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -137.75 65.55 46.64 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.969 0.908 . . . . 74.44 109.071 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.13 133.36 35.15 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.284 1.99 . . . . 75.05 111.727 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' C' ' 66' ' ' ALA . 29.4 tt0 -83.76 86.45 7.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.875 -1.158 . . . . 70.25 107.875 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -74.47 79.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.513 -1.221 . . . . 63.43 110.332 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -92.74 134.23 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.054 -1.43 . . . . 75.14 110.003 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.429 HD22 HD11 ' C' ' 128' ' ' LEU . 1.4 pp -87.72 167.25 14.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.727 0.811 . . . . 73.51 111.867 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.97 148.3 18.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.709 0.804 . . . . 75.25 109.429 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 tt -123.9 139.02 54.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.277 0.631 . . . . 63.35 109.86 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 14.0 m-20 -136.39 150.68 48.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.769 1.228 . . . . 53.52 109.156 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -115.0 143.56 44.99 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.572 0.749 . . . . 73.44 109.342 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.23 154.66 41.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.187 0.995 . . . . 74.15 108.328 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -163.77 152.96 14.21 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.849 0.357 . . . . 72.52 111.063 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -151.48 130.92 12.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.28 1.032 . . . . 62.43 109.043 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -75.85 129.06 36.41 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.723 -0.473 . . . . 70.31 109.723 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.538 HD12 HD13 ' C' ' 83' ' ' ILE . 47.0 mt -104.77 -36.23 7.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.504 0.722 . . . . 73.35 110.018 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -173.44 4.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.685 -1.143 . . . . 70.14 108.948 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -76.14 124.35 27.3 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.43 -0.804 . . . . 71.1 109.798 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 63.34 12.24 6.09 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.416 1.086 . . . . 73.21 112.483 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.31 130.28 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.874 1.27 . . . . 74.02 108.36 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.2 152.13 36.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.58 0.705 . . . . 74.12 111.458 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.411 ' HB2' HD12 ' C' ' 51' ' ' LEU . 27.6 tt0 -83.61 125.42 31.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.234 1.414 . . . . 71.2 109.448 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.9 t -112.37 130.57 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.99 -1.115 . . . . 75.35 107.99 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.4 107.69 19.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.865 0.866 . . . . 71.51 108.752 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.07 108.3 19.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.39 -1.337 . . . . 71.21 107.39 173.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.9 ttp180 -89.67 128.65 36.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.069 -0.514 . . . . 75.34 109.951 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.563 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.9 t -117.99 118.94 59.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.734 -1.21 . . . . 74.42 107.734 168.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 32.4 m -110.67 146.49 36.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 72.55 109.393 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.569 HG21 HG23 ' C' ' 114' ' ' ILE . 63.8 t -129.94 115.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.747 1.219 . . . . 75.44 109.131 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -98.67 143.44 29.04 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.481 -0.933 . . . . 72.13 108.481 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' C' ' 39' ' ' GLU . . . -127.67 121.08 29.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.485 -0.561 . . . . 63.45 109.485 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.0 m -137.96 131.73 31.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.316 0.579 . . . . 73.1 111.38 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.583 ' HB2' ' HB3' ' C' ' 71' ' ' GLU . 3.9 mt -87.79 41.12 0.97 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.192 1.397 . . . . 73.32 109.685 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.91 -102.66 2.28 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.287 -1.125 . . . . 54.23 110.287 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -92.35 -31.87 15.19 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.952 0.501 . . . . 64.4 110.152 174.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.583 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 3.8 tp10 -66.8 119.0 11.1 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.702 1.201 . . . . 72.51 109.758 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.2 m -73.06 124.63 25.9 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.174 -0.676 . . . . 75.22 109.174 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.64 -47.91 10.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.377 -0.601 . . . . 73.32 109.377 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -171.44 177.22 3.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.864 0.866 . . . . 74.51 110.76 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.41 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -132.43 144.6 50.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.484 -1.672 . . . . 64.55 106.484 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.464 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.4 t -140.04 143.02 36.18 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.829 -1.545 . . . . 74.1 106.829 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.72 135.07 9.25 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.146 0.498 . . . . 73.51 110.274 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.33 135.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.864 -1.062 . . . . 74.31 108.341 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -115.84 94.01 4.5 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.362 -1.348 . . . . 73.41 107.362 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -89.83 115.17 26.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.849 -1.068 . . . . 75.13 110.11 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.604 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -108.4 157.4 15.3 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.014 -0.539 . . . . 71.45 113.28 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -158.0 133.76 3.62 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.93 -1.268 . . . . 53.32 109.93 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.542 HD11 ' HH ' ' C' ' 17' ' ' TYR . 20.8 mm -91.59 122.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.907 -1.146 . . . . 74.11 107.907 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.01 130.74 52.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.966 0.506 . . . . 75.5 110.052 -173.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.6 t -104.97 119.31 38.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.3 -1.0 . . . . 71.12 108.3 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.17 150.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.017 0.927 . . . . 74.3 110.24 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.66 149.57 28.56 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.813 0.845 . . . . 74.44 109.579 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.38 60.22 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.195 -0.457 . . . . 65.32 113.212 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 pt . . . . . 0 CA--C 1.551 0.995 0 C-N-CA 123.849 0.86 . . . . 74.22 112.0 -175.628 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 111.921 0.341 . . . . 75.1 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 48.2 ttm -84.74 -44.06 13.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.633 0.373 . . . . 73.13 110.776 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.25 -39.49 65.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.418 0.687 . . . . 71.44 111.364 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -69.82 -31.95 70.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.756 0.822 . . . . 72.42 110.368 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 45.7 t -80.87 -61.9 1.83 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.886 0.474 . . . . 74.3 110.419 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.9 -40.36 91.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.146 0.978 . . . . 73.54 110.271 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.3 2.97 68.81 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.074 -0.848 . . . . 54.04 114.622 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.06 -59.41 0.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.404 1.102 . . . . 72.33 112.768 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 77.0 t80 -71.96 -48.49 44.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.062 0.764 . . . . 73.04 113.062 -166.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 33.2 m -60.35 -48.97 92.54 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.692 0.397 . . . . 75.25 110.57 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 54.2 Cg_exo -59.62 -30.47 92.37 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.277 1.985 . . . . 74.35 114.258 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.648 0.779 . . . . 54.42 110.846 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.403 HD13 HH12 ' A' ' 111' ' ' ARG . 23.2 mm -64.48 -36.76 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.246 0.618 . . . . 73.33 110.168 173.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.1 mt -83.44 -25.84 30.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.513 -0.767 . . . . 74.52 111.86 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.98 -40.15 83.02 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 124.324 1.05 . . . . 75.42 113.609 -175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.3 -53.63 6.78 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.692 2.262 . . . . 73.1 113.792 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.408 ' HE2' HG23 ' A' ' 115' ' ' THR . 53.7 m-85 -63.5 -34.42 77.74 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.58 -1.191 . . . . 73.33 110.793 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.81 -45.24 62.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.402 0.681 . . . . 60.42 110.853 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.402 ' HD3' ' CE1' ' A' ' 109' ' ' TYR . 37.0 ttt180 -55.83 -37.74 69.11 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.384 1.074 . . . . 72.34 110.647 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.451 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -77.94 -43.15 30.74 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.262 0.625 . . . . 74.44 111.075 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.56 -33.28 75.31 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.755 0.65 . . . . 75.15 112.755 -170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.569 HG23 HG21 ' C' ' 64' ' ' VAL . 70.4 mt -67.64 -49.08 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.871 0.469 . . . . 75.33 109.821 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.701 HG22 ' HB2' ' C' ' 125' ' ' GLN . 57.4 m -54.8 -37.16 65.74 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.251 -1.341 . . . . 74.22 111.603 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.1 t -57.42 -58.11 9.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.906 -1.043 . . . . 62.43 109.98 174.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.587 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -41.68 85.85 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.325 1.05 . . . . 74.53 113.195 -176.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.04 -42.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 122.594 0.358 . . . . 73.35 110.385 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.427 ' OG ' HG22 ' B' ' 115' ' ' THR . 38.1 t -71.78 -20.15 61.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.545 -0.752 . . . . 60.11 111.588 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.495 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.5 mtt-85 -73.98 -40.12 63.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.108 0.563 . . . . 72.22 110.051 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.02 -5.64 71.21 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.53 0.519 . . . . 72.33 111.909 167.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.406 HG21 ' HB3' ' D' ' 17' ' ' TYR . 11.3 p 65.37 23.05 12.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.491 2.316 . . . . 63.33 112.357 173.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.85 164.21 49.9 Favored Pre-proline 0 CA--C 1.548 0.865 0 CA-C-N 114.805 -1.089 . . . . 75.52 108.491 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.17 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.775 2.317 . . . . 73.33 113.072 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.701 ' HB2' HG22 ' C' ' 115' ' ' THR . 2.6 pt20 -49.78 133.29 21.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.806 1.242 . . . . 75.02 111.295 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.416 ' HG ' ' HG ' ' C' ' 128' ' ' LEU . 28.2 tp -90.9 82.33 5.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.519 0.676 . . . . 73.32 110.359 -170.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -94.59 85.94 4.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.058 -0.974 . . . . 74.02 108.867 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.429 HD11 HD22 ' C' ' 42' ' ' LEU . 93.7 mt -87.85 144.28 26.67 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.416 0.627 . . . . 74.14 111.714 -176.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.18 153.35 90.51 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 114.203 -1.362 . . . . 74.02 109.417 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.721 ' HB3' HD13 ' A' ' 16' ' ' ILE . 53.5 Cg_endo -64.47 142.19 77.23 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.783 2.322 . . . . 74.41 114.737 -168.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.08 84.11 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 107.54 -1.282 . . . . 63.24 107.54 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' C' ' 130' ' ' PRO . 8.9 m120 -86.1 99.99 11.88 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.48 0.657 . . . . 74.22 110.456 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 N--CA 1.473 0.712 0 CA-C-N 114.421 -1.263 . . . . 74.42 110.873 -178.459 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.238 0.467 0 N-CA-C 108.712 -0.848 . . . . 75.21 108.712 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -144.68 127.12 15.92 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.576 -1.268 . . . . 73.53 107.576 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.614 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 58.5 mt-30 -132.89 143.63 49.64 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.099 0.96 . . . . 73.03 108.68 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' B' ' 132' ' ' ASN . 38.5 mt -103.41 115.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.622 -0.881 . . . . 73.42 108.622 170.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -83.74 -44.33 14.55 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 110.152 -0.314 . . . . 70.34 110.152 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -165.11 141.1 5.51 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 111.52 0.193 . . . . 73.33 111.52 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 38.7 mm -120.47 126.05 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.309 -0.997 . . . . 73.51 108.309 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.406 ' HB3' HG21 ' C' ' 122' ' ' THR . 2.0 p90 -167.86 154.83 8.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.627 0.771 . . . . 73.42 111.534 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -79.55 118.87 21.79 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.401 -0.818 . . . . 73.41 110.604 -176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.37 -23.0 30.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.515 -0.766 . . . . 73.43 110.862 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 35.1 t70 -160.04 132.1 6.25 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.852 0.72 . . . . 65.15 109.696 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.587 HG23 ' HE1' ' C' ' 117' ' ' MET . 96.6 mt -132.48 135.73 57.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.089 -1.449 . . . . 73.22 107.089 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -138.61 132.15 30.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.574 -1.269 . . . . 70.14 107.574 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -145.14 112.17 5.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.923 -1.51 . . . . 74.04 106.923 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.9 112.19 18.01 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.691 0.796 . . . . 72.42 108.983 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.1 82.47 2.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 107.843 -1.169 . . . . 73.42 107.843 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.38 -30.5 5.24 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.424 2.083 . . . . 75.3 112.479 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.414 ' O ' HG21 ' D' ' 31' ' ' VAL . 88.8 m-20 -108.29 38.91 2.09 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.679 1.192 . . . . 75.53 108.962 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -53.39 65.49 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 115.147 1.536 . . . . 73.4 115.147 -169.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.487 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.2 Cg_endo -79.76 -7.21 14.53 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 122.191 1.818 . . . . 74.12 112.364 175.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -84.4 -24.67 29.53 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.372 1.469 . . . . 72.32 109.055 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.414 HG21 ' O ' ' D' ' 27' ' ' ASN . 13.4 t -66.25 -29.68 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.946 0.898 . . . . 72.11 110.135 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.549 ' HD1' HH11 ' C' ' 15' ' ' ARG . 91.7 t80 -51.25 -31.75 22.04 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.434 -0.803 . . . . 75.25 112.599 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -75.42 -17.51 60.16 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.777 0.831 . . . . 75.35 112.42 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.713 ' HZ2' ' HB2' ' D' ' 71' ' ' GLU . 92.3 mttt -122.55 110.79 16.01 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.337 0.655 . . . . 74.41 110.583 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -110.82 81.75 1.48 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.243 1.017 . . . . 63.32 110.672 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -150.81 174.96 12.47 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.203 -0.908 . . . . 74.12 109.143 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.73 117.58 58.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 119.494 -0.289 . . . . 73.3 110.278 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.506 ' HG3' HD22 ' D' ' 68' ' ' LEU . 77.6 Cg_exo -55.65 130.5 40.78 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.993 2.462 . . . . 72.33 112.411 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.35 122.27 15.27 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.755 -0.831 . . . . 61.53 108.755 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -98.45 112.08 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.108 0.563 . . . . 70.33 109.541 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 3.2 mppt? -99.32 120.05 38.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.984 -1.117 . . . . 74.32 107.984 170.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.06 121.18 39.67 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.092 -1.077 . . . . 75.41 108.092 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.3 t70 -119.4 135.61 54.66 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.837 -0.801 . . . . 75.34 108.837 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.416 HD11 HD23 ' D' ' 60' ' ' LEU . 29.1 tp -111.97 129.76 56.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.084 0.554 . . . . 74.35 109.852 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -139.12 152.42 47.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.335 1.054 . . . . 63.51 108.477 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -146.21 162.76 37.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.075 0.55 . . . . 73.54 110.295 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.36 147.66 27.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.334 1.054 . . . . 64.51 108.86 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 48.9 m -144.48 152.03 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.878 0.37 . . . . 70.05 111.061 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.1 p -163.13 125.99 2.7 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.303 1.041 . . . . 75.22 108.842 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -72.86 123.84 24.21 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.834 0.454 . . . . 75.11 111.106 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.8 mt -96.53 -29.41 13.9 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.536 0.734 . . . . 74.04 111.503 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.4 -172.49 3.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.507 0.723 . . . . 75.13 110.592 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -64.47 116.62 6.3 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.971 -0.559 . . . . 74.53 110.025 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 69.51 0.43 2.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.925 1.29 . . . . 73.41 112.365 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.95 131.56 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.844 0.857 . . . . 73.32 110.117 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.47 154.2 42.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.332 0.653 . . . . 75.3 109.734 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.601 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -95.16 118.56 32.15 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.643 0.777 . . . . 75.45 109.39 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.9 119.21 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.519 -0.919 . . . . 65.34 108.519 169.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.8 t -98.11 138.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.949 -1.13 . . . . 75.21 107.949 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.508 HD11 HG23 ' D' ' 62' ' ' VAL . 0.3 OUTLIER -125.55 116.19 21.37 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.973 -0.751 . . . . 72.3 108.973 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.612 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.1 ttm180 -97.75 110.52 23.07 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.613 -0.722 . . . . 74.45 109.244 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.508 HG23 HD11 ' D' ' 60' ' ' LEU . 65.8 t -99.59 123.28 52.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.061 -1.088 . . . . 75.44 108.061 170.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 70.4 m -122.29 130.42 53.14 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.324 -0.853 . . . . 54.14 110.145 -172.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.551 HG22 HG21 ' D' ' 114' ' ' ILE . 37.6 t -120.67 101.58 10.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 113.699 -1.591 . . . . 75.3 107.281 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 11.2 m -94.3 111.36 23.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.206 -1.405 . . . . 61.22 107.206 169.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.65 135.09 54.53 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.088 -0.708 . . . . 73.43 109.088 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.9 p -139.1 148.92 43.94 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.807 -0.633 . . . . 70.34 110.022 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.506 HD22 ' HG3' ' D' ' 38' ' ' PRO . 85.9 mt -109.96 92.06 3.9 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.376 -0.601 . . . . 74.51 109.376 169.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.27 -121.23 20.4 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.421 -0.809 . . . . 72.32 111.893 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -84.4 27.77 0.68 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.957 0.903 . . . . 72.32 112.127 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.713 ' HB2' ' HZ2' ' D' ' 34' ' ' LYS . 5.2 tp10 -135.63 135.64 40.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 118.889 -0.577 . . . . 71.31 110.048 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -73.85 113.17 10.7 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.905 -0.776 . . . . 73.14 108.905 167.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -76.23 -61.46 1.94 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.173 -0.677 . . . . 64.44 109.173 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.57 154.23 15.99 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.361 -1.29 . . . . 72.13 110.016 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.13 149.52 29.21 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.111 -1.44 . . . . 71.4 107.111 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.548 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 42.2 t -155.35 103.38 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.547 -0.538 . . . . 71.11 109.547 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -121.96 121.71 37.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.133 0.973 . . . . 74.51 108.667 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.43 114.18 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.758 -0.46 . . . . 73.04 109.758 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.613 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.78 91.25 8.55 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.639 0.776 . . . . 70.11 109.268 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -79.17 98.56 6.63 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.962 -1.017 . . . . 74.41 108.962 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.05 142.92 20.14 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.079 -0.808 . . . . 61.33 111.079 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.16 130.12 3.61 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.689 -0.964 . . . . 65.11 110.689 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.482 HG22 HD13 ' D' ' 51' ' ' LEU . 49.2 mt -90.73 128.72 42.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.502 -0.925 . . . . 72.15 108.502 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -134.06 148.38 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.091 0.556 . . . . 75.3 110.489 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 46.1 m -104.94 105.78 15.98 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.566 -0.902 . . . . 74.42 108.566 170.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.1 pt -109.57 145.38 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 118.488 0.585 . . . . 74.22 110.634 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.15 169.3 21.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.697 -1.138 . . . . 71.55 109.43 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 23.8 77.26 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 121.576 -0.345 . . . . 72.1 112.584 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' D' ' 94' ' ' MET . 2.2 pp -124.46 146.16 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.749 0.82 . . . . 73.21 110.755 -172.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.29 171.49 17.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 75.51 110.177 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.98 -134.48 31.69 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.941 0.776 . . . . 71.34 114.73 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -81.04 -13.25 58.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.269 0.628 . . . . 74.13 110.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -67.9 -36.69 80.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.235 0.614 . . . . 70.42 110.468 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.424 ' HB2' HD11 ' D' ' 89' ' ' ILE . 2.0 ppp? -70.45 -35.08 73.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.455 -0.572 . . . . 74.51 109.455 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.85 76.02 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 115.038 -0.983 . . . . 54.32 111.285 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -72.28 -37.68 68.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.25 0.62 . . . . 74.41 110.974 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.85 -38.96 76.63 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.043 0.537 . . . . 72.03 110.811 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.67 -45.86 20.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.662 0.785 . . . . 71.14 110.416 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.61 -26.9 40.72 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.626 -0.715 . . . . 70.23 114.009 -168.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.93 -51.02 2.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.142 0.471 . . . . 75.33 111.903 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -73.74 -47.29 40.32 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.282 0.475 . . . . 74.22 112.282 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.413 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 73.6 m -60.5 -47.84 95.18 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 118.976 -0.535 . . . . 74.43 111.274 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.486 ' HA ' ' HG ' ' D' ' 60' ' ' LEU . 86.8 Cg_exo -55.32 -37.0 94.89 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.447 2.098 . . . . 74.21 114.043 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.98 -29.61 70.54 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.099 0.56 . . . . 71.01 111.02 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.423 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 44.6 mm -75.34 -46.3 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.351 0.66 . . . . 70.11 110.409 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.81 -17.27 59.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.202 -0.908 . . . . 74.34 111.822 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.0 -47.6 52.33 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.256 1.022 . . . . 72.13 112.859 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 83.2 Cg_exo -49.42 -44.98 32.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.565 2.177 . . . . 74.43 113.945 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.452 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 80.6 m-85 -73.71 -37.08 65.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.319 0.648 . . . . 74.31 111.918 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.409 ' HB1' ' HB ' ' D' ' 62' ' ' VAL . . . -64.36 -53.38 49.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.212 0.605 . . . . 74.34 110.764 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.614 HH12 ' HB3' ' D' ' 130' ' ' PRO . 8.7 ptt180 -67.13 -30.85 70.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.703 -1.135 . . . . 74.14 110.898 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.3 tm-20 -67.82 -45.71 73.92 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.09 0.868 . . . . 75.33 110.446 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.696 0.622 . . . . 73.1 110.4 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.551 HG21 HG22 ' D' ' 64' ' ' VAL . 96.5 mt -58.25 -54.83 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 114.889 -1.051 . . . . 75.24 110.562 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.588 HG21 ' HG3' ' D' ' 125' ' ' GLN . 27.6 m -51.2 -48.24 62.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.878 1.271 . . . . 73.34 111.145 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -66.93 -44.78 79.79 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.464 -1.244 . . . . 62.54 110.176 -173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.548 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.5 mtm -65.47 -34.03 77.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.903 0.481 . . . . 74.54 111.405 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' D' ' 123' ' ' PHE . 56.5 t -64.91 -49.63 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.597 0.759 . . . . 74.33 110.454 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 90.4 p -69.29 -31.6 70.21 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.959 0.504 . . . . 65.53 111.066 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -70.43 -31.46 68.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.929 0.892 . . . . 75.12 109.945 173.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.85 64.13 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.536 -0.756 . . . . 73.31 113.202 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 125' ' ' GLN . 66.8 p 56.92 28.18 14.22 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.866 1.667 . . . . 75.35 113.112 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.526 ' HB2' HG11 ' D' ' 118' ' ' VAL . 20.4 m-85 -100.9 164.36 16.25 Favored Pre-proline 0 CA--C 1.561 1.396 0 N-CA-C 108.474 -0.936 . . . . 74.51 108.474 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 63.2 Cg_endo -68.77 133.53 27.69 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.311 2.007 . . . . 72.21 112.196 -175.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.588 ' HG3' HG21 ' D' ' 115' ' ' THR . 57.2 tt0 -56.58 129.91 42.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.688 0.795 . . . . 70.31 111.227 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -121.99 97.99 5.74 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.031 0.443 . . . . 64.25 110.121 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -99.43 105.05 16.95 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.218 -1.401 . . . . 72.43 107.218 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.82 115.0 12.75 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.888 -0.412 . . . . 70.31 109.888 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.11 86.83 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.543 0.737 . . . . 74.54 111.05 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.614 ' HB3' HH12 ' D' ' 111' ' ' ARG . 73.1 Cg_endo -79.82 108.72 2.3 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.581 2.187 . . . . 75.04 109.997 -174.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -104.26 113.26 40.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.43 -0.952 . . . . 74.43 108.43 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t30 . . . . . 0 C--O 1.241 0.611 0 N-CA-C 106.731 -1.581 . . . . 73.12 106.731 169.01 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.235 0.311 0 N-CA-C 108.212 -1.033 . . . . 65.41 108.212 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 60.3 t80 -135.04 135.91 41.67 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.287 -1.005 . . . . 75.52 108.287 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.48 135.7 15.79 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 116.134 -0.485 . . . . 75.22 110.2 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.439 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 3.7 mp -79.82 117.73 26.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.667 -0.864 . . . . 75.31 108.667 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -89.27 -39.65 13.35 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.155 0.582 . . . . 73.12 109.701 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -172.71 123.78 0.45 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.307 0.243 . . . . 74.1 111.078 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.796 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 85.6 mt -108.17 132.73 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 123.611 0.764 . . . . 74.53 109.208 173.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' HE2' ' HB3' ' B' ' 28' ' ' ALA . 9.3 p90 -167.73 170.74 10.65 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.047 0.939 . . . . 72.35 110.13 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -88.46 134.86 33.73 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.694 -0.854 . . . . 75.24 108.694 171.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 46.9 mtpt -94.44 -43.32 8.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.927 -0.768 . . . . 73.23 108.927 170.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 28.1 t70 -137.54 129.5 28.91 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.709 -1.132 . . . . 75.43 109.604 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -124.36 136.15 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.416 -1.328 . . . . 75.14 107.416 170.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -145.89 112.75 6.03 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 123.519 0.512 . . . . 62.31 109.725 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 77.7 t80 -114.23 111.78 22.08 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 106.609 -1.626 . . . . 75.33 106.609 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.76 110.19 16.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.976 -0.75 . . . . 75.01 108.976 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.47 93.04 7.75 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.566 -1.272 . . . . 70.14 107.566 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.46 -41.01 7.02 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.457 2.105 . . . . 75.13 111.182 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 78.0 m-20 -100.56 37.51 1.68 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.651 -1.159 . . . . 75.22 109.303 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.34 73.2 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.131 -0.938 . . . . 74.44 113.43 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.33 -27.93 10.92 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 121.541 1.586 . . . . 72.43 112.924 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 14.3 t60 -67.58 -26.26 66.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.761 1.224 . . . . 74.53 112.151 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.65 HG21 HD11 ' A' ' 68' ' ' LEU . 12.0 p -55.75 -30.18 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.517 1.127 . . . . 75.34 112.908 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.6 -34.46 75.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.892 0.877 . . . . 75.45 111.21 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -69.64 -32.03 70.47 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.282 1.033 . . . . 75.21 110.267 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 4.0 mmmp? -79.14 162.32 25.88 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.683 -1.144 . . . . 74.45 111.06 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.1 143.08 30.79 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 108.316 -0.994 . . . . 74.35 108.316 164.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -83.68 83.88 7.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.756 0.789 . . . . 75.02 110.038 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.67 69.77 16.97 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.416 1.086 . . . . 75.22 108.318 176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.27 110.02 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.534 2.156 . . . . 75.53 112.704 -170.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.11 114.4 26.53 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.634 -1.247 . . . . 74.02 107.634 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 65' ' ' THR . 22.8 m -87.63 118.25 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.066 -0.97 . . . . 63.03 110.877 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 64.1 tttm -85.33 116.74 23.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.198 -0.91 . . . . 71.11 108.753 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.34 123.51 41.19 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.863 -0.608 . . . . 73.43 110.206 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.1 m-20 -115.32 122.92 47.37 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.061 -1.089 . . . . 71.41 108.061 170.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.489 HD23 ' HE2' ' A' ' 133' ' ' PHE . 34.1 tp -124.21 121.23 34.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.033 -0.729 . . . . 74.22 109.033 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.15 146.06 34.89 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.893 0.877 . . . . 73.34 110.017 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -109.29 150.11 28.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.405 0.682 . . . . 74.14 109.811 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.28 154.17 49.04 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.767 1.227 . . . . 73.34 108.085 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -130.55 152.79 49.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.86 0.464 . . . . 73.43 110.454 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.9 t -154.66 119.38 4.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.213 1.005 . . . . 75.01 108.537 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -91.47 118.67 30.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.183 -1.043 . . . . 75.51 108.183 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 57' ' ' GLU . 40.5 mt -93.24 -33.27 14.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.751 0.82 . . . . 74.45 110.129 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.97 -169.97 1.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.307 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.68 106.31 0.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.898 1.279 . . . . 73.11 109.964 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.96 8.18 6.3 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.541 1.136 . . . . 74.44 112.515 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.36 19.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.736 -1.209 . . . . 72.32 107.736 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -122.32 123.32 41.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.442 -0.799 . . . . 71.15 109.592 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD13 ' A' ' 51' ' ' LEU . 35.9 tt0 -93.64 128.07 39.64 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.878 -1.055 . . . . 72.14 108.796 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.8 t -101.3 124.86 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.75 . . . . 74.34 106.276 166.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.9 t -101.83 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.725 -0.843 . . . . 62.14 108.725 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.445 HD21 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -102.85 107.05 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.127 -1.064 . . . . 73.32 108.127 -175.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -103.68 110.53 22.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.952 0.901 . . . . 74.14 109.984 -173.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.01 132.07 66.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.97 -1.013 . . . . 75.23 108.729 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.1 m -121.92 123.22 41.19 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.533 -0.543 . . . . 75.51 109.533 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 114' ' ' ILE . 52.4 t -116.69 107.23 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.727 1.211 . . . . 65.44 108.453 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.8 m -102.2 149.81 23.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.132 -1.062 . . . . 63.54 108.132 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.19 122.67 30.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.623 -0.51 . . . . 75.45 109.623 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -117.74 126.61 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.238 0.615 . . . . 75.1 110.39 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 31' ' ' VAL . 28.8 mt -92.92 82.42 4.66 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.791 -1.559 . . . . 65.51 106.791 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -83.63 1.0 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.177 -1.169 . . . . 50.53 110.177 -167.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.93 -18.2 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.472 1.109 . . . . 75.52 110.321 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.44 108.86 12.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.41 1.084 . . . . 73.43 110.505 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 m -66.16 119.15 10.95 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.967 0.348 . . . . 72.43 111.106 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.09 -50.89 17.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.184 0.994 . . . . 64.43 109.336 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -159.9 173.15 16.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 113.607 -1.633 . . . . 74.52 110.174 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.0 tp -141.1 141.2 34.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.737 1.215 . . . . 75.21 107.811 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.439 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 36.2 m -132.25 141.51 49.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.854 0.862 . . . . 74.42 108.877 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.99 121.39 9.65 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.568 -0.901 . . . . 70.13 108.568 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.49 112.38 29.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.524 0.73 . . . . 74.43 109.542 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -88.73 87.2 7.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.536 -1.211 . . . . 71.51 109.086 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -77.15 95.55 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.716 -1.129 . . . . 75.25 109.29 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.82 142.95 19.56 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.912 -0.475 . . . . 75.23 111.912 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.43 122.66 2.33 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 110.865 -0.894 . . . . 73.3 110.865 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.3 mt -79.76 131.0 35.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.726 -1.212 . . . . 74.21 107.726 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HD2' ' HA ' ' A' ' 13' ' ' ILE . 39.2 m-85 -135.9 138.34 42.32 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.197 0.599 . . . . 75.41 109.577 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.9 m -87.62 121.46 30.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 71.41 108.94 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.37 136.09 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.57 0.748 . . . . 74.13 111.26 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.27 174.31 3.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.711 1.204 . . . . 63.35 110.155 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.41 9.62 86.73 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-N 116.509 -0.314 . . . . 73.25 113.833 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 94' ' ' MET . 1.8 pp -120.22 149.4 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.311 1.044 . . . . 75.12 111.02 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.8 174.55 10.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.597 0.759 . . . . 74.33 110.634 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.43 -140.43 40.12 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 115.683 1.033 . . . . 75.24 115.683 167.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -78.63 -12.04 60.0 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.308 1.043 . . . . 71.53 111.064 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -36.9 79.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.752 0.821 . . . . 63.44 110.091 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.5 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 26.2 ptm -75.69 -20.15 58.61 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.397 -0.365 . . . . 75.44 111.191 174.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -23.8 66.61 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.781 0.432 . . . . 73.0 111.553 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -62.86 -45.0 94.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 75.4 110.522 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 41.9 t -68.85 -64.52 0.85 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.704 0.802 . . . . 72.52 111.601 -173.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.58 -26.1 61.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.557 0.343 . . . . 74.42 111.688 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.05 -34.15 11.21 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 114.659 0.624 . . . . 52.22 114.659 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.99 -39.25 0.41 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.96 0.88 . . . . 74.42 113.067 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.417 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.1 t80 -69.8 -58.96 3.26 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.844 0.458 . . . . 75.32 111.632 -174.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 65.3 m -67.19 -37.46 13.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.748 0.819 . . . . 75.42 112.66 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.17 -43.56 47.85 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.124 1.883 . . . . 75.13 113.309 162.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.3 -25.43 62.43 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.17 0.588 . . . . 75.5 111.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.0 mm -62.33 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.595 0.712 . . . . 74.44 109.176 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.526 HD22 ' HA3' ' A' ' 82' ' ' GLY . 45.5 mt -81.12 -18.74 45.4 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.584 -1.189 . . . . 75.12 112.061 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.452 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 51.4 t80 -63.42 -42.54 74.7 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 113.966 1.098 . . . . 75.21 113.966 -171.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.542 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 73.6 Cg_exo -55.13 -33.19 83.06 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 122.101 1.867 . . . . 73.5 113.785 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.94 -40.14 24.99 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.265 -0.88 . . . . 75.35 111.317 -175.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.06 -41.14 82.42 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.457 0.303 . . . . 73.14 110.586 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.542 ' NH1' ' HA ' ' A' ' 108' ' ' PRO . 34.0 ttm180 -51.98 -55.72 18.67 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.528 1.142 . . . . 75.33 109.537 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.45 -42.17 99.27 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.676 1.235 . . . . 75.35 111.845 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.458 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.5 t -57.54 -50.21 73.82 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.967 0.792 . . . . 73.42 110.302 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.479 HG21 HG22 ' A' ' 64' ' ' VAL . 95.1 mt -62.63 -46.5 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.141 -0.936 . . . . 74.32 110.667 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.0 m -54.41 -44.49 72.41 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.253 1.021 . . . . 64.4 110.902 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.2 t -72.13 -34.81 68.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.547 -1.206 . . . . 73.22 111.035 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.9 mtp -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.516 0.726 . . . . 65.12 111.193 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -59.97 -52.08 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.008 0.923 . . . . 75.54 110.064 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.627 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 71.1 p -68.04 -26.71 66.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.17 -0.923 . . . . 75.12 112.151 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.9 ttm-85 -72.81 -25.49 61.16 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.877 0.871 . . . . 75.14 109.985 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 22.16 12.03 Favored Glycine 0 C--N 1.358 1.791 0 CA-C-N 116.027 -0.533 . . . . 74.32 113.06 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t 55.96 27.86 11.82 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 127.154 2.182 . . . . 74.33 113.664 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 119' ' ' SER . 36.1 m-85 -98.48 153.15 38.11 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.398 0.679 . . . . 70.34 110.191 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.74 118.94 5.78 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.501 2.134 . . . . 74.1 111.14 166.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 11.9 pt20 -64.23 150.35 46.09 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.391 0.676 . . . . 73.04 112.345 -171.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -109.21 101.24 10.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 109.029 -0.73 . . . . 75.05 109.029 -171.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -98.2 84.7 3.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.735 -0.839 . . . . 73.34 108.735 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.452 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -59.43 139.95 56.61 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.875 0.87 . . . . 74.43 110.017 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.78 132.71 91.74 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.316 0.647 . . . . 62.14 111.852 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.663 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 39.8 Cg_endo -72.07 101.73 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.396 2.064 . . . . 74.43 111.483 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -101.03 111.52 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 122.389 1.09 . . . . 73.34 110.711 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.16 70.03 1.75 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.965 -1.471 . . . . 74.24 108.526 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.489 ' HE2' HD23 ' A' ' 44' ' ' LEU . 21.7 m-85 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 75.33 112.289 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 C--O 1.242 0.688 0 N-CA-C 107.8 -1.185 . . . . 74.11 107.8 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -137.21 140.48 41.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.179 -0.674 . . . . 75.33 109.179 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.649 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 23.9 tp60 -142.68 115.46 8.68 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.171 -0.677 . . . . 74.22 109.171 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.403 HD11 HG13 ' B' ' 16' ' ' ILE . 6.8 tp -68.88 127.6 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.953 -0.758 . . . . 75.1 108.953 171.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.78 -45.55 3.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.873 0.469 . . . . 71.45 110.332 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -167.09 143.74 4.48 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.329 0.393 . . . . 73.5 110.689 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.403 HG13 HD11 ' B' ' 13' ' ' ILE . 92.8 mt -120.04 143.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.442 -1.318 . . . . 73.5 107.442 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.434 ' HE1' HG13 ' B' ' 83' ' ' ILE . 22.1 p90 -173.19 156.27 3.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.167 0.508 . . . . 74.13 111.461 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.439 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 94.4 m -84.1 128.98 34.91 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.93 -0.767 . . . . 71.45 108.93 169.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.403 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.5 mtpt -90.41 -43.49 10.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.496 0.718 . . . . 75.3 109.738 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.0 t70 -148.19 142.44 26.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.316 -0.856 . . . . 74.34 111.323 -172.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.759 HD12 ' SG ' ' B' ' 113' ' ' CYS . 41.3 mm -128.27 135.36 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 124.768 1.227 . . . . 72.42 108.878 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.8 t -130.39 128.83 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.611 -1.177 . . . . 75.11 108.067 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 72.5 t80 -150.08 110.33 4.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.793 -1.558 . . . . 75.22 106.793 171.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.41 113.93 18.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.979 -1.119 . . . . 73.13 107.979 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.07 89.64 5.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.703 0.801 . . . . 73.24 108.903 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 44.7 Cg_endo -63.57 -38.28 42.48 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.25 2.634 . . . . 74.1 112.844 -171.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.33 30.69 6.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.302 1.041 . . . . 75.02 109.559 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.504 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -47.4 -50.02 51.0 Favored Pre-proline 0 CA--C 1.566 1.57 0 N-CA-C 114.856 1.428 . . . . 71.14 114.856 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -77.68 -23.28 9.8 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.871 1.714 . . . . 73.2 112.738 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.454 ' HA ' ' NE2' ' B' ' 33' ' ' GLN . 77.0 m80 -78.38 -8.29 58.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.568 0.747 . . . . 75.35 111.437 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.01 -24.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.074 0.95 . . . . 71.34 111.027 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -66.13 -43.49 86.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.665 0.386 . . . . 73.41 110.975 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' B' ' 30' ' ' HIS . 2.1 mp0 -72.54 -36.59 68.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.709 0.804 . . . . 74.32 110.049 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.38 76.6 10.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.651 0.739 . . . . 72.11 109.786 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.79 79.34 6.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.595 -1.184 . . . . 74.41 110.641 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -173.29 156.95 3.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.142 0.977 . . . . 75.4 109.482 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -58.54 128.38 83.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.881 0.872 . . . . 75.25 110.699 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -66.01 152.6 80.91 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.19 1.26 . . . . 73.34 110.281 168.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.27 101.66 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.026 -1.101 . . . . 74.5 108.026 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' B' ' 124' ' ' PRO . 4.2 t -84.58 123.21 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.143 -1.428 . . . . 71.01 107.143 -174.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 64' ' ' VAL . 1.5 tmtp? -145.83 113.97 6.59 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.629 -0.508 . . . . 70.34 109.629 -174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' B' ' 64' ' ' VAL . 10.0 mp -89.71 148.48 23.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.646 0.779 . . . . 74.5 109.157 172.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.39 150.33 43.76 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.13 -1.063 . . . . 61.43 108.13 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 tt -109.92 125.73 53.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.351 0.66 . . . . 74.44 109.257 -172.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -134.46 136.19 43.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.884 -1.154 . . . . 73.31 107.884 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -108.41 146.16 33.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.274 0.559 . . . . 74.13 109.957 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.528 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -137.75 159.17 42.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.5 1.12 . . . . 71.4 108.405 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.498 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 81.2 p -143.54 162.35 36.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.945 0.402 . . . . 53.1 110.94 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -160.48 154.36 22.75 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.781 1.233 . . . . 75.0 108.91 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -121.76 135.07 54.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.166 0.587 . . . . 75.15 109.657 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.5 mt -100.66 -47.9 4.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.474 0.71 . . . . 75.31 109.517 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.06 -175.39 5.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.99 -1.005 . . . . 73.31 110.295 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -71.83 130.11 40.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.736 -1.12 . . . . 71.32 109.072 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 66.07 -8.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.47 1.508 . . . . 72.2 112.743 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.02 94.18 2.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 107.942 -1.133 . . . . 74.11 107.942 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.498 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 2.8 t80 -98.12 165.32 11.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.701 -1.136 . . . . 74.31 109.134 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.8 106.01 4.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.548 -1.278 . . . . 72.14 107.548 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 56.7 t -97.94 131.5 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.205 0.602 . . . . 71.24 109.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 34.7 t -108.92 125.28 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.716 0.806 . . . . 74.33 109.726 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.25 130.95 40.31 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.511 -1.292 . . . . 72.35 107.511 172.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -121.26 106.74 11.77 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.681 . . . . 72.23 109.497 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.1 124.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.537 -0.912 . . . . 75.42 108.537 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.1 m -120.35 146.91 45.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.398 . . . . 74.31 110.931 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 55.1 t -116.88 120.1 64.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 124.644 1.177 . . . . 75.51 109.577 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.3 m -99.24 127.93 45.29 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.981 -1.488 . . . . 74.31 106.981 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.59 132.43 18.03 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.582 -0.896 . . . . 72.14 108.582 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -148.55 139.31 22.88 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.587 0.554 . . . . 52.04 111.803 -170.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 51.2 mt -100.24 100.28 11.08 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.054 1.342 . . . . 74.44 109.587 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.66 -111.18 3.61 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.801 -0.52 . . . . 73.45 111.801 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -108.16 4.43 24.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.566 0.747 . . . . 64.43 111.536 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -121.07 160.31 23.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.693 0.797 . . . . 73.43 109.843 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.9 m -78.74 136.99 37.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.738 0.415 . . . . 65.33 110.515 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.33 -61.42 1.9 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.412 1.101 . . . . 65.42 109.024 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' B' ' 76' ' ' CYS . 1.2 p90 -154.17 171.79 18.61 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 112.892 -1.958 . . . . 74.24 107.623 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -136.57 110.17 8.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.907 -1.886 . . . . 74.04 105.907 167.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.509 ' HB3' ' CE2' ' B' ' 74' ' ' PHE . 1.8 t -113.76 160.22 18.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.094 -0.503 . . . . 73.42 110.292 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.2 tt0 -164.98 143.73 6.59 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.653 -1.24 . . . . 75.24 107.653 -170.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.16 144.01 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.786 0.834 . . . . 73.34 108.871 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 46.7 mt-30 -122.69 92.53 3.73 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.748 0.819 . . . . 74.23 108.911 172.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -88.54 100.73 13.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.736 -1.12 . . . . 74.24 108.809 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.39 174.52 33.74 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 111.838 -0.505 . . . . 74.02 111.838 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.29 136.5 4.07 Favored Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.729 -0.548 . . . . 74.34 111.729 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.434 HG13 ' HE1' ' B' ' 17' ' ' TYR . 34.5 mt -86.15 124.88 40.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.445 -0.946 . . . . 73.21 108.445 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -138.61 131.53 29.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.976 -1.12 . . . . 74.01 107.976 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.649 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 75.1 m -91.03 107.37 19.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.716 -0.476 . . . . 75.12 109.716 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.486 ' HB ' HD13 ' B' ' 89' ' ' ILE . 24.7 pt -106.24 142.85 18.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.358 -0.837 . . . . 74.4 110.817 -176.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.38 166.13 33.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.313 1.045 . . . . 75.0 108.739 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.63 -53.33 4.84 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.924 -0.375 . . . . 71.44 113.523 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.486 HD13 ' HB ' ' B' ' 86' ' ' ILE . 1.5 pp -51.98 126.07 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.036 0.934 . . . . 73.11 112.474 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 10.2 pt-20 -159.36 154.36 24.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 74.54 110.768 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.33 -122.93 22.19 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.578 -0.737 . . . . 74.35 112.188 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -68.52 -31.27 70.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.66 0.784 . . . . 74.25 110.936 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -72.8 -34.85 67.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.642 0.777 . . . . 74.34 110.763 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.448 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 54.1 ttm -62.79 -49.23 75.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.527 -0.761 . . . . 75.13 109.36 171.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.0 -28.79 69.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.697 0.799 . . . . 65.41 112.071 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -69.83 -44.73 69.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 74.52 110.034 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.436 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 45.5 t -63.91 -59.47 4.47 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.753 0.821 . . . . 72.11 111.535 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.439 HD11 ' N ' ' B' ' 99' ' ' GLY . 4.2 pp -71.12 -28.66 64.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.475 0.71 . . . . 75.13 112.486 -175.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.439 ' N ' HD11 ' B' ' 98' ' ' LEU . . . -94.42 -38.41 5.04 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.478 -0.328 . . . . 22.12 113.521 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.9 -45.17 1.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 118.984 -0.531 . . . . 52.41 112.223 -171.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.436 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 93.0 t80 -71.04 -63.86 1.02 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.17 0.441 . . . . 74.53 111.819 -169.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.431 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 58.1 m -58.32 -45.99 99.67 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.777 -0.63 . . . . 75.51 111.1 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.466 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 82.3 Cg_exo -54.04 -38.91 87.15 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.314 2.009 . . . . 71.51 114.228 167.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -68.52 -30.14 68.88 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.576 0.626 . . . . 74.44 111.49 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.8 -50.18 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.528 0.68 . . . . 74.51 109.206 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.41 -13.5 59.91 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 113.841 -1.527 . . . . 74.42 111.963 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 55.2 t80 -67.56 -49.3 41.38 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 117.821 -1.085 . . . . 71.22 113.792 -166.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.21 -32.42 90.63 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.45 1.433 . . . . 71.45 112.231 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -65.23 -49.85 68.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 71.3 110.531 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.55 99.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.873 0.869 . . . . 73.14 111.15 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -61.28 -49.14 78.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.53 1.532 . . . . 74.54 111.265 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -36.85 77.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.512 -0.551 . . . . 74.42 109.512 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.759 ' SG ' HD12 ' B' ' 21' ' ' ILE . 37.9 t -62.18 -39.27 92.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.326 0.65 . . . . 73.41 112.217 -178.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mt -63.51 -51.84 65.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.716 -0.476 . . . . 72.35 109.716 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.9 m -61.52 -24.42 66.61 Favored 'General case' 0 CA--C 1.561 1.371 0 O-C-N 124.31 1.006 . . . . 74.42 111.438 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.4 t -69.74 -58.59 3.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.971 0.909 . . . . 64.15 109.884 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.498 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.4 mmt -65.9 -28.08 68.68 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.309 0.576 . . . . 73.12 111.477 -176.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -52.35 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.726 1.61 . . . . 72.42 109.548 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 96.7 p -65.97 -31.6 72.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.015 0.526 . . . . 75.24 111.007 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 79.8 mtt-85 -62.17 -39.85 94.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.406 0.682 . . . . 74.01 110.721 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 9.21 71.15 Favored Glycine 0 C--N 1.353 1.475 0 O-C-N 123.349 0.406 . . . . 63.11 113.489 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 17' ' ' TYR . 11.3 p 58.95 30.7 20.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.406 1.882 . . . . 75.35 112.362 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.84 161.53 35.6 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.749 1.22 . . . . 75.42 110.899 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.614 ' HB2' HG22 ' B' ' 40' ' ' VAL . 14.8 Cg_exo -74.89 145.46 31.94 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 124.157 3.238 . . . . 73.22 115.46 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.4 OUTLIER -67.41 143.13 56.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.25 1.42 . . . . 75.24 111.936 177.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.28 113.73 4.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.95 -1.13 . . . . 74.13 107.95 163.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -89.01 116.02 26.99 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.147 -1.057 . . . . 65.2 108.147 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.453 HD22 ' N ' ' B' ' 129' ' ' ALA . 2.3 tt -66.34 137.48 56.94 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.853 0.721 . . . . 74.44 110.063 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.453 ' N ' HD22 ' B' ' 128' ' ' LEU . . . -55.11 152.89 13.5 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 126.138 1.775 . . . . 70.23 113.539 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.604 ' HG3' HD11 ' D' ' 16' ' ' ILE . 92.6 Cg_endo -69.72 103.98 1.24 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.807 2.338 . . . . 72.44 110.701 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.6 m -85.29 52.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 122.374 1.083 . . . . 72.12 111.096 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.46 71.27 4.92 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.402 -1.333 . . . . 73.43 107.402 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 t80 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 114.308 -1.315 . . . . 73.5 110.974 -171.42 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.245 0.826 0 N-CA-C 110.49 -0.189 . . . . 73.55 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.5 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 44.0 t80 -125.31 118.64 26.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.953 -1.128 . . . . 74.55 107.953 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.438 ' NE2' ' HG2' ' C' ' 14' ' ' GLN . 11.9 tm0? -136.12 127.57 28.58 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 117.943 0.338 . . . . 75.34 110.235 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -89.15 129.03 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.224 -0.658 . . . . 73.44 109.224 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.438 ' HG2' ' NE2' ' C' ' 12' ' ' GLN . 5.5 mt-30 -99.99 -42.2 6.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.413 0.685 . . . . 75.41 110.42 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.484 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 60.6 ttt180 -174.6 128.19 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.153 0.581 . . . . 75.33 110.11 -168.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.85 142.1 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.961 -1.126 . . . . 73.22 107.961 172.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.506 ' HH ' HD11 ' C' ' 83' ' ' ILE . 26.2 p90 -177.84 161.37 1.59 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.824 0.703 . . . . 72.25 110.909 -175.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -80.41 120.32 24.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.609 0.764 . . . . 75.3 109.701 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.553 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.2 OUTLIER -74.02 -49.87 22.36 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.862 0.839 . . . . 74.32 108.964 178.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' C' ' 79' ' ' GLN . 25.0 m-20 -141.91 122.07 13.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.417 -1.72 . . . . 61.23 108.16 -174.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.2 mt -112.63 143.62 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 107.412 -1.329 . . . . 74.04 107.412 169.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.19 145.98 21.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.098 0.475 . . . . 64.51 110.214 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.471 ' HB3' ' HB ' ' D' ' 21' ' ' ILE . 91.8 t80 -148.21 123.99 10.56 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.562 -1.273 . . . . 73.35 107.562 176.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.06 115.35 24.11 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.14 0.976 . . . . 73.34 109.306 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.32 78.55 27.06 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 108.042 -1.095 . . . . 55.15 108.042 166.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.52 -15.34 24.73 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.373 2.049 . . . . 71.43 111.559 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -112.31 25.41 11.55 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 124.276 1.03 . . . . 53.45 109.945 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.33 77.01 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 114.435 1.272 . . . . 64.11 114.435 -172.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.69 -27.13 9.2 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 121.922 1.748 . . . . 71.21 112.45 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.84 -33.81 72.79 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.211 1.404 . . . . 71.41 111.395 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.74 HG12 HD13 ' C' ' 68' ' ' LEU . 53.5 t -79.9 -22.78 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 124.78 1.232 . . . . 73.34 111.487 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.65 -40.87 93.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.215 0.606 . . . . 73.55 111.78 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -101.97 45.69 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.415 0.686 . . . . 74.33 109.944 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.83 168.33 13.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.636 0.775 . . . . 75.33 110.019 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -74.08 115.41 13.52 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.032 -0.729 . . . . 72.33 109.032 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.458 ' HZ3' HG13 ' C' ' 31' ' ' VAL . 51.7 t-105 -85.25 93.94 8.8 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.659 0.784 . . . . 60.42 111.842 -167.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.49 73.39 20.5 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.148 0.979 . . . . 74.31 109.773 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 120.76 4.97 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.999 2.466 . . . . 61.13 112.408 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' C' ' 67' ' ' SER . 8.8 pt-20 -86.49 91.37 8.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.222 1.01 . . . . 63.42 109.346 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.742 ' HB ' HD13 ' C' ' 126' ' ' LEU . 26.2 m -82.03 89.01 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 122.532 1.158 . . . . 71.51 110.449 -173.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -109.61 142.04 41.29 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.691 -1.141 . . . . 74.35 109.507 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -129.85 160.78 32.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.895 0.478 . . . . 74.42 111.17 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -133.41 146.58 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.719 1.208 . . . . 62.1 109.053 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.556 ' HG ' HD21 ' C' ' 60' ' ' LEU . 6.0 tt -112.39 109.77 19.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.657 -1.238 . . . . 72.41 107.657 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -112.97 141.7 46.5 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.039 -1.097 . . . . 74.31 108.039 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 43.5 m -113.94 111.63 22.0 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.786 -0.82 . . . . 64.34 108.786 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.47 158.86 18.65 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.934 1.294 . . . . 71.12 108.971 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 p -165.69 154.48 11.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.789 0.436 . . . . 72.34 111.198 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -145.6 160.91 40.97 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.737 0.815 . . . . 63.14 109.172 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.68 121.83 35.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.494 -0.558 . . . . 71.55 109.494 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.505 HD13 HD13 ' C' ' 83' ' ' ILE . 61.6 mt -88.3 -53.06 4.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.561 -0.903 . . . . 75.14 108.561 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.16 -171.26 3.79 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.852 -1.067 . . . . 71.43 110.328 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.91 118.92 17.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.065 -0.97 . . . . 75.22 108.779 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 69.51 -0.55 2.55 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.805 1.242 . . . . 74.44 113.189 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.71 114.64 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.059 -0.719 . . . . 71.14 109.059 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -128.13 140.07 52.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.835 0.826 . . . . 75.04 110.839 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -85.24 109.3 18.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.373 -1.739 . . . . 74.31 108.138 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.32 115.97 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.714 -1.217 . . . . 74.41 107.714 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.6 114.07 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.695 0.798 . . . . 74.33 109.973 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.556 HD21 ' HG ' ' C' ' 44' ' ' LEU . 1.3 tt -86.58 106.44 17.56 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.97 -1.493 . . . . 73.0 106.97 169.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 45.0 mtp180 -87.61 106.51 18.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 74.54 109.738 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' C' ' 114' ' ' ILE . 8.2 t -100.19 120.63 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.85 -0.796 . . . . 71.21 108.85 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 86.0 m -104.35 145.42 30.28 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.454 -0.943 . . . . 73.22 108.454 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.486 HG22 HG23 ' C' ' 114' ' ' ILE . 46.8 t -136.88 127.56 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.846 0.858 . . . . 72.53 109.637 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.1 m -118.17 146.15 44.41 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.39 -0.967 . . . . 72.32 108.39 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.273 -1.01 . . . . 71.15 108.273 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 70.6 m -143.25 168.18 20.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.047 0.939 . . . . 63.54 110.058 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.74 HD13 HG12 ' C' ' 31' ' ' VAL . 13.2 mt -111.56 37.5 2.88 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.466 -1.309 . . . . 73.13 107.466 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 -79.13 0.29 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 109.473 -1.451 . . . . 75.52 109.473 -166.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -128.13 -28.02 2.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.153 0.981 . . . . 70.4 110.016 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.93 98.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.986 0.914 . . . . 65.01 109.499 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.8 m -65.4 117.1 7.44 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.156 0.503 . . . . 74.54 110.43 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -50.33 28.86 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.406 -1.27 . . . . 73.32 109.026 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -161.87 166.09 26.79 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.36 -0.836 . . . . 73.34 111.103 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.449 HD23 ' O ' ' C' ' 64' ' ' VAL . 2.8 tm? -122.65 146.75 47.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.831 -1.915 . . . . 75.3 105.831 167.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.5 t -152.6 153.35 33.19 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.37 -0.604 . . . . 74.2 109.37 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.25 128.52 6.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.834 0.453 . . . . 63.33 110.329 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.81 114.06 44.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.158 -1.053 . . . . 74.42 108.158 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.516 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 49.6 mt-30 -87.99 90.78 8.52 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.347 -1.353 . . . . 73.13 107.347 169.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.426 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.8 tp-100 -79.8 132.48 36.15 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.36 -0.836 . . . . 72.23 109.539 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.553 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -119.72 152.94 16.96 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 123.376 0.422 . . . . 73.02 112.767 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.491 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.12 126.64 2.22 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 109.321 -1.512 . . . . 73.21 109.321 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.506 HD11 ' HH ' ' C' ' 17' ' ' TYR . 19.3 mm -88.26 113.12 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 74.04 108.092 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -123.91 119.16 28.81 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.056 -1.09 . . . . 75.43 108.056 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -84.89 108.79 17.71 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.944 -0.761 . . . . 62.1 108.944 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 pp -112.19 132.41 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.871 0.869 . . . . 75.41 109.617 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.05 135.63 16.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.573 0.749 . . . . 42.53 109.962 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -19.62 27.87 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.352 0.408 . . . . 63.32 113.078 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.726 1.21 . . . . 65.41 111.552 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.864 -0.421 . . . . 72.12 109.864 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.42 -42.98 99.85 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.995 0.918 . . . . 74.42 111.773 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.55 84.3 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.024 0.827 . . . . 72.53 111.393 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -84.51 -26.59 27.99 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.845 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -70.11 -61.07 1.92 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.009 0.524 . . . . 75.13 111.361 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.494 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.6 pp -88.35 -18.6 28.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.663 0.245 . . . . 73.43 111.663 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.12 -29.69 27.55 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.433 0.458 . . . . 52.1 113.199 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.74 -46.5 0.96 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.72 0.408 . . . . 61.43 112.095 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.663 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 56.5 t80 -76.3 -39.32 54.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.542 0.737 . . . . 75.24 112.101 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 67.7 m -68.74 -46.79 33.81 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.919 -0.563 . . . . 72.52 110.032 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 58.1 Cg_exo -57.4 -34.31 97.73 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 121.884 1.723 . . . . 74.33 113.281 166.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.25 -35.87 82.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 123.412 0.685 . . . . 75.23 111.112 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.458 HG12 ' O ' ' C' ' 101' ' ' TYR . 23.2 mm -62.99 -43.0 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.629 -0.714 . . . . 72.5 109.777 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.491 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.8 mt -81.49 -21.56 38.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.672 -1.149 . . . . 72.12 112.582 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.75 -48.53 92.79 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-O 117.695 -1.145 . . . . 72.34 113.557 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 -33.91 97.83 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.704 1.603 . . . . 75.43 112.484 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -64.17 -52.78 57.33 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.775 . . . . 75.42 110.872 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -66.09 -38.77 89.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.482 . . . . 72.53 111.218 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -54.68 -47.29 73.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.222 1.409 . . . . 72.25 111.126 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -77.57 -36.23 52.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 75.1 110.285 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 41.6 t -67.02 -37.55 84.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.621 0.768 . . . . 70.14 112.046 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.643 HG22 HD22 ' C' ' 126' ' ' LEU . 74.7 mt -71.63 -47.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.225 -0.657 . . . . 74.25 109.225 175.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.6 m -54.82 -33.61 61.81 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 124.036 0.835 . . . . 63.12 111.355 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -61.64 -57.03 13.63 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.46 -0.791 . . . . 74.22 109.972 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.542 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.97 -43.2 63.44 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.817 1.247 . . . . 74.22 112.999 177.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.56 -47.38 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.508 1.123 . . . . 65.52 110.701 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -31.96 73.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.885 -1.052 . . . . 75.34 111.037 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.3 mtt-85 -66.95 -34.48 77.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.401 0.68 . . . . 74.13 110.441 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.23 81.65 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 72.32 113.262 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 15.9 p 67.96 29.51 6.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.789 2.036 . . . . 71.32 112.819 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.87 153.23 37.85 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.123 0.969 . . . . 72.44 109.844 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.52 173.97 1.81 Allowed 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.872 3.048 . . . . 73.44 114.803 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 38.4 mm-40 -59.31 122.95 15.18 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 115.892 -0.594 . . . . 75.43 111.17 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.742 HD13 ' HB ' ' C' ' 40' ' ' VAL . 51.5 tp -107.06 17.21 23.3 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.4 -1.273 . . . . 71.35 109.198 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -87.37 84.02 7.25 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.111 -1.811 . . . . 74.54 106.111 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.42 153.47 21.42 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 113.437 -1.711 . . . . 74.14 108.91 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.83 133.26 14.46 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.253 1.021 . . . . 72.31 112.726 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.796 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 54.1 Cg_exo -43.46 129.47 6.61 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 124.525 3.483 . . . . 64.34 114.304 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.06 81.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.882 -0.785 . . . . 64.41 108.882 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.48 HD22 ' HB2' ' C' ' 130' ' ' PRO . 46.0 m-80 -83.47 98.38 9.5 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.705 -0.68 . . . . 72.2 109.321 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 CA--C 1.548 0.869 0 CA-C-N 115.182 -0.917 . . . . 74.53 110.872 -178.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.23 0.538 . . . . 73.13 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -145.03 103.38 3.87 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.527 -1.286 . . . . 72.43 107.527 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.99 139.88 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.681 1.192 . . . . 65.11 108.989 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 tt -105.28 135.23 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 74.13 109.871 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.74 -46.64 4.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -158.27 146.72 18.77 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.214 0.206 . . . . 73.31 110.475 -171.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.604 HD11 ' HG3' ' B' ' 130' ' ' PRO . 1.0 OUTLIER -140.01 134.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.634 -1.247 . . . . 73.43 107.634 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -159.97 156.74 27.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.515 0.726 . . . . 73.45 110.677 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 55.7 p -85.14 110.07 18.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.483 -0.932 . . . . 71.45 108.483 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -75.93 -26.6 57.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.127 0.489 . . . . 75.04 110.171 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -155.08 133.82 12.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.699 -1.137 . . . . 74.04 109.011 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.542 HG23 ' HE1' ' C' ' 117' ' ' MET . 92.9 mt -132.68 132.2 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.785 -1.561 . . . . 73.54 106.785 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -137.94 138.22 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.166 -0.679 . . . . 72.14 109.166 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -145.15 109.94 5.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.403 -2.073 . . . . 73.3 105.403 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.07 113.93 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.928 -0.767 . . . . 74.03 108.928 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.9 83.71 3.02 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.66 -23.61 22.72 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.377 2.051 . . . . 75.34 112.011 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -106.65 20.07 19.56 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 124.415 1.086 . . . . 74.03 110.256 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.5 -63.93 0.98 Allowed Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.963 1.468 . . . . 63.42 114.963 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' C' ' 83' ' ' ILE . 91.9 Cg_endo -79.19 -17.8 11.54 Favored 'Trans proline' 0 C--N 1.387 2.572 0 CA-C-N 122.221 1.829 . . . . 61.43 113.331 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.79 -52.33 51.7 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.29 1.036 . . . . 73.23 110.319 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -84.15 -1.02 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 124.234 1.014 . . . . 74.23 110.463 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.484 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.8 t80 -54.57 -35.55 63.41 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.117 1.367 . . . . 72.15 111.161 165.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -70.9 -11.8 61.17 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.947 -1.024 . . . . 72.4 111.944 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.59 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 9.6 ttmt -106.78 114.05 27.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.364 0.665 . . . . 72.24 110.715 -173.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -101.56 56.58 0.83 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.147 1.379 . . . . 73.21 112.875 -167.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -125.82 173.97 8.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.609 0.764 . . . . 72.42 109.221 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -88.07 124.06 67.55 Favored Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 121.59 -0.694 . . . . 51.55 109.322 172.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.46 110.58 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.772 2.314 . . . . 73.21 112.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -68.82 113.02 5.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.193 0.997 . . . . 75.54 109.098 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.619 HG11 HG13 ' D' ' 64' ' ' VAL . 73.9 t -99.27 124.29 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.813 0.845 . . . . 75.41 110.763 -169.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -96.34 108.56 21.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.499 -1.667 . . . . 74.34 106.499 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.24 113.62 25.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.328 -0.99 . . . . 73.13 108.328 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.572 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.3 t70 -109.17 132.44 54.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.74 -0.837 . . . . 75.12 108.74 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.46 131.88 54.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.776 -1.194 . . . . 65.42 107.776 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.3 t70 -145.09 154.26 42.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.943 0.897 . . . . 62.31 108.786 173.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -126.66 164.6 20.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.225 0.61 . . . . 73.22 110.312 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.652 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -155.21 164.02 39.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 75.41 109.45 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 m -154.46 160.39 41.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.041 0.536 . . . . 63.44 110.928 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -157.1 120.02 4.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.161 0.984 . . . . 74.33 109.373 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -79.53 117.61 20.63 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.359 -0.608 . . . . 74.33 109.359 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.529 HD13 HG22 ' D' ' 83' ' ' ILE . 32.9 mt -99.81 -34.39 10.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.744 0.418 . . . . 73.54 110.85 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.6 -171.83 3.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.132 0.973 . . . . 75.33 109.773 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.04 118.48 11.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.754 0.821 . . . . 72.52 110.479 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 61.95 13.32 5.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.86 1.264 . . . . 72.22 112.669 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.45 122.64 66.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.032 -1.099 . . . . 74.11 108.032 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.506 ' HH ' HD13 ' D' ' 86' ' ' ILE . 27.5 p90 -151.71 145.88 25.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.517 0.675 . . . . 74.42 110.556 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.2 tt0 -86.67 125.27 33.75 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.887 -1.506 . . . . 71.32 108.744 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.05 137.78 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.623 -1.251 . . . . 73.23 107.623 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 41.6 t -115.19 145.29 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.366 1.066 . . . . 74.42 109.144 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.02 122.33 43.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.116 -1.068 . . . . 73.03 108.116 173.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 36.2 ttm-85 -96.07 100.38 12.05 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.46 -0.941 . . . . 74.31 108.46 172.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.51 107.11 18.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.246 -1.02 . . . . 71.31 108.246 171.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -98.65 131.86 44.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.049 0.452 . . . . 70.5 109.884 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.619 HG13 HG11 ' D' ' 40' ' ' VAL . 54.2 t -127.22 101.42 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.857 1.263 . . . . 73.43 108.104 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.7 m -101.92 94.38 5.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.286 -1.375 . . . . 74.32 107.286 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.02 143.62 27.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.734 -0.469 . . . . 65.42 109.734 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 38.4 p -146.76 133.3 19.77 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 121.199 0.523 . . . . 74.4 111.041 -173.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' D' ' 73' ' ' ALA . 55.4 mt -100.2 102.23 13.46 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.522 -1.288 . . . . 73.11 107.522 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -130.56 11.65 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.713 -0.676 . . . . 75.33 112.32 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.13 6.52 48.32 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.628 0.771 . . . . 75.54 111.403 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.59 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 8.9 tp10 -121.73 148.16 44.98 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.052 0.941 . . . . 72.44 109.56 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 76.3 m -65.82 131.38 46.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.363 0.665 . . . . 74.45 110.702 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -86.41 -59.55 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.483 -0.932 . . . . 62.41 108.483 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -160.7 150.39 17.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 113.925 -1.489 . . . . 74.13 109.558 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.33 146.65 29.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.781 -1.192 . . . . 74.15 107.781 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.588 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.1 t -158.73 137.94 11.48 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.704 -0.48 . . . . 65.15 109.704 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -156.88 129.36 7.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.664 -0.495 . . . . 61.33 109.664 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.12 116.1 43.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.672 0.789 . . . . 74.23 109.391 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.4 mt-30 -89.98 90.21 8.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.453 -0.794 . . . . 73.32 108.933 173.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.403 ' O ' HD11 ' D' ' 106' ' ' LEU . 8.2 tp-100 -80.28 104.37 10.79 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 114.769 -1.105 . . . . 74.54 109.089 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.91 145.03 16.88 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.634 -0.586 . . . . 75.3 111.634 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.1 139.1 7.68 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 110.661 -0.975 . . . . 71.0 110.661 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.529 HG22 HD13 ' D' ' 51' ' ' LEU . 52.9 mt -88.23 130.77 37.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.709 0.804 . . . . 75.32 109.159 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.15 125.19 34.43 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.72 0.408 . . . . 71.35 110.331 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 24.4 m -84.88 93.23 8.47 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.171 -1.048 . . . . 74.44 108.171 165.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.563 HD11 HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -129.32 134.72 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.521 0.728 . . . . 73.22 109.641 -171.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.66 159.55 21.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.502 1.121 . . . . 74.4 109.841 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.62 -19.53 14.26 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.091 0.797 . . . . 52.4 115.091 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.608 HD11 ' HA ' ' D' ' 94' ' ' MET . 2.2 pp -108.96 161.78 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.397 0.679 . . . . 72.44 111.014 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 2.6 pt-20 -158.03 -175.44 5.35 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.5 0.72 . . . . 74.3 110.851 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -132.05 47.54 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 123.653 0.644 . . . . 74.2 114.014 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -66.35 -28.73 68.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.764 0.826 . . . . 74.22 111.254 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -68.8 -33.31 73.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.464 0.706 . . . . 75.11 111.094 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.608 ' HA ' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -70.34 -47.51 60.71 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.567 -0.531 . . . . 72.33 109.567 177.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.85 72.94 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.46 -0.791 . . . . 71.13 111.151 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -72.26 -37.81 68.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.063 0.945 . . . . 71.51 111.11 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -72.17 -51.41 21.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.036 0.535 . . . . 74.34 111.394 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 tt -72.9 -36.36 67.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.019 0.528 . . . . 74.43 110.168 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.23 -23.85 62.46 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 114.304 0.481 . . . . 74.2 114.304 -174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.53 -56.34 1.01 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.502 0.651 . . . . 74.1 112.274 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -67.46 -46.46 72.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.307 0.854 . . . . 73.33 113.307 -166.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.7 -44.67 43.73 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.972 -0.537 . . . . 74.31 111.229 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.603 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 85.5 Cg_exo -53.68 -35.78 79.17 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 122.953 2.435 . . . . 55.01 114.119 165.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -61.85 -31.93 72.23 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.399 0.68 . . . . 73.44 112.097 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -72.51 -40.08 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.671 . . . . 74.4 110.351 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.403 HD11 ' O ' ' D' ' 80' ' ' GLN . 83.8 mt -75.25 -24.93 57.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.882 -1.054 . . . . 64.22 111.252 -175.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -61.69 -42.46 83.6 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.876 1.436 . . . . 75.04 114.876 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.15 -46.87 28.63 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.267 1.978 . . . . 64.41 113.752 171.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.0 -37.21 69.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.511 -0.768 . . . . 72.25 111.226 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.78 79.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.744 0.818 . . . . 73.22 110.6 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -57.08 -50.67 72.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 75.43 110.956 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -67.91 -39.62 83.54 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.039 0.837 . . . . 73.23 111.39 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.403 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.0 t -57.64 -40.99 80.5 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.732 0.645 . . . . 75.44 110.486 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.588 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -68.45 -52.15 39.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.86 -1.064 . . . . 72.32 110.388 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -50.82 -43.46 58.96 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.123 . . . . 74.24 111.673 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -67.45 -45.86 74.76 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.676 -1.147 . . . . 62.14 110.33 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.47 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 78.0 mtm -64.06 -34.04 77.12 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.005 0.522 . . . . 75.41 111.947 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.455 HG22 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.57 -46.23 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.666 0.786 . . . . 74.15 110.252 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.7 p -70.74 -29.13 65.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.68 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -70.05 -32.69 70.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.6 0.76 . . . . 63.44 109.622 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 11.1 60.95 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.617 0.573 . . . . 74.42 113.069 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p 60.27 20.5 9.95 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.402 1.881 . . . . 75.05 114.057 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -93.97 159.05 35.22 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 107.758 -1.201 . . . . 75.4 107.758 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.91 154.1 63.33 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.994 1.796 . . . . 64.15 111.672 -172.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -50.97 120.14 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.872 0.869 . . . . 72.52 111.438 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.506 HD21 HG23 ' D' ' 40' ' ' VAL . 2.4 tm? -109.57 91.78 3.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.446 -1.316 . . . . 72.34 107.446 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -108.85 106.2 16.09 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.077 -0.965 . . . . 72.45 109.62 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.76 134.68 53.67 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.796 -1.093 . . . . 74.11 110.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.68 130.98 85.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.782 0.833 . . . . 75.3 111.611 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.85 95.93 0.98 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.497 2.131 . . . . 75.52 110.548 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.66 139.94 50.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.174 -0.921 . . . . 72.42 110.447 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 C--O 1.237 0.407 0 N-CA-C 107.912 -1.144 . . . . 74.52 107.912 166.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.204 -0.665 . . . . 74.35 109.204 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 55.0 t80 -120.5 136.63 54.71 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.116 0.966 . . . . 63.05 109.76 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -147.69 136.83 22.27 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.375 0.422 . . . . 72.22 111.279 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.3 110.29 12.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.073 0.949 . . . . 74.52 108.44 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.86 -41.04 16.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.322 0.649 . . . . 74.2 109.275 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -161.32 141.08 10.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.014 0.526 . . . . 75.33 110.211 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -124.53 135.91 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.003 -1.11 . . . . 71.23 108.003 167.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' B' ' 28' ' ' ALA . 18.3 p90 -170.56 171.88 6.18 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.042 0.839 . . . . 73.41 110.645 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.401 HG23 ' HB3' ' B' ' 120' ' ' ARG . 71.1 p -94.54 124.19 38.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.896 -0.779 . . . . 62.33 108.896 170.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -82.63 -43.54 16.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.021 -0.733 . . . . 75.42 109.021 172.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.0 t70 -135.79 143.97 45.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.281 -1.327 . . . . 60.0 110.041 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.464 HG22 ' SD ' ' A' ' 117' ' ' MET . 83.3 mt -139.81 141.51 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 125.982 1.713 . . . . 74.53 106.624 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.35 123.24 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.48 -0.563 . . . . 73.14 109.48 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 85.0 t80 -121.74 126.52 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.823 -1.547 . . . . 74.13 106.823 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -123.56 126.57 46.91 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.896 -0.779 . . . . 74.14 108.896 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.03 70.98 14.77 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.236 1.014 . . . . 72.34 108.347 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.73 -26.31 27.85 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.053 1.835 . . . . 75.23 110.12 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 31' ' ' VAL . 81.9 m-20 -99.8 22.7 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.734 -1.121 . . . . 74.52 110.767 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.42 97.62 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.594 -0.717 . . . . 51.23 112.425 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.6 -21.38 22.21 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.898 1.732 . . . . 72.34 113.495 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.0 m170 -71.09 -36.51 72.25 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.867 0.467 . . . . 74.01 110.452 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 27' ' ' ASN . 73.4 t -56.34 -35.88 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.174 0.99 . . . . 71.44 112.87 -174.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.15 -35.17 80.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.322 0.649 . . . . 75.25 110.726 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -75.07 -37.9 61.48 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.126 0.97 . . . . 71.52 110.102 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -82.15 156.84 24.27 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.217 -0.901 . . . . 75.12 110.641 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -72.4 125.8 28.29 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.924 -0.769 . . . . 61.44 108.924 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -78.17 81.07 4.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.498 0.666 . . . . 74.21 110.949 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -118.09 84.34 21.59 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.822 -1.547 . . . . 64.14 106.822 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.63 115.3 4.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.255 1.97 . . . . 75.45 111.256 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -95.69 90.87 5.84 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.835 -1.542 . . . . 74.14 106.835 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' THR . 46.9 t -84.47 112.59 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.734 -1.121 . . . . 73.12 111.381 -168.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.463 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 12.6 mptt -80.08 146.07 32.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.06 0.944 . . . . 72.03 108.534 167.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.23 114.82 10.52 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.448 0.699 . . . . 74.51 109.539 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 26.0 m-20 -108.8 141.56 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.402 0.681 . . . . 75.33 109.384 173.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.3 tp -133.68 119.44 19.35 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.942 -1.132 . . . . 73.14 107.942 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -141.81 151.54 42.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.432 0.693 . . . . 72.52 110.018 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -131.35 150.13 52.27 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.894 0.877 . . . . 74.11 109.876 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . . . -147.34 152.53 38.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.73 1.212 . . . . 54.52 108.466 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.65 ' HB2' HD12 ' A' ' 98' ' ' LEU . 8.5 t -133.29 160.47 37.21 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.138 0.426 . . . . 75.43 111.345 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -149.57 120.42 7.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.212 1.005 . . . . 62.3 108.82 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -74.07 104.13 4.78 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.784 -0.821 . . . . 75.23 108.784 175.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.75 -32.61 27.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.114 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.65 -175.69 5.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.932 0.893 . . . . 74.05 109.705 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.71 125.23 24.12 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.16 -0.681 . . . . 71.44 109.16 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 70.44 -8.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.622 1.569 . . . . 73.42 112.44 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.78 110.94 28.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.996 -0.742 . . . . 74.03 108.996 -174.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.28 124.47 40.4 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.362 1.065 . . . . 75.43 108.562 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.33 127.19 35.48 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.202 -1.036 . . . . 74.34 108.202 168.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.97 121.86 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.242 -1.022 . . . . 70.2 108.242 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.6 t -103.33 130.21 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.199 0.6 . . . . 75.22 109.555 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -101.38 117.81 35.71 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.213 1.005 . . . . 73.04 108.668 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.401 ' NH2' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -91.9 106.12 18.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.071 -0.714 . . . . 74.42 109.071 169.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.468 HG21 ' HB1' ' A' ' 110' ' ' ALA . 17.7 t -105.92 126.97 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.527 -1.286 . . . . 73.22 107.527 169.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -122.92 134.23 54.36 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.731 -0.47 . . . . 75.04 109.731 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.5 t -130.36 107.31 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.352 1.461 . . . . 72.32 107.791 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 36.3 m -113.2 122.27 46.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.369 -0.604 . . . . 74.01 109.369 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.5 117.96 35.65 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.682 -1.229 . . . . 74.5 107.682 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.7 m -117.76 126.77 53.05 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.827 0.451 . . . . 75.33 109.846 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.478 HD21 ' CE3' ' A' ' 36' ' ' TRP . 66.6 mt -89.37 70.3 8.11 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.529 -1.285 . . . . 75.41 107.529 176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -85.29 0.95 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.42 -1.263 . . . . 74.45 110.733 -168.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.04 -25.17 5.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.94 0.896 . . . . 72.12 110.961 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.83 107.26 12.48 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.26 -0.645 . . . . 63.1 109.26 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -62.1 127.35 30.97 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.903 0.382 . . . . 73.13 110.16 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -53.52 6.51 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.125 0.97 . . . . 72.14 108.695 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.14 167.24 30.39 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 113.867 -1.515 . . . . 75.22 110.236 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -129.78 144.12 51.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.33 1.452 . . . . 73.1 107.861 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.599 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.4 m -134.19 138.18 44.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.872 0.869 . . . . 74.3 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.96 123.69 10.53 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.486 -0.931 . . . . 72.13 108.486 168.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.414 HG11 ' SG ' ' A' ' 113' ' ' CYS . 77.2 t -125.89 119.86 55.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.713 -0.847 . . . . 75.31 108.713 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 73.6 mt-30 -95.3 90.08 5.71 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.761 -1.109 . . . . 73.44 108.948 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.425 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.1 tp-100 -81.17 96.66 7.29 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.346 -1.297 . . . . 64.13 107.724 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.54 143.24 17.12 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.923 -0.871 . . . . 55.53 110.923 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.49 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.93 121.54 1.57 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.706 -0.958 . . . . 72.11 110.706 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.5 mt -82.91 129.11 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.102 -1.073 . . . . 73.53 108.102 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 43.4 m-85 -137.78 163.91 30.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.691 1.197 . . . . 74.21 109.208 -173.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 p -110.29 120.18 41.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.119 0.568 . . . . 74.22 109.65 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 119.6 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.865 0.866 . . . . 75.53 110.327 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.81 160.97 4.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.8 1.64 . . . . 65.32 108.711 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.33 11.83 40.73 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 112.633 -0.187 . . . . 62.12 112.633 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -115.79 169.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.669 1.188 . . . . 71.2 110.655 -173.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -167.79 173.95 7.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.194 -0.669 . . . . 75.34 109.194 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.84 -130.97 49.5 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 116.627 -0.26 . . . . 75.32 113.198 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.7 p -79.15 -15.01 58.74 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.693 0.797 . . . . 74.22 112.308 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.35 -36.94 69.36 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.047 0.939 . . . . 75.51 111.082 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.569 ' HE1' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -77.77 -40.86 39.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.469 -0.787 . . . . 74.12 110.523 -177.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.47 67.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 72.31 111.319 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -75.19 -44.2 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.82 0.848 . . . . 74.24 110.563 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.475 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 49.0 t -74.6 -64.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.913 -0.585 . . . . 72.44 109.938 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 48' ' ' SER . 65.5 tp -64.52 -41.74 96.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.674 0.789 . . . . 75.01 112.713 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.12 -36.86 44.62 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.234 -0.439 . . . . 74.23 113.464 -173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.63 -54.38 2.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.43 0.53 . . . . 71.32 112.43 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.4 t80 -74.27 -55.95 5.45 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.38 0.881 . . . . 73.14 113.38 -163.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.475 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 86.2 m -66.61 -38.18 18.3 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.589 0.959 . . . . 63.23 113.589 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.0 -26.24 43.68 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.627 1.551 . . . . 72.33 112.563 167.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.51 -26.61 61.84 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.765 0.426 . . . . 71.24 110.849 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -59.97 -42.3 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.873 0.844 . . . . 73.21 109.685 170.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.1 mt -78.56 -19.41 52.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.116 -1.402 . . . . 65.32 112.167 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.449 ' HZ ' HD11 ' A' ' 128' ' ' LEU . 34.0 t80 -64.6 -39.85 44.12 Favored Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.197 1.184 . . . . 73.02 114.197 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.58 -40.64 83.05 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.318 2.012 . . . . 63.43 113.282 170.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -75.58 -36.76 60.28 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.295 -0.866 . . . . 73.53 111.15 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.468 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.48 -48.34 75.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.519 0.728 . . . . 72.35 109.747 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -52.89 -50.79 63.16 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 124.706 1.254 . . . . 70.11 110.755 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -60.95 -46.72 89.57 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.536 1.148 . . . . 63.3 111.721 -175.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -59.04 -43.5 91.64 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.194 0.934 . . . . 71.22 110.752 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 64' ' ' VAL . 91.1 mt -63.31 -53.89 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 123.963 0.789 . . . . 74.52 110.293 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.497 HG22 ' HB2' ' A' ' 125' ' ' GLN . 61.6 m -51.59 -45.71 63.24 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.697 1.199 . . . . 71.53 111.188 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -66.96 -45.54 77.44 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.647 -1.16 . . . . 75.52 110.352 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.464 ' SD ' HG22 ' A' ' 21' ' ' ILE . 12.0 mtp -55.22 -44.7 75.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.762 0.825 . . . . 73.5 111.719 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -64.07 -46.95 92.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.207 1.003 . . . . 74.43 110.817 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.5 p -70.85 -28.59 64.7 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 115.802 -0.635 . . . . 73.03 110.784 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.8 mtt-85 -72.26 -33.57 67.59 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.022 0.929 . . . . 75.13 110.098 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.36 68.37 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.485 -0.779 . . . . 63.15 112.763 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m 69.28 40.34 1.52 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.774 1.229 . . . . 74.11 110.096 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.15 145.24 39.64 Favored Pre-proline 0 C--O 1.245 0.852 0 CA-C-N 115.356 -0.838 . . . . 70.41 109.208 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -51.99 114.39 1.6 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.025 2.484 . . . . 73.11 112.096 172.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HB2' HG22 ' A' ' 115' ' ' THR . 19.1 pt20 -63.19 156.13 26.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.088 -0.96 . . . . 73.14 111.945 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.39 118.68 37.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.772 -1.104 . . . . 71.54 108.881 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 79.0 m-20 -98.72 84.51 3.14 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.315 -1.365 . . . . 73.3 107.315 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.449 HD11 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -69.35 141.14 54.28 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.262 -0.881 . . . . 75.23 109.453 -174.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.9 129.41 94.43 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 122.629 0.372 . . . . 73.13 111.569 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.69 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 32.9 Cg_endo -85.66 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.559 2.173 . . . . 75.41 110.807 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.71 114.42 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.886 -1.052 . . . . 75.24 109.25 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -87.99 104.9 17.08 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.706 -1.22 . . . . 71.53 107.706 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 . . . . . 0 N--CA 1.477 0.888 0 O-C-N 124.533 1.145 . . . . 75.21 111.184 -175.07 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.983 -1.117 . . . . 73.34 107.983 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -137.28 137.0 38.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.804 -0.813 . . . . 72.45 108.804 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -147.72 126.66 12.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.886 0.475 . . . . 74.41 109.975 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -91.47 139.87 17.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 108.918 -0.771 . . . . 73.44 108.918 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -110.79 -44.27 3.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.838 0.455 . . . . 72.13 110.516 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -172.44 139.95 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.506 0.322 . . . . 73.5 110.219 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.47 146.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.06 -1.089 . . . . 74.44 108.06 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -167.2 164.87 15.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.619 0.723 . . . . 74.4 111.583 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.2 m -90.04 120.01 30.87 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.286 -1.005 . . . . 74.03 108.286 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -90.43 -24.88 20.62 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.842 0.457 . . . . 75.22 111.301 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.0 t70 -158.62 144.65 16.88 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.94 0.4 . . . . 73.14 111.829 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.746 HD12 ' SG ' ' B' ' 113' ' ' CYS . 42.8 mm -132.96 141.22 45.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.117 1.367 . . . . 75.12 108.755 173.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 38.3 m -137.87 122.25 18.29 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.219 1.407 . . . . 71.21 108.388 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 65.8 t80 -134.97 110.02 8.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.083 -1.821 . . . . 75.53 106.083 165.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -125.66 111.23 14.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.977 -1.12 . . . . 75.12 107.977 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.432 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -108.06 89.37 5.52 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.012 0.925 . . . . 53.03 109.162 177.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.68 -26.67 19.25 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.416 2.077 . . . . 75.12 111.831 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -117.62 24.58 10.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.317 1.047 . . . . 74.4 109.313 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.494 ' HB2' ' HE2' ' A' ' 17' ' ' TYR . . . -44.04 -53.2 13.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 125.905 1.682 . . . . 72.22 114.498 173.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.0 Cg_exo -74.84 -18.23 19.32 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.541 2.161 . . . . 75.41 112.185 -177.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.89 2.53 54.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.706 -1.134 . . . . 73.15 111.811 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.04 -18.13 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.172 0.589 . . . . 72.5 110.503 168.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -73.51 -34.48 65.3 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.683 -0.488 . . . . 64.23 109.683 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.11 -45.56 26.51 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.423 0.63 . . . . 75.11 109.4 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 27.3 mmtp -94.57 68.91 3.48 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.858 1.263 . . . . 71.11 109.191 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.16 75.86 3.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.314 -1.312 . . . . 64.02 110.905 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -162.25 151.95 16.18 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.474 -1.306 . . . . 64.4 107.474 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -88.08 119.37 70.37 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.472 -0.566 . . . . 71.5 109.472 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.63 144.4 60.16 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.963 1.776 . . . . 74.22 111.817 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 109.03 2.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.075 -0.966 . . . . 74.11 108.71 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -84.79 123.07 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 108.983 -0.747 . . . . 73.41 108.983 -167.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -124.44 147.09 48.54 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.38 1.072 . . . . 75.2 109.659 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.531 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -109.24 167.13 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.319 0.648 . . . . 75.4 111.605 179.028 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.477 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.9 t70 -153.51 139.98 18.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.892 1.277 . . . . 73.53 108.731 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.61 132.98 53.41 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.328 0.651 . . . . 74.33 109.36 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -146.81 151.63 37.42 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.551 1.141 . . . . 74.13 109.079 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.0 m -139.28 121.84 16.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.835 0.454 . . . . 64.42 110.02 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.91 160.42 19.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.64 1.176 . . . . 72.43 108.854 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -144.21 163.95 32.16 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.298 0.639 . . . . 74.44 110.601 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 7.3 p -159.97 137.3 9.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.094 0.958 . . . . 73.43 109.853 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -84.12 129.9 34.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.535 0.734 . . . . 73.42 110.402 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.53 -42.91 8.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.196 0.598 . . . . 74.2 109.479 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.41 -171.23 3.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.078 0.951 . . . . 71.35 110.04 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.55 112.93 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.859 -1.064 . . . . 65.11 110.252 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 69.49 -0.5 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.564 1.546 . . . . 74.45 112.979 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -104.83 104.7 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.377 -1.342 . . . . 74.43 107.377 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -124.09 149.77 45.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.395 0.678 . . . . 74.02 109.542 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.83 112.59 21.31 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.498 1.119 . . . . 71.41 108.665 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.85 118.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.429 -0.952 . . . . 73.3 108.429 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.49 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 50.5 t -102.42 109.33 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.394 -0.965 . . . . 72.45 108.394 175.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -93.75 117.06 29.6 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.576 -0.898 . . . . 74.14 108.576 -175.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.04 117.28 34.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.161 0.584 . . . . 73.42 110.128 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.431 HG11 HD12 ' B' ' 128' ' ' LEU . 11.8 t -116.19 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.989 -1.115 . . . . 72.32 107.989 169.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 6.7 m -115.31 150.45 36.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.52 0.728 . . . . 62.23 109.567 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.434 HG21 HD12 ' B' ' 114' ' ' ILE . 34.8 t -129.43 130.57 67.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.637 1.175 . . . . 71.53 109.139 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -126.12 140.81 52.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.181 0.992 . . . . 75.31 110.351 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HE2' ' B' ' 74' ' ' PHE . . . -150.63 161.78 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.045 -0.724 . . . . 74.21 109.045 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.9 p -146.91 141.46 26.57 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.45 0.643 . . . . 74.32 112.022 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 34.5 mt -91.89 98.85 11.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.831 -1.174 . . . . 73.32 107.831 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.14 -107.73 2.3 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.44 -1.064 . . . . 71.43 110.44 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.0 8.63 10.45 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.82 0.848 . . . . 75.32 110.376 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -112.39 142.97 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.192 -0.67 . . . . 72.2 109.192 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -56.55 126.05 24.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.765 0.826 . . . . 73.14 110.742 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.26 -59.62 2.7 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 122.222 1.011 . . . . 65.23 109.065 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.452 ' HE2' ' CB ' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -154.53 178.66 9.83 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 113.006 -1.906 . . . . 73.41 107.08 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.72 136.81 29.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.931 -1.137 . . . . 72.13 107.931 164.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 50.6 t -131.83 147.56 52.49 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.589 -0.893 . . . . 71.34 108.589 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.0 tt0 -163.66 134.72 4.62 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.807 -0.812 . . . . 71.43 108.807 -173.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -125.21 146.7 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.325 1.05 . . . . 74.1 109.014 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.3 mt-30 -126.05 88.95 2.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.382 -0.969 . . . . 72.05 108.382 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.52 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.7 tp-100 -85.07 100.86 11.98 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.899 -1.046 . . . . 71.4 109.523 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.79 156.46 25.55 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.693 -0.563 . . . . 71.43 111.693 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.83 130.22 2.38 Favored Glycine 0 C--O 1.239 0.456 0 N-CA-C 111.568 -0.613 . . . . 60.21 111.568 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.61 127.26 40.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.609 0.764 . . . . 75.1 109.401 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -134.22 158.21 44.28 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.773 1.229 . . . . 75.01 108.665 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -132.51 121.95 24.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.407 -0.96 . . . . 63.32 108.407 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.61 HG13 ' SG ' ' B' ' 97' ' ' CYS . 0.2 OUTLIER -133.24 141.65 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.568 -0.901 . . . . 74.13 108.568 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.464 ' N ' HD11 ' B' ' 86' ' ' ILE . . . -158.94 174.88 14.29 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.078 0.951 . . . . 71.34 109.487 169.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.14 -54.98 0.53 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.27 0.462 . . . . 72.23 112.275 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -78.85 170.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.506 0.722 . . . . 72.05 112.589 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.7 162.87 40.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.559 0.744 . . . . 73.2 110.634 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.73 -129.38 24.61 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.473 -0.785 . . . . 45.53 113.771 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -67.61 -28.5 67.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.355 1.062 . . . . 62.14 111.167 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.68 -18.43 65.37 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.62 0.768 . . . . 74.13 112.09 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.4 tpt -68.97 -39.95 79.13 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.991 0.516 . . . . 71.22 110.156 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.47 -21.32 66.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.295 -0.866 . . . . 63.2 111.587 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -65.14 -40.83 94.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.411 0.685 . . . . 62.44 110.849 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.61 ' SG ' HG13 ' B' ' 86' ' ' ILE . 53.9 t -75.23 -69.91 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.852 -0.613 . . . . 74.31 111.128 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.509 ' H ' HD12 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -88.79 -8.33 54.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 112.313 0.486 . . . . 73.45 112.313 -171.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.23 3.42 54.82 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.691 -0.505 . . . . 72.1 112.769 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.09 -67.9 0.18 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 117.142 0.471 . . . . 72.53 111.424 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -68.05 -50.85 52.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.819 0.674 . . . . 75.54 112.819 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.507 ' HA ' HD11 ' B' ' 105' ' ' ILE . 62.5 m -62.25 -43.4 85.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.921 0.888 . . . . 72.35 113.206 -173.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -39.4 49.23 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 121.476 1.451 . . . . 64.54 112.365 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -65.73 -18.33 65.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.761 0.652 . . . . 75.03 112.761 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.534 HG22 ' NH2' ' D' ' 111' ' ' ARG . 96.4 mt -69.83 -44.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.513 0.725 . . . . 75.14 109.988 170.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' B' ' 60' ' ' LEU . 30.9 mt -84.85 -18.19 35.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.754 -1.112 . . . . 72.11 111.437 -173.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.425 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 36.0 t80 -61.87 -40.95 73.86 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 124.736 1.214 . . . . 71.01 113.197 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.449 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 14.9 Cg_endo -56.71 -45.77 34.46 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.533 2.155 . . . . 64.42 113.479 169.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.52 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 85.1 m-85 -64.82 -42.71 94.76 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.073 0.549 . . . . 74.44 110.42 -177.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -39.99 89.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.651 0.78 . . . . 74.52 110.843 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.521 ' HA ' HD11 ' B' ' 128' ' ' LEU . 26.8 ttt180 -58.55 -52.91 63.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.402 1.081 . . . . 73.02 111.486 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -38.14 88.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.108 -0.951 . . . . 73.15 109.779 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' B' ' 21' ' ' ILE . 5.8 t -68.18 -36.84 80.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.477 -0.783 . . . . 74.12 111.474 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.434 HD12 HG21 ' B' ' 64' ' ' VAL . 53.5 mt -62.7 -60.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.364 1.215 0 N-CA-C 109.351 -0.611 . . . . 72.44 109.351 176.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.8 m -53.55 -38.04 63.46 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 124.724 1.265 . . . . 71.3 110.754 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.7 t -55.88 -54.23 47.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.133 0.973 . . . . 73.04 111.391 174.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.521 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 16.8 mmt -66.29 -37.2 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.902 0.481 . . . . 73.24 111.462 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.405 HG21 ' O ' ' B' ' 114' ' ' ILE . 91.1 t -63.74 -40.28 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.534 1.133 . . . . 74.51 110.577 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.4 m -65.32 -35.88 82.33 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.47 -1.241 . . . . 74.33 111.826 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 75.4 mtt-85 -65.22 -41.73 94.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.258 -0.883 . . . . 73.34 110.168 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.59 -1.48 82.87 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.875 0.734 . . . . 44.32 113.895 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p 60.0 49.84 7.25 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.74 1.616 . . . . 74.24 111.62 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -118.49 161.36 35.87 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 114.264 -1.335 . . . . 73.52 110.071 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.38 145.6 72.08 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.325 2.683 . . . . 74.44 114.89 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' C' ' 124' ' ' PRO . 3.9 pt20 -66.63 158.83 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.206 1.403 . . . . 74.42 113.803 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.11 104.27 7.46 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.671 -1.603 . . . . 73.42 106.671 162.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -90.05 93.1 9.25 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.371 -0.974 . . . . 65.51 108.371 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' B' ' 111' ' ' ARG . 40.0 mt -57.29 135.27 56.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.116 0.967 . . . . 73.01 113.478 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.2 117.51 58.24 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 114.621 -1.172 . . . . 71.14 108.625 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.67 151.1 85.54 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.399 2.733 . . . . 73.24 112.702 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 114.67 -1.15 . . . . 71.21 108.117 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.34 65.75 9.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.669 -0.863 . . . . 64.4 108.669 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 115.198 -0.91 . . . . 72.05 109.383 178.728 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.19 -1.041 . . . . 75.12 108.19 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -120.83 137.31 54.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.054 0.542 . . . . 65.25 109.552 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -148.6 124.16 10.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.707 0.803 . . . . 72.55 108.942 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 tp -78.57 133.57 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.037 -0.727 . . . . 74.11 109.037 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -103.17 -51.06 3.33 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.583 0.753 . . . . 73.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.512 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 57.4 ttt180 -165.1 123.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.231 -168.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -112.3 132.02 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.522 -0.918 . . . . 72.2 108.522 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.516 ' HB3' HG22 ' D' ' 122' ' ' THR . 22.1 p90 -173.19 148.03 1.63 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.126 0.891 . . . . 73.51 110.597 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -74.42 124.8 27.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 75.21 110.121 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -74.79 -48.94 22.69 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.288 1.042 . . . . 73.22 109.053 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 29.1 t70 -139.31 136.02 34.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.923 -1.49 . . . . 72.24 109.284 -167.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.8 mt -137.31 143.7 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 106.902 -1.518 . . . . 73.31 106.902 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -154.21 150.8 28.46 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.335 0.588 . . . . 71.43 109.79 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.424 ' HZ ' ' HD2' ' C' ' 123' ' ' PHE . 79.4 t80 -150.99 110.54 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.496 -1.298 . . . . 74.52 107.496 173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.07 124.85 50.26 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.597 0.759 . . . . 74.41 109.337 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.27 84.0 48.7 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 107.7 -1.222 . . . . 74.12 107.7 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.89 -25.71 38.67 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.471 2.114 . . . . 75.02 111.69 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.3 20.74 17.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.338 1.055 . . . . 74.45 110.412 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.86 -49.96 90.77 Favored Pre-proline 0 CA--C 1.569 1.711 0 N-CA-C 114.723 1.379 . . . . 73.41 114.723 -172.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 -30.89 10.87 Favored 'Trans proline' 0 C--N 1.387 2.569 0 CA-C-N 121.58 1.6 . . . . 75.14 112.723 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -68.83 -49.57 57.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.976 0.91 . . . . 74.24 111.423 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.441 HG22 HD13 ' C' ' 68' ' ' LEU . 14.3 p -59.51 -18.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.344 1.458 . . . . 71.33 112.932 -169.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.64 -33.56 71.68 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.172 0.989 . . . . 74.2 112.311 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.47 5.34 52.11 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.769 0.655 . . . . 75.23 112.769 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -87.6 163.88 16.37 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.562 -0.532 . . . . 75.44 109.562 176.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 27.1 t70 -64.61 107.07 1.3 Allowed 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.762 -1.199 . . . . 74.13 107.762 164.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -82.15 83.61 7.3 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.328 1.061 . . . . 72.41 110.348 -171.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.56 72.75 81.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 115.036 -0.983 . . . . 72.21 108.823 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.06 127.65 15.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.416 2.077 . . . . 74.5 111.153 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.06 76.72 9.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.377 -1.342 . . . . 74.01 107.377 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.19 85.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 123.055 1.407 . . . . 64.22 110.833 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 140.47 48.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.907 -1.497 . . . . 73.21 107.46 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' C' ' 64' ' ' VAL . 0.0 OUTLIER -128.48 155.94 44.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.159 0.583 . . . . 74.44 110.767 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.21 128.06 53.86 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.695 1.198 . . . . 63.5 108.118 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tp -106.02 101.26 10.77 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.138 0.575 . . . . 73.54 109.507 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.447 ' O ' HD22 ' C' ' 60' ' ' LEU . 10.3 t70 -113.91 139.03 49.54 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.62 1.168 . . . . 72.42 109.781 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.0 t -119.08 131.35 55.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.281 0.632 . . . . 74.24 109.631 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.39 151.72 32.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.357 1.063 . . . . 74.32 108.974 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -143.57 143.59 31.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.079 0.552 . . . . 72.33 110.404 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -153.21 156.46 38.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.569 1.148 . . . . 75.31 108.528 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.79 117.95 35.55 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.342 -0.614 . . . . 75.44 109.342 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' C' ' 57' ' ' GLU . 56.7 mt -86.52 -36.63 18.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.369 0.668 . . . . 73.23 110.093 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -160.75 -176.37 5.5 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.077 -0.965 . . . . 54.1 110.69 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.87 102.45 0.47 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.429 -1.26 . . . . 74.02 110.322 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 13.0 m-20 64.57 13.04 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.968 1.307 . . . . 73.41 113.581 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 98.9 t -106.03 107.74 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 107.973 -1.121 . . . . 74.11 107.973 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -114.89 146.05 41.53 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.48 -0.933 . . . . 72.0 108.48 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD12 ' C' ' 51' ' ' LEU . 32.6 tt0 -109.08 124.13 50.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.206 1.002 . . . . 74.03 108.557 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' C' ' 98' ' ' LEU . 92.8 t -119.38 124.55 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.189 -1.041 . . . . 73.14 108.189 172.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.9 115.43 47.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.581 1.152 . . . . 71.33 108.764 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.488 HD23 HG21 ' C' ' 62' ' ' VAL . 0.9 OUTLIER -86.27 105.25 16.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.356 -0.979 . . . . 74.32 108.356 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.12 106.45 16.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.242 0.617 . . . . 75.21 109.481 172.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.563 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.9 t -100.7 130.66 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.113 -1.069 . . . . 72.12 108.113 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -125.25 122.59 37.39 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.48 -0.563 . . . . 72.42 109.48 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.63 HG23 HG21 ' C' ' 114' ' ' ILE . 71.5 t -98.63 113.55 33.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.424 1.09 . . . . 71.02 109.302 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -99.34 134.46 42.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.401 -0.963 . . . . 71.44 108.401 171.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.16 124.53 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.676 0.79 . . . . 74.41 108.952 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.7 m -133.54 170.98 14.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.944 0.898 . . . . 75.04 110.136 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' C' ' 34' ' ' LYS . 27.8 mt -127.89 22.95 6.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.666 1.186 . . . . 74.01 108.551 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.24 -96.62 0.99 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.027 -1.229 . . . . 62.14 110.027 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -91.48 -30.94 16.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.44 110.744 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -85.69 121.99 29.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.145 0.978 . . . . 74.2 110.87 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -69.62 125.5 26.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.471 -0.566 . . . . 75.44 109.471 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -49.09 12.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.247 0.619 . . . . 72.33 109.782 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -171.27 177.09 3.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.976 0.91 . . . . 74.2 110.699 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -140.99 139.23 34.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.738 -1.579 . . . . 74.23 106.738 174.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.52 ' SG ' HG22 ' C' ' 114' ' ' ILE . 47.2 t -137.24 154.51 50.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.643 -0.873 . . . . 75.22 108.643 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.09 143.98 18.46 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.85 0.46 . . . . 74.03 109.831 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' C' ' 110' ' ' ALA . 19.6 t -142.99 114.28 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.857 1.263 . . . . 74.42 108.171 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 42.1 mt-30 -93.36 95.53 9.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.546 0.739 . . . . 74.33 109.308 169.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.489 ' NE2' ' HB3' ' C' ' 109' ' ' TYR . 8.4 tp-100 -83.17 104.61 13.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.779 -1.1 . . . . 63.53 109.829 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.73 146.63 22.41 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.4 0.437 . . . . 52.32 112.327 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.97 124.78 2.64 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.879 -0.888 . . . . 65.43 110.879 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.48 HG12 ' HE1' ' C' ' 17' ' ' TYR . 26.1 mm -93.72 118.04 38.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.3 -1.0 . . . . 72.13 108.3 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.46 118.55 28.61 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.526 -0.916 . . . . 72.23 108.526 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -95.75 102.84 14.68 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.183 -1.043 . . . . 74.43 108.183 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.7 pp -114.44 -177.76 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.744 0.818 . . . . 75.12 110.648 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 176.91 153.01 0.21 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.584 1.554 . . . . 65.0 108.657 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.32 -17.61 46.84 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 114.597 0.599 . . . . 73.34 114.597 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 pt . . . . . 0 CA--C 1.553 1.088 0 C-N-CA 123.833 0.853 . . . . 74.42 111.052 -179.331 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 119.663 -0.208 . . . . 63.14 110.501 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.3 ptp -63.57 -35.4 80.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.579 0.352 . . . . 71.2 111.422 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.22 -38.17 56.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.797 0.839 . . . . 74.44 111.245 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -77.96 -37.81 46.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.088 0.955 . . . . 71.32 111.23 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.53 -49.98 75.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.118 0.967 . . . . 73.13 111.277 -169.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.8 ' HB2' HG23 ' C' ' 58' ' ' VAL . 3.4 pp -108.88 -11.1 15.05 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.055 0.391 . . . . 63.1 112.055 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.17 -28.98 35.1 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.238 -0.201 . . . . 44.4 112.918 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.09 -45.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.009 0.524 . . . . 75.04 111.481 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.69 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 82.6 t80 -74.43 -47.24 34.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.743 0.817 . . . . 74.54 112.364 -172.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' C' ' 98' ' ' LEU . 97.7 m -65.78 -46.49 66.25 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 118.518 -0.753 . . . . 64.35 112.443 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.416 ' O ' HD13 ' C' ' 60' ' ' LEU . 37.8 Cg_endo -66.26 -23.1 52.49 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 121.135 1.441 . . . . 74.13 112.397 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.23 -31.72 70.48 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.349 0.522 . . . . 75.25 110.191 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' C' ' 102' ' ' CYS . 26.8 mm -62.89 -44.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.63 0.772 . . . . 63.32 109.592 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 66.4 mt -82.4 -18.15 42.95 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.766 0.826 . . . . 74.22 112.454 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.12 -47.56 90.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.46 -1.257 . . . . 73.22 112.955 -174.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.75 -38.63 92.3 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.021 1.814 . . . . 61.21 112.304 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.489 ' HB3' ' NE2' ' C' ' 80' ' ' GLN . 87.9 m-85 -63.46 -50.78 68.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.962 0.905 . . . . 63.15 111.318 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -67.96 -37.5 81.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.763 -0.653 . . . . 65.13 110.952 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.78 -50.41 70.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 65.01 110.053 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.11 -38.22 75.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.86 0.864 . . . . 72.2 110.854 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.1 t -64.98 -34.02 77.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.177 0.591 . . . . 75.12 110.89 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.63 HG21 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -70.66 -50.8 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 115.772 -0.649 . . . . 74.42 109.661 173.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.4 m -58.3 -34.77 70.92 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.957 0.786 . . . . 75.42 111.403 -173.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.9 p -67.88 -51.66 45.52 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.776 -0.647 . . . . 73.01 109.382 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.538 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.1 -41.41 62.41 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.859 1.264 . . . . 63.23 112.664 179.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.1 t -72.05 -41.21 67.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.091 -0.959 . . . . 63.12 110.397 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.42 -29.89 70.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.396 0.679 . . . . 72.51 111.271 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 61.5 mtt-85 -67.66 -44.14 78.59 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.634 -0.876 . . . . 73.33 108.634 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.85 -1.94 85.3 Favored Glycine 0 C--N 1.36 1.911 0 O-C-N 124.139 0.9 . . . . 63.33 113.434 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.1 p 66.84 41.84 2.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.877 1.671 . . . . 75.22 112.317 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HD2' ' HZ ' ' C' ' 23' ' ' PHE . 65.8 m-85 -114.41 163.89 17.93 Favored Pre-proline 0 CA--C 1.565 1.531 0 C-N-CA 124.958 1.303 . . . . 65.03 109.961 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 96.0 Cg_exo -49.41 151.77 6.59 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 124.341 3.36 . . . . 74.42 116.228 -175.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -48.46 132.37 16.92 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.648 1.179 . . . . 75.24 112.011 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.47 23.52 13.86 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.536 -0.756 . . . . 72.13 111.521 177.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -90.71 79.5 6.04 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-O 123.788 1.756 . . . . 74.13 106.951 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.416 HD11 HD13 ' C' ' 42' ' ' LEU . 82.3 mt -90.12 151.67 21.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.648 -1.615 . . . . 75.4 110.185 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -35.54 113.19 0.5 Allowed Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 126.231 1.812 . . . . 74.31 114.319 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.37 99.07 0.88 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.315 2.01 . . . . 71.21 111.816 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.35 97.96 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 115.214 -0.903 . . . . 74.21 110.524 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.51 68.11 10.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 71.41 109.821 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 18.8 p90 . . . . . 0 CA--C 1.546 0.807 0 CA-C-N 113.966 -1.47 . . . . 73.24 111.931 -179.813 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.15 -1.055 . . . . 73.24 108.15 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.421 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 73.2 t80 -169.74 91.14 0.21 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.314 -1.365 . . . . 71.41 107.314 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -126.09 153.37 44.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.77 0.828 . . . . 63.0 109.501 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 tp -103.53 142.84 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.201 0.6 . . . . 74.33 109.559 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.2 -45.39 2.94 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.781 0.833 . . . . 72.11 110.633 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -154.58 129.45 9.41 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 120.429 0.157 . . . . 75.01 111.19 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.494 ' N ' HD13 ' D' ' 16' ' ' ILE . 0.6 OUTLIER -121.28 112.16 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 106.256 -1.757 . . . . 72.51 106.256 -177.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.417 ' N ' ' HD1' ' D' ' 17' ' ' TYR . 0.0 OUTLIER -159.66 142.07 13.6 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 123.703 0.627 . . . . 74.1 111.704 -164.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.7 p -79.86 115.05 19.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.716 -1.129 . . . . 72.22 109.32 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -89.31 -28.83 19.59 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.007 -0.542 . . . . 73.4 110.365 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.5 t70 -147.08 133.49 19.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.324 -0.853 . . . . 65.41 109.582 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.538 HG23 ' HE1' ' C' ' 117' ' ' MET . 88.4 mt -133.5 139.5 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.688 1.195 . . . . 74.22 108.089 173.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -146.45 118.69 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.908 0.883 . . . . 72.41 109.289 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.479 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.7 t80 -124.93 131.96 53.35 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.247 -1.39 . . . . 73.05 107.247 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -137.97 118.63 14.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 75.24 108.803 -173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.96 89.87 26.02 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.722 -0.844 . . . . 70.22 108.722 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.87 -63.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.333 2.688 . . . . 70.25 113.134 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 10.2 m-80 -98.35 41.07 1.15 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.607 -1.257 . . . . 72.15 107.607 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' D' ' 31' ' ' VAL . . . -56.75 -53.0 69.37 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.154 1.168 . . . . 62.14 114.154 -168.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.471 ' HB3' HD11 ' C' ' 83' ' ' ILE . 55.5 Cg_endo -79.01 -8.45 15.47 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 122.394 1.891 . . . . 73.21 113.072 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.3 t-160 -74.27 -34.66 63.64 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 108.288 -1.004 . . . . 72.33 108.288 168.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.471 HG13 ' HE1' ' D' ' 123' ' ' PHE . 53.2 t -66.99 -26.63 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.512 1.125 . . . . 75.41 111.421 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.426 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.6 t80 -60.87 -34.53 74.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.032 0.444 . . . . 74.45 110.419 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' D' ' 30' ' ' HIS . 40.7 mt-30 -82.74 -33.2 27.54 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.462 -0.79 . . . . 74.13 110.289 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -91.94 90.86 7.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.737 0.815 . . . . 72.21 109.876 -173.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.85 59.27 3.62 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.39 1.076 . . . . 71.31 112.514 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -126.47 174.1 8.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.858 -0.793 . . . . 73.44 108.858 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -85.17 118.13 70.19 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 122.128 -0.358 . . . . 61.24 110.236 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.74 109.31 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.248 1.966 . . . . 74.45 110.633 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 52.2 mt-10 -62.51 111.85 2.22 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.953 0.783 . . . . 74.53 109.037 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.493 HG21 HD13 ' D' ' 126' ' ' LEU . 3.7 m -98.06 107.28 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.427 1.091 . . . . 63.35 109.267 -172.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -105.33 148.02 27.51 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.571 -0.74 . . . . 72.34 109.878 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -119.43 129.96 55.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.708 -0.678 . . . . 72.45 110.362 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 28.1 t70 -119.11 128.26 54.14 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.376 -0.972 . . . . 71.01 108.376 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -97.46 132.89 42.73 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.488 0.715 . . . . 73.34 110.03 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -146.96 156.3 42.95 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.939 -1.134 . . . . 64.45 107.939 169.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -144.57 164.39 31.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.218 0.533 . . . . 63.1 109.873 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 163.86 37.05 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.942 1.297 . . . . 70.12 108.277 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -167.13 153.47 8.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.903 0.382 . . . . 73.32 111.772 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.8 p -158.86 141.44 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.133 0.973 . . . . 71.31 109.716 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -81.75 124.06 29.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 74.42 110.856 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.7 mt -98.22 -35.71 10.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.589 0.756 . . . . 73.5 110.792 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -172.07 4.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.226 0.61 . . . . 74.21 111.085 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.53 112.56 4.18 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.288 1.035 . . . . 75.23 110.732 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 69.19 3.63 4.19 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.944 1.698 . . . . 71.12 112.847 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.2 t -109.14 118.27 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.297 0.639 . . . . 65.15 110.438 -173.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.81 130.26 45.09 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.092 1.357 . . . . 74.22 108.354 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.447 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.7 tt0 -87.08 111.87 21.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.702 -1.221 . . . . 75.32 107.702 169.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -100.09 121.01 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.961 -1.496 . . . . 75.14 106.961 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 44.3 t -99.58 132.55 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.788 0.835 . . . . 75.12 109.231 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.4 OUTLIER -105.06 128.0 53.13 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.646 -1.242 . . . . 73.1 107.646 176.075 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 31.8 ttm-85 -107.49 99.99 9.45 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.572 0.749 . . . . 74.32 109.138 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.24 122.49 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.425 -0.954 . . . . 71.54 108.425 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.8 m -114.9 142.37 46.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.638 -0.71 . . . . 55.14 109.61 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.575 HG22 HG21 ' D' ' 114' ' ' ILE . 81.1 t -130.78 127.45 61.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.127 1.371 . . . . 71.21 108.637 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -123.7 94.76 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.086 -1.079 . . . . 73.54 108.086 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -98.06 127.37 43.96 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.661 -0.866 . . . . 72.22 108.661 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.4 m -140.63 139.52 34.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.392 0.615 . . . . 73.23 111.298 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.413 ' O ' ' HG2' ' D' ' 71' ' ' GLU . 36.1 mt -110.52 116.98 32.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.284 1.434 . . . . 75.15 109.228 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.68 -129.05 44.15 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 120.14 -0.256 . . . . 71.51 112.894 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.81 4.06 50.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.504 0.721 . . . . 75.01 112.126 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' D' ' 68' ' ' LEU . 11.8 pt-20 -124.15 154.48 39.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.129 0.572 . . . . 74.35 110.174 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 33.9 m -74.47 136.13 42.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.286 -0.635 . . . . 71.13 109.286 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.46 -57.43 3.15 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.829 -1.175 . . . . 74.34 107.829 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.413 ' CE1' HG21 ' D' ' 118' ' ' VAL . 49.0 p90 -161.3 149.3 15.44 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 114.696 -1.138 . . . . 73.35 110.202 169.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -100.75 150.63 22.58 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.505 -0.924 . . . . 75.03 108.505 166.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.663 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 42.4 t -158.1 132.54 8.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.34 0.4 . . . . 65.24 109.922 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.87 132.81 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.553 0.741 . . . . 74.21 109.25 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -132.19 119.76 41.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.701 0.801 . . . . 72.24 109.687 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.564 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.88 88.2 7.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.729 0.812 . . . . 74.23 109.491 171.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.87 102.33 9.99 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 114.466 -1.243 . . . . 63.01 109.153 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.89 145.27 18.59 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.438 -0.665 . . . . 70.14 111.438 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -139.99 130.62 4.75 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.809 -0.916 . . . . 74.53 110.809 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.1 mt -90.13 115.78 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.677 -0.86 . . . . 74.44 108.677 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -117.58 152.42 35.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.431 1.092 . . . . 54.34 109.71 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -116.23 95.02 4.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.033 -1.099 . . . . 72.14 108.033 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.412 HD13 ' H ' ' D' ' 86' ' ' ILE . 0.1 OUTLIER -110.3 138.71 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.468 0.707 . . . . 72.03 110.038 -171.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 169.76 13.89 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.786 1.235 . . . . 71.02 109.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.21 21.76 56.18 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.56 -0.291 . . . . 70.15 112.397 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.01 161.04 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.485 1.114 . . . . 72.55 110.404 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -166.63 165.98 16.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.59 0.756 . . . . 74.53 110.467 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 60.35 -134.54 50.21 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 124.026 0.829 . . . . 74.12 114.178 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -79.39 -14.11 59.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.012 0.925 . . . . 62.1 112.527 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -63.89 -34.17 77.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.459 0.704 . . . . 72.43 111.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 22.3 ptp -71.38 -28.04 63.76 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.521 0.513 . . . . 74.2 111.038 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.81 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.568 0.747 . . . . 44.44 110.002 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -72.8 -32.9 65.88 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.058 -0.974 . . . . 72.44 110.542 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.82 -50.15 32.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.968 0.507 . . . . 73.13 110.517 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 tt -72.03 -46.02 58.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.105 0.562 . . . . 75.35 110.182 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.55 84.56 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.378 -0.679 . . . . 54.4 114.344 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.92 -63.75 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.881 0.84 . . . . 62.51 112.071 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -68.68 -44.54 73.78 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 113.474 0.916 . . . . 73.14 113.474 -165.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.421 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 56.1 m -67.22 -45.26 50.44 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 118.971 -0.538 . . . . 71.24 111.772 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.603 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.7 Cg_exo -53.7 -32.91 67.44 Favored 'Trans proline' 0 C--N 1.394 2.921 0 C-N-CA 122.931 2.421 . . . . 62.32 114.347 168.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.64 -28.12 68.31 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 122.786 0.434 . . . . 73.3 112.107 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.22 -42.13 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.604 0.716 . . . . 72.34 110.041 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.522 HD22 ' HA3' ' D' ' 82' ' ' GLY . 94.1 mt -76.33 -21.68 55.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 63.41 111.999 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -62.83 -42.98 81.5 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 117.693 -1.146 . . . . 74.12 113.623 -171.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.73 -43.85 44.0 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.061 1.841 . . . . 72.45 113.492 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 82.6 m-85 -74.22 -39.06 63.36 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.943 0.897 . . . . 64.12 112.044 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.95 80.54 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.604 0.761 . . . . 73.11 109.95 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.534 ' NH2' HG22 ' B' ' 105' ' ' ILE . 36.9 ttp180 -60.94 -48.82 80.04 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 124.353 1.033 . . . . 74.54 110.055 174.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 5.1 tm-20 -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.063 0.945 . . . . 72.24 111.956 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -58.64 -41.3 85.68 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.939 0.774 . . . . 75.15 111.147 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.631 HG22 ' SG ' ' D' ' 76' ' ' CYS . 65.1 mt -63.37 -56.28 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.021 0.928 . . . . 74.44 109.701 174.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 82.4 m -51.82 -40.1 59.88 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.095 1.758 . . . . 71.04 111.853 -175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 30.3 t -69.64 -45.04 69.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.531 -1.213 . . . . 74.34 110.226 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.663 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.2 mtm -67.0 -31.67 72.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.947 0.499 . . . . 71.41 111.847 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.483 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.7 t -62.14 -49.12 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.688 0.795 . . . . 73.41 109.677 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -72.79 -28.88 62.85 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.733 -0.667 . . . . 71.22 111.139 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.3 mtt-85 -71.74 -25.22 61.97 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.518 0.727 . . . . 74.14 110.056 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.9 11.43 70.58 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.791 0.682 . . . . 50.11 112.828 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.516 HG22 ' HB3' ' C' ' 17' ' ' TYR . 76.8 p 61.25 14.94 5.99 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.331 1.853 . . . . 75.22 113.661 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.471 ' HE1' HG13 ' D' ' 31' ' ' VAL . 62.0 m-85 -87.27 159.57 50.36 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.97 0.908 . . . . 73.21 109.804 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.35 127.53 20.27 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.928 2.419 . . . . 74.5 111.961 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -52.28 132.29 33.8 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.097 0.873 . . . . 73.11 111.318 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.493 HD13 HG21 ' D' ' 40' ' ' VAL . 42.4 tp -108.3 115.52 30.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.521 0.728 . . . . 53.31 110.122 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -113.41 100.78 8.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.364 0.666 . . . . 60.2 109.701 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 68.1 mt -74.49 148.51 40.93 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.928 -1.033 . . . . 74.11 110.138 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.99 125.42 83.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 123.787 0.68 . . . . 73.43 110.523 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.68 99.07 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.44 2.093 . . . . 73.12 109.271 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.07 119.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.107 -0.951 . . . . 75.41 110.95 -167.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 38.7 t30 . . . . . 0 C--O 1.236 0.387 0 N-CA-C 107.649 -1.241 . . . . 63.31 107.649 167.579 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.239 0.527 0 N-CA-C 106.868 -1.53 . . . . 64.34 106.868 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.457 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 32.5 t80 -136.43 128.58 29.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.049 0.54 . . . . 72.51 109.845 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -155.6 134.56 12.08 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.481 0.488 . . . . 74.12 110.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.69 116.22 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.917 -1.142 . . . . 75.14 107.917 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.53 -39.36 46.33 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.674 -0.491 . . . . 73.54 109.674 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.8 ttt85 -169.51 136.89 1.73 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.541 0.526 . . . . 73.01 110.921 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.37 130.77 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.809 -1.182 . . . . 73.43 107.809 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 3.2 p90 -168.23 151.65 5.77 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.923 0.765 . . . . 73.44 110.77 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -80.71 117.62 21.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.612 -0.884 . . . . 54.44 108.612 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.4 mtpt -76.26 -33.47 59.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.446 0.641 . . . . 74.53 109.495 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.2 t70 -150.85 140.78 21.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.229 -1.35 . . . . 72.35 109.797 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.0 mt -137.69 142.7 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.958 1.303 . . . . 74.43 108.022 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 m -152.34 112.73 4.09 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 123.621 0.769 . . . . 65.41 110.514 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.565 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 73.5 t80 -109.98 127.72 54.96 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 105.843 -1.91 . . . . 72.23 105.843 164.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.9 143.19 51.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.787 -0.82 . . . . 74.42 108.787 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.86 73.48 11.34 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 106.595 -1.631 . . . . 63.44 106.595 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.7 -28.15 44.3 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.86 2.373 . . . . 73.35 111.435 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -111.04 32.79 5.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.285 1.034 . . . . 75.21 109.017 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -57.52 -52.4 74.56 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 118.357 -0.83 . . . . 61.45 111.947 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 53.1 Cg_exo -53.52 -33.4 67.86 Favored 'Trans proline' 0 C--N 1.403 3.417 0 C-N-CA 122.119 1.879 . . . . 53.32 113.565 173.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 10.4 m170 -67.61 -35.29 78.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.542 0.737 . . . . 73.25 111.269 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.52 -34.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.366 0.666 . . . . 75.13 111.367 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -80.71 -22.21 40.53 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.355 -0.838 . . . . 75.2 111.996 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -92.9 -23.56 18.73 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.808 0.443 . . . . 72.4 109.981 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 5.3 tmtp? -81.41 163.89 22.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.626 1.17 . . . . 75.42 109.693 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -76.61 138.88 40.38 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.124 -1.065 . . . . 72.22 108.124 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -91.5 79.71 5.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.771 0.796 . . . . 70.41 109.977 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -127.89 82.47 68.33 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.114 -1.439 . . . . 71.11 107.114 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.53 166.15 12.12 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.866 2.377 . . . . 71.55 112.545 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -112.33 99.96 8.42 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.533 -1.284 . . . . 73.23 107.533 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.79 94.32 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.482 1.113 . . . . 75.52 110.1 -171.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.5 tttt -80.33 124.79 29.16 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.357 -0.838 . . . . 73.55 109.555 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -103.98 108.75 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.007 -0.738 . . . . 75.45 109.007 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 16.1 t70 -108.34 117.87 35.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.992 0.917 . . . . 73.41 108.617 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -99.79 121.0 40.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.68 -1.23 . . . . 74.14 107.68 171.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -119.09 148.57 42.9 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.084 -1.45 . . . . 74.3 107.084 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -149.77 146.15 27.02 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 74.41 110.4 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 151.94 46.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.674 1.19 . . . . 75.42 108.959 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -135.1 161.93 33.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.971 0.508 . . . . 51.34 111.438 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -168.65 131.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.116 0.966 . . . . 74.41 109.751 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.06 115.69 17.08 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.103 -0.703 . . . . 72.33 109.103 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.446 HD12 HG22 ' A' ' 83' ' ' ILE . 72.2 mt -82.45 -43.11 17.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 74.45 110.294 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -159.64 -173.66 4.24 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.967 -1.015 . . . . 41.54 110.487 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.81 114.59 5.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.37 0.668 . . . . 72.35 110.882 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 85' ' ' SER . 11.9 m-20 68.29 -0.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.508 1.523 . . . . 54.25 111.994 -177.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 58.3 t -105.18 101.86 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.568 -1.271 . . . . 41.23 107.568 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -119.03 154.0 33.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.375 -1.284 . . . . 72.21 107.756 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -124.24 123.94 41.35 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.694 -0.854 . . . . 71.44 108.694 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.61 116.29 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.802 -1.555 . . . . 75.42 106.802 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 66.0 t -96.72 132.93 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.794 -0.817 . . . . 75.01 108.794 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 112.52 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.622 -1.621 . . . . 73.22 106.622 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 23.1 ttp180 -109.63 102.34 11.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.277 -0.638 . . . . 74.01 109.277 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' A' ' 114' ' ' ILE . 40.5 t -93.75 127.93 45.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.976 -1.12 . . . . 74.03 107.976 176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.7 m -116.34 122.56 45.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.044 -0.725 . . . . 75.41 109.044 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 46.5 t -116.51 106.27 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.794 1.238 . . . . 72.21 107.896 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 20.8 m -104.39 139.71 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.731 -0.84 . . . . 74.03 108.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.38 125.21 38.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.066 -1.457 . . . . 64.23 107.066 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 m -129.99 128.79 42.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.194 0.598 . . . . 63.25 110.066 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 57.0 mt -87.63 75.62 9.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.13 -1.063 . . . . 75.42 108.13 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.72 -99.66 1.38 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.427 -0.806 . . . . 64.2 112.064 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.16 -18.47 16.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.77 0.828 . . . . 73.12 111.324 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -112.37 134.51 53.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.436 0.694 . . . . 64.32 109.939 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -68.82 136.73 53.18 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.078 0.551 . . . . 74.21 111.42 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -83.01 -59.88 2.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.379 1.072 . . . . 64.25 109.334 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.97 174.8 14.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.22 -0.9 . . . . 75.23 110.337 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 tp -141.32 141.23 33.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.283 1.433 . . . . 74.5 107.891 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.3 m -129.62 135.87 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.999 -1.111 . . . . 65.42 107.999 171.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.42 116.07 6.3 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.684 -0.858 . . . . 61.53 108.684 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 t -129.59 112.74 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.651 0.781 . . . . 73.21 109.899 -173.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.3 mt-30 -83.64 87.66 7.04 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.844 -0.799 . . . . 75.35 108.844 168.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.7 tp-100 -77.11 92.96 3.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.264 -1.384 . . . . 73.42 107.264 169.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.76 143.38 21.47 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.739 -0.944 . . . . 70.41 110.739 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.502 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.17 123.01 2.1 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 110.677 -0.969 . . . . 74.12 110.677 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.446 HG22 HD12 ' A' ' 51' ' ' LEU . 30.6 mt -90.92 121.8 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.345 -0.983 . . . . 74.32 108.345 175.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 28.6 m-85 -129.73 152.59 49.06 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.518 0.727 . . . . 63.42 109.948 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.8 m -91.49 121.71 33.43 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.604 0.762 . . . . 72.12 109.25 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' A' ' 94' ' ' MET . 5.8 tt -116.96 119.95 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.614 -0.513 . . . . 74.33 109.614 173.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.94 172.28 1.67 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.631 1.572 . . . . 75.11 108.895 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.44 -32.15 3.97 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 116.79 -0.187 . . . . 72.42 112.784 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 94' ' ' MET . 0.2 OUTLIER -111.12 170.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.475 1.11 . . . . 74.43 109.206 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.0 tt0 -164.29 175.68 9.84 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.493 0.495 . . . . 75.12 110.275 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.45 -130.85 37.9 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.674 -0.694 . . . . 72.13 113.172 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 t -62.32 -27.73 69.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.241 1.016 . . . . 61.2 111.772 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -68.16 -48.89 64.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.502 0.721 . . . . 75.35 110.861 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.636 ' HB2' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -75.59 -30.49 59.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.893 0.477 . . . . 74.31 111.116 -177.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.26 67.76 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.731 0.812 . . . . 51.03 110.612 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -76.61 -31.5 57.49 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.028 -0.987 . . . . 75.43 110.178 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.66 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.6 m -71.85 -66.13 0.68 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 123.029 0.532 . . . . 64.21 111.531 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.74 -29.41 68.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.325 0.65 . . . . 74.45 111.044 -172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.44 -19.97 57.54 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.682 -1.065 . . . . 71.11 114.721 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.35 -48.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.201 1.5 . . . . 70.13 113.911 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.66 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 44.9 t80 -66.76 -47.87 70.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.123 0.969 . . . . 74.25 111.879 -173.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.33 -41.83 8.45 Favored Pre-proline 0 CA--C 1.565 1.555 0 C-N-CA 123.494 0.717 . . . . 64.55 112.163 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.98 -31.78 65.3 Favored 'Trans proline' 0 C--N 1.393 2.876 0 C-N-CA 122.22 1.946 . . . . 73.32 113.919 163.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -68.74 -34.6 75.87 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.563 0.745 . . . . 72.41 110.283 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.07 -42.72 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.705 0.802 . . . . 75.55 110.172 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.502 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.5 mt -76.49 -24.77 53.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.553 -1.203 . . . . 71.12 112.462 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.13 -40.18 50.95 Favored Pre-proline 0 CA--C 1.563 1.474 0 N-CA-C 114.46 1.281 . . . . 72.23 114.46 -168.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -55.08 -38.78 93.29 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.97 1.78 . . . . 74.3 113.344 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -77.65 -38.84 46.88 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.756 0.823 . . . . 72.41 111.644 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.19 77.34 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.971 0.509 . . . . 72.31 110.178 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.425 ' NH1' HG22 ' C' ' 105' ' ' ILE . 36.1 ttm180 -55.57 -51.19 67.94 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.472 1.108 . . . . 70.43 110.025 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.4 tm-20 -64.0 -41.48 97.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.125 0.891 . . . . 75.14 111.401 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.89 -42.02 98.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.838 0.712 . . . . 71.44 111.005 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.442 HD11 ' HB ' ' A' ' 62' ' ' VAL . 91.5 mt -66.74 -51.48 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.384 0.674 . . . . 74.02 110.528 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.498 HG22 ' HB2' ' A' ' 125' ' ' GLN . 52.4 m -52.78 -44.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.624 1.17 . . . . 70.45 110.907 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 37.8 t -64.77 -41.06 96.17 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.403 -1.271 . . . . 65.43 110.907 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 32.2 mtm -67.87 -41.31 83.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.96 0.504 . . . . 75.31 111.541 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.4 -50.34 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.792 0.837 . . . . 72.52 110.095 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 90.5 p -67.09 -32.05 72.95 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.224 -0.898 . . . . 74.51 111.105 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.478 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 26.9 ttm-85 -75.24 -27.44 59.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.596 1.159 . . . . 75.55 110.206 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.18 8.86 62.43 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.62 -0.718 . . . . 74.11 112.86 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.449 HG23 ' HB3' ' D' ' 125' ' ' GLN . 9.4 m 67.07 29.63 7.83 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.794 1.238 . . . . 73.0 110.831 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.51 151.09 41.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 114.479 -1.237 . . . . 75.0 107.905 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.76 121.53 8.43 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.784 1.656 . . . . 75.13 110.104 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.57 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 18.5 pt20 -60.87 155.4 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.554 0.741 . . . . 70.21 111.873 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.12 122.08 26.05 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.828 -0.805 . . . . 75.3 108.828 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.427 ' ND2' ' HB ' ' C' ' 16' ' ' ILE . 2.3 m-20 -103.54 95.32 5.98 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.758 -1.201 . . . . 74.32 107.758 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 131.86 46.79 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.381 -0.6 . . . . 75.51 109.381 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.51 128.02 89.38 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 123.676 0.79 . . . . 74.24 111.886 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.01 110.24 3.08 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.025 1.817 . . . . 73.14 110.83 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.1 t -99.35 114.79 38.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.041 -1.096 . . . . 74.13 108.041 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -76.16 107.03 8.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.155 0.502 . . . . 74.24 110.117 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.3 0.571 . . . . 74.32 109.484 171.501 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.241 0.627 0 N-CA-C 109.304 -0.628 . . . . 65.52 109.304 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -129.67 128.52 42.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 75.34 109.565 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -135.43 114.63 12.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.568 0.747 . . . . 72.33 109.042 173.136 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' D' ' 129' ' ' ALA . 8.7 tt -89.91 107.12 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 108.118 -1.067 . . . . 74.21 108.118 171.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.58 -40.9 20.25 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 115.774 -0.648 . . . . 74.42 110.61 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -170.33 145.11 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.104 0.253 . . . . 74.25 111.123 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.53 149.83 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.492 -1.299 . . . . 75.03 107.492 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' B' ' 83' ' ' ILE . 23.4 p90 -171.42 150.01 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.172 0.511 . . . . 73.54 111.208 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.478 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 98.1 m -76.0 121.45 22.75 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.552 -0.907 . . . . 73.44 108.552 169.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.49 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.8 mtpt -88.98 -39.7 13.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.352 0.661 . . . . 72.3 109.865 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.05 148.04 27.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.08 -0.509 . . . . 74.54 110.62 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.415 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.0 mm -142.19 139.42 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.916 1.686 . . . . 75.24 107.462 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -141.22 136.03 31.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.182 -1.044 . . . . 60.52 108.182 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -143.72 120.94 11.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.009 -1.478 . . . . 74.53 107.009 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 23.1 mt-10 -128.76 112.0 13.72 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.447 -0.946 . . . . 73.2 108.447 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.44 88.65 16.1 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.7 -0.852 . . . . 73.55 108.7 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.08 -29.84 88.18 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.625 2.217 . . . . 61.32 112.059 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -119.99 29.41 7.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.345 1.058 . . . . 73.23 110.232 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.42 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.43 -50.07 51.1 Favored Pre-proline 0 CA--C 1.575 1.941 0 C-N-CA 125.236 1.414 . . . . 74.3 114.658 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 62.6 Cg_endo -81.14 -13.46 11.3 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.708 1.605 . . . . 72.11 113.422 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -94.39 2.9 55.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.419 0.687 . . . . 73.12 111.875 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p -64.02 -17.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.626 0.771 . . . . 74.21 110.896 169.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.44 -37.47 83.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.163 0.985 . . . . 74.32 111.065 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.45 -45.36 39.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.772 0.829 . . . . 71.11 110.391 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -94.39 67.62 3.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 74.23 109.513 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -81.44 76.51 8.36 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.122 0.963 . . . . 74.34 110.871 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -158.68 167.62 29.03 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.896 1.278 . . . . 71.15 109.897 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.41 121.94 75.19 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 115.89 -0.595 . . . . 74.31 109.476 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.02 150.31 48.29 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.213 1.942 . . . . 61.14 110.899 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.78 114.13 9.55 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.867 -0.79 . . . . 72.51 108.867 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.543 HG13 HD23 ' B' ' 42' ' ' LEU . 23.5 t -85.15 117.06 29.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 107.41 -1.33 . . . . 72.2 107.41 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -140.3 102.1 4.28 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.235 -1.024 . . . . 74.11 108.235 -170.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.566 ' HG ' HD22 ' B' ' 128' ' ' LEU . 1.1 pt? -127.85 138.69 52.78 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.197 -1.365 . . . . 72.24 109.652 -170.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -126.51 148.73 49.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.843 0.857 . . . . 71.23 111.067 -170.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' B' ' 60' ' ' LEU . 7.6 tt -89.42 131.44 35.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.241 1.017 . . . . 73.45 109.016 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -122.89 137.45 54.94 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.858 -1.534 . . . . 75.04 106.858 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' THR . . . . . 0.457 HG23 ' HA2' ' B' ' 99' ' ' GLY . 85.2 m -107.42 120.37 41.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.08 -0.711 . . . . 74.45 109.08 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.435 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -121.62 153.74 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.437 1.095 . . . . 61.42 108.129 170.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 49.5 m -143.86 172.0 13.45 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.112 0.482 . . . . 52.02 110.599 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -154.44 167.29 30.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.79 1.236 . . . . 72.34 108.591 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -123.43 130.47 52.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.054 0.541 . . . . 73.23 109.772 171.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.481 HD12 HG22 ' B' ' 83' ' ' ILE . 32.6 mt -100.82 -40.4 7.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 74.21 110.654 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.69 -169.92 3.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.063 0.545 . . . . 75.42 111.375 -174.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.62 111.3 1.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.754 -1.112 . . . . 71.1 110.967 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 68.65 0.78 2.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.033 1.333 . . . . 74.21 112.186 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -101.08 101.06 11.57 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.231 -1.025 . . . . 75.44 108.231 -172.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -108.97 136.42 48.53 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.484 -0.78 . . . . 74.55 109.969 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -105.92 96.76 6.71 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.97 -1.492 . . . . 72.04 106.97 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 64.4 t -87.08 122.83 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.746 0.818 . . . . 71.25 109.577 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.461 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -101.68 113.68 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.798 0.839 . . . . 72.41 109.263 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.519 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -91.77 105.94 18.1 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.811 -1.181 . . . . 75.55 107.811 177.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -97.8 108.66 21.42 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.336 -0.847 . . . . 72.3 109.497 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 18.3 t -105.41 113.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.925 -1.139 . . . . 74.24 107.925 170.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -104.4 150.89 24.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.534 0.733 . . . . 73.33 109.276 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 26.1 t -134.66 133.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.984 0.913 . . . . 75.04 110.341 -167.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.9 m -125.15 149.09 48.24 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.604 0.762 . . . . 73.33 109.253 170.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.07 147.45 29.56 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.731 0.812 . . . . 70.2 108.972 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.0 p -144.64 129.15 18.02 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.499 0.499 . . . . 74.35 111.325 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.0 mt -95.61 104.73 16.65 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.752 1.221 . . . . 74.31 108.3 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.39 -127.88 21.06 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 123.744 0.652 . . . . 71.45 111.631 -174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -96.56 17.16 16.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.706 0.802 . . . . 62.05 111.485 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -134.84 146.76 49.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.51 0.724 . . . . 74.45 109.724 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.7 m -63.78 135.65 56.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.177 0.591 . . . . 75.03 111.04 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.92 -59.7 1.99 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.931 0.892 . . . . 63.42 108.906 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -156.54 171.35 20.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 113.962 -1.472 . . . . 74.31 109.585 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.4 mt -139.94 154.69 47.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.882 1.673 . . . . 75.23 106.99 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.2 t -159.7 160.42 34.08 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.156 -0.683 . . . . 75.21 109.156 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.42 136.83 3.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.233 -1.025 . . . . 75.23 108.233 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 97.1 t -124.18 143.82 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.973 -0.751 . . . . 74.14 108.973 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -124.0 102.08 7.57 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.531 -0.914 . . . . 74.15 108.531 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -92.16 100.11 12.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.218 -1.03 . . . . 74.31 108.218 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.49 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.88 146.64 18.51 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.146 -0.782 . . . . 74.13 111.146 177.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.81 127.75 3.39 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 110.758 -0.937 . . . . 71.14 110.758 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.481 HG22 HD12 ' B' ' 51' ' ' LEU . 50.3 mt -84.45 115.7 26.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.25 -1.018 . . . . 72.15 108.25 176.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.52 164.39 19.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.303 1.041 . . . . 72.23 108.849 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.604 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 16.4 m -132.43 103.68 6.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.452 -0.944 . . . . 75.55 108.452 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.46 ' H ' HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -115.88 134.71 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.214 0.606 . . . . 75.11 110.739 -177.214 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 172.76 18.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.466 1.106 . . . . 61.15 108.553 172.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.35 -55.01 3.55 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.703 -0.559 . . . . 62.23 111.703 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.52 154.45 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.255 1.022 . . . . 74.42 111.996 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.75 166.24 26.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.501 0.72 . . . . 73.14 110.355 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.61 -127.1 43.84 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.737 0.648 . . . . 43.14 113.71 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -65.16 -30.24 71.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.106 0.963 . . . . 74.15 111.149 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -74.07 -34.98 64.21 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.513 -0.767 . . . . 74.43 110.71 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.3 tpt -66.56 -47.99 71.09 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.018 -0.537 . . . . 74.21 110.241 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.04 77.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.11 0.881 . . . . 63.12 110.844 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -65.78 -34.53 78.38 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.51 0.724 . . . . 72.44 110.666 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -67.04 -67.9 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.637 0.375 . . . . 75.44 111.528 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -17.64 61.25 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 118.106 0.412 . . . . 74.12 112.076 -171.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.457 ' HA2' HG23 ' B' ' 46' ' ' THR . . . -108.74 2.27 32.09 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.48 -0.622 . . . . 64.32 114.607 -174.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -49.06 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 117.948 0.874 . . . . 74.12 111.387 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -72.45 -50.63 24.77 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.697 0.399 . . . . 75.44 111.471 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.24 -46.46 79.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 118.435 -0.793 . . . . 74.1 111.183 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -51.58 -41.32 61.43 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.153 1.902 . . . . 73.2 113.835 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.84 -36.84 84.54 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 123.478 0.711 . . . . 75.14 111.689 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.408 HG22 ' NH2' ' D' ' 111' ' ' ARG . 64.9 mt -62.35 -47.25 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.625 0.77 . . . . 75.02 110.418 174.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.11 -10.54 54.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.804 -1.089 . . . . 61.41 111.692 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -64.88 -49.76 66.79 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 117.411 -1.28 . . . . 73.43 113.312 -171.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -58.73 -34.64 99.08 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 121.944 1.762 . . . . 73.44 112.341 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.0 m-85 -64.31 -52.56 57.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.388 0.675 . . . . 75.41 110.358 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.86 81.94 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.764 0.825 . . . . 73.32 111.329 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.651 HH22 HG23 ' C' ' 122' ' ' THR . 53.6 ttt180 -67.61 -49.95 60.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.223 1.409 . . . . 74.32 110.414 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -34.96 78.99 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.939 0.775 . . . . 74.51 110.191 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.1 t -67.37 -45.49 76.11 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.066 0.546 . . . . 74.32 111.787 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' B' ' 62' ' ' VAL . 81.5 mt -59.35 -46.36 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.143 0.577 . . . . 74.31 110.196 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.624 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 34.2 m -53.58 -50.15 66.21 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.673 1.233 . . . . 64.42 110.045 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.5 t -59.42 -50.72 72.86 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.303 1.041 . . . . 71.05 111.852 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.578 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 20.7 mmt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.165 0.586 . . . . 73.34 112.494 -170.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.91 -32.33 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.089 0.556 . . . . 74.34 110.846 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.5 m -64.22 -30.02 71.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.555 0.742 . . . . 61.43 111.276 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 80.2 mtt-85 -68.69 -39.78 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.861 0.864 . . . . 75.32 109.844 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.32 66.47 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.838 0.711 . . . . 73.14 113.198 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p 60.55 44.95 11.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.194 1.797 . . . . 71.34 111.96 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -119.01 144.91 36.81 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 114.718 -1.128 . . . . 75.24 109.785 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -68.1 94.76 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.736 2.957 . . . . 74.3 113.718 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.624 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 3.3 mm-40 -68.21 160.79 28.5 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.332 1.063 . . . . 72.42 113.163 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.02 124.83 15.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.074 -2.195 . . . . 74.12 105.074 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -87.03 136.19 33.01 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.918 -0.771 . . . . 72.3 108.918 -171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.566 HD22 ' HG ' ' B' ' 42' ' ' LEU . 38.1 mt -58.13 144.78 39.17 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.54 0.525 . . . . 72.42 112.296 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.69 108.56 2.47 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.629 1.206 . . . . 51.11 109.912 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 113.55 3.81 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.505 2.137 . . . . 74.4 111.185 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.08 142.77 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.405 0.682 . . . . 74.41 110.663 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -79.38 118.61 21.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.565 1.146 . . . . 70.1 109.91 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 CA--C 1.553 1.081 0 C-N-CA 123.448 0.699 . . . . 74.13 111.702 179.312 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.241 0.617 0 N-CA-C 107.595 -1.261 . . . . 75.41 107.595 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' C' ' 86' ' ' ILE . 37.7 t80 -91.02 132.43 36.0 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.442 -1.254 . . . . 75.42 108.27 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.411 ' HG2' ' NE2' ' C' ' 14' ' ' GLN . 25.4 tt0 -136.23 102.08 4.88 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.988 -1.115 . . . . 72.41 107.988 -178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.519 HD12 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -70.44 131.45 34.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 115.456 -0.793 . . . . 73.21 109.242 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.507 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 22.8 mm-40 -105.21 -49.37 3.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.305 0.642 . . . . 74.34 109.857 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.506 HH11 ' HB2' ' D' ' 32' ' ' PHE . 73.5 ttt180 -173.62 132.25 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.692 -0.685 . . . . 73.34 110.34 -169.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.519 HG13 HD12 ' C' ' 13' ' ' ILE . 84.0 mt -118.93 136.26 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.266 -1.013 . . . . 75.24 108.266 170.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.548 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 8.4 p90 -171.53 172.02 5.22 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.355 1.035 . . . . 75.04 110.081 -173.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -93.17 118.98 31.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.521 -0.763 . . . . 74.32 109.384 176.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -65.83 -47.11 76.09 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.124 -1.065 . . . . 74.24 108.124 168.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.5 t70 -141.52 147.09 37.21 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.472 -1.694 . . . . 72.33 110.008 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -135.1 144.73 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.767 1.627 . . . . 74.3 106.876 172.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -150.73 146.45 26.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.508 0.671 . . . . 74.22 110.706 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -151.64 118.45 5.79 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.566 -1.642 . . . . 74.44 106.566 167.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.62 133.08 56.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.72 -1.215 . . . . 64.3 107.72 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.88 85.22 39.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.376 -1.342 . . . . 74.12 107.376 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.16 -3.37 12.75 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.619 2.213 . . . . 75.21 112.183 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.62 18.24 8.78 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 123.921 0.889 . . . . 75.53 109.764 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.416 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -47.01 -50.85 43.87 Favored Pre-proline 0 CA--C 1.575 1.905 0 N-CA-C 114.309 1.226 . . . . 72.11 114.309 -169.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -86.68 -27.88 0.68 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.713 1.608 . . . . 75.05 114.107 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -71.09 -24.62 62.35 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.474 0.71 . . . . 72.55 112.471 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 p -75.28 -18.19 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.593 1.157 . . . . 75.22 110.922 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' D' ' 14' ' ' GLN . 42.6 t80 -59.74 -38.48 81.85 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.845 0.858 . . . . 75.11 110.81 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 5.48 51.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.283 0.633 . . . . 73.42 112.395 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.731 ' HE2' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -98.33 164.55 12.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.575 0.35 . . . . 75.2 111.866 -167.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.95 117.37 8.93 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.266 -1.013 . . . . 73.3 108.266 165.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -84.96 67.01 10.03 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.223 1.011 . . . . 74.13 111.242 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -125.07 78.52 66.37 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 124.582 1.153 . . . . 71.44 109.261 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.5 106.6 1.88 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.542 2.161 . . . . 73.2 111.422 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -84.17 120.36 26.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.098 -1.445 . . . . 72.24 107.098 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.477 HG11 HG13 ' C' ' 64' ' ' VAL . 95.6 t -96.86 148.84 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.885 -1.052 . . . . 73.5 110.959 -166.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -133.53 114.98 14.18 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.834 -1.543 . . . . 72.45 106.834 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.441 ' HG ' HD13 ' C' ' 128' ' ' LEU . 5.4 mp -86.44 152.73 22.44 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.64 -0.874 . . . . 72.12 108.64 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.2 t70 -154.63 148.6 25.7 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.052 -0.721 . . . . 75.44 109.052 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 tt -149.78 120.59 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.013 -0.736 . . . . 73.31 109.013 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.417 ' O ' HD22 ' C' ' 60' ' ' LEU . 11.7 m-20 -121.81 144.7 48.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.739 1.216 . . . . 75.41 108.656 176.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -113.01 132.8 55.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.18 -0.674 . . . . 63.4 109.18 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.17 157.32 38.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 74.32 109.044 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.0 p -144.87 150.35 36.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.886 -0.597 . . . . 75.22 110.008 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -156.32 143.16 18.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.792 1.237 . . . . 74.22 107.906 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -105.09 132.67 51.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.133 0.492 . . . . 75.22 109.692 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.505 HD13 HD13 ' C' ' 83' ' ' ILE . 69.0 mt -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.453 -0.794 . . . . 75.34 111.252 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -172.89 4.31 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.204 0.526 . . . . 74.34 111.174 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.94 112.79 2.73 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.331 -1.304 . . . . 72.24 110.312 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 60.87 23.87 13.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.643 1.177 . . . . 75.14 112.782 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -114.91 116.24 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.894 . . . . 71.01 109.284 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.09 159.97 15.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.06 0.933 . . . . 74.42 110.083 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.05 124.22 36.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.517 -1.674 . . . . 71.24 107.26 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.7 125.74 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.573 -1.269 . . . . 71.04 107.573 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.56 105.59 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.417 HD22 ' O ' ' C' ' 45' ' ' ASP . 2.4 tm? -91.33 112.61 24.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.216 -1.031 . . . . 63.4 108.216 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.416 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.4 ttp180 -91.68 110.76 22.1 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.823 0.849 . . . . 72.5 109.991 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.48 124.23 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 108.161 -1.051 . . . . 72.43 108.161 173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 7.5 m -123.44 137.05 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.491 -0.559 . . . . 75.52 109.491 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.558 HG21 HG23 ' C' ' 114' ' ' ILE . 56.1 t -125.17 115.74 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.861 1.264 . . . . 61.52 108.889 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.48 144.35 28.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.209 -1.034 . . . . 71.1 108.209 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.99 37.28 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.361 -0.607 . . . . 63.21 109.361 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -137.76 138.4 39.23 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.479 0.487 . . . . 54.02 110.665 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.637 HD11 ' HG2' ' C' ' 34' ' ' LYS . 10.1 mt -86.93 43.82 1.12 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.083 1.353 . . . . 74.23 109.356 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.96 -113.17 4.37 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.517 -1.033 . . . . 73.2 110.517 -170.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.77 -10.03 41.45 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.678 0.791 . . . . 73.45 110.883 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.731 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 8.3 tp10 -90.11 128.89 36.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.308 1.443 . . . . 74.13 110.049 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 16.3 m -64.82 129.34 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.853 0.751 . . . . 75.21 109.908 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' HG ' ' C' ' 68' ' ' LEU . . . -83.36 -54.73 4.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.128 -0.694 . . . . 72.31 109.128 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -168.57 178.51 4.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.401 -1.272 . . . . 74.14 110.31 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.45 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -141.09 146.22 36.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 106.423 -1.695 . . . . 72.03 106.423 175.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.45 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -146.66 145.89 30.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.912 -1.144 . . . . 71.4 107.912 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.29 136.85 11.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.563 -0.532 . . . . 74.34 109.563 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' C' ' 110' ' ' ALA . 53.6 t -134.87 112.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.038 0.935 . . . . 75.43 108.507 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.64 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.7 mt-30 -92.71 89.51 6.69 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.822 -0.807 . . . . 72.23 108.822 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.429 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.2 tp-100 -82.59 109.82 17.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.016 -0.993 . . . . 54.35 109.767 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 144.95 17.48 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.34 0.4 . . . . 71.11 112.434 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.547 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.29 128.29 3.35 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 110.358 -1.097 . . . . 71.23 110.358 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.548 HD11 ' HH ' ' C' ' 17' ' ' TYR . 11.8 mm -95.19 118.69 41.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.032 -1.099 . . . . 75.04 108.032 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.47 117.13 20.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.502 -0.925 . . . . 74.3 108.502 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -98.58 107.29 19.7 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.179 -1.045 . . . . 75.21 108.179 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' C' ' 11' ' ' PHE . 2.8 pp -131.7 154.31 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.036 0.534 . . . . 75.24 111.065 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.25 177.46 3.59 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.483 -1.235 . . . . 74.11 109.468 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -36.53 3.69 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 116.515 -0.312 . . . . 71.32 112.46 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 124.477 1.111 . . . . 75.15 111.402 176.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.237 -0.282 . . . . 74.14 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 54.8 tpp -65.46 -44.4 87.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.558 0.743 . . . . 74.41 110.243 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -26.42 68.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.553 0.741 . . . . 71.23 112.431 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -88.14 -33.51 18.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.518 0.727 . . . . 73.24 111.34 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -67.68 -61.58 1.82 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.19 0.596 . . . . 75.4 110.953 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.11 -6.64 47.56 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.191 0.441 . . . . 73.3 112.191 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.44 -29.67 21.26 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.919 -0.378 . . . . 72.41 113.527 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 -43.47 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.154 0.477 . . . . 72.11 111.778 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -72.29 -49.91 31.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.228 0.455 . . . . 71.54 112.228 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.05 -45.66 80.01 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.808 -0.615 . . . . 61.02 112.461 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.15 -23.1 60.65 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 121.877 1.718 . . . . 73.24 113.798 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -67.86 -39.74 83.72 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.352 0.661 . . . . 73.23 109.602 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.425 HG22 ' NH1' ' A' ' 111' ' ' ARG . 48.5 mm -61.61 -40.36 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 75.35 110.126 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.547 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -76.87 -27.03 54.89 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.129 -0.941 . . . . 74.43 112.288 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.402 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 51.2 t80 -57.67 -47.75 98.4 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 117.285 -1.341 . . . . 74.4 114.11 -170.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.78 -39.49 91.03 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.032 1.821 . . . . 75.22 112.863 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -63.48 -43.83 96.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.066 0.947 . . . . 75.14 111.3 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.437 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -76.04 -35.47 59.47 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.897 -0.592 . . . . 73.32 111.605 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -60.45 -47.39 86.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.275 1.43 . . . . 74.21 110.214 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -39.59 87.3 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.365 -0.834 . . . . 73.02 109.959 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.7 t -66.02 -27.99 68.53 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.398 0.679 . . . . 71.42 112.329 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.558 HG23 HG21 ' C' ' 64' ' ' VAL . 78.2 mt -73.12 -49.08 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.938 0.495 . . . . 74.43 110.113 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -58.18 -34.85 70.79 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.028 0.931 . . . . 64.04 111.143 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -62.58 -55.0 31.26 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.912 -1.495 . . . . 73.51 109.79 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.513 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -59.48 -36.92 76.94 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.802 1.241 . . . . 74.34 113.443 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.02 -41.37 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.848 0.459 . . . . 73.43 110.769 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.9 t -66.6 -30.25 70.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.278 -0.873 . . . . 63.05 110.986 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 89.4 mtt-85 -70.23 -33.46 71.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.535 0.734 . . . . 74.44 110.315 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.14 7.38 63.81 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-N 115.668 -0.696 . . . . 62.05 112.966 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.651 HG23 HH22 ' B' ' 111' ' ' ARG . 17.2 p 62.1 21.27 12.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.897 2.079 . . . . 73.03 113.488 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.31 166.4 15.51 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.168 0.987 . . . . 75.33 110.239 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.78 105.7 0.39 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.296 1.997 . . . . 72.52 111.236 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.432 HE22 ' ND2' ' C' ' 127' ' ' ASN . 0.0 OUTLIER -55.34 141.38 36.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.863 1.265 . . . . 75.43 111.418 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.76 118.14 36.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.631 0.372 . . . . 72.35 111.376 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.432 ' ND2' HE22 ' C' ' 125' ' ' GLN . 12.4 m120 -98.33 85.01 3.32 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.385 -0.969 . . . . 54.31 108.385 169.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.441 HD13 ' HG ' ' C' ' 42' ' ' LEU . 53.5 mt -78.36 142.63 37.52 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.882 -1.054 . . . . 62.41 109.15 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 141.4 94.11 Favored Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 123.934 0.894 . . . . 64.22 112.721 -169.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.402 ' HA ' ' HE2' ' C' ' 107' ' ' PHE . 82.6 Cg_endo -75.36 102.37 1.59 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.785 2.323 . . . . 75.33 111.521 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.2 t -69.19 91.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.295 0.638 . . . . 73.32 110.818 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -83.83 105.91 15.1 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.084 -0.962 . . . . 74.41 110.134 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 N--CA 1.483 1.183 0 C-N-CA 123.416 0.686 . . . . 74.31 111.229 175.066 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 62.41 108.468 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.83 100.07 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.896 -1.52 . . . . 73.33 106.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.0 mt-30 -118.31 153.73 33.49 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.421 -0.955 . . . . 74.54 108.421 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.1 141.44 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.881 -1.525 . . . . 75.41 106.881 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.435 ' HB3' ' CZ ' ' C' ' 32' ' ' PHE . 69.8 mt-30 -109.89 -35.2 6.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.84 0.456 . . . . 74.15 110.008 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -173.77 124.06 0.36 Allowed 'General case' 0 C--N 1.367 1.326 0 O-C-N 123.272 0.358 . . . . 74.24 111.028 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 38.4 mm -110.87 118.92 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 72.42 109.075 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.489 ' HB3' HG22 ' C' ' 122' ' ' THR . 9.0 p90 -149.6 175.96 11.07 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.909 0.861 . . . . 75.45 111.82 -171.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.2 p -98.99 119.03 37.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.238 -1.347 . . . . 62.43 109.733 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -84.49 -38.75 19.71 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.902 -0.59 . . . . 75.21 110.207 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.99 136.38 23.96 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.871 -0.788 . . . . 64.14 108.871 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.502 HG23 ' HE1' ' C' ' 117' ' ' MET . 60.9 mt -130.16 132.35 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.885 -1.524 . . . . 73.51 106.885 172.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -145.44 114.96 7.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 123.394 0.434 . . . . 64.54 110.244 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.4 t80 -111.39 120.25 41.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.751 -1.574 . . . . 73.41 106.751 167.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.85 119.38 25.53 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.62 94.57 10.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 109.114 -0.699 . . . . 70.33 109.114 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.27 -57.4 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.15 2.567 . . . . 70.43 112.727 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -92.57 22.09 4.93 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.634 -0.698 . . . . 63.44 111.055 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.548 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -28.19 -64.24 0.16 Allowed Pre-proline 0 CA--C 1.577 2.018 0 N-CA-C 117.401 2.371 . . . . 70.03 117.401 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' D' ' 28' ' ' ALA . 53.7 Cg_endo -82.95 -19.62 5.73 Favored 'Trans proline' 0 C--N 1.389 2.661 0 CA-C-N 122.491 1.925 . . . . 74.41 113.57 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -70.01 -40.99 74.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.346 1.058 . . . . 75.25 109.727 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.614 HG21 HD11 ' D' ' 68' ' ' LEU . 4.9 p -86.09 -0.87 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 C-N-CA 123.537 0.735 . . . . 74.32 111.249 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.506 ' HB2' HH11 ' C' ' 15' ' ' ARG . 82.3 t80 -62.1 -30.82 71.28 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.961 0.504 . . . . 73.23 110.665 164.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.44 -15.47 63.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 71.35 111.429 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.95 99.95 12.49 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.264 1.026 . . . . 73.42 109.739 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -96.88 50.75 1.11 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.33 1.052 . . . . 74.21 110.561 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -127.22 159.55 33.96 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.511 -0.922 . . . . 73.32 108.511 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -63.43 112.61 7.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.815 0.846 . . . . 60.14 109.96 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.47 118.23 5.09 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.652 2.235 . . . . 71.35 111.671 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 51.3 mt-10 -60.38 115.56 3.64 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.235 0.959 . . . . 75.44 110.243 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.577 HG21 HG13 ' D' ' 64' ' ' VAL . 2.5 p -96.14 110.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 122.12 0.962 . . . . 74.31 109.027 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -97.2 107.34 19.84 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.668 -1.604 . . . . 75.53 106.668 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.579 HD22 HD22 ' D' ' 128' ' ' LEU . 55.3 tp -97.14 113.71 25.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.248 -0.649 . . . . 73.22 109.248 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.8 t70 -113.6 148.74 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.503 -0.554 . . . . 62.11 109.503 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 tp -119.88 135.05 55.03 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.686 0.794 . . . . 72.4 110.543 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -144.05 142.95 30.94 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.155 -1.054 . . . . 74.42 108.155 168.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -120.89 166.54 13.66 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.45 0.7 . . . . 74.04 109.279 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.74 169.3 24.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.183 0.993 . . . . 73.44 109.015 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 13.3 p -165.0 155.8 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.947 0.404 . . . . 74.54 111.738 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -152.75 135.7 15.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 62.1 109.147 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.35 118.06 22.34 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.394 -0.595 . . . . 73.02 109.394 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' D' ' 57' ' ' GLU . 34.6 mt -95.19 -34.31 12.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.196 0.598 . . . . 72.03 110.267 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.45 -173.43 4.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.03 0.932 . . . . 70.53 110.357 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.58 120.62 14.29 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.316 -0.856 . . . . 75.21 109.519 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 63.46 14.43 7.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.742 1.217 . . . . 61.21 112.178 -176.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.87 119.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.225 -0.657 . . . . 74.21 109.225 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -133.08 130.48 39.39 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.243 1.017 . . . . 73.5 108.376 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.1 tt0 -87.18 112.71 22.24 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.949 -1.13 . . . . 75.52 107.949 169.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.32 124.13 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.006 -1.479 . . . . 73.2 107.006 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 32.8 t -105.02 135.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.691 0.797 . . . . 71.11 109.024 -177.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 121.18 44.6 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.923 -1.14 . . . . 64.41 107.923 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.4 ttm-85 -103.68 102.28 12.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.835 -1.172 . . . . 74.34 107.835 173.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.567 HG23 ' HB1' ' D' ' 110' ' ' ALA . 19.8 t -98.44 120.61 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.664 -0.865 . . . . 71.45 108.664 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.588 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.1 m -108.04 137.41 46.09 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.187 0.595 . . . . 74.3 109.931 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.577 HG13 HG21 ' D' ' 40' ' ' VAL . 50.7 t -136.89 108.04 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 73.53 108.054 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.9 m -101.07 126.94 47.8 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.317 -0.994 . . . . 61.24 108.317 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -111.94 141.44 45.58 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.323 -0.621 . . . . 70.35 109.323 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 57.5 p -145.13 141.99 29.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.708 0.63 . . . . 73.41 111.016 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.614 HD11 HG21 ' D' ' 31' ' ' VAL . 39.9 mt -136.35 112.51 9.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.777 1.231 . . . . 74.21 109.456 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.12 -109.72 2.97 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.368 -0.693 . . . . 72.24 111.368 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -122.54 4.09 9.6 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.495 0.718 . . . . 70.55 110.588 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.7 153.09 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.316 0.646 . . . . 72.45 110.601 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -76.53 116.61 17.37 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 122.774 0.429 . . . . 70.23 110.42 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -69.5 -56.58 6.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.541 -0.754 . . . . 74.21 111.026 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.96 174.06 15.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.43 -0.804 . . . . 64.43 110.654 170.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.36 145.19 51.73 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.88 -1.526 . . . . 73.12 106.88 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 53.0 t -157.79 121.21 4.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.863 -0.792 . . . . 73.53 108.863 -174.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.83 129.03 10.46 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.468 -0.567 . . . . 70.42 109.468 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.94 121.2 53.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.875 0.87 . . . . 72.33 109.577 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -87.84 85.01 6.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.387 -0.968 . . . . 74.2 108.387 167.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -79.98 97.8 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.324 -0.991 . . . . 60.12 108.324 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.59 143.72 16.74 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.859 -0.496 . . . . 63.34 111.859 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.541 ' HA3' HD23 ' D' ' 106' ' ' LEU . . . -141.43 131.48 4.86 Favored Glycine 0 CA--C 1.505 -0.532 0 N-CA-C 111.421 -0.672 . . . . 55.22 111.421 -175.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -90.31 125.72 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.574 -0.899 . . . . 73.24 108.574 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.5 127.86 43.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.942 0.897 . . . . 73.41 109.684 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 49.0 m -81.82 93.18 6.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.256 -1.016 . . . . 71.41 108.256 165.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.52 128.36 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.968 1.707 . . . . 64.42 109.751 -172.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 164.99 20.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 72.53 109.958 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.54 80.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.092 -0.504 . . . . 71.44 114.182 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.17 168.35 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.457 0.703 . . . . 74.12 110.571 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -162.51 146.61 11.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.894 -1.048 . . . . 73.34 109.815 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.88 -107.61 0.12 Allowed Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.307 1.004 . . . . 75.01 114.915 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -67.27 -38.58 85.33 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.492 0.717 . . . . 73.15 110.937 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.72 -31.95 73.28 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.77 0.828 . . . . 73.24 110.573 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 45.1 ttm -67.74 -50.77 55.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.682 0.793 . . . . 75.2 110.284 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.24 62.69 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.829 -0.623 . . . . 63.53 111.303 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -79.51 -32.37 42.33 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.398 0.679 . . . . 75.54 110.31 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.2 t -78.27 -52.75 8.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 117.729 0.24 . . . . 74.3 110.356 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.41 -18.52 31.56 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.658 0.383 . . . . 74.31 111.788 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.68 -8.98 29.54 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.266 -0.741 . . . . 70.32 114.254 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.33 -55.21 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.027 0.914 . . . . 73.03 112.329 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -76.34 -50.94 12.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.096 0.559 . . . . 75.24 111.994 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.0 m -60.96 -46.19 96.69 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 118.438 -0.791 . . . . 74.43 110.478 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.96 -39.57 59.27 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.263 1.976 . . . . 73.21 114.019 163.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.03 -26.61 65.07 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.353 0.661 . . . . 71.22 110.753 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -72.56 -38.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.892 0.877 . . . . 74.51 110.387 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.541 HD23 ' HA3' ' D' ' 82' ' ' GLY . 42.3 mt -79.64 -17.89 52.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.032 -0.986 . . . . 72.41 111.209 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -68.69 -38.64 12.46 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.18 1.178 . . . . 71.42 114.18 -171.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.34 -46.78 29.93 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.101 1.868 . . . . 74.12 113.095 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.86 -33.21 68.24 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.158 -0.928 . . . . 73.01 111.123 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -67.61 -54.24 21.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.927 0.891 . . . . 75.13 110.152 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -50.56 -46.5 57.65 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.987 1.43 . . . . 74.0 110.811 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -66.43 -46.07 77.7 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.175 0.922 . . . . 72.3 111.732 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.494 ' SG ' HD11 ' D' ' 21' ' ' ILE . 49.5 t -59.95 -41.71 92.44 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.737 0.648 . . . . 72.2 110.709 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.493 HG22 ' SG ' ' D' ' 76' ' ' CYS . 81.7 mt -59.45 -56.99 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.365 1.066 . . . . 74.53 110.671 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.572 HG22 ' HG3' ' D' ' 125' ' ' GLN . 54.9 m -53.93 -41.37 67.63 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.276 1.43 . . . . 75.31 111.865 -174.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -67.82 -42.59 81.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.923 -1.035 . . . . 73.33 109.958 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.626 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.6 mtm -71.11 -28.07 64.05 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.887 0.475 . . . . 74.45 111.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.42 -42.74 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.438 0.695 . . . . 72.22 110.135 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -74.38 -26.53 60.17 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.972 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -76.09 -24.16 55.02 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.458 0.703 . . . . 75.13 109.826 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.72 12.24 66.15 Favored Glycine 0 C--N 1.352 1.432 0 O-C-N 123.654 0.596 . . . . 74.33 112.258 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.526 HG22 ' HB3' ' C' ' 17' ' ' TYR . 80.6 p 62.95 9.98 4.09 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 127.385 2.274 . . . . 74.33 114.6 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.487 ' HZ ' HG13 ' D' ' 31' ' ' VAL . 41.9 m-85 -89.37 156.42 48.34 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.172 0.589 . . . . 74.31 110.65 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.89 141.37 89.52 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.714 2.276 . . . . 74.21 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.572 ' HG3' HG22 ' D' ' 115' ' ' THR . 28.2 tt0 -54.51 145.55 18.32 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.686 1.194 . . . . 74.34 112.107 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 114.8 15.74 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.065 -1.087 . . . . 74.12 108.065 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -100.78 93.24 5.46 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.12 -0.696 . . . . 72.32 109.12 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.579 HD22 HD22 ' D' ' 42' ' ' LEU . 89.0 mt -59.0 115.48 3.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.25 0.62 . . . . 72.23 110.92 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -65.3 127.84 93.26 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.773 0.429 . . . . 75.33 111.867 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.28 102.01 1.52 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 75.05 110.399 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.01 130.0 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.537 -0.756 . . . . 75.31 109.71 -174.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.4 -0.963 . . . . 75.54 108.4 173.853 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.7 m . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 109.52 -0.548 . . . . 75.3 109.52 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.471 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 65.3 t80 -128.13 147.35 50.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.053 0.941 . . . . 72.2 109.676 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -158.93 137.37 10.8 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 120.74 0.305 . . . . 75.25 111.394 173.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.503 HG13 ' HB3' ' C' ' 132' ' ' ASN . 13.5 mm -74.78 118.73 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.427 -0.953 . . . . 72.52 108.427 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -89.25 -38.39 14.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.685 -0.487 . . . . 74.1 109.685 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.98 153.24 4.64 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 123.39 0.432 . . . . 74.01 111.259 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.513 ' H ' ' HG3' ' C' ' 130' ' ' PRO . 98.3 mt -137.02 126.68 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.731 1.613 . . . . 74.42 106.814 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -154.61 157.11 37.71 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.461 1.104 . . . . 70.0 109.598 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.546 HG23 ' SG ' ' A' ' 113' ' ' CYS . 45.3 p -86.99 117.17 25.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.881 -0.785 . . . . 73.52 108.881 170.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 42.0 mtpt -83.56 -22.35 32.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.43 0.292 . . . . 75.04 110.284 173.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.4 t70 -153.8 140.02 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.681 -0.691 . . . . 75.22 109.667 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 40.8 mt -136.64 133.18 48.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.953 -1.499 . . . . 73.32 106.953 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -145.37 107.59 4.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.156 -0.683 . . . . 54.34 109.156 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.649 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.2 t80 -119.25 110.32 16.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.872 -1.529 . . . . 75.24 106.872 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 40.6 mt-10 -116.95 108.21 15.5 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.756 -1.572 . . . . 70.4 106.756 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.68 83.05 0.72 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 106.946 -1.502 . . . . 72.12 106.946 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 13.7 Cg_exo -68.69 -31.63 25.57 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.726 2.284 . . . . 72.35 111.704 -168.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 27.7 m-80 -118.24 39.99 3.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.059 -0.973 . . . . 75.22 108.807 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.23 -50.0 87.17 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.083 -0.962 . . . . 75.11 113.203 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 -24.67 22.33 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 121.775 1.65 . . . . 45.12 113.132 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -69.76 -24.45 63.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.408 0.683 . . . . 71.33 111.802 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG13 ' HE1' ' A' ' 123' ' ' PHE . 88.6 t -57.21 -33.26 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.401 0.68 . . . . 74.24 111.465 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -64.05 -32.13 73.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.748 0.819 . . . . 72.41 111.224 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -80.49 -27.04 37.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.352 1.061 . . . . 73.42 110.255 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -82.67 162.07 21.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 75.33 112.362 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.92 129.29 34.72 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.363 -1.347 . . . . 73.14 107.363 163.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.448 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.1 t-105 -77.32 84.17 3.76 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.745 0.784 . . . . 72.35 110.329 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -132.01 77.11 72.34 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.204 -1.406 . . . . 74.14 107.204 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.8 146.17 37.59 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.102 1.868 . . . . 73.42 112.077 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -96.34 86.12 4.12 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.39 -1.708 . . . . 75.15 106.39 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.01 102.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.54 -1.209 . . . . 74.02 110.823 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -111.49 146.18 37.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.918 0.887 . . . . 75.12 110.184 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.01 153.19 37.68 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.76 0.824 . . . . 73.21 110.659 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.0 t70 -142.9 113.82 7.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.883 0.873 . . . . 73.01 108.66 174.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -98.84 119.97 38.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.5 -0.926 . . . . 74.01 108.5 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.3 142.87 39.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 74.44 109.952 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -110.03 144.76 38.13 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.817 0.847 . . . . 70.4 108.815 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.34 113.63 12.81 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.077 -1.083 . . . . 73.15 108.077 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.409 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 35.5 p -88.04 151.02 23.06 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.268 0.627 . . . . 64.32 111.062 -172.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.0 t -163.0 136.72 5.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.207 1.003 . . . . 70.53 109.098 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.64 124.53 52.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.029 0.531 . . . . 72.22 109.75 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.82 -43.16 12.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.33 0.652 . . . . 74.3 110.055 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.28 175.43 13.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.638 -1.164 . . . . 74.21 109.676 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.06 119.1 11.44 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.609 -0.886 . . . . 74.42 108.609 173.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 78.26 -7.66 1.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.778 1.631 . . . . 72.21 113.19 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.83 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.786 -1.19 . . . . 74.21 107.786 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.409 ' OH ' ' HB2' ' A' ' 48' ' ' SER . 9.3 t80 -117.24 155.33 29.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.844 -0.798 . . . . 72.21 108.844 -171.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -127.23 113.77 16.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.315 -0.994 . . . . 72.41 108.315 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.09 117.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.863 -1.532 . . . . 71.5 106.863 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.617 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.6 t -98.36 131.87 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -102.12 112.27 24.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.261 -1.385 . . . . 75.41 107.261 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -101.87 99.98 10.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.439 -0.948 . . . . 75.24 108.439 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -98.0 132.94 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.991 -1.114 . . . . 74.53 107.991 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 18.7 m -128.77 137.69 51.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.169 0.509 . . . . 73.14 110.096 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.722 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.3 t -130.94 125.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.354 1.462 . . . . 72.31 108.695 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -118.58 150.64 39.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.684 0.394 . . . . 71.44 110.097 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.02 112.17 8.02 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.593 -0.892 . . . . 64.23 108.593 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -113.01 126.39 55.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.356 0.598 . . . . 74.34 110.411 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.448 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.0 mt -89.18 75.6 7.82 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.025 1.33 . . . . 71.43 108.652 175.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -82.91 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 111.07 -0.812 . . . . 73.42 111.07 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 -19.1 5.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.457 1.103 . . . . 71.24 111.742 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.68 126.94 36.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.031 0.933 . . . . 73.33 109.305 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -77.16 127.59 32.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.148 0.885 . . . . 75.33 110.388 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -77.9 -55.74 5.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.081 0.952 . . . . 71.33 108.818 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -157.66 169.34 24.88 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.895 -1.502 . . . . 74.3 110.429 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 tp -141.17 138.11 33.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.39 -1.277 . . . . 64.44 108.164 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.722 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.2 m -128.82 140.6 51.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.038 0.935 . . . . 73.32 109.531 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -149.42 133.53 17.23 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.388 -0.967 . . . . 74.24 108.388 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 113' ' ' CYS . 48.1 t -134.81 110.52 12.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.504 -0.924 . . . . 75.22 108.504 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.2 mt-30 -88.88 79.57 7.33 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.147 -1.057 . . . . 75.53 108.147 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.06 92.77 3.21 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.032 -0.985 . . . . 75.13 108.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.47 146.48 20.88 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.363 -0.38 . . . . 72.11 112.704 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.1 135.89 6.72 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.789 0.295 . . . . 64.53 112.409 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.7 mt -82.27 126.92 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.332 -0.988 . . . . 74.23 108.332 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.1 m-85 -133.18 121.0 21.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.876 -0.787 . . . . 71.5 108.876 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -78.31 113.36 16.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.644 -0.873 . . . . 41.45 108.644 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.31 133.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.559 0.744 . . . . 72.51 110.188 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.04 144.84 14.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.804 0.841 . . . . 75.41 109.698 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.37 9.21 86.79 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.783 0.677 . . . . 65.43 113.961 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.608 HD11 ' SD ' ' A' ' 94' ' ' MET . 0.9 OUTLIER -109.89 131.44 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.124 -0.695 . . . . 74.54 109.124 -173.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -147.22 176.33 10.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.073 0.949 . . . . 62.15 109.727 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 -114.98 3.89 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 124.185 0.928 . . . . 71.13 113.994 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.2 p -82.3 -27.29 32.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.51 1.124 . . . . 73.32 111.17 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.57 -42.55 67.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.896 0.879 . . . . 71.31 110.523 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.608 ' SD ' HD11 ' A' ' 89' ' ' ILE . 10.6 tpt -78.52 -34.65 47.15 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.174 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.06 -29.18 70.34 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.004 0.43 . . . . 74.12 111.313 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -70.71 -56.16 7.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.295 -0.866 . . . . 74.43 109.709 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 77.3 m -65.48 -65.53 0.66 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 123.867 0.729 . . . . 71.52 111.978 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.483 HD21 ' HE2' ' A' ' 94' ' ' MET . 59.4 tp -63.04 -33.73 76.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.334 1.053 . . . . 73.13 112.114 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.9 -37.26 9.44 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.66 0.624 . . . . 50.15 114.66 -170.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.31 -50.38 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 117.948 0.874 . . . . 75.0 113.348 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.471 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 90.1 t80 -68.06 -63.14 1.12 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.435 0.694 . . . . 74.51 111.7 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -61.81 -37.49 40.25 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 123.748 0.819 . . . . 63.44 113.209 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.84 -49.82 16.0 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.217 1.945 . . . . 62.11 113.081 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -73.93 -15.65 61.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.429 0.692 . . . . 73.34 112.007 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.14 -42.67 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.731 0.777 . . . . 74.03 109.505 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' HD13 ' A' ' 60' ' ' LEU . 52.3 mt -75.31 -21.62 58.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.423 -1.262 . . . . 73.12 112.156 -173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -67.05 -40.65 30.23 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 114.429 1.27 . . . . 75.53 114.429 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.27 -41.31 77.88 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.173 1.915 . . . . 75.34 112.813 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -72.95 -36.85 67.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.493 0.717 . . . . 71.44 110.976 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.46 94.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.471 0.708 . . . . 75.4 109.944 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.497 ' NH1' HD13 ' C' ' 105' ' ' ILE . 44.6 ttm105 -55.6 -48.98 73.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.618 1.199 . . . . 65.14 110.798 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -45.25 90.99 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.837 0.711 . . . . 65.21 110.301 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.546 ' SG ' HG23 ' A' ' 18' ' ' THR . 42.1 t -61.37 -24.41 66.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.338 -0.846 . . . . 54.3 112.468 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 64' ' ' VAL . 94.9 mt -85.02 -53.0 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.574 0.749 . . . . 70.04 110.002 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.3 m -55.3 -40.95 71.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.67 1.188 . . . . 74.01 112.216 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.2 t -60.98 -45.55 94.35 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.025 -0.989 . . . . 73.02 111.025 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.649 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.9 mtm -64.4 -46.03 85.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.389 0.675 . . . . 74.25 111.313 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -58.5 -51.02 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.572 -1.195 . . . . 75.0 110.846 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 24.1 t -68.05 -25.86 65.57 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.195 -0.912 . . . . 61.13 111.419 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -78.83 -26.0 44.18 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.421 1.088 . . . . 74.55 110.657 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 13.0 54.14 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-N 115.698 -0.683 . . . . 73.32 112.618 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.47 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 7.0 m 67.98 40.31 2.31 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 124.792 1.237 . . . . 74.33 110.336 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.44 ' HE1' HG13 ' A' ' 31' ' ' VAL . 48.0 m-85 -119.37 157.15 52.14 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.647 -1.161 . . . . 75.41 108.782 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.37 148.47 61.18 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.155 1.904 . . . . 71.23 111.298 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -60.01 139.89 57.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.525 0.73 . . . . 75.12 111.413 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.3 114.75 15.41 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.89 -0.781 . . . . 73.02 108.89 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -109.9 105.77 15.08 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.53 128.32 35.16 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.082 -0.71 . . . . 63.41 109.082 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.8 97.45 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.516 0.727 . . . . 70.41 111.01 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB3' HH22 ' A' ' 111' ' ' ARG . 63.3 Cg_endo -73.56 143.99 35.18 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.237 1.958 . . . . 54.21 110.978 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.55 109.68 25.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.042 -1.466 . . . . 72.55 107.042 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -99.95 74.7 1.82 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.402 -1.332 . . . . 73.43 107.402 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.474 0.733 0 CA-C-N 114.419 -1.264 . . . . 75.11 110.439 179.819 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 18.9 p . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 106.979 -1.489 . . . . 74.22 106.979 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -124.5 113.17 17.75 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.997 -0.742 . . . . 73.53 108.997 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.52 130.45 34.63 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.969 -0.752 . . . . 72.43 108.969 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.524 HD12 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -85.36 120.34 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.633 -1.247 . . . . 73.4 107.633 178.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -90.3 -42.47 10.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 75.21 110.451 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.47 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 48.3 ttt180 -168.5 137.41 2.28 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.041 -0.527 . . . . 71.52 109.728 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.524 HG13 HD12 ' B' ' 13' ' ' ILE . 69.4 mt -113.33 133.98 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.468 -1.678 . . . . 71.53 106.468 168.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.459 ' HE1' HG13 ' B' ' 83' ' ' ILE . 29.9 p90 -164.85 146.81 8.11 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.013 0.82 . . . . 74.02 110.973 -173.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.4 m -74.9 121.92 22.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.403 -0.817 . . . . 75.14 109.707 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -93.99 -31.66 14.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.335 0.654 . . . . 73.33 110.907 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.6 t70 -153.03 141.16 20.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.689 -0.687 . . . . 63.03 110.409 -170.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.564 HD13 ' SG ' ' B' ' 113' ' ' CYS . 36.0 mm -136.96 142.92 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.551 1.54 . . . . 71.55 107.831 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -148.1 133.62 18.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.222 -1.029 . . . . 55.54 108.222 172.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -150.41 127.73 11.36 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.334 -1.358 . . . . 75.25 107.334 169.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.24 155.97 41.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.523 1.129 . . . . 64.43 108.507 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 19' ' ' LYS . . . -149.34 79.86 8.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.597 -1.26 . . . . 71.32 107.597 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.75 -23.44 30.83 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.989 2.459 . . . . 74.21 112.3 -173.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 93.1 m-20 -124.97 31.11 5.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.194 0.998 . . . . 75.42 109.854 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.6 -47.91 69.67 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 124.967 1.307 . . . . 72.4 113.772 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.47 -23.05 10.29 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.024 1.816 . . . . 72.32 113.551 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.421 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 69.4 m-70 -78.42 3.45 15.77 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.973 0.909 . . . . 73.04 112.894 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.38 -18.88 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 123.425 0.69 . . . . 73.22 111.192 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -83.48 -28.06 29.0 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.894 0.477 . . . . 65.4 110.344 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.78 -42.48 70.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.12 0.968 . . . . 74.24 109.866 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.72 113.07 26.31 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.322 1.049 . . . . 75.42 109.53 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -72.9 80.78 1.17 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.166 0.586 . . . . 73.54 110.221 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -170.02 151.35 4.01 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.044 -1.095 . . . . 74.43 108.044 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -95.0 127.86 41.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.547 -0.74 . . . . 75.21 109.651 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 25.1 Cg_endo -60.02 121.97 10.65 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.995 2.463 . . . . 63.23 112.169 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 109.25 2.61 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.784 0.677 . . . . 74.42 109.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' B' ' 125' ' ' GLN . 6.2 t -85.5 117.16 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.054 -0.721 . . . . 75.23 109.054 -168.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -136.28 144.22 44.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.291 0.636 . . . . 73.04 110.465 -169.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.466 HD22 ' N ' ' B' ' 43' ' ' ASP . 8.6 tt -126.45 152.49 46.34 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.069 0.948 . . . . 74.13 109.874 -164.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.466 ' N ' HD22 ' B' ' 42' ' ' LEU . 29.5 t70 -137.11 140.85 42.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.753 1.221 . . . . 75.44 110.04 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.16 127.97 56.09 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.058 0.943 . . . . 61.32 109.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -140.62 152.76 45.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.865 1.266 . . . . 70.11 108.984 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.5 m -145.62 134.4 22.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.007 0.523 . . . . 61.13 110.601 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.66 162.97 30.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.071 1.348 . . . . 63.13 108.894 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.1 m -135.62 163.39 30.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.922 0.489 . . . . 74.23 110.369 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.37 139.21 18.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.888 0.875 . . . . 74.41 109.025 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -82.07 132.05 35.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.476 0.711 . . . . 74.52 109.408 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.0 mt -89.58 -53.08 4.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.792 -0.818 . . . . 73.41 108.792 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.39 -172.36 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.424 -0.807 . . . . 74.35 110.6 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.39 116.84 7.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.319 -0.855 . . . . 73.24 110.078 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 65.12 13.2 8.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.028 1.731 . . . . 75.24 112.602 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.29 100.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.232 1.013 . . . . 75.13 108.603 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -97.28 165.95 11.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.608 0.718 . . . . 75.4 109.847 171.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -144.61 104.63 4.06 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.316 -1.364 . . . . 73.44 107.316 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.63 123.4 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.711 0.804 . . . . 74.23 109.507 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 27.2 t -105.54 120.82 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 75.51 109.8 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.3 119.82 34.47 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.909 -1.145 . . . . 75.42 107.909 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -107.9 110.3 22.02 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.294 0.638 . . . . 74.23 110.394 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.2 115.15 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.237 -1.023 . . . . 74.34 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -110.68 129.37 55.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.941 0.497 . . . . 73.3 109.862 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.558 HG23 HG23 ' B' ' 114' ' ' ILE . 54.5 t -119.36 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.274 1.03 . . . . 74.02 110.317 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 37.7 m -114.7 150.56 35.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 74.5 109.726 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -147.28 146.78 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.232 -1.025 . . . . 71.34 108.232 167.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -148.2 139.48 23.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.351 0.596 . . . . 73.43 111.476 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.438 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 46.8 mt -113.42 118.4 34.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.329 1.051 . . . . 71.52 109.348 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.52 -111.92 3.77 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.864 0.728 . . . . 73.31 112.605 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 4.89 21.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.71 0.804 . . . . 75.31 111.712 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -139.21 175.48 9.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.604 0.362 . . . . 72.55 110.84 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -69.69 150.0 47.45 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.196 0.998 . . . . 75.32 111.0 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -105.89 -57.4 2.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 169.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.442 ' HZ ' HG12 ' B' ' 40' ' ' VAL . 5.5 p90 -147.41 159.66 43.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.574 -1.193 . . . . 73.32 109.575 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.8 mt -127.55 157.99 38.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.163 1.385 . . . . 73.43 108.67 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' B' ' 114' ' ' ILE . 16.4 t -156.77 158.05 36.15 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.495 -0.557 . . . . 72.4 109.495 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.54 132.55 2.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.622 1.169 . . . . 73.21 108.236 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.424 HG23 HD12 ' B' ' 21' ' ' ILE . 56.0 t -128.11 147.36 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.036 -0.727 . . . . 75.45 109.036 174.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 19.5 mt-30 -126.8 93.3 3.74 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.883 0.849 . . . . 75.21 109.291 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -86.11 100.25 12.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.59 -1.641 . . . . 74.33 109.65 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.65 164.48 26.64 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 111.966 -0.454 . . . . 72.44 111.966 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.25 126.24 1.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.047 -0.821 . . . . 71.31 111.047 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.459 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.3 mt -84.56 127.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.369 -0.975 . . . . 75.34 108.369 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.66 131.5 39.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.148 -1.427 . . . . 72.33 107.148 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -96.25 102.53 14.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.551 -0.907 . . . . 74.51 108.551 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' B' ' 10' ' ' THR . 2.8 pp -122.94 139.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 115.669 -0.696 . . . . 75.11 110.584 -175.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.65 173.66 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.076 1.351 . . . . 51.3 107.852 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.03 -51.12 2.83 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 122.633 0.159 . . . . 74.13 112.893 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.53 HD11 ' HG2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -51.28 143.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.958 0.903 . . . . 72.01 111.178 172.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 144.26 24.82 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.644 -0.502 . . . . 74.0 109.644 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.25 -110.9 3.54 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 124.518 1.136 . . . . 73.2 113.335 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -64.13 -47.79 78.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.297 0.639 . . . . 75.34 110.046 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' B' ' 89' ' ' ILE . 89.1 mt-30 -63.58 -35.3 80.04 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 124.664 1.227 . . . . 75.35 111.484 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.53 ' HG2' HD11 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -67.25 -56.8 8.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.364 -0.835 . . . . 74.42 110.24 -177.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -16.66 61.85 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.169 -0.923 . . . . 71.35 111.673 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -73.05 -39.17 66.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.098 0.959 . . . . 73.1 109.795 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -67.6 -63.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.102 -0.953 . . . . 71.22 110.969 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -77.82 -15.18 59.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 122.126 -0.359 . . . . 75.15 111.736 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.06 35.81 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.508 0.505 . . . . 61.43 113.711 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.55 -44.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.344 0.572 . . . . 74.52 112.535 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.97 -47.88 70.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.435 0.694 . . . . 75.22 112.282 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m -65.28 -50.49 59.11 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 123.583 0.753 . . . . 64.42 111.87 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.73 -24.09 55.2 Favored 'Trans proline' 0 C--N 1.398 3.162 0 C-N-CA 121.568 1.512 . . . . 64.21 113.291 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.06 -36.86 85.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.364 0.602 . . . . 75.43 110.904 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -61.05 -46.7 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.61 1.164 . . . . 75.33 110.564 173.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.52 -10.95 58.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.491 -1.231 . . . . 71.43 111.701 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -63.28 -52.18 63.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.587 1.155 . . . . 71.15 113.153 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.9 -31.88 66.8 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 121.772 1.648 . . . . 74.52 112.964 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.7 m-85 -63.81 -51.11 66.23 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.912 0.485 . . . . 74.24 110.845 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.53 91.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.288 1.035 . . . . 72.12 111.72 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -58.29 -63.07 1.4 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.197 0.936 . . . . 70.11 109.419 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.49 -29.2 66.07 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.207 1.003 . . . . 74.44 111.311 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.564 ' SG ' HD13 ' B' ' 21' ' ' ILE . 23.9 t -62.87 -60.22 3.77 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.473 0.709 . . . . 64.5 112.307 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.65 HG21 ' SG ' ' B' ' 76' ' ' CYS . 85.3 mt -57.82 -44.57 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.084 0.954 . . . . 74.33 110.388 176.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.501 HG23 ' HB3' ' B' ' 125' ' ' GLN . 22.8 m -64.61 -25.3 67.9 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.463 -1.699 . . . . 54.33 111.435 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -80.52 -31.38 37.12 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.469 0.708 . . . . 64.52 110.839 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.4 mmt -71.65 -42.71 67.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.224 0.609 . . . . 73.12 111.647 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' B' ' 125' ' ' GLN . 96.4 t -73.91 -27.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.532 0.733 . . . . 73.22 110.615 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.432 ' OG ' HG21 ' C' ' 115' ' ' THR . 34.0 t -56.94 -34.52 68.08 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.8 0.84 . . . . 62.11 111.063 171.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 53.3 mtt-85 -80.12 -35.54 36.58 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.85 -1.068 . . . . 74.12 110.359 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.68 1.69 36.19 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.849 0.718 . . . . 64.43 112.597 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 70.22 25.26 4.63 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 127.115 2.166 . . . . 73.24 113.598 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.424 ' O ' HG12 ' B' ' 118' ' ' VAL . 65.2 m-85 -120.32 149.12 48.95 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.765 0.826 . . . . 74.24 109.253 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.03 101.73 1.17 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.674 2.249 . . . . 75.54 112.303 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.721 ' HA ' HG11 ' B' ' 40' ' ' VAL . 0.0 OUTLIER -65.15 157.17 29.42 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.047 -0.978 . . . . 74.51 110.096 170.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 44.7 tp -110.11 129.34 55.71 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.406 1.882 . . . . 75.25 108.296 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.98 125.61 32.84 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 106.548 -1.649 . . . . 74.04 106.548 173.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.424 ' HG ' HD23 ' B' ' 42' ' ' LEU . 0.9 OUTLIER -52.73 134.33 36.38 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.877 1.361 . . . . 74.53 109.08 -175.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -38.35 103.02 0.26 Allowed Pre-proline 0 C--N 1.361 1.095 0 O-C-N 125.824 1.953 . . . . 74.34 111.236 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HG2' ' HD2' ' D' ' 15' ' ' ARG . 57.1 Cg_endo -67.89 99.76 0.57 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.516 2.144 . . . . 72.34 110.843 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -147.94 115.18 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.455 -1.313 . . . . 75.31 107.455 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.91 103.1 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.683 -1.228 . . . . 62.34 107.683 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 CA--C 1.552 1.027 0 C-N-CA 124.41 1.084 . . . . 73.5 111.937 -177.552 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.745 -0.465 . . . . 74.02 109.745 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.728 ' HA ' HG22 ' C' ' 86' ' ' ILE . 46.7 t80 -118.69 124.58 47.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.38 0.672 . . . . 74.24 109.673 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -139.35 124.94 19.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.328 0.651 . . . . 72.22 109.471 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.538 HD13 HG13 ' C' ' 16' ' ' ILE . 6.0 tp -82.01 134.19 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.945 -0.761 . . . . 75.21 108.945 170.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.552 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.6 mm-40 -97.82 -51.43 4.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.281 0.632 . . . . 75.12 109.986 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.576 HH11 ' HD1' ' D' ' 32' ' ' PHE . 34.3 ttt180 -176.07 126.83 0.21 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.57 -0.741 . . . . 70.04 110.055 -166.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.538 HG13 HD13 ' C' ' 13' ' ' ILE . 97.4 mt -113.32 135.0 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.762 0.825 . . . . 74.44 108.847 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.662 ' HH ' HD11 ' C' ' 83' ' ' ILE . 29.1 p90 -169.74 153.99 5.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.24 0.543 . . . . 70.1 110.067 -174.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -74.75 115.08 13.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.966 -1.016 . . . . 73.24 109.976 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -66.09 -39.32 89.92 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.819 -0.808 . . . . 75.14 108.819 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -151.44 147.48 26.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.448 -1.251 . . . . 63.12 110.434 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -136.34 145.08 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.053 1.741 . . . . 74.22 106.789 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -154.7 148.82 25.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.987 0.422 . . . . 75.22 110.269 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -153.58 108.61 3.16 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.584 -1.265 . . . . 75.0 107.584 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -117.57 121.33 40.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.571 0.748 . . . . 74.31 109.687 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.82 85.93 56.57 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.472 1.109 . . . . 65.01 108.533 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.68 -16.58 16.54 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.56 2.173 . . . . 72.34 112.006 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -99.51 19.64 15.31 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.933 1.293 . . . . 73.5 108.949 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.639 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -54.37 -52.13 71.95 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.332 1.053 . . . . 74.12 113.487 -172.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 6.2 Cg_exo -80.35 -31.31 1.68 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.923 1.749 . . . . 65.52 112.915 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.22 -30.8 67.97 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.425 1.09 . . . . 75.13 112.827 -173.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.26 -17.62 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.78 0.832 . . . . 75.12 111.796 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -59.79 -32.0 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.621 0.768 . . . . 75.3 111.781 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.63 6.48 34.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.613 0.765 . . . . 71.35 111.875 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.81 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -109.14 143.25 38.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.446 0.699 . . . . 75.23 110.205 -176.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 129.65 39.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.548 -0.908 . . . . 75.31 108.548 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -84.61 84.41 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.736 0.779 . . . . 73.31 111.808 -165.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -132.42 78.64 67.37 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 114.44 -1.255 . . . . 74.21 108.082 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' SER . 5.6 Cg_exo -82.79 146.44 13.16 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.647 2.231 . . . . 62.51 112.455 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -85.79 109.83 18.94 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.403 -1.332 . . . . 73.15 107.403 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 t -78.54 97.4 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 124.378 1.049 . . . . 61.43 109.44 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 92.9 mttt -99.45 104.28 16.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.579 0.752 . . . . 74.25 109.552 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.66 129.81 45.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.703 -0.851 . . . . 74.4 108.703 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -131.63 137.2 48.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.687 0.795 . . . . 74.33 109.201 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.57 113.78 20.27 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.988 -0.745 . . . . 75.31 108.988 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.54 143.77 43.98 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.195 -0.669 . . . . 73.23 109.195 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -114.64 128.3 56.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 73.02 110.842 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 161.93 19.36 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.983 1.313 . . . . 75.41 108.615 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.6 p -153.32 150.36 28.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.024 0.53 . . . . 75.41 111.137 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -146.0 143.02 29.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.663 1.185 . . . . 63.54 108.981 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -101.16 115.43 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.212 -1.403 . . . . 75.21 107.212 166.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.492 HD13 HD13 ' C' ' 83' ' ' ILE . 32.8 mt -87.43 -28.02 22.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.053 0.541 . . . . 72.4 109.944 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.5 -174.95 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.587 1.155 . . . . 71.33 109.442 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 120.73 12.43 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.261 -0.881 . . . . 74.13 109.077 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 65.76 7.06 4.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.893 1.277 . . . . 71.41 112.822 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.26 107.72 23.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.568 -1.271 . . . . 72.23 107.568 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -107.76 148.76 29.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.238 1.015 . . . . 64.23 109.591 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -128.13 110.37 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.183 -0.917 . . . . 75.2 108.796 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -100.14 125.63 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.654 -1.61 . . . . 75.21 106.654 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.54 104.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.453 -0.943 . . . . 50.41 108.453 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -91.78 104.54 16.97 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.029 -1.101 . . . . 73.54 108.029 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 16.4 mtm180 -84.18 137.49 33.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.657 -1.156 . . . . 75.25 108.425 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.0 t -126.94 132.28 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.873 -1.158 . . . . 75.11 107.873 172.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -121.73 122.51 39.71 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.986 -0.746 . . . . 73.02 108.986 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.462 HG22 HD12 ' C' ' 114' ' ' ILE . 71.1 t -110.84 111.48 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.9 m -100.1 146.12 27.17 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.679 -0.86 . . . . 73.32 108.679 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.96 124.72 33.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.101 -1.074 . . . . 65.3 108.101 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.2 m -126.61 168.54 14.17 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.895 0.878 . . . . 73.24 109.255 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.75 HD12 ' HG2' ' C' ' 34' ' ' LYS . 13.9 mt -128.89 26.42 5.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.378 1.071 . . . . 73.43 108.912 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.06 -92.8 0.68 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.74 -1.344 . . . . 73.4 109.74 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 -13.57 16.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.002 0.921 . . . . 75.11 111.12 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.488 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 6.7 tp10 -103.25 120.57 40.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.984 0.913 . . . . 74.04 109.689 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -70.65 132.3 45.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.017 0.372 . . . . 72.31 110.673 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -51.65 7.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.151 -0.685 . . . . 61.43 109.151 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -169.79 177.48 4.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.787 0.835 . . . . 73.14 111.167 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.436 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -134.02 146.89 50.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.745 1.218 . . . . 74.34 107.91 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.538 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.2 t -150.67 145.55 25.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.789 0.836 . . . . 74.24 109.381 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.09 136.35 15.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.362 0.665 . . . . 62.43 109.529 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -130.48 114.77 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.027 0.931 . . . . 74.02 108.964 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 15.1 mt-30 -91.63 96.16 10.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.688 -0.856 . . . . 71.21 108.688 176.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.5 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.9 tp-100 -87.77 111.93 21.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.9 0.48 . . . . 74.14 110.598 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.92 146.93 18.36 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 112.044 -0.422 . . . . 54.11 112.044 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.05 123.8 2.1 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 110.198 -1.161 . . . . 61.35 110.198 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.662 HD11 ' HH ' ' C' ' 17' ' ' TYR . 11.7 mm -92.36 125.31 44.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.8 -1.185 . . . . 72.41 107.8 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.87 119.68 26.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.486 -0.931 . . . . 75.2 108.486 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -89.31 97.48 11.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.408 -1.33 . . . . 74.12 107.408 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.728 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.2 pp -135.89 137.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 115.753 -0.658 . . . . 70.42 110.151 -170.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.29 166.08 32.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.926 0.89 . . . . 63.42 110.605 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -26.27 7.81 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.812 -0.631 . . . . 52.15 113.103 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.684 HG12 ' HG2' ' C' ' 94' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 124.401 1.08 . . . . 73.04 110.08 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.598 -0.519 . . . . 74.55 109.598 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.684 ' HG2' HG12 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -67.18 -50.52 60.76 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.583 -1.19 . . . . 74.22 109.026 178.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.86 77.64 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.162 0.985 . . . . 64.12 112.988 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -73.04 -39.11 66.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 63.44 110.494 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.4 t -73.47 -34.75 65.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.163 0.585 . . . . 72.04 110.974 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 47.0 tp -86.31 -56.93 3.21 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.571 1.148 . . . . 75.25 111.687 -170.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.49 11.39 68.67 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.869 -0.605 . . . . 51.23 114.554 -168.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -56.25 0.23 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.458 0.629 . . . . 74.11 111.215 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -66.72 -60.06 3.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.303 0.641 . . . . 71.01 111.989 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.36 -47.8 98.13 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.05 0.94 . . . . 65.03 113.159 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.73 -20.05 35.47 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.975 1.783 . . . . 73.3 113.356 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.26 -22.68 47.95 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.406 0.682 . . . . 64.3 110.467 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.497 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.0 mm -69.91 -33.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.082 0.553 . . . . 74.42 109.52 169.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 74.7 mt -89.9 -25.15 21.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.085 0.954 . . . . 74.34 112.613 -174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -58.45 -45.38 99.69 Favored Pre-proline 0 CA--C 1.558 1.253 0 CA-C-O 117.859 -1.067 . . . . 72.34 113.136 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.41 -43.67 56.58 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.112 1.875 . . . . 71.14 112.633 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -63.37 -44.84 93.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.051 0.54 . . . . 75.13 111.569 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -73.21 -37.2 66.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.065 -0.516 . . . . 62.14 111.682 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.95 -58.51 7.08 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 124.258 0.974 . . . . 75.35 108.97 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.68 66.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.222 1.409 . . . . 65.33 112.631 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 17.0 t -74.73 -38.71 62.21 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.048 0.539 . . . . 73.32 111.95 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.538 HG21 ' SG ' ' C' ' 76' ' ' CYS . 93.3 mt -67.14 -47.23 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 123.59 0.756 . . . . 74.24 109.737 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.647 HG22 ' HB3' ' C' ' 125' ' ' GLN . 91.8 m -56.61 -37.45 70.7 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.435 -1.257 . . . . 75.52 111.359 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.1 t -62.84 -49.28 75.51 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 114.91 -1.041 . . . . 63.33 110.251 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.675 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.73 -35.67 70.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.176 0.991 . . . . 73.15 112.96 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.78 -45.61 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.078 0.551 . . . . 71.04 110.414 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 54.1 p -70.48 -26.44 63.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.661 -0.7 . . . . 74.44 111.02 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.9 mtt-85 -66.6 -33.79 76.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 72.34 110.595 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.96 11.55 47.54 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.945 0.778 . . . . 74.31 112.826 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.501 HG22 ' HB3' ' D' ' 17' ' ' TYR . 43.9 p 57.93 28.2 15.79 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.826 2.05 . . . . 75.35 112.485 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -102.04 150.26 37.29 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.826 0.85 . . . . 73.53 108.899 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.5 130.74 31.02 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.029 2.486 . . . . 72.14 110.708 175.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.647 ' HB3' HG22 ' C' ' 115' ' ' THR . 31.4 mt-30 -61.01 153.74 24.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.167 0.987 . . . . 64.54 113.001 -170.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.43 67.42 0.84 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.348 -0.842 . . . . 61.03 109.704 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' C' ' 115' ' ' THR . 1.9 p-10 -90.69 80.99 5.86 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.407 -1.331 . . . . 74.21 107.407 167.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.24 103.89 15.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.866 -1.515 . . . . 71.33 110.607 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.11 155.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.385 1.624 . . . . 63.22 115.385 166.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.513 ' HG3' ' H ' ' A' ' 16' ' ' ILE . 69.5 Cg_endo -91.29 102.89 0.25 Allowed 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.774 2.316 . . . . 75.44 111.317 161.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 t -82.45 79.93 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.01 -0.737 . . . . 73.01 109.01 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.503 ' HB3' HG13 ' A' ' 13' ' ' ILE . 28.7 t-20 -82.16 107.19 14.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.454 -0.794 . . . . 75.44 109.378 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 CA--C 1.552 1.045 0 C-N-CA 125.195 1.398 . . . . 75.01 112.899 -172.207 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.425 -0.583 . . . . 64.34 109.425 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.458 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 76.6 t80 -159.39 89.57 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.441 -1.318 . . . . 73.44 107.441 171.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.8 142.85 45.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.227 1.011 . . . . 75.32 108.468 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -103.06 110.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.085 0.554 . . . . 70.11 110.963 -170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.92 -43.48 22.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.81 0.444 . . . . 70.42 111.577 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.414 ' HD2' ' HG2' ' B' ' 130' ' ' PRO . 6.2 tpt180 -166.32 148.61 6.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.038 0.384 . . . . 72.22 112.038 -165.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.86 128.39 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.986 -1.116 . . . . 74.3 107.986 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.639 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 11.4 p90 -163.32 164.01 24.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.584 0.706 . . . . 73.5 111.41 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -77.93 107.94 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.588 -1.187 . . . . 71.45 109.642 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 46.8 mtpt -77.23 -35.82 55.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.114 -0.494 . . . . 75.21 109.727 173.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.691 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -145.03 136.79 25.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.034 -0.984 . . . . 74.23 109.229 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.675 HG21 ' HE1' ' C' ' 117' ' ' MET . 73.1 mt -135.06 145.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.427 1.091 . . . . 75.52 108.371 175.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -149.32 132.43 16.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.989 -1.005 . . . . 64.31 108.606 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.3 t80 -137.01 117.49 13.75 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 106.333 -1.729 . . . . 74.45 106.333 167.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.23 133.61 54.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.729 -0.841 . . . . 72.21 108.729 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.54 84.66 19.35 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.214 -1.402 . . . . 62.23 107.214 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.87 -38.8 56.33 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.665 2.243 . . . . 72.1 112.295 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 25.3 m-80 -114.38 31.18 6.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.165 0.986 . . . . 74.24 109.275 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.548 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -35.16 -55.64 1.0 Allowed Pre-proline 0 CA--C 1.588 2.411 0 N-CA-C 117.487 2.403 . . . . 64.42 117.487 -172.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.87 -12.88 8.3 Favored 'Trans proline' 0 C--N 1.399 3.198 0 CA-C-N 122.595 1.963 . . . . 74.01 114.512 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -74.42 -35.69 63.4 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.423 1.089 . . . . 75.32 109.762 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.431 HG13 HD11 ' D' ' 68' ' ' LEU . 72.3 t -70.43 -34.26 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.527 1.131 . . . . 75.4 110.938 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.576 ' HD1' HH11 ' C' ' 15' ' ' ARG . 3.4 t80 -48.67 -36.68 16.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.446 1.499 . . . . 73.13 112.342 171.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' D' ' 30' ' ' HIS . 50.8 mt-30 -81.41 7.83 10.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.111 0.964 . . . . 75.44 113.116 -173.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 86.8 mttt -121.66 114.3 20.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.534 0.734 . . . . 74.12 110.164 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -95.82 73.62 3.09 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.109 -0.7 . . . . 74.23 109.109 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.565 ' HB2' HD21 ' D' ' 68' ' ' LEU . 6.7 m95 -125.8 157.43 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.05 -1.833 . . . . 74.01 106.05 174.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.415 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 32.1 tp60 -77.79 113.18 30.19 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.826 0.739 . . . . 72.52 109.258 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.456 ' HG3' HD22 ' D' ' 68' ' ' LEU . 44.6 Cg_exo -58.74 107.1 0.32 Allowed 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.963 2.442 . . . . 73.55 112.517 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.65 112.32 3.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.474 1.109 . . . . 71.52 108.736 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.8 113.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 122.205 1.002 . . . . 72.34 108.527 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.405 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 71.6 mmtt -92.71 120.48 33.15 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.633 -1.247 . . . . 75.12 107.633 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.462 HD23 HD22 ' D' ' 128' ' ' LEU . 7.3 mp -94.58 121.65 36.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.602 -0.518 . . . . 74.33 109.602 -175.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.625 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 6.5 t70 -111.22 135.56 51.57 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.045 -1.465 . . . . 72.32 107.045 169.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -130.77 130.17 43.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.532 -0.914 . . . . 74.0 108.532 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.46 153.72 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.753 -1.203 . . . . 72.31 107.753 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -143.57 149.19 37.04 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.218 -0.66 . . . . 70.43 109.218 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.1 167.54 25.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.095 -0.957 . . . . 72.42 108.458 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -155.13 156.65 36.16 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.937 0.399 . . . . 60.23 110.445 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -155.09 139.45 16.73 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.104 0.962 . . . . 64.21 109.143 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -76.84 129.01 35.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.672 0.389 . . . . 73.12 110.037 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.479 HD13 HG22 ' D' ' 83' ' ' ILE . 47.4 mt -97.69 -39.25 9.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.975 0.51 . . . . 75.35 110.102 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.01 -176.03 5.59 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.489 0.716 . . . . 74.31 110.353 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.03 121.64 11.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.043 -0.981 . . . . 71.12 110.309 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 66.85 3.6 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.473 1.509 . . . . 70.13 112.036 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -111.74 120.27 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.481 0.712 . . . . 74.24 110.171 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.21 129.06 41.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.648 1.179 . . . . 72.24 107.933 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.75 116.85 29.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.923 0.889 . . . . 61.3 108.887 173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.01 124.71 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 107.781 -1.192 . . . . 73.13 107.781 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.2 t -101.27 144.21 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.517 1.127 . . . . 51.31 109.331 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -118.05 128.87 55.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.196 -1.038 . . . . 72.24 108.196 175.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -109.41 106.87 16.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.255 1.022 . . . . 75.24 109.158 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.27 128.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.567 -1.272 . . . . 75.31 107.567 166.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.3 m -125.42 124.05 40.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.264 0.555 . . . . 55.13 109.7 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 69.0 t -106.59 101.93 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 125.002 1.321 . . . . 74.02 108.493 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 8.2 m -94.94 93.59 7.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.647 -1.242 . . . . 74.14 107.647 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.44 138.79 33.5 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.944 -0.762 . . . . 73.15 108.944 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.484 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.4 p -148.39 138.78 22.68 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.456 0.473 . . . . 73.43 112.128 -176.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' D' ' 36' ' ' TRP . 66.2 mt -107.48 110.58 22.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.773 1.229 . . . . 73.2 109.971 172.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.51 17.47 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.421 0.451 . . . . 72.14 112.997 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.68 6.25 46.58 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.407 0.683 . . . . 74.23 111.408 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.562 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 7.4 tp10 -140.04 149.36 43.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.391 0.676 . . . . 74.0 110.668 -166.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.8 m -70.44 138.42 51.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.057 0.943 . . . . 73.41 111.512 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.6 -63.13 1.35 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.561 1.144 . . . . 62.21 108.188 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -155.03 161.62 41.29 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.181 -0.918 . . . . 74.43 110.739 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -117.59 138.05 52.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.271 -1.331 . . . . 74.05 107.498 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.511 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 47.1 t -149.35 139.42 22.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.834 -0.802 . . . . 75.2 108.834 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -156.12 131.88 9.71 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.117 -0.697 . . . . 75.11 109.117 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.22 118.11 26.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 123.492 0.717 . . . . 74.32 109.282 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.691 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.0 mt-30 -90.08 85.47 6.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.912 0.863 . . . . 74.13 108.871 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.92 95.92 6.23 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.685 -1.598 . . . . 74.53 108.901 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.28 145.65 18.2 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 112.299 -0.32 . . . . 72.15 112.299 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.99 131.29 4.68 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.588 -0.605 . . . . 72.41 111.588 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.479 HG22 HD13 ' D' ' 51' ' ' LEU . 50.2 mt -90.88 131.39 38.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.903 -0.777 . . . . 73.02 108.903 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.26 142.64 48.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.94 0.496 . . . . 72.44 110.867 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -89.44 95.9 10.48 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.668 -0.864 . . . . 73.21 108.668 166.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.474 HD11 HG12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -122.04 134.46 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.146 0.978 . . . . 74.31 110.171 -173.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.33 171.1 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.256 1.023 . . . . 53.23 109.951 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.95 77.68 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.237 -0.438 . . . . 71.24 113.881 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.474 HG12 HD11 ' D' ' 86' ' ' ILE . 1.8 pp -103.99 158.08 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.201 1.0 . . . . 75.22 110.866 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.86 171.68 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.424 0.69 . . . . 65.03 110.643 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.8 -138.06 34.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.098 0.874 . . . . 62.44 114.912 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -72.55 -28.69 62.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.043 0.937 . . . . 75.43 110.954 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -63.87 -29.11 70.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.927 0.891 . . . . 74.14 111.652 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 24.2 ttt -59.93 -53.82 53.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.232 0.613 . . . . 73.41 110.525 173.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.95 64.5 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.419 -0.81 . . . . 73.33 111.205 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -69.12 -33.35 73.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.326 1.05 . . . . 75.11 110.316 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 46.5 t -78.93 -51.41 9.69 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.574 -0.739 . . . . 74.22 110.58 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.21 -49.48 27.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.284 0.633 . . . . 74.22 110.834 -171.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.34 -26.4 61.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.792 -0.64 . . . . 65.41 114.457 -172.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.18 -58.13 1.89 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.452 0.626 . . . . 75.04 112.063 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.418 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 76.8 t80 -68.73 -34.08 75.01 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.165 0.802 . . . . 75.4 113.165 -168.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.502 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 43.6 m -72.13 -48.92 10.2 Favored Pre-proline 0 CA--C 1.563 1.476 0 CA-C-O 118.977 -0.535 . . . . 75.2 110.995 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.597 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 71.0 Cg_exo -56.55 -30.97 84.89 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 122.49 2.126 . . . . 72.01 114.431 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.24 -29.32 69.77 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.039 0.536 . . . . 74.25 111.971 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -68.27 -38.98 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 73.42 110.595 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' D' ' 60' ' ' LEU . 43.1 mt -79.94 -25.37 40.49 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.063 -0.971 . . . . 75.02 111.651 -170.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.65 -41.82 80.22 Favored Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 114.231 1.197 . . . . 72.22 114.231 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.433 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 96.5 Cg_exo -50.1 -39.99 50.9 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.214 1.942 . . . . 75.45 114.19 171.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.19 -36.01 27.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.729 0.812 . . . . 74.34 111.109 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -44.19 96.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.445 0.698 . . . . 75.41 110.36 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.433 ' NH2' ' HA ' ' D' ' 108' ' ' PRO . 30.8 ttp180 -55.89 -54.97 38.23 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 124.965 1.415 . . . . 74.22 110.215 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.158 0.911 . . . . 73.53 111.837 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.425 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 43.0 t -59.7 -42.51 93.17 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.547 0.529 . . . . 74.53 110.96 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.479 HG22 ' SG ' ' D' ' 76' ' ' CYS . 83.4 mt -62.26 -55.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 115.123 -0.944 . . . . 73.41 110.338 172.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 97.1 m -53.44 -40.11 64.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.554 1.541 . . . . 74.34 112.4 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -71.73 -40.77 69.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.159 -0.928 . . . . 73.33 110.695 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.511 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.3 mtm -69.08 -31.09 69.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.864 0.465 . . . . 73.32 111.637 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.0 t -63.23 -46.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.622 0.769 . . . . 72.45 109.714 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -74.43 -29.19 61.4 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 116.009 -0.541 . . . . 74.54 111.506 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -74.12 -23.24 59.27 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.83 0.852 . . . . 74.33 110.479 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.36 12.19 65.57 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.725 -0.67 . . . . 71.23 112.43 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p 62.26 22.42 13.17 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 126.319 1.848 . . . . 74.41 113.972 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -97.99 161.26 26.16 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.265 1.026 . . . . 73.43 109.551 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.25 140.02 47.68 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.106 2.537 . . . . 75.32 111.625 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.08 119.39 8.26 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.547 0.739 . . . . 74.32 110.618 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.76 103.87 12.76 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.316 -0.994 . . . . 71.24 108.316 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -103.82 99.78 9.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 63.32 109.328 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.462 HD22 HD23 ' D' ' 42' ' ' LEU . 95.5 mt -71.29 126.88 30.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.29 0.636 . . . . 74.54 110.473 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.37 138.64 96.36 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 123.184 0.594 . . . . 71.12 111.064 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.78 96.59 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.946 1.764 . . . . 73.41 109.647 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 85.5 t -106.97 109.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.014 -1.106 . . . . 75.14 108.014 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.24 0.604 0 CA-C-N 115.588 -0.733 . . . . 75.22 109.137 -174.169 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 108.666 -0.864 . . . . 73.15 108.666 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -76.92 -18.87 58.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.419 0.688 . . . . 71.43 111.632 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.9 80.58 0.9 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.617 0.767 . . . . 74.35 109.828 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -103.8 77.33 1.45 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.732 -1.211 . . . . 72.31 107.732 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -160.76 137.16 8.59 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.342 -1.299 . . . . 74.33 107.51 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.88 140.64 45.83 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.304 0.377 . . . . 72.45 110.301 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -88.31 -163.96 1.05 Allowed 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 108.669 -0.863 . . . . 75.21 108.669 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.23 -7.14 33.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.21 0.604 . . . . 75.11 112.455 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.554 ' SD ' ' HA2' ' G' ' 169' ' ' GLY . 46.9 mtt -77.46 131.23 37.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.587 0.755 . . . . 74.32 110.207 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -164.44 136.33 4.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.875 1.27 . . . . 72.13 107.815 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -100.86 118.43 36.9 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.97 -0.752 . . . . 74.13 108.97 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -141.29 123.51 15.65 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.436 0.46 . . . . 75.53 110.908 -174.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.47 128.9 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.66 -1.237 . . . . 74.52 107.66 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -97.29 -28.91 13.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.472 -0.775 . . . . 75.42 111.341 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -175.85 127.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 123.428 0.455 . . . . 74.14 111.182 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.772 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 65.1 mt -107.74 133.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.359 -0.978 . . . . 74.24 108.359 168.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.429 ' HE1' HG13 ' A' ' 83' ' ' ILE . 17.0 p90 -165.26 154.43 12.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.034 0.934 . . . . 75.22 110.139 -174.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -81.14 121.15 25.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.316 -0.624 . . . . 73.35 109.316 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.2 mtpt -88.45 -24.57 22.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.623 0.369 . . . . 74.41 111.146 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.608 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 13.8 t70 -153.52 143.71 22.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.424 0.631 . . . . 71.42 109.955 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.402 HG21 HG21 ' B' ' 21' ' ' ILE . 65.9 mt -138.08 131.66 41.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 106.325 -1.731 . . . . 74.33 106.325 174.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.0 t -146.27 114.14 6.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.488 . . . . 71.33 109.684 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 88.8 t80 -116.11 120.33 38.7 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.242 -1.392 . . . . 74.53 107.242 172.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -119.95 130.8 54.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.365 -0.606 . . . . 75.31 109.365 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.84 76.03 23.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.844 -1.169 . . . . 73.03 107.844 172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 -20.43 21.74 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.639 2.226 . . . . 72.12 112.028 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -110.63 25.24 11.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.981 0.912 . . . . 73.13 109.179 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.69 89.96 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.536 0.734 . . . . 72.1 112.882 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 30.7 Cg_endo -68.8 -22.6 36.6 Favored 'Trans proline' 0 C--N 1.387 2.566 0 CA-C-N 121.293 1.498 . . . . 63.04 112.287 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -81.63 -20.54 39.47 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.971 1.309 . . . . 74.23 111.293 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 p -64.52 -29.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.708 0.803 . . . . 74.02 111.592 -174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -62.7 -32.47 73.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.302 1.041 . . . . 74.44 111.597 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -72.26 -35.46 68.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.003 -0.999 . . . . 74.45 110.365 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 1.5 mmmp? -83.95 153.15 24.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.929 0.891 . . . . 74.01 110.808 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.06 144.69 32.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.383 0.673 . . . . 75.42 109.99 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.419 ' CE3' HD21 ' A' ' 68' ' ' LEU . 57.7 t-105 -86.77 86.39 7.32 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.83 0.824 . . . . 74.41 110.247 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -131.96 82.63 59.02 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.951 -1.5 . . . . 74.32 106.951 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.62 127.42 7.21 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.635 2.223 . . . . 73.52 113.368 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 106.02 18.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.945 -1.502 . . . . 71.32 106.945 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.4 130.21 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 116.23 -0.441 . . . . 75.32 111.183 -171.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 59.9 mtpt -109.26 144.96 36.7 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 74.14 110.504 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD22 HD21 ' A' ' 128' ' ' LEU . 7.9 mp -126.01 112.27 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.691 -1.595 . . . . 75.23 107.603 171.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.65 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.1 m-20 -104.09 110.1 22.15 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.209 -1.404 . . . . 73.52 107.209 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.472 HD23 HD13 ' G' ' 186' ' ' LEU . 58.1 tp -96.52 127.32 42.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.185 -0.672 . . . . 74.33 109.185 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.63 162.09 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.191 0.596 . . . . 73.2 109.815 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.413 HG22 ' HE1' ' G' ' 175' ' ' PHE . 9.3 t -149.51 164.59 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.962 0.905 . . . . 71.23 110.261 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' HB1' ' NH2' ' A' ' 61' ' ' ARG . . . -148.68 154.13 39.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.634 1.174 . . . . 75.21 108.96 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 50.8 m -125.33 152.08 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.821 0.448 . . . . 74.1 110.264 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -150.14 138.59 20.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.953 0.901 . . . . 64.02 109.147 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -97.32 113.42 25.05 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.577 -0.527 . . . . 64.31 109.577 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.441 HD12 HG22 ' A' ' 83' ' ' ILE . 46.9 mt -89.19 -32.03 17.65 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.815 -0.629 . . . . 71.35 110.538 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.61 -173.86 3.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.671 0.788 . . . . 73.32 110.549 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.71 115.8 5.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.52 0.728 . . . . 74.51 109.285 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 71.69 -6.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.103 1.361 . . . . 71.01 112.613 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.4 t -99.11 112.48 31.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 70.22 108.055 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -122.62 167.31 13.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.227 -0.897 . . . . 73.23 110.27 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 48' ' ' SER . 35.4 tt0 -131.67 125.65 32.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.894 -1.503 . . . . 72.24 108.004 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.8 113.88 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.586 -1.264 . . . . 65.0 107.586 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.519 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -100.35 127.3 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.403 0.681 . . . . 74.21 109.836 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -96.49 118.55 33.24 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.944 -1.132 . . . . 73.2 107.944 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.547 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -96.39 101.85 13.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.002 -0.74 . . . . 72.51 109.002 170.042 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 18.3 t -95.64 128.66 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 107.387 -1.338 . . . . 74.22 107.387 169.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.65 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.8 m -117.84 132.03 56.48 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.844 -0.798 . . . . 73.31 108.844 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.633 HG22 HG21 ' A' ' 114' ' ' ILE . 54.9 t -126.83 109.52 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.689 1.196 . . . . 73.14 108.308 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.489 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 2.6 m -115.79 132.91 56.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.349 -0.611 . . . . 61.15 109.349 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.4 105.04 12.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.103 -1.444 . . . . 73.32 107.103 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -109.56 123.52 49.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.84 -0.43 . . . . 75.51 109.84 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.419 HD21 ' CE3' ' A' ' 36' ' ' TRP . 33.7 mt -89.94 75.12 7.25 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.017 -1.105 . . . . 74.03 108.017 173.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.74 -105.52 1.96 Allowed Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.922 -0.871 . . . . 65.43 110.922 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.58 13.48 25.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.579 0.752 . . . . 73.44 110.693 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.599 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -120.31 114.08 21.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.533 -0.746 . . . . 72.45 109.76 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -73.46 132.09 42.54 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.46 1.027 . . . . 75.24 110.726 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.63 -54.14 4.73 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.318 1.047 . . . . 71.0 108.942 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -157.3 173.34 17.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.593 -1.185 . . . . 73.23 111.233 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -142.79 142.94 31.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.678 1.591 . . . . 63.22 107.555 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 34.1 m -143.74 99.56 3.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.158 0.583 . . . . 74.53 109.838 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 40.3 tt0 -109.14 121.47 45.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.077 0.551 . . . . 75.2 109.98 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 t -122.69 119.29 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.935 0.894 . . . . 64.45 109.355 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.608 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 46.0 mt-30 -85.58 91.91 8.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.523 -0.762 . . . . 74.34 109.125 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.11 97.5 10.35 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.207 -1.034 . . . . 75.11 108.207 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.74 144.16 18.06 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 112.173 -0.371 . . . . 72.45 112.173 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.547 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.62 125.43 3.0 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.281 -0.728 . . . . 74.31 111.281 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.441 HG22 HD12 ' A' ' 51' ' ' LEU . 47.2 mt -80.36 129.71 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.625 -0.88 . . . . 75.42 108.625 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.7 120.85 27.26 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.268 -1.012 . . . . 74.02 108.268 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 t -105.39 94.22 5.1 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.437 -0.949 . . . . 74.13 108.437 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.408 HG13 ' HB3' ' G' ' 173' ' ' LEU . 1.5 pp -134.93 165.06 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.381 1.073 . . . . 73.5 108.4 -170.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 9' ' ' MET . . . -161.36 178.85 8.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.191 0.596 . . . . 72.04 111.073 170.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.86 67.66 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.739 -0.664 . . . . 71.23 114.522 170.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -113.6 147.71 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.203 0.601 . . . . 75.11 111.624 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -157.79 -170.25 3.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.98 1.312 . . . . 73.52 110.573 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 73.86 -149.41 41.31 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.996 0.808 . . . . 74.01 114.722 175.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.9 p -83.31 -23.43 32.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.577 1.151 . . . . 74.34 111.261 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.725 ' HG2' ' H2 ' ' G' ' 168' ' ' LYS . 24.6 mp0 -71.39 -35.45 71.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.488 1.115 . . . . 74.24 110.648 -176.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 27.7 ptm -62.24 -39.6 93.37 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.199 0.312 . . . . 73.41 110.3 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.5 94.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.48 0.712 . . . . 71.44 110.569 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -57.99 -45.67 86.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.923 0.889 . . . . 73.4 111.488 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.581 ' HB3' ' HB1' ' G' ' 172' ' ' ALA . 42.0 t -75.43 -54.27 7.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.315 -0.402 . . . . 74.25 111.334 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.0 -23.97 65.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.513 0.597 . . . . 74.11 111.449 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.85 -21.1 48.08 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-O 119.596 -0.558 . . . . 62.31 113.827 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -136.56 -54.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.654 0.727 . . . . 74.24 112.746 -173.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -72.81 -48.94 33.69 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.727 0.811 . . . . 73.45 112.475 -167.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.91 -46.8 75.13 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.258 1.023 . . . . 70.41 112.072 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.58 -20.82 40.51 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.588 1.525 . . . . 75.1 113.119 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 40.4 t-20 -67.85 -36.06 79.64 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.871 0.469 . . . . 73.11 109.829 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.0 mm -56.26 -43.18 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.677 0.791 . . . . 74.41 110.393 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.547 HD22 ' HA3' ' A' ' 82' ' ' GLY . 53.3 mt -81.46 -21.85 38.49 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.995 -1.002 . . . . 64.33 111.527 -172.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 29.3 t80 -66.14 -39.43 28.56 Favored Pre-proline 0 CA--C 1.56 1.35 0 N-CA-C 114.696 1.369 . . . . 73.01 114.696 -167.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 107' ' ' PHE . 12.2 Cg_endo -57.13 -40.05 86.14 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 121.878 1.718 . . . . 73.04 112.525 172.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.43 -35.38 63.37 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.552 0.741 . . . . 73.24 110.957 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.81 64.67 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.119 0.568 . . . . 75.4 110.153 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.482 ' NH1' HD13 ' C' ' 105' ' ' ILE . 34.8 ttm105 -51.41 -51.4 55.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.787 1.235 . . . . 71.44 110.333 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.82 -48.41 80.73 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.456 1.097 . . . . 75.22 111.362 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.413 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.1 t -54.18 -45.78 72.21 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.375 1.047 . . . . 72.5 110.698 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.633 HG21 HG22 ' A' ' 64' ' ' VAL . 9.0 mt -64.29 -53.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.051 -0.977 . . . . 63.01 110.901 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.411 HG21 ' HG3' ' A' ' 125' ' ' GLN . 66.1 m -53.22 -39.57 63.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 72.42 111.371 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -71.4 -42.11 68.77 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.192 -0.913 . . . . 75.54 109.807 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.552 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 21.9 mtp -57.79 -41.94 83.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.826 0.85 . . . . 73.0 111.215 175.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.5 t -61.02 -50.19 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.415 1.086 . . . . 74.34 110.387 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 82.2 p -72.1 -27.18 62.48 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.734 -0.666 . . . . 75.32 111.784 -175.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.509 HH12 ' HG3' ' B' ' 112' ' ' GLU . 76.8 mtt-85 -73.11 -24.74 60.66 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.442 0.697 . . . . 73.14 110.335 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.41 14.83 48.94 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-O 119.833 -0.426 . . . . 72.24 113.133 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.8 t 62.83 15.21 8.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 127.331 2.252 . . . . 73.42 113.42 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -91.91 157.75 40.86 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.319 0.648 . . . . 71.03 109.855 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.442 ' HB3' ' HE1' ' G' ' 195' ' ' PHE . 59.0 Cg_endo -68.22 151.99 76.35 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.68 2.253 . . . . 75.44 111.977 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' HG3' HG21 ' A' ' 115' ' ' THR . 28.1 tt0 -57.46 137.21 56.47 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.487 0.492 . . . . 61.43 110.818 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.4 tp -117.07 112.61 21.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.027 -0.988 . . . . 63.21 108.667 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.71 102.37 14.11 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.125 -1.065 . . . . 73.24 108.125 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.439 HD21 HD22 ' A' ' 42' ' ' LEU . 61.1 mt -71.35 117.98 13.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.05 -0.722 . . . . 75.45 109.05 177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.432 ' O ' HD12 ' G' ' 187' ' ' ILE . . . -65.48 128.84 94.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.285 0.366 . . . . 71.13 110.605 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HB3' HH22 ' A' ' 111' ' ' ARG . 57.9 Cg_endo -72.9 136.97 26.04 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 121.833 1.688 . . . . 72.33 110.584 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.565 HG22 HG22 ' G' ' 187' ' ' ILE . 39.7 t -97.88 113.7 33.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.23 -1.396 . . . . 75.21 107.23 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.89 63.94 8.35 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.887 1.327 . . . . 73.13 109.215 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.17 -24.37 64.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.822 -1.536 . . . . 75.31 110.064 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.01 -50.05 74.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.956 0.902 . . . . 61.22 110.385 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.55 -40.28 92.67 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.814 0.696 . . . . 71.34 111.168 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.14 -38.36 79.47 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.721 0.808 . . . . 65.32 110.925 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -73.01 -37.9 66.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.98 0.912 . . . . 75.13 109.979 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.183 0.593 . . . . 75.14 111.746 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 91.1 m-20 -59.37 -32.6 70.28 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.364 0.666 . . . . 74.35 110.82 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.92 -39.63 42.26 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.69 -1.141 . . . . 62.33 110.858 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' C' ' 149' ' ' THR . 98.5 mt -67.29 -49.51 63.97 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.454 0.701 . . . . 65.51 112.08 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -169.21 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.91 0.484 . . . . 64.04 110.612 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 25.2 tp60 65.02 -85.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.449 1.099 . . . . 73.31 110.325 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 23.3 tm0? -173.07 130.25 0.48 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.99 -0.744 . . . . 75.01 108.99 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.44 124.11 11.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.52 1.128 . . . . 64.13 108.411 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.79 73.2 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.788 -0.525 . . . . 72.23 111.788 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.84 101.13 13.73 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.341 0.656 . . . . 73.42 109.251 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.3 140.87 23.35 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 116.016 -0.538 . . . . 74.2 112.112 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 m -143.27 101.03 3.73 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.433 -0.58 . . . . 74.52 109.433 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.01 143.61 33.95 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.611 0.764 . . . . 73.32 109.707 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -164.18 -66.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.952 -1.129 . . . . 72.25 107.952 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.587 ' HB2' ' HB3' ' C' ' 140' ' ' TYR . 51.3 m80 -65.87 97.87 0.37 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.363 -0.606 . . . . 73.31 109.363 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.33 -64.89 0.76 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.357 -1.292 . . . . 70.53 110.782 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.75 142.48 13.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.016 -0.538 . . . . 52.43 111.177 -171.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.467 1.107 . . . . 73.22 108.746 174.517 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 108.852 -0.795 . . . . 74.32 108.852 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.517 ' H ' HD13 ' F' ' 173' ' ' LEU . 35.2 m -98.27 153.92 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.751 0.821 . . . . 72.41 109.923 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.16 90.65 2.39 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.606 0.762 . . . . 64.45 109.116 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -154.22 -39.07 0.09 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.151 0.981 . . . . 73.43 109.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.1 71.13 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.691 1.197 . . . . 74.22 111.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -169.7 75.36 0.09 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.411 -0.813 . . . . 74.12 109.337 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.1 m -147.82 153.13 38.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.125 0.57 . . . . 62.54 110.159 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -56.65 -32.12 65.05 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.991 1.316 . . . . 63.3 112.941 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.536 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 10.2 ptm 57.65 175.42 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 126.24 1.816 . . . . 73.23 113.699 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -168.54 146.26 4.03 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.137 0.975 . . . . 72.52 109.566 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.417 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 41.3 t80 -137.33 153.92 50.16 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.735 0.814 . . . . 63.02 108.916 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.587 HE21 ' HA ' ' B' ' 12' ' ' GLN . 0.0 OUTLIER -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.424 0.69 . . . . 71.23 111.381 170.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tp -86.95 133.77 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.019 0.528 . . . . 72.33 109.699 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -101.64 -37.85 8.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.869 0.468 . . . . 72.14 109.841 170.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -167.36 137.51 2.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.678 0.391 . . . . 74.02 111.006 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.81 141.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.653 -1.61 . . . . 71.01 106.653 169.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -172.06 144.17 1.64 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.961 0.41 . . . . 74.45 111.701 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.526 HG23 HD13 ' B' ' 21' ' ' ILE . 16.4 m -76.07 128.18 34.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.534 -0.913 . . . . 75.13 108.534 170.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.467 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 42.1 mtpt -98.4 -40.99 8.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.502 0.721 . . . . 74.02 109.564 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 30.7 t70 -138.77 143.27 38.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.34 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.633 HD13 ' SG ' ' B' ' 113' ' ' CYS . 34.7 mm -131.32 142.88 42.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 125.309 1.443 . . . . 74.45 107.758 170.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.7 m -144.4 129.09 18.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.825 -1.08 . . . . 61.01 108.798 168.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 75.0 t80 -138.79 106.7 5.67 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.125 -2.176 . . . . 75.41 105.125 164.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -119.64 108.55 14.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.205 -1.406 . . . . 75.11 107.205 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.04 89.26 6.44 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.561 1.144 . . . . 75.53 108.461 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.75 -44.2 6.14 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.714 2.276 . . . . 75.21 111.695 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 41.0 m-80 -105.98 32.17 4.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.349 1.059 . . . . 60.12 109.414 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.19 -46.42 55.69 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 125.022 1.329 . . . . 74.23 113.929 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.401 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 38.4 Cg_endo -69.89 -23.15 30.53 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 121.56 1.507 . . . . 73.24 113.32 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.4 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 0.3 OUTLIER -78.63 -2.77 40.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.408 0.683 . . . . 74.05 111.415 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.82 -20.96 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.115 0.566 . . . . 74.23 110.593 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -84.36 -21.48 30.88 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.709 0.803 . . . . 71.3 110.422 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -87.83 -22.84 24.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.408 0.683 . . . . 75.42 111.659 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -107.04 99.88 9.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.976 0.91 . . . . 75.1 111.09 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.02 76.55 8.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.579 0.752 . . . . 74.12 109.359 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 t90 179.88 159.04 0.75 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.106 0.962 . . . . 72.4 109.667 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' F' ' 193' ' ' TYR . 7.4 pt20 -58.56 137.81 85.98 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.081 0.953 . . . . 74.23 112.066 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.68 141.0 48.56 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.376 1.384 . . . . 73.42 110.271 163.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 44.6 mm-40 -75.21 99.24 3.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.247 -1.02 . . . . 75.25 108.247 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.413 ' HB ' ' HG ' ' B' ' 126' ' ' LEU . 14.1 t -97.57 118.21 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.763 -1.199 . . . . 72.11 107.763 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 134.29 46.41 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.666 -1.235 . . . . 72.3 107.666 -165.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.525 HD22 HD22 ' B' ' 128' ' ' LEU . 1.8 pp -86.67 162.49 17.89 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.086 0.773 . . . . 71.33 113.086 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.478 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.0 m-20 -146.94 131.75 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.002 -1.481 . . . . 73.34 107.002 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.13 142.83 34.22 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.229 -1.026 . . . . 55.23 108.229 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -145.11 140.31 27.94 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.305 -0.628 . . . . 73.31 109.305 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 48.3 m -108.93 111.43 23.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.512 0.725 . . . . 71.44 109.886 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.48 128.65 47.27 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 107.813 -1.181 . . . . 72.12 107.813 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.615 ' HB2' HD13 ' F' ' 177' ' ' LEU . 26.8 m -142.7 165.37 27.56 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.853 -0.529 . . . . 74.52 110.075 177.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.3 p -152.61 159.52 43.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 72.04 109.499 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.449 ' NE2' ' SD ' ' F' ' 174' ' ' MET . 56.1 tt0 -106.54 121.27 43.97 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.688 0.795 . . . . 75.31 109.5 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.437 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 85.5 mt -82.99 -43.1 16.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.251 0.62 . . . . 60.31 110.095 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.53 -177.07 6.27 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.381 -0.827 . . . . 74.43 111.019 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.23 112.54 5.87 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 113.76 -1.564 . . . . 72.35 109.096 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.628 ' HA ' ' HE3' ' F' ' 174' ' ' MET . 63.5 m-20 73.61 8.26 5.02 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.924 1.29 . . . . 52.4 112.584 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -119.34 96.08 4.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.988 0.915 . . . . 72.21 108.635 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.451 ' HE2' ' SD ' ' F' ' 174' ' ' MET . 17.0 m-85 -99.21 169.61 9.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.713 0.768 . . . . 72.22 110.964 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.437 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.5 tm-20 -142.7 96.77 2.99 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.581 -1.637 . . . . 74.1 106.581 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 79.1 t -94.86 122.58 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.194 -0.669 . . . . 75.13 109.194 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 32.5 t -103.44 118.91 51.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.309 -0.86 . . . . 75.31 109.226 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.03 112.33 24.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.263 -1.384 . . . . 74.13 107.263 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -104.17 111.79 24.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.463 -0.79 . . . . 73.15 109.655 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.533 ' HB ' HD11 ' B' ' 114' ' ' ILE . 67.1 t -105.4 112.42 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.941 -1.133 . . . . 74.41 107.941 170.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 8.8 m -98.44 152.08 19.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.801 -0.815 . . . . 73.55 108.801 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.555 HG22 HG21 ' B' ' 114' ' ' ILE . 84.9 t -141.6 126.49 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.422 1.089 . . . . 71.03 108.326 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -114.26 135.32 54.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.666 0.786 . . . . 75.51 109.388 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.28 146.18 44.39 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.081 0.552 . . . . 73.32 110.231 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -149.87 129.87 13.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.27 0.557 . . . . 74.1 112.255 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.593 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 65.7 mt -95.15 104.84 16.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.727 1.211 . . . . 74.31 109.605 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.05 -110.1 3.28 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.702 0.626 . . . . 74.43 113.047 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.7 3.57 37.16 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.106 1.362 . . . . 71.21 109.62 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.29 154.24 39.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.125 0.97 . . . . 61.32 109.879 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -73.53 137.88 44.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.13 0.572 . . . . 70.5 109.931 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.593 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -92.73 -61.98 1.48 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.784 0.834 . . . . 72.54 108.869 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.26 166.78 32.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.984 -1.462 . . . . 74.41 109.501 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.13 111.12 6.31 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.846 -1.539 . . . . 75.32 106.846 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -116.7 158.69 23.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.043 -0.725 . . . . 73.42 109.043 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -166.26 127.63 1.8 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.092 -1.077 . . . . 75.01 108.092 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.74 142.6 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.782 -0.451 . . . . 75.31 109.782 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -120.38 95.99 4.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.126 -0.943 . . . . 75.21 109.361 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -86.59 103.67 15.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.097 -0.956 . . . . 73.32 109.251 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.13 159.48 28.83 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 111.598 -0.601 . . . . 74.33 111.598 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.17 127.42 1.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.75 -0.94 . . . . 73.31 110.75 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.423 HG22 HD12 ' B' ' 51' ' ' LEU . 50.4 mt -85.41 113.2 23.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.609 -0.886 . . . . 73.43 108.609 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -118.82 133.74 55.63 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.177 -0.675 . . . . 75.24 109.177 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -93.49 110.29 21.87 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.108 -1.071 . . . . 71.12 108.108 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.613 ' HB ' HD13 ' B' ' 89' ' ' ILE . 2.8 pp -121.19 134.68 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.306 0.642 . . . . 75.41 109.74 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.87 33.68 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.152 0.981 . . . . 74.1 108.986 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.31 -44.98 3.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 122.863 0.268 . . . . 65.34 113.261 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.613 HD13 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.1 136.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.918 0.887 . . . . 73.34 111.655 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.514 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 10.8 pt-20 -151.67 146.97 26.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.744 0.418 . . . . 74.2 110.561 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.23 -105.83 0.79 Allowed Glycine 0 C--N 1.35 1.334 0 O-C-N 124.037 0.835 . . . . 74.21 113.469 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.421 HG21 HD13 ' B' ' 141' ' ' LEU . 22.1 m -79.65 -31.72 41.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.923 0.889 . . . . 72.13 110.846 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.514 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 21.1 mt-30 -60.88 -48.74 80.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.315 0.646 . . . . 70.32 110.107 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.437 ' HA ' ' SG ' ' B' ' 97' ' ' CYS . 10.3 ptm -72.82 -36.85 67.61 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.158 -0.928 . . . . 75.42 110.137 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.73 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.066 0.546 . . . . 72.53 111.286 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -75.27 -35.84 61.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.096 0.958 . . . . 72.53 111.139 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.437 ' SG ' ' HA ' ' B' ' 94' ' ' MET . 27.3 p -78.66 -56.91 4.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 110.466 -0.198 . . . . 75.21 110.466 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.6 -22.75 64.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.249 0.62 . . . . 74.31 111.49 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.38 -0.39 40.6 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.246 -0.752 . . . . 62.32 114.584 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.601 ' HA ' ' HZ3' ' F' ' 184' ' ' TRP . . . -147.95 -49.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.384 1.092 . . . . 75.2 112.319 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -72.22 -58.5 3.36 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.69 0.396 . . . . 75.45 111.193 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.06 -45.97 99.72 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 124.009 0.923 . . . . 73.2 111.956 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.72 -54.89 4.69 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.145 1.897 . . . . 73.24 112.349 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -63.56 -14.78 54.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.803 1.038 . . . . 60.12 113.803 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 75.4 mt -78.65 -48.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.738 -0.467 . . . . 65.43 109.738 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.01 -20.7 48.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.215 1.006 . . . . 65.53 111.785 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.87 -44.78 80.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.503 1.521 . . . . 72.32 112.517 -171.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.465 ' HA ' HH11 ' B' ' 111' ' ' ARG . 35.1 Cg_exo -56.69 -39.78 88.97 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 121.984 1.789 . . . . 74.41 112.94 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.431 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.8 m-85 -69.21 -41.62 76.84 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.138 0.575 . . . . 74.22 110.94 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.6 87.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.783 0.433 . . . . 71.33 110.121 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.465 HH11 ' HA ' ' B' ' 108' ' ' PRO . 28.9 mtp-105 -52.84 -63.41 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.778 1.231 . . . . 73.14 110.743 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.509 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.7 tp10 -55.28 -37.42 67.29 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.728 1.211 . . . . 63.32 111.493 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.633 ' SG ' HD13 ' B' ' 21' ' ' ILE . 2.0 t -72.57 -46.4 54.58 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 119.642 -0.218 . . . . 70.23 110.965 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.555 HG21 HG22 ' B' ' 64' ' ' VAL . 83.4 mt -60.02 -57.27 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.625 0.77 . . . . 63.33 110.668 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.412 HG23 ' H ' ' B' ' 126' ' ' LEU . 5.9 m -60.24 -28.19 67.82 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.123 0.889 . . . . 73.13 110.744 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.9 t -68.69 -53.12 24.13 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.476 0.711 . . . . 65.55 110.821 171.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.5 mmt -61.85 -37.69 85.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.004 0.522 . . . . 72.5 111.318 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.14 -49.46 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.859 1.264 . . . . 75.21 110.438 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' C' ' 126' ' ' LEU . 87.4 p -73.69 -22.99 59.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 74.12 112.258 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.8 mtt-85 -65.21 -32.37 74.01 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.472 0.709 . . . . 73.15 110.523 175.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 17.23 35.09 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.569 -0.741 . . . . 50.34 112.474 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 60.93 35.96 18.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.452 1.901 . . . . 73.51 112.648 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.32 159.37 29.52 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 124.24 1.016 . . . . 75.11 109.555 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.81 -175.06 2.49 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.948 2.432 . . . . 75.21 115.408 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.497 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 1.0 OUTLIER -65.58 133.43 51.16 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.971 1.308 . . . . 62.01 112.743 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.413 ' HG ' ' HB ' ' B' ' 40' ' ' VAL . 0.2 OUTLIER -153.72 86.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.199 -1.037 . . . . 64.34 108.199 163.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -102.62 136.89 41.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.643 -1.243 . . . . 73.53 107.643 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.525 HD22 HD22 ' B' ' 42' ' ' LEU . 10.8 mt -74.9 125.07 28.06 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.679 -0.489 . . . . 75.42 109.679 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -71.01 137.58 84.88 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.054 0.542 . . . . 73.11 110.7 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.683 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 12.8 Cg_exo -72.42 143.48 38.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.591 2.861 . . . . 74.1 113.138 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.53 128.35 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.259 0.624 . . . . 75.24 109.464 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.518 HD22 HG13 ' D' ' 105' ' ' ILE . 5.2 m-20 -83.62 81.59 8.68 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.167 0.587 . . . . 73.54 109.82 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.419 ' HB3' ' CE2' ' F' ' 181' ' ' TYR . 54.9 m-85 -68.45 -29.44 68.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.192 -0.913 . . . . 74.43 111.322 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.42 -42.16 95.45 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.046 0.841 . . . . 74.31 110.619 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.454 0.702 . . . . 63.33 111.142 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.46 -40.78 76.95 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.675 -0.693 . . . . 64.2 109.599 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.442 ' HB2' ' OH ' ' F' ' 181' ' ' TYR . 86.6 t80 -62.62 -42.56 99.66 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.302 1.441 . . . . 75.12 111.743 -175.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.416 ' SD ' ' HG3' ' B' ' 143' ' ' GLN . 25.5 mmt -62.43 -31.9 72.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.598 0.759 . . . . 72.45 111.368 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.12 -30.2 20.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.392 0.677 . . . . 72.34 110.892 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.59 -42.44 95.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.957 0.903 . . . . 75.34 110.297 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.421 HD13 HG21 ' B' ' 92' ' ' THR . 72.8 mt -101.91 3.98 39.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.874 -0.603 . . . . 75.14 111.684 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 55.31 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.488 1.115 . . . . 74.34 112.215 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.416 ' HG3' ' SD ' ' B' ' 138' ' ' MET . 29.6 mm-40 -100.34 -32.21 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 122.122 -0.361 . . . . 75.24 111.535 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 64.01 -163.79 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.167 0.987 . . . . 73.21 111.476 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.26 176.51 5.43 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.556 0.742 . . . . 73.03 110.869 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.17 84.46 0.93 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.474 -0.65 . . . . 50.03 111.474 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.94 123.26 16.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.163 0.985 . . . . 74.41 111.35 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.6 -98.02 0.11 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.29 0.369 . . . . 63.24 112.488 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -156.23 137.63 13.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.618 0.767 . . . . 71.41 109.557 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -83.2 150.22 26.34 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.62 0.768 . . . . 74.0 111.296 -174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.16 154.94 19.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.633 0.773 . . . . 64.35 110.52 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -104.03 -49.93 3.5 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.536 0.734 . . . . 74.25 110.438 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 68.29 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.198 1.399 . . . . 74.14 110.417 -169.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.94 94.86 2.94 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.931 -0.481 . . . . 71.32 109.986 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . 0.45 ' HB2' ' HB2' ' H' ' 168' ' ' LYS . . . . . . . . 0 C--O 1.248 0.976 0 C-N-CA 125.154 1.381 . . . . 71.1 108.042 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 85.0 mtp . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 111.548 0.203 . . . . 64.14 111.548 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -165.37 92.09 0.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.535 0.734 . . . . 75.33 109.473 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.07 99.15 9.69 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.283 -0.636 . . . . 73.5 109.283 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -60.22 125.55 24.09 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.554 -0.748 . . . . 64.21 110.845 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -103.69 -18.13 14.83 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.956 -0.757 . . . . 74.32 108.956 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 54.53 35.07 22.58 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.058 1.343 . . . . 75.53 110.36 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -70.37 117.38 11.85 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.297 -0.865 . . . . 65.24 109.718 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.21 -64.61 0.86 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.851 -1.068 . . . . 74.41 109.78 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ttt 63.19 116.78 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.707 1.203 . . . . 74.51 111.96 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -122.79 105.3 9.92 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 107.455 -1.313 . . . . 74.11 107.455 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.524 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.3 t80 -98.64 127.1 44.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.797 -0.816 . . . . 74.23 108.797 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -138.2 126.57 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.618 -0.512 . . . . 72.21 109.618 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.491 HD13 HD11 ' C' ' 16' ' ' ILE . 16.4 tt -80.75 140.31 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.047 0.939 . . . . 74.52 109.004 174.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.475 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -111.55 -51.44 2.86 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.913 0.387 . . . . 71.42 110.218 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.413 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 50.2 ttt180 -167.88 140.53 3.16 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.536 -0.756 . . . . 74.22 109.445 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.491 HD11 HD13 ' C' ' 13' ' ' ILE . 50.3 mt -122.27 146.95 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.316 -0.994 . . . . 63.05 108.316 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 24.5 p90 -175.65 158.27 2.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.275 0.559 . . . . 73.43 111.284 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -77.16 118.54 19.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.2 -0.909 . . . . 74.34 109.153 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -77.46 -47.72 18.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.423 -0.955 . . . . 72.3 108.423 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -137.3 137.33 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.207 -1.361 . . . . 73.42 109.054 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.7 mt -134.68 145.45 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.969 -1.493 . . . . 74.03 106.969 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -159.37 150.23 19.64 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.223 0.535 . . . . 73.54 109.918 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -139.47 122.67 16.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.875 -1.157 . . . . 71.21 107.875 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.62 111.07 18.69 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.818 0.847 . . . . 71.05 109.182 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.44 84.06 60.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.201 -1.407 . . . . 64.2 107.201 167.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.49 -31.8 60.53 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.927 2.418 . . . . 71.22 111.892 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.456 ' O ' HG12 ' C' ' 31' ' ' VAL . 66.7 m-20 -96.89 24.96 5.66 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.342 1.057 . . . . 53.11 110.456 -176.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.96 -42.74 97.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 115.26 1.578 . . . . 72.11 115.26 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -68.41 -41.97 5.95 Favored 'Trans proline' 0 C--N 1.384 2.44 0 CA-C-N 121.478 1.563 . . . . 73.31 112.082 169.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -64.02 -23.04 67.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.615 1.566 . . . . 73.03 113.131 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' C' ' 34' ' ' LYS . 15.8 m -57.63 -17.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.6 0.963 . . . . 73.51 113.6 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -59.66 -22.81 62.44 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.503 1.121 . . . . 71.52 112.436 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.6 22.53 5.92 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.428 0.529 . . . . 73.21 112.428 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.613 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -88.21 172.71 9.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.87 0.843 . . . . 74.33 111.337 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.45 ' O ' HD23 ' C' ' 68' ' ' LEU . 34.8 t70 -91.59 134.74 34.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.148 -1.387 . . . . 75.42 109.535 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.513 ' HB2' ' HB2' ' E' ' 195' ' ' PHE . 19.0 t-105 -89.31 81.93 6.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.216 0.607 . . . . 73.32 111.33 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -159.1 69.66 3.4 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.133 0.573 . . . . 72.55 109.896 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.615 ' HD2' ' HA3' ' E' ' 191' ' ' GLY . 42.1 Cg_endo -91.45 157.58 3.65 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.729 2.286 . . . . 75.32 113.368 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.92 76.77 7.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.078 -1.419 . . . . 74.45 108.798 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 m -73.39 96.35 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 122.141 0.972 . . . . 72.12 110.091 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 14.5 ptmm? -128.71 137.86 51.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.382 -1.281 . . . . 60.31 110.458 -173.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.92 139.47 36.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.833 0.853 . . . . 74.35 109.896 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.465 ' HA ' HD23 ' E' ' 186' ' ' LEU . 6.4 m-20 -120.25 106.65 12.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.377 0.671 . . . . 72.13 109.77 -174.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.407 ' HB2' ' NE1' ' E' ' 184' ' ' TRP . 5.9 mp -86.94 108.96 19.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.402 0.681 . . . . 71.43 109.503 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -113.74 129.48 56.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.004 1.322 . . . . 74.11 108.116 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 36.3 m -111.38 116.92 31.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.988 0.515 . . . . 71.03 110.712 -167.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.11 162.85 27.88 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.336 1.054 . . . . 70.21 109.423 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.0 m -148.56 165.8 30.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.133 0.973 . . . . 63.11 109.641 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -154.65 131.92 11.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.518 0.727 . . . . 74.31 109.511 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.34 120.03 19.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.149 0.579 . . . . 75.13 110.271 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' C' ' 57' ' ' GLU . 57.0 mt -94.2 -37.18 11.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.132 0.573 . . . . 73.2 109.508 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.07 -171.42 2.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.102 -0.954 . . . . 71.35 110.277 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.43 123.31 25.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.662 -0.699 . . . . 75.41 109.129 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 68.18 1.26 2.75 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.791 1.236 . . . . 74.35 112.906 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.98 112.71 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.067 -1.086 . . . . 74.53 108.067 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.37 133.9 43.04 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.91 -0.774 . . . . 74.31 108.91 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.678 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.7 tt0 -93.26 117.64 30.31 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.768 0.827 . . . . 70.43 109.77 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.37 118.27 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.144 -1.058 . . . . 73.43 108.144 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.35 106.44 20.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.165 -1.05 . . . . 71.54 108.165 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -99.67 109.69 22.15 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.096 -1.076 . . . . 75.33 108.096 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 31.1 ttm180 -81.24 110.2 16.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.889 0.875 . . . . 72.34 108.952 174.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 t -100.02 130.08 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.41 -1.33 . . . . 74.52 107.41 169.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -129.16 117.07 20.18 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.414 -0.587 . . . . 74.31 109.414 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.461 HG22 HD12 ' C' ' 114' ' ' ILE . 60.0 t -101.09 112.07 32.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.427 -0.953 . . . . 74.0 108.427 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.0 m -99.4 146.62 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.363 -0.835 . . . . 64.23 109.039 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.89 110.93 6.28 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.288 -1.004 . . . . 74.11 108.288 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 22.3 m -135.41 140.05 44.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.913 0.485 . . . . 64.45 110.438 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.725 HD12 ' HG3' ' C' ' 71' ' ' GLU . 6.5 mt -111.02 14.07 21.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.657 1.183 . . . . 72.1 110.667 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.86 -104.54 0.93 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.598 -1.001 . . . . 72.23 110.598 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -93.06 -33.01 14.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.437 0.695 . . . . 73.44 109.316 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.725 ' HG3' HD12 ' C' ' 68' ' ' LEU . 3.8 tp10 -76.84 119.75 21.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.199 1.4 . . . . 74.23 109.137 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -86.29 134.1 33.77 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.029 -0.73 . . . . 73.44 109.029 174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.613 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -75.08 -58.24 3.4 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.485 -0.561 . . . . 74.14 109.485 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.84 175.27 3.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.137 -0.938 . . . . 72.13 110.652 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.77 143.11 33.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.732 -1.581 . . . . 74.43 106.732 171.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.8 t -145.72 143.18 29.6 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.451 -0.944 . . . . 72.55 108.451 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -150.99 130.4 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.81 0.444 . . . . 75.2 109.979 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.98 115.07 23.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.291 1.036 . . . . 71.02 108.527 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 62.4 mt-30 -90.98 92.34 8.71 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.161 -1.051 . . . . 63.31 108.161 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -81.38 110.96 17.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.737 -1.12 . . . . 73.23 110.004 -176.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.6 146.08 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.782 -0.527 . . . . 61.3 111.782 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -142.62 120.42 1.57 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.889 -0.885 . . . . 64.53 110.889 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' D' ' 29' ' ' PRO . 11.0 mm -81.28 122.06 35.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.25 -1.018 . . . . 73.13 108.25 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -132.16 120.92 22.92 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.597 -0.89 . . . . 73.02 108.597 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.8 t -89.67 109.55 20.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.398 -0.964 . . . . 65.1 108.398 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.418 HG23 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -131.49 148.09 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.455 0.702 . . . . 75.34 111.036 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.8 152.75 9.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.796 1.238 . . . . 74.0 108.818 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.95 -16.38 58.65 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.967 -0.352 . . . . 74.33 113.176 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 42.4 pt -59.98 131.43 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.95 0.9 . . . . 73.3 110.325 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.555 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 40.9 tt0 -161.6 164.97 29.05 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.591 0.357 . . . . 72.31 110.407 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.01 -137.65 26.99 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.705 0.628 . . . . 71.0 111.902 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -79.32 -23.62 43.36 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.092 0.557 . . . . 74.12 110.787 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.91 -32.3 73.46 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 123.88 0.737 . . . . 72.13 111.161 -171.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.555 ' HE3' ' HA ' ' C' ' 90' ' ' GLU . 10.4 ptp -64.36 -48.02 77.11 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.295 0.372 . . . . 74.33 110.259 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.42 ' N ' ' HG3' ' C' ' 94' ' ' MET . . . -71.29 -25.15 62.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.63 0.772 . . . . 61.4 111.195 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -79.22 -29.79 42.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 73.14 110.108 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -80.51 -66.77 0.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 116.577 -0.283 . . . . 74.53 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -3.78 58.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.766 -0.584 . . . . 74.22 112.259 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.81 9.28 25.6 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.894 -0.392 . . . . 53.04 113.791 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.29 -59.45 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.06 0.544 . . . . 64.53 110.207 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -66.55 -54.53 22.63 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.721 0.808 . . . . 74.13 112.565 -171.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.524 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 20.7 m -62.76 -45.84 88.03 Favored Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 123.594 0.758 . . . . 54.25 111.505 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.6 Cg_exo -57.64 -32.07 93.56 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.067 1.844 . . . . 73.31 113.752 168.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -74.83 -23.55 58.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.544 0.738 . . . . 73.52 110.822 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.482 HD13 ' NH1' ' A' ' 111' ' ' ARG . 46.0 mm -69.96 -33.26 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.196 0.598 . . . . 73.55 109.41 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.455 HD22 ' HA3' ' C' ' 82' ' ' GLY . 80.5 mt -88.26 -23.66 23.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.132 0.973 . . . . 71.24 111.951 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.55 -49.39 91.3 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.455 1.102 . . . . 73.33 113.339 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -65.69 -38.57 23.84 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.979 1.786 . . . . 73.42 112.152 -176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -61.76 -49.5 76.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.777 0.831 . . . . 74.02 111.197 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.84 -42.41 94.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.031 -0.986 . . . . 74.52 110.607 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.494 HH12 ' HG3' ' C' ' 130' ' ' PRO . 57.0 ttp180 -61.56 -42.44 98.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.554 1.142 . . . . 75.12 109.953 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.55 -35.89 65.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.721 0.809 . . . . 74.52 109.929 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 40.7 t -69.19 -29.85 67.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.637 0.375 . . . . 71.25 111.174 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.461 HD12 HG22 ' C' ' 64' ' ' VAL . 66.3 mt -72.28 -47.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 72.31 109.539 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -56.73 -31.99 65.1 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.382 1.073 . . . . 71.45 111.283 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -64.82 -56.5 13.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.578 1.151 . . . . 53.42 109.662 174.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.658 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.81 -38.07 77.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.603 1.161 . . . . 73.13 112.581 -177.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 79.7 t -69.83 -40.02 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.176 0.591 . . . . 74.53 110.252 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.559 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 34.1 t -62.93 -38.12 89.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.452 0.644 . . . . 73.41 110.628 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.466 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 51.0 mtt-85 -67.07 -37.51 84.13 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 114.534 -1.212 . . . . 72.1 110.404 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 7.2 57.2 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 123.637 0.586 . . . . 72.33 113.248 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.408 HG22 ' HB3' ' D' ' 17' ' ' TYR . 50.7 p 60.57 26.78 16.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 126.38 1.872 . . . . 60.43 113.168 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -97.73 156.02 36.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 123.283 0.633 . . . . 72.24 109.632 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.85 78.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.747 2.965 . . . . 74.42 114.405 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.559 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 0.0 OUTLIER -65.63 155.16 36.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.518 1.127 . . . . 73.23 112.497 173.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.514 ' HA ' ' HB2' ' B' ' 119' ' ' SER . 2.0 pt? -168.13 162.16 12.86 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.111 -1.404 . . . . 75.21 108.934 165.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -88.22 100.79 13.25 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.455 -1.683 . . . . 74.52 106.455 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.04 149.81 35.73 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 124.48 1.112 . . . . 70.41 111.124 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.411 ' HB1' HD12 ' F' ' 204' ' ' ILE . . . -50.73 122.48 16.54 Favored Pre-proline 0 CA--C 1.551 1.014 0 O-C-N 124.841 1.338 . . . . 71.24 111.853 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.772 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 71.9 Cg_exo -52.68 120.6 7.78 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.552 2.835 . . . . 74.14 112.846 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.5 m -77.48 91.42 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.037 0.922 . . . . 74.33 109.712 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.499 HD21 HG22 ' F' ' 207' ' ' VAL . 47.5 m-80 -77.01 82.61 3.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.176 -0.92 . . . . 72.42 110.693 -173.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -66.45 -42.31 87.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.034 -0.985 . . . . 71.41 111.054 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.51 -49.97 73.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.027 0.931 . . . . 44.41 111.373 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.45 85.89 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.873 0.733 . . . . 62.42 111.583 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.08 -51.45 69.07 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.095 0.872 . . . . 71.34 110.595 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -57.26 -52.32 65.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.429 1.092 . . . . 75.2 111.972 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 96.5 mmm -65.42 -31.72 72.97 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.742 0.817 . . . . 74.24 111.126 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -70.74 -41.87 71.26 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 64.24 110.422 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.587 ' HB3' ' HB2' ' A' ' 152' ' ' HIS . 11.5 m-85 -71.9 -89.62 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.403 1.081 . . . . 63.43 112.223 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 96.2 mt 48.47 -133.97 1.32 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.594 1.157 . . . . 74.53 112.308 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -161.07 -67.05 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.54 -1.282 . . . . 75.22 107.54 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.88 163.38 17.21 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.848 -1.524 . . . . 60.11 108.702 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -72.89 -0.4 13.47 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.082 0.553 . . . . 74.24 111.852 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 75.33 -64.32 0.38 Allowed 'General case' 0 C--N 1.365 1.256 0 C-N-CA 126.183 1.793 . . . . 64.11 110.563 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.34 -173.27 37.73 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 115.807 -0.633 . . . . 65.41 111.928 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.33 63.53 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.794 0.807 . . . . 74.14 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.41 -35.9 9.16 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 114.413 -1.267 . . . . 64.41 112.262 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.63 ' HA ' HD12 ' A' ' 141' ' ' LEU . 9.1 t -81.57 16.48 1.71 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.379 1.072 . . . . 62.21 112.187 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -96.08 95.09 7.94 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.693 0.797 . . . . 64.12 110.547 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.72 145.7 7.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.369 -0.974 . . . . 74.43 108.369 166.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -70.41 -90.17 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.388 1.075 . . . . 74.02 110.753 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 161.94 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.06 1.744 . . . . 63.32 107.99 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.61 -76.88 0.58 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.594 -0.891 . . . . 73.21 108.594 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.503 -0.925 . . . . 63.43 108.503 178.756 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.428 ' SD ' ' HD2' ' E' ' 205' ' ' LYS . 1.2 tmt? . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.113 -0.699 . . . . 74.14 109.113 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -160.81 98.67 1.22 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.535 -1.283 . . . . 70.33 107.535 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . 0.5 ' HG3' ' HB3' ' D' ' 85' ' ' SER . 1.4 pm0 -143.71 126.73 16.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.152 0.981 . . . . 75.22 109.489 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -108.3 164.06 12.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.214 1.005 . . . . 72.25 109.947 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -70.23 -22.18 62.93 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.777 0.673 . . . . 74.53 111.658 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -73.01 82.4 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.677 0.791 . . . . 74.34 109.272 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -174.95 157.21 2.33 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.607 -1.179 . . . . 75.1 109.813 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.33 -168.8 2.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.901 0.88 . . . . 74.22 109.06 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.51 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.6 ttp -34.94 123.29 0.57 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.944 0.898 . . . . 73.24 112.788 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -138.01 144.77 41.22 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.503 -0.925 . . . . 64.14 108.503 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -154.61 98.12 2.05 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 77.5 mt-30 -112.56 143.05 44.37 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.476 -0.935 . . . . 73.24 108.476 174.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.7 tt -104.38 101.47 12.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.994 -1.113 . . . . 75.44 107.994 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.54 -46.6 31.13 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.894 -0.593 . . . . 75.12 111.808 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.47 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 32.4 ttt180 -170.68 126.68 0.74 Allowed 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.167 0.292 . . . . 72.31 111.067 -167.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.95 123.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.581 0.752 . . . . 74.04 109.002 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.47 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 15.8 p90 -147.29 160.69 42.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.675 0.79 . . . . 74.11 111.724 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -91.53 122.42 34.1 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.12 -0.946 . . . . 71.45 108.828 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -86.46 -45.56 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.636 -0.876 . . . . 74.05 108.636 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -130.75 133.84 46.37 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 113.692 -1.594 . . . . 74.12 109.082 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.658 HG23 ' HE1' ' C' ' 117' ' ' MET . 83.0 mt -134.29 145.55 32.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.603 -1.258 . . . . 74.3 107.603 170.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -148.84 144.64 27.06 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.715 0.806 . . . . 75.12 109.393 171.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -146.04 132.2 19.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.146 -1.798 . . . . 74.44 106.146 170.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.49 134.18 43.16 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.055 -1.091 . . . . 75.24 108.055 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' D' ' 28' ' ' ALA . . . -128.63 89.6 48.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.738 -1.208 . . . . 74.42 107.738 174.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.39 -51.92 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.053 2.502 . . . . 72.11 112.974 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -96.7 38.91 1.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.494 -0.928 . . . . 73.13 108.494 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.42 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.84 -52.58 63.44 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 115.329 1.603 . . . . 72.41 115.329 -164.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.534 ' HB3' HD11 ' C' ' 83' ' ' ILE . 98.0 Cg_endo -82.98 -15.8 7.86 Favored 'Trans proline' 0 C--N 1.388 2.607 0 CA-C-N 121.302 1.501 . . . . 73.23 113.534 176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -69.56 -38.96 77.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.659 1.183 . . . . 73.15 109.119 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 t -68.97 -29.57 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 125.426 1.491 . . . . 74.41 110.836 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.413 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 49.8 t80 -63.16 -36.02 82.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.137 0.575 . . . . 75.14 110.84 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.47 -1.83 56.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.984 0.914 . . . . 74.03 111.566 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.575 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 78.3 tttt -119.8 78.4 1.32 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.953 0.901 . . . . 71.3 109.407 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.64 ' HA ' ' HD2' ' H' ' 195' ' ' PHE . 8.0 p-10 -80.81 85.93 6.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.154 0.582 . . . . 74.42 112.388 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -139.85 177.34 8.03 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.371 1.069 . . . . 74.25 108.759 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -87.18 119.11 70.8 Favored Pre-proline 0 CA--C 1.554 1.128 0 O-C-N 121.985 -0.447 . . . . 72.52 110.16 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.27 113.4 2.85 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.854 2.369 . . . . 64.14 112.255 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.19 114.03 12.07 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.835 -0.802 . . . . 74.13 108.835 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.479 HG12 ' HB3' ' D' ' 66' ' ' ALA . 31.5 m -99.76 134.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.834 0.854 . . . . 73.52 110.934 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 39.5 mmtm -97.12 110.8 23.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.453 -0.944 . . . . 72.21 108.453 171.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' H' ' 188' ' ' ALA . 1.8 mm? -97.14 115.43 27.52 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.041 -1.096 . . . . 74.43 108.041 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.809 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -107.24 119.53 39.65 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.434 -0.95 . . . . 71.02 108.434 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.9 129.45 41.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.041 -0.725 . . . . 73.12 109.041 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.9 t70 -152.44 151.11 30.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 64.3 108.595 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -133.22 163.03 30.2 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.51 0.724 . . . . 70.42 110.047 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.57 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -150.2 166.97 28.27 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 74.04 109.652 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -152.2 154.25 35.43 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.105 0.562 . . . . 71.14 110.444 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -157.22 119.03 3.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.193 0.997 . . . . 73.2 108.859 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -70.85 128.22 35.26 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.688 0.395 . . . . 63.04 110.211 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.5 mt -103.57 -29.1 11.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.318 0.647 . . . . 74.04 110.166 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.498 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -165.8 -176.63 3.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.297 1.039 . . . . 72.55 110.017 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.54 121.02 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.579 -0.897 . . . . 63.34 108.579 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 63.89 16.82 10.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.4 1.08 . . . . 71.15 112.756 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.498 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 79.6 t -131.2 128.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.283 1.033 . . . . 72.21 108.765 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.436 ' CE1' HG12 ' D' ' 86' ' ' ILE . 0.0 OUTLIER -151.41 161.67 42.3 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 72.53 110.674 176.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.442 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -103.01 120.55 40.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 124.531 1.132 . . . . 70.34 108.848 173.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.65 123.09 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.403 -1.332 . . . . 62.42 107.403 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 29.7 t -102.75 133.93 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.883 -0.784 . . . . 64.24 108.883 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.24 111.08 22.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.219 -1.03 . . . . 74.11 108.219 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.0 ttm-85 -86.84 110.53 20.02 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 109.144 -0.688 . . . . 75.23 109.144 171.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -108.56 103.83 16.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.87 -1.159 . . . . 73.02 107.87 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.809 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -96.04 146.5 24.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.957 -0.757 . . . . 71.42 108.957 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 81.2 t -138.21 123.18 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.818 1.247 . . . . 74.42 108.368 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 60.6 m -125.63 97.78 5.3 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 71.44 108.644 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.479 ' HB3' HG12 ' D' ' 40' ' ' VAL . . . -94.16 137.62 33.14 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.49 0.716 . . . . 74.3 109.385 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.8 m -137.06 149.53 47.47 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.142 0.577 . . . . 74.25 110.694 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -132.58 117.42 17.93 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.047 1.339 . . . . 75.11 107.999 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.26 -112.43 4.68 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.695 -0.562 . . . . 74.43 111.695 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 4.48 13.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.768 0.827 . . . . 75.02 110.815 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.575 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 12.6 pt-20 -118.62 170.9 8.58 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.308 0.643 . . . . 74.33 110.511 -176.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -79.95 138.04 37.0 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.851 -0.613 . . . . 72.44 109.986 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.05 -56.74 2.96 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.704 0.802 . . . . 75.14 109.069 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -163.59 163.6 24.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.878 -1.055 . . . . 74.2 109.828 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.1 mt -118.82 153.04 35.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.048 1.339 . . . . 74.45 108.25 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.533 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 44.3 t -159.31 144.96 16.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.115 0.566 . . . . 64.04 109.988 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -156.83 139.71 15.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.61 . . . . 64.31 109.382 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.61 119.89 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 123.653 0.781 . . . . 75.03 108.936 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.2 mt-30 -97.47 87.84 4.22 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.768 0.827 . . . . 75.15 108.956 173.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -80.64 97.75 7.37 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.819 -1.537 . . . . 72.45 109.588 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.53 141.59 16.73 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.578 -0.609 . . . . 72.01 111.578 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.3 131.42 4.86 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.847 -0.501 . . . . 72.24 111.847 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -90.04 125.35 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.956 -0.757 . . . . 75.5 108.956 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -129.6 128.8 43.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.255 1.022 . . . . 74.45 109.493 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.5 ' HB3' ' HG3' ' D' ' 3' ' ' GLU . 6.0 m -88.29 95.18 10.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.054 0.942 . . . . 73.51 108.682 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' D' ' 56' ' ' TYR . 2.7 pp -109.42 140.23 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.66 0.384 . . . . 75.45 110.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.32 165.41 19.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.003 0.921 . . . . 74.03 109.113 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.36 23.83 76.45 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 121.529 0.516 . . . . 74.44 112.262 -174.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.439 HD11 ' SD ' ' D' ' 94' ' ' MET . 2.3 pp -109.18 147.16 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.967 1.307 . . . . 74.32 110.238 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -168.58 150.46 4.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.923 0.489 . . . . 73.21 111.332 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.05 -139.75 48.25 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.015 0.822 . . . . 72.4 114.959 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' THR . . . . . 0.61 ' HB ' HD22 ' D' ' 141' ' ' LEU . 12.6 p -68.54 -18.69 64.41 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.544 0.738 . . . . 72.23 111.739 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -47.85 61.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.518 0.727 . . . . 73.21 109.573 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.439 ' SD ' HD11 ' D' ' 89' ' ' ILE . 9.3 tpt -58.34 -53.06 62.6 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.94 0.775 . . . . 62.52 110.553 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.17 86.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.956 0.785 . . . . 74.24 111.424 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.43 ' HE1' ' HB3' ' D' ' 137' ' ' PHE . 83.5 t60 -70.86 -47.09 61.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.409 0.683 . . . . 52.22 111.526 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.155 0.582 . . . . 72.41 110.589 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.03 -48.39 18.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.137 0.975 . . . . 75.05 110.34 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.45 -14.31 60.22 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.772 -0.649 . . . . 72.0 114.231 -169.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.15 -60.97 1.32 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.025 0.53 . . . . 62.42 110.99 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -64.56 -47.45 78.69 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.818 0.673 . . . . 75.44 112.818 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.426 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 94.9 m -62.29 -50.17 80.84 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 118.8 -0.619 . . . . 74.12 111.246 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.459 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 60.1 Cg_exo -58.77 -31.0 94.19 Favored 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 122.542 2.161 . . . . 73.41 113.94 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.04 -32.9 74.65 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.09 0.556 . . . . 74.03 110.419 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.518 HG13 HD22 ' B' ' 132' ' ' ASN . 47.7 mm -69.9 -43.22 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.516 0.726 . . . . 71.05 110.21 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -73.36 -19.5 60.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.183 -0.917 . . . . 75.13 111.772 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -69.09 -44.33 27.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 N-CA-C 113.887 1.069 . . . . 75.23 113.887 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.03 -34.52 87.38 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 121.927 1.752 . . . . 74.31 113.237 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.683 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 97.0 m-85 -81.2 -33.87 32.66 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 75.42 111.441 -176.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.33 66.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.16 0.584 . . . . 73.44 109.71 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -58.82 -49.31 78.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.089 1.356 . . . . 73.23 110.596 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.45 -43.41 94.37 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.172 0.92 . . . . 75.15 110.881 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.466 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.3 t -56.09 -41.59 75.42 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.628 0.58 . . . . 72.13 110.737 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.47 HG23 HG21 ' D' ' 64' ' ' VAL . 78.8 mt -70.91 -44.59 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.153 -0.931 . . . . 75.03 110.782 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.484 HG22 ' HG3' ' D' ' 125' ' ' GLN . 74.2 m -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.015 0.926 . . . . 75.33 110.598 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.31 -48.08 71.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.511 -1.222 . . . . 64.01 110.305 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.526 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.6 mtm -64.44 -32.76 74.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.008 0.523 . . . . 75.02 112.126 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' D' ' 123' ' ' PHE . 72.3 t -67.42 -45.73 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.566 -0.743 . . . . 73.33 109.531 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.8 p -71.76 -23.17 61.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.625 0.37 . . . . 74.55 111.548 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.484 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.4 mtt-85 -77.6 -34.35 53.48 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.094 0.958 . . . . 75.23 109.85 175.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -0.01 79.93 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.587 -0.733 . . . . 71.44 111.926 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p 61.5 42.31 11.52 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.313 1.845 . . . . 72.44 111.552 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.413 ' HB2' HG13 ' D' ' 118' ' ' VAL . 37.1 m-85 -111.56 167.82 8.52 Favored Pre-proline 0 CA--C 1.56 1.347 0 CA-C-N 113.078 -1.874 . . . . 75.2 107.878 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.455 ' HD3' ' HE1' ' H' ' 195' ' ' PHE . 93.1 Cg_endo -75.17 140.37 24.91 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.996 1.797 . . . . 75.44 112.053 -171.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.484 ' HG3' HG22 ' D' ' 115' ' ' THR . 25.6 tt0 -45.61 123.78 4.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.502 1.121 . . . . 75.51 112.338 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.479 HD12 HG22 ' D' ' 40' ' ' VAL . 42.1 tp -108.56 93.02 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.524 -0.762 . . . . 74.32 109.021 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -115.53 106.0 13.44 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.03 0.932 . . . . 63.31 109.039 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.567 HD13 ' HG ' ' D' ' 42' ' ' LEU . 3.6 mm? -62.44 125.51 24.16 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.337 -0.847 . . . . 74.33 110.135 174.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.501 ' HB1' HE22 ' B' ' 12' ' ' GLN . . . -55.7 128.46 69.33 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 124.538 1.149 . . . . 60.45 110.562 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -73.59 95.23 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.307 2.671 . . . . 74.34 112.335 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 91.2 t -102.12 118.74 49.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.508 -1.293 . . . . 73.43 107.508 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -80.07 79.04 6.67 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.752 0.787 . . . . 62.42 109.215 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -68.16 -20.57 64.89 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.482 -1.236 . . . . 74.51 111.392 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.4 -56.02 13.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 109.092 -0.707 . . . . 75.11 109.092 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.536 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -61.74 -30.88 71.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.461 0.705 . . . . 50.11 112.011 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 56.0 tp -61.61 -48.46 80.79 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.849 0.859 . . . . 73.34 111.037 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.43 ' HB3' ' HE1' ' D' ' 96' ' ' HIS . 39.3 t80 -83.18 -26.6 30.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.531 0.733 . . . . 73.31 111.04 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.536 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 44.1 ttm -51.32 -38.57 53.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.24 1.416 . . . . 71.41 112.504 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.57 -31.69 71.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.802 -0.635 . . . . 64.55 111.091 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -74.92 -22.73 58.44 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.706 0.802 . . . . 74.13 111.831 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.61 HD22 ' HB ' ' D' ' 92' ' ' THR . 82.3 mt -61.87 -53.32 57.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.829 0.852 . . . . 74.51 111.503 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -79.23 5.55 11.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.159 -0.928 . . . . 75.4 111.978 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.05 46.25 2.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.929 0.892 . . . . 64.33 109.317 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -168.33 -178.67 3.68 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.836 0.854 . . . . 72.04 110.427 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.07 128.44 35.53 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.957 -0.757 . . . . 55.14 108.957 166.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.99 144.24 3.87 Favored Glycine 0 C--O 1.238 0.386 0 N-CA-C 109.996 -1.242 . . . . 64.34 109.996 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 67.15 111.09 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.067 0.947 . . . . 63.52 110.14 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -157.02 3.27 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.147 -0.479 . . . . 74.01 113.117 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.0 m 63.27 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.126 0.971 . . . . 74.52 109.813 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.68 145.94 32.54 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.116 0.966 . . . . 62.44 112.377 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -173.49 0.64 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.454 0.701 . . . . 74.31 111.353 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 64.3 t60 75.59 14.33 2.83 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.646 1.178 . . . . 74.44 110.384 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.76 81.5 7.77 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.019 -1.474 . . . . 75.21 107.019 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -173.64 159.64 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.457 1.103 . . . . 75.31 109.83 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.253 0 C-N-CA 123.697 0.799 . . . . 74.44 109.31 177.269 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' E' ' 169' ' ' GLY . 8.8 tmtt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 108.369 -0.975 . . . . 75.21 108.369 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . 0.421 ' N ' ' HD3' ' E' ' 168' ' ' LYS . . . 104.71 -130.66 10.32 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.873 -0.891 . . . . 74.43 110.873 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' E' ' 175' ' ' PHE . 20.5 ptmt -159.73 136.21 9.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.62 0.768 . . . . 75.11 111.163 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 34.2 m -124.12 31.67 5.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.108 0.963 . . . . 74.34 109.468 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -145.15 176.1 9.77 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.766 -1.106 . . . . 73.54 109.388 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -63.41 -30.86 71.92 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.264 0.554 . . . . 63.33 110.377 170.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 14.3 ptt? -147.48 120.15 8.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.931 1.292 . . . . 70.12 108.512 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' E' ' 170' ' ' LYS . 38.0 t80 -174.33 126.63 0.34 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.71 -1.589 . . . . 73.53 106.71 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -138.64 -73.08 0.4 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.069 -0.715 . . . . 75.41 109.069 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp 59.45 79.05 0.24 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.271 1.028 . . . . 74.32 111.46 173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.95 -59.16 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.4 -0.593 . . . . 75.5 109.4 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . 0.416 ' HB2' ' HD3' ' E' ' 180' ' ' PRO . 20.5 mp0 -74.53 -57.22 2.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.488 0.715 . . . . 72.4 110.901 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' E' ' 179' ' ' GLU . 66.2 Cg_endo -81.24 4.0 7.35 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.747 1.631 . . . . 73.11 112.521 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -98.2 88.44 4.19 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.227 -1.027 . . . . 74.35 108.227 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -83.98 165.87 18.27 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.494 -0.558 . . . . 75.52 109.494 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 23.5 p -81.01 112.05 18.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.852 0.461 . . . . 73.35 110.122 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.407 ' NE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -70.77 148.21 94.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.997 -0.547 . . . . 72.1 110.2 170.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.16 141.78 98.45 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.38 2.054 . . . . 73.34 111.161 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' C' ' 43' ' ' ASP . 88.0 mt -103.73 7.21 37.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.489 0.716 . . . . 72.24 110.568 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 tt 59.6 164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.527 1.931 . . . . 74.03 112.282 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.02 93.03 0.29 Allowed 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.753 -0.832 . . . . 61.44 108.753 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' F' ' 201' ' ' LYS . . . -97.48 128.2 44.05 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.766 -0.652 . . . . 74.25 109.508 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -83.33 128.59 34.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.773 0.829 . . . . 71.11 109.272 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . 0.615 ' HA3' ' HD2' ' C' ' 38' ' ' PRO . . . -79.83 16.0 13.12 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 115.021 0.768 . . . . 72.41 115.021 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.48 -107.2 2.9 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 118.168 0.984 . . . . 62.14 111.631 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 51.2 t80 179.9 131.25 0.09 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.0 0.92 . . . . 71.22 109.558 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.68 125.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.112 1.365 . . . . 73.43 113.334 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . 0.513 ' HB2' ' HB2' ' C' ' 36' ' ' TRP . 0.2 OUTLIER -96.08 163.09 13.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.977 -0.452 . . . . 74.2 110.141 -178.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.94 84.09 1.24 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.905 -0.776 . . . . 74.11 108.905 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -136.92 112.22 9.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.579 1.152 . . . . 74.44 108.213 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -174.42 -68.48 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.549 0.74 . . . . 71.01 109.128 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -92.79 -48.52 6.52 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.789 0.836 . . . . 74.02 109.628 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.32 123.37 1.25 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.79 -0.524 . . . . 75.52 111.79 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -136.34 12.14 3.26 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.131 0.572 . . . . 74.13 111.398 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' F' ' 190' ' ' ASP . 24.1 t80 -122.84 -12.6 8.01 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.34 0.656 . . . . 73.04 110.556 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.37 179.52 7.81 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.166 0.987 . . . . 63.21 110.722 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.81 103.26 15.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.313 0.578 . . . . 72.22 110.445 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . 0.428 ' HD2' ' SD ' ' D' ' 1' ' ' MET . 81.7 tttt -126.7 131.75 51.31 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.995 -1.113 . . . . 74.31 107.995 169.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -163.94 -50.63 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.456 0.702 . . . . 74.41 109.393 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 CA--C 1.554 1.097 0 CA-C-N 114.937 -1.029 . . . . 74.14 109.733 178.637 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.692 -0.485 . . . . 74.41 109.692 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.32 128.87 1.18 Allowed Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.175 -0.466 . . . . 72.35 112.086 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -113.42 -162.42 0.8 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.616 0.767 . . . . 72.51 109.407 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 9.4 m 67.56 174.39 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.259 1.024 . . . . 61.45 110.748 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . 0.49 ' HB3' HD21 ' F' ' 173' ' ' LEU . . . -82.17 -86.56 0.1 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.921 -0.487 . . . . 71.42 111.018 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.517 HD13 ' H ' ' B' ' 2' ' ' SER . 2.4 mm? -122.79 -66.47 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.934 -0.479 . . . . 74.4 111.307 -172.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.628 ' HE3' ' HA ' ' B' ' 54' ' ' ASP . 20.5 mmt 74.86 168.74 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.567 1.547 . . . . 75.42 111.054 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . 0.427 ' HD1' ' H ' ' F' ' 177' ' ' LEU . 43.5 p90 -159.57 164.87 33.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.528 0.731 . . . . 73.34 110.873 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -118.12 27.36 9.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.003 0.921 . . . . 73.24 109.274 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . 0.615 HD13 ' HB2' ' B' ' 48' ' ' SER . 7.0 mp 66.82 70.81 0.39 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.936 1.295 . . . . 71.43 109.977 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -89.82 102.61 15.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.534 -0.757 . . . . 75.3 109.589 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 55.6 83.96 0.22 Allowed Pre-proline 0 CA--C 1.555 1.157 0 O-C-N 124.578 1.174 . . . . 64.01 111.896 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.58 90.69 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.068 2.512 . . . . 71.15 112.253 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . 0.442 ' OH ' ' HB2' ' B' ' 137' ' ' PHE . 9.7 t80 68.11 -177.55 0.21 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.172 1.389 . . . . 74.32 112.208 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -87.25 57.17 4.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.59 1.156 . . . . 75.32 109.84 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 26.5 m 69.93 146.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.905 1.282 . . . . 75.42 112.014 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.601 ' HZ3' ' HA ' ' B' ' 100' ' ' ALA . 4.2 t-105 -125.7 85.64 58.69 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 108.693 -0.855 . . . . 75.45 108.693 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . 0.406 ' HD2' ' HE2' ' B' ' 133' ' ' PHE . 72.1 Cg_endo -76.79 149.84 30.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.606 2.204 . . . . 63.11 112.52 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 79.0 mt -142.51 168.72 19.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.582 1.153 . . . . 74.42 109.857 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.445 ' H ' HD11 ' F' ' 187' ' ' ILE . 0.2 OUTLIER -76.23 154.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.199 0.6 . . . . 74.13 110.163 175.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.11 -71.37 0.43 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.683 0.393 . . . . 63.1 110.468 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -169.48 143.51 2.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.128 0.971 . . . . 71.35 109.828 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' E' ' 202' ' ' TYR . 29.7 t70 -173.33 161.6 4.21 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.946 0.779 . . . . 72.3 110.259 174.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.78 -37.93 0.32 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.741 -0.944 . . . . 73.24 110.741 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.0 36.89 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.351 -0.424 . . . . 74.2 112.884 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' B' ' 37' ' ' GLN . 63.7 m-85 -75.14 171.96 13.22 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.978 0.911 . . . . 74.14 111.699 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -165.17 171.74 13.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.488 1.115 . . . . 72.22 108.894 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -107.09 -86.12 0.5 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 119.264 -0.398 . . . . 74.04 111.441 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 70.73 100.57 0.06 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.315 1.046 . . . . 74.45 109.984 -169.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . 0.481 ' HD1' ' HB2' ' F' ' 203' ' ' ASP . 23.3 m-85 -74.35 -18.83 60.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.868 0.467 . . . . 72.43 110.434 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.66 75.4 9.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.977 0.511 . . . . 75.12 109.786 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 64.2 23.9 13.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.521 1.129 . . . . 60.34 112.664 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -86.71 -116.2 1.0 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.678 -0.512 . . . . 65.11 112.511 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . 0.428 ' HZ2' ' HE1' ' C' ' 36' ' ' TRP . 36.9 pttt -155.73 153.59 30.15 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.617 0.767 . . . . 75.42 109.887 -168.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 63.81 8.74 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.721 1.208 . . . . 74.25 111.81 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . 0.481 ' HB2' ' HD1' ' F' ' 197' ' ' TYR . 5.1 p-10 -106.74 -169.58 1.58 Allowed 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.757 1.223 . . . . 75.24 109.139 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.411 HD12 ' HB1' ' C' ' 129' ' ' ALA . 10.9 tt -157.98 100.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 72.33 106.894 167.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -82.87 36.18 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.143 -1.39 . . . . 73.31 112.228 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 22.6 t70 71.42 124.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.26 1.424 . . . . 71.35 111.28 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.499 HG22 HD21 ' C' ' 132' ' ' ASN . 54.1 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.708 -0.663 . . . . 71.34 109.675 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . 0.725 ' H2 ' ' HG2' ' A' ' 93' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.893 -0.41 . . . . 74.1 109.893 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . 0.554 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 82.58 177.4 51.91 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.567 0.542 . . . . 45.21 113.189 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -147.18 2.61 0.77 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.613 0.765 . . . . 73.25 109.544 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -162.49 177.86 9.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 72.32 111.12 -167.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 97' ' ' CYS . . . -158.62 136.03 10.1 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 121.116 0.484 . . . . 73.44 112.065 172.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.68 ' HG ' ' HG3' ' G' ' 174' ' ' MET . 1.2 pt? -125.21 -174.03 2.96 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.074 1.35 . . . . 71.44 107.415 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.68 ' HG3' ' HG ' ' G' ' 173' ' ' LEU . 29.1 mtt 64.06 -166.45 0.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.259 0.624 . . . . 75.22 109.617 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.413 ' HE1' HG22 ' A' ' 46' ' ' THR . 8.7 t80 -129.86 -71.15 0.62 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.947 -1.131 . . . . 63.42 107.947 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 55.3 t30 42.85 75.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.449 1.499 . . . . 74.3 113.119 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.84 75.9 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.423 -0.954 . . . . 73.13 108.423 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -65.69 -47.03 76.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.716 -1.584 . . . . 72.22 110.704 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.16 137.62 11.91 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.317 1.047 . . . . 71.01 109.177 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.78 87.1 1.16 Allowed 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.078 2.519 . . . . 74.45 110.972 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -73.12 131.05 41.59 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.191 -0.913 . . . . 75.04 109.258 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 60.64 -165.91 0.21 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.208 1.003 . . . . 75.21 112.597 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -130.27 140.18 50.7 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.787 0.835 . . . . 64.32 109.312 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . 0.422 ' HD1' ' H ' ' G' ' 186' ' ' LEU . 4.5 t90 -135.22 92.13 18.36 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.098 -1.445 . . . . 75.34 107.098 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -81.91 0.5 9.8 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.788 2.325 . . . . 74.13 113.598 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . 0.472 HD13 HD23 ' A' ' 44' ' ' LEU . 4.5 mm? 62.81 -167.67 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.995 . . . . 73.22 110.903 -175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.608 HD13 ' HE1' ' H' ' 202' ' ' TYR . 13.9 pt -93.5 131.73 39.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.918 0.887 . . . . 75.32 109.96 176.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.62 91.52 2.87 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.545 -0.909 . . . . 74.2 108.545 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -72.65 83.25 1.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.556 -0.747 . . . . 75.54 111.213 -174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.32 125.66 14.77 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.889 -1.152 . . . . 73.33 107.889 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -125.3 -146.95 6.9 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 123.212 0.32 . . . . 73.24 113.668 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.63 54.79 0.74 Allowed Glycine 0 C--N 1.345 1.046 0 C-N-CA 123.36 0.505 . . . . 53.02 112.273 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 66.64 -178.72 0.2 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.52 1.128 . . . . 71.21 112.998 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -152.1 -162.72 1.57 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.558 1.143 . . . . 74.42 108.403 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . 0.458 ' HB3' ' O ' ' H' ' 195' ' ' PHE . 24.3 p90 -61.98 104.63 0.48 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.111 0.482 . . . . 72.1 109.806 171.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.538 ' HZ1' ' HB2' ' G' ' 196' ' ' LYS . 0.1 OUTLIER -83.66 53.55 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.72 0.772 . . . . 73.45 109.508 175.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.05 -77.3 0.02 OUTLIER 'General case' 0 C--N 1.358 0.96 0 C-N-CA 126.053 1.741 . . . . 75.34 112.297 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 66.77 120.82 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.611 1.164 . . . . 73.13 109.852 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.27 86.76 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.41 0.624 . . . . 74.22 111.066 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . 0.43 ' HA3' ' HA2' ' H' ' 192' ' ' GLY . . . -97.83 -176.35 33.7 Favored Glycine 0 C--O 1.244 0.761 0 CA-C-N 114.866 -1.061 . . . . 63.35 110.642 171.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -144.48 150.09 37.05 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.902 0.481 . . . . 72.12 110.029 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . 0.464 ' HE1' ' HB3' ' D' ' 129' ' ' ALA . 82.1 t80 -117.2 0.85 12.4 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.35 1.06 . . . . 71.14 109.882 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 36.6 t70 69.44 92.97 0.08 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 124.991 1.316 . . . . 74.32 109.492 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . 0.555 HG23 ' HG2' ' B' ' 12' ' ' GLN . 39.9 mm -93.75 92.6 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.172 -0.922 . . . . 71.22 111.622 -167.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 168.38 131.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.15 2.18 . . . . 73.05 108.251 171.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -90.05 -77.93 0.38 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.902 0.481 . . . . 54.33 109.996 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--O 1.245 0.835 0 N-CA-C 107.618 -1.253 . . . . 62.51 107.618 -177.081 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . 0.45 ' HB2' ' HB2' ' B' ' 155' ' ' ALA . 47.2 mmtm . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 110.128 -0.323 . . . . 71.24 110.128 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.29 120.73 23.83 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 123.845 0.716 . . . . 71.44 113.27 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.91 169.33 23.7 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.203 0.601 . . . . 72.55 110.356 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 51.8 m -107.84 -176.1 2.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 61.23 110.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.29 84.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.268 0.627 . . . . 73.41 110.539 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.55 112.27 24.63 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.152 -0.931 . . . . 73.51 109.766 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.42 ' H ' ' HE3' ' D' ' 94' ' ' MET . 18.9 mmt 64.69 -178.44 0.17 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.049 1.34 . . . . 70.41 112.987 171.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.19 178.01 9.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.825 0.85 . . . . 72.43 109.446 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -109.43 137.52 47.16 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.012 -1.107 . . . . 75.0 108.012 167.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 38.5 tp -77.33 77.53 3.86 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.753 0.787 . . . . 73.4 109.725 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . 0.441 ' HG3' ' HG2' ' H' ' 179' ' ' GLU . 4.2 pt20 -81.92 -26.47 34.04 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.131 -0.94 . . . . 71.34 110.515 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . 0.441 ' HG2' ' HG3' ' H' ' 178' ' ' GLN . 17.2 pt-20 -169.43 158.47 7.13 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.349 1.059 . . . . 73.54 109.796 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.44 -176.83 2.68 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.712 2.274 . . . . 53.13 111.391 164.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -166.72 -51.75 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.771 -0.826 . . . . 65.42 108.771 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.13 86.47 7.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.925 -1.034 . . . . 71.51 109.831 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 36.0 m -140.06 100.8 4.01 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.534 -0.757 . . . . 74.01 109.305 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -95.13 139.29 21.99 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.576 0.751 . . . . 75.44 110.293 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.33 115.05 3.29 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.692 2.261 . . . . 72.34 111.498 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.48 152.14 45.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.051 -0.522 . . . . 75.31 110.834 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.467 HG12 ' HB2' ' D' ' 129' ' ' ALA . 2.3 pp -60.47 -24.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 114.523 1.305 . . . . 75.32 114.523 -169.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . 0.576 ' HA ' HD21 ' D' ' 42' ' ' LEU . . . 67.84 170.98 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.613 1.165 . . . . 72.24 112.821 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.11 171.87 10.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.677 -0.692 . . . . 74.41 109.461 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -136.94 169.82 17.12 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.354 -0.98 . . . . 74.52 108.354 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.33 81.04 0.2 Allowed Glycine 0 C--N 1.346 1.129 0 O-C-N 123.355 0.41 . . . . 74.03 113.445 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . 0.43 ' HA2' ' HA3' ' G' ' 200' ' ' GLY . . . -97.03 -142.06 12.91 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 110.325 -1.11 . . . . 72.3 110.325 170.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -165.67 129.96 2.31 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.197 0.498 . . . . 72.0 109.741 171.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.22 36.86 0.14 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.92 0.762 . . . . 73.2 110.079 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.64 ' HD2' ' HA ' ' D' ' 35' ' ' ASP . 0.4 OUTLIER -109.06 -170.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.844 0.857 . . . . 71.44 110.422 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 68.04 89.11 0.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.872 0.869 . . . . 72.33 109.205 -173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -109.2 70.36 0.73 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.363 -0.977 . . . . 74.2 108.363 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 74.41 163.01 0.26 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 124.369 1.043 . . . . 71.54 110.544 -170.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -162.62 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.858 0.863 . . . . 73.01 109.732 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -100.27 51.28 1.04 Allowed Glycine 0 C--N 1.348 1.209 0 N-CA-C 110.949 -0.86 . . . . 74.52 110.949 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 119.38 3.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.894 1.278 . . . . 74.35 112.406 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . 0.608 ' HE1' HD13 ' G' ' 187' ' ' ILE . 37.5 p90 -61.28 140.37 57.98 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.826 -1.079 . . . . 73.13 111.524 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 170.83 13.5 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.191 0.596 . . . . 74.43 110.702 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.507 ' HA ' HG23 ' G' ' 187' ' ' ILE . 2.4 mp -86.44 -62.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.379 -0.971 . . . . 74.32 108.379 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -173.18 -63.17 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.75 0.82 . . . . 72.21 109.655 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t70 179.35 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.051 1.34 . . . . 74.15 107.753 -167.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 114.433 -1.258 . . . . 74.23 109.859 170.73 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 16.3 ptm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.802 -0.444 . . . . 73.4 109.802 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -129.27 -31.63 2.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.429 0.692 . . . . 73.3 110.742 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 66.23 -76.35 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 75.32 109.685 -170.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 55.7 93.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.706 1.203 . . . . 74.32 111.839 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' C' ' 142' ' ' GLN . 45.7 m-80 -71.32 85.88 0.8 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.284 0.564 . . . . 73.15 111.037 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -79.6 154.27 28.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.889 1.276 . . . . 73.05 108.761 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -136.14 30.92 2.98 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.292 0.567 . . . . 63.41 110.686 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.61 -56.2 11.81 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.807 0.813 . . . . 74.34 110.305 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.4 ' HB2' ' H3 ' ' C' ' 1' ' ' MET . 24.1 ttt -152.54 159.29 43.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.357 -1.292 . . . . 71.11 108.24 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 m -140.2 123.66 17.05 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 109.552 -0.536 . . . . 74.34 109.552 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.74 135.78 48.12 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.663 0.785 . . . . 74.45 108.956 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -160.52 141.17 11.7 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.647 0.592 . . . . 72.14 112.582 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.36 117.71 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 107.867 -1.16 . . . . 63.51 107.867 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 2.1 mp0 -84.69 -30.6 24.67 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.128 -0.463 . . . . 64.33 110.053 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -175.9 146.91 0.74 Allowed 'General case' 0 C--N 1.371 1.535 0 O-C-N 123.851 0.72 . . . . 71.04 111.046 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.838 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 96.5 mt -129.65 128.23 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.497 -1.297 . . . . 74.44 107.497 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -156.81 166.43 33.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.178 0.991 . . . . 75.13 110.656 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -92.26 119.0 31.44 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.921 -0.77 . . . . 72.44 108.921 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -82.62 -26.28 32.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.002 -0.37 . . . . 74.14 110.002 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.6 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.6 t70 -152.94 143.0 22.32 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.261 -0.881 . . . . 75.33 110.35 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.436 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 85.7 mt -138.39 140.88 39.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 C-N-CA 125.536 1.534 . . . . 72.32 106.926 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -149.15 126.68 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.753 0.658 . . . . 74.11 109.624 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.531 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 90.1 t80 -130.9 131.97 44.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.405 -1.332 . . . . 73.55 107.405 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.6 131.86 41.9 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.39 87.84 51.69 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.61 -1.256 . . . . 74.41 107.61 170.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.77 -22.76 42.74 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.672 2.248 . . . . 73.13 112.925 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -120.42 38.78 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.615 0.766 . . . . 73.24 109.448 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.412 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -59.41 -48.24 96.32 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.125 0.97 . . . . 64.23 113.055 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 10.1 Cg_exo -73.53 -42.04 0.99 Allowed 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.085 1.857 . . . . 72.03 112.266 168.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -62.8 -19.89 64.48 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.055 1.342 . . . . 73.24 112.792 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.66 -24.12 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.279 0.631 . . . . 73.1 111.814 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -54.98 -32.24 61.44 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.971 0.908 . . . . 73.32 112.698 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -86.21 -48.53 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.965 0.906 . . . . 74.22 110.359 -175.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -78.91 128.56 33.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.802 -1.09 . . . . 64.44 112.038 -169.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.56 134.75 57.31 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.482 1.113 . . . . 72.22 111.246 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.548 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 46.6 t-105 -84.49 80.46 9.22 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.906 0.754 . . . . 74.34 111.231 -173.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.92 75.92 74.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.675 -1.231 . . . . 74.05 107.675 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.01 155.96 11.33 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.745 2.296 . . . . 72.3 113.336 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.27 105.76 17.94 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.317 -1.364 . . . . 70.05 107.317 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' G' ' 189' ' ' ALA . 36.0 t -87.24 98.78 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.878 -0.416 . . . . 71.13 109.878 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 85.0 tttt -81.72 130.86 35.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.446 0.698 . . . . 75.12 109.897 175.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.549 HD23 ' HB ' ' G' ' 187' ' ' ILE . 5.7 mp -114.67 110.87 20.43 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.754 -0.832 . . . . 74.21 108.754 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.592 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.9 t70 -112.92 130.96 55.93 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.984 -1.117 . . . . 63.5 107.984 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.9 tp -117.54 131.27 56.72 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 74.42 109.307 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.68 146.74 40.03 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.945 -0.761 . . . . 71.42 108.945 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -147.55 143.13 27.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.283 -0.636 . . . . 64.44 109.283 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.54 134.11 15.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.63 0.772 . . . . 75.12 109.116 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.479 ' HG ' HG21 ' A' ' 58' ' ' VAL . 20.7 m -88.73 162.66 16.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.133 0.573 . . . . 75.22 110.556 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -149.86 141.15 23.19 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.536 1.134 . . . . 71.3 108.004 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -91.66 133.43 35.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.886 -0.413 . . . . 73.13 109.886 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.698 HD12 ' HB2' ' A' ' 57' ' ' GLU . 42.5 mt -118.43 -35.32 3.8 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.803 0.841 . . . . 74.42 109.144 171.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -147.04 179.57 7.52 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.599 -1.182 . . . . 62.43 109.848 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.11 122.89 21.74 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.27 -1.011 . . . . 72.42 108.27 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 70.77 -6.38 1.26 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.699 1.199 . . . . 75.32 112.925 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.596 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 59.5 t -105.3 111.07 33.14 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 N-CA-C 108.088 -1.078 . . . . 70.3 108.088 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -119.11 128.12 54.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 74.04 109.796 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.698 ' HB2' HD12 ' A' ' 51' ' ' LEU . 13.1 tt0 -82.66 112.22 19.34 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.326 -1.361 . . . . 72.15 107.326 166.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.479 HG21 ' HG ' ' A' ' 48' ' ' SER . 61.0 t -100.7 115.62 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.854 -1.535 . . . . 75.21 106.854 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.654 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.7 t -96.29 129.44 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.388 -0.597 . . . . 74.41 109.388 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 111.39 23.67 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.112 -1.44 . . . . 74.51 107.112 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -100.49 102.75 14.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.665 -0.865 . . . . 71.32 108.665 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.4 128.53 46.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.101 -1.074 . . . . 75.13 108.101 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.8 m -113.94 135.99 53.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.848 -0.797 . . . . 75.51 108.848 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -132.49 136.95 55.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 125.568 1.547 . . . . 62.35 107.135 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.7 m -141.63 138.3 32.46 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.99 127.56 45.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.676 -1.601 . . . . 73.34 106.676 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -139.95 131.97 27.85 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.349 0.595 . . . . 63.54 111.688 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.3 mt -89.62 78.19 7.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.577 -1.268 . . . . 73.23 107.577 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -117.04 4.36 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.081 -0.963 . . . . 65.44 111.184 -173.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -87.87 -25.22 23.39 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.522 0.729 . . . . 75.12 110.297 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -79.93 106.8 12.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.078 0.951 . . . . 70.14 109.371 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -65.62 129.92 41.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.238 0.542 . . . . 75.34 111.139 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.28 -52.94 7.11 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.592 1.157 . . . . 74.33 109.004 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -158.25 155.26 28.61 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.464 -0.789 . . . . 73.5 111.396 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.413 HD11 ' H ' ' A' ' 76' ' ' CYS . 34.7 tp -117.94 146.35 44.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.972 1.309 . . . . 75.42 108.422 170.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.574 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 80.9 m -144.93 131.12 19.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.563 1.145 . . . . 53.41 108.85 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.74 128.6 14.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.191 -0.67 . . . . 73.52 109.191 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -130.29 110.4 19.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.437 -0.949 . . . . 73.44 108.437 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.6 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.7 mt-30 -86.34 81.01 8.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.7 -0.852 . . . . 72.4 108.7 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.87 93.58 3.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.2 -1.364 . . . . 73.31 109.046 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.16 143.7 16.77 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.766 -0.534 . . . . 74.33 111.766 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.516 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -141.51 131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.044 -0.823 . . . . 74.41 111.044 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 17.3 mt -81.14 128.8 38.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 74.03 108.849 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -136.21 131.0 34.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.086 0.554 . . . . 71.34 110.699 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -83.5 119.67 24.97 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.052 -1.092 . . . . 74.02 108.052 168.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.32 122.48 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 75.23 110.096 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.17 162.95 28.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.632 0.773 . . . . 75.12 109.961 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.05 81.54 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.132 -0.485 . . . . 51.2 112.948 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.46 137.2 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.187 0.995 . . . . 61.1 109.808 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.527 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 20.2 tt0 -137.07 -179.11 5.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 73.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.527 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 48.95 -124.24 12.3 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 124.02 0.819 . . . . 63.31 114.94 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -79.11 -16.61 56.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.543 0.737 . . . . 60.14 111.608 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.69 -39.88 61.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.679 0.392 . . . . 74.42 110.369 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.05 36.61 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.299 0.24 . . . . 73.14 110.838 175.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.7 -30.01 67.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.501 . . . . 74.2 110.072 171.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.48 -44.11 45.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.86 0.864 . . . . 73.13 110.319 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.17 -63.91 1.08 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.259 0.623 . . . . 70.1 111.566 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 tt -71.12 -46.2 62.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.511 0.724 . . . . 73.53 111.031 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.69 -18.25 79.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.742 0.657 . . . . 52.5 114.742 -169.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.56 -51.78 0.69 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.578 0.689 . . . . 74.11 112.205 -172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.24 -37.29 71.98 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.328 0.651 . . . . 74.01 112.441 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.31 -45.79 13.81 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-O 118.355 -0.831 . . . . 54.01 113.028 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.78 -22.66 68.88 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 121.531 1.487 . . . . 73.14 112.578 168.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -79.38 -22.43 44.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.038 0.535 . . . . 71.25 111.79 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.72 -36.97 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.627 -0.879 . . . . 71.31 108.627 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD22 ' HA3' ' A' ' 82' ' ' GLY . 44.1 mt -85.8 -18.31 33.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.115 . . . . 73.14 112.568 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -66.25 -42.62 50.57 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-O 117.709 -1.139 . . . . 75.42 114.013 -171.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.21 -35.27 86.25 Favored 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 121.951 1.733 . . . . 74.51 112.745 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -74.07 -40.8 62.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.654 0.781 . . . . 72.55 111.343 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.22 75.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.332 0.653 . . . . 52.51 109.8 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' NH1' HG22 ' C' ' 105' ' ' ILE . 34.5 ttm180 -52.11 -55.21 22.27 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.65 1.218 . . . . 74.55 109.893 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.46 -40.65 97.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.204 0.94 . . . . 74.44 111.3 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.601 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -61.87 -35.69 79.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.983 0.513 . . . . 74.45 111.207 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.473 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 95.6 mt -72.62 -51.02 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 75.31 109.644 173.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.483 HG23 ' HG3' ' A' ' 125' ' ' GLN . 97.9 m -53.41 -37.17 62.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.318 1.447 . . . . 74.0 111.227 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.7 t -69.47 -49.65 52.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.927 -1.033 . . . . 65.54 110.118 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 60.7 mtm -57.83 -44.84 86.71 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.346 0.658 . . . . 74.31 110.984 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.73 -48.84 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.386 -1.279 . . . . 75.51 110.608 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -68.78 -29.53 67.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.744 -0.662 . . . . 73.52 111.544 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -73.93 -28.59 61.6 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.64 0.776 . . . . 73.33 110.529 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.89 10.67 51.36 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.954 0.784 . . . . 71.54 112.801 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.416 HG23 ' HB3' ' D' ' 125' ' ' GLN . 3.7 m 66.34 26.05 10.32 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.794 1.238 . . . . 75.34 110.467 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -103.33 157.73 33.23 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.019 -0.991 . . . . 75.41 108.852 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.548 ' HG3' ' HE1' ' A' ' 36' ' ' TRP . 73.1 Cg_endo -68.8 147.54 69.22 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.093 1.862 . . . . 73.22 111.744 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.483 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.4 tt0 -58.13 128.88 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 123.949 0.78 . . . . 70.35 110.878 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -108.98 101.32 10.42 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.895 -0.78 . . . . 74.3 108.895 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.428 ' HB3' HD13 ' C' ' 13' ' ' ILE . 92.4 m-20 -98.41 105.18 17.29 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.901 -0.777 . . . . 74.43 108.901 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.517 HD22 HD21 ' A' ' 42' ' ' LEU . 46.0 mt -72.96 139.12 46.51 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.537 -0.756 . . . . 74.23 109.218 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.514 ' HB1' HD13 ' H' ' 204' ' ' ILE . . . -60.03 138.03 90.97 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.667 0.604 . . . . 45.52 110.433 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.645 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 16.1 Cg_endo -76.57 96.93 1.1 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 121.611 1.541 . . . . 73.03 109.143 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.489 HG11 HG23 ' H' ' 207' ' ' VAL . 14.1 m -97.94 112.07 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.977 -1.01 . . . . 75.44 108.37 -171.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -103.91 109.98 21.94 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.797 -1.092 . . . . 65.32 108.325 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.59 -36.34 76.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.53 0.732 . . . . 74.12 111.281 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.05 -45.38 93.03 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.878 0.736 . . . . 73.01 110.441 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.51 81.42 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.995 -1.002 . . . . 53.31 110.653 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -69.81 -26.58 64.31 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 124.055 0.847 . . . . 73.05 111.481 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -70.21 -59.8 2.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.381 0.672 . . . . 73.1 109.292 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.454 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 8.3 mmt -60.35 -32.36 71.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.213 0.605 . . . . 74.12 111.033 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 56.3 t-20 -59.42 -55.23 37.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.589 1.156 . . . . 73.51 109.86 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -64.71 -37.15 86.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.458 -0.792 . . . . 74.44 110.997 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.99 -49.37 70.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.839 0.456 . . . . 75.53 110.979 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -167.95 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.795 0.665 . . . . 73.2 112.795 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 45.6 mt-30 62.04 76.14 0.38 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.41 1.084 . . . . 72.31 109.526 -165.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -101.9 107.24 18.34 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.234 -0.893 . . . . 73.0 109.486 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' C' ' 8' ' ' GLU . . . -145.25 111.96 5.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.952 0.901 . . . . 72.33 109.483 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.76 16.56 0.04 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.137 -0.483 . . . . 70.24 112.578 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.12 120.66 17.01 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.614 -0.513 . . . . 74.54 109.614 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.71 66.17 0.36 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.121 -0.49 . . . . 74.42 112.196 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 61.8 p -124.74 86.2 2.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.29 0.567 . . . . 73.3 110.545 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.61 124.82 9.41 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.004 -1.11 . . . . 74.42 108.004 166.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -161.14 -31.81 0.05 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.53 108.861 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -59.89 -39.32 84.92 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 124.098 0.874 . . . . 73.52 111.765 -169.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 44.76 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.48 1.512 . . . . 74.44 113.137 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 64.8 m-20 -69.8 -44.79 69.34 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 110.405 -0.22 . . . . 73.33 110.405 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.068 0 O-C-N 125.059 1.474 . . . . 72.11 110.877 178.801 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.674 ' SD ' ' HB3' ' D' ' 153' ' ' GLN . 27.8 ttt . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.086 0.469 . . . . 72.13 109.755 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 t -132.65 94.31 3.38 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.475 -1.306 . . . . 70.41 107.475 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.437 ' H ' ' HA ' ' D' ' 150' ' ' GLU . 15.5 mm-40 -75.37 91.29 2.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.272 -0.877 . . . . 72.05 110.847 -172.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -148.89 152.32 36.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.244 0.545 . . . . 60.33 111.173 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -116.12 69.9 0.75 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.009 -1.108 . . . . 74.25 108.009 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -142.1 168.21 20.29 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.311 -1.313 . . . . 75.02 109.477 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.567 HG22 ' HB3' ' D' ' 138' ' ' MET . 2.4 t -131.71 146.04 51.96 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.54 -1.281 . . . . 74.44 107.54 167.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -160.42 -82.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.793 -1.188 . . . . 75.2 107.793 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.488 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.7 ptm 47.78 171.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 126.5 1.92 . . . . 74.25 115.527 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -148.13 140.65 24.46 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.465 -1.243 . . . . 74.24 108.568 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.411 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 46.5 t80 -142.84 131.31 22.34 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 74.43 107.5 165.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -160.55 139.97 10.79 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.991 0.807 . . . . 75.11 110.021 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.596 HD13 HG13 ' B' ' 16' ' ' ILE . 16.9 tt -95.93 145.23 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.377 1.071 . . . . 74.32 109.836 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.18 -35.07 8.16 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 119.658 -0.21 . . . . 62.23 111.037 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -173.53 144.76 1.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.502 0.321 . . . . 75.24 111.565 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.596 HG13 HD13 ' B' ' 13' ' ' ILE . 60.9 mt -118.94 138.11 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.182 -1.414 . . . . 74.14 107.182 165.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -167.3 142.12 3.89 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.341 1.026 . . . . 75.31 109.339 -170.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.4 m -75.16 118.8 18.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.476 -0.935 . . . . 74.33 108.476 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -85.14 -34.64 22.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.824 -0.625 . . . . 72.54 110.832 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.03 145.92 15.54 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.407 0.442 . . . . 74.01 110.924 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.631 HD12 ' SG ' ' B' ' 113' ' ' CYS . 40.5 mm -135.63 142.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.431 1.092 . . . . 73.31 109.877 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -136.61 127.93 28.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.921 1.289 . . . . 72.12 108.569 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -144.38 109.5 5.07 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.873 -1.528 . . . . 73.22 106.873 165.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -123.42 113.35 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.469 -0.937 . . . . 72.05 108.469 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.33 90.02 5.36 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.662 1.185 . . . . 74.31 108.965 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.86 -25.18 53.01 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.285 1.99 . . . . 71.34 111.759 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 92.4 m-20 -121.28 31.46 6.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.441 1.097 . . . . 72.21 110.064 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.409 ' O ' HG12 ' B' ' 31' ' ' VAL . . . -46.87 -48.52 51.32 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 125.399 1.48 . . . . 71.51 113.476 172.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.05 -17.83 17.02 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.855 1.703 . . . . 74.31 113.396 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 2.0 m-70 -82.6 -1.24 50.25 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.206 0.817 . . . . 75.11 113.206 -171.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.409 HG12 ' O ' ' B' ' 28' ' ' ALA . 7.2 p -79.84 -25.99 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.239 0.542 . . . . 75.13 109.812 166.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -78.96 -32.01 45.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.489 -0.56 . . . . 75.53 109.489 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.505 ' HA ' HE21 ' B' ' 33' ' ' GLN . 0.0 OUTLIER -71.43 -45.0 63.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.146 -0.479 . . . . 75.52 110.716 177.518 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -108.08 110.46 22.14 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.234 1.014 . . . . 72.41 109.252 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -74.12 79.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.136 0.575 . . . . 71.23 111.487 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.45 ' HA ' ' HB2' ' F' ' 197' ' ' TYR . 1.7 t90 -162.15 151.09 15.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.194 -1.41 . . . . 75.55 107.194 169.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.582 ' HG3' ' HA ' ' F' ' 197' ' ' TYR . 72.9 mt-30 -92.23 133.17 30.53 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.08 0.952 . . . . 72.51 109.443 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 158.26 35.6 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.023 2.482 . . . . 74.54 113.818 -169.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.27 107.95 12.41 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.917 -0.771 . . . . 71.42 108.917 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.453 HG13 HD21 ' B' ' 126' ' ' LEU . 17.7 t -95.28 123.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.576 0.751 . . . . 75.14 109.12 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -136.85 145.31 44.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.624 0.77 . . . . 74.5 110.845 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.666 HD21 HD21 ' B' ' 128' ' ' LEU . 2.4 pt? -116.8 166.54 12.02 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.365 0.666 . . . . 74.41 111.572 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -150.14 154.35 37.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.225 1.41 . . . . 74.3 108.142 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -94.54 148.99 21.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.166 0.586 . . . . 75.32 111.106 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -141.79 154.59 45.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.855 1.262 . . . . 72.44 108.943 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 72.0 p -122.92 134.8 54.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.547 . . . . 74.51 110.468 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.34 32.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.241 -1.022 . . . . 72.1 108.241 170.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.2 p -147.93 167.7 24.18 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.801 0.334 . . . . 72.44 111.367 172.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.1 p -151.32 136.55 17.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.378 1.071 . . . . 73.34 108.69 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.84 129.69 35.12 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.471 -0.566 . . . . 63.21 109.471 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.555 HD12 HG22 ' B' ' 83' ' ' ILE . 26.9 mt -95.58 -47.21 6.32 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.442 -0.577 . . . . 75.02 109.442 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.26 -172.93 4.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.984 0.913 . . . . 74.53 110.179 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 103.07 0.3 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.09 -0.959 . . . . 74.43 110.148 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 4.9 m-20 65.38 12.82 8.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.917 1.287 . . . . 74.55 113.094 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -104.59 86.51 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 105.999 -1.852 . . . . 62.24 105.999 166.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.49 ' HE1' ' HG3' ' F' ' 174' ' ' MET . 17.1 p90 -109.39 141.6 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.877 0.846 . . . . 75.23 109.762 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -103.54 115.84 31.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.058 -1.428 . . . . 73.44 107.994 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.98 127.73 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.881 0.472 . . . . 73.35 109.784 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -102.03 115.97 44.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.168 0.987 . . . . 72.33 108.612 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.42 HD13 ' HB2' ' B' ' 106' ' ' LEU . 0.5 OUTLIER -92.14 109.6 20.96 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.8 -1.185 . . . . 75.04 107.8 178.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -99.99 126.03 46.11 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.738 -0.468 . . . . 74.41 109.738 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.4 t -118.25 126.83 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.153 -1.055 . . . . 74.35 108.153 171.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 29.1 m -97.13 149.64 21.75 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.548 0.739 . . . . 73.14 109.147 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.512 HG22 HG21 ' B' ' 114' ' ' ILE . 55.6 t -135.33 132.73 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.266 1.026 . . . . 73.23 109.358 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -124.16 139.22 54.14 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.444 -0.947 . . . . 74.45 108.444 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.38 149.63 36.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.797 0.839 . . . . 64.44 109.072 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.439 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.7 p -144.95 132.65 21.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.367 0.877 . . . . 74.1 113.367 -174.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 27.6 mt -95.6 104.73 16.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.151 1.38 . . . . 74.21 108.495 173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.75 -103.38 1.11 Allowed Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.042 -1.075 . . . . 72.44 111.18 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.18 3.55 11.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.47 1.508 . . . . 65.32 111.799 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.425 ' HB3' ' HG3' ' C' ' 153' ' ' GLN . 23.7 pt-20 -116.29 161.49 18.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.978 0.511 . . . . 63.43 111.15 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -77.65 113.28 15.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.066 0.547 . . . . 75.03 110.554 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -68.25 -59.39 3.24 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.872 -0.788 . . . . 73.33 108.872 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.02 168.47 27.15 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.117 -0.947 . . . . 73.44 111.425 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -130.39 113.28 14.14 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.743 -1.577 . . . . 64.33 106.743 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -118.11 153.14 34.27 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.893 -0.78 . . . . 74.12 108.893 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.82 132.8 3.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.88 144.07 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.709 0.803 . . . . 75.12 109.065 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -121.75 84.35 2.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.509 -0.923 . . . . 63.52 108.509 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.26 99.88 9.57 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 114.716 -1.129 . . . . 74.52 108.835 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.69 159.75 26.05 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.809 -0.517 . . . . 65.41 111.809 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.62 129.27 2.02 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.09 -0.804 . . . . 74.23 111.09 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.555 HG22 HD12 ' B' ' 51' ' ' LEU . 39.3 mt -86.64 130.71 36.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 N-CA-C 109.381 -0.6 . . . . 74.2 109.381 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -131.37 146.19 52.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.23 0.538 . . . . 73.21 110.205 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -127.92 112.83 15.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.883 1.273 . . . . 72.21 108.354 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.52 HD12 ' SD ' ' F' ' 174' ' ' MET . 5.1 tt -139.48 140.54 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.638 0.775 . . . . 73.43 110.476 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 173.52 16.87 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.745 0.418 . . . . 74.31 111.532 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.566 ' H ' ' HB1' ' F' ' 172' ' ' ALA . . . 95.59 -69.59 1.03 Allowed Glycine 0 C--N 1.351 1.392 0 C-N-CA 124.023 0.82 . . . . 71.23 112.886 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.437 HD11 HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -74.51 169.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.627 0.771 . . . . 75.25 111.559 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.88 -171.93 2.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.178 0.591 . . . . 73.05 111.552 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.47 -105.81 1.62 Allowed Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.13 -0.941 . . . . 75.04 112.837 172.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -77.73 -33.07 53.09 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 75.03 110.828 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -75.74 -38.85 58.11 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.184 0.593 . . . . 71.02 111.321 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptm -67.91 -34.43 76.62 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 120.871 0.367 . . . . 74.45 110.323 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.13 80.23 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.825 0.85 . . . . 75.53 110.899 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -71.32 -30.22 65.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.041 -0.981 . . . . 74.22 110.93 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' B' ' 102' ' ' CYS . 45.7 t -65.62 -69.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.169 0.293 . . . . 72.13 110.935 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.86 -19.78 60.62 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 111.928 0.344 . . . . 74.33 111.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.95 -25.65 44.32 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.574 0.546 . . . . 64.22 114.033 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -47.16 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.165 0.802 . . . . 75.31 113.165 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.03 -49.14 20.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.067 0.547 . . . . 74.25 111.955 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.437 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 80.4 m -60.45 -46.97 97.48 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.964 0.905 . . . . 75.2 111.91 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.76 -30.9 49.65 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 121.229 1.286 . . . . 70.53 112.951 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.83 -27.7 68.44 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.747 0.703 . . . . 75.21 111.22 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.51 -43.61 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 71.11 110.192 171.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HB2' HD13 ' B' ' 60' ' ' LEU . 41.0 mt -84.76 -14.54 47.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.09 0.956 . . . . 75.44 111.784 -174.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.565 ' HZ ' HD13 ' B' ' 128' ' ' LEU . 33.7 t80 -60.19 -47.26 97.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.063 1.345 . . . . 75.23 113.192 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.522 ' HB2' ' HB2' ' D' ' 112' ' ' GLU . 18.6 Cg_endo -58.06 -35.97 98.34 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.06 1.84 . . . . 74.4 113.706 174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 65.4 m-85 -69.7 -46.14 66.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 75.51 110.802 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.693 0.797 . . . . 71.21 110.345 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.452 HH11 ' HA ' ' B' ' 108' ' ' PRO . 33.4 mtp180 -50.48 -54.94 18.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.43 1.092 . . . . 75.33 110.789 173.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.8 -33.85 76.53 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.982 -1.008 . . . . 70.11 110.681 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.631 ' SG ' HD12 ' B' ' 21' ' ' ILE . 5.6 t -72.88 -41.15 65.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.098 0.559 . . . . 64.14 111.259 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' B' ' 62' ' ' VAL . 52.7 mt -65.6 -48.14 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.869 . . . . 74.23 108.652 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -51.51 -35.97 42.63 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 124.536 1.148 . . . . 63.01 111.177 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.9 t -69.24 -55.03 11.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.626 0.77 . . . . 62.21 110.826 175.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.474 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 18.0 mmt -65.67 -33.37 75.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.016 0.526 . . . . 72.32 111.901 -172.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.53 -41.42 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.055 0.942 . . . . 75.41 110.374 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.481 ' HB3' HE22 ' C' ' 125' ' ' GLN . 90.0 p -70.1 -26.05 63.79 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.27 0.557 . . . . 73.51 112.149 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.601 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 80.1 mtt-85 -68.6 -34.01 75.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.365 -0.834 . . . . 70.44 110.441 175.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.6 13.09 54.11 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.847 0.717 . . . . 72.43 112.738 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.25 42.21 12.32 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.554 1.942 . . . . 71.22 112.497 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.591 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 71.3 m-85 -120.32 172.78 4.27 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 114.167 -1.378 . . . . 75.1 109.333 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 85.3 Cg_endo -73.08 -167.55 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.965 2.444 . . . . 74.41 116.107 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -66.89 155.58 38.02 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.758 -1.564 . . . . 73.3 111.054 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' B' ' 42' ' ' LEU . 3.4 tm? -135.23 84.91 2.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.974 -2.232 . . . . 74.32 104.974 163.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -123.58 95.4 4.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.287 -1.375 . . . . 74.25 107.287 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.666 HD21 HD21 ' B' ' 42' ' ' LEU . 2.7 tm? -64.29 145.38 56.11 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.17 -0.923 . . . . 73.52 109.863 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.46 110.6 2.12 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 124.633 1.208 . . . . 74.22 110.426 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.643 ' HB2' HD12 ' D' ' 16' ' ' ILE . 10.3 Cg_exo -65.61 132.67 31.64 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.152 1.901 . . . . 73.24 110.319 -173.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.63 137.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.061 -0.348 . . . . 75.43 110.061 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -87.07 117.73 25.99 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.801 0.841 . . . . 71.21 109.015 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.472 ' HZ ' ' HB2' ' F' ' 182' ' ' PHE . 47.3 t80 -61.06 -16.45 43.96 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.531 1.132 . . . . 73.21 113.1 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.457 ' O ' ' HG2' ' B' ' 138' ' ' MET . 7.1 m-20 -55.06 -36.41 65.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.968 0.507 . . . . 73.42 112.011 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.22 -49.25 64.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.956 0.902 . . . . 63.23 111.837 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.05 -43.92 95.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.181 -0.918 . . . . 73.43 110.092 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -67.21 -35.85 80.47 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.725 -1.125 . . . . 72.51 111.092 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.457 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 24.6 mmt -65.69 -37.6 86.92 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.909 0.484 . . . . 75.23 110.147 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -76.4 -17.61 59.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.612 0.765 . . . . 74.43 112.076 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -73.18 -30.98 63.94 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.149 0.58 . . . . 75.01 110.977 178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.19 12.96 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.534 0.734 . . . . 75.11 111.255 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' B' ' 138' ' ' MET . 8.7 tt0 -96.47 142.91 27.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.423 0.689 . . . . 65.22 111.471 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -136.11 172.32 13.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.882 0.873 . . . . 74.24 109.485 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.51 ' HA ' ' HG2' ' D' ' 8' ' ' GLU . 4.8 pm0 -157.32 140.69 15.57 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.465 0.706 . . . . 75.23 110.011 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.92 18.09 0.1 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.608 0.763 . . . . 73.2 111.079 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.0 -147.8 22.83 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.338 -0.392 . . . . 72.04 113.631 -176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -141.63 144.33 34.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.803 0.841 . . . . 72.31 109.896 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 113.64 3.95 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.323 -1.111 . . . . 73.45 110.323 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' D' ' 4' ' ' GLN . 18.4 p -72.24 -177.92 2.3 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.917 0.487 . . . . 73.32 110.883 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.914 -0.491 . . . . 75.3 110.174 -169.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.18 93.79 0.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 106.718 -1.586 . . . . 60.15 106.718 168.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -132.11 64.65 1.59 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.899 -0.778 . . . . 73.14 108.899 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.9 92.51 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.268 -1.382 . . . . 70.44 107.268 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.74 -175.38 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.774 0.83 . . . . 75.44 110.238 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 N-CA-C 109.213 -0.662 . . . . 61.13 109.213 175.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.4 ' H3 ' ' HB2' ' A' ' 9' ' ' MET . 14.7 tpt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 108.433 -0.951 . . . . 74.25 108.433 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m 63.27 78.81 0.28 Allowed 'General case' 0 C--N 1.353 0.755 0 O-C-N 124.449 1.093 . . . . 71.23 109.11 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.77 -31.65 69.71 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.882 -1.054 . . . . 74.54 110.87 -172.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -67.8 92.85 0.36 Allowed 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 122.128 0.966 . . . . 71.11 109.916 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -91.88 -65.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.573 -0.899 . . . . 61.31 108.573 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -167.38 52.3 0.07 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.205 -1.406 . . . . 73.42 107.205 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -128.89 136.43 50.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.811 . . . . 75.12 110.813 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.553 ' HB3' ' HB3' ' A' ' 145' ' ' ALA . 43.6 tt0 -144.08 -77.28 0.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.975 0.91 . . . . 65.43 108.55 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.411 ' HG2' ' HB2' ' C' ' 97' ' ' CYS . 4.3 mpp? 59.53 114.97 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.125 1.37 . . . . 75.01 111.432 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.9 m -116.68 93.99 4.43 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.764 -0.653 . . . . 71.42 109.743 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.506 ' CE1' ' SG ' ' C' ' 102' ' ' CYS . 0.5 OUTLIER -120.91 163.53 18.08 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 116.04 -0.527 . . . . 73.42 109.79 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -136.12 129.76 32.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.005 -0.998 . . . . 74.53 108.993 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 127' ' ' ASN . 17.7 tt -66.19 137.79 24.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.253 1.021 . . . . 72.24 110.178 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.524 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 92.0 mm-40 -111.79 -45.45 3.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.202 -0.454 . . . . 64.15 110.101 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.56 HH22 ' HD1' ' H' ' 197' ' ' TYR . 18.9 ttt180 -174.98 142.02 0.62 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.604 0.565 . . . . 75.22 110.974 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.22 138.21 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.771 -1.196 . . . . 74.51 107.771 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.413 ' HE2' ' HB2' ' D' ' 28' ' ' ALA . 30.6 p90 -171.46 161.51 6.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.318 0.58 . . . . 71.34 110.95 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -86.36 105.0 16.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.03 -0.986 . . . . 74.32 109.01 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -67.46 -46.64 72.43 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.754 0.787 . . . . 74.32 109.426 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.4 t70 -136.12 145.25 45.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.224 -1.353 . . . . 53.11 109.441 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.7 mt -140.3 144.31 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.292 -1.373 . . . . 73.02 107.292 175.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.4 t -152.71 145.73 24.54 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.337 0.589 . . . . 72.01 110.198 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -149.15 120.79 8.03 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.373 -1.343 . . . . 71.14 107.373 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -126.01 124.11 39.98 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.482 -0.932 . . . . 71.55 108.482 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.39 89.72 10.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.172 -1.047 . . . . 72.33 108.172 174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.88 -31.41 93.75 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.473 2.782 . . . . 62.43 112.926 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 87.2 m-20 -119.04 36.03 4.61 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 114.53 -1.214 . . . . 73.45 109.668 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.79 -48.6 77.0 Favored Pre-proline 0 CA--C 1.572 1.82 0 N-CA-C 114.213 1.19 . . . . 75.15 114.213 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.37 -29.54 1.46 Allowed 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.782 1.655 . . . . 53.35 113.069 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.444 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 41.3 t60 -69.59 -31.36 69.47 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.803 1.241 . . . . 72.22 112.328 -171.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.573 HG21 HD11 ' C' ' 68' ' ' LEU . 12.8 p -79.66 -19.3 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.836 1.254 . . . . 74.13 112.074 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.34 -39.24 69.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.01 0.924 . . . . 75.12 112.518 -171.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -113.41 45.95 1.33 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.941 0.877 . . . . 72.21 109.389 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.418 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.9 OUTLIER -121.6 167.71 12.58 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.298 -0.631 . . . . 73.05 109.298 -178.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.15 116.97 4.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.911 -0.774 . . . . 74.2 108.911 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -84.8 68.9 10.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.788 0.68 . . . . 74.05 111.428 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -140.59 79.33 20.11 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.508 0.723 . . . . 74.1 109.512 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.613 ' HD2' ' HB2' ' E' ' 193' ' ' TYR . 3.9 Cg_exo -79.45 135.81 12.07 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.437 2.091 . . . . 73.43 109.963 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.56 118.74 24.01 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.003 -1.11 . . . . 64.14 108.003 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.617 HG13 HD22 ' C' ' 128' ' ' LEU . 24.7 t -65.46 95.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.095 1.497 . . . . 72.1 108.822 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 0.5 OUTLIER -110.95 116.13 30.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.241 -1.022 . . . . 74.02 108.241 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.62 137.54 54.87 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.107 -1.071 . . . . 75.54 108.107 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -147.81 145.44 28.75 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.328 0.651 . . . . 73.11 109.398 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.583 ' HB2' HD22 ' E' ' 186' ' ' LEU . 48.7 tp -113.6 132.56 55.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 64.32 110.275 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.685 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 4.3 m-20 -114.65 134.77 54.81 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 106.869 -1.53 . . . . 73.23 106.869 171.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -114.2 132.12 56.22 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.943 0.402 . . . . 73.34 110.391 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.06 147.15 45.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.984 0.914 . . . . 64.14 108.982 173.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -139.6 144.01 37.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.473 0.709 . . . . 74.11 109.805 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -146.23 134.26 21.48 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.832 0.853 . . . . 74.11 109.407 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -74.94 147.5 40.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.468 -0.938 . . . . 74.4 108.468 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.48 HD13 HD13 ' C' ' 83' ' ' ILE . 86.5 mt -118.25 -37.57 3.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.849 0.86 . . . . 74.43 110.401 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.39 -168.8 1.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.155 0.582 . . . . 73.13 110.858 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.47 116.26 5.41 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.197 -0.91 . . . . 73.41 109.419 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.65 ' HA ' HD22 ' E' ' 173' ' ' LEU . 20.2 m-20 62.09 18.11 9.71 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 124.549 1.14 . . . . 71.11 112.324 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.459 HG11 ' HB2' ' C' ' 51' ' ' LEU . 67.8 t -120.86 107.47 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.567 0.747 . . . . 71.23 109.299 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.89 161.53 14.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.847 0.832 . . . . 73.13 110.757 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -127.82 126.1 41.03 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.412 -1.722 . . . . 74.33 107.673 169.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 123.38 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.332 -0.618 . . . . 74.24 109.332 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.67 111.44 34.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.36 1.064 . . . . 73.52 108.668 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.99 100.01 12.3 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.055 -0.72 . . . . 74.02 109.055 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 41.2 ttm180 -82.33 100.09 9.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.85 -1.537 . . . . 74.14 106.85 171.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.5 t -103.16 113.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.495 -1.298 . . . . 71.43 107.495 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.8 m -118.71 131.52 56.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.883 -0.598 . . . . 72.43 110.106 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.576 HG21 HG21 ' C' ' 114' ' ' ILE . 55.2 t -114.89 131.39 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.668 1.187 . . . . 72.23 110.242 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 9.4 m -110.22 146.58 35.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 164.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 110.74 8.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.677 -1.231 . . . . 74.33 107.677 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -135.19 133.34 38.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.364 0.602 . . . . 74.02 111.449 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.573 HD11 HG21 ' C' ' 31' ' ' VAL . 4.0 mt -85.5 14.58 5.37 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 125.195 1.398 . . . . 75.41 110.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.75 -96.28 0.48 Allowed Glycine 0 C--N 1.35 1.357 0 N-CA-C 110.505 -1.038 . . . . 74.15 110.505 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.32 -25.77 15.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.23 1.012 . . . . 73.11 109.55 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.418 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.4 tp10 -87.71 116.94 26.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.211 1.004 . . . . 75.43 108.523 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -86.31 129.36 34.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.477 0.581 . . . . 73.21 110.256 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.66 -52.78 9.01 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.76 0.824 . . . . 74.12 109.843 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -163.39 175.13 11.11 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.553 0.692 . . . . 75.15 111.391 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.47 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -133.1 146.77 51.94 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.503 -1.666 . . . . 74.32 106.503 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.472 ' SG ' HG22 ' C' ' 114' ' ' ILE . 46.5 t -150.99 150.82 31.23 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.312 -0.625 . . . . 75.02 109.312 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.27 140.45 10.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.952 0.501 . . . . 62.4 109.929 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -135.35 134.05 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.344 -0.984 . . . . 73.41 108.344 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -109.63 92.68 4.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.088 -0.708 . . . . 75.04 109.088 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -81.21 107.32 13.9 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.556 -1.202 . . . . 74.13 109.934 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.63 145.35 18.3 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.449 -0.661 . . . . 70.52 111.449 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.22 117.24 0.98 Allowed Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.069 -0.812 . . . . 71.35 111.069 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.524 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 6.7 mm -86.53 126.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 N-CA-C 108.843 -0.799 . . . . 74.25 108.843 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -136.68 122.6 20.1 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.442 -0.947 . . . . 75.34 108.442 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -76.74 96.58 4.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.753 -0.832 . . . . 71.35 108.753 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.493 HD11 ' HE2' ' C' ' 94' ' ' MET . 2.7 pp -96.45 136.02 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.327 1.051 . . . . 73.41 111.131 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.42 -169.35 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.64 0.776 . . . . 74.31 110.018 172.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.39 -60.11 0.69 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.93 -0.468 . . . . 72.21 111.93 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.554 HD11 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -100.55 -167.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.337 1.055 . . . . 64.22 112.356 -171.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 174.57 11.89 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.09 0.956 . . . . 74.22 110.132 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.85 -120.0 8.43 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.583 1.393 . . . . 61.53 116.583 163.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -26.2 61.75 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.26 1.024 . . . . 74.11 111.763 -173.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -36.94 72.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.413 -0.958 . . . . 71.24 108.413 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.541 ' SD ' ' HB2' ' C' ' 98' ' ' LEU . 34.7 tpp -71.14 -44.81 64.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.175 -0.92 . . . . 73.13 110.064 169.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.16 -29.19 70.18 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.223 0.609 . . . . 73.03 112.21 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -83.01 -45.29 14.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.29 0.636 . . . . 74.33 110.309 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.411 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 53.5 t -66.55 -60.4 2.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.487 -0.779 . . . . 74.55 110.18 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.541 ' HB2' ' SD ' ' C' ' 94' ' ' MET . 14.6 tp -64.84 -21.42 66.79 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.605 1.162 . . . . 74.12 111.329 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.87 -29.54 38.21 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.99 -0.55 . . . . 75.42 114.379 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.6 -42.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.765 0.782 . . . . 73.24 112.767 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.645 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 63.9 t80 -71.21 -49.39 43.95 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.177 0.591 . . . . 73.4 112.13 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.521 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 22.0 m -61.96 -47.97 89.84 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 123.053 0.541 . . . . 73.11 110.782 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 79.6 Cg_exo -56.11 -37.25 96.7 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 122.1 1.867 . . . . 72.13 114.429 169.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.47 -27.79 69.22 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.841 0.456 . . . . 72.44 111.254 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.442 HG22 ' NH1' ' A' ' 111' ' ' ARG . 43.6 mm -65.39 -46.55 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.722 -0.672 . . . . 75.22 109.831 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.465 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.6 mt -79.89 -24.18 41.35 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.088 -0.96 . . . . 73.42 112.351 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.57 -50.57 86.15 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-O 117.592 -1.195 . . . . 74.15 113.608 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.65 -32.6 93.43 Favored 'Trans proline' 0 C--N 1.384 2.422 0 CA-C-N 121.589 1.603 . . . . 73.31 112.96 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -65.54 -47.63 75.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.12 0.568 . . . . 75.51 110.519 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.67 96.58 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.895 0.878 . . . . 74.43 111.166 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -62.89 -52.64 62.29 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.464 1.506 . . . . 74.0 110.123 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -68.98 -27.49 65.76 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.673 0.608 . . . . 72.11 110.441 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -64.42 -51.18 64.48 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.941 -0.392 . . . . 74.42 109.941 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.576 HG21 HG21 ' C' ' 64' ' ' VAL . 63.5 mt -61.54 -49.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 123.431 0.457 . . . . 75.34 110.104 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -43.81 -45.07 7.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.121 1.369 . . . . 75.34 111.493 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -68.14 -51.69 43.19 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 113.561 -1.654 . . . . 53.42 110.703 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.573 ' HE1' HD12 ' D' ' 21' ' ' ILE . 13.8 mmm -57.49 -40.35 78.44 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.951 0.9 . . . . 72.52 112.245 -173.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.544 HG22 ' HB2' ' C' ' 126' ' ' LEU . 98.9 t -64.78 -44.73 96.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.128 -0.942 . . . . 71.22 110.782 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.3 t -66.16 -26.56 67.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.059 -0.973 . . . . 73.35 111.021 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.1 mtt-85 -68.41 -32.74 72.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.769 0.828 . . . . 71.04 110.541 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 9.75 67.49 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 115.856 -0.611 . . . . 53.33 113.014 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.446 HG22 ' HB3' ' D' ' 17' ' ' TYR . 6.3 p 61.93 24.31 14.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.449 1.9 . . . . 73.44 113.122 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.89 158.7 32.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 109.208 -0.664 . . . . 75.35 109.208 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.75 115.98 2.9 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.331 2.021 . . . . 72.54 110.556 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.481 HE22 ' HB3' ' B' ' 119' ' ' SER . 3.4 pt20 -45.91 147.29 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.705 1.253 . . . . 70.35 112.591 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.544 ' HB2' HG22 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -98.32 76.23 2.3 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.513 -0.921 . . . . 72.44 108.513 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -110.52 89.43 3.03 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.701 -1.222 . . . . 71.14 107.701 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.617 HD22 HG13 ' C' ' 40' ' ' VAL . 30.4 mt -84.68 151.94 24.11 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.656 0.741 . . . . 72.32 110.248 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.521 ' HB1' ' HB ' ' F' ' 204' ' ' ILE . . . -60.59 156.02 46.26 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 112.858 -1.974 . . . . 63.21 113.071 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.838 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 38.3 Cg_endo -60.52 125.1 16.5 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 124.138 3.225 . . . . 75.44 113.956 -173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.03 111.69 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.304 0.642 . . . . 64.32 110.364 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -115.73 108.43 16.35 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.501 1.121 . . . . 72.21 109.162 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -52.49 -40.75 62.73 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.784 0.834 . . . . 74.11 112.488 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.38 -34.82 74.43 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.119 0.887 . . . . 75.52 110.419 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.69 75.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 74.21 111.062 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.413 HD11 ' HB ' ' F' ' 207' ' ' VAL . 10.4 tt -61.11 -38.4 86.19 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.632 0.773 . . . . 72.11 110.298 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -70.96 -42.38 69.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.701 0.801 . . . . 75.31 110.823 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 68.1 mtt -74.3 -29.69 61.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.503 0.721 . . . . 74.44 111.439 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -70.38 -37.13 74.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.999 0.92 . . . . 72.41 109.324 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -161.61 0.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.383 -0.826 . . . . 74.42 109.864 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 45.11 30.01 0.56 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.343 0.657 . . . . 74.44 111.703 -170.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.59 HE21 ' HB2' ' C' ' 144' ' ' GLN . 54.2 tt0 175.72 154.26 0.17 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.144 1.377 . . . . 73.13 108.937 -171.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 112.83 12.83 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.617 -1.623 . . . . 70.25 106.617 167.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.59 ' HB2' HE21 ' C' ' 142' ' ' GLN . 27.7 tt0 -127.65 131.48 49.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.281 0.632 . . . . 73.21 109.841 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.19 41.47 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.496 0.719 . . . . 62.41 110.742 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.15 178.21 22.68 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 111.458 -0.657 . . . . 43.1 111.458 173.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.45 127.48 22.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.895 0.478 . . . . 72.3 109.966 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.98 161.04 30.24 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.876 0.735 . . . . 71.05 112.663 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -138.71 176.05 9.03 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 72.31 111.147 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.73 -28.93 9.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.875 0.87 . . . . 75.42 110.003 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.93 -134.35 1.1 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.936 1.294 . . . . 64.43 109.183 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.92 140.92 31.35 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.21 0.914 . . . . 72.31 110.839 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.425 ' HG3' ' HB3' ' B' ' 71' ' ' GLU . 2.1 mp0 -62.97 101.72 0.3 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.521 1.128 . . . . 74.13 109.709 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.17 -46.73 76.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.603 0.761 . . . . 74.13 110.398 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.864 0 CA-C-N 114.98 -1.009 . . . . 72.15 110.4 177.454 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 122.355 1.074 . . . . 71.51 109.989 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -163.87 -168.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.588 -1.187 . . . . 72.14 108.394 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -75.57 123.62 25.8 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.358 0.663 . . . . 65.11 110.38 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.58 ' HG2' ' H ' ' D' ' 5' ' ' ASN . 25.5 tt0 -178.21 -156.37 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 106.5 -1.667 . . . . 72.34 106.5 173.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.58 ' H ' ' HG2' ' D' ' 4' ' ' GLN . 1.4 p-10 -68.54 79.91 0.27 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 119.253 0.933 . . . . 72.45 110.711 172.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -73.76 128.61 35.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.587 -0.894 . . . . 72.41 108.587 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -70.25 138.24 51.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 110.044 -0.354 . . . . 75.22 110.044 -170.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.51 ' HG2' ' HA ' ' B' ' 144' ' ' GLN . 5.5 mp0 64.52 84.74 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.055 1.342 . . . . 74.05 109.644 -165.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.425 ' HG3' HG21 ' D' ' 89' ' ' ILE . 8.8 ttp -30.32 127.5 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.187 1.395 . . . . 75.34 113.519 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.1 m -106.82 137.62 44.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.143 -1.058 . . . . 72.43 108.143 167.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.406 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 48.3 t80 -157.9 99.08 1.67 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.698 -1.223 . . . . 73.2 107.698 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.46 157.58 46.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.248 -1.019 . . . . 64.34 108.248 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.691 HG12 HD11 ' D' ' 16' ' ' ILE . 6.7 tp -98.18 140.5 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 123.197 0.599 . . . . 72.54 110.439 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -106.9 -33.04 7.65 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.579 0.752 . . . . 75.33 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -173.07 142.78 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 119.418 -0.325 . . . . 73.43 110.819 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.691 HD11 HG12 ' D' ' 13' ' ' ILE . 3.6 mp -121.11 130.12 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.291 -1.374 . . . . 74.44 107.291 171.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.446 ' HB3' HG22 ' C' ' 122' ' ' THR . 10.3 p90 -155.75 160.63 40.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.598 0.759 . . . . 72.53 110.679 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' THR . . . . . 0.423 HG22 HD11 ' D' ' 21' ' ' ILE . 60.9 p -86.43 118.31 25.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 71.31 109.567 172.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -86.88 -31.12 20.92 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.3 -0.409 . . . . 75.44 110.397 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.6 t70 -149.79 135.08 18.16 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.173 -0.921 . . . . 65.34 108.956 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.573 HD12 ' HE1' ' C' ' 117' ' ' MET . 84.3 mt -135.53 139.06 47.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.912 -1.144 . . . . 53.15 107.912 175.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -142.66 131.5 22.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.823 0.849 . . . . 71.23 108.755 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.497 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.8 t80 -134.4 117.52 16.41 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.162 -1.792 . . . . 74.42 106.162 167.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.4 122.95 32.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.311 0.644 . . . . 64.31 109.753 -170.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.05 88.81 18.11 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.595 -0.891 . . . . 71.15 108.595 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.67 -37.14 12.86 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.869 2.379 . . . . 72.32 113.243 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -112.4 35.03 3.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.935 -0.765 . . . . 73.54 108.935 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.413 ' HB2' ' HE2' ' C' ' 17' ' ' TYR . . . -44.83 -64.36 0.88 Allowed Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.973 1.471 . . . . 64.41 114.973 -163.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 83' ' ' ILE . 81.6 Cg_endo -78.15 -9.43 16.54 Favored 'Trans proline' 0 C--N 1.381 2.279 0 CA-C-N 122.3 1.857 . . . . 75.22 113.14 -176.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -84.45 -38.68 19.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 74.32 110.599 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.667 HG23 ' HA ' ' D' ' 73' ' ' ALA . 8.3 p -81.66 -12.29 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.979 0.418 . . . . 63.41 111.414 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.84 -7.57 53.86 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.257 0.465 . . . . 73.03 112.257 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.39 -20.8 59.93 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.513 0.725 . . . . 75.41 110.653 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.94 76.01 10.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.853 1.261 . . . . 71.05 110.083 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -84.96 67.89 10.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.152 0.977 . . . . 63.03 111.578 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -147.4 -179.43 6.84 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.634 1.174 . . . . 74.44 108.553 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -66.65 122.1 80.46 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.673 0.389 . . . . 70.55 111.444 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.474 ' HG3' HD22 ' D' ' 68' ' ' LEU . 7.7 Cg_exo -75.75 133.75 15.84 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.281 2.654 . . . . 72.25 111.631 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' H' ' 189' ' ' ALA . 57.4 tt0 -88.66 132.39 34.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.704 -0.48 . . . . 73.31 109.704 172.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.89 140.07 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.785 0.834 . . . . 74.12 110.004 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.493 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 75.2 mmtt -116.0 112.92 22.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.49 1.116 . . . . 64.04 108.033 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.721 HD23 HD21 ' D' ' 128' ' ' LEU . 10.0 mp -95.79 119.79 34.92 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.478 -0.564 . . . . 73.05 109.478 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -113.17 141.75 46.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.236 -1.024 . . . . 74.13 108.236 173.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -118.61 130.96 56.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.473 0.709 . . . . 73.33 110.142 -171.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.6 t70 -139.23 146.14 40.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.079 0.952 . . . . 65.14 108.687 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 49.0 m -141.86 143.98 33.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.63 -0.878 . . . . 75.04 108.63 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.97 162.96 38.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.065 0.946 . . . . 64.24 108.806 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -151.87 155.65 38.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.492 0.317 . . . . 51.4 111.535 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.0 p -155.37 126.92 7.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.63 1.172 . . . . 63.41 109.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.51 123.55 24.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.622 0.769 . . . . 70.34 111.121 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' D' ' 57' ' ' GLU . 60.6 mt -90.63 -33.52 15.81 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.328 0.393 . . . . 74.23 110.588 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.17 -170.11 0.94 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.06 0.544 . . . . 74.24 111.82 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.22 121.99 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.825 0.85 . . . . 74.14 110.043 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 64.42 4.33 2.18 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.346 1.458 . . . . 74.44 112.212 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.04 124.82 67.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.93 0.892 . . . . 64.22 108.833 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.74 128.98 23.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.735 -1.209 . . . . 74.53 107.735 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.43 ' HB2' HD12 ' D' ' 51' ' ' LEU . 16.8 tt0 -92.54 129.99 38.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.171 -1.048 . . . . 70.23 108.171 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.77 124.85 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.179 -1.045 . . . . 75.31 108.179 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.597 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -100.53 142.14 16.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.373 0.669 . . . . 74.45 109.594 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.44 120.91 39.58 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.932 -1.136 . . . . 74.4 107.932 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.4 ttm-85 -104.25 101.02 10.75 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.629 -0.878 . . . . 74.51 108.629 174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -92.29 107.35 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.167 -1.049 . . . . 73.15 108.167 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 35.4 m -97.23 137.21 36.59 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.597 -0.728 . . . . 73.45 109.228 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 67.5 t -128.94 127.37 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.857 -1.164 . . . . 73.13 107.857 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 86.7 m -125.96 105.72 9.11 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.395 -0.965 . . . . 75.41 108.395 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.51 142.15 35.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.419 -0.809 . . . . 74.43 108.973 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.6 m -145.25 132.78 20.83 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.659 0.599 . . . . 64.44 111.229 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.474 HD22 ' HG3' ' D' ' 38' ' ' PRO . 13.8 mt -106.24 112.67 25.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.466 -1.243 . . . . 74.25 109.458 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.94 -113.57 4.61 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.263 -0.426 . . . . 71.25 112.085 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 3.99 18.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.169 0.587 . . . . 74.43 111.452 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -121.36 161.69 21.66 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.732 0.413 . . . . 73.31 110.124 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -78.12 125.11 28.87 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.206 0.603 . . . . 73.11 110.624 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.667 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -75.09 -64.14 1.12 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.822 0.849 . . . . 61.32 109.124 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -155.42 164.35 38.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.596 -0.729 . . . . 65.44 111.435 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.22 110.08 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.978 -1.489 . . . . 73.32 106.978 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.541 ' SG ' HG22 ' D' ' 114' ' ' ILE . 45.2 t -122.12 116.37 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.241 -0.651 . . . . 70.42 109.241 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -144.07 125.88 15.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.201 0.6 . . . . 73.25 109.82 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 84.4 t -127.75 116.22 42.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.742 0.817 . . . . 72.43 109.569 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.685 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.5 mt-30 -89.52 86.71 6.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.896 0.855 . . . . 74.32 109.232 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -80.25 100.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.056 -1.429 . . . . 74.23 109.56 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.597 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.79 144.36 17.13 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.922 -0.471 . . . . 73.01 111.922 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.16 139.28 9.12 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.711 -0.556 . . . . 75.43 111.711 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.81 127.71 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.161 -1.052 . . . . 75.11 108.161 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.17 153.33 41.7 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.844 0.857 . . . . 74.32 110.09 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -107.44 94.1 4.91 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.973 -1.121 . . . . 73.44 107.973 169.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tt -116.31 137.33 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.97 0.908 . . . . 72.54 110.079 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.17 155.76 11.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.051 0.94 . . . . 74.52 110.305 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.44 ' H ' HD21 ' H' ' 173' ' ' LEU . . . 76.47 22.36 73.08 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 116.602 1.401 . . . . 75.31 116.602 167.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.468 HD11 ' HG2' ' D' ' 94' ' ' MET . 0.9 OUTLIER -121.16 152.22 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.281 0.632 . . . . 63.24 110.704 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -161.65 164.79 29.03 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 114.854 -1.066 . . . . 75.41 109.699 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.38 -129.2 36.86 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.443 -0.799 . . . . 74.13 113.362 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -70.96 -31.51 68.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.244 1.018 . . . . 73.32 111.635 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -70.73 -34.7 72.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 74.22 110.437 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.468 ' HG2' HD11 ' D' ' 89' ' ' ILE . 1.1 tmt? -74.57 -29.58 61.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.025 0.53 . . . . 73.31 110.22 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -38.89 91.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.285 0.634 . . . . 75.1 110.782 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.4 -29.07 41.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.247 -0.888 . . . . 75.33 111.313 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -78.6 -53.12 7.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.636 0.375 . . . . 65.12 111.027 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.566 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 52.8 tp -92.11 -48.28 6.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.109 0.564 . . . . 74.44 110.89 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.53 -14.13 82.3 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.403 0.44 . . . . 71.02 113.875 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.83 -55.88 1.06 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.877 0.471 . . . . 70.22 111.589 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -75.68 -37.03 59.9 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.908 0.707 . . . . 72.22 112.908 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 73.6 m -59.08 -52.9 71.47 Favored Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 118.851 -0.595 . . . . 73.4 111.441 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.65 -23.41 49.26 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.81 1.673 . . . . 73.51 113.221 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.59 -37.81 85.69 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.745 0.418 . . . . 74.44 110.785 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -61.31 -43.02 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.596 0.758 . . . . 75.21 110.177 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.5 mt -79.91 -17.46 53.03 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.03 -0.986 . . . . 75.14 112.031 -172.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -66.77 -43.65 50.13 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.139 1.163 . . . . 74.12 114.139 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.51 -33.78 79.54 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 121.951 1.768 . . . . 61.2 112.932 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -88.62 -26.24 22.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.709 -1.132 . . . . 73.14 111.03 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.34 72.36 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.903 0.859 . . . . 72.51 109.102 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -61.41 -41.33 96.97 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 113.4 -1.727 . . . . 75.25 110.709 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' B' ' 108' ' ' PRO . 9.6 tt0 -43.73 -54.64 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.779 1.232 . . . . 65.23 111.874 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.425 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 42.6 t -70.05 -48.31 58.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.604 -1.18 . . . . 63.43 111.083 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.541 HG22 ' SG ' ' D' ' 76' ' ' CYS . 45.5 mt -56.44 -58.73 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.812 0.845 . . . . 71.13 110.901 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -52.0 -42.87 63.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.8 1.24 . . . . 71.01 112.295 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.2 -41.55 66.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.193 -0.912 . . . . 71.51 110.923 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.529 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 57.8 mtm -68.46 -32.14 71.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.811 0.444 . . . . 75.22 111.424 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -61.84 -45.55 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 123.804 0.69 . . . . 74.23 109.896 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.4 -29.14 62.4 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.938 -0.574 . . . . 73.12 111.11 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -71.54 -33.05 68.82 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.697 0.799 . . . . 75.0 110.723 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.32 3.75 80.14 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.667 -0.697 . . . . 61.03 112.213 173.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 64.81 26.16 12.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.801 2.04 . . . . 74.11 112.933 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -91.94 161.9 32.28 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 114.556 -1.202 . . . . 71.21 108.818 167.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.64 126.97 17.01 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 122.287 1.991 . . . . 72.1 111.519 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.416 ' HB3' HG23 ' A' ' 122' ' ' THR . 51.5 tt0 -53.38 128.03 27.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.364 1.066 . . . . 74.11 111.827 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.7 tp -115.01 97.86 6.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.643 -0.708 . . . . 70.31 110.203 -166.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.487 ' OD1' ' HB ' ' B' ' 16' ' ' ILE . 46.6 m-80 -99.42 99.05 9.92 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.998 -0.742 . . . . 74.34 108.998 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.721 HD21 HD23 ' D' ' 42' ' ' LEU . 48.2 mt -66.85 120.99 14.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.039 0.936 . . . . 73.43 111.146 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.83 137.66 96.86 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.367 0.667 . . . . 74.5 111.978 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.411 ' HG2' ' HE2' ' B' ' 11' ' ' PHE . 3.2 Cg_exo -73.91 122.34 7.62 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.557 2.171 . . . . 74.43 110.446 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.474 HG21 HG11 ' G' ' 207' ' ' VAL . 2.5 p -107.86 120.52 59.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.25 0.62 . . . . 70.24 109.473 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -77.41 105.87 8.81 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.076 -0.965 . . . . 74.35 108.413 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -66.26 -30.28 70.68 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.767 0.827 . . . . 72.43 111.822 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.63 -29.86 59.31 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.662 -0.699 . . . . 75.0 110.632 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.596 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -57.67 -33.73 68.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.715 0.806 . . . . 74.01 111.808 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.422 HD21 ' HD2' ' H' ' 185' ' ' PRO . 7.7 mp -69.67 -41.8 75.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.154 0.582 . . . . 73.52 111.514 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 43.0 t80 -59.56 -46.93 87.48 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.755 0.659 . . . . 74.42 109.345 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.596 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 75.8 mtm -65.28 -38.88 91.62 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.905 -1.043 . . . . 73.33 111.095 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.57 -24.98 67.22 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.899 0.879 . . . . 75.15 110.741 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -78.22 -36.68 46.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.097 -0.501 . . . . 75.13 110.176 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 45.0 mt -73.35 -28.25 61.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.299 0.64 . . . . 74.3 112.084 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.3 30.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.772 0.656 . . . . 72.54 112.772 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -117.4 45.93 1.81 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.282 -1.007 . . . . 71.43 108.282 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -177.3 -61.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.171 1.388 . . . . 72.3 108.264 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.98 120.63 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 64.11 110.606 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.7 104.05 0.25 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.778 -0.529 . . . . 64.24 111.778 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.98 119.87 11.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.521 0.729 . . . . 65.43 109.68 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.25 113.53 1.38 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.083 -0.807 . . . . 71.32 111.083 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.2 t -144.6 58.28 1.31 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.664 0.786 . . . . 74.2 109.311 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . 0.437 ' HA ' ' H ' ' B' ' 3' ' ' GLU . 10.8 pt-20 -62.3 111.48 2.01 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.311 0.577 . . . . 74.11 110.665 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' B' ' 1' ' ' MET . 35.9 tt0 -77.78 117.18 18.91 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.211 -0.904 . . . . 73.34 109.552 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -63.42 110.76 2.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.533 1.133 . . . . 75.13 109.055 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . 0.674 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 11.9 pt20 -75.9 -30.57 58.85 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.368 0.667 . . . . 60.04 112.114 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.39 93.11 0.21 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.847 0.859 . . . . 74.3 110.957 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 C-N-CA 124.039 0.935 . . . . 72.14 110.298 179.494 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.057 -0.349 . . . . 73.03 110.057 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -90.48 150.87 21.03 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.8 0.687 . . . . 74.54 112.374 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -85.9 133.77 33.93 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.56 -0.533 . . . . 74.21 109.56 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 6.0 p -66.17 105.76 1.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.195 0.935 . . . . 74.31 111.608 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -101.75 31.16 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.463 1.105 . . . . 74.05 108.949 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.65 HD22 ' HA ' ' C' ' 54' ' ' ASP . 3.1 tm? -68.7 117.82 10.9 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.48 -0.782 . . . . 75.11 109.867 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -167.49 2.63 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.764 1.226 . . . . 70.3 108.762 176.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -144.02 -67.0 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.985 -1.117 . . . . 73.22 107.985 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 58.02 19.55 6.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.913 1.285 . . . . 75.22 113.38 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 51.8 tp -97.5 104.05 16.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.098 -1.075 . . . . 74.02 108.098 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -74.55 -68.46 0.53 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.134 -0.691 . . . . 64.21 109.134 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -129.09 159.9 66.5 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.768 0.827 . . . . 73.51 109.454 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.16 91.56 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.301 2.001 . . . . 65.44 110.043 167.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -53.06 142.22 20.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.075 1.35 . . . . 73.34 111.007 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 8.5 t80 62.87 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.346 1.058 . . . . 73.33 109.363 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 28.6 m -53.39 102.41 0.06 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.352 0.661 . . . . 74.23 111.541 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.83 107.35 60.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.293 1.037 . . . . 74.32 108.545 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -87.32 31.71 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.211 2.607 . . . . 71.13 112.286 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.583 HD22 ' HB2' ' C' ' 44' ' ' LEU . 39.2 tp 57.3 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.242 1.417 . . . . 72.34 110.254 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.97 145.18 23.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 124.052 0.941 . . . . 74.43 109.127 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -77.34 76.07 3.89 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.383 -0.599 . . . . 61.41 109.383 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -76.1 93.76 3.37 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.459 -0.791 . . . . 71.25 109.456 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -143.65 150.16 38.34 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.174 -0.921 . . . . 74.31 109.24 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.04 -52.16 0.71 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.686 -0.566 . . . . 74.13 111.686 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.68 137.64 1.98 Allowed Glycine 0 C--N 1.345 1.034 0 O-C-N 123.845 0.38 . . . . 52.12 113.502 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . 0.613 ' HB2' ' HD2' ' C' ' 38' ' ' PRO . 31.5 m-85 -69.76 173.5 6.16 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 74.14 112.431 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.81 14.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.126 -1.064 . . . . 72.55 108.126 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -152.63 176.65 11.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.475 0.484 . . . . 73.32 111.103 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' E' ' 199' ' ' ASN . 73.3 mmtt -121.05 122.74 40.74 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.586 1.154 . . . . 74.11 108.051 172.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.94 100.52 2.97 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.51 -1.293 . . . . 74.44 107.51 164.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . 0.567 ' HB3' ' HG2' ' E' ' 201' ' ' LYS . 42.0 mt-10 75.35 97.97 0.07 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.612 1.565 . . . . 75.24 111.165 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' E' ' 196' ' ' LYS . 4.1 p-10 -119.1 120.79 38.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.005 0.922 . . . . 74.52 110.057 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 53.86 34.43 51.36 Favored Glycine 0 C--N 1.36 1.885 0 O-C-N 123.635 0.584 . . . . 63.03 113.083 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.567 ' HG2' ' HB3' ' E' ' 198' ' ' GLU . 0.0 OUTLIER -73.62 163.27 28.24 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.575 0.954 . . . . 74.33 113.575 -167.837 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -85.11 1.69 46.76 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.714 1.206 . . . . 72.21 111.135 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 20.6 t0 73.63 127.37 0.04 OUTLIER 'General case' 0 C--N 1.36 1.042 0 C-N-CA 126.556 1.942 . . . . 74.43 109.642 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 11.9 tt -99.32 -37.21 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.093 0.557 . . . . 73.35 109.519 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -70.85 -18.72 62.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.451 1.101 . . . . 73.33 111.691 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -144.56 106.04 4.25 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.675 -0.491 . . . . 71.21 109.675 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.075 1.35 . . . . 75.12 108.0 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 57.5 tptt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.731 -0.47 . . . . 74.24 109.731 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.26 108.46 2.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.138 -0.812 . . . . 32.01 112.392 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 69.25 -69.37 0.16 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.02 1.728 . . . . 73.11 111.239 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 56.0 p -66.58 167.08 11.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.52 1.128 . . . . 74.03 110.917 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . 0.566 ' HB1' ' H ' ' B' ' 88' ' ' GLY . . . -117.93 -97.8 0.46 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.29 0.636 . . . . 64.04 111.675 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' F' ' 172' ' ' ALA . 0.0 OUTLIER -163.48 -6.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 113.853 1.057 . . . . 74.12 113.853 -166.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.52 ' SD ' HD12 ' B' ' 86' ' ' ILE . 20.6 ptp -106.42 109.29 21.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.697 1.369 . . . . 71.41 114.697 -159.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -161.26 85.94 0.67 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.29 -1.004 . . . . 74.44 108.29 157.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -177.48 135.35 0.19 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.215 1.006 . . . . 74.23 108.431 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 tp -86.63 135.45 33.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.706 0.802 . . . . 72.42 109.73 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -83.34 122.81 28.95 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.132 0.973 . . . . 74.13 109.714 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -64.12 -49.92 71.24 Favored Pre-proline 0 CA--C 1.564 1.491 0 O-C-N 124.52 1.138 . . . . 75.21 112.158 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.45 93.85 0.99 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.449 1.433 . . . . 74.55 111.082 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -133.81 167.31 20.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.566 -0.743 . . . . 72.44 109.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . 0.472 ' HB2' ' HZ ' ' B' ' 133' ' ' PHE . 52.2 m-85 -85.43 141.43 29.97 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.191 0.596 . . . . 72.54 110.27 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 89.5 m -71.54 139.15 49.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.722 0.809 . . . . 73.3 110.431 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -109.25 98.41 31.13 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 108.023 -1.103 . . . . 73.34 108.023 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.01 124.05 5.94 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.731 2.288 . . . . 74.34 112.331 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 66.2 mt -112.46 127.43 56.04 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.567 0.747 . . . . 75.11 109.044 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' E' ' 201' ' ' LYS . 2.6 pp -93.84 -175.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.481 0.712 . . . . 74.21 111.811 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -93.67 142.75 27.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.544 0.738 . . . . 74.53 110.622 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.62 83.14 4.82 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.827 0.851 . . . . 64.24 109.429 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 1.1 t70 63.29 -171.59 0.17 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.277 1.431 . . . . 75.01 111.912 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 141.12 -142.92 12.61 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.336 -1.106 . . . . 61.44 110.336 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.04 -89.92 0.1 OUTLIER Glycine 0 C--N 1.352 1.443 0 O-C-N 124.03 0.489 . . . . 72.23 113.424 173.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -142.15 -26.62 0.64 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.654 0.782 . . . . 72.4 110.603 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.98 82.89 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.257 0.623 . . . . 73.41 111.146 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.459 ' CE2' ' HB3' ' B' ' 37' ' ' GLN . 2.1 t80 -82.95 118.87 23.78 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.9 -0.778 . . . . 71.43 108.9 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -159.83 152.21 20.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.373 0.669 . . . . 73.44 109.904 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . 0.582 ' HA ' ' HG3' ' B' ' 37' ' ' GLN . 3.6 t80 -58.78 -44.99 90.82 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.297 1.039 . . . . 73.51 113.413 -164.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -64.55 -24.05 67.47 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.96 0.504 . . . . 63.44 111.471 -174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.57 90.61 5.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 75.34 110.166 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.44 79.93 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.809 -1.087 . . . . 54.43 113.463 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 70.63 -70.71 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.717 1.607 . . . . 73.04 112.48 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.508 ' HE2' ' HB3' ' B' ' 124' ' ' PRO . 4.5 m-30 57.81 40.69 25.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.178 0.991 . . . . 70.32 109.839 -168.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -159.18 148.43 18.54 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.624 -1.171 . . . . 75.43 109.625 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.521 ' HB ' ' HB1' ' C' ' 129' ' ' ALA . 7.2 tp -85.7 82.32 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.93 -1.137 . . . . 74.15 107.93 173.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.08 123.7 18.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.71 -1.132 . . . . 73.05 108.265 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -30.47 110.79 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 127.222 2.209 . . . . 75.52 113.692 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' C' ' 136' ' ' LEU . 2.4 m . . . . . 0 CA--C 1.565 1.527 0 C-N-CA 123.953 0.901 . . . . 74.2 111.954 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . 0.655 ' H3 ' ' HD2' ' G' ' 168' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.264 -0.643 . . . . 74.41 109.264 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.46 115.28 6.23 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.812 -0.515 . . . . 52.13 111.812 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 62.75 22.64 13.5 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.898 1.279 . . . . 63.41 112.439 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -161.76 139.69 9.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.375 -0.83 . . . . 73.5 109.468 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -78.51 0.06 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.95 -0.389 . . . . 74.21 109.95 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.44 HD21 ' SD ' ' G' ' 174' ' ' MET . 2.0 pt? -158.93 16.25 0.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.446 1.098 . . . . 73.42 108.942 170.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.44 ' SD ' HD21 ' G' ' 173' ' ' LEU . 0.0 OUTLIER -174.69 165.97 3.74 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.284 1.434 . . . . 72.44 108.964 -173.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -169.45 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.181 0.592 . . . . 75.02 109.99 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -74.04 104.64 4.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.883 -0.784 . . . . 75.24 108.883 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 52.3 tp -80.63 93.62 6.16 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.496 -0.927 . . . . 72.24 108.496 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -81.8 102.91 11.11 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.201 -0.909 . . . . 63.02 110.765 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 74.27 149.28 0.12 Allowed Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 125.555 1.542 . . . . 72.12 113.294 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.28 95.33 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.747 2.298 . . . . 75.35 110.658 169.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -60.6 -29.11 69.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.591 0.756 . . . . 75.23 111.437 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.2 154.59 45.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.615 0.766 . . . . 75.21 110.252 167.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 19.3 p -92.51 128.93 38.54 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.01 0.924 . . . . 75.2 108.978 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -126.49 114.5 23.11 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.213 0.605 . . . . 75.41 109.58 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.99 154.15 74.79 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.053 2.502 . . . . 73.21 112.898 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.93 51.37 2.04 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.868 0.867 . . . . 75.2 111.068 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.549 ' HB ' HD23 ' A' ' 42' ' ' LEU . 4.8 mp 60.31 -75.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.684 1.193 . . . . 73.41 111.747 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . 70.33 97.84 0.06 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.494 1.518 . . . . 61.13 109.875 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . 0.54 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . . . -112.01 161.35 16.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.82 -0.627 . . . . 62.34 111.648 -170.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -161.85 152.74 17.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.255 -0.884 . . . . 74.03 109.65 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 71.32 -146.33 40.66 Favored Glycine 0 C--N 1.345 1.064 0 O-C-N 123.643 0.59 . . . . 74.14 113.53 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.2 67.65 1.17 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.763 -0.535 . . . . 73.35 111.763 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.72 89.46 0.39 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.216 0.607 . . . . 74.51 110.335 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.94 -74.89 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.032 -0.729 . . . . 51.33 109.032 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -88.57 108.35 19.38 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.927 -0.768 . . . . 75.14 108.927 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -70.21 112.2 6.39 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.838 -0.801 . . . . 74.33 108.838 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -99.83 149.55 23.26 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.111 0.565 . . . . 73.54 110.413 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -171.71 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.122 1.369 . . . . 70.22 109.167 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -163.26 -178.17 5.8 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.403 1.081 . . . . 75.11 108.481 -174.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.25 128.53 46.06 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 112.159 -0.377 . . . . 61.4 112.159 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -102.86 -11.15 18.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.758 0.823 . . . . 72.15 110.699 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -139.0 121.28 15.92 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.394 -0.965 . . . . 74.31 108.394 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.78 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.211 0.944 . . . . 65.33 110.42 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp 62.39 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.11 0.964 . . . . 74.31 108.926 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? 179.24 -61.52 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.285 1.834 . . . . 75.32 108.074 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 4.2 p30 178.3 -174.43 0.16 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.342 1.457 . . . . 74.42 108.949 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . 0.474 HG11 HG21 ' D' ' 131' ' ' VAL . 60.7 t . . . . . 0 CA--C 1.553 1.06 0 N-CA-C 108.062 -1.088 . . . . 75.4 108.062 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.685 -0.858 . . . . 75.42 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -171.52 128.61 1.62 Allowed Glycine 0 C--N 1.347 1.156 0 C-N-CA 121.444 -0.408 . . . . 73.13 112.832 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -77.99 130.69 36.82 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.365 -0.976 . . . . 71.15 108.365 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 42.5 m 60.65 27.72 17.43 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.262 0.977 . . . . 54.21 111.641 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.1 4.65 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.658 -0.701 . . . . 75.01 111.203 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.44 HD21 ' H ' ' D' ' 88' ' ' GLY . 1.6 tm? 63.49 -75.5 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.458 1.503 . . . . 74.13 111.621 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.536 ' HA ' ' HE3' ' H' ' 174' ' ' MET . 24.5 mmt -86.64 -57.33 3.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.82 0.848 . . . . 71.41 111.373 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -167.44 135.64 2.5 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.327 -0.62 . . . . 75.24 109.327 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -153.48 -70.61 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.466 -1.309 . . . . 73.3 107.466 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . 0.488 HD13 HD22 ' D' ' 98' ' ' LEU . 8.5 mp 56.96 27.79 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.582 1.153 . . . . 73.44 112.94 171.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -79.41 -44.71 20.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.402 0.681 . . . . 75.22 110.524 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.02 141.45 71.21 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.74 -0.664 . . . . 63.42 109.921 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -83.93 164.19 13.66 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.708 2.272 . . . . 74.24 113.128 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.56 -169.3 2.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.07 0.948 . . . . 74.25 110.277 174.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -69.96 130.19 41.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.655 0.782 . . . . 73.21 110.433 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 47.5 p -70.48 161.32 30.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.064 0.546 . . . . 73.41 109.616 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -128.07 117.85 20.6 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.238 0.615 . . . . 73.11 109.964 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . 0.422 ' HD2' HD21 ' D' ' 136' ' ' LEU . 63.9 Cg_endo -73.71 117.06 4.89 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 72.4 112.065 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.64 145.32 30.65 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.605 -0.887 . . . . 72.25 108.605 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.19 170.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.988 0.915 . . . . 74.04 112.273 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.63 170.36 19.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.938 0.495 . . . . 74.1 110.938 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' D' ' 39' ' ' GLU . . . -87.07 132.26 33.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.35 0.66 . . . . 61.21 109.503 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.82 128.25 26.42 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.787 0.835 . . . . 72.44 109.759 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 57.78 -115.96 7.55 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 124.507 1.129 . . . . 73.13 113.433 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.97 -89.85 0.32 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 124.055 0.503 . . . . 73.23 112.741 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 58.74 19.4 6.83 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.966 1.306 . . . . 75.33 112.422 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.5 39.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.464 1.106 . . . . 73.31 109.303 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -138.6 142.13 39.16 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.693 0.797 . . . . 73.31 109.289 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.88 43.61 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.12 1.368 . . . . 74.43 108.147 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . 0.56 ' HD1' HH22 ' C' ' 15' ' ' ARG . 55.7 m-85 -93.6 -29.04 15.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.883 0.473 . . . . 75.22 111.124 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . 0.53 ' HG3' HD21 ' H' ' 199' ' ' ASN . 8.5 tp10 60.61 -89.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.113 0.965 . . . . 64.34 109.743 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . 0.53 HD21 ' HG3' ' H' ' 198' ' ' GLU . 0.1 OUTLIER 165.74 158.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.928 2.091 . . . . 72.22 107.355 174.593 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -87.37 46.1 3.46 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 112.194 -0.363 . . . . 50.23 112.194 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . 0.516 ' HG3' HD11 ' H' ' 204' ' ' ILE . 60.6 tttm -165.43 108.99 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.549 1.14 . . . . 73.35 108.599 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -72.0 -60.28 2.31 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.857 0.361 . . . . 75.25 110.314 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -151.93 -68.76 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.622 -0.881 . . . . 73.51 108.622 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' H' ' 201' ' ' LYS . 14.1 mt 56.17 74.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.502 1.521 . . . . 74.44 110.685 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -88.0 -21.16 24.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.174 0.989 . . . . 74.51 110.515 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.286 1.034 . . . . 70.13 112.259 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . 0.489 HG23 HG11 ' A' ' 131' ' ' VAL . 82.4 t . . . . . 0 C--O 1.255 1.35 0 C-N-CA 124.254 1.022 . . . . 75.42 108.445 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtm . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.442 -0.577 . . . . 74.42 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -87.26 99.42 11.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.187 -1.042 . . . . 74.51 108.187 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -145.91 123.91 12.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.121 0.568 . . . . 65.55 111.039 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.15 60.12 4.17 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.023 -1.103 . . . . 74.51 108.023 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -138.07 147.13 43.76 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.317 -0.856 . . . . 74.43 109.813 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -144.23 143.67 31.16 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.848 -1.167 . . . . 75.12 107.848 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 p -85.58 60.25 6.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.747 0.784 . . . . 73.14 110.542 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -97.53 -164.74 1.17 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.537 1.135 . . . . 74.54 110.354 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.587 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 25.0 ptm -55.19 148.42 14.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 75.32 112.257 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 m -140.54 130.7 24.91 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.77 0.828 . . . . 75.23 109.488 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.403 ' HD1' HD11 ' A' ' 86' ' ' ILE . 67.2 t80 -129.05 140.01 51.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.742 -1.207 . . . . 71.5 107.742 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.564 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 27.3 tp60 -149.79 130.51 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.685 0.394 . . . . 74.13 110.162 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.79 112.83 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.549 -1.278 . . . . 73.33 107.549 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' A' ' 85' ' ' SER . 8.0 mm-40 -87.88 -38.03 15.98 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.104 0.252 . . . . 70.34 110.94 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -171.95 124.32 0.53 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.954 0.502 . . . . 74.43 110.798 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 80.4 mt -108.6 135.78 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 74.3 108.767 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' HB3' HG21 ' B' ' 122' ' ' THR . 16.9 p90 -170.5 176.35 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.915 0.759 . . . . 74.52 111.489 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -98.78 128.95 45.16 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.114 -0.698 . . . . 72.15 109.114 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -92.5 -38.04 12.17 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.207 -0.664 . . . . 75.52 109.207 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.673 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -135.86 136.53 40.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.601 -1.181 . . . . 75.44 109.502 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.2 mt -135.97 139.52 45.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.949 -1.5 . . . . 63.21 106.949 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 t -149.28 122.78 9.11 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 123.474 0.484 . . . . 65.23 110.222 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.3 t80 -119.9 114.54 22.23 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.522 -1.658 . . . . 75.34 106.522 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.35 117.62 29.02 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.402 -0.592 . . . . 73.11 109.402 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.67 81.56 67.21 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 108.145 -1.057 . . . . 74.2 108.145 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.32 -35.03 42.15 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.563 2.175 . . . . 73.12 111.628 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.0 m-20 -104.98 31.54 4.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.26 -0.882 . . . . 74.43 109.62 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.41 99.66 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.299 1.039 . . . . 73.41 112.684 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.01 -26.24 11.08 Favored 'Trans proline' 0 C--N 1.38 2.23 0 CA-C-N 121.277 1.492 . . . . 63.4 113.721 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -70.7 -23.01 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.38 0.672 . . . . 74.43 112.357 -173.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.616 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.6 p -61.19 -20.39 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.15 0.58 . . . . 74.01 111.27 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.6 -39.57 91.69 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.246 1.018 . . . . 74.42 111.693 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.91 -28.27 17.38 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.679 0.392 . . . . 74.41 110.961 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.63 149.86 28.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.061 0.544 . . . . 71.34 111.204 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.5 147.36 41.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.443 0.697 . . . . 73.15 110.337 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.7 t-105 -93.81 76.96 4.23 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.605 0.717 . . . . 72.51 110.183 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -121.75 82.45 41.84 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 106.309 -1.737 . . . . 71.55 106.309 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.12 136.99 9.36 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.691 2.261 . . . . 52.41 113.082 -170.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.34 84.32 3.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.456 -1.683 . . . . 73.51 106.456 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.9 t -79.25 101.06 4.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 114.193 -1.367 . . . . 75.53 108.971 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -79.32 114.55 18.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.534 -0.913 . . . . 73.2 108.534 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.7 116.48 28.93 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.187 -1.412 . . . . 75.34 107.187 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.1 t70 -126.25 138.9 53.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.824 -0.806 . . . . 74.03 108.824 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.3 tp -130.38 120.03 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.995 -0.743 . . . . 72.44 108.995 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -135.65 157.15 47.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.676 0.79 . . . . 73.13 109.522 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -127.75 159.63 34.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.691 0.796 . . . . 74.31 109.662 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.39 136.06 21.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.694 1.198 . . . . 74.31 107.97 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.6 m -107.86 160.11 16.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 54.13 110.312 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -157.74 150.28 22.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.962 0.905 . . . . 65.15 109.385 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.01 140.25 47.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.239 -1.023 . . . . 75.51 108.239 170.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 HD12 HG22 ' A' ' 83' ' ' ILE . 82.3 mt -115.59 -37.68 3.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.567 0.747 . . . . 74.45 110.569 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.15 -179.28 7.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.912 0.885 . . . . 74.2 110.318 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.28 114.52 3.22 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.633 -0.712 . . . . 65.33 109.262 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 69.15 0.99 3.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.893 1.277 . . . . 72.41 113.402 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -106.73 108.62 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.885 -1.154 . . . . 64.32 107.885 172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 160.64 26.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.059 -0.719 . . . . 72.45 109.059 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.87 134.69 47.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.77 0.828 . . . . 74.15 108.948 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.5 t -118.13 122.23 69.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.321 -1.363 . . . . 64.31 107.321 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -98.69 134.74 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.727 0.811 . . . . 74.24 109.429 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.05 114.15 28.02 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.889 -1.152 . . . . 74.34 107.889 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.18 100.47 10.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.146 -0.687 . . . . 74.52 109.146 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 t -99.66 141.7 16.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.461 -0.94 . . . . 74.14 108.461 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 19.5 m -130.99 133.7 46.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.111 0.481 . . . . 65.41 110.533 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.5 t -130.62 109.48 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.341 1.457 . . . . 75.11 107.741 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.0 m -112.11 128.42 56.21 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.117 -0.697 . . . . 72.04 109.117 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.67 13.91 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.792 -0.818 . . . . 73.42 108.792 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 30.9 m -114.93 126.61 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.001 0.52 . . . . 74.22 110.051 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 HD21 ' CE3' ' A' ' 36' ' ' TRP . 25.7 mt -89.73 65.27 6.77 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.855 -1.165 . . . . 64.43 107.855 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 -101.8 1.23 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.101 -0.954 . . . . 75.03 110.999 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -88.36 -27.4 21.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.428 1.091 . . . . 75.32 110.126 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -98.05 94.79 7.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 74.43 110.08 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 92.6 m -67.41 125.58 26.58 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.839 0.745 . . . . 75.2 111.03 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.35 -56.85 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.83 0.852 . . . . 74.52 109.769 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -161.07 174.84 13.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.493 -1.23 . . . . 71.32 111.781 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -139.11 130.53 27.04 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.955 -1.498 . . . . 71.21 106.955 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.48 ' HB3' HG21 ' A' ' 114' ' ' ILE . 74.8 m -130.27 101.77 5.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.463 1.105 . . . . 64.44 109.761 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.44 121.56 29.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.836 -0.801 . . . . 74.21 108.836 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.4 t -129.49 129.62 66.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 123.458 0.703 . . . . 73.54 109.391 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.673 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.9 mt-30 -102.51 90.65 3.93 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.497 -0.774 . . . . 73.41 109.49 171.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.41 ' HG3' HD23 ' A' ' 106' ' ' LEU . 7.2 tp-100 -77.08 95.46 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.39 -1.277 . . . . 70.01 108.614 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.97 143.18 19.57 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 112.138 -0.385 . . . . 74.31 112.138 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.48 122.35 1.94 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 111.598 -0.601 . . . . 72.33 111.598 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 51' ' ' LEU . 43.9 mt -80.89 125.56 39.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.083 -1.08 . . . . 71.34 108.083 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -132.1 132.45 43.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.593 0.757 . . . . 74.23 110.582 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 33.4 t -80.24 122.79 27.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.451 -0.944 . . . . 72.54 108.451 166.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.507 ' O ' ' HE3' ' G' ' 174' ' ' MET . 5.8 tp -129.44 146.52 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.141 -0.688 . . . . 74.01 109.141 -178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.88 162.14 7.33 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.048 0.939 . . . . 74.12 110.978 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 79.03 7.61 88.35 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 115.688 1.035 . . . . 65.34 115.688 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.66 141.13 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.818 0.809 . . . . 73.24 109.864 -174.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -146.25 170.31 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.874 0.47 . . . . 73.41 110.345 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 -115.8 4.99 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.18 0.925 . . . . 73.13 114.22 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.2 p -68.3 -34.16 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.363 1.065 . . . . 72.2 111.653 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -57.97 -44.38 87.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.956 0.902 . . . . 74.25 110.839 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.462 ' HE1' HD21 ' A' ' 98' ' ' LEU . 12.0 tpt -76.61 -40.68 48.69 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.869 -0.605 . . . . 73.55 111.022 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.44 71.89 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.322 0.582 . . . . 72.54 111.066 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.481 ' HE1' ' HA ' ' A' ' 134' ' ' ASP . 65.9 t60 -79.25 -41.82 27.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.104 0.962 . . . . 74.34 111.097 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 23.3 t -74.24 -63.6 1.19 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.772 0.429 . . . . 71.32 110.233 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.462 HD21 ' HE1' ' A' ' 94' ' ' MET . 50.6 tp -62.06 -33.34 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.928 0.891 . . . . 75.22 111.57 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.78 -10.46 63.04 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 115.239 0.855 . . . . 63.14 115.239 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.15 -55.47 0.32 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.971 0.886 . . . . 74.32 111.799 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.24 -60.07 2.9 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.53 0.567 . . . . 73.22 112.53 -168.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 30.5 m -55.88 -48.24 97.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.573 0.749 . . . . 71.43 112.865 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.459 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.2 Cg_endo -67.82 -28.95 35.89 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 120.702 1.287 . . . . 60.13 113.809 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.79 -19.9 51.08 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.295 0.952 . . . . 65.24 111.807 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.54 -38.57 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.216 1.007 . . . . 75.03 109.497 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' A' ' 82' ' ' GLY . 51.7 mt -75.94 -18.97 59.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.017 -1.447 . . . . 74.04 112.124 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.444 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 38.9 t80 -65.87 -40.53 39.55 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.462 1.282 . . . . 75.42 114.462 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.91 -39.65 83.8 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.154 1.903 . . . . 71.32 113.444 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -80.68 -33.84 35.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.389 -0.823 . . . . 75.42 111.546 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.85 81.5 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.02 -0.733 . . . . 72.23 109.02 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -52.15 -53.93 36.96 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.624 -1.171 . . . . 73.21 110.566 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.6 tm-20 -61.14 -41.19 96.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.044 0.84 . . . . 75.14 111.315 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.79 -47.63 84.28 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.892 -0.595 . . . . 71.42 110.714 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.48 HG21 ' HB3' ' A' ' 76' ' ' CYS . 97.8 mt -63.11 -47.71 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.133 0.973 . . . . 74.31 110.717 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.529 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.7 m -60.68 -41.88 95.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.523 1.129 . . . . 54.11 111.56 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.01 -43.39 78.95 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.684 -0.689 . . . . 75.1 110.602 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -55.65 -43.84 76.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.617 0.767 . . . . 72.42 111.453 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.41 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.938 0.895 . . . . 74.31 111.113 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -70.36 -26.97 63.97 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.292 -0.413 . . . . 44.33 111.294 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -73.93 -32.1 63.36 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.712 0.805 . . . . 71.05 109.952 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.51 -1.62 71.57 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.958 0.786 . . . . 72.24 112.875 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.8 m 67.81 40.28 2.44 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.87 1.319 . . . . 63.34 110.071 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.616 ' HE1' HG11 ' A' ' 31' ' ' VAL . 43.9 m-85 -116.72 152.31 48.27 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 114.524 -1.217 . . . . 74.35 109.579 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 135.69 60.96 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.114 2.543 . . . . 74.41 113.459 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.529 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.5 tt0 -58.74 139.5 56.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 74.34 112.304 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 tp -117.08 115.08 24.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.136 -0.69 . . . . 74.41 109.136 176.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -100.3 93.65 5.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.683 -0.858 . . . . 74.3 108.683 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.444 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -65.89 135.33 54.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.45 0.7 . . . . 75.32 109.9 -176.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.472 ' HB2' HG21 ' H' ' 204' ' ' ILE . . . -68.79 131.07 91.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 122.957 0.503 . . . . 74.01 111.897 -175.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.39 110.77 2.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.596 2.197 . . . . 74.41 111.709 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.14 110.78 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.248 -1.019 . . . . 71.53 108.248 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 14.8 m120 -110.82 72.22 0.77 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.231 1.012 . . . . 74.22 112.749 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -70.84 -24.24 62.49 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 73.02 110.732 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HA ' ' HE1' ' A' ' 96' ' ' HIS . 19.1 p-10 -69.0 -47.77 64.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.687 -0.688 . . . . 75.11 110.437 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -69.0 -49.39 58.23 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.442 0.697 . . . . 74.14 111.491 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' H' ' 207' ' ' VAL . 54.0 tp -57.3 -43.1 82.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.563 0.539 . . . . 72.5 111.107 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 44.8 t80 -70.28 -38.13 75.0 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.675 -0.693 . . . . 72.34 110.934 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 94.9 mmm -63.72 -42.53 97.91 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.003 0.365 . . . . 73.14 110.046 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.546 ' HB3' ' NE2' ' C' ' 144' ' ' GLN . 96.0 m-20 -66.28 -18.54 65.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.432 1.093 . . . . 73.42 111.987 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -95.92 -42.03 8.5 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.91 0.884 . . . . 75.01 111.215 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -67.67 -27.25 66.68 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 124.966 1.306 . . . . 72.23 111.094 -167.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -141.31 31.72 1.72 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.691 -1.226 . . . . 61.52 107.691 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -55.96 -24.36 37.91 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 113.995 -1.457 . . . . 73.3 112.257 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.58 87.91 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.721 0.809 . . . . 74.41 109.457 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.11 13.8 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.907 -1.042 . . . . 72.33 110.593 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.03 118.63 0.97 Allowed Glycine 0 C--O 1.238 0.369 0 N-CA-C 111.201 -0.76 . . . . 70.11 111.201 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.85 149.84 36.11 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.608 -0.516 . . . . 71.35 109.608 170.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.32 100.04 0.14 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 109.792 -1.323 . . . . 73.12 109.792 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 t -148.92 168.89 21.83 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.217 0.607 . . . . 64.45 110.095 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -140.72 123.49 16.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.136 0.975 . . . . 73.01 108.858 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -84.58 148.43 26.48 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.531 -0.544 . . . . 73.15 109.531 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -166.8 -166.98 0.89 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.73 1.212 . . . . 74.34 109.367 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -145.87 154.56 42.11 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.788 0.835 . . . . 64.42 110.267 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.59 75.95 6.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.537 0.735 . . . . 74.54 109.864 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 123.451 0.7 . . . . 70.34 109.301 -177.553 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.452 ' HG3' ' HA ' ' B' ' 145' ' ' ALA . 26.6 mmt . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.425 -0.583 . . . . 74.25 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -67.2 119.96 12.97 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.964 0.506 . . . . 74.0 110.449 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.14 109.86 1.43 Allowed 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.98 -0.748 . . . . 74.15 108.98 171.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.93 150.53 30.95 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.889 -0.782 . . . . 72.25 108.889 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -72.27 128.71 36.49 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.485 -1.302 . . . . 75.12 107.485 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -81.21 71.59 8.2 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.855 0.835 . . . . 73.42 110.098 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -92.1 69.45 5.31 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.317 1.532 . . . . 64.53 107.71 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -112.96 159.27 19.27 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.44 -1.709 . . . . 61.24 109.571 -169.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 21.8 ptm 51.11 -175.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 126.503 1.921 . . . . 71.41 113.358 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -151.34 140.48 21.21 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.748 -0.66 . . . . 75.2 109.313 170.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.22 131.6 30.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.014 0.925 . . . . 75.11 108.9 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.585 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 24.4 tm0? -142.47 134.36 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.728 -1.212 . . . . 74.23 107.728 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -97.3 118.37 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 74.32 109.874 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.18 -53.56 4.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.692 0.282 . . . . 74.33 110.973 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 43.8 ttt180 -161.17 141.04 10.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.412 -0.358 . . . . 75.11 110.57 -169.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -115.8 143.64 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 107.96 -1.126 . . . . 74.45 107.96 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.425 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.9 p90 -168.9 158.22 8.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.356 0.598 . . . . 75.45 111.553 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -83.89 127.82 34.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.248 -0.887 . . . . 75.1 108.648 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -96.09 -41.2 8.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.165 0.586 . . . . 75.22 109.713 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.7 t70 -147.42 139.29 24.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.851 -0.613 . . . . 71.01 110.597 -168.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 42.2 mm -138.07 137.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.81 1.244 . . . . 74.2 108.811 177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -138.8 125.09 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.05 -1.092 . . . . 72.21 108.05 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.6 t80 -137.59 108.05 6.52 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.17 -1.419 . . . . 72.23 107.17 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.81 117.83 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.438 -0.949 . . . . 75.4 108.438 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.543 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -112.82 87.89 10.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.796 0.838 . . . . 75.0 109.504 -176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 -38.24 10.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.075 2.517 . . . . 74.54 112.736 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 66.1 m-20 -111.74 29.07 8.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.445 0.698 . . . . 74.21 109.622 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.543 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -48.12 -54.58 23.66 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.787 1.235 . . . . 74.53 113.107 172.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 5.6 Cg_exo -76.22 -19.17 15.63 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.036 1.824 . . . . 74.53 111.754 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.426 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 80.7 m-70 -85.43 3.03 41.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.312 1.045 . . . . 71.15 111.408 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.45 -14.94 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 CA-C-O 121.419 0.628 . . . . 71.43 109.736 163.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -70.58 -28.77 65.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.754 0.821 . . . . 72.21 109.832 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.62 -39.7 18.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.314 0.646 . . . . 74.53 109.609 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.479 ' HZ2' ' HA3' ' B' ' 69' ' ' GLY . 27.3 mmtp -102.51 75.23 1.44 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.292 1.037 . . . . 72.13 109.955 -178.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.49 76.44 5.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.824 0.849 . . . . 73.43 110.648 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -163.7 160.32 22.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.762 0.825 . . . . 75.1 109.403 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -69.84 118.61 64.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.208 1.003 . . . . 74.22 109.518 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.76 152.0 82.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.176 1.918 . . . . 63.14 113.026 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.24 119.06 13.87 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.473 -0.785 . . . . 74.23 109.033 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 t -85.01 119.66 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.466 -1.309 . . . . 73.21 107.466 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -134.73 138.59 44.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.643 ' HG ' ' HG ' ' B' ' 128' ' ' LEU . 0.0 OUTLIER -128.57 166.42 18.87 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.783 0.833 . . . . 75.43 111.542 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 121.24 1.55 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.423 -0.954 . . . . 71.12 108.423 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.1 163.74 21.81 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.361 0.6 . . . . 73.21 110.724 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -161.06 135.89 7.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.477 1.111 . . . . 75.41 108.447 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -108.65 119.68 40.24 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.843 0.354 . . . . 75.04 110.376 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.48 159.26 22.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.141 0.976 . . . . 73.01 108.711 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.498 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 73.9 m -144.39 162.69 35.84 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.178 -0.326 . . . . 71.22 111.464 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.1 t -157.12 137.9 13.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.078 0.951 . . . . 71.4 109.62 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -105.51 131.07 53.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.338 -0.616 . . . . 72.43 109.338 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.555 HD12 HG22 ' B' ' 83' ' ' ILE . 39.3 mt -98.36 -41.75 7.68 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.455 0.645 . . . . 73.44 109.472 175.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.84 10.87 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.596 -1.184 . . . . 63.53 109.358 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -76.57 134.17 39.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 72.34 108.414 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.3 -3.63 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.934 1.294 . . . . 62.45 111.811 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.54 95.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.298 1.039 . . . . 71.35 108.354 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.498 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 8.4 t80 -113.83 139.54 49.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.012 0.434 . . . . 72.32 110.623 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -121.85 108.4 13.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.873 0.869 . . . . 75.14 109.488 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.1 132.86 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.033 0.533 . . . . 71.22 110.093 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 40.8 t -104.14 116.94 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.308 0.643 . . . . 74.54 109.838 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 0.1 OUTLIER -94.1 115.77 28.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.876 -0.787 . . . . 73.34 108.876 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -102.16 123.75 46.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.955 0.407 . . . . 74.11 110.419 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 75.0 t -117.07 108.3 24.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.686 -1.227 . . . . 75.1 107.686 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.5 m -97.84 146.54 25.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.326 -0.62 . . . . 74.21 109.326 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 72.5 t -132.58 136.34 56.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 124.464 1.106 . . . . 73.1 109.578 -171.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.39 149.5 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.426 1.09 . . . . 53.32 109.012 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.46 161.76 37.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.214 0.606 . . . . 72.41 110.359 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.4 p -148.48 147.42 29.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.595 0.591 . . . . 72.22 112.595 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 44.5 mt -124.19 107.06 10.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.689 -1.597 . . . . 75.34 106.689 172.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.479 ' HA3' ' HZ2' ' B' ' 34' ' ' LYS . . . 73.42 -111.39 3.46 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.285 -0.731 . . . . 71.45 111.347 -171.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.18 3.24 12.66 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.901 0.85 . . . . 74.33 111.665 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.419 ' CD ' ' HZ3' ' B' ' 34' ' ' LYS . 12.8 pm0 -114.25 167.19 10.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.708 0.403 . . . . 74.44 110.402 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -64.88 144.03 57.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.324 0.65 . . . . 65.13 110.467 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.69 -58.77 1.83 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.374 -0.973 . . . . 71.44 108.374 173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -150.92 166.38 30.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 113.833 -1.53 . . . . 75.12 109.276 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -134.91 140.37 45.7 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.428 -1.323 . . . . 72.22 107.428 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.483 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.1 t -140.82 159.96 41.08 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.575 0.75 . . . . 75.44 109.146 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.33 137.45 4.21 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.942 0.897 . . . . 72.01 108.601 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 77.3 t -128.64 141.03 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.45 0.7 . . . . 73.03 109.179 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -124.63 91.61 3.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 72.5 108.992 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.425 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -89.15 102.17 14.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.875 -1.057 . . . . 73.51 108.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.477 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.57 142.82 16.36 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.775 -0.53 . . . . 51.24 111.775 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.74 128.43 4.44 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.407 -0.677 . . . . 54.04 111.407 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.555 HG22 HD12 ' B' ' 51' ' ' LEU . 44.7 mt -83.29 126.89 40.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.72 -0.844 . . . . 74.53 108.72 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -135.18 135.48 41.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.249 0.619 . . . . 74.55 109.623 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.585 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 20.2 m -87.43 100.46 12.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.033 -1.099 . . . . 61.2 108.033 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.6 122.34 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.709 0.804 . . . . 74.12 109.63 -170.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.22 172.33 18.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.13 0.972 . . . . 62.33 111.097 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -28.12 6.65 Favored Glycine 0 C--N 1.357 1.708 0 CA-C-N 116.046 -0.525 . . . . 75.01 112.832 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.93 157.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.039 1.336 . . . . 74.33 113.451 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -161.32 143.15 11.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.535 -0.757 . . . . 72.32 109.866 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.49 -93.42 0.03 OUTLIER Glycine 0 C--N 1.362 1.979 0 O-C-N 124.324 1.015 . . . . 62.2 113.912 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.2 m -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.369 1.068 . . . . 73.53 110.604 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -67.55 -29.17 68.49 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.443 0.697 . . . . 71.23 111.505 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 52.8 tpp -67.02 -50.08 63.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.745 0.418 . . . . 73.42 110.495 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.31 -30.47 64.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.6 0.76 . . . . 74.35 111.834 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.69 -55.17 5.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.72 0.408 . . . . 73.33 110.024 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.475 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 42.8 t -69.35 -66.73 0.55 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.647 0.592 . . . . 75.42 110.819 -172.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.631 ' HB3' HD11 ' F' ' 177' ' ' LEU . 2.9 tt -71.3 -26.74 62.98 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.751 0.421 . . . . 71.24 110.277 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.01 -39.06 13.65 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 114.976 0.751 . . . . 72.12 114.976 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.62 -46.88 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.718 0.759 . . . . 72.05 112.059 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.475 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 88.2 t80 -64.61 -54.35 33.32 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.554 0.741 . . . . 71.02 112.607 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.458 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.3 m -61.6 -46.82 93.87 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.476 0.71 . . . . 72.52 111.424 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.2 Cg_exo -58.04 -36.98 97.61 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 121.843 1.696 . . . . 74.44 113.873 167.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -72.16 -21.18 61.48 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 122.872 0.469 . . . . 75.43 111.463 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.447 HG22 ' NH2' ' D' ' 111' ' ' ARG . 56.9 mt -64.2 -45.0 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.641 0.776 . . . . 74.42 109.901 167.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 28.2 mt -84.4 -11.02 57.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.319 -1.31 . . . . 75.3 111.37 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.481 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 63.4 t80 -63.26 -45.49 85.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.023 1.329 . . . . 74.45 113.934 -172.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.27 -36.05 81.64 Favored 'Trans proline' 0 C--N 1.374 1.878 0 CA-C-N 121.226 1.473 . . . . 64.35 112.657 173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.425 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.2 m-85 -65.6 -40.5 92.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.969 0.508 . . . . 74.13 110.764 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -47.94 72.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.847 0.459 . . . . 72.52 110.266 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -51.35 -49.21 61.89 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.67 1.188 . . . . 73.12 111.369 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -38.97 79.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.632 -1.167 . . . . 74.42 109.898 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.497 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -71.28 -34.18 70.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.91 -0.586 . . . . 74.01 111.33 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.459 HG22 HG22 ' B' ' 64' ' ' VAL . 73.2 mt -67.54 -52.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.854 0.462 . . . . 75.34 109.766 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -53.36 -33.11 52.35 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 123.941 0.775 . . . . 74.54 111.401 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.0 t -65.8 -62.74 1.33 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.308 0.643 . . . . 71.14 110.648 172.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.527 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.8 mmt -61.25 -33.3 73.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.346 0.658 . . . . 65.31 112.449 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -76.96 -39.85 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.604 0.762 . . . . 74.44 110.693 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.473 ' HB3' HE22 ' C' ' 125' ' ' GLN . 91.3 p -66.39 -28.94 69.03 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.474 0.654 . . . . 53.51 111.15 176.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.527 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 84.2 mtt-85 -61.86 -31.78 72.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.523 -0.762 . . . . 74.24 110.205 174.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.58 12.85 58.04 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 119.425 -0.653 . . . . 73.5 114.145 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.612 HG21 ' HB3' ' A' ' 17' ' ' TYR . 15.0 p 61.63 21.27 11.99 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.01 1.724 . . . . 64.33 111.965 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -105.08 159.66 28.63 Favored Pre-proline 0 CA--C 1.567 1.624 0 C-N-CA 123.801 0.84 . . . . 73.51 110.738 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.71 156.85 64.38 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 123.814 3.009 . . . . 63.51 115.541 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.571 ' HB3' ' HB3' ' C' ' 125' ' ' GLN . 5.1 pm0 -63.06 156.81 23.75 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.741 0.816 . . . . 73.25 112.709 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.8 96.8 6.49 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.334 -0.987 . . . . 75.15 108.334 163.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -89.08 93.55 9.63 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.196 -2.15 . . . . 73.3 105.196 165.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.643 ' HG ' ' HG ' ' B' ' 42' ' ' LEU . 1.8 tt -81.44 135.79 35.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.101 -0.703 . . . . 73.44 109.101 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.4 ' HB2' HD11 ' F' ' 187' ' ' ILE . . . -59.74 132.86 89.1 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 124.067 0.855 . . . . 74.43 111.512 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.99 81.19 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.498 2.132 . . . . 75.2 111.471 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -78.21 75.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.279 -0.873 . . . . 74.35 110.34 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.11 84.84 1.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.482 -0.781 . . . . 73.14 109.013 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.528 ' HA ' HD21 ' B' ' 136' ' ' LEU . 8.3 t80 -78.75 -6.19 55.22 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.478 -0.783 . . . . 63.42 111.063 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -53.28 -44.4 68.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.671 1.188 . . . . 73.44 111.014 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.42 -33.06 69.26 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.203 1.001 . . . . 73.35 112.242 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.599 HD23 HG22 ' E' ' 207' ' ' VAL . 3.3 mm? -75.66 -38.92 58.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.513 0.725 . . . . 75.11 110.07 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.44 -29.51 68.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.967 0.507 . . . . 44.52 111.184 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 92.8 mmm -65.75 -36.93 84.97 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.822 0.449 . . . . 74.45 111.457 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -100.72 -30.03 11.95 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.442 0.464 . . . . 74.03 112.154 -168.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.73 -45.3 52.88 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.852 -0.425 . . . . 73.02 109.852 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.49 21.36 5.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.299 0.64 . . . . 72.0 110.905 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -74.35 93.05 2.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.887 0.875 . . . . 74.51 109.901 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -154.53 147.75 24.85 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.288 -0.869 . . . . 72.31 109.109 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -104.18 101.57 11.3 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.491 0.663 . . . . 73.34 109.727 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.452 ' HA ' ' HG3' ' B' ' 1' ' ' MET . . . -153.23 83.76 1.2 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.659 -0.7 . . . . 74.12 109.793 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.58 141.85 10.43 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.012 -0.835 . . . . 74.51 111.012 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.69 144.07 26.84 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.252 0.621 . . . . 74.51 109.756 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.18 135.29 17.3 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.764 0.665 . . . . 74.14 111.916 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -148.83 127.81 12.71 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.695 -0.854 . . . . 74.21 108.695 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -76.82 -82.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.515 -0.92 . . . . 64.44 108.515 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 60.36 162.66 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.943 1.297 . . . . 74.14 113.175 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -122.82 140.0 53.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.118 -0.946 . . . . 74.22 108.87 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.71 107.65 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.84 -0.8 . . . . 73.42 108.84 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -118.36 136.72 53.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.111 0.964 . . . . 74.52 109.013 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.821 0.848 . . . . 63.31 109.232 -179.278 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.428 ' N ' ' SD ' ' C' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.756 0.313 . . . . 72.12 111.043 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.8 p -149.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.306 0.642 . . . . 74.45 110.609 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.1 155.11 43.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.66 0.784 . . . . 75.34 110.586 -174.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -100.17 -55.43 2.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.671 0.788 . . . . 75.34 110.206 -173.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 56.8 77.96 0.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.745 1.218 . . . . 75.23 110.751 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.49 -82.2 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.284 -0.871 . . . . 72.32 109.969 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.3 m -155.19 93.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.333 0.653 . . . . 73.43 110.087 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -134.11 121.56 21.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.808 -1.182 . . . . 64.31 107.808 168.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.5 ttp 62.55 142.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 O-C-N 124.738 1.274 . . . . 75.43 112.039 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m -127.88 101.54 6.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.843 -0.799 . . . . 74.2 108.843 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' H' ' 206' ' ' ASP . 71.9 t80 -124.64 135.42 53.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.408 1.083 . . . . 70.53 108.352 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.573 ' HB3' ' HB3' ' C' ' 85' ' ' SER . 46.2 tt0 -146.35 105.28 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.09 0.556 . . . . 75.45 110.243 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.613 HD13 HD11 ' C' ' 16' ' ' ILE . 14.5 tt -72.14 129.91 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.43 0.692 . . . . 74.43 109.623 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.406 ' NE2' HE21 ' C' ' 12' ' ' GLN . 22.9 mm-40 -115.9 -49.16 2.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.919 0.487 . . . . 72.1 111.878 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -162.13 133.18 5.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.493 -0.558 . . . . 73.32 109.493 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.613 HD11 HD13 ' C' ' 13' ' ' ILE . 64.0 mt -123.14 138.35 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.583 -0.895 . . . . 74.41 108.583 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.461 ' HH ' HD11 ' C' ' 83' ' ' ILE . 26.3 p90 -174.73 162.75 3.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.806 0.336 . . . . 74.43 111.612 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -81.52 125.76 30.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.483 0.713 . . . . 74.55 110.064 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -75.57 -49.1 19.62 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.184 -1.043 . . . . 73.15 108.184 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.0 t70 -136.81 147.15 46.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.24 -1.345 . . . . 74.2 110.428 -172.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.5 mt -143.44 145.47 22.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 126.19 1.796 . . . . 74.03 106.622 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -161.03 149.25 15.9 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.256 0.551 . . . . 74.14 110.465 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -149.41 118.25 6.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.327 -1.36 . . . . 73.03 107.327 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.19 122.61 44.52 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.06 -0.719 . . . . 72.0 109.06 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.44 80.86 46.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.054 -1.091 . . . . 75.13 108.054 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.6 -26.43 16.5 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.207 1.938 . . . . 74.2 110.525 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.22 16.16 6.6 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.587 1.155 . . . . 74.02 110.759 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.11 99.99 Favored Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 113.649 0.981 . . . . 65.03 113.649 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.44 -26.5 3.99 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 121.79 1.66 . . . . 73.45 112.699 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -70.18 -33.47 71.78 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.383 1.073 . . . . 75.44 111.841 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 13.2 p -79.69 -18.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.447 1.099 . . . . 72.12 111.401 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.85 -28.44 66.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.293 1.037 . . . . 74.21 112.154 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -127.79 44.43 2.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 54.23 109.86 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -121.26 159.75 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.665 0.786 . . . . 73.54 110.389 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.16 120.32 11.25 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.709 0.63 . . . . 75.25 110.236 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -85.28 97.43 9.94 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.072 0.939 . . . . 75.24 109.905 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -140.56 62.57 19.05 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.417 -0.957 . . . . 74.55 108.417 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.47 97.98 0.64 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.858 1.705 . . . . 64.44 112.282 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.89 77.6 9.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.57 -1.65 . . . . 75.4 107.494 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.574 ' HB ' HD13 ' C' ' 126' ' ' LEU . 19.6 m -89.84 110.73 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 113.687 -1.597 . . . . 72.11 110.36 -170.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -133.09 147.07 52.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 74.31 110.948 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.515 ' HG ' HD11 ' C' ' 128' ' ' LEU . 1.5 pp -105.38 165.73 10.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.356 0.598 . . . . 71.41 112.103 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -140.91 130.78 24.4 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.262 1.425 . . . . 71.44 107.531 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.95 118.43 36.95 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.247 0.619 . . . . 75.33 110.265 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 35.7 t70 -115.14 155.97 26.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.304 -0.999 . . . . 64.44 108.304 166.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -134.49 140.72 46.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.438 0.695 . . . . 75.02 110.29 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.3 38.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.29 1.036 . . . . 74.25 109.253 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -155.3 148.88 25.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.49 0.716 . . . . 74.35 109.274 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 38.3 t -144.86 128.29 16.93 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.635 0.774 . . . . 75.33 109.153 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -82.75 117.11 22.43 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.992 -0.744 . . . . 74.51 108.992 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' C' ' 57' ' ' GLU . 79.6 mt -92.48 -32.61 14.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.464 0.706 . . . . 72.23 110.368 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.34 -179.82 8.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.134 -0.939 . . . . 74.12 109.229 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.17 127.29 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 71.25 108.996 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.97 18.29 10.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.477 1.111 . . . . 74.01 112.461 -174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.28 115.16 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.568 -0.901 . . . . 73.15 108.568 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -116.16 169.57 9.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.055 0.931 . . . . 75.3 110.844 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD12 ' C' ' 51' ' ' LEU . 33.9 tt0 -127.45 133.24 49.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.924 -1.944 . . . . 73.22 107.99 173.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.42 127.89 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.101 -1.444 . . . . 73.12 107.101 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.52 HG23 ' HA2' ' C' ' 81' ' ' GLY . 61.7 t -126.46 114.23 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.234 -0.654 . . . . 74.2 109.234 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.519 HD22 ' HB3' ' C' ' 103' ' ' PRO . 18.6 mt -86.6 130.53 34.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.585 -0.524 . . . . 74.23 109.585 172.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.605 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 49.1 mtp180 -101.45 104.27 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.197 -1.038 . . . . 74.34 108.197 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.59 110.42 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.475 -1.305 . . . . 74.54 107.475 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -110.85 145.65 37.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.842 -0.799 . . . . 74.03 108.842 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.753 HG11 ' HG ' ' C' ' 126' ' ' LEU . 53.3 t -128.58 135.26 62.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.899 0.88 . . . . 74.22 109.224 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -117.92 138.11 52.37 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.989 -1.115 . . . . 73.52 107.989 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.99 132.79 55.13 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.269 -1.012 . . . . 71.34 108.269 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -132.96 164.21 27.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.833 0.708 . . . . 72.1 109.262 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.4 mt -124.04 29.08 6.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 106.926 -1.509 . . . . 74.33 106.926 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.82 -100.76 1.73 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.082 -0.963 . . . . 74.54 110.85 -169.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -89.67 -32.51 17.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.392 0.677 . . . . 71.24 110.107 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.65 120.84 32.05 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.616 0.766 . . . . 73.43 109.454 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -67.65 140.47 56.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.89 0.476 . . . . 74.34 111.026 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.43 -51.41 4.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.803 0.441 . . . . 64.21 109.931 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -168.5 177.27 5.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.944 0.898 . . . . 75.25 111.299 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.462 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -137.04 147.34 46.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.086 1.354 . . . . 73.14 107.391 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.462 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.0 t -148.99 153.48 37.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.349 0.66 . . . . 74.25 109.395 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -158.82 140.96 13.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.458 0.703 . . . . 71.25 109.905 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.98 119.26 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.714 0.806 . . . . 74.52 109.531 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.605 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 47.8 mt-30 -91.14 98.4 11.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.052 0.941 . . . . 64.33 109.623 172.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.447 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.2 tp-100 -88.78 107.82 19.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.617 0.767 . . . . 74.32 110.615 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.52 ' HA2' HG23 ' C' ' 59' ' ' VAL . . . -84.07 158.72 35.02 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.77 0.669 . . . . 75.4 113.041 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.64 117.29 0.77 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.481 -0.648 . . . . 73.31 111.481 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.461 HD11 ' HH ' ' C' ' 17' ' ' TYR . 15.0 mm -81.81 122.47 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.34 -0.615 . . . . 75.21 109.34 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -135.71 119.23 16.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.682 0.793 . . . . 75.23 109.149 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' C' ' 12' ' ' GLN . 41.1 t -77.08 128.0 33.68 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.765 -0.828 . . . . 72.14 108.765 170.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.47 HD12 HD13 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -145.99 126.9 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.501 0.72 . . . . 75.14 110.433 -166.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.85 176.19 11.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.591 1.157 . . . . 72.22 110.176 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -50.96 4.0 Favored Glycine 0 N--CA 1.48 1.626 0 CA-C-O 121.295 0.386 . . . . 64.32 113.257 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.602 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.1 OUTLIER -64.83 156.34 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.448 1.499 . . . . 73.25 113.76 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -145.99 148.04 32.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.586 0.755 . . . . 74.3 109.24 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.38 -109.19 2.32 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.065 0.853 . . . . 35.4 114.345 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.636 HG23 ' HB3' ' C' ' 143' ' ' GLN . 56.6 p -53.99 -49.03 69.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 71.34 112.731 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 47.2 mt-30 -63.97 -46.62 83.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.122 0.569 . . . . 71.5 111.587 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.602 ' HB3' HG12 ' C' ' 89' ' ' ILE . 19.7 ptm -68.95 -37.22 78.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.053 0.221 . . . . 74.35 111.454 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -33.74 75.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.286 0.634 . . . . 65.2 111.185 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.475 ' HE1' ' HA ' ' C' ' 138' ' ' MET . 4.1 t60 -75.8 -33.56 60.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.75 -0.659 . . . . 74.51 109.97 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.47 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 18.8 t -66.77 -60.97 2.21 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 123.559 0.744 . . . . 75.01 111.279 -173.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.57 HD11 ' HB3' ' E' ' 175' ' ' PHE . 1.4 pt? -77.22 -18.43 57.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.173 -0.33 . . . . 71.23 111.275 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -25.83 61.13 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.115 -0.493 . . . . 54.24 113.892 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.03 -43.2 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.518 0.933 . . . . 63.2 113.518 -172.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.71 -65.27 0.7 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.26 0.624 . . . . 74.11 111.751 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.47 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 15.1 m -60.53 -43.1 91.65 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.827 0.851 . . . . 75.11 112.259 179.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.519 ' HB3' HD22 ' C' ' 60' ' ' LEU . 98.0 Cg_exo -51.02 -47.24 26.6 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.597 2.198 . . . . 74.24 114.771 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.05 -21.98 64.06 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 122.579 0.352 . . . . 74.4 111.485 -173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.5 mm -60.58 -45.53 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.563 0.745 . . . . 73.52 109.855 168.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 40.7 mt -85.8 -22.73 27.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.828 -1.078 . . . . 71.14 112.456 -170.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.88 -52.34 65.82 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.016 -0.992 . . . . 74.24 113.465 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.51 -31.88 70.93 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 121.599 1.532 . . . . 73.0 113.55 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -65.79 -47.88 73.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.04 0.536 . . . . 75.33 110.606 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.39 -41.9 96.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.444 0.698 . . . . 63.33 111.057 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.04 -50.13 75.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.687 1.195 . . . . 74.14 110.664 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.5 -33.96 76.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.517 0.727 . . . . 72.3 110.289 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.13 -36.21 74.63 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 122.688 0.395 . . . . 73.01 111.654 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.52 HG23 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -69.81 -43.36 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.578 -0.527 . . . . 75.54 109.578 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.795 HG23 ' HB2' ' C' ' 125' ' ' GLN . 52.8 m -55.22 -38.62 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.255 1.022 . . . . 75.21 110.715 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -67.77 -53.65 25.52 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.638 -1.165 . . . . 51.45 110.272 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.73 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -49.79 -45.4 49.79 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.845 1.258 . . . . 73.54 112.921 -177.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.444 HG11 ' O ' ' C' ' 124' ' ' PRO . 92.7 t -72.01 -40.66 67.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.748 -0.66 . . . . 74.5 111.346 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -61.83 -31.88 72.16 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.365 -0.834 . . . . 65.22 111.208 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.53 -34.99 79.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.866 0.866 . . . . 74.14 110.25 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.52 11.8 37.09 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 123.744 0.652 . . . . 75.33 113.687 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 44.7 p 59.81 27.58 16.91 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.949 1.699 . . . . 74.44 112.617 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -109.05 167.85 8.55 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.246 1.018 . . . . 73.15 110.704 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.444 ' O ' HG11 ' C' ' 118' ' ' VAL . 43.7 Cg_exo -56.78 118.12 4.92 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.255 2.637 . . . . 75.31 112.551 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.795 ' HB2' HG23 ' C' ' 115' ' ' THR . 3.6 pt20 -51.59 143.57 12.17 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.051 0.844 . . . . 74.54 111.709 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.753 ' HG ' HG11 ' C' ' 64' ' ' VAL . 2.5 mm? -97.58 59.66 1.53 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.726 1.25 . . . . 71.13 110.453 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' B' ' 122' ' ' THR . 32.1 t30 -95.61 83.85 3.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 112.927 -1.942 . . . . 75.44 107.414 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.515 HD11 ' HG ' ' C' ' 42' ' ' LEU . 21.7 mt -90.73 154.41 19.56 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.198 -0.91 . . . . 75.33 110.241 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.49 ' HB3' HD12 ' E' ' 187' ' ' ILE . . . -35.71 135.36 0.5 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 126.201 1.8 . . . . 73.45 115.107 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.77 93.73 0.44 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.636 2.224 . . . . 72.04 111.504 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.89 106.7 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.955 0.883 . . . . 70.21 111.759 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.48 71.69 0.75 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.773 0.829 . . . . 74.04 109.63 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -64.52 -29.12 70.16 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.974 -0.557 . . . . 71.53 111.085 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' C' ' 138' ' ' MET . 36.0 t70 -59.44 -23.44 62.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.491 0.716 . . . . 75.33 112.598 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.57 -32.77 63.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.042 0.449 . . . . 74.23 111.607 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.23 -42.73 25.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.975 0.91 . . . . 75.43 110.001 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.401 ' HB2' ' HA ' ' C' ' 134' ' ' ASP . 40.7 m-85 -70.4 -14.88 62.74 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.234 1.013 . . . . 73.31 112.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.475 ' HA ' ' HE1' ' C' ' 96' ' ' HIS . 89.6 mtp -61.97 -47.38 85.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.23 -0.655 . . . . 75.13 109.23 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -64.6 -36.83 85.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.99 0.916 . . . . 75.12 111.083 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -62.78 -82.09 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.911 0.885 . . . . 74.21 111.214 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.82 87.29 7.31 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.371 0.668 . . . . 72.13 111.464 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.97 120.46 24.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.665 1.186 . . . . 74.24 110.248 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.636 ' HB3' HG23 ' C' ' 92' ' ' THR . 52.5 tt0 -174.83 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.774 0.83 . . . . 74.42 109.232 171.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.546 ' NE2' ' HB3' ' A' ' 139' ' ' ASN . 0.6 OUTLIER -173.18 128.97 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.925 0.89 . . . . 64.4 110.331 -175.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.63 84.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.215 0.606 . . . . 75.43 110.071 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.64 92.94 0.91 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.617 -0.593 . . . . 52.32 111.617 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.9 143.08 33.32 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.15 0.58 . . . . 72.15 110.548 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.73 119.72 3.1 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.835 -0.62 . . . . 75.03 111.892 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 54.4 p -93.88 129.6 40.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.162 0.585 . . . . 73.42 109.937 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -87.71 126.85 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.461 0.704 . . . . 74.33 110.328 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -81.99 174.04 11.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.029 0.532 . . . . 75.23 111.503 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -150.24 122.78 8.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.573 0.749 . . . . 74.31 110.037 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.18 135.63 56.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.387 -0.597 . . . . 70.35 109.387 168.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -148.28 -66.61 0.24 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.884 0.311 . . . . 73.31 111.053 -171.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.408 0 C-N-CA 123.343 0.657 . . . . 64.12 109.431 -179.002 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.624 0.25 . . . . 73.13 110.853 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' E' ' 206' ' ' ASP . 18.1 m -81.46 15.99 1.85 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.245 0.831 . . . . 71.31 113.245 -170.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.74 -42.12 16.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.757 0.823 . . . . 73.0 110.666 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -77.23 139.75 39.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.443 -0.799 . . . . 73.12 110.736 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -77.79 69.06 3.97 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.309 1.043 . . . . 73.34 109.34 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -153.15 179.51 8.66 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.608 1.163 . . . . 72.32 108.557 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m 80.51 -67.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.834 1.654 . . . . 75.45 111.057 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' D' ' 9' ' ' MET . 21.1 tt0 -172.99 -170.93 0.69 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.513 0.725 . . . . 72.33 109.301 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.477 ' HG3' HG21 ' D' ' 89' ' ' ILE . 6.7 ttp -29.76 135.37 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.509 1.524 . . . . 64.01 113.032 161.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.1 m -107.34 140.63 39.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.158 -0.682 . . . . 74.21 109.158 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.403 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 40.5 t80 -152.28 97.82 2.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 106.477 -1.675 . . . . 64.42 106.477 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 75.8 mt-30 -112.25 118.32 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.746 0.419 . . . . 72.35 110.814 -173.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.5 103.14 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 107.926 -1.139 . . . . 72.21 107.926 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.96 -50.06 8.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.581 0.173 . . . . 73.21 111.405 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -170.8 134.04 0.99 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.767 0.427 . . . . 75.43 110.479 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.23 130.66 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 33.5 p90 -149.3 149.97 31.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.358 0.663 . . . . 75.14 111.895 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.6 p -77.71 114.66 16.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.669 -0.696 . . . . 75.21 109.75 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -86.06 -20.25 29.06 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.915 0.486 . . . . 73.05 110.059 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.717 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.8 t70 -153.55 140.24 18.96 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.72 -1.127 . . . . 61.32 109.594 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.73 HG21 ' HE1' ' C' ' 117' ' ' MET . 96.3 mt -136.67 144.72 31.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 125.189 1.396 . . . . 73.23 107.554 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -154.76 133.62 12.22 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.959 0.787 . . . . 73.33 109.507 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.5 t80 -132.48 126.8 33.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.283 -1.747 . . . . 74.41 106.283 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -121.63 142.75 49.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.03 -1.1 . . . . 74.21 108.03 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.421 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -138.42 76.71 36.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 106.374 -1.713 . . . . 75.33 106.374 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.19 -34.15 28.83 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.822 2.348 . . . . 65.44 112.783 -169.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.423 ' O ' HG21 ' D' ' 31' ' ' VAL . 41.2 m-20 -116.13 23.3 12.28 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.091 0.956 . . . . 74.24 110.294 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -46.28 -50.47 38.55 Favored Pre-proline 0 CA--C 1.567 1.631 0 N-CA-C 116.462 2.023 . . . . 64.44 116.462 -167.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.86 -15.98 10.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 CA-C-N 122.137 1.799 . . . . 74.23 113.319 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -75.16 -26.87 59.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.668 1.187 . . . . 75.21 109.782 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.423 HG21 ' O ' ' D' ' 27' ' ' ASN . 70.4 t -80.02 -13.27 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.919 0.888 . . . . 71.15 110.648 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.46 -25.41 67.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.561 0.345 . . . . 71.32 110.543 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.12 -7.48 55.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 72.12 111.411 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -110.89 92.0 3.88 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.077 0.951 . . . . 75.53 109.478 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -97.41 77.76 2.65 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.097 0.559 . . . . 71.4 109.885 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -165.01 172.37 12.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.886 0.474 . . . . 73.45 110.141 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -60.19 116.09 16.02 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.512 1.125 . . . . 74.24 110.965 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.75 123.94 12.43 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.026 1.817 . . . . 60.12 110.884 172.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -57.85 110.94 1.0 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.15 105.87 19.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.397 -0.819 . . . . 72.03 109.139 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.9 115.42 29.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.524 -1.658 . . . . 74.53 106.524 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.22 155.88 16.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.161 0.584 . . . . 73.54 109.972 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -149.47 132.28 16.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.131 0.572 . . . . 72.32 109.726 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -112.06 137.04 50.64 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.834 0.854 . . . . 74.32 109.655 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.622 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 3.8 t70 -133.57 154.84 50.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.931 1.292 . . . . 63.24 108.06 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.3 m -137.19 146.33 44.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.161 0.585 . . . . 75.23 110.294 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 167.03 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.389 1.075 . . . . 62.42 108.891 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -164.71 155.75 14.9 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.968 0.507 . . . . 75.33 110.844 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.1 p -158.75 132.99 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 65.23 109.323 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.402 ' NE2' ' HG ' ' H' ' 173' ' ' LEU . 52.5 tt0 -69.44 133.8 48.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.391 0.676 . . . . 73.43 110.541 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' D' ' 57' ' ' GLU . 38.6 mt -102.16 -40.52 6.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.43 0.692 . . . . 75.4 110.31 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.98 -169.48 2.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.257 0.623 . . . . 71.44 111.222 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.71 111.48 1.64 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.241 -0.89 . . . . 61.44 110.648 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.664 ' H ' HD22 ' H' ' 173' ' ' LEU . 20.0 m-20 75.89 5.29 3.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.485 1.514 . . . . 72.31 110.739 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.422 HG23 ' HG ' ' D' ' 85' ' ' SER . 67.4 t -108.57 121.19 61.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.216 0.606 . . . . 75.12 110.299 -175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.39 130.22 53.48 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.707 -1.22 . . . . 75.14 107.707 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.49 ' HB2' HD11 ' D' ' 51' ' ' LEU . 5.4 tm-20 -88.48 131.48 34.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.104 -1.813 . . . . 73.44 106.104 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.69 129.86 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.416 -0.957 . . . . 65.44 108.416 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.481 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -108.97 135.11 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.409 0.684 . . . . 74.34 110.604 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -115.74 124.08 49.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.789 -1.56 . . . . 74.13 106.789 171.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.622 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -106.77 99.6 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.72 -0.844 . . . . 74.42 108.72 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.87 122.52 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 74.43 108.136 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -121.43 134.37 55.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.357 -0.838 . . . . 63.14 109.635 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.557 HG23 HD11 ' D' ' 114' ' ' ILE . 86.2 t -124.58 102.77 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.79 0.836 . . . . 73.21 109.275 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -101.47 108.02 19.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.513 -0.921 . . . . 61.31 108.513 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.94 139.05 44.33 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.999 0.919 . . . . 75.23 109.131 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 79.2 p -143.39 138.93 29.74 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.077 0.551 . . . . 73.21 110.338 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -115.72 111.27 20.32 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.203 1.001 . . . . 74.25 109.656 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.03 10.94 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.517 0.511 . . . . 64.35 112.626 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 4.05 49.39 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.88 0.872 . . . . 75.51 110.95 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -131.32 147.87 52.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.513 0.725 . . . . 71.23 110.591 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -64.72 138.06 58.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.25 1.02 . . . . 63.42 111.277 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.11 -59.55 2.07 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.556 -0.905 . . . . 71.32 108.556 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -164.24 153.85 14.1 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.807 -1.088 . . . . 73.23 109.951 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 53.3 mt -113.41 154.47 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.019 . . . . 72.2 108.982 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG22 ' D' ' 114' ' ' ILE . 47.2 t -158.58 147.05 18.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.526 0.33 . . . . 74.44 110.436 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.52 121.31 5.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.896 0.878 . . . . 74.35 109.042 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.49 116.07 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 122.987 0.515 . . . . 75.53 109.846 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.717 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -90.11 87.85 7.04 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.638 0.732 . . . . 75.2 109.282 170.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.28 100.39 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.138 -1.392 . . . . 75.32 109.178 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.42 169.87 38.18 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.158 -0.377 . . . . 74.34 112.158 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.65 137.6 4.7 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 112.558 -0.217 . . . . 72.31 112.558 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.27 125.31 42.29 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.676 0.79 . . . . 73.22 109.653 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.07 142.63 50.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.654 0.782 . . . . 75.24 110.299 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.588 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 31.0 m -105.93 99.34 8.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.801 0.84 . . . . 63.21 108.796 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.69 138.4 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.423 1.089 . . . . 74.24 109.386 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.25 162.3 12.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.049 0.54 . . . . 63.51 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.51 85.06 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.979 -0.555 . . . . 72.4 113.665 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.477 HG21 ' HG3' ' D' ' 9' ' ' MET . 0.2 OUTLIER -126.74 169.04 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.501 0.72 . . . . 74.21 110.83 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -160.59 162.12 32.74 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.992 0.917 . . . . 74.1 109.54 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.67 -140.73 48.04 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.831 0.707 . . . . 74.54 114.035 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -62.22 -24.25 67.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.194 0.998 . . . . 73.3 111.909 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -61.47 -50.77 71.41 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.258 -0.645 . . . . 73.34 109.258 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.737 ' SD ' ' HG2' ' H' ' 174' ' ' MET . 5.3 ptm -66.4 -34.53 78.16 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.487 0.492 . . . . 75.44 110.507 -176.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.47 75.0 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.38 0.61 . . . . 75.4 111.294 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -69.32 -49.94 51.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 74.1 110.658 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -73.93 -38.39 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.848 -0.614 . . . . 74.41 111.672 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.522 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.6 tp -84.93 -29.67 24.96 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.353 0.661 . . . . 63.14 110.454 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.58 39.4 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.855 -0.611 . . . . 74.51 113.346 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -61.17 1.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.102 0.451 . . . . 74.14 111.705 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.33 -40.86 97.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.056 0.761 . . . . 74.54 113.056 -173.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 74.1 m -68.35 -47.4 37.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 CA-C-O 118.95 -0.547 . . . . 65.45 112.104 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.513 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.9 Cg_exo -59.45 -32.91 97.18 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 121.844 1.696 . . . . 63.33 113.267 168.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -64.38 -24.93 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.122 0.569 . . . . 73.04 111.717 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.41 -44.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.44 -0.578 . . . . 75.43 109.44 171.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' D' ' 60' ' ' LEU . 51.4 mt -70.86 -26.06 63.09 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.33 -0.85 . . . . 74.22 111.528 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.03 -44.9 91.06 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 115.076 1.51 . . . . 75.54 115.076 -166.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.72 -35.01 95.93 Favored 'Trans proline' 0 C--N 1.381 2.282 0 CA-C-N 122.039 1.764 . . . . 74.41 113.032 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -76.44 -35.38 58.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.708 0.803 . . . . 74.51 110.482 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -48.38 71.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.585 0.754 . . . . 63.22 110.025 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.447 ' NH2' HG22 ' B' ' 105' ' ' ILE . 36.9 ttp180 -56.52 -50.33 72.13 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 113.97 -1.468 . . . . 75.33 110.869 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.27 -45.44 94.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.085 0.866 . . . . 74.43 111.091 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.471 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.9 t -57.17 -39.83 76.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 73.2 111.05 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.563 HG22 ' SG ' ' D' ' 76' ' ' CYS . 76.6 mt -68.72 -56.98 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.465 0.706 . . . . 74.51 109.847 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.415 HG21 ' HG3' ' D' ' 125' ' ' GLN . 88.2 m -49.46 -45.27 46.52 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.921 1.289 . . . . 73.32 111.923 -173.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 46.4 t -64.56 -45.52 86.74 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.893 -1.049 . . . . 75.52 110.258 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.6 mtm -63.22 -36.8 84.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.428 0.691 . . . . 70.15 111.801 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.403 HG22 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -66.88 -45.16 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 75.33 109.784 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -71.29 -27.23 63.27 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.69 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -69.98 -30.95 68.42 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.79 0.836 . . . . 74.33 109.643 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 8.74 63.95 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.818 0.698 . . . . 73.44 113.165 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.4 p 54.12 39.77 31.0 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.838 1.655 . . . . 74.3 112.313 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.531 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 38.9 m-85 -110.65 167.95 8.31 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.605 1.162 . . . . 74.53 108.861 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.21 155.84 62.91 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.392 2.061 . . . . 62.23 112.564 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.415 ' HG3' HG21 ' D' ' 115' ' ' THR . 34.7 tt0 -72.78 123.24 22.95 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.226 -0.657 . . . . 74.32 109.226 172.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.18 105.83 16.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.489 -0.93 . . . . 74.35 108.489 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 91.4 m-20 -97.6 88.86 4.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.915 -1.143 . . . . 73.02 107.915 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.552 HD11 ' HE1' ' G' ' 202' ' ' TYR . 26.3 tp -71.19 119.87 15.95 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.431 -0.804 . . . . 73.51 109.664 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.99 88.12 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.085 0.954 . . . . 72.42 112.288 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.32 106.8 1.18 Allowed 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.157 1.905 . . . . 65.0 110.796 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.06 109.95 30.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.371 -0.974 . . . . 74.54 108.371 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.85 79.25 6.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.415 -0.957 . . . . 73.03 108.415 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -21.02 60.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.807 -1.088 . . . . 74.13 109.393 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -52.92 -35.99 59.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.774 1.23 . . . . 72.43 110.736 172.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.528 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -61.71 -36.58 81.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.072 0.949 . . . . 62.42 112.854 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.42 -48.57 79.08 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.405 0.622 . . . . 74.12 110.228 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -73.2 -30.13 63.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.892 -1.049 . . . . 72.03 110.519 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.528 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 39.7 ttm -55.85 -37.95 69.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.65 1.18 . . . . 64.21 110.877 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -55.82 -46.28 78.14 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.151 0.907 . . . . 75.52 111.116 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -69.82 -38.03 76.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.267 0.627 . . . . 75.1 111.315 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.3 -32.17 72.97 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.132 0.573 . . . . 73.33 111.523 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.16 2.06 56.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.01 0.524 . . . . 75.21 111.59 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -125.12 64.12 1.15 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.791 0.805 . . . . 74.42 108.857 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -168.51 -167.07 0.74 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.335 -1.302 . . . . 74.45 109.418 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.3 97.21 0.18 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.434 0.694 . . . . 73.22 111.007 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.81 40.34 0.1 OUTLIER Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.582 -1.007 . . . . 73.33 110.582 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.33 121.94 41.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.586 1.154 . . . . 74.44 110.065 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.02 49.13 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.815 -0.914 . . . . 71.11 110.815 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 40.9 p -61.36 95.55 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.943 0.897 . . . . 65.11 111.798 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.64 95.63 3.41 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.49 -0.929 . . . . 73.34 108.49 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.41 -62.28 1.78 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.51 1.124 . . . . 74.41 111.588 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -142.39 139.55 31.73 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.5 0.667 . . . . 73.2 111.414 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -121.97 173.12 7.73 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.03 1.332 . . . . 71.02 107.774 169.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.5 100.78 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.152 -0.314 . . . . 74.42 110.152 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.209 1.004 . . . . 63.34 108.637 -178.736 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.814 -0.439 . . . . 71.33 109.814 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . 0.463 ' HA3' ' SD ' ' E' ' 174' ' ' MET . . . -76.32 70.48 2.14 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 112.338 -0.305 . . . . 62.32 112.338 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.09 -52.34 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.618 1.167 . . . . 72.44 110.896 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 35.8 m -144.49 -44.84 0.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.762 0.825 . . . . 75.41 109.044 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.01 -171.14 3.44 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 61.54 110.288 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.4 HD21 ' O ' ' C' ' 89' ' ' ILE . 67.2 mt 68.54 -70.35 0.13 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.079 1.352 . . . . 74.32 109.341 -172.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.463 ' SD ' ' HA3' ' E' ' 169' ' ' GLY . 0.0 OUTLIER -69.03 124.13 22.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.857 0.863 . . . . 73.24 110.279 174.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' C' ' 98' ' ' LEU . 32.0 m-85 -62.06 98.04 0.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.908 0.883 . . . . 72.41 111.547 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -74.66 85.14 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.936 -1.135 . . . . 73.41 107.936 169.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 55.8 tp -104.37 100.65 10.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.654 0.782 . . . . 74.22 109.254 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -75.7 -75.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.861 0.464 . . . . 74.01 109.888 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . 0.482 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 29.3 tt0 178.38 -60.1 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.101 1.36 . . . . 71.21 109.53 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 98.6 Cg_endo -82.49 102.51 1.17 Allowed 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.581 1.52 . . . . 73.42 112.504 -173.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.45 -71.28 0.56 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.297 -1.001 . . . . 71.44 108.297 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -168.19 138.81 2.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.978 0.911 . . . . 75.55 109.229 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 54.1 m -122.47 133.51 54.6 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.222 -0.658 . . . . 71.51 109.222 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -80.03 127.65 76.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.415 0.686 . . . . 74.42 110.396 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -87.3 98.51 0.47 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.555 2.17 . . . . 72.0 110.936 169.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.52 174.22 9.95 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.737 -0.665 . . . . 74.22 111.114 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.537 HD13 ' HA2' ' F' ' 200' ' ' GLY . 21.3 pt -52.29 132.94 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.245 1.018 . . . . 73.2 111.684 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.25 86.3 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.705 0.802 . . . . 52.31 111.564 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . 0.415 ' HA ' ' HA3' ' F' ' 200' ' ' GLY . . . 65.52 11.19 7.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.649 1.18 . . . . 64.24 113.462 172.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.54 152.68 37.74 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.714 0.806 . . . . 74.52 110.699 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 66.99 -162.95 45.45 Favored Glycine 0 C--N 1.344 1.002 0 O-C-N 123.561 0.538 . . . . 70.35 113.632 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' F' ' 194' ' ' ALA . . . 127.51 -65.45 0.57 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.122 -0.539 . . . . 70.23 113.017 172.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . 0.43 ' HB3' ' CD1' ' F' ' 193' ' ' TYR . 80.3 m-85 69.36 52.76 0.45 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 74.52 108.948 -160.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -69.93 -2.19 11.74 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.85 0.685 . . . . 75.31 112.85 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -146.35 132.1 18.97 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.463 0.705 . . . . 75.44 109.821 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . 0.465 ' HG3' ' HA2' ' F' ' 192' ' ' GLY . 46.4 mtpt -86.96 138.1 31.81 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.496 -1.298 . . . . 75.45 107.496 164.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -142.08 36.62 1.56 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.97 -1.492 . . . . 64.15 106.97 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.2 -24.4 34.93 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 112.805 -1.998 . . . . 71.02 111.142 -172.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -138.93 169.35 17.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.284 -0.871 . . . . 73.35 111.119 -169.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -71.79 91.67 0.51 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.736 -0.945 . . . . 50.32 110.736 169.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' F' ' 190' ' ' ASP . 18.8 ptmt -116.23 11.67 15.2 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.954 0.902 . . . . 74.15 111.465 -173.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -161.87 39.09 0.13 Allowed 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.823 0.82 . . . . 64.22 110.518 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -125.96 141.33 52.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.923 -0.769 . . . . 74.43 108.923 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.413 HG22 ' HB ' ' E' ' 207' ' ' VAL . 3.1 mp -89.89 -60.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.995 -1.113 . . . . 71.51 107.995 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 78.14 -27.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.727 1.211 . . . . 73.44 112.572 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' D' ' 2' ' ' SER . 3.9 m-20 -86.88 -13.73 44.0 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.72 -0.612 . . . . 65.54 110.798 164.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.599 HG22 HD23 ' B' ' 136' ' ' LEU . 95.0 t . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 107.094 -1.447 . . . . 74.02 107.094 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.754 0.787 . . . . 63.24 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -142.8 149.44 21.31 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 111.09 -0.804 . . . . 72.22 111.09 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -101.85 128.51 48.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.813 0.845 . . . . 74.04 109.559 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m 65.9 18.41 11.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.565 1.146 . . . . 74.3 113.282 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -89.04 92.18 9.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.893 0.477 . . . . 35.5 111.726 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 tt -155.72 -70.99 0.11 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.853 -1.166 . . . . 72.34 107.853 170.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.575 ' HE3' ' HA ' ' F' ' 174' ' ' MET . 18.9 mmt -94.02 80.36 4.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.925 -0.398 . . . . 74.14 109.925 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 67.1 t80 66.82 114.89 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.433 1.493 . . . . 73.13 111.821 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -151.87 44.91 0.75 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.252 1.025 . . . . 75.15 109.212 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' B' ' 98' ' ' LEU . 6.5 mp -80.65 -59.19 2.78 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.505 -1.295 . . . . 72.15 107.505 172.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . 0.553 ' HG2' ' HG3' ' F' ' 179' ' ' GLU . 36.4 tt0 66.07 -74.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 70.11 111.5 175.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . 0.553 ' HG3' ' HG2' ' F' ' 178' ' ' GLN . 34.9 mt-10 -109.02 131.58 21.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.135 0.974 . . . . 74.44 109.005 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.18 111.6 2.06 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.431 2.088 . . . . 72.02 110.527 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -65.71 -43.31 89.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.04 0.536 . . . . 71.32 111.401 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -136.06 156.72 48.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.056 0.543 . . . . 74.03 109.934 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 42.6 p -117.64 130.1 56.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.065 0.946 . . . . 75.33 109.003 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -67.94 140.25 93.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.678 0.391 . . . . 75.2 110.714 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.26 109.52 2.23 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.221 1.948 . . . . 73.35 111.984 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.67 150.72 46.7 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.236 -0.893 . . . . 74.51 110.592 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' B' ' 129' ' ' ALA . 31.3 pt -86.42 160.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.403 0.681 . . . . 75.44 111.074 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.77 68.34 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.058 -0.519 . . . . 72.4 111.021 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . 62.05 156.11 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.273 1.429 . . . . 73.13 112.203 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . 0.457 ' HB3' ' HE3' ' E' ' 201' ' ' LYS . 29.7 t70 -167.01 147.08 5.52 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.218 -0.446 . . . . 71.21 110.455 -171.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -98.76 -124.12 5.04 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.399 -0.364 . . . . 71.33 113.468 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . 0.465 ' HA2' ' HG3' ' E' ' 196' ' ' LYS . . . -147.16 177.32 25.52 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.061 0.362 . . . . 74.21 113.009 -173.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' E' ' 193' ' ' TYR . 63.7 m-85 -83.76 -35.72 24.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.067 0.547 . . . . 75.24 110.848 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' E' ' 192' ' ' GLY . . . -96.44 153.3 17.91 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.98 1.104 . . . . 74.33 113.98 -168.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -175.78 -96.5 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 105.775 -1.935 . . . . 70.33 105.775 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt 62.06 7.75 2.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.307 1.595 . . . . 72.31 115.307 157.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 59.79 83.55 0.13 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.783 1.233 . . . . 74.31 112.358 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' F' ' 199' ' ' ASN . 22.7 tt0 -149.1 168.76 22.32 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.645 0.778 . . . . 74.01 109.932 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . 0.469 ' H ' ' HG2' ' F' ' 198' ' ' GLU . 31.9 m-80 -63.69 111.38 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.067 0.947 . . . . 73.41 110.946 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' E' ' 187' ' ' ILE . . . 104.64 -170.91 18.72 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.815 -0.63 . . . . 72.21 112.626 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? 62.39 -159.5 0.32 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.04 0.936 . . . . 65.51 110.626 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -73.06 -7.59 51.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 120.958 0.408 . . . . 74.52 110.978 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -98.9 -173.76 2.6 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.125 0.97 . . . . 64.42 110.818 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 12.3 tt -142.43 149.18 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.691 1.196 . . . . 74.41 109.293 -175.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.65 139.07 17.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.973 0.509 . . . . 74.52 110.197 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 11.6 t70 71.35 -92.0 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.534 1.534 . . . . 71.52 111.577 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.261 1.71 0 C-N-CA 123.885 0.874 . . . . 70.23 109.874 179.161 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 tttp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.284 -0.265 . . . . 74.31 110.284 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.51 -76.74 0.78 Allowed Glycine 0 C--N 1.357 1.74 0 O-C-N 123.563 0.54 . . . . 62.42 111.822 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -74.04 169.18 18.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.922 0.889 . . . . 71.1 109.995 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 52.0 m 64.04 87.76 0.11 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.569 1.147 . . . . 75.53 110.348 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -169.44 -162.33 0.34 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.338 1.455 . . . . 73.15 108.855 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 73.86 -66.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.906 1.682 . . . . 73.44 110.874 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.507 ' HE3' ' O ' ' A' ' 86' ' ' ILE . 18.6 mmt -122.26 106.9 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.27 1.028 . . . . 74.32 108.658 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 65.58 173.05 0.22 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.676 1.235 . . . . 73.5 112.222 -174.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 64.91 139.39 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.693 1.597 . . . . 74.24 113.14 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.32 143.3 29.03 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 106.484 -1.672 . . . . 72.35 106.484 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . 0.509 HE21 ' HG3' ' G' ' 179' ' ' GLU . 19.6 tp60 -66.26 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.815 -0.439 . . . . 72.22 109.815 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.509 ' HG3' HE21 ' G' ' 178' ' ' GLN . 49.7 mt-10 -153.17 154.61 31.07 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.179 0.992 . . . . 72.15 108.912 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.53 101.06 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.078 1.852 . . . . 65.53 111.441 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -67.61 -20.44 65.36 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.56 0.695 . . . . 74.32 109.82 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.35 -175.88 4.38 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.432 -1.258 . . . . 71.52 109.603 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 183' ' ' THR . . . . . 0.519 HG23 ' HD3' ' G' ' 185' ' ' PRO . 8.2 t -125.63 174.9 7.95 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.274 -0.639 . . . . 75.4 109.274 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -145.25 86.95 7.3 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.6 -0.889 . . . . 75.21 108.6 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . 0.519 ' HD3' HG23 ' G' ' 183' ' ' THR . 58.3 Cg_endo -71.11 104.84 1.59 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.841 2.361 . . . . 72.21 112.127 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.78 115.98 18.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.743 -0.662 . . . . 73.45 109.479 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.45 HD11 ' HB3' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -60.52 163.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 71.3 111.06 173.013 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -125.36 150.91 46.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.299 0.639 . . . . 73.41 110.528 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -73.01 114.64 11.39 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.79 0.436 . . . . 72.23 109.847 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -55.41 -61.52 2.28 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.019 0.824 . . . . 72.12 111.498 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 173.71 147.49 6.0 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-O 119.928 -0.373 . . . . 71.3 112.762 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.43 -151.86 26.5 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.875 -0.49 . . . . 42.21 111.875 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -155.07 -82.85 0.07 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.704 0.802 . . . . 71.33 109.169 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -174.09 108.54 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.113 0.965 . . . . 72.11 108.631 -173.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -84.33 112.77 20.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.981 -1.488 . . . . 72.42 106.981 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -68.77 90.21 0.41 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 123.909 0.755 . . . . 74.2 112.463 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.12 105.82 18.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.738 -1.119 . . . . 65.22 110.408 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.57 133.25 5.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.191 -1.411 . . . . 72.33 107.191 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -84.0 -32.27 25.04 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.05 0.54 . . . . 74.11 110.836 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.56 -85.19 0.74 Allowed Glycine 0 C--N 1.345 1.054 0 N-CA-C 109.429 -1.468 . . . . 75.41 109.429 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . 0.504 ' HE3' ' O ' ' G' ' 203' ' ' ASP . 36.5 ttpt -173.43 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.572 1.149 . . . . 73.51 110.07 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . 0.552 ' HE1' HD11 ' D' ' 128' ' ' LEU . 13.6 t80 70.98 48.43 0.38 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.589 1.555 . . . . 74.43 109.44 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . 0.504 ' O ' ' HE3' ' G' ' 201' ' ' LYS . 27.1 t70 62.63 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.605 1.562 . . . . 75.24 110.404 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . 0.461 HD12 ' HG2' ' B' ' 12' ' ' GLN . 45.2 mt 48.74 88.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.309 1.444 . . . . 74.21 113.116 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . 0.461 ' HE2' ' O ' ' H' ' 186' ' ' LEU . 57.5 pttt -77.35 -179.75 5.91 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.217 -0.901 . . . . 74.41 109.683 168.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.01 -71.33 0.18 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.578 0.751 . . . . 74.23 110.224 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.985 1.314 . . . . 70.43 109.023 174.41 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . 0.416 ' HZ3' ' HB3' ' H' ' 168' ' ' LYS . 9.5 mtpm? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.788 0.327 . . . . 74.11 110.664 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.96 -143.06 13.93 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.662 -0.975 . . . . 72.12 110.662 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -109.34 -30.39 8.0 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.817 0.847 . . . . 72.42 109.225 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 50.1 m 63.98 27.0 14.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.973 1.309 . . . . 65.14 111.615 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.37 75.74 10.2 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.816 0.847 . . . . 73.12 108.727 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.664 HD22 ' H ' ' D' ' 54' ' ' ASP . 4.1 mm? -109.82 81.66 1.47 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.05 0.929 . . . . 75.55 109.696 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.737 ' HG2' ' SD ' ' D' ' 94' ' ' MET . 0.2 OUTLIER -110.3 166.32 11.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.938 -1.483 . . . . 74.04 108.071 171.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -161.82 88.49 0.7 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.443 -0.947 . . . . 74.52 108.443 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -102.97 92.48 4.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 122.24 1.019 . . . . 72.33 108.492 173.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.22 21.76 0.65 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -65.2 -26.14 68.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.281 1.033 . . . . 74.21 111.583 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -133.47 147.3 64.21 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.043 0.937 . . . . 53.4 109.807 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.33 101.35 1.11 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.129 1.886 . . . . 73.45 110.708 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -59.77 -35.01 73.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 74.52 110.329 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.35 129.84 15.86 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.561 -1.2 . . . . 72.44 109.842 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -85.5 132.02 34.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.755 -0.831 . . . . 70.54 108.755 172.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -132.0 86.3 47.78 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.631 0.772 . . . . 73.41 111.111 -173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.98 115.31 3.99 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.753 2.302 . . . . 75.51 110.642 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . 0.461 ' O ' ' HE2' ' G' ' 205' ' ' LYS . 6.2 mp -67.85 -83.39 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.002 0.521 . . . . 74.21 111.066 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' G' ' 204' ' ' ILE . 2.3 pp -150.83 177.15 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.569 0.748 . . . . 75.1 111.406 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -118.85 -148.03 0.41 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.77 1.228 . . . . 73.5 107.747 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.68 141.89 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.458 0.703 . . . . 72.25 109.994 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.56 -178.04 3.44 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.27 -0.641 . . . . 73.03 109.27 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.22 -89.48 0.14 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.312 -0.715 . . . . 74.43 111.312 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 66.04 41.07 95.37 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.777 0.339 . . . . 73.4 113.281 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -99.92 148.41 24.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.214 0.606 . . . . 65.53 110.388 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.29 169.25 10.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.628 0.771 . . . . 75.33 110.028 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.456 ' HE2' ' HD3' ' D' ' 124' ' ' PRO . 3.2 m-30 -114.44 -55.07 2.53 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.665 0.386 . . . . 74.41 110.855 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.24 79.44 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.123 1.369 . . . . 74.12 109.098 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -63.12 81.23 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.809 -1.087 . . . . 75.25 111.418 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -80.54 82.49 6.54 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.626 0.727 . . . . 74.25 109.368 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -90.27 -165.94 1.47 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.801 -1.09 . . . . 74.22 111.454 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.43 73.41 1.37 Allowed Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.164 -0.774 . . . . 73.31 111.164 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -73.25 -12.33 60.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.993 0.917 . . . . 72.01 111.607 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -63.14 159.29 17.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.355 0.662 . . . . 74.45 111.089 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -86.31 124.33 32.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.917 -0.583 . . . . 75.33 109.879 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.501 ' HB ' ' HA ' ' C' ' 12' ' ' GLN . 3.4 mp -96.22 124.14 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.877 -0.786 . . . . 74.33 108.877 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.1 118.74 34.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.964 -1.495 . . . . 75.11 106.964 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' C' ' 11' ' ' PHE . 2.0 p-10 -53.44 -44.84 69.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.021 0.928 . . . . 73.11 111.531 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 136' ' ' LEU . 7.3 p . . . . . 0 C--O 1.254 1.327 0 C-N-CA 123.782 0.833 . . . . 74.24 109.214 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mmt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 108.599 -0.889 . . . . 75.34 108.599 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -94.41 8.68 41.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.873 . . . . 73.51 111.837 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' HB3' HE22 ' A' ' 144' ' ' GLN . 2.6 mp0 -73.11 177.05 5.29 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.403 0.681 . . . . 74.01 111.122 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 65.64 15.47 10.06 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.253 1.021 . . . . 75.34 111.325 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.37 78.84 9.57 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.904 -1.147 . . . . 43.25 107.904 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -78.96 -15.36 58.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.393 -1.276 . . . . 73.34 111.26 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -83.63 -179.96 7.46 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.572 0.749 . . . . 73.33 109.987 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 88' ' ' GLY . 9.0 tp10 78.22 -54.39 0.49 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.362 1.465 . . . . 73.45 111.663 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.459 ' SD ' ' HB3' ' A' ' 93' ' ' GLN . 56.2 mtm -67.32 136.0 54.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.6 0.76 . . . . 74.33 111.952 -175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -146.2 128.88 16.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.2 1.4 . . . . 72.35 108.796 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 55.9 t80 -131.88 147.85 52.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.444 0.697 . . . . 74.02 110.436 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.632 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 58.5 tp60 -145.44 134.05 22.14 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 123.67 0.606 . . . . 74.44 111.022 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.45 HD12 HG13 ' A' ' 16' ' ' ILE . 4.5 tp -92.76 128.93 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.011 0.924 . . . . 75.44 108.541 167.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -106.54 -41.87 5.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.463 0.305 . . . . 74.2 110.996 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -169.75 133.34 1.24 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 119.747 -0.168 . . . . 74.34 111.212 -171.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.811 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 67.9 mt -113.1 139.08 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.206 1.003 . . . . 72.34 109.017 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 29.9 p90 -165.3 175.53 9.12 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.008 0.818 . . . . 71.42 111.664 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.8 p -100.71 118.99 37.94 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.37 -0.974 . . . . 75.23 108.37 170.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.454 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 25.0 mtpt -74.1 -34.37 63.92 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.011 -0.737 . . . . 75.34 109.011 171.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 29.8 t70 -145.03 141.87 29.27 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.257 -1.338 . . . . 71.11 110.241 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.38 142.2 44.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 106.772 -1.566 . . . . 63.32 106.772 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 138.28 21.06 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.395 0.678 . . . . 75.33 109.46 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.594 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.5 t80 -143.33 128.43 18.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.824 -1.547 . . . . 64.44 106.824 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -129.95 131.71 46.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.305 -0.628 . . . . 72.03 109.305 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.6 77.96 22.1 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 107.486 -1.301 . . . . 72.04 107.486 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.0 -35.57 33.87 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.798 2.332 . . . . 75.4 111.023 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 31' ' ' VAL . 87.9 m-20 -95.25 25.71 4.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.17 0.988 . . . . 74.21 110.889 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.06 99.86 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.032 0.933 . . . . 74.12 112.221 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.83 -31.18 32.34 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 121.675 1.583 . . . . 72.43 112.106 173.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.6 m-70 -65.38 -30.97 71.85 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.707 0.803 . . . . 74.43 111.405 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 27' ' ' ASN . 48.1 t -58.54 -26.43 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 122.929 0.492 . . . . 72.22 111.376 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.95 -39.63 95.22 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.059 0.544 . . . . 75.13 110.431 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -74.28 -37.09 63.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.219 1.008 . . . . 75.51 110.336 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -82.34 160.07 22.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.208 -0.905 . . . . 73.41 111.28 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.42 141.54 35.2 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 108.266 -1.013 . . . . 72.24 108.266 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -79.93 82.69 5.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.203 0.525 . . . . 73.32 109.681 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.423 ' HG3' ' HA ' ' G' ' 193' ' ' TYR . 53.8 tt0 -132.73 72.91 76.91 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.161 -1.052 . . . . 71.12 108.161 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -83.05 157.77 15.33 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.563 2.175 . . . . 74.31 111.583 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -123.38 108.29 12.56 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.141 -1.059 . . . . 73.35 108.141 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.647 HG21 HD21 ' A' ' 128' ' ' LEU . 7.3 p -65.87 135.14 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 123.706 0.629 . . . . 72.42 111.64 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 47.6 mtpt -104.51 145.25 30.56 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.009 0.924 . . . . 74.3 108.731 167.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' G' ' 186' ' ' LEU . 4.6 mp -123.28 105.86 10.22 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.788 -1.19 . . . . 65.01 107.788 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.573 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.1 m-20 -115.88 102.76 9.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.766 -1.198 . . . . 74.13 107.766 173.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.96 122.65 43.19 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.84 -1.541 . . . . 63.44 106.84 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.11 154.12 49.79 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.742 -0.836 . . . . 70.03 108.742 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -106.83 157.68 17.56 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.502 0.668 . . . . 74.11 110.55 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.686 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . . . -149.98 143.94 25.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.681 -1.229 . . . . 65.11 107.681 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.453 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 54.3 m -130.1 152.09 49.92 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.95 0.5 . . . . 72.33 110.025 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -158.27 121.09 3.79 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.272 0.629 . . . . 73.0 109.62 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.65 109.26 15.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.458 -0.942 . . . . 75.24 108.458 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.406 HD12 HG22 ' A' ' 83' ' ' ILE . 74.4 mt -86.11 -41.11 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.113 0.565 . . . . 72.41 111.128 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.434 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -154.43 -172.11 4.09 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.689 0.796 . . . . 71.21 110.266 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.71 110.58 4.36 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.341 0.656 . . . . 71.13 109.455 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.58 0.43 2.95 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.226 1.41 . . . . 73.2 112.636 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.434 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 85.0 t -98.94 113.14 32.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.549 -1.278 . . . . 72.14 107.549 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.453 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 0.2 OUTLIER -116.96 169.74 9.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -129.99 121.98 27.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.552 -0.907 . . . . 74.54 108.552 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.17 120.95 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.536 -1.653 . . . . 73.42 106.536 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.686 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 41.6 t -108.36 132.24 56.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.736 -0.839 . . . . 72.42 108.736 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.96 111.21 23.44 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.205 -1.406 . . . . 74.01 107.205 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.86 98.4 8.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.864 -1.161 . . . . 74.53 107.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.0 t -96.96 142.08 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.255 -1.017 . . . . 64.43 108.255 178.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.7 m -135.62 127.03 28.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.467 -0.938 . . . . 75.25 108.467 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.615 HG13 HG22 ' A' ' 40' ' ' VAL . 55.2 t -125.24 107.75 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.723 1.209 . . . . 75.34 109.275 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 m -107.34 137.27 45.7 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.798 0.439 . . . . 75.42 109.943 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.03 122.36 39.93 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.931 -0.766 . . . . 74.43 108.931 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.548 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 67.2 m -118.81 130.78 55.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.0 0.52 . . . . 64.13 110.574 173.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.436 ' HG ' ' HB1' ' A' ' 73' ' ' ALA . 11.6 mt -87.79 69.58 9.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.432 1.493 . . . . 75.11 107.884 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -94.14 1.32 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 114.95 -1.023 . . . . 73.43 111.23 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.58 -25.98 14.24 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.726 0.81 . . . . 73.22 111.966 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -111.81 128.19 56.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.115 0.566 . . . . 64.45 110.691 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -67.38 133.26 49.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.21 0.604 . . . . 72.34 111.294 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.436 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -83.25 -56.64 3.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.613 1.165 . . . . 62.02 109.669 177.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -148.75 172.41 14.66 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.599 -1.182 . . . . 74.41 111.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -141.7 140.07 33.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.296 1.438 . . . . 72.41 107.733 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.615 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 29.9 m -128.04 140.59 51.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.988 -1.116 . . . . 71.52 107.988 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -148.85 118.31 6.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.255 -0.646 . . . . 73.32 109.255 168.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.14 110.6 23.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 123.752 0.821 . . . . 64.44 109.322 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.535 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.5 mt-30 -86.15 81.06 8.58 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.717 -0.846 . . . . 75.21 108.717 172.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.15 94.91 4.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.031 -0.986 . . . . 61.35 108.419 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -105.13 146.6 16.1 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 112.179 -0.368 . . . . 73.05 112.179 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.39 141.99 12.92 Favored Glycine 0 C--O 1.24 0.522 0 N-CA-C 111.433 -0.667 . . . . 75.53 111.433 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.416 HG13 ' HE1' ' A' ' 17' ' ' TYR . 50.6 mt -81.55 123.88 38.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.434 -0.95 . . . . 74.54 108.434 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -134.6 120.28 19.4 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.17 0.588 . . . . 75.0 109.743 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.632 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 24.0 m -83.6 103.25 12.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.881 -0.785 . . . . 72.41 108.881 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 HD13 ' A' ' 89' ' ' ILE . 45.2 pt -109.14 138.97 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.559 0.744 . . . . 71.41 110.709 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.5 153.79 33.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.206 -0.907 . . . . 73.42 109.344 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 8' ' ' GLU . . . 76.83 10.66 85.98 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 121.305 -0.474 . . . . 74.55 114.239 174.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.49 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 2.2 pp -107.37 130.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.513 -1.291 . . . . 65.23 107.513 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.49 ' HA ' ' HE1' ' A' ' 94' ' ' MET . 43.7 mt-10 -153.34 168.29 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.699 -1.223 . . . . 75.01 107.699 -174.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.97 -117.85 2.41 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 114.73 0.652 . . . . 75.14 114.73 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -81.82 -27.22 33.74 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 63.01 111.159 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 47.6 mt-30 -64.65 -36.11 83.2 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.808 0.843 . . . . 75.22 110.091 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.49 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 59.0 ttm -69.05 -45.94 69.13 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.305 -0.861 . . . . 74.03 109.403 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.23 -26.79 68.95 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.286 -0.87 . . . . 72.24 112.228 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -70.53 -43.85 68.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.775 0.43 . . . . 75.53 110.315 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -70.46 -64.25 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.856 0.722 . . . . 65.01 110.981 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.95 -19.76 60.57 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.149 0.425 . . . . 73.23 112.149 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.35 -35.15 8.16 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 114.23 0.452 . . . . 65.35 114.23 -170.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 133' ' ' PHE . . . -137.03 -48.01 0.6 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.793 0.294 . . . . 74.05 111.793 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.452 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.8 t80 -62.94 -61.44 2.39 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.407 0.683 . . . . 72.11 111.868 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.502 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.6 m -67.09 -37.45 13.57 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.72 0.808 . . . . 73.4 112.937 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.06 -44.05 48.4 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.149 1.9 . . . . 73.43 113.269 162.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -69.84 -23.43 63.3 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 75.22 111.664 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 102' ' ' CYS . 32.3 mm -65.77 -40.89 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.944 -0.762 . . . . 72.04 108.944 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.31 -23.06 26.41 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.364 1.066 . . . . 74.14 112.768 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -66.08 -42.84 53.86 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 114.249 1.203 . . . . 73.13 114.249 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.99 -34.56 99.2 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 121.938 1.758 . . . . 61.12 112.694 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -77.85 -39.0 44.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.761 0.825 . . . . 75.45 111.353 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.81 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.358 0.663 . . . . 75.13 109.548 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.478 ' NH1' HD13 ' C' ' 105' ' ' ILE . 34.6 ttm180 -48.59 -55.8 10.17 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.89 1.369 . . . . 75.54 110.717 176.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.438 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.0 tm-20 -66.07 -38.94 89.57 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.247 0.967 . . . . 74.21 111.18 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.573 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.2 t -62.37 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.221 0.608 . . . . 75.23 111.45 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.451 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 96.9 mt -76.6 -46.49 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.152 0.981 . . . . 65.34 110.534 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.2 m -57.04 -43.98 82.48 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.949 1.299 . . . . 72.11 111.373 -174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 29.0 t -68.68 -32.12 71.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.43 -0.805 . . . . 74.45 111.686 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.594 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 70.7 mtm -69.97 -38.28 76.04 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.581 0.352 . . . . 72.41 110.604 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -65.78 -48.51 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.559 0.743 . . . . 74.41 110.885 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.68 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 77.6 p -63.37 -35.61 80.96 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.516 0.674 . . . . 74.52 111.219 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -72.71 -20.5 61.21 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.3 -1.318 . . . . 74.45 110.656 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 16.39 37.87 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 119.413 -0.659 . . . . 75.13 113.295 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.456 HG22 ' HE ' ' B' ' 15' ' ' ARG . 0.5 OUTLIER 78.65 8.07 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 127.088 2.155 . . . . 75.43 112.082 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 119' ' ' SER . 19.0 m-85 -99.48 162.82 19.99 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.395 0.678 . . . . 74.45 110.127 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.98 125.93 13.18 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.857 1.704 . . . . 73.55 109.548 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.68 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 9.9 pt20 -61.72 147.54 45.77 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 123.554 0.534 . . . . 72.5 111.058 -173.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -121.77 113.0 19.07 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.984 -0.553 . . . . 75.3 110.118 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -110.72 111.68 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.388 -0.967 . . . . 74.32 108.388 174.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.647 HD21 HG21 ' A' ' 40' ' ' VAL . 86.7 mt -73.18 144.84 46.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.038 0.535 . . . . 71.33 110.284 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 153.64 75.36 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.788 0.835 . . . . 70.22 111.701 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.47 138.58 12.35 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 121.922 1.748 . . . . 71.15 111.847 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' G' ' 186' ' ' LEU . 5.8 m -103.45 112.44 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.485 -0.931 . . . . 64.41 108.485 171.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.71 69.9 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.466 0.651 . . . . 71.3 110.472 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.511 ' HD2' ' HB1' ' A' ' 100' ' ' ALA . 39.9 t80 -76.21 -23.53 54.62 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.687 -0.688 . . . . 72.55 110.007 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.54 -38.31 84.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.986 0.515 . . . . 64.11 109.821 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.25 -56.8 6.49 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.56 1.144 . . . . 71.03 110.748 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.14 -30.07 70.78 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.391 -0.822 . . . . 71.42 112.345 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -69.28 -57.03 5.86 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.66 0.784 . . . . 75.14 110.048 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -61.34 -34.14 74.79 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.86 0.464 . . . . 64.33 110.875 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.1 -35.67 69.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.22 1.008 . . . . 73.23 111.307 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.523 ' HD2' HD23 ' A' ' 141' ' ' LEU . 90.4 t80 -73.5 -60.27 2.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.34 0.656 . . . . 65.12 111.825 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.523 HD23 ' HD2' ' A' ' 140' ' ' TYR . 4.4 mm? -54.12 -45.45 71.9 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.971 0.794 . . . . 74.24 112.159 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -148.61 -14.02 0.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 112.821 0.674 . . . . 64.44 112.821 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 61.08 96.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.329 -1.36 . . . . 74.11 107.329 -158.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.491 HE22 ' HB3' ' A' ' 3' ' ' GLU . 10.8 pt20 -145.91 153.76 41.19 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.893 -0.594 . . . . 73.22 110.649 -169.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.34 -178.49 5.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.207 1.003 . . . . 64.34 109.675 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.29 168.11 31.96 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.754 -0.203 . . . . 65.11 113.087 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -164.93 115.35 1.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.027 -1.472 . . . . 74.31 107.027 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.72 89.95 0.33 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.144 -0.383 . . . . 72.15 112.144 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 p -80.36 153.83 28.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.401 0.68 . . . . 45.11 111.352 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.11 167.1 15.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.154 -1.054 . . . . 73.33 108.154 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -127.33 155.08 44.13 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.177 -1.046 . . . . 55.51 108.177 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -119.91 156.79 30.08 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.328 -0.619 . . . . 75.31 109.328 172.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -80.47 163.04 24.08 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.736 0.814 . . . . 73.53 109.665 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.87 157.12 12.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.097 0.959 . . . . 73.12 111.748 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 N-CA-C 108.518 -0.919 . . . . 74.41 108.518 176.157 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.474 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.886 -0.413 . . . . 72.44 109.886 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.506 ' HA ' HG21 ' B' ' 92' ' ' THR . 53.4 m -149.31 85.27 1.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.503 1.121 . . . . 74.34 108.568 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.93 -177.77 3.24 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.933 -1.03 . . . . 72.43 110.994 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.505 ' NE2' ' HB3' ' B' ' 144' ' ' GLN . 88.6 mm-40 -75.82 110.07 9.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.414 -0.812 . . . . 74.43 110.599 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.24 -173.4 2.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.515 1.126 . . . . 72.3 109.102 174.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -159.83 94.96 1.16 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.362 -0.607 . . . . 75.15 109.362 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -119.3 121.9 40.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.284 0.634 . . . . 73.33 109.604 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.19 -37.06 64.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.774 0.83 . . . . 75.54 110.32 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ptm 55.44 178.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.893 2.077 . . . . 75.13 116.091 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.7 m -148.35 139.0 22.86 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.722 -1.126 . . . . 74.35 108.567 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.44 123.45 13.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 73.52 109.82 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.526 ' HG2' ' HA ' ' G' ' 205' ' ' LYS . 1.8 mp0 -127.5 141.77 51.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.647 1.179 . . . . 73.31 109.83 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.599 HG13 ' HD3' ' D' ' 130' ' ' PRO . 61.4 mt -93.04 129.56 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.018 -1.104 . . . . 73.44 108.018 166.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -89.39 -40.92 12.42 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.581 0.55 . . . . 74.45 110.69 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.456 ' HE ' HG22 ' A' ' 122' ' ' THR . 68.8 ttt180 -167.55 150.46 6.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.774 0.43 . . . . 73.15 110.546 -170.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.11 145.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.998 -1.482 . . . . 75.04 106.998 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.452 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.1 p90 -170.62 162.21 7.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.685 0.394 . . . . 73.44 111.198 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 84.8 m -90.19 124.71 35.07 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.107 -0.701 . . . . 74.53 109.107 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.08 -45.19 11.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.899 -0.591 . . . . 75.4 109.505 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.481 ' HB3' HE21 ' B' ' 79' ' ' GLN . 19.4 t70 -148.92 146.05 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.889 -0.596 . . . . 74.34 111.807 -165.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.758 HD12 ' SG ' ' B' ' 113' ' ' CYS . 42.9 mm -138.35 150.01 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.463 1.505 . . . . 71.41 109.068 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -150.32 150.89 32.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.722 -0.672 . . . . 70.2 110.146 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 66.8 t80 -157.42 111.82 2.67 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.891 -1.522 . . . . 62.42 106.891 168.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -125.56 114.59 18.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 73.13 109.471 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' B' ' 74' ' ' PHE . . . -107.05 91.54 6.62 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.445 0.698 . . . . 72.44 109.503 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.84 -29.81 88.9 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.008 2.472 . . . . 75.1 112.62 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.45 31.27 6.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.873 0.869 . . . . 73.35 110.349 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.28 -55.59 13.31 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 125.115 1.366 . . . . 75.52 114.341 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.36 -13.91 10.82 Favored 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 121.751 1.634 . . . . 74.43 112.834 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -85.51 0.53 52.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.986 0.914 . . . . 75.02 111.841 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.47 -18.08 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 124.387 1.075 . . . . 74.12 111.008 170.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.55 -37.16 86.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.79 0.836 . . . . 64.44 110.825 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -85.85 -43.87 12.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.479 -0.782 . . . . 70.35 110.539 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 23.9 mmtp -78.08 89.9 4.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.059 0.544 . . . . 75.32 109.989 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -86.61 76.88 9.48 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.304 -0.862 . . . . 75.51 112.146 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -173.1 161.85 4.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.572 -0.74 . . . . 64.32 110.281 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' F' ' 195' ' ' PHE . 34.4 tt0 -75.24 117.29 61.92 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.519 0.728 . . . . 73.02 109.329 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.4 151.5 79.09 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.7 2.267 . . . . 75.1 113.333 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.28 102.82 8.81 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.032 -0.985 . . . . 75.23 108.391 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 13.6 t -86.75 121.78 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.807 -0.812 . . . . 73.01 108.807 -175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -130.52 133.84 46.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.095 0.958 . . . . 74.42 108.724 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.35 149.24 31.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.393 -0.595 . . . . 74.21 109.393 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -135.51 135.96 40.84 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.016 0.926 . . . . 64.05 109.313 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.29 146.76 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.813 0.845 . . . . 73.53 109.892 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.52 152.34 34.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.349 1.059 . . . . 71.34 108.275 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -137.27 137.93 39.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.184 0.594 . . . . 75.01 109.408 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.82 151.89 51.37 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.828 1.251 . . . . 61.13 107.961 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.0 m -132.11 161.89 32.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.096 0.558 . . . . 53.11 110.246 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -163.44 155.8 17.99 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.681 1.192 . . . . 65.31 108.399 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.5 tt0 -124.4 132.72 53.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.567 -0.531 . . . . 74.33 109.567 171.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.1 mt -100.7 -31.73 11.07 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.602 0.761 . . . . 75.44 111.342 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.494 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -162.31 -172.08 3.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.654 0.781 . . . . 64.12 111.326 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.36 107.19 1.56 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.034 -0.984 . . . . 72.44 111.119 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.0 16.41 7.0 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.651 1.181 . . . . 75.23 112.386 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.494 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 91.7 t -115.68 116.59 52.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.157 -1.423 . . . . 74.2 107.157 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.536 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 11.0 p90 -123.92 179.12 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.321 0.649 . . . . 65.52 109.894 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -142.44 134.18 26.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.556 -0.905 . . . . 74.13 108.556 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.72 125.91 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.142 -1.059 . . . . 73.0 108.142 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.08 113.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.594 -0.891 . . . . 74.34 108.594 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 0.4 OUTLIER -93.57 118.46 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.755 -0.831 . . . . 74.11 108.755 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 35.1 ttm180 -105.12 120.77 42.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.157 0.583 . . . . 75.52 109.83 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.464 HG21 HD23 ' B' ' 60' ' ' LEU . 48.4 t -116.53 110.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.734 -1.21 . . . . 74.21 107.734 167.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -106.65 128.39 54.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.02 0.528 . . . . 74.23 109.796 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.572 HG22 HG22 ' B' ' 114' ' ' ILE . 97.2 t -115.39 128.84 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.216 1.006 . . . . 65.34 109.696 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -121.94 142.5 50.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.263 1.025 . . . . 71.53 109.562 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.07 163.87 28.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.176 0.991 . . . . 65.25 109.564 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.5 p -146.71 138.49 24.56 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.462 0.541 . . . . 73.35 112.462 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 mt -110.47 106.09 15.28 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.029 1.332 . . . . 74.24 107.982 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.46 -106.27 2.21 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.329 -0.462 . . . . 75.4 112.485 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.46 5.89 11.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.156 0.983 . . . . 61.14 110.732 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -127.22 171.47 11.42 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.091 0.956 . . . . 74.43 109.424 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 59.6 m -76.7 142.78 40.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.085 0.554 . . . . 75.03 111.31 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.56 -64.08 1.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.527 0.731 . . . . 70.33 109.33 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 32.7 p90 -147.5 162.02 39.9 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.005 -0.998 . . . . 75.12 110.6 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -130.0 154.09 47.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.239 1.416 . . . . 72.14 107.567 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.477 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.4 t -154.75 159.49 40.7 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.059 0.944 . . . . 63.21 108.675 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -164.67 141.04 5.99 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.655 0.782 . . . . 75.41 109.253 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.497 HG21 ' SG ' ' B' ' 113' ' ' CYS . 69.9 t -129.13 140.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.755 0.822 . . . . 75.34 108.948 171.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.481 HE21 ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -126.89 92.77 3.6 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.849 0.718 . . . . 74.32 109.164 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -89.86 101.82 14.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.272 -1.331 . . . . 73.44 109.048 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.11 15.46 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.896 -0.882 . . . . 72.42 110.896 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.75 125.95 2.87 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.167 -0.773 . . . . 72.31 111.167 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.91 126.43 40.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.719 0.808 . . . . 74.32 109.252 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -132.9 161.57 33.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.665 1.186 . . . . 74.43 109.293 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -134.03 127.38 32.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.492 1.117 . . . . 73.32 108.504 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.509 HG12 HD12 ' B' ' 89' ' ' ILE . 8.5 tt -139.1 135.98 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.512 -0.551 . . . . 74.02 109.512 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.33 158.57 36.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.716 0.806 . . . . 74.4 109.999 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.31 -30.3 10.69 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 111.797 -0.521 . . . . 73.41 111.797 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.627 ' HB ' ' HB2' ' B' ' 93' ' ' GLN . 0.1 OUTLIER -83.31 169.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.967 1.307 . . . . 73.13 111.087 175.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -152.16 143.68 23.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.992 0.917 . . . . 75.3 109.718 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -99.8 0.16 Allowed Glycine 0 C--N 1.35 1.331 0 O-C-N 123.917 0.761 . . . . 74.1 114.715 170.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.506 HG21 ' HA ' ' B' ' 2' ' ' SER . 86.1 m -64.27 -42.75 96.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 74.45 112.349 -170.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.627 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 1.4 mp0 -62.13 -45.07 95.08 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.229 0.612 . . . . 74.42 110.093 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -39.97 65.93 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.233 -0.894 . . . . 73.24 110.164 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.56 69.13 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.252 0.621 . . . . 74.35 111.855 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -76.02 -40.58 53.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 74.54 110.501 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.524 ' SG ' ' SG ' ' B' ' 102' ' ' CYS . 49.6 t -66.2 -47.56 73.49 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.419 0.688 . . . . 75.44 109.674 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.65 -35.26 80.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.637 1.175 . . . . 74.51 110.837 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.69 2.14 87.78 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.375 -0.83 . . . . 63.15 114.172 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.99 -63.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.885 0.843 . . . . 63.4 112.732 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.8 -50.08 39.53 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.629 0.974 . . . . 72.43 113.629 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.524 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 61.4 m -58.44 -47.61 98.46 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.503 0.721 . . . . 63.23 112.081 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.03 -27.56 29.81 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 121.363 1.375 . . . . 73.51 112.898 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -64.84 -29.91 70.89 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.758 0.708 . . . . 73.1 110.515 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.523 HG22 ' NH2' ' D' ' 111' ' ' ARG . 63.7 mt -62.29 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.768 0.827 . . . . 62.51 110.372 172.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.424 ' HB2' HD13 ' B' ' 60' ' ' LEU . 39.2 mt -83.68 -11.85 56.66 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.882 -1.054 . . . . 75.22 111.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.539 ' HZ ' HD21 ' B' ' 128' ' ' LEU . 32.3 t80 -63.46 -46.8 84.28 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.298 1.439 . . . . 64.44 112.994 -170.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.419 ' HB3' ' HD2' ' D' ' 109' ' ' TYR . 29.1 Cg_endo -60.95 -36.93 80.71 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.64 1.56 . . . . 71.33 112.764 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.22 -42.25 99.13 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.247 0.619 . . . . 72.33 110.587 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -41.47 73.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.358 0.663 . . . . 65.2 111.357 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -56.53 -58.92 5.98 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.571 1.149 . . . . 74.42 111.275 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.39 -35.79 81.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.397 -0.819 . . . . 74.33 110.387 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.758 ' SG ' HD12 ' B' ' 21' ' ' ILE . 36.8 t -64.64 -37.14 86.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.476 0.547 . . . . 73.43 112.476 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.572 HG22 HG22 ' B' ' 64' ' ' VAL . 79.3 mt -70.76 -47.9 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.918 0.487 . . . . 73.42 110.131 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.6 m -62.49 -23.75 67.1 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.533 -0.758 . . . . 71.43 110.833 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -73.27 -54.71 7.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.567 1.147 . . . . 72.44 109.985 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.513 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -64.93 -33.74 76.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.982 0.913 . . . . 71.11 113.163 -172.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.91 -30.15 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 122.901 0.48 . . . . 75.24 110.175 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.51 ' HB3' ' HG2' ' B' ' 125' ' ' GLN . 54.5 p -72.14 -32.18 66.67 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.481 0.658 . . . . 65.53 110.478 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.573 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 67.7 mtt-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.722 -1.127 . . . . 73.01 109.814 171.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.37 15.79 52.34 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.097 -0.835 . . . . 71.44 113.342 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t 56.69 14.07 1.63 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 126.97 2.108 . . . . 74.05 113.884 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -106.14 160.15 27.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.698 0.799 . . . . 74.41 111.309 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.435 ' HA ' ' CE2' ' F' ' 202' ' ' TYR . 77.0 Cg_exo -52.77 101.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.782 2.988 . . . . 74.32 114.49 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.547 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 0.1 OUTLIER -68.86 155.45 40.21 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 113.356 -1.747 . . . . 72.4 110.293 176.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.6 tt -152.3 126.28 9.1 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.741 -0.837 . . . . 61.04 108.741 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.495 ' HB2' ' HG ' ' C' ' 119' ' ' SER . 24.9 t-20 -93.66 127.96 39.61 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.997 0.919 . . . . 62.42 108.661 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.563 HD12 HD21 ' F' ' 186' ' ' LEU . 1.7 tt -70.54 130.89 43.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.617 -0.512 . . . . 75.31 109.617 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.444 ' HB3' HG12 ' F' ' 187' ' ' ILE . . . -66.64 144.67 98.73 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.563 0.745 . . . . 60.21 111.042 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.465 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 57.8 Cg_endo -65.22 92.02 0.22 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.39 2.726 . . . . 75.03 113.431 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.459 HG11 HD12 ' F' ' 186' ' ' LEU . 19.6 m -84.95 108.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.953 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.444 ' HB3' HG21 ' D' ' 13' ' ' ILE . 52.5 t30 -109.84 105.93 15.32 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.188 0.595 . . . . 70.23 110.177 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.505 ' HD1' ' HB3' ' F' ' 184' ' ' TRP . 69.2 t80 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.803 0.841 . . . . 74.45 111.368 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.61 -36.77 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.364 0.665 . . . . 64.4 110.572 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.87 -40.57 84.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.955 0.902 . . . . 73.12 112.028 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.42 -40.81 73.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.358 0.663 . . . . 73.24 110.426 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.601 ' HA ' ' HD1' ' B' ' 140' ' ' TYR . 67.2 t80 -63.59 -31.25 72.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.892 0.877 . . . . 74.13 111.256 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 56.9 mtt -60.31 -36.99 79.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.435 0.694 . . . . 70.43 110.886 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 18.2 m120 -77.43 -25.16 50.45 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.501 0.72 . . . . 73.42 111.621 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.601 ' HD1' ' HA ' ' B' ' 137' ' ' PHE . 58.6 m-85 -74.15 -32.3 63.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.604 0.362 . . . . 71.34 111.043 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 42.9 mt -113.54 27.67 9.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.085 0.554 . . . . 72.12 110.873 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 28.0 tt0 -66.64 100.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.17 0.988 . . . . 71.34 111.505 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 54.99 28.03 10.1 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.316 1.046 . . . . 74.13 111.599 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.505 ' HB3' ' NE2' ' B' ' 4' ' ' GLN . 33.3 tt0 -75.15 80.46 2.3 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.174 0.99 . . . . 74.5 109.26 -175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.64 25.49 2.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.049 -0.978 . . . . 63.42 110.508 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.59 35.89 4.56 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.865 -0.894 . . . . 74.31 110.865 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.52 34.04 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.622 1.169 . . . . 74.12 109.085 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.45 85.64 0.08 OUTLIER Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.449 -0.796 . . . . 72.1 112.638 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -147.85 -178.53 6.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.643 1.177 . . . . 74.14 108.755 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.16 -160.54 0.14 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.211 1.004 . . . . 72.34 110.547 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.11 115.07 2.42 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.234 0.614 . . . . 74.33 111.159 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -125.28 -30.85 3.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.15 1.38 . . . . 61.42 110.178 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -86.23 18.26 3.24 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.626 0.77 . . . . 74.34 109.928 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.83 160.06 31.28 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.915 0.886 . . . . 72.23 111.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.538 -0.912 . . . . 73.11 108.538 179.82 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.181 -0.674 . . . . 75.34 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -78.17 89.97 4.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.636 -0.875 . . . . 70.13 108.636 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.23 113.91 13.14 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.004 -0.998 . . . . 75.42 108.724 -173.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 86.65 4.79 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.089 -0.708 . . . . 73.04 109.089 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -166.33 145.75 5.9 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.399 -1.334 . . . . 72.22 107.399 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -67.73 -73.45 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.215 -0.661 . . . . 72.33 109.215 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m 51.54 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.211 1.404 . . . . 74.53 110.889 -168.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 79.52 -43.25 0.29 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.218 1.807 . . . . 74.32 112.39 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 64.36 115.38 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.591 1.557 . . . . 71.54 112.308 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.414 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 80.5 m -124.46 103.61 8.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.393 -1.336 . . . . 75.02 107.393 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -122.83 123.7 41.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.343 -1.355 . . . . 74.45 107.343 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.429 ' HB3' ' HG ' ' C' ' 85' ' ' SER . 6.5 tp-100 -154.79 138.41 16.05 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.399 0.437 . . . . 72.33 110.733 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.17 142.35 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.869 0.867 . . . . 72.32 109.075 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 30.9 mm-40 -111.39 -35.73 5.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.416 0.686 . . . . 72.25 110.663 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.42 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 42.4 ttt180 -173.33 136.49 0.62 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.114 0.566 . . . . 74.44 109.654 -171.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -123.18 143.85 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.407 -1.331 . . . . 72.22 107.407 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -177.71 168.85 2.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 75.54 110.72 -177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -87.56 111.86 21.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.372 -0.831 . . . . 63.03 109.323 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.38 -43.92 89.22 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.2 -0.667 . . . . 75.33 109.2 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -147.34 147.1 29.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.222 -1.354 . . . . 75.45 110.078 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.88 144.57 29.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 125.782 1.633 . . . . 73.42 106.729 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -153.33 151.02 29.5 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.31 0.576 . . . . 63.23 110.644 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -155.08 134.04 12.23 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.573 -1.194 . . . . 74.14 108.077 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.8 147.28 52.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.439 1.096 . . . . 75.01 108.268 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 84.87 6.32 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.544 0.737 . . . . 74.44 109.785 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.38 -27.97 46.97 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.989 2.459 . . . . 74.21 111.302 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.804 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 6.8 m-80 -95.25 18.56 12.15 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.797 -1.092 . . . . 74.13 111.551 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.423 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -57.67 -50.29 88.98 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 118.613 0.642 . . . . 73.13 111.19 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 46.0 Cg_endo -94.18 -26.33 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.743 1.629 . . . . 74.34 113.571 164.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.804 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 61.2 t60 -69.05 -24.41 64.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.734 1.213 . . . . 74.41 113.312 -170.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.54 ' HB ' ' HB3' ' C' ' 27' ' ' ASN . 8.8 p -74.99 -12.01 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 122.825 0.45 . . . . 73.53 111.854 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.67 -41.34 81.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.402 0.681 . . . . 74.14 112.189 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -112.12 48.11 1.01 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.071 0.939 . . . . 64.54 108.949 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.594 ' HG2' HD11 ' C' ' 68' ' ' LEU . 1.9 tppp? -124.33 164.05 20.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.455 -0.793 . . . . 74.22 109.481 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.42 105.79 8.78 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.859 -1.164 . . . . 70.53 107.859 166.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.4 ' HA ' HD23 ' C' ' 68' ' ' LEU . 1.4 p90 -84.0 73.35 10.37 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.917 0.887 . . . . 74.32 111.466 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -124.93 77.62 66.17 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.048 -0.723 . . . . 73.01 109.048 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.779 ' HG2' ' HG3' ' C' ' 124' ' ' PRO . 1.3 Cg_endo -86.51 137.4 4.95 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.366 2.711 . . . . 74.14 111.794 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.63 117.02 24.27 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.61 -1.256 . . . . 75.34 107.61 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.31 79.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 115.236 -0.893 . . . . 74.13 109.406 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.07 141.56 35.63 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.209 0.604 . . . . 63.32 110.847 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.1 165.91 14.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.785 0.834 . . . . 73.33 110.846 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -145.83 148.4 32.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.914 1.286 . . . . 71.01 107.594 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 15.6 tp -116.47 148.91 40.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.213 0.461 . . . . 75.41 111.042 -172.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.665 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 12.9 m-20 -141.15 137.97 33.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.37 1.068 . . . . 73.42 109.17 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -113.97 126.22 54.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.502 -0.925 . . . . 73.23 108.502 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.96 165.29 25.04 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.38 1.072 . . . . 73.43 108.54 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 m -145.09 168.31 20.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.319 0.648 . . . . 73.52 110.441 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.19 128.0 4.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.729 1.211 . . . . 73.3 108.025 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -90.31 126.2 35.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.979 -0.749 . . . . 71.33 108.979 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.447 HD13 HD13 ' C' ' 83' ' ' ILE . 61.8 mt -97.93 -36.42 10.16 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.836 0.854 . . . . 72.34 110.18 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.99 -178.05 5.41 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.493 -0.776 . . . . 75.31 109.96 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -68.04 123.47 20.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.137 -1.061 . . . . 73.33 108.137 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.696 ' HA ' ' HE1' ' E' ' 174' ' ' MET . 21.6 m-20 73.06 -4.33 2.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.701 1.2 . . . . 73.32 112.823 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 98.01 6.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.91 0.884 . . . . 75.23 108.74 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.11 116.39 26.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.716 0.806 . . . . 75.21 110.481 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -82.83 121.92 27.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.985 -1.007 . . . . 75.32 109.484 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.85 124.56 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.98 -1.118 . . . . 74.23 107.98 170.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.06 103.41 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.016 -1.105 . . . . 73.24 108.016 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -93.01 110.07 21.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.193 0.997 . . . . 65.45 108.365 178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.665 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 47.5 ttp180 -103.34 137.33 41.6 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.035 0.534 . . . . 75.24 109.893 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.3 130.17 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.324 -1.362 . . . . 70.21 107.324 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -120.23 121.04 37.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.849 -0.797 . . . . 73.31 108.849 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.627 HG13 ' HG ' ' C' ' 126' ' ' LEU . 25.6 t -98.73 138.5 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.966 0.907 . . . . 73.51 109.319 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -123.35 138.75 54.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.153 -1.385 . . . . 73.2 107.486 171.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.946 -1.501 . . . . 62.54 106.946 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -134.49 128.85 34.22 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 123.643 0.589 . . . . 72.33 110.68 -176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.594 HD11 ' HG2' ' C' ' 34' ' ' LYS . 17.1 mt -84.65 47.55 1.39 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.482 1.513 . . . . 73.31 108.811 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.27 -82.82 0.49 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.847 -0.901 . . . . 75.33 110.847 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.98 -31.78 3.59 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.674 1.19 . . . . 73.34 108.829 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.55 ' HG2' ' HZ2' ' C' ' 34' ' ' LYS . 7.9 tp10 -62.49 121.84 14.27 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.902 0.881 . . . . 73.21 109.874 170.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -74.59 122.0 22.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.749 0.704 . . . . 73.34 109.62 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' C' ' 27' ' ' ASN . . . -72.35 -51.32 21.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.064 0.946 . . . . 61.41 109.92 177.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -167.17 176.68 6.64 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.916 -0.583 . . . . 75.4 110.443 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.42 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -131.02 142.89 50.37 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.59 -1.263 . . . . 75.14 107.59 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.46 ' SG ' HG21 ' C' ' 114' ' ' ILE . 47.2 t -144.63 147.73 33.45 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.373 -0.973 . . . . 73.43 108.373 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.99 141.47 14.07 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.714 0.406 . . . . 73.01 110.389 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.86 115.47 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.313 1.045 . . . . 74.34 108.922 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 45.6 mt-30 -91.51 95.3 9.87 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.557 -0.905 . . . . 74.53 108.557 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.96 111.49 20.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.775 0.83 . . . . 71.51 109.905 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 145.18 17.6 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 112.389 -0.284 . . . . 71.11 112.389 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.13 124.03 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.268 -1.133 . . . . 74.33 110.268 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 8.1 mm -81.87 121.5 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.193 -1.04 . . . . 75.02 108.193 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.42 118.86 28.42 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.291 -0.633 . . . . 71.11 109.291 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.429 ' HG ' ' HB3' ' C' ' 12' ' ' GLN . 23.5 p -85.43 100.44 11.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.833 -0.803 . . . . 61.32 108.833 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.37 146.49 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.594 0.758 . . . . 72.22 111.251 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.414 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -164.93 151.05 10.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.17 0.988 . . . . 73.41 109.959 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 -38.75 3.14 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 114.042 0.377 . . . . 72.04 114.042 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.56 148.93 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.455 1.102 . . . . 74.34 111.082 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.492 ' HA ' ' HB2' ' E' ' 172' ' ' ALA . 6.9 pt-20 -148.85 152.92 37.31 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.856 0.687 . . . . 75.52 112.856 -170.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.83 -139.37 38.66 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 114.724 -1.126 . . . . 70.22 114.008 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -69.17 -20.37 64.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.837 0.855 . . . . 72.25 111.195 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -65.36 -43.28 91.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.922 0.889 . . . . 74.33 109.978 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 52.5 ttm -62.95 -47.35 83.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.916 -0.583 . . . . 72.23 109.958 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.47 72.67 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.86 0.725 . . . . 73.53 111.732 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -73.42 -31.89 64.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.663 0.785 . . . . 70.11 110.027 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.14 -35.62 48.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 72.24 110.989 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.998 0.919 . . . . 74.42 110.303 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 11.11 62.44 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 115.914 -0.585 . . . . 71.4 114.18 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.01 -61.58 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.488 0.644 . . . . 71.35 111.34 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -73.77 -46.53 45.06 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.898 0.703 . . . . 74.43 112.898 -172.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.464 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 82.8 m -60.9 -48.73 91.9 Favored Pre-proline 0 CA--C 1.563 1.47 0 CA-C-O 118.977 -0.535 . . . . 74.21 110.75 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 71.9 Cg_exo -57.04 -33.67 96.17 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.439 2.093 . . . . 72.44 114.081 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.46 -34.87 79.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.313 0.645 . . . . 62.4 111.193 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.478 HD13 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -64.92 -41.57 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.229 0.612 . . . . 74.04 110.331 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.2 mt -81.49 -22.28 38.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.216 -0.902 . . . . 73.23 112.088 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.72 -48.51 95.06 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 117.723 -1.132 . . . . 75.32 113.55 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.03 -39.54 84.92 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.195 1.93 . . . . 71.22 112.607 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -62.88 -52.31 63.58 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.845 -1.07 . . . . 74.44 111.952 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.18 -34.81 73.44 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.319 -0.4 . . . . 71.53 111.397 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.83 -51.03 67.13 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.257 1.423 . . . . 75.31 110.473 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.98 -36.44 69.81 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.507 -0.77 . . . . 74.23 110.195 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.16 -30.96 71.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.09 0.556 . . . . 72.22 111.378 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.601 HG23 HG21 ' C' ' 64' ' ' VAL . 98.1 mt -72.3 -45.49 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.0 -0.546 . . . . 75.23 109.871 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -56.76 -37.32 70.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.801 0.688 . . . . 75.42 110.423 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.7 t -59.76 -56.95 15.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.923 1.289 . . . . 64.14 110.45 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.742 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.17 -41.91 89.53 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.586 1.154 . . . . 74.0 112.917 -176.153 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' C' ' 126' ' ' LEU . 69.2 t -66.29 -41.59 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.424 0.689 . . . . 72.33 110.747 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.575 ' HB2' HE22 ' C' ' 125' ' ' GLN . 45.5 t -63.31 -35.96 82.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.145 -0.934 . . . . 75.11 110.993 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.508 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.5 mtt-85 -66.89 -37.92 85.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.979 -1.01 . . . . 73.24 110.122 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.15 0.84 82.7 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.283 -0.732 . . . . 74.34 113.328 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p 57.09 50.94 11.1 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.523 1.529 . . . . 74.43 111.492 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.44 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 26.9 m-85 -121.65 169.74 8.75 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.474 1.11 . . . . 74.53 110.693 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.779 ' HG3' ' HG2' ' C' ' 38' ' ' PRO . 26.9 Cg_endo -57.8 126.71 22.6 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.732 2.288 . . . . 71.24 110.905 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.575 HE22 ' HB2' ' C' ' 119' ' ' SER . 15.5 mm100 -58.99 132.44 54.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.148 0.979 . . . . 75.11 112.486 -168.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.656 ' HB2' HG22 ' C' ' 118' ' ' VAL . 1.7 mm? -108.02 72.18 0.84 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.779 -0.646 . . . . 74.52 109.968 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -126.53 89.02 2.93 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.035 -1.468 . . . . 65.02 107.035 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.815 ' HB3' HD12 ' E' ' 187' ' ' ILE . 31.9 mt -84.27 151.16 24.96 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.552 -1.203 . . . . 75.14 108.785 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.834 ' HB1' ' HA ' ' F' ' 203' ' ' ASP . . . -55.58 147.53 39.3 Favored Pre-proline 0 CA--C 1.546 0.791 0 O-C-N 124.281 0.988 . . . . 62.14 113.295 -172.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.811 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 88.0 Cg_exo -50.36 115.2 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.545 2.83 . . . . 75.32 112.583 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.16 78.91 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-O 121.632 0.729 . . . . 71.53 109.128 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.64 93.46 8.4 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.189 -0.914 . . . . 73.23 109.978 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -74.9 -11.87 60.23 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.389 -1.278 . . . . 72.24 111.443 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.28 -46.58 89.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.88 0.872 . . . . 63.33 112.667 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.75 95.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.168 0.587 . . . . 71.13 110.167 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 61.6 tp -58.43 -39.99 81.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.654 -1.157 . . . . 63.11 110.444 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -70.51 -37.02 74.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.601 1.161 . . . . 74.15 110.205 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.6 mmt -69.63 -28.95 66.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.457 0.703 . . . . 74.34 111.066 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.68 -39.78 84.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.694 0.397 . . . . 72.22 110.147 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -68.65 -85.51 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.488 0.715 . . . . 74.02 110.269 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 pp -145.72 143.92 30.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.959 0.903 . . . . 75.22 110.066 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -91.96 96.75 10.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.511 0.724 . . . . 73.43 109.475 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.02 130.05 34.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.69 0.396 . . . . 75.32 109.958 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.44 173.01 13.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.726 0.81 . . . . 74.11 111.728 176.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.35 99.68 6.72 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.199 -1.037 . . . . 63.01 108.199 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.53 136.46 39.18 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.787 0.68 . . . . 72.41 112.589 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -144.64 -54.83 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.918 -1.141 . . . . 75.23 107.918 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.72 139.89 4.16 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.83 -0.623 . . . . 52.52 111.686 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 140' ' ' TYR . 85.6 m -151.68 141.55 21.99 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.247 0.619 . . . . 74.04 110.836 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -129.8 99.36 5.1 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.753 1.221 . . . . 74.11 108.509 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.65 143.98 50.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 75.44 110.152 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.99 103.22 4.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.977 0.911 . . . . 74.1 110.005 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.23 97.37 1.53 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.955 0.502 . . . . 71.34 109.792 173.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.43 136.45 39.44 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.216 1.006 . . . . 63.41 110.329 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 123.913 0.885 . . . . 73.34 109.332 179.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 110.088 -0.338 . . . . 64.12 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 45.1 p -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.878 0.871 . . . . 70.5 109.545 174.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.25 81.38 3.03 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.8 -0.815 . . . . 73.11 108.8 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -134.71 59.16 1.74 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.244 1.021 . . . . 74.0 109.161 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.662 HD21 ' HB2' ' D' ' 54' ' ' ASP . 11.8 p-10 -128.63 62.78 1.46 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.156 -0.929 . . . . 65.43 110.288 -173.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -159.23 88.26 0.87 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.743 -1.117 . . . . 75.32 108.82 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -166.31 -157.43 0.28 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.141 0.976 . . . . 74.1 108.4 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -69.63 -164.8 0.07 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.321 1.049 . . . . 75.14 110.725 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.3 ttp -33.67 125.97 0.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.346 1.058 . . . . 74.41 112.722 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m -138.4 141.57 39.59 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.72 0.808 . . . . 74.23 109.813 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.438 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 91.3 t80 -156.6 102.56 2.06 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.333 -1.358 . . . . 74.31 107.333 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 76.3 mt-30 -113.03 113.55 25.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.844 -0.799 . . . . 74.52 108.844 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' B' ' 132' ' ' ASN . 7.5 tt -91.43 98.31 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.581 -1.266 . . . . 64.35 107.581 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.53 -33.21 14.56 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.35 0.5 . . . . 75.22 112.35 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.434 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 75.2 ttt180 -170.53 122.42 0.63 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.059 -0.348 . . . . 74.42 110.059 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.407 HG12 ' HG3' ' B' ' 130' ' ' PRO . 35.4 mm -115.57 132.67 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.146 -1.057 . . . . 61.33 108.146 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.434 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 4.8 p90 -154.57 169.0 24.87 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.381 0.672 . . . . 73.12 112.024 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -97.7 119.59 36.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.016 -0.993 . . . . 73.4 108.815 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.02 -22.31 31.36 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.331 0.653 . . . . 74.13 110.2 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.3 t70 -160.85 139.5 10.07 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.102 0.961 . . . . 74.13 109.381 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.742 HG21 ' HE1' ' C' ' 117' ' ' MET . 67.3 mt -142.25 143.73 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.479 1.112 . . . . 72.32 108.258 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 60.7 m -141.98 136.76 30.64 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.228 1.011 . . . . 43.34 109.187 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.524 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.9 t80 -143.22 110.99 5.93 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 106.445 -1.687 . . . . 74.35 106.445 165.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -122.31 115.12 21.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.353 -0.61 . . . . 75.44 109.353 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' D' ' 28' ' ' ALA . . . -116.66 80.44 10.58 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.476 -0.935 . . . . 74.51 108.476 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . 0.403 ' HG2' ' ND2' ' D' ' 27' ' ' ASN . 58.2 Cg_endo -69.76 -29.83 23.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.669 2.246 . . . . 71.55 112.266 -174.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.403 ' ND2' ' HG2' ' D' ' 26' ' ' PRO . 3.2 m-80 -111.49 18.03 19.51 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.721 -0.672 . . . . 64.54 109.661 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' D' ' 25' ' ' ALA . . . -39.4 -54.35 3.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 115.586 1.699 . . . . 64.34 115.586 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.471 ' HB3' HD11 ' C' ' 83' ' ' ILE . 44.4 Cg_endo -81.67 -13.55 10.64 Favored 'Trans proline' 0 C--N 1.382 2.32 0 CA-C-N 121.307 1.503 . . . . 73.23 113.439 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -76.44 -36.83 57.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.687 1.195 . . . . 73.42 109.462 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.576 HG13 HD12 ' D' ' 68' ' ' LEU . 35.7 t -65.56 -23.96 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 124.877 1.271 . . . . 75.01 111.324 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.42 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 74.3 t80 -45.9 -36.64 5.55 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.335 1.454 . . . . 70.35 113.47 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -79.1 -6.54 56.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.637 0.775 . . . . 73.1 112.518 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -109.57 112.69 24.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.787 0.835 . . . . 64.52 110.029 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.2 60.3 1.41 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.927 0.891 . . . . 53.44 110.932 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' H' ' 193' ' ' TYR . 20.1 m95 -124.89 158.12 34.28 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.484 -0.561 . . . . 75.01 109.484 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -71.47 112.49 14.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.79 114.42 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.671 0 C-N-CA 122.783 2.322 . . . . 75.25 112.663 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.25 109.94 3.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.146 -1.057 . . . . 74.44 108.146 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 m -108.33 106.6 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.031 0.919 . . . . 63.22 109.142 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -94.28 115.97 28.29 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.248 -1.39 . . . . 74.22 107.248 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.05 136.08 34.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.498 -0.927 . . . . 73.32 108.498 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.731 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.7 m-20 -107.69 153.8 22.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.152 0.981 . . . . 73.0 108.562 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.432 ' HB2' HD21 ' H' ' 186' ' ' LEU . 47.6 tp -126.97 132.47 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.157 -0.683 . . . . 75.22 109.157 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t70 -140.62 141.18 35.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.018 -1.105 . . . . 72.23 108.018 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.1 m -118.53 143.64 46.6 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.979 -0.749 . . . . 71.22 108.979 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.9 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.323 1.049 . . . . 70.23 108.317 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.5 p -170.57 157.66 5.93 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.988 0.515 . . . . 72.22 110.894 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -149.57 140.44 22.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.911 -0.774 . . . . 72.42 108.911 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.2 119.93 25.16 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 109.405 -0.591 . . . . 72.13 109.405 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.6 mt -95.02 -34.92 12.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.18 0.592 . . . . 75.32 109.853 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.33 -177.43 6.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.207 -0.906 . . . . 52.53 110.392 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -66.91 129.97 41.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.81 -1.086 . . . . 64.3 109.254 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.662 ' HB2' HD21 ' D' ' 5' ' ' ASN . 66.5 m-20 58.31 17.84 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.669 1.187 . . . . 72.44 113.125 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.18 125.59 72.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 123.603 0.761 . . . . 75.31 109.144 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -123.64 135.23 53.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.815 -0.809 . . . . 74.12 108.815 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.9 tt0 -86.36 111.61 20.66 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.129 -1.804 . . . . 53.1 106.129 161.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -100.37 120.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 108.079 -1.082 . . . . 73.13 108.079 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 54.4 t -101.64 130.3 51.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.923 -1.035 . . . . 64.14 109.726 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.38 126.02 51.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.463 -1.31 . . . . 75.4 107.463 172.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -112.54 100.9 9.1 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.563 -0.903 . . . . 73.01 108.563 173.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.86 127.97 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.894 -1.15 . . . . 73.24 107.894 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.731 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -116.94 148.48 41.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.467 -0.938 . . . . 70.1 108.467 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.66 131.11 71.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.108 0.963 . . . . 72.42 108.875 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -117.09 95.81 5.16 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.246 -1.39 . . . . 74.35 107.246 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.57 129.44 43.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.061 -0.718 . . . . 74.34 109.061 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.453 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 36.9 m -143.6 137.27 28.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.369 0.604 . . . . 73.55 110.83 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.576 HD12 HG13 ' D' ' 31' ' ' VAL . 38.2 mt -104.16 97.34 7.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.593 1.157 . . . . 74.12 109.077 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.85 -119.79 19.6 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.162 0.914 . . . . 75.2 113.114 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.65 25.17 3.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.443 0.697 . . . . 71.5 111.882 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -141.2 146.57 37.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.54 0.336 . . . . 75.03 110.572 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.9 m -71.78 121.59 19.2 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.89 0.744 . . . . 73.35 109.818 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -77.7 -59.86 2.61 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.484 -0.932 . . . . 75.23 108.484 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -160.95 163.03 32.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.901 -1.045 . . . . 74.01 110.494 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.48 150.32 41.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.639 -1.245 . . . . 74.32 107.639 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.557 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.6 t -157.21 144.0 18.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.788 0.435 . . . . 64.32 110.153 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.05 130.69 9.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.284 0.633 . . . . 62.34 110.253 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.86 118.38 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 71.25 110.006 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.9 mt-30 -89.87 85.94 6.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.515 0.726 . . . . 73.23 109.358 168.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.29 93.74 5.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.259 -0.882 . . . . 64.45 108.859 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.34 144.08 17.04 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.619 -0.593 . . . . 74.14 111.619 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.59 139.34 9.63 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 112.213 -0.355 . . . . 61.1 112.213 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.9 mt -88.89 122.82 40.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.646 0.778 . . . . 71.31 108.916 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' D' ' 12' ' ' GLN . 59.5 m-85 -130.44 125.84 35.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.301 0.641 . . . . 74.1 110.145 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.0 m -92.71 105.04 17.25 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.73 -1.211 . . . . 65.43 107.73 169.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.68 140.16 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.357 0.663 . . . . 74.14 109.458 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.504 ' HA ' HD23 ' H' ' 173' ' ' LEU . . . -165.44 169.42 15.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.756 0.823 . . . . 75.53 110.612 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.64 22.16 77.6 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-N 116.655 -0.248 . . . . 72.04 113.466 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -132.01 161.79 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.493 1.117 . . . . 73.51 109.877 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 149.23 26.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.96 0.504 . . . . 73.14 111.127 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.6 -107.72 0.41 Allowed Glycine 0 C--N 1.35 1.356 0 O-C-N 124.541 1.151 . . . . 74.01 115.552 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -71.84 -42.86 66.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.031 0.933 . . . . 72.24 111.362 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -65.13 -35.06 79.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.012 0.525 . . . . 75.4 110.571 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.584 ' SD ' ' HB3' ' H' ' 175' ' ' PHE . 40.4 ttm -61.29 -53.56 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.852 -1.067 . . . . 72.33 110.539 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.85 -19.42 61.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.453 0.701 . . . . 61.35 111.748 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.05 -43.92 61.36 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.35 1.06 . . . . 74.02 110.163 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.12 -51.98 6.26 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.965 -0.561 . . . . 63.22 111.141 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.635 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.0 tp -80.51 -30.2 37.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.594 0.358 . . . . 60.25 111.514 -171.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.71 -29.92 41.42 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.821 -0.433 . . . . 71.35 113.554 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.25 -44.37 1.58 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.434 0.617 . . . . 74.33 112.371 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -73.4 -40.96 63.9 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 111.905 0.335 . . . . 74.14 111.905 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 82.8 m -67.23 -43.13 43.45 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-O 118.827 -0.606 . . . . 71.13 112.519 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -65.72 -27.07 52.67 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 121.334 1.356 . . . . 72.11 112.905 166.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -68.57 -27.42 66.06 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.422 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 19.7 mm -67.55 -45.91 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.422 0.689 . . . . 74.21 109.619 169.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.52 -22.36 61.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.732 -0.667 . . . . 74.25 111.961 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.72 -41.14 20.16 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.023 1.119 . . . . 72.32 114.023 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.457 ' HB3' ' HA ' ' B' ' 105' ' ' ILE . 72.2 Cg_exo -55.11 -41.94 73.77 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.959 1.772 . . . . 62.24 113.053 169.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.419 ' HD2' ' HB3' ' B' ' 108' ' ' PRO . 69.8 m-85 -71.05 -38.18 72.53 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.419 -0.809 . . . . 71.33 111.021 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.24 -43.7 70.03 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.741 0.816 . . . . 71.32 110.598 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.523 ' NH2' HG22 ' B' ' 105' ' ' ILE . 25.6 ttp180 -57.17 -53.2 60.81 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.781 -1.1 . . . . 74.1 109.72 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.56 -41.27 89.77 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.322 1.014 . . . . 75.33 111.451 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.403 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 37.0 t -57.61 -43.95 85.1 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.567 0.542 . . . . 72.32 110.732 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.557 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -66.08 -49.53 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.651 0.78 . . . . 74.34 110.114 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -56.02 -43.92 78.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 73.45 111.744 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.7 t -67.25 -42.06 84.57 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.038 -0.983 . . . . 54.51 110.3 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.1 mtm -66.72 -34.04 76.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.959 0.504 . . . . 74.43 111.46 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.494 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.2 t -62.23 -47.96 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 123.759 0.662 . . . . 74.45 109.736 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.3 p -72.21 -30.87 65.35 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.915 -0.584 . . . . 64.22 111.262 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -69.02 -30.5 68.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.798 0.839 . . . . 74.12 110.237 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.75 12.21 60.0 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.782 0.676 . . . . 64.25 112.982 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.469 HG23 ' HG2' ' A' ' 125' ' ' GLN . 30.2 p 59.58 28.69 18.16 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.956 1.702 . . . . 74.53 112.839 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.21 160.35 26.45 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.389 1.076 . . . . 73.2 108.928 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 126.54 16.65 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.719 2.28 . . . . 75.24 112.044 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.46 HE21 ' ND2' ' D' ' 127' ' ' ASN . 30.6 tt0 -50.83 121.81 6.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.315 1.046 . . . . 71.03 111.678 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.16 96.8 6.62 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.573 0.749 . . . . 72.44 110.144 -170.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.46 ' ND2' HE21 ' D' ' 125' ' ' GLN . 1.9 p30 -116.94 84.75 2.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.409 1.084 . . . . 74.32 109.975 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' H' ' 187' ' ' ILE . 90.7 mt -74.84 157.29 35.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.698 -1.137 . . . . 73.42 111.636 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.534 ' H ' HD13 ' G' ' 204' ' ' ILE . . . -67.64 156.62 88.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.968 0.907 . . . . 62.43 110.593 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.599 ' HD3' HG13 ' B' ' 13' ' ' ILE . 1.0 OUTLIER -80.4 147.36 17.94 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.115 1.876 . . . . 74.13 110.379 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.46 108.11 24.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.699 0.761 . . . . 73.52 109.332 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -97.09 101.09 12.59 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.804 -1.184 . . . . 61.54 107.804 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -68.63 -27.08 65.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.079 -0.964 . . . . 74.4 111.255 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.28 -40.4 62.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.346 0.659 . . . . 74.12 110.771 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.18 89.49 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.081 -0.508 . . . . 74.22 109.918 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.64 -42.36 96.76 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.116 0.885 . . . . 71.24 111.478 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.44 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 26.8 t80 -58.34 -51.63 68.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.599 0.759 . . . . 72.44 110.184 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 79.1 mtm -63.66 -42.84 98.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.798 0.839 . . . . 75.11 111.152 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.406 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 15.1 m120 -56.19 -51.52 67.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.31 0.644 . . . . 75.02 109.922 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -62.08 -31.41 71.83 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.574 -1.194 . . . . 73.42 111.831 -172.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 89.3 mt -62.91 -35.86 81.48 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 74.42 110.633 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -90.07 8.26 33.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.715 0.806 . . . . 73.23 111.901 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 96.4 mt-30 -120.53 84.12 2.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.442 0.697 . . . . 75.02 109.55 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -152.84 8.92 0.44 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.875 -1.057 . . . . 72.44 110.689 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.22 99.0 3.17 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.192 0.597 . . . . 74.43 109.583 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.22 130.45 13.69 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.56 0.537 . . . . 63.31 112.794 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.46 154.21 22.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.977 0.911 . . . . 71.33 110.191 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.58 160.32 31.43 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.05 0.219 . . . . 70.34 112.745 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 34.3 p -130.89 136.38 48.56 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.775 0.83 . . . . 74.41 110.1 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -96.58 153.33 17.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.454 0.702 . . . . 71.24 109.849 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -87.76 162.12 17.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.724 0.809 . . . . 73.41 110.79 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.22 137.09 40.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.933 0.893 . . . . 63.33 109.397 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -100.89 110.35 22.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.8 0.84 . . . . 74.33 109.443 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -168.17 102.51 0.45 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.952 0.901 . . . . 75.32 109.185 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 C-N-CA 123.897 0.879 . . . . 72.3 108.774 179.082 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.086 -0.709 . . . . 73.32 109.086 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.72 166.58 33.44 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 123.55 0.531 . . . . 74.22 111.887 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -69.77 85.61 0.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.873 0.844 . . . . 75.1 110.165 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 35.9 p -159.52 132.26 6.77 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.072 -0.967 . . . . 55.51 109.849 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . . . -96.48 123.99 40.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.451 0.7 . . . . 62.52 109.428 176.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' E' ' 174' ' ' MET . 1.1 tt -148.63 -61.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.31 -1.367 . . . . 75.31 107.31 178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.696 ' HE1' ' HA ' ' C' ' 54' ' ' ASP . 26.1 mmt -103.18 90.96 3.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.695 0.798 . . . . 72.14 110.854 -177.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 20.3 t80 57.65 90.32 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.107 1.363 . . . . 72.3 111.722 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -122.87 105.75 10.28 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.074 -1.084 . . . . 73.44 108.074 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 45.3 tp -150.14 111.54 4.44 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.39 -1.337 . . . . 71.35 107.39 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -78.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 107.778 -1.193 . . . . 70.42 107.778 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 39.2 tt0 -179.99 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.354 1.062 . . . . 73.31 110.669 175.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 92.8 Cg_endo -89.75 89.37 0.36 Allowed 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 122.137 1.891 . . . . 74.33 112.604 -170.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -120.56 84.21 2.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.576 -0.898 . . . . 72.0 108.576 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 60.75 -162.55 0.27 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.092 0.957 . . . . 74.32 110.931 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 90.7 m -147.13 128.29 14.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.211 0.604 . . . . 74.33 109.587 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.455 ' HZ3' ' HB2' ' C' ' 103' ' ' PRO . 5.6 t90 -87.97 108.84 23.28 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 107.355 -1.35 . . . . 74.52 107.355 168.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -68.47 164.54 32.37 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.702 2.268 . . . . 72.32 112.169 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.21 146.56 44.15 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.58 0.752 . . . . 75.33 109.984 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' C' ' 128' ' ' LEU . 3.4 tt -68.78 99.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 109.432 -0.581 . . . . 73.42 109.432 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.3 87.86 4.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.957 -0.757 . . . . 61.24 108.957 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -83.91 14.02 4.43 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.742 -0.663 . . . . 73.23 111.334 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.54 135.61 55.34 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.848 -0.797 . . . . 62.11 108.848 166.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 102.74 -24.1 31.79 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.57 -1.012 . . . . 73.03 110.57 -164.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.07 61.84 3.3 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.29 -0.724 . . . . 73.31 111.29 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.78 -162.96 0.47 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.463 1.105 . . . . 75.52 110.497 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 73.82 140.54 0.06 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.151 1.38 . . . . 73.21 111.723 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -135.96 -54.3 0.76 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.779 0.832 . . . . 74.11 110.093 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . 0.516 ' HD3' ' HB3' ' E' ' 199' ' ' ASN . 37.5 ttmt 73.02 136.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.723 1.209 . . . . 72.03 110.289 -173.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -119.06 -83.15 0.65 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 110.065 -0.346 . . . . 74.45 110.065 -176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -95.73 89.82 5.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.848 0.459 . . . . 61.42 110.373 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . 0.516 ' HB3' ' HD3' ' E' ' 196' ' ' LYS . 5.6 t30 -162.41 108.96 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.11 -1.07 . . . . 70.2 108.11 170.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 117.05 -151.51 18.19 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.959 -0.857 . . . . 72.11 110.959 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.572 ' HE3' ' HA ' ' E' ' 201' ' ' LYS . 0.2 OUTLIER -96.74 -10.66 26.35 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.089 0.444 . . . . 74.22 111.418 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -79.31 82.8 5.41 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.068 0.461 . . . . 73.14 110.738 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -175.8 145.45 0.68 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.896 1.678 . . . . 72.43 106.968 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.475 HG22 HG22 ' E' ' 207' ' ' VAL . 54.4 mt -92.96 92.06 3.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.754 0.788 . . . . 64.45 109.486 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.92 -64.64 0.69 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.844 -1.539 . . . . 73.25 106.844 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.4 87.84 2.59 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.585 0.754 . . . . 65.54 109.576 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.475 HG22 HG22 ' E' ' 204' ' ' ILE . 97.6 t . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 107.687 -1.227 . . . . 74.32 107.687 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 mttp . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.308 -0.627 . . . . 72.52 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.43 -56.13 4.5 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.457 -0.338 . . . . 52.11 112.711 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -84.72 170.11 13.59 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.344 0.658 . . . . 74.1 112.354 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 46.5 m 66.7 146.48 0.04 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.723 1.609 . . . . 71.34 112.255 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.54 99.16 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.867 -0.79 . . . . 63.43 108.867 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.49 179.79 2.79 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.81 -1.541 . . . . 75.33 108.411 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.592 ' HE1' ' HA ' ' F' ' 174' ' ' MET . 0.5 OUTLIER -151.81 -83.11 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.674 -0.491 . . . . 72.24 109.674 163.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.28 168.26 25.72 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 74.45 111.692 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -159.82 111.02 1.97 Allowed 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.196 -1.365 . . . . 71.13 107.941 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.22 98.37 0.6 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.737 0.815 . . . . 74.32 110.077 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -133.94 133.66 41.67 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.115 0.966 . . . . 71.32 109.011 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 70.9 161.03 0.16 Allowed Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 124.69 1.196 . . . . 74.43 112.233 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.15 -2.82 12.88 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.649 2.233 . . . . 72.33 112.769 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 62.99 71.37 0.52 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 124.772 1.229 . . . . 74.12 109.872 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.48 -95.76 0.05 Allowed 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.633 -1.621 . . . . 74.34 111.469 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 14.7 t -177.88 146.89 0.44 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.515 1.126 . . . . 73.21 108.984 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.505 ' HB3' ' HD1' ' B' ' 133' ' ' PHE . 0.4 OUTLIER -163.02 93.96 1.15 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.0 0.92 . . . . 74.15 109.213 177.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.82 172.08 16.99 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.937 2.424 . . . . 74.25 112.928 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.563 HD21 HD12 ' B' ' 128' ' ' LEU . 6.2 tp -115.87 -163.4 0.89 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.776 0.83 . . . . 75.35 109.866 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' B' ' 129' ' ' ALA . 2.5 pp -130.41 168.77 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.38 1.072 . . . . 72.51 110.924 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.37 132.16 3.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.223 1.009 . . . . 75.32 108.577 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.19 167.76 13.33 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.419 0.628 . . . . 72.3 112.632 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -119.6 112.67 19.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.819 -1.178 . . . . 65.01 107.819 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.18 176.71 23.72 Favored Glycine 0 N--CA 1.47 0.912 0 O-C-N 123.178 0.299 . . . . 71.33 112.597 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 140.52 -171.15 24.14 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-O 119.776 -0.458 . . . . 65.45 112.334 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.91 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.485 1.514 . . . . 75.43 111.546 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.35 86.98 4.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.959 0.903 . . . . 75.01 110.525 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' B' ' 37' ' ' GLN . 47.9 t80 -150.7 144.76 25.38 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.402 -1.333 . . . . 72.23 107.402 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' F' ' 205' ' ' LYS . 0.0 OUTLIER -65.68 89.44 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.26 0.624 . . . . 72.35 111.808 -168.209 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -147.45 -12.27 0.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.491 1.517 . . . . 70.44 108.462 159.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -155.51 -53.41 0.09 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.169 0.988 . . . . 75.42 109.188 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -102.54 96.11 6.69 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.513 -0.921 . . . . 73.14 108.513 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.12 177.71 27.86 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 114.725 0.65 . . . . 75.32 114.725 -173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -153.36 -81.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.316 0.647 . . . . 73.35 109.816 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' B' ' 124' ' ' PRO . 14.7 m-85 -105.36 11.65 32.52 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.996 0.519 . . . . 73.25 111.573 -166.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . 0.834 ' HA ' ' HB1' ' C' ' 129' ' ' ALA . 17.0 p-10 -156.21 147.02 21.98 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.547 0.739 . . . . 74.45 111.319 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.702 HG21 ' HB3' ' C' ' 129' ' ' ALA . 30.1 pt -81.71 158.74 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.161 0.985 . . . . 74.04 111.151 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . 0.721 ' HA ' ' HD3' ' F' ' 196' ' ' LYS . 97.9 mttt -75.78 -66.57 0.77 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.206 -0.664 . . . . 75.23 109.206 172.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -160.96 159.55 29.68 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.677 -0.692 . . . . 74.25 109.683 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.556 1.177 0 C-N-CA 123.972 0.909 . . . . 74.13 108.755 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.413 -0.217 . . . . 74.22 110.413 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.46 78.0 0.95 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.61 -0.596 . . . . 73.43 111.61 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.44 148.48 41.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.372 -0.603 . . . . 72.34 109.372 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 14.0 m -130.51 -41.6 1.2 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.407 1.083 . . . . 72.33 110.474 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.5 -64.87 0.29 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.348 0.659 . . . . 75.34 110.807 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.414 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 2.8 tt 65.08 -71.69 0.08 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.28 1.432 . . . . 72.03 109.901 -167.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.443 ' HE2' ' HA ' ' G' ' 174' ' ' MET . 25.3 mmt -84.26 175.03 9.69 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.311 0.644 . . . . 72.53 110.375 173.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.427 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 43.0 p90 -149.5 167.34 26.52 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.031 0.532 . . . . 74.03 111.33 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.29 89.59 2.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.427 -1.323 . . . . 72.51 107.427 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.14 85.42 2.99 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.818 0.847 . . . . 71.31 110.894 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -100.67 1.32 40.47 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.62 0.768 . . . . 71.44 111.351 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.39 163.01 53.02 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.942 0.897 . . . . 74.13 109.409 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.64 137.5 64.32 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.358 2.039 . . . . 71.44 112.278 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -78.8 -167.56 1.15 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.782 0.833 . . . . 74.12 110.528 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.0 100.34 0.31 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.525 -0.917 . . . . 74.33 108.525 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 28.2 m -58.3 146.14 35.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.513 1.125 . . . . 75.15 111.599 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -131.35 144.98 55.67 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.567 0.747 . . . . 74.04 111.537 -169.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.03 158.02 27.01 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.835 3.023 . . . . 74.1 114.199 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . 0.55 ' HA ' HG12 ' A' ' 131' ' ' VAL . 9.1 tt -141.44 126.05 17.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.938 0.895 . . . . 71.5 108.6 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.4 pp -80.94 -171.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.78 1.232 . . . . 65.3 112.904 -173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.0 121.32 14.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.988 0.915 . . . . 75.44 109.331 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . 0.413 ' O ' HG11 ' A' ' 40' ' ' VAL . . . -140.68 104.52 4.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.122 0.569 . . . . 75.31 111.383 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . 0.505 ' HB2' HG13 ' A' ' 40' ' ' VAL . 14.7 t70 -152.6 146.62 25.34 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 73.34 108.787 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.37 17.5 2.89 Favored Glycine 0 N--CA 1.475 1.293 0 O-C-N 123.861 0.726 . . . . 73.23 111.933 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.72 3.2 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 123.161 0.41 . . . . 74.11 112.577 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . 0.448 ' HB3' ' HG2' ' H' ' 198' ' ' GLU . 59.5 t80 -137.63 -38.14 0.59 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.515 -0.92 . . . . 65.4 108.515 172.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -135.67 169.55 17.37 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.632 1.173 . . . . 74.22 108.917 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -167.81 -88.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.609 0.764 . . . . 75.25 109.386 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' G' ' 196' ' ' LYS . 0.0 OUTLIER -108.37 -33.88 6.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.555 0.742 . . . . 75.3 109.21 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -78.39 87.23 4.41 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.336 -0.847 . . . . 72.43 109.063 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -169.31 -56.65 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.969 -1.014 . . . . 73.44 109.171 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -158.01 169.69 24.0 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.208 -1.034 . . . . 64.15 108.208 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 69.48 67.56 1.9 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.821 -0.912 . . . . 62.32 110.821 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.52 -34.04 70.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.183 0.593 . . . . 73.25 111.315 -176.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 70.2 t80 68.28 -78.01 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.85 1.26 . . . . 74.02 110.568 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 11.4 t70 66.34 149.86 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.529 1.532 . . . . 61.14 111.087 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . 0.534 HD13 ' H ' ' D' ' 129' ' ' ALA . 19.0 tt -149.94 4.45 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 121.335 0.588 . . . . 74.21 110.42 -172.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . 0.526 ' HA ' ' HG2' ' B' ' 12' ' ' GLN . 13.4 tmtt? -80.5 138.9 36.59 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.509 -0.923 . . . . 65.35 108.509 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 33.4 t70 74.16 110.42 0.07 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.728 1.611 . . . . 72.53 111.193 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 123.643 0.777 . . . . 65.21 109.807 177.108 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.936 -0.394 . . . . 74.34 109.936 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.93 75.4 1.27 Allowed Glycine 0 C--N 1.346 1.107 0 O-C-N 123.736 0.648 . . . . 72.33 113.087 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.81 76.64 5.3 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.151 -0.685 . . . . 75.1 109.151 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 33.6 t -154.58 55.93 0.68 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.296 0.638 . . . . 73.13 109.703 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -170.43 141.5 1.98 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.273 1.029 . . . . 33.24 109.125 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' D' ' 87' ' ' ALA . 1.6 tt -165.23 -68.78 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.2 -0.667 . . . . 73.54 109.2 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.459 ' HE2' ' HA ' ' H' ' 174' ' ' MET . 30.9 mmt -92.58 92.25 7.94 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.658 -0.497 . . . . 74.43 109.658 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . 0.584 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 0.2 OUTLIER -86.96 -177.92 6.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.391 -0.822 . . . . 74.52 112.043 -173.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -128.05 137.89 52.35 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.373 1.069 . . . . 74.32 108.257 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.39 94.87 1.28 Allowed 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.241 -0.651 . . . . 73.41 109.241 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -81.93 -63.36 1.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.893 0.877 . . . . 74.54 110.803 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -141.52 151.87 61.89 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.928 0.891 . . . . 75.42 110.545 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.36 153.83 61.17 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.407 2.072 . . . . 73.25 111.586 170.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -102.09 -52.84 3.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.014 0.926 . . . . 75.11 109.849 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -137.89 172.17 13.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.333 1.053 . . . . 73.53 110.476 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 36.8 p -74.07 148.22 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.784 0.834 . . . . 75.32 110.43 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -109.86 92.27 12.33 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.78 0.832 . . . . 75.15 109.34 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.34 115.13 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.642 2.228 . . . . 72.3 112.149 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' D' ' 44' ' ' LEU . 3.1 mm? -85.51 -179.58 6.94 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.463 -0.94 . . . . 75.43 108.463 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.438 ' HB ' HD12 ' D' ' 128' ' ' LEU . 3.4 mp -78.21 94.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.668 -0.864 . . . . 74.04 108.668 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.39 90.95 2.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.723 -0.843 . . . . 74.22 108.723 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -79.21 161.53 26.32 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.378 -0.828 . . . . 71.33 111.471 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.17 170.28 8.4 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.925 0.89 . . . . 73.22 109.69 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -77.08 -141.36 1.32 Allowed Glycine 0 C--N 1.351 1.378 0 CA-C-N 116.433 -0.349 . . . . 65.13 113.147 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 129.05 -150.15 18.73 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.987 -0.845 . . . . 74.41 110.987 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . 0.64 ' HA ' ' HA ' ' D' ' 36' ' ' TRP . 79.2 m-85 -129.46 -175.57 3.62 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.566 0.746 . . . . 75.13 111.142 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . 73.64 90.53 0.09 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.747 1.619 . . . . 73.43 111.237 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -153.14 41.27 0.56 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 104.2 -2.518 . . . . 75.45 104.2 169.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -93.47 117.46 30.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.287 -2.233 . . . . 74.44 110.17 -160.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.32 -8.66 59.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 64.43 109.938 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' G' ' 193' ' ' TYR . 10.0 tp10 65.73 -96.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.812 1.645 . . . . 73.25 110.834 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -154.38 178.41 10.06 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.521 1.129 . . . . 61.42 109.132 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.54 81.81 0.29 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.72 -0.952 . . . . 61.4 110.72 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.42 -54.38 47.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.953 1.301 . . . . 74.5 110.897 -171.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -73.98 0.37 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.15 -0.477 . . . . 73.34 111.187 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -162.01 -82.58 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.89 0.876 . . . . 73.11 108.675 -173.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 13.8 mt 51.87 54.62 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.875 1.27 . . . . 73.43 110.857 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -103.53 -58.67 1.84 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.784 -1.098 . . . . 74.04 111.144 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -168.36 163.93 12.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.057 0.543 . . . . 74.14 110.208 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--O 1.256 1.428 0 C-N-CA 123.944 0.898 . . . . 72.1 108.774 168.35 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 111.638 0.236 . . . . 73.4 111.638 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 t -149.16 39.62 0.84 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.749 -0.463 . . . . 71.32 109.749 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.18 149.99 44.02 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.7 -0.682 . . . . 61.21 111.038 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.84 164.73 29.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.339 0.655 . . . . 62.4 109.894 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -131.81 106.78 8.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 74.12 110.332 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -157.61 -66.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.283 0.633 . . . . 75.12 110.065 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -145.3 163.38 34.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.502 0.721 . . . . 73.53 110.225 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.55 -66.79 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.955 -0.757 . . . . 72.23 108.955 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.53 153.52 47.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.479 0.712 . . . . 73.31 111.058 -174.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -159.67 144.04 14.94 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.862 1.265 . . . . 73.31 109.633 174.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -106.25 141.32 37.78 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.587 -0.894 . . . . 73.52 108.587 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 7.4 tp-100 -149.16 139.74 22.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.043 0.537 . . . . 71.53 110.854 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 tp -94.81 127.2 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.803 0.841 . . . . 64.53 109.396 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.541 ' NE2' HG21 ' A' ' 83' ' ' ILE . 27.7 tt0 -103.09 -28.15 12.13 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 118.585 -0.721 . . . . 65.11 111.239 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -178.27 127.62 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.777 0.717 . . . . 74.55 111.154 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.52 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 64.2 mt -107.93 133.58 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.557 -0.905 . . . . 73.22 108.557 168.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -170.16 164.66 9.2 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.511 0.724 . . . . 74.21 110.664 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -85.97 117.69 24.98 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.77 -0.826 . . . . 63.32 108.77 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.6 mtpt -80.08 -29.95 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.345 -0.388 . . . . 70.21 110.145 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -153.97 148.12 25.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.54 0.525 . . . . 71.03 109.864 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.6 mt -138.74 145.4 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.969 1.307 . . . . 74.44 107.875 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 t -150.06 139.87 21.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.332 0.653 . . . . 64.32 109.761 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.517 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.7 t80 -145.22 112.26 6.01 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.415 -1.698 . . . . 74.53 106.415 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -123.02 109.99 14.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.243 -0.651 . . . . 65.11 109.243 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.28 86.49 9.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.79 -1.189 . . . . 74.24 107.79 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.02 -17.16 19.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.475 2.117 . . . . 72.13 111.343 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.99 31.12 6.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.269 1.027 . . . . 74.15 109.369 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.425 ' O ' HG13 ' A' ' 31' ' ' VAL . . . -59.54 -45.63 98.76 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-N 115.165 -0.925 . . . . 74.42 112.82 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.44 -25.05 48.84 Favored 'Trans proline' 0 C--N 1.398 3.161 0 CA-C-N 121.517 1.577 . . . . 74.41 112.456 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -71.02 -26.32 63.06 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.128 0.571 . . . . 75.43 111.006 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG21 ' HH ' ' G' ' 197' ' ' TYR . 7.2 p -65.67 -12.69 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 118.455 0.571 . . . . 74.23 111.904 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.15 -39.29 75.44 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.87 0.468 . . . . 72.43 110.668 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.455 ' HG3' ' HG2' ' A' ' 34' ' ' LYS . 9.1 pt20 -89.56 -38.71 13.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.308 0.643 . . . . 73.42 110.667 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 2.0 mmmp? -82.73 128.73 34.65 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.049 0.94 . . . . 74.11 109.219 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.03 153.21 32.54 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.127 -0.323 . . . . 75.32 110.127 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.668 ' HB3' ' HB2' ' G' ' 195' ' ' PHE . 73.9 t-105 -81.59 78.99 8.27 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.998 0.428 . . . . 64.14 110.654 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -124.64 82.34 59.63 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 107.459 -1.312 . . . . 74.15 107.459 168.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' G' ' 193' ' ' TYR . 40.7 Cg_endo -84.8 158.58 11.98 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.324 2.016 . . . . 73.44 112.466 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.3 103.38 11.51 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.654 -1.98 . . . . 74.12 105.654 159.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.38 135.28 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 70.33 109.704 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 87.6 tttt -110.89 129.77 55.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.458 0.703 . . . . 74.11 109.114 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.9 tp -97.2 109.74 22.43 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.149 -1.426 . . . . 74.02 107.149 166.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 25.5 t70 -105.74 139.76 39.83 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.068 -1.086 . . . . 74.31 108.068 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.13 128.08 41.1 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.689 -1.226 . . . . 74.23 107.689 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 28.0 t70 -140.7 159.23 42.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.224 1.01 . . . . 72.42 108.644 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.484 HG22 HD12 ' G' ' 177' ' ' LEU . 12.9 t -133.95 159.32 41.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.425 0.631 . . . . 73.24 111.063 -176.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -141.51 150.14 41.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.224 1.409 . . . . 71.32 107.727 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -132.15 149.76 52.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.02 -0.363 . . . . 71.03 110.02 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -158.36 118.89 3.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.81 0.844 . . . . 64.12 108.729 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.27 117.09 21.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.327 -0.62 . . . . 74.41 109.327 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.492 HD12 HG22 ' A' ' 83' ' ' ILE . 81.7 mt -86.35 -43.29 12.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.86 0.464 . . . . 62.32 110.715 -178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.82 -174.1 4.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.72 0.808 . . . . 72.25 110.163 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.9 121.5 18.21 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.433 ' H ' ' HB2' ' G' ' 171' ' ' SER . 2.0 m-20 73.25 -7.25 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.176 1.79 . . . . 74.35 111.807 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.78 120.67 55.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 124.433 1.093 . . . . 75.41 108.712 -177.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -135.34 170.51 15.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.218 -1.03 . . . . 75.15 108.218 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -131.23 136.8 48.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.28 -0.637 . . . . 72.3 109.28 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 75.4 t -114.42 121.29 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.62 -0.881 . . . . 71.33 108.62 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.8 t -100.5 125.99 54.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.982 -0.748 . . . . 72.25 108.982 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 114.93 26.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.343 -1.354 . . . . 74.24 107.343 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -92.39 99.56 12.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.633 -1.247 . . . . 74.12 107.633 170.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.551 HG21 ' HB1' ' A' ' 110' ' ' ALA . 11.9 t -94.62 135.12 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.83 -1.544 . . . . 73.0 106.83 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 31.8 m -134.09 123.34 24.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.538 0.685 . . . . 74.24 110.73 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.629 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.1 t -109.18 107.76 23.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.902 1.281 . . . . 65.51 108.779 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -108.23 112.79 25.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.623 -0.88 . . . . 71.31 108.623 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.74 116.85 28.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.417 -1.327 . . . . 72.12 107.417 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -123.31 132.12 53.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.018 0.437 . . . . 74.24 110.867 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 62.0 mt -87.24 84.25 7.26 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.879 1.271 . . . . 71.35 109.217 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -91.02 1.1 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.935 -1.03 . . . . 65.3 111.525 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.38 -29.94 7.6 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.426 0.69 . . . . 74.23 110.681 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.13 133.33 35.44 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.305 0.642 . . . . 74.43 109.673 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -69.85 135.97 50.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.802 0.441 . . . . 74.1 110.954 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.451 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -78.4 -56.4 4.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.762 -0.829 . . . . 74.14 108.762 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -164.36 174.62 10.85 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 113.97 -1.468 . . . . 74.31 110.26 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -138.58 116.6 11.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.752 -1.113 . . . . 75.51 108.741 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.629 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.5 m -103.56 139.65 38.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.514 -0.921 . . . . 73.2 108.514 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -146.88 117.88 7.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.616 -0.883 . . . . 75.11 108.616 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.04 113.84 39.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 123.766 0.827 . . . . 75.54 109.413 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 16.0 mp0 -84.6 85.28 7.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.491 -1.232 . . . . 74.32 108.352 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -83.79 92.38 7.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.109 -1.441 . . . . 74.33 107.109 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.87 142.83 18.67 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.409 -0.676 . . . . 75.13 111.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.558 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.32 122.03 2.2 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 110.759 -0.936 . . . . 73.35 110.759 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.541 HG21 ' NE2' ' A' ' 14' ' ' GLN . 39.4 mt -81.89 125.89 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 107.789 -1.189 . . . . 73.51 107.789 172.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -128.59 164.58 22.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.36 0.664 . . . . 73.03 109.932 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 20.4 t -120.26 121.23 38.23 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.553 1.141 . . . . 75.43 109.212 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -138.55 150.1 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 123.378 0.671 . . . . 73.3 109.766 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.676 ' HB3' ' HB2' ' G' ' 168' ' ' LYS . . . 175.93 173.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.21 1.404 . . . . 50.34 110.211 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.96 88.67 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.952 0.783 . . . . 75.15 113.598 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.446 ' O ' HD21 ' G' ' 173' ' ' LEU . 1.3 pp -117.36 172.34 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.213 1.405 . . . . 73.11 109.427 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.6 tt0 -169.45 -177.63 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.814 0.846 . . . . 75.32 109.238 172.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.474 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.78 -142.81 42.62 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 123.44 0.543 . . . . 70.11 113.808 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -68.91 -18.95 64.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.835 0.854 . . . . 75.32 111.527 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -48.76 53.71 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.071 0.548 . . . . 74.55 109.586 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.555 ' SD ' HD22 ' G' ' 173' ' ' LEU . 9.2 ptm -69.55 -36.67 76.57 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.691 0.281 . . . . 73.13 110.316 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.416 ' N ' ' HG3' ' A' ' 94' ' ' MET . . . -71.06 -28.52 64.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.651 0.78 . . . . 71.21 111.221 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.27 -37.75 13.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.38 -0.373 . . . . 74.12 110.942 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.481 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.8 t -66.02 -52.98 44.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.905 0.482 . . . . 74.43 110.39 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.463 HD21 ' HE1' ' G' ' 175' ' ' PHE . 4.2 tt -76.33 -39.38 54.16 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.605 0.762 . . . . 72.52 109.853 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.99 -24.16 58.24 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.031 0.772 . . . . 74.53 115.031 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -42.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.927 0.864 . . . . 70.4 112.306 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 59.4 t80 -78.73 -36.75 42.84 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 122.966 0.506 . . . . 74.14 112.339 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -72.52 -41.05 7.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-O 118.551 -0.738 . . . . 74.24 111.446 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.88 -21.93 63.69 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 121.485 1.457 . . . . 72.01 113.129 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -67.07 -37.29 83.76 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 122.795 0.438 . . . . 75.1 109.977 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -57.93 -41.8 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 65.5 110.064 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.558 HD22 ' HA3' ' A' ' 82' ' ' GLY . 60.4 mt -80.12 -24.65 40.35 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.486 -1.233 . . . . 70.3 111.651 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.56 -39.49 48.76 Favored Pre-proline 0 CA--C 1.575 1.915 0 N-CA-C 114.782 1.401 . . . . 54.23 114.782 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.17 -40.11 72.64 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 122.273 1.982 . . . . 74.43 112.58 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.41 ' CD2' ' HG3' ' C' ' 108' ' ' PRO . 90.8 m-85 -77.13 -32.44 56.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.03 -0.986 . . . . 73.23 110.833 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.551 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -68.62 -43.44 76.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 71.25 109.77 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.469 HH22 ' HG3' ' A' ' 130' ' ' PRO . 36.8 ttm180 -55.32 -54.26 45.85 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.629 1.205 . . . . 74.13 110.054 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.99 -40.58 98.2 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.347 1.029 . . . . 74.33 111.432 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.1 t -59.82 -37.01 77.96 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.919 0.762 . . . . 61.44 111.023 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.477 HG21 HG23 ' A' ' 64' ' ' VAL . 78.6 mt -72.52 -54.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.638 0.775 . . . . 64.41 110.147 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 125' ' ' GLN . 98.6 m -52.13 -37.04 53.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.797 1.639 . . . . 74.44 111.607 -174.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.09 -45.65 59.82 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.073 -0.967 . . . . 74.22 110.629 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.517 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.4 mtm -59.56 -41.47 90.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.107 0.48 . . . . 74.52 110.899 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.97 -46.97 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.828 1.251 . . . . 73.13 110.848 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -72.15 -30.66 65.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.699 0.4 . . . . 71.23 111.353 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.0 -26.94 63.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 75.33 110.418 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 7.77 57.72 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.897 -0.592 . . . . 73.05 113.342 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.7 m 66.98 30.85 7.34 Favored 'General case' 0 C--N 1.364 1.236 0 C-N-CA 124.671 1.188 . . . . 73.14 110.455 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -107.92 139.31 20.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.058 -1.089 . . . . 75.41 108.058 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 140.21 61.73 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.559 2.173 . . . . 73.41 112.609 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.475 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.0 tt0 -53.07 140.96 23.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.58 1.152 . . . . 72.05 112.163 -176.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.0 109.59 10.63 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.91 -1.145 . . . . 75.22 107.91 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -103.84 104.89 14.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.603 0.761 . . . . 74.31 108.96 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.413 ' HA ' ' OH ' ' H' ' 202' ' ' TYR . 66.3 mt -72.48 116.95 13.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.294 -0.632 . . . . 71.13 109.294 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.483 ' HB1' HG23 ' G' ' 187' ' ' ILE . . . -57.66 149.27 52.8 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.522 1.129 . . . . 61.3 111.922 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.469 ' HG3' HH22 ' A' ' 111' ' ' ARG . 5.4 Cg_exo -71.01 -176.75 1.95 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.573 2.182 . . . . 73.23 112.435 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -133.26 126.22 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.598 -0.89 . . . . 61.41 108.598 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.407 ' H ' HG13 ' H' ' 207' ' ' VAL . 17.0 p-10 -80.27 74.49 7.1 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.78 -0.822 . . . . 72.43 108.78 173.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -55.05 -43.44 73.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.674 0.79 . . . . 75.51 111.714 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.21 -40.15 74.74 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.62 1.168 . . . . 75.42 111.653 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' C' ' 8' ' ' GLU . . . -74.13 -39.38 63.36 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.672 -0.695 . . . . 62.04 110.957 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.478 HD11 ' HG2' ' G' ' 185' ' ' PRO . 88.5 mt -72.31 -23.81 61.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.709 0.804 . . . . 70.22 110.957 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.486 ' HE2' ' HD2' ' G' ' 182' ' ' PHE . 62.6 t80 -70.5 -52.75 19.74 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.497 -0.557 . . . . 74.43 109.497 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 tpp -55.26 -45.23 76.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.748 0.819 . . . . 65.55 110.356 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.475 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 42.0 t30 -60.76 -41.21 95.01 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.377 1.071 . . . . 73.5 111.333 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.86 -38.23 88.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.782 -0.645 . . . . 74.44 110.671 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.3 mt -66.58 -51.27 58.25 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.41 0.444 . . . . 74.52 111.274 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -175.88 -15.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.713 0.633 . . . . 65.23 111.286 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.475 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 25.0 tm0? 69.4 103.42 0.06 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.468 1.507 . . . . 74.51 112.078 176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -136.27 114.18 11.27 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.961 -1.125 . . . . 74.52 107.961 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.07 100.32 11.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.138 0.575 . . . . 73.52 110.188 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.609 ' HA2' ' HB3' ' C' ' 6' ' ' ASN . . . 85.08 63.55 1.58 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 116.661 -0.245 . . . . 54.54 113.396 173.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -69.48 -44.05 71.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.492 0.717 . . . . 75.25 109.574 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.73 165.81 12.78 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 114.875 -1.057 . . . . 60.24 112.205 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.1 t 179.2 -170.59 0.12 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.879 1.672 . . . . 72.45 107.931 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 65.98 40.97 3.86 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.506 1.146 . . . . 75.24 109.504 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.56 -3.13 35.91 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.68 -1.146 . . . . 73.5 111.71 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 77.65 -68.5 0.16 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.868 1.667 . . . . 75.45 111.078 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 177.57 -20.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.026 1.331 . . . . 54.23 110.184 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -145.8 148.59 33.09 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.021 0.929 . . . . 64.14 109.163 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 124.068 0.947 . . . . 73.31 108.634 178.748 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.164 -0.31 . . . . 62.43 110.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 16.8 m -83.11 86.97 6.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.258 -1.015 . . . . 72.32 108.258 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' F' ' 182' ' ' PHE . 18.9 mm-40 -86.54 81.94 8.1 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.437 0.637 . . . . 73.01 110.944 -171.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -115.51 -89.49 0.56 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.788 -1.096 . . . . 74.34 108.164 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.406 HD22 ' HB2' ' B' ' 100' ' ' ALA . 3.0 t-20 -179.37 -169.87 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.726 1.21 . . . . 74.21 109.029 173.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.535 ' ND2' ' HG3' ' B' ' 93' ' ' GLN . 4.4 t30 -154.49 92.08 1.46 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.0 0.818 . . . . 71.53 109.646 174.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.4 m -74.58 104.53 5.3 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.392 0.677 . . . . 64.54 110.21 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.615 ' HG3' ' H ' ' B' ' 9' ' ' MET . 8.8 tp10 -168.24 -159.26 0.27 Allowed 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 125.107 1.363 . . . . 73.4 107.632 -172.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.615 ' H ' ' HG3' ' B' ' 8' ' ' GLU . 19.8 ptm 65.55 176.23 0.21 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 126.911 2.084 . . . . 72.34 114.055 166.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p -136.65 141.89 43.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.22 1.008 . . . . 75.43 108.824 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.409 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 67.8 t80 -128.82 150.6 50.25 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.284 0.564 . . . . 75.41 111.899 -166.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.459 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 33.4 tp60 -142.54 123.63 14.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.054 1.342 . . . . 71.23 108.184 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.14 143.83 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.134 0.573 . . . . 75.33 109.984 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -116.94 -51.61 2.55 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.776 0.43 . . . . 74.32 110.841 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -162.53 143.65 10.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.405 0.282 . . . . 74.15 110.256 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -115.29 143.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.381 -1.34 . . . . 70.32 107.381 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -170.71 144.08 2.25 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.565 0.62 . . . . 73.31 111.716 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.3 m -75.25 121.72 22.59 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.976 -0.75 . . . . 71.4 108.976 172.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -88.73 -37.96 15.09 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.12 0.568 . . . . 75.41 110.312 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.6 t70 -152.89 144.08 23.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.283 -0.417 . . . . 72.5 112.071 -168.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.776 HD12 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -137.99 147.34 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.472 1.509 . . . . 65.55 108.492 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -150.58 150.69 31.52 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 73.23 108.78 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.9 t80 -160.19 114.7 2.24 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 106.625 -1.621 . . . . 72.31 106.625 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.78 113.91 20.34 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.408 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -106.96 89.23 4.24 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.649 -0.871 . . . . 71.04 108.649 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.46 -27.11 33.85 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.409 2.073 . . . . 74.44 112.035 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -123.3 30.59 6.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.372 1.069 . . . . 74.21 109.661 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -42.47 -52.07 10.74 Favored Pre-proline 0 CA--C 1.568 1.659 0 C-N-CA 125.525 1.53 . . . . 62.43 114.431 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -72.16 -17.61 27.8 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.359 2.04 . . . . 72.1 112.802 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.43 2.97 56.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.491 1.116 . . . . 73.23 111.244 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.02 -27.95 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.807 0.443 . . . . 74.23 111.327 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -64.74 -41.03 96.23 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.247 0.619 . . . . 75.35 109.996 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -65.0 -29.6 70.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.562 1.145 . . . . 75.44 110.799 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.459 ' HB2' HD12 ' B' ' 68' ' ' LEU . 33.0 mmtp -108.85 96.72 6.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.317 1.047 . . . . 74.45 110.637 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.37 78.02 7.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.048 0.539 . . . . 74.54 111.287 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.6 170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.238 1.015 . . . . 64.2 109.727 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.524 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 48.9 tt0 -67.29 119.04 62.03 Favored Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 123.789 0.681 . . . . 74.53 109.653 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.53 140.58 89.85 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.129 1.886 . . . . 74.34 110.842 167.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.795 ' HA ' ' HA3' ' F' ' 191' ' ' GLY . 36.3 mt-10 -67.04 100.45 0.75 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.708 -0.849 . . . . 74.2 108.708 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.09 120.84 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.758 -1.571 . . . . 72.32 106.758 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -144.08 126.68 16.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.577 -0.898 . . . . 75.33 108.577 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.485 HD11 HD11 ' B' ' 126' ' ' LEU . 1.8 pt? -129.29 159.02 37.45 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.982 0.513 . . . . 74.52 111.125 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -143.45 150.38 38.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.251 0.62 . . . . 74.11 110.77 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.13 144.03 29.29 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.726 1.21 . . . . 73.42 110.729 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.91 146.04 21.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 75.21 107.787 167.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.3 m -145.78 139.71 26.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.108 0.563 . . . . 73.42 110.004 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.31 134.76 18.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.101 0.96 . . . . 71.31 108.848 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.42 ' HG ' HD11 ' B' ' 98' ' ' LEU . 88.8 p -132.62 166.09 22.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.326 0.65 . . . . 73.4 110.343 -177.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.1 p -153.09 137.19 16.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.645 0.778 . . . . 75.12 109.454 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -80.85 120.38 24.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.331 0.652 . . . . 75.44 110.539 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' B' ' 57' ' ' GLU . 38.4 mt -82.23 -50.03 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.754 0.822 . . . . 74.43 109.995 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.54 -171.11 3.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.272 1.029 . . . . 72.3 110.174 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.58 113.06 3.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.448 0.699 . . . . 73.22 110.56 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.4 m-20 71.06 -5.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.021 1.728 . . . . 73.41 112.694 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.68 116.62 46.72 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 108.15 -1.056 . . . . 71.4 108.15 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 155.33 50.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.172 -0.677 . . . . 75.25 109.172 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.443 ' HB2' HD13 ' B' ' 51' ' ' LEU . 6.9 tm-20 -111.68 112.28 23.87 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.342 -1.355 . . . . 75.42 107.342 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.95 127.21 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.964 0.905 . . . . 63.5 110.031 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -108.36 128.22 64.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.714 0.805 . . . . 73.25 109.282 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -105.44 109.11 20.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.794 -1.188 . . . . 75.24 107.794 175.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -93.41 119.25 32.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.838 0.455 . . . . 75.11 110.489 170.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 43.6 t -113.1 105.69 19.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.658 -1.238 . . . . 72.31 107.658 167.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -99.18 133.26 43.73 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.459 -0.571 . . . . 71.42 109.459 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 21.7 t -119.62 126.92 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.261 1.425 . . . . 71.03 109.069 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -114.72 149.13 37.31 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.426 1.09 . . . . 54.13 108.27 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.33 153.01 50.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.136 0.575 . . . . 63.13 109.736 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 33.5 p -146.13 141.23 27.31 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.606 0.566 . . . . 72.51 111.152 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' B' ' 34' ' ' LYS . 22.2 mt -130.17 99.82 5.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.253 1.421 . . . . 65.12 108.68 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -109.15 2.78 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.339 -0.391 . . . . 55.3 112.411 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -118.09 23.6 11.52 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.387 1.075 . . . . 74.22 110.555 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.86 160.72 42.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.116 0.566 . . . . 73.21 110.301 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -72.61 134.25 45.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.763 -0.653 . . . . 65.11 110.249 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.11 -58.07 2.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 73.23 109.271 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -153.19 173.54 15.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.787 -1.097 . . . . 72.5 109.779 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 73.2 mt -138.89 155.85 47.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.251 1.821 . . . . 74.21 106.473 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.561 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.4 t -160.49 159.59 30.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.81 0.844 . . . . 73.41 108.817 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.21 140.52 6.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.505 -0.924 . . . . 72.4 108.505 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' B' ' 110' ' ' ALA . 72.7 t -129.82 142.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.932 -1.136 . . . . 73.32 107.932 171.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -124.98 87.76 2.77 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.207 -1.035 . . . . 74.02 108.207 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -81.94 100.87 9.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.455 -1.248 . . . . 71.33 109.129 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.43 175.22 35.8 Favored Glycine 0 C--O 1.241 0.534 0 N-CA-C 111.954 -0.458 . . . . 73.53 111.954 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.97 137.16 3.73 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.932 -0.467 . . . . 64.44 111.932 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 127.01 40.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.775 -0.824 . . . . 71.5 108.775 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -138.64 161.24 37.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.405 1.082 . . . . 72.44 109.581 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.0 m -132.39 133.6 44.13 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.777 1.231 . . . . 73.1 108.982 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.566 HG23 ' SG ' ' B' ' 97' ' ' CYS . 2.7 pp -139.18 147.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 122.876 0.47 . . . . 70.32 111.868 -171.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.92 170.58 16.32 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.986 0.915 . . . . 75.15 109.749 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.12 16.31 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.426 -0.352 . . . . 70.23 113.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.14 142.54 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.385 1.074 . . . . 70.31 112.848 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.661 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 14.1 pt-20 -160.73 142.07 12.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.324 1.05 . . . . 65.5 109.026 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.08 -106.15 0.76 Allowed Glycine 0 C--N 1.354 1.564 0 C-N-CA 123.081 0.372 . . . . 40.24 113.928 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.2 m -77.21 -30.27 54.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.768 1.227 . . . . 73.44 111.796 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.661 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 1.5 mp0 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.421 0.689 . . . . 74.42 110.793 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.504 ' HE1' ' HD2' ' F' ' 175' ' ' PHE . 41.9 mtp -70.44 -39.79 74.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.607 0.763 . . . . 73.34 110.057 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.53 64.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 73.02 111.397 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.52 -39.23 92.88 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.334 0.654 . . . . 75.23 110.934 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.566 ' SG ' HG23 ' B' ' 86' ' ' ILE . 44.9 t -61.12 -61.56 2.48 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.109 -0.95 . . . . 75.13 111.635 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.42 HD11 ' HG ' ' B' ' 48' ' ' SER . 1.9 pt? -90.77 -18.4 25.0 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.575 0.583 . . . . 71.2 112.575 -176.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.68 -26.72 11.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.232 0.333 . . . . 75.1 113.673 -173.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.406 ' HB2' HD22 ' B' ' 5' ' ' ASN . . . -121.98 -55.96 1.86 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.371 0.508 . . . . 54.33 112.371 -171.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -73.76 -60.06 2.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.524 0.33 . . . . 73.4 110.793 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.409 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 85.8 m -58.49 -46.18 99.63 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.196 -0.907 . . . . 72.51 112.225 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.418 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 53.9 Cg_exo -58.9 -36.52 96.78 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.039 1.826 . . . . 64.4 113.759 172.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -66.87 -29.83 69.84 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 118.625 0.648 . . . . 74.02 110.849 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -63.04 -50.25 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.03 0.532 . . . . 75.14 109.877 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -79.34 -10.42 59.81 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.162 -1.381 . . . . 75.35 111.883 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.403 ' HE1' HD13 ' B' ' 128' ' ' LEU . 24.1 t80 -65.55 -49.67 60.77 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.654 1.181 . . . . 75.54 113.109 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' B' ' 112' ' ' GLU . 25.1 Cg_exo -62.31 -35.72 71.8 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 121.494 1.463 . . . . 73.42 111.353 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -64.17 -48.6 75.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.069 0.947 . . . . 74.52 110.793 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.459 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -63.66 -49.08 74.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.127 0.971 . . . . 61.42 110.734 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -67.46 -43.31 81.36 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.95 0.781 . . . . 74.35 110.381 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' B' ' 108' ' ' PRO . 0.4 OUTLIER -69.26 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.131 0.972 . . . . 74.42 111.609 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.776 ' SG ' HD12 ' B' ' 21' ' ' ILE . 7.7 t -74.16 -39.05 63.5 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.8 -0.445 . . . . 71.42 109.8 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.48 HG21 HG22 ' B' ' 64' ' ' VAL . 94.2 mt -62.82 -46.76 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.604 0.762 . . . . 71.52 110.078 173.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.445 HG23 ' OE1' ' C' ' 125' ' ' GLN . 44.1 m -50.41 -39.52 47.45 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.958 1.303 . . . . 75.41 110.701 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.8 t -66.34 -56.15 12.51 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 113.957 -1.474 . . . . 72.34 110.552 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.7 mmt -64.26 -38.13 89.95 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.659 0.615 . . . . 73.54 112.659 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.28 -46.41 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.421 1.088 . . . . 74.32 110.409 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.556 ' HB3' ' NE2' ' C' ' 125' ' ' GLN . 81.9 p -71.71 -25.28 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.568 -0.742 . . . . 75.24 111.465 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.1 mtt-85 -65.47 -39.44 91.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.158 0.583 . . . . 73.21 110.091 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.11 3.85 50.06 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.631 -0.713 . . . . 74.42 113.15 172.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p 59.72 48.98 8.65 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 126.512 1.925 . . . . 75.42 111.27 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -115.69 161.61 29.5 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-N 113.867 -1.515 . . . . 74.32 110.585 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.524 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 89.0 Cg_exo -53.2 177.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 125.031 3.82 . . . . 74.41 118.509 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.65 147.48 52.9 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 113.824 -1.534 . . . . 74.42 113.688 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.485 HD11 HD11 ' B' ' 42' ' ' LEU . 3.5 tm? -149.97 106.73 3.54 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.166 -1.379 . . . . 74.35 107.626 173.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -137.72 118.82 14.43 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.679 -1.23 . . . . 60.43 107.679 163.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.451 HD22 ' N ' ' B' ' 129' ' ' ALA . 2.2 tt -79.91 135.3 36.39 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.241 -0.652 . . . . 74.21 109.241 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.451 ' N ' HD22 ' B' ' 128' ' ' LEU . . . -57.19 141.95 76.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.406 1.482 . . . . 71.13 113.078 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.487 ' HG3' ' H ' ' D' ' 16' ' ' ILE . 61.4 Cg_endo -71.97 99.26 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.673 2.249 . . . . 73.14 111.818 171.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.28 105.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 109.24 -0.652 . . . . 72.35 109.24 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -70.1 117.66 11.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.391 0.677 . . . . 73.23 110.719 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -83.44 -31.15 26.75 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.574 0.75 . . . . 74.35 112.911 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.78 -46.88 73.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.878 0.871 . . . . 74.15 112.41 -167.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.71 -30.5 65.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.421 0.688 . . . . 64.23 112.264 -175.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.46 -52.98 40.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.673 0.789 . . . . 72.53 110.455 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.76 -43.8 92.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.695 -0.684 . . . . 65.05 110.895 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.3 mmt -62.77 -36.05 81.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.53 0.732 . . . . 72.31 112.081 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -80.15 -40.34 27.54 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.145 -0.48 . . . . 73.1 110.391 -173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.73 -36.35 75.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.614 0.765 . . . . 73.32 110.816 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.49 33.63 2.87 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.886 0.874 . . . . 74.24 110.509 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -70.04 99.57 1.48 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.965 -1.124 . . . . 75.14 107.965 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -155.14 92.76 1.46 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.091 -0.707 . . . . 75.03 109.091 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -84.88 90.47 7.79 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.998 0.919 . . . . 72.11 109.069 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.54 77.64 2.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.812 -0.631 . . . . 75.14 109.396 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.91 105.72 0.18 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.872 -0.604 . . . . 62.33 112.158 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.23 13.15 2.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.537 1.135 . . . . 75.11 110.298 176.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.29 114.27 5.37 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.857 -0.61 . . . . 74.34 112.871 -174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 1.8 t -125.58 125.43 43.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.262 1.025 . . . . 74.34 109.066 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -65.66 138.15 57.8 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.462 0.705 . . . . 75.34 111.48 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -147.27 107.51 4.05 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.285 -1.006 . . . . 73.24 108.285 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -120.04 61.05 0.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.468 1.107 . . . . 74.13 108.598 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -83.04 167.12 18.19 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.206 -1.361 . . . . 73.01 108.312 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.55 151.35 41.71 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.127 0.489 . . . . 75.41 111.222 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.11 0.964 . . . . 73.24 108.81 177.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 44.6 m -143.9 115.34 8.06 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.95 -1.13 . . . . 74.24 107.95 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.16 129.53 31.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.439 0.695 . . . . 73.4 110.303 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.2 102.51 15.24 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.951 -0.759 . . . . 71.21 108.951 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -145.8 82.38 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.936 -0.765 . . . . 63.13 108.936 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.609 ' HB3' ' HA2' ' A' ' 146' ' ' GLY . 42.6 m-80 -142.02 97.25 3.1 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.459 1.103 . . . . 71.24 108.614 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -167.58 164.84 14.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.823 . . . . 74.13 110.367 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.547 ' HA ' ' HB1' ' A' ' 135' ' ' ALA . 35.5 mt-10 -126.02 -64.02 1.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.819 0.848 . . . . 73.22 109.143 172.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 65.25 115.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 74.31 112.842 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.0 m -102.35 94.61 5.79 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.226 1.01 . . . . 72.04 109.404 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.456 ' HB3' ' HA ' ' H' ' 207' ' ' VAL . 58.6 t80 -107.83 163.74 12.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.635 1.174 . . . . 73.13 111.317 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.023 0.929 . . . . 73.12 109.213 161.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.494 HD13 HG13 ' C' ' 16' ' ' ILE . 5.5 tp -78.55 133.62 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.03 -0.73 . . . . 72.21 109.03 167.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -103.7 -47.93 4.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.552 0.741 . . . . 73.22 110.388 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -169.65 134.31 1.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.637 -0.256 . . . . 74.32 110.435 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.494 HG13 HD13 ' C' ' 13' ' ' ILE . 92.3 mt -122.34 135.25 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.451 -0.944 . . . . 75.33 108.451 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.473 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 10.3 p90 -171.63 157.1 4.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.244 0.545 . . . . 71.34 111.821 -172.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -82.02 118.43 22.99 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.289 -0.869 . . . . 73.45 109.813 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -69.76 -45.96 66.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.661 0.743 . . . . 74.35 109.216 172.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -146.29 146.41 30.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 113.882 -1.508 . . . . 74.51 108.956 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.3 mt -138.99 140.16 39.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.99 -1.485 . . . . 73.14 106.99 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -152.52 148.63 27.61 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.273 0.558 . . . . 74.24 110.213 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -154.36 107.83 2.91 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.376 -1.342 . . . . 74.14 107.376 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.43 112.09 20.19 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.415 -0.958 . . . . 74.53 108.415 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.22 95.93 32.74 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.403 1.081 . . . . 75.25 109.355 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.5 -39.88 33.85 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.793 2.328 . . . . 73.5 111.977 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -96.25 29.4 2.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.931 -1.031 . . . . 75.55 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.43 -48.34 97.13 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.684 -0.674 . . . . 51.45 112.412 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.58 -31.14 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 121.455 1.437 . . . . 72.22 113.387 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -71.13 -25.11 62.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.383 0.673 . . . . 71.4 112.415 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.93 -22.08 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.531 0.732 . . . . 74.44 111.546 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.44 -36.81 71.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.269 1.027 . . . . 74.15 111.12 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.86 45.94 1.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.996 0.903 . . . . 73.43 109.012 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.806 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -123.49 155.1 38.17 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.931 0.892 . . . . 73.4 110.859 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.41 115.38 8.61 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.363 -0.977 . . . . 71.33 108.363 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -80.46 71.18 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.092 0.957 . . . . 71.43 111.887 -173.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' E' ' 193' ' ' TYR . 25.8 tt0 -122.66 78.18 47.7 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.897 0.879 . . . . 75.31 109.821 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' E' ' 193' ' ' TYR . 15.4 Cg_exo -71.06 128.58 15.02 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.262 1.975 . . . . 74.32 111.152 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -87.7 107.36 18.6 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 74.5 106.785 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.31 113.65 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 124.113 0.883 . . . . 75.41 109.913 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.07 115.43 23.09 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.457 -1.312 . . . . 73.4 107.457 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.445 ' H ' HD21 ' C' ' 42' ' ' LEU . 2.7 pt? -110.47 143.97 39.99 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.341 -0.985 . . . . 71.24 108.341 169.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.26 144.08 26.28 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.968 -0.752 . . . . 63.3 108.968 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 42.8 tp -113.89 123.94 51.0 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.588 0.555 . . . . 72.01 109.948 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -113.07 145.04 41.59 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.883 -1.525 . . . . 64.4 106.883 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -125.15 154.58 41.27 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.059 0.544 . . . . 64.34 110.001 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.6 161.51 39.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.499 1.119 . . . . 65.02 108.605 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.3 p -158.88 152.75 23.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.88 0.472 . . . . 62.32 110.978 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -156.84 130.28 8.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.721 0.808 . . . . 72.53 109.937 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -74.76 121.5 21.84 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.086 -0.709 . . . . 75.1 109.086 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.69 HD12 ' HB2' ' C' ' 57' ' ' GLU . 39.6 mt -94.98 -50.38 5.13 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.62 0.724 . . . . 74.45 110.864 -173.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.418 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -149.3 -172.19 4.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.749 -1.114 . . . . 74.25 109.945 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -69.96 113.89 7.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.852 0.461 . . . . 74.42 109.769 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 70.66 -0.38 2.97 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.674 1.589 . . . . 73.54 112.303 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 61.2 t -109.92 122.1 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 60.42 108.483 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.489 ' HH ' ' HB3' ' C' ' 98' ' ' LEU . 47.2 p90 -134.66 176.58 8.51 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.679 0.752 . . . . 74.42 109.711 174.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.69 ' HB2' HD12 ' C' ' 51' ' ' LEU . 36.7 tt0 -125.39 141.41 52.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.444 -1.253 . . . . 72.11 108.159 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.85 140.18 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.09 -1.078 . . . . 75.12 108.09 164.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.2 t -126.38 116.5 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.99 0.916 . . . . 74.53 109.465 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -87.8 104.88 16.99 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 122.761 0.424 . . . . 63.53 110.261 174.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -86.81 101.46 13.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.107 -1.071 . . . . 74.44 108.107 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.575 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.1 t -99.84 132.0 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.645 -1.243 . . . . 74.43 107.645 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -122.92 123.12 40.23 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.502 -0.555 . . . . 73.42 109.502 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.586 HG23 HG21 ' C' ' 114' ' ' ILE . 92.7 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.369 1.067 . . . . 73.33 108.858 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -98.57 139.46 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.004 -1.11 . . . . 74.23 108.004 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.43 114.21 8.04 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.633 -0.877 . . . . 70.41 108.633 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.8 m -123.73 135.35 53.8 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.941 0.497 . . . . 73.33 111.015 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.806 HD12 ' HG2' ' C' ' 34' ' ' LYS . 13.3 mt -85.53 55.17 3.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.032 1.333 . . . . 75.55 109.148 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -110.18 3.81 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.943 -1.263 . . . . 74.55 109.943 -172.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.7 -23.72 17.45 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.876 . . . . 75.22 110.244 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -91.47 108.63 20.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.4 1.08 . . . . 73.25 110.027 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 59.0 m -70.19 122.65 19.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.304 0.642 . . . . 75.01 112.43 -171.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.57 ' HB3' ' HG ' ' C' ' 68' ' ' LEU . . . -67.77 -58.47 4.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.607 1.163 . . . . 74.03 110.254 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -154.53 176.2 12.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.587 -1.188 . . . . 74.23 111.05 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.79 109.75 5.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.578 -1.638 . . . . 75.33 106.578 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.517 ' SG ' HG22 ' C' ' 114' ' ' ILE . 43.6 t -107.45 146.25 31.97 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.528 -0.916 . . . . 74.52 108.528 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -158.24 129.77 6.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.807 -0.442 . . . . 73.31 109.807 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.24 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.309 1.044 . . . . 73.14 108.592 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.4 mt-30 -114.5 98.68 7.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 74.21 108.753 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -91.33 105.24 17.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.938 0.895 . . . . 75.15 110.26 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.78 151.45 22.33 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.311 0.382 . . . . 52.52 112.274 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.503 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.54 121.34 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.448 -0.661 . . . . 75.0 111.448 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.481 HD13 ' HB3' ' D' ' 29' ' ' PRO . 23.9 mm -82.69 127.8 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.747 -0.834 . . . . 75.43 108.747 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -136.23 126.03 25.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.335 0.654 . . . . 74.35 110.051 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.1 p -101.43 106.54 17.69 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.662 -0.866 . . . . 75.01 108.662 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.435 HD11 ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER -148.42 143.94 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.622 0.725 . . . . 72.32 111.369 -177.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.62 179.38 7.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.293 1.437 . . . . 71.03 109.716 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.72 52.74 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 114.618 0.607 . . . . 64.03 114.618 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -80.02 166.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.331 0.653 . . . . 73.24 111.865 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.523 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 14.6 pt-20 -165.36 147.6 7.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.157 0.983 . . . . 73.44 109.668 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.2 -110.89 2.22 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.486 0.554 . . . . 73.35 114.486 170.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 82.7 p -68.85 -37.75 79.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.422 1.089 . . . . 72.24 111.34 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.523 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 22.2 mt-30 -60.66 -42.19 96.52 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.568 0.747 . . . . 74.31 109.722 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' E' ' 175' ' ' PHE . 41.8 ttm -63.89 -47.31 81.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 75.25 111.053 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.295 -0.866 . . . . 74.45 110.854 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -74.68 -24.91 58.86 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.98 -0.554 . . . . 74.5 111.731 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' C' ' 86' ' ' ILE . 42.7 t -72.06 -62.71 1.33 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.84 0.456 . . . . 74.43 111.503 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.489 ' HB3' ' HH ' ' C' ' 56' ' ' TYR . 0.0 OUTLIER -100.84 -6.86 24.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.764 -0.585 . . . . 72.12 112.433 -176.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.64 2.61 49.3 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.669 -0.517 . . . . 70.31 113.286 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.521 ' HA ' ' HZ3' ' E' ' 184' ' ' TRP . . . -154.56 -58.55 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.267 0.533 . . . . 75.31 111.858 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -65.4 -67.9 0.4 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.36 1.064 . . . . 74.44 112.212 -168.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -57.84 -43.98 99.05 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.299 1.039 . . . . 62.2 112.813 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.35 -34.18 55.89 Favored 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 121.638 1.559 . . . . 75.14 113.575 170.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -72.0 -19.14 61.91 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 118.76 0.709 . . . . 73.1 110.866 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.419 HD13 HH12 ' A' ' 111' ' ' ARG . 40.5 mm -66.08 -41.75 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.515 0.726 . . . . 75.52 109.551 167.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.503 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.1 mt -79.13 -28.1 42.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.26 -0.882 . . . . 63.15 112.053 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -53.74 -45.97 98.56 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.364 -1.303 . . . . 73.42 113.271 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.41 ' HG3' ' CD2' ' A' ' 109' ' ' TYR . 47.4 Cg_exo -53.96 -40.54 80.56 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 122.329 2.019 . . . . 72.11 113.274 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -69.21 -43.57 73.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.445 0.698 . . . . 72.33 110.651 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.82 98.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 73.41 110.718 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -57.94 -48.54 79.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.81 1.644 . . . . 73.54 110.751 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -72.35 -33.94 67.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.771 0.828 . . . . 73.45 110.541 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -65.03 -43.34 92.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.71 0.804 . . . . 74.33 110.466 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.586 HG21 HG23 ' C' ' 64' ' ' VAL . 87.9 mt -66.52 -50.03 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.212 0.605 . . . . 73.55 110.23 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.481 HG23 ' HB2' ' C' ' 125' ' ' GLN . 58.8 m -50.15 -44.28 52.5 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 124.555 1.16 . . . . 75.31 111.055 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.4 t -68.77 -46.82 67.76 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.484 -1.234 . . . . 75.4 110.012 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.566 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.75 -43.89 63.1 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.013 0.925 . . . . 71.43 112.229 178.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.1 t -66.1 -45.38 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.489 0.716 . . . . 71.5 110.668 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -70.47 -26.51 63.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.926 -0.579 . . . . 62.02 111.229 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.3 mtt-85 -65.99 -38.59 88.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.784 0.833 . . . . 74.23 110.413 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.69 3.7 63.09 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.755 -0.657 . . . . 71.43 112.826 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.447 HG21 ' HB3' ' D' ' 17' ' ' TYR . 25.5 p 63.32 33.42 14.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.349 1.86 . . . . 74.21 112.152 174.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.43 168.09 9.02 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.721 1.208 . . . . 71.12 109.609 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.48 106.51 0.6 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 122.386 2.058 . . . . 74.32 110.984 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.556 ' NE2' ' HB3' ' B' ' 119' ' ' SER . 18.7 pt20 -54.45 135.53 45.4 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.04 . . . . 72.22 111.842 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.01 89.67 3.71 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.402 0.62 . . . . 71.24 109.969 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -111.5 86.42 2.33 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.603 -1.629 . . . . 61.41 106.603 167.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.513 ' HB3' HD13 ' E' ' 187' ' ' ILE . 76.4 mt -87.52 153.8 21.13 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.261 -1.336 . . . . 75.41 109.985 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.423 ' HB2' HD11 ' E' ' 187' ' ' ILE . . . -45.25 127.84 5.85 Favored Pre-proline 0 CA--C 1.556 1.193 0 O-C-N 124.599 1.187 . . . . 52.01 112.817 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.52 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 37.0 Cg_endo -61.08 104.16 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.558 2.839 . . . . 73.12 113.054 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.68 91.66 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-O 121.955 0.883 . . . . 64.41 111.076 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -88.54 102.39 14.88 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.241 -1.022 . . . . 72.11 108.241 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.77 -36.9 82.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.877 0.871 . . . . 74.5 112.325 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.78 -43.28 80.11 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.3 0.64 . . . . 75.44 111.612 -170.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.19 93.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.168 0.587 . . . . 71.4 110.654 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.4 -31.54 69.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.017 0.927 . . . . 73.22 110.682 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -70.66 -45.02 65.88 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.994 0.917 . . . . 70.52 110.769 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.0 mtm -72.46 -33.26 66.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.959 -0.564 . . . . 72.22 110.535 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.38 -37.87 88.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.733 0.813 . . . . 73.22 110.251 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.57 -79.52 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.863 1.265 . . . . 73.14 110.839 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.97 -38.84 68.3 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.504 1.122 . . . . 71.51 110.454 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 69.64 9.81 7.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.284 1.434 . . . . 75.11 111.804 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 59.73 -81.12 0.02 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.63 1.572 . . . . 75.01 112.786 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.97 143.06 33.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.52 -0.918 . . . . 54.34 108.52 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.69 -179.75 4.91 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.608 0.718 . . . . 61.12 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.27 -140.71 5.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.902 -1.279 . . . . 73.45 109.902 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.5 -62.69 1.18 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 117.811 0.805 . . . . 75.43 110.415 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.74 78.46 1.41 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.977 -1.249 . . . . 64.33 109.977 -165.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.3 t -71.04 135.77 47.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.804 0.842 . . . . 61.33 110.255 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.64 113.5 25.32 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.787 -0.82 . . . . 75.22 108.787 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.419 ' HG3' ' HZ2' ' G' ' 170' ' ' LYS . 11.6 mm-40 -100.33 -82.3 0.45 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.323 1.049 . . . . 75.54 111.083 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 m170 58.32 147.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.935 1.294 . . . . 72.31 113.474 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -109.09 87.14 2.42 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.773 -1.195 . . . . 73.11 107.773 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.02 -13.23 36.46 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.968 -1.014 . . . . 61.45 110.9 -174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.84 0.856 . . . . 74.13 110.6 -178.251 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.531 ' SD ' ' HB1' ' H' ' 172' ' ' ALA . 16.9 ptt? . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.352 0.596 . . . . 71.45 109.497 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 61.8 p -128.39 7.72 5.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.045 0.538 . . . . 64.14 112.094 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.55 134.06 38.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.354 0.662 . . . . 74.43 109.541 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -126.43 105.24 8.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.15 0.98 . . . . 75.45 109.631 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.466 ' ND2' HG21 ' D' ' 7' ' ' THR . 3.8 t30 -75.16 143.78 43.08 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.572 -0.899 . . . . 70.41 108.572 165.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -69.04 99.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.736 -0.468 . . . . 74.32 109.736 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.466 HG21 ' ND2' ' D' ' 5' ' ' ASN . 5.0 p -122.0 136.79 54.95 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 125.019 1.327 . . . . 63.52 108.331 172.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -73.79 83.53 1.64 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.102 -0.703 . . . . 72.22 109.102 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttp -32.89 123.51 0.37 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.67 1.588 . . . . 73.23 112.937 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -120.14 138.94 53.3 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.763 0.825 . . . . 73.42 108.779 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -156.57 111.1 2.78 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.691 -1.226 . . . . 64.43 107.691 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 79.2 mt-30 -117.66 116.63 27.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.565 0.746 . . . . 71.52 110.312 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.7 mp -75.91 104.87 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.928 -1.508 . . . . 62.12 106.928 168.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.458 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 76.3 mt-30 -80.79 -41.9 22.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 119.106 -0.473 . . . . 75.13 110.759 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 177.96 144.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.686 0.616 . . . . 75.42 111.722 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.487 ' H ' ' HG3' ' B' ' 130' ' ' PRO . 2.0 mp -105.48 132.14 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 107.316 -1.364 . . . . 72.35 107.316 170.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.447 ' HB3' HG21 ' C' ' 122' ' ' THR . 32.9 p90 -158.28 159.8 36.35 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.321 1.049 . . . . 74.53 109.628 -174.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -92.37 118.13 30.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 72.14 109.812 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -89.07 -32.75 17.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.758 -0.655 . . . . 72.43 109.827 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.704 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.8 t70 -146.06 134.02 21.4 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.118 -0.946 . . . . 63.43 108.902 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.566 HG23 ' HE1' ' C' ' 117' ' ' MET . 68.3 mt -130.44 140.49 48.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.578 -1.268 . . . . 60.34 107.578 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -142.19 136.15 29.65 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.101 0.96 . . . . 73.34 108.837 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -144.31 119.83 10.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.558 -2.016 . . . . 73.33 105.558 166.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.69 134.29 54.96 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 108.973 -0.751 . . . . 72.42 108.973 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.53 82.22 47.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.758 -1.571 . . . . 74.31 106.758 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -65.91 -30.22 48.9 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.61 2.207 . . . . 71.44 112.043 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.7 24.9 12.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.726 -1.125 . . . . 54.31 109.898 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -41.22 -60.97 1.49 Allowed Pre-proline 0 CA--C 1.584 2.253 0 N-CA-C 116.018 1.859 . . . . 73.01 116.018 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.481 ' HB3' HD13 ' C' ' 83' ' ' ILE . 94.4 Cg_endo -79.6 -17.06 11.43 Favored 'Trans proline' 0 C--N 1.399 3.214 0 CA-C-N 122.923 2.08 . . . . 74.34 113.293 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -73.41 -39.22 65.23 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.989 1.316 . . . . 73.44 110.295 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.732 HG23 ' HA ' ' D' ' 73' ' ' ALA . 4.5 p -86.24 -7.86 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 124.296 1.038 . . . . 74.31 111.156 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.52 -25.34 59.71 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.363 1.065 . . . . 74.31 111.176 169.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.54 -14.21 62.85 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.232 1.013 . . . . 74.23 112.259 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.472 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 0.1 OUTLIER -96.92 106.28 18.57 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.854 0.862 . . . . 72.25 109.394 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' H' ' 196' ' ' LYS . 9.8 p-10 -112.7 50.08 0.89 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.579 1.152 . . . . 74.11 110.604 -171.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -146.59 177.51 9.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 75.42 110.509 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -62.05 113.98 10.16 Favored Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.058 0.943 . . . . 74.22 111.345 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HG3' HD22 ' D' ' 68' ' ' LEU . 15.4 Cg_exo -71.31 144.84 46.94 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.024 2.483 . . . . 71.34 113.037 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.87 142.69 47.94 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.489 -0.778 . . . . 75.4 109.053 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.433 HG22 HD11 ' D' ' 126' ' ' LEU . 95.7 t -124.95 118.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.21 108.385 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -112.67 118.26 34.55 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.24 -0.652 . . . . 75.33 109.24 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.624 HD23 HD23 ' D' ' 128' ' ' LEU . 5.7 mp -96.88 125.45 41.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.475 0.71 . . . . 75.32 109.696 -174.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.795 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.1 m-20 -107.06 126.86 52.9 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.459 -0.941 . . . . 73.01 108.459 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.58 132.23 40.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.258 0.623 . . . . 75.32 109.89 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.1 t70 -157.62 156.18 31.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 170.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -136.51 165.89 24.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.6 0.76 . . . . 74.03 109.794 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.99 177.57 10.03 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.889 1.275 . . . . 71.3 108.473 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -165.36 166.63 18.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.847 0.459 . . . . 73.43 111.249 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.6 p -154.24 131.69 11.28 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.292 1.037 . . . . 74.13 108.328 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.4 117.85 20.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.941 -0.762 . . . . 73.04 108.941 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.3 mt -92.27 -33.4 14.66 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.708 -0.478 . . . . 75.23 109.708 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.39 -177.04 5.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.538 0.735 . . . . 73.4 111.064 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -65.92 124.55 22.8 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.02 -0.991 . . . . 65.22 109.005 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 16.6 m-20 65.7 19.27 11.38 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.183 0.993 . . . . 64.34 111.821 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.24 119.93 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.735 0.814 . . . . 71.33 109.643 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.418 ' HE1' ' SD ' ' H' ' 174' ' ' MET . 20.1 m-85 -134.03 130.84 38.12 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.023 0.929 . . . . 71.12 108.668 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.443 ' HB2' HD11 ' D' ' 51' ' ' LEU . 4.2 tt0 -86.78 119.6 27.18 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.512 -1.292 . . . . 74.35 107.512 169.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -100.16 129.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.635 -1.246 . . . . 73.24 107.635 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.3 t -104.79 138.66 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 71.31 108.944 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -106.4 124.32 49.41 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.43 -1.322 . . . . 74.31 107.43 174.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.7 ttm-85 -99.5 98.99 9.82 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.544 -1.28 . . . . 72.11 107.544 173.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.597 HG23 ' HB1' ' D' ' 110' ' ' ALA . 9.3 t -100.51 112.72 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.397 -0.964 . . . . 75.24 108.397 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.795 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -114.5 145.76 41.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.791 -0.448 . . . . 72.32 109.791 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 39.3 t -133.95 105.17 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.889 1.276 . . . . 65.04 109.101 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -98.07 96.47 8.15 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.085 -1.08 . . . . 70.25 108.085 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.98 147.71 24.22 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.972 0.509 . . . . 70.11 110.131 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -137.23 133.49 35.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.346 0.593 . . . . 74.14 111.939 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.463 HD22 ' HG3' ' D' ' 38' ' ' PRO . 9.4 mt -119.69 108.87 14.97 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.008 1.323 . . . . 75.01 108.402 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.2 -118.41 4.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.724 -0.551 . . . . 75.01 111.724 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.75 4.72 15.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.534 0.734 . . . . 72.2 110.707 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.472 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 13.0 pt-20 -122.48 171.75 8.86 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.484 0.714 . . . . 71.45 110.549 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.8 m -68.18 123.76 21.6 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.938 -1.028 . . . . 74.11 110.734 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.732 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -73.35 -65.41 0.82 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.422 -0.955 . . . . 73.21 108.422 170.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -156.76 157.05 34.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.843 -1.072 . . . . 73.11 109.83 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.05 152.11 29.91 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.124 1.37 . . . . 70.34 108.608 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.464 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 39.3 t -157.85 143.39 17.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.487 0.715 . . . . 73.44 109.092 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.23 128.99 7.82 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.557 -0.535 . . . . 73.14 109.557 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.18 115.29 42.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.013 -0.736 . . . . 74.33 109.013 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.704 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.69 85.63 6.83 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.189 0.995 . . . . 63.25 108.627 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.04 96.9 6.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 113.324 -1.762 . . . . 75.2 108.241 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -97.72 144.14 17.11 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 112.061 -0.416 . . . . 70.55 112.061 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.61 137.64 7.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.366 -0.694 . . . . 50.13 111.366 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 62.0 mt -88.08 125.45 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.901 -0.777 . . . . 73.43 108.901 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -130.79 123.87 30.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.643 0.777 . . . . 74.55 109.62 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 66.5 m -80.77 106.23 12.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.611 -0.885 . . . . 72.15 108.611 170.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -108.23 103.55 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.998 0.904 . . . . 74.25 110.007 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' D' ' 54' ' ' ASP . . . -140.96 150.92 43.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.985 0.914 . . . . 71.54 109.711 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.6 14.83 75.22 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.093 0.246 . . . . 74.12 113.192 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.667 HD13 ' HG2' ' D' ' 94' ' ' MET . 24.7 pt -98.59 125.63 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.365 1.066 . . . . 74.22 108.708 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' H' ' 172' ' ' ALA . 42.8 mt-10 -140.67 172.83 12.15 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.228 0.537 . . . . 64.13 112.01 -174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.23 -143.9 47.92 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.31 -1.314 . . . . 74.34 113.684 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -85.32 -20.21 30.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.106 0.962 . . . . 63.14 110.724 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.82 -35.87 79.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.472 0.709 . . . . 73.13 110.627 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.667 ' HG2' HD13 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -58.33 -49.26 77.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.527 0.731 . . . . 71.35 110.69 175.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.01 94.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.309 -0.86 . . . . 74.42 111.047 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.25 -30.88 66.85 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.64 -0.709 . . . . 64.14 111.261 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.67 -48.35 64.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.822 0.449 . . . . 73.11 110.411 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.57 -36.5 65.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.141 0.576 . . . . 75.43 110.212 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.55 6.5 77.63 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.221 -0.766 . . . . 72.45 114.785 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' D' ' 133' ' ' PHE . . . -152.75 -57.92 0.14 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.364 1.082 . . . . 74.12 112.341 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -64.75 -51.7 60.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.183 0.593 . . . . 72.11 111.49 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.497 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 27.9 m -60.73 -47.93 94.5 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 118.498 -0.763 . . . . 75.44 111.357 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.536 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.2 Cg_exo -59.29 -31.38 94.98 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.418 2.078 . . . . 74.25 113.968 168.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.7 -31.29 70.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.861 0.465 . . . . 75.2 110.706 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.3 -33.82 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.505 0.722 . . . . 72.52 110.281 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.481 HD12 ' HB2' ' D' ' 60' ' ' LEU . 86.0 mt -76.95 -25.61 53.05 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.049 0.939 . . . . 73.4 111.731 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -63.74 -41.99 68.51 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 114.94 1.459 . . . . 74.1 114.94 -168.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.53 -41.85 71.71 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.106 1.87 . . . . 71.11 113.234 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.15 -30.74 38.95 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.134 -0.939 . . . . 73.14 110.365 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -63.89 -44.91 91.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.722 0.809 . . . . 72.42 110.179 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.0 -51.29 70.28 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 124.629 1.206 . . . . 74.34 110.515 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.2 -41.92 99.23 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.143 0.902 . . . . 73.43 110.559 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' D' ' 21' ' ' ILE . 47.1 t -56.51 -45.21 81.2 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 123.808 0.693 . . . . 71.14 110.356 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.445 HG12 ' SG ' ' D' ' 76' ' ' CYS . 77.4 mt -63.9 -54.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.024 0.828 . . . . 74.52 110.375 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m -51.38 -46.74 62.89 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.152 1.381 . . . . 75.12 111.893 -171.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.7 t -65.53 -44.5 86.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.6 -1.182 . . . . 71.43 110.271 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.7 mtm -65.74 -32.71 74.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.03 0.532 . . . . 71.32 111.692 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -63.93 -48.26 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.77 0.828 . . . . 73.04 109.982 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -72.25 -28.63 63.27 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.983 -0.553 . . . . 72.33 110.937 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.7 mtt-85 -69.81 -34.23 73.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.624 0.77 . . . . 74.44 110.041 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 8.65 64.16 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.982 -0.554 . . . . 64.32 113.001 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.8 p 61.27 30.62 19.26 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.956 1.702 . . . . 74.31 113.119 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -100.9 163.43 18.05 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 124.708 1.203 . . . . 75.22 108.697 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.12 143.21 43.78 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.212 1.942 . . . . 71.44 111.55 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -52.13 132.97 33.77 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.792 0.682 . . . . 75.11 111.384 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.433 HD11 HG22 ' D' ' 40' ' ' VAL . 29.4 tp -108.89 108.23 18.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.148 0.979 . . . . 74.12 109.715 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -102.12 102.75 13.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.395 0.678 . . . . 74.22 109.603 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.624 HD23 HD23 ' D' ' 42' ' ' LEU . 38.5 mt -72.75 118.47 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.125 -0.694 . . . . 75.45 109.125 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 125.09 79.25 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.341 0.656 . . . . 62.25 111.25 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -67.64 103.34 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.136 1.891 . . . . 72.34 110.605 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.461 HG22 HG22 ' G' ' 207' ' ' VAL . 2.8 p -106.84 110.12 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.107 0.956 . . . . 72.33 109.915 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -77.77 107.04 9.99 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.413 -1.267 . . . . 73.45 108.098 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' D' ' 100' ' ' ALA . 68.0 m-85 -68.04 -25.42 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.769 0.827 . . . . 73.32 111.285 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.48 -22.58 66.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.046 1.338 . . . . 73.33 112.305 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -45.27 79.84 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.503 0.721 . . . . 73.24 111.582 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.497 HD13 HG13 ' G' ' 207' ' ' VAL . 6.1 mp -75.31 -34.74 61.28 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.537 0.735 . . . . 74.24 111.065 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.3 -65.16 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.861 0.864 . . . . 74.32 109.588 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.37 -26.62 65.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.678 1.191 . . . . 74.44 112.354 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -62.0 -44.84 95.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.146 0.578 . . . . 73.54 110.483 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -63.05 -41.58 99.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.894 0.478 . . . . 75.03 110.765 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.7 -38.2 86.26 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.823 -0.626 . . . . 70.22 111.56 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -83.86 5.95 23.32 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.021 0.528 . . . . 73.44 111.277 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.95 49.06 1.36 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.637 -1.246 . . . . 72.12 107.637 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -139.33 13.69 2.59 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.073 -1.422 . . . . 75.14 108.814 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.98 146.09 24.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.112 0.965 . . . . 71.41 109.791 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.14 -148.86 5.96 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-O 120.076 -0.291 . . . . 75.24 112.572 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -149.71 138.19 20.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.088 0.555 . . . . 73.23 110.111 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.45 175.93 50.89 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.528 0.517 . . . . 74.33 112.803 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 34.4 m -75.92 102.53 5.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.943 0.497 . . . . 75.23 110.265 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -133.75 143.41 48.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.625 -0.88 . . . . 75.15 108.625 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -92.49 134.36 35.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.484 1.114 . . . . 74.13 110.506 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -103.03 109.48 21.05 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.912 -1.144 . . . . 74.13 107.912 166.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -73.41 139.49 45.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.421 0.451 . . . . 73.24 110.076 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.34 172.92 7.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.961 0.904 . . . . 74.44 110.313 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 N-CA-C 108.648 -0.871 . . . . 73.44 108.648 170.337 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.32 -0.252 . . . . 72.25 110.32 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.83 Favored Glycine 0 C--N 1.345 1.039 0 O-C-N 124.018 0.824 . . . . 73.55 111.222 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 66.79 129.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.126 1.371 . . . . 61.54 111.945 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 66.8 m -79.56 0.32 30.36 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.071 0.548 . . . . 72.23 112.055 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -162.07 156.89 22.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.369 0.668 . . . . 74.23 110.575 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.6 tt -156.48 -55.63 0.08 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 107.613 -1.254 . . . . 74.11 107.613 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.28 129.69 40.84 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.446 0.698 . . . . 72.15 109.428 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.606 ' HD2' ' HB2' ' E' ' 177' ' ' LEU . 12.9 p90 -73.5 152.52 40.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.856 -1.066 . . . . 74.45 111.236 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' E' ' 178' ' ' GLN . 29.7 p-10 -103.57 -38.01 7.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.554 0.742 . . . . 74.43 109.316 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . 0.606 ' HB2' ' HD2' ' E' ' 175' ' ' PHE . 0.6 OUTLIER 56.97 42.99 25.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.656 1.182 . . . . 75.33 109.749 -178.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . 0.414 ' HB2' ' ND2' ' E' ' 176' ' ' ASN . 0.1 OUTLIER -57.7 -53.55 56.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.634 0.774 . . . . 74.5 109.085 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -136.0 145.17 51.41 Favored Pre-proline 0 C--O 1.245 0.842 0 C-N-CA 124.416 1.086 . . . . 75.45 108.956 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.01 123.04 11.02 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.588 2.192 . . . . 74.24 110.506 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.89 -45.21 30.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.722 1.209 . . . . 74.05 111.434 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.68 136.28 38.94 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.298 -1.371 . . . . 72.55 107.298 168.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 24.4 p -68.92 134.67 49.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.447 0.699 . . . . 74.22 110.11 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.521 ' HZ3' ' HA ' ' C' ' 100' ' ' ALA . 8.2 t-105 -71.38 111.47 10.31 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.198 0.999 . . . . 73.31 109.881 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -87.84 117.23 1.11 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.701 2.267 . . . . 73.45 112.107 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.81 147.37 29.42 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.513 HD13 ' HB3' ' C' ' 128' ' ' LEU . 25.7 pt -61.09 149.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.363 0.665 . . . . 75.0 111.174 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.76 89.28 3.41 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.517 -0.92 . . . . 62.02 108.517 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.23 86.49 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.243 -0.89 . . . . 75.44 111.055 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 19.7 t0 73.16 -62.11 0.48 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.841 1.257 . . . . 72.33 111.912 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 99.37 -132.68 11.01 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-O 119.524 -0.598 . . . . 61.44 112.279 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.56 83.73 0.47 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.521 -0.632 . . . . 64.13 111.521 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . 0.459 ' HA ' ' HA ' ' C' ' 37' ' ' GLN . 70.8 m-85 68.36 -89.39 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.144 1.378 . . . . 72.1 111.131 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 56.08 24.83 8.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.939 0.896 . . . . 74.15 110.918 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -171.25 158.35 5.39 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.068 0.947 . . . . 74.02 110.335 -171.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . 0.419 ' HD2' ' HD2' ' F' ' 193' ' ' TYR . 14.3 ptmm? -146.13 127.63 15.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.538 1.135 . . . . 71.51 108.32 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -92.85 -58.48 2.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.212 -1.033 . . . . 74.54 108.212 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 63.15 -170.28 0.18 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.227 1.411 . . . . 73.33 112.694 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -119.55 153.02 36.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.86 0.864 . . . . 74.03 109.767 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.49 -71.29 2.29 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.992 -0.443 . . . . 53.23 111.992 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 128.88 33.84 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.414 -0.587 . . . . 73.23 109.414 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 8.6 t80 58.06 25.26 12.14 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.853 1.261 . . . . 71.3 111.382 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.48 -61.62 1.77 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.276 1.031 . . . . 71.44 108.546 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 4.0 mt 63.39 89.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.803 1.641 . . . . 72.23 111.051 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -160.94 37.97 0.15 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 74.35 109.769 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.0 -50.84 0.44 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.614 -0.513 . . . . 65.13 109.614 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.256 1.44 0 C-N-CA 123.86 0.864 . . . . 73.33 110.959 -178.247 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . 0.529 ' H3 ' ' HD2' ' F' ' 168' ' ' LYS . 12.1 mptt . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.149 -0.686 . . . . 73.34 109.149 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.07 43.7 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.057 0.223 . . . . 72.33 112.572 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . 0.519 ' H ' ' HD3' ' F' ' 170' ' ' LYS . 0.0 OUTLIER -108.38 36.13 2.93 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.447 0.641 . . . . 75.41 111.424 -176.272 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 75.0 m -145.91 118.83 8.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.544 0.738 . . . . 74.41 109.355 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' B' ' 90' ' ' GLU . . . -154.45 147.44 24.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.017 0.927 . . . . 63.12 109.513 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.421 HD12 ' SD ' ' F' ' 174' ' ' MET . 2.9 tm? -157.39 112.43 2.75 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.923 -1.14 . . . . 70.54 107.923 -177.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.421 ' SD ' HD12 ' F' ' 173' ' ' LEU . 0.0 OUTLIER 66.87 151.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.135 1.374 . . . . 64.1 113.047 -177.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . 0.504 ' HD2' ' HE1' ' B' ' 94' ' ' MET . 21.8 p90 -152.66 171.56 17.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.234 -0.894 . . . . 73.52 111.649 -171.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -142.87 62.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.667 -1.605 . . . . 75.01 106.667 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? 61.87 96.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.799 1.239 . . . . 62.22 109.184 -170.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.97 -84.23 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 122.85 0.46 . . . . 62.32 109.962 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -149.85 146.04 19.89 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.116 1.366 . . . . 71.22 108.093 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.86 87.08 0.14 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.119 2.546 . . . . 73.02 112.71 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.89 110.18 19.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.927 0.891 . . . . 64.45 109.005 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' B' ' 3' ' ' GLU . 8.8 m-85 60.07 34.41 21.31 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 123.777 0.673 . . . . 64.32 110.459 172.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 19.4 m -57.42 -33.03 67.46 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.467 1.507 . . . . 64.14 113.309 -166.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 46.9 t90 72.39 98.39 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.471 1.108 . . . . 73.2 110.827 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.77 162.2 7.69 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.701 2.268 . . . . 75.01 112.992 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.62 -177.59 3.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.281 1.033 . . . . 74.41 109.614 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.1 160.52 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.066 0.546 . . . . 73.24 111.241 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . 0.441 ' HA ' HD22 ' B' ' 42' ' ' LEU . . . -81.9 161.26 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.657 0.783 . . . . 71.02 110.009 175.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.61 -165.52 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.31 0.644 . . . . 74.25 110.586 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -115.92 158.18 23.41 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.973 0.909 . . . . 72.25 110.4 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' B' ' 39' ' ' GLU . . . -153.14 100.14 0.2 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.038 -0.528 . . . . 65.15 112.352 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.07 167.42 40.21 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.47 -0.628 . . . . 73.24 111.946 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . 0.419 ' HD2' ' HD2' ' E' ' 196' ' ' LYS . 89.1 m-85 51.18 -145.2 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.312 1.045 . . . . 74.42 110.056 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . 59.28 -160.12 0.28 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 123.897 0.879 . . . . 72.32 112.361 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 86.7 t80 65.56 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.655 1.182 . . . . 64.44 110.485 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 49.82 81.05 0.06 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.986 1.314 . . . . 75.4 112.072 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -67.85 87.08 0.24 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.449 -1.686 . . . . 74.31 106.449 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -145.82 -43.91 0.21 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.078 -0.51 . . . . 71.12 111.097 -163.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -177.42 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 123.911 0.757 . . . . 73.52 110.4 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.93 16.81 60.02 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.405 1.322 . . . . 54.35 116.405 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -87.38 -89.43 0.13 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.681 0.741 . . . . 74.41 109.581 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -104.54 34.03 3.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.181 -1.414 . . . . 74.42 107.181 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -155.37 -178.89 7.59 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.063 -1.426 . . . . 74.12 109.749 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 14.1 tt -133.69 136.21 54.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.488 -0.93 . . . . 74.21 108.488 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -149.57 161.74 41.55 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.467 -0.938 . . . . 75.4 108.467 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 29.9 t70 82.02 -26.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.398 1.479 . . . . 74.13 112.686 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.61 0.764 . . . . 64.11 109.939 177.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . 0.676 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 2.9 mppt? . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 108.303 -0.999 . . . . 74.21 108.303 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 73.1 -95.77 0.76 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.075 -0.966 . . . . 70.15 111.359 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . 0.419 ' HZ2' ' HG3' ' C' ' 151' ' ' GLU . 19.3 ptmt -71.93 150.94 43.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.515 0.726 . . . . 73.54 109.921 175.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 171' ' ' SER . . . . . 0.433 ' HB2' ' H ' ' A' ' 54' ' ' ASP . 69.5 p -89.09 44.33 1.21 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.465 0.706 . . . . 75.0 111.489 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . 62.08 -156.77 0.34 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.317 1.047 . . . . 70.21 111.197 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.555 HD22 ' SD ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -106.52 -50.72 3.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.859 -1.163 . . . . 75.44 107.859 -178.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 8.2 tpp 62.75 78.57 0.29 Allowed 'General case' 0 C--N 1.355 0.848 0 CA-C-N 113.624 -1.625 . . . . 72.44 110.754 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.463 ' HE1' HD21 ' A' ' 98' ' ' LEU . 1.3 p90 -76.0 162.1 28.35 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.441 -0.8 . . . . 75.3 111.913 -171.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -78.58 150.79 32.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.939 -1.028 . . . . 74.43 108.786 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 46' ' ' THR . 3.7 mm? -68.74 85.49 0.31 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.778 0.831 . . . . 63.11 111.268 -175.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -101.01 169.17 9.13 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.036 -0.984 . . . . 73.5 108.925 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.87 147.83 78.12 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-O 118.73 -0.653 . . . . 71.11 109.848 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -52.4 121.08 8.38 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.465 2.777 . . . . 75.14 113.552 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -45.35 -39.67 7.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.002 1.721 . . . . 75.42 112.179 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . 0.486 ' HD2' ' HE2' ' A' ' 137' ' ' PHE . 23.0 m-85 -126.11 116.11 20.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.721 -1.214 . . . . 74.42 107.721 166.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -71.16 107.21 4.07 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.824 0.702 . . . . 74.32 110.403 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 129.62 82.89 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.869 0.868 . . . . 74.43 109.89 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . 0.478 ' HG2' HD11 ' A' ' 136' ' ' LEU . 60.2 Cg_endo -72.45 146.89 45.51 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.286 1.99 . . . . 75.34 112.399 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.71 -179.33 3.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.057 0.943 . . . . 73.35 110.076 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.483 HG23 ' HB1' ' A' ' 129' ' ' ALA . 43.6 pt -68.57 166.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.89 0.876 . . . . 75.21 111.961 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.15 134.65 41.69 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 74.51 109.42 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.42 40.72 3.27 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.313 1.054 . . . . 64.22 108.385 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.51 21.64 1.75 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.92 -1.491 . . . . 74.44 112.308 -173.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' H' ' 201' ' ' LYS . . . -141.61 -160.29 8.26 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.81 -0.916 . . . . 72.14 110.81 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.82 -147.14 5.38 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.829 -0.224 . . . . 71.33 112.629 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . 0.498 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 46.2 m-85 -130.02 -166.19 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.184 1.394 . . . . 72.43 109.168 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . 0.656 ' HB1' ' HG2' ' H' ' 196' ' ' LYS . . . -145.7 157.58 43.94 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.021 0.928 . . . . 73.51 108.819 167.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . 0.668 ' HB2' ' HB3' ' A' ' 36' ' ' TRP . 2.5 t80 -112.55 -47.57 3.07 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.686 0.794 . . . . 74.44 108.895 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' H' ' 196' ' ' LYS . 41.1 mtpt 65.36 76.23 0.34 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.795 1.638 . . . . 72.31 111.162 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . 0.455 ' HH ' HG21 ' A' ' 31' ' ' VAL . 92.4 m-85 -75.29 130.4 39.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.773 -1.103 . . . . 73.33 110.086 171.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.12 97.13 1.77 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.132 0.573 . . . . 73.43 109.521 169.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 68.14 162.87 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.989 1.315 . . . . 73.21 112.464 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.48 120.19 5.11 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.345 -0.702 . . . . 70.13 111.345 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . 0.694 ' HE3' ' HB3' ' H' ' 194' ' ' ALA . 3.6 mptp? -75.46 -38.8 59.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.5 0.72 . . . . 73.44 110.802 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -75.13 73.87 2.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.142 0.577 . . . . 73.14 109.444 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.68 80.52 7.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.911 0.862 . . . . 63.31 108.993 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.3 134.26 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 107.173 -1.417 . . . . 72.34 107.173 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.11 -59.34 1.81 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.172 -0.677 . . . . 74.52 109.172 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -152.62 99.23 2.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.755 0.822 . . . . 71.44 108.967 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . 0.497 HG13 HD13 ' D' ' 136' ' ' LEU . 21.8 t . . . . . 0 CA--C 1.571 1.783 0 C-N-CA 125.5 1.52 . . . . 74.03 111.455 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 109.282 -0.636 . . . . 74.05 109.282 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.12 -88.37 0.29 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.714 -0.555 . . . . 64.31 111.714 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -147.38 -80.67 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.695 0.798 . . . . 74.45 109.495 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.6 p 159.5 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.351 2.26 . . . . 73.15 107.349 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.531 ' HB1' ' SD ' ' D' ' 1' ' ' MET . . . -142.61 146.62 34.71 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.563 0.345 . . . . 71.12 111.037 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.463 HD22 ' HE1' ' H' ' 174' ' ' MET . 0.8 OUTLIER -178.74 -70.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.581 1.175 . . . . 73.34 108.157 174.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.567 ' HE2' ' HA ' ' H' ' 174' ' ' MET . 24.0 mmt -94.79 98.08 10.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.427 1.091 . . . . 74.31 109.807 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 60.3 -97.21 0.07 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.574 1.549 . . . . 74.24 111.5 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 60.05 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.549 1.14 . . . . 74.41 111.554 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp 62.88 93.9 0.05 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.807 1.243 . . . . 72.51 111.081 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . 0.463 ' HB2' ' HG2' ' D' ' 1' ' ' MET . 18.6 mm100 -134.0 -175.22 3.77 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.626 0.77 . . . . 71.33 110.068 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 70.15 156.01 0.15 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 125.378 1.471 . . . . 74.11 112.992 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.07 111.91 3.18 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.476 2.118 . . . . 74.01 110.038 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -69.88 143.25 52.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.845 0.458 . . . . 74.15 110.461 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -64.49 107.56 1.41 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 108.739 -0.837 . . . . 73.02 108.739 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 34.0 p -65.67 97.66 0.33 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.638 0.775 . . . . 74.21 110.31 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -79.86 122.09 82.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.896 0.878 . . . . 72.23 110.25 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.24 130.04 37.34 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.947 2.431 . . . . 64.24 112.415 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.15 170.82 15.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 74.41 110.719 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.61 ' HB ' HD22 ' D' ' 42' ' ' LEU . 73.5 mt -72.63 123.78 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.632 0.773 . . . . 73.13 110.855 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -100.75 139.66 36.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.54 109.44 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.18 -88.3 0.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.057 0.543 . . . . 74.23 109.842 -177.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 59.48 -162.71 0.24 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.146 0.978 . . . . 71.12 111.846 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.11 155.25 7.39 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.699 -0.56 . . . . 72.13 111.699 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.43 -69.11 1.39 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 111.624 -0.59 . . . . 72.31 111.624 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.03 130.99 36.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.704 0.802 . . . . 74.51 109.43 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . 0.694 ' HB3' ' HE3' ' G' ' 201' ' ' LYS . . . -179.07 176.4 0.89 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.988 1.315 . . . . 74.3 109.396 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 54.5 t80 56.62 65.31 1.44 Allowed 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.579 1.175 . . . . 74.22 110.034 172.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . 0.656 ' HG2' ' HB1' ' G' ' 194' ' ' ALA . 0.1 OUTLIER -59.49 -47.43 85.52 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.479 -0.782 . . . . 74.2 109.956 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 2.9 t80 74.39 -58.66 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.778 1.299 . . . . 75.31 112.216 166.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -40.69 131.19 2.39 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.248 1.819 . . . . 64.34 112.295 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -67.55 127.35 32.41 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.242 1.017 . . . . 60.51 110.542 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.51 88.06 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 110.759 -0.936 . . . . 72.43 110.759 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . 0.467 ' HB3' ' HA3' ' G' ' 191' ' ' GLY . 1.5 tmtp? -173.69 113.52 0.21 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.044 -1.465 . . . . 75.43 107.044 171.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . 0.413 ' OH ' ' HA ' ' A' ' 128' ' ' LEU . 9.3 t80 -162.43 70.12 0.28 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.467 0.651 . . . . 64.32 109.56 173.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -137.4 115.02 11.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.919 0.888 . . . . 71.2 109.535 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.452 HG12 ' HB ' ' G' ' 187' ' ' ILE . 3.8 mp -93.57 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.402 -0.962 . . . . 72.12 108.402 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 65.76 23.01 11.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.114 1.366 . . . . 72.22 112.584 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . 0.434 ' H ' HG22 ' H' ' 204' ' ' ILE . 4.8 m-20 -117.3 -52.54 2.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.158 -1.423 . . . . 72.34 107.158 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' C' ' 11' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 126.132 1.773 . . . . 74.33 109.096 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.236 -0.283 . . . . 73.13 110.236 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 t -78.35 103.98 8.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.905 -0.776 . . . . 71.24 108.905 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -73.11 -170.83 0.81 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.024 0.93 . . . . 75.44 112.478 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -60.25 -66.09 0.58 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.148 0.979 . . . . 74.13 110.855 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -169.25 173.0 6.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.007 0.523 . . . . 75.53 110.497 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -140.45 156.81 46.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.137 0.975 . . . . 74.43 108.873 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -66.95 160.09 27.07 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.898 0.479 . . . . 73.22 109.766 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -51.22 -36.8 43.42 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.896 0.878 . . . . 65.44 111.238 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.437 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 20.7 ptt? -144.25 147.18 33.23 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.891 1.276 . . . . 73.53 107.808 173.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -139.51 141.39 37.33 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.183 0.516 . . . . 74.24 110.484 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -133.53 127.47 33.24 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 106.61 -1.626 . . . . 71.33 106.61 158.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -141.06 136.65 32.22 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.089 0.243 . . . . 74.53 110.681 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 mp -92.64 104.03 15.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 107.491 -1.299 . . . . 74.43 107.491 174.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' NE2' HG21 ' A' ' 83' ' ' ILE . 21.8 tt0 -81.28 -25.94 36.13 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 118.709 -0.662 . . . . 70.32 110.986 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.402 HH12 ' HA ' ' F' ' 203' ' ' ASP . 21.7 ttt85 -176.82 135.61 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.315 0.646 . . . . 65.35 110.711 173.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.5 136.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 123.765 0.826 . . . . 62.22 109.013 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' HE2' ' HG2' ' A' ' 19' ' ' LYS . 33.6 p90 -170.77 167.6 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.755 0.822 . . . . 75.2 110.863 -174.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -90.91 124.28 35.07 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 167.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -81.15 -33.34 33.2 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.352 -0.61 . . . . 72.0 109.352 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.5 t70 -148.23 140.84 24.49 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.797 -1.092 . . . . 74.33 109.911 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.1 mt -132.32 141.4 45.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.018 1.327 . . . . 73.32 107.442 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -149.65 130.85 14.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.127 -0.694 . . . . 75.3 109.127 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.7 t80 -132.46 135.85 46.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.7 -1.593 . . . . 74.0 106.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.11 152.63 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 75.43 108.29 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.84 79.35 46.02 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 106.541 -1.651 . . . . 73.24 106.541 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.9 -45.86 12.13 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.876 2.384 . . . . 73.34 112.094 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 28.2 m-80 -107.38 45.63 0.98 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.405 -0.816 . . . . 73.11 108.972 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -61.0 -50.16 85.95 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.187 0.995 . . . . 73.44 113.036 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -68.38 -7.99 21.73 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.823 1.682 . . . . 72.11 113.887 170.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.1 m80 -99.12 -13.4 19.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.766 0.826 . . . . 74.32 112.278 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -64.58 -23.02 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.896 0.316 . . . . 71.42 110.77 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.53 -34.92 74.83 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.078 0.951 . . . . 74.33 111.739 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -63.02 -54.71 34.0 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.555 0.742 . . . . 74.43 110.322 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -85.12 127.32 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.594 -1.185 . . . . 70.2 110.712 -172.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -66.8 136.36 55.33 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.785 -1.191 . . . . 74.12 107.785 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -60.05 100.78 0.1 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.453 1.095 . . . . 75.42 112.389 -163.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -127.35 76.51 76.52 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.633 1.173 . . . . 75.42 108.063 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.69 101.39 1.18 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.108 1.872 . . . . 74.53 111.642 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.01 94.67 9.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.674 -1.602 . . . . 64.05 106.674 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.8 m -84.37 129.76 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.832 -1.076 . . . . 75.11 111.666 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 3.0 mptp? -105.3 124.02 48.83 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.347 1.059 . . . . 75.4 108.577 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 128' ' ' LEU . 5.7 mp -97.52 120.96 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.574 1.15 . . . . 73.41 108.603 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.743 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 20.5 m-20 -117.57 111.27 18.99 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.279 -1.008 . . . . 75.24 108.279 167.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.7 tp -97.28 135.55 39.03 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.295 -1.002 . . . . 72.23 108.295 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 14.3 t70 -143.33 136.29 27.77 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -122.96 137.9 54.82 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.089 0.556 . . . . 75.42 109.643 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' A' ' 59' ' ' VAL . . . -134.43 153.17 52.06 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.444 1.098 . . . . 53.3 108.902 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.8 m -134.11 157.35 46.39 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.717 0.407 . . . . 70.51 110.69 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -149.82 119.45 6.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.981 0.912 . . . . 75.14 108.827 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -74.38 122.76 23.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.877 0.471 . . . . 75.22 109.986 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.77 -43.72 7.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.179 0.592 . . . . 73.31 110.154 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -150.81 -169.54 3.41 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 123.703 0.801 . . . . 74.22 109.991 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.64 126.25 30.64 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.757 -0.831 . . . . 71.22 108.757 169.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' G' ' 172' ' ' ALA . 17.4 m-20 69.44 -3.03 1.71 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.737 1.615 . . . . 75.43 112.653 -176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 41.1 t -115.4 120.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 N-CA-C 107.924 -1.139 . . . . 74.53 107.924 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.57 170.38 15.82 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.915 -1.143 . . . . 75.4 107.915 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 9.0 tm-20 -127.3 132.17 50.35 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.666 -1.235 . . . . 72.13 107.666 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.76 120.79 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.47 -0.937 . . . . 72.54 108.47 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 43.7 t -95.24 130.92 43.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 123.64 0.776 . . . . 75.22 109.047 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.09 107.54 18.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.896 -1.52 . . . . 74.41 106.896 170.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 24.3 ttp180 -100.06 100.79 11.71 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.39 -0.967 . . . . 74.32 108.39 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' A' ' 114' ' ' ILE . 7.9 t -94.74 137.57 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.834 -1.173 . . . . 75.14 107.834 174.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.743 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.9 m -128.66 126.79 40.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.505 -0.554 . . . . 61.43 109.505 173.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.1 t -122.06 109.5 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.675 1.19 . . . . 75.14 109.537 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 80.0 m -101.41 141.97 33.5 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.429 -0.952 . . . . 62.14 108.429 173.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.07 109.58 14.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.266 -1.013 . . . . 75.12 108.266 173.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 39.8 m -107.46 127.23 53.42 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.343 -0.614 . . . . 64.41 109.343 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.3 mt -90.75 81.93 5.76 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.518 -1.66 . . . . 73.34 106.518 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.15 -86.4 1.1 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.16 -0.927 . . . . 75.42 110.881 -168.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.1 -19.25 4.4 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 70.12 110.452 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.08 108.02 18.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.855 0.862 . . . . 71.35 110.247 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.1 m -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.293 0.568 . . . . 75.43 111.442 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -54.09 7.69 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.92 1.288 . . . . 73.42 109.455 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -148.92 165.26 32.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.389 -1.278 . . . . 75.45 110.82 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.5 tp -130.89 145.2 51.94 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.666 -1.235 . . . . 73.54 107.666 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -134.54 140.39 46.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.77 0.828 . . . . 72.41 109.268 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.85 117.1 6.43 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.89 -0.781 . . . . 74.02 108.89 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.91 111.34 28.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.773 0.829 . . . . 73.31 109.038 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.6 mt-30 -88.42 82.57 6.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.118 -0.946 . . . . 73.11 109.119 173.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -75.95 93.6 3.26 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.154 -0.93 . . . . 75.04 108.842 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.39 148.9 19.54 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 116.179 -0.464 . . . . 70.43 112.06 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.06 123.97 1.73 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.74 -0.944 . . . . 61.22 110.74 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.4 mt -79.08 127.85 38.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.981 -1.118 . . . . 74.13 107.981 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.89 143.42 50.8 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.398 -0.593 . . . . 74.14 109.398 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 t -112.54 112.98 24.9 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.088 -1.078 . . . . 74.44 108.088 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -129.01 143.42 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.089 0.555 . . . . 72.54 110.011 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.06 175.39 2.29 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.208 1.003 . . . . 74.43 111.215 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.437 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 83.72 5.16 88.42 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.392 -0.822 . . . . 74.23 114.478 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.505 HD12 ' HE2' ' G' ' 174' ' ' MET . 0.2 OUTLIER -131.31 -179.62 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.337 1.055 . . . . 73.52 109.422 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.418 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.9 tt0 -168.37 177.2 5.47 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.085 0.554 . . . . 72.33 110.139 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.418 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.86 -121.28 22.74 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 114.969 0.748 . . . . 74.21 114.969 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.6 p -64.67 -30.92 71.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.899 0.88 . . . . 75.23 111.593 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.54 -42.1 71.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.549 0.739 . . . . 75.13 111.041 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -76.55 -30.24 57.0 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.507 -0.315 . . . . 71.33 110.701 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.76 63.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.147 0.579 . . . . 75.31 110.74 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -67.61 -48.56 66.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.174 0.99 . . . . 75.32 110.234 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.501 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 20.2 t -74.59 -63.0 1.34 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.544 -0.753 . . . . 73.01 111.001 -172.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 tt -62.36 -38.34 89.16 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.164 0.586 . . . . 75.35 110.698 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.15 -31.1 32.42 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 115.26 0.864 . . . . 72.14 115.26 -168.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -48.37 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.342 1.071 . . . . 71.44 112.569 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 86.4 t80 -66.66 -50.08 64.09 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.615 0.766 . . . . 75.2 112.697 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.6 m -72.16 -37.6 4.94 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.554 0.742 . . . . 75.52 112.634 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.65 -40.89 82.16 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.18 1.92 . . . . 71.22 112.478 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.27 -29.4 68.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.553 0.741 . . . . 72.32 111.419 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.689 HD11 HD22 ' C' ' 132' ' ' ASN . 40.1 mm -60.66 -44.52 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.998 0.904 . . . . 73.45 109.855 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.45 HD21 ' HA3' ' A' ' 82' ' ' GLY . 79.2 mt -77.21 -18.77 57.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.166 -1.379 . . . . 73.35 112.176 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -68.42 -41.86 25.62 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.444 1.276 . . . . 72.21 114.444 -168.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.81 -39.03 90.39 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 121.966 1.777 . . . . 72.41 112.906 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -75.1 -36.74 61.67 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.491 0.717 . . . . 75.22 111.608 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.93 -46.83 76.79 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.576 -0.527 . . . . 74.41 109.576 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttm105 -55.22 -47.09 75.81 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 124.552 1.158 . . . . 73.31 110.52 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 6.7 tm-20 -59.42 -48.69 80.68 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.136 0.897 . . . . 74.43 111.061 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 51.1 t -57.73 -46.49 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.067 -0.97 . . . . 74.14 111.213 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 118' ' ' VAL . 89.5 mt -64.3 -53.19 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.525 0.73 . . . . 74.14 110.612 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.537 HG21 ' HG3' ' A' ' 125' ' ' GLN . 60.7 m -53.46 -44.39 68.89 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.799 1.24 . . . . 74.03 112.009 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 43.3 t -72.46 -32.65 66.43 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.298 -0.865 . . . . 61.42 111.166 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -64.29 -43.3 95.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.483 0.713 . . . . 74.22 110.851 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 114' ' ' ILE . 61.5 t -62.99 -49.27 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.627 1.171 . . . . 63.05 110.465 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.1 p -67.48 -26.04 66.17 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.846 -0.616 . . . . 62.44 111.6 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.527 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 26.4 ttm-85 -76.93 -26.06 53.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.272 1.029 . . . . 74.25 110.133 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 10.9 61.11 Favored Glycine 0 C--N 1.358 1.803 0 CA-C-N 115.887 -0.597 . . . . 74.14 112.618 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 67.66 36.49 3.63 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.815 1.293 . . . . 74.45 110.472 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -115.57 144.71 32.99 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 114.75 -1.114 . . . . 75.15 108.936 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.28 146.07 52.36 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.01 2.474 . . . . 72.01 113.275 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.537 ' HG3' HG21 ' A' ' 115' ' ' THR . 3.6 tt0 -59.07 140.92 55.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.135 0.974 . . . . 74.42 112.689 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.1 tp -124.86 114.16 18.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.935 0.894 . . . . 75.12 109.402 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -112.05 102.08 10.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.385 0.674 . . . . 71.15 109.505 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.75 127.11 31.54 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.867 -0.79 . . . . 72.13 108.867 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.4 132.03 95.24 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.784 0.834 . . . . 72.41 112.325 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -83.62 140.44 9.37 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.641 2.227 . . . . 72.14 112.153 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG22 HG23 ' H' ' 207' ' ' VAL . 2.3 p -116.67 125.3 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.96 0.904 . . . . 72.2 109.831 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.503 HD21 ' HB1' ' A' ' 135' ' ' ALA . 4.5 p-10 -92.03 63.81 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 122.218 1.009 . . . . 74.22 110.536 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.58 -30.93 70.68 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 75.33 110.188 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.34 -34.25 77.55 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.766 -1.106 . . . . 63.2 110.588 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.503 ' HB1' HD21 ' A' ' 132' ' ' ASN . . . -73.95 -36.4 64.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.363 0.665 . . . . 74.44 110.837 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.415 HD13 HG21 ' H' ' 207' ' ' VAL . 88.1 mt -62.53 -33.62 75.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.384 0.673 . . . . 74.33 110.975 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -65.01 -46.89 79.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.11 0.564 . . . . 72.11 109.999 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.4 -49.01 79.26 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.704 0.627 . . . . 75.42 110.633 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.439 ' HA ' ' HG2' ' A' ' 143' ' ' GLN . 19.9 t30 -53.53 -51.04 64.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.79 1.236 . . . . 73.41 111.528 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.63 -35.92 77.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.51 -0.768 . . . . 74.1 111.881 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.35 -54.39 20.99 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.478 0.486 . . . . 72.34 109.839 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -161.8 -17.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.799 0.84 . . . . 64.24 111.765 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' HG2' ' HA ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER 59.19 80.39 0.19 Allowed 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.356 1.063 . . . . 72.31 109.721 -176.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -90.76 120.97 32.23 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.823 0.675 . . . . 73.34 112.823 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.83 178.78 4.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.124 1.369 . . . . 74.32 110.422 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.03 -39.13 0.73 Allowed Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.656 -0.578 . . . . 61.22 111.656 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 65.59 -80.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.826 1.251 . . . . 75.21 111.149 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.95 -124.81 10.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.797 -0.446 . . . . 75.32 113.159 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m 68.16 92.69 0.08 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.454 1.501 . . . . 60.4 111.824 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -149.52 4.23 0.59 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.411 1.085 . . . . 73.44 110.767 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -127.85 149.66 50.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.724 0.809 . . . . 73.55 110.283 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.409 ' HA ' ' HE1' ' C' ' 140' ' ' TYR . 63.2 m80 -133.72 -56.17 0.89 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.557 1.143 . . . . 74.21 109.171 171.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.75 81.83 0.11 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.544 1.137 . . . . 75.12 109.007 -170.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.41 124.1 23.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.427 -0.806 . . . . 75.23 109.95 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.265 0 N-CA-C 108.62 -0.881 . . . . 74.11 108.62 179.597 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.425 -0.584 . . . . 72.01 109.425 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.9 t -151.15 88.55 1.46 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.658 -0.867 . . . . 62.03 108.658 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.77 143.01 27.16 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.536 -0.756 . . . . 73.31 110.458 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -165.7 153.09 10.43 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.746 0.818 . . . . 73.03 109.201 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -138.28 158.99 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.241 0.616 . . . . 70.32 109.45 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -63.51 95.28 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.974 -0.75 . . . . 74.31 108.974 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -119.17 49.54 1.32 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.953 0.882 . . . . 75.53 108.705 177.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.919 -1.037 . . . . 70.34 108.641 168.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.5 ptm 56.85 170.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.416 2.286 . . . . 75.45 114.923 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p -135.55 127.79 30.09 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.918 -1.037 . . . . 72.45 108.255 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.91 120.67 21.78 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.538 -0.912 . . . . 65.34 108.538 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.56 138.3 29.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.722 0.296 . . . . 72.42 110.243 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.471 HD11 HG13 ' B' ' 16' ' ' ILE . 16.1 tt -82.56 144.48 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.263 1.025 . . . . 63.51 110.031 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -109.28 -49.16 3.15 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.192 0.597 . . . . 72.53 110.035 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.725 HH12 ' HE1' ' G' ' 197' ' ' TYR . 39.3 ttt180 -171.38 146.27 2.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.172 0.589 . . . . 74.43 110.458 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.471 HG13 HD11 ' B' ' 13' ' ' ILE . 51.1 mt -116.47 145.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.191 -1.04 . . . . 75.41 108.191 169.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -168.71 145.47 3.73 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.759 0.423 . . . . 72.4 110.305 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.527 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 94.9 m -74.06 122.16 22.24 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.872 -0.788 . . . . 64.44 108.872 172.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -91.49 -37.45 13.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.619 -0.719 . . . . 75.41 110.341 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.1 t70 -154.3 146.28 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.666 0.27 . . . . 71.52 111.622 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.715 HD12 ' SG ' ' B' ' 113' ' ' CYS . 43.4 mm -138.56 143.73 31.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 125.378 1.471 . . . . 73.43 109.158 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.501 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.4 t -141.1 129.21 22.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.862 1.265 . . . . 74.2 108.424 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -143.2 131.9 22.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.096 -1.446 . . . . 74.41 107.096 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -136.01 140.15 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.674 -1.232 . . . . 74.5 107.674 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.557 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -134.85 85.09 36.37 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 107.904 -1.147 . . . . 74.02 107.904 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.95 -29.48 57.64 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.88 2.387 . . . . 74.12 111.99 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.81 28.91 8.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.945 0.898 . . . . 72.3 109.961 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.557 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -47.2 -52.75 32.86 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 125.429 1.491 . . . . 72.42 113.509 168.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.1 Cg_exo -81.63 -11.74 11.46 Favored 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 122.547 2.165 . . . . 75.41 112.876 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -89.17 3.07 53.14 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.214 1.006 . . . . 72.52 111.576 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.1 -21.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.247 0.619 . . . . 74.23 111.266 169.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -64.76 -40.54 95.44 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.706 0.802 . . . . 74.31 110.16 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.29 -30.03 30.82 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.061 -0.972 . . . . 74.41 111.135 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.79 90.33 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.261 1.025 . . . . 73.05 109.729 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.49 77.35 9.44 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.8 0.84 . . . . 73.42 110.567 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -172.01 156.36 4.04 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.853 0.861 . . . . 74.22 109.419 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.447 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 28.1 tt0 -66.25 125.52 90.4 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.536 1.135 . . . . 61.43 110.778 169.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.25 129.16 20.94 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.129 1.886 . . . . 71.44 110.691 169.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 134.04 48.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 120.933 0.396 . . . . 72.44 109.94 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 124' ' ' PRO . 18.9 t -114.99 127.37 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.9 0.48 . . . . 74.34 111.282 -166.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -134.78 134.28 40.75 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.406 -0.961 . . . . 75.23 108.406 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.492 HD21 ' H ' ' B' ' 42' ' ' LEU . 1.2 pt? -119.5 140.43 50.49 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.962 -1.125 . . . . 74.23 107.962 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -136.81 142.64 42.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.432 0.693 . . . . 61.21 109.389 -167.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 tt -94.77 138.91 31.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.353 0.661 . . . . 74.34 110.391 -169.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.74 135.83 31.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.564 1.145 . . . . 64.41 108.553 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.0 m -109.65 124.78 51.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.854 0.462 . . . . 73.1 110.646 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.05 156.37 38.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.197 0.999 . . . . 70.45 108.336 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 45.5 p -144.88 170.8 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.8 0.44 . . . . 74.24 110.684 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -150.49 143.66 24.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.614 0.766 . . . . 75.24 109.011 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -94.57 114.98 27.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.406 0.683 . . . . 75.51 110.025 173.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.2 -35.14 21.82 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.343 -0.614 . . . . 71.24 109.343 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.81 3.85 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.922 -1.036 . . . . 74.32 110.104 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.71 126.37 27.37 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.621 -1.172 . . . . 75.4 108.899 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 69.96 -4.36 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.592 1.157 . . . . 52.03 112.987 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.26 103.95 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.524 -0.917 . . . . 72.41 108.524 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' F' ' 175' ' ' PHE . 89.6 m-85 -123.99 137.78 54.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.2 0.524 . . . . 74.13 110.164 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -114.44 105.86 13.62 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.081 -1.451 . . . . 64.22 107.081 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 83.9 t -92.82 125.75 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.309 0.644 . . . . 62.1 109.541 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.446 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.2 t -103.04 117.42 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.599 0.76 . . . . 74.03 109.746 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 0.0 OUTLIER -93.87 112.11 23.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.144 -0.687 . . . . 73.15 109.144 -177.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 41.9 ttm180 -94.7 114.24 26.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.953 0.501 . . . . 74.41 109.907 171.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.546 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.4 t -114.02 122.26 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.947 -1.131 . . . . 70.12 107.947 169.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -115.71 147.9 40.36 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.171 0.589 . . . . 54.35 110.378 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.553 HG22 HG21 ' B' ' 114' ' ' ILE . 44.5 t -127.3 127.14 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 75.35 109.582 -172.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.5 m -105.0 140.09 38.71 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.808 0.843 . . . . 71.44 109.281 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.4 22.62 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.097 0.959 . . . . 73.34 108.732 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 73.6 p -146.27 141.08 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.115 0.483 . . . . 71.45 111.529 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.465 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 65.6 mt -102.72 109.39 20.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.938 1.295 . . . . 75.15 108.678 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -111.88 3.5 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.02 -0.432 . . . . 74.02 112.02 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.17 10.21 18.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.044 0.938 . . . . 74.13 110.494 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -132.07 144.69 50.91 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.24 0.616 . . . . 74.14 109.821 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -66.91 134.77 52.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.203 0.601 . . . . 75.52 111.49 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.465 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -88.71 -58.86 2.4 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.679 -0.86 . . . . 62.31 108.679 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 158.81 39.36 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.318 -1.31 . . . . 74.44 109.925 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -136.37 124.0 22.34 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.18 1.392 . . . . 75.13 107.759 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.34 159.94 23.21 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.458 -0.571 . . . . 74.33 109.458 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -164.81 139.38 5.24 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.209 -1.034 . . . . 73.13 108.209 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 67.4 t -129.03 145.69 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 123.887 0.875 . . . . 75.3 108.722 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.9 mt-30 -124.43 85.9 2.48 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.545 -0.909 . . . . 73.11 108.545 174.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.462 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -82.67 101.63 10.96 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 114.432 -1.258 . . . . 74.24 109.877 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.65 161.22 29.53 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 121.181 -0.533 . . . . 72.25 112.018 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.11 126.45 1.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.361 -0.696 . . . . 70.11 111.361 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.89 128.12 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.956 -0.757 . . . . 71.35 108.956 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -132.85 163.46 29.04 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.685 1.194 . . . . 74.54 107.945 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 71.6 m -126.75 121.28 31.54 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.199 -1.037 . . . . 63.2 108.199 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.513 HD12 HD13 ' B' ' 89' ' ' ILE . 2.9 pp -128.28 147.03 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 73.24 110.263 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.04 162.63 40.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.547 0.739 . . . . 75.23 109.979 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.28 -28.98 8.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.261 0.464 . . . . 53.23 114.261 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.513 HD13 HD12 ' B' ' 86' ' ' ILE . 44.7 pt -67.83 162.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 61.31 112.865 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -165.35 159.68 17.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.1 -0.955 . . . . 73.3 111.596 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -130.32 50.11 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 124.014 0.821 . . . . 74.0 114.14 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.5 m -70.72 -25.31 62.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.933 0.893 . . . . 71.15 111.087 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.76 -26.91 67.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 75.1 110.623 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.527 ' SD ' ' HB3' ' F' ' 172' ' ' ALA . 18.1 ttt -72.67 -46.04 55.89 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.12 0.568 . . . . 74.03 110.522 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.84 67.14 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.438 -0.801 . . . . 74.1 111.192 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.17 -36.1 35.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.306 0.642 . . . . 75.24 110.716 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -74.74 -67.45 0.63 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.961 0.504 . . . . 73.21 111.914 -173.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.544 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.2 pp -94.27 -20.51 19.74 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.156 0.428 . . . . 75.33 112.156 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.68 -15.44 59.82 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.913 -0.382 . . . . 64.4 113.293 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.96 -52.53 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.206 0.503 . . . . 61.21 112.0 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -76.76 -37.28 56.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.963 0.357 . . . . 75.43 111.963 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 97.9 m -63.43 -51.44 67.58 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.607 -0.711 . . . . 74.45 111.566 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.451 ' HD3' HG13 ' B' ' 58' ' ' VAL . 36.5 Cg_endo -65.48 -17.53 57.65 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 121.763 1.642 . . . . 75.34 113.524 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.34 -42.04 75.83 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 122.864 0.466 . . . . 74.54 110.562 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 69.6 mt -58.92 -41.95 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.068 0.947 . . . . 72.11 110.194 173.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -84.71 -12.94 52.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.546 -1.206 . . . . 74.21 111.969 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -63.49 -45.14 83.46 Favored Pre-proline 0 C--N 1.359 0.984 0 CA-C-O 117.576 -1.202 . . . . 74.44 112.706 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.13 -42.83 61.96 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.305 2.004 . . . . 63.25 113.177 172.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.462 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -70.55 -45.22 65.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.147 -0.933 . . . . 73.32 111.027 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.06 82.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.632 0.773 . . . . 74.21 111.096 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.69 -60.86 3.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.751 1.22 . . . . 72.54 109.236 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.87 -34.53 74.77 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.076 0.86 . . . . 65.43 110.413 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.715 ' SG ' HD12 ' B' ' 21' ' ' ILE . 14.7 t -60.33 -51.05 71.19 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.203 0.601 . . . . 74.12 111.46 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.553 HG21 HG22 ' B' ' 64' ' ' VAL . 80.8 mt -58.64 -52.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.441 0.696 . . . . 72.44 109.962 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.661 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 2.0 m -64.29 -21.0 66.45 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.903 -1.499 . . . . 75.04 111.236 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -83.55 -40.3 19.3 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.706 1.202 . . . . 64.52 112.061 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.9 mmt -69.12 -39.49 78.87 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.287 0.494 . . . . 63.22 111.926 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.53 -26.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.127 0.571 . . . . 74.35 110.436 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.3 t -64.93 -30.99 72.01 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 74.42 110.321 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.507 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 66.6 mtt-85 -72.81 -33.66 66.36 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.527 0.731 . . . . 71.23 110.129 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.83 -2.56 81.99 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-N 115.753 -0.658 . . . . 55.43 112.833 171.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 17' ' ' TYR . 5.4 t 55.41 34.3 22.68 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.77 2.028 . . . . 75.3 112.694 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.91 157.67 35.47 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.075 0.95 . . . . 71.21 110.851 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.447 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.4 Cg_exo -71.84 87.82 0.82 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.302 2.668 . . . . 74.14 113.771 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.661 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 0.0 OUTLIER -71.78 159.78 33.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.329 0.652 . . . . 72.45 112.225 171.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 33.1 tp -129.69 123.84 32.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.21 1.804 . . . . 75.02 107.542 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.448 HD22 ' HA ' ' C' ' 122' ' ' THR . 18.7 p-10 -91.5 110.24 21.55 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.09 -0.708 . . . . 71.31 109.09 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.5 137.74 54.64 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 74.03 110.621 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.402 ' HB3' ' CE2' ' E' ' 202' ' ' TYR . . . -63.24 141.78 97.78 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.057 0.943 . . . . 72.33 111.503 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.6 106.96 0.79 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.923 2.415 . . . . 51.43 112.74 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -73.89 106.71 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.986 -0.552 . . . . 64.34 110.025 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -79.08 94.75 5.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.263 0.554 . . . . 75.35 109.647 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -74.99 -28.75 60.67 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.161 -0.927 . . . . 71.24 111.25 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.36 -48.07 71.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.725 0.81 . . . . 75.13 111.698 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.19 68.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.853 0.721 . . . . 60.13 111.636 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.461 ' HG ' ' HE1' ' B' ' 140' ' ' TYR . 57.0 tp -70.26 -44.74 67.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.859 0.864 . . . . 74.41 110.261 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -69.63 -25.94 64.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.726 0.811 . . . . 74.23 111.676 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.8 mmt -60.99 -23.34 65.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.176 0.59 . . . . 74.55 111.904 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.468 ' N ' HD21 ' B' ' 139' ' ' ASN . 0.8 OUTLIER -81.94 -39.68 23.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.223 0.609 . . . . 74.34 110.237 178.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.461 ' HE1' ' HG ' ' B' ' 136' ' ' LEU . 44.3 m-85 -73.57 -37.33 65.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.639 0.776 . . . . 74.24 111.566 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.5 mt -90.9 11.75 21.69 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.882 0.873 . . . . 74.51 110.47 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 67.51 156.52 0.12 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.747 1.619 . . . . 70.12 112.188 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -104.1 166.0 10.69 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 71.01 110.914 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -162.07 164.53 28.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.451 1.1 . . . . 73.12 108.99 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.02 -55.1 0.08 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.627 0.371 . . . . 70.24 110.837 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.1 53.56 3.87 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.308 -0.717 . . . . 74.23 111.308 -173.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.17 149.9 31.48 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.234 1.014 . . . . 55.01 111.219 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 105.63 -135.58 12.7 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.311 -1.116 . . . . 74.53 110.311 -169.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.418 HG22 ' H ' ' D' ' 148' ' ' GLY . 1.4 m 58.45 31.03 20.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.293 1.037 . . . . 73.55 110.363 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.91 158.03 29.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.492 1.517 . . . . 74.01 112.623 -169.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 62.22 101.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.766 1.226 . . . . 74.24 112.208 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -166.95 112.18 0.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.781 -0.822 . . . . 75.41 108.781 167.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -66.73 155.19 38.75 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.516 -0.765 . . . . 64.2 110.611 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.61 147.67 24.45 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 75.24 110.33 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.804 0.842 . . . . 63.24 109.272 -179.198 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.518 ' HE2' ' HA ' ' C' ' 1' ' ' MET . 14.0 mmt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.959 -0.386 . . . . 75.3 109.959 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -77.96 138.5 38.88 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.503 0.721 . . . . 52.14 110.664 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -84.4 145.01 28.42 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.579 -0.526 . . . . 65.55 109.579 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -85.39 66.38 9.67 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.604 0.716 . . . . 72.04 110.755 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -159.18 12.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 114.626 -1.17 . . . . 74.44 109.035 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.37 151.36 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.665 0.786 . . . . 70.51 109.467 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.489 ' HB ' ' HA3' ' C' ' 88' ' ' GLY . 1.3 m -75.17 -2.14 26.45 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.307 0.643 . . . . 63.52 111.803 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 62.66 35.68 14.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.22 1.008 . . . . 63.43 110.988 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ttt 64.53 115.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.677 1.591 . . . . 74.5 111.814 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m -129.88 118.07 21.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.719 1.208 . . . . 72.03 109.102 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.511 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.9 t80 -117.17 127.46 54.14 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.428 -0.952 . . . . 74.42 108.428 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' H' ' 204' ' ' ILE . 9.7 tm0? -138.11 135.04 35.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.427 -0.953 . . . . 74.11 108.427 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.511 HD13 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -93.68 114.67 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.377 0.608 . . . . 72.51 109.779 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.484 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.0 mm-40 -82.04 -49.26 10.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 75.41 109.906 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -173.55 145.63 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.7 -0.682 . . . . 74.33 109.988 -170.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.511 HG13 HD13 ' C' ' 13' ' ' ILE . 87.0 mt -128.12 144.63 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.503 -1.295 . . . . 63.44 107.503 171.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.551 ' HB3' HG21 ' D' ' 122' ' ' THR . 21.0 p90 -174.71 166.57 3.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.452 0.644 . . . . 72.32 110.77 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -88.16 105.91 17.83 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.003 -0.999 . . . . 61.03 109.44 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -65.68 -36.28 83.19 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.547 0.689 . . . . 73.33 109.487 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.5 t70 -149.13 142.94 25.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.542 -1.208 . . . . 70.13 109.63 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -136.91 139.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.358 -1.719 . . . . 74.21 106.358 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.46 143.49 22.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.376 -0.602 . . . . 73.52 109.376 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -143.65 113.93 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.558 -1.275 . . . . 74.23 107.558 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -116.57 119.77 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.669 -0.864 . . . . 73.24 108.669 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.77 82.21 67.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.673 -1.232 . . . . 74.24 107.673 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.11 -37.29 33.2 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.572 2.181 . . . . 75.2 111.574 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.68 31.3 3.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.28 -1.327 . . . . 72.1 110.474 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 86.26 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 113.956 1.095 . . . . 75.31 113.956 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.18 -19.73 6.59 Favored 'Trans proline' 0 C--N 1.385 2.457 0 CA-C-N 121.298 1.499 . . . . 71.4 112.818 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.84 -33.53 70.76 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.189 0.996 . . . . 73.1 112.271 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.461 HG23 HD13 ' C' ' 68' ' ' LEU . 12.4 p -78.61 -10.63 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.064 0.946 . . . . 73.32 111.943 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -57.51 -40.63 79.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.852 0.861 . . . . 74.44 112.207 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -105.79 41.91 1.32 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.967 0.889 . . . . 71.41 109.248 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.724 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.3 tppp? -125.38 155.94 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.42 0.688 . . . . 71.33 110.443 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.56 127.11 31.57 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.332 0.653 . . . . 74.15 109.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.46 95.49 9.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.585 -0.734 . . . . 74.14 110.815 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.07 68.7 81.28 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.335 -0.987 . . . . 61.51 108.335 167.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.71 111.46 3.33 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.363 2.042 . . . . 75.41 110.57 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' E' ' 190' ' ' ASP . 38.2 mt-10 -85.09 92.82 8.47 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.649 -1.241 . . . . 74.42 107.649 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.411 HG22 HD23 ' C' ' 126' ' ' LEU . 40.1 t -81.58 86.16 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.225 -1.352 . . . . 72.12 110.633 -168.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -91.26 105.28 17.68 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.372 -1.344 . . . . 75.13 107.372 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.454 HD22 HD12 ' C' ' 128' ' ' LEU . 0.5 OUTLIER -87.85 160.71 17.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.367 0.603 . . . . 71.41 111.209 177.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HA ' HD11 ' E' ' 186' ' ' LEU . 4.5 m-20 -137.05 144.18 43.06 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.737 1.215 . . . . 64.01 108.775 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 46.4 tp -131.45 105.34 7.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.489 -0.93 . . . . 73.45 108.489 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 20.0 t70 -113.33 140.15 48.26 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 74.12 109.26 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -114.4 134.08 55.25 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.18 0.592 . . . . 72.24 109.959 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.96 151.66 46.71 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.335 1.054 . . . . 72.23 108.407 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 73.8 m -138.42 149.21 45.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.261 0.625 . . . . 75.24 110.556 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -150.21 158.87 44.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.396 1.079 . . . . 71.13 109.503 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -102.51 138.91 38.8 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.198 -1.038 . . . . 72.51 108.198 168.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.418 HD13 HD13 ' C' ' 83' ' ' ILE . 89.3 mt -109.86 -37.03 5.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.523 0.729 . . . . 72.05 110.226 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 -167.51 1.71 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.228 0.611 . . . . 75.41 110.744 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.81 109.41 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.825 -1.079 . . . . 62.32 111.484 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.49 9.59 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.847 1.259 . . . . 72.24 111.968 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.28 118.78 54.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.535 1.134 . . . . 72.23 109.279 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.87 162.35 14.9 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.165 0.986 . . . . 74.14 110.322 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -127.22 116.66 20.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.9 -1.045 . . . . 74.32 108.453 165.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -106.64 124.74 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.716 -1.216 . . . . 74.13 107.716 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.44 119.15 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.778 0.831 . . . . 75.31 109.341 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' C' ' 103' ' ' PRO . 38.5 mt -88.41 118.44 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.091 0.556 . . . . 74.45 110.683 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 33.4 mtm105 -82.65 105.23 13.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.687 -1.227 . . . . 75.41 107.687 164.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -109.12 117.23 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.878 -1.156 . . . . 65.21 107.878 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -123.12 126.01 46.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.858 0.463 . . . . 74.35 109.91 -171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.616 HG21 HD12 ' C' ' 114' ' ' ILE . 54.5 t -107.65 113.69 44.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.484 0.714 . . . . 60.34 109.109 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.4 HG21 HD23 ' C' ' 75' ' ' LEU . 5.8 m -99.48 140.37 33.76 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.311 -0.996 . . . . 70.31 108.311 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.8 108.66 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.925 -0.768 . . . . 63.04 108.925 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.2 m -130.17 140.65 50.74 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.202 0.525 . . . . 71.1 110.255 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.462 HD11 ' HG2' ' C' ' 34' ' ' LYS . 12.3 mt -93.39 40.75 1.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.337 1.455 . . . . 75.04 109.159 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.07 -112.36 4.12 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.125 -1.59 . . . . 73.33 109.125 -163.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.2 -27.53 19.48 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.336 0.655 . . . . 71.5 110.117 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.724 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 9.7 tp10 -72.86 92.28 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.628 1.171 . . . . 73.45 110.393 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 117.97 12.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.387 0.613 . . . . 74.43 110.164 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.99 25.92 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.363 -1.289 . . . . 74.45 109.75 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -163.62 172.98 13.55 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.628 -0.715 . . . . 75.34 111.849 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.4 HD23 HG21 ' C' ' 65' ' ' THR . 2.5 tm? -144.38 116.89 8.59 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.102 -1.444 . . . . 73.43 107.102 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.523 ' SG ' HG22 ' C' ' 114' ' ' ILE . 42.0 t -115.68 145.74 42.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.639 0.775 . . . . 72.41 109.492 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.11 135.6 20.64 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.703 0.401 . . . . 63.12 110.031 171.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.71 118.2 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.486 1.115 . . . . 71.15 108.798 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.9 mt-30 -90.14 93.71 9.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.83 -0.804 . . . . 70.14 108.83 172.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -83.2 107.87 16.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.445 -0.798 . . . . 74.24 109.921 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.56 146.33 18.11 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.165 -0.47 . . . . 65.25 112.21 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.45 126.3 3.13 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 111.129 -0.789 . . . . 63.0 111.129 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.0 mm -91.04 124.93 43.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.26 -1.015 . . . . 72.04 108.26 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.42 119.52 21.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.289 0.636 . . . . 75.13 109.468 -175.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -87.6 100.02 12.48 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.28 -1.378 . . . . 65.51 107.28 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.459 HG13 ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -143.8 133.79 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.469 0.652 . . . . 75.0 110.904 -170.415 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.03 -177.22 5.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.074 1.35 . . . . 73.13 109.132 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' C' ' 7' ' ' THR . . . 87.63 -18.81 36.32 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 114.712 0.645 . . . . 61.32 114.712 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 158.1 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.015 0.926 . . . . 64.33 111.819 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.519 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 10.5 pt-20 -148.98 -173.61 4.41 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.409 -0.589 . . . . 72.42 109.409 171.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.43 -152.38 21.17 Favored Glycine 0 C--N 1.359 1.827 0 N-CA-C 114.3 0.48 . . . . 70.11 114.3 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -64.53 -32.11 73.62 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.3 0.64 . . . . 74.42 111.49 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.467 HE22 ' HG3' ' C' ' 147' ' ' GLU . 27.0 mt-30 -52.62 -32.57 42.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.849 0.86 . . . . 65.35 111.854 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 38.1 ttm -58.67 -62.89 1.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.796 0.838 . . . . 73.44 111.417 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.43 ' HB1' ' CE2' ' E' ' 181' ' ' TYR . . . -71.2 -27.4 63.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.623 -0.717 . . . . 61.34 111.708 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -77.3 -22.99 51.13 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 71.5 110.314 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 44.7 t -71.96 -64.03 1.02 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.329 0.252 . . . . 73.31 110.44 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.458 ' HG ' HD13 ' E' ' 177' ' ' LEU . 2.5 pt? -79.24 -16.44 56.47 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 122.259 -0.275 . . . . 75.11 110.986 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.21 -26.05 27.05 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.691 0.636 . . . . 72.12 114.691 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.06 -40.2 0.25 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.489 0.922 . . . . 70.41 113.489 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.405 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 87.1 t80 -74.56 -48.64 25.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.048 0.539 . . . . 73.52 111.234 -174.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.511 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 56.0 m -66.13 -45.1 61.85 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.313 0.645 . . . . 65.2 110.184 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.652 ' HB3' HD23 ' C' ' 60' ' ' LEU . 76.2 Cg_exo -52.38 -38.59 73.78 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.417 2.078 . . . . 75.33 115.01 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -63.66 -30.6 71.69 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 123.252 0.621 . . . . 74.32 111.209 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -65.62 -39.28 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.744 0.817 . . . . 75.22 110.489 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -88.94 -21.57 23.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.744 0.818 . . . . 73.33 112.353 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.77 -46.4 99.74 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.131 0.972 . . . . 73.24 113.039 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.55 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 23.7 Cg_exo -60.96 -40.14 55.04 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.872 1.714 . . . . 71.44 112.526 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -63.81 -46.15 86.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.571 0.748 . . . . 74.41 111.459 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.65 -43.46 93.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.369 0.668 . . . . 60.33 110.87 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -56.87 -50.88 71.14 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.011 1.324 . . . . 73.41 110.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.2 -41.41 85.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.785 0.834 . . . . 63.34 110.54 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.4 t -66.52 -30.87 71.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.539 0.735 . . . . 73.4 111.987 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.616 HD12 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -72.58 -50.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.837 0.455 . . . . 75.11 110.086 173.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.528 HG23 ' NE2' ' C' ' 125' ' ' GLN . 10.3 m -61.99 -27.81 69.12 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.106 0.562 . . . . 74.14 110.67 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.3 t -60.73 -51.76 67.99 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.161 0.984 . . . . 73.42 110.076 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.86 -38.96 83.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.582 1.153 . . . . 70.43 112.618 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.63 -39.73 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.271 0.628 . . . . 73.33 110.25 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -60.23 -42.96 96.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.66 0.784 . . . . 74.12 110.89 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' C' ' 116' ' ' SER . 89.2 mtt-85 -63.12 -34.0 76.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.723 -0.671 . . . . 71.12 111.38 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.46 12.51 58.64 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.156 -0.802 . . . . 73.21 113.536 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.448 ' HA ' HD22 ' B' ' 127' ' ' ASN . 70.3 p 55.23 42.81 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.421 1.488 . . . . 75.43 112.277 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.6 154.27 44.74 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 107.972 -1.122 . . . . 75.14 107.972 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.72 148.15 36.27 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.322 2.015 . . . . 75.0 112.225 -171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.528 ' NE2' HG23 ' C' ' 115' ' ' THR . 12.8 mm100 -62.76 110.43 1.74 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.667 0.988 . . . . 74.23 113.667 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.411 HD23 HG22 ' C' ' 40' ' ' VAL . 65.1 mt -92.21 76.13 5.33 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.416 0.686 . . . . 72.31 109.884 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -92.31 89.41 6.83 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.01 -0.995 . . . . 63.25 109.356 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.454 HD12 HD22 ' C' ' 42' ' ' LEU . 12.7 mt -86.74 153.04 22.01 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.415 -1.266 . . . . 74.42 109.841 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.19 120.11 2.34 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 125.633 1.573 . . . . 74.22 113.633 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.62 94.48 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.666 2.244 . . . . 71.55 111.145 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.56 98.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-N 114.965 -1.016 . . . . 74.25 111.383 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.689 HD22 HD11 ' A' ' 105' ' ' ILE . 57.3 t-20 -75.76 87.15 2.78 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.197 -0.91 . . . . 71.51 108.952 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.423 ' CZ ' ' HB3' ' E' ' 182' ' ' PHE . 86.6 t80 -54.86 -39.17 68.34 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 71.32 112.631 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.39 -36.87 85.54 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.666 0.603 . . . . 74.31 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.71 83.89 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.739 0.649 . . . . 72.52 112.086 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.521 HD13 HG13 ' F' ' 207' ' ' VAL . 10.2 mp -64.83 -42.25 95.09 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.54 0.525 . . . . 74.15 110.088 176.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.6 -42.51 78.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.188 -0.301 . . . . 74.22 110.188 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.639 ' SD ' ' HG3' ' C' ' 142' ' ' GLN . 50.2 tpp -62.92 -35.15 79.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.332 1.053 . . . . 71.15 110.523 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -66.45 -52.48 45.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.119 1.368 . . . . 74.02 110.502 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.556 ' HB3' HD21 ' C' ' 141' ' ' LEU . 3.6 m-85 -69.93 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.389 1.075 . . . . 73.04 110.16 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.556 HD21 ' HB3' ' C' ' 140' ' ' TYR . 2.6 mm? -109.79 100.16 9.2 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.691 0.796 . . . . 74.43 109.902 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.639 ' HG3' ' SD ' ' C' ' 138' ' ' MET . 52.9 tt0 -75.18 -4.83 41.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.526 0.731 . . . . 71.44 111.39 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -72.83 77.93 1.14 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.713 0.805 . . . . 75.33 110.606 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -107.33 115.68 30.59 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.001 -1.111 . . . . 72.24 108.001 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.24 150.07 52.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 72.54 110.286 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' C' ' 93' ' ' GLN . . . 169.99 35.37 0.03 OUTLIER Glycine 0 CA--C 1.502 -0.746 0 C-N-CA 121.123 -0.561 . . . . 74.3 113.394 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.467 ' HG3' HE22 ' C' ' 93' ' ' GLN . 39.6 mt-10 -144.16 -162.63 1.51 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 106.821 -1.548 . . . . 75.42 106.821 170.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.46 41.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.997 0 N-CA-C 110.398 -1.081 . . . . 70.24 110.398 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 35.4 p -122.5 161.57 23.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.085 0.954 . . . . 72.42 110.576 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -140.57 -74.33 0.34 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.97 -1.863 . . . . 64.24 105.97 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.08 159.52 28.64 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.702 -0.681 . . . . 71.04 109.854 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -154.91 98.39 2.03 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.85 0.86 . . . . 72.4 108.972 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.41 149.65 31.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.767 -0.651 . . . . 61.12 110.02 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.52 113.07 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.039 0.837 . . . . 62.32 109.884 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 N-CA-C 108.17 -1.048 . . . . 75.41 108.17 178.649 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.35 -0.241 . . . . 75.11 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -143.13 27.52 1.59 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.596 0.758 . . . . 42.11 109.202 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.17 138.85 31.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.943 -0.571 . . . . 72.25 110.393 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.51 87.0 2.9 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.456 -0.942 . . . . 73.44 108.456 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -167.56 -152.84 0.13 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.707 -0.849 . . . . 64.14 108.707 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 71.41 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.701 1.6 . . . . 75.32 110.514 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p -134.47 161.65 34.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.274 1.03 . . . . 75.13 109.511 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.48 149.13 47.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.213 0.605 . . . . 75.11 110.013 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.2 ttp -34.72 130.01 0.41 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.107 0.963 . . . . 63.34 112.952 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -139.48 145.18 38.46 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.638 0.775 . . . . 65.41 109.067 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -154.37 105.68 2.69 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.862 -1.162 . . . . 75.14 107.862 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 74.9 mt-30 -117.34 115.94 26.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.992 0.517 . . . . 73.33 110.188 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -87.01 126.19 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.455 -0.943 . . . . 71.02 108.455 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.1 mt-30 -109.26 -47.53 3.39 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.114 0.413 . . . . 75.34 112.114 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -165.45 121.81 1.4 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.06 128.14 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.773 0.829 . . . . 74.11 109.057 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 40.3 p90 -161.99 174.58 12.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.95 0.881 . . . . 74.22 111.52 -171.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.51 120.68 40.67 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.72 -1.127 . . . . 71.13 108.985 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -84.77 -37.59 20.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.541 -0.54 . . . . 55.53 109.541 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.8 137.96 24.13 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.078 -0.965 . . . . 75.34 109.088 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.549 HG23 ' HE1' ' C' ' 117' ' ' MET . 74.9 mt -131.44 139.68 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 73.33 108.08 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.97 134.36 33.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.139 0.975 . . . . 70.1 108.812 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -146.94 116.18 6.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.614 -1.625 . . . . 72.31 106.614 170.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -122.23 144.35 49.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 73.14 109.499 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' D' ' 28' ' ' ALA . . . -134.25 75.2 65.68 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.896 -1.15 . . . . 62.05 107.896 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.96 -27.18 10.32 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.748 2.299 . . . . 63.41 113.081 -170.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.21 27.08 9.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.449 0.699 . . . . 71.2 109.978 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.574 ' HB1' ' HB1' ' D' ' 25' ' ' ALA . . . -54.95 -56.15 30.98 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 115.272 1.582 . . . . 62.04 115.272 -167.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.96 -6.23 13.14 Favored 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-N 121.474 1.562 . . . . 73.22 112.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -81.75 -44.46 17.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.642 1.177 . . . . 64.32 110.094 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.18 2.42 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.061 0.545 . . . . 74.34 111.202 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.427 ' HA ' ' CE2' ' H' ' 197' ' ' TYR . 63.9 t80 -58.25 -33.82 69.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.137 0.975 . . . . 73.13 110.34 165.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.59 -23.46 58.74 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.622 -1.172 . . . . 75.12 111.004 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -88.62 79.03 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 72.13 110.419 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.606 ' HB2' ' HD3' ' H' ' 196' ' ' LYS . 6.3 p-10 -87.17 57.49 4.5 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.199 1.0 . . . . 73.03 110.894 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -125.86 175.87 7.35 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.884 1.274 . . . . 72.33 108.425 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -72.44 112.79 16.24 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 119.194 -0.431 . . . . 72.43 109.969 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.08 113.73 2.15 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.524 2.149 . . . . 61.13 111.889 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.77 112.42 6.21 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.09 0.869 . . . . 73.43 109.655 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 m -99.65 122.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 73.25 110.045 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -104.56 112.57 25.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 74.44 108.498 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.497 HD21 HD22 ' D' ' 128' ' ' LEU . 6.8 mp -95.22 142.25 27.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.345 0.658 . . . . 74.35 110.093 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.2 t70 -132.61 137.09 46.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.633 -0.877 . . . . 71.42 108.633 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.429 HD11 HD23 ' H' ' 186' ' ' LEU . 22.6 tp -115.12 129.59 56.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.295 -0.631 . . . . 73.53 109.295 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.98 148.02 44.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.289 1.035 . . . . 73.4 108.389 172.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' H' ' 180' ' ' PRO . 88.6 m -128.97 150.59 50.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.166 0.987 . . . . 71.42 108.718 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.556 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -148.94 164.15 35.39 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.039 0.936 . . . . 74.34 109.755 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 96.5 p -167.43 155.33 9.12 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.5 0.72 . . . . 70.2 111.089 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -156.42 130.91 8.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.886 0.874 . . . . 70.51 109.031 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.74 126.13 27.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.836 0.454 . . . . 73.42 110.244 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.1 mt -98.69 -35.99 10.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.052 0.541 . . . . 75.21 110.183 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -159.25 -171.28 3.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.333 0.653 . . . . 72.43 111.186 -176.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.12 110.81 3.11 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.257 -0.883 . . . . 75.01 109.797 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 67.73 1.71 2.74 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.247 1.419 . . . . 71.43 112.707 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 52.2 t -110.24 134.16 53.3 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 123.87 0.868 . . . . 62.32 108.999 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -151.68 174.67 13.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.862 0.865 . . . . 71.03 109.08 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.0 tt0 -120.11 132.75 55.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.651 0.78 . . . . 73.41 109.127 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' D' ' 102' ' ' CYS . 58.5 t -100.24 132.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 108.045 -1.094 . . . . 65.1 108.045 168.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.556 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 47.0 t -111.12 136.15 48.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.48 -0.933 . . . . 73.2 108.48 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.515 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.87 127.49 56.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.138 -1.06 . . . . 74.43 108.138 179.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.58 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 35.3 ttm-85 -109.86 106.98 16.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.976 -0.749 . . . . 75.33 108.976 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -105.95 106.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 107.756 -1.201 . . . . 75.44 107.756 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 7.6 m -106.09 129.6 54.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.707 0.403 . . . . 70.33 110.183 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.451 HG21 HD12 ' D' ' 114' ' ' ILE . 63.4 t -119.64 102.89 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.719 1.208 . . . . 62.14 109.218 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -96.6 95.94 8.3 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.445 -0.946 . . . . 74.24 108.445 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 147.58 23.67 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.171 0.589 . . . . 63.35 110.495 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.515 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.4 p -155.8 129.16 8.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.564 0.697 . . . . 65.53 111.829 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.476 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 13.2 mt -92.51 98.33 11.39 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.695 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.04 -123.88 10.96 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.827 0.704 . . . . 73.43 112.133 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.92 5.98 37.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.17 0.588 . . . . 70.33 111.28 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -129.37 143.93 51.04 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.225 0.61 . . . . 71.11 110.8 -169.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.2 m -70.45 127.85 34.16 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.378 0.671 . . . . 73.43 110.982 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.515 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.67 -66.13 0.93 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.139 -1.059 . . . . 63.24 108.139 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.49 152.08 36.26 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.019 -0.991 . . . . 71.24 110.167 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.5 mt -104.93 147.11 28.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.573 -1.269 . . . . 75.15 107.573 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.406 ' SG ' HG21 ' D' ' 114' ' ' ILE . 45.5 t -156.92 143.4 18.26 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.87 -0.418 . . . . 65.23 109.87 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -157.15 141.23 16.26 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.505 -0.924 . . . . 71.41 108.505 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -135.51 116.64 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 74.22 109.555 175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -89.88 84.04 6.2 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.876 0.845 . . . . 73.54 108.889 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.88 100.33 7.98 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.208 -1.36 . . . . 64.35 109.292 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.58 143.87 16.47 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 111.683 -0.567 . . . . 54.52 111.683 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.97 139.26 6.82 Favored Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.279 -0.729 . . . . 72.2 111.279 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 49.0 mt -88.72 127.54 41.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 122.962 0.505 . . . . 70.12 109.91 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.68 146.27 52.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 72.22 109.49 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.5 m -116.32 105.14 12.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.356 0.663 . . . . 70.5 109.489 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.524 ' HB ' HD13 ' D' ' 89' ' ' ILE . 18.3 pt -109.33 142.4 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.413 0.551 . . . . 63.51 109.983 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.26 145.14 19.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.188 -0.915 . . . . 72.53 109.449 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.03 -10.05 61.79 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.108 0.403 . . . . 72.41 114.108 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.524 HD13 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -124.76 130.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.424 0.69 . . . . 73.41 110.368 -172.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.604 ' HG2' ' HG ' ' H' ' 173' ' ' LEU . 20.8 mt-10 -131.73 167.74 18.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.985 0.514 . . . . 73.13 111.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.43 -134.89 42.07 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.139 0.899 . . . . 53.31 113.208 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -66.39 -23.72 66.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.241 0.616 . . . . 71.31 111.608 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -66.52 -34.17 77.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.331 0.652 . . . . 71.53 110.912 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.498 ' HB3' HG12 ' D' ' 89' ' ' ILE . 3.2 ppp? -88.16 -27.76 21.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.433 0.293 . . . . 64.51 111.054 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.59 65.2 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.977 0.511 . . . . 71.3 111.879 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -84.56 -10.74 57.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.696 0.799 . . . . 71.43 110.338 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.03 -45.61 9.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.348 0.659 . . . . 74.23 109.543 170.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.93 -39.29 72.76 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.015 0.926 . . . . 74.0 111.432 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.16 12.44 67.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.068 -0.515 . . . . 61.32 113.018 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.54 -75.88 0.17 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.988 0.515 . . . . 61.01 111.716 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -72.74 -44.69 61.34 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.948 0.721 . . . . 75.4 112.948 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.468 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 61.7 m -61.52 -48.44 90.48 Favored Pre-proline 0 CA--C 1.567 1.626 0 CA-C-O 118.771 -0.633 . . . . 62.04 112.162 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.515 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 10.0 Cg_exo -72.76 -18.89 24.59 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.036 1.824 . . . . 75.53 112.977 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.31 -28.73 64.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.795 0.438 . . . . 71.42 110.563 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.11 -41.78 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-O 121.598 0.713 . . . . 71.42 109.413 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.72 -20.91 59.65 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.863 -1.062 . . . . 72.24 111.722 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.16 -41.42 14.29 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.252 1.205 . . . . 73.14 114.252 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -56.14 -36.04 95.91 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 121.762 1.641 . . . . 55.43 112.881 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.13 -32.82 33.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.81 0.844 . . . . 73.34 111.552 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.6 -50.74 63.94 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.584 -0.524 . . . . 74.54 109.584 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -58.31 -50.27 74.23 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.031 -1.441 . . . . 75.1 110.51 178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -63.06 -42.43 99.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.46 0.704 . . . . 72.41 111.643 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' D' ' 21' ' ' ILE . 49.2 t -59.47 -44.86 92.92 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.767 0.667 . . . . 73.54 110.944 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.451 HD12 HG21 ' D' ' 64' ' ' VAL . 74.3 mt -62.41 -57.24 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.612 0.765 . . . . 75.34 110.092 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.499 HG23 ' HG3' ' D' ' 125' ' ' GLN . 83.8 m -50.12 -43.83 51.93 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.533 1.533 . . . . 70.14 112.477 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.99 -44.66 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 70.34 110.486 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -64.48 -33.78 76.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.909 0.484 . . . . 74.14 111.43 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.416 HG22 ' O ' ' D' ' 114' ' ' ILE . 79.4 t -64.61 -45.8 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.108 0.963 . . . . 72.42 110.049 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.03 -27.98 63.07 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.683 0.278 . . . . 71.32 111.085 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -71.68 -30.59 65.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.6 0.76 . . . . 75.11 110.138 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 6.64 80.11 Favored Glycine 0 C--N 1.358 1.781 0 O-C-N 123.66 0.6 . . . . 75.02 112.731 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.551 HG21 ' HB3' ' C' ' 17' ' ' TYR . 51.0 p 65.41 21.28 11.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.309 1.844 . . . . 71.51 113.09 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.26 164.89 18.01 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 124.82 1.248 . . . . 72.34 109.314 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.07 140.34 22.52 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.394 2.063 . . . . 63.42 112.266 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.499 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.8 tt0 -55.75 126.65 26.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 75.23 111.013 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.93 105.65 15.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.411 0.684 . . . . 75.13 109.209 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -98.48 92.81 5.83 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.718 -0.845 . . . . 73.12 108.718 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.497 HD22 HD21 ' D' ' 42' ' ' LEU . 76.3 mt -69.89 123.33 21.2 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.098 0.559 . . . . 75.14 109.555 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' H' ' 187' ' ' ILE . . . -56.21 133.05 75.33 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.254 0.621 . . . . 55.01 111.145 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.65 108.66 2.3 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 121.877 1.718 . . . . 75.12 110.17 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.7 107.25 22.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.809 -1.182 . . . . 73.41 107.809 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.42 93.0 5.67 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.141 -0.936 . . . . 75.23 108.682 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' H' ' 184' ' ' TRP . 76.1 t80 -62.2 -19.29 62.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.483 -1.235 . . . . 75.25 111.189 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' D' ' 138' ' ' MET . 0.5 OUTLIER -58.19 -69.31 0.18 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.421 -0.799 . . . . 61.34 109.593 171.158 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.22 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.36 0.527 . . . . 75.11 112.064 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.0 -35.54 78.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.287 1.035 . . . . 72.22 111.952 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -101.17 -25.47 14.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.602 0.761 . . . . 71.24 111.716 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 29.1 ttm -54.39 -38.63 66.38 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 124.47 1.108 . . . . 75.42 112.301 -170.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -64.34 -40.45 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.62 -1.173 . . . . 73.54 110.884 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -55.56 -44.3 76.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.934 0.894 . . . . 75.02 112.131 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -57.83 -50.41 73.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.02 0.438 . . . . 73.45 110.649 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -86.28 3.92 41.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.972 -1.013 . . . . 75.2 112.188 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -125.72 62.22 1.23 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.83 0.852 . . . . 74.33 109.731 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -144.02 160.0 41.63 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.207 1.003 . . . . 74.41 109.097 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.02 -50.44 28.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.542 0.737 . . . . 74.03 111.206 -172.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.37 -102.02 0.78 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.368 -0.693 . . . . 61.53 111.368 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.18 155.21 17.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.464 0.705 . . . . 74.41 110.35 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . 0.418 ' H ' HG22 ' B' ' 149' ' ' THR . . . 165.7 51.63 0.02 OUTLIER Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.972 -0.558 . . . . 52.14 111.734 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 90.9 m -134.11 122.71 23.29 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.448 -0.575 . . . . 74.12 109.448 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . 0.627 ' HB3' ' HH ' ' H' ' 181' ' ' TYR . 1.5 mp0 -74.96 81.04 2.17 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.706 0.802 . . . . 61.11 109.069 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.35 161.3 31.02 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.579 -1.192 . . . . 73.24 111.174 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -142.71 154.7 44.55 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.739 -1.119 . . . . 75.22 108.604 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.18 148.13 37.95 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.158 -0.682 . . . . 54.24 109.158 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -71.6 90.89 1.05 Allowed 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.242 1.02 . . . . 75.22 109.359 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.858 -1.065 . . . . 63.21 108.853 -177.306 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . 0.603 ' HD2' ' H1 ' ' E' ' 168' ' ' LYS . 4.1 mptp? . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 108.653 -0.869 . . . . 74.43 108.653 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -75.39 -96.73 0.13 Allowed Glycine 0 C--N 1.349 1.288 0 N-CA-C 111.217 -0.753 . . . . 71.12 111.217 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -145.26 -72.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.722 0.809 . . . . 74.2 109.3 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 51.6 p -164.7 15.21 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.35 -0.841 . . . . 64.1 110.123 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 68.67 158.5 0.16 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.164 1.386 . . . . 54.22 110.855 -161.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.477 ' H ' HD23 ' E' ' 173' ' ' LEU . 2.3 pt? -85.02 37.13 0.65 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.536 0.734 . . . . 72.23 111.608 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.624 ' HG3' ' H ' ' E' ' 175' ' ' PHE . 12.2 ptt? -152.23 -96.45 0.05 Allowed 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.516 0.932 . . . . 75.04 113.516 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.624 ' H ' ' HG3' ' E' ' 174' ' ' MET . 4.8 t80 54.03 30.84 12.54 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.132 1.373 . . . . 74.4 110.463 -155.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.04 90.18 8.29 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 115.186 -0.915 . . . . 73.51 109.54 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . 0.458 HD13 ' HG ' ' C' ' 98' ' ' LEU . 1.7 tt -159.79 106.64 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.034 -1.469 . . . . 74.32 107.034 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -132.18 7.5 4.28 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.491 1.116 . . . . 73.31 109.036 172.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.0 151.27 4.75 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.541 1.537 . . . . 74.15 108.617 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.54 -8.3 22.32 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.091 2.527 . . . . 75.51 113.63 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . 0.43 ' CE2' ' HB1' ' C' ' 95' ' ' ALA . 94.7 m-85 66.0 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.247 1.419 . . . . 74.42 111.015 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . 0.423 ' HB3' ' CZ ' ' C' ' 133' ' ' PHE . 28.2 t80 -91.4 144.24 25.79 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.969 -1.123 . . . . 75.24 107.969 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 41.3 p -90.41 124.51 35.01 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.34 0.656 . . . . 75.41 111.454 -173.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.419 ' HA ' ' HD3' ' E' ' 185' ' ' PRO . 2.8 p90 -85.93 125.65 67.99 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.781 0.432 . . . . 75.25 110.045 169.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' E' ' 184' ' ' TRP . 8.3 Cg_exo -73.45 131.96 16.96 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.149 2.566 . . . . 72.24 112.115 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.612 HD11 ' HA ' ' C' ' 43' ' ' ASP . 73.7 mt -110.87 127.35 55.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.525 0.73 . . . . 74.13 109.707 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 pt -97.63 167.56 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.237 1.015 . . . . 75.52 111.971 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.24 81.79 2.04 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.066 0.946 . . . . 72.42 109.324 174.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.37 91.99 0.78 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.259 1.024 . . . . 75.12 111.979 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' C' ' 39' ' ' GLU . 6.8 p-10 -66.4 122.68 18.07 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.123 -0.695 . . . . 53.51 109.123 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.96 131.36 30.82 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.537 -0.591 . . . . 72.5 111.833 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.31 72.74 0.95 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 111.277 -0.729 . . . . 53.44 111.277 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 63.81 -85.48 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.907 1.683 . . . . 63.52 111.738 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 70.51 142.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.061 1.345 . . . . 73.32 111.71 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 66.64 171.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.205 1.402 . . . . 74.01 111.849 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -164.48 93.02 0.65 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.618 -0.882 . . . . 74.34 108.618 168.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.35 63.86 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.2 0.6 . . . . 71.44 110.117 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -113.04 5.6 17.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.089 0.556 . . . . 72.23 110.844 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -83.04 15.42 2.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.378 0.671 . . . . 65.22 111.633 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.37 85.96 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.362 -0.688 . . . . 63.04 113.18 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.502 ' HE3' ' HA ' ' E' ' 201' ' ' LYS . 1.1 tpmt? -170.98 -81.18 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.379 0.672 . . . . 75.42 111.367 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . 0.454 ' HB3' HG12 ' E' ' 204' ' ' ILE . 71.4 t80 -138.36 -169.69 2.65 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 107.681 -1.229 . . . . 71.14 107.681 -167.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.41 -24.0 66.21 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.423 0.689 . . . . 73.32 111.113 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.454 HG12 ' HB3' ' E' ' 202' ' ' TYR . 31.5 pt -81.63 166.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.322 0.582 . . . . 74.5 111.028 172.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -98.14 39.69 1.22 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.085 -0.962 . . . . 73.41 109.736 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.46 -159.76 0.31 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.299 1.04 . . . . 75.14 109.792 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.256 1.445 0 N-CA-C 109.219 -0.66 . . . . 73.24 109.219 176.128 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.365 0.126 . . . . 72.0 110.688 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.45 177.71 31.26 Favored Glycine 0 C--N 1.356 1.651 0 O-C-N 123.852 0.72 . . . . 72.42 113.06 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 32.66 4.7 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.585 -0.894 . . . . 64.51 108.585 172.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 45.4 m -70.23 86.8 0.58 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.05 0.94 . . . . 71.03 110.474 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . 0.527 ' HB3' ' SD ' ' B' ' 94' ' ' MET . . . -163.11 113.55 1.4 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.418 -0.956 . . . . 73.43 108.418 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.7 tt -170.14 -64.04 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.155 -1.424 . . . . 75.44 107.155 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.408 ' HE3' ' HA ' ' F' ' 174' ' ' MET . 29.5 mmt -108.96 98.94 8.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.964 0.906 . . . . 73.41 110.194 178.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 20.8 t80 53.59 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.124 1.77 . . . . 73.32 113.72 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 56.7 t30 179.9 130.87 0.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.004 0.922 . . . . 71.31 109.936 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 mp -99.26 80.19 2.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.186 -1.413 . . . . 71.12 107.186 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -70.8 114.4 8.84 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.969 -1.014 . . . . 75.41 111.131 -174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.99 118.72 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 125.391 1.476 . . . . 63.33 113.184 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.67 83.9 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.169 1.913 . . . . 74.04 110.755 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.46 -36.34 82.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.389 -0.823 . . . . 74.34 110.561 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.88 160.54 35.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 74.11 110.151 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 40.9 p -138.94 103.28 4.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.181 0.993 . . . . 74.04 109.254 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -72.82 123.92 90.14 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.004 0.522 . . . . 72.04 111.501 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -90.35 122.93 0.98 Allowed 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.12 2.547 . . . . 63.11 112.424 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.58 137.46 37.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.446 0.699 . . . . 72.34 110.229 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.434 HG12 HG23 ' E' ' 204' ' ' ILE . 2.8 pp -91.51 173.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.623 0.769 . . . . 73.33 112.979 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.34 165.89 20.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.85 1.26 . . . . 64.43 110.399 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.12 130.96 24.32 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.49 0.716 . . . . 62.35 109.906 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -129.45 15.11 6.06 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.433 1.093 . . . . 75.33 109.701 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.15 124.21 11.09 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.795 -0.639 . . . . 65.32 112.264 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.16 17.58 Favored Glycine 0 C--N 1.343 0.948 0 O-C-N 123.721 0.306 . . . . 61.42 113.415 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -83.41 -43.89 15.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.523 0.729 . . . . 73.24 109.644 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . 52.72 23.76 2.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.264 1.426 . . . . 75.53 114.633 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -147.88 132.03 17.35 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.859 0.864 . . . . 73.22 109.948 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . 0.499 ' HD2' ' HB2' ' F' ' 198' ' ' GLU . 10.1 tmtt? -130.77 -21.61 2.73 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.638 1.175 . . . . 72.34 108.342 175.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 35.4 t80 76.91 4.67 3.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.092 1.757 . . . . 74.41 110.388 -169.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' F' ' 205' ' ' LYS . 42.5 mt-10 -142.46 155.54 45.08 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.813 0.845 . . . . 75.41 110.529 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 64.9 t30 74.41 -1.61 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.161 1.784 . . . . 74.24 112.241 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 76.07 31.61 54.88 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.956 -0.458 . . . . 64.3 111.956 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.85 76.81 5.33 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.327 -0.99 . . . . 73.52 108.327 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 64.68 9.64 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.197 0.999 . . . . 74.34 110.696 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . 0.402 ' HA ' HH12 ' A' ' 15' ' ' ARG . 3.3 p30 -127.18 -156.74 0.77 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.319 1.448 . . . . 74.54 108.763 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 5.8 tt -155.48 121.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.381 0.672 . . . . 71.1 109.674 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' F' ' 198' ' ' GLU . 14.5 tmtt? -86.51 127.18 34.85 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.102 -1.073 . . . . 71.44 108.102 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.19 97.06 0.17 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.969 -0.752 . . . . 73.44 108.969 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.521 HG13 HD13 ' C' ' 136' ' ' LEU . 3.6 p . . . . . 0 CA--C 1.565 1.524 0 C-N-CA 125.264 1.425 . . . . 72.34 113.103 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.066 0.46 . . . . 73.31 110.012 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . 0.447 ' HA2' ' N ' ' G' ' 175' ' ' PHE . . . 90.6 -178.17 42.55 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.532 -0.758 . . . . 73.41 112.467 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -162.67 -40.48 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.564 0.346 . . . . 72.11 110.531 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 44.1 t -65.99 -69.29 0.31 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.977 0.511 . . . . 75.1 110.346 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' A' ' 54' ' ' ASP . . . -110.76 -92.17 0.46 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.805 -0.813 . . . . 75.22 108.805 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.507 HD13 ' H ' ' G' ' 173' ' ' LEU . 0.0 OUTLIER -117.92 -8.26 10.79 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.409 1.084 . . . . 72.22 108.783 169.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.505 ' HE2' HD12 ' A' ' 89' ' ' ILE . 9.3 ptp -126.19 145.37 50.41 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 124.874 1.269 . . . . 74.3 108.973 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.447 ' N ' ' HA2' ' G' ' 169' ' ' GLY . 17.0 t80 170.41 72.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.443 1.497 . . . . 75.33 108.039 167.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -165.04 94.19 0.64 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.529 -0.915 . . . . 53.44 108.529 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -84.54 81.72 8.72 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.349 -0.612 . . . . 72.42 109.349 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -99.22 -168.92 1.69 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.37 -0.832 . . . . 75.14 109.469 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.33 111.64 5.46 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.283 0.633 . . . . 74.4 109.543 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.58 -177.08 3.23 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.88 2.387 . . . . 73.44 112.951 -172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -85.52 164.94 17.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.474 -0.785 . . . . 73.1 110.047 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 63.51 -165.16 0.24 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.493 1.117 . . . . 74.02 110.729 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.7 t -149.16 141.63 24.29 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.76 0.424 . . . . 72.54 110.461 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -148.73 88.45 5.24 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.088 -1.079 . . . . 75.24 108.088 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.75 3.32 7.41 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.116 2.544 . . . . 75.35 114.085 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 79.7 mt 64.82 -168.63 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.591 1.156 . . . . 74.54 111.426 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' H' ' 206' ' ' ASP . 2.3 pp -127.22 163.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.558 0.743 . . . . 73.32 110.773 174.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.64 164.55 15.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 71.13 109.52 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.54 116.96 10.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.552 0.741 . . . . 74.31 109.699 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.58 169.72 17.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.956 0.502 . . . . 73.32 111.162 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.4 130.76 10.13 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.765 -0.652 . . . . 74.53 112.592 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.02 -129.78 1.78 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.547 -1.021 . . . . 71.1 110.547 168.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -166.68 142.14 4.4 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.822 0.849 . . . . 74.32 109.152 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' H' ' 198' ' ' GLU . . . -169.7 -168.64 0.8 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.069 0.948 . . . . 71.23 110.556 -172.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . 0.632 ' H ' ' HB3' ' H' ' 196' ' ' LYS . 2.4 t80 29.37 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.665 2.386 . . . . 74.41 113.401 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.65 103.2 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.021 -0.99 . . . . 74.12 109.791 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . 0.725 ' HE1' HH12 ' B' ' 15' ' ' ARG . 54.6 m-85 -87.57 -97.72 0.08 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.537 0.735 . . . . 74.53 109.247 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . 0.458 ' HG2' HD21 ' G' ' 199' ' ' ASN . 35.4 tt0 61.12 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.372 1.579 0 C-N-CA 124.963 1.305 . . . . 70.02 111.794 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . 0.458 HD21 ' HG2' ' G' ' 198' ' ' GLU . 7.4 p30 -150.26 26.55 0.78 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.84 0.856 . . . . 73.54 110.629 175.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -76.31 132.03 12.26 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.078 -0.51 . . . . 73.15 112.453 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.31 157.28 38.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 74.4 110.255 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -70.56 94.56 1.0 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.725 -0.843 . . . . 73.12 108.725 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.23 112.67 4.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.382 1.073 . . . . 75.34 111.323 -174.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 11.5 tt -171.86 138.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 122.713 0.405 . . . . 74.4 111.61 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -151.05 116.81 5.48 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.924 -1.139 . . . . 75.32 107.924 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.22 -75.1 0.57 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.22 -1.03 . . . . 61.03 108.22 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.716 -0.659 . . . . 73.43 109.474 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.039 -0.356 . . . . 71.2 110.039 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.99 -80.37 0.36 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.126 -0.79 . . . . 52.51 111.126 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -127.62 132.16 49.81 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.813 0.845 . . . . 74.44 111.008 -177.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 47.4 p -79.36 157.14 27.69 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.132 -1.062 . . . . 72.14 108.132 159.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.02 -65.37 0.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.386 0.275 . . . . 73.0 110.923 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.604 ' HG ' ' HG2' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -172.73 156.79 3.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.319 0.648 . . . . 72.13 110.144 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.551 ' HE2' ' HA ' ' H' ' 174' ' ' MET . 14.8 mmt -145.32 -179.45 6.65 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.632 1.173 . . . . 71.44 108.626 166.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -156.32 175.72 13.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.459 0.647 . . . . 74.24 111.078 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -128.23 10.37 6.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.103 1.361 . . . . 71.1 109.861 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 3.5 tt -65.75 97.67 0.35 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 108.319 -0.993 . . . . 75.53 108.319 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -125.47 30.4 5.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.76 1.224 . . . . 72.34 109.539 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -114.93 140.62 25.75 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.181 -1.372 . . . . 74.31 109.578 -171.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . 0.408 ' HG3' ' H ' ' D' ' 46' ' ' THR . 12.1 Cg_exo -70.23 77.6 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.885 2.39 . . . . 53.45 111.239 169.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . 0.627 ' HH ' ' HB3' ' D' ' 150' ' ' GLU . 65.4 t80 -101.62 -61.55 1.37 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.231 -0.895 . . . . 62.34 110.032 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -104.08 33.5 3.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.37 0.668 . . . . 75.21 109.346 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 24.6 p -92.33 165.62 12.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.399 1.08 . . . . 74.23 111.241 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . 0.483 ' HH2' ' HB2' ' D' ' 103' ' ' PRO . 44.9 p90 -93.48 160.51 32.88 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.521 0.728 . . . . 74.25 111.821 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.47 139.51 16.36 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.221 1.947 . . . . 75.44 111.588 166.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . 0.429 HD23 HD11 ' D' ' 44' ' ' LEU . 76.3 mt -79.51 164.09 24.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.057 0.456 . . . . 71.24 110.674 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' D' ' 129' ' ' ALA . 2.5 pp -100.65 176.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.092 0.957 . . . . 74.32 111.262 -175.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.65 25.86 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.471 0.708 . . . . 62.21 110.812 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.5 167.94 20.85 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.34 1.056 . . . . 64.43 109.177 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -146.54 -53.03 0.23 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 120.919 0.39 . . . . 74.44 111.51 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.65 33.47 4.16 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.233 -0.44 . . . . 73.54 114.106 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.77 -55.16 5.06 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.25 -0.34 . . . . 62.23 112.25 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 60.71 22.45 12.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.852 1.261 . . . . 73.33 112.022 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -90.98 75.34 6.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.373 0.669 . . . . 75.43 110.849 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -164.28 124.13 2.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.04 0.536 . . . . 75.44 109.952 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . 0.632 ' HB3' ' H ' ' G' ' 195' ' ' PHE . 9.2 tppt? -175.03 108.25 0.1 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.775 -1.565 . . . . 73.21 106.775 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' D' ' 32' ' ' PHE . 46.1 m-85 -60.1 -68.08 0.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.674 0.609 . . . . 74.44 111.675 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . 0.584 ' HA ' ' HB3' ' G' ' 194' ' ' ALA . 1.2 tm-20 -172.94 139.95 0.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 106.773 -1.566 . . . . 75.55 106.773 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -123.71 -19.98 5.61 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.067 0.394 . . . . 74.31 111.928 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -89.54 16.06 57.23 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-O 119.335 -0.703 . . . . 63.01 114.685 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? 60.03 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.584 1.553 . . . . 71.45 112.281 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -84.7 54.5 3.07 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 122.396 1.093 . . . . 74.3 108.548 171.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -101.06 93.41 5.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.738 1.215 . . . . 65.31 109.027 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.435 ' H ' ' NE2' ' C' ' 12' ' ' GLN . 46.6 mt -117.64 104.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.267 1.027 . . . . 75.53 110.147 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.59 168.41 10.2 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.582 -0.525 . . . . 74.43 109.582 170.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . 0.494 ' HB2' HG21 ' G' ' 187' ' ' ILE . 36.0 t70 -149.9 -56.34 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.764 -1.569 . . . . 52.5 106.764 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . 0.523 HG23 HG22 ' A' ' 131' ' ' VAL . 31.1 t . . . . . 0 C--O 1.254 1.29 0 N-CA-C 106.535 -1.654 . . . . 64.53 106.535 163.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.654 ' HE3' ' HG3' ' C' ' 147' ' ' GLU . 19.9 mmt . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 108.605 -0.887 . . . . 74.21 108.605 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m 52.07 81.57 0.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.265 1.026 . . . . 75.12 112.044 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.59 128.78 20.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.625 -1.25 . . . . 73.24 107.625 174.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.69 152.94 16.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.163 0.585 . . . . 75.4 110.699 -170.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -162.54 107.41 1.16 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.2 -1.407 . . . . 73.0 107.2 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 9' ' ' MET . 3.9 p-10 -157.23 -31.96 0.08 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.001 0.521 . . . . 74.31 111.473 -170.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -80.09 77.43 6.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.364 0.602 . . . . 75.13 109.862 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -167.92 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.43 -0.804 . . . . 70.2 110.154 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.49 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -77.01 161.36 28.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.846 0.684 . . . . 75.14 112.846 -166.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -140.11 126.82 20.49 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.266 0.626 . . . . 74.41 109.328 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 45.3 t80 -127.38 141.68 51.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.204 1.002 . . . . 73.22 108.878 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 60.0 tp60 -152.66 137.35 16.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.999 0.52 . . . . 70.22 110.296 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.99 117.05 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.754 -1.202 . . . . 71.43 107.754 173.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -90.08 -40.73 12.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.443 0.297 . . . . 75.13 110.539 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -172.77 125.02 0.46 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.704 0.401 . . . . 75.24 110.693 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.87 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 71.6 mt -106.67 136.34 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.504 -0.925 . . . . 74.51 108.504 171.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 31.7 p90 -167.14 171.0 11.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.888 0.875 . . . . 72.54 110.101 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -92.38 130.29 38.1 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.498 -0.927 . . . . 75.54 108.498 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -92.35 -42.94 9.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.61 -0.885 . . . . 75.3 108.61 172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.4 t70 -135.09 135.03 40.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.921 -1.036 . . . . 64.21 110.083 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.445 HG22 ' SD ' ' A' ' 117' ' ' MET . 82.5 mt -131.65 136.98 56.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.24 -1.393 . . . . 75.2 107.24 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -145.66 128.32 16.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.872 -0.418 . . . . 72.32 109.872 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 80.8 t80 -134.11 114.86 13.59 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.741 -1.578 . . . . 74.23 106.741 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.403 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 46.5 mt-10 -121.61 117.46 26.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.464 -0.569 . . . . 74.25 109.464 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.52 91.95 6.53 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 109.015 -0.735 . . . . 73.53 109.015 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 19.0 Cg_exo -67.39 -50.35 0.99 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.005 2.47 . . . . 71.4 111.854 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 40.1 m-80 -99.56 42.5 1.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.86 0.864 . . . . 73.34 109.86 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -48.39 96.45 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.76 1.224 . . . . 74.02 114.144 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HG3' ' HZ1' ' B' ' 19' ' ' LYS . 5.8 Cg_exo -78.88 -17.89 11.92 Favored 'Trans proline' 0 C--N 1.386 2.503 0 CA-C-N 121.168 1.453 . . . . 65.44 111.909 175.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -74.02 -38.79 63.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.14 111.546 -173.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.76 -14.15 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.758 0.823 . . . . 74.32 111.747 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.82 -39.63 89.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.487 0.715 . . . . 75.44 111.186 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -100.55 -30.28 11.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.604 0.762 . . . . 74.34 110.956 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.8 tmtp? -76.49 139.71 40.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.844 0.858 . . . . 73.32 108.95 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.1 m-20 -57.78 116.39 3.42 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.881 0.738 . . . . 72.43 109.793 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -79.17 80.45 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.191 0.996 . . . . 73.55 109.014 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -114.5 83.86 9.16 Favored Pre-proline 0 C--O 1.245 0.851 0 N-CA-C 107.404 -1.332 . . . . 64.24 107.404 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HB2' HG13 ' A' ' 40' ' ' VAL . 73.2 Cg_endo -73.76 122.16 7.56 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.921 1.747 . . . . 74.44 112.125 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -94.93 85.31 4.34 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 105.857 -1.905 . . . . 71.43 105.857 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 38' ' ' PRO . 14.0 m -75.25 93.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.703 -1.589 . . . . 74.4 110.744 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -77.78 144.7 36.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.268 -1.787 . . . . 74.54 108.891 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.37 147.7 38.46 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.711 -1.131 . . . . 75.1 108.866 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.4 132.04 18.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.425 -0.954 . . . . 64.24 108.425 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD21 HD23 ' G' ' 186' ' ' LEU . 55.7 tp -99.46 119.24 37.68 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.695 -0.854 . . . . 74.42 108.695 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.78 155.66 50.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.775 -0.454 . . . . 72.12 109.775 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -118.15 162.89 17.47 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.374 0.67 . . . . 73.43 109.443 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.02 116.12 6.92 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.618 -1.253 . . . . 63.42 107.618 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 p -98.88 150.27 22.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.321 -0.251 . . . . 72.31 110.321 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -159.34 121.07 3.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.449 0.7 . . . . 74.32 109.458 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.72 131.17 35.82 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.962 -0.755 . . . . 61.52 108.962 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 83' ' ' ILE . 82.8 mt -104.45 -38.32 6.85 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.313 0.645 . . . . 64.24 110.454 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -154.23 -177.61 6.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.098 0.959 . . . . 73.22 109.776 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.26 128.11 34.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.336 -0.987 . . . . 72.44 108.336 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 69.96 2.73 4.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.151 0.981 . . . . 72.34 111.935 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 54.5 t -120.31 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 107.01 -1.478 . . . . 74.21 107.01 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.407 ' HB2' ' SD ' ' G' ' 174' ' ' MET . 6.6 t80 -128.38 128.67 44.95 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 74.35 108.95 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.25 115.09 28.34 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.861 -1.063 . . . . 72.43 109.168 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.42 119.73 53.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.047 0 N-CA-C 106.087 -1.82 . . . . 73.54 106.087 169.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -97.3 132.14 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.847 0.859 . . . . 75.12 108.938 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 115.37 27.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.726 -1.213 . . . . 74.45 107.726 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -105.3 100.74 10.31 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.03 -0.73 . . . . 73.11 109.03 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.421 ' HB ' HD11 ' A' ' 114' ' ' ILE . 32.7 t -99.92 127.32 52.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.152 -1.055 . . . . 71.24 108.152 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -122.73 132.83 54.42 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.612 -0.514 . . . . 64.45 109.612 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 51.2 t -133.15 126.22 52.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 125.351 1.46 . . . . 72.41 108.569 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -118.66 137.03 53.58 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.44 109.437 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.66 111.8 23.49 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.049 -1.093 . . . . 72.31 108.049 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.9 m -108.46 131.29 54.94 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.973 0.416 . . . . 64.42 110.323 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.493 HD13 ' HB1' ' A' ' 73' ' ' ALA . 28.6 mt -105.14 43.1 1.14 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.699 -1.223 . . . . 74.04 107.699 173.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.98 -115.01 4.93 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.946 -1.261 . . . . 70.33 109.946 -168.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.41 -25.95 18.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.217 0.607 . . . . 73.44 110.411 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.64 99.6 5.85 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.84 -0.618 . . . . 74.45 110.015 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.9 m -68.75 127.45 33.11 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.206 -0.664 . . . . 74.41 109.206 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -78.83 -52.05 8.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.881 0.873 . . . . 72.0 109.101 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.46 159.74 43.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.163 -1.38 . . . . 74.33 110.328 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -130.55 132.37 45.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.049 -1.463 . . . . 61.45 107.049 173.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.9 m -122.09 135.21 54.78 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.145 0.978 . . . . 73.34 108.792 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -148.27 116.49 6.5 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.003 -1.11 . . . . 74.15 108.003 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.413 HG11 ' SG ' ' A' ' 113' ' ' CYS . 94.6 t -123.92 118.71 54.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.87 -0.789 . . . . 71.35 108.87 -177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.1 mt-30 -97.15 88.23 4.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.904 -1.044 . . . . 74.24 108.451 172.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.2 tp-100 -75.7 98.94 4.21 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 114.541 -1.209 . . . . 75.0 107.936 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.01 143.74 18.34 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 112.042 -0.423 . . . . 64.11 112.042 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.405 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.27 120.83 1.96 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.878 -0.889 . . . . 71.45 110.878 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' B' ' 29' ' ' PRO . 50.2 mt -81.71 126.73 39.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.304 -1.369 . . . . 70.14 107.304 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.434 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 64.8 m-85 -134.8 128.83 33.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.552 -0.536 . . . . 73.33 109.552 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 12' ' ' GLN . 9.3 p -84.08 96.62 8.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.58 -0.896 . . . . 74.45 108.58 170.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.4 HD11 HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -129.03 133.72 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 74.01 109.378 -169.347 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 175.61 4.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.594 0.757 . . . . 64.03 111.161 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 105.46 -22.86 31.54 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.433 -0.803 . . . . 70.12 113.314 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.4 HD13 HD11 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -110.25 150.84 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 73.42 110.152 -176.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.57 ' HA ' ' HB2' ' G' ' 172' ' ' ALA . 53.9 mt-10 -140.88 174.87 10.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.596 0.358 . . . . 75.35 110.834 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.6 -134.46 35.54 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.384 -0.371 . . . . 75.12 113.391 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -68.07 -21.79 64.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.814 0.846 . . . . 71.31 111.745 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -65.46 -35.76 81.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.676 0.79 . . . . 71.15 110.685 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 62.0 tpp -69.22 -39.89 78.29 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 116.201 -0.454 . . . . 72.2 109.972 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -28.59 69.67 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.937 0.495 . . . . 74.14 111.31 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -72.36 -61.76 1.68 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.408 0.683 . . . . 63.32 111.017 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 9.1 t -68.39 -43.3 77.6 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 62.12 110.773 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 tt -84.56 -41.2 16.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.023 0.929 . . . . 75.25 110.618 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.14 -36.19 28.33 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 114.822 0.689 . . . . 75.52 114.822 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.8 -44.44 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.939 0.496 . . . . 72.04 112.107 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -74.18 -53.62 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.909 0.883 . . . . 74.31 112.669 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.12 -40.79 30.72 Favored Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 113.206 0.817 . . . . 73.52 113.206 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.533 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.8 Cg_endo -66.7 -22.14 50.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 CA-C-N 121.05 1.411 . . . . 73.21 113.295 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.89 -31.17 68.83 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 118.269 0.486 . . . . 72.04 110.461 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.25 -33.07 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.786 0.803 . . . . 75.14 110.364 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 103' ' ' PRO . 86.5 mt -82.67 -23.64 34.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.866 1.266 . . . . 75.43 113.123 -174.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -62.3 -40.7 69.08 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.609 1.337 . . . . 74.1 114.609 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.52 -38.54 83.57 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 121.982 1.788 . . . . 62.43 112.992 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -82.56 -34.09 27.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.086 0.954 . . . . 74.42 111.515 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.06 78.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.063 0.545 . . . . 72.52 109.544 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.427 HH22 ' HB3' ' A' ' 130' ' ' PRO . 39.6 ttm180 -52.04 -52.7 49.23 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.709 1.256 . . . . 74.23 110.655 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.45 -45.74 92.99 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.403 1.064 . . . . 72.35 111.244 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.413 ' SG ' HG11 ' A' ' 78' ' ' VAL . 49.3 t -58.76 -45.35 89.95 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.771 0.669 . . . . 75.53 111.154 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.421 HD11 ' HB ' ' A' ' 62' ' ' VAL . 86.7 mt -62.52 -51.58 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.903 0.752 . . . . 73.23 109.793 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -56.14 -41.28 75.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.267 1.027 . . . . 53.21 111.805 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.9 t -66.21 -47.88 72.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.345 0.658 . . . . 73.53 110.006 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.445 ' SD ' HG22 ' A' ' 21' ' ' ILE . 13.5 mtp -55.59 -46.77 77.21 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.988 0.915 . . . . 71.41 111.048 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -60.1 -44.15 94.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.726 1.21 . . . . 73.11 111.17 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.4 t -68.38 -31.82 71.46 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.816 -0.629 . . . . 64.42 111.322 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.493 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 94.1 mtt-85 -74.16 -20.38 60.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.735 0.814 . . . . 74.24 110.844 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.04 11.55 57.03 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.511 0.507 . . . . 71.55 112.983 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.3 m 66.71 35.51 5.14 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.495 1.14 . . . . 63.34 110.323 177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.31 149.68 50.11 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.162 -0.926 . . . . 74.53 109.54 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.21 157.78 47.85 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.718 2.278 . . . . 64.22 112.564 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.83 141.74 58.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.637 -1.165 . . . . 73.53 112.628 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -123.48 107.06 11.16 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.156 -1.424 . . . . 71.43 107.156 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.55 99.97 8.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.148 0.979 . . . . 71.41 109.387 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.91 148.32 40.21 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.699 0.8 . . . . 71.33 110.421 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.62 147.45 98.69 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.634 0.774 . . . . 63.24 111.817 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HB3' HH22 ' A' ' 111' ' ' ARG . 71.7 Cg_endo -83.73 165.76 13.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.75 2.3 . . . . 75.44 112.801 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.41 114.68 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.744 -0.835 . . . . 75.04 108.744 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -99.98 63.82 1.2 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.948 -1.13 . . . . 72.33 107.948 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -70.27 -33.76 71.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.503 -1.226 . . . . 73.15 110.608 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -57.36 -44.27 84.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.224 1.009 . . . . 54.11 112.043 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.85 63.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.993 0.517 . . . . 74.44 110.601 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.68 -34.75 78.54 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.637 0.775 . . . . 71.44 110.871 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -67.52 -53.03 32.06 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.854 0.862 . . . . 75.35 109.667 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 59.6 mtp -55.84 -45.62 78.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.967 0.907 . . . . 74.33 110.866 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -52.75 -60.04 3.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.228 1.411 . . . . 74.31 110.908 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -64.43 -35.23 80.24 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.872 0.469 . . . . 75.52 111.57 -176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.83 -48.78 67.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.712 -0.676 . . . . 74.22 110.257 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -167.18 -14.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.684 0.624 . . . . 73.25 112.684 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -92.58 20.34 6.44 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.585 0.354 . . . . 63.41 111.626 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -82.66 60.37 5.21 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 107.568 -1.271 . . . . 74.31 107.568 166.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.97 136.74 10.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.982 -1.008 . . . . 74.34 110.996 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.25 -163.91 11.91 Favored Glycine 0 C--O 1.247 0.956 0 N-CA-C 110.346 -1.102 . . . . 63.51 110.346 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -156.21 128.1 7.39 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.504 -0.554 . . . . 72.2 109.504 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.49 57.59 0.02 OUTLIER Glycine 0 C--O 1.245 0.806 0 O-C-N 123.22 0.325 . . . . 74.43 112.824 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.7 m -69.01 98.1 0.93 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.163 -0.68 . . . . 74.44 109.163 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -111.69 -16.73 13.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.593 1.157 . . . . 73.14 110.001 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.38 114.63 16.41 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.296 0.638 . . . . 72.41 110.644 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -166.13 112.92 0.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.356 1.063 . . . . 75.25 109.256 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -74.42 140.05 44.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.821 -0.436 . . . . 71.33 109.821 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.82 114.8 2.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.749 -1.204 . . . . 71.14 107.749 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 C-N-CA 123.472 0.709 . . . . 63.04 109.093 -178.101 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.041 -0.726 . . . . 73.31 109.041 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 62.3 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.175 1.39 . . . . 72.33 112.52 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.444 ' HG2' ' HA2' ' B' ' 148' ' ' GLY . 4.5 mp0 -93.34 -164.64 1.2 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.199 0.6 . . . . 73.42 110.627 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -109.03 24.67 12.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.0 0.92 . . . . 74.4 109.286 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.435 ' OD1' ' HB2' ' B' ' 3' ' ' GLU . 2.6 p-10 -77.07 -176.02 3.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.147 0.975 . . . . 74.03 112.028 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -149.88 175.97 11.17 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.274 -1.33 . . . . 54.24 107.978 173.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -157.81 165.53 35.07 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.941 -0.763 . . . . 74.15 108.941 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -77.68 -37.75 49.02 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.544 0.738 . . . . 75.32 109.705 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm 50.53 -176.34 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.684 1.994 . . . . 74.21 113.781 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.8 m -146.07 127.05 14.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.424 -1.324 . . . . 74.34 107.424 172.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.9 140.95 38.54 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.813 -0.81 . . . . 71.13 108.813 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.6 140.26 18.93 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.631 0.582 . . . . 74.41 109.906 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 tt -95.09 133.03 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.939 0.896 . . . . 74.21 109.46 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -104.7 -50.55 3.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.814 0.446 . . . . 74.1 110.872 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -158.57 140.36 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.657 0.383 . . . . 75.14 110.8 -173.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -117.83 142.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.015 -1.105 . . . . 72.4 108.015 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -162.86 169.63 19.5 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.823 0.702 . . . . 73.32 110.69 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.8 m -99.2 123.23 43.32 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.065 -0.716 . . . . 72.33 109.065 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.44 ' HZ1' ' HG3' ' A' ' 29' ' ' PRO . 40.5 mttp -77.21 -52.7 8.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.926 -0.579 . . . . 73.42 110.402 170.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -140.79 140.93 34.82 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.111 0.481 . . . . 71.32 111.919 -165.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.8 HD12 ' SG ' ' B' ' 113' ' ' CYS . 46.4 mm -132.81 138.14 52.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.933 1.293 . . . . 73.43 108.396 174.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -143.1 135.98 27.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.063 -0.971 . . . . 74.44 108.509 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -153.35 111.85 3.67 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.851 -1.166 . . . . 74.11 107.851 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -119.83 118.66 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.594 -0.891 . . . . 72.21 108.594 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -115.89 86.88 17.11 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.721 0.808 . . . . 75.24 109.643 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.9 -50.57 2.16 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.868 2.379 . . . . 64.52 112.695 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 88.8 m-20 -101.56 20.6 15.79 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.561 0.744 . . . . 72.24 111.435 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -48.6 -52.73 42.17 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 124.898 1.279 . . . . 54.0 112.932 168.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.461 ' HA ' HD11 ' A' ' 83' ' ' ILE . 43.8 Cg_endo -74.62 -12.02 22.31 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 121.692 1.595 . . . . 71.33 113.207 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.457 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 82.8 m-70 -96.01 1.12 52.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.759 0.824 . . . . 72.12 110.915 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.01 -22.92 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.817 1.247 . . . . 64.22 112.936 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.84 -42.05 78.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.915 0.886 . . . . 72.45 110.937 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -83.46 -12.47 56.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.5 1.12 . . . . 74.41 111.136 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -100.54 75.3 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.031 0.932 . . . . 74.24 109.284 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.12 76.04 9.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 71.54 110.899 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.48 158.51 1.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.89 1.276 . . . . 74.31 109.885 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' F' ' 195' ' ' PHE . 63.8 tt0 -83.93 130.89 53.3 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 74.32 108.729 173.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.415 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 50.3 Cg_endo -65.6 153.39 78.4 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.51 2.14 . . . . 75.5 112.746 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 42.8 mt-10 -69.76 100.82 1.57 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.944 . . . . 73.03 108.453 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' B' ' 126' ' ' LEU . 33.1 t -90.24 121.23 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 107.871 -1.159 . . . . 73.42 107.871 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -148.76 139.78 23.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.468 -1.308 . . . . 64.32 107.468 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.444 HD22 HD12 ' B' ' 126' ' ' LEU . 0.8 OUTLIER -128.11 163.03 25.52 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.711 0.767 . . . . 75.3 112.475 -171.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.417 ' HA ' HD12 ' F' ' 186' ' ' LEU . 10.0 m-20 -126.9 154.15 44.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.049 -1.432 . . . . 74.52 108.555 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.458 HD23 ' CZ2' ' F' ' 184' ' ' TRP . 2.5 tt -134.94 116.17 14.4 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.792 -1.559 . . . . 72.24 106.792 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -126.46 155.28 42.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.754 0.822 . . . . 75.43 110.044 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 29.2 m -111.4 136.69 50.18 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 72.51 110.394 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.15 154.06 36.7 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.688 1.195 . . . . 73.42 108.177 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 m -141.68 160.69 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.006 0.431 . . . . 54.34 111.338 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -162.99 163.38 26.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.108 1.363 . . . . 73.54 108.332 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.447 ' NE2' ' HG3' ' F' ' 174' ' ' MET . 59.3 tt0 -123.02 137.24 55.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.056 0.943 . . . . 74.44 109.193 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.421 HD13 HG23 ' B' ' 83' ' ' ILE . 46.7 mt -101.15 -35.11 9.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.177 0.591 . . . . 73.53 111.117 176.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.46 -174.25 2.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.346 1.058 . . . . 74.15 110.316 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.05 119.09 14.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.347 -0.842 . . . . 71.1 109.823 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 67.02 12.46 8.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.659 1.184 . . . . 74.34 112.138 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -128.27 110.62 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.779 -1.193 . . . . 63.22 107.779 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.445 ' HB3' ' SD ' ' F' ' 174' ' ' MET . 2.8 p90 -122.31 163.96 18.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.137 -0.69 . . . . 75.2 109.137 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -137.93 110.46 7.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.681 -1.229 . . . . 73.43 107.681 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' B' ' 98' ' ' LEU . 24.4 m -107.77 150.66 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.211 0.529 . . . . 74.5 110.364 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 18.0 t -116.61 136.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 115.272 -0.876 . . . . 75.3 108.648 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.457 HD13 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -102.02 116.15 32.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.962 -1.125 . . . . 74.22 107.962 178.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -97.44 125.16 41.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.016 0.526 . . . . 63.43 109.98 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 12.7 t -125.7 116.86 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.486 -0.931 . . . . 74.4 108.486 166.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 38.0 m -99.08 152.13 20.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.452 1.101 . . . . 73.14 109.216 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 76.1 t -136.78 111.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.936 0.894 . . . . 71.03 109.242 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.2 m -92.31 138.41 31.54 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.514 0.725 . . . . 74.44 109.047 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.05 142.21 28.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.127 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 35.3 p -140.7 128.65 21.95 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.747 0.654 . . . . 73.53 111.824 -178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.8 99.04 11.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.951 -1.129 . . . . 74.41 107.951 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -112.81 3.79 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.341 -0.845 . . . . 54.21 111.467 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -108.26 1.32 21.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.091 0.956 . . . . 73.3 111.131 -176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.0 155.6 41.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.481 0.712 . . . . 74.34 110.213 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 130.72 44.17 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.034 0.534 . . . . 75.12 111.97 -173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.68 -58.85 2.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 64.3 108.72 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -161.55 162.93 30.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 113.536 -1.665 . . . . 71.34 109.352 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.4 mt -136.32 111.63 9.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.935 -1.506 . . . . 73.33 106.935 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -117.87 158.17 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.702 0.801 . . . . 74.24 109.068 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -165.68 146.69 7.0 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.003 -0.74 . . . . 75.12 109.003 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' B' ' 110' ' ' ALA . 74.8 t -129.15 144.5 37.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.566 -1.197 . . . . 73.23 108.353 174.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.527 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.1 mt-30 -127.36 93.46 3.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.547 -0.908 . . . . 74.42 108.547 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -86.08 102.66 14.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.95 -1.023 . . . . 70.34 109.449 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.57 148.87 20.76 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.759 -0.536 . . . . 71.44 111.759 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.25 126.09 2.16 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 117.27 0.535 . . . . 72.11 112.416 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.421 HG23 HD13 ' B' ' 51' ' ' LEU . 57.0 mt -85.98 127.2 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.535 0.734 . . . . 71.31 109.079 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -139.72 170.18 16.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 71.31 109.041 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -133.68 131.72 39.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 74.34 108.874 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.68 HD12 ' SG ' ' B' ' 97' ' ' CYS . 7.1 tt -140.32 145.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.417 0.287 . . . . 71.1 110.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.3 39.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.767 0.827 . . . . 72.24 110.078 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.05 -31.6 4.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.18 -0.464 . . . . 73.23 114.149 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.49 HG12 ' HB2' ' B' ' 94' ' ' MET . 0.1 OUTLIER -71.54 170.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.13 0.972 . . . . 75.4 112.679 -177.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HB1' ' F' ' 172' ' ' ALA . 13.8 pt-20 -164.12 160.25 21.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.326 0.65 . . . . 75.32 110.388 173.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.55 -128.74 47.57 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.469 0.48 . . . . 73.1 113.693 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 38.0 m -68.47 -21.88 64.59 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.367 0.667 . . . . 65.02 111.382 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' B' ' 90' ' ' GLU . 25.0 mt-30 -64.97 -31.7 73.06 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.907 0.483 . . . . 75.32 110.806 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.574 ' HE1' HD21 ' B' ' 98' ' ' LEU . 13.1 tpt -85.86 -46.3 10.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.457 -0.338 . . . . 73.23 110.574 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.67 66.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.781 0.833 . . . . 75.31 111.872 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.1 -38.67 75.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.638 0.775 . . . . 72.43 111.16 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.68 ' SG ' HD12 ' B' ' 86' ' ' ILE . 53.4 t -64.98 -68.37 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.882 0.31 . . . . 73.5 111.547 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.762 ' HB2' HG13 ' B' ' 58' ' ' VAL . 2.6 pt? -75.46 -18.02 59.98 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.785 0.266 . . . . 74.5 111.517 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.64 3.64 42.61 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-O 118.984 -0.898 . . . . 74.0 114.373 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.96 -50.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.076 0.938 . . . . 44.33 112.409 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -72.84 -46.57 52.27 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.557 0.743 . . . . 71.11 111.55 -170.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.0 -44.8 40.91 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 118.457 -0.782 . . . . 73.31 110.717 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.13 -45.35 21.8 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.033 1.822 . . . . 75.31 112.841 163.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -60.74 -36.52 79.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.509 0.724 . . . . 73.23 111.782 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.01 -48.37 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.358 0.663 . . . . 74.41 110.77 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.457 ' HB2' HD13 ' B' ' 60' ' ' LEU . 44.2 mt -83.0 -11.48 58.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.911 -1.04 . . . . 72.25 111.575 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -62.22 -48.42 87.77 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 117.904 -1.046 . . . . 72.43 113.724 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.17 -36.07 98.17 Favored 'Trans proline' 0 C--N 1.373 1.851 0 CA-C-N 121.04 1.407 . . . . 74.35 112.267 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.401 ' HE2' HG23 ' D' ' 115' ' ' THR . 91.0 m-85 -66.28 -51.37 58.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 74.33 111.261 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.429 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -60.84 -45.38 94.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.941 0.897 . . . . 64.32 110.832 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.424 ' NH2' HG22 ' C' ' 122' ' ' THR . 37.3 ttt180 -56.58 -50.34 72.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.204 1.401 . . . . 75.41 111.292 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.5 -35.75 81.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.236 0.614 . . . . 71.33 110.374 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.8 ' SG ' HD12 ' B' ' 21' ' ' ILE . 7.5 t -72.22 -37.96 69.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.152 -0.476 . . . . 62.22 111.065 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' B' ' 62' ' ' VAL . 54.0 mt -60.59 -50.22 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.352 0.661 . . . . 72.53 109.222 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.464 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 72.5 m -48.2 -46.49 35.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.842 1.339 . . . . 73.12 110.532 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.1 t -61.89 -56.51 18.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.446 -1.252 . . . . 62.02 110.882 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.472 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 20.0 mmt -67.6 -38.36 83.86 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.752 0.821 . . . . 75.12 112.389 -170.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.91 -44.45 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.424 0.631 . . . . 75.52 109.944 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.3 t -67.34 -25.16 65.85 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.648 -1.16 . . . . 72.0 112.222 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -70.94 -36.4 72.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.194 0.597 . . . . 64.23 109.933 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 6.75 56.59 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.662 0.601 . . . . 74.34 112.49 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.0 p 57.22 42.01 26.02 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.368 1.867 . . . . 75.42 111.457 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.462 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 48.3 m-85 -114.85 159.42 37.49 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.533 -1.212 . . . . 75.42 110.698 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.507 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 39.6 Cg_exo -60.53 104.56 0.26 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.58 2.853 . . . . 72.41 114.684 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.494 ' HG3' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -65.0 161.53 18.5 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.156 1.382 . . . . 61.21 111.447 171.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.46 ' HB2' HG13 ' B' ' 40' ' ' VAL . 1.1 tm? -132.29 117.99 18.89 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.395 -0.965 . . . . 72.3 108.395 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.41 94.85 10.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.132 -1.062 . . . . 62.11 108.132 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.452 HD21 ' N ' ' B' ' 129' ' ' ALA . 1.8 tt -58.4 138.99 56.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.681 -1.145 . . . . 72.12 110.565 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.518 ' HB3' ' CD2' ' E' ' 202' ' ' TYR . . . -51.51 148.98 8.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 70.33 112.228 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.473 ' HG3' HG12 ' D' ' 16' ' ' ILE . 80.1 Cg_endo -72.07 78.81 1.78 Allowed 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.331 2.021 . . . . 74.22 111.451 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.7 m -74.07 83.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.239 1.019 . . . . 75.12 110.691 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.58 111.33 7.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.807 -1.088 . . . . 72.11 108.891 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -75.45 -20.06 59.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.258 0.623 . . . . 74.41 110.91 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.07 -29.25 70.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.368 0.667 . . . . 72.0 110.824 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.63 81.72 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.653 0.596 . . . . 64.11 110.319 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -68.26 -34.29 75.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 72.43 110.872 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.548 ' HA ' HD11 ' B' ' 141' ' ' LEU . 60.3 m-85 -71.29 -36.32 71.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.596 0.358 . . . . 74.23 110.776 171.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.488 ' HE3' ' O ' ' D' ' 11' ' ' PHE . 38.0 ttp -69.16 -29.53 67.57 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.318 1.047 . . . . 74.43 111.413 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -105.96 -42.65 5.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.642 -0.708 . . . . 65.33 111.028 -166.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -89.5 -37.9 14.42 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.599 0.36 . . . . 70.05 110.618 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.548 HD11 ' HA ' ' B' ' 137' ' ' PHE . 5.0 mp -107.14 -9.63 16.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.698 0.399 . . . . 75.05 111.565 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' B' ' 138' ' ' MET . 90.4 mt-30 67.24 -67.07 0.18 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.844 1.258 . . . . 75.2 111.963 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.42 172.35 8.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.494 0.718 . . . . 74.23 110.819 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -149.85 127.8 11.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 73.21 109.316 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.96 -165.98 0.09 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.734 1.213 . . . . 62.22 109.46 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 166.7 87.52 0.07 OUTLIER Glycine 0 C--N 1.35 1.356 0 N-CA-C 111.714 -0.554 . . . . 75.23 111.714 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.412 ' HB3' ' ND2' ' B' ' 5' ' ' ASN . 3.0 tm-20 -155.3 -64.4 0.12 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.305 -0.998 . . . . 75.14 108.305 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . 0.444 ' HA2' ' HG2' ' B' ' 3' ' ' GLU . . . 126.54 -18.54 6.38 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.95 1.54 . . . . 43.13 116.95 166.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 46.6 p -105.17 -18.42 14.14 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.599 1.7 . . . . 72.42 111.967 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 62.7 90.14 0.08 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.612 1.165 . . . . 70.44 111.138 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -75.45 152.73 37.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 75.21 111.484 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -98.67 121.64 40.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.267 0.627 . . . . 72.14 109.878 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -84.54 132.19 34.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.721 -0.474 . . . . 73.44 109.721 172.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -108.75 -58.26 2.03 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.277 -1.379 . . . . 75.25 107.277 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.815 -1.084 . . . . 75.21 108.719 -178.649 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.2 mtt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 109.7 -0.482 . . . . 72.54 109.7 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 33.7 p -162.06 -79.86 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.51 107.801 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.484 ' HG2' ' H ' ' C' ' 4' ' ' GLN . 19.5 tt0 58.18 -168.83 0.13 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 124.81 1.244 . . . . 74.15 111.348 171.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.484 ' H ' ' HG2' ' C' ' 3' ' ' GLU . 34.8 mt-30 69.76 105.45 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.763 1.225 . . . . 74.34 110.89 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.91 84.14 7.01 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.295 0.569 . . . . 73.02 110.428 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -76.06 -14.1 60.21 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.222 -0.899 . . . . 72.41 110.636 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -68.07 -52.92 29.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.024 0.93 . . . . 74.03 111.077 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.98 155.56 40.13 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.888 0.699 . . . . 75.1 112.888 -171.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 62.62 113.3 0.02 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.633 1.573 . . . . 74.3 110.916 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m -116.83 114.53 24.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.001 -0.74 . . . . 63.41 109.001 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -124.35 119.07 28.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -146.66 130.17 16.83 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.459 -0.941 . . . . 74.21 108.459 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 tp -78.81 137.89 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 109.477 -0.564 . . . . 75.44 109.477 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.51 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.9 mm-40 -98.96 -47.33 5.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.273 0.629 . . . . 72.41 109.881 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.41 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 66.4 ttt180 -170.77 124.99 0.68 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.581 0.551 . . . . 74.44 110.48 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -109.35 141.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.665 -1.235 . . . . 74.22 107.665 169.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.444 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 6.8 p90 -179.39 164.94 1.38 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.438 0.695 . . . . 71.35 110.029 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -88.7 122.87 32.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 122.971 0.508 . . . . 71.25 109.913 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.604 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.8 mmtp -74.54 -50.56 17.6 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.069 0.938 . . . . 74.34 108.686 170.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.99 141.52 40.45 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.003 -1.453 . . . . 73.34 109.004 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 94.2 mt -137.28 139.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.808 -1.553 . . . . 72.13 106.808 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -149.85 146.3 27.04 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.557 -0.534 . . . . 74.33 109.557 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -152.48 108.84 3.41 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.162 -1.422 . . . . 75.24 107.162 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -116.47 118.68 33.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.91 -0.774 . . . . 63.04 108.91 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.49 86.94 5.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.28 -1.748 . . . . 74.13 106.28 167.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.55 -38.61 61.24 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 122.67 2.247 . . . . 61.12 110.989 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -99.9 44.79 1.01 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.394 -1.275 . . . . 73.32 109.064 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.415 ' O ' HG13 ' C' ' 31' ' ' VAL . . . -59.26 -64.3 3.13 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.903 1.281 . . . . 73.31 112.694 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.5 -12.47 22.62 Favored 'Trans proline' 0 C--N 1.382 2.319 0 CA-C-N 121.876 1.706 . . . . 61.43 112.203 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.503 ' CD2' ' HD3' ' C' ' 34' ' ' LYS . 3.5 t-160 -67.7 -30.41 69.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.214 1.006 . . . . 74.41 109.907 174.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.801 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 2.9 p -69.51 -26.66 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 111.835 0.309 . . . . 72.12 111.835 -173.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.92 -40.15 72.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.651 1.18 . . . . 75.32 112.515 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -122.87 39.0 4.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.642 0.777 . . . . 65.34 109.889 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.801 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 31.7 ttpt -114.19 153.14 30.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 74.32 111.463 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.2 116.56 10.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.246 1.018 . . . . 54.14 110.539 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -87.2 101.7 13.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.378 1.071 . . . . 74.24 111.93 -173.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.44 HE22 ' HB3' ' C' ' 68' ' ' LEU . 0.1 OUTLIER -150.38 63.07 5.83 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 124.037 0.935 . . . . 75.32 109.683 168.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.26 122.09 6.87 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.099 2.532 . . . . 71.24 111.529 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.07 88.27 7.45 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.62 -1.252 . . . . 75.31 107.62 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.82 119.06 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.072 -1.422 . . . . 71.1 110.903 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -130.9 146.54 52.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.716 0.807 . . . . 71.12 110.396 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.4 ' HB2' HD13 ' C' ' 128' ' ' LEU . 56.1 tp -116.15 124.23 49.8 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.11 0.964 . . . . 73.33 109.201 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.515 ' HA ' HD12 ' E' ' 186' ' ' LEU . 8.9 m-20 -119.21 116.84 27.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.843 0.857 . . . . 74.12 109.664 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.492 ' H ' HD23 ' E' ' 186' ' ' LEU . 5.8 mp -101.2 126.96 47.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.317 -0.994 . . . . 75.54 108.317 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -134.4 151.46 51.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.294 1.038 . . . . 74.13 108.863 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 24.5 m -112.17 115.83 29.48 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.108 0.563 . . . . 74.01 110.311 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.67 147.76 44.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.246 -1.02 . . . . 75.52 108.246 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -163.08 145.15 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.744 0.418 . . . . 70.22 110.649 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.2 t -145.35 125.98 14.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.214 1.005 . . . . 64.02 108.413 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.01 126.09 30.35 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.843 -0.428 . . . . 72.15 109.843 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.498 HD13 HD13 ' C' ' 83' ' ' ILE . 87.3 mt -91.34 -52.2 4.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.401 0.681 . . . . 75.02 110.675 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.83 -170.77 3.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.921 0.888 . . . . 75.23 110.646 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.13 117.89 7.76 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.184 -0.673 . . . . 71.24 109.184 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 64.76 12.19 7.46 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 124.232 0.958 . . . . 73.42 112.186 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.4 t -121.74 122.93 68.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.621 -1.252 . . . . 75.12 107.621 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.418 ' OH ' ' HB3' ' C' ' 98' ' ' LEU . 0.1 OUTLIER -138.99 157.91 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 175.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -105.02 116.29 31.7 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.575 -1.193 . . . . 74.42 108.563 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.98 132.03 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.911 -1.144 . . . . 72.23 107.911 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.5 t -128.0 111.25 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.205 -1.406 . . . . 64.33 107.205 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.417 HD23 HG21 ' C' ' 62' ' ' VAL . 0.3 OUTLIER -85.76 108.9 18.29 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.922 -1.51 . . . . 75.15 106.922 178.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -81.22 104.81 11.94 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.909 -1.145 . . . . 75.44 107.909 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.417 HG21 HD23 ' C' ' 60' ' ' LEU . 43.9 t -111.68 107.42 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.218 -0.66 . . . . 72.35 109.218 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -104.0 145.91 29.47 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.352 0.661 . . . . 74.04 109.285 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.654 HG21 HG23 ' C' ' 114' ' ' ILE . 38.9 t -140.54 117.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 124.706 1.202 . . . . 74.24 108.081 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -111.98 141.62 45.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.833 0.349 . . . . 63.25 110.097 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.37 103.17 6.29 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 107.155 -1.424 . . . . 64.42 107.155 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.1 m -125.55 137.9 53.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.163 0.506 . . . . 71.34 110.591 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.44 ' HB3' HE22 ' C' ' 37' ' ' GLN . 10.9 mt -89.51 37.55 0.87 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.859 1.264 . . . . 73.31 109.308 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.67 -115.47 5.11 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.213 -1.155 . . . . 72.34 110.213 -166.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.37 -31.48 16.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.582 0.753 . . . . 74.14 110.107 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.86 105.76 3.93 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.054 0.942 . . . . 64.04 108.922 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.06 135.61 37.76 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 122.27 -0.269 . . . . 74.13 110.95 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.55 -56.46 4.29 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.807 -0.812 . . . . 62.01 108.807 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -161.2 173.4 15.14 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.516 -0.765 . . . . 72.5 111.46 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.3 tm? -136.82 141.16 42.87 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.146 -1.428 . . . . 73.42 107.146 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.513 ' SG ' HG21 ' C' ' 114' ' ' ILE . 35.4 t -141.68 139.57 33.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.768 -1.197 . . . . 62.22 107.768 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.49 116.25 3.86 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.141 -0.689 . . . . 75.53 109.141 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -120.9 140.11 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.836 0.854 . . . . 74.51 109.623 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -107.7 109.02 20.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.941 0.896 . . . . 73.41 109.123 168.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -89.4 107.74 19.24 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.119 -0.697 . . . . 72.04 109.119 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.4 22.15 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.61 0.569 . . . . 53.03 112.033 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.524 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.43 116.83 0.77 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.694 -0.962 . . . . 73.32 110.694 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 13.7 mm -88.7 119.12 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.56 -0.904 . . . . 75.32 108.56 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 135.65 54.81 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.413 0.685 . . . . 75.0 109.725 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -103.47 99.66 9.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.845 -1.168 . . . . 60.34 107.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.82 156.23 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.096 0.558 . . . . 75.02 110.202 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.08 157.36 2.29 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.723 1.209 . . . . 71.23 108.949 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -18.27 54.26 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 120.333 -0.148 . . . . 73.44 113.178 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.708 HD11 ' HA ' ' C' ' 94' ' ' MET . 46.1 pt -76.31 165.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.126 0.57 . . . . 72.41 111.301 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.603 ' HG3' ' HA ' ' E' ' 171' ' ' SER . 37.5 tt0 -170.96 147.1 2.6 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.041 0.937 . . . . 70.14 108.911 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.72 -108.15 0.48 Allowed Glycine 0 C--N 1.362 1.997 0 O-C-N 124.108 0.88 . . . . 72.14 114.324 170.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.0 p -58.84 -47.61 84.24 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.663 1.185 . . . . 73.54 111.649 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.94 -32.33 73.51 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.101 0.56 . . . . 75.15 111.022 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.708 ' HA ' HD11 ' C' ' 89' ' ' ILE . 25.6 tpp -59.29 -55.37 35.65 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.536 0.523 . . . . 75.43 110.101 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.96 -34.6 78.47 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.644 -0.707 . . . . 74.41 112.229 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -77.78 -34.08 52.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.671 0.388 . . . . 75.23 111.772 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -68.8 -60.66 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.775 0.43 . . . . 70.24 110.755 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.707 HD22 ' SD ' ' C' ' 94' ' ' MET . 1.5 pp -94.43 -19.14 20.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.891 0.7 . . . . 75.22 112.891 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 6.73 73.76 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.785 -0.453 . . . . 71.5 113.326 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.69 -56.53 0.07 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.668 0.387 . . . . 72.25 111.873 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.53 -53.82 9.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.957 0.725 . . . . 71.25 112.957 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.35 -43.41 79.54 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 123.685 0.794 . . . . 72.4 112.456 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.04 -30.44 66.25 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 121.308 1.339 . . . . 75.04 112.706 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -66.64 -32.7 74.18 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.217 0.462 . . . . 72.31 110.315 177.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.422 HD13 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -60.22 -44.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.291 0.567 . . . . 72.14 109.903 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.524 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.8 mt -78.68 -21.12 48.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.9 -1.046 . . . . 74.55 111.926 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -56.69 -55.36 43.97 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 117.434 -1.27 . . . . 73.52 113.631 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.91 -30.7 84.15 Favored 'Trans proline' 0 C--N 1.377 2.03 0 CA-C-N 121.571 1.597 . . . . 74.51 112.732 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -63.39 -50.85 68.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.626 0.77 . . . . 75.01 110.83 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.42 -42.33 98.73 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.229 1.012 . . . . 70.32 111.225 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -61.12 -44.17 97.76 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.405 1.882 . . . . 74.23 110.521 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.2 -35.11 63.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.347 0.659 . . . . 64.11 110.3 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.5 t -64.1 -34.43 78.03 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.504 0.722 . . . . 73.34 111.357 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.654 HG23 HG21 ' C' ' 64' ' ' VAL . 97.3 mt -73.28 -45.01 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.805 0.842 . . . . 75.33 111.349 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.4 m -57.83 -35.39 70.83 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.803 0.441 . . . . 75.42 111.787 -177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.1 -48.66 70.16 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.29 -0.633 . . . . 71.43 109.29 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.596 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.34 -39.46 70.03 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.872 1.269 . . . . 73.12 113.144 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.407 HG22 ' HB3' ' C' ' 126' ' ' LEU . 94.2 t -62.09 -48.23 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.218 0.532 . . . . 74.3 110.399 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.9 t -66.52 -28.66 68.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.079 -0.964 . . . . 70.31 111.843 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.596 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 84.6 mtt-85 -67.16 -40.62 86.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.068 -0.715 . . . . 75.41 109.068 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.65 5.04 66.13 Favored Glycine 0 C--N 1.358 1.789 0 O-C-N 124.038 0.836 . . . . 71.34 112.912 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.549 HG21 ' HB3' ' D' ' 17' ' ' TYR . 29.9 p 56.1 53.66 8.8 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.063 1.745 . . . . 72.12 111.939 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.507 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 56.4 m-85 -113.22 172.57 3.44 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 114.516 -1.22 . . . . 74.22 109.492 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 18.3 Cg_endo -56.59 171.49 0.96 Allowed 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.639 2.226 . . . . 70.14 113.327 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.507 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 9.0 tm0? -60.53 140.7 57.21 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.377 -0.972 . . . . 73.42 108.377 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.407 ' HB3' HG22 ' C' ' 118' ' ' VAL . 9.5 tp -151.03 83.34 1.33 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.975 0.893 . . . . 73.31 110.363 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.99 98.42 3.75 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.812 -1.54 . . . . 73.51 107.092 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' C' ' 42' ' ' LEU . 49.8 mt -78.5 149.26 33.17 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.636 -0.505 . . . . 75.25 109.636 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.86 155.5 82.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.926 0.89 . . . . 61.1 112.749 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.87 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 76.6 Cg_exo -54.74 132.5 52.09 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.926 3.084 . . . . 73.01 113.949 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -111.37 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.798 -1.186 . . . . 63.34 107.798 174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -87.59 68.75 9.63 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.543 0.687 . . . . 71.43 110.0 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.403 ' HA ' HG13 ' F' ' 207' ' ' VAL . 71.5 t80 -72.09 -18.93 61.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.155 -0.929 . . . . 74.22 110.929 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.6 -32.27 71.4 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.353 0.661 . . . . 74.32 110.638 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.09 91.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.825 0.85 . . . . 75.42 111.356 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.94 -47.48 65.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.824 -0.806 . . . . 74.44 108.824 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -65.55 -24.84 67.2 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.68 1.192 . . . . 74.24 110.821 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.4 -59.33 4.48 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.231 1.012 . . . . 73.13 110.438 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.13 -35.02 78.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.856 0.862 . . . . 72.01 111.459 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -49.72 -80.58 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.559 1.544 . . . . 75.23 112.661 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -72.25 92.25 1.37 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.176 -0.675 . . . . 73.45 109.176 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -103.9 -5.6 22.15 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.115 0.783 . . . . 73.22 113.115 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -79.64 140.54 37.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.915 0.325 . . . . 74.52 111.54 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.7 121.32 0.69 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.334 1.054 . . . . 74.43 108.872 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.34 -178.19 0.18 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.643 1.177 . . . . 74.33 112.858 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.71 37.27 1.85 Allowed Glycine 0 N--CA 1.473 1.131 0 CA-C-N 116.045 -0.525 . . . . 75.23 112.346 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.654 ' HG3' ' HE3' ' A' ' 1' ' ' MET . 35.6 tt0 -154.84 148.68 25.58 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.988 0.915 . . . . 72.11 109.065 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.37 162.96 36.76 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 121.683 -0.294 . . . . 74.35 113.522 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 12.4 t -86.94 175.08 8.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.45 0.7 . . . . 64.42 110.912 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.39 17.99 0.34 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.126 0.97 . . . . 74.41 110.067 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.25 120.97 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.696 0.798 . . . . 74.11 110.911 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -82.03 92.95 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.645 -0.872 . . . . 70.12 108.645 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -80.24 82.17 6.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.699 -0.852 . . . . 75.21 108.699 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.84 154.87 17.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.395 -0.821 . . . . 71.44 109.675 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 C-N-CA 123.588 0.755 . . . . 61.4 108.97 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.821 -0.436 . . . . 74.14 109.821 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -160.3 81.05 0.68 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.549 1.14 . . . . 75.54 108.28 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' H' ' 172' ' ' ALA . 0.4 OUTLIER -136.8 70.26 1.41 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.255 1.026 . . . . 71.12 109.464 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -121.55 74.75 1.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.868 -1.06 . . . . 75.35 108.438 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -171.97 -176.76 1.76 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.835 -1.075 . . . . 73.21 108.21 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.49 80.56 0.1 Allowed 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 109.009 -0.737 . . . . 73.1 109.009 167.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -165.2 76.78 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.414 1.086 . . . . 74.33 108.532 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.11 172.74 10.51 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 115.14 -0.936 . . . . 71.51 109.079 169.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.49 ' SD ' HG22 ' D' ' 89' ' ' ILE . 11.1 tpt -33.43 124.26 0.41 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.416 1.086 . . . . 71.32 112.659 169.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.469 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 79.7 m -141.52 137.29 31.93 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.141 0.976 . . . . 71.45 109.507 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.52 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.7 t80 -156.31 104.72 2.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.212 -1.403 . . . . 75.0 107.212 172.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -110.35 112.08 23.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.926 -1.138 . . . . 74.01 107.926 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 tt -80.36 98.63 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.102 -1.444 . . . . 75.3 107.102 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.66 -50.04 7.51 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.6 -167.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -162.3 119.08 2.03 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.663 -0.495 . . . . 74.55 109.663 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.473 HG12 ' HG3' ' B' ' 130' ' ' PRO . 28.3 mm -111.49 118.21 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.897 -1.149 . . . . 74.35 107.897 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.549 ' HB3' HG21 ' C' ' 122' ' ' THR . 1.5 p90 -148.5 146.59 28.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.28 0.632 . . . . 75.11 111.232 -171.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 50.0 p -75.98 113.04 13.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.021 -0.99 . . . . 72.11 109.938 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -80.92 -36.03 31.59 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.415 -0.587 . . . . 75.44 109.415 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -144.77 137.59 26.56 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.081 -0.963 . . . . 72.54 109.617 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.58 HG23 ' HE1' ' C' ' 117' ' ' MET . 78.2 mt -137.55 139.63 43.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.872 -1.159 . . . . 65.31 107.872 174.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -142.09 140.72 32.61 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.498 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -151.8 120.95 6.72 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.625 -1.621 . . . . 72.21 106.625 173.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.04 112.95 11.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 64.15 109.778 -175.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -110.45 84.18 3.75 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.682 0.793 . . . . 64.13 109.581 177.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 -26.97 11.44 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.051 2.5 . . . . 73.33 113.183 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -114.82 25.35 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.922 0.889 . . . . 74.51 109.847 -174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.426 ' HB2' ' HE2' ' C' ' 17' ' ' TYR . . . -58.72 -57.42 26.86 Favored Pre-proline 0 CA--C 1.564 1.497 0 N-CA-C 115.038 1.496 . . . . 74.12 115.038 -164.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.604 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 86.6 Cg_endo -78.42 -15.07 14.25 Favored 'Trans proline' 0 C--N 1.38 2.217 0 CA-C-N 122.06 1.771 . . . . 75.22 112.799 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.42 -44.24 68.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.041 0.936 . . . . 74.12 109.543 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.519 HG23 ' HD2' ' D' ' 34' ' ' LYS . 2.1 p -84.38 0.77 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.61 0.764 . . . . 75.35 110.981 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.41 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 84.2 t80 -63.36 -17.33 62.49 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.464 1.106 . . . . 73.4 111.169 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -81.32 -1.31 44.77 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.69 0.796 . . . . 75.21 112.104 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.547 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 96.5 mttt -121.8 113.27 19.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.877 0.871 . . . . 74.15 112.446 -167.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.98 79.84 2.24 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.222 1.011 . . . . 73.13 111.228 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -127.04 171.38 11.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.508 -0.745 . . . . 75.24 110.572 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.482 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 29.4 tp60 -85.04 120.55 73.68 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.605 -1.257 . . . . 75.2 107.605 164.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.482 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 31.8 Cg_exo -57.4 114.5 1.97 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.977 1.784 . . . . 75.33 110.972 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -65.8 112.39 3.71 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 106.71 -1.589 . . . . 74.12 106.71 167.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.675 HG13 HG13 ' D' ' 64' ' ' VAL . 71.2 t -116.34 111.66 36.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 123.188 0.595 . . . . 73.12 109.591 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -87.21 133.67 33.63 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.961 -1.125 . . . . 75.21 107.961 169.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.15 127.41 53.79 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.706 -1.22 . . . . 75.43 107.706 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.559 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.2 t70 -112.76 125.18 54.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.228 -0.656 . . . . 70.44 109.228 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.613 ' HB2' HD13 ' H' ' 186' ' ' LEU . 62.0 tp -97.05 131.6 43.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.114 0.965 . . . . 73.4 109.758 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.0 t70 -147.59 155.45 41.84 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.631 -0.877 . . . . 71.21 108.631 168.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -146.28 151.36 37.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.384 0.674 . . . . 63.14 109.759 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.04 172.6 14.98 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.177 0.991 . . . . 74.14 108.853 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.2 p -163.76 163.68 23.97 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.729 0.412 . . . . 64.44 110.73 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 54.9 p -154.04 139.59 17.84 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.401 0.68 . . . . 74.41 109.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.15 122.98 25.1 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 110.207 -0.294 . . . . 71.23 110.207 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.0 mt -94.64 -35.99 11.96 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.631 0.582 . . . . 73.43 109.639 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.83 -176.6 5.34 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.038 0.935 . . . . 53.23 110.008 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.76 128.13 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.79 -0.641 . . . . 74.02 109.314 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 61.08 26.42 16.35 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.933 0.893 . . . . 63.42 110.854 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -139.68 122.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 C-N-CA 124.105 0.962 . . . . 72.32 109.717 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -136.07 137.37 41.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 73.32 108.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.486 ' HB2' HD11 ' D' ' 51' ' ' LEU . 20.5 tt0 -88.29 118.6 28.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.235 -1.024 . . . . 72.53 108.235 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.44 140.29 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.128 -1.064 . . . . 75.52 108.128 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.2 t -121.87 143.06 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.437 1.095 . . . . 72.42 108.997 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -119.74 126.83 52.03 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.511 -1.292 . . . . 72.25 107.511 174.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.3 ttm-85 -106.66 104.44 14.12 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.339 -0.986 . . . . 73.23 108.339 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 128.19 48.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.799 -1.186 . . . . 73.3 107.799 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.4 m -120.9 129.0 53.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.987 -0.375 . . . . 72.35 109.987 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.675 HG13 HG13 ' D' ' 40' ' ' VAL . 71.7 t -111.95 109.1 27.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 125.365 1.466 . . . . 71.11 109.318 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -102.17 93.75 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.397 -1.334 . . . . 74.13 107.397 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.92 144.01 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.586 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.407 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 18.5 m -142.87 135.72 27.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.451 0.469 . . . . 75.23 112.196 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' D' ' 73' ' ' ALA . 52.0 mt -116.65 125.44 51.77 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.87 0.868 . . . . 73.42 109.176 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.48 -113.09 4.11 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.143 -0.383 . . . . 42.01 112.143 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 7.01 10.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.273 0.629 . . . . 71.5 110.865 -176.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.547 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 15.2 pt-20 -129.42 174.62 9.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.37 0.668 . . . . 73.22 110.212 -175.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -72.62 132.85 44.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.541 -0.754 . . . . 73.22 110.91 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.517 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . . . -82.04 -57.98 3.17 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.62 -0.882 . . . . 72.34 108.62 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -164.8 165.53 20.52 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 113.623 -1.626 . . . . 74.11 108.921 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -122.77 153.45 39.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.452 -1.314 . . . . 74.24 107.452 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.562 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 40.1 t -158.7 146.91 18.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.742 0.417 . . . . 75.13 110.098 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.67 128.92 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.181 -0.674 . . . . 75.44 109.181 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.44 114.18 32.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.214 -0.662 . . . . 65.14 109.214 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.726 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.8 mt-30 -89.46 86.24 6.73 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.56 104.44 10.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 113.868 -1.515 . . . . 74.51 108.729 177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.35 164.74 28.41 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 111.848 -0.501 . . . . 61.22 111.848 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.65 131.82 2.56 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.774 -0.531 . . . . 73.54 111.774 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.45 HG22 HD13 ' D' ' 51' ' ' LEU . 59.1 mt -87.88 132.24 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.957 -0.757 . . . . 72.23 108.957 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.38 145.49 47.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.54 0.736 . . . . 73.32 110.075 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 67.0 m -96.34 136.91 36.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.019 -0.734 . . . . 71.25 109.019 167.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.438 ' HB ' ' HE3' ' H' ' 174' ' ' MET . 25.8 pt -127.35 126.49 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.401 1.081 . . . . 74.14 110.134 -176.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.469 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -167.93 156.03 8.84 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.733 0.813 . . . . 64.41 110.066 175.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 88.18 -20.68 28.37 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 120.147 -0.252 . . . . 74.44 112.951 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.49 HG22 ' SD ' ' D' ' 9' ' ' MET . 0.2 OUTLIER -116.83 157.94 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.12 0.968 . . . . 75.2 109.295 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.723 ' HA ' ' HG2' ' H' ' 174' ' ' MET . 0.3 OUTLIER -160.85 175.0 13.04 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.03 0.381 . . . . 75.23 112.03 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -133.45 46.79 Favored Glycine 0 C--N 1.355 1.596 0 O-C-N 124.153 0.908 . . . . 73.4 114.073 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.853 0.861 . . . . 74.51 111.398 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -58.77 -45.28 90.14 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.056 0.943 . . . . 74.22 110.074 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.72 ' SD ' HD22 ' D' ' 98' ' ' LEU . 1.7 tmt? -81.85 -30.74 31.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.097 -0.956 . . . . 73.21 110.982 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.27 75.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.133 0.573 . . . . 71.03 110.93 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -73.52 -38.42 65.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.92 -0.582 . . . . 74.21 109.957 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.1 t -62.5 -49.2 76.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.055 0.542 . . . . 73.54 111.575 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.72 HD22 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -69.03 -29.59 67.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.21 0.604 . . . . 74.34 111.973 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.19 -18.05 37.97 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.684 0.615 . . . . 63.02 113.342 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . . . -122.44 -65.17 1.13 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.859 0.464 . . . . 73.34 111.396 -175.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -67.66 -49.72 61.42 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.556 0.576 . . . . 73.35 112.556 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.465 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.4 m -61.85 -47.42 91.69 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.521 0.728 . . . . 31.25 111.837 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.545 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -61.25 -34.96 87.21 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.48 2.12 . . . . 73.41 112.854 169.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -64.73 -29.54 70.52 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.049 0.54 . . . . 62.41 110.718 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.95 -42.81 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.401 0.681 . . . . 73.25 110.388 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' D' ' 60' ' ' LEU . 63.9 mt -72.46 -23.74 61.1 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.201 -0.909 . . . . 71.22 111.222 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -64.91 -42.5 63.04 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.609 1.337 . . . . 72.12 114.609 -170.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.35 -41.4 59.34 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.115 1.876 . . . . 75.41 113.552 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -77.99 -36.83 48.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.81 0.844 . . . . 75.41 111.303 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.54 82.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.312 0.645 . . . . 72.21 109.895 176.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -54.59 -54.64 38.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.84 1.256 . . . . 74.41 110.467 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.1 -40.33 94.4 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.301 1.001 . . . . 74.22 111.381 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.411 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.4 t -57.41 -44.7 84.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.388 0.43 . . . . 75.43 110.406 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.498 HG12 ' SG ' ' D' ' 76' ' ' CYS . 86.7 mt -63.09 -55.15 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.164 -0.925 . . . . 75.34 110.238 173.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.52 HG21 ' HG3' ' D' ' 125' ' ' GLN . 95.7 m -50.09 -48.48 53.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.306 1.442 . . . . 72.23 111.882 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.7 t -65.1 -41.91 94.51 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.76 -1.109 . . . . 71.42 109.932 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.409 ' HG2' HD11 ' C' ' 21' ' ' ILE . 74.1 mtm -65.51 -36.84 85.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.154 0.581 . . . . 72.23 111.251 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -62.36 -49.54 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.461 -0.791 . . . . 74.15 109.91 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -71.32 -27.63 63.53 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.167 0.587 . . . . 72.04 111.403 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -73.47 -31.07 63.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.846 0.859 . . . . 75.42 110.178 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.42 5.41 68.31 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.675 0.61 . . . . 53.31 112.16 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.0 p 60.94 27.57 17.42 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 126.554 1.942 . . . . 75.33 112.663 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -93.32 162.47 27.96 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.826 1.251 . . . . 74.14 109.728 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.429 ' HD3' ' CZ ' ' H' ' 195' ' ' PHE . 19.8 Cg_exo -66.56 134.85 36.93 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.979 2.453 . . . . 74.01 111.485 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.52 ' HG3' HG21 ' D' ' 115' ' ' THR . 47.6 tt0 -55.59 134.21 50.85 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 124.314 1.009 . . . . 70.31 111.988 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 tp -106.58 96.5 6.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.129 -0.693 . . . . 74.22 109.129 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -99.55 84.74 3.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.368 -0.604 . . . . 72.31 109.368 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.76 129.24 39.31 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.726 -0.67 . . . . 73.32 110.631 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' G' ' 204' ' ' ILE . . . -68.26 140.46 92.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 123.243 0.617 . . . . 65.31 111.613 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -82.38 122.36 3.63 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.25 1.967 . . . . 74.41 109.689 171.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.2 m -107.47 134.82 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.188 0.518 . . . . 73.23 110.088 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -83.96 96.54 8.87 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.892 0.853 . . . . 71.44 109.716 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' D' ' 100' ' ' ALA . 80.8 m-85 -61.6 -21.74 64.6 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.943 -1.026 . . . . 73.34 112.033 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.85 -49.25 78.23 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.47 1.108 . . . . 73.22 111.587 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.22 74.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.532 -0.758 . . . . 75.43 111.041 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.56 -32.43 73.77 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.926 0.766 . . . . 73.02 110.215 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.492 ' HA ' ' HZ ' ' H' ' 182' ' ' PHE . 91.5 t80 -58.8 -56.24 24.71 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.041 0.536 . . . . 71.3 110.146 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 67.6 mtm -64.15 -42.6 96.7 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.279 -0.873 . . . . 63.44 110.691 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -62.92 -42.99 99.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 74.11 112.096 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -70.73 -39.86 73.12 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.585 0.754 . . . . 73.14 111.53 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 95.2 mt -59.79 -29.48 68.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.317 0.647 . . . . 74.33 111.856 -177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.33 0.36 49.5 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.627 0.771 . . . . 73.24 111.936 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -121.32 83.02 2.01 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.636 0.774 . . . . 75.44 109.593 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -164.12 18.2 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.391 0.615 . . . . 63.31 110.795 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.8 112.54 20.19 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.62 0.768 . . . . 74.32 109.896 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.27 153.69 25.49 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 122.919 0.137 . . . . 75.33 113.214 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.49 -162.7 1.61 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.026 0.931 . . . . 73.3 110.13 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.44 157.11 7.12 Favored Glycine 0 C--N 1.353 1.524 0 C-N-CA 122.579 0.133 . . . . 62.41 113.255 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.4 t -94.26 24.46 4.4 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.508 0.723 . . . . 64.5 109.794 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -76.71 134.37 39.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.647 0.779 . . . . 74.2 110.694 -175.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.68 102.25 4.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.221 0.608 . . . . 75.13 109.369 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -168.29 161.65 12.24 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.267 1.027 . . . . 75.13 109.515 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -84.76 83.2 8.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.41 -0.589 . . . . 74.42 109.41 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.27 95.45 3.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.155 0.982 . . . . 73.31 110.074 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.195 0 N-CA-C 109.062 -0.718 . . . . 73.21 109.062 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.242 -0.281 . . . . 75.35 110.242 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 162.35 66.39 0.02 OUTLIER Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.891 -0.483 . . . . 71.11 111.891 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.3 130.94 45.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.705 0.402 . . . . 73.44 110.639 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 171' ' ' SER . . . . . 0.603 ' HA ' ' HG3' ' C' ' 90' ' ' GLU . 52.3 m -65.63 122.17 16.64 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.132 0.895 . . . . 70.02 110.716 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.14 1.75 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.639 0.775 . . . . 75.24 109.089 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' E' ' 174' ' ' MET . 0.0 OUTLIER -89.05 -28.27 20.25 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.484 0.714 . . . . 71.12 112.749 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.505 ' HB2' HD22 ' E' ' 173' ' ' LEU . 0.0 OUTLIER -117.78 -75.42 0.58 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.908 0.483 . . . . 74.5 109.917 -172.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -165.91 89.78 0.43 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -115.29 35.31 4.43 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.031 0.92 . . . . 74.43 109.64 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.19 172.63 16.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.693 . . . . 75.11 109.703 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -122.89 -54.99 1.81 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.067 -0.716 . . . . 70.12 109.067 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -116.46 156.34 47.54 Favored Pre-proline 0 C--O 1.249 1.059 0 CA-C-N 114.986 -1.006 . . . . 72.1 109.254 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.17 164.43 33.99 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.267 1.978 . . . . 72.03 111.37 172.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.47 -35.24 67.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.692 0.797 . . . . 75.23 111.445 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -147.21 154.24 40.79 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.262 1.025 . . . . 74.3 108.826 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 13.4 t -80.85 157.25 25.74 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.958 0.503 . . . . 74.21 110.215 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.04 151.75 43.52 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.781 0.832 . . . . 65.15 111.914 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.51 136.86 56.74 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.996 2.464 . . . . 73.25 112.175 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' C' ' 43' ' ' ASP . 67.5 mt -106.32 143.43 34.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 74.24 109.784 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 tt -91.06 146.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 122.999 0.52 . . . . 72.22 110.159 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.71 146.36 28.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.653 0.781 . . . . 75.22 109.232 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -108.39 128.22 54.58 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.924 -0.769 . . . . 73.12 108.924 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.04 132.64 51.17 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.89 0.744 . . . . 74.55 109.753 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.04 56.31 4.32 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.322 0.389 . . . . 63.31 113.191 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -76.0 76.48 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.906 -0.877 . . . . 72.33 110.906 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 57.06 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.263 1.425 . . . . 75.25 112.581 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . 0.614 ' HB2' ' HE2' ' F' ' 201' ' ' LYS . . . 60.72 -166.39 0.2 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.564 0.745 . . . . 64.03 110.336 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 9.4 t80 55.92 97.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.637 1.175 . . . . 75.44 112.565 169.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -66.82 93.39 0.26 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.51 -0.552 . . . . 74.44 109.51 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 69.32 7.36 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.054 -1.091 . . . . 75.4 108.054 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -60.94 -49.97 75.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.251 1.02 . . . . 72.14 109.774 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . 0.458 ' HB3' ' HA ' ' E' ' 202' ' ' TYR . 56.6 t-20 -169.37 133.8 1.41 Allowed 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.936 -1.505 . . . . 74.12 106.936 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.55 -22.57 66.01 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.512 0.507 . . . . 72.41 113.557 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -112.72 -8.55 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.384 0.674 . . . . 73.32 111.947 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . 0.518 ' CD2' ' HB3' ' B' ' 129' ' ' ALA . 87.8 m-85 63.92 -159.15 0.31 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.312 1.045 . . . . 70.32 110.371 -167.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.73 82.78 6.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.082 0.553 . . . . 74.11 110.755 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.25 99.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.696 0.799 . . . . 74.52 109.703 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -158.07 -57.28 0.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.413 -0.958 . . . . 74.41 108.413 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.64 -5.33 57.97 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.667 -1.151 . . . . 75.23 111.266 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.439 HG22 ' HG2' ' F' ' 185' ' ' PRO . 48.3 t . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 118.392 -0.813 . . . . 72.34 108.851 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . 0.598 ' HD2' ' H1 ' ' F' ' 168' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.092 -0.336 . . . . 74.11 110.092 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.56 35.45 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 116.308 -0.405 . . . . 72.21 112.346 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -120.21 -69.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.129 0.572 . . . . 74.03 109.885 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 22.8 t -168.05 -151.59 0.11 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.812 -1.181 . . . . 72.15 107.812 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . 0.429 ' HB1' ' HA ' ' B' ' 90' ' ' GLU . . . -68.65 -12.39 61.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.94 0.496 . . . . 73.5 112.011 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.2 146.63 24.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.725 0.81 . . . . 72.22 110.288 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.447 ' HG3' ' NE2' ' B' ' 50' ' ' GLN . 31.8 mmt 66.95 -75.88 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.386 1.474 . . . . 71.31 111.85 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.43 91.94 3.76 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.199 -0.667 . . . . 71.42 109.199 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -94.98 -47.25 6.49 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.329 0.652 . . . . 70.21 110.423 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.136 0.898 . . . . 75.34 113.217 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 60.82 20.09 10.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.712 1.205 . . . . 73.23 111.693 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.31 148.45 8.14 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.849 0.86 . . . . 73.34 109.102 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.8 97.87 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.677 2.252 . . . . 70.24 111.894 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -71.03 110.76 5.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.929 -0.578 . . . . 74.41 110.385 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 68.68 -65.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.923 1.689 . . . . 74.11 112.904 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 30.8 m 82.04 120.83 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.631 1.972 . . . . 74.54 111.455 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.458 ' CZ2' HD23 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -50.92 141.79 18.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 125.641 1.577 . . . . 74.51 112.615 175.14 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . 0.439 ' HG2' HG22 ' E' ' 207' ' ' VAL . 19.9 Cg_exo -66.98 133.91 32.65 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.998 2.465 . . . . 62.24 112.228 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 43' ' ' ASP . 93.3 mt -99.86 115.71 30.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.828 0.851 . . . . 73.01 109.526 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.49 0.716 . . . . 74.13 111.469 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.52 139.7 33.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.889 0.876 . . . . 62.14 109.764 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.91 -31.31 20.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.376 0.671 . . . . 72.41 111.126 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 21.3 t70 70.55 158.82 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.795 1.238 . . . . 62.42 111.225 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.85 147.24 42.94 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.565 -0.289 . . . . 72.44 112.977 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.42 -153.51 6.55 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 111.705 -0.558 . . . . 61.53 111.705 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -133.1 8.35 4.03 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.521 0.728 . . . . 74.43 111.228 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.92 52.34 1.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 74.02 111.205 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.484 ' HB3' ' HA ' ' B' ' 37' ' ' GLN . 49.7 t80 -174.37 85.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.111 0.964 . . . . 72.25 108.853 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . 0.525 ' HE3' ' HB2' ' F' ' 199' ' ' ASN . 52.0 pttt -175.7 133.88 0.28 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.63 1.172 . . . . 74.25 108.705 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -51.34 -38.57 53.81 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.496 1.119 . . . . 74.45 113.216 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.77 -53.65 54.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 75.33 110.929 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . 0.525 ' HB2' ' HE3' ' F' ' 196' ' ' LYS . 10.4 t-20 -81.39 -12.39 58.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 74.01 110.395 -176.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.02 -152.19 21.19 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.235 -0.893 . . . . 63.02 111.716 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . 0.614 ' HE2' ' HB2' ' E' ' 194' ' ' ALA . 10.8 mptt 68.34 108.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.653 1.181 . . . . 74.43 111.695 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.448 ' CZ ' ' HB3' ' C' ' 125' ' ' GLN . 0.9 OUTLIER 68.49 25.82 6.69 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.354 1.461 . . . . 72.44 111.297 166.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -120.95 -174.15 2.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.694 1.197 . . . . 72.41 109.888 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 21.3 tt -106.19 133.12 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 72.33 110.502 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -115.68 -60.97 1.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.258 0.623 . . . . 75.32 109.577 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.43 122.89 44.59 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.27 -0.877 . . . . 64.12 111.014 -173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' C' ' 133' ' ' PHE . 14.5 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.801 1.64 . . . . 74.4 110.867 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 6.5 mptt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 108.909 -0.774 . . . . 75.33 108.909 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.76 0.22 62.76 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 116.611 -0.268 . . . . 73.15 113.32 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -83.44 -14.05 53.41 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.662 -0.496 . . . . 73.44 109.662 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 17.5 m -78.3 157.97 29.01 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 124.491 1.116 . . . . 72.02 112.1 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . 0.57 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . . . -136.88 3.8 2.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.713 0.805 . . . . 73.3 111.485 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.484 HD11 ' HG2' ' G' ' 174' ' ' MET . 0.8 OUTLIER -59.18 109.53 0.87 Allowed 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.432 0.693 . . . . 74.12 109.643 -173.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.484 ' HG2' HD11 ' G' ' 173' ' ' LEU . 29.3 mmt 75.08 89.15 0.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.806 1.642 . . . . 73.52 110.8 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 71.96 -108.8 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 74.43 111.608 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 8.4 t30 63.63 7.18 2.96 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.768 . . . . 74.04 112.599 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 11.2 mp -57.04 -67.47 0.31 Allowed 'General case' 0 C--N 1.364 1.226 0 C-N-CA 123.079 0.552 . . . . 73.13 109.911 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 60.99 115.41 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.638 1.175 . . . . 73.13 111.287 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 68.9 123.64 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 125.108 1.363 . . . . 73.22 109.844 -168.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.47 113.52 1.53 Allowed 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.422 2.082 . . . . 63.33 111.206 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -111.7 125.42 53.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.251 0.62 . . . . 71.5 109.383 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 66.15 92.97 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.456 1.502 . . . . 72.52 111.711 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 34.0 p -123.33 127.96 49.26 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.537 -0.912 . . . . 73.14 108.537 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -100.5 142.78 25.27 Favored Pre-proline 0 C--O 1.244 0.772 0 C-N-CA 123.964 0.906 . . . . 72.1 110.309 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.35 117.99 2.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.58 2.187 . . . . 71.4 111.715 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . 0.409 HD23 HD21 ' A' ' 44' ' ' LEU . 3.8 mm? -73.06 151.2 41.79 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.454 -0.794 . . . . 71.53 109.678 173.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.67 175.49 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.491 0.716 . . . . 75.13 111.551 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.32 44.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.02 0.528 . . . . 72.42 109.581 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -104.28 121.87 44.23 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.983 -0.747 . . . . 75.31 108.983 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.14 -54.23 49.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.656 1.182 . . . . 74.34 111.395 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.65 -68.78 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.251 -1.139 . . . . 74.41 110.251 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.21 -11.12 70.99 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.56 -0.32 . . . . 64.31 113.607 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -163.19 155.7 18.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.059 0.543 . . . . 71.41 110.533 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -105.85 4.36 29.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.255 1.022 . . . . 64.54 110.408 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 68.41 -171.1 0.18 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.401 1.48 . . . . 73.33 110.396 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -140.58 90.95 2.39 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.412 -0.588 . . . . 74.01 109.412 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -105.48 -31.91 8.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.389 1.076 . . . . 73.33 110.006 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.47 -54.28 43.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.082 0.953 . . . . 74.03 111.051 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -119.97 39.15 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.354 -0.98 . . . . 72.31 108.354 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -141.8 65.25 0.5 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.481 -0.781 . . . . 70.14 111.606 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -115.04 148.97 38.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.976 0.91 . . . . 74.55 108.849 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -73.09 -33.24 65.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.601 0.76 . . . . 71.44 110.476 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.04 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.694 1.998 . . . . 73.35 113.681 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' D' ' 129' ' ' ALA . 63.4 mt -90.93 134.29 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.336 -0.847 . . . . 75.12 110.575 -175.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . 0.567 ' HB2' ' HB2' ' H' ' 188' ' ' ALA . 12.2 mptt -93.61 105.52 17.56 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.365 -1.346 . . . . 72.23 107.365 170.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.48 162.34 29.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.571 0.748 . . . . 73.34 111.291 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.562 1.433 0 CA-C-O 118.386 -0.816 . . . . 71.41 109.967 175.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.324 -0.621 . . . . 73.44 109.324 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 179.59 -83.23 0.06 OUTLIER Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.606 -0.598 . . . . 52.43 111.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -114.2 18.61 16.95 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.149 0.58 . . . . 73.35 110.431 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 61.4 m 62.59 86.53 0.11 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.684 1.194 . . . . 72.33 111.683 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' D' ' 3' ' ' GLU . . . -89.18 23.35 2.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.69 -0.687 . . . . 71.03 111.238 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -61.44 144.63 53.82 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 121.989 0.899 . . . . 74.14 113.214 -166.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.723 ' HG2' ' HA ' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -161.97 168.46 22.81 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.057 -1.883 . . . . 75.42 108.492 -172.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -165.28 -68.51 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.297 -1.001 . . . . 74.11 108.297 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.9 -8.05 1.01 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.857 1.263 . . . . 75.43 113.728 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.56 73.05 10.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.429 0.633 . . . . 72.25 110.236 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.09 -35.15 10.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.243 -1.021 . . . . 73.14 108.243 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -108.42 140.59 21.9 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.074 -1.084 . . . . 74.22 108.074 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.6 -9.18 23.67 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.899 2.399 . . . . 72.33 114.235 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 65.43 -77.03 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.284 1.433 . . . . 73.25 109.524 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' D' ' 137' ' ' PHE . 45.1 p90 -165.16 152.47 10.9 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.655 1.182 . . . . 73.5 108.83 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 38.6 m -89.17 129.57 35.74 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.523 -0.547 . . . . 74.24 109.523 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 30.3 m-90 -73.64 138.08 77.26 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 122.933 0.493 . . . . 75.21 109.933 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.86 144.27 82.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.992 2.462 . . . . 73.24 111.818 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' D' ' 44' ' ' LEU . 89.7 mt -100.13 -164.51 1.13 Allowed 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.573 0.749 . . . . 75.21 111.026 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.463 HG22 ' HB2' ' H' ' 189' ' ' ALA . 3.8 mp -73.08 104.31 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.831 0.852 . . . . 72.21 109.391 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' G' ' 205' ' ' LYS . . . -72.08 85.18 1.01 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.21 -1.033 . . . . 73.3 108.21 168.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . 0.463 ' HB2' HG22 ' H' ' 187' ' ' ILE . . . -105.0 123.61 48.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.029 -0.987 . . . . 74.14 110.187 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -164.46 136.44 4.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.422 0.689 . . . . 72.22 109.573 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . 0.471 ' H ' ' HG2' ' D' ' 37' ' ' GLN . . . -131.74 0.18 4.94 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 124.013 0.82 . . . . 71.21 112.989 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.06 -69.81 2.87 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 117.239 0.52 . . . . 73.21 112.874 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.17 149.6 52.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.86 0.864 . . . . 74.43 110.45 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -154.38 -164.4 1.83 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.721 1.608 . . . . 64.33 107.073 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.429 ' CZ ' ' HD3' ' D' ' 124' ' ' PRO . 0.1 OUTLIER 67.0 177.38 0.24 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.287 0.635 . . . . 75.22 111.742 178.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -172.47 85.15 0.07 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.801 -1.09 . . . . 73.33 109.22 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -86.35 93.96 9.24 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.451 -0.574 . . . . 74.43 109.451 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -140.3 26.7 2.16 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.663 0.744 . . . . 74.42 110.371 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -79.08 -42.67 25.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.53 -0.759 . . . . 73.2 109.642 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 67.15 -83.93 0.12 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.484 -0.78 . . . . 71.32 112.926 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . 0.418 ' HE2' ' HA ' ' H' ' 203' ' ' ASP . 76.6 tttt -142.61 119.96 11.6 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.033 -1.099 . . . . 73.31 108.033 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.23 -32.32 72.98 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 71.1 110.848 172.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . 0.418 ' HA ' ' HE2' ' H' ' 201' ' ' LYS . 15.2 t70 69.9 5.31 5.19 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.986 1.314 . . . . 73.43 111.76 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 22.1 pt -80.83 140.5 16.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 123.883 0.873 . . . . 74.44 111.466 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -154.42 94.82 1.74 Allowed 'General case' 0 C--O 1.243 0.757 0 N-CA-C 106.254 -1.758 . . . . 72.55 106.254 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.0 -81.88 0.08 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 109.057 -0.719 . . . . 72.11 109.057 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.258 1.535 0 N-CA-C 106.944 -1.502 . . . . 73.42 106.944 171.934 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.0 mtp . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.168 -0.678 . . . . 74.2 109.168 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -147.38 123.0 10.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.124 -0.489 . . . . 64.22 110.82 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -102.42 113.4 26.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.443 -0.947 . . . . 71.43 108.443 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.81 -46.96 42.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.194 0.598 . . . . 74.31 111.067 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 61.87 91.47 0.06 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.599 1.16 . . . . 62.31 110.744 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -128.68 154.23 46.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 73.23 109.512 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 m -68.31 155.73 39.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.159 0.984 . . . . 73.21 110.121 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.93 79.82 0.31 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.649 0.78 . . . . 72.13 109.547 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.626 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 24.4 ptm -77.56 164.8 25.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 72.32 111.968 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.4 m -141.58 116.06 9.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.729 0.812 . . . . 71.4 109.365 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -115.83 126.93 54.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.957 -1.497 . . . . 74.35 106.957 165.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 4.1 tp60 -143.56 124.65 14.46 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.082 0.239 . . . . 64.54 110.632 -166.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.62 98.61 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.576 -0.898 . . . . 75.05 108.576 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -82.41 -30.64 30.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.915 -0.564 . . . . 75.44 111.535 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 179.22 121.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.458 0.703 . . . . 74.12 110.084 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.542 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 86.8 mt -105.84 130.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.846 -1.168 . . . . 72.25 107.846 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.69 ' HE2' ' HB3' ' B' ' 28' ' ' ALA . 22.6 p90 -171.95 152.44 2.96 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 124.193 0.933 . . . . 71.34 110.561 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -75.64 119.38 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.215 -0.661 . . . . 74.04 109.215 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 46.2 mtpt -78.69 -46.28 19.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.136 -0.69 . . . . 72.12 109.136 174.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.46 136.73 41.53 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.889 -1.05 . . . . 71.3 109.383 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -129.06 140.72 48.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.354 -1.35 . . . . 74.13 107.354 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -142.96 128.72 19.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.452 0.701 . . . . 74.32 109.436 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 81.8 t80 -139.19 115.86 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.841 -1.541 . . . . 74.13 106.841 171.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -115.89 144.97 43.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.335 -0.987 . . . . 72.33 108.335 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.34 74.29 11.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.248 -1.39 . . . . 50.24 107.248 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.09 -23.34 24.93 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.543 2.162 . . . . 71.33 111.437 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 80.0 m-20 -110.4 33.54 4.44 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.858 -1.065 . . . . 72.41 109.79 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.5 -43.42 95.92 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.28 1.032 . . . . 75.22 113.126 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -69.63 -27.83 26.63 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.715 1.61 . . . . 74.43 113.023 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.6 m170 -72.6 -37.17 68.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.082 0.553 . . . . 72.44 111.077 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 68' ' ' LEU . 13.6 p -68.3 -23.11 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.903 0.881 . . . . 75.33 112.317 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.568 ' HD1' HH11 ' B' ' 15' ' ' ARG . 78.5 t80 -70.39 -35.65 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.882 0.373 . . . . 73.31 110.393 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.73 -46.04 63.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.451 -0.795 . . . . 74.54 109.658 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 3.7 mmmp? -73.17 151.92 41.32 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.425 -1.261 . . . . 73.34 111.201 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.72 136.1 47.06 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.583 -0.735 . . . . 70.42 109.421 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -75.41 84.68 2.53 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.736 0.779 . . . . 71.14 109.261 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -118.23 76.79 12.47 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.882 -1.053 . . . . 64.31 108.434 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.17 125.64 9.91 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.914 1.742 . . . . 75.4 111.627 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -97.26 89.98 4.95 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.706 -1.59 . . . . 75.41 106.706 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.422 HG23 ' HA2' ' G' ' 191' ' ' GLY . 62.0 t -70.72 92.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.529 -0.76 . . . . 75.13 110.5 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.39 115.29 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.452 -0.944 . . . . 73.21 108.452 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.49 151.54 19.9 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.771 -0.826 . . . . 61.03 108.771 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.5 t70 -143.37 147.78 35.2 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.357 -0.979 . . . . 65.03 108.357 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp -134.96 126.31 28.35 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.453 -0.943 . . . . 71.53 108.453 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -143.47 156.66 44.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.609 -0.886 . . . . 42.42 108.609 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -140.3 151.56 45.17 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.095 0.558 . . . . 74.32 110.149 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.7 153.58 49.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.999 1.32 . . . . 70.31 108.088 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.6 m -131.82 157.43 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.867 0.365 . . . . 74.22 110.663 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -148.24 120.69 8.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.657 -0.868 . . . . 75.32 108.657 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -81.99 105.22 12.92 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.772 -0.825 . . . . 74.44 108.772 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.502 HD12 HG22 ' A' ' 83' ' ' ILE . 30.4 mt -84.18 -33.08 24.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.181 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.35 179.8 8.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.028 0.931 . . . . 73.04 109.736 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -70.35 125.03 25.62 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.843 -1.169 . . . . 65.45 107.843 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 75.11 -8.19 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.688 1.595 . . . . 73.54 112.785 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -107.45 110.6 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.683 -0.858 . . . . 71.32 108.683 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -133.65 123.67 25.44 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.271 -0.64 . . . . 74.5 109.271 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 28.0 tt0 -86.62 116.15 24.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.771 -0.649 . . . . 71.33 109.271 175.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.51 115.6 42.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 N-CA-C 107.233 -1.395 . . . . 63.24 107.233 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.565 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.3 t -98.78 136.6 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.694 0.798 . . . . 74.25 109.037 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.45 111.67 23.34 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.562 -1.273 . . . . 75.24 107.562 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.01 101.95 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.399 -0.963 . . . . 72.14 108.399 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.29 135.8 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.601 -1.259 . . . . 75.23 107.601 175.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 11.8 m -128.73 144.16 51.1 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.768 -0.456 . . . . 74.42 109.768 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 10.0 t -140.77 125.67 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.672 1.589 . . . . 75.33 107.793 -171.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -129.36 131.92 46.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.698 -0.482 . . . . 74.24 109.698 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.34 108.53 18.64 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.663 -0.866 . . . . 70.24 108.663 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.4 m -108.85 139.32 43.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.001 0.52 . . . . 74.11 110.17 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 31' ' ' VAL . 6.2 mt -113.65 78.48 1.15 Allowed 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.273 -1.01 . . . . 71.25 108.273 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.54 -86.13 1.24 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.97 -0.852 . . . . 44.32 110.97 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -131.05 -8.09 3.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.423 1.089 . . . . 71.32 111.303 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -99.71 110.35 22.75 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.264 -0.643 . . . . 71.41 109.264 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.0 m -70.76 132.12 44.87 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 110.056 -0.349 . . . . 73.32 110.056 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -77.21 -60.53 2.33 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.07 0.948 . . . . 74.23 109.367 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -151.99 172.18 16.67 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 114.613 -1.176 . . . . 74.33 111.075 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 HD11 ' H ' ' A' ' 76' ' ' CYS . 38.7 tp -132.57 147.43 52.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.903 1.281 . . . . 71.1 108.521 172.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -135.66 136.15 40.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.499 1.12 . . . . 72.41 109.145 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -147.37 129.28 15.34 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.489 -0.93 . . . . 75.54 108.489 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.21 109.56 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.959 -0.756 . . . . 72.32 108.959 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.57 82.84 8.09 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.186 -1.042 . . . . 74.13 108.186 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.0 tp-100 -75.69 92.26 2.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.553 -1.203 . . . . 71.5 108.403 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.68 144.23 21.17 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.315 -0.714 . . . . 63.44 111.315 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.89 118.26 1.22 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 110.11 -1.196 . . . . 63.24 110.11 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.612 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.4 mt -81.25 124.12 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.581 -1.266 . . . . 72.31 107.581 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 49.4 m-85 -133.35 121.05 21.78 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.411 -0.588 . . . . 73.42 109.411 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 22.4 t -79.36 96.67 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.026 -1.101 . . . . 71.03 108.026 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.531 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -121.2 128.07 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.067 -0.97 . . . . 75.14 109.418 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -174.15 178.15 2.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.535 1.134 . . . . 72.45 110.43 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.626 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 85.69 4.38 85.29 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.928 -0.578 . . . . 72.31 113.951 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.509 HD13 HD13 ' G' ' 173' ' ' LEU . 2.0 pp -114.21 153.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.983 0.913 . . . . 63.42 109.546 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -144.33 168.94 18.9 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 109.27 -0.641 . . . . 71.44 109.27 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.506 ' HA2' ' H ' ' G' ' 170' ' ' LYS . . . 54.77 -127.29 40.24 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.727 0.642 . . . . 74.13 114.688 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.6 p -62.25 -26.36 68.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.43 1.092 . . . . 72.11 112.077 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -64.07 -36.41 83.92 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.903 0.881 . . . . 75.32 111.074 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 77.7 mtp -67.27 -45.38 76.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.622 0.769 . . . . 74.15 110.2 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.85 71.98 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.884 -1.053 . . . . 72.53 111.255 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -66.96 -44.32 80.82 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.966 0.906 . . . . 73.12 110.362 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.57 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 14.3 t -71.81 -63.24 1.17 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.624 0.577 . . . . 73.33 110.791 -171.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.535 ' HB2' HD23 ' G' ' 173' ' ' LEU . 49.2 tp -68.75 -38.39 80.08 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 120.555 0.217 . . . . 72.43 111.525 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.15 -9.33 84.21 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.347 -0.696 . . . . 64.21 114.715 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.32 -53.68 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.904 0.852 . . . . 75.44 112.743 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.57 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 89.9 t80 -72.99 -60.97 1.98 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.72 0.808 . . . . 72.41 113.156 -164.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 72.0 m -61.22 -39.72 66.16 Favored Pre-proline 0 CA--C 1.557 1.23 0 N-CA-C 113.761 1.023 . . . . 64.05 113.761 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.47 -33.56 68.4 Favored 'Trans proline' 0 C--N 1.382 2.341 0 CA-C-N 120.976 1.384 . . . . 75.34 112.87 167.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -72.87 -23.62 60.76 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 117.903 0.319 . . . . 60.44 111.212 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.12 -42.31 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.952 0.882 . . . . 54.05 109.305 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.407 HD23 ' HG3' ' A' ' 80' ' ' GLN . 64.5 mt -80.1 -24.47 40.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.143 -1.39 . . . . 64.12 112.348 -174.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.39 -41.91 86.15 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.923 1.082 . . . . 75.04 113.923 -171.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.89 -39.33 91.79 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.421 2.081 . . . . 65.35 113.313 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -76.27 -41.69 48.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.308 -0.86 . . . . 65.23 111.387 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.86 85.93 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 74.32 109.984 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -49.86 -59.08 4.19 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 124.897 1.373 . . . . 73.32 109.683 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 4.4 tm-20 -58.32 -40.97 83.5 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.428 1.08 . . . . 73.04 112.251 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.482 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.0 t -62.07 -47.6 83.94 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.503 0.502 . . . . 63.21 110.91 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.2 mt -61.47 -43.96 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.76 0.824 . . . . 74.21 110.464 175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.741 HG23 ' HB2' ' A' ' 125' ' ' GLN . 74.0 m -58.26 -42.75 87.12 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.909 1.284 . . . . 70.33 111.586 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -72.93 -41.5 64.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.314 -0.857 . . . . 70.34 110.888 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.0 mtm -58.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.653 0.381 . . . . 71.22 111.324 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.9 -42.99 96.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.974 0.796 . . . . 75.44 111.47 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.4 p -67.56 -29.0 68.26 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.106 0.479 . . . . 73.43 110.958 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.8 -31.55 64.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.713 0.805 . . . . 74.14 109.943 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 29.53 4.56 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.972 0.796 . . . . 74.32 113.623 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.54 HG23 ' NE ' ' B' ' 15' ' ' ARG . 14.3 t 60.98 16.8 7.31 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.725 2.01 . . . . 74.51 114.994 169.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.18 159.36 52.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.618 -0.676 . . . . 72.42 111.962 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.18 139.76 90.91 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.82 2.346 . . . . 75.15 111.674 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.741 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.0 pt20 -55.44 151.64 9.9 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.576 1.173 . . . . 74.2 112.138 -173.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HG ' HG12 ' A' ' 64' ' ' VAL . 1.6 tm? -120.02 97.46 5.62 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 71.31 108.997 -176.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -124.6 101.82 7.31 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.522 1.129 . . . . 73.24 109.406 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.78 159.11 32.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.882 0.873 . . . . 74.42 112.006 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 152.37 95.98 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.895 0.878 . . . . 62.41 111.731 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HG3' ' HH ' ' C' ' 101' ' ' TYR . 35.3 Cg_endo -91.71 111.26 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.284 2.656 . . . . 74.42 112.191 -177.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' H' ' 207' ' ' VAL . 49.6 t -100.84 111.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.961 -1.126 . . . . 75.4 107.961 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -96.14 73.06 2.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.079 0.942 . . . . 73.1 109.258 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.461 ' HZ ' ' HB2' ' G' ' 182' ' ' PHE . 71.5 t80 -71.21 -25.3 62.45 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.069 -1.423 . . . . 73.43 110.25 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -67.8 -40.23 83.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.977 0.911 . . . . 74.52 110.665 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.71 -30.33 67.94 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 115.616 -0.72 . . . . 72.03 110.082 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.08 -35.98 76.39 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 123.81 0.694 . . . . 74.42 111.25 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 74.8 m-85 -59.43 -51.88 67.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.227 -0.286 . . . . 73.13 110.227 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.5 mmt -58.36 -42.84 87.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.872 0.869 . . . . 75.24 111.731 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -76.03 -50.26 15.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.98 -1.009 . . . . 74.42 111.419 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -73.8 -31.7 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 119.132 -0.461 . . . . 64.14 112.205 -172.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -55.71 -52.53 63.58 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.261 0.624 . . . . 72.11 110.782 -170.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -152.05 -17.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.647 0.779 . . . . 72.42 111.044 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' C' ' 144' ' ' GLN . 0.0 OUTLIER 48.05 81.43 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.697 1.199 . . . . 73.35 111.137 -171.139 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.37 156.97 47.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.969 0.507 . . . . 63.14 110.814 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.59 175.53 13.53 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.903 -1.044 . . . . 75.1 109.755 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.99 57.22 2.18 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.897 -0.481 . . . . 75.34 111.897 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.462 ' HB2' HE22 ' C' ' 142' ' ' GLN . 10.3 tp10 -76.78 142.63 40.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.294 0.638 . . . . 63.33 110.275 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.27 60.16 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 114.435 0.534 . . . . 74.52 114.435 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -100.64 122.15 42.82 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.329 0.564 . . . . 64.31 109.778 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.05 -29.4 23.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.577 0.751 . . . . 64.34 110.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.77 98.37 1.53 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.195 0.598 . . . . 73.14 109.585 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -99.45 21.61 11.9 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.877 -0.786 . . . . 73.25 108.877 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.1 101.83 0.93 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.202 -1.036 . . . . 74.22 108.202 172.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.51 128.71 34.74 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.665 -0.698 . . . . 74.31 109.979 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 123.779 0.832 . . . . 71.21 111.402 -176.316 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.577 -0.897 . . . . 75.21 108.577 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.511 ' HA ' HD12 ' F' ' 173' ' ' LEU . 33.4 p -61.32 93.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.846 0.858 . . . . 74.22 111.097 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.26 102.01 7.7 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.403 -1.332 . . . . 75.42 107.403 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -80.31 85.94 5.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.941 0.497 . . . . 74.15 110.885 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -106.99 147.67 29.61 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.102 -0.703 . . . . 74.43 109.102 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -73.62 83.21 1.55 Allowed 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 122.233 1.016 . . . . 74.02 110.937 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 144.95 43.78 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.633 -1.247 . . . . 74.13 107.633 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -84.79 64.67 8.71 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.417 -0.586 . . . . 74.24 109.417 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.3 ptm 47.78 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.033 2.133 . . . . 73.25 114.593 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -143.21 132.49 23.28 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.432 -1.322 . . . . 75.02 107.432 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.418 ' HA ' HG22 ' B' ' 86' ' ' ILE . 16.9 t80 -127.87 139.24 52.74 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -149.66 141.05 23.26 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.23 0.612 . . . . 72.42 109.789 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.432 HD11 HG13 ' B' ' 16' ' ' ILE . 7.2 tp -93.18 136.21 25.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 109.018 -0.734 . . . . 74.42 109.018 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.592 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.9 mm100 -104.95 -51.14 3.1 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.33 -0.619 . . . . 73.11 109.33 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.568 HH11 ' HD1' ' A' ' 32' ' ' PHE . 52.2 ttt180 -173.26 138.83 0.75 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.055 0.542 . . . . 75.23 110.543 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.432 HG13 HD11 ' B' ' 13' ' ' ILE . 55.8 mt -114.71 141.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.075 -1.083 . . . . 73.11 108.075 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.42 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 26.0 p90 -167.5 156.45 9.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.112 0.482 . . . . 75.43 111.957 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.9 m -81.57 125.83 31.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.31 -0.859 . . . . 74.33 108.685 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.36 -34.91 10.48 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.159 0.584 . . . . 74.13 111.301 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.655 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.6 t70 -153.95 132.82 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.743 -0.662 . . . . 65.23 109.942 -165.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.442 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.9 mm -135.94 138.31 47.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 124.102 0.961 . . . . 70.32 109.462 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.2 m -138.33 121.29 16.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.413 -1.267 . . . . 72.31 108.674 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.525 ' HZ ' ' HD2' ' B' ' 123' ' ' PHE . 83.3 t80 -130.65 108.59 10.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.652 -1.61 . . . . 72.24 106.652 163.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -122.45 114.67 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 71.33 108.746 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.21 87.15 3.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 74.14 108.867 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 35.7 Cg_endo -61.75 -41.12 40.52 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.173 2.582 . . . . 73.23 112.901 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -110.52 30.95 6.33 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.109 0.964 . . . . 72.33 109.912 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.69 ' HB3' ' HE2' ' A' ' 17' ' ' TYR . . . -47.66 -50.32 51.87 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 125.875 1.67 . . . . 62.03 115.057 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.89 -19.21 16.25 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.008 1.805 . . . . 73.41 112.445 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.04 5.01 53.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.923 1.289 . . . . 71.34 110.863 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.95 -28.85 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.548 0.739 . . . . 72.05 111.698 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -73.69 -33.51 64.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.38 0.672 . . . . 74.11 111.314 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.54 -20.38 63.69 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.135 0.974 . . . . 73.43 110.476 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -104.68 112.07 25.01 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.5 1.52 . . . . 72.21 111.379 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -93.54 77.97 4.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.229 0.612 . . . . 74.13 111.65 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 170.96 152.48 0.05 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 126.384 1.874 . . . . 74.13 109.307 161.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.439 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 0.6 OUTLIER -80.56 128.65 71.61 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 108.994 -0.743 . . . . 74.52 108.994 -177.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 10.6 Cg_endo -52.74 129.7 33.78 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.56 2.84 . . . . 73.11 114.048 -168.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.9 pt-20 -53.75 123.02 11.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.33 1.019 . . . . 64.45 110.358 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.445 HG23 ' HE3' ' E' ' 196' ' ' LYS . 21.8 t -85.41 124.1 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 107.973 -1.121 . . . . 74.31 107.973 -174.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -147.95 142.91 26.93 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.381 0.673 . . . . 75.11 109.598 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.55 164.59 21.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.67 0.788 . . . . 74.15 111.012 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.426 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.0 m-20 -140.25 144.26 36.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.166 1.386 . . . . 73.52 108.375 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tt -129.2 96.28 4.27 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.027 -1.101 . . . . 74.22 108.027 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.85 158.3 39.86 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.147 0.979 . . . . 74.42 109.156 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -139.63 137.4 35.26 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.02 0.438 . . . . 74.2 110.901 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.69 161.46 21.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.627 1.171 . . . . 70.35 108.377 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 p -146.14 167.44 23.43 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.278 0.231 . . . . 74.11 111.107 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -153.12 135.59 15.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.061 0.944 . . . . 72.11 109.192 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -84.89 132.88 34.33 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.71 0.804 . . . . 71.23 109.408 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -99.13 -41.9 7.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.125 0.57 . . . . 73.05 110.262 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -169.34 3.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.266 0.627 . . . . 73.1 110.871 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.39 119.05 19.73 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.322 -0.854 . . . . 73.34 110.22 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.443 ' HA ' ' HE1' ' F' ' 174' ' ' MET . 63.5 m-20 59.99 21.98 11.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.85 1.26 . . . . 62.21 112.41 -172.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.04 117.28 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.477 1.111 . . . . 75.42 108.376 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.624 ' HE2' ' HE1' ' B' ' 94' ' ' MET . 1.9 p90 -125.52 -177.79 4.02 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.339 0.59 . . . . 75.1 109.914 172.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -141.94 117.3 10.18 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.114 -1.81 . . . . 71.44 106.114 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.03 131.41 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 110.013 -0.366 . . . . 75.42 110.013 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -103.37 125.82 57.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.447 1.099 . . . . 74.53 109.253 176.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.17 122.25 34.47 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.244 -1.391 . . . . 74.14 107.244 169.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -108.22 106.63 16.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.718 0.807 . . . . 74.03 108.849 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 t -106.53 122.39 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.806 -0.813 . . . . 63.33 108.806 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.2 m -114.59 152.44 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.354 0.409 . . . . 74.41 109.943 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 39.3 t -129.47 126.11 62.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.818 1.247 . . . . 73.12 107.947 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -109.55 136.1 49.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.766 -1.198 . . . . 72.22 107.766 170.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.483 -0.932 . . . . 72.12 108.483 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -138.69 136.2 35.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.244 0.545 . . . . 63.33 112.201 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 46.5 mt -95.05 99.05 11.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.742 1.217 . . . . 74.51 108.019 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -129.8 15.58 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 120.016 -0.325 . . . . 45.31 112.517 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -98.86 36.92 1.59 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.973 0.892 . . . . 71.41 108.838 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -153.98 142.95 21.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.656 -0.702 . . . . 73.52 109.396 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -66.07 136.91 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.154 0.582 . . . . 75.34 111.562 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.527 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -92.83 -60.62 1.77 Allowed 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.105 0.962 . . . . 75.05 109.227 177.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.425 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 26.3 p90 -157.6 160.58 38.24 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 113.361 -1.745 . . . . 74.32 108.863 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.6 mt -134.56 115.69 14.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.926 -1.509 . . . . 74.35 106.926 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -115.54 153.78 30.56 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.216 -1.031 . . . . 72.14 108.216 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.45 131.66 3.19 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.556 -0.905 . . . . 75.02 108.556 -174.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -122.63 142.66 38.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.485 -0.932 . . . . 74.11 108.485 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.655 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.4 mt-30 -125.29 90.22 3.19 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.462 -0.94 . . . . 71.13 108.462 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -83.79 106.48 15.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.151 -1.386 . . . . 64.53 109.12 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.62 164.28 26.55 Favored Glycine 0 C--O 1.24 0.487 0 O-C-N 123.44 0.463 . . . . 75.13 112.838 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.85 126.86 1.6 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.828 -0.909 . . . . 62.21 110.828 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 20.1 mt -86.05 129.7 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.607 -0.886 . . . . 75.24 108.607 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -134.34 141.76 47.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.953 0.901 . . . . 74.42 108.9 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -116.92 114.04 23.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.645 0.778 . . . . 72.42 109.227 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.51 HD11 HD11 ' B' ' 89' ' ' ILE . 2.7 pp -135.93 149.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.957 0.903 . . . . 71.53 110.645 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.78 172.14 18.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.593 0.757 . . . . 70.14 110.119 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.11 -48.69 0.92 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.962 -0.354 . . . . 73.41 113.98 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.51 HD11 HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -73.23 162.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 117.21 0.505 . . . . 73.11 111.679 -177.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -152.3 153.65 34.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.28 0.632 . . . . 75.04 110.163 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.04 -136.56 25.53 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 123.888 0.756 . . . . 74.35 113.93 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -77.87 -16.98 57.85 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.249 1.02 . . . . 63.42 111.508 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.84 -39.69 59.25 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.682 0.793 . . . . 74.32 111.163 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.624 ' HE1' ' HE2' ' B' ' 56' ' ' TYR . 14.8 tpt -69.97 -33.66 72.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.79 -1.095 . . . . 74.34 111.746 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.438 ' HA ' ' ND2' ' F' ' 176' ' ' ASN . . . -62.5 -29.99 70.95 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.985 0.514 . . . . 71.43 111.527 177.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -73.44 -30.87 63.48 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.769 0.828 . . . . 64.32 111.385 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -79.22 -64.29 1.22 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.2 0.6 . . . . 63.13 110.817 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.64 -43.67 92.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 55.32 110.418 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.93 -2.13 86.47 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 118.788 -1.007 . . . . 74.11 114.992 -170.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.79 -52.38 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.642 1.221 . . . . 74.12 112.299 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -70.76 -44.11 67.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.419 0.287 . . . . 73.44 111.564 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -60.87 -47.89 94.37 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-O 118.765 -0.636 . . . . 74.12 111.593 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -47.48 -50.35 11.54 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.442 2.094 . . . . 75.42 113.967 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.9 -32.21 69.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.264 0.626 . . . . 72.33 112.507 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 60.6 mt -64.7 -48.1 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.484 0.714 . . . . 75.4 110.881 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.03 -9.32 56.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.044 0.938 . . . . 75.32 111.35 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.458 ' HZ ' HD21 ' B' ' 128' ' ' LEU . 20.5 t80 -60.56 -48.56 93.13 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.255 1.422 . . . . 74.34 113.207 -172.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -38.14 54.79 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 121.732 1.622 . . . . 61.0 113.271 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.5 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 90.2 m-85 -61.62 -45.83 92.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.102 0.561 . . . . 74.31 110.602 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.99 94.2 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.095 0.958 . . . . 72.55 111.219 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.477 1.111 . . . . 73.43 111.431 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -37.35 83.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.259 -0.882 . . . . 73.21 110.015 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.492 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.8 t -66.16 -39.12 89.55 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.811 -0.631 . . . . 55.32 111.279 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.13 -51.98 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.738 0.415 . . . . 74.42 110.301 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.444 HG23 ' HB2' ' B' ' 125' ' ' GLN . 41.8 m -57.95 -27.36 63.34 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 123.899 0.749 . . . . 64.23 111.269 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -71.24 -62.28 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.35 0.66 . . . . 70.12 110.462 172.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.9 mmt -61.06 -39.97 91.89 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.488 0.715 . . . . 73.24 112.391 -170.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.406 HG11 ' O ' ' B' ' 124' ' ' PRO . 78.5 t -65.82 -43.04 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.611 -0.722 . . . . 73.2 111.144 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.429 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 63.2 p -69.65 -25.64 64.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.341 0.4 . . . . 73.34 111.394 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.482 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.1 mtt-85 -65.56 -36.89 85.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.564 -0.744 . . . . 73.42 110.023 174.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -81.13 7.17 60.84 Favored Glycine 0 C--N 1.356 1.69 0 O-C-N 124.04 0.838 . . . . 74.14 112.897 172.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.9 p 54.96 47.64 21.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.562 1.945 . . . . 61.32 111.504 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.525 ' HD2' ' HZ ' ' B' ' 23' ' ' PHE . 29.1 m-85 -120.36 166.62 14.77 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 114.016 -1.447 . . . . 75.55 110.781 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 36.7 Cg_endo -61.44 137.03 67.23 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.915 3.077 . . . . 74.33 115.334 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' C' ' 124' ' ' PRO . 13.6 pm0 -59.78 154.56 17.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.487 1.115 . . . . 75.1 112.648 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.44 95.96 4.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.079 -1.082 . . . . 74.31 108.079 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.407 HD21 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -92.58 90.62 7.21 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.973 -1.862 . . . . 74.04 105.973 172.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.458 HD21 ' HZ ' ' B' ' 107' ' ' PHE . 1.2 tt -67.88 133.98 50.06 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.414 -0.958 . . . . 75.1 108.414 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.69 107.55 0.85 Allowed Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 124.602 1.189 . . . . 72.41 111.269 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.14 88.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.946 2.431 . . . . 74.23 112.494 -170.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.74 149.5 12.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.981 -1.009 . . . . 71.24 110.425 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -111.45 116.25 30.59 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.009 -1.108 . . . . 64.12 108.009 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -62.2 -28.91 70.01 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.907 0.883 . . . . 72.53 111.975 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' B' ' 138' ' ' MET . 19.6 t70 -56.11 -51.71 66.93 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.23 0.956 . . . . 63.13 111.358 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.76 64.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.93 0.892 . . . . 73.04 112.338 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.45 HD11 HG23 ' E' ' 207' ' ' VAL . 54.4 tp -69.94 -48.7 57.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.496 -0.774 . . . . 74.23 109.981 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.461 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 18.3 m-30 -76.6 -16.07 59.67 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.784 -0.644 . . . . 72.32 112.528 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' B' ' 134' ' ' ASP . 94.0 mtp -57.87 -33.97 69.27 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.916 0.886 . . . . 74.41 111.353 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -75.37 -29.54 59.92 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.103 -0.953 . . . . 71.22 110.697 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.461 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 97.3 m-85 -78.81 -17.0 56.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.595 0.758 . . . . 73.45 111.396 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.06 31.44 1.43 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.694 0.798 . . . . 73.14 111.071 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -45.73 78.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.676 0.791 . . . . 74.14 110.113 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -67.36 -23.86 65.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.17 0.588 . . . . 75.51 111.649 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -74.2 101.01 3.84 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.272 -0.64 . . . . 74.11 109.272 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.01 150.9 24.14 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.305 -0.861 . . . . 74.44 111.084 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.27 170.46 15.12 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 110.797 -0.921 . . . . 63.14 110.797 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.78 174.3 12.66 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.244 0.545 . . . . 64.34 111.737 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.62 -156.69 24.53 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.551 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.5 t -158.6 149.11 20.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 117.635 0.717 . . . . 63.33 110.824 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -92.65 110.24 21.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.644 -1.243 . . . . 72.34 107.644 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.92 129.53 56.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.238 -0.653 . . . . 72.04 109.238 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -77.28 172.43 13.29 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.352 0.661 . . . . 65.41 111.253 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -52.04 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.932 -1.507 . . . . 72.52 106.932 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 65.14 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.194 1.398 . . . . 63.43 112.089 173.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 124.899 1.279 . . . . 70.01 107.883 -174.249 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.307 0.099 . . . . 75.15 110.944 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -115.44 107.74 15.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.907 -1.146 . . . . 72.14 107.907 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -123.17 148.68 45.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.451 0.701 . . . . 75.42 109.632 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.7 159.83 29.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.601 -0.889 . . . . 75.23 108.601 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -157.13 159.7 38.09 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.714 -0.846 . . . . 70.21 108.714 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.485 ' HB2' ' HA2' ' C' ' 148' ' ' GLY . 21.3 m-80 -55.99 115.44 2.41 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.913 0.885 . . . . 73.34 109.234 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 34.9 p -63.75 93.35 0.08 Allowed 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.164 0.915 . . . . 71.32 111.526 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -156.37 127.3 6.87 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.782 0.833 . . . . 74.31 109.117 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 53.8 ttp 59.55 113.96 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.203 1.401 . . . . 75.12 110.93 -171.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -121.12 89.02 3.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.538 -0.912 . . . . 64.44 108.538 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.583 ' HB3' ' HB3' ' H' ' 206' ' ' ASP . 2.3 t80 -102.51 127.97 49.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.062 -1.426 . . . . 75.43 108.732 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -141.3 131.09 24.26 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.25 -1.389 . . . . 73.35 107.25 167.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.666 HD13 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -68.61 117.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 106.621 -1.622 . . . . 72.2 106.621 168.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.56 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -83.99 -50.6 7.86 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.007 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -176.13 133.71 0.25 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.77 0.669 . . . . 74.23 110.37 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.666 HG13 HD13 ' C' ' 13' ' ' ILE . 96.2 mt -115.48 140.06 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.098 -1.075 . . . . 72.04 108.098 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.564 ' HH ' HD11 ' C' ' 83' ' ' ILE . 30.5 p90 -177.91 147.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.703 0.401 . . . . 75.32 110.61 -173.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -72.89 121.67 20.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.388 -0.824 . . . . 75.33 109.896 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -76.18 -50.5 14.37 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.949 0.881 . . . . 74.23 108.667 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -135.0 136.96 42.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.763 -1.562 . . . . 73.4 108.952 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.8 mt -131.14 142.16 44.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.258 -1.756 . . . . 75.02 106.258 174.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -151.65 144.51 24.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.643 -0.503 . . . . 64.35 109.643 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -148.69 107.75 3.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.34 -1.356 . . . . 73.31 107.34 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.32 110.69 18.38 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.001 -0.74 . . . . 64.13 109.001 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.04 89.82 14.64 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.369 -0.974 . . . . 54.13 108.369 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.14 -39.67 22.73 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.554 2.169 . . . . 73.0 110.902 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -93.95 30.66 1.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.275 -1.33 . . . . 73.35 111.009 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.2 -48.26 97.68 Favored Pre-proline 0 CA--C 1.563 1.46 0 C-N-CA 123.388 0.675 . . . . 71.11 112.461 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -88.42 -22.68 1.23 Allowed 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 122.034 1.823 . . . . 75.2 112.601 171.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -69.63 -25.48 63.95 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.573 1.149 . . . . 71.33 111.682 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.15 -13.65 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.729 0.811 . . . . 73.32 111.388 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -58.32 -40.55 82.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.213 0.605 . . . . 70.5 111.636 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -102.14 38.9 1.57 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.114 0.566 . . . . 75.43 110.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.639 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.4 OUTLIER -126.65 162.27 26.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.563 0.745 . . . . 75.14 109.9 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.19 120.94 18.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.694 -0.854 . . . . 74.04 108.694 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.406 ' HD1' ' HB2' ' E' ' 194' ' ' ALA . 18.2 p90 -84.37 82.96 8.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.806 0.843 . . . . 73.2 110.943 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -139.67 70.48 37.59 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.854 -0.795 . . . . 75.05 108.854 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.423 ' HB2' HG12 ' C' ' 40' ' ' VAL . 3.2 Cg_exo -77.37 133.67 13.39 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.978 2.452 . . . . 75.45 112.231 -172.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.95 79.54 8.72 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.939 -1.504 . . . . 71.4 106.939 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.602 HG11 ' HG2' ' C' ' 124' ' ' PRO . 13.8 m -76.02 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.16 -1.382 . . . . 71.3 111.441 -170.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -97.0 136.13 38.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.17 -0.923 . . . . 75.01 110.25 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.517 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -114.43 140.99 48.25 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.656 -0.868 . . . . 61.31 108.656 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.08 119.65 33.96 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.718 0.807 . . . . 55.02 109.207 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.682 ' HG ' HD21 ' C' ' 60' ' ' LEU . 7.7 tt -85.9 114.14 22.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.779 -0.822 . . . . 72.33 108.779 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.449 ' O ' HD22 ' C' ' 60' ' ' LEU . 21.1 t70 -126.65 138.93 53.49 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.251 -1.018 . . . . 73.52 108.251 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -111.93 143.69 42.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.351 0.596 . . . . 75.24 110.541 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.94 150.38 50.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.542 1.137 . . . . 71.33 108.743 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -149.24 151.87 34.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.858 0.463 . . . . 72.22 110.048 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.1 t -160.58 140.42 11.09 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.376 -0.972 . . . . 65.22 108.376 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -86.96 137.55 32.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.916 0.388 . . . . 62.21 110.191 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.548 HD13 HD13 ' C' ' 83' ' ' ILE . 76.9 mt -101.38 -58.56 1.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.99 0.916 . . . . 73.51 109.348 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.74 -174.25 3.78 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.816 -1.084 . . . . 74.32 110.075 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -69.06 126.25 29.22 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.846 -1.07 . . . . 75.01 109.209 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.568 ' HA ' HD23 ' E' ' 173' ' ' LEU . 15.1 m-20 64.15 14.64 8.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.713 1.205 . . . . 75.54 111.898 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.77 104.48 11.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 124.447 1.099 . . . . 74.3 108.9 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.57 165.72 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.011 0.91 . . . . 75.34 110.203 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.02 119.22 27.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.844 -1.525 . . . . 75.14 107.416 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.02 120.03 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.881 -1.155 . . . . 74.01 107.881 172.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 90.0 t -106.65 113.49 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.297 -1.001 . . . . 74.52 108.297 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.682 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -84.29 102.79 12.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.337 -1.357 . . . . 74.25 107.337 176.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 3.1 tmm_? -84.31 104.53 14.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.337 -0.986 . . . . 75.31 108.337 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.0 t -101.09 130.07 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.257 -1.016 . . . . 73.12 108.257 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 39.5 m -120.39 126.47 50.56 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.695 -0.854 . . . . 74.23 108.695 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.625 HG23 HG21 ' C' ' 114' ' ' ILE . 40.1 t -99.79 124.28 53.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.333 1.053 . . . . 73.12 109.868 177.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -100.51 143.97 30.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.483 -1.303 . . . . 72.15 107.483 167.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.55 120.93 18.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.469 -1.308 . . . . 75.24 107.469 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.7 m -128.47 156.63 42.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.714 0.769 . . . . 54.31 110.627 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.407 ' HB2' ' HB3' ' C' ' 71' ' ' GLU . 22.8 mt -116.94 34.18 5.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.206 -1.405 . . . . 71.22 107.206 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.38 -82.94 0.32 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.924 -1.271 . . . . 70.52 109.924 -169.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.65 -24.77 4.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.873 0.869 . . . . 73.11 109.989 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.639 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.8 tp10 -67.65 120.5 14.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.93 0.892 . . . . 71.11 110.103 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -74.38 123.17 24.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.711 -0.478 . . . . 72.25 109.711 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.29 -49.54 22.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.502 0.721 . . . . 65.24 109.229 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -166.85 173.37 9.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.891 -1.05 . . . . 72.43 110.183 172.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.43 HD11 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -130.24 143.11 50.58 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 106.595 -1.631 . . . . 74.35 106.595 170.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.486 ' HB3' ' HB ' ' C' ' 64' ' ' VAL . 43.0 t -144.32 155.28 43.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.552 -0.907 . . . . 63.13 108.552 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -157.41 129.87 7.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.86 0.464 . . . . 74.24 110.165 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.53 115.66 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.498 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 62.8 mt-30 -88.6 91.17 8.7 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.614 -1.254 . . . . 70.44 107.614 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -78.07 107.04 10.35 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.546 -0.752 . . . . 75.52 109.725 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -82.04 152.44 31.35 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.874 -0.491 . . . . 54.4 111.874 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.17 118.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.601 -0.999 . . . . 72.31 110.601 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.564 HD11 ' HH ' ' C' ' 17' ' ' TYR . 10.0 mm -84.55 128.91 38.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.462 -0.94 . . . . 65.43 108.462 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.13 128.49 28.18 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.443 -0.577 . . . . 71.14 109.443 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.3 p -79.38 119.24 22.12 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.573 -0.899 . . . . 73.4 108.573 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.66 120.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.718 0.807 . . . . 74.42 109.761 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.492 ' HB2' ' H ' ' E' ' 172' ' ' ALA . . . -167.32 157.57 11.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.004 0.922 . . . . 74.31 110.711 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.498 ' H ' ' HB1' ' E' ' 172' ' ' ALA . . . 104.96 -18.7 42.57 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 123.129 0.268 . . . . 72.12 113.709 172.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.534 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -128.86 178.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.486 1.114 . . . . 74.55 110.625 -175.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.55 -172.97 4.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.465 -0.789 . . . . 74.33 109.775 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.86 -120.41 9.02 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.89 1.116 . . . . 63.13 115.89 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 78.7 p -74.3 -30.61 62.16 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.207 1.003 . . . . 71.44 111.459 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.01 -43.25 79.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.88 -0.6 . . . . 63.42 109.818 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.748 ' HE1' ' HA ' ' E' ' 175' ' ' PHE . 11.2 ptm -78.3 -28.11 47.43 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.979 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.34 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.202 0.525 . . . . 72.24 110.407 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.79 -30.78 51.52 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.426 -0.807 . . . . 75.32 110.681 172.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.529 ' HB3' ' HA ' ' C' ' 94' ' ' MET . 48.7 t -81.53 -21.84 38.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.817 1.247 . . . . 73.33 113.521 -169.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.567 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.0 OUTLIER -139.04 -23.73 0.91 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 119.064 0.847 . . . . 71.24 111.997 172.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.51 -30.64 53.05 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 120.141 -0.255 . . . . 73.32 112.897 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.16 -42.11 2.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.017 0.527 . . . . 75.32 110.815 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.514 ' CE1' HG13 ' C' ' 105' ' ' ILE . 10.6 t80 -50.8 -71.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.927 0.891 . . . . 75.45 110.87 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 60.3 m -55.34 -45.81 99.8 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 113.558 -1.656 . . . . 74.3 113.71 -168.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HB3' HD22 ' C' ' 44' ' ' LEU . 74.2 Cg_exo -55.78 -45.94 35.27 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.446 1.431 . . . . 73.14 113.313 168.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 81.1 m-20 -66.81 -25.56 66.51 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.519 0.728 . . . . 55.1 112.649 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.514 HG13 ' CE1' ' C' ' 101' ' ' TYR . 29.3 mm -85.55 -43.29 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.621 0.768 . . . . 74.51 110.611 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.22 -14.32 57.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.935 -0.575 . . . . 62.12 111.032 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.435 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 91.8 t80 -56.53 -54.35 54.39 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 117.705 -1.14 . . . . 72.11 111.761 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' C' ' 105' ' ' ILE . 32.5 Cg_exo -56.37 -40.33 85.36 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.338 2.025 . . . . 64.54 113.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -63.55 -52.35 61.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.045 0.938 . . . . 74.5 111.944 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.63 96.51 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 74.51 110.34 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -54.47 -47.85 72.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.973 1.709 . . . . 71.42 111.403 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.436 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -76.93 -37.58 55.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.964 0.505 . . . . 75.41 110.604 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 25.6 t -65.85 -32.58 74.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.042 0.537 . . . . 72.43 111.494 -177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.625 HG21 HG23 ' C' ' 64' ' ' VAL . 96.6 mt -72.31 -51.07 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.716 -0.675 . . . . 72.12 109.545 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m -51.12 -34.75 32.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.614 0.766 . . . . 74.32 111.562 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.9 t -59.4 -61.25 2.76 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.714 -1.13 . . . . 75.34 109.489 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.575 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.28 -45.24 54.27 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.514 1.526 . . . . 74.34 113.148 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.43 -46.71 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 72.2 110.43 -178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.988 -1.005 . . . . 73.44 111.43 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' C' ' 116' ' ' SER . 81.0 mtt-85 -69.1 -37.26 78.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.205 0.602 . . . . 72.33 109.861 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 6.7 72.57 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.884 0.74 . . . . 71.31 112.835 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.0 p 65.0 37.89 6.58 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.993 1.717 . . . . 60.43 111.982 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.564 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 60.0 m-85 -107.35 172.65 3.63 Favored Pre-proline 0 CA--C 1.572 1.821 0 C-N-CA 124.897 1.279 . . . . 70.15 109.803 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.602 ' HG2' HG11 ' C' ' 40' ' ' VAL . 73.8 Cg_endo -70.77 179.64 4.09 Favored 'Trans proline' 0 C--N 1.403 3.429 0 C-N-CA 122.49 2.126 . . . . 75.1 114.368 -171.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.404 ' HG2' ' HB3' ' B' ' 125' ' ' GLN . 28.2 mm-40 -60.37 125.73 24.78 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.609 -0.723 . . . . 75.03 112.025 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.41 2.61 36.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.408 0.683 . . . . 63.11 110.346 170.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.429 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 43.2 t-20 -88.46 82.8 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.719 -1.586 . . . . 72.34 106.719 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 73.1 mt -89.86 158.27 17.53 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 112.555 -2.111 . . . . 74.4 110.33 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' F' ' 204' ' ' ILE . . . -34.62 130.89 0.45 Allowed Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.854 1.661 . . . . 74.03 114.583 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.542 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 74.1 Cg_endo -71.77 109.01 2.55 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.164 2.576 . . . . 75.04 112.664 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.88 104.73 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 75.43 109.123 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 103.4 15.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.41 0.684 . . . . 72.43 109.902 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -79.39 -23.03 43.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.614 0.366 . . . . 72.42 111.349 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.448 ' HB2' ' ND2' ' C' ' 104' ' ' ASN . 3.9 t70 -60.78 -30.14 69.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.149 0.499 . . . . 75.44 110.779 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.14 96.96 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.139 -0.937 . . . . 75.14 111.563 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.524 HD12 HG22 ' F' ' 207' ' ' VAL . 74.7 mt -74.58 -34.05 62.79 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.66 0.784 . . . . 75.41 111.139 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.13 -32.63 48.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.23 1.012 . . . . 73.41 111.98 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.5 mtm -57.67 -45.08 86.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.972 0.909 . . . . 74.34 112.105 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -72.52 -37.7 68.27 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 110.448 -0.205 . . . . 72.21 110.448 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -68.01 -84.78 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 75.24 111.597 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 37.8 tp -106.95 120.72 42.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.274 -0.639 . . . . 74.34 109.274 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.462 HE22 ' HB2' ' A' ' 147' ' ' GLU . 96.4 mt-30 -82.16 156.9 24.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.29 0.636 . . . . 73.34 111.465 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -117.09 136.26 53.13 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.314 1.045 . . . . 74.14 109.348 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.58 ' HA ' HE22 ' A' ' 143' ' ' GLN . 55.0 mt-30 -103.76 -165.09 1.12 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.174 0.59 . . . . 70.43 109.673 170.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.25 -161.97 0.29 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.762 0.825 . . . . 60.5 111.782 176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.5 30.6 Favored Glycine 0 C--N 1.348 1.221 0 C-N-CA 122.852 0.263 . . . . 75.54 112.837 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 98.71 0.23 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 74.44 109.509 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' C' ' 6' ' ' ASN . . . -166.72 124.8 1.26 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.527 -1.029 . . . . 63.11 110.527 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.469 ' H ' HD21 ' C' ' 6' ' ' ASN . 4.1 t -167.66 92.76 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.48 0.712 . . . . 73.01 109.178 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -147.23 163.37 36.59 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.253 1.021 . . . . 72.43 110.752 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -167.05 121.91 1.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.959 -1.019 . . . . 64.22 110.0 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -159.74 26.31 0.18 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.39 1.076 . . . . 74.31 109.689 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -47.85 116.84 1.62 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.222 1.409 . . . . 75.45 112.453 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 -69.27 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.213 1.005 . . . . 73.11 108.894 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.351 0 N-CA-C 107.227 -1.397 . . . . 73.51 107.227 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.807 -0.442 . . . . 74.44 109.807 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 83.1 p -157.66 149.3 21.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.81 0.844 . . . . 60.44 109.879 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -32.53 25.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.15 0.58 . . . . 74.4 109.981 168.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 63.14 -78.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.851 1.661 . . . . 74.12 110.688 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -174.7 179.18 1.75 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.317 0.647 . . . . 72.22 111.04 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.473 HD22 ' HA ' ' H' ' 172' ' ' ALA . 35.4 m-80 -82.57 67.55 8.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.776 0.831 . . . . 75.01 109.435 174.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 96.4 m -149.82 -72.29 0.18 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.145 -1.057 . . . . 64.22 108.145 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -90.3 78.62 6.46 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.157 -1.053 . . . . 73.22 108.157 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.472 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 3.2 ptm -34.34 132.24 0.29 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.457 -1.247 . . . . 74.55 112.436 170.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -122.36 141.04 51.99 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.273 -0.64 . . . . 74.32 109.273 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -149.02 100.13 3.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.029 -1.471 . . . . 72.53 107.029 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -121.58 150.97 40.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.356 -0.979 . . . . 75.43 108.356 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 tp -102.81 137.16 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.156 -0.683 . . . . 75.04 109.156 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -99.3 -45.47 5.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.549 0.74 . . . . 74.35 109.507 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -168.43 147.26 4.35 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.942 0.497 . . . . 73.12 111.104 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.45 HD12 HD23 ' D' ' 106' ' ' LEU . 48.0 mm -115.81 122.76 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 105.958 -1.867 . . . . 74.15 105.958 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.69 156.27 34.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.098 0.951 . . . . 74.51 111.027 -169.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.3 p -91.86 116.99 29.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.945 -1.48 . . . . 72.23 109.152 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -85.84 -29.52 23.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.493 -0.776 . . . . 75.33 109.419 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.65 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.3 t70 -149.76 135.96 18.92 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.803 -1.09 . . . . 75.31 109.574 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.575 HG23 ' HE1' ' C' ' 117' ' ' MET . 60.6 mt -139.37 143.32 31.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.853 -1.165 . . . . 74.32 107.853 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -144.75 144.6 31.27 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.071 0.948 . . . . 71.51 108.861 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.626 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.4 t80 -145.6 129.63 17.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.53 -2.026 . . . . 73.0 105.53 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.3 mt-10 -133.07 136.03 45.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 73.43 108.498 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.432 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -131.0 75.27 78.81 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.032 -1.099 . . . . 74.34 108.032 174.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.0 -28.89 18.72 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.776 2.317 . . . . 74.23 112.571 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -114.37 32.76 5.72 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 123.726 0.811 . . . . 73.1 108.959 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.432 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -57.65 -58.31 19.23 Favored Pre-proline 0 N--CA 1.483 1.203 0 N-CA-C 114.543 1.312 . . . . 72.34 114.543 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.12 -4.08 13.59 Favored 'Trans proline' 0 C--N 1.381 2.256 0 CA-C-N 121.918 1.721 . . . . 74.3 112.637 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -84.25 -32.36 24.49 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.415 1.486 . . . . 74.1 109.107 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 2.1 t -65.57 -27.66 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.227 1.411 . . . . 74.42 111.952 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.448 ' HA ' ' HH ' ' H' ' 197' ' ' TYR . 10.4 m-30 -62.43 -14.71 43.61 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 112.717 0.636 . . . . 74.34 112.717 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.908 0.883 . . . . 75.34 110.932 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.443 ' HZ2' ' HG2' ' D' ' 71' ' ' GLU . 32.1 mmtp -84.26 104.28 14.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.715 1.206 . . . . 60.4 109.904 178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.34 75.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 74.35 111.763 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -170.05 179.69 3.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.006 0.923 . . . . 73.32 109.924 171.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.554 HE21 ' HD2' ' D' ' 38' ' ' PRO . 37.8 tp60 -78.38 123.83 85.68 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.774 0.829 . . . . 72.35 108.787 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.554 ' HD2' HE21 ' D' ' 37' ' ' GLN . 39.7 Cg_exo -56.28 142.13 88.01 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.815 2.343 . . . . 72.23 115.006 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.16 112.24 2.3 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.652 -0.87 . . . . 74.34 108.652 167.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 22.5 m -103.33 117.29 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.579 0.704 . . . . 72.05 109.983 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -108.41 116.81 32.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.118 0.967 . . . . 74.41 108.756 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' D' ' 63' ' ' THR . 6.6 mp -104.64 135.72 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.283 0.364 . . . . 74.05 110.361 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.48 135.28 50.74 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.411 -0.813 . . . . 71.12 108.87 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.481 HD13 ' H ' ' H' ' 184' ' ' TRP . 5.3 tt -96.55 127.15 42.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.893 -1.151 . . . . 73.43 107.893 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.2 t70 -150.05 155.73 40.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.432 -0.951 . . . . 63.02 108.432 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.4 t -139.6 160.92 38.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.347 0.594 . . . . 75.51 110.167 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.69 176.74 10.1 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.019 1.328 . . . . 74.3 107.79 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.458 ' HB2' ' CE1' ' D' ' 56' ' ' TYR . 78.2 p -172.98 165.94 5.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.526 0.565 . . . . 74.13 112.526 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 4.4 m -152.11 140.72 20.77 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.017 0.927 . . . . 75.43 109.484 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -83.53 118.24 23.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.315 -0.995 . . . . 73.31 108.315 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' D' ' 57' ' ' GLU . 22.0 mt -99.79 -29.3 12.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.906 0.482 . . . . 73.4 110.177 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.13 -172.75 2.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.589 0.756 . . . . 63.13 111.029 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -71.41 120.24 16.71 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.979 -1.009 . . . . 64.1 109.082 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 62.28 18.08 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.47 1.108 . . . . 71.52 111.276 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 74.0 t -121.22 121.65 65.4 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 107.009 -1.478 . . . . 75.35 107.009 174.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.462 ' HB2' ' HE2' ' H' ' 174' ' ' MET . 12.4 t80 -144.64 128.27 17.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.909 -0.775 . . . . 73.5 108.909 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.4 tt0 -88.11 131.27 34.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.625 -0.88 . . . . 63.32 108.625 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.06 123.61 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.096 -1.446 . . . . 75.23 107.096 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.609 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 27.1 t -100.67 139.61 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 73.14 109.178 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -111.98 126.54 55.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.976 -1.12 . . . . 74.15 107.976 175.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.5 ttm-85 -102.92 101.62 11.65 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.715 -0.846 . . . . 73.34 108.715 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.9 t -102.91 121.85 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.706 -0.85 . . . . 74.41 108.706 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 23.7 m -125.7 130.92 52.51 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.397 0.679 . . . . 74.41 109.636 -171.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.534 HG22 HG21 ' D' ' 114' ' ' ILE . 32.1 t -120.8 103.66 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.677 1.191 . . . . 72.44 109.324 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -100.54 96.52 7.43 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.375 -0.972 . . . . 71.52 108.375 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 143.11 27.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.46 -0.791 . . . . 71.2 109.328 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.6 p -151.46 130.47 12.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.403 0.439 . . . . 51.02 111.867 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.4 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 21.3 mt -107.06 108.6 20.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.037 0.935 . . . . 73.14 110.283 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.12 -115.15 4.14 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.562 -0.615 . . . . 74.21 111.562 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 4.51 15.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.909 0.884 . . . . 73.33 110.598 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' HZ2' ' D' ' 34' ' ' LYS . 11.6 pt-20 -116.14 161.89 18.26 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.786 -0.45 . . . . 54.05 109.786 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.5 m -71.54 133.86 46.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.537 -0.756 . . . . 63.44 110.572 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.427 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.88 -64.91 1.07 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.441 -0.948 . . . . 62.13 108.441 173.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -156.15 147.7 22.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.4 -0.818 . . . . 75.41 109.971 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.1 mt -100.39 153.94 18.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.853 0.861 . . . . 74.11 108.952 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.478 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.6 t -159.31 143.72 15.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.284 0.633 . . . . 73.13 109.651 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.39 128.54 7.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.108 0.563 . . . . 65.14 109.845 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.0 t -127.46 114.66 37.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 123.98 0.912 . . . . 73.33 109.017 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.65 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.6 mt-30 -89.54 86.36 6.73 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.838 0.828 . . . . 70.35 108.879 170.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.42 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.8 tp-100 -79.73 98.9 7.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.969 -1.468 . . . . 74.11 108.66 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.609 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.5 154.91 23.71 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.822 -0.511 . . . . 73.13 111.822 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.436 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -149.18 131.16 3.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.695 -0.962 . . . . 65.21 110.695 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.458 HG22 HD13 ' D' ' 51' ' ' LEU . 59.3 mt -94.97 109.02 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.398 -0.594 . . . . 73.55 109.398 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -110.53 126.64 54.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.484 0.714 . . . . 72.22 110.385 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -79.56 97.19 6.37 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.735 -0.839 . . . . 75.24 108.735 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.68 130.24 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.224 0.61 . . . . 75.25 110.803 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.76 153.63 14.93 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.779 0.832 . . . . 70.11 109.945 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 84.96 5.39 86.19 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.393 -0.367 . . . . 74.02 113.302 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -119.32 126.33 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.898 0.879 . . . . 70.42 109.465 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 174.38 10.68 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 122.046 -0.409 . . . . 73.15 111.215 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -139.79 39.53 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.934 0.772 . . . . 71.23 113.358 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.9 p -69.27 -32.33 71.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.641 0.776 . . . . 73.53 111.464 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.22 -40.99 96.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.745 . . . . 74.31 110.619 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.406 ' HG3' HD22 ' H' ' 173' ' ' LEU . 1.2 tmt? -68.6 -55.86 10.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 74.53 110.754 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.64 69.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.453 0.701 . . . . 72.54 112.089 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -85.59 -35.36 21.07 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.466 0.707 . . . . 73.43 110.655 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -66.29 -41.83 89.22 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.662 0.268 . . . . 75.05 110.29 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 tt -78.06 -35.18 49.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.207 0.603 . . . . 74.43 110.065 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.42 -3.32 81.7 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.353 -0.693 . . . . 50.31 114.448 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.448 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . . . -142.93 -57.28 0.43 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 117.974 0.887 . . . . 73.23 111.818 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -72.37 -41.77 66.0 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 112.288 0.477 . . . . 71.44 112.288 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 69.8 m -66.76 -44.97 55.11 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.109 0.564 . . . . 75.41 111.088 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.547 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.9 Cg_exo -55.73 -35.55 93.5 Favored 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.491 2.127 . . . . 64.51 113.402 165.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.48 -29.96 70.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.911 0.484 . . . . 54.41 111.161 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -68.35 -38.49 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.087 0.555 . . . . 71.24 109.619 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.45 HD23 HD12 ' D' ' 16' ' ' ILE . 94.3 mt -79.14 -22.9 44.44 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.311 1.045 . . . . 62.15 112.589 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -66.21 -40.8 38.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.161 1.171 . . . . 75.4 114.161 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.74 -39.23 92.36 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.054 1.836 . . . . 53.45 113.296 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -79.44 -33.17 42.72 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.895 0.878 . . . . 75.23 110.799 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.85 68.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.562 0.745 . . . . 75.33 109.899 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -52.39 -54.27 34.07 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.226 -1.352 . . . . 74.2 110.553 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.34 -45.45 93.4 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.472 1.107 . . . . 75.33 111.687 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.7 t -54.82 -44.74 74.13 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.016 0.822 . . . . 74.11 110.961 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.534 HG21 HG22 ' D' ' 64' ' ' VAL . 77.0 mt -66.33 -53.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.203 -0.908 . . . . 74.31 110.885 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 54.0 m -53.85 -41.5 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.67 1.188 . . . . 74.35 111.567 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.3 t -67.57 -44.7 77.59 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 114.712 -1.131 . . . . 73.12 110.08 179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.58 -32.58 74.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.977 0.511 . . . . 74.01 111.808 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.4 t -64.14 -46.51 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.298 0.639 . . . . 72.33 109.474 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -73.61 -27.78 61.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.704 -0.68 . . . . 64.21 111.35 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' D' ' 116' ' ' SER . 93.0 mtt-85 -72.24 -28.79 63.38 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.542 0.737 . . . . 75.41 110.118 174.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.04 10.06 70.0 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 123.83 0.706 . . . . 74.43 112.302 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.7 p 58.46 18.87 5.99 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.624 1.97 . . . . 75.32 113.691 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -86.58 152.07 54.0 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.889 -0.782 . . . . 74.4 108.889 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.05 133.02 55.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.732 2.288 . . . . 74.04 112.667 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -49.82 139.15 13.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.611 1.195 . . . . 75.42 112.376 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -120.35 102.4 8.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.822 . . . . 62.54 108.904 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -99.21 100.83 11.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.777 -0.823 . . . . 73.23 108.777 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 55.4 mt -72.02 136.0 46.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.616 0.572 . . . . 75.13 110.137 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.01 81.79 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.262 0.625 . . . . 64.24 110.998 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.39 96.79 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.407 2.071 . . . . 72.32 110.259 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -108.15 124.83 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.279 0.561 . . . . 75.52 110.153 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -79.8 113.7 18.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.375 -0.972 . . . . 73.21 108.375 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' D' ' 100' ' ' ALA . 91.8 m-85 -68.78 -15.77 63.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.167 0.587 . . . . 74.43 112.062 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.98 -41.88 90.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.55 0.74 . . . . 64.24 110.584 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.02 -53.45 49.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.635 -0.711 . . . . 73.13 109.174 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -57.3 -28.23 62.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.013 0.925 . . . . 74.23 112.116 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.543 ' HA ' ' HE1' ' H' ' 184' ' ' TRP . 66.5 t80 -62.55 -48.45 79.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.088 0.955 . . . . 64.22 110.643 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 71.6 mtm -74.22 -34.19 63.61 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.765 0.826 . . . . 74.43 111.066 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.464 HD21 ' NE2' ' D' ' 142' ' ' GLN . 16.5 m120 -78.67 -9.69 59.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.924 0.89 . . . . 73.53 111.75 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -69.36 -31.09 69.28 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.045 0.538 . . . . 75.32 110.501 171.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.46 -31.89 72.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.33 0.652 . . . . 71.2 111.297 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.464 ' NE2' HD21 ' D' ' 139' ' ' ASN . 13.8 pt20 -90.99 25.28 2.48 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.448 0.699 . . . . 55.44 111.809 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -116.07 63.77 0.7 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.164 0.983 . . . . 75.44 108.804 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -140.66 77.63 1.61 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.818 -1.549 . . . . 72.42 106.818 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.28 93.5 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.531 -0.759 . . . . 71.42 109.907 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.25 -36.84 0.75 Allowed Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.574 -0.739 . . . . 61.34 112.108 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . 0.444 ' HG2' ' H ' ' D' ' 148' ' ' GLY . 15.1 tt0 -163.98 -172.04 2.67 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 122.907 0.483 . . . . 75.42 110.24 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' D' ' 147' ' ' GLU . . . -74.31 -92.58 0.14 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 114.263 0.465 . . . . 72.34 114.263 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.4 t -91.55 163.2 14.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.317 0.647 . . . . 74.02 111.324 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.06 123.93 48.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.496 0.718 . . . . 75.52 109.575 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -161.98 13.98 0.08 Allowed 'General case' 0 CA--C 1.551 0.991 0 O-C-N 124.032 0.832 . . . . 74.21 109.643 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m170 67.94 132.0 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.574 1.549 . . . . 72.41 111.408 -174.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.84 107.67 0.42 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.685 1.194 . . . . 74.43 110.887 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.21 82.83 2.37 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.743 0.782 . . . . 74.22 109.934 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.394 0 CA-C-N 114.78 -1.1 . . . . 63.51 108.322 -178.725 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.607 0.241 . . . . 75.13 110.413 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.0 -178.46 49.98 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.687 -0.688 . . . . 75.53 112.424 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -139.16 80.53 1.79 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.525 -1.287 . . . . 72.53 107.525 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 23.3 p -66.02 115.28 5.9 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.126 -0.943 . . . . 74.33 110.725 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . 0.498 ' HB1' ' H ' ' C' ' 88' ' ' GLY . . . -164.64 85.62 0.43 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.521 1.128 . . . . 74.31 108.176 -175.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' C' ' 54' ' ' ASP . 1.8 tm? -88.54 140.03 29.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.205 -1.035 . . . . 71.43 108.205 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' E' ' 174' ' ' MET . 0.0 OUTLIER -146.66 -52.41 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.984 0.914 . . . . 74.24 109.986 -170.381 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.748 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 52.4 t80 43.58 78.81 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.755 1.622 . . . . 75.33 113.234 -173.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -91.7 85.43 5.65 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.439 -0.948 . . . . 71.42 108.439 172.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 3.5 tt -158.92 81.56 0.79 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.312 -1.736 . . . . 73.22 106.312 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.85 -36.21 31.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.231 -1.349 . . . . 75.32 109.524 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -154.73 156.67 31.68 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.082 0.953 . . . . 72.24 109.443 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.04 97.12 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.041 1.827 . . . . 73.4 110.965 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -64.85 -28.22 69.4 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.526 0.73 . . . . 74.5 110.428 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.29 156.05 37.67 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.67 1.188 . . . . 74.32 108.875 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 40.7 m -147.55 147.23 29.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.497 -0.927 . . . . 64.25 108.497 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.466 ' HE1' HD13 ' C' ' 44' ' ' LEU . 45.1 p90 -93.97 155.28 40.37 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.52 0.728 . . . . 74.22 111.957 -175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.62 160.09 47.28 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.922 2.415 . . . . 75.41 111.562 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.7 -167.75 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.448 0.699 . . . . 74.42 110.715 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 13.5 tt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.935 0.494 . . . . 75.24 111.617 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . 59.21 78.46 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.296 1.038 . . . . 72.24 110.793 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.35 152.79 26.08 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.837 -0.62 . . . . 75.43 111.501 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -131.25 163.79 27.01 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.732 0.813 . . . . 73.2 109.585 -174.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -73.62 -100.21 0.08 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.023 -1.231 . . . . 51.21 110.023 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 72.82 -71.96 1.09 Allowed Glycine 0 C--N 1.343 0.932 0 O-C-N 123.843 0.379 . . . . 73.5 114.046 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.64 163.47 14.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.519 0.728 . . . . 71.53 111.528 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . 0.406 ' HB2' ' HD1' ' C' ' 36' ' ' TRP . . . -101.53 -158.61 0.68 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.265 1.026 . . . . 70.11 110.103 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' E' ' 197' ' ' TYR . 6.2 p90 -154.92 -162.76 1.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.255 0.622 . . . . 74.35 110.626 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . 0.476 ' HE2' ' HE2' ' F' ' 202' ' ' TYR . 3.4 mptp? -81.1 15.58 1.83 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.596 0.758 . . . . 74.32 112.582 -169.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . 0.419 ' HB2' ' CE2' ' E' ' 195' ' ' PHE . 0.2 OUTLIER -96.1 100.44 12.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.611 0.641 . . . . 74.02 109.557 172.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . 0.716 ' HB3' ' HD3' ' E' ' 201' ' ' LYS . 3.1 tm-20 -168.24 148.73 4.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.387 -2.079 . . . . 73.55 105.387 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -60.58 -29.76 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.532 0.733 . . . . 72.35 112.657 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -76.57 -16.29 80.86 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 122.96 0.314 . . . . 61.45 113.632 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.716 ' HD3' ' HB3' ' E' ' 198' ' ' GLU . 12.7 mptt -89.85 143.88 26.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.29 1.036 . . . . 71.32 109.864 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 54.14 36.74 25.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.388 1.075 . . . . 75.24 112.727 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.95 128.4 37.05 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.766 0.826 . . . . 74.24 112.229 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 13.1 pt -131.99 37.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.362 1.065 . . . . 75.43 109.896 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.32 -13.0 33.96 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.788 -0.642 . . . . 72.33 112.328 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.16 -54.96 28.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.514 1.126 . . . . 63.14 110.91 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.45 HG23 HD11 ' B' ' 136' ' ' LEU . 37.3 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.795 0.838 . . . . 72.3 109.643 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 120.656 0.265 . . . . 74.21 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.7 61.21 3.18 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.533 -0.758 . . . . 73.04 111.643 -175.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.31 140.65 20.52 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.888 0.475 . . . . 74.14 110.401 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 56.5 m 61.97 83.51 0.15 Allowed 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.887 1.275 . . . . 75.33 111.509 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . -66.2 -48.4 70.75 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.415 -0.811 . . . . 63.22 110.673 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' B' ' 2' ' ' SER . 63.0 mt -56.29 111.07 0.87 Allowed 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.257 0.973 . . . . 71.33 110.133 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.443 ' HE1' ' HA ' ' B' ' 54' ' ' ASP . 32.1 mmt 77.33 98.65 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.125 1.77 . . . . 74.35 110.993 -178.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.37 80.95 0.19 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.107 1.363 . . . . 73.52 112.028 173.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . 0.438 ' ND2' ' HA ' ' B' ' 95' ' ' ALA . 3.1 p-10 -86.91 9.58 18.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.054 0.941 . . . . 64.34 111.823 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.58 80.43 0.58 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.327 0.651 . . . . 75.31 109.425 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 177.88 -43.54 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.148 1.379 . . . . 72.23 107.659 -167.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -56.77 138.68 77.7 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.856 -1.066 . . . . 73.12 111.268 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.2 113.03 3.15 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.338 2.025 . . . . 74.55 111.305 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -130.01 112.52 13.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.199 0.6 . . . . 74.31 109.881 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -66.9 138.2 57.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.702 . . . . 75.52 110.48 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 7.5 m -94.51 155.74 16.78 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.517 0.727 . . . . 72.13 110.537 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.523 ' HB2' ' HG ' ' F' ' 186' ' ' LEU . 28.2 p90 -74.66 127.08 87.85 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.613 1.165 . . . . 75.42 111.304 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -99.73 24.47 0.19 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.672 2.914 . . . . 75.23 112.969 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.523 ' HG ' ' HB2' ' F' ' 184' ' ' TRP . 0.8 OUTLIER -90.13 170.72 10.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.59 0.756 . . . . 71.55 112.331 -175.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.48 HG13 HD13 ' F' ' 186' ' ' LEU . 57.7 mt 72.97 140.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 126.125 1.77 . . . . 74.52 113.204 173.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.21 -172.52 3.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.264 1.025 . . . . 63.24 109.476 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.3 -156.64 0.74 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.899 0.88 . . . . 75.24 108.671 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -161.91 154.63 20.11 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.452 0.569 . . . . 54.34 110.556 -175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -131.98 -174.26 13.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.137 -0.483 . . . . 72.12 113.625 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.49 -102.68 2.87 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 111.452 -0.659 . . . . 73.43 111.452 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 57.6 -169.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.497 1.119 . . . . 75.23 112.546 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -164.9 156.68 15.42 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.11 0.564 . . . . 72.41 111.292 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.41 ' CD2' ' HB3' ' F' ' 203' ' ' ASP . 97.4 m-85 -91.18 -159.85 0.67 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.856 0.862 . . . . 73.22 109.441 170.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -58.82 -9.76 1.99 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.266 1.026 . . . . 73.05 113.642 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -55.32 -36.95 66.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.319 0.647 . . . . 74.33 110.423 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.06 31.75 5.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.481 1.112 . . . . 73.21 109.608 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 42.0 t30 66.22 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.223 1.409 . . . . 72.21 110.742 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -132.3 -166.34 11.52 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.744 -0.662 . . . . 70.1 112.899 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.65 -35.76 0.88 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.94 0.896 . . . . 65.31 110.73 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.476 ' HE2' ' HE2' ' E' ' 196' ' ' LYS . 14.5 m-30 -89.88 34.03 0.85 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.809 0.844 . . . . 73.41 111.965 -165.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . 0.41 ' HB3' ' CD2' ' F' ' 195' ' ' PHE . 2.9 p30 -125.16 -146.89 0.36 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.013 1.325 . . . . 70.43 108.221 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.554 ' HA ' ' HB1' ' C' ' 129' ' ' ALA . 2.6 pp -131.66 156.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.384 0.611 . . . . 74.02 111.428 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -119.68 113.1 20.15 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.734 -1.21 . . . . 72.32 107.734 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -72.72 150.66 42.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.295 0.638 . . . . 75.22 109.773 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.524 HG22 HD12 ' C' ' 136' ' ' LEU . 4.3 p . . . . . 0 CA--C 1.565 1.546 0 CA-C-O 118.382 -0.818 . . . . 74.42 110.24 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.216 -1.031 . . . . 74.04 108.216 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.21 -95.7 0.13 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.308 -0.717 . . . . 75.35 111.308 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . 0.506 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 3.9 mptp? -116.05 124.78 51.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.385 -0.968 . . . . 73.22 108.385 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 31.6 p -88.21 63.24 7.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.78 0.832 . . . . 64.05 110.0 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -87.8 -168.05 2.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.248 -0.887 . . . . 64.33 110.176 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 98' ' ' LEU . 77.7 mt 64.1 179.82 0.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.023 0.929 . . . . 73.52 111.592 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 7.0 mmt 60.87 10.13 2.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.099 1.36 . . . . 73.33 112.587 171.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.54 -165.81 0.15 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.747 1.219 . . . . 72.25 111.526 -169.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 64.53 18.0 11.14 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.057 0.943 . . . . 72.23 110.604 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 3.5 pp -73.34 159.37 33.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.231 0.612 . . . . 73.52 111.21 -175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -117.29 162.41 17.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.606 0.762 . . . . 75.32 110.044 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 69.6 137.31 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.216 1.407 . . . . 75.34 113.103 167.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.33 94.35 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.115 1.877 . . . . 61.4 109.542 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -53.8 110.84 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.07 0.948 . . . . 75.44 111.739 -174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . 0.461 ' HB2' ' HZ ' ' A' ' 133' ' ' PHE . 28.5 m-85 54.49 33.98 20.05 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.085 1.354 . . . . 73.14 111.306 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 91.6 m 77.73 -50.08 0.51 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 126.554 1.942 . . . . 74.4 113.626 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 69.94 84.05 0.15 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.414 1.486 . . . . 74.04 109.353 -167.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.67 94.13 1.05 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.695 2.263 . . . . 73.25 110.84 170.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.14 131.69 34.75 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.507 -1.294 . . . . 75.11 107.507 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.84 152.57 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 120.738 0.304 . . . . 75.51 110.84 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -102.14 114.71 29.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.025 -0.732 . . . . 72.3 109.025 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -80.12 102.08 9.15 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.961 -0.755 . . . . 74.14 108.961 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.32 155.72 38.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.532 -0.758 . . . . 72.15 110.751 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 40' ' ' VAL . . . -78.69 74.25 2.15 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.117 -0.492 . . . . 64.13 113.07 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.3 123.14 28.9 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.024 -0.431 . . . . 64.32 112.024 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' H' ' 198' ' ' GLU . 49.3 m-85 -87.66 39.06 0.86 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.198 0.999 . . . . 75.41 110.945 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.68 129.88 40.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.975 -0.75 . . . . 75.52 108.975 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 62.8 t80 77.3 29.21 0.57 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 125.169 1.543 . . . . 64.33 110.726 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' G' ' 193' ' ' TYR . 12.1 tmtt? -69.11 80.66 0.33 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.637 -0.875 . . . . 73.41 108.637 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -90.88 149.96 21.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.283 -0.871 . . . . 74.45 108.989 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -128.42 61.46 1.47 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.941 -0.763 . . . . 75.2 108.941 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 71.7 152.04 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.034 1.334 . . . . 72.21 111.54 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.5 119.36 2.89 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.956 -0.358 . . . . 74.24 112.51 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . 0.436 ' HD3' ' HA ' ' G' ' 201' ' ' LYS . 35.0 mmtt -147.38 -59.79 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.382 0.673 . . . . 74.13 111.303 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -123.33 -70.23 0.78 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.776 -1.194 . . . . 73.35 107.776 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 54.85 25.63 6.9 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.303 1.223 . . . . 74.34 114.303 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 34.2 pt -89.42 144.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 120.787 0.327 . . . . 65.51 110.168 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -166.58 104.15 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.525 -0.916 . . . . 75.23 108.525 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -132.16 -90.62 0.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.11 -0.7 . . . . 65.35 109.11 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.568 1.673 0 C-N-CA 124.848 1.259 . . . . 73.0 111.156 -177.528 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 119.927 -0.082 . . . . 74.45 111.169 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.55 144.57 4.49 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.516 -0.234 . . . . 65.31 112.516 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -111.4 133.24 53.85 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.64 0.776 . . . . 75.1 109.605 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 47.7 m 67.85 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.752 1.221 . . . . 53.33 112.855 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.473 ' HA ' HD22 ' D' ' 6' ' ' ASN . . . -84.01 -66.56 0.88 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.198 0.599 . . . . 70.44 111.315 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.406 HD22 ' HG3' ' D' ' 94' ' ' MET . 0.0 OUTLIER -169.52 176.34 5.06 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.465 1.106 . . . . 74.22 108.586 -176.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.565 ' HE1' ' HA ' ' H' ' 174' ' ' MET . 1.0 OUTLIER -131.22 -58.65 1.0 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.606 0.965 . . . . 73.03 113.606 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -149.97 147.67 28.15 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 117.853 0.297 . . . . 75.24 111.764 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -158.02 119.2 3.51 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.282 1.033 . . . . 73.22 108.705 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -163.34 30.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.451 0.7 . . . . 74.45 109.453 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.39 -38.85 72.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.22 1.008 . . . . 73.53 111.599 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.18 138.98 24.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.589 0.755 . . . . 72.23 109.804 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.79 114.75 2.71 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.152 2.568 . . . . 75.44 112.721 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.96 120.98 34.96 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.588 -0.893 . . . . 75.23 108.588 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -67.47 150.23 49.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.986 0.515 . . . . 73.35 111.325 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 72.0 p -97.39 -176.72 3.59 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 109.144 -0.687 . . . . 74.23 109.144 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . 0.543 ' HE1' ' HA ' ' D' ' 137' ' ' PHE . 16.3 m-90 -123.05 87.44 51.05 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 122.816 0.447 . . . . 74.21 110.592 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.94 122.59 2.26 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.799 2.332 . . . . 72.01 111.855 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -169.06 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.405 0.682 . . . . 75.13 111.42 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.498 HG23 ' HB2' ' D' ' 42' ' ' LEU . 15.6 tt -80.47 89.08 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 122.668 1.223 . . . . 74.04 110.447 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -147.23 83.56 1.56 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.238 -1.346 . . . . 62.11 108.263 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.17 133.32 33.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.174 -0.921 . . . . 75.21 110.243 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.55 157.34 32.12 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.537 -0.542 . . . . 74.5 109.537 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' D' ' 37' ' ' GLN . . . -95.73 154.56 20.97 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.918 -0.583 . . . . 63.01 112.739 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' D' ' 37' ' ' GLN . . . -116.11 177.05 16.79 Favored Glycine 0 C--N 1.346 1.112 0 C-N-CA 122.834 0.254 . . . . 72.44 112.671 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -80.87 89.92 5.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.174 0.59 . . . . 74.2 110.052 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.17 78.16 0.58 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.461 -0.791 . . . . 65.23 109.884 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.78 -47.43 0.13 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.679 -1.23 . . . . 75.03 107.679 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 tptt 39.84 81.04 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.51 1.924 . . . . 74.44 114.0 161.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . 0.448 ' HH ' ' HA ' ' D' ' 32' ' ' PHE . 68.5 m-85 -76.86 63.05 2.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.002 0.921 . . . . 64.52 110.513 176.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . 0.643 ' HB3' ' HB2' ' G' ' 193' ' ' TYR . 2.1 mm-40 -81.5 103.67 11.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.099 -0.704 . . . . 74.11 109.099 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 63.94 35.37 10.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.282 1.033 . . . . 71.13 110.951 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.09 52.19 4.68 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.795 -0.639 . . . . 64.12 112.531 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -160.18 96.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 106.418 -1.697 . . . . 74.21 106.418 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -64.67 -34.42 78.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.866 0.866 . . . . 74.14 112.983 -172.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 15.5 t70 64.45 28.11 13.53 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.782 0.833 . . . . 74.41 111.048 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 15.5 pt -99.36 159.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.476 0.71 . . . . 74.54 110.94 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -97.89 163.24 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.633 0.773 . . . . 72.41 109.655 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' C' ' 11' ' ' PHE . 3.3 p-10 -55.85 -59.17 5.25 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.31 1.044 . . . . 64.43 111.24 171.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . 0.439 ' HB ' HG12 ' A' ' 131' ' ' VAL . 2.5 p . . . . . 0 C--O 1.26 1.614 0 N-CA-C 107.681 -1.229 . . . . 72.52 107.681 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 118.803 -0.618 . . . . 75.02 110.41 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t 65.69 164.75 0.17 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.137 1.375 . . . . 71.32 113.951 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -102.81 145.74 29.31 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.055 0.942 . . . . 74.52 109.718 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 90' ' ' GLU . 89.7 mt-30 -126.08 135.05 51.27 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.63 0.772 . . . . 75.23 110.099 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.32 -76.75 0.31 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.021 -0.733 . . . . 62.23 109.021 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 t30 51.1 70.34 0.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.045 1.338 . . . . 72.33 112.096 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 p -125.01 -58.88 1.45 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.321 0.648 . . . . 72.1 109.594 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.424 ' HG3' ' HB3' ' C' ' 145' ' ' ALA . 2.2 tm-20 -145.81 127.58 15.31 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.618 -1.623 . . . . 74.1 106.618 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -136.19 156.77 48.21 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.226 0.536 . . . . 73.42 112.408 -166.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -144.18 134.81 24.88 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.896 0.878 . . . . 73.34 109.344 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.484 ' HD2' HG21 ' A' ' 86' ' ' ILE . 36.2 t80 -121.32 130.01 53.41 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.767 -1.197 . . . . 75.12 107.767 166.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -144.52 123.39 12.7 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.997 0.186 . . . . 64.45 111.37 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 tp -68.7 130.95 34.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.956 -0.757 . . . . 73.32 108.956 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.458 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 28.1 mm-40 -110.62 -39.97 4.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.928 -0.578 . . . . 74.5 109.919 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.582 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 27.1 ttt180 -173.58 144.29 1.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 119.871 -0.109 . . . . 74.21 110.755 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.541 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 71.7 mt -123.01 132.31 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.535 -1.283 . . . . 64.44 107.535 170.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.582 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 15.4 p90 -156.73 155.45 31.68 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.416 0.686 . . . . 73.5 110.633 -174.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -88.52 109.39 20.02 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.851 -0.613 . . . . 74.13 109.697 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -72.4 -32.53 66.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.165 0.507 . . . . 74.44 109.985 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.72 142.84 27.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.961 -1.018 . . . . 72.23 109.537 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.47 137.88 53.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.665 -1.605 . . . . 75.2 106.665 169.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -144.41 136.54 26.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.925 -0.769 . . . . 74.14 108.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.5 t80 -142.32 112.19 6.86 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 106.939 -1.504 . . . . 74.13 106.939 175.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -118.67 108.45 14.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.98 -0.748 . . . . 63.22 108.98 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.95 81.95 2.87 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.479 -1.304 . . . . 72.44 107.479 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.31 -19.07 20.04 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.153 1.902 . . . . 71.44 111.694 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 45.7 m-80 -120.65 38.5 4.0 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.014 0.925 . . . . 74.42 109.181 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.66 -44.47 99.5 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.073 -0.967 . . . . 74.11 112.632 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.85 -28.96 67.61 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.394 1.533 . . . . 73.54 112.856 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.1 m170 -82.19 -26.31 33.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.543 0.737 . . . . 64.41 112.158 -169.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG22 HD13 ' A' ' 68' ' ' LEU . 7.3 p -63.9 -19.2 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.202 0.525 . . . . 74.12 111.807 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -83.29 -39.78 20.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.725 0.81 . . . . 75.03 110.998 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.79 -28.22 58.29 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.92 0.488 . . . . 75.21 110.724 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.68 160.87 22.31 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.284 0.634 . . . . 74.55 110.099 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.32 144.88 26.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.245 -0.65 . . . . 61.43 109.245 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.413 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.2 t-105 -75.77 89.01 2.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.66 0.784 . . . . 74.35 110.557 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -122.36 77.09 44.31 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 107.718 -1.215 . . . . 72.2 107.718 169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -84.97 145.89 10.09 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.486 2.124 . . . . 70.45 113.174 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -98.86 104.61 16.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.19 -1.411 . . . . 65.14 107.19 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 t -80.64 116.14 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.802 0.841 . . . . 74.43 108.881 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 59.2 tttm -120.35 113.99 21.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.713 0.805 . . . . 75.22 109.391 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.626 HD22 HD21 ' A' ' 128' ' ' LEU . 10.5 mp -104.87 125.74 51.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.968 -0.752 . . . . 72.35 108.968 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.663 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.3 m-20 -117.05 128.57 55.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.175 -1.046 . . . . 72.42 108.175 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -115.2 121.02 41.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.263 0.625 . . . . 71.52 109.69 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -138.86 154.57 48.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.208 1.003 . . . . 74.43 109.037 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -140.05 153.2 46.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.487 0.715 . . . . 72.52 109.484 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.38 113.28 6.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.015 -0.735 . . . . 74.03 109.015 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.2 p -90.07 165.58 13.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.711 0.404 . . . . 74.45 110.33 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 47.8 t -166.46 157.34 12.64 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.227 1.011 . . . . 61.32 108.568 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.63 132.8 55.62 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.899 -0.778 . . . . 74.23 108.899 169.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 57' ' ' GLU . 70.3 mt -105.52 -37.45 6.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.885 0.874 . . . . 74.44 110.405 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.49 -175.14 5.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.727 0.811 . . . . 71.0 109.82 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.31 104.71 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.046 0.538 . . . . 62.31 110.398 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.548 ' H ' HD23 ' G' ' 173' ' ' LEU . 9.2 m-20 70.82 10.11 6.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.742 1.617 . . . . 71.41 112.432 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.07 112.42 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.0 -1.482 . . . . 73.52 107.0 170.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -117.74 150.18 39.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.502 0.721 . . . . 74.01 109.403 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 33.2 tt0 -111.11 118.31 35.66 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.48 -0.933 . . . . 71.13 108.48 171.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.8 115.57 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.916 -1.142 . . . . 74.23 107.916 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.618 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 53.7 t -98.01 137.52 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.387 0.675 . . . . 75.45 109.323 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.96 110.1 21.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.053 -1.462 . . . . 72.31 107.053 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -101.39 101.62 12.28 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.806 -0.813 . . . . 72.2 108.806 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -94.6 140.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.746 -1.205 . . . . 74.33 107.746 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 m -128.33 144.49 51.14 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.666 -0.864 . . . . 74.43 108.666 171.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.568 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 35.1 t -142.06 109.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.489 1.116 . . . . 71.34 108.543 -171.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -109.63 137.94 46.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.538 -0.541 . . . . 70.22 109.538 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.36 120.48 34.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.625 -1.25 . . . . 71.14 107.625 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -130.52 131.7 45.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.611 . . . . 74.44 110.866 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 HG22 ' A' ' 31' ' ' VAL . 49.6 mt -87.12 83.64 7.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.02 1.328 . . . . 74.23 107.852 177.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.93 -89.47 0.77 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.768 -0.651 . . . . 53.51 111.88 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.41 -28.67 9.24 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.771 0.828 . . . . 74.11 110.866 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.17 117.15 29.38 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.907 0.483 . . . . 74.25 111.144 -171.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -66.95 110.38 3.32 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.117 0.484 . . . . 74.33 112.021 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.73 -57.01 14.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.796 1.239 . . . . 74.13 110.221 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.21 173.6 16.73 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.732 0.777 . . . . 71.42 111.986 175.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.1 tp -141.25 144.04 34.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.504 1.522 . . . . 74.45 107.837 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.568 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -140.61 125.04 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.36 1.064 . . . . 63.44 108.769 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.99 116.52 8.09 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.929 0.491 . . . . 72.25 109.725 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.78 111.76 26.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.105 0.962 . . . . 72.23 109.021 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.05 79.66 9.55 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.027 -1.101 . . . . 73.23 108.027 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.44 90.29 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.931 1.292 . . . . 73.5 108.699 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.55 144.23 19.65 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 116.064 -0.516 . . . . 75.43 112.119 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.83 130.26 4.81 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 111.791 -0.524 . . . . 75.45 111.791 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 39.2 mt -82.14 125.27 39.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.53 -0.915 . . . . 74.3 108.53 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 21.0 m-85 -131.51 119.45 21.56 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.895 -1.15 . . . . 65.52 107.895 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -79.03 99.83 7.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.977 -0.749 . . . . 73.22 108.977 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.484 HG21 ' HD2' ' A' ' 11' ' ' PHE . 2.7 pp -112.61 153.48 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.354 0.662 . . . . 74.44 110.408 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.88 158.05 7.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.85 0.86 . . . . 73.14 110.231 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.1 -10.36 60.93 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 114.929 0.732 . . . . 75.41 114.929 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.534 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.32 138.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.244 0.618 . . . . 75.12 109.469 -179.003 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 4' ' ' GLN . 12.8 tt0 -148.21 175.7 10.84 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.535 -0.913 . . . . 73.55 108.535 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.444 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 63.45 -133.61 41.88 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.098 0.249 . . . . 72.14 112.953 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -73.43 -21.7 60.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.976 0.511 . . . . 53.31 111.113 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -71.14 -41.19 70.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 74.41 110.169 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.404 ' CE ' ' HA ' ' G' ' 175' ' ' PHE . 26.7 ttt -74.01 -38.8 63.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.681 -0.69 . . . . 73.42 109.936 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.21 69.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.648 -0.705 . . . . 75.52 111.545 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -77.12 -38.51 52.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.408 0.683 . . . . 72.3 109.964 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.4 -66.83 0.53 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.502 0.502 . . . . 72.02 110.649 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -82.24 -10.96 58.94 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.017 0.747 . . . . 72.14 113.017 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.97 2.99 25.69 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 118.947 -0.919 . . . . 74.3 114.469 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.23 -58.47 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.583 1.191 . . . . 73.34 112.051 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.463 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.9 t80 -67.06 -51.51 53.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.988 0.915 . . . . 75.5 111.737 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.0 m -71.73 -37.69 5.5 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.249 -0.882 . . . . 64.12 112.084 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.3 -39.57 72.27 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.911 1.741 . . . . 74.15 113.002 161.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.06 -24.27 61.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.619 0.768 . . . . 74.42 111.132 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.8 mm -64.79 -43.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 109.149 -0.686 . . . . 72.11 109.149 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.546 HD22 ' HA3' ' A' ' 82' ' ' GLY . 47.3 mt -75.8 -25.48 56.42 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.988 -1.006 . . . . 64.34 111.769 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -64.41 -40.35 50.23 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 114.381 1.252 . . . . 73.44 114.381 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.55 -31.57 86.97 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 121.873 1.716 . . . . 74.3 113.502 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -87.64 -29.91 20.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.549 0.74 . . . . 73.24 111.001 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.9 86.06 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.725 -0.843 . . . . 74.44 108.725 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -62.45 -44.44 96.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.362 1.065 . . . . 73.3 110.029 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.431 ' HG2' HH12 ' B' ' 120' ' ' ARG . 10.4 tt0 -49.66 -54.28 19.53 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.278 1.031 . . . . 71.04 110.927 176.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.14 -42.95 88.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.566 -1.197 . . . . 63.11 111.561 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.533 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 97.2 mt -67.01 -62.58 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.911 0.485 . . . . 72.54 110.415 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.457 HG23 ' HG3' ' A' ' 125' ' ' GLN . 57.9 m -48.96 -35.37 14.97 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.004 1.322 . . . . 75.41 111.986 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.5 t -71.13 -49.65 41.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.027 -0.511 . . . . 72.42 110.875 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.591 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 58.5 mtm -56.33 -42.89 78.41 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.06 0.457 . . . . 74.52 110.847 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.3 t -61.12 -49.16 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.912 1.285 . . . . 72.14 110.633 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.7 -30.96 68.73 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.615 0.366 . . . . 64.44 111.385 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.481 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.5 mtt-85 -71.08 -30.76 66.96 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.928 0.891 . . . . 72.53 110.532 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.0 6.34 49.47 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.021 -0.536 . . . . 53.12 113.507 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.412 HG22 ' HE ' ' B' ' 15' ' ' ARG . 37.8 m 74.06 7.84 4.76 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 125.413 1.485 . . . . 73.24 111.054 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 31' ' ' VAL . 89.0 m-85 -81.71 159.02 67.39 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 123.493 0.717 . . . . 64.53 109.163 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.467 ' HB3' ' HA ' ' G' ' 195' ' ' PHE . 73.2 Cg_endo -69.06 161.57 45.3 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.475 2.117 . . . . 74.22 111.614 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.457 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.5 tt0 -67.54 132.68 48.03 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.854 0.359 . . . . 74.33 110.551 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -111.69 106.62 15.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.93 0.892 . . . . 74.33 109.134 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.97 90.79 4.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.546 . . . . 63.51 110.335 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.626 HD21 HD22 ' A' ' 42' ' ' LEU . 48.4 mt -74.57 116.51 15.34 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.586 -0.894 . . . . 75.33 108.586 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 141.58 97.29 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 122.068 0.147 . . . . 62.1 111.242 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.12 121.23 8.63 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.193 1.928 . . . . 71.4 110.341 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.593 HG21 ' HG ' ' G' ' 186' ' ' LEU . 86.5 t -98.14 109.06 23.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.803 -1.184 . . . . 62.22 107.803 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.5 91.71 6.76 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.657 -1.156 . . . . 72.24 108.238 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -61.34 -28.59 69.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.945 -1.025 . . . . 73.54 110.814 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.67 -39.24 61.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.193 1.397 . . . . 74.34 112.047 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.31 -58.71 7.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.597 0.759 . . . . 72.4 110.945 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.28 -33.75 74.92 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.632 0.582 . . . . 74.11 111.537 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.414 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.6 t80 -65.73 -60.51 2.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.569 0.747 . . . . 74.35 110.508 -175.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.72 -41.99 99.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.939 0.775 . . . . 75.01 111.02 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 29.7 t30 -55.49 -51.45 66.94 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.544 1.153 . . . . 74.23 110.939 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -62.76 -39.88 95.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.597 0.759 . . . . 75.42 111.643 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 77.5 mt -67.39 -51.28 53.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.556 0.535 . . . . 73.23 111.533 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -176.93 22.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.565 0.541 . . . . 72.44 110.931 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 87.1 mt-30 52.55 48.46 22.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.917 0.865 . . . . 75.04 110.979 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -70.02 112.29 6.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.171 -1.377 . . . . 74.43 109.443 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.19 84.72 1.04 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.285 0.564 . . . . 65.32 110.124 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.19 39.85 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.316 -0.856 . . . . 62.55 112.914 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.38 99.8 6.68 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.371 -0.974 . . . . 75.41 108.371 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.96 72.3 0.11 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.601 -0.6 . . . . 73.11 111.601 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 m -76.19 85.95 3.03 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.303 0.573 . . . . 73.21 109.596 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 95.04 7.64 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.53 -0.915 . . . . 72.03 108.53 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.24 -36.7 12.46 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.178 0.991 . . . . 73.12 110.118 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 79.9 -44.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.004 1.722 . . . . 75.03 114.352 167.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -77.03 157.68 31.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.176 0.59 . . . . 74.35 111.584 -170.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.65 108.95 3.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.884 0.874 . . . . 75.13 110.255 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.734 0.813 . . . . 75.14 110.098 -176.505 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.46 ' HB2' ' HG2' ' B' ' 3' ' ' GLU . 15.4 ptp . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.93 0.872 . . . . 71.43 110.244 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -88.21 66.98 8.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.788 -0.819 . . . . 71.44 108.788 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.46 ' HG2' ' HB2' ' B' ' 1' ' ' MET . 9.8 mm-40 -94.62 174.94 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.153 -0.931 . . . . 74.33 110.517 -174.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.74 163.98 15.68 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.603 0.761 . . . . 74.44 110.075 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -133.55 144.76 49.55 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.131 0.572 . . . . 73.23 109.985 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -122.0 -143.06 0.33 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.34 -0.985 . . . . 74.53 108.34 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.8 p -63.82 87.91 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.258 0.551 . . . . 75.2 109.625 169.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.9 -171.12 2.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.072 0.949 . . . . 71.24 110.424 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.2 ptm 54.67 178.23 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.316 1.846 . . . . 63.53 113.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -150.56 143.0 24.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.487 0.715 . . . . 72.15 110.176 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -139.44 134.0 31.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.273 -1.01 . . . . 74.52 108.273 171.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -149.62 108.35 3.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.251 -0.648 . . . . 74.12 109.251 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -78.47 133.97 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.524 0.73 . . . . 74.41 109.309 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -105.6 -50.09 3.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.674 0.39 . . . . 65.21 110.925 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.412 ' HE ' HG22 ' A' ' 122' ' ' THR . 45.9 ttt180 -159.99 146.34 15.86 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.456 0.17 . . . . 71.51 110.963 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.1 143.02 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.067 -1.457 . . . . 72.24 107.067 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.412 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.1 p90 -171.29 141.87 1.65 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 118.741 0.701 . . . . 73.13 111.198 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.6 m -74.15 118.55 17.24 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.739 -0.837 . . . . 74.14 108.739 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -86.71 -33.05 20.14 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.997 0.519 . . . . 74.05 110.524 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -158.21 143.46 16.63 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.867 0.321 . . . . 75.05 111.867 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.736 HD12 ' SG ' ' B' ' 113' ' ' CYS . 44.3 mm -131.88 142.35 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.823 1.249 . . . . 75.02 108.977 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.99 134.86 28.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.397 -0.964 . . . . 74.32 108.397 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -148.7 127.86 12.87 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 107.047 -1.464 . . . . 75.45 107.047 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.7 112.25 9.98 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.081 -1.081 . . . . 71.2 108.081 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.75 89.54 7.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.787 0.835 . . . . 75.32 108.954 175.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.7 -27.56 38.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.092 1.861 . . . . 75.54 111.696 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -113.82 29.44 8.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.626 0.77 . . . . 64.12 110.463 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.3 -48.45 55.85 Favored Pre-proline 0 CA--C 1.574 1.896 0 C-N-CA 124.905 1.282 . . . . 74.45 113.008 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.42 -25.48 3.8 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.044 1.83 . . . . 74.34 113.396 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.54 1.7 44.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.411 0.684 . . . . 74.54 111.923 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.47 -14.18 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.471 1.108 . . . . 73.13 111.237 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.09 -42.12 93.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.916 0.886 . . . . 73.23 110.408 169.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -75.56 -40.67 56.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.306 1.042 . . . . 74.14 110.289 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 32.1 mmtp -108.37 67.96 0.68 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.392 -1.276 . . . . 74.23 109.521 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.404 ' HB2' ' N ' ' F' ' 197' ' ' TYR . 8.5 p-10 -89.37 75.64 7.65 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.116 -0.947 . . . . 72.51 111.078 -173.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -169.61 170.95 7.82 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 126.098 1.759 . . . . 75.33 109.637 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.495 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 54.1 tt0 -67.57 122.06 81.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 123.318 0.647 . . . . 73.25 110.404 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.31 151.41 80.76 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.92 2.413 . . . . 74.22 113.377 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.41 106.63 6.11 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.836 -0.802 . . . . 74.33 108.836 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.77 131.94 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.242 1.017 . . . . 75.05 110.803 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -124.43 143.1 50.82 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.992 -0.744 . . . . 75.14 108.992 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.596 HD23 HD12 ' B' ' 126' ' ' LEU . 1.0 OUTLIER -129.3 140.99 51.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.881 0.372 . . . . 71.53 110.829 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.49 145.13 49.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.372 1.069 . . . . 75.15 109.558 -168.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.404 HD23 HD23 ' F' ' 186' ' ' LEU . 31.0 tp -93.96 131.82 39.04 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.4 0.68 . . . . 74.21 109.719 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.48 124.38 28.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.971 0.908 . . . . 75.44 108.695 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.4 m -112.55 113.95 26.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.758 0.423 . . . . 73.44 110.169 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.95 149.03 39.42 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.774 -1.195 . . . . 74.24 107.774 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -143.15 173.03 11.93 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.84 0.352 . . . . 74.12 110.544 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.3 p -157.32 173.99 16.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.383 1.073 . . . . 70.31 108.948 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -124.58 121.72 35.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.674 0.39 . . . . 73.24 110.566 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.486 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 70.8 mt -80.57 -44.35 19.16 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.158 0.583 . . . . 72.35 111.126 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 -173.2 4.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.917 0.887 . . . . 74.13 109.746 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -61.72 112.77 2.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.433 -0.803 . . . . 74.31 110.277 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.451 ' N ' HD22 ' F' ' 173' ' ' LEU . 4.2 m-20 70.52 0.28 3.19 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.922 1.689 . . . . 63.13 112.745 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.66 92.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 N-CA-C 107.543 -1.28 . . . . 74.22 107.543 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.26 171.05 8.96 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.29 0.636 . . . . 65.23 109.837 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.486 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 5.0 tm-20 -143.72 101.2 3.72 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.281 -1.377 . . . . 74.02 107.281 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.3 122.57 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.5 0.72 . . . . 70.32 110.304 -174.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 41.2 t -102.38 114.52 42.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.508 0.723 . . . . 73.54 109.532 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.16 106.87 18.79 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.714 -1.217 . . . . 71.44 107.714 178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -95.18 116.41 28.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.252 -0.647 . . . . 65.23 109.252 170.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.432 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.0 t -105.43 120.88 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.292 -1.374 . . . . 72.14 107.292 164.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -96.51 146.84 24.44 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 71.11 109.0 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.51 HG22 HG21 ' B' ' 114' ' ' ILE . 41.6 t -134.7 128.66 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.816 0.846 . . . . 75.3 109.461 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.5 m -123.61 138.78 54.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.111 -0.949 . . . . 73.51 108.543 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.71 149.82 37.75 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.498 0.719 . . . . 53.21 109.205 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.1 p -143.94 137.74 28.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.708 0.63 . . . . 73.02 110.25 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 38.8 mt -90.9 98.73 11.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.077 -1.823 . . . . 74.23 106.077 170.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.63 -129.68 14.09 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.538 -0.755 . . . . 65.15 111.686 -169.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -92.75 2.83 56.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.054 0.941 . . . . 74.42 111.021 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -115.65 138.09 51.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.244 1.018 . . . . 74.24 109.02 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 132.7 49.85 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.317 0.58 . . . . 73.43 111.846 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.403 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -92.87 -58.65 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.376 1.071 . . . . 73.24 109.073 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -157.82 157.03 32.53 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.275 -1.329 . . . . 74.1 110.544 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.3 mt -135.18 110.71 9.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 106.673 -1.603 . . . . 72.55 106.673 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.95 157.86 25.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.357 -0.608 . . . . 50.44 109.357 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -164.6 135.08 4.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.979 -0.749 . . . . 71.21 108.979 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.425 HG11 ' HA ' ' B' ' 110' ' ' ALA . 68.9 t -123.92 139.83 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.546 -0.752 . . . . 71.24 109.086 173.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -122.66 89.13 3.06 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.489 -0.93 . . . . 74.54 108.489 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.36 101.23 12.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.2 -1.037 . . . . 64.41 108.2 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.5 159.32 28.27 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.24 -0.744 . . . . 74.12 111.24 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.92 129.36 2.38 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 112.002 -0.439 . . . . 33.0 112.002 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.412 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.2 mt -85.15 124.13 39.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.578 -0.897 . . . . 75.24 108.578 174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -136.33 158.11 45.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.162 0.985 . . . . 75.32 108.883 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -130.93 114.8 15.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.344 -0.613 . . . . 71.2 109.344 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.411 ' HB ' HD12 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -125.72 143.02 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.384 0.673 . . . . 74.12 110.003 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.03 167.86 29.19 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.98 0.912 . . . . 73.51 109.099 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.47 -70.19 1.22 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.847 -0.501 . . . . 74.15 111.847 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.411 HD12 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -57.62 141.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.823 0.449 . . . . 71.14 110.623 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.558 ' HG3' ' HG3' ' F' ' 174' ' ' MET . 31.0 tt0 -151.4 154.24 36.26 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.93 0.332 . . . . 75.52 110.593 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.21 -124.33 13.52 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.389 0.431 . . . . 73.53 112.7 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.6 m -65.76 -32.33 73.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.61 0.764 . . . . 75.34 110.121 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -69.38 -36.45 76.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.804 0.842 . . . . 73.11 110.512 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.707 ' SD ' ' HG2' ' F' ' 174' ' ' MET . 18.0 ttt -72.6 -45.6 58.28 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.96 -0.385 . . . . 75.0 109.96 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.92 66.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.87 0.468 . . . . 71.34 112.057 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -73.36 -33.2 64.94 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.686 0.794 . . . . 75.42 110.806 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -86.26 -67.42 0.81 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.284 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.684 HD23 ' HE3' ' B' ' 94' ' ' MET . 16.8 tp -61.15 -32.36 72.08 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.597 1.159 . . . . 74.24 112.709 -175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.73 1.97 52.56 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.354 -0.692 . . . . 73.25 114.663 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.96 -52.2 0.33 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.904 0.852 . . . . 72.42 111.492 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -73.63 -46.8 44.62 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.017 0.527 . . . . 63.02 111.993 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 78.8 m -63.41 -44.16 81.36 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 118.814 -0.612 . . . . 75.53 111.207 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.96 -36.53 89.69 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.893 1.729 . . . . 73.34 113.396 164.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.7 -31.04 71.16 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 122.835 0.454 . . . . 72.41 111.432 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.403 HG22 ' NH2' ' D' ' 111' ' ' ARG . 94.7 mt -61.41 -50.76 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.913 0.885 . . . . 75.42 109.964 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 46.4 mt -77.58 -11.51 59.87 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.487 1.115 . . . . 73.12 112.135 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -69.24 -44.06 26.02 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.883 1.273 . . . . 73.13 113.621 -165.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.64 -34.47 51.46 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 121.568 1.512 . . . . 75.21 112.344 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -63.71 -41.67 98.06 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.715 0.634 . . . . 75.44 110.136 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -69.03 -42.76 75.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.447 -0.797 . . . . 73.43 110.325 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -57.24 -54.71 43.7 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.643 1.177 . . . . 73.13 111.776 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.08 -38.81 91.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.176 0.99 . . . . 73.32 110.395 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' B' ' 21' ' ' ILE . 8.7 t -67.65 -32.91 73.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.6 -0.727 . . . . 74.53 111.78 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.51 HG21 HG22 ' B' ' 64' ' ' VAL . 74.5 mt -65.52 -55.64 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.466 -0.568 . . . . 73.24 109.466 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 5.0 m -56.93 -32.17 65.71 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.277 0.986 . . . . 62.44 110.983 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.62 -53.2 51.42 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.484 -1.235 . . . . 70.42 110.747 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.1 mmt -67.68 -32.01 72.38 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.663 0.385 . . . . 74.51 111.703 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.13 -42.75 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.237 1.015 . . . . 73.4 110.688 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.03 -25.32 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.94 0.496 . . . . 74.52 111.739 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' B' ' 116' ' ' SER . 80.8 mtt-85 -66.85 -38.58 86.63 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.799 0.439 . . . . 75.51 109.848 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.41 4.21 56.37 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.263 -0.88 . . . . 75.32 113.148 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 66.8 p 59.44 50.73 7.25 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.921 1.688 . . . . 73.02 112.035 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.536 ' HA ' ' HZ ' ' F' ' 195' ' ' PHE . 59.6 m-85 -120.41 158.53 50.92 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.684 1.194 . . . . 72.25 109.795 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.495 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.2 Cg_exo -72.37 -174.65 1.49 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.57 2.847 . . . . 72.24 115.435 -166.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -58.85 130.66 48.05 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.839 -1.528 . . . . 74.23 112.118 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.596 HD12 HD23 ' B' ' 42' ' ' LEU . 59.0 tp -138.64 83.83 1.98 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.669 -1.234 . . . . 75.41 107.669 171.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.663 -1.236 . . . . 75.44 107.663 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.547 HD11 HD13 ' F' ' 186' ' ' LEU . 2.5 tt -87.0 130.62 34.38 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.581 -0.896 . . . . 75.0 108.581 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.43 34.76 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.236 0.615 . . . . 73.44 110.466 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.06 131.86 26.45 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.192 1.928 . . . . 74.33 110.984 175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.89 143.79 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 122.957 0.503 . . . . 71.54 110.384 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -86.99 111.83 21.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.735 0.814 . . . . 62.14 109.24 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -67.28 -27.89 67.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.95 0.9 . . . . 72.14 111.43 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.8 -44.69 40.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.261 1.025 . . . . 65.2 111.01 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.98 -34.19 74.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.096 -0.502 . . . . 72.32 111.064 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.473 HD21 ' HE1' ' F' ' 184' ' ' TRP . 5.5 tt -56.88 -48.54 77.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.947 0.899 . . . . 74.11 111.139 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -65.83 -33.6 76.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.794 0.838 . . . . 74.43 110.909 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.411 ' HE2' ' SD ' ' D' ' 9' ' ' MET . 1.1 tmt? -72.23 -37.23 69.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.192 0.597 . . . . 64.52 111.856 -176.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -74.41 -20.25 60.12 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 120.561 0.219 . . . . 72.12 110.799 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -86.4 -42.83 13.32 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 74.53 109.995 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.94 37.15 2.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.844 0.858 . . . . 74.5 110.062 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.5 147.93 20.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.119 0.968 . . . . 72.43 111.698 171.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.12 117.63 10.3 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.602 -0.888 . . . . 74.21 108.602 -173.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' D' ' 8' ' ' GLU . 22.2 tt0 -148.63 79.69 1.43 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.044 -1.095 . . . . 72.12 108.044 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.57 148.52 48.08 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.68 -0.691 . . . . 73.21 112.255 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.14 -45.79 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.791 -1.095 . . . . 74.32 110.799 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -168.55 163.56 12.39 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.539 1.136 . . . . 75.25 110.026 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.67 141.92 13.1 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.286 -0.726 . . . . 72.14 111.286 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 152.22 34.48 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.704 0.801 . . . . 75.15 110.37 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.62 85.6 2.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.738 -0.838 . . . . 75.22 108.738 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.432 ' HG3' ' HG2' ' B' ' 153' ' ' GLN . 13.5 tp10 -164.19 153.68 14.03 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.496 -0.775 . . . . 74.21 109.714 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -133.29 83.29 2.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.845 0.858 . . . . 72.33 109.177 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.432 ' HG2' ' HG3' ' B' ' 151' ' ' GLU . 21.0 pt20 -158.63 163.69 36.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.749 0.819 . . . . 63.21 110.166 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -151.73 149.32 28.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.918 0.887 . . . . 74.35 109.321 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.663 0.785 . . . . 75.31 109.497 -177.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtm . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.294 -0.262 . . . . 65.24 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m 57.8 51.91 8.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.339 1.056 . . . . 71.54 112.327 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -66.53 -39.04 88.41 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 114.781 -1.099 . . . . 75.21 109.573 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.59 85.71 0.92 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.743 1.217 . . . . 72.33 108.504 168.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.98 -92.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.223 1.409 . . . . 74.54 111.32 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 97.7 6.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.016 -1.105 . . . . 74.01 108.016 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -111.69 -73.88 0.66 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.037 -1.098 . . . . 75.33 108.037 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 53.93 83.25 0.08 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.639 1.175 . . . . 75.3 112.499 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 64.18 115.4 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.093 1.357 . . . . 73.25 112.217 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m -115.56 111.71 21.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.818 1.247 . . . . 75.3 107.711 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.582 ' HA ' HG21 ' C' ' 86' ' ' ILE . 41.5 t80 -125.99 120.1 29.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.11 0.564 . . . . 75.23 109.841 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -139.02 128.94 25.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.64 0.376 . . . . 71.11 110.066 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 tp -80.99 136.83 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.388 -0.597 . . . . 72.44 109.388 170.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.65 -49.7 3.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.46 0.704 . . . . 73.21 110.17 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -160.73 136.47 8.16 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.144 -0.48 . . . . 74.32 110.313 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.83 143.52 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.338 -1.356 . . . . 73.54 107.338 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -171.5 162.66 6.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.33 0.586 . . . . 72.21 110.754 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -83.8 113.64 21.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.456 -0.793 . . . . 64.32 109.137 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.4 ' HZ1' ' HD3' ' D' ' 29' ' ' PRO . 57.7 mmtt -64.76 -46.9 80.23 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 167.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -142.8 141.61 31.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.42 -1.718 . . . . 75.54 109.791 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.569 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -140.73 143.43 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.388 -1.708 . . . . 71.33 106.388 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -155.69 151.6 27.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.745 0.418 . . . . 61.04 110.117 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -155.62 121.49 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.769 -1.197 . . . . 52.31 107.769 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.36 136.61 54.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.374 0.67 . . . . 71.35 109.804 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.59 77.93 8.56 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.843 -1.169 . . . . 64.31 107.843 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.53 -9.75 23.09 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.371 2.047 . . . . 74.03 111.943 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -109.38 19.43 19.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.716 1.206 . . . . 73.33 110.213 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.72 -49.8 81.13 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 124.903 1.281 . . . . 74.43 113.475 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.95 -30.12 1.43 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.421 1.414 . . . . 73.45 113.31 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -69.41 -28.06 65.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.524 0.729 . . . . 73.04 111.955 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.87 -12.29 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.217 0.607 . . . . 74.0 111.411 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.88 -31.67 72.74 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.888 0.875 . . . . 74.25 111.261 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.7 20.83 17.96 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.4 0.68 . . . . 73.54 110.146 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.734 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -100.83 158.27 16.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.095 0.558 . . . . 74.0 109.887 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -77.44 121.32 23.67 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.281 -1.007 . . . . 74.25 108.281 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -85.0 91.15 8.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.598 0.713 . . . . 74.23 110.434 -172.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -131.32 69.66 82.0 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.559 -1.2 . . . . 72.04 108.239 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.56 104.65 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.655 2.236 . . . . 72.13 111.933 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -86.99 118.01 26.08 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.753 -0.832 . . . . 64.34 108.753 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.434 HG12 HD21 ' C' ' 126' ' ' LEU . 48.2 t -80.2 128.29 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 74.33 111.448 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.36 104.31 7.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.688 1.195 . . . . 73.32 107.865 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.586 HD12 HD13 ' E' ' 186' ' ' LEU . 0.3 OUTLIER -86.65 165.83 15.83 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.838 0.352 . . . . 75.44 110.407 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -138.35 146.25 42.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.384 -1.339 . . . . 75.53 107.384 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.7 tp -138.2 102.26 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.921 -0.77 . . . . 72.3 108.921 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.72 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 7.1 m-20 -120.09 142.32 48.99 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.427 0.691 . . . . 73.12 109.758 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -114.88 117.56 31.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.137 -0.69 . . . . 63.03 109.137 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.92 153.9 24.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.718 -1.216 . . . . 73.13 107.718 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.3 p -164.34 154.17 14.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.934 0.397 . . . . 70.12 111.328 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 15.5 p -170.34 138.92 1.63 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.248 1.019 . . . . 73.24 109.174 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -80.32 135.99 36.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.955 0.502 . . . . 72.31 109.817 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' C' ' 57' ' ' GLU . 63.7 mt -104.57 -26.56 12.3 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.83 0.852 . . . . 74.54 111.591 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.23 -172.99 1.39 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.383 0.673 . . . . 64.4 110.955 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.28 105.92 0.67 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 123.985 0.803 . . . . 72.33 110.919 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.53 10.04 5.52 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.254 1.422 . . . . 72.31 112.519 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.41 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 108.234 -1.024 . . . . 75.33 108.234 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -108.31 158.67 17.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.124 0.97 . . . . 73.45 108.75 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.575 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.4 tt0 -126.07 127.78 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.281 -1.007 . . . . 74.41 108.281 172.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 81.1 t -117.93 129.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.939 -1.134 . . . . 63.03 107.939 170.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.09 107.48 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.336 -0.987 . . . . 71.42 108.336 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.415 HD23 HG21 ' C' ' 62' ' ' VAL . 0.9 OUTLIER -86.19 106.21 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.069 -1.086 . . . . 75.04 108.069 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.72 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 57.4 ttt180 -82.12 105.38 13.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.415 HG21 HD23 ' C' ' 60' ' ' LEU . 13.6 t -105.42 130.99 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.213 -1.032 . . . . 75.13 108.213 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 21.9 m -129.7 146.29 51.48 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.02 -0.733 . . . . 74.41 109.02 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.485 HG22 HD12 ' C' ' 114' ' ' ILE . 50.8 t -131.07 127.94 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.948 0.899 . . . . 72.5 108.655 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.485 HG23 HD22 ' C' ' 75' ' ' LEU . 4.2 m -123.2 109.16 13.64 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.657 -1.238 . . . . 72.42 107.657 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.67 121.14 41.14 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.056 -1.09 . . . . 54.31 108.056 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -129.8 133.05 46.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.282 0.563 . . . . 71.31 110.593 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.734 HD12 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -87.1 33.88 0.68 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 125.726 1.61 . . . . 74.34 110.085 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.77 -103.1 2.17 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.176 -0.769 . . . . 60.02 111.176 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.35 -31.61 17.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.427 0.691 . . . . 75.32 110.16 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.411 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 4.0 tp10 -79.21 120.22 23.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 75.32 109.2 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -77.56 122.36 25.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.15 -0.685 . . . . 74.52 109.15 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.15 -50.29 34.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 63.31 109.598 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -160.84 170.66 20.23 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.422 -1.263 . . . . 74.31 110.98 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.485 HD22 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -136.35 147.23 47.27 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.996 -1.483 . . . . 73.33 106.996 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.4 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -147.81 149.21 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.478 -0.934 . . . . 75.44 108.478 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -157.61 118.81 3.58 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.848 0.459 . . . . 75.33 109.884 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -121.64 112.47 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.517 0.727 . . . . 73.01 109.364 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 49.7 mt-30 -94.82 99.64 11.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.704 -0.85 . . . . 74.54 108.704 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.584 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.1 tp-100 -85.07 104.93 15.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 71.43 110.542 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.06 145.67 22.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.47 -0.332 . . . . 71.11 112.326 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.456 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.92 127.85 2.72 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.057 -0.417 . . . . 62.53 112.057 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' D' ' 29' ' ' PRO . 12.6 mm -91.19 125.03 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.606 0.762 . . . . 64.44 109.124 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -133.69 118.31 17.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.864 -0.791 . . . . 74.22 108.864 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.1 p -85.69 97.37 10.09 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.817 -1.179 . . . . 74.23 107.817 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.582 HG21 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -125.22 135.48 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-O 121.531 0.682 . . . . 70.42 111.235 -174.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.95 -178.54 5.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.191 1.396 . . . . 74.54 107.905 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.74 -30.56 4.18 Favored Glycine 0 N--CA 1.477 1.419 0 C-N-CA 121.391 -0.433 . . . . 71.4 113.642 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -68.0 140.77 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.098 0.959 . . . . 74.42 111.764 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.469 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 41.3 tt0 -155.28 151.51 28.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.267 0.627 . . . . 72.21 110.447 -174.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.3 -115.99 6.79 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.063 0.227 . . . . 73.44 112.847 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -71.95 -29.93 64.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.242 0.617 . . . . 74.22 110.874 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.469 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 42.4 mt-30 -64.1 -35.17 79.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.862 0.865 . . . . 74.22 111.105 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.1 tpt -55.07 -36.93 66.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.892 0.877 . . . . 53.04 111.054 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.49 -47.44 11.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.636 0.774 . . . . 74.23 111.523 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -73.7 -34.61 64.93 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.482 0.713 . . . . 73.45 112.656 -167.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -63.6 -55.97 19.54 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.614 0.571 . . . . 75.14 111.233 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.708 HD13 HD12 ' E' ' 177' ' ' LEU . 1.0 OUTLIER -92.83 -16.69 25.01 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.198 0.599 . . . . 74.05 112.528 -175.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.413 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.95 -14.87 38.24 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.395 -0.67 . . . . 73.34 113.8 -172.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.08 -46.25 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.46 0.63 . . . . 70.35 111.979 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -74.7 -44.25 51.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.119 0.567 . . . . 72.43 111.972 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.513 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 73.2 m -67.63 -45.48 45.94 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.464 -0.779 . . . . 73.05 111.331 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.11 -36.65 96.63 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.249 1.966 . . . . 75.12 112.734 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -61.91 -33.44 74.24 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.546 0.738 . . . . 64.43 111.712 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.0 mm -68.37 -39.31 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.165 0.586 . . . . 73.12 110.413 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.456 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.7 mt -80.84 -32.73 34.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.274 -0.876 . . . . 74.02 112.483 -171.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -54.19 -48.72 93.49 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 117.288 -1.339 . . . . 75.44 113.182 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -45.04 -43.19 15.86 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.974 2.449 . . . . 64.11 114.544 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -70.45 -45.32 66.01 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.285 0.634 . . . . 74.01 111.052 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -67.9 -37.01 81.19 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.117 0.567 . . . . 72.42 110.959 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -54.12 -51.08 65.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.341 1.456 . . . . 73.05 110.517 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.24 -32.03 66.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.224 -0.898 . . . . 64.53 110.92 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -74.6 -30.84 61.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.896 0.478 . . . . 73.51 111.609 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.485 HD12 HG22 ' C' ' 64' ' ' VAL . 94.3 mt -71.7 -46.31 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.572 -0.529 . . . . 73.42 109.572 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.587 HG23 ' HB2' ' C' ' 125' ' ' GLN . 54.2 m -51.28 -42.54 61.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 71.35 110.834 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -63.68 -52.56 60.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.811 -1.541 . . . . 75.22 110.219 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.636 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.93 -40.96 81.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.362 1.065 . . . . 73.31 113.162 -176.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.44 -46.44 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.283 0.633 . . . . 75.21 110.151 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -64.83 -27.69 69.05 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.001 -1.0 . . . . 71.03 111.648 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.6 mtt-85 -70.06 -37.26 75.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.616 0.767 . . . . 72.31 110.286 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.92 8.55 56.54 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.172 -0.793 . . . . 72.41 113.135 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 42.8 p 61.28 26.99 16.75 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 125.933 1.693 . . . . 74.14 112.664 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 51.5 m-85 -100.15 167.73 10.52 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.385 1.074 . . . . 73.14 109.606 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 45.0 Cg_endo -66.06 111.65 2.05 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 122.051 1.834 . . . . 62.42 111.682 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.587 ' HB2' HG23 ' C' ' 115' ' ' THR . 0.0 OUTLIER -47.47 143.32 3.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.569 1.147 . . . . 71.42 112.048 -173.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.434 HD21 HG12 ' C' ' 40' ' ' VAL . 1.2 tm? -111.13 91.25 3.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.21 0.529 . . . . 75.45 110.13 -173.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -129.95 92.33 3.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.866 -1.161 . . . . 64.1 107.866 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.476 HD13 ' HB1' ' E' ' 189' ' ' ALA . 61.6 mt -87.36 154.25 20.82 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.104 0.962 . . . . 73.43 111.442 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.72 136.27 13.28 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 124.42 1.075 . . . . 75.11 112.143 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.541 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 40.8 Cg_endo -63.85 108.4 0.9 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.989 2.46 . . . . 75.24 112.537 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.33 87.75 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.375 0.67 . . . . 71.12 109.492 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.77 101.59 8.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.945 -0.761 . . . . 61.1 108.945 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.88 -43.66 73.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.07 0.948 . . . . 74.05 111.096 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.07 -19.37 62.48 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.99 -1.004 . . . . 65.01 111.66 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.42 -48.51 64.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.623 0.369 . . . . 63.02 110.746 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -38.37 89.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.275 -0.421 . . . . 72.34 110.044 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.88 -29.82 70.79 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.767 0.827 . . . . 65.15 110.868 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -52.2 27.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.761 0.824 . . . . 70.53 110.967 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -69.17 -44.85 71.38 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.926 0.393 . . . . 74.44 110.715 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.91 -153.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 115.429 -0.805 . . . . 74.44 110.378 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.22 -70.62 0.11 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 125.488 1.515 . . . . 73.42 109.699 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.413 ' OE1' ' HG3' ' C' ' 144' ' ' GLN . 3.2 pp0? -88.32 -177.27 5.62 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.923 0.889 . . . . 73.43 110.92 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 97.44 2.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.552 -1.277 . . . . 75.32 107.552 172.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.413 ' HG3' ' OE1' ' C' ' 142' ' ' GLN . 22.2 mt-30 -80.67 -72.13 0.43 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.783 0.433 . . . . 74.15 110.871 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . . . -155.59 -54.84 0.09 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.338 0.655 . . . . 72.45 109.954 172.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.59 -31.8 2.62 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.618 -0.265 . . . . 62.04 112.671 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 162.63 41.09 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.659 0.784 . . . . 75.13 110.268 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.8 -163.0 9.82 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.297 -1.521 . . . . 55.25 109.297 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 92.0 m -158.16 128.95 6.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.691 -0.855 . . . . 75.43 108.691 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -109.6 88.27 2.7 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 73.43 108.818 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -79.8 73.35 6.55 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.231 -1.026 . . . . 73.43 108.231 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -154.06 174.79 14.23 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.846 1.258 . . . . 73.22 109.045 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 73.71 -2.09 2.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.833 1.253 . . . . 75.33 112.689 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t70 51.53 54.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.959 1.362 . . . . 73.21 108.211 -166.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' G' ' 173' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-N 113.428 -1.714 . . . . 65.42 111.323 -168.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.433 -0.318 . . . . 73.13 110.468 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m 73.65 173.63 0.28 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 125.283 1.433 . . . . 72.53 110.554 -164.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -77.52 -89.73 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.805 0.442 . . . . 73.32 110.901 -172.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 167.47 151.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.337 1.455 . . . . 75.41 109.087 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -160.02 140.73 12.07 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.755 -0.461 . . . . 43.42 109.755 165.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -103.68 98.29 8.18 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 65.55 108.506 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 23.8 p -76.13 -53.56 8.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.735 0.414 . . . . 64.35 109.92 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.424 ' HB3' ' OE1' ' B' ' 144' ' ' GLN . 8.8 pt-20 -161.39 45.56 0.18 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.263 -0.881 . . . . 74.04 110.165 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.411 ' SD ' ' HE2' ' B' ' 138' ' ' MET . 0.7 OUTLIER -30.61 131.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.209 1.559 . . . . 74.03 115.209 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -136.14 143.92 44.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.725 0.81 . . . . 73.1 109.11 168.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -150.47 94.05 2.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.26 -1.385 . . . . 74.32 107.26 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.447 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 80.9 mt-30 -112.11 131.89 55.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.644 0.778 . . . . 62.51 108.967 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.431 HG23 HD11 ' E' ' 204' ' ' ILE . 1.6 mp -80.04 138.68 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.231 -1.026 . . . . 75.13 108.231 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.563 ' HG2' ' HD3' ' E' ' 205' ' ' LYS . 52.8 mt-30 -106.04 -48.95 3.48 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 110.282 -0.266 . . . . 75.24 110.282 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 ttt85 -176.23 130.26 0.22 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.071 0.232 . . . . 74.4 111.618 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.408 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.1 mp -117.71 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.199 -1.037 . . . . 71.24 108.199 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -150.21 165.02 34.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.396 1.079 . . . . 73.51 110.546 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -90.85 113.55 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.289 -0.634 . . . . 74.34 109.289 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -78.95 -31.64 45.16 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.133 0.492 . . . . 74.45 109.964 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -150.37 142.29 23.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.053 -0.976 . . . . 73.3 109.3 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.636 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.1 mt -141.34 144.33 26.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.51 -1.293 . . . . 75.45 107.51 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -147.53 142.62 27.1 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.65 -0.87 . . . . 71.31 108.65 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.569 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.5 t80 -147.36 125.51 12.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.672 -1.603 . . . . 73.01 106.672 170.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.7 147.01 51.45 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.92 0.888 . . . . 75.44 108.707 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 78.43 37.08 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 107.498 -1.297 . . . . 74.24 107.498 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.21 -29.52 47.02 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.429 2.086 . . . . 74.03 112.275 -174.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -114.4 27.95 9.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.892 0.877 . . . . 64.31 110.139 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.12 -57.22 6.5 Favored Pre-proline 0 CA--C 1.576 1.974 0 N-CA-C 116.24 1.941 . . . . 64.13 116.24 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' C' ' 83' ' ' ILE . 24.1 Cg_endo -87.97 -5.17 6.91 Favored 'Trans proline' 0 C--N 1.384 2.404 0 CA-C-N 122.321 1.865 . . . . 74.24 112.955 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -79.0 -30.95 44.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.11 1.364 . . . . 74.45 108.751 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.449 HG12 ' CE1' ' D' ' 123' ' ' PHE . 3.1 t -68.13 -28.59 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.81 1.244 . . . . 61.45 110.82 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -53.65 -23.41 11.18 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.44 0.696 . . . . 74.11 112.605 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -86.56 -0.03 55.31 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.644 0.778 . . . . 64.14 112.704 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.674 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 95.6 mttt -126.96 113.12 16.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.234 1.013 . . . . 74.53 110.764 -176.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' H' ' 195' ' ' PHE . 7.7 p-10 -98.69 64.62 1.51 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.189 0.995 . . . . 65.12 110.874 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.421 ' HB2' HD21 ' D' ' 68' ' ' LEU . 14.5 m95 -126.18 173.79 8.99 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.858 0.863 . . . . 75.24 109.508 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' H' ' 194' ' ' ALA . 8.6 tp-100 -89.49 125.62 60.92 Favored Pre-proline 0 N--CA 1.476 0.842 0 N-CA-C 108.259 -1.015 . . . . 74.02 108.259 169.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.06 127.44 21.25 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.852 1.701 . . . . 75.1 111.588 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.4 OUTLIER -65.41 111.16 2.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.678 -1.23 . . . . 74.03 107.678 172.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.652 HG12 HG13 ' D' ' 64' ' ' VAL . 59.6 t -104.35 114.42 43.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 122.864 0.465 . . . . 73.34 110.36 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.404 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 4.7 tppp? -87.45 120.27 28.58 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.569 -0.741 . . . . 74.24 109.325 169.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.466 HD22 HD21 ' D' ' 128' ' ' LEU . 7.4 mp -96.27 111.72 23.7 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.486 -1.302 . . . . 64.03 107.486 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.6 t70 -109.47 119.6 39.95 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.227 -1.027 . . . . 64.44 108.227 175.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -96.58 131.12 43.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.298 0.639 . . . . 71.0 109.987 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.9 t70 -139.42 151.71 46.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.096 0.958 . . . . 74.23 108.528 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 155.98 44.76 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.401 0.68 . . . . 75.32 109.598 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.86 163.72 37.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.908 0.883 . . . . 74.12 109.096 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -150.12 153.17 35.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.113 0.565 . . . . 75.14 110.006 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.6 p -154.26 123.38 6.41 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.849 0.86 . . . . 55.34 109.005 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.99 121.07 22.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.891 0.476 . . . . 75.52 110.083 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.2 mt -89.38 -38.63 13.98 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.502 0.668 . . . . 74.35 109.393 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.16 -176.69 5.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.38 -1.282 . . . . 71.53 109.504 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 122.43 15.69 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.799 -0.637 . . . . 75.14 110.918 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 71.04 1.71 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.519 1.528 . . . . 71.34 112.55 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -110.04 123.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 124.198 0.999 . . . . 75.04 109.871 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.59 129.94 33.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.106 0.563 . . . . 64.45 109.998 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' D' ' 51' ' ' LEU . 9.3 tt0 -95.16 120.38 35.28 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.828 -1.175 . . . . 72.24 107.828 167.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.07 134.62 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.028 -0.731 . . . . 74.32 109.028 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.9 t -108.92 129.21 63.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.037 0.535 . . . . 73.05 110.029 -175.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -101.49 123.04 44.88 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.562 -1.273 . . . . 74.22 107.562 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.7 ttm-85 -108.8 102.84 11.84 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.876 -0.787 . . . . 74.43 108.876 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.82 107.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.114 -1.069 . . . . 73.3 108.114 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 45.6 m -97.68 136.1 38.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.922 -0.581 . . . . 63.12 109.603 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.652 HG13 HG12 ' D' ' 40' ' ' VAL . 53.4 t -126.67 103.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.825 1.25 . . . . 74.35 108.742 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 29.2 m -104.62 94.52 5.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.917 -1.142 . . . . 74.24 107.917 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.06 140.64 30.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.851 -0.613 . . . . 75.22 110.115 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.485 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.5 m -148.43 126.12 11.81 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.158 0.504 . . . . 70.23 111.577 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' D' ' 36' ' ' TRP . 26.2 mt -94.72 109.25 21.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.704 0.802 . . . . 71.41 109.634 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.25 -111.52 3.28 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.366 0.417 . . . . 61.03 112.283 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.57 7.96 12.78 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.367 0.667 . . . . 75.15 110.745 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.674 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 11.3 pt-20 -125.12 165.46 18.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.835 0.854 . . . . 74.32 109.302 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -75.8 136.37 40.24 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.278 0.631 . . . . 72.03 111.217 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.485 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.93 -1.137 . . . . 71.21 107.93 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.04 151.3 30.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.984 -1.007 . . . . 75.34 110.333 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.37 146.15 29.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.929 -1.137 . . . . 71.3 107.929 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.549 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 47.1 t -159.36 138.68 11.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.568 -0.53 . . . . 61.2 109.568 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.35 133.87 9.86 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.027 0.376 . . . . 74.24 110.602 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.8 118.13 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.175 0.59 . . . . 73.2 110.071 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.6 mt-30 -90.25 86.03 6.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.703 0.801 . . . . 72.24 109.24 170.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.16 95.16 6.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.661 1.185 . . . . 75.15 109.604 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.27 143.29 18.63 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 111.88 -0.488 . . . . 73.3 111.88 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.419 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -144.14 130.88 4.16 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.969 -0.453 . . . . 74.34 111.969 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 35.9 mt -90.47 133.6 31.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.693 0.797 . . . . 72.43 109.534 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -136.7 134.61 37.39 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.319 0.648 . . . . 75.2 110.176 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 40.0 m -82.46 104.36 12.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.984 -0.747 . . . . 75.14 108.984 166.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 134.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.282 1.033 . . . . 74.02 109.432 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.98 167.11 12.93 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.644 0.778 . . . . 73.01 111.39 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.13 -2.07 77.56 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 115.993 1.157 . . . . 73.52 115.993 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -123.18 169.99 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.353 1.061 . . . . 72.52 109.469 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.473 ' HB2' ' H ' ' H' ' 172' ' ' ALA . 2.6 pp20? -164.18 -173.37 3.11 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.568 0.581 . . . . 75.1 112.568 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 -145.14 31.16 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 123.932 0.777 . . . . 63.02 114.171 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.0 m -69.43 -27.19 65.05 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.363 0.665 . . . . 75.24 110.251 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -60.79 -43.41 98.16 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 110.223 -0.288 . . . . 74.12 110.223 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.591 ' HE3' ' HA ' ' H' ' 173' ' ' LEU . 50.3 ttm -68.08 -49.29 62.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.935 0.494 . . . . 74.32 111.118 176.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.22 96.52 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.5 0.72 . . . . 74.04 112.228 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -87.63 -25.02 23.76 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.558 -0.746 . . . . 73.14 110.744 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.441 HD22 HD12 ' H' ' 177' ' ' LEU . 27.3 tp -65.51 -42.79 91.67 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.151 -0.931 . . . . 72.3 111.05 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.54 -7.15 76.15 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.753 -0.658 . . . . 75.11 114.615 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.7 -62.75 0.55 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 117.672 0.736 . . . . 64.52 112.077 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -64.88 -47.01 79.4 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.562 0.579 . . . . 74.32 112.562 -167.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -65.25 -45.55 71.24 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.662 -0.685 . . . . 74.34 110.809 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.402 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 83.9 Cg_exo -52.71 -38.86 77.61 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.266 1.978 . . . . 73.43 113.995 163.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -65.46 -27.73 68.72 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 122.852 0.461 . . . . 73.11 111.603 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.25 -44.88 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.266 -0.642 . . . . 75.31 109.266 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.419 HD22 ' HA3' ' D' ' 82' ' ' GLY . 65.0 mt -76.17 -20.26 57.71 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.829 -1.078 . . . . 75.04 111.732 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -68.25 -40.22 19.89 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 117.436 -1.269 . . . . 74.31 113.989 -168.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.95 -42.2 59.49 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.722 1.651 . . . . 62.43 112.771 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -76.73 -34.94 58.08 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.186 0.994 . . . . 73.41 110.982 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.91 51.91 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.465 0.706 . . . . 70.01 110.016 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -56.22 -47.73 77.87 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.818 1.324 . . . . 74.4 110.851 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.74 -46.78 88.16 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.236 0.96 . . . . 73.24 111.727 -175.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.452 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.6 t -55.73 -41.17 73.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.301 1.001 . . . . 75.11 110.349 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.476 HG22 ' SG ' ' D' ' 76' ' ' CYS . 67.8 mt -66.73 -53.75 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.347 1.029 . . . . 73.52 110.935 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.2 m -55.82 -39.2 71.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.555 1.142 . . . . 74.52 111.148 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.69 -46.23 76.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.573 -1.194 . . . . 72.41 110.261 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.549 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.1 mtm -66.23 -30.72 71.23 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.811 0.445 . . . . 72.52 112.097 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.8 t -64.37 -45.06 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 64.21 109.394 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -74.93 -24.32 58.47 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.258 -0.428 . . . . 63.33 111.458 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -74.16 -33.11 63.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.449 0.7 . . . . 74.41 109.938 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.11 4.58 85.81 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.976 -0.556 . . . . 63.13 112.531 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p 61.44 29.6 18.51 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.168 1.787 . . . . 74.43 113.349 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.449 ' CE1' HG12 ' D' ' 31' ' ' VAL . 97.3 m-85 -87.91 168.67 16.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.001 1.32 . . . . 72.34 109.451 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.56 140.1 38.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.792 2.328 . . . . 70.11 111.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.77 130.37 32.61 Favored 'General case' 0 C--O 1.243 0.763 0 O-C-N 124.057 0.848 . . . . 72.43 111.804 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -119.32 96.43 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.24 1.016 . . . . 73.42 109.401 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.73 98.34 9.18 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.672 -0.862 . . . . 72.41 108.672 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.561 ' HA ' ' HH ' ' G' ' 202' ' ' TYR . 75.5 mt -69.23 115.33 8.38 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.213 0.605 . . . . 75.31 109.692 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.84 135.77 87.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.264 0.625 . . . . 60.34 111.828 -172.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -79.53 101.13 1.37 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.972 1.781 . . . . 71.22 110.029 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.405 HG22 HG21 ' G' ' 207' ' ' VAL . 5.9 p -107.95 114.27 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.058 0.943 . . . . 74.4 109.656 -172.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -73.64 107.9 6.17 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.661 0.743 . . . . 60.55 109.588 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -62.64 -13.19 28.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.368 1.067 . . . . 72.34 112.101 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -64.39 -50.09 69.03 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.717 1.207 . . . . 70.52 111.118 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -42.35 96.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.877 0.736 . . . . 71.32 110.322 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.408 -0.815 . . . . 74.02 111.1 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -65.73 -57.9 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 75.04 111.155 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.37 -47.12 86.64 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.325 1.015 . . . . 75.13 111.005 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.3 -38.12 84.48 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.723 0.639 . . . . 73.34 111.881 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -58.04 -46.53 85.19 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.76 0.824 . . . . 75.34 111.132 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.82 -29.77 68.18 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.644 -0.707 . . . . 72.02 111.392 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -78.68 1.29 23.39 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.188 0.595 . . . . 75.22 111.998 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -122.8 91.39 3.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 75.21 109.136 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -144.07 -42.85 0.26 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.853 0.861 . . . . 73.0 110.071 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.93 129.13 37.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.337 0.655 . . . . 70.21 110.432 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.07 -175.58 39.47 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.627 0.58 . . . . 72.11 112.06 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.33 159.01 38.41 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.978 0.511 . . . . 64.0 110.525 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -135.23 162.77 24.85 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.653 -0.703 . . . . 74.54 111.67 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -116.79 140.71 49.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.275 0.559 . . . . 74.44 110.334 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.92 147.34 29.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.744 -0.836 . . . . 74.14 108.744 168.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -165.53 90.09 0.46 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.433 -0.951 . . . . 64.55 108.433 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -159.59 173.19 16.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.356 1.462 . . . . 74.33 108.746 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -159.02 156.13 28.75 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.62 0.768 . . . . 75.21 109.647 172.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -123.05 21.32 9.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.353 0.661 . . . . 75.35 109.345 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 C-N-CA 123.568 0.747 . . . . 74.43 110.147 178.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.263 -0.273 . . . . 73.33 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.32 26.39 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 O-C-N 123.726 0.641 . . . . 75.11 112.382 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -66.92 89.42 0.16 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.246 1.018 . . . . 73.21 110.872 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 56.8 p -175.88 -58.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.085 1.354 . . . . 62.53 108.349 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -159.42 166.17 31.61 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.126 1.371 . . . . 73.1 108.725 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 87.7 mt 62.88 173.51 0.15 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.293 1.037 . . . . 73.24 111.923 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.43 ' HE3' ' H ' ' E' ' 174' ' ' MET . 29.8 mmt 55.98 30.73 16.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.806 1.642 . . . . 75.11 113.538 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 55.2 t80 66.79 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.995 1.318 . . . . 72.14 111.245 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -108.7 -81.25 0.57 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.434 0.694 . . . . 70.31 110.337 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . 0.708 HD12 HD13 ' C' ' 98' ' ' LEU . 6.1 mp 57.28 -151.73 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.47 1.108 . . . . 74.42 111.775 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 76.62 -62.47 0.41 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.983 1.313 . . . . 74.24 111.004 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . 0.414 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 26.1 tt0 -84.36 -58.37 0.37 Allowed Pre-proline 0 CA--C 1.56 1.353 0 CA-C-O 118.298 -0.858 . . . . 75.43 110.688 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 83.2 Cg_endo -83.16 102.36 1.06 Allowed 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.778 1.671 . . . . 73.43 111.544 172.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.77 113.96 2.85 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.347 -0.842 . . . . 74.31 108.747 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.25 134.83 34.25 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.034 -0.728 . . . . 75.32 109.034 -176.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 19.4 p -76.14 141.11 42.0 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.449 0.7 . . . . 71.51 110.772 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -83.79 125.36 73.44 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.752 0.821 . . . . 73.44 111.442 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -93.81 103.29 0.14 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.063 2.509 . . . . 73.34 111.846 166.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.586 HD13 HD12 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -120.68 156.59 31.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.94 0.896 . . . . 75.41 111.537 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.493 ' O ' HD11 ' C' ' 42' ' ' LEU . 37.4 pt -89.76 142.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.025 0.93 . . . . 73.42 111.313 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -102.96 74.16 1.29 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.124 -1.065 . . . . 75.11 108.124 165.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . 0.476 ' HB1' HD13 ' C' ' 128' ' ' LEU . . . -75.0 88.29 2.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.572 -0.74 . . . . 71.5 111.167 -174.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.66 -170.42 2.81 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.378 -1.283 . . . . 63.53 111.251 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -142.12 98.57 0.22 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.381 -1.088 . . . . 71.01 110.381 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.9 80.22 0.01 OUTLIER Glycine 0 C--N 1.355 1.639 0 O-C-N 124.513 0.772 . . . . 71.4 113.143 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 63.86 4.04 1.82 Allowed 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.615 1.566 . . . . 74.44 112.458 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.46 80.73 4.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.619 0.768 . . . . 75.24 111.028 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -164.75 146.37 8.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.182 1.393 . . . . 72.33 108.719 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -122.71 115.39 21.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 74.31 109.777 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -108.61 -57.99 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.602 0.761 . . . . 73.01 109.711 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -80.77 -40.48 25.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.689 -0.687 . . . . 72.42 110.911 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -85.38 123.07 30.42 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.964 -1.124 . . . . 62.22 107.964 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 115.21 -20.17 14.34 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 110.485 -1.046 . . . . 70.32 110.485 -164.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tptp 58.84 48.44 11.22 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 125.443 1.497 . . . . 73.1 111.247 172.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.86 78.13 5.31 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 121.853 0.835 . . . . 75.43 109.435 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -176.42 147.24 0.66 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.64 1.576 . . . . 73.34 107.95 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.431 HD11 HG23 ' D' ' 13' ' ' ILE . 3.1 mp -91.21 -87.05 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.912 -0.773 . . . . 75.2 108.912 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . 0.563 ' HD3' ' HG2' ' D' ' 14' ' ' GLN . 13.9 mmmm 46.43 41.52 9.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.388 1.075 . . . . 75.35 113.776 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -152.7 -61.21 0.15 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.043 -1.095 . . . . 71.12 108.043 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . 0.251 10.7 p . . . . . 0 CA--C 1.571 1.773 0 C-N-CA 126.58 1.952 . . . . 72.43 113.915 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 8.3 mptt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.894 -0.409 . . . . 75.32 109.894 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.28 53.11 0.68 Allowed Glycine 0 N--CA 1.471 0.968 0 N-CA-C 111.426 -0.67 . . . . 45.24 111.426 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -170.77 168.55 7.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.051 0.941 . . . . 75.45 109.348 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 26.8 p -57.15 150.18 18.03 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.39 1.076 . . . . 71.24 111.987 170.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -145.08 114.07 6.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.581 0.753 . . . . 72.53 109.197 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.451 HD22 ' N ' ' B' ' 54' ' ' ASP . 85.6 mt -124.5 111.8 16.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.48 0.712 . . . . 72.41 111.519 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.707 ' HG2' ' SD ' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.68 89.74 1.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.1 0.96 . . . . 72.11 109.106 -175.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.46 78.11 8.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.598 0.713 . . . . 75.12 109.931 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -95.58 71.48 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.574 -0.739 . . . . 74.45 109.377 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 40.4 tp -80.47 -29.97 37.46 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.038 -0.983 . . . . 75.33 109.696 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -67.33 139.34 57.22 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.987 0.915 . . . . 75.55 112.349 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 59.34 83.81 0.21 Allowed Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 125.395 1.478 . . . . 71.14 111.741 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.55 128.55 16.39 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.152 2.568 . . . . 63.1 111.836 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -66.37 107.24 1.95 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.23 0.612 . . . . 75.14 110.105 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 65.92 100.52 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.942 1.297 . . . . 73.11 111.206 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 43.2 p -67.5 107.67 2.56 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.236 0.614 . . . . 75.34 109.646 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.473 ' HE1' HD21 ' B' ' 136' ' ' LEU . 5.3 m-90 -87.69 110.48 35.01 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.517 0.727 . . . . 72.31 110.549 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.74 2.28 8.66 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.492 2.128 . . . . 73.03 112.45 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.547 HD13 HD11 ' B' ' 128' ' ' LEU . 58.4 mt 63.69 -92.33 0.03 OUTLIER 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.523 1.529 . . . . 74.32 111.025 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.472 HD13 ' HA ' ' B' ' 128' ' ' LEU . 1.8 pp -161.85 -178.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.176 1.391 . . . . 74.2 109.327 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.31 167.06 31.62 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 62.2 109.73 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.45 120.2 27.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.188 0.995 . . . . 62.21 108.51 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.84 -7.87 38.47 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.228 0.825 . . . . 65.53 113.228 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.19 -162.43 46.15 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.427 -0.669 . . . . 72.52 111.427 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.91 -144.9 13.19 Favored Glycine 0 N--CA 1.467 0.746 0 CA-C-N 117.222 0.511 . . . . 62.43 112.461 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . 0.415 ' H ' ' HD1' ' F' ' 193' ' ' TYR . 0.4 OUTLIER -81.25 130.56 35.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.224 0.61 . . . . 73.23 111.001 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.61 -83.8 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.532 0.733 . . . . 71.22 110.601 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.536 ' HZ ' ' HA ' ' B' ' 123' ' ' PHE . 96.6 m-85 -54.52 -67.33 0.27 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.84 0.856 . . . . 73.33 112.663 -169.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 17.3 tptm 52.13 29.59 6.63 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 124.525 1.141 . . . . 62.12 111.035 -167.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . 0.404 ' N ' ' HB2' ' B' ' 35' ' ' ASP . 51.5 t80 50.19 -85.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.66 1.984 . . . . 72.33 113.191 -176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.22 -13.46 62.19 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.728 0.811 . . . . 63.45 112.339 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' F' ' 195' ' ' PHE . 27.9 t-20 -64.09 -29.52 70.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.725 0.81 . . . . 74.03 110.92 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' F' ' 205' ' ' LYS . . . 88.99 13.55 62.08 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 115.244 0.858 . . . . 62.43 115.244 169.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -71.34 92.85 1.08 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 117.163 0.481 . . . . 74.44 109.774 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 63.13 29.43 16.14 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.13 1.372 . . . . 65.21 109.612 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' F' ' 195' ' ' PHE . 4.9 t0 -144.92 171.56 14.28 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.864 -1.516 . . . . 74.11 107.52 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 14.8 tt -67.68 141.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.28 0.562 . . . . 73.24 110.294 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . 0.406 ' HB2' ' HA3' ' F' ' 200' ' ' GLY . 59.9 tttm -129.61 -77.69 0.55 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.428 0.691 . . . . 71.34 109.4 -177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.44 149.45 48.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.3 0.64 . . . . 74.2 109.73 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 124.949 1.3 . . . . 74.21 109.176 174.842 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 87.2 tttt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.224 -0.287 . . . . 73.15 110.224 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.59 -99.63 0.05 OUTLIER Glycine 0 C--N 1.361 1.959 0 O-C-N 124.341 1.025 . . . . 63.2 112.81 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -127.09 137.14 52.96 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.501 -0.926 . . . . 75.14 108.501 166.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 9.6 m -103.32 -33.28 9.18 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.161 0.984 . . . . 74.5 109.549 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.67 -78.67 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.063 0.945 . . . . 72.41 109.764 172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 54' ' ' ASP . 0.2 OUTLIER 65.66 104.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.794 1.637 . . . . 75.22 110.72 -175.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 33.0 mtm -139.76 -64.46 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.365 1.066 . . . . 73.23 109.201 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.404 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 44.4 t80 56.8 97.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.636 1.574 . . . . 72.45 112.751 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -118.66 119.57 34.85 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.881 -0.785 . . . . 71.32 108.881 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 tp -154.22 37.7 0.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.879 -1.156 . . . . 73.42 107.879 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.91 -22.17 64.18 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.537 -1.21 . . . . 75.31 112.846 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.37 152.73 69.86 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.158 0.983 . . . . 75.52 109.894 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 109.33 2.72 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.151 1.901 . . . . 74.31 109.69 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -67.88 -57.42 6.27 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.318 -0.855 . . . . 74.34 111.176 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.31 154.11 45.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.699 0.8 . . . . 71.15 109.698 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 17.8 p -80.81 140.29 35.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.416 -0.587 . . . . 75.41 109.416 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -145.29 86.01 7.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.326 0.651 . . . . 75.34 109.997 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 161.79 39.42 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.113 1.875 . . . . 74.34 112.015 174.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . 0.593 ' HG ' HG21 ' A' ' 131' ' ' VAL . 8.3 tt -135.22 156.15 49.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.852 -1.166 . . . . 73.03 107.852 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.64 HG21 HG21 ' H' ' 204' ' ' ILE . 34.7 pt -57.17 155.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.123 0.969 . . . . 73.2 112.669 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -112.21 -11.79 13.71 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.37 0.668 . . . . 70.52 111.19 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . 60.62 51.43 5.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.969 0.908 . . . . 71.21 111.735 175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.73 95.09 5.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.389 -0.823 . . . . 64.34 110.621 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 152.15 78.95 0.02 OUTLIER Glycine 0 C--N 1.346 1.128 0 C-N-CA 121.461 -0.399 . . . . 71.34 112.812 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.39 139.52 10.73 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.149 -0.78 . . . . 73.45 111.149 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -145.25 -18.98 0.49 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.451 0.7 . . . . 71.13 110.557 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.83 135.18 52.17 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.978 0.511 . . . . 75.5 111.579 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . 0.467 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 5.4 t80 -133.21 -127.18 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.25 -1.018 . . . . 65.33 108.25 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.425 ' N ' ' HD1' ' G' ' 195' ' ' PHE . 95.3 mttt -152.53 8.0 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.794 1.238 . . . . 75.11 109.965 -170.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.94 156.4 48.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.537 0.735 . . . . 73.54 109.521 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' H' ' 193' ' ' TYR . 1.0 OUTLIER -164.34 113.91 1.19 Allowed 'General case' 0 C--O 1.242 0.659 0 N-CA-C 105.839 -1.911 . . . . 62.03 105.839 168.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.79 176.15 0.26 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.6 1.188 . . . . 72.41 109.888 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.57 80.51 0.12 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.011 -0.836 . . . . 71.21 111.011 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 178.34 8.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.555 0.742 . . . . 75.41 110.878 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . 0.561 ' HH ' ' HA ' ' D' ' 128' ' ' LEU . 55.6 t80 63.85 72.09 0.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.704 -0.85 . . . . 74.41 108.704 -176.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.51 95.6 1.41 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.193 -0.912 . . . . 73.41 109.133 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . 0.723 HG12 ' H ' ' G' ' 206' ' ' ASP . 5.5 tt -73.72 145.38 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-N 114.545 -1.207 . . . . 73.35 110.598 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.37 -16.86 61.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.924 0.889 . . . . 70.44 110.521 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . 0.723 ' H ' HG12 ' G' ' 204' ' ' ILE . 2.5 m-20 75.43 169.4 0.28 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.239 1.816 . . . . 73.42 110.29 -169.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . 0.405 HG21 HG22 ' D' ' 131' ' ' VAL . 3.6 p . . . . . 0 CA--C 1.564 1.502 0 CA-C-O 118.531 -0.747 . . . . 62.41 110.269 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.139 -0.689 . . . . 74.3 109.139 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.19 -96.21 0.61 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.992 -0.843 . . . . 62.11 110.992 -174.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -137.65 158.72 43.78 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.059 0.943 . . . . 75.5 109.155 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 171' ' ' SER . . . . . 0.504 ' HB2' ' HG ' ' H' ' 173' ' ' LEU . 89.9 p -164.98 110.07 0.92 Allowed 'General case' 0 CA--C 1.542 0.656 0 O-C-N 123.653 0.595 . . . . 65.11 110.4 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.473 ' H ' ' HB2' ' D' ' 90' ' ' GLU . . . -51.51 -66.38 0.39 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.099 0.96 . . . . 72.04 109.975 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.591 ' HA ' ' HE3' ' D' ' 94' ' ' MET . 76.7 mt 42.73 92.05 0.01 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 125.273 1.608 . . . . 74.34 114.082 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' H' ' 174' ' ' MET . 0.0 OUTLIER 72.01 156.6 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.752 1.221 . . . . 75.44 112.103 171.166 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.47 -167.56 0.53 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.29 0.636 . . . . 74.45 111.594 -161.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.28 -61.33 1.68 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.53 -1.285 . . . . 75.23 107.53 161.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . 0.441 HD12 HD22 ' D' ' 98' ' ' LEU . 17.7 tp -142.56 -81.99 0.2 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 106.217 -1.772 . . . . 72.43 106.217 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 162.21 -74.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.226 1.811 . . . . 64.13 106.324 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -173.67 152.96 2.13 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 113.976 -1.465 . . . . 74.34 108.091 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.92 -14.75 32.61 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.262 1.974 . . . . 73.02 113.952 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 62.2 -171.42 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.922 0.889 . . . . 72.22 110.526 -169.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -85.28 0.04 53.22 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.985 -0.447 . . . . 74.32 111.312 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 33.2 p 58.88 172.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.882 1.673 . . . . 72.51 112.099 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -133.56 145.21 55.38 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.556 -0.715 . . . . 75.34 110.593 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.95 122.19 8.25 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.811 2.34 . . . . 62.05 111.925 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.18 -101.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.817 0.447 . . . . 75.43 110.277 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.69 152.17 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 107.622 -1.251 . . . . 75.41 107.622 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -130.17 92.51 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.838 -0.801 . . . . 44.54 108.838 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.55 81.06 5.94 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.285 0.634 . . . . 71.55 109.975 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.96 -29.14 9.18 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.66 -0.7 . . . . 72.22 111.998 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.73 169.56 37.23 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.499 0.5 . . . . 73.2 113.887 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 84.15 178.52 51.6 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.889 0.405 . . . . 60.44 113.005 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' G' ' 198' ' ' GLU . 96.3 m-85 -130.89 -176.04 3.87 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.215 0.606 . . . . 73.24 110.169 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . 0.485 ' HB3' ' NE2' ' D' ' 37' ' ' GLN . . . -168.19 -170.24 1.26 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.462 0.705 . . . . 63.33 110.763 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.441 ' HB2' ' HA ' ' D' ' 35' ' ' ASP . 53.7 m-85 76.58 -51.76 0.59 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.482 1.513 . . . . 73.52 113.87 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp 61.0 40.13 15.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.969 0.907 . . . . 73.02 111.98 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -67.48 93.01 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.086 0.554 . . . . 74.04 110.988 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -135.91 -65.55 0.58 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.06 -1.459 . . . . 71.45 107.06 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -108.02 133.11 52.79 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.338 -0.616 . . . . 74.55 109.338 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.79 29.78 0.09 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.584 -1.006 . . . . 75.45 110.584 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -87.5 -38.59 15.91 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.505 0.722 . . . . 74.33 109.873 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 72.49 -11.64 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.446 1.499 . . . . 73.52 113.503 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 48.15 36.74 7.01 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.77 1.228 . . . . 63.15 113.049 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.64 HG21 HG21 ' G' ' 187' ' ' ILE . 85.6 mt -69.58 -50.32 51.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.121 -0.945 . . . . 73.02 109.857 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 65.22 -79.18 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.857 1.348 . . . . 74.03 110.016 -170.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -138.95 -77.33 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.008 0.432 . . . . 74.31 110.188 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 124.83 1.252 . . . . 73.23 109.693 -167.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.353 -0.61 . . . . 73.21 109.353 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m 63.71 -79.15 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.878 1.271 . . . . 75.33 111.52 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.73 6.38 2.65 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.536 1.534 . . . . 54.42 113.853 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -104.55 92.4 4.28 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.414 -0.958 . . . . 63.22 108.414 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -158.48 136.71 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.946 -0.57 . . . . 73.15 110.448 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -74.21 -25.0 59.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.34 1.056 . . . . 54.03 111.309 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -87.37 -11.65 48.68 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.606 0.362 . . . . 72.53 111.625 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.34 -15.37 35.82 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.056 0.542 . . . . 70.44 110.488 169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.7 mtp -64.79 131.25 46.27 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.873 -0.788 . . . . 74.12 108.873 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 73.4 m -149.63 133.32 16.81 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.921 -1.141 . . . . 74.14 107.921 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' HB3' ' HE2' ' C' ' 138' ' ' MET . 64.5 t80 -136.57 144.0 43.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.143 -0.688 . . . . 73.01 109.143 172.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.76 137.24 11.98 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.499 0.5 . . . . 74.44 110.999 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.39 119.86 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 N-CA-C 109.374 -0.602 . . . . 73.25 109.374 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -97.93 -37.23 9.88 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.401 0.681 . . . . 74.1 110.393 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt85 -172.95 141.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.806 0.442 . . . . 74.23 111.3 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.6 mt -116.61 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 108.352 -0.981 . . . . 71.22 108.352 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -166.24 155.53 11.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.713 0.805 . . . . 72.41 111.226 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.416 HG23 ' HB3' ' B' ' 120' ' ' ARG . 60.0 p -87.04 114.64 23.82 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.973 -0.751 . . . . 74.54 108.973 169.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 mtpt -76.72 -27.03 55.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.768 0.427 . . . . 74.34 109.986 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.9 t70 -154.59 140.75 18.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.414 -0.812 . . . . 65.53 109.466 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.8 mt -136.72 140.09 43.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.317 -1.364 . . . . 72.41 107.317 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.6 t -145.53 128.99 16.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.03 -0.729 . . . . 61.02 109.03 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 91.8 t80 -137.92 112.86 9.06 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.296 -1.742 . . . . 74.42 106.296 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -118.22 134.94 54.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.549 -0.537 . . . . 73.51 109.549 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.88 78.5 69.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 106.045 -1.835 . . . . 74.1 106.045 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.5 -24.49 26.21 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.186 1.924 . . . . 64.5 111.177 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -110.52 29.33 7.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.518 -1.219 . . . . 73.21 109.232 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.11 -43.64 97.51 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.283 1.033 . . . . 73.31 112.407 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.44 -25.57 70.67 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.231 1.475 . . . . 63.12 113.253 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -82.87 -13.77 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.022 0.529 . . . . 64.41 112.188 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.25 -18.17 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.468 0.577 . . . . 74.42 111.994 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.67 -40.26 20.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.921 0.888 . . . . 65.13 110.521 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.98 -25.82 31.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.987 0.515 . . . . 72.2 110.751 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.25 146.67 28.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.392 0.677 . . . . 74.15 111.184 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.65 122.04 18.33 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.547 -1.206 . . . . 74.35 108.602 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.583 ' HD1' ' HA ' ' G' ' 194' ' ' ALA . 74.4 t-105 -82.03 86.71 6.52 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.494 0.664 . . . . 71.11 110.165 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -124.45 83.42 57.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.487 -1.301 . . . . 74.01 107.487 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.65 119.29 5.13 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.519 2.146 . . . . 72.44 112.337 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.45 112.03 24.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.012 -1.107 . . . . 70.14 108.012 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.23 111.29 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.27 1.028 . . . . 72.4 110.729 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -101.82 140.35 36.22 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.836 -0.802 . . . . 74.42 108.836 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.402 HD21 HD21 ' A' ' 128' ' ' LEU . 6.0 mp -111.54 131.52 55.18 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.425 -0.954 . . . . 75.53 108.425 171.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.677 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -117.9 128.95 55.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.047 -1.094 . . . . 72.5 108.047 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.8 tp -98.15 128.9 44.9 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.215 -0.661 . . . . 74.24 109.215 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -134.09 151.65 51.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.67 -0.863 . . . . 74.32 108.67 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.1 m -141.49 147.96 38.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.075 0.95 . . . . 73.44 108.493 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HA ' HD21 ' G' ' 177' ' ' LEU . . . -132.34 142.95 49.53 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.493 -0.929 . . . . 72.03 108.493 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.549 ' H ' ' HB2' ' G' ' 177' ' ' LEU . 18.7 m -132.67 150.15 52.2 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.209 -0.293 . . . . 74.24 110.209 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -159.79 151.43 20.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.999 0.919 . . . . 65.04 109.128 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -95.53 114.08 25.8 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.838 -0.801 . . . . 70.43 108.838 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.49 HD12 HG22 ' A' ' 83' ' ' ILE . 83.8 mt -84.09 -43.59 14.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.723 0.409 . . . . 74.31 110.198 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.6 -178.16 6.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.027 0.931 . . . . 71.43 109.277 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.98 122.88 18.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.967 -0.753 . . . . 63.22 108.967 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 66.67 13.66 9.44 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.81 1.244 . . . . 72.13 112.133 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.33 125.54 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.494 -0.928 . . . . 75.35 108.494 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.522 ' HB3' ' HG3' ' G' ' 174' ' ' MET . 0.1 OUTLIER -130.87 168.32 17.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.277 0.56 . . . . 73.31 110.212 176.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' HB2' HD13 ' A' ' 51' ' ' LEU . 31.2 tt0 -127.34 121.78 31.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.159 -1.052 . . . . 75.15 108.159 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.51 119.02 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.778 -1.193 . . . . 74.2 107.778 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.615 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -99.16 135.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.79 0.836 . . . . 70.43 108.983 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.37 112.01 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.9 -1.518 . . . . 75.11 106.9 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.496 ' HD3' ' HG2' ' A' ' 79' ' ' GLN . 12.2 ttp180 -108.42 104.33 13.67 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.387 -0.597 . . . . 75.25 109.387 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.99 132.42 39.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.237 -1.023 . . . . 64.42 108.237 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.677 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.1 m -114.02 138.2 50.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.823 -0.806 . . . . 73.03 108.823 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 39.9 t -133.71 108.58 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 125.104 1.361 . . . . 75.24 108.382 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -106.02 140.48 38.94 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.568 -0.53 . . . . 74.44 109.568 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.9 117.27 27.67 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.172 -1.047 . . . . 73.34 108.172 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 m -113.88 127.56 56.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.189 0.596 . . . . 74.3 110.367 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.4 mt -93.41 53.46 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.292 1.437 . . . . 72.32 109.642 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.6 -84.93 0.97 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.119 -0.491 . . . . 74.25 112.147 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.04 -28.41 16.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.666 0.786 . . . . 73.44 111.724 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -123.39 133.69 54.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.714 0.806 . . . . 73.55 109.893 -169.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -71.34 136.89 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 120.916 0.388 . . . . 74.33 110.459 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -61.8 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.19 0.996 . . . . 61.44 109.214 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.83 167.64 26.85 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.34 -1.3 . . . . 72.11 110.297 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -134.43 140.36 46.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.806 1.242 . . . . 74.51 108.178 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.57 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.4 m -131.0 135.87 48.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.272 1.029 . . . . 74.15 108.973 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.17 123.45 8.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.602 0.361 . . . . 75.44 110.123 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 39.3 t -130.41 113.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.974 0.91 . . . . 74.21 109.749 -174.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HG2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 mt-30 -85.6 81.09 8.8 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.641 0.776 . . . . 73.51 108.916 172.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.74 90.53 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.154 0.982 . . . . 72.52 108.572 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.99 144.84 18.28 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 116.087 -0.506 . . . . 61.43 112.325 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.12 130.83 5.0 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 111.983 -0.447 . . . . 72.44 111.983 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.49 HG22 HD12 ' A' ' 51' ' ' LEU . 40.8 mt -81.29 131.34 34.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 107.426 -1.324 . . . . 74.13 107.426 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.46 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . 37.7 m-85 -131.79 155.43 47.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.725 -0.843 . . . . 74.23 108.725 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -111.49 114.22 27.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.603 1.161 . . . . 72.52 108.035 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.559 HG23 ' HE3' ' G' ' 174' ' ' MET . 6.2 tt -139.08 152.92 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 118.086 0.403 . . . . 75.52 111.033 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.82 169.34 13.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.374 1.069 . . . . 72.0 110.352 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.45 5.76 86.04 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 123.901 0.751 . . . . 73.21 114.701 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.407 ' H ' HD11 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.05 153.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.154 0.981 . . . . 74.42 109.606 -177.06 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.23 170.48 22.38 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.165 0.586 . . . . 75.03 109.444 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.73 -125.3 34.59 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 123.701 0.667 . . . . 73.32 113.889 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.409 HG23 ' HG3' ' C' ' 147' ' ' GLU . 64.4 p -75.49 -21.39 58.08 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.731 0.812 . . . . 73.42 111.422 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.55 -40.16 92.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.004 0.522 . . . . 71.24 109.797 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.579 ' HE1' ' HA ' ' G' ' 173' ' ' LEU . 0.0 OUTLIER -76.1 -47.44 24.47 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.311 -0.859 . . . . 75.12 109.92 179.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -34.05 77.09 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.106 -0.952 . . . . 72.52 112.636 -172.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -78.89 -20.81 48.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.194 0.598 . . . . 72.04 110.855 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 49.4 t -80.42 -64.39 1.2 Allowed 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.413 0.285 . . . . 71.53 110.242 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.19 -37.12 84.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.961 0.504 . . . . 64.51 111.786 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.46 -15.11 64.62 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 114.92 0.728 . . . . 75.22 114.92 -172.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.437 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -140.88 -51.19 0.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.637 0.718 . . . . 74.54 112.656 -171.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.5 t80 -77.71 -51.69 10.17 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.216 0.607 . . . . 75.41 112.55 -168.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.548 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 67.7 m -70.84 -38.9 8.03 Favored Pre-proline 0 CA--C 1.569 1.688 0 C-N-CA 123.935 0.894 . . . . 74.22 113.112 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.37 -22.01 46.4 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.709 1.606 . . . . 62.23 112.434 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -71.42 -30.36 65.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.872 0.469 . . . . 73.22 110.492 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.03 -40.08 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.375 -0.602 . . . . 74.45 109.375 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.468 HD22 ' HA3' ' A' ' 82' ' ' GLY . 36.1 mt -82.1 -21.85 36.54 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.077 -0.965 . . . . 74.3 112.253 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -65.53 -39.31 32.26 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.697 1.369 . . . . 74.33 114.697 -170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.65 -34.76 99.11 Favored 'Trans proline' 0 C--N 1.393 2.899 0 CA-C-N 122.153 1.805 . . . . 75.21 112.51 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -80.76 -36.66 31.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.815 0.846 . . . . 73.3 110.459 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.87 79.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.09 0.556 . . . . 72.31 109.927 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -52.0 -57.77 8.49 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.593 1.183 . . . . 74.13 109.286 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.77 -43.64 97.77 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.592 1.183 . . . . 71.31 111.793 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.62 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.8 t -57.64 -47.64 81.69 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.945 0.898 . . . . 71.44 110.832 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.569 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 89.2 mt -64.34 -53.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.041 0.838 . . . . 74.31 110.463 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.3 m -50.25 -41.83 50.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.394 1.478 . . . . 74.01 111.505 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -72.78 -42.76 63.61 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.825 -1.08 . . . . 72.52 110.926 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.569 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 50.3 mtm -58.35 -42.61 87.25 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 74.1 110.86 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 81.8 t -60.12 -49.01 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.241 -1.345 . . . . 72.3 111.27 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.6 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 80.9 p -66.89 -31.41 71.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.887 0.475 . . . . 74.42 111.507 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.424 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.9 mtt-85 -68.7 -27.12 65.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.827 0.851 . . . . 72.34 111.358 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 13.06 53.24 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.628 -0.54 . . . . 71.01 113.545 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m 63.91 27.29 14.41 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.8 1.24 . . . . 72.24 110.871 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.36 150.0 37.97 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.555 -0.905 . . . . 71.11 108.555 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.516 ' HB2' ' H ' ' G' ' 192' ' ' GLY . 60.8 Cg_endo -70.77 120.56 7.17 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.882 1.721 . . . . 75.42 109.674 176.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.6 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 10.8 pt20 -61.69 150.89 35.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.338 0.655 . . . . 63.42 111.719 -171.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.42 108.71 20.18 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.746 -0.835 . . . . 74.13 108.746 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -96.69 96.14 8.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.84 -1.17 . . . . 74.23 107.84 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' G' ' 189' ' ' ALA . 91.5 mt -65.72 148.63 51.44 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.473 -0.785 . . . . 72.23 110.58 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.549 ' HB2' HG12 ' H' ' 204' ' ' ILE . . . -79.92 162.84 60.83 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.013 0.525 . . . . 74.4 110.72 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.34 164.0 26.92 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.134 1.889 . . . . 64.44 111.924 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.01 114.13 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.997 0.919 . . . . 73.02 109.797 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.84 85.61 6.06 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.454 0.701 . . . . 72.31 109.476 173.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -57.07 -28.18 62.37 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.544 1.138 . . . . 74.33 111.869 173.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -74.4 -38.8 62.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.192 0.997 . . . . 72.14 110.317 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.46 80.7 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 116.277 -0.42 . . . . 61.14 110.038 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.429 HD23 ' HD3' ' G' ' 185' ' ' PRO . 42.2 tp -60.0 -37.95 81.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.314 1.046 . . . . 74.55 111.279 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 87.8 t80 -57.14 -52.12 66.57 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 123.754 0.659 . . . . 64.22 110.378 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.555 ' HB2' HE21 ' C' ' 4' ' ' GLN . 24.8 ptt? -80.63 -21.63 41.32 Favored 'General case' 0 CA--C 1.554 1.107 0 O-C-N 123.771 0.67 . . . . 73.11 111.739 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -77.77 -28.31 50.52 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.094 0.957 . . . . 75.32 110.276 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -85.71 -37.84 18.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.093 -0.503 . . . . 74.22 109.967 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -66.42 -43.18 86.42 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.301 0.64 . . . . 73.23 111.475 -177.121 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -147.7 -5.14 0.48 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.538 0.57 . . . . 73.43 112.538 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.66 130.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.701 1.2 . . . . 72.13 110.946 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.457 ' HA ' ' HG2' ' C' ' 4' ' ' GLN . 3.3 pp0? -78.32 147.94 34.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.808 0.443 . . . . 74.11 111.351 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.54 172.14 16.48 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.5 0.72 . . . . 72.22 110.299 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.74 -150.39 17.86 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.245 -0.888 . . . . 64.0 111.893 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.7 42.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.632 1.173 . . . . 72.32 108.636 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.62 77.45 0.1 OUTLIER Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.452 -0.795 . . . . 72.13 113.334 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 t -121.96 140.2 52.74 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.483 1.513 . . . . 73.34 107.966 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -162.5 132.84 4.69 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.507 -0.553 . . . . 74.21 109.507 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.93 95.11 8.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.335 1.054 . . . . 70.54 110.534 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -66.14 96.18 0.32 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.735 -0.469 . . . . 73.14 109.735 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -125.45 96.35 4.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.349 -0.982 . . . . 71.23 108.349 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.6 -39.41 45.62 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.887 -0.783 . . . . 73.35 108.887 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.499 1.519 . . . . 75.53 111.513 178.398 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 108.019 -1.104 . . . . 74.41 108.019 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.9 p -79.13 80.49 5.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.503 0.721 . . . . 64.13 111.001 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.17 -9.54 58.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.233 -0.894 . . . . 72.45 110.99 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -82.8 124.82 30.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.22 1.008 . . . . 64.43 109.475 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -84.06 169.89 14.46 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.288 0.635 . . . . 74.32 111.116 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -121.6 134.25 55.0 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.87 0.868 . . . . 64.12 109.523 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.59 HG22 ' HA ' ' B' ' 89' ' ' ILE . 87.3 m -77.72 120.72 23.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.104 0.562 . . . . 74.44 109.646 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.0 -49.63 76.93 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.121 0.888 . . . . 64.32 110.907 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 17.2 ptm 45.83 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 126.85 2.06 . . . . 74.0 115.208 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.3 t -154.14 142.73 20.79 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.756 -0.831 . . . . 70.11 108.756 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -133.44 144.67 49.64 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.21 0.604 . . . . 74.12 109.826 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -147.77 136.42 21.8 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.962 -1.017 . . . . 75.12 109.114 169.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.24 144.06 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.614 -0.884 . . . . 74.13 108.614 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.49 -49.36 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.412 0.285 . . . . 72.42 110.836 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -162.53 139.49 7.92 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.584 -0.154 . . . . 73.34 110.584 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.401 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 93.9 mt -115.28 137.83 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 106.744 -1.576 . . . . 71.24 106.744 170.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.467 ' HE1' HG13 ' B' ' 83' ' ' ILE . 16.2 p90 -165.65 144.91 6.34 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.66 0.6 . . . . 72.42 111.654 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.6 m -76.31 119.38 20.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.314 -0.857 . . . . 73.41 108.934 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -93.8 -26.96 16.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.383 0.673 . . . . 74.24 111.238 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.9 t70 -160.78 143.13 12.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.165 0.291 . . . . 72.0 110.78 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.3 mm -137.78 138.3 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.991 1.316 . . . . 72.14 108.992 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 7.9 t -137.91 138.76 39.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.22 -1.4 . . . . 75.31 107.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.466 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.8 t80 -160.62 114.53 2.11 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 107.753 -1.203 . . . . 73.21 107.753 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.8 147.89 42.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.811 -1.181 . . . . 74.22 107.811 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.85 81.92 61.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 106.911 -1.514 . . . . 72.53 106.911 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.55 -21.34 52.85 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.803 2.335 . . . . 73.22 113.094 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.33 30.47 6.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.917 0.887 . . . . 60.4 109.938 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.64 -50.54 59.12 Favored Pre-proline 0 CA--C 1.569 1.71 0 C-N-CA 124.752 1.221 . . . . 65.44 114.164 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.3 -16.77 6.9 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.87 1.713 . . . . 74.1 112.769 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.63 0.86 55.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.657 0.783 . . . . 64.34 110.817 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.24 -15.35 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 124.268 1.027 . . . . 61.32 111.385 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.81 -42.59 89.53 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.437 0.695 . . . . 74.54 110.607 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.68 -43.41 96.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.74 0.816 . . . . 73.52 110.85 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -103.2 76.42 1.44 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.631 -1.168 . . . . 75.4 109.989 -171.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' F' ' 196' ' ' LYS . 9.2 p-10 -95.28 76.71 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.557 -1.656 . . . . 74.24 110.368 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.414 ' HZ2' ' H ' ' B' ' 69' ' ' GLY . 2.4 p-90 -157.65 176.59 12.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.831 -1.077 . . . . 74.32 109.5 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.83 99.46 0.99 Allowed Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.878 0.871 . . . . 74.11 108.832 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.505 ' HB3' HD22 ' B' ' 68' ' ' LEU . 55.9 Cg_endo -67.15 161.36 43.2 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.234 1.956 . . . . 73.03 112.94 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -75.18 102.18 4.88 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.903 -1.044 . . . . 74.25 108.964 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' B' ' 124' ' ' PRO . 8.0 t -92.21 119.03 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 N-CA-C 107.547 -1.279 . . . . 74.55 107.547 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -146.84 145.77 29.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.032 0.933 . . . . 72.44 108.992 -170.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.609 HD23 HD21 ' B' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 170.01 12.87 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.828 0.851 . . . . 74.53 111.003 -176.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.16 139.59 41.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.584 1.153 . . . . 75.2 109.335 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 129.73 36.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.838 . . . . 72.02 109.535 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -139.97 149.51 43.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.741 0.817 . . . . 75.13 109.601 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.507 ' H ' ' HG3' ' F' ' 180' ' ' PRO . 45.2 m -145.22 134.31 22.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.166 0.587 . . . . 61.15 110.02 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.88 149.27 43.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.747 1.219 . . . . 74.14 107.738 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -143.89 160.97 39.87 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.343 0.657 . . . . 72.05 110.678 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.3 p -163.12 140.15 7.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.694 0.797 . . . . 73.24 109.352 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.8 tt0 -82.64 134.43 35.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 74.05 109.871 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -92.87 -55.2 3.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.297 0.639 . . . . 71.01 110.028 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.59 -165.13 1.97 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.577 -0.738 . . . . 63.3 110.942 -170.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.517 ' HA ' ' HG2' ' F' ' 170' ' ' LYS . 13.7 m-20 -69.06 109.89 4.22 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.547 -0.752 . . . . 71.44 110.206 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.53 4.43 4.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.028 1.331 . . . . 64.53 111.908 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.94 114.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 124.734 1.214 . . . . 75.34 109.121 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 15.5 p90 -117.46 174.39 6.17 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.817 . . . . 75.22 109.224 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.17 117.66 8.55 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.469 -0.937 . . . . 73.44 108.469 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.13 127.47 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 71.5 109.585 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.7 t -101.38 113.77 38.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.989 0.915 . . . . 73.1 108.826 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.05 110.1 21.58 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.005 -1.48 . . . . 73.31 107.005 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.92 121.89 42.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.906 -0.405 . . . . 75.33 109.906 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.2 t -112.65 126.67 70.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.541 -1.281 . . . . 64.34 107.541 167.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.507 HG22 ' HB2' ' B' ' 77' ' ' GLU . 5.1 m -121.43 127.06 50.76 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 110.062 -0.347 . . . . 63.32 110.062 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' B' ' 42' ' ' LEU . 38.6 t -99.04 127.9 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.995 . . . . 75.14 109.995 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -107.61 131.87 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.583 -1.189 . . . . 75.43 108.648 164.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.26 152.33 50.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.024 -0.732 . . . . 75.14 109.024 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.0 p -145.4 135.39 23.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.047 0.758 . . . . 75.32 113.047 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' B' ' 38' ' ' PRO . 75.9 mt -95.29 97.08 9.59 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.752 -1.567 . . . . 74.11 108.003 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.414 ' H ' ' HZ2' ' B' ' 36' ' ' TRP . . . 71.86 -117.04 6.29 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.482 -0.647 . . . . 71.32 111.482 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -105.43 9.33 33.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.494 1.118 . . . . 74.52 110.427 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.71 151.09 34.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.045 1.338 . . . . 72.55 108.414 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.88 133.83 43.17 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.164 0.438 . . . . 71.53 110.726 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.4 -63.3 1.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.89 0.876 . . . . 74.44 108.952 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.456 ' CE1' HG13 ' B' ' 64' ' ' VAL . 50.1 p90 -157.27 160.36 38.52 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.639 -1.164 . . . . 73.3 109.392 176.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.87 113.86 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.963 -1.125 . . . . 72.0 107.963 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.478 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.9 t -115.41 161.11 19.01 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.526 -0.916 . . . . 74.31 108.526 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.626 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.76 135.62 3.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.416 -0.587 . . . . 72.13 109.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.4 t -126.62 144.04 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.819 . . . . 73.12 108.79 171.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -122.97 91.8 3.57 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.784 -0.821 . . . . 54.55 108.784 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.474 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -84.61 100.68 11.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.419 -0.81 . . . . 74.32 109.161 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.2 158.41 23.78 Favored Glycine 0 C--O 1.24 0.521 0 N-CA-C 111.459 -0.656 . . . . 73.35 111.459 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.37 128.9 2.38 Favored Glycine 0 C--O 1.237 0.297 0 N-CA-C 112.011 -0.436 . . . . 74.13 112.011 -176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.467 HG13 ' HE1' ' B' ' 17' ' ' TYR . 55.2 mt -85.32 125.64 40.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.516 -0.92 . . . . 74.41 108.516 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.405 ' HB2' ' CZ ' ' B' ' 56' ' ' TYR . 29.7 m-85 -137.89 170.3 16.29 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.196 0.999 . . . . 54.4 108.574 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 43.5 m -135.14 132.63 38.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.93 0.892 . . . . 74.42 110.327 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.434 HD12 HG12 ' B' ' 89' ' ' ILE . 2.8 pp -136.25 146.19 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 123.541 0.736 . . . . 75.13 111.02 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.91 28.24 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.126 1.37 . . . . 74.45 108.245 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.76 -27.83 4.69 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-O 119.931 -0.372 . . . . 71.13 113.811 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.59 ' HA ' HG22 ' B' ' 7' ' ' THR . 1.6 pp -53.24 142.99 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.626 1.17 . . . . 72.52 113.057 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -150.57 148.66 28.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.163 0.985 . . . . 73.35 110.434 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -136.09 49.94 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 124.387 1.054 . . . . 70.15 114.481 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -84.39 -19.21 33.92 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.746 0.818 . . . . 75.02 110.646 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.24 -21.73 63.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.101 0.56 . . . . 74.54 110.875 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.3 -42.49 93.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.375 0.67 . . . . 75.24 110.515 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -21.15 65.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 72.32 112.367 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.11 -42.02 89.76 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.257 0.623 . . . . 65.11 110.483 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' B' ' 86' ' ' ILE . 46.4 t -67.52 -57.06 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.096 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.36 -31.12 66.97 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.766 -0.652 . . . . 73.11 112.542 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.401 ' HA3' ' HD1' ' F' ' 182' ' ' PHE . . . -94.52 -9.59 58.78 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.37 -0.683 . . . . 74.33 114.627 -171.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.68 -48.1 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 117.636 0.718 . . . . 73.03 112.576 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -69.49 -48.44 60.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.657 0.383 . . . . 74.45 111.457 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -62.18 -48.91 86.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 118.216 -0.897 . . . . 74.15 110.793 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_exo -50.58 -44.7 38.75 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.416 2.077 . . . . 75.24 113.515 166.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.13 -34.86 75.66 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.299 1.039 . . . . 74.11 112.178 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.21 -49.28 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.355 0.662 . . . . 64.33 110.176 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -76.55 -14.77 59.99 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.481 -1.236 . . . . 74.4 111.856 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.4 ' CE1' HD11 ' B' ' 128' ' ' LEU . 27.3 t80 -62.06 -52.64 65.99 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.271 1.428 . . . . 75.11 113.249 -167.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.57 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 36.9 Cg_endo -62.23 -32.55 82.41 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.022 1.815 . . . . 62.12 113.17 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.474 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.2 m-85 -64.36 -46.29 84.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.153 0.581 . . . . 74.23 110.057 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.2 90.16 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.959 0.903 . . . . 73.01 110.468 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.57 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 31.9 mtp180 -52.3 -56.11 16.98 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.586 1.155 . . . . 75.42 111.871 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -32.51 64.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.284 -0.871 . . . . 74.11 110.676 -173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -69.69 -34.6 74.16 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.831 0.452 . . . . 70.21 111.008 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.443 HD11 ' HB ' ' B' ' 62' ' ' VAL . 58.2 mt -62.69 -58.95 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.773 -0.825 . . . . 73.33 108.773 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -51.69 -32.65 30.79 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 124.86 1.35 . . . . 75.03 112.263 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -64.47 -50.33 67.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.076 0.95 . . . . 72.21 110.345 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.477 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 13.4 mmt -71.14 -30.86 67.01 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.105 0.479 . . . . 75.15 111.43 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.9 t -70.48 -37.8 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.18 0.992 . . . . 75.42 110.978 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 96.2 p -67.35 -33.04 74.41 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.169 0.509 . . . . 75.35 110.955 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.62 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 58.6 mtt-85 -64.64 -35.26 80.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.399 -0.819 . . . . 75.52 110.292 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.31 10.45 71.26 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.971 -0.905 . . . . 54.42 113.817 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.462 ' HA ' ' OD1' ' C' ' 127' ' ' ASN . 62.8 p 59.23 34.92 23.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.569 1.548 . . . . 65.43 113.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 23.7 m-85 -117.86 164.84 17.97 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 124.211 1.004 . . . . 75.35 110.631 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.591 ' HB2' HG22 ' B' ' 40' ' ' VAL . 7.3 Cg_exo -75.45 137.72 21.11 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 123.693 2.929 . . . . 71.12 115.257 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.577 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.9 OUTLIER -66.81 159.0 29.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.517 1.527 . . . . 72.42 113.282 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -126.3 117.47 23.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.106 -1.072 . . . . 73.4 108.106 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.479 ' ND2' ' HA ' ' C' ' 122' ' ' THR . 3.8 m120 -92.11 97.51 10.97 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.042 -1.466 . . . . 72.33 107.042 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.609 HD21 HD23 ' B' ' 42' ' ' LEU . 0.5 OUTLIER -66.18 148.19 52.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.258 0.481 . . . . 73.11 110.961 -170.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.605 ' H ' HD22 ' B' ' 128' ' ' LEU . . . -41.11 107.0 0.45 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 127.335 2.254 . . . . 60.11 113.783 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.08 54.33 4.57 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.726 2.284 . . . . 70.24 111.774 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.646 HG22 HD11 ' E' ' 204' ' ' ILE . 67.0 t -87.35 113.63 25.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 124.782 1.233 . . . . 73.42 109.034 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -69.8 98.47 1.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.045 -1.095 . . . . 73.23 108.045 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -61.33 -25.19 66.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.157 -0.929 . . . . 73.33 110.993 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.67 -38.84 61.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.744 1.618 . . . . 73.34 111.892 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.52 -30.66 70.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.704 0.802 . . . . 73.13 111.563 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.1 tt -68.75 -48.37 63.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.957 0.503 . . . . 73.25 109.685 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -62.6 -31.54 72.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.402 0.681 . . . . 73.41 111.684 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.71 -36.4 74.2 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.09 0.956 . . . . 75.13 111.496 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -94.82 -36.65 11.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.515 0.726 . . . . 71.15 111.412 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -72.66 -47.69 45.39 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.461 0.705 . . . . 74.4 110.961 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.92 -4.4 59.16 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.515 0.726 . . . . 74.05 112.116 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -149.35 -104.67 0.08 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 119.174 -0.441 . . . . 75.41 110.181 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -147.53 -82.38 0.13 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.582 0.628 . . . . 74.53 109.742 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -143.66 -67.1 0.35 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.121 -1.066 . . . . 74.13 108.121 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.51 160.18 4.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.352 1.061 . . . . 62.42 110.408 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.13 61.42 0.41 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.319 -0.401 . . . . 72.01 112.115 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.87 149.3 28.13 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.737 0.815 . . . . 74.32 110.002 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.72 74.76 1.26 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 123.551 0.532 . . . . 75.33 113.562 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.3 p -150.84 116.43 5.45 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 73.13 108.827 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.46 159.39 24.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.13 0.572 . . . . 72.13 111.079 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -166.58 109.05 0.72 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.987 0.915 . . . . 74.14 109.435 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -124.19 77.02 1.51 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.458 -1.312 . . . . 73.32 107.458 169.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 163.04 28.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.533 -0.758 . . . . 75.13 110.195 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -149.19 101.88 3.18 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.36 -0.607 . . . . 54.41 109.36 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.8 0.84 . . . . 52.44 108.821 -178.871 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.425 -0.583 . . . . 75.33 109.425 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 59.1 p -157.59 -43.45 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.508 0.723 . . . . 71.34 110.102 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.79 110.43 22.29 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.366 0.667 . . . . 72.25 109.62 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.555 HE21 ' HB2' ' A' ' 138' ' ' MET . 24.2 mp0 -75.08 -63.54 1.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.451 0.7 . . . . 75.0 109.373 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.02 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.017 1.327 . . . . 73.12 111.583 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -135.18 72.48 1.45 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.881 -0.785 . . . . 74.24 108.881 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -133.31 59.62 1.73 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.368 -0.833 . . . . 73.13 109.895 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.424 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 48.4 mt-10 -68.72 -63.4 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.256 -1.016 . . . . 75.53 108.256 172.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.5 ttt 56.08 109.71 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.514 1.925 . . . . 71.24 113.593 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.2 m -115.76 79.22 1.27 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.017 -1.475 . . . . 74.32 107.017 167.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -95.17 116.64 29.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.341 -1.726 . . . . 75.32 106.341 168.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -143.69 141.87 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.722 -0.844 . . . . 71.32 108.722 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.0 133.5 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 123.71 0.631 . . . . 62.35 109.435 176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -113.29 -28.96 7.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.58 0.752 . . . . 71.34 110.107 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.442 ' NH2' ' HB ' ' D' ' 122' ' ' THR . 16.1 ttt85 -179.65 144.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 122.976 0.511 . . . . 72.45 110.605 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 51.7 mt -124.39 134.17 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.407 -1.331 . . . . 73.32 107.407 168.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.584 ' HH ' HD11 ' C' ' 83' ' ' ILE . 21.5 p90 -176.94 155.01 1.17 Allowed 'General case' 0 C--O 1.227 -0.122 0 O-C-N 123.997 0.81 . . . . 70.12 110.421 -174.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.23 120.94 22.19 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.629 0.772 . . . . 73.01 109.664 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.458 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 28.9 mmtp -70.55 -49.09 51.72 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 107.974 -1.121 . . . . 75.12 107.974 167.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -138.51 142.68 39.34 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.803 -1.544 . . . . 75.22 109.498 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.24 144.8 28.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.936 -1.505 . . . . 75.31 106.936 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.2 t -155.21 148.3 24.71 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.254 0.55 . . . . 71.11 110.593 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.4 t80 -147.8 125.96 12.18 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 114.694 -1.139 . . . . 74.52 107.926 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.36 139.25 51.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.361 1.064 . . . . 70.41 108.321 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 76.26 36.24 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 105.954 -1.869 . . . . 74.41 105.954 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.25 -19.68 29.03 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.369 2.046 . . . . 74.53 111.071 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.75 11.4 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.679 -1.146 . . . . 74.32 110.376 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.05 -61.73 3.07 Favored Pre-proline 0 CA--C 1.573 1.85 0 N-CA-C 114.064 1.135 . . . . 73.14 114.064 -165.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.9 Cg_exo -76.05 -23.49 12.09 Favored 'Trans proline' 0 C--N 1.387 2.594 0 CA-C-N 121.746 1.659 . . . . 71.23 112.28 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -71.09 -38.16 72.4 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.797 1.239 . . . . 74.2 111.894 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.36 -10.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.377 1.071 . . . . 74.11 111.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.566 ' HA ' ' HE2' ' E' ' 197' ' ' TYR . 73.2 t80 -55.09 -40.52 70.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.759 0.824 . . . . 75.4 111.7 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.514 ' HA ' HE21 ' C' ' 33' ' ' GLN . 0.0 OUTLIER -116.52 38.78 3.33 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.997 0.903 . . . . 72.24 109.811 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.719 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -99.98 152.23 20.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.68 -0.638 . . . . 73.12 110.945 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.62 108.57 4.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.633 -1.247 . . . . 52.33 107.633 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -70.99 104.58 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.927 0.891 . . . . 74.24 110.68 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -134.47 49.88 4.38 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 124.174 0.99 . . . . 74.31 110.724 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 112.62 3.42 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.182 1.922 . . . . 73.42 112.302 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -86.0 95.08 9.39 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.579 -1.267 . . . . 72.34 107.579 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.716 ' HB ' ' HB1' ' E' ' 189' ' ' ALA . 76.0 t -80.7 89.63 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.095 -0.957 . . . . 74.13 110.118 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.88 139.14 31.24 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.837 -0.801 . . . . 75.45 108.837 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.593 ' HB3' HG23 ' C' ' 64' ' ' VAL . 0.6 OUTLIER -129.12 144.98 51.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.379 0.671 . . . . 54.34 109.633 172.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.46 139.19 53.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.796 1.239 . . . . 55.25 108.836 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.685 ' HG ' HD21 ' C' ' 60' ' ' LEU . 8.9 tt -114.21 135.7 53.76 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.629 0.772 . . . . 74.52 109.16 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -155.63 149.95 25.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.229 1.011 . . . . 75.34 108.835 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -112.16 152.11 28.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.466 0.65 . . . . 73.44 109.895 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.0 158.39 41.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.5 1.12 . . . . 75.43 108.173 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.4 t -153.26 148.84 27.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.899 0.38 . . . . 74.34 110.675 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -157.74 128.09 6.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.62 1.168 . . . . 74.12 108.917 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -81.41 131.22 35.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.312 -0.625 . . . . 73.32 109.312 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.507 HD13 HD13 ' C' ' 83' ' ' ILE . 84.2 mt -98.01 -40.1 8.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.542 0.737 . . . . 75.22 110.34 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.36 179.48 9.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.221 -0.899 . . . . 65.32 109.526 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.14 126.04 28.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.661 -0.866 . . . . 75.42 108.661 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.402 ' HA ' HG22 ' C' ' 86' ' ' ILE . 3.0 m-20 67.11 13.83 9.58 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.625 1.17 . . . . 64.54 112.606 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.68 117.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.405 1.082 . . . . 64.4 108.587 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 165.76 23.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.66 0.743 . . . . 72.5 109.547 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -126.57 136.63 52.8 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.328 1.051 . . . . 74.24 108.474 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.0 t -123.37 127.43 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.179 -1.415 . . . . 73.22 107.179 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.507 HG23 ' HA2' ' C' ' 81' ' ' GLY . 90.2 t -120.44 117.4 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.798 -0.815 . . . . 72.23 108.798 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.685 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -86.53 113.05 22.13 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.786 -0.82 . . . . 65.41 108.786 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -90.92 106.76 18.74 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.307 -0.998 . . . . 74.43 108.307 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.439 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.5 t -107.19 135.47 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.152 -1.055 . . . . 61.34 108.152 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -127.39 124.99 39.85 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.951 -0.388 . . . . 72.23 109.951 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.602 HG21 HG23 ' C' ' 114' ' ' ILE . 43.3 t -102.71 115.86 45.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 74.31 110.612 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -99.4 134.76 41.79 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.178 -1.045 . . . . 65.25 108.178 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.26 129.92 45.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.32 -0.993 . . . . 73.12 108.32 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 70.2 m -146.88 135.63 22.18 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.626 0.579 . . . . 72.2 111.146 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.719 HD12 ' HG2' ' C' ' 34' ' ' LYS . 5.9 mt -86.83 40.74 0.92 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.319 1.848 . . . . 74.22 109.413 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.42 -109.71 3.29 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.724 -0.95 . . . . 73.33 110.724 -168.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.25 -24.47 22.08 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.519 0.728 . . . . 75.52 110.136 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 6.9 tp10 -76.94 120.45 22.08 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.389 1.075 . . . . 75.11 110.027 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.1 m -66.65 125.36 25.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.958 0.799 . . . . 74.54 109.404 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.06 -51.9 8.46 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.842 -0.799 . . . . 72.52 108.842 174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -164.81 175.29 9.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.777 -1.101 . . . . 74.12 109.863 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -134.33 144.81 48.5 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.677 -1.601 . . . . 73.55 106.677 170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.488 ' SG ' HG21 ' C' ' 114' ' ' ILE . 42.1 t -143.83 148.33 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.21 -1.033 . . . . 72.1 108.21 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.62 134.85 9.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.922 -0.77 . . . . 60.25 108.922 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.73 139.24 52.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.364 1.066 . . . . 75.54 108.521 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -116.4 90.34 3.31 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.116 -1.068 . . . . 75.42 108.116 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -79.56 106.6 11.7 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.675 -1.148 . . . . 75.25 109.991 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.507 ' HA2' HG23 ' C' ' 59' ' ' VAL . . . -82.72 148.41 26.05 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.371 0.419 . . . . 74.1 112.166 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.74 116.19 0.77 Allowed Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 110.795 -0.922 . . . . 74.33 110.795 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.584 HD11 ' HH ' ' C' ' 17' ' ' TYR . 10.9 mm -87.6 125.23 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.245 -1.02 . . . . 63.34 108.245 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -130.56 156.59 44.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.498 -0.927 . . . . 74.02 108.498 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -91.75 137.22 32.54 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.933 -0.766 . . . . 72.34 108.933 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.48 HG12 ' HE1' ' E' ' 174' ' ' MET . 0.0 OUTLIER -108.52 134.67 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.655 -0.868 . . . . 73.11 108.655 172.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -178.39 153.56 0.75 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.574 0.75 . . . . 71.03 110.992 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.85 -36.53 3.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.652 1.021 . . . . 53.41 115.652 163.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.621 HD11 ' HE3' ' C' ' 94' ' ' MET . 1.6 pp -70.14 167.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.99 0.916 . . . . 73.42 112.282 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.464 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 0.9 OUTLIER -168.43 148.57 4.64 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.935 -1.029 . . . . 73.35 108.676 173.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.43 -122.58 6.16 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.145 0.278 . . . . 74.03 113.444 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -77.31 -24.96 50.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.247 0.619 . . . . 75.4 112.575 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -41.75 98.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.79 0.436 . . . . 73.44 110.883 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.621 ' HE3' HD11 ' C' ' 89' ' ' ILE . 15.9 ptp -72.47 -27.37 62.25 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.298 -0.41 . . . . 72.13 111.816 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.94 76.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.491 0.716 . . . . 71.33 111.826 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -72.46 -24.57 61.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.063 0.545 . . . . 73.42 111.222 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.436 ' SG ' ' SD ' ' E' ' 174' ' ' MET . 32.3 t -62.96 -63.46 1.2 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.537 0.523 . . . . 61.24 111.089 -172.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.52 -23.92 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.49 0.586 . . . . 74.14 110.516 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.85 -24.44 76.63 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.486 -0.779 . . . . 64.15 113.521 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.418 ' HA ' ' CZ2' ' E' ' 184' ' ' TRP . . . -158.61 -38.01 0.06 Allowed 'General case' 0 C--N 1.358 0.967 0 N-CA-C 113.723 1.009 . . . . 71.52 113.723 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.21 -39.01 82.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.517 0.727 . . . . 70.03 112.057 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.82 -50.28 4.22 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.46 -0.781 . . . . 72.23 111.301 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.49 -23.16 64.84 Favored 'Trans proline' 0 C--N 1.398 3.183 0 C-N-CA 121.637 1.558 . . . . 75.55 113.306 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -65.37 -36.13 83.05 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 122.984 0.514 . . . . 71.13 110.394 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.27 -41.52 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.895 0.878 . . . . 72.4 110.165 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 57.5 mt -86.64 -15.95 38.13 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.591 -1.186 . . . . 72.44 112.07 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -59.63 -51.58 80.03 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 117.617 -1.182 . . . . 72.41 113.182 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.94 -34.39 99.1 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 121.927 1.751 . . . . 74.45 112.596 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.64 -46.68 75.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.506 0.722 . . . . 73.3 110.864 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.59 94.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 42.33 110.402 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.19 -45.67 93.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.421 1.488 . . . . 72.23 110.716 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.59 -30.19 59.53 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.004 0.921 . . . . 63.11 110.324 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.1 t -68.67 -39.82 80.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.1 0.56 . . . . 75.01 110.481 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.602 HG23 HG21 ' C' ' 64' ' ' VAL . 86.4 mt -68.31 -45.06 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.064 0.546 . . . . 65.42 109.932 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.2 m -55.01 -38.87 68.46 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.634 0.774 . . . . 74.21 111.184 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -59.8 -60.6 3.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.187 -0.915 . . . . 71.42 109.716 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.809 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -48.2 -47.63 35.26 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.474 1.51 . . . . 73.22 113.349 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.547 HG11 HD21 ' C' ' 126' ' ' LEU . 53.5 t -70.69 -43.89 77.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.12 0.968 . . . . 75.24 111.796 -173.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.5 t -64.72 -30.57 71.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.889 -0.596 . . . . 64.51 110.793 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.455 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 75.2 mtt-85 -66.02 -32.53 74.06 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.816 -0.629 . . . . 73.5 110.564 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.28 12.3 60.9 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.526 0.516 . . . . 73.35 113.557 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.576 HG22 ' HB3' ' D' ' 17' ' ' TYR . 46.5 p 58.79 35.93 24.54 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.793 1.637 . . . . 75.41 112.922 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 41.5 m-85 -110.21 163.94 16.0 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.171 0.988 . . . . 74.5 110.504 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 32.7 Cg_endo -59.48 173.35 1.54 Allowed 'Trans proline' 0 C--N 1.402 3.361 0 C-N-CA 123.631 2.888 . . . . 73.34 114.905 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.577 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 5.7 mm-40 -60.68 136.26 58.01 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.393 -0.821 . . . . 73.42 111.732 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.547 HD21 HG11 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -112.32 24.81 12.15 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.278 -0.874 . . . . 74.52 111.683 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 7.1 p30 -92.56 84.0 5.01 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.523 1.63 . . . . 74.22 108.207 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.526 ' HB3' HD12 ' E' ' 187' ' ' ILE . 3.5 mm? -91.91 157.03 17.06 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.915 -1.038 . . . . 75.1 112.63 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' F' ' 204' ' ' ILE . . . -33.58 135.91 0.31 Allowed Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 126.542 1.937 . . . . 74.31 115.101 -174.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.75 109.99 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.851 2.367 . . . . 74.42 111.609 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.05 30.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.428 0.691 . . . . 74.42 111.381 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -71.2 103.8 2.9 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -67.17 -5.0 11.79 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.119 -0.946 . . . . 75.22 111.988 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.547 ' HA ' ' HB3' ' C' ' 137' ' ' PHE . 9.9 m-20 -63.46 -19.02 64.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.821 1.248 . . . . 65.31 112.999 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.24 89.28 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.468 0.651 . . . . 73.11 109.857 167.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.1 mt -87.9 -25.41 23.25 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.241 1.016 . . . . 74.23 111.739 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' C' ' 134' ' ' ASP . 77.2 t80 -64.54 -46.96 80.62 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.891 0.769 . . . . 74.33 111.278 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.523 ' HE2' ' HB3' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -64.99 -32.89 74.84 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 123.38 0.425 . . . . 73.45 110.324 178.196 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -65.94 -38.57 88.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.135 1.374 . . . . 71.25 110.914 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.493 ' HB3' HD22 ' C' ' 141' ' ' LEU . 8.4 m-85 -71.03 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.939 0.896 . . . . 73.23 109.123 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.493 HD22 ' HB3' ' C' ' 140' ' ' TYR . 2.3 mm? -93.94 111.88 23.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.517 0.727 . . . . 75.54 110.034 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -72.24 143.38 48.82 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.419 0.687 . . . . 74.42 109.891 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.07 -28.41 63.31 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 74.01 112.121 -174.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 61.6 88.95 0.08 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.961 1.304 . . . . 73.42 110.044 -172.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.05 170.95 15.29 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.344 0.658 . . . . 53.45 111.671 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -129.27 175.79 18.75 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 110.219 -1.152 . . . . 45.33 110.219 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.409 ' HG3' HG23 ' A' ' 92' ' ' THR . 33.3 tt0 -152.45 109.11 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.875 -0.417 . . . . 75.2 109.875 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.94 165.11 33.31 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.423 -0.671 . . . . 72.21 111.423 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 24.3 m 62.29 82.79 0.17 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.496 1.118 . . . . 74.13 111.839 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.58 100.42 13.27 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.499 -1.667 . . . . 62.31 106.499 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -149.14 147.33 28.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.986 -0.746 . . . . 62.3 108.986 -167.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -128.49 8.84 5.97 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.789 1.033 . . . . 72.24 113.789 -166.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -73.19 -81.34 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.264 0.938 . . . . 71.3 109.834 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -158.09 172.17 18.9 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.406 1.082 . . . . 74.44 109.652 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.505 -0.77 . . . . 72.12 109.795 171.376 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.734 -0.469 . . . . 73.21 109.734 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.9 p -145.45 88.6 1.87 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.5 0.72 . . . . 60.11 109.686 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -105.88 111.54 24.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.269 -1.011 . . . . 72.12 108.269 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -146.69 117.22 7.51 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.656 0.782 . . . . 70.32 109.389 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.72 140.86 34.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.145 -1.057 . . . . 64.53 108.145 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -150.44 -51.33 0.13 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.448 0.699 . . . . 73.01 109.63 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -66.52 141.37 57.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.225 -0.898 . . . . 73.41 110.206 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -64.19 116.54 6.07 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.902 -1.147 . . . . 75.44 107.902 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.437 ' HG3' HG21 ' D' ' 89' ' ' ILE . 4.4 ttp -31.97 122.86 0.3 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.638 1.211 . . . . 71.31 112.464 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.433 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 47.7 m -116.46 141.21 48.47 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.633 -0.877 . . . . 75.24 108.633 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -153.49 99.53 2.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.378 -0.971 . . . . 75.51 108.378 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -123.58 114.4 19.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.77 0.828 . . . . 75.14 108.774 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.464 HD11 HD11 ' D' ' 16' ' ' ILE . 1.1 pp -78.75 127.05 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 107.157 -1.424 . . . . 75.22 107.157 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -85.09 -35.37 21.86 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.271 -0.27 . . . . 71.41 110.271 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.448 ' HB3' ' HE1' ' D' ' 17' ' ' TYR . 1.6 tpt180 -172.74 157.29 3.71 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.852 0.461 . . . . 71.32 110.514 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.464 HD11 HD11 ' D' ' 13' ' ' ILE . 19.7 mt -144.31 124.19 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.514 1.126 . . . . 75.53 108.038 178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.576 ' HB3' HG22 ' C' ' 122' ' ' THR . 23.9 p90 -168.96 162.91 11.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.758 1.223 . . . . 73.4 109.996 -168.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.8 p -80.94 122.17 26.92 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.314 -0.857 . . . . 62.3 109.912 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 45.7 mtpt -86.09 -44.42 12.27 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 107.98 -1.118 . . . . 74.54 107.98 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.76 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.9 t70 -131.59 141.88 49.77 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.963 -1.017 . . . . 75.11 109.848 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.809 HG21 ' HE1' ' C' ' 117' ' ' MET . 55.4 mt -137.7 146.33 27.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.375 1.47 . . . . 74.14 107.778 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.1 140.5 17.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.498 0.666 . . . . 62.41 111.101 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.9 t80 -140.8 137.89 33.66 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.514 -1.662 . . . . 73.04 106.514 168.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.5 mt-10 -138.09 136.94 37.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.291 1.036 . . . . 73.15 108.489 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.463 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -148.11 74.17 10.97 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.959 -0.756 . . . . 71.23 108.959 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.71 -26.72 13.37 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.697 2.265 . . . . 73.33 112.407 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -99.46 -0.44 40.78 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.05 -0.977 . . . . 73.14 111.508 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -42.39 -57.87 4.13 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 116.071 1.878 . . . . 65.32 116.071 -163.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.458 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 67.1 Cg_endo -77.44 -25.18 8.47 Favored 'Trans proline' 0 C--N 1.387 2.59 0 CA-C-N 121.101 1.429 . . . . 75.44 113.221 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -87.14 -24.17 24.59 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.702 0.287 . . . . 74.12 110.585 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -8.93 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 123.495 0.718 . . . . 65.25 110.12 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -65.98 -38.17 87.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.774 0.829 . . . . 72.23 110.614 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -75.9 -2.1 28.6 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.81 0.338 . . . . 75.34 111.363 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.451 ' HZ3' ' HG2' ' D' ' 71' ' ' GLU . 77.2 tttt -105.68 76.87 1.22 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.635 1.174 . . . . 74.02 107.975 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.62 95.19 8.27 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.015 -0.993 . . . . 73.12 112.325 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -150.05 176.13 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.401 -0.592 . . . . 75.23 109.401 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -73.3 114.12 28.45 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.139 0.976 . . . . 74.44 109.231 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.51 111.16 0.86 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.111 1.874 . . . . 74.1 110.421 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.66 111.17 2.28 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.862 -1.162 . . . . 73.53 107.862 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -98.35 121.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.352 0.661 . . . . 72.04 109.385 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.538 ' HZ2' ' HB2' ' D' ' 43' ' ' ASP . 13.9 tmtt? -109.06 114.26 27.83 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.568 -1.271 . . . . 75.1 107.568 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -96.61 116.27 28.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.852 0.861 . . . . 74.54 108.968 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.538 ' HB2' ' HZ2' ' D' ' 41' ' ' LYS . 15.7 t70 -108.41 125.87 52.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.712 -0.847 . . . . 71.44 108.712 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.71 129.82 42.8 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.423 -0.584 . . . . 73.43 109.423 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.533 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.5 t70 -144.55 152.82 41.11 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.147 -1.057 . . . . 73.3 108.147 172.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -145.19 157.31 44.11 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.326 0.651 . . . . 74.32 109.506 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.93 166.85 28.37 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.811 1.245 . . . . 71.23 107.793 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.446 ' OG ' HD12 ' H' ' 177' ' ' LEU . 68.9 p -168.1 166.01 13.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.828 0.451 . . . . 55.05 110.813 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.1 p -156.65 132.63 9.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.26 -0.882 . . . . 63.02 109.12 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -70.3 126.99 31.23 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.53 -0.544 . . . . 61.43 109.53 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.3 mt -91.45 -40.89 11.16 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.263 0.554 . . . . 74.01 109.824 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.22 -173.26 3.94 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.117 -0.947 . . . . 75.55 110.172 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.97 123.06 19.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.657 -0.701 . . . . 74.34 110.014 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 64.56 17.39 10.85 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.551 1.157 . . . . 75.31 112.242 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.12 123.47 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.563 0.745 . . . . 73.23 110.16 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.531 ' HE1' ' HG3' ' H' ' 174' ' ' MET . 12.0 m-85 -125.29 166.33 16.72 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.902 1.281 . . . . 71.14 108.419 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.475 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.5 tm-20 -130.6 126.93 37.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.737 -1.949 . . . . 71.23 105.737 168.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.86 133.23 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.189 0.996 . . . . 63.43 108.552 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.13 135.91 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.367 1.067 . . . . 70.43 110.079 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.46 126.6 52.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.212 -1.403 . . . . 73.31 107.212 171.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.533 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -104.51 102.95 12.57 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.883 -0.784 . . . . 74.12 108.883 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.5 t -95.18 119.39 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.373 -0.973 . . . . 73.41 108.373 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 32.0 m -115.76 136.92 52.58 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.677 -0.692 . . . . 74.12 110.164 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.577 HG22 HG23 ' D' ' 114' ' ' ILE . 76.4 t -126.76 102.3 9.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.897 1.279 . . . . 64.15 108.167 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -97.84 92.53 5.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.091 -1.448 . . . . 73.23 107.091 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.3 137.35 37.15 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.453 -0.943 . . . . 74.14 108.453 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.414 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.2 p -148.78 130.26 14.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.321 0.581 . . . . 75.44 111.782 -170.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.437 ' HG ' ' HB3' ' D' ' 73' ' ' ALA . 59.5 mt -98.31 107.67 20.18 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.694 1.198 . . . . 73.15 108.316 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.9 -134.58 22.05 Favored Glycine 0 C--N 1.343 0.932 0 O-C-N 123.536 0.523 . . . . 64.33 112.272 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.32 4.54 38.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.669 0.787 . . . . 63.45 111.943 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.451 ' HG2' ' HZ3' ' D' ' 34' ' ' LYS . 13.7 pt-20 -132.08 162.73 30.1 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.836 0.454 . . . . 75.42 110.608 -172.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.0 m -66.83 136.4 55.36 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.148 -0.933 . . . . 71.33 111.552 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.437 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . . . -90.12 -56.44 3.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.931 -1.137 . . . . 73.51 107.931 169.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -162.62 144.42 10.47 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.201 -1.363 . . . . 71.34 109.802 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -110.53 111.52 22.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.832 0.853 . . . . 74.43 108.785 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.604 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 20.2 t -127.09 127.71 45.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.012 0.525 . . . . 75.23 109.936 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -148.38 139.77 23.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.431 0.692 . . . . 75.53 109.74 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' D' ' 113' ' ' CYS . 99.1 t -132.87 124.67 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.435 0.694 . . . . 70.21 109.678 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.76 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.8 mt-30 -91.74 88.32 6.64 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.751 -0.833 . . . . 74.43 108.751 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -80.05 109.71 14.75 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 114.401 -1.272 . . . . 75.05 108.353 177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.07 166.8 21.33 Favored Glycine 0 C--O 1.241 0.545 0 N-CA-C 111.946 -0.462 . . . . 70.24 111.946 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.15 140.24 6.11 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.002 -0.839 . . . . 73.22 111.002 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.2 mt -88.71 126.25 41.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.81 -0.811 . . . . 71.13 108.81 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -124.61 124.71 42.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.104 0.561 . . . . 74.3 109.965 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -93.28 111.34 22.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.052 0.941 . . . . 72.2 108.809 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 42.2 pt -116.68 142.98 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.237 0.615 . . . . 75.31 111.431 -172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.433 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -157.93 160.64 37.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.858 1.263 . . . . 65.21 108.585 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.75 22.4 78.12 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 123.062 0.226 . . . . 74.23 113.404 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.608 HD11 ' HG2' ' D' ' 94' ' ' MET . 1.2 pp -113.1 148.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.311 1.044 . . . . 75.21 109.959 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' H' ' 172' ' ' ALA . 0.0 OUTLIER -144.27 146.41 32.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.34 0.656 . . . . 74.34 111.152 -176.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 35.45 -97.65 0.01 OUTLIER Glycine 0 C--N 1.359 1.828 0 N-CA-C 116.494 1.357 . . . . 62.04 116.494 169.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -64.25 -53.82 43.15 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.722 1.209 . . . . 64.31 110.934 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.46 -31.06 71.94 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.94 -1.027 . . . . 64.03 110.876 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.608 ' HG2' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -71.96 -54.71 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.421 1.088 . . . . 61.23 109.915 -178.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.72 -25.79 68.36 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.835 -1.075 . . . . 65.14 111.563 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.67 -44.89 18.08 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.969 0.508 . . . . 70.12 111.01 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.9 -43.27 96.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.032 0.533 . . . . 73.14 111.033 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 tt -92.77 -33.39 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 73.34 110.682 -176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -20.73 57.36 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.401 0.52 . . . . 64.3 114.401 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.24 -49.86 1.1 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.577 0.689 . . . . 63.43 111.851 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -73.4 -45.01 57.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.868 0.467 . . . . 73.0 111.473 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 93.2 m -61.5 -48.04 91.64 Favored Pre-proline 0 CA--C 1.567 1.6 0 CA-C-O 118.286 -0.864 . . . . 64.44 111.637 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.8 Cg_exo -56.9 -38.17 96.55 Favored 'Trans proline' 0 C--N 1.399 3.228 0 C-N-CA 122.353 2.035 . . . . 64.52 113.366 168.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.91 -32.35 73.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.365 0.666 . . . . 70.53 111.251 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.65 -41.5 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.55 0.74 . . . . 62.51 110.259 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 61.7 mt -75.14 -23.52 57.83 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.152 -0.931 . . . . 74.04 111.607 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.405 ' HZ ' HD11 ' D' ' 128' ' ' LEU . 66.4 t80 -60.64 -45.39 97.07 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.733 1.382 . . . . 73.33 114.733 -169.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.12 -42.63 58.15 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 122.118 1.879 . . . . 72.23 112.816 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -76.49 -35.65 58.25 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.921 -1.036 . . . . 71.31 110.724 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.57 78.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.896 0.878 . . . . 62.31 110.905 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.401 HH12 ' HB3' ' D' ' 130' ' ' PRO . 28.8 ttp180 -58.87 -55.09 39.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.448 1.093 . . . . 75.52 109.956 176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.56 -40.32 86.9 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.273 0.983 . . . . 75.51 111.895 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.496 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -59.28 -42.71 91.86 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.02 0.825 . . . . 53.34 110.333 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.577 HG23 HG22 ' D' ' 64' ' ' VAL . 66.5 mt -63.65 -52.02 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.018 0.927 . . . . 75.42 110.364 172.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.8 m -53.66 -43.61 68.96 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.361 1.464 . . . . 70.43 112.099 -172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -68.48 -43.05 77.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.011 -0.995 . . . . 71.02 110.377 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.604 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.7 mtm -66.35 -30.92 71.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.868 0.467 . . . . 75.23 111.964 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.426 HG22 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -71.02 -42.39 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.391 0.676 . . . . 75.12 110.397 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -71.06 -29.95 65.97 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 116.553 -0.294 . . . . 74.24 110.442 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -69.74 -28.67 65.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.762 0.825 . . . . 75.43 110.148 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 11.09 62.91 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.717 0.636 . . . . 74.1 112.922 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.539 HG22 ' HB3' ' C' ' 17' ' ' TYR . 75.1 p 56.06 25.12 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.292 1.837 . . . . 75.52 113.46 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.454 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 28.2 m-85 -103.34 166.22 12.18 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 125.055 1.342 . . . . 72.41 109.687 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 34.2 Cg_endo -59.23 124.71 16.19 Favored 'Trans proline' 0 C--N 1.394 2.933 0 C-N-CA 123.052 2.501 . . . . 75.23 112.791 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -55.16 119.64 5.8 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 123.883 0.74 . . . . 73.31 109.869 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.01 98.41 8.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.327 0.584 . . . . 73.1 109.831 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.401 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 79.6 m-20 -99.13 86.3 3.41 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.006 -1.109 . . . . 74.41 108.006 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.405 HD11 ' HZ ' ' D' ' 107' ' ' PHE . 1.0 OUTLIER -72.59 138.16 46.64 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.934 -1.03 . . . . 74.22 109.896 -173.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 131.5 95.21 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.993 0.517 . . . . 73.42 111.891 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HB3' HH12 ' D' ' 111' ' ' ARG . 58.4 Cg_endo -78.3 119.44 4.58 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.906 1.737 . . . . 72.4 110.072 174.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.75 120.22 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.63 0.728 . . . . 72.53 110.031 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -74.34 104.24 5.02 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.316 -0.994 . . . . 72.14 108.316 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -61.75 -32.87 73.15 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.403 1.081 . . . . 73.13 111.361 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.59 -40.55 73.2 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.707 0.803 . . . . 73.43 111.122 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.35 78.38 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.028 0.531 . . . . 70.43 110.729 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.592 HD11 ' HD2' ' H' ' 185' ' ' PRO . 87.0 mt -70.93 -45.18 64.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.344 0.658 . . . . 75.33 111.308 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.36 -58.18 9.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.051 0.54 . . . . 63.5 110.686 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtm -59.02 -52.86 63.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.892 0.877 . . . . 74.43 111.285 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.07 -33.41 70.77 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.583 0.753 . . . . 74.42 111.938 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -64.97 -43.26 93.23 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.972 0.909 . . . . 74.12 110.235 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.59 -39.06 32.56 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.9 0.88 . . . . 74.2 112.239 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.43 35.76 0.88 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.513 0.725 . . . . 73.54 111.351 -173.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -113.32 89.16 3.01 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.253 1.025 . . . . 72.13 108.309 -168.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.87 136.9 25.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.378 -1.712 . . . . 75.51 106.378 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.76 96.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.601 0.76 . . . . 72.41 110.179 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.61 51.97 0.05 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.111 -1.196 . . . . 75.31 110.111 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -63.16 152.63 36.82 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.165 0.986 . . . . 73.22 110.631 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.25 80.7 0.14 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.864 -0.894 . . . . 65.43 110.864 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 33.5 p -69.83 -32.26 70.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.15 0.98 . . . . 72.04 109.775 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.31 100.75 0.07 Allowed 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.911 -1.04 . . . . 72.43 109.572 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -175.85 1.85 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.616 0.767 . . . . 73.42 110.69 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -123.73 154.34 39.61 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.004 -0.435 . . . . 74.24 110.92 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -71.49 -175.69 1.36 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.757 0.823 . . . . 75.1 109.996 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.86 76.51 1.15 Allowed 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.533 0.682 . . . . 71.15 109.854 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 C-N-CA 124.969 1.308 . . . . 74.21 108.22 -172.888 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.075 -0.343 . . . . 74.54 110.075 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.12 96.93 0.49 Allowed Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.123 -1.191 . . . . 62.4 110.123 175.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.64 -19.92 52.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.42 1.088 . . . . 73.41 113.126 -168.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 69.2 m 64.18 39.36 7.59 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.597 0.759 . . . . 74.34 111.084 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.82 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 C-N-CA 124.547 1.139 . . . . 73.53 110.958 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 45.31 41.01 5.79 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 125.102 1.361 . . . . 65.54 114.372 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.48 ' HE1' HG12 ' C' ' 86' ' ' ILE . 53.0 mtt 56.69 53.47 8.35 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.83 0.852 . . . . 74.12 110.512 -174.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.47 -114.89 0.21 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.399 -0.963 . . . . 73.4 108.399 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 54.98 -103.01 0.16 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.384 1.074 . . . . 75.33 110.776 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.3 mp 53.83 178.7 0.02 OUTLIER 'General case' 0 C--N 1.366 1.291 0 C-N-CA 124.779 1.232 . . . . 74.45 113.434 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -167.39 -49.43 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 106.545 -1.65 . . . . 74.31 106.545 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -132.85 164.39 44.17 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 114.776 -1.102 . . . . 74.11 109.17 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.71 108.72 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.292 1.995 . . . . 72.25 110.442 164.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.65 -4.5 51.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.213 0.605 . . . . 73.13 111.27 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.49 140.92 51.13 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.138 0.975 . . . . 72.52 109.563 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 26.6 m -77.1 111.18 12.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.903 0.881 . . . . 74.24 110.148 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.418 ' CZ2' ' HA ' ' C' ' 100' ' ' ALA . 74.2 m95 -83.53 113.2 45.29 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.46 0.704 . . . . 75.3 109.697 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.88 143.97 37.83 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.183 1.922 . . . . 75.1 110.943 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 92.1 mt -119.85 110.29 16.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.204 -0.665 . . . . 73.14 109.204 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' C' ' 128' ' ' LEU . 0.0 OUTLIER -82.72 143.09 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.672 -0.862 . . . . 64.54 108.672 173.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.5 108.13 5.35 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.374 -0.973 . . . . 72.54 108.374 177.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . 0.716 ' HB1' ' HB ' ' C' ' 40' ' ' VAL . . . -65.61 121.11 14.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.73 0.812 . . . . 72.4 109.786 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.6 163.34 25.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.258 0.623 . . . . 74.53 111.235 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.37 160.67 31.69 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.877 -0.602 . . . . 45.12 113.606 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.34 146.4 6.73 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.782 -0.454 . . . . 72.44 112.466 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -114.9 106.14 13.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.901 0.88 . . . . 74.43 110.702 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -171.69 90.24 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.037 0.935 . . . . 74.13 110.203 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -147.3 160.38 42.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.94 0.896 . . . . 62.45 111.366 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -115.82 106.66 14.09 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.423 -1.325 . . . . 73.2 107.423 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . 0.566 ' HE2' ' HA ' ' C' ' 32' ' ' PHE . 44.9 t80 -158.5 3.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.705 0.402 . . . . 75.44 111.827 -170.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -65.81 96.26 0.28 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.36 1.064 . . . . 72.14 110.564 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 63.56 -75.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.641 1.577 . . . . 74.54 111.289 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -127.69 -108.48 1.48 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.452 -1.459 . . . . 74.13 109.452 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 62.4 tttp 69.12 -59.63 0.47 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.188 1.795 . . . . 74.41 111.672 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . 0.491 ' O ' ' HA ' ' F' ' 187' ' ' ILE . 9.3 t80 -46.61 -49.49 18.9 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.569 1.148 . . . . 63.43 109.55 172.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.49 -167.6 2.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.068 0.547 . . . . 73.44 111.169 173.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.646 HD11 HG22 ' B' ' 131' ' ' VAL . 45.8 mm 73.67 -60.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.403 0 C-N-CA 125.888 1.675 . . . . 74.51 110.566 -171.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 28.8 tptp 71.59 -74.58 0.09 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.127 1.371 . . . . 75.32 110.183 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -165.92 -44.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.766 0.826 . . . . 73.32 109.308 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 CA--C 1.561 1.392 0 C-N-CA 124.859 1.263 . . . . 61.22 110.221 -175.296 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.155 -0.313 . . . . 65.41 110.155 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 123.76 -51.72 0.8 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.362 -1.495 . . . . 74.43 109.362 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . 0.517 ' HG2' ' HA ' ' B' ' 53' ' ' ASP . 50.6 mttp -69.66 88.19 0.51 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.199 -1.038 . . . . 72.44 108.199 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 32.3 t -67.7 -45.25 75.64 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.563 1.145 . . . . 74.24 111.817 -165.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.78 134.13 45.99 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.635 0.585 . . . . 74.44 110.729 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -62.23 106.17 0.7 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 124.212 0.945 . . . . 71.33 109.055 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' B' ' 56' ' ' TYR . 0.0 OUTLIER -106.41 -176.23 3.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.524 -0.762 . . . . 72.34 109.524 -174.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.51 156.23 45.12 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.264 1.025 . . . . 75.34 109.43 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -130.8 46.25 2.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.964 0.906 . . . . 71.2 109.493 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.57 119.66 8.5 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.114 0.565 . . . . 74.11 110.076 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.43 -17.63 15.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.945 0.498 . . . . 74.35 110.119 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.59 150.1 40.76 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.731 1.212 . . . . 73.03 110.096 -175.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . 0.507 ' HG3' ' H ' ' B' ' 46' ' ' THR . 3.9 Cg_exo -72.75 95.3 0.8 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.647 2.231 . . . . 75.32 110.553 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -61.07 -31.67 71.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.289 0.635 . . . . 73.34 110.45 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . 0.401 ' HD1' ' HA3' ' B' ' 99' ' ' GLY . 63.0 m-85 -116.33 81.4 1.61 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.517 0.727 . . . . 70.44 109.489 171.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 82.5 m -77.13 110.51 11.86 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.933 -0.766 . . . . 71.24 108.933 170.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -111.11 93.09 16.83 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.186 0.595 . . . . 74.14 109.625 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -88.02 128.82 2.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.58 2.187 . . . . 74.51 112.283 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.34 177.03 8.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.715 0.406 . . . . 74.14 111.76 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.526 HD11 HD11 ' B' ' 42' ' ' LEU . 64.3 mt 81.36 131.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 126.724 2.009 . . . . 75.33 112.534 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.08 87.95 2.13 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -89.72 111.66 22.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.649 -0.5 . . . . 72.21 109.649 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -139.11 163.03 33.48 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.78 0.832 . . . . 64.42 109.724 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.47 172.2 35.39 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.784 -0.644 . . . . 62.42 111.745 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -76.96 -110.64 0.14 Allowed Glycine 0 C--N 1.343 0.932 0 O-C-N 123.499 0.176 . . . . 74.01 112.755 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -112.96 74.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.636 0.774 . . . . 74.42 109.583 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -107.84 37.42 2.45 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.236 -0.893 . . . . 74.52 109.539 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.491 ' HD1' ' HB2' ' F' ' 202' ' ' TYR . 73.4 t80 -146.16 -81.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.796 -1.093 . . . . 72.04 108.698 -175.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 88.0 tttt 50.73 108.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.21 1.404 . . . . 73.35 113.177 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . 0.428 ' H ' ' HB2' ' B' ' 35' ' ' ASP . 3.2 t80 -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.436 0.694 . . . . 73.4 111.467 -172.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.46 -50.11 72.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 72.11 110.283 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -172.32 115.63 0.33 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.591 0.756 . . . . 75.51 109.635 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.9 -91.11 0.08 OUTLIER Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.733 -0.547 . . . . 61.22 111.733 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 24.3 pttt -177.08 170.56 2.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.904 1.282 . . . . 74.21 111.071 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.491 ' HB2' ' HD1' ' F' ' 195' ' ' PHE . 3.7 m-30 63.29 22.62 13.41 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 124.993 1.317 . . . . 74.44 110.071 -170.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -151.19 174.8 12.81 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 115.148 -0.933 . . . . 75.42 109.172 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.537 ' HA ' ' HB3' ' C' ' 129' ' ' ALA . 16.5 mt -93.08 93.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.295 0.569 . . . . 62.01 109.524 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -101.76 -21.11 14.69 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.486 -0.779 . . . . 74.25 110.789 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -138.58 130.1 27.53 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.957 0.503 . . . . 72.34 109.758 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.558 1.25 0 C-N-CA 124.663 1.185 . . . . 74.41 109.201 170.766 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.238 0.471 0 CA-C-O 120.944 0.402 . . . . 73.23 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.68 175.35 43.02 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 116.172 -0.467 . . . . 72.11 112.511 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . 0.425 ' N ' ' HE2' ' G' ' 170' ' ' LYS . 0.0 OUTLIER -165.23 -158.49 0.39 Allowed 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.63 1.172 . . . . 75.2 107.86 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 31.2 t -56.09 96.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.994 -0.743 . . . . 70.2 108.994 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -174.27 -60.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.377 1.071 . . . . 62.13 109.696 -171.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.63 ' HB2' ' SD ' ' G' ' 174' ' ' MET . 0.6 OUTLIER -132.72 173.37 11.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.25 -1.341 . . . . 72.34 110.737 -170.032 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.63 ' SD ' ' HB2' ' G' ' 173' ' ' LEU . 0.0 OUTLIER 61.92 21.17 12.09 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.438 1.095 . . . . 72.11 113.481 171.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -64.36 157.98 24.84 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.046 0.538 . . . . 63.55 111.74 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -83.98 60.38 5.81 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.966 0.906 . . . . 63.15 109.299 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . 0.549 ' HB2' ' H ' ' A' ' 48' ' ' SER . 55.8 tp 55.45 94.25 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.215 1.406 . . . . 73.44 112.511 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' G' ' 179' ' ' GLU . 48.6 tt0 -84.4 -75.87 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.602 -0.888 . . . . 74.45 108.602 171.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.497 ' HG3' ' HG2' ' G' ' 178' ' ' GLN . 43.3 mt-10 -146.57 150.2 39.49 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 124.222 1.009 . . . . 74.33 109.513 -172.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.9 -37.66 53.0 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.591 2.194 . . . . 75.33 112.024 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 60.5 t80 69.24 133.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.656 1.182 . . . . 74.24 111.746 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 33.4 t80 67.23 161.75 0.17 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.955 1.302 . . . . 63.3 110.859 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 39.2 p -76.48 143.07 40.72 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.999 0.52 . . . . 70.42 110.704 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . 0.437 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 29.3 t-105 -124.82 127.21 25.2 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 108.14 -1.059 . . . . 75.31 108.14 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . 0.554 ' HG3' HG21 ' H' ' 207' ' ' VAL . 87.5 Cg_endo -84.63 127.63 3.77 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.594 2.196 . . . . 70.34 112.185 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 91.7 mt -89.15 99.71 12.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.616 -0.883 . . . . 74.33 108.616 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 pp -71.77 -178.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.13 0.972 . . . . 74.31 112.167 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.35 178.58 4.45 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.452 0.701 . . . . 74.33 111.03 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . 0.638 ' HB2' HD23 ' A' ' 128' ' ' LEU . . . -133.78 147.34 51.26 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.387 0.675 . . . . 53.14 111.644 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -86.65 153.09 22.03 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.896 0.878 . . . . 74.01 110.201 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.59 -170.15 23.8 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.414 -0.812 . . . . 75.23 111.306 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . 0.516 ' H ' ' HB2' ' A' ' 124' ' ' PRO . . . -86.87 3.43 87.01 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 122.664 -0.315 . . . . 72.53 112.878 175.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . 0.413 ' HE1' ' HG3' ' H' ' 201' ' ' LYS . 77.5 t80 63.52 -80.69 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.075 1.75 . . . . 73.11 111.27 -172.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . 0.583 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . . . -148.45 155.54 41.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.316 0.579 . . . . 74.32 111.452 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.9 3.55 55.22 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.701 -1.136 . . . . 72.25 110.671 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 72.11 -59.63 0.55 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.584 1.554 . . . . 74.41 111.531 -169.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 72.21 143.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.161 1.384 . . . . 74.33 112.208 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . 0.441 ' HB3' ' HE3' ' G' ' 201' ' ' LYS . 5.0 tm-20 -167.5 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.173 -1.418 . . . . 74.05 107.173 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 9.0 t30 179.21 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.047 1.339 . . . . 64.5 108.269 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -88.67 61.22 3.85 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.581 -0.736 . . . . 71.4 112.398 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' G' ' 201' ' ' LYS . 11.4 mmpt? -89.02 -54.33 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.697 -0.853 . . . . 74.21 108.697 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -87.8 113.17 23.21 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.258 -1.386 . . . . 72.43 107.258 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.72 116.17 6.64 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.13 -1.063 . . . . 70.42 108.13 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 6.6 tp -126.33 99.65 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.739 0.78 . . . . 74.25 109.193 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.84 160.39 23.51 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.232 -0.895 . . . . 75.52 109.585 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.12 170.84 16.05 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.464 -0.569 . . . . 72.34 109.464 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.567 1.627 0 CA-C-O 118.517 -0.754 . . . . 75.03 111.183 -178.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . 0.739 ' H2 ' ' HD2' ' H' ' 168' ' ' LYS . 3.2 mptp? . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.201 -1.037 . . . . 72.11 108.201 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.69 85.84 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 O-C-N 124.076 0.86 . . . . 73.23 114.427 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -158.84 -67.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.541 0.736 . . . . 73.44 110.313 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 49.3 m -151.18 141.05 21.94 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.658 0.383 . . . . 73.22 111.076 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' D' ' 90' ' ' GLU . . . -104.25 -76.57 0.59 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.384 0.674 . . . . 71.45 110.509 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.661 ' HB3' ' SD ' ' H' ' 174' ' ' MET . 87.3 mt -85.09 126.47 33.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.787 -1.097 . . . . 74.14 110.193 -171.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.661 ' SD ' ' HB3' ' H' ' 173' ' ' LEU . 0.7 OUTLIER 69.08 147.43 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.084 1.354 . . . . 74.41 112.93 172.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.08 174.7 14.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.24 0.616 . . . . 73.13 110.835 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -116.46 27.52 9.15 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.643 0.777 . . . . 74.21 109.027 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . 0.446 HD12 ' OG ' ' D' ' 48' ' ' SER . 7.3 mp 64.81 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.144 1.378 . . . . 72.11 110.645 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.17 -66.08 0.66 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.759 -0.655 . . . . 64.43 111.711 -171.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.57 149.41 9.61 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.179 0.592 . . . . 64.01 110.138 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.76 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.757 2.305 . . . . 74.24 111.091 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.11 -43.61 78.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.881 0.873 . . . . 75.22 111.397 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -134.95 138.69 44.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.089 0.956 . . . . 71.2 109.069 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -97.88 -30.69 12.61 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.483 0.713 . . . . 72.53 110.196 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 66.59 136.1 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 125.545 1.538 . . . . 74.32 112.005 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . 0.592 ' HD2' HD11 ' D' ' 136' ' ' LEU . 64.1 Cg_endo -75.79 108.98 2.81 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.02 1.813 . . . . 74.43 112.233 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 mp -79.37 128.12 32.95 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.021 -0.733 . . . . 73.3 109.021 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.58 162.61 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.868 0.467 . . . . 75.2 110.917 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -149.58 -167.06 2.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.768 0.827 . . . . 73.24 109.5 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -157.26 133.88 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.104 0.562 . . . . 72.54 110.156 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.22 175.97 9.88 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.377 1.071 . . . . 73.22 108.646 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 68.6 -109.21 2.79 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.595 -0.602 . . . . 74.25 111.595 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.47 -61.85 4.67 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 114.343 0.497 . . . . 63.11 114.343 170.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 90.2 t80 63.32 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 74.45 110.271 -166.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -159.63 -171.73 3.41 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.699 0.8 . . . . 74.45 108.91 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 71.36 169.22 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.542 1.137 . . . . 55.35 112.14 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -153.91 -39.1 0.09 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.74 -0.664 . . . . 72.42 109.732 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 55.57 90.82 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.291 0.995 . . . . 75.15 112.31 170.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -129.03 126.1 38.75 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.831 -0.543 . . . . 74.45 111.246 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -85.45 80.19 9.18 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.035 -1.098 . . . . 74.4 108.035 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 164.8 -162.06 35.23 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.007 -0.997 . . . . 75.33 111.031 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . 0.413 ' HG3' ' HE1' ' G' ' 193' ' ' TYR . 6.8 tmtt? 61.71 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.179 1.392 . . . . 72.24 108.911 -171.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 64.79 82.52 0.18 Allowed 'General case' 0 C--N 1.355 0.836 0 N-CA-C 106.838 -1.541 . . . . 73.4 106.838 -167.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -109.19 158.75 17.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.14 -0.937 . . . . 74.35 110.517 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.549 HG12 ' HB2' ' A' ' 129' ' ' ALA . 3.8 mp -87.58 140.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.322 1.049 . . . . 72.31 109.976 -170.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.81 175.67 5.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.164 0.986 . . . . 72.52 110.708 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -64.67 143.56 57.84 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.481 -0.782 . . . . 71.23 110.053 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . 0.554 HG21 ' HG3' ' G' ' 185' ' ' PRO . 2.5 p . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 118.224 -0.893 . . . . 75.43 110.69 -172.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.664 0.269 . . . . 74.23 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -85.41 89.57 7.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.392 0.677 . . . . 71.13 110.52 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.37 116.92 29.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.79 0.836 . . . . 74.24 110.622 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -172.18 153.25 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.186 0.994 . . . . 75.41 110.45 -174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.557 ' ND2' ' HB2' ' C' ' 144' ' ' GLN . 6.1 p30 -160.09 121.23 3.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.044 -1.095 . . . . 72.41 108.044 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -142.04 172.93 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.597 0.759 . . . . 74.31 109.536 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.1 p -81.12 70.42 7.94 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.999 0.904 . . . . 74.45 108.932 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.12 174.22 10.42 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.398 1.079 . . . . 74.13 109.193 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.467 ' HG2' HG22 ' A' ' 89' ' ' ILE . 52.2 mtm 68.24 134.95 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.749 1.22 . . . . 71.53 111.071 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.2 m -146.46 122.0 10.41 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.674 -0.862 . . . . 75.11 108.674 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -126.59 116.57 21.24 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.07 -1.085 . . . . 75.51 108.07 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -137.55 110.66 7.79 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.701 0.8 . . . . 64.04 108.997 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.91 125.29 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 171.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -88.55 -33.4 17.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.152 -0.685 . . . . 62.44 109.152 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -172.61 145.31 1.54 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.34 0.4 . . . . 74.42 110.901 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.579 HD11 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -121.81 129.96 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.912 -1.144 . . . . 74.51 107.912 168.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 38.9 p90 -163.6 159.13 21.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.607 0.763 . . . . 74.43 110.751 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -84.92 118.53 24.58 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.354 -0.61 . . . . 74.04 109.354 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.62 ' HZ3' ' HB1' ' B' ' 28' ' ' ALA . 23.6 mtpp -78.7 -40.64 33.2 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.752 -0.833 . . . . 75.12 108.752 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -136.42 142.17 43.65 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.985 -1.007 . . . . 75.01 110.234 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.534 HG21 ' SD ' ' B' ' 117' ' ' MET . 74.7 mt -139.84 140.72 35.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.56 1.544 . . . . 73.33 107.271 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -154.05 116.18 4.3 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 75.25 109.289 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 69.8 t80 -111.24 122.62 48.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.523 -1.658 . . . . 74.11 106.523 166.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.58 130.85 56.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.645 -0.872 . . . . 72.23 108.645 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.53 79.14 73.86 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.102 -1.814 . . . . 74.51 106.102 165.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.6 -27.25 45.81 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.439 2.093 . . . . 75.12 111.149 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -111.33 31.89 5.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.338 -1.301 . . . . 71.33 109.12 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.76 99.85 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.681 0.993 . . . . 71.21 113.681 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.52 -22.94 17.77 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 121.905 1.737 . . . . 71.24 113.415 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.45 -39.52 70.92 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.188 0.595 . . . . 75.15 111.011 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.604 HG12 ' HA ' ' A' ' 73' ' ' ALA . 28.2 m -73.3 -15.64 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.352 0.661 . . . . 73.21 112.045 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.457 ' HD1' ' HD2' ' B' ' 15' ' ' ARG . 79.3 t80 -61.94 -38.92 90.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.784 0.834 . . . . 72.43 110.849 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -100.75 -13.26 18.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.239 0.616 . . . . 70.41 112.016 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.7 mmtp -83.29 150.71 25.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 117.977 0.353 . . . . 75.21 111.724 175.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.49 132.19 45.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.099 0.96 . . . . 74.42 109.895 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.504 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -77.63 93.44 4.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.216 0.531 . . . . 74.14 110.162 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' H ' HD23 ' A' ' 68' ' ' LEU . 8.5 tt0 -125.13 82.82 61.4 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.183 1.393 . . . . 75.34 107.745 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.4 114.32 3.77 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.537 2.158 . . . . 71.35 112.852 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -94.74 90.5 6.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.238 -1.764 . . . . 74.03 106.238 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.39 130.53 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.327 -0.851 . . . . 73.2 110.499 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.538 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.0 tttm -119.59 115.04 23.18 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.722 -1.214 . . . . 71.13 107.722 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.31 123.95 45.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.829 0.851 . . . . 73.11 109.222 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.486 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -118.84 109.21 15.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.989 0.916 . . . . 71.02 109.569 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.77 120.53 40.23 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.604 -0.887 . . . . 71.53 108.604 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -154.46 162.46 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.395 -0.594 . . . . 71.41 109.395 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -134.25 164.05 28.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.158 0.583 . . . . 72.35 110.842 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.79 108.27 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.826 -1.176 . . . . 73.24 107.826 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.8 m -109.9 152.44 25.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.135 0.574 . . . . 72.2 110.339 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.9 t -157.11 142.86 17.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.48 0.712 . . . . 65.43 110.062 -172.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -90.68 118.96 30.53 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.938 -0.764 . . . . 74.42 108.938 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 57' ' ' GLU . 71.3 mt -90.14 -39.64 12.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.086 0.555 . . . . 73.33 110.569 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.96 -174.09 3.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.789 0.836 . . . . 75.31 110.415 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.04 120.2 13.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.34 -0.985 . . . . 74.1 108.34 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 69.25 3.48 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.59 1.156 . . . . 54.23 112.811 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.32 114.59 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.821 -1.177 . . . . 72.34 107.821 176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -142.58 133.05 25.02 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.488 -0.93 . . . . 74.15 108.488 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' HB2' HD13 ' A' ' 51' ' ' LEU . 75.4 tt0 -114.09 120.14 39.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.737 0.415 . . . . 73.54 110.55 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -100.69 121.81 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.114 -1.81 . . . . 73.42 106.114 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -106.18 134.97 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.975 -0.75 . . . . 72.2 108.975 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.53 114.89 26.59 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.254 -1.017 . . . . 75.25 108.254 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -101.77 99.94 10.23 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.824 -0.806 . . . . 74.42 108.824 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.84 137.69 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 107.795 -1.187 . . . . 73.54 107.795 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.9 m -129.55 124.63 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.624 -0.88 . . . . 74.02 108.624 171.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.37 130.62 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 107.828 -1.175 . . . . 74.53 107.828 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 7.3 m -121.98 148.15 45.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.763 -1.569 . . . . 75.45 106.763 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.07 124.29 14.57 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.967 -1.123 . . . . 72.45 107.967 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 48.5 m -122.4 141.45 51.58 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 123.205 0.602 . . . . 73.11 110.298 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.504 HD21 ' CE3' ' A' ' 36' ' ' TRP . 51.1 mt -90.68 52.6 2.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.335 1.054 . . . . 75.3 109.791 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.14 -85.46 0.91 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.217 -0.901 . . . . 74.12 111.825 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -88.29 -31.09 19.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.443 0.697 . . . . 73.13 111.309 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.96 124.49 46.08 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 118.79 -0.624 . . . . 75.23 109.687 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.6 m -65.97 132.53 48.82 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.274 0.359 . . . . 65.24 110.797 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.604 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -75.51 -53.87 7.93 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.0 0.813 . . . . 75.01 109.697 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -164.06 169.77 17.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.583 -1.19 . . . . 74.23 111.304 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 tp -130.21 148.17 52.01 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.985 -1.461 . . . . 74.14 107.444 167.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.431 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -142.35 134.55 27.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.127 -1.064 . . . . 70.44 108.127 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -145.93 119.9 9.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.313 -0.995 . . . . 73.04 108.313 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.43 126.76 64.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.082 0.953 . . . . 75.32 109.635 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -104.99 90.15 3.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.044 -0.98 . . . . 74.01 108.781 172.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' O ' HD11 ' A' ' 106' ' ' LEU . 8.0 tp-100 -76.83 97.64 4.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.929 -1.137 . . . . 74.31 107.929 173.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.82 143.52 20.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.122 -0.791 . . . . 71.25 111.122 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.429 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.61 120.87 1.74 Allowed Glycine 0 CA--C 1.495 -1.163 0 N-CA-C 110.304 -1.118 . . . . 73.24 110.304 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -83.96 125.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.791 -1.189 . . . . 75.52 107.791 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.57 118.03 23.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.197 0.999 . . . . 73.53 108.331 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -87.5 100.11 12.53 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.161 -1.422 . . . . 75.22 107.161 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.6 HG21 HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -134.07 118.39 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.706 -0.679 . . . . 72.21 110.128 -168.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.8 177.67 11.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.727 1.211 . . . . 75.42 109.85 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.58 74.09 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 120.883 0.157 . . . . 43.02 112.958 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 94' ' ' MET . 1.1 pp -129.45 161.35 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.311 1.444 . . . . 72.31 110.169 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.69 171.18 14.46 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.542 0.737 . . . . 73.24 109.965 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.13 -120.0 2.11 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.387 1.315 . . . . 73.01 116.387 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -76.21 -15.97 59.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.994 0.918 . . . . 63.32 112.695 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.53 -50.86 69.67 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.583 -0.525 . . . . 75.2 109.583 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.607 ' HE2' HD11 ' A' ' 98' ' ' LEU . 14.4 ttt -74.22 -32.71 63.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.114 -0.948 . . . . 73.54 110.756 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.74 92.31 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.123 0.487 . . . . 60.31 111.137 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.01 -37.99 78.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.778 0.831 . . . . 74.34 110.668 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.82 -63.38 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.514 -0.766 . . . . 72.34 110.198 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.607 HD11 ' HE2' ' A' ' 94' ' ' MET . 53.8 mt -71.23 -22.78 61.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.251 0.62 . . . . 75.52 111.967 -176.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.6 -28.57 46.89 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.435 0.46 . . . . 71.03 113.887 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.93 -52.38 0.62 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.347 0.573 . . . . 72.24 112.397 -173.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -64.26 -54.42 33.58 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.328 0.651 . . . . 75.54 112.602 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.415 ' SG ' HD21 ' A' ' 98' ' ' LEU . 52.9 m -65.91 -46.45 64.86 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 123.839 0.856 . . . . 71.23 112.645 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.3 Cg_endo -66.32 -24.36 50.53 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 121.587 1.525 . . . . 72.44 112.852 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -74.32 -28.76 61.3 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.107 0.412 . . . . 73.34 111.032 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.42 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 19.6 mt -60.75 -43.07 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 121.369 0.604 . . . . 73.04 109.539 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.429 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.3 mt -70.53 -19.14 62.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.533 -1.212 . . . . 75.01 112.193 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -70.46 -42.49 15.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-O 117.563 -1.208 . . . . 74.44 113.6 -169.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 99.0 Cg_exo -49.43 -35.1 35.06 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.045 1.83 . . . . 72.44 114.022 168.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -84.74 -37.49 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.296 0.638 . . . . 72.43 111.439 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.33 -42.6 79.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.158 0.504 . . . . 71.44 109.984 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -53.37 -57.26 11.22 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.497 1.519 . . . . 75.44 109.909 171.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.35 -36.58 84.61 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.393 1.058 . . . . 64.24 111.671 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.23 -48.79 80.25 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.183 0.593 . . . . 71.34 110.026 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.89 -44.8 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 115.049 -0.978 . . . . 73.51 110.793 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.5 HG23 ' HB2' ' A' ' 125' ' ' GLN . 60.2 m -57.55 -40.73 79.54 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.924 0.889 . . . . 74.45 111.116 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 t -69.0 -46.64 67.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.164 -0.925 . . . . 74.21 110.412 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.6 mtp -56.82 -40.69 76.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.764 0.825 . . . . 65.23 111.81 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.5 t -65.19 -46.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.506 1.123 . . . . 71.22 110.719 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -71.34 -26.49 62.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.598 0.359 . . . . 71.01 111.621 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.7 mtt-85 -73.2 -32.57 64.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.73 0.812 . . . . 73.24 110.082 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 4.4 60.25 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.999 -0.546 . . . . 74.42 112.901 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 m 68.07 44.19 1.5 Allowed 'General case' 0 C--N 1.36 1.052 0 CA-C-O 122.721 1.248 . . . . 72.34 110.268 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.9 149.13 50.22 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 114.769 -1.105 . . . . 74.14 108.955 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.29 141.58 93.34 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.087 1.858 . . . . 63.5 110.633 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -61.41 159.74 12.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.286 1.034 . . . . 73.53 112.448 -168.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.55 102.25 6.29 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 74.33 108.348 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -98.17 94.24 6.69 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.173 -0.676 . . . . 74.33 109.173 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 134.99 57.52 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.63 0.772 . . . . 72.14 110.906 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 139.45 91.74 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.162 0.585 . . . . 72.24 112.176 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.86 97.55 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.461 2.107 . . . . 72.33 109.991 177.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.13 112.76 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.647 -0.872 . . . . 72.02 108.647 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.57 87.84 3.47 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.806 -0.634 . . . . 75.4 110.434 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -66.87 -34.27 77.43 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.611 -0.722 . . . . 72.14 109.259 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -55.67 -50.55 69.96 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.256 -0.884 . . . . 73.43 110.89 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.36 -37.69 88.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.084 0.553 . . . . 72.5 111.864 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.71 -51.62 68.59 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.006 -0.738 . . . . 75.32 109.006 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.535 ' HA ' ' HB3' ' A' ' 140' ' ' TYR . 61.8 m-85 -76.13 -18.03 59.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.625 0.77 . . . . 73.31 112.778 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 88.4 mmm -61.22 -52.63 63.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.26 0.482 . . . . 73.24 109.919 170.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -73.93 -35.77 64.62 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 116.056 -0.52 . . . . 72.34 111.362 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' A' ' 137' ' ' PHE . 77.1 t80 -63.6 -42.48 98.25 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.389 1.076 . . . . 74.31 110.906 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.26 -50.01 56.73 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.066 -0.516 . . . . 75.42 110.624 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -165.24 -18.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 112.533 0.568 . . . . 75.04 112.533 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' C' ' 145' ' ' ALA . 0.0 OUTLIER 46.98 84.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.636 0.774 . . . . 71.43 109.468 -172.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -169.58 139.86 2.12 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.99 -0.374 . . . . 72.24 109.99 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.18 -178.98 6.11 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.716 0.806 . . . . 71.4 109.85 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.37 144.02 12.26 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.748 -0.941 . . . . 63.34 110.748 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.51 93.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.027 0.931 . . . . 74.53 110.634 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.35 0.58 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.256 -0.883 . . . . 72.42 113.012 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -148.67 161.3 42.02 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.332 0.587 . . . . 71.4 111.29 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.94 -35.21 2.88 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.127 1.371 . . . . 71.2 109.687 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.74 162.0 30.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.139 0.976 . . . . 73.53 112.684 -170.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -142.3 143.03 32.61 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.837 1.255 . . . . 74.24 108.887 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.48 83.1 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.682 0.753 . . . . 75.52 109.453 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.14 83.8 6.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.401 -1.272 . . . . 72.33 109.92 -171.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.032 0.933 . . . . 74.33 109.214 -177.174 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.851 0.358 . . . . 64.43 110.948 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 63.6 p -101.16 21.95 13.14 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.227 0.611 . . . . 65.1 110.356 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.7 142.69 31.08 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.691 0.797 . . . . 75.53 109.722 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' D' ' 140' ' ' TYR . 2.9 pp0? -89.91 -3.75 57.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.267 0.627 . . . . 74.2 111.745 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -81.48 78.22 8.26 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.778 0.799 . . . . 75.33 109.084 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -143.6 -44.26 0.28 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.162 -0.926 . . . . 71.05 109.545 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m 56.56 69.51 0.73 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.668 1.187 . . . . 75.15 110.911 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.06 178.2 5.01 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.701 -1.136 . . . . 73.21 110.765 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.473 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 8.9 ptm 57.58 171.24 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 127.348 2.259 . . . . 60.22 113.699 -174.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t -162.24 142.51 10.02 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.294 0.637 . . . . 70.33 110.018 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -131.96 113.58 13.58 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.622 -1.251 . . . . 63.13 107.622 172.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 21.2 tp60 -127.87 98.66 5.23 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.388 0.613 . . . . 72.52 109.983 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 tt -78.61 119.68 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 115.393 -0.821 . . . . 75.15 109.733 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.85 -48.35 7.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.049 0.54 . . . . 75.42 110.562 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.457 ' HD2' ' HD1' ' A' ' 32' ' ' PHE . 55.2 ttt180 -165.26 142.91 5.99 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.484 -0.325 . . . . 75.23 110.563 -172.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.2 mt -114.5 142.93 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.449 -1.315 . . . . 72.13 107.449 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -164.83 158.44 17.4 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.031 0.443 . . . . 74.34 110.567 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.512 HG21 HD13 ' B' ' 21' ' ' ILE . 89.5 m -85.62 123.36 30.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.158 -0.682 . . . . 72.44 109.158 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.425 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 30.9 mtpt -88.09 -35.87 17.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.453 -0.794 . . . . 72.21 111.183 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -161.92 147.89 13.49 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.999 0.428 . . . . 63.14 111.013 -173.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.512 HD13 HG21 ' B' ' 18' ' ' THR . 38.7 mm -142.33 145.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.101 1.76 . . . . 73.12 108.093 -175.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -154.44 148.43 25.69 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.676 0.61 . . . . 73.22 110.217 170.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 88.2 t80 -156.12 107.22 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.166 -1.42 . . . . 74.02 107.166 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.71 118.58 28.41 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.446 0.699 . . . . 72.41 109.793 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.12 87.89 9.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.429 1.092 . . . . 70.11 109.821 -175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.509 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 37.5 Cg_endo -63.67 -41.55 24.42 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.65 2.233 . . . . 75.52 113.072 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -106.27 31.51 5.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.58 0.752 . . . . 72.12 110.036 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.62 ' HB1' ' HZ3' ' A' ' 19' ' ' LYS . . . -48.59 -48.11 69.17 Favored Pre-proline 0 CA--C 1.573 1.855 0 C-N-CA 125.217 1.407 . . . . 75.42 114.698 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HG3' ' HZ1' ' A' ' 19' ' ' LYS . 89.9 Cg_endo -92.66 -5.34 3.27 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.086 1.857 . . . . 65.12 113.087 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -98.4 -0.47 43.58 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.689 0.796 . . . . 70.31 110.814 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.99 -28.02 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.39 1.076 . . . . 71.13 111.089 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -71.23 -18.25 62.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.878 0.871 . . . . 74.25 112.519 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.33 -41.01 79.18 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.396 0.617 . . . . 74.14 109.887 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.515 ' HB2' HD11 ' B' ' 68' ' ' LEU . 81.4 mttt -108.73 106.74 16.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.58 -1.191 . . . . 72.42 108.465 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.44 79.28 1.91 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.74 0.781 . . . . 73.11 110.13 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.575 ' HA ' ' H ' ' F' ' 197' ' ' TYR . 10.0 t-105 -153.52 151.37 29.73 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.996 -1.483 . . . . 71.52 106.996 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -90.64 114.93 62.97 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.507 -1.664 . . . . 72.11 106.507 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.53 131.36 37.72 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.305 2.004 . . . . 71.0 111.978 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 120.41 14.05 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.914 0.759 . . . . 73.53 109.107 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.804 HG11 HD21 ' B' ' 126' ' ' LEU . 2.1 t -86.02 118.74 33.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 106.503 -1.666 . . . . 75.52 106.503 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -138.46 134.92 34.64 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.496 -0.557 . . . . 71.44 109.496 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' B' ' 128' ' ' LEU . 0.7 OUTLIER -128.96 156.63 43.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.248 0.619 . . . . 73.02 112.393 -169.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.19 141.32 48.03 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.932 1.293 . . . . 65.54 108.622 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.42 HD23 HD13 ' F' ' 186' ' ' LEU . 50.2 tp -85.61 136.57 33.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.655 0.782 . . . . 75.11 110.99 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.9 m-20 -129.77 144.27 51.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.988 -1.116 . . . . 74.45 107.988 172.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.9 m -130.18 125.64 35.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.296 0.638 . . . . 72.32 109.968 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.418 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -132.23 159.07 40.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.169 0.988 . . . . 63.25 109.11 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 62.1 m -143.01 168.91 18.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.071 0.549 . . . . 73.01 109.98 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.5 t -151.45 164.35 36.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.515 1.126 . . . . 75.41 108.408 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.505 HE22 HD13 ' F' ' 173' ' ' LEU . 65.3 tt0 -124.05 124.11 41.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.082 0.553 . . . . 72.43 109.54 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.518 HD12 HG22 ' B' ' 83' ' ' ILE . 85.7 mt -93.41 -28.55 16.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.342 0.657 . . . . 74.13 110.783 176.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.93 -171.48 0.75 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 71.04 111.223 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.48 113.14 4.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.615 -1.175 . . . . 74.21 110.152 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.732 ' H ' HD22 ' F' ' 173' ' ' LEU . 28.3 m-20 75.93 -5.15 2.23 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.773 2.029 . . . . 73.05 112.09 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 51.1 t -104.86 99.73 9.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 108.106 -1.072 . . . . 74.24 108.106 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.91 168.48 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.513 0.673 . . . . 75.43 110.062 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -138.41 100.06 4.01 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.402 -1.703 . . . . 63.31 106.402 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.46 128.82 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.197 0.599 . . . . 64.22 109.739 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' B' ' 47' ' ' ALA . 47.1 t -105.37 145.07 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.006 0.922 . . . . 73.41 109.815 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 112.96 18.99 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.443 -1.688 . . . . 75.04 106.443 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 34.0 ttm180 -102.83 130.84 49.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.06 -0.718 . . . . 72.35 109.06 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.458 HG12 HD13 ' B' ' 42' ' ' LEU . 50.7 t -121.14 108.83 23.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 107.218 -1.401 . . . . 73.24 107.218 169.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -98.28 136.79 37.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.167 0.508 . . . . 74.1 109.93 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.56 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 89.8 t -122.97 137.98 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.195 1.398 . . . . 71.14 110.705 -169.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 57.4 m -123.9 151.38 43.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.873 1.269 . . . . 73.23 109.038 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.04 146.87 31.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.686 0.795 . . . . 41.53 108.913 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 67.3 p -153.68 158.72 41.47 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 75.04 111.554 -171.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' B' ' 34' ' ' LYS . 72.6 mt -128.27 107.0 9.41 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.581 -1.266 . . . . 74.42 107.581 169.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.8 -110.6 3.21 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 123.422 0.451 . . . . 73.13 112.322 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -110.0 0.25 18.42 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.54 0.736 . . . . 75.24 111.517 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.61 159.19 28.36 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.504 -0.747 . . . . 65.24 111.358 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -73.9 139.08 44.72 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.434 -0.803 . . . . 52.23 110.488 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.96 -53.67 3.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.149 -1.056 . . . . 53.24 108.149 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.509 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 46.0 p90 -156.44 170.16 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.724 -1.125 . . . . 73.1 110.415 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.65 155.14 48.54 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.68 1.592 . . . . 65.22 107.939 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.56 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 54.1 t -152.91 158.67 42.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.125 -0.694 . . . . 73.45 109.125 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -155.76 137.94 14.69 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.723 -1.214 . . . . 74.01 107.723 171.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.0 146.38 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.303 0.641 . . . . 72.22 109.277 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -129.65 99.24 5.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.783 0.833 . . . . 64.12 108.969 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.467 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -91.42 106.47 18.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.42 -0.809 . . . . 70.43 109.394 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.92 168.11 21.15 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.839 -0.505 . . . . 62.24 111.839 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.45 129.86 2.11 Favored Glycine 0 C--O 1.236 0.28 0 N-CA-C 111.005 -0.838 . . . . 63.22 111.005 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.518 HG22 HD12 ' B' ' 51' ' ' LEU . 45.0 mt -85.15 115.65 27.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.604 -0.887 . . . . 74.43 108.604 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.89 131.76 52.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.526 -0.916 . . . . 75.21 108.526 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -107.71 106.9 17.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.329 -0.989 . . . . 73.21 108.329 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -128.35 144.8 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.797 0.839 . . . . 75.42 111.277 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.73 171.92 19.43 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.348 1.059 . . . . 74.53 109.183 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.68 -48.33 2.06 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.368 -0.378 . . . . 74.24 112.733 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 163.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.533 0.733 . . . . 70.22 110.177 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 158.11 21.19 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.732 0.413 . . . . 72.22 111.529 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -113.72 5.45 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.858 0.724 . . . . 63.51 114.298 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.4 m -66.08 -38.29 87.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.318 1.047 . . . . 75.43 110.471 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.66 -31.32 66.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.674 -1.148 . . . . 75.12 110.002 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.5 tpt -70.39 -43.19 70.6 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.942 0.897 . . . . 70.25 109.945 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.63 67.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.196 -0.911 . . . . 72.32 111.278 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -83.51 -29.19 28.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.802 0.841 . . . . 73.42 110.561 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -68.98 -61.96 1.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.285 0.634 . . . . 72.24 110.789 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.73 -12.66 25.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.828 0.677 . . . . 73.23 112.828 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.68 1.42 42.19 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-O 119.92 -0.378 . . . . 75.21 113.66 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.1 -58.27 0.31 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.173 0.486 . . . . 73.23 111.114 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.409 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 52.7 t80 -74.66 -45.32 45.47 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.106 -0.497 . . . . 75.03 111.798 -172.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.537 ' HA ' HD12 ' B' ' 105' ' ' ILE . 99.8 m -63.64 -46.26 82.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.422 -0.799 . . . . 74.42 111.734 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.58 -39.19 92.47 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.777 1.651 . . . . 75.53 113.226 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.22 -30.54 71.66 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 123.014 0.525 . . . . 74.11 111.83 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' B' ' 102' ' ' CYS . 96.7 mt -64.43 -47.46 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.389 1.076 . . . . 75.31 110.41 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 mt -81.6 -12.62 58.67 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.345 -1.298 . . . . 65.12 111.384 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.452 ' HE2' ' HA ' ' B' ' 130' ' ' PRO . 26.1 t80 -63.29 -49.94 77.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.944 1.298 . . . . 72.2 113.084 -170.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.2 -33.25 95.0 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.867 1.711 . . . . 74.43 113.073 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.467 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 81.7 m-85 -66.11 -48.26 71.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.023 0.529 . . . . 74.42 110.837 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -40.88 97.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.954 0.902 . . . . 72.51 110.961 177.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -55.57 -52.61 63.17 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.317 1.047 . . . . 73.22 110.454 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.31 -39.83 92.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.197 -0.91 . . . . 65.41 111.33 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.501 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.6 t -70.74 -43.43 68.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.871 -0.604 . . . . 75.21 111.559 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.447 HG22 HG22 ' B' ' 64' ' ' VAL . 95.5 mt -63.11 -46.78 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 122.815 0.446 . . . . 74.22 110.474 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.402 HG23 ' CB ' ' C' ' 119' ' ' SER . 22.6 m -52.24 -41.18 62.57 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.81 0.693 . . . . 74.24 111.092 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.9 t -62.7 -53.92 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.927 -0.578 . . . . 71.52 110.383 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.534 ' SD ' HG21 ' A' ' 21' ' ' ILE . 36.8 mmt -59.49 -44.58 93.04 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.208 0.603 . . . . 62.44 111.76 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.04 -40.47 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.513 1.125 . . . . 74.22 111.235 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 94.3 p -70.52 -31.91 69.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.422 -0.354 . . . . 53.31 110.834 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.1 mtt-85 -63.12 -27.73 69.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.321 0.648 . . . . 72.21 111.063 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.13 10.55 63.02 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 123.632 0.582 . . . . 72.31 113.059 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.409 HG21 ' HB3' ' A' ' 17' ' ' TYR . 30.2 p 64.62 44.06 4.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.749 2.019 . . . . 75.21 112.377 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.54 161.87 35.32 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.385 0.674 . . . . 73.34 110.908 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.433 ' HA ' ' OE1' ' C' ' 125' ' ' GLN . 32.1 Cg_exo -62.25 172.89 3.73 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.496 2.797 . . . . 65.13 114.326 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.681 ' HB3' ' HG3' ' C' ' 125' ' ' GLN . 12.9 pm0 -64.57 154.99 34.55 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 115.28 -0.873 . . . . 74.53 111.841 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.804 HD21 HG11 ' B' ' 40' ' ' VAL . 23.0 tp -142.48 83.98 1.84 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.477 -0.935 . . . . 63.51 108.477 165.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -115.84 106.31 13.69 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.037 -1.468 . . . . 74.24 107.037 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' B' ' 42' ' ' LEU . 4.0 tt -55.26 136.53 48.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.724 -1.125 . . . . 75.21 109.336 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.93 140.17 21.07 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 124.034 0.834 . . . . 52.34 110.985 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.496 ' HG2' ' HB ' ' D' ' 16' ' ' ILE . 25.8 Cg_exo -65.13 71.62 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.15 2.567 . . . . 74.53 113.242 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.62 85.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.298 -1.001 . . . . 71.15 108.298 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.428 ' ND2' HG22 ' D' ' 105' ' ' ILE . 2.1 m-20 -78.38 113.11 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.541 -0.911 . . . . 75.04 108.541 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.512 ' HZ ' ' HB2' ' F' ' 182' ' ' PHE . 74.0 t80 -55.64 -32.16 62.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.963 0.905 . . . . 75.54 110.709 175.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' B' ' 138' ' ' MET . 6.3 m-20 -56.78 -28.75 61.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.391 1.477 . . . . 74.4 112.155 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.55 71.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.617 0.767 . . . . 74.5 111.16 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.88 -46.34 85.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.248 1.019 . . . . 75.14 109.609 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.57 -32.68 71.75 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.891 -1.504 . . . . 73.43 111.186 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.513 ' O ' ' HG2' ' B' ' 142' ' ' GLN . 94.7 mmm -67.7 -36.29 80.36 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.772 0.429 . . . . 75.03 111.662 177.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -74.78 -38.03 62.26 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.643 0.377 . . . . 72.02 111.413 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -73.21 -41.59 63.61 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.789 -0.641 . . . . 75.01 110.7 -176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.16 19.38 5.88 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.085 0.772 . . . . 75.33 113.085 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' B' ' 138' ' ' MET . 11.6 pt20 -162.32 175.64 11.38 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.101 0.477 . . . . 71.3 111.468 168.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -147.36 -58.16 0.26 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.361 1.064 . . . . 75.41 108.575 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -80.82 -75.31 0.28 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.007 -0.997 . . . . 74.45 109.767 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 51.14 80.3 0.08 Allowed 'General case' 0 C--N 1.358 0.939 0 C-N-CA 124.737 1.215 . . . . 75.2 111.786 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' D' ' 90' ' ' GLU . . . -136.25 -84.68 0.17 Allowed Glycine 0 C--O 1.244 0.732 0 CA-C-N 115.327 -0.851 . . . . 64.32 111.33 -175.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 53.7 39.39 30.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.341 1.056 . . . . 72.4 110.809 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.99 118.43 12.1 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.946 -1.025 . . . . 50.33 112.088 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -59.39 107.61 0.59 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.568 1.147 . . . . 74.14 110.897 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 146.93 51.43 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.007 -0.738 . . . . 72.21 109.007 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 80.03 137.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 73.33 110.955 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -153.86 130.2 10.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.256 1.022 . . . . 72.22 108.848 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -129.01 110.09 11.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.071 0.948 . . . . 73.21 109.613 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -164.38 152.96 12.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.321 1.048 . . . . 75.25 109.649 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 124.937 1.295 . . . . 65.13 110.587 -175.237 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.602 ' H3 ' ' HB3' ' G' ' 182' ' ' PHE . 1.2 mpt? . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.236 -0.653 . . . . 73.23 109.236 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 30.7 p -157.23 132.23 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.881 0.872 . . . . 74.44 109.402 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -122.53 8.15 9.55 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.244 0.545 . . . . 73.15 110.707 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -148.58 105.43 3.59 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 70.5 109.612 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -92.39 127.01 37.72 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.639 -1.245 . . . . 71.0 107.639 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.99 110.65 22.53 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.193 -0.669 . . . . 72.13 109.193 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -92.96 96.95 10.42 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.103 -0.703 . . . . 74.21 109.103 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.63 115.02 8.45 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.235 -1.024 . . . . 71.32 108.235 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.5 ttp 62.45 111.42 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.407 1.083 . . . . 73.5 110.979 -172.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -105.37 114.15 28.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.875 0.87 . . . . 75.34 109.109 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 72.8 t80 -96.36 131.94 42.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.611 -0.885 . . . . 75.11 108.611 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -139.83 124.4 18.19 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.147 0.579 . . . . 71.43 109.878 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -93.35 133.24 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.535 0.734 . . . . 73.01 109.262 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -105.17 -45.96 4.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.618 0.767 . . . . 73.43 110.371 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -167.81 124.35 1.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.999 -0.371 . . . . 75.53 109.999 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.22 135.45 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.552 -0.907 . . . . 75.11 108.552 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.42 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 27.3 p90 -173.45 163.13 4.39 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.176 0.59 . . . . 71.35 109.804 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -85.78 124.28 32.1 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.812 0.445 . . . . 73.21 110.374 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.598 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.2 mmtp -78.1 -49.95 12.94 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.869 0.842 . . . . 70.11 108.977 170.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.685 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -135.41 142.47 45.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.989 -1.459 . . . . 72.51 109.38 -169.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.4 mt -143.99 146.13 21.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.714 -1.587 . . . . 74.52 106.714 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -159.7 149.75 18.65 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.266 0.555 . . . . 73.02 110.42 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -142.65 116.5 9.3 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.614 -1.254 . . . . 75.55 107.614 171.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.57 126.21 52.97 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.847 0.859 . . . . 75.14 109.725 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 81.32 70.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 107.998 -1.112 . . . . 70.23 107.998 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.22 -25.74 42.75 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.131 2.554 . . . . 73.31 112.194 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.25 26.72 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.985 0.914 . . . . 72.15 110.44 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.16 -53.5 22.09 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.161 1.171 . . . . 74.35 114.161 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -81.33 -18.74 8.29 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 121.566 1.511 . . . . 74.52 113.824 177.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.57 -49.26 42.24 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.303 0.641 . . . . 64.41 111.472 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -77.83 -13.37 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.802 1.241 . . . . 74.51 111.4 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.554 ' HE2' ' HD3' ' D' ' 15' ' ' ARG . 79.3 t80 -53.93 -43.06 69.46 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.322 1.049 . . . . 75.23 112.24 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -103.94 27.59 7.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.637 0.732 . . . . 74.32 110.046 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.11 165.18 11.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.404 0.682 . . . . 75.43 109.411 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.35 120.55 24.54 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.99 -0.744 . . . . 64.22 108.99 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -85.56 88.96 7.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.585 0.754 . . . . 71.24 110.688 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.417 ' H ' HD23 ' C' ' 68' ' ' LEU . 35.0 tt0 -128.75 74.32 80.69 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 107.768 -1.197 . . . . 75.24 107.768 169.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.82 143.21 4.18 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.503 2.802 . . . . 75.04 113.404 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.89 115.38 25.31 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.251 -1.018 . . . . 74.33 108.251 167.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.468 HG11 HD21 ' C' ' 128' ' ' LEU . 26.1 t -83.32 85.42 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.05 -0.722 . . . . 73.55 109.05 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -93.87 100.94 13.02 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.746 -1.205 . . . . 70.24 107.746 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.451 HD12 HD11 ' E' ' 186' ' ' LEU . 4.2 pp -90.27 154.53 19.65 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.144 -0.688 . . . . 74.54 109.144 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.488 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -120.9 145.33 47.77 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.437 1.095 . . . . 74.44 108.19 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.5 tp -117.73 134.45 54.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.749 0.82 . . . . 70.23 108.861 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.15 150.08 27.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.222 -1.029 . . . . 74.24 108.222 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 91.6 m -137.95 123.97 20.23 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.096 -0.705 . . . . 75.41 109.096 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.98 23.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.287 1.035 . . . . 63.42 108.497 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 p -145.27 144.37 30.74 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.748 0.419 . . . . 72.0 110.455 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -145.1 129.77 18.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.919 0.888 . . . . 72.11 109.109 -176.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -76.95 131.86 38.73 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.527 -0.546 . . . . 74.42 109.527 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.552 HD12 HD13 ' C' ' 83' ' ' ILE . 35.4 mt -106.46 -42.71 4.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.681 . . . . 74.05 109.568 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.78 -177.11 5.41 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.45 -1.25 . . . . 73.24 109.138 175.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.99 109.08 6.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.053 -0.522 . . . . 73.24 109.935 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.86 18.04 11.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.039 1.336 . . . . 75.21 112.222 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.93 114.48 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.66 -1.608 . . . . 74.11 106.66 169.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.424 ' HE2' HG12 ' C' ' 86' ' ' ILE . 43.6 p90 -134.64 -178.74 5.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.656 0.741 . . . . 64.34 110.95 -174.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD12 ' C' ' 51' ' ' LEU . 23.9 tt0 -126.34 113.24 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.877 -1.511 . . . . 74.13 108.904 -170.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.9 129.52 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.219 -1.03 . . . . 75.31 108.219 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.1 106.36 16.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.486 -1.302 . . . . 64.53 107.486 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.47 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.1 OUTLIER -86.13 103.09 14.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.066 -1.087 . . . . 71.23 108.066 -177.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -84.83 106.11 16.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.768 0.827 . . . . 74.04 109.349 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.84 130.73 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.313 -0.995 . . . . 73.34 108.313 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 5.8 m -116.8 148.31 41.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.041 -1.096 . . . . 64.43 108.041 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.674 HG23 HG21 ' C' ' 114' ' ' ILE . 46.1 t -132.91 110.43 15.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.872 -1.159 . . . . 73.55 107.872 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m -102.57 139.02 38.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.0 -0.741 . . . . 74.4 109.0 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.53 112.75 15.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.513 -1.291 . . . . 65.1 107.513 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -129.82 130.03 44.78 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.346 0.404 . . . . 72.52 110.256 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.417 HD23 ' H ' ' C' ' 37' ' ' GLN . 41.7 mt -87.29 27.88 1.01 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.961 1.304 . . . . 75.54 110.906 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.22 -103.1 1.92 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.933 -0.867 . . . . 70.12 110.933 -171.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.69 -29.37 18.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.979 0.512 . . . . 74.2 110.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.82 121.12 22.92 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.977 0.911 . . . . 74.22 110.146 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.2 m -80.81 124.76 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.789 -0.819 . . . . 74.24 108.789 166.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.69 -51.16 9.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.405 -0.816 . . . . 73.22 109.973 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -166.53 176.45 7.31 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.263 -0.881 . . . . 74.12 110.729 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -143.4 141.4 30.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.906 -1.516 . . . . 73.53 106.906 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.493 ' SG ' HG22 ' C' ' 114' ' ' ILE . 42.0 t -147.4 125.4 12.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.864 0.465 . . . . 73.35 109.896 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -129.66 133.55 47.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.878 0.471 . . . . 64.33 110.122 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.51 137.83 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.024 0.93 . . . . 74.42 108.56 168.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.685 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -112.15 102.09 10.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.294 1.037 . . . . 74.42 108.665 171.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -86.93 108.98 19.04 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.452 -0.794 . . . . 75.02 110.251 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 150.21 25.76 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 123.232 0.332 . . . . 52.34 112.305 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.443 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.36 119.33 0.93 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.31 -0.716 . . . . 75.2 111.31 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.552 HD13 HD12 ' C' ' 51' ' ' LEU . 11.7 mm -84.82 124.66 40.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.52 -0.918 . . . . 74.21 108.52 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -132.12 126.35 33.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.656 0.782 . . . . 75.25 110.014 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -96.08 134.98 38.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.912 -1.144 . . . . 72.14 107.912 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.462 HD11 HG12 ' C' ' 89' ' ' ILE . 2.7 pp -131.87 162.65 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.536 0.684 . . . . 73.34 111.911 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.92 29.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.29 -1.323 . . . . 51.04 108.096 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . 0.542 ' H ' ' HE3' ' E' ' 174' ' ' MET . . . 88.48 -17.36 49.17 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.528 -1.151 . . . . 72.41 114.991 173.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.462 HG12 HD11 ' C' ' 86' ' ' ILE . 36.5 pt -62.1 98.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-N 118.489 1.144 . . . . 73.45 110.753 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.529 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 41.3 mt-10 -145.35 160.17 41.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.12 0.968 . . . . 74.41 109.294 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -115.07 7.51 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.844 0.715 . . . . 75.34 112.451 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 60.6 p -75.86 -36.35 59.62 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.376 0.67 . . . . 72.33 110.57 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.91 -32.77 69.85 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.92 0.888 . . . . 65.23 112.652 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.529 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 5.5 ptm -82.74 5.88 19.94 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.307 0.643 . . . . 73.25 112.149 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.15 -21.38 2.64 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 72.32 110.929 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.549 1.14 . . . . 64.04 110.207 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.469 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 43.7 t -72.18 -60.46 2.22 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.224 0.61 . . . . 74.25 111.008 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.455 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.3 pp -75.01 -14.47 60.61 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.003 0.521 . . . . 72.24 112.392 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.63 6.96 68.02 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.933 -0.37 . . . . 63.45 113.246 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.16 -63.54 0.11 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.082 0.441 . . . . 74.34 111.607 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -69.75 -50.79 40.04 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.984 0.913 . . . . 74.31 112.639 -169.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.456 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -59.7 -47.14 98.22 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 118.7 -0.667 . . . . 64.42 112.314 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.47 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 33.2 Cg_exo -63.56 -34.73 63.1 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.858 1.705 . . . . 74.52 113.28 171.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -69.69 -22.07 63.45 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.718 0.407 . . . . 72.04 111.314 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -69.35 -41.43 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.215 0.606 . . . . 75.03 109.965 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.443 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.1 mt -78.2 -20.15 52.43 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.911 -1.041 . . . . 73.4 111.366 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -57.79 -51.56 80.84 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 113.855 1.057 . . . . 74.44 113.855 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.48 -34.94 99.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.851 1.7 . . . . 75.11 112.606 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.45 -43.32 77.3 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.32 0.648 . . . . 74.2 111.243 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.65 91.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.634 0.773 . . . . 70.45 110.48 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.22 -58.98 6.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.843 1.657 . . . . 75.24 110.615 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -33.2 73.88 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.392 0.433 . . . . 74.2 110.65 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -63.05 -33.34 75.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.147 0.579 . . . . 74.5 111.559 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.674 HG21 HG23 ' C' ' 64' ' ' VAL . 91.4 mt -75.04 -47.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 75.13 109.98 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.4 HG22 ' HB2' ' C' ' 125' ' ' GLN . 21.5 m -59.58 -28.5 67.2 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 115.252 -0.885 . . . . 54.24 111.183 -174.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.1 t -70.74 -50.43 36.27 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.321 -0.854 . . . . 73.11 110.155 170.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.559 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.98 -38.47 73.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.112 0.965 . . . . 71.22 113.323 -175.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.92 -36.27 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.337 -0.392 . . . . 73.54 110.604 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.402 ' CB ' HG23 ' B' ' 115' ' ' THR . 39.6 p -76.36 -22.08 55.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.797 0.439 . . . . 71.12 111.298 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 82.8 mtt-85 -68.39 -36.39 79.09 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 75.42 109.512 171.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.8 3.51 49.84 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.084 -0.962 . . . . 54.31 112.604 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.9 p 56.22 21.36 5.22 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 126.765 2.026 . . . . 72.41 112.321 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -97.84 161.24 26.36 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.516 1.126 . . . . 74.45 108.865 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.05 107.99 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.674 2.25 . . . . 72.42 111.734 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.681 ' HG3' ' HB3' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.62 155.97 17.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.846 0.716 . . . . 75.13 112.067 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -117.11 91.94 3.72 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.394 -0.965 . . . . 74.42 108.394 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -90.73 88.98 7.3 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.995 -1.483 . . . . 72.51 106.995 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.468 HD21 HG11 ' C' ' 40' ' ' VAL . 48.7 mt -79.55 142.66 35.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.52 -1.218 . . . . 73.32 112.093 -164.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.43 96.72 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.924 -1.034 . . . . 74.41 111.116 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.579 ' HG3' HD11 ' A' ' 16' ' ' ILE . 86.2 Cg_endo -75.26 -171.9 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.81 2.34 . . . . 73.33 113.875 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.447 HG23 ' NE1' ' E' ' 184' ' ' TRP . 2.6 m -140.72 117.15 7.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 114.185 -1.371 . . . . 72.43 107.412 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.41 65.72 9.33 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.246 0.546 . . . . 71.41 109.656 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' E' ' 184' ' ' TRP . 59.4 t80 -66.43 -35.39 80.19 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.565 -0.902 . . . . 71.32 108.565 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' C' ' 138' ' ' MET . 4.1 p-10 -51.41 -59.85 3.79 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.53 1.144 . . . . 65.01 110.917 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.74 76.2 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.766 0.827 . . . . 73.43 112.173 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.9 tt -74.84 -41.17 60.39 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.475 0.71 . . . . 73.41 110.929 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -82.17 -25.64 34.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.077 0.951 . . . . 74.32 112.166 -169.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' C' ' 134' ' ' ASP . 23.9 mmt -71.86 -41.88 67.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.582 0.353 . . . . 74.31 110.581 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.77 -32.58 67.81 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 122.53 0.332 . . . . 73.25 110.577 177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.92 -155.99 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.819 1.248 . . . . 62.32 110.941 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 91.7 mt 64.56 -75.1 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.983 1.313 . . . . 74.14 112.718 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.65 154.24 41.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.992 0.917 . . . . 75.44 109.083 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -116.01 154.34 30.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.633 1.173 . . . . 71.01 108.667 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.557 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 57.4 tp60 68.04 134.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.765 1.226 . . . . 73.44 113.006 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -159.08 166.72 30.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.334 0.654 . . . . 74.51 110.351 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.98 2.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.713 -0.676 . . . . 74.2 112.514 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.52 -155.15 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 106.725 -1.583 . . . . 64.33 106.725 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.9 98.22 2.03 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.722 -0.551 . . . . 73.54 111.722 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 46.1 p -75.92 166.95 22.76 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.514 0.726 . . . . 74.25 110.635 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.95 162.06 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.619 0.767 . . . . 74.11 109.883 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.13 -101.21 0.07 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.853 0.861 . . . . 63.34 109.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 m80 58.55 76.51 0.34 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.096 1.358 . . . . 74.5 112.523 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -124.57 111.95 16.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.595 -0.891 . . . . 74.1 108.595 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -89.39 145.21 25.49 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.515 0.726 . . . . 72.14 110.164 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.078 0 C-N-CA 123.283 0.633 . . . . 75.25 110.479 178.185 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.535 -0.542 . . . . 53.22 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' SER . . . . . 0.562 ' HB2' ' HG2' ' E' ' 201' ' ' LYS . 25.7 t -63.52 101.91 0.38 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.277 0.631 . . . . 71.2 109.966 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.64 -62.77 1.57 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.503 0.721 . . . . 75.41 110.605 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -106.32 153.13 22.63 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.909 0.884 . . . . 74.32 110.106 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -114.33 -161.09 0.75 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.587 0.755 . . . . 75.04 110.435 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -54.94 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.638 1.175 . . . . 62.43 110.657 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -104.51 -56.17 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.994 -0.743 . . . . 72.3 108.994 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.21 -140.64 0.25 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.312 . . . . 73.11 107.889 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.496 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 11.5 tpt -30.6 125.14 0.18 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.503 1.521 . . . . 74.02 113.568 170.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.1 m -148.62 139.79 23.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.582 1.153 . . . . 75.01 109.685 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.418 ' HD2' HG23 ' D' ' 86' ' ' ILE . 71.1 t80 -158.81 91.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.443 -1.317 . . . . 72.24 107.443 170.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.4 mt-30 -111.89 136.22 51.48 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.263 0.625 . . . . 75.51 109.707 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.487 HG22 HG22 ' E' ' 207' ' ' VAL . 0.0 OUTLIER -91.3 131.92 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.02 -1.104 . . . . 71.54 108.02 171.703 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -106.29 -49.0 3.44 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.718 0.407 . . . . 62.3 111.456 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.554 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 62.2 ttt180 -178.46 134.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 122.262 0.225 . . . . 73.53 111.282 -174.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.496 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 3.0 mp -123.23 130.07 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.742 -1.207 . . . . 73.4 107.742 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -156.31 163.63 39.29 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 123.728 0.643 . . . . 75.2 111.842 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.02 110.11 10.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.736 -1.12 . . . . 74.13 109.634 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' D' ' 19' ' ' LYS . 46.0 mtpt -77.57 -32.81 54.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.86 -0.609 . . . . 73.24 109.734 172.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.737 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -146.4 138.41 24.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.79 -1.095 . . . . 53.15 109.718 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.559 HG21 ' HE1' ' C' ' 117' ' ' MET . 60.2 mt -137.15 147.75 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.528 1.131 . . . . 74.03 108.411 171.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -147.63 143.75 27.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.878 0.871 . . . . 63.4 108.668 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.504 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.3 t80 -147.54 124.98 11.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.919 -1.882 . . . . 74.41 105.919 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.61 142.01 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.735 0.814 . . . . 75.12 108.817 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.456 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -135.46 77.65 52.75 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 107.431 -1.322 . . . . 71.13 107.431 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.38 -28.89 17.54 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.748 2.299 . . . . 64.21 112.36 -172.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 50.8 m-20 -114.46 28.66 8.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.424 1.089 . . . . 65.13 109.338 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -60.25 -47.96 95.32 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.714 1.746 . . . . 75.5 115.714 -170.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.598 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 61.1 Cg_endo -80.94 -15.47 10.54 Favored 'Trans proline' 0 C--N 1.379 2.149 0 CA-C-N 122.021 1.757 . . . . 72.33 112.138 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.413 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.8 t-160 -68.41 -32.07 71.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.93 0.892 . . . . 70.41 108.918 167.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.466 HG21 HD12 ' D' ' 68' ' ' LEU . 12.9 t -68.08 -23.33 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.265 1.026 . . . . 75.53 111.499 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -55.66 -32.92 63.63 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 122.677 0.391 . . . . 75.13 111.67 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.85 -27.56 61.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.572 0.749 . . . . 74.13 111.42 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.499 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 66.1 mttt -97.12 111.21 23.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.839 0.856 . . . . 75.44 111.704 -174.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.485 ' HB2' ' H ' ' H' ' 197' ' ' TYR . 7.9 p-10 -108.02 52.32 0.72 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.947 1.299 . . . . 71.43 111.148 -176.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -126.01 165.34 18.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.713 0.805 . . . . 65.52 108.94 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 59.4 tp60 -81.61 122.05 80.27 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.641 -0.503 . . . . 75.43 109.641 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.58 126.21 18.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.691 2.261 . . . . 74.21 112.013 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.85 119.71 12.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.411 0.684 . . . . 74.54 109.206 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.8 107.19 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.22 0.608 . . . . 74.3 109.669 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.502 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 46.9 mmtm -98.82 114.46 27.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.425 0.69 . . . . 74.24 109.28 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.72 131.59 43.26 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.215 -0.661 . . . . 72.45 109.215 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 17.3 t70 -120.63 123.18 42.18 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.626 -1.25 . . . . 61.34 107.626 171.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -95.42 130.24 42.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.038 0.535 . . . . 61.52 109.893 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.8 t70 -138.35 150.43 46.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.433 -1.321 . . . . 64.41 107.433 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -145.31 157.11 44.12 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.271 -0.64 . . . . 73.5 109.271 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.01 167.57 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.062 0.945 . . . . 70.12 108.835 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.2 p -164.92 155.91 14.57 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.058 0.543 . . . . 73.13 110.571 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 19.5 p -164.55 132.29 3.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.04 0.936 . . . . 70.21 109.4 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.46 131.59 45.54 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.078 0.551 . . . . 73.31 111.309 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.647 HD11 ' HB2' ' D' ' 57' ' ' GLU . 64.7 mt -103.65 -37.72 7.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.632 0.773 . . . . 74.33 110.93 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -158.43 -167.54 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.356 0.662 . . . . 72.13 110.929 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -70.87 112.93 7.43 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.25 -0.887 . . . . 61.21 110.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.408 ' HA ' HD21 ' H' ' 173' ' ' LEU . 28.9 m-20 70.76 -2.62 2.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.579 1.552 . . . . 71.41 112.313 -176.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 82.5 t -109.88 133.43 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.204 1.002 . . . . 74.41 109.434 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.03 154.08 36.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 74.31 109.306 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.647 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.1 tt0 -92.2 134.87 34.47 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.801 0.841 . . . . 73.43 109.346 176.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.86 124.3 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.832 -1.173 . . . . 64.21 107.832 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.7 t -105.82 138.55 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.201 0.601 . . . . 65.22 109.448 175.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HB2' HD12 ' D' ' 106' ' ' LEU . 0.0 OUTLIER -113.11 123.85 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.948 -1.13 . . . . 74.11 107.948 176.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.6 ttm-85 -106.64 103.65 13.15 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.813 -0.81 . . . . 75.4 108.813 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.02 123.07 52.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.756 -0.831 . . . . 71.24 108.756 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.2 m -114.6 139.14 49.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.538 0.735 . . . . 71.22 109.599 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.548 HG22 HG23 ' D' ' 114' ' ' ILE . 50.8 t -131.67 100.6 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.804 1.242 . . . . 75.15 108.376 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.7 m -95.02 94.05 7.75 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.16 -1.422 . . . . 73.23 107.16 170.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.06 134.2 40.72 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.577 -0.897 . . . . 64.41 108.577 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 16.6 p -148.57 129.88 14.69 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.074 0.464 . . . . 62.22 111.524 -170.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.466 HD12 HG21 ' D' ' 31' ' ' VAL . 41.5 mt -95.16 104.71 16.6 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.569 1.147 . . . . 74.14 110.867 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.15 -110.91 3.6 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.556 0.535 . . . . 74.21 112.523 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.22 7.26 35.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 70.13 111.632 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.499 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 10.0 tp10 -126.38 150.15 48.77 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.212 0.605 . . . . 54.33 110.326 -175.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -73.22 132.55 43.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.27 0.628 . . . . 73.1 110.362 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.431 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -86.98 -57.68 2.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.547 0.739 . . . . 70.14 109.192 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.81 152.89 14.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.801 -1.091 . . . . 74.25 110.245 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -117.52 120.4 37.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.282 1.033 . . . . 72.33 108.788 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 48.5 t -133.07 142.0 48.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.415 0.686 . . . . 72.31 110.004 -175.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -156.5 129.65 7.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.916 0.486 . . . . 63.42 110.257 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . 0.45 HG21 HG22 ' D' ' 21' ' ' ILE . 84.8 t -128.37 122.72 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.989 0.916 . . . . 71.52 110.051 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -93.01 87.55 5.8 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.673 0.749 . . . . 74.51 109.531 169.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -80.27 96.62 6.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.19 -1.368 . . . . 62.33 108.954 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.92 157.76 29.92 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.812 -0.515 . . . . 70.31 111.812 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 138.44 5.45 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.946 -0.462 . . . . 74.23 111.946 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.435 HG22 HD13 ' D' ' 51' ' ' LEU . 54.0 mt -91.85 132.97 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 123.762 0.825 . . . . 73.21 109.941 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.1 150.1 52.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.499 0.72 . . . . 75.34 110.602 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.422 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.7 m -116.55 101.34 8.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.315 1.046 . . . . 63.53 109.248 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.452 ' HB ' HD13 ' D' ' 89' ' ' ILE . 39.2 pt -109.33 132.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.031 0.443 . . . . 74.33 110.747 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.98 165.77 26.97 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.971 0.909 . . . . 61.02 109.469 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.69 ' H ' ' HB1' ' H' ' 172' ' ' ALA . . . 81.78 -21.6 6.45 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 114.198 0.439 . . . . 71.45 114.198 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -107.01 169.37 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.272 1.029 . . . . 75.35 109.308 175.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.501 ' O ' ' HA2' ' B' ' 146' ' ' GLY . 1.1 pp20? -170.78 -168.63 0.69 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 73.5 110.895 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.65 -141.9 29.2 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.243 -0.435 . . . . 63.25 113.837 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.9 m -82.68 -25.67 32.79 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.383 0.673 . . . . 74.44 111.339 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -63.46 -48.88 75.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.011 0.524 . . . . 73.24 109.788 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.508 ' HE1' ' SD ' ' H' ' 174' ' ' MET . 2.9 ppp? -66.06 -31.77 72.84 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.426 0.454 . . . . 74.22 110.95 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.77 98.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.202 0.601 . . . . 74.15 111.212 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.519 ' HE1' ' HA ' ' D' ' 134' ' ' ASP . 8.9 t-160 -79.22 -37.71 37.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.432 -0.349 . . . . 74.45 110.224 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.87 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.322 0.649 . . . . 70.04 111.481 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.498 HD22 HD12 ' H' ' 177' ' ' LEU . 5.2 tt -75.78 -50.68 14.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.763 0.825 . . . . 74.03 109.042 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.01 14.1 65.08 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.868 -0.605 . . . . 61.02 114.398 -170.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -56.67 0.2 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.548 0.674 . . . . 75.33 111.618 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -72.09 -43.24 65.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.695 0.628 . . . . 72.53 112.695 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 98.8 m -63.37 -46.41 84.71 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 118.747 -0.644 . . . . 51.45 111.084 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.534 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.0 Cg_exo -58.82 -31.52 95.39 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 122.608 2.205 . . . . 74.13 114.013 166.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -65.86 -34.94 79.3 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.149 0.58 . . . . 74.21 110.757 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.428 HG22 ' ND2' ' B' ' 132' ' ' ASN . 37.3 mm -63.48 -39.76 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.382 0.673 . . . . 73.53 110.29 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' D' ' 60' ' ' LEU . 84.5 mt -74.24 -21.24 59.86 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.374 -0.83 . . . . 75.23 111.672 -175.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -67.9 -40.72 24.64 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 114.584 1.327 . . . . 72.11 114.584 -168.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.451 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 98.2 Cg_exo -49.72 -38.54 46.57 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 121.982 1.788 . . . . 71.25 113.586 170.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -83.87 -29.81 26.93 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.74 -1.118 . . . . 71.13 110.834 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.79 -49.73 64.9 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.31 0.644 . . . . 74.11 110.346 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.521 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.1 ttp-105 -50.98 -56.61 11.62 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.809 1.318 . . . . 72.4 110.273 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.97 -44.39 94.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.619 1.2 . . . . 72.05 111.595 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.459 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 40.8 t -56.3 -44.03 79.48 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.88 0.738 . . . . 63.42 111.075 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.548 HG23 HG22 ' D' ' 64' ' ' VAL . 74.2 mt -67.85 -53.28 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.883 . . . . 74.14 110.382 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -51.56 -43.64 62.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.071 1.348 . . . . 65.43 112.265 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.9 t -69.71 -41.56 75.2 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.149 -0.932 . . . . 74.5 110.525 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.509 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.5 mtm -64.36 -35.1 79.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.028 0.531 . . . . 73.43 111.534 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.3 t -61.53 -48.15 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.221 -0.9 . . . . 72.14 110.319 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.7 p -73.98 -23.02 59.41 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.079 -0.51 . . . . 70.12 111.604 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -73.97 -36.28 64.55 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.726 0.81 . . . . 74.25 110.235 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 2.48 71.66 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.714 0.634 . . . . 71.4 112.07 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 62.29 30.76 17.56 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.85 2.06 . . . . 71.31 112.45 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -88.92 168.64 15.07 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 125.232 1.413 . . . . 75.34 108.077 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.404 ' HG3' ' HB2' ' H' ' 195' ' ' PHE . 60.6 Cg_endo -78.36 153.89 27.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.706 1.604 . . . . 75.53 110.884 -174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.48 132.31 47.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.174 0.19 . . . . 71.41 110.816 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.76 113.03 22.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.735 -0.839 . . . . 75.42 108.735 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.35 88.85 4.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.795 -1.187 . . . . 74.23 107.795 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.521 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 75.9 mt -63.56 114.56 4.01 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.568 -0.742 . . . . 73.01 109.425 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.55 137.92 89.45 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.215 0.82 . . . . 75.33 113.215 -168.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.409 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 60.0 Cg_endo -80.3 104.87 1.68 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.618 2.212 . . . . 71.24 110.55 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.43 111.32 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.954 -1.021 . . . . 73.42 110.542 -169.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -95.62 70.89 3.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.405 1.098 . . . . 72.25 108.267 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -82.92 -8.87 59.53 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.021 -1.445 . . . . 73.43 109.971 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.519 ' HA ' ' HE1' ' D' ' 96' ' ' HIS . 7.9 t0 -66.22 -40.91 90.64 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.921 0.888 . . . . 64.52 109.317 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.484 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -55.23 -36.45 66.02 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.97 0.908 . . . . 74.22 112.687 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.65 -48.91 79.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.54 0.736 . . . . 73.24 109.936 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' D' ' 96' ' ' HIS . 91.3 m-85 -75.49 -29.13 59.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.549 -0.75 . . . . 72.43 112.34 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.484 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 56.8 mtm -65.03 -35.96 82.86 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 120.663 0.268 . . . . 74.33 110.927 174.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.9 -27.79 57.81 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.108 0.563 . . . . 74.24 110.593 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.422 ' HB2' ' HG2' ' B' ' 4' ' ' GLN . 71.7 t80 -80.5 -25.17 38.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 74.24 111.498 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -36.44 84.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.196 0.998 . . . . 73.31 110.234 -172.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -90.01 21.54 3.63 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.586 -0.734 . . . . 72.44 111.76 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.9 71.7 0.83 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.929 -1.137 . . . . 71.43 107.929 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.47 156.12 39.95 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.96 -1.473 . . . . 75.31 108.72 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 106.77 1.36 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.274 0.629 . . . . 72.51 109.862 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.0 -105.47 1.2 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 123.943 0.777 . . . . 63.05 113.918 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -85.22 147.25 26.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.61 0.764 . . . . 74.34 111.122 -175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.62 70.5 2.93 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.32 -0.712 . . . . 75.11 111.32 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 22.7 p -65.61 93.51 0.17 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.785 0.834 . . . . 73.23 111.278 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 175.41 -35.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.871 1.668 . . . . 74.53 108.189 -172.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 55.44 -100.24 0.11 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.526 1.53 . . . . 61.2 111.937 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.1 m80 62.34 155.11 0.04 OUTLIER 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.739 1.215 . . . . 74.4 111.955 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 57.04 39.49 29.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.863 0.865 . . . . 75.31 110.357 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.01 -45.84 93.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.677 -1.147 . . . . 72.02 111.389 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.596 -0.716 . . . . 73.44 109.11 177.451 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.18 -0.674 . . . . 75.54 109.18 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -78.96 67.52 3.22 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 112.387 -0.285 . . . . 71.41 112.387 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -132.27 41.1 3.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.117 0.967 . . . . 72.23 109.673 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 66.9 m -134.98 136.94 42.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.13 -0.941 . . . . 64.34 109.458 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . 0.656 ' HB2' ' HB3' ' E' ' 175' ' ' PHE . . . -80.56 -161.67 0.4 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.815 0.846 . . . . 72.43 110.869 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.81 -26.35 67.24 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.336 0.516 . . . . 73.34 110.375 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.542 ' HE3' ' H ' ' C' ' 88' ' ' GLY . 17.5 ptt? -144.17 -36.04 0.35 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.812 0.845 . . . . 73.31 110.88 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.656 ' HB3' ' HB2' ' E' ' 172' ' ' ALA . 41.2 t80 -56.52 106.86 0.32 Allowed 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.074 0.549 . . . . 74.33 110.884 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -137.96 99.41 3.89 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.84 -1.541 . . . . 74.14 106.84 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 52.5 tp -112.08 102.6 10.8 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.05 -64.11 1.25 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.117 -1.438 . . . . 74.32 107.117 174.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -147.16 137.69 12.57 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.435 1.094 . . . . 71.23 109.396 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.39 108.48 2.38 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.479 2.119 . . . . 73.43 111.05 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -82.01 7.29 13.6 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.348 0.659 . . . . 74.44 112.08 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -118.24 125.7 50.67 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.956 0.902 . . . . 74.33 109.188 170.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 9.6 t -136.84 163.88 29.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.144 0.978 . . . . 75.04 109.006 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.447 ' NE1' HG23 ' C' ' 131' ' ' VAL . 27.3 p90 -108.18 161.56 22.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 123.834 0.854 . . . . 74.34 110.141 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.47 108.4 1.39 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.131 1.887 . . . . 75.3 111.753 169.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.451 HD11 HD12 ' C' ' 42' ' ' LEU . 4.0 mm? -73.47 128.57 35.87 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 74.31 109.677 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' F' ' 205' ' ' LYS . 2.7 pp -100.87 154.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.283 0.633 . . . . 73.14 111.526 -170.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.0 149.43 30.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.843 0.857 . . . . 70.24 109.348 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.24 122.83 25.62 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.673 -0.491 . . . . 75.12 109.673 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -95.22 160.87 14.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.906 0.882 . . . . 71.22 110.979 -175.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' F' ' 199' ' ' ASN . . . 89.13 101.88 1.03 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.111 -0.495 . . . . 65.34 112.866 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.13 -177.46 50.84 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 123.662 0.272 . . . . 72.52 112.781 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -162.11 -172.18 3.13 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.346 1.058 . . . . 72.35 109.535 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.89 -67.6 0.9 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.27 0.628 . . . . 72.32 110.03 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 19.4 t80 52.41 30.34 8.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.923 1.289 . . . . 64.22 112.451 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -71.75 133.08 45.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.485 0.714 . . . . 75.25 109.884 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -90.58 136.38 33.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.42 -0.585 . . . . 75.23 109.42 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -38.0 62.58 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.627 -0.508 . . . . 73.04 109.627 169.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 12.0 t30 64.95 157.3 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.973 1.309 . . . . 74.0 113.227 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 102.53 -103.13 2.39 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 111.014 -0.834 . . . . 44.13 111.014 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.562 ' HG2' ' HB2' ' D' ' 2' ' ' SER . 18.5 tptt -89.82 74.89 7.38 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.769 -1.197 . . . . 75.33 107.769 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -77.11 81.09 3.62 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.723 -1.126 . . . . 73.41 109.422 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . 0.492 ' HB2' HG23 ' F' ' 187' ' ' ILE . 12.8 m-20 73.73 -59.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.106 1.762 . . . . 75.41 111.827 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.437 HG23 ' HB2' ' F' ' 185' ' ' PRO . 28.7 pt -60.21 103.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 71.13 111.936 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -84.94 -33.12 22.73 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.667 -1.151 . . . . 72.43 110.048 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.41 91.14 8.34 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.603 -0.888 . . . . 74.5 108.603 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.487 HG22 HG22 ' D' ' 13' ' ' ILE . 7.6 p . . . . . 0 CA--C 1.559 1.32 0 C-N-CA 124.497 1.119 . . . . 71.43 109.557 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.543 -0.54 . . . . 74.45 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.66 82.72 1.21 Allowed Glycine 0 C--N 1.347 1.189 0 N-CA-C 111.643 -0.583 . . . . 74.25 111.643 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . 0.488 ' HB3' ' HZ3' ' F' ' 170' ' ' LYS . 3.5 mmmp? -67.24 -69.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.679 0.792 . . . . 74.0 110.917 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 55.5 m 64.27 178.67 0.17 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.336 1.055 . . . . 64.31 112.422 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -127.88 78.38 1.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.044 -1.095 . . . . 72.2 108.044 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.732 HD22 ' H ' ' B' ' 54' ' ' ASP . 62.4 mt -110.81 80.48 1.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.802 0.811 . . . . 74.01 109.581 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.66 52.08 2.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.464 -1.244 . . . . 74.13 109.076 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.68 91.45 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.606 -1.179 . . . . 73.45 109.992 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -148.64 104.19 3.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.687 0.795 . . . . 62.34 108.978 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.23 -50.01 4.09 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.537 0.735 . . . . 72.54 109.5 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 54.26 80.44 0.12 Allowed 'General case' 0 C--N 1.355 0.837 0 O-C-N 124.802 1.314 . . . . 63.24 111.446 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 66.5 172.71 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 124.171 0.988 . . . . 75.42 111.898 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.2 99.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 121.829 1.686 . . . . 74.4 111.888 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -56.57 -32.34 65.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.653 1.181 . . . . 74.23 110.906 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . 0.512 ' HB2' ' HZ ' ' B' ' 133' ' ' PHE . 77.0 m-85 -137.27 155.41 49.51 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.224 -1.028 . . . . 74.44 108.224 160.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 79.5 m -70.87 129.7 39.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.272 0.629 . . . . 74.12 110.974 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -115.67 92.73 34.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 107.948 -1.13 . . . . 73.0 107.948 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . 0.437 ' HB2' HG23 ' E' ' 204' ' ' ILE . 3.6 Cg_exo -75.54 156.98 40.68 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.829 2.352 . . . . 71.34 112.358 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.42 HD13 HD23 ' B' ' 44' ' ' LEU . 3.1 mm? -119.02 178.32 4.54 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.915 0.886 . . . . 72.43 110.306 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.492 HG23 ' HB2' ' E' ' 203' ' ' ASP . 2.6 pp -110.89 154.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.2 0.6 . . . . 74.42 111.26 -175.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.51 56.35 1.53 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.922 0.889 . . . . 71.12 111.055 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . 62.38 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.167 1.387 . . . . 72.01 111.748 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -138.55 -29.7 0.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.135 1.374 . . . . 65.31 109.325 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 143.89 -21.92 2.14 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.495 -1.042 . . . . 74.11 110.495 -166.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.94 81.56 Favored Glycine 0 C--N 1.356 1.658 0 C-N-CA 123.881 0.753 . . . . 64.52 112.911 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.41 11.02 3.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.592 0.96 . . . . 74.31 113.592 -166.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.3 -15.97 55.71 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.987 -0.746 . . . . 53.35 108.987 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -75.59 138.01 41.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.558 1.543 . . . . 73.33 111.668 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' F' ' 198' ' ' GLU . 39.3 ttpt 179.51 133.99 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.491 1.516 . . . . 73.24 108.029 171.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . 0.575 ' H ' ' HA ' ' B' ' 36' ' ' TRP . 1.6 t80 -87.44 77.38 8.87 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 106.803 -1.555 . . . . 73.02 106.803 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . 0.423 ' HB2' ' HE3' ' F' ' 196' ' ' LYS . 40.1 tt0 -69.68 -67.03 0.51 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.729 -1.123 . . . . 74.31 109.958 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . 0.431 ' O ' ' HA3' ' E' ' 191' ' ' GLY . 15.5 m120 -145.68 158.35 43.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.176 1.39 . . . . 74.42 107.574 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 58.82 -97.7 0.09 OUTLIER Glycine 0 CA--C 1.532 1.112 0 O-C-N 123.874 0.734 . . . . 54.35 114.684 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 55.32 76.66 0.25 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.255 1.422 . . . . 74.45 111.55 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 62.0 39.29 13.47 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.798 1.239 . . . . 73.02 110.672 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.34 152.72 24.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.648 -1.16 . . . . 73.3 112.324 -172.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.04 97.72 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 107.882 -1.155 . . . . 62.5 107.882 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . 0.529 ' HZ2' ' HB2' ' F' ' 205' ' ' LYS . 0.0 OUTLIER -73.77 -55.34 6.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.539 -0.755 . . . . 73.42 112.227 -169.509 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.84 -86.52 0.64 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 119.296 -0.383 . . . . 72.33 111.575 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 C--O 1.255 1.355 0 CA-C-N 118.479 0.581 . . . . 73.35 109.893 -177.182 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.44 -0.578 . . . . 75.24 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.65 136.91 9.34 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.644 -0.583 . . . . 72.31 111.644 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -75.15 86.53 2.4 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 72.53 110.139 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 32.0 t -71.55 117.32 12.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.518 -0.764 . . . . 75.2 110.489 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -165.64 -39.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.427 1.091 . . . . 75.23 109.622 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.89 124.66 23.08 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.258 1.023 . . . . 73.01 111.551 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.448 ' SD ' ' HE3' ' A' ' 94' ' ' MET . 0.0 OUTLIER 64.39 47.4 3.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.368 1.067 . . . . 65.42 111.617 173.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.4 168.88 3.23 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.42 -0.809 . . . . 73.2 112.022 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -68.89 -42.9 76.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.672 0.789 . . . . 74.23 111.478 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 5.6 tt 68.3 95.54 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.714 1.206 . . . . 74.43 109.13 -173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -153.65 -23.13 0.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.071 0.549 . . . . 75.42 110.652 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.5 139.99 94.59 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.108 0.563 . . . . 73.13 110.619 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 131.71 24.85 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.927 2.418 . . . . 74.35 112.258 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -82.9 -167.98 1.87 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.578 0.751 . . . . 72.15 110.656 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . 0.602 ' HB3' ' H3 ' ' C' ' 1' ' ' MET . 74.0 m-85 -56.02 -71.56 0.09 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.027 0.931 . . . . 74.22 111.674 -173.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 14.7 t 177.69 162.59 0.57 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.979 1.312 . . . . 64.34 109.286 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.23 89.11 2.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.277 0.631 . . . . 73.13 111.344 172.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 -36.33 1.39 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.204 2.603 . . . . 71.11 114.063 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.88 -172.86 0.17 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.66 1.184 . . . . 74.32 112.57 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 39.0 pt -73.83 165.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.735 0.814 . . . . 75.32 110.938 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -134.93 146.21 48.92 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.584 0.754 . . . . 73.23 109.838 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.54 135.0 20.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.477 0.711 . . . . 71.43 110.35 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -153.14 132.17 12.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.932 -0.766 . . . . 74.04 108.932 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 82.46 -170.46 50.51 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.054 -0.521 . . . . 63.54 113.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 125.45 84.54 0.56 Allowed Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.581 -1.008 . . . . 64.14 110.581 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -76.91 70.84 3.39 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.858 0.837 . . . . 75.33 109.662 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -122.27 176.69 5.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.08 1.352 . . . . 51.45 108.343 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 41.3 t80 52.73 31.47 10.44 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.467 1.127 . . . . 74.24 109.925 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.23 118.86 11.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.763 -1.562 . . . . 73.24 110.558 -163.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -71.15 85.06 0.74 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 124.361 1.038 . . . . 71.33 110.633 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -87.28 -53.92 4.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.76 -0.83 . . . . 74.41 108.76 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -159.43 161.6 35.57 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.449 -0.796 . . . . 73.55 109.129 174.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.14 16.52 0.05 OUTLIER Glycine 0 N--CA 1.471 0.98 0 CA-C-O 120.149 -0.25 . . . . 74.04 113.09 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -78.3 109.58 12.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.537 -0.542 . . . . 75.15 109.537 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.42 97.63 0.43 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.437 -0.949 . . . . 64.13 108.437 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.65 87.05 0.48 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.92 0.888 . . . . 53.43 111.815 -169.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . 0.759 HG13 HG23 ' H' ' 187' ' ' ILE . 1.7 mp -108.36 132.36 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.758 1.223 . . . . 73.51 108.247 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.09 -40.65 4.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.903 0.881 . . . . 73.31 110.218 -175.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -99.46 178.53 4.85 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.237 1.015 . . . . 71.43 111.761 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 123.586 0.754 . . . . 73.33 111.095 -179.724 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.2 -0.667 . . . . 73.24 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 112.39 0.05 OUTLIER Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.833 -0.621 . . . . 74.24 113.858 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -75.91 128.93 36.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.473 -0.936 . . . . 73.33 108.473 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.0 m -80.82 -58.61 3.02 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.827 -0.805 . . . . 70.31 108.827 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.69 ' HB1' ' H ' ' D' ' 88' ' ' GLY . . . -161.66 54.05 0.25 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.204 -0.907 . . . . 73.3 109.761 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' D' ' 54' ' ' ASP . 3.1 tm? -76.31 121.49 23.05 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 107.748 -1.205 . . . . 74.43 107.748 169.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.508 ' SD ' ' HE1' ' D' ' 94' ' ' MET . 0.0 OUTLIER -144.24 63.18 1.33 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.474 1.11 . . . . 74.44 109.495 -170.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -63.47 86.92 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.267 0.627 . . . . 74.21 110.24 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -115.74 84.58 2.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.161 0.984 . . . . 74.51 109.555 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . 0.498 HD12 HD22 ' D' ' 98' ' ' LEU . 6.6 tt -156.35 132.54 9.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.05 -0.722 . . . . 74.12 109.05 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.98 93.9 2.6 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.727 1.211 . . . . 73.43 107.761 172.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 64.48 169.46 0.1 OUTLIER Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 124.615 1.166 . . . . 63.11 112.573 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.91 122.73 11.39 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.992 1.794 . . . . 74.32 111.184 168.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.25 -53.05 6.36 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.598 0.759 . . . . 74.41 110.752 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -118.66 14.33 13.49 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.776 0.83 . . . . 73.32 111.97 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 183' ' ' THR . . . . . 0.48 HG21 ' HD3' ' H' ' 185' ' ' PRO . 20.2 m 70.05 150.9 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.046 1.339 . . . . 75.21 112.749 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -147.44 82.91 7.93 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.117 0.567 . . . . 74.24 109.484 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . 0.48 ' HD3' HG21 ' H' ' 183' ' ' THR . 74.0 Cg_endo -77.13 144.91 24.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.275 2.65 . . . . 74.13 113.487 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.29 -173.53 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.865 0.866 . . . . 74.42 110.52 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.759 HG23 HG13 ' G' ' 204' ' ' ILE . 2.4 pp -73.67 170.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.854 0.861 . . . . 72.44 113.107 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.75 -22.23 19.49 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.226 -0.897 . . . . 72.42 111.371 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . 62.21 5.36 1.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.816 1.246 . . . . 64.42 113.495 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -94.7 132.96 38.89 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.243 1.017 . . . . 74.11 108.57 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 147.99 78.86 0.03 OUTLIER Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.44 -0.664 . . . . 72.42 111.44 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.14 174.98 44.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.47 -0.252 . . . . 71.44 112.47 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . 0.545 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 21.3 t80 -174.07 91.45 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.376 . . . . 72.24 107.743 173.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.27 15.65 2.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.537 0.735 . . . . 65.03 110.787 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.404 ' HB2' ' HG3' ' D' ' 124' ' ' PRO . 10.5 t80 -103.66 27.51 7.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.955 0.502 . . . . 73.52 109.672 178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -79.59 105.36 10.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.108 -0.701 . . . . 74.1 109.108 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . 0.485 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 0.5 OUTLIER -150.15 115.93 5.57 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.197 0.999 . . . . 74.34 109.603 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.29 58.09 0.76 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.868 0.867 . . . . 75.32 109.054 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 33.1 t30 62.91 88.89 0.09 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.596 -1.261 . . . . 73.41 107.596 -165.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.9 -61.01 7.93 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.887 0.742 . . . . 72.24 113.542 -168.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -175.1 -44.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.182 0.593 . . . . 74.35 110.314 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -59.01 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 125.018 1.449 . . . . 74.52 111.742 -166.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -102.8 139.93 37.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.907 -1.146 . . . . 74.13 107.907 172.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 91.7 mt -103.89 135.69 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.507 0.723 . . . . 74.31 109.405 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.25 112.34 3.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.935 -1.505 . . . . 74.42 106.935 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -162.59 -58.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.827 0.285 . . . . 73.1 111.306 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.624 0.77 . . . . 63.32 109.185 -178.403 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 110.436 -0.209 . . . . 72.11 110.436 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -76.59 105.58 7.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.207 0.603 . . . . 74.24 110.024 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 49.0 mt-10 -146.24 124.47 12.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.505 0.722 . . . . 64.42 109.827 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -91.95 72.29 5.6 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.729 0.776 . . . . 74.14 110.343 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.423 ' O ' ' HG3' ' A' ' 9' ' ' MET . 60.6 m-80 -90.1 44.87 1.23 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.151 -0.931 . . . . 73.04 110.183 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -60.15 -40.36 89.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.381 0.672 . . . . 75.14 111.444 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' A' ' 155' ' ' ALA . 71.1 p -128.59 38.36 3.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.966 0.907 . . . . 73.04 108.661 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.96 26.81 6.07 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.687 -0.857 . . . . 74.12 108.687 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.449 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -154.8 158.25 39.16 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.672 1.189 . . . . 65.42 108.61 173.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -142.17 137.91 31.18 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.631 0.772 . . . . 75.14 109.947 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 52.4 t80 -135.96 129.17 31.72 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.596 -1.261 . . . . 74.24 107.596 170.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -148.82 123.41 9.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.266 0.469 . . . . 71.3 112.266 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.571 HD13 HG13 ' A' ' 16' ' ' ILE . 3.4 tp -75.19 118.26 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.949 -1.023 . . . . 63.52 109.056 168.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.9 -20.75 13.34 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.292 0.637 . . . . 71.34 111.048 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -178.41 127.16 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.249 0.477 . . . . 74.31 111.157 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.571 HG13 HD13 ' A' ' 13' ' ' ILE . 48.3 mt -106.48 132.22 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.761 -0.829 . . . . 74.15 108.761 169.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -148.45 171.84 15.42 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.27 1.428 . . . . 75.22 109.931 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -102.15 123.49 46.09 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.959 -0.756 . . . . 74.11 108.959 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -81.53 -32.19 32.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.387 0.675 . . . . 75.42 110.556 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.7 t70 -150.1 144.34 25.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.13 110.083 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.441 HG23 ' SD ' ' A' ' 117' ' ' MET . 61.6 mt -137.38 130.3 43.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.852 -1.536 . . . . 71.14 106.852 171.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -140.33 116.17 10.3 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.113 -1.069 . . . . 71.14 108.113 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.4 t80 -126.68 109.2 11.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 106.667 -1.605 . . . . 71.22 106.667 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.97 108.91 15.85 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.403 -0.962 . . . . 75.54 108.403 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 74' ' ' PHE . . . -106.76 89.48 4.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.335 -0.987 . . . . 61.32 108.335 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.59 -43.45 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.446 2.098 . . . . 63.23 112.794 -172.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.408 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.6 m-80 -101.42 29.27 4.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.24 0.616 . . . . 73.25 109.891 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -50.79 -48.65 82.99 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 124.359 1.064 . . . . 74.54 113.163 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 21.8 Cg_exo -67.84 -26.39 38.37 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 121.688 1.592 . . . . 62.21 112.517 176.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.52 -28.4 60.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.625 -0.716 . . . . 73.12 110.857 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.724 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 41.4 t -58.79 -20.34 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 123.667 0.787 . . . . 72.13 111.645 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.474 ' HE1' ' HB3' ' G' ' 201' ' ' LYS . 66.5 t80 -59.77 -41.4 90.98 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.262 1.025 . . . . 75.24 111.776 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -101.27 -22.21 14.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.246 0.618 . . . . 70.51 111.436 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.724 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.9 mmmt -69.88 134.72 48.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.269 0.627 . . . . 72.24 110.001 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.42 131.94 44.84 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.339 -0.846 . . . . 65.25 109.087 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.432 ' HA ' HD23 ' A' ' 68' ' ' LEU . 75.4 t-105 -80.79 90.6 5.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.479 0.656 . . . . 75.44 110.006 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -121.22 83.97 39.85 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 106.866 -1.531 . . . . 74.2 106.866 165.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.05 132.24 16.51 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.295 1.996 . . . . 43.43 111.389 -171.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -94.49 91.51 6.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.097 -1.446 . . . . 74.13 107.097 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.34 98.59 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 124.612 1.195 . . . . 62.05 111.586 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.44 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 20.2 tptm -100.42 130.52 46.52 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.428 -1.26 . . . . 72.21 108.763 175.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -131.67 114.08 14.37 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.41 0.684 . . . . 72.51 109.367 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.512 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -108.08 137.56 45.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.394 1.078 . . . . 73.21 108.535 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.8 tp -119.0 118.9 32.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.747 -0.835 . . . . 70.3 108.747 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -128.58 149.99 50.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.012 0.925 . . . . 71.04 108.953 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -140.63 151.25 44.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.378 0.671 . . . . 74.43 109.858 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -142.53 155.29 45.0 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.226 1.01 . . . . 71.05 109.38 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 p -125.6 159.81 31.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.602 0.761 . . . . 64.24 110.329 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -159.12 122.43 3.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.683 0.793 . . . . 74.01 109.68 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -79.84 111.9 16.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.755 0.422 . . . . 74.54 109.869 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 57' ' ' GLU . 52.5 mt -88.52 -34.16 17.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.124 0.569 . . . . 75.34 110.667 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.58 -172.38 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.437 1.095 . . . . 71.51 109.937 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.19 107.41 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 72.12 109.522 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 68.56 3.66 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.219 1.408 . . . . 70.21 112.87 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.5 t -99.64 115.04 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.351 -1.351 . . . . 75.45 107.351 175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -123.2 167.04 14.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.67 0.747 . . . . 74.34 110.745 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' HB2' HD13 ' A' ' 51' ' ' LEU . 19.3 tt0 -128.59 126.26 39.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.043 -1.435 . . . . 65.31 107.143 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -106.48 122.05 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.464 -1.31 . . . . 75.45 107.464 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.506 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.5 t -97.51 139.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 124.313 1.045 . . . . 74.4 108.291 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.12 112.77 19.1 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.434 -1.321 . . . . 74.53 107.434 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -109.75 103.03 11.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.658 0.742 . . . . 74.22 109.752 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.49 136.12 28.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.703 -1.135 . . . . 75.22 108.414 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.8 m -123.5 128.97 50.53 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.039 0.447 . . . . 73.2 110.276 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.5 t -125.33 110.5 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 74.41 109.394 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -107.73 138.59 43.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.19 0.45 . . . . 74.24 109.827 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.48 105.85 12.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.286 -1.376 . . . . 74.54 107.286 168.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 47.6 m -106.42 126.52 52.35 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.552 -0.536 . . . . 72.31 109.552 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 36' ' ' TRP . 17.0 mt -93.27 80.84 4.44 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.137 -1.431 . . . . 72.2 107.137 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -89.24 0.86 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.951 -1.022 . . . . 54.42 111.285 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -121.5 -15.06 8.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.167 0.987 . . . . 71.04 110.477 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -97.16 101.74 13.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.404 1.082 . . . . 73.24 109.83 -177.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.4 m -66.17 127.19 31.19 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.263 0.554 . . . . 64.54 111.192 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -74.28 -55.06 6.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.738 1.215 . . . . 73.23 108.986 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 25' ' ' ALA . 42.5 p90 -151.22 164.87 35.6 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.749 -1.114 . . . . 64.33 111.125 175.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.21 143.38 50.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.3 1.44 . . . . 71.02 107.224 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.8 m -130.11 136.05 48.9 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 123.712 0.805 . . . . 73.41 108.855 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -148.57 115.72 6.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.582 -0.896 . . . . 73.24 108.582 173.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.89 112.84 30.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.652 0.781 . . . . 74.34 109.518 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -86.67 84.49 7.38 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.751 -0.833 . . . . 65.32 108.751 172.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.53 93.3 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.588 -0.893 . . . . 74.54 108.588 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.37 148.44 20.08 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.413 -0.675 . . . . 73.12 111.413 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 131.92 4.03 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.865 -0.894 . . . . 64.13 110.865 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.78 121.33 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.662 -0.866 . . . . 73.42 108.662 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' CE2' HD11 ' A' ' 13' ' ' ILE . 34.5 m-85 -130.87 117.33 19.14 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.723 -1.214 . . . . 74.52 107.723 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 p -79.15 115.8 19.03 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.416 -0.957 . . . . 75.43 108.416 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HB ' HD12 ' A' ' 89' ' ' ILE . 44.4 pt -118.37 142.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.481 0.712 . . . . 72.4 110.594 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.81 155.74 17.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.099 0.96 . . . . 54.45 109.628 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 76.17 9.48 85.54 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.616 0.606 . . . . 75.44 114.616 173.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.453 HD12 ' HB ' ' A' ' 86' ' ' ILE . 1.3 pp -119.61 132.58 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 117.409 0.604 . . . . 74.24 110.678 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HA ' ' HB1' ' G' ' 172' ' ' ALA . 50.6 mt-10 -151.76 173.39 14.79 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.373 1.069 . . . . 64.41 110.217 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.19 -136.26 51.13 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.602 0.564 . . . . 63.32 113.896 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -70.34 -25.95 63.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.759 0.824 . . . . 73.22 111.371 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -65.29 -43.35 91.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 73.34 110.492 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.51 ' HE3' ' H ' ' G' ' 175' ' ' PHE . 28.0 ttt -76.11 -38.17 57.21 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.874 -0.603 . . . . 65.21 110.64 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.26 67.83 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.797 0.439 . . . . 70.04 111.489 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -71.72 -39.44 70.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.949 0.9 . . . . 75.04 110.473 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.606 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 t -77.36 -65.87 0.9 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.65 -0.704 . . . . 74.35 110.222 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.54 -17.95 61.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.745 0.818 . . . . 75.5 112.365 -176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.29 -16.91 54.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.852 -0.416 . . . . 61.23 113.964 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -55.7 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.403 0.601 . . . . 62.22 111.75 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 92.1 t80 -66.79 -61.05 2.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.904 0.882 . . . . 70.42 113.361 -168.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.606 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 79.1 m -62.78 -40.91 68.33 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.157 -0.925 . . . . 70.4 113.372 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -63.79 -32.53 67.29 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 121.098 1.428 . . . . 73.3 112.868 168.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -72.02 -24.64 61.59 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 117.945 0.339 . . . . 65.43 111.204 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -57.74 -43.26 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.638 0.733 . . . . 74.33 109.406 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 mt -77.49 -21.84 52.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.146 -1.388 . . . . 74.44 112.27 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -64.61 -41.35 57.04 Favored Pre-proline 0 CA--C 1.562 1.424 0 CA-C-O 117.475 -1.25 . . . . 75.53 114.116 -168.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.69 -31.26 91.54 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.119 1.879 . . . . 74.31 113.26 172.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.95 -41.07 21.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.616 0.766 . . . . 74.5 110.924 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.53 87.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.947 0.499 . . . . 73.11 110.061 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.483 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.9 ttm180 -50.51 -58.79 4.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.867 1.267 . . . . 64.43 110.154 173.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.19 -40.55 96.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.516 1.135 . . . . 74.52 111.754 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.407 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 49.6 t -57.59 -48.43 79.42 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 123.854 0.721 . . . . 74.31 110.1 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.467 HG21 HG22 ' A' ' 64' ' ' VAL . 95.1 mt -62.16 -51.16 75.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 O-C-N 124.306 1.004 . . . . 65.3 110.203 175.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.53 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.8 m -53.0 -42.72 65.87 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.81 1.244 . . . . 73.41 111.621 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 32.1 t -68.91 -47.01 66.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.969 -1.014 . . . . 62.24 109.985 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.441 ' SD ' HG23 ' A' ' 21' ' ' ILE . 15.6 mtp -53.45 -45.61 69.57 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.856 0.862 . . . . 72.45 111.394 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.09 -49.11 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.076 1.351 . . . . 74.24 111.046 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -68.48 -28.84 67.39 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.899 0.479 . . . . 74.34 111.454 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 116' ' ' SER . 90.5 mtt-85 -70.3 -27.59 64.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.694 0.798 . . . . 75.12 110.976 178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.96 11.96 58.83 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 119.498 -0.612 . . . . 71.41 113.776 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.413 ' HB ' HH21 ' B' ' 15' ' ' ARG . 11.9 m 65.18 32.53 10.04 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.351 1.072 . . . . 75.41 110.316 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.413 ' HE1' HG11 ' A' ' 31' ' ' VAL . 65.2 m-85 -109.4 152.69 42.83 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 115.106 -0.952 . . . . 74.12 109.101 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 149.57 80.23 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.103 1.868 . . . . 71.23 111.319 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.53 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.7 tt0 -56.7 142.29 40.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.699 0.8 . . . . 73.33 111.313 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp -133.8 101.79 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.57 0.748 . . . . 74.1 109.434 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.485 ' ND2' HD22 ' H' ' 199' ' ' ASN . 76.3 m-20 -98.63 100.7 11.95 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.61 117.85 6.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 75.14 109.928 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.94 150.36 50.03 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.345 0.658 . . . . 75.23 111.859 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.71 160.86 7.75 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.378 2.052 . . . . 73.31 112.763 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.89 114.3 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.806 -1.183 . . . . 72.03 107.806 165.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.515 ' HB3' ' HB1' ' A' ' 135' ' ' ALA . 1.6 m120 -98.8 63.41 1.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.648 0.737 . . . . 71.43 109.945 176.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -77.08 -32.5 56.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.24 -0.891 . . . . 73.52 109.035 173.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.57 -42.23 99.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.078 -0.964 . . . . 72.44 110.659 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 132' ' ' ASN . . . -75.61 -26.43 57.81 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.86 0.725 . . . . 73.1 110.965 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.8 tp -73.07 -44.68 60.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.307 0.643 . . . . 74.01 110.658 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.442 ' HE2' HD23 ' A' ' 141' ' ' LEU . 45.9 t80 -84.66 -23.68 29.34 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.043 -0.526 . . . . 75.43 111.487 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -32.76 72.43 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.559 0.618 . . . . 65.12 110.004 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -52.28 -61.22 2.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.378 1.049 . . . . 74.55 109.292 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -63.53 -31.59 72.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.611 -0.722 . . . . 73.53 112.477 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.442 HD23 ' HE2' ' A' ' 137' ' ' PHE . 2.3 tm? -61.3 -51.11 70.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.262 0.625 . . . . 75.24 109.388 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -176.79 -12.54 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.898 0.749 . . . . 71.31 112.378 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -68.53 -17.84 64.24 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.168 0.433 . . . . 74.11 112.168 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.45 ' HA ' ' HB2' ' C' ' 143' ' ' GLN . 49.4 tt0 -70.22 -23.42 62.93 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 72.43 110.178 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' C' ' 147' ' ' GLU . . . -83.68 53.59 2.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.543 0.737 . . . . 73.14 109.745 169.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.01 59.62 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.955 -0.566 . . . . 72.41 112.312 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -78.38 -27.94 46.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.127 0.971 . . . . 74.12 109.412 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.01 119.59 0.44 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.623 -0.717 . . . . 64.43 111.44 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -136.85 100.02 4.19 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.816 -1.179 . . . . 75.13 107.816 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.82 127.09 31.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.385 -0.825 . . . . 75.23 110.205 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.66 111.28 3.51 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 105.393 -2.077 . . . . 72.3 105.393 173.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -71.48 -97.92 0.01 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-O 118.255 -0.878 . . . . 60.12 109.817 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 42.5 -89.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.927 1.291 . . . . 75.1 112.066 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 168.06 -63.88 0.0 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 126.656 1.983 . . . . 60.31 106.585 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.42 ' HA ' ' HB ' ' A' ' 7' ' ' THR . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.309 -1.314 . . . . 71.03 108.492 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.451 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 108.743 -0.836 . . . . 64.31 108.743 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 94.72 0.76 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.775 0.83 . . . . 65.51 110.513 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -81.02 155.33 26.42 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.901 -0.778 . . . . 72.31 108.901 169.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 65.57 111.46 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.689 1.196 . . . . 75.24 110.555 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -68.89 -5.75 23.08 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.376 0.67 . . . . 72.51 112.546 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.32 73.53 1.84 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.87 0.868 . . . . 74.44 109.799 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.6 m -105.68 106.03 16.35 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.351 -1.352 . . . . 64.02 107.351 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -61.03 -50.95 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.711 0.805 . . . . 65.34 110.426 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.549 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.0 ptm 50.36 171.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.908 2.083 . . . . 73.25 115.071 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.2 p -142.13 134.97 28.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 75.01 109.089 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -139.97 117.17 11.22 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.834 -0.802 . . . . 72.15 108.834 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -128.03 103.5 7.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.191 0.596 . . . . 75.43 109.797 176.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.473 HG21 ' HA ' ' D' ' 129' ' ' ALA . 12.5 tt -67.92 121.63 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 108.819 -0.808 . . . . 74.44 108.819 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -101.1 -47.38 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.86 0.464 . . . . 71.32 110.715 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.413 HH21 ' HB ' ' A' ' 122' ' ' THR . 66.9 ttt180 -163.25 135.59 5.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.098 -171.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.15 138.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 106.805 -1.554 . . . . 73.1 106.805 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.492 ' HE1' HG13 ' B' ' 83' ' ' ILE . 15.1 p90 -164.78 146.35 8.02 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 123.711 0.632 . . . . 72.21 111.178 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -74.64 116.84 15.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.864 -0.791 . . . . 75.4 108.864 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -89.48 -30.18 18.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.26 0.624 . . . . 73.23 111.158 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.5 t70 -158.25 142.89 16.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.091 -0.504 . . . . 60.32 110.376 -171.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.9 mm -138.29 141.46 37.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 125.336 1.455 . . . . 75.05 108.071 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -140.49 133.17 28.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.73 -1.123 . . . . 75.35 108.073 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.1 t80 -142.43 127.43 18.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.447 -1.686 . . . . 73.22 106.447 164.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.57 147.05 49.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.446 -1.316 . . . . 64.35 107.446 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.31 81.74 15.26 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 105.829 -1.915 . . . . 54.22 105.829 172.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.87 -29.08 76.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.574 2.183 . . . . 74.42 111.13 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.25 30.7 6.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.66 -1.155 . . . . 54.33 110.435 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.45 -52.45 29.63 Favored Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 124.734 1.214 . . . . 71.24 111.972 169.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.25 -16.84 9.43 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.007 1.804 . . . . 74.31 113.072 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -87.59 3.15 48.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.339 0.656 . . . . 71.21 111.419 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.486 HG13 HD11 ' B' ' 68' ' ' LEU . 22.0 m -67.04 -17.12 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.644 0.778 . . . . 74.1 110.766 166.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -71.33 -31.28 67.21 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.403 1.081 . . . . 74.41 110.123 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.18 -42.65 15.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.351 0.66 . . . . 72.12 109.383 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -91.45 78.52 5.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.076 0.95 . . . . 72.51 109.377 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.652 ' HB3' ' HA ' ' F' ' 196' ' ' LYS . 24.0 m-20 -83.11 74.87 9.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.42 -1.264 . . . . 75.44 110.471 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -179.46 171.64 1.24 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.199 1.0 . . . . 74.1 109.471 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -71.15 135.57 84.79 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.181 0.992 . . . . 70.45 111.276 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.54 157.41 48.89 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.135 1.89 . . . . 73.0 111.742 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 52.5 mt-10 -70.2 102.19 2.04 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.826 -1.176 . . . . 61.33 107.826 167.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.5 136.6 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.436 -0.95 . . . . 74.44 108.436 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -136.68 141.45 43.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.62 0.768 . . . . 74.31 109.23 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.557 ' HB3' HD12 ' B' ' 126' ' ' LEU . 2.8 pp -104.83 142.23 35.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.475 0.71 . . . . 74.33 109.366 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.512 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.2 m-20 -139.6 155.71 47.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.687 1.595 . . . . 70.42 106.916 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 165.09 36.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.944 0.402 . . . . 74.32 110.327 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.53 141.51 13.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.346 1.058 . . . . 75.22 109.057 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.56 HG23 ' HA2' ' B' ' 99' ' ' GLY . 88.8 m -108.57 120.06 41.34 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.251 0.621 . . . . 73.14 109.361 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.33 153.82 32.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.765 1.226 . . . . 64.14 108.539 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -142.99 163.41 32.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.096 0.558 . . . . 75.14 110.889 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -154.03 170.59 20.75 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.05 1.34 . . . . 75.04 109.222 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 64.0 tt0 -125.79 135.36 51.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.786 0.834 . . . . 72.55 109.818 169.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 59.3 mt -100.62 -44.75 5.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.677 0.791 . . . . 74.35 110.767 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -147.8 179.23 7.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.944 -1.025 . . . . 74.44 109.733 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.11 119.29 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.526 -0.761 . . . . 65.1 109.851 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' B' ' 85' ' ' SER . 16.6 m-20 70.76 -6.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.144 1.778 . . . . 75.12 112.674 -174.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.0 t -104.58 94.95 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.131 -1.062 . . . . 73.51 108.131 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.468 ' HE2' HD22 ' F' ' 173' ' ' LEU . 8.0 m-85 -94.93 169.39 10.16 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.435 0.694 . . . . 73.31 109.517 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.519 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 6.8 tm-20 -142.89 101.72 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.518 -1.289 . . . . 71.43 107.518 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.87 125.12 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.446 -0.576 . . . . 73.3 109.446 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.451 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.8 t -102.98 111.58 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.569 0.748 . . . . 74.02 109.605 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.37 112.09 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.381 -0.97 . . . . 74.42 108.381 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -96.44 131.45 43.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.592 -1.186 . . . . 74.34 109.708 173.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -126.89 120.29 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.579 -1.267 . . . . 72.53 107.579 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.4 m -109.48 153.97 23.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.494 1.117 . . . . 73.2 109.805 -174.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 85.1 t -133.33 126.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.631 1.172 . . . . 74.25 108.766 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 43.2 m -112.8 143.22 44.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.679 0.792 . . . . 75.44 109.335 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.7 151.37 34.79 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.56 0.344 . . . . 73.33 110.81 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.4 p -144.37 133.39 22.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.099 0.56 . . . . 75.05 111.203 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.486 HD11 HG13 ' B' ' 31' ' ' VAL . 41.8 mt -100.87 99.67 10.2 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 74.13 108.365 171.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.68 -120.01 6.73 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.018 -0.833 . . . . 41.33 111.018 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.17 6.0 35.37 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.803 0.841 . . . . 75.51 112.191 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -115.19 165.57 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.44 0.696 . . . . 64.43 109.793 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -77.82 133.14 38.26 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.121 0.568 . . . . 73.25 111.111 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.46 -60.2 2.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.64 0.776 . . . . 74.11 109.291 178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.5 150.98 21.91 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.533 -1.212 . . . . 72.23 110.041 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.45 114.22 15.87 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.215 1.006 . . . . 74.41 108.729 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.539 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 51.4 t -115.38 157.94 23.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.766 -0.827 . . . . 74.0 108.766 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.88 135.97 2.85 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.451 -0.944 . . . . 71.1 108.451 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.74 143.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.51 -0.922 . . . . 73.25 108.51 172.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -127.15 89.25 2.94 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.68 -0.859 . . . . 73.14 108.68 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -83.45 104.71 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.939 -1.028 . . . . 74.23 108.506 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.21 162.52 29.71 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.574 -0.61 . . . . 72.52 111.574 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.09 128.81 2.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.519 -0.632 . . . . 64.12 111.519 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.498 HG22 HD12 ' B' ' 51' ' ' LEU . 37.8 mt -85.72 118.39 32.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.748 -0.834 . . . . 71.14 108.748 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.69 134.71 43.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.773 0.829 . . . . 75.13 109.375 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.568 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 43.2 m -97.58 113.85 25.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.268 0.627 . . . . 74.34 109.993 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 137.47 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.772 0.829 . . . . 73.14 111.608 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.41 173.09 17.17 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.698 1.199 . . . . 72.52 108.782 165.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 86.53 -44.29 3.32 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-O 120.279 -0.179 . . . . 75.21 112.771 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.91 152.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.876 0.87 . . . . 74.44 110.654 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -155.93 144.25 20.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 120.406 0.146 . . . . 71.13 110.64 -174.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.39 -114.36 6.12 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.707 0.67 . . . . 73.43 114.034 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -67.01 -31.13 71.48 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.867 0.867 . . . . 74.13 110.996 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.34 0.656 . . . . 73.54 110.475 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.564 ' SD ' ' HB2' ' F' ' 174' ' ' MET . 26.2 ttt -73.11 -37.86 66.53 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.767 -0.651 . . . . 64.42 110.681 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.84 -24.85 67.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 71.01 111.121 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -88.75 -23.38 22.92 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.048 0.939 . . . . 73.23 110.985 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.64 -67.66 0.64 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.716 0.406 . . . . 74.21 109.926 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.59 -18.4 58.66 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.034 0.383 . . . . 73.1 112.034 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.56 ' HA2' HG23 ' B' ' 46' ' ' THR . . . -90.11 -20.19 43.49 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.769 -0.462 . . . . 73.42 114.043 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.42 -52.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.766 0.654 . . . . 75.21 112.766 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -67.22 -50.17 61.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.104 0.561 . . . . 74.34 111.401 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.68 -47.41 82.17 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 118.236 -0.888 . . . . 65.33 110.42 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.8 -43.03 36.04 Favored 'Trans proline' 0 C--N 1.404 3.495 0 C-N-CA 122.296 1.998 . . . . 72.53 114.463 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -31.42 72.31 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.257 0.623 . . . . 73.21 111.867 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.9 -45.69 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.547 0.739 . . . . 74.03 110.372 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.24 -16.38 33.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.009 -0.996 . . . . 73.24 111.786 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.14 -44.17 95.73 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 125.773 1.629 . . . . 75.51 113.757 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.59 -40.32 74.93 Favored 'Trans proline' 0 C--N 1.4 3.286 0 C-N-CA 121.873 1.715 . . . . 74.05 112.494 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.8 m-85 -63.79 -44.09 94.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.17 0.588 . . . . 74.44 110.33 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.445 0.698 . . . . 70.41 111.045 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.52 -47.2 87.21 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.966 1.307 . . . . 74.1 111.063 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.82 -40.41 75.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.643 0.777 . . . . 73.32 110.0 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.492 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.7 t -67.45 -35.24 78.82 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 115.797 -0.638 . . . . 72.34 111.218 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.431 HG21 HG22 ' B' ' 64' ' ' VAL . 52.1 mt -62.81 -57.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.167 0.587 . . . . 74.51 109.548 174.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 90.1 m -59.84 -26.43 65.8 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.328 1.018 . . . . 70.53 111.183 -176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.6 t -66.03 -58.79 4.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.528 0.731 . . . . 75.33 109.852 171.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.2 mmt -62.79 -39.05 93.03 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.99 0.516 . . . . 61.25 112.267 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.0 -41.82 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.498 1.119 . . . . 63.3 110.631 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -72.69 -25.64 61.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.661 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.9 mtt-85 -65.32 -38.63 90.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.509 -0.552 . . . . 73.04 109.509 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 1.55 62.86 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.908 -0.587 . . . . 73.23 113.191 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.9 p 63.25 39.99 9.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 73.12 111.816 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -112.74 159.26 35.01 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.937 1.295 . . . . 72.3 111.207 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.41 141.46 95.64 Favored 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 123.745 2.964 . . . . 74.2 115.181 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' C' ' 124' ' ' PRO . 0.9 OUTLIER -65.61 160.39 22.66 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 126.322 1.849 . . . . 64.12 113.701 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' B' ' 42' ' ' LEU . 24.3 mt -127.54 102.46 6.87 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.254 -0.885 . . . . 74.01 110.004 163.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -91.05 100.24 13.13 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.542 -1.281 . . . . 74.24 107.542 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.87 136.33 33.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.112 0.565 . . . . 71.55 112.236 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.54 142.26 74.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.708 0.803 . . . . 72.42 110.324 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.417 ' HG2' HG21 ' D' ' 13' ' ' ILE . 29.0 Cg_endo -64.24 100.4 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.156 1.904 . . . . 75.44 111.396 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' F' ' 184' ' ' TRP . 7.5 m -75.5 71.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.024 0.916 . . . . 74.2 109.189 168.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.1 93.2 1.77 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.962 -1.125 . . . . 75.32 107.962 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.4 -21.88 66.78 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.031 -1.44 . . . . 74.12 111.886 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.43 -36.88 65.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.505 0.722 . . . . 74.43 110.642 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.38 -24.81 67.33 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.433 0.693 . . . . 63.22 111.478 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.69 -46.61 86.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.039 0.936 . . . . 64.44 110.353 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.88 -17.82 59.65 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.702 -0.681 . . . . 72.21 111.879 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.82 0.282 . . . . 73.21 111.254 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -86.56 -32.96 20.39 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.876 0.471 . . . . 75.03 111.69 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -89.76 -34.08 16.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.731 0.412 . . . . 74.34 112.11 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -105.95 23.94 13.16 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.031 0.533 . . . . 72.13 110.788 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.31 -43.73 88.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.405 0.282 . . . . 73.12 110.324 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? 56.46 23.91 7.98 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.481 1.112 . . . . 74.01 111.82 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -130.83 130.28 43.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.035 0.934 . . . . 75.34 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' D' ' 5' ' ' ASN . . . -83.29 136.39 34.39 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.428 0.691 . . . . 74.15 109.552 174.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.85 -173.07 49.52 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.261 0.351 . . . . 45.11 112.915 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.2 163.66 39.48 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.679 0.792 . . . . 63.41 109.858 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.29 -54.37 0.25 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.727 -0.669 . . . . 74.43 111.805 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.3 m 48.82 64.23 1.8 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.682 1.193 . . . . 74.45 110.221 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.15 92.95 1.39 Allowed 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.372 -0.831 . . . . 65.3 109.781 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.07 162.38 16.81 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.006 0.922 . . . . 74.05 109.263 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -111.1 163.23 14.09 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.977 0.511 . . . . 75.44 111.117 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -104.99 115.94 31.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.039 0.936 . . . . 72.03 108.948 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -128.39 140.37 51.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.769 0.828 . . . . 72.35 108.975 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.903 0.881 . . . . 75.3 109.09 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.494 ' SD ' ' NZ ' ' H' ' 201' ' ' LYS . 40.1 ttp . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.791 -0.818 . . . . 75.22 108.791 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -71.74 96.84 1.67 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 74.12 109.714 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.86 78.2 3.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.721 -1.214 . . . . 64.3 107.721 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -143.56 49.86 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.243 -1.344 . . . . 74.12 107.508 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -59.76 -21.78 61.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.64 -1.618 . . . . 75.41 112.89 -173.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -164.25 130.19 2.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.077 0.551 . . . . 73.3 110.391 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -136.44 -51.93 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.696 -1.594 . . . . 65.02 106.696 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -167.87 100.37 0.47 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.404 -1.271 . . . . 72.3 107.739 168.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.78 ' HG3' HG22 ' C' ' 89' ' ' ILE . 24.6 ttt 60.62 111.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.547 1.539 . . . . 75.21 111.621 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m -122.25 118.84 29.51 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.148 0.979 . . . . 75.14 109.571 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -117.65 125.16 50.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.504 1.122 . . . . 74.32 108.159 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.675 ' HG3' HD11 ' H' ' 204' ' ' ILE . 53.7 tt0 -137.14 112.16 9.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.054 0.542 . . . . 74.22 109.601 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.448 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -64.47 130.87 30.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-N 115.862 -0.608 . . . . 75.02 109.926 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.574 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -103.75 -51.51 3.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.085 -0.709 . . . . 74.31 109.085 174.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.423 ' NH2' ' HD1' ' H' ' 197' ' ' TYR . 28.4 ttt85 -166.53 155.96 11.28 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.439 0.162 . . . . 71.52 111.439 -174.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.448 HG13 HD11 ' C' ' 13' ' ' ILE . 93.9 mt -138.19 137.48 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.608 1.163 . . . . 74.32 108.128 173.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.505 ' HB3' HG22 ' D' ' 122' ' ' THR . 23.5 p90 -171.84 155.04 3.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.524 0.678 . . . . 74.44 111.786 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -78.72 117.99 20.37 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.67 -1.15 . . . . 74.33 108.461 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 17.4 mtmt -92.61 -38.57 11.81 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.903 -0.777 . . . . 74.4 108.903 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.682 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.9 t70 -133.9 134.89 43.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.683 -1.144 . . . . 74.21 108.729 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -138.82 141.02 37.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.078 -1.453 . . . . 75.24 107.078 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -151.95 150.22 29.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.394 0.616 . . . . 54.44 109.823 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -150.83 113.33 4.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.889 -1.523 . . . . 74.21 106.889 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -115.16 111.15 20.57 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.883 -0.784 . . . . 73.31 108.883 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.02 75.69 53.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.09 0.956 . . . . 72.24 108.711 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.54 -24.35 30.77 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.092 1.862 . . . . 73.25 110.465 168.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -92.23 19.12 7.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.18 0.992 . . . . 75.21 110.731 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.2 94.76 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.908 0.883 . . . . 75.24 113.353 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.63 -25.92 7.52 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 121.46 1.44 . . . . 75.31 112.06 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -69.48 -32.98 72.21 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.088 1.355 . . . . 74.24 111.29 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.428 HG12 ' CE1' ' C' ' 123' ' ' PHE . 12.6 p -72.05 -24.24 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.809 0.844 . . . . 74.42 111.689 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.31 -39.15 93.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.199 0.6 . . . . 75.12 111.139 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -100.74 39.9 1.33 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.752 0.821 . . . . 62.33 109.858 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.649 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -124.72 173.86 8.27 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.36 0.664 . . . . 72.54 110.459 -176.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.27 115.42 25.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.041 -1.096 . . . . 74.24 108.041 167.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.13 68.02 10.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.832 0.853 . . . . 75.11 111.839 -167.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.712 ' HG3' ' HA2' ' E' ' 192' ' ' GLY . 53.8 tt0 -125.73 79.26 68.28 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.251 -1.018 . . . . 73.25 108.251 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.472 ' HB2' HG12 ' C' ' 40' ' ' VAL . 18.8 Cg_endo -89.42 137.57 3.02 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.472 2.115 . . . . 73.11 111.285 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.25 79.8 9.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.37 -1.344 . . . . 72.32 107.37 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.55 ' HB ' HD13 ' C' ' 126' ' ' LEU . 17.2 m -84.21 111.29 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.314 -1.766 . . . . 53.34 110.166 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -136.83 140.27 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.608 0.363 . . . . 74.3 110.104 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.517 HD11 HD12 ' E' ' 186' ' ' LEU . 3.4 pp -88.47 155.36 19.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.964 0.506 . . . . 74.41 109.796 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -144.31 125.27 14.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.689 -0.486 . . . . 51.52 109.689 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.601 ' HB2' ' HE1' ' E' ' 184' ' ' TRP . 7.4 mp -92.11 120.2 32.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.112 0.965 . . . . 73.44 110.229 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.428 ' O ' HD22 ' C' ' 60' ' ' LEU . 30.4 t70 -117.32 146.8 43.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.707 1.203 . . . . 64.34 109.27 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.8 m -112.83 118.25 34.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.393 0.677 . . . . 75.3 110.592 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.87 160.29 29.14 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.88 1.272 . . . . 73.3 108.352 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -161.34 154.13 20.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.835 0.854 . . . . 74.34 110.077 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.1 p -147.75 143.45 27.56 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.592 1.157 . . . . 63.43 109.379 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -85.28 136.4 33.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.351 0.66 . . . . 75.02 110.351 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.507 HD13 HD13 ' C' ' 83' ' ' ILE . 85.8 mt -107.24 -39.66 5.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.871 0.868 . . . . 74.54 109.731 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.58 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -160.1 -178.54 7.06 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.587 -1.188 . . . . 73.01 109.752 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -73.33 119.99 18.33 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.678 -1.146 . . . . 73.02 108.462 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' E' ' 172' ' ' ALA . 14.7 m-20 66.22 19.66 11.08 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.81 1.244 . . . . 75.43 111.256 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 48.4 t -135.14 105.79 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 107.314 -1.365 . . . . 73.34 107.314 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.476 ' CE2' ' SD ' ' E' ' 174' ' ' MET . 93.1 m-85 -123.09 166.57 14.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.456 0.703 . . . . 74.44 110.78 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.86 110.71 13.98 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.261 -1.336 . . . . 72.21 108.537 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.449 HG12 ' HD3' ' C' ' 103' ' ' PRO . 59.9 t -96.08 136.1 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.435 -1.32 . . . . 72.5 107.435 174.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.8 t -128.41 107.01 15.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.096 0.959 . . . . 74.35 108.92 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.479 HD13 ' O ' ' C' ' 103' ' ' PRO . 0.4 OUTLIER -87.35 108.09 18.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.951 -1.129 . . . . 72.31 107.951 176.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -89.64 104.94 17.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.121 -0.696 . . . . 75.02 109.121 173.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.25 -1.019 . . . . 72.11 108.25 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -103.39 121.91 43.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.161 0.584 . . . . 72.43 109.503 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.59 HG23 HG23 ' C' ' 114' ' ' ILE . 88.5 t -102.34 136.44 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.762 1.225 . . . . 72.43 109.984 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 54.8 m -122.79 140.42 52.93 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.819 0.848 . . . . 74.25 109.044 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 117.87 17.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.036 -1.098 . . . . 71.32 108.036 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -135.0 131.78 37.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.481 0.658 . . . . 75.15 110.76 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.649 HD12 ' HG2' ' C' ' 34' ' ' LYS . 14.3 mt -89.61 41.97 1.07 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.423 1.889 . . . . 71.01 109.479 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.26 -109.11 3.29 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.529 -1.028 . . . . 75.43 110.529 -169.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -91.83 -31.4 15.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.622 0.769 . . . . 75.44 110.584 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -75.53 119.43 19.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.683 1.193 . . . . 72.52 109.074 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -75.79 124.96 28.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.772 -0.455 . . . . 71.11 109.772 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.6 -51.99 13.01 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.078 -0.712 . . . . 74.14 109.078 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -166.69 174.87 8.32 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 115.174 -0.921 . . . . 73.44 110.351 173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.465 HD11 ' N ' ' C' ' 76' ' ' CYS . 1.6 tm? -133.14 146.79 51.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.329 -1.73 . . . . 74.15 106.329 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.551 ' SG ' HG21 ' C' ' 114' ' ' ILE . 44.7 t -145.53 146.4 31.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.447 -0.946 . . . . 63.13 108.447 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.28 130.32 6.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.072 0.396 . . . . 72.24 110.698 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.87 134.55 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.232 1.013 . . . . 64.41 109.236 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.682 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.6 mt-30 -107.18 97.73 7.46 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.648 1.179 . . . . 70.52 108.361 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.417 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.8 tp-100 -82.71 101.24 10.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.526 -0.761 . . . . 74.44 109.027 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.02 145.38 20.67 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.948 -0.861 . . . . 64.13 110.948 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.26 122.65 1.54 Allowed Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.508 -1.037 . . . . 72.42 110.508 -177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 7.7 mm -84.02 128.15 39.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.246 -1.02 . . . . 75.14 108.246 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -134.69 120.92 20.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.653 0.781 . . . . 73.11 109.412 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -78.85 116.74 19.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.631 -1.248 . . . . 73.4 107.631 168.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.595 HG12 HD11 ' C' ' 89' ' ' ILE . 1.5 tt -133.58 114.46 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 C-N-CA 123.937 0.895 . . . . 74.5 109.743 -170.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.23 41.88 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.582 0.753 . . . . 62.51 110.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.7 -19.02 35.28 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 114.217 0.447 . . . . 72.25 114.217 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.78 HG22 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -63.39 130.85 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 125.053 1.341 . . . . 70.51 111.283 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.602 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 44.9 mt-10 -147.29 147.2 30.13 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.809 0.443 . . . . 75.41 110.719 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.63 -136.99 18.2 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.828 -0.624 . . . . 64.31 112.825 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.453 ' HB ' ' HZ ' ' C' ' 137' ' ' PHE . 37.5 p -66.28 -19.51 65.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.67 0.788 . . . . 75.12 111.357 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -64.19 -49.5 71.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.609 0.764 . . . . 61.21 110.604 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.602 ' HE3' ' HA ' ' C' ' 90' ' ' GLU . 15.3 ptp -71.38 -32.8 68.9 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.776 0.262 . . . . 74.33 110.652 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.9 94.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.933 0.893 . . . . 74.12 111.705 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -83.4 -30.92 26.98 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.046 -0.525 . . . . 71.52 111.031 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.16 -58.16 8.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.424 0.289 . . . . 63.45 110.575 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -82.31 -38.39 24.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.784 0.434 . . . . 75.14 110.517 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.74 10.23 75.07 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.001 -0.888 . . . . 73.54 115.029 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.92 -49.03 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.365 1.083 . . . . 74.02 112.452 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -76.14 -49.26 17.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.314 0.646 . . . . 73.44 111.079 -171.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 99.4 m -59.35 -48.03 96.87 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.218 -0.896 . . . . 72.0 111.639 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.479 ' O ' HD13 ' C' ' 60' ' ' LEU . 39.5 Cg_endo -66.75 -27.29 44.68 Favored 'Trans proline' 0 C--N 1.399 3.234 0 C-N-CA 121.487 1.458 . . . . 74.4 112.781 172.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.91 -35.58 81.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.224 0.465 . . . . 71.43 110.974 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.483 HD13 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -65.01 -36.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.507 0.723 . . . . 74.44 110.092 174.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.47 -19.68 30.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.165 0.986 . . . . 74.4 112.455 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.9 -53.0 70.32 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.256 -1.354 . . . . 64.23 112.68 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.85 -33.85 97.52 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 121.94 1.76 . . . . 74.34 112.273 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.416 ' HE2' HG22 ' A' ' 115' ' ' THR . 89.6 m-85 -67.81 -50.48 56.6 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.005 0.922 . . . . 73.33 111.187 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -62.3 -41.4 98.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 64.35 110.392 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -57.76 -48.13 80.51 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.988 1.715 . . . . 73.1 110.902 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.435 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -74.89 -33.06 61.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.249 0.62 . . . . 73.21 110.581 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.1 t -63.85 -33.78 76.46 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.322 0.649 . . . . 74.34 110.824 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.59 HG23 HG23 ' C' ' 64' ' ' VAL . 96.8 mt -75.98 -46.35 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.096 -0.957 . . . . 73.33 110.507 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -55.92 -35.99 67.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.524 0.73 . . . . 62.33 110.851 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 44.6 t -60.62 -57.56 12.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.26 -1.336 . . . . 75.23 109.89 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.598 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.62 -39.39 70.76 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.907 1.283 . . . . 72.51 113.538 -177.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.33 -44.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.09 0.956 . . . . 75.44 110.439 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.3 t -63.03 -34.99 78.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.272 -0.876 . . . . 73.01 111.086 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.548 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 67.0 mtt-85 -64.83 -45.13 87.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.07 -0.968 . . . . 74.21 109.925 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.47 69.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.402 -0.817 . . . . 71.51 113.447 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 65.91 34.46 7.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.867 1.667 . . . . 65.44 113.23 170.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.505 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 87.1 m-85 -97.9 169.98 7.75 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 124.417 1.087 . . . . 62.13 109.802 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 72.1 Cg_endo -70.71 175.32 9.05 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.6 2.2 . . . . 73.42 112.803 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -60.23 130.64 47.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.859 0.464 . . . . 63.3 112.121 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.55 HD13 ' HB ' ' C' ' 40' ' ' VAL . 1.5 mm? -122.81 18.48 10.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.42 1.088 . . . . 74.4 110.857 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -90.44 81.15 6.0 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.001 -1.481 . . . . 63.25 107.001 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.71 101.71 14.11 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.196 -1.366 . . . . 71.2 111.088 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.553 ' HB2' HD12 ' E' ' 187' ' ' ILE . . . 54.03 175.63 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 115.399 1.629 . . . . 74.22 115.399 162.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -91.58 -172.33 0.44 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.449 2.099 . . . . 75.54 113.334 165.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.48 122.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.765 0.826 . . . . 74.42 109.81 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -114.9 102.78 10.29 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.937 0.895 . . . . 72.14 109.276 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -82.49 -21.02 35.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.819 0.448 . . . . 74.42 111.77 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.88 -29.84 68.59 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.795 0.838 . . . . 74.41 111.768 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.53 97.37 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.728 0.811 . . . . 71.53 110.926 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 68.8 mt -80.01 -28.05 39.45 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.906 0.882 . . . . 71.32 111.495 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.453 ' HZ ' ' HB ' ' C' ' 92' ' ' THR . 84.1 t80 -71.3 -45.68 62.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.13 0.572 . . . . 71.42 110.175 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.518 ' HA ' ' HG3' ' C' ' 142' ' ' GLN . 0.0 OUTLIER -68.86 -28.38 66.66 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.518 0.512 . . . . 73.21 110.664 178.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.18 -46.05 88.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.523 1.129 . . . . 73.35 109.848 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -71.73 -85.59 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.761 0.824 . . . . 73.21 110.907 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 55.8 tp -148.31 130.67 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.055 0.942 . . . . 73.34 108.809 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.518 ' HG3' ' HA ' ' C' ' 138' ' ' MET . 9.3 mp0 -101.99 -77.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 74.43 109.449 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 144' ' ' GLN . 21.0 mm-40 -145.17 108.41 4.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.683 1.193 . . . . 65.32 107.92 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.54 101.9 13.62 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.672 -1.233 . . . . 75.54 107.672 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.06 -68.91 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.742 0.417 . . . . 75.53 110.403 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.97 174.71 25.21 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 116.664 -0.244 . . . . 65.31 113.497 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.54 ' HB2' ' HB1' ' A' ' 145' ' ' ALA . 2.9 tm-20 -152.36 156.91 40.5 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.69 -1.226 . . . . 74.12 107.69 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.44 -54.53 0.28 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.195 -0.762 . . . . 75.14 111.195 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -74.9 86.99 2.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.544 0.738 . . . . 74.42 109.876 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.06 92.21 3.35 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.011 -1.107 . . . . 74.43 108.011 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.14 104.59 13.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.454 -0.943 . . . . 61.21 108.454 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -90.11 63.76 5.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.742 0.782 . . . . 75.15 110.136 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -95.97 92.6 6.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.506 -0.77 . . . . 74.13 109.077 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -136.1 140.81 44.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.217 1.007 . . . . 74.44 108.477 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 N-CA-C 109.326 -0.62 . . . . 73.21 109.326 177.111 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.442 ' SD ' ' N ' ' D' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 111.743 0.275 . . . . 71.22 111.743 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m -131.15 88.08 2.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.192 0.597 . . . . 71.23 109.482 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.22 8.54 3.92 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.581 0.752 . . . . 74.11 112.308 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -60.7 2.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.038 1.335 . . . . 72.31 109.622 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.527 ' HB3' ' HB2' ' D' ' 8' ' ' GLU . 89.7 m-20 -91.74 75.75 5.71 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.665 -0.865 . . . . 74.03 108.665 171.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -75.01 -17.59 60.5 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.084 -0.962 . . . . 70.54 111.203 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -108.56 26.37 10.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.264 1.025 . . . . 72.04 110.726 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' D' ' 5' ' ' ASN . 10.3 tp10 -70.75 -94.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.393 0.677 . . . . 74.51 110.787 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.459 ' HG3' HG13 ' D' ' 89' ' ' ILE . 20.2 ttp -37.97 134.48 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.42 1.088 . . . . 74.13 112.947 171.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.4 m -130.46 138.17 50.16 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.783 -0.451 . . . . 63.52 109.783 172.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' D' ' 85' ' ' SER . 73.5 t80 -156.73 93.06 1.34 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.968 1.307 . . . . 71.45 107.651 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.82 146.75 45.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.811 -0.631 . . . . 75.3 110.149 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.417 HG21 ' HG2' ' B' ' 130' ' ' PRO . 2.2 mp -83.12 125.83 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 72.12 108.688 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.0 -46.42 4.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.059 0.544 . . . . 75.11 111.403 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.443 ' NH1' ' HE2' ' E' ' 202' ' ' TYR . 7.9 tpt180 -166.45 122.44 1.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.919 -0.562 . . . . 73.52 110.938 -169.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.27 124.1 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.627 -1.249 . . . . 74.22 107.627 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -158.98 152.77 23.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 73.12 111.895 -168.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -86.49 117.8 25.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.162 -0.926 . . . . 72.11 109.087 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -88.67 -23.28 23.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.759 -0.655 . . . . 73.23 110.183 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.5 t70 -158.53 133.92 8.69 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.258 -0.883 . . . . 72.11 109.416 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.598 HG23 ' HE1' ' C' ' 117' ' ' MET . 76.7 mt -137.61 143.68 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.347 1.059 . . . . 71.42 108.386 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -142.12 143.96 33.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.958 1.303 . . . . 74.53 108.023 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.57 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.9 t80 -151.49 110.82 3.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.511 -2.033 . . . . 74.4 105.511 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -128.12 108.22 10.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.164 -0.68 . . . . 73.31 109.164 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.46 91.15 4.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 106.896 -1.52 . . . . 73.43 106.896 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 -24.96 11.95 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.426 2.084 . . . . 60.41 112.24 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -112.7 36.03 3.62 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 124.186 0.994 . . . . 72.23 108.419 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.443 ' HB2' ' HD2' ' C' ' 19' ' ' LYS . . . -59.96 -50.18 87.69 Favored Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.974 1.472 . . . . 61.53 114.974 -166.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.528 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.8 Cg_endo -83.98 -4.84 10.52 Favored 'Trans proline' 0 C--N 1.392 2.854 0 CA-C-N 121.803 1.68 . . . . 75.14 113.076 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -83.52 -37.04 23.58 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.288 1.035 . . . . 72.35 109.231 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.709 HG13 ' HA ' ' D' ' 73' ' ' ALA . 33.1 m -83.63 -4.24 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.864 0.865 . . . . 72.04 111.534 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.94 -25.73 67.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.671 0.788 . . . . 73.53 109.965 165.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -83.19 0.07 47.03 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.135 0.974 . . . . 71.32 111.447 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -116.94 86.23 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.536 1.134 . . . . 72.23 109.641 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.81 51.53 2.17 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.805 0.812 . . . . 75.13 110.186 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -130.15 -175.95 3.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.934 0.894 . . . . 74.11 109.222 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.463 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 33.9 tp60 -79.68 116.88 64.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 122.968 0.507 . . . . 70.22 110.293 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 13.9 Cg_exo -67.52 87.92 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.999 1.799 . . . . 74.23 109.375 169.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.88 120.66 14.53 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.539 -0.755 . . . . 63.33 110.548 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.626 HG11 HG13 ' D' ' 64' ' ' VAL . 84.8 t -95.83 117.65 40.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 114.991 -1.004 . . . . 75.14 110.291 -167.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.514 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.3 mmtt -89.58 115.2 26.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.712 -1.218 . . . . 74.31 107.712 171.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.51 124.53 37.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.218 -1.03 . . . . 73.14 108.218 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.466 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.8 t70 -116.59 125.39 51.76 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.388 -0.967 . . . . 64.11 108.388 174.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.61 132.3 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.749 0.82 . . . . 75.32 109.744 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.0 t70 -143.04 118.31 10.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.252 -1.388 . . . . 65.14 107.252 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -120.02 145.02 47.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.046 0.538 . . . . 63.1 110.27 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.29 43.94 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.17 0.988 . . . . 72.11 109.087 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -147.65 156.06 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.778 0.831 . . . . 65.23 109.521 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 63.4 p -151.77 127.27 10.04 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.329 0.651 . . . . 60.25 109.985 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -69.49 119.58 13.96 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.666 -0.494 . . . . 72.25 109.666 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' D' ' 57' ' ' GLU . 52.7 mt -92.35 -34.02 14.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.009 0.523 . . . . 75.33 110.348 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.84 -171.68 3.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.152 0.981 . . . . 75.22 109.856 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.12 109.59 1.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.036 0.534 . . . . 62.23 109.837 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.637 ' HA ' HD21 ' H' ' 173' ' ' LEU . 2.5 m-20 64.85 11.16 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.067 1.347 . . . . 73.12 113.193 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.89 133.27 58.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.386 . . . . 74.11 107.259 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.66 174.35 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.322 0.582 . . . . 71.14 109.822 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.484 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.8 tt0 -124.86 147.83 48.57 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 124.251 1.02 . . . . 74.11 108.511 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -120.15 125.57 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.521 -1.289 . . . . 73.15 107.521 167.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 82.4 t -103.54 126.81 57.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.019 0.928 . . . . 64.35 108.691 174.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.2 122.08 46.79 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.712 -1.218 . . . . 74.43 107.712 178.288 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.8 ttm-85 -109.47 99.97 9.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.298 -1.001 . . . . 73.23 108.298 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.08 126.68 44.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.19 -1.411 . . . . 75.35 107.19 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.0 m -120.44 127.22 52.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.585 0.707 . . . . 63.21 110.351 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.626 HG13 HG11 ' D' ' 40' ' ' VAL . 17.3 t -112.43 107.29 22.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 126.151 1.78 . . . . 75.2 109.144 -175.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 22.6 m -107.6 93.07 4.34 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.7 -1.222 . . . . 61.21 107.7 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.5 137.59 34.34 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.151 -0.685 . . . . 71.32 109.151 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.462 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 43.4 m -137.68 134.4 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 74.43 111.48 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.412 HD12 ' HB ' ' D' ' 31' ' ' VAL . 21.7 mt -108.08 107.05 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.004 1.322 . . . . 75.21 110.397 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.55 -112.29 3.67 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.936 -0.466 . . . . 74.12 111.936 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.86 6.3 17.87 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.089 0.955 . . . . 74.12 111.002 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -124.17 168.32 13.07 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.659 0.784 . . . . 74.22 110.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -81.31 126.6 31.77 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.312 0.645 . . . . 74.32 110.283 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.709 ' HA ' HG13 ' D' ' 31' ' ' VAL . . . -78.05 -67.17 0.76 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.783 0.833 . . . . 53.31 109.243 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.08 153.68 32.31 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 115.169 -0.923 . . . . 74.41 110.117 173.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.5 mt -109.66 152.75 25.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.623 -1.251 . . . . 72.41 107.623 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 42.0 t -158.9 146.73 17.86 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.528 0.731 . . . . 71.25 109.095 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -156.1 128.95 7.9 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.302 -0.629 . . . . 75.41 109.302 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.78 115.58 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.03 0.532 . . . . 72.3 109.708 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.54 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.9 mt-30 -90.36 89.1 7.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.571 0.749 . . . . 74.24 109.817 170.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -81.31 100.39 9.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.684 -1.144 . . . . 75.04 108.838 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -95.6 144.62 17.35 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.491 -0.644 . . . . 63.32 111.491 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.82 130.52 3.93 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.317 -0.713 . . . . 62.31 111.317 -178.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.6 mt -89.73 124.86 42.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 124.249 1.02 . . . . 72.43 109.011 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.91 168.77 16.76 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.047 1.339 . . . . 73.44 108.973 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.6 m -114.07 137.0 52.31 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.765 0.826 . . . . 75.15 109.637 171.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.601 ' HB ' ' HE1' ' H' ' 174' ' ' MET . 1.8 pp -129.44 125.44 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.296 0.638 . . . . 74.32 109.939 172.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' H' ' 171' ' ' SER . . . -162.32 164.64 27.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.343 0.657 . . . . 73.43 110.602 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.04 -20.63 19.63 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 123.837 0.71 . . . . 73.42 114.788 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.459 HG13 ' HG3' ' D' ' 9' ' ' MET . 2.1 pp -133.49 163.3 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.993 0.917 . . . . 65.33 110.555 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -143.95 -176.12 4.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.08 0.952 . . . . 72.11 110.414 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.33 -133.54 20.05 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.347 -0.842 . . . . 74.2 113.565 171.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.1 m -59.3 -39.7 83.87 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.463 1.105 . . . . 73.23 111.812 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -58.62 -45.29 89.51 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.038 0.935 . . . . 73.11 111.604 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 3.4 ppp? -81.64 -39.26 24.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.547 0.339 . . . . 62.31 111.513 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.471 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.5 -40.3 92.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 73.52 111.272 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -78.96 -26.37 43.48 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.288 -0.869 . . . . 73.13 110.735 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.3 t -68.73 -52.5 30.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.437 0.295 . . . . 75.44 110.861 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' D' ' 94' ' ' MET . 1.7 pp -76.82 -18.34 58.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.096 0.406 . . . . 70.3 112.096 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.16 0.03 68.49 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.241 -0.755 . . . . 52.04 113.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' D' ' 133' ' ' PHE . . . -151.53 -61.56 0.17 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.081 0.94 . . . . 74.32 112.421 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -67.05 -48.88 66.95 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.533 0.733 . . . . 75.52 112.631 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 23.4 m -66.05 -42.7 53.19 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.384 0.674 . . . . 73.22 112.264 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.417 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 49.4 Cg_exo -59.15 -35.62 97.39 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.168 1.912 . . . . 72.15 112.762 166.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.85 -28.69 69.17 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.126 0.571 . . . . 73.02 111.356 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -65.97 -40.96 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.231 0.612 . . . . 75.53 110.011 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.57 -23.01 56.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.021 -0.99 . . . . 75.32 111.762 -174.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -64.14 -40.9 57.5 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 117.495 -1.241 . . . . 74.33 113.904 -171.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.46 -41.9 42.85 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.224 1.949 . . . . 74.34 113.719 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -78.09 -38.69 43.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.749 0.82 . . . . 73.14 111.422 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.04 95.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.152 0.581 . . . . 74.2 109.913 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -57.14 -56.82 16.81 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 124.875 1.27 . . . . 72.54 109.732 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.11 -39.62 90.67 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.325 1.016 . . . . 70.53 111.837 -172.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -45.36 88.35 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.743 0.652 . . . . 74.01 110.408 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.503 HG12 ' SG ' ' D' ' 76' ' ' CYS . 84.2 mt -64.51 -53.66 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.124 0.97 . . . . 74.44 110.155 174.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.0 m -52.4 -41.18 62.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.99 1.716 . . . . 74.4 111.546 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -69.7 -44.9 69.46 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.685 -1.143 . . . . 61.21 110.105 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.72 -30.21 70.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.963 0.505 . . . . 72.15 112.007 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.5 t -65.57 -47.37 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.805 0.842 . . . . 73.53 109.75 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -72.18 -29.08 63.66 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.047 -0.524 . . . . 72.55 110.744 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -70.18 -30.91 68.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.651 0.78 . . . . 75.35 110.166 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 10.46 63.99 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 115.788 -0.642 . . . . 65.41 112.797 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.505 HG22 ' HB3' ' C' ' 17' ' ' TYR . 40.7 p 64.01 18.53 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.663 1.985 . . . . 74.11 113.841 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.442 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 88.0 m-85 -88.28 164.71 31.93 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.036 0.934 . . . . 74.25 108.875 171.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.42 140.89 71.89 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.707 2.271 . . . . 73.32 111.012 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.5 118.18 7.2 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 109.521 -0.548 . . . . 74.43 109.521 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.3 101.76 11.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.377 0.671 . . . . 64.23 109.689 -171.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -98.8 96.12 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.508 -0.923 . . . . 63.25 108.508 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 129.63 40.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.939 0.896 . . . . 74.23 110.758 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -57.44 132.07 81.57 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.717 0.807 . . . . 75.23 111.121 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.44 114.25 3.87 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 121.962 1.775 . . . . 73.34 110.656 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.8 t -106.03 107.09 21.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.033 -1.099 . . . . 72.45 108.033 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -80.74 106.03 12.43 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.722 -1.214 . . . . 74.53 107.722 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.529 ' HB2' ' HB2' ' D' ' 100' ' ' ALA . 51.4 m-85 -66.06 -38.02 87.27 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.038 -0.983 . . . . 73.33 110.546 -175.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.98 -42.34 94.64 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.105 -0.952 . . . . 64.44 110.667 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.55 -53.08 62.37 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.066 0.854 . . . . 74.22 111.045 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.575 HD21 HG11 ' G' ' 207' ' ' VAL . 77.3 mt -63.66 -33.28 75.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.402 0.681 . . . . 73.45 112.257 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -62.78 -47.67 82.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.65 0.78 . . . . 75.44 110.477 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 71.9 mtm -73.37 -44.22 59.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.589 -0.732 . . . . 62.41 111.299 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -64.75 -43.11 94.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.539 0.736 . . . . 63.34 111.154 -175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -65.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.72 0.638 . . . . 74.23 110.913 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.07 -36.47 82.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.955 0.902 . . . . 74.44 109.725 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -79.16 5.44 12.07 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.95 0.9 . . . . 74.51 111.86 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.52 92.09 3.71 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.279 1.032 . . . . 75.04 108.834 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -141.27 14.99 2.22 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.671 0.788 . . . . 73.42 109.655 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.37 131.63 2.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.964 0.905 . . . . 74.4 109.364 174.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.1 124.02 7.71 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.921 -0.872 . . . . 74.45 110.921 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.31 148.15 40.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.398 0.679 . . . . 74.5 110.481 -174.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.19 39.9 0.1 Allowed Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.901 -0.59 . . . . 70.42 111.925 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 19.5 m -80.81 87.17 5.9 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.603 0.761 . . . . 73.2 110.534 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -163.3 164.22 24.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.07 0.948 . . . . 75.23 108.765 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 66.36 144.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.049 1.34 . . . . 73.34 111.908 -171.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -139.29 163.17 33.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.071 0.949 . . . . 75.41 109.351 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -135.29 114.87 12.67 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.392 1.077 . . . . 74.42 109.153 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.42 102.74 6.1 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.251 0.62 . . . . 65.1 109.624 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 123.831 0.853 . . . . 62.22 110.867 -177.749 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 109.635 -0.506 . . . . 75.22 109.635 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.81 142.88 4.64 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.475 0.484 . . . . 63.13 112.019 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -72.0 121.38 19.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.296 0.638 . . . . 75.23 110.795 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 51.6 m -84.51 144.73 28.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.906 -0.775 . . . . 62.35 108.906 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . 0.562 ' HB1' ' SD ' ' E' ' 174' ' ' MET . . . -69.55 154.13 42.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.929 0.492 . . . . 73.31 111.475 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.621 HD22 ' HE1' ' E' ' 174' ' ' MET . 0.0 OUTLIER -114.93 7.13 15.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.806 0.842 . . . . 72.13 112.75 -169.541 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.621 ' HE1' HD22 ' E' ' 173' ' ' LEU . 1.0 OUTLIER -122.33 -165.92 1.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.377 0.671 . . . . 64.41 109.335 -176.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 19.9 t80 72.37 34.02 1.39 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.752 1.221 . . . . 72.22 110.966 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -62.67 -47.59 83.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.052 -1.092 . . . . 72.3 108.052 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 1.6 tt 52.32 70.58 0.55 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.46 1.504 . . . . 72.34 110.821 171.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -93.13 73.74 4.66 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.258 -1.015 . . . . 75.23 108.258 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 67.29 170.17 0.11 Allowed Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.65 1.18 . . . . 71.44 111.621 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.63 79.57 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.272 1.981 . . . . 75.32 110.564 165.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -70.67 -25.3 62.92 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.23 -0.896 . . . . 72.43 111.581 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.04 118.4 36.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.136 -0.69 . . . . 75.11 109.136 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 49.9 p -131.48 146.17 52.11 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.479 1.112 . . . . 74.1 110.627 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.601 ' HE1' ' HB2' ' C' ' 44' ' ' LEU . 2.8 p90 -101.16 143.51 26.74 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.944 1.298 . . . . 74.22 109.144 175.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.57 -41.27 26.16 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.795 2.33 . . . . 74.24 111.831 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.517 HD12 HD11 ' C' ' 42' ' ' LEU . 2.6 tm? 70.54 138.91 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.365 1.466 . . . . 74.42 110.308 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' C' ' 129' ' ' ALA . 45.0 pt -55.76 142.23 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 124.116 0.966 . . . . 74.44 112.498 -174.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.76 91.84 4.17 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.86 -1.163 . . . . 74.21 107.86 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.28 128.63 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.896 0.478 . . . . 72.25 110.65 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . 0.608 ' HB2' HD21 ' F' ' 199' ' ' ASN . 25.4 t70 -53.17 -45.51 68.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 72.21 112.443 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.38 -170.23 54.88 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.925 -0.579 . . . . 74.51 112.124 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . 0.712 ' HA2' ' HG3' ' C' ' 37' ' ' GLN . . . 130.98 -161.45 23.49 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 117.314 0.557 . . . . 74.51 113.048 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -82.84 162.42 21.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.921 0.889 . . . . 73.23 111.265 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . 0.453 ' HB2' ' HZ1' ' F' ' 201' ' ' LYS . . . -164.33 10.02 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.789 0.835 . . . . 75.14 111.432 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . 0.401 ' HE2' ' HD3' ' C' ' 124' ' ' PRO . 57.9 m-85 -136.96 134.26 36.5 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.751 0.821 . . . . 74.32 109.928 -177.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -119.64 82.13 1.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.209 -1.404 . . . . 74.12 107.209 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . 0.517 ' HA ' ' HB3' ' E' ' 201' ' ' LYS . 59.1 m-85 -74.46 1.88 10.83 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.317 0.647 . . . . 75.5 112.716 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -108.86 -7.03 15.55 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.47 0.708 . . . . 64.34 110.683 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -134.98 -76.3 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 63.14 110.804 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -85.68 24.23 7.85 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 114.333 0.493 . . . . 74.23 114.333 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.517 ' HB3' ' HA ' ' E' ' 197' ' ' TYR . 63.3 pttt -66.42 -179.65 0.85 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.822 1.249 . . . . 74.04 112.426 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . 0.443 ' HE2' ' NH1' ' D' ' 15' ' ' ARG . 44.5 m-85 -74.69 77.79 2.04 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.77 -1.196 . . . . 73.24 107.77 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.51 95.42 2.25 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.829 -0.434 . . . . 75.42 109.829 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 14.0 tt -131.15 137.67 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.274 1.029 . . . . 73.21 109.114 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 3.32 1.56 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.856 1.262 . . . . 72.51 109.724 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.99 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.701 1.2 . . . . 74.01 109.261 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.484 1.241 0 C-N-CA 124.835 1.254 . . . . 74.3 109.441 -172.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.292 -0.262 . . . . 73.21 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.19 -62.49 3.19 Favored Glycine 0 C--N 1.345 1.067 0 O-C-N 123.74 0.65 . . . . 65.11 113.354 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -91.75 98.63 11.73 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.653 0.781 . . . . 70.41 111.683 -171.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 1.4 m 60.19 -85.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.625 1.57 . . . . 75.0 112.227 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.02 96.76 0.62 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.133 -1.062 . . . . 63.45 108.133 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.468 HD22 ' HE2' ' B' ' 56' ' ' TYR . 58.2 mt -117.48 96.22 5.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.563 0.697 . . . . 73.11 111.108 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.564 ' HB2' ' SD ' ' B' ' 94' ' ' MET . 2.8 mpp? -99.09 178.6 4.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.749 1.22 . . . . 73.42 108.45 173.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -172.95 89.87 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.528 -0.545 . . . . 71.24 109.528 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.04 84.97 2.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.756 0.822 . . . . 75.22 109.936 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 32.4 tp -88.64 59.52 5.16 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.621 -1.252 . . . . 75.03 107.621 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -102.82 -73.79 0.65 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.88 -1.055 . . . . 74.35 110.146 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -94.99 109.18 42.86 Favored Pre-proline 0 C--O 1.243 0.731 0 C-N-CA 123.573 0.749 . . . . 72.24 110.564 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.54 94.43 0.94 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.172 1.914 . . . . 62.44 110.244 170.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -62.28 104.26 0.47 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.56 -0.745 . . . . 73.11 109.226 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 69.01 163.45 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.704 1.601 . . . . 74.42 110.546 -166.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 30.6 p -140.18 151.43 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.789 -0.57 . . . . 73.24 111.001 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.416 ' HB2' ' HB ' ' B' ' 131' ' ' VAL . 38.3 p90 -71.0 152.37 94.94 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.044 1.338 . . . . 74.41 110.864 176.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.52 160.29 41.73 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.738 2.292 . . . . 74.11 112.488 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.6 147.42 25.97 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.627 -0.879 . . . . 74.03 108.627 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.94 154.57 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 108.674 -0.862 . . . . 73.54 108.674 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -82.25 -179.23 7.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.21 0.604 . . . . 64.34 110.819 172.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.32 19.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.395 0.678 . . . . 70.11 109.818 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -92.82 -82.5 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.525 0.73 . . . . 73.21 111.189 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.96 -105.75 0.6 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 111.631 -0.588 . . . . 50.42 111.631 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -144.56 -145.94 4.41 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.795 -0.522 . . . . 63.21 111.795 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -97.9 -84.19 0.39 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 117.039 0.419 . . . . 75.43 109.979 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -134.67 -22.64 1.66 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.724 0.81 . . . . 45.3 110.503 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 63.98 -84.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.294 1.438 . . . . 73.3 110.339 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . 0.652 ' HA ' ' HB3' ' B' ' 35' ' ' ASP . 31.2 ttpt 56.43 20.03 4.49 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.889 1.275 . . . . 75.01 111.379 -171.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 58.8 t80 68.07 -58.33 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.026 1.731 . . . . 74.35 111.553 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.94 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.406 1.482 . . . . 73.21 111.746 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . 0.662 HD22 ' HD2' ' F' ' 205' ' ' LYS . 23.6 m120 -57.34 94.9 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 CA-C-O 122.122 0.963 . . . . 72.32 112.358 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -164.7 32.39 0.25 Allowed Glycine 0 C--O 1.244 0.778 0 CA-C-N 113.638 -1.619 . . . . 75.22 109.615 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . 0.453 ' HZ1' ' HB2' ' E' ' 194' ' ' ALA . 82.7 tttt 75.33 143.34 0.08 Allowed 'General case' 0 C--N 1.363 1.191 0 C-N-CA 126.605 1.962 . . . . 74.32 111.847 -174.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 63.94 37.96 9.08 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.568 1.547 . . . . 74.2 109.575 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.7 -176.68 3.67 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.57 -1.65 . . . . 73.12 111.999 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.413 HD11 ' HB1' ' C' ' 129' ' ' ALA . 2.9 tp -132.1 -44.51 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.282 -1.326 . . . . 74.33 109.158 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . 0.662 ' HD2' HD22 ' F' ' 199' ' ' ASN . 21.2 ptmt 46.57 -74.0 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 126.414 1.886 . . . . 74.2 113.0 -167.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.91 152.22 5.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.384 1.074 . . . . 74.54 108.839 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.564 1.485 0 C-N-CA 124.531 1.133 . . . . 74.15 111.635 -179.54 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . 0.605 ' HD3' ' H3 ' ' G' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 121.407 0.623 . . . . 72.23 109.559 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.27 -149.64 19.32 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.428 -0.669 . . . . 73.54 111.428 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.63 113.64 24.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.88 -0.785 . . . . 74.05 108.88 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 66.5 p -65.5 142.12 58.24 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.846 0.859 . . . . 74.31 110.972 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' A' ' 90' ' ' GLU . . . -139.47 -101.58 0.16 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 117.88 -1.057 . . . . 64.24 110.836 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 77.1 mt 66.3 -67.09 0.16 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.822 1.249 . . . . 74.2 113.241 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 36.2 mmt -93.16 40.68 1.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.33 1.052 . . . . 74.41 112.375 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.51 ' H ' ' HE3' ' A' ' 94' ' ' MET . 53.5 t80 60.59 94.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.243 1.417 . . . . 71.33 110.707 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . 0.505 ' OD1' ' HG2' ' G' ' 178' ' ' GLN . 24.4 t-20 -108.65 -77.93 0.59 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.846 0.858 . . . . 74.14 109.702 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.59 65.76 1.42 Allowed 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.194 0.998 . . . . 75.42 110.805 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . 0.505 ' HG2' ' OD1' ' G' ' 176' ' ' ASN . 25.6 mm-40 -56.42 -40.97 75.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.323 0.649 . . . . 72.42 111.518 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.22 143.83 29.05 Favored Pre-proline 0 C--O 1.245 0.821 0 C-N-CA 124.532 1.133 . . . . 73.45 108.738 -173.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.78 90.36 1.06 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.473 2.115 . . . . 74.01 111.404 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.98 -49.7 73.67 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.513 0.725 . . . . 75.25 110.358 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -96.07 90.09 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.742 -1.117 . . . . 75.51 109.979 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 33.6 p -88.14 80.13 7.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.103 -0.953 . . . . 74.54 108.786 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -102.27 135.66 19.57 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 116.021 -0.536 . . . . 75.42 111.003 -174.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.02 166.9 18.52 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.674 2.25 . . . . 75.15 112.894 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.86 163.59 14.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.951 -1.022 . . . . 74.4 110.413 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.9 pp -73.64 169.77 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.799 -1.092 . . . . 73.11 111.241 173.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -131.7 176.15 8.58 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.602 0.761 . . . . 74.14 109.454 171.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -113.91 104.74 12.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.225 0.61 . . . . 72.23 109.952 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' H' ' 201' ' ' LYS . 25.5 t70 -85.55 -58.31 2.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.559 0.744 . . . . 72.53 110.306 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.62 97.18 1.92 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.324 -0.398 . . . . 75.01 112.381 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.11 36.05 0.17 Allowed Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.733 0.267 . . . . 70.31 113.361 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.03 88.2 2.09 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.169 0.988 . . . . 75.31 109.192 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -165.58 -26.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.284 0.846 . . . . 75.23 113.284 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -80.39 53.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 75.45 109.222 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.552 ' HZ3' ' HB3' ' G' ' 196' ' ' LYS . 7.0 mtpm? -83.99 30.2 0.52 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.29 -0.881 . . . . 75.12 111.562 -170.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 60.01 176.14 0.09 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 125.466 1.507 . . . . 65.4 111.928 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -160.62 -63.73 0.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.603 -0.888 . . . . 74.34 108.603 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.16 -56.96 3.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.279 -0.873 . . . . 74.2 111.994 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.18 -67.88 0.52 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.163 -0.775 . . . . 71.4 111.163 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 32' ' ' PHE . 25.0 pttm -146.88 176.99 9.47 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.619 0.723 . . . . 74.24 111.924 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.11 100.9 6.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.468 -1.242 . . . . 74.43 109.312 170.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.26 95.87 6.44 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.954 0.501 . . . . 55.54 110.718 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.94 -18.07 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 N-CA-C 108.149 -1.056 . . . . 73.24 108.149 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt 74.38 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.218 1.807 . . . . 74.02 111.137 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -141.55 170.09 16.38 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.881 0.872 . . . . 74.45 110.318 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . 0.575 HG11 HD21 ' D' ' 136' ' ' LEU . 50.0 t . . . . . 0 CA--C 1.557 1.223 0 C-N-CA 124.308 1.043 . . . . 74.4 108.813 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 20.6 tptm . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 108.919 -0.771 . . . . 72.53 108.919 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.02 65.07 3.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.154 0.407 . . . . 70.52 112.697 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -169.93 102.18 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.648 1.579 . . . . 75.53 108.356 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 171' ' ' SER . . . . . 0.526 ' HB2' ' HB2' ' D' ' 87' ' ' ALA . 56.7 m -151.74 -59.47 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.43 0.692 . . . . 62.22 111.242 -173.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.01 76.99 1.55 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.286 -0.635 . . . . 72.21 109.286 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' D' ' 54' ' ' ASP . 2.8 tm? -78.56 129.88 35.32 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.493 -0.928 . . . . 75.34 108.493 176.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.601 ' HE1' ' HB ' ' D' ' 86' ' ' ILE . 0.0 OUTLIER -151.88 29.08 0.6 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 109.739 -168.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.18 102.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.423 1.089 . . . . 74.31 111.305 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . 0.411 ' H ' ' HE2' ' D' ' 94' ' ' MET . 9.6 t30 -144.76 96.54 2.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.333 1.053 . . . . 65.52 109.348 -176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 43.9 tp -112.56 93.96 4.69 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.853 -1.165 . . . . 75.52 107.853 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -81.1 -69.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.416 -0.811 . . . . 73.35 109.525 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.9 147.36 23.97 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.853 1.261 . . . . 75.15 108.814 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.09 113.87 3.2 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.764 2.31 . . . . 72.25 110.666 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -70.43 130.84 42.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.17 0.588 . . . . 72.43 111.358 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 65.6 -176.02 0.18 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.237 1.415 . . . . 63.25 111.04 -174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 85.7 m -129.63 125.97 37.33 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.36 0.664 . . . . 72.33 109.638 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -98.62 123.63 49.23 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.694 0.798 . . . . 74.12 109.566 -177.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . 0.568 ' HD2' HD11 ' D' ' 136' ' ' LEU . 46.4 Cg_exo -58.09 126.02 20.32 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.424 2.749 . . . . 71.43 114.031 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 72.2 mt -85.54 137.61 32.76 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.045 0.938 . . . . 72.05 109.212 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 pt -72.91 148.02 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.446 0.698 . . . . 74.22 111.233 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.66 156.41 17.09 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.682 0.793 . . . . 74.4 109.882 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.33 127.1 31.72 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.776 0.831 . . . . 61.33 109.81 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.76 127.62 32.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.468 0.707 . . . . 75.1 109.439 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.9 95.2 0.19 Allowed Glycine 0 C--N 1.348 1.212 0 O-C-N 123.846 0.716 . . . . 61.04 111.452 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.16 15.39 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 124.073 0.514 . . . . 73.12 114.335 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 63.53 8.96 3.89 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.933 1.293 . . . . 75.52 112.464 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.91 81.57 2.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.576 -1.268 . . . . 73.43 107.576 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -130.88 -92.42 0.42 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.36 0.664 . . . . 74.22 109.461 -177.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 43.37 77.49 0.06 Allowed 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.23 1.012 . . . . 72.42 110.01 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . 0.423 ' HD1' ' NH2' ' C' ' 15' ' ' ARG . 69.9 m-85 -45.18 96.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.388 1.075 . . . . 75.51 113.416 -166.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.23 175.7 2.55 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.894 1.278 . . . . 73.53 110.299 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . 0.485 HD22 ' ND2' ' A' ' 127' ' ' ASN . 32.3 t30 70.34 96.44 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.254 1.022 . . . . 73.15 109.746 -176.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.72 169.49 15.54 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 110.171 -1.172 . . . . 73.31 110.171 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . 0.494 ' NZ ' ' SD ' ' C' ' 1' ' ' MET . 44.1 tttp 61.91 36.24 15.93 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.591 0.756 . . . . 73.15 111.101 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.28 165.84 24.29 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.246 0.618 . . . . 74.35 111.568 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.99 102.49 10.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.152 0.981 . . . . 74.0 109.511 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.675 HD11 ' HG3' ' C' ' 12' ' ' GLN . 4.2 mp -123.25 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.921 -0.77 . . . . 74.43 108.921 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . 0.476 ' HG3' ' H ' ' H' ' 206' ' ' ASP . 5.0 ptmt -62.64 -75.91 0.07 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.648 0.779 . . . . 74.11 110.162 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . 0.476 ' H ' ' HG3' ' H' ' 205' ' ' LYS . 1.6 m-20 -155.21 -73.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 106.319 -1.734 . . . . 75.41 106.319 -174.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . 0.45 ' H ' ' HE2' ' H' ' 205' ' ' LYS . 4.3 m . . . . . 0 CA--C 1.568 1.637 0 C-N-CA 125.019 1.328 . . . . 74.42 108.503 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 mmt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 112.036 0.384 . . . . 73.22 112.036 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -161.28 72.68 0.43 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 122.931 0.492 . . . . 53.04 110.954 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -169.1 -79.52 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.233 1.013 . . . . 72.12 109.197 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -161.02 -162.58 0.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.676 0.791 . . . . 73.04 109.29 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.727 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 14.5 t-20 82.37 -57.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 126.467 1.907 . . . . 74.33 109.932 -172.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 67.33 170.63 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.225 1.41 . . . . 73.34 111.578 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -84.87 -59.3 2.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.818 0.847 . . . . 72.43 109.418 171.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -81.5 -69.17 0.63 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.208 1.003 . . . . 62.41 110.52 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 ppp? 179.93 152.52 0.46 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.296 1.038 . . . . 72.11 109.826 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.3 m -144.63 139.82 28.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.985 0.914 . . . . 62.14 108.638 171.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.463 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.2 t80 -109.2 149.99 28.58 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.748 -0.834 . . . . 74.54 108.748 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.558 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 51.0 tp60 -148.68 114.77 5.79 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.289 -0.263 . . . . 75.25 110.289 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.419 HD11 HG13 ' A' ' 16' ' ' ILE . 2.3 tp -72.1 90.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.907 -1.516 . . . . 75.34 106.907 164.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -82.98 -22.69 33.61 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.698 -1.137 . . . . 75.1 110.611 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -176.88 145.23 0.49 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.07 0.395 . . . . 72.44 111.297 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.575 HD13 ' HG3' ' C' ' 130' ' ' PRO . 95.3 mt -106.12 139.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.606 -1.627 . . . . 73.22 106.606 162.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.545 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.0 p90 -169.03 135.9 1.8 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.951 0.9 . . . . 63.52 109.712 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.492 HG23 ' HB3' ' B' ' 120' ' ' ARG . 46.7 p -77.71 118.02 19.67 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.141 -0.482 . . . . 63.24 109.799 174.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -84.15 -27.05 28.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.764 -0.653 . . . . 75.21 110.114 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -151.8 138.0 18.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.026 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.9 mt -132.69 139.23 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.981 -1.489 . . . . 75.3 106.981 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -152.34 110.53 3.7 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.076 0.465 . . . . 75.53 110.501 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.624 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 72.6 t80 -109.71 120.49 42.64 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 106.397 -1.705 . . . . 73.44 106.397 169.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -119.14 130.71 55.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.36 -0.978 . . . . 75.41 108.36 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.65 19.49 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.529 -1.286 . . . . 72.14 107.529 172.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.31 -15.94 28.12 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.648 2.232 . . . . 74.03 112.129 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -113.44 28.49 8.74 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 124.188 0.995 . . . . 73.34 109.544 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -45.68 99.67 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 113.962 1.097 . . . . 73.31 113.962 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.79 -32.75 8.85 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 121.538 1.492 . . . . 71.53 112.333 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -74.27 -20.36 60.17 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.75 1.22 . . . . 75.41 111.678 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 p -75.32 -20.53 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.366 0.666 . . . . 75.02 112.097 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.65 -29.85 65.08 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.019 -0.537 . . . . 75.45 110.224 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -71.14 -28.83 64.57 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.148 0.979 . . . . 74.12 110.72 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -72.98 142.65 47.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 73.23 111.484 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -73.08 115.31 12.25 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.489 -1.301 . . . . 71.42 107.489 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.585 ' CD1' ' HA ' ' G' ' 196' ' ' LYS . 63.8 t-105 -84.43 96.48 9.1 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.431 0.634 . . . . 74.55 110.867 -170.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -137.25 80.0 35.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 106.515 -1.661 . . . . 62.24 106.515 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.31 148.54 16.63 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.393 2.062 . . . . 73.3 112.544 -170.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.438 ' HA ' ' HA2' ' G' ' 192' ' ' GLY . 42.5 tt0 -98.37 92.82 5.87 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.25 -1.389 . . . . 75.31 107.25 171.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' G' ' 190' ' ' ASP . 7.1 p -65.32 124.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.062 -0.972 . . . . 72.55 109.207 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -124.06 117.62 25.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.778 0.831 . . . . 74.43 109.321 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.4 tp -97.21 129.38 44.56 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.753 -0.832 . . . . 72.23 108.753 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.748 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.7 m-20 -115.19 134.35 55.23 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.273 1.029 . . . . 73.1 108.567 172.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -113.3 125.23 54.06 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.755 0.822 . . . . 74.01 109.246 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.27 145.52 37.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.334 0.653 . . . . 64.23 109.596 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.3 m -135.63 133.11 37.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 75.14 109.313 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 117.04 17.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.213 1.005 . . . . 74.5 109.439 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.3 p -118.47 153.27 34.42 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.46 0.704 . . . . 75.2 111.964 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -168.02 153.1 6.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.786 1.234 . . . . 73.53 109.523 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.4 138.6 32.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.887 -0.412 . . . . 74.42 109.887 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 55' ' ' VAL . 98.1 mt -107.5 -39.56 5.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.851 0.86 . . . . 75.41 111.134 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -157.95 -170.7 3.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.268 0.627 . . . . 64.3 110.305 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 26.1 t70 -66.96 113.18 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.248 1.019 . . . . 75.43 110.444 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 66.87 -4.29 0.81 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.488 1.515 . . . . 72.01 113.571 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.431 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 72.6 t -97.59 117.45 42.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.087 0.955 . . . . 71.34 108.439 -172.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -119.66 168.76 10.73 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.117 0.967 . . . . 74.32 109.367 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -130.67 130.84 44.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.541 -1.209 . . . . 70.43 108.459 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 111.94 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.477 -1.675 . . . . 72.02 106.477 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.2 t -98.35 131.57 45.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.898 -0.778 . . . . 65.22 108.898 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -101.28 108.57 20.25 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.073 -1.454 . . . . 74.03 107.073 177.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.02 101.47 12.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.356 -0.979 . . . . 75.41 108.356 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.517 HG21 ' HB1' ' A' ' 110' ' ' ALA . 9.9 t -98.62 145.06 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.677 -1.147 . . . . 71.15 108.286 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.748 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 42.5 m -133.11 137.52 46.34 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.735 -0.469 . . . . 72.4 109.735 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.12 107.74 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.675 1.19 . . . . 75.23 107.998 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 24.6 m -103.13 138.48 39.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.777 -0.823 . . . . 71.44 108.777 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.09 102.81 9.32 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.603 -1.629 . . . . 63.31 106.603 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.542 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 52.5 m -108.45 124.0 49.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.339 0.59 . . . . 74.14 109.677 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.554 HD13 ' HB1' ' A' ' 73' ' ' ALA . 14.7 mt -90.02 80.46 6.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.105 -1.443 . . . . 75.42 107.105 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -89.27 0.84 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.177 -0.919 . . . . 63.2 111.442 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -114.8 -26.39 7.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.451 0.7 . . . . 73.31 110.759 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -99.58 124.48 44.82 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.976 -0.379 . . . . 65.0 109.976 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 74.6 m -76.4 137.7 39.91 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.406 0.682 . . . . 73.31 111.437 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.554 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -78.87 -62.56 1.66 Allowed 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.815 1.246 . . . . 71.33 109.615 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -144.04 151.68 39.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.442 -1.254 . . . . 74.15 109.61 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.8 tp -126.09 115.56 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.038 1.335 . . . . 72.51 108.409 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.1 m -103.99 139.33 39.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.792 0.837 . . . . 75.12 108.94 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HG3' ' HG1' ' A' ' 63' ' ' THR . 23.5 tt0 -145.1 133.21 21.47 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.887 -1.524 . . . . 74.13 106.887 167.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.454 HG11 ' SG ' ' A' ' 113' ' ' CYS . 76.8 t -135.71 120.92 28.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.781 -0.822 . . . . 73.43 108.781 178.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.34 79.5 5.0 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.745 -1.205 . . . . 65.42 107.745 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.435 ' O ' HD12 ' A' ' 106' ' ' LEU . 7.0 tp-100 -76.65 93.93 3.7 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 106.917 -1.512 . . . . 73.42 106.917 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.07 160.07 19.39 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.746 -0.264 . . . . 72.51 113.0 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.59 138.86 6.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 112.197 -0.361 . . . . 73.51 112.197 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.545 HG13 ' HE1' ' A' ' 17' ' ' TYR . 74.8 mt -81.76 125.47 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.892 -1.151 . . . . 73.42 107.892 169.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.463 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 57.3 m-85 -131.26 117.84 19.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.897 -1.149 . . . . 63.4 107.897 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.558 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 18.9 m -81.37 114.34 20.07 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.171 -1.048 . . . . 71.13 108.171 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.7 140.12 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.403 0.681 . . . . 74.31 110.971 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.727 ' HB3' ' HA ' ' A' ' 5' ' ' ASN . . . -178.75 168.53 1.69 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.679 1.592 . . . . 71.03 108.924 172.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.08 -27.51 7.02 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-N 116.161 -0.472 . . . . 74.23 112.889 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.54 179.85 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.907 1.283 . . . . 72.11 110.114 -170.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.63 174.12 15.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.012 0.525 . . . . 74.34 110.068 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.91 -128.12 28.55 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.819 -0.628 . . . . 75.32 113.753 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 p -67.5 -29.82 69.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.263 1.025 . . . . 75.32 111.516 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.65 -36.64 70.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.608 0.568 . . . . 62.43 110.934 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.602 ' SD ' ' HG2' ' G' ' 174' ' ' MET . 23.2 ttt -74.1 -37.31 64.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.003 -0.369 . . . . 74.03 110.003 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.21 68.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.007 0.523 . . . . 53.21 111.016 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -74.92 -52.19 11.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.667 0.787 . . . . 74.45 110.282 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.1 t -65.21 -62.19 1.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.957 0.785 . . . . 65.11 110.553 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -65.66 -38.77 90.27 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.971 0.908 . . . . 63.13 111.957 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.78 -28.52 38.14 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 115.238 0.855 . . . . 74.24 115.238 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 -40.61 0.6 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.165 0.983 . . . . 72.54 112.423 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 56.1 t80 -74.89 -39.44 61.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.582 0.753 . . . . 71.14 112.296 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -79.58 -39.8 1.37 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 123.235 0.614 . . . . 74.42 111.752 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.511 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 53.1 Cg_exo -54.91 -30.15 67.36 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.372 2.048 . . . . 75.34 112.98 164.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.81 -24.26 66.15 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.755 0.822 . . . . 75.21 111.553 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 mm -67.55 -42.5 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.913 0.864 . . . . 73.3 109.757 172.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.435 HD12 ' O ' ' A' ' 80' ' ' GLN . 44.3 mt -86.99 -15.98 37.13 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.272 -1.331 . . . . 74.52 112.25 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.36 -41.31 17.15 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-O 118.054 -0.974 . . . . 74.33 113.418 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.78 -35.28 80.02 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.81 1.673 . . . . 74.34 112.007 171.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.472 ' CE1' ' HD3' ' C' ' 111' ' ' ARG . 41.6 m-85 -77.0 -29.68 55.57 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.641 0.776 . . . . 72.51 112.213 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.517 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -72.36 -47.02 52.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.786 -0.82 . . . . 74.11 108.786 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.419 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.0 ttm180 -49.51 -50.13 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.048 1.467 . . . . 73.43 110.561 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.66 -40.47 73.0 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.36 1.038 . . . . 73.14 111.596 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.577 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.5 t -62.83 -41.83 99.49 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.483 0.489 . . . . 73.31 110.598 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -65.97 -51.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.259 -0.882 . . . . 74.43 109.658 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.1 m -55.36 -39.75 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.077 0.951 . . . . 75.34 111.259 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.1 t -66.73 -45.22 79.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 123.776 0.673 . . . . 73.15 110.342 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.624 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 34.1 mtm -63.13 -40.32 97.24 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.73 0.412 . . . . 70.21 111.146 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.7 t -61.1 -50.29 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.499 1.12 . . . . 74.45 110.149 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 94.8 p -70.98 -25.92 62.91 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.796 -0.638 . . . . 71.24 111.633 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 116' ' ' SER . 37.7 ttm-85 -79.04 -28.9 43.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.35 1.06 . . . . 75.53 109.461 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.21 9.77 56.38 Favored Glycine 0 C--N 1.356 1.672 0 CA-C-N 115.196 -0.911 . . . . 73.21 112.825 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.417 HG21 ' NH2' ' B' ' 15' ' ' ARG . 31.1 m 69.22 33.65 3.22 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 123.476 1.607 . . . . 73.14 111.122 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 119' ' ' SER . 75.7 m-85 -101.89 158.2 32.23 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 113.994 -1.457 . . . . 74.33 107.135 161.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.84 -174.1 0.56 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.974 1.783 . . . . 75.15 112.004 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -76.01 141.59 42.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.893 0.477 . . . . 75.43 112.135 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.08 94.13 3.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.455 -1.313 . . . . 63.34 107.455 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.11 110.86 22.63 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.331 0.652 . . . . 74.21 110.242 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.4 mt -74.15 145.37 44.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.378 -0.828 . . . . 75.14 110.949 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' G' ' 187' ' ' ILE . . . -67.12 146.39 98.98 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.096 0.559 . . . . 75.41 111.396 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.48 141.0 45.12 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.284 1.989 . . . . 73.15 111.721 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.23 108.74 22.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 108.457 -0.942 . . . . 74.02 108.457 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -109.18 74.75 0.92 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 72.31 109.06 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.667 -0.697 . . . . 74.42 110.641 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.83 -33.53 75.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.011 0.434 . . . . 65.41 109.952 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.82 31.5 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 115.265 -0.88 . . . . 71.32 110.673 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.4 tt -49.71 -45.56 49.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.991 0.916 . . . . 72.53 111.721 -177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.441 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.3 t80 -57.17 -55.25 37.2 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.447 1.092 . . . . 72.22 111.137 -176.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -70.72 -37.38 73.5 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.562 0.539 . . . . 74.11 111.156 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -65.57 -33.92 77.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.377 0.671 . . . . 74.53 110.278 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.59 -42.76 98.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.62 0.768 . . . . 71.31 110.49 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 81.6 mt -62.26 -52.06 65.23 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.787 0.679 . . . . 74.1 110.875 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 178.61 -5.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.909 0.756 . . . . 73.35 112.725 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.13 102.51 0.38 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.437 0.637 . . . . 72.34 110.14 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.784 ' HA ' ' HG2' ' C' ' 8' ' ' GLU . 0.6 OUTLIER -147.92 -43.41 0.16 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.236 1.415 . . . . 74.25 109.079 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.83 77.8 10.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.46 -0.791 . . . . 54.35 111.402 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.96 43.91 3.19 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.496 -1.042 . . . . 52.21 110.496 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.22 86.56 3.66 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.332 1.053 . . . . 75.13 110.523 -170.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.03 -39.21 4.93 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.704 -1.358 . . . . 71.32 109.704 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 65.6 m 71.47 107.08 0.06 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.765 1.626 . . . . 70.11 111.159 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 77.85 59.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.911 1.285 . . . . 72.35 111.102 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.74 108.44 19.69 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.808 -1.087 . . . . 74.45 109.316 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -169.11 167.03 10.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.84 0.856 . . . . 63.41 109.357 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.98 107.07 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.603 1.161 . . . . 75.04 109.516 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' E' ' 177' ' ' LEU . 9.0 m-20 -80.81 -62.77 1.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.499 0.72 . . . . 55.41 109.992 -175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 124.035 0.934 . . . . 61.34 109.249 179.151 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 109.77 -0.455 . . . . 75.4 109.77 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -142.99 26.86 1.66 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.803 0.841 . . . . 65.41 110.312 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 131.62 50.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.587 0.755 . . . . 73.33 111.031 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -161.26 92.11 0.89 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.946 0.898 . . . . 75.21 108.843 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -79.31 -6.43 56.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.615 0.766 . . . . 74.04 110.796 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -60.29 135.82 57.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.676 1.19 . . . . 73.24 110.222 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -153.26 162.14 41.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.998 0.519 . . . . 75.33 110.811 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 68.22 -74.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.737 1.615 . . . . 54.15 111.668 -173.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.522 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 9.2 ptm 54.79 171.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.849 2.06 . . . . 71.34 113.659 -171.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -167.04 143.5 4.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 115.107 -0.951 . . . . 73.4 109.201 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -148.75 125.21 10.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.407 -1.331 . . . . 75.34 107.407 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -144.96 140.76 28.45 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.312 -0.625 . . . . 71.52 109.312 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.525 HD12 HG13 ' B' ' 16' ' ' ILE . 10.8 tt -90.75 144.07 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.521 0.728 . . . . 72.42 109.459 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.66 -44.59 3.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.959 0.504 . . . . 74.4 109.772 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.417 ' NH2' HG21 ' A' ' 122' ' ' THR . 19.7 ttt180 -169.6 146.22 3.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.3 0.24 . . . . 74.51 110.76 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.525 HG13 HD12 ' B' ' 13' ' ' ILE . 94.2 mt -120.42 144.49 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.378 -1.342 . . . . 73.45 107.378 173.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -169.37 158.98 8.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.69 0.677 . . . . 75.01 112.176 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.8 m -83.54 127.67 33.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.191 -0.913 . . . . 64.52 108.835 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -96.37 -36.62 10.79 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.666 0.786 . . . . 74.44 110.885 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -161.74 145.3 12.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.352 -0.385 . . . . 73.21 110.375 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.412 HD13 ' SG ' ' B' ' 113' ' ' CYS . 37.3 mm -137.2 138.93 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.682 1.193 . . . . 74.01 109.8 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 74.0 m -134.81 125.52 27.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.144 1.378 . . . . 75.45 108.492 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.487 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -142.78 108.2 5.04 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.54 -1.282 . . . . 75.11 107.54 167.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -119.2 122.99 43.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 45.2 108.462 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.11 89.43 14.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.991 0.917 . . . . 70.12 109.278 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.3 -32.04 73.11 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.194 2.596 . . . . 72.21 113.136 -172.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -117.96 32.09 6.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.911 0.884 . . . . 72.13 110.122 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.424 ' HB1' ' CE2' ' A' ' 17' ' ' TYR . . . -45.91 -54.76 15.16 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 125.646 1.578 . . . . 53.4 113.829 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.77 -24.36 34.63 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 122.511 2.141 . . . . 74.32 112.881 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -89.19 1.79 55.15 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.777 -1.101 . . . . 64.33 111.786 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.31 -23.88 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.927 0.491 . . . . 71.03 110.462 170.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -63.62 -38.85 92.69 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.543 0.737 . . . . 74.53 110.416 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -82.88 -41.75 18.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.927 0.891 . . . . 74.32 110.296 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -85.38 70.66 10.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.686 1.194 . . . . 75.21 109.032 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.53 74.58 9.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.263 1.03 . . . . 61.13 110.798 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -167.08 154.07 8.7 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.235 -1.394 . . . . 75.3 107.235 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.706 ' HB3' ' HB2' ' F' ' 194' ' ' ALA . 0.0 OUTLIER -64.07 127.74 92.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.049 0.54 . . . . 74.45 110.226 175.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.69 151.79 81.72 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.257 1.972 . . . . 72.53 112.164 167.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 2.8 pt-20 -61.01 102.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.035 -0.984 . . . . 70.21 109.303 169.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.0 t -88.46 116.51 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.896 -1.15 . . . . 72.11 107.896 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -138.96 138.27 37.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.308 0.643 . . . . 75.34 109.275 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.56 HD23 HG13 ' F' ' 187' ' ' ILE . 0.8 OUTLIER -118.71 147.35 43.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 74.15 110.14 -168.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.26 149.5 52.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.214 1.406 . . . . 75.4 108.054 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.67 135.41 51.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.437 -0.579 . . . . 75.42 109.437 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -136.57 154.19 50.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.158 1.383 . . . . 75.24 108.363 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -132.03 139.94 48.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.986 0.514 . . . . 65.25 110.508 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.7 160.8 37.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 74.24 108.551 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -142.32 162.85 34.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.082 0.553 . . . . 72.25 110.588 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -153.35 168.2 26.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.821 1.248 . . . . 74.25 108.526 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -123.3 130.73 53.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.262 0.625 . . . . 64.23 111.134 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.54 HD12 HG22 ' B' ' 83' ' ' ILE . 65.7 mt -97.81 -49.86 4.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.469 0.708 . . . . 70.33 110.183 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.51 -170.89 3.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.501 -0.772 . . . . 71.02 110.387 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -65.71 116.19 6.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.702 -1.136 . . . . 73.33 109.704 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.721 ' H ' HD23 ' F' ' 173' ' ' LEU . 1.9 m-20 72.62 2.78 4.48 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.817 1.647 . . . . 65.04 111.605 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 95.51 3.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 124.291 1.036 . . . . 73.11 108.33 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.462 ' HB2' HD12 ' B' ' 86' ' ' ILE . 0.1 OUTLIER -94.58 139.02 31.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.842 177.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.458 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.2 tm-20 -103.65 95.99 6.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 106.622 -1.622 . . . . 64.43 106.622 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.29 123.1 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.267 -0.642 . . . . 72.42 109.267 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.6 t -102.31 123.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.568 0.747 . . . . 73.44 109.482 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -93.13 126.67 38.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.259 -1.386 . . . . 72.44 107.259 173.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.401 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 29.3 ttt180 -119.41 104.36 10.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.19 -0.67 . . . . 74.11 109.19 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.5 120.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.571 -0.9 . . . . 73.4 108.571 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -109.39 150.5 27.97 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.065 -0.717 . . . . 63.02 109.065 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.613 HG21 HG23 ' B' ' 114' ' ' ILE . 90.3 t -139.32 122.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.865 0.866 . . . . 75.13 109.279 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 79.8 m -113.76 138.78 49.78 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.638 0.775 . . . . 75.01 109.27 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.3 147.03 28.85 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.887 -1.052 . . . . 70.1 109.071 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 9.2 m -143.77 135.27 26.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.497 0.554 . . . . 64.23 112.497 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.433 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 50.0 mt -88.47 101.39 13.87 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.69 -1.596 . . . . 64.5 106.69 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -111.25 3.22 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.053 -0.819 . . . . 52.3 111.053 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.85 4.88 12.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.319 1.048 . . . . 75.22 110.734 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.75 139.07 50.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.578 1.151 . . . . 75.54 108.098 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -61.98 133.49 55.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.11 0.564 . . . . 71.53 112.141 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.433 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -86.95 -61.19 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.5 1.12 . . . . 74.01 109.176 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.02 167.1 28.7 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.456 -1.702 . . . . 72.24 109.618 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.69 118.86 11.35 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.661 1.585 . . . . 72.53 106.726 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -119.4 153.42 35.23 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.436 -0.579 . . . . 74.25 109.436 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.23 134.85 7.6 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.161 -1.052 . . . . 60.42 108.161 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.431 HG22 HG13 ' B' ' 114' ' ' ILE . 69.6 t -123.39 143.02 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 123.604 0.762 . . . . 74.33 109.738 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.401 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.4 mt-30 -118.15 90.93 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.653 -0.869 . . . . 74.02 108.653 171.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -89.88 100.8 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.339 -0.985 . . . . 72.24 108.339 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.68 163.69 29.85 Favored Glycine 0 C--O 1.242 0.643 0 N-CA-C 111.75 -0.54 . . . . 71.22 111.75 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.97 130.8 2.84 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.597 -0.601 . . . . 51.1 111.597 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.54 HG22 HD12 ' B' ' 51' ' ' LEU . 42.7 mt -86.39 116.31 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.725 0.81 . . . . 74.11 109.195 176.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -133.87 134.59 42.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.212 1.005 . . . . 73.2 109.183 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 41.8 m -95.34 110.86 22.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.768 0.827 . . . . 61.4 110.028 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.462 HD12 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -118.69 138.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.146 0.978 . . . . 71.24 110.606 -177.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.98 167.64 27.47 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.598 0.759 . . . . 64.23 109.744 167.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.25 -41.65 3.01 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 123.549 0.53 . . . . 51.21 113.045 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.42 156.14 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.308 1.043 . . . . 74.52 110.872 169.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.06 154.98 7.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.146 0.578 . . . . 72.1 109.732 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.505 ' HA2' HD21 ' F' ' 176' ' ' ASN . . . 64.75 -113.33 5.77 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.25 0.452 . . . . 75.42 113.444 170.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 -36.94 74.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.599 0.76 . . . . 70.42 110.643 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.48 -46.39 86.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.782 0.433 . . . . 72.31 110.731 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ttt -68.47 -40.87 80.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.017 -0.538 . . . . 71.41 110.326 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.65 70.34 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.324 0.649 . . . . 73.21 111.434 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -74.11 -36.33 64.2 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.585 0.754 . . . . 74.05 109.513 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.06 -68.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.791 -0.64 . . . . 62.43 110.446 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.76 -20.32 61.9 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.138 0.421 . . . . 72.42 112.138 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.46 -6.7 52.78 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.144 -0.809 . . . . 73.41 114.528 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.62 -42.54 0.14 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.255 1.028 . . . . 50.53 112.716 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -79.9 -53.04 7.13 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.932 0.333 . . . . 74.12 111.538 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.69 -45.56 99.82 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.648 0.779 . . . . 63.53 110.991 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -50.14 -46.93 26.03 Favored 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.512 2.142 . . . . 74.5 113.582 164.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.4 -35.6 70.24 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.624 0.769 . . . . 74.42 112.098 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.444 HG22 ' NH2' ' D' ' 111' ' ' ARG . 82.6 mt -65.13 -49.11 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.637 0.775 . . . . 71.13 110.332 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.44 ' HB2' HD12 ' B' ' 60' ' ' LEU . 50.8 mt -78.92 -12.65 60.04 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.684 -1.144 . . . . 74.55 111.966 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -67.77 -46.11 44.59 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.06 1.344 . . . . 71.12 113.451 -166.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.47 -33.67 78.34 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.554 1.503 . . . . 75.43 112.203 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -65.8 -45.2 83.23 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.088 0.555 . . . . 71.01 110.531 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.79 77.79 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.318 0.647 . . . . 72.24 110.912 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -57.57 -53.41 58.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.04 0.936 . . . . 73.22 110.275 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.434 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.7 tm-20 -68.0 -29.79 68.89 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.046 0.842 . . . . 75.31 110.387 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 117' ' ' MET . 33.7 t -68.22 -45.63 72.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.158 0.583 . . . . 64.12 111.182 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.613 HG23 HG21 ' B' ' 64' ' ' VAL . 95.0 mt -63.11 -44.25 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 71.05 109.847 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.575 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . 32.6 m -66.34 -23.29 66.33 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.829 -1.078 . . . . 74.43 111.534 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.2 t -75.59 -40.87 55.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 75.1 110.627 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.4 mmt -79.29 -38.46 35.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.849 0.685 . . . . 74.3 112.849 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.786 ' HB ' ' HG3' ' B' ' 125' ' ' GLN . 95.5 t -75.62 -27.14 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.326 0.65 . . . . 62.42 110.77 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.9 p -66.72 -37.67 85.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.027 0.441 . . . . 63.33 110.248 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.577 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 60.5 mtt-85 -63.57 -40.3 96.62 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.147 -0.933 . . . . 74.24 110.508 175.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.94 80.93 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.716 0.635 . . . . 64.0 113.199 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p 62.38 33.45 16.32 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.548 1.939 . . . . 72.02 112.874 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.37 -177.17 0.58 Allowed Pre-proline 0 CA--C 1.568 1.635 0 CA-C-N 114.284 -1.325 . . . . 71.33 109.024 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.562 ' HB2' HG21 ' B' ' 40' ' ' VAL . 3.9 Cg_exo -81.87 116.72 2.86 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.853 2.369 . . . . 74.13 112.964 169.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.786 ' HG3' ' HB ' ' B' ' 118' ' ' VAL . 0.5 OUTLIER -72.02 164.01 26.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.908 0.883 . . . . 73.04 111.324 164.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.426 ' HB3' HD22 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -137.26 127.16 25.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.205 -1.035 . . . . 70.33 108.205 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -91.71 102.81 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.816 -1.179 . . . . 73.31 107.816 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.737 HD12 HD22 ' F' ' 186' ' ' LEU . 0.3 OUTLIER -66.08 139.34 58.17 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 110.361 -0.237 . . . . 70.41 110.361 -170.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.66 148.23 98.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.768 0.827 . . . . 70.2 111.118 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.405 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 93.4 Cg_endo -74.33 97.07 1.0 Allowed 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.22 1.946 . . . . 75.31 111.239 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.91 110.95 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.263 -0.643 . . . . 71.54 109.263 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -72.68 97.07 2.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.23 0.612 . . . . 74.01 109.452 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -70.82 -13.46 62.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.636 0.774 . . . . 75.32 112.17 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -76.31 -66.13 0.84 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.882 0.873 . . . . 75.41 111.287 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.65 -11.43 59.87 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.146 0.579 . . . . 61.3 111.673 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' F' ' 184' ' ' TRP . 10.5 tt -48.15 -55.27 10.74 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.74 1.216 . . . . 74.43 110.718 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.21 -41.61 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.889 0.876 . . . . 73.41 110.667 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -36.18 82.63 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.486 0.714 . . . . 71.54 110.651 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -73.79 -32.47 63.78 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.991 0.517 . . . . 72.33 110.522 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -67.34 -32.87 74.12 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.978 0.511 . . . . 73.21 110.837 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.83 5.39 28.93 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.689 0.796 . . . . 73.03 111.402 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -118.76 -179.23 3.74 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.29 1.036 . . . . 74.32 110.109 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.01 99.96 3.56 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.152 -1.055 . . . . 65.22 108.152 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.42 115.39 17.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.018 0.927 . . . . 74.31 110.306 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.12 156.62 22.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.465 1.106 . . . . 72.02 109.449 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.16 -33.13 0.08 OUTLIER Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.595 -0.558 . . . . 51.42 114.011 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 72.7 160.01 0.22 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.025 1.33 . . . . 74.42 111.384 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.9 -177.87 41.11 Favored Glycine 0 N--CA 1.473 1.13 0 CA-C-N 115.999 -0.546 . . . . 73.23 112.206 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.9 m 60.9 82.78 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.446 1.098 . . . . 75.23 110.815 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.15 -45.55 5.87 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.275 1.03 . . . . 74.23 110.581 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.76 93.04 0.03 OUTLIER 'General case' 0 C--N 1.358 0.955 0 O-C-N 124.3 1.0 . . . . 74.02 111.533 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -83.01 90.54 7.03 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.617 -1.623 . . . . 73.11 106.617 167.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -68.32 119.78 13.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.403 -0.591 . . . . 74.34 109.403 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.04 154.87 41.34 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.566 -0.743 . . . . 63.12 109.898 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.604 0.761 . . . . 74.25 109.07 -179.643 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.524 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 108.929 -0.767 . . . . 75.45 108.929 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 41.4 m -85.9 -64.42 1.16 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.629 0.372 . . . . 64.54 110.767 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 57.82 -80.72 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.209 1.403 . . . . 73.21 111.623 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -160.69 -81.38 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.012 -0.736 . . . . 74.12 109.012 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -173.04 93.04 0.1 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.531 -0.915 . . . . 74.03 108.531 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -71.15 -25.1 62.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.615 0.766 . . . . 75.42 112.039 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -90.95 -146.92 0.2 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.874 1.27 . . . . 73.1 109.833 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.784 ' HG2' ' HA ' ' A' ' 144' ' ' GLN . 15.8 tp10 -150.54 152.42 34.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.913 0.779 . . . . 75.55 110.691 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.56 111.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.772 1.629 . . . . 75.45 109.529 -173.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 75.2 m -107.85 97.22 6.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.012 -0.54 . . . . 75.31 109.596 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.533 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 48.4 t80 -92.84 119.76 32.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.676 -1.231 . . . . 72.41 107.676 169.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -137.1 117.95 14.15 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 109.255 -0.646 . . . . 73.5 109.255 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 tp -70.53 131.44 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 109.437 -0.579 . . . . 72.41 109.437 173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.507 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.9 mm-40 -96.15 -48.69 5.55 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.37 -0.832 . . . . 75.4 108.989 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.452 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 61.9 ttt180 -176.37 133.95 0.24 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.387 -0.824 . . . . 72.4 109.787 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -108.64 150.32 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.767 -1.197 . . . . 75.32 107.767 170.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.586 ' HH ' HD11 ' C' ' 83' ' ' ILE . 28.9 p90 -179.62 154.29 0.6 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.74 . . . . 74.4 109.471 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -74.87 118.4 17.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.763 -0.828 . . . . 74.31 108.763 173.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.619 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -69.92 -43.3 71.96 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.315 -0.994 . . . . 63.13 108.315 176.085 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.6 t70 -154.02 138.89 17.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.425 -1.716 . . . . 75.04 108.928 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.8 mt -129.3 145.72 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.714 -1.217 . . . . 64.31 107.714 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -153.23 150.06 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.527 0.679 . . . . 74.32 110.0 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -143.91 127.19 16.71 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.815 -1.55 . . . . 73.4 106.815 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 48.5 mt-10 -116.47 125.12 51.52 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.118 -0.697 . . . . 73.14 109.118 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.68 74.91 38.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.626 1.17 . . . . 74.12 108.189 171.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.98 -28.57 49.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.306 2.004 . . . . 74.45 110.452 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 93.1 m-20 -97.9 24.83 6.51 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.768 -1.106 . . . . 74.41 111.094 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.451 ' HA ' ' HZ ' ' C' ' 123' ' ' PHE . . . -57.09 -48.28 97.68 Favored Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.454 0.701 . . . . 64.2 111.74 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' C' ' 32' ' ' PHE . 56.4 Cg_endo -86.82 -25.46 1.16 Allowed 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.164 1.909 . . . . 75.41 113.27 168.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.407 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 83.0 t60 -70.01 -23.39 63.12 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.64 0.776 . . . . 74.43 112.627 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.602 HG11 ' HE1' ' C' ' 123' ' ' PHE . 9.9 p -78.03 1.3 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 124.278 1.031 . . . . 74.04 112.189 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' C' ' 29' ' ' PRO . 36.5 t80 -49.34 -43.45 43.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.72 1.608 . . . . 72.14 113.913 -171.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -128.65 48.81 2.27 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.364 -0.976 . . . . 72.33 108.364 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.89 155.31 19.46 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.834 -0.621 . . . . 75.52 109.63 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.27 118.39 12.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.776 . . . . 73.22 109.97 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -78.48 94.57 4.97 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.72 0.808 . . . . 74.03 110.755 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.33 54.06 2.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 114.986 -1.006 . . . . 71.4 110.082 171.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.32 97.88 0.17 Allowed 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.09 1.86 . . . . 75.45 111.715 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.645 ' HG2' ' HA ' ' E' ' 190' ' ' ASP . 2.4 tm-20 -84.24 108.83 17.33 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.401 -1.703 . . . . 75.43 106.401 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' C' ' 126' ' ' LEU . 46.4 t -94.02 102.64 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 113.897 -1.501 . . . . 63.15 110.218 -166.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.532 ' HB2' ' HZ1' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -92.87 112.52 24.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.3 0.64 . . . . 70.31 110.442 178.837 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.665 HD13 HD13 ' C' ' 128' ' ' LEU . 7.0 mp -91.24 141.01 29.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.733 -0.84 . . . . 74.53 108.733 172.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -143.18 138.48 29.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.899 0.88 . . . . 63.25 109.476 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.509 ' HB3' HD13 ' E' ' 186' ' ' LEU . 0.0 OUTLIER -109.79 127.23 54.52 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.321 -0.622 . . . . 63.43 109.321 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.73 145.36 48.47 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.353 1.461 . . . . 74.04 108.276 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.2 t -123.67 139.45 53.98 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.275 0.559 . . . . 72.33 109.66 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.47 147.61 34.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.997 1.319 . . . . 75.31 107.682 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -145.75 155.43 42.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.937 0.398 . . . . 74.51 111.346 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.0 m -142.62 136.42 29.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.266 1.027 . . . . 63.41 108.527 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -84.66 116.76 23.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.554 -0.906 . . . . 71.45 108.554 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.483 HD13 HD13 ' C' ' 83' ' ' ILE . 76.4 mt -91.0 -34.4 15.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.752 -0.658 . . . . 75.15 109.579 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.75 -174.19 2.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.101 -0.954 . . . . 54.41 110.004 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.25 122.49 22.04 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.38 -0.827 . . . . 74.2 109.256 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 65.4 11.4 7.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.09 1.356 . . . . 74.3 112.406 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.23 110.67 30.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 108.18 -1.044 . . . . 71.34 108.18 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -127.03 129.82 48.8 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.631 -0.713 . . . . 75.22 109.623 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.27 109.92 16.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.241 -1.345 . . . . 74.45 108.462 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 64.8 t -97.68 114.7 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.102 -1.073 . . . . 73.21 108.102 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.8 105.34 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.676 -0.861 . . . . 63.12 108.676 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -96.7 104.4 16.39 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.754 -1.202 . . . . 73.15 107.754 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -85.8 116.48 24.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.627 0.771 . . . . 74.33 109.957 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.45 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.8 t -101.54 127.92 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.71 -1.218 . . . . 74.04 107.71 168.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.8 m -124.61 124.23 41.77 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.087 -0.709 . . . . 74.1 109.087 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.573 HG21 HG23 ' C' ' 114' ' ' ILE . 38.3 t -110.58 131.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 73.02 109.447 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 25.9 m -116.52 149.69 39.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.233 -1.395 . . . . 73.51 107.233 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.52 130.94 41.05 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.768 -1.197 . . . . 75.04 107.768 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.6 m -133.54 161.64 34.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.485 0.66 . . . . 74.32 110.693 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 mt -128.45 28.5 5.44 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.647 1.579 . . . . 75.54 108.016 -173.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.41 -113.85 2.62 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.349 -1.9 . . . . 75.3 108.349 -165.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.5 -27.12 19.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.204 0.601 . . . . 62.43 109.717 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.6 117.98 9.54 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 124.658 1.183 . . . . 75.41 110.214 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -79.17 126.43 30.73 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.523 -0.547 . . . . 74.13 109.523 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.03 -52.13 11.85 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.593 0.757 . . . . 55.34 109.011 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.413 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 43.1 p90 -164.18 172.68 13.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.535 -1.211 . . . . 74.41 110.129 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.52 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -137.72 145.13 42.14 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.754 -1.573 . . . . 74.4 106.754 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.433 ' N ' HD12 ' C' ' 75' ' ' LEU . 53.6 t -144.18 144.54 31.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.572 -0.899 . . . . 74.53 108.572 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.05 125.68 9.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.404 -0.591 . . . . 75.21 109.404 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' C' ' 110' ' ' ALA . 75.0 t -126.66 114.66 38.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.263 1.025 . . . . 72.52 108.424 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -96.81 87.51 4.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.62 -0.881 . . . . 75.53 108.62 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -85.14 119.81 25.95 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.075 -0.966 . . . . 70.12 109.542 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.619 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -114.05 153.77 17.38 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 123.453 0.471 . . . . 62.54 112.507 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -147.31 130.98 3.74 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.969 -1.252 . . . . 72.51 109.969 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.586 HD11 ' HH ' ' C' ' 17' ' ' TYR . 18.6 mm -88.56 119.01 35.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.764 -1.199 . . . . 71.35 107.764 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.58 122.88 39.3 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.39 -0.967 . . . . 71.14 108.39 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -90.19 100.4 13.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.886 -1.524 . . . . 73.2 106.886 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.504 HD11 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -122.72 133.45 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.697 0.799 . . . . 72.43 110.818 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.33 177.39 11.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.547 -0.751 . . . . 72.54 110.921 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.08 -63.69 2.07 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.641 -0.709 . . . . 62.15 112.731 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.567 HD13 ' SD ' ' E' ' 174' ' ' MET . 3.0 mp 61.67 123.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 125.161 1.384 . . . . 65.11 112.787 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.88 156.76 20.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.253 0.834 . . . . 63.32 113.253 172.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.93 48.61 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 114.31 -1.314 . . . . 75.51 113.766 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.8 p -78.07 -17.82 56.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.172 0.989 . . . . 63.41 111.366 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.69 -31.96 68.71 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.569 0.748 . . . . 73.53 111.944 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.6 tpt -45.77 -54.13 8.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.941 0.719 . . . . 62.23 112.941 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.26 -34.32 18.98 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.622 0.369 . . . . 74.01 111.378 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -74.6 -20.05 60.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.127 0.788 . . . . 72.21 113.127 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -68.02 -62.19 1.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.136 0.425 . . . . 74.01 110.696 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' E' ' 175' ' ' PHE . 2.7 pt? -79.89 -20.3 46.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.239 -0.437 . . . . 73.24 111.294 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.67 -30.22 30.25 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.369 0.507 . . . . 70.42 114.369 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.2 -35.29 0.18 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.223 0.823 . . . . 60.14 113.223 -173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -73.38 -56.83 4.54 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.17 0.588 . . . . 73.11 111.169 -169.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.533 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 36.9 m -61.63 -46.36 93.61 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 123.73 0.812 . . . . 71.55 111.226 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 84.2 Cg_exo -53.44 -34.39 71.45 Favored 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 122.798 2.332 . . . . 72.53 114.61 167.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.6 -30.36 69.08 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.821 0.849 . . . . 71.24 111.365 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.419 HG23 ' NH1' ' A' ' 111' ' ' ARG . 46.2 mm -68.05 -29.88 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 123.199 0.6 . . . . 73.01 110.206 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.463 HD22 ' HA3' ' C' ' 82' ' ' GLY . 70.9 mt -93.05 -29.71 15.67 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.304 1.042 . . . . 73.42 112.567 -173.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -56.96 -38.32 67.38 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.79 -1.1 . . . . 73.24 113.956 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.17 -50.9 12.37 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.079 2.519 . . . . 75.01 113.897 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -62.05 -36.7 82.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.989 -1.005 . . . . 75.45 110.873 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.538 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -76.44 -40.0 51.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.459 -0.791 . . . . 74.34 111.2 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.472 ' HD3' ' CE1' ' A' ' 109' ' ' TYR . 29.1 ttt180 -58.15 -36.95 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.782 0.833 . . . . 75.12 111.142 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -44.96 25.18 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.197 0.599 . . . . 64.14 110.872 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.05 -30.17 71.11 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.325 0.65 . . . . 70.44 112.597 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.573 HG23 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -67.33 -49.91 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.339 0.655 . . . . 74.12 109.98 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.533 HG23 ' HB2' ' C' ' 125' ' ' GLN . 90.5 m -54.0 -42.74 69.36 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.253 0.971 . . . . 62.02 110.951 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.6 t -62.34 -49.26 76.3 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.168 -1.378 . . . . 73.33 110.754 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.575 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.19 -39.49 94.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.883 0.873 . . . . 72.32 112.373 -177.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.03 -41.85 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.152 0.581 . . . . 60.35 110.886 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 28.2 t -59.8 -35.74 75.3 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.439 -1.255 . . . . 73.53 111.851 179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.573 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 73.6 mtt-85 -68.91 -38.6 79.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.313 -0.858 . . . . 72.44 110.895 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.22 4.66 66.25 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.699 -0.682 . . . . 75.25 112.85 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.46 HG22 ' O ' ' D' ' 16' ' ' ILE . 71.0 p 60.51 38.31 19.11 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.829 1.652 . . . . 63.44 112.207 172.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.602 ' HE1' HG11 ' C' ' 31' ' ' VAL . 43.9 m-85 -106.57 163.53 16.79 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.206 -1.361 . . . . 60.25 109.821 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.472 ' HD3' ' HE2' ' E' ' 195' ' ' PHE . 31.7 Cg_endo -61.34 104.45 0.3 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.263 1.975 . . . . 75.34 111.181 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.775 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -56.07 150.77 13.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.237 1.415 . . . . 74.24 112.746 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' C' ' 40' ' ' VAL . 1.9 mm? -129.45 99.87 5.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.807 0.443 . . . . 74.24 110.737 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -109.32 84.63 1.96 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.37 -1.715 . . . . 74.21 106.37 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.665 HD13 HD13 ' C' ' 42' ' ' LEU . 55.4 mt -90.02 156.68 18.24 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.337 -1.301 . . . . 71.54 111.848 -172.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.482 ' HB1' ' HA ' ' F' ' 204' ' ' ILE . . . -34.62 121.98 0.55 Allowed Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.218 1.807 . . . . 73.34 113.65 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.575 ' HG3' HD13 ' A' ' 16' ' ' ILE . 74.4 Cg_endo -71.29 110.24 2.79 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.73 2.287 . . . . 63.42 111.559 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 86.0 t -76.0 94.32 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.94 -0.763 . . . . 71.4 108.94 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.56 104.67 3.37 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -55.9 -45.41 78.65 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.075 1.484 . . . . 74.23 112.761 -170.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.76 -29.87 25.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.302 -0.408 . . . . 65.33 111.73 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.057 0.143 . . . . 73.31 111.041 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.06 -46.11 90.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.986 0.514 . . . . 71.44 110.534 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -63.6 -39.78 95.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.623 0.769 . . . . 73.24 111.391 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt -66.09 -47.6 73.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.452 1.101 . . . . 72.54 111.377 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -72.35 -41.77 66.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 73.02 111.085 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.07 -155.04 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.803 -0.635 . . . . 75.42 109.727 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 18.1 tp 61.72 9.88 3.1 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.662 1.185 . . . . 73.41 111.529 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -172.51 158.69 4.29 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.949 1.3 . . . . 74.03 108.716 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.78 74.9 1.47 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.922 0.489 . . . . 75.31 109.908 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -124.16 151.26 44.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.715 0.806 . . . . 74.41 109.106 168.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.42 148.23 16.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.817 0.847 . . . . 71.42 109.92 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 5' ' ' ASN . . . -96.0 -126.44 5.06 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.636 -0.711 . . . . 75.42 113.273 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.04 -23.42 0.3 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.967 0.728 . . . . 74.3 112.967 -158.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.09 -123.72 7.36 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-O 119.995 -0.336 . . . . 74.15 113.184 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.3 m 68.34 101.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.04 1.736 . . . . 73.14 111.214 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 29.9 mt-10 -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.584 1.153 . . . . 73.11 112.574 -170.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -168.84 143.9 3.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.479 1.112 . . . . 71.42 108.921 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.573 ' HA ' ' HB3' ' G' ' 175' ' ' PHE . 4.5 p-80 -154.63 122.28 5.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.972 0.909 . . . . 74.0 109.738 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -83.79 -39.23 20.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.082 0.553 . . . . 74.24 110.071 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.41 164.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.165 1.386 . . . . 64.21 112.741 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.339 1.056 . . . . 70.34 109.289 -173.908 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.61 ' HG2' HD22 ' E' ' 199' ' ' ASN . 64.7 mtm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.071 -0.344 . . . . 75.33 110.071 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.6 p -157.7 137.71 12.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.749 0.419 . . . . 74.33 111.017 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.66 126.61 30.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.702 0.801 . . . . 53.31 109.023 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.428 ' NE2' ' HB1' ' D' ' 52' ' ' ALA . 46.2 mt-30 -76.83 98.59 4.89 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.812 0.845 . . . . 74.12 110.606 -171.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -178.64 167.48 1.76 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.753 1.621 . . . . 55.04 106.844 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -73.45 74.58 1.42 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.661 1.22 . . . . 75.24 108.682 168.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 16.6 m -84.15 169.76 14.5 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 113.773 -1.558 . . . . 55.42 109.303 -175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.38 135.25 57.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 119.075 -0.488 . . . . 73.34 109.883 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.413 ' HG3' HG23 ' D' ' 89' ' ' ILE . 3.2 ttp -29.4 122.99 0.15 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 125.603 1.814 . . . . 62.51 114.059 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m -134.46 142.61 47.15 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.007 0.432 . . . . 73.14 109.946 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -145.97 94.5 2.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 106.431 -1.692 . . . . 74.01 106.431 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -129.47 139.45 51.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.306 0.642 . . . . 71.34 109.468 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.48 142.81 12.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.152 0.581 . . . . 74.23 109.738 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 56.9 mt-30 -103.36 -43.93 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.15 0.58 . . . . 70.23 110.683 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.547 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 55.6 ttt180 -170.13 148.72 3.4 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 111.784 0.29 . . . . 75.44 111.784 -169.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.46 ' O ' HG22 ' C' ' 122' ' ' THR . 1.1 mp -120.68 144.2 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 106.205 -1.776 . . . . 74.02 106.205 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.547 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 16.3 p90 -165.9 151.07 8.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.478 0.656 . . . . 75.43 111.226 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -86.95 113.05 22.39 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.033 -0.985 . . . . 53.15 109.082 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -81.06 -28.84 35.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.978 -0.555 . . . . 73.32 110.289 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -151.82 136.44 17.0 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.788 -1.096 . . . . 73.11 109.131 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.575 HG23 ' HE1' ' C' ' 117' ' ' MET . 96.7 mt -130.81 138.3 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.694 -1.224 . . . . 71.15 107.694 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -141.59 137.11 31.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.138 0.975 . . . . 73.2 109.053 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.2 t80 -145.52 114.23 6.82 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.263 -1.755 . . . . 73.33 106.263 170.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 38.3 mt-10 -122.26 111.09 16.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.228 0.611 . . . . 75.44 109.707 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -108.91 88.99 5.97 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.331 -0.989 . . . . 74.41 108.331 174.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.48 -33.94 1.64 Allowed 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 122.634 2.223 . . . . 73.02 113.295 -173.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -101.26 28.25 5.55 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.944 0.897 . . . . 73.5 109.317 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' D' ' 25' ' ' ALA . . . -51.58 -55.22 31.43 Favored Pre-proline 0 CA--C 1.574 1.893 0 N-CA-C 116.149 1.907 . . . . 64.32 116.149 -165.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.2 -16.24 11.09 Favored 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 122.049 1.768 . . . . 73.25 113.43 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -72.64 -44.78 61.46 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.066 0.946 . . . . 73.35 109.81 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.693 HG23 ' HA ' ' D' ' 73' ' ' ALA . 5.3 p -82.93 -0.27 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.818 -172.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.452 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 80.2 t80 -57.82 -29.84 65.26 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.1 0.96 . . . . 75.45 111.098 164.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -78.95 4.36 14.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.705 0.802 . . . . 74.12 111.543 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -108.3 110.24 21.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.285 1.034 . . . . 74.41 108.717 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.597 ' HB2' ' HA ' ' H' ' 196' ' ' LYS . 5.3 p-10 -112.59 48.83 0.97 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.343 1.057 . . . . 74.24 111.793 -164.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -154.29 -174.55 5.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.533 0.733 . . . . 73.22 110.403 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.424 ' HG2' ' HA3' ' H' ' 191' ' ' GLY . 60.1 tp60 -72.24 126.8 90.97 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.147 0.579 . . . . 71.24 110.893 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.06 134.13 30.92 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.548 2.165 . . . . 74.21 111.898 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 38.1 mt-10 -60.14 115.08 3.21 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.218 0.949 . . . . 74.31 108.95 170.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.12 107.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.099 -1.075 . . . . 75.41 108.099 -176.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' D' ' 65' ' ' THR . 0.2 OUTLIER -88.07 119.23 28.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.569 -1.271 . . . . 71.25 107.569 171.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.19 141.86 29.05 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.448 -0.945 . . . . 62.33 108.448 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.405 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -144.44 130.43 19.42 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.503 -0.925 . . . . 75.52 108.503 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.3 135.53 52.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.511 0.725 . . . . 74.34 109.958 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -144.67 156.96 44.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.505 1.122 . . . . 64.43 108.894 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -139.04 164.53 29.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 75.54 109.55 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 174.21 14.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.44 1.096 . . . . 73.52 108.594 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 95.8 p -164.14 157.57 18.25 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.006 0.432 . . . . 74.01 110.82 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.3 p -151.29 129.99 12.33 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.155 -0.93 . . . . 74.44 108.948 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.5 116.81 15.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.635 -0.505 . . . . 75.44 109.635 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' D' ' 57' ' ' GLU . 81.7 mt -92.64 -35.28 13.6 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.359 0.664 . . . . 74.43 109.709 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.545 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -154.99 -177.47 6.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.279 -0.873 . . . . 72.23 110.133 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.08 125.16 27.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.162 -1.051 . . . . 75.23 108.162 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.522 ' HA ' ' HE2' ' H' ' 174' ' ' MET . 12.9 m-20 64.42 16.43 10.19 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.267 1.027 . . . . 75.31 112.271 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 65.2 t -136.72 127.19 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.569 1.147 . . . . 75.52 108.089 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.29 152.62 34.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.194 0.521 . . . . 74.4 110.102 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.6 tt0 -88.58 131.48 34.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.989 -1.005 . . . . 71.33 109.109 175.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.65 131.68 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.618 -1.253 . . . . 74.34 107.618 167.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.503 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 58.4 t -106.29 133.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.953 -0.758 . . . . 72.33 108.953 173.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.489 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -104.58 125.34 50.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.645 -1.613 . . . . 64.12 106.645 172.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.9 ttm-85 -106.97 100.2 9.72 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.211 -1.033 . . . . 71.14 108.211 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.79 121.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.298 -1.371 . . . . 74.53 107.298 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.0 m -124.84 128.99 49.54 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.454 0.645 . . . . 74.2 109.965 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.2 t -120.84 132.18 71.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.223 1.409 . . . . 75.11 109.171 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' D' ' 41' ' ' LYS . 89.0 m -128.65 98.75 5.11 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.649 -1.241 . . . . 74.44 107.649 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.13 141.95 28.9 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.869 -0.605 . . . . 72.33 109.599 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.445 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.7 p -143.14 129.13 19.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.41 0.443 . . . . 75.34 111.227 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 mt -108.99 99.76 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 73.13 108.751 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.87 -132.05 10.81 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.476 0.485 . . . . 60.03 111.972 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.94 5.03 52.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.463 0.705 . . . . 73.22 111.569 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -123.68 167.46 13.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.77 . . . . 71.4 110.557 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.9 m -77.68 132.01 37.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.2 -0.909 . . . . 74.54 110.293 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.693 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -82.53 -65.8 0.97 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.815 0.846 . . . . 74.52 108.73 176.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -154.75 170.39 21.71 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.202 -0.908 . . . . 75.12 110.116 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.0 mt -128.12 153.46 46.83 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.42 -1.326 . . . . 74.15 107.42 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.505 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.0 t -158.58 144.1 16.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.841 0.456 . . . . 71.43 110.253 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.34 124.44 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.244 -0.65 . . . . 75.11 109.244 170.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -125.75 116.2 45.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.47 0.708 . . . . 73.32 109.862 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.61 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -91.85 86.89 6.04 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.705 0.764 . . . . 74.14 109.809 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.72 98.36 7.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.112 1.365 . . . . 74.54 109.736 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.99 158.99 26.25 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.117 -0.393 . . . . 74.41 112.117 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.65 140.31 6.85 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.842 -0.503 . . . . 52.3 111.842 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.44 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.9 mt -91.55 120.89 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.518 0.727 . . . . 75.11 109.786 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -118.77 126.42 51.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 74.31 110.407 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 75.2 m -91.31 101.53 14.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.487 1.115 . . . . 71.33 109.541 171.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.87 141.76 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.072 0.549 . . . . 75.04 110.814 -177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.5 162.74 14.61 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.632 1.173 . . . . 73.22 109.129 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.79 77.52 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.356 0.41 . . . . 64.42 113.233 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.579 HG12 ' HB2' ' D' ' 94' ' ' MET . 0.1 OUTLIER -123.26 130.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 124.097 0.959 . . . . 73.15 109.462 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.455 ' HA ' ' HB3' ' H' ' 172' ' ' ALA . 47.4 mt-10 -142.89 170.77 15.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.894 0.878 . . . . 74.45 110.357 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.15 -141.98 33.6 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.211 -0.904 . . . . 71.42 113.569 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -75.32 -16.06 60.44 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.716 0.807 . . . . 62.32 111.948 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -60.85 -48.29 82.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.345 0.658 . . . . 75.33 109.992 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.662 ' HG3' HD23 ' D' ' 98' ' ' LEU . 11.2 tpt -80.97 -41.16 23.26 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.38 -0.827 . . . . 73.23 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.78 -39.92 78.6 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 64.32 112.143 -177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.431 ' O ' ' HB1' ' D' ' 100' ' ' ALA . 80.4 t60 -76.84 -27.07 54.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.625 0.77 . . . . 72.25 110.69 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.439 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 37.3 t -75.33 -51.51 13.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.448 0.299 . . . . 73.51 111.273 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.662 HD23 ' HG3' ' D' ' 94' ' ' MET . 4.1 pp -67.38 -32.72 73.82 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.573 0.749 . . . . 74.41 112.217 -172.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.67 13.56 42.37 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.543 -0.587 . . . . 75.24 113.877 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' D' ' 96' ' ' HIS . . . -156.55 -59.86 0.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.35 0.575 . . . . 71.43 111.946 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.439 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 70.3 t80 -73.69 -42.29 61.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.888 0.699 . . . . 75.01 112.888 -168.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 76.0 m -67.04 -44.8 51.56 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.92 -0.562 . . . . 73.13 111.18 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.489 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.3 Cg_exo -56.74 -32.62 91.86 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.127 1.885 . . . . 72.54 113.663 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.18 -35.96 82.49 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.435 0.694 . . . . 75.44 111.272 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.87 -41.78 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.387 0.675 . . . . 71.33 110.208 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 86.8 mt -75.06 -21.22 59.13 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.955 -1.021 . . . . 74.23 111.757 -175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -64.9 -44.61 72.76 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.784 1.402 . . . . 62.22 114.784 -167.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.37 -39.53 86.89 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.244 1.963 . . . . 73.1 113.279 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -78.0 -37.69 46.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.014 -0.993 . . . . 71.23 110.932 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.41 90.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 72.02 110.694 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.444 ' NH2' HG22 ' B' ' 105' ' ' ILE . 40.1 ttp180 -57.47 -49.89 74.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.113 1.365 . . . . 74.44 111.009 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.17 -41.5 99.23 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.277 0.986 . . . . 75.02 111.648 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.465 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 45.0 t -56.58 -40.17 74.76 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.926 0.766 . . . . 75.24 110.896 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.505 HG23 ' SG ' ' D' ' 76' ' ' CYS . 39.8 mt -69.14 -50.36 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.088 -0.96 . . . . 72.14 110.087 175.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.431 HG22 ' HG3' ' D' ' 125' ' ' GLN . 20.2 m -52.05 -42.43 63.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.678 1.191 . . . . 72.15 111.981 -175.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -70.54 -43.45 69.52 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.894 -1.048 . . . . 73.42 110.948 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.7 mtm -64.62 -30.32 71.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.694 0.398 . . . . 61.03 111.615 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.4 t -66.17 -47.9 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.862 0.726 . . . . 73.44 110.346 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.3 p -71.43 -27.67 63.45 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.656 0.383 . . . . 73.15 111.061 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -75.9 -32.77 59.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.791 0.837 . . . . 73.24 109.795 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.64 -4.88 89.45 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 115.718 -0.674 . . . . 61.42 112.119 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 67.88 33.13 4.86 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.496 1.918 . . . . 70.52 113.117 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -102.6 166.22 12.37 Favored Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.806 1.242 . . . . 72.15 109.949 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.01 140.15 91.28 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 123.278 2.652 . . . . 73.32 112.889 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG22 ' D' ' 115' ' ' THR . 29.4 tt0 -52.18 140.06 22.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.087 0.867 . . . . 74.41 111.897 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.1 tp -128.3 106.12 8.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.634 -0.712 . . . . 74.25 109.519 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.0 106.29 8.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.832 0.853 . . . . 74.11 109.021 173.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.26 151.23 45.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 73.42 110.72 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.83 136.63 95.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.462 0.705 . . . . 71.13 111.16 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -69.5 113.11 3.22 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.005 1.804 . . . . 73.13 109.461 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.52 104.43 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.174 0.987 . . . . 72.44 109.663 -171.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.81 105.62 17.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 105.913 -1.884 . . . . 74.01 105.913 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -68.15 -27.27 66.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.055 0.942 . . . . 75.43 112.106 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.64 -57.16 9.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.197 0.999 . . . . 73.31 109.276 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.15 67.62 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 114.649 -1.159 . . . . 74.41 111.723 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.65 -44.2 94.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.734 1.213 . . . . 73.05 110.894 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -64.8 -51.34 62.74 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.71 0.632 . . . . 73.21 110.365 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 74.3 mtm -65.49 -30.03 70.75 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.47 -0.786 . . . . 70.15 111.521 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' G' ' 207' ' ' VAL . 7.9 t30 -76.35 -36.89 57.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 70.2 110.283 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.72 -46.09 88.15 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.706 0.802 . . . . 74.31 111.349 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.49 -29.45 65.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.33 -0.85 . . . . 62.44 112.118 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -90.65 6.19 44.93 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.48 0.312 . . . . 72.11 111.819 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -118.27 84.12 2.12 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.373 0.669 . . . . 73.24 109.685 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -153.09 94.8 1.88 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.664 -1.236 . . . . 72.45 107.664 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.12 165.42 15.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.918 0.887 . . . . 73.5 109.457 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.96 -174.38 48.67 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 116.053 -0.521 . . . . 72.15 113.391 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.93 147.83 27.67 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.223 1.009 . . . . 73.43 108.896 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.74 63.91 4.38 Favored Glycine 0 C--N 1.344 1.013 0 O-C-N 123.26 0.35 . . . . 51.42 112.988 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -80.97 115.0 20.22 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.433 0.693 . . . . 72.54 109.72 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.59 177.48 6.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.657 0.783 . . . . 74.34 111.183 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.52 159.45 22.83 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.012 -0.54 . . . . 71.42 110.36 173.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.59 149.16 5.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.589 0.755 . . . . 73.42 110.018 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -79.76 167.98 19.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.823 -0.626 . . . . 73.21 110.035 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -145.02 -85.21 0.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.761 -0.459 . . . . 74.4 109.761 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 107.836 -1.172 . . . . 72.12 107.836 -176.617 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.485 0.183 . . . . 73.32 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -123.9 35.08 3.37 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.224 -0.75 . . . . 63.14 111.224 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.16 104.95 17.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.771 0.828 . . . . 73.52 109.442 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 21.3 p -76.85 -174.77 3.2 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.532 0.733 . . . . 70.13 110.866 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.84 139.89 58.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.095 0.558 . . . . 61.22 110.308 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.03 102.74 2.99 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.722 -0.844 . . . . 72.51 108.722 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.567 ' SD ' HD13 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -65.44 76.23 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.435 1.094 . . . . 64.13 112.685 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.438 ' HA ' HD12 ' C' ' 98' ' ' LEU . 12.9 t80 -165.07 57.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.201 1.001 . . . . 73.51 108.458 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -147.85 103.08 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 114.086 -1.415 . . . . 64.22 108.612 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 7.6 mp -100.61 -168.51 1.58 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.187 -1.042 . . . . 74.43 108.187 168.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -161.37 -66.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.351 -1.351 . . . . 71.43 107.351 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -120.24 159.37 47.81 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.781 1.232 . . . . 74.32 107.742 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.09 148.3 89.87 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.596 2.197 . . . . 73.41 112.645 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -74.58 -178.08 3.43 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.398 -0.964 . . . . 73.13 108.398 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -48.84 108.44 0.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.333 0.653 . . . . 73.11 110.337 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 44.8 p -58.51 126.26 26.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.382 1.073 . . . . 75.1 110.898 -174.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -103.91 96.48 9.36 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.02 0.928 . . . . 74.12 109.877 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.55 112.73 3.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.075 1.85 . . . . 71.43 110.998 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' C' ' 44' ' ' LEU . 21.9 mt -67.52 137.8 56.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 109.324 -0.621 . . . . 63.33 109.324 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.68 147.08 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 123.825 0.703 . . . . 75.44 112.267 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -118.44 100.46 7.48 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.557 0.743 . . . . 64.42 109.536 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . 0.404 ' HB2' ' HB ' ' C' ' 40' ' ' VAL . . . -70.84 95.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.395 0.678 . . . . 64.02 110.888 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . 0.645 ' HA ' ' HG2' ' C' ' 39' ' ' GLU . 35.0 t70 -70.27 151.75 44.97 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.846 0.858 . . . . 73.32 111.531 -174.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.4 -114.38 3.34 Favored Glycine 0 C--N 1.354 1.555 0 O-C-N 124.021 0.826 . . . . 72.24 113.758 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . 0.489 ' HA3' ' HE2' ' F' ' 201' ' ' LYS . . . 67.98 82.2 0.16 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.623 -0.543 . . . . 52.32 111.924 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -50.09 -43.15 51.3 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.411 1.084 . . . . 71.4 112.245 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 69.02 -74.98 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.914 1.286 . . . . 55.02 111.737 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . 0.472 ' HE2' ' HD3' ' C' ' 124' ' ' PRO . 2.3 p90 -150.92 178.27 9.32 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.316 0.646 . . . . 65.05 110.547 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -119.96 150.76 40.0 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.899 0.88 . . . . 74.41 109.498 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -153.71 112.46 3.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.011 0.924 . . . . 74.31 110.041 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.18 114.96 8.18 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 107.572 -1.27 . . . . 75.34 107.572 164.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . 0.61 HD22 ' HG2' ' D' ' 1' ' ' MET . 7.3 t30 73.31 159.65 0.22 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.44 1.096 . . . . 71.54 111.524 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.7 69.24 1.21 Allowed Glycine 0 C--N 1.351 1.403 0 CA-C-N 116.221 -0.445 . . . . 74.04 112.58 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' E' ' 204' ' ' ILE . 79.6 tttt -139.95 15.75 2.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.165 0.986 . . . . 75.24 109.36 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.47 -36.59 80.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.389 1.075 . . . . 74.14 111.337 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . 0.677 ' HB2' ' H ' ' F' ' 187' ' ' ILE . 13.3 p-10 -150.91 -46.51 0.12 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.116 -0.947 . . . . 75.13 110.005 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' E' ' 201' ' ' LYS . 0.2 OUTLIER -85.21 167.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.455 -0.572 . . . . 71.14 109.455 172.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -132.07 -55.8 0.98 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.385 -1.339 . . . . 75.23 107.385 172.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.35 122.76 23.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.844 -1.525 . . . . 73.14 108.187 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.254 1.318 0 C-N-CA 123.022 0.529 . . . . 71.4 110.409 -172.415 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.594 -0.521 . . . . 75.41 109.594 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.07 -58.16 5.05 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 116.216 -0.447 . . . . 72.13 112.072 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -117.16 153.89 32.03 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.937 1.295 . . . . 53.14 109.3 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 41.2 p -171.82 105.06 0.19 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.348 1.059 . . . . 64.2 109.043 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -135.67 76.71 1.63 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.805 0.842 . . . . 64.41 109.422 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.721 HD23 ' H ' ' B' ' 54' ' ' ASP . 2.3 mm? -122.32 33.34 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.393 1.077 . . . . 74.33 109.982 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.99 -51.66 5.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.007 1.723 . . . . 74.42 113.275 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 50.4 t80 54.58 80.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.45 1.1 . . . . 74.24 111.372 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . 0.505 HD21 ' HA2' ' B' ' 91' ' ' GLY . 73.1 m-20 -78.24 -74.82 0.25 Allowed 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.339 -0.615 . . . . 73.11 109.339 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 tp 54.64 31.01 14.32 Favored 'General case' 0 CA--C 1.559 1.31 0 O-C-N 124.204 0.94 . . . . 75.4 110.07 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -83.97 136.24 34.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.187 -0.915 . . . . 75.33 109.866 -172.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 70.5 136.48 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.675 1.59 . . . . 75.33 111.726 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 102.13 1.2 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.575 2.183 . . . . 75.54 110.819 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -63.78 170.21 3.54 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.659 0.784 . . . . 65.25 111.543 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -61.3 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.118 0.967 . . . . 74.32 110.86 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 13.0 m -75.76 150.18 37.83 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.171 -0.922 . . . . 74.12 110.207 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.487 ' HB3' HD11 ' B' ' 136' ' ' LEU . 32.6 p90 -96.26 109.78 49.06 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.846 0.858 . . . . 75.31 110.549 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.12 137.1 10.59 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.49 2.127 . . . . 73.51 111.197 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.737 HD22 HD12 ' B' ' 128' ' ' LEU . 1.0 OUTLIER -150.69 161.56 42.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.597 0.713 . . . . 73.41 112.624 -172.506 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.677 ' H ' ' HB2' ' E' ' 203' ' ' ASP . 49.0 mm 77.37 133.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 127.069 2.148 . . . . 74.45 113.288 167.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.62 45.17 1.29 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.765 1.226 . . . . 60.0 108.466 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.92 33.47 0.94 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.195 0.998 . . . . 71.14 112.08 -173.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -93.84 130.7 39.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.163 0.985 . . . . 71.02 110.038 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 71.96 87.59 0.15 Allowed Glycine 0 C--N 1.353 1.498 0 O-C-N 123.161 0.288 . . . . 75.15 112.882 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -130.37 -137.88 4.24 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.257 -0.737 . . . . 73.44 111.257 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.16 117.01 14.13 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 117.563 0.682 . . . . 74.41 111.465 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' B' ' 37' ' ' GLN . . . -175.55 178.64 1.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.603 1.161 . . . . 72.12 111.621 170.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 64.28 76.57 0.34 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.939 1.695 . . . . 72.45 112.065 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.58 102.81 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.255 -1.387 . . . . 72.15 107.255 169.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.54 -4.63 27.91 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.08 0.952 . . . . 75.22 112.713 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.38 5.13 51.8 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.038 0.935 . . . . 72.22 110.839 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -139.42 -43.94 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.051 0.54 . . . . 51.14 112.37 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.07 29.89 7.36 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 114.285 0.474 . . . . 75.51 114.285 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . 0.489 ' HE2' ' HA3' ' E' ' 192' ' ' GLY . 6.9 mmtm -91.53 93.33 8.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.123 0.569 . . . . 75.01 109.563 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.421 ' HE2' ' HB3' ' B' ' 124' ' ' PRO . 1.8 m-30 74.48 15.52 3.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.109 1.364 . . . . 64.43 111.724 177.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -136.67 -163.56 1.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.479 0.712 . . . . 63.2 111.075 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.482 ' HA ' ' HB1' ' C' ' 129' ' ' ALA . 3.8 tp -108.14 110.21 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.076 0.951 . . . . 74.22 109.506 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -89.44 151.36 22.06 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.796 -0.816 . . . . 74.13 108.796 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.23 122.49 11.9 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.158 0.583 . . . . 64.44 110.152 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.751 0.821 . . . . 73.0 110.913 -176.934 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.651 -0.5 . . . . 74.03 109.651 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -179.76 109.02 0.25 Allowed Glycine 0 C--N 1.35 1.36 0 C-N-CA 121.474 -0.393 . . . . 73.42 113.534 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -87.74 -51.97 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.556 0.743 . . . . 73.31 109.601 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 35.5 m 58.26 74.71 0.42 Allowed 'General case' 0 C--N 1.356 0.874 0 O-C-N 124.766 1.291 . . . . 71.22 109.982 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.38 17.45 2.6 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.174 -0.921 . . . . 74.44 111.661 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -83.96 117.15 23.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.175 0.99 . . . . 73.43 108.466 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.602 ' HG2' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -137.12 163.45 30.8 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.943 0.897 . . . . 62.14 110.245 -170.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.573 ' HB3' ' HA ' ' C' ' 152' ' ' HIS . 33.7 t80 -170.88 77.81 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.787 0.835 . . . . 74.3 109.703 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -96.07 -65.53 0.96 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.356 -0.609 . . . . 75.31 109.356 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 30.5 tp 54.6 80.41 0.12 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.938 1.295 . . . . 73.14 109.563 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -103.72 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.746 0.818 . . . . 60.31 110.619 -173.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.6 153.57 40.54 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.789 0.836 . . . . 71.5 110.104 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.38 -169.8 0.57 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.935 2.424 . . . . 65.11 111.759 166.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -151.67 142.45 22.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.657 -0.497 . . . . 75.01 109.657 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 9.0 t80 59.82 -157.28 0.33 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.196 0.998 . . . . 73.44 109.993 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -132.26 140.14 48.52 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.554 0.742 . . . . 74.13 109.139 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -149.47 124.29 4.8 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 122.999 0.52 . . . . 75.13 111.203 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.91 -179.54 1.85 Allowed 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.684 2.256 . . . . 74.44 110.658 164.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.81 -173.63 2.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.842 -0.799 . . . . 74.24 108.842 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.456 HG21 ' HB3' ' A' ' 129' ' ' ALA . 45.3 pt -62.78 -23.52 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 70.3 111.425 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . 59.94 69.8 0.68 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.59 1.156 . . . . 61.35 110.293 -174.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -81.35 70.5 8.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.861 -1.063 . . . . 71.3 108.681 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 35.9 t70 -147.63 101.88 3.38 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.259 -1.337 . . . . 73.45 107.86 -174.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.8 6.96 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.617 0.573 . . . . 72.5 111.797 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 39' ' ' GLU . . . -93.49 21.54 40.27 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.264 -0.742 . . . . 75.02 113.807 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -158.75 84.76 0.82 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.081 0.944 . . . . 74.14 109.628 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . 0.43 ' HB2' ' HA2' ' H' ' 200' ' ' GLY . . . -168.89 145.49 3.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.798 0.839 . . . . 72.11 108.87 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 35.3 t80 70.0 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.44 1.087 . . . . 75.52 110.319 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 3.9 ttmp? -137.29 138.38 39.98 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.646 -0.659 . . . . 73.03 112.203 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 166.89 17.95 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 124.004 0.815 . . . . 75.42 111.103 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . 0.751 ' HA ' ' HA ' ' H' ' 195' ' ' PHE . 0.0 OUTLIER -73.85 -179.92 3.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.613 -0.721 . . . . 71.21 111.296 174.31 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -130.79 49.33 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.209 -1.034 . . . . 64.24 108.209 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.78 81.44 0.23 Allowed Glycine 0 C--N 1.354 1.552 0 CA-C-N 114.562 -1.199 . . . . 45.42 112.574 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . 0.466 ' HB2' ' HZ1' ' G' ' 201' ' ' LYS . 9.6 mtmp? -77.08 -34.73 56.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.105 0.962 . . . . 73.33 110.495 178.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.72 95.62 0.04 OUTLIER 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.623 1.202 . . . . 72.23 109.867 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.23 38.16 0.8 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.213 1.005 . . . . 74.45 110.744 -173.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.34 131.54 61.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.26 1.024 . . . . 65.35 109.81 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -155.35 127.24 7.53 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.864 0.866 . . . . 72.02 108.669 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -168.47 -53.41 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.488 -1.301 . . . . 65.14 107.488 -172.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . 0.412 ' HA ' HD22 ' D' ' 139' ' ' ASN . 61.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.482 -1.235 . . . . 75.43 107.678 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 110.354 -0.239 . . . . 74.12 110.354 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.49 98.72 0.95 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 116.077 -0.51 . . . . 74.54 112.057 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.83 -40.7 79.33 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.815 -0.809 . . . . 70.1 108.815 168.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 34.2 p -131.7 155.44 47.64 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.067 1.347 . . . . 73.34 108.621 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' D' ' 90' ' ' GLU . . . -163.7 127.52 2.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.365 0.666 . . . . 74.04 110.305 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.13 -156.33 0.69 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.49 1.116 . . . . 73.02 109.075 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' D' ' 54' ' ' ASP . 1.0 OUTLIER -61.01 94.97 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.888 1.275 . . . . 65.45 111.562 -171.368 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 40.1 t80 69.2 104.28 0.06 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.578 1.551 . . . . 71.14 111.609 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.99 105.39 2.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.1 0.96 . . . . 74.44 109.02 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.09 100.73 10.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.172 -1.047 . . . . 72.42 108.172 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -104.49 -43.0 5.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 73.0 110.516 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.42 115.36 5.34 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.24 1.016 . . . . 73.54 108.988 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.58 95.78 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.777 2.318 . . . . 74.01 112.23 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -81.25 125.18 30.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.819 0.848 . . . . 75.21 109.593 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 10.4 t80 68.23 165.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.86 1.264 . . . . 75.13 111.303 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.6 t -134.66 161.61 34.64 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.722 -0.611 . . . . 63.3 111.216 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -107.46 121.41 44.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.358 1.063 . . . . 74.13 109.965 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.85 107.09 2.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.208 1.939 . . . . 74.54 111.241 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.01 98.5 0.97 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.819 -0.628 . . . . 73.2 109.703 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.66 110.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 C-N-CA 124.694 1.198 . . . . 75.23 113.031 -171.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.54 97.48 7.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.447 1.099 . . . . 71.51 109.239 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -85.87 140.43 30.4 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.41 0.684 . . . . 74.41 111.382 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -72.74 -29.44 63.35 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.502 0.721 . . . . 74.24 109.853 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . 0.424 ' HA3' ' HG2' ' D' ' 37' ' ' GLN . . . 76.34 -86.07 0.92 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 123.8 0.687 . . . . 51.4 111.566 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.09 156.09 21.79 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.281 -0.328 . . . . 63.22 112.281 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -84.9 -10.23 57.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.5 0.72 . . . . 73.33 111.303 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.69 39.87 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.843 0.857 . . . . 73.41 110.459 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.751 ' HA ' ' HA ' ' G' ' 198' ' ' GLU . 4.7 t80 -164.88 -65.87 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.426 1.09 . . . . 71.24 109.027 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . 0.597 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 74.9 mmtt 62.42 -162.91 0.27 Allowed 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.224 0.952 . . . . 72.22 110.889 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -149.73 -77.68 0.14 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.999 -0.741 . . . . 74.25 108.999 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 55.61 -165.67 0.12 Allowed 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.536 -1.211 . . . . 73.11 111.351 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -163.73 -34.55 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.633 1.173 . . . . 72.44 107.945 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' G' ' 194' ' ' ALA . . . 120.37 105.79 2.07 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 114.36 -1.291 . . . . 74.02 109.941 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.59 92.0 2.37 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.117 -1.068 . . . . 73.34 108.117 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -75.74 164.43 26.27 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.178 -1.374 . . . . 73.44 109.164 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.93 45.54 1.22 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 122.148 0.975 . . . . 72.44 109.277 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.25 105.17 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 114.219 -1.355 . . . . 75.32 111.721 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -133.32 18.62 4.01 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.718 -1.216 . . . . 73.31 107.718 162.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.94 14.11 2.94 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.169 0.987 . . . . 62.54 112.687 -172.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 C--O 1.255 1.369 0 C-N-CA 124.561 1.144 . . . . 74.03 108.018 178.783 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttm . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.128 -0.693 . . . . 64.34 109.128 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -84.3 85.57 7.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.827 0.851 . . . . 71.13 109.014 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -73.34 93.4 1.91 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.571 0.749 . . . . 74.44 110.216 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -59.44 132.15 53.13 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.348 1.059 . . . . 71.22 110.838 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.572 HD22 HG21 ' A' ' 7' ' ' THR . 5.9 t30 -139.33 106.89 5.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.483 0.713 . . . . 74.4 109.287 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.654 ' HA ' ' HA2' ' C' ' 146' ' ' GLY . 20.4 t-20 -101.37 93.46 5.42 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.985 0.514 . . . . 72.23 109.904 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.572 HG21 HD22 ' A' ' 5' ' ' ASN . 16.3 p -80.76 -75.78 0.26 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.844 -0.799 . . . . 74.13 108.844 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.544 ' HG3' ' HG3' ' A' ' 9' ' ' MET . 12.0 tp10 -130.38 -83.22 0.54 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.167 -0.679 . . . . 73.21 109.167 -174.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.557 ' HG2' HG22 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -176.36 158.54 1.87 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 73.35 110.244 -174.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -152.84 145.02 23.87 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.29 1.036 . . . . 73.01 110.282 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.407 ' CE2' ' SG ' ' A' ' 102' ' ' CYS . 58.1 t80 -98.54 139.82 33.69 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.098 -0.955 . . . . 74.34 108.513 162.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.603 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -156.39 137.37 13.55 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 112.329 0.492 . . . . 74.1 112.329 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 83' ' ' ILE . 7.9 tp -80.02 134.63 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.531 0.732 . . . . 74.13 110.149 169.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.419 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -101.77 -40.25 7.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.957 -0.757 . . . . 73.51 108.957 174.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.485 ' NH1' ' HA ' ' F' ' 203' ' ' ASP . 20.7 ttt180 -173.75 127.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.999 -0.524 . . . . 74.34 110.948 -171.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.05 133.75 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.614 -0.884 . . . . 72.42 108.614 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 34.0 p90 -169.04 170.34 8.94 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.899 0.88 . . . . 74.34 110.578 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.8 p -93.39 120.08 33.26 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.32 -0.992 . . . . 73.45 108.32 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.475 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.7 mtpt -86.94 -42.94 12.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.204 -0.665 . . . . 75.5 109.204 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 12.0 t70 -135.16 128.51 32.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.145 -0.934 . . . . 70.54 108.499 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -122.95 143.28 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.952 -1.129 . . . . 73.41 107.952 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -143.5 125.91 15.73 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.798 -0.816 . . . . 70.23 108.798 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.564 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 89.9 t80 -131.1 129.87 42.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.586 -1.635 . . . . 74.11 106.586 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.91 138.83 47.09 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.313 -0.625 . . . . 72.11 109.313 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 76.18 11.39 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.385 -1.339 . . . . 72.03 107.385 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.53 -24.07 16.53 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.296 1.998 . . . . 73.32 111.202 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.03 25.76 7.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.078 0.951 . . . . 73.13 109.104 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.524 ' HB2' ' CE2' ' B' ' 17' ' ' TYR . . . -59.2 -47.64 97.93 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 124.389 1.075 . . . . 72.02 112.317 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -61.17 -27.99 84.68 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.982 1.788 . . . . 70.02 113.738 171.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -76.07 -48.79 19.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.7 0.8 . . . . 72.01 112.134 -173.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG21 HD11 ' A' ' 68' ' ' LEU . 7.4 p -57.11 -27.21 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.975 0.91 . . . . 75.43 112.362 -175.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.45 -36.32 75.73 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.381 1.072 . . . . 73.44 112.328 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.72 -12.39 20.02 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.063 0.545 . . . . 71.25 111.363 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.694 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 4.6 mmmp? -83.51 143.23 30.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.729 0.812 . . . . 74.54 111.972 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.47 143.59 57.69 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 124.324 1.015 . . . . 74.41 110.578 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.428 ' CE3' HD21 ' A' ' 68' ' ' LEU . 65.9 t-105 -93.0 86.69 5.5 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.758 0.79 . . . . 75.24 110.326 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -125.55 79.8 66.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 107.058 -1.46 . . . . 73.42 107.058 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 142.38 11.86 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.326 2.017 . . . . 72.31 112.928 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.55 86.04 3.49 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.257 -1.757 . . . . 74.41 106.257 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' G' ' 189' ' ' ALA . 19.7 t -76.49 93.76 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.02 -0.991 . . . . 74.31 108.966 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.3 tttt -79.22 124.42 28.35 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.55 -0.75 . . . . 75.3 109.096 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' HG ' HD23 ' A' ' 128' ' ' LEU . 2.4 mm? -107.38 112.25 24.97 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.01 -1.107 . . . . 71.33 108.01 170.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 28.9 t70 -105.17 129.86 53.47 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.647 -0.872 . . . . 75.22 108.647 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.657 ' HB2' HD12 ' G' ' 186' ' ' LEU . 31.1 tp -106.04 131.93 52.73 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.174 -0.676 . . . . 75.43 109.174 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -143.0 152.61 42.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.131 -1.063 . . . . 74.32 108.131 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -138.01 156.59 47.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.929 0.892 . . . . 71.31 109.313 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 153.75 34.42 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.139 0.975 . . . . 75.34 108.797 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.46 152.43 51.52 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.896 0.478 . . . . 74.51 110.754 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -149.94 121.19 7.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.998 0.919 . . . . 63.12 109.046 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.37 -0.604 . . . . 74.13 109.37 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.428 HD12 HG23 ' A' ' 83' ' ' ILE . 68.7 mt -88.58 -43.38 11.42 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.581 -0.736 . . . . 75.01 111.048 -175.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 -174.87 4.7 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.411 -0.813 . . . . 74.34 110.577 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -75.53 123.33 25.28 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.359 -0.837 . . . . 73.13 108.825 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.605 ' HA ' HD21 ' G' ' 173' ' ' LEU . 20.5 m-20 72.33 14.78 5.38 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.304 1.442 . . . . 73.21 111.77 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.26 114.13 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.771 0.828 . . . . 74.42 110.381 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -124.26 126.14 45.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.742 0.817 . . . . 72.23 108.992 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 33.8 tt0 -90.34 120.43 31.46 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.406 1.082 . . . . 60.15 109.152 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.499 HG21 ' HG ' ' A' ' 98' ' ' LEU . 21.5 t -102.61 116.71 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.73 -1.211 . . . . 53.2 107.73 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.578 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.0 t -99.23 126.28 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.038 -0.727 . . . . 74.11 109.038 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.27 115.67 31.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.349 -1.352 . . . . 75.01 107.349 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -108.83 105.38 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.42 0.628 . . . . 74.11 109.742 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -101.99 133.51 45.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.778 -1.101 . . . . 74.34 108.152 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.2 m -121.69 118.23 28.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.372 0.606 . . . . 73.34 110.528 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.7 t -105.6 107.08 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.701 -1.136 . . . . 75.45 108.931 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 12.4 m -106.51 131.78 53.28 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.625 -0.88 . . . . 75.34 108.625 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.78 107.78 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.073 -1.084 . . . . 72.24 108.073 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.565 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 44.8 m -115.24 126.98 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.643 0.377 . . . . 63.1 110.392 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.546 HD11 HG21 ' A' ' 31' ' ' VAL . 18.9 mt -88.97 58.95 4.8 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.093 -1.077 . . . . 75.54 108.093 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.36 -89.0 0.71 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-N 114.999 -1.001 . . . . 72.22 112.136 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -92.92 -28.1 16.67 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.049 0.94 . . . . 74.21 110.709 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.694 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -107.54 103.53 12.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.592 0.757 . . . . 75.5 109.631 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 91.8 m -66.03 130.34 42.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.638 0.654 . . . . 74.4 109.576 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.25 -56.3 4.57 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.806 0.843 . . . . 75.4 109.831 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.5 172.92 16.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.83 -1.077 . . . . 73.42 111.36 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -132.09 144.42 50.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.138 -1.392 . . . . 73.53 108.276 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -136.82 139.82 42.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.895 0.878 . . . . 72.14 108.665 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.453 ' HG2' ' OE1' ' A' ' 79' ' ' GLN . 43.6 tt0 -149.77 120.22 7.41 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.465 -0.568 . . . . 73.35 109.465 173.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.65 113.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.457 0.703 . . . . 71.21 110.485 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.453 ' OE1' ' HG2' ' A' ' 77' ' ' GLU . 1.7 mp0 -89.0 80.48 7.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.388 1.475 . . . . 74.24 108.36 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.36 94.27 3.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.713 -1.13 . . . . 73.14 108.879 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.88 140.74 19.65 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.409 -0.677 . . . . 64.41 111.409 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.619 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -142.89 122.22 1.88 Allowed Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.417 -1.073 . . . . 73.21 110.417 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.0 mt -83.74 125.91 40.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.685 -0.857 . . . . 72.4 108.685 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -128.36 120.47 27.06 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.079 -0.711 . . . . 64.24 109.079 -177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.3 t -81.27 102.17 10.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.504 0.722 . . . . 61.12 109.295 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 149.84 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.375 0.67 . . . . 73.23 110.402 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.07 177.06 2.01 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.708 1.203 . . . . 73.04 109.58 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.548 ' H ' ' HB1' ' G' ' 172' ' ' ALA . . . 90.36 -34.35 4.19 Favored Glycine 0 N--CA 1.473 1.122 0 CA-C-N 116.126 -0.488 . . . . 73.44 114.076 173.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.557 HG22 ' HG2' ' A' ' 9' ' ' MET . 1.6 pp -110.55 150.85 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.97 0.908 . . . . 71.24 108.772 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.644 ' HA ' ' SD ' ' G' ' 174' ' ' MET . 44.8 mt-10 -136.37 176.94 8.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.121 0.568 . . . . 74.51 112.065 -171.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.41 -126.71 40.52 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.118 -0.947 . . . . 74.25 113.089 172.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 40.9 p -71.45 -15.06 62.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.689 0.796 . . . . 71.35 112.568 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -72.15 -45.65 59.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.475 0.71 . . . . 63.4 110.584 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.507 ' HG3' ' HE3' ' G' ' 174' ' ' MET . 1.0 OUTLIER -82.97 -28.99 29.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.443 0.697 . . . . 74.43 109.981 177.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.487 ' HB2' ' HG2' ' G' ' 180' ' ' PRO . . . -72.93 -22.99 60.64 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.195 0.598 . . . . 62.51 111.177 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -65.89 -46.55 77.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.906 0.882 . . . . 74.43 109.616 169.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.598 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.4 m -60.55 -64.72 0.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.711 -1.131 . . . . 70.22 110.318 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.499 ' HG ' HG21 ' A' ' 58' ' ' VAL . 9.7 mp -73.8 -9.91 59.14 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.898 0.703 . . . . 73.54 112.898 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.89 -29.4 13.1 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.795 -0.447 . . . . 61.13 113.747 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.522 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -145.33 -44.47 0.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.876 0.695 . . . . 72.42 112.876 -172.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.9 t80 -78.32 -60.44 2.37 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.246 0.618 . . . . 53.42 112.318 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 97' ' ' CYS . 59.1 m -66.64 -37.9 16.99 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 114.325 1.231 . . . . 64.21 114.325 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.51 -27.05 69.97 Favored 'Trans proline' 0 C--N 1.391 2.767 0 CA-C-N 121.391 1.533 . . . . 74.42 112.664 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -73.0 -26.5 61.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.974 0.509 . . . . 75.02 110.149 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -64.78 -43.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.311 0.576 . . . . 70.44 109.568 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.619 HD22 ' HA3' ' A' ' 82' ' ' GLY . 92.4 mt -76.85 -26.45 54.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.093 -0.958 . . . . 71.23 112.031 -175.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -64.32 -36.67 20.12 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.52 1.304 . . . . 62.44 114.52 -168.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 -34.37 95.03 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.074 1.849 . . . . 53.14 113.292 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -85.65 -36.29 20.39 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.667 0.787 . . . . 74.54 111.149 -174.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.89 85.03 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.377 -0.601 . . . . 65.42 109.377 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -53.16 -56.48 16.05 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.798 1.311 . . . . 63.51 109.492 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.8 -41.84 87.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.156 0.982 . . . . 74.02 111.8 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.479 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 48.3 t -62.5 -50.5 71.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.357 0.663 . . . . 74.44 110.674 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.531 HG21 HG22 ' A' ' 64' ' ' VAL . 89.7 mt -61.83 -51.22 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.92 0.763 . . . . 75.23 110.451 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.6 m -51.57 -45.16 63.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.923 1.289 . . . . 74.25 111.4 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -73.41 -41.49 63.23 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.841 -1.072 . . . . 64.31 110.833 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.564 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 21.5 mtp -55.13 -43.47 74.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.652 0.781 . . . . 75.11 111.424 175.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.08 -45.81 93.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.523 -1.217 . . . . 51.3 111.103 -177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.677 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.2 p -69.18 -32.52 71.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.383 0.273 . . . . 60.33 111.595 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.54 -28.43 67.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.614 0.766 . . . . 74.52 110.829 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.96 67.14 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.475 0.484 . . . . 63.11 113.496 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.413 ' HB ' HH21 ' B' ' 15' ' ' ARG . 9.5 m 64.07 43.24 5.2 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.74 1.216 . . . . 71.31 110.525 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.4 156.63 50.82 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 114.908 -1.042 . . . . 73.11 108.918 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.27 115.56 3.39 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.98 1.787 . . . . 72.43 110.395 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.677 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 8.5 pt20 -62.92 143.18 57.92 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.422 0.451 . . . . 65.33 110.222 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.84 122.16 46.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.88 -0.785 . . . . 73.55 108.88 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -97.11 94.15 6.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.429 HD23 ' HG ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -68.05 126.18 28.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.274 -0.875 . . . . 75.41 109.893 -172.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' G' ' 187' ' ' ILE . . . -66.08 128.13 93.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 O-C-N 123.466 0.479 . . . . 74.22 110.537 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.19 123.74 5.71 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.615 2.21 . . . . 74.34 111.567 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.4 112.43 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.129 -1.063 . . . . 73.11 108.129 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -90.91 72.26 6.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.082 -1.081 . . . . 72.32 108.082 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -62.85 -29.66 70.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.032 -0.985 . . . . 71.43 111.103 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.95 -29.74 69.68 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.278 1.031 . . . . 75.23 111.933 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.31 93.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.924 0.489 . . . . 71.11 110.568 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.16 -38.55 60.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.38 -0.827 . . . . 74.24 110.047 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t80 -55.55 -50.18 70.7 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.623 1.169 . . . . 75.2 110.951 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.7 mmt -61.83 -44.58 96.55 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 74.34 111.469 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -65.02 -33.39 75.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.261 0.624 . . . . 75.3 111.567 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -74.12 -37.11 64.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.437 -0.801 . . . . 74.33 110.634 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 65.0 mt -67.51 -49.73 62.08 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.373 0.42 . . . . 73.14 111.059 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -165.74 -17.04 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.453 0.538 . . . . 75.34 112.453 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 62.15 105.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.603 1.161 . . . . 72.05 110.103 -172.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.8 -60.82 2.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.965 0.506 . . . . 74.23 111.53 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.86 34.89 16.77 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.362 1.065 . . . . 53.42 111.068 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.3 -110.96 1.65 Allowed Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.714 -0.676 . . . . 70.32 112.383 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 53.17 70.88 0.54 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.92 1.288 . . . . 63.04 110.891 -177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.36 72.8 0.08 OUTLIER Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.166 -0.47 . . . . 64.21 112.609 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 61.0 p -94.29 -62.63 1.3 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.6 -0.889 . . . . 70.32 108.6 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 73.9 -29.83 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.03 1.732 . . . . 75.04 112.643 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.42 109.64 0.58 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.806 1.242 . . . . 74.21 109.593 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 170.33 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.272 1.829 . . . . 73.12 108.715 166.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -97.16 0.49 48.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.679 0.792 . . . . 72.23 110.667 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.51 118.66 11.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.828 0.851 . . . . 74.3 110.435 -173.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.844 0.857 . . . . 53.03 109.003 175.851 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.864 -0.791 . . . . 74.41 108.864 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -74.0 -5.85 43.84 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.744 0.818 . . . . 53.52 111.716 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' D' ' 141' ' ' LEU . 9.8 pt-20 -60.87 -17.59 51.19 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.864 0.865 . . . . 75.21 112.099 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.09 166.12 8.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.681 0.792 . . . . 74.43 111.376 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -137.86 154.7 49.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.87 0.468 . . . . 74.41 110.777 177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' D' ' 135' ' ' ALA . 5.8 m-20 -112.26 41.64 1.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.584 -0.895 . . . . 72.12 108.584 169.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -84.13 60.78 6.11 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 123.101 1.429 . . . . 75.43 107.562 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' B' ' 9' ' ' MET . 23.6 tt0 -161.41 177.18 10.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.957 -1.929 . . . . 74.52 106.58 -170.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.639 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 17.9 ptm 56.13 176.45 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.931 1.693 . . . . 74.41 113.285 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.2 m -150.96 125.99 9.84 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.423 -1.325 . . . . 74.12 107.423 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -143.18 132.22 22.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.485 -0.932 . . . . 74.33 108.485 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -154.12 140.93 19.12 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.396 0.435 . . . . 53.13 111.702 173.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.562 HD12 HD11 ' B' ' 16' ' ' ILE . 58.8 mt -84.66 115.04 25.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.45 -0.944 . . . . 74.33 108.45 168.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -87.9 -35.07 17.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.604 0.565 . . . . 73.23 110.039 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.413 HH21 ' HB ' ' A' ' 122' ' ' THR . 70.8 ttt180 -167.27 137.73 2.98 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.139 -0.482 . . . . 75.01 110.045 -177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.562 HD11 HD12 ' B' ' 13' ' ' ILE . 98.0 mt -116.98 135.95 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.934 -1.506 . . . . 73.11 106.934 169.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.524 ' CE2' ' HB2' ' A' ' 28' ' ' ALA . 16.2 p90 -168.99 152.04 5.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.274 0.559 . . . . 72.43 111.479 -170.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.2 m -83.04 121.48 27.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.343 -0.984 . . . . 75.34 108.343 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -92.24 -32.88 14.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.102 0.561 . . . . 73.34 110.773 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 25.7 t70 -155.95 142.42 18.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.981 -0.554 . . . . 75.45 110.851 -168.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 34.4 mm -138.87 142.08 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 62.51 108.881 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 41.4 t -141.36 133.76 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.451 -1.25 . . . . 52.33 107.856 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.0 t80 -147.34 107.54 4.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.493 -1.299 . . . . 74.45 107.493 171.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.45 120.97 39.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.127 0.971 . . . . 70.53 108.656 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.23 87.19 34.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.959 0.904 . . . . 70.15 109.857 -174.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 -48.83 4.66 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.904 2.403 . . . . 64.14 112.672 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.494 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 28.1 m-80 -104.11 28.57 6.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.204 0.602 . . . . 73.33 110.66 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.522 ' HA ' ' HZ ' ' B' ' 123' ' ' PHE . . . -49.99 -51.66 59.58 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.885 1.274 . . . . 70.34 113.411 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.434 ' HD3' ' HB1' ' B' ' 28' ' ' ALA . 97.2 Cg_endo -86.98 -13.06 4.73 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.435 2.09 . . . . 62.42 113.394 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.494 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 88.3 m-70 -89.27 2.97 53.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.378 0.671 . . . . 73.24 111.078 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -62.66 -16.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.973 1.309 . . . . 72.22 111.942 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.893 0.877 . . . . 75.25 111.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.14 -45.91 72.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.775 -0.648 . . . . 62.13 110.806 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.644 ' HZ2' ' HB3' ' B' ' 71' ' ' GLU . 89.4 mttt -109.07 81.61 1.47 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.721 0.809 . . . . 74.03 109.511 -176.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -80.24 74.11 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.114 0.959 . . . . 70.43 111.41 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -159.29 174.28 15.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.997 1.319 . . . . 75.33 109.745 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.74 129.97 80.09 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 115.284 -0.871 . . . . 75.2 109.757 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.15 153.41 69.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.341 2.028 . . . . 72.4 111.723 167.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.3 mt-10 -65.65 99.79 0.47 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.05 -1.092 . . . . 73.13 108.05 172.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.516 HG13 ' HB2' ' B' ' 126' ' ' LEU . 21.7 t -87.18 117.43 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.413 -1.328 . . . . 74.13 107.413 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -151.67 132.86 14.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.066 -0.716 . . . . 74.24 109.066 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.615 ' HB3' HG21 ' B' ' 64' ' ' VAL . 1.5 pt? -128.92 164.55 22.89 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.032 0.444 . . . . 74.42 111.877 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -149.49 149.93 31.54 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.963 -1.017 . . . . 72.41 109.556 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.449 ' HB2' HD13 ' F' ' 186' ' ' LEU . 7.9 tt -107.14 136.69 46.56 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 74.5 111.121 -170.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.697 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 1.2 m-20 -123.61 150.92 43.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.223 1.409 . . . . 73.14 107.574 172.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -136.41 134.19 37.5 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.77 147.38 27.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.348 1.059 . . . . 72.42 108.237 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -142.65 162.54 35.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.843 0.457 . . . . 74.12 110.555 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -154.33 166.4 33.33 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.566 1.146 . . . . 73.45 109.064 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -115.05 132.67 56.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.858 0.463 . . . . 73.41 110.373 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.93 -48.19 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.859 0.864 . . . . 74.25 110.063 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.86 -175.81 5.48 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.797 -1.092 . . . . 75.55 109.779 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -61.43 122.05 14.19 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.241 -0.89 . . . . 74.42 109.455 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 71.69 -5.29 1.69 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.23 1.412 . . . . 75.41 111.882 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -109.64 100.21 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.301 1.04 . . . . 75.13 108.715 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.49 172.44 6.97 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.623 0.769 . . . . 71.03 110.814 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -144.04 115.45 8.05 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.903 -1.517 . . . . 75.35 106.903 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.473 HG21 ' HB2' ' B' ' 98' ' ' LEU . 43.3 t -117.33 125.6 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.54 0.736 . . . . 74.13 109.805 -173.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.6 t -106.29 121.16 58.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.993 0.917 . . . . 73.2 110.319 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -93.81 114.47 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 107.653 -1.24 . . . . 72.52 107.653 170.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.697 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.0 ttm180 -100.64 112.56 24.96 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.11 118.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.11 -1.071 . . . . 74.41 108.11 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.2 m -115.9 137.08 52.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.616 0.766 . . . . 72.35 109.812 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' B' ' 42' ' ' LEU . 94.1 t -111.85 119.99 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.842 1.257 . . . . 74.22 110.453 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 67.5 m -89.67 140.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.896 -1.15 . . . . 63.41 107.896 165.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.54 143.61 26.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.013 -0.366 . . . . 71.02 110.013 175.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.6 p -156.03 135.2 12.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.687 0.625 . . . . 75.33 112.687 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -92.88 99.1 11.82 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.548 -1.279 . . . . 64.32 107.548 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.44 -130.93 41.13 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.65 0.594 . . . . 65.31 112.494 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -90.89 44.92 1.22 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.025 0.93 . . . . 74.22 110.091 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.644 ' HB3' ' HZ2' ' B' ' 34' ' ' LYS . 10.4 tp10 -158.06 139.02 13.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.455 0.702 . . . . 72.13 109.42 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.0 m -72.85 133.12 44.3 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.021 0.529 . . . . 71.43 110.466 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 -56.18 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.839 0.856 . . . . 71.43 109.281 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -152.85 165.93 33.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.301 -1.318 . . . . 72.12 109.83 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -140.73 121.07 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.419 -1.697 . . . . 73.3 106.419 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.549 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.4 t -116.31 158.96 22.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.319 -0.993 . . . . 74.41 108.319 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.424 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.3 tt0 -165.88 130.36 2.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.131 -0.692 . . . . 74.21 109.131 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -124.33 142.93 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.229 -1.026 . . . . 65.01 108.229 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.576 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -122.05 87.22 2.71 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.126 -1.065 . . . . 72.24 108.126 172.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.431 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -80.59 101.05 8.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.235 -1.348 . . . . 64.23 108.539 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.66 171.13 37.53 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.404 -0.678 . . . . 75.33 111.404 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.92 131.61 2.46 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.2 -0.76 . . . . 75.42 111.2 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.12 122.87 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.376 -1.342 . . . . 70.41 107.376 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -129.85 129.73 44.34 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.653 -1.24 . . . . 75.22 107.653 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -97.41 102.65 14.47 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.216 -0.661 . . . . 64.41 109.216 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.36 138.41 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.177 0.991 . . . . 74.03 110.901 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.8 172.06 19.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.449 1.099 . . . . 75.32 109.585 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.639 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 89.64 -43.28 2.99 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-N 116.173 -0.467 . . . . 62.21 112.859 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 163.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.934 0.894 . . . . 75.33 111.019 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.407 ' HA ' ' SD ' ' F' ' 174' ' ' MET . 9.9 pt-20 -159.37 143.82 15.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.005 0.522 . . . . 74.33 110.873 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.11 -104.36 0.45 Allowed Glycine 0 C--N 1.353 1.515 0 O-C-N 124.226 0.954 . . . . 44.12 114.121 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.3 m -65.88 -41.35 91.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.231 1.012 . . . . 65.03 110.258 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -61.33 -40.56 94.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.475 -0.784 . . . . 75.3 111.035 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.636 ' HE3' HD22 ' B' ' 98' ' ' LEU . 20.2 ttt -71.52 -40.7 69.93 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.509 0.505 . . . . 72.11 110.676 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.3 66.96 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.466 -0.788 . . . . 73.13 111.692 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -93.73 -21.22 19.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.973 0.909 . . . . 74.33 110.648 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -79.17 -67.2 0.78 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.563 -0.532 . . . . 75.14 109.563 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.636 HD22 ' HE3' ' B' ' 94' ' ' MET . 2.2 pp -95.34 -4.85 44.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.177 0.806 . . . . 71.01 113.177 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -3.21 56.59 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 120.04 -0.311 . . . . 73.53 112.665 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.05 -56.51 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.013 0.375 . . . . 74.13 112.013 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -74.78 -41.26 60.35 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.106 0.41 . . . . 75.51 112.106 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 85.6 m -68.9 -45.72 31.68 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.698 -0.668 . . . . 73.35 110.532 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.495 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.6 Cg_exo -55.69 -31.54 80.28 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.132 1.888 . . . . 73.52 113.895 165.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.409 HD21 ' HE1' ' B' ' 133' ' ' PHE . 54.6 t-20 -66.97 -40.79 87.53 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 122.886 0.474 . . . . 72.42 110.173 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.492 HG22 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -58.57 -49.17 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.66 0.784 . . . . 74.51 109.871 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.71 -9.64 59.67 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.781 -1.1 . . . . 74.43 112.005 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.502 ' HZ ' HD11 ' B' ' 128' ' ' LEU . 76.9 t80 -64.94 -51.06 59.18 Favored Pre-proline 0 N--CA 1.484 1.256 0 CA-C-O 117.991 -1.004 . . . . 74.12 113.402 -172.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.79 -35.8 87.14 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.788 1.658 . . . . 74.25 112.174 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.431 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.7 m-85 -64.17 -47.87 78.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.745 0.818 . . . . 74.34 110.858 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.61 91.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.379 -0.828 . . . . 54.14 110.467 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -65.1 -45.0 86.99 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.375 1.07 . . . . 75.31 109.948 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.08 -37.82 69.52 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.148 -0.933 . . . . 72.11 110.132 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 10.0 t -64.97 -35.69 82.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.945 0.498 . . . . 75.3 110.993 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.7 -53.31 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.22 0.608 . . . . 72.01 109.778 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -56.74 -31.55 64.68 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.139 0.899 . . . . 73.13 110.892 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -64.38 -53.26 51.42 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 114.805 -1.089 . . . . 74.51 110.111 172.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.4 mmt -66.53 -33.84 76.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.065 0.394 . . . . 72.02 112.065 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.25 -40.86 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.731 0.812 . . . . 71.32 109.906 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.6 p -73.03 -29.31 62.89 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.022 -0.535 . . . . 75.35 111.642 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.479 ' NH1' ' HA ' ' A' ' 113' ' ' CYS . 72.5 mtt-85 -65.73 -36.9 84.92 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.46 -0.791 . . . . 75.43 109.484 172.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.98 3.61 69.88 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 124.024 0.827 . . . . 75.31 113.5 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.4 p 59.56 29.67 19.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.824 1.65 . . . . 73.11 112.748 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.522 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 63.7 m-85 -102.24 155.51 36.39 Favored Pre-proline 0 N--CA 1.488 1.461 0 C-N-CA 124.206 1.003 . . . . 73.42 111.278 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.65 178.85 0.83 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.731 2.954 . . . . 74.04 115.662 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.565 HE22 ' HB1' ' F' ' 189' ' ' ALA . 1.4 pp0? -64.93 152.85 42.13 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.56 -1.655 . . . . 73.31 114.573 -162.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.573 HD22 HD12 ' B' ' 42' ' ' LEU . 26.6 tp -149.32 106.08 3.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.003 -1.453 . . . . 75.22 108.861 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.52 92.36 2.9 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.588 -1.264 . . . . 73.24 107.588 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' F' ' 186' ' ' LEU . 2.4 tt -58.95 141.45 53.68 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.745 -1.116 . . . . 75.45 109.649 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.53 ' H ' HD11 ' F' ' 187' ' ' ILE . . . -57.46 106.48 0.69 Allowed Pre-proline 0 N--CA 1.477 0.912 0 O-C-N 124.359 1.037 . . . . 65.33 110.831 173.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.642 ' HB2' ' HB ' ' D' ' 16' ' ' ILE . 6.1 Cg_exo -79.3 123.16 5.42 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.662 2.241 . . . . 72.21 109.739 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.408 HG23 ' HB ' ' D' ' 13' ' ' ILE . 10.0 p -155.44 155.34 5.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 123.694 0.621 . . . . 74.54 109.732 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.496 ' H ' HD12 ' D' ' 13' ' ' ILE . 32.6 t30 -69.09 114.47 7.39 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 107.784 -1.191 . . . . 75.41 107.784 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.409 ' HE1' HD21 ' B' ' 104' ' ' ASN . 46.3 p90 -50.12 -35.64 26.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.507 1.123 . . . . 74.12 112.015 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.93 -45.45 70.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.398 1.079 . . . . 64.41 110.917 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.25 80.05 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.792 0.437 . . . . 75.23 110.749 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.2 tt -71.29 -34.67 70.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.368 0.667 . . . . 63.44 110.094 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -63.13 -48.38 78.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.203 0.601 . . . . 73.45 110.38 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -37.9 87.61 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.807 0.813 . . . . 72.43 109.387 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.58 1.79 54.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.702 -1.136 . . . . 74.25 111.545 -175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -89.88 -41.71 11.64 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.767 -0.457 . . . . 75.23 109.767 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 9.87 25.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.346 0.658 . . . . 71.01 112.037 -176.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.73 177.47 8.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.124 0.57 . . . . 73.15 111.155 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -143.71 84.01 1.78 Allowed 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.541 -1.281 . . . . 74.04 107.541 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -167.65 105.22 0.52 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.436 -0.802 . . . . 71.44 108.915 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.2 111.37 5.09 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.867 -0.79 . . . . 71.15 108.867 171.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.44 93.33 0.11 Allowed Glycine 0 C--N 1.342 0.913 0 O-C-N 123.701 0.626 . . . . 61.22 111.894 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.75 159.59 27.85 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.279 -0.637 . . . . 71.04 109.279 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.68 125.19 3.12 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.558 -1.017 . . . . 73.5 110.558 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.7 t -159.65 -178.06 6.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.098 -0.705 . . . . 71.42 109.098 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -155.38 145.0 21.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.044 -1.095 . . . . 73.51 108.044 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.5 5.67 1.23 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.161 0.584 . . . . 74.2 111.582 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -87.46 97.98 11.13 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.472 -0.566 . . . . 74.03 109.472 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -87.93 120.41 29.24 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.985 0.514 . . . . 72.41 109.988 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.41 -28.77 66.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.779 0.832 . . . . 52.33 111.371 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 124.083 0.953 . . . . 75.23 110.397 -177.6 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtm . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.613 -0.232 . . . . 74.44 110.891 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 34.6 m 66.27 115.9 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.333 1.453 . . . . 74.44 111.524 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -88.92 110.08 20.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.949 0.9 . . . . 71.05 110.003 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.3 20.94 9.66 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.585 1.154 . . . . 75.34 109.246 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -150.98 158.82 44.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.887 0.875 . . . . 75.31 108.702 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -71.99 70.41 0.77 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 122.569 1.176 . . . . 71.2 111.196 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.4 m -152.1 86.4 1.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.13 1.372 . . . . 72.34 107.847 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.01 -56.28 0.14 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.276 -1.379 . . . . 62.22 107.276 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.456 ' HE2' HG21 ' C' ' 89' ' ' ILE . 53.8 ttm 64.53 112.65 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.616 1.566 . . . . 74.52 111.176 -176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 38.9 m -104.78 103.96 13.66 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.553 -1.277 . . . . 52.24 107.553 167.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -120.94 119.01 31.35 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.133 -1.432 . . . . 72.44 107.133 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -146.13 136.3 23.71 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 171.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.429 HD13 ' O ' ' C' ' 83' ' ' ILE . 5.5 tp -80.47 132.17 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.369 -0.832 . . . . 73.23 108.79 169.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.462 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 76.2 mm-40 -99.59 -45.61 5.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.263 -0.881 . . . . 71.23 109.866 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -165.41 122.03 1.44 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.512 -0.767 . . . . 72.41 109.174 -170.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 56.1 mt -112.95 134.53 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.319 -1.363 . . . . 74.04 107.319 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.507 ' HH ' HD11 ' C' ' 83' ' ' ILE . 18.9 p90 -173.71 168.86 4.32 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 123.816 0.698 . . . . 73.04 110.636 -173.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -91.3 128.29 37.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.26 -0.882 . . . . 74.52 109.615 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.469 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 30.0 mmtp -80.01 -52.79 7.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.577 0.703 . . . . 75.11 109.413 170.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 28.9 t70 -135.75 115.09 12.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.6 -1.182 . . . . 75.21 109.267 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 54.8 mt -111.27 139.46 35.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.515 -1.661 . . . . 74.32 106.515 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -152.74 142.51 22.01 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.276 0.56 . . . . 43.32 109.819 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -132.48 133.77 44.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.322 -1.362 . . . . 74.54 107.322 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -125.89 127.55 46.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.954 -1.128 . . . . 74.31 107.954 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.7 76.61 12.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.867 -1.16 . . . . 63.01 107.867 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.62 -27.57 22.2 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.486 2.124 . . . . 63.44 110.785 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -106.56 29.12 7.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.484 1.113 . . . . 61.43 109.558 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -58.59 -50.67 86.76 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.072 1.138 . . . . 72.45 114.072 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 86.4 Cg_endo -86.21 -15.99 4.28 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.367 1.378 . . . . 73.44 112.356 171.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -72.12 -29.65 64.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.429 1.092 . . . . 73.52 111.548 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.616 HG23 HD12 ' C' ' 68' ' ' LEU . 14.7 p -79.03 -18.15 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.69 0.796 . . . . 74.0 111.842 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -53.99 -41.65 68.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.487 1.115 . . . . 72.33 112.201 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 52.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.509 -0.922 . . . . 71.3 108.509 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.505 ' HG2' ' HG2' ' C' ' 71' ' ' GLU . 0.1 OUTLIER -125.56 164.92 19.48 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.816 -0.552 . . . . 73.43 110.337 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.34 104.06 1.77 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.542 -0.91 . . . . 63.22 108.542 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.93 88.46 7.44 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.252 1.025 . . . . 74.22 112.616 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -133.1 71.43 77.46 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.62 1.168 . . . . 74.13 108.611 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.33 127.26 12.44 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.473 2.115 . . . . 73.13 111.638 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.702 ' HA ' ' HA2' ' E' ' 191' ' ' GLY . 42.1 tt0 -87.09 112.91 22.37 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 72.22 108.525 173.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.454 HG11 HD23 ' C' ' 126' ' ' LEU . 21.8 t -79.88 80.49 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.141 -0.936 . . . . 71.42 108.691 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.509 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 25.5 tptp -90.95 102.03 14.79 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.585 -0.894 . . . . 65.32 108.585 -175.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.91 152.54 22.0 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.605 -0.725 . . . . 72.11 109.817 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 4.6 m-20 -139.75 136.36 34.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.075 0.95 . . . . 74.21 109.336 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.511 HD23 HD13 ' E' ' 186' ' ' LEU . 42.0 tp -112.8 108.88 18.04 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.768 0.827 . . . . 71.51 109.283 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 14.4 t70 -113.77 148.05 37.22 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.64 -1.245 . . . . 72.31 107.64 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 63.2 m -126.97 126.38 43.1 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.934 0.494 . . . . 62.14 109.884 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.13 146.32 45.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.11 -1.07 . . . . 75.14 108.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -149.37 143.66 25.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.77 0.828 . . . . 73.32 109.049 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 34.8 p -154.66 129.28 9.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.369 0.667 . . . . 73.03 110.45 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.29 133.95 42.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 110.037 -0.357 . . . . 75.13 110.037 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.514 HD13 HD13 ' C' ' 83' ' ' ILE . 47.8 mt -98.66 -52.92 3.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.96 0.904 . . . . 71.24 110.417 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.92 -170.78 3.55 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.304 -0.862 . . . . 74.4 110.581 -170.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.44 109.64 3.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.135 0.974 . . . . 55.12 110.1 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 67.74 -4.02 1.04 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.911 1.285 . . . . 72.52 112.762 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.9 t -92.93 111.96 25.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 N-CA-C 108.308 -0.997 . . . . 72.4 108.308 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -119.04 157.88 26.93 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.197 0.999 . . . . 71.1 108.433 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.62 139.44 53.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.578 -0.897 . . . . 72.3 108.578 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.57 116.84 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.307 -1.368 . . . . 74.12 107.307 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.81 105.54 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.523 -0.917 . . . . 64.51 108.523 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.11 122.16 29.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.841 -1.17 . . . . 74.33 107.841 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 60.0 mtp180 -105.44 114.04 27.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.834 0.854 . . . . 75.13 110.036 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.518 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.9 t -106.91 128.24 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.1 -0.704 . . . . 72.45 109.1 172.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 14.3 m -111.59 138.14 48.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.473 -0.936 . . . . 65.42 108.473 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.701 HG23 HG21 ' C' ' 114' ' ' ILE . 97.5 t -123.19 112.22 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.957 -1.127 . . . . 73.44 107.957 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.75 142.57 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.86 -0.793 . . . . 72.52 108.86 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.17 102.9 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.758 -1.571 . . . . 74.22 106.758 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -136.77 142.82 42.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.38 0.61 . . . . 72.15 111.275 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.616 HD12 HG23 ' C' ' 31' ' ' VAL . 17.6 mt -94.02 30.62 1.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.405 1.482 . . . . 74.31 109.369 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.93 -110.58 2.81 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 109.773 -1.331 . . . . 63.51 109.773 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 -22.45 19.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.071 0.548 . . . . 74.42 110.513 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HG2' ' C' ' 34' ' ' LYS . 11.4 tp10 -79.58 90.1 5.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.03 0.932 . . . . 74.13 109.706 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -73.04 123.25 23.16 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 120.953 0.406 . . . . 75.12 110.987 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.24 26.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.68 1.192 . . . . 74.42 109.779 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.08 168.57 24.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.223 -0.899 . . . . 71.35 110.896 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -136.44 136.52 39.58 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.311 -1.737 . . . . 64.25 106.311 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -146.8 113.05 5.87 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.097 0.408 . . . . 71.1 109.989 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -118.43 133.21 56.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.546 -0.538 . . . . 72.03 109.546 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 54.9 t -119.3 143.36 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.508 -0.923 . . . . 75.31 108.508 169.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -119.57 94.44 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.246 -1.02 . . . . 75.05 108.246 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -81.77 106.49 13.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.783 0.833 . . . . 73.02 110.822 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.01 146.8 23.27 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.201 -0.454 . . . . 74.32 112.542 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.436 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.16 120.72 1.29 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.23 -0.748 . . . . 74.03 111.23 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.514 HD13 HD13 ' C' ' 51' ' ' LEU . 14.8 mm -90.97 115.51 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.18 -0.674 . . . . 70.35 109.18 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -120.9 117.37 27.19 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.642 -0.873 . . . . 73.0 108.642 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -88.46 104.75 17.09 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.608 -1.256 . . . . 71.35 107.608 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' C' ' 10' ' ' THR . 1.8 pp -130.97 138.25 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.296 0.638 . . . . 75.23 112.038 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.74 163.02 18.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.813 1.245 . . . . 55.14 109.83 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 -26.2 7.88 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.293 -0.412 . . . . 63.1 113.287 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.579 HD11 ' SD ' ' E' ' 174' ' ' MET . 0.2 OUTLIER -67.98 145.62 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.443 1.097 . . . . 74.42 110.213 176.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.581 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 0.4 OUTLIER -155.41 146.11 22.22 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.767 -0.457 . . . . 75.12 109.767 -179.078 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.84 -121.61 23.9 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.459 0.475 . . . . 74.41 113.513 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 36.1 p -64.16 -25.9 68.29 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.015 0.926 . . . . 64.25 111.875 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -59.54 -56.03 27.06 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.263 0.625 . . . . 74.21 109.839 174.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.581 ' HE1' ' HA ' ' C' ' 90' ' ' GLU . 14.3 ptp -77.58 -28.19 51.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.847 0.459 . . . . 73.14 111.897 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.53 -45.48 75.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.34 0.656 . . . . 74.34 110.802 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -78.76 -33.98 46.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.073 -0.512 . . . . 73.54 110.259 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 38.8 t -63.82 -59.99 3.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.96 0.504 . . . . 72.33 111.047 -177.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 tt -71.63 -35.84 70.54 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.521 -0.548 . . . . 74.14 109.521 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.66 -4.68 90.22 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.163 -0.798 . . . . 70.04 114.882 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -155.08 -60.47 0.11 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.396 1.098 . . . . 72.12 112.143 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -60.68 -60.54 3.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.006 0.923 . . . . 73.43 113.26 -165.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.472 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 64.7 m -59.72 -47.71 96.87 Favored Pre-proline 0 CA--C 1.564 1.512 0 N-CA-C 113.181 0.808 . . . . 75.31 113.181 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.24 -32.05 42.95 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 120.982 1.386 . . . . 75.42 113.014 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -67.78 -27.88 67.13 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.958 0.503 . . . . 62.22 110.625 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.83 -42.61 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 65.12 110.15 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.436 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -78.87 -21.63 47.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.427 -0.806 . . . . 73.53 112.342 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -55.64 -51.98 75.73 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 117.799 -1.096 . . . . 73.14 113.881 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.28 -33.97 92.57 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.026 1.817 . . . . 70.44 113.508 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.89 -45.92 66.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 75.4 110.807 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.02 90.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.446 0.698 . . . . 74.41 110.382 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -54.47 -53.23 57.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.742 1.617 . . . . 75.4 111.127 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.4 -34.34 75.85 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.618 0.767 . . . . 72.42 110.65 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.6 t -70.45 -33.88 71.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.381 0.673 . . . . 74.21 112.107 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.701 HG21 HG23 ' C' ' 64' ' ' VAL . 92.5 mt -72.58 -49.08 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.014 0.526 . . . . 73.32 109.742 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.6 HG22 ' HB2' ' C' ' 125' ' ' GLN . 99.3 m -57.12 -33.98 67.9 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.158 0.911 . . . . 75.33 111.321 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.5 t -58.66 -57.36 13.33 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.57 -1.195 . . . . 73.32 109.743 170.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.617 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.22 -42.53 86.45 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.159 1.384 . . . . 75.21 113.914 -175.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.19 -47.33 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 123.635 0.584 . . . . 72.24 109.836 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -72.29 -22.56 61.18 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.888 -1.051 . . . . 74.25 111.777 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.445 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 86.0 mtt-85 -71.06 -39.26 72.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.118 0.567 . . . . 71.34 109.863 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' D' ' 17' ' ' TYR . . . -79.95 5.26 62.77 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.893 0.746 . . . . 63.42 112.591 171.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.658 ' HB ' HH21 ' D' ' 15' ' ' ARG . 43.0 p 58.04 38.71 26.7 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 74.23 112.143 174.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -102.32 164.15 16.28 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.046 1.338 . . . . 74.23 108.792 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.49 102.54 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.08 1.853 . . . . 74.5 112.336 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.6 ' HB2' HG22 ' C' ' 115' ' ' THR . 0.0 OUTLIER -60.63 140.87 57.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.154 0.582 . . . . 74.13 110.267 177.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.454 HD23 HG11 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -112.2 144.2 41.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.237 0.615 . . . . 74.23 110.912 -173.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -118.21 93.3 4.08 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.948 -1.13 . . . . 65.13 107.948 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.401 ' HB3' HD13 ' E' ' 187' ' ' ILE . 77.9 mt -75.87 133.04 40.67 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.684 -1.144 . . . . 74.42 107.95 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.29 146.99 77.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 124.293 0.996 . . . . 74.51 111.09 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.21 100.63 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.117 2.545 . . . . 74.2 112.728 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.28 82.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.378 -0.828 . . . . 64.23 109.635 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.86 105.49 17.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.49 -1.3 . . . . 64.44 107.49 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -50.86 -41.14 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.424 0.69 . . . . 73.44 112.176 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -57.7 -35.53 70.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.243 1.017 . . . . 64.33 111.974 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.402 ' HB1' HG23 ' A' ' 13' ' ' ILE . . . -62.96 -43.97 97.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.556 0.742 . . . . 71.41 111.523 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.533 HD12 HG11 ' F' ' 207' ' ' VAL . 6.1 mp -77.24 -28.52 53.69 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.52 0.728 . . . . 73.15 110.595 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.21 -47.5 79.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.245 1.018 . . . . 74.23 109.793 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 97.3 mmm -69.41 -47.8 63.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.636 -0.711 . . . . 70.0 110.159 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.07 -41.94 65.34 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.597 1.159 . . . . 74.03 111.551 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -70.51 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.873 -1.058 . . . . 72.55 110.667 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.54 -19.14 64.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.907 1.283 . . . . 75.44 114.111 -160.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -66.23 155.02 38.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.932 0.493 . . . . 72.15 110.039 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -83.15 59.71 5.11 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.695 0.798 . . . . 65.24 112.007 -171.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 67.96 152.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.875 1.67 . . . . 72.52 112.607 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.71 153.97 42.64 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.252 -0.886 . . . . 74.41 111.582 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.654 ' HA2' ' HA ' ' A' ' 6' ' ' ASN . . . -128.34 84.16 0.33 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.7 -0.682 . . . . 75.42 111.726 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.72 165.37 23.15 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.787 0.803 . . . . 73.31 112.527 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.07 -153.3 12.19 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 114.444 -1.253 . . . . 61.41 109.992 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.0 t -171.54 129.36 0.68 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.915 -0.772 . . . . 75.35 108.915 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' G' ' 173' ' ' LEU . 43.2 tt0 -177.78 144.12 0.35 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.284 0.634 . . . . 64.22 110.329 -171.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -109.01 175.26 5.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.332 -0.988 . . . . 64.1 108.332 166.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.521 ' CG ' ' HA ' ' G' ' 174' ' ' MET . 49.8 p-80 -155.27 162.06 40.98 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 122.17 -0.332 . . . . 61.02 111.64 -174.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? 58.52 -76.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.486 1.741 . . . . 75.13 112.306 164.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.0 t70 69.14 88.98 0.11 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.204 1.402 . . . . 71.42 110.04 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.998 0 CA-C-N 115.19 -0.914 . . . . 73.31 110.814 178.475 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.531 ' H2 ' ' HB2' ' H' ' 171' ' ' SER . 46.8 ttm . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 108.049 -1.093 . . . . 74.21 108.049 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 22.2 m 67.78 25.96 7.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.877 1.271 . . . . 73.04 111.294 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -79.08 125.78 29.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.449 -0.575 . . . . 74.21 109.449 174.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -71.52 170.78 12.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.584 0.754 . . . . 74.02 109.266 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.23 84.0 0.75 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.501 0.667 . . . . 74.41 109.604 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.53 4.84 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.552 1.141 . . . . 75.23 109.556 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 46.5 m -115.64 169.23 9.35 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.064 1.345 . . . . 71.21 108.911 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -76.97 57.32 1.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.668 0.787 . . . . 75.35 111.949 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.9 ttp -34.67 125.92 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.421 1.488 . . . . 75.43 112.643 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -135.61 141.54 45.1 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.685 0.794 . . . . 74.21 109.238 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 63.9 t80 -162.58 89.26 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.354 -2.091 . . . . 75.23 105.354 174.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -131.13 144.83 51.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.908 -1.145 . . . . 71.11 107.908 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.496 HD12 ' H ' ' B' ' 132' ' ' ASN . 47.8 mt -104.12 120.17 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 117.676 0.216 . . . . 64.2 111.452 -170.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.34 -28.47 34.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.593 0.757 . . . . 73.13 111.39 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.658 HH21 ' HB ' ' C' ' 122' ' ' THR . 14.1 tpt180 177.89 156.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.691 0.396 . . . . 74.24 110.242 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.642 ' HB ' ' HB2' ' B' ' 130' ' ' PRO . 17.8 mt -141.14 127.52 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 106.439 -1.689 . . . . 75.22 106.439 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.436 ' HB2' ' HA2' ' C' ' 121' ' ' GLY . 47.3 p90 -165.71 173.35 10.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.053 0.93 . . . . 74.52 110.906 -172.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.084 -1.417 . . . . 74.33 109.606 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -82.25 -17.95 44.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.104 -0.702 . . . . 74.35 109.104 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -158.17 135.92 10.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.117 1.367 . . . . 75.43 109.03 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.617 HG21 ' HE1' ' C' ' 117' ' ' MET . 21.1 mt -137.61 145.27 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.877 -1.157 . . . . 63.04 107.877 170.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -144.02 141.29 30.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.391 0.676 . . . . 73.44 110.224 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.1 t80 -147.53 122.61 10.13 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 105.842 -1.91 . . . . 74.11 105.842 169.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.16 123.47 28.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.118 -1.438 . . . . 64.44 107.118 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.04 78.33 41.91 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.545 -0.909 . . . . 64.33 108.545 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.24 -41.81 6.54 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.116 2.544 . . . . 73.43 112.963 -165.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 58.0 m-20 -106.47 17.9 22.7 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 123.884 0.873 . . . . 75.15 110.231 -175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . . . -42.61 -51.29 11.94 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 116.369 1.988 . . . . 72.34 116.369 -164.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 14.9 Cg_endo -88.05 -14.38 3.45 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.807 1.671 . . . . 64.15 113.92 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -75.72 -40.57 55.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.417 1.087 . . . . 72.54 109.034 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.02 -1.07 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 114.702 -1.135 . . . . 75.21 110.257 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.17 -34.95 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.918 1.287 . . . . 74.11 110.578 164.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.95 -12.76 61.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.806 1.243 . . . . 72.44 112.156 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -89.94 101.93 14.63 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.097 0.959 . . . . 62.34 109.188 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.557 ' HB2' ' HA ' ' H' ' 196' ' ' LYS . 10.7 p-10 -99.37 52.56 0.95 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.145 0.978 . . . . 71.55 111.234 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.45 -169.46 3.22 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.489 -0.778 . . . . 72.33 109.246 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -78.07 118.27 71.14 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.243 1.017 . . . . 74.23 111.528 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -65.47 97.39 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.304 2.003 . . . . 73.33 109.682 167.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.63 115.51 4.79 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 124.337 1.023 . . . . 74.43 109.847 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 m -97.09 113.31 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.908 0.861 . . . . 74.12 109.555 -174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.548 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.8 tmtt? -88.3 118.56 27.99 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.175 -1.417 . . . . 75.11 107.175 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.45 HD21 HD23 ' D' ' 128' ' ' LEU . 10.2 mp -94.27 144.33 25.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.623 -0.88 . . . . 72.31 108.623 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 24.6 t70 -145.27 118.66 9.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.142 -0.936 . . . . 64.21 108.839 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.525 HD22 HD11 ' H' ' 186' ' ' LEU . 48.5 tp -96.79 130.39 44.05 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.342 0.657 . . . . 73.11 109.869 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -147.09 157.43 43.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.144 -1.058 . . . . 61.21 108.144 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -146.41 166.28 26.86 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.939 0.495 . . . . 72.33 110.479 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 166.72 31.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.457 1.103 . . . . 65.14 109.484 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -149.12 153.85 38.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.268 0.627 . . . . 61.11 109.743 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.5 126.83 9.26 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.502 0.721 . . . . 72.22 109.138 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' D' ' 55' ' ' VAL . 52.2 tt0 -71.84 119.27 15.78 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.536 -0.542 . . . . 75.12 109.536 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.15 -38.1 12.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.2 0.524 . . . . 72.13 110.12 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.08 174.4 11.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.803 -1.09 . . . . 61.31 109.561 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.67 133.25 45.54 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.245 -0.889 . . . . 74.01 109.534 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.88 15.4 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.797 1.239 . . . . 74.04 112.057 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' D' ' 50' ' ' GLN . 87.6 t -130.54 129.6 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.221 0.608 . . . . 74.12 110.784 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.14 129.36 41.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.016 0.926 . . . . 75.23 109.066 171.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -95.48 111.58 23.46 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.709 -0.848 . . . . 75.42 108.709 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 41.5 t -100.52 124.37 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.27 -1.011 . . . . 75.23 108.27 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.517 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.9 t -101.06 135.27 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.754 0.822 . . . . 71.42 109.282 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.65 43.66 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.897 -1.149 . . . . 73.32 107.897 175.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.506 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -98.75 108.37 21.04 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.708 HG23 ' HB1' ' D' ' 110' ' ' ALA . 48.1 t -105.35 116.66 49.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.966 -1.124 . . . . 71.54 107.966 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.588 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.6 m -111.81 137.1 50.22 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.156 0.503 . . . . 72.4 109.892 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.431 HG22 HG23 ' D' ' 114' ' ' ILE . 37.7 t -132.48 100.01 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.129 1.372 . . . . 74.43 107.885 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 40.3 m -96.51 94.59 7.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.409 -1.33 . . . . 71.54 107.409 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.83 141.23 30.28 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.577 -0.527 . . . . 72.4 109.577 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.437 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.88 137.46 18.79 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.502 0.501 . . . . 72.53 111.798 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 12.1 mt -110.53 107.85 17.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.919 1.288 . . . . 74.0 109.059 172.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -143.55 37.27 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.553 0.533 . . . . 75.2 112.183 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 8.24 15.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.629 0.772 . . . . 74.52 111.866 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.431 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.7 pt-20 -121.78 157.13 31.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.371 0.668 . . . . 63.34 109.894 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.3 m -73.05 141.02 47.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.67 -0.695 . . . . 73.42 110.534 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.56 -58.36 2.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.873 -1.158 . . . . 73.54 107.873 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -160.45 143.19 13.2 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 115.405 -0.816 . . . . 74.12 110.902 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.09 111.03 23.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.159 0.984 . . . . 74.12 109.209 171.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.552 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 42.5 t -125.06 133.72 52.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.427 0.691 . . . . 73.35 109.509 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -154.99 135.25 13.18 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.275 -0.639 . . . . 75.31 109.275 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . 0.541 HG21 HG22 ' D' ' 21' ' ' ILE . 97.6 t -127.23 142.32 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.686 0.795 . . . . 73.51 109.191 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.609 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 16.2 mt-30 -115.25 91.42 3.6 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.757 0.823 . . . . 75.14 109.078 171.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.61 93.04 6.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.899 -1.501 . . . . 65.54 108.861 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.32 141.26 18.94 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.282 -0.727 . . . . 74.35 111.282 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.53 130.57 4.63 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.558 -1.017 . . . . 73.34 110.558 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.63 121.01 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.069 -1.085 . . . . 71.32 108.069 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.5 122.6 35.64 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.584 0.754 . . . . 74.33 109.591 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -75.87 103.1 5.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.118 -0.697 . . . . 73.44 109.118 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.82 136.78 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.406 0.683 . . . . 74.24 110.546 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.88 160.95 12.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.215 1.006 . . . . 62.23 109.062 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.5 14.14 74.6 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 121.807 -0.235 . . . . 73.14 113.61 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.575 HD11 ' SD ' ' D' ' 94' ' ' MET . 1.8 pp -114.34 143.17 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 75.54 110.248 -174.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' H' ' 172' ' ' ALA . 0.3 OUTLIER -170.13 177.4 4.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.719 0.807 . . . . 73.24 110.084 175.214 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.418 ' HA2' ' HG2' ' H' ' 178' ' ' GLN . . . 64.84 -137.87 39.29 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.561 0.538 . . . . 75.23 112.709 178.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.8 m -68.63 -30.73 69.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.384 1.074 . . . . 72.44 111.692 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.48 -49.3 75.95 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.49 0.716 . . . . 74.31 110.559 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.575 ' SD ' HD11 ' D' ' 89' ' ' ILE . 10.0 tpt -76.5 -33.53 58.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.1 0.56 . . . . 73.24 111.245 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.48 80.42 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.677 0.751 . . . . 73.32 110.633 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -80.15 -38.65 30.99 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.382 -1.281 . . . . 73.22 110.738 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 43.5 t -63.4 -45.11 92.55 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.082 0.553 . . . . 75.52 111.486 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.01 -54.11 6.35 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.743 0.817 . . . . 74.34 110.73 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.11 -4.7 83.94 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 115.005 0.762 . . . . 74.41 115.005 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.44 -49.74 0.41 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.992 0.896 . . . . 71.14 112.126 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 56.9 t80 -76.04 -37.39 58.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.795 0.438 . . . . 75.21 111.582 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 72.1 m -65.06 -50.07 63.66 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.539 -0.743 . . . . 45.44 110.386 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -51.22 -36.02 54.82 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.299 1.999 . . . . 72.02 114.254 167.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.37 -40.15 93.18 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.488 0.715 . . . . 70.31 111.022 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.81 -43.28 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.674 0.79 . . . . 74.52 110.348 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.2 -20.41 59.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.122 -0.944 . . . . 71.2 111.867 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -66.34 -41.4 41.69 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.469 1.285 . . . . 74.44 114.469 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.44 -45.18 41.52 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.937 1.758 . . . . 74.12 112.846 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -75.06 -35.83 61.85 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.892 0.877 . . . . 73.24 111.219 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.708 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -64.04 -52.44 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.094 0.957 . . . . 74.02 110.243 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.492 ' NH2' HG22 ' B' ' 105' ' ' ILE . 33.9 ttp180 -57.37 -49.84 74.87 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.231 -1.35 . . . . 75.41 109.993 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.47 -41.5 89.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.501 1.126 . . . . 75.23 111.775 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.46 ' SG ' HD11 ' D' ' 21' ' ' ILE . 36.6 t -57.96 -44.05 86.79 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.899 0.749 . . . . 55.24 110.689 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' D' ' 118' ' ' VAL . 71.1 mt -67.81 -49.16 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.68 0.792 . . . . 74.13 110.498 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.42 HG23 ' HG3' ' D' ' 125' ' ' GLN . 91.1 m -52.42 -48.11 65.92 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.379 1.472 . . . . 74.32 112.095 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -67.91 -41.24 82.96 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.369 -1.287 . . . . 73.25 110.533 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.552 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.1 mtm -65.15 -34.79 79.23 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.818 0.447 . . . . 73.45 111.964 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.3 t -66.4 -44.18 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 123.718 0.637 . . . . 75.41 110.295 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -71.8 -31.59 66.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.353 -0.385 . . . . 72.12 110.783 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -69.02 -27.65 65.87 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.747 0.819 . . . . 75.45 110.06 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.24 11.26 68.14 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.873 0.733 . . . . 64.54 112.901 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.497 HG22 ' HB3' ' C' ' 17' ' ' TYR . 42.2 p 56.02 33.8 22.51 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.829 1.651 . . . . 72.13 113.08 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.457 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 39.1 m-85 -110.98 166.37 10.89 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 125.141 1.376 . . . . 73.41 109.725 175.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 41.5 Cg_endo -61.42 123.46 12.82 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.046 2.497 . . . . 73.03 112.167 -176.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.42 ' HG3' HG23 ' D' ' 115' ' ' THR . 50.6 tt0 -52.06 122.21 8.09 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.051 0.844 . . . . 71.23 110.397 178.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 36.8 tp -103.9 93.91 5.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.391 0.615 . . . . 71.2 109.658 -166.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -100.53 82.44 2.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.01 -0.996 . . . . 72.12 108.481 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.45 HD23 HD21 ' D' ' 42' ' ' LEU . 95.9 mt -67.4 139.54 57.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.16 -0.927 . . . . 73.23 110.669 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 143.83 98.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.426 0.691 . . . . 64.41 110.779 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.36 142.18 14.74 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.059 1.839 . . . . 73.24 110.233 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.419 HG23 HD13 ' H' ' 186' ' ' LEU . 38.7 t -106.76 108.78 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 107.967 -1.124 . . . . 72.21 107.967 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -77.8 88.33 4.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.223 -1.399 . . . . 75.54 107.223 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.01 -33.59 70.9 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.916 -1.038 . . . . 75.33 111.202 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.47 -49.48 76.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.48 1.112 . . . . 73.03 110.664 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' B' ' 6' ' ' ASN . . . -57.46 -52.35 65.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.122 0.889 . . . . 72.45 111.929 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.498 HD21 ' HD2' ' H' ' 185' ' ' PRO . 9.2 mp -70.41 -28.29 64.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.767 0.827 . . . . 72.5 111.892 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.51 -55.45 11.71 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.132 0.973 . . . . 73.1 110.245 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 73.1 mtm -73.38 -20.37 60.77 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.592 -0.731 . . . . 73.32 111.472 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -67.6 -40.24 84.76 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.317 0.647 . . . . 64.43 110.243 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' H' ' 182' ' ' PHE . 45.3 t80 -68.23 -26.99 65.97 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.833 -0.621 . . . . 74.41 110.844 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' B' ' 3' ' ' GLU . 20.3 tp -67.86 -44.16 77.75 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.779 0.832 . . . . 63.42 111.399 175.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.45 26.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.678 0.391 . . . . 75.34 111.797 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -117.18 46.96 1.58 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.354 -1.35 . . . . 74.44 107.354 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -151.23 -58.37 0.16 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 113.77 -1.559 . . . . 75.41 107.928 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.94 112.29 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.511 -0.768 . . . . 72.52 109.468 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.35 112.62 0.49 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.055 -0.818 . . . . 72.51 111.055 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.86 93.07 1.66 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.357 0.663 . . . . 74.54 109.673 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.71 112.47 0.7 Allowed Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.849 -1.301 . . . . 74.11 109.849 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 18.3 m -85.3 51.97 2.32 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.366 1.079 . . . . 73.32 110.296 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.7 162.19 33.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.763 1.225 . . . . 73.33 108.481 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.6 88.15 3.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.541 . . . . 71.31 110.83 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -114.05 142.17 46.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.302 0.641 . . . . 74.41 110.284 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.79 -166.7 1.47 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.474 1.11 . . . . 72.53 110.315 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.53 -55.91 15.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.519 0.728 . . . . 73.43 111.783 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.603 0.761 . . . . 64.34 109.449 -176.742 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.697 -0.483 . . . . 74.41 109.697 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.48 140.12 15.77 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.234 -0.439 . . . . 74.32 112.495 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.98 -11.45 50.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.97 0.908 . . . . 72.41 110.333 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 56.2 m -67.22 156.24 36.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.07 0.948 . . . . 72.14 111.754 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.43 79.22 2.48 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.291 -0.868 . . . . 72.01 109.574 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 81.7 mt -114.5 97.58 6.38 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.542 -0.754 . . . . 75.13 110.028 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.579 ' SD ' HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -57.12 96.34 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.607 -1.179 . . . . 72.11 111.32 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -162.01 11.54 0.08 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.312 -0.858 . . . . 70.52 109.7 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.03 -67.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.244 1.018 . . . . 72.55 110.29 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.6 mp 60.07 39.0 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.095 0.958 . . . . 72.14 112.731 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -69.51 -19.86 63.72 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.537 0.335 . . . . 52.44 111.652 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.64 116.81 6.41 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.881 0.872 . . . . 74.22 110.685 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.73 149.28 11.16 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.697 2.265 . . . . 72.22 111.438 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -101.72 137.63 39.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.021 0.528 . . . . 75.21 109.649 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 61.71 -90.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.188 1.395 . . . . 71.21 110.686 -170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t 174.86 -23.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.3 1.04 . . . . 72.31 111.083 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 2.3 t90 67.3 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.363 1.173 0 C-N-CA 124.836 1.254 . . . . 75.33 108.373 -161.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.93 113.23 3.74 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.569 2.179 . . . . 73.3 111.835 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.511 HD13 HD23 ' C' ' 44' ' ' LEU . 3.8 mm? -81.87 175.26 10.56 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.508 0.723 . . . . 75.1 111.436 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.401 HD13 ' HB3' ' C' ' 128' ' ' LEU . 34.1 pt -115.82 -177.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 75.34 110.999 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.26 126.66 10.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.424 0.69 . . . . 73.44 110.378 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -91.82 1.87 56.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.621 0.768 . . . . 75.51 111.88 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 29.2 t70 75.16 162.98 0.26 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.851 1.661 . . . . 72.13 113.097 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . 0.702 ' HA2' ' HA ' ' C' ' 39' ' ' GLU . . . -102.53 63.5 0.46 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.372 -0.831 . . . . 63.22 112.243 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.62 -165.22 23.48 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 112.696 -0.162 . . . . 71.41 112.696 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -70.39 120.21 15.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.562 0.745 . . . . 75.24 109.956 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -154.54 76.28 1.02 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.64 0.776 . . . . 72.54 109.957 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -170.52 160.37 7.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.02 -0.733 . . . . 73.21 109.02 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 69.44 0.64 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.088 0.947 . . . . 73.32 112.153 -168.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -142.63 4.63 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.464 0.705 . . . . 74.21 111.006 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.34 -51.73 2.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.767 -0.827 . . . . 73.41 108.767 -175.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -52.08 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.235 1.414 . . . . 65.4 113.358 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.53 55.41 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 115.316 -0.856 . . . . 63.22 113.768 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm 66.91 153.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.76 1.624 . . . . 72.41 110.884 -167.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -91.66 41.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.609 0.718 . . . . 64.53 109.189 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 55.29 29.71 13.4 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.367 1.067 . . . . 63.2 111.461 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.46 122.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 108.974 -0.75 . . . . 75.11 108.974 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 46.4 tptt 179.88 -56.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.77 0.828 . . . . 73.5 110.371 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.41 -15.91 63.08 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.699 1.199 . . . . 70.23 112.586 -168.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.561 1.392 0 C-N-CA 123.908 0.883 . . . . 74.44 109.137 172.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.474 -0.195 . . . . 71.12 110.474 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.1 102.59 0.33 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.919 -0.582 . . . . 71.53 112.945 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.03 179.88 6.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.279 -0.637 . . . . 75.43 109.279 164.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 98.8 p -59.54 154.73 16.76 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.903 -0.777 . . . . 72.54 108.903 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.19 84.7 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.625 0.726 . . . . 73.14 110.077 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tt -137.61 128.16 26.7 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.532 -1.284 . . . . 72.41 107.532 -167.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.574 ' SD ' ' SD ' ' B' ' 94' ' ' MET . 0.0 OUTLIER -154.14 177.08 11.49 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.362 1.465 . . . . 74.32 108.106 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -164.25 -87.77 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.493 -0.558 . . . . 73.14 109.493 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 53.16 23.73 3.24 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.539 1.135 . . . . 74.44 112.867 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.4 tt -107.34 116.42 31.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.072 0.549 . . . . 74.43 109.741 -173.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -144.52 9.14 1.37 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.544 1.138 . . . . 71.53 109.079 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.24 128.48 25.36 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.398 1.079 . . . . 74.42 109.787 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.5 102.79 1.53 Allowed 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 121.964 1.776 . . . . 73.23 111.317 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -66.66 179.16 1.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.534 0.733 . . . . 72.23 110.432 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.18 94.45 0.08 Allowed 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.578 0.704 . . . . 72.51 109.651 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 22.2 p -71.96 120.95 18.28 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.113 -1.403 . . . . 73.4 108.238 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 -68.68 115.97 35.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.807 0.692 . . . . 74.43 109.841 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.17 104.57 0.21 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.965 2.443 . . . . 63.34 112.534 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.611 ' HB3' HD13 ' B' ' 128' ' ' LEU . 73.6 mt -65.86 144.25 56.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.517 -1.219 . . . . 73.52 110.344 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.53 HD11 ' H ' ' B' ' 129' ' ' ALA . 2.7 pp -89.11 158.87 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.455 . . . . 75.12 111.522 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.06 178.1 7.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.564 0.746 . . . . 62.53 111.211 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . 0.565 ' HB1' HE22 ' B' ' 125' ' ' GLN . . . -120.9 88.35 2.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.676 0.79 . . . . 74.32 110.199 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -100.26 145.15 28.43 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.416 0.687 . . . . 74.33 109.216 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 115.68 -158.27 14.5 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.621 -0.718 . . . . 71.22 112.527 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.41 -79.78 1.48 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.685 -1.366 . . . . 64.45 109.685 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 66.01 29.2 10.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.856 1.262 . . . . 74.44 111.004 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' F' ' 199' ' ' ASN . . . -95.36 83.91 3.93 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.684 -1.144 . . . . 74.0 108.754 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -162.91 -175.46 4.4 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.899 -1.046 . . . . 75.51 108.601 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 48.0 tttp 77.61 42.94 0.11 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.301 1.441 . . . . 65.01 111.637 165.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 59.05 17.27 5.35 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.403 1.081 . . . . 73.55 113.464 167.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -137.98 -55.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.625 -0.88 . . . . 74.42 108.625 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . 0.412 ' HB3' ' HA ' ' F' ' 194' ' ' ALA . 4.1 m-20 -93.57 14.06 20.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.521 0.728 . . . . 74.25 109.229 168.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.68 -126.22 0.34 Allowed Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.348 0.899 . . . . 72.45 115.348 -166.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 81.72 -30.48 0.11 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.974 1.71 . . . . 75.13 110.48 -165.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.433 ' HE1' HD22 ' C' ' 126' ' ' LEU . 0.8 OUTLIER -61.58 -22.88 65.59 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.668 1.187 . . . . 75.54 109.835 163.6 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . 0.485 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -106.76 -89.46 0.44 Allowed 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.324 1.449 . . . . 74.4 109.996 174.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 14' ' ' GLN . 7.1 tp -178.32 141.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.765 1.626 . . . . 74.3 108.088 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -159.83 100.93 1.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.634 -0.876 . . . . 75.5 108.634 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t70 66.93 -75.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.94 1.296 . . . . 75.44 108.662 -167.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.533 HG11 HD12 ' C' ' 136' ' ' LEU . 5.2 p . . . . . 0 C--O 1.255 1.384 0 N-CA-C 106.402 -1.703 . . . . 75.11 106.402 162.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 110.434 -0.209 . . . . 74.44 110.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.17 -44.36 3.15 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 123.237 0.336 . . . . 72.34 112.405 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.42 138.42 58.26 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.492 1.517 . . . . 73.44 111.287 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 30.2 t -74.45 153.92 38.97 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.163 0.585 . . . . 74.4 109.617 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . 0.548 ' HB1' ' H ' ' A' ' 88' ' ' GLY . . . -151.11 76.85 1.25 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.304 -0.628 . . . . 75.14 109.304 -174.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.605 HD21 ' HA ' ' A' ' 54' ' ' ASP . 71.4 mt -123.63 95.22 4.5 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.037 -1.097 . . . . 73.0 108.037 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.653 ' H ' ' HE1' ' G' ' 174' ' ' MET . 0.0 OUTLIER -155.27 162.81 40.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.032 -1.44 . . . . 75.32 110.467 -167.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -176.86 112.6 0.09 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.39 -1.337 . . . . 74.44 107.39 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . 0.513 ' HB3' ' HG3' ' G' ' 180' ' ' PRO . 27.3 t-20 -52.46 -51.88 57.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.48 1.112 . . . . 63.43 111.012 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tt 76.08 -20.92 0.33 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.018 1.327 . . . . 75.43 112.741 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -85.68 46.8 1.35 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.372 1.069 . . . . 74.14 111.1 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.4 68.04 3.89 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.091 1.356 . . . . 73.41 112.794 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . 0.513 ' HG3' ' HB3' ' G' ' 176' ' ' ASN . 69.2 Cg_endo -83.83 4.45 6.98 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 122.921 2.414 . . . . 71.31 112.476 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -106.11 163.39 12.82 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.583 1.153 . . . . 74.22 109.762 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -77.73 167.31 21.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.406 0.682 . . . . 72.42 110.894 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 10.9 t -68.75 129.27 39.44 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.725 -0.67 . . . . 75.33 111.407 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . 0.522 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 3.2 t-105 -92.39 118.94 68.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 74.23 109.444 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -85.44 113.08 1.38 Allowed 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.485 2.123 . . . . 64.13 112.428 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . 0.657 HD12 ' HB2' ' A' ' 44' ' ' LEU . 96.9 mt -90.2 158.73 17.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.239 0.616 . . . . 74.22 110.21 175.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.433 HD11 ' HB2' ' A' ' 129' ' ' ALA . 33.6 pt -77.13 89.03 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 121.471 0.653 . . . . 73.14 111.327 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.49 98.93 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.437 -0.579 . . . . 70.24 109.437 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . 0.599 ' HB2' ' HB ' ' A' ' 40' ' ' VAL . . . -99.27 94.98 6.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.55 0.74 . . . . 74.54 110.051 -172.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -108.13 105.26 14.91 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.914 -0.772 . . . . 60.05 108.914 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 117.15 -153.55 17.25 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.749 -0.94 . . . . 74.21 110.749 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.65 66.13 0.72 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.477 -1.049 . . . . 61.31 110.477 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -70.43 107.75 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.078 0.551 . . . . 74.15 111.138 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.8 -179.59 4.74 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.999 0.92 . . . . 75.32 108.545 170.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 61.74 -84.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.39 1.076 . . . . 74.11 111.234 -174.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 65.25 31.48 10.65 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.037 0.935 . . . . 71.45 110.1 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 80.51 7.7 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.742 -1.117 . . . . 73.2 111.016 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.71 -27.19 67.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.818 0.847 . . . . 74.05 111.568 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.09 163.7 28.67 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.777 1.231 . . . . 74.14 108.224 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.44 93.76 0.63 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-O 120.329 -0.151 . . . . 51.21 113.46 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . 0.581 ' HG2' ' HB3' ' H' ' 193' ' ' TYR . 4.0 mptp? -96.31 151.58 19.39 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.156 -0.683 . . . . 72.45 109.156 170.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 24.7 t80 63.54 29.78 15.23 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.539 1.161 . . . . 73.35 109.451 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 93.14 6.16 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.986 -1.461 . . . . 74.12 108.867 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.79 107.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.28 -0.637 . . . . 75.1 109.28 -175.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.11 59.77 5.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.24 1.016 . . . . 74.25 111.134 -171.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 t70 71.08 174.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.401 1.48 . . . . 73.11 111.885 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.567 1.598 0 C-N-CA 123.939 0.896 . . . . 75.52 110.719 179.408 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 59.3 mttm . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.134 -0.321 . . . . 74.1 110.134 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.25 112.09 0.32 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.406 -0.678 . . . . 73.24 111.406 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . 0.425 ' HD2' HD11 ' H' ' 173' ' ' LEU . 57.5 pttt -150.09 156.36 41.51 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.43 1.092 . . . . 73.11 108.418 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 171' ' ' SER . . . . . 0.531 ' HB2' ' H2 ' ' D' ' 1' ' ' MET . 15.9 m -136.22 -29.56 0.98 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.358 0.663 . . . . 73.32 110.408 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' D' ' 90' ' ' GLU . . . -122.08 147.64 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.941 0.896 . . . . 74.5 109.384 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.425 HD11 ' HD2' ' H' ' 170' ' ' LYS . 28.9 mt -156.16 -66.52 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.695 1.198 . . . . 74.03 109.883 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.54 99.21 3.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.008 0.923 . . . . 74.22 112.464 -168.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 34.1 t80 59.01 35.05 23.88 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.148 1.379 . . . . 70.32 111.327 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.07 101.17 13.89 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.008 -0.542 . . . . 72.54 110.104 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.19 -13.42 59.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.141 0.576 . . . . 75.32 110.405 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . 0.524 ' HG3' ' H ' ' H' ' 179' ' ' GLU . 9.6 tp60 63.47 -172.09 0.17 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 125.042 1.337 . . . . 72.13 110.808 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . 0.524 ' H ' ' HG3' ' H' ' 178' ' ' GLN . 3.4 mp0 -64.78 148.68 97.03 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 123.563 0.745 . . . . 71.51 110.82 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.62 96.59 0.36 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.61 2.206 . . . . 74.21 111.907 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -78.89 -151.99 0.06 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.777 0.831 . . . . 73.1 110.934 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . 0.562 ' HB3' ' HB3' ' D' ' 140' ' ' TYR . 29.4 m-85 -63.68 140.97 58.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.881 0.872 . . . . 75.5 111.479 -173.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 35.6 p -82.84 150.53 26.51 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.218 0.607 . . . . 73.32 111.272 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -137.1 98.76 10.22 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.442 1.097 . . . . 73.2 109.695 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . 0.498 ' HD2' HD21 ' D' ' 136' ' ' LEU . 18.1 Cg_exo -69.45 160.03 51.36 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.551 2.167 . . . . 71.11 112.667 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . 0.525 HD11 HD22 ' D' ' 44' ' ' LEU . 3.0 mm? -93.82 169.91 9.95 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.877 0.471 . . . . 74.54 109.826 174.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.417 HG22 HG22 ' D' ' 131' ' ' VAL . 2.7 pp -70.57 171.84 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.679 0.792 . . . . 74.24 112.276 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.82 150.54 51.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.66 0.784 . . . . 63.12 110.456 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -94.73 133.79 38.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.808 0.843 . . . . 62.34 110.082 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.44 157.15 30.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.37 0.668 . . . . 74.52 110.05 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.62 103.85 0.69 Allowed Glycine 0 C--N 1.348 1.21 0 O-C-N 123.801 0.688 . . . . 73.23 112.654 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.53 152.09 26.05 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 123.021 0.343 . . . . 65.05 113.416 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . 0.581 ' HB3' ' HG2' ' G' ' 201' ' ' LYS . 91.2 t80 -168.73 105.32 0.43 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.92 1.288 . . . . 75.42 107.866 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -171.21 56.09 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.624 1.17 . . . . 75.04 109.038 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -142.07 151.53 42.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.015 0.526 . . . . 74.34 111.98 -168.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . 0.557 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 1.4 tmtm? -158.45 -46.69 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 O-C-N 123.895 0.747 . . . . 72.31 110.506 168.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 68.83 -64.85 0.31 Allowed 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.787 1.235 . . . . 72.51 110.882 -171.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.16 165.91 6.68 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.348 1.059 . . . . 74.01 108.614 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 81.79 5.24 1.23 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.427 1.491 . . . . 70.31 111.327 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -132.84 30.01 3.15 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 122.851 0.262 . . . . 75.44 112.925 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -102.35 148.27 25.68 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.65 0.78 . . . . 73.52 109.848 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -97.84 -48.39 5.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.169 0.587 . . . . 74.43 111.951 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 64.48 93.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.2 1.4 . . . . 74.44 110.822 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 34.2 pt -118.86 136.71 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.288 0.635 . . . . 73.44 110.836 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -137.69 151.33 48.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.43 1.492 . . . . 72.05 109.162 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 23.6 t70 60.71 110.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.646 1.216 . . . . 70.44 112.856 166.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.564 1.5 0 C-N-CA 122.918 0.487 . . . . 72.44 110.591 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.332 -0.618 . . . . 72.53 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m 65.98 17.53 10.82 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.975 1.31 . . . . 73.23 112.855 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.15 156.27 19.77 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 65.41 111.066 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.49 ' HB3' ' HA3' ' G' ' 169' ' ' GLY . 12.3 pt20 -157.43 175.32 14.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.112 0.965 . . . . 74.54 109.498 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -98.88 -62.24 1.26 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.176 0.99 . . . . 73.55 108.717 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -161.9 171.43 17.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.453 -0.794 . . . . 74.45 110.556 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 p -104.02 -162.16 0.88 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.054 0.942 . . . . 74.04 109.851 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.4 84.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.426 1.09 . . . . 74.43 109.815 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.496 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 24.3 ptt? -83.14 139.37 33.23 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.488 0.661 . . . . 73.13 112.348 -175.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.505 HG21 ' H ' ' C' ' 145' ' ' ALA . 72.3 m -145.1 105.75 4.12 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.401 -1.272 . . . . 71.54 108.29 173.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.44 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 72.1 t80 -95.38 142.39 27.82 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.658 -0.867 . . . . 72.51 108.658 168.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.477 ' NE2' HD22 ' C' ' 139' ' ' ASN . 6.0 tp60 -162.14 137.26 7.15 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.678 0.611 . . . . 72.01 112.501 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.406 HD11 ' CE2' ' A' ' 84' ' ' PHE . 3.8 tp -75.96 121.6 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.516 1.126 . . . . 74.22 109.16 170.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.475 ' O ' HG21 ' F' ' 204' ' ' ILE . 24.3 mm-40 -107.09 -13.8 15.08 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-O 117.781 -1.105 . . . . 72.5 112.163 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 178.38 126.58 0.05 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 119.193 0.906 . . . . 74.1 110.691 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.453 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 77.2 mt -106.44 131.62 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.015 -1.105 . . . . 70.42 108.015 172.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 11.7 p90 -158.67 170.06 23.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.6 0.714 . . . . 75.11 111.136 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -99.5 114.31 27.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.795 -1.093 . . . . 72.43 108.71 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -77.65 -38.77 47.08 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.552 -0.536 . . . . 74.34 109.552 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.84 136.13 32.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.592 -1.186 . . . . 73.31 109.343 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.1 mt -129.95 130.34 66.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.107 -1.442 . . . . 75.21 107.107 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -136.32 106.1 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.523 -0.917 . . . . 73.54 108.523 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.1 t80 -120.65 110.09 16.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.178 -1.786 . . . . 70.24 106.178 167.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -119.43 127.11 52.79 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.278 0.631 . . . . 74.41 109.379 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.24 79.4 70.07 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.648 -1.241 . . . . 74.42 107.648 174.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.07 -22.07 23.21 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.889 2.393 . . . . 74.21 112.372 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -119.07 33.12 5.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.179 0.992 . . . . 72.24 109.048 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.16 -44.69 99.83 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.773 1.229 . . . . 71.23 113.331 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.47 -29.68 71.38 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.463 1.442 . . . . 70.34 112.555 173.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -76.62 -28.73 56.21 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.516 -0.766 . . . . 73.11 111.828 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.6 p -61.74 -23.08 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 118.193 0.451 . . . . 73.35 112.143 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.61 -39.65 67.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.176 0.99 . . . . 75.3 110.869 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -88.39 -19.59 26.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 71.41 110.744 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.38 148.83 33.53 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.419 0.688 . . . . 74.02 110.289 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.36 127.47 32.78 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 74.24 108.327 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.48 ' NE1' ' HB3' ' G' ' 195' ' ' PHE . 25.3 t-105 -86.26 84.94 7.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.578 0.704 . . . . 75.11 110.182 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 80.32 68.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.283 -1.377 . . . . 71.32 107.283 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' G' ' 194' ' ' ALA . 75.9 Cg_endo -81.67 153.26 17.58 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.929 2.419 . . . . 74.42 113.154 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -96.06 90.72 5.64 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.001 -1.111 . . . . 71.1 108.001 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 m -69.98 93.18 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.381 1.086 . . . . 71.31 109.532 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -103.34 121.0 41.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.751 -1.113 . . . . 75.23 109.951 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.34 132.33 43.17 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.044 0.937 . . . . 71.51 109.348 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.747 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.4 m-20 -126.56 132.45 51.32 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.025 0.93 . . . . 74.33 108.754 176.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.528 HD21 HD11 ' G' ' 186' ' ' LEU . 54.5 tp -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.746 -0.835 . . . . 74.4 108.746 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -134.29 145.42 49.07 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.679 -0.489 . . . . 70.24 109.679 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 m -109.42 121.38 45.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.865 0.866 . . . . 72.11 108.864 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.97 123.37 27.23 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 107.412 -1.329 . . . . 72.33 107.412 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.6 m -133.16 152.63 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.661 0.384 . . . . 74.35 110.704 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -149.96 130.84 14.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.838 0.855 . . . . 63.05 109.311 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -87.79 117.82 26.89 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.866 -0.791 . . . . 74.4 108.866 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 57' ' ' GLU . 54.9 mt -84.63 -44.57 13.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.543 0.737 . . . . 73.14 110.696 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.47 -171.94 4.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.692 0.797 . . . . 63.13 109.923 -178.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -59.96 102.75 0.17 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.375 0.67 . . . . 74.02 110.39 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 65.3 12.11 7.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.823 1.249 . . . . 74.41 112.997 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -99.83 113.82 36.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.859 -1.534 . . . . 74.13 106.859 171.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.495 ' OH ' ' HA ' ' G' ' 174' ' ' MET . 5.9 m-30 -108.82 165.91 11.21 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.199 1.0 . . . . 74.13 111.3 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.435 ' HB2' HD13 ' A' ' 51' ' ' LEU . 28.0 tt0 -131.26 118.59 20.6 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 112.574 -2.103 . . . . 74.34 106.862 164.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.61 117.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.344 -1.724 . . . . 71.42 106.344 170.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.536 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.4 t -97.9 127.99 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.114 -0.698 . . . . 71.3 109.114 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 109.85 21.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.427 -1.323 . . . . 75.45 107.427 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -106.01 106.74 17.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.019 -0.991 . . . . 73.2 109.559 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.95 133.47 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 114.95 -1.023 . . . . 75.4 108.553 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.747 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.8 m -117.69 131.71 56.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.912 -0.773 . . . . 75.14 108.912 173.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 37.1 t -126.21 111.42 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.869 1.268 . . . . 75.42 108.263 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 m -102.26 145.1 29.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.578 -0.527 . . . . 72.54 109.578 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.43 109.94 7.98 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.233 -1.025 . . . . 73.32 108.233 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.7 m -126.81 145.69 50.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.275 0.559 . . . . 75.15 110.363 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.445 HD21 ' CE3' ' A' ' 36' ' ' TRP . 49.1 mt -107.84 51.56 0.74 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.542 1.537 . . . . 73.15 108.031 -175.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.93 -85.44 0.89 Allowed Glycine 0 C--N 1.349 1.282 0 CA-C-N 114.569 -1.196 . . . . 51.0 111.483 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -89.92 -24.73 21.25 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.131 0.973 . . . . 75.12 111.846 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -118.15 107.03 13.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.086 0.554 . . . . 75.4 110.392 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.2 123.44 20.72 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 118.525 0.602 . . . . 72.54 109.889 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.39 -54.73 6.33 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.852 -1.067 . . . . 70.44 109.648 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.5 172.48 17.14 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.467 -1.242 . . . . 74.41 110.912 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.6 141.31 33.46 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.114 -1.403 . . . . 72.03 107.364 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.542 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 54.9 m -140.16 99.78 3.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.285 -0.635 . . . . 74.41 109.285 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -121.58 122.86 40.61 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.508 -0.923 . . . . 64.53 108.508 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.47 131.13 70.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.511 0.725 . . . . 74.41 109.293 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -104.59 93.44 4.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.931 -1.031 . . . . 72.02 109.434 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -81.67 92.88 6.66 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.112 -1.069 . . . . 74.33 108.112 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.12 143.7 20.51 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.242 -0.743 . . . . 54.13 111.242 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.82 129.92 4.49 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.491 -0.644 . . . . 72.21 111.491 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -78.53 129.5 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 107.648 -1.242 . . . . 65.22 107.648 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.406 ' CE2' HD11 ' A' ' 13' ' ' ILE . 49.5 m-85 -133.49 121.72 22.59 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.134 -0.691 . . . . 73.35 109.134 174.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.9 t -74.3 115.27 13.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.591 -1.262 . . . . 73.45 107.591 169.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -137.78 119.06 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.682 0.793 . . . . 75.0 109.729 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.01 161.6 28.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.931 0.893 . . . . 72.42 109.849 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 78.3 5.24 87.48 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.646 0.591 . . . . 63.31 114.399 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.34 166.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.753 . . . . 72.2 108.972 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -172.74 175.97 3.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.343 -0.614 . . . . 75.31 109.343 -168.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.42 -126.01 38.04 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.813 0.695 . . . . 75.21 114.437 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.3 p -82.47 -20.39 36.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.689 0.796 . . . . 73.34 110.98 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.96 -43.45 98.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.012 0.925 . . . . 74.43 111.006 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -49.48 67.07 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.879 0.737 . . . . 74.35 110.352 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.95 71.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.354 0.662 . . . . 71.42 111.534 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -71.56 -41.8 68.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.732 0.813 . . . . 64.4 110.528 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.67 -65.25 0.81 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.029 0.532 . . . . 64.24 110.489 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.62 -40.58 84.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.222 0.609 . . . . 74.22 111.046 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.78 -38.81 49.28 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.601 0.563 . . . . 72.15 113.793 -168.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.507 ' HB3' ' HB2' ' A' ' 133' ' ' PHE . . . -126.55 -53.53 1.46 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.124 0.462 . . . . 51.03 112.149 -171.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.44 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 82.9 t80 -63.7 -42.27 97.99 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.011 0.924 . . . . 74.4 112.862 -171.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 11' ' ' PHE . 73.7 m -77.62 -41.43 2.26 Favored Pre-proline 0 CA--C 1.557 1.243 0 N-CA-C 113.048 0.758 . . . . 72.41 113.048 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.76 -23.64 55.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 CA-C-N 121.139 1.442 . . . . 65.01 112.544 166.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -70.8 -24.92 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.966 0.506 . . . . 73.31 111.463 172.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.73 -42.82 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.968 0.89 . . . . 75.13 109.299 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.479 HD22 ' HA3' ' A' ' 82' ' ' GLY . 25.1 mt -84.06 -27.72 28.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.421 -1.263 . . . . 74.34 112.444 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -61.92 -40.74 71.6 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 114.504 1.298 . . . . 74.02 114.504 -171.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.89 -36.22 82.57 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.963 1.775 . . . . 74.24 113.057 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' C' ' 108' ' ' PRO . 87.5 m-85 -81.56 -35.33 30.39 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.181 -0.918 . . . . 75.42 111.352 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.49 80.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.886 0.474 . . . . 64.45 110.566 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.0 ttm105 -56.46 -54.83 41.14 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 114.796 -1.093 . . . . 75.24 109.216 174.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.27 -41.33 88.61 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.393 1.058 . . . . 71.41 111.564 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.0 t -57.78 -50.98 71.42 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.742 0.651 . . . . 73.12 110.102 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.57 -42.72 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.937 0.895 . . . . 73.44 111.306 177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.458 HG21 ' HB2' ' A' ' 125' ' ' GLN . 90.7 m -57.35 -45.19 84.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.243 1.017 . . . . 73.4 110.616 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -70.93 -41.41 71.22 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.702 -1.135 . . . . 73.44 110.054 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.53 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 19.4 mtp -57.66 -46.14 84.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.864 0.866 . . . . 75.41 111.67 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.05 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.961 0.904 . . . . 73.42 110.67 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 82.5 p -69.66 -33.07 72.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.406 0.282 . . . . 61.34 111.62 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.59 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.7 mtt-85 -68.65 -27.31 65.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.48 0.712 . . . . 72.33 110.789 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.75 9.88 58.21 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.502 0.501 . . . . 64.13 113.2 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m 69.31 42.17 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.869 1.319 . . . . 65.54 110.584 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 119' ' ' SER . 90.5 m-85 -120.66 156.48 55.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.837 -1.074 . . . . 64.22 109.523 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.19 124.65 16.07 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.565 1.51 . . . . 73.24 109.789 166.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 19.7 pt20 -60.69 146.38 45.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.827 0.451 . . . . 73.12 111.34 -174.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -114.22 105.8 13.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.008 -0.542 . . . . 73.4 110.19 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -118.28 93.22 4.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 74.44 109.742 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.499 ' HB3' HD13 ' G' ' 187' ' ' ILE . 96.8 mt -73.02 160.66 31.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.697 -1.138 . . . . 74.51 110.824 176.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.478 ' HA ' HG23 ' C' ' 13' ' ' ILE . . . -68.84 145.3 96.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.279 0.632 . . . . 54.51 112.441 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.25 114.5 4.01 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.118 1.879 . . . . 75.02 110.818 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 109.19 23.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.797 -1.557 . . . . 74.23 106.797 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -104.53 92.03 4.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.982 0.913 . . . . 72.53 110.358 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 100' ' ' ALA . 93.2 m-85 -66.5 -21.44 66.17 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.988 -1.005 . . . . 74.51 111.67 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.47 -51.18 70.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.308 1.043 . . . . 72.24 110.434 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.76 49.57 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.517 -0.765 . . . . 74.24 110.629 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.499 ' HB3' ' HA ' ' A' ' 133' ' ' PHE . 46.3 tp -53.45 -39.38 64.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.359 1.063 . . . . 74.24 111.852 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 86.9 t80 -57.65 -56.78 17.53 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.838 0.711 . . . . 71.34 110.504 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.5 mtm -67.63 -36.03 80.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.71 0.804 . . . . 74.41 111.352 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -58.61 -58.02 10.42 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.268 1.427 . . . . 74.11 109.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -69.01 -30.93 69.43 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.14 -0.936 . . . . 74.14 111.261 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -61.57 -38.32 87.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.972 0.909 . . . . 74.44 110.968 -176.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -148.5 29.98 0.84 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.984 0.735 . . . . 71.34 112.984 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -34.54 71.31 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.365 0.53 . . . . 74.31 109.838 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -59.47 -39.89 85.17 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.856 0.862 . . . . 75.21 111.229 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.89 83.96 1.15 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.088 0.555 . . . . 62.04 110.723 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.24 161.35 19.11 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.588 -0.733 . . . . 72.32 111.534 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' C' ' 5' ' ' ASN . 11.0 tp10 -166.26 147.77 6.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.218 0.607 . . . . 72.3 109.684 176.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.77 153.37 6.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.933 -0.467 . . . . 62.01 111.933 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -153.26 152.92 31.71 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.541 0.686 . . . . 74.44 110.578 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.629 ' H ' HG21 ' C' ' 92' ' ' THR . 29.9 mt-10 -121.36 -12.23 8.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.408 1.483 . . . . 72.41 109.612 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.422 ' HB2' HG23 ' C' ' 92' ' ' THR . 35.4 tt0 -88.82 94.45 9.93 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.09 0.956 . . . . 74.44 111.922 -163.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -179.5 76.14 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.862 0.865 . . . . 74.3 109.677 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.485 ' HB3' ' HG3' ' E' ' 180' ' ' PRO . 40.3 tt0 -176.89 23.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.192 0.597 . . . . 71.3 109.745 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.85 90.47 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.136 0.974 . . . . 73.53 112.314 -167.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.452 0 C-N-CA 125.978 1.711 . . . . 63.35 106.91 175.709 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 110.172 -0.307 . . . . 65.43 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -141.77 150.13 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.752 . . . . 73.42 109.853 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -83.5 116.59 22.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.182 0.593 . . . . 74.32 111.811 -172.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -77.52 -12.97 60.02 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.226 1.01 . . . . 74.02 110.605 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -65.66 131.36 46.15 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.582 0.753 . . . . 65.3 110.061 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -143.64 167.17 22.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.719 0.808 . . . . 75.43 110.145 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -133.43 138.43 46.22 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.275 -1.009 . . . . 63.3 108.275 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -44.78 95.89 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.647 0.779 . . . . 64.11 110.93 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.576 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.1 ptm 55.67 168.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.197 2.199 . . . . 73.54 114.589 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -176.74 145.05 0.51 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.224 -1.353 . . . . 64.55 109.017 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.02 156.43 39.96 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.382 -0.372 . . . . 75.12 111.177 162.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -122.78 111.37 16.62 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.75 -1.204 . . . . 73.52 107.75 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 tt -61.34 101.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.914 -1.494 . . . . 72.12 109.318 170.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -78.4 -33.25 48.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.677 -0.692 . . . . 75.53 109.672 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -173.19 141.36 0.94 Allowed 'General case' 0 C--N 1.361 1.089 0 O-C-N 123.354 0.409 . . . . 74.22 110.761 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.36 136.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 106.545 -1.65 . . . . 63.22 106.545 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -166.04 148.65 7.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.099 0.476 . . . . 74.14 111.069 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.526 HG21 HD13 ' B' ' 21' ' ' ILE . 86.3 m -76.92 117.42 18.5 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.712 -0.847 . . . . 73.43 108.712 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -88.38 -25.61 22.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.152 0.581 . . . . 74.25 110.633 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 15.8 t70 -158.55 143.54 16.24 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.347 0.594 . . . . 75.43 111.845 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.597 HD13 ' SG ' ' B' ' 113' ' ' CYS . 39.9 mm -134.18 138.59 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 C-N-CA 125.897 1.679 . . . . 72.32 106.867 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -146.62 133.4 20.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.606 -0.887 . . . . 74.04 108.606 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.2 115.59 6.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.395 -1.335 . . . . 74.33 107.395 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.06 127.16 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.51 86.95 48.98 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 108.383 -0.969 . . . . 73.11 108.383 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.28 -19.2 50.36 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.916 2.41 . . . . 64.45 111.928 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.453 HD22 ' HB2' ' C' ' 154' ' ' ASP . 33.4 m-80 -126.6 30.58 5.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.021 0.928 . . . . 70.41 110.739 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.416 ' HB1' ' CE2' ' A' ' 17' ' ' TYR . . . -47.05 -49.51 50.23 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 124.55 1.14 . . . . 74.45 112.894 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.64 -24.46 1.86 Allowed 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 121.8 1.666 . . . . 73.14 113.699 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -76.56 -5.36 47.34 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.354 0.662 . . . . 72.32 112.356 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.14 -13.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.849 0.86 . . . . 72.43 110.653 170.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . 0.521 ' HZ ' ' HG3' ' C' ' 147' ' ' GLU . 65.3 t80 -57.2 -41.95 80.36 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.223 1.009 . . . . 75.41 110.78 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.65 ' NE2' ' HB3' ' C' ' 150' ' ' GLU . 64.2 mm-40 -75.75 -37.99 58.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.933 -1.031 . . . . 73.44 110.714 -173.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -107.93 89.03 2.87 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.462 -0.79 . . . . 72.33 109.71 -174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.75 76.21 10.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.846 1.258 . . . . 73.14 112.025 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -172.93 156.23 3.3 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.357 0.663 . . . . 73.25 110.468 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -58.29 119.21 33.56 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.537 1.135 . . . . 70.41 111.473 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.565 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 37.8 Cg_endo -65.92 163.64 30.24 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.906 2.404 . . . . 73.3 112.018 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -76.08 100.92 5.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.724 -1.213 . . . . 73.32 107.724 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.473 HG13 HD11 ' B' ' 126' ' ' LEU . 16.8 t -88.6 120.6 37.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.361 -1.348 . . . . 75.45 107.361 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -145.31 144.6 30.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.017 0.527 . . . . 64.32 110.276 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.472 HD23 ' HG ' ' B' ' 128' ' ' LEU . 1.9 pt? -115.81 160.24 20.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 73.44 110.065 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.24 138.18 44.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.455 1.102 . . . . 71.11 108.721 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -90.96 134.34 34.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.248 0.619 . . . . 75.12 109.574 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.32 150.05 34.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.973 0.909 . . . . 74.31 108.609 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.3 m -142.92 113.42 7.37 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.105 -0.702 . . . . 75.01 109.105 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.75 120.81 32.84 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.384 -1.339 . . . . 70.11 107.384 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -132.92 172.26 12.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.941 0.496 . . . . 74.31 111.368 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.3 p -152.77 179.08 8.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.864 0.866 . . . . 74.25 109.999 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -122.13 121.74 37.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.629 0.771 . . . . 71.25 110.083 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.451 HD12 HG22 ' B' ' 83' ' ' ILE . 81.4 mt -79.03 -44.8 21.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.619 0.767 . . . . 74.05 110.642 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.18 -172.01 3.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.56 -0.745 . . . . 63.13 110.911 -172.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.87 111.95 1.66 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.767 -1.106 . . . . 75.31 110.265 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 70.43 -5.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.047 1.739 . . . . 60.44 112.932 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.85 93.17 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.054 -1.091 . . . . 74.43 108.054 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.13 141.07 30.7 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.898 -1.046 . . . . 73.31 110.005 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.637 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.7 tm-20 -105.2 100.15 9.74 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.888 -1.523 . . . . 64.4 106.888 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.64 117.68 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.25 0.62 . . . . 74.44 109.822 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.94 121.1 55.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 109.286 -0.635 . . . . 73.44 109.286 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.403 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.6 OUTLIER -93.06 118.08 30.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.05 -1.463 . . . . 75.03 107.05 172.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -106.45 116.45 31.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.494 0.717 . . . . 74.32 109.355 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.3 t -109.7 119.04 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.145 -1.057 . . . . 74.42 108.145 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -116.32 125.82 52.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.988 0.515 . . . . 71.3 110.21 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.633 HG23 HG23 ' B' ' 114' ' ' ILE . 77.8 t -107.72 137.43 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.729 1.212 . . . . 71.13 110.898 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.3 m -124.41 146.85 48.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.212 1.005 . . . . 74.21 109.923 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 156.26 42.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.066 0.946 . . . . 73.21 109.402 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.7 p -153.1 142.61 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.655 0.613 . . . . 75.22 112.655 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.1 mt -118.56 98.18 6.12 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.629 -0.878 . . . . 73.11 108.629 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.87 -110.44 2.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 122.954 0.311 . . . . 52.0 113.05 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -88.48 4.97 44.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.843 0.857 . . . . 75.21 110.285 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' B' ' 68' ' ' LEU . 1.2 mp0 -114.4 153.07 30.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.79 1.236 . . . . 65.41 109.998 -167.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -87.43 129.24 35.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.064 -1.088 . . . . 75.12 108.064 162.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.17 -55.8 4.14 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.849 -0.797 . . . . 75.21 108.849 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.1 150.29 20.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.804 -1.089 . . . . 71.44 110.694 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -124.88 113.87 18.44 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.505 1.522 . . . . 53.41 107.643 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.7 t -116.29 160.1 20.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.407 -0.961 . . . . 72.33 108.407 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.02 131.84 3.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.628 -0.878 . . . . 73.41 108.628 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.52 142.78 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.715 -0.846 . . . . 75.3 108.715 172.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.5 mt-30 -120.73 97.91 5.77 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.183 -0.917 . . . . 74.41 109.071 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -87.77 101.29 13.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.12 154.49 24.47 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 111.16 -0.776 . . . . 71.45 111.16 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.73 126.16 2.01 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.673 -1.371 . . . . 55.4 109.673 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.637 HG12 ' HG2' ' B' ' 57' ' ' GLU . 27.9 mt -85.25 115.89 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.114 -1.069 . . . . 73.33 108.114 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -124.93 132.47 53.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.798 -1.556 . . . . 74.25 106.798 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -88.97 88.63 7.66 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.025 -1.102 . . . . 73.23 108.025 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.68 129.83 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.935 0.494 . . . . 74.02 110.626 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.28 170.99 20.67 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.966 -1.015 . . . . 64.21 110.249 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 92.52 -49.35 2.62 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 75.21 112.219 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.524 ' H ' HD12 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -72.12 152.28 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.871 0.468 . . . . 74.51 111.316 174.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -160.4 172.48 17.2 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.848 -1.069 . . . . 65.01 108.97 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.93 -125.42 38.97 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.616 0.572 . . . . 61.12 113.747 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.0 m -74.57 -27.51 60.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.744 0.818 . . . . 62.34 111.109 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -68.9 -40.19 79.28 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.682 0.793 . . . . 71.33 109.881 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.627 ' HG3' ' HE3' ' F' ' 174' ' ' MET . 0.9 OUTLIER -74.48 -41.91 59.92 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.045 -0.525 . . . . 72.23 110.116 176.624 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.73 62.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.149 0.98 . . . . 75.11 111.649 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' B' ' 134' ' ' ASP . 39.0 t-80 -93.34 -13.1 28.52 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.061 -0.972 . . . . 74.44 111.191 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.31 -64.32 1.01 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.623 0.369 . . . . 70.24 110.195 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -15.83 60.93 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.146 0.178 . . . . 62.43 111.167 -176.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 -6.08 53.67 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.227 -0.763 . . . . 74.52 114.198 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.5 -47.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.399 1.1 . . . . 74.41 112.875 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -73.21 -54.02 9.48 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.052 0.541 . . . . 74.3 111.254 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 68.1 m -63.01 -45.3 86.65 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.529 0.732 . . . . 75.54 111.335 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -50.78 -45.0 38.05 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.416 2.077 . . . . 73.02 113.893 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 123.176 0.591 . . . . 74.13 112.057 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.514 HG22 ' NH2' ' D' ' 111' ' ' ARG . 79.5 mt -71.57 -47.98 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.659 0.784 . . . . 73.41 110.863 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.403 ' HB2' HD12 ' B' ' 60' ' ' LEU . 87.4 mt -80.3 -20.88 43.33 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.233 -0.894 . . . . 75.51 112.298 -172.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.42 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 64.5 t80 -64.71 -45.78 75.82 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.653 -1.165 . . . . 64.24 113.387 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 19.1 Cg_endo -56.72 -37.64 97.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 CA-C-N 121.581 1.6 . . . . 73.31 113.076 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.81 -49.6 65.29 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.31 0.644 . . . . 75.14 110.973 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.99 -42.39 98.34 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.717 0.807 . . . . 64.24 111.181 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.447 ' NH2' HG23 ' C' ' 122' ' ' THR . 50.1 ttt180 -58.87 -55.22 37.92 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.681 1.593 . . . . 71.31 110.96 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -38.5 90.88 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.487 0.715 . . . . 74.33 109.918 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.597 ' SG ' HD13 ' B' ' 21' ' ' ILE . 7.8 t -67.69 -42.08 82.64 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.745 -0.662 . . . . 73.52 112.103 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.633 HG23 HG23 ' B' ' 64' ' ' VAL . 96.8 mt -62.52 -50.61 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.696 -0.483 . . . . 74.43 109.696 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.497 HG23 HE21 ' C' ' 125' ' ' GLN . 86.7 m -55.59 -31.52 62.3 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.092 0.87 . . . . 75.53 111.183 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.9 t -66.05 -52.56 47.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.572 0.749 . . . . 72.35 110.403 172.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.6 mmt -67.36 -36.14 80.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.55 0.574 . . . . 73.34 112.55 -172.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.94 -42.02 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.639 0.776 . . . . 74.02 110.475 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.735 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 90.3 p -71.73 -30.31 65.47 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.469 -0.787 . . . . 71.1 111.872 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -63.44 -33.7 76.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 74.05 110.368 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.77 9.0 58.05 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.839 0.712 . . . . 74.21 113.329 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.9 p 56.15 27.97 12.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.892 1.677 . . . . 74.54 112.466 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.86 158.66 32.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.249 -0.887 . . . . 73.34 110.578 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.565 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 38.8 Cg_exo -61.98 179.73 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.484 2.789 . . . . 73.31 115.999 -171.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.668 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -62.84 150.21 42.29 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 113.894 -1.503 . . . . 71.13 114.347 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.473 HD11 HG13 ' B' ' 40' ' ' VAL . 53.3 tp -141.61 86.04 1.98 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.008 -1.478 . . . . 63.02 107.008 167.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.434 ' ND2' ' HA ' ' C' ' 119' ' ' SER . 7.1 m120 -116.11 90.62 3.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.485 -1.302 . . . . 75.04 107.485 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.472 ' HG ' HD23 ' B' ' 42' ' ' LEU . 1.9 tm? -84.88 138.01 32.79 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.512 -0.922 . . . . 75.34 108.512 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.409 ' HB2' ' NH1' ' D' ' 15' ' ' ARG . . . -67.62 107.24 1.64 Allowed Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 124.357 1.035 . . . . 75.51 109.913 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 129.71 25.28 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.09 1.86 . . . . 74.3 110.925 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' D' ' 13' ' ' ILE . 30.2 m -118.36 140.52 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.277 0.631 . . . . 75.44 110.522 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.714 ' H ' HG21 ' D' ' 13' ' ' ILE . 15.6 m-20 -69.76 104.97 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.256 -0.883 . . . . 73.42 109.093 170.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -64.19 -14.37 54.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 120.858 0.361 . . . . 74.14 110.427 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.431 ' HA ' ' CE1' ' B' ' 96' ' ' HIS . 29.1 t70 -79.56 -55.12 5.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.085 0.954 . . . . 74.44 111.361 172.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.16 77.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.225 0.61 . . . . 74.33 111.64 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.98 -44.12 85.83 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.963 0.505 . . . . 74.4 110.266 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.5 -45.21 94.62 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.412 0.685 . . . . 72.23 110.425 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.424 ' HE3' ' HA ' ' D' ' 10' ' ' THR . 1.9 tmt? -58.41 -38.81 78.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.301 1.04 . . . . 74.43 110.088 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -77.08 -29.11 54.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.407 -1.269 . . . . 73.24 111.05 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -69.5 -23.19 63.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.357 0.663 . . . . 72.21 111.206 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.26 -6.47 15.52 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 74.11 111.888 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -167.44 101.79 0.51 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.14 0.576 . . . . 73.24 110.907 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -132.02 101.96 5.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.918 -1.141 . . . . 75.53 107.918 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.69 ' HG2' ' HA ' ' D' ' 8' ' ' GLU . 7.5 tp60 -106.23 -58.5 1.91 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.83 -0.804 . . . . 72.53 108.83 175.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.98 92.88 0.05 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.328 1.451 . . . . 73.4 111.522 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.98 -169.09 23.72 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.313 -0.403 . . . . 74.41 113.079 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.76 93.37 3.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 122.101 0.953 . . . . 75.2 111.747 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -85.3 -166.12 41.37 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 114.961 -1.018 . . . . 75.5 111.196 165.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.3 t -163.63 150.58 12.21 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.341 0.57 . . . . 73.04 110.564 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -173.14 107.0 0.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.399 0.68 . . . . 71.54 110.098 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.27 95.51 2.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.406 -0.59 . . . . 62.11 109.406 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -78.64 100.85 7.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.437 0.637 . . . . 73.23 109.987 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -87.91 97.23 10.82 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.103 -0.499 . . . . 71.23 109.752 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.79 168.46 25.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.03 0.932 . . . . 71.14 109.846 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.132 -0.937 . . . . 65.51 108.784 176.377 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.651 -0.87 . . . . 72.24 108.651 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 88.5 p 53.39 -172.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.659 1.584 . . . . 71.43 112.375 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.499 ' HG3' HG23 ' C' ' 7' ' ' THR . 24.9 tt0 -87.58 121.64 30.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.804 -1.184 . . . . 73.34 107.804 166.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -87.18 84.96 7.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 73.53 109.13 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 16.4 t-20 76.74 -70.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.634 1.974 . . . . 74.52 111.33 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -156.2 139.15 15.36 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.146 -0.687 . . . . 74.22 109.146 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.499 HG23 ' HG3' ' C' ' 3' ' ' GLU . 6.5 t -158.33 177.14 11.59 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-O 121.42 0.629 . . . . 73.32 110.995 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -160.25 -36.48 0.05 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.754 1.622 . . . . 74.12 107.141 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 63.69 112.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 126.294 1.838 . . . . 73.35 111.163 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 74.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.054 -1.091 . . . . 74.35 108.054 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -100.28 119.67 38.75 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.104 -0.702 . . . . 61.12 109.104 -174.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -141.25 119.25 11.93 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.948 -0.76 . . . . 75.43 108.948 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.668 HD13 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -74.28 127.35 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 108.682 -0.859 . . . . 73.11 108.682 171.249 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.518 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 77.1 mm-40 -96.36 -49.52 5.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.096 0.558 . . . . 74.11 110.36 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.401 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 76.4 ttt180 -162.65 123.29 2.44 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.971 -0.381 . . . . 72.23 109.971 -171.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.668 HG13 HD13 ' C' ' 13' ' ' ILE . 76.6 mt -113.69 135.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.038 -1.097 . . . . 72.11 108.038 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.44 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.9 p90 -174.5 158.29 2.79 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 124.132 0.895 . . . . 75.12 110.866 -172.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -80.3 136.71 36.48 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.376 -0.829 . . . . 70.34 109.487 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -89.55 -51.39 5.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.27 1.033 . . . . 75.02 108.846 171.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.481 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 25.9 t70 -134.91 132.91 39.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.134 -1.848 . . . . 70.31 108.2 -171.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.4 mt -129.29 140.52 48.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.728 -1.582 . . . . 73.11 106.728 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -148.71 145.02 27.48 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.402 -0.592 . . . . 74.43 109.402 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.72 111.64 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.032 -1.47 . . . . 75.35 107.032 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.06 117.87 31.79 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.832 -1.173 . . . . 62.11 107.832 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.36 87.84 8.16 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 108.112 -1.07 . . . . 71.32 108.112 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.3 3.41 7.49 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.05 2.5 . . . . 74.31 111.709 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.3 12.56 8.21 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 124.246 1.019 . . . . 73.34 109.936 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.39 -49.43 82.18 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.737 1.014 . . . . 75.25 113.737 -171.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.53 -27.87 0.54 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.666 1.578 . . . . 62.02 113.449 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -70.12 -25.74 63.63 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.205 1.002 . . . . 63.11 112.905 -173.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.57 -6.86 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.328 1.051 . . . . 73.12 111.564 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -56.95 -41.7 78.75 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.357 1.063 . . . . 74.01 112.638 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -100.42 4.24 43.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.702 0.801 . . . . 70.25 110.606 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.418 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.5 OUTLIER -87.68 168.21 13.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.058 0.543 . . . . 74.52 111.76 -168.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.08 113.53 10.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.008 -0.738 . . . . 75.13 109.008 167.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -86.78 65.21 8.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.497 0.719 . . . . 65.03 110.157 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -135.57 78.98 48.74 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.414 -0.958 . . . . 73.21 108.414 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.96 167.57 26.77 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.826 2.351 . . . . 64.24 112.448 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -122.83 109.25 13.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.971 -1.122 . . . . 74.24 107.971 171.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.509 HG13 HD12 ' C' ' 126' ' ' LEU . 97.6 t -78.45 103.11 5.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.829 -0.804 . . . . 74.33 108.829 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -91.66 116.33 28.79 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.522 -1.288 . . . . 73.42 107.522 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.407 HD13 HG12 ' C' ' 40' ' ' VAL . 9.2 mp -85.93 149.1 25.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.974 0.51 . . . . 73.42 109.84 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.35 142.29 25.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.847 0.859 . . . . 74.21 108.976 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -135.17 136.02 41.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.897 -0.779 . . . . 75.12 108.897 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 28.0 t70 -141.18 145.9 36.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.991 -1.114 . . . . 75.32 107.991 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -114.2 137.5 51.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.096 0.558 . . . . 75.21 110.472 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.28 47.13 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.444 1.097 . . . . 60.14 108.589 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 70.2 p -160.22 150.53 18.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.741 0.416 . . . . 74.41 110.95 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.3 t -149.43 133.24 16.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.554 0.742 . . . . 75.03 109.511 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -77.98 139.03 39.14 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.602 -0.518 . . . . 74.23 109.602 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.461 HD12 HD13 ' C' ' 83' ' ' ILE . 53.1 mt -114.65 -30.52 6.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.773 0.829 . . . . 74.13 110.893 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.545 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -162.33 -175.07 4.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.25 1.02 . . . . 74.34 110.142 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.39 100.16 0.34 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.445 -0.798 . . . . 53.44 110.223 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.421 ' HA ' ' SD ' ' E' ' 174' ' ' MET . 0.9 OUTLIER 64.75 9.25 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.273 1.429 . . . . 75.31 113.843 -177.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 89.9 t -100.41 117.95 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.635 -1.617 . . . . 62.42 106.635 164.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.401 ' HB3' ' SD ' ' E' ' 174' ' ' MET . 1.2 p90 -137.06 -178.1 5.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.852 -0.796 . . . . 73.35 108.852 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -128.51 138.9 52.49 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.336 1.055 . . . . 63.43 109.829 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.69 127.72 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.767 -1.197 . . . . 72.22 107.767 168.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 111.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.913 0.885 . . . . 75.44 109.123 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.472 HD21 ' HB3' ' C' ' 103' ' ' PRO . 54.4 mt -87.53 109.06 19.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.077 0.551 . . . . 71.35 110.316 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 79.6 ttt180 -85.38 102.03 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.308 -0.997 . . . . 75.44 108.308 172.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.46 124.13 55.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.913 -1.143 . . . . 73.33 107.913 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -124.99 142.34 51.55 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.407 0.622 . . . . 72.04 109.769 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.51 HG11 HD23 ' C' ' 126' ' ' LEU . 70.6 t -135.52 130.22 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.442 1.097 . . . . 65.53 108.93 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.6 m -112.35 141.41 46.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.112 -1.07 . . . . 75.03 108.112 172.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.54 125.52 45.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.475 -1.306 . . . . 74.13 107.475 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -135.58 131.31 35.74 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.102 0.477 . . . . 74.34 110.5 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.418 HD12 ' HG2' ' C' ' 34' ' ' LYS . 11.7 mt -86.6 35.13 0.66 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.602 1.561 . . . . 74.53 109.321 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.57 -112.01 3.57 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 110.743 -0.943 . . . . 63.42 110.743 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.56 -31.52 18.6 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.632 0.773 . . . . 74.01 109.67 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -70.03 121.98 18.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.807 1.243 . . . . 74.41 110.363 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.5 m -80.05 131.66 35.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.765 0.257 . . . . 73.34 110.33 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.23 -53.89 4.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.112 0.565 . . . . 70.4 110.005 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -162.28 176.7 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.568 0.747 . . . . 73.01 111.07 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.467 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -136.73 143.96 43.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.656 -1.609 . . . . 75.11 106.656 171.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.467 ' N ' HD13 ' C' ' 75' ' ' LEU . 39.1 t -144.69 141.49 29.35 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.394 -0.965 . . . . 64.44 108.394 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.22 131.66 10.41 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.677 -0.49 . . . . 70.41 109.677 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.76 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.401 1.08 . . . . 74.11 108.305 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -121.1 96.84 5.26 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.232 1.013 . . . . 73.53 108.335 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.28 105.13 15.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.272 0.629 . . . . 74.21 110.556 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.45 150.57 25.86 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 123.668 0.605 . . . . 63.25 112.566 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -155.72 117.74 0.8 Allowed Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 111.47 -0.652 . . . . 64.21 111.47 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' D' ' 29' ' ' PRO . 9.5 mm -80.99 128.63 38.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 N-CA-C 108.733 -0.84 . . . . 62.13 108.733 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -135.11 131.17 36.57 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.193 0.597 . . . . 73.41 110.101 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -92.0 122.42 34.49 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.389 -1.337 . . . . 53.31 107.389 164.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 40.8 pt -113.71 -142.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 118.379 -0.819 . . . . 74.2 109.175 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 97.78 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.896 2.079 . . . . 74.34 110.596 176.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -39.56 3.1 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.316 -0.714 . . . . 64.45 111.316 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -77.65 162.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 124.366 1.066 . . . . 75.32 111.166 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -168.77 157.65 8.49 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.133 0.573 . . . . 65.4 110.462 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.07 -119.45 8.01 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-N 116.011 -0.541 . . . . 75.32 112.88 170.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.629 HG21 ' H ' ' A' ' 150' ' ' GLU . 60.3 p -57.64 -44.0 85.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.119 0.968 . . . . 73.44 111.036 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.13 -46.72 87.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.531 -1.213 . . . . 70.33 110.519 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.1 ttt -69.98 -41.94 73.76 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.676 -0.693 . . . . 74.44 110.957 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.1 76.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.976 0.51 . . . . 71.2 110.908 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.445 ' HA ' ' OH ' ' E' ' 181' ' ' TYR . 62.1 m170 -84.31 -21.48 30.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.672 0.789 . . . . 73.23 112.148 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 97.9 m -73.88 -59.75 2.57 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.701 0.401 . . . . 74.42 109.997 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.69 -26.3 68.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.179 0.991 . . . . 74.14 111.827 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 -22.44 42.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.375 -0.68 . . . . 75.02 114.295 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.84 -50.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.077 0.938 . . . . 64.5 113.428 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.441 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 85.4 t80 -69.87 -55.64 9.21 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 112.482 0.549 . . . . 74.25 112.482 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.426 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 32.0 m -60.9 -45.11 96.64 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.544 0.738 . . . . 74.34 111.277 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.472 ' HB3' HD21 ' C' ' 60' ' ' LEU . 91.5 Cg_exo -53.08 -40.37 76.96 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.591 2.194 . . . . 74.32 114.912 167.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.341 0.656 . . . . 72.01 111.511 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.4 mm -62.87 -42.4 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.471 -0.786 . . . . 72.22 110.554 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.478 HD21 ' HA3' ' C' ' 82' ' ' GLY . 73.8 mt -82.79 -25.43 32.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.988 0.915 . . . . 73.32 112.544 -171.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.16 -51.49 74.7 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.753 1.02 . . . . 73.11 113.753 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.42 ' HB3' ' CD2' ' A' ' 109' ' ' TYR . 19.5 Cg_endo -58.32 -33.95 98.19 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.837 1.691 . . . . 74.01 113.665 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -67.65 -47.73 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.436 0.694 . . . . 75.43 110.812 177.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.84 92.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.762 0.825 . . . . 71.02 110.677 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.47 -53.26 59.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.678 1.591 . . . . 74.22 110.726 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.43 -30.94 70.81 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.699 0.799 . . . . 73.01 110.513 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.77 -38.04 87.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 74.21 110.655 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 61.0 mt -73.24 -42.07 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.021 -0.536 . . . . 73.12 110.385 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -55.94 -44.24 78.21 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.496 0.719 . . . . 62.42 110.928 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 85.6 p -70.58 -47.41 60.36 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.248 -0.887 . . . . 73.41 110.462 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.589 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -54.22 -45.77 72.34 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.319 1.048 . . . . 75.23 112.768 -177.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 -42.86 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.673 0.608 . . . . 74.42 110.509 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.434 ' HA ' ' ND2' ' B' ' 127' ' ' ASN . 37.6 t -67.82 -27.78 67.01 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.318 -0.855 . . . . 71.33 112.373 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.5 mtt-85 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.245 0.618 . . . . 74.31 109.575 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.96 7.96 64.78 Favored Glycine 0 C--N 1.36 1.895 0 O-C-N 123.794 0.684 . . . . 71.13 112.951 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.447 HG23 ' NH2' ' B' ' 111' ' ' ARG . 17.3 p 63.37 16.18 9.31 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 127.369 2.268 . . . . 74.21 113.586 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.91 153.38 63.73 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 107.894 -1.15 . . . . 71.54 107.894 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.487 ' HB2' ' OH ' ' F' ' 202' ' ' TYR . 17.0 Cg_endo -51.98 118.56 4.63 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.969 2.446 . . . . 63.42 112.088 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.668 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 3.5 pt20 -44.77 146.89 0.7 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 124.906 1.282 . . . . 63.52 112.434 -172.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.51 HD23 HG11 ' C' ' 64' ' ' VAL . 14.7 tp -109.59 79.83 1.25 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.71 0.767 . . . . 74.42 112.845 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.735 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 6.9 p-10 -97.47 90.3 5.0 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.572 -1.195 . . . . 72.12 109.564 172.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 66.9 mt -74.83 146.0 42.37 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.478 -1.237 . . . . 74.2 109.465 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.03 130.03 92.83 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.339 0.399 . . . . 71.32 110.334 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.453 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 42.6 Cg_endo -65.61 101.31 0.44 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.955 2.437 . . . . 60.2 112.27 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.63 ' HB ' HD12 ' C' ' 136' ' ' LEU . 31.2 m -84.66 130.01 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.504 -0.771 . . . . 73.42 111.153 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -97.32 105.28 17.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.659 -1.238 . . . . 73.05 107.659 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.455 ' HA ' HD11 ' C' ' 136' ' ' LEU . 57.3 t80 -48.14 -44.93 32.61 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.575 1.15 . . . . 72.34 113.529 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.96 -41.32 91.39 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.484 0.49 . . . . 63.43 110.327 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.471 ' HB3' ' OE1' ' A' ' 12' ' ' GLN . . . -62.93 -38.13 89.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.837 0.855 . . . . 75.1 111.951 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' C' ' 131' ' ' VAL . 65.9 mt -64.57 -38.99 92.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.624 0.77 . . . . 75.22 110.646 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -71.58 -42.9 67.22 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.263 -0.88 . . . . 74.35 110.728 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 70.8 mtm -63.74 -50.18 70.11 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.294 0.638 . . . . 74.45 110.678 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.477 HD22 ' NE2' ' A' ' 12' ' ' GLN . 95.0 m-20 -57.55 -36.07 71.16 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.896 0.879 . . . . 75.12 112.025 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -58.61 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.303 0.641 . . . . 75.45 110.011 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.07 -27.96 68.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.863 0.865 . . . . 74.45 112.707 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.27 116.16 18.71 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.41 -0.959 . . . . 72.53 108.41 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.28 154.02 36.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.376 0.67 . . . . 72.51 112.525 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -88.45 151.23 22.7 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.241 -0.436 . . . . 71.44 110.249 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.505 ' H ' HG21 ' A' ' 10' ' ' THR . . . -74.28 157.42 35.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.537 0.735 . . . . 72.02 110.216 170.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.63 163.17 53.52 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 114.159 0.424 . . . . 60.02 114.159 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.521 ' HG3' ' HZ ' ' B' ' 32' ' ' PHE . 0.0 OUTLIER -84.44 177.27 8.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.644 0.778 . . . . 74.02 110.939 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.96 168.95 23.1 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.916 -0.584 . . . . 72.01 111.927 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p -77.2 133.24 38.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.635 0.774 . . . . 61.14 111.091 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.65 ' HB3' ' NE2' ' B' ' 33' ' ' GLN . 11.6 tt0 -121.71 149.91 42.56 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.442 1.097 . . . . 72.15 108.676 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.404 ' HG3' HE22 ' C' ' 153' ' ' GLN . 10.6 pt-20 -98.17 142.96 29.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.103 0.561 . . . . 73.33 110.944 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -112.1 139.17 47.84 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.986 0.914 . . . . 75.23 108.594 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.404 HE22 ' HG3' ' C' ' 151' ' ' GLU . 0.0 OUTLIER -149.85 97.27 2.57 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.583 0.706 . . . . 75.54 109.571 -176.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . 0.453 ' HB2' HD22 ' B' ' 27' ' ' ASN . 9.4 t70 -135.77 79.01 1.75 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.834 -1.172 . . . . 74.35 107.834 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.046 -0.979 . . . . 64.21 110.117 -179.177 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.826 -0.435 . . . . 62.41 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -119.79 144.98 47.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.686 0.794 . . . . 75.14 109.517 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.83 158.62 32.13 Favored 'General case' 0 C--O 1.241 0.645 0 O-C-N 123.681 0.613 . . . . 73.33 110.143 170.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.4 HE21 ' HG2' ' D' ' 90' ' ' GLU . 5.3 pp0? -117.57 134.37 54.94 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.497 -0.927 . . . . 72.41 108.497 168.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -126.93 89.87 3.06 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.04 -1.096 . . . . 63.01 108.04 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.55 179.82 5.26 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.306 -0.861 . . . . 72.45 109.305 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -65.18 -9.87 26.72 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.533 0.733 . . . . 63.12 112.126 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.69 ' HA ' ' HG2' ' B' ' 144' ' ' GLN . 1.2 mp0 -51.81 -43.74 63.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.023 0.529 . . . . 74.24 111.976 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.549 ' SD ' HG21 ' D' ' 89' ' ' ILE . 13.3 tpt -33.83 121.29 0.44 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 125.082 1.489 . . . . 72.35 112.878 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.424 ' HA ' ' HE3' ' B' ' 138' ' ' MET . 83.3 m -151.76 143.18 23.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.674 1.19 . . . . 74.44 108.535 177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.453 ' CZ ' ' SG ' ' D' ' 102' ' ' CYS . 43.4 t80 -157.31 126.48 5.92 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.608 ' HB3' HG11 ' E' ' 207' ' ' VAL . 47.7 mt-30 -140.08 158.11 44.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.143 0.577 . . . . 74.04 110.205 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.714 HG21 ' H ' ' B' ' 132' ' ' ASN . 10.5 tt -104.39 144.18 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.25 1.02 . . . . 74.52 110.191 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.44 -45.88 3.0 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.382 0.273 . . . . 73.22 111.624 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.409 ' NH1' ' HB2' ' B' ' 129' ' ' ALA . 12.7 tpt180 -169.79 130.75 1.04 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 119.33 -0.367 . . . . 73.22 110.923 -171.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.509 HG12 HD13 ' D' ' 13' ' ' ILE . 32.9 mm -116.73 130.37 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.206 -0.664 . . . . 73.31 109.206 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.442 ' HB3' HG22 ' C' ' 122' ' ' THR . 5.1 p90 -155.09 158.79 39.59 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.741 0.817 . . . . 75.25 111.731 -173.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -88.09 116.35 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.358 -0.608 . . . . 74.54 109.358 172.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.17 -29.13 26.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.109 175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.2 t70 -149.99 137.58 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.114 -0.948 . . . . 71.35 109.746 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.589 HG23 ' HE1' ' C' ' 117' ' ' MET . 63.7 mt -133.57 139.54 48.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.333 -1.358 . . . . 61.34 107.333 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -147.94 112.0 5.17 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.502 0.501 . . . . 71.44 110.012 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.6 t80 -109.73 122.22 46.99 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 105.674 -1.973 . . . . 71.21 105.674 167.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -132.97 109.28 9.46 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.598 -0.89 . . . . 71.22 108.598 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.73 83.45 4.57 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.75 -0.834 . . . . 72.22 108.75 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.75 -27.61 31.46 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.494 2.129 . . . . 62.31 112.074 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -114.14 35.59 4.09 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 124.588 1.155 . . . . 72.51 109.238 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.44 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.57 -58.76 16.74 Favored Pre-proline 0 CA--C 1.576 1.963 0 N-CA-C 114.947 1.462 . . . . 75.13 114.947 -164.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.533 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.2 Cg_endo -81.68 -14.31 10.24 Favored 'Trans proline' 0 C--N 1.389 2.708 0 CA-C-N 122.384 1.887 . . . . 74.33 113.027 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -68.67 -42.27 78.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.824 0.85 . . . . 73.44 109.934 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' D' ' 73' ' ' ALA . 1.0 OUTLIER -85.76 -2.37 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.082 -0.963 . . . . 63.52 110.226 -172.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.401 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 86.1 t80 -56.4 -35.37 67.7 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 73.41 111.005 164.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -65.42 -29.06 69.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 71.5 111.146 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -91.74 74.19 5.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.228 1.011 . . . . 75.01 110.189 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' H' ' 196' ' ' LYS . 11.9 p-10 -87.42 79.46 8.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.079 0.942 . . . . 73.35 109.001 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -134.17 178.16 7.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.139 1.376 . . . . 72.04 108.168 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.522 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 59.0 tp60 -75.68 118.38 70.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 118.547 0.612 . . . . 73.32 109.446 170.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.26 109.52 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.225 1.95 . . . . 55.12 111.182 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.49 113.64 3.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.135 -1.061 . . . . 73.14 108.135 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.56 HG12 HG13 ' D' ' 64' ' ' VAL . 97.5 t -95.76 106.2 17.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.616 -0.883 . . . . 75.24 108.616 -172.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.477 ' HZ2' ' HB2' ' D' ' 43' ' ' ASP . 14.0 tmtt? -87.78 110.35 20.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.124 -1.806 . . . . 74.42 106.124 169.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' H' ' 188' ' ' ALA . 3.9 pp -94.66 157.22 16.06 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.04 -1.096 . . . . 72.24 108.04 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 11.4 t70 -146.18 132.37 19.42 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.899 -0.408 . . . . 62.13 109.899 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' H' ' 186' ' ' LEU . 61.2 tp -102.31 130.5 49.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.168 0.987 . . . . 74.21 109.036 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -147.44 150.19 34.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.846 . . . . 75.3 108.914 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.6 t -126.42 159.33 33.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.256 0.622 . . . . 72.13 110.4 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.13 161.64 42.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 75.11 108.958 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 67.5 p -162.31 153.4 17.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.977 0.511 . . . . 71.43 110.936 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -155.47 147.81 23.8 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.717 0.807 . . . . 74.04 109.644 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -82.35 118.08 22.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.274 -0.639 . . . . 74.53 109.274 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.678 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.0 mt -92.66 -33.49 14.35 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.074 -0.343 . . . . 75.24 110.074 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.52 -177.96 2.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.282 1.033 . . . . 75.25 109.809 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.03 124.44 21.6 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.407 0.683 . . . . 65.42 109.977 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 65.0 14.25 9.22 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.036 1.334 . . . . 74.53 112.487 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -119.22 128.9 75.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.624 0.77 . . . . 74.15 109.404 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.35 149.78 50.37 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.848 0.859 . . . . 75.4 109.733 174.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.678 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.9 tt0 -109.38 117.47 34.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.299 -1.371 . . . . 73.42 107.299 163.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.27 129.75 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.528 -1.286 . . . . 74.15 107.528 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 40.7 t -113.19 132.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.67 -0.863 . . . . 71.22 108.67 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.427 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -108.62 126.05 52.53 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.949 -1.13 . . . . 73.2 107.949 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 40.7 ttm-85 -101.01 105.06 16.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.211 -1.033 . . . . 72.02 108.211 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.13 120.78 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.586 -1.264 . . . . 72.24 107.586 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.5 m -117.73 147.02 43.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.258 0.623 . . . . 75.52 109.452 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.56 HG13 HG12 ' D' ' 40' ' ' VAL . 69.2 t -133.87 100.57 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.014 1.326 . . . . 73.14 107.822 176.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -91.97 89.96 7.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.594 -2.002 . . . . 75.23 105.594 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.416 ' HB1' ' CE1' ' D' ' 74' ' ' PHE . . . -100.0 132.6 45.26 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.895 -1.048 . . . . 60.33 108.389 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 71.5 m -141.15 137.36 32.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 122.113 0.959 . . . . 73.41 111.814 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 54.8 mt -100.19 100.53 11.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.363 -1.744 . . . . 64.42 109.669 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.1 -123.6 10.68 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.835 -0.621 . . . . 71.22 111.957 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.92 4.21 53.46 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.353 0.661 . . . . 75.14 110.941 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.71 144.74 46.04 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.195 0.598 . . . . 72.1 110.026 -171.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -72.03 128.94 37.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.482 0.488 . . . . 70.33 110.208 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.559 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -78.33 -61.09 2.12 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.587 -0.894 . . . . 73.23 108.587 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.474 ' CZ ' HG21 ' D' ' 118' ' ' VAL . 0.5 OUTLIER -159.59 177.62 10.71 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 113.859 -1.519 . . . . 74.12 108.329 171.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -134.34 107.47 7.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 73.5 106.447 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' D' ' 114' ' ' ILE . 1.9 t -113.77 146.29 40.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.836 0.454 . . . . 74.14 111.763 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.32 136.53 11.88 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.26 1.024 . . . . 75.12 109.158 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.36 116.26 24.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.998 -0.742 . . . . 72.31 108.998 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.573 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -91.89 88.21 6.53 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.703 0.764 . . . . 74.14 109.518 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -82.09 104.19 12.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.239 -1.346 . . . . 74.15 109.034 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.95 155.36 23.03 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.444 -0.662 . . . . 62.11 111.444 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.421 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -159.08 132.03 2.93 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.574 -0.61 . . . . 50.33 111.574 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.45 HG22 HD13 ' D' ' 51' ' ' LEU . 34.3 mt -88.51 134.15 28.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 109.141 -0.689 . . . . 73.44 109.141 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.37 148.5 46.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 72.01 110.06 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 30.7 m -90.58 135.54 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.92 0.888 . . . . 65.2 109.138 170.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 5.0 tt -138.08 117.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 123.87 0.868 . . . . 75.34 110.166 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.27 146.29 5.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 70.33 110.103 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.81 0.27 59.04 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 113.737 0.255 . . . . 63.24 113.737 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.549 HG21 ' SD ' ' D' ' 9' ' ' MET . 1.8 pp -103.06 164.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.098 0.959 . . . . 75.54 110.831 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.4 ' HG2' HE21 ' D' ' 4' ' ' GLN . 0.0 OUTLIER -172.54 164.21 5.5 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.132 0.895 . . . . 75.51 110.31 173.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.58 -127.09 38.86 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 115.566 -0.743 . . . . 65.45 113.986 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.6 p -77.1 -27.31 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.777 0.831 . . . . 63.31 111.54 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -48.01 82.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.938 0.895 . . . . 71.22 110.846 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' H' ' 172' ' ' ALA . 25.3 ptm -68.73 -41.27 79.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.0 -0.545 . . . . 73.21 111.714 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.15 72.25 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.484 0.714 . . . . 73.21 111.104 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -81.16 -37.47 28.72 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.348 -0.842 . . . . 72.0 110.453 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -66.0 -49.79 66.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.166 0.586 . . . . 74.14 111.879 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.763 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.5 pp -83.82 -26.32 29.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.541 0.336 . . . . 74.22 111.23 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.31 -27.75 29.63 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.304 0.378 . . . . 70.52 113.447 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -115.76 -60.06 1.92 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.155 0.582 . . . . 75.34 110.469 -174.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.403 ' O ' HG12 ' D' ' 105' ' ' ILE . 86.4 t80 -63.54 -49.61 72.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.733 0.413 . . . . 73.2 111.995 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.763 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 60.9 m -58.24 -51.58 80.74 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-O 118.642 -0.694 . . . . 72.23 112.494 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 39.3 Cg_exo -64.91 -32.79 54.26 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 121.66 1.574 . . . . 72.34 112.827 173.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.58 -32.17 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.971 0.508 . . . . 71.52 111.148 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.403 HG12 ' O ' ' D' ' 101' ' ' TYR . 38.2 mm -71.37 -35.68 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.756 0.822 . . . . 75.43 110.997 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.421 HD22 ' HA3' ' D' ' 82' ' ' GLY . 66.7 mt -75.04 -19.84 59.84 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.399 -0.819 . . . . 72.31 110.827 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -68.32 -42.5 29.35 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.294 1.22 . . . . 73.43 114.294 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -56.15 -40.42 84.96 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.069 1.846 . . . . 73.05 113.401 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -77.96 -35.0 50.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.052 0.941 . . . . 72.44 111.25 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.59 -42.87 77.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.467 0.707 . . . . 74.34 109.841 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.514 ' NH2' HG22 ' B' ' 105' ' ' ILE . 36.7 ttp180 -62.43 -46.62 87.7 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.438 -1.255 . . . . 74.14 109.888 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.92 -46.8 89.23 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.963 0.79 . . . . 71.51 110.743 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.431 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.8 t -59.23 -40.98 87.6 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.587 0.555 . . . . 72.21 110.678 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.586 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.8 mt -59.92 -57.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.915 0.486 . . . . 72.21 109.87 171.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 55.9 m -52.53 -44.49 65.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.36 1.464 . . . . 72.41 111.709 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.45 -44.55 78.39 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.528 -1.215 . . . . 71.22 110.07 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.7 mtm -66.01 -38.47 88.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.74 0.416 . . . . 71.32 111.411 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' D' ' 74' ' ' PHE . 98.6 t -62.53 -45.27 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 O-C-N 124.141 0.901 . . . . 72.44 109.795 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -71.45 -32.8 68.75 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.933 0.493 . . . . 74.33 111.03 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -70.08 -27.15 64.38 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.577 0.751 . . . . 75.54 109.949 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.17 11.89 70.8 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.918 0.761 . . . . 53.32 112.83 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 55.8 p 58.26 32.08 21.61 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.863 1.665 . . . . 61.34 113.356 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.43 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 84.9 m-85 -101.92 165.06 14.61 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.233 1.013 . . . . 73.13 108.296 168.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 57.3 Cg_endo -67.41 149.72 80.6 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.487 2.124 . . . . 61.34 112.423 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -59.19 126.92 29.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.294 0.637 . . . . 64.44 111.091 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.455 HD13 HG21 ' D' ' 40' ' ' VAL . 60.4 tp -107.79 96.48 6.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.529 0.732 . . . . 72.22 110.458 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -103.89 95.04 5.75 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.478 -0.564 . . . . 73.12 109.478 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.96 134.28 43.1 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.227 -0.657 . . . . 74.53 109.227 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.86 138.53 87.07 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.812 0.845 . . . . 65.42 111.569 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -83.6 103.8 1.1 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.306 2.004 . . . . 71.43 110.889 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -107.71 110.92 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.708 0.766 . . . . 70.25 110.415 -171.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.45 116.41 28.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.045 -0.98 . . . . 71.53 109.648 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.471 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 79.5 m-85 -63.72 -12.38 34.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.269 0.628 . . . . 72.3 111.127 175.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.62 -57.23 13.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.39 1.076 . . . . 60.33 110.962 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.06 85.44 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.589 0.555 . . . . 72.13 111.635 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -70.54 -41.13 72.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.612 0.765 . . . . 73.23 111.61 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -71.71 -54.51 10.08 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 74.22 110.313 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mtm -61.07 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.337 0.655 . . . . 73.13 111.397 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -51.49 -38.02 51.96 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.04 0.936 . . . . 72.42 111.938 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -77.33 -42.23 37.5 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.597 0.759 . . . . 74.44 110.826 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.39 -29.87 47.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.03 0.752 . . . . 73.32 113.03 -171.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -89.07 30.34 0.96 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.098 0.559 . . . . 70.35 111.677 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -119.72 51.35 1.18 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.192 0.997 . . . . 73.13 108.886 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -163.93 10.8 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.957 -1.02 . . . . 75.44 111.093 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.72 -54.69 2.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.547 0.739 . . . . 74.44 110.379 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.14 -122.08 6.3 Favored Glycine 0 C--O 1.239 0.451 0 CA-C-N 115.001 -1.0 . . . . 74.11 111.558 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.48 138.96 40.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.249 -1.019 . . . . 73.41 108.249 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.32 -124.97 0.21 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.73 0.644 . . . . 61.22 112.342 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 91.1 m -153.68 145.45 23.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.843 0.857 . . . . 64.32 109.246 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.33 119.96 7.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.665 0.786 . . . . 72.13 110.529 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.69 123.75 18.81 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.344 1.028 . . . . 74.43 109.317 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -62.55 141.25 58.53 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.856 0.723 . . . . 75.41 110.139 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.92 103.03 0.18 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.417 1.087 . . . . 75.11 109.406 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.82 151.32 35.95 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.692 0.797 . . . . 74.34 111.065 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.389 0 C-N-CA 123.995 0.918 . . . . 65.12 109.393 179.159 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 23.8 pttm . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 122.215 1.007 . . . . 71.01 110.056 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.7 -16.12 79.24 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.61 -1.177 . . . . 72.23 112.719 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . 0.404 ' HB3' ' H ' ' E' ' 171' ' ' SER . 95.9 mttt 62.07 -162.45 0.28 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.983 1.313 . . . . 72.42 111.653 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 171' ' ' SER . . . . . 0.404 ' H ' ' HB3' ' E' ' 170' ' ' LYS . 18.9 m -49.98 104.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 75.14 111.896 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.85 -59.3 1.95 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 75.4 110.325 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.88 145.57 13.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.102 0.561 . . . . 71.5 110.274 -174.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' C' ' 54' ' ' ASP . 0.1 OUTLIER -122.26 131.82 54.11 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 122.3 -0.25 . . . . 75.22 111.007 -176.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 56.6 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.084 1.754 . . . . 73.33 114.314 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . 0.411 HD22 ' NE2' ' E' ' 178' ' ' GLN . 56.0 t30 -159.72 90.77 0.94 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.085 -1.45 . . . . 74.03 107.085 165.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.02 83.37 2.88 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.166 -0.925 . . . . 75.42 108.662 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . 0.411 ' NE2' HD22 ' E' ' 176' ' ' ASN . 48.4 mt-30 -90.25 -158.62 0.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.81 -1.086 . . . . 73.43 109.166 170.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 73.76 137.67 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.64 1.176 . . . . 71.13 111.341 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . 0.485 ' HG3' ' HB3' ' A' ' 153' ' ' GLN . 29.7 Cg_endo -60.44 -43.54 33.18 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.478 2.119 . . . . 74.42 111.56 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . 0.445 ' OH ' ' HA ' ' C' ' 96' ' ' HIS . 0.8 OUTLIER 64.55 -169.83 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.557 1.143 . . . . 71.12 111.04 -171.882 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -128.18 168.34 15.57 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.323 -0.992 . . . . 65.44 108.323 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 25.8 m -63.79 -18.94 64.6 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.817 0.847 . . . . 74.21 112.622 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 67.84 89.65 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.216 1.406 . . . . 71.13 108.746 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . 0.479 ' HG2' ' HB3' ' C' ' 136' ' ' LEU . 51.2 Cg_exo -57.25 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.223 2.616 . . . . 75.21 114.085 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.93 125.34 33.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.81 -0.811 . . . . 73.44 108.81 172.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 31.5 pt -71.3 167.73 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.517 0.727 . . . . 74.34 111.255 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.05 128.28 54.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.134 -1.062 . . . . 70.22 108.134 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -99.58 -19.33 16.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.595 0.358 . . . . 70.4 111.34 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . 0.401 ' O ' HG21 ' C' ' 40' ' ' VAL . 2.6 m-20 59.05 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.806 1.242 . . . . 72.42 112.192 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.62 -35.65 2.3 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.423 -1.071 . . . . 74.23 110.423 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.52 -83.67 0.2 Allowed Glycine 0 C--N 1.35 1.346 0 O-C-N 124.304 0.649 . . . . 53.12 113.826 171.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -166.81 107.05 0.63 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.898 0.879 . . . . 74.35 108.839 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' E' ' 195' ' ' PHE . . . -172.09 123.0 0.49 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 70.1 109.858 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' E' ' 194' ' ' ALA . 0.6 OUTLIER 170.36 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.257 -1.386 . . . . 64.52 107.257 171.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' F' ' 190' ' ' ASP . 3.3 tppp? 67.08 106.03 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.407 1.483 . . . . 71.33 113.634 169.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.77 -168.37 1.77 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.919 1.287 . . . . 75.12 108.802 167.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 58.93 83.35 0.13 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.223 1.009 . . . . 72.3 109.519 -175.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' E' ' 205' ' ' LYS . 38.6 t30 64.01 -73.9 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.012 1.325 . . . . 75.15 110.827 -170.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.4 79.4 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.517 -0.765 . . . . 74.31 112.722 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.1 17.82 7.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.236 1.014 . . . . 74.11 111.416 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.61 150.54 21.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.277 -1.009 . . . . 73.52 108.277 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.26 -13.24 57.9 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.295 0.638 . . . . 75.14 111.792 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.458 HG22 HG21 ' E' ' 207' ' ' VAL . 9.3 mt -57.37 -61.54 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.458 1.103 . . . . 74.03 110.47 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' E' ' 199' ' ' ASN . 77.0 mttt 60.84 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.292 1.037 . . . . 74.0 110.968 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.76 -30.59 1.82 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.596 1.159 . . . . 72.34 109.243 173.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.608 HG11 ' HB3' ' D' ' 12' ' ' GLN . 2.9 t . . . . . 0 C--O 1.254 1.337 0 C-N-CA 126.2 1.8 . . . . 64.43 109.099 -168.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.52 -0.548 . . . . 74.31 109.52 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -155.85 73.64 0.24 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.751 -0.939 . . . . 74.11 110.751 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -105.47 172.67 6.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.841 0.856 . . . . 74.03 110.129 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -81.06 -159.25 0.24 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.538 -0.912 . . . . 64.51 108.538 164.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.55 61.97 4.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.622 -0.674 . . . . 64.23 109.698 171.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -132.91 123.83 26.73 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.406 -1.331 . . . . 75.13 107.406 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.627 ' HE3' ' HG3' ' B' ' 94' ' ' MET . 0.0 OUTLIER -164.99 142.79 6.21 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.481 -1.236 . . . . 55.44 108.456 -172.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.28 103.09 2.15 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.129 -1.063 . . . . 71.04 108.129 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.62 -76.3 0.6 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.885 -0.783 . . . . 75.1 108.885 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 32.1 tp 55.64 27.8 11.06 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.545 1.138 . . . . 74.12 110.796 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -104.07 -24.73 13.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.899 -1.046 . . . . 63.14 110.763 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.62 142.75 28.18 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 124.867 1.267 . . . . 72.21 109.185 -174.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.06 98.87 0.74 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.777 2.318 . . . . 64.0 110.954 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -60.35 -42.73 96.34 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.515 -0.766 . . . . 75.32 110.499 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.341 -0.845 . . . . 73.51 109.826 171.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 26.4 m 60.75 84.87 0.12 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.446 1.098 . . . . 73.53 110.341 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -69.8 121.09 81.49 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.406 0.682 . . . . 73.03 111.02 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -70.44 106.51 1.8 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.795 2.33 . . . . 74.32 111.454 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.81 120.5 21.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.11 -0.495 . . . . 61.3 110.07 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.54 171.39 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.474 1.11 . . . . 73.34 111.362 172.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.37 -91.72 0.46 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.922 0.489 . . . . 73.34 110.874 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -176.44 112.46 0.1 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.538 -1.282 . . . . 75.4 107.538 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . 0.418 ' HB3' ' HG2' ' E' ' 196' ' ' LYS . 31.7 t70 -74.31 90.91 2.15 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 120.803 0.335 . . . . 64.03 110.554 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 70.38 -172.34 41.93 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.062 -0.972 . . . . 65.44 114.147 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.33 129.02 1.33 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.522 -0.631 . . . . 62.22 111.522 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.68 28.77 8.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.928 0.891 . . . . 73.43 109.255 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.4 -0.28 28.53 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.919 0.888 . . . . 74.51 111.936 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' F' ' 201' ' ' LYS . 42.8 t80 -137.87 135.1 35.83 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.637 0.775 . . . . 74.41 109.215 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.08 115.9 1.35 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.553 1.158 . . . . 74.12 108.462 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.98 145.03 56.87 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.595 0.56 . . . . 73.14 110.533 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 79.46 -45.86 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.914 1.685 . . . . 73.42 111.057 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . 0.462 HD22 ' HE2' ' F' ' 201' ' ' LYS . 4.5 t30 -61.68 -54.53 41.5 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.604 1.162 . . . . 72.33 111.272 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.13 -171.96 20.85 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 111.36 -0.696 . . . . 74.45 111.36 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . 0.462 ' HE2' HD22 ' F' ' 199' ' ' ASN . 43.2 mtmt 69.91 106.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.983 1.313 . . . . 75.03 110.593 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' C' ' 124' ' ' PRO . 21.6 m-30 56.11 21.12 4.88 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 124.27 1.028 . . . . 74.51 111.597 -172.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -138.39 151.1 47.19 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.205 -1.361 . . . . 71.43 108.05 -172.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.475 HG21 ' O ' ' A' ' 14' ' ' GLN . 8.2 tp -65.75 -37.02 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.404 -1.271 . . . . 72.45 111.429 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.11 147.93 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.108 1.363 . . . . 73.0 109.269 -165.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.2 85.71 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.293 0.568 . . . . 72.32 110.465 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.246 0.905 0 C-N-CA 123.658 0.783 . . . . 74.11 109.409 -179.308 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.438 0.161 . . . . 74.4 110.632 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 4' ' ' GLN . . . -87.34 -132.4 3.59 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.089 -0.505 . . . . 63.33 114.096 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -148.09 -88.07 0.09 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.611 0.764 . . . . 74.32 110.002 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 59.3 p -178.4 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.879 0.872 . . . . 71.13 110.091 -167.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -138.96 71.75 1.39 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.921 0.888 . . . . 72.54 109.297 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 10.6 mt -154.72 143.62 20.9 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.944 -1.025 . . . . 74.23 109.196 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.495 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 34.8 mmt 55.62 64.63 1.69 Allowed 'General case' 0 C--O 1.243 0.736 0 O-C-N 124.493 1.121 . . . . 64.02 110.525 -175.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 55.98 -94.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 112.584 -2.098 . . . . 64.05 109.679 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 55.89 28.53 12.67 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.7 1.2 . . . . 71.41 112.015 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.67 86.25 0.21 Allowed 'General case' 0 C--N 1.358 0.939 0 N-CA-C 108.699 -0.852 . . . . 74.33 108.699 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -64.97 -54.21 34.12 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 109.049 -0.723 . . . . 75.5 109.049 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.93 138.1 26.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.845 -1.07 . . . . 73.33 108.51 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.66 -6.0 17.98 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.849 2.366 . . . . 74.12 113.274 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 67.78 -75.9 0.06 Allowed 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.608 1.563 . . . . 75.53 110.439 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.87 179.95 6.93 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.042 0.937 . . . . 72.44 110.997 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 20.6 m -128.49 159.69 34.65 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.033 0.933 . . . . 74.13 108.544 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -97.99 105.15 25.91 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.498 0.719 . . . . 75.1 110.608 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.12 -58.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.332 2.021 . . . . 63.31 112.621 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 44' ' ' LEU . 6.7 mp 60.83 176.71 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.299 1.44 . . . . 63.42 111.569 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.673 ' HA ' ' HB2' ' H' ' 206' ' ' ASP . 36.0 pt -68.99 150.86 10.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.052 -0.522 . . . . 72.34 110.575 171.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.7 -2.14 28.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.529 -0.76 . . . . 73.12 112.007 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . 66.61 -76.22 0.05 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.799 1.64 . . . . 71.04 110.986 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -57.81 131.02 49.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.116 0.966 . . . . 63.32 111.798 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.24 21.19 9.44 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.006 -0.543 . . . . 72.01 111.771 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.51 -50.69 4.07 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 123.044 0.354 . . . . 72.4 112.725 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -87.78 46.26 1.36 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.039 0.935 . . . . 75.23 110.125 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 38' ' ' PRO . . . -80.3 81.57 6.52 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.573 -0.739 . . . . 74.21 110.034 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . 0.48 ' HB3' ' NE1' ' A' ' 36' ' ' TRP . 2.0 m-30 68.32 153.55 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.73 1.212 . . . . 71.25 113.26 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -163.89 139.45 6.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.466 0.706 . . . . 71.03 110.129 170.492 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -78.06 155.55 30.56 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.306 0.574 . . . . 73.3 110.651 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -114.13 147.21 39.19 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.893 -1.049 . . . . 75.35 108.171 172.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.65 24.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.495 0.924 . . . . 74.13 113.495 -168.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.7 -42.31 62.38 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.65 -0.528 . . . . 72.24 113.468 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 74.16 -38.73 0.4 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.606 1.563 . . . . 74.52 113.731 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 56.8 t80 68.67 66.76 0.3 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.801 1.241 . . . . 74.12 110.063 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -103.69 138.27 40.57 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.679 -1.146 . . . . 72.33 109.001 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 3.4 mp -97.4 -70.04 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 107.779 -1.193 . . . . 72.15 107.779 179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 176.11 -71.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.275 1.83 . . . . 75.35 107.187 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.92 -79.92 0.13 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.676 1.19 . . . . 71.15 108.586 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 CA--C 1.565 1.55 0 C-N-CA 124.231 1.012 . . . . 70.23 108.646 -173.741 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 109.537 -0.542 . . . . 73.21 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 162.83 -152.64 22.9 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.758 -0.937 . . . . 73.01 110.758 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -111.98 -79.64 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.067 0.547 . . . . 71.42 110.014 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.8 t -169.47 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.341 0.656 . . . . 71.54 109.729 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.595 ' HB3' ' SD ' ' D' ' 94' ' ' MET . . . -139.91 114.77 9.53 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.993 0.517 . . . . 63.22 111.445 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 32.8 mt -135.56 -49.69 0.72 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.61 1.164 . . . . 73.04 109.21 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.52 166.02 20.66 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.716 -0.674 . . . . 74.33 109.822 173.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -49.57 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.807 1.643 . . . . 74.43 111.958 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -89.98 -81.79 0.28 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.955 0.902 . . . . 75.31 109.696 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . 0.739 HD12 HD11 ' D' ' 98' ' ' LEU . 6.0 mp 55.99 34.51 23.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.6 1.16 . . . . 72.22 111.579 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -62.18 -48.32 80.59 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.841 0.856 . . . . 71.52 111.21 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -80.02 140.4 53.75 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 115.846 -0.615 . . . . 73.3 110.297 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.26 99.98 0.25 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.528 2.152 . . . . 75.11 110.788 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -78.24 81.8 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.069 -0.514 . . . . 75.41 110.069 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 55.88 -99.88 0.1 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.718 1.207 . . . . 75.31 111.194 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 183' ' ' THR . . . . . 0.576 HG23 ' HD3' ' H' ' 185' ' ' PRO . 15.3 t -178.08 -36.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.627 1.171 . . . . 73.13 109.461 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 36.09 76.17 0.46 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 126.443 1.897 . . . . 74.42 114.213 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . 0.576 ' HD3' HG23 ' H' ' 183' ' ' THR . 93.4 Cg_endo -77.27 141.75 20.75 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.464 2.11 . . . . 74.35 112.566 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . 0.413 ' HB2' HD22 ' D' ' 44' ' ' LEU . 5.7 tt -81.86 136.52 35.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.827 -1.175 . . . . 75.45 107.827 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.9 164.02 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.436 0.695 . . . . 73.1 112.282 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . 0.652 ' HA ' HD22 ' D' ' 42' ' ' LEU . . . -107.61 -178.71 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.181 0.592 . . . . 74.23 110.952 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.26 86.41 1.55 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.464 0.705 . . . . 70.34 109.425 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.96 105.22 15.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.19 -1.041 . . . . 71.33 108.19 171.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.93 -164.98 35.62 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 123.628 0.58 . . . . 75.23 112.455 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.35 171.9 45.88 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 112.024 -0.431 . . . . 65.53 112.024 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . 0.522 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 43.4 t80 -176.87 98.35 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.373 -1.343 . . . . 72.22 107.373 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.91 102.94 0.31 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.115 0.966 . . . . 72.44 109.63 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.413 ' CD1' ' HD3' ' D' ' 124' ' ' PRO . 32.6 t80 -178.28 -13.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.989 0.916 . . . . 74.42 110.86 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . 0.518 ' HB3' ' HZ3' ' H' ' 196' ' ' LYS . 2.0 mmmp? -51.27 115.0 1.37 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.325 1.05 . . . . 74.1 111.531 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . 0.413 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 36.4 m-85 -84.16 -177.17 6.57 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.425 1.09 . . . . 74.21 110.671 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -138.69 160.16 40.32 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.769 -0.65 . . . . 63.23 109.531 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.71 143.52 31.8 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.327 -0.851 . . . . 70.05 109.746 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.79 2.87 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.608 -0.551 . . . . 64.4 113.05 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 77.8 tttt 64.84 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.364 1.213 0 C-N-CA 124.861 1.264 . . . . 75.3 109.318 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.57 141.13 31.95 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.407 1.483 . . . . 74.12 107.046 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -101.15 100.69 11.28 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.752 -0.462 . . . . 54.52 109.752 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.3 90.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.525 0.73 . . . . 75.3 109.438 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -94.01 -29.7 15.09 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.791 -1.095 . . . . 75.15 109.521 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . 0.673 ' HB2' ' HA ' ' G' ' 187' ' ' ILE . 4.2 m-20 -99.99 129.7 46.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.614 -1.175 . . . . 73.22 111.062 -166.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.251 1.152 0 N-CA-C 106.363 -1.717 . . . . 74.13 106.363 165.453 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 111.207 0.077 . . . . 75.51 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -126.46 -27.67 3.14 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.27 0.47 . . . . 73.34 112.27 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -76.54 113.5 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.878 0.37 . . . . 74.1 110.959 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -114.83 130.25 56.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 64.54 108.636 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -114.44 136.19 53.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.981 0.512 . . . . 73.25 111.16 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -169.56 113.09 0.51 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.806 1.242 . . . . 74.24 108.661 170.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -141.67 -52.56 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.149 -1.056 . . . . 74.33 108.149 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -84.43 169.25 14.75 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.702 -1.135 . . . . 74.21 108.33 166.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.512 ' SD ' ' HE3' ' C' ' 138' ' ' MET . 12.3 tmm? -171.33 134.19 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.082 0.553 . . . . 72.03 110.348 173.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -156.69 135.6 11.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.255 1.022 . . . . 73.51 109.618 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.536 ' HB3' ' SD ' ' C' ' 138' ' ' MET . 50.5 t80 -136.32 136.96 40.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 75.1 108.72 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -151.18 125.88 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.864 -0.153 . . . . 73.4 110.965 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -76.26 132.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 75.03 108.385 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.512 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 79.6 mm-40 -103.85 -38.61 6.96 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 123.88 0.737 . . . . 74.45 109.906 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -168.94 141.84 2.78 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 112.074 0.398 . . . . 75.22 112.074 -171.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.721 HD13 ' HB3' ' C' ' 130' ' ' PRO . 74.4 mt -106.71 142.47 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 124.932 1.293 . . . . 74.3 107.516 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' HH ' ' HB3' ' B' ' 29' ' ' PRO . 15.3 p90 -166.21 146.22 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.723 0.773 . . . . 75.43 111.003 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 p -88.46 105.06 17.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.845 -1.07 . . . . 73.11 109.321 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.49 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.1 mtpt -76.06 -28.21 57.54 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.857 -0.423 . . . . 74.13 109.857 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.3 t70 -148.77 130.77 15.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.87 -1.059 . . . . 73.12 109.67 174.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -122.84 136.36 59.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 105.983 -1.858 . . . . 74.13 105.983 167.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.82 108.26 3.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.831 0.348 . . . . 72.35 110.649 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.7 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.9 t80 -109.83 131.0 55.46 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.035 -1.468 . . . . 73.42 107.035 171.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.62 131.6 41.58 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.441 -0.948 . . . . 65.14 108.441 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.8 72.67 12.51 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.913 -0.773 . . . . 64.2 108.913 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.44 -13.22 25.2 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.509 2.139 . . . . 73.24 111.853 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -118.04 25.53 10.28 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.762 0.825 . . . . 74.23 109.296 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.47 99.8 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.166 0.987 . . . . 72.14 112.898 178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.03 -18.08 18.96 Favored 'Trans proline' 0 C--N 1.391 2.812 0 CA-C-N 120.933 1.369 . . . . 72.41 113.208 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.95 -18.99 61.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.249 0.62 . . . . 73.42 111.938 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 8.6 p -64.69 -18.39 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 112.783 0.66 . . . . 70.33 112.783 -176.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -71.45 -40.32 70.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.965 0.506 . . . . 74.5 110.604 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -86.68 -19.54 29.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.658 -0.701 . . . . 74.3 110.713 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 29.8 mmmt -81.97 151.0 27.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.12 0.568 . . . . 75.35 111.29 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.703 ' HB3' ' HE1' ' G' ' 193' ' ' TYR . 9.5 m-20 -80.5 124.01 28.57 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.931 -1.031 . . . . 54.43 108.714 168.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.453 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.4 t-105 -76.13 87.42 3.01 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.115 0.483 . . . . 75.15 110.54 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.86 80.66 70.63 Favored Pre-proline 0 C--O 1.245 0.837 0 C-N-CA 124.505 1.122 . . . . 74.24 108.035 169.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' G' ' 192' ' ' GLY . 94.3 Cg_endo -79.45 129.41 8.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.269 1.979 . . . . 75.23 111.804 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.79 84.17 3.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 105.626 -1.99 . . . . 74.35 105.626 172.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -77.19 93.85 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.344 -1.298 . . . . 74.43 109.854 -172.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.88 116.11 23.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 113.976 -1.466 . . . . 75.34 110.867 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 128' ' ' LEU . 6.6 mp -97.38 106.94 19.34 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.45 -1.25 . . . . 70.42 107.882 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.508 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.2 t70 -107.47 147.26 30.7 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.793 1.237 . . . . 73.31 109.364 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -129.8 137.61 50.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.013 0.925 . . . . 73.14 109.528 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -144.41 145.8 32.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.31 0.644 . . . . 72.33 109.485 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.8 m -107.19 125.93 51.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.619 0.768 . . . . 72.13 110.032 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.78 138.32 45.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.999 0.92 . . . . 70.01 108.825 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -135.65 162.46 32.67 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.434 0.693 . . . . 74.43 110.341 172.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 t -161.34 123.27 2.97 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.047 0.939 . . . . 72.01 108.661 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.08 146.26 39.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.812 -0.44 . . . . 73.33 109.812 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' A' ' 57' ' ' GLU . 49.9 mt -117.35 -34.92 4.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.507 0.723 . . . . 74.31 111.355 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -159.1 -175.28 5.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.987 0.915 . . . . 75.51 109.441 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.09 121.13 17.72 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.735 -0.839 . . . . 75.41 108.735 173.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' G' ' 174' ' ' MET . 21.5 m-20 67.94 9.86 7.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.388 1.475 . . . . 70.51 113.013 -177.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 71.1 t -124.12 122.24 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.152 -1.055 . . . . 73.21 108.152 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -140.84 170.47 15.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.998 -0.741 . . . . 75.34 108.998 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.504 ' HB2' HD13 ' A' ' 51' ' ' LEU . 23.0 tt0 -126.51 140.08 52.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.174 0.99 . . . . 74.31 108.75 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -117.48 124.86 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 107.138 -1.43 . . . . 74.54 107.138 164.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -98.29 127.04 51.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 172.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.86 109.47 21.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.843 -1.54 . . . . 74.44 106.843 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -98.52 100.33 11.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.267 -1.012 . . . . 74.44 108.267 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.81 117.14 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.582 -1.19 . . . . 74.4 108.756 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.508 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.1 m -112.74 128.01 56.3 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.55 -0.537 . . . . 71.12 109.55 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.28 107.54 21.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 107.948 -1.13 . . . . 72.14 107.948 176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.0 m -102.16 141.35 35.14 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.318 -0.993 . . . . 71.22 108.318 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.19 106.88 10.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.068 -1.086 . . . . 63.21 108.068 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -108.97 125.96 52.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.049 0.54 . . . . 63.22 110.467 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 HD21 ' CE3' ' A' ' 36' ' ' TRP . 46.7 mt -88.46 62.33 6.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.47 -1.307 . . . . 73.55 107.47 171.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.39 1.32 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.57 -1.196 . . . . 74.24 111.371 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.01 -20.26 27.47 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.969 0.908 . . . . 75.14 111.161 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -109.2 118.86 37.82 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.351 -0.611 . . . . 75.3 109.351 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -73.18 130.17 39.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.559 0.618 . . . . 73.4 110.129 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.413 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -78.56 -56.75 4.19 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.78 -0.822 . . . . 71.01 108.78 177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.19 168.6 26.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.167 -1.379 . . . . 75.51 110.558 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.4 116.91 11.36 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.545 1.138 . . . . 75.31 108.733 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 84.4 m -104.31 138.82 40.19 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 124.319 1.048 . . . . 75.35 108.893 172.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -148.04 117.33 6.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.255 -1.017 . . . . 74.3 108.255 171.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -122.81 111.48 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 109.316 -0.624 . . . . 75.42 109.316 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.0 mt-30 -86.42 82.19 8.05 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.89 -1.05 . . . . 74.44 108.732 170.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -77.96 95.63 4.85 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.358 -1.292 . . . . 71.11 109.405 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.14 154.53 29.02 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 112.057 -0.417 . . . . 72.33 112.057 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.57 131.8 3.0 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 112.136 -0.385 . . . . 52.11 112.136 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 37.0 mt -81.6 128.28 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.446 -0.946 . . . . 74.13 108.446 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.38 154.32 48.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.819 -0.808 . . . . 75.14 108.819 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -119.26 119.44 34.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.649 1.18 . . . . 72.53 108.051 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.446 HD12 HD13 ' A' ' 89' ' ' ILE . 2.9 pp -122.17 158.79 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.019 0.438 . . . . 74.02 111.098 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 151.91 8.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.591 -1.186 . . . . 74.44 109.094 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.23 83.82 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 115.26 0.864 . . . . 73.45 115.26 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.446 HD13 HD12 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -115.88 136.58 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.538 0.669 . . . . 75.55 110.357 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -144.75 172.37 13.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.836 0.455 . . . . 65.4 111.54 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -120.67 23.77 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.899 -0.591 . . . . 71.11 113.31 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.7 p -79.58 -16.38 55.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.779 0.832 . . . . 71.0 111.832 -174.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.75 -42.43 90.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.767 0.827 . . . . 74.21 109.263 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 43.5 tpp -67.1 -38.37 85.55 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.976 -1.011 . . . . 75.24 110.509 175.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.44 81.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.704 0.802 . . . . 70.54 111.969 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -84.17 -36.67 22.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.766 0.426 . . . . 72.32 111.095 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -71.95 -64.73 0.88 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.703 0.401 . . . . 72.43 110.669 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -68.42 -34.54 76.18 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 72.43 110.324 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -5.59 78.19 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 119.077 -0.846 . . . . 72.11 114.968 -172.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.84 -55.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.534 1.167 . . . . 71.11 112.742 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.425 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 81.1 t80 -68.9 -45.74 70.14 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.882 0.697 . . . . 74.42 112.882 -169.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -73.58 -37.42 3.53 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.05 0.54 . . . . 72.41 112.315 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -48.84 -33.68 26.05 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.503 2.136 . . . . 72.54 113.901 162.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.19 -16.55 64.03 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.576 0.75 . . . . 75.43 111.991 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -74.63 -44.3 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 122.002 0.906 . . . . 74.11 109.639 171.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.0 mt -85.74 -19.26 31.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.164 -1.38 . . . . 73.54 112.33 -172.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.44 -44.24 25.04 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.215 -0.898 . . . . 73.35 112.483 -173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.37 -35.26 98.87 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 121.996 1.797 . . . . 74.31 113.062 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.402 ' CE1' ' HD3' ' C' ' 111' ' ' ARG . 27.7 m-85 -82.77 -31.81 28.1 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.107 0.78 . . . . 71.5 113.107 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 -47.84 61.28 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.515 -0.92 . . . . 72.44 108.515 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.403 HH12 HD13 ' C' ' 105' ' ' ILE . 29.9 ttm180 -46.74 -59.7 2.87 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 125.331 1.644 . . . . 74.24 109.559 172.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.24 -38.35 90.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.433 1.083 . . . . 73.23 111.895 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 117' ' ' MET . 44.8 t -62.12 -46.43 89.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.659 0.384 . . . . 71.12 110.471 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 118' ' ' VAL . 34.1 mt -62.33 -47.19 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.882 0.873 . . . . 74.12 110.13 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 125' ' ' GLN . 67.5 m -55.68 -42.77 75.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.097 1.359 . . . . 65.13 110.71 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -68.87 -39.18 79.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.583 -1.189 . . . . 71.43 110.321 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -66.79 -35.56 80.36 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.425 0.29 . . . . 74.22 111.299 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -66.37 -40.09 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.478 0.711 . . . . 72.24 110.292 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.534 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.6 p -73.47 -34.3 65.28 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.36 -0.382 . . . . 64.03 111.259 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.12 -23.98 63.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.512 0.725 . . . . 71.22 110.261 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 31.04 3.55 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 123.743 0.687 . . . . 63.23 113.522 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.488 HG23 ' NE ' ' B' ' 15' ' ' ARG . 14.7 t 58.68 15.96 4.06 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.943 2.097 . . . . 72.01 114.683 173.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 119' ' ' SER . 42.0 m-85 -123.49 159.82 53.5 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.174 0.589 . . . . 74.4 111.066 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.61 135.63 57.91 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.447 2.098 . . . . 75.32 110.141 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.575 ' HB2' HG21 ' A' ' 115' ' ' THR . 12.7 pt20 -57.84 153.27 14.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.064 0.946 . . . . 75.44 111.709 -174.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.18 112.17 24.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.162 -1.051 . . . . 72.42 108.162 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' C' ' 16' ' ' ILE . 76.6 m-20 -97.31 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.316 -0.994 . . . . 70.44 108.316 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 42' ' ' LEU . 5.8 mp -69.0 142.12 54.72 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.744 -0.662 . . . . 75.1 109.622 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.1 74.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 122.704 0.401 . . . . 72.24 110.453 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.457 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 16.8 Cg_exo -68.05 124.78 12.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.459 2.106 . . . . 75.23 109.995 170.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.0 m -97.12 111.9 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 122.077 0.942 . . . . 75.43 108.951 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.461 HD21 ' HB2' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -75.91 86.46 2.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.167 -1.378 . . . . 65.24 109.396 177.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -51.78 -37.62 52.23 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.148 1.379 . . . . 73.24 112.951 -171.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.55 -47.51 47.64 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.294 -0.867 . . . . 73.31 110.996 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 132' ' ' ASN . . . -74.27 -20.18 60.23 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 116.034 -0.53 . . . . 74.42 110.972 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.53 -35.47 60.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.028 0.931 . . . . 75.44 109.017 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.02 -45.36 87.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.835 0.854 . . . . 75.41 109.877 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 84.1 mmm -74.52 -29.49 61.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.752 -0.658 . . . . 73.43 111.163 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 143' ' ' GLN . 37.9 t30 -70.0 -27.13 64.44 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.643 0.777 . . . . 75.54 110.552 174.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -81.27 -38.21 27.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.245 -0.65 . . . . 75.01 109.245 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.86 -47.43 74.96 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.099 0.959 . . . . 75.13 110.75 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.416 ' OE1' ' HA ' ' C' ' 4' ' ' GLN . 0.1 OUTLIER -147.69 10.85 0.96 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.388 0.275 . . . . 65.4 111.043 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 139' ' ' ASN . 29.6 tt0 71.19 149.72 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.134 0.973 . . . . 72.51 111.734 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -77.51 171.71 14.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.125 0.57 . . . . 72.22 111.24 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.85 149.48 21.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.434 0.693 . . . . 70.45 109.906 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.97 152.07 6.32 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 110.844 -0.903 . . . . 75.54 110.844 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -138.27 114.21 9.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.441 0.696 . . . . 71.13 109.331 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.0 151.58 27.51 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.375 -0.69 . . . . 75.03 111.375 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.9 p -116.23 160.53 20.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.842 0.857 . . . . 74.42 109.342 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -112.28 52.8 0.75 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.602 0.715 . . . . 63.51 109.11 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.66 ' HG3' ' HG2' ' E' ' 170' ' ' LYS . 61.0 mm-40 -81.85 85.24 6.69 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.461 -0.79 . . . . 74.12 110.391 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -112.42 113.12 25.14 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.547 -1.279 . . . . 74.15 107.547 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -59.44 -43.15 93.2 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.331 0.586 . . . . 74.12 109.863 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -164.14 -62.02 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.577 -1.192 . . . . 74.32 108.329 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 CA-C-N 114.771 -1.104 . . . . 73.41 108.654 -179.912 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' B' ' 1' ' ' MET . 2.7 mpp? . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 109.484 -0.561 . . . . 75.53 109.484 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -169.51 11.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.634 1.174 . . . . 73.1 110.974 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.0 168.35 10.32 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.316 0.487 . . . . 75.4 112.316 -169.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -83.84 123.48 29.95 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.854 -0.612 . . . . 72.41 111.017 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' B' ' 90' ' ' GLU . 10.2 p30 -148.37 167.13 26.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.182 0.593 . . . . 74.03 110.522 173.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -124.93 148.5 48.32 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.053 0.941 . . . . 74.43 108.748 172.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -162.99 178.4 8.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.581 0.752 . . . . 72.0 110.346 -175.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -72.33 -27.69 62.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.298 1.039 . . . . 74.24 111.1 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ptm 55.48 -173.61 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.434 1.893 . . . . 72.24 114.158 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -132.45 102.57 5.78 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.534 1.134 . . . . 74.43 107.982 173.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.454 ' HA ' ' O ' ' B' ' 85' ' ' SER . 31.5 t80 -122.07 134.82 54.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.69 -0.855 . . . . 75.45 108.69 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -165.87 141.45 4.93 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.79 0.681 . . . . 74.21 109.248 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.6 HD12 HD12 ' B' ' 16' ' ' ILE . 78.4 mt -86.22 121.05 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.93 0.492 . . . . 72.51 110.326 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -80.65 -36.72 32.14 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.662 0.601 . . . . 73.04 111.249 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.488 ' NE ' HG23 ' A' ' 122' ' ' THR . 38.6 ttt180 -171.32 142.44 1.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.994 0.518 . . . . 70.51 109.949 -178.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.6 HD12 HD12 ' B' ' 13' ' ' ILE . 90.1 mt -121.26 140.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.911 -1.144 . . . . 74.33 107.911 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.408 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 31.5 p90 -165.53 152.23 10.07 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.896 0.747 . . . . 74.21 111.079 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -75.42 123.98 26.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.262 -1.014 . . . . 72.34 108.262 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -92.54 -37.11 12.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.988 0.515 . . . . 75.43 109.679 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.0 t70 -148.84 147.96 29.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.531 -0.759 . . . . 75.54 110.712 -170.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.564 HD13 ' SG ' ' B' ' 113' ' ' CYS . 36.7 mm -143.11 143.41 24.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.504 1.521 . . . . 75.33 107.79 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 55.6 m -149.09 131.73 15.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.203 -0.908 . . . . 63.34 108.706 168.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -140.08 106.95 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.228 -1.768 . . . . 74.33 106.228 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.52 110.6 15.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.665 -0.865 . . . . 75.44 108.665 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.42 88.56 5.11 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.499 1.12 . . . . 73.41 109.205 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.68 -30.21 59.94 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.084 2.523 . . . . 74.13 112.374 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -118.45 31.39 6.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 71.22 110.22 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.63 -52.24 32.11 Favored Pre-proline 0 CA--C 1.572 1.799 0 C-N-CA 125.327 1.451 . . . . 75.14 113.648 173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 96.0 Cg_endo -77.7 -12.57 16.57 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.814 1.676 . . . . 71.4 113.142 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -86.98 1.12 53.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.897 0.879 . . . . 74.52 111.803 -175.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.13 -14.03 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 123.653 0.781 . . . . 73.53 110.334 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -65.76 -41.27 92.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.798 0.439 . . . . 73.03 110.266 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -47.27 12.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.327 -0.62 . . . . 73.54 109.327 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.38 67.82 9.57 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.12 -1.067 . . . . 75.41 108.12 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.21 75.56 9.13 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.432 -1.258 . . . . 74.53 111.442 -168.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -177.27 172.44 1.89 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.255 -1.339 . . . . 75.42 108.216 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.635 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 3.9 pt20 -71.05 134.84 85.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.322 0.649 . . . . 65.51 111.731 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.88 156.12 60.04 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.549 2.166 . . . . 73.35 112.461 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 27.2 mt-10 -70.31 98.86 1.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.372 -0.973 . . . . 73.22 108.372 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.574 ' HB ' HD12 ' B' ' 126' ' ' LEU . 16.4 m -87.67 122.55 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 74.52 109.445 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -153.22 130.31 11.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.476 1.11 . . . . 72.33 109.645 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.691 HD22 HD11 ' B' ' 126' ' ' LEU . 1.4 pt? -130.81 164.98 23.97 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.993 0.738 . . . . 65.21 112.993 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.96 141.19 38.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.188 1.395 . . . . 72.34 109.79 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -94.68 124.85 38.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 75.03 108.988 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -124.36 156.14 37.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.862 1.265 . . . . 72.0 108.427 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.2 t -129.4 140.85 51.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.616 0.722 . . . . 72.32 111.518 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 161.6 32.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.738 1.615 . . . . 64.03 107.981 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -143.12 165.77 26.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.46 0.648 . . . . 71.34 111.525 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.7 t -152.09 157.83 42.15 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.149 1.38 . . . . 74.41 108.379 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -123.66 129.01 50.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.17 -39.48 12.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.319 0.648 . . . . 71.01 110.125 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 179.96 8.1 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.517 1.127 . . . . 70.25 109.826 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.29 121.25 9.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.342 0.657 . . . . 71.45 109.517 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 66.17 -5.74 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 126.04 1.736 . . . . 64.51 113.712 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.71 86.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.945 -1.502 . . . . 72.22 106.945 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -95.82 168.71 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.609 . . . . 74.33 110.183 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -145.38 97.64 3.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.833 -1.544 . . . . 64.13 106.833 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.34 130.24 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.946 -0.761 . . . . 73.43 108.946 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.1 t -106.89 124.03 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.645 0.778 . . . . 72.41 109.734 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 1.0 OUTLIER -93.68 121.41 35.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.11 -1.07 . . . . 74.13 108.11 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -113.11 113.46 25.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.221 0.608 . . . . 75.02 109.821 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.557 ' HB ' HD11 ' B' ' 114' ' ' ILE . 47.9 t -104.93 125.48 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 63.02 108.546 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -98.64 137.66 36.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.784 -0.821 . . . . 73.13 108.784 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 50.6 t -128.67 123.76 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.774 -0.825 . . . . 65.24 108.774 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.7 m -108.07 139.07 43.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.023 0.929 . . . . 74.33 109.637 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.33 143.28 30.9 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.438 0.695 . . . . 70.32 109.216 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -151.46 134.13 15.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.462 0.541 . . . . 73.34 112.462 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -107.41 104.23 13.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.943 1.297 . . . . 63.03 108.758 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.96 -113.88 5.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.813 -0.437 . . . . 74.34 112.523 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -97.94 2.76 49.4 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.325 0.65 . . . . 71.34 111.502 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -130.81 157.68 42.21 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.556 0.342 . . . . 70.44 111.864 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.2 m -76.04 133.69 40.29 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.786 -0.643 . . . . 74.14 110.669 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.34 -55.77 3.29 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.533 0.733 . . . . 74.31 109.701 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -154.01 162.34 41.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.26 -0.882 . . . . 74.33 109.956 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.7 mt -142.25 116.05 9.24 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.075 1.35 . . . . 75.44 107.453 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -117.79 120.49 38.09 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.528 -0.545 . . . . 63.42 109.528 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -123.37 124.2 42.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.434 -0.95 . . . . 71.03 108.434 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.547 HG12 HD11 ' B' ' 21' ' ' ILE . 55.3 t -121.47 146.0 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.314 -0.995 . . . . 71.2 108.314 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.703 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.8 mt-30 -127.06 99.28 5.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.14 109.255 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.513 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -92.41 104.22 16.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.144 -1.389 . . . . 74.44 108.751 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.44 159.27 25.99 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 112.142 -0.383 . . . . 74.33 112.142 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.19 127.98 2.12 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.837 -0.905 . . . . 60.34 110.837 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.84 125.0 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.608 -0.886 . . . . 74.53 108.608 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.88 136.73 47.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.298 1.039 . . . . 74.13 109.979 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 5.7 m -90.22 110.48 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.043 -1.095 . . . . 73.4 108.043 172.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 38.3 pt -126.68 109.19 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.824 0.821 . . . . 72.43 110.553 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.5 170.71 20.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.645 -1.162 . . . . 72.53 109.441 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.406 ' H ' ' HB1' ' F' ' 172' ' ' ALA . . . 99.53 -49.14 1.21 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 111.413 -0.675 . . . . 65.22 111.413 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 165.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.755 0.822 . . . . 71.1 111.387 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.766 ' HA ' ' SD ' ' F' ' 174' ' ' MET . 38.0 tt0 -163.7 144.87 9.03 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.89 0.744 . . . . 73.22 110.561 169.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.51 -110.44 3.13 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.555 -0.748 . . . . 73.51 113.031 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 m -65.26 -44.92 86.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 65.4 112.309 -170.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.9 -22.4 61.5 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.573 -0.74 . . . . 75.34 112.126 -167.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.59 ' SD ' ' HB2' ' F' ' 174' ' ' MET . 17.4 ttt -72.15 -38.73 69.13 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.405 -0.22 . . . . 75.44 110.405 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.53 74.26 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.945 0.498 . . . . 55.34 110.845 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.434 ' O ' ' HB1' ' B' ' 100' ' ' ALA . 59.2 t-80 -74.45 -20.51 60.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.687 0.795 . . . . 74.14 110.848 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -86.92 -67.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.131 0.573 . . . . 72.3 111.289 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.444 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.5 pp -74.19 -24.26 59.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.126 0.57 . . . . 72.23 112.301 -172.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.37 72.94 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.905 -0.386 . . . . 52.24 113.35 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' B' ' 96' ' ' HIS . . . -145.37 -69.92 0.28 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.502 0.556 . . . . 72.55 112.502 -173.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -74.03 -39.53 63.49 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.318 0.386 . . . . 72.32 111.562 -168.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 61.0 m -61.98 -50.33 81.34 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.865 -0.588 . . . . 53.53 111.522 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.64 -25.82 28.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.427 1.418 . . . . 71.54 113.415 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.83 -33.03 74.78 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.281 0.562 . . . . 74.35 110.962 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.423 HD12 HD11 ' B' ' 13' ' ' ILE . 59.6 mt -65.67 -44.9 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.257 1.023 . . . . 74.5 110.89 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.9 mt -81.33 -12.9 58.89 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.126 -0.943 . . . . 64.42 111.017 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -60.01 -49.94 88.75 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.755 -1.117 . . . . 72.2 112.093 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.49 -41.38 77.51 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.887 1.725 . . . . 72.34 113.011 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.513 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.2 m-85 -65.99 -50.22 65.06 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.483 0.713 . . . . 74.11 112.204 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.73 81.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.759 0.824 . . . . 70.12 110.847 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.402 HH22 HG23 ' C' ' 122' ' ' THR . 41.9 ttt180 -56.09 -48.6 75.81 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.379 1.472 . . . . 74.21 110.299 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.63 -36.36 80.66 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.399 0.68 . . . . 70.25 110.428 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.564 ' SG ' HD13 ' B' ' 21' ' ' ILE . 8.0 t -68.51 -45.02 73.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.752 0.421 . . . . 72.31 111.82 -174.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.557 HD11 ' HB ' ' B' ' 62' ' ' VAL . 92.1 mt -59.22 -50.77 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.955 0.902 . . . . 75.31 110.429 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.427 HG22 ' OG ' ' C' ' 119' ' ' SER . 86.9 m -58.26 -33.06 68.98 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 124.481 1.113 . . . . 65.25 111.175 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.7 t -69.75 -35.18 74.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.219 1.008 . . . . 74.44 111.357 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -79.24 -33.21 43.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.862 0.465 . . . . 72.04 111.481 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.56 -31.9 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.675 0.79 . . . . 74.14 110.748 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.504 ' HB3' HG21 ' C' ' 115' ' ' THR . 80.7 p -68.48 -33.45 74.18 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 116.03 -0.532 . . . . 64.03 112.068 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.451 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 83.7 mtt-85 -65.55 -36.96 85.34 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.011 -0.995 . . . . 74.45 110.96 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.89 9.09 63.9 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.508 -0.769 . . . . 71.21 113.85 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p 63.84 12.66 6.92 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.436 1.894 . . . . 75.21 113.192 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.477 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 58.3 m-85 -77.99 170.98 13.74 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.915 0.886 . . . . 74.3 110.269 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' B' ' 37' ' ' GLN . 62.5 Cg_endo -77.18 -169.11 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.101 1.867 . . . . 64.05 114.718 -170.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.426 ' HA ' ' CG ' ' C' ' 125' ' ' GLN . 17.7 pt20 -64.92 142.11 58.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.945 -1.48 . . . . 73.14 112.434 177.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.691 HD11 HD22 ' B' ' 42' ' ' LEU . 32.5 tp -151.57 98.34 2.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.334 -0.848 . . . . 74.2 108.895 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -134.65 126.04 28.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.644 . . . . 75.22 109.769 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.466 HD11 ' HG ' ' F' ' 186' ' ' LEU . 39.0 mt -77.01 151.17 35.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.875 0.87 . . . . 73.34 111.807 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.69 106.54 15.77 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.981 -0.748 . . . . 64.14 108.981 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.452 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 21.6 Cg_endo -60.2 113.47 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.026 2.484 . . . . 75.22 112.938 -175.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.48 HG23 ' HE1' ' F' ' 184' ' ' TRP . 30.7 m -102.23 153.84 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.52 0.728 . . . . 75.33 110.152 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.404 ' HB2' HD12 ' D' ' 13' ' ' ILE . 50.2 t-20 -110.55 115.83 30.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.635 0.774 . . . . 70.22 110.562 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.528 ' HD1' ' HB2' ' F' ' 184' ' ' TRP . 54.4 t80 -66.32 -42.24 88.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.973 0.509 . . . . 75.0 111.201 175.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.12 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 110.021 -0.363 . . . . 73.33 110.021 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.53 -42.54 98.98 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.875 0.734 . . . . 72.52 110.922 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' B' ' 140' ' ' TYR . 9.4 tt -53.74 -47.73 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.538 0.735 . . . . 75.42 110.16 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -68.77 -37.8 79.6 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.683 1.193 . . . . 73.02 111.208 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.7 mmt -69.13 -38.29 78.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 73.04 110.613 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -92.28 -0.58 57.39 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.839 -0.619 . . . . 74.12 111.188 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' B' ' 136' ' ' LEU . 0.3 OUTLIER -87.7 -37.56 16.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.227 0.611 . . . . 74.01 109.352 172.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.01 4.25 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.225 0.61 . . . . 74.42 111.02 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.601 ' HG3' ' HB3' ' D' ' 8' ' ' GLU . 36.3 tt0 -71.85 148.63 45.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.249 0.62 . . . . 73.44 109.636 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -94.01 -91.98 0.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.746 -0.835 . . . . 74.51 108.746 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -153.45 132.51 12.57 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.066 0.947 . . . . 72.31 109.947 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.77 143.01 49.04 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.739 1.216 . . . . 73.24 108.858 174.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.51 66.77 0.21 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.274 -0.73 . . . . 63.42 111.274 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -161.39 176.47 11.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.841 0.857 . . . . 71.34 110.365 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.68 31.61 12.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.257 -0.429 . . . . 63.11 113.098 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -71.82 88.1 1.01 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.311 -0.626 . . . . 63.5 109.311 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.84 98.67 7.18 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.106 -1.072 . . . . 72.33 108.106 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -122.18 39.17 3.96 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 73.42 110.305 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -118.65 79.39 1.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.501 -0.555 . . . . 75.42 109.501 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 105.77 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.543 0.737 . . . . 74.32 109.931 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.38 95.27 2.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.149 0.58 . . . . 52.35 109.796 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.243 0 C-N-CA 123.399 0.68 . . . . 74.33 109.354 176.427 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.048 0.451 . . . . 72.03 110.713 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.0 t -138.71 91.05 2.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.354 -1.35 . . . . 63.34 107.354 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.449 ' HG3' ' H ' ' C' ' 4' ' ' GLN . 6.1 tp10 -82.97 -164.72 0.91 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.967 0.907 . . . . 73.5 109.814 -177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' C' ' 3' ' ' GLU . 2.4 mp0 77.16 76.28 0.08 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.497 1.519 . . . . 55.3 109.444 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 m120 64.87 25.32 12.82 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.337 -1.301 . . . . 52.1 113.074 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.482 ' N ' HD21 ' C' ' 6' ' ' ASN . 0.0 OUTLIER -61.66 99.77 0.12 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.081 0.952 . . . . 74.04 112.416 -178.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.2 m -110.23 99.37 8.44 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.016 0.926 . . . . 73.51 109.201 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.37 104.04 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.987 0.515 . . . . 73.22 110.048 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.2 ttt 64.22 115.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.254 1.422 . . . . 72.11 112.219 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.3 m -103.6 111.59 24.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.569 0.748 . . . . 75.53 109.484 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -104.34 140.3 38.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.702 0.801 . . . . 71.11 108.892 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -150.02 140.09 22.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.869 0.366 . . . . 74.04 111.305 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -93.34 141.49 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.232 1.013 . . . . 74.24 109.578 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.517 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.7 mm-40 -108.49 -49.11 3.22 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.37 0.668 . . . . 74.3 110.087 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.549 HH11 ' HD1' ' D' ' 32' ' ' PHE . 63.5 ttt180 -170.57 125.39 0.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.608 0.363 . . . . 74.25 110.354 -173.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.477 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 73.0 mt -109.6 141.73 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.344 -1.354 . . . . 75.34 107.344 176.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.542 ' HH ' HD11 ' C' ' 83' ' ' ILE . 40.6 p90 -176.94 156.69 1.36 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.037 0.836 . . . . 74.52 110.768 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -78.73 123.34 27.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.428 -0.806 . . . . 72.34 109.954 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.604 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -81.16 -44.87 17.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.007 -0.738 . . . . 72.1 109.007 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -149.87 134.19 17.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.41 -1.268 . . . . 70.42 109.606 -171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.549 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.0 mt -134.15 145.07 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.519 1.128 . . . . 74.12 108.499 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -156.24 151.99 27.22 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.223 0.535 . . . . 73.21 111.154 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -152.94 108.52 3.29 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.152 -1.425 . . . . 73.34 107.152 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.18 114.88 25.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.449 0.7 . . . . 70.03 110.298 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.72 83.44 62.3 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.609 1.163 . . . . 75.54 109.333 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.29 -23.15 24.5 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.412 2.074 . . . . 73.42 111.46 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -93.54 15.28 16.43 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.25 1.42 . . . . 70.44 109.535 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -56.95 -49.0 96.48 Favored Pre-proline 0 CA--C 1.567 1.616 0 N-CA-C 113.991 1.108 . . . . 51.21 113.991 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.98 -29.57 6.62 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.041 1.407 . . . . 73.31 113.132 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -70.25 -39.84 74.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.198 0.599 . . . . 75.2 111.739 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.424 HG22 HD11 ' C' ' 68' ' ' LEU . 10.5 p -71.18 -12.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.672 0.789 . . . . 74.52 111.16 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.97 -41.0 77.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 110.562 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -100.57 48.54 0.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.033 0.92 . . . . 74.32 109.842 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.575 ' HG2' HD12 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -125.52 158.75 33.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.803 0.841 . . . . 75.22 110.12 177.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.85 107.2 9.0 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 106.766 -1.568 . . . . 63.41 106.766 164.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.01 90.01 3.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.824 -0.625 . . . . 74.21 111.962 -164.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -137.75 65.55 46.64 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.969 0.908 . . . . 74.44 109.071 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' E' ' 192' ' ' GLY . 28.9 Cg_exo -65.13 133.36 35.15 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.284 1.99 . . . . 75.05 111.727 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' C' ' 66' ' ' ALA . 29.4 tt0 -83.76 86.45 7.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.875 -1.158 . . . . 70.25 107.875 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -74.47 79.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.513 -1.221 . . . . 63.43 110.332 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' E' ' 189' ' ' ALA . 41.5 tttp -92.74 134.23 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.054 -1.43 . . . . 75.14 110.003 -174.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.429 HD22 HD11 ' C' ' 128' ' ' LEU . 1.4 pp -87.72 167.25 14.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.727 0.811 . . . . 73.51 111.867 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.97 148.3 18.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.709 0.804 . . . . 75.25 109.429 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 tt -123.9 139.02 54.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.277 0.631 . . . . 63.35 109.86 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.562 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 14.0 m-20 -136.39 150.68 48.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.769 1.228 . . . . 53.52 109.156 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -115.0 143.56 44.99 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.572 0.749 . . . . 73.44 109.342 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.23 154.66 41.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.187 0.995 . . . . 74.15 108.328 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -163.77 152.96 14.21 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.849 0.357 . . . . 72.52 111.063 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -151.48 130.92 12.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.28 1.032 . . . . 62.43 109.043 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.548 ' HB2' ' HE2' ' E' ' 175' ' ' PHE . 60.5 tt0 -75.85 129.06 36.41 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.723 -0.473 . . . . 70.31 109.723 175.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.538 HD12 HD13 ' C' ' 83' ' ' ILE . 47.0 mt -104.77 -36.23 7.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.504 0.722 . . . . 73.35 110.018 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -173.44 4.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.685 -1.143 . . . . 70.14 108.948 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -76.14 124.35 27.3 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.43 -0.804 . . . . 71.1 109.798 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.59 ' H ' ' HB2' ' E' ' 172' ' ' ALA . 3.1 m-20 63.34 12.24 6.09 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.416 1.086 . . . . 73.21 112.483 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.31 130.28 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.874 1.27 . . . . 74.02 108.36 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.2 152.13 36.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.58 0.705 . . . . 74.12 111.458 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.411 ' HB2' HD12 ' C' ' 51' ' ' LEU . 27.6 tt0 -83.61 125.42 31.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.234 1.414 . . . . 71.2 109.448 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.9 t -112.37 130.57 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.99 -1.115 . . . . 75.35 107.99 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.4 107.69 19.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.865 0.866 . . . . 71.51 108.752 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -92.07 108.3 19.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.39 -1.337 . . . . 71.21 107.39 173.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.9 ttp180 -89.67 128.65 36.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.069 -0.514 . . . . 75.34 109.951 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.563 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.9 t -117.99 118.94 59.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.734 -1.21 . . . . 74.42 107.734 168.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 32.4 m -110.67 146.49 36.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 72.55 109.393 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.569 HG21 HG23 ' C' ' 114' ' ' ILE . 63.8 t -129.94 115.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.747 1.219 . . . . 75.44 109.131 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -98.67 143.44 29.04 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.481 -0.933 . . . . 72.13 108.481 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' C' ' 39' ' ' GLU . . . -127.67 121.08 29.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.485 -0.561 . . . . 63.45 109.485 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.0 m -137.96 131.73 31.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.316 0.579 . . . . 73.1 111.38 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.583 ' HB2' ' HB3' ' C' ' 71' ' ' GLU . 3.9 mt -87.79 41.12 0.97 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.192 1.397 . . . . 73.32 109.685 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.91 -102.66 2.28 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.287 -1.125 . . . . 54.23 110.287 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -92.35 -31.87 15.19 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.952 0.501 . . . . 64.4 110.152 174.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.583 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 3.8 tp10 -66.8 119.0 11.1 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.702 1.201 . . . . 72.51 109.758 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.2 m -73.06 124.63 25.9 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.174 -0.676 . . . . 75.22 109.174 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.64 -47.91 10.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.377 -0.601 . . . . 73.32 109.377 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -171.44 177.22 3.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.864 0.866 . . . . 74.51 110.76 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.41 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -132.43 144.6 50.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.484 -1.672 . . . . 64.55 106.484 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.464 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.4 t -140.04 143.02 36.18 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.829 -1.545 . . . . 74.1 106.829 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.72 135.07 9.25 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.146 0.498 . . . . 73.51 110.274 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.33 135.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.864 -1.062 . . . . 74.31 108.341 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -115.84 94.01 4.5 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.362 -1.348 . . . . 73.41 107.362 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -89.83 115.17 26.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.849 -1.068 . . . . 75.13 110.11 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.604 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -108.4 157.4 15.3 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.014 -0.539 . . . . 71.45 113.28 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.437 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -158.0 133.76 3.62 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.93 -1.268 . . . . 53.32 109.93 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.542 HD11 ' HH ' ' C' ' 17' ' ' TYR . 20.8 mm -91.59 122.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.907 -1.146 . . . . 74.11 107.907 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.01 130.74 52.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.966 0.506 . . . . 75.5 110.052 -173.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.6 t -104.97 119.31 38.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.3 -1.0 . . . . 71.12 108.3 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.17 150.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.017 0.927 . . . . 74.3 110.24 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.66 149.57 28.56 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.813 0.845 . . . . 74.44 109.579 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.38 60.22 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.195 -0.457 . . . . 65.32 113.212 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.607 HD11 ' HG3' ' E' ' 174' ' ' MET . 48.0 pt -63.22 139.34 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.849 0.86 . . . . 74.22 112.0 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.611 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 44.7 tt0 -163.97 145.24 8.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.145 0.978 . . . . 73.44 108.767 175.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -112.92 3.09 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.211 0.944 . . . . 34.32 113.127 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -56.59 -46.25 80.94 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 75.42 111.326 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.611 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 25.7 mt-30 -61.52 -31.13 71.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.431 0.693 . . . . 75.1 111.921 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 48.2 ttm -84.74 -44.06 13.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.633 0.373 . . . . 73.13 110.776 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.25 -39.49 65.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.418 0.687 . . . . 71.44 111.364 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -69.82 -31.95 70.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.756 0.822 . . . . 72.42 110.368 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 45.7 t -80.87 -61.9 1.83 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.886 0.474 . . . . 74.3 110.419 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.9 -40.36 91.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.146 0.978 . . . . 73.54 110.271 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.3 2.97 68.81 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.074 -0.848 . . . . 54.04 114.622 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.06 -59.41 0.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.404 1.102 . . . . 72.33 112.768 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 77.0 t80 -71.96 -48.49 44.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.062 0.764 . . . . 73.04 113.062 -166.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 33.2 m -60.35 -48.97 92.54 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.692 0.397 . . . . 75.25 110.57 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 54.2 Cg_exo -59.62 -30.47 92.37 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.277 1.985 . . . . 74.35 114.258 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.648 0.779 . . . . 54.42 110.846 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.403 HD13 HH12 ' A' ' 111' ' ' ARG . 23.2 mm -64.48 -36.76 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.246 0.618 . . . . 73.33 110.168 173.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.437 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.1 mt -83.44 -25.84 30.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.513 -0.767 . . . . 74.52 111.86 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.98 -40.15 83.02 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 124.324 1.05 . . . . 75.42 113.609 -175.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.3 -53.63 6.78 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.692 2.262 . . . . 73.1 113.792 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.408 ' HE2' HG23 ' A' ' 115' ' ' THR . 53.7 m-85 -63.5 -34.42 77.74 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.58 -1.191 . . . . 73.33 110.793 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.81 -45.24 62.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.402 0.681 . . . . 60.42 110.853 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.402 ' HD3' ' CE1' ' A' ' 109' ' ' TYR . 37.0 ttt180 -55.83 -37.74 69.11 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.384 1.074 . . . . 72.34 110.647 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.451 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -77.94 -43.15 30.74 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.262 0.625 . . . . 74.44 111.075 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.56 -33.28 75.31 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.755 0.65 . . . . 75.15 112.755 -170.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.569 HG23 HG21 ' C' ' 64' ' ' VAL . 70.4 mt -67.64 -49.08 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.871 0.469 . . . . 75.33 109.821 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.701 HG22 ' HB2' ' C' ' 125' ' ' GLN . 57.4 m -54.8 -37.16 65.74 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.251 -1.341 . . . . 74.22 111.603 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.1 t -57.42 -58.11 9.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.906 -1.043 . . . . 62.43 109.98 174.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.587 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -41.68 85.85 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.325 1.05 . . . . 74.53 113.195 -176.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.04 -42.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 122.594 0.358 . . . . 73.35 110.385 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.427 ' OG ' HG22 ' B' ' 115' ' ' THR . 38.1 t -71.78 -20.15 61.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.545 -0.752 . . . . 60.11 111.588 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.495 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.5 mtt-85 -73.98 -40.12 63.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.108 0.563 . . . . 72.22 110.051 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.02 -5.64 71.21 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.53 0.519 . . . . 72.33 111.909 167.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.406 HG21 ' HB3' ' D' ' 17' ' ' TYR . 11.3 p 65.37 23.05 12.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.491 2.316 . . . . 63.33 112.357 173.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.85 164.21 49.9 Favored Pre-proline 0 CA--C 1.548 0.865 0 CA-C-N 114.805 -1.089 . . . . 75.52 108.491 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.17 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.775 2.317 . . . . 73.33 113.072 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.701 ' HB2' HG22 ' C' ' 115' ' ' THR . 2.6 pt20 -49.78 133.29 21.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.806 1.242 . . . . 75.02 111.295 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.416 ' HG ' ' HG ' ' C' ' 128' ' ' LEU . 28.2 tp -90.9 82.33 5.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.519 0.676 . . . . 73.32 110.359 -170.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -94.59 85.94 4.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.058 -0.974 . . . . 74.02 108.867 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.429 HD11 HD22 ' C' ' 42' ' ' LEU . 93.7 mt -87.85 144.28 26.67 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.416 0.627 . . . . 74.14 111.714 -176.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.18 153.35 90.51 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 114.203 -1.362 . . . . 74.02 109.417 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.721 ' HB3' HD13 ' A' ' 16' ' ' ILE . 53.5 Cg_endo -64.47 142.19 77.23 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.783 2.322 . . . . 74.41 114.737 -168.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' E' ' 186' ' ' LEU . 3.0 t -104.08 84.11 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 107.54 -1.282 . . . . 63.24 107.54 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' C' ' 130' ' ' PRO . 8.9 m120 -86.1 99.99 11.88 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.48 0.657 . . . . 74.22 110.456 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -68.67 -29.45 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.421 -1.263 . . . . 74.42 110.873 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.86 -37.21 86.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.87 0.868 . . . . 71.21 111.076 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.4 77.8 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.708 0.803 . . . . 73.31 110.65 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' C' ' 140' ' ' TYR . 7.6 mp -72.94 -22.17 60.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.957 -1.019 . . . . 74.15 111.094 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -79.36 -48.32 14.25 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.758 . . . . 73.23 110.662 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 4.6 ppp? -76.45 -27.71 56.29 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.28 0.632 . . . . 73.55 111.011 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -70.95 -37.43 72.81 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.877 0.471 . . . . 72.03 110.73 169.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' C' ' 136' ' ' LEU . 4.7 t80 -72.17 -159.42 0.05 Allowed 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 109.818 -0.438 . . . . 75.22 109.818 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 51.17 23.54 1.64 Allowed 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.362 0.665 . . . . 72.11 110.797 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -174.97 115.65 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.354 1.062 . . . . 62.5 108.622 -164.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -76.26 -43.79 40.29 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.98 0.419 . . . . 74.54 110.323 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -81.3 90.95 6.16 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.8 -0.636 . . . . 72.12 110.05 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.3 -68.2 0.44 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.478 -0.564 . . . . 74.42 109.478 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.54 -26.77 3.3 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.471 -0.627 . . . . 63.14 114.491 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 66.0 -178.83 0.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.126 0.971 . . . . 74.31 112.11 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.88 139.05 29.24 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.568 -0.742 . . . . 75.13 112.187 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.4 m -137.26 12.84 3.04 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.217 0.607 . . . . 71.25 110.612 -174.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.1 157.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 74.23 112.067 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.433 ' HB3' ' SD ' ' G' ' 174' ' ' MET . 0.0 OUTLIER -123.42 -179.13 4.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.219 1.007 . . . . 73.34 109.596 174.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -145.1 68.85 1.24 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.002 -1.11 . . . . 71.54 108.002 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -157.22 120.77 4.14 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.586 -0.734 . . . . 75.11 110.908 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -103.34 -49.98 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.836 0.855 . . . . 74.54 110.289 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.636 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 -178.437 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.733 -0.84 . . . . 73.52 108.733 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -78.3 84.05 4.51 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.445 0.698 . . . . 72.22 110.61 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -82.08 104.51 12.48 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.283 -0.871 . . . . 74.23 109.192 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -74.5 85.21 2.03 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.46 0.704 . . . . 52.41 110.097 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -82.52 58.95 4.4 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 72.1 110.582 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -123.43 86.13 2.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.752 0.787 . . . . 73.53 109.828 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -164.89 157.36 16.13 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 113.927 -1.488 . . . . 74.44 108.216 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.601 ' HB3' ' HG3' ' B' ' 142' ' ' GLN . 32.2 mm-40 -83.14 71.24 10.17 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.1 0.56 . . . . 65.53 111.358 -172.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.56 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm -33.72 137.17 0.1 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.164 1.385 . . . . 73.45 113.575 170.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.4 m -125.6 142.46 51.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.115 0.966 . . . . 75.21 108.712 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -144.68 127.12 15.92 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.576 -1.268 . . . . 73.53 107.576 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.614 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 58.5 mt-30 -132.89 143.63 49.64 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.099 0.96 . . . . 73.03 108.68 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' B' ' 132' ' ' ASN . 38.5 mt -103.41 115.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.622 -0.881 . . . . 73.42 108.622 170.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -83.74 -44.33 14.55 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 110.152 -0.314 . . . . 70.34 110.152 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -165.11 141.1 5.51 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 111.52 0.193 . . . . 73.33 111.52 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 38.7 mm -120.47 126.05 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.309 -0.997 . . . . 73.51 108.309 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.406 ' HB3' HG21 ' C' ' 122' ' ' THR . 2.0 p90 -167.86 154.83 8.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.627 0.771 . . . . 73.42 111.534 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.3 p -79.55 118.87 21.79 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.401 -0.818 . . . . 73.41 110.604 -176.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.37 -23.0 30.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.515 -0.766 . . . . 73.43 110.862 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.613 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 35.1 t70 -160.04 132.1 6.25 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.852 0.72 . . . . 65.15 109.696 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.587 HG23 ' HE1' ' C' ' 117' ' ' MET . 96.6 mt -132.48 135.73 57.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.089 -1.449 . . . . 73.22 107.089 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -138.61 132.15 30.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.574 -1.269 . . . . 70.14 107.574 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -145.14 112.17 5.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.923 -1.51 . . . . 74.04 106.923 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.9 112.19 18.01 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.691 0.796 . . . . 72.42 108.983 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.1 82.47 2.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 107.843 -1.169 . . . . 73.42 107.843 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.38 -30.5 5.24 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.424 2.083 . . . . 75.3 112.479 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.414 ' O ' HG21 ' D' ' 31' ' ' VAL . 88.8 m-20 -108.29 38.91 2.09 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.679 1.192 . . . . 75.53 108.962 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -53.39 65.49 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 115.147 1.536 . . . . 73.4 115.147 -169.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.487 ' HB3' HD11 ' C' ' 83' ' ' ILE . 89.2 Cg_endo -79.76 -7.21 14.53 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 122.191 1.818 . . . . 74.12 112.364 175.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -84.4 -24.67 29.53 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.372 1.469 . . . . 72.32 109.055 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.414 HG21 ' O ' ' D' ' 27' ' ' ASN . 13.4 t -66.25 -29.68 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.946 0.898 . . . . 72.11 110.135 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.549 ' HD1' HH11 ' C' ' 15' ' ' ARG . 91.7 t80 -51.25 -31.75 22.04 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.434 -0.803 . . . . 75.25 112.599 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -75.42 -17.51 60.16 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.777 0.831 . . . . 75.35 112.42 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.713 ' HZ2' ' HB2' ' D' ' 71' ' ' GLU . 92.3 mttt -122.55 110.79 16.01 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.337 0.655 . . . . 74.41 110.583 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -110.82 81.75 1.48 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.243 1.017 . . . . 63.32 110.672 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -150.81 174.96 12.47 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.203 -0.908 . . . . 74.12 109.143 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.54 ' H ' ' HA ' ' H' ' 193' ' ' TYR . 59.9 tp60 -71.73 117.58 58.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 119.494 -0.289 . . . . 73.3 110.278 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.506 ' HG3' HD22 ' D' ' 68' ' ' LEU . 77.6 Cg_exo -55.65 130.5 40.78 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.993 2.462 . . . . 72.33 112.411 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.35 122.27 15.27 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.755 -0.831 . . . . 61.53 108.755 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -98.45 112.08 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.108 0.563 . . . . 70.33 109.541 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 3.2 mppt? -99.32 120.05 38.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.984 -1.117 . . . . 74.32 107.984 170.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.06 121.18 39.67 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.092 -1.077 . . . . 75.41 108.092 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.3 t70 -119.4 135.61 54.66 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.837 -0.801 . . . . 75.34 108.837 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.416 HD11 HD23 ' D' ' 60' ' ' LEU . 29.1 tp -111.97 129.76 56.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.084 0.554 . . . . 74.35 109.852 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -139.12 152.42 47.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.335 1.054 . . . . 63.51 108.477 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -146.21 162.76 37.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.075 0.55 . . . . 73.54 110.295 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.413 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.36 147.66 27.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.334 1.054 . . . . 64.51 108.86 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 48.9 m -144.48 152.03 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.878 0.37 . . . . 70.05 111.061 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.1 p -163.13 125.99 2.7 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.303 1.041 . . . . 75.22 108.842 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -72.86 123.84 24.21 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.834 0.454 . . . . 75.11 111.106 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.8 mt -96.53 -29.41 13.9 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.536 0.734 . . . . 74.04 111.503 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.4 -172.49 3.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.507 0.723 . . . . 75.13 110.592 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -64.47 116.62 6.3 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.971 -0.559 . . . . 74.53 110.025 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 69.51 0.43 2.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.925 1.29 . . . . 73.41 112.365 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.95 131.56 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.844 0.857 . . . . 73.32 110.117 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.47 154.2 42.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.332 0.653 . . . . 75.3 109.734 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.601 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -95.16 118.56 32.15 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.643 0.777 . . . . 75.45 109.39 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.9 119.21 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.519 -0.919 . . . . 65.34 108.519 169.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.8 t -98.11 138.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.949 -1.13 . . . . 75.21 107.949 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.508 HD11 HG23 ' D' ' 62' ' ' VAL . 0.3 OUTLIER -125.55 116.19 21.37 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.973 -0.751 . . . . 72.3 108.973 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.612 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.1 ttm180 -97.75 110.52 23.07 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.613 -0.722 . . . . 74.45 109.244 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.508 HG23 HD11 ' D' ' 60' ' ' LEU . 65.8 t -99.59 123.28 52.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.061 -1.088 . . . . 75.44 108.061 170.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 70.4 m -122.29 130.42 53.14 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.324 -0.853 . . . . 54.14 110.145 -172.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.551 HG22 HG21 ' D' ' 114' ' ' ILE . 37.6 t -120.67 101.58 10.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 113.699 -1.591 . . . . 75.3 107.281 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 11.2 m -94.3 111.36 23.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.206 -1.405 . . . . 61.22 107.206 169.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.65 135.09 54.53 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.088 -0.708 . . . . 73.43 109.088 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.9 p -139.1 148.92 43.94 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.807 -0.633 . . . . 70.34 110.022 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.506 HD22 ' HG3' ' D' ' 38' ' ' PRO . 85.9 mt -109.96 92.06 3.9 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.376 -0.601 . . . . 74.51 109.376 169.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.27 -121.23 20.4 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.421 -0.809 . . . . 72.32 111.893 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -84.4 27.77 0.68 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.957 0.903 . . . . 72.32 112.127 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.713 ' HB2' ' HZ2' ' D' ' 34' ' ' LYS . 5.2 tp10 -135.63 135.64 40.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 118.889 -0.577 . . . . 71.31 110.048 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -73.85 113.17 10.7 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.905 -0.776 . . . . 73.14 108.905 167.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -76.23 -61.46 1.94 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.173 -0.677 . . . . 64.44 109.173 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.57 154.23 15.99 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.361 -1.29 . . . . 72.13 110.016 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.13 149.52 29.21 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.111 -1.44 . . . . 71.4 107.111 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.548 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 42.2 t -155.35 103.38 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.547 -0.538 . . . . 71.11 109.547 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -121.96 121.71 37.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.133 0.973 . . . . 74.51 108.667 -174.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.43 114.18 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.758 -0.46 . . . . 73.04 109.758 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.613 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.78 91.25 8.55 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.639 0.776 . . . . 70.11 109.268 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -79.17 98.56 6.63 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.962 -1.017 . . . . 74.41 108.962 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.05 142.92 20.14 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.079 -0.808 . . . . 61.33 111.079 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.16 130.12 3.61 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.689 -0.964 . . . . 65.11 110.689 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.482 HG22 HD13 ' D' ' 51' ' ' LEU . 49.2 mt -90.73 128.72 42.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.502 -0.925 . . . . 72.15 108.502 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -134.06 148.38 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.091 0.556 . . . . 75.3 110.489 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.614 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 46.1 m -104.94 105.78 15.98 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.566 -0.902 . . . . 74.42 108.566 170.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.1 pt -109.57 145.38 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 118.488 0.585 . . . . 74.22 110.634 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.15 169.3 21.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.697 -1.138 . . . . 71.55 109.43 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 72.67 23.8 77.26 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 121.576 -0.345 . . . . 72.1 112.584 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.424 HD11 ' HB2' ' D' ' 94' ' ' MET . 2.2 pp -124.46 146.16 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.749 0.82 . . . . 73.21 110.755 -172.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.29 171.49 17.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 75.51 110.177 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.98 -134.48 31.69 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.941 0.776 . . . . 71.34 114.73 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -81.04 -13.25 58.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.269 0.628 . . . . 74.13 110.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -67.9 -36.69 80.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.235 0.614 . . . . 70.42 110.468 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.424 ' HB2' HD11 ' D' ' 89' ' ' ILE . 2.0 ppp? -70.45 -35.08 73.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.455 -0.572 . . . . 74.51 109.455 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.85 76.02 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 115.038 -0.983 . . . . 54.32 111.285 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -72.28 -37.68 68.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.25 0.62 . . . . 74.41 110.974 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.85 -38.96 76.63 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.043 0.537 . . . . 72.03 110.811 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.67 -45.86 20.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.662 0.785 . . . . 71.14 110.416 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.61 -26.9 40.72 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.626 -0.715 . . . . 70.23 114.009 -168.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.93 -51.02 2.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.142 0.471 . . . . 75.33 111.903 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -73.74 -47.29 40.32 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.282 0.475 . . . . 74.22 112.282 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.413 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 73.6 m -60.5 -47.84 95.18 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 118.976 -0.535 . . . . 74.43 111.274 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.486 ' HA ' ' HG ' ' D' ' 60' ' ' LEU . 86.8 Cg_exo -55.32 -37.0 94.89 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.447 2.098 . . . . 74.21 114.043 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.98 -29.61 70.54 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.099 0.56 . . . . 71.01 111.02 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.423 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 44.6 mm -75.34 -46.3 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.351 0.66 . . . . 70.11 110.409 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.81 -17.27 59.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.202 -0.908 . . . . 74.34 111.822 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.0 -47.6 52.33 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.256 1.022 . . . . 72.13 112.859 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 83.2 Cg_exo -49.42 -44.98 32.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.565 2.177 . . . . 74.43 113.945 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.452 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 80.6 m-85 -73.71 -37.08 65.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.319 0.648 . . . . 74.31 111.918 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.409 ' HB1' ' HB ' ' D' ' 62' ' ' VAL . . . -64.36 -53.38 49.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.212 0.605 . . . . 74.34 110.764 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.614 HH12 ' HB3' ' D' ' 130' ' ' PRO . 8.7 ptt180 -67.13 -30.85 70.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.703 -1.135 . . . . 74.14 110.898 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.3 tm-20 -67.82 -45.71 73.92 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.09 0.868 . . . . 75.33 110.446 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.696 0.622 . . . . 73.1 110.4 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.551 HG21 HG22 ' D' ' 64' ' ' VAL . 96.5 mt -58.25 -54.83 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 114.889 -1.051 . . . . 75.24 110.562 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.588 HG21 ' HG3' ' D' ' 125' ' ' GLN . 27.6 m -51.2 -48.24 62.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.878 1.271 . . . . 73.34 111.145 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -66.93 -44.78 79.79 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.464 -1.244 . . . . 62.54 110.176 -173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.548 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.5 mtm -65.47 -34.03 77.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.903 0.481 . . . . 74.54 111.405 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' D' ' 123' ' ' PHE . 56.5 t -64.91 -49.63 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.597 0.759 . . . . 74.33 110.454 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 90.4 p -69.29 -31.6 70.21 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.959 0.504 . . . . 65.53 111.066 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -70.43 -31.46 68.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.929 0.892 . . . . 75.12 109.945 173.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.85 64.13 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.536 -0.756 . . . . 73.31 113.202 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 125' ' ' GLN . 66.8 p 56.92 28.18 14.22 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.866 1.667 . . . . 75.35 113.112 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.526 ' HB2' HG11 ' D' ' 118' ' ' VAL . 20.4 m-85 -100.9 164.36 16.25 Favored Pre-proline 0 CA--C 1.561 1.396 0 N-CA-C 108.474 -0.936 . . . . 74.51 108.474 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 63.2 Cg_endo -68.77 133.53 27.69 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.311 2.007 . . . . 72.21 112.196 -175.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.588 ' HG3' HG21 ' D' ' 115' ' ' THR . 57.2 tt0 -56.58 129.91 42.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.688 0.795 . . . . 70.31 111.227 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -121.99 97.99 5.74 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.031 0.443 . . . . 64.25 110.121 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -99.43 105.05 16.95 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.218 -1.401 . . . . 72.43 107.218 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.82 115.0 12.75 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.888 -0.412 . . . . 70.31 109.888 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.11 86.83 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.543 0.737 . . . . 74.54 111.05 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.614 ' HB3' HH12 ' D' ' 111' ' ' ARG . 73.1 Cg_endo -79.82 108.72 2.3 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.581 2.187 . . . . 75.04 109.997 -174.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -104.26 113.26 40.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.43 -0.952 . . . . 74.43 108.43 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.3 91.37 0.17 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.731 -1.581 . . . . 73.12 106.731 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.68 -24.51 63.99 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 115.797 -0.638 . . . . 75.3 110.609 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.55 -40.51 19.1 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.336 1.054 . . . . 74.41 111.521 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.75 -50.37 72.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.784 0.833 . . . . 64.43 111.142 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 29.4 tp -72.76 -22.53 60.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.535 -0.757 . . . . 72.41 110.846 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 83.2 t80 -76.58 -44.37 34.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.438 1.095 . . . . 73.1 109.188 -177.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 74.7 mtm -61.81 -39.89 93.35 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.846 0.716 . . . . 74.0 110.305 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -70.62 -27.85 64.39 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.549 -0.751 . . . . 64.11 111.11 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -76.37 -31.14 57.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.052 0.541 . . . . 75.25 110.882 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 74.4 mt -65.21 -27.12 68.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.107 0.563 . . . . 73.51 110.324 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.93 3.87 11.17 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 72.22 111.727 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.452 ' HG2' ' H ' ' D' ' 148' ' ' GLY . 47.2 mt-30 -118.17 73.35 0.9 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.196 0.998 . . . . 73.51 108.988 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -144.25 6.42 1.31 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.996 -1.002 . . . . 75.14 110.75 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.9 -58.38 0.05 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.66 -1.237 . . . . 73.42 107.66 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' D' ' 143' ' ' GLN . . . -110.9 -168.66 19.11 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.099 -0.955 . . . . 74.53 110.886 167.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -101.92 144.1 30.97 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.083 0.553 . . . . 73.21 110.907 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . 0.452 ' H ' ' HG2' ' D' ' 143' ' ' GLN . . . -88.05 158.56 29.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.858 -0.897 . . . . 74.25 110.858 172.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -120.09 129.82 54.37 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 117.349 0.575 . . . . 72.4 111.336 -172.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.415 -2.068 . . . . 62.21 105.415 168.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -85.04 -77.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.985 0.514 . . . . 72.24 110.523 -166.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -175.57 166.54 3.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.578 0.751 . . . . 75.14 110.724 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -105.93 124.11 49.06 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.474 -1.676 . . . . 64.34 106.474 161.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.26 -41.62 98.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.679 0.792 . . . . 71.15 111.981 -173.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 C-N-CA 124.004 0.922 . . . . 72.41 109.038 179.148 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.09 -0.707 . . . . 74.54 109.09 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.25 -78.89 0.66 Allowed Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.807 -1.317 . . . . 72.2 109.807 -165.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . 0.66 ' HG2' ' HG3' ' A' ' 151' ' ' GLU . 10.5 mptt -117.16 -166.92 1.23 Allowed 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.163 -1.051 . . . . 75.35 108.163 168.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m 61.8 19.77 10.86 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.389 1.076 . . . . 71.24 112.386 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . 0.721 ' HB3' ' SD ' ' E' ' 174' ' ' MET . . . 61.14 165.04 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.309 1.444 . . . . 65.41 113.392 -175.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.493 HD21 ' SD ' ' E' ' 174' ' ' MET . 0.0 OUTLIER -124.31 20.07 8.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.552 1.141 . . . . 75.23 109.844 172.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.721 ' SD ' ' HB3' ' E' ' 172' ' ' ALA . 0.1 OUTLIER -84.95 -177.55 6.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.48 1.112 . . . . 65.14 111.733 -169.033 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.548 ' HE2' ' HB2' ' C' ' 50' ' ' GLN . 56.7 m-85 59.46 81.04 0.18 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.731 1.212 . . . . 73.11 110.865 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -146.42 -63.11 0.31 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.538 -0.756 . . . . 73.31 109.186 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.89 -2.84 0.84 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.702 1.201 . . . . 63.11 113.096 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . 0.579 ' HG3' ' HG3' ' E' ' 179' ' ' GLU . 55.6 tp60 55.31 -81.94 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.16 1.784 . . . . 74.11 112.16 -173.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . 0.579 ' HG3' ' HG3' ' E' ' 178' ' ' GLN . 49.2 mt-10 -135.99 144.23 47.52 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 124.417 1.087 . . . . 54.25 108.654 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.87 95.13 0.29 Allowed 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.617 2.211 . . . . 73.34 111.833 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -76.35 -173.24 2.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.633 0.773 . . . . 74.12 110.466 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -56.56 143.73 34.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.513 0.725 . . . . 75.52 111.444 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 10.9 t -82.98 -178.14 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.036 0.535 . . . . 71.43 111.434 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -138.01 84.93 20.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 124.186 0.994 . . . . 73.21 109.471 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -84.16 153.59 12.62 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.223 2.615 . . . . 73.41 113.91 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . 0.609 ' HA ' HG11 ' C' ' 131' ' ' VAL . 95.9 mt -84.98 171.01 12.46 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.492 -0.777 . . . . 74.31 110.889 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.569 HG21 HG22 ' C' ' 131' ' ' VAL . 30.4 pt -68.13 162.02 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.616 0.766 . . . . 73.04 111.834 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.41 105.03 10.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.912 -0.585 . . . . 52.33 109.644 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' C' ' 41' ' ' LYS . . . -118.54 105.0 11.2 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.965 0.906 . . . . 63.33 108.808 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -142.66 88.27 2.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.428 0.691 . . . . 74.14 109.785 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.51 123.6 2.0 Favored Glycine 0 C--N 1.354 1.535 0 C-N-CA 121.277 -0.487 . . . . 72.34 113.71 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' C' ' 38' ' ' PRO . . . -125.86 83.99 0.35 Allowed Glycine 0 C--N 1.341 0.829 0 N-CA-C 108.88 -1.688 . . . . 72.31 108.88 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.96 129.42 34.46 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.34 0.656 . . . . 73.55 111.692 -164.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . 0.449 ' HB1' ' HD2' ' F' ' 193' ' ' TYR . . . 75.14 112.02 0.07 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.753 1.621 . . . . 71.4 113.151 173.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -91.75 150.58 21.03 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.601 -1.259 . . . . 74.14 107.601 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.16 76.53 2.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.676 0.79 . . . . 74.14 110.584 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -136.05 127.46 28.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.61 1.164 . . . . 74.25 109.336 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . 0.509 ' N ' ' HB2' ' E' ' 202' ' ' TYR . 22.6 mt-10 60.85 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.554 1.542 . . . . 74.35 113.608 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -56.66 114.49 2.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.737 1.215 . . . . 73.54 110.153 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 101.51 21.65 11.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.705 -0.68 . . . . 74.44 112.292 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? 58.48 71.85 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.371 1.468 . . . . 72.31 111.119 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . 0.509 ' HB2' ' N ' ' E' ' 198' ' ' GLU . 96.3 m-85 -120.58 15.27 11.95 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.796 -1.093 . . . . 73.34 109.791 172.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.54 130.0 38.31 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.646 0.778 . . . . 72.3 108.991 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.431 HG23 HG21 ' E' ' 207' ' ' VAL . 89.0 mt -122.88 99.5 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.964 0.906 . . . . 75.14 109.529 -172.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -121.68 -30.33 4.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.54 0.736 . . . . 64.2 111.146 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.31 -29.78 60.14 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.525 0.33 . . . . 74.11 111.327 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.431 HG21 HG23 ' E' ' 204' ' ' ILE . 16.6 m . . . . . 0 C--O 1.254 1.314 0 CA-C-O 121.499 0.666 . . . . 73.14 109.968 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.604 -0.517 . . . . 72.41 109.604 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.91 97.74 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.949 0.781 . . . . 63.11 111.873 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.29 99.7 4.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.21 0.604 . . . . 73.12 109.623 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 12.6 m -87.35 130.43 34.64 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 64.54 109.529 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . 0.406 ' HB1' ' H ' ' B' ' 88' ' ' GLY . . . -74.6 79.09 1.99 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.7 0.762 . . . . 73.11 109.594 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -136.2 132.5 35.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.636 -1.616 . . . . 63.13 106.636 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.766 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 4.1 mtm -142.01 -48.35 0.37 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.052 0.39 . . . . 65.23 112.052 -169.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . 0.494 ' H ' ' HE3' ' B' ' 94' ' ' MET . 14.3 t80 58.79 50.74 8.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.925 0.89 . . . . 75.54 108.957 -162.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.91 95.43 0.37 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.593 -1.185 . . . . 73.41 109.523 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . 0.605 HD23 ' H ' ' F' ' 178' ' ' GLN . 1.4 tt -153.91 157.66 39.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.279 -0.873 . . . . 74.22 108.779 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . 0.605 ' H ' HD23 ' F' ' 177' ' ' LEU . 8.8 mm-40 71.18 86.77 0.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.338 1.455 . . . . 73.14 110.034 -175.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.02 160.67 18.85 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 114.429 -1.259 . . . . 73.43 108.863 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.06 53.82 4.92 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.67 2.247 . . . . 73.25 111.377 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -66.58 171.69 4.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.057 0.543 . . . . 74.32 110.112 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -59.98 100.33 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.863 -0.792 . . . . 75.02 108.863 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 62.9 p -59.34 111.42 1.36 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.082 0.553 . . . . 75.44 109.567 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.528 ' HB2' ' HD1' ' B' ' 133' ' ' PHE . 30.2 t90 -109.53 93.9 15.05 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 123.344 0.658 . . . . 74.12 109.521 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -98.84 -152.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 123.19 2.593 . . . . 75.31 109.985 170.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.466 ' HG ' HD11 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -131.7 171.8 13.05 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.342 -0.984 . . . . 72.04 108.342 170.629 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.4 164.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.858 -0.423 . . . . 73.53 109.858 171.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.46 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.912 -0.773 . . . . 54.03 108.912 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . 0.502 ' HA ' ' HH ' ' E' ' 202' ' ' TYR . . . 176.45 146.39 0.09 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.2 1.0 . . . . 63.11 110.025 175.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -160.66 154.1 22.03 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.214 1.006 . . . . 73.34 109.245 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 106.08 59.51 0.61 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 110.53 -1.028 . . . . 55.45 110.53 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.85 97.86 0.77 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.52 -0.34 . . . . 55.03 112.298 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . 0.449 ' HD2' ' HB1' ' E' ' 194' ' ' ALA . 45.5 m-85 -129.4 21.18 5.65 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.387 0.675 . . . . 73.43 110.013 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.04 -171.34 2.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.654 0.782 . . . . 65.51 110.162 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 63.5 93.53 0.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.844 0.858 . . . . 73.42 109.351 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -76.49 -57.6 3.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.359 -0.978 . . . . 75.43 108.359 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 46.7 t80 62.87 147.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.746 1.218 . . . . 72.34 110.139 -171.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 62.57 23.11 13.73 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.11 0.957 . . . . 75.42 109.287 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -167.0 -71.12 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.387 -0.824 . . . . 74.14 110.204 -169.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.04 21.1 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.508 -0.607 . . . . 73.54 112.443 -175.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.73 95.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.901 1.28 . . . . 75.45 112.304 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 69.48 -68.79 0.18 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.552 1.541 . . . . 75.52 110.644 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.48 171.84 14.52 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.667 0.787 . . . . 62.43 109.154 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' F' ' 207' ' ' VAL . 3.5 pt -133.26 -77.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.792 0.837 . . . . 74.51 108.847 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . 0.59 ' H ' HG13 ' F' ' 204' ' ' ILE . 87.6 tttt 153.17 -54.4 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.045 2.138 . . . . 72.0 107.065 -173.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -143.44 -80.61 0.2 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.013 -1.449 . . . . 63.13 108.025 -171.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.633 ' HA ' HD12 ' F' ' 204' ' ' ILE . 61.3 t . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 107.018 -1.475 . . . . 73.41 107.018 166.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.91 -0.404 . . . . 74.12 109.91 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.26 -47.19 3.78 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 112.328 -0.309 . . . . 72.32 112.328 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.18 -179.09 5.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.757 1.223 . . . . 74.52 108.755 173.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 49.9 m -65.57 94.48 0.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.721 0.808 . . . . 72.44 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -176.51 176.61 1.56 Allowed 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.947 0.899 . . . . 72.43 111.606 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 85.5 mt 70.11 102.1 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.568 1.547 . . . . 73.23 112.34 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.539 ' HE3' ' HA ' ' A' ' 54' ' ' ASP . 0.9 OUTLIER 78.03 -33.07 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.237 1.815 . . . . 74.33 112.787 171.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -164.81 -167.64 1.28 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.059 0.944 . . . . 74.12 108.573 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 69.88 104.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.067 1.347 . . . . 74.3 110.355 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.63 -17.77 0.69 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.666 0.786 . . . . 74.13 110.166 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 59.76 -82.59 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.72 1.608 . . . . 72.12 112.683 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.29 85.51 56.57 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.61 -1.255 . . . . 75.11 107.61 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.89 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.806 2.338 . . . . 75.34 112.418 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -170.84 170.07 6.6 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 125.44 1.496 . . . . 75.34 107.562 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -57.87 138.94 55.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.043 0.537 . . . . 74.44 110.814 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 31.8 m -72.58 131.39 42.4 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 74.32 109.216 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -63.39 134.46 95.86 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 123.766 0.666 . . . . 64.13 110.382 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -52.06 113.09 1.03 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.931 2.421 . . . . 70.35 112.413 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.29 156.55 34.04 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.844 -0.616 . . . . 75.51 111.209 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 79.3 mt -66.54 112.03 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.164 -0.926 . . . . 73.4 109.66 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.23 -58.39 7.32 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.206 0.941 . . . . 64.41 110.755 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . 0.659 ' HA ' ' HB3' ' H' ' 203' ' ' ASP . . . 49.55 69.35 0.6 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.496 1.118 . . . . 61.42 112.234 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -68.13 -27.19 66.24 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.63 -0.714 . . . . 72.51 111.124 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 81.05 -141.3 22.28 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.581 -0.736 . . . . 74.4 112.279 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 38' ' ' PRO . . . 147.83 -164.63 28.85 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.535 -0.626 . . . . 64.04 111.535 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . 0.703 ' HE1' ' HB3' ' A' ' 35' ' ' ASP . 81.2 m-85 -82.72 148.25 27.99 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.428 . . . . 72.43 112.009 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' H' ' 197' ' ' TYR . . . -151.29 -70.33 0.17 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.641 -1.163 . . . . 71.13 108.321 174.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.57 132.43 34.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.66 0.784 . . . . 75.5 111.597 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -173.4 112.85 0.21 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.192 -1.411 . . . . 73.5 107.192 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -139.41 108.02 5.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.403 0.681 . . . . 74.12 110.112 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.78 -153.57 0.49 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.456 1.102 . . . . 74.24 109.228 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 8.4 t30 76.5 -72.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.599 1.56 . . . . 72.03 111.056 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.04 138.15 4.01 Favored Glycine 0 C--O 1.246 0.858 0 N-CA-C 110.167 -1.173 . . . . 72.02 110.167 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -155.53 -176.59 6.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.266 0.533 . . . . 73.54 109.917 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . 0.562 ' HH ' HG23 ' H' ' 187' ' ' ILE . 2.4 t80 -60.72 94.61 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.847 -1.538 . . . . 74.01 106.847 159.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -72.47 -61.19 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.876 -1.056 . . . . 74.41 111.116 -165.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 8.4 tp -174.38 -39.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.377 -1.283 . . . . 72.02 108.634 -170.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -79.77 -127.63 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.674 1.59 . . . . 75.2 109.356 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 68.51 29.58 5.56 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.032 0.933 . . . . 72.22 111.258 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.533 -1.212 . . . . 75.23 109.3 174.707 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 25.9 pttm . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 111.307 0.114 . . . . 74.42 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.39 71.94 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.124 0.393 . . . . 75.44 113.407 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . 0.448 ' HB2' ' ND2' ' H' ' 176' ' ' ASN . 0.1 OUTLIER -78.05 151.65 33.37 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.728 0.811 . . . . 74.42 110.532 173.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 48.4 t -160.85 -59.64 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.755 0.422 . . . . 72.02 110.114 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -162.26 175.84 11.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.271 1.029 . . . . 71.4 109.945 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 1.1 tt 70.14 106.98 0.06 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.859 1.264 . . . . 75.42 109.418 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 17.2 mmt 65.21 93.55 0.06 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.903 1.281 . . . . 71.54 110.231 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.48 -155.27 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.696 1.198 . . . . 64.41 110.197 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . 0.448 ' ND2' ' HB2' ' H' ' 170' ' ' LYS . 4.9 m120 69.1 80.33 0.19 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.567 1.147 . . . . 74.31 109.453 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -163.51 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.598 -0.728 . . . . 73.34 111.448 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -66.55 -35.97 81.53 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.399 0.68 . . . . 72.13 112.009 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -64.01 -50.48 69.19 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.675 -0.679 . . . . 64.51 111.654 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.09 5.67 6.08 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.187 1.924 . . . . 72.11 113.694 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -100.85 -179.56 4.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.552 0.741 . . . . 75.23 111.284 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -149.07 174.27 12.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.602 1.161 . . . . 75.33 109.789 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 69.1 p -70.3 99.69 1.59 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.852 -0.796 . . . . 75.13 108.852 174.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -66.0 112.06 8.02 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.068 0.947 . . . . 75.15 112.074 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.66 107.31 2.42 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.376 2.051 . . . . 75.52 110.665 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.49 -71.24 0.19 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.527 0.731 . . . . 73.13 110.916 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.562 HG23 ' HH ' ' G' ' 202' ' ' TYR . 80.3 mt -140.45 137.0 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.231 1.012 . . . . 75.24 108.569 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.75 75.0 9.71 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.768 -0.827 . . . . 72.4 108.768 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.9 154.87 31.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.317 -0.856 . . . . 64.2 110.542 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.64 -77.11 0.42 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.155 0.582 . . . . 71.44 109.511 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.46 -80.03 1.18 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.774 -0.53 . . . . 65.41 111.774 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.73 -65.94 3.11 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.797 0.351 . . . . 72.53 112.626 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . 0.54 ' HA ' ' H ' ' D' ' 37' ' ' GLN . 24.7 p90 -140.03 125.13 18.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.495 0.718 . . . . 71.12 109.118 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -167.28 -42.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.349 1.059 . . . . 41.43 108.735 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -67.44 96.94 0.54 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.574 -1.194 . . . . 75.43 110.22 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -120.32 112.24 18.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.002 0.921 . . . . 72.32 109.099 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . 0.491 ' OH ' ' HA ' ' D' ' 32' ' ' PHE . 4.0 p90 -138.23 155.0 49.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.691 0.396 . . . . 71.54 110.155 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' H' ' 200' ' ' GLY . 11.6 pt-20 -170.02 -154.26 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.272 1.029 . . . . 75.25 108.417 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.43 1.59 9.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.551 0.741 . . . . 70.32 112.138 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . 0.429 ' H ' ' HG3' ' H' ' 198' ' ' GLU . . . -78.44 60.78 3.97 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 121.098 0.277 . . . . 71.44 112.489 174.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . 0.473 ' HZ3' ' HB2' ' H' ' 201' ' ' LYS . 0.0 OUTLIER -174.47 -19.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.871 1.268 . . . . 75.4 110.293 -175.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -170.5 147.43 2.94 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.925 0.89 . . . . 63.34 109.778 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . 0.659 ' HB3' ' HA ' ' G' ' 189' ' ' ALA . 22.6 t70 -148.83 147.53 28.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.939 0.495 . . . . 72.14 111.188 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.17 104.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.379 1.472 . . . . 71.42 108.724 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.94 32.58 5.52 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.145 0.578 . . . . 74.42 111.019 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -125.71 -53.39 1.56 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.992 -0.744 . . . . 74.33 108.992 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.15 0.98 . . . . 75.2 108.692 172.109 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.778 -0.452 . . . . 74.34 109.778 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -152.33 -43.93 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.964 1.306 . . . . 75.41 108.049 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -81.81 169.52 16.79 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.474 -0.784 . . . . 64.22 109.565 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -72.12 -45.04 62.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 171.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -75.89 119.82 20.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.379 -0.828 . . . . 74.32 109.56 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -135.19 91.56 2.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.062 0.945 . . . . 62.43 109.237 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m 62.07 78.41 0.29 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.324 1.05 . . . . 74.14 110.385 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.15 95.71 5.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.195 -0.912 . . . . 72.32 109.089 -173.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtt -88.97 175.45 7.41 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.664 -0.698 . . . . 71.12 109.661 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.9 m -140.34 109.16 5.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.212 -1.033 . . . . 65.41 108.212 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' HB3' ' SD ' ' C' ' 138' ' ' MET . 60.3 t80 -135.04 135.91 41.67 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.287 -1.005 . . . . 75.52 108.287 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.48 135.7 15.79 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 116.134 -0.485 . . . . 75.22 110.2 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.46 HD12 ' HB1' ' C' ' 135' ' ' ALA . 3.7 mp -79.82 117.73 26.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.667 -0.864 . . . . 75.31 108.667 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -89.27 -39.65 13.35 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.155 0.582 . . . . 73.12 109.701 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -172.71 123.78 0.45 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.307 0.243 . . . . 74.1 111.078 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.796 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 85.6 mt -108.17 132.73 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 123.611 0.764 . . . . 74.53 109.208 173.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' HE2' ' HB3' ' B' ' 28' ' ' ALA . 9.3 p90 -167.73 170.74 10.65 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.047 0.939 . . . . 72.35 110.13 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -88.46 134.86 33.73 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.694 -0.854 . . . . 75.24 108.694 171.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 46.9 mtpt -94.44 -43.32 8.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.927 -0.768 . . . . 73.23 108.927 170.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 28.1 t70 -137.54 129.5 28.91 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.709 -1.132 . . . . 75.43 109.604 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -124.36 136.15 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.416 -1.328 . . . . 75.14 107.416 170.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -145.89 112.75 6.03 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 123.519 0.512 . . . . 62.31 109.725 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 77.7 t80 -114.23 111.78 22.08 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 106.609 -1.626 . . . . 75.33 106.609 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.76 110.19 16.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.976 -0.75 . . . . 75.01 108.976 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.47 93.04 7.75 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.566 -1.272 . . . . 70.14 107.566 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.46 -41.01 7.02 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.457 2.105 . . . . 75.13 111.182 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 78.0 m-20 -100.56 37.51 1.68 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.651 -1.159 . . . . 75.22 109.303 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.34 73.2 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.131 -0.938 . . . . 74.44 113.43 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.33 -27.93 10.92 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 121.541 1.586 . . . . 72.43 112.924 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 14.3 t60 -67.58 -26.26 66.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.761 1.224 . . . . 74.53 112.151 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.65 HG21 HD11 ' A' ' 68' ' ' LEU . 12.0 p -55.75 -30.18 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.517 1.127 . . . . 75.34 112.908 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.6 -34.46 75.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.892 0.877 . . . . 75.45 111.21 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -69.64 -32.03 70.47 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.282 1.033 . . . . 75.21 110.267 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.667 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 4.0 mmmp? -79.14 162.32 25.88 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.683 -1.144 . . . . 74.45 111.06 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.1 143.08 30.79 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 108.316 -0.994 . . . . 74.35 108.316 164.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.443 ' H ' ' HA ' ' G' ' 196' ' ' LYS . 62.8 t-105 -83.68 83.88 7.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.756 0.789 . . . . 75.02 110.038 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.67 69.77 16.97 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.416 1.086 . . . . 75.22 108.318 176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.27 110.02 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.534 2.156 . . . . 75.53 112.704 -170.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.672 ' HA ' ' HA2' ' G' ' 191' ' ' GLY . 44.8 tt0 -94.11 114.4 26.53 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.634 -1.247 . . . . 74.02 107.634 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 65' ' ' THR . 22.8 m -87.63 118.25 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.066 -0.97 . . . . 63.03 110.877 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.443 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 64.1 tttm -85.33 116.74 23.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.198 -0.91 . . . . 71.11 108.753 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.34 123.51 41.19 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.863 -0.608 . . . . 73.43 110.206 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.1 m-20 -115.32 122.92 47.37 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.061 -1.089 . . . . 71.41 108.061 170.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.489 HD23 ' HE2' ' A' ' 133' ' ' PHE . 34.1 tp -124.21 121.23 34.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.033 -0.729 . . . . 74.22 109.033 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.15 146.06 34.89 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.893 0.877 . . . . 73.34 110.017 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -109.29 150.11 28.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.405 0.682 . . . . 74.14 109.811 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.28 154.17 49.04 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.767 1.227 . . . . 73.34 108.085 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -130.55 152.79 49.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.86 0.464 . . . . 73.43 110.454 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.9 t -154.66 119.38 4.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.213 1.005 . . . . 75.01 108.537 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -91.47 118.67 30.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.183 -1.043 . . . . 75.51 108.183 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 57' ' ' GLU . 40.5 mt -93.24 -33.27 14.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.751 0.82 . . . . 74.45 110.129 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.97 -169.97 1.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.307 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.68 106.31 0.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.898 1.279 . . . . 73.11 109.964 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' HA ' ' HE2' ' G' ' 174' ' ' MET . 3.2 m-20 67.96 8.18 6.3 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.541 1.136 . . . . 74.44 112.515 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.36 19.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.736 -1.209 . . . . 72.32 107.736 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.56 ' HE1' ' HB2' ' G' ' 175' ' ' PHE . 9.2 m-85 -122.32 123.32 41.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.442 -0.799 . . . . 71.15 109.592 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD13 ' A' ' 51' ' ' LEU . 35.9 tt0 -93.64 128.07 39.64 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.878 -1.055 . . . . 72.14 108.796 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.8 t -101.3 124.86 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.75 . . . . 74.34 106.276 166.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.9 t -101.83 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.725 -0.843 . . . . 62.14 108.725 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.445 HD21 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -102.85 107.05 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.127 -1.064 . . . . 73.32 108.127 -175.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -103.68 110.53 22.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.952 0.901 . . . . 74.14 109.984 -173.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.01 132.07 66.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.97 -1.013 . . . . 75.23 108.729 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.1 m -121.92 123.22 41.19 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.533 -0.543 . . . . 75.51 109.533 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.479 HG22 HG21 ' A' ' 114' ' ' ILE . 52.4 t -116.69 107.23 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.727 1.211 . . . . 65.44 108.453 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.8 m -102.2 149.81 23.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.132 -1.062 . . . . 63.54 108.132 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.19 122.67 30.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.623 -0.51 . . . . 75.45 109.623 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -117.74 126.61 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.238 0.615 . . . . 75.1 110.39 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 31' ' ' VAL . 28.8 mt -92.92 82.42 4.66 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.791 -1.559 . . . . 65.51 106.791 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -83.63 1.0 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.177 -1.169 . . . . 50.53 110.177 -167.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.93 -18.2 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.472 1.109 . . . . 75.52 110.321 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.44 108.86 12.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.41 1.084 . . . . 73.43 110.505 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 m -66.16 119.15 10.95 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.967 0.348 . . . . 72.43 111.106 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.09 -50.89 17.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.184 0.994 . . . . 64.43 109.336 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -159.9 173.15 16.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 113.607 -1.633 . . . . 74.52 110.174 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 19.0 tp -141.1 141.2 34.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.737 1.215 . . . . 75.21 107.811 173.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.439 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 36.2 m -132.25 141.51 49.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.854 0.862 . . . . 74.42 108.877 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.99 121.39 9.65 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.568 -0.901 . . . . 70.13 108.568 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.49 112.38 29.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.524 0.73 . . . . 74.43 109.542 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.436 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -88.73 87.2 7.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.536 -1.211 . . . . 71.51 109.086 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -77.15 95.55 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.716 -1.129 . . . . 75.25 109.29 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.82 142.95 19.56 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.912 -0.475 . . . . 75.23 111.912 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.526 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.43 122.66 2.33 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 110.865 -0.894 . . . . 73.3 110.865 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.3 mt -79.76 131.0 35.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.726 -1.212 . . . . 74.21 107.726 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.439 ' HD2' ' HA ' ' A' ' 13' ' ' ILE . 39.2 m-85 -135.9 138.34 42.32 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.197 0.599 . . . . 75.41 109.577 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.9 m -87.62 121.46 30.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 71.41 108.94 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.37 136.09 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.57 0.748 . . . . 74.13 111.26 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.27 174.31 3.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.711 1.204 . . . . 63.35 110.155 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.41 9.62 86.73 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-N 116.509 -0.314 . . . . 73.25 113.833 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 94' ' ' MET . 1.8 pp -120.22 149.4 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.311 1.044 . . . . 75.12 111.02 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.8 174.55 10.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.597 0.759 . . . . 74.33 110.634 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.43 -140.43 40.12 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 115.683 1.033 . . . . 75.24 115.683 167.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -78.63 -12.04 60.0 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.308 1.043 . . . . 71.53 111.064 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -36.9 79.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.752 0.821 . . . . 63.44 110.091 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.5 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 26.2 ptm -75.69 -20.15 58.61 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.397 -0.365 . . . . 75.44 111.191 174.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.4 ' HA ' HD21 ' G' ' 177' ' ' LEU . . . -66.05 -23.8 66.61 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.781 0.432 . . . . 73.0 111.553 177.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' CD2' ' HB2' ' A' ' 134' ' ' ASP . 10.8 t-160 -62.86 -45.0 94.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 75.4 110.522 169.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 41.9 t -68.85 -64.52 0.85 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.704 0.802 . . . . 72.52 111.601 -173.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.58 -26.1 61.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.557 0.343 . . . . 74.42 111.688 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.05 -34.15 11.21 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 114.659 0.624 . . . . 52.22 114.659 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.99 -39.25 0.41 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.96 0.88 . . . . 74.42 113.067 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.417 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.1 t80 -69.8 -58.96 3.26 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.844 0.458 . . . . 75.32 111.632 -174.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.432 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 65.3 m -67.19 -37.46 13.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.748 0.819 . . . . 75.42 112.66 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.17 -43.56 47.85 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.124 1.883 . . . . 75.13 113.309 162.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.3 -25.43 62.43 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.17 0.588 . . . . 75.5 111.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.0 mm -62.33 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.595 0.712 . . . . 74.44 109.176 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.526 HD22 ' HA3' ' A' ' 82' ' ' GLY . 45.5 mt -81.12 -18.74 45.4 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.584 -1.189 . . . . 75.12 112.061 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.452 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 51.4 t80 -63.42 -42.54 74.7 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 113.966 1.098 . . . . 75.21 113.966 -171.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.542 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 73.6 Cg_exo -55.13 -33.19 83.06 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 122.101 1.867 . . . . 73.5 113.785 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.94 -40.14 24.99 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.265 -0.88 . . . . 75.35 111.317 -175.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.06 -41.14 82.42 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.457 0.303 . . . . 73.14 110.586 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.542 ' NH1' ' HA ' ' A' ' 108' ' ' PRO . 34.0 ttm180 -51.98 -55.72 18.67 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.528 1.142 . . . . 75.33 109.537 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.45 -42.17 99.27 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.676 1.235 . . . . 75.35 111.845 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.458 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.5 t -57.54 -50.21 73.82 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.967 0.792 . . . . 73.42 110.302 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.479 HG21 HG22 ' A' ' 64' ' ' VAL . 95.1 mt -62.63 -46.5 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.141 -0.936 . . . . 74.32 110.667 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 82.0 m -54.41 -44.49 72.41 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.253 1.021 . . . . 64.4 110.902 -176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.2 t -72.13 -34.81 68.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.547 -1.206 . . . . 73.22 111.035 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.9 mtp -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.516 0.726 . . . . 65.12 111.193 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -59.97 -52.08 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.008 0.923 . . . . 75.54 110.064 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.627 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 71.1 p -68.04 -26.71 66.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.17 -0.923 . . . . 75.12 112.151 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.9 ttm-85 -72.81 -25.49 61.16 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.877 0.871 . . . . 75.14 109.985 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 22.16 12.03 Favored Glycine 0 C--N 1.358 1.791 0 CA-C-N 116.027 -0.533 . . . . 74.32 113.06 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t 55.96 27.86 11.82 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 127.154 2.182 . . . . 74.33 113.664 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 119' ' ' SER . 36.1 m-85 -98.48 153.15 38.11 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.398 0.679 . . . . 70.34 110.191 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.74 118.94 5.78 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.501 2.134 . . . . 74.1 111.14 166.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.627 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 11.9 pt20 -64.23 150.35 46.09 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.391 0.676 . . . . 73.04 112.345 -171.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -109.21 101.24 10.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 109.029 -0.73 . . . . 75.05 109.029 -171.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -98.2 84.7 3.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.735 -0.839 . . . . 73.34 108.735 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.452 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -59.43 139.95 56.61 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.875 0.87 . . . . 74.43 110.017 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.78 132.71 91.74 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.316 0.647 . . . . 62.14 111.852 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.663 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 39.8 Cg_endo -72.07 101.73 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.396 2.064 . . . . 74.43 111.483 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -101.03 111.52 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 122.389 1.09 . . . . 73.34 110.711 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.472 HD21 ' HB1' ' A' ' 135' ' ' ALA . 1.7 p-10 -99.16 70.03 1.75 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.965 -1.471 . . . . 74.24 108.526 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.489 ' HE2' HD23 ' A' ' 44' ' ' LEU . 21.7 m-85 -57.18 -33.16 67.17 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 75.33 112.289 -175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 96' ' ' HIS . 9.8 p-10 -74.98 -36.32 62.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.657 0.783 . . . . 61.12 111.001 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HB1' HD21 ' A' ' 132' ' ' ASN . . . -77.41 -29.37 52.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.454 0.702 . . . . 74.14 110.828 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.79 -38.32 76.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.709 1.204 . . . . 74.31 108.924 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.04 -22.14 29.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.602 -0.727 . . . . 73.43 111.073 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -61.26 -46.54 89.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.504 0.722 . . . . 72.52 111.067 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -68.4 -17.66 64.27 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.902 -0.59 . . . . 71.11 111.499 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -91.85 -35.51 14.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.887 0.875 . . . . 73.31 111.289 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.1 -23.2 67.23 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.36 1.464 . . . . 74.04 110.648 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -146.31 33.77 0.98 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.451 -0.944 . . . . 75.32 108.451 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.17 97.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.02 1.728 . . . . 63.3 114.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -174.44 123.05 0.28 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.97 1.308 . . . . 73.32 107.723 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB3' ' ND2' ' C' ' 6' ' ' ASN . . . -72.93 120.17 18.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.243 0.617 . . . . 73.41 110.544 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.8 39.47 0.43 Allowed Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.79 -0.524 . . . . 75.14 111.79 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.32 141.34 34.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.127 0.571 . . . . 73.31 110.455 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.69 49.87 0.2 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.455 -1.058 . . . . 73.41 110.455 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.7 p -89.31 109.42 20.32 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.384 0.673 . . . . 65.31 109.232 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.86 78.48 3.45 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.038 0.935 . . . . 73.25 109.478 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -97.21 78.62 2.76 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.441 0.696 . . . . 72.31 109.864 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -88.8 -45.8 9.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.225 -1.028 . . . . 74.31 108.225 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.93 131.55 43.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.292 0.637 . . . . 72.12 109.343 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.519 ' HB2' ' HB3' ' C' ' 141' ' ' LEU . 4.1 p-10 -97.38 -26.2 14.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.261 0.624 . . . . 70.01 111.095 -175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 O-C-N 124.074 0.859 . . . . 72.43 109.22 -176.023 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.427 -0.583 . . . . 73.3 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -153.42 117.84 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.491 0.716 . . . . 74.52 109.57 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.3 103.75 7.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.518 0.727 . . . . 71.24 109.284 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.82 88.78 1.2 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.014 -1.476 . . . . 73.34 107.014 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.97 -21.25 66.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.617 -1.174 . . . . 72.23 112.073 -174.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -87.92 66.81 8.84 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.757 0.789 . . . . 74.32 108.893 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -95.03 150.82 19.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.83 -0.623 . . . . 63.31 110.595 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.34 -29.45 57.24 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.483 0.713 . . . . 75.25 109.759 173.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.612 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.9 ptm 55.98 172.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.272 2.229 . . . . 74.12 114.575 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -157.37 130.09 7.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.681 1.193 . . . . 74.11 107.8 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -137.21 140.48 41.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.179 -0.674 . . . . 75.33 109.179 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.649 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 23.9 tp60 -142.68 115.46 8.68 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.171 -0.677 . . . . 74.22 109.171 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.403 HD11 HG13 ' B' ' 16' ' ' ILE . 6.8 tp -68.88 127.6 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.953 -0.758 . . . . 75.1 108.953 171.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.78 -45.55 3.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.873 0.469 . . . . 71.45 110.332 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -167.09 143.74 4.48 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.329 0.393 . . . . 73.5 110.689 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.403 HG13 HD11 ' B' ' 13' ' ' ILE . 92.8 mt -120.04 143.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.442 -1.318 . . . . 73.5 107.442 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.434 ' HE1' HG13 ' B' ' 83' ' ' ILE . 22.1 p90 -173.19 156.27 3.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.167 0.508 . . . . 74.13 111.461 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.439 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 94.4 m -84.1 128.98 34.91 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.93 -0.767 . . . . 71.45 108.93 169.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.403 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.5 mtpt -90.41 -43.49 10.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.496 0.718 . . . . 75.3 109.738 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.0 t70 -148.19 142.44 26.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.316 -0.856 . . . . 74.34 111.323 -172.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.759 HD12 ' SG ' ' B' ' 113' ' ' CYS . 41.3 mm -128.27 135.36 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 124.768 1.227 . . . . 72.42 108.878 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.8 t -130.39 128.83 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.611 -1.177 . . . . 75.11 108.067 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 72.5 t80 -150.08 110.33 4.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.793 -1.558 . . . . 75.22 106.793 171.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.41 113.93 18.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.979 -1.119 . . . . 73.13 107.979 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.07 89.64 5.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.703 0.801 . . . . 73.24 108.903 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 44.7 Cg_endo -63.57 -38.28 42.48 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.25 2.634 . . . . 74.1 112.844 -171.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.33 30.69 6.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.302 1.041 . . . . 75.02 109.559 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.504 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -47.4 -50.02 51.0 Favored Pre-proline 0 CA--C 1.566 1.57 0 N-CA-C 114.856 1.428 . . . . 71.14 114.856 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -77.68 -23.28 9.8 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.871 1.714 . . . . 73.2 112.738 175.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.454 ' HA ' ' NE2' ' B' ' 33' ' ' GLN . 77.0 m80 -78.38 -8.29 58.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.568 0.747 . . . . 75.35 111.437 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.01 -24.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.074 0.95 . . . . 71.34 111.027 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -66.13 -43.49 86.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.665 0.386 . . . . 73.41 110.975 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.454 ' NE2' ' HA ' ' B' ' 30' ' ' HIS . 2.1 mp0 -72.54 -36.59 68.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.709 0.804 . . . . 74.32 110.049 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.38 76.6 10.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.651 0.739 . . . . 72.11 109.786 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.79 79.34 6.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.595 -1.184 . . . . 74.41 110.641 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -173.29 156.95 3.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.142 0.977 . . . . 75.4 109.482 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -58.54 128.38 83.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.881 0.872 . . . . 75.25 110.699 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -66.01 152.6 80.91 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.19 1.26 . . . . 73.34 110.281 168.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.27 101.66 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.026 -1.101 . . . . 74.5 108.026 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' B' ' 124' ' ' PRO . 4.2 t -84.58 123.21 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.143 -1.428 . . . . 71.01 107.143 -174.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 64' ' ' VAL . 1.5 tmtp? -145.83 113.97 6.59 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.629 -0.508 . . . . 70.34 109.629 -174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' B' ' 64' ' ' VAL . 10.0 mp -89.71 148.48 23.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.646 0.779 . . . . 74.5 109.157 172.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.39 150.33 43.76 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.13 -1.063 . . . . 61.43 108.13 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 tt -109.92 125.73 53.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.351 0.66 . . . . 74.44 109.257 -172.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -134.46 136.19 43.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.884 -1.154 . . . . 73.31 107.884 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -108.41 146.16 33.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.274 0.559 . . . . 74.13 109.957 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.528 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -137.75 159.17 42.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.5 1.12 . . . . 71.4 108.405 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.498 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 81.2 p -143.54 162.35 36.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.945 0.402 . . . . 53.1 110.94 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -160.48 154.36 22.75 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.781 1.233 . . . . 75.0 108.91 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -121.76 135.07 54.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.166 0.587 . . . . 75.15 109.657 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.5 mt -100.66 -47.9 4.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.474 0.71 . . . . 75.31 109.517 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.06 -175.39 5.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.99 -1.005 . . . . 73.31 110.295 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -71.83 130.11 40.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.736 -1.12 . . . . 71.32 109.072 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 66.07 -8.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.47 1.508 . . . . 72.2 112.743 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.02 94.18 2.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 107.942 -1.133 . . . . 74.11 107.942 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.498 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 2.8 t80 -98.12 165.32 11.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.701 -1.136 . . . . 74.31 109.134 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.8 106.01 4.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.548 -1.278 . . . . 72.14 107.548 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 56.7 t -97.94 131.5 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.205 0.602 . . . . 71.24 109.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 34.7 t -108.92 125.28 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.716 0.806 . . . . 74.33 109.726 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.25 130.95 40.31 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.511 -1.292 . . . . 72.35 107.511 172.167 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -121.26 106.74 11.77 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.681 . . . . 72.23 109.497 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.1 124.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.537 -0.912 . . . . 75.42 108.537 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.1 m -120.35 146.91 45.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.398 . . . . 74.31 110.931 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 55.1 t -116.88 120.1 64.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 124.644 1.177 . . . . 75.51 109.577 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.3 m -99.24 127.93 45.29 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.981 -1.488 . . . . 74.31 106.981 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.59 132.43 18.03 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.582 -0.896 . . . . 72.14 108.582 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -148.55 139.31 22.88 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.587 0.554 . . . . 52.04 111.803 -170.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 51.2 mt -100.24 100.28 11.08 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.054 1.342 . . . . 74.44 109.587 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.66 -111.18 3.61 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.801 -0.52 . . . . 73.45 111.801 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -108.16 4.43 24.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.566 0.747 . . . . 64.43 111.536 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -121.07 160.31 23.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.693 0.797 . . . . 73.43 109.843 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.9 m -78.74 136.99 37.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.738 0.415 . . . . 65.33 110.515 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.33 -61.42 1.9 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.412 1.101 . . . . 65.42 109.024 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.509 ' CE2' ' HB3' ' B' ' 76' ' ' CYS . 1.2 p90 -154.17 171.79 18.61 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 112.892 -1.958 . . . . 74.24 107.623 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -136.57 110.17 8.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.907 -1.886 . . . . 74.04 105.907 167.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.509 ' HB3' ' CE2' ' B' ' 74' ' ' PHE . 1.8 t -113.76 160.22 18.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.094 -0.503 . . . . 73.42 110.292 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.2 tt0 -164.98 143.73 6.59 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.653 -1.24 . . . . 75.24 107.653 -170.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.16 144.01 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.786 0.834 . . . . 73.34 108.871 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' B' ' 60' ' ' LEU . 46.7 mt-30 -122.69 92.53 3.73 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.748 0.819 . . . . 74.23 108.911 172.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -88.54 100.73 13.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.736 -1.12 . . . . 74.24 108.809 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.39 174.52 33.74 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 111.838 -0.505 . . . . 74.02 111.838 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.29 136.5 4.07 Favored Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.729 -0.548 . . . . 74.34 111.729 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.434 HG13 ' HE1' ' B' ' 17' ' ' TYR . 34.5 mt -86.15 124.88 40.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.445 -0.946 . . . . 73.21 108.445 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -138.61 131.53 29.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.976 -1.12 . . . . 74.01 107.976 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.649 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 75.1 m -91.03 107.37 19.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.716 -0.476 . . . . 75.12 109.716 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.486 ' HB ' HD13 ' B' ' 89' ' ' ILE . 24.7 pt -106.24 142.85 18.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.358 -0.837 . . . . 74.4 110.817 -176.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.38 166.13 33.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.313 1.045 . . . . 75.0 108.739 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.63 -53.33 4.84 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.924 -0.375 . . . . 71.44 113.523 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.486 HD13 ' HB ' ' B' ' 86' ' ' ILE . 1.5 pp -51.98 126.07 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.036 0.934 . . . . 73.11 112.474 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.555 ' HB3' ' HG ' ' F' ' 173' ' ' LEU . 10.2 pt-20 -159.36 154.36 24.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 74.54 110.768 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.33 -122.93 22.19 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.578 -0.737 . . . . 74.35 112.188 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -68.52 -31.27 70.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.66 0.784 . . . . 74.25 110.936 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -72.8 -34.85 67.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.642 0.777 . . . . 74.34 110.763 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.448 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 54.1 ttm -62.79 -49.23 75.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.527 -0.761 . . . . 75.13 109.36 171.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.0 -28.79 69.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.697 0.799 . . . . 65.41 112.071 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -69.83 -44.73 69.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 74.52 110.034 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.436 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 45.5 t -63.91 -59.47 4.47 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.753 0.821 . . . . 72.11 111.535 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.439 HD11 ' N ' ' B' ' 99' ' ' GLY . 4.2 pp -71.12 -28.66 64.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.475 0.71 . . . . 75.13 112.486 -175.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.439 ' N ' HD11 ' B' ' 98' ' ' LEU . . . -94.42 -38.41 5.04 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.478 -0.328 . . . . 22.12 113.521 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.9 -45.17 1.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 118.984 -0.531 . . . . 52.41 112.223 -171.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.436 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 93.0 t80 -71.04 -63.86 1.02 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.17 0.441 . . . . 74.53 111.819 -169.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.431 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 58.1 m -58.32 -45.99 99.67 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.777 -0.63 . . . . 75.51 111.1 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.466 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 82.3 Cg_exo -54.04 -38.91 87.15 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.314 2.009 . . . . 71.51 114.228 167.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -68.52 -30.14 68.88 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.576 0.626 . . . . 74.44 111.49 -176.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.8 -50.18 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.528 0.68 . . . . 74.51 109.206 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.41 -13.5 59.91 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 113.841 -1.527 . . . . 74.42 111.963 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 55.2 t80 -67.56 -49.3 41.38 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 117.821 -1.085 . . . . 71.22 113.792 -166.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.21 -32.42 90.63 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.45 1.433 . . . . 71.45 112.231 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -65.23 -49.85 68.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 71.3 110.531 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.55 99.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.873 0.869 . . . . 73.14 111.15 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -61.28 -49.14 78.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.53 1.532 . . . . 74.54 111.265 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -36.85 77.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.512 -0.551 . . . . 74.42 109.512 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.759 ' SG ' HD12 ' B' ' 21' ' ' ILE . 37.9 t -62.18 -39.27 92.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.326 0.65 . . . . 73.41 112.217 -178.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mt -63.51 -51.84 65.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.716 -0.476 . . . . 72.35 109.716 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.9 m -61.52 -24.42 66.61 Favored 'General case' 0 CA--C 1.561 1.371 0 O-C-N 124.31 1.006 . . . . 74.42 111.438 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.4 t -69.74 -58.59 3.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.971 0.909 . . . . 64.15 109.884 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.498 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.4 mmt -65.9 -28.08 68.68 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.309 0.576 . . . . 73.12 111.477 -176.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -52.35 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.726 1.61 . . . . 72.42 109.548 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 96.7 p -65.97 -31.6 72.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.015 0.526 . . . . 75.24 111.007 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 79.8 mtt-85 -62.17 -39.85 94.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.406 0.682 . . . . 74.01 110.721 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 9.21 71.15 Favored Glycine 0 C--N 1.353 1.475 0 O-C-N 123.349 0.406 . . . . 63.11 113.489 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 17' ' ' TYR . 11.3 p 58.95 30.7 20.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.406 1.882 . . . . 75.35 112.362 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.84 161.53 35.6 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.749 1.22 . . . . 75.42 110.899 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.614 ' HB2' HG22 ' B' ' 40' ' ' VAL . 14.8 Cg_exo -74.89 145.46 31.94 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 124.157 3.238 . . . . 73.22 115.46 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.428 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.4 OUTLIER -67.41 143.13 56.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.25 1.42 . . . . 75.24 111.936 177.2 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.28 113.73 4.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.95 -1.13 . . . . 74.13 107.95 163.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -89.01 116.02 26.99 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.147 -1.057 . . . . 65.2 108.147 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.636 ' HA ' HD13 ' F' ' 187' ' ' ILE . 2.3 tt -66.34 137.48 56.94 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.853 0.721 . . . . 74.44 110.063 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.5 ' HB1' ' HE2' ' E' ' 202' ' ' TYR . . . -55.11 152.89 13.5 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 126.138 1.775 . . . . 70.23 113.539 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.604 ' HG3' HD11 ' D' ' 16' ' ' ILE . 92.6 Cg_endo -69.72 103.98 1.24 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.807 2.338 . . . . 72.44 110.701 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.6 m -85.29 52.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 122.374 1.083 . . . . 72.12 111.096 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.46 71.27 4.92 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.402 -1.333 . . . . 73.43 107.402 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -66.47 -31.1 71.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.308 -1.315 . . . . 73.5 110.974 -171.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.42 -42.95 88.37 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.212 0.945 . . . . 73.33 111.301 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -48.76 76.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.457 0.703 . . . . 72.15 111.481 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.15 -47.91 75.39 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.756 0.823 . . . . 72.5 110.136 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -62.75 -29.79 70.95 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.399 1.08 . . . . 73.41 111.565 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.45 ' O ' ' HB3' ' B' ' 142' ' ' GLN . 1.4 tmt? -67.49 -37.18 82.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.244 0.618 . . . . 72.12 110.931 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -92.2 -18.21 23.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.972 0.509 . . . . 74.13 111.515 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -88.49 -48.38 7.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.666 0.386 . . . . 74.4 110.686 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -90.02 -8.98 50.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.5 0.72 . . . . 74.04 109.778 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' B' ' 138' ' ' MET . 6.3 tp-100 -132.88 108.41 8.92 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 73.44 108.872 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -78.23 125.84 29.94 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.143 -1.058 . . . . 73.53 108.143 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.54 144.66 50.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.783 0.833 . . . . 75.15 108.936 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.08 152.16 40.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.549 0.74 . . . . 64.22 111.087 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.51 2.75 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.958 -0.457 . . . . 70.4 111.958 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' D' ' 87' ' ' ALA . 10.5 pt-20 -152.65 162.73 40.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.593 1.157 . . . . 75.13 108.756 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.71 171.36 12.96 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 112.268 -0.333 . . . . 54.4 112.268 -176.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.2 t -79.54 32.3 0.24 Allowed 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.782 1.03 . . . . 71.52 113.782 -168.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.55 80.73 4.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.767 -1.197 . . . . 75.34 107.767 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.46 89.9 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.7 0.8 . . . . 75.05 112.528 -166.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.465 ' H ' HG22 ' D' ' 7' ' ' THR . 40.8 m170 -93.64 146.51 23.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.219 1.008 . . . . 75.31 109.897 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.8 5.41 43.73 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.107 0.963 . . . . 71.11 111.177 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.23 157.36 16.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.816 0.847 . . . . 73.14 110.646 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.019 0.928 . . . . 71.32 111.041 -174.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 108.619 -0.882 . . . . 72.45 108.619 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -161.31 176.68 10.93 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.683 -1.144 . . . . 74.02 109.809 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.59 22.39 4.69 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.175 0.99 . . . . 71.25 110.781 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -52.95 140.89 23.5 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.921 0.888 . . . . 74.24 110.883 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.45 66.59 7.07 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.085 0.945 . . . . 74.45 110.429 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 145' ' ' ALA . 22.0 m120 -146.73 170.44 16.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.209 1.404 . . . . 74.22 107.946 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.7 p -76.8 135.5 38.94 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.698 0.399 . . . . 74.24 110.615 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -33.28 59.56 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.555 1.142 . . . . 73.01 112.396 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.617 ' HG3' HG22 ' C' ' 89' ' ' ILE . 23.7 ttt 64.81 114.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 75.21 111.413 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m -96.04 117.41 30.62 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.167 0.587 . . . . 73.55 110.49 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.5 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 44.0 t80 -125.31 118.64 26.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.953 -1.128 . . . . 74.55 107.953 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.438 ' NE2' ' HG2' ' C' ' 14' ' ' GLN . 11.9 tm0? -136.12 127.57 28.58 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 117.943 0.338 . . . . 75.34 110.235 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -89.15 129.03 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.224 -0.658 . . . . 73.44 109.224 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.438 ' HG2' ' NE2' ' C' ' 12' ' ' GLN . 5.5 mt-30 -99.99 -42.2 6.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.413 0.685 . . . . 75.41 110.42 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.484 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 60.6 ttt180 -174.6 128.19 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.153 0.581 . . . . 75.33 110.11 -168.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.85 142.1 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.961 -1.126 . . . . 73.22 107.961 172.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.506 ' HH ' HD11 ' C' ' 83' ' ' ILE . 26.2 p90 -177.84 161.37 1.59 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.824 0.703 . . . . 72.25 110.909 -175.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -80.41 120.32 24.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.609 0.764 . . . . 75.3 109.701 175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.553 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.2 OUTLIER -74.02 -49.87 22.36 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.862 0.839 . . . . 74.32 108.964 178.177 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.511 ' HB2' ' HB2' ' C' ' 79' ' ' GLN . 25.0 m-20 -141.91 122.07 13.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.417 -1.72 . . . . 61.23 108.16 -174.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.2 mt -112.63 143.62 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 107.412 -1.329 . . . . 74.04 107.412 169.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.19 145.98 21.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.098 0.475 . . . . 64.51 110.214 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.471 ' HB3' ' HB ' ' D' ' 21' ' ' ILE . 91.8 t80 -148.21 123.99 10.56 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.562 -1.273 . . . . 73.35 107.562 176.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.06 115.35 24.11 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.14 0.976 . . . . 73.34 109.306 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.32 78.55 27.06 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 108.042 -1.095 . . . . 55.15 108.042 166.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.52 -15.34 24.73 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.373 2.049 . . . . 71.43 111.559 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -112.31 25.41 11.55 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 124.276 1.03 . . . . 53.45 109.945 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.33 77.01 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 114.435 1.272 . . . . 64.11 114.435 -172.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.69 -27.13 9.2 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 121.922 1.748 . . . . 71.21 112.45 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.84 -33.81 72.79 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.211 1.404 . . . . 71.41 111.395 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.74 HG12 HD13 ' C' ' 68' ' ' LEU . 53.5 t -79.9 -22.78 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 124.78 1.232 . . . . 73.34 111.487 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.65 -40.87 93.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.215 0.606 . . . . 73.55 111.78 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -101.97 45.69 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.415 0.686 . . . . 74.33 109.944 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.83 168.33 13.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.636 0.775 . . . . 75.33 110.019 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -74.08 115.41 13.52 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.032 -0.729 . . . . 72.33 109.032 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.485 ' HE1' ' HB2' ' E' ' 194' ' ' ALA . 51.7 t-105 -85.25 93.94 8.8 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.659 0.784 . . . . 60.42 111.842 -167.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.49 73.39 20.5 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.148 0.979 . . . . 74.31 109.773 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 120.76 4.97 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.999 2.466 . . . . 61.13 112.408 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' C' ' 67' ' ' SER . 8.8 pt-20 -86.49 91.37 8.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.222 1.01 . . . . 63.42 109.346 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.742 ' HB ' HD13 ' C' ' 126' ' ' LEU . 26.2 m -82.03 89.01 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 122.532 1.158 . . . . 71.51 110.449 -173.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -109.61 142.04 41.29 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.691 -1.141 . . . . 74.35 109.507 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -129.85 160.78 32.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.895 0.478 . . . . 74.42 111.17 -177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -133.41 146.58 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.719 1.208 . . . . 62.1 109.053 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.556 ' HG ' HD21 ' C' ' 60' ' ' LEU . 6.0 tt -112.39 109.77 19.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.657 -1.238 . . . . 72.41 107.657 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -112.97 141.7 46.5 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.039 -1.097 . . . . 74.31 108.039 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 43.5 m -113.94 111.63 22.0 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.786 -0.82 . . . . 64.34 108.786 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.47 158.86 18.65 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.934 1.294 . . . . 71.12 108.971 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 p -165.69 154.48 11.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.789 0.436 . . . . 72.34 111.198 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -145.6 160.91 40.97 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.737 0.815 . . . . 63.14 109.172 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.68 121.83 35.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.494 -0.558 . . . . 71.55 109.494 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.505 HD13 HD13 ' C' ' 83' ' ' ILE . 61.6 mt -88.3 -53.06 4.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.561 -0.903 . . . . 75.14 108.561 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.16 -171.26 3.79 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.852 -1.067 . . . . 71.43 110.328 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.91 118.92 17.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.065 -0.97 . . . . 75.22 108.779 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.597 ' HA ' ' HE1' ' E' ' 174' ' ' MET . 92.9 m-20 69.51 -0.55 2.55 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.805 1.242 . . . . 74.44 113.189 -173.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.71 114.64 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.059 -0.719 . . . . 71.14 109.059 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -128.13 140.07 52.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.835 0.826 . . . . 75.04 110.839 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -85.24 109.3 18.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.373 -1.739 . . . . 74.31 108.138 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.32 115.97 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.714 -1.217 . . . . 74.41 107.714 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.6 114.07 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.695 0.798 . . . . 74.33 109.973 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.556 HD21 ' HG ' ' C' ' 44' ' ' LEU . 1.3 tt -86.58 106.44 17.56 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.97 -1.493 . . . . 73.0 106.97 169.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 45.0 mtp180 -87.61 106.51 18.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 74.54 109.738 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' C' ' 114' ' ' ILE . 8.2 t -100.19 120.63 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.85 -0.796 . . . . 71.21 108.85 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 86.0 m -104.35 145.42 30.28 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.454 -0.943 . . . . 73.22 108.454 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.486 HG22 HG23 ' C' ' 114' ' ' ILE . 46.8 t -136.88 127.56 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.846 0.858 . . . . 72.53 109.637 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.1 m -118.17 146.15 44.41 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.39 -0.967 . . . . 72.32 108.39 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.273 -1.01 . . . . 71.15 108.273 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 70.6 m -143.25 168.18 20.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.047 0.939 . . . . 63.54 110.058 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.74 HD13 HG12 ' C' ' 31' ' ' VAL . 13.2 mt -111.56 37.5 2.88 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.466 -1.309 . . . . 73.13 107.466 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 -79.13 0.29 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 109.473 -1.451 . . . . 75.52 109.473 -166.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -128.13 -28.02 2.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.153 0.981 . . . . 70.4 110.016 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.93 98.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.986 0.914 . . . . 65.01 109.499 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.8 m -65.4 117.1 7.44 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.156 0.503 . . . . 74.54 110.43 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.12 -50.33 28.86 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.406 -1.27 . . . . 73.32 109.026 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -161.87 166.09 26.79 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.36 -0.836 . . . . 73.34 111.103 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.449 HD23 ' O ' ' C' ' 64' ' ' VAL . 2.8 tm? -122.65 146.75 47.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.831 -1.915 . . . . 75.3 105.831 167.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.557 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.5 t -152.6 153.35 33.19 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.37 -0.604 . . . . 74.2 109.37 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.25 128.52 6.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.834 0.453 . . . . 63.33 110.329 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.81 114.06 44.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.158 -1.053 . . . . 74.42 108.158 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.516 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 49.6 mt-30 -87.99 90.78 8.52 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.347 -1.353 . . . . 73.13 107.347 169.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.426 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.8 tp-100 -79.8 132.48 36.15 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.36 -0.836 . . . . 72.23 109.539 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.553 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -119.72 152.94 16.96 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 123.376 0.422 . . . . 73.02 112.767 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.491 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.12 126.64 2.22 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 109.321 -1.512 . . . . 73.21 109.321 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.506 HD11 ' HH ' ' C' ' 17' ' ' TYR . 19.3 mm -88.26 113.12 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 74.04 108.092 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -123.91 119.16 28.81 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.056 -1.09 . . . . 75.43 108.056 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -84.89 108.79 17.71 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.944 -0.761 . . . . 62.1 108.944 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 pp -112.19 132.41 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.871 0.869 . . . . 75.41 109.617 -178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.05 135.63 16.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.573 0.749 . . . . 42.53 109.962 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -19.62 27.87 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.352 0.408 . . . . 63.32 113.078 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.617 HG22 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -60.09 127.85 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.726 1.21 . . . . 65.41 111.552 -174.766 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -157.99 170.11 23.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.437 0.695 . . . . 71.12 110.451 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.22 -154.09 53.04 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.781 -0.645 . . . . 71.43 113.485 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -69.89 -24.54 63.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.627 0.771 . . . . 73.22 112.151 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.17 -53.35 59.26 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.516 0.51 . . . . 72.12 109.864 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.42 -42.98 99.85 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.995 0.918 . . . . 74.42 111.773 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.55 84.3 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.024 0.827 . . . . 72.53 111.393 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -84.51 -26.59 27.99 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.134 -0.484 . . . . 75.34 110.845 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -70.11 -61.07 1.92 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.009 0.524 . . . . 75.13 111.361 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.494 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.6 pp -88.35 -18.6 28.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.663 0.245 . . . . 73.43 111.663 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.12 -29.69 27.55 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.433 0.458 . . . . 52.1 113.199 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.74 -46.5 0.96 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.72 0.408 . . . . 61.43 112.095 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.663 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 56.5 t80 -76.3 -39.32 54.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.542 0.737 . . . . 75.24 112.101 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.5 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 67.7 m -68.74 -46.79 33.81 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.919 -0.563 . . . . 72.52 110.032 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 58.1 Cg_exo -57.4 -34.31 97.73 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 121.884 1.723 . . . . 74.33 113.281 166.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.25 -35.87 82.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 123.412 0.685 . . . . 75.23 111.112 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.458 HG12 ' O ' ' C' ' 101' ' ' TYR . 23.2 mm -62.99 -43.0 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.629 -0.714 . . . . 72.5 109.777 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.491 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.8 mt -81.49 -21.56 38.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.672 -1.149 . . . . 72.12 112.582 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.75 -48.53 92.79 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-O 117.695 -1.145 . . . . 72.34 113.557 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 -33.91 97.83 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.704 1.603 . . . . 75.43 112.484 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -64.17 -52.78 57.33 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.775 . . . . 75.42 110.872 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -66.09 -38.77 89.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.482 . . . . 72.53 111.218 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -54.68 -47.29 73.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.222 1.409 . . . . 72.25 111.126 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -77.57 -36.23 52.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 75.1 110.285 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 41.6 t -67.02 -37.55 84.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.621 0.768 . . . . 70.14 112.046 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.643 HG22 HD22 ' C' ' 126' ' ' LEU . 74.7 mt -71.63 -47.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.225 -0.657 . . . . 74.25 109.225 175.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.6 m -54.82 -33.61 61.81 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 124.036 0.835 . . . . 63.12 111.355 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -61.64 -57.03 13.63 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.46 -0.791 . . . . 74.22 109.972 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.542 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.97 -43.2 63.44 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.817 1.247 . . . . 74.22 112.999 177.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.56 -47.38 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.508 1.123 . . . . 65.52 110.701 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -31.96 73.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.885 -1.052 . . . . 75.34 111.037 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.3 mtt-85 -66.95 -34.48 77.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.401 0.68 . . . . 74.13 110.441 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.23 81.65 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 72.32 113.262 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 15.9 p 67.96 29.51 6.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.789 2.036 . . . . 71.32 112.819 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.87 153.23 37.85 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.123 0.969 . . . . 72.44 109.844 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.52 173.97 1.81 Allowed 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.872 3.048 . . . . 73.44 114.803 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 38.4 mm-40 -59.31 122.95 15.18 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 115.892 -0.594 . . . . 75.43 111.17 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.742 HD13 ' HB ' ' C' ' 40' ' ' VAL . 51.5 tp -107.06 17.21 23.3 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.4 -1.273 . . . . 71.35 109.198 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -87.37 84.02 7.25 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.111 -1.811 . . . . 74.54 106.111 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.42 153.47 21.42 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 113.437 -1.711 . . . . 74.14 108.91 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.83 133.26 14.46 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.253 1.021 . . . . 72.31 112.726 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.796 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 54.1 Cg_exo -43.46 129.47 6.61 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 124.525 3.483 . . . . 64.34 114.304 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.06 81.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.882 -0.785 . . . . 64.41 108.882 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.48 HD22 ' HB2' ' C' ' 130' ' ' PRO . 46.0 m-80 -83.47 98.38 9.5 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.705 -0.68 . . . . 72.2 109.321 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.06 -38.97 75.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.182 -0.917 . . . . 74.53 110.872 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.11 -27.83 69.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.395 0.678 . . . . 72.31 111.459 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.46 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.5 -41.97 83.61 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.009 0.524 . . . . 73.54 110.623 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.14 -38.84 80.64 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.535 0.522 . . . . 73.32 111.395 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.22 -43.55 98.58 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.244 0.617 . . . . 73.1 111.068 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.505 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 62.8 mtt -75.49 -30.51 59.9 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.715 0.806 . . . . 75.01 111.26 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -70.59 -36.95 73.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.534 1.134 . . . . 74.35 110.65 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -69.29 -82.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.893 1.277 . . . . 75.54 110.778 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 154' ' ' ASP . 2.2 pp -85.87 172.22 10.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.147 0.579 . . . . 75.33 112.214 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 64.57 -97.01 0.05 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.329 1.451 . . . . 75.02 111.868 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -177.98 148.66 0.53 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.48 0.712 . . . . 75.52 110.3 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -137.39 98.1 3.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.474 1.11 . . . . 72.53 108.328 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.6 147.2 25.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.371 0.668 . . . . 73.21 110.787 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.16 177.78 50.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.793 -0.639 . . . . 61.2 111.906 172.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.66 -36.7 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.844 0.457 . . . . 74.22 111.285 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.73 165.4 49.57 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.87 0.15 . . . . 75.32 113.234 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 94.5 m -147.19 114.17 6.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.708 0.803 . . . . 75.24 109.487 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.55 125.74 4.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.587 0.755 . . . . 74.43 110.111 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 121.45 20.31 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.109 -0.7 . . . . 75.14 109.109 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -162.36 132.21 4.56 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.073 -1.084 . . . . 73.5 108.073 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -122.55 178.4 5.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.158 0.983 . . . . 73.4 109.31 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -160.36 -164.86 1.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.311 -0.996 . . . . 75.41 108.311 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.767 -0.635 . . . . 75.45 109.794 175.777 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.79 0.328 . . . . 72.4 110.461 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.1 m -147.84 102.63 3.43 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.97 0.908 . . . . 74.13 108.97 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.98 147.47 35.23 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.819 0.848 . . . . 75.12 108.946 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 177.63 2.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.757 0.423 . . . . 73.51 110.942 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -151.18 -179.47 7.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.222 -1.029 . . . . 73.35 108.222 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -65.21 88.04 0.07 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.864 -0.421 . . . . 75.4 109.864 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.465 HG22 ' H ' ' B' ' 152' ' ' HIS . 17.5 p 45.68 -139.7 0.44 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.694 1.598 . . . . 74.22 113.324 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.85 171.92 9.77 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.819 0.736 . . . . 70.04 112.246 -166.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.2 tpt -29.15 125.72 0.12 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.839 2.056 . . . . 74.33 114.299 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.5 m -141.22 143.75 34.34 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.348 0.659 . . . . 73.13 111.022 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -145.03 103.38 3.87 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.527 -1.286 . . . . 72.43 107.527 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.99 139.88 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.681 1.192 . . . . 65.11 108.989 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 tt -105.28 135.23 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 74.13 109.871 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.74 -46.64 4.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -158.27 146.72 18.77 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.214 0.206 . . . . 73.31 110.475 -171.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.604 HD11 ' HG3' ' B' ' 130' ' ' PRO . 1.0 OUTLIER -140.01 134.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.634 -1.247 . . . . 73.43 107.634 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -159.97 156.74 27.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.515 0.726 . . . . 73.45 110.677 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 55.7 p -85.14 110.07 18.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.483 -0.932 . . . . 71.45 108.483 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -75.93 -26.6 57.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.127 0.489 . . . . 75.04 110.171 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -155.08 133.82 12.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.699 -1.137 . . . . 74.04 109.011 -177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.542 HG23 ' HE1' ' C' ' 117' ' ' MET . 92.9 mt -132.68 132.2 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.785 -1.561 . . . . 73.54 106.785 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -137.94 138.22 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.166 -0.679 . . . . 72.14 109.166 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -145.15 109.94 5.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.403 -2.073 . . . . 73.3 105.403 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.07 113.93 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.928 -0.767 . . . . 74.03 108.928 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.9 83.71 3.02 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.66 -23.61 22.72 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.377 2.051 . . . . 75.34 112.011 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -106.65 20.07 19.56 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 124.415 1.086 . . . . 74.03 110.256 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.5 -63.93 0.98 Allowed Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.963 1.468 . . . . 63.42 114.963 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' C' ' 83' ' ' ILE . 91.9 Cg_endo -79.19 -17.8 11.54 Favored 'Trans proline' 0 C--N 1.387 2.572 0 CA-C-N 122.221 1.829 . . . . 61.43 113.331 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.79 -52.33 51.7 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.29 1.036 . . . . 73.23 110.319 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -84.15 -1.02 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 124.234 1.014 . . . . 74.23 110.463 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.484 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.8 t80 -54.57 -35.55 63.41 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.117 1.367 . . . . 72.15 111.161 165.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -70.9 -11.8 61.17 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.947 -1.024 . . . . 72.4 111.944 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.59 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 9.6 ttmt -106.78 114.05 27.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.364 0.665 . . . . 72.24 110.715 -173.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -101.56 56.58 0.83 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.147 1.379 . . . . 73.21 112.875 -167.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -125.82 173.97 8.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.609 0.764 . . . . 72.42 109.221 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.624 ' HG2' ' HA3' ' H' ' 191' ' ' GLY . 55.3 tp60 -88.07 124.06 67.55 Favored Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 121.59 -0.694 . . . . 51.55 109.322 172.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.46 110.58 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.772 2.314 . . . . 73.21 112.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -68.82 113.02 5.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.193 0.997 . . . . 75.54 109.098 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.619 HG11 HG13 ' D' ' 64' ' ' VAL . 73.9 t -99.27 124.29 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.813 0.845 . . . . 75.41 110.763 -169.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -96.34 108.56 21.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.499 -1.667 . . . . 74.34 106.499 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.24 113.62 25.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.328 -0.99 . . . . 73.13 108.328 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.572 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.3 t70 -109.17 132.44 54.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.74 -0.837 . . . . 75.12 108.74 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.46 131.88 54.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.776 -1.194 . . . . 65.42 107.776 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.3 t70 -145.09 154.26 42.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.943 0.897 . . . . 62.31 108.786 173.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -126.66 164.6 20.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.225 0.61 . . . . 73.22 110.312 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.652 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -155.21 164.02 39.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 75.41 109.45 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 m -154.46 160.39 41.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.041 0.536 . . . . 63.44 110.928 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -157.1 120.02 4.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.161 0.984 . . . . 74.33 109.373 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -79.53 117.61 20.63 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.359 -0.608 . . . . 74.33 109.359 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.529 HD13 HG22 ' D' ' 83' ' ' ILE . 32.9 mt -99.81 -34.39 10.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.744 0.418 . . . . 73.54 110.85 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.6 -171.83 3.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.132 0.973 . . . . 75.33 109.773 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.04 118.48 11.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.754 0.821 . . . . 72.52 110.479 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.628 ' HA ' ' HE3' ' H' ' 174' ' ' MET . 7.1 m-20 61.95 13.32 5.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.86 1.264 . . . . 72.22 112.669 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.45 122.64 66.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.032 -1.099 . . . . 74.11 108.032 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.506 ' HH ' HD13 ' D' ' 86' ' ' ILE . 27.5 p90 -151.71 145.88 25.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.517 0.675 . . . . 74.42 110.556 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.2 tt0 -86.67 125.27 33.75 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.887 -1.506 . . . . 71.32 108.744 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.05 137.78 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.623 -1.251 . . . . 73.23 107.623 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.652 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 41.6 t -115.19 145.29 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.366 1.066 . . . . 74.42 109.144 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.02 122.33 43.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.116 -1.068 . . . . 73.03 108.116 173.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.5 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 36.2 ttm-85 -96.07 100.38 12.05 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.46 -0.941 . . . . 74.31 108.46 172.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.51 107.11 18.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.246 -1.02 . . . . 71.31 108.246 171.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -98.65 131.86 44.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.049 0.452 . . . . 70.5 109.884 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.619 HG13 HG11 ' D' ' 40' ' ' VAL . 54.2 t -127.22 101.42 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.857 1.263 . . . . 73.43 108.104 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.7 m -101.92 94.38 5.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.286 -1.375 . . . . 74.32 107.286 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.02 143.62 27.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.734 -0.469 . . . . 65.42 109.734 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 38.4 p -146.76 133.3 19.77 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 121.199 0.523 . . . . 74.4 111.041 -173.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.403 ' HG ' ' HB3' ' D' ' 73' ' ' ALA . 55.4 mt -100.2 102.23 13.46 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.522 -1.288 . . . . 73.11 107.522 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -130.56 11.65 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.713 -0.676 . . . . 75.33 112.32 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.13 6.52 48.32 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.628 0.771 . . . . 75.54 111.403 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.59 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 8.9 tp10 -121.73 148.16 44.98 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.052 0.941 . . . . 72.44 109.56 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 76.3 m -65.82 131.38 46.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.363 0.665 . . . . 74.45 110.702 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -86.41 -59.55 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.483 -0.932 . . . . 62.41 108.483 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -160.7 150.39 17.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 113.925 -1.489 . . . . 74.13 109.558 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.33 146.65 29.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.781 -1.192 . . . . 74.15 107.781 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.588 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.1 t -158.73 137.94 11.48 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.704 -0.48 . . . . 65.15 109.704 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -156.88 129.36 7.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.664 -0.495 . . . . 61.33 109.664 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.12 116.1 43.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.672 0.789 . . . . 74.23 109.391 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.4 mt-30 -89.98 90.21 8.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.453 -0.794 . . . . 73.32 108.933 173.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.403 ' O ' HD11 ' D' ' 106' ' ' LEU . 8.2 tp-100 -80.28 104.37 10.79 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 114.769 -1.105 . . . . 74.54 109.089 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.91 145.03 16.88 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.634 -0.586 . . . . 75.3 111.634 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.1 139.1 7.68 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 110.661 -0.975 . . . . 71.0 110.661 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.529 HG22 HD13 ' D' ' 51' ' ' LEU . 52.9 mt -88.23 130.77 37.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.709 0.804 . . . . 75.32 109.159 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.15 125.19 34.43 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.72 0.408 . . . . 71.35 110.331 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 24.4 m -84.88 93.23 8.47 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.171 -1.048 . . . . 74.44 108.171 165.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.563 HD11 HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -129.32 134.72 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.521 0.728 . . . . 73.22 109.641 -171.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.415 ' HB2' ' HG3' ' B' ' 147' ' ' GLU . . . -163.66 159.55 21.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.502 1.121 . . . . 74.4 109.841 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.62 -19.53 14.26 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.091 0.797 . . . . 52.4 115.091 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.608 HD11 ' HA ' ' D' ' 94' ' ' MET . 2.2 pp -108.96 161.78 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.397 0.679 . . . . 72.44 111.014 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 2.6 pt-20 -158.03 -175.44 5.35 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.5 0.72 . . . . 74.3 110.851 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -132.05 47.54 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 123.653 0.644 . . . . 74.2 114.014 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -66.35 -28.73 68.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.764 0.826 . . . . 74.22 111.254 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -68.8 -33.31 73.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.464 0.706 . . . . 75.11 111.094 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.608 ' HA ' HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -70.34 -47.51 60.71 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.567 -0.531 . . . . 72.33 109.567 177.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.85 72.94 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.46 -0.791 . . . . 71.13 111.151 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -72.26 -37.81 68.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.063 0.945 . . . . 71.51 111.11 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -72.17 -51.41 21.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.036 0.535 . . . . 74.34 111.394 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 tt -72.9 -36.36 67.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.019 0.528 . . . . 74.43 110.168 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.23 -23.85 62.46 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 114.304 0.481 . . . . 74.2 114.304 -174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.53 -56.34 1.01 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.502 0.651 . . . . 74.1 112.274 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -67.46 -46.46 72.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.307 0.854 . . . . 73.33 113.307 -166.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.7 -44.67 43.73 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.972 -0.537 . . . . 74.31 111.229 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.603 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 85.5 Cg_exo -53.68 -35.78 79.17 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 122.953 2.435 . . . . 55.01 114.119 165.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -61.85 -31.93 72.23 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.399 0.68 . . . . 73.44 112.097 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -72.51 -40.08 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.671 . . . . 74.4 110.351 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.403 HD11 ' O ' ' D' ' 80' ' ' GLN . 83.8 mt -75.25 -24.93 57.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.882 -1.054 . . . . 64.22 111.252 -175.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -61.69 -42.46 83.6 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.876 1.436 . . . . 75.04 114.876 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.15 -46.87 28.63 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.267 1.978 . . . . 64.41 113.752 171.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.0 -37.21 69.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.511 -0.768 . . . . 72.25 111.226 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.78 79.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.744 0.818 . . . . 73.22 110.6 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -57.08 -50.67 72.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 75.43 110.956 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -67.91 -39.62 83.54 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.039 0.837 . . . . 73.23 111.39 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.403 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.0 t -57.64 -40.99 80.5 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.732 0.645 . . . . 75.44 110.486 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.588 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -68.45 -52.15 39.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.86 -1.064 . . . . 72.32 110.388 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -50.82 -43.46 58.96 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.123 . . . . 74.24 111.673 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -67.45 -45.86 74.76 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.676 -1.147 . . . . 62.14 110.33 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.47 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 78.0 mtm -64.06 -34.04 77.12 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.005 0.522 . . . . 75.41 111.947 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.455 HG22 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.57 -46.23 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.666 0.786 . . . . 74.15 110.252 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.7 p -70.74 -29.13 65.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.68 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -70.05 -32.69 70.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.6 0.76 . . . . 63.44 109.622 172.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 11.1 60.95 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.617 0.573 . . . . 74.42 113.069 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 41.4 p 60.27 20.5 9.95 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.402 1.881 . . . . 75.05 114.057 177.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -93.97 159.05 35.22 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 107.758 -1.201 . . . . 75.4 107.758 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.502 ' HD3' ' CE1' ' H' ' 195' ' ' PHE . 72.4 Cg_endo -70.91 154.1 63.33 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.994 1.796 . . . . 64.15 111.672 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -50.97 120.14 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.872 0.869 . . . . 72.52 111.438 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.506 HD21 HG23 ' D' ' 40' ' ' VAL . 2.4 tm? -109.57 91.78 3.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.446 -1.316 . . . . 72.34 107.446 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -108.85 106.2 16.09 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.077 -0.965 . . . . 72.45 109.62 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.654 ' HB3' HD11 ' H' ' 187' ' ' ILE . 62.5 mt -65.76 134.68 53.67 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.796 -1.093 . . . . 74.11 110.911 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.68 130.98 85.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.782 0.833 . . . . 75.3 111.611 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.85 95.93 0.98 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.497 2.131 . . . . 75.52 110.548 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.538 HG23 HG23 ' G' ' 207' ' ' VAL . 7.6 p -129.66 139.94 50.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.174 -0.921 . . . . 72.42 110.447 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -69.64 116.12 9.67 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.912 -1.144 . . . . 74.52 107.912 166.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -53.17 -33.11 51.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.063 0.945 . . . . 74.45 112.542 -177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -67.82 -24.08 65.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.575 1.15 . . . . 74.31 112.277 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.98 70.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.037 0.535 . . . . 61.42 111.523 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.89 -40.53 72.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.29 0.636 . . . . 71.23 110.434 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.589 ' HB2' ' HE1' ' H' ' 184' ' ' TRP . 63.2 t80 -59.01 -33.16 70.4 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.195 0.998 . . . . 74.32 111.198 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.1 mmt -54.64 -52.87 60.93 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.325 0.65 . . . . 74.11 109.87 175.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -65.97 -50.09 65.57 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 113.968 -1.469 . . . . 74.11 110.924 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -51.6 -34.76 38.7 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.763 1.225 . . . . 74.15 113.848 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.96 -47.74 17.87 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.061 0.545 . . . . 72.2 110.739 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.09 13.94 4.65 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.215 0.606 . . . . 72.13 112.503 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -118.92 90.18 3.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.305 0.642 . . . . 73.45 109.272 -171.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -143.51 -19.18 0.61 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.418 1.087 . . . . 74.24 110.195 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.91 142.18 28.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.921 0.888 . . . . 61.3 110.439 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.4 44.56 1.16 Allowed Glycine 0 N--CA 1.471 0.978 0 N-CA-C 111.269 -0.732 . . . . 72.32 111.269 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.5 86.43 6.34 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.036 0.934 . . . . 71.42 110.748 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.33 38.8 0.24 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.021 -0.991 . . . . 41.11 110.998 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.3 t -81.57 85.2 6.57 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.917 0.887 . . . . 74.13 110.83 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -173.64 141.32 0.84 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.497 1.119 . . . . 64.34 109.824 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -163.21 -96.55 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.585 -1.265 . . . . 73.25 107.585 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -159.3 132.42 7.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.543 1.537 . . . . 74.44 107.012 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -137.21 82.37 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.992 -1.114 . . . . 71.24 107.992 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -134.98 101.99 5.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.814 0.846 . . . . 72.05 109.012 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 C-N-CA 124.137 0.975 . . . . 72.1 108.686 177.31 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.2 -0.296 . . . . 75.02 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -92.34 -122.61 3.06 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.407 -0.677 . . . . 52.32 111.407 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -131.86 142.84 49.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.207 1.003 . . . . 72.14 108.871 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 72.3 m -154.92 114.28 3.68 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.963 1.305 . . . . 72.51 107.763 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 65.15 -170.07 0.2 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.247 1.019 . . . . 75.03 110.904 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 66.55 -76.11 0.05 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.079 1.351 . . . . 64.24 109.53 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.597 ' HE1' ' HA ' ' C' ' 54' ' ' ASP . 30.8 mmt -86.61 69.91 10.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.378 0.671 . . . . 73.44 110.093 173.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 53.75 -90.73 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.496 1.518 . . . . 73.51 112.784 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 54.75 58.18 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.229 1.014 . . . . 65.32 110.398 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.19 70.19 7.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.206 -0.906 . . . . 71.12 108.973 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.79 -61.18 2.09 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.384 -0.969 . . . . 64.55 108.384 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.26 154.5 54.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.913 0.885 . . . . 74.23 110.24 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.92 173.98 11.2 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.679 2.253 . . . . 75.52 112.605 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -112.83 162.31 15.94 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.081 0.952 . . . . 70.24 109.562 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.02 122.71 12.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.22 1.008 . . . . 72.44 108.789 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 32.7 m -73.66 124.45 26.0 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.17 0.588 . . . . 73.12 111.403 -171.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -75.66 155.98 85.05 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.812 0.845 . . . . 74.33 111.528 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.69 169.24 22.7 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.654 2.236 . . . . 62.45 112.26 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -129.23 118.98 23.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.066 -1.087 . . . . 74.44 108.066 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.17 139.28 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.912 -1.144 . . . . 74.43 107.912 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.38 31.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.807 0.843 . . . . 73.13 109.151 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -107.99 134.39 50.96 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.593 -0.521 . . . . 52.43 109.593 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.44 -169.17 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.124 0.97 . . . . 45.43 111.61 -174.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.39 -68.31 1.74 Allowed Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.912 -0.585 . . . . 71.45 113.041 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 55.7 -125.33 36.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 124.13 0.547 . . . . 62.51 112.52 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -145.83 -176.13 5.01 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.469 1.108 . . . . 74.43 108.672 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . 0.485 ' HB2' ' HE1' ' C' ' 36' ' ' TRP . . . -165.97 -63.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.578 0.751 . . . . 75.5 109.283 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -113.55 -175.05 2.59 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.083 0.953 . . . . 72.1 110.023 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -150.87 139.91 21.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.646 1.178 . . . . 74.02 108.935 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . 0.643 ' HA ' ' HA ' ' E' ' 201' ' ' LYS . 65.1 m-85 -128.11 -41.41 1.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.665 0.617 . . . . 75.21 112.665 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.54 -14.87 56.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.057 0.143 . . . . 63.14 111.211 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -146.26 113.0 6.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 72.9 49.5 16.92 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 123.545 0.528 . . . . 71.4 112.618 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' E' ' 197' ' ' TYR . 23.3 ttmm -49.29 -50.11 40.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.905 1.282 . . . . 73.22 112.97 -171.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . 0.5 ' HE2' ' HB1' ' B' ' 129' ' ' ALA . 60.1 t80 -173.99 -52.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.019 -0.992 . . . . 73.12 108.859 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . 0.452 ' HB3' ' HB3' ' F' ' 188' ' ' ALA . 18.3 t0 69.32 107.9 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.342 1.457 . . . . 74.11 112.571 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.55 HD11 ' HB ' ' E' ' 207' ' ' VAL . 17.1 pt -121.31 13.91 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.938 1.295 . . . . 74.0 109.945 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.27 -73.66 0.09 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.702 1.601 . . . . 73.41 110.382 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -168.45 101.49 0.42 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.712 -0.848 . . . . 65.1 108.712 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.55 ' HB ' HD11 ' E' ' 204' ' ' ILE . 57.5 t . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.934 . . . . 75.35 108.539 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 60.4 mttp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.223 -0.658 . . . . 75.31 109.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.03 100.48 0.35 Allowed Glycine 0 C--N 1.346 1.123 0 O-C-N 123.503 0.502 . . . . 72.2 112.863 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -80.46 74.37 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.475 -0.565 . . . . 74.52 109.475 172.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 80.1 p -167.01 -176.05 3.25 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.882 0.873 . . . . 73.11 109.791 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 162.59 21.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.157 0.583 . . . . 61.41 110.384 168.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -103.34 89.8 3.5 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.28 0.632 . . . . 71.51 109.3 -171.401 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.9 138.3 38.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.655 -0.869 . . . . 74.34 108.655 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.07 176.3 8.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.759 0.824 . . . . 74.13 111.719 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.8 108.0 11.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.89 -1.522 . . . . 73.34 106.89 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.69 115.89 9.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.907 0.483 . . . . 74.34 112.038 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -165.47 44.13 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.51 -1.292 . . . . 74.04 107.51 167.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.13 149.3 91.95 Favored Pre-proline 0 N--CA 1.483 1.178 0 CA-C-N 115.527 -0.761 . . . . 64.1 111.318 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.14 89.3 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.612 2.208 . . . . 72.21 111.633 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.6 150.66 26.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.794 0.837 . . . . 63.53 110.423 176.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -90.56 -173.83 3.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.777 0.831 . . . . 74.11 110.749 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 25.5 p -63.09 102.26 0.36 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.758 0.823 . . . . 71.41 112.114 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -69.05 -41.72 19.73 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.863 0.865 . . . . 74.22 112.168 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.49 81.84 0.73 Allowed 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 121.679 1.586 . . . . 70.42 111.967 170.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 2.4 pp -96.92 -26.59 15.0 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.122 0.969 . . . . 74.12 110.484 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.636 HD13 ' HA ' ' B' ' 128' ' ' LEU . 6.0 tt -60.71 130.79 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.694 1.197 . . . . 73.33 111.996 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' E' ' 203' ' ' ASP . . . -114.65 161.81 17.61 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.725 0.81 . . . . 71.44 109.552 169.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.02 100.28 2.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.586 0.754 . . . . 73.32 109.618 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.96 11.03 37.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.852 0.861 . . . . 64.25 109.993 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.81 143.91 42.64 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.609 -0.597 . . . . 72.44 111.609 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -165.84 55.99 0.25 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.219 -0.753 . . . . 62.35 111.219 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.6 -175.31 4.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 74.34 111.264 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' F' ' 201' ' ' LYS . . . 75.58 -66.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.818 1.647 . . . . 74.24 111.998 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.81 104.17 0.17 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.229 1.412 . . . . 74.45 111.935 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -154.78 105.21 2.57 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.68 1.192 . . . . 72.53 109.333 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . 0.574 ' HA ' ' HB2' ' F' ' 203' ' ' ASP . 53.8 m-85 -69.26 81.69 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.404 0.682 . . . . 71.42 110.803 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 176.78 -68.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.794 1.237 . . . . 74.2 107.956 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -153.04 95.7 1.99 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.568 -1.197 . . . . 75.34 108.587 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 178.14 -106.27 0.21 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.881 -0.599 . . . . 75.04 112.023 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' F' ' 194' ' ' ALA . 34.1 ttmt -163.52 163.64 24.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.83 -0.804 . . . . 73.44 108.83 -170.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.474 ' HE2' ' HB3' ' B' ' 124' ' ' PRO . 2.2 m-30 63.0 17.19 9.9 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 124.489 1.116 . . . . 73.42 110.853 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . 0.574 ' HB2' ' HA ' ' F' ' 197' ' ' TYR . 14.2 p-10 -124.39 171.63 9.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.591 0.756 . . . . 74.22 112.449 -163.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.422 ' H ' ' HD1' ' F' ' 197' ' ' TYR . 7.2 tp -94.7 135.66 28.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 114.704 -1.135 . . . . 73.31 108.264 167.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -118.28 -178.56 3.54 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.635 -0.876 . . . . 72.53 108.635 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 161.62 28.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.663 0.385 . . . . 75.45 110.25 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.507 0.723 . . . . 74.22 109.586 -176.402 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . 0.451 ' H2 ' ' HD3' ' G' ' 168' ' ' LYS . 2.7 mppt? . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.846 -0.428 . . . . 74.23 109.846 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -169.43 -146.19 4.95 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.057 -0.817 . . . . 75.3 111.057 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.77 20.69 11.61 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.942 0.897 . . . . 75.15 111.75 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 66.4 m -141.25 165.59 27.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.51 1.124 . . . . 71.32 109.288 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.36 45.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.832 0.453 . . . . 64.34 111.655 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 2.7 tt -177.0 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.114 -1.439 . . . . 73.55 107.114 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.471 ' HE2' ' HA ' ' A' ' 54' ' ' ASP . 30.2 mmt -76.1 174.98 9.37 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.069 -0.969 . . . . 71.42 110.85 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.56 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 17.5 t80 -56.74 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.008 0.923 . . . . 73.31 112.138 -167.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -90.24 0.87 57.0 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.948 -1.024 . . . . 71.24 110.64 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . 0.4 HD21 ' HA ' ' A' ' 95' ' ' ALA . 5.1 mp -87.79 165.54 15.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.372 -0.603 . . . . 74.43 109.372 172.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -138.84 -64.68 0.51 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.255 -1.387 . . . . 75.13 107.255 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -170.47 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.489 0 C-N-CA 123.945 0.898 . . . . 71.11 111.41 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -78.35 76.64 4.33 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.51 2.14 . . . . 75.44 111.732 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -138.02 123.07 19.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.539 1.136 . . . . 75.31 108.286 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 63.94 -172.9 0.17 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 124.493 1.12 . . . . 71.43 110.974 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 69.3 p -89.81 -32.2 17.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.067 -0.396 . . . . 75.14 111.074 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 54.88 80.31 0.3 Allowed Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.942 1.297 . . . . 70.52 110.95 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.76 167.26 24.95 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.244 1.963 . . . . 72.11 112.402 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -154.1 135.39 14.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.672 -0.862 . . . . 73.55 108.672 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -82.88 131.32 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.415 0.686 . . . . 75.43 110.968 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.24 86.37 3.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 73.13 110.097 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.39 130.86 48.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.93 0.892 . . . . 71.44 112.349 -173.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.3 174.69 7.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 73.41 113.278 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 39' ' ' GLU . . . -113.91 123.96 6.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 114.574 -1.194 . . . . 74.21 112.059 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.49 153.29 51.15 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.057 -0.417 . . . . 73.54 112.057 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -141.91 14.39 2.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.534 0.734 . . . . 72.0 109.818 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . 0.541 ' HB2' ' HB2' ' H' ' 196' ' ' LYS . . . -120.14 170.05 9.66 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.01 0.924 . . . . 71.32 110.365 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . 0.425 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 58.5 t80 66.99 21.39 10.3 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.658 1.183 . . . . 72.22 110.582 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.443 ' HA ' ' H ' ' A' ' 36' ' ' TRP . 9.7 mtmp? -64.05 128.0 33.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 73.23 110.711 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.19 83.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.134 0.974 . . . . 73.32 110.494 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.27 -6.73 4.3 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.938 0.895 . . . . 72.13 111.148 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -141.26 162.52 35.29 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.25 0.62 . . . . 73.45 109.828 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -64.42 125.64 31.77 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.782 0.676 . . . . 73.41 112.596 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -90.25 -60.73 1.85 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.589 0.355 . . . . 75.23 110.73 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . 0.488 ' HH ' ' HA ' ' D' ' 128' ' ' LEU . 45.6 t80 -109.68 -67.8 0.96 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.481 -0.933 . . . . 74.22 108.481 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 18.3 t70 58.63 106.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.412 1.485 . . . . 73.52 112.784 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.65 110.83 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.988 0.915 . . . . 71.52 109.547 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -81.5 97.43 7.79 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.473 -0.936 . . . . 75.22 108.473 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 63.48 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.669 1.188 . . . . 74.41 110.111 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . 0.538 HG23 HG23 ' D' ' 131' ' ' VAL . 1.1 p . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 125.426 1.49 . . . . 75.51 107.751 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 56.8 tptt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.14 -0.689 . . . . 73.14 109.14 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.17 178.6 19.55 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.521 0.513 . . . . 51.01 112.949 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -86.54 67.76 9.98 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 108.923 -0.769 . . . . 74.45 108.923 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 33.5 t -90.64 60.96 4.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.159 0.984 . . . . 64.3 110.164 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -174.37 -157.13 0.07 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.959 1.303 . . . . 63.03 109.004 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.435 ' H ' ' HG3' ' D' ' 94' ' ' MET . 49.0 mt 71.94 117.2 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.195 1.398 . . . . 73.33 111.407 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.628 ' HE3' ' HA ' ' D' ' 54' ' ' ASP . 0.0 OUTLIER 54.86 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.01 1.324 . . . . 71.53 111.661 170.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 74.0 110.38 0.07 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.897 1.679 . . . . 74.21 110.36 -172.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . 0.508 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 64.8 t30 -153.45 177.28 11.07 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.428 -1.323 . . . . 64.52 107.428 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 6.7 tt 77.9 87.06 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.478 1.111 . . . . 74.23 108.818 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.4 -48.15 2.52 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.282 -1.007 . . . . 73.44 108.282 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -95.24 -48.46 0.26 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.402 1.081 . . . . 74.31 112.449 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.05 159.18 34.01 Favored 'Trans proline' 0 C--N 1.393 2.887 0 CA-C-N 121.511 1.575 . . . . 73.52 112.349 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 63.26 178.05 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.905 1.282 . . . . 74.53 113.426 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -168.23 175.5 6.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.144 1.378 . . . . 74.32 108.54 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 76.8 p -81.57 122.98 28.26 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.075 -0.713 . . . . 74.55 109.075 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . 0.589 ' HE1' ' HB2' ' D' ' 137' ' ' PHE . 16.3 m-90 -83.57 118.33 71.19 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.789 0.835 . . . . 75.34 110.295 -171.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.72 102.24 1.0 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.672 2.248 . . . . 74.35 111.796 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -141.54 173.97 11.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.59 0.756 . . . . 74.53 111.372 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.654 HD11 ' HB3' ' D' ' 128' ' ' LEU . 76.2 mt 70.18 83.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 125.1 1.36 . . . . 73.54 110.46 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.11 92.47 9.16 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.874 -1.057 . . . . 75.4 108.921 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.37 41.03 0.91 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.697 1.199 . . . . 75.03 111.131 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.01 99.07 5.94 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.856 0.863 . . . . 74.21 109.576 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . 0.624 ' HA3' ' HG2' ' D' ' 37' ' ' GLN . . . -100.63 -169.97 28.93 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.251 -0.431 . . . . 71.24 112.05 175.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -120.53 -105.69 2.04 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.611 0.205 . . . . 72.44 113.278 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.86 -159.3 0.85 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.81 0.844 . . . . 60.45 111.163 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . 67.99 80.2 0.21 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 125.237 1.415 . . . . 52.55 111.073 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' D' ' 124' ' ' PRO . 40.1 t80 -162.22 33.74 0.12 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.884 0.849 . . . . 72.52 109.25 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . 0.541 ' HB2' ' HB2' ' G' ' 194' ' ' ALA . 0.2 OUTLIER -73.83 -0.58 16.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.493 0.553 . . . . 72.52 112.493 -173.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 61.34 -160.69 0.3 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 123.671 0.788 . . . . 75.11 111.284 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 113.34 3.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.009 -1.478 . . . . 75.44 107.009 170.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -72.85 117.93 15.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.32 -0.993 . . . . 74.44 108.32 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.0 110.17 2.28 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.644 1.215 . . . . 63.01 114.827 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -95.95 -72.57 0.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.006 -0.739 . . . . 74.52 109.006 174.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 60.6 20.06 9.96 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.303 1.041 . . . . 71.23 112.707 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 33.5 t70 67.05 66.86 0.42 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.458 1.103 . . . . 73.43 111.542 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.86 112.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.345 -0.983 . . . . 73.41 108.345 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -118.94 -38.98 2.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.4 0.28 . . . . 74.51 111.569 -166.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -137.55 -52.49 0.65 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.563 -0.903 . . . . 63.42 108.563 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.299 0 N-CA-C 108.095 -1.076 . . . . 71.13 108.095 172.072 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.887 -0.412 . . . . 74.32 109.887 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.6 p -112.26 110.57 20.88 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.803 -1.184 . . . . 70.04 107.803 171.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.601 ' HB3' ' HA3' ' C' ' 146' ' ' GLY . 42.5 mt-10 -76.04 82.9 2.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 62.25 110.335 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -92.76 166.77 12.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.759 -1.109 . . . . 71.31 110.049 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 64.09 66.98 0.62 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.258 1.023 . . . . 73.14 109.888 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -67.31 136.37 54.76 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-N 114.447 -1.251 . . . . 65.35 109.07 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -159.32 157.29 30.18 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.397 0.679 . . . . 73.44 109.562 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.03 146.04 51.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.904 0.881 . . . . 61.23 109.615 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.446 ' HE3' ' HB2' ' A' ' 11' ' ' PHE . 5.0 ppp? -137.9 166.74 23.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.55 0.74 . . . . 74.43 110.733 -173.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.1 m -141.37 132.5 26.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.643 0.777 . . . . 74.35 109.204 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.446 ' HB2' ' HE3' ' A' ' 9' ' ' MET . 55.0 t80 -120.5 136.63 54.71 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.116 0.966 . . . . 63.05 109.76 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.456 ' NE2' ' HB ' ' F' ' 207' ' ' VAL . 56.7 tp60 -147.69 136.83 22.27 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.375 0.422 . . . . 72.22 111.279 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.3 110.29 12.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.073 0.949 . . . . 74.52 108.44 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.86 -41.04 16.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.322 0.649 . . . . 74.2 109.275 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.513 ' HA ' HD12 ' F' ' 204' ' ' ILE . 12.2 ttt180 -161.32 141.08 10.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.014 0.526 . . . . 75.33 110.211 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -124.53 135.91 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.003 -1.11 . . . . 71.23 108.003 167.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' HE2' ' HB2' ' B' ' 28' ' ' ALA . 18.3 p90 -170.56 171.88 6.18 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.042 0.839 . . . . 73.41 110.645 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.401 HG23 ' HB3' ' B' ' 120' ' ' ARG . 71.1 p -94.54 124.19 38.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.896 -0.779 . . . . 62.33 108.896 170.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -82.63 -43.54 16.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.021 -0.733 . . . . 75.42 109.021 172.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.0 t70 -135.79 143.97 45.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.281 -1.327 . . . . 60.0 110.041 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.464 HG22 ' SD ' ' A' ' 117' ' ' MET . 83.3 mt -139.81 141.51 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 125.982 1.713 . . . . 74.53 106.624 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.35 123.24 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.48 -0.563 . . . . 73.14 109.48 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 85.0 t80 -121.74 126.52 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.823 -1.547 . . . . 74.13 106.823 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -123.56 126.57 46.91 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.896 -0.779 . . . . 74.14 108.896 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.03 70.98 14.77 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.236 1.014 . . . . 72.34 108.347 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.73 -26.31 27.85 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.053 1.835 . . . . 75.23 110.12 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' O ' HG23 ' A' ' 31' ' ' VAL . 81.9 m-20 -99.8 22.7 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.734 -1.121 . . . . 74.52 110.767 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.42 97.62 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.594 -0.717 . . . . 51.23 112.425 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.6 -21.38 22.21 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.898 1.732 . . . . 72.34 113.495 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.0 m170 -71.09 -36.51 72.25 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.867 0.467 . . . . 74.01 110.452 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 27' ' ' ASN . 73.4 t -56.34 -35.88 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.174 0.99 . . . . 71.44 112.87 -174.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.15 -35.17 80.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.322 0.649 . . . . 75.25 110.726 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -75.07 -37.9 61.48 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.126 0.97 . . . . 71.52 110.102 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -82.15 156.84 24.27 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.217 -0.901 . . . . 75.12 110.641 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -72.4 125.8 28.29 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.924 -0.769 . . . . 61.44 108.924 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -78.17 81.07 4.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.498 0.666 . . . . 74.21 110.949 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -118.09 84.34 21.59 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.822 -1.547 . . . . 64.14 106.822 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.63 115.3 4.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.255 1.97 . . . . 75.45 111.256 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -95.69 90.87 5.84 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.835 -1.542 . . . . 74.14 106.835 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' THR . 46.9 t -84.47 112.59 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.734 -1.121 . . . . 73.12 111.381 -168.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.463 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 12.6 mptt -80.08 146.07 32.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.06 0.944 . . . . 72.03 108.534 167.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.23 114.82 10.52 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.448 0.699 . . . . 74.51 109.539 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 26.0 m-20 -108.8 141.56 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.402 0.681 . . . . 75.33 109.384 173.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.3 tp -133.68 119.44 19.35 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.942 -1.132 . . . . 73.14 107.942 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -141.81 151.54 42.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.432 0.693 . . . . 72.52 110.018 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -131.35 150.13 52.27 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.894 0.877 . . . . 74.11 109.876 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' HB3' ' NH2' ' A' ' 61' ' ' ARG . . . -147.34 152.53 38.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.73 1.212 . . . . 54.52 108.466 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.65 ' HB2' HD12 ' A' ' 98' ' ' LEU . 8.5 t -133.29 160.47 37.21 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.138 0.426 . . . . 75.43 111.345 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -149.57 120.42 7.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.212 1.005 . . . . 62.3 108.82 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -74.07 104.13 4.78 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.784 -0.821 . . . . 75.23 108.784 175.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.75 -32.61 27.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.114 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.65 -175.69 5.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.932 0.893 . . . . 74.05 109.705 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.71 125.23 24.12 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.16 -0.681 . . . . 71.44 109.16 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 70.44 -8.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.622 1.569 . . . . 73.42 112.44 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.78 110.94 28.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.996 -0.742 . . . . 74.03 108.996 -174.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.28 124.47 40.4 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.362 1.065 . . . . 75.43 108.562 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.33 127.19 35.48 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.202 -1.036 . . . . 74.34 108.202 168.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.97 121.86 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.242 -1.022 . . . . 70.2 108.242 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.6 t -103.33 130.21 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.199 0.6 . . . . 75.22 109.555 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.438 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -101.38 117.81 35.71 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.213 1.005 . . . . 73.04 108.668 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.401 ' NH2' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -91.9 106.12 18.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.071 -0.714 . . . . 74.42 109.071 169.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.468 HG21 ' HB1' ' A' ' 110' ' ' ALA . 17.7 t -105.92 126.97 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.527 -1.286 . . . . 73.22 107.527 169.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -122.92 134.23 54.36 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.731 -0.47 . . . . 75.04 109.731 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.599 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.5 t -130.36 107.31 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.352 1.461 . . . . 72.32 107.791 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 36.3 m -113.2 122.27 46.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.369 -0.604 . . . . 74.01 109.369 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.5 117.96 35.65 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.682 -1.229 . . . . 74.5 107.682 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.7 m -117.76 126.77 53.05 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.827 0.451 . . . . 75.33 109.846 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.478 HD21 ' CE3' ' A' ' 36' ' ' TRP . 66.6 mt -89.37 70.3 8.11 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.529 -1.285 . . . . 75.41 107.529 176.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -85.29 0.95 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.42 -1.263 . . . . 74.45 110.733 -168.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.04 -25.17 5.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.94 0.896 . . . . 72.12 110.961 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.83 107.26 12.48 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.26 -0.645 . . . . 63.1 109.26 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -62.1 127.35 30.97 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.903 0.382 . . . . 73.13 110.16 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -53.52 6.51 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.125 0.97 . . . . 72.14 108.695 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.14 167.24 30.39 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 113.867 -1.515 . . . . 75.22 110.236 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -129.78 144.12 51.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.33 1.452 . . . . 73.1 107.861 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.599 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.4 m -134.19 138.18 44.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.872 0.869 . . . . 74.3 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.96 123.69 10.53 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.486 -0.931 . . . . 72.13 108.486 168.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.414 HG11 ' SG ' ' A' ' 113' ' ' CYS . 77.2 t -125.89 119.86 55.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.713 -0.847 . . . . 75.31 108.713 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 73.6 mt-30 -95.3 90.08 5.71 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.761 -1.109 . . . . 73.44 108.948 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.425 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.1 tp-100 -81.17 96.66 7.29 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.346 -1.297 . . . . 64.13 107.724 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.54 143.24 17.12 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.923 -0.871 . . . . 55.53 110.923 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.49 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.93 121.54 1.57 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.706 -0.958 . . . . 72.11 110.706 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.5 mt -82.91 129.11 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.102 -1.073 . . . . 73.53 108.102 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.409 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 43.4 m-85 -137.78 163.91 30.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.691 1.197 . . . . 74.21 109.208 -173.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 p -110.29 120.18 41.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.119 0.568 . . . . 74.22 109.65 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 119.6 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.865 0.866 . . . . 75.53 110.327 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.81 160.97 4.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.8 1.64 . . . . 65.32 108.711 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.33 11.83 40.73 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 112.633 -0.187 . . . . 62.12 112.633 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.677 HD12 ' HB3' ' G' ' 173' ' ' LEU . 0.1 OUTLIER -115.79 169.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.669 1.188 . . . . 71.2 110.655 -173.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -167.79 173.95 7.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.194 -0.669 . . . . 75.34 109.194 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.84 -130.97 49.5 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 116.627 -0.26 . . . . 75.32 113.198 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.7 p -79.15 -15.01 58.74 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.693 0.797 . . . . 74.22 112.308 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.35 -36.94 69.36 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.047 0.939 . . . . 75.51 111.082 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.569 ' HE1' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -77.77 -40.86 39.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.469 -0.787 . . . . 74.12 110.523 -177.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.47 67.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 72.31 111.319 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -75.19 -44.2 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.82 0.848 . . . . 74.24 110.563 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.475 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 49.0 t -74.6 -64.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.913 -0.585 . . . . 72.44 109.938 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 48' ' ' SER . 65.5 tp -64.52 -41.74 96.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.674 0.789 . . . . 75.01 112.713 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.12 -36.86 44.62 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.234 -0.439 . . . . 74.23 113.464 -173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.44 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -119.63 -54.38 2.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.43 0.53 . . . . 71.32 112.43 -170.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.433 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.4 t80 -74.27 -55.95 5.45 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.38 0.881 . . . . 73.14 113.38 -163.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.475 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 86.2 m -66.61 -38.18 18.3 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.589 0.959 . . . . 63.23 113.589 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.0 -26.24 43.68 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.627 1.551 . . . . 72.33 112.563 167.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.51 -26.61 61.84 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.765 0.426 . . . . 71.24 110.849 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -59.97 -42.3 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.873 0.844 . . . . 73.21 109.685 170.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.1 mt -78.56 -19.41 52.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.116 -1.402 . . . . 65.32 112.167 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.449 ' HZ ' HD11 ' A' ' 128' ' ' LEU . 34.0 t80 -64.6 -39.85 44.12 Favored Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.197 1.184 . . . . 73.02 114.197 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.58 -40.64 83.05 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.318 2.012 . . . . 63.43 113.282 170.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -75.58 -36.76 60.28 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.295 -0.866 . . . . 73.53 111.15 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.468 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.48 -48.34 75.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.519 0.728 . . . . 72.35 109.747 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -52.89 -50.79 63.16 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 124.706 1.254 . . . . 70.11 110.755 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -60.95 -46.72 89.57 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.536 1.148 . . . . 63.3 111.721 -175.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -59.04 -43.5 91.64 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.194 0.934 . . . . 71.22 110.752 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 64' ' ' VAL . 91.1 mt -63.31 -53.89 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 123.963 0.789 . . . . 74.52 110.293 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.497 HG22 ' HB2' ' A' ' 125' ' ' GLN . 61.6 m -51.59 -45.71 63.24 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.697 1.199 . . . . 71.53 111.188 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -66.96 -45.54 77.44 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.647 -1.16 . . . . 75.52 110.352 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.464 ' SD ' HG22 ' A' ' 21' ' ' ILE . 12.0 mtp -55.22 -44.7 75.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.762 0.825 . . . . 73.5 111.719 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -64.07 -46.95 92.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.207 1.003 . . . . 74.43 110.817 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.5 p -70.85 -28.59 64.7 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 115.802 -0.635 . . . . 73.03 110.784 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.8 mtt-85 -72.26 -33.57 67.59 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.022 0.929 . . . . 75.13 110.098 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.36 68.37 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.485 -0.779 . . . . 63.15 112.763 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m 69.28 40.34 1.52 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.774 1.229 . . . . 74.11 110.096 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.15 145.24 39.64 Favored Pre-proline 0 C--O 1.245 0.852 0 CA-C-N 115.356 -0.838 . . . . 70.41 109.208 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -51.99 114.39 1.6 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.025 2.484 . . . . 73.11 112.096 172.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.497 ' HB2' HG22 ' A' ' 115' ' ' THR . 19.1 pt20 -63.19 156.13 26.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.088 -0.96 . . . . 73.14 111.945 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.39 118.68 37.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.772 -1.104 . . . . 71.54 108.881 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 79.0 m-20 -98.72 84.51 3.14 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.315 -1.365 . . . . 73.3 107.315 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.449 HD11 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -69.35 141.14 54.28 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.262 -0.881 . . . . 75.23 109.453 -174.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.477 ' HB1' ' HB ' ' H' ' 204' ' ' ILE . . . -64.9 129.41 94.43 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 122.629 0.372 . . . . 73.13 111.569 -175.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.69 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 32.9 Cg_endo -85.66 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.559 2.173 . . . . 75.41 110.807 174.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.71 114.42 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.886 -1.052 . . . . 75.24 109.25 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -87.99 104.9 17.08 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.706 -1.22 . . . . 71.53 107.706 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -59.82 -31.66 69.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.533 1.145 . . . . 75.21 111.184 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.649 ' HA ' ' HE2' ' G' ' 182' ' ' PHE . 27.6 t70 -77.6 -53.45 7.57 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 115.461 -0.79 . . . . 71.23 111.105 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.81 92.49 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.031 0.832 . . . . 70.04 112.523 -169.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 53.0 tp -62.23 -41.14 98.13 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.07 0.462 . . . . 74.32 111.085 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.413 ' O ' HD11 ' A' ' 141' ' ' LEU . 40.5 t80 -80.57 -32.22 36.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.632 -0.713 . . . . 73.15 110.791 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.7 ttt -65.28 -40.41 93.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.093 0.957 . . . . 75.23 110.4 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.535 ' HB3' ' HB3' ' C' ' 8' ' ' GLU . 87.0 m-20 -63.13 -31.95 73.21 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.239 -0.891 . . . . 74.22 110.988 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.19 -40.49 71.17 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.841 -0.618 . . . . 74.31 110.89 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 137' ' ' PHE . 6.1 mp -61.17 -48.94 79.26 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.679 . . . . 74.41 111.599 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.495 ' HB3' ' NE2' ' A' ' 144' ' ' GLN . 23.6 tm0? -170.98 -18.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 123.729 0.643 . . . . 75.53 110.744 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.423 ' HG3' ' HG3' ' C' ' 8' ' ' GLU . 0.6 OUTLIER 58.89 94.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.974 0.91 . . . . 72.21 109.552 -171.508 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.495 ' NE2' ' HB3' ' A' ' 142' ' ' GLN . 24.7 mp0 -87.7 91.81 8.88 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.876 0.471 . . . . 72.04 109.809 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.28 136.9 48.16 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.212 -0.662 . . . . 74.32 109.212 172.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.29 90.07 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.52 -0.632 . . . . 72.25 111.52 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.11 152.29 35.89 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.282 -0.636 . . . . 75.22 109.282 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.64 37.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.875 -0.89 . . . . 74.13 110.875 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.1 t -112.33 149.68 32.08 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.292 0.637 . . . . 40.14 110.524 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 20.94 0.59 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.5 1.12 . . . . 71.34 108.766 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.09 110.14 17.76 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.744 0.783 . . . . 75.02 110.478 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -108.35 82.34 1.61 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.99 0.916 . . . . 64.33 108.915 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -100.29 137.11 39.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.274 0.559 . . . . 75.13 110.329 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -151.95 31.31 0.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.486 1.114 . . . . 62.22 108.917 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 CA-C-N 114.492 -1.231 . . . . 72.52 110.972 -177.759 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.677 ' H1 ' ' HB3' ' D' ' 144' ' ' GLN . 55.0 ttm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.317 -0.623 . . . . 71.45 109.317 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -77.49 80.2 3.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.221 0.609 . . . . 65.23 110.482 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -74.4 106.5 6.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.956 0.902 . . . . 75.4 110.18 -171.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.505 ' H ' ' NE2' ' D' ' 143' ' ' GLN . 61.9 mt-30 -122.84 87.83 2.82 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 107.201 -1.407 . . . . 73.5 107.201 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 70.15 156.03 0.14 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 124.474 1.109 . . . . 75.24 110.882 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.53 147.47 45.95 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.628 -0.508 . . . . 73.53 109.628 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -136.54 -34.54 0.76 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.88 1.272 . . . . 75.34 108.785 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.58 98.85 0.28 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 123.433 0.693 . . . . 73.04 109.769 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.533 ' HB3' HG22 ' B' ' 89' ' ' ILE . 13.6 ptm 49.49 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.898 2.079 . . . . 63.04 114.556 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -146.8 137.15 23.66 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.983 -1.117 . . . . 73.34 107.983 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -137.28 137.0 38.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.804 -0.813 . . . . 72.45 108.804 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -147.72 126.66 12.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.886 0.475 . . . . 74.41 109.975 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -91.47 139.87 17.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 108.918 -0.771 . . . . 73.44 108.918 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -110.79 -44.27 3.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.838 0.455 . . . . 72.13 110.516 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -172.44 139.95 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.506 0.322 . . . . 73.5 110.219 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.47 146.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.06 -1.089 . . . . 74.44 108.06 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -167.2 164.87 15.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.619 0.723 . . . . 74.4 111.583 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.2 m -90.04 120.01 30.87 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.286 -1.005 . . . . 74.03 108.286 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -90.43 -24.88 20.62 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.842 0.457 . . . . 75.22 111.301 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.0 t70 -158.62 144.65 16.88 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.94 0.4 . . . . 73.14 111.829 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.746 HD12 ' SG ' ' B' ' 113' ' ' CYS . 42.8 mm -132.96 141.22 45.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.117 1.367 . . . . 75.12 108.755 173.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 38.3 m -137.87 122.25 18.29 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.219 1.407 . . . . 71.21 108.388 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 65.8 t80 -134.97 110.02 8.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.083 -1.821 . . . . 75.53 106.083 165.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -125.66 111.23 14.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.977 -1.12 . . . . 75.12 107.977 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.432 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -108.06 89.37 5.52 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.012 0.925 . . . . 53.03 109.162 177.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.68 -26.67 19.25 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.416 2.077 . . . . 75.12 111.831 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -117.62 24.58 10.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.317 1.047 . . . . 74.4 109.313 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.494 ' HB2' ' HE2' ' A' ' 17' ' ' TYR . . . -44.04 -53.2 13.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 125.905 1.682 . . . . 72.22 114.498 173.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.0 Cg_exo -74.84 -18.23 19.32 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.541 2.161 . . . . 75.41 112.185 -177.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.89 2.53 54.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.706 -1.134 . . . . 73.15 111.811 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.04 -18.13 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.172 0.589 . . . . 72.5 110.503 168.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -73.51 -34.48 65.3 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.683 -0.488 . . . . 64.23 109.683 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.11 -45.56 26.51 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.423 0.63 . . . . 75.11 109.4 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.613 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 27.3 mmtp -94.57 68.91 3.48 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.858 1.263 . . . . 71.11 109.191 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.16 75.86 3.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.314 -1.312 . . . . 64.02 110.905 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -162.25 151.95 16.18 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.474 -1.306 . . . . 64.4 107.474 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.445 ' HB2' ' N ' ' F' ' 195' ' ' PHE . 22.7 tt0 -88.08 119.37 70.37 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.472 -0.566 . . . . 71.5 109.472 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -68.63 144.4 60.16 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.963 1.776 . . . . 74.22 111.817 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 109.03 2.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.075 -0.966 . . . . 74.11 108.71 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.511 HG21 ' HA2' ' F' ' 191' ' ' GLY . 1.1 t -84.79 123.07 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 108.983 -0.747 . . . . 73.41 108.983 -167.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -124.44 147.09 48.54 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.38 1.072 . . . . 75.2 109.659 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.531 ' H ' HD13 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -109.24 167.13 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.319 0.648 . . . . 75.4 111.605 179.028 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.477 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.9 t70 -153.51 139.98 18.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.892 1.277 . . . . 73.53 108.731 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.61 132.98 53.41 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.328 0.651 . . . . 74.33 109.36 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -146.81 151.63 37.42 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.551 1.141 . . . . 74.13 109.079 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.0 m -139.28 121.84 16.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.835 0.454 . . . . 64.42 110.02 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.91 160.42 19.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.64 1.176 . . . . 72.43 108.854 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -144.21 163.95 32.16 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.298 0.639 . . . . 74.44 110.601 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 7.3 p -159.97 137.3 9.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.094 0.958 . . . . 73.43 109.853 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -84.12 129.9 34.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.535 0.734 . . . . 73.42 110.402 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.53 -42.91 8.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.196 0.598 . . . . 74.2 109.479 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.41 -171.23 3.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.078 0.951 . . . . 71.35 110.04 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.55 112.93 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.859 -1.064 . . . . 65.11 110.252 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 69.49 -0.5 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.564 1.546 . . . . 74.45 112.979 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -104.83 104.7 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.377 -1.342 . . . . 74.43 107.377 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -124.09 149.77 45.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.395 0.678 . . . . 74.02 109.542 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.83 112.59 21.31 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.498 1.119 . . . . 71.41 108.665 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.85 118.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.429 -0.952 . . . . 73.3 108.429 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.49 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 50.5 t -102.42 109.33 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.394 -0.965 . . . . 72.45 108.394 175.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -93.75 117.06 29.6 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.576 -0.898 . . . . 74.14 108.576 -175.077 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.04 117.28 34.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.161 0.584 . . . . 73.42 110.128 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.431 HG11 HD12 ' B' ' 128' ' ' LEU . 11.8 t -116.19 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.989 -1.115 . . . . 72.32 107.989 169.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 6.7 m -115.31 150.45 36.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.52 0.728 . . . . 62.23 109.567 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.434 HG21 HD12 ' B' ' 114' ' ' ILE . 34.8 t -129.43 130.57 67.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.637 1.175 . . . . 71.53 109.139 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -126.12 140.81 52.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.181 0.992 . . . . 75.31 110.351 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.452 ' CB ' ' HE2' ' B' ' 74' ' ' PHE . . . -150.63 161.78 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.045 -0.724 . . . . 74.21 109.045 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.9 p -146.91 141.46 26.57 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.45 0.643 . . . . 74.32 112.022 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 34.5 mt -91.89 98.85 11.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.831 -1.174 . . . . 73.32 107.831 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.14 -107.73 2.3 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.44 -1.064 . . . . 71.43 110.44 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.0 8.63 10.45 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.82 0.848 . . . . 75.32 110.376 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -112.39 142.97 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.192 -0.67 . . . . 72.2 109.192 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -56.55 126.05 24.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.765 0.826 . . . . 73.14 110.742 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.26 -59.62 2.7 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 122.222 1.011 . . . . 65.23 109.065 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.452 ' HE2' ' CB ' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -154.53 178.66 9.83 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 113.006 -1.906 . . . . 73.41 107.08 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.72 136.81 29.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.931 -1.137 . . . . 72.13 107.931 164.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 50.6 t -131.83 147.56 52.49 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.589 -0.893 . . . . 71.34 108.589 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.437 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.0 tt0 -163.66 134.72 4.62 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.807 -0.812 . . . . 71.43 108.807 -173.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -125.21 146.7 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.325 1.05 . . . . 74.1 109.014 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.3 mt-30 -126.05 88.95 2.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.382 -0.969 . . . . 72.05 108.382 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.52 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.7 tp-100 -85.07 100.86 11.98 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.899 -1.046 . . . . 71.4 109.523 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.79 156.46 25.55 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.693 -0.563 . . . . 71.43 111.693 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.83 130.22 2.38 Favored Glycine 0 C--O 1.239 0.456 0 N-CA-C 111.568 -0.613 . . . . 60.21 111.568 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.61 127.26 40.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.609 0.764 . . . . 75.1 109.401 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -134.22 158.21 44.28 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.773 1.229 . . . . 75.01 108.665 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -132.51 121.95 24.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.407 -0.96 . . . . 63.32 108.407 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.61 HG13 ' SG ' ' B' ' 97' ' ' CYS . 0.2 OUTLIER -133.24 141.65 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.568 -0.901 . . . . 74.13 108.568 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.464 ' N ' HD11 ' B' ' 86' ' ' ILE . . . -158.94 174.88 14.29 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.078 0.951 . . . . 71.34 109.487 169.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.14 -54.98 0.53 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.27 0.462 . . . . 72.23 112.275 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.533 HG22 ' HB3' ' B' ' 9' ' ' MET . 2.1 pp -78.85 170.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.506 0.722 . . . . 72.05 112.589 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.7 162.87 40.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.559 0.744 . . . . 73.2 110.634 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.73 -129.38 24.61 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.473 -0.785 . . . . 45.53 113.771 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -67.61 -28.5 67.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.355 1.062 . . . . 62.14 111.167 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.68 -18.43 65.37 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.62 0.768 . . . . 74.13 112.09 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.4 tpt -68.97 -39.95 79.13 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.991 0.516 . . . . 71.22 110.156 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.47 -21.32 66.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.295 -0.866 . . . . 63.2 111.587 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -65.14 -40.83 94.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.411 0.685 . . . . 62.44 110.849 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.61 ' SG ' HG13 ' B' ' 86' ' ' ILE . 53.9 t -75.23 -69.91 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.852 -0.613 . . . . 74.31 111.128 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.509 HD12 ' H ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -88.79 -8.33 54.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 112.313 0.486 . . . . 73.45 112.313 -171.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.23 3.42 54.82 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.691 -0.505 . . . . 72.1 112.769 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.09 -67.9 0.18 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 117.142 0.471 . . . . 72.53 111.424 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -68.05 -50.85 52.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.819 0.674 . . . . 75.54 112.819 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.507 ' HA ' HD11 ' B' ' 105' ' ' ILE . 62.5 m -62.25 -43.4 85.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.921 0.888 . . . . 72.35 113.206 -173.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -39.4 49.23 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 121.476 1.451 . . . . 64.54 112.365 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -65.73 -18.33 65.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.761 0.652 . . . . 75.03 112.761 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.534 HG22 ' NH2' ' D' ' 111' ' ' ARG . 96.4 mt -69.83 -44.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.513 0.725 . . . . 75.14 109.988 170.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' B' ' 60' ' ' LEU . 30.9 mt -84.85 -18.19 35.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.754 -1.112 . . . . 72.11 111.437 -173.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.425 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 36.0 t80 -61.87 -40.95 73.86 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 124.736 1.214 . . . . 71.01 113.197 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.449 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 14.9 Cg_endo -56.71 -45.77 34.46 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.533 2.155 . . . . 64.42 113.479 169.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.52 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 85.1 m-85 -64.82 -42.71 94.76 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.073 0.549 . . . . 74.44 110.42 -177.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -39.99 89.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.651 0.78 . . . . 74.52 110.843 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.521 ' HA ' HD11 ' B' ' 128' ' ' LEU . 26.8 ttt180 -58.55 -52.91 63.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.402 1.081 . . . . 73.02 111.486 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -38.14 88.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.108 -0.951 . . . . 73.15 109.779 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.746 ' SG ' HD12 ' B' ' 21' ' ' ILE . 5.8 t -68.18 -36.84 80.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.477 -0.783 . . . . 74.12 111.474 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.434 HD12 HG21 ' B' ' 64' ' ' VAL . 53.5 mt -62.7 -60.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.364 1.215 0 N-CA-C 109.351 -0.611 . . . . 72.44 109.351 176.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.8 m -53.55 -38.04 63.46 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 124.724 1.265 . . . . 71.3 110.754 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.7 t -55.88 -54.23 47.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.133 0.973 . . . . 73.04 111.391 174.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.521 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 16.8 mmt -66.29 -37.2 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.902 0.481 . . . . 73.24 111.462 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.405 HG21 ' O ' ' B' ' 114' ' ' ILE . 91.1 t -63.74 -40.28 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.534 1.133 . . . . 74.51 110.577 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.4 m -65.32 -35.88 82.33 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.47 -1.241 . . . . 74.33 111.826 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 75.4 mtt-85 -65.22 -41.73 94.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.258 -0.883 . . . . 73.34 110.168 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.59 -1.48 82.87 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.875 0.734 . . . . 44.32 113.895 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p 60.0 49.84 7.25 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.74 1.616 . . . . 74.24 111.62 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -118.49 161.36 35.87 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 114.264 -1.335 . . . . 73.52 110.071 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.38 145.6 72.08 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.325 2.683 . . . . 74.44 114.89 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' C' ' 124' ' ' PRO . 3.9 pt20 -66.63 158.83 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.206 1.403 . . . . 74.42 113.803 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.11 104.27 7.46 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.671 -1.603 . . . . 73.42 106.671 162.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -90.05 93.1 9.25 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.371 -0.974 . . . . 65.51 108.371 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' B' ' 111' ' ' ARG . 40.0 mt -57.29 135.27 56.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.116 0.967 . . . . 73.01 113.478 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.2 117.51 58.24 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 114.621 -1.172 . . . . 71.14 108.625 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -65.67 151.1 85.54 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.399 2.733 . . . . 73.24 112.702 177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 114.67 -1.15 . . . . 71.21 108.117 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.34 65.75 9.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.669 -0.863 . . . . 64.4 108.669 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.81 -26.95 63.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.198 -0.91 . . . . 72.05 109.383 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.31 -39.8 88.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.489 1.116 . . . . 74.43 110.136 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.2 -44.0 48.81 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.975 0.91 . . . . 51.21 110.982 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.427 ' HB2' HG22 ' E' ' 207' ' ' VAL . 48.3 tp -61.51 -35.41 77.63 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.701 0.8 . . . . 74.31 111.082 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -61.23 -39.86 91.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.88 1.272 . . . . 74.2 110.792 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 50.0 mtt -61.88 -42.92 99.64 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.903 0.752 . . . . 74.13 109.985 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -75.97 -29.57 58.3 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.993 -1.003 . . . . 73.24 110.981 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -64.65 -36.34 83.96 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.731 0.645 . . . . 75.02 109.95 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -90.76 35.66 0.89 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.807 0.843 . . . . 74.14 111.091 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 62.33 42.25 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.641 1.176 . . . . 74.31 111.825 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 62.61 -157.84 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.423 1.089 . . . . 74.54 110.918 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.468 ' NE2' ' SD ' ' D' ' 138' ' ' MET . 11.1 pt20 -149.67 -163.63 1.83 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.428 0.691 . . . . 74.31 109.718 -176.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.569 ' HB1' HD11 ' D' ' 141' ' ' LEU . . . -67.46 -3.2 7.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.139 0.976 . . . . 61.44 113.487 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.443 ' HA2' ' HE2' ' D' ' 137' ' ' PHE . . . -73.65 62.09 1.97 Allowed Glycine 0 C--N 1.355 1.607 0 C-N-CA 123.273 0.463 . . . . 52.1 112.557 173.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.38 6.67 4.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.391 1.476 . . . . 73.31 109.495 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.31 71.8 2.92 Favored Glycine 0 C--N 1.358 1.79 0 N-CA-C 110.912 -0.875 . . . . 74.24 110.912 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.713 ' HA ' ' HB2' ' D' ' 93' ' ' GLN . 41.2 p -74.82 -64.87 0.95 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.749 0.82 . . . . 64.51 111.123 -172.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 55.23 88.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.395 1.078 . . . . 73.23 111.945 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -61.43 117.07 5.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.517 0.727 . . . . 72.43 110.38 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -165.74 99.89 0.68 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.223 -1.028 . . . . 73.42 108.223 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.57 HE22 ' HB3' ' H' ' 172' ' ' ALA . 42.5 mt-30 -121.17 -62.19 1.46 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.757 0.823 . . . . 73.34 109.217 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.7 -74.72 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.646 0.778 . . . . 75.24 110.473 -174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.965 0 C-N-CA 124.201 1.0 . . . . 53.24 108.742 -177.897 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.413 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.854 -0.795 . . . . 71.51 108.854 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.4 m -134.46 169.51 17.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.821 0.848 . . . . 74.55 110.386 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.63 96.06 2.96 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.53 -0.915 . . . . 74.55 108.53 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.96 113.27 22.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.157 0.583 . . . . 74.23 109.854 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -167.04 118.63 0.92 Allowed 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.729 -1.212 . . . . 74.34 107.729 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -160.09 133.92 7.18 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.899 -0.778 . . . . 75.35 108.899 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -84.58 -12.67 53.63 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 73.51 112.022 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.535 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 0.2 OUTLIER -86.2 112.7 21.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.742 -0.836 . . . . 73.41 108.742 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.4 ttp 63.03 115.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.385 1.474 . . . . 72.33 112.369 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -116.53 118.95 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.732 1.213 . . . . 75.12 108.19 170.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -120.83 137.31 54.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.054 0.542 . . . . 65.25 109.552 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.447 ' HG3' HG13 ' H' ' 204' ' ' ILE . 54.1 tt0 -148.6 124.16 10.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.707 0.803 . . . . 72.55 108.942 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 tp -78.57 133.57 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.037 -0.727 . . . . 74.11 109.037 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -103.17 -51.06 3.33 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.583 0.753 . . . . 73.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.512 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 57.4 ttt180 -165.1 123.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.231 -168.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -112.3 132.02 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.522 -0.918 . . . . 72.2 108.522 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.516 ' HB3' HG22 ' D' ' 122' ' ' THR . 22.1 p90 -173.19 148.03 1.63 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.126 0.891 . . . . 73.51 110.597 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -74.42 124.8 27.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 75.21 110.121 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -74.79 -48.94 22.69 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.288 1.042 . . . . 73.22 109.053 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 29.1 t70 -139.31 136.02 34.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.923 -1.49 . . . . 72.24 109.284 -167.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.8 mt -137.31 143.7 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 106.902 -1.518 . . . . 73.31 106.902 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -154.21 150.8 28.46 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.335 0.588 . . . . 71.43 109.79 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.424 ' HZ ' ' HD2' ' C' ' 123' ' ' PHE . 79.4 t80 -150.99 110.54 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.496 -1.298 . . . . 74.52 107.496 173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.07 124.85 50.26 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.597 0.759 . . . . 74.41 109.337 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.27 84.0 48.7 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 107.7 -1.222 . . . . 74.12 107.7 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.89 -25.71 38.67 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.471 2.114 . . . . 75.02 111.69 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.3 20.74 17.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.338 1.055 . . . . 74.45 110.412 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.86 -49.96 90.77 Favored Pre-proline 0 CA--C 1.569 1.711 0 N-CA-C 114.723 1.379 . . . . 73.41 114.723 -172.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 -30.89 10.87 Favored 'Trans proline' 0 C--N 1.387 2.569 0 CA-C-N 121.58 1.6 . . . . 75.14 112.723 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -68.83 -49.57 57.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.976 0.91 . . . . 74.24 111.423 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.441 HG22 HD13 ' C' ' 68' ' ' LEU . 14.3 p -59.51 -18.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.344 1.458 . . . . 71.33 112.932 -169.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.64 -33.56 71.68 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.172 0.989 . . . . 74.2 112.311 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.47 5.34 52.11 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.769 0.655 . . . . 75.23 112.769 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.726 ' HG2' HD11 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -87.6 163.88 16.37 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.562 -0.532 . . . . 75.44 109.562 176.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' C' ' 34' ' ' LYS . 27.1 t70 -64.61 107.07 1.3 Allowed 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.762 -1.199 . . . . 74.13 107.762 164.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -82.15 83.61 7.3 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.328 1.061 . . . . 72.41 110.348 -171.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.56 72.75 81.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 115.036 -0.983 . . . . 72.21 108.823 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.06 127.65 15.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.416 2.077 . . . . 74.5 111.153 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.06 76.72 9.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.377 -1.342 . . . . 74.01 107.377 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.19 85.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 123.055 1.407 . . . . 64.22 110.833 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 140.47 48.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.907 -1.497 . . . . 73.21 107.46 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.45 ' HB3' HG22 ' C' ' 64' ' ' VAL . 0.0 OUTLIER -128.48 155.94 44.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.159 0.583 . . . . 74.44 110.767 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.21 128.06 53.86 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.695 1.198 . . . . 63.5 108.118 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.554 ' HB3' ' HE1' ' E' ' 184' ' ' TRP . 7.5 tp -106.02 101.26 10.77 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.138 0.575 . . . . 73.54 109.507 -173.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.447 ' O ' HD22 ' C' ' 60' ' ' LEU . 10.3 t70 -113.91 139.03 49.54 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.62 1.168 . . . . 72.42 109.781 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.0 t -119.08 131.35 55.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.281 0.632 . . . . 74.24 109.631 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.39 151.72 32.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.357 1.063 . . . . 74.32 108.974 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -143.57 143.59 31.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.079 0.552 . . . . 72.33 110.404 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -153.21 156.46 38.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.569 1.148 . . . . 75.31 108.528 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.496 ' HB2' ' H ' ' E' ' 172' ' ' ALA . 63.5 tt0 -103.79 117.95 35.55 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.342 -0.614 . . . . 75.44 109.342 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' C' ' 57' ' ' GLU . 56.7 mt -86.52 -36.63 18.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.369 0.668 . . . . 73.23 110.093 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -160.75 -176.37 5.5 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.077 -0.965 . . . . 54.1 110.69 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.87 102.45 0.47 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.429 -1.26 . . . . 74.02 110.322 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 13.0 m-20 64.57 13.04 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.968 1.307 . . . . 73.41 113.581 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 98.9 t -106.03 107.74 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 107.973 -1.121 . . . . 74.11 107.973 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -114.89 146.05 41.53 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.48 -0.933 . . . . 72.0 108.48 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD12 ' C' ' 51' ' ' LEU . 32.6 tt0 -109.08 124.13 50.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.206 1.002 . . . . 74.03 108.557 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.8 HG23 ' HB2' ' C' ' 98' ' ' LEU . 92.8 t -119.38 124.55 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.189 -1.041 . . . . 73.14 108.189 172.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.9 115.43 47.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.581 1.152 . . . . 71.33 108.764 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.488 HD23 HG21 ' C' ' 62' ' ' VAL . 0.9 OUTLIER -86.27 105.25 16.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.356 -0.979 . . . . 74.32 108.356 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.12 106.45 16.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.242 0.617 . . . . 75.21 109.481 172.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.563 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.9 t -100.7 130.66 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.113 -1.069 . . . . 72.12 108.113 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -125.25 122.59 37.39 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.48 -0.563 . . . . 72.42 109.48 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.63 HG23 HG21 ' C' ' 114' ' ' ILE . 71.5 t -98.63 113.55 33.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.424 1.09 . . . . 71.02 109.302 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -99.34 134.46 42.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.401 -0.963 . . . . 71.44 108.401 171.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.16 124.53 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.676 0.79 . . . . 74.41 108.952 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.7 m -133.54 170.98 14.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.944 0.898 . . . . 75.04 110.136 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.726 HD11 ' HG2' ' C' ' 34' ' ' LYS . 27.8 mt -127.89 22.95 6.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.666 1.186 . . . . 74.01 108.551 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.24 -96.62 0.99 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.027 -1.229 . . . . 62.14 110.027 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -91.48 -30.94 16.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.44 110.744 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -85.69 121.99 29.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.145 0.978 . . . . 74.2 110.87 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -69.62 125.5 26.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.471 -0.566 . . . . 75.44 109.471 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -49.09 12.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.247 0.619 . . . . 72.33 109.782 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -171.27 177.09 3.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.976 0.91 . . . . 74.2 110.699 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -140.99 139.23 34.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.738 -1.579 . . . . 74.23 106.738 174.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.52 ' SG ' HG22 ' C' ' 114' ' ' ILE . 47.2 t -137.24 154.51 50.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.643 -0.873 . . . . 75.22 108.643 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.09 143.98 18.46 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.85 0.46 . . . . 74.03 109.831 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' C' ' 110' ' ' ALA . 19.6 t -142.99 114.28 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.857 1.263 . . . . 74.42 108.171 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 42.1 mt-30 -93.36 95.53 9.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.546 0.739 . . . . 74.33 109.308 169.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.489 ' NE2' ' HB3' ' C' ' 109' ' ' TYR . 8.4 tp-100 -83.17 104.61 13.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.779 -1.1 . . . . 63.53 109.829 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.73 146.63 22.41 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.4 0.437 . . . . 52.32 112.327 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.97 124.78 2.64 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.879 -0.888 . . . . 65.43 110.879 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.48 HG12 ' HE1' ' C' ' 17' ' ' TYR . 26.1 mm -93.72 118.04 38.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.3 -1.0 . . . . 72.13 108.3 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.46 118.55 28.61 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.526 -0.916 . . . . 72.23 108.526 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -95.75 102.84 14.68 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.183 -1.043 . . . . 74.43 108.183 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.7 pp -114.44 -177.76 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.744 0.818 . . . . 75.12 110.648 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 176.91 153.01 0.21 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.584 1.554 . . . . 65.0 108.657 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.32 -17.61 46.84 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 114.597 0.599 . . . . 73.34 114.597 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 pt -57.43 133.09 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.833 0.853 . . . . 74.42 111.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.585 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 8.8 pt-20 -145.0 -177.9 5.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.643 0.777 . . . . 73.53 109.356 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.59 -124.53 23.31 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 124.042 0.839 . . . . 73.43 113.779 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -83.55 -18.48 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.817 0.847 . . . . 72.12 112.255 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.404 HE22 ' HG3' ' C' ' 90' ' ' GLU . 0.5 OUTLIER -69.23 -40.43 77.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.004 0.522 . . . . 63.14 110.501 -172.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.585 ' HE2' ' HA ' ' C' ' 90' ' ' GLU . 11.3 ptp -63.57 -35.4 80.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.579 0.352 . . . . 71.2 111.422 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.546 ' HB3' ' HE1' ' E' ' 181' ' ' TYR . . . -76.22 -38.17 56.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.797 0.839 . . . . 74.44 111.245 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -77.96 -37.81 46.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.088 0.955 . . . . 71.32 111.23 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.53 -49.98 75.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.118 0.967 . . . . 73.13 111.277 -169.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.8 ' HB2' HG23 ' C' ' 58' ' ' VAL . 3.4 pp -108.88 -11.1 15.05 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.055 0.391 . . . . 63.1 112.055 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.17 -28.98 35.1 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.238 -0.201 . . . . 44.4 112.918 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.09 -45.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.009 0.524 . . . . 75.04 111.481 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.69 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 82.6 t80 -74.43 -47.24 34.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.743 0.817 . . . . 74.54 112.364 -172.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.542 ' HB2' ' HA ' ' C' ' 98' ' ' LEU . 97.7 m -65.78 -46.49 66.25 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 118.518 -0.753 . . . . 64.35 112.443 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.416 ' O ' HD13 ' C' ' 60' ' ' LEU . 37.8 Cg_endo -66.26 -23.1 52.49 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 121.135 1.441 . . . . 74.13 112.397 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.23 -31.72 70.48 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.349 0.522 . . . . 75.25 110.191 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.441 ' HB ' ' O ' ' C' ' 102' ' ' CYS . 26.8 mm -62.89 -44.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.63 0.772 . . . . 63.32 109.592 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 66.4 mt -82.4 -18.15 42.95 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.766 0.826 . . . . 74.22 112.454 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.12 -47.56 90.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.46 -1.257 . . . . 73.22 112.955 -174.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.75 -38.63 92.3 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.021 1.814 . . . . 61.21 112.304 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.489 ' HB3' ' NE2' ' C' ' 80' ' ' GLN . 87.9 m-85 -63.46 -50.78 68.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.962 0.905 . . . . 63.15 111.318 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -67.96 -37.5 81.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.763 -0.653 . . . . 65.13 110.952 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.78 -50.41 70.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 65.01 110.053 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.11 -38.22 75.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.86 0.864 . . . . 72.2 110.854 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.1 t -64.98 -34.02 77.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.177 0.591 . . . . 75.12 110.89 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.63 HG21 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -70.66 -50.8 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 115.772 -0.649 . . . . 74.42 109.661 173.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.4 m -58.3 -34.77 70.92 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.957 0.786 . . . . 75.42 111.403 -173.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.9 p -67.88 -51.66 45.52 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.776 -0.647 . . . . 73.01 109.382 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.538 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.1 -41.41 62.41 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.859 1.264 . . . . 63.23 112.664 179.013 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.1 t -72.05 -41.21 67.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.091 -0.959 . . . . 63.12 110.397 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.42 -29.89 70.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.396 0.679 . . . . 72.51 111.271 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 61.5 mtt-85 -67.66 -44.14 78.59 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.634 -0.876 . . . . 73.33 108.634 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.85 -1.94 85.3 Favored Glycine 0 C--N 1.36 1.911 0 O-C-N 124.139 0.9 . . . . 63.33 113.434 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.1 p 66.84 41.84 2.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.877 1.671 . . . . 75.22 112.317 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HD2' ' HZ ' ' C' ' 23' ' ' PHE . 65.8 m-85 -114.41 163.89 17.93 Favored Pre-proline 0 CA--C 1.565 1.531 0 C-N-CA 124.958 1.303 . . . . 65.03 109.961 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 96.0 Cg_exo -49.41 151.77 6.59 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 124.341 3.36 . . . . 74.42 116.228 -175.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -48.46 132.37 16.92 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.648 1.179 . . . . 75.24 112.011 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.47 23.52 13.86 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.536 -0.756 . . . . 72.13 111.521 177.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -90.71 79.5 6.04 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-O 123.788 1.756 . . . . 74.13 106.951 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.574 HD13 ' HB1' ' E' ' 189' ' ' ALA . 82.3 mt -90.12 151.67 21.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.648 -1.615 . . . . 75.4 110.185 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.49 ' HB2' HG13 ' F' ' 204' ' ' ILE . . . -35.54 113.19 0.5 Allowed Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 126.231 1.812 . . . . 74.31 114.319 -173.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.37 99.07 0.88 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.315 2.01 . . . . 71.21 111.816 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.35 97.96 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 115.214 -0.903 . . . . 74.21 110.524 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.51 68.11 10.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 71.41 109.821 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -51.05 -44.15 61.07 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.966 -1.47 . . . . 73.24 111.931 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.79 -35.26 76.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.253 1.021 . . . . 72.2 111.574 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.69 84.53 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.501 -0.772 . . . . 62.04 111.055 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.04 -48.21 82.83 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.869 -0.605 . . . . 73.54 110.234 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -68.77 -28.9 67.2 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.975 0.797 . . . . 73.25 111.449 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -50.6 35.07 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 123.854 0.721 . . . . 72.22 110.617 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -70.28 -30.9 68.04 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.677 0.391 . . . . 71.22 111.121 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.29 -149.68 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.29 1.436 . . . . 73.23 110.919 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 84.9 mt 64.84 95.47 0.05 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 123.974 0.909 . . . . 74.33 109.874 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -50.25 121.69 5.9 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.585 1.554 . . . . 75.53 111.381 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -140.17 165.84 26.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.817 0.847 . . . . 71.15 109.586 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -103.5 -23.33 13.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.733 0.813 . . . . 74.31 111.098 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.19 -159.76 0.31 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.389 1.076 . . . . 74.3 111.209 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.601 ' HA3' ' HB3' ' A' ' 3' ' ' GLU . . . 166.45 69.59 0.03 OUTLIER Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.136 -0.786 . . . . 73.1 111.136 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -158.48 142.39 15.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.984 0.514 . . . . 74.32 110.407 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 170.6 141.02 3.17 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.456 -0.793 . . . . 70.31 111.651 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 91.6 m -148.82 86.13 1.51 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.224 -1.028 . . . . 71.23 108.224 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -86.76 110.9 20.23 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.319 -0.993 . . . . 75.33 108.319 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.16 175.33 13.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.959 0.903 . . . . 64.12 110.084 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -169.54 168.78 9.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.414 1.086 . . . . 73.35 110.041 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -126.37 102.29 7.08 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.55 0.74 . . . . 72.53 110.144 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -173.69 156.35 2.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.789 1.236 . . . . 64.14 109.825 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.988 0.915 . . . . 63.23 108.876 -177.206 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.635 0.255 . . . . 73.4 110.769 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.8 p -115.18 5.76 14.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.651 0.78 . . . . 75.34 109.484 164.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.72 128.06 49.59 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.327 1.051 . . . . 74.41 109.0 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -77.29 133.12 38.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.771 0.828 . . . . 74.43 110.574 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -63.23 -35.05 79.04 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.142 0.977 . . . . 72.41 111.636 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 60.75 -89.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.382 1.473 . . . . 73.31 110.551 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -163.12 99.21 0.95 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.563 0.697 . . . . 73.14 109.588 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 57.88 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.381 1.472 . . . . 75.54 111.025 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.8 ttp -36.35 126.35 0.8 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.36 1.064 . . . . 74.44 111.945 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 31.7 m -128.05 138.91 52.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.055 . . . . 73.24 108.15 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.421 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 73.2 t80 -169.74 91.14 0.21 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.314 -1.365 . . . . 71.41 107.314 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -126.09 153.37 44.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.77 0.828 . . . . 63.0 109.501 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.462 HG22 HD12 ' E' ' 204' ' ' ILE . 10.4 tp -103.53 142.84 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.201 0.6 . . . . 74.33 109.559 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.2 -45.39 2.94 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.781 0.833 . . . . 72.11 110.633 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -154.58 129.45 9.41 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 120.429 0.157 . . . . 75.01 111.19 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.494 HD13 ' N ' ' D' ' 16' ' ' ILE . 0.6 OUTLIER -121.28 112.16 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 106.256 -1.757 . . . . 72.51 106.256 -177.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.417 ' HD1' ' N ' ' D' ' 17' ' ' TYR . 0.0 OUTLIER -159.66 142.07 13.6 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 123.703 0.627 . . . . 74.1 111.704 -164.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.7 p -79.86 115.05 19.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.716 -1.129 . . . . 72.22 109.32 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -89.31 -28.83 19.59 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.007 -0.542 . . . . 73.4 110.365 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.5 t70 -147.08 133.49 19.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.324 -0.853 . . . . 65.41 109.582 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.538 HG23 ' HE1' ' C' ' 117' ' ' MET . 88.4 mt -133.5 139.5 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.688 1.195 . . . . 74.22 108.089 173.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -146.45 118.69 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.908 0.883 . . . . 72.41 109.289 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.479 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.7 t80 -124.93 131.96 53.35 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.247 -1.39 . . . . 73.05 107.247 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -137.97 118.63 14.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 75.24 108.803 -173.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.96 89.87 26.02 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.722 -0.844 . . . . 70.22 108.722 175.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.87 -63.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.333 2.688 . . . . 70.25 113.134 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 10.2 m-80 -98.35 41.07 1.15 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.607 -1.257 . . . . 72.15 107.607 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' D' ' 31' ' ' VAL . . . -56.75 -53.0 69.37 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.154 1.168 . . . . 62.14 114.154 -168.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.471 ' HB3' HD11 ' C' ' 83' ' ' ILE . 55.5 Cg_endo -79.01 -8.45 15.47 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 122.394 1.891 . . . . 73.21 113.072 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.3 t-160 -74.27 -34.66 63.64 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 108.288 -1.004 . . . . 72.33 108.288 168.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.471 HG13 ' HE1' ' D' ' 123' ' ' PHE . 53.2 t -66.99 -26.63 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.512 1.125 . . . . 75.41 111.421 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.426 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.6 t80 -60.87 -34.53 74.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.032 0.444 . . . . 74.45 110.419 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' D' ' 30' ' ' HIS . 40.7 mt-30 -82.74 -33.2 27.54 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.462 -0.79 . . . . 74.13 110.289 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -91.94 90.86 7.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.737 0.815 . . . . 72.21 109.876 -173.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.85 59.27 3.62 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.39 1.076 . . . . 71.31 112.514 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -126.47 174.1 8.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.858 -0.793 . . . . 73.44 108.858 -177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.82 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 8.2 tp-100 -85.17 118.13 70.19 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 122.128 -0.358 . . . . 61.24 110.236 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.74 109.31 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.248 1.966 . . . . 74.45 110.633 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 52.2 mt-10 -62.51 111.85 2.22 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.953 0.783 . . . . 74.53 109.037 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.493 HG21 HD13 ' D' ' 126' ' ' LEU . 3.7 m -98.06 107.28 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.427 1.091 . . . . 63.35 109.267 -172.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -105.33 148.02 27.51 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.571 -0.74 . . . . 72.34 109.878 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -119.43 129.96 55.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.708 -0.678 . . . . 72.45 110.362 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 28.1 t70 -119.11 128.26 54.14 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.376 -0.972 . . . . 71.01 108.376 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -97.46 132.89 42.73 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.488 0.715 . . . . 73.34 110.03 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -146.96 156.3 42.95 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.939 -1.134 . . . . 64.45 107.939 169.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -144.57 164.39 31.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.218 0.533 . . . . 63.1 109.873 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 163.86 37.05 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.942 1.297 . . . . 70.12 108.277 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -167.13 153.47 8.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.903 0.382 . . . . 73.32 111.772 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.8 p -158.86 141.44 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.133 0.973 . . . . 71.31 109.716 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -81.75 124.06 29.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 74.42 110.856 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.7 mt -98.22 -35.71 10.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.589 0.756 . . . . 73.5 110.792 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -172.07 4.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.226 0.61 . . . . 74.21 111.085 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.53 112.56 4.18 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.288 1.035 . . . . 75.23 110.732 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.686 ' HA ' HD21 ' H' ' 173' ' ' LEU . 27.5 m-20 69.19 3.63 4.19 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.944 1.698 . . . . 71.12 112.847 -174.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.2 t -109.14 118.27 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.297 0.639 . . . . 65.15 110.438 -173.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.81 130.26 45.09 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.092 1.357 . . . . 74.22 108.354 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.447 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.7 tt0 -87.08 111.87 21.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.702 -1.221 . . . . 75.32 107.702 169.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -100.09 121.01 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.961 -1.496 . . . . 75.14 106.961 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.544 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 44.3 t -99.58 132.55 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.788 0.835 . . . . 75.12 109.231 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.4 OUTLIER -105.06 128.0 53.13 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.646 -1.242 . . . . 73.1 107.646 176.075 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 31.8 ttm-85 -107.49 99.99 9.45 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.572 0.749 . . . . 74.32 109.138 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.24 122.49 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.425 -0.954 . . . . 71.54 108.425 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.8 m -114.9 142.37 46.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.638 -0.71 . . . . 55.14 109.61 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.575 HG22 HG21 ' D' ' 114' ' ' ILE . 81.1 t -130.78 127.45 61.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.127 1.371 . . . . 71.21 108.637 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -123.7 94.76 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.086 -1.079 . . . . 73.54 108.086 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -98.06 127.37 43.96 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.661 -0.866 . . . . 72.22 108.661 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.428 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.4 m -140.63 139.52 34.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.392 0.615 . . . . 73.23 111.298 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.413 ' O ' ' HG2' ' D' ' 71' ' ' GLU . 36.1 mt -110.52 116.98 32.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.284 1.434 . . . . 75.15 109.228 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.68 -129.05 44.15 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 120.14 -0.256 . . . . 71.51 112.894 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.81 4.06 50.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.504 0.721 . . . . 75.01 112.126 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' D' ' 68' ' ' LEU . 11.8 pt-20 -124.15 154.48 39.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.129 0.572 . . . . 74.35 110.174 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 33.9 m -74.47 136.13 42.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.286 -0.635 . . . . 71.13 109.286 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.428 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.46 -57.43 3.15 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.829 -1.175 . . . . 74.34 107.829 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.413 ' CE1' HG21 ' D' ' 118' ' ' VAL . 49.0 p90 -161.3 149.3 15.44 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 114.696 -1.138 . . . . 73.35 110.202 169.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -100.75 150.63 22.58 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.505 -0.924 . . . . 75.03 108.505 166.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.663 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 42.4 t -158.1 132.54 8.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.34 0.4 . . . . 65.24 109.922 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.87 132.81 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.553 0.741 . . . . 74.21 109.25 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -132.19 119.76 41.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.701 0.801 . . . . 72.24 109.687 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.564 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.88 88.2 7.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.729 0.812 . . . . 74.23 109.491 171.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.87 102.33 9.99 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 114.466 -1.243 . . . . 63.01 109.153 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.89 145.27 18.59 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.438 -0.665 . . . . 70.14 111.438 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.522 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -139.99 130.62 4.75 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.809 -0.916 . . . . 74.53 110.809 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.1 mt -90.13 115.78 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.677 -0.86 . . . . 74.44 108.677 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -117.58 152.42 35.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.431 1.092 . . . . 54.34 109.71 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -116.23 95.02 4.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.033 -1.099 . . . . 72.14 108.033 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.412 ' H ' HD13 ' D' ' 86' ' ' ILE . 0.1 OUTLIER -110.3 138.71 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.468 0.707 . . . . 72.03 110.038 -171.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 169.76 13.89 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.786 1.235 . . . . 71.02 109.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.21 21.76 56.18 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.56 -0.291 . . . . 70.15 112.397 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.01 161.04 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.485 1.114 . . . . 72.55 110.404 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.561 ' HG3' ' HB ' ' B' ' 149' ' ' THR . 6.6 pt-20 -166.63 165.98 16.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.59 0.756 . . . . 74.53 110.467 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.454 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 60.35 -134.54 50.21 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 124.026 0.829 . . . . 74.12 114.178 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -79.39 -14.11 59.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.012 0.925 . . . . 62.1 112.527 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.713 ' HB2' ' HA ' ' B' ' 149' ' ' THR . 27.3 tp60 -63.89 -34.17 77.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.459 0.704 . . . . 72.43 111.564 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 22.3 ptp -71.38 -28.04 63.76 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.521 0.513 . . . . 74.2 111.038 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.81 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.568 0.747 . . . . 44.44 110.002 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -72.8 -32.9 65.88 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.058 -0.974 . . . . 72.44 110.542 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.82 -50.15 32.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.968 0.507 . . . . 73.13 110.517 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' H' ' 174' ' ' MET . 7.8 tt -72.03 -46.02 58.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.105 0.562 . . . . 75.35 110.182 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.55 84.56 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.378 -0.679 . . . . 54.4 114.344 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -148.92 -63.75 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.881 0.84 . . . . 62.51 112.071 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -68.68 -44.54 73.78 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 113.474 0.916 . . . . 73.14 113.474 -165.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.421 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 56.1 m -67.22 -45.26 50.44 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 118.971 -0.538 . . . . 71.24 111.772 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.603 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.7 Cg_exo -53.7 -32.91 67.44 Favored 'Trans proline' 0 C--N 1.394 2.921 0 C-N-CA 122.931 2.421 . . . . 62.32 114.347 168.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.64 -28.12 68.31 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 122.786 0.434 . . . . 73.3 112.107 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.22 -42.13 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.604 0.716 . . . . 72.34 110.041 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.522 HD22 ' HA3' ' D' ' 82' ' ' GLY . 94.1 mt -76.33 -21.68 55.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 63.41 111.999 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -62.83 -42.98 81.5 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 117.693 -1.146 . . . . 74.12 113.623 -171.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.73 -43.85 44.0 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.061 1.841 . . . . 72.45 113.492 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 82.6 m-85 -74.22 -39.06 63.36 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.943 0.897 . . . . 64.12 112.044 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.95 80.54 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.604 0.761 . . . . 73.11 109.95 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.534 ' NH2' HG22 ' B' ' 105' ' ' ILE . 36.9 ttp180 -60.94 -48.82 80.04 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 124.353 1.033 . . . . 74.54 110.055 174.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 5.1 tm-20 -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.063 0.945 . . . . 72.24 111.956 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -58.64 -41.3 85.68 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.939 0.774 . . . . 75.15 111.147 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.631 HG22 ' SG ' ' D' ' 76' ' ' CYS . 65.1 mt -63.37 -56.28 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.021 0.928 . . . . 74.44 109.701 174.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 82.4 m -51.82 -40.1 59.88 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.095 1.758 . . . . 71.04 111.853 -175.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 30.3 t -69.64 -45.04 69.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.531 -1.213 . . . . 74.34 110.226 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.663 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.2 mtm -67.0 -31.67 72.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.947 0.499 . . . . 71.41 111.847 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.483 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.7 t -62.14 -49.12 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.688 0.795 . . . . 73.41 109.677 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -72.79 -28.88 62.85 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.733 -0.667 . . . . 71.22 111.139 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.3 mtt-85 -71.74 -25.22 61.97 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.518 0.727 . . . . 74.14 110.056 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.9 11.43 70.58 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.791 0.682 . . . . 50.11 112.828 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.516 HG22 ' HB3' ' C' ' 17' ' ' TYR . 76.8 p 61.25 14.94 5.99 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.331 1.853 . . . . 75.22 113.661 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.471 ' HE1' HG13 ' D' ' 31' ' ' VAL . 62.0 m-85 -87.27 159.57 50.36 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.97 0.908 . . . . 73.21 109.804 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.35 127.53 20.27 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.928 2.419 . . . . 74.5 111.961 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -52.28 132.29 33.8 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.097 0.873 . . . . 73.11 111.318 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.493 HD13 HG21 ' D' ' 40' ' ' VAL . 42.4 tp -108.3 115.52 30.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.521 0.728 . . . . 53.31 110.122 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -113.41 100.78 8.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.364 0.666 . . . . 60.2 109.701 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 68.1 mt -74.49 148.51 40.93 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.928 -1.033 . . . . 74.11 110.138 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.99 125.42 83.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 123.787 0.68 . . . . 73.43 110.523 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.68 99.07 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.44 2.093 . . . . 73.12 109.271 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.07 119.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.107 -0.951 . . . . 75.41 110.95 -167.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -103.47 107.2 17.94 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.649 -1.241 . . . . 63.31 107.649 167.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.587 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 13.3 m-85 -67.74 -21.31 65.28 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.48 0.712 . . . . 71.54 111.893 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 -23.92 61.75 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 73.34 111.05 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.407 ' HA ' ' HE2' ' D' ' 138' ' ' MET . . . -58.67 -33.25 69.91 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.82 0.448 . . . . 74.23 111.873 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.613 HD13 ' HD2' ' H' ' 185' ' ' PRO . 52.3 mt -84.01 -17.5 40.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.9 0.88 . . . . 74.02 111.81 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.443 ' HE2' ' HA2' ' B' ' 146' ' ' GLY . 82.4 t80 -76.38 -47.26 23.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.826 0.85 . . . . 74.53 109.629 173.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.549 ' HG2' ' HB2' ' B' ' 145' ' ' ALA . 78.5 mtm -62.47 -42.44 99.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.276 -0.874 . . . . 70.42 110.131 174.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -61.4 -45.34 94.73 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.032 0.833 . . . . 74.24 110.436 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -47.54 -48.88 27.49 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.194 0.934 . . . . 65.41 111.238 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.569 HD11 ' HB1' ' B' ' 145' ' ' ALA . 81.3 mt -71.4 -47.39 56.39 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.081 -0.963 . . . . 71.34 111.79 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -84.4 2.91 38.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.669 0.618 . . . . 75.34 112.669 -173.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.505 ' NE2' ' H ' ' B' ' 4' ' ' GLN . 0.0 OUTLIER -115.2 93.1 4.15 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.937 -1.505 . . . . 63.34 106.937 -175.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . 0.677 ' HB3' ' H1 ' ' B' ' 1' ' ' MET . 17.0 pt20 -158.9 13.84 0.16 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.66 -1.155 . . . . 75.22 110.211 177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.23 105.85 3.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.671 0.789 . . . . 71.51 109.65 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.81 97.46 0.15 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 111.657 -0.577 . . . . 74.24 111.657 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.34 96.65 9.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.148 -0.686 . . . . 73.25 109.148 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.61 63.12 4.5 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.325 -0.398 . . . . 70.31 112.352 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.1 p -71.58 94.71 1.34 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.898 0.879 . . . . 64.41 109.422 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.06 112.71 7.59 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.786 -0.82 . . . . 73.15 108.786 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.71 -165.5 1.2 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.311 1.044 . . . . 75.2 111.609 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -137.85 168.16 20.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.068 0.947 . . . . 71.11 109.753 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -78.85 153.95 30.19 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.343 1.057 . . . . 72.43 109.888 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.17 78.41 0.96 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.931 -0.766 . . . . 73.35 108.931 170.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.767 1.227 . . . . 74.34 108.652 -178.085 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.207 -0.664 . . . . 74.3 109.207 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.06 82.56 0.75 Allowed Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.552 -0.619 . . . . 63.4 111.552 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.16 115.98 24.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.319 1.048 . . . . 75.21 110.574 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 30.4 t -113.47 89.94 3.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.758 -0.83 . . . . 74.43 108.758 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . 0.496 ' H ' ' HB2' ' C' ' 50' ' ' GLN . . . 65.41 178.43 0.2 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.569 1.148 . . . . 64.01 112.301 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.507 HD13 ' HG2' ' E' ' 174' ' ' MET . 2.4 pp -114.96 7.0 15.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.965 0.506 . . . . 72.1 112.152 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.507 ' HG2' HD13 ' E' ' 173' ' ' LEU . 18.2 ptt? -168.56 -4.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.504 0.722 . . . . 74.41 111.842 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.41 ' CE2' HD13 ' C' ' 98' ' ' LEU . 55.2 t80 -120.78 151.66 39.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 75.32 110.884 -174.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.08 147.59 11.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.763 1.225 . . . . 74.34 108.404 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.15 106.5 2.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.838 0.855 . . . . 74.54 109.771 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -127.12 137.38 52.98 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.199 1.0 . . . . 71.12 110.693 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 67.98 162.57 0.14 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 125.129 1.372 . . . . 72.4 113.774 169.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.62 120.58 7.21 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.989 1.793 . . . . 73.22 111.117 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . 0.546 ' HE1' ' HB3' ' C' ' 95' ' ' ALA . 99.1 m-85 -76.72 -180.0 5.7 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.583 -0.735 . . . . 74.32 110.031 176.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.96 155.64 30.34 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.868 0.467 . . . . 72.42 110.0 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 6.9 t -50.46 129.19 21.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.95 0.9 . . . . 74.31 111.869 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . 0.554 ' HE1' ' HB3' ' C' ' 44' ' ' LEU . 19.4 t-105 -112.4 91.1 15.69 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 74.33 108.282 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.06 110.33 2.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.737 2.291 . . . . 64.41 111.304 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.07 68.42 5.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.682 0.793 . . . . 74.31 109.652 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 tt 34.18 -71.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.666 0 C-N-CA 127.809 2.444 . . . . 74.41 116.614 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . 79.28 99.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.275 1.83 . . . . 74.15 110.482 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . 0.574 ' HB1' HD13 ' C' ' 128' ' ' LEU . . . -136.2 36.88 2.76 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.367 1.067 . . . . 74.42 109.807 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.54 145.54 48.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.739 1.215 . . . . 71.24 111.645 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 67.86 60.3 5.82 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.738 0.649 . . . . 74.32 113.511 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.07 76.21 0.59 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 111.445 -0.662 . . . . 73.4 111.445 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -88.53 106.44 18.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.571 1.148 . . . . 74.33 110.205 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.99 -171.59 3.49 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.139 0.975 . . . . 73.52 110.314 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 66.7 173.63 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.705 1.202 . . . . 75.51 113.468 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -151.9 73.9 1.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 108.153 -1.055 . . . . 74.44 108.153 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -86.18 26.29 1.05 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.874 0.87 . . . . 75.34 111.27 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.27 -36.41 79.97 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.184 0.594 . . . . 74.5 110.931 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -136.91 -61.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.599 0.759 . . . . 62.23 109.549 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.11 105.97 0.25 Allowed Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.192 -0.458 . . . . 74.02 112.432 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.596 ' HZ2' ' HB1' ' F' ' 189' ' ' ALA . 6.3 tmtt? -73.95 111.69 9.36 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 107.239 -1.393 . . . . 75.53 107.239 173.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' F' ' 187' ' ' ILE . 42.4 m-85 69.74 92.74 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.246 1.418 . . . . 75.14 109.243 -169.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.26 91.19 1.29 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.018 0.527 . . . . 44.01 110.774 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.462 HD12 HG22 ' D' ' 13' ' ' ILE . 47.3 mt -79.63 82.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.526 -0.916 . . . . 72.54 108.526 175.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -78.28 -44.98 23.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.633 -1.167 . . . . 74.22 110.548 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -111.31 120.92 43.86 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.197 -0.911 . . . . 73.05 109.329 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.427 HG22 ' HB2' ' B' ' 136' ' ' LEU . 9.6 m . . . . . 0 CA--C 1.575 1.912 0 C-N-CA 126.477 1.911 . . . . 72.42 114.563 172.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.1 99.89 0.17 Allowed Glycine 0 C--N 1.348 1.198 0 N-CA-C 110.854 -0.899 . . . . 35.34 110.854 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 106.69 9.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.721 0.808 . . . . 72.33 110.038 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -143.8 -163.25 1.62 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.958 1.303 . . . . 72.25 108.16 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . 0.477 ' HB3' ' HE3' ' F' ' 174' ' ' MET . . . -67.69 -70.55 0.25 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.051 0.387 . . . . 51.24 110.171 172.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -164.29 40.89 0.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.248 0.547 . . . . 63.11 111.763 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' F' ' 174' ' ' MET . 0.0 OUTLIER -71.0 87.93 0.75 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.585 0.754 . . . . 73.12 112.181 -173.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 23.6 p90 43.13 -165.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 126.84 2.056 . . . . 73.31 115.792 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -166.2 -36.0 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.389 1.075 . . . . 74.14 109.826 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp 57.9 67.43 0.96 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.882 1.273 . . . . 72.34 110.329 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -133.89 11.92 3.98 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.854 -1.066 . . . . 63.34 109.267 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -168.81 134.88 1.47 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.793 0.837 . . . . 54.25 109.939 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.82 89.36 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.619 2.213 . . . . 74.0 111.393 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.3 118.2 29.61 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.167 -0.679 . . . . 74.23 109.167 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 68.86 144.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.327 1.451 . . . . 73.33 111.705 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 17.6 p -138.86 103.02 4.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.874 0.87 . . . . 75.31 109.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.02 130.82 74.41 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.754 0.822 . . . . 74.01 111.167 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.59 132.19 9.79 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.085 1.857 . . . . 75.44 111.974 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.12 -172.12 3.37 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.261 0.624 . . . . 72.53 110.608 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.493 ' H ' HD11 ' F' ' 187' ' ' ILE . 0.2 OUTLIER -117.26 154.75 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.258 1.023 . . . . 75.12 110.072 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.75 169.83 9.74 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.694 0.798 . . . . 73.34 109.924 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . 0.596 ' HB1' ' HZ2' ' E' ' 201' ' ' LYS . . . -160.49 143.98 13.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.027 -0.533 . . . . 73.45 110.776 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -108.73 165.2 11.73 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.455 1.102 . . . . 62.23 108.339 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . 0.511 ' HA2' HG21 ' B' ' 40' ' ' VAL . . . -65.6 -37.88 94.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.395 0.435 . . . . 65.22 112.847 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 104.08 -72.34 0.26 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.57 -0.612 . . . . 71.24 111.57 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -140.0 140.27 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.921 0.888 . . . . 72.2 109.299 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.46 154.72 39.51 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.553 1.141 . . . . 74.25 113.73 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.445 ' N ' ' HB2' ' B' ' 37' ' ' GLN . 17.5 m-85 -53.51 136.54 38.13 Favored 'General case' 0 C--N 1.376 1.748 0 C-N-CA 124.242 1.017 . . . . 74.31 109.722 173.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -127.54 127.2 43.54 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.749 -0.463 . . . . 75.33 109.749 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -82.54 -3.33 55.78 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.035 1.334 . . . . 75.35 109.758 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -81.75 96.72 7.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.549 -1.649 . . . . 72.13 106.549 167.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 70.42 167.22 0.3 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.969 1.308 . . . . 72.13 110.78 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . 0.454 ' H ' ' HA ' ' E' ' 189' ' ' ALA . . . -81.46 62.77 4.45 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.901 -0.59 . . . . 74.34 112.328 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -79.51 79.74 5.95 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 108.193 -1.04 . . . . 75.21 108.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 75.45 -42.62 0.48 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.592 1.557 . . . . 74.25 111.499 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -80.59 -174.54 4.74 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.122 1.369 . . . . 54.22 109.834 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 15' ' ' ARG . 13.6 tt -122.84 121.19 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.048 0.939 . . . . 74.24 109.453 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 -55.31 3.82 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.432 -0.804 . . . . 73.33 110.612 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -151.14 166.07 31.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.413 1.085 . . . . 65.3 108.827 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.456 ' HB ' ' NE2' ' A' ' 12' ' ' GLN . 21.3 t . . . . . 0 C--O 1.252 1.232 0 N-CA-C 107.322 -1.362 . . . . 71.34 107.322 171.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.117 -0.327 . . . . 72.31 110.117 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 149.45 -46.96 0.64 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.548 -1.021 . . . . 53.44 110.548 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . 0.56 ' HB3' ' HB2' ' G' ' 178' ' ' GLN . 26.7 tptp 47.88 68.82 0.6 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.44 1.496 . . . . 74.33 110.521 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 171' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' G' ' 177' ' ' LEU . 49.3 p -152.49 157.95 41.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.184 -0.916 . . . . 74.44 111.735 -170.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.99 -174.33 2.64 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.932 1.293 . . . . 75.33 108.06 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.677 ' HB3' HD12 ' A' ' 89' ' ' ILE . 1.3 pt? -58.62 170.55 0.76 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.676 0.79 . . . . 75.41 112.361 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.548 ' HE1' HD11 ' G' ' 173' ' ' LEU . 32.1 mmt 74.3 14.61 3.68 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.504 1.522 . . . . 75.13 111.302 -173.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 29.8 t80 63.8 106.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.272 1.429 . . . . 73.04 111.075 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -132.73 -87.22 0.44 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.317 -0.623 . . . . 72.43 109.317 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . 0.42 ' HA ' ' HB3' ' G' ' 171' ' ' SER . 6.9 mp 57.9 89.94 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.931 1.292 . . . . 74.35 112.194 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . 0.56 ' HB2' ' HB3' ' G' ' 170' ' ' LYS . 28.5 mm-40 -91.94 -64.25 1.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.054 0.454 . . . . 74.43 110.374 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.34 132.56 28.79 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.835 0.854 . . . . 75.34 110.325 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.53 135.92 63.95 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.027 2.485 . . . . 73.31 111.583 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -146.11 167.15 24.12 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.265 0.626 . . . . 74.43 110.518 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . 0.649 ' HE2' ' HA ' ' A' ' 134' ' ' ASP . 9.7 t80 72.38 27.81 2.41 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.558 1.543 . . . . 75.13 110.646 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 90.8 m 76.91 -49.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.135 1.774 . . . . 74.11 112.598 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . 0.44 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 75.7 t-105 58.66 69.11 1.5 Allowed Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 124.716 1.206 . . . . 74.14 110.703 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.55 139.64 31.6 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.162 2.575 . . . . 72.32 112.69 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 64.9 mt -142.88 141.47 31.54 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.709 0.804 . . . . 75.23 111.083 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . 0.534 ' H ' HD11 ' G' ' 187' ' ' ILE . 0.2 OUTLIER -84.01 165.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.726 0.81 . . . . 74.34 110.65 170.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.82 128.33 55.73 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.833 0.853 . . . . 73.3 109.284 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -80.46 149.21 30.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.283 0.633 . . . . 75.11 110.291 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -135.15 -86.75 0.38 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.433 0.693 . . . . 71.25 109.554 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 146.2 -173.32 26.53 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 112.044 -0.422 . . . . 64.41 112.044 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' H' ' 199' ' ' ASN . . . -152.34 125.86 1.91 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.526 -0.63 . . . . 71.33 111.526 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -74.05 89.44 1.95 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.581 0.705 . . . . 74.45 109.324 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . 0.447 ' H ' ' HD1' ' A' ' 36' ' ' TRP . . . -102.86 -166.01 1.23 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.714 1.205 . . . . 75.42 108.782 171.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . 0.423 ' HA ' ' HB2' ' H' ' 194' ' ' ALA . 18.3 m-85 55.79 78.55 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.877 0.871 . . . . 72.11 110.725 -173.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . 0.415 ' HB2' ' HG3' ' H' ' 196' ' ' LYS . 33.3 tttp -70.91 93.79 1.01 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.818 -1.179 . . . . 74.35 107.818 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.53 75.88 1.97 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.719 0.808 . . . . 72.44 110.787 -176.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -99.72 39.1 1.35 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.389 1.076 . . . . 74.53 109.902 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 68.06 110.08 0.05 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.95 1.3 . . . . 61.21 109.297 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.73 -127.79 0.05 OUTLIER Glycine 0 C--N 1.352 1.427 0 CA-C-O 119.363 -0.687 . . . . 61.24 112.095 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 60.1 114.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.236 1.014 . . . . 70.52 111.281 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . 0.635 ' HB3' HG22 ' G' ' 204' ' ' ILE . 24.5 m-85 -59.7 -29.11 67.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.498 0.719 . . . . 74.2 112.038 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 14.1 t70 57.54 38.59 28.01 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.773 1.273 . . . . 63.43 110.081 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . 0.635 HG22 ' HB3' ' G' ' 202' ' ' TYR . 4.5 pt -83.44 40.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.912 -1.494 . . . . 71.43 111.113 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' H' ' 187' ' ' ILE . 45.5 mtpt 59.71 -171.13 0.13 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 124.493 1.117 . . . . 73.4 111.627 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -92.58 -84.32 0.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.933 -1.136 . . . . 75.53 107.933 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . 0.445 HG12 HD12 ' D' ' 136' ' ' LEU . 36.2 t . . . . . 0 C--O 1.259 1.604 0 N-CA-C 107.911 -1.144 . . . . 64.22 107.911 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 110.229 -0.286 . . . . 71.5 110.229 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.91 -133.25 24.67 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 124.105 0.878 . . . . 62.31 111.828 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -104.65 -9.41 18.24 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.88 0.872 . . . . 73.53 111.371 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 36.6 m -80.87 78.42 7.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.23 0.612 . . . . 62.41 110.121 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.57 ' HB3' HE22 ' B' ' 153' ' ' GLN . . . -96.45 78.86 3.04 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.023 -0.535 . . . . 72.42 110.222 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.686 HD21 ' HA ' ' D' ' 54' ' ' ASP . 15.8 tp -168.86 86.06 0.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 105.929 -1.878 . . . . 72.15 105.929 173.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.456 ' HB3' HD12 ' D' ' 98' ' ' LEU . 3.0 mpp? 63.73 176.27 0.17 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.086 0.954 . . . . 74.41 112.27 -171.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 69.44 0.41 2.9 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.264 1.425 . . . . 72.32 113.3 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.83 54.39 3.0 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.995 0.902 . . . . 73.43 109.973 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.48 101.75 14.42 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.357 -1.349 . . . . 71.44 107.357 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -79.81 -105.6 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.353 -0.61 . . . . 75.23 109.353 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -151.59 -54.75 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.615 1.166 . . . . 64.42 109.428 175.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.07 99.19 1.24 Allowed 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 121.437 1.425 . . . . 74.51 112.935 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -155.23 136.85 14.27 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.277 -1.008 . . . . 73.21 108.277 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.78 126.23 27.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.192 0.597 . . . . 73.51 111.074 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.9 t -91.67 -173.25 3.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.609 0.764 . . . . 72.34 110.588 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -115.51 152.18 46.83 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.192 0.997 . . . . 75.5 109.395 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . 0.613 ' HD2' HD13 ' D' ' 136' ' ' LEU . 72.7 Cg_endo -74.37 138.16 24.31 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.377 2.052 . . . . 74.34 111.885 166.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.65 169.34 15.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.404 0.681 . . . . 75.31 110.605 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' G' ' 205' ' ' LYS . 37.5 pt -82.92 179.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.9 0.88 . . . . 74.13 111.39 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.68 -168.64 1.67 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.807 0.843 . . . . 73.35 109.423 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -169.53 125.98 0.88 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.115 0.566 . . . . 75.34 111.26 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -165.25 152.32 10.64 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.201 1.0 . . . . 65.2 109.538 174.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.57 160.13 13.48 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 111.313 -0.715 . . . . 73.51 111.313 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.41 31.26 2.96 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 114.292 0.477 . . . . 73.25 114.292 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . 0.82 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 98.5 m-85 62.88 14.61 7.58 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.397 1.479 . . . . 74.52 113.811 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . 0.423 ' HB2' ' HA ' ' G' ' 195' ' ' PHE . . . -74.22 103.47 4.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 74.21 110.994 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.79 -83.99 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 109.538 -0.542 . . . . 75.12 109.538 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . 0.415 ' HG3' ' HB2' ' G' ' 196' ' ' LYS . 22.1 mtpp 72.18 -64.51 0.39 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.131 1.772 . . . . 74.12 115.344 170.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 57.8 21.13 7.16 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 123.455 0.702 . . . . 73.21 111.449 -168.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.22 83.54 6.8 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.249 -0.649 . . . . 64.42 109.249 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . 0.453 ' HA ' ' HA2' ' G' ' 192' ' ' GLY . 94.5 m-20 -69.57 121.73 17.67 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.181 -0.918 . . . . 64.21 109.123 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.93 -60.24 9.39 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.284 0.99 . . . . 74.43 111.532 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -124.71 -74.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.401 -1.703 . . . . 72.21 106.401 167.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 16.6 t80 53.37 24.19 3.74 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.386 1.474 . . . . 75.24 112.07 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.46 80.02 5.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.58 1.181 . . . . 54.44 109.166 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.477 ' HB ' ' HB1' ' A' ' 129' ' ' ALA . 6.6 pt -74.97 81.46 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 114.183 -1.371 . . . . 75.24 110.988 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.1 142.37 33.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.489 -1.232 . . . . 74.43 110.441 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -173.41 -60.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.875 1.359 . . . . 72.35 108.05 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 C--O 1.252 1.236 0 CA-C-N 114.297 -1.319 . . . . 73.34 107.953 175.339 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.798 -0.815 . . . . 74.21 108.798 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -77.27 108.66 10.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.954 0.901 . . . . 75.23 110.501 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -142.12 96.81 3.02 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.261 -1.385 . . . . 74.32 107.261 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.64 125.1 50.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.751 0.821 . . . . 70.21 110.911 -171.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -91.16 87.01 6.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.858 -0.793 . . . . 70.34 108.858 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -140.55 106.9 5.26 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.81 -1.181 . . . . 74.4 107.81 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.484 HG23 ' H ' ' C' ' 143' ' ' GLN . 6.6 m -124.02 5.25 8.63 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.244 -0.65 . . . . 71.34 109.244 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.413 ' HB3' ' HB3' ' C' ' 145' ' ' ALA . 6.6 mp0 -92.47 36.28 1.0 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.345 1.058 . . . . 73.0 110.953 -171.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -82.88 177.09 8.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.488 0.715 . . . . 74.31 109.82 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.415 ' HA ' HE22 ' C' ' 142' ' ' GLN . 32.4 m -147.45 101.27 3.35 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.868 -1.53 . . . . 64.34 106.868 162.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.457 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 32.5 t80 -136.43 128.58 29.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.049 0.54 . . . . 72.51 109.845 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -155.6 134.56 12.08 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.481 0.488 . . . . 74.12 110.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' C' ' 135' ' ' ALA . 1.8 mp -79.69 116.22 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.917 -1.142 . . . . 75.14 107.917 172.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.53 -39.36 46.33 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.674 -0.491 . . . . 73.54 109.674 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.8 ttt85 -169.51 136.89 1.73 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.541 0.526 . . . . 73.01 110.921 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.37 130.77 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.809 -1.182 . . . . 73.43 107.809 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 3.2 p90 -168.23 151.65 5.77 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.923 0.765 . . . . 73.44 110.77 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -80.71 117.62 21.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.612 -0.884 . . . . 54.44 108.612 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.4 mtpt -76.26 -33.47 59.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.446 0.641 . . . . 74.53 109.495 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.2 t70 -150.85 140.78 21.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.229 -1.35 . . . . 72.35 109.797 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.0 mt -137.69 142.7 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.958 1.303 . . . . 74.43 108.022 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 m -152.34 112.73 4.09 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 123.621 0.769 . . . . 65.41 110.514 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.565 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 73.5 t80 -109.98 127.72 54.96 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 105.843 -1.91 . . . . 72.23 105.843 164.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.9 143.19 51.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.787 -0.82 . . . . 74.42 108.787 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.86 73.48 11.34 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 106.595 -1.631 . . . . 63.44 106.595 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.7 -28.15 44.3 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.86 2.373 . . . . 73.35 111.435 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -111.04 32.79 5.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.285 1.034 . . . . 75.21 109.017 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -57.52 -52.4 74.56 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 118.357 -0.83 . . . . 61.45 111.947 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.449 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 53.1 Cg_exo -53.52 -33.4 67.86 Favored 'Trans proline' 0 C--N 1.403 3.417 0 C-N-CA 122.119 1.879 . . . . 53.32 113.565 173.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 10.4 m170 -67.61 -35.29 78.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.542 0.737 . . . . 73.25 111.269 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.52 -34.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.366 0.666 . . . . 75.13 111.367 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -80.71 -22.21 40.53 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.355 -0.838 . . . . 75.2 111.996 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -92.9 -23.56 18.73 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.808 0.443 . . . . 72.4 109.981 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 5.3 tmtp? -81.41 163.89 22.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.626 1.17 . . . . 75.42 109.693 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -76.61 138.88 40.38 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.124 -1.065 . . . . 72.22 108.124 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -91.5 79.71 5.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.771 0.796 . . . . 70.41 109.977 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -127.89 82.47 68.33 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.114 -1.439 . . . . 71.11 107.114 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.53 166.15 12.12 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.866 2.377 . . . . 71.55 112.545 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -112.33 99.96 8.42 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.533 -1.284 . . . . 73.23 107.533 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.79 94.32 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.482 1.113 . . . . 75.52 110.1 -171.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.551 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.5 tttt -80.33 124.79 29.16 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.357 -0.838 . . . . 73.55 109.555 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -103.98 108.75 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.007 -0.738 . . . . 75.45 109.007 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 16.1 t70 -108.34 117.87 35.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.992 0.917 . . . . 73.41 108.617 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -99.79 121.0 40.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.68 -1.23 . . . . 74.14 107.68 171.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -119.09 148.57 42.9 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.084 -1.45 . . . . 74.3 107.084 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -149.77 146.15 27.02 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 74.41 110.4 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 151.94 46.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.674 1.19 . . . . 75.42 108.959 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -135.1 161.93 33.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.971 0.508 . . . . 51.34 111.438 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -168.65 131.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.116 0.966 . . . . 74.41 109.751 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.06 115.69 17.08 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.103 -0.703 . . . . 72.33 109.103 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.446 HD12 HG22 ' A' ' 83' ' ' ILE . 72.2 mt -82.45 -43.11 17.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 74.45 110.294 178.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -159.64 -173.66 4.24 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.967 -1.015 . . . . 41.54 110.487 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.81 114.59 5.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.37 0.668 . . . . 72.35 110.882 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.475 ' H ' ' HA ' ' G' ' 171' ' ' SER . 11.9 m-20 68.29 -0.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.508 1.523 . . . . 54.25 111.994 -177.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 58.3 t -105.18 101.86 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.568 -1.271 . . . . 41.23 107.568 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -119.03 154.0 33.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.375 -1.284 . . . . 72.21 107.756 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -124.24 123.94 41.35 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.694 -0.854 . . . . 71.44 108.694 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.61 116.29 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.802 -1.555 . . . . 75.42 106.802 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 66.0 t -96.72 132.93 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.794 -0.817 . . . . 75.01 108.794 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 112.52 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.622 -1.621 . . . . 73.22 106.622 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 23.1 ttp180 -109.63 102.34 11.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.277 -0.638 . . . . 74.01 109.277 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' A' ' 114' ' ' ILE . 40.5 t -93.75 127.93 45.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.976 -1.12 . . . . 74.03 107.976 176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.7 m -116.34 122.56 45.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.044 -0.725 . . . . 75.41 109.044 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 46.5 t -116.51 106.27 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.794 1.238 . . . . 72.21 107.896 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.551 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 20.8 m -104.39 139.71 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.731 -0.84 . . . . 74.03 108.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.38 125.21 38.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.066 -1.457 . . . . 64.23 107.066 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 m -129.99 128.79 42.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.194 0.598 . . . . 63.25 110.066 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 57.0 mt -87.63 75.62 9.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.13 -1.063 . . . . 75.42 108.13 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.72 -99.66 1.38 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.427 -0.806 . . . . 64.2 112.064 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.16 -18.47 16.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.77 0.828 . . . . 73.12 111.324 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -112.37 134.51 53.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.436 0.694 . . . . 64.32 109.939 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -68.82 136.73 53.18 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.078 0.551 . . . . 74.21 111.42 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.569 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -83.01 -59.88 2.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.379 1.072 . . . . 64.25 109.334 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.97 174.8 14.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.22 -0.9 . . . . 75.23 110.337 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 tp -141.32 141.23 33.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.283 1.433 . . . . 74.5 107.891 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.3 m -129.62 135.87 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.999 -1.111 . . . . 65.42 107.999 171.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.42 116.07 6.3 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.684 -0.858 . . . . 61.53 108.684 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 t -129.59 112.74 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.651 0.781 . . . . 73.21 109.899 -173.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.3 mt-30 -83.64 87.66 7.04 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.844 -0.799 . . . . 75.35 108.844 168.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG3' HD23 ' A' ' 106' ' ' LEU . 8.7 tp-100 -77.11 92.96 3.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.264 -1.384 . . . . 73.42 107.264 169.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.76 143.38 21.47 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.739 -0.944 . . . . 70.41 110.739 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.502 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.17 123.01 2.1 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 110.677 -0.969 . . . . 74.12 110.677 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.446 HG22 HD12 ' A' ' 51' ' ' LEU . 30.6 mt -90.92 121.8 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.345 -0.983 . . . . 74.32 108.345 175.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 28.6 m-85 -129.73 152.59 49.06 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.518 0.727 . . . . 63.42 109.948 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.8 m -91.49 121.71 33.43 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.604 0.762 . . . . 72.12 109.25 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' A' ' 94' ' ' MET . 5.8 tt -116.96 119.95 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.614 -0.513 . . . . 74.33 109.614 173.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.94 172.28 1.67 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.631 1.572 . . . . 75.11 108.895 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.44 -32.15 3.97 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 116.79 -0.187 . . . . 72.42 112.784 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.487 HG12 ' HB3' ' A' ' 94' ' ' MET . 0.2 OUTLIER -111.12 170.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.475 1.11 . . . . 74.43 109.206 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.0 tt0 -164.29 175.68 9.84 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.493 0.495 . . . . 75.12 110.275 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.45 -130.85 37.9 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.674 -0.694 . . . . 72.13 113.172 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 t -62.32 -27.73 69.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.241 1.016 . . . . 61.2 111.772 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -68.16 -48.89 64.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.502 0.721 . . . . 75.35 110.861 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.636 ' HB2' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -75.59 -30.49 59.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.893 0.477 . . . . 74.31 111.116 -177.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.26 67.76 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.731 0.812 . . . . 51.03 110.612 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' CE1' ' HA ' ' A' ' 134' ' ' ASP . 11.1 t-80 -76.61 -31.5 57.49 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.028 -0.987 . . . . 75.43 110.178 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.66 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.6 m -71.85 -66.13 0.68 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 123.029 0.532 . . . . 64.21 111.531 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.575 HD11 ' HA ' ' G' ' 175' ' ' PHE . 7.0 tt -67.74 -29.41 68.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.325 0.65 . . . . 74.45 111.044 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.44 -19.97 57.54 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.682 -1.065 . . . . 71.11 114.721 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.35 -48.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.201 1.5 . . . . 70.13 113.911 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.66 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 44.9 t80 -66.76 -47.87 70.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.123 0.969 . . . . 74.25 111.879 -173.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.33 -41.83 8.45 Favored Pre-proline 0 CA--C 1.565 1.555 0 C-N-CA 123.494 0.717 . . . . 64.55 112.163 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.98 -31.78 65.3 Favored 'Trans proline' 0 C--N 1.393 2.876 0 C-N-CA 122.22 1.946 . . . . 73.32 113.919 163.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -68.74 -34.6 75.87 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.563 0.745 . . . . 72.41 110.283 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.07 -42.72 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.705 0.802 . . . . 75.55 110.172 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.502 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.5 mt -76.49 -24.77 53.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.553 -1.203 . . . . 71.12 112.462 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.13 -40.18 50.95 Favored Pre-proline 0 CA--C 1.563 1.474 0 N-CA-C 114.46 1.281 . . . . 72.23 114.46 -168.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -55.08 -38.78 93.29 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.97 1.78 . . . . 74.3 113.344 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -77.65 -38.84 46.88 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.756 0.823 . . . . 72.41 111.644 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.19 77.34 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.971 0.509 . . . . 72.31 110.178 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' NH1' HG22 ' C' ' 105' ' ' ILE . 36.1 ttm180 -55.57 -51.19 67.94 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.472 1.108 . . . . 70.43 110.025 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.4 tm-20 -64.0 -41.48 97.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.125 0.891 . . . . 75.14 111.401 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.89 -42.02 98.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.838 0.712 . . . . 71.44 111.005 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.442 HD11 ' HB ' ' A' ' 62' ' ' VAL . 91.5 mt -66.74 -51.48 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.384 0.674 . . . . 74.02 110.528 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.498 HG22 ' HB2' ' A' ' 125' ' ' GLN . 52.4 m -52.78 -44.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.624 1.17 . . . . 70.45 110.907 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 37.8 t -64.77 -41.06 96.17 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.403 -1.271 . . . . 65.43 110.907 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.565 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 32.2 mtm -67.87 -41.31 83.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.96 0.504 . . . . 75.31 111.541 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.4 -50.34 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.792 0.837 . . . . 72.52 110.095 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.57 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 90.5 p -67.09 -32.05 72.95 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.224 -0.898 . . . . 74.51 111.105 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.478 ' HG2' ' HG1' ' B' ' 18' ' ' THR . 26.9 ttm-85 -75.24 -27.44 59.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.596 1.159 . . . . 75.55 110.206 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.18 8.86 62.43 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.62 -0.718 . . . . 74.11 112.86 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.449 HG23 ' HB3' ' D' ' 125' ' ' GLN . 9.4 m 67.07 29.63 7.83 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.794 1.238 . . . . 73.0 110.831 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.51 151.09 41.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 114.479 -1.237 . . . . 75.0 107.905 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.76 121.53 8.43 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.784 1.656 . . . . 75.13 110.104 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.57 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 18.5 pt20 -60.87 155.4 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.554 0.741 . . . . 70.21 111.873 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.12 122.08 26.05 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.828 -0.805 . . . . 75.3 108.828 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.427 ' ND2' ' HB ' ' C' ' 16' ' ' ILE . 2.3 m-20 -103.54 95.32 5.98 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.758 -1.201 . . . . 74.32 107.758 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 131.86 46.79 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.381 -0.6 . . . . 75.51 109.381 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.51 128.02 89.38 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 123.676 0.79 . . . . 74.24 111.886 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.01 110.24 3.08 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.025 1.817 . . . . 73.14 110.83 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.1 t -99.35 114.79 38.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.041 -1.096 . . . . 74.13 108.041 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.507 ' OD1' ' HB1' ' A' ' 135' ' ' ALA . 7.6 p30 -76.16 107.03 8.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.155 0.502 . . . . 74.24 110.117 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' G' ' 184' ' ' TRP . 65.3 t80 -76.85 -21.81 54.45 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.3 0.571 . . . . 74.32 109.484 171.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' HA ' ' CE1' ' A' ' 96' ' ' HIS . 2.2 p-10 -66.0 -49.04 69.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.588 1.155 . . . . 74.44 111.724 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.514 ' HA ' ' HE2' ' A' ' 138' ' ' MET . . . -89.06 -26.13 21.56 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.276 0.473 . . . . 71.52 112.276 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' H' ' 207' ' ' VAL . 6.9 tt -63.12 -32.43 73.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 123.015 0.526 . . . . 64.21 109.865 171.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.432 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 50.2 t80 -58.18 -48.01 81.62 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.632 0.773 . . . . 74.0 111.006 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.514 ' HE2' ' HA ' ' A' ' 135' ' ' ALA . 52.1 mtm -73.65 -38.0 65.14 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.457 0.703 . . . . 72.41 110.658 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 53.7 t-20 -51.62 -38.6 55.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.693 1.197 . . . . 72.33 110.311 173.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -70.61 -42.79 70.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.493 -0.776 . . . . 75.51 111.45 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 84.2 mt -62.68 -49.59 74.52 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.581 0.551 . . . . 71.43 111.529 -172.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -162.75 13.18 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.879 0.326 . . . . 72.13 111.879 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.4 tt0 78.76 -52.26 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.143 1.377 . . . . 73.34 111.793 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 72.88 -77.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.117 1.367 . . . . 70.44 112.234 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.98 79.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.21 0.604 . . . . 72.52 111.198 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.26 -79.41 0.3 Allowed Glycine 0 C--N 1.345 1.068 0 O-C-N 123.956 0.785 . . . . 63.22 111.186 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -156.12 138.74 15.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.119 0.967 . . . . 73.11 109.498 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.63 -73.4 0.82 Allowed Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.163 -1.175 . . . . 53.25 110.163 171.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 m 56.17 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.961 1.705 . . . . 63.12 114.721 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.44 96.06 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.982 0.513 . . . . 73.15 111.219 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -176.53 140.44 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.634 1.174 . . . . 75.14 108.782 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.565 ' HA ' ' HA ' ' E' ' 174' ' ' MET . 25.1 t-80 -156.54 137.37 13.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.297 0.639 . . . . 74.0 110.274 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -112.12 131.24 55.56 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.405 -0.961 . . . . 75.22 108.405 171.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.99 -61.94 1.95 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.628 0.771 . . . . 74.42 109.919 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.188 0 N-CA-C 107.747 -1.205 . . . . 71.21 107.747 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.854 -0.424 . . . . 74.33 109.854 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -155.75 87.4 1.08 Allowed 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.077 0.951 . . . . 73.02 108.684 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -76.48 170.72 15.85 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.116 -0.493 . . . . 75.03 110.744 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 61.06 70.33 0.62 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.34 1.056 . . . . 74.23 111.074 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -69.69 126.8 30.81 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.881 -0.6 . . . . 73.44 109.553 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -138.73 106.08 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.958 -0.756 . . . . 74.42 108.958 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -160.85 143.81 12.97 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.473 -0.785 . . . . 74.34 109.792 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.65 -18.35 33.48 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.562 0.745 . . . . 74.11 109.74 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.473 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 20.2 ptm 52.69 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.379 2.272 . . . . 75.43 114.519 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -137.56 128.38 27.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.035 0.934 . . . . 65.52 109.304 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -129.67 128.52 42.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 75.34 109.565 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -135.43 114.63 12.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.568 0.747 . . . . 72.33 109.042 173.136 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.439 HG21 ' HA ' ' D' ' 129' ' ' ALA . 8.7 tt -89.91 107.12 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 108.118 -1.067 . . . . 74.21 108.118 171.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.58 -40.9 20.25 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 115.774 -0.648 . . . . 74.42 110.61 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -170.33 145.11 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.104 0.253 . . . . 74.25 111.123 -173.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.53 149.83 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.492 -1.299 . . . . 75.03 107.492 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' B' ' 83' ' ' ILE . 23.4 p90 -171.42 150.01 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.172 0.511 . . . . 73.54 111.208 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.478 ' HG1' ' HG2' ' A' ' 120' ' ' ARG . 98.1 m -76.0 121.45 22.75 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.552 -0.907 . . . . 73.44 108.552 169.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.49 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.8 mtpt -88.98 -39.7 13.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.352 0.661 . . . . 72.3 109.865 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.05 148.04 27.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.08 -0.509 . . . . 74.54 110.62 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.415 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.0 mm -142.19 139.42 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.916 1.686 . . . . 75.24 107.462 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -141.22 136.03 31.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.182 -1.044 . . . . 60.52 108.182 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -143.72 120.94 11.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.009 -1.478 . . . . 74.53 107.009 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 23.1 mt-10 -128.76 112.0 13.72 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.447 -0.946 . . . . 73.2 108.447 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.44 88.65 16.1 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.7 -0.852 . . . . 73.55 108.7 176.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.08 -29.84 88.18 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.625 2.217 . . . . 61.32 112.059 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -119.99 29.41 7.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.345 1.058 . . . . 73.23 110.232 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.42 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.43 -50.07 51.1 Favored Pre-proline 0 CA--C 1.575 1.941 0 C-N-CA 125.236 1.414 . . . . 74.3 114.658 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 62.6 Cg_endo -81.14 -13.46 11.3 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.708 1.605 . . . . 72.11 113.422 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -94.39 2.9 55.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.419 0.687 . . . . 73.12 111.875 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p -64.02 -17.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.626 0.771 . . . . 74.21 110.896 169.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.44 -37.47 83.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.163 0.985 . . . . 74.32 111.065 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.45 -45.36 39.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.772 0.829 . . . . 71.11 110.391 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -94.39 67.62 3.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 74.23 109.513 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -81.44 76.51 8.36 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.122 0.963 . . . . 74.34 110.871 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -158.68 167.62 29.03 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.896 1.278 . . . . 71.15 109.897 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.41 121.94 75.19 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 115.89 -0.595 . . . . 74.31 109.476 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.02 150.31 48.29 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.213 1.942 . . . . 61.14 110.899 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.78 114.13 9.55 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.867 -0.79 . . . . 72.51 108.867 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.543 HG13 HD23 ' B' ' 42' ' ' LEU . 23.5 t -85.15 117.06 29.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 107.41 -1.33 . . . . 72.2 107.41 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -140.3 102.1 4.28 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.235 -1.024 . . . . 74.11 108.235 -170.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.566 ' HG ' HD22 ' B' ' 128' ' ' LEU . 1.1 pt? -127.85 138.69 52.78 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.197 -1.365 . . . . 72.24 109.652 -170.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -126.51 148.73 49.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.843 0.857 . . . . 71.23 111.067 -170.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.519 ' HG ' HD21 ' B' ' 60' ' ' LEU . 7.6 tt -89.42 131.44 35.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.241 1.017 . . . . 73.45 109.016 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -122.89 137.45 54.94 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.858 -1.534 . . . . 75.04 106.858 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.457 HG23 ' HA2' ' B' ' 99' ' ' GLY . 85.2 m -107.42 120.37 41.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.08 -0.711 . . . . 74.45 109.08 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.435 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -121.62 153.74 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.437 1.095 . . . . 61.42 108.129 170.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 49.5 m -143.86 172.0 13.45 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.112 0.482 . . . . 52.02 110.599 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -154.44 167.29 30.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.79 1.236 . . . . 72.34 108.591 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -123.43 130.47 52.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.054 0.541 . . . . 73.23 109.772 171.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.481 HD12 HG22 ' B' ' 83' ' ' ILE . 32.6 mt -100.82 -40.4 7.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 74.21 110.654 177.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.69 -169.92 3.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.063 0.545 . . . . 75.42 111.375 -174.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.62 111.3 1.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.754 -1.112 . . . . 71.1 110.967 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.427 ' H ' HD11 ' F' ' 173' ' ' LEU . 10.2 m-20 68.65 0.78 2.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.033 1.333 . . . . 74.21 112.186 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 95.8 t -101.08 101.06 11.57 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.231 -1.025 . . . . 75.44 108.231 -172.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.574 ' HE2' HD23 ' F' ' 173' ' ' LEU . 17.7 m-85 -108.97 136.42 48.53 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.484 -0.78 . . . . 74.55 109.969 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -105.92 96.76 6.71 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.97 -1.492 . . . . 72.04 106.97 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 64.4 t -87.08 122.83 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.746 0.818 . . . . 71.25 109.577 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.461 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -101.68 113.68 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.798 0.839 . . . . 72.41 109.263 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.519 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -91.77 105.94 18.1 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.811 -1.181 . . . . 75.55 107.811 177.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -97.8 108.66 21.42 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.336 -0.847 . . . . 72.3 109.497 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 18.3 t -105.41 113.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.925 -1.139 . . . . 74.24 107.925 170.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -104.4 150.89 24.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.534 0.733 . . . . 73.33 109.276 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 26.1 t -134.66 133.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.984 0.913 . . . . 75.04 110.341 -167.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.9 m -125.15 149.09 48.24 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.604 0.762 . . . . 73.33 109.253 170.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.07 147.45 29.56 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.731 0.812 . . . . 70.2 108.972 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.0 p -144.64 129.15 18.02 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.499 0.499 . . . . 74.35 111.325 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 37.0 mt -95.61 104.73 16.65 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.752 1.221 . . . . 74.31 108.3 171.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.39 -127.88 21.06 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 123.744 0.652 . . . . 71.45 111.631 -174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -96.56 17.16 16.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.706 0.802 . . . . 62.05 111.485 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -134.84 146.76 49.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.51 0.724 . . . . 74.45 109.724 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.7 m -63.78 135.65 56.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.177 0.591 . . . . 75.03 111.04 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.92 -59.7 1.99 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.931 0.892 . . . . 63.42 108.906 176.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -156.54 171.35 20.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 113.962 -1.472 . . . . 74.31 109.585 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.4 mt -139.94 154.69 47.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.882 1.673 . . . . 75.23 106.99 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.443 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.2 t -159.7 160.42 34.08 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.156 -0.683 . . . . 75.21 109.156 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.42 136.83 3.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.233 -1.025 . . . . 75.23 108.233 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 97.1 t -124.18 143.82 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.973 -0.751 . . . . 74.14 108.973 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -124.0 102.08 7.57 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.531 -0.914 . . . . 74.15 108.531 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -92.16 100.11 12.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.218 -1.03 . . . . 74.31 108.218 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.49 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.88 146.64 18.51 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.146 -0.782 . . . . 74.13 111.146 177.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.81 127.75 3.39 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 110.758 -0.937 . . . . 71.14 110.758 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.481 HG22 HD12 ' B' ' 51' ' ' LEU . 50.3 mt -84.45 115.7 26.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.25 -1.018 . . . . 72.15 108.25 176.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.52 164.39 19.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.303 1.041 . . . . 72.23 108.849 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.604 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 16.4 m -132.43 103.68 6.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.452 -0.944 . . . . 75.55 108.452 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.46 ' H ' HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -115.88 134.71 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.214 0.606 . . . . 75.11 110.739 -177.214 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 172.76 18.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.466 1.106 . . . . 61.15 108.553 172.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.35 -55.01 3.55 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.703 -0.559 . . . . 62.23 111.703 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.52 154.45 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.255 1.022 . . . . 74.42 111.996 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.75 166.24 26.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.501 0.72 . . . . 73.14 110.355 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.61 -127.1 43.84 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.737 0.648 . . . . 43.14 113.71 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -65.16 -30.24 71.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.106 0.963 . . . . 74.15 111.149 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -74.07 -34.98 64.21 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.513 -0.767 . . . . 74.43 110.71 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.766 ' HG2' ' SD ' ' F' ' 174' ' ' MET . 12.3 tpt -66.56 -47.99 71.09 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.018 -0.537 . . . . 74.21 110.241 172.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.04 77.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.11 0.881 . . . . 63.12 110.844 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -65.78 -34.53 78.38 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.51 0.724 . . . . 72.44 110.666 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -67.04 -67.9 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.637 0.375 . . . . 75.44 111.528 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.478 HD22 ' HA ' ' F' ' 177' ' ' LEU . 0.0 OUTLIER -73.39 -17.64 61.25 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 118.106 0.412 . . . . 74.12 112.076 -171.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' F' ' 178' ' ' GLN . . . -108.74 2.27 32.09 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.48 -0.622 . . . . 64.32 114.607 -174.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -49.06 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 117.948 0.874 . . . . 74.12 111.387 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -72.45 -50.63 24.77 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.697 0.399 . . . . 75.44 111.471 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.24 -46.46 79.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 118.435 -0.793 . . . . 74.1 111.183 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -51.58 -41.32 61.43 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.153 1.902 . . . . 73.2 113.835 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.84 -36.84 84.54 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 123.478 0.711 . . . . 75.14 111.689 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.408 HG22 ' NH2' ' D' ' 111' ' ' ARG . 64.9 mt -62.35 -47.25 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.625 0.77 . . . . 75.02 110.418 174.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.11 -10.54 54.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.804 -1.089 . . . . 61.41 111.692 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -64.88 -49.76 66.79 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 117.411 -1.28 . . . . 73.43 113.312 -171.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -58.73 -34.64 99.08 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 121.944 1.762 . . . . 73.44 112.341 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.0 m-85 -64.31 -52.56 57.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.388 0.675 . . . . 75.41 110.358 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.86 81.94 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.764 0.825 . . . . 73.32 111.329 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.651 HH22 HG23 ' C' ' 122' ' ' THR . 53.6 ttt180 -67.61 -49.95 60.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.223 1.409 . . . . 74.32 110.414 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -34.96 78.99 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.939 0.775 . . . . 74.51 110.191 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.1 t -67.37 -45.49 76.11 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.066 0.546 . . . . 74.32 111.787 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.521 HD11 ' HB ' ' B' ' 62' ' ' VAL . 81.5 mt -59.35 -46.36 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.143 0.577 . . . . 74.31 110.196 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.624 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 34.2 m -53.58 -50.15 66.21 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.673 1.233 . . . . 64.42 110.045 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.5 t -59.42 -50.72 72.86 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.303 1.041 . . . . 71.05 111.852 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.578 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 20.7 mmt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.165 0.586 . . . . 73.34 112.494 -170.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.91 -32.33 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.089 0.556 . . . . 74.34 110.846 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.5 m -64.22 -30.02 71.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.555 0.742 . . . . 61.43 111.276 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 80.2 mtt-85 -68.69 -39.78 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.861 0.864 . . . . 75.32 109.844 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.32 66.47 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.838 0.711 . . . . 73.14 113.198 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p 60.55 44.95 11.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.194 1.797 . . . . 71.34 111.96 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -119.01 144.91 36.81 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 114.718 -1.128 . . . . 75.24 109.785 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.491 ' HG2' ' HB2' ' F' ' 195' ' ' PHE . 20.9 Cg_exo -68.1 94.76 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.736 2.957 . . . . 74.3 113.718 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.624 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 3.3 mm-40 -68.21 160.79 28.5 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.332 1.063 . . . . 72.42 113.163 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.02 124.83 15.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.074 -2.195 . . . . 74.12 105.074 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -87.03 136.19 33.01 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.918 -0.771 . . . . 72.3 108.918 -171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.566 HD22 ' HG ' ' B' ' 42' ' ' LEU . 38.1 mt -58.13 144.78 39.17 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.54 0.525 . . . . 72.42 112.296 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.657 ' HB2' HG12 ' E' ' 204' ' ' ILE . . . -66.69 108.56 2.47 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.629 1.206 . . . . 51.11 109.912 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 113.55 3.81 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.505 2.137 . . . . 74.4 111.185 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.08 142.77 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.405 0.682 . . . . 74.41 110.663 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -79.38 118.61 21.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.565 1.146 . . . . 70.1 109.91 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -67.38 -25.8 66.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.448 0.699 . . . . 74.13 111.702 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.12 -29.57 65.42 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.461 0.704 . . . . 75.45 111.223 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.49 95.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.139 0.576 . . . . 73.0 110.509 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.0 -40.26 95.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.409 -0.814 . . . . 74.04 110.546 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -66.45 -39.9 89.13 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.923 . . . . 75.24 110.588 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.0 mtt -65.13 -38.73 91.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.568 0.747 . . . . 70.52 111.245 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -88.07 -19.2 27.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.546 -0.752 . . . . 74.32 110.636 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -87.01 -35.35 18.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.998 0.519 . . . . 74.44 110.658 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.34 1.6 56.99 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.056 0.542 . . . . 72.21 110.662 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -70.37 100.28 1.72 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.623 -0.88 . . . . 73.43 108.623 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -97.55 -12.55 22.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.051 0.94 . . . . 71.11 110.422 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.426 ' HB3' ' HG3' ' D' ' 8' ' ' GLU . 21.5 mp0 -76.46 97.72 4.39 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.517 -0.92 . . . . 74.14 108.517 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.69 121.26 26.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.712 0.805 . . . . 72.44 109.391 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.05 -168.92 41.88 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.521 0.513 . . . . 72.0 112.169 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -143.27 178.47 7.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.276 0.631 . . . . 73.1 110.791 -171.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -164.31 82.63 0.11 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 115.557 -0.747 . . . . 75.03 111.815 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -112.89 132.68 55.21 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 108.696 -0.853 . . . . 73.13 108.696 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -140.77 155.15 46.48 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.527 0.731 . . . . 74.15 109.83 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.78 108.47 0.58 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.978 0.911 . . . . 71.54 109.55 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -65.28 93.5 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.842 0.857 . . . . 64.34 109.002 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -55.7 -72.83 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.93 0.892 . . . . 74.42 111.85 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.98 130.93 38.39 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.689 -0.856 . . . . 75.24 108.689 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 O-C-N 123.919 0.762 . . . . 74.44 110.302 178.207 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.272 -0.64 . . . . 75.31 109.272 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -75.3 -169.92 1.08 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.055 0.942 . . . . 64.04 111.795 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -80.79 17.0 1.24 Allowed 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.161 0.984 . . . . 73.21 112.448 -167.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -76.34 73.1 3.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.94 0.896 . . . . 73.12 108.956 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.477 ' HA ' ' SD ' ' A' ' 138' ' ' MET . 1.0 OUTLIER -123.12 134.17 54.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.739 1.215 . . . . 64.44 108.067 176.722 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.6 m120 76.88 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.726 1.611 . . . . 71.25 112.979 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -59.37 135.05 57.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.671 1.188 . . . . 75.32 111.69 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.78 -61.0 1.45 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.376 -0.972 . . . . 72.51 108.376 166.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 55.5 ttp 64.67 136.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.283 1.433 . . . . 74.44 112.311 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 61.4 m -115.67 96.69 5.74 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.595 -1.261 . . . . 75.41 107.595 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.569 ' HA ' HG21 ' C' ' 86' ' ' ILE . 37.7 t80 -91.02 132.43 36.0 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.442 -1.254 . . . . 75.42 108.27 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.411 ' HG2' ' NE2' ' C' ' 14' ' ' GLN . 25.4 tt0 -136.23 102.08 4.88 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.988 -1.115 . . . . 72.41 107.988 -178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.519 HD12 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -70.44 131.45 34.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 115.456 -0.793 . . . . 73.21 109.242 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.507 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 22.8 mm-40 -105.21 -49.37 3.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.305 0.642 . . . . 74.34 109.857 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.506 HH11 ' HB2' ' D' ' 32' ' ' PHE . 73.5 ttt180 -173.62 132.25 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.692 -0.685 . . . . 73.34 110.34 -169.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.519 HG13 HD12 ' C' ' 13' ' ' ILE . 84.0 mt -118.93 136.26 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.266 -1.013 . . . . 75.24 108.266 170.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.548 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 8.4 p90 -171.53 172.02 5.22 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.355 1.035 . . . . 75.04 110.081 -173.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -93.17 118.98 31.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.521 -0.763 . . . . 74.32 109.384 176.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mmtp -65.83 -47.11 76.09 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.124 -1.065 . . . . 74.24 108.124 168.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.64 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.5 t70 -141.52 147.09 37.21 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.472 -1.694 . . . . 72.33 110.008 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -135.1 144.73 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.767 1.627 . . . . 74.3 106.876 172.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -150.73 146.45 26.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.508 0.671 . . . . 74.22 110.706 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -151.64 118.45 5.79 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.566 -1.642 . . . . 74.44 106.566 167.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.62 133.08 56.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.72 -1.215 . . . . 64.3 107.72 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.88 85.22 39.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.376 -1.342 . . . . 74.12 107.376 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.16 -3.37 12.75 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.619 2.213 . . . . 75.21 112.183 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.62 18.24 8.78 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 123.921 0.889 . . . . 75.53 109.764 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.416 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -47.01 -50.85 43.87 Favored Pre-proline 0 CA--C 1.575 1.905 0 N-CA-C 114.309 1.226 . . . . 72.11 114.309 -169.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -86.68 -27.88 0.68 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.713 1.608 . . . . 75.05 114.107 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -71.09 -24.62 62.35 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.474 0.71 . . . . 72.55 112.471 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 p -75.28 -18.19 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.593 1.157 . . . . 75.22 110.922 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' D' ' 14' ' ' GLN . 42.6 t80 -59.74 -38.48 81.85 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.845 0.858 . . . . 75.11 110.81 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 5.48 51.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.283 0.633 . . . . 73.42 112.395 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.731 ' HE2' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -98.33 164.55 12.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.575 0.35 . . . . 75.2 111.866 -167.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.95 117.37 8.93 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.266 -1.013 . . . . 73.3 108.266 165.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -84.96 67.01 10.03 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.223 1.011 . . . . 74.13 111.242 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -125.07 78.52 66.37 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 124.582 1.153 . . . . 71.44 109.261 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.5 106.6 1.88 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.542 2.161 . . . . 73.2 111.422 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -84.17 120.36 26.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.098 -1.445 . . . . 72.24 107.098 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.477 HG11 HG13 ' C' ' 64' ' ' VAL . 95.6 t -96.86 148.84 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.885 -1.052 . . . . 73.5 110.959 -166.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -133.53 114.98 14.18 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.834 -1.543 . . . . 72.45 106.834 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.441 ' HG ' HD13 ' C' ' 128' ' ' LEU . 5.4 mp -86.44 152.73 22.44 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.64 -0.874 . . . . 72.12 108.64 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.2 t70 -154.63 148.6 25.7 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.052 -0.721 . . . . 75.44 109.052 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 tt -149.78 120.59 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.013 -0.736 . . . . 73.31 109.013 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.417 ' O ' HD22 ' C' ' 60' ' ' LEU . 11.7 m-20 -121.81 144.7 48.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.739 1.216 . . . . 75.41 108.656 176.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -113.01 132.8 55.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.18 -0.674 . . . . 63.4 109.18 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.17 157.32 38.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 74.32 109.044 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.0 p -144.87 150.35 36.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.886 -0.597 . . . . 75.22 110.008 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -156.32 143.16 18.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.792 1.237 . . . . 74.22 107.906 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -105.09 132.67 51.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.133 0.492 . . . . 75.22 109.692 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.505 HD13 HD13 ' C' ' 83' ' ' ILE . 69.0 mt -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.453 -0.794 . . . . 75.34 111.252 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -172.89 4.31 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.204 0.526 . . . . 74.34 111.174 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.94 112.79 2.73 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.331 -1.304 . . . . 72.24 110.312 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.698 ' HA ' HD23 ' E' ' 173' ' ' LEU . 18.5 m-20 60.87 23.87 13.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.643 1.177 . . . . 75.14 112.782 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -114.91 116.24 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.894 . . . . 71.01 109.284 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.09 159.97 15.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.06 0.933 . . . . 74.42 110.083 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.05 124.22 36.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.517 -1.674 . . . . 71.24 107.26 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.7 125.74 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.573 -1.269 . . . . 71.04 107.573 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.56 105.59 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.417 HD22 ' O ' ' C' ' 45' ' ' ASP . 2.4 tm? -91.33 112.61 24.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.216 -1.031 . . . . 63.4 108.216 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.416 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.4 ttp180 -91.68 110.76 22.1 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.823 0.849 . . . . 72.5 109.991 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.48 124.23 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 108.161 -1.051 . . . . 72.43 108.161 173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 7.5 m -123.44 137.05 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.491 -0.559 . . . . 75.52 109.491 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.558 HG21 HG23 ' C' ' 114' ' ' ILE . 56.1 t -125.17 115.74 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.861 1.264 . . . . 61.52 108.889 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.48 144.35 28.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.209 -1.034 . . . . 71.1 108.209 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.99 37.28 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.361 -0.607 . . . . 63.21 109.361 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -137.76 138.4 39.23 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.479 0.487 . . . . 54.02 110.665 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.637 HD11 ' HG2' ' C' ' 34' ' ' LYS . 10.1 mt -86.93 43.82 1.12 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.083 1.353 . . . . 74.23 109.356 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.96 -113.17 4.37 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.517 -1.033 . . . . 73.2 110.517 -170.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.77 -10.03 41.45 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.678 0.791 . . . . 73.45 110.883 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.731 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 8.3 tp10 -90.11 128.89 36.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.308 1.443 . . . . 74.13 110.049 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 16.3 m -64.82 129.34 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.853 0.751 . . . . 75.21 109.908 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.468 ' HB3' ' HG ' ' C' ' 68' ' ' LEU . . . -83.36 -54.73 4.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.128 -0.694 . . . . 72.31 109.128 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -168.57 178.51 4.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.401 -1.272 . . . . 74.14 110.31 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.45 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -141.09 146.22 36.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 106.423 -1.695 . . . . 72.03 106.423 175.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.45 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -146.66 145.89 30.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.912 -1.144 . . . . 71.4 107.912 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.29 136.85 11.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.563 -0.532 . . . . 74.34 109.563 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' C' ' 110' ' ' ALA . 53.6 t -134.87 112.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.038 0.935 . . . . 75.43 108.507 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.64 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.7 mt-30 -92.71 89.51 6.69 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.822 -0.807 . . . . 72.23 108.822 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.429 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.2 tp-100 -82.59 109.82 17.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.016 -0.993 . . . . 54.35 109.767 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 144.95 17.48 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.34 0.4 . . . . 71.11 112.434 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.547 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.29 128.29 3.35 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 110.358 -1.097 . . . . 71.23 110.358 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.548 HD11 ' HH ' ' C' ' 17' ' ' TYR . 11.8 mm -95.19 118.69 41.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.032 -1.099 . . . . 75.04 108.032 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.47 117.13 20.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.502 -0.925 . . . . 74.3 108.502 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -98.58 107.29 19.7 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.179 -1.045 . . . . 75.21 108.179 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.569 HG21 ' HA ' ' C' ' 11' ' ' PHE . 2.8 pp -131.7 154.31 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.036 0.534 . . . . 75.24 111.065 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.25 177.46 3.59 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.483 -1.235 . . . . 74.11 109.468 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -36.53 3.69 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 116.515 -0.312 . . . . 71.32 112.46 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.6 -173.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.477 1.111 . . . . 75.15 111.402 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.424 ' HA ' ' HE2' ' E' ' 174' ' ' MET . 4.0 tm-20 -168.54 147.11 4.22 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.41 0.522 . . . . 64.31 112.41 -174.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.555 ' H ' ' HG2' ' E' ' 174' ' ' MET . . . 54.24 -116.02 5.85 Favored Glycine 0 C--N 1.354 1.564 0 C-N-CA 124.113 0.863 . . . . 53.1 115.001 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.2 p -69.07 -24.82 64.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.378 0.671 . . . . 54.21 111.914 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -56.46 -39.38 73.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.274 0.63 . . . . 74.14 110.237 174.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.621 ' HE2' ' SD ' ' E' ' 174' ' ' MET . 54.8 tpp -65.46 -44.4 87.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.558 0.743 . . . . 74.41 110.243 173.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.451 ' HA ' HD12 ' E' ' 177' ' ' LEU . . . -64.62 -26.42 68.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.553 0.741 . . . . 71.23 112.431 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -88.14 -33.51 18.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.518 0.727 . . . . 73.24 111.34 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -67.68 -61.58 1.82 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.19 0.596 . . . . 75.4 110.953 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.11 -6.64 47.56 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.191 0.441 . . . . 73.3 112.191 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.44 -29.67 21.26 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.919 -0.378 . . . . 72.41 113.527 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 -43.47 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.154 0.477 . . . . 72.11 111.778 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -72.29 -49.91 31.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.228 0.455 . . . . 71.54 112.228 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.05 -45.66 80.01 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.808 -0.615 . . . . 61.02 112.461 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.15 -23.1 60.65 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 121.877 1.718 . . . . 73.24 113.798 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -67.86 -39.74 83.72 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.352 0.661 . . . . 73.23 109.602 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.425 HG22 ' NH1' ' A' ' 111' ' ' ARG . 48.5 mm -61.61 -40.36 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 75.35 110.126 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.547 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -76.87 -27.03 54.89 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.129 -0.941 . . . . 74.43 112.288 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.402 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 51.2 t80 -57.67 -47.75 98.4 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 117.285 -1.341 . . . . 74.4 114.11 -170.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.78 -39.49 91.03 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.032 1.821 . . . . 75.22 112.863 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -63.48 -43.83 96.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.066 0.947 . . . . 75.14 111.3 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.437 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -76.04 -35.47 59.47 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.897 -0.592 . . . . 73.32 111.605 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -60.45 -47.39 86.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.275 1.43 . . . . 74.21 110.214 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -39.59 87.3 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.365 -0.834 . . . . 73.02 109.959 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.7 t -66.02 -27.99 68.53 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.398 0.679 . . . . 71.42 112.329 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.558 HG23 HG21 ' C' ' 64' ' ' VAL . 78.2 mt -73.12 -49.08 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.938 0.495 . . . . 74.43 110.113 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -58.18 -34.85 70.79 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.028 0.931 . . . . 64.04 111.143 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -62.58 -55.0 31.26 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.912 -1.495 . . . . 73.51 109.79 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.513 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -59.48 -36.92 76.94 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.802 1.241 . . . . 74.34 113.443 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.02 -41.37 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.848 0.459 . . . . 73.43 110.769 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.9 t -66.6 -30.25 70.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.278 -0.873 . . . . 63.05 110.986 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.513 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 89.4 mtt-85 -70.23 -33.46 71.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.535 0.734 . . . . 74.44 110.315 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.14 7.38 63.81 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-N 115.668 -0.696 . . . . 62.05 112.966 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.651 HG23 HH22 ' B' ' 111' ' ' ARG . 17.2 p 62.1 21.27 12.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.897 2.079 . . . . 73.03 113.488 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.31 166.4 15.51 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.168 0.987 . . . . 75.33 110.239 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.78 105.7 0.39 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.296 1.997 . . . . 72.52 111.236 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.432 HE22 ' ND2' ' C' ' 127' ' ' ASN . 0.0 OUTLIER -55.34 141.38 36.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.863 1.265 . . . . 75.43 111.418 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.76 118.14 36.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.631 0.372 . . . . 72.35 111.376 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.432 ' ND2' HE22 ' C' ' 125' ' ' GLN . 12.4 m120 -98.33 85.01 3.32 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.385 -0.969 . . . . 54.31 108.385 169.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.441 HD13 ' HG ' ' C' ' 42' ' ' LEU . 53.5 mt -78.36 142.63 37.52 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.882 -1.054 . . . . 62.41 109.15 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 141.4 94.11 Favored Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 123.934 0.894 . . . . 64.22 112.721 -169.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.402 ' HA ' ' HE2' ' C' ' 107' ' ' PHE . 82.6 Cg_endo -75.36 102.37 1.59 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.785 2.323 . . . . 75.33 111.521 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.2 t -69.19 91.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.295 0.638 . . . . 73.32 110.818 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -83.83 105.91 15.1 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.084 -0.962 . . . . 74.41 110.134 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -52.22 -44.32 64.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.416 0.686 . . . . 74.31 111.229 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.48 -48.27 81.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.582 1.153 . . . . 73.5 111.066 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.659 ' HB3' HD11 ' A' ' 13' ' ' ILE . . . -66.3 -50.22 64.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.617 -0.72 . . . . 72.32 111.054 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.621 HD13 HG21 ' F' ' 207' ' ' VAL . 7.4 tt -58.53 -39.61 80.64 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.204 1.002 . . . . 75.54 110.963 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -70.31 -42.74 71.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.393 0.677 . . . . 75.05 110.304 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.535 ' HE2' ' HA ' ' C' ' 138' ' ' MET . 18.9 mmt -74.63 -26.68 60.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.95 0.9 . . . . 75.1 111.354 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -70.55 -46.92 62.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.125 0.97 . . . . 75.31 109.456 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -73.18 -84.2 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.001 -1.0 . . . . 75.51 110.329 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.523 HD21 ' H ' ' C' ' 141' ' ' LEU . 1.8 pt? -100.53 106.59 18.13 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.834 0.826 . . . . 75.34 110.884 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.415 HE22 ' HA ' ' A' ' 10' ' ' THR . 20.6 tt0 -167.61 139.31 3.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.728 1.211 . . . . 71.32 108.167 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.484 ' H ' HG23 ' A' ' 7' ' ' THR . 6.0 tp-100 -76.2 114.35 14.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.114 -0.699 . . . . 73.01 109.114 175.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.85 96.62 1.02 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.292 -0.632 . . . . 72.14 109.292 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 8' ' ' GLU . . . -75.33 -57.49 3.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.14 -0.689 . . . . 74.51 109.14 172.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.42 -143.1 30.06 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.147 -0.933 . . . . 51.23 111.235 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 62.41 130.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.019 1.728 . . . . 74.21 112.752 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.32 144.79 6.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.136 -0.786 . . . . 75.13 111.136 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.475 ' H ' HD13 ' G' ' 173' ' ' LEU . 10.0 t -111.37 136.72 50.1 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.824 -1.176 . . . . 62.23 107.824 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -68.73 125.06 25.38 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.967 0.507 . . . . 72.3 111.027 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.94 153.9 42.65 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 108.573 -0.899 . . . . 72.33 108.573 169.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -48.67 -61.35 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.52 0.728 . . . . 75.35 110.703 172.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 179.68 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.936 1.294 . . . . 73.34 109.652 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.7 t70 58.63 83.13 0.13 Allowed 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.945 1.403 . . . . 62.42 109.516 -170.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 123.917 0.887 . . . . 74.11 108.972 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtp . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.316 -0.624 . . . . 73.45 109.316 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -158.78 121.85 3.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.461 -0.94 . . . . 64.5 108.461 -174.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.83 42.94 2.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.527 0.731 . . . . 72.52 110.064 -167.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -69.91 -71.52 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.229 0.612 . . . . 65.42 111.069 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -172.44 134.8 0.69 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.759 0.823 . . . . 72.04 109.804 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.449 HD21 HD21 ' H' ' 173' ' ' LEU . 25.0 t30 -171.89 74.78 0.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.445 -1.687 . . . . 70.01 106.445 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -105.64 -160.88 0.77 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.943 -1.48 . . . . 73.44 109.665 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.426 ' HG3' ' HB3' ' B' ' 144' ' ' GLN . 3.6 mp0 60.84 50.82 5.06 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 123.719 0.808 . . . . 73.43 109.162 -171.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.564 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 6.0 ptm -30.11 131.01 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.91 2.084 . . . . 64.13 115.707 -171.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.5 m -130.31 139.47 50.71 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 62.41 108.468 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.83 100.07 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.896 -1.52 . . . . 73.33 106.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.56 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.0 mt-30 -118.31 153.73 33.49 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.421 -0.955 . . . . 74.54 108.421 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.1 141.44 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.881 -1.525 . . . . 75.41 106.881 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.435 ' HB3' ' CZ ' ' C' ' 32' ' ' PHE . 69.8 mt-30 -109.89 -35.2 6.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.84 0.456 . . . . 74.15 110.008 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -173.77 124.06 0.36 Allowed 'General case' 0 C--N 1.367 1.326 0 O-C-N 123.272 0.358 . . . . 74.24 111.028 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 38.4 mm -110.87 118.92 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 72.42 109.075 175.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.489 ' HB3' HG22 ' C' ' 122' ' ' THR . 9.0 p90 -149.6 175.96 11.07 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.909 0.861 . . . . 75.45 111.82 -171.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.2 p -98.99 119.03 37.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.238 -1.347 . . . . 62.43 109.733 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -84.49 -38.75 19.71 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.902 -0.59 . . . . 75.21 110.207 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.99 136.38 23.96 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.871 -0.788 . . . . 64.14 108.871 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.502 HG23 ' HE1' ' C' ' 117' ' ' MET . 60.9 mt -130.16 132.35 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.885 -1.524 . . . . 73.51 106.885 172.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -145.44 114.96 7.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 123.394 0.434 . . . . 64.54 110.244 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.4 t80 -111.39 120.25 41.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.751 -1.574 . . . . 73.41 106.751 167.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.85 119.38 25.53 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.62 94.57 10.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 109.114 -0.699 . . . . 70.33 109.114 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.27 -57.4 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.15 2.567 . . . . 70.43 112.727 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -92.57 22.09 4.93 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.634 -0.698 . . . . 63.44 111.055 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.548 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -28.19 -64.24 0.16 Allowed Pre-proline 0 CA--C 1.577 2.018 0 N-CA-C 117.401 2.371 . . . . 70.03 117.401 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' D' ' 28' ' ' ALA . 53.7 Cg_endo -82.95 -19.62 5.73 Favored 'Trans proline' 0 C--N 1.389 2.661 0 CA-C-N 122.491 1.925 . . . . 74.41 113.57 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -70.01 -40.99 74.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.346 1.058 . . . . 75.25 109.727 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.614 HG21 HD11 ' D' ' 68' ' ' LEU . 4.9 p -86.09 -0.87 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 C-N-CA 123.537 0.735 . . . . 74.32 111.249 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.506 ' HB2' HH11 ' C' ' 15' ' ' ARG . 82.3 t80 -62.1 -30.82 71.28 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.961 0.504 . . . . 73.23 110.665 164.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.44 -15.47 63.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 71.35 111.429 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.95 99.95 12.49 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.264 1.026 . . . . 73.42 109.739 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -96.88 50.75 1.11 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.33 1.052 . . . . 74.21 110.561 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -127.22 159.55 33.96 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.511 -0.922 . . . . 73.32 108.511 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -63.43 112.61 7.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.815 0.846 . . . . 60.14 109.96 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -61.47 118.23 5.09 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.652 2.235 . . . . 71.35 111.671 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 51.3 mt-10 -60.38 115.56 3.64 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.235 0.959 . . . . 75.44 110.243 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.577 HG21 HG13 ' D' ' 64' ' ' VAL . 2.5 p -96.14 110.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 122.12 0.962 . . . . 74.31 109.027 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -97.2 107.34 19.84 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.668 -1.604 . . . . 75.53 106.668 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.579 HD22 HD22 ' D' ' 128' ' ' LEU . 55.3 tp -97.14 113.71 25.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.248 -0.649 . . . . 73.22 109.248 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.588 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.8 t70 -113.6 148.74 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.503 -0.554 . . . . 62.11 109.503 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 tp -119.88 135.05 55.03 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.686 0.794 . . . . 72.4 110.543 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -144.05 142.95 30.94 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.155 -1.054 . . . . 74.42 108.155 168.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -120.89 166.54 13.66 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.45 0.7 . . . . 74.04 109.279 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.545 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.74 169.3 24.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.183 0.993 . . . . 73.44 109.015 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 13.3 p -165.0 155.8 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.947 0.404 . . . . 74.54 111.738 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -152.75 135.7 15.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 62.1 109.147 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.35 118.06 22.34 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.394 -0.595 . . . . 73.02 109.394 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' D' ' 57' ' ' GLU . 34.6 mt -95.19 -34.31 12.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.196 0.598 . . . . 72.03 110.267 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.45 -173.43 4.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.03 0.932 . . . . 70.53 110.357 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.58 120.62 14.29 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.316 -0.856 . . . . 75.21 109.519 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 63.46 14.43 7.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.742 1.217 . . . . 61.21 112.178 -176.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.87 119.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.225 -0.657 . . . . 74.21 109.225 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -133.08 130.48 39.39 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.243 1.017 . . . . 73.5 108.376 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.1 tt0 -87.18 112.71 22.24 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.949 -1.13 . . . . 75.52 107.949 169.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.32 124.13 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.006 -1.479 . . . . 73.2 107.006 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 32.8 t -105.02 135.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.691 0.797 . . . . 71.11 109.024 -177.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 121.18 44.6 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.923 -1.14 . . . . 64.41 107.923 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.4 ttm-85 -103.68 102.28 12.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.835 -1.172 . . . . 74.34 107.835 173.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.567 HG23 ' HB1' ' D' ' 110' ' ' ALA . 19.8 t -98.44 120.61 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.664 -0.865 . . . . 71.45 108.664 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.588 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.1 m -108.04 137.41 46.09 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.187 0.595 . . . . 74.3 109.931 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.577 HG13 HG21 ' D' ' 40' ' ' VAL . 50.7 t -136.89 108.04 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 73.53 108.054 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.9 m -101.07 126.94 47.8 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.317 -0.994 . . . . 61.24 108.317 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -111.94 141.44 45.58 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.323 -0.621 . . . . 70.35 109.323 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 57.5 p -145.13 141.99 29.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.708 0.63 . . . . 73.41 111.016 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.614 HD11 HG21 ' D' ' 31' ' ' VAL . 39.9 mt -136.35 112.51 9.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.777 1.231 . . . . 74.21 109.456 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.12 -109.72 2.97 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.368 -0.693 . . . . 72.24 111.368 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -122.54 4.09 9.6 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.495 0.718 . . . . 70.55 110.588 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.7 153.09 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.316 0.646 . . . . 72.45 110.601 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -76.53 116.61 17.37 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 122.774 0.429 . . . . 70.23 110.42 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -69.5 -56.58 6.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.541 -0.754 . . . . 74.21 111.026 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.96 174.06 15.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.43 -0.804 . . . . 64.43 110.654 170.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.36 145.19 51.73 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.88 -1.526 . . . . 73.12 106.88 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 53.0 t -157.79 121.21 4.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.863 -0.792 . . . . 73.53 108.863 -174.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.83 129.03 10.46 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.468 -0.567 . . . . 70.42 109.468 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.94 121.2 53.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.875 0.87 . . . . 72.33 109.577 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -87.84 85.01 6.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.387 -0.968 . . . . 74.2 108.387 167.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -79.98 97.8 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.324 -0.991 . . . . 60.12 108.324 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.59 143.72 16.74 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.859 -0.496 . . . . 63.34 111.859 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.541 ' HA3' HD23 ' D' ' 106' ' ' LEU . . . -141.43 131.48 4.86 Favored Glycine 0 CA--C 1.505 -0.532 0 N-CA-C 111.421 -0.672 . . . . 55.22 111.421 -175.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -90.31 125.72 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.574 -0.899 . . . . 73.24 108.574 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.5 127.86 43.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.942 0.897 . . . . 73.41 109.684 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 49.0 m -81.82 93.18 6.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.256 -1.016 . . . . 71.41 108.256 165.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.52 128.36 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.968 1.707 . . . . 64.42 109.751 -172.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 164.99 20.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 72.53 109.958 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 83.07 11.54 80.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.092 -0.504 . . . . 71.44 114.182 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.17 168.35 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.457 0.703 . . . . 74.12 110.571 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.471 ' HB2' ' H ' ' H' ' 172' ' ' ALA . 5.7 pt-20 -162.51 146.61 11.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.894 -1.048 . . . . 73.34 109.815 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.672 ' H ' ' HB3' ' H' ' 172' ' ' ALA . . . 42.88 -107.61 0.12 Allowed Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.307 1.004 . . . . 75.01 114.915 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -67.27 -38.58 85.33 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.492 0.717 . . . . 73.15 110.937 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.72 -31.95 73.28 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.77 0.828 . . . . 73.24 110.573 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 45.1 ttm -67.74 -50.77 55.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.682 0.793 . . . . 75.2 110.284 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.24 62.69 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.829 -0.623 . . . . 63.53 111.303 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -79.51 -32.37 42.33 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.398 0.679 . . . . 75.54 110.31 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.2 t -78.27 -52.75 8.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 117.729 0.24 . . . . 74.3 110.356 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.41 -18.52 31.56 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.658 0.383 . . . . 74.31 111.788 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.68 -8.98 29.54 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.266 -0.741 . . . . 70.32 114.254 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.33 -55.21 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.027 0.914 . . . . 73.03 112.329 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -76.34 -50.94 12.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.096 0.559 . . . . 75.24 111.994 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 71.0 m -60.96 -46.19 96.69 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 118.438 -0.791 . . . . 74.43 110.478 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.96 -39.57 59.27 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.263 1.976 . . . . 73.21 114.019 163.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.03 -26.61 65.07 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.353 0.661 . . . . 71.22 110.753 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -72.56 -38.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.892 0.877 . . . . 74.51 110.387 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.541 HD23 ' HA3' ' D' ' 82' ' ' GLY . 42.3 mt -79.64 -17.89 52.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.032 -0.986 . . . . 72.41 111.209 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -68.69 -38.64 12.46 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.18 1.178 . . . . 71.42 114.18 -171.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.34 -46.78 29.93 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.101 1.868 . . . . 74.12 113.095 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.86 -33.21 68.24 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.158 -0.928 . . . . 73.01 111.123 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -67.61 -54.24 21.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.927 0.891 . . . . 75.13 110.152 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -50.56 -46.5 57.65 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.987 1.43 . . . . 74.0 110.811 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -66.43 -46.07 77.7 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.175 0.922 . . . . 72.3 111.732 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.494 ' SG ' HD11 ' D' ' 21' ' ' ILE . 49.5 t -59.95 -41.71 92.44 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.737 0.648 . . . . 72.2 110.709 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.493 HG22 ' SG ' ' D' ' 76' ' ' CYS . 81.7 mt -59.45 -56.99 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.365 1.066 . . . . 74.53 110.671 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.572 HG22 ' HG3' ' D' ' 125' ' ' GLN . 54.9 m -53.93 -41.37 67.63 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.276 1.43 . . . . 75.31 111.865 -174.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -67.82 -42.59 81.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.923 -1.035 . . . . 73.33 109.958 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.626 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.6 mtm -71.11 -28.07 64.05 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.887 0.475 . . . . 74.45 111.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.42 -42.74 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.438 0.695 . . . . 72.22 110.135 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -74.38 -26.53 60.17 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.972 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -76.09 -24.16 55.02 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.458 0.703 . . . . 75.13 109.826 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.72 12.24 66.15 Favored Glycine 0 C--N 1.352 1.432 0 O-C-N 123.654 0.596 . . . . 74.33 112.258 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.526 HG22 ' HB3' ' C' ' 17' ' ' TYR . 80.6 p 62.95 9.98 4.09 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 127.385 2.274 . . . . 74.33 114.6 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.487 ' HZ ' HG13 ' D' ' 31' ' ' VAL . 41.9 m-85 -89.37 156.42 48.34 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.172 0.589 . . . . 74.31 110.65 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.89 141.37 89.52 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.714 2.276 . . . . 74.21 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.572 ' HG3' HG22 ' D' ' 115' ' ' THR . 28.2 tt0 -54.51 145.55 18.32 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.686 1.194 . . . . 74.34 112.107 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 114.8 15.74 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.065 -1.087 . . . . 74.12 108.065 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -100.78 93.24 5.46 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.12 -0.696 . . . . 72.32 109.12 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.579 HD22 HD22 ' D' ' 42' ' ' LEU . 89.0 mt -59.0 115.48 3.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.25 0.62 . . . . 72.23 110.92 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -65.3 127.84 93.26 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.773 0.429 . . . . 75.33 111.867 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.28 102.01 1.52 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 75.05 110.399 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.01 130.0 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.537 -0.756 . . . . 75.31 109.71 -174.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -92.64 116.37 28.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.4 -0.963 . . . . 75.54 108.4 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -63.62 -14.74 54.6 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 119.58 -0.248 . . . . 74.21 111.148 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.56 -50.37 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.875 1.27 . . . . 74.23 111.127 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.76 54.6 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.405 1.066 . . . . 65.23 110.706 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.487 HD23 HG21 ' G' ' 207' ' ' VAL . 2.7 mm? -71.52 -25.01 62.07 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.105 0.562 . . . . 73.02 112.001 -174.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.28 -49.71 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.261 1.024 . . . . 75.34 109.613 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.46 -46.13 50.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.621 0.768 . . . . 73.43 110.731 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -62.1 -31.28 71.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.603 0.761 . . . . 72.32 112.125 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -55.44 -40.38 71.46 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.475 0.484 . . . . 75.04 110.901 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.89 -46.97 10.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.14 0.576 . . . . 71.43 112.106 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -85.3 4.97 32.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.043 0.757 . . . . 65.44 113.043 -170.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -117.21 90.3 3.3 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.509 -0.923 . . . . 74.52 108.509 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.67 17.59 1.82 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.079 -1.419 . . . . 63.02 109.188 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.54 14.73 23.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.993 0.917 . . . . 74.44 111.371 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.77 -16.68 59.49 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.632 0.634 . . . . 71.31 114.231 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -63.24 91.59 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.77 0.795 . . . . 74.4 109.978 168.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.47 -128.99 2.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-O 119.146 -0.808 . . . . 62.34 111.431 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 30.8 m 59.2 85.51 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.642 1.177 . . . . 63.33 109.496 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 63.2 -167.82 0.21 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.187 0.995 . . . . 73.23 111.316 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 103.38 1.71 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.121 -0.696 . . . . 64.12 109.121 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -113.23 115.94 28.99 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.614 0.766 . . . . 75.04 108.965 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -76.88 94.69 3.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.563 -0.532 . . . . 74.1 109.563 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.76 136.35 36.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.183 0.593 . . . . 74.04 109.968 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 C-N-CA 123.837 0.855 . . . . 73.12 110.356 -178.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.368 -0.604 . . . . 75.41 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . 0.552 ' HA2' ' HB2' ' E' ' 173' ' ' LEU . . . 163.19 -123.7 1.21 Allowed Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.366 -0.686 . . . . 41.31 111.555 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? 66.75 -76.8 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.233 1.413 . . . . 62.24 109.66 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -78.5 82.15 4.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.589 0.756 . . . . 74.03 109.018 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 62.57 -128.22 0.62 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.276 0.985 . . . . 71.33 110.599 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . 0.698 HD23 ' HA ' ' C' ' 54' ' ' ASP . 44.0 mt 61.86 74.83 0.43 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 124.468 1.107 . . . . 73.03 110.838 172.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 174' ' ' MET . . . . . 0.621 ' SD ' ' HE2' ' C' ' 94' ' ' MET . 1.0 OUTLIER -81.01 -42.64 20.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.883 -1.508 . . . . 73.33 110.281 -172.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 32.5 t80 56.99 -85.12 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.601 1.16 . . . . 72.12 109.67 -164.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.94 25.72 4.84 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.153 0.981 . . . . 74.14 112.774 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' C' ' 95' ' ' ALA . 6.5 mp -101.26 128.68 47.29 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.785 -0.82 . . . . 74.32 108.785 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -145.06 99.38 3.32 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.272 -1.381 . . . . 75.34 107.272 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 69.48 151.74 0.13 Allowed Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 125.664 1.585 . . . . 72.13 111.496 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.95 103.05 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.319 2.013 . . . . 65.25 110.991 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -61.21 -30.43 70.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.74 0.816 . . . . 75.32 111.987 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -135.39 114.21 11.95 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.15 -1.056 . . . . 72.14 108.15 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 33.6 m -79.93 139.73 36.96 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.558 0.743 . . . . 72.3 109.918 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -112.05 94.96 27.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 N-CA-C 109.029 -0.73 . . . . 73.22 109.029 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.98 124.95 15.41 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.716 2.277 . . . . 74.31 112.824 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.05 165.06 16.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 74.01 109.863 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 46.2 pt -68.99 148.65 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.027 0.441 . . . . 74.41 111.634 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -77.62 123.52 26.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.373 -0.973 . . . . 74.52 108.373 167.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.74 -88.21 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 O-C-N 123.862 0.726 . . . . 62.23 111.707 -173.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 27.6 t70 44.62 -90.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.301 1.44 . . . . 73.33 112.01 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 51.66 -90.7 0.01 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 124.992 1.282 . . . . 72.14 115.841 167.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' F' ' 194' ' ' ALA . . . -74.11 96.37 0.88 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.704 -0.748 . . . . 74.51 113.153 -174.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -87.08 -24.46 24.56 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.431 0.692 . . . . 72.43 110.174 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' F' ' 193' ' ' TYR . . . -106.94 130.23 54.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.049 0.54 . . . . 63.45 111.254 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -144.72 150.18 36.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.913 1.285 . . . . 75.04 108.507 175.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.71 110.02 21.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.221 -0.659 . . . . 73.14 109.221 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -142.25 116.5 9.51 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.43 -1.693 . . . . 73.05 106.43 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . 0.554 ' HG2' ' H ' ' E' ' 199' ' ' ASN . 17.5 tt0 67.41 -171.04 0.19 Allowed 'General case' 0 CA--C 1.571 1.777 0 O-C-N 124.139 0.899 . . . . 75.53 110.526 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . 0.554 ' H ' ' HG2' ' E' ' 198' ' ' GLU . 21.5 t-20 69.97 105.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.384 1.474 . . . . 74.1 111.828 171.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.76 -67.24 3.46 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 111.342 -0.703 . . . . 62.42 111.342 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.94 171.21 19.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.277 1.031 . . . . 73.44 108.543 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 49.4 t80 76.75 18.07 1.68 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.571 1.548 . . . . 71.31 109.187 -169.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -87.91 -31.34 19.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.86 1.664 . . . . 74.35 110.65 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' B' ' 129' ' ' ALA . 8.0 mt 71.41 -8.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 126.142 1.777 . . . . 64.4 112.027 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.36 -11.68 59.87 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.235 1.014 . . . . 75.13 110.605 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.59 67.98 6.64 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.45 1.1 . . . . 64.55 110.152 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 75.3 t . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.638 1.175 . . . . 74.0 108.835 -178.038 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.638 -0.134 . . . . 74.21 110.638 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -156.58 -135.59 1.98 Allowed Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.535 -0.592 . . . . 64.55 111.757 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.61 0.764 . . . . 70.33 110.93 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 39.7 m -75.62 1.19 15.09 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.545 0.738 . . . . 72.21 111.643 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -95.48 15.84 18.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.57 0.748 . . . . 73.41 110.729 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.574 HD23 ' HE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -63.83 124.51 21.68 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.289 -0.634 . . . . 73.14 109.289 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.766 ' SD ' ' HG2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -153.61 178.83 9.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.146 1.378 . . . . 71.42 109.206 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -149.25 140.65 23.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.349 0.659 . . . . 72.23 109.629 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -157.2 109.2 2.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.96 -1.126 . . . . 75.25 107.96 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . 0.478 ' HA ' HD22 ' B' ' 98' ' ' LEU . 38.8 tp -67.06 100.53 0.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.785 -0.45 . . . . 75.5 109.785 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . 0.565 ' HB3' ' HA3' ' B' ' 99' ' ' GLY . 51.4 tp60 -69.39 116.87 10.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.29 0.636 . . . . 72.33 110.202 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . 0.537 ' H ' ' HD2' ' F' ' 180' ' ' PRO . 34.7 mt-10 -128.73 -50.34 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.145 0.978 . . . . 72.4 111.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . 0.537 ' HD2' ' H ' ' F' ' 179' ' ' GLU . 85.6 Cg_endo -74.76 -159.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.4 3.246 0 C-N-CA 121.923 1.749 . . . . 73.2 112.687 177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 68.5 135.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.237 1.415 . . . . 64.12 112.705 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 69.13 -71.48 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.253 1.421 . . . . 74.31 113.118 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 15.5 m 69.92 105.21 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.094 1.358 . . . . 74.42 110.121 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.514 ' HE1' ' HB3' ' B' ' 44' ' ' LEU . 4.6 p90 -87.17 110.08 30.4 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.221 1.008 . . . . 74.52 111.589 -173.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.76 77.13 4.0 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.411 2.074 . . . . 73.1 111.734 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.53 HD11 HD21 ' B' ' 128' ' ' LEU . 0.5 OUTLIER -97.16 10.9 38.13 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.061 0.763 . . . . 74.14 113.061 -174.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 7.7 tp -158.87 169.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 110.052 -0.351 . . . . 74.11 110.052 175.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.29 -19.86 0.13 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 72.43 111.422 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . 61.11 -146.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.903 0.881 . . . . 64.31 109.897 -170.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 34.2 t70 73.78 158.88 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.436 1.094 . . . . 75.42 112.109 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 65.51 11.68 53.85 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 115.549 0.979 . . . . 52.21 115.549 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.52 108.54 3.66 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.733 -0.547 . . . . 75.24 111.733 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' E' ' 194' ' ' ALA . 64.9 m-85 -138.64 87.8 2.25 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 123.795 0.838 . . . . 74.42 108.946 173.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . 0.442 ' HA ' ' HA2' ' E' ' 192' ' ' GLY . . . -130.95 -8.17 3.92 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.447 -1.251 . . . . 52.03 111.289 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . 0.491 ' HB2' ' HG2' ' B' ' 124' ' ' PRO . 56.8 t80 -91.57 106.69 18.67 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.69 0.796 . . . . 74.42 109.531 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -144.93 136.22 25.11 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.799 -1.185 . . . . 70.42 107.799 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -71.45 -55.01 8.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 74.51 108.202 171.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.84 112.64 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.011 -0.737 . . . . 74.25 109.011 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 16.4 m120 60.73 83.09 0.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.182 0.993 . . . . 71.3 109.841 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.04 127.17 2.07 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.906 -0.588 . . . . 65.25 112.102 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . 0.409 ' HG3' ' CD1' ' F' ' 202' ' ' TYR . 39.7 pttt -92.93 -6.54 48.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.089 0.956 . . . . 74.01 111.002 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . 0.409 ' CD1' ' HG3' ' F' ' 201' ' ' LYS . 2.8 m-30 -103.91 1.91 31.88 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.177 0.991 . . . . 74.31 110.975 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -137.47 165.73 25.55 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.016 0.526 . . . . 74.35 109.716 -171.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 10.1 tt -101.69 119.93 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.543 1.137 . . . . 75.0 109.863 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -78.78 -47.77 16.12 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.404 0.621 . . . . 74.22 109.702 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -144.34 -55.48 0.35 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.228 -1.397 . . . . 53.13 107.228 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . 0.621 HG21 HD13 ' C' ' 136' ' ' LEU . 28.2 m . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 125.132 1.373 . . . . 74.41 109.157 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 6.4 mptt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 108.676 -0.861 . . . . 72.11 108.676 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -66.25 83.88 0.1 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.691 -0.564 . . . . 63.01 111.691 173.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -126.44 -86.66 0.6 Allowed 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.592 1.157 . . . . 74.13 108.19 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 171' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' A' ' 54' ' ' ASP . 16.8 t 66.06 176.8 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.722 1.209 . . . . 60.03 113.581 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -102.97 -175.08 2.7 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.81 -0.811 . . . . 74.12 108.81 166.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . 0.475 HD13 ' H ' ' C' ' 149' ' ' THR . 0.0 OUTLIER -133.91 23.08 3.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.277 0.631 . . . . 75.13 111.895 -169.002 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.578 ' SD ' ' HG2' ' A' ' 94' ' ' MET . 7.5 ptt? -159.28 151.85 21.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.864 0.69 . . . . 75.41 112.864 -161.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.575 ' HA ' HD11 ' A' ' 98' ' ' LEU . 57.7 m-85 -137.85 -61.93 0.61 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.246 1.418 . . . . 75.05 108.778 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 73.81 -4.1 2.34 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.987 1.715 . . . . 74.05 112.038 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.0 -25.03 64.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.329 0.652 . . . . 75.53 111.62 -172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . 0.564 ' HG2' ' HG3' ' G' ' 179' ' ' GLU . 27.4 tt0 -49.65 -49.82 45.74 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.237 1.015 . . . . 75.13 110.961 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . 0.564 ' HG3' ' HG2' ' G' ' 178' ' ' GLN . 31.0 mt-10 -134.06 101.31 12.6 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.415 1.086 . . . . 75.31 108.157 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.54 106.84 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.731 2.287 . . . . 74.4 110.746 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -52.88 -35.87 58.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.731 1.212 . . . . 74.22 113.22 -172.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -94.46 -24.12 17.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.691 0.796 . . . . 75.34 110.974 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 56.8 m 69.73 126.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.715 1.206 . . . . 72.31 112.671 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 1.5 p-90 -146.91 91.65 5.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.488 0.715 . . . . 64.34 110.622 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.24 -19.55 19.71 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.657 2.238 . . . . 72.42 112.946 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 79.2 mt 61.15 -176.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.21 1.404 . . . . 74.15 112.689 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -92.91 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.557 -0.747 . . . . 75.4 110.592 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -136.81 178.8 6.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.061 0.945 . . . . 45.21 109.179 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -125.42 171.71 10.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.542 0.737 . . . . 73.11 110.624 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -127.48 -60.48 1.18 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.111 0.564 . . . . 64.41 109.591 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.3 -110.67 0.46 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.047 -0.421 . . . . 53.32 112.047 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' H' ' 200' ' ' GLY . . . 89.85 46.33 4.26 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.753 -0.539 . . . . 73.33 111.753 -176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.48 -174.52 2.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.171 0.989 . . . . 75.12 109.424 175.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -157.57 -65.65 0.09 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.443 0.534 . . . . 72.4 112.443 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 64.07 172.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.579 1.152 . . . . 71.43 112.127 -168.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -136.91 93.0 2.79 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.603 -0.517 . . . . 74.44 109.603 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -115.0 73.4 0.83 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.666 0.786 . . . . 75.52 110.15 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.46 -3.38 55.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.701 -0.681 . . . . 71.2 109.206 164.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -158.03 -173.16 4.21 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.167 1.387 . . . . 75.24 109.596 -167.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -81.95 -15.56 74.71 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.634 -0.536 . . . . 73.44 112.91 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.68 -0.55 3.13 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.775 1.23 . . . . 74.24 112.685 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.96 22.59 0.38 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 107.308 -1.368 . . . . 74.25 107.308 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.65 106.45 4.07 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.439 -1.255 . . . . 74.13 111.742 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 11.0 pt -129.92 118.69 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.15 -1.426 . . . . 74.04 107.15 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.19 -34.3 14.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.459 1.104 . . . . 71.03 113.638 -165.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.43 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.194 -1.039 . . . . 71.22 108.194 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . 0.487 HG21 HD23 ' D' ' 136' ' ' LEU . 4.2 p . . . . . 0 CA--C 1.556 1.177 0 C-N-CA 123.928 0.891 . . . . 73.01 108.946 174.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 46.7 tptt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.159 -0.682 . . . . 74.11 109.159 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -125.29 -152.49 8.25 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 112.282 -0.327 . . . . 64.22 112.282 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -79.89 140.2 36.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.232 -1.025 . . . . 65.51 108.232 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 14.8 p -65.66 85.01 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.833 0.825 . . . . 62.41 110.73 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.672 ' HB3' ' H ' ' D' ' 91' ' ' GLY . . . -115.74 -173.68 2.39 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.053 1.341 . . . . 75.43 110.016 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.449 HD21 HD21 ' D' ' 6' ' ' ASN . 1.5 tt -157.77 -74.19 0.09 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 122.841 0.456 . . . . 73.51 109.922 -176.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.534 ' HE1' ' HA ' ' H' ' 174' ' ' MET . 27.4 mmt -81.62 159.61 23.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.753 0.421 . . . . 73.34 111.218 -175.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -46.78 103.04 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 O-C-N 125.031 1.457 . . . . 71.4 112.493 -166.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -107.98 -66.6 1.02 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.562 1.145 . . . . 73.1 108.599 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 21.3 tp 59.93 22.6 11.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.681 1.192 . . . . 75.21 111.655 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -88.69 6.97 35.98 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.647 0.779 . . . . 75.11 111.381 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -79.11 116.69 62.06 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.706 0.802 . . . . 72.41 110.438 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.11 110.82 1.32 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.4 2.067 . . . . 73.51 111.518 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.636 -0.875 . . . . 74.2 108.636 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -63.82 -71.82 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.201 0.6 . . . . 75.31 110.861 -172.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.1 p -145.64 164.17 32.58 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.216 1.007 . . . . 74.43 108.619 174.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -113.31 92.03 21.39 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 107.995 -1.113 . . . . 75.24 107.995 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.64 88.08 1.17 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.153 2.569 . . . . 74.23 111.874 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.86 125.94 30.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.784 -0.821 . . . . 75.01 108.784 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 24.4 pt -62.03 138.98 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 124.234 0.959 . . . . 75.53 111.366 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.44 1.01 43.77 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.485 -0.779 . . . . 73.12 110.389 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . 75.92 -65.67 0.31 Allowed 'General case' 0 C--N 1.363 1.153 0 C-N-CA 126.029 1.732 . . . . 74.21 112.485 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 65.15 -172.12 0.18 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.745 1.218 . . . . 74.2 111.186 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.3 100.43 0.14 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.84 -0.618 . . . . 75.34 112.621 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -174.74 100.34 0.15 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 112.245 -0.342 . . . . 74.24 112.245 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.63 -54.39 3.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.793 -0.817 . . . . 74.45 108.793 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.45 -174.25 2.17 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.267 -1.333 . . . . 72.24 109.266 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -172.63 -15.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.931 0.769 . . . . 74.31 111.579 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 68.52 94.51 0.07 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.849 0.86 . . . . 73.5 109.141 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . 0.448 ' HE2' ' HA ' ' D' ' 32' ' ' PHE . 10.3 t80 -80.83 -30.32 35.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.453 1.101 . . . . 74.51 111.869 -170.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -85.47 178.52 7.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.226 1.01 . . . . 70.42 111.65 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . 0.414 ' HB3' ' CD2' ' H' ' 202' ' ' TYR . 93.2 m-20 -92.41 -170.8 2.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.309 1.043 . . . . 75.33 109.862 172.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . 0.418 ' HA3' ' HA3' ' G' ' 192' ' ' GLY . . . -147.9 -79.03 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.296 -0.321 . . . . 72.12 112.296 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.11 68.14 9.88 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.651 0.78 . . . . 75.21 109.945 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' H' ' 199' ' ' ASN . 79.4 m-85 -136.75 92.44 2.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 74.02 108.809 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.18 82.12 8.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.465 -0.789 . . . . 72.51 109.128 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.46 73.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 107.883 -1.155 . . . . 72.43 107.883 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -122.87 24.91 8.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.221 -1.354 . . . . 73.31 109.864 -171.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.1 -172.07 2.36 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.69 0.796 . . . . 72.54 109.803 -177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 136' ' ' LEU . 7.0 m . . . . . 0 C--O 1.257 1.456 0 C-N-CA 123.018 0.527 . . . . 75.2 110.594 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 111.376 0.139 . . . . 73.53 111.376 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -132.33 40.17 3.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 73.02 109.215 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.64 120.23 12.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.508 0.723 . . . . 74.53 110.879 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.26 102.11 0.81 Allowed 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.007 0.817 . . . . 73.05 109.043 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -73.95 72.35 1.6 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.003 0.906 . . . . 74.42 110.583 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -69.71 103.43 2.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.987 -1.006 . . . . 73.41 108.301 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -83.9 30.61 0.5 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 70.12 111.635 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -54.36 -44.58 72.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.252 1.421 . . . . 73.33 109.829 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.88 167.18 17.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.657 -1.156 . . . . 75.15 112.238 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.7 m -149.43 143.88 26.0 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.114 0.965 . . . . 75.3 109.52 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.471 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 65.3 t80 -128.13 147.35 50.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.053 0.941 . . . . 72.2 109.676 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -158.93 137.37 10.8 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 120.74 0.305 . . . . 75.25 111.394 173.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.503 HG13 ' HB3' ' C' ' 132' ' ' ASN . 13.5 mm -74.78 118.73 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.427 -0.953 . . . . 72.52 108.427 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -89.25 -38.39 14.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.685 -0.487 . . . . 74.1 109.685 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.98 153.24 4.64 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 123.39 0.432 . . . . 74.01 111.259 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.513 ' H ' ' HG3' ' C' ' 130' ' ' PRO . 98.3 mt -137.02 126.68 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.731 1.613 . . . . 74.42 106.814 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -154.61 157.11 37.71 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.461 1.104 . . . . 70.0 109.598 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.546 HG23 ' SG ' ' A' ' 113' ' ' CYS . 45.3 p -86.99 117.17 25.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.881 -0.785 . . . . 73.52 108.881 170.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 42.0 mtpt -83.56 -22.35 32.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.43 0.292 . . . . 75.04 110.284 173.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.4 t70 -153.8 140.02 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.681 -0.691 . . . . 75.22 109.667 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 40.8 mt -136.64 133.18 48.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.953 -1.499 . . . . 73.32 106.953 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -145.37 107.59 4.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.156 -0.683 . . . . 54.34 109.156 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.649 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.2 t80 -119.25 110.32 16.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.872 -1.529 . . . . 75.24 106.872 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 40.6 mt-10 -116.95 108.21 15.5 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.756 -1.572 . . . . 70.4 106.756 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.68 83.05 0.72 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 106.946 -1.502 . . . . 72.12 106.946 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 13.7 Cg_exo -68.69 -31.63 25.57 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.726 2.284 . . . . 72.35 111.704 -168.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 27.7 m-80 -118.24 39.99 3.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.059 -0.973 . . . . 75.22 108.807 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.23 -50.0 87.17 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.083 -0.962 . . . . 75.11 113.203 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 -24.67 22.33 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 121.775 1.65 . . . . 45.12 113.132 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -69.76 -24.45 63.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.408 0.683 . . . . 71.33 111.802 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG13 ' HE1' ' A' ' 123' ' ' PHE . 88.6 t -57.21 -33.26 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.401 0.68 . . . . 74.24 111.465 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -64.05 -32.13 73.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.748 0.819 . . . . 72.41 111.224 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -80.49 -27.04 37.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.352 1.061 . . . . 73.42 110.255 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -82.67 162.07 21.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 75.33 112.362 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.92 129.29 34.72 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.363 -1.347 . . . . 73.14 107.363 163.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.448 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.1 t-105 -77.32 84.17 3.76 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.745 0.784 . . . . 72.35 110.329 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -132.01 77.11 72.34 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.204 -1.406 . . . . 74.14 107.204 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.8 146.17 37.59 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.102 1.868 . . . . 73.42 112.077 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -96.34 86.12 4.12 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.39 -1.708 . . . . 75.15 106.39 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.01 102.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.54 -1.209 . . . . 74.02 110.823 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -111.49 146.18 37.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.918 0.887 . . . . 75.12 110.184 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.01 153.19 37.68 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.76 0.824 . . . . 73.21 110.659 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.0 t70 -142.9 113.82 7.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.883 0.873 . . . . 73.01 108.66 174.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -98.84 119.97 38.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.5 -0.926 . . . . 74.01 108.5 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.3 142.87 39.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 74.44 109.952 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -110.03 144.76 38.13 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.817 0.847 . . . . 70.4 108.815 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.34 113.63 12.81 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.077 -1.083 . . . . 73.15 108.077 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.409 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 35.5 p -88.04 151.02 23.06 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.268 0.627 . . . . 64.32 111.062 -172.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.0 t -163.0 136.72 5.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.207 1.003 . . . . 70.53 109.098 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.64 124.53 52.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.029 0.531 . . . . 72.22 109.75 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.82 -43.16 12.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.33 0.652 . . . . 74.3 110.055 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.28 175.43 13.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.638 -1.164 . . . . 74.21 109.676 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.06 119.1 11.44 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.609 -0.886 . . . . 74.42 108.609 173.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.564 ' HA ' ' HE3' ' G' ' 174' ' ' MET . 65.2 m-20 78.26 -7.66 1.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.778 1.631 . . . . 72.21 113.19 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.83 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.786 -1.19 . . . . 74.21 107.786 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.547 ' HH ' ' HB2' ' G' ' 175' ' ' PHE . 9.3 t80 -117.24 155.33 29.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.844 -0.798 . . . . 72.21 108.844 -171.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -127.23 113.77 16.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.315 -0.994 . . . . 72.41 108.315 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.09 117.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.863 -1.532 . . . . 71.5 106.863 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.617 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.6 t -98.36 131.87 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -102.12 112.27 24.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.261 -1.385 . . . . 75.41 107.261 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -101.87 99.98 10.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.439 -0.948 . . . . 75.24 108.439 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -98.0 132.94 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.991 -1.114 . . . . 74.53 107.991 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 18.7 m -128.77 137.69 51.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.169 0.509 . . . . 73.14 110.096 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.722 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.3 t -130.94 125.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.354 1.462 . . . . 72.31 108.695 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -118.58 150.64 39.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.684 0.394 . . . . 71.44 110.097 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.02 112.17 8.02 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.593 -0.892 . . . . 64.23 108.593 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -113.01 126.39 55.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.356 0.598 . . . . 74.34 110.411 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.448 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.0 mt -89.18 75.6 7.82 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.025 1.33 . . . . 71.43 108.652 175.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -82.91 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 111.07 -0.812 . . . . 73.42 111.07 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 -19.1 5.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.457 1.103 . . . . 71.24 111.742 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.68 126.94 36.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.031 0.933 . . . . 73.33 109.305 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -77.16 127.59 32.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.148 0.885 . . . . 75.33 110.388 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -77.9 -55.74 5.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.081 0.952 . . . . 71.33 108.818 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -157.66 169.34 24.88 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.895 -1.502 . . . . 74.3 110.429 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 tp -141.17 138.11 33.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.39 -1.277 . . . . 64.44 108.164 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.722 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.2 m -128.82 140.6 51.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.038 0.935 . . . . 73.32 109.531 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -149.42 133.53 17.23 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.388 -0.967 . . . . 74.24 108.388 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 113' ' ' CYS . 48.1 t -134.81 110.52 12.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.504 -0.924 . . . . 75.22 108.504 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.2 mt-30 -88.88 79.57 7.33 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.147 -1.057 . . . . 75.53 108.147 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.06 92.77 3.21 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.032 -0.985 . . . . 75.13 108.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.47 146.48 20.88 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.363 -0.38 . . . . 72.11 112.704 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.1 135.89 6.72 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.789 0.295 . . . . 64.53 112.409 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.7 mt -82.27 126.92 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.332 -0.988 . . . . 74.23 108.332 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.45 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.1 m-85 -133.18 121.0 21.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.876 -0.787 . . . . 71.5 108.876 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -78.31 113.36 16.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.644 -0.873 . . . . 41.45 108.644 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.31 133.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.559 0.744 . . . . 72.51 110.188 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.04 144.84 14.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.804 0.841 . . . . 75.41 109.698 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.37 9.21 86.79 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.783 0.677 . . . . 65.43 113.961 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.608 HD11 ' SD ' ' A' ' 94' ' ' MET . 0.9 OUTLIER -109.89 131.44 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.124 -0.695 . . . . 74.54 109.124 -173.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -147.22 176.33 10.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.073 0.949 . . . . 62.15 109.727 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 -114.98 3.89 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 124.185 0.928 . . . . 71.13 113.994 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.2 p -82.3 -27.29 32.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.51 1.124 . . . . 73.32 111.17 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.57 -42.55 67.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.896 0.879 . . . . 71.31 110.523 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.608 ' SD ' HD11 ' A' ' 89' ' ' ILE . 10.6 tpt -78.52 -34.65 47.15 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.174 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.06 -29.18 70.34 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.004 0.43 . . . . 74.12 111.313 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -70.71 -56.16 7.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.295 -0.866 . . . . 74.43 109.709 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 77.3 m -65.48 -65.53 0.66 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 123.867 0.729 . . . . 71.52 111.978 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.483 HD21 ' HE2' ' A' ' 94' ' ' MET . 59.4 tp -63.04 -33.73 76.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.334 1.053 . . . . 73.13 112.114 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.9 -37.26 9.44 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.66 0.624 . . . . 50.15 114.66 -170.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.31 -50.38 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 117.948 0.874 . . . . 75.0 113.348 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.471 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 90.1 t80 -68.06 -63.14 1.12 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.435 0.694 . . . . 74.51 111.7 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -61.81 -37.49 40.25 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 123.748 0.819 . . . . 63.44 113.209 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.84 -49.82 16.0 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.217 1.945 . . . . 62.11 113.081 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -73.93 -15.65 61.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.429 0.692 . . . . 73.34 112.007 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.1 mm -62.14 -42.67 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.731 0.777 . . . . 74.03 109.505 169.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' HD13 ' A' ' 60' ' ' LEU . 52.3 mt -75.31 -21.62 58.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.423 -1.262 . . . . 73.12 112.156 -173.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -67.05 -40.65 30.23 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 114.429 1.27 . . . . 75.53 114.429 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.27 -41.31 77.88 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.173 1.915 . . . . 75.34 112.813 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -72.95 -36.85 67.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.493 0.717 . . . . 71.44 110.976 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.46 94.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.471 0.708 . . . . 75.4 109.944 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.497 ' NH1' HD13 ' C' ' 105' ' ' ILE . 44.6 ttm105 -55.6 -48.98 73.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.618 1.199 . . . . 65.14 110.798 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -45.25 90.99 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.837 0.711 . . . . 65.21 110.301 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.546 ' SG ' HG23 ' A' ' 18' ' ' THR . 42.1 t -61.37 -24.41 66.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.338 -0.846 . . . . 54.3 112.468 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.51 HG21 HG22 ' A' ' 64' ' ' VAL . 94.9 mt -85.02 -53.0 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.574 0.749 . . . . 70.04 110.002 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.3 m -55.3 -40.95 71.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.67 1.188 . . . . 74.01 112.216 -173.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.2 t -60.98 -45.55 94.35 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.025 -0.989 . . . . 73.02 111.025 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.649 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.9 mtm -64.4 -46.03 85.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.389 0.675 . . . . 74.25 111.313 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -58.5 -51.02 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.572 -1.195 . . . . 75.0 110.846 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 24.1 t -68.05 -25.86 65.57 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.195 -0.912 . . . . 61.13 111.419 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -78.83 -26.0 44.18 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.421 1.088 . . . . 74.55 110.657 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 13.0 54.14 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-N 115.698 -0.683 . . . . 73.32 112.618 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.47 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 7.0 m 67.98 40.31 2.31 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 124.792 1.237 . . . . 74.33 110.336 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.44 ' HE1' HG13 ' A' ' 31' ' ' VAL . 48.0 m-85 -119.37 157.15 52.14 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.647 -1.161 . . . . 75.41 108.782 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.479 ' HD3' ' HE2' ' G' ' 195' ' ' PHE . 69.3 Cg_endo -70.37 148.47 61.18 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.155 1.904 . . . . 71.23 111.298 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -60.01 139.89 57.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.525 0.73 . . . . 75.12 111.413 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.3 114.75 15.41 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.89 -0.781 . . . . 73.02 108.89 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -109.9 105.77 15.08 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.53 128.32 35.16 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.082 -0.71 . . . . 63.41 109.082 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.8 97.45 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.516 0.727 . . . . 70.41 111.01 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB3' HH22 ' A' ' 111' ' ' ARG . 63.3 Cg_endo -73.56 143.99 35.18 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.237 1.958 . . . . 54.21 110.978 -179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.55 109.68 25.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.042 -1.466 . . . . 72.55 107.042 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -99.95 74.7 1.82 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.402 -1.332 . . . . 73.43 107.402 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -64.44 -29.62 70.67 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.419 -1.264 . . . . 75.11 110.439 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.02 -50.17 69.7 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.54 1.136 . . . . 75.1 110.905 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.94 -52.42 65.12 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.49 0.494 . . . . 73.41 110.861 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.42 -46.37 73.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.319 0.648 . . . . 71.04 111.868 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.36 -61.79 2.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.062 -0.972 . . . . 74.13 110.351 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 25.7 mmt -58.97 -50.46 73.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.941 0.776 . . . . 73.25 111.685 -172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 91.3 m-20 -53.16 -51.37 62.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.07 0.856 . . . . 65.34 111.262 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -65.9 -38.25 88.24 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.14 -0.936 . . . . 72.25 111.547 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.02 -49.76 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.934 -0.576 . . . . 75.32 111.403 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -176.17 -13.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.63 0.974 . . . . 74.3 113.63 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 19.9 tp60 -82.44 74.79 9.39 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.074 0.94 . . . . 75.35 110.346 -174.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -78.78 -35.97 43.6 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.547 -1.206 . . . . 73.13 111.478 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.62 103.65 1.38 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.445 0.698 . . . . 70.4 109.738 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.43 69.23 3.37 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.618 -0.593 . . . . 75.02 111.618 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -54.46 121.81 9.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.751 1.22 . . . . 75.41 111.421 -172.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.41 ' N ' HG21 ' C' ' 92' ' ' THR . . . -77.15 148.88 35.05 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.411 -0.813 . . . . 52.33 113.507 -167.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 m -122.11 108.7 13.65 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.881 0.873 . . . . 75.43 109.229 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.477 ' HA ' ' HE1' ' E' ' 182' ' ' PHE . 0.3 OUTLIER -74.77 95.17 2.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.679 -1.23 . . . . 73.25 107.679 173.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -119.25 87.62 2.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.307 -0.998 . . . . 73.1 108.307 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -74.27 127.17 32.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.127 0.971 . . . . 70.1 110.66 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -161.49 144.12 12.14 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.823 0.849 . . . . 75.51 109.198 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.37 168.21 15.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.01 0.924 . . . . 55.24 110.304 173.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 N-CA-C 108.774 -0.824 . . . . 70.22 108.774 177.182 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.635 0.255 . . . . 71.34 110.686 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -144.35 89.95 2.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.023 0.929 . . . . 73.21 108.661 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.05 -176.99 6.21 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.296 1.038 . . . . 73.12 109.761 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.402 ' HB2' ' HA3' ' B' ' 91' ' ' GLY . 34.7 mm-40 66.44 119.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.18 1.392 . . . . 73.2 111.079 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -138.06 140.69 40.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.233 0.613 . . . . 73.2 109.624 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -146.22 89.33 1.86 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.852 -1.166 . . . . 75.44 107.852 173.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.5 m -83.99 76.67 10.03 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.541 -0.754 . . . . 70.43 110.922 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.21 -68.72 0.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.737 -1.579 . . . . 61.15 106.737 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.53 ' HE3' ' HB2' ' B' ' 11' ' ' PHE . 25.4 ttt 64.52 166.63 0.16 Allowed 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.697 1.599 . . . . 72.53 114.371 166.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.518 ' N ' ' HG2' ' B' ' 9' ' ' MET . 18.9 p -146.8 120.66 9.3 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 125.599 1.559 . . . . 74.22 106.979 169.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.53 ' HB2' ' HE3' ' B' ' 9' ' ' MET . 36.6 t80 -124.5 113.17 17.75 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.997 -0.742 . . . . 73.53 108.997 170.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.52 130.45 34.63 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.969 -0.752 . . . . 72.43 108.969 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.524 HD12 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -85.36 120.34 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.633 -1.247 . . . . 73.4 107.633 178.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -90.3 -42.47 10.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 75.21 110.451 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.47 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 48.3 ttt180 -168.5 137.41 2.28 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.041 -0.527 . . . . 71.52 109.728 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.524 HG13 HD12 ' B' ' 13' ' ' ILE . 69.4 mt -113.33 133.98 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.468 -1.678 . . . . 71.53 106.468 168.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.459 ' HE1' HG13 ' B' ' 83' ' ' ILE . 29.9 p90 -164.85 146.81 8.11 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.013 0.82 . . . . 74.02 110.973 -173.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.4 m -74.9 121.92 22.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.403 -0.817 . . . . 75.14 109.707 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -93.99 -31.66 14.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.335 0.654 . . . . 73.33 110.907 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.6 t70 -153.03 141.16 20.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.689 -0.687 . . . . 63.03 110.409 -170.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.564 HD13 ' SG ' ' B' ' 113' ' ' CYS . 36.0 mm -136.96 142.92 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.551 1.54 . . . . 71.55 107.831 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -148.1 133.62 18.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.222 -1.029 . . . . 55.54 108.222 172.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -150.41 127.73 11.36 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.334 -1.358 . . . . 75.25 107.334 169.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.24 155.97 41.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.523 1.129 . . . . 64.43 108.507 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 19' ' ' LYS . . . -149.34 79.86 8.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.597 -1.26 . . . . 71.32 107.597 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.75 -23.44 30.83 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.989 2.459 . . . . 74.21 112.3 -173.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 93.1 m-20 -124.97 31.11 5.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.194 0.998 . . . . 75.42 109.854 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.6 -47.91 69.67 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 124.967 1.307 . . . . 72.4 113.772 175.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.47 -23.05 10.29 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.024 1.816 . . . . 72.32 113.551 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.421 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 69.4 m-70 -78.42 3.45 15.77 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.973 0.909 . . . . 73.04 112.894 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.38 -18.88 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 123.425 0.69 . . . . 73.22 111.192 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -83.48 -28.06 29.0 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.894 0.477 . . . . 65.4 110.344 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.78 -42.48 70.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.12 0.968 . . . . 74.24 109.866 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.72 113.07 26.31 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.322 1.049 . . . . 75.42 109.53 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -72.9 80.78 1.17 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.166 0.586 . . . . 73.54 110.221 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -170.02 151.35 4.01 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.044 -1.095 . . . . 74.43 108.044 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -95.0 127.86 41.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.547 -0.74 . . . . 75.21 109.651 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 25.1 Cg_endo -60.02 121.97 10.65 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.995 2.463 . . . . 63.23 112.169 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 109.25 2.61 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.784 0.677 . . . . 74.42 109.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' B' ' 125' ' ' GLN . 6.2 t -85.5 117.16 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.054 -0.721 . . . . 75.23 109.054 -168.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -136.28 144.22 44.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.291 0.636 . . . . 73.04 110.465 -169.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.767 ' HB3' HG13 ' F' ' 187' ' ' ILE . 8.6 tt -126.45 152.49 46.34 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.069 0.948 . . . . 74.13 109.874 -164.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.466 ' N ' HD22 ' B' ' 42' ' ' LEU . 29.5 t70 -137.11 140.85 42.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.753 1.221 . . . . 75.44 110.04 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.16 127.97 56.09 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.058 0.943 . . . . 61.32 109.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -140.62 152.76 45.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.865 1.266 . . . . 70.11 108.984 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.5 m -145.62 134.4 22.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.007 0.523 . . . . 61.13 110.601 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.66 162.97 30.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.071 1.348 . . . . 63.13 108.894 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.1 m -135.62 163.39 30.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.922 0.489 . . . . 74.23 110.369 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.37 139.21 18.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.888 0.875 . . . . 74.41 109.025 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -82.07 132.05 35.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.476 0.711 . . . . 74.52 109.408 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.0 mt -89.58 -53.08 4.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.792 -0.818 . . . . 73.41 108.792 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.39 -172.36 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.424 -0.807 . . . . 74.35 110.6 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.39 116.84 7.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.319 -0.855 . . . . 73.24 110.078 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.591 ' H ' HD21 ' F' ' 173' ' ' LEU . 12.2 m-20 65.12 13.2 8.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.028 1.731 . . . . 75.24 112.602 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.29 100.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.232 1.013 . . . . 75.13 108.603 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -97.28 165.95 11.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.608 0.718 . . . . 75.4 109.847 171.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -144.61 104.63 4.06 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.316 -1.364 . . . . 73.44 107.316 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.63 123.4 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.711 0.804 . . . . 74.23 109.507 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 27.2 t -105.54 120.82 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 75.51 109.8 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.3 119.82 34.47 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.909 -1.145 . . . . 75.42 107.909 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -107.9 110.3 22.02 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.294 0.638 . . . . 74.23 110.394 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.2 115.15 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.237 -1.023 . . . . 74.34 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -110.68 129.37 55.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.941 0.497 . . . . 73.3 109.862 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.558 HG23 HG23 ' B' ' 114' ' ' ILE . 54.5 t -119.36 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.274 1.03 . . . . 74.02 110.317 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 37.7 m -114.7 150.56 35.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 74.5 109.726 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -147.28 146.78 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.232 -1.025 . . . . 71.34 108.232 167.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -148.2 139.48 23.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.351 0.596 . . . . 73.43 111.476 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.438 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 46.8 mt -113.42 118.4 34.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.329 1.051 . . . . 71.52 109.348 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.52 -111.92 3.77 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.864 0.728 . . . . 73.31 112.605 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 4.89 21.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.71 0.804 . . . . 75.31 111.712 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -139.21 175.48 9.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.604 0.362 . . . . 72.55 110.84 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -69.69 150.0 47.45 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.196 0.998 . . . . 75.32 111.0 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.438 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -105.89 -57.4 2.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.987 -1.116 . . . . 73.42 107.987 169.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.442 ' HZ ' HG12 ' B' ' 40' ' ' VAL . 5.5 p90 -147.41 159.66 43.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.574 -1.193 . . . . 73.32 109.575 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.8 mt -127.55 157.99 38.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.163 1.385 . . . . 73.43 108.67 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' B' ' 114' ' ' ILE . 16.4 t -156.77 158.05 36.15 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.495 -0.557 . . . . 72.4 109.495 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.54 132.55 2.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.622 1.169 . . . . 73.21 108.236 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.424 HG23 HD12 ' B' ' 21' ' ' ILE . 56.0 t -128.11 147.36 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.036 -0.727 . . . . 75.45 109.036 174.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 19.5 mt-30 -126.8 93.3 3.74 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.883 0.849 . . . . 75.21 109.291 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -86.11 100.25 12.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.59 -1.641 . . . . 74.33 109.65 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.65 164.48 26.64 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 111.966 -0.454 . . . . 72.44 111.966 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.25 126.24 1.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.047 -0.821 . . . . 71.31 111.047 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.459 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.3 mt -84.56 127.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.369 -0.975 . . . . 75.34 108.369 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.66 131.5 39.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.148 -1.427 . . . . 72.33 107.148 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -96.25 102.53 14.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.551 -0.907 . . . . 74.51 108.551 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' B' ' 10' ' ' THR . 2.8 pp -122.94 139.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 115.669 -0.696 . . . . 75.11 110.584 -175.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.65 173.66 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.076 1.351 . . . . 51.3 107.852 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.03 -51.12 2.83 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 122.633 0.159 . . . . 74.13 112.893 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.53 HD11 ' HG2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -51.28 143.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.958 0.903 . . . . 72.01 111.178 172.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 144.26 24.82 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.644 -0.502 . . . . 74.0 109.644 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' B' ' 4' ' ' GLN . . . 62.25 -110.9 3.54 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 124.518 1.136 . . . . 73.2 113.335 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -64.13 -47.79 78.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.297 0.639 . . . . 75.34 110.046 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' B' ' 89' ' ' ILE . 89.1 mt-30 -63.58 -35.3 80.04 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 124.664 1.227 . . . . 75.35 111.484 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.53 ' HG2' HD11 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -67.25 -56.8 8.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.364 -0.835 . . . . 74.42 110.24 -177.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -16.66 61.85 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.169 -0.923 . . . . 71.35 111.673 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -73.05 -39.17 66.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.098 0.959 . . . . 73.1 109.795 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -67.6 -63.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.102 -0.953 . . . . 71.22 110.969 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -77.82 -15.18 59.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 122.126 -0.359 . . . . 75.15 111.736 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.06 35.81 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.508 0.505 . . . . 61.43 113.711 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.55 -44.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.344 0.572 . . . . 74.52 112.535 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.97 -47.88 70.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.435 0.694 . . . . 75.22 112.282 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m -65.28 -50.49 59.11 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 123.583 0.753 . . . . 64.42 111.87 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.73 -24.09 55.2 Favored 'Trans proline' 0 C--N 1.398 3.162 0 C-N-CA 121.568 1.512 . . . . 64.21 113.291 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.06 -36.86 85.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.364 0.602 . . . . 75.43 110.904 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 66.7 mt -61.05 -46.7 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.61 1.164 . . . . 75.33 110.564 173.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.52 -10.95 58.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.491 -1.231 . . . . 71.43 111.701 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -63.28 -52.18 63.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.587 1.155 . . . . 71.15 113.153 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.9 -31.88 66.8 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 121.772 1.648 . . . . 74.52 112.964 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.455 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.7 m-85 -63.81 -51.11 66.23 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.912 0.485 . . . . 74.24 110.845 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.53 91.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.288 1.035 . . . . 72.12 111.72 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -58.29 -63.07 1.4 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.197 0.936 . . . . 70.11 109.419 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.49 -29.2 66.07 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.207 1.003 . . . . 74.44 111.311 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.564 ' SG ' HD13 ' B' ' 21' ' ' ILE . 23.9 t -62.87 -60.22 3.77 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.473 0.709 . . . . 64.5 112.307 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.65 HG21 ' SG ' ' B' ' 76' ' ' CYS . 85.3 mt -57.82 -44.57 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.084 0.954 . . . . 74.33 110.388 176.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.501 HG23 ' HB3' ' B' ' 125' ' ' GLN . 22.8 m -64.61 -25.3 67.9 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.463 -1.699 . . . . 54.33 111.435 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -80.52 -31.38 37.12 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.469 0.708 . . . . 64.52 110.839 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.4 mmt -71.65 -42.71 67.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.224 0.609 . . . . 73.12 111.647 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' B' ' 125' ' ' GLN . 96.4 t -73.91 -27.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.532 0.733 . . . . 73.22 110.615 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.432 ' OG ' HG21 ' C' ' 115' ' ' THR . 34.0 t -56.94 -34.52 68.08 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.8 0.84 . . . . 62.11 111.063 171.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 53.3 mtt-85 -80.12 -35.54 36.58 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.85 -1.068 . . . . 74.12 110.359 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.68 1.69 36.19 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.849 0.718 . . . . 64.43 112.597 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 70.22 25.26 4.63 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 127.115 2.166 . . . . 73.24 113.598 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.424 ' O ' HG12 ' B' ' 118' ' ' VAL . 65.2 m-85 -120.32 149.12 48.95 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.765 0.826 . . . . 74.24 109.253 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.03 101.73 1.17 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.674 2.249 . . . . 75.54 112.303 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.721 ' HA ' HG11 ' B' ' 40' ' ' VAL . 0.0 OUTLIER -65.15 157.17 29.42 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.047 -0.978 . . . . 74.51 110.096 170.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 44.7 tp -110.11 129.34 55.71 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.406 1.882 . . . . 75.25 108.296 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.98 125.61 32.84 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 106.548 -1.649 . . . . 74.04 106.548 173.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' F' ' 186' ' ' LEU . 0.9 OUTLIER -52.73 134.33 36.38 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.877 1.361 . . . . 74.53 109.08 -175.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -38.35 103.02 0.26 Allowed Pre-proline 0 C--N 1.361 1.095 0 O-C-N 125.824 1.953 . . . . 74.34 111.236 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.414 ' HG2' ' HD2' ' D' ' 15' ' ' ARG . 57.1 Cg_endo -67.89 99.76 0.57 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.516 2.144 . . . . 72.34 110.843 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -147.94 115.18 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.455 -1.313 . . . . 75.31 107.455 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.91 103.1 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.683 -1.228 . . . . 62.34 107.683 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.53 ' HA ' HD21 ' B' ' 136' ' ' LEU . 64.9 t80 -65.75 -14.95 62.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.41 1.084 . . . . 73.5 111.937 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.2 -28.55 69.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.637 1.175 . . . . 74.3 111.037 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.5 -35.46 77.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.562 0.745 . . . . 74.05 111.004 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' B' ' 133' ' ' PHE . 4.2 mm? -66.15 -27.58 68.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.566 0.747 . . . . 74.41 111.354 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -62.84 -46.81 86.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.739 . . . . 74.51 109.959 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -67.03 -35.59 80.25 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.644 -1.162 . . . . 74.32 110.555 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -74.64 -35.09 62.88 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.656 0.783 . . . . 74.32 111.148 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -68.93 -43.92 74.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.754 0.822 . . . . 64.4 110.55 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -93.42 0.0 56.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.742 -0.663 . . . . 74.12 112.384 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.65 82.98 4.04 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.936 0.494 . . . . 64.14 109.751 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -155.65 120.89 4.85 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.818 1.247 . . . . 74.33 109.799 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -139.79 -87.29 0.21 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.966 0.906 . . . . 71.22 109.387 168.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.79 166.82 13.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.576 0.75 . . . . 72.5 109.453 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.92 94.81 0.1 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.359 -0.696 . . . . 53.51 111.359 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.56 139.45 31.43 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.106 0.562 . . . . 74.43 109.89 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . 0.543 ' HA3' ' SD ' ' D' ' 1' ' ' MET . . . -118.38 96.09 0.66 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.937 -0.574 . . . . 71.24 111.954 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -132.97 137.74 46.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.967 0.907 . . . . 75.52 109.947 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.45 148.46 22.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.774 0.83 . . . . 70.15 109.69 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.71 167.7 10.75 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.737 0.648 . . . . 63.22 111.022 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.41 143.52 50.52 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.804 0.842 . . . . 74.25 110.656 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -113.22 15.2 19.42 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.761 1.224 . . . . 75.33 108.975 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.88 161.43 21.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.167 0.987 . . . . 73.03 111.067 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 C-N-CA 123.582 0.753 . . . . 75.43 109.771 174.194 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 110.291 -0.262 . . . . 74.3 110.291 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -138.55 -54.11 0.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.619 1.168 . . . . 74.41 108.968 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -107.12 89.97 3.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.621 0.768 . . . . 73.11 109.384 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 170.43 16.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.709 1.204 . . . . 74.03 109.951 177.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 67.12 120.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.739 1.216 . . . . 74.25 109.825 -174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.82 -49.08 77.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.2 0.6 . . . . 75.23 110.52 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.8 m 73.76 -18.22 0.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.877 1.271 . . . . 73.23 112.765 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.65 148.67 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.503 0.721 . . . . 75.22 110.689 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.648 ' HG3' HG23 ' C' ' 89' ' ' ILE . 25.3 ttt 60.42 111.69 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.391 1.476 . . . . 72.51 109.482 -164.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.762 ' HB ' ' HG2' ' H' ' 205' ' ' LYS . 73.5 p -123.6 119.47 29.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.039 0.536 . . . . 74.02 109.745 -173.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.728 ' HA ' HG22 ' C' ' 86' ' ' ILE . 46.7 t80 -118.69 124.58 47.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.38 0.672 . . . . 74.24 109.673 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -139.35 124.94 19.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.328 0.651 . . . . 72.22 109.471 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.538 HD13 HG13 ' C' ' 16' ' ' ILE . 6.0 tp -82.01 134.19 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.945 -0.761 . . . . 75.21 108.945 170.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.552 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.6 mm-40 -97.82 -51.43 4.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.281 0.632 . . . . 75.12 109.986 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.576 HH11 ' HD1' ' D' ' 32' ' ' PHE . 34.3 ttt180 -176.07 126.83 0.21 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.57 -0.741 . . . . 70.04 110.055 -166.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.538 HG13 HD13 ' C' ' 13' ' ' ILE . 97.4 mt -113.32 135.0 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.762 0.825 . . . . 74.44 108.847 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.662 ' HH ' HD11 ' C' ' 83' ' ' ILE . 29.1 p90 -169.74 153.99 5.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.24 0.543 . . . . 70.1 110.067 -174.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -74.75 115.08 13.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.966 -1.016 . . . . 73.24 109.976 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -66.09 -39.32 89.92 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.819 -0.808 . . . . 75.14 108.819 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -151.44 147.48 26.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.448 -1.251 . . . . 63.12 110.434 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -136.34 145.08 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.053 1.741 . . . . 74.22 106.789 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -154.7 148.82 25.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.987 0.422 . . . . 75.22 110.269 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -153.58 108.61 3.16 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.584 -1.265 . . . . 75.0 107.584 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -117.57 121.33 40.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.571 0.748 . . . . 74.31 109.687 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.82 85.93 56.57 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.472 1.109 . . . . 65.01 108.533 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.68 -16.58 16.54 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.56 2.173 . . . . 72.34 112.006 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -99.51 19.64 15.31 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.933 1.293 . . . . 73.5 108.949 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.639 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -54.37 -52.13 71.95 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.332 1.053 . . . . 74.12 113.487 -172.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 6.2 Cg_exo -80.35 -31.31 1.68 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.923 1.749 . . . . 65.52 112.915 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.22 -30.8 67.97 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.425 1.09 . . . . 75.13 112.827 -173.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.26 -17.62 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.78 0.832 . . . . 75.12 111.796 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -59.79 -32.0 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.621 0.768 . . . . 75.3 111.781 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.63 6.48 34.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.613 0.765 . . . . 71.35 111.875 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.81 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -109.14 143.25 38.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.446 0.699 . . . . 75.23 110.205 -176.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 129.65 39.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.548 -0.908 . . . . 75.31 108.548 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.551 ' HB3' ' HB2' ' E' ' 194' ' ' ALA . 75.6 m95 -84.61 84.41 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.736 0.779 . . . . 73.31 111.808 -165.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -132.42 78.64 67.37 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 114.44 -1.255 . . . . 74.21 108.082 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.497 ' HA ' ' O ' ' C' ' 67' ' ' SER . 5.6 Cg_exo -82.79 146.44 13.16 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.647 2.231 . . . . 62.51 112.455 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -85.79 109.83 18.94 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.403 -1.332 . . . . 73.15 107.403 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 t -78.54 97.4 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 124.378 1.049 . . . . 61.43 109.44 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 92.9 mttt -99.45 104.28 16.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.579 0.752 . . . . 74.25 109.552 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.66 129.81 45.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.703 -0.851 . . . . 74.4 108.703 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -131.63 137.2 48.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.687 0.795 . . . . 74.33 109.201 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.57 113.78 20.27 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.988 -0.745 . . . . 75.31 108.988 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.54 143.77 43.98 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.195 -0.669 . . . . 73.23 109.195 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -114.64 128.3 56.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 73.02 110.842 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 161.93 19.36 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.983 1.313 . . . . 75.41 108.615 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.6 p -153.32 150.36 28.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.024 0.53 . . . . 75.41 111.137 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -146.0 143.02 29.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.663 1.185 . . . . 63.54 108.981 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -101.16 115.43 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.212 -1.403 . . . . 75.21 107.212 166.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.492 HD13 HD13 ' C' ' 83' ' ' ILE . 32.8 mt -87.43 -28.02 22.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.053 0.541 . . . . 72.4 109.944 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.5 -174.95 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.587 1.155 . . . . 71.33 109.442 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 120.73 12.43 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.261 -0.881 . . . . 74.13 109.077 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 65.76 7.06 4.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.893 1.277 . . . . 71.41 112.822 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.26 107.72 23.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.568 -1.271 . . . . 72.23 107.568 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -107.76 148.76 29.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.238 1.015 . . . . 64.23 109.591 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -128.13 110.37 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.183 -0.917 . . . . 75.2 108.796 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -100.14 125.63 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.654 -1.61 . . . . 75.21 106.654 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.54 104.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.453 -0.943 . . . . 50.41 108.453 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -91.78 104.54 16.97 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.029 -1.101 . . . . 73.54 108.029 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 16.4 mtm180 -84.18 137.49 33.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.657 -1.156 . . . . 75.25 108.425 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.404 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.0 t -126.94 132.28 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.873 -1.158 . . . . 75.11 107.873 172.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -121.73 122.51 39.71 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.986 -0.746 . . . . 73.02 108.986 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.462 HG22 HD12 ' C' ' 114' ' ' ILE . 71.1 t -110.84 111.48 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.9 m -100.1 146.12 27.17 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.679 -0.86 . . . . 73.32 108.679 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.96 124.72 33.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.101 -1.074 . . . . 65.3 108.101 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.497 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.2 m -126.61 168.54 14.17 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.895 0.878 . . . . 73.24 109.255 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.75 HD12 ' HG2' ' C' ' 34' ' ' LYS . 13.9 mt -128.89 26.42 5.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.378 1.071 . . . . 73.43 108.912 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.06 -92.8 0.68 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.74 -1.344 . . . . 73.4 109.74 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 -13.57 16.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.002 0.921 . . . . 75.11 111.12 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.488 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 6.7 tp10 -103.25 120.57 40.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.984 0.913 . . . . 74.04 109.689 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -70.65 132.3 45.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.017 0.372 . . . . 72.31 110.673 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -51.65 7.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.151 -0.685 . . . . 61.43 109.151 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -169.79 177.48 4.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.787 0.835 . . . . 73.14 111.167 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.436 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -134.02 146.89 50.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.745 1.218 . . . . 74.34 107.91 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.538 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.2 t -150.67 145.55 25.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.789 0.836 . . . . 74.24 109.381 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.09 136.35 15.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.362 0.665 . . . . 62.43 109.529 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -130.48 114.77 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.027 0.931 . . . . 74.02 108.964 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 15.1 mt-30 -91.63 96.16 10.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.688 -0.856 . . . . 71.21 108.688 176.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.5 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.9 tp-100 -87.77 111.93 21.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.9 0.48 . . . . 74.14 110.598 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.92 146.93 18.36 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 112.044 -0.422 . . . . 54.11 112.044 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.05 123.8 2.1 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 110.198 -1.161 . . . . 61.35 110.198 178.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.662 HD11 ' HH ' ' C' ' 17' ' ' TYR . 11.7 mm -92.36 125.31 44.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.8 -1.185 . . . . 72.41 107.8 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.87 119.68 26.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.486 -0.931 . . . . 75.2 108.486 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -89.31 97.48 11.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.408 -1.33 . . . . 74.12 107.408 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.728 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.2 pp -135.89 137.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 115.753 -0.658 . . . . 70.42 110.151 -170.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.29 166.08 32.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.926 0.89 . . . . 63.42 110.605 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -26.27 7.81 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.812 -0.631 . . . . 52.15 113.103 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.684 HG12 ' HG2' ' C' ' 94' ' ' MET . 0.2 OUTLIER -65.61 134.9 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.401 1.08 . . . . 73.04 110.08 178.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -159.23 157.61 31.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.74 0.416 . . . . 73.33 110.241 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -134.51 40.67 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.826 0.704 . . . . 70.13 111.744 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.41 HG21 ' N ' ' A' ' 148' ' ' GLY . 46.7 p -74.65 -18.68 60.5 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.68 . . . . 71.33 111.809 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -64.84 -40.89 95.9 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.552 0.741 . . . . 74.55 109.598 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.684 ' HG2' HG12 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -67.18 -50.52 60.76 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.583 -1.19 . . . . 74.22 109.026 178.516 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.86 77.64 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.162 0.985 . . . . 64.12 112.988 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -73.04 -39.11 66.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 63.44 110.494 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.4 t -73.47 -34.75 65.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.163 0.585 . . . . 72.04 110.974 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 47.0 tp -86.31 -56.93 3.21 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.571 1.148 . . . . 75.25 111.687 -170.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.49 11.39 68.67 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.869 -0.605 . . . . 51.23 114.554 -168.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -56.25 0.23 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.458 0.629 . . . . 74.11 111.215 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -66.72 -60.06 3.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.303 0.641 . . . . 71.01 111.989 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.36 -47.8 98.13 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.05 0.94 . . . . 65.03 113.159 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.73 -20.05 35.47 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.975 1.783 . . . . 73.3 113.356 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.26 -22.68 47.95 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.406 0.682 . . . . 64.3 110.467 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.497 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.0 mm -69.91 -33.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.082 0.553 . . . . 74.42 109.52 169.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 74.7 mt -89.9 -25.15 21.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.085 0.954 . . . . 74.34 112.613 -174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -58.45 -45.38 99.69 Favored Pre-proline 0 CA--C 1.558 1.253 0 CA-C-O 117.859 -1.067 . . . . 72.34 113.136 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.41 -43.67 56.58 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.112 1.875 . . . . 71.14 112.633 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -63.37 -44.84 93.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.051 0.54 . . . . 75.13 111.569 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.5 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -73.21 -37.2 66.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.065 -0.516 . . . . 62.14 111.682 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.95 -58.51 7.08 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 124.258 0.974 . . . . 75.35 108.97 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.68 66.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.222 1.409 . . . . 65.33 112.631 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 17.0 t -74.73 -38.71 62.21 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.048 0.539 . . . . 73.32 111.95 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.538 HG21 ' SG ' ' C' ' 76' ' ' CYS . 93.3 mt -67.14 -47.23 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 123.59 0.756 . . . . 74.24 109.737 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.647 HG22 ' HB3' ' C' ' 125' ' ' GLN . 91.8 m -56.61 -37.45 70.7 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.435 -1.257 . . . . 75.52 111.359 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.1 t -62.84 -49.28 75.51 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 114.91 -1.041 . . . . 63.33 110.251 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.675 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.73 -35.67 70.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.176 0.991 . . . . 73.15 112.96 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.78 -45.61 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.078 0.551 . . . . 71.04 110.414 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 54.1 p -70.48 -26.44 63.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.661 -0.7 . . . . 74.44 111.02 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.9 mtt-85 -66.6 -33.79 76.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 72.34 110.595 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.96 11.55 47.54 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.945 0.778 . . . . 74.31 112.826 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.501 HG22 ' HB3' ' D' ' 17' ' ' TYR . 43.9 p 57.93 28.2 15.79 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.826 2.05 . . . . 75.35 112.485 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -102.04 150.26 37.29 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.826 0.85 . . . . 73.53 108.899 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.666 ' HG3' ' HB1' ' E' ' 194' ' ' ALA . 36.8 Cg_endo -62.5 130.74 31.02 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.029 2.486 . . . . 72.14 110.708 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.647 ' HB3' HG22 ' C' ' 115' ' ' THR . 31.4 mt-30 -61.01 153.74 24.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.167 0.987 . . . . 64.54 113.001 -170.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.43 67.42 0.84 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.348 -0.842 . . . . 61.03 109.704 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.499 ' HB3' HG21 ' C' ' 115' ' ' THR . 1.9 p-10 -90.69 80.99 5.86 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.407 -1.331 . . . . 74.21 107.407 167.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.528 ' HB3' HD11 ' E' ' 187' ' ' ILE . 2.0 mm? -95.24 103.89 15.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.866 -1.515 . . . . 71.33 110.607 -170.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.11 155.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.385 1.624 . . . . 63.22 115.385 166.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.513 ' HG3' ' H ' ' A' ' 16' ' ' ILE . 69.5 Cg_endo -91.29 102.89 0.25 Allowed 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.774 2.316 . . . . 75.44 111.317 161.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 t -82.45 79.93 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.01 -0.737 . . . . 73.01 109.01 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.503 ' HB3' HG13 ' A' ' 13' ' ' ILE . 28.7 t-20 -82.16 107.19 14.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.454 -0.794 . . . . 75.44 109.378 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.449 ' HB3' ' O ' ' E' ' 183' ' ' THR . 29.9 m-85 -68.9 -21.74 64.21 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.195 1.398 . . . . 75.01 112.899 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.19 -43.44 33.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.936 0.894 . . . . 63.4 112.386 -169.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.52 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.925 0.713 . . . . 74.04 112.925 -172.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.25 -30.1 64.55 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.481 -0.327 . . . . 65.12 111.208 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -70.52 -33.6 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.421 0.288 . . . . 74.55 110.528 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.5 mtp -65.76 -34.65 78.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.075 0.55 . . . . 73.55 110.489 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -65.95 -36.2 82.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.354 0.662 . . . . 63.03 110.747 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.34 -87.47 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.211 0.604 . . . . 72.51 110.717 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -129.93 139.01 51.19 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.648 0.779 . . . . 71.43 110.404 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -162.9 163.67 26.26 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.055 0.942 . . . . 71.13 110.698 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -150.57 95.9 2.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.007 0.923 . . . . 73.22 108.991 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.93 24.01 0.95 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.143 0.977 . . . . 74.32 109.866 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.99 143.14 47.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.615 0.766 . . . . 74.34 110.424 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.12 -68.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.895 0 N-CA-C 110.464 -1.055 . . . . 62.51 110.464 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -168.53 -70.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.307 0.643 . . . . 71.34 109.416 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 168.79 -135.17 3.49 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.648 -0.581 . . . . 54.2 111.648 -173.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -134.41 -77.03 0.46 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.847 0.859 . . . . 74.15 110.087 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -172.87 161.98 4.68 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.847 0.859 . . . . 72.41 108.882 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.94 137.92 58.41 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.213 0.605 . . . . 73.51 110.15 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -88.85 169.22 11.78 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.457 -0.572 . . . . 74.14 109.457 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -163.1 115.26 1.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.313 -0.995 . . . . 75.13 108.313 172.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.75 96.89 9.67 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.244 -1.021 . . . . 72.11 108.244 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 N-CA-C 108.647 -0.871 . . . . 75.22 108.647 -178.454 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.543 ' SD ' ' HA3' ' B' ' 148' ' ' GLY . 56.3 mtp . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.251 0.548 . . . . 73.23 109.561 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -153.14 -165.03 2.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.649 1.18 . . . . 72.12 108.706 -173.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -42.82 67.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.324 0.65 . . . . 64.51 111.579 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 52.06 -90.27 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.51 1.524 . . . . 74.55 112.979 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.95 -70.99 0.51 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.7 -1.222 . . . . 72.41 107.7 170.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -171.75 87.02 0.09 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.433 1.093 . . . . 74.13 108.434 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -162.28 -179.84 7.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.488 0.715 . . . . 75.33 109.865 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 77.99 -58.26 0.46 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.566 1.546 . . . . 74.44 112.317 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.414 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 4.0 ttp -30.09 123.68 0.17 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.149 1.78 . . . . 74.42 113.187 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -125.79 145.51 50.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.953 0.901 . . . . 64.34 109.425 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.458 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 76.6 t80 -159.39 89.57 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.441 -1.318 . . . . 73.44 107.441 171.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.8 142.85 45.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.227 1.011 . . . . 75.32 108.468 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -103.06 110.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.085 0.554 . . . . 70.11 110.963 -170.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.92 -43.48 22.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.81 0.444 . . . . 70.42 111.577 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.414 ' HD2' ' HG2' ' B' ' 130' ' ' PRO . 6.2 tpt180 -166.32 148.61 6.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.038 0.384 . . . . 72.22 112.038 -165.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.86 128.39 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.986 -1.116 . . . . 74.3 107.986 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.639 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 11.4 p90 -163.32 164.01 24.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.584 0.706 . . . . 73.5 111.41 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -77.93 107.94 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.588 -1.187 . . . . 71.45 109.642 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 46.8 mtpt -77.23 -35.82 55.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.114 -0.494 . . . . 75.21 109.727 173.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.691 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -145.03 136.79 25.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.034 -0.984 . . . . 74.23 109.229 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.675 HG21 ' HE1' ' C' ' 117' ' ' MET . 73.1 mt -135.06 145.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.427 1.091 . . . . 75.52 108.371 175.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -149.32 132.43 16.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.989 -1.005 . . . . 64.31 108.606 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.3 t80 -137.01 117.49 13.75 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 106.333 -1.729 . . . . 74.45 106.333 167.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.23 133.61 54.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.729 -0.841 . . . . 72.21 108.729 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.54 84.66 19.35 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.214 -1.402 . . . . 62.23 107.214 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.87 -38.8 56.33 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.665 2.243 . . . . 72.1 112.295 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.463 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 25.3 m-80 -114.38 31.18 6.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.165 0.986 . . . . 74.24 109.275 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.548 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -35.16 -55.64 1.0 Allowed Pre-proline 0 CA--C 1.588 2.411 0 N-CA-C 117.487 2.403 . . . . 64.42 117.487 -172.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.87 -12.88 8.3 Favored 'Trans proline' 0 C--N 1.399 3.198 0 CA-C-N 122.595 1.963 . . . . 74.01 114.512 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -74.42 -35.69 63.4 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.423 1.089 . . . . 75.32 109.762 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.431 HG13 HD11 ' D' ' 68' ' ' LEU . 72.3 t -70.43 -34.26 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.527 1.131 . . . . 75.4 110.938 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.576 ' HD1' HH11 ' C' ' 15' ' ' ARG . 3.4 t80 -48.67 -36.68 16.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.446 1.499 . . . . 73.13 112.342 171.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' D' ' 30' ' ' HIS . 50.8 mt-30 -81.41 7.83 10.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.111 0.964 . . . . 75.44 113.116 -173.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.562 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 86.8 mttt -121.66 114.3 20.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.534 0.734 . . . . 74.12 110.164 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -95.82 73.62 3.09 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.109 -0.7 . . . . 74.23 109.109 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.565 ' HB2' HD21 ' D' ' 68' ' ' LEU . 6.7 m95 -125.8 157.43 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.05 -1.833 . . . . 74.01 106.05 174.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.415 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 32.1 tp60 -77.79 113.18 30.19 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.826 0.739 . . . . 72.52 109.258 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.456 ' HG3' HD22 ' D' ' 68' ' ' LEU . 44.6 Cg_exo -58.74 107.1 0.32 Allowed 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.963 2.442 . . . . 73.55 112.517 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.65 112.32 3.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.474 1.109 . . . . 71.52 108.736 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.423 HG21 ' OH ' ' G' ' 202' ' ' TYR . 34.5 m -96.8 113.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 122.205 1.002 . . . . 72.34 108.527 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.405 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 71.6 mmtt -92.71 120.48 33.15 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.633 -1.247 . . . . 75.12 107.633 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' H' ' 187' ' ' ILE . 7.3 mp -94.58 121.65 36.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.602 -0.518 . . . . 74.33 109.602 -175.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.625 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 6.5 t70 -111.22 135.56 51.57 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.045 -1.465 . . . . 72.32 107.045 169.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -130.77 130.17 43.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.532 -0.914 . . . . 74.0 108.532 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.46 153.72 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.753 -1.203 . . . . 72.31 107.753 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -143.57 149.19 37.04 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.218 -0.66 . . . . 70.43 109.218 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.1 167.54 25.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.095 -0.957 . . . . 72.42 108.458 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -155.13 156.65 36.16 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.937 0.399 . . . . 60.23 110.445 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -155.09 139.45 16.73 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.104 0.962 . . . . 64.21 109.143 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -76.84 129.01 35.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.672 0.389 . . . . 73.12 110.037 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.479 HD13 HG22 ' D' ' 83' ' ' ILE . 47.4 mt -97.69 -39.25 9.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.975 0.51 . . . . 75.35 110.102 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.01 -176.03 5.59 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.489 0.716 . . . . 74.31 110.353 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.03 121.64 11.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.043 -0.981 . . . . 71.12 110.309 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 66.85 3.6 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.473 1.509 . . . . 70.13 112.036 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -111.74 120.27 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.481 0.712 . . . . 74.24 110.171 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.44 ' CE2' ' HB2' ' H' ' 175' ' ' PHE . 65.4 m-85 -131.21 129.06 41.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.648 1.179 . . . . 72.24 107.933 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.75 116.85 29.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.923 0.889 . . . . 61.3 108.887 173.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.01 124.71 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 107.781 -1.192 . . . . 73.13 107.781 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.604 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.2 t -101.27 144.21 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.517 1.127 . . . . 51.31 109.331 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -118.05 128.87 55.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.196 -1.038 . . . . 72.24 108.196 175.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -109.41 106.87 16.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.255 1.022 . . . . 75.24 109.158 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.27 128.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.567 -1.272 . . . . 75.31 107.567 166.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.3 m -125.42 124.05 40.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.264 0.555 . . . . 55.13 109.7 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 69.0 t -106.59 101.93 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 125.002 1.321 . . . . 74.02 108.493 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 8.2 m -94.94 93.59 7.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.647 -1.242 . . . . 74.14 107.647 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.44 138.79 33.5 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.944 -0.762 . . . . 73.15 108.944 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.484 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.4 p -148.39 138.78 22.68 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.456 0.473 . . . . 73.43 112.128 -176.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.565 HD21 ' HB2' ' D' ' 36' ' ' TRP . 66.2 mt -107.48 110.58 22.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.773 1.229 . . . . 73.2 109.971 172.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.51 17.47 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.421 0.451 . . . . 72.14 112.997 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.68 6.25 46.58 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.407 0.683 . . . . 74.23 111.408 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.562 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 7.4 tp10 -140.04 149.36 43.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.391 0.676 . . . . 74.0 110.668 -166.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.8 m -70.44 138.42 51.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.057 0.943 . . . . 73.41 111.512 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.6 -63.13 1.35 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.561 1.144 . . . . 62.21 108.188 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -155.03 161.62 41.29 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.181 -0.918 . . . . 74.43 110.739 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -117.59 138.05 52.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.271 -1.331 . . . . 74.05 107.498 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.511 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 47.1 t -149.35 139.42 22.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.834 -0.802 . . . . 75.2 108.834 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -156.12 131.88 9.71 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.117 -0.697 . . . . 75.11 109.117 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.22 118.11 26.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 123.492 0.717 . . . . 74.32 109.282 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.691 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.0 mt-30 -90.08 85.47 6.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.912 0.863 . . . . 74.13 108.871 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.92 95.92 6.23 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.685 -1.598 . . . . 74.53 108.901 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.28 145.65 18.2 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 112.299 -0.32 . . . . 72.15 112.299 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.99 131.29 4.68 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.588 -0.605 . . . . 72.41 111.588 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.479 HG22 HD13 ' D' ' 51' ' ' LEU . 50.2 mt -90.88 131.39 38.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.903 -0.777 . . . . 73.02 108.903 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.26 142.64 48.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.94 0.496 . . . . 72.44 110.867 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -89.44 95.9 10.48 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.668 -0.864 . . . . 73.21 108.668 166.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.474 HD11 HG12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -122.04 134.46 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.146 0.978 . . . . 74.31 110.171 -173.193 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.33 171.1 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.256 1.023 . . . . 53.23 109.951 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.76 22.95 77.68 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.237 -0.438 . . . . 71.24 113.881 172.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.474 HG12 HD11 ' D' ' 86' ' ' ILE . 1.8 pp -103.99 158.08 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.201 1.0 . . . . 75.22 110.866 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.407 ' HB2' ' HG ' ' H' ' 171' ' ' SER . 0.1 OUTLIER -158.86 171.68 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.424 0.69 . . . . 65.03 110.643 179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.8 -138.06 34.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.098 0.874 . . . . 62.44 114.912 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -72.55 -28.69 62.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.043 0.937 . . . . 75.43 110.954 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -63.87 -29.11 70.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.927 0.891 . . . . 74.14 111.652 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.552 ' SD ' ' HB1' ' H' ' 172' ' ' ALA . 24.2 ttt -59.93 -53.82 53.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.232 0.613 . . . . 73.41 110.525 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.95 64.5 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.419 -0.81 . . . . 73.33 111.205 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -69.12 -33.35 73.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.326 1.05 . . . . 75.11 110.316 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.418 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 46.5 t -78.93 -51.41 9.69 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.574 -0.739 . . . . 74.22 110.58 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.21 -49.48 27.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.284 0.633 . . . . 74.22 110.834 -171.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.34 -26.4 61.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.792 -0.64 . . . . 65.41 114.457 -172.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.18 -58.13 1.89 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.452 0.626 . . . . 75.04 112.063 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.418 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 76.8 t80 -68.73 -34.08 75.01 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.165 0.802 . . . . 75.4 113.165 -168.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.502 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 43.6 m -72.13 -48.92 10.2 Favored Pre-proline 0 CA--C 1.563 1.476 0 CA-C-O 118.977 -0.535 . . . . 75.2 110.995 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.597 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 71.0 Cg_exo -56.55 -30.97 84.89 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 122.49 2.126 . . . . 72.01 114.431 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.24 -29.32 69.77 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.039 0.536 . . . . 74.25 111.971 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -68.27 -38.98 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 73.42 110.595 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' D' ' 60' ' ' LEU . 43.1 mt -79.94 -25.37 40.49 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.063 -0.971 . . . . 75.02 111.651 -170.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.65 -41.82 80.22 Favored Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 114.231 1.197 . . . . 72.22 114.231 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.433 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 96.5 Cg_exo -50.1 -39.99 50.9 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.214 1.942 . . . . 75.45 114.19 171.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.19 -36.01 27.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.729 0.812 . . . . 74.34 111.109 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -44.19 96.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.445 0.698 . . . . 75.41 110.36 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.433 ' NH2' ' HA ' ' D' ' 108' ' ' PRO . 30.8 ttp180 -55.89 -54.97 38.23 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 124.965 1.415 . . . . 74.22 110.215 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.158 0.911 . . . . 73.53 111.837 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.425 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 43.0 t -59.7 -42.51 93.17 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.547 0.529 . . . . 74.53 110.96 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.479 HG22 ' SG ' ' D' ' 76' ' ' CYS . 83.4 mt -62.26 -55.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 115.123 -0.944 . . . . 73.41 110.338 172.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 97.1 m -53.44 -40.11 64.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.554 1.541 . . . . 74.34 112.4 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -71.73 -40.77 69.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.159 -0.928 . . . . 73.33 110.695 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.511 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.3 mtm -69.08 -31.09 69.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.864 0.465 . . . . 73.32 111.637 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.0 t -63.23 -46.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.622 0.769 . . . . 72.45 109.714 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -74.43 -29.19 61.4 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 116.009 -0.541 . . . . 74.54 111.506 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -74.12 -23.24 59.27 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.83 0.852 . . . . 74.33 110.479 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.36 12.19 65.57 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.725 -0.67 . . . . 71.23 112.43 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p 62.26 22.42 13.17 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 126.319 1.848 . . . . 74.41 113.972 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -97.99 161.26 26.16 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.265 1.026 . . . . 73.43 109.551 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.25 140.02 47.68 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.106 2.537 . . . . 75.32 111.625 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.08 119.39 8.26 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.547 0.739 . . . . 74.32 110.618 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.76 103.87 12.76 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.316 -0.994 . . . . 71.24 108.316 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -103.82 99.78 9.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 63.32 109.328 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.462 HD22 HD23 ' D' ' 42' ' ' LEU . 95.5 mt -71.29 126.88 30.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.29 0.636 . . . . 74.54 110.473 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.37 138.64 96.36 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 123.184 0.594 . . . . 71.12 111.064 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -74.78 96.59 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.946 1.764 . . . . 73.41 109.647 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 85.5 t -106.97 109.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.014 -1.106 . . . . 75.14 108.014 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -79.44 117.99 20.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.588 -0.733 . . . . 75.22 109.137 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -46.89 -33.0 4.17 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.841 1.256 . . . . 72.4 113.136 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.78 -36.39 80.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.038 0.935 . . . . 74.35 111.535 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.6 98.74 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.584 . . . . 61.33 111.108 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -67.6 -41.14 84.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.236 0.615 . . . . 72.02 110.262 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.99 -46.33 85.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.925 0.89 . . . . 74.32 110.804 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.44 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 77.8 mtm -65.96 -57.43 7.84 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.637 0.586 . . . . 73.21 110.481 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -57.93 -31.54 66.91 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.816 0.846 . . . . 73.43 111.885 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -58.59 -53.64 56.11 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.536 0.734 . . . . 72.42 110.38 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.94 -32.84 74.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.556 0.742 . . . . 74.24 111.502 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' D' ' 138' ' ' MET . 43.9 mt-30 -77.41 3.52 13.08 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.295 0.638 . . . . 75.33 112.309 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.82 90.11 3.21 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.702 0.801 . . . . 64.4 109.504 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -161.85 -65.97 0.05 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.413 1.085 . . . . 75.51 108.663 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.87 132.52 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.886 1.275 . . . . 70.03 108.21 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.4 57.03 0.3 Allowed Glycine 0 C--N 1.345 1.028 0 O-C-N 123.209 0.318 . . . . 73.13 112.78 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.9 179.02 7.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.998 -0.371 . . . . 71.31 109.998 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 82.32 0.62 Allowed Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.776 -0.53 . . . . 72.34 111.776 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.6 t -133.48 9.94 4.03 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.389 1.076 . . . . 73.25 109.037 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.98 111.2 2.4 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.048 0.939 . . . . 74.43 111.315 -170.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.81 163.57 27.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.892 1.277 . . . . 72.33 111.256 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -147.74 -65.9 0.26 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.239 0.615 . . . . 73.14 110.439 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -69.98 126.15 28.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.313 0.645 . . . . 74.21 111.158 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -112.87 145.38 40.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.747 0.819 . . . . 74.34 110.049 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.806 1.642 . . . . 72.41 110.708 -176.408 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 56.0 mttm . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.048 -0.723 . . . . 71.4 109.048 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.36 66.84 3.81 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.459 0.474 . . . . 61.11 112.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 8.34 21.33 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.638 1.175 . . . . 73.45 110.847 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 44.3 p -136.45 -67.83 0.5 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.255 0.622 . . . . 64.15 110.787 -166.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 172' ' ' ALA . . . . . 0.541 ' HB3' ' HB2' ' E' ' 175' ' ' PHE . . . -169.22 -175.95 2.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.583 0.753 . . . . 73.42 111.026 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -76.87 -30.63 56.34 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.771 -1.104 . . . . 71.55 109.961 175.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -57.36 1.17 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.741 1.216 . . . . 75.54 109.268 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 175' ' ' PHE . . . . . 0.541 ' HB2' ' HB3' ' E' ' 172' ' ' ALA . 16.0 t80 62.19 86.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.442 1.497 . . . . 73.54 111.422 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 176' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' C' ' 94' ' ' MET . 22.1 m-80 -93.49 103.31 15.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.451 -0.944 . . . . 73.31 108.451 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 177' ' ' LEU . . . . . 0.463 ' HG ' ' H ' ' E' ' 178' ' ' GLN . 11.8 tp -167.42 -169.38 1.21 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.343 -0.984 . . . . 74.05 108.343 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 178' ' ' GLN . . . . . 0.463 ' H ' ' HG ' ' E' ' 177' ' ' LEU . 2.0 mp0 78.23 -41.39 0.32 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.627 1.571 . . . . 74.22 111.862 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.29 150.22 43.76 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.081 1.352 . . . . 64.12 111.319 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.87 85.12 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.754 2.302 . . . . 70.31 112.536 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 181' ' ' TYR . . . . . 0.431 ' HE2' ' HA ' ' E' ' 177' ' ' LEU . 34.8 m-85 -94.51 96.91 9.78 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.545 -1.28 . . . . 72.52 107.545 171.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 182' ' ' PHE . . . . . 0.477 ' HE1' ' HA ' ' A' ' 150' ' ' GLU . 10.9 p90 -78.4 65.56 3.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.354 1.062 . . . . 74.51 110.803 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 183' ' ' THR . . . . . 0.449 ' O ' ' HB3' ' C' ' 133' ' ' PHE . 13.5 t -132.11 6.27 4.22 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.759 -1.11 . . . . 75.5 109.958 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -118.06 87.07 27.51 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 122.954 0.502 . . . . 74.32 110.014 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.16 154.93 19.32 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.427 2.084 . . . . 70.22 112.371 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.52 151.62 34.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.923 -1.14 . . . . 71.41 107.923 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 187' ' ' ILE . . . . . 0.528 HD11 ' HB3' ' C' ' 128' ' ' LEU . 2.7 tt -80.78 134.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.663 0.385 . . . . 72.35 110.052 175.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.44 83.62 1.84 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.906 0.882 . . . . 73.32 109.326 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.16 95.73 4.33 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.734 -0.839 . . . . 74.54 108.734 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -68.36 105.96 2.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.903 0.881 . . . . 74.04 110.585 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 60.39 -124.41 35.77 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 124.1 0.875 . . . . 72.4 111.663 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 139.53 171.48 12.29 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.761 -0.536 . . . . 55.12 111.761 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 193' ' ' TYR . . . . . 0.512 ' HE2' ' HB2' ' F' ' 194' ' ' ALA . 53.7 t80 -146.78 160.52 42.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.494 -0.928 . . . . 70.4 108.494 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . 0.666 ' HB1' ' HG3' ' C' ' 124' ' ' PRO . . . -134.45 -78.9 0.46 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.037 0.535 . . . . 74.11 110.4 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -165.77 178.08 6.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.576 0.703 . . . . 74.24 111.894 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -109.65 121.74 45.9 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.321 1.448 . . . . 75.2 109.06 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.06 104.35 11.49 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.196 -0.668 . . . . 73.33 109.196 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.7 171.3 8.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.925 0.89 . . . . 73.21 109.702 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -90.16 8.59 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.32 0.648 . . . . 74.23 110.934 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -151.97 -131.09 1.69 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 109.985 -1.246 . . . . 51.21 109.985 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . 0.532 ' HZ1' ' HB2' ' E' ' 201' ' ' LYS . 0.1 OUTLIER 64.84 -74.9 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.198 1.399 . . . . 73.03 110.057 -173.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -81.95 -172.82 4.13 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.31 1.044 . . . . 74.42 110.645 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -77.18 -145.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 106.982 -1.488 . . . . 74.22 106.982 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 204' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' E' ' 207' ' ' VAL . 17.4 mm 55.96 32.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.444 1.116 . . . . 73.42 109.15 -170.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 205' ' ' LYS . . . . . 0.405 ' HB2' ' HZ2' ' E' ' 205' ' ' LYS . 4.4 ttmp? -73.81 -51.62 15.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.276 -1.329 . . . . 73.04 109.119 -174.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -137.58 64.29 1.52 Allowed 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 73.15 109.118 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' E' ' 204' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 124.584 1.154 . . . . 74.34 109.808 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.784 0.326 . . . . 72.15 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.51 -61.3 1.77 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.812 -0.631 . . . . 30.14 112.124 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -78.83 124.77 28.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.174 0.59 . . . . 75.15 110.142 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 4.3 m -82.53 -63.12 1.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.388 1.075 . . . . 70.24 109.178 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.2 68.61 1.19 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 75.53 108.551 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 173' ' ' LEU . . . . . 0.591 HD21 ' H ' ' B' ' 54' ' ' ASP . 1.4 tm? -98.63 101.1 12.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.21 -1.359 . . . . 74.13 107.791 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 174' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' F' ' 174' ' ' MET . 0.0 OUTLIER -156.38 108.62 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.529 0.731 . . . . 73.3 109.174 174.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -158.83 121.71 3.7 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.019 0.528 . . . . 75.52 110.135 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.04 130.47 19.93 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.994 -1.854 . . . . 72.34 105.994 170.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.79 -71.27 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.559 0.537 . . . . 74.05 109.614 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 61.91 -71.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.096 1.359 . . . . 70.13 111.606 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -108.82 136.28 20.02 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 107.757 -1.201 . . . . 71.11 107.757 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.69 143.11 60.67 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 70.0 110.162 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.2 -57.81 11.24 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.253 -0.647 . . . . 74.23 109.253 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -148.01 143.71 27.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.622 1.169 . . . . 75.23 108.606 166.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 69.5 p -72.14 144.72 48.5 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.297 -0.631 . . . . 72.53 109.297 172.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 184' ' ' TRP . . . . . 0.501 ' CD1' HD13 ' F' ' 186' ' ' LEU . 8.3 t90 -142.65 65.02 16.39 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 122.63 0.372 . . . . 72.42 110.026 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -98.04 132.96 0.3 Allowed 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.762 2.975 . . . . 71.31 112.876 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 186' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' B' ' 128' ' ' LEU . 0.8 OUTLIER -138.92 -165.1 1.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.086 0.555 . . . . 73.41 110.913 -175.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' F' F ' 187' ' ' ILE . . . . . 0.767 HG13 ' HB3' ' B' ' 42' ' ' LEU . 29.8 mm 69.53 134.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 127.041 2.136 . . . . 75.15 112.985 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.01 35.55 1.74 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.668 -0.696 . . . . 74.02 110.65 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.88 64.25 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.52 0.728 . . . . 73.55 111.963 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.08 -49.82 70.71 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.808 1.243 . . . . 64.11 110.897 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -95.59 10.81 68.82 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.87 -0.605 . . . . 62.22 112.941 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.22 87.26 0.32 Allowed Glycine 0 C--N 1.35 1.356 0 C-N-CA 123.216 0.436 . . . . 71.33 112.178 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -72.89 89.83 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.906 0.882 . . . . 75.13 109.69 -177.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . 0.512 ' HB2' ' HE2' ' E' ' 193' ' ' TYR . . . -170.71 -37.74 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.402 1.081 . . . . 63.31 108.69 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.32 108.01 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.994 -1.003 . . . . 72.21 110.173 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -159.55 155.68 26.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.641 1.176 . . . . 73.05 108.91 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -78.98 -42.48 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.815 0.446 . . . . 74.1 110.717 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -80.62 66.4 6.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.376 0.671 . . . . 65.51 111.058 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -166.67 -73.45 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.061 0.544 . . . . 74.21 109.812 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -136.94 84.52 0.25 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.896 -0.882 . . . . 73.24 110.896 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.96 117.1 9.37 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.77 0.828 . . . . 71.32 111.409 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -75.97 -29.0 58.1 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.863 0.84 . . . . 73.35 109.403 167.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.91 130.83 36.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 113.943 -1.48 . . . . 61.1 110.099 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.38 107.48 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 74.3 108.685 167.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -63.14 -38.97 93.28 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.063 -0.971 . . . . 72.23 109.72 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -159.85 159.91 33.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.251 1.021 . . . . 74.23 108.738 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.258 1.518 0 CA-C-O 118.11 -0.948 . . . . 70.51 109.604 175.124 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' G' G ' 168' ' ' LYS . . . . . 0.577 ' H2 ' ' HD2' ' G' ' 168' ' ' LYS . 3.3 mptp? . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.607 -0.886 . . . . 75.41 108.607 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.86 -165.49 15.39 Favored Glycine 0 C--N 1.344 0.991 0 O-C-N 123.587 0.554 . . . . 74.54 113.587 173.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 170' ' ' LYS . . . . . 0.51 ' HG2' ' H ' ' G' ' 171' ' ' SER . 33.5 ttpt -177.07 -170.11 0.28 Allowed 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.445 1.498 . . . . 72.21 107.494 -172.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 171' ' ' SER . . . . . 0.51 ' H ' ' HG2' ' G' ' 170' ' ' LYS . 32.3 t 68.41 10.38 7.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.893 0.877 . . . . 62.44 111.932 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -165.87 -46.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.535 0.734 . . . . 53.34 109.353 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.47 125.41 21.93 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 124.107 0.88 . . . . 65.03 110.377 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 174' ' ' MET . . . . . 0.564 ' HE3' ' HA ' ' A' ' 54' ' ' ASP . 30.0 mmt 72.77 -71.41 0.14 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.089 1.756 . . . . 75.12 109.793 -173.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 175' ' ' PHE . . . . . 0.547 ' HB2' ' HH ' ' A' ' 56' ' ' TYR . 26.7 t80 -148.46 -86.36 0.09 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.966 -0.753 . . . . 71.44 108.966 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 14.4 m120 49.84 26.41 1.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.009 1.324 . . . . 73.12 113.282 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.5 109.78 4.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.473 0.709 . . . . 75.41 110.319 -172.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 178' ' ' GLN . . . . . 0.528 ' HA ' HE21 ' G' ' 178' ' ' GLN . 0.0 OUTLIER -139.46 134.98 33.07 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.67 -1.233 . . . . 71.33 107.67 177.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 84.58 0.18 Allowed Pre-proline 0 CA--C 1.557 1.216 0 O-C-N 124.559 1.162 . . . . 74.04 109.513 -165.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.42 138.03 53.43 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.409 2.739 . . . . 74.05 112.607 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -72.19 95.16 1.63 Allowed 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.694 0.798 . . . . 74.41 109.219 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 68.86 -179.38 0.23 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.234 1.414 . . . . 75.12 111.26 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 76.8 p -109.87 -5.9 15.38 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.601 0.76 . . . . 74.22 111.048 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 67.61 100.91 0.04 OUTLIER Pre-proline 0 C--N 1.366 1.307 0 C-N-CA 125.115 1.366 . . . . 74.13 110.886 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.52 117.08 3.34 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.351 2.034 . . . . 74.3 111.457 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.16 -175.84 5.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.401 0.68 . . . . 75.0 110.27 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.99 146.59 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.489 0.716 . . . . 72.44 109.421 167.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -100.06 85.08 2.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.442 0.697 . . . . 50.53 109.539 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 189' ' ' ALA . . . . . 0.464 ' HB1' HD11 ' H' ' 204' ' ' ILE . . . -86.36 108.02 18.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.415 -0.811 . . . . 71.24 109.631 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -146.64 174.69 11.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.412 0.685 . . . . 71.32 110.002 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 90.1 113.33 1.53 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.469 -1.052 . . . . 71.34 110.469 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -145.79 116.61 0.91 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.58 -0.566 . . . . 60.32 111.941 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -170.29 130.19 0.91 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.492 1.117 . . . . 74.24 108.849 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -156.54 171.58 20.05 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.448 0.699 . . . . 72.41 110.231 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 195' ' ' PHE . . . . . 0.479 ' HE2' ' HD3' ' A' ' 124' ' ' PRO . 25.8 m-85 60.65 -166.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.477 1.111 . . . . 73.52 111.269 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -136.79 92.91 2.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.817 0.847 . . . . 75.14 109.439 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -83.5 69.51 10.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.857 0.863 . . . . 73.41 108.875 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.76 -65.47 1.17 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.182 0.993 . . . . 75.52 108.72 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -169.4 141.58 2.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.417 1.087 . . . . 72.31 109.01 174.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 160.64 141.02 3.02 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.684 -0.566 . . . . 74.24 111.684 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.93 -39.55 5.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.448 0.699 . . . . 74.41 111.324 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 202' ' ' TYR . . . . . 0.423 ' OH ' HG21 ' D' ' 40' ' ' VAL . 37.3 t80 63.8 106.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.963 1.305 . . . . 74.52 108.396 -167.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.12 85.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 113.502 0.927 . . . . 74.03 113.502 -161.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mt -130.88 44.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 106.416 -1.698 . . . . 75.31 106.416 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -67.32 163.31 20.92 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.607 -1.179 . . . . 74.31 112.053 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -55.06 103.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.987 0.915 . . . . 71.31 111.471 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.797 1.639 . . . . 74.34 111.791 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 55.6 tptt . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.79 -0.448 . . . . 73.54 109.79 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 165.45 35.92 0.02 OUTLIER Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.445 -0.343 . . . . 70.23 113.29 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -95.16 152.95 17.9 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.685 -0.857 . . . . 73.52 108.685 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 171' ' ' SER . . . . . 0.407 ' HG ' ' HB2' ' D' ' 90' ' ' GLU . 40.2 m -75.19 76.02 2.33 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.932 0.893 . . . . 60.11 109.922 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 172' ' ' ALA . . . . . 0.681 ' HB3' ' HB3' ' H' ' 176' ' ' ASN . . . -74.68 -38.97 62.27 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.672 -1.149 . . . . 63.4 110.823 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 173' ' ' LEU . . . . . 0.542 HD22 ' HE1' ' H' ' 174' ' ' MET . 0.5 OUTLIER 72.11 -73.77 0.09 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.419 1.488 . . . . 64.43 111.201 175.134 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' H' H ' 174' ' ' MET . . . . . 0.542 ' HE1' HD22 ' H' ' 173' ' ' LEU . 25.2 mmt -91.51 75.56 5.91 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.602 0.761 . . . . 75.32 111.569 -176.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 175' ' ' PHE . . . . . 0.44 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 49.8 t80 54.37 94.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.139 1.776 . . . . 75.42 113.779 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 176' ' ' ASN . . . . . 0.681 ' HB3' ' HB3' ' H' ' 172' ' ' ALA . 28.0 t-20 -171.62 98.83 0.19 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.954 0.902 . . . . 73.35 109.113 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.3 107.61 19.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.074 -1.454 . . . . 75.22 107.074 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -66.03 93.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.397 0.679 . . . . 72.34 110.796 -171.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . 0.315 1.2 mp0 34.99 -85.12 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.346 0 C-N-CA 127.857 2.463 . . . . 73.45 116.015 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.19 133.19 32.08 Favored 'Trans proline' 0 C--N 1.401 3.322 0 CA-C-N 124.036 2.477 . . . . 73.23 112.138 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -107.86 -79.19 0.58 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.468 -0.938 . . . . 73.44 108.468 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 15.4 t80 178.6 153.04 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.531 1.133 . . . . 65.22 108.312 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 15.2 t -78.12 148.15 34.31 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.567 0.747 . . . . 72.33 110.996 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 184' ' ' TRP . . . . . 0.505 ' HB2' HD12 ' H' ' 186' ' ' LEU . 0.1 OUTLIER -149.27 115.54 3.65 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 122.911 0.484 . . . . 71.41 111.768 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.74 -63.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.219 2.613 . . . . 74.12 111.907 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 186' ' ' LEU . . . . . 0.505 HD12 ' HB2' ' H' ' 184' ' ' TRP . 10.2 mp 59.23 86.08 0.09 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.384 1.473 . . . . 75.33 112.803 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 187' ' ' ILE . . . . . 0.529 ' HB ' HD22 ' D' ' 42' ' ' LEU . 56.8 mt 64.97 108.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.767 1.627 . . . . 72.22 112.469 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -112.75 66.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.98 145.57 48.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.877 -1.056 . . . . 74.13 112.84 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.27 172.57 18.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.952 0.901 . . . . 75.45 110.309 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -160.71 -152.3 6.53 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 111.241 -0.744 . . . . 75.1 111.241 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -135.23 -62.31 0.06 OUTLIER Glycine 0 C--N 1.351 1.388 0 CA-C-N 117.585 0.693 . . . . 55.21 112.73 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 193' ' ' TYR . . . . . 0.453 ' HE1' ' HB2' ' H' ' 196' ' ' LYS . 3.2 t80 -158.89 118.54 3.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.464 0.706 . . . . 75.42 109.129 -175.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.49 25.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.993 0.917 . . . . 75.3 110.338 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -122.22 23.57 9.78 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.18 0.992 . . . . 73.21 110.058 -168.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 196' ' ' LYS . . . . . 0.453 ' HB2' ' HE1' ' H' ' 193' ' ' TYR . 6.6 tmtm? -73.84 105.59 5.18 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.605 -0.725 . . . . 75.44 110.396 -171.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.2 179.34 7.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.048 0.939 . . . . 74.41 111.537 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.109 1.363 . . . . 60.42 111.834 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.85 1.55 52.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.136 -0.938 . . . . 75.31 110.433 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 80.59 -59.45 4.66 Favored Glycine 0 C--N 1.361 1.932 0 O-C-N 123.754 0.659 . . . . 52.22 111.455 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -110.19 118.9 37.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.919 1.288 . . . . 73.35 107.593 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 67.9 t80 179.63 89.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.286 -1.376 . . . . 75.55 107.286 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -132.58 96.42 3.83 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.174 0.59 . . . . 72.22 110.562 -169.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 204' ' ' ILE . . . . . 0.464 HD11 ' HB1' ' G' ' 189' ' ' ALA . 15.6 pt -142.9 112.32 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.466 1.107 . . . . 74.45 109.27 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 205' ' ' LYS . . . . . 0.762 ' HG2' ' HB ' ' C' ' 10' ' ' THR . 41.3 ttmt -147.16 -61.84 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.905 0.482 . . . . 73.23 110.906 -173.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.22 164.43 16.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.943 -0.571 . . . . 74.22 110.758 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.559 1.301 0 CA-C-O 117.962 -1.018 . . . . 73.2 109.885 -176.597 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.815 -1.18 . . . . 72.13 107.815 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -100.86 118.43 36.9 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.97 -0.752 . . . . 64.24 108.97 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' H ' HG22 ' A' ' 86' ' ' ILE . 52.3 tp60 -141.29 123.51 15.65 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.436 0.46 . . . . 62.42 110.908 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.47 128.9 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.66 -1.237 . . . . 71.14 107.66 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -97.29 -28.91 13.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.472 -0.775 . . . . 72.23 111.341 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -175.85 127.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 123.428 0.455 . . . . 73.12 111.182 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.795 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 65.1 mt -107.74 133.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.359 -0.978 . . . . 53.42 108.359 168.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' HE1' HG13 ' A' ' 83' ' ' ILE . 17.0 p90 -165.26 154.43 12.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.034 0.934 . . . . 75.22 110.139 -174.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -81.14 121.15 25.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.316 -0.624 . . . . 63.52 109.316 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.2 mtpt -88.45 -24.57 22.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.623 0.369 . . . . 74.41 111.146 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 13.8 t70 -153.52 143.71 22.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.424 0.631 . . . . 71.42 109.955 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.08 131.66 41.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 106.325 -1.731 . . . . 72.54 106.325 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.0 t -146.27 114.14 6.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.488 . . . . 71.33 109.684 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 88.8 t80 -116.11 120.33 38.7 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.242 -1.392 . . . . 74.53 107.242 172.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -119.95 130.8 54.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.365 -0.606 . . . . 73.51 109.365 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -140.84 76.03 23.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.844 -1.169 . . . . 73.03 107.844 172.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 -20.43 21.74 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.639 2.226 . . . . 72.05 112.028 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -110.63 25.24 11.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.981 0.912 . . . . 71.1 109.179 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.529 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.99 -49.69 89.96 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.536 0.734 . . . . 72.1 112.882 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 30.7 Cg_endo -68.8 -22.6 36.6 Favored 'Trans proline' 0 C--N 1.387 2.566 0 CA-C-N 121.293 1.498 . . . . 63.04 112.287 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -81.63 -20.54 39.47 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.971 1.309 . . . . 74.23 111.293 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 28' ' ' ALA . 4.0 p -64.52 -29.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.708 0.803 . . . . 61.34 111.592 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -62.7 -32.47 73.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.302 1.041 . . . . 74.44 111.597 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -72.26 -35.46 68.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.003 -0.999 . . . . 73.35 110.365 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 1.5 mmmp? -83.95 153.15 24.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.929 0.891 . . . . 74.01 110.808 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.06 144.69 32.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.383 0.673 . . . . 75.42 109.99 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -86.77 86.39 7.32 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.83 0.824 . . . . 74.41 110.247 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -131.96 82.63 59.02 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.951 -1.5 . . . . 74.32 106.951 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.62 127.42 7.21 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.635 2.223 . . . . 73.52 113.368 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 106.02 18.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.945 -1.502 . . . . 71.32 106.945 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.4 130.21 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 116.23 -0.441 . . . . 65.32 111.183 -171.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 59.9 mtpt -109.26 144.96 36.7 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 74.14 110.504 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD22 ' A' ' 128' ' ' LEU . 7.9 mp -126.01 112.27 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.691 -1.595 . . . . 71.33 107.603 171.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.633 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.1 m-20 -104.09 110.1 22.15 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.209 -1.404 . . . . 73.52 107.209 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -96.52 127.32 42.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.185 -0.672 . . . . 74.12 109.185 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.63 162.09 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.191 0.596 . . . . 73.2 109.815 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -149.51 164.59 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.962 0.905 . . . . 71.23 110.261 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . . . -148.68 154.13 39.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.634 1.174 . . . . 75.21 108.96 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 50.8 m -125.33 152.08 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.821 0.448 . . . . 73.34 110.264 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -150.14 138.59 20.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.953 0.901 . . . . 64.02 109.147 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -97.32 113.42 25.05 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.577 -0.527 . . . . 64.31 109.577 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.19 -32.03 17.65 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.815 -0.629 . . . . 71.33 110.538 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.61 -173.86 3.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.671 0.788 . . . . 64.54 110.549 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.71 115.8 5.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.52 0.728 . . . . 62.04 109.285 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 71.69 -6.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.103 1.361 . . . . 71.01 112.613 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 56.4 t -99.11 112.48 31.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 64.13 108.055 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -122.62 167.31 13.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.227 -0.897 . . . . 73.23 110.27 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 48' ' ' SER . 35.4 tt0 -131.67 125.65 32.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.894 -1.503 . . . . 71.52 108.004 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.8 113.88 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.586 -1.264 . . . . 61.12 107.586 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -100.35 127.3 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.403 0.681 . . . . 73.43 109.836 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -96.49 118.55 33.24 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.944 -1.132 . . . . 73.2 107.944 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -96.39 101.85 13.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.002 -0.74 . . . . 72.51 109.002 170.042 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 18.3 t -95.64 128.66 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 107.387 -1.338 . . . . 74.22 107.387 169.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.8 m -117.84 132.03 56.48 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.844 -0.798 . . . . 73.31 108.844 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 114' ' ' ILE . 54.9 t -126.83 109.52 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.689 1.196 . . . . 73.14 108.308 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 2.6 m -115.79 132.91 56.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.349 -0.611 . . . . 51.52 109.349 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.4 105.04 12.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.103 -1.444 . . . . 73.32 107.103 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -109.56 123.52 49.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.84 -0.43 . . . . 75.51 109.84 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.94 75.12 7.25 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.017 -1.105 . . . . 72.44 108.017 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.74 -105.52 1.96 Allowed Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.922 -0.871 . . . . 65.43 110.922 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.58 13.48 25.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.579 0.752 . . . . 73.44 110.693 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.611 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -120.31 114.08 21.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.533 -0.746 . . . . 72.45 109.76 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -73.46 132.09 42.54 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.46 1.027 . . . . 75.24 110.726 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.63 -54.14 4.73 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.318 1.047 . . . . 71.0 108.942 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -157.3 173.34 17.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.593 -1.185 . . . . 70.52 111.233 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -142.79 142.94 31.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.678 1.591 . . . . 63.22 107.555 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 34.1 m -143.74 99.56 3.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.158 0.583 . . . . 74.53 109.838 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 40.3 tt0 -109.14 121.47 45.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.077 0.551 . . . . 75.2 109.98 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 t -122.69 119.29 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.935 0.894 . . . . 51.22 109.355 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.9 mt-30 -85.58 91.91 8.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.523 -0.762 . . . . 74.34 109.125 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.11 97.5 10.35 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.207 -1.034 . . . . 75.11 108.207 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.74 144.16 18.06 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 112.173 -0.371 . . . . 72.45 112.173 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.62 125.43 3.0 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.281 -0.728 . . . . 65.34 111.281 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.423 HG13 ' HE1' ' A' ' 17' ' ' TYR . 47.2 mt -80.36 129.71 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.625 -0.88 . . . . 75.42 108.625 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.7 120.85 27.26 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.268 -1.012 . . . . 64.52 108.268 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 t -105.39 94.22 5.1 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.437 -0.949 . . . . 74.13 108.437 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 12' ' ' GLN . 1.5 pp -134.93 165.06 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.381 1.073 . . . . 64.34 108.4 -170.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.36 178.85 8.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.191 0.596 . . . . 72.04 111.073 170.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.86 67.66 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.739 -0.664 . . . . 71.23 114.522 170.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -113.6 147.71 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.203 0.601 . . . . 73.2 111.624 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -157.79 -170.25 3.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.98 1.312 . . . . 73.52 110.573 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 73.86 -149.41 41.31 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.996 0.808 . . . . 74.01 114.722 175.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.9 p -83.31 -23.43 32.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.577 1.151 . . . . 71.32 111.261 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -71.39 -35.45 71.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.488 1.115 . . . . 74.24 110.648 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 27.7 ptm -62.24 -39.6 93.37 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.199 0.312 . . . . 72.44 110.3 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.5 94.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.48 0.712 . . . . 71.44 110.569 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -57.99 -45.67 86.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.923 0.889 . . . . 73.4 111.488 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.43 -54.27 7.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.315 -0.402 . . . . 74.25 111.334 -173.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.0 -23.97 65.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.513 0.597 . . . . 72.44 111.449 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.85 -21.1 48.08 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-O 119.596 -0.558 . . . . 62.31 113.827 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -136.56 -54.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.654 0.727 . . . . 72.13 112.746 -173.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -72.81 -48.94 33.69 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.727 0.811 . . . . 73.45 112.475 -167.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.91 -46.8 75.13 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.258 1.023 . . . . 70.41 112.072 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.58 -20.82 40.51 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.588 1.525 . . . . 75.1 113.119 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 40.4 t-20 -67.85 -36.06 79.64 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.871 0.469 . . . . 73.11 109.829 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.0 mm -56.26 -43.18 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.677 0.791 . . . . 73.13 110.393 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 82' ' ' GLY . 53.3 mt -81.46 -21.85 38.49 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.995 -1.002 . . . . 61.24 111.527 -172.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.411 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 29.3 t80 -66.14 -39.43 28.56 Favored Pre-proline 0 CA--C 1.56 1.35 0 N-CA-C 114.696 1.369 . . . . 73.01 114.696 -167.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HB3' HD13 ' C' ' 105' ' ' ILE . 12.2 Cg_endo -57.13 -40.05 86.14 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 121.878 1.718 . . . . 63.4 112.525 172.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.43 -35.38 63.37 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.552 0.741 . . . . 70.11 110.957 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.81 64.67 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.119 0.568 . . . . 72.01 110.153 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.8 ttm105 -51.41 -51.4 55.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.787 1.235 . . . . 71.2 110.333 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.82 -48.41 80.73 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.456 1.097 . . . . 72.13 111.362 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.413 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.1 t -54.18 -45.78 72.21 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.375 1.047 . . . . 72.5 110.698 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.663 HG21 HG21 ' A' ' 64' ' ' VAL . 9.0 mt -64.29 -53.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.051 -0.977 . . . . 53.31 110.901 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 125' ' ' GLN . 66.1 m -53.22 -39.57 63.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 72.42 111.371 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -71.4 -42.11 68.77 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.192 -0.913 . . . . 75.54 109.807 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.9 mtp -57.79 -41.94 83.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.826 0.85 . . . . 70.31 111.215 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.5 t -61.02 -50.19 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.415 1.086 . . . . 74.04 110.387 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 82.2 p -72.1 -27.18 62.48 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.734 -0.666 . . . . 73.5 111.784 -175.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.531 HH12 ' HG3' ' B' ' 112' ' ' GLU . 76.8 mtt-85 -73.11 -24.74 60.66 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.442 0.697 . . . . 65.42 110.335 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.41 14.83 48.94 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-O 119.833 -0.426 . . . . 60.45 113.133 171.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.489 HG22 HH21 ' B' ' 15' ' ' ARG . 1.8 t 62.83 15.21 8.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 127.331 2.252 . . . . 73.42 113.42 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -91.91 157.75 40.86 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.319 0.648 . . . . 71.03 109.855 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.22 151.99 76.35 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.68 2.253 . . . . 75.44 111.977 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.493 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.1 tt0 -57.46 137.21 56.47 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.487 0.492 . . . . 55.2 110.818 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.4 tp -117.07 112.61 21.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.027 -0.988 . . . . 53.41 108.667 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.71 102.37 14.11 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.125 -1.065 . . . . 73.24 108.125 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.457 HD22 HD21 ' A' ' 42' ' ' LEU . 61.1 mt -71.35 117.98 13.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.05 -0.722 . . . . 75.45 109.05 177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.48 128.84 94.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.285 0.366 . . . . 71.13 110.605 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HB3' HH22 ' A' ' 111' ' ' ARG . 57.9 Cg_endo -72.9 136.97 26.04 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 121.833 1.688 . . . . 44.43 110.584 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.88 113.7 33.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.23 -1.396 . . . . 62.11 107.23 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.89 63.94 8.35 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.887 1.327 . . . . 73.13 109.215 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 113.822 -1.536 . . . . 75.31 110.064 179.354 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.248 0.991 0 N-CA-C 109.566 -0.531 . . . . 72.52 109.566 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 41.3 t80 -137.33 153.92 50.16 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.735 0.814 . . . . 63.02 108.916 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.424 0.69 . . . . 71.23 111.381 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tp -86.95 133.77 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.019 0.528 . . . . 45.21 109.699 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -101.64 -37.85 8.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.869 0.468 . . . . 65.33 109.841 170.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.489 HH21 HG22 ' A' ' 122' ' ' THR . 68.2 ttt180 -167.36 137.51 2.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.678 0.391 . . . . 73.51 111.006 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.81 141.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.653 -1.61 . . . . 70.31 106.653 169.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -172.06 144.17 1.64 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.961 0.41 . . . . 74.45 111.701 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.599 HG21 HD11 ' B' ' 21' ' ' ILE . 16.4 m -76.07 128.18 34.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.534 -0.913 . . . . 54.51 108.534 170.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.48 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 42.1 mtpt -98.4 -40.99 8.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.502 0.721 . . . . 72.02 109.564 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 30.7 t70 -138.77 143.27 38.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.34 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.599 HD11 HG21 ' B' ' 18' ' ' THR . 34.7 mm -131.32 142.88 42.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 125.309 1.443 . . . . 73.03 107.758 170.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.7 m -144.4 129.09 18.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.825 -1.08 . . . . 61.01 108.798 168.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 75.0 t80 -138.79 106.7 5.67 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.125 -2.176 . . . . 75.41 105.125 164.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -119.64 108.55 14.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.205 -1.406 . . . . 73.11 107.205 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.497 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.04 89.26 6.44 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.561 1.144 . . . . 75.2 108.461 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.75 -44.2 6.14 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.714 2.276 . . . . 74.54 111.695 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 41.0 m-80 -105.98 32.17 4.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.349 1.059 . . . . 53.34 109.414 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.497 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.19 -46.42 55.69 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 125.022 1.329 . . . . 74.23 113.929 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 38.4 Cg_endo -69.89 -23.15 30.53 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 121.56 1.507 . . . . 54.23 113.32 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 0.3 OUTLIER -78.63 -2.77 40.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.408 0.683 . . . . 74.05 111.415 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.82 -20.96 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.115 0.566 . . . . 74.23 110.593 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -84.36 -21.48 30.88 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.709 0.803 . . . . 63.41 110.422 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -87.83 -22.84 24.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.408 0.683 . . . . 72.45 111.659 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -107.04 99.88 9.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.976 0.91 . . . . 74.15 111.09 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.02 76.55 8.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.579 0.752 . . . . 74.12 109.359 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 t90 179.88 159.04 0.75 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.106 0.962 . . . . 72.4 109.667 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.56 137.81 85.98 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.081 0.953 . . . . 71.4 112.066 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.68 141.0 48.56 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.376 1.384 . . . . 73.42 110.271 163.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 44.6 mm-40 -75.21 99.24 3.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.247 -1.02 . . . . 75.25 108.247 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.403 ' HB ' ' HG ' ' B' ' 126' ' ' LEU . 14.1 t -97.57 118.21 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.763 -1.199 . . . . 72.11 107.763 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 134.29 46.41 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.666 -1.235 . . . . 72.22 107.666 -165.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.534 HD23 HD22 ' B' ' 128' ' ' LEU . 1.8 pp -86.67 162.49 17.89 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.086 0.773 . . . . 71.33 113.086 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.0 m-20 -146.94 131.75 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.002 -1.481 . . . . 71.44 107.002 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.13 142.83 34.22 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.229 -1.026 . . . . 42.33 108.229 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -145.11 140.31 27.94 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.305 -0.628 . . . . 73.31 109.305 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 48.3 m -108.93 111.43 23.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.512 0.725 . . . . 62.04 109.886 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.48 128.65 47.27 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 107.813 -1.181 . . . . 72.12 107.813 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.8 m -142.7 165.37 27.56 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.853 -0.529 . . . . 72.04 110.075 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.3 p -152.61 159.52 43.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 72.04 109.499 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -106.54 121.27 43.97 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.688 0.795 . . . . 75.31 109.5 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 85.5 mt -82.99 -43.1 16.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.251 0.62 . . . . 53.41 110.095 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -158.53 -177.07 6.27 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.381 -0.827 . . . . 71.42 111.019 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.23 112.54 5.87 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 113.76 -1.564 . . . . 72.35 109.096 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 73.61 8.26 5.02 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.924 1.29 . . . . 52.4 112.584 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 48.5 t -119.34 96.08 4.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.988 0.915 . . . . 72.21 108.635 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -99.21 169.61 9.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.713 0.768 . . . . 71.35 110.964 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.436 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.5 tm-20 -142.7 96.77 2.99 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.581 -1.637 . . . . 74.1 106.581 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 79.1 t -94.86 122.58 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.194 -0.669 . . . . 75.13 109.194 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 32.5 t -103.44 118.91 51.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.309 -0.86 . . . . 73.22 109.226 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.479 HD22 HG23 ' B' ' 62' ' ' VAL . 1.9 tt -92.03 112.33 24.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.263 -1.384 . . . . 70.33 107.263 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -104.17 111.79 24.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.463 -0.79 . . . . 73.15 109.655 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' B' ' 114' ' ' ILE . 67.1 t -105.4 112.42 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.941 -1.133 . . . . 74.12 107.941 170.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 8.8 m -98.44 152.08 19.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.801 -0.815 . . . . 73.55 108.801 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.562 HG21 HG21 ' B' ' 114' ' ' ILE . 84.9 t -141.6 126.49 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.422 1.089 . . . . 71.03 108.326 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -114.26 135.32 54.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.666 0.786 . . . . 51.34 109.388 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.28 146.18 44.39 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.081 0.552 . . . . 61.23 110.231 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -149.87 129.87 13.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.27 0.557 . . . . 72.33 112.255 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 65.7 mt -95.15 104.84 16.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.727 1.211 . . . . 72.54 109.605 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.05 -110.1 3.28 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.702 0.626 . . . . 74.43 113.047 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.7 3.57 37.16 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.106 1.362 . . . . 71.21 109.62 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.29 154.24 39.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.125 0.97 . . . . 61.32 109.879 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -73.53 137.88 44.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.13 0.572 . . . . 61.42 109.931 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.657 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.73 -61.98 1.48 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.784 0.834 . . . . 72.54 108.869 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.26 166.78 32.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.984 -1.462 . . . . 74.41 109.501 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.13 111.12 6.31 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.846 -1.539 . . . . 51.21 106.846 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -116.7 158.69 23.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.043 -0.725 . . . . 73.42 109.043 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -166.26 127.63 1.8 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.092 -1.077 . . . . 75.01 108.092 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.74 142.6 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.782 -0.451 . . . . 75.31 109.782 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -120.38 95.99 4.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.126 -0.943 . . . . 73.21 109.361 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -86.59 103.67 15.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.097 -0.956 . . . . 73.32 109.251 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.13 159.48 28.83 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 111.598 -0.601 . . . . 71.45 111.598 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.17 127.42 1.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.75 -0.94 . . . . 73.31 110.75 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.4 mt -85.41 113.2 23.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.609 -0.886 . . . . 73.43 108.609 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -118.82 133.74 55.63 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.177 -0.675 . . . . 75.24 109.177 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -93.49 110.29 21.87 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.108 -1.071 . . . . 71.12 108.108 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.632 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -121.19 134.68 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.306 0.642 . . . . 75.41 109.74 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.87 33.68 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.152 0.981 . . . . 42.35 108.986 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.31 -44.98 3.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 122.863 0.268 . . . . 64.53 113.261 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.1 136.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.918 0.887 . . . . 64.24 111.655 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.551 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 10.8 pt-20 -151.67 146.97 26.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.744 0.418 . . . . 74.2 110.561 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.23 -105.83 0.79 Allowed Glycine 0 C--N 1.35 1.334 0 O-C-N 124.037 0.835 . . . . 74.21 113.469 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.1 m -79.65 -31.72 41.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.923 0.889 . . . . 72.13 110.846 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.551 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 73.0 mt-30 -60.88 -48.74 80.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.315 0.646 . . . . 63.22 110.107 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.452 ' HA ' ' SG ' ' B' ' 97' ' ' CYS . 10.3 ptm -72.82 -36.85 67.61 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.158 -0.928 . . . . 64.12 110.137 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.73 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.066 0.546 . . . . 72.53 111.286 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -75.27 -35.84 61.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.096 0.958 . . . . 72.53 111.139 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' B' ' 94' ' ' MET . 27.3 p -78.66 -56.91 4.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 110.466 -0.198 . . . . 75.21 110.466 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.6 -22.75 64.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.249 0.62 . . . . 70.04 111.49 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.38 -0.39 40.6 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.246 -0.752 . . . . 23.41 114.584 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.95 -49.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.384 1.092 . . . . 75.2 112.319 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -72.22 -58.5 3.36 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.69 0.396 . . . . 75.45 111.193 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.06 -45.97 99.72 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 124.009 0.923 . . . . 62.04 111.956 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.72 -54.89 4.69 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.145 1.897 . . . . 52.41 112.349 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -63.56 -14.78 54.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.803 1.038 . . . . 60.12 113.803 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 75.4 mt -78.65 -48.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.738 -0.467 . . . . 63.21 109.738 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.01 -20.7 48.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.215 1.006 . . . . 60.35 111.785 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.87 -44.78 80.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.503 1.521 . . . . 72.32 112.517 -171.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.473 ' HA ' HH11 ' B' ' 111' ' ' ARG . 35.1 Cg_exo -56.69 -39.78 88.97 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 121.984 1.789 . . . . 72.31 112.94 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.8 m-85 -69.21 -41.62 76.84 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.138 0.575 . . . . 74.22 110.94 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.6 87.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.783 0.433 . . . . 71.33 110.121 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.473 HH11 ' HA ' ' B' ' 108' ' ' PRO . 28.9 mtp-105 -52.84 -63.41 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.778 1.231 . . . . 65.15 110.743 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.531 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.7 tp10 -55.28 -37.42 67.29 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.728 1.211 . . . . 63.32 111.493 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.538 ' O ' ' HG2' ' B' ' 117' ' ' MET . 2.0 t -72.57 -46.4 54.58 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 119.642 -0.218 . . . . 61.04 110.965 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.562 HG21 HG21 ' B' ' 64' ' ' VAL . 83.4 mt -60.02 -57.27 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.625 0.77 . . . . 55.33 110.668 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.466 HG23 ' H ' ' B' ' 126' ' ' LEU . 5.9 m -60.24 -28.19 67.82 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.123 0.889 . . . . 71.44 110.744 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.9 t -68.69 -53.12 24.13 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.476 0.711 . . . . 65.55 110.821 171.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.5 mmt -61.85 -37.69 85.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.004 0.522 . . . . 53.53 111.318 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.14 -49.46 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.859 1.264 . . . . 52.15 110.438 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.499 ' HB2' ' HA ' ' C' ' 126' ' ' LEU . 87.4 p -73.69 -22.99 59.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 64.14 112.258 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.8 mtt-85 -65.21 -32.37 74.01 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.472 0.709 . . . . 72.51 110.523 175.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 17.23 35.09 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.569 -0.741 . . . . 50.34 112.474 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 60.93 35.96 18.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.452 1.901 . . . . 73.5 112.648 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.32 159.37 29.52 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 124.24 1.016 . . . . 75.11 109.555 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.81 -175.06 2.49 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.948 2.432 . . . . 41.04 115.408 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.487 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 1.0 OUTLIER -65.58 133.43 51.16 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.971 1.308 . . . . 62.01 112.743 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.466 ' H ' HG23 ' B' ' 115' ' ' THR . 0.2 OUTLIER -153.72 86.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.199 -1.037 . . . . 63.33 108.199 163.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -102.62 136.89 41.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.643 -1.243 . . . . 73.53 107.643 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.534 HD22 HD23 ' B' ' 42' ' ' LEU . 10.8 mt -74.9 125.07 28.06 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.679 -0.489 . . . . 72.55 109.679 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -71.01 137.58 84.88 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.054 0.542 . . . . 73.11 110.7 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 12.8 Cg_exo -72.42 143.48 38.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.591 2.861 . . . . 74.1 113.138 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.53 128.35 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.259 0.624 . . . . 75.24 109.464 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.566 HD21 HG13 ' D' ' 105' ' ' ILE . 5.2 m-20 -83.62 81.59 8.68 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.167 0.587 . . . . 73.54 109.82 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 N--CA 1.471 0.583 0 CA-C-N 115.192 -0.913 . . . . 74.21 111.322 175.968 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.245 0.854 0 N-CA-C 107.455 -1.313 . . . . 74.11 107.455 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.661 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 53.3 t80 -98.64 127.1 44.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.797 -0.816 . . . . 74.23 108.797 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -138.2 126.57 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.618 -0.512 . . . . 62.14 109.618 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -80.75 140.31 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.047 0.939 . . . . 72.51 109.004 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.463 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -111.55 -51.44 2.86 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.913 0.387 . . . . 71.42 110.218 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 50.2 ttt180 -167.88 140.53 3.16 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.536 -0.756 . . . . 73.43 109.445 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mt -122.27 146.95 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.316 -0.994 . . . . 63.05 108.316 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.565 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 24.5 p90 -175.65 158.27 2.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.275 0.559 . . . . 73.43 111.284 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -77.16 118.54 19.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.2 -0.909 . . . . 74.34 109.153 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -77.46 -47.72 18.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.423 -0.955 . . . . 72.23 108.423 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -137.3 137.33 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.207 -1.361 . . . . 73.42 109.054 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.7 mt -134.68 145.45 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.969 -1.493 . . . . 72.1 106.969 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -159.37 150.23 19.64 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.223 0.535 . . . . 73.54 109.918 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -139.47 122.67 16.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.875 -1.157 . . . . 71.21 107.875 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.62 111.07 18.69 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.818 0.847 . . . . 71.05 109.182 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.44 84.06 60.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.201 -1.407 . . . . 52.22 107.201 167.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.49 -31.8 60.53 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.927 2.418 . . . . 71.22 111.892 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.484 ' O ' HG13 ' C' ' 31' ' ' VAL . 66.7 m-20 -96.89 24.96 5.66 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.342 1.057 . . . . 53.11 110.456 -176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.408 ' O ' HG22 ' C' ' 31' ' ' VAL . . . -54.96 -42.74 97.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 115.26 1.578 . . . . 72.11 115.26 -169.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -68.41 -41.97 5.95 Favored 'Trans proline' 0 C--N 1.384 2.44 0 CA-C-N 121.478 1.563 . . . . 64.43 112.082 169.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -64.02 -23.04 67.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.615 1.566 . . . . 73.03 113.131 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.544 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 15.8 m -57.63 -17.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.6 0.963 . . . . 64.53 113.6 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -59.66 -22.81 62.44 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.503 1.121 . . . . 71.52 112.436 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.6 22.53 5.92 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.428 0.529 . . . . 73.21 112.428 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -88.21 172.71 9.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.87 0.843 . . . . 74.33 111.337 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.416 ' O ' HD22 ' C' ' 68' ' ' LEU . 34.8 t70 -91.59 134.74 34.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.148 -1.387 . . . . 75.42 109.535 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -89.31 81.93 6.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.216 0.607 . . . . 73.32 111.33 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -159.1 69.66 3.4 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.133 0.573 . . . . 72.55 109.896 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' C' ' 67' ' ' SER . 42.1 Cg_endo -91.45 157.58 3.65 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.729 2.286 . . . . 75.32 113.368 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.92 76.77 7.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.078 -1.419 . . . . 65.01 108.798 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 m -73.39 96.35 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 122.141 0.972 . . . . 72.12 110.091 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 14.5 ptmm? -128.71 137.86 51.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.382 -1.281 . . . . 60.14 110.458 -173.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.92 139.47 36.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.833 0.853 . . . . 64.32 109.896 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -120.25 106.65 12.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.377 0.671 . . . . 72.13 109.77 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.94 108.96 19.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.402 0.681 . . . . 63.21 109.503 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -113.74 129.48 56.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.004 1.322 . . . . 74.11 108.116 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 36.3 m -111.38 116.92 31.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.988 0.515 . . . . 64.43 110.712 -167.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.11 162.85 27.88 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.336 1.054 . . . . 70.21 109.423 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.0 m -148.56 165.8 30.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.133 0.973 . . . . 63.11 109.641 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -154.65 131.92 11.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.518 0.727 . . . . 74.31 109.511 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.34 120.03 19.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.149 0.579 . . . . 43.11 110.271 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' C' ' 57' ' ' GLU . 57.0 mt -94.2 -37.18 11.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.132 0.573 . . . . 60.22 109.508 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.07 -171.42 2.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.102 -0.954 . . . . 71.35 110.277 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.43 123.31 25.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.129 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 68.18 1.26 2.75 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.791 1.236 . . . . 61.11 112.906 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.98 112.71 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.067 -1.086 . . . . 74.41 108.067 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.37 133.9 43.04 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.91 -0.774 . . . . 74.31 108.91 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.621 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.7 tt0 -93.26 117.64 30.31 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.768 0.827 . . . . 70.43 109.77 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.37 118.27 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.144 -1.058 . . . . 73.43 108.144 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.35 106.44 20.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.165 -1.05 . . . . 64.42 108.165 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -99.67 109.69 22.15 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.096 -1.076 . . . . 74.21 108.096 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 31.1 ttm180 -81.24 110.2 16.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.889 0.875 . . . . 64.32 108.952 174.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 t -100.02 130.08 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.41 -1.33 . . . . 62.12 107.41 169.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -129.16 117.07 20.18 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.414 -0.587 . . . . 65.34 109.414 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.563 HG23 HD13 ' C' ' 114' ' ' ILE . 60.0 t -101.09 112.07 32.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.427 -0.953 . . . . 74.0 108.427 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.433 HG23 HD23 ' C' ' 75' ' ' LEU . 5.0 m -99.4 146.62 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.363 -0.835 . . . . 64.23 109.039 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.89 110.93 6.28 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 22.3 m -135.41 140.05 44.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.913 0.485 . . . . 21.21 110.438 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.722 HD12 ' HG3' ' C' ' 71' ' ' GLU . 6.5 mt -111.02 14.07 21.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.657 1.183 . . . . 71.24 110.667 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.86 -104.54 0.93 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.598 -1.001 . . . . 54.33 110.598 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -93.06 -33.01 14.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.437 0.695 . . . . 73.44 109.316 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.722 ' HG3' HD12 ' C' ' 68' ' ' LEU . 3.8 tp10 -76.84 119.75 21.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.199 1.4 . . . . 74.23 109.137 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -86.29 134.1 33.77 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.029 -0.73 . . . . 64.1 109.029 174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -75.08 -58.24 3.4 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.485 -0.561 . . . . 74.14 109.485 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.84 175.27 3.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.137 -0.938 . . . . 72.13 110.652 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.433 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -141.77 143.11 33.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.732 -1.581 . . . . 74.43 106.732 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.8 t -145.72 143.18 29.6 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.451 -0.944 . . . . 72.55 108.451 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -150.99 130.4 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.81 0.444 . . . . 74.45 109.979 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.98 115.07 23.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.291 1.036 . . . . 71.02 108.527 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 17.6 mt-30 -90.98 92.34 8.71 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.161 -1.051 . . . . 63.31 108.161 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.533 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -81.38 110.96 17.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.737 -1.12 . . . . 64.53 110.004 -176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.6 146.08 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.782 -0.527 . . . . 61.3 111.782 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.62 120.42 1.57 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.889 -0.885 . . . . 64.53 110.889 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.478 HD12 HD11 ' C' ' 51' ' ' LEU . 11.0 mm -81.28 122.06 35.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.25 -1.018 . . . . 55.54 108.25 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -132.16 120.92 22.92 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.597 -0.89 . . . . 73.02 108.597 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.8 t -89.67 109.55 20.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.398 -0.964 . . . . 65.1 108.398 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -131.49 148.09 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.455 0.702 . . . . 75.34 111.036 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.8 152.75 9.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.796 1.238 . . . . 73.15 108.818 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.95 -16.38 58.65 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.967 -0.352 . . . . 74.33 113.176 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 42.4 pt . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 123.95 0.9 . . . . 65.45 110.325 178.321 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.943 -0.075 . . . . 72.13 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.425 ' HG3' ' N ' ' C' ' 95' ' ' ALA . 10.4 ptp -64.36 -48.02 77.11 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.295 0.372 . . . . 74.33 110.259 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' C' ' 94' ' ' MET . . . -71.29 -25.15 62.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.63 0.772 . . . . 60.11 111.195 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -79.22 -29.79 42.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 60.33 110.108 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -80.51 -66.77 0.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 116.577 -0.283 . . . . 63.42 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -3.78 58.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.766 -0.584 . . . . 50.34 112.259 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.81 9.28 25.6 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.894 -0.392 . . . . 44.02 113.791 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.29 -59.45 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.06 0.544 . . . . 64.53 110.207 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.403 ' O ' HG12 ' C' ' 105' ' ' ILE . 81.0 t80 -66.55 -54.53 22.63 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.721 0.808 . . . . 33.42 112.565 -171.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.661 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 20.7 m -62.76 -45.84 88.03 Favored Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 123.594 0.758 . . . . 44.32 111.505 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.6 Cg_exo -57.64 -32.07 93.56 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.067 1.844 . . . . 64.21 113.752 168.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' C' ' 108' ' ' PRO . 25.9 t-20 -74.83 -23.55 58.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.544 0.738 . . . . 64.52 110.822 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 108' ' ' PRO . 46.0 mm -69.96 -33.26 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.196 0.598 . . . . 73.55 109.41 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' C' ' 82' ' ' GLY . 80.5 mt -88.26 -23.66 23.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.132 0.973 . . . . 63.53 111.951 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.55 -49.39 91.3 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.455 1.102 . . . . 73.33 113.339 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' C' ' 104' ' ' ASN . 16.0 Cg_exo -65.69 -38.57 23.84 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.979 1.786 . . . . 73.42 112.152 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -61.76 -49.5 76.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.777 0.831 . . . . 74.02 111.197 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.84 -42.41 94.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.031 -0.986 . . . . 74.52 110.607 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.503 HH12 ' HG3' ' C' ' 130' ' ' PRO . 57.0 ttp180 -61.56 -42.44 98.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.554 1.142 . . . . 70.14 109.953 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.55 -35.89 65.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.721 0.809 . . . . 74.52 109.929 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.489 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 40.7 t -69.19 -29.85 67.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.637 0.375 . . . . 71.25 111.174 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.563 HD13 HG23 ' C' ' 64' ' ' VAL . 66.3 mt -72.28 -47.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 61.41 109.539 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -56.73 -31.99 65.1 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.382 1.073 . . . . 51.31 111.283 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -64.82 -56.5 13.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.578 1.151 . . . . 53.4 109.662 174.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.81 -38.07 77.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.603 1.161 . . . . 72.05 112.581 -177.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.7 t -69.83 -40.02 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.176 0.591 . . . . 65.42 110.252 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.543 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 34.1 t -62.93 -38.12 89.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.452 0.644 . . . . 73.41 110.628 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 51.0 mtt-85 -67.07 -37.51 84.13 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 114.534 -1.212 . . . . 72.1 110.404 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 7.2 57.2 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 123.637 0.586 . . . . 61.23 113.248 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 60.57 26.78 16.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 126.38 1.872 . . . . 44.44 113.168 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.481 ' HB2' HG13 ' C' ' 118' ' ' VAL . 67.2 m-85 -97.73 156.02 36.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 123.283 0.633 . . . . 63.1 109.632 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.85 78.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.747 2.965 . . . . 71.55 114.405 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.543 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 0.0 OUTLIER -65.63 155.16 36.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.518 1.127 . . . . 62.42 112.497 173.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 119' ' ' SER . 2.0 pt? -168.13 162.16 12.86 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.111 -1.404 . . . . 75.21 108.934 165.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -88.22 100.79 13.25 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.455 -1.683 . . . . 73.25 106.455 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.04 149.81 35.73 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 124.48 1.112 . . . . 64.43 111.124 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.73 122.48 16.54 Favored Pre-proline 0 CA--C 1.551 1.014 0 O-C-N 124.841 1.338 . . . . 71.24 111.853 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.795 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 71.9 Cg_exo -52.68 120.6 7.78 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.552 2.835 . . . . 72.21 112.846 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.5 m -77.48 91.42 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.037 0.922 . . . . 63.45 109.712 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -77.01 82.61 3.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.176 -0.92 . . . . 72.42 110.693 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 t80 . . . . . 0 N--CA 1.476 0.851 0 CA-C-N 115.034 -0.985 . . . . 71.14 111.054 178.855 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.241 0.614 0 N-CA-C 108.503 -0.925 . . . . 64.14 108.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -154.61 98.12 2.05 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -112.56 143.05 44.37 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.476 -0.935 . . . . 73.24 108.476 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.7 tt -104.38 101.47 12.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.994 -1.113 . . . . 71.41 107.994 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.54 -46.6 31.13 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.894 -0.593 . . . . 75.12 111.808 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.464 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 32.4 ttt180 -170.68 126.68 0.74 Allowed 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.167 0.292 . . . . 72.31 111.067 -167.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.95 123.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.581 0.752 . . . . 72.21 109.002 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.464 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 15.8 p90 -147.29 160.69 42.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.675 0.79 . . . . 74.11 111.724 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -91.53 122.42 34.1 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.12 -0.946 . . . . 70.0 108.828 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -86.46 -45.56 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.636 -0.876 . . . . 72.53 108.636 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -130.75 133.84 46.37 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 113.692 -1.594 . . . . 74.12 109.082 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.551 HD13 ' HE3' ' C' ' 117' ' ' MET . 83.0 mt -134.29 145.55 32.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.603 -1.258 . . . . 74.3 107.603 170.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -148.84 144.64 27.06 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.715 0.806 . . . . 75.12 109.393 171.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.575 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -146.04 132.2 19.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.146 -1.798 . . . . 74.44 106.146 170.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.49 134.18 43.16 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.055 -1.091 . . . . 75.24 108.055 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.63 89.6 48.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.738 -1.208 . . . . 74.42 107.738 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.39 -51.92 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.053 2.502 . . . . 71.35 112.974 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -96.7 38.91 1.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.494 -0.928 . . . . 73.13 108.494 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.565 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.84 -52.58 63.44 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 115.329 1.603 . . . . 72.41 115.329 -164.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.98 -15.8 7.86 Favored 'Trans proline' 0 C--N 1.388 2.607 0 CA-C-N 121.302 1.501 . . . . 64.51 113.534 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -69.56 -38.96 77.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.659 1.183 . . . . 64.14 109.119 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 t -68.97 -29.57 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 125.426 1.491 . . . . 74.24 110.836 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.423 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 49.8 t80 -63.16 -36.02 82.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.137 0.575 . . . . 75.14 110.84 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.47 -1.83 56.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.984 0.914 . . . . 73.43 111.566 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -119.8 78.4 1.32 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.953 0.901 . . . . 71.3 109.407 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.81 85.93 6.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.154 0.582 . . . . 74.42 112.388 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -139.85 177.34 8.03 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.371 1.069 . . . . 74.25 108.759 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -87.18 119.11 70.8 Favored Pre-proline 0 CA--C 1.554 1.128 0 O-C-N 121.985 -0.447 . . . . 72.52 110.16 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.27 113.4 2.85 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.854 2.369 . . . . 64.14 112.255 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.19 114.03 12.07 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.835 -0.802 . . . . 74.13 108.835 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' D' ' 66' ' ' ALA . 31.5 m -99.76 134.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.834 0.854 . . . . 63.24 110.934 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 39.5 mmtm -97.12 110.8 23.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.453 -0.944 . . . . 71.35 108.453 171.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.573 ' HG ' HD11 ' D' ' 128' ' ' LEU . 1.8 mm? -97.14 115.43 27.52 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.041 -1.096 . . . . 62.52 108.041 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.81 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -107.24 119.53 39.65 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.434 -0.95 . . . . 71.02 108.434 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.9 129.45 41.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.041 -0.725 . . . . 60.52 109.041 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.9 t70 -152.44 151.11 30.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 64.3 108.595 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -133.22 163.03 30.2 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.51 0.724 . . . . 70.42 110.047 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.2 166.97 28.27 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 74.04 109.652 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -152.2 154.25 35.43 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.105 0.562 . . . . 63.21 110.444 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -157.22 119.03 3.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.193 0.997 . . . . 71.13 108.859 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -70.85 128.22 35.26 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.688 0.395 . . . . 63.04 110.211 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.5 mt -103.57 -29.1 11.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.318 0.647 . . . . 63.3 110.166 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -165.8 -176.63 3.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.297 1.039 . . . . 72.55 110.017 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.54 121.02 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.579 -0.897 . . . . 53.33 108.579 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 63.89 16.82 10.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.4 1.08 . . . . 71.15 112.756 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 79.6 t -131.2 128.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.283 1.033 . . . . 71.31 108.765 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' D' ' 86' ' ' ILE . 0.0 OUTLIER -151.41 161.67 42.3 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 72.53 110.674 176.659 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -103.01 120.55 40.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 124.531 1.132 . . . . 70.34 108.848 173.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.65 123.09 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.403 -1.332 . . . . 43.35 107.403 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 29.7 t -102.75 133.93 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.883 -0.784 . . . . 63.55 108.883 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.24 111.08 22.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.219 -1.03 . . . . 72.21 108.219 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.0 ttm-85 -86.84 110.53 20.02 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 109.144 -0.688 . . . . 75.23 109.144 171.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -108.56 103.83 16.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.87 -1.159 . . . . 65.14 107.87 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.81 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -96.04 146.5 24.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.957 -0.757 . . . . 71.42 108.957 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 81.2 t -138.21 123.18 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.818 1.247 . . . . 74.42 108.368 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 60.6 m -125.63 97.78 5.3 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 71.04 108.644 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -94.16 137.62 33.14 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.49 0.716 . . . . 71.15 109.385 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.8 m -137.06 149.53 47.47 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.142 0.577 . . . . 53.41 110.694 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -132.58 117.42 17.93 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.047 1.339 . . . . 71.32 107.999 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.26 -112.43 4.68 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.695 -0.562 . . . . 74.43 111.695 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 4.48 13.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.768 0.827 . . . . 73.15 110.815 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -118.62 170.9 8.58 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.308 0.643 . . . . 74.33 110.511 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -79.95 138.04 37.0 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.851 -0.613 . . . . 72.44 109.986 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.05 -56.74 2.96 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.704 0.802 . . . . 72.05 109.069 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -163.59 163.6 24.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.878 -1.055 . . . . 71.34 109.828 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.1 mt -118.82 153.04 35.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.048 1.339 . . . . 74.45 108.25 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.541 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 44.3 t -159.31 144.96 16.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.115 0.566 . . . . 64.04 109.988 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -156.83 139.71 15.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.61 . . . . 64.31 109.382 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.61 119.89 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 123.653 0.781 . . . . 75.03 108.936 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.2 mt-30 -97.47 87.84 4.22 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.768 0.827 . . . . 74.51 108.956 173.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -80.64 97.75 7.37 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.819 -1.537 . . . . 72.45 109.588 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.53 141.59 16.73 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.578 -0.609 . . . . 72.01 111.578 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.3 131.42 4.86 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.847 -0.501 . . . . 72.24 111.847 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -90.04 125.35 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.956 -0.757 . . . . 74.44 108.956 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -129.6 128.8 43.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.255 1.022 . . . . 74.45 109.493 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m -88.29 95.18 10.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.054 0.942 . . . . 73.51 108.682 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.465 HG12 ' CE1' ' D' ' 56' ' ' TYR . 2.7 pp -109.42 140.23 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.66 0.384 . . . . 75.45 110.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.32 165.41 19.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.003 0.921 . . . . 74.03 109.113 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.36 23.83 76.45 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 121.529 0.516 . . . . 74.44 112.262 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.47 HD13 ' SD ' ' D' ' 94' ' ' MET . 2.3 pp -109.18 147.16 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.967 1.307 . . . . 70.23 110.238 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -168.58 150.46 4.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.923 0.489 . . . . 73.21 111.332 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.05 -139.75 48.25 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.015 0.822 . . . . 70.22 114.959 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.6 p -68.54 -18.69 64.41 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.544 0.738 . . . . 72.23 111.739 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -47.85 61.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.518 0.727 . . . . 72.25 109.573 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.47 ' SD ' HD13 ' D' ' 89' ' ' ILE . 9.3 tpt -58.34 -53.06 62.6 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.94 0.775 . . . . 62.52 110.553 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.17 86.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.956 0.785 . . . . 34.21 111.424 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -70.86 -47.09 61.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.409 0.683 . . . . 51.44 111.526 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.155 0.582 . . . . 55.02 110.589 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.03 -48.39 18.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.137 0.975 . . . . 65.42 110.34 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.45 -14.31 60.22 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.772 -0.649 . . . . 71.42 114.231 -169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.15 -60.97 1.32 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.025 0.53 . . . . 62.42 110.99 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -64.56 -47.45 78.69 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.818 0.673 . . . . 72.33 112.818 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.463 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 94.9 m -62.29 -50.17 80.84 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 118.8 -0.619 . . . . 74.12 111.246 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 60.1 Cg_exo -58.77 -31.0 94.19 Favored 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 122.542 2.161 . . . . 73.41 113.94 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.04 -32.9 74.65 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.09 0.556 . . . . 74.03 110.419 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.566 HG13 HD21 ' B' ' 132' ' ' ASN . 47.7 mm -69.9 -43.22 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.516 0.726 . . . . 70.23 110.21 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.448 HD21 ' HA3' ' D' ' 82' ' ' GLY . 90.7 mt -73.36 -19.5 60.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.183 -0.917 . . . . 75.13 111.772 -175.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -69.09 -44.33 27.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 N-CA-C 113.887 1.069 . . . . 75.23 113.887 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.03 -34.52 87.38 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 121.927 1.752 . . . . 74.31 113.237 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.2 -33.87 32.66 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 75.42 111.441 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.33 66.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.16 0.584 . . . . 50.13 109.71 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -58.82 -49.31 78.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.089 1.356 . . . . 64.12 110.596 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.45 -43.41 94.37 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.172 0.92 . . . . 75.15 110.881 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.3 t -56.09 -41.59 75.42 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.628 0.58 . . . . 25.34 110.737 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' D' ' 118' ' ' VAL . 78.8 mt -70.91 -44.59 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.153 -0.931 . . . . 55.42 110.782 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.513 HG23 ' HG3' ' D' ' 125' ' ' GLN . 74.2 m -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.015 0.926 . . . . 75.33 110.598 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.31 -48.08 71.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.511 -1.222 . . . . 33.43 110.305 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.44 -32.76 74.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.008 0.523 . . . . 63.25 112.126 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.3 t -67.42 -45.73 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.566 -0.743 . . . . 65.53 109.531 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.8 p -71.76 -23.17 61.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.625 0.37 . . . . 72.24 111.548 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.489 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.4 mtt-85 -77.6 -34.35 53.48 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.094 0.958 . . . . 71.14 109.85 175.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -0.01 79.93 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.587 -0.733 . . . . 32.3 111.926 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p 61.5 42.31 11.52 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.313 1.845 . . . . 41.44 111.552 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.417 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 37.1 m-85 -111.56 167.82 8.52 Favored Pre-proline 0 CA--C 1.56 1.347 0 CA-C-N 113.078 -1.874 . . . . 75.2 107.878 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 93.1 Cg_endo -75.17 140.37 24.91 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.996 1.797 . . . . 75.44 112.053 -171.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.513 ' HG3' HG23 ' D' ' 115' ' ' THR . 20.3 tt0 -45.61 123.78 4.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.502 1.121 . . . . 75.13 112.338 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.51 HD11 HG21 ' D' ' 40' ' ' VAL . 42.1 tp -108.56 93.02 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.524 -0.762 . . . . 65.1 109.021 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.53 106.0 13.44 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.03 0.932 . . . . 61.01 109.039 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.573 HD11 ' HG ' ' D' ' 42' ' ' LEU . 3.6 mm? -62.44 125.51 24.16 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.337 -0.847 . . . . 72.41 110.135 174.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -55.7 128.46 69.33 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 124.538 1.149 . . . . 60.45 110.562 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -73.59 95.23 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.307 2.671 . . . . 74.34 112.335 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 91.2 t -102.12 118.74 49.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.508 -1.293 . . . . 64.12 107.508 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 121.752 0.787 . . . . 62.42 109.215 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.245 0.841 0 N-CA-C 109.552 -0.536 . . . . 74.34 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.74 135.78 48.12 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.663 0.785 . . . . 53.21 108.956 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -160.52 141.17 11.7 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.647 0.592 . . . . 64.22 112.582 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.36 117.71 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 107.867 -1.16 . . . . 63.51 107.867 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 2.1 mp0 -84.69 -30.6 24.67 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.128 -0.463 . . . . 64.33 110.053 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -175.9 146.91 0.74 Allowed 'General case' 0 C--N 1.371 1.535 0 O-C-N 123.851 0.72 . . . . 64.3 111.046 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.86 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 96.5 mt -129.65 128.23 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.497 -1.297 . . . . 74.44 107.497 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -156.81 166.43 33.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.178 0.991 . . . . 75.13 110.656 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -92.26 119.0 31.44 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.921 -0.77 . . . . 51.21 108.921 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -82.62 -26.28 32.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.002 -0.37 . . . . 61.45 110.002 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.6 t70 -152.94 143.0 22.32 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.261 -0.881 . . . . 75.33 110.35 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.436 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 85.7 mt -138.39 140.88 39.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 C-N-CA 125.536 1.534 . . . . 64.44 106.926 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -149.15 126.68 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.753 0.658 . . . . 74.11 109.624 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 90.1 t80 -130.9 131.97 44.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.405 -1.332 . . . . 72.33 107.405 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.6 131.86 41.9 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -123.39 87.84 51.69 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.61 -1.256 . . . . 74.41 107.61 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.77 -22.76 42.74 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.672 2.248 . . . . 73.13 112.925 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -120.42 38.78 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.615 0.766 . . . . 73.24 109.448 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -59.41 -48.24 96.32 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.125 0.97 . . . . 64.23 113.055 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 10.1 Cg_exo -73.53 -42.04 0.99 Allowed 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.085 1.857 . . . . 43.41 112.266 168.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -62.8 -19.89 64.48 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.055 1.342 . . . . 73.24 112.792 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.66 -24.12 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.279 0.631 . . . . 60.35 111.814 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -54.98 -32.24 61.44 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.971 0.908 . . . . 73.32 112.698 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -86.21 -48.53 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.965 0.906 . . . . 64.4 110.359 -175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -78.91 128.56 33.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.802 -1.09 . . . . 62.43 112.038 -169.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.56 134.75 57.31 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.482 1.113 . . . . 72.22 111.246 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.581 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 46.6 t-105 -84.49 80.46 9.22 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.906 0.754 . . . . 74.34 111.231 -173.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.92 75.92 74.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.675 -1.231 . . . . 70.1 107.675 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.01 155.96 11.33 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.745 2.296 . . . . 72.3 113.336 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.27 105.76 17.94 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.317 -1.364 . . . . 70.05 107.317 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 65' ' ' THR . 36.0 t -87.24 98.78 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.878 -0.416 . . . . 31.3 109.878 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 85.0 tttt -81.72 130.86 35.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.446 0.698 . . . . 74.41 109.897 175.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.554 HD21 HD22 ' A' ' 128' ' ' LEU . 5.7 mp -114.67 110.87 20.43 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.754 -0.832 . . . . 64.52 108.754 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.9 t70 -112.92 130.96 55.93 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.984 -1.117 . . . . 63.5 107.984 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.9 tp -117.54 131.27 56.72 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 73.22 109.307 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.68 146.74 40.03 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.945 -0.761 . . . . 71.14 108.945 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -147.55 143.13 27.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.283 -0.636 . . . . 64.44 109.283 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.54 134.11 15.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.63 0.772 . . . . 75.12 109.116 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 20.7 m -88.73 162.66 16.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.133 0.573 . . . . 74.35 110.556 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -149.86 141.15 23.19 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.536 1.134 . . . . 64.31 108.004 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -91.66 133.43 35.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.886 -0.413 . . . . 63.24 109.886 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 57' ' ' GLU . 42.5 mt -118.43 -35.32 3.8 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.803 0.841 . . . . 74.42 109.144 171.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.632 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.04 179.57 7.52 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.599 -1.182 . . . . 62.21 109.848 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.11 122.89 21.74 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.27 -1.011 . . . . 72.42 108.27 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 70.77 -6.38 1.26 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.699 1.199 . . . . 75.32 112.925 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.5 t -105.3 111.07 33.14 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 N-CA-C 108.088 -1.078 . . . . 65.12 108.088 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -119.11 128.12 54.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 64.32 109.796 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 51' ' ' LEU . 13.1 tt0 -82.66 112.22 19.34 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.326 -1.361 . . . . 72.15 107.326 166.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.0 t -100.7 115.62 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.854 -1.535 . . . . 71.12 106.854 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.669 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.7 t -96.29 129.44 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.388 -0.597 . . . . 70.01 109.388 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 111.39 23.67 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.112 -1.44 . . . . 71.02 107.112 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -100.49 102.75 14.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.665 -0.865 . . . . 71.12 108.665 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.4 128.53 46.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.101 -1.074 . . . . 75.13 108.101 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.8 m -113.94 135.99 53.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.848 -0.797 . . . . 73.43 108.848 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -132.49 136.95 55.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 125.568 1.547 . . . . 62.35 107.135 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.7 m -141.63 138.3 32.46 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.99 127.56 45.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.676 -1.601 . . . . 73.34 106.676 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -139.95 131.97 27.85 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.349 0.595 . . . . 63.54 111.688 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.3 mt -89.62 78.19 7.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.577 -1.268 . . . . 73.23 107.577 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -117.04 4.36 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.081 -0.963 . . . . 65.44 111.184 -173.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -87.87 -25.22 23.39 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.522 0.729 . . . . 65.52 110.297 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -79.93 106.8 12.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.078 0.951 . . . . 70.14 109.371 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -65.62 129.92 41.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.238 0.542 . . . . 75.25 111.139 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.28 -52.94 7.11 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.592 1.157 . . . . 71.23 109.004 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -158.25 155.26 28.61 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.464 -0.789 . . . . 62.44 111.396 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -117.94 146.35 44.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.972 1.309 . . . . 75.02 108.422 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 80.9 m -144.93 131.12 19.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.563 1.145 . . . . 23.45 108.85 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.74 128.6 14.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.191 -0.67 . . . . 62.24 109.191 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -130.29 110.4 19.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.437 -0.949 . . . . 73.44 108.437 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.7 mt-30 -86.34 81.01 8.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.7 -0.852 . . . . 72.4 108.7 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.87 93.58 3.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.2 -1.364 . . . . 71.21 109.046 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.16 143.7 16.77 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.766 -0.534 . . . . 74.33 111.766 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.51 131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.044 -0.823 . . . . 34.44 111.044 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 17.3 mt -81.14 128.8 38.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 70.42 108.849 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -136.21 131.0 34.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.086 0.554 . . . . 71.34 110.699 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -83.5 119.67 24.97 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.052 -1.092 . . . . 74.02 108.052 168.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.32 122.48 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 75.23 110.096 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.17 162.95 28.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.632 0.773 . . . . 75.12 109.961 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.05 81.54 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.132 -0.485 . . . . 51.2 112.948 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.46 137.2 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.187 0.995 . . . . 61.1 109.808 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 20.2 tt0 -137.07 -179.11 5.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 73.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 48.95 -124.24 12.3 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 124.02 0.819 . . . . 51.44 114.94 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -79.11 -16.61 56.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.543 0.737 . . . . 50.43 111.608 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.69 -39.88 61.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.679 0.392 . . . . 71.44 110.369 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.05 36.61 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.299 0.24 . . . . 73.14 110.838 175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.7 -30.01 67.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.501 . . . . 62.22 110.072 171.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.48 -44.11 45.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.86 0.864 . . . . 73.13 110.319 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.17 -63.91 1.08 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.259 0.623 . . . . 70.1 111.566 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 tt -71.12 -46.2 62.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.511 0.724 . . . . 64.12 111.031 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.69 -18.25 79.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.742 0.657 . . . . 25.41 114.742 -169.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.56 -51.78 0.69 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.578 0.689 . . . . 74.11 112.205 -172.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.24 -37.29 71.98 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.328 0.651 . . . . 74.01 112.441 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.31 -45.79 13.81 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-O 118.355 -0.831 . . . . 54.01 113.028 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.78 -22.66 68.88 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 121.531 1.487 . . . . 65.24 112.578 168.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -79.38 -22.43 44.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.038 0.535 . . . . 71.13 111.79 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.72 -36.97 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.627 -0.879 . . . . 71.31 108.627 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' A' ' 82' ' ' GLY . 44.1 mt -85.8 -18.31 33.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.115 . . . . 73.14 112.568 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -66.25 -42.62 50.57 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-O 117.709 -1.139 . . . . 75.22 114.013 -171.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.21 -35.27 86.25 Favored 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 121.951 1.733 . . . . 74.51 112.745 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -74.07 -40.8 62.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.654 0.781 . . . . 72.55 111.343 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.22 75.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.332 0.653 . . . . 42.33 109.8 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.584 ' NH1' HG23 ' C' ' 105' ' ' ILE . 34.5 ttm180 -52.11 -55.21 22.27 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.65 1.218 . . . . 73.04 109.893 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.46 -40.65 97.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.204 0.94 . . . . 74.44 111.3 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.604 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -61.87 -35.69 79.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.983 0.513 . . . . 72.21 111.207 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 64' ' ' VAL . 95.6 mt -72.62 -51.02 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 75.31 109.644 173.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 125' ' ' GLN . 97.9 m -53.41 -37.17 62.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.318 1.447 . . . . 64.24 111.227 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.7 t -69.47 -49.65 52.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.927 -1.033 . . . . 54.22 110.118 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 60.7 mtm -57.83 -44.84 86.71 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.346 0.658 . . . . 71.23 110.984 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.3 t -58.73 -48.84 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.386 -1.279 . . . . 75.51 110.608 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -68.78 -29.53 67.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.744 -0.662 . . . . 44.33 111.544 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -73.93 -28.59 61.6 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.64 0.776 . . . . 72.3 110.529 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.89 10.67 51.36 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.954 0.784 . . . . 71.54 112.801 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.452 HG23 ' HB3' ' D' ' 125' ' ' GLN . 3.7 m 66.34 26.05 10.32 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.794 1.238 . . . . 74.04 110.467 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -103.33 157.73 33.23 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.019 -0.991 . . . . 64.13 108.852 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.581 ' HG3' ' HE1' ' A' ' 36' ' ' TRP . 73.1 Cg_endo -68.8 147.54 69.22 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.093 1.862 . . . . 71.13 111.744 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.4 tt0 -58.13 128.88 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 123.949 0.78 . . . . 70.35 110.878 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -108.98 101.32 10.42 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.895 -0.78 . . . . 74.23 108.895 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.471 ' HB3' HD13 ' C' ' 13' ' ' ILE . 92.4 m-20 -98.41 105.18 17.29 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.901 -0.777 . . . . 54.5 108.901 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.554 HD22 HD21 ' A' ' 42' ' ' LEU . 46.0 mt -72.96 139.12 46.51 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.537 -0.756 . . . . 63.43 109.218 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.03 138.03 90.97 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.667 0.604 . . . . 45.52 110.433 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 16.1 Cg_endo -76.57 96.93 1.1 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 121.611 1.541 . . . . 63.43 109.143 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 m -97.94 112.07 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.977 -1.01 . . . . 75.44 108.37 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -103.91 109.98 21.94 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.797 -1.092 . . . . 55.44 108.325 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.4 t80 . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.53 0.732 . . . . 72.44 111.281 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 108.568 -0.901 . . . . 74.24 108.568 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -142.84 131.31 22.34 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 73.14 107.5 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -160.55 139.97 10.79 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.991 0.807 . . . . 75.11 110.021 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.652 HD11 HG13 ' B' ' 16' ' ' ILE . 16.9 tt -95.93 145.23 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.377 1.071 . . . . 71.43 109.836 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.18 -35.07 8.16 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 119.658 -0.21 . . . . 53.41 111.037 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.439 HH21 ' HB ' ' A' ' 122' ' ' THR . 23.0 ttt180 -173.53 144.76 1.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.502 0.321 . . . . 75.24 111.565 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.652 HG13 HD11 ' B' ' 13' ' ' ILE . 60.9 mt -118.94 138.11 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.182 -1.414 . . . . 74.14 107.182 165.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -167.3 142.12 3.89 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.341 1.026 . . . . 74.22 109.339 -170.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.4 m -75.16 118.8 18.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.476 -0.935 . . . . 74.33 108.476 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -85.14 -34.64 22.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.824 -0.625 . . . . 72.54 110.832 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.03 145.92 15.54 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.407 0.442 . . . . 70.03 110.924 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 40.5 mm -135.63 142.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.431 1.092 . . . . 54.03 109.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -136.61 127.93 28.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.921 1.289 . . . . 72.12 108.569 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.42 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.4 t80 -144.38 109.5 5.07 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.873 -1.528 . . . . 72.24 106.873 165.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -123.42 113.35 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.469 -0.937 . . . . 44.42 108.469 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.33 90.02 5.36 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.662 1.185 . . . . 64.23 108.965 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.86 -25.18 53.01 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.285 1.99 . . . . 63.35 111.759 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 92.4 m-20 -121.28 31.46 6.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.441 1.097 . . . . 72.21 110.064 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -46.87 -48.52 51.32 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 125.399 1.48 . . . . 71.51 113.476 172.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.05 -17.83 17.02 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.855 1.703 . . . . 74.31 113.396 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 2.0 m-70 -82.6 -1.24 50.25 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.206 0.817 . . . . 75.11 113.206 -171.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 28' ' ' ALA . 7.2 p -79.84 -25.99 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.239 0.542 . . . . 54.45 109.812 166.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -78.96 -32.01 45.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.444 ' CG ' ' HA ' ' B' ' 30' ' ' HIS . 9.6 mm-40 -71.43 -45.0 63.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.146 -0.479 . . . . 61.21 110.716 177.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -108.08 110.46 22.14 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.234 1.014 . . . . 72.22 109.252 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -74.12 79.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.136 0.575 . . . . 71.23 111.487 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -162.15 151.09 15.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.194 -1.41 . . . . 75.55 107.194 169.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -92.23 133.17 30.53 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.08 0.952 . . . . 42.42 109.443 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 158.26 35.6 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.023 2.482 . . . . 73.01 113.818 -169.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.27 107.95 12.41 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.917 -0.771 . . . . 71.42 108.917 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.549 HG12 HD23 ' B' ' 126' ' ' LEU . 17.7 t -95.28 123.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.576 0.751 . . . . 73.42 109.12 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -136.85 145.31 44.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.624 0.77 . . . . 72.14 110.845 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.701 HD21 HD23 ' B' ' 128' ' ' LEU . 2.4 pt? -116.8 166.54 12.02 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.365 0.666 . . . . 73.33 111.572 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -150.14 154.35 37.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.225 1.41 . . . . 74.3 108.142 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -94.54 148.99 21.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.166 0.586 . . . . 63.21 111.106 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -141.79 154.59 45.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.855 1.262 . . . . 72.44 108.943 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 72.0 p -122.92 134.8 54.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.547 . . . . 74.5 110.468 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.34 32.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.241 -1.022 . . . . 72.1 108.241 170.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.2 p -147.93 167.7 24.18 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.801 0.334 . . . . 71.24 111.367 172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.1 p -151.32 136.55 17.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.378 1.071 . . . . 73.34 108.69 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.84 129.69 35.12 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.471 -0.566 . . . . 62.02 109.471 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 mt -95.58 -47.21 6.32 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.442 -0.577 . . . . 75.02 109.442 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.26 -172.93 4.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.984 0.913 . . . . 74.53 110.179 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 103.07 0.3 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.09 -0.959 . . . . 74.43 110.148 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.52 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 4.9 m-20 65.38 12.82 8.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.917 1.287 . . . . 74.44 113.094 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -104.59 86.51 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 105.999 -1.852 . . . . 61.33 105.999 166.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -109.39 141.6 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.877 0.846 . . . . 75.23 109.762 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -103.54 115.84 31.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.058 -1.428 . . . . 73.44 107.994 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.98 127.73 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.881 0.472 . . . . 73.35 109.784 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -102.03 115.97 44.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.168 0.987 . . . . 72.22 108.612 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 109.6 20.96 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.8 -1.185 . . . . 75.04 107.8 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -99.99 126.03 46.11 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.738 -0.468 . . . . 74.41 109.738 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.4 t -118.25 126.83 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.153 -1.055 . . . . 52.12 108.153 171.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 29.1 m -97.13 149.64 21.75 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.548 0.739 . . . . 73.14 109.147 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.727 HG21 HG21 ' B' ' 114' ' ' ILE . 55.6 t -135.33 132.73 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.266 1.026 . . . . 65.41 109.358 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -124.16 139.22 54.14 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.444 -0.947 . . . . 73.41 108.444 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.38 149.63 36.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.797 0.839 . . . . 64.44 109.072 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.7 p -144.95 132.65 21.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.367 0.877 . . . . 71.41 113.367 -174.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 27.6 mt -95.6 104.73 16.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.151 1.38 . . . . 61.34 108.495 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.75 -103.38 1.11 Allowed Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.042 -1.075 . . . . 54.53 111.18 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.18 3.55 11.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.47 1.508 . . . . 65.32 111.799 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.404 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 23.7 pt-20 -116.29 161.49 18.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.978 0.511 . . . . 61.53 111.15 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -77.65 113.28 15.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.066 0.547 . . . . 74.15 110.554 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.475 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -68.25 -59.39 3.24 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.872 -0.788 . . . . 73.33 108.872 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.02 168.47 27.15 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.117 -0.947 . . . . 73.44 111.425 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -130.39 113.28 14.14 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.743 -1.577 . . . . 63.04 106.743 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.0 t -118.11 153.14 34.27 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.893 -0.78 . . . . 71.14 108.893 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.82 132.8 3.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.88 144.07 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.709 0.803 . . . . 73.3 109.065 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -121.75 84.35 2.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.509 -0.923 . . . . 63.52 108.509 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 59.4 tp60 -82.26 99.88 9.57 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 114.716 -1.129 . . . . 74.52 108.835 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.69 159.75 26.05 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.809 -0.517 . . . . 65.41 111.809 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.62 129.27 2.02 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.09 -0.804 . . . . 74.23 111.09 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.3 mt -86.64 130.71 36.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 N-CA-C 109.381 -0.6 . . . . 70.21 109.381 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -131.37 146.19 52.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.23 0.538 . . . . 73.21 110.205 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -127.92 112.83 15.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.883 1.273 . . . . 72.21 108.354 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 5.1 tt -139.48 140.54 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.638 0.775 . . . . 63.01 110.476 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 173.52 16.87 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.745 0.418 . . . . 25.42 111.532 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.59 -69.59 1.03 Allowed Glycine 0 C--N 1.351 1.392 0 C-N-CA 124.023 0.82 . . . . 64.12 112.886 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.518 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -74.51 169.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.627 0.771 . . . . 75.25 111.559 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.88 -171.93 2.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.178 0.591 . . . . 73.05 111.552 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.47 -105.81 1.62 Allowed Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.13 -0.941 . . . . 75.04 112.837 172.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -77.73 -33.07 53.09 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 64.35 110.828 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -75.74 -38.85 58.11 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.184 0.593 . . . . 71.02 111.321 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptm -67.91 -34.43 76.62 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 120.871 0.367 . . . . 74.45 110.323 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.13 80.23 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.825 0.85 . . . . 75.53 110.899 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -71.32 -30.22 65.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.041 -0.981 . . . . 74.22 110.93 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.62 -69.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.169 0.293 . . . . 72.13 110.935 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.86 -19.78 60.62 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 111.928 0.344 . . . . 72.43 111.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.95 -25.65 44.32 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.574 0.546 . . . . 62.32 114.033 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -47.16 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.165 0.802 . . . . 75.31 113.165 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.03 -49.14 20.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.067 0.547 . . . . 74.25 111.955 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.4 m -60.45 -46.97 97.48 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.964 0.905 . . . . 42.13 111.91 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.76 -30.9 49.65 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 121.229 1.286 . . . . 70.53 112.951 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.83 -27.7 68.44 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.747 0.703 . . . . 75.21 111.22 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.472 HG23 ' NH2' ' D' ' 111' ' ' ARG . 70.3 mt -64.51 -43.61 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 64.44 110.192 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.76 -14.54 47.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.09 0.956 . . . . 75.44 111.784 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' B' ' 128' ' ' LEU . 33.7 t80 -60.19 -47.26 97.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.063 1.345 . . . . 74.01 113.192 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' D' ' 112' ' ' GLU . 18.6 Cg_endo -58.06 -35.97 98.34 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.06 1.84 . . . . 74.4 113.706 174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 65.4 m-85 -69.7 -46.14 66.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 75.51 110.802 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.459 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.693 0.797 . . . . 71.21 110.345 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.444 ' NH2' ' HG3' ' B' ' 130' ' ' PRO . 33.4 mtp180 -50.48 -54.94 18.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.43 1.092 . . . . 75.33 110.789 173.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.8 -33.85 76.53 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.982 -1.008 . . . . 63.11 110.681 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -72.88 -41.15 65.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.098 0.559 . . . . 61.23 111.259 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.727 HG21 HG21 ' B' ' 64' ' ' VAL . 52.7 mt -65.6 -48.14 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.869 . . . . 74.23 108.652 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -51.51 -35.97 42.63 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 124.536 1.148 . . . . 61.24 111.177 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.9 t -69.24 -55.03 11.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.626 0.77 . . . . 62.21 110.826 175.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.465 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 18.0 mmt -65.67 -33.37 75.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.016 0.526 . . . . 72.32 111.901 -172.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.53 -41.42 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.055 0.942 . . . . 73.11 110.374 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.475 ' HB3' HE22 ' C' ' 125' ' ' GLN . 90.0 p -70.1 -26.05 63.79 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.27 0.557 . . . . 71.45 112.149 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.604 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 80.1 mtt-85 -68.6 -34.01 75.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.365 -0.834 . . . . 44.23 110.441 175.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.6 13.09 54.11 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.847 0.717 . . . . 72.43 112.738 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.25 42.21 12.32 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.554 1.942 . . . . 62.15 112.497 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.602 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 71.3 m-85 -120.32 172.78 4.27 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 114.167 -1.378 . . . . 75.1 109.333 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 85.3 Cg_endo -73.08 -167.55 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.965 2.444 . . . . 74.41 116.107 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -66.89 155.58 38.02 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.758 -1.564 . . . . 62.41 111.054 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' B' ' 42' ' ' LEU . 3.4 tm? -135.23 84.91 2.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.974 -2.232 . . . . 74.32 104.974 163.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -123.58 95.4 4.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.287 -1.375 . . . . 74.25 107.287 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.701 HD23 HD21 ' B' ' 42' ' ' LEU . 2.7 tm? -64.29 145.38 56.11 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.17 -0.923 . . . . 72.53 109.863 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -53.46 110.6 2.12 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 124.633 1.208 . . . . 74.22 110.426 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.687 ' HB2' HD13 ' D' ' 16' ' ' ILE . 10.3 Cg_exo -65.61 132.67 31.64 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.152 1.901 . . . . 73.24 110.319 -173.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.63 137.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.061 -0.348 . . . . 75.43 110.061 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -87.07 117.73 25.99 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.801 0.841 . . . . 50.23 109.015 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 47.3 t80 . . . . . 0 N--CA 1.485 1.292 0 C-N-CA 124.531 1.132 . . . . 73.21 113.1 -174.138 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.743 -0.466 . . . . 71.42 109.743 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.434 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 0.5 OUTLIER -120.91 163.53 18.08 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 116.04 -0.527 . . . . 72.33 109.79 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -136.12 129.76 32.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.005 -0.998 . . . . 71.41 108.993 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 127' ' ' ASN . 17.7 tt -66.19 137.79 24.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.253 1.021 . . . . 61.23 110.178 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 92.0 mm-40 -111.79 -45.45 3.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.202 -0.454 . . . . 64.15 110.101 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -174.98 142.02 0.62 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.604 0.565 . . . . 75.13 110.974 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.22 138.21 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.771 -1.196 . . . . 73.14 107.771 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.45 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -171.46 161.51 6.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.318 0.58 . . . . 71.34 110.95 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -86.36 105.0 16.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.03 -0.986 . . . . 74.32 109.01 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -67.46 -46.64 72.43 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.754 0.787 . . . . 64.2 109.426 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.4 t70 -136.12 145.25 45.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.224 -1.353 . . . . 52.23 109.441 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.7 mt -140.3 144.31 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.292 -1.373 . . . . 72.33 107.292 175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.4 t -152.71 145.73 24.54 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.337 0.589 . . . . 72.01 110.198 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -149.15 120.79 8.03 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.373 -1.343 . . . . 71.14 107.373 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -126.01 124.11 39.98 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.482 -0.932 . . . . 71.55 108.482 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -111.39 89.72 10.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.172 -1.047 . . . . 72.03 108.172 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.88 -31.41 93.75 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.473 2.782 . . . . 53.52 112.926 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.432 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 87.2 m-20 -119.04 36.03 4.61 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 114.53 -1.214 . . . . 73.45 109.668 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' C' ' 25' ' ' ALA . . . -49.79 -48.6 77.0 Favored Pre-proline 0 CA--C 1.572 1.82 0 N-CA-C 114.213 1.19 . . . . 73.34 114.213 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.37 -29.54 1.46 Allowed 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.782 1.655 . . . . 40.42 113.069 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.432 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 41.3 t60 -69.59 -31.36 69.47 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.803 1.241 . . . . 72.22 112.328 -171.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.606 HG23 HD11 ' C' ' 68' ' ' LEU . 12.8 p -79.66 -19.3 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.836 1.254 . . . . 73.54 112.074 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.34 -39.24 69.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.01 0.924 . . . . 60.12 112.518 -171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -113.41 45.95 1.33 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.941 0.877 . . . . 72.21 109.389 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 167.71 12.58 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.298 -0.631 . . . . 73.05 109.298 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.15 116.97 4.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.911 -0.774 . . . . 72.12 108.911 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -84.8 68.9 10.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.788 0.68 . . . . 74.05 111.428 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -140.59 79.33 20.11 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.508 0.723 . . . . 74.1 109.512 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.45 135.81 12.07 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.437 2.091 . . . . 54.1 109.963 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.56 118.74 24.01 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.003 -1.11 . . . . 64.14 108.003 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.628 HG11 HD21 ' C' ' 128' ' ' LEU . 24.7 t -65.46 95.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.095 1.497 . . . . 72.1 108.822 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 0.5 OUTLIER -110.95 116.13 30.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.241 -1.022 . . . . 73.05 108.241 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.62 137.54 54.87 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.107 -1.071 . . . . 72.31 108.107 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -147.81 145.44 28.75 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.328 0.651 . . . . 65.24 109.398 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.7 tp -113.6 132.56 55.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 64.32 110.275 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.686 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 4.3 m-20 -114.65 134.77 54.81 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 106.869 -1.53 . . . . 73.23 106.869 171.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -114.2 132.12 56.22 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.943 0.402 . . . . 73.34 110.391 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.06 147.15 45.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.984 0.914 . . . . 64.14 108.982 173.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -139.6 144.01 37.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.473 0.709 . . . . 74.11 109.805 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -146.23 134.26 21.48 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.832 0.853 . . . . 74.11 109.407 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -74.94 147.5 40.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.468 -0.938 . . . . 65.31 108.468 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.56 HD11 HD12 ' C' ' 83' ' ' ILE . 86.5 mt -118.25 -37.57 3.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.849 0.86 . . . . 74.43 110.401 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.39 -168.8 1.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.155 0.582 . . . . 73.13 110.858 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.47 116.26 5.41 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.197 -0.91 . . . . 73.41 109.419 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 62.09 18.11 9.71 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 124.549 1.14 . . . . 71.11 112.324 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' C' ' 51' ' ' LEU . 67.8 t -120.86 107.47 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.567 0.747 . . . . 71.23 109.299 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.89 161.53 14.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.847 0.832 . . . . 73.13 110.757 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.547 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.2 tt0 -127.82 126.1 41.03 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.412 -1.722 . . . . 74.33 107.673 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 123.38 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.332 -0.618 . . . . 72.44 109.332 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.67 111.44 34.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.36 1.064 . . . . 73.21 108.668 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.99 100.01 12.3 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.055 -0.72 . . . . 74.02 109.055 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 41.2 ttm180 -82.33 100.09 9.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.85 -1.537 . . . . 73.51 106.85 171.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.5 t -103.16 113.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.495 -1.298 . . . . 64.42 107.495 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.8 m -118.71 131.52 56.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.883 -0.598 . . . . 71.03 110.106 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.606 HG21 HG21 ' C' ' 114' ' ' ILE . 55.2 t -114.89 131.39 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.668 1.187 . . . . 64.41 110.242 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 9.4 m -110.22 146.58 35.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 164.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 110.74 8.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.677 -1.231 . . . . 74.33 107.677 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -135.19 133.34 38.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.364 0.602 . . . . 74.02 111.449 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.606 HD11 HG23 ' C' ' 31' ' ' VAL . 4.0 mt -85.5 14.58 5.37 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 125.195 1.398 . . . . 65.34 110.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.75 -96.28 0.48 Allowed Glycine 0 C--N 1.35 1.357 0 N-CA-C 110.505 -1.038 . . . . 74.15 110.505 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.32 -25.77 15.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.23 1.012 . . . . 73.11 109.55 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -87.71 116.94 26.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.211 1.004 . . . . 75.43 108.523 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -86.31 129.36 34.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.477 0.581 . . . . 62.2 110.256 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.66 -52.78 9.01 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.76 0.824 . . . . 74.12 109.843 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -163.39 175.13 11.11 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.553 0.692 . . . . 75.15 111.391 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.461 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -133.1 146.77 51.94 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.503 -1.666 . . . . 62.35 106.503 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.607 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.5 t -150.99 150.82 31.23 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.312 -0.625 . . . . 75.02 109.312 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.27 140.45 10.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.952 0.501 . . . . 52.04 109.929 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -135.35 134.05 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.344 -0.984 . . . . 51.52 108.344 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.706 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -109.63 92.68 4.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.088 -0.708 . . . . 75.04 109.088 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -81.21 107.32 13.9 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.556 -1.202 . . . . 71.32 109.934 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.63 145.35 18.3 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.449 -0.661 . . . . 70.52 111.449 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.484 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.22 117.24 0.98 Allowed Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.069 -0.812 . . . . 71.35 111.069 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.56 HD12 HD11 ' C' ' 51' ' ' LEU . 6.7 mm -86.53 126.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 N-CA-C 108.843 -0.799 . . . . 74.25 108.843 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -136.68 122.6 20.1 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.442 -0.947 . . . . 73.14 108.442 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -76.74 96.58 4.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.753 -0.832 . . . . 71.35 108.753 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.652 HD13 ' HE3' ' C' ' 94' ' ' MET . 2.7 pp -96.45 136.02 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.327 1.051 . . . . 73.41 111.131 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.42 -169.35 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.64 0.776 . . . . 65.1 110.018 172.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.39 -60.11 0.69 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.93 -0.468 . . . . 55.04 111.93 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.656 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.337 1.055 . . . . 54.22 112.356 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 108.413 -0.958 . . . . 64.32 108.413 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.652 ' HE3' HD13 ' C' ' 86' ' ' ILE . 34.7 tpp -71.14 -44.81 64.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.175 -0.92 . . . . 73.13 110.064 169.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.16 -29.19 70.18 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.223 0.609 . . . . 54.11 112.21 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -83.01 -45.29 14.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.29 0.636 . . . . 73.54 110.309 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -66.55 -60.4 2.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.487 -0.779 . . . . 73.12 110.18 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.543 ' HB2' ' SD ' ' C' ' 94' ' ' MET . 14.6 tp -64.84 -21.42 66.79 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.605 1.162 . . . . 64.14 111.329 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.87 -29.54 38.21 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.99 -0.55 . . . . 75.42 114.379 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.6 -42.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.765 0.782 . . . . 65.14 112.767 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 63.9 t80 -71.21 -49.39 43.95 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.177 0.591 . . . . 73.34 112.13 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 22.0 m -61.96 -47.97 89.84 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 123.053 0.541 . . . . 62.11 110.782 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 79.6 Cg_exo -56.11 -37.25 96.7 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 122.1 1.867 . . . . 41.35 114.429 169.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.47 -27.79 69.22 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.841 0.456 . . . . 60.21 111.254 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.584 HG23 ' NH1' ' A' ' 111' ' ' ARG . 43.6 mm -65.39 -46.55 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.722 -0.672 . . . . 73.42 109.831 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.484 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.6 mt -79.89 -24.18 41.35 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.088 -0.96 . . . . 73.42 112.351 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.57 -50.57 86.15 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-O 117.592 -1.195 . . . . 74.15 113.608 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.65 -32.6 93.43 Favored 'Trans proline' 0 C--N 1.384 2.422 0 CA-C-N 121.589 1.603 . . . . 71.42 112.96 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -65.54 -47.63 75.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.12 0.568 . . . . 75.51 110.519 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.67 96.58 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.895 0.878 . . . . 74.43 111.166 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -62.89 -52.64 62.29 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.464 1.506 . . . . 74.0 110.123 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -68.98 -27.49 65.76 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.673 0.608 . . . . 72.11 110.441 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -64.42 -51.18 64.48 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.941 -0.392 . . . . 71.41 109.941 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.607 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -61.54 -49.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 123.431 0.457 . . . . 75.34 110.104 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -43.81 -45.07 7.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.121 1.369 . . . . 74.32 111.493 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -68.14 -51.69 43.19 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 113.561 -1.654 . . . . 35.25 110.703 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.493 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 13.8 mmm -57.49 -40.35 78.44 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.951 0.9 . . . . 64.02 112.245 -173.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' C' ' 126' ' ' LEU . 98.9 t -64.78 -44.73 96.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.128 -0.942 . . . . 61.45 110.782 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.3 t -66.16 -26.56 67.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.059 -0.973 . . . . 73.35 111.021 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.1 mtt-85 -68.41 -32.74 72.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.769 0.828 . . . . 45.22 110.541 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 9.75 67.49 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 115.856 -0.611 . . . . 53.33 113.014 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 6.3 p 61.93 24.31 14.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.449 1.9 . . . . 73.44 113.122 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.89 158.7 32.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 109.208 -0.664 . . . . 75.35 109.208 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.75 115.98 2.9 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.331 2.021 . . . . 72.54 110.556 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.475 HE22 ' HB3' ' B' ' 119' ' ' SER . 3.4 pt20 -45.91 147.29 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.705 1.253 . . . . 70.35 112.591 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.553 ' HB2' HG21 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -98.32 76.23 2.3 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.513 -0.921 . . . . 71.2 108.513 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -110.52 89.43 3.03 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.701 -1.222 . . . . 61.43 107.701 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.628 HD21 HG11 ' C' ' 40' ' ' VAL . 30.4 mt -84.68 151.94 24.11 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.656 0.741 . . . . 70.04 110.248 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.59 156.02 46.26 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 112.858 -1.974 . . . . 51.04 113.071 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.86 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 38.3 Cg_endo -60.52 125.1 16.5 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 124.138 3.225 . . . . 75.44 113.956 -173.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.03 111.69 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.304 0.642 . . . . 64.32 110.364 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -115.73 108.43 16.35 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.501 1.121 . . . . 63.21 109.162 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 123.784 0.834 . . . . 74.11 112.488 179.674 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.236 0.354 0 N-CA-C 108.143 -1.058 . . . . 72.43 108.143 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 48.3 t80 -157.9 99.08 1.67 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.698 -1.223 . . . . 70.31 107.698 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.46 157.58 46.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.248 -1.019 . . . . 64.34 108.248 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.657 HG12 HD11 ' D' ' 16' ' ' ILE . 6.7 tp -98.18 140.5 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 123.197 0.599 . . . . 72.54 110.439 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -106.9 -33.04 7.65 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.579 0.752 . . . . 75.33 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -173.07 142.78 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 119.418 -0.325 . . . . 73.43 110.819 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' B' ' 130' ' ' PRO . 3.6 mp -121.11 130.12 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.291 -1.374 . . . . 63.23 107.291 171.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -155.75 160.63 40.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.598 0.759 . . . . 72.53 110.679 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -86.43 118.31 25.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 71.31 109.567 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -86.88 -31.12 20.92 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.3 -0.409 . . . . 53.35 110.397 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.691 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.6 t70 -149.79 135.08 18.16 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.173 -0.921 . . . . 61.42 108.956 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.472 HD13 ' SG ' ' D' ' 113' ' ' CYS . 84.3 mt -135.53 139.06 47.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.912 -1.144 . . . . 51.13 107.912 175.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -142.66 131.5 22.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.823 0.849 . . . . 71.23 108.755 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.8 t80 -134.4 117.52 16.41 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.162 -1.792 . . . . 74.42 106.162 167.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.4 122.95 32.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.311 0.644 . . . . 64.31 109.753 -170.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.05 88.81 18.11 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.595 -0.891 . . . . 71.15 108.595 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.67 -37.14 12.86 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.869 2.379 . . . . 64.11 113.243 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -112.4 35.03 3.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.935 -0.765 . . . . 73.54 108.935 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.83 -64.36 0.88 Allowed Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.973 1.471 . . . . 33.13 114.973 -163.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.15 -9.43 16.54 Favored 'Trans proline' 0 C--N 1.381 2.279 0 CA-C-N 122.3 1.857 . . . . 75.22 113.14 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -84.45 -38.68 19.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 71.12 110.599 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.3 p -81.66 -12.29 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.979 0.418 . . . . 63.22 111.414 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.84 -7.57 53.86 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.257 0.465 . . . . 72.14 112.257 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -74.39 -20.8 59.93 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.513 0.725 . . . . 71.13 110.653 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.94 76.01 10.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.853 1.261 . . . . 61.12 110.083 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -84.96 67.89 10.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.152 0.977 . . . . 62.41 111.578 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -147.4 -179.43 6.84 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.634 1.174 . . . . 74.44 108.553 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -66.65 122.1 80.46 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.673 0.389 . . . . 55.45 111.444 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HG3' HD21 ' D' ' 68' ' ' LEU . 7.7 Cg_exo -75.75 133.75 15.84 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.281 2.654 . . . . 72.25 111.631 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -88.66 132.39 34.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.704 -0.48 . . . . 73.31 109.704 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.89 140.07 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.785 0.834 . . . . 74.12 110.004 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 75.2 mmtt -116.0 112.92 22.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.49 1.116 . . . . 64.04 108.033 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.745 HD21 HD22 ' D' ' 128' ' ' LEU . 10.0 mp -95.79 119.79 34.92 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.478 -0.564 . . . . 73.05 109.478 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -113.17 141.75 46.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.236 -1.024 . . . . 72.14 108.236 173.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -118.61 130.96 56.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.473 0.709 . . . . 72.22 110.142 -171.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.6 t70 -139.23 146.14 40.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.079 0.952 . . . . 65.14 108.687 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 49.0 m -141.86 143.98 33.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.63 -0.878 . . . . 60.54 108.63 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.97 162.96 38.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.065 0.946 . . . . 62.24 108.806 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -151.87 155.65 38.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.492 0.317 . . . . 51.4 111.535 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.0 p -155.37 126.92 7.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.63 1.172 . . . . 53.3 109.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.51 123.55 24.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.622 0.769 . . . . 70.34 111.121 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.6 mt -90.63 -33.52 15.81 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.328 0.393 . . . . 72.23 110.588 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.17 -170.11 0.94 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.06 0.544 . . . . 74.24 111.82 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.22 121.99 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.825 0.85 . . . . 60.42 110.043 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 64.42 4.33 2.18 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.346 1.458 . . . . 74.44 112.212 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.04 124.82 67.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.93 0.892 . . . . 62.11 108.833 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.74 128.98 23.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.735 -1.209 . . . . 74.53 107.735 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.426 ' HB2' HD11 ' D' ' 51' ' ' LEU . 16.8 tt0 -92.54 129.99 38.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.171 -1.048 . . . . 70.23 108.171 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.77 124.85 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.179 -1.045 . . . . 75.31 108.179 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.6 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -100.53 142.14 16.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.373 0.669 . . . . 74.45 109.594 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' CB ' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.44 120.91 39.58 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.932 -1.136 . . . . 73.32 107.932 177.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.4 ttm-85 -104.25 101.02 10.75 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.629 -0.878 . . . . 74.51 108.629 174.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -92.29 107.35 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.167 -1.049 . . . . 73.15 108.167 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 35.4 m -97.23 137.21 36.59 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.597 -0.728 . . . . 52.21 109.228 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 67.5 t -128.94 127.37 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.857 -1.164 . . . . 64.22 107.857 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 86.7 m -125.96 105.72 9.11 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.395 -0.965 . . . . 74.14 108.395 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.51 142.15 35.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.419 -0.809 . . . . 74.43 108.973 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.6 m -145.25 132.78 20.83 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.659 0.599 . . . . 51.13 111.229 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' D' ' 38' ' ' PRO . 13.8 mt -106.24 112.67 25.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.466 -1.243 . . . . 74.25 109.458 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.94 -113.57 4.61 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.263 -0.426 . . . . 71.25 112.085 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 3.99 18.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.169 0.587 . . . . 74.43 111.452 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -121.36 161.69 21.66 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.732 0.413 . . . . 73.31 110.124 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -78.12 125.11 28.87 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.206 0.603 . . . . 61.15 110.624 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.726 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.09 -64.14 1.12 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.822 0.849 . . . . 44.22 109.124 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -155.42 164.35 38.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.596 -0.729 . . . . 61.02 111.435 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.22 110.08 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.978 -1.489 . . . . 65.24 106.978 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.573 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.2 t -122.12 116.37 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.241 -0.651 . . . . 70.13 109.241 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -144.07 125.88 15.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.201 0.6 . . . . 72.01 109.82 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' D' ' 113' ' ' CYS . 84.4 t -127.75 116.22 42.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.742 0.817 . . . . 54.3 109.569 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.691 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.5 mt-30 -89.52 86.71 6.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.896 0.855 . . . . 74.32 109.232 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.405 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.5 tp-100 -80.25 100.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.056 -1.429 . . . . 63.2 109.56 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.79 144.36 17.13 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.922 -0.471 . . . . 72.53 111.922 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.16 139.28 9.12 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.711 -0.556 . . . . 61.24 111.711 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.81 127.71 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.161 -1.052 . . . . 53.44 108.161 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.17 153.33 41.7 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.844 0.857 . . . . 71.43 110.09 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -107.44 94.1 4.91 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.973 -1.121 . . . . 73.11 107.973 169.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tt -116.31 137.33 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.97 0.908 . . . . 72.54 110.079 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.17 155.76 11.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.051 0.94 . . . . 63.15 110.305 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.47 22.36 73.08 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 116.602 1.401 . . . . 75.31 116.602 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' D' ' 94' ' ' MET . 0.9 OUTLIER -121.16 152.22 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.281 0.632 . . . . 52.01 110.704 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -161.65 164.79 29.03 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 114.854 -1.066 . . . . 75.41 109.699 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.38 -129.2 36.86 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.443 -0.799 . . . . 74.13 113.362 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -70.96 -31.51 68.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.244 1.018 . . . . 73.32 111.635 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -70.73 -34.7 72.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 72.14 110.437 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.497 ' HG2' HD13 ' D' ' 89' ' ' ILE . 1.1 tmt? -74.57 -29.58 61.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.025 0.53 . . . . 64.31 110.22 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -38.89 91.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.285 0.634 . . . . 75.1 110.782 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.4 -29.07 41.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.247 -0.888 . . . . 73.44 111.313 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -78.6 -53.12 7.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.636 0.375 . . . . 61.42 111.027 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.57 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 52.8 tp -92.11 -48.28 6.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.109 0.564 . . . . 52.22 110.89 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.53 -14.13 82.3 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.403 0.44 . . . . 63.34 113.875 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.83 -55.88 1.06 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.877 0.471 . . . . 70.22 111.589 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -75.68 -37.03 59.9 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.908 0.707 . . . . 72.22 112.908 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 73.6 m -59.08 -52.9 71.47 Favored Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 118.851 -0.595 . . . . 73.4 111.441 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.406 ' CB ' ' HG ' ' D' ' 60' ' ' LEU . 37.5 Cg_endo -66.65 -23.41 49.26 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.81 1.673 . . . . 73.51 113.221 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.59 -37.81 85.69 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.745 0.418 . . . . 74.44 110.785 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -61.31 -43.02 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.596 0.758 . . . . 75.21 110.177 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' D' ' 80' ' ' GLN . 65.5 mt -79.91 -17.46 53.03 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.03 -0.986 . . . . 72.02 112.031 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -66.77 -43.65 50.13 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.139 1.163 . . . . 73.45 114.139 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.51 -33.78 79.54 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 121.951 1.768 . . . . 61.2 112.932 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -88.62 -26.24 22.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.709 -1.132 . . . . 73.14 111.03 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.34 72.36 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.903 0.859 . . . . 64.22 109.102 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.472 ' NH2' HG23 ' B' ' 105' ' ' ILE . 41.3 ttp180 -61.41 -41.33 96.97 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 113.4 -1.727 . . . . 72.41 110.709 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 108' ' ' PRO . 9.6 tt0 -43.73 -54.64 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.779 1.232 . . . . 62.51 111.874 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' D' ' 21' ' ' ILE . 42.6 t -70.05 -48.31 58.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.604 -1.18 . . . . 63.43 111.083 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.573 HG23 ' SG ' ' D' ' 76' ' ' CYS . 45.5 mt -56.44 -58.73 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.812 0.845 . . . . 71.13 110.901 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -52.0 -42.87 63.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.8 1.24 . . . . 71.01 112.295 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.2 -41.55 66.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.193 -0.912 . . . . 71.51 110.923 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 57.8 mtm -68.46 -32.14 71.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.811 0.444 . . . . 63.24 111.424 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -61.84 -45.55 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 123.804 0.69 . . . . 64.32 109.896 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.4 -29.14 62.4 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.938 -0.574 . . . . 73.12 111.11 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -71.54 -33.05 68.82 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.697 0.799 . . . . 75.0 110.723 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.32 3.75 80.14 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.667 -0.697 . . . . 61.03 112.213 173.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 64.81 26.16 12.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.801 2.04 . . . . 74.11 112.933 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -91.94 161.9 32.28 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 114.556 -1.202 . . . . 71.21 108.818 167.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.64 126.97 17.01 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 122.287 1.991 . . . . 72.1 111.519 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.452 ' HB3' HG23 ' A' ' 122' ' ' THR . 51.5 tt0 -53.38 128.03 27.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.364 1.066 . . . . 74.11 111.827 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.7 tp -115.01 97.86 6.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.643 -0.708 . . . . 62.34 110.203 -166.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.49 ' OD1' ' HB ' ' B' ' 16' ' ' ILE . 46.6 m-80 -99.42 99.05 9.92 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.998 -0.742 . . . . 72.31 108.998 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.745 HD22 HD21 ' D' ' 42' ' ' LEU . 48.2 mt -66.85 120.99 14.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.039 0.936 . . . . 73.43 111.146 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.83 137.66 96.86 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.367 0.667 . . . . 74.5 111.978 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 3.2 Cg_exo -73.91 122.34 7.62 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.557 2.171 . . . . 73.31 110.446 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.86 120.52 59.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.25 0.62 . . . . 70.24 109.473 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 . . . . . 0 CA--C 1.542 0.64 0 CA-C-N 115.076 -0.965 . . . . 62.42 108.413 177.086 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.24 0.592 0 N-CA-C 109.488 -0.56 . . . . 75.23 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HE1' ' HG ' ' A' ' 102' ' ' CYS . 67.2 t80 -129.05 140.01 51.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.742 -1.207 . . . . 71.5 107.742 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 8.0 tp-100 -149.79 130.51 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.685 0.394 . . . . 70.01 110.162 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.79 112.83 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.549 -1.278 . . . . 73.33 107.549 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.461 ' NE2' ' HB2' ' A' ' 85' ' ' SER . 8.0 mm-40 -87.88 -38.03 15.98 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.104 0.252 . . . . 70.34 110.94 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -171.95 124.32 0.53 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.954 0.502 . . . . 71.41 110.798 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 80.4 mt -108.6 135.78 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 74.3 108.767 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.635 ' HB3' HG23 ' B' ' 122' ' ' THR . 16.9 p90 -170.5 176.35 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.915 0.759 . . . . 70.43 111.489 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -98.78 128.95 45.16 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.114 -0.698 . . . . 62.35 109.114 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -92.5 -38.04 12.17 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.207 -0.664 . . . . 75.52 109.207 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -135.86 136.53 40.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.601 -1.181 . . . . 75.44 109.502 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.2 mt -135.97 139.52 45.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.949 -1.5 . . . . 62.12 106.949 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 t -149.28 122.78 9.11 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 123.474 0.484 . . . . 65.23 110.222 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.3 t80 -119.9 114.54 22.23 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.522 -1.658 . . . . 75.34 106.522 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.35 117.62 29.02 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.402 -0.592 . . . . 73.11 109.402 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.67 81.56 67.21 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 108.145 -1.057 . . . . 72.31 108.145 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.32 -35.03 42.15 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.563 2.175 . . . . 60.41 111.628 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.0 m-20 -104.98 31.54 4.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.26 -0.882 . . . . 74.43 109.62 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.41 99.66 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.299 1.039 . . . . 54.23 112.684 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.01 -26.24 11.08 Favored 'Trans proline' 0 C--N 1.38 2.23 0 CA-C-N 121.277 1.492 . . . . 63.4 113.721 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -70.7 -23.01 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.38 0.672 . . . . 61.5 112.357 -173.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.608 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.6 p -61.19 -20.39 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.15 0.58 . . . . 74.01 111.27 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.6 -39.57 91.69 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.246 1.018 . . . . 63.31 111.693 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.91 -28.27 17.38 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.679 0.392 . . . . 60.12 110.961 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.63 149.86 28.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.061 0.544 . . . . 64.43 111.204 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.5 147.36 41.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.443 0.697 . . . . 71.51 110.337 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.462 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.7 t-105 -93.81 76.96 4.23 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.605 0.717 . . . . 63.3 110.183 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -121.75 82.45 41.84 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 106.309 -1.737 . . . . 61.32 106.309 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.12 136.99 9.36 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.691 2.261 . . . . 52.41 113.082 -170.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.34 84.32 3.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.456 -1.683 . . . . 65.23 106.456 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.25 101.06 4.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 114.193 -1.367 . . . . 75.53 108.971 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -79.32 114.55 18.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.534 -0.913 . . . . 73.2 108.534 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.7 116.48 28.93 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.187 -1.412 . . . . 74.32 107.187 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.1 t70 -126.25 138.9 53.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.824 -0.806 . . . . 62.22 108.824 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.3 tp -130.38 120.03 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.995 -0.743 . . . . 71.21 108.995 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -135.65 157.15 47.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.676 0.79 . . . . 73.13 109.522 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -127.75 159.63 34.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.691 0.796 . . . . 64.11 109.662 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.39 136.06 21.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.694 1.198 . . . . 74.31 107.97 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.6 m -107.86 160.11 16.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 52.4 110.312 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -157.74 150.28 22.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.962 0.905 . . . . 54.45 109.385 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.01 140.25 47.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.239 -1.023 . . . . 74.34 108.239 170.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -115.59 -37.68 3.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.567 0.747 . . . . 74.33 110.569 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -158.15 -179.28 7.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.912 0.885 . . . . 74.2 110.318 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.28 114.52 3.22 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.633 -0.712 . . . . 65.33 109.262 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 69.15 0.99 3.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.893 1.277 . . . . 55.14 113.402 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 23.9 t -106.73 108.62 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.885 -1.154 . . . . 64.32 107.885 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 160.64 26.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.059 -0.719 . . . . 70.43 109.059 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.87 134.69 47.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.77 0.828 . . . . 70.12 108.948 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.5 t -118.13 122.23 69.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.321 -1.363 . . . . 64.31 107.321 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -98.69 134.74 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.727 0.811 . . . . 43.44 109.429 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.05 114.15 28.02 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.889 -1.152 . . . . 74.34 107.889 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.18 100.47 10.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.146 -0.687 . . . . 71.21 109.146 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 t -99.66 141.7 16.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.461 -0.94 . . . . 71.31 108.461 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 19.5 m -130.99 133.7 46.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.111 0.481 . . . . 65.41 110.533 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.5 t -130.62 109.48 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.341 1.457 . . . . 75.11 107.741 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -112.11 128.42 56.21 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.117 -0.697 . . . . 65.33 109.117 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.67 13.91 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.792 -0.818 . . . . 60.24 108.792 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 30.9 m -114.93 126.61 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.001 0.52 . . . . 74.22 110.051 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD21 ' CE3' ' A' ' 36' ' ' TRP . 25.7 mt -89.73 65.27 6.77 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.855 -1.165 . . . . 53.2 107.855 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 -101.8 1.23 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.101 -0.954 . . . . 75.03 110.999 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -88.36 -27.4 21.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.428 1.091 . . . . 74.02 110.126 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -98.05 94.79 7.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 71.24 110.08 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 92.6 m -67.41 125.58 26.58 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.839 0.745 . . . . 54.23 111.03 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.35 -56.85 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.83 0.852 . . . . 74.52 109.769 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -161.07 174.84 13.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.493 -1.23 . . . . 71.32 111.781 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -139.11 130.53 27.04 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.955 -1.498 . . . . 71.21 106.955 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.514 ' HB3' HG23 ' A' ' 114' ' ' ILE . 74.8 m -130.27 101.77 5.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.463 1.105 . . . . 64.44 109.761 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.44 121.56 29.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.836 -0.801 . . . . 71.01 108.836 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.4 t -129.49 129.62 66.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 123.458 0.703 . . . . 45.42 109.391 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.9 mt-30 -102.51 90.65 3.93 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.497 -0.774 . . . . 73.41 109.49 171.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -77.08 95.46 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.39 -1.277 . . . . 70.01 108.614 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.97 143.18 19.57 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 112.138 -0.385 . . . . 74.31 112.138 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.48 122.35 1.94 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 111.598 -0.601 . . . . 72.33 111.598 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -80.89 125.56 39.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.083 -1.08 . . . . 71.34 108.083 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -132.1 132.45 43.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.593 0.757 . . . . 74.23 110.582 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 33.4 t -80.24 122.79 27.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.451 -0.944 . . . . 72.54 108.451 166.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 tp -129.44 146.52 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.141 -0.688 . . . . 64.52 109.141 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.88 162.14 7.33 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.048 0.939 . . . . 61.1 110.978 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.61 88.35 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 115.688 1.035 . . . . 65.34 115.688 168.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' H ' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -114.66 141.13 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.818 0.809 . . . . 55.02 109.864 -174.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -146.25 170.31 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.874 0.47 . . . . 73.41 110.345 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 -115.8 4.99 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.18 0.925 . . . . 42.03 114.22 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.2 p -68.3 -34.16 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.363 1.065 . . . . 72.2 111.653 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -57.97 -44.38 87.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.956 0.902 . . . . 74.25 110.839 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.0 tpt -76.61 -40.68 48.69 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.869 -0.605 . . . . 70.41 111.022 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.44 71.89 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.322 0.582 . . . . 63.42 111.066 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -79.25 -41.82 27.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.104 0.962 . . . . 73.22 111.097 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 23.3 t -74.24 -63.6 1.19 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.772 0.429 . . . . 71.32 110.233 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.06 -33.34 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.928 0.891 . . . . 75.22 111.57 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.78 -10.46 63.04 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 115.239 0.855 . . . . 63.14 115.239 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.15 -55.47 0.32 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.971 0.886 . . . . 72.13 111.799 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.24 -60.07 2.9 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.53 0.567 . . . . 73.22 112.53 -168.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.402 ' HG ' ' HE1' ' A' ' 11' ' ' PHE . 30.5 m -55.88 -48.24 97.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.573 0.749 . . . . 71.43 112.865 -176.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.2 Cg_endo -67.82 -28.95 35.89 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 120.702 1.287 . . . . 60.13 113.809 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -78.79 -19.9 51.08 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.295 0.952 . . . . 63.54 111.807 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.54 -38.57 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.216 1.007 . . . . 75.03 109.497 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.515 HD21 ' HA3' ' A' ' 82' ' ' GLY . 51.7 mt -75.94 -18.97 59.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.017 -1.447 . . . . 74.04 112.124 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 38.9 t80 -65.87 -40.53 39.55 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.462 1.282 . . . . 75.42 114.462 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.91 -39.65 83.8 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.154 1.903 . . . . 63.51 113.444 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -80.68 -33.84 35.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.389 -0.823 . . . . 75.42 111.546 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.85 81.5 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.02 -0.733 . . . . 71.31 109.02 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -52.15 -53.93 36.96 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.624 -1.171 . . . . 65.34 110.566 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.6 tm-20 -61.14 -41.19 96.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.044 0.84 . . . . 75.14 111.315 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.79 -47.63 84.28 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.892 -0.595 . . . . 71.42 110.714 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 76' ' ' CYS . 97.8 mt -63.11 -47.71 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.133 0.973 . . . . 64.0 110.717 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.545 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.7 m -60.68 -41.88 95.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.523 1.129 . . . . 51.13 111.56 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.01 -43.39 78.95 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.684 -0.689 . . . . 60.22 110.602 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -55.65 -43.84 76.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.617 0.767 . . . . 70.43 111.453 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.41 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.938 0.895 . . . . 74.31 111.113 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -70.36 -26.97 63.97 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.292 -0.413 . . . . 42.23 111.294 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -73.93 -32.1 63.36 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.712 0.805 . . . . 71.05 109.952 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.51 -1.62 71.57 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.958 0.786 . . . . 72.24 112.875 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.8 m 67.81 40.28 2.44 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.87 1.319 . . . . 55.44 110.071 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.608 ' HE1' HG11 ' A' ' 31' ' ' VAL . 43.9 m-85 -116.72 152.31 48.27 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 114.524 -1.217 . . . . 73.5 109.579 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 135.69 60.96 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.114 2.543 . . . . 74.41 113.459 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.5 tt0 -58.74 139.5 56.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 54.31 112.304 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 tp -117.08 115.08 24.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.136 -0.69 . . . . 70.15 109.136 176.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -100.3 93.65 5.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.683 -0.858 . . . . 74.3 108.683 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -65.89 135.33 54.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.45 0.7 . . . . 53.35 109.9 -176.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.79 131.07 91.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 122.957 0.503 . . . . 74.01 111.897 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.39 110.77 2.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.596 2.197 . . . . 70.31 111.709 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.14 110.78 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.248 -1.019 . . . . 52.54 108.248 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -110.82 72.22 0.77 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.231 1.012 . . . . 74.22 112.749 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 73.02 110.732 169.068 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.244 0.788 0 N-CA-C 109.313 -0.625 . . . . 75.2 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.22 131.6 30.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.014 0.925 . . . . 72.01 108.9 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 24.4 tm0? -142.47 134.36 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.728 -1.212 . . . . 74.23 107.728 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -97.3 118.37 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 32.51 109.874 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.18 -53.56 4.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.692 0.282 . . . . 74.33 110.973 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 43.8 ttt180 -161.17 141.04 10.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.412 -0.358 . . . . 74.43 110.57 -169.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -115.8 143.64 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 107.96 -1.126 . . . . 74.44 107.96 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.426 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.9 p90 -168.9 158.22 8.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.356 0.598 . . . . 75.45 111.553 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -83.89 127.82 34.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.248 -0.887 . . . . 75.1 108.648 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.499 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -96.09 -41.2 8.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.165 0.586 . . . . 71.32 109.713 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.7 t70 -147.42 139.29 24.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.851 -0.613 . . . . 71.01 110.597 -168.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.442 HD12 HG22 ' B' ' 78' ' ' VAL . 42.2 mm -138.07 137.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.81 1.244 . . . . 53.02 108.811 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -138.8 125.09 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.05 -1.092 . . . . 55.22 108.05 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.6 t80 -137.59 108.05 6.52 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.17 -1.419 . . . . 60.21 107.17 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.81 117.83 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.438 -0.949 . . . . 75.4 108.438 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.823 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -112.82 87.89 10.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.796 0.838 . . . . 75.0 109.504 -176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 -38.24 10.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.075 2.517 . . . . 74.54 112.736 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.43 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 66.1 m-20 -111.74 29.07 8.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.445 0.698 . . . . 74.21 109.622 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.823 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.12 -54.58 23.66 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.787 1.235 . . . . 74.53 113.107 172.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 5.6 Cg_exo -76.22 -19.17 15.63 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.036 1.824 . . . . 64.32 111.754 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.43 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 80.7 m-70 -85.43 3.03 41.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.312 1.045 . . . . 71.15 111.408 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.45 -14.94 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 CA-C-O 121.419 0.628 . . . . 70.41 109.736 163.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -70.58 -28.77 65.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.754 0.821 . . . . 72.21 109.832 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.62 -39.7 18.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.314 0.646 . . . . 73.0 109.609 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -102.51 75.23 1.44 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.292 1.037 . . . . 62.33 109.955 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.49 76.44 5.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.824 0.849 . . . . 73.43 110.648 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -163.7 160.32 22.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.762 0.825 . . . . 74.12 109.403 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -69.84 118.61 64.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.208 1.003 . . . . 74.22 109.518 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.76 152.0 82.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.176 1.918 . . . . 55.11 113.026 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.24 119.06 13.87 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.473 -0.785 . . . . 71.54 109.033 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 t -85.01 119.66 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.466 -1.309 . . . . 73.12 107.466 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -134.73 138.59 44.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' B' ' 128' ' ' LEU . 0.0 OUTLIER -128.57 166.42 18.87 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.783 0.833 . . . . 71.35 111.542 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 121.24 1.55 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.423 -0.954 . . . . 71.12 108.423 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.1 163.74 21.81 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.361 0.6 . . . . 63.13 110.724 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -161.06 135.89 7.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.477 1.111 . . . . 74.13 108.447 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -108.65 119.68 40.24 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.843 0.354 . . . . 74.41 110.376 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.48 159.26 22.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.141 0.976 . . . . 73.01 108.711 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.497 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 73.9 m -144.39 162.69 35.84 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.178 -0.326 . . . . 71.22 111.464 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.1 t -157.12 137.9 13.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.078 0.951 . . . . 71.4 109.62 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -105.51 131.07 53.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.338 -0.616 . . . . 64.44 109.338 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -98.36 -41.75 7.68 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.455 0.645 . . . . 73.44 109.472 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.84 10.87 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.596 -1.184 . . . . 63.25 109.358 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -76.57 134.17 39.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 70.51 108.414 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.3 -3.63 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.934 1.294 . . . . 62.45 111.811 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.54 95.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.298 1.039 . . . . 71.35 108.354 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.497 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 8.4 t80 -113.83 139.54 49.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.012 0.434 . . . . 72.32 110.623 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -121.85 108.4 13.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.873 0.869 . . . . 75.14 109.488 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.1 132.86 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.033 0.533 . . . . 34.12 110.093 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 40.8 t -104.14 116.94 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.308 0.643 . . . . 73.43 109.838 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -94.1 115.77 28.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.876 -0.787 . . . . 64.35 108.876 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -102.16 123.75 46.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.955 0.407 . . . . 61.23 110.419 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 75.0 t -117.07 108.3 24.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.686 -1.227 . . . . 72.02 107.686 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.5 m -97.84 146.54 25.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.326 -0.62 . . . . 74.21 109.326 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.531 HG21 HG21 ' B' ' 114' ' ' ILE . 72.5 t -132.58 136.34 56.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 124.464 1.106 . . . . 72.43 109.578 -171.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.39 149.5 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.426 1.09 . . . . 53.32 109.012 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.46 161.76 37.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.214 0.606 . . . . 72.41 110.359 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.4 p -148.48 147.42 29.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.595 0.591 . . . . 63.44 112.595 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.5 mt -124.19 107.06 10.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.689 -1.597 . . . . 72.11 106.689 172.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -111.39 3.46 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.285 -0.731 . . . . 71.45 111.347 -171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.18 3.24 12.66 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.901 0.85 . . . . 62.31 111.665 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -114.25 167.19 10.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.708 0.403 . . . . 71.24 110.402 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -64.88 144.03 57.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.324 0.65 . . . . 61.44 110.467 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.425 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -100.69 -58.77 1.83 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.374 -0.973 . . . . 41.41 108.374 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -150.92 166.38 30.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 113.833 -1.53 . . . . 75.12 109.276 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -134.91 140.37 45.7 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.428 -1.323 . . . . 72.22 107.428 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.498 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.1 t -140.82 159.96 41.08 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.575 0.75 . . . . 74.33 109.146 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.33 137.45 4.21 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.942 0.897 . . . . 72.01 108.601 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.442 HG22 HD12 ' B' ' 21' ' ' ILE . 77.3 t -128.64 141.03 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.45 0.7 . . . . 73.03 109.179 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -124.63 91.61 3.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 72.5 108.992 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.434 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -89.15 102.17 14.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.875 -1.057 . . . . 60.31 108.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.499 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.57 142.82 16.36 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.775 -0.53 . . . . 44.1 111.775 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.74 128.43 4.44 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.407 -0.677 . . . . 43.4 111.407 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.426 HG13 ' HE1' ' B' ' 17' ' ' TYR . 44.7 mt -83.29 126.89 40.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -135.18 135.48 41.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.249 0.619 . . . . 74.55 109.623 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 20.2 m -87.43 100.46 12.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.033 -1.099 . . . . 61.2 108.033 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.6 122.34 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.709 0.804 . . . . 74.12 109.63 -170.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.22 172.33 18.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.13 0.972 . . . . 62.33 111.097 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -28.12 6.65 Favored Glycine 0 C--N 1.357 1.708 0 CA-C-N 116.046 -0.525 . . . . 75.01 112.832 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.93 157.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.039 1.336 . . . . 63.21 113.451 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -161.32 143.15 11.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.535 -0.757 . . . . 72.32 109.866 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.49 -93.42 0.03 OUTLIER Glycine 0 C--N 1.362 1.979 0 O-C-N 124.324 1.015 . . . . 23.24 113.912 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.2 m -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.369 1.068 . . . . 73.44 110.604 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -67.55 -29.17 68.49 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.443 0.697 . . . . 60.34 111.505 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 52.8 tpp -67.02 -50.08 63.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.745 0.418 . . . . 63.14 110.495 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.31 -30.47 64.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.6 0.76 . . . . 71.04 111.834 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.69 -55.17 5.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.72 0.408 . . . . 71.04 110.024 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 42.8 t -69.35 -66.73 0.55 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.647 0.592 . . . . 75.42 110.819 -172.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.3 -26.74 62.98 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.751 0.421 . . . . 65.25 110.277 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.01 -39.06 13.65 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 114.976 0.751 . . . . 72.12 114.976 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.62 -46.88 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.718 0.759 . . . . 72.05 112.059 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.487 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 88.2 t80 -64.61 -54.35 33.32 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.554 0.741 . . . . 71.02 112.607 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.471 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.3 m -61.6 -46.82 93.87 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.476 0.71 . . . . 72.52 111.424 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.2 Cg_exo -58.04 -36.98 97.61 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 121.843 1.696 . . . . 74.44 113.873 167.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -72.16 -21.18 61.48 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 122.872 0.469 . . . . 75.43 111.463 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.469 HG23 ' NH2' ' D' ' 111' ' ' ARG . 56.9 mt -64.2 -45.0 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.641 0.776 . . . . 72.41 109.901 167.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 28.2 mt -84.4 -11.02 57.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.319 -1.31 . . . . 75.3 111.37 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.498 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 63.4 t80 -63.26 -45.49 85.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.023 1.329 . . . . 74.45 113.934 -172.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.27 -36.05 81.64 Favored 'Trans proline' 0 C--N 1.374 1.878 0 CA-C-N 121.226 1.473 . . . . 64.35 112.657 173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.2 m-85 -65.6 -40.5 92.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.969 0.508 . . . . 74.13 110.764 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -47.94 72.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.847 0.459 . . . . 61.52 110.266 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -51.35 -49.21 61.89 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.67 1.188 . . . . 71.24 111.369 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -38.97 79.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.632 -1.167 . . . . 74.42 109.898 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -71.28 -34.18 70.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.91 -0.586 . . . . 74.01 111.33 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.531 HG21 HG21 ' B' ' 64' ' ' VAL . 73.2 mt -67.54 -52.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.854 0.462 . . . . 61.33 109.766 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -53.36 -33.11 52.35 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 123.941 0.775 . . . . 63.22 111.401 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.0 t -65.8 -62.74 1.33 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.308 0.643 . . . . 62.32 110.648 172.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.52 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.8 mmt -61.25 -33.3 73.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.346 0.658 . . . . 65.31 112.449 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -76.96 -39.85 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.604 0.762 . . . . 74.03 110.693 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.3 p -66.39 -28.94 69.03 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.474 0.654 . . . . 44.25 111.15 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.52 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 84.2 mtt-85 -61.86 -31.78 72.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.523 -0.762 . . . . 74.24 110.205 174.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.58 12.85 58.04 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 119.425 -0.653 . . . . 73.5 114.145 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 17' ' ' TYR . 15.0 p 61.63 21.27 11.99 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.01 1.724 . . . . 64.33 111.965 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -105.08 159.66 28.63 Favored Pre-proline 0 CA--C 1.567 1.624 0 C-N-CA 123.801 0.84 . . . . 63.21 110.738 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.71 156.85 64.38 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 123.814 3.009 . . . . 63.51 115.541 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' C' ' 125' ' ' GLN . 5.1 pm0 -63.06 156.81 23.75 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.741 0.816 . . . . 72.22 112.709 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.8 96.8 6.49 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.334 -0.987 . . . . 75.15 108.334 163.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -89.08 93.55 9.63 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.196 -2.15 . . . . 64.31 105.196 165.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' B' ' 42' ' ' LEU . 1.8 tt -81.44 135.79 35.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.101 -0.703 . . . . 73.44 109.101 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 132.86 89.1 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 124.067 0.855 . . . . 73.35 111.512 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.99 81.19 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.498 2.132 . . . . 75.2 111.471 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -78.21 75.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.279 -0.873 . . . . 74.35 110.34 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -74.11 84.84 1.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.482 -0.781 . . . . 65.31 109.013 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 CA--C 1.546 0.808 0 CA-C-N 115.478 -0.783 . . . . 63.42 111.063 -175.229 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 108.843 -0.799 . . . . 34.15 108.843 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -124.64 135.42 53.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.408 1.083 . . . . 70.53 108.352 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' C' ' 85' ' ' SER . 46.2 tt0 -146.35 105.28 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.09 0.556 . . . . 75.45 110.243 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.503 HD11 HD11 ' C' ' 16' ' ' ILE . 14.5 tt -72.14 129.91 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.43 0.692 . . . . 74.43 109.623 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -115.9 -49.16 2.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.919 0.487 . . . . 71.53 111.878 -172.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -162.13 133.18 5.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.493 -0.558 . . . . 73.32 109.493 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.503 HD11 HD11 ' C' ' 13' ' ' ILE . 64.0 mt -123.14 138.35 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.583 -0.895 . . . . 74.41 108.583 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.3 p90 -174.73 162.75 3.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.806 0.336 . . . . 74.43 111.612 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -81.52 125.76 30.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.483 0.713 . . . . 72.23 110.064 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -75.57 -49.1 19.62 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.184 -1.043 . . . . 73.15 108.184 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -136.81 147.15 46.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.24 -1.345 . . . . 74.2 110.428 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.5 mt -143.44 145.47 22.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 126.19 1.796 . . . . 63.43 106.622 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -161.03 149.25 15.9 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.256 0.551 . . . . 70.44 110.465 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' D' ' 21' ' ' ILE . 85.7 t80 -149.41 118.25 6.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.327 -1.36 . . . . 72.11 107.327 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.19 122.61 44.52 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.06 -0.719 . . . . 63.0 109.06 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.44 80.86 46.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.054 -1.091 . . . . 43.14 108.054 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.6 -26.43 16.5 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.207 1.938 . . . . 74.2 110.525 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.22 16.16 6.6 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.587 1.155 . . . . 60.1 110.759 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.11 99.99 Favored Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 113.649 0.981 . . . . 65.03 113.649 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.44 -26.5 3.99 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 121.79 1.66 . . . . 72.24 112.699 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -70.18 -33.47 71.78 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.383 1.073 . . . . 64.33 111.841 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.455 HG23 HD11 ' C' ' 68' ' ' LEU . 13.2 p -79.69 -18.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.447 1.099 . . . . 72.12 111.401 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.85 -28.44 66.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.293 1.037 . . . . 72.41 112.154 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -127.79 44.43 2.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 54.23 109.86 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -121.26 159.75 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.665 0.786 . . . . 62.21 110.389 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.16 120.32 11.25 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.709 0.63 . . . . 75.25 110.236 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -85.28 97.43 9.94 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.072 0.939 . . . . 75.24 109.905 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -140.56 62.57 19.05 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.417 -0.957 . . . . 74.55 108.417 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' C' ' 67' ' ' SER . 14.8 Cg_exo -69.47 97.98 0.64 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.858 1.705 . . . . 64.44 112.282 -175.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.89 77.6 9.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.57 -1.65 . . . . 75.4 107.494 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' C' ' 126' ' ' LEU . 19.6 m -89.84 110.73 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 113.687 -1.597 . . . . 72.11 110.36 -170.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -133.09 147.07 52.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 60.31 110.948 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' C' ' 128' ' ' LEU . 1.5 pp -105.38 165.73 10.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.356 0.598 . . . . 71.41 112.103 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -140.91 130.78 24.4 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.262 1.425 . . . . 71.44 107.531 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.95 118.43 36.95 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.247 0.619 . . . . 75.33 110.265 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 35.7 t70 -115.14 155.97 26.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.304 -0.999 . . . . 64.44 108.304 166.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -134.49 140.72 46.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.438 0.695 . . . . 74.25 110.29 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.3 38.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.29 1.036 . . . . 70.34 109.253 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -155.3 148.88 25.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.49 0.716 . . . . 61.15 109.274 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 38.3 t -144.86 128.29 16.93 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.635 0.774 . . . . 75.33 109.153 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -82.75 117.11 22.43 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.992 -0.744 . . . . 64.32 108.992 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' C' ' 57' ' ' GLU . 79.6 mt -92.48 -32.61 14.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.464 0.706 . . . . 72.23 110.368 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.34 -179.82 8.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.134 -0.939 . . . . 74.12 109.229 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.17 127.29 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 71.25 108.996 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.97 18.29 10.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.477 1.111 . . . . 74.01 112.461 -174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.28 115.16 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.568 -0.901 . . . . 60.13 108.568 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -116.16 169.57 9.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.055 0.931 . . . . 75.3 110.844 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.9 tt0 -127.45 133.24 49.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.924 -1.944 . . . . 61.34 107.99 173.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.42 127.89 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.101 -1.444 . . . . 72.45 107.101 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.5 HG22 ' HA2' ' C' ' 81' ' ' GLY . 61.7 t -126.46 114.23 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.234 -0.654 . . . . 70.54 109.234 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' C' ' 103' ' ' PRO . 18.6 mt -86.6 130.53 34.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.585 -0.524 . . . . 64.34 109.585 172.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.597 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 49.1 mtp180 -101.45 104.27 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.197 -1.038 . . . . 73.43 108.197 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.59 110.42 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.475 -1.305 . . . . 74.23 107.475 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -110.85 145.65 37.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.842 -0.799 . . . . 74.03 108.842 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.795 HG11 ' HG ' ' C' ' 126' ' ' LEU . 53.3 t -128.58 135.26 62.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.899 0.88 . . . . 65.54 109.224 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -117.92 138.11 52.37 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.989 -1.115 . . . . 73.52 107.989 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.99 132.79 55.13 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.269 -1.012 . . . . 44.54 108.269 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.7 m -132.96 164.21 27.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.833 0.708 . . . . 64.44 109.262 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.455 HD11 HG23 ' C' ' 31' ' ' VAL . 14.4 mt -124.04 29.08 6.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 106.926 -1.509 . . . . 74.33 106.926 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.82 -100.76 1.73 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.082 -0.963 . . . . 74.54 110.85 -169.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -89.67 -32.51 17.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.392 0.677 . . . . 71.24 110.107 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.65 120.84 32.05 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.616 0.766 . . . . 71.14 109.454 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -67.65 140.47 56.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.89 0.476 . . . . 74.34 111.026 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.43 -51.41 4.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.803 0.441 . . . . 64.21 109.931 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -168.5 177.27 5.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.944 0.898 . . . . 70.22 111.299 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.476 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -137.04 147.34 46.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.086 1.354 . . . . 73.14 107.391 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.476 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.0 t -148.99 153.48 37.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.349 0.66 . . . . 71.14 109.395 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -158.82 140.96 13.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.458 0.703 . . . . 71.11 109.905 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.98 119.26 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.714 0.806 . . . . 74.52 109.531 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.597 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 47.8 mt-30 -91.14 98.4 11.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.052 0.941 . . . . 64.33 109.623 172.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.473 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.2 tp-100 -88.78 107.82 19.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.617 0.767 . . . . 71.31 110.615 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.5 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -84.07 158.72 35.02 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.77 0.669 . . . . 75.4 113.041 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.64 117.29 0.77 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.481 -0.648 . . . . 33.23 111.481 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.457 HD12 ' CD1' ' C' ' 51' ' ' LEU . 15.0 mm -81.81 122.47 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.34 -0.615 . . . . 62.22 109.34 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -135.71 119.23 16.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.682 0.793 . . . . 75.23 109.149 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.581 ' HB3' ' HB3' ' C' ' 12' ' ' GLN . 41.1 t -77.08 128.0 33.68 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.765 -0.828 . . . . 72.14 108.765 170.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.469 HD11 HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -145.99 126.9 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.501 0.72 . . . . 64.34 110.433 -166.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.85 176.19 11.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.591 1.157 . . . . 72.22 110.176 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -50.96 4.0 Favored Glycine 0 N--CA 1.48 1.626 0 CA-C-O 121.295 0.386 . . . . 62.04 113.257 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 125.448 1.499 . . . . 51.5 113.76 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 47.2 mt-30 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 111.587 0.217 . . . . 71.5 111.587 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.631 ' HB3' HG12 ' C' ' 89' ' ' ILE . 19.7 ptm -68.95 -37.22 78.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.053 0.221 . . . . 74.35 111.454 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -33.74 75.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.286 0.634 . . . . 65.2 111.185 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -75.8 -33.56 60.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.75 -0.659 . . . . 74.51 109.97 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -66.77 -60.97 2.21 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 123.559 0.744 . . . . 75.01 111.279 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.22 -18.43 57.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.173 -0.33 . . . . 71.23 111.275 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -25.83 61.13 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.115 -0.493 . . . . 51.51 113.892 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.03 -43.2 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.518 0.933 . . . . 61.15 113.518 -172.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.71 -65.27 0.7 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.26 0.624 . . . . 74.11 111.751 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 15.1 m -60.53 -43.1 91.65 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.827 0.851 . . . . 75.11 112.259 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.523 ' HB3' HD21 ' C' ' 60' ' ' LEU . 98.0 Cg_exo -51.02 -47.24 26.6 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.597 2.198 . . . . 74.24 114.771 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -69.05 -21.98 64.06 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 122.579 0.352 . . . . 74.4 111.485 -173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.5 mm -60.58 -45.53 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.563 0.745 . . . . 72.21 109.855 168.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 40.7 mt -85.8 -22.73 27.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.828 -1.078 . . . . 70.2 112.456 -170.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.88 -52.34 65.82 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.016 -0.992 . . . . 74.24 113.465 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.51 -31.88 70.93 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 121.599 1.532 . . . . 73.0 113.55 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -65.79 -47.88 73.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.04 0.536 . . . . 75.33 110.606 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.39 -41.9 96.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.444 0.698 . . . . 63.23 111.057 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.04 -50.13 75.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.687 1.195 . . . . 74.14 110.664 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.5 -33.96 76.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.517 0.727 . . . . 72.3 110.289 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.13 -36.21 74.63 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 122.688 0.395 . . . . 62.33 111.654 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -69.81 -43.36 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.578 -0.527 . . . . 74.11 109.578 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' GLN . 52.8 m -55.22 -38.62 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.255 1.022 . . . . 61.23 110.715 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -67.77 -53.65 25.52 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.638 -1.165 . . . . 50.22 110.272 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.717 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -49.79 -45.4 49.79 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.845 1.258 . . . . 73.42 112.921 -177.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.42 HG21 HD23 ' C' ' 126' ' ' LEU . 92.7 t -72.01 -40.66 67.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.748 -0.66 . . . . 74.5 111.346 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -61.83 -31.88 72.16 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.365 -0.834 . . . . 61.35 111.208 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.495 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.53 -34.99 79.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.866 0.866 . . . . 53.34 110.25 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.52 11.8 37.09 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 123.744 0.652 . . . . 75.33 113.687 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.582 HG23 ' HB3' ' D' ' 17' ' ' TYR . 44.7 p 59.81 27.58 16.91 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.949 1.699 . . . . 74.44 112.617 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -109.05 167.85 8.55 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.246 1.018 . . . . 73.15 110.704 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.78 118.12 4.92 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.255 2.637 . . . . 75.31 112.551 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.705 ' HB2' HG23 ' C' ' 115' ' ' THR . 9.1 pt20 -51.59 143.57 12.17 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.051 0.844 . . . . 74.54 111.709 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.795 ' HG ' HG11 ' C' ' 64' ' ' VAL . 2.5 mm? -97.58 59.66 1.53 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.726 1.25 . . . . 61.43 110.453 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' B' ' 122' ' ' THR . 32.1 t30 -95.61 83.85 3.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 112.927 -1.942 . . . . 75.44 107.414 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.517 HD12 ' HG ' ' C' ' 42' ' ' LEU . 21.7 mt -90.73 154.41 19.56 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.198 -0.91 . . . . 75.33 110.241 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -35.71 135.36 0.5 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 126.201 1.8 . . . . 73.45 115.107 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.77 93.73 0.44 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.636 2.224 . . . . 72.04 111.504 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.89 106.7 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.955 0.883 . . . . 64.21 111.759 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.48 71.69 0.75 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.773 0.829 . . . . 74.04 109.63 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 115.974 -0.557 . . . . 71.53 111.085 176.251 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.1 m . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.158 -0.682 . . . . 74.21 109.158 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.402 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 40.5 t80 -152.28 97.82 2.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 106.477 -1.675 . . . . 64.42 106.477 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 75.8 mt-30 -112.25 118.32 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.746 0.419 . . . . 53.13 110.814 -173.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.5 103.14 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 107.926 -1.139 . . . . 64.32 107.926 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.96 -50.06 8.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.581 0.173 . . . . 73.21 111.405 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -170.8 134.04 0.99 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.767 0.427 . . . . 75.43 110.479 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.23 130.66 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.582 ' HB3' HG23 ' C' ' 122' ' ' THR . 33.5 p90 -149.3 149.97 31.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.358 0.663 . . . . 73.25 111.895 -176.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.6 p -77.71 114.66 16.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.669 -0.696 . . . . 75.21 109.75 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -86.06 -20.25 29.06 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.915 0.486 . . . . 63.1 110.059 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.8 t70 -153.55 140.24 18.96 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.72 -1.127 . . . . 54.01 109.594 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.717 HD13 ' HE3' ' C' ' 117' ' ' MET . 96.3 mt -136.67 144.72 31.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 125.189 1.396 . . . . 73.23 107.554 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -154.76 133.62 12.22 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.959 0.787 . . . . 73.15 109.507 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.5 t80 -132.48 126.8 33.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.283 -1.747 . . . . 74.41 106.283 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -121.63 142.75 49.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.03 -1.1 . . . . 74.21 108.03 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.42 76.71 36.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 106.374 -1.713 . . . . 54.32 106.374 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.19 -34.15 28.83 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.822 2.348 . . . . 65.44 112.783 -169.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.457 ' O ' HG23 ' D' ' 31' ' ' VAL . 41.2 m-20 -116.13 23.3 12.28 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.091 0.956 . . . . 55.22 110.294 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -46.28 -50.47 38.55 Favored Pre-proline 0 CA--C 1.567 1.631 0 N-CA-C 116.462 2.023 . . . . 53.41 116.462 -167.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.86 -15.98 10.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 CA-C-N 122.137 1.799 . . . . 70.41 113.319 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -75.16 -26.87 59.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.668 1.187 . . . . 63.21 109.782 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 27' ' ' ASN . 70.4 t -80.02 -13.27 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.919 0.888 . . . . 52.43 110.648 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.46 -25.41 67.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.561 0.345 . . . . 71.32 110.543 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -77.12 -7.48 55.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 72.12 111.411 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -110.89 92.0 3.88 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.077 0.951 . . . . 75.53 109.478 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -97.41 77.76 2.65 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.097 0.559 . . . . 71.12 109.885 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -165.01 172.37 12.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.886 0.474 . . . . 72.23 110.141 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -60.19 116.09 16.02 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.512 1.125 . . . . 74.24 110.965 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.75 123.94 12.43 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.026 1.817 . . . . 55.4 110.884 172.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -57.85 110.94 1.0 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.15 105.87 19.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.397 -0.819 . . . . 63.51 109.139 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.9 115.42 29.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.524 -1.658 . . . . 74.53 106.524 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.22 155.88 16.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.161 0.584 . . . . 61.12 109.972 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -149.47 132.28 16.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.131 0.572 . . . . 61.42 109.726 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -112.06 137.04 50.64 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.834 0.854 . . . . 74.32 109.655 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.633 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 3.8 t70 -133.57 154.84 50.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.931 1.292 . . . . 63.24 108.06 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.3 m -137.19 146.33 44.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.161 0.585 . . . . 75.23 110.294 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 167.03 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.389 1.075 . . . . 62.42 108.891 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -164.71 155.75 14.9 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.968 0.507 . . . . 75.33 110.844 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.1 p -158.75 132.99 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 65.23 109.323 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.44 133.8 48.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.391 0.676 . . . . 71.52 110.541 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' D' ' 57' ' ' GLU . 38.6 mt -102.16 -40.52 6.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.43 0.692 . . . . 75.4 110.31 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.98 -169.48 2.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.257 0.623 . . . . 65.12 111.222 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.71 111.48 1.64 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.241 -0.89 . . . . 61.44 110.648 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 75.89 5.29 3.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.485 1.514 . . . . 72.31 110.739 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -108.57 121.19 61.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.216 0.606 . . . . 75.12 110.299 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.39 130.22 53.48 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.707 -1.22 . . . . 75.14 107.707 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' D' ' 51' ' ' LEU . 5.4 tm-20 -88.48 131.48 34.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.104 -1.813 . . . . 62.44 106.104 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.69 129.86 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.416 -0.957 . . . . 63.5 108.416 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -108.97 135.11 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.409 0.684 . . . . 74.34 110.604 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -115.74 124.08 49.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.789 -1.56 . . . . 74.13 106.789 171.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -106.77 99.6 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.72 -0.844 . . . . 71.31 108.72 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.87 122.52 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 74.43 108.136 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -121.43 134.37 55.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.357 -0.838 . . . . 50.51 109.635 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' D' ' 114' ' ' ILE . 86.2 t -124.58 102.77 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.79 0.836 . . . . 54.3 109.275 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -101.47 108.02 19.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.513 -0.921 . . . . 54.4 108.513 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.94 139.05 44.33 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.999 0.919 . . . . 54.03 109.131 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 79.2 p -143.39 138.93 29.74 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.077 0.551 . . . . 73.21 110.338 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -115.72 111.27 20.32 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.203 1.001 . . . . 74.25 109.656 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.03 10.94 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.517 0.511 . . . . 64.35 112.626 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 4.05 49.39 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.88 0.872 . . . . 73.2 110.95 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -131.32 147.87 52.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.513 0.725 . . . . 63.43 110.591 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -64.72 138.06 58.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.25 1.02 . . . . 50.11 111.277 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.11 -59.55 2.07 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.556 -0.905 . . . . 54.41 108.556 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -164.24 153.85 14.1 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.807 -1.088 . . . . 62.41 109.951 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 53.3 mt -113.41 154.47 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.019 . . . . 65.21 108.982 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.564 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.2 t -158.58 147.05 18.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.526 0.33 . . . . 74.44 110.436 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.52 121.31 5.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.896 0.878 . . . . 74.35 109.042 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.49 116.07 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 122.987 0.515 . . . . 75.53 109.846 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.726 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -90.11 87.85 7.04 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.638 0.732 . . . . 73.43 109.282 170.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.28 100.39 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.138 -1.392 . . . . 75.32 109.178 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.42 169.87 38.18 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.158 -0.377 . . . . 72.01 112.158 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.65 137.6 4.7 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 112.558 -0.217 . . . . 72.31 112.558 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.27 125.31 42.29 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.676 0.79 . . . . 72.14 109.653 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.07 142.63 50.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.654 0.782 . . . . 75.24 110.299 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 31.0 m -105.93 99.34 8.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.801 0.84 . . . . 54.03 108.796 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.69 138.4 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.423 1.089 . . . . 73.33 109.386 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.25 162.3 12.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.049 0.54 . . . . 54.44 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.51 85.06 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.979 -0.555 . . . . 72.4 113.665 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.419 ' H ' HD13 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -126.74 169.04 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.501 0.72 . . . . 74.21 110.83 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -160.59 162.12 32.74 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.992 0.917 . . . . 72.43 109.54 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.67 -140.73 48.04 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.831 0.707 . . . . 72.45 114.035 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -62.22 -24.25 67.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.194 0.998 . . . . 72.43 111.909 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -61.47 -50.77 71.41 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.258 -0.645 . . . . 64.14 109.258 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 5.3 ptm -66.4 -34.53 78.16 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.487 0.492 . . . . 75.44 110.507 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.47 75.0 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.38 0.61 . . . . 55.24 111.294 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -69.32 -49.94 51.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 74.1 110.658 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -73.93 -38.39 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.848 -0.614 . . . . 74.41 111.672 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.523 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.6 tp -84.93 -29.67 24.96 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.353 0.661 . . . . 63.14 110.454 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.58 39.4 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.855 -0.611 . . . . 74.51 113.346 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -61.17 1.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.102 0.451 . . . . 74.14 111.705 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.33 -40.86 97.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.056 0.761 . . . . 74.54 113.056 -173.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 74.1 m -68.35 -47.4 37.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 CA-C-O 118.95 -0.547 . . . . 65.45 112.104 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.533 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.9 Cg_exo -59.45 -32.91 97.18 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 121.844 1.696 . . . . 61.31 113.267 168.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -64.38 -24.93 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.122 0.569 . . . . 73.04 111.717 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.41 -44.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.44 -0.578 . . . . 75.43 109.44 171.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' D' ' 60' ' ' LEU . 51.4 mt -70.86 -26.06 63.09 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.33 -0.85 . . . . 63.23 111.528 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.03 -44.9 91.06 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 115.076 1.51 . . . . 73.35 115.076 -166.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.72 -35.01 95.93 Favored 'Trans proline' 0 C--N 1.381 2.282 0 CA-C-N 122.039 1.764 . . . . 74.41 113.032 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -76.44 -35.38 58.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.708 0.803 . . . . 74.51 110.482 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -48.38 71.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.585 0.754 . . . . 52.31 110.025 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.469 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.9 ttp180 -56.52 -50.33 72.13 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 113.97 -1.468 . . . . 72.12 110.869 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.27 -45.44 94.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.085 0.866 . . . . 74.41 111.091 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.472 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.9 t -57.17 -39.83 76.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 71.14 111.05 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.564 HG23 ' SG ' ' D' ' 76' ' ' CYS . 76.6 mt -68.72 -56.98 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.465 0.706 . . . . 61.41 109.847 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -49.46 -45.27 46.52 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.921 1.289 . . . . 64.05 111.923 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 46.4 t -64.56 -45.52 86.74 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.893 -1.049 . . . . 75.52 110.258 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.6 mtm -63.22 -36.8 84.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.428 0.691 . . . . 70.15 111.801 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -66.88 -45.16 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 75.33 109.784 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -71.29 -27.23 63.27 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.69 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -69.98 -30.95 68.42 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.79 0.836 . . . . 74.33 109.643 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 8.74 63.95 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.818 0.698 . . . . 73.3 113.165 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.433 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.4 p 54.12 39.77 31.0 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.838 1.655 . . . . 72.15 112.313 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.538 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 38.9 m-85 -110.65 167.95 8.31 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.605 1.162 . . . . 74.53 108.861 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.21 155.84 62.91 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.392 2.061 . . . . 62.22 112.564 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.78 123.24 22.95 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.226 -0.657 . . . . 45.12 109.226 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.18 105.83 16.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.489 -0.93 . . . . 74.35 108.489 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 91.4 m-20 -97.6 88.86 4.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.915 -1.143 . . . . 42.41 107.915 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 26.3 tp -71.19 119.87 15.95 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.431 -0.804 . . . . 73.34 109.664 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.99 88.12 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.085 0.954 . . . . 72.42 112.288 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.32 106.8 1.18 Allowed 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.157 1.905 . . . . 65.0 110.796 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.06 109.95 30.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.371 -0.974 . . . . 63.51 108.371 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 108.415 -0.957 . . . . 73.03 108.415 175.349 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.551 1.002 0 N-CA-C 108.796 -0.816 . . . . 61.33 108.796 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 55.9 t80 -131.88 147.85 52.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.444 0.697 . . . . 64.33 110.436 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 58.5 tp60 -145.44 134.05 22.14 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 123.67 0.606 . . . . 74.44 111.022 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.498 HD11 HG13 ' A' ' 16' ' ' ILE . 4.5 tp -92.76 128.93 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.011 0.924 . . . . 73.44 108.541 167.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -106.54 -41.87 5.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.463 0.305 . . . . 73.41 110.996 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -169.75 133.34 1.24 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 119.747 -0.168 . . . . 71.15 111.212 -171.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.819 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 67.9 mt -113.1 139.08 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.206 1.003 . . . . 72.34 109.017 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 29.9 p90 -165.3 175.53 9.12 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.008 0.818 . . . . 71.42 111.664 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.424 ' H ' ' HA2' ' B' ' 121' ' ' GLY . 75.8 p -100.71 118.99 37.94 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.37 -0.974 . . . . 75.23 108.37 170.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 25.0 mtpt -74.1 -34.37 63.92 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.011 -0.737 . . . . 75.34 109.011 171.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 29.8 t70 -145.03 141.87 29.27 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.257 -1.338 . . . . 53.51 110.241 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.38 142.2 44.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 106.772 -1.566 . . . . 50.43 106.772 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 138.28 21.06 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.395 0.678 . . . . 61.12 109.46 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.5 t80 -143.33 128.43 18.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.824 -1.547 . . . . 64.31 106.824 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -129.95 131.71 46.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.305 -0.628 . . . . 64.32 109.305 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.6 77.96 22.1 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 107.486 -1.301 . . . . 72.04 107.486 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.0 -35.57 33.87 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.798 2.332 . . . . 75.4 111.023 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 87.9 m-20 -95.25 25.71 4.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.17 0.988 . . . . 74.21 110.889 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.06 99.86 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.032 0.933 . . . . 74.12 112.221 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.83 -31.18 32.34 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 121.675 1.583 . . . . 71.31 112.106 173.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.6 m-70 -65.38 -30.97 71.85 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.707 0.803 . . . . 73.41 111.405 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' ASN . 48.1 t -58.54 -26.43 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 122.929 0.492 . . . . 65.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.95 -39.63 95.22 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.059 0.544 . . . . 73.42 110.431 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -74.28 -37.09 63.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.219 1.008 . . . . 75.51 110.336 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -82.34 160.07 22.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.208 -0.905 . . . . 72.31 111.28 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.42 141.54 35.2 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 108.266 -1.013 . . . . 72.24 108.266 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -79.93 82.69 5.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.203 0.525 . . . . 73.12 109.681 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -132.73 72.91 76.91 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.161 -1.052 . . . . 71.12 108.161 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 52.8 Cg_endo -83.05 157.77 15.33 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.563 2.175 . . . . 73.23 111.583 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -123.38 108.29 12.56 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.141 -1.059 . . . . 73.35 108.141 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.679 HG23 HG13 ' A' ' 64' ' ' VAL . 7.3 p -65.87 135.14 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 123.706 0.629 . . . . 72.42 111.64 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 47.6 mtpt -104.51 145.25 30.56 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.009 0.924 . . . . 74.1 108.731 167.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mp -123.28 105.86 10.22 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.788 -1.19 . . . . 65.01 107.788 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.1 m-20 -115.88 102.76 9.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.766 -1.198 . . . . 61.51 107.766 173.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.96 122.65 43.19 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.84 -1.541 . . . . 54.41 106.84 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.11 154.12 49.79 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.742 -0.836 . . . . 70.03 108.742 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -106.83 157.68 17.56 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.502 0.668 . . . . 63.35 110.55 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -149.98 143.94 25.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.681 -1.229 . . . . 55.5 107.681 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 54.3 m -130.1 152.09 49.92 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.95 0.5 . . . . 72.33 110.025 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -158.27 121.09 3.79 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.272 0.629 . . . . 43.12 109.62 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.65 109.26 15.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.458 -0.942 . . . . 75.12 108.458 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.4 mt -86.11 -41.11 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.113 0.565 . . . . 72.05 111.128 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -154.43 -172.11 4.09 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.689 0.796 . . . . 33.42 110.266 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.71 110.58 4.36 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.341 0.656 . . . . 71.13 109.455 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.58 0.43 2.95 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.226 1.41 . . . . 73.2 112.636 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 85.0 t -98.94 113.14 32.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.549 -1.278 . . . . 71.23 107.549 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.467 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 0.2 OUTLIER -116.96 169.74 9.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -129.99 121.98 27.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.552 -0.907 . . . . 74.54 108.552 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.17 120.95 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.536 -1.653 . . . . 71.41 106.536 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 41.6 t -108.36 132.24 56.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.736 -0.839 . . . . 72.41 108.736 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -102.96 111.21 23.44 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.205 -1.406 . . . . 70.13 107.205 177.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.86 98.4 8.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.864 -1.161 . . . . 74.53 107.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 60' ' ' LEU . 4.0 t -96.96 142.08 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.255 -1.017 . . . . 23.42 108.255 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.7 m -135.62 127.03 28.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.467 -0.938 . . . . 75.25 108.467 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.679 HG13 HG23 ' A' ' 40' ' ' VAL . 55.2 t -125.24 107.75 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.723 1.209 . . . . 75.34 109.275 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 m -107.34 137.27 45.7 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.798 0.439 . . . . 72.54 109.943 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -121.03 122.36 39.93 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.931 -0.766 . . . . 74.43 108.931 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 67.2 m -118.81 130.78 55.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.0 0.52 . . . . 50.03 110.574 173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -87.79 69.58 9.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.432 1.493 . . . . 71.41 107.884 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -94.14 1.32 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 114.95 -1.023 . . . . 73.43 111.23 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.58 -25.98 14.24 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.726 0.81 . . . . 73.22 111.966 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -111.81 128.19 56.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.115 0.566 . . . . 54.54 110.691 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -67.38 133.26 49.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.21 0.604 . . . . 72.34 111.294 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -56.64 3.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.613 1.165 . . . . 45.34 109.669 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -148.75 172.41 14.66 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.599 -1.182 . . . . 74.41 111.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -141.7 140.07 33.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.296 1.438 . . . . 53.34 107.733 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.6 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 29.9 m -128.04 140.59 51.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.988 -1.116 . . . . 71.52 107.988 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -148.85 118.31 6.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.255 -0.646 . . . . 73.32 109.255 168.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.14 110.6 23.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 123.752 0.821 . . . . 53.03 109.322 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.5 mt-30 -86.15 81.06 8.58 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.717 -0.846 . . . . 75.21 108.717 172.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.15 94.91 4.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.031 -0.986 . . . . 61.01 108.419 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -105.13 146.6 16.1 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 112.179 -0.368 . . . . 53.54 112.179 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.39 141.99 12.92 Favored Glycine 0 C--O 1.24 0.522 0 N-CA-C 111.433 -0.667 . . . . 75.1 111.433 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.421 HG13 ' HE1' ' A' ' 17' ' ' TYR . 50.6 mt -81.55 123.88 38.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.434 -0.95 . . . . 74.54 108.434 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.402 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -134.6 120.28 19.4 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.17 0.588 . . . . 71.3 109.743 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.634 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 24.0 m -83.6 103.25 12.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.881 -0.785 . . . . 72.41 108.881 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.478 HD12 HD11 ' A' ' 89' ' ' ILE . 45.2 pt -109.14 138.97 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.559 0.744 . . . . 71.41 110.709 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.5 153.79 33.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.206 -0.907 . . . . 72.3 109.344 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.66 85.98 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 121.305 -0.474 . . . . 74.55 114.239 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 2.2 pp -107.37 130.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.513 -1.291 . . . . 64.44 107.513 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -153.34 168.29 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.699 -1.223 . . . . 74.53 107.699 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.97 -117.85 2.41 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 114.73 0.652 . . . . 30.32 114.73 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -81.82 -27.22 33.74 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 63.01 111.159 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -64.65 -36.11 83.2 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.808 0.843 . . . . 75.22 110.091 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.48 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 59.0 ttm -69.05 -45.94 69.13 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.305 -0.861 . . . . 73.4 109.403 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.23 -26.79 68.95 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.286 -0.87 . . . . 62.43 112.228 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -70.53 -43.85 68.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.775 0.43 . . . . 75.53 110.315 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -70.46 -64.25 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.856 0.722 . . . . 65.01 110.981 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.95 -19.76 60.57 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.149 0.425 . . . . 73.23 112.149 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.35 -35.15 8.16 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 114.23 0.452 . . . . 63.42 114.23 -170.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -137.03 -48.01 0.6 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.793 0.294 . . . . 74.05 111.793 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.454 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.8 t80 -62.94 -61.44 2.39 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.407 0.683 . . . . 72.11 111.868 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.551 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.6 m -67.09 -37.45 13.57 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.72 0.808 . . . . 62.23 112.937 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.06 -44.05 48.4 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.149 1.9 . . . . 71.13 113.269 162.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -69.84 -23.43 63.3 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 71.34 111.664 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 102' ' ' CYS . 32.3 mm -65.77 -40.89 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.944 -0.762 . . . . 72.04 108.944 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.31 -23.06 26.41 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.364 1.066 . . . . 74.11 112.768 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -66.08 -42.84 53.86 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 114.249 1.203 . . . . 63.33 114.249 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.99 -34.56 99.2 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 121.938 1.758 . . . . 61.12 112.694 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -77.85 -39.0 44.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.761 0.825 . . . . 73.34 111.353 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.81 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.358 0.663 . . . . 75.13 109.548 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.6 ttm180 -48.59 -55.8 10.17 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.89 1.369 . . . . 74.1 110.717 176.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.458 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.0 tm-20 -66.07 -38.94 89.57 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.247 0.967 . . . . 63.25 111.18 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.583 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.2 t -62.37 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.221 0.608 . . . . 75.23 111.45 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.6 -46.49 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.152 0.981 . . . . 65.04 110.534 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' HE2' ' C' ' 109' ' ' TYR . 99.2 m -57.04 -43.98 82.48 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.949 1.299 . . . . 72.11 111.373 -174.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 29.0 t -68.68 -32.12 71.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.43 -0.805 . . . . 74.45 111.686 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.605 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 70.7 mtm -69.97 -38.28 76.04 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.581 0.352 . . . . 72.12 110.604 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -65.78 -48.51 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.559 0.743 . . . . 73.12 110.885 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.701 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 77.6 p -63.37 -35.61 80.96 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.516 0.674 . . . . 63.41 111.219 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -72.71 -20.5 61.21 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.3 -1.318 . . . . 74.45 110.656 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 16.39 37.87 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 119.413 -0.659 . . . . 75.13 113.295 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.504 HG21 ' HE ' ' B' ' 15' ' ' ARG . 0.5 OUTLIER 78.65 8.07 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 127.088 2.155 . . . . 75.43 112.082 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 119' ' ' SER . 19.0 m-85 -99.48 162.82 19.99 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.395 0.678 . . . . 74.45 110.127 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.98 125.93 13.18 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.857 1.704 . . . . 62.05 109.548 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.701 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 3.2 pt20 -61.72 147.54 45.77 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 123.554 0.534 . . . . 72.5 111.058 -173.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -121.77 113.0 19.07 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.984 -0.553 . . . . 71.32 110.118 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -110.72 111.68 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.388 -0.967 . . . . 65.21 108.388 174.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 40' ' ' VAL . 86.7 mt -73.18 144.84 46.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.038 0.535 . . . . 64.43 110.284 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 153.64 75.36 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.788 0.835 . . . . 51.23 111.701 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.47 138.58 12.35 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 121.922 1.748 . . . . 51.23 111.847 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 m -103.45 112.44 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.485 -0.931 . . . . 63.52 108.485 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.71 69.9 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.466 0.651 . . . . 71.3 110.472 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 39.9 t80 . . . . . 0 C--O 1.218 -0.582 0 CA-C-N 115.687 -0.688 . . . . 72.55 110.007 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 108.567 -0.901 . . . . 74.35 108.567 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.44 123.45 13.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 64.14 109.82 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -127.5 141.77 51.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.647 1.179 . . . . 73.31 109.83 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.6 HG13 ' HD3' ' D' ' 130' ' ' PRO . 61.4 mt -93.04 129.56 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.018 -1.104 . . . . 73.44 108.018 166.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -89.39 -40.92 12.42 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.581 0.55 . . . . 62.22 110.69 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.504 ' HE ' HG21 ' A' ' 122' ' ' THR . 68.8 ttt180 -167.55 150.46 6.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.774 0.43 . . . . 73.02 110.546 -170.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.11 145.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.998 -1.482 . . . . 73.35 106.998 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.1 p90 -170.62 162.21 7.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.685 0.394 . . . . 73.35 111.198 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 84.8 m -90.19 124.71 35.07 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.107 -0.701 . . . . 72.31 109.107 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.08 -45.19 11.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.899 -0.591 . . . . 64.45 109.505 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.516 ' HB3' HE21 ' B' ' 79' ' ' GLN . 19.4 t70 -148.92 146.05 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.889 -0.596 . . . . 74.34 111.807 -165.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 42.9 mm -138.35 150.01 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.463 1.505 . . . . 64.35 109.068 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -150.32 150.89 32.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.722 -0.672 . . . . 52.1 110.146 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 66.8 t80 -157.42 111.82 2.67 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.891 -1.522 . . . . 62.42 106.891 168.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -125.56 114.59 18.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 73.13 109.471 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.707 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.05 91.54 6.62 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.445 0.698 . . . . 53.44 109.503 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.84 -29.81 88.9 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.008 2.472 . . . . 61.25 112.62 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.45 31.27 6.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.873 0.869 . . . . 73.35 110.349 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -46.28 -55.59 13.31 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 125.115 1.366 . . . . 75.52 114.341 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.36 -13.91 10.82 Favored 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 121.751 1.634 . . . . 74.43 112.834 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -85.51 0.53 52.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.986 0.914 . . . . 72.45 111.841 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.47 -18.08 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 124.387 1.075 . . . . 63.25 111.008 170.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.55 -37.16 86.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.79 0.836 . . . . 64.44 110.825 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -85.85 -43.87 12.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.479 -0.782 . . . . 70.35 110.539 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 34' ' ' LYS . 23.9 mmtp -78.08 89.9 4.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.059 0.544 . . . . 70.43 109.989 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -86.61 76.88 9.48 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.304 -0.862 . . . . 64.51 112.146 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -173.1 161.85 4.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.572 -0.74 . . . . 64.32 110.281 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -75.24 117.29 61.92 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.519 0.728 . . . . 73.02 109.329 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.4 151.5 79.09 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.7 2.267 . . . . 75.1 113.333 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.28 102.82 8.81 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.032 -0.985 . . . . 75.23 108.391 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.401 ' HB ' HD12 ' B' ' 126' ' ' LEU . 13.6 t -86.75 121.78 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.807 -0.812 . . . . 63.02 108.807 -175.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -130.52 133.84 46.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.095 0.958 . . . . 74.42 108.724 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.35 149.24 31.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.393 -0.595 . . . . 62.2 109.393 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -135.51 135.96 40.84 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.016 0.926 . . . . 64.05 109.313 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.29 146.76 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.813 0.845 . . . . 73.31 109.892 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.52 152.34 34.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.349 1.059 . . . . 61.44 108.275 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -137.27 137.93 39.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.184 0.594 . . . . 74.11 109.408 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.82 151.89 51.37 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.828 1.251 . . . . 61.13 107.961 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.0 m -132.11 161.89 32.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.096 0.558 . . . . 51.35 110.246 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -163.44 155.8 17.99 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.681 1.192 . . . . 62.41 108.399 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.5 tt0 -124.4 132.72 53.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.567 -0.531 . . . . 74.33 109.567 171.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.1 mt -100.7 -31.73 11.07 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.602 0.761 . . . . 75.44 111.342 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.31 -172.08 3.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.654 0.781 . . . . 64.12 111.326 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.36 107.19 1.56 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.034 -0.984 . . . . 72.44 111.119 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.0 16.41 7.0 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.651 1.181 . . . . 75.23 112.386 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 91.7 t -115.68 116.59 52.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.157 -1.423 . . . . 62.31 107.157 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 11.0 p90 -123.92 179.12 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.321 0.649 . . . . 65.52 109.894 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -142.44 134.18 26.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.556 -0.905 . . . . 73.23 108.556 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.72 125.91 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.142 -1.059 . . . . 72.12 108.142 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.08 113.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.594 -0.891 . . . . 74.34 108.594 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -93.57 118.46 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.755 -0.831 . . . . 72.43 108.755 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 35.1 ttm180 -105.12 120.77 42.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.157 0.583 . . . . 71.21 109.83 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.451 HG23 HD22 ' B' ' 60' ' ' LEU . 48.4 t -116.53 110.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.734 -1.21 . . . . 60.54 107.734 167.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -106.65 128.39 54.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.02 0.528 . . . . 64.21 109.796 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.7 HG21 HG21 ' B' ' 114' ' ' ILE . 97.2 t -115.39 128.84 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.216 1.006 . . . . 61.45 109.696 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -121.94 142.5 50.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.263 1.025 . . . . 71.53 109.562 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.07 163.87 28.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.176 0.991 . . . . 64.43 109.564 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.5 p -146.71 138.49 24.56 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.462 0.541 . . . . 73.35 112.462 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 39.3 mt -110.47 106.09 15.28 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.029 1.332 . . . . 70.24 107.982 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.46 -106.27 2.21 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.329 -0.462 . . . . 75.4 112.485 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.46 5.89 11.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.156 0.983 . . . . 54.34 110.732 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -127.22 171.47 11.42 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.091 0.956 . . . . 74.43 109.424 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 59.6 m -76.7 142.78 40.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.085 0.554 . . . . 72.03 111.31 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.469 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.56 -64.08 1.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.527 0.731 . . . . 70.33 109.33 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 32.7 p90 -147.5 162.02 39.9 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.005 -0.998 . . . . 75.12 110.6 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -130.0 154.09 47.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.239 1.416 . . . . 70.12 107.567 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.4 t -154.75 159.49 40.7 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.059 0.944 . . . . 63.21 108.675 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -164.67 141.04 5.99 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.655 0.782 . . . . 75.41 109.253 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 69.9 t -129.13 140.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.755 0.822 . . . . 64.42 108.948 171.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.516 HE21 ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -126.89 92.77 3.6 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.849 0.718 . . . . 74.32 109.164 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -89.86 101.82 14.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.272 -1.331 . . . . 62.24 109.048 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.11 15.46 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.896 -0.882 . . . . 72.42 110.896 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -141.75 125.95 2.87 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.167 -0.773 . . . . 72.31 111.167 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.91 126.43 40.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.719 0.808 . . . . 72.02 109.252 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -132.9 161.57 33.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.665 1.186 . . . . 74.43 109.293 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -134.03 127.38 32.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.492 1.117 . . . . 73.32 108.504 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.55 HG12 HD12 ' B' ' 89' ' ' ILE . 8.5 tt -139.1 135.98 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.512 -0.551 . . . . 72.34 109.512 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.33 158.57 36.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.716 0.806 . . . . 74.4 109.999 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.31 -30.3 10.69 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 111.797 -0.521 . . . . 65.02 111.797 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' B' ' 93' ' ' GLN . 0.1 OUTLIER -83.31 169.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.967 1.307 . . . . 73.13 111.087 175.533 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -152.16 143.68 23.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.992 0.917 . . . . 75.3 109.718 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -99.8 0.16 Allowed Glycine 0 C--N 1.35 1.331 0 O-C-N 123.917 0.761 . . . . 74.1 114.715 170.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 86.1 m -64.27 -42.75 96.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 74.45 112.349 -170.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.625 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 1.1 mp0 -62.13 -45.07 95.08 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.229 0.612 . . . . 64.22 110.093 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -39.97 65.93 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.233 -0.894 . . . . 61.24 110.164 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.56 69.13 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.252 0.621 . . . . 74.35 111.855 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -76.02 -40.58 53.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 70.43 110.501 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' B' ' 102' ' ' CYS . 49.6 t -66.2 -47.56 73.49 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.419 0.688 . . . . 64.42 109.674 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.65 -35.26 80.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.637 1.175 . . . . 73.52 110.837 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.69 2.14 87.78 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.375 -0.83 . . . . 52.41 114.172 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.99 -63.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.885 0.843 . . . . 63.4 112.732 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.8 -50.08 39.53 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.629 0.974 . . . . 72.43 113.629 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 61.4 m -58.44 -47.61 98.46 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.503 0.721 . . . . 63.23 112.081 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.03 -27.56 29.81 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 121.363 1.375 . . . . 73.51 112.898 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -64.84 -29.91 70.89 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.758 0.708 . . . . 64.4 110.515 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.517 HG23 ' NH2' ' D' ' 111' ' ' ARG . 63.7 mt -62.29 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.768 0.827 . . . . 62.24 110.372 172.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.488 ' HB2' HD12 ' B' ' 60' ' ' LEU . 39.2 mt -83.68 -11.85 56.66 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.882 -1.054 . . . . 75.22 111.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.554 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 32.3 t80 -63.46 -46.8 84.28 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.298 1.439 . . . . 51.13 112.994 -170.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.416 ' HB3' ' HD2' ' D' ' 109' ' ' TYR . 29.1 Cg_endo -60.95 -36.93 80.71 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.64 1.56 . . . . 63.24 112.764 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.22 -42.25 99.13 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.247 0.619 . . . . 70.34 110.587 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -41.47 73.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.358 0.663 . . . . 65.2 111.357 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -56.53 -58.92 5.98 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.571 1.149 . . . . 72.12 111.275 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.39 -35.79 81.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.397 -0.819 . . . . 62.21 110.387 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.408 ' HB3' HG21 ' B' ' 78' ' ' VAL . 36.8 t -64.64 -37.14 86.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.476 0.547 . . . . 73.43 112.476 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.7 HG21 HG21 ' B' ' 64' ' ' VAL . 79.3 mt -70.76 -47.9 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.918 0.487 . . . . 64.42 110.131 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.6 m -62.49 -23.75 67.1 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.533 -0.758 . . . . 71.43 110.833 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -73.27 -54.71 7.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.567 1.147 . . . . 71.51 109.985 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.503 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -64.93 -33.74 76.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.982 0.913 . . . . 70.3 113.163 -172.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.91 -30.15 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 122.901 0.48 . . . . 75.24 110.175 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' B' ' 125' ' ' GLN . 54.5 p -72.14 -32.18 66.67 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.481 0.658 . . . . 43.24 110.478 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.583 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 67.7 mtt-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.722 -1.127 . . . . 73.01 109.814 171.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 18' ' ' THR . . . -87.37 15.79 52.34 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.097 -0.835 . . . . 71.44 113.342 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t 56.69 14.07 1.63 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 126.97 2.108 . . . . 53.14 113.884 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -106.14 160.15 27.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.698 0.799 . . . . 73.21 111.309 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -52.77 101.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.782 2.988 . . . . 53.24 114.49 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.547 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 0.1 OUTLIER -68.86 155.45 40.21 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 113.356 -1.747 . . . . 71.53 110.293 176.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.401 HD12 ' HB ' ' B' ' 40' ' ' VAL . 2.6 tt -152.3 126.28 9.1 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.741 -0.837 . . . . 54.4 108.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -93.66 127.96 39.61 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.997 0.919 . . . . 62.42 108.661 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.554 HD22 ' HZ ' ' B' ' 107' ' ' PHE . 1.7 tt -70.54 130.89 43.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.617 -0.512 . . . . 75.31 109.617 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.64 144.67 98.73 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.563 0.745 . . . . 60.21 111.042 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.469 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 57.8 Cg_endo -65.22 92.02 0.22 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.39 2.726 . . . . 75.03 113.431 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -84.95 108.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.953 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.444 ' HB3' HG21 ' D' ' 13' ' ' ILE . 52.5 t30 -109.84 105.93 15.32 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.188 0.595 . . . . 70.23 110.177 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 t80 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 123.803 0.841 . . . . 74.45 111.368 176.421 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 80.5 m . . . . . 0 CA--C 1.528 0.134 0 N-CA-C 107.393 -1.336 . . . . 75.02 107.393 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -122.83 123.7 41.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.343 -1.355 . . . . 73.34 107.343 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.79 138.41 16.05 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.399 0.437 . . . . 64.5 110.733 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.17 142.35 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.869 0.867 . . . . 72.32 109.075 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.533 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 30.9 mm-40 -111.39 -35.73 5.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.416 0.686 . . . . 62.23 110.663 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 42.4 ttt180 -173.33 136.49 0.62 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.114 0.566 . . . . 65.23 109.654 -171.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -123.18 143.85 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.407 -1.331 . . . . 62.42 107.407 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.411 ' HB3' HG23 ' D' ' 122' ' ' THR . 39.2 p90 -177.71 168.85 2.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 75.54 110.72 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -87.56 111.86 21.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.372 -0.831 . . . . 50.34 109.323 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.38 -43.92 89.22 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.2 -0.667 . . . . 63.32 109.2 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -147.34 147.1 29.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.222 -1.354 . . . . 75.45 110.078 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.88 144.57 29.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 125.782 1.633 . . . . 73.42 106.729 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -153.33 151.02 29.5 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.31 0.576 . . . . 54.44 110.644 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -155.08 134.04 12.23 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.573 -1.194 . . . . 73.31 108.077 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.8 147.28 52.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.439 1.096 . . . . 74.43 108.268 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 84.87 6.32 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.544 0.737 . . . . 74.44 109.785 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.38 -27.97 46.97 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.989 2.459 . . . . 74.21 111.302 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.815 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 6.8 m-80 -95.25 18.56 12.15 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.797 -1.092 . . . . 55.51 111.551 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.29 88.98 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 118.613 0.642 . . . . 70.34 111.19 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -94.18 -26.33 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.743 1.629 . . . . 73.33 113.571 164.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.815 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 61.2 t60 -69.05 -24.41 64.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.734 1.213 . . . . 72.05 113.312 -170.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' C' ' 27' ' ' ASN . 8.8 p -74.99 -12.01 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 122.825 0.45 . . . . 73.53 111.854 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.67 -41.34 81.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.402 0.681 . . . . 74.14 112.189 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -112.12 48.11 1.01 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.071 0.939 . . . . 64.54 108.949 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.619 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.9 tppp? -124.33 164.05 20.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.455 -0.793 . . . . 73.35 109.481 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.42 105.79 8.78 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.859 -1.164 . . . . 70.53 107.859 166.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -84.0 73.35 10.37 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.917 0.887 . . . . 71.02 111.466 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -124.93 77.62 66.17 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.048 -0.723 . . . . 55.4 109.048 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.793 ' HG2' ' HG3' ' C' ' 124' ' ' PRO . 1.3 Cg_endo -86.51 137.4 4.95 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.366 2.711 . . . . 44.34 111.794 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.63 117.02 24.27 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.61 -1.256 . . . . 75.34 107.61 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.31 79.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 115.236 -0.893 . . . . 42.42 109.406 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.07 141.56 35.63 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.209 0.604 . . . . 54.03 110.847 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.1 165.91 14.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.785 0.834 . . . . 73.33 110.846 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -145.83 148.4 32.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.914 1.286 . . . . 71.01 107.594 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.415 HD11 HD21 ' C' ' 60' ' ' LEU . 15.6 tp -116.47 148.91 40.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.213 0.461 . . . . 75.41 111.042 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 12.9 m-20 -141.15 137.97 33.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.37 1.068 . . . . 73.42 109.17 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -113.97 126.22 54.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.502 -0.925 . . . . 64.45 108.502 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.96 165.29 25.04 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.38 1.072 . . . . 43.12 108.54 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 m -145.09 168.31 20.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.319 0.648 . . . . 71.11 110.441 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.19 128.0 4.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.729 1.211 . . . . 73.3 108.025 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -90.31 126.2 35.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.979 -0.749 . . . . 71.33 108.979 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.623 HD11 HD12 ' C' ' 83' ' ' ILE . 61.8 mt -97.93 -36.42 10.16 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.836 0.854 . . . . 61.12 110.18 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.99 -178.05 5.41 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.493 -0.776 . . . . 73.42 109.96 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -68.04 123.47 20.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.137 -1.061 . . . . 73.33 108.137 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' C' ' 85' ' ' SER . 21.6 m-20 73.06 -4.33 2.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.701 1.2 . . . . 73.32 112.823 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 98.01 6.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.91 0.884 . . . . 62.32 108.74 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.11 116.39 26.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.716 0.806 . . . . 75.21 110.481 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -82.83 121.92 27.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.985 -1.007 . . . . 74.2 109.484 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.85 124.56 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.98 -1.118 . . . . 64.24 107.98 170.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.06 103.41 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.016 -1.105 . . . . 73.24 108.016 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -93.01 110.07 21.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.193 0.997 . . . . 65.45 108.365 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 47.5 ttp180 -103.34 137.33 41.6 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.035 0.534 . . . . 72.5 109.893 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.3 130.17 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.324 -1.362 . . . . 70.21 107.324 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -120.23 121.04 37.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.849 -0.797 . . . . 44.12 108.849 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' C' ' 126' ' ' LEU . 25.6 t -98.73 138.5 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.966 0.907 . . . . 61.32 109.319 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -123.35 138.75 54.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.153 -1.385 . . . . 73.2 107.486 171.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.946 -1.501 . . . . 62.31 106.946 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -134.49 128.85 34.22 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 123.643 0.589 . . . . 71.22 110.68 -176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.619 HD13 ' HG2' ' C' ' 34' ' ' LYS . 17.1 mt -84.65 47.55 1.39 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.482 1.513 . . . . 73.31 108.811 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.27 -82.82 0.49 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.847 -0.901 . . . . 75.33 110.847 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.98 -31.78 3.59 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.674 1.19 . . . . 73.34 108.829 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.49 121.84 14.27 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.902 0.881 . . . . 72.15 109.874 170.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -74.59 122.0 22.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.749 0.704 . . . . 73.34 109.62 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' C' ' 27' ' ' ASN . . . -72.35 -51.32 21.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.064 0.946 . . . . 61.41 109.92 177.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -167.17 176.68 6.64 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.916 -0.583 . . . . 71.12 110.443 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.439 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -131.02 142.89 50.37 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.59 -1.263 . . . . 64.5 107.59 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -144.63 147.73 33.45 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.373 -0.973 . . . . 73.43 108.373 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.99 141.47 14.07 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.714 0.406 . . . . 64.2 110.389 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.86 115.47 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.313 1.045 . . . . 71.33 108.922 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 45.6 mt-30 -91.51 95.3 9.87 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.557 -0.905 . . . . 74.53 108.557 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.579 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -86.96 111.49 20.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.775 0.83 . . . . 71.51 109.905 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 145.18 17.6 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 112.389 -0.284 . . . . 43.15 112.389 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.13 124.03 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.268 -1.133 . . . . 71.44 110.268 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.623 HD12 HD11 ' C' ' 51' ' ' LEU . 8.1 mm -81.87 121.5 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.193 -1.04 . . . . 44.43 108.193 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.42 118.86 28.42 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.291 -0.633 . . . . 71.11 109.291 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' C' ' 54' ' ' ASP . 23.5 p -85.43 100.44 11.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.833 -0.803 . . . . 61.32 108.833 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.37 146.49 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.594 0.758 . . . . 72.22 111.251 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -164.93 151.05 10.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.17 0.988 . . . . 73.41 109.959 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 -38.75 3.14 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 114.042 0.377 . . . . 61.24 114.042 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 124.455 1.102 . . . . 74.34 111.082 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.978 -0.379 . . . . 74.33 109.978 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 52.5 ttm -62.95 -47.35 83.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.916 -0.583 . . . . 72.23 109.958 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.47 72.67 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.86 0.725 . . . . 73.53 111.732 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -73.42 -31.89 64.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.663 0.785 . . . . 70.1 110.027 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.14 -35.62 48.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 52.04 110.989 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.998 0.919 . . . . 53.01 110.303 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 11.11 62.44 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 115.914 -0.585 . . . . 71.4 114.18 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.01 -61.58 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.488 0.644 . . . . 71.35 111.34 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -73.77 -46.53 45.06 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.898 0.703 . . . . 74.43 112.898 -172.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.495 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 82.8 m -60.9 -48.73 91.9 Favored Pre-proline 0 CA--C 1.563 1.47 0 CA-C-O 118.977 -0.535 . . . . 71.44 110.75 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 71.9 Cg_exo -57.04 -33.67 96.17 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.439 2.093 . . . . 71.33 114.081 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.46 -34.87 79.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.313 0.645 . . . . 62.4 111.193 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.455 HD12 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -64.92 -41.57 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.229 0.612 . . . . 64.2 110.331 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.2 mt -81.49 -22.28 38.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.216 -0.902 . . . . 65.31 112.088 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.72 -48.51 95.06 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 117.723 -1.132 . . . . 73.22 113.55 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.03 -39.54 84.92 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.195 1.93 . . . . 71.22 112.607 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.448 ' HE2' HG21 ' A' ' 115' ' ' THR . 87.4 m-85 -62.88 -52.31 63.58 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.845 -1.07 . . . . 74.44 111.952 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -70.18 -34.81 73.44 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.319 -0.4 . . . . 71.53 111.397 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.83 -51.03 67.13 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.257 1.423 . . . . 64.31 110.473 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.98 -36.44 69.81 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.507 -0.77 . . . . 74.23 110.195 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.16 -30.96 71.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.09 0.556 . . . . 64.11 111.378 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.577 HG21 HG21 ' C' ' 64' ' ' VAL . 98.1 mt -72.3 -45.49 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.0 -0.546 . . . . 75.23 109.871 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -56.76 -37.32 70.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.801 0.688 . . . . 73.41 110.423 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.7 t -59.76 -56.95 15.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.923 1.289 . . . . 64.14 110.45 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.686 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.17 -41.91 89.53 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.586 1.154 . . . . 74.0 112.917 -176.153 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' C' ' 126' ' ' LEU . 69.2 t -66.29 -41.59 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.424 0.689 . . . . 72.33 110.747 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 45.5 t -63.31 -35.96 82.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.145 -0.934 . . . . 75.11 110.993 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.5 mtt-85 -66.89 -37.92 85.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.979 -1.01 . . . . 70.24 110.122 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.15 0.84 82.7 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.283 -0.732 . . . . 74.34 113.328 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p 57.09 50.94 11.1 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.523 1.529 . . . . 74.43 111.492 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.42 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 26.9 m-85 -121.65 169.74 8.75 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.474 1.11 . . . . 74.53 110.693 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.793 ' HG3' ' HG2' ' C' ' 38' ' ' PRO . 26.9 Cg_endo -57.8 126.71 22.6 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.732 2.288 . . . . 61.54 110.905 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.547 ' HG3' ' HB2' ' B' ' 125' ' ' GLN . 87.5 mm-40 -58.99 132.44 54.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.148 0.979 . . . . 75.11 112.486 -168.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.775 ' HG ' HG11 ' C' ' 64' ' ' VAL . 1.7 mm? -108.02 72.18 0.84 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.779 -0.646 . . . . 73.14 109.968 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -126.53 89.02 2.93 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.035 -1.468 . . . . 65.02 107.035 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 31.9 mt -84.27 151.16 24.96 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.552 -1.203 . . . . 75.14 108.785 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.58 147.53 39.3 Favored Pre-proline 0 CA--C 1.546 0.791 0 O-C-N 124.281 0.988 . . . . 51.01 113.295 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.819 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 88.0 Cg_exo -50.36 115.2 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.545 2.83 . . . . 43.13 112.583 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.16 78.91 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-O 121.632 0.729 . . . . 62.23 109.128 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.64 93.46 8.4 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.189 -0.914 . . . . 73.23 109.978 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 33.4 p90 . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 114.389 -1.278 . . . . 72.24 111.443 179.663 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m . . . . . 0 C--O 1.244 0.797 0 N-CA-C 109.813 -0.44 . . . . 74.23 109.813 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 91.3 t80 -156.6 102.56 2.06 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.333 -1.358 . . . . 74.31 107.333 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 76.3 mt-30 -113.03 113.55 25.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.844 -0.799 . . . . 74.52 108.844 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' B' ' 132' ' ' ASN . 7.5 tt -91.43 98.31 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.581 -1.266 . . . . 64.35 107.581 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -92.53 -33.21 14.56 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.35 0.5 . . . . 51.23 112.35 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 75.2 ttt180 -170.53 122.42 0.63 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.059 -0.348 . . . . 74.13 110.059 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' B' ' 130' ' ' PRO . 35.4 mm -115.57 132.67 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.146 -1.057 . . . . 54.42 108.146 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 4.8 p90 -154.57 169.0 24.87 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.381 0.672 . . . . 73.12 112.024 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -97.7 119.59 36.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.016 -0.993 . . . . 62.13 108.815 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.02 -22.31 31.36 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.331 0.653 . . . . 72.24 110.2 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.3 t70 -160.85 139.5 10.07 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.102 0.961 . . . . 74.13 109.381 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.686 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.3 mt -142.25 143.73 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.479 1.112 . . . . 63.11 108.258 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 60.7 m -141.98 136.76 30.64 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.228 1.011 . . . . 43.34 109.187 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.527 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.9 t80 -143.22 110.99 5.93 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 106.445 -1.687 . . . . 73.02 106.445 165.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -122.31 115.12 21.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.353 -0.61 . . . . 74.41 109.353 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -116.66 80.44 10.58 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.476 -0.935 . . . . 74.51 108.476 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.76 -29.83 23.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.669 2.246 . . . . 53.43 112.266 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -111.49 18.03 19.51 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.721 -0.672 . . . . 51.1 109.661 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.486 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -39.4 -54.35 3.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 115.586 1.699 . . . . 64.34 115.586 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.412 ' HB3' HD11 ' C' ' 83' ' ' ILE . 44.4 Cg_endo -81.67 -13.55 10.64 Favored 'Trans proline' 0 C--N 1.382 2.32 0 CA-C-N 121.307 1.503 . . . . 73.23 113.439 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -76.44 -36.83 57.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.687 1.195 . . . . 70.44 109.462 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.611 HG13 HD12 ' D' ' 68' ' ' LEU . 35.7 t -65.56 -23.96 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 124.877 1.271 . . . . 75.01 111.324 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.41 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 74.3 t80 -45.9 -36.64 5.55 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.335 1.454 . . . . 62.12 113.47 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -79.1 -6.54 56.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.637 0.775 . . . . 72.52 112.518 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -109.57 112.69 24.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.787 0.835 . . . . 64.52 110.029 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.2 60.3 1.41 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.927 0.891 . . . . 44.12 110.932 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.605 ' HB2' HD22 ' D' ' 68' ' ' LEU . 20.1 m95 -124.89 158.12 34.28 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.484 -0.561 . . . . 64.05 109.484 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.47 112.49 14.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 175.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.79 114.42 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.671 0 C-N-CA 122.783 2.322 . . . . 51.55 112.663 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.25 109.94 3.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.146 -1.057 . . . . 74.44 108.146 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 m -108.33 106.6 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.031 0.919 . . . . 53.32 109.142 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -94.28 115.97 28.29 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.248 -1.39 . . . . 71.03 107.248 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.05 136.08 34.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.498 -0.927 . . . . 54.31 108.498 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.72 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.7 m-20 -107.69 153.8 22.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.152 0.981 . . . . 64.01 108.562 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 tp -126.97 132.47 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.157 -0.683 . . . . 75.22 109.157 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t70 -140.62 141.18 35.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.018 -1.105 . . . . 42.33 108.018 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.1 m -118.53 143.64 46.6 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.979 -0.749 . . . . 71.22 108.979 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.9 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.323 1.049 . . . . 70.23 108.317 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.5 p -170.57 157.66 5.93 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.988 0.515 . . . . 72.22 110.894 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -149.57 140.44 22.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.911 -0.774 . . . . 72.42 108.911 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.2 119.93 25.16 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 109.405 -0.591 . . . . 72.13 109.405 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.6 mt -95.02 -34.92 12.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.18 0.592 . . . . 73.23 109.853 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.33 -177.43 6.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.207 -0.906 . . . . 52.53 110.392 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -66.91 129.97 41.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.81 -1.086 . . . . 64.3 109.254 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 58.31 17.84 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.669 1.187 . . . . 72.44 113.125 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.18 125.59 72.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 123.603 0.761 . . . . 75.31 109.144 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -123.64 135.23 53.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.815 -0.809 . . . . 72.4 108.815 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.9 tt0 -86.36 111.61 20.66 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.129 -1.804 . . . . 53.1 106.129 161.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -100.37 120.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 108.079 -1.082 . . . . 70.32 108.079 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.582 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 54.4 t -101.64 130.3 51.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.923 -1.035 . . . . 61.22 109.726 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.38 126.02 51.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.463 -1.31 . . . . 75.4 107.463 172.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -112.54 100.9 9.1 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.563 -0.903 . . . . 64.15 108.563 173.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.86 127.97 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.894 -1.15 . . . . 73.24 107.894 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.72 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -116.94 148.48 41.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.467 -0.938 . . . . 64.32 108.467 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.66 131.11 71.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.108 0.963 . . . . 72.42 108.875 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -117.09 95.81 5.16 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.246 -1.39 . . . . 74.35 107.246 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.57 129.44 43.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.061 -0.718 . . . . 53.22 109.061 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.514 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 36.9 m -143.6 137.27 28.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.369 0.604 . . . . 42.52 110.83 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.611 HD12 HG13 ' D' ' 31' ' ' VAL . 38.2 mt -104.16 97.34 7.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.593 1.157 . . . . 72.3 109.077 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.85 -119.79 19.6 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.162 0.914 . . . . 73.42 113.114 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.65 25.17 3.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.443 0.697 . . . . 71.5 111.882 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -141.2 146.57 37.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.54 0.336 . . . . 75.03 110.572 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.9 m -71.78 121.59 19.2 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.89 0.744 . . . . 73.35 109.818 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.514 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -77.7 -59.86 2.61 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.484 -0.932 . . . . 75.23 108.484 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -160.95 163.03 32.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.901 -1.045 . . . . 73.43 110.494 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.48 150.32 41.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.639 -1.245 . . . . 74.32 107.639 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.6 t -157.21 144.0 18.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.788 0.435 . . . . 64.32 110.153 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.05 130.69 9.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.284 0.633 . . . . 62.34 110.253 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.86 118.38 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 71.25 110.006 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -89.87 85.94 6.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.515 0.726 . . . . 73.23 109.358 168.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.29 93.74 5.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.259 -0.882 . . . . 64.45 108.859 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.34 144.08 17.04 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.619 -0.593 . . . . 74.14 111.619 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.59 139.34 9.63 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 112.213 -0.355 . . . . 61.1 112.213 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.9 mt -88.89 122.82 40.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.646 0.778 . . . . 62.44 108.916 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' D' ' 12' ' ' GLN . 59.5 m-85 -130.44 125.84 35.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.301 0.641 . . . . 54.12 110.145 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.0 m -92.71 105.04 17.25 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.73 -1.211 . . . . 63.44 107.73 169.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.68 140.16 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.357 0.663 . . . . 44.44 109.458 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.44 169.42 15.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.756 0.823 . . . . 40.32 110.612 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.64 22.16 77.6 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-N 116.655 -0.248 . . . . 64.11 113.466 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -132.01 161.79 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.493 1.117 . . . . 43.42 109.877 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 149.23 26.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.96 0.504 . . . . 73.14 111.127 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.6 -107.72 0.41 Allowed Glycine 0 C--N 1.35 1.356 0 O-C-N 124.541 1.151 . . . . 32.03 115.552 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -71.84 -42.86 66.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.031 0.933 . . . . 72.24 111.362 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -65.13 -35.06 79.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.012 0.525 . . . . 74.11 110.571 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 40.4 ttm -61.29 -53.56 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.852 -1.067 . . . . 52.41 110.539 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.85 -19.42 61.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.453 0.701 . . . . 54.41 111.748 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.05 -43.92 61.36 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.35 1.06 . . . . 74.02 110.163 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.12 -51.98 6.26 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.965 -0.561 . . . . 63.22 111.141 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.637 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.0 tp -80.51 -30.2 37.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.594 0.358 . . . . 60.25 111.514 -171.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.71 -29.92 41.42 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.821 -0.433 . . . . 71.35 113.554 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.25 -44.37 1.58 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.434 0.617 . . . . 53.21 112.371 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -73.4 -40.96 63.9 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 111.905 0.335 . . . . 74.14 111.905 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 82.8 m -67.23 -43.13 43.45 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-O 118.827 -0.606 . . . . 71.13 112.519 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -65.72 -27.07 52.67 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 121.334 1.356 . . . . 71.21 112.905 166.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -27.42 66.06 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 19.7 mm -67.55 -45.91 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.422 0.689 . . . . 74.21 109.619 169.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.52 -22.36 61.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.732 -0.667 . . . . 74.25 111.961 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.72 -41.14 20.16 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.023 1.119 . . . . 72.32 114.023 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' B' ' 105' ' ' ILE . 72.2 Cg_exo -55.11 -41.94 73.77 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.959 1.772 . . . . 62.24 113.053 169.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.416 ' HD2' ' HB3' ' B' ' 108' ' ' PRO . 69.8 m-85 -71.05 -38.18 72.53 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.419 -0.809 . . . . 71.03 111.021 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.24 -43.7 70.03 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.741 0.816 . . . . 71.32 110.598 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.517 ' NH2' HG23 ' B' ' 105' ' ' ILE . 25.6 ttp180 -57.17 -53.2 60.81 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.781 -1.1 . . . . 64.02 109.72 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.56 -41.27 89.77 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.322 1.014 . . . . 54.03 111.451 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.404 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 37.0 t -57.61 -43.95 85.1 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.567 0.542 . . . . 65.31 110.732 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -66.08 -49.53 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.651 0.78 . . . . 64.42 110.114 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -56.02 -43.92 78.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 73.45 111.744 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.7 t -67.25 -42.06 84.57 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.038 -0.983 . . . . 54.51 110.3 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.1 mtm -66.72 -34.04 76.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.959 0.504 . . . . 60.33 111.46 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.509 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.2 t -62.23 -47.96 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 123.759 0.662 . . . . 70.21 109.736 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.3 p -72.21 -30.87 65.35 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.915 -0.584 . . . . 45.33 111.262 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -69.02 -30.5 68.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.798 0.839 . . . . 61.55 110.237 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.75 12.21 60.0 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.782 0.676 . . . . 44.12 112.982 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 125' ' ' GLN . 30.2 p 59.58 28.69 18.16 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.956 1.702 . . . . 74.53 112.839 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.21 160.35 26.45 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.389 1.076 . . . . 72.4 108.928 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 126.54 16.65 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.719 2.28 . . . . 62.15 112.044 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -50.83 121.81 6.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.315 1.046 . . . . 71.03 111.678 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.16 96.8 6.62 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.573 0.749 . . . . 72.44 110.144 -170.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.94 84.75 2.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.409 1.084 . . . . 72.02 109.975 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.84 157.29 35.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.698 -1.137 . . . . 73.42 111.636 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.64 156.62 88.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.968 0.907 . . . . 43.13 110.593 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.6 ' HD3' HG13 ' B' ' 13' ' ' ILE . 1.0 OUTLIER -80.4 147.36 17.94 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.115 1.876 . . . . 74.13 110.379 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.46 108.11 24.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.699 0.761 . . . . 73.52 109.332 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 . . . . . 0 C--O 1.242 0.68 0 N-CA-C 107.804 -1.184 . . . . 61.2 107.804 175.963 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.633 -0.506 . . . . 73.31 109.633 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -106.25 141.32 37.78 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.587 -0.894 . . . . 71.4 108.587 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 7.4 tp-100 -149.16 139.74 22.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.043 0.537 . . . . 64.23 110.854 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 tp -94.81 127.2 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.803 0.841 . . . . 64.53 109.396 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -103.09 -28.15 12.13 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 118.585 -0.721 . . . . 64.45 111.239 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -178.27 127.62 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.777 0.717 . . . . 74.55 111.154 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 64.2 mt -107.93 133.58 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.557 -0.905 . . . . 73.22 108.557 168.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.761 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 14.4 p90 -170.16 164.66 9.2 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.511 0.724 . . . . 74.21 110.664 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -85.97 117.69 24.98 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.77 -0.826 . . . . 63.32 108.77 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.6 mtpt -80.08 -29.95 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.345 -0.388 . . . . 64.31 110.145 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -153.97 148.12 25.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.54 0.525 . . . . 71.03 109.864 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.6 mt -138.74 145.4 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.969 1.307 . . . . 74.44 107.875 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 t -150.06 139.87 21.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.332 0.653 . . . . 63.23 109.761 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.7 t80 -145.22 112.26 6.01 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.415 -1.698 . . . . 64.25 106.415 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -123.02 109.99 14.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.243 -0.651 . . . . 61.34 109.243 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.28 86.49 9.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.79 -1.189 . . . . 71.24 107.79 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.02 -17.16 19.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.475 2.117 . . . . 72.13 111.343 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.99 31.12 6.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.269 1.027 . . . . 74.15 109.369 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.54 -45.63 98.76 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-N 115.165 -0.925 . . . . 74.42 112.82 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.44 -25.05 48.84 Favored 'Trans proline' 0 C--N 1.398 3.161 0 CA-C-N 121.517 1.577 . . . . 74.41 112.456 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -71.02 -26.32 63.06 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.128 0.571 . . . . 74.22 111.006 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.2 p -65.67 -12.69 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 118.455 0.571 . . . . 74.23 111.904 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.15 -39.29 75.44 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.87 0.468 . . . . 72.43 110.668 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HG3' ' HG2' ' A' ' 34' ' ' LYS . 9.1 pt20 -89.56 -38.71 13.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.308 0.643 . . . . 73.42 110.667 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 2.0 mmmp? -82.73 128.73 34.65 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.049 0.94 . . . . 63.42 109.219 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.03 153.21 32.54 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.127 -0.323 . . . . 75.32 110.127 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.9 t-105 -81.59 78.99 8.27 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.998 0.428 . . . . 64.14 110.654 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -124.64 82.34 59.63 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 107.459 -1.312 . . . . 70.53 107.459 168.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.8 158.58 11.98 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.324 2.016 . . . . 72.02 112.466 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.3 103.38 11.51 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.654 -1.98 . . . . 73.31 105.654 159.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.38 135.28 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 70.21 109.704 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 87.6 tttt -110.89 129.77 55.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.458 0.703 . . . . 52.24 109.114 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 128' ' ' LEU . 20.9 tp -97.2 109.74 22.43 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.149 -1.426 . . . . 74.02 107.149 166.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 25.5 t70 -105.74 139.76 39.83 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.068 -1.086 . . . . 62.01 108.068 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.13 128.08 41.1 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.689 -1.226 . . . . 65.44 107.689 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 28.0 t70 -140.7 159.23 42.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.224 1.01 . . . . 53.44 108.644 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 t -133.95 159.32 41.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.425 0.631 . . . . 73.24 111.063 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -141.51 150.14 41.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.224 1.409 . . . . 53.41 107.727 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -132.15 149.76 52.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.02 -0.363 . . . . 71.03 110.02 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -158.36 118.89 3.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.81 0.844 . . . . 64.12 108.729 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.27 117.09 21.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.327 -0.62 . . . . 74.41 109.327 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.35 -43.29 12.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.86 0.464 . . . . 62.32 110.715 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.82 -174.1 4.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.72 0.808 . . . . 65.13 110.163 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.9 121.5 18.21 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.25 -7.25 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.176 1.79 . . . . 74.35 111.807 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.5 t -104.78 120.67 55.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 124.433 1.093 . . . . 72.11 108.712 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 84' ' ' PHE . 7.8 p90 -135.34 170.51 15.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.218 -1.03 . . . . 72.51 108.218 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -131.23 136.8 48.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.28 -0.637 . . . . 72.3 109.28 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 75.4 t -114.42 121.29 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.62 -0.881 . . . . 62.34 108.62 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.8 t -100.5 125.99 54.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.982 -0.748 . . . . 72.25 108.982 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 114.93 26.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.343 -1.354 . . . . 74.0 107.343 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -92.39 99.56 12.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.633 -1.247 . . . . 61.42 107.633 170.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' HB1' ' A' ' 110' ' ' ALA . 11.9 t -94.62 135.12 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.83 -1.544 . . . . 73.0 106.83 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 31.8 m -134.09 123.34 24.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.538 0.685 . . . . 74.24 110.73 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.1 t -109.18 107.76 23.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.902 1.281 . . . . 65.51 108.779 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -108.23 112.79 25.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.623 -0.88 . . . . 71.31 108.623 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.74 116.85 28.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.417 -1.327 . . . . 63.44 107.417 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -123.31 132.12 53.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.018 0.437 . . . . 74.24 110.867 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 62.0 mt -87.24 84.25 7.26 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.879 1.271 . . . . 71.35 109.217 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -91.02 1.1 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.935 -1.03 . . . . 65.3 111.525 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.38 -29.94 7.6 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.426 0.69 . . . . 60.25 110.681 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.13 133.33 35.44 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.305 0.642 . . . . 74.43 109.673 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -69.85 135.97 50.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.802 0.441 . . . . 64.42 110.954 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -78.4 -56.4 4.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.762 -0.829 . . . . 70.13 108.762 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -164.36 174.62 10.85 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 113.97 -1.468 . . . . 74.31 110.26 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -138.58 116.6 11.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.752 -1.113 . . . . 75.25 108.741 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.625 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.5 m -103.56 139.65 38.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.514 -0.921 . . . . 60.33 108.514 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -146.88 117.88 7.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.616 -0.883 . . . . 75.11 108.616 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.04 113.84 39.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 123.766 0.827 . . . . 72.54 109.413 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 16.0 mp0 -84.6 85.28 7.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.491 -1.232 . . . . 74.32 108.352 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -83.79 92.38 7.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.109 -1.441 . . . . 74.33 107.109 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.87 142.83 18.67 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.409 -0.676 . . . . 75.13 111.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.593 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.32 122.03 2.2 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 110.759 -0.936 . . . . 71.31 110.759 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.4 mt -81.89 125.89 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 107.789 -1.189 . . . . 73.51 107.789 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 26.0 m-85 -128.59 164.58 22.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.36 0.664 . . . . 73.03 109.932 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 20.4 t -120.26 121.23 38.23 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.553 1.141 . . . . 75.43 109.212 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -138.55 150.1 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 123.378 0.671 . . . . 71.34 109.766 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.93 173.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.21 1.404 . . . . 50.34 110.211 167.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.96 88.67 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.952 0.783 . . . . 54.31 113.598 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -117.36 172.34 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.213 1.405 . . . . 73.11 109.427 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.6 tt0 -169.45 -177.63 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.814 0.846 . . . . 75.32 109.238 172.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.488 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.78 -142.81 42.62 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 123.44 0.543 . . . . 70.11 113.808 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -68.91 -18.95 64.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.835 0.854 . . . . 75.32 111.527 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -48.76 53.71 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.071 0.548 . . . . 74.55 109.586 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.43 ' HG3' ' N ' ' A' ' 95' ' ' ALA . 9.2 ptm -69.55 -36.67 76.57 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.691 0.281 . . . . 53.13 110.316 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 94' ' ' MET . . . -71.06 -28.52 64.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.651 0.78 . . . . 60.11 111.221 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.27 -37.75 13.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.38 -0.373 . . . . 73.32 110.942 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.8 t -66.02 -52.98 44.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.905 0.482 . . . . 73.32 110.39 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 tt -76.33 -39.38 54.16 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.605 0.762 . . . . 72.33 109.853 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.99 -24.16 58.24 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.031 0.772 . . . . 60.44 115.031 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -42.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.927 0.864 . . . . 70.4 112.306 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 59.4 t80 -78.73 -36.75 42.84 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 122.966 0.506 . . . . 74.14 112.339 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -72.52 -41.05 7.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-O 118.551 -0.738 . . . . 74.24 111.446 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.88 -21.93 63.69 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 121.485 1.457 . . . . 61.4 113.129 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.07 -37.29 83.76 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 122.795 0.438 . . . . 75.1 109.977 174.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -57.93 -41.8 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 44.5 110.064 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.593 HD21 ' HA3' ' A' ' 82' ' ' GLY . 60.4 mt -80.12 -24.65 40.35 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.486 -1.233 . . . . 70.3 111.651 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.56 -39.49 48.76 Favored Pre-proline 0 CA--C 1.575 1.915 0 N-CA-C 114.782 1.401 . . . . 53.24 114.782 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.17 -40.11 72.64 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 122.273 1.982 . . . . 74.43 112.58 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' C' ' 108' ' ' PRO . 90.8 m-85 -77.13 -32.44 56.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.03 -0.986 . . . . 73.23 110.833 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -68.62 -43.44 76.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 55.54 109.77 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.625 HH12 HD12 ' C' ' 105' ' ' ILE . 36.8 ttm180 -55.32 -54.26 45.85 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.629 1.205 . . . . 74.13 110.054 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.99 -40.58 98.2 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.347 1.029 . . . . 74.33 111.432 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.513 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.1 t -59.82 -37.01 77.96 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.919 0.762 . . . . 54.04 111.023 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.596 HG21 HG21 ' A' ' 64' ' ' VAL . 78.6 mt -72.52 -54.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.638 0.775 . . . . 64.41 110.147 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.468 HG23 ' HG3' ' A' ' 125' ' ' GLN . 98.6 m -52.13 -37.04 53.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.797 1.639 . . . . 70.2 111.607 -174.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.09 -45.65 59.82 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.073 -0.967 . . . . 60.24 110.629 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.4 mtm -59.56 -41.47 90.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.107 0.48 . . . . 73.14 110.899 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.97 -46.97 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.828 1.251 . . . . 73.13 110.848 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -72.15 -30.66 65.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.699 0.4 . . . . 55.24 111.353 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.0 -26.94 63.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 70.31 110.418 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 7.77 57.72 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.897 -0.592 . . . . 73.05 113.342 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.7 m 66.98 30.85 7.34 Favored 'General case' 0 C--N 1.364 1.236 0 C-N-CA 124.671 1.188 . . . . 51.31 110.455 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -107.92 139.31 20.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.058 -1.089 . . . . 73.1 108.058 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 140.21 61.73 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.559 2.173 . . . . 63.41 112.609 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.468 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.0 tt0 -53.07 140.96 23.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.58 1.152 . . . . 62.15 112.163 -176.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.0 109.59 10.63 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.91 -1.145 . . . . 75.22 107.91 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -103.84 104.89 14.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.603 0.761 . . . . 70.44 108.96 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 42' ' ' LEU . 66.3 mt -72.48 116.95 13.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.294 -0.632 . . . . 70.02 109.294 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.66 149.27 52.8 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.522 1.129 . . . . 61.3 111.922 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HG3' HH22 ' A' ' 111' ' ' ARG . 5.4 Cg_exo -71.01 -176.75 1.95 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.573 2.182 . . . . 73.23 112.435 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -133.26 126.22 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.598 -0.89 . . . . 61.41 108.598 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -80.27 74.49 7.1 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.78 -0.822 . . . . 61.11 108.78 173.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 123.674 0.79 . . . . 75.51 111.714 -174.671 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 108.824 -0.806 . . . . 75.43 108.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.406 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 67.8 t80 -128.82 150.6 50.25 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.284 0.564 . . . . 75.41 111.899 -166.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 33.4 tp60 -142.54 123.63 14.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.054 1.342 . . . . 71.23 108.184 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.14 143.83 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.134 0.573 . . . . 75.33 109.984 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -116.94 -51.61 2.55 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.776 0.43 . . . . 74.32 110.841 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -162.53 143.65 10.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.405 0.282 . . . . 73.02 110.256 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -115.29 143.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.381 -1.34 . . . . 63.32 107.381 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -170.71 144.08 2.25 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.565 0.62 . . . . 70.3 111.716 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.3 m -75.25 121.72 22.59 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.976 -0.75 . . . . 70.14 108.976 172.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -88.73 -37.96 15.09 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.12 0.568 . . . . 75.41 110.312 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.6 t70 -152.89 144.08 23.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.283 -0.417 . . . . 72.5 112.071 -168.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -137.99 147.34 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.472 1.509 . . . . 65.55 108.492 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -150.58 150.69 31.52 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 73.23 108.78 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.9 t80 -160.19 114.7 2.24 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 106.625 -1.621 . . . . 72.31 106.625 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.78 113.91 20.34 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.607 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.96 89.23 4.24 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.649 -0.871 . . . . 64.34 108.649 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.46 -27.11 33.85 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.409 2.073 . . . . 74.44 112.035 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -123.3 30.59 6.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.372 1.069 . . . . 74.21 109.661 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.761 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -42.47 -52.07 10.74 Favored Pre-proline 0 CA--C 1.568 1.659 0 C-N-CA 125.525 1.53 . . . . 62.43 114.431 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.4 Cg_exo -72.16 -17.61 27.8 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.359 2.04 . . . . 72.1 112.802 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.43 2.97 56.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.491 1.116 . . . . 73.23 111.244 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.02 -27.95 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.807 0.443 . . . . 74.23 111.327 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -64.74 -41.03 96.23 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.247 0.619 . . . . 74.42 109.996 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -65.0 -29.6 70.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.562 1.145 . . . . 72.0 110.799 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' B' ' 68' ' ' LEU . 33.0 mmtp -108.85 96.72 6.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.317 1.047 . . . . 72.42 110.637 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.37 78.02 7.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.048 0.539 . . . . 74.54 111.287 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.6 170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.238 1.015 . . . . 64.2 109.727 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.539 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 48.9 tt0 -67.29 119.04 62.03 Favored Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 123.789 0.681 . . . . 65.15 109.653 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' 37' ' ' GLN . 12.3 Cg_endo -56.53 140.58 89.85 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.129 1.886 . . . . 62.43 110.842 167.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 36.3 mt-10 -67.04 100.45 0.75 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.708 -0.849 . . . . 73.51 108.708 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.09 120.84 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.758 -1.571 . . . . 65.41 106.758 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -144.08 126.68 16.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.577 -0.898 . . . . 75.33 108.577 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.5 HD13 HD11 ' B' ' 126' ' ' LEU . 1.8 pt? -129.29 159.02 37.45 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.982 0.513 . . . . 73.53 111.125 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -143.45 150.38 38.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.251 0.62 . . . . 74.11 110.77 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.13 144.03 29.29 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.726 1.21 . . . . 72.04 110.729 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.91 146.04 21.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 75.21 107.787 167.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.3 m -145.78 139.71 26.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.108 0.563 . . . . 73.42 110.004 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.31 134.76 18.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.101 0.96 . . . . 71.31 108.848 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -132.62 166.09 22.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.326 0.65 . . . . 53.44 110.343 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.1 p -153.09 137.19 16.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.645 0.778 . . . . 75.12 109.454 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -80.85 120.38 24.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.331 0.652 . . . . 75.44 110.539 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' B' ' 57' ' ' GLU . 38.4 mt -82.23 -50.03 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.754 0.822 . . . . 64.51 109.995 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.54 -171.11 3.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.272 1.029 . . . . 72.3 110.174 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.58 113.06 3.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.448 0.699 . . . . 61.12 110.56 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.4 m-20 71.06 -5.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.021 1.728 . . . . 45.12 112.694 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.68 116.62 46.72 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 108.15 -1.056 . . . . 53.31 108.15 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 155.33 50.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.172 -0.677 . . . . 75.25 109.172 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' B' ' 51' ' ' LEU . 6.9 tm-20 -111.68 112.28 23.87 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.342 -1.355 . . . . 75.42 107.342 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.95 127.21 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.964 0.905 . . . . 63.43 110.031 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -108.36 128.22 64.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.714 0.805 . . . . 70.42 109.282 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.44 109.11 20.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.794 -1.188 . . . . 74.22 107.794 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -93.41 119.25 32.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.838 0.455 . . . . 72.33 110.489 170.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.492 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.6 t -113.1 105.69 19.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.658 -1.238 . . . . 51.52 107.658 167.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -99.18 133.26 43.73 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.459 -0.571 . . . . 63.43 109.459 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.666 HG21 HG21 ' B' ' 114' ' ' ILE . 21.7 t -119.62 126.92 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.261 1.425 . . . . 63.51 109.069 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -114.72 149.13 37.31 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.426 1.09 . . . . 54.13 108.27 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.33 153.01 50.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.136 0.575 . . . . 63.13 109.736 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 33.5 p -146.13 141.23 27.31 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.606 0.566 . . . . 72.51 111.152 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' B' ' 34' ' ' LYS . 22.2 mt -130.17 99.82 5.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.253 1.421 . . . . 44.24 108.68 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -109.15 2.78 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.339 -0.391 . . . . 55.3 112.411 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -118.09 23.6 11.52 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.387 1.075 . . . . 74.22 110.555 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.86 160.72 42.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.116 0.566 . . . . 73.21 110.301 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -72.61 134.25 45.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.763 -0.653 . . . . 65.11 110.249 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.11 -58.07 2.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 50.2 109.271 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -153.19 173.54 15.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.787 -1.097 . . . . 63.31 109.779 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 73.2 mt -138.89 155.85 47.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.251 1.821 . . . . 71.11 106.473 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.565 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.4 t -160.49 159.59 30.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.81 0.844 . . . . 73.41 108.817 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.21 140.52 6.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.505 -0.924 . . . . 72.4 108.505 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.82 142.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.932 -1.136 . . . . 73.22 107.932 171.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -124.98 87.76 2.77 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.207 -1.035 . . . . 73.14 108.207 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -81.94 100.87 9.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.455 -1.248 . . . . 71.33 109.129 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.43 175.22 35.8 Favored Glycine 0 C--O 1.241 0.534 0 N-CA-C 111.954 -0.458 . . . . 73.53 111.954 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.97 137.16 3.73 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.932 -0.467 . . . . 64.44 111.932 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 127.01 40.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.775 -0.824 . . . . 62.01 108.775 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -138.64 161.24 37.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.405 1.082 . . . . 64.3 109.581 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.0 m -132.39 133.6 44.13 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.777 1.231 . . . . 61.41 108.982 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.57 HG21 ' SG ' ' B' ' 97' ' ' CYS . 2.7 pp -139.18 147.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 122.876 0.47 . . . . 70.32 111.868 -171.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.92 170.58 16.32 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.986 0.915 . . . . 75.15 109.749 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.12 16.31 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.426 -0.352 . . . . 65.22 113.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.14 142.54 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.385 1.074 . . . . 51.34 112.848 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.716 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 14.1 pt-20 -160.73 142.07 12.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.324 1.05 . . . . 65.5 109.026 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.08 -106.15 0.76 Allowed Glycine 0 C--N 1.354 1.564 0 C-N-CA 123.081 0.372 . . . . 34.11 113.928 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.2 m -77.21 -30.27 54.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.768 1.227 . . . . 43.43 111.796 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.716 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 1.5 mp0 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.421 0.689 . . . . 73.41 110.793 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 41.9 mtp -70.44 -39.79 74.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.607 0.763 . . . . 62.31 110.057 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.53 64.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 71.2 111.397 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.52 -39.23 92.88 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.334 0.654 . . . . 74.32 110.934 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.57 ' SG ' HG21 ' B' ' 86' ' ' ILE . 44.9 t -61.12 -61.56 2.48 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.109 -0.95 . . . . 73.35 111.635 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.77 -18.4 25.0 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.575 0.583 . . . . 71.2 112.575 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.68 -26.72 11.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.232 0.333 . . . . 75.1 113.673 -173.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -55.96 1.86 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.371 0.508 . . . . 54.32 112.371 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -73.76 -60.06 2.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.524 0.33 . . . . 73.34 110.793 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.406 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 85.8 m -58.49 -46.18 99.63 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.196 -0.907 . . . . 71.44 112.225 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.9 -36.52 96.78 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.039 1.826 . . . . 64.4 113.759 172.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -66.87 -29.83 69.84 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 118.625 0.648 . . . . 74.02 110.849 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -63.04 -50.25 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.03 0.532 . . . . 75.14 109.877 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -79.34 -10.42 59.81 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.162 -1.381 . . . . 64.2 111.883 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.44 ' HE1' HD13 ' B' ' 128' ' ' LEU . 24.1 t80 -65.55 -49.67 60.77 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.654 1.181 . . . . 75.54 113.109 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 112' ' ' GLU . 25.1 Cg_exo -62.31 -35.72 71.8 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 121.494 1.463 . . . . 73.42 111.353 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.475 ' HE2' HG21 ' D' ' 115' ' ' THR . 72.9 m-85 -64.17 -48.6 75.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.069 0.947 . . . . 74.14 110.793 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.08 74.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.127 0.971 . . . . 61.42 110.734 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -67.46 -43.31 81.36 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.95 0.781 . . . . 74.35 110.381 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 108' ' ' PRO . 0.4 OUTLIER -69.26 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.131 0.972 . . . . 74.42 111.609 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.7 t -74.16 -39.05 63.5 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.8 -0.445 . . . . 71.42 109.8 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 64' ' ' VAL . 94.2 mt -62.82 -46.76 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.604 0.762 . . . . 64.55 110.078 173.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.429 HG23 ' OE1' ' C' ' 125' ' ' GLN . 44.1 m -50.41 -39.52 47.45 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.958 1.303 . . . . 75.41 110.701 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.8 t -66.34 -56.15 12.51 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 113.957 -1.474 . . . . 72.34 110.552 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.7 mmt -64.26 -38.13 89.95 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.659 0.615 . . . . 73.54 112.659 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.28 -46.41 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.421 1.088 . . . . 74.32 110.409 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.568 ' HB3' ' NE2' ' C' ' 125' ' ' GLN . 81.9 p -71.71 -25.28 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.568 -0.742 . . . . 60.32 111.465 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.513 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.1 mtt-85 -65.47 -39.44 91.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.158 0.583 . . . . 73.21 110.091 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.11 3.85 50.06 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.631 -0.713 . . . . 61.2 113.15 172.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p 59.72 48.98 8.65 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 126.512 1.925 . . . . 75.42 111.27 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -115.69 161.61 29.5 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-N 113.867 -1.515 . . . . 74.32 110.585 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.539 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 89.0 Cg_exo -53.2 177.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 125.031 3.82 . . . . 74.41 118.509 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.65 147.48 52.9 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 113.824 -1.534 . . . . 74.42 113.688 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.5 HD11 HD13 ' B' ' 42' ' ' LEU . 3.5 tm? -149.97 106.73 3.54 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.166 -1.379 . . . . 71.31 107.626 173.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -137.72 118.82 14.43 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.679 -1.23 . . . . 53.53 107.679 163.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.447 HD23 ' N ' ' B' ' 129' ' ' ALA . 2.2 tt -79.91 135.3 36.39 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.241 -0.652 . . . . 64.12 109.241 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.447 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -57.19 141.95 76.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.406 1.482 . . . . 70.31 113.078 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' D' ' 16' ' ' ILE . 61.4 Cg_endo -71.97 99.26 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.673 2.249 . . . . 73.14 111.818 171.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.28 105.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 109.24 -0.652 . . . . 50.25 109.24 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.406 ' ND2' HD13 ' D' ' 13' ' ' ILE . 45.8 t30 -70.1 117.66 11.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.391 0.677 . . . . 72.35 110.719 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 19.2 p90 . . . . . 0 CA--C 1.555 1.173 0 C-N-CA 123.574 0.75 . . . . 73.22 112.911 177.793 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 89.0 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.404 -0.591 . . . . 71.44 109.404 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -107.83 163.74 12.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.635 1.174 . . . . 73.13 111.317 -169.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.023 0.929 . . . . 70.03 109.213 161.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.548 HD11 HG13 ' C' ' 16' ' ' ILE . 5.5 tp -78.55 133.62 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.03 -0.73 . . . . 72.21 109.03 167.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -103.7 -47.93 4.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.552 0.741 . . . . 42.11 110.388 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -169.65 134.31 1.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.637 -0.256 . . . . 64.55 110.435 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.548 HG13 HD11 ' C' ' 13' ' ' ILE . 92.3 mt -122.34 135.25 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.451 -0.944 . . . . 75.33 108.451 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.693 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 10.3 p90 -171.63 157.1 4.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.244 0.545 . . . . 70.2 111.821 -172.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -82.02 118.43 22.99 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.289 -0.869 . . . . 51.41 109.813 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -69.76 -45.96 66.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.661 0.743 . . . . 71.11 109.216 172.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -146.29 146.41 30.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 113.882 -1.508 . . . . 65.3 108.956 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.3 mt -138.99 140.16 39.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.99 -1.485 . . . . 72.33 106.99 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -152.52 148.63 27.61 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.273 0.558 . . . . 45.21 110.213 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -154.36 107.83 2.91 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.376 -1.342 . . . . 73.0 107.376 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.43 112.09 20.19 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.415 -0.958 . . . . 74.53 108.415 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.22 95.93 32.74 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.403 1.081 . . . . 75.25 109.355 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.5 -39.88 33.85 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.793 2.328 . . . . 73.5 111.977 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -96.25 29.4 2.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.931 -1.031 . . . . 75.55 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.43 -48.34 97.13 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.684 -0.674 . . . . 51.45 112.412 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.58 -31.14 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 121.455 1.437 . . . . 63.23 113.387 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -71.13 -25.11 62.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.383 0.673 . . . . 70.03 112.415 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.93 -22.08 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.531 0.732 . . . . 72.1 111.546 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.44 -36.81 71.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.269 1.027 . . . . 65.4 111.12 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.86 45.94 1.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.996 0.903 . . . . 71.41 109.012 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.854 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -123.49 155.1 38.17 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.931 0.892 . . . . 70.42 110.859 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.41 115.38 8.61 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.363 -0.977 . . . . 71.33 108.363 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -80.46 71.18 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.092 0.957 . . . . 71.43 111.887 -173.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' C' ' 68' ' ' LEU . 25.8 tt0 -122.66 78.18 47.7 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.897 0.879 . . . . 75.31 109.821 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.06 128.58 15.02 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.262 1.975 . . . . 74.32 111.152 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -87.7 107.36 18.6 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 70.23 106.785 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.31 113.65 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 124.113 0.883 . . . . 75.12 109.913 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.07 115.43 23.09 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.457 -1.312 . . . . 73.4 107.457 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.51 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.7 pt? -110.47 143.97 39.99 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.341 -0.985 . . . . 71.24 108.341 169.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.26 144.08 26.28 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.968 -0.752 . . . . 63.3 108.968 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.417 HD11 HD22 ' C' ' 60' ' ' LEU . 42.8 tp -113.89 123.94 51.0 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.588 0.555 . . . . 71.42 109.948 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -113.07 145.04 41.59 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.883 -1.525 . . . . 64.4 106.883 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -125.15 154.58 41.27 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.059 0.544 . . . . 64.13 110.001 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.6 161.51 39.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.499 1.119 . . . . 64.04 108.605 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.3 p -158.88 152.75 23.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.88 0.472 . . . . 54.2 110.978 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -156.84 130.28 8.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.721 0.808 . . . . 72.53 109.937 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -74.76 121.5 21.84 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.086 -0.709 . . . . 75.1 109.086 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' C' ' 57' ' ' GLU . 39.6 mt -94.98 -50.38 5.13 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.62 0.724 . . . . 74.42 110.864 -173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -149.3 -172.19 4.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.749 -1.114 . . . . 74.25 109.945 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -69.96 113.89 7.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.852 0.461 . . . . 74.42 109.769 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 70.66 -0.38 2.97 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.674 1.589 . . . . 73.54 112.303 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 61.2 t -109.92 122.1 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 60.42 108.483 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -134.66 176.58 8.51 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.679 0.752 . . . . 72.51 109.711 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.701 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.7 tt0 -125.39 141.41 52.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.444 -1.253 . . . . 72.11 108.159 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.85 140.18 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.09 -1.078 . . . . 75.12 108.09 164.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.2 t -126.38 116.5 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.99 0.916 . . . . 74.53 109.465 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.417 HD22 HD11 ' C' ' 44' ' ' LEU . 15.2 mt -87.8 104.88 16.99 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 122.761 0.424 . . . . 63.53 110.261 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -86.81 101.46 13.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.107 -1.071 . . . . 74.44 108.107 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.1 t -99.84 132.0 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.645 -1.243 . . . . 62.24 107.645 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -122.92 123.12 40.23 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.502 -0.555 . . . . 73.42 109.502 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.643 HG21 HG21 ' C' ' 114' ' ' ILE . 92.7 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.369 1.067 . . . . 73.33 108.858 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -98.57 139.46 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.004 -1.11 . . . . 74.23 108.004 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.43 114.21 8.04 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.633 -0.877 . . . . 70.41 108.633 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.8 m -123.73 135.35 53.8 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.941 0.497 . . . . 70.42 111.015 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.854 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.3 mt -85.53 55.17 3.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.032 1.333 . . . . 75.55 109.148 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -110.18 3.81 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.943 -1.263 . . . . 74.55 109.943 -172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.7 -23.72 17.45 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.876 . . . . 73.14 110.244 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -91.47 108.63 20.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.4 1.08 . . . . 72.03 110.027 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 59.0 m -70.19 122.65 19.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.304 0.642 . . . . 70.13 112.43 -171.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.643 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -67.77 -58.47 4.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.607 1.163 . . . . 51.11 110.254 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -154.53 176.2 12.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.587 -1.188 . . . . 71.01 111.05 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.79 109.75 5.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.578 -1.638 . . . . 75.33 106.578 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.516 ' SG ' HG23 ' C' ' 114' ' ' ILE . 43.6 t -107.45 146.25 31.97 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.528 -0.916 . . . . 74.52 108.528 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -158.24 129.77 6.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.807 -0.442 . . . . 71.21 109.807 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.24 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.309 1.044 . . . . 73.14 108.592 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.4 mt-30 -114.5 98.68 7.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 63.5 108.753 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -91.33 105.24 17.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.938 0.895 . . . . 75.15 110.26 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.78 151.45 22.33 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.311 0.382 . . . . 52.51 112.274 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.54 121.34 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.448 -0.661 . . . . 75.0 111.448 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.429 HD11 ' HB3' ' D' ' 29' ' ' PRO . 23.9 mm -82.69 127.8 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.747 -0.834 . . . . 75.12 108.747 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -136.23 126.03 25.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.335 0.654 . . . . 74.12 110.051 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.1 p -101.43 106.54 17.69 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.662 -0.866 . . . . 75.01 108.662 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.425 HD12 ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER -148.42 143.94 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.622 0.725 . . . . 72.22 111.369 -177.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.62 179.38 7.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.293 1.437 . . . . 54.24 109.716 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.72 52.74 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 114.618 0.607 . . . . 64.03 114.618 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 123.331 0.653 . . . . 70.22 111.865 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.722 -0.473 . . . . 73.23 109.722 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.8 ttm -63.89 -47.31 81.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 65.31 111.053 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.295 -0.866 . . . . 74.24 110.854 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -74.68 -24.91 58.86 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.98 -0.554 . . . . 74.23 111.731 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' C' ' 86' ' ' ILE . 42.7 t -72.06 -62.71 1.33 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.84 0.456 . . . . 74.43 111.503 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 -6.86 24.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.764 -0.585 . . . . 70.02 112.433 -176.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.64 2.61 49.3 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.669 -0.517 . . . . 70.31 113.286 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.56 -58.55 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.267 0.533 . . . . 75.31 111.858 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -65.4 -67.9 0.4 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.36 1.064 . . . . 74.44 112.212 -168.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -57.84 -43.98 99.05 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.299 1.039 . . . . 54.35 112.813 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.35 -34.18 55.89 Favored 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 121.638 1.559 . . . . 75.14 113.575 170.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -72.0 -19.14 61.91 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 118.76 0.709 . . . . 73.1 110.866 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.625 HD12 HH12 ' A' ' 111' ' ' ARG . 40.5 mm -66.08 -41.75 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.515 0.726 . . . . 73.44 109.551 167.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.53 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.1 mt -79.13 -28.1 42.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.26 -0.882 . . . . 62.33 112.053 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -53.74 -45.97 98.56 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.364 -1.303 . . . . 73.14 113.271 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.418 ' HG3' ' CD2' ' A' ' 109' ' ' TYR . 47.4 Cg_exo -53.96 -40.54 80.56 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 122.329 2.019 . . . . 72.11 113.274 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -69.21 -43.57 73.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.445 0.698 . . . . 53.22 110.651 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.82 98.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 71.33 110.718 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -57.94 -48.54 79.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.81 1.644 . . . . 73.54 110.751 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.434 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -72.35 -33.94 67.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.771 0.828 . . . . 65.42 110.541 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -65.03 -43.34 92.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.71 0.804 . . . . 54.33 110.466 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.643 HG21 HG21 ' C' ' 64' ' ' VAL . 87.9 mt -66.52 -50.03 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.212 0.605 . . . . 62.33 110.23 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.467 HG23 ' HB2' ' C' ' 125' ' ' GLN . 58.8 m -50.15 -44.28 52.5 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 124.555 1.16 . . . . 75.31 111.055 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.4 t -68.77 -46.82 67.76 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.484 -1.234 . . . . 75.4 110.012 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.602 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.75 -43.89 63.1 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.013 0.925 . . . . 63.54 112.229 178.158 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.1 t -66.1 -45.38 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.489 0.716 . . . . 63.54 110.668 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -70.47 -26.51 63.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.926 -0.579 . . . . 62.02 111.229 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.3 mtt-85 -65.99 -38.59 88.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.784 0.833 . . . . 74.23 110.413 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.69 3.7 63.09 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.755 -0.657 . . . . 54.11 112.826 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.5 p 63.32 33.42 14.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.349 1.86 . . . . 61.45 112.152 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.43 168.09 9.02 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.721 1.208 . . . . 71.12 109.609 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.48 106.51 0.6 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 122.386 2.058 . . . . 73.23 110.984 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' B' ' 119' ' ' SER . 18.7 pt20 -54.45 135.53 45.4 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.04 . . . . 72.22 111.842 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.01 89.67 3.71 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.402 0.62 . . . . 63.15 109.969 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -111.5 86.42 2.33 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.603 -1.629 . . . . 61.41 106.603 167.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 76.4 mt -87.52 153.8 21.13 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.261 -1.336 . . . . 73.24 109.985 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.25 127.84 5.85 Favored Pre-proline 0 CA--C 1.556 1.193 0 O-C-N 124.599 1.187 . . . . 52.01 112.817 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 37.0 Cg_endo -61.08 104.16 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.558 2.839 . . . . 61.03 113.054 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.68 91.66 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-O 121.955 0.883 . . . . 64.41 111.076 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -88.54 102.39 14.88 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.241 -1.022 . . . . 71.24 108.241 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 64.8 t80 . . . . . 0 CA--C 1.547 0.865 0 C-N-CA 123.877 0.871 . . . . 74.5 112.325 -173.509 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.779 -0.823 . . . . 73.42 108.779 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -156.57 111.1 2.78 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.691 -1.226 . . . . 63.44 107.691 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.473 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 79.2 mt-30 -117.66 116.63 27.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.565 0.746 . . . . 71.14 110.312 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.406 HD13 ' ND2' ' B' ' 132' ' ' ASN . 1.7 mp -75.91 104.87 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.928 -1.508 . . . . 61.23 106.928 168.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.466 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 76.3 mt-30 -80.79 -41.9 22.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 119.106 -0.473 . . . . 75.13 110.759 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 177.96 144.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.686 0.616 . . . . 75.23 111.722 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.551 ' H ' ' HG3' ' B' ' 130' ' ' PRO . 2.0 mp -105.48 132.14 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 107.316 -1.364 . . . . 72.35 107.316 170.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -158.28 159.8 36.35 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.321 1.049 . . . . 74.53 109.628 -174.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -92.37 118.13 30.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 72.14 109.812 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -89.07 -32.75 17.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.758 -0.655 . . . . 72.43 109.827 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.8 t70 -146.06 134.02 21.4 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.118 -0.946 . . . . 63.43 108.902 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.602 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.3 mt -130.44 140.49 48.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.578 -1.268 . . . . 60.34 107.578 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -142.19 136.15 29.65 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.101 0.96 . . . . 73.34 108.837 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -144.31 119.83 10.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.558 -2.016 . . . . 72.43 105.558 166.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.69 134.29 54.96 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 108.973 -0.751 . . . . 72.42 108.973 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.53 82.22 47.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.758 -1.571 . . . . 74.31 106.758 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -65.91 -30.22 48.9 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.61 2.207 . . . . 71.44 112.043 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.7 24.9 12.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.726 -1.125 . . . . 52.54 109.898 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.693 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -41.22 -60.97 1.49 Allowed Pre-proline 0 CA--C 1.584 2.253 0 N-CA-C 116.018 1.859 . . . . 73.01 116.018 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.429 ' HB3' HD11 ' C' ' 83' ' ' ILE . 94.4 Cg_endo -79.6 -17.06 11.43 Favored 'Trans proline' 0 C--N 1.399 3.214 0 CA-C-N 122.923 2.08 . . . . 74.34 113.293 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -73.41 -39.22 65.23 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.989 1.316 . . . . 73.44 110.295 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.5 p -86.24 -7.86 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 124.296 1.038 . . . . 74.31 111.156 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.52 -25.34 59.71 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.363 1.065 . . . . 74.31 111.176 169.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.54 -14.21 62.85 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.232 1.013 . . . . 51.41 112.259 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.428 ' HB3' HD22 ' D' ' 68' ' ' LEU . 0.1 OUTLIER -96.92 106.28 18.57 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.854 0.862 . . . . 51.21 109.394 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.7 50.08 0.89 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.579 1.152 . . . . 74.11 110.604 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -146.59 177.51 9.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 75.42 110.509 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -62.05 113.98 10.16 Favored Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.058 0.943 . . . . 74.22 111.345 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HG3' HD21 ' D' ' 68' ' ' LEU . 15.4 Cg_exo -71.31 144.84 46.94 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.024 2.483 . . . . 55.14 113.037 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.87 142.69 47.94 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.489 -0.778 . . . . 73.13 109.053 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.523 HG13 HG13 ' D' ' 64' ' ' VAL . 95.7 t -124.95 118.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.21 108.385 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -112.67 118.26 34.55 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.24 -0.652 . . . . 64.13 109.24 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.642 HD21 HD22 ' D' ' 128' ' ' LEU . 5.7 mp -96.88 125.45 41.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.475 0.71 . . . . 75.32 109.696 -174.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.811 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.1 m-20 -107.06 126.86 52.9 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.459 -0.941 . . . . 73.01 108.459 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.58 132.23 40.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.258 0.623 . . . . 75.32 109.89 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.1 t70 -157.62 156.18 31.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 170.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -136.51 165.89 24.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.6 0.76 . . . . 63.42 109.794 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.99 177.57 10.03 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.889 1.275 . . . . 71.3 108.473 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -165.36 166.63 18.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.847 0.459 . . . . 73.43 111.249 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.6 p -154.24 131.69 11.28 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.292 1.037 . . . . 71.31 108.328 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.4 117.85 20.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.941 -0.762 . . . . 71.42 108.941 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.3 mt -92.27 -33.4 14.66 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.708 -0.478 . . . . 65.15 109.708 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.39 -177.04 5.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.538 0.735 . . . . 73.4 111.064 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -65.92 124.55 22.8 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.02 -0.991 . . . . 65.22 109.005 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 16.6 m-20 65.7 19.27 11.38 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.183 0.993 . . . . 64.34 111.821 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.24 119.93 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.735 0.814 . . . . 64.51 109.643 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -134.03 130.84 38.12 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.023 0.929 . . . . 71.12 108.668 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.424 ' HB2' HD11 ' D' ' 51' ' ' LEU . 4.2 tt0 -86.78 119.6 27.18 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.512 -1.292 . . . . 74.35 107.512 169.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -100.16 129.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.635 -1.246 . . . . 73.1 107.635 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.3 t -104.79 138.66 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 54.32 108.944 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -106.4 124.32 49.41 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.43 -1.322 . . . . 74.31 107.43 174.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.7 ttm-85 -99.5 98.99 9.82 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.544 -1.28 . . . . 72.11 107.544 173.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.611 HG21 ' HB1' ' D' ' 110' ' ' ALA . 9.3 t -100.51 112.72 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.397 -0.964 . . . . 75.24 108.397 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -114.5 145.76 41.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.791 -0.448 . . . . 72.32 109.791 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.523 HG13 HG13 ' D' ' 40' ' ' VAL . 39.3 t -133.95 105.17 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.889 1.276 . . . . 60.22 109.101 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -98.07 96.47 8.15 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.085 -1.08 . . . . 70.25 108.085 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.98 147.71 24.22 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.972 0.509 . . . . 44.12 110.131 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -137.23 133.49 35.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.346 0.593 . . . . 74.14 111.939 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.444 HD21 ' HG3' ' D' ' 38' ' ' PRO . 9.4 mt -119.69 108.87 14.97 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.008 1.323 . . . . 75.01 108.402 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.2 -118.41 4.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.724 -0.551 . . . . 75.01 111.724 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.75 4.72 15.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.534 0.734 . . . . 72.2 110.707 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -122.48 171.75 8.86 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.484 0.714 . . . . 71.45 110.549 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.8 m -68.18 123.76 21.6 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.938 -1.028 . . . . 73.12 110.734 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.751 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -73.35 -65.41 0.82 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.422 -0.955 . . . . 73.21 108.422 170.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -156.76 157.05 34.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.843 -1.072 . . . . 64.45 109.83 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.05 152.11 29.91 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.124 1.37 . . . . 70.34 108.608 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 39.3 t -157.85 143.39 17.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.487 0.715 . . . . 73.44 109.092 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.23 128.99 7.82 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.557 -0.535 . . . . 64.45 109.557 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.18 115.29 42.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.013 -0.736 . . . . 70.21 109.013 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.69 85.63 6.83 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.189 0.995 . . . . 41.33 108.627 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.461 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -80.04 96.9 6.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 113.324 -1.762 . . . . 75.2 108.241 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -97.72 144.14 17.11 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 112.061 -0.416 . . . . 70.55 112.061 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.61 137.64 7.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.366 -0.694 . . . . 50.13 111.366 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 62.0 mt -88.08 125.45 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.901 -0.777 . . . . 73.43 108.901 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -130.79 123.87 30.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.643 0.777 . . . . 74.55 109.62 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 66.5 m -80.77 106.23 12.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.611 -0.885 . . . . 62.03 108.611 170.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -108.23 103.55 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.998 0.904 . . . . 74.25 110.007 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -140.96 150.92 43.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.985 0.914 . . . . 71.54 109.711 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.6 14.83 75.22 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.093 0.246 . . . . 74.12 113.192 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.667 HD12 ' HG2' ' D' ' 94' ' ' MET . 24.7 pt -98.59 125.63 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.365 1.066 . . . . 65.11 108.708 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -140.67 172.83 12.15 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.228 0.537 . . . . 64.13 112.01 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.23 -143.9 47.92 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.31 -1.314 . . . . 74.34 113.684 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -85.32 -20.21 30.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.106 0.962 . . . . 62.4 110.724 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.82 -35.87 79.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.472 0.709 . . . . 63.44 110.627 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.667 ' HG2' HD12 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -58.33 -49.26 77.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.527 0.731 . . . . 71.35 110.69 175.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.01 94.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.309 -0.86 . . . . 71.33 111.047 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.25 -30.88 66.85 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.64 -0.709 . . . . 64.14 111.261 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.67 -48.35 64.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.822 0.449 . . . . 73.11 110.411 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.57 -36.5 65.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.141 0.576 . . . . 54.11 110.212 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.55 6.5 77.63 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.221 -0.766 . . . . 72.45 114.785 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.75 -57.92 0.14 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.364 1.082 . . . . 55.23 112.341 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -64.75 -51.7 60.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.183 0.593 . . . . 72.11 111.49 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.524 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 27.9 m -60.73 -47.93 94.5 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 118.498 -0.763 . . . . 75.44 111.357 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.2 Cg_exo -59.29 -31.38 94.98 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.418 2.078 . . . . 65.3 113.968 168.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.7 -31.29 70.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.861 0.465 . . . . 73.4 110.706 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.3 -33.82 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.505 0.722 . . . . 64.3 110.281 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.526 HD23 HG13 ' D' ' 16' ' ' ILE . 86.0 mt -76.95 -25.61 53.05 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.049 0.939 . . . . 73.4 111.731 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -63.74 -41.99 68.51 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 114.94 1.459 . . . . 64.1 114.94 -168.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.53 -41.85 71.71 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.106 1.87 . . . . 62.35 113.234 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.15 -30.74 38.95 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.134 -0.939 . . . . 65.3 110.365 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.611 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -63.89 -44.91 91.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.722 0.809 . . . . 72.42 110.179 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.0 -51.29 70.28 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 124.629 1.206 . . . . 64.44 110.515 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.2 -41.92 99.23 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.143 0.902 . . . . 73.43 110.559 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -56.51 -45.21 81.2 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 123.808 0.693 . . . . 63.04 110.356 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' D' ' 76' ' ' CYS . 77.4 mt -63.9 -54.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.024 0.828 . . . . 74.52 110.375 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.475 HG21 ' HE2' ' B' ' 109' ' ' TYR . 86.8 m -51.38 -46.74 62.89 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.152 1.381 . . . . 75.12 111.893 -171.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -65.53 -44.5 86.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.6 -1.182 . . . . 62.41 110.271 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.7 mtm -65.74 -32.71 74.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.03 0.532 . . . . 71.32 111.692 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -63.93 -48.26 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.77 0.828 . . . . 55.23 109.982 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -72.25 -28.63 63.27 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.983 -0.553 . . . . 64.1 110.937 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -69.81 -34.23 73.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.624 0.77 . . . . 74.44 110.041 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 8.65 64.16 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.982 -0.554 . . . . 64.32 113.001 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.8 p 61.27 30.62 19.26 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.956 1.702 . . . . 74.31 113.119 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 74.2 m-85 -100.9 163.43 18.05 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 124.708 1.203 . . . . 71.11 108.697 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 73.1 Cg_endo -71.12 143.21 43.78 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.212 1.942 . . . . 71.31 111.55 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -52.13 132.97 33.77 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.792 0.682 . . . . 75.11 111.384 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.454 HD13 HG21 ' D' ' 40' ' ' VAL . 29.4 tp -108.89 108.23 18.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.148 0.979 . . . . 71.33 109.715 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -102.12 102.75 13.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.395 0.678 . . . . 54.1 109.603 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.642 HD22 HD21 ' D' ' 42' ' ' LEU . 38.5 mt -72.75 118.47 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.125 -0.694 . . . . 75.45 109.125 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 125.09 79.25 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.341 0.656 . . . . 62.25 111.25 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -67.64 103.34 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.136 1.891 . . . . 72.34 110.605 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.84 110.12 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.107 0.956 . . . . 72.33 109.915 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 CA--C 1.539 0.527 0 CA-C-N 114.413 -1.267 . . . . 73.05 108.098 173.876 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 121.183 0.516 . . . . 72.11 110.484 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -133.53 127.47 33.24 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 106.61 -1.626 . . . . 71.33 106.61 158.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -141.06 136.65 32.22 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.089 0.243 . . . . 74.33 110.681 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 13' ' ' ILE . 2.8 mp -92.64 104.03 15.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 107.491 -1.299 . . . . 73.1 107.491 174.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -81.28 -25.94 36.13 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 118.709 -0.662 . . . . 70.32 110.986 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.409 HH21 HG23 ' B' ' 122' ' ' THR . 21.7 ttt85 -176.82 135.61 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.315 0.646 . . . . 65.35 110.711 173.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.5 136.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 123.765 0.826 . . . . 53.25 109.013 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.524 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 33.6 p90 -170.77 167.6 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.755 0.822 . . . . 65.3 110.863 -174.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -90.91 124.28 35.07 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 167.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -81.15 -33.34 33.2 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.352 -0.61 . . . . 52.3 109.352 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.5 t70 -148.23 140.84 24.49 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.797 -1.092 . . . . 74.33 109.911 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.1 mt -132.32 141.4 45.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.018 1.327 . . . . 62.11 107.442 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -149.65 130.85 14.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.127 -0.694 . . . . 75.3 109.127 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.7 t80 -132.46 135.85 46.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.7 -1.593 . . . . 74.0 106.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.11 152.63 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 75.43 108.29 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.84 79.35 46.02 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 106.541 -1.651 . . . . 73.24 106.541 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.9 -45.86 12.13 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.876 2.384 . . . . 73.34 112.094 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 28.2 m-80 -107.38 45.63 0.98 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.405 -0.816 . . . . 15.41 108.972 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -61.0 -50.16 85.95 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.187 0.995 . . . . 65.33 113.036 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -68.38 -7.99 21.73 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.823 1.682 . . . . 71.14 113.887 170.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.1 m80 -99.12 -13.4 19.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.766 0.826 . . . . 74.32 112.278 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -64.58 -23.02 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.896 0.316 . . . . 60.44 110.77 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.53 -34.92 74.83 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.078 0.951 . . . . 61.35 111.739 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -63.02 -54.71 34.0 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.555 0.742 . . . . 62.31 110.322 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HB2' HD13 ' A' ' 68' ' ' LEU . 33.8 mmtp -85.12 127.32 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.594 -1.185 . . . . 70.2 110.712 -172.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -66.8 136.36 55.33 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.785 -1.191 . . . . 74.12 107.785 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -60.05 100.78 0.1 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.453 1.095 . . . . 75.42 112.389 -163.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -127.35 76.51 76.52 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.633 1.173 . . . . 73.55 108.063 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.69 101.39 1.18 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.108 1.872 . . . . 74.33 111.642 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.01 94.67 9.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.674 -1.602 . . . . 54.45 106.674 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.8 m -84.37 129.76 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.832 -1.076 . . . . 63.44 111.666 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 3.0 mptp? -105.3 124.02 48.83 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.347 1.059 . . . . 63.22 108.577 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 128' ' ' LEU . 5.7 mp -97.52 120.96 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.574 1.15 . . . . 73.41 108.603 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 20.5 m-20 -117.57 111.27 18.99 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.279 -1.008 . . . . 75.24 108.279 167.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD11 HD21 ' A' ' 60' ' ' LEU . 29.7 tp -97.28 135.55 39.03 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.295 -1.002 . . . . 70.44 108.295 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 14.3 t70 -143.33 136.29 27.77 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -122.96 137.9 54.82 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.089 0.556 . . . . 75.42 109.643 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.43 153.17 52.06 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.444 1.098 . . . . 53.3 108.902 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.8 m -134.11 157.35 46.39 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.717 0.407 . . . . 54.45 110.69 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -149.82 119.45 6.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.981 0.912 . . . . 60.42 108.827 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -74.38 122.76 23.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.877 0.471 . . . . 75.22 109.986 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.77 -43.72 7.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.179 0.592 . . . . 73.31 110.154 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.81 -169.54 3.41 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 123.703 0.801 . . . . 74.22 109.991 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.64 126.25 30.64 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.757 -0.831 . . . . 71.22 108.757 169.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 69.44 -3.03 1.71 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.737 1.615 . . . . 70.35 112.653 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 41.1 t -115.4 120.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 N-CA-C 107.924 -1.139 . . . . 53.42 107.924 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.57 170.38 15.82 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.915 -1.143 . . . . 65.31 107.915 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 9.0 tm-20 -127.3 132.17 50.35 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.666 -1.235 . . . . 72.13 107.666 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.76 120.79 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.47 -0.937 . . . . 64.44 108.47 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 43.7 t -95.24 130.92 43.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 123.64 0.776 . . . . 72.44 109.047 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -105.09 107.54 18.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.896 -1.52 . . . . 74.41 106.896 170.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 24.3 ttp180 -100.06 100.79 11.71 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.39 -0.967 . . . . 74.03 108.39 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 t -94.74 137.57 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.834 -1.173 . . . . 75.14 107.834 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.9 m -128.66 126.79 40.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.505 -0.554 . . . . 54.12 109.505 173.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.1 t -122.06 109.5 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.675 1.19 . . . . 75.14 109.537 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 80.0 m -101.41 141.97 33.5 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.429 -0.952 . . . . 54.22 108.429 173.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.07 109.58 14.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.266 -1.013 . . . . 62.55 108.266 173.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 39.8 m -107.46 127.23 53.42 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.343 -0.614 . . . . 64.41 109.343 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 34' ' ' LYS . 22.3 mt -90.75 81.93 5.76 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.518 -1.66 . . . . 73.34 106.518 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.15 -86.4 1.1 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.16 -0.927 . . . . 75.42 110.881 -168.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.1 -19.25 4.4 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 70.12 110.452 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.08 108.02 18.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.855 0.862 . . . . 71.35 110.247 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.1 m -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.293 0.568 . . . . 63.33 111.442 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -54.09 7.69 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.92 1.288 . . . . 72.32 109.455 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -148.92 165.26 32.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.389 -1.278 . . . . 75.45 110.82 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.5 tp -130.89 145.2 51.94 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.666 -1.235 . . . . 73.03 107.666 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -134.54 140.39 46.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.77 0.828 . . . . 72.41 109.268 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.85 117.1 6.43 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.89 -0.781 . . . . 70.44 108.89 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.91 111.34 28.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.773 0.829 . . . . 62.32 109.038 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.6 mt-30 -88.42 82.57 6.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.118 -0.946 . . . . 63.03 109.119 173.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -75.95 93.6 3.26 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.154 -0.93 . . . . 73.14 108.842 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.39 148.9 19.54 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 116.179 -0.464 . . . . 70.43 112.06 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.06 123.97 1.73 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.74 -0.944 . . . . 51.33 110.74 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.4 mt -79.08 127.85 38.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.981 -1.118 . . . . 74.13 107.981 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.89 143.42 50.8 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.398 -0.593 . . . . 71.32 109.398 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 t -112.54 112.98 24.9 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.088 -1.078 . . . . 72.31 108.088 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -129.01 143.42 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.089 0.555 . . . . 72.54 110.011 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.06 175.39 2.29 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.208 1.003 . . . . 74.43 111.215 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 5.16 88.42 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.392 -0.822 . . . . 74.23 114.478 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -131.31 -179.62 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.337 1.055 . . . . 73.12 109.422 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.9 tt0 -168.37 177.2 5.47 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.085 0.554 . . . . 72.33 110.139 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.86 -121.28 22.74 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 114.969 0.748 . . . . 73.2 114.969 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.6 p -64.67 -30.92 71.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.899 0.88 . . . . 73.33 111.593 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.54 -42.1 71.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.549 0.739 . . . . 62.31 111.041 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -76.55 -30.24 57.0 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.507 -0.315 . . . . 55.12 110.701 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.76 63.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.147 0.579 . . . . 75.31 110.74 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -67.61 -48.56 66.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.174 0.99 . . . . 75.32 110.234 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 20.2 t -74.59 -63.0 1.34 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.544 -0.753 . . . . 71.2 111.001 -172.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 tt -62.36 -38.34 89.16 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.164 0.586 . . . . 75.35 110.698 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.15 -31.1 32.42 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 115.26 0.864 . . . . 72.14 115.26 -168.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -48.37 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.342 1.071 . . . . 54.42 112.569 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 86.4 t80 -66.66 -50.08 64.09 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.615 0.766 . . . . 74.03 112.697 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.426 ' HA ' HG12 ' A' ' 105' ' ' ILE . 63.6 m -72.16 -37.6 4.94 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.554 0.742 . . . . 62.25 112.634 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.65 -40.89 82.16 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.18 1.92 . . . . 71.22 112.478 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.27 -29.4 68.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.553 0.741 . . . . 72.32 111.419 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 102' ' ' CYS . 40.1 mm -60.66 -44.52 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.998 0.904 . . . . 62.11 109.855 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 82' ' ' GLY . 79.2 mt -77.21 -18.77 57.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.166 -1.379 . . . . 64.54 112.176 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -68.42 -41.86 25.62 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.444 1.276 . . . . 63.52 114.444 -168.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.81 -39.03 90.39 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 121.966 1.777 . . . . 72.11 112.906 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -75.1 -36.74 61.67 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.491 0.717 . . . . 75.22 111.608 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.93 -46.83 76.79 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.576 -0.527 . . . . 74.41 109.576 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttm105 -55.22 -47.09 75.81 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 124.552 1.158 . . . . 73.31 110.52 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.554 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 6.7 tm-20 -59.42 -48.69 80.68 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.136 0.897 . . . . 74.43 111.061 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.512 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 51.1 t -57.73 -46.49 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.067 -0.97 . . . . 74.14 111.213 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.5 mt -64.3 -53.19 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.525 0.73 . . . . 64.23 110.612 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 125' ' ' GLN . 60.7 m -53.46 -44.39 68.89 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.799 1.24 . . . . 61.2 112.009 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 43.3 t -72.46 -32.65 66.43 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.298 -0.865 . . . . 61.42 111.166 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -64.29 -43.3 95.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.483 0.713 . . . . 74.22 110.851 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.5 t -62.99 -49.27 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.627 1.171 . . . . 63.05 110.465 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.1 p -67.48 -26.04 66.17 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.846 -0.616 . . . . 24.3 111.6 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 116' ' ' SER . 26.4 ttm-85 -76.93 -26.06 53.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.272 1.029 . . . . 63.54 110.133 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 10.9 61.11 Favored Glycine 0 C--N 1.358 1.803 0 CA-C-N 115.887 -0.597 . . . . 74.14 112.618 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 67.66 36.49 3.63 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.815 1.293 . . . . 74.45 110.472 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -115.57 144.71 32.99 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 114.75 -1.114 . . . . 63.05 108.936 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.28 146.07 52.36 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.01 2.474 . . . . 72.01 113.275 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.595 ' HG3' HG23 ' A' ' 115' ' ' THR . 3.6 tt0 -59.07 140.92 55.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.135 0.974 . . . . 70.23 112.689 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.1 tp -124.86 114.16 18.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.935 0.894 . . . . 75.12 109.402 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -112.05 102.08 10.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.385 0.674 . . . . 63.42 109.505 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.75 127.11 31.54 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.867 -0.79 . . . . 72.03 108.867 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.4 132.03 95.24 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.784 0.834 . . . . 42.03 112.325 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -83.62 140.44 9.37 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.641 2.227 . . . . 32.5 112.153 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.67 125.3 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.96 0.904 . . . . 52.35 109.831 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -92.03 63.81 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 122.218 1.009 . . . . 71.35 110.536 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 75.33 110.188 176.305 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.238 0.475 0 N-CA-C 108.255 -1.017 . . . . 72.45 108.255 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.91 120.67 21.78 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.538 -0.912 . . . . 64.15 108.538 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -143.56 138.3 29.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.722 0.296 . . . . 72.42 110.243 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.472 HD11 HG13 ' B' ' 16' ' ' ILE . 16.1 tt -82.56 144.48 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.263 1.025 . . . . 61.52 110.031 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -109.28 -49.16 3.15 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.192 0.597 . . . . 72.53 110.035 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -171.38 146.27 2.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.172 0.589 . . . . 74.43 110.458 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.472 HG13 HD11 ' B' ' 13' ' ' ILE . 51.1 mt -116.47 145.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.191 -1.04 . . . . 74.43 108.191 169.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -168.71 145.47 3.73 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.759 0.423 . . . . 64.33 110.305 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -74.06 122.16 22.24 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.872 -0.788 . . . . 64.44 108.872 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -91.49 -37.45 13.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.619 -0.719 . . . . 74.54 110.341 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.1 t70 -154.3 146.28 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.666 0.27 . . . . 71.52 111.622 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.436 HD11 ' SG ' ' B' ' 113' ' ' CYS . 43.4 mm -138.56 143.73 31.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 125.378 1.471 . . . . 52.42 109.158 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.4 t -141.1 129.21 22.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.862 1.265 . . . . 74.2 108.424 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -143.2 131.9 22.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.096 -1.446 . . . . 74.22 107.096 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -136.01 140.15 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.674 -1.232 . . . . 74.5 107.674 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.667 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -134.85 85.09 36.37 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 107.904 -1.147 . . . . 74.02 107.904 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.95 -29.48 57.64 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.88 2.387 . . . . 70.14 111.99 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.81 28.91 8.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.945 0.898 . . . . 63.44 109.961 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.667 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.2 -52.75 32.86 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 125.429 1.491 . . . . 70.35 113.509 168.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.1 Cg_exo -81.63 -11.74 11.46 Favored 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 122.547 2.165 . . . . 71.4 112.876 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -89.17 3.07 53.14 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.214 1.006 . . . . 72.52 111.576 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.1 -21.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.247 0.619 . . . . 74.23 111.266 169.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -64.76 -40.54 95.44 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.706 0.802 . . . . 61.34 110.16 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.29 -30.03 30.82 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.061 -0.972 . . . . 74.41 111.135 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.79 90.33 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.261 1.025 . . . . 71.52 109.729 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.49 77.35 9.44 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.8 0.84 . . . . 70.24 110.567 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -172.01 156.36 4.04 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.853 0.861 . . . . 74.22 109.419 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.449 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 28.1 tt0 -66.25 125.52 90.4 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.536 1.135 . . . . 50.42 110.778 169.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.25 129.16 20.94 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.129 1.886 . . . . 71.44 110.691 169.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 134.04 48.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 120.933 0.396 . . . . 61.01 109.94 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.437 HG21 ' O ' ' B' ' 124' ' ' PRO . 18.9 t -114.99 127.37 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.9 0.48 . . . . 71.23 111.282 -166.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -134.78 134.28 40.75 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.406 -0.961 . . . . 75.23 108.406 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.563 ' H ' HD23 ' B' ' 42' ' ' LEU . 1.2 pt? -119.5 140.43 50.49 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.962 -1.125 . . . . 74.23 107.962 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -136.81 142.64 42.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.432 0.693 . . . . 61.21 109.389 -167.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.4 ' HG ' HD21 ' B' ' 60' ' ' LEU . 6.6 tt -94.77 138.91 31.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.353 0.661 . . . . 74.34 110.391 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.74 135.83 31.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.564 1.145 . . . . 64.41 108.553 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.0 m -109.65 124.78 51.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.854 0.462 . . . . 73.1 110.646 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.05 156.37 38.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.197 0.999 . . . . 70.45 108.336 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 45.5 p -144.88 170.8 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.8 0.44 . . . . 63.45 110.684 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -150.49 143.66 24.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.614 0.766 . . . . 75.24 109.011 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -94.57 114.98 27.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.406 0.683 . . . . 75.51 110.025 173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.2 -35.14 21.82 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.343 -0.614 . . . . 71.24 109.343 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.81 3.85 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.922 -1.036 . . . . 74.32 110.104 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.71 126.37 27.37 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.621 -1.172 . . . . 64.33 108.899 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 69.96 -4.36 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.592 1.157 . . . . 52.03 112.987 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.26 103.95 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.524 -0.917 . . . . 72.41 108.524 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.99 137.78 54.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.2 0.524 . . . . 64.3 110.164 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -114.44 105.86 13.62 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.081 -1.451 . . . . 64.22 107.081 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 83.9 t -92.82 125.75 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.309 0.644 . . . . 62.1 109.541 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.2 t -103.04 117.42 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.599 0.76 . . . . 74.03 109.746 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.4 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -93.87 112.11 23.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.144 -0.687 . . . . 52.25 109.144 -177.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 41.9 ttm180 -94.7 114.24 26.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.953 0.501 . . . . 74.41 109.907 171.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.58 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.4 t -114.02 122.26 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.947 -1.131 . . . . 70.12 107.947 169.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -115.71 147.9 40.36 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.171 0.589 . . . . 42.53 110.378 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.613 HG21 HG21 ' B' ' 114' ' ' ILE . 44.5 t -127.3 127.14 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 75.35 109.582 -172.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.5 m -105.0 140.09 38.71 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.808 0.843 . . . . 71.44 109.281 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.4 22.62 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.097 0.959 . . . . 52.03 108.732 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.42 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 73.6 p -146.27 141.08 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.115 0.483 . . . . 53.31 111.529 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 65.6 mt -102.72 109.39 20.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.938 1.295 . . . . 75.15 108.678 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -111.88 3.5 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.02 -0.432 . . . . 42.3 112.02 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.17 10.21 18.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.044 0.938 . . . . 62.23 110.494 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -132.07 144.69 50.91 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.24 0.616 . . . . 74.14 109.821 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -66.91 134.77 52.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.203 0.601 . . . . 74.42 111.49 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -88.71 -58.86 2.4 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.679 -0.86 . . . . 53.14 108.679 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 158.81 39.36 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.318 -1.31 . . . . 74.44 109.925 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -136.37 124.0 22.34 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.18 1.392 . . . . 75.13 107.759 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.34 159.94 23.21 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -164.81 139.38 5.24 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.209 -1.034 . . . . 70.32 108.209 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 67.4 t -129.03 145.69 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 123.887 0.875 . . . . 75.3 108.722 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.9 mt-30 -124.43 85.9 2.48 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.545 -0.909 . . . . 73.11 108.545 174.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -82.67 101.63 10.96 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 114.432 -1.258 . . . . 74.24 109.877 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.65 161.22 29.53 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 121.181 -0.533 . . . . 72.25 112.018 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.11 126.45 1.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.361 -0.696 . . . . 70.11 111.361 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.89 128.12 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.956 -0.757 . . . . 51.32 108.956 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -132.85 163.46 29.04 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.685 1.194 . . . . 74.54 107.945 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 71.6 m -126.75 121.28 31.54 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.199 -1.037 . . . . 63.2 108.199 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.571 HD13 HD11 ' B' ' 89' ' ' ILE . 2.9 pp -128.28 147.03 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 73.24 110.263 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.04 162.63 40.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.547 0.739 . . . . 75.23 109.979 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.28 -28.98 8.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.261 0.464 . . . . 41.31 114.261 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.571 HD11 HD13 ' B' ' 86' ' ' ILE . 44.7 pt -67.83 162.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 60.1 112.865 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -165.35 159.68 17.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.1 -0.955 . . . . 73.3 111.596 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -130.32 50.11 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 124.014 0.821 . . . . 74.0 114.14 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.5 m -70.72 -25.31 62.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.933 0.893 . . . . 70.34 111.087 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.76 -26.91 67.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 74.44 110.623 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.474 ' HG3' HD12 ' B' ' 89' ' ' ILE . 18.1 ttt -72.67 -46.04 55.89 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.12 0.568 . . . . 74.03 110.522 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.84 67.14 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.438 -0.801 . . . . 74.1 111.192 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.17 -36.1 35.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.306 0.642 . . . . 72.3 110.716 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -74.74 -67.45 0.63 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.961 0.504 . . . . 73.21 111.914 -173.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.54 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.2 pp -94.27 -20.51 19.74 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.156 0.428 . . . . 75.33 112.156 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.68 -15.44 59.82 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.913 -0.382 . . . . 64.4 113.293 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.96 -52.53 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.206 0.503 . . . . 61.21 112.0 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -76.76 -37.28 56.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.963 0.357 . . . . 75.43 111.963 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 97.9 m -63.43 -51.44 67.58 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.607 -0.711 . . . . 72.32 111.566 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.449 ' HD3' HG11 ' B' ' 58' ' ' VAL . 36.5 Cg_endo -65.48 -17.53 57.65 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 121.763 1.642 . . . . 75.34 113.524 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.34 -42.04 75.83 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 122.864 0.466 . . . . 74.54 110.562 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.507 HG23 ' NH2' ' D' ' 111' ' ' ARG . 69.6 mt -58.92 -41.95 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.068 0.947 . . . . 72.11 110.194 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -84.71 -12.94 52.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.546 -1.206 . . . . 64.43 111.969 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -63.49 -45.14 83.46 Favored Pre-proline 0 C--N 1.359 0.984 0 CA-C-O 117.576 -1.202 . . . . 54.24 112.706 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.13 -42.83 61.96 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.305 2.004 . . . . 62.55 113.177 172.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -70.55 -45.22 65.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.147 -0.933 . . . . 73.32 111.027 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.06 82.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.632 0.773 . . . . 42.21 111.096 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.69 -60.86 3.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.751 1.22 . . . . 72.5 109.236 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.87 -34.53 74.77 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.076 0.86 . . . . 65.43 110.413 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.7 t -60.33 -51.05 71.19 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.203 0.601 . . . . 74.12 111.46 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.613 HG21 HG21 ' B' ' 64' ' ' VAL . 80.8 mt -58.64 -52.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.441 0.696 . . . . 72.44 109.962 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.657 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 2.0 m -64.29 -21.0 66.45 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.903 -1.499 . . . . 75.04 111.236 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -83.55 -40.3 19.3 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.706 1.202 . . . . 64.52 112.061 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.9 mmt -69.12 -39.49 78.87 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.287 0.494 . . . . 52.41 111.926 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.53 -26.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.127 0.571 . . . . 74.35 110.436 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.3 t -64.93 -30.99 72.01 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 74.42 110.321 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.512 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 66.6 mtt-85 -72.81 -33.66 66.36 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.527 0.731 . . . . 71.23 110.129 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.83 -2.56 81.99 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-N 115.753 -0.658 . . . . 55.43 112.833 171.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 17' ' ' TYR . 5.4 t 55.41 34.3 22.68 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.77 2.028 . . . . 73.25 112.694 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.91 157.67 35.47 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.075 0.95 . . . . 71.21 110.851 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.449 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.4 Cg_exo -71.84 87.82 0.82 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.302 2.668 . . . . 71.31 113.771 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.657 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 0.0 OUTLIER -71.78 159.78 33.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.329 0.652 . . . . 43.3 112.225 171.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.446 ' H ' ' NE2' ' B' ' 125' ' ' GLN . 33.1 tp -129.69 123.84 32.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.21 1.804 . . . . 75.02 107.542 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.48 HD21 ' HA ' ' C' ' 122' ' ' THR . 18.7 p-10 -91.5 110.24 21.55 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.09 -0.708 . . . . 71.31 109.09 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.5 137.74 54.64 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 72.3 110.621 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.24 141.78 97.78 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.057 0.943 . . . . 72.33 111.503 176.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.6 106.96 0.79 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.923 2.415 . . . . 44.03 112.74 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -73.89 106.71 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.986 -0.552 . . . . 64.13 110.025 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -79.08 94.75 5.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.263 0.554 . . . . 75.35 109.647 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 23.6 p90 . . . . . 0 CA--C 1.546 0.809 0 CA-C-N 115.161 -0.927 . . . . 71.24 111.25 177.63 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.102 -0.703 . . . . 64.31 109.102 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.745 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 53.9 t80 -117.17 127.46 54.14 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.428 -0.952 . . . . 62.3 108.428 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -138.11 135.04 35.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.427 -0.953 . . . . 74.11 108.427 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.543 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -93.68 114.67 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.377 0.608 . . . . 30.54 109.779 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.481 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.0 mm-40 -82.04 -49.26 10.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 75.41 109.906 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.413 HH21 ' HG1' ' D' ' 122' ' ' THR . 71.0 ttt180 -173.55 145.63 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.7 -0.682 . . . . 74.33 109.988 -170.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.543 HG13 HD11 ' C' ' 13' ' ' ILE . 87.0 mt -128.12 144.63 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.503 -1.295 . . . . 45.41 107.503 171.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.455 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.0 p90 -174.71 166.57 3.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.452 0.644 . . . . 72.32 110.77 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -88.16 105.91 17.83 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.003 -0.999 . . . . 55.32 109.44 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -65.68 -36.28 83.19 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.547 0.689 . . . . 73.33 109.487 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.5 t70 -149.13 142.94 25.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.542 -1.208 . . . . 70.13 109.63 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -136.91 139.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.358 -1.719 . . . . 70.43 106.358 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.46 143.49 22.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.376 -0.602 . . . . 73.52 109.376 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -143.65 113.93 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.558 -1.275 . . . . 74.23 107.558 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -116.57 119.77 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.669 -0.864 . . . . 73.24 108.669 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.77 82.21 67.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.673 -1.232 . . . . 65.32 107.673 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.11 -37.29 33.2 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.572 2.181 . . . . 74.21 111.574 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.68 31.3 3.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.28 -1.327 . . . . 72.1 110.474 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 86.26 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 113.956 1.095 . . . . 75.31 113.956 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.18 -19.73 6.59 Favored 'Trans proline' 0 C--N 1.385 2.457 0 CA-C-N 121.298 1.499 . . . . 71.4 112.818 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.84 -33.53 70.76 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.189 0.996 . . . . 73.1 112.271 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.497 HG23 HD11 ' C' ' 68' ' ' LEU . 12.4 p -78.61 -10.63 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.064 0.946 . . . . 73.32 111.943 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -57.51 -40.63 79.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.852 0.861 . . . . 74.44 112.207 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -105.79 41.91 1.32 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.967 0.889 . . . . 71.24 109.248 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.3 tppp? -125.38 155.94 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.42 0.688 . . . . 70.05 110.443 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.56 127.11 31.57 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.332 0.653 . . . . 64.51 109.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.46 95.49 9.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.585 -0.734 . . . . 70.43 110.815 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.07 68.7 81.28 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.335 -0.987 . . . . 61.51 108.335 167.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.71 111.46 3.33 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.363 2.042 . . . . 74.5 110.57 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -85.09 92.82 8.47 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.649 -1.241 . . . . 74.42 107.649 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.428 HG21 HD22 ' C' ' 126' ' ' LEU . 40.1 t -81.58 86.16 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.225 -1.352 . . . . 72.12 110.633 -168.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -91.26 105.28 17.68 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.372 -1.344 . . . . 64.12 107.372 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.51 HD23 HD12 ' C' ' 128' ' ' LEU . 0.5 OUTLIER -87.85 160.71 17.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.367 0.603 . . . . 71.41 111.209 177.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -137.05 144.18 43.06 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.737 1.215 . . . . 64.01 108.775 175.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 46.4 tp -131.45 105.34 7.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.489 -0.93 . . . . 73.4 108.489 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 20.0 t70 -113.33 140.15 48.26 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 74.12 109.26 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -114.4 134.08 55.25 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.18 0.592 . . . . 63.44 109.959 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.96 151.66 46.71 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.335 1.054 . . . . 64.1 108.407 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 73.8 m -138.42 149.21 45.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.261 0.625 . . . . 75.24 110.556 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -150.21 158.87 44.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.396 1.079 . . . . 62.14 109.503 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -102.51 138.91 38.8 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.198 -1.038 . . . . 61.44 108.198 168.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' C' ' 57' ' ' GLU . 89.3 mt -109.86 -37.03 5.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.523 0.729 . . . . 63.4 110.226 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 -167.51 1.71 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.228 0.611 . . . . 32.44 110.744 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.81 109.41 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.825 -1.079 . . . . 62.32 111.484 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.49 9.59 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.847 1.259 . . . . 72.24 111.968 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.28 118.78 54.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.535 1.134 . . . . 71.11 109.279 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.87 162.35 14.9 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.165 0.986 . . . . 72.44 110.322 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.9 tt0 -127.22 116.66 20.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.9 -1.045 . . . . 74.13 108.453 165.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -106.64 124.74 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.716 -1.216 . . . . 74.13 107.716 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.44 119.15 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.778 0.831 . . . . 63.14 109.341 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' C' ' 103' ' ' PRO . 38.5 mt -88.41 118.44 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.091 0.556 . . . . 74.45 110.683 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 33.4 mtm105 -82.65 105.23 13.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.687 -1.227 . . . . 75.41 107.687 164.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -109.12 117.23 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.878 -1.156 . . . . 61.43 107.878 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -123.12 126.01 46.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.858 0.463 . . . . 62.04 109.91 -171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.552 HG23 HD13 ' C' ' 114' ' ' ILE . 54.5 t -107.65 113.69 44.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.484 0.714 . . . . 44.45 109.109 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.424 HG23 HD23 ' C' ' 75' ' ' LEU . 5.8 m -99.48 140.37 33.76 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.311 -0.996 . . . . 70.31 108.311 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.8 108.66 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.925 -0.768 . . . . 51.51 108.925 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.2 m -130.17 140.65 50.74 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.202 0.525 . . . . 63.25 110.255 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.497 HD11 HG23 ' C' ' 31' ' ' VAL . 12.3 mt -93.39 40.75 1.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.337 1.455 . . . . 75.04 109.159 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.07 -112.36 4.12 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.125 -1.59 . . . . 73.33 109.125 -163.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.2 -27.53 19.48 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.336 0.655 . . . . 43.31 110.117 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.86 92.28 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.628 1.171 . . . . 64.31 110.393 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 117.97 12.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.387 0.613 . . . . 74.43 110.164 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.99 25.92 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.363 -1.289 . . . . 40.42 109.75 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -163.62 172.98 13.55 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.628 -0.715 . . . . 75.34 111.849 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.424 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -144.38 116.89 8.59 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.102 -1.444 . . . . 70.51 107.102 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -115.68 145.74 42.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.639 0.775 . . . . 72.41 109.492 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.11 135.6 20.64 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.703 0.401 . . . . 63.12 110.031 171.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.71 118.2 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.486 1.115 . . . . 71.15 108.798 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.9 mt-30 -90.14 93.71 9.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.83 -0.804 . . . . 70.14 108.83 172.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -83.2 107.87 16.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.445 -0.798 . . . . 74.24 109.921 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.56 146.33 18.11 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.165 -0.47 . . . . 41.41 112.21 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.45 126.3 3.13 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 111.129 -0.789 . . . . 63.0 111.129 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.0 mm -91.04 124.93 43.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.26 -1.015 . . . . 64.25 108.26 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.42 119.52 21.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.289 0.636 . . . . 62.42 109.468 -175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -87.6 100.02 12.48 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.28 -1.378 . . . . 65.51 107.28 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.476 HG13 ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -143.8 133.79 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.469 0.652 . . . . 74.33 110.904 -170.415 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.03 -177.22 5.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.074 1.35 . . . . 55.12 109.132 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -18.81 36.32 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 114.712 0.645 . . . . 55.0 114.712 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.015 0.926 . . . . 62.33 111.819 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 111.854 0.316 . . . . 64.41 111.854 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 38.1 ttm -58.67 -62.89 1.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.796 0.838 . . . . 73.44 111.417 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -27.4 63.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.623 -0.717 . . . . 43.51 111.708 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -77.3 -22.99 51.13 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 71.5 110.314 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.7 t -71.96 -64.03 1.02 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.329 0.252 . . . . 61.42 110.44 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.24 -16.44 56.47 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 122.259 -0.275 . . . . 75.11 110.986 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.21 -26.05 27.05 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.691 0.636 . . . . 72.12 114.691 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.06 -40.2 0.25 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.489 0.922 . . . . 52.4 113.489 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -74.56 -48.64 25.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.048 0.539 . . . . 73.52 111.234 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.745 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 56.0 m -66.13 -45.1 61.85 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.313 0.645 . . . . 44.22 110.184 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.666 ' HB3' HD21 ' C' ' 60' ' ' LEU . 76.2 Cg_exo -52.38 -38.59 73.78 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.417 2.078 . . . . 75.33 115.01 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -63.66 -30.6 71.69 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 123.252 0.621 . . . . 74.32 111.209 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -65.62 -39.28 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.744 0.817 . . . . 71.3 110.489 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -88.94 -21.57 23.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.744 0.818 . . . . 71.1 112.353 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.77 -46.4 99.74 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.131 0.972 . . . . 73.24 113.039 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.554 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 23.7 Cg_exo -60.96 -40.14 55.04 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.872 1.714 . . . . 71.44 112.526 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -63.81 -46.15 86.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.571 0.748 . . . . 74.24 111.459 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.65 -43.46 93.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.369 0.668 . . . . 52.44 110.87 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -56.87 -50.88 71.14 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.011 1.324 . . . . 45.12 110.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.2 -41.41 85.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.785 0.834 . . . . 55.4 110.54 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.4 t -66.52 -30.87 71.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.539 0.735 . . . . 73.4 111.987 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.561 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.7 mt -72.58 -50.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.837 0.455 . . . . 60.4 110.086 173.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.538 HG22 ' NE2' ' C' ' 125' ' ' GLN . 10.3 m -61.99 -27.81 69.12 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.106 0.562 . . . . 74.14 110.67 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.3 t -60.73 -51.76 67.99 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.161 0.984 . . . . 73.42 110.076 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.493 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.86 -38.96 83.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.582 1.153 . . . . 51.34 112.618 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.63 -39.73 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.271 0.628 . . . . 73.33 110.25 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -60.23 -42.96 96.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.66 0.784 . . . . 64.43 110.89 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' C' ' 116' ' ' SER . 89.2 mtt-85 -63.12 -34.0 76.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.723 -0.671 . . . . 71.12 111.38 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.46 12.51 58.64 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.156 -0.802 . . . . 73.21 113.536 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.48 ' HA ' HD21 ' B' ' 127' ' ' ASN . 70.3 p 55.23 42.81 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.421 1.488 . . . . 75.43 112.277 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.6 154.27 44.74 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 107.972 -1.122 . . . . 75.14 107.972 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.72 148.15 36.27 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.322 2.015 . . . . 75.0 112.225 -171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.538 ' NE2' HG22 ' C' ' 115' ' ' THR . 12.8 mm100 -62.76 110.43 1.74 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.667 0.988 . . . . 74.23 113.667 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.428 HD22 HG21 ' C' ' 40' ' ' VAL . 65.1 mt -92.21 76.13 5.33 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.416 0.686 . . . . 72.31 109.884 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -92.31 89.41 6.83 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.01 -0.995 . . . . 63.25 109.356 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.51 HD12 HD23 ' C' ' 42' ' ' LEU . 12.7 mt -86.74 153.04 22.01 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.415 -1.266 . . . . 74.42 109.841 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.19 120.11 2.34 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 125.633 1.573 . . . . 74.22 113.633 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.62 94.48 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.666 2.244 . . . . 71.55 111.145 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.56 98.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-N 114.965 -1.016 . . . . 74.25 111.383 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' ASN . . . . . 0.408 ' C ' HD21 ' C' ' 132' ' ' ASN . 0.2 OUTLIER -75.76 87.15 2.78 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.197 -0.91 . . . . 62.4 108.952 175.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.6 t80 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 64.44 112.631 -176.577 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.238 0.464 0 N-CA-C 109.067 -0.716 . . . . 42.42 109.067 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -154.37 105.68 2.69 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.862 -1.162 . . . . 75.12 107.862 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 74.9 mt-30 -117.34 115.94 26.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.992 0.517 . . . . 73.33 110.188 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -87.01 126.19 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.455 -0.943 . . . . 62.44 108.455 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.446 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.1 mt-30 -109.26 -47.53 3.39 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.114 0.413 . . . . 61.4 112.114 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -165.45 121.81 1.4 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.06 128.14 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.773 0.829 . . . . 71.55 109.057 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' C' ' 122' ' ' THR . 40.3 p90 -161.99 174.58 12.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.95 0.881 . . . . 73.22 111.52 -171.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.51 120.68 40.67 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.72 -1.127 . . . . 63.15 108.985 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -84.77 -37.59 20.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.541 -0.54 . . . . 55.53 109.541 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.8 137.96 24.13 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.078 -0.965 . . . . 75.34 109.088 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' C' ' 117' ' ' MET . 74.9 mt -131.44 139.68 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 73.33 108.08 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.97 134.36 33.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.139 0.975 . . . . 70.1 108.812 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -146.94 116.18 6.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.614 -1.625 . . . . 72.31 106.614 170.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -122.23 144.35 49.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 72.44 109.499 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.706 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -134.25 75.2 65.68 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.896 -1.15 . . . . 60.33 107.896 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.96 -27.18 10.32 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.748 2.299 . . . . 63.41 113.081 -170.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -115.21 27.08 9.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.449 0.699 . . . . 60.24 109.978 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.706 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.95 -56.15 30.98 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 115.272 1.582 . . . . 62.04 115.272 -167.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.96 -6.23 13.14 Favored 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-N 121.474 1.562 . . . . 73.22 112.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.75 -44.46 17.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.642 1.177 . . . . 63.53 110.094 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.18 2.42 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.061 0.545 . . . . 74.34 111.202 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.25 -33.82 69.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.137 0.975 . . . . 73.13 110.34 165.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.59 -23.46 58.74 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.622 -1.172 . . . . 75.12 111.004 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -88.62 79.03 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 72.13 110.419 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -87.17 57.49 4.5 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.199 1.0 . . . . 72.11 110.894 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -125.86 175.87 7.35 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.884 1.274 . . . . 72.33 108.425 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -72.44 112.79 16.24 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 119.194 -0.431 . . . . 72.43 109.969 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.08 113.73 2.15 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.524 2.149 . . . . 61.13 111.889 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.77 112.42 6.21 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.09 0.869 . . . . 73.43 109.655 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 m -99.65 122.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 73.25 110.045 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -104.56 112.57 25.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 74.44 108.498 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.551 HD21 HD22 ' D' ' 128' ' ' LEU . 6.8 mp -95.22 142.25 27.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.345 0.658 . . . . 74.35 110.093 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.2 t70 -132.61 137.09 46.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.633 -0.877 . . . . 63.51 108.633 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 22.6 tp -115.12 129.59 56.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.295 -0.631 . . . . 73.34 109.295 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.98 148.02 44.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.289 1.035 . . . . 73.4 108.389 172.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 88.6 m -128.97 150.59 50.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.166 0.987 . . . . 71.42 108.718 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.94 164.15 35.39 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.039 0.936 . . . . 62.33 109.755 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 96.5 p -167.43 155.33 9.12 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.5 0.72 . . . . 70.2 111.089 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -156.42 130.91 8.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.886 0.874 . . . . 70.51 109.031 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.74 126.13 27.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.836 0.454 . . . . 73.42 110.244 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.1 mt -98.69 -35.99 10.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.052 0.541 . . . . 72.12 110.183 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -159.25 -171.28 3.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.333 0.653 . . . . 72.43 111.186 -176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.12 110.81 3.11 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.257 -0.883 . . . . 75.01 109.797 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 67.73 1.71 2.74 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.247 1.419 . . . . 71.43 112.707 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 52.2 t -110.24 134.16 53.3 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 123.87 0.868 . . . . 62.32 108.999 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -151.68 174.67 13.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.862 0.865 . . . . 71.03 109.08 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.0 tt0 -120.11 132.75 55.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.651 0.78 . . . . 73.41 109.127 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' D' ' 102' ' ' CYS . 58.5 t -100.24 132.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 108.045 -1.094 . . . . 65.1 108.045 168.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.0 t -111.12 136.15 48.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.48 -0.933 . . . . 63.13 108.48 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.87 127.49 56.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.138 -1.06 . . . . 74.33 108.138 179.119 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 35.3 ttm-85 -109.86 106.98 16.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.976 -0.749 . . . . 54.42 108.976 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -105.95 106.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 107.756 -1.201 . . . . 61.43 107.756 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 7.6 m -106.09 129.6 54.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.707 0.403 . . . . 54.43 110.183 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.64 102.89 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.719 1.208 . . . . 62.14 109.218 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -96.6 95.94 8.3 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.445 -0.946 . . . . 74.24 108.445 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 147.58 23.67 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.171 0.589 . . . . 62.1 110.495 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.568 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.4 p -155.8 129.16 8.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.564 0.697 . . . . 65.53 111.829 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 13.2 mt -92.51 98.33 11.39 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.695 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.04 -123.88 10.96 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.827 0.704 . . . . 73.43 112.133 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.92 5.98 37.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.17 0.588 . . . . 64.11 111.28 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -129.37 143.93 51.04 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.225 0.61 . . . . 54.01 110.8 -169.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.2 m -70.45 127.85 34.16 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.378 0.671 . . . . 73.43 110.982 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.568 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.67 -66.13 0.93 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.139 -1.059 . . . . 63.24 108.139 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.49 152.08 36.26 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.019 -0.991 . . . . 71.24 110.167 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.5 mt -104.93 147.11 28.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.573 -1.269 . . . . 73.35 107.573 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.5 t -156.92 143.4 18.26 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.87 -0.418 . . . . 55.21 109.87 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -157.15 141.23 16.26 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.505 -0.924 . . . . 64.32 108.505 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -135.51 116.64 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 71.51 109.555 175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -89.88 84.04 6.2 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.876 0.845 . . . . 72.24 108.889 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.41 ' O ' HD13 ' D' ' 106' ' ' LEU . 59.8 tp60 -79.88 100.33 7.98 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.208 -1.36 . . . . 64.11 109.292 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.58 143.87 16.47 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 111.683 -0.567 . . . . 54.52 111.683 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.97 139.26 6.82 Favored Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.279 -0.729 . . . . 72.2 111.279 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 49.0 mt -88.72 127.54 41.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 122.962 0.505 . . . . 63.52 109.91 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.68 146.27 52.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 72.22 109.49 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.5 m -116.32 105.14 12.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.356 0.663 . . . . 63.53 109.489 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.576 ' HB ' HD11 ' D' ' 89' ' ' ILE . 18.3 pt -109.33 142.4 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.413 0.551 . . . . 54.04 109.983 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.26 145.14 19.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.188 -0.915 . . . . 72.53 109.449 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.03 -10.05 61.79 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.108 0.403 . . . . 72.41 114.108 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.576 HD11 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -124.76 130.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.424 0.69 . . . . 72.24 110.368 -172.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.73 167.74 18.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.985 0.514 . . . . 61.34 111.173 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.43 -134.89 42.07 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.139 0.899 . . . . 53.31 113.208 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -66.39 -23.72 66.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.241 0.616 . . . . 63.43 111.608 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -66.52 -34.17 77.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.331 0.652 . . . . 65.43 110.912 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.524 ' HB3' HG12 ' D' ' 89' ' ' ILE . 3.2 ppp? -88.16 -27.76 21.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.433 0.293 . . . . 60.45 111.054 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.59 65.2 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.977 0.511 . . . . 71.3 111.879 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 8.0 t-160 -84.56 -10.74 57.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.696 0.799 . . . . 71.43 110.338 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.03 -45.61 9.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.348 0.659 . . . . 54.32 109.543 170.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.93 -39.29 72.76 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.015 0.926 . . . . 54.55 111.432 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.16 12.44 67.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.068 -0.515 . . . . 51.35 113.018 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.54 -75.88 0.17 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.988 0.515 . . . . 61.01 111.716 -176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -72.74 -44.69 61.34 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.948 0.721 . . . . 61.43 112.948 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.485 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 61.7 m -61.52 -48.44 90.48 Favored Pre-proline 0 CA--C 1.567 1.626 0 CA-C-O 118.771 -0.633 . . . . 62.04 112.162 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.549 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 10.0 Cg_exo -72.76 -18.89 24.59 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.036 1.824 . . . . 75.53 112.977 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.31 -28.73 64.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.795 0.438 . . . . 44.43 110.563 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.11 -41.78 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-O 121.598 0.713 . . . . 71.42 109.413 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.41 HD13 ' O ' ' D' ' 80' ' ' GLN . 92.4 mt -74.72 -20.91 59.65 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.863 -1.062 . . . . 64.41 111.722 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.16 -41.42 14.29 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.252 1.205 . . . . 64.01 114.252 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -56.14 -36.04 95.91 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 121.762 1.641 . . . . 53.3 112.881 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.13 -32.82 33.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.81 0.844 . . . . 73.34 111.552 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.6 -50.74 63.94 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.584 -0.524 . . . . 74.54 109.584 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.507 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.7 ttp180 -58.31 -50.27 74.23 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.031 -1.441 . . . . 75.1 110.51 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -63.06 -42.43 99.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.46 0.704 . . . . 72.41 111.643 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.2 t -59.47 -44.86 92.92 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.767 0.667 . . . . 72.24 110.944 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.436 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.3 mt -62.41 -57.24 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.612 0.765 . . . . 75.34 110.092 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.524 HG23 ' HG3' ' D' ' 125' ' ' GLN . 83.8 m -50.12 -43.83 51.93 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.533 1.533 . . . . 70.14 112.477 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.99 -44.66 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 70.34 110.486 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -64.48 -33.78 76.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.909 0.484 . . . . 74.14 111.43 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 79.4 t -64.61 -45.8 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.108 0.963 . . . . 52.12 110.049 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.03 -27.98 63.07 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.683 0.278 . . . . 61.34 111.085 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -71.68 -30.59 65.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.6 0.76 . . . . 72.21 110.138 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 6.64 80.11 Favored Glycine 0 C--N 1.358 1.781 0 O-C-N 123.66 0.6 . . . . 60.34 112.731 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.455 HG23 ' HB3' ' C' ' 17' ' ' TYR . 51.0 p 65.41 21.28 11.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.309 1.844 . . . . 71.51 113.09 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.26 164.89 18.01 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 124.82 1.248 . . . . 72.34 109.314 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.07 140.34 22.52 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.394 2.063 . . . . 63.42 112.266 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.524 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.8 tt0 -55.75 126.65 26.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 75.23 111.013 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.93 105.65 15.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.411 0.684 . . . . 75.13 109.209 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -98.48 92.81 5.83 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.718 -0.845 . . . . 73.12 108.718 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.551 HD22 HD21 ' D' ' 42' ' ' LEU . 76.3 mt -69.89 123.33 21.2 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.098 0.559 . . . . 75.14 109.555 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.21 133.05 75.33 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.254 0.621 . . . . 54.3 111.145 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.65 108.66 2.3 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 121.877 1.718 . . . . 63.14 110.17 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.7 107.25 22.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.809 -1.182 . . . . 73.41 107.809 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 . . . . . 0 C--O 1.241 0.649 0 CA-C-N 115.141 -0.936 . . . . 75.23 108.682 178.035 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.239 0.52 0 N-CA-C 109.328 -0.619 . . . . 60.52 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 45.3 t80 -127.38 141.68 51.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.204 1.002 . . . . 70.4 108.878 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 60.0 tp60 -152.66 137.35 16.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.999 0.52 . . . . 64.25 110.296 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.99 117.05 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.754 -1.202 . . . . 53.3 107.754 173.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -90.08 -40.73 12.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.443 0.297 . . . . 75.13 110.539 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -172.77 125.02 0.46 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.704 0.401 . . . . 51.2 110.693 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.891 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 71.6 mt -106.67 136.34 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.504 -0.925 . . . . 63.43 108.504 171.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 31.7 p90 -167.14 171.0 11.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.888 0.875 . . . . 72.54 110.101 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -92.38 130.29 38.1 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.498 -0.927 . . . . 75.43 108.498 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.6 mtpt -92.35 -42.94 9.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.61 -0.885 . . . . 65.05 108.61 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.4 t70 -135.09 135.03 40.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.921 -1.036 . . . . 63.41 110.083 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 117' ' ' MET . 82.5 mt -131.65 136.98 56.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.24 -1.393 . . . . 51.24 107.24 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -145.66 128.32 16.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.872 -0.418 . . . . 72.32 109.872 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 80.8 t80 -134.11 114.86 13.59 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.741 -1.578 . . . . 74.23 106.741 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 46.5 mt-10 -121.61 117.46 26.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.464 -0.569 . . . . 62.25 109.464 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.52 91.95 6.53 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 109.015 -0.735 . . . . 72.03 109.015 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 19.0 Cg_exo -67.39 -50.35 0.99 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.005 2.47 . . . . 71.4 111.854 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 40.1 m-80 -99.56 42.5 1.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.86 0.864 . . . . 73.34 109.86 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' B' ' 17' ' ' TYR . . . -59.19 -48.39 96.45 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.76 1.224 . . . . 74.02 114.144 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.88 -17.89 11.92 Favored 'Trans proline' 0 C--N 1.386 2.503 0 CA-C-N 121.168 1.453 . . . . 65.44 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -74.02 -38.79 63.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.14 111.546 -173.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.76 -14.15 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.758 0.823 . . . . 74.32 111.747 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.82 -39.63 89.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.487 0.715 . . . . 75.44 111.186 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -100.55 -30.28 11.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.604 0.762 . . . . 74.34 110.956 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.8 tmtp? -76.49 139.71 40.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.844 0.858 . . . . 73.32 108.95 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.1 m-20 -57.78 116.39 3.42 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.881 0.738 . . . . 72.43 109.793 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -79.17 80.45 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.191 0.996 . . . . 63.13 109.014 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -114.5 83.86 9.16 Favored Pre-proline 0 C--O 1.245 0.851 0 N-CA-C 107.404 -1.332 . . . . 63.41 107.404 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB2' HG13 ' A' ' 40' ' ' VAL . 73.2 Cg_endo -73.76 122.16 7.56 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.921 1.747 . . . . 72.24 112.125 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -94.93 85.31 4.34 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 105.857 -1.905 . . . . 71.43 105.857 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 38' ' ' PRO . 14.0 m -75.25 93.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.703 -1.589 . . . . 63.41 110.744 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -77.78 144.7 36.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.268 -1.787 . . . . 64.31 108.891 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.37 147.7 38.46 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.711 -1.131 . . . . 75.1 108.866 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.4 132.04 18.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.425 -0.954 . . . . 63.44 108.425 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 tp -99.46 119.24 37.68 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.695 -0.854 . . . . 74.42 108.695 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.78 155.66 50.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.775 -0.454 . . . . 72.12 109.775 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -118.15 162.89 17.47 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.374 0.67 . . . . 73.43 109.443 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.02 116.12 6.92 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.618 -1.253 . . . . 63.23 107.618 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 p -98.88 150.27 22.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.321 -0.251 . . . . 72.31 110.321 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -159.34 121.07 3.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.449 0.7 . . . . 72.42 109.458 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.72 131.17 35.82 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.962 -0.755 . . . . 61.52 108.962 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -104.45 -38.32 6.85 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.313 0.645 . . . . 51.1 110.454 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -154.23 -177.61 6.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.098 0.959 . . . . 73.22 109.776 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.26 128.11 34.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.336 -0.987 . . . . 72.31 108.336 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 69.96 2.73 4.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.151 0.981 . . . . 72.34 111.935 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 54.5 t -120.31 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 107.01 -1.478 . . . . 73.34 107.01 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.38 128.67 44.95 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 72.13 108.95 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.25 115.09 28.34 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.861 -1.063 . . . . 52.53 109.168 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.42 119.73 53.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.047 0 N-CA-C 106.087 -1.82 . . . . 73.54 106.087 169.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -97.3 132.14 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.847 0.859 . . . . 55.33 108.938 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 115.37 27.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.726 -1.213 . . . . 53.5 107.726 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -105.3 100.74 10.31 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.03 -0.73 . . . . 70.43 109.03 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 114' ' ' ILE . 32.7 t -99.92 127.32 52.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.152 -1.055 . . . . 71.24 108.152 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -122.73 132.83 54.42 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.612 -0.514 . . . . 64.45 109.612 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 51.2 t -133.15 126.22 52.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 125.351 1.46 . . . . 61.24 108.569 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -118.66 137.03 53.58 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.44 109.437 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.66 111.8 23.49 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.049 -1.093 . . . . 72.31 108.049 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.9 m -108.46 131.29 54.94 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.973 0.416 . . . . 62.23 110.323 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 mt -105.14 43.1 1.14 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.699 -1.223 . . . . 74.04 107.699 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.98 -115.01 4.93 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.946 -1.261 . . . . 63.44 109.946 -168.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.41 -25.95 18.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.217 0.607 . . . . 73.44 110.411 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.64 99.6 5.85 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.84 -0.618 . . . . 74.33 110.015 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.9 m -68.75 127.45 33.11 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.206 -0.664 . . . . 74.41 109.206 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -52.05 8.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.881 0.873 . . . . 64.32 109.101 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.46 159.74 43.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.163 -1.38 . . . . 74.33 110.328 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -130.55 132.37 45.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.049 -1.463 . . . . 61.45 107.049 173.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.9 m -122.09 135.21 54.78 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.145 0.978 . . . . 73.34 108.792 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -148.27 116.49 6.5 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.003 -1.11 . . . . 72.13 108.003 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.6 t -123.92 118.71 54.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.87 -0.789 . . . . 71.35 108.87 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.1 mt-30 -97.15 88.23 4.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.904 -1.044 . . . . 74.24 108.451 172.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.2 tp-100 -75.7 98.94 4.21 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 114.541 -1.209 . . . . 74.53 107.936 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.01 143.74 18.34 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 112.042 -0.423 . . . . 64.11 112.042 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.27 120.83 1.96 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.878 -0.889 . . . . 71.45 110.878 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' B' ' 29' ' ' PRO . 50.2 mt -81.71 126.73 39.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.304 -1.369 . . . . 41.22 107.304 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 64.8 m-85 -134.8 128.83 33.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.552 -0.536 . . . . 73.33 109.552 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 12' ' ' GLN . 9.3 p -84.08 96.62 8.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.58 -0.896 . . . . 72.15 108.58 170.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 133.72 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 60.3 109.378 -169.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 175.61 4.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.594 0.757 . . . . 64.03 111.161 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.46 -22.86 31.54 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.433 -0.803 . . . . 33.42 113.314 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -110.25 150.84 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 53.2 110.152 -176.138 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -140.88 174.87 10.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.596 0.358 . . . . 75.35 110.834 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.6 -134.46 35.54 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.384 -0.371 . . . . 75.12 113.391 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -68.07 -21.79 64.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.814 0.846 . . . . 54.11 111.745 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -65.46 -35.76 81.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.676 0.79 . . . . 65.23 110.685 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 62.0 tpp -69.22 -39.89 78.29 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 116.201 -0.454 . . . . 72.2 109.972 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -28.59 69.67 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.937 0.495 . . . . 74.14 111.31 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -72.36 -61.76 1.68 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.408 0.683 . . . . 63.32 111.017 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 9.1 t -68.39 -43.3 77.6 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 52.13 110.773 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 tt -84.56 -41.2 16.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.023 0.929 . . . . 75.25 110.618 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.14 -36.19 28.33 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 114.822 0.689 . . . . 75.52 114.822 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.8 -44.44 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.939 0.496 . . . . 72.04 112.107 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.414 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -74.18 -53.62 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.909 0.883 . . . . 74.31 112.669 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.12 -40.79 30.72 Favored Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 113.206 0.817 . . . . 73.05 113.206 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.8 Cg_endo -66.7 -22.14 50.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 CA-C-N 121.05 1.411 . . . . 64.11 113.295 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.89 -31.17 68.83 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 118.269 0.486 . . . . 71.21 110.461 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.25 -33.07 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.786 0.803 . . . . 74.52 110.364 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 103' ' ' PRO . 86.5 mt -82.67 -23.64 34.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.866 1.266 . . . . 65.24 113.123 -174.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -62.3 -40.7 69.08 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.609 1.337 . . . . 71.24 114.609 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.52 -38.54 83.57 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 121.982 1.788 . . . . 35.13 112.992 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -82.56 -34.09 27.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.086 0.954 . . . . 74.42 111.515 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.06 78.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.063 0.545 . . . . 72.52 109.544 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.431 ' NH1' HD12 ' C' ' 105' ' ' ILE . 39.6 ttm180 -52.04 -52.7 49.23 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.709 1.256 . . . . 74.23 110.655 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.45 -45.74 92.99 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.403 1.064 . . . . 72.35 111.244 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -58.76 -45.35 89.95 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.771 0.669 . . . . 75.53 111.154 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 118' ' ' VAL . 86.7 mt -62.52 -51.58 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.903 0.752 . . . . 73.23 109.793 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -56.14 -41.28 75.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.267 1.027 . . . . 52.03 111.805 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.9 t -66.21 -47.88 72.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.345 0.658 . . . . 73.53 110.006 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 21' ' ' ILE . 13.5 mtp -55.59 -46.77 77.21 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.988 0.915 . . . . 71.41 111.048 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -60.1 -44.15 94.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.726 1.21 . . . . 73.11 111.17 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.4 t -68.38 -31.82 71.46 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.816 -0.629 . . . . 64.42 111.322 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 94.1 mtt-85 -74.16 -20.38 60.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.735 0.814 . . . . 53.21 110.844 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.04 11.55 57.03 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.511 0.507 . . . . 71.55 112.983 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' HH21 ' B' ' 15' ' ' ARG . 17.3 m 66.71 35.51 5.14 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.495 1.14 . . . . 54.44 110.323 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.31 149.68 50.11 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.162 -0.926 . . . . 74.53 109.54 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.21 157.78 47.85 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.718 2.278 . . . . 64.22 112.564 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.83 141.74 58.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.637 -1.165 . . . . 73.53 112.628 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -123.48 107.06 11.16 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.156 -1.424 . . . . 71.43 107.156 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.55 99.97 8.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.148 0.979 . . . . 70.42 109.387 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.91 148.32 40.21 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.699 0.8 . . . . 71.33 110.421 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.62 147.45 98.69 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.634 0.774 . . . . 63.24 111.817 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.426 ' HB3' HH22 ' A' ' 111' ' ' ARG . 71.7 Cg_endo -83.73 165.76 13.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.75 2.3 . . . . 75.21 112.801 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.41 114.68 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.744 -0.835 . . . . 72.11 108.744 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -99.98 63.82 1.2 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.948 -1.13 . . . . 71.35 107.948 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.479 0.991 0 CA-C-N 114.503 -1.226 . . . . 73.15 110.608 -176.512 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.424 -1.324 . . . . 74.34 107.424 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.9 140.95 38.54 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.813 -0.81 . . . . 71.13 108.813 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.6 140.26 18.93 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.631 0.582 . . . . 74.41 109.906 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 tt -95.09 133.03 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.939 0.896 . . . . 41.0 109.46 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -104.7 -50.55 3.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.814 0.446 . . . . 73.41 110.872 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.458 HH21 ' HB ' ' A' ' 122' ' ' THR . 63.3 ttt180 -158.57 140.36 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.657 0.383 . . . . 75.14 110.8 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -117.83 142.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.015 -1.105 . . . . 65.44 108.015 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.441 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 40.4 p90 -162.86 169.63 19.5 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.823 0.702 . . . . 73.02 110.69 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.8 m -99.2 123.23 43.32 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.065 -0.716 . . . . 72.33 109.065 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -77.21 -52.7 8.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.926 -0.579 . . . . 73.42 110.402 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -140.79 140.93 34.82 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.111 0.481 . . . . 71.02 111.919 -165.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mm -132.81 138.14 52.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.933 1.293 . . . . 72.31 108.396 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -143.1 135.98 27.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.063 -0.971 . . . . 62.44 108.509 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -153.35 111.85 3.67 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.851 -1.166 . . . . 74.11 107.851 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -119.83 118.66 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.594 -0.891 . . . . 64.22 108.594 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.793 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -115.89 86.88 17.11 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.721 0.808 . . . . 74.04 109.643 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.9 -50.57 2.16 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.868 2.379 . . . . 64.25 112.695 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -101.56 20.6 15.79 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.561 0.744 . . . . 72.24 111.435 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.793 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.6 -52.73 42.17 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 124.898 1.279 . . . . 54.0 112.932 168.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 83' ' ' ILE . 43.8 Cg_endo -74.62 -12.02 22.31 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 121.692 1.595 . . . . 64.54 113.207 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -96.01 1.12 52.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.759 0.824 . . . . 72.12 110.915 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.01 -22.92 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.817 1.247 . . . . 42.41 112.936 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.84 -42.05 78.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.915 0.886 . . . . 72.15 110.937 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -83.46 -12.47 56.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.5 1.12 . . . . 74.41 111.136 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -100.54 75.3 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.031 0.932 . . . . 74.24 109.284 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.12 76.04 9.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 71.54 110.899 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.48 158.51 1.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.89 1.276 . . . . 74.31 109.885 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.471 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 63.8 tt0 -83.93 130.89 53.3 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 74.32 108.729 173.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 50.3 Cg_endo -65.6 153.39 78.4 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.51 2.14 . . . . 64.2 112.746 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 42.8 mt-10 -69.76 100.82 1.57 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.944 . . . . 73.03 108.453 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' B' ' 126' ' ' LEU . 33.1 t -90.24 121.23 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 107.871 -1.159 . . . . 73.42 107.871 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -148.76 139.78 23.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.468 -1.308 . . . . 64.32 107.468 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.464 HD21 HD12 ' B' ' 126' ' ' LEU . 0.8 OUTLIER -128.11 163.03 25.52 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.711 0.767 . . . . 63.23 112.475 -171.626 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -126.9 154.15 44.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.049 -1.432 . . . . 74.52 108.555 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.451 HD21 HD21 ' B' ' 60' ' ' LEU . 2.5 tt -134.94 116.17 14.4 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.792 -1.559 . . . . 72.24 106.792 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -126.46 155.28 42.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.754 0.822 . . . . 74.43 110.044 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 29.2 m -111.4 136.69 50.18 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 64.13 110.394 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.583 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.15 154.06 36.7 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.688 1.195 . . . . 71.44 108.177 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 m -141.68 160.69 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.006 0.431 . . . . 54.34 111.338 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -162.99 163.38 26.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.108 1.363 . . . . 65.41 108.332 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -123.02 137.24 55.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.056 0.943 . . . . 74.44 109.193 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.15 -35.11 9.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.177 0.591 . . . . 73.53 111.117 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.46 -174.25 2.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.346 1.058 . . . . 74.15 110.316 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.05 119.09 14.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.347 -0.842 . . . . 62.15 109.823 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 67.02 12.46 8.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.659 1.184 . . . . 74.34 112.138 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -128.27 110.62 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.779 -1.193 . . . . 63.22 107.779 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -122.31 163.96 18.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.137 -0.69 . . . . 75.2 109.137 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -137.93 110.46 7.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.681 -1.229 . . . . 71.31 107.681 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' B' ' 98' ' ' LEU . 24.4 m -107.77 150.66 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.211 0.529 . . . . 74.5 110.364 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 18.0 t -116.61 136.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 115.272 -0.876 . . . . 64.51 108.648 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -102.02 116.15 32.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.962 -1.125 . . . . 73.21 107.962 178.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -97.44 125.16 41.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.016 0.526 . . . . 61.22 109.98 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' B' ' 114' ' ' ILE . 12.7 t -125.7 116.86 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.486 -0.931 . . . . 74.4 108.486 166.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 38.0 m -99.08 152.13 20.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.452 1.101 . . . . 73.14 109.216 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' B' ' 42' ' ' LEU . 76.1 t -136.78 111.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.936 0.894 . . . . 71.03 109.242 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.2 m -92.31 138.41 31.54 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.514 0.725 . . . . 74.44 109.047 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.05 142.21 28.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.127 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -140.7 128.65 21.95 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.747 0.654 . . . . 73.53 111.824 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.8 99.04 11.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.951 -1.129 . . . . 54.14 107.951 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -112.81 3.79 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.341 -0.845 . . . . 54.21 111.467 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -108.26 1.32 21.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.091 0.956 . . . . 73.3 111.131 -176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.0 155.6 41.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.481 0.712 . . . . 72.14 110.213 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 130.72 44.17 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.034 0.534 . . . . 73.53 111.97 -173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.409 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -84.68 -58.85 2.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 60.24 108.72 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -161.55 162.93 30.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 113.536 -1.665 . . . . 63.31 109.352 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.4 mt -136.32 111.63 9.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.935 -1.506 . . . . 72.55 106.935 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -117.87 158.17 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.702 0.801 . . . . 62.14 109.068 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -165.68 146.69 7.0 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.003 -0.74 . . . . 71.34 109.003 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.15 144.5 37.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.566 -1.197 . . . . 70.42 108.353 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.1 mt-30 -127.36 93.46 3.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.547 -0.908 . . . . 71.13 108.547 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.407 ' O ' HD13 ' B' ' 106' ' ' LEU . 55.6 tp60 -86.08 102.66 14.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.95 -1.023 . . . . 62.11 109.449 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.57 148.87 20.76 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.759 -0.536 . . . . 71.44 111.759 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.25 126.09 2.16 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 117.27 0.535 . . . . 64.25 112.416 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.98 127.2 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.535 0.734 . . . . 63.5 109.079 173.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -139.72 170.18 16.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 70.31 109.041 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -133.68 131.72 39.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 74.34 108.874 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.691 HD12 ' SG ' ' B' ' 97' ' ' CYS . 7.1 tt -140.32 145.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.417 0.287 . . . . 71.1 110.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.3 39.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.767 0.827 . . . . 72.24 110.078 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.05 -31.6 4.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.18 -0.464 . . . . 64.22 114.149 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' B' ' 94' ' ' MET . 0.1 OUTLIER -71.54 170.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.13 0.972 . . . . 75.4 112.679 -177.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 93' ' ' GLN . 13.8 pt-20 -164.12 160.25 21.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.326 0.65 . . . . 75.32 110.388 173.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.55 -128.74 47.57 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.469 0.48 . . . . 33.33 113.693 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 38.0 m -68.47 -21.88 64.59 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.367 0.667 . . . . 63.45 111.382 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' B' ' 90' ' ' GLU . 97.1 mt-30 -64.97 -31.7 73.06 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.907 0.483 . . . . 75.32 110.806 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.497 ' HB2' HG12 ' B' ' 89' ' ' ILE . 13.1 tpt -85.86 -46.3 10.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.457 -0.338 . . . . 64.32 110.574 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.67 66.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.781 0.833 . . . . 75.31 111.872 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.1 -38.67 75.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.638 0.775 . . . . 72.43 111.16 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' B' ' 86' ' ' ILE . 53.4 t -64.98 -68.37 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.882 0.31 . . . . 73.5 111.547 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.77 ' HB2' HG11 ' B' ' 58' ' ' VAL . 2.6 pt? -75.46 -18.02 59.98 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.785 0.266 . . . . 74.23 111.517 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.64 3.64 42.61 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-O 118.984 -0.898 . . . . 74.0 114.373 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.96 -50.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.076 0.938 . . . . 44.33 112.409 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -72.84 -46.57 52.27 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.557 0.743 . . . . 63.02 111.55 -170.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.0 -44.8 40.91 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 118.457 -0.782 . . . . 73.31 110.717 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.13 -45.35 21.8 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.033 1.822 . . . . 75.31 112.841 163.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -60.74 -36.52 79.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.509 0.724 . . . . 73.23 111.782 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.01 -48.37 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.358 0.663 . . . . 71.34 110.77 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 60' ' ' LEU . 44.2 mt -83.0 -11.48 58.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.911 -1.04 . . . . 71.02 111.575 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -62.22 -48.42 87.77 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 117.904 -1.046 . . . . 72.43 113.724 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.17 -36.07 98.17 Favored 'Trans proline' 0 C--N 1.373 1.851 0 CA-C-N 121.04 1.407 . . . . 44.31 112.267 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -66.28 -51.37 58.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 74.15 111.261 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.38 94.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.941 0.897 . . . . 63.33 110.832 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -56.58 -50.34 72.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.204 1.401 . . . . 75.41 111.292 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.5 -35.75 81.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.236 0.614 . . . . 71.33 110.374 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.5 t -72.22 -37.96 69.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.152 -0.476 . . . . 61.32 111.065 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' B' ' 62' ' ' VAL . 54.0 mt -60.59 -50.22 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.352 0.661 . . . . 60.23 109.222 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 72.5 m -48.2 -46.49 35.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.842 1.339 . . . . 63.2 110.532 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.1 t -61.89 -56.51 18.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.446 -1.252 . . . . 62.02 110.882 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 20.0 mmt -67.6 -38.36 83.86 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.752 0.821 . . . . 51.0 112.389 -170.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.91 -44.45 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.424 0.631 . . . . 75.52 109.944 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.485 ' OG ' HG21 ' C' ' 115' ' ' THR . 48.3 t -67.34 -25.16 65.85 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.648 -1.16 . . . . 72.0 112.222 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -70.94 -36.4 72.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.194 0.597 . . . . 63.35 109.933 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 6.75 56.59 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.662 0.601 . . . . 74.34 112.49 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.0 p 57.22 42.01 26.02 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.368 1.867 . . . . 72.11 111.457 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 48.3 m-85 -114.85 159.42 37.49 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.533 -1.212 . . . . 75.42 110.698 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.573 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 39.6 Cg_exo -60.53 104.56 0.26 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.58 2.853 . . . . 72.41 114.684 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.503 ' HG3' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -65.0 161.53 18.5 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.156 1.382 . . . . 61.21 111.447 171.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.464 HD12 HD21 ' B' ' 42' ' ' LEU . 1.1 tm? -132.29 117.99 18.89 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.395 -0.965 . . . . 72.3 108.395 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.41 94.85 10.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.132 -1.062 . . . . 62.11 108.132 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.444 HD23 ' N ' ' B' ' 129' ' ' ALA . 1.8 tt -58.4 138.99 56.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.681 -1.145 . . . . 72.12 110.565 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.444 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -51.51 148.98 8.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 70.33 112.228 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.499 ' HG3' HG12 ' D' ' 16' ' ' ILE . 80.1 Cg_endo -72.07 78.81 1.78 Allowed 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.331 2.021 . . . . 74.22 111.451 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.7 m -74.07 83.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.239 1.019 . . . . 74.22 110.691 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.58 111.33 7.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.807 -1.088 . . . . 42.04 108.891 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.8 t80 . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.258 0.623 . . . . 74.41 110.91 -177.454 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.001 -0.74 . . . . 63.41 109.001 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -124.35 119.07 28.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -146.66 130.17 16.83 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.459 -0.941 . . . . 72.45 108.459 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 tp -78.81 137.89 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 109.477 -0.564 . . . . 72.44 109.477 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.5 mm100 -98.96 -47.33 5.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.273 0.629 . . . . 72.41 109.881 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.411 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 66.4 ttt180 -170.77 124.99 0.68 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.581 0.551 . . . . 74.44 110.48 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -109.35 141.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.665 -1.235 . . . . 74.22 107.665 169.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.455 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 6.8 p90 -179.39 164.94 1.38 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.438 0.695 . . . . 71.35 110.029 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -88.7 122.87 32.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 122.971 0.508 . . . . 71.25 109.913 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.595 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.8 mmtp -74.54 -50.56 17.6 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.069 0.938 . . . . 74.34 108.686 170.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.99 141.52 40.45 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.003 -1.453 . . . . 73.34 109.004 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 94.2 mt -137.28 139.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.808 -1.553 . . . . 65.12 106.808 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -149.85 146.3 27.04 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.557 -0.534 . . . . 74.33 109.557 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -152.48 108.84 3.41 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.162 -1.422 . . . . 75.24 107.162 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -116.47 118.68 33.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.91 -0.774 . . . . 61.43 108.91 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.49 86.94 5.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.28 -1.748 . . . . 72.53 106.28 167.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.55 -38.61 61.24 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 122.67 2.247 . . . . 43.42 110.989 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -99.9 44.79 1.01 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.394 -1.275 . . . . 52.3 109.064 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.462 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -59.26 -64.3 3.13 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.903 1.281 . . . . 61.33 112.694 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 61.3 Cg_endo -74.5 -12.47 22.62 Favored 'Trans proline' 0 C--N 1.382 2.319 0 CA-C-N 121.876 1.706 . . . . 53.42 112.203 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -67.7 -30.41 69.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.214 1.006 . . . . 73.42 109.907 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.824 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 2.9 p -69.51 -26.66 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 111.835 0.309 . . . . 70.33 111.835 -173.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.92 -40.15 72.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.651 1.18 . . . . 75.32 112.515 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -122.87 39.0 4.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.642 0.777 . . . . 65.34 109.889 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.824 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 31.7 ttpt -114.19 153.14 30.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 71.1 111.463 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.2 116.56 10.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.246 1.018 . . . . 54.14 110.539 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -87.2 101.7 13.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.378 1.071 . . . . 74.24 111.93 -173.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.47 HE22 ' HB3' ' C' ' 68' ' ' LEU . 0.1 OUTLIER -150.38 63.07 5.83 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 124.037 0.935 . . . . 75.1 109.683 168.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.26 122.09 6.87 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.099 2.532 . . . . 71.24 111.529 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.07 88.27 7.45 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.62 -1.252 . . . . 75.31 107.62 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.82 119.06 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.072 -1.422 . . . . 64.05 110.903 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -130.9 146.54 52.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.716 0.807 . . . . 71.12 110.396 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' C' ' 128' ' ' LEU . 56.1 tp -116.15 124.23 49.8 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.11 0.964 . . . . 70.41 109.201 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -119.21 116.84 27.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.843 0.857 . . . . 74.12 109.664 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.2 126.96 47.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.317 -0.994 . . . . 65.52 108.317 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -134.4 151.46 51.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.294 1.038 . . . . 74.13 108.863 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 24.5 m -112.17 115.83 29.48 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.108 0.563 . . . . 74.01 110.311 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.67 147.76 44.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.246 -1.02 . . . . 74.45 108.246 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -163.08 145.15 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.744 0.418 . . . . 55.5 110.649 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.2 t -145.35 125.98 14.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.214 1.005 . . . . 52.22 108.413 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.01 126.09 30.35 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.843 -0.428 . . . . 62.02 109.843 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.636 HD11 HD12 ' C' ' 83' ' ' ILE . 87.3 mt -91.34 -52.2 4.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.401 0.681 . . . . 75.02 110.675 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.83 -170.77 3.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.921 0.888 . . . . 72.42 110.646 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.13 117.89 7.76 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.184 -0.673 . . . . 71.24 109.184 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 64.76 12.19 7.46 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 124.232 0.958 . . . . 73.42 112.186 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.4 t -121.74 122.93 68.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.621 -1.252 . . . . 72.55 107.621 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.42 ' OH ' ' HB3' ' C' ' 98' ' ' LEU . 0.1 OUTLIER -138.99 157.91 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 175.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -105.02 116.29 31.7 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.575 -1.193 . . . . 73.15 108.563 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.98 132.03 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.911 -1.144 . . . . 62.51 107.911 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.5 t -128.0 111.25 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.205 -1.406 . . . . 63.02 107.205 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.76 108.9 18.29 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.922 -1.51 . . . . 74.5 106.922 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -81.22 104.81 11.94 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.909 -1.145 . . . . 73.1 107.909 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.68 107.42 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.218 -0.66 . . . . 53.32 109.218 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -104.0 145.91 29.47 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.352 0.661 . . . . 72.43 109.285 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.612 HG21 HG21 ' C' ' 114' ' ' ILE . 38.9 t -140.54 117.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 124.706 1.202 . . . . 72.45 108.081 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -111.98 141.62 45.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.833 0.349 . . . . 63.14 110.097 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.37 103.17 6.29 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 107.155 -1.424 . . . . 64.42 107.155 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.1 m -125.55 137.9 53.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.163 0.506 . . . . 71.34 110.591 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.47 ' HB3' HE22 ' C' ' 37' ' ' GLN . 10.9 mt -89.51 37.55 0.87 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.859 1.264 . . . . 72.5 109.308 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.67 -115.47 5.11 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.213 -1.155 . . . . 72.34 110.213 -166.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.37 -31.48 16.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.582 0.753 . . . . 74.14 110.107 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.86 105.76 3.93 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.054 0.942 . . . . 62.41 108.922 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.06 135.61 37.76 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 122.27 -0.269 . . . . 62.24 110.95 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.55 -56.46 4.29 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.807 -0.812 . . . . 62.01 108.807 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -161.2 173.4 15.14 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.516 -0.765 . . . . 72.5 111.46 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.3 tm? -136.82 141.16 42.87 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.146 -1.428 . . . . 71.04 107.146 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' C' ' 114' ' ' ILE . 35.4 t -141.68 139.57 33.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.768 -1.197 . . . . 53.11 107.768 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.49 116.25 3.86 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.141 -0.689 . . . . 75.53 109.141 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -120.9 140.11 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.836 0.854 . . . . 71.22 109.623 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -107.7 109.02 20.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.941 0.896 . . . . 73.41 109.123 168.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.474 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -89.4 107.74 19.24 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.119 -0.697 . . . . 72.04 109.119 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.4 22.15 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.61 0.569 . . . . 53.03 112.033 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.43 116.83 0.77 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.694 -0.962 . . . . 64.5 110.694 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.636 HD12 HD11 ' C' ' 51' ' ' LEU . 13.7 mm -88.7 119.12 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.56 -0.904 . . . . 60.32 108.56 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 135.65 54.81 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.413 0.685 . . . . 75.0 109.725 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -103.47 99.66 9.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.845 -1.168 . . . . 60.34 107.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.82 156.23 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.096 0.558 . . . . 71.43 110.202 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.08 157.36 2.29 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.723 1.209 . . . . 71.23 108.949 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -18.27 54.26 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 120.333 -0.148 . . . . 73.44 113.178 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' C' ' 94' ' ' MET . 46.1 pt . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 123.126 0.57 . . . . 51.01 111.301 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 119.657 -0.211 . . . . 75.15 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.741 ' SD ' HD21 ' C' ' 98' ' ' LEU . 25.6 tpp -59.29 -55.37 35.65 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.536 0.523 . . . . 75.43 110.101 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.96 -34.6 78.47 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.644 -0.707 . . . . 74.41 112.229 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -77.78 -34.08 52.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.671 0.388 . . . . 75.23 111.772 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -68.8 -60.66 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.775 0.43 . . . . 62.52 110.755 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.741 HD21 ' SD ' ' C' ' 94' ' ' MET . 1.5 pp -94.43 -19.14 20.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.891 0.7 . . . . 75.22 112.891 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 6.73 73.76 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.785 -0.453 . . . . 71.5 113.326 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.69 -56.53 0.07 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.668 0.387 . . . . 61.01 111.873 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.53 -53.82 9.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.957 0.725 . . . . 71.25 112.957 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.35 -43.41 79.54 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 123.685 0.794 . . . . 61.0 112.456 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.04 -30.44 66.25 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 121.308 1.339 . . . . 65.13 112.706 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.64 -32.7 74.18 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.217 0.462 . . . . 72.31 110.315 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.431 HD12 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -60.22 -44.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.291 0.567 . . . . 70.15 109.903 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.8 mt -78.68 -21.12 48.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.9 -1.046 . . . . 61.42 111.926 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -56.69 -55.36 43.97 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 117.434 -1.27 . . . . 73.21 113.631 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.91 -30.7 84.15 Favored 'Trans proline' 0 C--N 1.377 2.03 0 CA-C-N 121.571 1.597 . . . . 42.32 112.732 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -63.39 -50.85 68.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.626 0.77 . . . . 75.01 110.83 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.42 -42.33 98.73 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.229 1.012 . . . . 70.32 111.225 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -61.12 -44.17 97.76 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.405 1.882 . . . . 61.1 110.521 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.2 -35.11 63.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.347 0.659 . . . . 64.11 110.3 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.5 t -64.1 -34.43 78.03 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.504 0.722 . . . . 71.35 111.357 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.612 HG21 HG21 ' C' ' 64' ' ' VAL . 97.3 mt -73.28 -45.01 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.805 0.842 . . . . 75.33 111.349 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.485 HG21 ' OG ' ' B' ' 119' ' ' SER . 28.4 m -57.83 -35.39 70.83 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.803 0.441 . . . . 75.42 111.787 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.1 -48.66 70.16 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.29 -0.633 . . . . 71.43 109.29 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.578 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.34 -39.46 70.03 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.872 1.269 . . . . 71.41 113.144 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' C' ' 126' ' ' LEU . 94.2 t -62.09 -48.23 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.218 0.532 . . . . 61.1 110.399 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.9 t -66.52 -28.66 68.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.079 -0.964 . . . . 54.42 111.843 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 84.6 mtt-85 -67.16 -40.62 86.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.068 -0.715 . . . . 73.41 109.068 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.65 5.04 66.13 Favored Glycine 0 C--N 1.358 1.789 0 O-C-N 124.038 0.836 . . . . 71.34 112.912 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 56.1 53.66 8.8 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.063 1.745 . . . . 71.31 111.939 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.508 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 56.4 m-85 -113.22 172.57 3.44 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 114.516 -1.22 . . . . 74.22 109.492 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 18.3 Cg_endo -56.59 171.49 0.96 Allowed 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.639 2.226 . . . . 70.14 113.327 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 9.0 tm0? -60.53 140.7 57.21 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.377 -0.972 . . . . 72.54 108.377 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.431 ' HB3' HG21 ' C' ' 118' ' ' VAL . 9.5 tp -151.03 83.34 1.33 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.975 0.893 . . . . 73.31 110.363 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.99 98.42 3.75 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.812 -1.54 . . . . 73.51 107.092 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' C' ' 42' ' ' LEU . 49.8 mt -78.5 149.26 33.17 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.636 -0.505 . . . . 63.33 109.636 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.86 155.5 82.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.926 0.89 . . . . 61.1 112.749 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.891 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 76.6 Cg_exo -54.74 132.5 52.09 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.926 3.084 . . . . 72.1 113.949 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -111.37 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.798 -1.186 . . . . 63.34 107.798 174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -87.59 68.75 9.63 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.543 0.687 . . . . 71.43 110.0 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.155 -0.929 . . . . 71.53 110.929 177.687 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 79.7 m . . . . . 0 C--O 1.244 0.792 0 N-CA-C 109.507 -0.553 . . . . 71.45 109.507 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.7 t80 -156.31 104.72 2.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.212 -1.403 . . . . 74.23 107.212 172.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -110.35 112.08 23.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.926 -1.138 . . . . 50.23 107.926 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 tt -80.36 98.63 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.102 -1.444 . . . . 72.25 107.102 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.66 -50.04 7.51 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.6 -167.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -162.3 119.08 2.03 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.663 -0.495 . . . . 74.55 109.663 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.499 HG12 ' HG3' ' B' ' 130' ' ' PRO . 28.3 mm -111.49 118.21 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.897 -1.149 . . . . 74.35 107.897 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.5 146.59 28.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.28 0.632 . . . . 71.21 111.232 -171.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 50.0 p -75.98 113.04 13.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.021 -0.99 . . . . 62.31 109.938 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -80.92 -36.03 31.59 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.415 -0.587 . . . . 62.42 109.415 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -144.77 137.59 26.56 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.081 -0.963 . . . . 72.54 109.617 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.521 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.2 mt -137.55 139.63 43.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.872 -1.159 . . . . 65.3 107.872 174.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -142.09 140.72 32.61 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -151.8 120.95 6.72 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.625 -1.621 . . . . 65.1 106.625 173.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.04 112.95 11.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 64.15 109.778 -175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -110.45 84.18 3.75 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.682 0.793 . . . . 64.13 109.581 177.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 -26.97 11.44 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.051 2.5 . . . . 64.13 113.183 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -114.82 25.35 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.922 0.889 . . . . 74.51 109.847 -174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -58.72 -57.42 26.86 Favored Pre-proline 0 CA--C 1.564 1.497 0 N-CA-C 115.038 1.496 . . . . 74.12 115.038 -164.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 86.6 Cg_endo -78.42 -15.07 14.25 Favored 'Trans proline' 0 C--N 1.38 2.217 0 CA-C-N 122.06 1.771 . . . . 75.22 112.799 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.42 -44.24 68.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.041 0.936 . . . . 71.2 109.543 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.497 HG23 ' HD2' ' D' ' 34' ' ' LYS . 2.1 p -84.38 0.77 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.61 0.764 . . . . 75.35 110.981 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.411 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 84.2 t80 -63.36 -17.33 62.49 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.464 1.106 . . . . 73.4 111.169 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -81.32 -1.31 44.77 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.69 0.796 . . . . 75.21 112.104 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.497 ' HD2' HG23 ' D' ' 31' ' ' VAL . 96.5 mttt -121.8 113.27 19.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.877 0.871 . . . . 74.05 112.446 -167.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.98 79.84 2.24 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.222 1.011 . . . . 73.13 111.228 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.425 ' HB2' HD22 ' D' ' 68' ' ' LEU . 22.3 m95 -127.04 171.38 11.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.508 -0.745 . . . . 74.34 110.572 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -85.04 120.55 73.68 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.605 -1.257 . . . . 75.2 107.605 164.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.403 ' O ' HG23 ' D' ' 40' ' ' VAL . 31.8 Cg_exo -57.4 114.5 1.97 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.977 1.784 . . . . 71.44 110.972 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -65.8 112.39 3.71 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 106.71 -1.589 . . . . 73.51 106.71 167.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.699 HG13 HG13 ' D' ' 64' ' ' VAL . 71.2 t -116.34 111.66 36.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 123.188 0.595 . . . . 61.3 109.591 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -87.21 133.67 33.63 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.961 -1.125 . . . . 74.12 107.961 169.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.15 127.41 53.79 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.706 -1.22 . . . . 75.43 107.706 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.2 t70 -112.76 125.18 54.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.228 -0.656 . . . . 54.53 109.228 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 62.0 tp -97.05 131.6 43.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.114 0.965 . . . . 71.21 109.758 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.0 t70 -147.59 155.45 41.84 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.631 -0.877 . . . . 51.24 108.631 168.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -146.28 151.36 37.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.384 0.674 . . . . 63.14 109.759 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.04 172.6 14.98 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.177 0.991 . . . . 74.14 108.853 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.2 p -163.76 163.68 23.97 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.729 0.412 . . . . 44.02 110.73 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 54.9 p -154.04 139.59 17.84 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.401 0.68 . . . . 74.41 109.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.15 122.98 25.1 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 110.207 -0.294 . . . . 71.23 110.207 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.0 mt -94.64 -35.99 11.96 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.631 0.582 . . . . 51.23 109.639 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.83 -176.6 5.34 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.038 0.935 . . . . 53.21 110.008 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.76 128.13 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.79 -0.641 . . . . 74.02 109.314 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 61.08 26.42 16.35 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.933 0.893 . . . . 52.52 110.854 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -139.68 122.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 C-N-CA 124.105 0.962 . . . . 61.14 109.717 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -136.07 137.37 41.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 72.33 108.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.495 ' HB2' HD11 ' D' ' 51' ' ' LEU . 20.5 tt0 -88.29 118.6 28.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.235 -1.024 . . . . 62.23 108.235 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.44 140.29 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.128 -1.064 . . . . 75.52 108.128 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.2 t -121.87 143.06 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.437 1.095 . . . . 72.42 108.997 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -119.74 126.83 52.03 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.511 -1.292 . . . . 72.13 107.511 174.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.3 ttm-85 -106.66 104.44 14.12 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.339 -0.986 . . . . 73.23 108.339 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 128.19 48.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.799 -1.186 . . . . 64.02 107.799 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.4 m -120.9 129.0 53.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.987 -0.375 . . . . 53.41 109.987 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.699 HG13 HG13 ' D' ' 40' ' ' VAL . 71.7 t -111.95 109.1 27.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 125.365 1.466 . . . . 71.11 109.318 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -102.17 93.75 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.397 -1.334 . . . . 65.12 107.397 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.92 144.01 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.586 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 18.5 m -142.87 135.72 27.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.451 0.469 . . . . 75.23 112.196 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 52.0 mt -116.65 125.44 51.77 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.87 0.868 . . . . 73.42 109.176 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.48 -113.09 4.11 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.143 -0.383 . . . . 34.42 112.143 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 7.01 10.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.273 0.629 . . . . 65.51 110.865 -176.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -129.42 174.62 9.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.37 0.668 . . . . 73.22 110.212 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -72.62 132.85 44.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.541 -0.754 . . . . 64.12 110.91 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.558 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -82.04 -57.98 3.17 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.62 -0.882 . . . . 72.34 108.62 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -164.8 165.53 20.52 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 113.623 -1.626 . . . . 74.11 108.921 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -122.77 153.45 39.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.452 -1.314 . . . . 61.41 107.452 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.571 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 40.1 t -158.7 146.91 18.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.742 0.417 . . . . 75.13 110.098 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.67 128.92 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.181 -0.674 . . . . 74.12 109.181 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.44 114.18 32.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.214 -0.662 . . . . 64.51 109.214 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.8 mt-30 -89.46 86.24 6.73 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.422 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.56 104.44 10.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 113.868 -1.515 . . . . 74.32 108.729 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.35 164.74 28.41 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 111.848 -0.501 . . . . 60.12 111.848 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.65 131.82 2.56 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.774 -0.531 . . . . 73.54 111.774 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -87.88 132.24 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.957 -0.757 . . . . 55.14 108.957 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.38 145.49 47.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.54 0.736 . . . . 72.43 110.075 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 67.0 m -96.34 136.91 36.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.019 -0.734 . . . . 71.25 109.019 167.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.35 126.49 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.401 1.081 . . . . 70.03 110.134 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -167.93 156.03 8.84 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.733 0.813 . . . . 64.41 110.066 175.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.18 -20.68 28.37 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 120.147 -0.252 . . . . 34.23 112.951 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.527 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -116.83 157.94 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.12 0.968 . . . . 74.4 109.295 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.85 175.0 13.04 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.03 0.381 . . . . 75.23 112.03 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -133.45 46.79 Favored Glycine 0 C--N 1.355 1.596 0 O-C-N 124.153 0.908 . . . . 63.13 114.073 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.853 0.861 . . . . 72.23 111.398 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -58.77 -45.28 90.14 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.056 0.943 . . . . 74.11 110.074 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.733 ' SD ' HD23 ' D' ' 98' ' ' LEU . 1.7 tmt? -81.85 -30.74 31.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.097 -0.956 . . . . 64.33 110.982 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.27 75.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.133 0.573 . . . . 71.03 110.93 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -73.52 -38.42 65.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.92 -0.582 . . . . 74.14 109.957 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.1 t -62.5 -49.2 76.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.055 0.542 . . . . 73.54 111.575 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.733 HD23 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -69.03 -29.59 67.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.21 0.604 . . . . 72.42 111.973 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.19 -18.05 37.97 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.684 0.615 . . . . 63.02 113.342 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -65.17 1.13 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.859 0.464 . . . . 73.12 111.396 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -67.66 -49.72 61.42 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.556 0.576 . . . . 73.35 112.556 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.494 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.4 m -61.85 -47.42 91.69 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.521 0.728 . . . . 31.25 111.837 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.562 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -61.25 -34.96 87.21 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.48 2.12 . . . . 73.41 112.854 169.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -64.73 -29.54 70.52 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.049 0.54 . . . . 62.41 110.718 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.95 -42.81 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.401 0.681 . . . . 73.25 110.388 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.422 HD13 ' O ' ' D' ' 80' ' ' GLN . 63.9 mt -72.46 -23.74 61.1 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.201 -0.909 . . . . 71.22 111.222 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -64.91 -42.5 63.04 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.609 1.337 . . . . 63.02 114.609 -170.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.35 -41.4 59.34 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.115 1.876 . . . . 75.41 113.552 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -77.99 -36.83 48.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.81 0.844 . . . . 75.41 111.303 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.54 82.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.312 0.645 . . . . 52.4 109.895 176.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -54.59 -54.64 38.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.84 1.256 . . . . 74.41 110.467 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.1 -40.33 94.4 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.301 1.001 . . . . 71.0 111.381 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.416 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.4 t -57.41 -44.7 84.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.388 0.43 . . . . 71.14 110.406 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.56 HG21 HG21 ' D' ' 64' ' ' VAL . 86.7 mt -63.09 -55.15 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.164 -0.925 . . . . 75.34 110.238 173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' D' ' 125' ' ' GLN . 95.7 m -50.09 -48.48 53.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.306 1.442 . . . . 64.33 111.882 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.7 t -65.1 -41.91 94.51 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.76 -1.109 . . . . 71.03 109.932 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.51 -36.84 85.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.154 0.581 . . . . 72.23 111.251 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -62.36 -49.54 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.461 -0.791 . . . . 74.15 109.91 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -71.32 -27.63 63.53 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.167 0.587 . . . . 72.04 111.403 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -73.47 -31.07 63.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.846 0.859 . . . . 75.42 110.178 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.42 5.41 68.31 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.675 0.61 . . . . 53.31 112.16 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.0 p 60.94 27.57 17.42 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 126.554 1.942 . . . . 75.33 112.663 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -93.32 162.47 27.96 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.826 1.251 . . . . 74.14 109.728 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.56 134.85 36.93 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.979 2.453 . . . . 61.42 111.485 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' D' ' 115' ' ' THR . 47.6 tt0 -55.59 134.21 50.85 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 124.314 1.009 . . . . 70.31 111.988 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 tp -106.58 96.5 6.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.129 -0.693 . . . . 74.22 109.129 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -99.55 84.74 3.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.368 -0.604 . . . . 72.31 109.368 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.76 129.24 39.31 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.726 -0.67 . . . . 72.44 110.631 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -68.26 140.46 92.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 123.243 0.617 . . . . 55.33 111.613 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.5 Cg_endo -82.38 122.36 3.63 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.25 1.967 . . . . 63.34 109.689 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.2 m -107.47 134.82 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.188 0.518 . . . . 73.23 110.088 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 121.892 0.853 . . . . 71.44 109.716 176.112 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.365 -0.606 . . . . 51.43 109.365 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -115.83 126.93 54.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.957 -1.497 . . . . 74.35 106.957 165.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 4.1 tp60 -143.56 124.65 14.46 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.082 0.239 . . . . 64.54 110.632 -166.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.62 98.61 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.576 -0.898 . . . . 75.05 108.576 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -82.41 -30.64 30.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.915 -0.564 . . . . 73.51 111.535 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 179.22 121.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.458 0.703 . . . . 74.12 110.084 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.571 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 86.8 mt -105.84 130.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.846 -1.168 . . . . 72.21 107.846 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.813 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 22.6 p90 -171.95 152.44 2.96 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 124.193 0.933 . . . . 71.34 110.561 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -75.64 119.38 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.215 -0.661 . . . . 74.04 109.215 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -78.69 -46.28 19.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.136 -0.69 . . . . 60.44 109.136 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.46 136.73 41.53 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.889 -1.05 . . . . 71.3 109.383 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -129.06 140.72 48.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.354 -1.35 . . . . 74.13 107.354 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -142.96 128.72 19.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.452 0.701 . . . . 64.11 109.436 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 81.8 t80 -139.19 115.86 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.841 -1.541 . . . . 72.33 106.841 171.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -115.89 144.97 43.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.335 -0.987 . . . . 71.14 108.335 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.34 74.29 11.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.248 -1.39 . . . . 50.24 107.248 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.09 -23.34 24.93 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.543 2.162 . . . . 71.33 111.437 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 80.0 m-20 -110.4 33.54 4.44 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.858 -1.065 . . . . 53.4 109.79 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' B' ' 17' ' ' TYR . . . -59.5 -43.42 95.92 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.28 1.032 . . . . 75.22 113.126 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -69.63 -27.83 26.63 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.715 1.61 . . . . 72.24 113.023 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.6 m170 -72.6 -37.17 68.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.082 0.553 . . . . 72.44 111.077 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 68' ' ' LEU . 13.6 p -68.3 -23.11 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.903 0.881 . . . . 63.33 112.317 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.572 ' HD1' HH11 ' B' ' 15' ' ' ARG . 78.5 t80 -70.39 -35.65 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.882 0.373 . . . . 72.32 110.393 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -70.73 -46.04 63.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.451 -0.795 . . . . 74.54 109.658 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 3.7 mmmp? -73.17 151.92 41.32 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.425 -1.261 . . . . 64.43 111.201 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.72 136.1 47.06 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.583 -0.735 . . . . 70.42 109.421 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -75.41 84.68 2.53 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.736 0.779 . . . . 71.14 109.261 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -118.23 76.79 12.47 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.882 -1.053 . . . . 64.31 108.434 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.17 125.64 9.91 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.914 1.742 . . . . 61.41 111.627 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -97.26 89.98 4.95 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.706 -1.59 . . . . 75.41 106.706 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.72 92.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.529 -0.76 . . . . 64.31 110.5 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.39 115.29 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.452 -0.944 . . . . 51.05 108.452 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.49 151.54 19.9 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.771 -0.826 . . . . 61.03 108.771 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.5 t70 -143.37 147.78 35.2 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.357 -0.979 . . . . 65.03 108.357 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp -134.96 126.31 28.35 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.453 -0.943 . . . . 61.44 108.453 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -143.47 156.66 44.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.609 -0.886 . . . . 32.45 108.609 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -140.3 151.56 45.17 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.095 0.558 . . . . 61.12 110.149 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.7 153.58 49.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.999 1.32 . . . . 61.23 108.088 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.6 m -131.82 157.43 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.867 0.365 . . . . 74.22 110.663 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -148.24 120.69 8.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.657 -0.868 . . . . 75.32 108.657 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -81.99 105.22 12.92 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.772 -0.825 . . . . 74.44 108.772 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.18 -33.08 24.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.181 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.35 179.8 8.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.028 0.931 . . . . 65.31 109.736 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -70.35 125.03 25.62 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.843 -1.169 . . . . 54.11 107.843 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 75.11 -8.19 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.688 1.595 . . . . 73.54 112.785 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -107.45 110.6 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.683 -0.858 . . . . 71.32 108.683 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -133.65 123.67 25.44 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.271 -0.64 . . . . 71.14 109.271 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 28.0 tt0 -86.62 116.15 24.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.771 -0.649 . . . . 71.33 109.271 175.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.51 115.6 42.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 N-CA-C 107.233 -1.395 . . . . 55.21 107.233 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.3 t -98.78 136.6 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.694 0.798 . . . . 71.32 109.037 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.45 111.67 23.34 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.562 -1.273 . . . . 71.43 107.562 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.01 101.95 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.399 -0.963 . . . . 72.14 108.399 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.29 135.8 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.601 -1.259 . . . . 75.23 107.601 175.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 11.8 m -128.73 144.16 51.1 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.768 -0.456 . . . . 74.42 109.768 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 10.0 t -140.77 125.67 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.672 1.589 . . . . 75.33 107.793 -171.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -129.36 131.92 46.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.698 -0.482 . . . . 62.12 109.698 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.34 108.53 18.64 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.663 -0.866 . . . . 51.13 108.663 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.4 m -108.85 139.32 43.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.001 0.52 . . . . 74.11 110.17 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.647 HD11 HG23 ' A' ' 31' ' ' VAL . 6.2 mt -113.65 78.48 1.15 Allowed 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.273 -1.01 . . . . 63.42 108.273 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.54 -86.13 1.24 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.97 -0.852 . . . . 44.32 110.97 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -131.05 -8.09 3.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.423 1.089 . . . . 64.32 111.303 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -99.71 110.35 22.75 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.264 -0.643 . . . . 71.41 109.264 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.0 m -70.76 132.12 44.87 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 110.056 -0.349 . . . . 50.12 110.056 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 -60.53 2.33 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.07 0.948 . . . . 61.21 109.367 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -151.99 172.18 16.67 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 114.613 -1.176 . . . . 74.33 111.075 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.7 tp -132.57 147.43 52.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.903 1.281 . . . . 63.32 108.521 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -135.66 136.15 40.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.499 1.12 . . . . 71.23 109.145 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -147.37 129.28 15.34 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.489 -0.93 . . . . 75.54 108.489 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.21 109.56 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.959 -0.756 . . . . 71.22 108.959 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.57 82.84 8.09 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.186 -1.042 . . . . 74.13 108.186 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -75.69 92.26 2.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.553 -1.203 . . . . 63.34 108.403 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.68 144.23 21.17 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.315 -0.714 . . . . 63.44 111.315 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.89 118.26 1.22 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 110.11 -1.196 . . . . 63.02 110.11 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.4 mt -81.25 124.12 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.581 -1.266 . . . . 44.41 107.581 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 49.4 m-85 -133.35 121.05 21.78 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.411 -0.588 . . . . 73.12 109.411 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 22.4 t -79.36 96.67 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.026 -1.101 . . . . 65.51 108.026 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.53 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -121.2 128.07 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.067 -0.97 . . . . 64.42 109.418 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -174.15 178.15 2.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.535 1.134 . . . . 72.45 110.43 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.69 4.38 85.29 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.928 -0.578 . . . . 65.01 113.951 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -114.21 153.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.983 0.913 . . . . 63.42 109.546 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -144.33 168.94 18.9 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 109.27 -0.641 . . . . 62.53 109.27 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.77 -127.29 40.24 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.727 0.642 . . . . 61.01 114.688 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.6 p -62.25 -26.36 68.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.43 1.092 . . . . 65.21 112.077 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -64.07 -36.41 83.92 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.903 0.881 . . . . 75.32 111.074 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 77.7 mtp -67.27 -45.38 76.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.622 0.769 . . . . 65.1 110.2 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.85 71.98 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.884 -1.053 . . . . 72.53 111.255 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -66.96 -44.32 80.82 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.966 0.906 . . . . 61.41 110.362 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 14.3 t -71.81 -63.24 1.17 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.624 0.577 . . . . 73.33 110.791 -171.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.2 tp -68.75 -38.39 80.08 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 120.555 0.217 . . . . 72.43 111.525 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.15 -9.33 84.21 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.347 -0.696 . . . . 25.33 114.715 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.32 -53.68 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.904 0.852 . . . . 71.43 112.743 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 89.9 t80 -72.99 -60.97 1.98 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.72 0.808 . . . . 72.41 113.156 -164.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 72.0 m -61.22 -39.72 66.16 Favored Pre-proline 0 CA--C 1.557 1.23 0 N-CA-C 113.761 1.023 . . . . 64.05 113.761 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.47 -33.56 68.4 Favored 'Trans proline' 0 C--N 1.382 2.341 0 CA-C-N 120.976 1.384 . . . . 62.14 112.87 167.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -72.87 -23.62 60.76 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 117.903 0.319 . . . . 60.44 111.212 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.12 -42.31 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.952 0.882 . . . . 52.35 109.305 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.1 -24.47 40.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.143 -1.39 . . . . 64.12 112.348 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.39 -41.91 86.15 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.923 1.082 . . . . 73.21 113.923 -171.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.89 -39.33 91.79 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.421 2.081 . . . . 65.24 113.313 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -76.27 -41.69 48.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.308 -0.86 . . . . 65.23 111.387 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.86 85.93 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 73.0 109.984 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.401 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.8 ttm180 -49.86 -59.08 4.19 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 124.897 1.373 . . . . 70.33 109.683 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 4.4 tm-20 -58.32 -40.97 83.5 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.428 1.08 . . . . 71.42 112.251 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.485 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.0 t -62.07 -47.6 83.94 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.503 0.502 . . . . 63.21 110.91 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.415 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 96.2 mt -61.47 -43.96 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.76 0.824 . . . . 60.13 110.464 175.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 125' ' ' GLN . 74.0 m -58.26 -42.75 87.12 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.909 1.284 . . . . 54.32 111.586 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -72.93 -41.5 64.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.314 -0.857 . . . . 33.11 110.888 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.0 mtm -58.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.653 0.381 . . . . 60.44 111.324 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.9 -42.99 96.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.974 0.796 . . . . 51.32 111.47 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.4 p -67.56 -29.0 68.26 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.106 0.479 . . . . 71.12 110.958 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.8 -31.55 64.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.713 0.805 . . . . 73.13 109.943 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 29.53 4.56 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.972 0.796 . . . . 74.32 113.623 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t 60.98 16.8 7.31 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.725 2.01 . . . . 70.14 114.994 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.18 159.36 52.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.618 -0.676 . . . . 72.42 111.962 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.18 139.76 90.91 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.82 2.346 . . . . 51.23 111.674 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.606 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.0 pt20 -55.44 151.64 9.9 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.576 1.173 . . . . 74.2 112.138 -173.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.02 97.46 5.62 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 71.31 108.997 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -124.6 101.82 7.31 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.522 1.129 . . . . 73.24 109.406 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.78 159.11 32.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.882 0.873 . . . . 74.42 112.006 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 152.37 95.98 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.895 0.878 . . . . 62.41 111.731 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -91.71 111.26 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.284 2.656 . . . . 74.42 112.191 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.6 t -100.84 111.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.961 -1.126 . . . . 75.4 107.961 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -96.14 73.06 2.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.079 0.942 . . . . 71.04 109.258 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 CA--C 1.547 0.828 0 CA-C-N 114.069 -1.423 . . . . 73.43 110.25 176.62 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 C--O 1.238 0.45 0 N-CA-C 107.432 -1.322 . . . . 75.02 107.432 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.43 ' HA ' HG22 ' B' ' 86' ' ' ILE . 16.9 t80 -127.87 139.24 52.74 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -149.66 141.05 23.26 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.23 0.612 . . . . 63.43 109.789 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.447 HD11 HG13 ' B' ' 16' ' ' ILE . 7.2 tp -93.18 136.21 25.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 109.018 -0.734 . . . . 62.34 109.018 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.589 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.9 mm100 -104.95 -51.14 3.1 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.33 -0.619 . . . . 63.53 109.33 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.572 HH11 ' HD1' ' A' ' 32' ' ' PHE . 52.2 ttt180 -173.26 138.83 0.75 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.055 0.542 . . . . 75.23 110.543 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.447 HG13 HD11 ' B' ' 13' ' ' ILE . 55.8 mt -114.71 141.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.075 -1.083 . . . . 72.52 108.075 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 26.0 p90 -167.5 156.45 9.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.112 0.482 . . . . 75.43 111.957 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.9 m -81.57 125.83 31.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.31 -0.859 . . . . 74.0 108.685 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.436 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.36 -34.91 10.48 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.159 0.584 . . . . 71.42 111.301 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.6 t70 -153.95 132.82 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.743 -0.662 . . . . 65.23 109.942 -165.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.9 mm -135.94 138.31 47.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 124.102 0.961 . . . . 62.53 109.462 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.2 m -138.33 121.29 16.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.413 -1.267 . . . . 72.31 108.674 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.529 ' HZ ' ' HD2' ' B' ' 123' ' ' PHE . 83.3 t80 -130.65 108.59 10.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.652 -1.61 . . . . 72.24 106.652 163.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -122.45 114.67 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 63.4 108.746 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.21 87.15 3.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 74.14 108.867 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 35.7 Cg_endo -61.75 -41.12 40.52 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.173 2.582 . . . . 72.42 112.901 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -110.52 30.95 6.33 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.109 0.964 . . . . 63.44 109.912 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.813 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.66 -50.32 51.87 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 125.875 1.67 . . . . 62.03 115.057 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.89 -19.21 16.25 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.008 1.805 . . . . 73.41 112.445 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.04 5.01 53.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.923 1.289 . . . . 65.42 110.863 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.95 -28.85 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.548 0.739 . . . . 72.05 111.698 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -73.69 -33.51 64.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.38 0.672 . . . . 70.34 111.314 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.54 -20.38 63.69 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.135 0.974 . . . . 73.43 110.476 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -104.68 112.07 25.01 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.5 1.52 . . . . 64.1 111.379 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -93.54 77.97 4.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.229 0.612 . . . . 63.4 111.65 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 170.96 152.48 0.05 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 126.384 1.874 . . . . 72.34 109.307 161.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.436 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 0.2 OUTLIER -80.56 128.65 71.61 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 108.994 -0.743 . . . . 74.52 108.994 -177.041 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.519 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 10.6 Cg_endo -52.74 129.7 33.78 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.56 2.84 . . . . 53.1 114.048 -168.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.9 pt-20 -53.75 123.02 11.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.33 1.019 . . . . 52.43 110.358 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.41 124.1 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 107.973 -1.121 . . . . 74.31 107.973 -174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -147.95 142.91 26.93 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.381 0.673 . . . . 75.11 109.598 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.55 164.59 21.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.67 0.788 . . . . 51.42 111.012 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.0 m-20 -140.25 144.26 36.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.166 1.386 . . . . 73.52 108.375 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tt -129.2 96.28 4.27 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.027 -1.101 . . . . 74.22 108.027 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.85 158.3 39.86 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.147 0.979 . . . . 74.42 109.156 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -139.63 137.4 35.26 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.02 0.438 . . . . 74.2 110.901 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.69 161.46 21.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.627 1.171 . . . . 62.12 108.377 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 p -146.14 167.44 23.43 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.278 0.231 . . . . 53.45 111.107 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -153.12 135.59 15.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.061 0.944 . . . . 64.23 109.192 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -84.89 132.88 34.33 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.71 0.804 . . . . 71.23 109.408 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -99.13 -41.9 7.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.125 0.57 . . . . 61.11 110.262 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -169.34 3.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.266 0.627 . . . . 70.42 110.871 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.39 119.05 19.73 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.322 -0.854 . . . . 73.34 110.22 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 59.99 21.98 11.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.85 1.26 . . . . 62.21 112.41 -172.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.04 117.28 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.477 1.111 . . . . 75.42 108.376 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -125.52 -177.79 4.02 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.339 0.59 . . . . 72.11 109.914 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -141.94 117.3 10.18 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.114 -1.81 . . . . 71.44 106.114 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.03 131.41 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 110.013 -0.366 . . . . 62.11 110.013 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -103.37 125.82 57.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.447 1.099 . . . . 72.53 109.253 176.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.409 HD22 HG23 ' B' ' 62' ' ' VAL . 0.3 OUTLIER -92.17 122.25 34.47 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.244 -1.391 . . . . 74.14 107.244 169.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -108.22 106.63 16.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.718 0.807 . . . . 74.03 108.849 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.409 HG23 HD22 ' B' ' 60' ' ' LEU . 31.6 t -106.53 122.39 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.806 -0.813 . . . . 63.33 108.806 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.2 m -114.59 152.44 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.354 0.409 . . . . 73.1 109.943 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 39.3 t -129.47 126.11 62.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.818 1.247 . . . . 73.12 107.947 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -109.55 136.1 49.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.766 -1.198 . . . . 70.13 107.766 170.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.483 -0.932 . . . . 72.12 108.483 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -138.69 136.2 35.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.244 0.545 . . . . 61.23 112.201 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.6 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 46.5 mt -95.05 99.05 11.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.742 1.217 . . . . 62.0 108.019 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -129.8 15.58 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 120.016 -0.325 . . . . 45.31 112.517 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -98.86 36.92 1.59 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.973 0.892 . . . . 65.13 108.838 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -153.98 142.95 21.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.656 -0.702 . . . . 72.42 109.396 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -66.07 136.91 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.154 0.582 . . . . 75.34 111.562 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.6 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.83 -60.62 1.77 Allowed 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.105 0.962 . . . . 75.05 109.227 177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.435 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 26.3 p90 -157.6 160.58 38.24 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 113.361 -1.745 . . . . 62.52 108.863 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.6 mt -134.56 115.69 14.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.926 -1.509 . . . . 74.1 106.926 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -115.54 153.78 30.56 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.216 -1.031 . . . . 54.43 108.216 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.45 131.66 3.19 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.556 -0.905 . . . . 74.22 108.556 -174.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -122.63 142.66 38.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.485 -0.932 . . . . 74.11 108.485 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 71.4 mt-30 -125.29 90.22 3.19 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.462 -0.94 . . . . 62.13 108.462 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 59.8 tp60 -83.79 106.48 15.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.151 -1.386 . . . . 63.31 109.12 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.62 164.28 26.55 Favored Glycine 0 C--O 1.24 0.487 0 O-C-N 123.44 0.463 . . . . 64.41 112.838 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.85 126.86 1.6 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.828 -0.909 . . . . 62.21 110.828 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 20.1 mt -86.05 129.7 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.607 -0.886 . . . . 75.24 108.607 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -134.34 141.76 47.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.953 0.901 . . . . 62.14 108.9 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -116.92 114.04 23.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.645 0.778 . . . . 50.12 109.227 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.55 HD13 HD11 ' B' ' 89' ' ' ILE . 2.7 pp -135.93 149.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.957 0.903 . . . . 71.53 110.645 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.78 172.14 18.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.593 0.757 . . . . 70.14 110.119 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.11 -48.69 0.92 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.962 -0.354 . . . . 73.41 113.98 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.55 HD11 HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -73.23 162.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 117.21 0.505 . . . . 73.11 111.679 -177.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -152.3 153.65 34.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.28 0.632 . . . . 73.15 110.163 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.04 -136.56 25.53 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 123.888 0.756 . . . . 52.21 113.93 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -77.87 -16.98 57.85 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.249 1.02 . . . . 62.42 111.508 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.84 -39.69 59.25 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.682 0.793 . . . . 74.32 111.163 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 14.8 tpt -69.97 -33.66 72.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.79 -1.095 . . . . 54.24 111.746 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.99 70.95 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.985 0.514 . . . . 71.41 111.527 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -73.44 -30.87 63.48 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.769 0.828 . . . . 64.32 111.385 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -79.22 -64.29 1.22 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.2 0.6 . . . . 62.44 110.817 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.64 -43.67 92.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 52.1 110.418 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.93 -2.13 86.47 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 118.788 -1.007 . . . . 74.11 114.992 -170.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.79 -52.38 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.642 1.221 . . . . 62.43 112.299 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -70.76 -44.11 67.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.419 0.287 . . . . 73.4 111.564 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -60.87 -47.89 94.37 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-O 118.765 -0.636 . . . . 74.12 111.593 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -47.48 -50.35 11.54 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.442 2.094 . . . . 75.42 113.967 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.9 -32.21 69.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.264 0.626 . . . . 71.2 112.507 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.427 HG23 ' NH2' ' D' ' 111' ' ' ARG . 60.6 mt -64.7 -48.1 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.484 0.714 . . . . 74.11 110.881 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.03 -9.32 56.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.044 0.938 . . . . 74.33 111.35 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.467 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 20.5 t80 -60.56 -48.56 93.13 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.255 1.422 . . . . 74.34 113.207 -172.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -38.14 54.79 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 121.732 1.622 . . . . 31.22 113.271 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.499 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 90.2 m-85 -61.62 -45.83 92.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.102 0.561 . . . . 72.01 110.602 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.99 94.2 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.095 0.958 . . . . 71.25 111.219 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.477 1.111 . . . . 64.13 111.431 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -37.35 83.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.259 -0.882 . . . . 62.42 110.015 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.8 t -66.16 -39.12 89.55 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.811 -0.631 . . . . 55.32 111.279 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.13 -51.98 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.738 0.415 . . . . 44.21 110.301 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.449 HG23 ' HB2' ' B' ' 125' ' ' GLN . 41.8 m -57.95 -27.36 63.34 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 123.899 0.749 . . . . 64.23 111.269 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -71.24 -62.28 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.35 0.66 . . . . 70.12 110.462 172.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.9 mmt -61.06 -39.97 91.89 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.488 0.715 . . . . 73.24 112.391 -170.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.425 HG11 ' O ' ' B' ' 124' ' ' PRO . 78.5 t -65.82 -43.04 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.611 -0.722 . . . . 73.2 111.144 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 63.2 p -69.65 -25.64 64.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.341 0.4 . . . . 73.34 111.394 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.485 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.1 mtt-85 -65.56 -36.89 85.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.564 -0.744 . . . . 72.34 110.023 174.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -81.13 7.17 60.84 Favored Glycine 0 C--N 1.356 1.69 0 O-C-N 124.04 0.838 . . . . 74.14 112.897 172.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.9 p 54.96 47.64 21.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.562 1.945 . . . . 61.32 111.504 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.529 ' HD2' ' HZ ' ' B' ' 23' ' ' PHE . 29.1 m-85 -120.36 166.62 14.77 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 114.016 -1.447 . . . . 64.2 110.781 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 36.7 Cg_endo -61.44 137.03 67.23 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.915 3.077 . . . . 73.55 115.334 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.541 ' NE2' ' HA ' ' C' ' 124' ' ' PRO . 13.6 pm0 -59.78 154.56 17.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.487 1.115 . . . . 75.1 112.648 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.44 95.96 4.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.079 -1.082 . . . . 44.25 108.079 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.423 HD22 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -92.58 90.62 7.21 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.973 -1.862 . . . . 64.23 105.973 172.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.467 HD22 ' HZ ' ' B' ' 107' ' ' PHE . 1.2 tt -67.88 133.98 50.06 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.414 -0.958 . . . . 54.24 108.414 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.69 107.55 0.85 Allowed Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 124.602 1.189 . . . . 63.31 111.269 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.411 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 95.9 Cg_endo -75.14 88.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.946 2.431 . . . . 63.22 112.494 -170.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.74 149.5 12.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.981 -1.009 . . . . 61.32 110.425 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -111.45 116.25 30.59 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.009 -1.108 . . . . 64.12 108.009 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 123.907 0.883 . . . . 64.02 111.975 -174.595 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.24 0.605 0 N-CA-C 108.538 -0.912 . . . . 64.44 108.538 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.439 ' CD1' ' SG ' ' C' ' 97' ' ' CYS . 2.3 t80 -102.51 127.97 49.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.062 -1.426 . . . . 71.55 108.732 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -141.3 131.09 24.26 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.25 -1.389 . . . . 73.35 107.25 167.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.676 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -68.61 117.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 106.621 -1.622 . . . . 65.14 106.621 168.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -83.99 -50.6 7.86 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.149 -0.478 . . . . 65.33 110.007 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -176.13 133.71 0.25 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.77 0.669 . . . . 64.52 110.37 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.676 HG13 HD11 ' C' ' 13' ' ' ILE . 96.2 mt -115.48 140.06 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.098 -1.075 . . . . 71.32 108.098 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.5 ' HB3' HG23 ' D' ' 122' ' ' THR . 30.5 p90 -177.91 147.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.703 0.401 . . . . 75.32 110.61 -173.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.495 HG21 ' SG ' ' C' ' 113' ' ' CYS . 77.3 p -72.89 121.67 20.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.388 -0.824 . . . . 73.53 109.896 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -76.18 -50.5 14.37 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.949 0.881 . . . . 71.34 108.667 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -135.0 136.96 42.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.763 -1.562 . . . . 73.4 108.952 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.8 mt -131.14 142.16 44.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.258 -1.756 . . . . 74.45 106.258 174.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -151.65 144.51 24.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.643 -0.503 . . . . 64.35 109.643 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -148.69 107.75 3.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.34 -1.356 . . . . 71.11 107.34 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.32 110.69 18.38 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.001 -0.74 . . . . 54.43 109.001 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.04 89.82 14.64 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.369 -0.974 . . . . 54.13 108.369 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.14 -39.67 22.73 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.554 2.169 . . . . 73.0 110.902 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -93.95 30.66 1.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.275 -1.33 . . . . 73.35 111.009 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -57.2 -48.26 97.68 Favored Pre-proline 0 CA--C 1.563 1.46 0 C-N-CA 123.388 0.675 . . . . 71.11 112.461 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.8 Cg_endo -88.42 -22.68 1.23 Allowed 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 122.034 1.823 . . . . 75.2 112.601 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -69.63 -25.48 63.95 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.573 1.149 . . . . 71.33 111.682 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.15 -13.65 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.729 0.811 . . . . 63.43 111.388 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -58.32 -40.55 82.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.213 0.605 . . . . 63.52 111.636 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -102.14 38.9 1.57 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.114 0.566 . . . . 75.43 110.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.479 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -126.65 162.27 26.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.563 0.745 . . . . 70.01 109.9 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.19 120.94 18.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.694 -0.854 . . . . 73.14 108.694 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -84.37 82.96 8.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.806 0.843 . . . . 60.41 110.943 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -139.67 70.48 37.59 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.854 -0.795 . . . . 75.05 108.854 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' C' ' 40' ' ' VAL . 3.2 Cg_exo -77.37 133.67 13.39 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.978 2.452 . . . . 75.45 112.231 -172.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.95 79.54 8.72 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.939 -1.504 . . . . 71.4 106.939 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.619 HG11 ' HG2' ' C' ' 124' ' ' PRO . 13.8 m -76.02 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.16 -1.382 . . . . 71.3 111.441 -170.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -97.0 136.13 38.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.17 -0.923 . . . . 75.01 110.25 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.592 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -114.43 140.99 48.25 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.656 -0.868 . . . . 61.31 108.656 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.08 119.65 33.96 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.718 0.807 . . . . 55.02 109.207 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.706 ' HG ' HD21 ' C' ' 60' ' ' LEU . 7.7 tt -85.9 114.14 22.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.779 -0.822 . . . . 63.32 108.779 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.456 ' O ' HD23 ' C' ' 60' ' ' LEU . 21.1 t70 -126.65 138.93 53.49 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.251 -1.018 . . . . 73.24 108.251 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -111.93 143.69 42.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.351 0.596 . . . . 72.41 110.541 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.94 150.38 50.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.542 1.137 . . . . 53.42 108.743 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -149.24 151.87 34.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.858 0.463 . . . . 64.53 110.048 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.1 t -160.58 140.42 11.09 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.376 -0.972 . . . . 65.22 108.376 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -86.96 137.55 32.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.916 0.388 . . . . 62.21 110.191 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.667 HD11 HD12 ' C' ' 83' ' ' ILE . 76.9 mt -101.38 -58.56 1.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.99 0.916 . . . . 73.51 109.348 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.74 -174.25 3.78 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.816 -1.084 . . . . 74.32 110.075 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -69.06 126.25 29.22 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.846 -1.07 . . . . 75.01 109.209 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 15.1 m-20 64.15 14.64 8.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.713 1.205 . . . . 75.54 111.898 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.77 104.48 11.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 124.447 1.099 . . . . 71.44 108.9 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.57 165.72 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.011 0.91 . . . . 73.25 110.203 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.02 119.22 27.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.844 -1.525 . . . . 75.14 107.416 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.02 120.03 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.881 -1.155 . . . . 63.42 107.881 172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.404 HG22 ' HA2' ' C' ' 81' ' ' GLY . 90.0 t -106.65 113.49 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.297 -1.001 . . . . 53.14 108.297 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.706 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -84.29 102.79 12.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.337 -1.357 . . . . 74.25 107.337 176.282 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 3.1 tmm_? -84.31 104.53 14.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.337 -0.986 . . . . 74.31 108.337 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.0 t -101.09 130.07 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.257 -1.016 . . . . 63.51 108.257 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 39.5 m -120.39 126.47 50.56 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.695 -0.854 . . . . 53.31 108.695 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.741 HG21 HG21 ' C' ' 114' ' ' ILE . 40.1 t -99.79 124.28 53.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.333 1.053 . . . . 72.34 109.868 177.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -100.51 143.97 30.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.483 -1.303 . . . . 71.5 107.483 167.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.55 120.93 18.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.469 -1.308 . . . . 74.42 107.469 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.7 m -128.47 156.63 42.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.714 0.769 . . . . 44.43 110.627 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' C' ' 34' ' ' LYS . 22.8 mt -116.94 34.18 5.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.206 -1.405 . . . . 71.22 107.206 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.38 -82.94 0.32 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.924 -1.271 . . . . 70.52 109.924 -169.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.65 -24.77 4.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.873 0.869 . . . . 72.24 109.989 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 7.8 tp10 -67.65 120.5 14.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.93 0.892 . . . . 71.11 110.103 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -74.38 123.17 24.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.711 -0.478 . . . . 45.43 109.711 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.29 -49.54 22.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.502 0.721 . . . . 62.24 109.229 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -166.85 173.37 9.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.891 -1.05 . . . . 72.43 110.183 172.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.432 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -130.24 143.11 50.58 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 106.595 -1.631 . . . . 64.24 106.595 170.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' C' ' 64' ' ' VAL . 43.0 t -144.32 155.28 43.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.552 -0.907 . . . . 63.13 108.552 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -157.41 129.87 7.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.86 0.464 . . . . 74.24 110.165 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.53 115.66 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 62.8 mt-30 -88.6 91.17 8.7 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.614 -1.254 . . . . 41.31 107.614 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -78.07 107.04 10.35 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.546 -0.752 . . . . 62.03 109.725 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -82.04 152.44 31.35 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.874 -0.491 . . . . 42.22 111.874 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.17 118.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.601 -0.999 . . . . 72.31 110.601 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.667 HD12 HD11 ' C' ' 51' ' ' LEU . 10.0 mm -84.55 128.91 38.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.462 -0.94 . . . . 54.41 108.462 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.13 128.49 28.18 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.443 -0.577 . . . . 70.22 109.443 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.3 p -79.38 119.24 22.12 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.573 -0.899 . . . . 71.23 108.573 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.66 120.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.718 0.807 . . . . 73.11 109.761 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -167.32 157.57 11.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.004 0.922 . . . . 74.31 110.711 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.96 -18.7 42.57 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 123.129 0.268 . . . . 52.43 113.709 172.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.594 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.486 1.114 . . . . 74.55 110.625 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.818 -0.438 . . . . 63.42 109.818 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' C' ' 97' ' ' CYS . 11.2 ptm -78.3 -28.11 47.43 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.979 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.34 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.202 0.525 . . . . 72.24 110.407 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.79 -30.78 51.52 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.426 -0.807 . . . . 75.32 110.681 172.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' C' ' 94' ' ' MET . 48.7 t -81.53 -21.84 38.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.817 1.247 . . . . 73.33 113.521 -169.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.585 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.0 OUTLIER -139.04 -23.73 0.91 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 119.064 0.847 . . . . 64.42 111.997 172.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.51 -30.64 53.05 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 120.141 -0.255 . . . . 73.32 112.897 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.16 -42.11 2.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.017 0.527 . . . . 75.32 110.815 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.524 ' CE1' HG13 ' C' ' 105' ' ' ILE . 10.6 t80 -50.8 -71.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.927 0.891 . . . . 75.45 110.87 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 60.3 m -55.34 -45.81 99.8 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 113.558 -1.656 . . . . 74.3 113.71 -168.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.469 ' HB3' HD21 ' C' ' 44' ' ' LEU . 74.2 Cg_exo -55.78 -45.94 35.27 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.446 1.431 . . . . 73.14 113.313 168.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.81 -25.56 66.51 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.519 0.728 . . . . 53.55 112.649 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.524 HG13 ' CE1' ' C' ' 101' ' ' TYR . 29.3 mm -85.55 -43.29 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.621 0.768 . . . . 74.51 110.611 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.22 -14.32 57.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.935 -0.575 . . . . 55.21 111.032 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.446 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 91.8 t80 -56.53 -54.35 54.39 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 117.705 -1.14 . . . . 71.44 111.761 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' C' ' 105' ' ' ILE . 32.5 Cg_exo -56.37 -40.33 85.36 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.338 2.025 . . . . 55.13 113.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.506 ' HE2' HG21 ' A' ' 115' ' ' THR . 84.2 m-85 -63.55 -52.35 61.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.045 0.938 . . . . 74.5 111.944 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.63 96.51 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 64.22 110.34 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -54.47 -47.85 72.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.973 1.709 . . . . 71.42 111.403 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.432 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -76.93 -37.58 55.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.964 0.505 . . . . 72.11 110.604 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' C' ' 18' ' ' THR . 25.6 t -65.85 -32.58 74.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.042 0.537 . . . . 72.43 111.494 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.741 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -72.31 -51.07 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.716 -0.675 . . . . 54.45 109.545 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m -51.12 -34.75 32.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.614 0.766 . . . . 72.54 111.562 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.9 t -59.4 -61.25 2.76 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.714 -1.13 . . . . 75.34 109.489 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.506 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.28 -45.24 54.27 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.514 1.526 . . . . 74.34 113.148 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.0 t -64.43 -46.71 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 53.23 110.43 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.988 -1.005 . . . . 62.1 111.43 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -69.1 -37.26 78.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.205 0.602 . . . . 72.13 109.861 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 6.7 72.57 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.884 0.74 . . . . 71.31 112.835 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.0 p 65.0 37.89 6.58 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.993 1.717 . . . . 60.43 111.982 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.578 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 60.0 m-85 -107.35 172.65 3.63 Favored Pre-proline 0 CA--C 1.572 1.821 0 C-N-CA 124.897 1.279 . . . . 54.31 109.803 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.619 ' HG2' HG11 ' C' ' 40' ' ' VAL . 73.8 Cg_endo -70.77 179.64 4.09 Favored 'Trans proline' 0 C--N 1.403 3.429 0 C-N-CA 122.49 2.126 . . . . 60.32 114.368 -171.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.405 ' HG2' ' HB3' ' B' ' 125' ' ' GLN . 28.2 mm-40 -60.37 125.73 24.78 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.609 -0.723 . . . . 74.14 112.025 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.41 2.61 36.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.408 0.683 . . . . 62.24 110.346 170.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 43.2 t-20 -88.46 82.8 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.719 -1.586 . . . . 72.34 106.719 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 73.1 mt -89.86 158.27 17.53 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 112.555 -2.111 . . . . 71.14 110.33 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -34.62 130.89 0.45 Allowed Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.854 1.661 . . . . 61.14 114.583 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.571 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 74.1 Cg_endo -71.77 109.01 2.55 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.164 2.576 . . . . 73.14 112.664 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.88 104.73 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.32 109.123 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -96.64 103.4 15.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.41 0.684 . . . . 63.42 109.902 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 122.614 0.366 . . . . 63.32 111.349 175.565 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.241 0.612 0 N-CA-C 109.273 -0.64 . . . . 74.32 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -149.02 100.13 3.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.029 -1.471 . . . . 65.14 107.029 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -121.58 150.97 40.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.356 -0.979 . . . . 75.43 108.356 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 tp -102.81 137.16 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.156 -0.683 . . . . 64.53 109.156 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -99.3 -45.47 5.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.549 0.74 . . . . 74.35 109.507 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HD3' HD12 ' D' ' 83' ' ' ILE . 4.8 ptm180 -168.43 147.26 4.35 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.942 0.497 . . . . 73.12 111.104 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.476 HD12 HD23 ' D' ' 106' ' ' LEU . 48.0 mm -115.81 122.76 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 105.958 -1.867 . . . . 72.53 105.958 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 0.3 OUTLIER -155.69 156.27 34.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.098 0.951 . . . . 74.51 111.027 -169.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.403 HG21 HD11 ' D' ' 21' ' ' ILE . 73.3 p -91.86 116.99 29.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.945 -1.48 . . . . 72.23 109.152 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -85.84 -29.52 23.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.493 -0.776 . . . . 75.33 109.419 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.3 t70 -149.76 135.96 18.92 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.803 -1.09 . . . . 75.31 109.574 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.506 HD13 ' HE3' ' C' ' 117' ' ' MET . 60.6 mt -139.37 143.32 31.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.853 -1.165 . . . . 74.32 107.853 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -144.75 144.6 31.27 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.071 0.948 . . . . 52.21 108.861 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.634 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.4 t80 -145.6 129.63 17.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.53 -2.026 . . . . 73.0 105.53 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.3 mt-10 -133.07 136.03 45.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 73.43 108.498 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -131.0 75.27 78.81 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.032 -1.099 . . . . 62.3 108.032 174.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.0 -28.89 18.72 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.776 2.317 . . . . 74.23 112.571 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -114.37 32.76 5.72 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 123.726 0.811 . . . . 73.1 108.959 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -57.65 -58.31 19.23 Favored Pre-proline 0 N--CA 1.483 1.203 0 N-CA-C 114.543 1.312 . . . . 62.44 114.543 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.12 -4.08 13.59 Favored 'Trans proline' 0 C--N 1.381 2.256 0 CA-C-N 121.918 1.721 . . . . 74.14 112.637 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -84.25 -32.36 24.49 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.415 1.486 . . . . 43.32 109.107 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.411 HG13 ' CD1' ' D' ' 68' ' ' LEU . 2.1 t -65.57 -27.66 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.227 1.411 . . . . 63.41 111.952 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -62.43 -14.71 43.61 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 112.717 0.636 . . . . 74.34 112.717 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.908 0.883 . . . . 72.43 110.932 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -84.26 104.28 14.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.715 1.206 . . . . 60.4 109.904 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.34 75.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 74.35 111.763 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.41 ' HZ2' ' H ' ' D' ' 69' ' ' GLY . 1.6 p-90 -170.05 179.69 3.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.006 0.923 . . . . 73.15 109.924 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -78.38 123.83 85.68 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.774 0.829 . . . . 72.35 108.787 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.28 142.13 88.01 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.815 2.343 . . . . 72.22 115.006 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.16 112.24 2.3 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.652 -0.87 . . . . 74.34 108.652 167.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 22.5 m -103.33 117.29 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.579 0.704 . . . . 64.45 109.983 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -108.41 116.81 32.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.118 0.967 . . . . 74.41 108.756 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' D' ' 63' ' ' THR . 6.6 mp -104.64 135.72 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.283 0.364 . . . . 70.22 110.361 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.48 135.28 50.74 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.411 -0.813 . . . . 71.12 108.87 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 tt -96.55 127.15 42.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.893 -1.151 . . . . 60.33 107.893 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.2 t70 -150.05 155.73 40.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.432 -0.951 . . . . 63.02 108.432 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.4 t -139.6 160.92 38.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.347 0.594 . . . . 65.0 110.167 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.69 176.74 10.1 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.019 1.328 . . . . 74.3 107.79 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' D' ' 56' ' ' TYR . 78.2 p -172.98 165.94 5.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.526 0.565 . . . . 74.13 112.526 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 4.4 m -152.11 140.72 20.77 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.017 0.927 . . . . 75.43 109.484 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -83.53 118.24 23.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.315 -0.995 . . . . 61.41 108.315 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' D' ' 57' ' ' GLU . 22.0 mt -99.79 -29.3 12.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.906 0.482 . . . . 64.0 110.177 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -165.13 -172.75 2.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.589 0.756 . . . . 54.32 111.029 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -71.41 120.24 16.71 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.979 -1.009 . . . . 64.1 109.082 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 62.28 18.08 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.47 1.108 . . . . 71.45 111.276 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 74.0 t -121.22 121.65 65.4 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 107.009 -1.478 . . . . 75.35 107.009 174.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' D' ' 48' ' ' SER . 12.4 t80 -144.64 128.27 17.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.909 -0.775 . . . . 73.5 108.909 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.4 tt0 -88.11 131.27 34.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.625 -0.88 . . . . 63.32 108.625 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.06 123.61 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.096 -1.446 . . . . 75.23 107.096 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.612 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 27.1 t -100.67 139.61 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 73.14 109.178 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.543 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -111.98 126.54 55.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.976 -1.12 . . . . 71.52 107.976 175.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.5 ttm-85 -102.92 101.62 11.65 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.715 -0.846 . . . . 70.14 108.715 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.9 t -102.91 121.85 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.706 -0.85 . . . . 34.41 108.706 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 23.7 m -125.7 130.92 52.51 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.397 0.679 . . . . 73.45 109.636 -171.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.489 HG21 HG21 ' D' ' 114' ' ' ILE . 32.1 t -120.8 103.66 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.677 1.191 . . . . 53.12 109.324 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -100.54 96.52 7.43 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.375 -0.972 . . . . 71.44 108.375 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 143.11 27.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.46 -0.791 . . . . 71.2 109.328 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.6 p -151.46 130.47 12.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.403 0.439 . . . . 44.54 111.867 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' D' ' 31' ' ' VAL . 21.3 mt -107.06 108.6 20.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.037 0.935 . . . . 61.42 110.283 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' GLY . . . . . 0.41 ' H ' ' HZ2' ' D' ' 36' ' ' TRP . . . 78.12 -115.15 4.14 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.562 -0.615 . . . . 74.21 111.562 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 4.51 15.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.909 0.884 . . . . 64.32 110.598 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -116.14 161.89 18.26 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.786 -0.45 . . . . 54.05 109.786 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.5 m -71.54 133.86 46.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.537 -0.756 . . . . 63.33 110.572 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.88 -64.91 1.07 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.441 -0.948 . . . . 45.13 108.441 173.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -156.15 147.7 22.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.4 -0.818 . . . . 75.41 109.971 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.1 mt -100.39 153.94 18.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.853 0.861 . . . . 73.33 108.952 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.6 t -159.31 143.72 15.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.284 0.633 . . . . 73.13 109.651 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.39 128.54 7.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.108 0.563 . . . . 65.14 109.845 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.455 HG22 HG23 ' D' ' 21' ' ' ILE . 88.0 t -127.46 114.66 37.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 123.98 0.912 . . . . 73.33 109.017 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.649 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.6 mt-30 -89.54 86.36 6.73 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.838 0.828 . . . . 70.35 108.879 170.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.433 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.8 tp-100 -79.73 98.9 7.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.969 -1.468 . . . . 72.42 108.66 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.5 154.91 23.71 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.822 -0.511 . . . . 73.13 111.822 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -149.18 131.16 3.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.695 -0.962 . . . . 54.15 110.695 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' D' ' 15' ' ' ARG . 59.3 mt -94.97 109.02 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.398 -0.594 . . . . 73.55 109.398 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -110.53 126.64 54.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.484 0.714 . . . . 72.2 110.385 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -79.56 97.19 6.37 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.735 -0.839 . . . . 75.24 108.735 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.68 130.24 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.224 0.61 . . . . 72.13 110.803 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.76 153.63 14.93 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.779 0.832 . . . . 65.52 109.945 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 5.39 86.19 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.393 -0.367 . . . . 74.02 113.302 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -119.32 126.33 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.898 0.879 . . . . 70.42 109.465 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 174.38 10.68 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 122.046 -0.409 . . . . 73.15 111.215 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -139.79 39.53 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.934 0.772 . . . . 71.23 113.358 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.9 p -69.27 -32.33 71.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.641 0.776 . . . . 52.42 111.464 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.22 -40.99 96.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.745 . . . . 71.23 110.619 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.6 -55.86 10.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 74.53 110.754 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.64 69.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.453 0.701 . . . . 53.14 112.089 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -85.59 -35.36 21.07 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.466 0.707 . . . . 73.43 110.655 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -66.29 -41.83 89.22 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.662 0.268 . . . . 75.05 110.29 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 tt -78.06 -35.18 49.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.207 0.603 . . . . 74.43 110.065 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.42 -3.32 81.7 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.353 -0.693 . . . . 50.31 114.448 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -57.28 0.43 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 117.974 0.887 . . . . 73.05 111.818 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -72.37 -41.77 66.0 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 112.288 0.477 . . . . 71.44 112.288 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 69.8 m -66.76 -44.97 55.11 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.109 0.564 . . . . 51.2 111.088 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.543 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.9 Cg_exo -55.73 -35.55 93.5 Favored 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.491 2.127 . . . . 55.12 113.402 165.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.48 -29.96 70.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.911 0.484 . . . . 54.41 111.161 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -68.35 -38.49 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.087 0.555 . . . . 64.32 109.619 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.476 HD23 HD12 ' D' ' 16' ' ' ILE . 94.3 mt -79.14 -22.9 44.44 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.311 1.045 . . . . 62.15 112.589 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -66.21 -40.8 38.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.161 1.171 . . . . 75.4 114.161 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.74 -39.23 92.36 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.054 1.836 . . . . 50.32 113.296 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -79.44 -33.17 42.72 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.895 0.878 . . . . 74.13 110.799 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.85 68.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.562 0.745 . . . . 72.25 109.899 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.427 ' NH2' HG23 ' B' ' 105' ' ' ILE . 27.6 ttp180 -52.39 -54.27 34.07 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.226 -1.352 . . . . 74.2 110.553 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.403 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.9 tm-20 -60.34 -45.45 93.4 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.472 1.107 . . . . 75.33 111.687 -175.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.439 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 42.7 t -54.82 -44.74 74.13 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.016 0.822 . . . . 73.33 110.961 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.489 HG21 HG21 ' D' ' 64' ' ' VAL . 77.0 mt -66.33 -53.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.203 -0.908 . . . . 50.13 110.885 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 54.0 m -53.85 -41.5 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.67 1.188 . . . . 65.41 111.567 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -67.57 -44.7 77.59 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 114.712 -1.131 . . . . 73.12 110.08 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.58 -32.58 74.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.977 0.511 . . . . 73.43 111.808 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.4 t -64.14 -46.51 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.298 0.639 . . . . 52.43 109.474 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -73.61 -27.78 61.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.704 -0.68 . . . . 62.44 111.35 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.24 -28.79 63.38 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.542 0.737 . . . . 74.04 110.118 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.04 10.06 70.0 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 123.83 0.706 . . . . 74.43 112.302 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.5 HG23 ' HB3' ' C' ' 17' ' ' TYR . 71.7 p 58.46 18.87 5.99 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.624 1.97 . . . . 71.04 113.691 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -86.58 152.07 54.0 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.889 -0.782 . . . . 54.14 108.889 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.05 133.02 55.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.732 2.288 . . . . 72.01 112.667 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -49.82 139.15 13.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.611 1.195 . . . . 65.42 112.376 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -120.35 102.4 8.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.822 . . . . 62.54 108.904 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -99.21 100.83 11.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.777 -0.823 . . . . 73.23 108.777 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 55.4 mt -72.02 136.0 46.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.616 0.572 . . . . 75.13 110.137 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.01 81.79 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.262 0.625 . . . . 64.24 110.998 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.39 96.79 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.407 2.071 . . . . 51.02 110.259 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -108.15 124.83 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.279 0.561 . . . . 71.42 110.153 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 108.375 -0.972 . . . . 73.21 108.375 174.554 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 109.344 -0.613 . . . . 65.01 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.485 ' HD2' HG22 ' A' ' 86' ' ' ILE . 36.2 t80 -121.32 130.01 53.41 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.767 -1.197 . . . . 72.3 107.767 166.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -144.52 123.39 12.7 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.997 0.186 . . . . 63.43 111.37 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.402 HD11 HG13 ' A' ' 16' ' ' ILE . 6.8 tp -68.7 130.95 34.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.956 -0.757 . . . . 63.55 108.956 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 15.5 mm100 -110.62 -39.97 4.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.928 -0.578 . . . . 65.04 109.919 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 27.1 ttt180 -173.58 144.29 1.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 119.871 -0.109 . . . . 74.21 110.755 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.556 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 71.7 mt -123.01 132.31 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.535 -1.283 . . . . 61.02 107.535 170.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 15.4 p90 -156.73 155.45 31.68 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.416 0.686 . . . . 73.5 110.633 -174.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -88.52 109.39 20.02 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.851 -0.613 . . . . 72.31 109.697 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -72.4 -32.53 66.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.165 0.507 . . . . 74.44 109.985 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.72 142.84 27.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.961 -1.018 . . . . 72.23 109.537 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.47 137.88 53.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.665 -1.605 . . . . 75.2 106.665 169.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -144.41 136.54 26.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.925 -0.769 . . . . 74.14 108.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.601 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.5 t80 -142.32 112.19 6.86 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 106.939 -1.504 . . . . 74.13 106.939 175.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 46.7 mt-10 -118.67 108.45 14.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.98 -0.748 . . . . 63.22 108.98 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.95 81.95 2.87 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.479 -1.304 . . . . 72.44 107.479 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.31 -19.07 20.04 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.153 1.902 . . . . 71.44 111.694 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 45.7 m-80 -120.65 38.5 4.0 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.014 0.925 . . . . 72.15 109.181 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.66 -44.47 99.5 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.073 -0.967 . . . . 74.11 112.632 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.85 -28.96 67.61 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.394 1.533 . . . . 73.54 112.856 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.1 m170 -82.19 -26.31 33.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.543 0.737 . . . . 64.41 112.158 -169.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG23 HD11 ' A' ' 68' ' ' LEU . 7.3 p -63.9 -19.2 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.202 0.525 . . . . 72.43 111.807 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -83.29 -39.78 20.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.725 0.81 . . . . 75.03 110.998 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.79 -28.22 58.29 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.92 0.488 . . . . 75.21 110.724 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.68 160.87 22.31 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.284 0.634 . . . . 74.55 110.099 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.32 144.88 26.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.245 -0.65 . . . . 60.1 109.245 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.2 t-105 -75.77 89.01 2.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.66 0.784 . . . . 64.44 110.557 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.3 tt0 -122.36 77.09 44.31 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 107.718 -1.215 . . . . 72.2 107.718 169.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -84.97 145.89 10.09 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.486 2.124 . . . . 43.23 113.174 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -98.86 104.61 16.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.19 -1.411 . . . . 65.14 107.19 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 t -80.64 116.14 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.802 0.841 . . . . 74.34 108.881 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 59.2 tttm -120.35 113.99 21.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.713 0.805 . . . . 70.04 109.391 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.681 HD21 HD22 ' A' ' 128' ' ' LEU . 10.5 mp -104.87 125.74 51.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.968 -0.752 . . . . 72.35 108.968 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.646 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.3 m-20 -117.05 128.57 55.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.175 -1.046 . . . . 64.41 108.175 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -115.2 121.02 41.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.263 0.625 . . . . 71.52 109.69 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -138.86 154.57 48.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.208 1.003 . . . . 74.43 109.037 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -140.05 153.2 46.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.487 0.715 . . . . 52.51 109.484 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.38 113.28 6.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.015 -0.735 . . . . 63.13 109.015 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.2 p -90.07 165.58 13.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.711 0.404 . . . . 74.45 110.33 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 47.8 t -166.46 157.34 12.64 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.227 1.011 . . . . 61.32 108.568 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.63 132.8 55.62 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.899 -0.778 . . . . 74.23 108.899 169.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 57' ' ' GLU . 70.3 mt -105.52 -37.45 6.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.885 0.874 . . . . 74.44 110.405 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.49 -175.14 5.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.727 0.811 . . . . 52.41 109.82 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.31 104.71 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.046 0.538 . . . . 62.31 110.398 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 70.82 10.11 6.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.742 1.617 . . . . 65.33 112.432 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.07 112.42 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.0 -1.482 . . . . 52.04 107.0 170.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -117.74 150.18 39.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.502 0.721 . . . . 74.01 109.403 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 33.2 tt0 -111.11 118.31 35.66 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.48 -0.933 . . . . 71.13 108.48 171.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.8 115.57 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.916 -1.142 . . . . 73.34 107.916 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.629 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 53.7 t -98.01 137.52 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.387 0.675 . . . . 65.41 109.323 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.96 110.1 21.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.053 -1.462 . . . . 72.31 107.053 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -101.39 101.62 12.28 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.806 -0.813 . . . . 72.01 108.806 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -94.6 140.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.746 -1.205 . . . . 74.33 107.746 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 m -128.33 144.49 51.14 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.666 -0.864 . . . . 74.43 108.666 171.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 35.1 t -142.06 109.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.489 1.116 . . . . 32.21 108.543 -171.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -109.63 137.94 46.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.538 -0.541 . . . . 70.22 109.538 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.36 120.48 34.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.625 -1.25 . . . . 61.2 107.625 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -130.52 131.7 45.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.611 . . . . 74.44 110.866 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 31' ' ' VAL . 49.6 mt -87.12 83.64 7.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.02 1.328 . . . . 74.21 107.852 177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.93 -89.47 0.77 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.768 -0.651 . . . . 53.51 111.88 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.41 -28.67 9.24 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.771 0.828 . . . . 53.31 110.866 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.17 117.15 29.38 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.907 0.483 . . . . 74.25 111.144 -171.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -66.95 110.38 3.32 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.117 0.484 . . . . 74.33 112.021 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.73 -57.01 14.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.796 1.239 . . . . 73.12 110.221 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.21 173.6 16.73 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.732 0.777 . . . . 71.1 111.986 175.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 64.1 tp -141.25 144.04 34.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.504 1.522 . . . . 74.45 107.837 174.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -140.61 125.04 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.36 1.064 . . . . 63.44 108.769 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.99 116.52 8.09 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.929 0.491 . . . . 72.25 109.725 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.78 111.76 26.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.105 0.962 . . . . 72.23 109.021 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.05 79.66 9.55 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.027 -1.101 . . . . 73.23 108.027 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.44 90.29 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.931 1.292 . . . . 73.5 108.699 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.55 144.23 19.65 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 116.064 -0.516 . . . . 75.43 112.119 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.83 130.26 4.81 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 111.791 -0.524 . . . . 52.03 111.791 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 39.2 mt -82.14 125.27 39.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.53 -0.915 . . . . 74.3 108.53 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 21.0 m-85 -131.51 119.45 21.56 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.895 -1.15 . . . . 65.52 107.895 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -79.03 99.83 7.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.977 -0.749 . . . . 72.1 108.977 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.485 HG22 ' HD2' ' A' ' 11' ' ' PHE . 2.7 pp -112.61 153.48 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.354 0.662 . . . . 74.32 110.408 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.88 158.05 7.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.85 0.86 . . . . 73.14 110.231 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.1 -10.36 60.93 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 114.929 0.732 . . . . 75.41 114.929 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.32 138.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.244 0.618 . . . . 72.5 109.469 -179.003 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 12.8 tt0 -148.21 175.7 10.84 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.535 -0.913 . . . . 73.55 108.535 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 63.45 -133.61 41.88 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.098 0.249 . . . . 64.22 112.953 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -73.43 -21.7 60.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.976 0.511 . . . . 53.31 111.113 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -71.14 -41.19 70.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 74.41 110.169 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.7 ttt -74.01 -38.8 63.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.681 -0.69 . . . . 63.13 109.936 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.21 69.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.648 -0.705 . . . . 75.52 111.545 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -77.12 -38.51 52.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.408 0.683 . . . . 63.33 109.964 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.4 -66.83 0.53 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.502 0.502 . . . . 72.02 110.649 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -82.24 -10.96 58.94 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.017 0.747 . . . . 72.03 113.017 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.97 2.99 25.69 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 118.947 -0.919 . . . . 74.3 114.469 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.23 -58.47 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.583 1.191 . . . . 64.35 112.051 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.473 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.9 t80 -67.06 -51.51 53.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.988 0.915 . . . . 75.5 111.737 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.0 m -71.73 -37.69 5.5 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.249 -0.882 . . . . 41.22 112.084 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.3 -39.57 72.27 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.911 1.741 . . . . 55.34 113.002 161.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.06 -24.27 61.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.619 0.768 . . . . 62.14 111.132 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 16' ' ' ILE . 47.8 mm -64.79 -43.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 109.149 -0.686 . . . . 53.5 109.149 169.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 82' ' ' GLY . 47.3 mt -75.8 -25.48 56.42 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.988 -1.006 . . . . 64.34 111.769 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -64.41 -40.35 50.23 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 114.381 1.252 . . . . 63.12 114.381 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.55 -31.57 86.97 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 121.873 1.716 . . . . 73.31 113.502 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -87.64 -29.91 20.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.549 0.74 . . . . 72.53 111.001 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.9 86.06 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.725 -0.843 . . . . 74.44 108.725 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.432 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -62.45 -44.44 96.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.362 1.065 . . . . 73.3 110.029 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' HH12 ' B' ' 120' ' ' ARG . 10.4 tt0 -49.66 -54.28 19.53 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.278 1.031 . . . . 71.04 110.927 176.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.14 -42.95 88.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.566 -1.197 . . . . 61.13 111.561 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 97.2 mt -67.01 -62.58 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.911 0.485 . . . . 72.13 110.415 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 125' ' ' GLN . 57.9 m -48.96 -35.37 14.97 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.004 1.322 . . . . 75.41 111.986 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.5 t -71.13 -49.65 41.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.027 -0.511 . . . . 42.3 110.875 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.601 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 58.5 mtm -56.33 -42.89 78.41 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.06 0.457 . . . . 71.14 110.847 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 114' ' ' ILE . 69.3 t -61.12 -49.16 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.912 1.285 . . . . 63.41 110.633 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.7 -30.96 68.73 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.615 0.366 . . . . 64.44 111.385 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.5 mtt-85 -71.08 -30.76 66.96 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.928 0.891 . . . . 72.53 110.532 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.0 6.34 49.47 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.021 -0.536 . . . . 53.12 113.507 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.454 ' HB ' HH21 ' B' ' 15' ' ' ARG . 37.8 m 74.06 7.84 4.76 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 125.413 1.485 . . . . 65.41 111.054 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.429 ' HE1' HG21 ' A' ' 31' ' ' VAL . 89.0 m-85 -81.71 159.02 67.39 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 123.493 0.717 . . . . 64.53 109.163 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.06 161.57 45.3 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.475 2.117 . . . . 65.44 111.614 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.5 tt0 -67.54 132.68 48.03 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.854 0.359 . . . . 74.33 110.551 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -111.69 106.62 15.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.93 0.892 . . . . 74.33 109.134 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.97 90.79 4.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.546 . . . . 63.51 110.335 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.681 HD22 HD21 ' A' ' 42' ' ' LEU . 48.4 mt -74.57 116.51 15.34 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.586 -0.894 . . . . 74.22 108.586 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 141.58 97.29 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 122.068 0.147 . . . . 53.34 111.242 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.12 121.23 8.63 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.193 1.928 . . . . 45.24 110.341 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.14 109.06 23.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.803 -1.184 . . . . 62.22 107.803 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.5 91.71 6.76 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.657 -1.156 . . . . 51.31 108.238 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.477 0.875 0 CA-C-N 114.945 -1.025 . . . . 71.4 110.814 -178.648 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.176 -0.305 . . . . 63.01 110.176 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -139.44 134.0 31.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.273 -1.01 . . . . 73.21 108.273 171.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -149.62 108.35 3.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.251 -0.648 . . . . 74.12 109.251 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -78.47 133.97 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.524 0.73 . . . . 65.14 109.309 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -105.6 -50.09 3.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.674 0.39 . . . . 63.12 110.925 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.454 HH21 ' HB ' ' A' ' 122' ' ' THR . 45.9 ttt180 -159.99 146.34 15.86 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.456 0.17 . . . . 71.1 110.963 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.1 143.02 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.067 -1.457 . . . . 71.03 107.067 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.405 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.1 p90 -171.29 141.87 1.65 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 118.741 0.701 . . . . 73.13 111.198 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.6 m -74.15 118.55 17.24 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.739 -0.837 . . . . 74.14 108.739 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -86.71 -33.05 20.14 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.997 0.519 . . . . 74.05 110.524 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -158.21 143.46 16.63 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.867 0.321 . . . . 75.05 111.867 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 44.3 mm -131.88 142.35 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.823 1.249 . . . . 75.02 108.977 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.99 134.86 28.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.397 -0.964 . . . . 64.33 108.397 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -148.7 127.86 12.87 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 107.047 -1.464 . . . . 75.44 107.047 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.7 112.25 9.98 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.081 -1.081 . . . . 55.3 108.081 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -109.75 89.54 7.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.787 0.835 . . . . 73.43 108.954 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.7 -27.56 38.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.092 1.861 . . . . 72.45 111.696 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -113.82 29.44 8.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.626 0.77 . . . . 64.12 110.463 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -47.3 -48.45 55.85 Favored Pre-proline 0 CA--C 1.574 1.896 0 C-N-CA 124.905 1.282 . . . . 74.45 113.008 170.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.42 -25.48 3.8 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.044 1.83 . . . . 71.12 113.396 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.54 1.7 44.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.411 0.684 . . . . 73.41 111.923 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.47 -14.18 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.471 1.108 . . . . 44.14 111.237 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.09 -42.12 93.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.916 0.886 . . . . 72.53 110.408 169.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -75.56 -40.67 56.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.306 1.042 . . . . 72.33 110.289 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 32.1 mmtp -108.37 67.96 0.68 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.392 -1.276 . . . . 74.04 109.521 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.37 75.64 7.65 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.116 -0.947 . . . . 72.51 111.078 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -169.61 170.95 7.82 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 126.098 1.759 . . . . 75.33 109.637 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.494 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 54.1 tt0 -67.57 122.06 81.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 123.318 0.647 . . . . 73.25 110.404 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.31 151.41 80.76 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.92 2.413 . . . . 62.45 113.377 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.41 106.63 6.11 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.836 -0.802 . . . . 74.12 108.836 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.77 131.94 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.242 1.017 . . . . 73.24 110.803 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -124.43 143.1 50.82 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.992 -0.744 . . . . 70.24 108.992 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.602 HD22 HD11 ' B' ' 126' ' ' LEU . 1.0 OUTLIER -129.3 140.99 51.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.881 0.372 . . . . 71.53 110.829 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.49 145.13 49.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.372 1.069 . . . . 75.15 109.558 -168.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 31.0 tp -93.96 131.82 39.04 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.4 0.68 . . . . 64.44 109.719 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.48 124.38 28.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.971 0.908 . . . . 75.44 108.695 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.4 m -112.55 113.95 26.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.758 0.423 . . . . 32.43 110.169 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.95 149.03 39.42 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.774 -1.195 . . . . 74.24 107.774 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -143.15 173.03 11.93 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.84 0.352 . . . . 74.12 110.544 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.3 p -157.32 173.99 16.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.383 1.073 . . . . 70.31 108.948 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -124.58 121.72 35.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.674 0.39 . . . . 73.24 110.566 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 70.8 mt -80.57 -44.35 19.16 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.158 0.583 . . . . 61.34 111.126 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 -173.2 4.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.917 0.887 . . . . 74.13 109.746 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -61.72 112.77 2.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.433 -0.803 . . . . 74.31 110.277 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.52 0.28 3.19 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.922 1.689 . . . . 63.13 112.745 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.66 92.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 N-CA-C 107.543 -1.28 . . . . 74.22 107.543 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.26 171.05 8.96 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.29 0.636 . . . . 64.32 109.837 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.483 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 5.0 tm-20 -143.72 101.2 3.72 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.281 -1.377 . . . . 74.02 107.281 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.3 122.57 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.5 0.72 . . . . 64.2 110.304 -174.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 41.2 t -102.38 114.52 42.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.508 0.723 . . . . 73.54 109.532 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.5 OUTLIER -92.16 106.87 18.79 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.714 -1.217 . . . . 71.44 107.714 178.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -95.18 116.41 28.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.252 -0.647 . . . . 63.44 109.252 170.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.0 t -105.43 120.88 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.292 -1.374 . . . . 72.14 107.292 164.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -96.51 146.84 24.44 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 52.12 109.0 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.651 HG21 HG21 ' B' ' 114' ' ' ILE . 41.6 t -134.7 128.66 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.816 0.846 . . . . 71.21 109.461 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.5 m -123.61 138.78 54.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.111 -0.949 . . . . 73.51 108.543 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.71 149.82 37.75 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.498 0.719 . . . . 32.45 109.205 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.1 p -143.94 137.74 28.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.708 0.63 . . . . 64.35 110.25 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 38.8 mt -90.9 98.73 11.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.077 -1.823 . . . . 53.14 106.077 170.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.63 -129.68 14.09 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.538 -0.755 . . . . 65.15 111.686 -169.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -92.75 2.83 56.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.054 0.941 . . . . 74.42 111.021 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -115.65 138.09 51.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.244 1.018 . . . . 74.24 109.02 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 132.7 49.85 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.317 0.58 . . . . 65.33 111.846 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.477 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.87 -58.65 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.376 1.071 . . . . 73.24 109.073 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -157.82 157.03 32.53 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.275 -1.329 . . . . 74.1 110.544 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.3 mt -135.18 110.71 9.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 106.673 -1.603 . . . . 72.55 106.673 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.95 157.86 25.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.357 -0.608 . . . . 50.44 109.357 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -164.6 135.08 4.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.979 -0.749 . . . . 52.55 108.979 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.92 139.83 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.546 -0.752 . . . . 71.24 109.086 173.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -122.66 89.13 3.06 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.489 -0.93 . . . . 74.54 108.489 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.36 101.23 12.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.2 -1.037 . . . . 64.41 108.2 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.5 159.32 28.27 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.24 -0.744 . . . . 61.43 111.24 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.92 129.36 2.38 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 112.002 -0.439 . . . . 30.51 112.002 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.405 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.2 mt -85.15 124.13 39.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.578 -0.897 . . . . 74.45 108.578 174.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -136.33 158.11 45.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.162 0.985 . . . . 75.32 108.883 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -130.93 114.8 15.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.344 -0.613 . . . . 60.33 109.344 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.501 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.72 143.02 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.384 0.673 . . . . 74.12 110.003 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.03 167.86 29.19 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.98 0.912 . . . . 73.51 109.099 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.47 -70.19 1.22 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.847 -0.501 . . . . 72.4 111.847 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.431 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -57.62 141.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.823 0.449 . . . . 53.11 110.623 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 31.0 tt0 -151.4 154.24 36.26 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.93 0.332 . . . . 75.52 110.593 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.21 -124.33 13.52 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.389 0.431 . . . . 71.34 112.7 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.6 m -65.76 -32.33 73.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.61 0.764 . . . . 75.34 110.121 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -69.38 -36.45 76.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.804 0.842 . . . . 52.41 110.512 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.4 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 18.0 ttt -72.6 -45.6 58.28 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.96 -0.385 . . . . 64.51 109.96 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.92 66.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.87 0.468 . . . . 54.14 112.057 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -73.36 -33.2 64.94 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.686 0.794 . . . . 75.42 110.806 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -86.26 -67.42 0.81 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.284 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 16.8 tp -61.15 -32.36 72.08 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.597 1.159 . . . . 71.1 112.709 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.73 1.97 52.56 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.354 -0.692 . . . . 63.12 114.663 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.96 -52.2 0.33 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.904 0.852 . . . . 61.32 111.492 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -73.63 -46.8 44.62 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.017 0.527 . . . . 63.02 111.993 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.412 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 78.8 m -63.41 -44.16 81.36 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 118.814 -0.612 . . . . 63.54 111.207 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.7 Cg_exo -59.96 -36.53 89.69 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.893 1.729 . . . . 73.34 113.396 164.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.7 -31.04 71.16 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 122.835 0.454 . . . . 72.41 111.432 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.453 HG23 ' NH2' ' D' ' 111' ' ' ARG . 94.7 mt -61.41 -50.76 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.913 0.885 . . . . 75.42 109.964 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.439 ' HB2' HD12 ' B' ' 60' ' ' LEU . 46.4 mt -77.58 -11.51 59.87 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.487 1.115 . . . . 72.52 112.135 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -69.24 -44.06 26.02 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.883 1.273 . . . . 70.12 113.621 -165.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.64 -34.47 51.46 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 121.568 1.512 . . . . 75.21 112.344 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -63.71 -41.67 98.06 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.715 0.634 . . . . 75.44 110.136 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -69.03 -42.76 75.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.447 -0.797 . . . . 73.12 110.325 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -57.24 -54.71 43.7 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.643 1.177 . . . . 52.52 111.776 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.08 -38.81 91.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.176 0.99 . . . . 73.32 110.395 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.49 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -67.65 -32.91 73.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.6 -0.727 . . . . 71.54 111.78 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.651 HG21 HG21 ' B' ' 64' ' ' VAL . 74.5 mt -65.52 -55.64 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.466 -0.568 . . . . 63.24 109.466 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 5.0 m -56.93 -32.17 65.71 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.277 0.986 . . . . 62.44 110.983 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.62 -53.2 51.42 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.484 -1.235 . . . . 63.12 110.747 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.1 mmt -67.68 -32.01 72.38 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.663 0.385 . . . . 74.51 111.703 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.13 -42.75 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.237 1.015 . . . . 73.0 110.688 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.03 -25.32 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.94 0.496 . . . . 64.31 111.739 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 116' ' ' SER . 80.8 mtt-85 -66.85 -38.58 86.63 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.799 0.439 . . . . 75.51 109.848 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.41 4.21 56.37 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.263 -0.88 . . . . 73.41 113.148 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 66.8 p 59.44 50.73 7.25 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.921 1.688 . . . . 72.01 112.035 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -120.41 158.53 50.92 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.684 1.194 . . . . 72.25 109.795 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.494 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.2 Cg_exo -72.37 -174.65 1.49 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.57 2.847 . . . . 63.51 115.435 -166.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -58.85 130.66 48.05 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.839 -1.528 . . . . 74.23 112.118 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.602 HD11 HD22 ' B' ' 42' ' ' LEU . 59.0 tp -138.64 83.83 1.98 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.669 -1.234 . . . . 42.11 107.669 171.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.663 -1.236 . . . . 75.44 107.663 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 tt -87.0 130.62 34.38 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.581 -0.896 . . . . 75.0 108.581 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.43 34.76 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.236 0.615 . . . . 73.44 110.466 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.429 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 45.1 Cg_endo -67.06 131.86 26.45 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.192 1.928 . . . . 74.33 110.984 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.89 143.79 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 122.957 0.503 . . . . 63.45 110.384 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -86.99 111.83 21.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.735 0.814 . . . . 62.14 109.24 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 123.95 0.9 . . . . 72.14 111.43 -177.395 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 107.711 -1.218 . . . . 75.3 107.711 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.602 ' HA ' HG22 ' C' ' 86' ' ' ILE . 41.5 t80 -125.99 120.1 29.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.11 0.564 . . . . 75.23 109.841 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -139.02 128.94 25.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.64 0.376 . . . . 61.35 110.066 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.421 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.6 tp -80.99 136.83 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.388 -0.597 . . . . 70.55 109.388 170.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -106.65 -49.7 3.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.46 0.704 . . . . 73.21 110.17 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -160.73 136.47 8.16 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.144 -0.48 . . . . 74.01 110.313 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.83 143.52 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.338 -1.356 . . . . 73.54 107.338 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -171.5 162.66 6.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.33 0.586 . . . . 72.21 110.754 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -83.8 113.64 21.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.456 -0.793 . . . . 64.32 109.137 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -64.76 -46.9 80.23 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.987 -1.116 . . . . 72.22 107.987 167.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -142.8 141.61 31.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.42 -1.718 . . . . 71.44 109.791 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -140.73 143.43 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.388 -1.708 . . . . 53.22 106.388 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -155.69 151.6 27.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.745 0.418 . . . . 53.43 110.117 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -155.62 121.49 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.769 -1.197 . . . . 52.31 107.769 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.36 136.61 54.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.374 0.67 . . . . 61.15 109.804 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.59 77.93 8.56 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.843 -1.169 . . . . 63.04 107.843 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.53 -9.75 23.09 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.371 2.047 . . . . 61.1 111.943 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -109.38 19.43 19.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.716 1.206 . . . . 73.33 110.213 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -51.72 -49.8 81.13 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 124.903 1.281 . . . . 74.43 113.475 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.95 -30.12 1.43 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.421 1.414 . . . . 73.45 113.31 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -69.41 -28.06 65.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.524 0.729 . . . . 63.05 111.955 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.87 -12.29 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.217 0.607 . . . . 74.0 111.411 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.88 -31.67 72.74 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.888 0.875 . . . . 74.25 111.261 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.7 20.83 17.96 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.4 0.68 . . . . 61.02 110.146 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.812 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -100.83 158.27 16.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.095 0.558 . . . . 73.34 109.887 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -77.44 121.32 23.67 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.281 -1.007 . . . . 71.03 108.281 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -85.0 91.15 8.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.598 0.713 . . . . 74.0 110.434 -172.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -131.32 69.66 82.0 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.559 -1.2 . . . . 71.43 108.239 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.56 104.65 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.655 2.236 . . . . 63.14 111.933 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -86.99 118.01 26.08 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.753 -0.832 . . . . 61.55 108.753 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.467 HG11 HD21 ' C' ' 126' ' ' LEU . 48.2 t -80.2 128.29 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 74.33 111.448 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.36 104.31 7.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.688 1.195 . . . . 72.13 107.865 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.511 HD23 HD12 ' C' ' 128' ' ' LEU . 0.3 OUTLIER -86.65 165.83 15.83 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.838 0.352 . . . . 75.31 110.407 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.692 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -138.35 146.25 42.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.384 -1.339 . . . . 75.53 107.384 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.7 tp -138.2 102.26 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.921 -0.77 . . . . 72.3 108.921 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 7.1 m-20 -120.09 142.32 48.99 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.427 0.691 . . . . 73.12 109.758 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -114.88 117.56 31.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.137 -0.69 . . . . 63.03 109.137 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.92 153.9 24.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.718 -1.216 . . . . 54.14 107.718 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.3 p -164.34 154.17 14.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.934 0.397 . . . . 70.12 111.328 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 15.5 p -170.34 138.92 1.63 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.248 1.019 . . . . 73.24 109.174 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -80.32 135.99 36.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.955 0.502 . . . . 44.11 109.817 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.444 ' CD1' HD12 ' C' ' 83' ' ' ILE . 63.7 mt -104.57 -26.56 12.3 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.83 0.852 . . . . 73.52 111.591 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.23 -172.99 1.39 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.383 0.673 . . . . 41.05 110.955 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.28 105.92 0.67 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 123.985 0.803 . . . . 72.33 110.919 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.53 10.04 5.52 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.254 1.422 . . . . 54.33 112.519 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.41 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 108.234 -1.024 . . . . 74.34 108.234 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -108.31 158.67 17.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.124 0.97 . . . . 73.34 108.75 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.4 tt0 -126.07 127.78 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.281 -1.007 . . . . 73.14 108.281 172.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 81.1 t -117.93 129.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.939 -1.134 . . . . 61.32 107.939 170.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.09 107.48 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.336 -0.987 . . . . 64.03 108.336 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.472 HD22 HG22 ' C' ' 62' ' ' VAL . 0.9 OUTLIER -86.19 106.21 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.069 -1.086 . . . . 72.33 108.069 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 57.4 ttt180 -82.12 105.38 13.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.472 HG22 HD22 ' C' ' 60' ' ' LEU . 13.6 t -105.42 130.99 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.213 -1.032 . . . . 64.32 108.213 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 21.9 m -129.7 146.29 51.48 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.02 -0.733 . . . . 74.41 109.02 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.519 HG21 HG21 ' C' ' 114' ' ' ILE . 50.8 t -131.07 127.94 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.948 0.899 . . . . 72.5 108.655 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.484 HG23 HD23 ' C' ' 75' ' ' LEU . 4.2 m -123.2 109.16 13.64 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.657 -1.238 . . . . 72.42 107.657 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.67 121.14 41.14 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.056 -1.09 . . . . 54.31 108.056 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -129.8 133.05 46.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.282 0.563 . . . . 71.31 110.593 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.812 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -87.1 33.88 0.68 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 125.726 1.61 . . . . 74.14 110.085 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.77 -103.1 2.17 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.176 -0.769 . . . . 60.02 111.176 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.35 -31.61 17.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.427 0.691 . . . . 74.44 110.16 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 4.0 tp10 -79.21 120.22 23.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 75.32 109.2 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -77.56 122.36 25.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.15 -0.685 . . . . 64.41 109.15 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -71.15 -50.29 34.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 63.31 109.598 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -160.84 170.66 20.23 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.422 -1.263 . . . . 74.14 110.98 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.484 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -136.35 147.23 47.27 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.996 -1.483 . . . . 53.13 106.996 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.418 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -147.81 149.21 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.478 -0.934 . . . . 72.12 108.478 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -157.61 118.81 3.58 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.848 0.459 . . . . 75.33 109.884 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -121.64 112.47 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.517 0.727 . . . . 54.52 109.364 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.454 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 49.7 mt-30 -94.82 99.64 11.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.704 -0.85 . . . . 73.44 108.704 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.62 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.1 tp-100 -85.07 104.93 15.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 71.43 110.542 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.06 145.67 22.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.47 -0.332 . . . . 42.13 112.326 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.92 127.85 2.72 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.057 -0.417 . . . . 54.44 112.057 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.444 HD12 ' CD1' ' C' ' 51' ' ' LEU . 12.6 mm -91.19 125.03 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.606 0.762 . . . . 64.44 109.124 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.421 ' CE2' HD13 ' C' ' 13' ' ' ILE . 58.4 m-85 -133.69 118.31 17.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.864 -0.791 . . . . 72.01 108.864 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.1 p -85.69 97.37 10.09 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -125.22 135.48 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-O 121.531 0.682 . . . . 43.35 111.235 -174.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.95 -178.54 5.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.191 1.396 . . . . 73.4 107.905 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.74 -30.56 4.18 Favored Glycine 0 N--CA 1.477 1.419 0 C-N-CA 121.391 -0.433 . . . . 52.15 113.642 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.422 HG13 ' H ' ' C' ' 89' ' ' ILE . 2.4 pp . . . . . 0 CA--C 1.549 0.918 0 C-N-CA 124.098 0.959 . . . . 64.11 111.764 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.345 0.117 . . . . 74.22 111.105 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.1 tpt -55.07 -36.93 66.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.892 0.877 . . . . 45.35 111.054 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.49 -47.44 11.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.636 0.774 . . . . 62.33 111.523 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -73.7 -34.61 64.93 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.482 0.713 . . . . 72.12 112.656 -167.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -63.6 -55.97 19.54 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.614 0.571 . . . . 75.14 111.233 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.414 HD12 ' N ' ' C' ' 99' ' ' GLY . 1.0 OUTLIER -92.83 -16.69 25.01 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.198 0.599 . . . . 60.42 112.528 -175.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.414 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.95 -14.87 38.24 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.395 -0.67 . . . . 71.11 113.8 -172.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.08 -46.25 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.46 0.63 . . . . 70.35 111.979 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -74.7 -44.25 51.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.119 0.567 . . . . 63.41 111.972 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.511 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 73.2 m -67.63 -45.48 45.94 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.464 -0.779 . . . . 72.21 111.331 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.11 -36.65 96.63 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.249 1.966 . . . . 75.12 112.734 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -61.91 -33.44 74.24 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.546 0.738 . . . . 64.43 111.712 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.432 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -68.37 -39.31 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.165 0.586 . . . . 72.32 110.413 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.7 mt -80.84 -32.73 34.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.274 -0.876 . . . . 74.02 112.483 -171.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -54.19 -48.72 93.49 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 117.288 -1.339 . . . . 73.22 113.182 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -45.04 -43.19 15.86 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.974 2.449 . . . . 64.11 114.544 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -70.45 -45.32 66.01 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.285 0.634 . . . . 73.23 111.052 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.9 -37.01 81.19 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.117 0.567 . . . . 72.42 110.959 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -54.12 -51.08 65.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.341 1.456 . . . . 73.05 110.517 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.24 -32.03 66.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.224 -0.898 . . . . 64.53 110.92 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -74.6 -30.84 61.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.896 0.478 . . . . 73.51 111.609 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.519 HG21 HG21 ' C' ' 64' ' ' VAL . 94.3 mt -71.7 -46.31 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.572 -0.529 . . . . 73.22 109.572 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.521 HG23 ' HB2' ' C' ' 125' ' ' GLN . 54.2 m -51.28 -42.54 61.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 71.35 110.834 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -63.68 -52.56 60.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.811 -1.541 . . . . 55.44 110.219 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.469 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.93 -40.96 81.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.362 1.065 . . . . 73.31 113.162 -176.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.44 -46.44 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.283 0.633 . . . . 75.21 110.151 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -64.83 -27.69 69.05 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.001 -1.0 . . . . 71.03 111.648 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 76.6 mtt-85 -70.06 -37.26 75.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.616 0.767 . . . . 72.31 110.286 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.92 8.55 56.54 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.172 -0.793 . . . . 55.24 113.135 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 42.8 p 61.28 26.99 16.75 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 125.933 1.693 . . . . 74.14 112.664 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 51.5 m-85 -100.15 167.73 10.52 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.385 1.074 . . . . 72.44 109.606 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 45.0 Cg_endo -66.06 111.65 2.05 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 122.051 1.834 . . . . 54.32 111.682 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' C' ' 115' ' ' THR . 4.5 pp0? -47.47 143.32 3.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.569 1.147 . . . . 71.42 112.048 -173.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.467 HD21 HG11 ' C' ' 40' ' ' VAL . 1.2 tm? -111.13 91.25 3.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.21 0.529 . . . . 74.11 110.13 -173.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -129.95 92.33 3.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.866 -1.161 . . . . 64.1 107.866 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.511 HD12 HD23 ' C' ' 42' ' ' LEU . 61.6 mt -87.36 154.25 20.82 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.104 0.962 . . . . 72.14 111.442 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.72 136.27 13.28 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 124.42 1.075 . . . . 73.41 112.143 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.556 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 40.8 Cg_endo -63.85 108.4 0.9 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.989 2.46 . . . . 75.24 112.537 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.33 87.75 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.375 0.67 . . . . 71.12 109.492 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.77 101.59 8.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.945 -0.761 . . . . 43.31 108.945 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.3 t80 . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 124.07 0.948 . . . . 72.53 111.096 179.433 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 109.11 -0.7 . . . . 73.1 109.11 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -150.47 94.05 2.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.26 -1.385 . . . . 52.52 107.26 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.449 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 80.9 mt-30 -112.11 131.89 55.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.644 0.778 . . . . 62.51 108.967 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 138.68 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.231 -1.026 . . . . 75.13 108.231 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.41 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 52.8 mt-30 -106.04 -48.95 3.48 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 110.282 -0.266 . . . . 71.21 110.282 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 ttt85 -176.23 130.26 0.22 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.071 0.232 . . . . 74.13 111.618 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.429 ' HB ' ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -117.71 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.199 -1.037 . . . . 71.24 108.199 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -150.21 165.02 34.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.396 1.079 . . . . 73.51 110.546 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -90.85 113.55 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.289 -0.634 . . . . 74.34 109.289 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 44.3 mtpt -78.95 -31.64 45.16 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.133 0.492 . . . . 72.15 109.964 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -150.37 142.29 23.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.053 -0.976 . . . . 73.3 109.3 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.469 HD13 ' HE3' ' C' ' 117' ' ' MET . 63.1 mt -141.34 144.33 26.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.51 -1.293 . . . . 73.44 107.51 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -147.53 142.62 27.1 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.65 -0.87 . . . . 71.31 108.65 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.5 t80 -147.36 125.51 12.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.672 -1.603 . . . . 65.45 106.672 170.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.7 147.01 51.45 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.92 0.888 . . . . 75.44 108.707 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 78.43 37.08 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 107.498 -1.297 . . . . 74.24 107.498 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.21 -29.52 47.02 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.429 2.086 . . . . 52.4 112.275 -174.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -114.4 27.95 9.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.892 0.877 . . . . 52.43 110.139 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.12 -57.22 6.5 Favored Pre-proline 0 CA--C 1.576 1.974 0 N-CA-C 116.24 1.941 . . . . 54.21 116.24 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 83' ' ' ILE . 24.1 Cg_endo -87.97 -5.17 6.91 Favored 'Trans proline' 0 C--N 1.384 2.404 0 CA-C-N 122.321 1.865 . . . . 74.24 112.955 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -79.0 -30.95 44.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.11 1.364 . . . . 74.45 108.751 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' D' ' 123' ' ' PHE . 3.1 t -68.13 -28.59 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.81 1.244 . . . . 61.13 110.82 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -53.65 -23.41 11.18 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.44 0.696 . . . . 74.11 112.605 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -86.56 -0.03 55.31 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.644 0.778 . . . . 62.32 112.704 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.96 113.12 16.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.234 1.013 . . . . 73.43 110.764 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.69 64.62 1.51 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.189 0.995 . . . . 65.12 110.874 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.507 ' HB2' HD22 ' D' ' 68' ' ' LEU . 14.5 m95 -126.18 173.79 8.99 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.858 0.863 . . . . 75.24 109.508 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -89.49 125.62 60.92 Favored Pre-proline 0 N--CA 1.476 0.842 0 N-CA-C 108.259 -1.015 . . . . 65.24 108.259 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.06 127.44 21.25 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.852 1.701 . . . . 75.1 111.588 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.4 OUTLIER -65.41 111.16 2.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.678 -1.23 . . . . 74.03 107.678 172.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.674 HG13 HG13 ' D' ' 64' ' ' VAL . 59.6 t -104.35 114.42 43.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 122.864 0.465 . . . . 72.13 110.36 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 4.7 tppp? -87.45 120.27 28.58 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.569 -0.741 . . . . 74.24 109.325 169.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.474 HD21 HD22 ' D' ' 128' ' ' LEU . 7.4 mp -96.27 111.72 23.7 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.486 -1.302 . . . . 64.03 107.486 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.6 t70 -109.47 119.6 39.95 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.227 -1.027 . . . . 51.22 108.227 175.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -96.58 131.12 43.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.298 0.639 . . . . 70.55 109.987 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.9 t70 -139.42 151.71 46.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.096 0.958 . . . . 62.11 108.528 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 155.98 44.76 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.401 0.68 . . . . 75.32 109.598 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.86 163.72 37.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.908 0.883 . . . . 62.21 109.096 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -150.12 153.17 35.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.113 0.565 . . . . 75.14 110.006 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.6 p -154.26 123.38 6.41 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.849 0.86 . . . . 55.34 109.005 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.99 121.07 22.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.891 0.476 . . . . 75.52 110.083 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.2 mt -89.38 -38.63 13.98 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.502 0.668 . . . . 64.4 109.393 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.16 -176.69 5.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.38 -1.282 . . . . 40.12 109.504 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 122.43 15.69 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.799 -0.637 . . . . 75.14 110.918 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 71.04 1.71 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.519 1.528 . . . . 62.43 112.55 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -110.04 123.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 124.198 0.999 . . . . 75.04 109.871 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.59 129.94 33.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.106 0.563 . . . . 64.45 109.998 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' D' ' 51' ' ' LEU . 9.3 tt0 -95.16 120.38 35.28 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.828 -1.175 . . . . 72.24 107.828 167.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.07 134.62 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.028 -0.731 . . . . 74.32 109.028 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.9 t -108.92 129.21 63.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.037 0.535 . . . . 73.05 110.029 -175.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.49 123.04 44.88 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.562 -1.273 . . . . 70.43 107.562 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.7 ttm-85 -108.8 102.84 11.84 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.876 -0.787 . . . . 74.43 108.876 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.82 107.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.114 -1.069 . . . . 73.3 108.114 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 45.6 m -97.68 136.1 38.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.922 -0.581 . . . . 63.12 109.603 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.674 HG13 HG13 ' D' ' 40' ' ' VAL . 53.4 t -126.67 103.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.825 1.25 . . . . 62.43 108.742 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 29.2 m -104.62 94.52 5.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.917 -1.142 . . . . 73.53 107.917 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.06 140.64 30.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.851 -0.613 . . . . 34.11 110.115 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.5 m -148.43 126.12 11.81 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.158 0.504 . . . . 65.54 111.577 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' D' ' 36' ' ' TRP . 26.2 mt -94.72 109.25 21.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.704 0.802 . . . . 70.0 109.634 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.25 -111.52 3.28 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.366 0.417 . . . . 61.03 112.283 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.57 7.96 12.78 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.367 0.667 . . . . 75.15 110.745 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.12 165.46 18.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.835 0.854 . . . . 73.12 109.302 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -75.8 136.37 40.24 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.278 0.631 . . . . 45.52 111.217 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.516 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.93 -1.137 . . . . 71.21 107.93 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.04 151.3 30.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.984 -1.007 . . . . 71.22 110.333 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.37 146.15 29.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.929 -1.137 . . . . 71.3 107.929 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.1 t -159.36 138.68 11.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.568 -0.53 . . . . 61.2 109.568 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.35 133.87 9.86 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.027 0.376 . . . . 74.11 110.602 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.8 118.13 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.175 0.59 . . . . 73.2 110.071 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.6 mt-30 -90.25 86.03 6.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.703 0.801 . . . . 72.24 109.24 170.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.16 95.16 6.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.661 1.185 . . . . 75.15 109.604 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.27 143.29 18.63 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 111.88 -0.488 . . . . 73.3 111.88 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.14 130.88 4.16 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.969 -0.453 . . . . 62.33 111.969 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 35.9 mt -90.47 133.6 31.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.693 0.797 . . . . 71.43 109.534 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -136.7 134.61 37.39 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.319 0.648 . . . . 75.2 110.176 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 40.0 m -82.46 104.36 12.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.984 -0.747 . . . . 72.45 108.984 166.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 134.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.282 1.033 . . . . 70.34 109.432 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.98 167.11 12.93 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.644 0.778 . . . . 73.01 111.39 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.13 -2.07 77.56 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 115.993 1.157 . . . . 72.41 115.993 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.449 HD12 ' HE3' ' D' ' 94' ' ' MET . 2.4 pp -123.18 169.99 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.353 1.061 . . . . 61.31 109.469 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -164.18 -173.37 3.11 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.568 0.581 . . . . 75.1 112.568 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 -145.14 31.16 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 123.932 0.777 . . . . 62.25 114.171 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.0 m -69.43 -27.19 65.05 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.363 0.665 . . . . 75.24 110.251 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -60.79 -43.41 98.16 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 110.223 -0.288 . . . . 74.12 110.223 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.449 ' HE3' HD12 ' D' ' 89' ' ' ILE . 50.3 ttm -68.08 -49.29 62.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.935 0.494 . . . . 74.32 111.118 176.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.22 96.52 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.5 0.72 . . . . 61.4 112.228 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -87.63 -25.02 23.76 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.558 -0.746 . . . . 73.14 110.744 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.3 tp -65.51 -42.79 91.67 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.151 -0.931 . . . . 61.21 111.05 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.54 -7.15 76.15 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.753 -0.658 . . . . 64.12 114.615 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.7 -62.75 0.55 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 117.672 0.736 . . . . 64.52 112.077 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -64.88 -47.01 79.4 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.562 0.579 . . . . 74.32 112.562 -167.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -65.25 -45.55 71.24 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.662 -0.685 . . . . 74.34 110.809 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.71 -38.86 77.61 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.266 1.978 . . . . 73.11 113.995 163.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -65.46 -27.73 68.72 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 122.852 0.461 . . . . 72.41 111.603 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.25 -44.88 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' D' ' 82' ' ' GLY . 65.0 mt -76.17 -20.26 57.71 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.829 -1.078 . . . . 65.03 111.732 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -68.25 -40.22 19.89 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 117.436 -1.269 . . . . 70.23 113.989 -168.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.95 -42.2 59.49 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.722 1.651 . . . . 62.43 112.771 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -76.73 -34.94 58.08 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.186 0.994 . . . . 73.41 110.982 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.91 51.91 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.465 0.706 . . . . 70.01 110.016 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -56.22 -47.73 77.87 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.818 1.324 . . . . 74.4 110.851 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.74 -46.78 88.16 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.236 0.96 . . . . 73.24 111.727 -175.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.6 t -55.73 -41.17 73.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.301 1.001 . . . . 75.11 110.349 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.491 HG21 HG21 ' D' ' 64' ' ' VAL . 67.8 mt -66.73 -53.75 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.347 1.029 . . . . 64.44 110.935 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.2 m -55.82 -39.2 71.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.555 1.142 . . . . 74.52 111.148 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.69 -46.23 76.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.573 -1.194 . . . . 52.15 110.261 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.1 mtm -66.23 -30.72 71.23 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.811 0.445 . . . . 64.23 112.097 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.8 t -64.37 -45.06 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 64.21 109.394 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -74.93 -24.32 58.47 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.258 -0.428 . . . . 62.11 111.458 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -74.16 -33.11 63.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.449 0.7 . . . . 74.41 109.938 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.11 4.58 85.81 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.976 -0.556 . . . . 63.13 112.531 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p 61.44 29.6 18.51 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.168 1.787 . . . . 62.01 113.349 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' D' ' 31' ' ' VAL . 97.3 m-85 -87.91 168.67 16.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.001 1.32 . . . . 60.32 109.451 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.56 140.1 38.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.792 2.328 . . . . 70.11 111.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -52.77 130.37 32.61 Favored 'General case' 0 C--O 1.243 0.763 0 O-C-N 124.057 0.848 . . . . 72.43 111.804 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -119.32 96.43 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.24 1.016 . . . . 64.01 109.401 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.73 98.34 9.18 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.672 -0.862 . . . . 72.41 108.672 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.474 HD22 HD21 ' D' ' 42' ' ' LEU . 75.5 mt -69.23 115.33 8.38 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.213 0.605 . . . . 75.31 109.692 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.84 135.77 87.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.264 0.625 . . . . 52.21 111.828 -172.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 11.2 Cg_endo -79.53 101.13 1.37 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.972 1.781 . . . . 71.22 110.029 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 114.27 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.058 0.943 . . . . 71.01 109.656 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 121.661 0.743 . . . . 60.55 109.588 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 73.4 m . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 107.921 -1.141 . . . . 74.14 107.921 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -136.57 144.0 43.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.143 -0.688 . . . . 72.42 109.143 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.76 137.24 11.98 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.499 0.5 . . . . 74.44 110.999 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.39 119.86 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 N-CA-C 109.374 -0.602 . . . . 73.25 109.374 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -97.93 -37.23 9.88 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.401 0.681 . . . . 70.12 110.393 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt85 -172.95 141.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.806 0.442 . . . . 74.23 111.3 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.6 mt -116.61 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 108.352 -0.981 . . . . 71.22 108.352 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -166.24 155.53 11.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.713 0.805 . . . . 72.41 111.226 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -87.04 114.64 23.82 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.973 -0.751 . . . . 74.54 108.973 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 37.2 mtpt -76.72 -27.03 55.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.768 0.427 . . . . 73.33 109.986 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.9 t70 -154.59 140.75 18.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.414 -0.812 . . . . 65.53 109.466 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.8 mt -136.72 140.09 43.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.317 -1.364 . . . . 72.41 107.317 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.6 t -145.53 128.99 16.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.03 -0.729 . . . . 61.02 109.03 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 91.8 t80 -137.92 112.86 9.06 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.296 -1.742 . . . . 74.04 106.296 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -118.22 134.94 54.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.88 78.5 69.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 106.045 -1.835 . . . . 55.02 106.045 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.5 -24.49 26.21 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.186 1.924 . . . . 64.5 111.177 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -110.52 29.33 7.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.518 -1.219 . . . . 73.21 109.232 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.11 -43.64 97.51 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.283 1.033 . . . . 70.5 112.407 175.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.44 -25.57 70.67 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.231 1.475 . . . . 63.12 113.253 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -82.87 -13.77 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.022 0.529 . . . . 62.23 112.188 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.5 p -63.25 -18.17 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.468 0.577 . . . . 62.34 111.994 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.67 -40.26 20.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.921 0.888 . . . . 65.13 110.521 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.98 -25.82 31.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.987 0.515 . . . . 72.2 110.751 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.25 146.67 28.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.392 0.677 . . . . 73.31 111.184 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.65 122.04 18.33 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.547 -1.206 . . . . 54.24 108.602 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.468 ' CE3' HD21 ' A' ' 68' ' ' LEU . 74.4 t-105 -82.03 86.71 6.52 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.494 0.664 . . . . 71.11 110.165 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -124.45 83.42 57.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.487 -1.301 . . . . 74.01 107.487 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.65 119.29 5.13 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.519 2.146 . . . . 71.05 112.337 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.45 112.03 24.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.012 -1.107 . . . . 64.4 108.012 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.23 111.29 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.27 1.028 . . . . 71.2 110.729 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -101.82 140.35 36.22 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.836 -0.802 . . . . 74.42 108.836 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.54 131.52 55.18 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.425 -0.954 . . . . 73.15 108.425 171.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.662 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -117.9 128.95 55.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.047 -1.094 . . . . 72.5 108.047 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.8 tp -98.15 128.9 44.9 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.215 -0.661 . . . . 74.24 109.215 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -134.09 151.65 51.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.67 -0.863 . . . . 74.32 108.67 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.1 m -141.49 147.96 38.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.075 0.95 . . . . 73.44 108.493 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.34 142.95 49.53 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.493 -0.929 . . . . 64.22 108.493 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.7 m -132.67 150.15 52.2 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -159.79 151.43 20.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.999 0.919 . . . . 65.04 109.128 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -95.53 114.08 25.8 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.838 -0.801 . . . . 53.3 108.838 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 57' ' ' GLU . 83.8 mt -84.09 -43.59 14.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.723 0.409 . . . . 73.31 110.198 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.6 -178.16 6.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.027 0.931 . . . . 60.22 109.277 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.98 122.88 18.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.967 -0.753 . . . . 63.22 108.967 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 66.67 13.66 9.44 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.81 1.244 . . . . 72.13 112.133 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.33 125.54 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.494 -0.928 . . . . 75.35 108.494 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -130.87 168.32 17.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.277 0.56 . . . . 71.41 110.212 176.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 51' ' ' LEU . 31.2 tt0 -127.34 121.78 31.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.159 -1.052 . . . . 72.15 108.159 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.51 119.02 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.778 -1.193 . . . . 74.2 107.778 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -99.16 135.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.79 0.836 . . . . 70.43 108.983 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.37 112.01 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.9 -1.518 . . . . 75.11 106.9 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.508 ' HD3' ' HG2' ' A' ' 79' ' ' GLN . 12.2 ttp180 -108.42 104.33 13.67 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.387 -0.597 . . . . 75.25 109.387 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.99 132.42 39.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.237 -1.023 . . . . 64.42 108.237 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.1 m -114.02 138.2 50.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.823 -0.806 . . . . 72.12 108.823 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 39.9 t -133.71 108.58 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 125.104 1.361 . . . . 75.24 108.382 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -106.02 140.48 38.94 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.568 -0.53 . . . . 74.44 109.568 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.9 117.27 27.67 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.172 -1.047 . . . . 73.34 108.172 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 m -113.88 127.56 56.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.189 0.596 . . . . 74.3 110.367 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.4 mt -93.41 53.46 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.292 1.437 . . . . 72.32 109.642 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.6 -84.93 0.97 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.119 -0.491 . . . . 74.25 112.147 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.04 -28.41 16.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.666 0.786 . . . . 72.31 111.724 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -123.39 133.69 54.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.714 0.806 . . . . 73.55 109.893 -169.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -71.34 136.89 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 120.916 0.388 . . . . 62.31 110.459 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -61.8 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.19 0.996 . . . . 61.44 109.214 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.83 167.64 26.85 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.34 -1.3 . . . . 60.43 110.297 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -134.43 140.36 46.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.806 1.242 . . . . 64.24 108.178 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.4 m -131.0 135.87 48.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.272 1.029 . . . . 53.31 108.973 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.17 123.45 8.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.602 0.361 . . . . 75.44 110.123 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.41 113.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.974 0.91 . . . . 74.21 109.749 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.508 ' HG2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 mt-30 -85.6 81.09 8.8 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.641 0.776 . . . . 73.51 108.916 172.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.74 90.53 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.154 0.982 . . . . 64.04 108.572 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.99 144.84 18.28 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 116.087 -0.506 . . . . 53.4 112.325 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.12 130.83 5.0 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 111.983 -0.447 . . . . 32.02 111.983 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -81.29 131.34 34.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 107.426 -1.324 . . . . 73.44 107.426 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . 37.7 m-85 -131.79 155.43 47.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.725 -0.843 . . . . 72.13 108.725 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -111.49 114.22 27.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.603 1.161 . . . . 72.52 108.035 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 tt -139.08 152.92 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 118.086 0.403 . . . . 73.35 111.033 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.82 169.34 13.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.374 1.069 . . . . 63.3 110.352 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.45 5.76 86.04 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 123.901 0.751 . . . . 73.21 114.701 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.05 153.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.154 0.981 . . . . 72.33 109.606 -177.06 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.23 170.48 22.38 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.165 0.586 . . . . 72.31 109.444 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.73 -125.3 34.59 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 123.701 0.667 . . . . 73.32 113.889 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.4 p -75.49 -21.39 58.08 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.731 0.812 . . . . 51.11 111.422 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.55 -40.16 92.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.004 0.522 . . . . 70.44 109.797 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -47.44 24.47 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.311 -0.859 . . . . 72.53 109.92 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -34.05 77.09 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.106 -0.952 . . . . 72.52 112.636 -172.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -78.89 -20.81 48.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.194 0.598 . . . . 55.53 110.855 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.532 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 49.4 t -80.42 -64.39 1.2 Allowed 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.413 0.285 . . . . 53.31 110.242 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.19 -37.12 84.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.961 0.504 . . . . 60.33 111.786 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.46 -15.11 64.62 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 114.92 0.728 . . . . 75.22 114.92 -172.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.88 -51.19 0.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.637 0.718 . . . . 74.54 112.656 -171.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.5 t80 -77.71 -51.69 10.17 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.216 0.607 . . . . 71.04 112.55 -168.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 67.7 m -70.84 -38.9 8.03 Favored Pre-proline 0 CA--C 1.569 1.688 0 C-N-CA 123.935 0.894 . . . . 74.22 113.112 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.37 -22.01 46.4 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.709 1.606 . . . . 62.23 112.434 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -71.42 -30.36 65.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.872 0.469 . . . . 73.22 110.492 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.03 -40.08 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.375 -0.602 . . . . 61.01 109.375 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 82' ' ' GLY . 36.1 mt -82.1 -21.85 36.54 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.077 -0.965 . . . . 74.3 112.253 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -65.53 -39.31 32.26 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.697 1.369 . . . . 74.33 114.697 -170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.65 -34.76 99.11 Favored 'Trans proline' 0 C--N 1.393 2.899 0 CA-C-N 122.153 1.805 . . . . 64.31 112.51 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -80.76 -36.66 31.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.815 0.846 . . . . 64.31 110.459 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.87 79.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.09 0.556 . . . . 54.44 109.927 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -52.0 -57.77 8.49 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.593 1.183 . . . . 74.12 109.286 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.77 -43.64 97.77 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.592 1.183 . . . . 71.31 111.793 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.628 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.8 t -57.64 -47.64 81.69 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.945 0.898 . . . . 70.33 110.832 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 64' ' ' VAL . 89.2 mt -64.34 -53.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.041 0.838 . . . . 74.31 110.463 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.3 m -50.25 -41.83 50.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.394 1.478 . . . . 74.01 111.505 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -72.78 -42.76 63.61 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.825 -1.08 . . . . 72.52 110.926 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.3 mtm -58.35 -42.61 87.25 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 74.1 110.86 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 81.8 t -60.12 -49.01 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.241 -1.345 . . . . 72.3 111.27 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 80.9 p -66.89 -31.41 71.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.887 0.475 . . . . 74.42 111.507 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.9 mtt-85 -68.7 -27.12 65.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.827 0.851 . . . . 72.21 111.358 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 13.06 53.24 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.628 -0.54 . . . . 71.01 113.545 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m 63.91 27.29 14.41 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.8 1.24 . . . . 72.24 110.871 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.36 150.0 37.97 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.555 -0.905 . . . . 71.11 108.555 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HD2' ' CZ2' ' A' ' 36' ' ' TRP . 60.8 Cg_endo -70.77 120.56 7.17 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.882 1.721 . . . . 73.23 109.674 176.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 10.8 pt20 -61.69 150.89 35.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.338 0.655 . . . . 63.42 111.719 -171.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.42 108.71 20.18 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.746 -0.835 . . . . 60.15 108.746 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -96.69 96.14 8.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.84 -1.17 . . . . 74.23 107.84 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.72 148.63 51.44 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.473 -0.785 . . . . 72.23 110.58 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.84 60.83 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.013 0.525 . . . . 74.4 110.72 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.34 164.0 26.92 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.134 1.889 . . . . 64.44 111.924 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.01 114.13 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.997 0.919 . . . . 73.02 109.797 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.84 85.61 6.06 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.454 0.701 . . . . 72.31 109.476 173.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 124.544 1.138 . . . . 74.33 111.869 173.945 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.244 0.77 0 N-CA-C 108.756 -0.831 . . . . 70.11 108.756 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -133.44 144.67 49.64 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.21 0.604 . . . . 74.12 109.826 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -147.77 136.42 21.8 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.962 -1.017 . . . . 73.04 109.114 169.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.24 144.06 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.614 -0.884 . . . . 74.05 108.614 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.49 -49.36 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.412 0.285 . . . . 71.53 110.836 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -162.53 139.49 7.92 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.584 -0.154 . . . . 73.34 110.584 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.9 mt -115.28 137.83 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 106.744 -1.576 . . . . 71.24 106.744 170.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.47 ' HE1' HG13 ' B' ' 83' ' ' ILE . 16.2 p90 -165.65 144.91 6.34 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.66 0.6 . . . . 72.42 111.654 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.6 m -76.31 119.38 20.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.314 -0.857 . . . . 73.41 108.934 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -93.8 -26.96 16.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.383 0.673 . . . . 74.13 111.238 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.9 t70 -160.78 143.13 12.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.165 0.291 . . . . 72.0 110.78 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.3 mm -137.78 138.3 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.991 1.316 . . . . 60.41 108.992 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 7.9 t -137.91 138.76 39.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.22 -1.4 . . . . 35.41 107.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.8 t80 -160.62 114.53 2.11 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 107.753 -1.203 . . . . 73.21 107.753 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.8 147.89 42.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.811 -1.181 . . . . 74.22 107.811 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -131.85 81.92 61.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 106.911 -1.514 . . . . 72.53 106.911 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.55 -21.34 52.85 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.803 2.335 . . . . 73.22 113.094 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.33 30.47 6.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.917 0.887 . . . . 60.4 109.938 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.469 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -48.64 -50.54 59.12 Favored Pre-proline 0 CA--C 1.569 1.71 0 C-N-CA 124.752 1.221 . . . . 63.3 114.164 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.3 -16.77 6.9 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.87 1.713 . . . . 65.13 112.769 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.63 0.86 55.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.657 0.783 . . . . 63.11 110.817 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.24 -15.35 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 124.268 1.027 . . . . 45.24 111.385 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.81 -42.59 89.53 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.437 0.695 . . . . 74.03 110.607 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.68 -43.41 96.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.74 0.816 . . . . 62.22 110.85 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -103.2 76.42 1.44 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.631 -1.168 . . . . 71.24 109.989 -171.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.28 76.71 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.557 -1.656 . . . . 74.24 110.368 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' B' ' 68' ' ' LEU . 2.4 p-90 -157.65 176.59 12.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.831 -1.077 . . . . 74.32 109.5 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.83 99.46 0.99 Allowed Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.878 0.871 . . . . 70.53 108.832 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.52 ' HB3' HD23 ' B' ' 68' ' ' LEU . 55.9 Cg_endo -67.15 161.36 43.2 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.234 1.956 . . . . 65.15 112.94 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.4 mt-10 -75.18 102.18 4.88 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.903 -1.044 . . . . 74.25 108.964 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 124' ' ' PRO . 8.0 t -92.21 119.03 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 N-CA-C 107.547 -1.279 . . . . 60.43 107.547 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -146.84 145.77 29.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.032 0.933 . . . . 62.41 108.992 -170.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.568 HD21 HD21 ' B' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 170.01 12.87 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.828 0.851 . . . . 70.43 111.003 -176.134 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.16 139.59 41.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.584 1.153 . . . . 62.11 109.335 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 129.73 36.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.838 . . . . 63.23 109.535 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -139.97 149.51 43.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.741 0.817 . . . . 55.32 109.601 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -145.22 134.31 22.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.166 0.587 . . . . 61.15 110.02 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.88 149.27 43.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.747 1.219 . . . . 64.33 107.738 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -143.89 160.97 39.87 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.343 0.657 . . . . 71.15 110.678 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.3 p -163.12 140.15 7.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.694 0.797 . . . . 73.24 109.352 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.8 tt0 -82.64 134.43 35.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 74.05 109.871 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -92.87 -55.2 3.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.297 0.639 . . . . 64.45 110.028 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.59 -165.13 1.97 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.577 -0.738 . . . . 51.52 110.942 -170.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.06 109.89 4.22 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.547 -0.752 . . . . 51.22 110.206 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.53 4.43 4.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.028 1.331 . . . . 64.53 111.908 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.94 114.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 124.734 1.214 . . . . 75.34 109.121 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 15.5 p90 -117.46 174.39 6.17 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.817 . . . . 75.22 109.224 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.17 117.66 8.55 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.469 -0.937 . . . . 71.43 108.469 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.13 127.47 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 62.11 109.585 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.7 t -101.38 113.77 38.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.989 0.915 . . . . 73.1 108.826 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.05 110.1 21.58 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.005 -1.48 . . . . 73.31 107.005 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.92 121.89 42.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.906 -0.405 . . . . 55.04 109.906 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.2 t -112.65 126.67 70.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.541 -1.281 . . . . 51.53 107.541 167.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 77' ' ' GLU . 5.1 m -121.43 127.06 50.76 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 110.062 -0.347 . . . . 61.31 110.062 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' B' ' 42' ' ' LEU . 38.6 t -99.04 127.9 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.995 . . . . 75.14 109.995 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -107.61 131.87 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.583 -1.189 . . . . 60.54 108.648 164.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -136.26 152.33 50.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.024 -0.732 . . . . 75.14 109.024 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.0 p -145.4 135.39 23.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.047 0.758 . . . . 75.32 113.047 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.52 HD23 ' HB3' ' B' ' 38' ' ' PRO . 75.9 mt -95.29 97.08 9.59 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.752 -1.567 . . . . 74.11 108.003 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . 0.459 ' H ' ' HZ2' ' B' ' 36' ' ' TRP . . . 71.86 -117.04 6.29 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.482 -0.647 . . . . 40.04 111.482 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -105.43 9.33 33.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.494 1.118 . . . . 61.53 110.427 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.71 151.09 34.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.045 1.338 . . . . 72.55 108.414 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.88 133.83 43.17 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.164 0.438 . . . . 71.53 110.726 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.4 -63.3 1.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.89 0.876 . . . . 72.51 108.952 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -157.27 160.36 38.52 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.639 -1.164 . . . . 73.3 109.392 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.87 113.86 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.963 -1.125 . . . . 64.23 107.963 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.494 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.9 t -115.41 161.11 19.01 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.526 -0.916 . . . . 74.31 108.526 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.76 135.62 3.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.416 -0.587 . . . . 72.13 109.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.4 t -126.62 144.04 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.819 . . . . 73.0 108.79 171.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -122.97 91.8 3.57 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.784 -0.821 . . . . 53.5 108.784 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -84.61 100.68 11.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.419 -0.81 . . . . 74.32 109.161 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.2 158.41 23.78 Favored Glycine 0 C--O 1.24 0.521 0 N-CA-C 111.459 -0.656 . . . . 52.12 111.459 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -155.37 128.9 2.38 Favored Glycine 0 C--O 1.237 0.297 0 N-CA-C 112.011 -0.436 . . . . 74.13 112.011 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.47 HG13 ' HE1' ' B' ' 17' ' ' TYR . 55.2 mt -85.32 125.64 40.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.516 -0.92 . . . . 73.24 108.516 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.415 ' HB2' ' CZ ' ' B' ' 56' ' ' TYR . 29.7 m-85 -137.89 170.3 16.29 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.196 0.999 . . . . 54.4 108.574 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 43.5 m -135.14 132.63 38.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.93 0.892 . . . . 71.12 110.327 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.451 HD13 HG12 ' B' ' 89' ' ' ILE . 2.8 pp -136.25 146.19 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 123.541 0.736 . . . . 72.33 111.02 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.91 28.24 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.126 1.37 . . . . 73.15 108.245 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.76 -27.83 4.69 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-O 119.931 -0.372 . . . . 62.33 113.811 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.451 HG12 HD13 ' B' ' 86' ' ' ILE . 1.6 pp -53.24 142.99 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.626 1.17 . . . . 72.52 113.057 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -150.57 148.66 28.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.163 0.985 . . . . 73.35 110.434 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -136.09 49.94 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 124.387 1.054 . . . . 70.15 114.481 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -84.39 -19.21 33.92 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.746 0.818 . . . . 75.02 110.646 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.24 -21.73 63.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.101 0.56 . . . . 74.54 110.875 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.3 -42.49 93.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.375 0.67 . . . . 65.12 110.515 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -21.15 65.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 72.32 112.367 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.11 -42.02 89.76 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.257 0.623 . . . . 53.34 110.483 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.417 ' SG ' HG21 ' B' ' 86' ' ' ILE . 46.4 t -67.52 -57.06 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.096 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.36 -31.12 66.97 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.766 -0.652 . . . . 72.35 112.542 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.59 58.78 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.37 -0.683 . . . . 73.21 114.627 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.68 -48.1 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 117.636 0.718 . . . . 73.03 112.576 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -69.49 -48.44 60.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.657 0.383 . . . . 74.45 111.457 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 60.4 m -62.18 -48.91 86.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 118.216 -0.897 . . . . 74.15 110.793 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 95.7 Cg_exo -50.58 -44.7 38.75 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.416 2.077 . . . . 64.43 113.515 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.13 -34.86 75.66 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.299 1.039 . . . . 61.31 112.178 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.21 -49.28 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.355 0.662 . . . . 61.31 110.176 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' B' ' 82' ' ' GLY . 50.0 mt -76.55 -14.77 59.99 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.481 -1.236 . . . . 70.01 111.856 -174.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' B' ' 128' ' ' LEU . 27.3 t80 -62.06 -52.64 65.99 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.271 1.428 . . . . 75.11 113.249 -167.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.558 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 36.9 Cg_endo -62.23 -32.55 82.41 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.022 1.815 . . . . 50.32 113.17 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.457 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.2 m-85 -64.36 -46.29 84.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.153 0.581 . . . . 74.23 110.057 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.2 90.16 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.959 0.903 . . . . 54.3 110.468 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 31.9 mtp180 -52.3 -56.11 16.98 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.586 1.155 . . . . 73.32 111.871 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -32.51 64.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.284 -0.871 . . . . 74.11 110.676 -173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -69.69 -34.6 74.16 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.831 0.452 . . . . 70.21 111.008 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.453 HG21 HG21 ' B' ' 64' ' ' VAL . 58.2 mt -62.69 -58.95 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.773 -0.825 . . . . 73.33 108.773 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -51.69 -32.65 30.79 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 124.86 1.35 . . . . 75.03 112.263 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -64.47 -50.33 67.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.076 0.95 . . . . 72.21 110.345 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -71.14 -30.86 67.01 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.105 0.479 . . . . 75.15 111.43 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.9 t -70.48 -37.8 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.18 0.992 . . . . 72.22 110.978 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 96.2 p -67.35 -33.04 74.41 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.169 0.509 . . . . 61.24 110.955 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.628 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 58.6 mtt-85 -64.64 -35.26 80.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.399 -0.819 . . . . 71.44 110.292 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.31 10.45 71.26 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.971 -0.905 . . . . 54.42 113.817 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.468 ' HA ' ' OD1' ' C' ' 127' ' ' ASN . 62.8 p 59.23 34.92 23.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.569 1.548 . . . . 65.43 113.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 23.7 m-85 -117.86 164.84 17.97 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 124.211 1.004 . . . . 75.21 110.631 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.562 ' HB2' HG21 ' B' ' 40' ' ' VAL . 7.3 Cg_exo -75.45 137.72 21.11 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 123.693 2.929 . . . . 70.22 115.257 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.636 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.9 OUTLIER -66.81 159.0 29.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.517 1.527 . . . . 72.42 113.282 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -126.3 117.47 23.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.106 -1.072 . . . . 44.0 108.106 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' C' ' 122' ' ' THR . 3.8 m120 -92.11 97.51 10.97 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.042 -1.466 . . . . 72.33 107.042 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.63 HD23 ' H ' ' B' ' 129' ' ' ALA . 0.5 OUTLIER -66.18 148.19 52.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.258 0.481 . . . . 54.42 110.961 -170.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.63 ' H ' HD23 ' B' ' 128' ' ' LEU . . . -41.11 107.0 0.45 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 127.335 2.254 . . . . 60.0 113.783 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.08 54.33 4.57 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.726 2.284 . . . . 70.23 111.774 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.616 HG23 ' HB1' ' B' ' 129' ' ' ALA . 67.0 t -87.35 113.63 25.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 124.782 1.233 . . . . 71.34 109.034 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -69.8 98.47 1.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.045 -1.095 . . . . 73.23 108.045 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 115.157 -0.929 . . . . 72.0 110.993 -175.979 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.2 m . . . . . 0 C--O 1.237 0.414 0 N-CA-C 107.017 -1.475 . . . . 60.41 107.017 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -95.17 116.64 29.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.341 -1.726 . . . . 72.24 106.341 168.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -143.69 141.87 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.722 -0.844 . . . . 71.32 108.722 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.422 HD11 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -73.0 133.5 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 123.71 0.631 . . . . 62.35 109.435 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -113.29 -28.96 7.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.58 0.752 . . . . 71.34 110.107 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.43 ' NH2' ' HB ' ' D' ' 122' ' ' THR . 16.1 ttt85 -179.65 144.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 122.976 0.511 . . . . 72.45 110.605 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.422 HG13 HD11 ' C' ' 13' ' ' ILE . 51.7 mt -124.39 134.17 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.407 -1.331 . . . . 73.32 107.407 168.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.568 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.5 p90 -176.94 155.01 1.17 Allowed 'General case' 0 C--O 1.227 -0.122 0 O-C-N 123.997 0.81 . . . . 62.45 110.421 -174.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.23 120.94 22.19 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.629 0.772 . . . . 73.01 109.664 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.446 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 28.9 mmtp -70.55 -49.09 51.72 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 107.974 -1.121 . . . . 75.0 107.974 167.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -138.51 142.68 39.34 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.803 -1.544 . . . . 75.22 109.498 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.24 144.8 28.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.936 -1.505 . . . . 72.42 106.936 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.2 t -155.21 148.3 24.71 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.254 0.55 . . . . 61.4 110.593 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.4 t80 -147.8 125.96 12.18 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 114.694 -1.139 . . . . 74.52 107.926 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.36 139.25 51.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.361 1.064 . . . . 63.33 108.321 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 76.26 36.24 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 105.954 -1.869 . . . . 63.52 105.954 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.25 -19.68 29.03 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.369 2.046 . . . . 74.53 111.071 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.75 11.4 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.679 -1.146 . . . . 72.2 110.376 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.604 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.05 -61.73 3.07 Favored Pre-proline 0 CA--C 1.573 1.85 0 N-CA-C 114.064 1.135 . . . . 63.03 114.064 -165.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.9 Cg_exo -76.05 -23.49 12.09 Favored 'Trans proline' 0 C--N 1.387 2.594 0 CA-C-N 121.746 1.659 . . . . 71.23 112.28 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -71.09 -38.16 72.4 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.797 1.239 . . . . 73.13 111.894 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.36 -10.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.377 1.071 . . . . 74.11 111.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.09 -40.52 70.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.759 0.824 . . . . 75.4 111.7 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -116.52 38.78 3.33 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.997 0.903 . . . . 72.24 109.811 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.823 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -99.98 152.23 20.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.68 -0.638 . . . . 64.2 110.945 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.62 108.57 4.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.633 -1.247 . . . . 52.33 107.633 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -70.99 104.58 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.927 0.891 . . . . 74.24 110.68 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -134.47 49.88 4.38 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 124.174 0.99 . . . . 74.31 110.724 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 112.62 3.42 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.182 1.922 . . . . 73.42 112.302 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -86.0 95.08 9.39 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.579 -1.267 . . . . 63.23 107.579 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 76.0 t -80.7 89.63 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.095 -0.957 . . . . 74.13 110.118 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.88 139.14 31.24 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.837 -0.801 . . . . 63.25 108.837 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' C' ' 64' ' ' VAL . 0.6 OUTLIER -129.12 144.98 51.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.379 0.671 . . . . 54.34 109.633 172.041 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.46 139.19 53.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.796 1.239 . . . . 55.25 108.836 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.674 ' HG ' HD21 ' C' ' 60' ' ' LEU . 8.9 tt -114.21 135.7 53.76 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.629 0.772 . . . . 73.13 109.16 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -155.63 149.95 25.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.229 1.011 . . . . 74.41 108.835 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -112.16 152.11 28.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.466 0.65 . . . . 51.14 109.895 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.0 158.39 41.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.5 1.12 . . . . 75.43 108.173 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.4 t -153.26 148.84 27.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.899 0.38 . . . . 64.33 110.675 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -157.74 128.09 6.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.62 1.168 . . . . 74.12 108.917 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -81.41 131.22 35.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.312 -0.625 . . . . 73.32 109.312 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 HD12 ' C' ' 83' ' ' ILE . 84.2 mt -98.01 -40.1 8.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.542 0.737 . . . . 75.22 110.34 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.36 179.48 9.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.221 -0.899 . . . . 65.32 109.526 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.14 126.04 28.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.661 -0.866 . . . . 75.42 108.661 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.434 ' HA ' HG23 ' C' ' 86' ' ' ILE . 3.0 m-20 67.11 13.83 9.58 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.625 1.17 . . . . 64.54 112.606 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.68 117.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.405 1.082 . . . . 64.4 108.587 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 165.76 23.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.66 0.743 . . . . 72.5 109.547 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -126.57 136.63 52.8 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.328 1.051 . . . . 74.24 108.474 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.0 t -123.37 127.43 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.179 -1.415 . . . . 73.22 107.179 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.507 HG22 ' HA2' ' C' ' 81' ' ' GLY . 90.2 t -120.44 117.4 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.798 -0.815 . . . . 72.23 108.798 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.674 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -86.53 113.05 22.13 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.786 -0.82 . . . . 64.42 108.786 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -90.92 106.76 18.74 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.307 -0.998 . . . . 73.33 108.307 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.5 t -107.19 135.47 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.152 -1.055 . . . . 51.44 108.152 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -127.39 124.99 39.85 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.951 -0.388 . . . . 72.23 109.951 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.633 HG22 ' HB3' ' C' ' 42' ' ' LEU . 43.3 t -102.71 115.86 45.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 74.31 110.612 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -99.4 134.76 41.79 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.178 -1.045 . . . . 60.55 108.178 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.26 129.92 45.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.32 -0.993 . . . . 52.25 108.32 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 70.2 m -146.88 135.63 22.18 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.626 0.579 . . . . 70.44 111.146 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' C' ' 34' ' ' LYS . 5.9 mt -86.83 40.74 0.92 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.319 1.848 . . . . 74.22 109.413 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.42 -109.71 3.29 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.724 -0.95 . . . . 73.33 110.724 -168.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.25 -24.47 22.08 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.519 0.728 . . . . 72.2 110.136 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.531 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 6.9 tp10 -76.94 120.45 22.08 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.389 1.075 . . . . 62.23 110.027 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.1 m -66.65 125.36 25.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.958 0.799 . . . . 74.54 109.404 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -80.06 -51.9 8.46 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.842 -0.799 . . . . 72.52 108.842 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -164.81 175.29 9.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.777 -1.101 . . . . 74.12 109.863 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.406 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -134.33 144.81 48.5 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.677 -1.601 . . . . 65.35 106.677 170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.1 t -143.83 148.33 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.21 -1.033 . . . . 53.32 108.21 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.62 134.85 9.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.922 -0.77 . . . . 55.51 108.922 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.73 139.24 52.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.364 1.066 . . . . 75.4 108.521 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -116.4 90.34 3.31 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.116 -1.068 . . . . 75.42 108.116 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -79.56 106.6 11.7 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.675 -1.148 . . . . 75.25 109.991 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -82.72 148.41 26.05 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.371 0.419 . . . . 64.5 112.166 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.74 116.19 0.77 Allowed Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 110.795 -0.922 . . . . 74.33 110.795 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.632 HD12 HD11 ' C' ' 51' ' ' LEU . 10.9 mm -87.6 125.23 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.245 -1.02 . . . . 63.0 108.245 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -130.56 156.59 44.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.498 -0.927 . . . . 74.02 108.498 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -91.75 137.22 32.54 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.933 -0.766 . . . . 72.34 108.933 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' C' ' 54' ' ' ASP . 0.0 OUTLIER -108.52 134.67 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.655 -0.868 . . . . 71.41 108.655 172.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -178.39 153.56 0.75 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.574 0.75 . . . . 54.11 110.992 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.85 -36.53 3.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.652 1.021 . . . . 20.15 115.652 163.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' C' ' 94' ' ' MET . 1.6 pp . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 123.99 0.916 . . . . 73.42 112.282 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.537 0.208 . . . . 73.44 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.423 ' HB3' HD13 ' C' ' 89' ' ' ILE . 15.9 ptp -72.47 -27.37 62.25 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.298 -0.41 . . . . 72.13 111.816 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.94 76.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.491 0.716 . . . . 52.14 111.826 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -72.46 -24.57 61.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.063 0.545 . . . . 73.42 111.222 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 32.3 t -62.96 -63.46 1.2 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.537 0.523 . . . . 61.24 111.089 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.52 -23.92 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.49 0.586 . . . . 74.14 110.516 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.85 -24.44 76.63 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.486 -0.779 . . . . 64.15 113.521 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.61 -38.01 0.06 Allowed 'General case' 0 C--N 1.358 0.967 0 N-CA-C 113.723 1.009 . . . . 61.12 113.723 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.21 -39.01 82.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.517 0.727 . . . . 64.03 112.057 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.82 -50.28 4.22 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.46 -0.781 . . . . 72.23 111.301 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.411 ' O ' HD12 ' C' ' 60' ' ' LEU . 34.3 Cg_endo -64.49 -23.16 64.84 Favored 'Trans proline' 0 C--N 1.398 3.183 0 C-N-CA 121.637 1.558 . . . . 75.55 113.306 175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -65.37 -36.13 83.05 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 122.984 0.514 . . . . 71.13 110.394 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.27 -41.52 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.895 0.878 . . . . 72.4 110.165 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 57.5 mt -86.64 -15.95 38.13 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.591 -1.186 . . . . 62.2 112.07 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -59.63 -51.58 80.03 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 117.617 -1.182 . . . . 70.22 113.182 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.94 -34.39 99.1 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 121.927 1.751 . . . . 74.45 112.596 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.64 -46.68 75.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.506 0.722 . . . . 73.3 110.864 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.59 94.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 40.14 110.402 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.19 -45.67 93.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.421 1.488 . . . . 72.23 110.716 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.59 -30.19 59.53 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.004 0.921 . . . . 63.11 110.324 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.1 t -68.67 -39.82 80.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.1 0.56 . . . . 44.32 110.481 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.58 HG21 HG21 ' C' ' 64' ' ' VAL . 86.4 mt -68.31 -45.06 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.064 0.546 . . . . 64.5 109.932 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.2 m -55.01 -38.87 68.46 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.634 0.774 . . . . 74.11 111.184 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -59.8 -60.6 3.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.187 -0.915 . . . . 71.42 109.716 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.524 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -48.2 -47.63 35.26 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.474 1.51 . . . . 73.22 113.349 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.622 HG11 HD23 ' C' ' 126' ' ' LEU . 53.5 t -70.69 -43.89 77.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.12 0.968 . . . . 75.24 111.796 -173.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.5 t -64.72 -30.57 71.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.889 -0.596 . . . . 64.51 110.793 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 75.2 mtt-85 -66.02 -32.53 74.06 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.816 -0.629 . . . . 73.5 110.564 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.28 12.3 60.9 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.526 0.516 . . . . 73.35 113.557 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.636 HG23 ' HB3' ' D' ' 17' ' ' TYR . 46.5 p 58.79 35.93 24.54 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.793 1.637 . . . . 71.22 112.922 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.418 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 41.5 m-85 -110.21 163.94 16.0 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.171 0.988 . . . . 71.33 110.504 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 32.7 Cg_endo -59.48 173.35 1.54 Allowed 'Trans proline' 0 C--N 1.402 3.361 0 C-N-CA 123.631 2.888 . . . . 64.41 114.905 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.636 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 5.7 mm-40 -60.68 136.26 58.01 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.393 -0.821 . . . . 73.42 111.732 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.622 HD23 HG11 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -112.32 24.81 12.15 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.278 -0.874 . . . . 53.12 111.683 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 7.1 p30 -92.56 84.0 5.01 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.523 1.63 . . . . 74.22 108.207 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' C' ' 128' ' ' LEU . 3.5 mm? -91.91 157.03 17.06 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.915 -1.038 . . . . 74.45 112.63 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -33.58 135.91 0.31 Allowed Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 126.542 1.937 . . . . 73.22 115.101 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.75 109.99 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.851 2.367 . . . . 60.23 111.609 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.05 30.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.428 0.691 . . . . 74.34 111.381 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -71.2 103.8 2.9 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 115.119 -0.946 . . . . 75.22 111.988 -175.418 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 47.7 m . . . . . 0 C--O 1.237 0.397 0 N-CA-C 108.633 -0.877 . . . . 73.35 108.633 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -153.49 99.53 2.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.378 -0.971 . . . . 75.22 108.378 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -123.58 114.4 19.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.77 0.828 . . . . 75.14 108.774 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.417 HG22 ' HD2' ' D' ' 84' ' ' PHE . 1.1 pp -78.75 127.05 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 107.157 -1.424 . . . . 73.25 107.157 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 78.3 mt-30 -85.09 -35.37 21.86 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.271 -0.27 . . . . 71.41 110.271 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.448 ' HB3' ' HE1' ' D' ' 17' ' ' TYR . 1.6 tpt180 -172.74 157.29 3.71 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.852 0.461 . . . . 64.35 110.514 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 19.7 mt -144.31 124.19 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.514 1.126 . . . . 64.44 108.038 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.636 ' HB3' HG23 ' C' ' 122' ' ' THR . 23.9 p90 -168.96 162.91 11.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.758 1.223 . . . . 72.21 109.996 -168.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.8 p -80.94 122.17 26.92 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.314 -0.857 . . . . 62.3 109.912 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 45.7 mtpt -86.09 -44.42 12.27 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 107.98 -1.118 . . . . 74.42 107.98 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.765 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.9 t70 -131.59 141.88 49.77 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.963 -1.017 . . . . 75.11 109.848 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.524 HD13 ' HE3' ' C' ' 117' ' ' MET . 55.4 mt -137.7 146.33 27.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.375 1.47 . . . . 74.14 107.778 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.1 140.5 17.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.498 0.666 . . . . 54.4 111.101 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.9 t80 -140.8 137.89 33.66 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.514 -1.662 . . . . 73.04 106.514 168.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.5 mt-10 -138.09 136.94 37.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.291 1.036 . . . . 73.15 108.489 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.11 74.17 10.97 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.959 -0.756 . . . . 71.23 108.959 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.71 -26.72 13.37 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.697 2.265 . . . . 73.33 112.407 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -99.46 -0.44 40.78 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.05 -0.977 . . . . 73.14 111.508 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.679 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.39 -57.87 4.13 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 116.071 1.878 . . . . 63.43 116.071 -163.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 67.1 Cg_endo -77.44 -25.18 8.47 Favored 'Trans proline' 0 C--N 1.387 2.59 0 CA-C-N 121.101 1.429 . . . . 62.45 113.221 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -87.14 -24.17 24.59 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.702 0.287 . . . . 74.12 110.585 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -8.93 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 123.495 0.718 . . . . 43.41 110.12 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -65.98 -38.17 87.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.774 0.829 . . . . 72.23 110.614 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -75.9 -2.1 28.6 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.81 0.338 . . . . 75.34 111.363 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -105.68 76.87 1.22 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.635 1.174 . . . . 65.51 107.975 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.62 95.19 8.27 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.015 -0.993 . . . . 73.12 112.325 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -150.05 176.13 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.401 -0.592 . . . . 75.23 109.401 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -73.3 114.12 28.45 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.139 0.976 . . . . 74.44 109.231 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.51 111.16 0.86 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.111 1.874 . . . . 73.04 110.421 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.66 111.17 2.28 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.862 -1.162 . . . . 70.21 107.862 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -98.35 121.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.352 0.661 . . . . 71.33 109.385 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -109.06 114.26 27.83 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.568 -1.271 . . . . 61.43 107.568 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -96.61 116.27 28.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.852 0.861 . . . . 74.54 108.968 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.41 125.87 52.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.712 -0.847 . . . . 63.1 108.712 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.71 129.82 42.8 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.423 -0.584 . . . . 64.35 109.423 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.5 t70 -144.55 152.82 41.11 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.147 -1.057 . . . . 54.13 108.147 172.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -145.19 157.31 44.11 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.326 0.651 . . . . 62.14 109.506 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.93 166.85 28.37 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.811 1.245 . . . . 71.23 107.793 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 68.9 p -168.1 166.01 13.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.828 0.451 . . . . 55.05 110.813 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.1 p -156.65 132.63 9.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.26 -0.882 . . . . 62.21 109.12 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -70.3 126.99 31.23 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.53 -0.544 . . . . 45.32 109.53 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.3 mt -91.45 -40.89 11.16 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.263 0.554 . . . . 65.01 109.824 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.22 -173.26 3.94 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.117 -0.947 . . . . 75.55 110.172 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.97 123.06 19.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.657 -0.701 . . . . 74.34 110.014 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 64.56 17.39 10.85 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.551 1.157 . . . . 75.31 112.242 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.12 123.47 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.563 0.745 . . . . 71.52 110.16 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.29 166.33 16.72 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.902 1.281 . . . . 71.14 108.419 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.5 tm-20 -130.6 126.93 37.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.737 -1.949 . . . . 64.31 105.737 168.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.86 133.23 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.189 0.996 . . . . 63.43 108.552 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.13 135.91 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.367 1.067 . . . . 65.13 110.079 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.46 126.6 52.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.212 -1.403 . . . . 72.34 107.212 171.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -104.51 102.95 12.57 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.883 -0.784 . . . . 73.55 108.883 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.5 t -95.18 119.39 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.373 -0.973 . . . . 63.33 108.373 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 32.0 m -115.76 136.92 52.58 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.677 -0.692 . . . . 74.12 110.164 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.482 HG21 HG21 ' D' ' 114' ' ' ILE . 76.4 t -126.76 102.3 9.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.897 1.279 . . . . 64.15 108.167 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -97.84 92.53 5.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.091 -1.448 . . . . 73.23 107.091 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.3 137.35 37.15 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.453 -0.943 . . . . 74.14 108.453 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.2 p -148.78 130.26 14.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.321 0.581 . . . . 75.44 111.782 -170.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 59.5 mt -98.31 107.67 20.18 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.694 1.198 . . . . 73.15 108.316 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.9 -134.58 22.05 Favored Glycine 0 C--N 1.343 0.932 0 O-C-N 123.536 0.523 . . . . 34.01 112.272 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.32 4.54 38.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.669 0.787 . . . . 43.23 111.943 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.08 162.73 30.1 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.836 0.454 . . . . 62.43 110.608 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.0 m -66.83 136.4 55.36 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.148 -0.933 . . . . 71.33 111.552 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -90.12 -56.44 3.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.931 -1.137 . . . . 62.24 107.931 169.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -162.62 144.42 10.47 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.201 -1.363 . . . . 54.44 109.802 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -110.53 111.52 22.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.832 0.853 . . . . 74.43 108.785 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG23 ' D' ' 114' ' ' ILE . 20.2 t -127.09 127.71 45.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.012 0.525 . . . . 63.11 109.936 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -148.38 139.77 23.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.431 0.692 . . . . 75.53 109.74 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' D' ' 113' ' ' CYS . 99.1 t -132.87 124.67 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.435 0.694 . . . . 64.03 109.678 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.765 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.8 mt-30 -91.74 88.32 6.64 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.751 -0.833 . . . . 74.43 108.751 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.405 ' O ' HD13 ' D' ' 106' ' ' LEU . 57.8 tp60 -80.05 109.71 14.75 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 114.401 -1.272 . . . . 74.23 108.353 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.07 166.8 21.33 Favored Glycine 0 C--O 1.241 0.545 0 N-CA-C 111.946 -0.462 . . . . 53.24 111.946 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.15 140.24 6.11 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.002 -0.839 . . . . 73.22 111.002 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 59.2 mt -88.71 126.25 41.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.81 -0.811 . . . . 71.13 108.81 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.417 ' HD2' HG22 ' D' ' 13' ' ' ILE . 69.3 m-85 -124.61 124.71 42.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.104 0.561 . . . . 72.03 109.965 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -93.28 111.34 22.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.052 0.941 . . . . 61.5 108.809 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.412 HD13 HD12 ' D' ' 98' ' ' LEU . 42.2 pt -116.68 142.98 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.237 0.615 . . . . 61.44 111.431 -172.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -157.93 160.64 37.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.858 1.263 . . . . 63.4 108.585 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.75 22.4 78.12 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 123.062 0.226 . . . . 52.1 113.404 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.662 HD13 ' HG2' ' D' ' 94' ' ' MET . 1.2 pp -113.1 148.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.311 1.044 . . . . 74.04 109.959 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.27 146.41 32.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.34 0.656 . . . . 74.34 111.152 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 35.45 -97.65 0.01 OUTLIER Glycine 0 C--N 1.359 1.828 0 N-CA-C 116.494 1.357 . . . . 62.04 116.494 169.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -64.25 -53.82 43.15 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.722 1.209 . . . . 60.24 110.934 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.46 -31.06 71.94 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.94 -1.027 . . . . 64.03 110.876 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.662 ' HG2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -71.96 -54.71 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.421 1.088 . . . . 53.04 109.915 -178.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.72 -25.79 68.36 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.835 -1.075 . . . . 65.14 111.563 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.67 -44.89 18.08 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.969 0.508 . . . . 65.21 111.01 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.9 -43.27 96.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.032 0.533 . . . . 72.55 111.033 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.412 HD12 HD13 ' D' ' 86' ' ' ILE . 6.7 tt -92.77 -33.39 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 72.14 110.682 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -20.73 57.36 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.401 0.52 . . . . 34.02 114.401 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.24 -49.86 1.1 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.577 0.689 . . . . 42.12 111.851 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -73.4 -45.01 57.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.868 0.467 . . . . 73.0 111.473 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 93.2 m -61.5 -48.04 91.64 Favored Pre-proline 0 CA--C 1.567 1.6 0 CA-C-O 118.286 -0.864 . . . . 34.14 111.637 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.58 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.8 Cg_exo -56.9 -38.17 96.55 Favored 'Trans proline' 0 C--N 1.399 3.228 0 C-N-CA 122.353 2.035 . . . . 64.3 113.366 168.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.91 -32.35 73.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.365 0.666 . . . . 70.53 111.251 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.65 -41.5 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.55 0.74 . . . . 55.41 110.259 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' D' ' 80' ' ' GLN . 61.7 mt -75.14 -23.52 57.83 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.152 -0.931 . . . . 74.04 111.607 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.403 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 66.4 t80 -60.64 -45.39 97.07 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.733 1.382 . . . . 73.33 114.733 -169.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.12 -42.63 58.15 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 122.118 1.879 . . . . 62.54 112.816 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -76.49 -35.65 58.25 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.921 -1.036 . . . . 71.31 110.724 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.57 78.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.896 0.878 . . . . 62.31 110.905 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -58.87 -55.09 39.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.448 1.093 . . . . 73.54 109.956 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.56 -40.32 86.9 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.273 0.983 . . . . 74.3 111.895 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.493 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -59.28 -42.71 91.86 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.02 0.825 . . . . 53.34 110.333 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.563 HG23 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -63.65 -52.02 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.018 0.927 . . . . 75.42 110.364 172.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.8 m -53.66 -43.61 68.96 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.361 1.464 . . . . 65.53 112.099 -172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -68.48 -43.05 77.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.011 -0.995 . . . . 44.4 110.377 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 76.7 mtm -66.35 -30.92 71.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.868 0.467 . . . . 55.54 111.964 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -71.02 -42.39 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.391 0.676 . . . . 75.12 110.397 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -71.06 -29.95 65.97 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 116.553 -0.294 . . . . 74.24 110.442 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -69.74 -28.67 65.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.762 0.825 . . . . 75.31 110.148 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 11.09 62.91 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.717 0.636 . . . . 74.1 112.922 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.568 HG23 ' HB3' ' C' ' 17' ' ' TYR . 75.1 p 56.06 25.12 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.292 1.837 . . . . 75.52 113.46 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.441 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 28.2 m-85 -103.34 166.22 12.18 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 125.055 1.342 . . . . 72.41 109.687 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 34.2 Cg_endo -59.23 124.71 16.19 Favored 'Trans proline' 0 C--N 1.394 2.933 0 C-N-CA 123.052 2.501 . . . . 75.23 112.791 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -55.16 119.64 5.8 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 123.883 0.74 . . . . 70.52 109.869 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.01 98.41 8.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.327 0.584 . . . . 73.1 109.831 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -99.13 86.3 3.41 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.006 -1.109 . . . . 74.41 108.006 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.403 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 1.0 OUTLIER -72.59 138.16 46.64 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.934 -1.03 . . . . 61.55 109.896 -173.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 131.5 95.21 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.993 0.517 . . . . 64.13 111.891 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.3 119.44 4.58 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.906 1.737 . . . . 72.4 110.072 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.75 120.22 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.63 0.728 . . . . 72.53 110.031 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 108.316 -0.994 . . . . 52.21 108.316 176.43 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.674 -0.862 . . . . 75.11 108.674 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -126.59 116.57 21.24 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.07 -1.085 . . . . 75.51 108.07 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -137.55 110.66 7.79 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.701 0.8 . . . . 64.04 108.997 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -65.91 125.29 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 171.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -88.55 -33.4 17.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.152 -0.685 . . . . 61.21 109.152 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -172.61 145.31 1.54 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.34 0.4 . . . . 74.42 110.901 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.652 HD12 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -121.81 129.96 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.912 -1.144 . . . . 74.51 107.912 168.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 38.9 p90 -163.6 159.13 21.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.607 0.763 . . . . 74.43 110.751 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -84.92 118.53 24.58 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.354 -0.61 . . . . 74.04 109.354 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HZ1' ' HD3' ' B' ' 29' ' ' PRO . 23.6 mtpp -78.7 -40.64 33.2 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.752 -0.833 . . . . 55.22 108.752 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -136.42 142.17 43.65 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.985 -1.007 . . . . 75.01 110.234 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG21 ' SD ' ' B' ' 117' ' ' MET . 74.7 mt -139.84 140.72 35.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.56 1.544 . . . . 73.33 107.271 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -154.05 116.18 4.3 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 62.4 109.289 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 69.8 t80 -111.24 122.62 48.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.523 -1.658 . . . . 63.33 106.523 166.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.58 130.85 56.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.645 -0.872 . . . . 72.23 108.645 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.53 79.14 73.86 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.102 -1.814 . . . . 43.54 106.102 165.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.6 -27.25 45.81 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.439 2.093 . . . . 75.12 111.149 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -111.33 31.89 5.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.338 -1.301 . . . . 71.33 109.12 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.76 99.85 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.681 0.993 . . . . 71.21 113.681 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.52 -22.94 17.77 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 121.905 1.737 . . . . 54.33 113.415 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.45 -39.52 70.92 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.188 0.595 . . . . 75.15 111.011 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 73' ' ' ALA . 28.2 m -73.3 -15.64 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.352 0.661 . . . . 72.33 112.045 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' HD1' ' HD2' ' B' ' 15' ' ' ARG . 79.3 t80 -61.94 -38.92 90.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.784 0.834 . . . . 71.13 110.849 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -100.75 -13.26 18.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.239 0.616 . . . . 70.41 112.016 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.7 mmtp -83.29 150.71 25.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 117.977 0.353 . . . . 73.02 111.724 175.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.49 132.19 45.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.099 0.96 . . . . 63.5 109.895 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.537 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -77.63 93.44 4.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.216 0.531 . . . . 62.31 110.162 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' H ' HD22 ' A' ' 68' ' ' LEU . 8.5 tt0 -125.13 82.82 61.4 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.183 1.393 . . . . 75.34 107.745 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.4 114.32 3.77 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.537 2.158 . . . . 53.13 112.852 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -94.74 90.5 6.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.238 -1.764 . . . . 74.03 106.238 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.39 130.53 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.327 -0.851 . . . . 73.2 110.499 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.0 tttm -119.59 115.04 23.18 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.722 -1.214 . . . . 61.21 107.722 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.31 123.95 45.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.829 0.851 . . . . 73.11 109.222 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -118.84 109.21 15.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.989 0.916 . . . . 71.02 109.569 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.77 120.53 40.23 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.604 -0.887 . . . . 71.53 108.604 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -154.46 162.46 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.395 -0.594 . . . . 71.41 109.395 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -134.25 164.05 28.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.158 0.583 . . . . 72.35 110.842 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.79 108.27 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.826 -1.176 . . . . 73.24 107.826 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.8 m -109.9 152.44 25.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.135 0.574 . . . . 72.2 110.339 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.9 t -157.11 142.86 17.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.48 0.712 . . . . 53.02 110.062 -172.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -90.68 118.96 30.53 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.938 -0.764 . . . . 74.23 108.938 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 57' ' ' GLU . 71.3 mt -90.14 -39.64 12.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.086 0.555 . . . . 73.33 110.569 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -162.96 -174.09 3.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.789 0.836 . . . . 75.31 110.415 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.04 120.2 13.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.34 -0.985 . . . . 74.1 108.34 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 69.25 3.48 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.59 1.156 . . . . 41.13 112.811 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 21.2 t -115.32 114.59 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.821 -1.177 . . . . 70.35 107.821 176.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -142.58 133.05 25.02 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.488 -0.93 . . . . 74.15 108.488 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' HD11 ' A' ' 51' ' ' LEU . 75.4 tt0 -114.09 120.14 39.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.737 0.415 . . . . 73.54 110.55 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -100.69 121.81 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.114 -1.81 . . . . 73.42 106.114 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -106.18 134.97 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.975 -0.75 . . . . 72.2 108.975 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.421 HD11 ' HD1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -96.53 114.89 26.59 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.254 -1.017 . . . . 72.25 108.254 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -101.77 99.94 10.23 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.824 -0.806 . . . . 74.42 108.824 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.84 137.69 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 107.795 -1.187 . . . . 71.24 107.795 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.9 m -129.55 124.63 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.624 -0.88 . . . . 73.11 108.624 171.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.37 130.62 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 107.828 -1.175 . . . . 74.53 107.828 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 7.3 m -121.98 148.15 45.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.763 -1.569 . . . . 75.45 106.763 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.07 124.29 14.57 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.967 -1.123 . . . . 72.45 107.967 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 48.5 m -122.4 141.45 51.58 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 123.205 0.602 . . . . 73.11 110.298 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.537 HD21 ' CE3' ' A' ' 36' ' ' TRP . 51.1 mt -90.68 52.6 2.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.335 1.054 . . . . 74.04 109.791 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.14 -85.46 0.91 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.217 -0.901 . . . . 74.12 111.825 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -88.29 -31.09 19.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.443 0.697 . . . . 72.15 111.309 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.96 124.49 46.08 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 118.79 -0.624 . . . . 75.23 109.687 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.6 m -65.97 132.53 48.82 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.274 0.359 . . . . 65.24 110.797 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -75.51 -53.87 7.93 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.0 0.813 . . . . 44.13 109.697 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -164.06 169.77 17.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.583 -1.19 . . . . 74.23 111.304 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 tp -130.21 148.17 52.01 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.985 -1.461 . . . . 73.13 107.444 167.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -142.35 134.55 27.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.127 -1.064 . . . . 70.41 108.127 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -145.93 119.9 9.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.313 -0.995 . . . . 64.14 108.313 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.43 126.76 64.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.082 0.953 . . . . 75.32 109.635 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -104.99 90.15 3.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.044 -0.98 . . . . 74.01 108.781 172.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.408 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.0 tp-100 -76.83 97.64 4.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.929 -1.137 . . . . 64.41 107.929 173.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.82 143.52 20.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.122 -0.791 . . . . 71.25 111.122 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.61 120.87 1.74 Allowed Glycine 0 CA--C 1.495 -1.163 0 N-CA-C 110.304 -1.118 . . . . 71.14 110.304 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -83.96 125.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.791 -1.189 . . . . 75.52 107.791 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.57 118.03 23.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.197 0.999 . . . . 70.41 108.331 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -87.5 100.11 12.53 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.161 -1.422 . . . . 75.22 107.161 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.629 HG21 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -134.07 118.39 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.706 -0.679 . . . . 72.21 110.128 -168.219 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.8 177.67 11.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.727 1.211 . . . . 73.11 109.85 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.58 74.09 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 120.883 0.157 . . . . 43.02 112.958 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.507 HD13 ' HB2' ' A' ' 94' ' ' MET . 1.1 pp -129.45 161.35 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.311 1.444 . . . . 70.33 110.169 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.69 171.18 14.46 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.542 0.737 . . . . 70.44 109.965 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.13 -120.0 2.11 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.387 1.315 . . . . 53.51 116.387 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -76.21 -15.97 59.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.994 0.918 . . . . 63.32 112.695 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.53 -50.86 69.67 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.583 -0.525 . . . . 75.2 109.583 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.507 ' HB2' HD13 ' A' ' 89' ' ' ILE . 14.4 ttt -74.22 -32.71 63.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.114 -0.948 . . . . 65.13 110.756 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.74 92.31 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.123 0.487 . . . . 45.21 111.137 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.01 -37.99 78.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.778 0.831 . . . . 74.34 110.668 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.82 -63.38 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.514 -0.766 . . . . 72.34 110.198 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.629 HD21 HG21 ' A' ' 86' ' ' ILE . 53.8 mt -71.23 -22.78 61.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.251 0.62 . . . . 73.41 111.967 -176.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.6 -28.57 46.89 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.435 0.46 . . . . 71.03 113.887 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.93 -52.38 0.62 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.347 0.573 . . . . 72.24 112.397 -173.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -64.26 -54.42 33.58 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.328 0.651 . . . . 75.54 112.602 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' A' ' 98' ' ' LEU . 52.9 m -65.91 -46.45 64.86 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 123.839 0.856 . . . . 64.04 112.645 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -24.36 50.53 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 121.587 1.525 . . . . 72.44 112.852 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -74.32 -28.76 61.3 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.107 0.412 . . . . 73.34 111.032 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.421 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 19.6 mt -60.75 -43.07 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 121.369 0.604 . . . . 30.22 109.539 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.3 mt -70.53 -19.14 62.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.533 -1.212 . . . . 62.12 112.193 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.421 ' HD1' HD11 ' A' ' 60' ' ' LEU . 49.4 t80 -70.46 -42.49 15.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-O 117.563 -1.208 . . . . 74.44 113.6 -169.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 99.0 Cg_exo -49.43 -35.1 35.06 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.045 1.83 . . . . 55.3 114.022 168.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -84.74 -37.49 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.296 0.638 . . . . 62.55 111.439 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.33 -42.6 79.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.158 0.504 . . . . 71.44 109.984 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -53.37 -57.26 11.22 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.497 1.519 . . . . 75.32 109.909 171.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.35 -36.58 84.61 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.393 1.058 . . . . 62.04 111.671 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.23 -48.79 80.25 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.183 0.593 . . . . 43.12 110.026 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.89 -44.8 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 115.049 -0.978 . . . . 73.51 110.793 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 125' ' ' GLN . 60.2 m -57.55 -40.73 79.54 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.924 0.889 . . . . 74.45 111.116 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 t -69.0 -46.64 67.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.164 -0.925 . . . . 74.21 110.412 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.6 mtp -56.82 -40.69 76.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.764 0.825 . . . . 64.14 111.81 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.5 t -65.19 -46.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.506 1.123 . . . . 71.22 110.719 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -71.34 -26.49 62.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.598 0.359 . . . . 71.01 111.621 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.7 mtt-85 -73.2 -32.57 64.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.73 0.812 . . . . 73.24 110.082 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 4.4 60.25 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.999 -0.546 . . . . 50.03 112.901 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 m 68.07 44.19 1.5 Allowed 'General case' 0 C--N 1.36 1.052 0 CA-C-O 122.721 1.248 . . . . 64.32 110.268 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.9 149.13 50.22 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 114.769 -1.105 . . . . 74.14 108.955 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.29 141.58 93.34 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.087 1.858 . . . . 63.5 110.633 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.493 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -61.41 159.74 12.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.286 1.034 . . . . 61.33 112.448 -168.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.55 102.25 6.29 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 74.33 108.348 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -98.17 94.24 6.69 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.173 -0.676 . . . . 72.32 109.173 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 134.99 57.52 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.63 0.772 . . . . 65.54 110.906 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 139.45 91.74 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.162 0.585 . . . . 53.04 112.176 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.86 97.55 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.461 2.107 . . . . 72.22 109.991 177.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.13 112.76 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.647 -0.872 . . . . 72.02 108.647 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.57 87.84 3.47 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.806 -0.634 . . . . 72.43 110.434 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.475 0.813 0 CA-C-N 115.611 -0.722 . . . . 70.05 109.259 169.499 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 110.018 -0.364 . . . . 55.31 110.018 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -131.96 113.58 13.58 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.622 -1.251 . . . . 63.13 107.622 172.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 21.2 tp60 -127.87 98.66 5.23 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.388 0.613 . . . . 71.22 109.983 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 tt -78.61 119.68 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 115.393 -0.821 . . . . 72.23 109.733 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.85 -48.35 7.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.049 0.54 . . . . 74.45 110.562 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.466 ' HD2' ' HD1' ' A' ' 32' ' ' PHE . 55.2 ttt180 -165.26 142.91 5.99 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.484 -0.325 . . . . 72.14 110.563 -172.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.2 mt -114.5 142.93 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.449 -1.315 . . . . 65.42 107.449 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -164.83 158.44 17.4 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.031 0.443 . . . . 71.23 110.567 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.46 HG21 HD11 ' B' ' 21' ' ' ILE . 89.5 m -85.62 123.36 30.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.158 -0.682 . . . . 55.41 109.158 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.442 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 30.9 mtpt -88.09 -35.87 17.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.453 -0.794 . . . . 54.13 111.183 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -161.92 147.89 13.49 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.999 0.428 . . . . 63.14 111.013 -173.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.7 mm -142.33 145.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.101 1.76 . . . . 72.14 108.093 -175.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -154.44 148.43 25.69 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.676 0.61 . . . . 73.22 110.217 170.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 88.2 t80 -156.12 107.22 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.166 -1.42 . . . . 74.02 107.166 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.71 118.58 28.41 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.446 0.699 . . . . 72.41 109.793 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -112.12 87.89 9.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.429 1.092 . . . . 70.11 109.821 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 37.5 Cg_endo -63.67 -41.55 24.42 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.65 2.233 . . . . 75.52 113.072 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -106.27 31.51 5.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.58 0.752 . . . . 72.12 110.036 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -48.59 -48.11 69.17 Favored Pre-proline 0 CA--C 1.573 1.855 0 C-N-CA 125.217 1.407 . . . . 75.42 114.698 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HZ1' ' A' ' 19' ' ' LYS . 89.9 Cg_endo -92.66 -5.34 3.27 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.086 1.857 . . . . 54.22 113.087 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -98.4 -0.47 43.58 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.689 0.796 . . . . 64.52 110.814 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.99 -28.02 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.39 1.076 . . . . 71.13 111.089 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -71.23 -18.25 62.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.878 0.871 . . . . 74.25 112.519 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.33 -41.01 79.18 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.396 0.617 . . . . 74.14 109.887 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.519 ' HB2' HD13 ' B' ' 68' ' ' LEU . 81.4 mttt -108.73 106.74 16.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.58 -1.191 . . . . 72.42 108.465 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.44 79.28 1.91 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.74 0.781 . . . . 73.11 110.13 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -153.52 151.37 29.73 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.996 -1.483 . . . . 71.52 106.996 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -90.64 114.93 62.97 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.507 -1.664 . . . . 70.11 106.507 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.53 131.36 37.72 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.305 2.004 . . . . 63.22 111.978 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 120.41 14.05 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.914 0.759 . . . . 73.53 109.107 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.844 HG12 HD22 ' B' ' 126' ' ' LEU . 2.1 t -86.02 118.74 33.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 106.503 -1.666 . . . . 72.24 106.503 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -138.46 134.92 34.64 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.496 -0.557 . . . . 64.55 109.496 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' B' ' 126' ' ' LEU . 0.7 OUTLIER -128.96 156.63 43.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.248 0.619 . . . . 73.02 112.393 -169.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.19 141.32 48.03 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.932 1.293 . . . . 65.54 108.622 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.2 tp -85.61 136.57 33.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.655 0.782 . . . . 72.43 110.99 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.9 m-20 -129.77 144.27 51.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.988 -1.116 . . . . 74.24 107.988 172.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.9 m -130.18 125.64 35.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.296 0.638 . . . . 72.32 109.968 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -132.23 159.07 40.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.169 0.988 . . . . 63.11 109.11 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 62.1 m -143.01 168.91 18.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.071 0.549 . . . . 73.01 109.98 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.5 t -151.45 164.35 36.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.515 1.126 . . . . 74.12 108.408 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -124.05 124.11 41.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.082 0.553 . . . . 63.01 109.54 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.41 -28.55 16.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.342 0.657 . . . . 64.5 110.783 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.93 -171.48 0.75 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 62.34 111.223 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.48 113.14 4.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.615 -1.175 . . . . 74.21 110.152 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 75.93 -5.15 2.23 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.773 2.029 . . . . 73.05 112.09 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 51.1 t -104.86 99.73 9.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 108.106 -1.072 . . . . 64.21 108.106 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.91 168.48 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.513 0.673 . . . . 75.34 110.062 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -138.41 100.06 4.01 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.402 -1.703 . . . . 63.31 106.402 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.46 128.82 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.197 0.599 . . . . 63.05 109.739 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 47.1 t -105.37 145.07 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.006 0.922 . . . . 73.04 109.815 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 112.96 18.99 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.443 -1.688 . . . . 75.04 106.443 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 34.0 ttm180 -102.83 130.84 49.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.06 -0.718 . . . . 65.45 109.06 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.489 HG11 HD12 ' B' ' 42' ' ' LEU . 50.7 t -121.14 108.83 23.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 107.218 -1.401 . . . . 71.22 107.218 169.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -98.28 136.79 37.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.167 0.508 . . . . 74.1 109.93 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 89.8 t -122.97 137.98 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.195 1.398 . . . . 71.14 110.705 -169.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 57.4 m -123.9 151.38 43.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.873 1.269 . . . . 71.31 109.038 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.04 146.87 31.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.686 0.795 . . . . 41.23 108.913 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 67.3 p -153.68 158.72 41.47 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 75.04 111.554 -171.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' B' ' 34' ' ' LYS . 72.6 mt -128.27 107.0 9.41 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.581 -1.266 . . . . 61.02 107.581 169.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.8 -110.6 3.21 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 123.422 0.451 . . . . 73.13 112.322 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -110.0 0.25 18.42 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.54 0.736 . . . . 75.24 111.517 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.61 159.19 28.36 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.504 -0.747 . . . . 65.24 111.358 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -73.9 139.08 44.72 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.434 -0.803 . . . . 51.41 110.488 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.96 -53.67 3.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.149 -1.056 . . . . 53.24 108.149 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.524 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 46.0 p90 -156.44 170.16 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.724 -1.125 . . . . 70.24 110.415 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.65 155.14 48.54 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.68 1.592 . . . . 65.22 107.939 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.589 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 54.1 t -152.91 158.67 42.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.125 -0.694 . . . . 73.45 109.125 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -155.76 137.94 14.69 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.723 -1.214 . . . . 74.01 107.723 171.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.0 146.38 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.303 0.641 . . . . 72.22 109.277 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -129.65 99.24 5.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.783 0.833 . . . . 64.12 108.969 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -91.42 106.47 18.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.42 -0.809 . . . . 70.43 109.394 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.92 168.11 21.15 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.839 -0.505 . . . . 62.24 111.839 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.45 129.86 2.11 Favored Glycine 0 C--O 1.236 0.28 0 N-CA-C 111.005 -0.838 . . . . 63.22 111.005 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -85.15 115.65 27.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.604 -0.887 . . . . 61.55 108.604 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.89 131.76 52.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.526 -0.916 . . . . 75.21 108.526 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -107.71 106.9 17.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.329 -0.989 . . . . 51.53 108.329 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -128.35 144.8 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.797 0.839 . . . . 75.42 111.277 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.73 171.92 19.43 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.348 1.059 . . . . 74.53 109.183 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.68 -48.33 2.06 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.368 -0.378 . . . . 73.11 112.733 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 163.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.533 0.733 . . . . 63.35 110.177 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 158.11 21.19 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.732 0.413 . . . . 45.04 111.529 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -113.72 5.45 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.858 0.724 . . . . 63.51 114.298 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.4 m -66.08 -38.29 87.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.318 1.047 . . . . 64.14 110.471 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.66 -31.32 66.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.674 -1.148 . . . . 75.12 110.002 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.5 tpt -70.39 -43.19 70.6 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.942 0.897 . . . . 63.45 109.945 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.63 67.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.196 -0.911 . . . . 72.32 111.278 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -83.51 -29.19 28.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.802 0.841 . . . . 70.43 110.561 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -68.98 -61.96 1.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.285 0.634 . . . . 54.23 110.789 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.73 -12.66 25.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.828 0.677 . . . . 73.23 112.828 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.68 1.42 42.19 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-O 119.92 -0.378 . . . . 52.12 113.66 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.1 -58.27 0.31 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.173 0.486 . . . . 53.42 111.114 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.409 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 52.7 t80 -74.66 -45.32 45.47 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.106 -0.497 . . . . 63.53 111.798 -172.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.558 ' HA ' HD12 ' B' ' 105' ' ' ILE . 99.8 m -63.64 -46.26 82.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.422 -0.799 . . . . 71.41 111.734 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.58 -39.19 92.47 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.777 1.651 . . . . 73.53 113.226 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.22 -30.54 71.66 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 123.014 0.525 . . . . 70.25 111.83 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' B' ' 102' ' ' CYS . 96.7 mt -64.43 -47.46 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.389 1.076 . . . . 73.05 110.41 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 mt -81.6 -12.62 58.67 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.345 -1.298 . . . . 60.33 111.384 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.471 ' HE2' ' HA ' ' B' ' 130' ' ' PRO . 26.1 t80 -63.29 -49.94 77.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.944 1.298 . . . . 72.2 113.084 -170.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.2 -33.25 95.0 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.867 1.711 . . . . 74.43 113.073 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 81.7 m-85 -66.11 -48.26 71.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.023 0.529 . . . . 71.22 110.837 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -40.88 97.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.954 0.902 . . . . 72.51 110.961 177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.452 ' HE ' ' HB2' ' B' ' 127' ' ' ASN . 81.4 mtp180 -55.57 -52.61 63.17 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.317 1.047 . . . . 54.3 110.454 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.31 -39.83 92.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.197 -0.91 . . . . 65.41 111.33 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.6 t -70.74 -43.43 68.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.871 -0.604 . . . . 70.04 111.559 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.474 HD11 ' HB ' ' B' ' 62' ' ' VAL . 95.5 mt -63.11 -46.78 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 122.815 0.446 . . . . 74.22 110.474 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.409 HG21 ' CB ' ' C' ' 119' ' ' SER . 22.6 m -52.24 -41.18 62.57 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.81 0.693 . . . . 74.24 111.092 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.9 t -62.7 -53.92 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.927 -0.578 . . . . 71.52 110.383 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 21' ' ' ILE . 36.8 mmt -59.49 -44.58 93.04 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.208 0.603 . . . . 62.44 111.76 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.04 -40.47 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.513 1.125 . . . . 70.54 111.235 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 94.3 p -70.52 -31.91 69.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.422 -0.354 . . . . 53.31 110.834 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.1 mtt-85 -63.12 -27.73 69.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.321 0.648 . . . . 65.04 111.063 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.13 10.55 63.02 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 123.632 0.582 . . . . 52.33 113.059 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.2 p 64.62 44.06 4.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.749 2.019 . . . . 65.43 112.377 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.54 161.87 35.32 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.385 0.674 . . . . 73.34 110.908 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.49 ' HA ' ' OE1' ' C' ' 125' ' ' GLN . 32.1 Cg_exo -62.25 172.89 3.73 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.496 2.797 . . . . 65.13 114.326 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.691 ' HB3' ' HG3' ' C' ' 125' ' ' GLN . 12.9 pm0 -64.57 154.99 34.55 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 115.28 -0.873 . . . . 74.53 111.841 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.844 HD22 HG12 ' B' ' 40' ' ' VAL . 23.0 tp -142.48 83.98 1.84 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.477 -0.935 . . . . 63.51 108.477 165.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.452 ' HB2' ' HE ' ' B' ' 111' ' ' ARG . 6.2 p30 -115.84 106.31 13.69 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.037 -1.468 . . . . 74.24 107.037 170.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.634 ' HB2' HD11 ' B' ' 42' ' ' LEU . 4.0 tt -55.26 136.53 48.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.724 -1.125 . . . . 73.51 109.336 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -50.93 140.17 21.07 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 124.034 0.834 . . . . 52.34 110.985 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' D' ' 16' ' ' ILE . 25.8 Cg_exo -65.13 71.62 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.15 2.567 . . . . 74.53 113.242 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.62 85.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.298 -1.001 . . . . 63.52 108.298 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.496 ' ND2' HG23 ' D' ' 105' ' ' ILE . 2.1 m-20 -78.38 113.11 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.541 -0.911 . . . . 61.04 108.541 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 123.963 0.905 . . . . 75.54 110.709 175.018 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m . . . . . 0 C--O 1.239 0.545 0 N-CA-C 109.109 -0.7 . . . . 75.15 109.109 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 72.8 t80 -96.36 131.94 42.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.611 -0.885 . . . . 75.11 108.611 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -139.83 124.4 18.19 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.147 0.579 . . . . 63.31 109.878 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -93.35 133.24 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.535 0.734 . . . . 73.01 109.262 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -105.17 -45.96 4.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.618 0.767 . . . . 71.03 110.371 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -167.81 124.35 1.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.999 -0.371 . . . . 73.3 109.999 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.22 135.45 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.552 -0.907 . . . . 75.11 108.552 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 27.3 p90 -173.45 163.13 4.39 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.176 0.59 . . . . 65.34 109.804 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -85.78 124.28 32.1 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.812 0.445 . . . . 71.42 110.374 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.601 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.2 mmtp -78.1 -49.95 12.94 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.869 0.842 . . . . 53.01 108.977 170.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -135.41 142.47 45.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.989 -1.459 . . . . 72.51 109.38 -169.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.4 mt -143.99 146.13 21.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.714 -1.587 . . . . 63.14 106.714 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -159.7 149.75 18.65 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.266 0.555 . . . . 55.25 110.42 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -142.65 116.5 9.3 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.614 -1.254 . . . . 75.55 107.614 171.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.57 126.21 52.97 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.847 0.859 . . . . 75.14 109.725 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 81.32 70.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 107.998 -1.112 . . . . 65.23 107.998 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.22 -25.74 42.75 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.131 2.554 . . . . 72.13 112.194 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.25 26.72 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.985 0.914 . . . . 71.22 110.44 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.479 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -46.16 -53.5 22.09 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.161 1.171 . . . . 44.43 114.161 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 59.9 Cg_endo -81.33 -18.74 8.29 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 121.566 1.511 . . . . 74.52 113.824 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.57 -49.26 42.24 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.303 0.641 . . . . 64.41 111.472 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -77.83 -13.37 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.802 1.241 . . . . 74.32 111.4 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.563 ' HE2' ' HD3' ' D' ' 15' ' ' ARG . 79.3 t80 -53.93 -43.06 69.46 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.322 1.049 . . . . 63.43 112.24 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -103.94 27.59 7.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.637 0.732 . . . . 71.14 110.046 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.11 165.18 11.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.404 0.682 . . . . 72.43 109.411 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.35 120.55 24.54 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.99 -0.744 . . . . 64.22 108.99 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -85.56 88.96 7.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.585 0.754 . . . . 71.24 110.688 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.457 ' H ' HD22 ' C' ' 68' ' ' LEU . 35.0 tt0 -128.75 74.32 80.69 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 107.768 -1.197 . . . . 75.24 107.768 169.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.82 143.21 4.18 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.503 2.802 . . . . 64.41 113.404 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.89 115.38 25.31 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.251 -1.018 . . . . 74.33 108.251 167.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.476 HG11 HD21 ' C' ' 128' ' ' LEU . 26.1 t -83.32 85.42 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.05 -0.722 . . . . 73.55 109.05 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -93.87 100.94 13.02 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.746 -1.205 . . . . 70.24 107.746 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.433 HD22 HD13 ' C' ' 128' ' ' LEU . 4.2 pp -90.27 154.53 19.65 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.144 -0.688 . . . . 74.54 109.144 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -120.9 145.33 47.77 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.437 1.095 . . . . 74.44 108.19 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.5 tp -117.73 134.45 54.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.749 0.82 . . . . 70.23 108.861 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.15 150.08 27.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.222 -1.029 . . . . 71.33 108.222 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 91.6 m -137.95 123.97 20.23 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.096 -0.705 . . . . 75.41 109.096 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.98 23.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.287 1.035 . . . . 54.21 108.497 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 p -145.27 144.37 30.74 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.748 0.419 . . . . 64.3 110.455 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -145.1 129.77 18.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.919 0.888 . . . . 72.11 109.109 -176.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -76.95 131.86 38.73 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.527 -0.546 . . . . 64.01 109.527 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.594 HD11 HD12 ' C' ' 83' ' ' ILE . 35.4 mt -106.46 -42.71 4.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.681 . . . . 63.53 109.568 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.78 -177.11 5.41 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.45 -1.25 . . . . 73.24 109.138 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.99 109.08 6.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.053 -0.522 . . . . 73.24 109.935 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.86 18.04 11.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.039 1.336 . . . . 75.21 112.222 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 48.1 t -121.93 114.48 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.66 -1.608 . . . . 74.11 106.66 169.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.433 ' HE2' HG12 ' C' ' 86' ' ' ILE . 43.6 p90 -134.64 -178.74 5.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.656 0.741 . . . . 64.34 110.95 -174.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' C' ' 51' ' ' LEU . 23.9 tt0 -126.34 113.24 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.877 -1.511 . . . . 74.13 108.904 -170.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.9 129.52 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.219 -1.03 . . . . 65.04 108.219 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.1 106.36 16.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.486 -1.302 . . . . 64.53 107.486 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.1 OUTLIER -86.13 103.09 14.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.066 -1.087 . . . . 71.01 108.066 -177.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -84.83 106.11 16.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.768 0.827 . . . . 72.24 109.349 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.84 130.73 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.313 -0.995 . . . . 54.53 108.313 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 5.8 m -116.8 148.31 41.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.041 -1.096 . . . . 64.43 108.041 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.702 HG21 HG21 ' C' ' 114' ' ' ILE . 46.1 t -132.91 110.43 15.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.872 -1.159 . . . . 62.13 107.872 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m -102.57 139.02 38.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.0 -0.741 . . . . 74.4 109.0 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.53 112.75 15.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.513 -1.291 . . . . 65.1 107.513 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -129.82 130.03 44.78 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.346 0.404 . . . . 55.43 110.256 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.457 HD22 ' H ' ' C' ' 37' ' ' GLN . 41.7 mt -87.29 27.88 1.01 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.961 1.304 . . . . 74.44 110.906 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.22 -103.1 1.92 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.933 -0.867 . . . . 62.53 110.933 -171.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.69 -29.37 18.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.979 0.512 . . . . 63.03 110.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.82 121.12 22.92 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.977 0.911 . . . . 72.02 110.146 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.2 m -80.81 124.76 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.789 -0.819 . . . . 74.13 108.789 166.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.69 -51.16 9.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.405 -0.816 . . . . 73.22 109.973 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -166.53 176.45 7.31 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.263 -0.881 . . . . 74.12 110.729 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -143.4 141.4 30.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.906 -1.516 . . . . 73.34 106.906 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.506 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -147.4 125.4 12.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.864 0.465 . . . . 73.35 109.896 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -129.66 133.55 47.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.878 0.471 . . . . 64.33 110.122 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.51 137.83 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.024 0.93 . . . . 74.42 108.56 168.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -112.15 102.09 10.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.294 1.037 . . . . 73.23 108.665 171.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -86.93 108.98 19.04 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.452 -0.794 . . . . 75.02 110.251 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 150.21 25.76 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 123.232 0.332 . . . . 50.4 112.305 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.36 119.33 0.93 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.31 -0.716 . . . . 75.2 111.31 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.594 HD12 HD11 ' C' ' 51' ' ' LEU . 11.7 mm -84.82 124.66 40.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.52 -0.918 . . . . 64.12 108.52 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -132.12 126.35 33.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.656 0.782 . . . . 75.25 110.014 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -96.08 134.98 38.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.912 -1.144 . . . . 35.51 107.912 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.452 HD13 HG12 ' C' ' 89' ' ' ILE . 2.7 pp -131.87 162.65 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.536 0.684 . . . . 43.44 111.911 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.92 29.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.29 -1.323 . . . . 34.31 108.096 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.36 49.17 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.528 -1.151 . . . . 72.41 114.991 173.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.456 ' O ' HG13 ' C' ' 89' ' ' ILE . 36.5 pt . . . . . 0 C--N 1.366 1.321 0 CA-C-N 118.489 1.144 . . . . 70.55 110.753 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 112.652 0.612 . . . . 65.23 112.652 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.5 ptm -82.74 5.88 19.94 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.307 0.643 . . . . 71.44 112.149 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.15 -21.38 2.64 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 72.32 110.929 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.549 1.14 . . . . 64.04 110.207 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.18 -60.46 2.22 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.224 0.61 . . . . 74.25 111.008 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.434 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.3 pp -75.01 -14.47 60.61 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.003 0.521 . . . . 62.01 112.392 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.63 6.96 68.02 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.933 -0.37 . . . . 55.21 113.246 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.16 -63.54 0.11 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.082 0.441 . . . . 74.34 111.607 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -69.75 -50.79 40.04 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.984 0.913 . . . . 74.31 112.639 -169.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.466 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -59.7 -47.14 98.22 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 118.7 -0.667 . . . . 61.21 112.314 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 33.2 Cg_exo -63.56 -34.73 63.1 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.858 1.705 . . . . 71.53 113.28 171.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -69.69 -22.07 63.45 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.718 0.407 . . . . 65.43 111.314 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -69.35 -41.43 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.215 0.606 . . . . 70.13 109.965 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.1 mt -78.2 -20.15 52.43 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.911 -1.041 . . . . 73.4 111.366 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -57.79 -51.56 80.84 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 113.855 1.057 . . . . 74.44 113.855 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.48 -34.94 99.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.851 1.7 . . . . 75.11 112.606 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.45 -43.32 77.3 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.32 0.648 . . . . 73.13 111.243 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.65 91.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.634 0.773 . . . . 70.45 110.48 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.22 -58.98 6.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.843 1.657 . . . . 75.24 110.615 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -33.2 73.88 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.392 0.433 . . . . 71.54 110.65 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -63.05 -33.34 75.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.147 0.579 . . . . 74.5 111.559 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.702 HG21 HG21 ' C' ' 64' ' ' VAL . 91.4 mt -75.04 -47.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 63.31 109.98 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -28.5 67.2 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 115.252 -0.885 . . . . 31.24 111.183 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.1 t -70.74 -50.43 36.27 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.321 -0.854 . . . . 73.11 110.155 170.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.547 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.98 -38.47 73.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.112 0.965 . . . . 71.22 113.323 -175.599 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.92 -36.27 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.337 -0.392 . . . . 72.2 110.604 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.409 ' CB ' HG21 ' B' ' 115' ' ' THR . 39.6 p -76.36 -22.08 55.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.797 0.439 . . . . 71.12 111.298 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.463 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 82.8 mtt-85 -68.39 -36.39 79.09 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 73.05 109.512 171.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.8 3.51 49.84 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.084 -0.962 . . . . 54.31 112.604 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.443 HG23 ' HB3' ' D' ' 17' ' ' TYR . 67.9 p 56.22 21.36 5.22 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 126.765 2.026 . . . . 72.41 112.321 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -97.84 161.24 26.36 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.516 1.126 . . . . 74.22 108.865 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.05 107.99 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.674 2.25 . . . . 72.42 111.734 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.62 155.97 17.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.846 0.716 . . . . 72.22 112.067 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -117.11 91.94 3.72 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.394 -0.965 . . . . 62.43 108.394 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -90.73 88.98 7.3 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.995 -1.483 . . . . 72.51 106.995 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.476 HD21 HG11 ' C' ' 40' ' ' VAL . 48.7 mt -79.55 142.66 35.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.52 -1.218 . . . . 52.32 112.093 -164.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.43 96.72 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.924 -1.034 . . . . 63.11 111.116 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.652 ' HG3' HD12 ' A' ' 16' ' ' ILE . 86.2 Cg_endo -75.26 -171.9 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.81 2.34 . . . . 73.33 113.875 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.72 117.15 7.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 114.185 -1.371 . . . . 44.51 107.412 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.41 65.72 9.33 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.246 0.546 . . . . 71.41 109.656 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.215 -0.758 0 N-CA-C 108.565 -0.902 . . . . 64.52 108.565 179.09 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.685 -0.487 . . . . 74.24 109.685 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.435 ' HD2' HG22 ' D' ' 86' ' ' ILE . 71.1 t80 -158.81 91.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.443 -1.317 . . . . 61.21 107.443 170.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.4 mt-30 -111.89 136.22 51.48 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.263 0.625 . . . . 75.51 109.707 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.3 131.92 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.02 -1.104 . . . . 71.54 108.02 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -106.29 -49.0 3.44 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.718 0.407 . . . . 51.41 111.456 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.563 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 62.2 ttt180 -178.46 134.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 122.262 0.225 . . . . 53.54 111.282 -174.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.521 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 3.0 mp -123.23 130.07 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.742 -1.207 . . . . 73.4 107.742 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.443 ' HB3' HG23 ' C' ' 122' ' ' THR . 47.1 p90 -156.31 163.63 39.29 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 123.728 0.643 . . . . 75.2 111.842 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.02 110.11 10.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.736 -1.12 . . . . 74.13 109.634 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.479 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 46.0 mtpt -77.57 -32.81 54.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.86 -0.609 . . . . 73.24 109.734 172.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.744 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -146.4 138.41 24.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.79 -1.095 . . . . 43.15 109.718 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.547 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.2 mt -137.15 147.75 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.528 1.131 . . . . 65.31 108.411 171.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -147.63 143.75 27.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.878 0.871 . . . . 63.4 108.668 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.3 t80 -147.54 124.98 11.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.919 -1.882 . . . . 74.41 105.919 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.61 142.01 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.735 0.814 . . . . 52.13 108.817 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -135.46 77.65 52.75 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 107.431 -1.322 . . . . 71.13 107.431 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.38 -28.89 17.54 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.748 2.299 . . . . 64.21 112.36 -172.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 50.8 m-20 -114.46 28.66 8.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.424 1.089 . . . . 65.13 109.338 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.554 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.25 -47.96 95.32 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.714 1.746 . . . . 33.42 115.714 -170.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 61.1 Cg_endo -80.94 -15.47 10.54 Favored 'Trans proline' 0 C--N 1.379 2.149 0 CA-C-N 122.021 1.757 . . . . 72.33 112.138 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 1.1 t60 -68.41 -32.07 71.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.93 0.892 . . . . 65.33 108.918 167.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' D' ' 28' ' ' ALA . 12.9 t -68.08 -23.33 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.265 1.026 . . . . 73.44 111.499 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -55.66 -32.92 63.63 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 122.677 0.391 . . . . 74.03 111.67 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -73.85 -27.56 61.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.572 0.749 . . . . 74.01 111.42 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -97.12 111.21 23.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.839 0.856 . . . . 70.1 111.704 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -108.02 52.32 0.72 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.947 1.299 . . . . 71.43 111.148 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -126.01 165.34 18.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.713 0.805 . . . . 62.13 108.94 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -81.61 122.05 80.27 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.641 -0.503 . . . . 75.43 109.641 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.58 126.21 18.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.691 2.261 . . . . 70.32 112.013 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.85 119.71 12.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.411 0.684 . . . . 74.54 109.206 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.8 107.19 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.22 0.608 . . . . 61.43 109.669 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 46.9 mmtm -98.82 114.46 27.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.425 0.69 . . . . 74.24 109.28 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.72 131.59 43.26 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.215 -0.661 . . . . 64.21 109.215 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.63 123.18 42.18 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.626 -1.25 . . . . 61.34 107.626 171.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -95.42 130.24 42.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.038 0.535 . . . . 61.52 109.893 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.8 t70 -138.35 150.43 46.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.433 -1.321 . . . . 55.0 107.433 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -145.31 157.11 44.12 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.271 -0.64 . . . . 71.03 109.271 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.01 167.57 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.062 0.945 . . . . 70.12 108.835 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.2 p -164.92 155.91 14.57 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.058 0.543 . . . . 73.13 110.571 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 19.5 p -164.55 132.29 3.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.04 0.936 . . . . 70.21 109.4 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.46 131.59 45.54 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.078 0.551 . . . . 73.31 111.309 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' D' ' 57' ' ' GLU . 64.7 mt -103.65 -37.72 7.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.632 0.773 . . . . 72.05 110.93 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -158.43 -167.54 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.356 0.662 . . . . 21.21 110.929 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -70.87 112.93 7.43 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.25 -0.887 . . . . 53.11 110.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 70.76 -2.62 2.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.579 1.552 . . . . 64.25 112.313 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 82.5 t -109.88 133.43 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.204 1.002 . . . . 73.44 109.434 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.03 154.08 36.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 74.31 109.306 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.1 tt0 -92.2 134.87 34.47 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.801 0.841 . . . . 65.22 109.346 176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.86 124.3 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.832 -1.173 . . . . 64.21 107.832 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.7 t -105.82 138.55 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.201 0.601 . . . . 65.22 109.448 175.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -113.11 123.85 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.948 -1.13 . . . . 54.21 107.948 176.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.6 ttm-85 -106.64 103.65 13.15 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.813 -0.81 . . . . 75.4 108.813 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.02 123.07 52.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.756 -0.831 . . . . 71.24 108.756 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -114.6 139.14 49.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.538 0.735 . . . . 60.11 109.599 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.478 HG21 HG21 ' D' ' 114' ' ' ILE . 50.8 t -131.67 100.6 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.804 1.242 . . . . 60.13 108.376 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.7 m -95.02 94.05 7.75 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.16 -1.422 . . . . 73.23 107.16 170.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.06 134.2 40.72 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.577 -0.897 . . . . 51.12 108.577 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.453 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 16.6 p -148.57 129.88 14.69 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.074 0.464 . . . . 62.22 111.524 -170.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 41.5 mt -95.16 104.71 16.6 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.569 1.147 . . . . 73.0 110.867 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.15 -110.91 3.6 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.556 0.535 . . . . 74.21 112.523 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.22 7.26 35.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 63.42 111.632 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.38 150.15 48.77 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.212 0.605 . . . . 54.33 110.326 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -73.22 132.55 43.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.27 0.628 . . . . 73.1 110.362 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -86.98 -57.68 2.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.547 0.739 . . . . 70.14 109.192 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.81 152.89 14.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.801 -1.091 . . . . 63.03 110.245 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -117.52 120.4 37.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.282 1.033 . . . . 63.23 108.788 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.5 t -133.07 142.0 48.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.415 0.686 . . . . 71.51 110.004 -175.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -156.5 129.65 7.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.916 0.486 . . . . 63.42 110.257 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.49 HG22 HG23 ' D' ' 21' ' ' ILE . 84.8 t -128.37 122.72 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.989 0.916 . . . . 62.31 110.051 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.744 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -93.01 87.55 5.8 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.673 0.749 . . . . 74.51 109.531 169.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.425 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.3 tp-100 -80.27 96.62 6.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.19 -1.368 . . . . 61.33 108.954 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.92 157.76 29.92 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.812 -0.515 . . . . 63.53 111.812 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 138.44 5.45 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.946 -0.462 . . . . 74.23 111.946 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.0 mt -91.85 132.97 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 123.762 0.825 . . . . 61.03 109.941 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.1 150.1 52.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.499 0.72 . . . . 72.33 110.602 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.7 m -116.55 101.34 8.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.315 1.046 . . . . 63.22 109.248 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.463 ' HB ' HD11 ' D' ' 89' ' ' ILE . 39.2 pt -109.33 132.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.031 0.443 . . . . 74.12 110.747 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.98 165.77 26.97 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.971 0.909 . . . . 61.02 109.469 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.78 -21.6 6.45 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 114.198 0.439 . . . . 71.45 114.198 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.485 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -107.01 169.37 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.272 1.029 . . . . 75.35 109.308 175.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -170.78 -168.63 0.69 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 71.35 110.895 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.65 -141.9 29.2 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.243 -0.435 . . . . 35.13 113.837 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.9 m -82.68 -25.67 32.79 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.383 0.673 . . . . 74.44 111.339 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -63.46 -48.88 75.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.011 0.524 . . . . 70.42 109.788 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -66.06 -31.77 72.84 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.426 0.454 . . . . 70.24 110.95 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.77 98.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.202 0.601 . . . . 74.15 111.212 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -79.22 -37.71 37.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.432 -0.349 . . . . 74.45 110.224 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.87 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.322 0.649 . . . . 30.0 111.481 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.2 tt -75.78 -50.68 14.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.763 0.825 . . . . 74.03 109.042 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.01 14.1 65.08 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.868 -0.605 . . . . 61.02 114.398 -170.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -56.67 0.2 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.548 0.674 . . . . 43.12 111.618 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -72.09 -43.24 65.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.695 0.628 . . . . 72.53 112.695 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 98.8 m -63.37 -46.41 84.71 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 118.747 -0.644 . . . . 51.45 111.084 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.0 Cg_exo -58.82 -31.52 95.39 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 122.608 2.205 . . . . 64.54 114.013 166.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -65.86 -34.94 79.3 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.149 0.58 . . . . 74.21 110.757 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.496 HG23 ' ND2' ' B' ' 132' ' ' ASN . 37.3 mm -63.48 -39.76 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.382 0.673 . . . . 73.53 110.29 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.425 HD13 ' O ' ' D' ' 80' ' ' GLN . 84.5 mt -74.24 -21.24 59.86 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.374 -0.83 . . . . 74.23 111.672 -175.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -67.9 -40.72 24.64 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 114.584 1.327 . . . . 65.22 114.584 -168.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.412 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 98.2 Cg_exo -49.72 -38.54 46.57 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 121.982 1.788 . . . . 71.25 113.586 170.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -83.87 -29.81 26.93 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.74 -1.118 . . . . 71.13 110.834 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.79 -49.73 64.9 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.31 0.644 . . . . 74.11 110.346 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.1 ttp-105 -50.98 -56.61 11.62 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.809 1.318 . . . . 71.52 110.273 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.97 -44.39 94.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.619 1.2 . . . . 64.04 111.595 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.463 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 40.8 t -56.3 -44.03 79.48 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.88 0.738 . . . . 63.42 111.075 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.478 HG21 HG21 ' D' ' 64' ' ' VAL . 74.2 mt -67.85 -53.28 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.883 . . . . 74.14 110.382 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -51.56 -43.64 62.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.071 1.348 . . . . 60.13 112.265 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.9 t -69.71 -41.56 75.2 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.149 -0.932 . . . . 74.5 110.525 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.5 mtm -64.36 -35.1 79.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.028 0.531 . . . . 65.23 111.534 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.3 t -61.53 -48.15 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.221 -0.9 . . . . 54.32 110.319 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.7 p -73.98 -23.02 59.41 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.079 -0.51 . . . . 70.12 111.604 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -73.97 -36.28 64.55 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.726 0.81 . . . . 74.25 110.235 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 2.48 71.66 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.714 0.634 . . . . 71.4 112.07 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 62.29 30.76 17.56 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.85 2.06 . . . . 71.31 112.45 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -88.92 168.64 15.07 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 125.232 1.413 . . . . 75.34 108.077 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.36 153.89 27.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.706 1.604 . . . . 54.24 110.884 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.48 132.31 47.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.174 0.19 . . . . 71.41 110.816 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.76 113.03 22.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.735 -0.839 . . . . 70.45 108.735 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.35 88.85 4.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.795 -1.187 . . . . 63.55 107.795 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.53 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 75.9 mt -63.56 114.56 4.01 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.568 -0.742 . . . . 55.53 109.425 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.55 137.92 89.45 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.215 0.82 . . . . 73.15 113.215 -168.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.409 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 60.0 Cg_endo -80.3 104.87 1.68 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.618 2.212 . . . . 63.4 110.55 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.43 111.32 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.954 -1.021 . . . . 73.42 110.542 -169.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--O 1.242 0.66 0 CA-C-O 122.405 1.098 . . . . 62.13 108.267 177.328 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.238 0.497 0 CA-C-O 121.018 0.437 . . . . 75.14 109.947 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 52.4 t80 -135.96 129.17 31.72 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.596 -1.261 . . . . 65.0 107.596 170.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -148.82 123.41 9.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.266 0.469 . . . . 62.12 112.266 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 16' ' ' ILE . 3.4 tp -75.19 118.26 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.949 -1.023 . . . . 63.52 109.056 168.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.9 -20.75 13.34 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.292 0.637 . . . . 71.34 111.048 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -178.41 127.16 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.249 0.477 . . . . 74.31 111.157 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 13' ' ' ILE . 48.3 mt -106.48 132.22 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.761 -0.829 . . . . 74.15 108.761 169.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -148.45 171.84 15.42 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.27 1.428 . . . . 74.23 109.931 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -102.15 123.49 46.09 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.959 -0.756 . . . . 74.11 108.959 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -81.53 -32.19 32.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.387 0.675 . . . . 61.25 110.556 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.7 t70 -150.1 144.34 25.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.13 110.083 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.454 HG23 ' SD ' ' A' ' 117' ' ' MET . 61.6 mt -137.38 130.3 43.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.852 -1.536 . . . . 53.03 106.852 171.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -140.33 116.17 10.3 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.113 -1.069 . . . . 71.14 108.113 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.4 t80 -126.68 109.2 11.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 106.667 -1.605 . . . . 71.22 106.667 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.97 108.91 15.85 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.403 -0.962 . . . . 75.54 108.403 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -106.76 89.48 4.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.335 -0.987 . . . . 61.32 108.335 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.59 -43.45 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.446 2.098 . . . . 63.23 112.794 -172.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.6 m-80 -101.42 29.27 4.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.24 0.616 . . . . 73.25 109.891 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -50.79 -48.65 82.99 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 124.359 1.064 . . . . 52.41 113.163 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 21.8 Cg_exo -67.84 -26.39 38.37 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 121.688 1.592 . . . . 62.21 112.517 176.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.52 -28.4 60.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.625 -0.716 . . . . 73.12 110.857 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.734 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 41.4 t -58.79 -20.34 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 123.667 0.787 . . . . 62.01 111.645 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.77 -41.4 90.98 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.262 1.025 . . . . 75.24 111.776 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -101.27 -22.21 14.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.246 0.618 . . . . 70.51 111.436 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.9 mmmt -69.88 134.72 48.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.269 0.627 . . . . 72.24 110.001 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.42 131.94 44.84 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.339 -0.846 . . . . 65.25 109.087 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HA ' HD22 ' A' ' 68' ' ' LEU . 75.4 t-105 -80.79 90.6 5.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.479 0.656 . . . . 75.44 110.006 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -121.22 83.97 39.85 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 106.866 -1.531 . . . . 74.2 106.866 165.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.05 132.24 16.51 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.295 1.996 . . . . 43.43 111.389 -171.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -94.49 91.51 6.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.097 -1.446 . . . . 74.13 107.097 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.34 98.59 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 124.612 1.195 . . . . 62.05 111.586 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 20.2 tptm -100.42 130.52 46.52 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.428 -1.26 . . . . 72.21 108.763 175.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -131.67 114.08 14.37 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.41 0.684 . . . . 60.15 109.367 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -108.08 137.56 45.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.394 1.078 . . . . 73.21 108.535 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.8 tp -119.0 118.9 32.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.747 -0.835 . . . . 64.42 108.747 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -128.58 149.99 50.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.012 0.925 . . . . 60.23 108.953 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -140.63 151.25 44.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.378 0.671 . . . . 74.43 109.858 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -142.53 155.29 45.0 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.226 1.01 . . . . 62.01 109.38 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 p -125.6 159.81 31.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.602 0.761 . . . . 64.24 110.329 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -159.12 122.43 3.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.683 0.793 . . . . 74.01 109.68 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -79.84 111.9 16.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.755 0.422 . . . . 51.31 109.869 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.5 mt -88.52 -34.16 17.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.124 0.569 . . . . 45.22 110.667 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -161.58 -172.38 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.437 1.095 . . . . 54.13 109.937 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.19 107.41 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 54.21 109.522 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 68.56 3.66 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.219 1.408 . . . . 70.21 112.87 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.5 t -99.64 115.04 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.351 -1.351 . . . . 75.45 107.351 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -123.2 167.04 14.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.67 0.747 . . . . 74.34 110.745 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' A' ' 51' ' ' LEU . 19.3 tt0 -128.59 126.26 39.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.043 -1.435 . . . . 65.31 107.143 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -106.48 122.05 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.464 -1.31 . . . . 74.0 107.464 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.51 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.5 t -97.51 139.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 124.313 1.045 . . . . 72.52 108.291 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.12 112.77 19.1 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.434 -1.321 . . . . 71.3 107.434 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -109.75 103.03 11.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.658 0.742 . . . . 74.22 109.752 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.49 136.12 28.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.703 -1.135 . . . . 75.22 108.414 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.8 m -123.5 128.97 50.53 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.039 0.447 . . . . 73.2 110.276 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.5 t -125.33 110.5 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 74.41 109.394 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -107.73 138.59 43.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.19 0.45 . . . . 74.24 109.827 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.48 105.85 12.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.286 -1.376 . . . . 74.54 107.286 168.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 47.6 m -106.42 126.52 52.35 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.552 -0.536 . . . . 72.31 109.552 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 36' ' ' TRP . 17.0 mt -93.27 80.84 4.44 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.137 -1.431 . . . . 72.2 107.137 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -89.24 0.86 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.951 -1.022 . . . . 54.42 111.285 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -121.5 -15.06 8.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.167 0.987 . . . . 71.04 110.477 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 4.8 mp0 -97.16 101.74 13.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.404 1.082 . . . . 55.42 109.83 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.4 m -66.17 127.19 31.19 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.263 0.554 . . . . 53.14 111.192 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -74.28 -55.06 6.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.738 1.215 . . . . 62.25 108.986 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.22 164.87 35.6 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.749 -1.114 . . . . 64.33 111.125 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.21 143.38 50.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.3 1.44 . . . . 71.02 107.224 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.8 m -130.11 136.05 48.9 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 123.712 0.805 . . . . 73.41 108.855 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -148.57 115.72 6.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.582 -0.896 . . . . 63.3 108.582 173.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.89 112.84 30.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.652 0.781 . . . . 73.23 109.518 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -86.67 84.49 7.38 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.751 -0.833 . . . . 64.41 108.751 172.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.53 93.3 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.588 -0.893 . . . . 74.54 108.588 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.37 148.44 20.08 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.413 -0.675 . . . . 73.12 111.413 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 131.92 4.03 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.865 -0.894 . . . . 64.13 110.865 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.78 121.33 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.662 -0.866 . . . . 64.5 108.662 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' HD13 ' A' ' 13' ' ' ILE . 34.5 m-85 -130.87 117.33 19.14 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.723 -1.214 . . . . 74.52 107.723 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 p -79.15 115.8 19.03 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.416 -0.957 . . . . 75.43 108.416 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.471 ' HB ' HD11 ' A' ' 89' ' ' ILE . 44.4 pt -118.37 142.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.481 0.712 . . . . 72.4 110.594 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.81 155.74 17.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.099 0.96 . . . . 54.45 109.628 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 9.48 85.54 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.616 0.606 . . . . 53.52 114.616 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB ' ' A' ' 86' ' ' ILE . 1.3 pp -119.61 132.58 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 117.409 0.604 . . . . 74.24 110.678 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -151.76 173.39 14.79 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.373 1.069 . . . . 64.41 110.217 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.19 -136.26 51.13 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.602 0.564 . . . . 61.12 113.896 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -70.34 -25.95 63.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.759 0.824 . . . . 73.22 111.371 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -65.29 -43.35 91.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 62.1 110.492 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.426 ' HG3' HD23 ' A' ' 98' ' ' LEU . 28.0 ttt -76.11 -38.17 57.21 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.874 -0.603 . . . . 65.21 110.64 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.26 67.83 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.797 0.439 . . . . 63.22 111.489 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -71.72 -39.44 70.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.949 0.9 . . . . 75.04 110.473 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.604 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 t -77.36 -65.87 0.9 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.65 -0.704 . . . . 65.33 110.222 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 ' HG3' ' A' ' 94' ' ' MET . 3.8 mm? -73.54 -17.95 61.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.745 0.818 . . . . 74.11 112.365 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.29 -16.91 54.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.852 -0.416 . . . . 61.23 113.964 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -55.7 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.403 0.601 . . . . 62.22 111.75 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 92.1 t80 -66.79 -61.05 2.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.904 0.882 . . . . 42.31 113.361 -168.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.604 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 79.1 m -62.78 -40.91 68.33 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.157 -0.925 . . . . 60.04 113.372 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -63.79 -32.53 67.29 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 121.098 1.428 . . . . 72.12 112.868 168.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -72.02 -24.64 61.59 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 117.945 0.339 . . . . 63.14 111.204 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -57.74 -43.26 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.638 0.733 . . . . 73.43 109.406 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 mt -77.49 -21.84 52.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.146 -1.388 . . . . 74.44 112.27 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -64.61 -41.35 57.04 Favored Pre-proline 0 CA--C 1.562 1.424 0 CA-C-O 117.475 -1.25 . . . . 75.53 114.116 -168.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.69 -31.26 91.54 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.119 1.879 . . . . 74.21 113.26 172.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.95 -41.07 21.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.616 0.766 . . . . 72.03 110.924 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.53 87.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.947 0.499 . . . . 73.11 110.061 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.471 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.9 ttm180 -50.51 -58.79 4.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.867 1.267 . . . . 54.13 110.154 173.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.19 -40.55 96.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.516 1.135 . . . . 74.52 111.754 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.6 t -57.59 -48.43 79.42 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 123.854 0.721 . . . . 61.3 110.1 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 64' ' ' VAL . 95.1 mt -62.16 -51.16 75.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 O-C-N 124.306 1.004 . . . . 65.3 110.203 175.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.8 m -53.0 -42.72 65.87 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.81 1.244 . . . . 70.4 111.621 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.91 -47.01 66.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.969 -1.014 . . . . 61.13 109.985 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.454 ' SD ' HG23 ' A' ' 21' ' ' ILE . 15.6 mtp -53.45 -45.61 69.57 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.856 0.862 . . . . 72.45 111.394 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 114' ' ' ILE . 73.8 t -61.09 -49.11 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.076 1.351 . . . . 74.24 111.046 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -68.48 -28.84 67.39 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.899 0.479 . . . . 70.22 111.454 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.3 -27.59 64.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.694 0.798 . . . . 70.22 110.976 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.96 11.96 58.83 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 119.498 -0.612 . . . . 71.41 113.776 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.48 ' HB ' HH21 ' B' ' 15' ' ' ARG . 11.9 m 65.18 32.53 10.04 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.351 1.072 . . . . 74.24 110.316 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.424 ' HE1' HG11 ' A' ' 31' ' ' VAL . 65.2 m-85 -109.4 152.69 42.83 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 115.106 -0.952 . . . . 74.12 109.101 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 149.57 80.23 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.103 1.868 . . . . 65.33 111.319 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HG23 ' A' ' 115' ' ' THR . 29.5 tt0 -56.7 142.29 40.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.699 0.8 . . . . 73.33 111.313 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp -133.8 101.79 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.57 0.748 . . . . 71.13 109.434 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -98.63 100.7 11.95 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.61 117.85 6.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 75.14 109.928 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.94 150.36 50.03 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.345 0.658 . . . . 62.43 111.859 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.71 160.86 7.75 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.378 2.052 . . . . 73.31 112.763 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.89 114.3 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.806 -1.183 . . . . 72.03 107.806 165.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -98.8 63.41 1.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.648 0.737 . . . . 64.24 109.945 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 t80 . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 115.24 -0.891 . . . . 73.52 109.035 173.323 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.089 -0.708 . . . . 63.13 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -139.97 117.17 11.22 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.834 -0.802 . . . . 72.15 108.834 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.1 tp60 -128.03 103.5 7.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.191 0.596 . . . . 75.43 109.797 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' D' ' 129' ' ' ALA . 12.5 tt -67.92 121.63 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 108.819 -0.808 . . . . 74.41 108.819 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -101.1 -47.38 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.86 0.464 . . . . 71.32 110.715 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.48 HH21 ' HB ' ' A' ' 122' ' ' THR . 66.9 ttt180 -163.25 135.59 5.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.098 -171.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.15 138.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 106.805 -1.554 . . . . 64.23 106.805 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.507 ' HE1' HG13 ' B' ' 83' ' ' ILE . 15.1 p90 -164.78 146.35 8.02 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 123.711 0.632 . . . . 64.32 111.178 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -74.64 116.84 15.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.864 -0.791 . . . . 75.4 108.864 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -89.48 -30.18 18.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.26 0.624 . . . . 73.21 111.158 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.5 t70 -158.25 142.89 16.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.091 -0.504 . . . . 60.32 110.376 -171.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.9 mm -138.29 141.46 37.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 125.336 1.455 . . . . 65.23 108.071 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -140.49 133.17 28.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.73 -1.123 . . . . 75.35 108.073 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.1 t80 -142.43 127.43 18.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.447 -1.686 . . . . 73.22 106.447 164.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.57 147.05 49.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.446 -1.316 . . . . 64.35 107.446 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -141.31 81.74 15.26 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 105.829 -1.915 . . . . 51.42 105.829 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.87 -29.08 76.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.574 2.183 . . . . 72.1 111.13 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.25 30.7 6.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.66 -1.155 . . . . 42.34 110.435 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.45 -52.45 29.63 Favored Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 124.734 1.214 . . . . 71.24 111.972 169.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.25 -16.84 9.43 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.007 1.804 . . . . 72.32 113.072 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -87.59 3.15 48.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.339 0.656 . . . . 71.21 111.419 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.494 HG12 HD11 ' B' ' 68' ' ' LEU . 22.0 m -67.04 -17.12 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.644 0.778 . . . . 74.1 110.766 166.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -71.33 -31.28 67.21 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.403 1.081 . . . . 74.41 110.123 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.18 -42.65 15.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.351 0.66 . . . . 72.12 109.383 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -91.45 78.52 5.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.076 0.95 . . . . 45.43 109.377 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -83.11 74.87 9.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.42 -1.264 . . . . 75.44 110.471 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -179.46 171.64 1.24 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.199 1.0 . . . . 74.1 109.471 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -71.15 135.57 84.79 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.181 0.992 . . . . 70.45 111.276 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.54 157.41 48.89 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.135 1.89 . . . . 73.0 111.742 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 52.5 mt-10 -70.2 102.19 2.04 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.826 -1.176 . . . . 61.33 107.826 167.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.5 136.6 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.436 -0.95 . . . . 71.11 108.436 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -136.68 141.45 43.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.62 0.768 . . . . 65.14 109.23 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' B' ' 126' ' ' LEU . 2.8 pp -104.83 142.23 35.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.475 0.71 . . . . 74.33 109.366 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.543 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.2 m-20 -139.6 155.71 47.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.687 1.595 . . . . 61.34 106.916 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 165.09 36.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.944 0.402 . . . . 64.43 110.327 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.53 141.51 13.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.346 1.058 . . . . 75.22 109.057 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' THR . . . . . 0.577 HG21 ' HA2' ' B' ' 99' ' ' GLY . 88.8 m -108.57 120.06 41.34 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.251 0.621 . . . . 73.14 109.361 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.33 153.82 32.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.765 1.226 . . . . 64.14 108.539 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -142.99 163.41 32.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.096 0.558 . . . . 75.14 110.889 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -154.03 170.59 20.75 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.05 1.34 . . . . 72.13 109.222 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 64.0 tt0 -125.79 135.36 51.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.786 0.834 . . . . 72.55 109.818 169.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 59.3 mt -100.62 -44.75 5.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.677 0.791 . . . . 71.23 110.767 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -147.8 179.23 7.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.944 -1.025 . . . . 74.44 109.733 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.11 119.29 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.526 -0.761 . . . . 65.1 109.851 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' B' ' 85' ' ' SER . 16.6 m-20 70.76 -6.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.144 1.778 . . . . 75.12 112.674 -174.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.0 t -104.58 94.95 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.131 -1.062 . . . . 62.34 108.131 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 8.0 m-85 -94.93 169.39 10.16 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.435 0.694 . . . . 61.32 109.517 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 6.8 tm-20 -142.89 101.72 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.518 -1.289 . . . . 71.43 107.518 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.87 125.12 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.446 -0.576 . . . . 73.3 109.446 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.8 t -102.98 111.58 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.569 0.748 . . . . 74.02 109.605 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.37 112.09 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.381 -0.97 . . . . 74.42 108.381 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -96.44 131.45 43.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.592 -1.186 . . . . 71.02 109.708 173.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -126.89 120.29 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.579 -1.267 . . . . 72.53 107.579 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.4 m -109.48 153.97 23.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.494 1.117 . . . . 51.41 109.805 -174.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 85.1 t -133.33 126.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.631 1.172 . . . . 72.44 108.766 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 43.2 m -112.8 143.22 44.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.679 0.792 . . . . 73.21 109.335 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.7 151.37 34.79 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.56 0.344 . . . . 73.33 110.81 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.4 p -144.37 133.39 22.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.099 0.56 . . . . 75.05 111.203 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.494 HD11 HG12 ' B' ' 31' ' ' VAL . 41.8 mt -100.87 99.67 10.2 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 73.21 108.365 171.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.68 -120.01 6.73 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.018 -0.833 . . . . 24.33 111.018 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.17 6.0 35.37 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.803 0.841 . . . . 75.51 112.191 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -115.19 165.57 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.44 0.696 . . . . 64.43 109.793 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -77.82 133.14 38.26 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.121 0.568 . . . . 73.25 111.111 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.46 -60.2 2.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.64 0.776 . . . . 74.11 109.291 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.5 150.98 21.91 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.533 -1.212 . . . . 72.23 110.041 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.45 114.22 15.87 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.215 1.006 . . . . 74.41 108.729 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.544 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 51.4 t -115.38 157.94 23.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.766 -0.827 . . . . 71.12 108.766 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.88 135.97 2.85 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.451 -0.944 . . . . 71.1 108.451 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.74 143.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.51 -0.922 . . . . 35.31 108.51 172.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -127.15 89.25 2.94 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.68 -0.859 . . . . 73.14 108.68 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -83.45 104.71 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.939 -1.028 . . . . 62.21 108.506 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.21 162.52 29.71 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.574 -0.61 . . . . 72.52 111.574 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.09 128.81 2.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.519 -0.632 . . . . 64.12 111.519 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.507 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.8 mt -85.72 118.39 32.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.748 -0.834 . . . . 71.14 108.748 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.69 134.71 43.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.773 0.829 . . . . 75.13 109.375 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 43.2 m -97.58 113.85 25.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.268 0.627 . . . . 62.24 109.993 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 137.47 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.772 0.829 . . . . 64.44 111.608 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.41 173.09 17.17 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.698 1.199 . . . . 72.52 108.782 165.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.53 -44.29 3.32 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-O 120.279 -0.179 . . . . 75.21 112.771 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.91 152.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.876 0.87 . . . . 74.44 110.654 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 1.1 tm-20 -155.93 144.25 20.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 120.406 0.146 . . . . 64.53 110.64 -174.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.39 -114.36 6.12 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.707 0.67 . . . . 73.15 114.034 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -67.01 -31.13 71.48 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.867 0.867 . . . . 74.13 110.996 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 92.1 mt-30 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.34 0.656 . . . . 73.54 110.475 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.2 ttt -73.11 -37.86 66.53 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.767 -0.651 . . . . 64.42 110.681 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.84 -24.85 67.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 71.01 111.121 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -88.75 -23.38 22.92 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.048 0.939 . . . . 73.23 110.985 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.64 -67.66 0.64 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.716 0.406 . . . . 74.21 109.926 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.59 -18.4 58.66 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.034 0.383 . . . . 73.1 112.034 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.577 ' HA2' HG21 ' B' ' 46' ' ' THR . . . -90.11 -20.19 43.49 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.769 -0.462 . . . . 73.42 114.043 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.42 -52.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.766 0.654 . . . . 61.35 112.766 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -67.22 -50.17 61.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.104 0.561 . . . . 74.34 111.401 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.68 -47.41 82.17 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 118.236 -0.888 . . . . 65.33 110.42 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.8 -43.03 36.04 Favored 'Trans proline' 0 C--N 1.404 3.495 0 C-N-CA 122.296 1.998 . . . . 72.44 114.463 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -31.42 72.31 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.257 0.623 . . . . 73.21 111.867 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.9 -45.69 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.547 0.739 . . . . 72.43 110.372 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.24 -16.38 33.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.009 -0.996 . . . . 72.34 111.786 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.14 -44.17 95.73 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 125.773 1.629 . . . . 61.35 113.757 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.0 Cg_endo -58.59 -40.32 74.93 Favored 'Trans proline' 0 C--N 1.4 3.286 0 C-N-CA 121.873 1.715 . . . . 74.05 112.494 174.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.444 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.8 m-85 -63.79 -44.09 94.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.17 0.588 . . . . 74.44 110.33 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.445 0.698 . . . . 62.0 111.045 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.52 -47.2 87.21 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.966 1.307 . . . . 74.1 111.063 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.82 -40.41 75.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.643 0.777 . . . . 62.42 110.0 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.7 t -67.45 -35.24 78.82 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 115.797 -0.638 . . . . 62.5 111.218 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.485 HG21 HG21 ' B' ' 64' ' ' VAL . 52.1 mt -62.81 -57.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.167 0.587 . . . . 74.51 109.548 174.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.406 HG21 ' HB2' ' C' ' 119' ' ' SER . 90.1 m -59.84 -26.43 65.8 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.328 1.018 . . . . 70.53 111.183 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.6 t -66.03 -58.79 4.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.528 0.731 . . . . 75.33 109.852 171.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.2 mmt -62.79 -39.05 93.03 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.99 0.516 . . . . 61.25 112.267 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.0 -41.82 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.498 1.119 . . . . 63.3 110.631 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -72.69 -25.64 61.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.661 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.9 mtt-85 -65.32 -38.63 90.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.509 -0.552 . . . . 72.34 109.509 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 1.55 62.86 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.908 -0.587 . . . . 73.23 113.191 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.9 p 63.25 39.99 9.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 61.12 111.816 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -112.74 159.26 35.01 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.937 1.295 . . . . 72.22 111.207 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.41 141.46 95.64 Favored 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 123.745 2.964 . . . . 71.44 115.181 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' C' ' 124' ' ' PRO . 0.9 OUTLIER -65.61 160.39 22.66 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 126.322 1.849 . . . . 64.12 113.701 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.552 HD13 ' HB3' ' B' ' 42' ' ' LEU . 24.3 mt -127.54 102.46 6.87 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.254 -0.885 . . . . 74.01 110.004 163.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -91.05 100.24 13.13 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.542 -1.281 . . . . 74.24 107.542 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.87 136.33 33.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.112 0.565 . . . . 61.23 112.236 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.54 142.26 74.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.708 0.803 . . . . 72.42 110.324 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.419 ' HG2' HG21 ' D' ' 13' ' ' ILE . 29.0 Cg_endo -64.24 100.4 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.156 1.904 . . . . 74.45 111.396 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 m -75.5 71.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.024 0.916 . . . . 74.2 109.189 168.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.1 93.2 1.77 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.962 -1.125 . . . . 75.32 107.962 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.6 t80 . . . . . 0 CA--C 1.546 0.804 0 CA-C-N 114.031 -1.44 . . . . 71.34 111.886 -172.945 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.24 0.587 0 N-CA-C 109.571 -0.529 . . . . 73.33 109.571 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -117.65 125.16 50.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.504 1.122 . . . . 73.5 108.159 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -137.14 112.16 9.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.054 0.542 . . . . 72.03 109.601 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.458 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -64.47 130.87 30.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-N 115.862 -0.608 . . . . 73.2 109.926 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.551 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.3 mm100 -103.75 -51.51 3.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.085 -0.709 . . . . 74.31 109.085 174.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -166.53 155.96 11.28 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.439 0.162 . . . . 71.52 111.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.458 HG13 HD11 ' C' ' 13' ' ' ILE . 93.9 mt -138.19 137.48 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.608 1.163 . . . . 63.52 108.128 173.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.569 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.5 p90 -171.84 155.04 3.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.524 0.678 . . . . 74.44 111.786 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -78.72 117.99 20.37 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.67 -1.15 . . . . 74.33 108.461 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 17.4 mtmt -92.61 -38.57 11.81 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.903 -0.777 . . . . 74.4 108.903 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.9 t70 -133.9 134.89 43.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.683 -1.144 . . . . 74.21 108.729 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -138.82 141.02 37.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.078 -1.453 . . . . 52.15 107.078 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -151.95 150.22 29.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.394 0.616 . . . . 51.41 109.823 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -150.83 113.33 4.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.889 -1.523 . . . . 64.42 106.889 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -115.16 111.15 20.57 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.883 -0.784 . . . . 73.31 108.883 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.02 75.69 53.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.09 0.956 . . . . 53.54 108.711 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.54 -24.35 30.77 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.092 1.862 . . . . 72.24 110.465 168.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -92.23 19.12 7.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.18 0.992 . . . . 75.21 110.731 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.2 94.76 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.908 0.883 . . . . 75.24 113.353 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.63 -25.92 7.52 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 121.46 1.44 . . . . 74.0 112.06 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.48 -32.98 72.21 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.088 1.355 . . . . 72.53 111.29 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.507 HG23 HD11 ' C' ' 68' ' ' LEU . 12.6 p -72.05 -24.24 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.809 0.844 . . . . 74.42 111.689 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.31 -39.15 93.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.199 0.6 . . . . 75.12 111.139 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -100.74 39.9 1.33 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.752 0.821 . . . . 62.33 109.858 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.768 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -124.72 173.86 8.27 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.36 0.664 . . . . 72.54 110.459 -176.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.27 115.42 25.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.041 -1.096 . . . . 74.21 108.041 167.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.13 68.02 10.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.832 0.853 . . . . 75.11 111.839 -167.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -125.73 79.26 68.28 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.251 -1.018 . . . . 70.11 108.251 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.487 ' HB2' HG13 ' C' ' 40' ' ' VAL . 18.8 Cg_endo -89.42 137.57 3.02 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.472 2.115 . . . . 71.13 111.285 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.25 79.8 9.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.37 -1.344 . . . . 72.32 107.37 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.623 ' HB ' HD11 ' C' ' 126' ' ' LEU . 17.2 m -84.21 111.29 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.314 -1.766 . . . . 34.4 110.166 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -136.83 140.27 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.608 0.363 . . . . 74.3 110.104 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.468 ' HA ' HG22 ' C' ' 64' ' ' VAL . 3.4 pp -88.47 155.36 19.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.964 0.506 . . . . 73.51 109.796 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -144.31 125.27 14.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.689 -0.486 . . . . 51.52 109.689 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.11 120.2 32.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.112 0.965 . . . . 73.44 110.229 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.438 ' O ' HD23 ' C' ' 60' ' ' LEU . 30.4 t70 -117.32 146.8 43.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.707 1.203 . . . . 54.13 109.27 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.8 m -112.83 118.25 34.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.393 0.677 . . . . 75.3 110.592 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.87 160.29 29.14 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.88 1.272 . . . . 73.3 108.352 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -161.34 154.13 20.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.835 0.854 . . . . 70.32 110.077 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.1 p -147.75 143.45 27.56 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.592 1.157 . . . . 63.43 109.379 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -85.28 136.4 33.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.351 0.66 . . . . 71.52 110.351 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.617 HD11 HD12 ' C' ' 83' ' ' ILE . 85.8 mt -107.24 -39.66 5.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.871 0.868 . . . . 74.54 109.731 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.1 -178.54 7.06 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.587 -1.188 . . . . 73.01 109.752 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -73.33 119.99 18.33 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.678 -1.146 . . . . 73.02 108.462 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 66.22 19.66 11.08 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.81 1.244 . . . . 75.43 111.256 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 48.4 t -135.14 105.79 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 107.314 -1.365 . . . . 62.15 107.314 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.09 166.57 14.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.456 0.703 . . . . 71.33 110.78 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.86 110.71 13.98 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.261 -1.336 . . . . 72.21 108.537 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.44 HG11 ' HD3' ' C' ' 103' ' ' PRO . 59.9 t -96.08 136.1 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.435 -1.32 . . . . 72.5 107.435 174.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.8 t -128.41 107.01 15.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.096 0.959 . . . . 74.35 108.92 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.492 HD12 ' O ' ' C' ' 103' ' ' PRO . 0.4 OUTLIER -87.35 108.09 18.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.951 -1.129 . . . . 72.31 107.951 176.23 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -89.64 104.94 17.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.121 -0.696 . . . . 71.54 109.121 173.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.25 -1.019 . . . . 72.11 108.25 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -103.39 121.91 43.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.161 0.584 . . . . 72.43 109.503 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.744 HG21 HG21 ' C' ' 114' ' ' ILE . 88.5 t -102.34 136.44 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.762 1.225 . . . . 72.43 109.984 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 54.8 m -122.79 140.42 52.93 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.819 0.848 . . . . 74.25 109.044 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 117.87 17.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.036 -1.098 . . . . 64.34 108.036 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -135.0 131.78 37.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.481 0.658 . . . . 75.15 110.76 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.768 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.3 mt -89.61 41.97 1.07 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.423 1.889 . . . . 71.01 109.479 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.26 -109.11 3.29 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.529 -1.028 . . . . 73.3 110.529 -169.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -91.83 -31.4 15.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.622 0.769 . . . . 75.44 110.584 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -75.53 119.43 19.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.683 1.193 . . . . 61.35 109.074 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -75.79 124.96 28.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.772 -0.455 . . . . 71.11 109.772 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.6 -51.99 13.01 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.078 -0.712 . . . . 55.04 109.078 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -166.69 174.87 8.32 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 115.174 -0.921 . . . . 63.11 110.351 173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.6 tm? -133.14 146.79 51.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.329 -1.73 . . . . 62.24 106.329 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.583 ' SG ' HG23 ' C' ' 114' ' ' ILE . 44.7 t -145.53 146.4 31.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.447 -0.946 . . . . 53.2 108.447 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.28 130.32 6.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.072 0.396 . . . . 72.24 110.698 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.87 134.55 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.232 1.013 . . . . 62.43 109.236 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.679 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.6 mt-30 -107.18 97.73 7.46 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.648 1.179 . . . . 70.52 108.361 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 61.6 tp60 -82.71 101.24 10.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.526 -0.761 . . . . 74.44 109.027 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.02 145.38 20.67 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.948 -0.861 . . . . 64.13 110.948 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.26 122.65 1.54 Allowed Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.508 -1.037 . . . . 54.44 110.508 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.617 HD12 HD11 ' C' ' 51' ' ' LEU . 7.7 mm -84.02 128.15 39.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.246 -1.02 . . . . 75.14 108.246 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -134.69 120.92 20.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.653 0.781 . . . . 72.42 109.412 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -78.85 116.74 19.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.631 -1.248 . . . . 65.03 107.631 168.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.573 HG12 HD12 ' C' ' 89' ' ' ILE . 1.5 tt -133.58 114.46 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 C-N-CA 123.937 0.895 . . . . 65.12 109.743 -170.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.23 41.88 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.582 0.753 . . . . 54.12 110.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.7 -19.02 35.28 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 114.217 0.447 . . . . 63.25 114.217 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.573 HD12 HG12 ' C' ' 86' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 125.053 1.341 . . . . 65.13 111.283 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 119.273 -0.394 . . . . 61.21 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.3 ptp -71.38 -32.8 68.9 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.776 0.262 . . . . 54.2 110.652 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.9 94.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.933 0.893 . . . . 54.31 111.705 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -83.4 -30.92 26.98 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.046 -0.525 . . . . 62.5 111.031 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.16 -58.16 8.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.424 0.289 . . . . 63.45 110.575 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -82.31 -38.39 24.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.784 0.434 . . . . 75.14 110.517 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.74 10.23 75.07 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.001 -0.888 . . . . 71.14 115.029 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.92 -49.03 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.365 1.083 . . . . 60.2 112.452 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.401 ' O ' HG12 ' C' ' 105' ' ' ILE . 82.5 t80 -76.14 -49.26 17.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.314 0.646 . . . . 72.52 111.079 -171.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 99.4 m -59.35 -48.03 96.87 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.218 -0.896 . . . . 52.23 111.639 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.492 ' O ' HD12 ' C' ' 60' ' ' LEU . 39.5 Cg_endo -66.75 -27.29 44.68 Favored 'Trans proline' 0 C--N 1.399 3.234 0 C-N-CA 121.487 1.458 . . . . 73.31 112.781 172.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.91 -35.58 81.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.224 0.465 . . . . 54.21 110.974 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.471 HD12 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -65.01 -36.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.507 0.723 . . . . 74.04 110.092 174.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.6 mt -85.47 -19.68 30.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.165 0.986 . . . . 64.32 112.455 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.9 -53.0 70.32 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.256 -1.354 . . . . 62.13 112.68 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.85 -33.85 97.52 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 121.94 1.76 . . . . 72.44 112.273 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.446 ' HE2' HG21 ' A' ' 115' ' ' THR . 89.6 m-85 -67.81 -50.48 56.6 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.005 0.922 . . . . 73.24 111.187 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -62.3 -41.4 98.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 64.35 110.392 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -57.76 -48.13 80.51 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.988 1.715 . . . . 73.1 110.902 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -74.89 -33.06 61.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.249 0.62 . . . . 73.21 110.581 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.1 t -63.85 -33.78 76.46 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.322 0.649 . . . . 63.05 110.824 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.744 HG21 HG21 ' C' ' 64' ' ' VAL . 96.8 mt -75.98 -46.35 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.096 -0.957 . . . . 73.33 110.507 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -55.92 -35.99 67.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.524 0.73 . . . . 62.33 110.851 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 44.6 t -60.62 -57.56 12.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.26 -1.336 . . . . 75.23 109.89 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.546 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.62 -39.39 70.76 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.907 1.283 . . . . 60.44 113.538 -177.482 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' C' ' 123' ' ' PHE . 77.5 t -68.33 -44.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.09 0.956 . . . . 62.13 110.439 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.406 ' HB2' HG21 ' B' ' 115' ' ' THR . 40.3 t -63.03 -34.99 78.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.272 -0.876 . . . . 73.01 111.086 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.546 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 67.0 mtt-85 -64.83 -45.13 87.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.07 -0.968 . . . . 74.21 109.925 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.47 69.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.402 -0.817 . . . . 63.23 113.447 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 65.91 34.46 7.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.867 1.667 . . . . 55.25 113.23 170.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.517 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 87.1 m-85 -97.9 169.98 7.75 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 124.417 1.087 . . . . 62.13 109.802 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.533 ' HA ' HE21 ' B' ' 125' ' ' GLN . 72.1 Cg_endo -70.71 175.32 9.05 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.6 2.2 . . . . 73.42 112.803 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -60.23 130.64 47.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.859 0.464 . . . . 63.3 112.121 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.623 HD11 ' HB ' ' C' ' 40' ' ' VAL . 1.5 mm? -122.81 18.48 10.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.42 1.088 . . . . 72.43 110.857 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -90.44 81.15 6.0 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.001 -1.481 . . . . 63.25 107.001 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.71 101.71 14.11 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.196 -1.366 . . . . 71.2 111.088 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . 54.03 175.63 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 115.399 1.629 . . . . 74.22 115.399 162.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -91.58 -172.33 0.44 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.449 2.099 . . . . 72.23 113.334 165.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.48 122.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.765 0.826 . . . . 63.13 109.81 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -114.9 102.78 10.29 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.937 0.895 . . . . 72.14 109.276 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 t80 . . . . . 0 N--CA 1.479 1.023 0 C-N-CA 122.819 0.448 . . . . 74.42 111.77 177.587 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 C--O 1.24 0.567 0 N-CA-C 109.783 -0.451 . . . . 63.52 109.783 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' D' ' 85' ' ' SER . 73.5 t80 -156.73 93.06 1.34 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.968 1.307 . . . . 64.21 107.651 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.82 146.75 45.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.811 -0.631 . . . . 74.54 110.149 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.419 HG21 ' HG2' ' B' ' 130' ' ' PRO . 2.2 mp -83.12 125.83 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 71.31 108.688 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.0 -46.42 4.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.059 0.544 . . . . 75.11 111.403 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -166.45 122.44 1.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.919 -0.562 . . . . 42.45 110.938 -169.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.27 124.1 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.627 -1.249 . . . . 74.22 107.627 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -158.98 152.77 23.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 73.12 111.895 -168.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -86.49 117.8 25.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.162 -0.926 . . . . 61.13 109.087 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -88.67 -23.28 23.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.759 -0.655 . . . . 60.51 110.183 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.5 t70 -158.53 133.92 8.69 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.258 -0.883 . . . . 62.12 109.416 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.53 HD13 ' HE3' ' C' ' 117' ' ' MET . 76.7 mt -137.61 143.68 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.347 1.059 . . . . 60.44 108.386 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -142.12 143.96 33.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.958 1.303 . . . . 74.53 108.023 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.9 t80 -151.49 110.82 3.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.511 -2.033 . . . . 64.41 105.511 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -128.12 108.22 10.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.164 -0.68 . . . . 73.31 109.164 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.46 91.15 4.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 106.896 -1.52 . . . . 73.43 106.896 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 -24.96 11.95 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.426 2.084 . . . . 51.21 112.24 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -112.7 36.03 3.62 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 124.186 0.994 . . . . 72.23 108.419 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.569 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -59.96 -50.18 87.69 Favored Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.974 1.472 . . . . 44.12 114.974 -166.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.401 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.8 Cg_endo -83.98 -4.84 10.52 Favored 'Trans proline' 0 C--N 1.392 2.854 0 CA-C-N 121.803 1.68 . . . . 75.14 113.076 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.52 -37.04 23.58 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.288 1.035 . . . . 72.35 109.231 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' D' ' 73' ' ' ALA . 33.1 m -83.63 -4.24 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.864 0.865 . . . . 63.45 111.534 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.94 -25.73 67.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.671 0.788 . . . . 70.34 109.965 165.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -83.19 0.07 47.03 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.135 0.974 . . . . 52.43 111.447 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -116.94 86.23 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.536 1.134 . . . . 72.23 109.641 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.81 51.53 2.17 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.805 0.812 . . . . 64.41 110.186 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -130.15 -175.95 3.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.934 0.894 . . . . 73.05 109.222 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -79.68 116.88 64.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 122.968 0.507 . . . . 65.11 110.293 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -67.52 87.92 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.999 1.799 . . . . 74.23 109.375 169.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.88 120.66 14.53 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.539 -0.755 . . . . 61.24 110.548 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.659 HG13 HG13 ' D' ' 64' ' ' VAL . 84.8 t -95.83 117.65 40.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 114.991 -1.004 . . . . 73.54 110.291 -167.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.3 mmtt -89.58 115.2 26.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.712 -1.218 . . . . 74.31 107.712 171.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.51 124.53 37.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.218 -1.03 . . . . 73.14 108.218 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.8 t70 -116.59 125.39 51.76 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.388 -0.967 . . . . 53.2 108.388 174.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.61 132.3 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.749 0.82 . . . . 75.32 109.744 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.0 t70 -143.04 118.31 10.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.252 -1.388 . . . . 63.14 107.252 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -120.02 145.02 47.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.046 0.538 . . . . 63.1 110.27 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.29 43.94 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.17 0.988 . . . . 72.11 109.087 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -147.65 156.06 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.778 0.831 . . . . 65.23 109.521 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 63.4 p -151.77 127.27 10.04 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.329 0.651 . . . . 60.25 109.985 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -69.49 119.58 13.96 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.666 -0.494 . . . . 72.25 109.666 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' D' ' 57' ' ' GLU . 52.7 mt -92.35 -34.02 14.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.009 0.523 . . . . 75.33 110.348 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.84 -171.68 3.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.152 0.981 . . . . 75.22 109.856 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.12 109.59 1.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.036 0.534 . . . . 62.23 109.837 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.85 11.16 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.067 1.347 . . . . 73.12 113.193 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.89 133.27 58.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.386 . . . . 51.25 107.259 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.66 174.35 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.322 0.582 . . . . 71.14 109.822 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.8 tt0 -124.86 147.83 48.57 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 124.251 1.02 . . . . 72.44 108.511 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -120.15 125.57 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.521 -1.289 . . . . 73.15 107.521 167.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.423 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 82.4 t -103.54 126.81 57.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.019 0.928 . . . . 64.35 108.691 174.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.2 122.08 46.79 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.712 -1.218 . . . . 74.43 107.712 178.288 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.8 ttm-85 -109.47 99.97 9.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.298 -1.001 . . . . 53.2 108.298 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.08 126.68 44.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.19 -1.411 . . . . 33.41 107.19 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.0 m -120.44 127.22 52.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.585 0.707 . . . . 63.21 110.351 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.659 HG13 HG13 ' D' ' 40' ' ' VAL . 17.3 t -112.43 107.29 22.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 126.151 1.78 . . . . 75.2 109.144 -175.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 22.6 m -107.6 93.07 4.34 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.7 -1.222 . . . . 61.21 107.7 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.5 137.59 34.34 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.151 -0.685 . . . . 64.24 109.151 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.514 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 43.4 m -137.68 134.4 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 70.5 111.48 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.491 HD12 ' HB ' ' D' ' 31' ' ' VAL . 21.7 mt -108.08 107.05 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.004 1.322 . . . . 75.21 110.397 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.55 -112.29 3.67 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.936 -0.466 . . . . 74.12 111.936 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.86 6.3 17.87 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.089 0.955 . . . . 74.12 111.002 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -124.17 168.32 13.07 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.659 0.784 . . . . 64.11 110.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -81.31 126.6 31.77 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.312 0.645 . . . . 74.11 110.283 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG11 ' D' ' 31' ' ' VAL . . . -78.05 -67.17 0.76 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.783 0.833 . . . . 53.31 109.243 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.08 153.68 32.31 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 115.169 -0.923 . . . . 74.41 110.117 173.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.5 mt -109.66 152.75 25.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.623 -1.251 . . . . 61.42 107.623 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.571 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 42.0 t -158.9 146.73 17.86 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.528 0.731 . . . . 70.14 109.095 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -156.1 128.95 7.9 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.302 -0.629 . . . . 71.32 109.302 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.78 115.58 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.03 0.532 . . . . 64.45 109.708 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.537 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.9 mt-30 -90.36 89.1 7.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.571 0.749 . . . . 74.24 109.817 170.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -81.31 100.39 9.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.684 -1.144 . . . . 75.04 108.838 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -95.6 144.62 17.35 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.491 -0.644 . . . . 63.32 111.491 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.82 130.52 3.93 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.317 -0.713 . . . . 62.31 111.317 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.6 mt -89.73 124.86 42.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 124.249 1.02 . . . . 72.43 109.011 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.91 168.77 16.76 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.047 1.339 . . . . 71.44 108.973 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.6 m -114.07 137.0 52.31 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.765 0.826 . . . . 73.24 109.637 171.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.44 125.44 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.296 0.638 . . . . 60.24 109.939 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.32 164.64 27.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.343 0.657 . . . . 71.21 110.602 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.04 -20.63 19.63 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 123.837 0.71 . . . . 73.42 114.788 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.49 163.3 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.993 0.917 . . . . 65.33 110.555 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -143.95 -176.12 4.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.08 0.952 . . . . 72.02 110.414 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.33 -133.54 20.05 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.347 -0.842 . . . . 74.2 113.565 171.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.1 m -59.3 -39.7 83.87 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.463 1.105 . . . . 70.33 111.812 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -58.62 -45.29 89.51 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.038 0.935 . . . . 73.11 111.604 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 3.4 ppp? -81.64 -39.26 24.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.547 0.339 . . . . 61.53 111.513 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.471 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.5 -40.3 92.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 73.52 111.272 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -78.96 -26.37 43.48 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.288 -0.869 . . . . 73.13 110.735 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.3 t -68.73 -52.5 30.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.437 0.295 . . . . 41.44 110.861 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' D' ' 94' ' ' MET . 1.7 pp -76.82 -18.34 58.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.096 0.406 . . . . 70.3 112.096 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.16 0.03 68.49 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.241 -0.755 . . . . 44.03 113.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.53 -61.56 0.17 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.081 0.94 . . . . 74.32 112.421 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -67.05 -48.88 66.95 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.533 0.733 . . . . 75.52 112.631 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 23.4 m -66.05 -42.7 53.19 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.384 0.674 . . . . 73.22 112.264 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 49.4 Cg_exo -59.15 -35.62 97.39 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.168 1.912 . . . . 70.41 112.762 166.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.85 -28.69 69.17 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.126 0.571 . . . . 73.02 111.356 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -65.97 -40.96 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.231 0.612 . . . . 75.53 110.011 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.431 HD21 ' HA3' ' D' ' 82' ' ' GLY . 77.1 mt -75.57 -23.01 56.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.021 -0.99 . . . . 73.14 111.762 -174.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -64.14 -40.9 57.5 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 117.495 -1.241 . . . . 70.44 113.904 -171.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.46 -41.9 42.85 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.224 1.949 . . . . 74.1 113.719 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.2 m-85 -78.09 -38.69 43.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.749 0.82 . . . . 73.14 111.422 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.04 95.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.152 0.581 . . . . 73.02 109.913 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -57.14 -56.82 16.81 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 124.875 1.27 . . . . 72.54 109.732 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.11 -39.62 90.67 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.325 1.016 . . . . 70.53 111.837 -172.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -45.36 88.35 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.743 0.652 . . . . 74.01 110.408 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.553 HG21 HG21 ' D' ' 64' ' ' VAL . 84.2 mt -64.51 -53.66 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.124 0.97 . . . . 50.44 110.155 174.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.0 m -52.4 -41.18 62.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.99 1.716 . . . . 71.11 111.546 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -69.7 -44.9 69.46 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.685 -1.143 . . . . 61.21 110.105 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.72 -30.21 70.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.963 0.505 . . . . 72.15 112.007 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.5 t -65.57 -47.37 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.805 0.842 . . . . 73.53 109.75 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -72.18 -29.08 63.66 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.047 -0.524 . . . . 44.51 110.744 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -70.18 -30.91 68.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.651 0.78 . . . . 55.24 110.166 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 10.46 63.99 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 115.788 -0.642 . . . . 51.44 112.797 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.535 HG23 ' HB3' ' C' ' 17' ' ' TYR . 40.7 p 64.01 18.53 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.663 1.985 . . . . 74.11 113.841 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 88.0 m-85 -88.28 164.71 31.93 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.036 0.934 . . . . 74.25 108.875 171.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.42 140.89 71.89 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.707 2.271 . . . . 72.21 111.012 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.5 118.18 7.2 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 109.521 -0.548 . . . . 72.43 109.521 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.3 101.76 11.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.377 0.671 . . . . 64.23 109.689 -171.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -98.8 96.12 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.508 -0.923 . . . . 63.25 108.508 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 129.63 40.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.939 0.896 . . . . 74.23 110.758 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -57.44 132.07 81.57 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.717 0.807 . . . . 75.23 111.121 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.44 114.25 3.87 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 121.962 1.775 . . . . 70.32 110.656 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.8 t -106.03 107.09 21.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.033 -1.099 . . . . 65.35 108.033 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 107.722 -1.214 . . . . 74.53 107.722 177.014 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.3 m . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.638 -0.875 . . . . 55.42 108.638 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.2 t80 -109.2 149.99 28.58 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.748 -0.834 . . . . 72.12 108.748 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 51.0 tp60 -148.68 114.77 5.79 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.289 -0.263 . . . . 75.25 110.289 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.45 HD11 HG13 ' A' ' 16' ' ' ILE . 2.3 tp -72.1 90.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.907 -1.516 . . . . 74.22 106.907 164.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -82.98 -22.69 33.61 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.698 -1.137 . . . . 73.53 110.611 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -176.88 145.23 0.49 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.07 0.395 . . . . 72.44 111.297 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.3 mt -106.12 139.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.606 -1.627 . . . . 73.22 106.606 162.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.0 p90 -169.03 135.9 1.8 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.951 0.9 . . . . 63.52 109.712 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.7 p -77.71 118.02 19.67 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.141 -0.482 . . . . 61.4 109.799 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -84.15 -27.05 28.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.764 -0.653 . . . . 75.21 110.114 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -151.8 138.0 18.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.026 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.9 mt -132.69 139.23 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.981 -1.489 . . . . 75.1 106.981 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -152.34 110.53 3.7 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.076 0.465 . . . . 75.53 110.501 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 72.6 t80 -109.71 120.49 42.64 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 106.397 -1.705 . . . . 73.44 106.397 169.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -119.14 130.71 55.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.36 -0.978 . . . . 50.22 108.36 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.65 19.49 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.529 -1.286 . . . . 65.1 107.529 172.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.31 -15.94 28.12 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.648 2.232 . . . . 62.41 112.129 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -113.44 28.49 8.74 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 124.188 0.995 . . . . 73.34 109.544 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -58.41 -45.68 99.67 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 113.962 1.097 . . . . 61.45 113.962 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.79 -32.75 8.85 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 121.538 1.492 . . . . 55.04 112.333 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -74.27 -20.36 60.17 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.75 1.22 . . . . 75.41 111.678 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 28' ' ' ALA . 5.2 p -75.32 -20.53 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.366 0.666 . . . . 75.02 112.097 -170.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.65 -29.85 65.08 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.019 -0.537 . . . . 71.44 110.224 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -71.14 -28.83 64.57 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.148 0.979 . . . . 71.4 110.72 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -72.98 142.65 47.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 73.23 111.484 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -73.08 115.31 12.25 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.489 -1.301 . . . . 71.42 107.489 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -84.43 96.48 9.1 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.431 0.634 . . . . 74.55 110.867 -170.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -137.25 80.0 35.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 106.515 -1.661 . . . . 62.24 106.515 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.31 148.54 16.63 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.393 2.062 . . . . 73.3 112.544 -170.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.37 92.82 5.87 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.25 -1.389 . . . . 75.31 107.25 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -65.32 124.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.062 -0.972 . . . . 72.55 109.207 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -124.06 117.62 25.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.778 0.831 . . . . 74.43 109.321 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.4 tp -97.21 129.38 44.56 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.753 -0.832 . . . . 72.23 108.753 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.755 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.7 m-20 -115.19 134.35 55.23 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.273 1.029 . . . . 73.1 108.567 172.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -113.3 125.23 54.06 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.755 0.822 . . . . 74.01 109.246 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.27 145.52 37.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.334 0.653 . . . . 51.03 109.596 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.3 m -135.63 133.11 37.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 75.14 109.313 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 117.04 17.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.213 1.005 . . . . 40.32 109.439 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.3 p -118.47 153.27 34.42 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.46 0.704 . . . . 74.44 111.964 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -168.02 153.1 6.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.786 1.234 . . . . 73.53 109.523 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.4 138.6 32.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.887 -0.412 . . . . 70.25 109.887 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 55' ' ' VAL . 98.1 mt -107.5 -39.56 5.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.851 0.86 . . . . 75.41 111.134 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.95 -170.7 3.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.268 0.627 . . . . 64.3 110.305 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.96 113.18 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.248 1.019 . . . . 75.43 110.444 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 66.87 -4.29 0.81 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.488 1.515 . . . . 53.5 113.571 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 72.6 t -97.59 117.45 42.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.087 0.955 . . . . 65.25 108.439 -172.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -119.66 168.76 10.73 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.117 0.967 . . . . 70.11 109.367 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.9 tt0 -130.67 130.84 44.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.541 -1.209 . . . . 62.54 108.459 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 111.94 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.477 -1.675 . . . . 65.32 106.477 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.2 t -98.35 131.57 45.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.898 -0.778 . . . . 62.14 108.898 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -101.28 108.57 20.25 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.073 -1.454 . . . . 73.15 107.073 177.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.02 101.47 12.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.356 -0.979 . . . . 74.3 108.356 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' HB1' ' A' ' 110' ' ' ALA . 9.9 t -98.62 145.06 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.677 -1.147 . . . . 71.15 108.286 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 42.5 m -133.11 137.52 46.34 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.735 -0.469 . . . . 72.15 109.735 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.12 107.74 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.675 1.19 . . . . 75.23 107.998 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 24.6 m -103.13 138.48 39.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.777 -0.823 . . . . 71.44 108.777 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.09 102.81 9.32 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.603 -1.629 . . . . 55.25 106.603 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 52.5 m -108.45 124.0 49.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.339 0.59 . . . . 74.14 109.677 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 73' ' ' ALA . 14.7 mt -90.02 80.46 6.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.105 -1.443 . . . . 75.42 107.105 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -89.27 0.84 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.177 -0.919 . . . . 63.2 111.442 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -114.8 -26.39 7.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.451 0.7 . . . . 73.31 110.759 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -99.58 124.48 44.82 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.976 -0.379 . . . . 65.0 109.976 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 74.6 m -76.4 137.7 39.91 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.406 0.682 . . . . 43.25 111.437 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -78.87 -62.56 1.66 Allowed 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.815 1.246 . . . . 70.25 109.615 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -144.04 151.68 39.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.442 -1.254 . . . . 64.53 109.61 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.8 tp -126.09 115.56 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.038 1.335 . . . . 72.51 108.409 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.1 m -103.99 139.33 39.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.792 0.837 . . . . 63.33 108.94 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -145.1 133.21 21.47 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.887 -1.524 . . . . 74.13 106.887 167.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -135.71 120.92 28.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.781 -0.822 . . . . 61.02 108.781 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.34 79.5 5.0 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.745 -1.205 . . . . 62.21 107.745 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 106' ' ' LEU . 7.0 tp-100 -76.65 93.93 3.7 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 106.917 -1.512 . . . . 73.35 106.917 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.07 160.07 19.39 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.746 -0.264 . . . . 72.51 113.0 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.59 138.86 6.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 112.197 -0.361 . . . . 44.52 112.197 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.561 HG13 ' HE1' ' A' ' 17' ' ' TYR . 74.8 mt -81.76 125.47 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.892 -1.151 . . . . 73.42 107.892 169.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 57.3 m-85 -131.26 117.84 19.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.897 -1.149 . . . . 63.4 107.897 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 18.9 m -81.37 114.34 20.07 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.171 -1.048 . . . . 64.24 108.171 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.7 140.12 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.403 0.681 . . . . 72.23 110.971 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -178.75 168.53 1.69 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.679 1.592 . . . . 60.44 108.924 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.08 -27.51 7.02 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-N 116.161 -0.472 . . . . 73.41 112.889 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.54 179.85 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.907 1.283 . . . . 71.11 110.114 -170.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.63 174.12 15.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.012 0.525 . . . . 73.34 110.068 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.91 -128.12 28.55 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.819 -0.628 . . . . 62.42 113.753 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 p -67.5 -29.82 69.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.263 1.025 . . . . 64.22 111.516 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.65 -36.64 70.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.608 0.568 . . . . 62.43 110.934 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.2 ttt -74.1 -37.31 64.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.003 -0.369 . . . . 62.03 110.003 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.21 68.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.007 0.523 . . . . 40.15 111.016 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -74.92 -52.19 11.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.667 0.787 . . . . 74.45 110.282 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.1 t -65.21 -62.19 1.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.957 0.785 . . . . 53.54 110.553 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -65.66 -38.77 90.27 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.971 0.908 . . . . 63.13 111.957 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.78 -28.52 38.14 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 115.238 0.855 . . . . 51.35 115.238 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 -40.61 0.6 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.165 0.983 . . . . 24.11 112.423 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 56.1 t80 -74.89 -39.44 61.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.582 0.753 . . . . 62.13 112.296 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -79.58 -39.8 1.37 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 123.235 0.614 . . . . 74.24 111.752 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 53.1 Cg_exo -54.91 -30.15 67.36 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.372 2.048 . . . . 65.12 112.98 164.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.81 -24.26 66.15 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.755 0.822 . . . . 62.32 111.553 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 13' ' ' ILE . 47.3 mm -67.55 -42.5 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.913 0.864 . . . . 73.3 109.757 172.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 80' ' ' GLN . 44.3 mt -86.99 -15.98 37.13 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.272 -1.331 . . . . 71.13 112.25 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.36 -41.31 17.15 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-O 118.054 -0.974 . . . . 74.33 113.418 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.78 -35.28 80.02 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.81 1.673 . . . . 71.05 112.007 171.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.467 ' CE1' ' HD3' ' C' ' 111' ' ' ARG . 41.6 m-85 -77.0 -29.68 55.57 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.641 0.776 . . . . 72.51 112.213 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -72.36 -47.02 52.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.786 -0.82 . . . . 74.11 108.786 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.0 ttm180 -49.51 -50.13 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.048 1.467 . . . . 53.15 110.561 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.66 -40.47 73.0 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.36 1.038 . . . . 73.14 111.596 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.582 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.5 t -62.83 -41.83 99.49 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.483 0.489 . . . . 54.1 110.598 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.3 mt -65.97 -51.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.259 -0.882 . . . . 65.22 109.658 174.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.1 m -55.36 -39.75 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.077 0.951 . . . . 74.22 111.259 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.1 t -66.73 -45.22 79.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 123.776 0.673 . . . . 73.15 110.342 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 34.1 mtm -63.13 -40.32 97.24 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.73 0.412 . . . . 70.21 111.146 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.7 t -61.1 -50.29 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.499 1.12 . . . . 72.35 110.149 177.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 94.8 p -70.98 -25.92 62.91 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.796 -0.638 . . . . 71.24 111.633 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 116' ' ' SER . 37.7 ttm-85 -79.04 -28.9 43.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.35 1.06 . . . . 74.55 109.461 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.21 9.77 56.38 Favored Glycine 0 C--N 1.356 1.672 0 CA-C-N 115.196 -0.911 . . . . 61.3 112.825 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.448 HG22 ' NH2' ' B' ' 15' ' ' ARG . 31.1 m 69.22 33.65 3.22 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 123.476 1.607 . . . . 60.22 111.122 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 119' ' ' SER . 75.7 m-85 -101.89 158.2 32.23 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 113.994 -1.457 . . . . 74.33 107.135 161.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.84 -174.1 0.56 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.974 1.783 . . . . 72.25 112.004 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -76.01 141.59 42.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.893 0.477 . . . . 75.43 112.135 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.08 94.13 3.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.455 -1.313 . . . . 63.34 107.455 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.11 110.86 22.63 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.331 0.652 . . . . 74.21 110.242 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.4 mt -74.15 145.37 44.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.378 -0.828 . . . . 75.14 110.949 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.12 146.39 98.98 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.096 0.559 . . . . 73.43 111.396 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.48 141.0 45.12 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.284 1.989 . . . . 73.15 111.721 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.23 108.74 22.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 108.457 -0.942 . . . . 74.02 108.457 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -109.18 74.75 0.92 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 72.31 109.06 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 115.667 -0.697 . . . . 71.24 110.641 177.263 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.245 0.841 0 N-CA-C 109.201 -0.666 . . . . 63.24 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -148.75 125.21 10.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.407 -1.331 . . . . 74.1 107.407 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -144.96 140.76 28.45 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.312 -0.625 . . . . 71.52 109.312 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.531 HD11 HG13 ' B' ' 16' ' ' ILE . 10.8 tt -90.75 144.07 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.521 0.728 . . . . 72.42 109.459 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.66 -44.59 3.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.959 0.504 . . . . 74.4 109.772 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.448 ' NH2' HG22 ' A' ' 122' ' ' THR . 19.7 ttt180 -169.6 146.22 3.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.3 0.24 . . . . 74.51 110.76 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.531 HG13 HD11 ' B' ' 13' ' ' ILE . 94.2 mt -120.42 144.49 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.378 -1.342 . . . . 61.41 107.378 173.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -169.37 158.98 8.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.69 0.677 . . . . 74.13 112.176 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.8 m -83.54 127.67 33.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.191 -0.913 . . . . 53.55 108.835 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -96.37 -36.62 10.79 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.666 0.786 . . . . 72.42 110.885 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -161.74 145.3 12.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.352 -0.385 . . . . 73.21 110.375 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.411 HD11 ' SG ' ' B' ' 113' ' ' CYS . 37.3 mm -137.2 138.93 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.682 1.193 . . . . 72.5 109.8 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 74.0 m -134.81 125.52 27.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.144 1.378 . . . . 74.43 108.492 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -142.78 108.2 5.04 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.54 -1.282 . . . . 75.11 107.54 167.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -119.2 122.99 43.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 45.2 108.462 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.11 89.43 14.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.991 0.917 . . . . 61.2 109.278 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.3 -32.04 73.11 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.194 2.596 . . . . 72.21 113.136 -172.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -117.96 32.09 6.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.911 0.884 . . . . 34.42 110.122 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.55 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -45.91 -54.76 15.16 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 125.646 1.578 . . . . 41.21 113.829 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.2 Cg_exo -68.77 -24.36 34.63 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 122.511 2.141 . . . . 74.32 112.881 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -89.19 1.79 55.15 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.777 -1.101 . . . . 63.52 111.786 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.31 -23.88 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.927 0.491 . . . . 52.13 110.462 170.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -63.62 -38.85 92.69 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.543 0.737 . . . . 74.53 110.416 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -82.88 -41.75 18.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.927 0.891 . . . . 74.32 110.296 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -85.38 70.66 10.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.686 1.194 . . . . 73.03 109.032 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.53 74.58 9.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.263 1.03 . . . . 61.13 110.798 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -167.08 154.07 8.7 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.235 -1.394 . . . . 75.3 107.235 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.07 127.74 92.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.049 0.54 . . . . 73.34 110.226 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.69 151.79 81.72 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.257 1.972 . . . . 72.23 112.164 167.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 2.8 pt-20 -61.01 102.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.035 -0.984 . . . . 62.42 109.303 169.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.0 t -88.46 116.51 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.896 -1.15 . . . . 72.11 107.896 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -138.96 138.27 37.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.308 0.643 . . . . 72.32 109.275 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.459 ' HG ' HD23 ' B' ' 128' ' ' LEU . 0.8 OUTLIER -118.71 147.35 43.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 74.15 110.14 -168.14 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.26 149.5 52.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.214 1.406 . . . . 75.4 108.054 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.67 135.41 51.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.437 -0.579 . . . . 65.42 109.437 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -136.57 154.19 50.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.158 1.383 . . . . 65.41 108.363 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -132.03 139.94 48.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.986 0.514 . . . . 65.25 110.508 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.7 160.8 37.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 74.24 108.551 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -142.32 162.85 34.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.082 0.553 . . . . 72.25 110.588 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -153.35 168.2 26.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.821 1.248 . . . . 74.25 108.526 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -123.3 130.73 53.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.262 0.625 . . . . 63.01 111.134 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 65.7 mt -97.81 -49.86 4.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.469 0.708 . . . . 70.33 110.183 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.51 -170.89 3.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.501 -0.772 . . . . 71.02 110.387 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -65.71 116.19 6.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.702 -1.136 . . . . 73.33 109.704 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' B' ' 85' ' ' SER . 1.9 m-20 72.62 2.78 4.48 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.817 1.647 . . . . 65.04 111.605 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 95.51 3.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 124.291 1.036 . . . . 64.51 108.33 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.467 ' HB2' HD12 ' B' ' 86' ' ' ILE . 0.1 OUTLIER -94.58 139.02 31.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.842 177.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.45 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.2 tm-20 -103.65 95.99 6.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 106.622 -1.622 . . . . 64.43 106.622 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.29 123.1 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.267 -0.642 . . . . 65.42 109.267 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.6 t -102.31 123.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.568 0.747 . . . . 73.03 109.482 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -93.13 126.67 38.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.259 -1.386 . . . . 52.51 107.259 173.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.409 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 29.3 ttt180 -119.41 104.36 10.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.19 -0.67 . . . . 74.11 109.19 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.5 120.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.571 -0.9 . . . . 61.31 108.571 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -109.39 150.5 27.97 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.065 -0.717 . . . . 63.02 109.065 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.555 HG21 HG21 ' B' ' 114' ' ' ILE . 90.3 t -139.32 122.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.865 0.866 . . . . 73.31 109.279 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 79.8 m -113.76 138.78 49.78 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.638 0.775 . . . . 73.5 109.27 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.3 147.03 28.85 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.887 -1.052 . . . . 70.1 109.071 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 9.2 m -143.77 135.27 26.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.497 0.554 . . . . 61.35 112.497 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 50.0 mt -88.47 101.39 13.87 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.69 -1.596 . . . . 62.22 106.69 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -111.25 3.22 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.053 -0.819 . . . . 52.23 111.053 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.85 4.88 12.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.319 1.048 . . . . 72.0 110.734 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.75 139.07 50.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.578 1.151 . . . . 75.54 108.098 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -61.98 133.49 55.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.11 0.564 . . . . 71.53 112.141 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.95 -61.19 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.5 1.12 . . . . 74.01 109.176 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.02 167.1 28.7 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.456 -1.702 . . . . 71.04 109.618 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.69 118.86 11.35 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.661 1.585 . . . . 72.43 106.726 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -119.4 153.42 35.23 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.436 -0.579 . . . . 72.34 109.436 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.23 134.85 7.6 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.161 -1.052 . . . . 52.43 108.161 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -123.39 143.02 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 123.604 0.762 . . . . 72.22 109.738 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.4 mt-30 -118.15 90.93 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.653 -0.869 . . . . 70.13 108.653 171.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.8 tp-100 -89.88 100.8 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.339 -0.985 . . . . 72.24 108.339 175.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.68 163.69 29.85 Favored Glycine 0 C--O 1.242 0.643 0 N-CA-C 111.75 -0.54 . . . . 71.22 111.75 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.97 130.8 2.84 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.597 -0.601 . . . . 30.22 111.597 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -86.39 116.31 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.725 0.81 . . . . 74.11 109.195 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -133.87 134.59 42.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.212 1.005 . . . . 73.2 109.183 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 41.8 m -95.34 110.86 22.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.768 0.827 . . . . 61.4 110.028 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -118.69 138.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.146 0.978 . . . . 71.14 110.606 -177.161 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.98 167.64 27.47 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.598 0.759 . . . . 44.13 109.744 167.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.25 -41.65 3.01 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 123.549 0.53 . . . . 51.21 113.045 176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.409 ' H ' HG13 ' B' ' 89' ' ' ILE . 2.2 pp -63.42 156.14 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.308 1.043 . . . . 74.52 110.872 169.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.06 154.98 7.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.146 0.578 . . . . 72.1 109.732 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.75 -113.33 5.77 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.25 0.452 . . . . 75.42 113.444 170.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 -36.94 74.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.599 0.76 . . . . 70.42 110.643 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.48 -46.39 86.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.782 0.433 . . . . 61.32 110.731 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ttt -68.47 -40.87 80.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.017 -0.538 . . . . 61.54 110.326 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.65 70.34 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.324 0.649 . . . . 64.3 111.434 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -74.11 -36.33 64.2 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.585 0.754 . . . . 72.11 109.513 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.06 -68.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.791 -0.64 . . . . 61.23 110.446 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.76 -20.32 61.9 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.138 0.421 . . . . 72.42 112.138 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.46 -6.7 52.78 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.144 -0.809 . . . . 72.11 114.528 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.62 -42.54 0.14 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.255 1.028 . . . . 50.53 112.716 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -79.9 -53.04 7.13 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.932 0.333 . . . . 74.04 111.538 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.405 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 61.7 m -57.69 -45.56 99.82 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.648 0.779 . . . . 62.12 110.991 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 79.9 Cg_exo -50.14 -46.93 26.03 Favored 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.512 2.142 . . . . 74.13 113.582 164.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.4 -35.6 70.24 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.624 0.769 . . . . 74.2 112.098 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.459 HG23 ' NH2' ' D' ' 111' ' ' ARG . 82.6 mt -65.13 -49.11 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.637 0.775 . . . . 65.43 110.332 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 80' ' ' GLN . 50.8 mt -78.92 -12.65 60.04 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.684 -1.144 . . . . 73.21 111.966 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.432 ' HZ ' HD12 ' B' ' 128' ' ' LEU . 22.1 t80 -67.77 -46.11 44.59 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.06 1.344 . . . . 70.11 113.451 -166.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.47 -33.67 78.34 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.554 1.503 . . . . 70.1 112.203 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -65.8 -45.2 83.23 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.088 0.555 . . . . 64.13 110.531 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.79 77.79 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.318 0.647 . . . . 71.23 110.912 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -57.57 -53.41 58.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.04 0.936 . . . . 72.02 110.275 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.7 tm-20 -68.0 -29.79 68.89 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.046 0.842 . . . . 53.32 110.387 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 117' ' ' MET . 33.7 t -68.22 -45.63 72.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.158 0.583 . . . . 64.12 111.182 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.555 HG21 HG21 ' B' ' 64' ' ' VAL . 95.0 mt -63.11 -44.25 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 64.13 109.847 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.639 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . 32.6 m -66.34 -23.29 66.33 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.829 -1.078 . . . . 74.43 111.534 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.2 t -75.59 -40.87 55.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 72.1 110.627 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.4 mmt -79.29 -38.46 35.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.849 0.685 . . . . 74.3 112.849 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.798 ' HB ' ' HG3' ' B' ' 125' ' ' GLN . 95.5 t -75.62 -27.14 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.326 0.65 . . . . 52.12 110.77 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.451 ' HB3' HG21 ' C' ' 115' ' ' THR . 91.9 p -66.72 -37.67 85.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.027 0.441 . . . . 63.33 110.248 174.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.582 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 60.5 mtt-85 -63.57 -40.3 96.62 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.147 -0.933 . . . . 65.41 110.508 175.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.94 80.93 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.716 0.635 . . . . 45.43 113.199 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p 62.38 33.45 16.32 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.548 1.939 . . . . 61.33 112.874 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.37 -177.17 0.58 Allowed Pre-proline 0 CA--C 1.568 1.635 0 CA-C-N 114.284 -1.325 . . . . 70.14 109.024 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.542 ' HB2' HG21 ' B' ' 40' ' ' VAL . 3.9 Cg_exo -81.87 116.72 2.86 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.853 2.369 . . . . 73.15 112.964 169.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.798 ' HG3' ' HB ' ' B' ' 118' ' ' VAL . 0.5 OUTLIER -72.02 164.01 26.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.908 0.883 . . . . 71.22 111.324 164.369 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.436 ' HB3' HD21 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -137.26 127.16 25.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.205 -1.035 . . . . 62.3 108.205 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -91.71 102.81 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.816 -1.179 . . . . 73.31 107.816 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.459 HD23 ' HG ' ' B' ' 42' ' ' LEU . 0.3 OUTLIER -66.08 139.34 58.17 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 110.361 -0.237 . . . . 54.55 110.361 -170.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.66 148.23 98.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.768 0.827 . . . . 70.2 111.118 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.405 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 93.4 Cg_endo -74.33 97.07 1.0 Allowed 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.22 1.946 . . . . 65.25 111.239 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.91 110.95 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.263 -0.643 . . . . 71.54 109.263 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -72.68 97.07 2.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.23 0.612 . . . . 74.01 109.452 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.636 0.774 . . . . 70.43 112.17 -175.728 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.236 0.356 0 N-CA-C 109.596 -0.52 . . . . 75.31 109.596 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.532 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 48.4 t80 -92.84 119.76 32.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.676 -1.231 . . . . 72.41 107.676 169.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -137.1 117.95 14.15 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 109.255 -0.646 . . . . 73.31 109.255 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.412 HD11 HG13 ' C' ' 16' ' ' ILE . 6.5 tp -70.53 131.44 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 109.437 -0.579 . . . . 72.41 109.437 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.501 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.1 mm100 -96.15 -48.69 5.55 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.37 -0.832 . . . . 74.24 108.989 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.467 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 61.9 ttt180 -176.37 133.95 0.24 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.387 -0.824 . . . . 72.03 109.787 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.412 HG13 HD11 ' C' ' 13' ' ' ILE . 80.9 mt -108.64 150.32 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.767 -1.197 . . . . 75.32 107.767 170.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.516 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 28.9 p90 -179.62 154.29 0.6 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.74 . . . . 74.2 109.471 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.437 HG21 HD11 ' C' ' 21' ' ' ILE . 75.2 p -74.87 118.4 17.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.763 -0.828 . . . . 52.24 108.763 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.59 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -69.92 -43.3 71.96 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.315 -0.994 . . . . 61.25 108.315 176.085 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.6 t70 -154.02 138.89 17.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.425 -1.716 . . . . 75.04 108.928 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.437 HD11 HG21 ' C' ' 18' ' ' THR . 97.8 mt -129.3 145.72 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.714 -1.217 . . . . 64.11 107.714 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -153.23 150.06 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.527 0.679 . . . . 70.32 110.0 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -143.91 127.19 16.71 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.815 -1.55 . . . . 73.4 106.815 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 48.5 mt-10 -116.47 125.12 51.52 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.118 -0.697 . . . . 61.43 109.118 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.68 74.91 38.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.626 1.17 . . . . 74.12 108.189 171.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.98 -28.57 49.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.306 2.004 . . . . 74.45 110.452 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 93.1 m-20 -97.9 24.83 6.51 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.768 -1.106 . . . . 74.41 111.094 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HA ' ' HZ ' ' C' ' 123' ' ' PHE . . . -57.09 -48.28 97.68 Favored Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.454 0.701 . . . . 64.2 111.74 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' C' ' 32' ' ' PHE . 56.4 Cg_endo -86.82 -25.46 1.16 Allowed 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.164 1.909 . . . . 75.41 113.27 168.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.427 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 83.0 t60 -70.01 -23.39 63.12 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.64 0.776 . . . . 74.43 112.627 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.616 HG11 ' HE1' ' C' ' 123' ' ' PHE . 9.9 p -78.03 1.3 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 124.278 1.031 . . . . 74.04 112.189 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' C' ' 29' ' ' PRO . 36.5 t80 -49.34 -43.45 43.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.72 1.608 . . . . 72.14 113.913 -171.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -128.65 48.81 2.27 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.364 -0.976 . . . . 72.31 108.364 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.89 155.31 19.46 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.834 -0.621 . . . . 75.52 109.63 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.27 118.39 12.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.776 . . . . 73.22 109.97 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -78.48 94.57 4.97 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.72 0.808 . . . . 74.03 110.755 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.33 54.06 2.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 114.986 -1.006 . . . . 64.22 110.082 171.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.32 97.88 0.17 Allowed 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.09 1.86 . . . . 73.44 111.715 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.24 108.83 17.33 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.401 -1.703 . . . . 75.43 106.401 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.68 HG11 ' HG ' ' C' ' 126' ' ' LEU . 46.4 t -94.02 102.64 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 113.897 -1.501 . . . . 63.15 110.218 -166.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.87 112.52 24.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.3 0.64 . . . . 70.31 110.442 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.704 HD11 HD12 ' C' ' 128' ' ' LEU . 7.0 mp -91.24 141.01 29.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.733 -0.84 . . . . 74.53 108.733 172.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -143.18 138.48 29.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.899 0.88 . . . . 63.25 109.476 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.79 127.23 54.52 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.321 -0.622 . . . . 63.43 109.321 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.73 145.36 48.47 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.353 1.461 . . . . 74.04 108.276 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.2 t -123.67 139.45 53.98 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.275 0.559 . . . . 72.33 109.66 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.47 147.61 34.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.997 1.319 . . . . 75.31 107.682 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -145.75 155.43 42.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.937 0.398 . . . . 74.51 111.346 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.0 m -142.62 136.42 29.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.266 1.027 . . . . 60.2 108.527 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -84.66 116.76 23.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.554 -0.906 . . . . 71.45 108.554 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.581 HD11 HD12 ' C' ' 83' ' ' ILE . 76.4 mt -91.0 -34.4 15.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.752 -0.658 . . . . 72.01 109.579 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.75 -174.19 2.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.101 -0.954 . . . . 52.32 110.004 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.25 122.49 22.04 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.38 -0.827 . . . . 45.33 109.256 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 65.4 11.4 7.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.09 1.356 . . . . 74.3 112.406 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.23 110.67 30.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 108.18 -1.044 . . . . 70.33 108.18 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -127.03 129.82 48.8 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.631 -0.713 . . . . 75.22 109.623 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.27 109.92 16.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.241 -1.345 . . . . 73.23 108.462 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 64.8 t -97.68 114.7 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.102 -1.073 . . . . 73.21 108.102 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.8 105.34 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.676 -0.861 . . . . 63.12 108.676 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -96.7 104.4 16.39 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.754 -1.202 . . . . 65.31 107.754 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -85.8 116.48 24.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.627 0.771 . . . . 74.33 109.957 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.8 t -101.54 127.92 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.71 -1.218 . . . . 64.25 107.71 168.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.8 m -124.61 124.23 41.77 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.087 -0.709 . . . . 71.42 109.087 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.544 HG22 ' HG ' ' C' ' 42' ' ' LEU . 38.3 t -110.58 131.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 72.23 109.447 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 25.9 m -116.52 149.69 39.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.233 -1.395 . . . . 65.3 107.233 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.52 130.94 41.05 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.768 -1.197 . . . . 75.04 107.768 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.6 m -133.54 161.64 34.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.485 0.66 . . . . 42.4 110.693 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 mt -128.45 28.5 5.44 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.647 1.579 . . . . 75.54 108.016 -173.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.41 -113.85 2.62 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.349 -1.9 . . . . 75.3 108.349 -165.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.5 -27.12 19.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.204 0.601 . . . . 62.43 109.717 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.6 117.98 9.54 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 124.658 1.183 . . . . 72.55 110.214 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -79.17 126.43 30.73 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.523 -0.547 . . . . 71.23 109.523 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.03 -52.13 11.85 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.593 0.757 . . . . 54.52 109.011 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.408 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 43.1 p90 -164.18 172.68 13.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.535 -1.211 . . . . 64.14 110.129 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -137.72 145.13 42.14 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.754 -1.573 . . . . 74.4 106.754 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.469 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.6 t -144.18 144.54 31.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.572 -0.899 . . . . 74.53 108.572 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.05 125.68 9.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.404 -0.591 . . . . 75.21 109.404 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' C' ' 110' ' ' ALA . 75.0 t -126.66 114.66 38.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.263 1.025 . . . . 72.52 108.424 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -96.81 87.51 4.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.62 -0.881 . . . . 52.41 108.62 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -85.14 119.81 25.95 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.075 -0.966 . . . . 42.51 109.542 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.59 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -114.05 153.77 17.38 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 123.453 0.471 . . . . 62.54 112.507 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.31 130.98 3.74 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.969 -1.252 . . . . 63.41 109.969 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.581 HD12 HD11 ' C' ' 51' ' ' LEU . 18.6 mm -88.56 119.01 35.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.764 -1.199 . . . . 71.35 107.764 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.58 122.88 39.3 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.39 -0.967 . . . . 71.14 108.39 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -90.19 100.4 13.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.886 -1.524 . . . . 73.2 106.886 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.57 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -122.72 133.45 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.697 0.799 . . . . 72.34 110.818 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.33 177.39 11.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.547 -0.751 . . . . 72.54 110.921 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.08 -63.69 2.07 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.641 -0.709 . . . . 32.53 112.731 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.5 2.032 0 C-N-CA 125.161 1.384 . . . . 65.11 112.787 176.06 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 118.851 -0.595 . . . . 65.14 111.944 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.6 tpt -45.77 -54.13 8.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.941 0.719 . . . . 43.25 112.941 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.26 -34.32 18.98 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.622 0.369 . . . . 53.52 111.378 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -74.6 -20.05 60.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.127 0.788 . . . . 72.21 113.127 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -68.02 -62.19 1.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.136 0.425 . . . . 73.35 110.696 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.471 ' H ' HD23 ' C' ' 98' ' ' LEU . 2.7 pt? -79.89 -20.3 46.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.239 -0.437 . . . . 54.43 111.294 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.67 -30.22 30.25 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.369 0.507 . . . . 54.34 114.369 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.2 -35.29 0.18 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.223 0.823 . . . . 52.23 113.223 -173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -73.38 -56.83 4.54 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.17 0.588 . . . . 73.11 111.169 -169.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 36.9 m -61.63 -46.36 93.61 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 123.73 0.812 . . . . 61.33 111.226 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 84.2 Cg_exo -53.44 -34.39 71.45 Favored 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 122.798 2.332 . . . . 60.43 114.61 167.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.6 -30.36 69.08 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.821 0.849 . . . . 62.15 111.365 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.427 HG23 ' NH1' ' A' ' 111' ' ' ARG . 46.2 mm -68.05 -29.88 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 123.199 0.6 . . . . 44.12 110.206 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.9 mt -93.05 -29.71 15.67 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.304 1.042 . . . . 63.43 112.567 -173.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -56.96 -38.32 67.38 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.79 -1.1 . . . . 52.34 113.956 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.17 -50.9 12.37 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.079 2.519 . . . . 75.01 113.897 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -62.05 -36.7 82.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.989 -1.005 . . . . 75.45 110.873 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.483 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -76.44 -40.0 51.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.459 -0.791 . . . . 54.2 111.2 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' CE1' ' A' ' 109' ' ' TYR . 29.1 ttt180 -58.15 -36.95 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.782 0.833 . . . . 74.22 111.142 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -44.96 25.18 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.197 0.599 . . . . 53.1 110.872 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.05 -30.17 71.11 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.325 0.65 . . . . 61.31 112.597 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.53 HD13 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -67.33 -49.91 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.339 0.655 . . . . 52.53 109.98 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.46 HG23 ' HB2' ' C' ' 125' ' ' GLN . 90.5 m -54.0 -42.74 69.36 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.253 0.971 . . . . 61.11 110.951 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.6 t -62.34 -49.26 76.3 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.168 -1.378 . . . . 65.23 110.754 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.554 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -63.19 -39.49 94.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.883 0.873 . . . . 72.32 112.373 -177.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.03 -41.85 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.152 0.581 . . . . 60.35 110.886 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.441 ' CB ' HG21 ' B' ' 115' ' ' THR . 28.2 t -59.8 -35.74 75.3 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.439 -1.255 . . . . 73.53 111.851 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.554 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 73.6 mtt-85 -68.91 -38.6 79.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.313 -0.858 . . . . 72.44 110.895 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.22 4.66 66.25 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.699 -0.682 . . . . 75.25 112.85 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 60.51 38.31 19.11 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.829 1.652 . . . . 63.44 112.207 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.616 ' HE1' HG11 ' C' ' 31' ' ' VAL . 43.9 m-85 -106.57 163.53 16.79 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.206 -1.361 . . . . 60.25 109.821 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.34 104.45 0.3 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.263 1.975 . . . . 75.34 111.181 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.792 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -56.07 150.77 13.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.237 1.415 . . . . 74.24 112.746 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.68 ' HG ' HG11 ' C' ' 40' ' ' VAL . 1.9 mm? -129.45 99.87 5.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.807 0.443 . . . . 74.24 110.737 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -109.32 84.63 1.96 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.37 -1.715 . . . . 71.32 106.37 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.704 HD12 HD11 ' C' ' 42' ' ' LEU . 55.4 mt -90.02 156.68 18.24 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.337 -1.301 . . . . 53.52 111.848 -172.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -34.62 121.98 0.55 Allowed Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.218 1.807 . . . . 54.3 113.65 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HG3' HD12 ' A' ' 16' ' ' ILE . 74.4 Cg_endo -71.29 110.24 2.79 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.73 2.287 . . . . 63.42 111.559 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 86.0 t -76.0 94.32 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.94 -0.763 . . . . 71.4 108.94 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.56 104.67 3.37 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 CA--C 1.549 0.934 0 O-C-N 125.075 1.484 . . . . 74.01 112.761 -170.241 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.237 0.396 0 CA-C-O 121.007 0.432 . . . . 45.42 109.946 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -145.97 94.5 2.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 106.431 -1.692 . . . . 74.01 106.431 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -129.47 139.45 51.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.306 0.642 . . . . 71.34 109.468 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.48 142.81 12.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.152 0.581 . . . . 71.01 109.738 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 56.9 mt-30 -103.36 -43.93 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.15 0.58 . . . . 70.23 110.683 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.542 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 55.6 ttt180 -170.13 148.72 3.4 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 111.784 0.29 . . . . 73.25 111.784 -169.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.405 ' HB ' ' HG3' ' B' ' 130' ' ' PRO . 1.1 mp -120.68 144.2 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 106.205 -1.776 . . . . 74.02 106.205 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.542 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 16.3 p90 -165.9 151.07 8.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.478 0.656 . . . . 75.43 111.226 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -86.95 113.05 22.39 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.033 -0.985 . . . . 50.22 109.082 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -81.06 -28.84 35.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.978 -0.555 . . . . 71.04 110.289 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -151.82 136.44 17.0 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.788 -1.096 . . . . 71.22 109.131 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' C' ' 117' ' ' MET . 96.7 mt -130.81 138.3 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.694 -1.224 . . . . 62.14 107.694 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -141.59 137.11 31.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.138 0.975 . . . . 73.2 109.053 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.2 t80 -145.52 114.23 6.82 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.263 -1.755 . . . . 60.13 106.263 170.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 38.3 mt-10 -122.26 111.09 16.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.228 0.611 . . . . 75.44 109.707 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.91 88.99 5.97 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.331 -0.989 . . . . 74.41 108.331 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.48 -33.94 1.64 Allowed 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 122.634 2.223 . . . . 71.52 113.295 -173.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -101.26 28.25 5.55 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.944 0.897 . . . . 73.5 109.317 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -51.58 -55.22 31.43 Favored Pre-proline 0 CA--C 1.574 1.893 0 N-CA-C 116.149 1.907 . . . . 64.32 116.149 -165.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.2 -16.24 11.09 Favored 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 122.049 1.768 . . . . 73.25 113.43 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -72.64 -44.78 61.46 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.066 0.946 . . . . 65.35 109.81 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.3 p -82.93 -0.27 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.818 -172.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 80.2 t80 -57.82 -29.84 65.26 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.1 0.96 . . . . 74.12 111.098 164.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -78.95 4.36 14.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.705 0.802 . . . . 70.13 111.543 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -108.3 110.24 21.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.285 1.034 . . . . 62.13 108.717 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -112.59 48.83 0.97 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.343 1.057 . . . . 74.24 111.793 -164.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -154.29 -174.55 5.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.533 0.733 . . . . 73.22 110.403 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -72.24 126.8 90.97 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.147 0.579 . . . . 64.14 110.893 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 17.4 Cg_exo -68.06 134.13 30.92 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.548 2.165 . . . . 64.22 111.898 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 38.1 mt-10 -60.14 115.08 3.21 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.218 0.949 . . . . 74.31 108.95 170.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.4 HG21 HD13 ' D' ' 126' ' ' LEU . 57.6 t -95.12 107.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.099 -1.075 . . . . 75.41 108.099 -176.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' D' ' 65' ' ' THR . 0.2 OUTLIER -88.07 119.23 28.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.569 -1.271 . . . . 61.5 107.569 171.511 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.19 141.86 29.05 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.448 -0.945 . . . . 62.33 108.448 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -144.44 130.43 19.42 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.503 -0.925 . . . . 75.52 108.503 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.3 135.53 52.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.511 0.725 . . . . 61.43 109.958 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -144.67 156.96 44.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.505 1.122 . . . . 64.43 108.894 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -139.04 164.53 29.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 53.35 109.55 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 174.21 14.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.44 1.096 . . . . 73.52 108.594 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 95.8 p -164.14 157.57 18.25 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.006 0.432 . . . . 74.01 110.82 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.3 p -151.29 129.99 12.33 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.155 -0.93 . . . . 63.05 108.948 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.5 116.81 15.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.635 -0.505 . . . . 75.44 109.635 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' D' ' 57' ' ' GLU . 81.7 mt -92.64 -35.28 13.6 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.359 0.664 . . . . 74.43 109.709 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.99 -177.47 6.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.279 -0.873 . . . . 53.52 110.133 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.08 125.16 27.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.162 -1.051 . . . . 75.23 108.162 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.42 16.43 10.19 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.267 1.027 . . . . 75.31 112.271 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 65.2 t -136.72 127.19 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.569 1.147 . . . . 73.15 108.089 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.29 152.62 34.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.194 0.521 . . . . 74.22 110.102 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.6 tt0 -88.58 131.48 34.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.989 -1.005 . . . . 70.05 109.109 175.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.65 131.68 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.618 -1.253 . . . . 73.41 107.618 167.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 58.4 t -106.29 133.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.953 -0.758 . . . . 71.4 108.953 173.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -104.58 125.34 50.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.645 -1.613 . . . . 64.12 106.645 172.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.9 ttm-85 -106.97 100.2 9.72 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.211 -1.033 . . . . 71.14 108.211 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.79 121.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.298 -1.371 . . . . 62.02 107.298 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.0 m -124.84 128.99 49.54 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.454 0.645 . . . . 64.42 109.965 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.2 t -120.84 132.18 71.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.223 1.409 . . . . 75.11 109.171 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' D' ' 41' ' ' LYS . 89.0 m -128.65 98.75 5.11 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.649 -1.241 . . . . 74.44 107.649 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.13 141.95 28.9 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.869 -0.605 . . . . 62.31 109.599 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.7 p -143.14 129.13 19.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.41 0.443 . . . . 74.22 111.227 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 mt -108.99 99.76 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 73.13 108.751 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.87 -132.05 10.81 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.476 0.485 . . . . 60.03 111.972 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.94 5.03 52.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.463 0.705 . . . . 73.22 111.569 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -123.68 167.46 13.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.77 . . . . 71.4 110.557 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.9 m -77.68 132.01 37.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.2 -0.909 . . . . 72.45 110.293 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.53 -65.8 0.97 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.815 0.846 . . . . 74.52 108.73 176.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -154.75 170.39 21.71 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.202 -0.908 . . . . 75.12 110.116 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.0 mt -128.12 153.46 46.83 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.42 -1.326 . . . . 73.44 107.42 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.0 t -158.58 144.1 16.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.841 0.456 . . . . 71.43 110.253 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.34 124.44 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.244 -0.65 . . . . 75.11 109.244 170.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -125.75 116.2 45.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.47 0.708 . . . . 73.32 109.862 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -91.85 86.89 6.04 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.705 0.764 . . . . 74.14 109.809 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.421 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.1 tp-100 -80.72 98.36 7.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.112 1.365 . . . . 74.54 109.736 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.99 158.99 26.25 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.117 -0.393 . . . . 32.23 112.117 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.65 140.31 6.85 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.842 -0.503 . . . . 52.3 111.842 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.9 mt -91.55 120.89 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.518 0.727 . . . . 62.42 109.786 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -118.77 126.42 51.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 72.23 110.407 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 75.2 m -91.31 101.53 14.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.487 1.115 . . . . 63.45 109.541 171.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.87 141.76 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.072 0.549 . . . . 55.43 110.814 -177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.5 162.74 14.61 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.632 1.173 . . . . 73.22 109.129 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.79 77.52 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.356 0.41 . . . . 64.42 113.233 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' D' ' 94' ' ' MET . 0.1 OUTLIER -123.26 130.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 124.097 0.959 . . . . 73.15 109.462 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.89 170.77 15.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.894 0.878 . . . . 74.45 110.357 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.15 -141.98 33.6 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.211 -0.904 . . . . 71.42 113.569 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' D' ' 95' ' ' ALA . 16.9 p -75.32 -16.06 60.44 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.716 0.807 . . . . 62.32 111.948 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -60.85 -48.29 82.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.345 0.658 . . . . 75.33 109.992 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.672 ' HG3' HD23 ' D' ' 98' ' ' LEU . 11.2 tpt -80.97 -41.16 23.26 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.38 -0.827 . . . . 72.43 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' D' ' 92' ' ' THR . . . -57.78 -39.92 78.6 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 62.23 112.143 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 80.4 t60 -76.84 -27.07 54.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.625 0.77 . . . . 71.41 110.69 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 37.3 t -75.33 -51.51 13.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.448 0.299 . . . . 73.51 111.273 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.672 HD23 ' HG3' ' D' ' 94' ' ' MET . 4.1 pp -67.38 -32.72 73.82 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.573 0.749 . . . . 74.41 112.217 -172.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.67 13.56 42.37 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.543 -0.587 . . . . 72.34 113.877 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -156.55 -59.86 0.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.35 0.575 . . . . 71.43 111.946 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.455 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 70.3 t80 -73.69 -42.29 61.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.888 0.699 . . . . 64.25 112.888 -168.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 76.0 m -67.04 -44.8 51.56 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.92 -0.562 . . . . 51.24 111.18 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.5 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.3 Cg_exo -56.74 -32.62 91.86 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.127 1.885 . . . . 65.21 113.663 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.18 -35.96 82.49 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.435 0.694 . . . . 75.44 111.272 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.87 -41.78 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.387 0.675 . . . . 62.51 110.208 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.421 HD13 ' O ' ' D' ' 80' ' ' GLN . 86.8 mt -75.06 -21.22 59.13 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.955 -1.021 . . . . 74.23 111.757 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -64.9 -44.61 72.76 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.784 1.402 . . . . 61.24 114.784 -167.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.37 -39.53 86.89 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.244 1.963 . . . . 73.1 113.279 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -78.0 -37.69 46.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.014 -0.993 . . . . 71.23 110.932 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.41 90.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 70.33 110.694 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.459 ' NH2' HG23 ' B' ' 105' ' ' ILE . 40.1 ttp180 -57.47 -49.89 74.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.113 1.365 . . . . 64.31 111.009 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.17 -41.5 99.23 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.277 0.986 . . . . 53.12 111.648 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.464 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 45.0 t -56.58 -40.17 74.76 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.926 0.766 . . . . 75.24 110.896 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.484 HG12 ' SG ' ' D' ' 76' ' ' CYS . 39.8 mt -69.14 -50.36 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.088 -0.96 . . . . 72.14 110.087 175.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.442 HG23 ' HG3' ' D' ' 125' ' ' GLN . 20.2 m -52.05 -42.43 63.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.678 1.191 . . . . 72.15 111.981 -175.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -70.54 -43.45 69.52 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.894 -1.048 . . . . 73.42 110.948 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.7 mtm -64.62 -30.32 71.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.694 0.398 . . . . 54.21 111.615 178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.4 t -66.17 -47.9 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.862 0.726 . . . . 73.44 110.346 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.3 p -71.43 -27.67 63.45 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.656 0.383 . . . . 71.04 111.061 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -75.9 -32.77 59.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.791 0.837 . . . . 65.44 109.795 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.64 -4.88 89.45 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 115.718 -0.674 . . . . 61.42 112.119 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 67.88 33.13 4.86 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.496 1.918 . . . . 70.52 113.117 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -102.6 166.22 12.37 Favored Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.806 1.242 . . . . 72.15 109.949 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.417 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 35.4 Cg_exo -60.01 140.15 91.28 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 123.278 2.652 . . . . 73.32 112.889 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' D' ' 115' ' ' THR . 24.1 tt0 -52.18 140.06 22.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.087 0.867 . . . . 74.01 111.897 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.4 HD13 HG21 ' D' ' 40' ' ' VAL . 46.1 tp -128.3 106.12 8.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.634 -0.712 . . . . 73.02 109.519 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.0 106.29 8.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.832 0.853 . . . . 74.11 109.021 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.26 151.23 45.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 73.3 110.72 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.83 136.63 95.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.462 0.705 . . . . 50.04 111.16 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -69.5 113.11 3.22 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.005 1.804 . . . . 73.13 109.461 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.52 104.43 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.174 0.987 . . . . 70.1 109.663 -171.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 105.913 -1.884 . . . . 73.54 105.913 174.529 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.898 0.38 . . . . 73.01 110.282 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -98.54 139.82 33.69 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.098 -0.955 . . . . 72.44 108.513 162.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -156.39 137.37 13.55 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 112.329 0.492 . . . . 74.1 112.329 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 83' ' ' ILE . 7.9 tp -80.02 134.63 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.531 0.732 . . . . 73.24 110.149 169.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -101.77 -40.25 7.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.957 -0.757 . . . . 71.04 108.957 174.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -173.75 127.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.999 -0.524 . . . . 74.34 110.948 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.05 133.75 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.614 -0.884 . . . . 72.42 108.614 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 34.0 p90 -169.04 170.34 8.94 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.899 0.88 . . . . 74.34 110.578 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.8 p -93.39 120.08 33.26 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.32 -0.992 . . . . 73.45 108.32 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.7 mtpt -86.94 -42.94 12.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.204 -0.665 . . . . 75.5 109.204 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 12.0 t70 -135.16 128.51 32.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.145 -0.934 . . . . 70.54 108.499 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -122.95 143.28 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.952 -1.129 . . . . 64.3 107.952 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -143.5 125.91 15.73 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.798 -0.816 . . . . 70.03 108.798 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.9 t80 -131.1 129.87 42.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.586 -1.635 . . . . 72.52 106.586 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.91 138.83 47.09 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.313 -0.625 . . . . 72.11 109.313 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 76.18 11.39 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.385 -1.339 . . . . 72.03 107.385 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.53 -24.07 16.53 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.296 1.998 . . . . 63.34 111.202 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.03 25.76 7.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.078 0.951 . . . . 73.13 109.104 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -59.2 -47.64 97.93 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 124.389 1.075 . . . . 11.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 52.8 Cg_exo -61.17 -27.99 84.68 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.982 1.788 . . . . 70.02 113.738 171.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -76.07 -48.79 19.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.7 0.8 . . . . 62.22 112.134 -173.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.596 HG23 HD11 ' A' ' 68' ' ' LEU . 7.4 p -57.11 -27.21 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.975 0.91 . . . . 64.2 112.362 -175.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.45 -36.32 75.73 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.381 1.072 . . . . 73.44 112.328 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.72 -12.39 20.02 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.063 0.545 . . . . 61.24 111.363 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 4.6 mmmp? -83.51 143.23 30.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.729 0.812 . . . . 55.31 111.972 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.47 143.59 57.69 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 124.324 1.015 . . . . 74.41 110.578 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CE3' HD21 ' A' ' 68' ' ' LEU . 65.9 t-105 -93.0 86.69 5.5 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.758 0.79 . . . . 75.24 110.326 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -125.55 79.8 66.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 107.058 -1.46 . . . . 62.35 107.058 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 142.38 11.86 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.326 2.017 . . . . 72.31 112.928 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.55 86.04 3.49 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.257 -1.757 . . . . 64.31 106.257 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.49 93.76 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.02 -0.991 . . . . 74.31 108.966 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.3 tttt -79.22 124.42 28.35 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.55 -0.75 . . . . 63.53 109.096 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.415 ' HG ' HD21 ' A' ' 128' ' ' LEU . 2.4 mm? -107.38 112.25 24.97 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.01 -1.107 . . . . 71.33 108.01 170.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 28.9 t70 -105.17 129.86 53.47 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.647 -0.872 . . . . 75.22 108.647 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.1 tp -106.04 131.93 52.73 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.174 -0.676 . . . . 73.4 109.174 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -143.0 152.61 42.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.131 -1.063 . . . . 74.32 108.131 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -138.01 156.59 47.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.929 0.892 . . . . 63.41 109.313 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 153.75 34.42 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.139 0.975 . . . . 51.24 108.797 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.46 152.43 51.52 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.896 0.478 . . . . 74.51 110.754 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -149.94 121.19 7.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.998 0.919 . . . . 62.42 109.046 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.37 -0.604 . . . . 74.13 109.37 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -88.58 -43.38 11.42 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.581 -0.736 . . . . 75.01 111.048 -175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 -174.87 4.7 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.411 -0.813 . . . . 74.34 110.577 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -75.53 123.33 25.28 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.359 -0.837 . . . . 73.13 108.825 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.33 14.78 5.38 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.304 1.442 . . . . 73.21 111.77 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.26 114.13 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.771 0.828 . . . . 73.31 110.381 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -124.26 126.14 45.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.742 0.817 . . . . 72.23 108.992 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 33.8 tt0 -90.34 120.43 31.46 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.406 1.082 . . . . 60.15 109.152 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.523 HG21 ' HG ' ' A' ' 98' ' ' LEU . 21.5 t -102.61 116.71 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.73 -1.211 . . . . 53.2 107.73 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.0 t -99.23 126.28 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.038 -0.727 . . . . 73.54 109.038 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.27 115.67 31.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.349 -1.352 . . . . 75.01 107.349 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -108.83 105.38 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.42 0.628 . . . . 74.11 109.742 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -101.99 133.51 45.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.778 -1.101 . . . . 72.33 108.152 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.2 m -121.69 118.23 28.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.372 0.606 . . . . 73.34 110.528 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.7 t -105.6 107.08 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.701 -1.136 . . . . 62.41 108.931 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 12.4 m -106.51 131.78 53.28 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.625 -0.88 . . . . 61.42 108.625 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.78 107.78 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.073 -1.084 . . . . 72.24 108.073 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 44.8 m -115.24 126.98 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.643 0.377 . . . . 63.1 110.392 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.596 HD11 HG23 ' A' ' 31' ' ' VAL . 18.9 mt -88.97 58.95 4.8 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.093 -1.077 . . . . 75.54 108.093 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.36 -89.0 0.71 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-N 114.999 -1.001 . . . . 64.33 112.136 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -92.92 -28.1 16.67 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.049 0.94 . . . . 72.14 110.709 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.706 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -107.54 103.53 12.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.592 0.757 . . . . 75.5 109.631 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 91.8 m -66.03 130.34 42.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.638 0.654 . . . . 74.4 109.576 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.25 -56.3 4.57 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.806 0.843 . . . . 65.44 109.831 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.5 172.92 16.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.83 -1.077 . . . . 64.23 111.36 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -132.09 144.42 50.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.138 -1.392 . . . . 71.14 108.276 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.6 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -136.82 139.82 42.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.895 0.878 . . . . 72.14 108.665 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.465 ' HG2' ' OE1' ' A' ' 79' ' ' GLN . 43.6 tt0 -149.77 120.22 7.41 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.465 -0.568 . . . . 73.35 109.465 173.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.65 113.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.457 0.703 . . . . 70.02 110.485 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.465 ' OE1' ' HG2' ' A' ' 77' ' ' GLU . 1.7 mp0 -89.0 80.48 7.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.388 1.475 . . . . 74.24 108.36 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.36 94.27 3.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.713 -1.13 . . . . 73.14 108.879 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.88 140.74 19.65 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.409 -0.677 . . . . 52.4 111.409 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.672 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.89 122.22 1.88 Allowed Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.417 -1.073 . . . . 73.21 110.417 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.0 mt -83.74 125.91 40.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.685 -0.857 . . . . 63.21 108.685 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CE2' HD13 ' A' ' 13' ' ' ILE . 53.1 m-85 -128.36 120.47 27.06 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.079 -0.711 . . . . 64.24 109.079 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.3 t -81.27 102.17 10.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.504 0.722 . . . . 54.32 109.295 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 149.84 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.375 0.67 . . . . 63.53 110.402 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.07 177.06 2.01 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.708 1.203 . . . . 43.32 109.58 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.36 -34.35 4.19 Favored Glycine 0 N--CA 1.473 1.122 0 CA-C-N 116.126 -0.488 . . . . 73.44 114.076 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.55 150.85 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.97 0.908 . . . . 71.24 108.772 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.37 176.94 8.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.121 0.568 . . . . 74.51 112.065 -171.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.41 -126.71 40.52 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.118 -0.947 . . . . 74.25 113.089 172.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.505 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 40.9 p -71.45 -15.06 62.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.689 0.796 . . . . 71.35 112.568 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -72.15 -45.65 59.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.475 0.71 . . . . 63.4 110.584 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.97 -28.99 29.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.443 0.697 . . . . 74.43 109.981 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -72.93 -22.99 60.64 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.195 0.598 . . . . 62.11 111.177 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -65.89 -46.55 77.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.906 0.882 . . . . 74.43 109.616 169.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.4 m -60.55 -64.72 0.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.711 -1.131 . . . . 63.32 110.318 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.523 ' HG ' HG21 ' A' ' 58' ' ' VAL . 9.7 mp -73.8 -9.91 59.14 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.898 0.703 . . . . 63.21 112.898 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.89 -29.4 13.1 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.795 -0.447 . . . . 52.1 113.747 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.33 -44.47 0.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.876 0.695 . . . . 72.42 112.876 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.9 t80 -78.32 -60.44 2.37 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.246 0.618 . . . . 44.2 112.318 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 97' ' ' CYS . 59.1 m -66.64 -37.9 16.99 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 114.325 1.231 . . . . 64.21 114.325 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.51 -27.05 69.97 Favored 'Trans proline' 0 C--N 1.391 2.767 0 CA-C-N 121.391 1.533 . . . . 65.44 112.664 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.0 -26.5 61.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.974 0.509 . . . . 75.02 110.149 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -64.78 -43.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.311 0.576 . . . . 63.13 109.568 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.672 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.4 mt -76.85 -26.45 54.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.093 -0.958 . . . . 71.23 112.031 -175.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -64.32 -36.67 20.12 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.52 1.304 . . . . 62.44 114.52 -168.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 -34.37 95.03 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.074 1.849 . . . . 43.55 113.292 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -85.65 -36.29 20.39 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.667 0.787 . . . . 73.02 111.149 -174.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.89 85.03 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.377 -0.601 . . . . 65.42 109.377 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -53.16 -56.48 16.05 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.798 1.311 . . . . 63.51 109.492 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.8 -41.84 87.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.156 0.982 . . . . 74.02 111.8 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.476 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 48.3 t -62.5 -50.5 71.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.357 0.663 . . . . 74.32 110.674 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.554 HG21 HG21 ' A' ' 64' ' ' VAL . 89.7 mt -61.83 -51.22 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.92 0.763 . . . . 61.13 110.451 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.6 m -51.57 -45.16 63.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.923 1.289 . . . . 72.34 111.4 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -73.41 -41.49 63.23 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.841 -1.072 . . . . 50.15 110.833 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.5 mtp -55.13 -43.47 74.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.652 0.781 . . . . 50.15 111.424 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 54.5 t -65.08 -45.81 93.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.523 -1.217 . . . . 51.3 111.103 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.69 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.2 p -69.18 -32.52 71.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.383 0.273 . . . . 42.22 111.595 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.54 -28.43 67.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.614 0.766 . . . . 74.52 110.829 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.96 67.14 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.475 0.484 . . . . 63.11 113.496 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.481 ' HB ' HH21 ' B' ' 15' ' ' ARG . 9.5 m 64.07 43.24 5.2 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.74 1.216 . . . . 71.31 110.525 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.4 156.63 50.82 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 114.908 -1.042 . . . . 73.11 108.918 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.27 115.56 3.39 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.98 1.787 . . . . 70.0 110.395 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 8.5 pt20 -62.92 143.18 57.92 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.422 0.451 . . . . 62.44 110.222 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.84 122.16 46.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.88 -0.785 . . . . 73.55 108.88 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -97.11 94.15 6.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.415 HD21 ' HG ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -68.05 126.18 28.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.274 -0.875 . . . . 75.41 109.893 -172.019 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -66.08 128.13 93.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 O-C-N 123.466 0.479 . . . . 52.52 110.537 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 4.8 Cg_exo -79.19 123.74 5.71 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.615 2.21 . . . . 74.34 111.567 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.4 112.43 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.129 -1.063 . . . . 73.11 108.129 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -90.91 72.26 6.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.082 -1.081 . . . . 63.22 108.082 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.032 -0.985 . . . . 63.14 111.103 -178.164 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.2 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.423 -1.325 . . . . 74.12 107.423 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -143.18 132.22 22.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.485 -0.932 . . . . 74.33 108.485 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -154.12 140.93 19.12 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.396 0.435 . . . . 53.13 111.702 173.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.56 HD13 HD11 ' B' ' 16' ' ' ILE . 58.8 mt -84.66 115.04 25.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.45 -0.944 . . . . 74.33 108.45 168.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -87.9 -35.07 17.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.604 0.565 . . . . 71.15 110.039 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.481 HH21 ' HB ' ' A' ' 122' ' ' THR . 70.8 ttt180 -167.27 137.73 2.98 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.139 -0.482 . . . . 72.23 110.045 -177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.56 HD11 HD13 ' B' ' 13' ' ' ILE . 98.0 mt -116.98 135.95 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.934 -1.506 . . . . 61.43 106.934 169.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -168.99 152.04 5.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.274 0.559 . . . . 64.23 111.479 -170.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.2 m -83.04 121.48 27.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.343 -0.984 . . . . 70.15 108.343 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -92.24 -32.88 14.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.102 0.561 . . . . 73.34 110.773 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 25.7 t70 -155.95 142.42 18.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.981 -0.554 . . . . 75.45 110.851 -168.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 34.4 mm -138.87 142.08 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 62.45 108.881 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 41.4 t -141.36 133.76 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.451 -1.25 . . . . 52.33 107.856 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.0 t80 -147.34 107.54 4.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.493 -1.299 . . . . 71.02 107.493 171.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.45 120.97 39.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.127 0.971 . . . . 64.41 108.656 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -119.23 87.19 34.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.959 0.904 . . . . 62.52 109.857 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 -48.83 4.66 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.904 2.403 . . . . 64.14 112.672 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -104.11 28.57 6.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.204 0.602 . . . . 73.33 110.66 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -49.99 -51.66 59.58 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.885 1.274 . . . . 70.34 113.411 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 97.2 Cg_endo -86.98 -13.06 4.73 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.435 2.09 . . . . 53.44 113.394 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -89.27 2.97 53.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.378 0.671 . . . . 73.24 111.078 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -62.66 -16.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.973 1.309 . . . . 72.22 111.942 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.893 0.877 . . . . 75.25 111.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.14 -45.91 72.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.775 -0.648 . . . . 62.13 110.806 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.07 81.61 1.47 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.721 0.809 . . . . 74.03 109.511 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -80.24 74.11 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.114 0.959 . . . . 70.43 111.41 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -159.29 174.28 15.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.997 1.319 . . . . 75.33 109.745 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.74 129.97 80.09 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 115.284 -0.871 . . . . 75.2 109.757 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.15 153.41 69.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.341 2.028 . . . . 72.4 111.723 167.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.3 mt-10 -65.65 99.79 0.47 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.05 -1.092 . . . . 73.04 108.05 172.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' 126' ' ' LEU . 21.7 t -87.18 117.43 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.413 -1.328 . . . . 54.21 107.413 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -151.67 132.86 14.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.066 -0.716 . . . . 65.45 109.066 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' B' ' 64' ' ' VAL . 1.5 pt? -128.92 164.55 22.89 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.032 0.444 . . . . 74.42 111.877 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -149.49 149.93 31.54 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.963 -1.017 . . . . 63.04 109.556 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.9 tt -107.14 136.69 46.56 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 52.45 111.121 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 1.2 m-20 -123.61 150.92 43.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.223 1.409 . . . . 71.44 107.574 172.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -136.41 134.19 37.5 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.77 147.38 27.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.348 1.059 . . . . 72.41 108.237 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -142.65 162.54 35.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.843 0.457 . . . . 54.34 110.555 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -154.33 166.4 33.33 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.566 1.146 . . . . 70.44 109.064 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -115.05 132.67 56.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.858 0.463 . . . . 73.41 110.373 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.93 -48.19 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.859 0.864 . . . . 74.25 110.063 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.86 -175.81 5.48 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.797 -1.092 . . . . 53.43 109.779 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -61.43 122.05 14.19 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.241 -0.89 . . . . 74.42 109.455 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 71.69 -5.29 1.69 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.23 1.412 . . . . 73.3 111.882 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -109.64 100.21 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.301 1.04 . . . . 75.13 108.715 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.49 172.44 6.97 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.623 0.769 . . . . 71.03 110.814 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -144.04 115.45 8.05 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.903 -1.517 . . . . 71.52 106.903 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' B' ' 98' ' ' LEU . 43.3 t -117.33 125.6 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.54 0.736 . . . . 53.03 109.805 -173.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.6 t -106.29 121.16 58.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.993 0.917 . . . . 65.44 110.319 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -93.81 114.47 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 107.653 -1.24 . . . . 72.42 107.653 170.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.0 ttm180 -100.64 112.56 24.96 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.11 118.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.11 -1.071 . . . . 61.45 108.11 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.2 m -115.9 137.08 52.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.616 0.766 . . . . 72.12 109.812 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' B' ' 42' ' ' LEU . 94.1 t -111.85 119.99 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.842 1.257 . . . . 74.22 110.453 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 67.5 m -89.67 140.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.896 -1.15 . . . . 63.41 107.896 165.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.54 143.61 26.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.013 -0.366 . . . . 63.23 110.013 175.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.6 p -156.03 135.2 12.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.687 0.625 . . . . 75.33 112.687 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -92.88 99.1 11.82 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.548 -1.279 . . . . 64.32 107.548 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.44 -130.93 41.13 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.65 0.594 . . . . 43.01 112.494 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -90.89 44.92 1.22 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.025 0.93 . . . . 74.22 110.091 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.06 139.02 13.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.455 0.702 . . . . 72.13 109.42 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.0 m -72.85 133.12 44.3 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.021 0.529 . . . . 71.43 110.466 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 -56.18 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.839 0.856 . . . . 71.43 109.281 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -152.85 165.93 33.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.301 -1.318 . . . . 60.01 109.83 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -140.73 121.07 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.419 -1.697 . . . . 73.3 106.419 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.548 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.4 t -116.31 158.96 22.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.319 -0.993 . . . . 64.33 108.319 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.3 tt0 -165.88 130.36 2.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.131 -0.692 . . . . 74.21 109.131 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -124.33 142.93 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.229 -1.026 . . . . 60.33 108.229 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -122.05 87.22 2.71 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.126 -1.065 . . . . 72.24 108.126 172.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 63.2 tp60 -80.59 101.05 8.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.235 -1.348 . . . . 64.23 108.539 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.66 171.13 37.53 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.404 -0.678 . . . . 75.33 111.404 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.92 131.61 2.46 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.2 -0.76 . . . . 71.53 111.2 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.12 122.87 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.376 -1.342 . . . . 62.32 107.376 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -129.85 129.73 44.34 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.653 -1.24 . . . . 75.22 107.653 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -97.41 102.65 14.47 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.216 -0.661 . . . . 64.41 109.216 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.36 138.41 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.177 0.991 . . . . 71.42 110.901 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.8 172.06 19.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.449 1.099 . . . . 45.35 109.585 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -43.28 2.99 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-N 116.173 -0.467 . . . . 62.21 112.859 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 163.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.934 0.894 . . . . 75.33 111.019 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 9.9 pt-20 -159.37 143.82 15.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.005 0.522 . . . . 74.33 110.873 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.11 -104.36 0.45 Allowed Glycine 0 C--N 1.353 1.515 0 O-C-N 124.226 0.954 . . . . 44.12 114.121 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.3 m -65.88 -41.35 91.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.231 1.012 . . . . 63.11 110.258 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.419 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 72.6 mt-30 -61.33 -40.56 94.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.475 -0.784 . . . . 75.3 111.035 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.2 ttt -71.52 -40.7 69.93 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.509 0.505 . . . . 72.11 110.676 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.3 66.96 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.466 -0.788 . . . . 71.21 111.692 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -93.73 -21.22 19.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.973 0.909 . . . . 74.33 110.648 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -79.17 -67.2 0.78 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.563 -0.532 . . . . 75.14 109.563 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' B' ' 58' ' ' VAL . 2.2 pp -95.34 -4.85 44.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.177 0.806 . . . . 70.43 113.177 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -3.21 56.59 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 120.04 -0.311 . . . . 73.53 112.665 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.05 -56.51 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.013 0.375 . . . . 71.02 112.013 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -74.78 -41.26 60.35 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.106 0.41 . . . . 75.51 112.106 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 85.6 m -68.9 -45.72 31.68 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.698 -0.668 . . . . 73.35 110.532 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.6 Cg_exo -55.69 -31.54 80.28 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.132 1.888 . . . . 73.52 113.895 165.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.97 -40.79 87.53 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 122.886 0.474 . . . . 72.42 110.173 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.489 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -58.57 -49.17 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.66 0.784 . . . . 65.41 109.871 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.71 -9.64 59.67 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.781 -1.1 . . . . 71.22 112.005 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.512 ' HZ ' HD13 ' B' ' 128' ' ' LEU . 76.9 t80 -64.94 -51.06 59.18 Favored Pre-proline 0 N--CA 1.484 1.256 0 CA-C-O 117.991 -1.004 . . . . 74.12 113.402 -172.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.79 -35.8 87.14 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.788 1.658 . . . . 74.25 112.174 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.51 ' HE2' HG21 ' D' ' 115' ' ' THR . 88.7 m-85 -64.17 -47.87 78.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.745 0.818 . . . . 74.21 110.858 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.61 91.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.379 -0.828 . . . . 54.14 110.467 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -65.1 -45.0 86.99 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.375 1.07 . . . . 64.42 109.948 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.08 -37.82 69.52 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.148 -0.933 . . . . 72.11 110.132 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG2' ' B' ' 117' ' ' MET . 10.0 t -64.97 -35.69 82.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.945 0.498 . . . . 75.3 110.993 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' B' ' 64' ' ' VAL . 73.3 mt -64.7 -53.31 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.22 0.608 . . . . 72.01 109.778 173.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -56.74 -31.55 64.68 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.139 0.899 . . . . 52.01 110.892 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -64.38 -53.26 51.42 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 114.805 -1.089 . . . . 72.32 110.111 172.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.4 mmt -66.53 -33.84 76.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.065 0.394 . . . . 72.02 112.065 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.25 -40.86 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.731 0.812 . . . . 44.41 109.906 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.6 p -73.03 -29.31 62.89 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.022 -0.535 . . . . 75.35 111.642 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' HA ' ' A' ' 113' ' ' CYS . 72.5 mtt-85 -65.73 -36.9 84.92 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.46 -0.791 . . . . 72.41 109.484 172.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.98 3.61 69.88 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 124.024 0.827 . . . . 75.31 113.5 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.4 p 59.56 29.67 19.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.824 1.65 . . . . 73.11 112.748 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 63.7 m-85 -102.24 155.51 36.39 Favored Pre-proline 0 N--CA 1.488 1.461 0 C-N-CA 124.206 1.003 . . . . 73.42 111.278 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.65 178.85 0.83 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.731 2.954 . . . . 74.04 115.662 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -64.93 152.85 42.13 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.56 -1.655 . . . . 61.11 114.573 -162.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.579 HD21 HD13 ' B' ' 42' ' ' LEU . 26.6 tp -149.32 106.08 3.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.003 -1.453 . . . . 75.22 108.861 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.52 92.36 2.9 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.588 -1.264 . . . . 73.24 107.588 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.522 HD12 HD11 ' B' ' 42' ' ' LEU . 2.4 tt -58.95 141.45 53.68 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.745 -1.116 . . . . 64.32 109.649 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.45 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -57.46 106.48 0.69 Allowed Pre-proline 0 N--CA 1.477 0.912 0 O-C-N 124.359 1.037 . . . . 65.33 110.831 173.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.648 ' HB2' ' HB ' ' D' ' 16' ' ' ILE . 6.1 Cg_exo -79.3 123.16 5.42 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.662 2.241 . . . . 72.21 109.739 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' D' ' 13' ' ' ILE . 10.0 p -155.44 155.34 5.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 123.694 0.621 . . . . 54.13 109.732 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.536 ' H ' HD12 ' D' ' 13' ' ' ILE . 32.6 t30 -69.09 114.47 7.39 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 107.784 -1.191 . . . . 75.41 107.784 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 46.3 p90 . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 124.507 1.123 . . . . 43.22 112.015 178.594 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 38.9 m . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 107.553 -1.277 . . . . 52.24 107.553 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -120.94 119.01 31.35 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.133 -1.432 . . . . 71.24 107.133 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -146.13 136.3 23.71 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 171.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.429 HD12 ' O ' ' C' ' 83' ' ' ILE . 5.5 tp -80.47 132.17 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.369 -0.832 . . . . 72.3 108.79 169.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 21.5 mm100 -99.59 -45.61 5.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.263 -0.881 . . . . 61.45 109.866 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -165.41 122.03 1.44 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.512 -0.767 . . . . 71.01 109.174 -170.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 56.1 mt -112.95 134.53 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.319 -1.363 . . . . 74.04 107.319 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.485 ' HB3' HG23 ' D' ' 122' ' ' THR . 18.9 p90 -173.71 168.86 4.32 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 123.816 0.698 . . . . 73.04 110.636 -173.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -91.3 128.29 37.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.26 -0.882 . . . . 65.15 109.615 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.469 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 30.0 mmtp -80.01 -52.79 7.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.577 0.703 . . . . 71.05 109.413 170.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 28.9 t70 -135.75 115.09 12.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.6 -1.182 . . . . 75.21 109.267 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 54.8 mt -111.27 139.46 35.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.515 -1.661 . . . . 74.32 106.515 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -152.74 142.51 22.01 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.276 0.56 . . . . 41.24 109.819 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -132.48 133.77 44.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.322 -1.362 . . . . 55.35 107.322 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -125.89 127.55 46.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.954 -1.128 . . . . 73.23 107.954 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -145.7 76.61 12.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.867 -1.16 . . . . 63.01 107.867 170.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.62 -27.57 22.2 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.486 2.124 . . . . 63.44 110.785 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -106.56 29.12 7.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.484 1.113 . . . . 43.54 109.558 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -58.59 -50.67 86.76 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.072 1.138 . . . . 63.54 114.072 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.21 -15.99 4.28 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.367 1.378 . . . . 53.52 112.356 171.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -72.12 -29.65 64.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.429 1.092 . . . . 73.52 111.548 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.626 HG23 HD11 ' C' ' 68' ' ' LEU . 14.7 p -79.03 -18.15 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.69 0.796 . . . . 73.31 111.842 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -53.99 -41.65 68.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.487 1.115 . . . . 71.24 112.201 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 52.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.509 -0.922 . . . . 71.3 108.509 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.521 ' HG2' ' HG2' ' C' ' 71' ' ' GLU . 0.1 OUTLIER -125.56 164.92 19.48 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.816 -0.552 . . . . 63.43 110.337 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.34 104.06 1.77 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.542 -0.91 . . . . 63.22 108.542 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.93 88.46 7.44 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.252 1.025 . . . . 62.53 112.616 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -133.1 71.43 77.46 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.62 1.168 . . . . 73.34 108.611 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.33 127.26 12.44 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.473 2.115 . . . . 73.13 111.638 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -87.09 112.91 22.37 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 62.21 108.525 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.483 HG21 HD21 ' C' ' 126' ' ' LEU . 21.8 t -79.88 80.49 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.141 -0.936 . . . . 44.22 108.691 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.497 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 25.5 tptp -90.95 102.03 14.79 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.585 -0.894 . . . . 65.32 108.585 -175.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.91 152.54 22.0 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.605 -0.725 . . . . 72.11 109.817 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.56 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 4.6 m-20 -139.75 136.36 34.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.075 0.95 . . . . 73.34 109.336 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 42.0 tp -112.8 108.88 18.04 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.768 0.827 . . . . 71.41 109.283 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 14.4 t70 -113.77 148.05 37.22 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.64 -1.245 . . . . 72.31 107.64 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 63.2 m -126.97 126.38 43.1 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.934 0.494 . . . . 62.14 109.884 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.13 146.32 45.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.11 -1.07 . . . . 75.14 108.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -149.37 143.66 25.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.77 0.828 . . . . 63.34 109.049 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 34.8 p -154.66 129.28 9.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.369 0.667 . . . . 60.33 110.45 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.29 133.95 42.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 110.037 -0.357 . . . . 75.13 110.037 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 47.8 mt -98.66 -52.92 3.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.96 0.904 . . . . 71.14 110.417 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.92 -170.78 3.55 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.304 -0.862 . . . . 74.4 110.581 -170.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.44 109.64 3.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.135 0.974 . . . . 54.32 110.1 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 67.74 -4.02 1.04 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.911 1.285 . . . . 72.52 112.762 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.9 t -92.93 111.96 25.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 N-CA-C 108.308 -0.997 . . . . 72.4 108.308 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -119.04 157.88 26.93 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.197 0.999 . . . . 63.03 108.433 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.62 139.44 53.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.578 -0.897 . . . . 72.3 108.578 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.57 116.84 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.307 -1.368 . . . . 74.12 107.307 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.81 105.54 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.523 -0.917 . . . . 62.23 108.523 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.11 122.16 29.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.841 -1.17 . . . . 74.33 107.841 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 60.0 mtp180 -105.44 114.04 27.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.834 0.854 . . . . 72.25 110.036 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.53 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.9 t -106.91 128.24 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.1 -0.704 . . . . 72.45 109.1 172.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 14.3 m -111.59 138.14 48.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.473 -0.936 . . . . 50.33 108.473 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.668 HG21 HG21 ' C' ' 114' ' ' ILE . 97.5 t -123.19 112.22 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.957 -1.127 . . . . 63.4 107.957 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.75 142.57 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.86 -0.793 . . . . 53.31 108.86 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.17 102.9 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.758 -1.571 . . . . 74.22 106.758 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -136.77 142.82 42.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.38 0.61 . . . . 44.1 111.275 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.626 HD11 HG23 ' C' ' 31' ' ' VAL . 17.6 mt -94.02 30.62 1.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.405 1.482 . . . . 62.44 109.369 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.93 -110.58 2.81 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 109.773 -1.331 . . . . 62.43 109.773 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 -22.45 19.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.071 0.548 . . . . 74.42 110.513 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.521 ' HG2' ' HG2' ' C' ' 34' ' ' LYS . 11.4 tp10 -79.58 90.1 5.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.03 0.932 . . . . 74.13 109.706 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -73.04 123.25 23.16 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 120.953 0.406 . . . . 61.13 110.987 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.24 26.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.68 1.192 . . . . 74.42 109.779 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.08 168.57 24.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.223 -0.899 . . . . 71.35 110.896 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -136.44 136.52 39.58 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.311 -1.737 . . . . 44.04 106.311 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -146.8 113.05 5.87 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.097 0.408 . . . . 61.23 109.989 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -118.43 133.21 56.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.546 -0.538 . . . . 54.54 109.546 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.409 HG22 HG23 ' C' ' 21' ' ' ILE . 54.9 t -119.3 143.36 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.508 -0.923 . . . . 74.42 108.508 169.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -119.57 94.44 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.246 -1.02 . . . . 63.42 108.246 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -81.77 106.49 13.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.783 0.833 . . . . 73.02 110.822 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.01 146.8 23.27 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.201 -0.454 . . . . 64.11 112.542 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.16 120.72 1.29 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.23 -0.748 . . . . 55.31 111.23 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 14.8 mm -90.97 115.51 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.18 -0.674 . . . . 64.24 109.18 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -120.9 117.37 27.19 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.642 -0.873 . . . . 55.01 108.642 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -88.46 104.75 17.09 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.608 -1.256 . . . . 61.11 107.608 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' C' ' 10' ' ' THR . 1.8 pp -130.97 138.25 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.296 0.638 . . . . 71.23 112.038 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.74 163.02 18.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.813 1.245 . . . . 55.14 109.83 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 -26.2 7.88 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.293 -0.412 . . . . 63.1 113.287 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.443 1.097 . . . . 74.42 110.213 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.839 -0.43 . . . . 74.01 109.839 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.502 ' HB3' HG12 ' C' ' 89' ' ' ILE . 14.3 ptp -77.58 -28.19 51.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.847 0.459 . . . . 64.31 111.897 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.53 -45.48 75.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.34 0.656 . . . . 74.34 110.802 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -78.76 -33.98 46.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.073 -0.512 . . . . 63.3 110.259 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 38.8 t -63.82 -59.99 3.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.96 0.504 . . . . 41.42 111.047 -177.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 tt -71.63 -35.84 70.54 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.521 -0.548 . . . . 53.14 109.521 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.66 -4.68 90.22 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.163 -0.798 . . . . 53.22 114.882 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -155.08 -60.47 0.11 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.396 1.098 . . . . 61.52 112.143 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -60.68 -60.54 3.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.006 0.923 . . . . 73.43 113.26 -165.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 64.7 m -59.72 -47.71 96.87 Favored Pre-proline 0 CA--C 1.564 1.512 0 N-CA-C 113.181 0.808 . . . . 73.23 113.181 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.24 -32.05 42.95 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 120.982 1.386 . . . . 74.52 113.014 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -67.78 -27.88 67.13 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.958 0.503 . . . . 62.22 110.625 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.83 -42.61 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 65.12 110.15 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.465 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -78.87 -21.63 47.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.427 -0.806 . . . . 51.52 112.342 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -55.64 -51.98 75.73 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 117.799 -1.096 . . . . 73.14 113.881 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.28 -33.97 92.57 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.026 1.817 . . . . 70.44 113.508 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.89 -45.92 66.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 63.23 110.807 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.02 90.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.446 0.698 . . . . 44.22 110.382 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -54.47 -53.23 57.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.742 1.617 . . . . 72.01 111.127 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.4 -34.34 75.85 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.618 0.767 . . . . 72.42 110.65 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.6 t -70.45 -33.88 71.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.381 0.673 . . . . 73.1 112.107 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.668 HG21 HG21 ' C' ' 64' ' ' VAL . 92.5 mt -72.58 -49.08 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.014 0.526 . . . . 72.35 109.742 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.567 HG23 ' HB2' ' C' ' 125' ' ' GLN . 99.3 m -57.12 -33.98 67.9 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.158 0.911 . . . . 73.42 111.321 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.5 t -58.66 -57.36 13.33 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.57 -1.195 . . . . 63.23 109.743 170.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.413 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.22 -42.53 86.45 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.159 1.384 . . . . 75.21 113.914 -175.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.19 -47.33 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 123.635 0.584 . . . . 72.24 109.836 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -72.29 -22.56 61.18 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.888 -1.051 . . . . 74.25 111.777 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 86.0 mtt-85 -71.06 -39.26 72.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.118 0.567 . . . . 71.34 109.863 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' D' ' 17' ' ' TYR . . . -79.95 5.26 62.77 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.893 0.746 . . . . 63.42 112.591 171.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.68 ' HB ' HH21 ' D' ' 15' ' ' ARG . 43.0 p 58.04 38.71 26.7 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 74.23 112.143 174.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -102.32 164.15 16.28 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.046 1.338 . . . . 74.23 108.792 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.49 102.54 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.08 1.853 . . . . 72.45 112.336 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.567 ' HB2' HG23 ' C' ' 115' ' ' THR . 1.4 pp0? -60.63 140.87 57.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.154 0.582 . . . . 74.13 110.267 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.483 HD21 HG21 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -112.2 144.2 41.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.237 0.615 . . . . 72.1 110.912 -173.319 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -118.21 93.3 4.08 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.87 133.04 40.67 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.684 -1.144 . . . . 74.42 107.95 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.29 146.99 77.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 124.293 0.996 . . . . 74.51 111.09 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.21 100.63 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.117 2.545 . . . . 74.2 112.728 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.28 82.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.378 -0.828 . . . . 63.33 109.635 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.86 105.49 17.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.49 -1.3 . . . . 64.35 107.49 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 t80 . . . . . 0 N--CA 1.488 1.474 0 C-N-CA 123.424 0.69 . . . . 70.21 112.176 -176.995 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.241 0.65 0 N-CA-C 109.238 -0.653 . . . . 62.04 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 63.9 t80 -162.58 89.26 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.354 -2.091 . . . . 71.42 105.354 174.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -131.13 144.83 51.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.908 -1.145 . . . . 60.31 107.908 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.593 HD13 HD11 ' D' ' 16' ' ' ILE . 47.8 mt -104.12 120.17 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 117.676 0.216 . . . . 64.04 111.452 -170.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.34 -28.47 34.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.593 0.757 . . . . 73.13 111.39 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.68 HH21 ' HB ' ' C' ' 122' ' ' THR . 14.1 tpt180 177.89 156.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.691 0.396 . . . . 74.24 110.242 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' B' ' 130' ' ' PRO . 17.8 mt -141.14 127.52 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 106.439 -1.689 . . . . 73.35 106.439 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' HA2' ' C' ' 121' ' ' GLY . 47.3 p90 -165.71 173.35 10.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.053 0.93 . . . . 74.52 110.906 -172.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.084 -1.417 . . . . 74.33 109.606 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -82.25 -17.95 44.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.104 -0.702 . . . . 74.35 109.104 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -158.17 135.92 10.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.117 1.367 . . . . 75.43 109.03 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.573 HG23 HG22 ' D' ' 78' ' ' VAL . 21.1 mt -137.61 145.27 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.877 -1.157 . . . . 63.04 107.877 170.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -144.02 141.29 30.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.391 0.676 . . . . 61.41 110.224 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.1 t80 -147.53 122.61 10.13 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 105.842 -1.91 . . . . 74.11 105.842 169.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.16 123.47 28.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.118 -1.438 . . . . 64.44 107.118 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -122.04 78.33 41.91 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.545 -0.909 . . . . 62.24 108.545 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.24 -41.81 6.54 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.116 2.544 . . . . 73.43 112.963 -165.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -106.47 17.9 22.7 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 123.884 0.873 . . . . 75.15 110.231 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.61 -51.29 11.94 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 116.369 1.988 . . . . 32.0 116.369 -164.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 14.9 Cg_endo -88.05 -14.38 3.45 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.807 1.671 . . . . 64.15 113.92 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -75.72 -40.57 55.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.417 1.087 . . . . 62.43 109.034 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.02 -1.07 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 114.702 -1.135 . . . . 75.21 110.257 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.17 -34.95 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.918 1.287 . . . . 74.11 110.578 164.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.95 -12.76 61.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.806 1.243 . . . . 72.42 112.156 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -89.94 101.93 14.63 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.097 0.959 . . . . 62.34 109.188 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -99.37 52.56 0.95 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.145 0.978 . . . . 71.55 111.234 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.45 -169.46 3.22 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.489 -0.778 . . . . 72.33 109.246 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -78.07 118.27 71.14 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.243 1.017 . . . . 73.24 111.528 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' D' ' 68' ' ' LEU . 17.0 Cg_exo -65.47 97.39 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.304 2.003 . . . . 65.24 109.682 167.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.63 115.51 4.79 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 124.337 1.023 . . . . 74.43 109.847 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.405 HG21 HD11 ' D' ' 126' ' ' LEU . 16.7 m -97.09 113.31 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.908 0.861 . . . . 45.24 109.555 -174.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.564 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.8 tmtt? -88.3 118.56 27.99 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.175 -1.417 . . . . 75.11 107.175 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.472 HD21 HD22 ' D' ' 128' ' ' LEU . 10.2 mp -94.27 144.33 25.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.623 -0.88 . . . . 72.31 108.623 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 24.6 t70 -145.27 118.66 9.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.142 -0.936 . . . . 64.21 108.839 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.79 130.39 44.05 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.342 0.657 . . . . 73.11 109.869 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -147.09 157.43 43.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.144 -1.058 . . . . 61.21 108.144 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -146.41 166.28 26.86 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.939 0.495 . . . . 72.33 110.479 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 166.72 31.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.457 1.103 . . . . 64.45 109.484 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -149.12 153.85 38.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.268 0.627 . . . . 61.11 109.743 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.5 126.83 9.26 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.502 0.721 . . . . 72.22 109.138 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' D' ' 55' ' ' VAL . 52.2 tt0 -71.84 119.27 15.78 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.536 -0.542 . . . . 73.43 109.536 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.15 -38.1 12.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.2 0.524 . . . . 72.13 110.12 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.08 174.4 11.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.803 -1.09 . . . . 55.13 109.561 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.67 133.25 45.54 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.245 -0.889 . . . . 74.01 109.534 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.88 15.4 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.797 1.239 . . . . 74.04 112.057 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' D' ' 50' ' ' GLN . 87.6 t -130.54 129.6 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.221 0.608 . . . . 71.12 110.784 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.14 129.36 41.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.016 0.926 . . . . 72.5 109.066 171.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -95.48 111.58 23.46 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.709 -0.848 . . . . 71.25 108.709 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 41.5 t -100.52 124.37 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.27 -1.011 . . . . 63.22 108.27 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.9 t -101.06 135.27 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.754 0.822 . . . . 71.42 109.282 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.65 43.66 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.897 -1.149 . . . . 72.24 107.897 175.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -98.75 108.37 21.04 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.641 HG21 ' HB1' ' D' ' 110' ' ' ALA . 48.1 t -105.35 116.66 49.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.966 -1.124 . . . . 55.32 107.966 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.6 m -111.81 137.1 50.22 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.156 0.503 . . . . 72.35 109.892 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 100.01 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.129 1.372 . . . . 74.23 107.885 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 40.3 m -96.51 94.59 7.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.409 -1.33 . . . . 71.32 107.409 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.83 141.23 30.28 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.577 -0.527 . . . . 72.4 109.577 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.88 137.46 18.79 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.502 0.501 . . . . 72.53 111.798 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' D' ' 38' ' ' PRO . 12.1 mt -110.53 107.85 17.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.919 1.288 . . . . 74.0 109.059 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -143.55 37.27 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.553 0.533 . . . . 75.2 112.183 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 8.24 15.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.629 0.772 . . . . 73.05 111.866 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -121.78 157.13 31.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.371 0.668 . . . . 62.45 109.894 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.3 m -73.05 141.02 47.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.67 -0.695 . . . . 63.02 110.534 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.56 -58.36 2.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.873 -1.158 . . . . 73.54 107.873 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -160.45 143.19 13.2 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 115.405 -0.816 . . . . 72.14 110.902 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.09 111.03 23.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.159 0.984 . . . . 74.12 109.209 171.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.556 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.5 t -125.06 133.72 52.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.427 0.691 . . . . 73.35 109.509 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -154.99 135.25 13.18 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.275 -0.639 . . . . 75.31 109.275 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.573 HG22 HG23 ' D' ' 21' ' ' ILE . 97.6 t -127.23 142.32 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.686 0.795 . . . . 73.51 109.191 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.617 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 62.2 mt-30 -115.25 91.42 3.6 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.757 0.823 . . . . 75.14 109.078 171.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.61 93.04 6.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.899 -1.501 . . . . 61.12 108.861 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.32 141.26 18.94 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.282 -0.727 . . . . 74.35 111.282 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.53 130.57 4.63 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.558 -1.017 . . . . 51.1 110.558 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.63 121.01 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.069 -1.085 . . . . 71.12 108.069 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.5 122.6 35.64 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.584 0.754 . . . . 74.33 109.591 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -75.87 103.1 5.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.118 -0.697 . . . . 73.44 109.118 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.82 136.78 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.406 0.683 . . . . 74.24 110.546 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.88 160.95 12.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.215 1.006 . . . . 61.14 109.062 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.5 14.14 74.6 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 121.807 -0.235 . . . . 73.14 113.61 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.602 HD13 ' SD ' ' D' ' 94' ' ' MET . 1.8 pp -114.34 143.17 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 73.12 110.248 -174.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.13 177.4 4.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.719 0.807 . . . . 64.31 110.084 175.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.84 -137.87 39.29 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.561 0.538 . . . . 75.23 112.709 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.8 m -68.63 -30.73 69.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.384 1.074 . . . . 72.44 111.692 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.48 -49.3 75.95 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.49 0.716 . . . . 74.31 110.559 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.602 ' SD ' HD13 ' D' ' 89' ' ' ILE . 10.0 tpt -76.5 -33.53 58.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.1 0.56 . . . . 73.24 111.245 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.48 80.42 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.677 0.751 . . . . 73.32 110.633 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -80.15 -38.65 30.99 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.382 -1.281 . . . . 71.41 110.738 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 43.5 t -63.4 -45.11 92.55 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.082 0.553 . . . . 52.15 111.486 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.01 -54.11 6.35 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.743 0.817 . . . . 74.34 110.73 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.11 -4.7 83.94 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 115.005 0.762 . . . . 71.22 115.005 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.44 -49.74 0.41 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.992 0.896 . . . . 71.14 112.126 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.414 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 56.9 t80 -76.04 -37.39 58.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.795 0.438 . . . . 70.41 111.582 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 72.1 m -65.06 -50.07 63.66 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.539 -0.743 . . . . 45.44 110.386 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 88.3 Cg_exo -51.22 -36.02 54.82 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.299 1.999 . . . . 72.02 114.254 167.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.37 -40.15 93.18 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.488 0.715 . . . . 55.14 111.022 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.81 -43.28 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.674 0.79 . . . . 74.52 110.348 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.2 -20.41 59.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.122 -0.944 . . . . 64.13 111.867 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -66.34 -41.4 41.69 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.469 1.285 . . . . 74.44 114.469 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.44 -45.18 41.52 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.937 1.758 . . . . 54.04 112.846 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -75.06 -35.83 61.85 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.892 0.877 . . . . 73.24 111.219 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.641 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.04 -52.44 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.094 0.957 . . . . 65.23 110.243 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.489 ' NH2' HG23 ' B' ' 105' ' ' ILE . 33.9 ttp180 -57.37 -49.84 74.87 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.231 -1.35 . . . . 71.03 109.993 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.47 -41.5 89.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.501 1.126 . . . . 64.43 111.775 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.444 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 36.6 t -57.96 -44.05 86.79 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.899 0.749 . . . . 55.24 110.689 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.556 HG23 ' SG ' ' D' ' 76' ' ' CYS . 71.1 mt -67.81 -49.16 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.68 0.792 . . . . 71.14 110.498 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.51 HG21 ' HE2' ' B' ' 109' ' ' TYR . 91.1 m -52.42 -48.11 65.92 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.379 1.472 . . . . 74.32 112.095 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -67.91 -41.24 82.96 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.369 -1.287 . . . . 73.25 110.533 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -65.15 -34.79 79.23 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.818 0.447 . . . . 73.2 111.964 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.3 t -66.4 -44.18 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 123.718 0.637 . . . . 74.42 110.295 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -71.8 -31.59 66.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.353 -0.385 . . . . 72.12 110.783 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -69.02 -27.65 65.87 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.747 0.819 . . . . 71.24 110.06 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.24 11.26 68.14 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.873 0.733 . . . . 60.11 112.901 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.485 HG23 ' HB3' ' C' ' 17' ' ' TYR . 42.2 p 56.02 33.8 22.51 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.829 1.651 . . . . 72.13 113.08 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 39.1 m-85 -110.98 166.37 10.89 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 125.141 1.376 . . . . 73.41 109.725 175.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 41.5 Cg_endo -61.42 123.46 12.82 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.046 2.497 . . . . 72.31 112.167 -176.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -52.06 122.21 8.09 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.051 0.844 . . . . 71.04 110.397 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.405 HD11 HG21 ' D' ' 40' ' ' VAL . 36.8 tp -103.9 93.91 5.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.391 0.615 . . . . 51.14 109.658 -166.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -100.53 82.44 2.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.01 -0.996 . . . . 70.53 108.481 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.472 HD22 HD21 ' D' ' 42' ' ' LEU . 95.9 mt -67.4 139.54 57.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.16 -0.927 . . . . 73.23 110.669 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 143.83 98.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.426 0.691 . . . . 52.04 110.779 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.36 142.18 14.74 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.059 1.839 . . . . 73.24 110.233 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.76 108.78 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 107.967 -1.124 . . . . 62.11 107.967 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 . . . . . 0 C--O 1.239 0.549 0 N-CA-C 107.223 -1.399 . . . . 75.54 107.223 174.843 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.24 0.601 0 N-CA-C 108.29 -1.004 . . . . 64.12 108.29 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 72.1 t80 -95.38 142.39 27.82 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.658 -0.867 . . . . 64.42 108.658 168.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -162.14 137.26 7.15 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.678 0.611 . . . . 72.01 112.501 170.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.438 HD13 ' CE2' ' A' ' 84' ' ' PHE . 3.8 tp -75.96 121.6 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.516 1.126 . . . . 74.22 109.16 170.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -107.09 -13.8 15.08 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-O 117.781 -1.105 . . . . 65.44 112.163 -177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 178.38 126.58 0.05 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 119.193 0.906 . . . . 74.1 110.691 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.483 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 77.2 mt -106.44 131.62 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.015 -1.105 . . . . 61.41 108.015 172.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -158.67 170.06 23.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.6 0.714 . . . . 75.11 111.136 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -99.5 114.31 27.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.795 -1.093 . . . . 72.43 108.71 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -77.65 -38.77 47.08 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.84 136.13 32.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.592 -1.186 . . . . 73.31 109.343 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.1 mt -129.95 130.34 66.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.107 -1.442 . . . . 74.32 107.107 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -136.32 106.1 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.523 -0.917 . . . . 72.15 108.523 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.1 t80 -120.65 110.09 16.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.178 -1.786 . . . . 70.24 106.178 167.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -119.43 127.11 52.79 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.278 0.631 . . . . 73.05 109.379 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -126.24 79.4 70.07 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.648 -1.241 . . . . 74.42 107.648 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.07 -22.07 23.21 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.889 2.393 . . . . 65.13 112.372 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -119.07 33.12 5.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.179 0.992 . . . . 61.51 109.048 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.16 -44.69 99.83 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.773 1.229 . . . . 63.05 113.331 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.47 -29.68 71.38 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.463 1.442 . . . . 70.34 112.555 173.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -76.62 -28.73 56.21 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.516 -0.766 . . . . 73.11 111.828 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.6 p -61.74 -23.08 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 118.193 0.451 . . . . 73.35 112.143 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.61 -39.65 67.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.176 0.99 . . . . 75.3 110.869 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -88.39 -19.59 26.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 71.41 110.744 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.38 148.83 33.53 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.419 0.688 . . . . 72.34 110.289 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.36 127.47 32.78 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 74.24 108.327 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.442 ' CE3' HD21 ' A' ' 68' ' ' LEU . 25.3 t-105 -86.26 84.94 7.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.578 0.704 . . . . 73.32 110.182 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 80.32 68.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.283 -1.377 . . . . 71.32 107.283 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.67 153.26 17.58 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.929 2.419 . . . . 74.42 113.154 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -96.06 90.72 5.64 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.001 -1.111 . . . . 71.1 108.001 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 m -69.98 93.18 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.381 1.086 . . . . 64.01 109.532 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -103.34 121.0 41.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.751 -1.113 . . . . 71.14 109.951 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.34 132.33 43.17 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.044 0.937 . . . . 71.51 109.348 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.722 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.4 m-20 -126.56 132.45 51.32 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.025 0.93 . . . . 73.15 108.754 176.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.746 -0.835 . . . . 74.35 108.746 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -134.29 145.42 49.07 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.679 -0.489 . . . . 70.24 109.679 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 m -109.42 121.38 45.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.865 0.866 . . . . 72.11 108.864 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.97 123.37 27.23 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 107.412 -1.329 . . . . 72.33 107.412 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.6 m -133.16 152.63 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.661 0.384 . . . . 60.54 110.704 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -149.96 130.84 14.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.838 0.855 . . . . 63.05 109.311 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -87.79 117.82 26.89 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.866 -0.791 . . . . 74.4 108.866 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 57' ' ' GLU . 54.9 mt -84.63 -44.57 13.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.543 0.737 . . . . 73.14 110.696 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.47 -171.94 4.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.692 0.797 . . . . 63.13 109.923 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -59.96 102.75 0.17 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.375 0.67 . . . . 74.02 110.39 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 65.3 12.11 7.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.823 1.249 . . . . 73.12 112.997 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.4 t -99.83 113.82 36.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.859 -1.534 . . . . 55.33 106.859 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -108.82 165.91 11.21 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.199 1.0 . . . . 74.13 111.3 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 51' ' ' LEU . 28.0 tt0 -131.26 118.59 20.6 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 112.574 -2.103 . . . . 74.34 106.862 164.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.61 117.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.344 -1.724 . . . . 63.14 106.344 170.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.4 t -97.9 127.99 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.114 -0.698 . . . . 53.21 109.114 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 109.85 21.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.427 -1.323 . . . . 74.14 107.427 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -106.01 106.74 17.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.019 -0.991 . . . . 73.2 109.559 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.95 133.47 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 114.95 -1.023 . . . . 75.4 108.553 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.722 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.8 m -117.69 131.71 56.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.912 -0.773 . . . . 75.14 108.912 173.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 37.1 t -126.21 111.42 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.869 1.268 . . . . 53.34 108.263 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 m -102.26 145.1 29.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.578 -0.527 . . . . 72.54 109.578 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.43 109.94 7.98 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.233 -1.025 . . . . 72.25 108.233 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.7 m -126.81 145.69 50.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.275 0.559 . . . . 75.15 110.363 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.442 HD21 ' CE3' ' A' ' 36' ' ' TRP . 49.1 mt -107.84 51.56 0.74 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.542 1.537 . . . . 73.15 108.031 -175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.93 -85.44 0.89 Allowed Glycine 0 C--N 1.349 1.282 0 CA-C-N 114.569 -1.196 . . . . 33.15 111.483 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -89.92 -24.73 21.25 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.131 0.973 . . . . 75.12 111.846 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -118.15 107.03 13.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.086 0.554 . . . . 75.4 110.392 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.2 123.44 20.72 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 118.525 0.602 . . . . 72.54 109.889 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.39 -54.73 6.33 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.852 -1.067 . . . . 70.44 109.648 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.5 172.48 17.14 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.467 -1.242 . . . . 74.41 110.912 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.6 141.31 33.46 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.114 -1.403 . . . . 51.5 107.364 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.544 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 54.9 m -140.16 99.78 3.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.285 -0.635 . . . . 61.21 109.285 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -121.58 122.86 40.61 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.508 -0.923 . . . . 64.2 108.508 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.47 131.13 70.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.511 0.725 . . . . 71.23 109.293 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -104.59 93.44 4.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.931 -1.031 . . . . 64.4 109.434 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -81.67 92.88 6.66 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.112 -1.069 . . . . 65.34 108.112 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.12 143.7 20.51 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.242 -0.743 . . . . 54.13 111.242 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.82 129.92 4.49 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.491 -0.644 . . . . 72.21 111.491 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -78.53 129.5 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 107.648 -1.242 . . . . 65.22 107.648 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' CE2' HD13 ' A' ' 13' ' ' ILE . 49.5 m-85 -133.49 121.72 22.59 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.134 -0.691 . . . . 62.44 109.134 174.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.9 t -74.3 115.27 13.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.591 -1.262 . . . . 64.51 107.591 169.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -137.78 119.06 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.682 0.793 . . . . 71.23 109.729 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.01 161.6 28.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.931 0.893 . . . . 61.23 109.849 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.3 5.24 87.48 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.646 0.591 . . . . 63.31 114.399 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.34 166.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.753 . . . . 72.2 108.972 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -172.74 175.97 3.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.343 -0.614 . . . . 64.25 109.343 -168.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.42 -126.01 38.04 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.813 0.695 . . . . 74.34 114.437 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.3 p -82.47 -20.39 36.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.689 0.796 . . . . 73.34 110.98 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.96 -43.45 98.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.012 0.925 . . . . 71.24 111.006 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -49.48 67.07 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.879 0.737 . . . . 74.35 110.352 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.95 71.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.354 0.662 . . . . 62.13 111.534 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -71.56 -41.8 68.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.732 0.813 . . . . 64.4 110.528 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.67 -65.25 0.81 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.029 0.532 . . . . 64.24 110.489 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.62 -40.58 84.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.222 0.609 . . . . 74.22 111.046 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.78 -38.81 49.28 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.601 0.563 . . . . 51.04 113.793 -168.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 133' ' ' PHE . . . -126.55 -53.53 1.46 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.124 0.462 . . . . 40.31 112.149 -171.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.437 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 82.9 t80 -63.7 -42.27 97.99 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.011 0.924 . . . . 74.4 112.862 -171.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' CE2' ' A' ' 11' ' ' PHE . 73.7 m -77.62 -41.43 2.26 Favored Pre-proline 0 CA--C 1.557 1.243 0 N-CA-C 113.048 0.758 . . . . 72.33 113.048 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.76 -23.64 55.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 CA-C-N 121.139 1.442 . . . . 65.01 112.544 166.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -70.8 -24.92 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.966 0.506 . . . . 73.31 111.463 172.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.73 -42.82 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.968 0.89 . . . . 70.33 109.299 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.511 HD21 ' HA3' ' A' ' 82' ' ' GLY . 25.1 mt -84.06 -27.72 28.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.421 -1.263 . . . . 62.03 112.444 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -61.92 -40.74 71.6 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 114.504 1.298 . . . . 73.23 114.504 -171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.89 -36.22 82.57 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.963 1.775 . . . . 71.45 113.057 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' C' ' 108' ' ' PRO . 87.5 m-85 -81.56 -35.33 30.39 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.181 -0.918 . . . . 75.42 111.352 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.49 80.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.886 0.474 . . . . 62.01 110.566 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm105 -56.46 -54.83 41.14 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 114.796 -1.093 . . . . 50.12 109.216 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.27 -41.33 88.61 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.393 1.058 . . . . 70.21 111.564 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.0 t -57.78 -50.98 71.42 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.742 0.651 . . . . 73.12 110.102 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.449 HG21 HG21 ' A' ' 64' ' ' VAL . 96.5 mt -63.57 -42.72 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.937 0.895 . . . . 72.25 111.306 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.43 HG21 ' HE2' ' C' ' 109' ' ' TYR . 90.7 m -57.35 -45.19 84.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.243 1.017 . . . . 73.4 110.616 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -70.93 -41.41 71.22 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.702 -1.135 . . . . 73.44 110.054 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 19.4 mtp -57.66 -46.14 84.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.864 0.866 . . . . 75.41 111.67 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.05 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.961 0.904 . . . . 73.32 110.67 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 82.5 p -69.66 -33.07 72.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.406 0.282 . . . . 35.04 111.62 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.598 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.7 mtt-85 -68.65 -27.31 65.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.48 0.712 . . . . 63.13 110.789 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.75 9.88 58.21 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.502 0.501 . . . . 61.44 113.2 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m 69.31 42.17 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.869 1.319 . . . . 65.54 110.584 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' SER . 90.5 m-85 -120.66 156.48 55.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.837 -1.074 . . . . 64.22 109.523 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.19 124.65 16.07 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.565 1.51 . . . . 72.02 109.789 166.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 7.5 pt20 -60.69 146.38 45.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.827 0.451 . . . . 73.12 111.34 -174.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -114.22 105.8 13.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.008 -0.542 . . . . 62.12 110.19 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.28 93.22 4.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 74.44 109.742 178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.02 160.66 31.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.697 -1.138 . . . . 71.04 110.824 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' C' ' 13' ' ' ILE . . . -68.84 145.3 96.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.279 0.632 . . . . 54.43 112.441 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.25 114.5 4.01 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.118 1.879 . . . . 75.02 110.818 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 109.19 23.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.797 -1.557 . . . . 74.22 106.797 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -104.53 92.03 4.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.982 0.913 . . . . 72.53 110.358 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.516 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 93.2 m-85 . . . . . 0 N--CA 1.481 1.094 0 CA-C-N 114.988 -1.005 . . . . 74.51 111.67 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.245 0.829 0 N-CA-C 109.017 -0.735 . . . . 50.34 109.017 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.02 156.43 39.96 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.382 -0.372 . . . . 73.04 111.177 162.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -122.78 111.37 16.62 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.75 -1.204 . . . . 73.4 107.75 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 tt -61.34 101.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.914 -1.494 . . . . 72.12 109.318 170.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -78.4 -33.25 48.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.677 -0.692 . . . . 71.2 109.672 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -173.19 141.36 0.94 Allowed 'General case' 0 C--N 1.361 1.089 0 O-C-N 123.354 0.409 . . . . 70.04 110.761 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.36 136.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 106.545 -1.65 . . . . 61.14 106.545 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -166.04 148.65 7.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.099 0.476 . . . . 73.43 111.069 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.616 HG21 HD11 ' B' ' 21' ' ' ILE . 86.3 m -76.92 117.42 18.5 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.712 -0.847 . . . . 73.43 108.712 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -88.38 -25.61 22.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.152 0.581 . . . . 52.23 110.633 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 15.8 t70 -158.55 143.54 16.24 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.347 0.594 . . . . 75.43 111.845 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.616 HD11 HG21 ' B' ' 18' ' ' THR . 39.9 mm -134.18 138.59 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 C-N-CA 125.897 1.679 . . . . 72.32 106.867 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -146.62 133.4 20.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.606 -0.887 . . . . 74.04 108.606 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.2 115.59 6.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.395 -1.335 . . . . 74.33 107.395 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.06 127.16 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -122.51 86.95 48.98 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 108.383 -0.969 . . . . 60.51 108.383 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.28 -19.2 50.36 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.916 2.41 . . . . 62.13 111.928 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -126.6 30.58 5.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.021 0.928 . . . . 70.41 110.739 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.05 -49.51 50.23 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 124.55 1.14 . . . . 72.21 112.894 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.64 -24.46 1.86 Allowed 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 121.8 1.666 . . . . 72.44 113.699 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -76.56 -5.36 47.34 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.354 0.662 . . . . 72.32 112.356 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.14 -13.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.849 0.86 . . . . 72.43 110.653 170.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.2 -41.95 80.36 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.223 1.009 . . . . 75.41 110.78 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -75.75 -37.99 58.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.933 -1.031 . . . . 72.43 110.714 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.406 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 77.5 mttt -107.93 89.03 2.87 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.462 -0.79 . . . . 64.34 109.71 -174.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.75 76.21 10.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.846 1.258 . . . . 73.14 112.025 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -172.93 156.23 3.3 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.357 0.663 . . . . 73.25 110.468 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -58.29 119.21 33.56 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.537 1.135 . . . . 61.33 111.473 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 37.8 Cg_endo -65.92 163.64 30.24 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.906 2.404 . . . . 72.44 112.018 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -76.08 100.92 5.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.724 -1.213 . . . . 73.15 107.724 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.496 HG12 HD13 ' B' ' 126' ' ' LEU . 16.8 t -88.6 120.6 37.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.361 -1.348 . . . . 71.2 107.361 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -145.31 144.6 30.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.017 0.527 . . . . 64.32 110.276 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.528 HD21 ' HG ' ' B' ' 128' ' ' LEU . 1.9 pt? -115.81 160.24 20.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 70.35 110.065 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.24 138.18 44.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.455 1.102 . . . . 64.33 108.721 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -90.96 134.34 34.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.248 0.619 . . . . 75.12 109.574 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.32 150.05 34.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.973 0.909 . . . . 74.31 108.609 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.3 m -142.92 113.42 7.37 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.105 -0.702 . . . . 75.01 109.105 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.75 120.81 32.84 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.384 -1.339 . . . . 70.11 107.384 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -132.92 172.26 12.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.941 0.496 . . . . 63.04 111.368 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.3 p -152.77 179.08 8.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.864 0.866 . . . . 74.25 109.999 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -122.13 121.74 37.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.629 0.771 . . . . 71.24 110.083 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 81.4 mt -79.03 -44.8 21.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.619 0.767 . . . . 74.05 110.642 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.18 -172.01 3.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.56 -0.745 . . . . 35.32 110.911 -172.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.87 111.95 1.66 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.767 -1.106 . . . . 75.23 110.265 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 70.43 -5.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.047 1.739 . . . . 52.04 112.932 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.85 93.17 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.054 -1.091 . . . . 65.23 108.054 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.13 141.07 30.7 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.898 -1.046 . . . . 73.31 110.005 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.657 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.7 tm-20 -105.2 100.15 9.74 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.888 -1.523 . . . . 64.4 106.888 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.64 117.68 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.25 0.62 . . . . 73.33 109.822 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.94 121.1 55.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 109.286 -0.635 . . . . 73.14 109.286 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.06 118.08 30.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.05 -1.463 . . . . 72.33 107.05 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -106.45 116.45 31.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.494 0.717 . . . . 71.25 109.355 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.3 t -109.7 119.04 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.145 -1.057 . . . . 74.35 108.145 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -116.32 125.82 52.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.988 0.515 . . . . 71.3 110.21 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.666 HG21 HG21 ' B' ' 114' ' ' ILE . 77.8 t -107.72 137.43 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.729 1.212 . . . . 71.13 110.898 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.3 m -124.41 146.85 48.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.212 1.005 . . . . 74.21 109.923 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 156.26 42.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.066 0.946 . . . . 73.21 109.402 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.7 p -153.1 142.61 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.655 0.613 . . . . 75.22 112.655 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.1 mt -118.56 98.18 6.12 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.629 -0.878 . . . . 73.11 108.629 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.87 -110.44 2.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 122.954 0.311 . . . . 52.0 113.05 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -88.48 4.97 44.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.843 0.857 . . . . 61.1 110.285 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 68' ' ' LEU . 1.2 mp0 -114.4 153.07 30.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.79 1.236 . . . . 65.41 109.998 -167.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -87.43 129.24 35.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 162.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.47 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -83.17 -55.8 4.14 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.849 -0.797 . . . . 43.33 108.849 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.1 150.29 20.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.804 -1.089 . . . . 71.44 110.694 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -124.88 113.87 18.44 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.505 1.522 . . . . 53.41 107.643 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.521 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.7 t -116.29 160.1 20.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.407 -0.961 . . . . 72.33 108.407 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.02 131.84 3.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.628 -0.878 . . . . 73.41 108.628 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.52 142.78 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.715 -0.846 . . . . 75.21 108.715 172.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.5 mt-30 -120.73 97.91 5.77 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.183 -0.917 . . . . 63.32 109.071 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -87.77 101.29 13.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.12 154.49 24.47 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 111.16 -0.776 . . . . 71.45 111.16 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.73 126.16 2.01 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.673 -1.371 . . . . 55.4 109.673 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.657 HG12 ' HG2' ' B' ' 57' ' ' GLU . 27.9 mt -85.25 115.89 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.114 -1.069 . . . . 73.15 108.114 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -124.93 132.47 53.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.798 -1.556 . . . . 74.25 106.798 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -88.97 88.63 7.66 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.025 -1.102 . . . . 62.43 108.025 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.68 129.83 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.935 0.494 . . . . 65.22 110.626 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.28 170.99 20.67 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.966 -1.015 . . . . 53.02 110.249 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.52 -49.35 2.62 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 75.21 112.219 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.615 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -72.12 152.28 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.871 0.468 . . . . 74.51 111.316 174.75 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -160.4 172.48 17.2 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.848 -1.069 . . . . 63.01 108.97 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.93 -125.42 38.97 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.616 0.572 . . . . 61.12 113.747 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.0 m -74.57 -27.51 60.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.744 0.818 . . . . 54.34 111.109 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -68.9 -40.19 79.28 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.682 0.793 . . . . 71.33 109.881 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -41.91 59.92 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.045 -0.525 . . . . 54.5 110.116 176.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.73 62.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.149 0.98 . . . . 75.11 111.649 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 39.0 t-80 -93.34 -13.1 28.52 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.061 -0.972 . . . . 74.44 111.191 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.31 -64.32 1.01 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.623 0.369 . . . . 70.24 110.195 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -15.83 60.93 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.146 0.178 . . . . 50.12 111.167 -176.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 -6.08 53.67 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.227 -0.763 . . . . 73.43 114.198 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -149.5 -47.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.399 1.1 . . . . 60.2 112.875 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -73.21 -54.02 9.48 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.052 0.541 . . . . 74.3 111.254 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 68.1 m -63.01 -45.3 86.65 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.529 0.732 . . . . 60.23 111.335 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -50.78 -45.0 38.05 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.416 2.077 . . . . 73.02 113.893 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 123.176 0.591 . . . . 62.13 112.057 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.525 HG23 ' NH2' ' D' ' 111' ' ' ARG . 79.5 mt -71.57 -47.98 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.659 0.784 . . . . 70.54 110.863 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -80.3 -20.88 43.33 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.233 -0.894 . . . . 61.11 112.298 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 64.5 t80 -64.71 -45.78 75.82 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.653 -1.165 . . . . 64.24 113.387 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 19.1 Cg_endo -56.72 -37.64 97.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 CA-C-N 121.581 1.6 . . . . 55.02 113.076 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.81 -49.6 65.29 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.31 0.644 . . . . 75.14 110.973 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.99 -42.39 98.34 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.717 0.807 . . . . 64.24 111.181 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.436 ' NH2' HG22 ' C' ' 122' ' ' THR . 50.1 ttt180 -58.87 -55.22 37.92 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.681 1.593 . . . . 70.41 110.96 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -38.5 90.88 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.487 0.715 . . . . 74.12 109.918 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.598 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.8 t -67.69 -42.08 82.64 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.745 -0.662 . . . . 60.22 112.103 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 64' ' ' VAL . 96.8 mt -62.52 -50.61 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.696 -0.483 . . . . 60.13 109.696 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 86.7 m -55.59 -31.52 62.3 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.092 0.87 . . . . 75.53 111.183 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.9 t -66.05 -52.56 47.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.572 0.749 . . . . 72.21 110.403 172.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.6 mmt -67.36 -36.14 80.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.55 0.574 . . . . 64.42 112.55 -172.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.94 -42.02 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.639 0.776 . . . . 74.02 110.475 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.763 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 90.3 p -71.73 -30.31 65.47 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.469 -0.787 . . . . 63.44 111.872 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -63.44 -33.7 76.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 65.15 110.368 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.77 9.0 58.05 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.839 0.712 . . . . 71.3 113.329 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.9 p 56.15 27.97 12.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.892 1.677 . . . . 42.24 112.466 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.86 158.66 32.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.249 -0.887 . . . . 71.01 110.578 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.576 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 38.8 Cg_exo -61.98 179.73 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.484 2.789 . . . . 72.43 115.999 -171.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.63 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -62.84 150.21 42.29 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 113.894 -1.503 . . . . 71.13 114.347 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.496 HD13 HG12 ' B' ' 40' ' ' VAL . 53.3 tp -141.61 86.04 1.98 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.008 -1.478 . . . . 63.02 107.008 167.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' C' ' 119' ' ' SER . 7.1 m120 -116.11 90.62 3.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.485 -1.302 . . . . 75.04 107.485 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.528 ' HG ' HD21 ' B' ' 42' ' ' LEU . 1.9 tm? -84.88 138.01 32.79 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.512 -0.922 . . . . 73.43 108.512 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.433 ' HB2' ' NH1' ' D' ' 15' ' ' ARG . . . -67.62 107.24 1.64 Allowed Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 124.357 1.035 . . . . 75.13 109.913 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 129.71 25.28 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.09 1.86 . . . . 63.43 110.925 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.516 ' HA ' HD13 ' D' ' 13' ' ' ILE . 30.2 m -118.36 140.52 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.277 0.631 . . . . 71.34 110.522 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.715 ' H ' HG21 ' D' ' 13' ' ' ILE . 15.6 m-20 -69.76 104.97 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.256 -0.883 . . . . 73.42 109.093 170.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 CA--C 1.554 1.104 0 CA-C-O 120.858 0.361 . . . . 72.23 110.427 172.843 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 108.054 -1.091 . . . . 74.35 108.054 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.591 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 8.0 t80 -100.28 119.67 38.75 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.104 -0.702 . . . . 61.1 109.104 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -141.25 119.25 11.93 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.948 -0.76 . . . . 64.22 108.948 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.679 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -74.28 127.35 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 108.682 -0.859 . . . . 72.34 108.682 171.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.5 mm100 -96.36 -49.52 5.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.096 0.558 . . . . 71.25 110.36 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -162.65 123.29 2.44 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.971 -0.381 . . . . 72.23 109.971 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.679 HG13 HD11 ' C' ' 13' ' ' ILE . 76.6 mt -113.69 135.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.038 -1.097 . . . . 72.11 108.038 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.9 p90 -174.5 158.29 2.79 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 124.132 0.895 . . . . 64.4 110.866 -172.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -80.3 136.71 36.48 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.376 -0.829 . . . . 70.34 109.487 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -89.55 -51.39 5.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.27 1.033 . . . . 72.32 108.846 171.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 25.9 t70 -134.91 132.91 39.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.134 -1.848 . . . . 52.44 108.2 -171.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.4 mt -129.29 140.52 48.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.728 -1.582 . . . . 73.11 106.728 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -148.71 145.02 27.48 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.402 -0.592 . . . . 74.43 109.402 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.72 111.64 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.032 -1.47 . . . . 75.35 107.032 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.06 117.87 31.79 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.832 -1.173 . . . . 62.11 107.832 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.36 87.84 8.16 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 108.112 -1.07 . . . . 71.32 108.112 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.3 3.41 7.49 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.05 2.5 . . . . 62.42 111.709 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.3 12.56 8.21 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 124.246 1.019 . . . . 73.01 109.936 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.39 -49.43 82.18 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.737 1.014 . . . . 75.25 113.737 -171.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.53 -27.87 0.54 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.666 1.578 . . . . 54.11 113.449 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -70.12 -25.74 63.63 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.205 1.002 . . . . 63.11 112.905 -173.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.57 -6.86 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.328 1.051 . . . . 71.41 111.564 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -56.95 -41.7 78.75 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.357 1.063 . . . . 72.4 112.638 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -100.42 4.24 43.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.702 0.801 . . . . 53.31 110.606 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.496 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.5 OUTLIER -87.68 168.21 13.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.058 0.543 . . . . 62.13 111.76 -168.449 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.08 113.53 10.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.008 -0.738 . . . . 63.45 109.008 167.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -86.78 65.21 8.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.497 0.719 . . . . 65.03 110.157 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -135.57 78.98 48.74 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.414 -0.958 . . . . 73.21 108.414 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.96 167.57 26.77 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.826 2.351 . . . . 53.03 112.448 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -122.83 109.25 13.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.971 -1.122 . . . . 73.03 107.971 171.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.568 HG11 HD11 ' C' ' 126' ' ' LEU . 97.6 t -78.45 103.11 5.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.829 -0.804 . . . . 65.22 108.829 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -91.66 116.33 28.79 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.522 -1.288 . . . . 60.4 107.522 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.418 HD12 HG12 ' C' ' 40' ' ' VAL . 9.2 mp -85.93 149.1 25.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.974 0.51 . . . . 73.42 109.84 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.35 142.29 25.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.847 0.859 . . . . 74.21 108.976 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -135.17 136.02 41.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.897 -0.779 . . . . 74.23 108.897 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 28.0 t70 -141.18 145.9 36.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.991 -1.114 . . . . 71.42 107.991 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -114.2 137.5 51.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.096 0.558 . . . . 55.41 110.472 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.28 47.13 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.444 1.097 . . . . 35.11 108.589 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 70.2 p -160.22 150.53 18.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.741 0.416 . . . . 74.25 110.95 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.3 t -149.43 133.24 16.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.554 0.742 . . . . 75.03 109.511 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -77.98 139.03 39.14 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.602 -0.518 . . . . 74.23 109.602 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.585 HD11 HD12 ' C' ' 83' ' ' ILE . 53.1 mt -114.65 -30.52 6.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.773 0.829 . . . . 73.03 110.893 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.33 -175.07 4.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.25 1.02 . . . . 74.34 110.142 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.39 100.16 0.34 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.445 -0.798 . . . . 24.33 110.223 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.75 9.25 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.273 1.429 . . . . 75.31 113.843 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 89.9 t -100.41 117.95 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.635 -1.617 . . . . 62.42 106.635 164.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -137.06 -178.1 5.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.852 -0.796 . . . . 73.35 108.852 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -128.51 138.9 52.49 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.336 1.055 . . . . 63.43 109.829 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.69 127.72 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.767 -1.197 . . . . 72.22 107.767 168.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 111.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.913 0.885 . . . . 40.01 109.123 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' C' ' 103' ' ' PRO . 54.4 mt -87.53 109.06 19.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.077 0.551 . . . . 71.35 110.316 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 79.6 ttt180 -85.38 102.03 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.308 -0.997 . . . . 73.42 108.308 172.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.46 124.13 55.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.913 -1.143 . . . . 52.23 107.913 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -124.99 142.34 51.55 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.407 0.622 . . . . 71.14 109.769 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.531 HG11 HD22 ' C' ' 126' ' ' LEU . 70.6 t -135.52 130.22 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.442 1.097 . . . . 65.53 108.93 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.6 m -112.35 141.41 46.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.112 -1.07 . . . . 75.03 108.112 172.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.54 125.52 45.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.475 -1.306 . . . . 74.13 107.475 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -135.58 131.31 35.74 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.102 0.477 . . . . 65.32 110.5 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.496 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.7 mt -86.6 35.13 0.66 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.602 1.561 . . . . 65.42 109.321 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.57 -112.01 3.57 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 110.743 -0.943 . . . . 53.21 110.743 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.56 -31.52 18.6 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.632 0.773 . . . . 74.01 109.67 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -70.03 121.98 18.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.807 1.243 . . . . 74.41 110.363 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.5 m -80.05 131.66 35.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.765 0.257 . . . . 72.3 110.33 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.23 -53.89 4.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.112 0.565 . . . . 64.05 110.005 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -162.28 176.7 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.568 0.747 . . . . 73.01 111.07 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.482 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -136.73 143.96 43.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.656 -1.609 . . . . 63.3 106.656 171.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.482 ' N ' HD13 ' C' ' 75' ' ' LEU . 39.1 t -144.69 141.49 29.35 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.394 -0.965 . . . . 64.44 108.394 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.22 131.66 10.41 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.677 -0.49 . . . . 63.33 109.677 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.76 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.401 1.08 . . . . 64.21 108.305 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -121.1 96.84 5.26 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.232 1.013 . . . . 72.14 108.335 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.28 105.13 15.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.272 0.629 . . . . 74.21 110.556 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.45 150.57 25.86 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 123.668 0.605 . . . . 63.25 112.566 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.54 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -155.72 117.74 0.8 Allowed Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 111.47 -0.652 . . . . 64.21 111.47 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.585 HD12 HD11 ' C' ' 51' ' ' LEU . 9.5 mm -80.99 128.63 38.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 N-CA-C 108.733 -0.84 . . . . 52.33 108.733 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -135.11 131.17 36.57 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.193 0.597 . . . . 73.41 110.101 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -92.0 122.42 34.49 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.389 -1.337 . . . . 50.53 107.389 164.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 40.8 pt -113.71 -142.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 118.379 -0.819 . . . . 74.2 109.175 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 97.78 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.896 2.079 . . . . 72.2 110.596 176.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -39.56 3.1 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.316 -0.714 . . . . 64.45 111.316 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.416 HG13 ' H ' ' C' ' 89' ' ' ILE . 2.2 pp . . . . . 0 CA--C 1.551 1.018 0 C-N-CA 124.366 1.066 . . . . 75.32 111.166 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.684 0.278 . . . . 70.33 110.519 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.1 ttt -69.98 -41.94 73.76 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.676 -0.693 . . . . 74.34 110.957 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.1 76.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.976 0.51 . . . . 71.2 110.908 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -84.31 -21.48 30.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.672 0.789 . . . . 72.11 112.148 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 97.9 m -73.88 -59.75 2.57 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.701 0.401 . . . . 74.42 109.997 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.69 -26.3 68.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.179 0.991 . . . . 70.11 111.827 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 -22.44 42.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.375 -0.68 . . . . 75.02 114.295 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.84 -50.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.077 0.938 . . . . 64.5 113.428 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.457 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 85.4 t80 -69.87 -55.64 9.21 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 112.482 0.549 . . . . 74.25 112.482 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.591 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 32.0 m -60.9 -45.11 96.64 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.544 0.738 . . . . 52.45 111.277 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' C' ' 60' ' ' LEU . 91.5 Cg_exo -53.08 -40.37 76.96 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.591 2.194 . . . . 74.32 114.912 167.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.341 0.656 . . . . 72.01 111.511 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.455 HG23 ' NH1' ' A' ' 111' ' ' ARG . 51.4 mm -62.87 -42.4 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.471 -0.786 . . . . 72.22 110.554 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA3' ' C' ' 82' ' ' GLY . 73.8 mt -82.79 -25.43 32.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.988 0.915 . . . . 73.32 112.544 -171.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.16 -51.49 74.7 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.753 1.02 . . . . 73.11 113.753 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.423 ' HB3' ' CD2' ' A' ' 109' ' ' TYR . 19.5 Cg_endo -58.32 -33.95 98.19 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.837 1.691 . . . . 72.54 113.665 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.43 ' HE2' HG21 ' A' ' 115' ' ' THR . 86.5 m-85 -67.65 -47.73 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.436 0.694 . . . . 72.25 110.812 177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.84 92.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.762 0.825 . . . . 71.02 110.677 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.47 -53.26 59.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.678 1.591 . . . . 62.22 110.726 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.43 -30.94 70.81 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.699 0.799 . . . . 65.44 110.513 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.77 -38.04 87.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 74.21 110.655 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.458 HG23 ' SG ' ' C' ' 76' ' ' CYS . 61.0 mt -73.24 -42.07 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.021 -0.536 . . . . 73.12 110.385 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -55.94 -44.24 78.21 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.496 0.719 . . . . 53.42 110.928 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 85.6 p -70.58 -47.41 60.36 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.248 -0.887 . . . . 70.23 110.462 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.512 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -54.22 -45.77 72.34 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.319 1.048 . . . . 74.44 112.768 -177.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 -42.86 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.673 0.608 . . . . 74.13 110.509 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.417 ' HA ' ' ND2' ' B' ' 127' ' ' ASN . 37.6 t -67.82 -27.78 67.01 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.318 -0.855 . . . . 63.14 112.373 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.5 mtt-85 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.245 0.618 . . . . 72.53 109.575 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.96 7.96 64.78 Favored Glycine 0 C--N 1.36 1.895 0 O-C-N 123.794 0.684 . . . . 71.13 112.951 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.436 HG22 ' NH2' ' B' ' 111' ' ' ARG . 17.3 p 63.37 16.18 9.31 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 127.369 2.268 . . . . 74.21 113.586 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.91 153.38 63.73 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 107.894 -1.15 . . . . 71.54 107.894 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -51.98 118.56 4.63 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.969 2.446 . . . . 63.42 112.088 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.63 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 9.1 pt20 -44.77 146.89 0.7 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 124.906 1.282 . . . . 63.52 112.434 -172.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.568 HD11 HG11 ' C' ' 40' ' ' VAL . 14.7 tp -109.59 79.83 1.25 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.71 0.767 . . . . 74.42 112.845 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.763 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 6.9 p-10 -97.47 90.3 5.0 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.572 -1.195 . . . . 72.12 109.564 172.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 66.9 mt -74.83 146.0 42.37 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.478 -1.237 . . . . 72.24 109.465 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.03 130.03 92.83 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.339 0.399 . . . . 52.51 110.334 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.483 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 42.6 Cg_endo -65.61 101.31 0.44 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.955 2.437 . . . . 60.2 112.27 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 m -84.66 130.01 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.504 -0.771 . . . . 73.42 111.153 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -97.32 105.28 17.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.659 -1.238 . . . . 73.05 107.659 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.3 t80 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 124.575 1.15 . . . . 72.34 113.529 -176.14 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 C--O 1.242 0.679 0 N-CA-C 108.535 -0.913 . . . . 71.44 108.535 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.452 ' CZ ' ' SG ' ' D' ' 102' ' ' CYS . 43.4 t80 -157.31 126.48 5.92 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.7 mt-30 -140.08 158.11 44.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.143 0.577 . . . . 74.04 110.205 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.715 HG21 ' H ' ' B' ' 132' ' ' ASN . 10.5 tt -104.39 144.18 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.25 1.02 . . . . 74.52 110.191 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.44 -45.88 3.0 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.382 0.273 . . . . 73.22 111.624 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.433 ' NH1' ' HB2' ' B' ' 129' ' ' ALA . 12.7 tpt180 -169.79 130.75 1.04 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 119.33 -0.367 . . . . 70.31 110.923 -171.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.557 HG12 HD11 ' D' ' 13' ' ' ILE . 32.9 mm -116.73 130.37 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.206 -0.664 . . . . 65.04 109.206 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.09 158.79 39.59 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.741 0.817 . . . . 75.25 111.731 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -88.09 116.35 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.358 -0.608 . . . . 72.53 109.358 172.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.17 -29.13 26.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.109 175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.2 t70 -149.99 137.58 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.114 -0.948 . . . . 65.33 109.746 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.512 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.7 mt -133.57 139.54 48.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.333 -1.358 . . . . 61.34 107.333 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -147.94 112.0 5.17 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.502 0.501 . . . . 44.04 110.012 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.559 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.6 t80 -109.73 122.22 46.99 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 105.674 -1.973 . . . . 71.21 105.674 167.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -132.97 109.28 9.46 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.598 -0.89 . . . . 63.41 108.598 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.73 83.45 4.57 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.75 -0.834 . . . . 52.5 108.75 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.75 -27.61 31.46 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.494 2.129 . . . . 62.31 112.074 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -114.14 35.59 4.09 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 124.588 1.155 . . . . 61.41 109.238 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.57 -58.76 16.74 Favored Pre-proline 0 CA--C 1.576 1.963 0 N-CA-C 114.947 1.462 . . . . 75.13 114.947 -164.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.2 Cg_endo -81.68 -14.31 10.24 Favored 'Trans proline' 0 C--N 1.389 2.708 0 CA-C-N 122.384 1.887 . . . . 62.41 113.027 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -68.67 -42.27 78.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.824 0.85 . . . . 62.12 109.934 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' D' ' 73' ' ' ALA . 1.0 OUTLIER -85.76 -2.37 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.082 -0.963 . . . . 63.52 110.226 -172.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -56.4 -35.37 67.7 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 73.41 111.005 164.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -65.42 -29.06 69.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 71.5 111.146 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.463 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -91.74 74.19 5.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.228 1.011 . . . . 75.01 110.189 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -87.42 79.46 8.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.079 0.942 . . . . 65.14 109.001 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -134.17 178.16 7.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.139 1.376 . . . . 71.24 108.168 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -75.68 118.38 70.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 118.547 0.612 . . . . 73.32 109.446 170.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.26 109.52 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.225 1.95 . . . . 52.54 111.182 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.49 113.64 3.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.135 -1.061 . . . . 72.4 108.135 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.568 HG13 HG13 ' D' ' 64' ' ' VAL . 97.5 t -95.76 106.2 17.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.616 -0.883 . . . . 75.24 108.616 -172.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.78 110.35 20.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.124 -1.806 . . . . 73.51 106.124 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -94.66 157.22 16.06 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.04 -1.096 . . . . 72.24 108.04 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 11.4 t70 -146.18 132.37 19.42 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.899 -0.408 . . . . 62.13 109.899 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -102.31 130.5 49.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.168 0.987 . . . . 72.43 109.036 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -147.44 150.19 34.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.846 . . . . 53.2 108.914 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.6 t -126.42 159.33 33.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.256 0.622 . . . . 72.13 110.4 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.13 161.64 42.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 75.11 108.958 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 67.5 p -162.31 153.4 17.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.977 0.511 . . . . 64.24 110.936 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -155.47 147.81 23.8 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.717 0.807 . . . . 45.35 109.644 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -82.35 118.08 22.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.274 -0.639 . . . . 73.52 109.274 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.687 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.0 mt -92.66 -33.49 14.35 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.074 -0.343 . . . . 75.24 110.074 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.52 -177.96 2.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.282 1.033 . . . . 75.24 109.809 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.03 124.44 21.6 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.407 0.683 . . . . 53.14 109.977 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 65.0 14.25 9.22 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.036 1.334 . . . . 74.53 112.487 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -119.22 128.9 75.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.624 0.77 . . . . 72.01 109.404 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.35 149.78 50.37 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.848 0.859 . . . . 75.4 109.733 174.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.687 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.9 tt0 -109.38 117.47 34.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.299 -1.371 . . . . 73.42 107.299 163.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.27 129.75 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.528 -1.286 . . . . 73.42 107.528 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 40.7 t -113.19 132.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.67 -0.863 . . . . 62.11 108.67 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -108.62 126.05 52.53 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.949 -1.13 . . . . 63.15 107.949 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 40.7 ttm-85 -101.01 105.06 16.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.211 -1.033 . . . . 72.02 108.211 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.13 120.78 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.586 -1.264 . . . . 52.44 107.586 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.5 m -117.73 147.02 43.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.258 0.623 . . . . 65.11 109.452 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.568 HG13 HG13 ' D' ' 40' ' ' VAL . 69.2 t -133.87 100.57 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.014 1.326 . . . . 70.33 107.822 176.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -91.97 89.96 7.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.594 -2.002 . . . . 62.55 105.594 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' D' ' 74' ' ' PHE . . . -100.0 132.6 45.26 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.895 -1.048 . . . . 54.54 108.389 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.502 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 71.5 m -141.15 137.36 32.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 122.113 0.959 . . . . 73.15 111.814 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 54.8 mt -100.19 100.53 11.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.363 -1.744 . . . . 41.12 109.669 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.1 -123.6 10.68 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.835 -0.621 . . . . 71.22 111.957 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.92 4.21 53.46 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.353 0.661 . . . . 73.43 110.941 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.71 144.74 46.04 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.195 0.598 . . . . 62.41 110.026 -171.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -72.03 128.94 37.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.482 0.488 . . . . 70.33 110.208 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -78.33 -61.09 2.12 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.587 -0.894 . . . . 73.23 108.587 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' D' ' 118' ' ' VAL . 0.5 OUTLIER -159.59 177.62 10.71 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 113.859 -1.519 . . . . 74.12 108.329 171.507 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -134.34 107.47 7.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 73.01 106.447 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.597 ' SG ' HG12 ' D' ' 114' ' ' ILE . 1.9 t -113.77 146.29 40.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.836 0.454 . . . . 63.12 111.763 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.32 136.53 11.88 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.26 1.024 . . . . 73.24 109.158 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.36 116.26 24.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.998 -0.742 . . . . 71.34 108.998 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -91.89 88.21 6.53 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.703 0.764 . . . . 72.14 109.518 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.442 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -82.09 104.19 12.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.239 -1.346 . . . . 74.15 109.034 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.95 155.36 23.03 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.444 -0.662 . . . . 21.34 111.444 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.419 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -159.08 132.03 2.93 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.574 -0.61 . . . . 50.33 111.574 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.51 134.15 28.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 109.141 -0.689 . . . . 73.23 109.141 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.37 148.5 46.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 72.01 110.06 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 30.7 m -90.58 135.54 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.92 0.888 . . . . 65.2 109.138 170.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 5.0 tt -138.08 117.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 123.87 0.868 . . . . 71.41 110.166 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.27 146.29 5.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 44.31 110.103 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.81 0.27 59.04 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 113.737 0.255 . . . . 63.24 113.737 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 1.8 pp -103.06 164.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.098 0.959 . . . . 75.54 110.831 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.54 164.21 5.5 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.132 0.895 . . . . 75.51 110.31 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.58 -127.09 38.86 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 115.566 -0.743 . . . . 65.45 113.986 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.6 p -77.1 -27.31 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.777 0.831 . . . . 61.35 111.54 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -48.01 82.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.938 0.895 . . . . 64.25 110.846 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.48 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 25.3 ptm -68.73 -41.27 79.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.0 -0.545 . . . . 73.21 111.714 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.15 72.25 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.484 0.714 . . . . 73.21 111.104 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -81.16 -37.47 28.72 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.348 -0.842 . . . . 72.0 110.453 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -66.0 -49.79 66.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.166 0.586 . . . . 74.14 111.879 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.766 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.5 pp -83.82 -26.32 29.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.541 0.336 . . . . 74.03 111.23 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.31 -27.75 29.63 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.304 0.378 . . . . 64.5 113.447 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.76 -60.06 1.92 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.155 0.582 . . . . 75.34 110.469 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.419 ' O ' HG12 ' D' ' 105' ' ' ILE . 86.4 t80 -63.54 -49.61 72.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.733 0.413 . . . . 71.12 111.995 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 60.9 m -58.24 -51.58 80.74 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-O 118.642 -0.694 . . . . 72.23 112.494 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 39.3 Cg_exo -64.91 -32.79 54.26 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 121.66 1.574 . . . . 72.34 112.827 173.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.58 -32.17 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.971 0.508 . . . . 70.41 111.148 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.419 HG12 ' O ' ' D' ' 101' ' ' TYR . 38.2 mm -71.37 -35.68 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.756 0.822 . . . . 72.34 110.997 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' D' ' 80' ' ' GLN . 66.7 mt -75.04 -19.84 59.84 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.399 -0.819 . . . . 64.04 110.827 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -68.32 -42.5 29.35 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.294 1.22 . . . . 62.44 114.294 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -56.15 -40.42 84.96 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.069 1.846 . . . . 73.05 113.401 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -77.96 -35.0 50.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.052 0.941 . . . . 72.44 111.25 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.59 -42.87 77.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.467 0.707 . . . . 65.24 109.841 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.525 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.7 ttp180 -62.43 -46.62 87.7 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.438 -1.255 . . . . 74.14 109.888 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.92 -46.8 89.23 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.963 0.79 . . . . 71.51 110.743 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.426 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.8 t -59.23 -40.98 87.6 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.587 0.555 . . . . 62.32 110.678 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.597 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.8 mt -59.92 -57.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.915 0.486 . . . . 71.3 109.87 171.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 55.9 m -52.53 -44.49 65.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.36 1.464 . . . . 72.41 111.709 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.45 -44.55 78.39 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.528 -1.215 . . . . 44.32 110.07 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.7 mtm -66.01 -38.47 88.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.74 0.416 . . . . 71.32 111.411 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' D' ' 74' ' ' PHE . 98.6 t -62.53 -45.27 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 O-C-N 124.141 0.901 . . . . 62.33 109.795 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -71.45 -32.8 68.75 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.933 0.493 . . . . 74.33 111.03 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -70.08 -27.15 64.38 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.577 0.751 . . . . 74.23 109.949 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.17 11.89 70.8 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.918 0.761 . . . . 53.32 112.83 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.478 HG23 ' HB3' ' C' ' 17' ' ' TYR . 55.8 p 58.26 32.08 21.61 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.863 1.665 . . . . 42.51 113.356 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.431 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 84.9 m-85 -101.92 165.06 14.61 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.233 1.013 . . . . 73.13 108.296 168.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 57.3 Cg_endo -67.41 149.72 80.6 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.487 2.124 . . . . 61.34 112.423 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -59.19 126.92 29.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.294 0.637 . . . . 64.31 111.091 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.472 HD13 HG21 ' D' ' 40' ' ' VAL . 60.4 tp -107.79 96.48 6.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.529 0.732 . . . . 72.22 110.458 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -103.89 95.04 5.75 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.478 -0.564 . . . . 73.12 109.478 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' D' ' 128' ' ' LEU . 0.8 OUTLIER -73.96 134.28 43.1 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.227 -0.657 . . . . 73.31 109.227 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.86 138.53 87.07 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.812 0.845 . . . . 65.42 111.569 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -83.6 103.8 1.1 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.306 2.004 . . . . 53.24 110.889 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -107.71 110.92 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.708 0.766 . . . . 60.1 110.415 -171.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.243 0.711 0 CA-C-N 115.045 -0.98 . . . . 71.53 109.648 175.191 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 109.618 -0.512 . . . . 63.14 109.618 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.422 ' CD1' ' HE2' ' A' ' 101' ' ' TYR . 50.5 t80 -136.32 136.96 40.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 75.1 108.72 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -151.18 125.88 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.864 -0.153 . . . . 73.4 110.965 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -76.26 132.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.44 108.385 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 79.6 mm-40 -103.85 -38.61 6.96 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 123.88 0.737 . . . . 72.13 109.906 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -168.94 141.84 2.78 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 112.074 0.398 . . . . 75.01 112.074 -171.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.455 HD13 ' CD2' ' A' ' 109' ' ' TYR . 74.4 mt -106.71 142.47 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 124.932 1.293 . . . . 63.53 107.516 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.411 ' HE1' HG13 ' A' ' 83' ' ' ILE . 15.3 p90 -166.21 146.22 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.723 0.773 . . . . 75.43 111.003 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 p -88.46 105.06 17.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.845 -1.07 . . . . 73.11 109.321 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.1 mtpt -76.06 -28.21 57.54 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.857 -0.423 . . . . 74.13 109.857 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.3 t70 -148.77 130.77 15.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.87 -1.059 . . . . 73.12 109.67 174.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -122.84 136.36 59.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 105.983 -1.858 . . . . 65.43 105.983 167.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.82 108.26 3.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.831 0.348 . . . . 72.35 110.649 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.727 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.9 t80 -109.83 131.0 55.46 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.035 -1.468 . . . . 64.01 107.035 171.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.62 131.6 41.58 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.441 -0.948 . . . . 53.13 108.441 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -146.8 72.67 12.51 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.913 -0.773 . . . . 64.2 108.913 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.44 -13.22 25.2 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.509 2.139 . . . . 73.24 111.853 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -118.04 25.53 10.28 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.762 0.825 . . . . 74.23 109.296 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.37 -46.47 99.8 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.166 0.987 . . . . 72.14 112.898 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.03 -18.08 18.96 Favored 'Trans proline' 0 C--N 1.391 2.812 0 CA-C-N 120.933 1.369 . . . . 51.33 113.208 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.95 -18.99 61.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.249 0.62 . . . . 73.42 111.938 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 8.6 p -64.69 -18.39 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 112.783 0.66 . . . . 44.43 112.783 -176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -71.45 -40.32 70.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.965 0.506 . . . . 65.0 110.604 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -86.68 -19.54 29.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.658 -0.701 . . . . 74.3 110.713 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 29.8 mmmt -81.97 151.0 27.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.12 0.568 . . . . 74.11 111.29 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.5 124.01 28.57 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.931 -1.031 . . . . 54.43 108.714 168.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.477 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.4 t-105 -76.13 87.42 3.01 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.115 0.483 . . . . 75.15 110.54 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.86 80.66 70.63 Favored Pre-proline 0 C--O 1.245 0.837 0 C-N-CA 124.505 1.122 . . . . 74.24 108.035 169.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.45 129.41 8.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.269 1.979 . . . . 62.41 111.804 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.79 84.17 3.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 105.626 -1.99 . . . . 74.35 105.626 172.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -77.19 93.85 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.344 -1.298 . . . . 55.04 109.854 -172.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.88 116.11 23.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 113.976 -1.466 . . . . 61.54 110.867 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD23 HD23 ' A' ' 128' ' ' LEU . 6.6 mp -97.38 106.94 19.34 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.45 -1.25 . . . . 70.42 107.882 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.2 t70 -107.47 147.26 30.7 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.793 1.237 . . . . 63.15 109.364 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -129.8 137.61 50.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.013 0.925 . . . . 70.4 109.528 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -144.41 145.8 32.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.31 0.644 . . . . 72.33 109.485 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.8 m -107.19 125.93 51.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.619 0.768 . . . . 72.13 110.032 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.78 138.32 45.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.999 0.92 . . . . 55.24 108.825 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -135.65 162.46 32.67 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.434 0.693 . . . . 74.03 110.341 172.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 t -161.34 123.27 2.97 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.047 0.939 . . . . 72.01 108.661 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.08 146.26 39.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.812 -0.44 . . . . 62.2 109.812 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 57' ' ' GLU . 49.9 mt -117.35 -34.92 4.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.507 0.723 . . . . 74.31 111.355 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.1 -175.28 5.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.987 0.915 . . . . 75.51 109.441 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.09 121.13 17.72 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.735 -0.839 . . . . 73.44 108.735 173.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.94 9.86 7.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.388 1.475 . . . . 70.51 113.013 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 71.1 t -124.12 122.24 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.152 -1.055 . . . . 64.44 108.152 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -140.84 170.47 15.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.998 -0.741 . . . . 74.32 108.998 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' A' ' 51' ' ' LEU . 23.0 tt0 -126.51 140.08 52.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.174 0.99 . . . . 74.31 108.75 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -117.48 124.86 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 107.138 -1.43 . . . . 74.54 107.138 164.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -98.29 127.04 51.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 172.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.86 109.47 21.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.843 -1.54 . . . . 60.13 106.843 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -98.52 100.33 11.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.267 -1.012 . . . . 74.34 108.267 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.81 117.14 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.582 -1.19 . . . . 44.3 108.756 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.1 m -112.74 128.01 56.3 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.55 -0.537 . . . . 71.12 109.55 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 25.2 t -120.28 107.54 21.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 107.948 -1.13 . . . . 63.2 107.948 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.0 m -102.16 141.35 35.14 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.318 -0.993 . . . . 71.22 108.318 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.19 106.88 10.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.068 -1.086 . . . . 63.21 108.068 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -108.97 125.96 52.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.049 0.54 . . . . 63.22 110.467 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD21 ' CE3' ' A' ' 36' ' ' TRP . 46.7 mt -88.46 62.33 6.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.47 -1.307 . . . . 73.55 107.47 171.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.39 1.32 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.57 -1.196 . . . . 43.4 111.371 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.01 -20.26 27.47 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.969 0.908 . . . . 75.14 111.161 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -109.2 118.86 37.82 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.351 -0.611 . . . . 75.3 109.351 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -73.18 130.17 39.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.559 0.618 . . . . 73.4 110.129 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.75 4.19 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.78 -0.822 . . . . 53.1 108.78 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.19 168.6 26.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.167 -1.379 . . . . 54.23 110.558 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.4 116.91 11.36 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.545 1.138 . . . . 73.05 108.733 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.4 m -104.31 138.82 40.19 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 124.319 1.048 . . . . 75.35 108.893 172.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -148.04 117.33 6.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.255 -1.017 . . . . 74.3 108.255 171.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -122.81 111.48 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 109.316 -0.624 . . . . 73.14 109.316 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.0 mt-30 -86.42 82.19 8.05 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.89 -1.05 . . . . 74.23 108.732 170.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' HG3' HD22 ' A' ' 106' ' ' LEU . 45.3 tp60 -77.96 95.63 4.85 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.358 -1.292 . . . . 61.15 109.405 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.14 154.53 29.02 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 112.057 -0.417 . . . . 51.52 112.057 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.57 131.8 3.0 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 112.136 -0.385 . . . . 52.04 112.136 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 37.0 mt -81.6 128.28 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.446 -0.946 . . . . 64.35 108.446 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.38 154.32 48.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -119.26 119.44 34.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.649 1.18 . . . . 64.41 108.051 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 89' ' ' ILE . 2.9 pp -122.17 158.79 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.019 0.438 . . . . 73.2 111.098 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 151.91 8.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.591 -1.186 . . . . 64.53 109.094 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.23 83.82 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 115.26 0.864 . . . . 73.45 115.26 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.481 HD11 HD13 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -115.88 136.58 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.538 0.669 . . . . 75.55 110.357 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -144.75 172.37 13.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.836 0.455 . . . . 61.31 111.54 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -120.67 23.77 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.899 -0.591 . . . . 71.11 113.31 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.7 p -79.58 -16.38 55.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.779 0.832 . . . . 71.0 111.832 -174.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.75 -42.43 90.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.767 0.827 . . . . 74.21 109.263 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 98' ' ' LEU . 43.5 tpp -67.1 -38.37 85.55 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.976 -1.011 . . . . 75.11 110.509 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.44 81.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.704 0.802 . . . . 51.34 111.969 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -84.17 -36.67 22.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.766 0.426 . . . . 63.43 111.095 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -71.95 -64.73 0.88 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.703 0.401 . . . . 65.12 110.669 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.417 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 7.4 tt -68.42 -34.54 76.18 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 72.1 110.324 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -5.59 78.19 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 119.077 -0.846 . . . . 44.13 114.968 -172.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.84 -55.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.534 1.167 . . . . 63.14 112.742 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 81.1 t80 -68.9 -45.74 70.14 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.882 0.697 . . . . 73.41 112.882 -169.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -73.58 -37.42 3.53 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.05 0.54 . . . . 53.34 112.315 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -48.84 -33.68 26.05 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.503 2.136 . . . . 71.15 113.901 162.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.19 -16.55 64.03 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.576 0.75 . . . . 75.43 111.991 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.409 HG23 HD21 ' C' ' 132' ' ' ASN . 47.7 mm -74.63 -44.3 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 122.002 0.906 . . . . 61.41 109.639 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.493 HD22 ' HG3' ' A' ' 80' ' ' GLN . 89.0 mt -85.74 -19.26 31.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.164 -1.38 . . . . 73.54 112.33 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.44 -44.24 25.04 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.215 -0.898 . . . . 73.35 112.483 -173.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.37 -35.26 98.87 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 121.996 1.797 . . . . 63.11 113.062 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.455 ' CD2' HD13 ' A' ' 16' ' ' ILE . 27.7 m-85 -82.77 -31.81 28.1 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.107 0.78 . . . . 71.5 113.107 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 -47.84 61.28 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.515 -0.92 . . . . 72.44 108.515 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -46.74 -59.7 2.87 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 125.331 1.644 . . . . 74.24 109.559 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.7 tm-20 -64.24 -38.35 90.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.433 1.083 . . . . 64.15 111.895 -172.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 117' ' ' MET . 44.8 t -62.12 -46.43 89.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.659 0.384 . . . . 71.12 110.471 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 118' ' ' VAL . 34.1 mt -62.33 -47.19 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.882 0.873 . . . . 72.24 110.13 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.592 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.5 m -55.68 -42.77 75.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.097 1.359 . . . . 61.33 110.71 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -68.87 -39.18 79.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.583 -1.189 . . . . 71.43 110.321 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -66.79 -35.56 80.36 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.425 0.29 . . . . 74.22 111.299 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -66.37 -40.09 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.478 0.711 . . . . 72.24 110.292 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.6 p -73.47 -34.3 65.28 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.36 -0.382 . . . . 62.23 111.259 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.12 -23.98 63.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.512 0.725 . . . . 71.22 110.261 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 31.04 3.55 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 123.743 0.687 . . . . 61.45 113.522 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 14.7 t 58.68 15.96 4.06 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.943 2.097 . . . . 71.21 114.683 173.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' SER . 42.0 m-85 -123.49 159.82 53.5 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.174 0.589 . . . . 74.4 111.066 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.61 135.63 57.91 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.447 2.098 . . . . 75.32 110.141 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 3.4 pt20 -57.84 153.27 14.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.064 0.946 . . . . 71.24 111.709 -174.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.18 112.17 24.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.162 -1.051 . . . . 61.34 108.162 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -97.31 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.316 -0.994 . . . . 64.03 108.316 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.443 HD23 HD23 ' A' ' 42' ' ' LEU . 5.8 mp -69.0 142.12 54.72 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.744 -0.662 . . . . 75.1 109.622 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.1 74.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 122.704 0.401 . . . . 50.43 110.453 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.455 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 16.8 Cg_exo -68.05 124.78 12.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.459 2.106 . . . . 75.23 109.995 170.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.0 m -97.12 111.9 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 122.077 0.942 . . . . 74.25 108.951 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 86.46 2.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.167 -1.378 . . . . 65.24 109.396 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.489 1.497 0 C-N-CA 125.148 1.379 . . . . 73.24 112.951 -171.498 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--O 1.241 0.649 0 N-CA-C 107.982 -1.118 . . . . 61.31 107.982 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.615 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 31.5 t80 -122.07 134.82 54.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.69 -0.855 . . . . 73.32 108.69 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -165.87 141.45 4.93 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.79 0.681 . . . . 72.14 109.248 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.616 HD13 HD11 ' B' ' 16' ' ' ILE . 78.4 mt -86.22 121.05 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.93 0.492 . . . . 72.51 110.326 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -80.65 -36.72 32.14 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.662 0.601 . . . . 73.04 111.249 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -171.32 142.44 1.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.994 0.518 . . . . 65.23 109.949 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.616 HD11 HD13 ' B' ' 13' ' ' ILE . 90.1 mt -121.26 140.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.911 -1.144 . . . . 74.33 107.911 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 31.5 p90 -165.53 152.23 10.07 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.896 0.747 . . . . 74.21 111.079 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -75.42 123.98 26.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.262 -1.014 . . . . 72.34 108.262 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -92.54 -37.11 12.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.988 0.515 . . . . 74.22 109.679 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.0 t70 -148.84 147.96 29.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.531 -0.759 . . . . 75.54 110.712 -170.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.479 HD13 HG13 ' B' ' 78' ' ' VAL . 36.7 mm -143.11 143.41 24.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.504 1.521 . . . . 72.12 107.79 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 55.6 m -149.09 131.73 15.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.203 -0.908 . . . . 63.34 108.706 168.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -140.08 106.95 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.228 -1.768 . . . . 74.33 106.228 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.52 110.6 15.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.665 -0.865 . . . . 75.44 108.665 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 74' ' ' PHE . . . -108.42 88.56 5.11 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.499 1.12 . . . . 73.41 109.205 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.68 -30.21 59.94 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.084 2.523 . . . . 74.13 112.374 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -118.45 31.39 6.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 71.22 110.22 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.63 -52.24 32.11 Favored Pre-proline 0 CA--C 1.572 1.799 0 C-N-CA 125.327 1.451 . . . . 75.14 113.648 173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 96.0 Cg_endo -77.7 -12.57 16.57 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.814 1.676 . . . . 70.4 113.142 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -86.98 1.12 53.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.897 0.879 . . . . 74.52 111.803 -175.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.13 -14.03 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 123.653 0.781 . . . . 73.34 110.334 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -65.76 -41.27 92.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.798 0.439 . . . . 73.03 110.266 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -47.27 12.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.327 -0.62 . . . . 73.54 109.327 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.38 67.82 9.57 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.12 -1.067 . . . . 75.41 108.12 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.21 75.56 9.13 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.432 -1.258 . . . . 63.12 111.442 -168.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -177.27 172.44 1.89 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.255 -1.339 . . . . 62.22 108.216 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.627 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 11.7 pt20 -71.05 134.84 85.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.322 0.649 . . . . 65.51 111.731 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.88 156.12 60.04 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.549 2.166 . . . . 73.35 112.461 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 27.2 mt-10 -70.31 98.86 1.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.372 -0.973 . . . . 63.52 108.372 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.606 ' HB ' HD13 ' B' ' 126' ' ' LEU . 16.4 m -87.67 122.55 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 74.52 109.445 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -153.22 130.31 11.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.476 1.11 . . . . 70.25 109.645 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.71 HD22 HD11 ' B' ' 126' ' ' LEU . 1.4 pt? -130.81 164.98 23.97 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.993 0.738 . . . . 64.15 112.993 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.96 141.19 38.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.188 1.395 . . . . 72.34 109.79 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -94.68 124.85 38.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 74.23 108.988 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -124.36 156.14 37.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.862 1.265 . . . . 65.45 108.427 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.2 t -129.4 140.85 51.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.616 0.722 . . . . 71.54 111.518 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 161.6 32.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.738 1.615 . . . . 64.03 107.981 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -143.12 165.77 26.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.46 0.648 . . . . 64.35 111.525 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.7 t -152.09 157.83 42.15 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.149 1.38 . . . . 55.2 108.379 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -123.66 129.01 50.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.17 -39.48 12.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.319 0.648 . . . . 71.01 110.125 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 179.96 8.1 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.517 1.127 . . . . 70.25 109.826 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.29 121.25 9.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.342 0.657 . . . . 71.45 109.517 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 66.17 -5.74 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 126.04 1.736 . . . . 43.14 113.712 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.71 86.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.945 -1.502 . . . . 54.23 106.945 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -95.82 168.71 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.609 . . . . 73.34 110.183 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -145.38 97.64 3.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.833 -1.544 . . . . 64.13 106.833 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.34 130.24 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.946 -0.761 . . . . 73.43 108.946 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.1 t -106.89 124.03 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.645 0.778 . . . . 72.41 109.734 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 1.0 OUTLIER -93.68 121.41 35.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.11 -1.07 . . . . 74.05 108.11 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -113.11 113.46 25.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.221 0.608 . . . . 71.11 109.821 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.574 ' HB ' HD11 ' B' ' 114' ' ' ILE . 47.9 t -104.93 125.48 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 62.23 108.546 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -98.64 137.66 36.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.784 -0.821 . . . . 73.13 108.784 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' B' ' 114' ' ' ILE . 50.6 t -128.67 123.76 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.774 -0.825 . . . . 50.01 108.774 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.7 m -108.07 139.07 43.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.023 0.929 . . . . 74.33 109.637 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.33 143.28 30.9 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.438 0.695 . . . . 41.21 109.216 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -151.46 134.13 15.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.462 0.541 . . . . 73.34 112.462 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -107.41 104.23 13.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.943 1.297 . . . . 62.32 108.758 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.96 -113.88 5.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.813 -0.437 . . . . 65.41 112.523 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -97.94 2.76 49.4 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.325 0.65 . . . . 71.34 111.502 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -130.81 157.68 42.21 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.556 0.342 . . . . 70.21 111.864 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.2 m -76.04 133.69 40.29 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.786 -0.643 . . . . 71.42 110.669 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.34 -55.77 3.29 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.533 0.733 . . . . 74.31 109.701 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 30.8 p90 -154.01 162.34 41.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.26 -0.882 . . . . 73.24 109.956 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.7 mt -142.25 116.05 9.24 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.075 1.35 . . . . 72.33 107.453 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -117.79 120.49 38.09 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.528 -0.545 . . . . 33.43 109.528 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -123.37 124.2 42.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.434 -0.95 . . . . 70.24 108.434 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.479 HG13 HD13 ' B' ' 21' ' ' ILE . 55.3 t -121.47 146.0 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.314 -0.995 . . . . 71.2 108.314 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.8 mt-30 -127.06 99.28 5.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.14 109.255 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.533 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 49.2 tp60 -92.41 104.22 16.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.144 -1.389 . . . . 74.44 108.751 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.44 159.27 25.99 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 112.142 -0.383 . . . . 74.33 112.142 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -156.19 127.98 2.12 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.837 -0.905 . . . . 51.34 110.837 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.84 125.0 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.608 -0.886 . . . . 73.21 108.608 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.88 136.73 47.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.298 1.039 . . . . 63.22 109.979 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 5.7 m -90.22 110.48 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.043 -1.095 . . . . 62.44 108.043 172.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 38.3 pt -126.68 109.19 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.824 0.821 . . . . 72.43 110.553 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.5 170.71 20.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.645 -1.162 . . . . 64.22 109.441 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.53 -49.14 1.21 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 111.413 -0.675 . . . . 65.22 111.413 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 165.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.755 0.822 . . . . 71.1 111.387 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -163.7 144.87 9.03 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.89 0.744 . . . . 73.22 110.561 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.51 -110.44 3.13 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.555 -0.748 . . . . 73.23 113.031 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 m -65.26 -44.92 86.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 65.4 112.309 -170.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.9 -22.4 61.5 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.573 -0.74 . . . . 72.43 112.126 -167.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.416 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 17.4 ttt -72.15 -38.73 69.13 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.405 -0.22 . . . . 75.44 110.405 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.53 74.26 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.945 0.498 . . . . 40.01 110.845 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 59.2 t-80 -74.45 -20.51 60.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.687 0.795 . . . . 74.14 110.848 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -86.92 -67.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.131 0.573 . . . . 61.55 111.289 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.435 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.5 pp -74.19 -24.26 59.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.126 0.57 . . . . 64.35 112.301 -172.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.37 72.94 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.905 -0.386 . . . . 52.24 113.35 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -145.37 -69.92 0.28 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.502 0.556 . . . . 72.55 112.502 -173.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -74.03 -39.53 63.49 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.318 0.386 . . . . 63.33 111.562 -168.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.615 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 61.0 m -61.98 -50.33 81.34 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.865 -0.588 . . . . 53.53 111.522 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.64 -25.82 28.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.427 1.418 . . . . 64.11 113.415 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.83 -33.03 74.78 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.281 0.562 . . . . 74.35 110.962 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.442 HD13 HD11 ' B' ' 13' ' ' ILE . 59.6 mt -65.67 -44.9 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.257 1.023 . . . . 74.44 110.89 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' B' ' 82' ' ' GLY . 44.9 mt -81.33 -12.9 58.89 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.126 -0.943 . . . . 62.14 111.017 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -60.01 -49.94 88.75 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.755 -1.117 . . . . 72.2 112.093 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.49 -41.38 77.51 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.887 1.725 . . . . 41.01 113.011 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.533 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.2 m-85 -65.99 -50.22 65.06 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.483 0.713 . . . . 74.11 112.204 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.73 81.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.759 0.824 . . . . 70.12 110.847 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -56.09 -48.6 75.81 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.379 1.472 . . . . 65.15 110.299 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.63 -36.36 80.66 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.399 0.68 . . . . 61.35 110.428 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.0 t -68.51 -45.02 73.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.752 0.421 . . . . 72.31 111.82 -174.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.574 HD11 ' HB ' ' B' ' 62' ' ' VAL . 92.1 mt -59.22 -50.77 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.955 0.902 . . . . 71.24 110.429 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.436 HG21 ' OG ' ' C' ' 119' ' ' SER . 86.9 m -58.26 -33.06 68.98 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 124.481 1.113 . . . . 65.25 111.175 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.7 t -69.75 -35.18 74.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.219 1.008 . . . . 74.44 111.357 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -79.24 -33.21 43.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.862 0.465 . . . . 72.04 111.481 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.56 -31.9 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.675 0.79 . . . . 74.14 110.748 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.505 ' HB3' HG21 ' C' ' 115' ' ' THR . 80.7 p -68.48 -33.45 74.18 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 116.03 -0.532 . . . . 55.01 112.068 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.454 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 83.7 mtt-85 -65.55 -36.96 85.34 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.011 -0.995 . . . . 72.31 110.96 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.89 9.09 63.9 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.508 -0.769 . . . . 71.13 113.85 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p 63.84 12.66 6.92 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.436 1.894 . . . . 74.44 113.192 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.498 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 58.3 m-85 -77.99 170.98 13.74 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.915 0.886 . . . . 74.3 110.269 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.627 ' HG3' ' HB2' ' B' ' 37' ' ' GLN . 62.5 Cg_endo -77.18 -169.11 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.101 1.867 . . . . 64.05 114.718 -170.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' C' ' 125' ' ' GLN . 17.7 pt20 -64.92 142.11 58.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.945 -1.48 . . . . 61.23 112.434 177.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.71 HD11 HD22 ' B' ' 42' ' ' LEU . 32.5 tp -151.57 98.34 2.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.334 -0.848 . . . . 72.0 108.895 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -134.65 126.04 28.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.644 . . . . 75.22 109.769 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.01 151.17 35.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.875 0.87 . . . . 73.34 111.807 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.69 106.54 15.77 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.981 -0.748 . . . . 64.14 108.981 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.2 113.47 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.026 2.484 . . . . 64.32 112.938 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.23 153.84 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.52 0.728 . . . . 73.55 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ASN . . . . . 0.447 ' HB2' HD12 ' D' ' 13' ' ' ILE . 50.2 t-20 -110.55 115.83 30.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.635 0.774 . . . . 70.22 110.562 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.48 1.055 0 C-N-CA 122.973 0.509 . . . . 74.34 111.201 175.188 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.3 m . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.484 -0.561 . . . . 75.53 109.484 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -104.34 140.3 38.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.702 0.801 . . . . 63.54 108.892 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -150.02 140.09 22.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.869 0.366 . . . . 74.04 111.305 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -93.34 141.49 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.232 1.013 . . . . 72.42 109.578 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.519 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.7 mm-40 -108.49 -49.11 3.22 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.37 0.668 . . . . 74.3 110.087 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.555 HH11 ' HD1' ' D' ' 32' ' ' PHE . 63.5 ttt180 -170.57 125.39 0.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.608 0.363 . . . . 74.25 110.354 -173.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 73.0 mt -109.6 141.73 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.344 -1.354 . . . . 63.1 107.344 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.544 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 40.6 p90 -176.94 156.69 1.36 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.037 0.836 . . . . 74.52 110.768 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -78.73 123.34 27.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.428 -0.806 . . . . 72.34 109.954 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.58 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -81.16 -44.87 17.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.007 -0.738 . . . . 52.14 109.007 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -149.87 134.19 17.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.41 -1.268 . . . . 70.42 109.606 -171.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.0 mt -134.15 145.07 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.519 1.128 . . . . 74.12 108.499 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -156.24 151.99 27.22 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.223 0.535 . . . . 73.21 111.154 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -152.94 108.52 3.29 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.152 -1.425 . . . . 71.01 107.152 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.18 114.88 25.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.449 0.7 . . . . 70.03 110.298 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.72 83.44 62.3 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.609 1.163 . . . . 75.54 109.333 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.29 -23.15 24.5 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.412 2.074 . . . . 72.55 111.46 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -93.54 15.28 16.43 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.25 1.42 . . . . 70.44 109.535 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' D' ' 17' ' ' TYR . . . -56.95 -49.0 96.48 Favored Pre-proline 0 CA--C 1.567 1.616 0 N-CA-C 113.991 1.108 . . . . 51.21 113.991 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.98 -29.57 6.62 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.041 1.407 . . . . 71.44 113.132 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -70.25 -39.84 74.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.198 0.599 . . . . 75.2 111.739 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.443 HG23 HD11 ' C' ' 68' ' ' LEU . 10.5 p -71.18 -12.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.672 0.789 . . . . 51.1 111.16 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.97 -41.0 77.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 110.562 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -100.57 48.54 0.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.033 0.92 . . . . 74.32 109.842 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.622 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -125.52 158.75 33.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.803 0.841 . . . . 75.14 110.12 177.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.85 107.2 9.0 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 106.766 -1.568 . . . . 54.01 106.766 164.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.01 90.01 3.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.824 -0.625 . . . . 74.21 111.962 -164.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -137.75 65.55 46.64 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.969 0.908 . . . . 73.31 109.071 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.13 133.36 35.15 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.284 1.99 . . . . 75.05 111.727 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' C' ' 66' ' ' ALA . 29.4 tt0 -83.76 86.45 7.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.875 -1.158 . . . . 70.25 107.875 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -74.47 79.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.513 -1.221 . . . . 60.52 110.332 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -92.74 134.23 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.054 -1.43 . . . . 72.31 110.003 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.424 HD23 HD13 ' C' ' 128' ' ' LEU . 1.4 pp -87.72 167.25 14.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.727 0.811 . . . . 73.51 111.867 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.97 148.3 18.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.709 0.804 . . . . 75.25 109.429 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 tt -123.9 139.02 54.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.277 0.631 . . . . 63.35 109.86 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 14.0 m-20 -136.39 150.68 48.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.769 1.228 . . . . 53.52 109.156 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -115.0 143.56 44.99 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.572 0.749 . . . . 73.44 109.342 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.23 154.66 41.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.187 0.995 . . . . 60.3 108.328 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -163.77 152.96 14.21 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.849 0.357 . . . . 72.52 111.063 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -151.48 130.92 12.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.28 1.032 . . . . 24.41 109.043 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -75.85 129.06 36.41 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.723 -0.473 . . . . 60.11 109.723 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 47.0 mt -104.77 -36.23 7.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.504 0.722 . . . . 73.35 110.018 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -173.44 4.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.685 -1.143 . . . . 70.14 108.948 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -76.14 124.35 27.3 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.43 -0.804 . . . . 63.21 109.798 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 63.34 12.24 6.09 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.416 1.086 . . . . 65.13 112.483 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.31 130.28 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.874 1.27 . . . . 50.03 108.36 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.2 152.13 36.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.58 0.705 . . . . 74.12 111.458 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.439 ' HB2' HD11 ' C' ' 51' ' ' LEU . 27.6 tt0 -83.61 125.42 31.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.234 1.414 . . . . 71.2 109.448 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.9 t -112.37 130.57 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.99 -1.115 . . . . 75.35 107.99 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.4 107.69 19.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.865 0.866 . . . . 64.21 108.752 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' C' ' 103' ' ' PRO . 3.1 tm? -92.07 108.3 19.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.39 -1.337 . . . . 64.34 107.39 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.9 ttp180 -89.67 128.65 36.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.069 -0.514 . . . . 75.34 109.951 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.577 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.9 t -117.99 118.94 59.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.734 -1.21 . . . . 72.53 107.734 168.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 32.4 m -110.67 146.49 36.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 72.55 109.393 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.556 HG21 HG21 ' C' ' 114' ' ' ILE . 63.8 t -129.94 115.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.747 1.219 . . . . 65.34 109.131 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -98.67 143.44 29.04 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.481 -0.933 . . . . 62.52 108.481 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' C' ' 39' ' ' GLU . . . -127.67 121.08 29.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.485 -0.561 . . . . 63.45 109.485 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.0 m -137.96 131.73 31.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.316 0.579 . . . . 73.1 111.38 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.622 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.9 mt -87.79 41.12 0.97 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.192 1.397 . . . . 73.32 109.685 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.91 -102.66 2.28 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.287 -1.125 . . . . 54.23 110.287 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -92.35 -31.87 15.19 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.952 0.501 . . . . 64.32 110.152 174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.584 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 3.8 tp10 -66.8 119.0 11.1 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.702 1.201 . . . . 72.51 109.758 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.2 m -73.06 124.63 25.9 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.174 -0.676 . . . . 75.22 109.174 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.64 -47.91 10.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.377 -0.601 . . . . 73.32 109.377 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -171.44 177.22 3.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.864 0.866 . . . . 74.51 110.76 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.426 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -132.43 144.6 50.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.484 -1.672 . . . . 64.21 106.484 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.426 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.4 t -140.04 143.02 36.18 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.829 -1.545 . . . . 74.1 106.829 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.72 135.07 9.25 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.146 0.498 . . . . 73.32 110.274 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.33 135.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.864 -1.062 . . . . 61.12 108.341 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -115.84 94.01 4.5 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.362 -1.348 . . . . 73.41 107.362 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -89.83 115.17 26.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.849 -1.068 . . . . 75.13 110.11 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.58 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -108.4 157.4 15.3 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.014 -0.539 . . . . 63.31 113.28 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -158.0 133.76 3.62 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.93 -1.268 . . . . 53.32 109.93 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 20.8 mm -91.59 122.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.907 -1.146 . . . . 74.11 107.907 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.01 130.74 52.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.966 0.506 . . . . 75.5 110.052 -173.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.6 t -104.97 119.31 38.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.3 -1.0 . . . . 71.12 108.3 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.17 150.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.017 0.927 . . . . 65.44 110.24 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.66 149.57 28.56 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.813 0.845 . . . . 74.44 109.579 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.38 60.22 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.195 -0.457 . . . . 63.2 113.212 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 pt . . . . . 0 CA--C 1.551 0.995 0 C-N-CA 123.849 0.86 . . . . 62.1 112.0 -175.628 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 111.921 0.341 . . . . 75.1 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 48.2 ttm -84.74 -44.06 13.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.633 0.373 . . . . 73.13 110.776 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.25 -39.49 65.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.418 0.687 . . . . 71.44 111.364 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -69.82 -31.95 70.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.756 0.822 . . . . 72.42 110.368 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 45.7 t -80.87 -61.9 1.83 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.886 0.474 . . . . 73.34 110.419 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.9 -40.36 91.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.146 0.978 . . . . 73.3 110.271 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.3 2.97 68.81 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.074 -0.848 . . . . 54.04 114.622 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.06 -59.41 0.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.404 1.102 . . . . 72.33 112.768 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 77.0 t80 -71.96 -48.49 44.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.062 0.764 . . . . 73.04 113.062 -166.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.56 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -60.35 -48.97 92.54 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.692 0.397 . . . . 75.25 110.57 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 54.2 Cg_exo -59.62 -30.47 92.37 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.277 1.985 . . . . 74.35 114.258 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.648 0.779 . . . . 52.44 110.846 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.48 -36.76 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.246 0.618 . . . . 73.33 110.168 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.1 mt -83.44 -25.84 30.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.513 -0.767 . . . . 74.41 111.86 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.98 -40.15 83.02 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 124.324 1.05 . . . . 75.42 113.609 -175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.3 -53.63 6.78 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.692 2.262 . . . . 65.25 113.792 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.592 ' HE2' HG21 ' A' ' 115' ' ' THR . 53.7 m-85 -63.5 -34.42 77.74 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.58 -1.191 . . . . 73.33 110.793 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.81 -45.24 62.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.402 0.681 . . . . 54.3 110.853 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.83 -37.74 69.11 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.384 1.074 . . . . 72.0 110.647 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.454 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -77.94 -43.15 30.74 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.262 0.625 . . . . 72.04 111.075 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.56 -33.28 75.31 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.755 0.65 . . . . 73.14 112.755 -170.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' C' ' 62' ' ' VAL . 70.4 mt -67.64 -49.08 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.871 0.469 . . . . 60.4 109.821 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.676 HG23 ' HB2' ' C' ' 125' ' ' GLN . 57.4 m -54.8 -37.16 65.74 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.251 -1.341 . . . . 74.11 111.603 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.1 t -57.42 -58.11 9.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.906 -1.043 . . . . 62.43 109.98 174.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -41.68 85.85 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.325 1.05 . . . . 71.12 113.195 -176.579 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.04 -42.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 122.594 0.358 . . . . 64.12 110.385 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.436 ' OG ' HG21 ' B' ' 115' ' ' THR . 38.1 t -71.78 -20.15 61.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.545 -0.752 . . . . 55.42 111.588 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.5 mtt-85 -73.98 -40.12 63.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.108 0.563 . . . . 71.2 110.051 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.02 -5.64 71.21 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.53 0.519 . . . . 71.44 111.909 167.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p 65.37 23.05 12.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.491 2.316 . . . . 63.33 112.357 173.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.85 164.21 49.9 Favored Pre-proline 0 CA--C 1.548 0.865 0 CA-C-N 114.805 -1.089 . . . . 75.52 108.491 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.17 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.775 2.317 . . . . 73.21 113.072 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.676 ' HB2' HG23 ' C' ' 115' ' ' THR . 2.6 pt20 -49.78 133.29 21.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.806 1.242 . . . . 75.02 111.295 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.405 ' HG ' ' HG ' ' C' ' 128' ' ' LEU . 28.2 tp -90.9 82.33 5.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.519 0.676 . . . . 51.43 110.359 -170.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -94.59 85.94 4.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.058 -0.974 . . . . 73.03 108.867 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.424 HD13 HD23 ' C' ' 42' ' ' LEU . 93.7 mt -87.85 144.28 26.67 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.416 0.627 . . . . 61.43 111.714 -176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.18 153.35 90.51 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 114.203 -1.362 . . . . 71.45 109.417 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.446 ' HB3' HD12 ' A' ' 16' ' ' ILE . 53.5 Cg_endo -64.47 142.19 77.23 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.783 2.322 . . . . 71.34 114.737 -168.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.08 84.11 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 107.54 -1.282 . . . . 62.33 107.54 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 132' ' ' ASN . . . . . 0.409 HD21 HG23 ' A' ' 105' ' ' ILE . 8.9 m120 -86.1 99.99 11.88 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.48 0.657 . . . . 74.22 110.456 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 N--CA 1.473 0.712 0 CA-C-N 114.421 -1.263 . . . . 74.23 110.873 -178.459 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.238 0.467 0 N-CA-C 108.712 -0.848 . . . . 75.21 108.712 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -144.68 127.12 15.92 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.576 -1.268 . . . . 54.4 107.576 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 58.5 mt-30 -132.89 143.63 49.64 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.099 0.96 . . . . 63.44 108.68 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' B' ' 132' ' ' ASN . 38.5 mt -103.41 115.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.622 -0.881 . . . . 72.41 108.622 170.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -83.74 -44.33 14.55 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 110.152 -0.314 . . . . 70.34 110.152 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -165.11 141.1 5.51 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 111.52 0.193 . . . . 73.33 111.52 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 38.7 mm -120.47 126.05 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.309 -0.997 . . . . 73.51 108.309 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' C' ' 28' ' ' ALA . 2.0 p90 -167.86 154.83 8.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.627 0.771 . . . . 72.44 111.534 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.44 HG21 HD11 ' D' ' 21' ' ' ILE . 81.3 p -79.55 118.87 21.79 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.401 -0.818 . . . . 63.33 110.604 -176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.37 -23.0 30.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.515 -0.766 . . . . 65.24 110.862 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.614 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 35.1 t70 -160.04 132.1 6.25 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.852 0.72 . . . . 65.15 109.696 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.591 HD13 ' HE3' ' C' ' 117' ' ' MET . 96.6 mt -132.48 135.73 57.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.089 -1.449 . . . . 73.22 107.089 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -138.61 132.15 30.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.574 -1.269 . . . . 70.14 107.574 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.545 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -145.14 112.17 5.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.923 -1.51 . . . . 65.2 106.923 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.9 112.19 18.01 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.691 0.796 . . . . 51.13 108.983 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.1 82.47 2.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 107.843 -1.169 . . . . 63.22 107.843 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.38 -30.5 5.24 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.424 2.083 . . . . 75.3 112.479 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.43 ' O ' HG23 ' D' ' 31' ' ' VAL . 88.8 m-20 -108.29 38.91 2.09 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.679 1.192 . . . . 72.3 108.962 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.544 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.19 -53.39 65.49 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 115.147 1.536 . . . . 70.3 115.147 -169.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.76 -7.21 14.53 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 122.191 1.818 . . . . 70.34 112.364 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -84.4 -24.67 29.53 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.372 1.469 . . . . 72.32 109.055 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 27' ' ' ASN . 13.4 t -66.25 -29.68 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.946 0.898 . . . . 72.11 110.135 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.555 ' HD1' HH11 ' C' ' 15' ' ' ARG . 91.7 t80 -51.25 -31.75 22.04 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.434 -0.803 . . . . 64.12 112.599 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -75.42 -17.51 60.16 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.777 0.831 . . . . 74.21 112.42 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' D' ' 71' ' ' GLU . 92.3 mttt -122.55 110.79 16.01 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.337 0.655 . . . . 73.33 110.583 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -110.82 81.75 1.48 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.243 1.017 . . . . 63.32 110.672 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -150.81 174.96 12.47 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.203 -0.908 . . . . 73.41 109.143 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.73 117.58 58.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 119.494 -0.289 . . . . 73.3 110.278 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.466 ' HG3' HD21 ' D' ' 68' ' ' LEU . 77.6 Cg_exo -55.65 130.5 40.78 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.993 2.462 . . . . 71.15 112.411 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.35 122.27 15.27 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.755 -0.831 . . . . 51.12 108.755 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -98.45 112.08 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.108 0.563 . . . . 65.32 109.541 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 3.2 mppt? -99.32 120.05 38.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.984 -1.117 . . . . 73.44 107.984 170.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.06 121.18 39.67 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.092 -1.077 . . . . 75.41 108.092 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.471 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.3 t70 -119.4 135.61 54.66 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.837 -0.801 . . . . 75.34 108.837 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.44 HD11 HD21 ' D' ' 60' ' ' LEU . 29.1 tp -111.97 129.76 56.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.084 0.554 . . . . 74.35 109.852 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -139.12 152.42 47.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.335 1.054 . . . . 63.51 108.477 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -146.21 162.76 37.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.075 0.55 . . . . 73.54 110.295 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.36 147.66 27.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.334 1.054 . . . . 64.51 108.86 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 48.9 m -144.48 152.03 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.878 0.37 . . . . 70.05 111.061 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.1 p -163.13 125.99 2.7 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.303 1.041 . . . . 71.31 108.842 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -72.86 123.84 24.21 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.834 0.454 . . . . 63.23 111.106 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.8 mt -96.53 -29.41 13.9 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.536 0.734 . . . . 74.04 111.503 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.4 -172.49 3.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.507 0.723 . . . . 71.04 110.592 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -64.47 116.62 6.3 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.971 -0.559 . . . . 72.2 110.025 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 69.51 0.43 2.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.925 1.29 . . . . 65.33 112.365 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.95 131.56 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.844 0.857 . . . . 64.55 110.117 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.47 154.2 42.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.332 0.653 . . . . 65.31 109.734 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.603 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -95.16 118.56 32.15 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.643 0.777 . . . . 75.45 109.39 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.9 119.21 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.519 -0.919 . . . . 65.34 108.519 169.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.8 t -98.11 138.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.949 -1.13 . . . . 75.21 107.949 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.561 HD13 HG23 ' D' ' 62' ' ' VAL . 0.3 OUTLIER -125.55 116.19 21.37 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.973 -0.751 . . . . 72.3 108.973 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.1 ttm180 -97.75 110.52 23.07 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.613 -0.722 . . . . 74.45 109.244 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.561 HG23 HD13 ' D' ' 60' ' ' LEU . 65.8 t -99.59 123.28 52.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.061 -1.088 . . . . 75.44 108.061 170.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.491 HG23 ' HG3' ' D' ' 77' ' ' GLU . 70.4 m -122.29 130.42 53.14 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.324 -0.853 . . . . 45.25 110.145 -172.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.53 HG21 HG21 ' D' ' 114' ' ' ILE . 37.6 t -120.67 101.58 10.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 113.699 -1.591 . . . . 40.15 107.281 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 11.2 m -94.3 111.36 23.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.206 -1.405 . . . . 61.22 107.206 169.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.65 135.09 54.53 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.088 -0.708 . . . . 73.43 109.088 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.9 p -139.1 148.92 43.94 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.807 -0.633 . . . . 55.3 110.022 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.466 HD21 ' HG3' ' D' ' 38' ' ' PRO . 85.9 mt -109.96 92.06 3.9 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.376 -0.601 . . . . 74.51 109.376 169.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.27 -121.23 20.4 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.421 -0.809 . . . . 31.41 111.893 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -84.4 27.77 0.68 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.957 0.903 . . . . 62.04 112.127 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.537 ' HB2' ' NZ ' ' D' ' 34' ' ' LYS . 5.2 tp10 -135.63 135.64 40.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 118.889 -0.577 . . . . 61.42 110.048 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -73.85 113.17 10.7 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.905 -0.776 . . . . 54.42 108.905 167.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -76.23 -61.46 1.94 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.173 -0.677 . . . . 63.33 109.173 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.57 154.23 15.99 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.361 -1.29 . . . . 63.11 110.016 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.13 149.52 29.21 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.111 -1.44 . . . . 63.02 107.111 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.2 t -155.35 103.38 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.547 -0.538 . . . . 71.11 109.547 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' D' ' 63' ' ' THR . 5.2 mp0 -121.96 121.71 37.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.133 0.973 . . . . 64.14 108.667 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.43 114.18 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.758 -0.46 . . . . 73.04 109.758 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.78 91.25 8.55 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.639 0.776 . . . . 70.11 109.268 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -79.17 98.56 6.63 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.962 -1.017 . . . . 74.35 108.962 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.05 142.92 20.14 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.079 -0.808 . . . . 14.53 111.079 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.16 130.12 3.61 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.689 -0.964 . . . . 62.41 110.689 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.73 128.72 42.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.502 -0.925 . . . . 70.1 108.502 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -134.06 148.38 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.091 0.556 . . . . 73.03 110.489 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 46.1 m -104.94 105.78 15.98 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.566 -0.902 . . . . 74.42 108.566 170.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.1 pt -109.57 145.38 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 118.488 0.585 . . . . 63.14 110.634 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.15 169.3 21.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.697 -1.138 . . . . 62.22 109.43 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 23.8 77.26 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 121.576 -0.345 . . . . 72.1 112.584 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.434 HD13 ' HB2' ' D' ' 94' ' ' MET . 2.2 pp -124.46 146.16 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.749 0.82 . . . . 32.12 110.755 -172.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.29 171.49 17.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 75.51 110.177 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.98 -134.48 31.69 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.941 0.776 . . . . 54.34 114.73 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -81.04 -13.25 58.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.269 0.628 . . . . 74.13 110.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -67.9 -36.69 80.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.235 0.614 . . . . 70.42 110.468 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.434 ' HB2' HD13 ' D' ' 89' ' ' ILE . 2.0 ppp? -70.45 -35.08 73.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.455 -0.572 . . . . 74.1 109.455 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.85 76.02 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 115.038 -0.983 . . . . 54.32 111.285 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -72.28 -37.68 68.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.25 0.62 . . . . 51.41 110.974 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.85 -38.96 76.63 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.043 0.537 . . . . 72.03 110.811 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.67 -45.86 20.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.662 0.785 . . . . 64.21 110.416 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.61 -26.9 40.72 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.626 -0.715 . . . . 70.23 114.009 -168.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.93 -51.02 2.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.142 0.471 . . . . 73.24 111.903 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -73.74 -47.29 40.32 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.282 0.475 . . . . 74.22 112.282 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 73.6 m -60.5 -47.84 95.18 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 118.976 -0.535 . . . . 61.4 111.274 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.8 Cg_exo -55.32 -37.0 94.89 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.447 2.098 . . . . 74.21 114.043 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.98 -29.61 70.54 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.099 0.56 . . . . 71.01 111.02 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 44.6 mm -75.34 -46.3 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.351 0.66 . . . . 70.11 110.409 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.81 -17.27 59.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.202 -0.908 . . . . 71.51 111.822 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.0 -47.6 52.33 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.256 1.022 . . . . 71.54 112.859 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 83.2 Cg_exo -49.42 -44.98 32.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.565 2.177 . . . . 73.13 113.945 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -73.71 -37.08 65.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.319 0.648 . . . . 74.31 111.918 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' D' ' 62' ' ' VAL . . . -64.36 -53.38 49.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.212 0.605 . . . . 74.34 110.764 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.602 HH12 ' HB3' ' D' ' 130' ' ' PRO . 8.7 ptt180 -67.13 -30.85 70.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.703 -1.135 . . . . 64.54 110.898 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.419 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.3 tm-20 -67.82 -45.71 73.92 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.09 0.868 . . . . 75.33 110.446 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.696 0.622 . . . . 22.24 110.4 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' D' ' 64' ' ' VAL . 96.5 mt -58.25 -54.83 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 114.889 -1.051 . . . . 74.41 110.562 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.611 HG23 ' HG3' ' D' ' 125' ' ' GLN . 27.6 m -51.2 -48.24 62.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.878 1.271 . . . . 73.34 111.145 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -66.93 -44.78 79.79 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.464 -1.244 . . . . 62.54 110.176 -173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.5 mtm -65.47 -34.03 77.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.903 0.481 . . . . 73.14 111.405 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.657 HG13 ' HB2' ' D' ' 123' ' ' PHE . 56.5 t -64.91 -49.63 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.597 0.759 . . . . 74.33 110.454 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 90.4 p -69.29 -31.6 70.21 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.959 0.504 . . . . 65.53 111.066 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -70.43 -31.46 68.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.929 0.892 . . . . 75.12 109.945 173.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.85 64.13 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.536 -0.756 . . . . 73.31 113.202 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 125' ' ' GLN . 66.8 p 56.92 28.18 14.22 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.866 1.667 . . . . 75.35 113.112 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.657 ' HB2' HG13 ' D' ' 118' ' ' VAL . 20.4 m-85 -100.9 164.36 16.25 Favored Pre-proline 0 CA--C 1.561 1.396 0 N-CA-C 108.474 -0.936 . . . . 73.44 108.474 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 63.2 Cg_endo -68.77 133.53 27.69 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.311 2.007 . . . . 72.21 112.196 -175.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' D' ' 115' ' ' THR . 57.2 tt0 -56.58 129.91 42.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.688 0.795 . . . . 64.23 111.227 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -121.99 97.99 5.74 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.031 0.443 . . . . 64.25 110.121 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -99.43 105.05 16.95 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.218 -1.401 . . . . 72.43 107.218 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.82 115.0 12.75 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.888 -0.412 . . . . 70.31 109.888 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.11 86.83 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.543 0.737 . . . . 64.31 111.05 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.602 ' HB3' HH12 ' D' ' 111' ' ' ARG . 73.1 Cg_endo -79.82 108.72 2.3 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.581 2.187 . . . . 75.04 109.997 -174.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -104.26 113.26 40.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t30 . . . . . 0 C--O 1.241 0.611 0 N-CA-C 106.731 -1.581 . . . . 52.34 106.731 169.01 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.235 0.311 0 N-CA-C 108.212 -1.033 . . . . 65.41 108.212 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.412 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 60.3 t80 -135.04 135.91 41.67 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.287 -1.005 . . . . 63.4 108.287 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -152.48 135.7 15.79 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 116.134 -0.485 . . . . 61.34 110.2 175.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.454 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 3.7 mp -79.82 117.73 26.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.667 -0.864 . . . . 55.23 108.667 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -89.27 -39.65 13.35 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.155 0.582 . . . . 72.34 109.701 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -172.71 123.78 0.45 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.307 0.243 . . . . 74.1 111.078 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.82 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 85.6 mt -108.17 132.73 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 123.611 0.764 . . . . 74.31 109.208 173.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.702 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 9.3 p90 -167.73 170.74 10.65 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.047 0.939 . . . . 63.15 110.13 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -88.46 134.86 33.73 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.694 -0.854 . . . . 75.24 108.694 171.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 46.9 mtpt -94.44 -43.32 8.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.927 -0.768 . . . . 62.21 108.927 170.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 28.1 t70 -137.54 129.5 28.91 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.709 -1.132 . . . . 74.21 109.604 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -124.36 136.15 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.416 -1.328 . . . . 61.54 107.416 170.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -145.89 112.75 6.03 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 123.519 0.512 . . . . 62.31 109.725 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.567 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 77.7 t80 -114.23 111.78 22.08 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 106.609 -1.626 . . . . 65.01 106.609 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.76 110.19 16.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.976 -0.75 . . . . 75.01 108.976 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.47 93.04 7.75 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.566 -1.272 . . . . 70.14 107.566 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.46 -41.01 7.02 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.457 2.105 . . . . 65.1 111.182 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 78.0 m-20 -100.56 37.51 1.68 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.651 -1.159 . . . . 75.22 109.303 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.34 73.2 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.131 -0.938 . . . . 74.44 113.43 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.33 -27.93 10.92 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 121.541 1.586 . . . . 71.04 112.924 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 14.3 t60 -67.58 -26.26 66.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.761 1.224 . . . . 62.34 112.151 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 HD11 ' A' ' 68' ' ' LEU . 12.0 p -55.75 -30.18 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.517 1.127 . . . . 74.14 112.908 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.6 -34.46 75.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.892 0.877 . . . . 73.23 111.21 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -69.64 -32.03 70.47 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.282 1.033 . . . . 75.21 110.267 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -79.14 162.32 25.88 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.683 -1.144 . . . . 74.45 111.06 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.1 143.08 30.79 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 108.316 -0.994 . . . . 74.35 108.316 164.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -83.68 83.88 7.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.756 0.789 . . . . 75.02 110.038 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.67 69.77 16.97 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.416 1.086 . . . . 73.42 108.318 176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.27 110.02 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.534 2.156 . . . . 73.25 112.704 -170.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.11 114.4 26.53 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.634 -1.247 . . . . 74.02 107.634 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 65' ' ' THR . 22.8 m -87.63 118.25 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.066 -0.97 . . . . 63.03 110.877 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 64.1 tttm -85.33 116.74 23.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.198 -0.91 . . . . 64.13 108.753 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.34 123.51 41.19 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.863 -0.608 . . . . 51.44 110.206 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.1 m-20 -115.32 122.92 47.37 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.061 -1.089 . . . . 71.41 108.061 170.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD23 ' HE2' ' A' ' 133' ' ' PHE . 34.1 tp -124.21 121.23 34.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.033 -0.729 . . . . 71.43 109.033 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.15 146.06 34.89 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.893 0.877 . . . . 73.34 110.017 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -109.29 150.11 28.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.405 0.682 . . . . 73.33 109.811 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.28 154.17 49.04 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.767 1.227 . . . . 54.34 108.085 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -130.55 152.79 49.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.86 0.464 . . . . 70.33 110.454 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.9 t -154.66 119.38 4.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.213 1.005 . . . . 62.42 108.537 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -91.47 118.67 30.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.183 -1.043 . . . . 62.34 108.183 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 57' ' ' GLU . 40.5 mt -93.24 -33.27 14.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.751 0.82 . . . . 71.52 110.129 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.97 -169.97 1.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.307 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.68 106.31 0.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.898 1.279 . . . . 72.34 109.964 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.96 8.18 6.3 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.541 1.136 . . . . 74.44 112.515 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.36 19.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.736 -1.209 . . . . 71.43 107.736 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -122.32 123.32 41.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.442 -0.799 . . . . 71.15 109.592 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.9 tt0 -93.64 128.07 39.64 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.878 -1.055 . . . . 64.43 108.796 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.8 t -101.3 124.86 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.75 . . . . 74.34 106.276 166.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.9 t -101.83 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.725 -0.843 . . . . 45.02 108.725 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -102.85 107.05 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.127 -1.064 . . . . 63.54 108.127 -175.78 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -103.68 110.53 22.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.952 0.901 . . . . 74.1 109.984 -173.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.01 132.07 66.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.97 -1.013 . . . . 75.23 108.729 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.1 m -121.92 123.22 41.19 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.533 -0.543 . . . . 75.51 109.533 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 114' ' ' ILE . 52.4 t -116.69 107.23 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.727 1.211 . . . . 65.44 108.453 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.8 m -102.2 149.81 23.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.132 -1.062 . . . . 44.25 108.132 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.19 122.67 30.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.623 -0.51 . . . . 64.31 109.623 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -117.74 126.61 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.238 0.615 . . . . 75.1 110.39 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD11 HG23 ' A' ' 31' ' ' VAL . 28.8 mt -92.92 82.42 4.66 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.791 -1.559 . . . . 65.51 106.791 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -83.63 1.0 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.177 -1.169 . . . . 50.53 110.177 -167.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.93 -18.2 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.472 1.109 . . . . 75.45 110.321 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.44 108.86 12.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.41 1.084 . . . . 73.43 110.505 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 m -66.16 119.15 10.95 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.967 0.348 . . . . 72.43 111.106 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.09 -50.89 17.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.184 0.994 . . . . 64.43 109.336 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -159.9 173.15 16.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 113.607 -1.633 . . . . 71.23 110.174 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 76' ' ' CYS . 19.0 tp -141.1 141.2 34.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.737 1.215 . . . . 60.4 107.811 173.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.567 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 36.2 m -132.25 141.51 49.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.854 0.862 . . . . 71.13 108.877 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.99 121.39 9.65 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.568 -0.901 . . . . 70.13 108.568 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.49 112.38 29.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.524 0.73 . . . . 74.43 109.542 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -88.73 87.2 7.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.536 -1.211 . . . . 71.11 109.086 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -77.15 95.55 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.716 -1.129 . . . . 75.25 109.29 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.82 142.95 19.56 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.912 -0.475 . . . . 65.43 111.912 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.43 122.66 2.33 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 110.865 -0.894 . . . . 72.34 110.865 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.3 mt -79.76 131.0 35.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.726 -1.212 . . . . 62.02 107.726 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD2' ' HA ' ' A' ' 13' ' ' ILE . 39.2 m-85 -135.9 138.34 42.32 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.197 0.599 . . . . 75.41 109.577 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.9 m -87.62 121.46 30.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 63.51 108.94 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.37 136.09 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.57 0.748 . . . . 72.23 111.26 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.27 174.31 3.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.711 1.204 . . . . 54.5 110.155 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.41 9.62 86.73 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-N 116.509 -0.314 . . . . 54.32 113.833 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 94' ' ' MET . 1.8 pp -120.22 149.4 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.311 1.044 . . . . 64.31 111.02 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.8 174.55 10.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.597 0.759 . . . . 74.33 110.634 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.43 -140.43 40.12 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 115.683 1.033 . . . . 75.24 115.683 167.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -78.63 -12.04 60.0 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.308 1.043 . . . . 71.53 111.064 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -36.9 79.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.752 0.821 . . . . 63.44 110.091 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.519 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 26.2 ptm -75.69 -20.15 58.61 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.397 -0.365 . . . . 74.22 111.191 174.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -23.8 66.61 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.781 0.432 . . . . 73.0 111.553 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -62.86 -45.0 94.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 72.22 110.522 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 41.9 t -68.85 -64.52 0.85 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.704 0.802 . . . . 72.52 111.601 -173.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.58 -26.1 61.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.557 0.343 . . . . 74.33 111.688 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.05 -34.15 11.21 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 114.659 0.624 . . . . 52.22 114.659 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.99 -39.25 0.41 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.96 0.88 . . . . 74.42 113.067 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.1 t80 -69.8 -58.96 3.26 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.844 0.458 . . . . 75.32 111.632 -174.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -67.19 -37.46 13.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.748 0.819 . . . . 75.42 112.66 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.17 -43.56 47.85 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.124 1.883 . . . . 75.13 113.309 162.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.3 -25.43 62.43 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.17 0.588 . . . . 75.5 111.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.0 mm -62.33 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.595 0.712 . . . . 74.44 109.176 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.566 HD21 ' HA3' ' A' ' 82' ' ' GLY . 45.5 mt -81.12 -18.74 45.4 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.584 -1.189 . . . . 52.43 112.061 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.481 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 51.4 t80 -63.42 -42.54 74.7 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 113.966 1.098 . . . . 75.21 113.966 -171.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.514 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 73.6 Cg_exo -55.13 -33.19 83.06 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 122.101 1.867 . . . . 73.5 113.785 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.94 -40.14 24.99 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.265 -0.88 . . . . 73.43 111.317 -175.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.06 -41.14 82.42 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.457 0.303 . . . . 63.22 110.586 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.523 ' NH1' HG23 ' C' ' 105' ' ' ILE . 34.0 ttm180 -51.98 -55.72 18.67 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.528 1.142 . . . . 75.33 109.537 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.45 -42.17 99.27 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.676 1.235 . . . . 75.35 111.845 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.466 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.5 t -57.54 -50.21 73.82 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.967 0.792 . . . . 72.11 110.302 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.1 mt -62.63 -46.5 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.141 -0.936 . . . . 64.33 110.667 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' HE2' ' C' ' 109' ' ' TYR . 82.0 m -54.41 -44.49 72.41 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.253 1.021 . . . . 64.4 110.902 -176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.2 t -72.13 -34.81 68.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.547 -1.206 . . . . 73.22 111.035 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.9 mtp -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.516 0.726 . . . . 65.12 111.193 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -59.97 -52.08 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.008 0.923 . . . . 75.54 110.064 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 71.1 p -68.04 -26.71 66.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.17 -0.923 . . . . 75.12 112.151 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.9 ttm-85 -72.81 -25.49 61.16 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.877 0.871 . . . . 60.3 109.985 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 22.16 12.03 Favored Glycine 0 C--N 1.358 1.791 0 CA-C-N 116.027 -0.533 . . . . 62.11 113.06 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t 55.96 27.86 11.82 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 127.154 2.182 . . . . 74.33 113.664 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 119' ' ' SER . 36.1 m-85 -98.48 153.15 38.11 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.398 0.679 . . . . 63.23 110.191 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.74 118.94 5.78 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.501 2.134 . . . . 74.1 111.14 166.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 3.3 pt20 -64.23 150.35 46.09 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.391 0.676 . . . . 43.21 112.345 -171.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -109.21 101.24 10.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 109.029 -0.73 . . . . 62.35 109.029 -171.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' C' ' 16' ' ' ILE . 10.9 m120 -98.2 84.7 3.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.735 -0.839 . . . . 71.14 108.735 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.481 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -59.43 139.95 56.61 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.875 0.87 . . . . 74.11 110.017 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' HD13 ' A' ' 128' ' ' LEU . . . -60.78 132.71 91.74 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.316 0.647 . . . . 62.14 111.852 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.456 ' HB3' ' NH2' ' A' ' 111' ' ' ARG . 39.8 Cg_endo -72.07 101.73 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.396 2.064 . . . . 73.21 111.483 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -101.03 111.52 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 122.389 1.09 . . . . 73.34 110.711 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.16 70.03 1.75 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.965 -1.471 . . . . 70.14 108.526 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.498 ' HE2' HD23 ' A' ' 44' ' ' LEU . 21.7 m-85 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 75.33 112.289 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 C--O 1.242 0.688 0 N-CA-C 107.8 -1.185 . . . . 71.33 107.8 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -137.21 140.48 41.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.179 -0.674 . . . . 71.44 109.179 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 23.9 tp60 -142.68 115.46 8.68 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.171 -0.677 . . . . 51.41 109.171 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.409 HD11 HG13 ' B' ' 16' ' ' ILE . 6.8 tp -68.88 127.6 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.953 -0.758 . . . . 63.22 108.953 171.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.78 -45.55 3.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.873 0.469 . . . . 63.23 110.332 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -167.09 143.74 4.48 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.329 0.393 . . . . 63.13 110.689 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.409 HG13 HD11 ' B' ' 13' ' ' ILE . 92.8 mt -120.04 143.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.442 -1.318 . . . . 73.5 107.442 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.445 ' HE1' HG13 ' B' ' 83' ' ' ILE . 22.1 p90 -173.19 156.27 3.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.167 0.508 . . . . 73.51 111.461 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -84.1 128.98 34.91 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.93 -0.767 . . . . 63.11 108.93 169.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.5 mtpt -90.41 -43.49 10.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.496 0.718 . . . . 75.3 109.738 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.0 t70 -148.19 142.44 26.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.316 -0.856 . . . . 74.34 111.323 -172.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 41.3 mm -128.27 135.36 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 124.768 1.227 . . . . 63.12 108.878 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.8 t -130.39 128.83 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.611 -1.177 . . . . 75.11 108.067 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 72.5 t80 -150.08 110.33 4.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.793 -1.558 . . . . 75.22 106.793 171.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.41 113.93 18.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.979 -1.119 . . . . 71.03 107.979 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.07 89.64 5.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.703 0.801 . . . . 73.24 108.903 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 44.7 Cg_endo -63.57 -38.28 42.48 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.25 2.634 . . . . 74.1 112.844 -171.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.33 30.69 6.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.302 1.041 . . . . 75.02 109.559 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.702 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.4 -50.02 51.0 Favored Pre-proline 0 CA--C 1.566 1.57 0 N-CA-C 114.856 1.428 . . . . 32.43 114.856 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.9 Cg_endo -77.68 -23.28 9.8 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.871 1.714 . . . . 43.32 112.738 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -78.38 -8.29 58.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.568 0.747 . . . . 75.35 111.437 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.01 -24.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.074 0.95 . . . . 71.33 111.027 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -66.13 -43.49 86.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.665 0.386 . . . . 71.12 110.975 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -72.54 -36.59 68.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.709 0.804 . . . . 62.34 110.049 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.38 76.6 10.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.651 0.739 . . . . 72.11 109.786 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.79 79.34 6.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.595 -1.184 . . . . 55.52 110.641 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -173.29 156.95 3.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.142 0.977 . . . . 72.02 109.482 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -58.54 128.38 83.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.881 0.872 . . . . 75.25 110.699 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -66.01 152.6 80.91 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.19 1.26 . . . . 73.34 110.281 168.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.27 101.66 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.026 -1.101 . . . . 74.12 108.026 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.594 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.2 t -84.58 123.21 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.143 -1.428 . . . . 42.34 107.143 -174.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 64' ' ' VAL . 1.5 tmtp? -145.83 113.97 6.59 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.629 -0.508 . . . . 61.45 109.629 -174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.71 148.48 23.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.646 0.779 . . . . 74.5 109.157 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.39 150.33 43.76 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.13 -1.063 . . . . 53.14 108.13 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.401 HD12 HG11 ' B' ' 131' ' ' VAL . 5.5 tt -109.92 125.73 53.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.351 0.66 . . . . 74.44 109.257 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -134.46 136.19 43.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.884 -1.154 . . . . 73.24 107.884 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -108.41 146.16 33.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.274 0.559 . . . . 62.14 109.957 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.75 159.17 42.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.5 1.12 . . . . 71.4 108.405 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.519 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 81.2 p -143.54 162.35 36.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.945 0.402 . . . . 43.22 110.94 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -160.48 154.36 22.75 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.781 1.233 . . . . 75.0 108.91 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -121.76 135.07 54.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.166 0.587 . . . . 75.15 109.657 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.5 mt -100.66 -47.9 4.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.474 0.71 . . . . 75.24 109.517 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.06 -175.39 5.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.99 -1.005 . . . . 60.21 110.295 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -71.83 130.11 40.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.736 -1.12 . . . . 70.13 109.072 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 66.07 -8.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.47 1.508 . . . . 64.32 112.743 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.02 94.18 2.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 107.942 -1.133 . . . . 63.43 107.942 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.519 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 2.8 t80 -98.12 165.32 11.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.701 -1.136 . . . . 74.31 109.134 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.8 106.01 4.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.548 -1.278 . . . . 70.02 107.548 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 56.7 t -97.94 131.5 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.205 0.602 . . . . 71.24 109.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 34.7 t -108.92 125.28 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.716 0.806 . . . . 53.14 109.726 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.455 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.25 130.95 40.31 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.511 -1.292 . . . . 64.4 107.511 172.167 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -121.26 106.74 11.77 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.681 . . . . 71.32 109.497 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.1 124.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.537 -0.912 . . . . 75.42 108.537 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.1 m -120.35 146.91 45.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.398 . . . . 63.15 110.931 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 55.1 t -116.88 120.1 64.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 124.644 1.177 . . . . 75.51 109.577 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.3 m -99.24 127.93 45.29 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.981 -1.488 . . . . 74.31 106.981 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.59 132.43 18.03 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.582 -0.896 . . . . 72.14 108.582 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -148.55 139.31 22.88 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.587 0.554 . . . . 51.44 111.803 -170.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 51.2 mt -100.24 100.28 11.08 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.054 1.342 . . . . 74.44 109.587 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.66 -111.18 3.61 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.801 -0.52 . . . . 73.45 111.801 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -108.16 4.43 24.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.566 0.747 . . . . 43.34 111.536 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -121.07 160.31 23.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.693 0.797 . . . . 73.43 109.843 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.9 m -78.74 136.99 37.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.738 0.415 . . . . 65.33 110.515 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -82.33 -61.42 1.9 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.412 1.101 . . . . 65.42 109.024 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' B' ' 76' ' ' CYS . 1.2 p90 -154.17 171.79 18.61 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 112.892 -1.958 . . . . 72.23 107.623 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -136.57 110.17 8.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.907 -1.886 . . . . 74.04 105.907 167.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.484 ' HB2' ' HD1' ' B' ' 23' ' ' PHE . 1.8 t -113.76 160.22 18.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.094 -0.503 . . . . 71.31 110.292 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.2 tt0 -164.98 143.73 6.59 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.653 -1.24 . . . . 75.24 107.653 -170.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.16 144.01 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.786 0.834 . . . . 73.13 108.871 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.69 92.53 3.73 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.748 0.819 . . . . 74.23 108.911 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -88.54 100.73 13.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.736 -1.12 . . . . 74.24 108.809 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.39 174.52 33.74 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 111.838 -0.505 . . . . 74.02 111.838 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.29 136.5 4.07 Favored Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.729 -0.548 . . . . 74.34 111.729 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.445 HG13 ' HE1' ' B' ' 17' ' ' TYR . 34.5 mt -86.15 124.88 40.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.445 -0.946 . . . . 72.23 108.445 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -138.61 131.53 29.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.976 -1.12 . . . . 74.01 107.976 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 75.1 m -91.03 107.37 19.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.716 -0.476 . . . . 75.12 109.716 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.505 ' HB ' HD11 ' B' ' 89' ' ' ILE . 24.7 pt -106.24 142.85 18.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.358 -0.837 . . . . 70.41 110.817 -176.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.38 166.13 33.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.313 1.045 . . . . 52.11 108.739 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.63 -53.33 4.84 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.924 -0.375 . . . . 53.3 113.523 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.5 pp -51.98 126.07 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.036 0.934 . . . . 73.11 112.474 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.447 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 10.2 pt-20 -159.36 154.36 24.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 73.01 110.768 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.33 -122.93 22.19 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.578 -0.737 . . . . 74.35 112.188 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -68.52 -31.27 70.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.66 0.784 . . . . 72.03 110.936 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -72.8 -34.85 67.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.642 0.777 . . . . 74.34 110.763 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.447 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 54.1 ttm -62.79 -49.23 75.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.527 -0.761 . . . . 75.13 109.36 171.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.0 -28.79 69.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.697 0.799 . . . . 65.41 112.071 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -69.83 -44.73 69.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 74.33 110.034 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 45.5 t -63.91 -59.47 4.47 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.753 0.821 . . . . 62.44 111.535 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.449 HD12 ' N ' ' B' ' 99' ' ' GLY . 4.2 pp -71.12 -28.66 64.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.475 0.71 . . . . 75.13 112.486 -175.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.449 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -94.42 -38.41 5.04 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.478 -0.328 . . . . 22.12 113.521 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 104' ' ' ASN . . . -125.9 -45.17 1.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 118.984 -0.531 . . . . 52.41 112.223 -171.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.454 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 93.0 t80 -71.04 -63.86 1.02 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.17 0.441 . . . . 74.53 111.819 -169.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.46 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 58.1 m -58.32 -45.99 99.67 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.777 -0.63 . . . . 73.13 111.1 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.3 Cg_exo -54.04 -38.91 87.15 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.314 2.009 . . . . 65.22 114.228 167.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 14.1 t-20 -68.52 -30.14 68.88 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.576 0.626 . . . . 64.12 111.49 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.8 -50.18 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.528 0.68 . . . . 74.24 109.206 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.41 -13.5 59.91 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 113.841 -1.527 . . . . 74.42 111.963 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 55.2 t80 -67.56 -49.3 41.38 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 117.821 -1.085 . . . . 70.5 113.792 -166.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.21 -32.42 90.63 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.45 1.433 . . . . 71.45 112.231 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -65.23 -49.85 68.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 71.3 110.531 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.55 99.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.873 0.869 . . . . 73.14 111.15 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -61.28 -49.14 78.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.53 1.532 . . . . 73.51 111.265 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -36.85 77.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.512 -0.551 . . . . 74.42 109.512 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 37.9 t -62.18 -39.27 92.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.326 0.65 . . . . 73.41 112.217 -178.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mt -63.51 -51.84 65.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.716 -0.476 . . . . 63.23 109.716 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.9 m -61.52 -24.42 66.61 Favored 'General case' 0 CA--C 1.561 1.371 0 O-C-N 124.31 1.006 . . . . 74.12 111.438 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.4 t -69.74 -58.59 3.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.971 0.909 . . . . 64.15 109.884 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.483 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.4 mmt -65.9 -28.08 68.68 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.309 0.576 . . . . 71.43 111.477 -176.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -52.35 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.726 1.61 . . . . 65.41 109.548 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 96.7 p -65.97 -31.6 72.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.015 0.526 . . . . 71.51 111.007 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 79.8 mtt-85 -62.17 -39.85 94.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.406 0.682 . . . . 65.24 110.721 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 9.21 71.15 Favored Glycine 0 C--N 1.353 1.475 0 O-C-N 123.349 0.406 . . . . 62.04 113.489 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p 58.95 30.7 20.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.406 1.882 . . . . 71.41 112.362 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.84 161.53 35.6 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.749 1.22 . . . . 65.3 110.899 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.594 ' HB2' HG21 ' B' ' 40' ' ' VAL . 14.8 Cg_exo -74.89 145.46 31.94 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 124.157 3.238 . . . . 73.22 115.46 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.485 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.4 OUTLIER -67.41 143.13 56.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.25 1.42 . . . . 75.23 111.936 177.2 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.28 113.73 4.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.95 -1.13 . . . . 74.13 107.95 163.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -89.01 116.02 26.99 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.147 -1.057 . . . . 65.2 108.147 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 129' ' ' ALA . 2.3 tt -66.34 137.48 56.94 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.853 0.721 . . . . 74.44 110.063 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.475 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -55.11 152.89 13.5 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 126.138 1.775 . . . . 70.23 113.539 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.646 ' HG3' HD11 ' D' ' 16' ' ' ILE . 92.6 Cg_endo -69.72 103.98 1.24 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.807 2.338 . . . . 72.44 110.701 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.401 HG11 HD12 ' B' ' 44' ' ' LEU . 16.6 m -85.29 52.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 122.374 1.083 . . . . 61.24 111.096 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.46 71.27 4.92 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.402 -1.333 . . . . 73.43 107.402 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 t80 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 114.308 -1.315 . . . . 73.5 110.974 -171.42 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.245 0.826 0 N-CA-C 110.49 -0.189 . . . . 43.23 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.501 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 44.0 t80 -125.31 118.64 26.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.953 -1.128 . . . . 74.55 107.953 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.442 ' NE2' ' HG2' ' C' ' 14' ' ' GLN . 11.9 tm0? -136.12 127.57 28.58 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 117.943 0.338 . . . . 75.34 110.235 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -89.15 129.03 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.224 -0.658 . . . . 73.31 109.224 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.442 ' HG2' ' NE2' ' C' ' 12' ' ' GLN . 5.5 mt-30 -99.99 -42.2 6.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.413 0.685 . . . . 73.14 110.42 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.498 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 60.6 ttt180 -174.6 128.19 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.153 0.581 . . . . 75.33 110.11 -168.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.468 ' HB ' ' ND2' ' A' ' 127' ' ' ASN . 68.2 mt -112.85 142.1 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.961 -1.126 . . . . 64.41 107.961 172.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.556 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 26.2 p90 -177.84 161.37 1.59 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.824 0.703 . . . . 72.25 110.909 -175.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.464 HG21 ' SG ' ' C' ' 113' ' ' CYS . 64.9 p -80.41 120.32 24.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.609 0.764 . . . . 75.3 109.701 175.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.2 OUTLIER -74.02 -49.87 22.36 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.862 0.839 . . . . 74.32 108.964 178.177 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' C' ' 79' ' ' GLN . 25.0 m-20 -141.91 122.07 13.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.417 -1.72 . . . . 51.01 108.16 -174.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.2 mt -112.63 143.62 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 107.412 -1.329 . . . . 73.24 107.412 169.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.19 145.98 21.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.098 0.475 . . . . 53.34 110.214 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' D' ' 21' ' ' ILE . 91.8 t80 -148.21 123.99 10.56 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.562 -1.273 . . . . 55.11 107.562 176.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.06 115.35 24.11 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.14 0.976 . . . . 73.34 109.306 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.32 78.55 27.06 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 108.042 -1.095 . . . . 55.15 108.042 166.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.52 -15.34 24.73 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.373 2.049 . . . . 71.43 111.559 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -112.31 25.41 11.55 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 124.276 1.03 . . . . 51.25 109.945 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.33 77.01 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 114.435 1.272 . . . . 64.11 114.435 -172.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.69 -27.13 9.2 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 121.922 1.748 . . . . 71.21 112.45 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.84 -33.81 72.79 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.211 1.404 . . . . 71.41 111.395 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.705 HG13 HD11 ' C' ' 68' ' ' LEU . 53.5 t -79.9 -22.78 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 124.78 1.232 . . . . 73.34 111.487 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.65 -40.87 93.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.215 0.606 . . . . 70.34 111.78 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -101.97 45.69 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.415 0.686 . . . . 71.11 109.944 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.83 168.33 13.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.636 0.775 . . . . 62.12 110.019 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -74.08 115.41 13.52 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.032 -0.729 . . . . 72.33 109.032 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.472 ' HZ3' HG12 ' C' ' 31' ' ' VAL . 51.7 t-105 -85.25 93.94 8.8 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.659 0.784 . . . . 60.42 111.842 -167.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.49 73.39 20.5 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.148 0.979 . . . . 74.31 109.773 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 120.76 4.97 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.999 2.466 . . . . 61.13 112.408 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' C' ' 67' ' ' SER . 8.8 pt-20 -86.49 91.37 8.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.222 1.01 . . . . 63.42 109.346 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.755 ' HB ' HD13 ' C' ' 126' ' ' LEU . 26.2 m -82.03 89.01 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 122.532 1.158 . . . . 65.53 110.449 -173.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -109.61 142.04 41.29 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.691 -1.141 . . . . 73.3 109.507 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.416 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -129.85 160.78 32.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.895 0.478 . . . . 74.42 111.17 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -133.41 146.58 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.719 1.208 . . . . 62.1 109.053 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.578 ' HG ' HD21 ' C' ' 60' ' ' LEU . 6.0 tt -112.39 109.77 19.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.657 -1.238 . . . . 72.41 107.657 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 24.0 t70 -112.97 141.7 46.5 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.039 -1.097 . . . . 74.31 108.039 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 43.5 m -113.94 111.63 22.0 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.786 -0.82 . . . . 45.13 108.786 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.47 158.86 18.65 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.934 1.294 . . . . 71.12 108.971 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 p -165.69 154.48 11.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.789 0.436 . . . . 70.25 111.198 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -145.6 160.91 40.97 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.737 0.815 . . . . 52.4 109.172 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.68 121.83 35.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.494 -0.558 . . . . 54.34 109.494 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.615 HD11 HD12 ' C' ' 83' ' ' ILE . 61.6 mt -88.3 -53.06 4.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.561 -0.903 . . . . 63.21 108.561 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.16 -171.26 3.79 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.852 -1.067 . . . . 71.43 110.328 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.91 118.92 17.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.065 -0.97 . . . . 75.22 108.779 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 69.51 -0.55 2.55 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.805 1.242 . . . . 74.44 113.189 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.71 114.64 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.059 -0.719 . . . . 70.31 109.059 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -128.13 140.07 52.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.835 0.826 . . . . 75.04 110.839 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -85.24 109.3 18.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.373 -1.739 . . . . 64.44 108.138 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.32 115.97 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.714 -1.217 . . . . 74.41 107.714 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.6 114.07 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.695 0.798 . . . . 62.42 109.973 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.578 HD21 ' HG ' ' C' ' 44' ' ' LEU . 1.3 tt -86.58 106.44 17.56 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.97 -1.493 . . . . 73.0 106.97 169.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 45.0 mtp180 -87.61 106.51 18.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 74.1 109.738 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' C' ' 114' ' ' ILE . 8.2 t -100.19 120.63 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.85 -0.796 . . . . 64.24 108.85 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 86.0 m -104.35 145.42 30.28 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.454 -0.943 . . . . 73.22 108.454 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.545 HG21 HD21 ' C' ' 126' ' ' LEU . 46.8 t -136.88 127.56 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.846 0.858 . . . . 65.52 109.637 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.1 m -118.17 146.15 44.41 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.39 -0.967 . . . . 72.32 108.39 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.273 -1.01 . . . . 71.15 108.273 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 70.6 m -143.25 168.18 20.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.047 0.939 . . . . 63.54 110.058 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.705 HD11 HG13 ' C' ' 31' ' ' VAL . 13.2 mt -111.56 37.5 2.88 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.466 -1.309 . . . . 73.13 107.466 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 -79.13 0.29 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 109.473 -1.451 . . . . 71.53 109.473 -166.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -128.13 -28.02 2.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.153 0.981 . . . . 61.25 110.016 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.93 98.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.986 0.914 . . . . 65.01 109.499 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.8 m -65.4 117.1 7.44 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.156 0.503 . . . . 62.43 110.43 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.12 -50.33 28.86 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.406 -1.27 . . . . 73.32 109.026 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -161.87 166.09 26.79 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.36 -0.836 . . . . 61.12 111.103 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -122.65 146.75 47.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.831 -1.915 . . . . 75.3 105.831 167.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.614 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -152.6 153.35 33.19 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.37 -0.604 . . . . 74.2 109.37 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.25 128.52 6.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.834 0.453 . . . . 63.33 110.329 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.81 114.06 44.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.158 -1.053 . . . . 74.42 108.158 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' C' ' 20' ' ' ASP . 49.6 mt-30 -87.99 90.78 8.52 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.347 -1.353 . . . . 73.13 107.347 169.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 69.1 tp60 -79.8 132.48 36.15 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.36 -0.836 . . . . 72.23 109.539 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -119.72 152.94 16.96 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 123.376 0.422 . . . . 73.02 112.767 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.12 126.64 2.22 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 109.321 -1.512 . . . . 71.33 109.321 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.615 HD12 HD11 ' C' ' 51' ' ' LEU . 19.3 mm -88.26 113.12 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 42.23 108.092 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -123.91 119.16 28.81 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.056 -1.09 . . . . 72.43 108.056 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -84.89 108.79 17.71 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.944 -0.761 . . . . 62.1 108.944 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.408 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.2 pp -112.19 132.41 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.871 0.869 . . . . 75.41 109.617 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.05 135.63 16.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.573 0.749 . . . . 42.53 109.962 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -19.62 27.87 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.352 0.408 . . . . 63.32 113.078 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.726 1.21 . . . . 54.43 111.552 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.864 -0.421 . . . . 72.12 109.864 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.42 -42.98 99.85 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.995 0.918 . . . . 74.1 111.773 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.55 84.3 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.024 0.827 . . . . 72.53 111.393 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -84.51 -26.59 27.99 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.134 -0.484 . . . . 55.23 110.845 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -70.11 -61.07 1.92 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.009 0.524 . . . . 72.1 111.361 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.482 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.6 pp -88.35 -18.6 28.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.663 0.245 . . . . 61.41 111.663 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.12 -29.69 27.55 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.433 0.458 . . . . 43.34 113.199 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.74 -46.5 0.96 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.72 0.408 . . . . 60.14 112.095 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.461 ' O ' HG12 ' C' ' 105' ' ' ILE . 56.5 t80 -76.3 -39.32 54.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.542 0.737 . . . . 71.41 112.101 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.501 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 67.7 m -68.74 -46.79 33.81 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.919 -0.563 . . . . 72.52 110.032 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 58.1 Cg_exo -57.4 -34.31 97.73 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 121.884 1.723 . . . . 54.51 113.281 166.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.25 -35.87 82.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 123.412 0.685 . . . . 74.52 111.112 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.523 HG23 ' NH1' ' A' ' 111' ' ' ARG . 23.2 mm -62.99 -43.0 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.629 -0.714 . . . . 72.5 109.777 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.573 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.8 mt -81.49 -21.56 38.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.672 -1.149 . . . . 71.22 112.582 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.75 -48.53 92.79 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-O 117.695 -1.145 . . . . 71.24 113.557 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 -33.91 97.83 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.704 1.603 . . . . 75.43 112.484 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.466 ' HE2' HG21 ' A' ' 115' ' ' THR . 87.5 m-85 -64.17 -52.78 57.33 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.775 . . . . 73.45 110.872 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.09 -38.77 89.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.482 . . . . 72.53 111.218 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -54.68 -47.29 73.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.222 1.409 . . . . 72.01 111.126 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -77.57 -36.23 52.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 74.51 110.285 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.464 ' SG ' HG21 ' C' ' 18' ' ' THR . 41.6 t -67.02 -37.55 84.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.621 0.768 . . . . 70.14 112.046 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.614 HG23 ' SG ' ' C' ' 76' ' ' CYS . 74.7 mt -71.63 -47.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.225 -0.657 . . . . 62.31 109.225 175.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.6 m -54.82 -33.61 61.81 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 124.036 0.835 . . . . 62.41 111.355 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -61.64 -57.03 13.63 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.46 -0.791 . . . . 71.12 109.972 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.77 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.97 -43.2 63.44 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.817 1.247 . . . . 61.14 112.999 177.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 114' ' ' ILE . 77.2 t -64.56 -47.38 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.508 1.123 . . . . 65.52 110.701 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -31.96 73.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.885 -1.052 . . . . 75.34 111.037 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.3 mtt-85 -66.95 -34.48 77.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.401 0.68 . . . . 73.52 110.441 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.23 81.65 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 60.12 113.262 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 15.9 p 67.96 29.51 6.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.789 2.036 . . . . 71.32 112.819 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.87 153.23 37.85 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.123 0.969 . . . . 62.4 109.844 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.52 173.97 1.81 Allowed 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.872 3.048 . . . . 73.44 114.803 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 38.4 mm-40 -59.31 122.95 15.18 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 115.892 -0.594 . . . . 73.11 111.17 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.755 HD13 ' HB ' ' C' ' 40' ' ' VAL . 51.5 tp -107.06 17.21 23.3 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.4 -1.273 . . . . 71.35 109.198 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -87.37 84.02 7.25 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.111 -1.811 . . . . 74.54 106.111 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.42 153.47 21.42 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 113.437 -1.711 . . . . 61.14 108.91 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.83 133.26 14.46 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.253 1.021 . . . . 72.31 112.726 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.82 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 54.1 Cg_exo -43.46 129.47 6.61 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 124.525 3.483 . . . . 64.34 114.304 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.06 81.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.882 -0.785 . . . . 64.41 108.882 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -83.47 98.38 9.5 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.705 -0.68 . . . . 63.14 109.321 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 CA--C 1.548 0.869 0 CA-C-N 115.182 -0.917 . . . . 74.53 110.872 -178.964 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.23 0.538 . . . . 73.13 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -145.03 103.38 3.87 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.527 -1.286 . . . . 64.02 107.527 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.99 139.88 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.681 1.192 . . . . 65.11 108.989 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 tt -105.28 135.23 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 70.42 109.871 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.74 -46.64 4.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -158.27 146.72 18.77 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.214 0.206 . . . . 73.31 110.475 -171.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.646 HD11 ' HG3' ' B' ' 130' ' ' PRO . 1.0 OUTLIER -140.01 134.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.634 -1.247 . . . . 73.43 107.634 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -159.97 156.74 27.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.515 0.726 . . . . 72.21 110.677 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 55.7 p -85.14 110.07 18.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.483 -0.932 . . . . 63.4 108.483 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -75.93 -26.6 57.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.127 0.489 . . . . 63.31 110.171 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.08 133.82 12.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.699 -1.137 . . . . 74.04 109.011 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.77 HD13 ' HE3' ' C' ' 117' ' ' MET . 92.9 mt -132.68 132.2 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.785 -1.561 . . . . 70.15 106.785 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -137.94 138.22 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.166 -0.679 . . . . 53.22 109.166 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -145.15 109.94 5.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.403 -2.073 . . . . 73.3 105.403 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.07 113.93 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.928 -0.767 . . . . 74.03 108.928 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.9 83.71 3.02 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.66 -23.61 22.72 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.377 2.051 . . . . 75.34 112.011 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -106.65 20.07 19.56 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 124.415 1.086 . . . . 74.03 110.256 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.5 -63.93 0.98 Allowed Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.963 1.468 . . . . 63.42 114.963 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.19 -17.8 11.54 Favored 'Trans proline' 0 C--N 1.387 2.572 0 CA-C-N 122.221 1.829 . . . . 61.43 113.331 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.79 -52.33 51.7 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.29 1.036 . . . . 45.53 110.319 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -84.15 -1.02 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 124.234 1.014 . . . . 74.23 110.463 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.498 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.8 t80 -54.57 -35.55 63.41 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.117 1.367 . . . . 71.54 111.161 165.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -70.9 -11.8 61.17 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.947 -1.024 . . . . 72.4 111.944 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.597 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 9.6 ttmt -106.78 114.05 27.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.364 0.665 . . . . 71.14 110.715 -173.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -101.56 56.58 0.83 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.147 1.379 . . . . 73.21 112.875 -167.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -125.82 173.97 8.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.609 0.764 . . . . 71.33 109.221 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -88.07 124.06 67.55 Favored Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 121.59 -0.694 . . . . 51.55 109.322 172.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.46 110.58 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.772 2.314 . . . . 73.21 112.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -68.82 113.02 5.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.193 0.997 . . . . 71.2 109.098 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.628 HG13 HG13 ' D' ' 64' ' ' VAL . 73.9 t -99.27 124.29 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.813 0.845 . . . . 71.25 110.763 -169.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -96.34 108.56 21.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.499 -1.667 . . . . 72.31 106.499 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.24 113.62 25.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.328 -0.99 . . . . 72.31 108.328 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.3 t70 -109.17 132.44 54.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.74 -0.837 . . . . 63.13 108.74 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.46 131.88 54.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.776 -1.194 . . . . 65.42 107.776 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.3 t70 -145.09 154.26 42.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.943 0.897 . . . . 54.03 108.786 173.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -126.66 164.6 20.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.225 0.61 . . . . 73.22 110.312 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.655 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.21 164.02 39.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 52.34 109.45 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 m -154.46 160.39 41.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.041 0.536 . . . . 63.44 110.928 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -157.1 120.02 4.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.161 0.984 . . . . 74.33 109.373 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -79.53 117.61 20.63 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.359 -0.608 . . . . 71.34 109.359 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.9 mt -99.81 -34.39 10.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.744 0.418 . . . . 73.54 110.85 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.6 -171.83 3.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.132 0.973 . . . . 75.33 109.773 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.04 118.48 11.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.754 0.821 . . . . 61.43 110.479 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 61.95 13.32 5.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.86 1.264 . . . . 72.22 112.669 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.45 122.64 66.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.032 -1.099 . . . . 74.11 108.032 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -151.71 145.88 25.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.517 0.675 . . . . 72.23 110.556 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.2 tt0 -86.67 125.27 33.75 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.887 -1.506 . . . . 71.32 108.744 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.05 137.78 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.623 -1.251 . . . . 72.12 107.623 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.655 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.6 t -115.19 145.29 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.366 1.066 . . . . 70.32 109.144 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.02 122.33 43.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.116 -1.068 . . . . 55.33 108.116 173.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 36.2 ttm-85 -96.07 100.38 12.05 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.46 -0.941 . . . . 72.03 108.46 172.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.51 107.11 18.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.246 -1.02 . . . . 71.31 108.246 171.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -98.65 131.86 44.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.049 0.452 . . . . 70.31 109.884 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.628 HG13 HG13 ' D' ' 40' ' ' VAL . 54.2 t -127.22 101.42 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.857 1.263 . . . . 73.43 108.104 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.7 m -101.92 94.38 5.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.286 -1.375 . . . . 74.32 107.286 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.02 143.62 27.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.734 -0.469 . . . . 65.42 109.734 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 38.4 p -146.76 133.3 19.77 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 121.199 0.523 . . . . 74.4 111.041 -173.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 55.4 mt -100.2 102.23 13.46 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.522 -1.288 . . . . 73.11 107.522 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -130.56 11.65 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.713 -0.676 . . . . 64.21 112.32 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.13 6.52 48.32 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.628 0.771 . . . . 75.54 111.403 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.597 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 8.9 tp10 -121.73 148.16 44.98 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.052 0.941 . . . . 72.44 109.56 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 76.3 m -65.82 131.38 46.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.363 0.665 . . . . 73.05 110.702 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.518 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -86.41 -59.55 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.483 -0.932 . . . . 62.41 108.483 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -160.7 150.39 17.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 113.925 -1.489 . . . . 74.13 109.558 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.33 146.65 29.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.781 -1.192 . . . . 74.15 107.781 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.586 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.1 t -158.73 137.94 11.48 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.704 -0.48 . . . . 65.15 109.704 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -156.88 129.36 7.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.664 -0.495 . . . . 43.05 109.664 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.12 116.1 43.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.672 0.789 . . . . 74.11 109.391 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -89.98 90.21 8.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.453 -0.794 . . . . 70.03 108.933 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.419 ' O ' HD13 ' D' ' 106' ' ' LEU . 8.2 tp-100 -80.28 104.37 10.79 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 114.769 -1.105 . . . . 74.54 109.089 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.91 145.03 16.88 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.634 -0.586 . . . . 72.44 111.634 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.1 139.1 7.68 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 110.661 -0.975 . . . . 71.0 110.661 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.23 130.77 37.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.709 0.804 . . . . 74.14 109.159 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.15 125.19 34.43 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.72 0.408 . . . . 51.2 110.331 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 24.4 m -84.88 93.23 8.47 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.171 -1.048 . . . . 74.44 108.171 165.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.594 HD11 HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -129.32 134.72 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.521 0.728 . . . . 73.21 109.641 -171.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.66 159.55 21.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.502 1.121 . . . . 71.25 109.841 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.62 -19.53 14.26 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.091 0.797 . . . . 50.11 115.091 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' D' ' 94' ' ' MET . 2.2 pp -108.96 161.78 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.397 0.679 . . . . 64.14 111.014 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 2.6 pt-20 -158.03 -175.44 5.35 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.5 0.72 . . . . 60.21 110.851 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -132.05 47.54 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 123.653 0.644 . . . . 74.2 114.014 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -66.35 -28.73 68.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.764 0.826 . . . . 74.22 111.254 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -68.8 -33.31 73.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.464 0.706 . . . . 75.11 111.094 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.638 ' HA ' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -70.34 -47.51 60.71 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.567 -0.531 . . . . 72.33 109.567 177.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.85 72.94 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.46 -0.791 . . . . 71.13 111.151 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -72.26 -37.81 68.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.063 0.945 . . . . 71.51 111.11 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -72.17 -51.41 21.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.036 0.535 . . . . 71.24 111.394 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 tt -72.9 -36.36 67.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.019 0.528 . . . . 62.54 110.168 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.23 -23.85 62.46 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 114.304 0.481 . . . . 74.2 114.304 -174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.53 -56.34 1.01 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.502 0.651 . . . . 53.43 112.274 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -67.46 -46.46 72.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.307 0.854 . . . . 73.33 113.307 -166.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.7 -44.67 43.73 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.972 -0.537 . . . . 74.31 111.229 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.603 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 85.5 Cg_exo -53.68 -35.78 79.17 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 122.953 2.435 . . . . 50.41 114.119 165.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -61.85 -31.93 72.23 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.399 0.68 . . . . 73.21 112.097 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -72.51 -40.08 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.671 . . . . 71.22 110.351 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.419 HD13 ' O ' ' D' ' 80' ' ' GLN . 83.8 mt -75.25 -24.93 57.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.882 -1.054 . . . . 64.22 111.252 -175.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -61.69 -42.46 83.6 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.876 1.436 . . . . 75.04 114.876 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.15 -46.87 28.63 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.267 1.978 . . . . 64.41 113.752 171.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.0 -37.21 69.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.511 -0.768 . . . . 72.25 111.226 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.78 79.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.744 0.818 . . . . 41.45 110.6 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -57.08 -50.67 72.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 70.14 110.956 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -67.91 -39.62 83.54 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.039 0.837 . . . . 72.43 111.39 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.4 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.0 t -57.64 -40.99 80.5 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.732 0.645 . . . . 70.44 110.486 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.586 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -68.45 -52.15 39.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.86 -1.064 . . . . 61.13 110.388 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -50.82 -43.46 58.96 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.123 . . . . 70.41 111.673 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -67.45 -45.86 74.76 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.676 -1.147 . . . . 62.14 110.33 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.06 -34.04 77.12 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.005 0.522 . . . . 75.41 111.947 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.57 -46.23 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.666 0.786 . . . . 73.31 110.252 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.7 p -70.74 -29.13 65.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.68 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -70.05 -32.69 70.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.6 0.76 . . . . 63.02 109.622 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 11.1 60.95 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.617 0.573 . . . . 64.42 113.069 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.445 HG23 ' HB3' ' C' ' 17' ' ' TYR . 41.4 p 60.27 20.5 9.95 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.402 1.881 . . . . 75.05 114.057 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.461 ' HB2' HG13 ' D' ' 118' ' ' VAL . 79.7 m-85 -93.97 159.05 35.22 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 107.758 -1.201 . . . . 72.55 107.758 171.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.91 154.1 63.33 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.994 1.796 . . . . 64.15 111.672 -172.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -50.97 120.14 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.872 0.869 . . . . 72.52 111.438 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.467 HD21 HG21 ' D' ' 40' ' ' VAL . 2.4 tm? -109.57 91.78 3.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.446 -1.316 . . . . 72.34 107.446 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -108.85 106.2 16.09 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.077 -0.965 . . . . 72.45 109.62 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.76 134.68 53.67 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.796 -1.093 . . . . 74.11 110.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.68 130.98 85.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.782 0.833 . . . . 75.3 111.611 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.85 95.93 0.98 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.497 2.131 . . . . 75.52 110.548 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.66 139.94 50.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.174 -0.921 . . . . 61.23 110.447 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 C--O 1.237 0.407 0 N-CA-C 107.912 -1.144 . . . . 74.15 107.912 166.831 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.204 -0.665 . . . . 74.35 109.204 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.5 136.63 54.71 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.116 0.966 . . . . 62.11 109.76 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -147.69 136.83 22.27 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.375 0.422 . . . . 72.22 111.279 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.3 110.29 12.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.073 0.949 . . . . 74.44 108.44 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.86 -41.04 16.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.322 0.649 . . . . 74.2 109.275 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -161.32 141.08 10.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.014 0.526 . . . . 53.1 110.211 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -124.53 135.91 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.003 -1.11 . . . . 71.23 108.003 167.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.678 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 18.3 p90 -170.56 171.88 6.18 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.042 0.839 . . . . 62.24 110.645 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -94.54 124.19 38.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.896 -0.779 . . . . 61.41 108.896 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.3 mtpt -82.63 -43.54 16.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.021 -0.733 . . . . 72.3 109.021 172.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.0 t70 -135.79 143.97 45.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.281 -1.327 . . . . 54.41 110.041 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.434 HG23 ' SD ' ' A' ' 117' ' ' MET . 83.3 mt -139.81 141.51 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 125.982 1.713 . . . . 74.13 106.624 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.35 123.24 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.48 -0.563 . . . . 65.25 109.48 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 85.0 t80 -121.74 126.52 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.823 -1.547 . . . . 74.13 106.823 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -123.56 126.57 46.91 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.896 -0.779 . . . . 74.14 108.896 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.03 70.98 14.77 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.236 1.014 . . . . 72.34 108.347 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.73 -26.31 27.85 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.053 1.835 . . . . 65.55 110.12 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 31' ' ' VAL . 81.9 m-20 -99.8 22.7 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.734 -1.121 . . . . 71.23 110.767 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.42 97.62 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.594 -0.717 . . . . 51.23 112.425 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.6 -21.38 22.21 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.898 1.732 . . . . 70.54 113.495 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.0 m170 -71.09 -36.51 72.25 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.867 0.467 . . . . 74.01 110.452 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 27' ' ' ASN . 73.4 t -56.34 -35.88 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.174 0.99 . . . . 71.44 112.87 -174.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.15 -35.17 80.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.322 0.649 . . . . 75.25 110.726 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -75.07 -37.9 61.48 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.126 0.97 . . . . 71.52 110.102 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -82.15 156.84 24.27 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.217 -0.901 . . . . 73.52 110.641 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -72.4 125.8 28.29 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.924 -0.769 . . . . 61.44 108.924 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.485 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -78.17 81.07 4.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.498 0.666 . . . . 74.21 110.949 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -118.09 84.34 21.59 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.822 -1.547 . . . . 64.14 106.822 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.63 115.3 4.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.255 1.97 . . . . 75.45 111.256 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -95.69 90.87 5.84 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.835 -1.542 . . . . 72.43 106.835 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 46.9 t -84.47 112.59 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.734 -1.121 . . . . 54.32 111.381 -168.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 12.6 mptt -80.08 146.07 32.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.06 0.944 . . . . 64.33 108.534 167.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.23 114.82 10.52 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.448 0.699 . . . . 70.5 109.539 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 26.0 m-20 -108.8 141.56 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.402 0.681 . . . . 75.33 109.384 173.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.3 tp -133.68 119.44 19.35 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.942 -1.132 . . . . 73.14 107.942 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 30.9 t70 -141.81 151.54 42.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.432 0.693 . . . . 72.33 110.018 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -131.35 150.13 52.27 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.894 0.877 . . . . 74.11 109.876 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . . . -147.34 152.53 38.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.73 1.212 . . . . 54.51 108.466 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.686 ' HB2' HD11 ' A' ' 98' ' ' LEU . 8.5 t -133.29 160.47 37.21 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.138 0.426 . . . . 73.11 111.345 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -149.57 120.42 7.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.212 1.005 . . . . 55.21 108.82 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -74.07 104.13 4.78 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.784 -0.821 . . . . 74.44 108.784 175.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.75 -32.61 27.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.114 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.65 -175.69 5.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.932 0.893 . . . . 63.43 109.705 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.71 125.23 24.12 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.16 -0.681 . . . . 71.44 109.16 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 70.44 -8.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.622 1.569 . . . . 73.42 112.44 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.78 110.94 28.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.996 -0.742 . . . . 73.15 108.996 -174.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.28 124.47 40.4 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.362 1.065 . . . . 71.25 108.562 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.33 127.19 35.48 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.202 -1.036 . . . . 74.34 108.202 168.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.97 121.86 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.242 -1.022 . . . . 60.33 108.242 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.6 t -103.33 130.21 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.199 0.6 . . . . 75.22 109.555 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -101.38 117.81 35.71 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.213 1.005 . . . . 73.04 108.668 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' NH2' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -91.9 106.12 18.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.071 -0.714 . . . . 74.42 109.071 169.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' HB1' ' A' ' 110' ' ' ALA . 17.7 t -105.92 126.97 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.527 -1.286 . . . . 30.41 107.527 169.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -122.92 134.23 54.36 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.731 -0.47 . . . . 64.53 109.731 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.5 t -130.36 107.31 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.352 1.461 . . . . 72.32 107.791 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 36.3 m -113.2 122.27 46.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.369 -0.604 . . . . 74.01 109.369 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.5 117.96 35.65 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.682 -1.229 . . . . 64.32 107.682 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.7 m -117.76 126.77 53.05 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.827 0.451 . . . . 32.01 109.846 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.485 HD21 ' CE3' ' A' ' 36' ' ' TRP . 66.6 mt -89.37 70.3 8.11 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.529 -1.285 . . . . 75.41 107.529 176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -85.29 0.95 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.42 -1.263 . . . . 43.52 110.733 -168.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.04 -25.17 5.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.94 0.896 . . . . 72.12 110.961 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.83 107.26 12.48 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.26 -0.645 . . . . 63.1 109.26 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -62.1 127.35 30.97 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.903 0.382 . . . . 65.53 110.16 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -53.52 6.51 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.125 0.97 . . . . 34.11 108.695 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.14 167.24 30.39 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 113.867 -1.515 . . . . 75.22 110.236 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -129.78 144.12 51.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.33 1.452 . . . . 71.24 107.861 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.4 m -134.19 138.18 44.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.872 0.869 . . . . 74.3 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.96 123.69 10.53 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.486 -0.931 . . . . 72.13 108.486 168.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.89 119.86 55.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.713 -0.847 . . . . 72.11 108.713 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 73.6 mt-30 -95.3 90.08 5.71 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.761 -1.109 . . . . 62.31 108.948 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 60.9 tp60 -81.17 96.66 7.29 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.346 -1.297 . . . . 64.13 107.724 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.54 143.24 17.12 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.923 -0.871 . . . . 55.53 110.923 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.93 121.54 1.57 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.706 -0.958 . . . . 72.11 110.706 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.5 mt -82.91 129.11 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.102 -1.073 . . . . 65.32 108.102 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -137.78 163.91 30.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.691 1.197 . . . . 73.14 109.208 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 p -110.29 120.18 41.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.119 0.568 . . . . 73.1 109.65 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 119.6 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.865 0.866 . . . . 75.53 110.327 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.81 160.97 4.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.8 1.64 . . . . 61.12 108.711 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.33 11.83 40.73 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 112.633 -0.187 . . . . 62.12 112.633 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -115.79 169.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.669 1.188 . . . . 70.41 110.655 -173.09 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -167.79 173.95 7.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.194 -0.669 . . . . 73.04 109.194 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.84 -130.97 49.5 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 116.627 -0.26 . . . . 75.32 113.198 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.7 p -79.15 -15.01 58.74 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.693 0.797 . . . . 71.44 112.308 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.35 -36.94 69.36 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.047 0.939 . . . . 75.51 111.082 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -40.86 39.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.469 -0.787 . . . . 73.3 110.523 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.47 67.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 72.31 111.319 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -75.19 -44.2 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.82 0.848 . . . . 61.3 110.563 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.0 t -74.6 -64.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.913 -0.585 . . . . 42.11 109.938 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 48' ' ' SER . 65.5 tp -64.52 -41.74 96.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.674 0.789 . . . . 71.11 112.713 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.12 -36.86 44.62 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.234 -0.439 . . . . 73.41 113.464 -173.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.63 -54.38 2.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.43 0.53 . . . . 71.32 112.43 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.446 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.4 t80 -74.27 -55.95 5.45 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.38 0.881 . . . . 73.14 113.38 -163.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 86.2 m -66.61 -38.18 18.3 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.589 0.959 . . . . 62.41 113.589 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.0 -26.24 43.68 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.627 1.551 . . . . 72.33 112.563 167.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.51 -26.61 61.84 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.765 0.426 . . . . 71.22 110.849 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -59.97 -42.3 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.873 0.844 . . . . 73.21 109.685 170.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.1 mt -78.56 -19.41 52.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.116 -1.402 . . . . 65.32 112.167 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 34.0 t80 -64.6 -39.85 44.12 Favored Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.197 1.184 . . . . 70.01 114.197 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.58 -40.64 83.05 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.318 2.012 . . . . 63.43 113.282 170.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -75.58 -36.76 60.28 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.295 -0.866 . . . . 54.5 111.15 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.48 -48.34 75.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.519 0.728 . . . . 72.35 109.747 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -52.89 -50.79 63.16 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 124.706 1.254 . . . . 70.11 110.755 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -60.95 -46.72 89.57 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.536 1.148 . . . . 63.3 111.721 -175.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.467 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -59.04 -43.5 91.64 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.194 0.934 . . . . 71.22 110.752 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 118' ' ' VAL . 91.1 mt -63.31 -53.89 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 123.963 0.789 . . . . 74.52 110.293 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 125' ' ' GLN . 61.6 m -51.59 -45.71 63.24 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.697 1.199 . . . . 71.53 111.188 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -66.96 -45.54 77.44 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.647 -1.16 . . . . 73.12 110.352 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' HG23 ' A' ' 21' ' ' ILE . 12.0 mtp -55.22 -44.7 75.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.762 0.825 . . . . 73.5 111.719 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -64.07 -46.95 92.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.207 1.003 . . . . 73.31 110.817 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.5 p -70.85 -28.59 64.7 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 115.802 -0.635 . . . . 73.03 110.784 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.509 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.8 mtt-85 -72.26 -33.57 67.59 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.022 0.929 . . . . 75.13 110.098 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.36 68.37 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.485 -0.779 . . . . 54.44 112.763 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m 69.28 40.34 1.52 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.774 1.229 . . . . 71.42 110.096 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.15 145.24 39.64 Favored Pre-proline 0 C--O 1.245 0.852 0 CA-C-N 115.356 -0.838 . . . . 70.41 109.208 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -51.99 114.39 1.6 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.025 2.484 . . . . 73.11 112.096 172.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.641 ' HB2' HG23 ' A' ' 115' ' ' THR . 19.1 pt20 -63.19 156.13 26.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.088 -0.96 . . . . 73.14 111.945 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.39 118.68 37.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.772 -1.104 . . . . 31.53 108.881 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 79.0 m-20 -98.72 84.51 3.14 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.315 -1.365 . . . . 73.3 107.315 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.478 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -69.35 141.14 54.28 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.262 -0.881 . . . . 73.11 109.453 -174.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.9 129.41 94.43 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 122.629 0.372 . . . . 73.13 111.569 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.66 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.559 2.173 . . . . 63.33 110.807 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.71 114.42 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.886 -1.052 . . . . 64.02 109.25 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -87.99 104.9 17.08 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.706 -1.22 . . . . 70.35 107.706 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 . . . . . 0 N--CA 1.477 0.888 0 O-C-N 124.533 1.145 . . . . 75.21 111.184 -175.07 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.983 -1.117 . . . . 71.01 107.983 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -137.28 137.0 38.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.804 -0.813 . . . . 72.45 108.804 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -147.72 126.66 12.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.886 0.475 . . . . 74.41 109.975 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -91.47 139.87 17.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 108.918 -0.771 . . . . 70.44 108.918 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -110.79 -44.27 3.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.838 0.455 . . . . 62.43 110.516 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -172.44 139.95 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.506 0.322 . . . . 72.21 110.219 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.47 146.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.06 -1.089 . . . . 74.14 108.06 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -167.2 164.87 15.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.619 0.723 . . . . 74.4 111.583 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.2 m -90.04 120.01 30.87 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.286 -1.005 . . . . 74.03 108.286 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -90.43 -24.88 20.62 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.842 0.457 . . . . 72.3 111.301 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.0 t70 -158.62 144.65 16.88 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.94 0.4 . . . . 73.14 111.829 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.476 HD11 ' SG ' ' B' ' 113' ' ' CYS . 42.8 mm -132.96 141.22 45.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.117 1.367 . . . . 75.12 108.755 173.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 38.3 m -137.87 122.25 18.29 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.219 1.407 . . . . 71.21 108.388 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 65.8 t80 -134.97 110.02 8.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.083 -1.821 . . . . 73.25 106.083 165.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -125.66 111.23 14.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.977 -1.12 . . . . 75.12 107.977 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.662 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.06 89.37 5.52 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.012 0.925 . . . . 50.53 109.162 177.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.68 -26.67 19.25 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.416 2.077 . . . . 63.3 111.831 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -117.62 24.58 10.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.317 1.047 . . . . 74.12 109.313 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.678 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.04 -53.2 13.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 125.905 1.682 . . . . 64.13 114.498 173.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.0 Cg_exo -74.84 -18.23 19.32 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.541 2.161 . . . . 75.02 112.185 -177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.89 2.53 54.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.706 -1.134 . . . . 71.32 111.811 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.04 -18.13 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.172 0.589 . . . . 72.5 110.503 168.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -73.51 -34.48 65.3 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.683 -0.488 . . . . 64.23 109.683 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.11 -45.56 26.51 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.423 0.63 . . . . 75.11 109.4 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 27.3 mmtp -94.57 68.91 3.48 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.858 1.263 . . . . 64.42 109.191 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.16 75.86 3.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.314 -1.312 . . . . 64.02 110.905 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -162.25 151.95 16.18 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.474 -1.306 . . . . 63.23 107.474 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -88.08 119.37 70.37 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.472 -0.566 . . . . 71.5 109.472 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.656 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 68.8 Cg_endo -68.63 144.4 60.16 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.963 1.776 . . . . 73.3 111.817 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 109.03 2.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.075 -0.966 . . . . 71.25 108.71 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -84.79 123.07 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 108.983 -0.747 . . . . 72.33 108.983 -167.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -124.44 147.09 48.54 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.38 1.072 . . . . 75.2 109.659 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.641 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -109.24 167.13 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.319 0.648 . . . . 71.24 111.605 179.028 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.9 t70 -153.51 139.98 18.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.892 1.277 . . . . 73.53 108.731 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.61 132.98 53.41 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.328 0.651 . . . . 74.33 109.36 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -146.81 151.63 37.42 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.551 1.141 . . . . 74.13 109.079 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.0 m -139.28 121.84 16.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.835 0.454 . . . . 64.42 110.02 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.91 160.42 19.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.64 1.176 . . . . 51.21 108.854 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -144.21 163.95 32.16 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.298 0.639 . . . . 73.21 110.601 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 7.3 p -159.97 137.3 9.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.094 0.958 . . . . 73.3 109.853 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -84.12 129.9 34.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.535 0.734 . . . . 73.42 110.402 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.53 -42.91 8.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.196 0.598 . . . . 74.2 109.479 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.41 -171.23 3.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.078 0.951 . . . . 54.42 110.04 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.55 112.93 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.859 -1.064 . . . . 62.34 110.252 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 69.49 -0.5 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.564 1.546 . . . . 74.45 112.979 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -104.83 104.7 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.377 -1.342 . . . . 50.24 107.377 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -124.09 149.77 45.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.395 0.678 . . . . 74.02 109.542 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.83 112.59 21.31 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.498 1.119 . . . . 71.41 108.665 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.85 118.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.429 -0.952 . . . . 73.3 108.429 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 50.5 t -102.42 109.33 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.394 -0.965 . . . . 71.0 108.394 175.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -93.75 117.06 29.6 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.576 -0.898 . . . . 72.44 108.576 -175.077 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.04 117.28 34.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.161 0.584 . . . . 73.42 110.128 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.51 HG11 HD11 ' B' ' 128' ' ' LEU . 11.8 t -116.19 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.989 -1.115 . . . . 72.32 107.989 169.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 6.7 m -115.31 150.45 36.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.52 0.728 . . . . 44.0 109.567 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.442 HG23 HD13 ' B' ' 114' ' ' ILE . 34.8 t -129.43 130.57 67.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.637 1.175 . . . . 61.3 109.139 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -126.12 140.81 52.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.181 0.992 . . . . 75.31 110.351 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.844 ' HB3' ' HE2' ' B' ' 74' ' ' PHE . . . -150.63 161.78 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.045 -0.724 . . . . 64.11 109.045 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.9 p -146.91 141.46 26.57 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.45 0.643 . . . . 63.23 112.022 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 34.5 mt -91.89 98.85 11.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.831 -1.174 . . . . 70.54 107.831 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.14 -107.73 2.3 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.44 -1.064 . . . . 71.43 110.44 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.0 8.63 10.45 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.82 0.848 . . . . 73.54 110.376 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -112.39 142.97 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.192 -0.67 . . . . 72.2 109.192 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -56.55 126.05 24.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.765 0.826 . . . . 73.14 110.742 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.26 -59.62 2.7 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 122.222 1.011 . . . . 65.23 109.065 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.844 ' HE2' ' HB3' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -154.53 178.66 9.83 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 113.006 -1.906 . . . . 73.41 107.08 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.72 136.81 29.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.931 -1.137 . . . . 65.23 107.931 164.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 50.6 t -131.83 147.56 52.49 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.589 -0.893 . . . . 71.34 108.589 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.0 tt0 -163.66 134.72 4.62 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.807 -0.812 . . . . 71.43 108.807 -173.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -125.21 146.7 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.325 1.05 . . . . 71.4 109.014 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 78.4 mt-30 -126.05 88.95 2.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.382 -0.969 . . . . 72.05 108.382 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.528 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 43.7 tp60 -85.07 100.86 11.98 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.899 -1.046 . . . . 71.4 109.523 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.79 156.46 25.55 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.693 -0.563 . . . . 55.21 111.693 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.83 130.22 2.38 Favored Glycine 0 C--O 1.239 0.456 0 N-CA-C 111.568 -0.613 . . . . 60.21 111.568 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.61 127.26 40.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.609 0.764 . . . . 62.21 109.401 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -134.22 158.21 44.28 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.773 1.229 . . . . 75.01 108.665 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -132.51 121.95 24.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.407 -0.96 . . . . 63.32 108.407 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.623 HG13 ' SG ' ' B' ' 97' ' ' CYS . 0.2 OUTLIER -133.24 141.65 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.568 -0.901 . . . . 74.13 108.568 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.469 ' N ' HD13 ' B' ' 86' ' ' ILE . . . -158.94 174.88 14.29 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.078 0.951 . . . . 71.34 109.487 169.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.14 -54.98 0.53 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.27 0.462 . . . . 45.05 112.275 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -78.85 170.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.506 0.722 . . . . 55.24 112.589 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.7 162.87 40.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.559 0.744 . . . . 73.2 110.634 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.73 -129.38 24.61 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.473 -0.785 . . . . 44.43 113.771 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -67.61 -28.5 67.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.355 1.062 . . . . 54.03 111.167 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.68 -18.43 65.37 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.62 0.768 . . . . 65.21 112.09 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.4 tpt -68.97 -39.95 79.13 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.991 0.516 . . . . 71.22 110.156 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.47 -21.32 66.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.295 -0.866 . . . . 62.44 111.587 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -65.14 -40.83 94.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.411 0.685 . . . . 62.44 110.849 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.623 ' SG ' HG13 ' B' ' 86' ' ' ILE . 53.9 t -75.23 -69.91 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.852 -0.613 . . . . 74.31 111.128 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.589 HD13 ' H ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -88.79 -8.33 54.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 112.313 0.486 . . . . 73.45 112.313 -171.441 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.23 3.42 54.82 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.691 -0.505 . . . . 71.4 112.769 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.09 -67.9 0.18 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 117.142 0.471 . . . . 72.53 111.424 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -68.05 -50.85 52.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.819 0.674 . . . . 75.54 112.819 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.551 ' HA ' HD12 ' B' ' 105' ' ' ILE . 62.5 m -62.25 -43.4 85.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.921 0.888 . . . . 72.35 113.206 -173.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -39.4 49.23 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 121.476 1.451 . . . . 64.54 112.365 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -65.73 -18.33 65.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.761 0.652 . . . . 75.03 112.761 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.592 HG23 ' NH2' ' D' ' 111' ' ' ARG . 96.4 mt -69.83 -44.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.513 0.725 . . . . 75.14 109.988 170.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.483 ' HB2' HD12 ' B' ' 60' ' ' LEU . 30.9 mt -84.85 -18.19 35.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.754 -1.112 . . . . 63.31 111.437 -173.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.427 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 36.0 t80 -61.87 -40.95 73.86 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 124.736 1.214 . . . . 71.01 113.197 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.443 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 14.9 Cg_endo -56.71 -45.77 34.46 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.533 2.155 . . . . 61.45 113.479 169.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.528 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 85.1 m-85 -64.82 -42.71 94.76 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.073 0.549 . . . . 74.44 110.42 -177.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -39.99 89.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.651 0.78 . . . . 74.52 110.843 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' B' ' 128' ' ' LEU . 26.8 ttt180 -58.55 -52.91 63.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.402 1.081 . . . . 63.1 111.486 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -38.14 88.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.108 -0.951 . . . . 73.15 109.779 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.509 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 5.8 t -68.18 -36.84 80.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.477 -0.783 . . . . 74.12 111.474 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.442 HD13 HG23 ' B' ' 64' ' ' VAL . 53.5 mt -62.7 -60.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.364 1.215 0 N-CA-C 109.351 -0.611 . . . . 65.2 109.351 176.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.8 m -53.55 -38.04 63.46 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 124.724 1.265 . . . . 71.3 110.754 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.7 t -55.88 -54.23 47.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.133 0.973 . . . . 73.04 111.391 174.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.505 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 16.8 mmt -66.29 -37.2 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.902 0.481 . . . . 73.24 111.462 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.498 HG22 ' HE1' ' B' ' 74' ' ' PHE . 91.1 t -63.74 -40.28 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.534 1.133 . . . . 71.35 110.577 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.4 m -65.32 -35.88 82.33 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.47 -1.241 . . . . 74.33 111.826 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 75.4 mtt-85 -65.22 -41.73 94.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.258 -0.883 . . . . 71.32 110.168 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.59 -1.48 82.87 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.875 0.734 . . . . 44.32 113.895 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p 60.0 49.84 7.25 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.74 1.616 . . . . 74.24 111.62 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -118.49 161.36 35.87 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 114.264 -1.335 . . . . 73.52 110.071 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.38 145.6 72.08 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.325 2.683 . . . . 74.44 114.89 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' C' ' 124' ' ' PRO . 3.9 pt20 -66.63 158.83 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.206 1.403 . . . . 74.42 113.803 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.11 104.27 7.46 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.671 -1.603 . . . . 70.42 106.671 162.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -90.05 93.1 9.25 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.371 -0.974 . . . . 65.51 108.371 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' B' ' 111' ' ' ARG . 40.0 mt -57.29 135.27 56.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.116 0.967 . . . . 70.25 113.478 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.2 117.51 58.24 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 114.621 -1.172 . . . . 65.22 108.625 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -65.67 151.1 85.54 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.399 2.733 . . . . 63.34 112.702 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 114.67 -1.15 . . . . 71.21 108.117 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.34 65.75 9.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.669 -0.863 . . . . 64.4 108.669 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 115.198 -0.91 . . . . 71.23 109.383 178.728 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.19 -1.041 . . . . 64.22 108.19 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -120.83 137.31 54.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.054 0.542 . . . . 65.25 109.552 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -148.6 124.16 10.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.707 0.803 . . . . 61.42 108.942 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 tp -78.57 133.57 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.037 -0.727 . . . . 72.04 109.037 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -103.17 -51.06 3.33 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.583 0.753 . . . . 73.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.513 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 57.4 ttt180 -165.1 123.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.231 -168.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -112.3 132.02 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.522 -0.918 . . . . 72.2 108.522 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.546 ' HB3' HG23 ' D' ' 122' ' ' THR . 22.1 p90 -173.19 148.03 1.63 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.126 0.891 . . . . 73.34 110.597 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -74.42 124.8 27.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 75.21 110.121 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -74.79 -48.94 22.69 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.288 1.042 . . . . 73.22 109.053 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 29.1 t70 -139.31 136.02 34.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.923 -1.49 . . . . 51.32 109.284 -167.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.8 mt -137.31 143.7 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 106.902 -1.518 . . . . 72.51 106.902 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -154.21 150.8 28.46 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.335 0.588 . . . . 71.43 109.79 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.427 ' HZ ' ' HD2' ' C' ' 123' ' ' PHE . 79.4 t80 -150.99 110.54 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.496 -1.298 . . . . 74.12 107.496 173.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.07 124.85 50.26 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.597 0.759 . . . . 74.41 109.337 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.27 84.0 48.7 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 107.7 -1.222 . . . . 74.12 107.7 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.89 -25.71 38.67 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.471 2.114 . . . . 64.31 111.69 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.3 20.74 17.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.338 1.055 . . . . 71.41 110.412 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.86 -49.96 90.77 Favored Pre-proline 0 CA--C 1.569 1.711 0 N-CA-C 114.723 1.379 . . . . 73.41 114.723 -172.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 -30.89 10.87 Favored 'Trans proline' 0 C--N 1.387 2.569 0 CA-C-N 121.58 1.6 . . . . 75.14 112.723 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -68.83 -49.57 57.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.976 0.91 . . . . 61.33 111.423 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.45 HG23 HD11 ' C' ' 68' ' ' LEU . 14.3 p -59.51 -18.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.344 1.458 . . . . 60.24 112.932 -169.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.64 -33.56 71.68 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.172 0.989 . . . . 74.2 112.311 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.47 5.34 52.11 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.769 0.655 . . . . 72.11 112.769 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -87.6 163.88 16.37 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.562 -0.532 . . . . 73.53 109.562 176.136 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.61 107.07 1.3 Allowed 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.762 -1.199 . . . . 74.13 107.762 164.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -82.15 83.61 7.3 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.328 1.061 . . . . 72.41 110.348 -171.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.56 72.75 81.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 115.036 -0.983 . . . . 72.21 108.823 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.06 127.65 15.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.416 2.077 . . . . 74.5 111.153 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.06 76.72 9.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.377 -1.342 . . . . 74.01 107.377 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.19 85.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 123.055 1.407 . . . . 64.22 110.833 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 140.47 48.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.907 -1.497 . . . . 73.21 107.46 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.484 HD12 HD12 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -128.48 155.94 44.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.159 0.583 . . . . 74.44 110.767 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.21 128.06 53.86 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.695 1.198 . . . . 63.5 108.118 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tp -106.02 101.26 10.77 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.138 0.575 . . . . 73.54 109.507 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.469 ' O ' HD23 ' C' ' 60' ' ' LEU . 10.3 t70 -113.91 139.03 49.54 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.62 1.168 . . . . 72.42 109.781 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.0 t -119.08 131.35 55.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.281 0.632 . . . . 73.11 109.631 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.39 151.72 32.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.357 1.063 . . . . 72.32 108.974 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -143.57 143.59 31.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.079 0.552 . . . . 72.33 110.404 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -153.21 156.46 38.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.569 1.148 . . . . 75.13 108.528 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.79 117.95 35.55 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.342 -0.614 . . . . 75.44 109.342 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' C' ' 57' ' ' GLU . 56.7 mt -86.52 -36.63 18.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.369 0.668 . . . . 73.23 110.093 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.75 -176.37 5.5 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.077 -0.965 . . . . 54.1 110.69 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.87 102.45 0.47 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.429 -1.26 . . . . 74.02 110.322 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 13.0 m-20 64.57 13.04 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.968 1.307 . . . . 71.14 113.581 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 98.9 t -106.03 107.74 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 107.973 -1.121 . . . . 74.11 107.973 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' C' ' 86' ' ' ILE . 7.9 m-30 -114.89 146.05 41.53 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.48 -0.933 . . . . 72.0 108.48 -174.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.6 tt0 -109.08 124.13 50.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.206 1.002 . . . . 71.32 108.557 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.809 HG21 ' HB2' ' C' ' 98' ' ' LEU . 92.8 t -119.38 124.55 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.189 -1.041 . . . . 31.33 108.189 172.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.9 115.43 47.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.581 1.152 . . . . 71.33 108.764 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.469 HD23 ' O ' ' C' ' 45' ' ' ASP . 0.9 OUTLIER -86.27 105.25 16.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.356 -0.979 . . . . 64.12 108.356 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.12 106.45 16.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.242 0.617 . . . . 72.02 109.481 172.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.577 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.9 t -100.7 130.66 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.113 -1.069 . . . . 62.44 108.113 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -125.25 122.59 37.39 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.48 -0.563 . . . . 72.42 109.48 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.66 HG21 HG21 ' C' ' 114' ' ' ILE . 71.5 t -98.63 113.55 33.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.424 1.09 . . . . 64.12 109.302 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -99.34 134.46 42.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.401 -0.963 . . . . 50.12 108.401 171.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.16 124.53 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.676 0.79 . . . . 64.13 108.952 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.7 m -133.54 170.98 14.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.944 0.898 . . . . 75.04 110.136 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.652 HD13 ' HG2' ' C' ' 34' ' ' LYS . 27.8 mt -127.89 22.95 6.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.666 1.186 . . . . 74.01 108.551 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.24 -96.62 0.99 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.027 -1.229 . . . . 50.05 110.027 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -91.48 -30.94 16.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.44 110.744 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -85.69 121.99 29.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.145 0.978 . . . . 74.2 110.87 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -69.62 125.5 26.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.471 -0.566 . . . . 75.44 109.471 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -49.09 12.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.247 0.619 . . . . 21.51 109.782 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -171.27 177.09 3.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.976 0.91 . . . . 54.31 110.699 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -140.99 139.23 34.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.738 -1.579 . . . . 74.23 106.738 174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -137.24 154.51 50.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.643 -0.873 . . . . 71.02 108.643 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.09 143.98 18.46 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.85 0.46 . . . . 74.03 109.831 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' C' ' 113' ' ' CYS . 19.6 t -142.99 114.28 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.857 1.263 . . . . 74.42 108.171 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 42.1 mt-30 -93.36 95.53 9.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.546 0.739 . . . . 71.14 109.308 169.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -83.17 104.61 13.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.779 -1.1 . . . . 45.11 109.829 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.73 146.63 22.41 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.4 0.437 . . . . 52.32 112.327 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.97 124.78 2.64 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.879 -0.888 . . . . 55.45 110.879 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.487 HG12 ' HE1' ' C' ' 17' ' ' TYR . 26.1 mm -93.72 118.04 38.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.3 -1.0 . . . . 63.53 108.3 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.46 118.55 28.61 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.526 -0.916 . . . . 72.23 108.526 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -95.75 102.84 14.68 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.183 -1.043 . . . . 74.34 108.183 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.7 pp -114.44 -177.76 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.744 0.818 . . . . 70.22 110.648 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 176.91 153.01 0.21 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.584 1.554 . . . . 65.0 108.657 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.32 -17.61 46.84 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 114.597 0.599 . . . . 64.14 114.597 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 pt . . . . . 0 CA--C 1.553 1.088 0 C-N-CA 123.833 0.853 . . . . 70.02 111.052 -179.331 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 119.663 -0.208 . . . . 63.14 110.501 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.3 ptp -63.57 -35.4 80.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.579 0.352 . . . . 63.41 111.422 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.22 -38.17 56.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.797 0.839 . . . . 74.44 111.245 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -77.96 -37.81 46.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.088 0.955 . . . . 61.15 111.23 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.53 -49.98 75.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.118 0.967 . . . . 73.13 111.277 -169.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.809 ' HB2' HG21 ' C' ' 58' ' ' VAL . 3.4 pp -108.88 -11.1 15.05 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.055 0.391 . . . . 51.12 112.055 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.17 -28.98 35.1 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.238 -0.201 . . . . 34.43 112.918 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.09 -45.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.009 0.524 . . . . 75.04 111.481 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -74.43 -47.24 34.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.743 0.817 . . . . 74.54 112.364 -172.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.539 ' HB2' ' HA ' ' C' ' 98' ' ' LEU . 97.7 m -65.78 -46.49 66.25 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 118.518 -0.753 . . . . 63.2 112.443 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.426 ' O ' HD12 ' C' ' 60' ' ' LEU . 37.8 Cg_endo -66.26 -23.1 52.49 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 121.135 1.441 . . . . 61.22 112.397 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.23 -31.72 70.48 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.349 0.522 . . . . 75.25 110.191 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' C' ' 102' ' ' CYS . 26.8 mm -62.89 -44.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.63 0.772 . . . . 61.43 109.592 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 66.4 mt -82.4 -18.15 42.95 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.766 0.826 . . . . 74.22 112.454 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.12 -47.56 90.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.46 -1.257 . . . . 70.35 112.955 -174.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.75 -38.63 92.3 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.021 1.814 . . . . 44.54 112.304 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.495 ' HB3' ' NE2' ' C' ' 80' ' ' GLN . 87.9 m-85 -63.46 -50.78 68.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.962 0.905 . . . . 63.15 111.318 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.96 -37.5 81.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.763 -0.653 . . . . 65.13 110.952 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.78 -50.41 70.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 61.44 110.053 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.11 -38.22 75.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.86 0.864 . . . . 71.42 110.854 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.422 ' HB3' HG11 ' C' ' 78' ' ' VAL . 9.1 t -64.98 -34.02 77.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.177 0.591 . . . . 73.34 110.89 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.66 HG21 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -70.66 -50.8 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 115.772 -0.649 . . . . 74.42 109.661 173.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.406 HG23 ' H ' ' C' ' 126' ' ' LEU . 27.4 m -58.3 -34.77 70.92 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.957 0.786 . . . . 75.42 111.403 -173.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.9 p -67.88 -51.66 45.52 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.776 -0.647 . . . . 50.22 109.382 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.579 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.1 -41.41 62.41 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.859 1.264 . . . . 61.21 112.664 179.013 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.53 HG11 HD23 ' C' ' 126' ' ' LEU . 88.1 t -72.05 -41.21 67.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.091 -0.959 . . . . 61.14 110.397 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.42 -29.89 70.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.396 0.679 . . . . 72.51 111.271 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 61.5 mtt-85 -67.66 -44.14 78.59 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.634 -0.876 . . . . 73.33 108.634 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.85 -1.94 85.3 Favored Glycine 0 C--N 1.36 1.911 0 O-C-N 124.139 0.9 . . . . 63.33 113.434 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.1 p 66.84 41.84 2.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.877 1.671 . . . . 71.05 112.317 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HD2' ' HZ ' ' C' ' 23' ' ' PHE . 65.8 m-85 -114.41 163.89 17.93 Favored Pre-proline 0 CA--C 1.565 1.531 0 C-N-CA 124.958 1.303 . . . . 65.03 109.961 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.485 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 96.0 Cg_exo -49.41 151.77 6.59 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 124.341 3.36 . . . . 74.42 116.228 -175.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -48.46 132.37 16.92 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.648 1.179 . . . . 75.24 112.011 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.53 HD23 HG11 ' C' ' 118' ' ' VAL . 0.5 OUTLIER -111.47 23.52 13.86 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.536 -0.756 . . . . 72.13 111.521 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.71 79.5 6.04 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-O 123.788 1.756 . . . . 64.23 106.951 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.484 HD12 HD12 ' C' ' 42' ' ' LEU . 82.3 mt -90.12 151.67 21.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.648 -1.615 . . . . 72.23 110.185 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -35.54 113.19 0.5 Allowed Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 126.231 1.812 . . . . 63.43 114.319 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.37 99.07 0.88 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.315 2.01 . . . . 64.03 111.816 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.35 97.96 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 115.214 -0.903 . . . . 74.21 110.524 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.51 68.11 10.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 71.41 109.821 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 18.8 p90 . . . . . 0 CA--C 1.546 0.807 0 CA-C-N 113.966 -1.47 . . . . 73.24 111.931 -179.813 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.15 -1.055 . . . . 73.24 108.15 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.418 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 73.2 t80 -169.74 91.14 0.21 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.314 -1.365 . . . . 71.41 107.314 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -126.09 153.37 44.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.77 0.828 . . . . 63.0 109.501 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.41 HD12 ' O ' ' D' ' 83' ' ' ILE . 10.4 tp -103.53 142.84 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.201 0.6 . . . . 73.03 109.559 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.2 -45.39 2.94 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.781 0.833 . . . . 72.11 110.633 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -154.58 129.45 9.41 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 120.429 0.157 . . . . 75.01 111.19 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.536 HD12 ' N ' ' D' ' 16' ' ' ILE . 0.6 OUTLIER -121.28 112.16 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 106.256 -1.757 . . . . 72.51 106.256 -177.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -159.66 142.07 13.6 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 123.703 0.627 . . . . 72.13 111.704 -164.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.7 p -79.86 115.05 19.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.716 -1.129 . . . . 72.22 109.32 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -89.31 -28.83 19.59 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.007 -0.542 . . . . 72.5 110.365 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.5 t70 -147.08 133.49 19.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.324 -0.853 . . . . 65.41 109.582 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.579 HD13 ' HE3' ' C' ' 117' ' ' MET . 88.4 mt -133.5 139.5 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.688 1.195 . . . . 70.03 108.089 173.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -146.45 118.69 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.908 0.883 . . . . 71.14 109.289 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.7 t80 -124.93 131.96 53.35 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.247 -1.39 . . . . 73.05 107.247 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -137.97 118.63 14.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 75.24 108.803 -173.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -115.96 89.87 26.02 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.722 -0.844 . . . . 70.22 108.722 175.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.87 -63.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.333 2.688 . . . . 70.25 113.134 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 10.2 m-80 -98.35 41.07 1.15 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.607 -1.257 . . . . 72.15 107.607 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' D' ' 31' ' ' VAL . . . -56.75 -53.0 69.37 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.154 1.168 . . . . 62.14 114.154 -168.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.01 -8.45 15.47 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 122.394 1.891 . . . . 71.01 113.072 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.3 t-160 -74.27 -34.66 63.64 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 108.288 -1.004 . . . . 72.33 108.288 168.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.526 HG11 ' HE1' ' D' ' 123' ' ' PHE . 53.2 t -66.99 -26.63 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.512 1.125 . . . . 55.01 111.421 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.435 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.6 t80 -60.87 -34.53 74.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.032 0.444 . . . . 74.45 110.419 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -82.74 -33.2 27.54 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.462 -0.79 . . . . 65.03 110.289 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -91.94 90.86 7.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.737 0.815 . . . . 54.22 109.876 -173.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.85 59.27 3.62 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.39 1.076 . . . . 60.1 112.514 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.438 ' HB2' HD22 ' D' ' 68' ' ' LEU . 24.9 m95 -126.47 174.1 8.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.858 -0.793 . . . . 73.44 108.858 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -85.17 118.13 70.19 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 122.128 -0.358 . . . . 43.22 110.236 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.74 109.31 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.248 1.966 . . . . 74.45 110.633 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 52.2 mt-10 -62.51 111.85 2.22 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.953 0.783 . . . . 74.53 109.037 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.516 HG21 HD13 ' D' ' 126' ' ' LEU . 3.7 m -98.06 107.28 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.427 1.091 . . . . 60.31 109.267 -172.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -105.33 148.02 27.51 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.571 -0.74 . . . . 72.34 109.878 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -119.43 129.96 55.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.708 -0.678 . . . . 72.45 110.362 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 28.1 t70 -119.11 128.26 54.14 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.376 -0.972 . . . . 71.01 108.376 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -97.46 132.89 42.73 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.488 0.715 . . . . 73.34 110.03 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -146.96 156.3 42.95 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.939 -1.134 . . . . 62.14 107.939 169.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -144.57 164.39 31.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.218 0.533 . . . . 40.53 109.873 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 163.86 37.05 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.942 1.297 . . . . 70.12 108.277 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -167.13 153.47 8.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.903 0.382 . . . . 63.24 111.772 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.8 p -158.86 141.44 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.133 0.973 . . . . 71.31 109.716 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -81.75 124.06 29.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 74.42 110.856 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.7 mt -98.22 -35.71 10.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.589 0.756 . . . . 73.5 110.792 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -172.07 4.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.226 0.61 . . . . 73.43 111.085 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.53 112.56 4.18 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.288 1.035 . . . . 75.23 110.732 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 69.19 3.63 4.19 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.944 1.698 . . . . 71.12 112.847 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.2 t -109.14 118.27 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.297 0.639 . . . . 52.41 110.438 -173.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.81 130.26 45.09 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.092 1.357 . . . . 73.23 108.354 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.7 tt0 -87.08 111.87 21.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.702 -1.221 . . . . 75.32 107.702 169.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -100.09 121.01 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.961 -1.496 . . . . 72.41 106.961 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.548 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 44.3 t -99.58 132.55 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.788 0.835 . . . . 75.12 109.231 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.4 OUTLIER -105.06 128.0 53.13 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.646 -1.242 . . . . 73.1 107.646 176.075 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 31.8 ttm-85 -107.49 99.99 9.45 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.572 0.749 . . . . 74.25 109.138 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.24 122.49 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.425 -0.954 . . . . 61.11 108.425 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.8 m -114.9 142.37 46.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.638 -0.71 . . . . 55.14 109.61 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.786 HG21 HG21 ' D' ' 114' ' ' ILE . 81.1 t -130.78 127.45 61.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.127 1.371 . . . . 65.02 108.637 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -123.7 94.76 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.086 -1.079 . . . . 54.44 108.086 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -98.06 127.37 43.96 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.661 -0.866 . . . . 72.22 108.661 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.484 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.4 m -140.63 139.52 34.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.392 0.615 . . . . 73.23 111.298 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' D' ' 36' ' ' TRP . 36.1 mt -110.52 116.98 32.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.284 1.434 . . . . 71.13 109.228 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.68 -129.05 44.15 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 120.14 -0.256 . . . . 41.43 112.894 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.81 4.06 50.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.504 0.721 . . . . 75.01 112.126 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' D' ' 68' ' ' LEU . 11.8 pt-20 -124.15 154.48 39.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.129 0.572 . . . . 71.33 110.174 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 33.9 m -74.47 136.13 42.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.286 -0.635 . . . . 71.13 109.286 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.46 -57.43 3.15 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.829 -1.175 . . . . 74.34 107.829 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' D' ' 118' ' ' VAL . 49.0 p90 -161.3 149.3 15.44 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 114.696 -1.138 . . . . 73.35 110.202 169.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -100.75 150.63 22.58 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.505 -0.924 . . . . 74.24 108.505 166.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.695 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.4 t -158.1 132.54 8.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.34 0.4 . . . . 65.24 109.922 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.87 132.81 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.553 0.741 . . . . 74.21 109.25 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -132.19 119.76 41.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.701 0.801 . . . . 72.11 109.687 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.88 88.2 7.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.729 0.812 . . . . 74.23 109.491 171.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.87 102.33 9.99 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 114.466 -1.243 . . . . 63.01 109.153 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.89 145.27 18.59 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.438 -0.665 . . . . 70.14 111.438 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.99 130.62 4.75 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.809 -0.916 . . . . 73.41 110.809 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.41 ' O ' HD12 ' D' ' 13' ' ' ILE . 56.1 mt -90.13 115.78 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.677 -0.86 . . . . 74.44 108.677 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -117.58 152.42 35.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.431 1.092 . . . . 53.45 109.71 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -116.23 95.02 4.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.033 -1.099 . . . . 72.14 108.033 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.479 ' H ' HD12 ' D' ' 86' ' ' ILE . 0.1 OUTLIER -110.3 138.71 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.468 0.707 . . . . 72.03 110.038 -171.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 169.76 13.89 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.786 1.235 . . . . 53.13 109.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.21 21.76 56.18 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.56 -0.291 . . . . 70.15 112.397 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.01 161.04 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.485 1.114 . . . . 65.1 110.404 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -166.63 165.98 16.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.59 0.756 . . . . 74.53 110.467 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 91' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 60.35 -134.54 50.21 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 124.026 0.829 . . . . 74.12 114.178 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -79.39 -14.11 59.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.012 0.925 . . . . 55.13 112.527 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -63.89 -34.17 77.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.459 0.704 . . . . 72.43 111.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 22.3 ptp -71.38 -28.04 63.76 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.521 0.513 . . . . 63.31 111.038 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.81 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.568 0.747 . . . . 42.01 110.002 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 82.1 t60 -72.8 -32.9 65.88 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.058 -0.974 . . . . 63.41 110.542 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.82 -50.15 32.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.968 0.507 . . . . 60.14 110.517 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 tt -72.03 -46.02 58.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.105 0.562 . . . . 75.35 110.182 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.55 84.56 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.378 -0.679 . . . . 54.4 114.344 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.92 -63.75 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.881 0.84 . . . . 54.41 112.071 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -68.68 -44.54 73.78 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 113.474 0.916 . . . . 73.14 113.474 -165.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 56.1 m -67.22 -45.26 50.44 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 118.971 -0.538 . . . . 61.44 111.772 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.7 Cg_exo -53.7 -32.91 67.44 Favored 'Trans proline' 0 C--N 1.394 2.921 0 C-N-CA 122.931 2.421 . . . . 62.32 114.347 168.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -60.64 -28.12 68.31 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 122.786 0.434 . . . . 73.3 112.107 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.22 -42.13 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.604 0.716 . . . . 65.34 110.041 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.1 mt -76.33 -21.68 55.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 61.12 111.999 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -62.83 -42.98 81.5 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 117.693 -1.146 . . . . 74.12 113.623 -171.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.73 -43.85 44.0 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.061 1.841 . . . . 63.35 113.492 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 82.6 m-85 -74.22 -39.06 63.36 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.943 0.897 . . . . 64.12 112.044 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.95 80.54 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.604 0.761 . . . . 42.13 109.95 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.592 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.9 ttp180 -60.94 -48.82 80.04 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 124.353 1.033 . . . . 71.23 110.055 174.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 5.1 tm-20 -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.063 0.945 . . . . 62.44 111.956 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -58.64 -41.3 85.68 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.939 0.774 . . . . 75.15 111.147 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.786 HG21 HG21 ' D' ' 64' ' ' VAL . 65.1 mt -63.37 -56.28 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.021 0.928 . . . . 74.44 109.701 174.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 82.4 m -51.82 -40.1 59.88 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.095 1.758 . . . . 71.04 111.853 -175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.3 t -69.64 -45.04 69.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.531 -1.213 . . . . 72.04 110.226 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.2 mtm -67.0 -31.67 72.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.947 0.499 . . . . 71.41 111.847 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.496 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.7 t -62.14 -49.12 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.688 0.795 . . . . 53.13 109.677 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -72.79 -28.88 62.85 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.733 -0.667 . . . . 62.34 111.139 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.74 -25.22 61.97 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.518 0.727 . . . . 74.14 110.056 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 121' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.9 11.43 70.58 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.791 0.682 . . . . 42.35 112.828 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.546 HG23 ' HB3' ' C' ' 17' ' ' TYR . 76.8 p 61.25 14.94 5.99 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.331 1.853 . . . . 75.22 113.661 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.526 ' HE1' HG11 ' D' ' 31' ' ' VAL . 62.0 m-85 -87.27 159.57 50.36 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.97 0.908 . . . . 63.32 109.804 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.35 127.53 20.27 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.928 2.419 . . . . 64.53 111.961 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -52.28 132.29 33.8 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.097 0.873 . . . . 73.11 111.318 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.516 HD13 HG21 ' D' ' 40' ' ' VAL . 42.4 tp -108.3 115.52 30.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.521 0.728 . . . . 51.33 110.122 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -113.41 100.78 8.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.364 0.666 . . . . 43.31 109.701 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 68.1 mt -74.49 148.51 40.93 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.928 -1.033 . . . . 62.44 110.138 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.99 125.42 83.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 123.787 0.68 . . . . 73.43 110.523 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.68 99.07 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.44 2.093 . . . . 63.04 109.271 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.07 119.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.107 -0.951 . . . . 31.24 110.95 -167.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--O 1.236 0.387 0 N-CA-C 107.649 -1.241 . . . . 63.31 107.649 167.579 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.239 0.527 0 N-CA-C 106.868 -1.53 . . . . 64.34 106.868 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 32.5 t80 -136.43 128.58 29.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.049 0.54 . . . . 72.51 109.845 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -155.6 134.56 12.08 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.481 0.488 . . . . 74.12 110.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.69 116.22 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.917 -1.142 . . . . 72.14 107.917 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.53 -39.36 46.33 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.674 -0.491 . . . . 73.54 109.674 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.8 ttt85 -169.51 136.89 1.73 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.541 0.526 . . . . 72.33 110.921 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.37 130.77 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.809 -1.182 . . . . 62.5 107.809 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 3.2 p90 -168.23 151.65 5.77 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.923 0.765 . . . . 73.02 110.77 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -80.71 117.62 21.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.612 -0.884 . . . . 54.44 108.612 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.4 mtpt -76.26 -33.47 59.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.446 0.641 . . . . 73.54 109.495 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.2 t70 -150.85 140.78 21.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.229 -1.35 . . . . 72.35 109.797 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.0 mt -137.69 142.7 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.958 1.303 . . . . 65.13 108.022 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 m -152.34 112.73 4.09 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 123.621 0.769 . . . . 65.41 110.514 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 73.5 t80 -109.98 127.72 54.96 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 105.843 -1.91 . . . . 53.53 105.843 164.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.9 143.19 51.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.787 -0.82 . . . . 74.42 108.787 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -147.86 73.48 11.34 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 106.595 -1.631 . . . . 34.43 106.595 171.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.7 -28.15 44.3 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.86 2.373 . . . . 73.35 111.435 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -111.04 32.79 5.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.285 1.034 . . . . 75.21 109.017 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -57.52 -52.4 74.56 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 118.357 -0.83 . . . . 61.45 111.947 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 53.1 Cg_exo -53.52 -33.4 67.86 Favored 'Trans proline' 0 C--N 1.403 3.417 0 C-N-CA 122.119 1.879 . . . . 51.33 113.565 173.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 10.4 m170 -67.61 -35.29 78.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.542 0.737 . . . . 73.25 111.269 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.52 -34.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.366 0.666 . . . . 73.21 111.367 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -80.71 -22.21 40.53 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.355 -0.838 . . . . 75.2 111.996 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -92.9 -23.56 18.73 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.808 0.443 . . . . 72.4 109.981 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 5.3 tmtp? -81.41 163.89 22.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.626 1.17 . . . . 75.42 109.693 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -76.61 138.88 40.38 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.124 -1.065 . . . . 60.33 108.124 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -91.5 79.71 5.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.771 0.796 . . . . 55.45 109.977 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -127.89 82.47 68.33 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.114 -1.439 . . . . 70.43 107.114 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.53 166.15 12.12 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.866 2.377 . . . . 63.31 112.545 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -112.33 99.96 8.42 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.533 -1.284 . . . . 73.23 107.533 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.79 94.32 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.482 1.113 . . . . 70.1 110.1 -171.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.5 tttt -80.33 124.79 29.16 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.357 -0.838 . . . . 73.55 109.555 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -103.98 108.75 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.007 -0.738 . . . . 75.45 109.007 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 16.1 t70 -108.34 117.87 35.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.992 0.917 . . . . 73.41 108.617 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -99.79 121.0 40.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.68 -1.23 . . . . 74.14 107.68 171.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -119.09 148.57 42.9 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.084 -1.45 . . . . 52.24 107.084 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -149.77 146.15 27.02 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 73.21 110.4 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 151.94 46.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.674 1.19 . . . . 54.23 108.959 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -135.1 161.93 33.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.971 0.508 . . . . 51.34 111.438 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -168.65 131.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.116 0.966 . . . . 73.31 109.751 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.06 115.69 17.08 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.103 -0.703 . . . . 72.33 109.103 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.45 -43.11 17.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 70.42 110.294 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.64 -173.66 4.24 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.967 -1.015 . . . . 35.03 110.487 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.81 114.59 5.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.37 0.668 . . . . 72.35 110.882 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 85' ' ' SER . 11.9 m-20 68.29 -0.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.508 1.523 . . . . 54.25 111.994 -177.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.3 t -105.18 101.86 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.568 -1.271 . . . . 41.23 107.568 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -119.03 154.0 33.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.375 -1.284 . . . . 72.21 107.756 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -124.24 123.94 41.35 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.694 -0.854 . . . . 42.04 108.694 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.61 116.29 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.802 -1.555 . . . . 75.42 106.802 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 66.0 t -96.72 132.93 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.794 -0.817 . . . . 72.04 108.794 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 112.52 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.622 -1.621 . . . . 73.22 106.622 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 23.1 ttp180 -109.63 102.34 11.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.277 -0.638 . . . . 73.3 109.277 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.75 127.93 45.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.976 -1.12 . . . . 74.03 107.976 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.7 m -116.34 122.56 45.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.044 -0.725 . . . . 53.5 109.044 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 46.5 t -116.51 106.27 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.794 1.238 . . . . 64.42 107.896 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 20.8 m -104.39 139.71 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.731 -0.84 . . . . 74.03 108.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.38 125.21 38.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.066 -1.457 . . . . 52.42 107.066 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 m -129.99 128.79 42.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.194 0.598 . . . . 63.1 110.066 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 57.0 mt -87.63 75.62 9.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.13 -1.063 . . . . 75.33 108.13 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.72 -99.66 1.38 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.427 -0.806 . . . . 50.31 112.064 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.16 -18.47 16.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.77 0.828 . . . . 62.43 111.324 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -112.37 134.51 53.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.436 0.694 . . . . 64.32 109.939 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -68.82 136.73 53.18 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.078 0.551 . . . . 74.21 111.42 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -83.01 -59.88 2.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.379 1.072 . . . . 64.13 109.334 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.97 174.8 14.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.22 -0.9 . . . . 75.23 110.337 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 tp -141.32 141.23 33.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.283 1.433 . . . . 64.11 107.891 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.3 m -129.62 135.87 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.999 -1.111 . . . . 51.42 107.999 171.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.42 116.07 6.3 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.684 -0.858 . . . . 61.53 108.684 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 t -129.59 112.74 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.651 0.781 . . . . 73.21 109.899 -173.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.3 mt-30 -83.64 87.66 7.04 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.844 -0.799 . . . . 61.24 108.844 168.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.7 tp-100 -77.11 92.96 3.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.264 -1.384 . . . . 73.42 107.264 169.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.76 143.38 21.47 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.739 -0.944 . . . . 64.35 110.739 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.17 123.01 2.1 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 110.677 -0.969 . . . . 74.12 110.677 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.6 mt -90.92 121.8 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.345 -0.983 . . . . 72.41 108.345 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 28.6 m-85 -129.73 152.59 49.06 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.518 0.727 . . . . 53.2 109.948 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.8 m -91.49 121.71 33.43 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.604 0.762 . . . . 72.12 109.25 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 94' ' ' MET . 5.8 tt -116.96 119.95 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.614 -0.513 . . . . 74.33 109.614 173.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.94 172.28 1.67 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.631 1.572 . . . . 75.11 108.895 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.44 -32.15 3.97 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 116.79 -0.187 . . . . 55.3 112.784 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.12 170.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.475 1.11 . . . . 73.11 109.206 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.0 tt0 -164.29 175.68 9.84 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.493 0.495 . . . . 75.12 110.275 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.45 -130.85 37.9 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.674 -0.694 . . . . 72.13 113.172 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 t -62.32 -27.73 69.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.241 1.016 . . . . 54.45 111.772 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -68.16 -48.89 64.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.502 0.721 . . . . 75.35 110.861 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.64 ' HB2' HD11 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -75.59 -30.49 59.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.893 0.477 . . . . 72.13 111.116 -177.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.26 67.76 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.731 0.812 . . . . 41.14 110.612 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -76.61 -31.5 57.49 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.028 -0.987 . . . . 72.41 110.178 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.6 m -71.85 -66.13 0.68 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 123.029 0.532 . . . . 64.21 111.531 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.74 -29.41 68.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.325 0.65 . . . . 53.34 111.044 -172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.44 -19.97 57.54 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.682 -1.065 . . . . 45.32 114.721 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.35 -48.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.201 1.5 . . . . 70.13 113.911 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 44.9 t80 -66.76 -47.87 70.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.123 0.969 . . . . 71.43 111.879 -173.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.33 -41.83 8.45 Favored Pre-proline 0 CA--C 1.565 1.555 0 C-N-CA 123.494 0.717 . . . . 64.55 112.163 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.98 -31.78 65.3 Favored 'Trans proline' 0 C--N 1.393 2.876 0 C-N-CA 122.22 1.946 . . . . 24.12 113.919 163.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -68.74 -34.6 75.87 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.563 0.745 . . . . 62.14 110.283 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.07 -42.72 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.705 0.802 . . . . 75.55 110.172 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.5 mt -76.49 -24.77 53.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.553 -1.203 . . . . 71.12 112.462 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.13 -40.18 50.95 Favored Pre-proline 0 CA--C 1.563 1.474 0 N-CA-C 114.46 1.281 . . . . 72.23 114.46 -168.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -55.08 -38.78 93.29 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.97 1.78 . . . . 72.13 113.344 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -77.65 -38.84 46.88 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.756 0.823 . . . . 72.41 111.644 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.19 77.34 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.971 0.509 . . . . 44.44 110.178 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.1 ttm180 -55.57 -51.19 67.94 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.472 1.108 . . . . 70.43 110.025 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.4 tm-20 -64.0 -41.48 97.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.125 0.891 . . . . 75.14 111.401 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.89 -42.02 98.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.838 0.712 . . . . 54.11 111.005 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.416 HG21 HG21 ' A' ' 64' ' ' VAL . 91.5 mt -66.74 -51.48 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.384 0.674 . . . . 70.52 110.528 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.694 HG23 ' HB2' ' A' ' 125' ' ' GLN . 52.4 m -52.78 -44.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.624 1.17 . . . . 70.45 110.907 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 37.8 t -64.77 -41.06 96.17 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.403 -1.271 . . . . 65.43 110.907 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 32.2 mtm -67.87 -41.31 83.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.96 0.504 . . . . 75.14 111.541 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.4 -50.34 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.792 0.837 . . . . 62.3 110.095 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 90.5 p -67.09 -32.05 72.95 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.224 -0.898 . . . . 74.51 111.105 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 116' ' ' SER . 26.9 ttm-85 -75.24 -27.44 59.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.596 1.159 . . . . 71.45 110.206 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.18 8.86 62.43 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.62 -0.718 . . . . 74.11 112.86 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' D' ' 125' ' ' GLN . 9.4 m 67.07 29.63 7.83 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.794 1.238 . . . . 73.0 110.831 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.51 151.09 41.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 114.479 -1.237 . . . . 75.0 107.905 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.76 121.53 8.43 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.784 1.656 . . . . 75.13 110.104 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.694 ' HB2' HG23 ' A' ' 115' ' ' THR . 18.5 pt20 -60.87 155.4 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.554 0.741 . . . . 65.45 111.873 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.12 122.08 26.05 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.828 -0.805 . . . . 73.42 108.828 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.432 ' ND2' ' HB ' ' C' ' 16' ' ' ILE . 2.3 m-20 -103.54 95.32 5.98 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.758 -1.201 . . . . 74.32 107.758 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 131.86 46.79 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.381 -0.6 . . . . 71.45 109.381 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.51 128.02 89.38 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 123.676 0.79 . . . . 54.23 111.886 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.01 110.24 3.08 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.025 1.817 . . . . 73.14 110.83 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.1 t -99.35 114.79 38.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.041 -1.096 . . . . 74.13 108.041 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -76.16 107.03 8.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.155 0.502 . . . . 74.24 110.117 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.3 0.571 . . . . 72.44 109.484 171.501 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.241 0.627 0 N-CA-C 109.304 -0.628 . . . . 65.52 109.304 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -129.67 128.52 42.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 71.1 109.565 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 5.6 tp60 -135.43 114.63 12.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.568 0.747 . . . . 72.12 109.042 173.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' D' ' 129' ' ' ALA . 8.7 tt -89.91 107.12 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 108.118 -1.067 . . . . 62.33 108.118 171.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.58 -40.9 20.25 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 115.774 -0.648 . . . . 74.42 110.61 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.436 HH21 HG22 ' A' ' 122' ' ' THR . 16.3 ttt180 -170.33 145.11 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.104 0.253 . . . . 70.24 111.123 -173.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.53 149.83 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.492 -1.299 . . . . 74.23 107.492 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' B' ' 83' ' ' ILE . 23.4 p90 -171.42 150.01 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.172 0.511 . . . . 73.35 111.208 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -76.0 121.45 22.75 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.552 -0.907 . . . . 62.3 108.552 169.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.51 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.8 mtpt -88.98 -39.7 13.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.352 0.661 . . . . 63.12 109.865 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.05 148.04 27.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.08 -0.509 . . . . 74.54 110.62 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.405 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 46.0 mm -142.19 139.42 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.916 1.686 . . . . 72.42 107.462 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -141.22 136.03 31.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.182 -1.044 . . . . 60.52 108.182 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -143.72 120.94 11.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.009 -1.478 . . . . 71.11 107.009 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 23.1 mt-10 -128.76 112.0 13.72 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.447 -0.946 . . . . 73.2 108.447 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -114.44 88.65 16.1 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.7 -0.852 . . . . 73.55 108.7 176.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.08 -29.84 88.18 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.625 2.217 . . . . 61.32 112.059 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -119.99 29.41 7.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.345 1.058 . . . . 73.23 110.232 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -47.43 -50.07 51.1 Favored Pre-proline 0 CA--C 1.575 1.941 0 C-N-CA 125.236 1.414 . . . . 62.51 114.658 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.453 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 62.6 Cg_endo -81.14 -13.46 11.3 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.708 1.605 . . . . 72.11 113.422 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -94.39 2.9 55.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.419 0.687 . . . . 72.0 111.875 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.411 HG23 HD11 ' B' ' 68' ' ' LEU . 10.6 p -64.02 -17.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.626 0.771 . . . . 74.21 110.896 169.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.44 -37.47 83.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.163 0.985 . . . . 64.2 111.065 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.45 -45.36 39.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.772 0.829 . . . . 71.11 110.391 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -94.39 67.62 3.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 73.22 109.513 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -81.44 76.51 8.36 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.122 0.963 . . . . 73.32 110.871 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -158.68 167.62 29.03 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.896 1.278 . . . . 65.13 109.897 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.41 121.94 75.19 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 115.89 -0.595 . . . . 65.53 109.476 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.02 150.31 48.29 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.213 1.942 . . . . 61.14 110.899 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.78 114.13 9.55 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.867 -0.79 . . . . 65.32 108.867 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.548 HG12 HD22 ' B' ' 42' ' ' LEU . 23.5 t -85.15 117.06 29.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 107.41 -1.33 . . . . 65.31 107.41 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -140.3 102.1 4.28 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.235 -1.024 . . . . 74.11 108.235 -170.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.582 ' HG ' HD21 ' B' ' 128' ' ' LEU . 1.1 pt? -127.85 138.69 52.78 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.197 -1.365 . . . . 72.24 109.652 -170.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -126.51 148.73 49.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.843 0.857 . . . . 70.1 111.067 -170.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.566 ' HG ' HD21 ' B' ' 60' ' ' LEU . 7.6 tt -89.42 131.44 35.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.241 1.017 . . . . 73.45 109.016 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -122.89 137.45 54.94 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.858 -1.534 . . . . 72.41 106.858 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' THR . . . . . 0.472 HG21 ' HA2' ' B' ' 99' ' ' GLY . 85.2 m -107.42 120.37 41.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.08 -0.711 . . . . 74.45 109.08 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.446 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.62 153.74 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.437 1.095 . . . . 61.42 108.129 170.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 49.5 m -143.86 172.0 13.45 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.112 0.482 . . . . 52.02 110.599 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -154.44 167.29 30.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.79 1.236 . . . . 65.2 108.591 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -123.43 130.47 52.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.054 0.541 . . . . 73.23 109.772 171.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -100.82 -40.4 7.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 63.23 110.654 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.69 -169.92 3.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.063 0.545 . . . . 73.13 111.375 -174.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ASP . . . . . 0.401 ' O ' HG23 ' B' ' 55' ' ' VAL . 1.1 m-20 -57.62 111.3 1.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.754 -1.112 . . . . 60.21 110.967 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 68.65 0.78 2.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.033 1.333 . . . . 73.15 112.186 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 53' ' ' ASP . 95.8 t -101.08 101.06 11.57 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.231 -1.025 . . . . 43.45 108.231 -172.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -108.97 136.42 48.53 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.484 -0.78 . . . . 74.55 109.969 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -105.92 96.76 6.71 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.97 -1.492 . . . . 64.04 106.97 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 64.4 t -87.08 122.83 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.746 0.818 . . . . 63.32 109.577 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -101.68 113.68 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.798 0.839 . . . . 51.51 109.263 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.566 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -91.77 105.94 18.1 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.811 -1.181 . . . . 64.14 107.811 177.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -97.8 108.66 21.42 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.336 -0.847 . . . . 65.02 109.497 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' B' ' 114' ' ' ILE . 18.3 t -105.41 113.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.925 -1.139 . . . . 74.24 107.925 170.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -104.4 150.89 24.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.534 0.733 . . . . 71.43 109.276 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 26.1 t -134.66 133.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.984 0.913 . . . . 61.12 110.341 -167.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.9 m -125.15 149.09 48.24 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.604 0.762 . . . . 71.14 109.253 170.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.07 147.45 29.56 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.731 0.812 . . . . 70.2 108.972 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.0 p -144.64 129.15 18.02 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.499 0.499 . . . . 74.35 111.325 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 37.0 mt -95.61 104.73 16.65 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.752 1.221 . . . . 62.4 108.3 171.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.39 -127.88 21.06 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 123.744 0.652 . . . . 71.45 111.631 -174.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -96.56 17.16 16.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.706 0.802 . . . . 62.05 111.485 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -134.84 146.76 49.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.51 0.724 . . . . 74.45 109.724 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.7 m -63.78 135.65 56.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.177 0.591 . . . . 74.34 111.04 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.92 -59.7 1.99 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.931 0.892 . . . . 63.24 108.906 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -156.54 171.35 20.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 113.962 -1.472 . . . . 64.41 109.585 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.4 mt -139.94 154.69 47.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.882 1.673 . . . . 75.23 106.99 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.2 t -159.7 160.42 34.08 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.156 -0.683 . . . . 74.53 109.156 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.42 136.83 3.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.233 -1.025 . . . . 75.23 108.233 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 97.1 t -124.18 143.82 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.973 -0.751 . . . . 74.14 108.973 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -124.0 102.08 7.57 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.531 -0.914 . . . . 74.15 108.531 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -92.16 100.11 12.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.218 -1.03 . . . . 65.32 108.218 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.51 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.88 146.64 18.51 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.146 -0.782 . . . . 74.13 111.146 177.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.81 127.75 3.39 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 110.758 -0.937 . . . . 71.14 110.758 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.455 HG13 ' HE1' ' B' ' 17' ' ' TYR . 50.3 mt -84.45 115.7 26.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.25 -1.018 . . . . 63.33 108.25 176.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.52 164.39 19.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.303 1.041 . . . . 72.23 108.849 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 16.4 m -132.43 103.68 6.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.452 -0.944 . . . . 75.55 108.452 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.556 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -115.88 134.71 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.214 0.606 . . . . 75.11 110.739 -177.214 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 172.76 18.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.466 1.106 . . . . 61.15 108.553 172.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.35 -55.01 3.55 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.703 -0.559 . . . . 62.23 111.703 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.52 154.45 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.255 1.022 . . . . 74.42 111.996 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.75 166.24 26.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.501 0.72 . . . . 73.14 110.355 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.61 -127.1 43.84 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.737 0.648 . . . . 43.14 113.71 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -65.16 -30.24 71.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.106 0.963 . . . . 62.15 111.149 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -74.07 -34.98 64.21 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.513 -0.767 . . . . 74.25 110.71 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.3 tpt -66.56 -47.99 71.09 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.018 -0.537 . . . . 64.21 110.241 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.04 77.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.11 0.881 . . . . 63.12 110.844 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -65.78 -34.53 78.38 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.51 0.724 . . . . 64.0 110.666 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -67.04 -67.9 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.637 0.375 . . . . 75.44 111.528 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -17.64 61.25 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 118.106 0.412 . . . . 74.12 112.076 -171.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.472 ' HA2' HG21 ' B' ' 46' ' ' THR . . . -108.74 2.27 32.09 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.48 -0.622 . . . . 64.32 114.607 -174.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -49.06 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 117.948 0.874 . . . . 74.12 111.387 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -72.45 -50.63 24.77 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.697 0.399 . . . . 65.01 111.471 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.24 -46.46 79.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 118.435 -0.793 . . . . 74.1 111.183 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -51.58 -41.32 61.43 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.153 1.902 . . . . 71.43 113.835 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.84 -36.84 84.54 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 123.478 0.711 . . . . 75.14 111.689 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.44 HG23 ' NH2' ' D' ' 111' ' ' ARG . 64.9 mt -62.35 -47.25 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.625 0.77 . . . . 74.25 110.418 174.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.11 -10.54 54.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.804 -1.089 . . . . 61.41 111.692 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -64.88 -49.76 66.79 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 117.411 -1.28 . . . . 73.43 113.312 -171.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -58.73 -34.64 99.08 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 121.944 1.762 . . . . 73.13 112.341 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.422 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.0 m-85 -64.31 -52.56 57.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.388 0.675 . . . . 75.41 110.358 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.86 81.94 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.764 0.825 . . . . 62.33 111.329 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.694 HH22 HG22 ' C' ' 122' ' ' THR . 53.6 ttt180 -67.61 -49.95 60.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.223 1.409 . . . . 74.32 110.414 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -34.96 78.99 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.939 0.775 . . . . 74.51 110.191 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.1 t -67.37 -45.49 76.11 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.066 0.546 . . . . 74.32 111.787 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' B' ' 62' ' ' VAL . 81.5 mt -59.35 -46.36 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.143 0.577 . . . . 55.42 110.196 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.626 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 34.2 m -53.58 -50.15 66.21 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.673 1.233 . . . . 62.2 110.045 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.5 t -59.42 -50.72 72.86 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.303 1.041 . . . . 63.21 111.852 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.559 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 20.7 mmt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.165 0.586 . . . . 73.34 112.494 -170.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.91 -32.33 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.089 0.556 . . . . 74.34 110.846 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.5 m -64.22 -30.02 71.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.555 0.742 . . . . 54.54 111.276 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 80.2 mtt-85 -68.69 -39.78 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.861 0.864 . . . . 63.45 109.844 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.32 66.47 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.838 0.711 . . . . 73.14 113.198 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p 60.55 44.95 11.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.194 1.797 . . . . 44.21 111.96 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -119.01 144.91 36.81 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 114.718 -1.128 . . . . 75.24 109.785 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -68.1 94.76 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.736 2.957 . . . . 74.3 113.718 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.626 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 3.3 mm-40 -68.21 160.79 28.5 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.332 1.063 . . . . 72.42 113.163 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.02 124.83 15.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.074 -2.195 . . . . 62.01 105.074 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -87.03 136.19 33.01 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.918 -0.771 . . . . 72.3 108.918 -171.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.582 HD21 ' HG ' ' B' ' 42' ' ' LEU . 38.1 mt -58.13 144.78 39.17 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.54 0.525 . . . . 54.41 112.296 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.69 108.56 2.47 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.629 1.206 . . . . 42.23 109.912 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.457 ' HG2' ' H ' ' D' ' 16' ' ' ILE . 73.1 Cg_endo -73.59 113.55 3.81 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.505 2.137 . . . . 73.05 111.185 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.08 142.77 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.405 0.682 . . . . 74.41 110.663 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -79.38 118.61 21.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.565 1.146 . . . . 70.1 109.91 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 CA--C 1.553 1.081 0 C-N-CA 123.448 0.699 . . . . 52.31 111.702 179.312 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.241 0.617 0 N-CA-C 107.595 -1.261 . . . . 75.41 107.595 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HA ' HG22 ' C' ' 86' ' ' ILE . 37.7 t80 -91.02 132.43 36.0 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.442 -1.254 . . . . 71.21 108.27 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -136.23 102.08 4.88 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.988 -1.115 . . . . 61.42 107.988 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.532 HD11 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -70.44 131.45 34.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 115.456 -0.793 . . . . 73.21 109.242 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.502 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.4 mm100 -105.21 -49.37 3.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.305 0.642 . . . . 65.44 109.857 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.519 HH11 ' HB2' ' D' ' 32' ' ' PHE . 73.5 ttt180 -173.62 132.25 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.692 -0.685 . . . . 72.43 110.34 -169.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.532 HG13 HD11 ' C' ' 13' ' ' ILE . 84.0 mt -118.93 136.26 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.266 -1.013 . . . . 75.24 108.266 170.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.667 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 8.4 p90 -171.53 172.02 5.22 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.355 1.035 . . . . 75.04 110.081 -173.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -93.17 118.98 31.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.521 -0.763 . . . . 74.32 109.384 176.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.414 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 17.4 mmtp -65.83 -47.11 76.09 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.124 -1.065 . . . . 74.24 108.124 168.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.5 t70 -141.52 147.09 37.21 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.472 -1.694 . . . . 72.33 110.008 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -135.1 144.73 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.767 1.627 . . . . 72.44 106.876 172.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -150.73 146.45 26.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.508 0.671 . . . . 74.22 110.706 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -151.64 118.45 5.79 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.566 -1.642 . . . . 65.34 106.566 167.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.62 133.08 56.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.72 -1.215 . . . . 54.51 107.72 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.88 85.22 39.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.376 -1.342 . . . . 74.12 107.376 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.16 -3.37 12.75 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.619 2.213 . . . . 75.21 112.183 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.62 18.24 8.78 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 123.921 0.889 . . . . 74.34 109.764 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -47.01 -50.85 43.87 Favored Pre-proline 0 CA--C 1.575 1.905 0 N-CA-C 114.309 1.226 . . . . 72.11 114.309 -169.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 85.2 Cg_endo -86.68 -27.88 0.68 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.713 1.608 . . . . 75.05 114.107 171.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -71.09 -24.62 62.35 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.474 0.71 . . . . 55.15 112.471 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.444 HG23 HD11 ' C' ' 68' ' ' LEU . 14.4 p -75.28 -18.19 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.593 1.157 . . . . 43.44 110.922 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' D' ' 14' ' ' GLN . 42.6 t80 -59.74 -38.48 81.85 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.845 0.858 . . . . 74.22 110.81 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 5.48 51.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.283 0.633 . . . . 73.42 112.395 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.72 ' HE2' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -98.33 164.55 12.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.575 0.35 . . . . 55.32 111.866 -167.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.95 117.37 8.93 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.266 -1.013 . . . . 73.3 108.266 165.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -84.96 67.01 10.03 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.223 1.011 . . . . 73.23 111.242 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -125.07 78.52 66.37 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 124.582 1.153 . . . . 71.44 109.261 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.5 106.6 1.88 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.542 2.161 . . . . 73.2 111.422 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -84.17 120.36 26.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.098 -1.445 . . . . 72.24 107.098 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.474 HG13 HG13 ' C' ' 64' ' ' VAL . 95.6 t -96.86 148.84 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.885 -1.052 . . . . 70.1 110.959 -166.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -133.53 114.98 14.18 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.834 -1.543 . . . . 61.21 106.834 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' C' ' 128' ' ' LEU . 5.4 mp -86.44 152.73 22.44 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.64 -0.874 . . . . 63.23 108.64 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.2 t70 -154.63 148.6 25.7 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.052 -0.721 . . . . 75.44 109.052 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 tt -149.78 120.59 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.013 -0.736 . . . . 54.32 109.013 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 11.7 m-20 -121.81 144.7 48.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.739 1.216 . . . . 75.41 108.656 176.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -113.01 132.8 55.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.18 -0.674 . . . . 63.4 109.18 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.17 157.32 38.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 64.24 109.044 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.0 p -144.87 150.35 36.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.886 -0.597 . . . . 75.22 110.008 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -156.32 143.16 18.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.792 1.237 . . . . 74.22 107.906 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -105.09 132.67 51.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.133 0.492 . . . . 71.25 109.692 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.61 HD11 HD12 ' C' ' 83' ' ' ILE . 69.0 mt -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.453 -0.794 . . . . 73.24 111.252 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -172.89 4.31 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.204 0.526 . . . . 60.12 111.174 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.94 112.79 2.73 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.331 -1.304 . . . . 43.54 110.312 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 60.87 23.87 13.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.643 1.177 . . . . 74.14 112.782 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -114.91 116.24 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.894 . . . . 62.34 109.284 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.09 159.97 15.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.06 0.933 . . . . 74.42 110.083 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.05 124.22 36.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.517 -1.674 . . . . 52.31 107.26 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.7 125.74 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.573 -1.269 . . . . 52.31 107.573 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.56 105.59 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.412 HD22 ' O ' ' C' ' 45' ' ' ASP . 2.4 tm? -91.33 112.61 24.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.216 -1.031 . . . . 55.14 108.216 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.4 ttp180 -91.68 110.76 22.1 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.823 0.849 . . . . 72.21 109.991 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.48 124.23 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 108.161 -1.051 . . . . 71.12 108.161 173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 7.5 m -123.44 137.05 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.491 -0.559 . . . . 75.52 109.491 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.522 HG21 HG21 ' C' ' 114' ' ' ILE . 56.1 t -125.17 115.74 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.861 1.264 . . . . 41.33 108.889 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.48 144.35 28.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.209 -1.034 . . . . 55.24 108.209 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.99 37.28 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.361 -0.607 . . . . 63.21 109.361 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -137.76 138.4 39.23 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.479 0.487 . . . . 54.02 110.665 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.65 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.1 mt -86.93 43.82 1.12 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.083 1.353 . . . . 62.02 109.356 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.96 -113.17 4.37 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.517 -1.033 . . . . 73.2 110.517 -170.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.77 -10.03 41.45 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.678 0.791 . . . . 73.45 110.883 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.72 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 8.3 tp10 -90.11 128.89 36.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.308 1.443 . . . . 63.52 110.049 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 16.3 m -64.82 129.34 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.853 0.751 . . . . 75.21 109.908 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.534 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -83.36 -54.73 4.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.128 -0.694 . . . . 72.31 109.128 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -168.57 178.51 4.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.401 -1.272 . . . . 74.14 110.31 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -141.09 146.22 36.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 106.423 -1.695 . . . . 70.43 106.423 175.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.451 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -146.66 145.89 30.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.912 -1.144 . . . . 71.4 107.912 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.29 136.85 11.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.563 -0.532 . . . . 53.43 109.563 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' C' ' 110' ' ' ALA . 53.6 t -134.87 112.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.038 0.935 . . . . 61.23 108.507 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.7 mt-30 -92.71 89.51 6.69 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.822 -0.807 . . . . 65.44 108.822 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 63.3 tp60 -82.59 109.82 17.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.016 -0.993 . . . . 43.34 109.767 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 144.95 17.48 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.34 0.4 . . . . 71.11 112.434 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.607 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.29 128.29 3.35 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 110.358 -1.097 . . . . 71.23 110.358 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.61 HD12 HD11 ' C' ' 51' ' ' LEU . 11.8 mm -95.19 118.69 41.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.032 -1.099 . . . . 75.04 108.032 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.47 117.13 20.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.502 -0.925 . . . . 55.13 108.502 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -98.58 107.29 19.7 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.179 -1.045 . . . . 75.21 108.179 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.8 pp -131.7 154.31 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.036 0.534 . . . . 73.45 111.065 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.25 177.46 3.59 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.483 -1.235 . . . . 63.02 109.468 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -36.53 3.69 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 116.515 -0.312 . . . . 71.32 112.46 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.409 ' H ' HG13 ' C' ' 89' ' ' ILE . 2.5 pp . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 124.477 1.111 . . . . 75.15 111.402 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.237 -0.282 . . . . 74.14 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 54.8 tpp -65.46 -44.4 87.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.558 0.743 . . . . 74.41 110.243 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -26.42 68.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.553 0.741 . . . . 65.23 112.431 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -88.14 -33.51 18.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.518 0.727 . . . . 73.24 111.34 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -67.68 -61.58 1.82 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.19 0.596 . . . . 75.4 110.953 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.11 -6.64 47.56 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.191 0.441 . . . . 70.0 112.191 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.44 -29.67 21.26 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.919 -0.378 . . . . 70.11 113.527 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 -43.47 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.154 0.477 . . . . 62.11 111.778 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -72.29 -49.91 31.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.228 0.455 . . . . 71.14 112.228 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.05 -45.66 80.01 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.808 -0.615 . . . . 51.41 112.461 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.15 -23.1 60.65 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 121.877 1.718 . . . . 71.33 113.798 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -67.86 -39.74 83.72 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.352 0.661 . . . . 73.23 109.602 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.46 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.5 mm -61.61 -40.36 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 75.35 110.126 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.607 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -76.87 -27.03 54.89 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.129 -0.941 . . . . 74.43 112.288 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 51.2 t80 -57.67 -47.75 98.4 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 117.285 -1.341 . . . . 74.31 114.11 -170.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.78 -39.49 91.03 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.032 1.821 . . . . 73.31 112.863 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -63.48 -43.83 96.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.066 0.947 . . . . 75.14 111.3 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -76.04 -35.47 59.47 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.897 -0.592 . . . . 73.32 111.605 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -60.45 -47.39 86.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.275 1.43 . . . . 64.41 110.214 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -39.59 87.3 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.365 -0.834 . . . . 61.12 109.959 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.7 t -66.02 -27.99 68.53 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.398 0.679 . . . . 60.35 112.329 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.522 HG21 HG21 ' C' ' 64' ' ' VAL . 78.2 mt -73.12 -49.08 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.938 0.495 . . . . 64.21 110.113 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -58.18 -34.85 70.79 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.028 0.931 . . . . 61.11 111.143 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -62.58 -55.0 31.26 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.912 -1.495 . . . . 73.51 109.79 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.503 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -59.48 -36.92 76.94 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.802 1.241 . . . . 73.44 113.443 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.02 -41.37 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.848 0.459 . . . . 71.1 110.769 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.9 t -66.6 -30.25 70.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.278 -0.873 . . . . 63.05 110.986 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.503 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 89.4 mtt-85 -70.23 -33.46 71.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.535 0.734 . . . . 73.34 110.315 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.14 7.38 63.81 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-N 115.668 -0.696 . . . . 53.04 112.966 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.694 HG22 HH22 ' B' ' 111' ' ' ARG . 17.2 p 62.1 21.27 12.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.897 2.079 . . . . 72.02 113.488 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.31 166.4 15.51 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.168 0.987 . . . . 75.33 110.239 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.78 105.7 0.39 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.296 1.997 . . . . 71.13 111.236 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.34 141.38 36.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.863 1.265 . . . . 72.54 111.418 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.76 118.14 36.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.631 0.372 . . . . 62.14 111.376 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.33 85.01 3.32 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.385 -0.969 . . . . 53.3 108.385 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.419 HD13 ' HG ' ' C' ' 42' ' ' LEU . 53.5 mt -78.36 142.63 37.52 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.882 -1.054 . . . . 43.23 109.15 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 141.4 94.11 Favored Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 123.934 0.894 . . . . 63.33 112.721 -169.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' C' ' 107' ' ' PHE . 82.6 Cg_endo -75.36 102.37 1.59 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.785 2.323 . . . . 73.11 111.521 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.2 t -69.19 91.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.295 0.638 . . . . 63.41 110.818 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -83.83 105.91 15.1 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.084 -0.962 . . . . 74.31 110.134 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 N--CA 1.483 1.183 0 C-N-CA 123.416 0.686 . . . . 72.52 111.229 175.066 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 62.41 108.468 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.83 100.07 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.896 -1.52 . . . . 73.33 106.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.557 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.0 mt-30 -118.31 153.73 33.49 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.421 -0.955 . . . . 64.35 108.421 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.1 141.44 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.881 -1.525 . . . . 72.54 106.881 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.448 ' HB3' ' CZ ' ' C' ' 32' ' ' PHE . 69.8 mt-30 -109.89 -35.2 6.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.84 0.456 . . . . 64.4 110.008 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -173.77 124.06 0.36 Allowed 'General case' 0 C--N 1.367 1.326 0 O-C-N 123.272 0.358 . . . . 74.24 111.028 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' B' ' 130' ' ' PRO . 38.4 mm -110.87 118.92 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 72.42 109.075 175.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' C' ' 122' ' ' THR . 9.0 p90 -149.6 175.96 11.07 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.909 0.861 . . . . 75.45 111.82 -171.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.44 HG21 HD11 ' D' ' 21' ' ' ILE . 72.2 p -98.99 119.03 37.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.238 -1.347 . . . . 62.43 109.733 175.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -84.49 -38.75 19.71 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.902 -0.59 . . . . 74.42 110.207 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.99 136.38 23.96 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.871 -0.788 . . . . 42.01 108.871 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.478 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.9 mt -130.16 132.35 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.885 -1.524 . . . . 73.51 106.885 172.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -145.44 114.96 7.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 123.394 0.434 . . . . 64.54 110.244 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.4 t80 -111.39 120.25 41.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.751 -1.574 . . . . 73.41 106.751 167.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.85 119.38 25.53 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.62 94.57 10.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 109.114 -0.699 . . . . 70.33 109.114 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.27 -57.4 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.15 2.567 . . . . 70.43 112.727 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -92.57 22.09 4.93 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.634 -0.698 . . . . 63.44 111.055 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.667 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -28.19 -64.24 0.16 Allowed Pre-proline 0 CA--C 1.577 2.018 0 N-CA-C 117.401 2.371 . . . . 70.03 117.401 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -82.95 -19.62 5.73 Favored 'Trans proline' 0 C--N 1.389 2.661 0 CA-C-N 122.491 1.925 . . . . 74.41 113.57 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -70.01 -40.99 74.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.346 1.058 . . . . 73.25 109.727 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.9 p -86.09 -0.87 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 C-N-CA 123.537 0.735 . . . . 74.32 111.249 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.519 ' HB2' HH11 ' C' ' 15' ' ' ARG . 82.3 t80 -62.1 -30.82 71.28 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.961 0.504 . . . . 53.33 110.665 164.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -68.44 -15.47 63.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 71.35 111.429 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.95 99.95 12.49 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.264 1.026 . . . . 73.42 109.739 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -96.88 50.75 1.11 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.33 1.052 . . . . 74.21 110.561 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -127.22 159.55 33.96 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.511 -0.922 . . . . 72.01 108.511 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -63.43 112.61 7.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.815 0.846 . . . . 60.14 109.96 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' D' ' 68' ' ' LEU . 25.8 Cg_exo -61.47 118.23 5.09 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.652 2.235 . . . . 71.35 111.671 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 51.3 mt-10 -60.38 115.56 3.64 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.235 0.959 . . . . 75.44 110.243 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.602 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -96.14 110.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 122.12 0.962 . . . . 74.11 109.027 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -97.2 107.34 19.84 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.668 -1.604 . . . . 72.21 106.668 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.584 HD22 HD22 ' D' ' 128' ' ' LEU . 55.3 tp -97.14 113.71 25.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.248 -0.649 . . . . 72.51 109.248 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.8 t70 -113.6 148.74 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.503 -0.554 . . . . 62.11 109.503 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 tp -119.88 135.05 55.03 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.686 0.794 . . . . 72.4 110.543 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -144.05 142.95 30.94 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.155 -1.054 . . . . 74.42 108.155 168.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -120.89 166.54 13.66 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.45 0.7 . . . . 74.04 109.279 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.74 169.3 24.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.183 0.993 . . . . 62.53 109.015 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 13.3 p -165.0 155.8 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.947 0.404 . . . . 74.54 111.738 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -152.75 135.7 15.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 51.11 109.147 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.35 118.06 22.34 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.394 -0.595 . . . . 70.01 109.394 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' D' ' 57' ' ' GLU . 34.6 mt -95.19 -34.31 12.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.196 0.598 . . . . 60.31 110.267 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.45 -173.43 4.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.03 0.932 . . . . 70.53 110.357 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.58 120.62 14.29 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.316 -0.856 . . . . 75.21 109.519 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 63.46 14.43 7.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.742 1.217 . . . . 61.21 112.178 -176.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.87 119.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.225 -0.657 . . . . 74.15 109.225 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -133.08 130.48 39.39 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.243 1.017 . . . . 73.5 108.376 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.49 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.1 tt0 -87.18 112.71 22.24 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.949 -1.13 . . . . 75.52 107.949 169.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.32 124.13 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.006 -1.479 . . . . 73.2 107.006 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 32.8 t -105.02 135.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.691 0.797 . . . . 70.24 109.024 -177.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 121.18 44.6 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.923 -1.14 . . . . 64.41 107.923 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.4 ttm-85 -103.68 102.28 12.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.835 -1.172 . . . . 64.14 107.835 173.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.571 HG21 ' HB1' ' D' ' 110' ' ' ALA . 19.8 t -98.44 120.61 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.664 -0.865 . . . . 71.45 108.664 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.1 m -108.04 137.41 46.09 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.187 0.595 . . . . 72.3 109.931 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.602 HG13 HG23 ' D' ' 40' ' ' VAL . 50.7 t -136.89 108.04 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 61.24 108.054 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.9 m -101.07 126.94 47.8 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.317 -0.994 . . . . 54.21 108.317 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -111.94 141.44 45.58 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.323 -0.621 . . . . 53.21 109.323 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 57.5 p -145.13 141.99 29.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.708 0.63 . . . . 73.41 111.016 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' D' ' 38' ' ' PRO . 39.9 mt -136.35 112.51 9.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.777 1.231 . . . . 74.21 109.456 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.12 -109.72 2.97 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.368 -0.693 . . . . 72.24 111.368 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -122.54 4.09 9.6 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.495 0.718 . . . . 65.43 110.588 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.7 153.09 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.316 0.646 . . . . 72.45 110.601 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -76.53 116.61 17.37 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 122.774 0.429 . . . . 70.23 110.42 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -69.5 -56.58 6.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.541 -0.754 . . . . 73.44 111.026 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.96 174.06 15.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.43 -0.804 . . . . 64.43 110.654 170.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.36 145.19 51.73 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.88 -1.526 . . . . 73.12 106.88 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.523 ' SG ' HG23 ' D' ' 114' ' ' ILE . 53.0 t -157.79 121.21 4.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.863 -0.792 . . . . 72.13 108.863 -174.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.83 129.03 10.46 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.468 -0.567 . . . . 70.42 109.468 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.94 121.2 53.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.875 0.87 . . . . 63.22 109.577 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -87.84 85.01 6.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.387 -0.968 . . . . 74.2 108.387 167.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -79.98 97.8 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.324 -0.991 . . . . 60.12 108.324 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.59 143.72 16.74 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.859 -0.496 . . . . 42.14 111.859 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.43 131.48 4.86 Favored Glycine 0 CA--C 1.505 -0.532 0 N-CA-C 111.421 -0.672 . . . . 53.32 111.421 -175.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -90.31 125.72 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.574 -0.899 . . . . 71.04 108.574 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.5 127.86 43.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.942 0.897 . . . . 72.12 109.684 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 49.0 m -81.82 93.18 6.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.256 -1.016 . . . . 53.42 108.256 165.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.52 128.36 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.968 1.707 . . . . 64.42 109.751 -172.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 164.99 20.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 72.53 109.958 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.54 80.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.092 -0.504 . . . . 71.44 114.182 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.17 168.35 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.457 0.703 . . . . 74.12 110.571 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -162.51 146.61 11.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.894 -1.048 . . . . 73.34 109.815 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.88 -107.61 0.12 Allowed Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.307 1.004 . . . . 60.24 114.915 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -67.27 -38.58 85.33 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.492 0.717 . . . . 62.45 110.937 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.72 -31.95 73.28 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.77 0.828 . . . . 72.43 110.573 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 45.1 ttm -67.74 -50.77 55.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.682 0.793 . . . . 64.23 110.284 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.24 62.69 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.829 -0.623 . . . . 63.53 111.303 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -79.51 -32.37 42.33 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.398 0.679 . . . . 72.33 110.31 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.2 t -78.27 -52.75 8.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 117.729 0.24 . . . . 55.2 110.356 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.41 -18.52 31.56 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.658 0.383 . . . . 74.31 111.788 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.68 -8.98 29.54 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.266 -0.741 . . . . 61.24 114.254 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.33 -55.21 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.027 0.914 . . . . 65.04 112.329 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -76.34 -50.94 12.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.096 0.559 . . . . 70.45 111.994 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 106' ' ' LEU . 71.0 m -60.96 -46.19 96.69 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 118.438 -0.791 . . . . 74.43 110.478 176.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.96 -39.57 59.27 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.263 1.976 . . . . 65.42 114.019 163.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.03 -26.61 65.07 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.353 0.661 . . . . 63.15 110.753 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -72.56 -38.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.892 0.877 . . . . 74.51 110.387 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.53 HD21 ' HA3' ' D' ' 82' ' ' GLY . 42.3 mt -79.64 -17.89 52.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.032 -0.986 . . . . 55.21 111.209 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -68.69 -38.64 12.46 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.18 1.178 . . . . 62.42 114.18 -171.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.34 -46.78 29.93 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.101 1.868 . . . . 74.05 113.095 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.86 -33.21 68.24 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.158 -0.928 . . . . 65.14 111.123 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -67.61 -54.24 21.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.927 0.891 . . . . 72.21 110.152 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -50.56 -46.5 57.65 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.987 1.43 . . . . 74.0 110.811 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -66.43 -46.07 77.7 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.175 0.922 . . . . 72.3 111.732 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.95 -41.71 92.44 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.737 0.648 . . . . 72.2 110.709 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.523 HG23 ' SG ' ' D' ' 76' ' ' CYS . 81.7 mt -59.45 -56.99 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.365 1.066 . . . . 51.53 110.671 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.633 HG23 ' HG3' ' D' ' 125' ' ' GLN . 54.9 m -53.93 -41.37 67.63 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.276 1.43 . . . . 75.31 111.865 -174.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -67.82 -42.59 81.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.923 -1.035 . . . . 73.13 109.958 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.444 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.6 mtm -71.11 -28.07 64.05 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.887 0.475 . . . . 64.34 111.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.42 -42.74 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.438 0.695 . . . . 64.41 110.135 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -74.38 -26.53 60.17 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.972 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -76.09 -24.16 55.02 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.458 0.703 . . . . 72.23 109.826 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.72 12.24 66.15 Favored Glycine 0 C--N 1.352 1.432 0 O-C-N 123.654 0.596 . . . . 74.33 112.258 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.595 HG23 ' HB3' ' C' ' 17' ' ' TYR . 80.6 p 62.95 9.98 4.09 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 127.385 2.274 . . . . 71.43 114.6 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.467 ' HZ ' HG13 ' D' ' 31' ' ' VAL . 41.9 m-85 -89.37 156.42 48.34 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.172 0.589 . . . . 74.31 110.65 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.89 141.37 89.52 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.714 2.276 . . . . 74.21 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.633 ' HG3' HG23 ' D' ' 115' ' ' THR . 28.2 tt0 -54.51 145.55 18.32 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.686 1.194 . . . . 74.34 112.107 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 114.8 15.74 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.065 -1.087 . . . . 71.43 108.065 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -100.78 93.24 5.46 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.12 -0.696 . . . . 72.32 109.12 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.584 HD22 HD22 ' D' ' 42' ' ' LEU . 89.0 mt -59.0 115.48 3.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.25 0.62 . . . . 72.23 110.92 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -65.3 127.84 93.26 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.773 0.429 . . . . 74.54 111.867 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.28 102.01 1.52 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 75.05 110.399 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.01 130.0 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.537 -0.756 . . . . 73.2 109.71 -174.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.4 -0.963 . . . . 75.24 108.4 173.853 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.7 m . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 109.52 -0.548 . . . . 75.3 109.52 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.473 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 65.3 t80 -128.13 147.35 50.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.053 0.941 . . . . 72.2 109.676 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -158.93 137.37 10.8 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 120.74 0.305 . . . . 75.25 111.394 173.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' C' ' 132' ' ' ASN . 13.5 mm -74.78 118.73 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.427 -0.953 . . . . 72.52 108.427 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -89.25 -38.39 14.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.685 -0.487 . . . . 74.1 109.685 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.98 153.24 4.64 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 123.39 0.432 . . . . 74.01 111.259 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' C' ' 130' ' ' PRO . 98.3 mt -137.02 126.68 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.731 1.613 . . . . 54.25 106.814 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -154.61 157.11 37.71 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.461 1.104 . . . . 70.0 109.598 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.56 HG21 ' SG ' ' A' ' 113' ' ' CYS . 45.3 p -86.99 117.17 25.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.881 -0.785 . . . . 71.31 108.881 170.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 42.0 mtpt -83.56 -22.35 32.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.43 0.292 . . . . 71.03 110.284 173.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.4 t70 -153.8 140.02 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.681 -0.691 . . . . 75.22 109.667 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 40.8 mt -136.64 133.18 48.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.953 -1.499 . . . . 73.32 106.953 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -145.37 107.59 4.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.156 -0.683 . . . . 33.42 109.156 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.2 t80 -119.25 110.32 16.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.872 -1.529 . . . . 73.13 106.872 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 40.6 mt-10 -116.95 108.21 15.5 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.756 -1.572 . . . . 70.4 106.756 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.68 83.05 0.72 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 106.946 -1.502 . . . . 72.12 106.946 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 13.7 Cg_exo -68.69 -31.63 25.57 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.726 2.284 . . . . 72.35 111.704 -168.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 27.7 m-80 -118.24 39.99 3.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.059 -0.973 . . . . 61.43 108.807 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.23 -50.0 87.17 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.083 -0.962 . . . . 75.11 113.203 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 -24.67 22.33 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 121.775 1.65 . . . . 45.12 113.132 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -69.76 -24.45 63.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.408 0.683 . . . . 70.02 111.802 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG11 ' HE1' ' A' ' 123' ' ' PHE . 88.6 t -57.21 -33.26 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.401 0.68 . . . . 43.34 111.465 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -64.05 -32.13 73.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.748 0.819 . . . . 72.41 111.224 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -80.49 -27.04 37.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.352 1.061 . . . . 64.23 110.255 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -82.67 162.07 21.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 75.33 112.362 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.92 129.29 34.72 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.363 -1.347 . . . . 71.21 107.363 163.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.1 t-105 -77.32 84.17 3.76 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.745 0.784 . . . . 72.35 110.329 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -132.01 77.11 72.34 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.204 -1.406 . . . . 74.14 107.204 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.8 146.17 37.59 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.102 1.868 . . . . 64.34 112.077 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -96.34 86.12 4.12 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.39 -1.708 . . . . 75.15 106.39 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.01 102.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.54 -1.209 . . . . 62.54 110.823 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -111.49 146.18 37.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.918 0.887 . . . . 73.31 110.184 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.01 153.19 37.68 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.76 0.824 . . . . 62.51 110.659 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.0 t70 -142.9 113.82 7.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.883 0.873 . . . . 54.21 108.66 174.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -98.84 119.97 38.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.5 -0.926 . . . . 45.04 108.5 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.3 142.87 39.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 74.44 109.952 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -110.03 144.76 38.13 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.817 0.847 . . . . 70.4 108.815 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.34 113.63 12.81 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.077 -1.083 . . . . 23.44 108.077 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 35.5 p -88.04 151.02 23.06 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.268 0.627 . . . . 64.32 111.062 -172.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.0 t -163.0 136.72 5.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.207 1.003 . . . . 64.11 109.098 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.64 124.53 52.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.029 0.531 . . . . 72.22 109.75 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.82 -43.16 12.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.33 0.652 . . . . 73.4 110.055 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.28 175.43 13.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.638 -1.164 . . . . 73.42 109.676 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.06 119.1 11.44 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.609 -0.886 . . . . 74.42 108.609 173.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 78.26 -7.66 1.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.778 1.631 . . . . 72.21 113.19 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.83 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.786 -1.19 . . . . 74.21 107.786 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' A' ' 48' ' ' SER . 9.3 t80 -117.24 155.33 29.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.844 -0.798 . . . . 71.14 108.844 -171.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -127.23 113.77 16.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.315 -0.994 . . . . 71.04 108.315 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.09 117.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.863 -1.532 . . . . 71.14 106.863 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.6 t -98.36 131.87 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -102.12 112.27 24.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.261 -1.385 . . . . 72.11 107.261 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -101.87 99.98 10.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.439 -0.948 . . . . 75.24 108.439 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -98.0 132.94 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.991 -1.114 . . . . 74.34 107.991 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 18.7 m -128.77 137.69 51.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.169 0.509 . . . . 72.32 110.096 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.729 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.3 t -130.94 125.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.354 1.462 . . . . 61.44 108.695 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -118.58 150.64 39.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.684 0.394 . . . . 71.44 110.097 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.02 112.17 8.02 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.593 -0.892 . . . . 64.23 108.593 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -113.01 126.39 55.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.356 0.598 . . . . 64.34 110.411 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.0 mt -89.18 75.6 7.82 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.025 1.33 . . . . 71.21 108.652 175.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -82.91 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 111.07 -0.812 . . . . 45.23 111.07 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 -19.1 5.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.457 1.103 . . . . 71.24 111.742 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.68 126.94 36.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.031 0.933 . . . . 70.31 109.305 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -77.16 127.59 32.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.148 0.885 . . . . 74.44 110.388 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -77.9 -55.74 5.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.081 0.952 . . . . 71.33 108.818 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -157.66 169.34 24.88 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.895 -1.502 . . . . 72.12 110.429 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 tp -141.17 138.11 33.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.39 -1.277 . . . . 64.44 108.164 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.2 m -128.82 140.6 51.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.038 0.935 . . . . 73.32 109.531 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -149.42 133.53 17.23 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.388 -0.967 . . . . 74.24 108.388 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.81 110.52 12.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.504 -0.924 . . . . 74.43 108.504 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.2 mt-30 -88.88 79.57 7.33 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.147 -1.057 . . . . 75.53 108.147 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.06 92.77 3.21 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.032 -0.985 . . . . 75.13 108.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.47 146.48 20.88 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.363 -0.38 . . . . 72.11 112.704 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.1 135.89 6.72 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.789 0.295 . . . . 64.53 112.409 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.7 mt -82.27 126.92 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.332 -0.988 . . . . 74.23 108.332 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.464 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.1 m-85 -133.18 121.0 21.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.876 -0.787 . . . . 71.45 108.876 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -78.31 113.36 16.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.644 -0.873 . . . . 41.45 108.644 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.31 133.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.559 0.744 . . . . 65.14 110.188 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.04 144.84 14.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.804 0.841 . . . . 75.41 109.698 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.37 9.21 86.79 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.783 0.677 . . . . 65.43 113.961 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' SD ' ' A' ' 94' ' ' MET . 0.9 OUTLIER -109.89 131.44 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.124 -0.695 . . . . 73.13 109.124 -173.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -147.22 176.33 10.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.073 0.949 . . . . 53.24 109.727 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 -114.98 3.89 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 124.185 0.928 . . . . 71.13 113.994 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.2 p -82.3 -27.29 32.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.51 1.124 . . . . 60.34 111.17 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -71.57 -42.55 67.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.896 0.879 . . . . 63.32 110.523 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.635 ' SD ' HD13 ' A' ' 89' ' ' ILE . 10.6 tpt -78.52 -34.65 47.15 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.174 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.06 -29.18 70.34 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.004 0.43 . . . . 52.13 111.313 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -70.71 -56.16 7.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.295 -0.866 . . . . 74.43 109.709 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 77.3 m -65.48 -65.53 0.66 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 123.867 0.729 . . . . 52.32 111.978 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.04 -33.73 76.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.334 1.053 . . . . 73.13 112.114 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.9 -37.26 9.44 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.66 0.624 . . . . 50.15 114.66 -170.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.31 -50.38 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 117.948 0.874 . . . . 64.44 113.348 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 90.1 t80 -68.06 -63.14 1.12 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.435 0.694 . . . . 71.21 111.7 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -61.81 -37.49 40.25 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 123.748 0.819 . . . . 63.44 113.209 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.84 -49.82 16.0 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.217 1.945 . . . . 62.11 113.081 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -73.93 -15.65 61.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.429 0.692 . . . . 73.34 112.007 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 13' ' ' ILE . 48.1 mm -62.14 -42.67 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.731 0.777 . . . . 64.33 109.505 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 60' ' ' LEU . 52.3 mt -75.31 -21.62 58.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.423 -1.262 . . . . 73.12 112.156 -173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -67.05 -40.65 30.23 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 114.429 1.27 . . . . 74.12 114.429 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.27 -41.31 77.88 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.173 1.915 . . . . 75.34 112.813 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -72.95 -36.85 67.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.493 0.717 . . . . 71.44 110.976 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.46 94.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.471 0.708 . . . . 75.4 109.944 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 44.6 ttm105 -55.6 -48.98 73.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.618 1.199 . . . . 62.14 110.798 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -45.25 90.99 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.837 0.711 . . . . 64.12 110.301 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.56 ' SG ' HG21 ' A' ' 18' ' ' THR . 42.1 t -61.37 -24.41 66.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.338 -0.846 . . . . 52.32 112.468 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 64' ' ' VAL . 94.9 mt -85.02 -53.0 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.574 0.749 . . . . 62.24 110.002 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -55.3 -40.95 71.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.67 1.188 . . . . 74.01 112.216 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.2 t -60.98 -45.55 94.35 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.025 -0.989 . . . . 73.02 111.025 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.667 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.9 mtm -64.4 -46.03 85.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.389 0.675 . . . . 74.25 111.313 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -58.5 -51.02 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.572 -1.195 . . . . 75.0 110.846 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 24.1 t -68.05 -25.86 65.57 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.195 -0.912 . . . . 61.13 111.419 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -78.83 -26.0 44.18 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.421 1.088 . . . . 74.55 110.657 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 13.0 54.14 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-N 115.698 -0.683 . . . . 73.32 112.618 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.512 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 7.0 m 67.98 40.31 2.31 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 124.792 1.237 . . . . 74.33 110.336 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.45 ' HE1' HG11 ' A' ' 31' ' ' VAL . 48.0 m-85 -119.37 157.15 52.14 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.647 -1.161 . . . . 75.34 108.782 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.37 148.47 61.18 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.155 1.904 . . . . 62.44 111.298 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.6 tt0 -60.01 139.89 57.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.525 0.73 . . . . 75.12 111.413 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.3 114.75 15.41 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.89 -0.781 . . . . 73.02 108.89 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -109.9 105.77 15.08 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.53 128.32 35.16 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.082 -0.71 . . . . 51.24 109.082 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.8 97.45 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.516 0.727 . . . . 50.42 111.01 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.56 143.99 35.18 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.237 1.958 . . . . 54.21 110.978 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.55 109.68 25.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.042 -1.466 . . . . 64.22 107.042 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -99.95 74.7 1.82 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.402 -1.332 . . . . 65.41 107.402 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.474 0.733 0 CA-C-N 114.419 -1.264 . . . . 75.11 110.439 179.819 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 18.9 p . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 106.979 -1.489 . . . . 74.22 106.979 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -124.5 113.17 17.75 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.997 -0.742 . . . . 73.53 108.997 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.52 130.45 34.63 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.969 -0.752 . . . . 72.43 108.969 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.543 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -85.36 120.34 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.633 -1.247 . . . . 73.4 107.633 178.394 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -90.3 -42.47 10.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 75.21 110.451 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.512 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 48.3 ttt180 -168.5 137.41 2.28 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.041 -0.527 . . . . 64.42 109.728 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.543 HG13 HD11 ' B' ' 13' ' ' ILE . 69.4 mt -113.33 133.98 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.468 -1.678 . . . . 71.53 106.468 168.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.458 ' HE1' HG13 ' B' ' 83' ' ' ILE . 29.9 p90 -164.85 146.81 8.11 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.013 0.82 . . . . 74.02 110.973 -173.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.4 m -74.9 121.92 22.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.403 -0.817 . . . . 75.14 109.707 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -93.99 -31.66 14.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.335 0.654 . . . . 73.33 110.907 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.6 t70 -153.03 141.16 20.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.689 -0.687 . . . . 63.03 110.409 -170.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.483 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 36.0 mm -136.96 142.92 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.551 1.54 . . . . 61.22 107.831 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -148.1 133.62 18.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.222 -1.029 . . . . 34.25 108.222 172.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -150.41 127.73 11.36 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.334 -1.358 . . . . 75.25 107.334 169.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.24 155.97 41.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.523 1.129 . . . . 64.43 108.507 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -149.34 79.86 8.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.597 -1.26 . . . . 71.32 107.597 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.75 -23.44 30.83 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.989 2.459 . . . . 62.23 112.3 -173.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 93.1 m-20 -124.97 31.11 5.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.194 0.998 . . . . 72.31 109.854 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.573 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.6 -47.91 69.67 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 124.967 1.307 . . . . 70.15 113.772 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.47 -23.05 10.29 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.024 1.816 . . . . 72.32 113.551 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 69.4 m-70 -78.42 3.45 15.77 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.973 0.909 . . . . 72.4 112.894 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.38 -18.88 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 123.425 0.69 . . . . 73.21 111.192 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -83.48 -28.06 29.0 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.894 0.477 . . . . 65.4 110.344 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.78 -42.48 70.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.12 0.968 . . . . 74.24 109.866 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.72 113.07 26.31 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.322 1.049 . . . . 54.21 109.53 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -72.9 80.78 1.17 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.166 0.586 . . . . 73.2 110.221 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -170.02 151.35 4.01 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.044 -1.095 . . . . 74.43 108.044 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -95.0 127.86 41.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.547 -0.74 . . . . 64.44 109.651 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.518 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 25.1 Cg_endo -60.02 121.97 10.65 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.995 2.463 . . . . 63.23 112.169 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 109.25 2.61 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.784 0.677 . . . . 74.42 109.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' B' ' 125' ' ' GLN . 6.2 t -85.5 117.16 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.054 -0.721 . . . . 75.23 109.054 -168.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -136.28 144.22 44.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.291 0.636 . . . . 61.13 110.465 -169.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.477 HD23 ' N ' ' B' ' 43' ' ' ASP . 8.6 tt -126.45 152.49 46.34 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.069 0.948 . . . . 74.13 109.874 -164.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.477 ' N ' HD23 ' B' ' 42' ' ' LEU . 29.5 t70 -137.11 140.85 42.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.753 1.221 . . . . 65.33 110.04 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.16 127.97 56.09 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.058 0.943 . . . . 60.2 109.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -140.62 152.76 45.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.865 1.266 . . . . 70.11 108.984 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.5 m -145.62 134.4 22.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.007 0.523 . . . . 52.11 110.601 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.66 162.97 30.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.071 1.348 . . . . 63.13 108.894 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.1 m -135.62 163.39 30.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.922 0.489 . . . . 74.23 110.369 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.37 139.21 18.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.888 0.875 . . . . 74.22 109.025 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -82.07 132.05 35.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.476 0.711 . . . . 71.14 109.408 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.0 mt -89.58 -53.08 4.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.792 -0.818 . . . . 64.3 108.792 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.39 -172.36 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.424 -0.807 . . . . 74.35 110.6 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.39 116.84 7.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.319 -0.855 . . . . 72.33 110.078 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 65.12 13.2 8.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.028 1.731 . . . . 75.23 112.602 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.29 100.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.232 1.013 . . . . 75.13 108.603 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -97.28 165.95 11.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.608 0.718 . . . . 75.4 109.847 171.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -144.61 104.63 4.06 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.316 -1.364 . . . . 73.44 107.316 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.63 123.4 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.711 0.804 . . . . 72.31 109.507 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.2 t -105.54 120.82 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 75.51 109.8 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.3 119.82 34.47 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.909 -1.145 . . . . 75.42 107.909 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -107.9 110.3 22.02 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.294 0.638 . . . . 73.22 110.394 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.2 115.15 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.237 -1.023 . . . . 34.02 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -110.68 129.37 55.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.941 0.497 . . . . 73.3 109.862 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.568 HG21 HG21 ' B' ' 114' ' ' ILE . 54.5 t -119.36 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.274 1.03 . . . . 74.02 110.317 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 37.7 m -114.7 150.56 35.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 74.33 109.726 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -147.28 146.78 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.232 -1.025 . . . . 71.34 108.232 167.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -148.2 139.48 23.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.351 0.596 . . . . 63.41 111.476 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 46.8 mt -113.42 118.4 34.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.329 1.051 . . . . 71.52 109.348 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.52 -111.92 3.77 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.864 0.728 . . . . 44.4 112.605 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 4.89 21.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.71 0.804 . . . . 75.31 111.712 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -139.21 175.48 9.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.604 0.362 . . . . 72.55 110.84 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -69.69 150.0 47.45 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.196 0.998 . . . . 75.32 111.0 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.401 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -105.89 -57.4 2.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.987 -1.116 . . . . 71.04 107.987 169.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.447 ' HZ ' HG13 ' B' ' 40' ' ' VAL . 5.5 p90 -147.41 159.66 43.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.574 -1.193 . . . . 73.02 109.575 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.8 mt -127.55 157.99 38.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.163 1.385 . . . . 73.43 108.67 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' B' ' 114' ' ' ILE . 16.4 t -156.77 158.05 36.15 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.495 -0.557 . . . . 40.21 109.495 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.54 132.55 2.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.622 1.169 . . . . 71.24 108.236 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' B' ' 21' ' ' ILE . 56.0 t -128.11 147.36 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.036 -0.727 . . . . 75.33 109.036 174.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 19.5 mt-30 -126.8 93.3 3.74 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.883 0.849 . . . . 75.21 109.291 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -86.11 100.25 12.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.59 -1.641 . . . . 73.34 109.65 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.65 164.48 26.64 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 111.966 -0.454 . . . . 72.44 111.966 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.25 126.24 1.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.047 -0.821 . . . . 71.31 111.047 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.458 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.3 mt -84.56 127.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.369 -0.975 . . . . 74.05 108.369 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.66 131.5 39.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.148 -1.427 . . . . 72.33 107.148 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -96.25 102.53 14.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.551 -0.907 . . . . 61.14 108.551 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' B' ' 10' ' ' THR . 2.8 pp -122.94 139.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 115.669 -0.696 . . . . 75.11 110.584 -175.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.65 173.66 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.076 1.351 . . . . 51.3 107.852 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.03 -51.12 2.83 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 122.633 0.159 . . . . 74.13 112.893 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.532 HD13 ' HG2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -51.28 143.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.958 0.903 . . . . 71.44 111.178 172.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 144.26 24.82 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.644 -0.502 . . . . 74.0 109.644 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.25 -110.9 3.54 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 124.518 1.136 . . . . 73.2 113.335 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -64.13 -47.79 78.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.297 0.639 . . . . 75.34 110.046 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.505 ' HB3' HG22 ' B' ' 89' ' ' ILE . 89.1 mt-30 -63.58 -35.3 80.04 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 124.664 1.227 . . . . 75.35 111.484 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.532 ' HG2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -67.25 -56.8 8.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.364 -0.835 . . . . 71.11 110.24 -177.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -16.66 61.85 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.169 -0.923 . . . . 71.31 111.673 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -73.05 -39.17 66.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.098 0.959 . . . . 73.1 109.795 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -67.6 -63.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.102 -0.953 . . . . 54.32 110.969 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -77.82 -15.18 59.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 122.126 -0.359 . . . . 75.15 111.736 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.06 35.81 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.508 0.505 . . . . 61.43 113.711 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.55 -44.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.344 0.572 . . . . 64.43 112.535 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.97 -47.88 70.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.435 0.694 . . . . 73.11 112.282 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m -65.28 -50.49 59.11 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 123.583 0.753 . . . . 64.42 111.87 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.73 -24.09 55.2 Favored 'Trans proline' 0 C--N 1.398 3.162 0 C-N-CA 121.568 1.512 . . . . 55.22 113.291 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.06 -36.86 85.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.364 0.602 . . . . 75.43 110.904 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.412 HG23 ' NH2' ' D' ' 111' ' ' ARG . 66.7 mt -61.05 -46.7 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.61 1.164 . . . . 75.33 110.564 173.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.52 -10.95 58.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.491 -1.231 . . . . 63.52 111.701 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -63.28 -52.18 63.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.587 1.155 . . . . 71.15 113.153 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.9 -31.88 66.8 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 121.772 1.648 . . . . 74.52 112.964 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.472 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.7 m-85 -63.81 -51.11 66.23 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.912 0.485 . . . . 74.24 110.845 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.53 91.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.288 1.035 . . . . 72.12 111.72 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -58.29 -63.07 1.4 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.197 0.936 . . . . 70.11 109.419 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.49 -29.2 66.07 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.207 1.003 . . . . 73.51 111.311 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.483 ' SG ' ' CD1' ' B' ' 21' ' ' ILE . 23.9 t -62.87 -60.22 3.77 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.473 0.709 . . . . 45.33 112.307 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.699 HG23 ' SG ' ' B' ' 76' ' ' CYS . 85.3 mt -57.82 -44.57 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.084 0.954 . . . . 73.52 110.388 176.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.572 HG23 ' HB3' ' B' ' 125' ' ' GLN . 22.8 m -64.61 -25.3 67.9 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.463 -1.699 . . . . 54.33 111.435 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -80.52 -31.38 37.12 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.469 0.708 . . . . 62.33 110.839 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.4 mmt -71.65 -42.71 67.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.224 0.609 . . . . 62.42 111.647 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' B' ' 125' ' ' GLN . 96.4 t -73.91 -27.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.532 0.733 . . . . 61.04 110.615 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.428 ' OG ' HG21 ' C' ' 115' ' ' THR . 34.0 t -56.94 -34.52 68.08 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.8 0.84 . . . . 61.45 111.063 171.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.481 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 53.3 mtt-85 -80.12 -35.54 36.58 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.85 -1.068 . . . . 74.12 110.359 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.68 1.69 36.19 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.849 0.718 . . . . 60.23 112.597 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 70.22 25.26 4.63 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 127.115 2.166 . . . . 73.24 113.598 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.434 ' O ' HG12 ' B' ' 118' ' ' VAL . 65.2 m-85 -120.32 149.12 48.95 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.765 0.826 . . . . 71.11 109.253 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.03 101.73 1.17 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.674 2.249 . . . . 75.43 112.303 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.717 ' HA ' HG11 ' B' ' 40' ' ' VAL . 0.0 OUTLIER -65.15 157.17 29.42 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.047 -0.978 . . . . 74.51 110.096 170.2 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 44.7 tp -110.11 129.34 55.71 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.406 1.882 . . . . 60.12 108.296 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.98 125.61 32.84 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 106.548 -1.649 . . . . 73.24 106.548 173.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.426 ' HG ' HD22 ' B' ' 42' ' ' LEU . 0.9 OUTLIER -52.73 134.33 36.38 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.877 1.361 . . . . 74.53 109.08 -175.326 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -38.35 103.02 0.26 Allowed Pre-proline 0 C--N 1.361 1.095 0 O-C-N 125.824 1.953 . . . . 74.34 111.236 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.487 ' HG3' HG21 ' C' ' 122' ' ' THR . 57.1 Cg_endo -67.89 99.76 0.57 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.516 2.144 . . . . 65.14 110.843 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -147.94 115.18 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.455 -1.313 . . . . 72.43 107.455 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.91 103.1 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.683 -1.228 . . . . 43.32 107.683 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 CA--C 1.552 1.027 0 C-N-CA 124.41 1.084 . . . . 73.5 111.937 -177.552 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.745 -0.465 . . . . 65.12 109.745 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.758 ' HA ' HG22 ' C' ' 86' ' ' ILE . 46.7 t80 -118.69 124.58 47.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.38 0.672 . . . . 73.44 109.673 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -139.35 124.94 19.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.328 0.651 . . . . 54.44 109.471 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.578 HD11 HG13 ' C' ' 16' ' ' ILE . 6.0 tp -82.01 134.19 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.945 -0.761 . . . . 75.21 108.945 170.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.554 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.7 mm100 -97.82 -51.43 4.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.281 0.632 . . . . 71.15 109.986 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.58 HH11 ' HD1' ' D' ' 32' ' ' PHE . 34.3 ttt180 -176.07 126.83 0.21 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.57 -0.741 . . . . 70.04 110.055 -166.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.578 HG13 HD11 ' C' ' 13' ' ' ILE . 97.4 mt -113.32 135.0 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.762 0.825 . . . . 71.42 108.847 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.754 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.1 p90 -169.74 153.99 5.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.24 0.543 . . . . 63.33 110.067 -174.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -74.75 115.08 13.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.966 -1.016 . . . . 73.24 109.976 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -66.09 -39.32 89.92 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.819 -0.808 . . . . 75.14 108.819 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -151.44 147.48 26.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.448 -1.251 . . . . 53.11 110.434 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -136.34 145.08 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.053 1.741 . . . . 73.43 106.789 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -154.7 148.82 25.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.987 0.422 . . . . 75.22 110.269 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -153.58 108.61 3.16 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.584 -1.265 . . . . 75.0 107.584 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -117.57 121.33 40.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.571 0.748 . . . . 71.21 109.687 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.82 85.93 56.57 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.472 1.109 . . . . 65.01 108.533 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.68 -16.58 16.54 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.56 2.173 . . . . 71.41 112.006 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' C' ' 30' ' ' HIS . 0.2 OUTLIER -99.51 19.64 15.31 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.933 1.293 . . . . 73.5 108.949 178.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.638 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -54.37 -52.13 71.95 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.332 1.053 . . . . 74.12 113.487 -172.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 6.2 Cg_exo -80.35 -31.31 1.68 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.923 1.749 . . . . 65.52 112.915 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.458 ' HB3' ' ND2' ' C' ' 27' ' ' ASN . 52.1 t-80 -70.22 -30.8 67.97 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.425 1.09 . . . . 75.13 112.827 -173.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.26 -17.62 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.78 0.832 . . . . 73.15 111.796 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -59.79 -32.0 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.621 0.768 . . . . 75.3 111.781 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.63 6.48 34.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.613 0.765 . . . . 71.35 111.875 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.841 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.14 143.25 38.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.446 0.699 . . . . 73.12 110.205 -176.455 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 129.65 39.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.548 -0.908 . . . . 74.2 108.548 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -84.61 84.41 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.736 0.779 . . . . 73.31 111.808 -165.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -132.42 78.64 67.37 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 114.44 -1.255 . . . . 74.21 108.082 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' C' ' 67' ' ' SER . 5.6 Cg_exo -82.79 146.44 13.16 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.647 2.231 . . . . 54.43 112.455 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -85.79 109.83 18.94 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.403 -1.332 . . . . 70.21 107.403 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 t -78.54 97.4 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 124.378 1.049 . . . . 61.43 109.44 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 92.9 mttt -99.45 104.28 16.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.579 0.752 . . . . 51.1 109.552 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.66 129.81 45.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.703 -0.851 . . . . 74.4 108.703 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -131.63 137.2 48.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.687 0.795 . . . . 73.24 109.201 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.57 113.78 20.27 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.988 -0.745 . . . . 64.12 108.988 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.54 143.77 43.98 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.195 -0.669 . . . . 62.13 109.195 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -114.64 128.3 56.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 73.02 110.842 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 161.93 19.36 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.983 1.313 . . . . 74.25 108.615 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.6 p -153.32 150.36 28.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.024 0.53 . . . . 75.41 111.137 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -146.0 143.02 29.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.663 1.185 . . . . 63.54 108.981 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -101.16 115.43 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.212 -1.403 . . . . 75.21 107.212 166.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 HD12 ' C' ' 83' ' ' ILE . 32.8 mt -87.43 -28.02 22.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.053 0.541 . . . . 72.4 109.944 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.5 -174.95 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.587 1.155 . . . . 62.23 109.442 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 120.73 12.43 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.261 -0.881 . . . . 74.13 109.077 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 65.76 7.06 4.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.893 1.277 . . . . 64.41 112.822 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.26 107.72 23.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.568 -1.271 . . . . 72.23 107.568 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -107.76 148.76 29.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.238 1.015 . . . . 64.23 109.591 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -128.13 110.37 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.183 -0.917 . . . . 75.2 108.796 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -100.14 125.63 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.654 -1.61 . . . . 60.44 106.654 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.54 104.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.453 -0.943 . . . . 50.41 108.453 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -91.78 104.54 16.97 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.029 -1.101 . . . . 72.01 108.029 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 16.4 mtm180 -84.18 137.49 33.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.657 -1.156 . . . . 75.25 108.425 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -126.94 132.28 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.873 -1.158 . . . . 74.33 107.873 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -121.73 122.51 39.71 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.986 -0.746 . . . . 73.02 108.986 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.533 HG23 HD13 ' C' ' 114' ' ' ILE . 71.1 t -110.84 111.48 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.9 m -100.1 146.12 27.17 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.679 -0.86 . . . . 63.13 108.679 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.96 124.72 33.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.101 -1.074 . . . . 64.35 108.101 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.2 m -126.61 168.54 14.17 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.895 0.878 . . . . 51.42 109.255 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.841 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.9 mt -128.89 26.42 5.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.378 1.071 . . . . 71.21 108.912 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.06 -92.8 0.68 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.74 -1.344 . . . . 73.4 109.74 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 -13.57 16.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.002 0.921 . . . . 75.11 111.12 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.25 120.57 40.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.984 0.913 . . . . 74.04 109.689 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -70.65 132.3 45.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.017 0.372 . . . . 62.41 110.673 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -51.65 7.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.151 -0.685 . . . . 61.43 109.151 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -169.79 177.48 4.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.787 0.835 . . . . 71.52 111.167 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.455 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -134.02 146.89 50.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.745 1.218 . . . . 50.54 107.91 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.2 t -150.67 145.55 25.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.789 0.836 . . . . 74.24 109.381 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.09 136.35 15.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.362 0.665 . . . . 62.43 109.529 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -130.48 114.77 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.027 0.931 . . . . 74.02 108.964 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 15.1 mt-30 -91.63 96.16 10.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.688 -0.856 . . . . 65.13 108.688 176.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.596 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -87.77 111.93 21.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.9 0.48 . . . . 72.54 110.598 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.92 146.93 18.36 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 112.044 -0.422 . . . . 52.44 112.044 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.05 123.8 2.1 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 110.198 -1.161 . . . . 61.35 110.198 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.7 mm -92.36 125.31 44.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.8 -1.185 . . . . 65.33 107.8 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.87 119.68 26.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.486 -0.931 . . . . 75.2 108.486 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -89.31 97.48 11.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.408 -1.33 . . . . 44.13 107.408 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.758 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.2 pp -135.89 137.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 115.753 -0.658 . . . . 70.42 110.151 -170.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.29 166.08 32.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.926 0.89 . . . . 54.12 110.605 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -26.27 7.81 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.812 -0.631 . . . . 52.15 113.103 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.709 HG12 ' HG2' ' C' ' 94' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 124.401 1.08 . . . . 73.04 110.08 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.598 -0.519 . . . . 74.55 109.598 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.709 ' HG2' HG12 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -67.18 -50.52 60.76 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.583 -1.19 . . . . 73.43 109.026 178.516 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.86 77.64 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.162 0.985 . . . . 63.42 112.988 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -73.04 -39.11 66.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 63.44 110.494 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.4 t -73.47 -34.75 65.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.163 0.585 . . . . 72.04 110.974 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.406 HD22 ' SD ' ' C' ' 94' ' ' MET . 47.0 tp -86.31 -56.93 3.21 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.571 1.148 . . . . 72.13 111.687 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.49 11.39 68.67 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.869 -0.605 . . . . 51.23 114.554 -168.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -56.25 0.23 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.458 0.629 . . . . 74.11 111.215 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -66.72 -60.06 3.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.303 0.641 . . . . 71.01 111.989 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.36 -47.8 98.13 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.05 0.94 . . . . 62.43 113.159 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.73 -20.05 35.47 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.975 1.783 . . . . 71.23 113.356 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.26 -22.68 47.95 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.406 0.682 . . . . 61.11 110.467 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.47 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.0 mm -69.91 -33.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.082 0.553 . . . . 54.12 109.52 169.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.7 mt -89.9 -25.15 21.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.085 0.954 . . . . 72.23 112.613 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -58.45 -45.38 99.69 Favored Pre-proline 0 CA--C 1.558 1.253 0 CA-C-O 117.859 -1.067 . . . . 72.12 113.136 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.41 -43.67 56.58 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.112 1.875 . . . . 53.32 112.633 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -63.37 -44.84 93.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.051 0.54 . . . . 75.13 111.569 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -73.21 -37.2 66.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.065 -0.516 . . . . 62.14 111.682 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.95 -58.51 7.08 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 124.258 0.974 . . . . 73.22 108.97 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.68 66.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.222 1.409 . . . . 65.33 112.631 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 17.0 t -74.73 -38.71 62.21 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.048 0.539 . . . . 73.32 111.95 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.56 HG23 ' SG ' ' C' ' 76' ' ' CYS . 93.3 mt -67.14 -47.23 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 123.59 0.756 . . . . 73.22 109.737 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.663 HG23 ' HB3' ' C' ' 125' ' ' GLN . 91.8 m -56.61 -37.45 70.7 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.435 -1.257 . . . . 74.12 111.359 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.1 t -62.84 -49.28 75.51 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 114.91 -1.041 . . . . 61.32 110.251 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.624 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.73 -35.67 70.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.176 0.991 . . . . 73.15 112.96 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.78 -45.61 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.078 0.551 . . . . 70.34 110.414 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 54.1 p -70.48 -26.44 63.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.661 -0.7 . . . . 74.44 111.02 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.9 mtt-85 -66.6 -33.79 76.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 72.34 110.595 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.96 11.55 47.54 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.945 0.778 . . . . 42.42 112.826 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.664 HG23 ' HB3' ' D' ' 17' ' ' TYR . 43.9 p 57.93 28.2 15.79 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.826 2.05 . . . . 74.02 112.485 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -102.04 150.26 37.29 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.826 0.85 . . . . 73.04 108.899 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.5 130.74 31.02 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.029 2.486 . . . . 72.14 110.708 175.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.663 ' HB3' HG23 ' C' ' 115' ' ' THR . 37.6 mt-30 -61.01 153.74 24.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.167 0.987 . . . . 64.22 113.001 -170.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.43 67.42 0.84 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.348 -0.842 . . . . 53.11 109.704 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.527 ' HB3' HG21 ' C' ' 115' ' ' THR . 1.9 p-10 -90.69 80.99 5.86 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.407 -1.331 . . . . 65.43 107.407 167.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.24 103.89 15.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.866 -1.515 . . . . 71.33 110.607 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.11 155.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.385 1.624 . . . . 42.24 115.385 166.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.563 ' HG3' ' H ' ' A' ' 16' ' ' ILE . 69.5 Cg_endo -91.29 102.89 0.25 Allowed 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.774 2.316 . . . . 73.02 111.317 161.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 t -82.45 79.93 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.01 -0.737 . . . . 61.45 109.01 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 132' ' ' ASN . . . . . 0.518 ' HB3' HG13 ' A' ' 13' ' ' ILE . 12.4 t30 -82.16 107.19 14.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.454 -0.794 . . . . 73.4 109.378 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 CA--C 1.552 1.045 0 C-N-CA 125.195 1.398 . . . . 75.01 112.899 -172.207 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.425 -0.583 . . . . 64.34 109.425 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.515 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 76.6 t80 -159.39 89.57 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.441 -1.318 . . . . 73.44 107.441 171.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.8 142.85 45.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.227 1.011 . . . . 70.41 108.468 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -103.06 110.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.085 0.554 . . . . 53.4 110.963 -170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.92 -43.48 22.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.81 0.444 . . . . 64.33 111.577 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.429 ' HD2' ' HG2' ' B' ' 130' ' ' PRO . 6.2 tpt180 -166.32 148.61 6.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.038 0.384 . . . . 62.31 112.038 -165.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.86 128.39 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.986 -1.116 . . . . 74.3 107.986 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.664 ' HB3' HG23 ' C' ' 122' ' ' THR . 11.4 p90 -163.32 164.01 24.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.584 0.706 . . . . 73.5 111.41 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -77.93 107.94 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.588 -1.187 . . . . 52.41 109.642 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 46.8 mtpt -77.23 -35.82 55.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.114 -0.494 . . . . 75.21 109.727 173.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -145.03 136.79 25.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.034 -0.984 . . . . 74.23 109.229 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.624 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.1 mt -135.06 145.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.427 1.091 . . . . 75.52 108.371 175.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -149.32 132.43 16.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.989 -1.005 . . . . 64.31 108.606 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.3 t80 -137.01 117.49 13.75 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 106.333 -1.729 . . . . 74.45 106.333 167.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.23 133.61 54.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.729 -0.841 . . . . 72.21 108.729 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.54 84.66 19.35 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.214 -1.402 . . . . 62.23 107.214 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.87 -38.8 56.33 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.665 2.243 . . . . 72.1 112.295 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 25.3 m-80 -114.38 31.18 6.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.165 0.986 . . . . 74.24 109.275 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.754 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -35.16 -55.64 1.0 Allowed Pre-proline 0 CA--C 1.588 2.411 0 N-CA-C 117.487 2.403 . . . . 64.42 117.487 -172.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.87 -12.88 8.3 Favored 'Trans proline' 0 C--N 1.399 3.198 0 CA-C-N 122.595 1.963 . . . . 64.23 114.512 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -74.42 -35.69 63.4 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.423 1.089 . . . . 75.32 109.762 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.647 HG13 HD12 ' D' ' 68' ' ' LEU . 72.3 t -70.43 -34.26 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.527 1.131 . . . . 75.14 110.938 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.58 ' HD1' HH11 ' C' ' 15' ' ' ARG . 3.4 t80 -48.67 -36.68 16.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.446 1.499 . . . . 72.34 112.342 171.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -81.41 7.83 10.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.111 0.964 . . . . 75.44 113.116 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.565 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 86.8 mttt -121.66 114.3 20.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.534 0.734 . . . . 74.12 110.164 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -95.82 73.62 3.09 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.109 -0.7 . . . . 74.23 109.109 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.67 ' HB2' HD22 ' D' ' 68' ' ' LEU . 6.7 m95 -125.8 157.43 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.05 -1.833 . . . . 73.13 106.05 174.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -77.79 113.18 30.19 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.826 0.739 . . . . 71.12 109.258 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.404 ' HG3' HD21 ' D' ' 68' ' ' LEU . 44.6 Cg_exo -58.74 107.1 0.32 Allowed 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.963 2.442 . . . . 65.34 112.517 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.65 112.32 3.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.474 1.109 . . . . 71.52 108.736 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.8 113.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 122.205 1.002 . . . . 70.32 108.527 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 71.6 mmtt -92.71 120.48 33.15 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.633 -1.247 . . . . 75.12 107.633 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.48 HD21 HD22 ' D' ' 128' ' ' LEU . 7.3 mp -94.58 121.65 36.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.602 -0.518 . . . . 72.32 109.602 -175.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 6.5 t70 -111.22 135.56 51.57 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.045 -1.465 . . . . 72.32 107.045 169.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -130.77 130.17 43.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.532 -0.914 . . . . 74.0 108.532 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.46 153.72 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.753 -1.203 . . . . 51.33 107.753 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -143.57 149.19 37.04 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.218 -0.66 . . . . 64.43 109.218 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.1 167.54 25.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.095 -0.957 . . . . 41.41 108.458 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -155.13 156.65 36.16 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.937 0.399 . . . . 60.23 110.445 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -155.09 139.45 16.73 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.104 0.962 . . . . 64.21 109.143 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -76.84 129.01 35.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.672 0.389 . . . . 65.01 110.037 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -97.69 -39.25 9.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.975 0.51 . . . . 75.35 110.102 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.01 -176.03 5.59 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.489 0.716 . . . . 72.54 110.353 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.03 121.64 11.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.043 -0.981 . . . . 71.12 110.309 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 66.85 3.6 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.473 1.509 . . . . 70.13 112.036 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -111.74 120.27 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.481 0.712 . . . . 70.33 110.171 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.21 129.06 41.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.648 1.179 . . . . 72.2 107.933 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.75 116.85 29.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.923 0.889 . . . . 52.12 108.887 173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.01 124.71 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 107.781 -1.192 . . . . 72.32 107.781 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.608 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.2 t -101.27 144.21 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.517 1.127 . . . . 45.01 109.331 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.615 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -118.05 128.87 55.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.196 -1.038 . . . . 64.52 108.196 175.39 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -109.41 106.87 16.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.255 1.022 . . . . 74.01 109.158 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.27 128.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.567 -1.272 . . . . 53.02 107.567 166.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.3 m -125.42 124.05 40.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.264 0.555 . . . . 54.35 109.7 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.442 HG21 HG21 ' D' ' 114' ' ' ILE . 69.0 t -106.59 101.93 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 125.002 1.321 . . . . 63.23 108.493 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 8.2 m -94.94 93.59 7.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.647 -1.242 . . . . 70.14 107.647 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.44 138.79 33.5 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.944 -0.762 . . . . 73.15 108.944 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.4 p -148.39 138.78 22.68 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.456 0.473 . . . . 73.43 112.128 -176.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' D' ' 36' ' ' TRP . 66.2 mt -107.48 110.58 22.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.773 1.229 . . . . 73.2 109.971 172.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.51 17.47 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.421 0.451 . . . . 71.21 112.997 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.68 6.25 46.58 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.407 0.683 . . . . 54.41 111.408 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.565 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 7.4 tp10 -140.04 149.36 43.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.391 0.676 . . . . 74.0 110.668 -166.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.8 m -70.44 138.42 51.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.057 0.943 . . . . 73.41 111.512 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -87.6 -63.13 1.35 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.561 1.144 . . . . 62.21 108.188 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -155.03 161.62 41.29 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.181 -0.918 . . . . 73.13 110.739 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -117.59 138.05 52.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.271 -1.331 . . . . 72.23 107.498 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.1 t -149.35 139.42 22.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.834 -0.802 . . . . 74.55 108.834 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.434 ' HB2' HG23 ' D' ' 63' ' ' THR . 43.0 tt0 -156.12 131.88 9.71 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.117 -0.697 . . . . 75.11 109.117 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.22 118.11 26.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 123.492 0.717 . . . . 74.32 109.282 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.701 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.0 mt-30 -90.08 85.47 6.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.912 0.863 . . . . 52.13 108.871 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.92 95.92 6.23 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.685 -1.598 . . . . 70.52 108.901 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.28 145.65 18.2 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 112.299 -0.32 . . . . 71.44 112.299 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.99 131.29 4.68 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.588 -0.605 . . . . 72.41 111.588 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -90.88 131.39 38.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.903 -0.777 . . . . 43.24 108.903 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.26 142.64 48.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.94 0.496 . . . . 72.13 110.867 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -89.44 95.9 10.48 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.668 -0.864 . . . . 73.21 108.668 166.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.522 HD11 HG12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -122.04 134.46 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.146 0.978 . . . . 74.31 110.171 -173.193 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.33 171.1 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.256 1.023 . . . . 53.23 109.951 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.95 77.68 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.237 -0.438 . . . . 32.32 113.881 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.522 HG12 HD11 ' D' ' 86' ' ' ILE . 1.8 pp -103.99 158.08 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.201 1.0 . . . . 63.24 110.866 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.86 171.68 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.424 0.69 . . . . 65.03 110.643 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.8 -138.06 34.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.098 0.874 . . . . 60.24 114.912 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -72.55 -28.69 62.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.043 0.937 . . . . 73.14 110.954 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -63.87 -29.11 70.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.927 0.891 . . . . 60.04 111.652 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.412 ' HG3' HD13 ' D' ' 89' ' ' ILE . 24.2 ttt -59.93 -53.82 53.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.232 0.613 . . . . 73.41 110.525 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.95 64.5 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.419 -0.81 . . . . 73.33 111.205 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -69.12 -33.35 73.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.326 1.05 . . . . 75.11 110.316 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 46.5 t -78.93 -51.41 9.69 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.574 -0.739 . . . . 74.22 110.58 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.21 -49.48 27.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.284 0.633 . . . . 60.41 110.834 -171.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.34 -26.4 61.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.792 -0.64 . . . . 65.41 114.457 -172.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.18 -58.13 1.89 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.452 0.626 . . . . 63.44 112.063 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 76.8 t80 -68.73 -34.08 75.01 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.165 0.802 . . . . 75.4 113.165 -168.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.518 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 43.6 m -72.13 -48.92 10.2 Favored Pre-proline 0 CA--C 1.563 1.476 0 CA-C-O 118.977 -0.535 . . . . 75.15 110.995 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.615 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 71.0 Cg_exo -56.55 -30.97 84.89 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 122.49 2.126 . . . . 71.34 114.431 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.24 -29.32 69.77 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.039 0.536 . . . . 74.25 111.971 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -68.27 -38.98 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 73.42 110.595 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.94 -25.37 40.49 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.063 -0.971 . . . . 71.13 111.651 -170.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.65 -41.82 80.22 Favored Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 114.231 1.197 . . . . 63.21 114.231 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -50.1 -39.99 50.9 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.214 1.942 . . . . 75.45 114.19 171.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.19 -36.01 27.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.729 0.812 . . . . 71.53 111.109 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -44.19 96.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.445 0.698 . . . . 75.41 110.36 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.412 ' NH2' HG23 ' B' ' 105' ' ' ILE . 30.8 ttp180 -55.89 -54.97 38.23 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 124.965 1.415 . . . . 73.42 110.215 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.158 0.911 . . . . 72.35 111.837 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.427 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 43.0 t -59.7 -42.51 93.17 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.547 0.529 . . . . 74.53 110.96 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.491 HG23 ' SG ' ' D' ' 76' ' ' CYS . 83.4 mt -62.26 -55.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 115.123 -0.944 . . . . 73.41 110.338 172.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 97.1 m -53.44 -40.11 64.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.554 1.541 . . . . 74.34 112.4 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -71.73 -40.77 69.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.159 -0.928 . . . . 73.33 110.695 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.3 mtm -69.08 -31.09 69.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.864 0.465 . . . . 72.42 111.637 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.0 t -63.23 -46.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.622 0.769 . . . . 72.45 109.714 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -74.43 -29.19 61.4 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 116.009 -0.541 . . . . 74.54 111.506 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -74.12 -23.24 59.27 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.83 0.852 . . . . 64.54 110.479 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.36 12.19 65.57 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.725 -0.67 . . . . 60.15 112.43 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p 62.26 22.42 13.17 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 126.319 1.848 . . . . 73.34 113.972 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -97.99 161.26 26.16 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.265 1.026 . . . . 72.21 109.551 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.25 140.02 47.68 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.106 2.537 . . . . 74.53 111.625 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.08 119.39 8.26 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.547 0.739 . . . . 72.04 110.618 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.76 103.87 12.76 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.316 -0.994 . . . . 70.22 108.316 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -103.82 99.78 9.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 54.31 109.328 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.48 HD22 HD21 ' D' ' 42' ' ' LEU . 95.5 mt -71.29 126.88 30.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.29 0.636 . . . . 74.54 110.473 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.37 138.64 96.36 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 123.184 0.594 . . . . 54.41 111.064 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 2.1 Cg_endo -74.78 96.59 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.946 1.764 . . . . 73.41 109.647 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 85.5 t -106.97 109.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.014 -1.106 . . . . 72.42 108.014 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.24 0.604 0 CA-C-N 115.588 -0.733 . . . . 71.2 109.137 -174.169 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 108.666 -0.864 . . . . 62.2 108.666 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -76.92 -18.87 58.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.419 0.688 . . . . 54.2 111.632 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.9 80.58 0.9 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.617 0.767 . . . . 74.33 109.828 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -103.8 77.33 1.45 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.732 -1.211 . . . . 54.42 107.732 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -160.76 137.16 8.59 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.342 -1.299 . . . . 61.42 107.51 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.88 140.64 45.83 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.304 0.377 . . . . 72.45 110.301 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 9' ' ' MET . 10.2 t -88.31 -163.96 1.05 Allowed 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 108.669 -0.863 . . . . 74.2 108.669 173.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.23 -7.14 33.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.21 0.604 . . . . 55.01 112.455 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.542 ' SD ' ' HA2' ' G' ' 169' ' ' GLY . 46.9 mtt -77.46 131.23 37.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.587 0.755 . . . . 72.44 110.207 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -164.44 136.33 4.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.875 1.27 . . . . 72.13 107.815 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -100.86 118.43 36.9 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.97 -0.752 . . . . 64.24 108.97 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' H ' HG22 ' A' ' 86' ' ' ILE . 52.3 tp60 -141.29 123.51 15.65 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.436 0.46 . . . . 62.42 110.908 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.47 128.9 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.66 -1.237 . . . . 71.14 107.66 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -97.29 -28.91 13.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.472 -0.775 . . . . 72.23 111.341 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -175.85 127.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 123.428 0.455 . . . . 73.12 111.182 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.795 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 65.1 mt -107.74 133.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.359 -0.978 . . . . 53.42 108.359 168.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' HE1' HG13 ' A' ' 83' ' ' ILE . 17.0 p90 -165.26 154.43 12.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.034 0.934 . . . . 75.22 110.139 -174.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -81.14 121.15 25.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.316 -0.624 . . . . 63.52 109.316 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.2 mtpt -88.45 -24.57 22.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.623 0.369 . . . . 74.41 111.146 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 13.8 t70 -153.52 143.71 22.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.424 0.631 . . . . 71.42 109.955 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.08 131.66 41.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 106.325 -1.731 . . . . 72.54 106.325 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.0 t -146.27 114.14 6.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.488 . . . . 71.33 109.684 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 88.8 t80 -116.11 120.33 38.7 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.242 -1.392 . . . . 74.53 107.242 172.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -119.95 130.8 54.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.365 -0.606 . . . . 73.51 109.365 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -140.84 76.03 23.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.844 -1.169 . . . . 73.03 107.844 172.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 -20.43 21.74 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.639 2.226 . . . . 72.05 112.028 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -110.63 25.24 11.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.981 0.912 . . . . 71.1 109.179 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.529 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.99 -49.69 89.96 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.536 0.734 . . . . 72.1 112.882 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 30.7 Cg_endo -68.8 -22.6 36.6 Favored 'Trans proline' 0 C--N 1.387 2.566 0 CA-C-N 121.293 1.498 . . . . 63.04 112.287 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -81.63 -20.54 39.47 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.971 1.309 . . . . 74.23 111.293 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 28' ' ' ALA . 4.0 p -64.52 -29.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.708 0.803 . . . . 61.34 111.592 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -62.7 -32.47 73.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.302 1.041 . . . . 74.44 111.597 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -72.26 -35.46 68.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.003 -0.999 . . . . 73.35 110.365 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 1.5 mmmp? -83.95 153.15 24.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.929 0.891 . . . . 74.01 110.808 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.06 144.69 32.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.383 0.673 . . . . 75.42 109.99 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -86.77 86.39 7.32 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.83 0.824 . . . . 74.41 110.247 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -131.96 82.63 59.02 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.951 -1.5 . . . . 74.32 106.951 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.62 127.42 7.21 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.635 2.223 . . . . 73.52 113.368 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 106.02 18.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.945 -1.502 . . . . 71.32 106.945 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.4 130.21 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 116.23 -0.441 . . . . 65.32 111.183 -171.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 59.9 mtpt -109.26 144.96 36.7 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 74.14 110.504 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD22 ' A' ' 128' ' ' LEU . 7.9 mp -126.01 112.27 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.691 -1.595 . . . . 71.33 107.603 171.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.633 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.1 m-20 -104.09 110.1 22.15 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.209 -1.404 . . . . 73.52 107.209 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.519 HD22 HD11 ' G' ' 186' ' ' LEU . 58.1 tp -96.52 127.32 42.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.185 -0.672 . . . . 74.12 109.185 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.63 162.09 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.191 0.596 . . . . 73.2 109.815 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.416 HG23 ' HE1' ' G' ' 175' ' ' PHE . 9.3 t -149.51 164.59 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.962 0.905 . . . . 71.23 110.261 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . . . -148.68 154.13 39.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.634 1.174 . . . . 75.21 108.96 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 50.8 m -125.33 152.08 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.821 0.448 . . . . 73.34 110.264 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -150.14 138.59 20.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.953 0.901 . . . . 64.02 109.147 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -97.32 113.42 25.05 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.577 -0.527 . . . . 64.31 109.577 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.19 -32.03 17.65 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.815 -0.629 . . . . 71.33 110.538 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.61 -173.86 3.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.671 0.788 . . . . 64.54 110.549 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.71 115.8 5.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.52 0.728 . . . . 62.04 109.285 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 71.69 -6.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.103 1.361 . . . . 71.01 112.613 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 56.4 t -99.11 112.48 31.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 64.13 108.055 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -122.62 167.31 13.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.227 -0.897 . . . . 73.23 110.27 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 48' ' ' SER . 35.4 tt0 -131.67 125.65 32.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.894 -1.503 . . . . 71.52 108.004 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.8 113.88 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.586 -1.264 . . . . 61.12 107.586 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -100.35 127.3 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.403 0.681 . . . . 73.43 109.836 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -96.49 118.55 33.24 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.944 -1.132 . . . . 73.2 107.944 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -96.39 101.85 13.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.002 -0.74 . . . . 72.51 109.002 170.042 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 18.3 t -95.64 128.66 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 107.387 -1.338 . . . . 74.22 107.387 169.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.8 m -117.84 132.03 56.48 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.844 -0.798 . . . . 73.31 108.844 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 114' ' ' ILE . 54.9 t -126.83 109.52 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.689 1.196 . . . . 73.14 108.308 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 2.6 m -115.79 132.91 56.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.349 -0.611 . . . . 51.52 109.349 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.4 105.04 12.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.103 -1.444 . . . . 73.32 107.103 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -109.56 123.52 49.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.84 -0.43 . . . . 75.51 109.84 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.94 75.12 7.25 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.017 -1.105 . . . . 72.44 108.017 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.74 -105.52 1.96 Allowed Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.922 -0.871 . . . . 65.43 110.922 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.58 13.48 25.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.579 0.752 . . . . 73.44 110.693 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.611 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -120.31 114.08 21.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.533 -0.746 . . . . 72.45 109.76 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -73.46 132.09 42.54 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.46 1.027 . . . . 75.24 110.726 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.63 -54.14 4.73 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.318 1.047 . . . . 71.0 108.942 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -157.3 173.34 17.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.593 -1.185 . . . . 70.52 111.233 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -142.79 142.94 31.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.678 1.591 . . . . 63.22 107.555 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 34.1 m -143.74 99.56 3.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.158 0.583 . . . . 74.53 109.838 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 40.3 tt0 -109.14 121.47 45.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.077 0.551 . . . . 75.2 109.98 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 t -122.69 119.29 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.935 0.894 . . . . 51.22 109.355 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.9 mt-30 -85.58 91.91 8.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.523 -0.762 . . . . 74.34 109.125 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.11 97.5 10.35 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.207 -1.034 . . . . 75.11 108.207 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.74 144.16 18.06 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 112.173 -0.371 . . . . 72.45 112.173 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.62 125.43 3.0 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.281 -0.728 . . . . 65.34 111.281 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.423 HG13 ' HE1' ' A' ' 17' ' ' TYR . 47.2 mt -80.36 129.71 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.625 -0.88 . . . . 75.42 108.625 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.7 120.85 27.26 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.268 -1.012 . . . . 64.52 108.268 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.5 t -105.39 94.22 5.1 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.437 -0.949 . . . . 74.13 108.437 178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.428 HD11 HD22 ' G' ' 173' ' ' LEU . 1.5 pp -134.93 165.06 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.381 1.073 . . . . 64.34 108.4 -170.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 9' ' ' MET . . . -161.36 178.85 8.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.191 0.596 . . . . 72.04 111.073 170.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.86 67.66 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.739 -0.664 . . . . 71.23 114.522 170.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -113.6 147.71 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.203 0.601 . . . . 73.2 111.624 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -157.79 -170.25 3.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.98 1.312 . . . . 73.52 110.573 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 73.86 -149.41 41.31 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.996 0.808 . . . . 74.01 114.722 175.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.9 p -83.31 -23.43 32.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.577 1.151 . . . . 71.32 111.261 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -71.39 -35.45 71.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.488 1.115 . . . . 74.24 110.648 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 27.7 ptm -62.24 -39.6 93.37 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.199 0.312 . . . . 72.44 110.3 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.5 94.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.48 0.712 . . . . 71.44 110.569 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -57.99 -45.67 86.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.923 0.889 . . . . 73.4 111.488 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' G' ' 172' ' ' ALA . 42.0 t -75.43 -54.27 7.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.315 -0.402 . . . . 74.25 111.334 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.0 -23.97 65.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.513 0.597 . . . . 72.44 111.449 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.85 -21.1 48.08 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-O 119.596 -0.558 . . . . 62.31 113.827 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -136.56 -54.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.654 0.727 . . . . 72.13 112.746 -173.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -72.81 -48.94 33.69 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.727 0.811 . . . . 73.45 112.475 -167.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.91 -46.8 75.13 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.258 1.023 . . . . 70.41 112.072 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.58 -20.82 40.51 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.588 1.525 . . . . 75.1 113.119 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 40.4 t-20 -67.85 -36.06 79.64 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.871 0.469 . . . . 73.11 109.829 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.0 mm -56.26 -43.18 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.677 0.791 . . . . 73.13 110.393 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 82' ' ' GLY . 53.3 mt -81.46 -21.85 38.49 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.995 -1.002 . . . . 61.24 111.527 -172.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.411 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 29.3 t80 -66.14 -39.43 28.56 Favored Pre-proline 0 CA--C 1.56 1.35 0 N-CA-C 114.696 1.369 . . . . 73.01 114.696 -167.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HB3' HD13 ' C' ' 105' ' ' ILE . 12.2 Cg_endo -57.13 -40.05 86.14 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 121.878 1.718 . . . . 63.4 112.525 172.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.43 -35.38 63.37 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.552 0.741 . . . . 70.11 110.957 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.81 64.67 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.119 0.568 . . . . 72.01 110.153 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.8 ttm105 -51.41 -51.4 55.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.787 1.235 . . . . 71.2 110.333 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.82 -48.41 80.73 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.456 1.097 . . . . 72.13 111.362 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.413 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.1 t -54.18 -45.78 72.21 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.375 1.047 . . . . 72.5 110.698 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.663 HG21 HG21 ' A' ' 64' ' ' VAL . 9.0 mt -64.29 -53.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.051 -0.977 . . . . 53.31 110.901 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 125' ' ' GLN . 66.1 m -53.22 -39.57 63.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 72.42 111.371 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -71.4 -42.11 68.77 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.192 -0.913 . . . . 75.54 109.807 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.9 mtp -57.79 -41.94 83.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.826 0.85 . . . . 70.31 111.215 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.5 t -61.02 -50.19 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.415 1.086 . . . . 74.04 110.387 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 82.2 p -72.1 -27.18 62.48 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.734 -0.666 . . . . 73.5 111.784 -175.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.531 HH12 ' HG3' ' B' ' 112' ' ' GLU . 76.8 mtt-85 -73.11 -24.74 60.66 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.442 0.697 . . . . 65.42 110.335 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.41 14.83 48.94 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-O 119.833 -0.426 . . . . 60.45 113.133 171.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.489 HG22 HH21 ' B' ' 15' ' ' ARG . 1.8 t 62.83 15.21 8.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 127.331 2.252 . . . . 73.42 113.42 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -91.91 157.75 40.86 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.319 0.648 . . . . 71.03 109.855 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.421 ' HB3' ' HE1' ' G' ' 195' ' ' PHE . 59.0 Cg_endo -68.22 151.99 76.35 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.68 2.253 . . . . 75.44 111.977 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.493 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.1 tt0 -57.46 137.21 56.47 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.487 0.492 . . . . 55.2 110.818 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.4 tp -117.07 112.61 21.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.027 -0.988 . . . . 53.41 108.667 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.71 102.37 14.11 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.125 -1.065 . . . . 73.24 108.125 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.457 HD22 HD21 ' A' ' 42' ' ' LEU . 61.1 mt -71.35 117.98 13.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.05 -0.722 . . . . 75.45 109.05 177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.455 ' O ' HD13 ' G' ' 187' ' ' ILE . . . -65.48 128.84 94.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.285 0.366 . . . . 71.13 110.605 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HB3' HH22 ' A' ' 111' ' ' ARG . 57.9 Cg_endo -72.9 136.97 26.04 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 121.833 1.688 . . . . 44.43 110.584 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.566 HG22 HG23 ' G' ' 187' ' ' ILE . 39.7 t -97.88 113.7 33.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.23 -1.396 . . . . 62.11 107.23 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.89 63.94 8.35 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.887 1.327 . . . . 73.13 109.215 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.17 -24.37 64.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.822 -1.536 . . . . 75.31 110.064 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.01 -50.05 74.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.956 0.902 . . . . 61.22 110.385 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.55 -40.28 92.67 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.814 0.696 . . . . 43.2 111.168 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.14 -38.36 79.47 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.721 0.808 . . . . 65.32 110.925 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -73.01 -37.9 66.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.98 0.912 . . . . 75.13 109.979 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.183 0.593 . . . . 75.14 111.746 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 91.1 m-20 -59.37 -32.6 70.28 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.364 0.666 . . . . 72.34 110.82 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.92 -39.63 42.26 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.69 -1.141 . . . . 62.33 110.858 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.646 HD13 ' HA ' ' C' ' 149' ' ' THR . 98.5 mt -67.29 -49.51 63.97 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.454 0.701 . . . . 65.2 112.08 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -169.21 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.91 0.484 . . . . 64.04 110.612 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 25.2 tp60 65.02 -85.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.449 1.099 . . . . 73.31 110.325 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.405 ' OE1' ' HB2' ' C' ' 5' ' ' ASN . 23.3 tm0? -173.07 130.25 0.48 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.99 -0.744 . . . . 41.42 108.99 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.44 124.11 11.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.52 1.128 . . . . 54.32 108.411 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.79 73.2 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.788 -0.525 . . . . 72.23 111.788 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.84 101.13 13.73 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.341 0.656 . . . . 73.42 109.251 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.3 140.87 23.35 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 116.016 -0.538 . . . . 74.2 112.112 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 m -143.27 101.03 3.73 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.433 -0.58 . . . . 71.1 109.433 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.01 143.61 33.95 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.611 0.764 . . . . 73.32 109.707 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -164.18 -66.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.952 -1.129 . . . . 72.25 107.952 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.598 ' HB2' ' HB3' ' C' ' 140' ' ' TYR . 51.3 m80 -65.87 97.87 0.37 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.363 -0.606 . . . . 73.13 109.363 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.33 -64.89 0.76 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.357 -1.292 . . . . 70.53 110.782 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.75 142.48 13.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.016 -0.538 . . . . 45.3 111.177 -171.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.467 1.107 . . . . 73.22 108.746 174.517 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 108.852 -0.795 . . . . 74.14 108.852 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.589 ' H ' HD12 ' F' ' 173' ' ' LEU . 35.2 m -98.27 153.92 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.751 0.821 . . . . 72.11 109.923 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.16 90.65 2.39 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.606 0.762 . . . . 64.45 109.116 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -154.22 -39.07 0.09 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.151 0.981 . . . . 73.43 109.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.1 71.13 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.691 1.197 . . . . 61.41 111.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -169.7 75.36 0.09 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.411 -0.813 . . . . 72.44 109.337 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.1 m -147.82 153.13 38.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.125 0.57 . . . . 52.23 110.159 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -56.65 -32.12 65.05 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.991 1.316 . . . . 43.44 112.941 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.555 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 10.2 ptm 57.65 175.42 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 126.24 1.816 . . . . 73.23 113.699 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -168.54 146.26 4.03 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.137 0.975 . . . . 72.52 109.566 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 41.3 t80 -137.33 153.92 50.16 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.735 0.814 . . . . 63.02 108.916 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.792 HE21 ' HA ' ' G' ' 204' ' ' ILE . 8.3 tp60 -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.424 0.69 . . . . 71.23 111.381 170.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tp -86.95 133.77 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.019 0.528 . . . . 45.21 109.699 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -101.64 -37.85 8.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.869 0.468 . . . . 65.33 109.841 170.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.489 HH21 HG22 ' A' ' 122' ' ' THR . 68.2 ttt180 -167.36 137.51 2.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.678 0.391 . . . . 73.51 111.006 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.81 141.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.653 -1.61 . . . . 70.31 106.653 169.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -172.06 144.17 1.64 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.961 0.41 . . . . 74.45 111.701 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.599 HG21 HD11 ' B' ' 21' ' ' ILE . 16.4 m -76.07 128.18 34.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.534 -0.913 . . . . 54.51 108.534 170.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.48 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 42.1 mtpt -98.4 -40.99 8.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.502 0.721 . . . . 72.02 109.564 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 30.7 t70 -138.77 143.27 38.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.34 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.599 HD11 HG21 ' B' ' 18' ' ' THR . 34.7 mm -131.32 142.88 42.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 125.309 1.443 . . . . 73.03 107.758 170.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.7 m -144.4 129.09 18.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.825 -1.08 . . . . 61.01 108.798 168.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 75.0 t80 -138.79 106.7 5.67 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.125 -2.176 . . . . 75.41 105.125 164.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -119.64 108.55 14.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.205 -1.406 . . . . 73.11 107.205 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.497 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.04 89.26 6.44 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.561 1.144 . . . . 75.2 108.461 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.75 -44.2 6.14 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.714 2.276 . . . . 74.54 111.695 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 41.0 m-80 -105.98 32.17 4.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.349 1.059 . . . . 53.34 109.414 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.497 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.19 -46.42 55.69 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 125.022 1.329 . . . . 74.23 113.929 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 38.4 Cg_endo -69.89 -23.15 30.53 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 121.56 1.507 . . . . 54.23 113.32 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 0.3 OUTLIER -78.63 -2.77 40.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.408 0.683 . . . . 74.05 111.415 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.82 -20.96 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.115 0.566 . . . . 74.23 110.593 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -84.36 -21.48 30.88 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.709 0.803 . . . . 63.41 110.422 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -87.83 -22.84 24.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.408 0.683 . . . . 72.45 111.659 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -107.04 99.88 9.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.976 0.91 . . . . 74.15 111.09 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.02 76.55 8.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.579 0.752 . . . . 74.12 109.359 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 t90 179.88 159.04 0.75 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.106 0.962 . . . . 72.4 109.667 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' F' ' 193' ' ' TYR . 7.4 pt20 -58.56 137.81 85.98 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.081 0.953 . . . . 71.4 112.066 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.68 141.0 48.56 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.376 1.384 . . . . 73.42 110.271 163.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 44.6 mm-40 -75.21 99.24 3.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.247 -1.02 . . . . 75.25 108.247 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.403 ' HB ' ' HG ' ' B' ' 126' ' ' LEU . 14.1 t -97.57 118.21 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.763 -1.199 . . . . 72.11 107.763 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 134.29 46.41 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.666 -1.235 . . . . 72.22 107.666 -165.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.534 HD23 HD22 ' B' ' 128' ' ' LEU . 1.8 pp -86.67 162.49 17.89 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.086 0.773 . . . . 71.33 113.086 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.0 m-20 -146.94 131.75 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.002 -1.481 . . . . 71.44 107.002 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.13 142.83 34.22 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.229 -1.026 . . . . 42.33 108.229 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -145.11 140.31 27.94 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.305 -0.628 . . . . 73.31 109.305 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 48.3 m -108.93 111.43 23.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.512 0.725 . . . . 62.04 109.886 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.48 128.65 47.27 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 107.813 -1.181 . . . . 72.12 107.813 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.636 ' HB2' HD11 ' F' ' 177' ' ' LEU . 26.8 m -142.7 165.37 27.56 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.853 -0.529 . . . . 72.04 110.075 177.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.3 p -152.61 159.52 43.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 72.04 109.499 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -106.54 121.27 43.97 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.688 0.795 . . . . 75.31 109.5 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 85.5 mt -82.99 -43.1 16.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.251 0.62 . . . . 53.41 110.095 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -158.53 -177.07 6.27 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.381 -0.827 . . . . 71.42 111.019 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.23 112.54 5.87 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 113.76 -1.564 . . . . 72.35 109.096 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.417 ' HA ' ' HE3' ' F' ' 174' ' ' MET . 63.5 m-20 73.61 8.26 5.02 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.924 1.29 . . . . 52.4 112.584 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 48.5 t -119.34 96.08 4.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.988 0.915 . . . . 72.21 108.635 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.45 ' HE2' ' SD ' ' F' ' 174' ' ' MET . 17.0 m-85 -99.21 169.61 9.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.713 0.768 . . . . 71.35 110.964 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.436 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.5 tm-20 -142.7 96.77 2.99 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.581 -1.637 . . . . 74.1 106.581 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 79.1 t -94.86 122.58 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.194 -0.669 . . . . 75.13 109.194 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 32.5 t -103.44 118.91 51.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.309 -0.86 . . . . 73.22 109.226 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.479 HD22 HG23 ' B' ' 62' ' ' VAL . 1.9 tt -92.03 112.33 24.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.263 -1.384 . . . . 70.33 107.263 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -104.17 111.79 24.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.463 -0.79 . . . . 73.15 109.655 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' B' ' 114' ' ' ILE . 67.1 t -105.4 112.42 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.941 -1.133 . . . . 74.12 107.941 170.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 8.8 m -98.44 152.08 19.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.801 -0.815 . . . . 73.55 108.801 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.562 HG21 HG21 ' B' ' 114' ' ' ILE . 84.9 t -141.6 126.49 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.422 1.089 . . . . 71.03 108.326 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -114.26 135.32 54.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.666 0.786 . . . . 51.34 109.388 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.28 146.18 44.39 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.081 0.552 . . . . 61.23 110.231 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -149.87 129.87 13.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.27 0.557 . . . . 72.33 112.255 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 65.7 mt -95.15 104.84 16.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.727 1.211 . . . . 72.54 109.605 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.05 -110.1 3.28 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.702 0.626 . . . . 74.43 113.047 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.7 3.57 37.16 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.106 1.362 . . . . 71.21 109.62 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.29 154.24 39.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.125 0.97 . . . . 61.32 109.879 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -73.53 137.88 44.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.13 0.572 . . . . 61.42 109.931 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.657 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.73 -61.98 1.48 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.784 0.834 . . . . 72.54 108.869 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.26 166.78 32.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.984 -1.462 . . . . 74.41 109.501 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.13 111.12 6.31 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.846 -1.539 . . . . 51.21 106.846 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -116.7 158.69 23.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.043 -0.725 . . . . 73.42 109.043 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -166.26 127.63 1.8 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.092 -1.077 . . . . 75.01 108.092 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.74 142.6 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.782 -0.451 . . . . 75.31 109.782 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -120.38 95.99 4.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.126 -0.943 . . . . 73.21 109.361 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -86.59 103.67 15.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.097 -0.956 . . . . 73.32 109.251 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.13 159.48 28.83 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 111.598 -0.601 . . . . 71.45 111.598 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.17 127.42 1.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.75 -0.94 . . . . 73.31 110.75 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.4 mt -85.41 113.2 23.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.609 -0.886 . . . . 73.43 108.609 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -118.82 133.74 55.63 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.177 -0.675 . . . . 75.24 109.177 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -93.49 110.29 21.87 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.108 -1.071 . . . . 71.12 108.108 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.632 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -121.19 134.68 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.306 0.642 . . . . 75.41 109.74 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.87 33.68 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.152 0.981 . . . . 42.35 108.986 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.31 -44.98 3.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 122.863 0.268 . . . . 64.53 113.261 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.1 136.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.918 0.887 . . . . 64.24 111.655 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.551 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 10.8 pt-20 -151.67 146.97 26.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.744 0.418 . . . . 74.2 110.561 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.23 -105.83 0.79 Allowed Glycine 0 C--N 1.35 1.334 0 O-C-N 124.037 0.835 . . . . 74.21 113.469 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.443 HG21 HD11 ' B' ' 141' ' ' LEU . 22.1 m -79.65 -31.72 41.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.923 0.889 . . . . 72.13 110.846 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.551 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 21.1 mt-30 -60.88 -48.74 80.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.315 0.646 . . . . 63.22 110.107 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.452 ' HA ' ' SG ' ' B' ' 97' ' ' CYS . 10.3 ptm -72.82 -36.85 67.61 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.158 -0.928 . . . . 64.12 110.137 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.73 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.066 0.546 . . . . 72.53 111.286 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -75.27 -35.84 61.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.096 0.958 . . . . 72.53 111.139 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' B' ' 94' ' ' MET . 27.3 p -78.66 -56.91 4.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 110.466 -0.198 . . . . 75.21 110.466 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.6 -22.75 64.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.249 0.62 . . . . 70.04 111.49 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.38 -0.39 40.6 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.246 -0.752 . . . . 23.41 114.584 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.598 ' HA ' ' HZ3' ' F' ' 184' ' ' TRP . . . -147.95 -49.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.384 1.092 . . . . 75.2 112.319 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -72.22 -58.5 3.36 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.69 0.396 . . . . 75.45 111.193 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.06 -45.97 99.72 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 124.009 0.923 . . . . 62.04 111.956 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.72 -54.89 4.69 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.145 1.897 . . . . 52.41 112.349 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -63.56 -14.78 54.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.803 1.038 . . . . 60.12 113.803 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 75.4 mt -78.65 -48.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.738 -0.467 . . . . 63.21 109.738 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.01 -20.7 48.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.215 1.006 . . . . 60.35 111.785 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.87 -44.78 80.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.503 1.521 . . . . 72.32 112.517 -171.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.473 ' HA ' HH11 ' B' ' 111' ' ' ARG . 35.1 Cg_exo -56.69 -39.78 88.97 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 121.984 1.789 . . . . 72.31 112.94 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.8 m-85 -69.21 -41.62 76.84 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.138 0.575 . . . . 74.22 110.94 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.6 87.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.783 0.433 . . . . 71.33 110.121 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.473 HH11 ' HA ' ' B' ' 108' ' ' PRO . 28.9 mtp-105 -52.84 -63.41 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.778 1.231 . . . . 65.15 110.743 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.531 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.7 tp10 -55.28 -37.42 67.29 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.728 1.211 . . . . 63.32 111.493 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.538 ' O ' ' HG2' ' B' ' 117' ' ' MET . 2.0 t -72.57 -46.4 54.58 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 119.642 -0.218 . . . . 61.04 110.965 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.562 HG21 HG21 ' B' ' 64' ' ' VAL . 83.4 mt -60.02 -57.27 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.625 0.77 . . . . 55.33 110.668 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.466 HG23 ' H ' ' B' ' 126' ' ' LEU . 5.9 m -60.24 -28.19 67.82 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.123 0.889 . . . . 71.44 110.744 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.9 t -68.69 -53.12 24.13 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.476 0.711 . . . . 65.55 110.821 171.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.5 mmt -61.85 -37.69 85.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.004 0.522 . . . . 53.53 111.318 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.14 -49.46 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.859 1.264 . . . . 52.15 110.438 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.499 ' HB2' ' HA ' ' C' ' 126' ' ' LEU . 87.4 p -73.69 -22.99 59.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 64.14 112.258 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.8 mtt-85 -65.21 -32.37 74.01 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.472 0.709 . . . . 72.51 110.523 175.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 17.23 35.09 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.569 -0.741 . . . . 50.34 112.474 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 60.93 35.96 18.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.452 1.901 . . . . 73.5 112.648 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.32 159.37 29.52 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 124.24 1.016 . . . . 75.11 109.555 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.81 -175.06 2.49 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.948 2.432 . . . . 41.04 115.408 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.487 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 1.0 OUTLIER -65.58 133.43 51.16 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.971 1.308 . . . . 62.01 112.743 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.466 ' H ' HG23 ' B' ' 115' ' ' THR . 0.2 OUTLIER -153.72 86.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.199 -1.037 . . . . 63.33 108.199 163.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -102.62 136.89 41.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.643 -1.243 . . . . 73.53 107.643 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.534 HD22 HD23 ' B' ' 42' ' ' LEU . 10.8 mt -74.9 125.07 28.06 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.679 -0.489 . . . . 72.55 109.679 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -71.01 137.58 84.88 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.054 0.542 . . . . 73.11 110.7 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 12.8 Cg_exo -72.42 143.48 38.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.591 2.861 . . . . 74.1 113.138 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.53 128.35 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.259 0.624 . . . . 75.24 109.464 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.566 HD21 HG13 ' D' ' 105' ' ' ILE . 5.2 m-20 -83.62 81.59 8.68 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.167 0.587 . . . . 73.54 109.82 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' F' ' 181' ' ' TYR . 54.9 m-85 -68.45 -29.44 68.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.192 -0.913 . . . . 74.21 111.322 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.42 -42.16 95.45 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.046 0.841 . . . . 71.53 110.619 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.454 0.702 . . . . 62.5 111.142 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.46 -40.78 76.95 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.675 -0.693 . . . . 62.34 109.599 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.451 ' HB2' ' OH ' ' F' ' 181' ' ' TYR . 86.6 t80 -62.62 -42.56 99.66 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.302 1.441 . . . . 75.12 111.743 -175.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.427 ' SD ' ' HG3' ' B' ' 143' ' ' GLN . 25.5 mmt -62.43 -31.9 72.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.598 0.759 . . . . 61.15 111.368 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.12 -30.2 20.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.392 0.677 . . . . 63.42 110.892 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.59 -42.44 95.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.957 0.903 . . . . 63.44 110.297 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.443 HD11 HG21 ' B' ' 92' ' ' THR . 72.8 mt -101.91 3.98 39.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.874 -0.603 . . . . 75.14 111.684 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 55.31 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.488 1.115 . . . . 73.13 112.215 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLN . . . . . 0.427 ' HG3' ' SD ' ' B' ' 138' ' ' MET . 29.6 mm-40 -100.34 -32.21 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 122.122 -0.361 . . . . 71.34 111.535 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 64.01 -163.79 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.167 0.987 . . . . 55.42 111.476 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.26 176.51 5.43 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.556 0.742 . . . . 72.5 110.869 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.17 84.46 0.93 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.474 -0.65 . . . . 50.03 111.474 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.94 123.26 16.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.163 0.985 . . . . 73.11 111.35 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.6 -98.02 0.11 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.29 0.369 . . . . 63.24 112.488 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -156.23 137.63 13.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.618 0.767 . . . . 55.22 109.557 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -83.2 150.22 26.34 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.62 0.768 . . . . 63.45 111.296 -174.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.16 154.94 19.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.633 0.773 . . . . 64.35 110.52 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -104.03 -49.93 3.5 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.536 0.734 . . . . 61.15 110.438 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 68.29 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.198 1.399 . . . . 74.14 110.417 -169.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.94 94.86 2.94 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.931 -0.481 . . . . 71.32 109.986 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' H' ' 168' ' ' LYS . . . . . . . . 0 C--O 1.248 0.976 0 C-N-CA 125.154 1.381 . . . . 54.22 108.042 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 85.0 mtp . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 111.548 0.203 . . . . 63.31 111.548 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -165.37 92.09 0.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.535 0.734 . . . . 74.14 109.473 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.07 99.15 9.69 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.283 -0.636 . . . . 73.5 109.283 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -60.22 125.55 24.09 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.554 -0.748 . . . . 63.2 110.845 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.405 ' HB2' ' OE1' ' A' ' 144' ' ' GLN . 10.1 m120 -103.69 -18.13 14.83 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.956 -0.757 . . . . 74.32 108.956 172.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 54.53 35.07 22.58 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.058 1.343 . . . . 75.53 110.36 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -70.37 117.38 11.85 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.297 -0.865 . . . . 61.33 109.718 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.21 -64.61 0.86 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.851 -1.068 . . . . 44.53 109.78 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ttt 63.19 116.78 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.707 1.203 . . . . 61.21 111.96 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -122.79 105.3 9.92 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 107.455 -1.313 . . . . 74.11 107.455 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.661 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 53.3 t80 -98.64 127.1 44.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.797 -0.816 . . . . 74.23 108.797 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -138.2 126.57 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.618 -0.512 . . . . 62.14 109.618 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -80.75 140.31 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.047 0.939 . . . . 72.51 109.004 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.463 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -111.55 -51.44 2.86 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.913 0.387 . . . . 71.42 110.218 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 50.2 ttt180 -167.88 140.53 3.16 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.536 -0.756 . . . . 73.43 109.445 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mt -122.27 146.95 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.316 -0.994 . . . . 63.05 108.316 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.565 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 24.5 p90 -175.65 158.27 2.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.275 0.559 . . . . 73.43 111.284 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -77.16 118.54 19.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.2 -0.909 . . . . 74.34 109.153 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -77.46 -47.72 18.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.423 -0.955 . . . . 72.23 108.423 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -137.3 137.33 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.207 -1.361 . . . . 73.42 109.054 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.7 mt -134.68 145.45 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.969 -1.493 . . . . 72.1 106.969 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -159.37 150.23 19.64 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.223 0.535 . . . . 73.54 109.918 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -139.47 122.67 16.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.875 -1.157 . . . . 71.21 107.875 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.62 111.07 18.69 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.818 0.847 . . . . 71.05 109.182 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.44 84.06 60.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.201 -1.407 . . . . 52.22 107.201 167.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.49 -31.8 60.53 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.927 2.418 . . . . 71.22 111.892 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.484 ' O ' HG13 ' C' ' 31' ' ' VAL . 66.7 m-20 -96.89 24.96 5.66 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.342 1.057 . . . . 53.11 110.456 -176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.408 ' O ' HG22 ' C' ' 31' ' ' VAL . . . -54.96 -42.74 97.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 115.26 1.578 . . . . 72.11 115.26 -169.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -68.41 -41.97 5.95 Favored 'Trans proline' 0 C--N 1.384 2.44 0 CA-C-N 121.478 1.563 . . . . 64.43 112.082 169.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -64.02 -23.04 67.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.615 1.566 . . . . 73.03 113.131 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.544 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 15.8 m -57.63 -17.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.6 0.963 . . . . 64.53 113.6 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -59.66 -22.81 62.44 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.503 1.121 . . . . 71.52 112.436 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.6 22.53 5.92 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.428 0.529 . . . . 73.21 112.428 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -88.21 172.71 9.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.87 0.843 . . . . 74.33 111.337 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.416 ' O ' HD22 ' C' ' 68' ' ' LEU . 34.8 t70 -91.59 134.74 34.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.148 -1.387 . . . . 75.42 109.535 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.515 ' HB2' ' HB2' ' E' ' 195' ' ' PHE . 19.0 t-105 -89.31 81.93 6.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.216 0.607 . . . . 73.32 111.33 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -159.1 69.66 3.4 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.133 0.573 . . . . 72.55 109.896 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.641 ' HD2' ' HA3' ' E' ' 191' ' ' GLY . 42.1 Cg_endo -91.45 157.58 3.65 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.729 2.286 . . . . 75.32 113.368 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.92 76.77 7.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.078 -1.419 . . . . 65.01 108.798 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 m -73.39 96.35 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 122.141 0.972 . . . . 72.12 110.091 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 14.5 ptmm? -128.71 137.86 51.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.382 -1.281 . . . . 60.14 110.458 -173.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.92 139.47 36.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.833 0.853 . . . . 64.32 109.896 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.477 ' HA ' HD22 ' E' ' 186' ' ' LEU . 6.4 m-20 -120.25 106.65 12.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.377 0.671 . . . . 72.13 109.77 -174.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.409 ' HB2' ' NE1' ' E' ' 184' ' ' TRP . 5.9 mp -86.94 108.96 19.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.402 0.681 . . . . 63.21 109.503 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -113.74 129.48 56.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.004 1.322 . . . . 74.11 108.116 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 36.3 m -111.38 116.92 31.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.988 0.515 . . . . 64.43 110.712 -167.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.11 162.85 27.88 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.336 1.054 . . . . 70.21 109.423 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.0 m -148.56 165.8 30.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.133 0.973 . . . . 63.11 109.641 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -154.65 131.92 11.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.518 0.727 . . . . 74.31 109.511 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.34 120.03 19.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.149 0.579 . . . . 43.11 110.271 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' C' ' 57' ' ' GLU . 57.0 mt -94.2 -37.18 11.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.132 0.573 . . . . 60.22 109.508 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.07 -171.42 2.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.102 -0.954 . . . . 71.35 110.277 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.43 123.31 25.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.129 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 68.18 1.26 2.75 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.791 1.236 . . . . 61.11 112.906 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.98 112.71 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.067 -1.086 . . . . 74.41 108.067 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.37 133.9 43.04 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.91 -0.774 . . . . 74.31 108.91 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.621 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.7 tt0 -93.26 117.64 30.31 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.768 0.827 . . . . 70.43 109.77 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.37 118.27 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.144 -1.058 . . . . 73.43 108.144 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.35 106.44 20.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.165 -1.05 . . . . 64.42 108.165 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -99.67 109.69 22.15 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.096 -1.076 . . . . 74.21 108.096 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 31.1 ttm180 -81.24 110.2 16.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.889 0.875 . . . . 64.32 108.952 174.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 t -100.02 130.08 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.41 -1.33 . . . . 62.12 107.41 169.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -129.16 117.07 20.18 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.414 -0.587 . . . . 65.34 109.414 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.563 HG23 HD13 ' C' ' 114' ' ' ILE . 60.0 t -101.09 112.07 32.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.427 -0.953 . . . . 74.0 108.427 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.433 HG23 HD23 ' C' ' 75' ' ' LEU . 5.0 m -99.4 146.62 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.363 -0.835 . . . . 64.23 109.039 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.89 110.93 6.28 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 22.3 m -135.41 140.05 44.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.913 0.485 . . . . 21.21 110.438 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.722 HD12 ' HG3' ' C' ' 71' ' ' GLU . 6.5 mt -111.02 14.07 21.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.657 1.183 . . . . 71.24 110.667 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.86 -104.54 0.93 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.598 -1.001 . . . . 54.33 110.598 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -93.06 -33.01 14.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.437 0.695 . . . . 73.44 109.316 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.722 ' HG3' HD12 ' C' ' 68' ' ' LEU . 3.8 tp10 -76.84 119.75 21.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.199 1.4 . . . . 74.23 109.137 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -86.29 134.1 33.77 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.029 -0.73 . . . . 64.1 109.029 174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -75.08 -58.24 3.4 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.485 -0.561 . . . . 74.14 109.485 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.84 175.27 3.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.137 -0.938 . . . . 72.13 110.652 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.433 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -141.77 143.11 33.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.732 -1.581 . . . . 74.43 106.732 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.8 t -145.72 143.18 29.6 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.451 -0.944 . . . . 72.55 108.451 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -150.99 130.4 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.81 0.444 . . . . 74.45 109.979 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.98 115.07 23.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.291 1.036 . . . . 71.02 108.527 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 17.6 mt-30 -90.98 92.34 8.71 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.161 -1.051 . . . . 63.31 108.161 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.533 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -81.38 110.96 17.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.737 -1.12 . . . . 64.53 110.004 -176.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.6 146.08 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.782 -0.527 . . . . 61.3 111.782 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.62 120.42 1.57 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.889 -0.885 . . . . 64.53 110.889 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.478 HD12 HD11 ' C' ' 51' ' ' LEU . 11.0 mm -81.28 122.06 35.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.25 -1.018 . . . . 55.54 108.25 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -132.16 120.92 22.92 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.597 -0.89 . . . . 73.02 108.597 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.8 t -89.67 109.55 20.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.398 -0.964 . . . . 65.1 108.398 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -131.49 148.09 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.455 0.702 . . . . 75.34 111.036 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.8 152.75 9.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.796 1.238 . . . . 73.15 108.818 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.95 -16.38 58.65 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.967 -0.352 . . . . 74.33 113.176 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 42.4 pt -59.98 131.43 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.95 0.9 . . . . 65.45 110.325 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -161.6 164.97 29.05 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.591 0.357 . . . . 72.31 110.407 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.01 -137.65 26.99 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.705 0.628 . . . . 71.0 111.902 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -79.32 -23.62 43.36 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.092 0.557 . . . . 72.33 110.787 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -66.91 -32.3 73.46 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 123.88 0.737 . . . . 72.13 111.161 -171.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.425 ' HG3' ' N ' ' C' ' 95' ' ' ALA . 10.4 ptp -64.36 -48.02 77.11 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.295 0.372 . . . . 74.33 110.259 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' C' ' 94' ' ' MET . . . -71.29 -25.15 62.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.63 0.772 . . . . 60.11 111.195 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -79.22 -29.79 42.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 60.33 110.108 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -80.51 -66.77 0.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 116.577 -0.283 . . . . 63.42 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -3.78 58.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.766 -0.584 . . . . 50.34 112.259 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.81 9.28 25.6 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.894 -0.392 . . . . 44.02 113.791 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.29 -59.45 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.06 0.544 . . . . 64.53 110.207 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.403 ' O ' HG12 ' C' ' 105' ' ' ILE . 81.0 t80 -66.55 -54.53 22.63 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.721 0.808 . . . . 33.42 112.565 -171.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.661 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 20.7 m -62.76 -45.84 88.03 Favored Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 123.594 0.758 . . . . 44.32 111.505 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.6 Cg_exo -57.64 -32.07 93.56 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.067 1.844 . . . . 64.21 113.752 168.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' C' ' 108' ' ' PRO . 25.9 t-20 -74.83 -23.55 58.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.544 0.738 . . . . 64.52 110.822 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 108' ' ' PRO . 46.0 mm -69.96 -33.26 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.196 0.598 . . . . 73.55 109.41 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' C' ' 82' ' ' GLY . 80.5 mt -88.26 -23.66 23.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.132 0.973 . . . . 63.53 111.951 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.55 -49.39 91.3 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.455 1.102 . . . . 73.33 113.339 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' C' ' 104' ' ' ASN . 16.0 Cg_exo -65.69 -38.57 23.84 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.979 1.786 . . . . 73.42 112.152 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -61.76 -49.5 76.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.777 0.831 . . . . 74.02 111.197 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.84 -42.41 94.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.031 -0.986 . . . . 74.52 110.607 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.503 HH12 ' HG3' ' C' ' 130' ' ' PRO . 57.0 ttp180 -61.56 -42.44 98.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.554 1.142 . . . . 70.14 109.953 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.55 -35.89 65.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.721 0.809 . . . . 74.52 109.929 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.489 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 40.7 t -69.19 -29.85 67.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.637 0.375 . . . . 71.25 111.174 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.563 HD13 HG23 ' C' ' 64' ' ' VAL . 66.3 mt -72.28 -47.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 61.41 109.539 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -56.73 -31.99 65.1 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.382 1.073 . . . . 51.31 111.283 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -64.82 -56.5 13.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.578 1.151 . . . . 53.4 109.662 174.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.81 -38.07 77.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.603 1.161 . . . . 72.05 112.581 -177.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.7 t -69.83 -40.02 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.176 0.591 . . . . 65.42 110.252 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.543 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 34.1 t -62.93 -38.12 89.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.452 0.644 . . . . 73.41 110.628 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 51.0 mtt-85 -67.07 -37.51 84.13 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 114.534 -1.212 . . . . 72.1 110.404 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 7.2 57.2 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 123.637 0.586 . . . . 61.23 113.248 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 60.57 26.78 16.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 126.38 1.872 . . . . 44.44 113.168 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.481 ' HB2' HG13 ' C' ' 118' ' ' VAL . 67.2 m-85 -97.73 156.02 36.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 123.283 0.633 . . . . 63.1 109.632 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.85 78.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.747 2.965 . . . . 71.55 114.405 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.543 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 0.0 OUTLIER -65.63 155.16 36.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.518 1.127 . . . . 62.42 112.497 173.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 119' ' ' SER . 2.0 pt? -168.13 162.16 12.86 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.111 -1.404 . . . . 75.21 108.934 165.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -88.22 100.79 13.25 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.455 -1.683 . . . . 73.25 106.455 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.04 149.81 35.73 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 124.48 1.112 . . . . 64.43 111.124 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.412 ' HB1' HD12 ' F' ' 204' ' ' ILE . . . -50.73 122.48 16.54 Favored Pre-proline 0 CA--C 1.551 1.014 0 O-C-N 124.841 1.338 . . . . 71.24 111.853 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.795 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 71.9 Cg_exo -52.68 120.6 7.78 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.552 2.835 . . . . 72.21 112.846 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.5 m -77.48 91.42 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.037 0.922 . . . . 63.45 109.712 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -77.01 82.61 3.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.176 -0.92 . . . . 72.42 110.693 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -66.45 -42.31 87.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.034 -0.985 . . . . 71.14 111.054 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.51 -49.97 73.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.027 0.931 . . . . 44.41 111.373 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.45 85.89 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.873 0.733 . . . . 54.04 111.583 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.08 -51.45 69.07 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.095 0.872 . . . . 63.03 110.595 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -57.26 -52.32 65.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.429 1.092 . . . . 73.01 111.972 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 96.5 mmm -65.42 -31.72 72.97 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.742 0.817 . . . . 72.22 111.126 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -70.74 -41.87 71.26 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 64.24 110.422 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.598 ' HB3' ' HB2' ' A' ' 152' ' ' HIS . 11.5 m-85 -71.9 -89.62 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.403 1.081 . . . . 63.43 112.223 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 96.2 mt 48.47 -133.97 1.32 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.594 1.157 . . . . 73.03 112.308 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -161.07 -67.05 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.54 -1.282 . . . . 75.01 107.54 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.88 163.38 17.21 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.848 -1.524 . . . . 51.25 108.702 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -72.89 -0.4 13.47 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.082 0.553 . . . . 74.24 111.852 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 75.33 -64.32 0.38 Allowed 'General case' 0 C--N 1.365 1.256 0 C-N-CA 126.183 1.793 . . . . 62.31 110.563 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.34 -173.27 37.73 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 115.807 -0.633 . . . . 65.41 111.928 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.33 63.53 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.794 0.807 . . . . 74.14 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.41 -35.9 9.16 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 114.413 -1.267 . . . . 53.31 112.262 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.646 ' HA ' HD13 ' A' ' 141' ' ' LEU . 9.1 t -81.57 16.48 1.71 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.379 1.072 . . . . 52.24 112.187 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -96.08 95.09 7.94 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.693 0.797 . . . . 51.33 110.547 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.72 145.7 7.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.369 -0.974 . . . . 74.43 108.369 166.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -70.41 -90.17 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.388 1.075 . . . . 72.33 110.753 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 161.94 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.06 1.744 . . . . 62.52 107.99 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.61 -76.88 0.58 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.594 -0.891 . . . . 73.21 108.594 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.503 -0.925 . . . . 63.43 108.503 178.756 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.435 ' SD ' ' HD2' ' E' ' 205' ' ' LYS . 1.2 tmt? . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.113 -0.699 . . . . 74.14 109.113 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -160.81 98.67 1.22 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.535 -1.283 . . . . 70.33 107.535 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' D' ' 85' ' ' SER . 1.4 pm0 -143.71 126.73 16.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.152 0.981 . . . . 75.22 109.489 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -108.3 164.06 12.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.214 1.005 . . . . 62.51 109.947 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -70.23 -22.18 62.93 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.777 0.673 . . . . 72.41 111.658 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -73.01 82.4 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.677 0.791 . . . . 74.34 109.272 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -174.95 157.21 2.33 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.607 -1.179 . . . . 62.5 109.813 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.33 -168.8 2.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.901 0.88 . . . . 74.22 109.06 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.526 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.6 ttp -34.94 123.29 0.57 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.944 0.898 . . . . 73.24 112.788 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -138.01 144.77 41.22 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.503 -0.925 . . . . 64.14 108.503 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -154.61 98.12 2.05 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -112.56 143.05 44.37 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.476 -0.935 . . . . 73.24 108.476 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.7 tt -104.38 101.47 12.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.994 -1.113 . . . . 71.41 107.994 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.54 -46.6 31.13 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.894 -0.593 . . . . 75.12 111.808 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.464 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 32.4 ttt180 -170.68 126.68 0.74 Allowed 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.167 0.292 . . . . 72.31 111.067 -167.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.95 123.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.581 0.752 . . . . 72.21 109.002 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.464 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 15.8 p90 -147.29 160.69 42.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.675 0.79 . . . . 74.11 111.724 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -91.53 122.42 34.1 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.12 -0.946 . . . . 70.0 108.828 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -86.46 -45.56 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.636 -0.876 . . . . 72.53 108.636 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -130.75 133.84 46.37 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 113.692 -1.594 . . . . 74.12 109.082 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.551 HD13 ' HE3' ' C' ' 117' ' ' MET . 83.0 mt -134.29 145.55 32.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.603 -1.258 . . . . 74.3 107.603 170.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -148.84 144.64 27.06 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.715 0.806 . . . . 75.12 109.393 171.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.575 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -146.04 132.2 19.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.146 -1.798 . . . . 74.44 106.146 170.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.49 134.18 43.16 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.055 -1.091 . . . . 75.24 108.055 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.63 89.6 48.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.738 -1.208 . . . . 74.42 107.738 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.39 -51.92 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.053 2.502 . . . . 71.35 112.974 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -96.7 38.91 1.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.494 -0.928 . . . . 73.13 108.494 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.565 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.84 -52.58 63.44 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 115.329 1.603 . . . . 72.41 115.329 -164.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.98 -15.8 7.86 Favored 'Trans proline' 0 C--N 1.388 2.607 0 CA-C-N 121.302 1.501 . . . . 64.51 113.534 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -69.56 -38.96 77.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.659 1.183 . . . . 64.14 109.119 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 t -68.97 -29.57 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 125.426 1.491 . . . . 74.24 110.836 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.423 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 49.8 t80 -63.16 -36.02 82.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.137 0.575 . . . . 75.14 110.84 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.47 -1.83 56.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.984 0.914 . . . . 73.43 111.566 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -119.8 78.4 1.32 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.953 0.901 . . . . 71.3 109.407 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.635 ' HA ' ' HD2' ' H' ' 195' ' ' PHE . 8.0 p-10 -80.81 85.93 6.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.154 0.582 . . . . 74.42 112.388 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -139.85 177.34 8.03 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.371 1.069 . . . . 74.25 108.759 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -87.18 119.11 70.8 Favored Pre-proline 0 CA--C 1.554 1.128 0 O-C-N 121.985 -0.447 . . . . 72.52 110.16 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.27 113.4 2.85 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.854 2.369 . . . . 64.14 112.255 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.19 114.03 12.07 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.835 -0.802 . . . . 74.13 108.835 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' D' ' 66' ' ' ALA . 31.5 m -99.76 134.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.834 0.854 . . . . 63.24 110.934 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 39.5 mmtm -97.12 110.8 23.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.453 -0.944 . . . . 71.35 108.453 171.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' H' ' 188' ' ' ALA . 1.8 mm? -97.14 115.43 27.52 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.041 -1.096 . . . . 62.52 108.041 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.81 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -107.24 119.53 39.65 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.434 -0.95 . . . . 71.02 108.434 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.9 129.45 41.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.041 -0.725 . . . . 60.52 109.041 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.9 t70 -152.44 151.11 30.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 64.3 108.595 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -133.22 163.03 30.2 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.51 0.724 . . . . 70.42 110.047 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.2 166.97 28.27 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 74.04 109.652 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -152.2 154.25 35.43 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.105 0.562 . . . . 63.21 110.444 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -157.22 119.03 3.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.193 0.997 . . . . 71.13 108.859 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -70.85 128.22 35.26 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.688 0.395 . . . . 63.04 110.211 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.5 mt -103.57 -29.1 11.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.318 0.647 . . . . 63.3 110.166 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -165.8 -176.63 3.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.297 1.039 . . . . 72.55 110.017 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.54 121.02 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.579 -0.897 . . . . 53.33 108.579 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 63.89 16.82 10.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.4 1.08 . . . . 71.15 112.756 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 79.6 t -131.2 128.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.283 1.033 . . . . 71.31 108.765 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' D' ' 86' ' ' ILE . 0.0 OUTLIER -151.41 161.67 42.3 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 72.53 110.674 176.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -103.01 120.55 40.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 124.531 1.132 . . . . 70.34 108.848 173.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.65 123.09 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.403 -1.332 . . . . 43.35 107.403 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 29.7 t -102.75 133.93 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.883 -0.784 . . . . 63.55 108.883 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.24 111.08 22.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.219 -1.03 . . . . 72.21 108.219 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.0 ttm-85 -86.84 110.53 20.02 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 109.144 -0.688 . . . . 75.23 109.144 171.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -108.56 103.83 16.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.87 -1.159 . . . . 65.14 107.87 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.81 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -96.04 146.5 24.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.957 -0.757 . . . . 71.42 108.957 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 81.2 t -138.21 123.18 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.818 1.247 . . . . 74.42 108.368 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 60.6 m -125.63 97.78 5.3 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 71.04 108.644 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -94.16 137.62 33.14 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.49 0.716 . . . . 71.15 109.385 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.8 m -137.06 149.53 47.47 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.142 0.577 . . . . 53.41 110.694 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -132.58 117.42 17.93 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.047 1.339 . . . . 71.32 107.999 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.26 -112.43 4.68 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.695 -0.562 . . . . 74.43 111.695 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 4.48 13.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.768 0.827 . . . . 73.15 110.815 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -118.62 170.9 8.58 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.308 0.643 . . . . 74.33 110.511 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -79.95 138.04 37.0 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.851 -0.613 . . . . 72.44 109.986 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.05 -56.74 2.96 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.704 0.802 . . . . 72.05 109.069 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -163.59 163.6 24.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.878 -1.055 . . . . 71.34 109.828 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.1 mt -118.82 153.04 35.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.048 1.339 . . . . 74.45 108.25 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.541 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 44.3 t -159.31 144.96 16.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.115 0.566 . . . . 64.04 109.988 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -156.83 139.71 15.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.61 . . . . 64.31 109.382 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.61 119.89 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 123.653 0.781 . . . . 75.03 108.936 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.2 mt-30 -97.47 87.84 4.22 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.768 0.827 . . . . 74.51 108.956 173.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -80.64 97.75 7.37 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.819 -1.537 . . . . 72.45 109.588 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.53 141.59 16.73 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.578 -0.609 . . . . 72.01 111.578 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.3 131.42 4.86 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.847 -0.501 . . . . 72.24 111.847 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -90.04 125.35 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.956 -0.757 . . . . 74.44 108.956 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -129.6 128.8 43.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.255 1.022 . . . . 74.45 109.493 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.493 ' HB3' ' HG3' ' D' ' 3' ' ' GLU . 6.0 m -88.29 95.18 10.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.054 0.942 . . . . 73.51 108.682 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.465 HG12 ' CE1' ' D' ' 56' ' ' TYR . 2.7 pp -109.42 140.23 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.66 0.384 . . . . 75.45 110.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.32 165.41 19.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.003 0.921 . . . . 74.03 109.113 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.36 23.83 76.45 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 121.529 0.516 . . . . 74.44 112.262 -174.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.47 HD13 ' SD ' ' D' ' 94' ' ' MET . 2.3 pp -109.18 147.16 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.967 1.307 . . . . 70.23 110.238 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -168.58 150.46 4.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.923 0.489 . . . . 73.21 111.332 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.05 -139.75 48.25 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.015 0.822 . . . . 70.22 114.959 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' THR . . . . . 0.618 ' HB ' HD22 ' D' ' 141' ' ' LEU . 12.6 p -68.54 -18.69 64.41 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.544 0.738 . . . . 72.23 111.739 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' D' ' 147' ' ' GLU . 0.6 OUTLIER -69.84 -47.85 61.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.518 0.727 . . . . 72.25 109.573 175.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.47 ' SD ' HD13 ' D' ' 89' ' ' ILE . 9.3 tpt -58.34 -53.06 62.6 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.94 0.775 . . . . 62.52 110.553 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.17 86.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.956 0.785 . . . . 34.21 111.424 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.434 ' HE1' ' HB3' ' D' ' 137' ' ' PHE . 83.5 t60 -70.86 -47.09 61.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.409 0.683 . . . . 51.44 111.526 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.155 0.582 . . . . 55.02 110.589 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.03 -48.39 18.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.137 0.975 . . . . 65.42 110.34 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.45 -14.31 60.22 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.772 -0.649 . . . . 71.42 114.231 -169.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.15 -60.97 1.32 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.025 0.53 . . . . 62.42 110.99 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -64.56 -47.45 78.69 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.818 0.673 . . . . 72.33 112.818 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.463 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 94.9 m -62.29 -50.17 80.84 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 118.8 -0.619 . . . . 74.12 111.246 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 60.1 Cg_exo -58.77 -31.0 94.19 Favored 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 122.542 2.161 . . . . 73.41 113.94 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.04 -32.9 74.65 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.09 0.556 . . . . 74.03 110.419 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.566 HG13 HD21 ' B' ' 132' ' ' ASN . 47.7 mm -69.9 -43.22 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.516 0.726 . . . . 70.23 110.21 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.448 HD21 ' HA3' ' D' ' 82' ' ' GLY . 90.7 mt -73.36 -19.5 60.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.183 -0.917 . . . . 75.13 111.772 -175.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -69.09 -44.33 27.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 N-CA-C 113.887 1.069 . . . . 75.23 113.887 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.03 -34.52 87.38 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 121.927 1.752 . . . . 74.31 113.237 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.2 -33.87 32.66 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 75.42 111.441 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.33 66.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.16 0.584 . . . . 50.13 109.71 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -58.82 -49.31 78.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.089 1.356 . . . . 64.12 110.596 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.45 -43.41 94.37 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.172 0.92 . . . . 75.15 110.881 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.3 t -56.09 -41.59 75.42 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.628 0.58 . . . . 25.34 110.737 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' D' ' 118' ' ' VAL . 78.8 mt -70.91 -44.59 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.153 -0.931 . . . . 55.42 110.782 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.513 HG23 ' HG3' ' D' ' 125' ' ' GLN . 74.2 m -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.015 0.926 . . . . 75.33 110.598 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.31 -48.08 71.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.511 -1.222 . . . . 33.43 110.305 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.44 -32.76 74.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.008 0.523 . . . . 63.25 112.126 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.3 t -67.42 -45.73 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.566 -0.743 . . . . 65.53 109.531 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.8 p -71.76 -23.17 61.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.625 0.37 . . . . 72.24 111.548 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.489 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.4 mtt-85 -77.6 -34.35 53.48 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.094 0.958 . . . . 71.14 109.85 175.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -0.01 79.93 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.587 -0.733 . . . . 32.3 111.926 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p 61.5 42.31 11.52 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.313 1.845 . . . . 41.44 111.552 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.417 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 37.1 m-85 -111.56 167.82 8.52 Favored Pre-proline 0 CA--C 1.56 1.347 0 CA-C-N 113.078 -1.874 . . . . 75.2 107.878 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.479 ' HD3' ' HE1' ' H' ' 195' ' ' PHE . 93.1 Cg_endo -75.17 140.37 24.91 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.996 1.797 . . . . 75.44 112.053 -171.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.513 ' HG3' HG23 ' D' ' 115' ' ' THR . 20.3 tt0 -45.61 123.78 4.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.502 1.121 . . . . 75.13 112.338 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.51 HD11 HG21 ' D' ' 40' ' ' VAL . 42.1 tp -108.56 93.02 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.524 -0.762 . . . . 65.1 109.021 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.53 106.0 13.44 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.03 0.932 . . . . 61.01 109.039 177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.573 HD11 ' HG ' ' D' ' 42' ' ' LEU . 3.6 mm? -62.44 125.51 24.16 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.337 -0.847 . . . . 72.41 110.135 174.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.503 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -55.7 128.46 69.33 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 124.538 1.149 . . . . 60.45 110.562 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -73.59 95.23 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.307 2.671 . . . . 74.34 112.335 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 91.2 t -102.12 118.74 49.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.508 -1.293 . . . . 64.12 107.508 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -80.07 79.04 6.67 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.752 0.787 . . . . 62.42 109.215 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -68.16 -20.57 64.89 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.482 -1.236 . . . . 74.51 111.392 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.4 -56.02 13.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 109.092 -0.707 . . . . 75.11 109.092 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.74 -30.88 71.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.461 0.705 . . . . 50.11 112.011 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 56.0 tp -61.61 -48.46 80.79 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.849 0.859 . . . . 64.32 111.037 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.434 ' HB3' ' HE1' ' D' ' 96' ' ' HIS . 39.3 t80 -83.18 -26.6 30.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.531 0.733 . . . . 73.31 111.04 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 44.1 ttm -51.32 -38.57 53.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.24 1.416 . . . . 71.41 112.504 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.57 -31.69 71.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.802 -0.635 . . . . 64.55 111.091 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -74.92 -22.73 58.44 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.706 0.802 . . . . 73.22 111.831 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.618 HD22 ' HB ' ' D' ' 92' ' ' THR . 82.3 mt -61.87 -53.32 57.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.829 0.852 . . . . 72.52 111.503 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -79.23 5.55 11.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.159 -0.928 . . . . 73.12 111.978 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.05 46.25 2.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.929 0.892 . . . . 61.01 109.317 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -168.33 -178.67 3.68 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.836 0.854 . . . . 64.42 110.427 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.07 128.44 35.53 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.957 -0.757 . . . . 55.14 108.957 166.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.99 144.24 3.87 Favored Glycine 0 C--O 1.238 0.386 0 N-CA-C 109.996 -1.242 . . . . 64.34 109.996 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' D' ' 93' ' ' GLN . 16.7 mt-10 67.15 111.09 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.067 0.947 . . . . 62.13 110.14 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -157.02 3.27 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.147 -0.479 . . . . 63.35 113.117 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.0 m 63.27 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.126 0.971 . . . . 74.52 109.813 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.68 145.94 32.54 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.116 0.966 . . . . 62.02 112.377 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -173.49 0.64 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.454 0.701 . . . . 74.31 111.353 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 64.3 t60 75.59 14.33 2.83 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.646 1.178 . . . . 73.25 110.384 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.76 81.5 7.77 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.019 -1.474 . . . . 75.21 107.019 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -173.64 159.64 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.457 1.103 . . . . 75.31 109.83 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.253 0 C-N-CA 123.697 0.799 . . . . 74.44 109.31 177.269 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 168' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' E' ' 169' ' ' GLY . 8.8 tmtt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 108.369 -0.975 . . . . 54.52 108.369 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 169' ' ' GLY . . . . . 0.43 ' N ' ' HD3' ' E' ' 168' ' ' LYS . . . 104.71 -130.66 10.32 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.873 -0.891 . . . . 74.43 110.873 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 170' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' E' ' 175' ' ' PHE . 20.5 ptmt -159.73 136.21 9.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.62 0.768 . . . . 75.11 111.163 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 34.2 m -124.12 31.67 5.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.108 0.963 . . . . 52.45 109.468 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -145.15 176.1 9.77 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.766 -1.106 . . . . 64.1 109.388 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -63.41 -30.86 71.92 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.264 0.554 . . . . 33.13 110.377 170.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 14.3 ptt? -147.48 120.15 8.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.931 1.292 . . . . 70.12 108.512 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' E' ' 170' ' ' LYS . 38.0 t80 -174.33 126.63 0.34 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.71 -1.589 . . . . 73.25 106.71 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -138.64 -73.08 0.4 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.069 -0.715 . . . . 75.41 109.069 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp 59.45 79.05 0.24 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.271 1.028 . . . . 52.01 111.46 173.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.95 -59.16 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.4 -0.593 . . . . 74.44 109.4 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 179' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' E' ' 180' ' ' PRO . 20.5 mp0 -74.53 -57.22 2.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.488 0.715 . . . . 64.03 110.901 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 180' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' E' ' 179' ' ' GLU . 66.2 Cg_endo -81.24 4.0 7.35 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.747 1.631 . . . . 63.14 112.521 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -98.2 88.44 4.19 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.227 -1.027 . . . . 72.11 108.227 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -83.98 165.87 18.27 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.494 -0.558 . . . . 75.52 109.494 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 23.5 p -81.01 112.05 18.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.852 0.461 . . . . 53.14 110.122 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.409 ' NE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -70.77 148.21 94.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.997 -0.547 . . . . 71.32 110.2 170.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.16 141.78 98.45 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.38 2.054 . . . . 62.43 111.161 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' C' ' 43' ' ' ASP . 88.0 mt -103.73 7.21 37.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.489 0.716 . . . . 65.43 110.568 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 tt 59.6 164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.527 1.931 . . . . 74.03 112.282 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.02 93.03 0.29 Allowed 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.753 -0.832 . . . . 61.24 108.753 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 189' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' F' ' 201' ' ' LYS . . . -97.48 128.2 44.05 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.766 -0.652 . . . . 54.3 109.508 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -83.33 128.59 34.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.773 0.829 . . . . 71.11 109.272 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 191' ' ' GLY . . . . . 0.641 ' HA3' ' HD2' ' C' ' 38' ' ' PRO . . . -79.83 16.0 13.12 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 115.021 0.768 . . . . 54.11 115.021 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.48 -107.2 2.9 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 118.168 0.984 . . . . 32.51 111.631 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 51.2 t80 179.9 131.25 0.09 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.0 0.92 . . . . 65.24 109.558 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.68 125.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.112 1.365 . . . . 73.43 113.334 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 195' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' C' ' 36' ' ' TRP . 0.2 OUTLIER -96.08 163.09 13.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.977 -0.452 . . . . 74.2 110.141 -178.262 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.94 84.09 1.24 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.905 -0.776 . . . . 73.33 108.905 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -136.92 112.22 9.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.579 1.152 . . . . 73.04 108.213 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -174.42 -68.48 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.549 0.74 . . . . 71.01 109.128 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -92.79 -48.52 6.52 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.789 0.836 . . . . 74.02 109.628 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.32 123.37 1.25 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.79 -0.524 . . . . 75.52 111.79 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -136.34 12.14 3.26 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.131 0.572 . . . . 72.31 111.398 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 202' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' F' ' 190' ' ' ASP . 24.1 t80 -122.84 -12.6 8.01 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.34 0.656 . . . . 73.04 110.556 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.37 179.52 7.81 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.166 0.987 . . . . 60.1 110.722 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.81 103.26 15.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.313 0.578 . . . . 64.33 110.445 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 205' ' ' LYS . . . . . 0.435 ' HD2' ' SD ' ' D' ' 1' ' ' MET . 81.7 tttt -126.7 131.75 51.31 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.995 -1.113 . . . . 74.31 107.995 169.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -163.94 -50.63 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.456 0.702 . . . . 74.41 109.393 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 CA--C 1.554 1.097 0 CA-C-N 114.937 -1.029 . . . . 73.52 109.733 178.637 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.692 -0.485 . . . . 74.12 109.692 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.32 128.87 1.18 Allowed Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.175 -0.466 . . . . 72.35 112.086 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -113.42 -162.42 0.8 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.616 0.767 . . . . 64.52 109.407 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 9.4 m 67.56 174.39 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.259 1.024 . . . . 51.12 110.748 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 172' ' ' ALA . . . . . 0.555 ' HB1' HD22 ' F' ' 173' ' ' LEU . . . -82.17 -86.56 0.1 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.921 -0.487 . . . . 71.42 111.018 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.589 HD12 ' H ' ' B' ' 2' ' ' SER . 2.4 mm? -122.79 -66.47 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.934 -0.479 . . . . 74.4 111.307 -172.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.45 ' SD ' ' HE2' ' B' ' 56' ' ' TYR . 20.5 mmt 74.86 168.74 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.567 1.547 . . . . 75.42 111.054 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 175' ' ' PHE . . . . . 0.491 ' HD1' ' H ' ' F' ' 177' ' ' LEU . 43.5 p90 -159.57 164.87 33.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.528 0.731 . . . . 73.34 110.873 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -118.12 27.36 9.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.003 0.921 . . . . 73.24 109.274 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 177' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' B' ' 48' ' ' SER . 7.0 mp 66.82 70.81 0.39 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.936 1.295 . . . . 64.44 109.977 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -89.82 102.61 15.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.534 -0.757 . . . . 75.3 109.589 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 55.6 83.96 0.22 Allowed Pre-proline 0 CA--C 1.555 1.157 0 O-C-N 124.578 1.174 . . . . 64.01 111.896 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.58 90.69 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.068 2.512 . . . . 55.31 112.253 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 181' ' ' TYR . . . . . 0.451 ' OH ' ' HB2' ' B' ' 137' ' ' PHE . 9.7 t80 68.11 -177.55 0.21 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.172 1.389 . . . . 73.24 112.208 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -87.25 57.17 4.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.59 1.156 . . . . 75.32 109.84 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 26.5 m 69.93 146.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.905 1.282 . . . . 75.42 112.014 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.598 ' HZ3' ' HA ' ' B' ' 100' ' ' ALA . 4.2 t-105 -125.7 85.64 58.69 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 108.693 -0.855 . . . . 73.33 108.693 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 185' ' ' PRO . . . . . 0.409 ' HD2' ' HE2' ' B' ' 133' ' ' PHE . 72.1 Cg_endo -76.79 149.84 30.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.606 2.204 . . . . 63.11 112.52 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.425 HD21 ' HE1' ' F' ' 184' ' ' TRP . 79.0 mt -142.51 168.72 19.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.582 1.153 . . . . 74.42 109.857 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.507 ' H ' HD13 ' F' ' 187' ' ' ILE . 0.2 OUTLIER -76.23 154.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.199 0.6 . . . . 74.13 110.163 175.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.11 -71.37 0.43 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.683 0.393 . . . . 62.23 110.468 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -169.48 143.51 2.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.128 0.971 . . . . 71.35 109.828 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 190' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' E' ' 202' ' ' TYR . 29.7 t70 -173.33 161.6 4.21 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.946 0.779 . . . . 72.3 110.259 174.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.78 -37.93 0.32 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.741 -0.944 . . . . 62.32 110.741 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.0 36.89 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.351 -0.424 . . . . 74.2 112.884 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 193' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' B' ' 37' ' ' GLN . 63.7 m-85 -75.14 171.96 13.22 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.978 0.911 . . . . 74.14 111.699 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -165.17 171.74 13.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.488 1.115 . . . . 60.32 108.894 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -107.09 -86.12 0.5 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 119.264 -0.398 . . . . 73.03 111.441 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 70.73 100.57 0.06 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.315 1.046 . . . . 64.44 109.984 -169.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 197' ' ' TYR . . . . . 0.482 ' HD1' ' HB2' ' F' ' 203' ' ' ASP . 23.3 m-85 -74.35 -18.83 60.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.868 0.467 . . . . 72.43 110.434 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.66 75.4 9.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.977 0.511 . . . . 73.01 109.786 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 64.2 23.9 13.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.521 1.129 . . . . 60.34 112.664 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -86.71 -116.2 1.0 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.678 -0.512 . . . . 65.11 112.511 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 201' ' ' LYS . . . . . 0.412 ' HA ' ' HB1' ' E' ' 189' ' ' ALA . 36.9 pttt -155.73 153.59 30.15 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.617 0.767 . . . . 73.12 109.887 -168.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 63.81 8.74 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.721 1.208 . . . . 74.25 111.81 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 203' ' ' ASP . . . . . 0.482 ' HB2' ' HD1' ' F' ' 197' ' ' TYR . 5.1 p-10 -106.74 -169.58 1.58 Allowed 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.757 1.223 . . . . 75.24 109.139 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.412 HD12 ' HB1' ' C' ' 129' ' ' ALA . 10.9 tt -157.98 100.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 72.33 106.894 167.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -82.87 36.18 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.143 -1.39 . . . . 71.45 112.228 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 22.6 t70 71.42 124.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.26 1.424 . . . . 71.35 111.28 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.708 -0.663 . . . . 62.4 109.675 -178.285 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.893 -0.41 . . . . 74.1 109.893 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 169' ' ' GLY . . . . . 0.542 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 82.58 177.4 51.91 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.567 0.542 . . . . 45.21 113.189 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -147.18 2.61 0.77 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.613 0.765 . . . . 64.12 109.544 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -162.49 177.86 9.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 72.32 111.12 -167.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 172' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 97' ' ' CYS . . . -158.62 136.03 10.1 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 121.116 0.484 . . . . 73.44 112.065 172.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.685 ' HG ' ' HG3' ' G' ' 174' ' ' MET . 1.2 pt? -125.21 -174.03 2.96 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.074 1.35 . . . . 65.03 107.415 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.685 ' HG3' ' HG ' ' G' ' 173' ' ' LEU . 29.1 mtt 64.06 -166.45 0.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.259 0.624 . . . . 73.22 109.617 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.416 ' HE1' HG23 ' A' ' 46' ' ' THR . 8.7 t80 -129.86 -71.15 0.62 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.947 -1.131 . . . . 63.42 107.947 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 55.3 t30 42.85 75.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.449 1.499 . . . . 63.42 113.119 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.84 75.9 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.423 -0.954 . . . . 71.1 108.423 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -65.69 -47.03 76.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.716 -1.584 . . . . 72.22 110.704 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.16 137.62 11.91 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.317 1.047 . . . . 71.01 109.177 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.78 87.1 1.16 Allowed 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.078 2.519 . . . . 74.45 110.972 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -73.12 131.05 41.59 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.191 -0.913 . . . . 74.41 109.258 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 60.64 -165.91 0.21 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.208 1.003 . . . . 75.21 112.597 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -130.27 140.18 50.7 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.787 0.835 . . . . 53.11 109.312 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 184' ' ' TRP . . . . . 0.477 ' HD1' ' H ' ' G' ' 186' ' ' LEU . 4.5 t90 -135.22 92.13 18.36 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.098 -1.445 . . . . 75.34 107.098 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -81.91 0.5 9.8 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.788 2.325 . . . . 74.13 113.598 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 186' ' ' LEU . . . . . 0.519 HD11 HD22 ' A' ' 44' ' ' LEU . 4.5 mm? 62.81 -167.67 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.995 . . . . 71.21 110.903 -175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.633 HD12 ' HE1' ' H' ' 202' ' ' TYR . 13.9 pt -93.5 131.73 39.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.918 0.887 . . . . 74.32 109.96 176.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.62 91.52 2.87 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.545 -0.909 . . . . 74.2 108.545 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -72.65 83.25 1.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.556 -0.747 . . . . 75.54 111.213 -174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.32 125.66 14.77 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.889 -1.152 . . . . 73.33 107.889 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -125.3 -146.95 6.9 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 123.212 0.32 . . . . 33.43 113.668 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.63 54.79 0.74 Allowed Glycine 0 C--N 1.345 1.046 0 C-N-CA 123.36 0.505 . . . . 53.02 112.273 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 66.64 -178.72 0.2 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.52 1.128 . . . . 71.14 112.998 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -152.1 -162.72 1.57 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.558 1.143 . . . . 74.42 108.403 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.456 ' HB3' ' O ' ' H' ' 195' ' ' PHE . 24.3 p90 -61.98 104.63 0.48 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.111 0.482 . . . . 72.1 109.806 171.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.66 53.55 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.72 0.772 . . . . 53.34 109.508 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.05 -77.3 0.02 OUTLIER 'General case' 0 C--N 1.358 0.96 0 C-N-CA 126.053 1.741 . . . . 72.2 112.297 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 66.77 120.82 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.611 1.164 . . . . 73.13 109.852 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.27 86.76 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.41 0.624 . . . . 51.13 111.066 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 200' ' ' GLY . . . . . 0.46 ' HA3' ' HA2' ' H' ' 192' ' ' GLY . . . -97.83 -176.35 33.7 Favored Glycine 0 C--O 1.244 0.761 0 CA-C-N 114.866 -1.061 . . . . 63.35 110.642 171.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -144.48 150.09 37.05 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.902 0.481 . . . . 71.44 110.029 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 202' ' ' TYR . . . . . 0.439 ' HE1' ' HB2' ' D' ' 129' ' ' ALA . 82.1 t80 -117.2 0.85 12.4 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.35 1.06 . . . . 61.11 109.882 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 36.6 t70 69.44 92.97 0.08 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 124.991 1.316 . . . . 74.32 109.492 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.792 ' HA ' HE21 ' B' ' 12' ' ' GLN . 39.9 mm -93.75 92.6 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.172 -0.922 . . . . 63.21 111.622 -167.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 168.38 131.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.15 2.18 . . . . 63.5 108.251 171.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -90.05 -77.93 0.38 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.902 0.481 . . . . 54.33 109.996 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--O 1.245 0.835 0 N-CA-C 107.618 -1.253 . . . . 41.22 107.618 -177.081 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 168' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' B' ' 155' ' ' ALA . 47.2 mmtm . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 110.128 -0.323 . . . . 64.44 110.128 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.29 120.73 23.83 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 123.845 0.716 . . . . 62.01 113.27 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.91 169.33 23.7 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.203 0.601 . . . . 72.55 110.356 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 51.8 m -107.84 -176.1 2.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 50.51 110.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.29 84.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.268 0.627 . . . . 65.2 110.539 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.55 112.27 24.63 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.152 -0.931 . . . . 65.11 109.766 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 18.9 mmt 64.69 -178.44 0.17 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.049 1.34 . . . . 70.41 112.987 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.19 178.01 9.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.825 0.85 . . . . 72.43 109.446 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -109.43 137.52 47.16 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.012 -1.107 . . . . 75.0 108.012 167.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 38.5 tp -77.33 77.53 3.86 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.753 0.787 . . . . 72.42 109.725 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 178' ' ' GLN . . . . . 0.447 ' HG3' ' HG2' ' H' ' 179' ' ' GLU . 4.2 pt20 -81.92 -26.47 34.04 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.131 -0.94 . . . . 61.0 110.515 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 179' ' ' GLU . . . . . 0.447 ' HG2' ' HG3' ' H' ' 178' ' ' GLN . 17.2 pt-20 -169.43 158.47 7.13 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.349 1.059 . . . . 73.54 109.796 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.44 -176.83 2.68 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.712 2.274 . . . . 53.13 111.391 164.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -166.72 -51.75 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.771 -0.826 . . . . 65.42 108.771 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.13 86.47 7.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.925 -1.034 . . . . 43.03 109.831 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 36.0 m -140.06 100.8 4.01 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.534 -0.757 . . . . 74.01 109.305 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -95.13 139.29 21.99 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.576 0.751 . . . . 70.11 110.293 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.33 115.05 3.29 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.692 2.261 . . . . 72.34 111.498 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.48 152.14 45.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.051 -0.522 . . . . 71.43 110.834 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.468 HG12 ' HB3' ' D' ' 129' ' ' ALA . 2.3 pp -60.47 -24.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 114.523 1.305 . . . . 73.22 114.523 -169.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 188' ' ' ALA . . . . . 0.598 ' HA ' HD23 ' D' ' 42' ' ' LEU . . . 67.84 170.98 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.613 1.165 . . . . 52.01 112.821 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.11 171.87 10.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.677 -0.692 . . . . 74.1 109.461 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -136.94 169.82 17.12 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.354 -0.98 . . . . 74.52 108.354 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.33 81.04 0.2 Allowed Glycine 0 C--N 1.346 1.129 0 O-C-N 123.355 0.41 . . . . 74.03 113.445 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 192' ' ' GLY . . . . . 0.46 ' HA2' ' HA3' ' G' ' 200' ' ' GLY . . . -97.03 -142.06 12.91 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 110.325 -1.11 . . . . 72.3 110.325 170.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -165.67 129.96 2.31 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.197 0.498 . . . . 72.0 109.741 171.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.22 36.86 0.14 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.92 0.762 . . . . 65.1 110.079 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.635 ' HD2' ' HA ' ' D' ' 35' ' ' ASP . 0.4 OUTLIER -109.06 -170.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.844 0.857 . . . . 71.44 110.422 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 68.04 89.11 0.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.872 0.869 . . . . 42.12 109.205 -173.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -109.2 70.36 0.73 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.363 -0.977 . . . . 73.24 108.363 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 74.41 163.01 0.26 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 124.369 1.043 . . . . 71.54 110.544 -170.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -162.62 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.858 0.863 . . . . 73.01 109.732 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -100.27 51.28 1.04 Allowed Glycine 0 C--N 1.348 1.209 0 N-CA-C 110.949 -0.86 . . . . 35.12 110.949 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 119.38 3.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.894 1.278 . . . . 74.35 112.406 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 202' ' ' TYR . . . . . 0.633 ' HE1' HD12 ' G' ' 187' ' ' ILE . 37.5 p90 -61.28 140.37 57.98 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.826 -1.079 . . . . 73.13 111.524 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 170.83 13.5 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.191 0.596 . . . . 74.43 110.702 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.521 ' HA ' HG22 ' G' ' 187' ' ' ILE . 2.4 mp -86.44 -62.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.379 -0.971 . . . . 65.45 108.379 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -173.18 -63.17 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.75 0.82 . . . . 71.41 109.655 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t70 179.35 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.051 1.34 . . . . 74.15 107.753 -167.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 114.433 -1.258 . . . . 74.23 109.859 170.73 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 16.3 ptm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.802 -0.444 . . . . 73.4 109.802 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -129.27 -31.63 2.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.429 0.692 . . . . 73.3 110.742 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' C' ' 141' ' ' LEU . 37.2 tt0 66.23 -76.35 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 73.23 109.685 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 55.7 93.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.706 1.203 . . . . 74.32 111.839 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' C' ' 142' ' ' GLN . 45.7 m-80 -71.32 85.88 0.8 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.284 0.564 . . . . 61.41 111.037 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -79.6 154.27 28.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.889 1.276 . . . . 50.12 108.761 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -136.14 30.92 2.98 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.292 0.567 . . . . 61.42 110.686 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.61 -56.2 11.81 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.807 0.813 . . . . 74.34 110.305 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ttt -152.54 159.29 43.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.357 -1.292 . . . . 64.15 108.24 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 m -140.2 123.66 17.05 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 109.552 -0.536 . . . . 74.34 109.552 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.74 135.78 48.12 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.663 0.785 . . . . 53.21 108.956 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -160.52 141.17 11.7 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.647 0.592 . . . . 64.22 112.582 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.36 117.71 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 107.867 -1.16 . . . . 63.51 107.867 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 2.1 mp0 -84.69 -30.6 24.67 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.128 -0.463 . . . . 64.33 110.053 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -175.9 146.91 0.74 Allowed 'General case' 0 C--N 1.371 1.535 0 O-C-N 123.851 0.72 . . . . 64.3 111.046 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.86 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 96.5 mt -129.65 128.23 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.497 -1.297 . . . . 74.44 107.497 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -156.81 166.43 33.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.178 0.991 . . . . 75.13 110.656 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -92.26 119.0 31.44 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.921 -0.77 . . . . 51.21 108.921 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -82.62 -26.28 32.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.002 -0.37 . . . . 61.45 110.002 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.6 t70 -152.94 143.0 22.32 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.261 -0.881 . . . . 75.33 110.35 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.436 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 85.7 mt -138.39 140.88 39.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 C-N-CA 125.536 1.534 . . . . 64.44 106.926 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -149.15 126.68 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.753 0.658 . . . . 74.11 109.624 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 90.1 t80 -130.9 131.97 44.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.405 -1.332 . . . . 72.33 107.405 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.6 131.86 41.9 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -123.39 87.84 51.69 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.61 -1.256 . . . . 74.41 107.61 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.77 -22.76 42.74 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.672 2.248 . . . . 73.13 112.925 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -120.42 38.78 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.615 0.766 . . . . 73.24 109.448 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -59.41 -48.24 96.32 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.125 0.97 . . . . 64.23 113.055 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 10.1 Cg_exo -73.53 -42.04 0.99 Allowed 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.085 1.857 . . . . 43.41 112.266 168.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -62.8 -19.89 64.48 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.055 1.342 . . . . 73.24 112.792 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.66 -24.12 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.279 0.631 . . . . 60.35 111.814 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -54.98 -32.24 61.44 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.971 0.908 . . . . 73.32 112.698 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -86.21 -48.53 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.965 0.906 . . . . 64.4 110.359 -175.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -78.91 128.56 33.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.802 -1.09 . . . . 62.43 112.038 -169.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.56 134.75 57.31 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.482 1.113 . . . . 72.22 111.246 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.581 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 46.6 t-105 -84.49 80.46 9.22 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.906 0.754 . . . . 74.34 111.231 -173.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.92 75.92 74.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.675 -1.231 . . . . 70.1 107.675 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.01 155.96 11.33 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.745 2.296 . . . . 72.3 113.336 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.27 105.76 17.94 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.317 -1.364 . . . . 70.05 107.317 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' G' ' 189' ' ' ALA . 36.0 t -87.24 98.78 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.878 -0.416 . . . . 31.3 109.878 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 85.0 tttt -81.72 130.86 35.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.446 0.698 . . . . 74.41 109.897 175.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD22 ' HB ' ' G' ' 187' ' ' ILE . 5.7 mp -114.67 110.87 20.43 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.754 -0.832 . . . . 64.52 108.754 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.9 t70 -112.92 130.96 55.93 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.984 -1.117 . . . . 63.5 107.984 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.9 tp -117.54 131.27 56.72 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 73.22 109.307 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.68 146.74 40.03 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.945 -0.761 . . . . 71.14 108.945 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -147.55 143.13 27.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.283 -0.636 . . . . 64.44 109.283 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.54 134.11 15.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.63 0.772 . . . . 75.12 109.116 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 20.7 m -88.73 162.66 16.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.133 0.573 . . . . 74.35 110.556 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -149.86 141.15 23.19 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.536 1.134 . . . . 64.31 108.004 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -91.66 133.43 35.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.886 -0.413 . . . . 63.24 109.886 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 57' ' ' GLU . 42.5 mt -118.43 -35.32 3.8 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.803 0.841 . . . . 74.42 109.144 171.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.632 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.04 179.57 7.52 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.599 -1.182 . . . . 62.21 109.848 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.11 122.89 21.74 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.27 -1.011 . . . . 72.42 108.27 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 70.77 -6.38 1.26 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.699 1.199 . . . . 75.32 112.925 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.5 t -105.3 111.07 33.14 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 N-CA-C 108.088 -1.078 . . . . 65.12 108.088 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' G' ' 171' ' ' SER . 21.1 m-30 -119.11 128.12 54.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 64.32 109.796 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 51' ' ' LEU . 13.1 tt0 -82.66 112.22 19.34 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.326 -1.361 . . . . 72.15 107.326 166.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.0 t -100.7 115.62 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.854 -1.535 . . . . 71.12 106.854 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.669 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.7 t -96.29 129.44 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.388 -0.597 . . . . 70.01 109.388 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 111.39 23.67 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.112 -1.44 . . . . 71.02 107.112 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -100.49 102.75 14.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.665 -0.865 . . . . 71.12 108.665 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.4 128.53 46.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.101 -1.074 . . . . 75.13 108.101 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.8 m -113.94 135.99 53.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.848 -0.797 . . . . 73.43 108.848 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -132.49 136.95 55.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 125.568 1.547 . . . . 62.35 107.135 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.7 m -141.63 138.3 32.46 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.99 127.56 45.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.676 -1.601 . . . . 73.34 106.676 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -139.95 131.97 27.85 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.349 0.595 . . . . 63.54 111.688 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.3 mt -89.62 78.19 7.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.577 -1.268 . . . . 73.23 107.577 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -117.04 4.36 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.081 -0.963 . . . . 65.44 111.184 -173.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -87.87 -25.22 23.39 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.522 0.729 . . . . 65.52 110.297 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -79.93 106.8 12.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.078 0.951 . . . . 70.14 109.371 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -65.62 129.92 41.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.238 0.542 . . . . 75.25 111.139 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.28 -52.94 7.11 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.592 1.157 . . . . 71.23 109.004 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -158.25 155.26 28.61 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.464 -0.789 . . . . 62.44 111.396 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -117.94 146.35 44.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.972 1.309 . . . . 75.02 108.422 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 80.9 m -144.93 131.12 19.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.563 1.145 . . . . 23.45 108.85 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.74 128.6 14.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.191 -0.67 . . . . 62.24 109.191 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -130.29 110.4 19.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.437 -0.949 . . . . 73.44 108.437 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.7 mt-30 -86.34 81.01 8.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.7 -0.852 . . . . 72.4 108.7 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.87 93.58 3.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.2 -1.364 . . . . 71.21 109.046 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.16 143.7 16.77 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.766 -0.534 . . . . 74.33 111.766 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.51 131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.044 -0.823 . . . . 34.44 111.044 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 17.3 mt -81.14 128.8 38.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 70.42 108.849 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -136.21 131.0 34.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.086 0.554 . . . . 71.34 110.699 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -83.5 119.67 24.97 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.052 -1.092 . . . . 74.02 108.052 168.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.32 122.48 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 75.23 110.096 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.17 162.95 28.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.632 0.773 . . . . 75.12 109.961 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.05 81.54 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.132 -0.485 . . . . 51.2 112.948 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.46 137.2 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.187 0.995 . . . . 61.1 109.808 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 20.2 tt0 -137.07 -179.11 5.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 73.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 48.95 -124.24 12.3 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 124.02 0.819 . . . . 51.44 114.94 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -79.11 -16.61 56.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.543 0.737 . . . . 50.43 111.608 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.69 -39.88 61.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.679 0.392 . . . . 71.44 110.369 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.05 36.61 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.299 0.24 . . . . 73.14 110.838 175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.7 -30.01 67.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.501 . . . . 62.22 110.072 171.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.48 -44.11 45.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.86 0.864 . . . . 73.13 110.319 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.17 -63.91 1.08 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.259 0.623 . . . . 70.1 111.566 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 tt -71.12 -46.2 62.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.511 0.724 . . . . 64.12 111.031 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.69 -18.25 79.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.742 0.657 . . . . 25.41 114.742 -169.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.56 -51.78 0.69 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.578 0.689 . . . . 74.11 112.205 -172.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.24 -37.29 71.98 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.328 0.651 . . . . 74.01 112.441 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.31 -45.79 13.81 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-O 118.355 -0.831 . . . . 54.01 113.028 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.78 -22.66 68.88 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 121.531 1.487 . . . . 65.24 112.578 168.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -79.38 -22.43 44.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.038 0.535 . . . . 71.13 111.79 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.72 -36.97 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.627 -0.879 . . . . 71.31 108.627 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' A' ' 82' ' ' GLY . 44.1 mt -85.8 -18.31 33.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.115 . . . . 73.14 112.568 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -66.25 -42.62 50.57 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-O 117.709 -1.139 . . . . 75.22 114.013 -171.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.21 -35.27 86.25 Favored 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 121.951 1.733 . . . . 74.51 112.745 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -74.07 -40.8 62.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.654 0.781 . . . . 72.55 111.343 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.22 75.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.332 0.653 . . . . 42.33 109.8 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.584 ' NH1' HG23 ' C' ' 105' ' ' ILE . 34.5 ttm180 -52.11 -55.21 22.27 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.65 1.218 . . . . 73.04 109.893 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.46 -40.65 97.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.204 0.94 . . . . 74.44 111.3 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.604 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -61.87 -35.69 79.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.983 0.513 . . . . 72.21 111.207 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 64' ' ' VAL . 95.6 mt -72.62 -51.02 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 75.31 109.644 173.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 125' ' ' GLN . 97.9 m -53.41 -37.17 62.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.318 1.447 . . . . 64.24 111.227 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.7 t -69.47 -49.65 52.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.927 -1.033 . . . . 54.22 110.118 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 60.7 mtm -57.83 -44.84 86.71 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.346 0.658 . . . . 71.23 110.984 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.3 t -58.73 -48.84 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.386 -1.279 . . . . 75.51 110.608 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -68.78 -29.53 67.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.744 -0.662 . . . . 44.33 111.544 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -73.93 -28.59 61.6 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.64 0.776 . . . . 72.3 110.529 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.89 10.67 51.36 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.954 0.784 . . . . 71.54 112.801 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.452 HG23 ' HB3' ' D' ' 125' ' ' GLN . 3.7 m 66.34 26.05 10.32 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.794 1.238 . . . . 74.04 110.467 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -103.33 157.73 33.23 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.019 -0.991 . . . . 64.13 108.852 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.581 ' HG3' ' HE1' ' A' ' 36' ' ' TRP . 73.1 Cg_endo -68.8 147.54 69.22 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.093 1.862 . . . . 71.13 111.744 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.4 tt0 -58.13 128.88 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 123.949 0.78 . . . . 70.35 110.878 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -108.98 101.32 10.42 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.895 -0.78 . . . . 74.23 108.895 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.471 ' HB3' HD13 ' C' ' 13' ' ' ILE . 92.4 m-20 -98.41 105.18 17.29 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.901 -0.777 . . . . 54.5 108.901 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.554 HD22 HD21 ' A' ' 42' ' ' LEU . 46.0 mt -72.96 139.12 46.51 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.537 -0.756 . . . . 63.43 109.218 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' H' ' 204' ' ' ILE . . . -60.03 138.03 90.97 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.667 0.604 . . . . 45.52 110.433 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 16.1 Cg_endo -76.57 96.93 1.1 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 121.611 1.541 . . . . 63.43 109.143 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.499 HG12 HG21 ' H' ' 207' ' ' VAL . 14.1 m -97.94 112.07 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.977 -1.01 . . . . 75.44 108.37 -171.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -103.91 109.98 21.94 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.797 -1.092 . . . . 55.44 108.325 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.59 -36.34 76.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.53 0.732 . . . . 72.44 111.281 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.05 -45.38 93.03 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.878 0.736 . . . . 73.01 110.441 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.51 81.42 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.995 -1.002 . . . . 53.31 110.653 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -69.81 -26.58 64.31 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 124.055 0.847 . . . . 73.04 111.481 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -70.21 -59.8 2.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.381 0.672 . . . . 65.0 109.292 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.3 mmt -60.35 -32.36 71.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.213 0.605 . . . . 73.21 111.033 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 56.3 t-20 -59.42 -55.23 37.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.589 1.156 . . . . 73.51 109.86 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -64.71 -37.15 86.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.458 -0.792 . . . . 74.44 110.997 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.99 -49.37 70.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.839 0.456 . . . . 64.43 110.979 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -167.95 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.795 0.665 . . . . 72.14 112.795 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 45.6 mt-30 62.04 76.14 0.38 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.41 1.084 . . . . 72.31 109.526 -165.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -101.9 107.24 18.34 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.234 -0.893 . . . . 71.42 109.486 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.576 ' HB2' ' HB3' ' C' ' 8' ' ' GLU . . . -145.25 111.96 5.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.952 0.901 . . . . 51.21 109.483 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.76 16.56 0.04 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.137 -0.483 . . . . 70.24 112.578 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.12 120.66 17.01 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.614 -0.513 . . . . 73.12 109.614 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.71 66.17 0.36 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.121 -0.49 . . . . 41.04 112.196 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 61.8 p -124.74 86.2 2.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.29 0.567 . . . . 73.21 110.545 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.61 124.82 9.41 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.004 -1.11 . . . . 74.42 108.004 166.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 152' ' ' HIS . 36.1 tt0 -161.14 -31.81 0.05 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.53 108.861 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.417 ' H ' ' H ' ' A' ' 151' ' ' GLU . 14.5 p-80 -59.89 -39.32 84.92 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 124.098 0.874 . . . . 73.52 111.765 -169.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 44.76 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.48 1.512 . . . . 71.23 113.137 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 64.8 m-20 -69.8 -44.79 69.34 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 110.405 -0.22 . . . . 73.33 110.405 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.068 0 O-C-N 125.059 1.474 . . . . 64.12 110.877 178.801 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.685 ' SD ' ' HB3' ' D' ' 153' ' ' GLN . 27.8 ttt . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.086 0.469 . . . . 72.12 109.755 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 t -132.65 94.31 3.38 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.475 -1.306 . . . . 70.41 107.475 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.512 ' H ' ' HA ' ' D' ' 150' ' ' GLU . 15.5 mm-40 -75.37 91.29 2.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.272 -0.877 . . . . 72.05 110.847 -172.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -148.89 152.32 36.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.244 0.545 . . . . 60.33 111.173 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -116.12 69.9 0.75 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.009 -1.108 . . . . 64.34 108.009 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -142.1 168.21 20.29 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.311 -1.313 . . . . 75.02 109.477 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.595 HG21 ' HB3' ' D' ' 138' ' ' MET . 2.4 t -131.71 146.04 51.96 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.54 -1.281 . . . . 74.44 107.54 167.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -160.42 -82.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.793 -1.188 . . . . 75.2 107.793 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.49 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.7 ptm 47.78 171.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 126.5 1.92 . . . . 74.25 115.527 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -148.13 140.65 24.46 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.465 -1.243 . . . . 74.24 108.568 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -142.84 131.31 22.34 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 73.14 107.5 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -160.55 139.97 10.79 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.991 0.807 . . . . 75.11 110.021 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.652 HD11 HG13 ' B' ' 16' ' ' ILE . 16.9 tt -95.93 145.23 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.377 1.071 . . . . 71.43 109.836 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.18 -35.07 8.16 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 119.658 -0.21 . . . . 53.41 111.037 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.439 HH21 ' HB ' ' A' ' 122' ' ' THR . 23.0 ttt180 -173.53 144.76 1.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.502 0.321 . . . . 75.24 111.565 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.652 HG13 HD11 ' B' ' 13' ' ' ILE . 60.9 mt -118.94 138.11 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.182 -1.414 . . . . 74.14 107.182 165.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -167.3 142.12 3.89 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.341 1.026 . . . . 74.22 109.339 -170.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.4 m -75.16 118.8 18.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.476 -0.935 . . . . 74.33 108.476 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -85.14 -34.64 22.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.824 -0.625 . . . . 72.54 110.832 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.03 145.92 15.54 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.407 0.442 . . . . 70.03 110.924 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 40.5 mm -135.63 142.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.431 1.092 . . . . 54.03 109.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -136.61 127.93 28.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.921 1.289 . . . . 72.12 108.569 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.42 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.4 t80 -144.38 109.5 5.07 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.873 -1.528 . . . . 72.24 106.873 165.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -123.42 113.35 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.469 -0.937 . . . . 44.42 108.469 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.33 90.02 5.36 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.662 1.185 . . . . 64.23 108.965 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.86 -25.18 53.01 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.285 1.99 . . . . 63.35 111.759 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 92.4 m-20 -121.28 31.46 6.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.441 1.097 . . . . 72.21 110.064 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -46.87 -48.52 51.32 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 125.399 1.48 . . . . 71.51 113.476 172.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.05 -17.83 17.02 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.855 1.703 . . . . 74.31 113.396 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 2.0 m-70 -82.6 -1.24 50.25 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.206 0.817 . . . . 75.11 113.206 -171.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 28' ' ' ALA . 7.2 p -79.84 -25.99 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.239 0.542 . . . . 54.45 109.812 166.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -78.96 -32.01 45.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.564 ' HA ' HE21 ' B' ' 33' ' ' GLN . 0.0 OUTLIER -71.43 -45.0 63.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.146 -0.479 . . . . 61.21 110.716 177.518 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -108.08 110.46 22.14 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.234 1.014 . . . . 72.22 109.252 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -74.12 79.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.136 0.575 . . . . 71.23 111.487 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -162.15 151.09 15.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.194 -1.41 . . . . 75.55 107.194 169.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' F' ' 197' ' ' TYR . 72.9 mt-30 -92.23 133.17 30.53 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.08 0.952 . . . . 42.42 109.443 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 158.26 35.6 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.023 2.482 . . . . 73.01 113.818 -169.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.27 107.95 12.41 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.917 -0.771 . . . . 71.42 108.917 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.549 HG12 HD23 ' B' ' 126' ' ' LEU . 17.7 t -95.28 123.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.576 0.751 . . . . 73.42 109.12 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -136.85 145.31 44.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.624 0.77 . . . . 72.14 110.845 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.701 HD21 HD23 ' B' ' 128' ' ' LEU . 2.4 pt? -116.8 166.54 12.02 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.365 0.666 . . . . 73.33 111.572 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -150.14 154.35 37.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.225 1.41 . . . . 74.3 108.142 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -94.54 148.99 21.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.166 0.586 . . . . 63.21 111.106 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -141.79 154.59 45.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.855 1.262 . . . . 72.44 108.943 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 72.0 p -122.92 134.8 54.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.547 . . . . 74.5 110.468 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.34 32.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.241 -1.022 . . . . 72.1 108.241 170.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.2 p -147.93 167.7 24.18 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.801 0.334 . . . . 71.24 111.367 172.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.1 p -151.32 136.55 17.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.378 1.071 . . . . 73.34 108.69 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.84 129.69 35.12 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.471 -0.566 . . . . 62.02 109.471 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 mt -95.58 -47.21 6.32 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.442 -0.577 . . . . 75.02 109.442 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.26 -172.93 4.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.984 0.913 . . . . 74.53 110.179 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 103.07 0.3 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.09 -0.959 . . . . 74.43 110.148 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.52 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 4.9 m-20 65.38 12.82 8.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.917 1.287 . . . . 74.44 113.094 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -104.59 86.51 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 105.999 -1.852 . . . . 61.33 105.999 166.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.489 ' HE1' ' HG3' ' F' ' 174' ' ' MET . 17.1 p90 -109.39 141.6 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.877 0.846 . . . . 75.23 109.762 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -103.54 115.84 31.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.058 -1.428 . . . . 73.44 107.994 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.98 127.73 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.881 0.472 . . . . 73.35 109.784 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -102.03 115.97 44.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.168 0.987 . . . . 72.22 108.612 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 109.6 20.96 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.8 -1.185 . . . . 75.04 107.8 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -99.99 126.03 46.11 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.738 -0.468 . . . . 74.41 109.738 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.4 t -118.25 126.83 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.153 -1.055 . . . . 52.12 108.153 171.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 29.1 m -97.13 149.64 21.75 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.548 0.739 . . . . 73.14 109.147 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.727 HG21 HG21 ' B' ' 114' ' ' ILE . 55.6 t -135.33 132.73 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.266 1.026 . . . . 65.41 109.358 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -124.16 139.22 54.14 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.444 -0.947 . . . . 73.41 108.444 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.38 149.63 36.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.797 0.839 . . . . 64.44 109.072 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.7 p -144.95 132.65 21.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.367 0.877 . . . . 71.41 113.367 -174.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 27.6 mt -95.6 104.73 16.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.151 1.38 . . . . 61.34 108.495 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.75 -103.38 1.11 Allowed Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.042 -1.075 . . . . 54.53 111.18 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.18 3.55 11.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.47 1.508 . . . . 65.32 111.799 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.451 ' HB3' ' HG3' ' C' ' 153' ' ' GLN . 23.7 pt-20 -116.29 161.49 18.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.978 0.511 . . . . 61.53 111.15 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -77.65 113.28 15.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.066 0.547 . . . . 74.15 110.554 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.475 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -68.25 -59.39 3.24 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.872 -0.788 . . . . 73.33 108.872 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.02 168.47 27.15 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.117 -0.947 . . . . 73.44 111.425 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -130.39 113.28 14.14 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.743 -1.577 . . . . 63.04 106.743 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.0 t -118.11 153.14 34.27 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.893 -0.78 . . . . 71.14 108.893 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.82 132.8 3.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.88 144.07 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.709 0.803 . . . . 73.3 109.065 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -121.75 84.35 2.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.509 -0.923 . . . . 63.52 108.509 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 59.4 tp60 -82.26 99.88 9.57 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 114.716 -1.129 . . . . 74.52 108.835 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.69 159.75 26.05 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.809 -0.517 . . . . 65.41 111.809 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.62 129.27 2.02 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.09 -0.804 . . . . 74.23 111.09 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.3 mt -86.64 130.71 36.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 N-CA-C 109.381 -0.6 . . . . 70.21 109.381 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -131.37 146.19 52.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.23 0.538 . . . . 73.21 110.205 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -127.92 112.83 15.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.883 1.273 . . . . 72.21 108.354 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 5.1 tt -139.48 140.54 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.638 0.775 . . . . 63.01 110.476 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 173.52 16.87 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.745 0.418 . . . . 25.42 111.532 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' F' ' 172' ' ' ALA . . . 95.59 -69.59 1.03 Allowed Glycine 0 C--N 1.351 1.392 0 C-N-CA 124.023 0.82 . . . . 64.12 112.886 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.518 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -74.51 169.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.627 0.771 . . . . 75.25 111.559 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.88 -171.93 2.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.178 0.591 . . . . 73.05 111.552 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.47 -105.81 1.62 Allowed Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.13 -0.941 . . . . 75.04 112.837 172.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -77.73 -33.07 53.09 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 64.35 110.828 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -75.74 -38.85 58.11 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.184 0.593 . . . . 71.02 111.321 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptm -67.91 -34.43 76.62 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 120.871 0.367 . . . . 74.45 110.323 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.13 80.23 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.825 0.85 . . . . 75.53 110.899 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -71.32 -30.22 65.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.041 -0.981 . . . . 74.22 110.93 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.62 -69.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.169 0.293 . . . . 72.13 110.935 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.86 -19.78 60.62 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 111.928 0.344 . . . . 72.43 111.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.95 -25.65 44.32 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.574 0.546 . . . . 62.32 114.033 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -47.16 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.165 0.802 . . . . 75.31 113.165 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.03 -49.14 20.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.067 0.547 . . . . 74.25 111.955 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.4 m -60.45 -46.97 97.48 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.964 0.905 . . . . 42.13 111.91 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.76 -30.9 49.65 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 121.229 1.286 . . . . 70.53 112.951 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.83 -27.7 68.44 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.747 0.703 . . . . 75.21 111.22 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.472 HG23 ' NH2' ' D' ' 111' ' ' ARG . 70.3 mt -64.51 -43.61 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 64.44 110.192 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.76 -14.54 47.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.09 0.956 . . . . 75.44 111.784 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' B' ' 128' ' ' LEU . 33.7 t80 -60.19 -47.26 97.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.063 1.345 . . . . 74.01 113.192 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' D' ' 112' ' ' GLU . 18.6 Cg_endo -58.06 -35.97 98.34 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.06 1.84 . . . . 74.4 113.706 174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 65.4 m-85 -69.7 -46.14 66.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 75.51 110.802 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.459 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.693 0.797 . . . . 71.21 110.345 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.444 ' NH2' ' HG3' ' B' ' 130' ' ' PRO . 33.4 mtp180 -50.48 -54.94 18.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.43 1.092 . . . . 75.33 110.789 173.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.8 -33.85 76.53 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.982 -1.008 . . . . 63.11 110.681 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -72.88 -41.15 65.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.098 0.559 . . . . 61.23 111.259 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.727 HG21 HG21 ' B' ' 64' ' ' VAL . 52.7 mt -65.6 -48.14 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.869 . . . . 74.23 108.652 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -51.51 -35.97 42.63 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 124.536 1.148 . . . . 61.24 111.177 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.9 t -69.24 -55.03 11.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.626 0.77 . . . . 62.21 110.826 175.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.465 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 18.0 mmt -65.67 -33.37 75.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.016 0.526 . . . . 72.32 111.901 -172.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.53 -41.42 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.055 0.942 . . . . 73.11 110.374 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.475 ' HB3' HE22 ' C' ' 125' ' ' GLN . 90.0 p -70.1 -26.05 63.79 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.27 0.557 . . . . 71.45 112.149 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.604 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 80.1 mtt-85 -68.6 -34.01 75.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.365 -0.834 . . . . 44.23 110.441 175.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.6 13.09 54.11 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.847 0.717 . . . . 72.43 112.738 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.25 42.21 12.32 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.554 1.942 . . . . 62.15 112.497 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.602 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 71.3 m-85 -120.32 172.78 4.27 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 114.167 -1.378 . . . . 75.1 109.333 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 85.3 Cg_endo -73.08 -167.55 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.965 2.444 . . . . 74.41 116.107 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -66.89 155.58 38.02 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.758 -1.564 . . . . 62.41 111.054 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' B' ' 42' ' ' LEU . 3.4 tm? -135.23 84.91 2.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.974 -2.232 . . . . 74.32 104.974 163.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -123.58 95.4 4.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.287 -1.375 . . . . 74.25 107.287 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.701 HD23 HD21 ' B' ' 42' ' ' LEU . 2.7 tm? -64.29 145.38 56.11 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.17 -0.923 . . . . 72.53 109.863 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -53.46 110.6 2.12 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 124.633 1.208 . . . . 74.22 110.426 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.687 ' HB2' HD13 ' D' ' 16' ' ' ILE . 10.3 Cg_exo -65.61 132.67 31.64 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.152 1.901 . . . . 73.24 110.319 -173.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.63 137.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.061 -0.348 . . . . 75.43 110.061 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -87.07 117.73 25.99 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.801 0.841 . . . . 50.23 109.015 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.489 ' HZ ' ' HB2' ' F' ' 182' ' ' PHE . 47.3 t80 -61.06 -16.45 43.96 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.531 1.132 . . . . 73.21 113.1 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' B' ' 138' ' ' MET . 7.1 m-20 -55.06 -36.41 65.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.968 0.507 . . . . 64.43 112.011 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.22 -49.25 64.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.956 0.902 . . . . 63.23 111.837 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.05 -43.92 95.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.181 -0.918 . . . . 71.05 110.092 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -67.21 -35.85 80.47 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.725 -1.125 . . . . 72.33 111.092 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 24.6 mmt -65.69 -37.6 86.92 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.909 0.484 . . . . 75.23 110.147 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -76.4 -17.61 59.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.612 0.765 . . . . 74.43 112.076 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -73.18 -30.98 63.94 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.149 0.58 . . . . 71.5 110.977 178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.19 12.96 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.534 0.734 . . . . 70.5 111.255 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' B' ' 138' ' ' MET . 52.6 tt0 -96.47 142.91 27.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.423 0.689 . . . . 65.12 111.471 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -136.11 172.32 13.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.882 0.873 . . . . 74.24 109.485 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.511 ' HA ' ' HG2' ' D' ' 8' ' ' GLU . 4.8 pm0 -157.32 140.69 15.57 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.465 0.706 . . . . 73.43 110.011 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.92 18.09 0.1 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.608 0.763 . . . . 73.2 111.079 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.401 ' HA3' ' HB ' ' D' ' 7' ' ' THR . . . -98.0 -147.8 22.83 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.338 -0.392 . . . . 72.04 113.631 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -141.63 144.33 34.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.803 0.841 . . . . 72.31 109.896 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 113.64 3.95 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.323 -1.111 . . . . 73.45 110.323 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' D' ' 4' ' ' GLN . 18.4 p -72.24 -177.92 2.3 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.917 0.487 . . . . 71.35 110.883 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.914 -0.491 . . . . 75.3 110.174 -169.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.18 93.79 0.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 106.718 -1.586 . . . . 60.15 106.718 168.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -132.11 64.65 1.59 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.899 -0.778 . . . . 73.14 108.899 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.9 92.51 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.268 -1.382 . . . . 70.44 107.268 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.74 -175.38 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.774 0.83 . . . . 75.44 110.238 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 N-CA-C 109.213 -0.662 . . . . 61.13 109.213 175.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 108.433 -0.951 . . . . 73.33 108.433 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m 63.27 78.81 0.28 Allowed 'General case' 0 C--N 1.353 0.755 0 O-C-N 124.449 1.093 . . . . 71.23 109.11 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.77 -31.65 69.71 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.882 -1.054 . . . . 65.12 110.87 -172.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -67.8 92.85 0.36 Allowed 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 122.128 0.966 . . . . 63.43 109.916 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -91.88 -65.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.573 -0.899 . . . . 61.31 108.573 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -167.38 52.3 0.07 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.205 -1.406 . . . . 73.42 107.205 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -128.89 136.43 50.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.811 . . . . 63.44 110.813 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 145' ' ' ALA . 43.6 tt0 -144.08 -77.28 0.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.975 0.91 . . . . 63.52 108.55 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.421 ' HG2' ' HB2' ' C' ' 97' ' ' CYS . 4.3 mpp? 59.53 114.97 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.125 1.37 . . . . 70.44 111.432 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.9 m -116.68 93.99 4.43 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.764 -0.653 . . . . 71.42 109.743 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.434 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 0.5 OUTLIER -120.91 163.53 18.08 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 116.04 -0.527 . . . . 72.33 109.79 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -136.12 129.76 32.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.005 -0.998 . . . . 71.41 108.993 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 127' ' ' ASN . 17.7 tt -66.19 137.79 24.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.253 1.021 . . . . 61.23 110.178 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 92.0 mm-40 -111.79 -45.45 3.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.202 -0.454 . . . . 64.15 110.101 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.585 HH22 ' HD1' ' H' ' 197' ' ' TYR . 18.9 ttt180 -174.98 142.02 0.62 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.604 0.565 . . . . 75.13 110.974 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.22 138.21 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.771 -1.196 . . . . 73.14 107.771 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.45 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -171.46 161.51 6.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.318 0.58 . . . . 71.34 110.95 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -86.36 105.0 16.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.03 -0.986 . . . . 74.32 109.01 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -67.46 -46.64 72.43 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.754 0.787 . . . . 64.2 109.426 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.4 t70 -136.12 145.25 45.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.224 -1.353 . . . . 52.23 109.441 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.7 mt -140.3 144.31 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.292 -1.373 . . . . 72.33 107.292 175.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.4 t -152.71 145.73 24.54 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.337 0.589 . . . . 72.01 110.198 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -149.15 120.79 8.03 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.373 -1.343 . . . . 71.14 107.373 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -126.01 124.11 39.98 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.482 -0.932 . . . . 71.55 108.482 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -111.39 89.72 10.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.172 -1.047 . . . . 72.03 108.172 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.88 -31.41 93.75 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.473 2.782 . . . . 53.52 112.926 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.432 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 87.2 m-20 -119.04 36.03 4.61 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 114.53 -1.214 . . . . 73.45 109.668 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' C' ' 25' ' ' ALA . . . -49.79 -48.6 77.0 Favored Pre-proline 0 CA--C 1.572 1.82 0 N-CA-C 114.213 1.19 . . . . 73.34 114.213 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.37 -29.54 1.46 Allowed 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.782 1.655 . . . . 40.42 113.069 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.432 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 41.3 t60 -69.59 -31.36 69.47 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.803 1.241 . . . . 72.22 112.328 -171.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.606 HG23 HD11 ' C' ' 68' ' ' LEU . 12.8 p -79.66 -19.3 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.836 1.254 . . . . 73.54 112.074 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.34 -39.24 69.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.01 0.924 . . . . 60.12 112.518 -171.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -113.41 45.95 1.33 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.941 0.877 . . . . 72.21 109.389 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 167.71 12.58 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.298 -0.631 . . . . 73.05 109.298 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.15 116.97 4.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.911 -0.774 . . . . 72.12 108.911 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -84.8 68.9 10.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.788 0.68 . . . . 74.05 111.428 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -140.59 79.33 20.11 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.508 0.723 . . . . 74.1 109.512 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.629 ' HD2' ' HB2' ' E' ' 193' ' ' TYR . 3.9 Cg_exo -79.45 135.81 12.07 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.437 2.091 . . . . 54.1 109.963 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.56 118.74 24.01 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.003 -1.11 . . . . 64.14 108.003 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.628 HG11 HD21 ' C' ' 128' ' ' LEU . 24.7 t -65.46 95.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.095 1.497 . . . . 72.1 108.822 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 0.5 OUTLIER -110.95 116.13 30.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.241 -1.022 . . . . 73.05 108.241 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.62 137.54 54.87 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.107 -1.071 . . . . 72.31 108.107 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -147.81 145.44 28.75 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.328 0.651 . . . . 65.24 109.398 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.599 ' HB2' HD22 ' E' ' 186' ' ' LEU . 48.7 tp -113.6 132.56 55.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 64.32 110.275 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.686 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 4.3 m-20 -114.65 134.77 54.81 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 106.869 -1.53 . . . . 73.23 106.869 171.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -114.2 132.12 56.22 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.943 0.402 . . . . 73.34 110.391 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.06 147.15 45.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.984 0.914 . . . . 64.14 108.982 173.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -139.6 144.01 37.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.473 0.709 . . . . 74.11 109.805 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -146.23 134.26 21.48 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.832 0.853 . . . . 74.11 109.407 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -74.94 147.5 40.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.468 -0.938 . . . . 65.31 108.468 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.56 HD11 HD12 ' C' ' 83' ' ' ILE . 86.5 mt -118.25 -37.57 3.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.849 0.86 . . . . 74.43 110.401 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.39 -168.8 1.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.155 0.582 . . . . 73.13 110.858 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.47 116.26 5.41 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.197 -0.91 . . . . 73.41 109.419 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.631 ' HA ' HD23 ' E' ' 173' ' ' LEU . 20.2 m-20 62.09 18.11 9.71 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 124.549 1.14 . . . . 71.11 112.324 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' C' ' 51' ' ' LEU . 67.8 t -120.86 107.47 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.567 0.747 . . . . 71.23 109.299 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.89 161.53 14.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.847 0.832 . . . . 73.13 110.757 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.547 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.2 tt0 -127.82 126.1 41.03 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.412 -1.722 . . . . 74.33 107.673 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 123.38 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.332 -0.618 . . . . 72.44 109.332 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.67 111.44 34.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.36 1.064 . . . . 73.21 108.668 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.99 100.01 12.3 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.055 -0.72 . . . . 74.02 109.055 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 41.2 ttm180 -82.33 100.09 9.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.85 -1.537 . . . . 73.51 106.85 171.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.5 t -103.16 113.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.495 -1.298 . . . . 64.42 107.495 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.8 m -118.71 131.52 56.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.883 -0.598 . . . . 71.03 110.106 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.606 HG21 HG21 ' C' ' 114' ' ' ILE . 55.2 t -114.89 131.39 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.668 1.187 . . . . 64.41 110.242 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 9.4 m -110.22 146.58 35.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 164.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 110.74 8.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.677 -1.231 . . . . 74.33 107.677 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -135.19 133.34 38.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.364 0.602 . . . . 74.02 111.449 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.606 HD11 HG23 ' C' ' 31' ' ' VAL . 4.0 mt -85.5 14.58 5.37 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 125.195 1.398 . . . . 65.34 110.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.75 -96.28 0.48 Allowed Glycine 0 C--N 1.35 1.357 0 N-CA-C 110.505 -1.038 . . . . 74.15 110.505 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.32 -25.77 15.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.23 1.012 . . . . 73.11 109.55 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -87.71 116.94 26.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.211 1.004 . . . . 75.43 108.523 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -86.31 129.36 34.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.477 0.581 . . . . 62.2 110.256 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.66 -52.78 9.01 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.76 0.824 . . . . 74.12 109.843 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -163.39 175.13 11.11 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.553 0.692 . . . . 75.15 111.391 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.461 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -133.1 146.77 51.94 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.503 -1.666 . . . . 62.35 106.503 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.607 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.5 t -150.99 150.82 31.23 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.312 -0.625 . . . . 75.02 109.312 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.27 140.45 10.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.952 0.501 . . . . 52.04 109.929 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -135.35 134.05 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.344 -0.984 . . . . 51.52 108.344 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.706 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -109.63 92.68 4.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.088 -0.708 . . . . 75.04 109.088 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -81.21 107.32 13.9 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.556 -1.202 . . . . 71.32 109.934 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.63 145.35 18.3 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.449 -0.661 . . . . 70.52 111.449 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.484 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.22 117.24 0.98 Allowed Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.069 -0.812 . . . . 71.35 111.069 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.56 HD12 HD11 ' C' ' 51' ' ' LEU . 6.7 mm -86.53 126.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 N-CA-C 108.843 -0.799 . . . . 74.25 108.843 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -136.68 122.6 20.1 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.442 -0.947 . . . . 73.14 108.442 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -76.74 96.58 4.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.753 -0.832 . . . . 71.35 108.753 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.652 HD13 ' HE3' ' C' ' 94' ' ' MET . 2.7 pp -96.45 136.02 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.327 1.051 . . . . 73.41 111.131 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.42 -169.35 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.64 0.776 . . . . 65.1 110.018 172.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.39 -60.11 0.69 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.93 -0.468 . . . . 55.04 111.93 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.656 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -100.55 -167.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.337 1.055 . . . . 54.22 112.356 -171.008 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 174.57 11.89 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.09 0.956 . . . . 52.24 110.132 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.85 -120.0 8.43 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.583 1.393 . . . . 61.53 116.583 163.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -26.2 61.75 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.26 1.024 . . . . 71.42 111.763 -173.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -36.94 72.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.413 -0.958 . . . . 64.32 108.413 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.652 ' HE3' HD13 ' C' ' 86' ' ' ILE . 34.7 tpp -71.14 -44.81 64.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.175 -0.92 . . . . 73.13 110.064 169.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.16 -29.19 70.18 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.223 0.609 . . . . 54.11 112.21 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -83.01 -45.29 14.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.29 0.636 . . . . 73.54 110.309 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.421 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 53.5 t -66.55 -60.4 2.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.487 -0.779 . . . . 73.12 110.18 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.543 ' HB2' ' SD ' ' C' ' 94' ' ' MET . 14.6 tp -64.84 -21.42 66.79 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.605 1.162 . . . . 64.14 111.329 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.87 -29.54 38.21 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.99 -0.55 . . . . 75.42 114.379 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.6 -42.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.765 0.782 . . . . 65.14 112.767 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 63.9 t80 -71.21 -49.39 43.95 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.177 0.591 . . . . 73.34 112.13 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 22.0 m -61.96 -47.97 89.84 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 123.053 0.541 . . . . 62.11 110.782 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 79.6 Cg_exo -56.11 -37.25 96.7 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 122.1 1.867 . . . . 41.35 114.429 169.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -64.47 -27.79 69.22 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.841 0.456 . . . . 60.21 111.254 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.584 HG23 ' NH1' ' A' ' 111' ' ' ARG . 43.6 mm -65.39 -46.55 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.722 -0.672 . . . . 73.42 109.831 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.484 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.6 mt -79.89 -24.18 41.35 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.088 -0.96 . . . . 73.42 112.351 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.57 -50.57 86.15 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-O 117.592 -1.195 . . . . 74.15 113.608 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.65 -32.6 93.43 Favored 'Trans proline' 0 C--N 1.384 2.422 0 CA-C-N 121.589 1.603 . . . . 71.42 112.96 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -65.54 -47.63 75.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.12 0.568 . . . . 75.51 110.519 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.67 96.58 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.895 0.878 . . . . 74.43 111.166 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -62.89 -52.64 62.29 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.464 1.506 . . . . 74.0 110.123 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -68.98 -27.49 65.76 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.673 0.608 . . . . 72.11 110.441 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -64.42 -51.18 64.48 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.941 -0.392 . . . . 71.41 109.941 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.607 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -61.54 -49.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 123.431 0.457 . . . . 75.34 110.104 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -43.81 -45.07 7.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.121 1.369 . . . . 74.32 111.493 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -68.14 -51.69 43.19 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 113.561 -1.654 . . . . 35.25 110.703 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.493 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 13.8 mmm -57.49 -40.35 78.44 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.951 0.9 . . . . 64.02 112.245 -173.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' C' ' 126' ' ' LEU . 98.9 t -64.78 -44.73 96.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.128 -0.942 . . . . 61.45 110.782 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.3 t -66.16 -26.56 67.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.059 -0.973 . . . . 73.35 111.021 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.1 mtt-85 -68.41 -32.74 72.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.769 0.828 . . . . 45.22 110.541 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 9.75 67.49 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 115.856 -0.611 . . . . 53.33 113.014 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 6.3 p 61.93 24.31 14.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.449 1.9 . . . . 73.44 113.122 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.89 158.7 32.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 109.208 -0.664 . . . . 75.35 109.208 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.75 115.98 2.9 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.331 2.021 . . . . 72.54 110.556 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.475 HE22 ' HB3' ' B' ' 119' ' ' SER . 3.4 pt20 -45.91 147.29 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.705 1.253 . . . . 70.35 112.591 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.553 ' HB2' HG21 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -98.32 76.23 2.3 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.513 -0.921 . . . . 71.2 108.513 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -110.52 89.43 3.03 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.701 -1.222 . . . . 61.43 107.701 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.628 HD21 HG11 ' C' ' 40' ' ' VAL . 30.4 mt -84.68 151.94 24.11 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.656 0.741 . . . . 70.04 110.248 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.558 ' HB1' ' HB ' ' F' ' 204' ' ' ILE . . . -60.59 156.02 46.26 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 112.858 -1.974 . . . . 51.04 113.071 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.86 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 38.3 Cg_endo -60.52 125.1 16.5 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 124.138 3.225 . . . . 75.44 113.956 -173.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.03 111.69 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.304 0.642 . . . . 64.32 110.364 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -115.73 108.43 16.35 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.501 1.121 . . . . 63.21 109.162 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -52.49 -40.75 62.73 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.784 0.834 . . . . 74.11 112.488 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.38 -34.82 74.43 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.119 0.887 . . . . 75.52 110.419 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.69 75.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 71.12 111.062 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.407 HD12 ' HB ' ' F' ' 207' ' ' VAL . 10.4 tt -61.11 -38.4 86.19 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.632 0.773 . . . . 65.44 110.298 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -70.96 -42.38 69.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.701 0.801 . . . . 75.31 110.823 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 68.1 mtt -74.3 -29.69 61.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.503 0.721 . . . . 74.44 111.439 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -70.38 -37.13 74.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.999 0.92 . . . . 72.41 109.324 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -161.61 0.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.383 -0.826 . . . . 74.41 109.864 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 3.5 mm? 45.11 30.01 0.56 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.343 0.657 . . . . 64.23 111.703 -170.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 7.7 tt0 175.72 154.26 0.17 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.144 1.377 . . . . 73.13 108.937 -171.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 112.83 12.83 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.617 -1.623 . . . . 70.25 106.617 167.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -127.65 131.48 49.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.281 0.632 . . . . 73.21 109.841 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.19 41.47 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.496 0.719 . . . . 62.33 110.742 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.15 178.21 22.68 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 111.458 -0.657 . . . . 35.43 111.458 173.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.45 127.48 22.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.895 0.478 . . . . 72.3 109.966 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.98 161.04 30.24 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.876 0.735 . . . . 42.35 112.663 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -138.71 176.05 9.03 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 61.03 111.147 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.73 -28.93 9.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.875 0.87 . . . . 71.31 110.003 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.93 -134.35 1.1 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.936 1.294 . . . . 63.14 109.183 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.92 140.92 31.35 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.21 0.914 . . . . 71.13 110.839 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.451 ' HG3' ' HB3' ' B' ' 71' ' ' GLU . 2.1 mp0 -62.97 101.72 0.3 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.521 1.128 . . . . 63.0 109.709 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.17 -46.73 76.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.603 0.761 . . . . 74.13 110.398 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.864 0 CA-C-N 114.98 -1.009 . . . . 44.35 110.4 177.454 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 122.355 1.074 . . . . 62.15 109.989 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -163.87 -168.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.588 -1.187 . . . . 62.52 108.394 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -75.57 123.62 25.8 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.358 0.663 . . . . 62.12 110.38 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.568 ' HG2' ' H ' ' D' ' 5' ' ' ASN . 25.5 tt0 -178.21 -156.37 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 106.5 -1.667 . . . . 72.34 106.5 173.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.568 ' H ' ' HG2' ' D' ' 4' ' ' GLN . 1.4 p-10 -68.54 79.91 0.27 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 119.253 0.933 . . . . 72.24 110.711 172.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -73.76 128.61 35.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.587 -0.894 . . . . 64.53 108.587 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.401 ' HB ' ' HA3' ' B' ' 146' ' ' GLY . 6.1 m -70.25 138.24 51.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 110.044 -0.354 . . . . 75.22 110.044 -170.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' B' ' 144' ' ' GLN . 5.5 mp0 64.52 84.74 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.055 1.342 . . . . 74.05 109.644 -165.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.416 ' HG3' HG23 ' D' ' 89' ' ' ILE . 8.8 ttp -30.32 127.5 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.187 1.395 . . . . 75.34 113.519 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.1 m -106.82 137.62 44.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.143 -1.058 . . . . 72.43 108.143 167.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 48.3 t80 -157.9 99.08 1.67 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.698 -1.223 . . . . 70.31 107.698 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.46 157.58 46.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.248 -1.019 . . . . 64.34 108.248 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.657 HG12 HD11 ' D' ' 16' ' ' ILE . 6.7 tp -98.18 140.5 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 123.197 0.599 . . . . 72.54 110.439 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -106.9 -33.04 7.65 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.579 0.752 . . . . 75.33 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -173.07 142.78 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 119.418 -0.325 . . . . 73.43 110.819 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' B' ' 130' ' ' PRO . 3.6 mp -121.11 130.12 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.291 -1.374 . . . . 63.23 107.291 171.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -155.75 160.63 40.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.598 0.759 . . . . 72.53 110.679 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -86.43 118.31 25.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 71.31 109.567 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -86.88 -31.12 20.92 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.3 -0.409 . . . . 53.35 110.397 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.691 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.6 t70 -149.79 135.08 18.16 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.173 -0.921 . . . . 61.42 108.956 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.472 HD13 ' SG ' ' D' ' 113' ' ' CYS . 84.3 mt -135.53 139.06 47.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.912 -1.144 . . . . 51.13 107.912 175.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -142.66 131.5 22.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.823 0.849 . . . . 71.23 108.755 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.8 t80 -134.4 117.52 16.41 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.162 -1.792 . . . . 74.42 106.162 167.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.4 122.95 32.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.311 0.644 . . . . 64.31 109.753 -170.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.05 88.81 18.11 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.595 -0.891 . . . . 71.15 108.595 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.67 -37.14 12.86 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.869 2.379 . . . . 64.11 113.243 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -112.4 35.03 3.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.935 -0.765 . . . . 73.54 108.935 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.83 -64.36 0.88 Allowed Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.973 1.471 . . . . 33.13 114.973 -163.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.15 -9.43 16.54 Favored 'Trans proline' 0 C--N 1.381 2.279 0 CA-C-N 122.3 1.857 . . . . 75.22 113.14 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -84.45 -38.68 19.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 71.12 110.599 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.3 p -81.66 -12.29 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.979 0.418 . . . . 63.22 111.414 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.84 -7.57 53.86 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.257 0.465 . . . . 72.14 112.257 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -74.39 -20.8 59.93 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.513 0.725 . . . . 71.13 110.653 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.94 76.01 10.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.853 1.261 . . . . 61.12 110.083 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -84.96 67.89 10.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.152 0.977 . . . . 62.41 111.578 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -147.4 -179.43 6.84 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.634 1.174 . . . . 74.44 108.553 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -66.65 122.1 80.46 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.673 0.389 . . . . 55.45 111.444 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HG3' HD21 ' D' ' 68' ' ' LEU . 7.7 Cg_exo -75.75 133.75 15.84 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.281 2.654 . . . . 72.25 111.631 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' H' ' 189' ' ' ALA . 57.4 tt0 -88.66 132.39 34.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.704 -0.48 . . . . 73.31 109.704 172.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.89 140.07 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.785 0.834 . . . . 74.12 110.004 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 75.2 mmtt -116.0 112.92 22.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.49 1.116 . . . . 64.04 108.033 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.745 HD21 HD22 ' D' ' 128' ' ' LEU . 10.0 mp -95.79 119.79 34.92 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.478 -0.564 . . . . 73.05 109.478 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -113.17 141.75 46.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.236 -1.024 . . . . 72.14 108.236 173.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -118.61 130.96 56.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.473 0.709 . . . . 72.22 110.142 -171.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.6 t70 -139.23 146.14 40.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.079 0.952 . . . . 65.14 108.687 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 49.0 m -141.86 143.98 33.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.63 -0.878 . . . . 60.54 108.63 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.97 162.96 38.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.065 0.946 . . . . 62.24 108.806 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -151.87 155.65 38.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.492 0.317 . . . . 51.4 111.535 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.0 p -155.37 126.92 7.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.63 1.172 . . . . 53.3 109.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.51 123.55 24.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.622 0.769 . . . . 70.34 111.121 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.6 mt -90.63 -33.52 15.81 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.328 0.393 . . . . 72.23 110.588 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.17 -170.11 0.94 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.06 0.544 . . . . 74.24 111.82 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.22 121.99 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.825 0.85 . . . . 60.42 110.043 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 64.42 4.33 2.18 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.346 1.458 . . . . 74.44 112.212 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.04 124.82 67.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.93 0.892 . . . . 62.11 108.833 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.74 128.98 23.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.735 -1.209 . . . . 74.53 107.735 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.426 ' HB2' HD11 ' D' ' 51' ' ' LEU . 16.8 tt0 -92.54 129.99 38.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.171 -1.048 . . . . 70.23 108.171 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.77 124.85 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.179 -1.045 . . . . 75.31 108.179 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.6 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -100.53 142.14 16.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.373 0.669 . . . . 74.45 109.594 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' CB ' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.44 120.91 39.58 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.932 -1.136 . . . . 73.32 107.932 177.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.4 ttm-85 -104.25 101.02 10.75 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.629 -0.878 . . . . 74.51 108.629 174.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -92.29 107.35 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.167 -1.049 . . . . 73.15 108.167 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 35.4 m -97.23 137.21 36.59 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.597 -0.728 . . . . 52.21 109.228 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 67.5 t -128.94 127.37 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.857 -1.164 . . . . 64.22 107.857 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 86.7 m -125.96 105.72 9.11 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.395 -0.965 . . . . 74.14 108.395 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.51 142.15 35.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.419 -0.809 . . . . 74.43 108.973 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.6 m -145.25 132.78 20.83 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.659 0.599 . . . . 51.13 111.229 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' D' ' 38' ' ' PRO . 13.8 mt -106.24 112.67 25.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.466 -1.243 . . . . 74.25 109.458 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.94 -113.57 4.61 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.263 -0.426 . . . . 71.25 112.085 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 3.99 18.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.169 0.587 . . . . 74.43 111.452 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -121.36 161.69 21.66 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.732 0.413 . . . . 73.31 110.124 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -78.12 125.11 28.87 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.206 0.603 . . . . 61.15 110.624 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.726 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.09 -64.14 1.12 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.822 0.849 . . . . 44.22 109.124 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -155.42 164.35 38.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.596 -0.729 . . . . 61.02 111.435 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.22 110.08 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.978 -1.489 . . . . 65.24 106.978 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.573 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.2 t -122.12 116.37 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.241 -0.651 . . . . 70.13 109.241 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -144.07 125.88 15.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.201 0.6 . . . . 72.01 109.82 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' D' ' 113' ' ' CYS . 84.4 t -127.75 116.22 42.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.742 0.817 . . . . 54.3 109.569 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.691 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.5 mt-30 -89.52 86.71 6.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.896 0.855 . . . . 74.32 109.232 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.405 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.5 tp-100 -80.25 100.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.056 -1.429 . . . . 63.2 109.56 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.79 144.36 17.13 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.922 -0.471 . . . . 72.53 111.922 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.16 139.28 9.12 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.711 -0.556 . . . . 61.24 111.711 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.81 127.71 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.161 -1.052 . . . . 53.44 108.161 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.17 153.33 41.7 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.844 0.857 . . . . 71.43 110.09 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -107.44 94.1 4.91 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.973 -1.121 . . . . 73.11 107.973 169.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tt -116.31 137.33 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.97 0.908 . . . . 72.54 110.079 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.17 155.76 11.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.051 0.94 . . . . 63.15 110.305 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.504 ' H ' HD21 ' H' ' 173' ' ' LEU . . . 76.47 22.36 73.08 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 116.602 1.401 . . . . 75.31 116.602 167.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' D' ' 94' ' ' MET . 0.9 OUTLIER -121.16 152.22 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.281 0.632 . . . . 52.01 110.704 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' H' ' 171' ' ' SER . 7.3 pt-20 -161.65 164.79 29.03 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 114.854 -1.066 . . . . 75.41 109.699 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.38 -129.2 36.86 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.443 -0.799 . . . . 74.13 113.362 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -70.96 -31.51 68.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.244 1.018 . . . . 73.32 111.635 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -70.73 -34.7 72.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 72.14 110.437 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.497 ' HG2' HD13 ' D' ' 89' ' ' ILE . 1.1 tmt? -74.57 -29.58 61.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.025 0.53 . . . . 64.31 110.22 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -38.89 91.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.285 0.634 . . . . 75.1 110.782 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.4 -29.07 41.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.247 -0.888 . . . . 73.44 111.313 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -78.6 -53.12 7.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.636 0.375 . . . . 61.42 111.027 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.57 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 52.8 tp -92.11 -48.28 6.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.109 0.564 . . . . 52.22 110.89 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.53 -14.13 82.3 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.403 0.44 . . . . 63.34 113.875 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.83 -55.88 1.06 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.877 0.471 . . . . 70.22 111.589 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -75.68 -37.03 59.9 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.908 0.707 . . . . 72.22 112.908 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 73.6 m -59.08 -52.9 71.47 Favored Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 118.851 -0.595 . . . . 73.4 111.441 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.406 ' CB ' ' HG ' ' D' ' 60' ' ' LEU . 37.5 Cg_endo -66.65 -23.41 49.26 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.81 1.673 . . . . 73.51 113.221 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.59 -37.81 85.69 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.745 0.418 . . . . 74.44 110.785 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -61.31 -43.02 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.596 0.758 . . . . 75.21 110.177 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' D' ' 80' ' ' GLN . 65.5 mt -79.91 -17.46 53.03 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.03 -0.986 . . . . 72.02 112.031 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -66.77 -43.65 50.13 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.139 1.163 . . . . 73.45 114.139 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.51 -33.78 79.54 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 121.951 1.768 . . . . 61.2 112.932 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -88.62 -26.24 22.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.709 -1.132 . . . . 73.14 111.03 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.34 72.36 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.903 0.859 . . . . 64.22 109.102 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.472 ' NH2' HG23 ' B' ' 105' ' ' ILE . 41.3 ttp180 -61.41 -41.33 96.97 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 113.4 -1.727 . . . . 72.41 110.709 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 108' ' ' PRO . 9.6 tt0 -43.73 -54.64 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.779 1.232 . . . . 62.51 111.874 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' D' ' 21' ' ' ILE . 42.6 t -70.05 -48.31 58.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.604 -1.18 . . . . 63.43 111.083 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.573 HG23 ' SG ' ' D' ' 76' ' ' CYS . 45.5 mt -56.44 -58.73 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.812 0.845 . . . . 71.13 110.901 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -52.0 -42.87 63.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.8 1.24 . . . . 71.01 112.295 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.2 -41.55 66.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.193 -0.912 . . . . 71.51 110.923 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 57.8 mtm -68.46 -32.14 71.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.811 0.444 . . . . 63.24 111.424 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -61.84 -45.55 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 123.804 0.69 . . . . 64.32 109.896 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.4 -29.14 62.4 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.938 -0.574 . . . . 73.12 111.11 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -71.54 -33.05 68.82 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.697 0.799 . . . . 75.0 110.723 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.32 3.75 80.14 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.667 -0.697 . . . . 61.03 112.213 173.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 64.81 26.16 12.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.801 2.04 . . . . 74.11 112.933 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.445 ' HD1' ' HH ' ' H' ' 197' ' ' TYR . 97.2 m-85 -91.94 161.9 32.28 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 114.556 -1.202 . . . . 71.21 108.818 167.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.64 126.97 17.01 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 122.287 1.991 . . . . 72.1 111.519 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.452 ' HB3' HG23 ' A' ' 122' ' ' THR . 51.5 tt0 -53.38 128.03 27.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.364 1.066 . . . . 74.11 111.827 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.7 tp -115.01 97.86 6.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.643 -0.708 . . . . 62.34 110.203 -166.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.49 ' OD1' ' HB ' ' B' ' 16' ' ' ILE . 46.6 m-80 -99.42 99.05 9.92 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.998 -0.742 . . . . 72.31 108.998 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.745 HD22 HD21 ' D' ' 42' ' ' LEU . 48.2 mt -66.85 120.99 14.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.039 0.936 . . . . 73.43 111.146 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.83 137.66 96.86 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.367 0.667 . . . . 74.5 111.978 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 3.2 Cg_exo -73.91 122.34 7.62 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.557 2.171 . . . . 73.31 110.446 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.502 HG23 HG11 ' G' ' 207' ' ' VAL . 2.5 p -107.86 120.52 59.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.25 0.62 . . . . 70.24 109.473 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -77.41 105.87 8.81 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.076 -0.965 . . . . 62.42 108.413 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -66.26 -30.28 70.68 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.767 0.827 . . . . 72.43 111.822 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.63 -29.86 59.31 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.662 -0.699 . . . . 75.0 110.632 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.67 -33.73 68.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.715 0.806 . . . . 52.42 111.808 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.473 HD21 ' HD2' ' H' ' 185' ' ' PRO . 7.7 mp -69.67 -41.8 75.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.154 0.582 . . . . 63.43 111.514 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.416 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 43.0 t80 -59.56 -46.93 87.48 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.755 0.659 . . . . 73.24 109.345 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.595 ' HB3' HG21 ' B' ' 7' ' ' THR . 75.8 mtm -65.28 -38.88 91.62 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.905 -1.043 . . . . 64.31 111.095 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.57 -24.98 67.22 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.899 0.879 . . . . 70.14 110.741 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -78.22 -36.68 46.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.097 -0.501 . . . . 75.13 110.176 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 45.0 mt -73.35 -28.25 61.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.299 0.64 . . . . 74.3 112.084 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.3 30.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.772 0.656 . . . . 72.54 112.772 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -117.4 45.93 1.81 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.282 -1.007 . . . . 71.43 108.282 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -177.3 -61.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.171 1.388 . . . . 72.3 108.264 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.98 120.63 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 23.33 110.606 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.7 104.05 0.25 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.778 -0.529 . . . . 64.24 111.778 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.98 119.87 11.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.521 0.729 . . . . 65.43 109.68 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.25 113.53 1.38 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.083 -0.807 . . . . 71.32 111.083 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.2 t -144.6 58.28 1.31 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.664 0.786 . . . . 74.2 109.311 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 150' ' ' GLU . . . . . 0.512 ' HA ' ' H ' ' B' ' 3' ' ' GLU . 10.8 pt-20 -62.3 111.48 2.01 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.311 0.577 . . . . 74.11 110.665 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.78 117.18 18.91 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.211 -0.904 . . . . 73.34 109.552 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -63.42 110.76 2.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.533 1.133 . . . . 74.5 109.055 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 153' ' ' GLN . . . . . 0.685 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 20.2 pt20 -75.9 -30.57 58.85 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.368 0.667 . . . . 60.04 112.114 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.39 93.11 0.21 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.847 0.859 . . . . 74.3 110.957 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 C-N-CA 124.039 0.935 . . . . 72.14 110.298 179.494 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.057 -0.349 . . . . 72.15 110.057 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -90.48 150.87 21.03 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.8 0.687 . . . . 74.54 112.374 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -85.9 133.77 33.93 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.56 -0.533 . . . . 74.21 109.56 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 6.0 p -66.17 105.76 1.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.195 0.935 . . . . 74.31 111.608 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -101.75 31.16 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.463 1.105 . . . . 73.42 108.949 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' C' ' 54' ' ' ASP . 3.1 tm? -68.7 117.82 10.9 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.48 -0.782 . . . . 74.31 109.867 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -167.49 2.63 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.764 1.226 . . . . 70.3 108.762 176.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -144.02 -67.0 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.985 -1.117 . . . . 73.22 107.985 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 58.02 19.55 6.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.913 1.285 . . . . 75.22 113.38 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 51.8 tp -97.5 104.05 16.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.098 -1.075 . . . . 70.22 108.098 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -74.55 -68.46 0.53 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.134 -0.691 . . . . 64.21 109.134 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -129.09 159.9 66.5 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.768 0.827 . . . . 73.51 109.454 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.16 91.56 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.301 2.001 . . . . 65.44 110.043 167.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -53.06 142.22 20.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.075 1.35 . . . . 73.34 111.007 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 8.5 t80 62.87 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.346 1.058 . . . . 73.33 109.363 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 28.6 m -53.39 102.41 0.06 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.352 0.661 . . . . 63.31 111.541 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.83 107.35 60.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.293 1.037 . . . . 73.23 108.545 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -87.32 31.71 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.211 2.607 . . . . 71.13 112.286 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.599 HD22 ' HB2' ' C' ' 44' ' ' LEU . 39.2 tp 57.3 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.242 1.417 . . . . 72.34 110.254 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.97 145.18 23.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 124.052 0.941 . . . . 71.21 109.127 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -77.34 76.07 3.89 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.383 -0.599 . . . . 61.41 109.383 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -76.1 93.76 3.37 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.459 -0.791 . . . . 71.25 109.456 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -143.65 150.16 38.34 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.174 -0.921 . . . . 74.31 109.24 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.04 -52.16 0.71 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.686 -0.566 . . . . 74.13 111.686 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.68 137.64 1.98 Allowed Glycine 0 C--N 1.345 1.034 0 O-C-N 123.845 0.38 . . . . 52.12 113.502 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 193' ' ' TYR . . . . . 0.629 ' HB2' ' HD2' ' C' ' 38' ' ' PRO . 31.5 m-85 -69.76 173.5 6.16 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 74.14 112.431 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.81 14.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.126 -1.064 . . . . 64.22 108.126 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -152.63 176.65 11.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.475 0.484 . . . . 73.32 111.103 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 196' ' ' LYS . . . . . 0.552 ' HB2' ' HB3' ' E' ' 199' ' ' ASN . 73.3 mmtt -121.05 122.74 40.74 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.586 1.154 . . . . 74.11 108.051 172.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.94 100.52 2.97 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.51 -1.293 . . . . 74.44 107.51 164.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 198' ' ' GLU . . . . . 0.584 ' HB3' ' HG2' ' E' ' 201' ' ' LYS . 42.0 mt-10 75.35 97.97 0.07 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.612 1.565 . . . . 75.24 111.165 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 199' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' E' ' 196' ' ' LYS . 4.1 p-10 -119.1 120.79 38.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.005 0.922 . . . . 62.43 110.057 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 53.86 34.43 51.36 Favored Glycine 0 C--N 1.36 1.885 0 O-C-N 123.635 0.584 . . . . 54.33 113.083 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.584 ' HG2' ' HB3' ' E' ' 198' ' ' GLU . 0.0 OUTLIER -73.62 163.27 28.24 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.575 0.954 . . . . 74.33 113.575 -167.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -85.11 1.69 46.76 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.714 1.206 . . . . 71.12 111.135 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 20.6 t0 73.63 127.37 0.04 OUTLIER 'General case' 0 C--N 1.36 1.042 0 C-N-CA 126.556 1.942 . . . . 64.54 109.642 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 11.9 tt -99.32 -37.21 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.093 0.557 . . . . 73.35 109.519 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -70.85 -18.72 62.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.451 1.101 . . . . 73.33 111.691 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -144.56 106.04 4.25 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.675 -0.491 . . . . 71.21 109.675 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.075 1.35 . . . . 75.12 108.0 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 57.5 tptt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.731 -0.47 . . . . 74.24 109.731 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.26 108.46 2.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.138 -0.812 . . . . 32.01 112.392 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 69.25 -69.37 0.16 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.02 1.728 . . . . 71.51 111.239 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 56.0 p -66.58 167.08 11.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.52 1.128 . . . . 42.41 110.917 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 172' ' ' ALA . . . . . 0.587 ' HB2' ' H ' ' B' ' 88' ' ' GLY . . . -117.93 -97.8 0.46 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.29 0.636 . . . . 53.23 111.675 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.411 HD13 ' HB1' ' F' ' 172' ' ' ALA . 0.0 OUTLIER -163.48 -6.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 113.853 1.057 . . . . 74.12 113.853 -166.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.499 ' SD ' HD13 ' B' ' 86' ' ' ILE . 20.6 ptp -106.42 109.29 21.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.697 1.369 . . . . 63.22 114.697 -159.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -161.26 85.94 0.67 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.29 -1.004 . . . . 74.44 108.29 157.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -177.48 135.35 0.19 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.215 1.006 . . . . 50.31 108.431 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 tp -86.63 135.45 33.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.706 0.802 . . . . 72.4 109.73 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -83.34 122.81 28.95 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.132 0.973 . . . . 74.13 109.714 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -64.12 -49.92 71.24 Favored Pre-proline 0 CA--C 1.564 1.491 0 O-C-N 124.52 1.138 . . . . 75.21 112.158 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.45 93.85 0.99 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.449 1.433 . . . . 74.55 111.082 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -133.81 167.31 20.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.566 -0.743 . . . . 70.53 109.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 182' ' ' PHE . . . . . 0.489 ' HB2' ' HZ ' ' B' ' 133' ' ' PHE . 52.2 m-85 -85.43 141.43 29.97 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.191 0.596 . . . . 72.54 110.27 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 89.5 m -71.54 139.15 49.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.722 0.809 . . . . 73.3 110.431 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -109.25 98.41 31.13 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 108.023 -1.103 . . . . 73.34 108.023 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.01 124.05 5.94 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.731 2.288 . . . . 74.34 112.331 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 66.2 mt -112.46 127.43 56.04 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.567 0.747 . . . . 64.31 109.044 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' E' ' 201' ' ' LYS . 2.6 pp -93.84 -175.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.481 0.712 . . . . 73.11 111.811 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -93.67 142.75 27.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.544 0.738 . . . . 54.34 110.622 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.62 83.14 4.82 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.827 0.851 . . . . 52.52 109.429 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 1.1 t70 63.29 -171.59 0.17 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.277 1.431 . . . . 75.01 111.912 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 141.12 -142.92 12.61 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.336 -1.106 . . . . 61.44 110.336 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.04 -89.92 0.1 OUTLIER Glycine 0 C--N 1.352 1.443 0 O-C-N 124.03 0.489 . . . . 55.11 113.424 173.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -142.15 -26.62 0.64 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.654 0.782 . . . . 72.4 110.603 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.98 82.89 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.257 0.623 . . . . 73.41 111.146 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' B' ' 37' ' ' GLN . 2.1 t80 -82.95 118.87 23.78 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.9 -0.778 . . . . 70.35 108.9 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -159.83 152.21 20.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.373 0.669 . . . . 72.14 109.904 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 197' ' ' TYR . . . . . 0.59 ' HA ' ' HG3' ' B' ' 37' ' ' GLN . 3.6 t80 -58.78 -44.99 90.82 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.297 1.039 . . . . 73.51 113.413 -164.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -64.55 -24.05 67.47 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.96 0.504 . . . . 63.44 111.471 -174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.57 90.61 5.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 75.34 110.166 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.44 79.93 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.809 -1.087 . . . . 53.12 113.463 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 70.63 -70.71 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.717 1.607 . . . . 62.22 112.48 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 202' ' ' TYR . . . . . 0.48 ' HE2' ' HB3' ' B' ' 124' ' ' PRO . 4.5 m-30 57.81 40.69 25.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.178 0.991 . . . . 70.32 109.839 -168.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -159.18 148.43 18.54 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.624 -1.171 . . . . 74.33 109.625 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.558 ' HB ' ' HB1' ' C' ' 129' ' ' ALA . 7.2 tp -85.7 82.32 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.93 -1.137 . . . . 72.35 107.93 173.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.08 123.7 18.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.71 -1.132 . . . . 62.43 108.265 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -30.47 110.79 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 127.222 2.209 . . . . 75.52 113.692 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.407 ' HB ' HD12 ' C' ' 136' ' ' LEU . 2.4 m . . . . . 0 CA--C 1.565 1.527 0 C-N-CA 123.953 0.901 . . . . 72.44 111.954 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 168' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' G' ' 168' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.264 -0.643 . . . . 74.41 109.264 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.46 115.28 6.23 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.812 -0.515 . . . . 51.33 111.812 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 62.75 22.64 13.5 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.898 1.279 . . . . 63.41 112.439 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 171' ' ' SER . . . . . 0.415 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 34.9 p -161.76 139.69 9.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.375 -0.83 . . . . 73.5 109.468 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -78.51 0.06 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.95 -0.389 . . . . 74.21 109.95 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.459 HD23 ' SD ' ' G' ' 174' ' ' MET . 2.0 pt? -158.93 16.25 0.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.446 1.098 . . . . 73.42 108.942 170.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.459 ' SD ' HD23 ' G' ' 173' ' ' LEU . 0.0 OUTLIER -174.69 165.97 3.74 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.284 1.434 . . . . 70.2 108.964 -173.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -169.45 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.181 0.592 . . . . 75.02 109.99 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -74.04 104.64 4.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.883 -0.784 . . . . 75.24 108.883 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 52.3 tp -80.63 93.62 6.16 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.496 -0.927 . . . . 72.24 108.496 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -81.8 102.91 11.11 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.201 -0.909 . . . . 54.34 110.765 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 74.27 149.28 0.12 Allowed Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 125.555 1.542 . . . . 72.12 113.294 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.28 95.33 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.747 2.298 . . . . 75.35 110.658 169.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -60.6 -29.11 69.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.591 0.756 . . . . 75.23 111.437 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.2 154.59 45.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.615 0.766 . . . . 75.21 110.252 167.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 19.3 p -92.51 128.93 38.54 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.01 0.924 . . . . 74.31 108.978 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -126.49 114.5 23.11 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.213 0.605 . . . . 71.33 109.58 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.99 154.15 74.79 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.053 2.502 . . . . 73.21 112.898 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.93 51.37 2.04 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.868 0.867 . . . . 71.44 111.068 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.569 ' HB ' HD22 ' A' ' 42' ' ' LEU . 4.8 mp 60.31 -75.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.684 1.193 . . . . 71.12 111.747 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . 70.33 97.84 0.06 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.494 1.518 . . . . 61.13 109.875 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 189' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -112.01 161.35 16.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.82 -0.627 . . . . 61.44 111.648 -170.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -161.85 152.74 17.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.255 -0.884 . . . . 74.03 109.65 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 71.32 -146.33 40.66 Favored Glycine 0 C--N 1.345 1.064 0 O-C-N 123.643 0.59 . . . . 72.44 113.53 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.2 67.65 1.17 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.763 -0.535 . . . . 73.35 111.763 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.72 89.46 0.39 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.216 0.607 . . . . 74.24 110.335 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.94 -74.89 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.032 -0.729 . . . . 51.33 109.032 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -88.57 108.35 19.38 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.927 -0.768 . . . . 75.14 108.927 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -70.21 112.2 6.39 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.838 -0.801 . . . . 74.33 108.838 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -99.83 149.55 23.26 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.111 0.565 . . . . 73.54 110.413 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -171.71 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.122 1.369 . . . . 70.22 109.167 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -163.26 -178.17 5.8 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.403 1.081 . . . . 62.44 108.481 -174.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.25 128.53 46.06 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 112.159 -0.377 . . . . 61.4 112.159 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -102.86 -11.15 18.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.758 0.823 . . . . 64.1 110.699 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -139.0 121.28 15.92 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.394 -0.965 . . . . 74.31 108.394 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.78 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.211 0.944 . . . . 65.33 110.42 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp 62.39 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.11 0.964 . . . . 74.31 108.926 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? 179.24 -61.52 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.285 1.834 . . . . 73.31 108.074 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 4.2 p30 178.3 -174.43 0.16 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.342 1.457 . . . . 74.42 108.949 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 207' ' ' VAL . . . . . 0.502 HG11 HG23 ' D' ' 131' ' ' VAL . 60.7 t . . . . . 0 CA--C 1.553 1.06 0 N-CA-C 108.062 -1.088 . . . . 72.15 108.062 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.685 -0.858 . . . . 75.42 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -171.52 128.61 1.62 Allowed Glycine 0 C--N 1.347 1.156 0 C-N-CA 121.444 -0.408 . . . . 53.45 112.832 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -77.99 130.69 36.82 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.365 -0.976 . . . . 71.13 108.365 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 171' ' ' SER . . . . . 0.435 ' H ' ' HB2' ' D' ' 90' ' ' GLU . 42.5 m 60.65 27.72 17.43 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.262 0.977 . . . . 54.21 111.641 -173.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.1 4.65 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.658 -0.701 . . . . 75.01 111.203 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.504 HD21 ' H ' ' D' ' 88' ' ' GLY . 1.6 tm? 63.49 -75.5 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.458 1.503 . . . . 74.13 111.621 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 24.5 mmt -86.64 -57.33 3.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.82 0.848 . . . . 63.4 111.373 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -167.44 135.64 2.5 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.327 -0.62 . . . . 75.24 109.327 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -153.48 -70.61 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.466 -1.309 . . . . 73.3 107.466 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 177' ' ' LEU . . . . . 0.536 HD11 HD23 ' D' ' 98' ' ' LEU . 8.5 mp 56.96 27.79 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.582 1.153 . . . . 71.04 112.94 171.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -79.41 -44.71 20.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.402 0.681 . . . . 73.43 110.524 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.02 141.45 71.21 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.74 -0.664 . . . . 63.42 109.921 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -83.93 164.19 13.66 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.708 2.272 . . . . 74.24 113.128 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.56 -169.3 2.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.07 0.948 . . . . 74.25 110.277 174.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -69.96 130.19 41.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.655 0.782 . . . . 64.25 110.433 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 47.5 p -70.48 161.32 30.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.064 0.546 . . . . 73.41 109.616 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -128.07 117.85 20.6 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.238 0.615 . . . . 71.22 109.964 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 185' ' ' PRO . . . . . 0.473 ' HD2' HD21 ' D' ' 136' ' ' LEU . 63.9 Cg_endo -73.71 117.06 4.89 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 72.4 112.065 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.64 145.32 30.65 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.605 -0.887 . . . . 72.25 108.605 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.406 HG13 ' H ' ' H' ' 187' ' ' ILE . 2.6 pp -64.19 170.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.988 0.915 . . . . 65.1 112.273 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.63 170.36 19.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.938 0.495 . . . . 74.1 110.938 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 189' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' D' ' 39' ' ' GLU . . . -87.07 132.26 33.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.35 0.66 . . . . 54.51 109.503 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.82 128.25 26.42 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.787 0.835 . . . . 72.44 109.759 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 57.78 -115.96 7.55 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 124.507 1.129 . . . . 73.13 113.433 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.97 -89.85 0.32 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 124.055 0.503 . . . . 72.11 112.741 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 58.74 19.4 6.83 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.966 1.306 . . . . 73.12 112.422 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.5 39.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.464 1.106 . . . . 63.11 109.303 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -138.6 142.13 39.16 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.693 0.797 . . . . 73.31 109.289 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.88 43.61 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.12 1.368 . . . . 71.04 108.147 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 197' ' ' TYR . . . . . 0.585 ' HD1' HH22 ' C' ' 15' ' ' ARG . 55.7 m-85 -93.6 -29.04 15.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.883 0.473 . . . . 70.21 111.124 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 60.61 -89.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.113 0.965 . . . . 54.33 109.743 -174.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 165.74 158.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.928 2.091 . . . . 72.22 107.355 174.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -87.37 46.1 3.46 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 112.194 -0.363 . . . . 22.43 112.194 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 201' ' ' LYS . . . . . 0.491 ' HG3' HD12 ' H' ' 204' ' ' ILE . 60.6 tttm -165.43 108.99 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.549 1.14 . . . . 73.35 108.599 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -72.0 -60.28 2.31 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.857 0.361 . . . . 75.25 110.314 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -151.93 -68.76 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.622 -0.881 . . . . 73.51 108.622 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' A' ' 129' ' ' ALA . 14.1 mt 56.17 74.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.502 1.521 . . . . 73.55 110.685 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -88.0 -21.16 24.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.174 0.989 . . . . 74.51 110.515 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.286 1.034 . . . . 70.13 112.259 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.499 HG21 HG12 ' A' ' 131' ' ' VAL . 82.4 t . . . . . 0 C--O 1.255 1.35 0 C-N-CA 124.254 1.022 . . . . 75.42 108.445 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtm . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.442 -0.577 . . . . 55.52 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -87.26 99.42 11.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.187 -1.042 . . . . 70.43 108.187 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -145.91 123.91 12.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.121 0.568 . . . . 65.55 111.039 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.15 60.12 4.17 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.023 -1.103 . . . . 74.51 108.023 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -138.07 147.13 43.76 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.317 -0.856 . . . . 55.13 109.813 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -144.23 143.67 31.16 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.848 -1.167 . . . . 53.54 107.848 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 p -85.58 60.25 6.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.747 0.784 . . . . 73.14 110.542 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -97.53 -164.74 1.17 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.537 1.135 . . . . 71.44 110.354 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.576 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 25.0 ptm -55.19 148.42 14.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 53.54 112.257 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 m -140.54 130.7 24.91 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.77 0.828 . . . . 75.23 109.488 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HE1' ' HG ' ' A' ' 102' ' ' CYS . 67.2 t80 -129.05 140.01 51.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.742 -1.207 . . . . 71.5 107.742 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 8.0 tp-100 -149.79 130.51 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.685 0.394 . . . . 70.01 110.162 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.79 112.83 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.549 -1.278 . . . . 73.33 107.549 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.461 ' NE2' ' HB2' ' A' ' 85' ' ' SER . 8.0 mm-40 -87.88 -38.03 15.98 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.104 0.252 . . . . 70.34 110.94 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -171.95 124.32 0.53 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.954 0.502 . . . . 71.41 110.798 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 80.4 mt -108.6 135.78 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 74.3 108.767 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.635 ' HB3' HG23 ' B' ' 122' ' ' THR . 16.9 p90 -170.5 176.35 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.915 0.759 . . . . 70.43 111.489 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -98.78 128.95 45.16 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.114 -0.698 . . . . 62.35 109.114 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -92.5 -38.04 12.17 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.207 -0.664 . . . . 75.52 109.207 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -135.86 136.53 40.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.601 -1.181 . . . . 75.44 109.502 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.2 mt -135.97 139.52 45.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.949 -1.5 . . . . 62.12 106.949 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 t -149.28 122.78 9.11 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 123.474 0.484 . . . . 65.23 110.222 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.3 t80 -119.9 114.54 22.23 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.522 -1.658 . . . . 75.34 106.522 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.35 117.62 29.02 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.402 -0.592 . . . . 73.11 109.402 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.67 81.56 67.21 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 108.145 -1.057 . . . . 72.31 108.145 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.32 -35.03 42.15 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.563 2.175 . . . . 60.41 111.628 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.0 m-20 -104.98 31.54 4.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.26 -0.882 . . . . 74.43 109.62 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.41 99.66 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.299 1.039 . . . . 54.23 112.684 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.01 -26.24 11.08 Favored 'Trans proline' 0 C--N 1.38 2.23 0 CA-C-N 121.277 1.492 . . . . 63.4 113.721 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -70.7 -23.01 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.38 0.672 . . . . 61.5 112.357 -173.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.608 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.6 p -61.19 -20.39 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.15 0.58 . . . . 74.01 111.27 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.6 -39.57 91.69 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.246 1.018 . . . . 63.31 111.693 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.91 -28.27 17.38 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.679 0.392 . . . . 60.12 110.961 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.63 149.86 28.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.061 0.544 . . . . 64.43 111.204 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.5 147.36 41.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.443 0.697 . . . . 71.51 110.337 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.462 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.7 t-105 -93.81 76.96 4.23 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.605 0.717 . . . . 63.3 110.183 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -121.75 82.45 41.84 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 106.309 -1.737 . . . . 61.32 106.309 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.12 136.99 9.36 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.691 2.261 . . . . 52.41 113.082 -170.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.34 84.32 3.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.456 -1.683 . . . . 65.23 106.456 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.25 101.06 4.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 114.193 -1.367 . . . . 75.53 108.971 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -79.32 114.55 18.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.534 -0.913 . . . . 73.2 108.534 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.7 116.48 28.93 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.187 -1.412 . . . . 74.32 107.187 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.1 t70 -126.25 138.9 53.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.824 -0.806 . . . . 62.22 108.824 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.3 tp -130.38 120.03 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.995 -0.743 . . . . 71.21 108.995 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -135.65 157.15 47.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.676 0.79 . . . . 73.13 109.522 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -127.75 159.63 34.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.691 0.796 . . . . 64.11 109.662 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.39 136.06 21.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.694 1.198 . . . . 74.31 107.97 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.6 m -107.86 160.11 16.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 52.4 110.312 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -157.74 150.28 22.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.962 0.905 . . . . 54.45 109.385 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.01 140.25 47.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.239 -1.023 . . . . 74.34 108.239 170.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -115.59 -37.68 3.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.567 0.747 . . . . 74.33 110.569 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -158.15 -179.28 7.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.912 0.885 . . . . 74.2 110.318 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.28 114.52 3.22 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.633 -0.712 . . . . 65.33 109.262 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 69.15 0.99 3.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.893 1.277 . . . . 55.14 113.402 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 23.9 t -106.73 108.62 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.885 -1.154 . . . . 64.32 107.885 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 160.64 26.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.059 -0.719 . . . . 70.43 109.059 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.87 134.69 47.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.77 0.828 . . . . 70.12 108.948 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.5 t -118.13 122.23 69.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.321 -1.363 . . . . 64.31 107.321 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -98.69 134.74 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.727 0.811 . . . . 43.44 109.429 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.05 114.15 28.02 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.889 -1.152 . . . . 74.34 107.889 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.18 100.47 10.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.146 -0.687 . . . . 71.21 109.146 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 t -99.66 141.7 16.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.461 -0.94 . . . . 71.31 108.461 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 19.5 m -130.99 133.7 46.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.111 0.481 . . . . 65.41 110.533 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.5 t -130.62 109.48 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.341 1.457 . . . . 75.11 107.741 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -112.11 128.42 56.21 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.117 -0.697 . . . . 65.33 109.117 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.67 13.91 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.792 -0.818 . . . . 60.24 108.792 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 30.9 m -114.93 126.61 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.001 0.52 . . . . 74.22 110.051 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD21 ' CE3' ' A' ' 36' ' ' TRP . 25.7 mt -89.73 65.27 6.77 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.855 -1.165 . . . . 53.2 107.855 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 -101.8 1.23 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.101 -0.954 . . . . 75.03 110.999 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -88.36 -27.4 21.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.428 1.091 . . . . 74.02 110.126 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -98.05 94.79 7.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 71.24 110.08 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 92.6 m -67.41 125.58 26.58 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.839 0.745 . . . . 54.23 111.03 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.35 -56.85 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.83 0.852 . . . . 74.52 109.769 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -161.07 174.84 13.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.493 -1.23 . . . . 71.32 111.781 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -139.11 130.53 27.04 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.955 -1.498 . . . . 71.21 106.955 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.514 ' HB3' HG23 ' A' ' 114' ' ' ILE . 74.8 m -130.27 101.77 5.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.463 1.105 . . . . 64.44 109.761 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.44 121.56 29.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.836 -0.801 . . . . 71.01 108.836 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.4 t -129.49 129.62 66.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 123.458 0.703 . . . . 45.42 109.391 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.9 mt-30 -102.51 90.65 3.93 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.497 -0.774 . . . . 73.41 109.49 171.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -77.08 95.46 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.39 -1.277 . . . . 70.01 108.614 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.97 143.18 19.57 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 112.138 -0.385 . . . . 74.31 112.138 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.48 122.35 1.94 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 111.598 -0.601 . . . . 72.33 111.598 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -80.89 125.56 39.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.083 -1.08 . . . . 71.34 108.083 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -132.1 132.45 43.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.593 0.757 . . . . 74.23 110.582 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 33.4 t -80.24 122.79 27.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.451 -0.944 . . . . 72.54 108.451 166.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 tp -129.44 146.52 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.141 -0.688 . . . . 64.52 109.141 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.88 162.14 7.33 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.048 0.939 . . . . 61.1 110.978 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 79.03 7.61 88.35 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 115.688 1.035 . . . . 65.34 115.688 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' H ' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -114.66 141.13 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.818 0.809 . . . . 55.02 109.864 -174.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -146.25 170.31 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.874 0.47 . . . . 73.41 110.345 173.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 -115.8 4.99 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.18 0.925 . . . . 42.03 114.22 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.2 p -68.3 -34.16 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.363 1.065 . . . . 72.2 111.653 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -57.97 -44.38 87.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.956 0.902 . . . . 74.25 110.839 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.0 tpt -76.61 -40.68 48.69 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.869 -0.605 . . . . 70.41 111.022 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.44 71.89 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.322 0.582 . . . . 63.42 111.066 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.473 ' HE1' ' HA ' ' A' ' 134' ' ' ASP . 65.9 t60 -79.25 -41.82 27.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.104 0.962 . . . . 73.22 111.097 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 23.3 t -74.24 -63.6 1.19 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.772 0.429 . . . . 71.32 110.233 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.06 -33.34 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.928 0.891 . . . . 75.22 111.57 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.78 -10.46 63.04 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 115.239 0.855 . . . . 63.14 115.239 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.15 -55.47 0.32 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.971 0.886 . . . . 72.13 111.799 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.24 -60.07 2.9 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.53 0.567 . . . . 73.22 112.53 -168.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.402 ' HG ' ' HE1' ' A' ' 11' ' ' PHE . 30.5 m -55.88 -48.24 97.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.573 0.749 . . . . 71.43 112.865 -176.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.2 Cg_endo -67.82 -28.95 35.89 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 120.702 1.287 . . . . 60.13 113.809 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -78.79 -19.9 51.08 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.295 0.952 . . . . 63.54 111.807 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.54 -38.57 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.216 1.007 . . . . 75.03 109.497 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.515 HD21 ' HA3' ' A' ' 82' ' ' GLY . 51.7 mt -75.94 -18.97 59.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.017 -1.447 . . . . 74.04 112.124 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 38.9 t80 -65.87 -40.53 39.55 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.462 1.282 . . . . 75.42 114.462 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.91 -39.65 83.8 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.154 1.903 . . . . 63.51 113.444 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -80.68 -33.84 35.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.389 -0.823 . . . . 75.42 111.546 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.85 81.5 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.02 -0.733 . . . . 71.31 109.02 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -52.15 -53.93 36.96 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.624 -1.171 . . . . 65.34 110.566 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.6 tm-20 -61.14 -41.19 96.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.044 0.84 . . . . 75.14 111.315 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.79 -47.63 84.28 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.892 -0.595 . . . . 71.42 110.714 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 76' ' ' CYS . 97.8 mt -63.11 -47.71 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.133 0.973 . . . . 64.0 110.717 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.545 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.7 m -60.68 -41.88 95.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.523 1.129 . . . . 51.13 111.56 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.01 -43.39 78.95 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.684 -0.689 . . . . 60.22 110.602 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -55.65 -43.84 76.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.617 0.767 . . . . 70.43 111.453 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.41 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.938 0.895 . . . . 74.31 111.113 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -70.36 -26.97 63.97 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.292 -0.413 . . . . 42.23 111.294 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -73.93 -32.1 63.36 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.712 0.805 . . . . 71.05 109.952 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.51 -1.62 71.57 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.958 0.786 . . . . 72.24 112.875 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.8 m 67.81 40.28 2.44 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.87 1.319 . . . . 55.44 110.071 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.608 ' HE1' HG11 ' A' ' 31' ' ' VAL . 43.9 m-85 -116.72 152.31 48.27 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 114.524 -1.217 . . . . 73.5 109.579 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 135.69 60.96 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.114 2.543 . . . . 74.41 113.459 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.5 tt0 -58.74 139.5 56.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 54.31 112.304 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 tp -117.08 115.08 24.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.136 -0.69 . . . . 70.15 109.136 176.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -100.3 93.65 5.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.683 -0.858 . . . . 74.3 108.683 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -65.89 135.33 54.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.45 0.7 . . . . 53.35 109.9 -176.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.489 ' HB3' HD12 ' G' ' 187' ' ' ILE . . . -68.79 131.07 91.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 122.957 0.503 . . . . 74.01 111.897 -175.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.39 110.77 2.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.596 2.197 . . . . 70.31 111.709 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.14 110.78 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.248 -1.019 . . . . 52.54 108.248 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 14.8 m120 -110.82 72.22 0.77 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.231 1.012 . . . . 74.22 112.749 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -70.84 -24.24 62.49 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 73.02 110.732 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.473 ' HA ' ' HE1' ' A' ' 96' ' ' HIS . 19.1 p-10 -69.0 -47.77 64.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.687 -0.688 . . . . 75.11 110.437 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -69.0 -49.39 58.23 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.442 0.697 . . . . 74.14 111.491 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.494 ' HB2' HG11 ' H' ' 207' ' ' VAL . 54.0 tp -57.3 -43.1 82.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.563 0.539 . . . . 52.41 111.107 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 44.8 t80 -70.28 -38.13 75.0 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.675 -0.693 . . . . 64.24 110.934 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 94.9 mmm -63.72 -42.53 97.91 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.003 0.365 . . . . 72.23 110.046 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.555 ' HB3' ' NE2' ' C' ' 144' ' ' GLN . 96.0 m-20 -66.28 -18.54 65.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.432 1.093 . . . . 73.42 111.987 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -95.92 -42.03 8.5 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.91 0.884 . . . . 75.01 111.215 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -67.67 -27.25 66.68 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 124.966 1.306 . . . . 62.35 111.094 -167.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -141.31 31.72 1.72 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.691 -1.226 . . . . 61.52 107.691 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -55.96 -24.36 37.91 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 113.995 -1.457 . . . . 73.3 112.257 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.58 87.91 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.721 0.809 . . . . 71.4 109.457 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.11 13.8 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.907 -1.042 . . . . 53.53 110.593 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.03 118.63 0.97 Allowed Glycine 0 C--O 1.238 0.369 0 N-CA-C 111.201 -0.76 . . . . 70.11 111.201 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.85 149.84 36.11 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.608 -0.516 . . . . 71.35 109.608 170.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.32 100.04 0.14 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 109.792 -1.323 . . . . 73.12 109.792 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 t -148.92 168.89 21.83 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.217 0.607 . . . . 64.45 110.095 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -140.72 123.49 16.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.136 0.975 . . . . 73.01 108.858 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -84.58 148.43 26.48 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.531 -0.544 . . . . 73.15 109.531 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -166.8 -166.98 0.89 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.73 1.212 . . . . 74.34 109.367 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -145.87 154.56 42.11 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.788 0.835 . . . . 64.42 110.267 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.59 75.95 6.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.537 0.735 . . . . 74.54 109.864 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 123.451 0.7 . . . . 63.22 109.301 -177.553 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.436 ' HG3' ' HA ' ' B' ' 145' ' ' ALA . 26.6 mmt . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.425 -0.583 . . . . 71.13 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -67.2 119.96 12.97 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.964 0.506 . . . . 71.45 110.449 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.14 109.86 1.43 Allowed 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.98 -0.748 . . . . 74.15 108.98 171.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.93 150.53 30.95 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.889 -0.782 . . . . 62.05 108.889 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -72.27 128.71 36.49 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.485 -1.302 . . . . 75.12 107.485 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -81.21 71.59 8.2 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.855 0.835 . . . . 73.42 110.098 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -92.1 69.45 5.31 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.317 1.532 . . . . 64.53 107.71 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -112.96 159.27 19.27 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.44 -1.709 . . . . 61.24 109.571 -169.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 21.8 ptm 51.11 -175.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 126.503 1.921 . . . . 63.11 113.358 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -151.34 140.48 21.21 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.748 -0.66 . . . . 75.2 109.313 170.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.22 131.6 30.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.014 0.925 . . . . 72.01 108.9 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 24.4 tm0? -142.47 134.36 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.728 -1.212 . . . . 74.23 107.728 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -97.3 118.37 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 32.51 109.874 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.18 -53.56 4.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.692 0.282 . . . . 74.33 110.973 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 43.8 ttt180 -161.17 141.04 10.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.412 -0.358 . . . . 74.43 110.57 -169.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -115.8 143.64 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 107.96 -1.126 . . . . 74.44 107.96 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.426 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.9 p90 -168.9 158.22 8.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.356 0.598 . . . . 75.45 111.553 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -83.89 127.82 34.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.248 -0.887 . . . . 75.1 108.648 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.499 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -96.09 -41.2 8.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.165 0.586 . . . . 71.32 109.713 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.7 t70 -147.42 139.29 24.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.851 -0.613 . . . . 71.01 110.597 -168.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.442 HD12 HG22 ' B' ' 78' ' ' VAL . 42.2 mm -138.07 137.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.81 1.244 . . . . 53.02 108.811 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -138.8 125.09 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.05 -1.092 . . . . 55.22 108.05 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.6 t80 -137.59 108.05 6.52 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.17 -1.419 . . . . 60.21 107.17 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.81 117.83 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.438 -0.949 . . . . 75.4 108.438 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.823 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -112.82 87.89 10.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.796 0.838 . . . . 75.0 109.504 -176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 -38.24 10.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.075 2.517 . . . . 74.54 112.736 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.43 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 66.1 m-20 -111.74 29.07 8.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.445 0.698 . . . . 74.21 109.622 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.823 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.12 -54.58 23.66 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.787 1.235 . . . . 74.53 113.107 172.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 5.6 Cg_exo -76.22 -19.17 15.63 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.036 1.824 . . . . 64.32 111.754 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.43 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 80.7 m-70 -85.43 3.03 41.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.312 1.045 . . . . 71.15 111.408 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.407 HG13 ' OH ' ' F' ' 197' ' ' TYR . 9.7 p -69.45 -14.94 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 CA-C-O 121.419 0.628 . . . . 70.41 109.736 163.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -70.58 -28.77 65.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.754 0.821 . . . . 72.21 109.832 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.62 -39.7 18.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.314 0.646 . . . . 73.0 109.609 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -102.51 75.23 1.44 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.292 1.037 . . . . 62.33 109.955 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.49 76.44 5.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.824 0.849 . . . . 73.43 110.648 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -163.7 160.32 22.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.762 0.825 . . . . 74.12 109.403 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -69.84 118.61 64.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.208 1.003 . . . . 74.22 109.518 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.76 152.0 82.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.176 1.918 . . . . 55.11 113.026 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.24 119.06 13.87 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.473 -0.785 . . . . 71.54 109.033 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 t -85.01 119.66 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.466 -1.309 . . . . 73.12 107.466 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -134.73 138.59 44.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' B' ' 128' ' ' LEU . 0.0 OUTLIER -128.57 166.42 18.87 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.783 0.833 . . . . 71.35 111.542 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 121.24 1.55 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.423 -0.954 . . . . 71.12 108.423 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.1 163.74 21.81 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.361 0.6 . . . . 63.13 110.724 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -161.06 135.89 7.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.477 1.111 . . . . 74.13 108.447 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -108.65 119.68 40.24 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.843 0.354 . . . . 74.41 110.376 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.48 159.26 22.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.141 0.976 . . . . 73.01 108.711 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.497 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 73.9 m -144.39 162.69 35.84 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.178 -0.326 . . . . 71.22 111.464 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.1 t -157.12 137.9 13.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.078 0.951 . . . . 71.4 109.62 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -105.51 131.07 53.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.338 -0.616 . . . . 64.44 109.338 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -98.36 -41.75 7.68 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.455 0.645 . . . . 73.44 109.472 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.84 10.87 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.596 -1.184 . . . . 63.25 109.358 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -76.57 134.17 39.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 70.51 108.414 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.3 -3.63 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.934 1.294 . . . . 62.45 111.811 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.54 95.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.298 1.039 . . . . 71.35 108.354 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.497 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 8.4 t80 -113.83 139.54 49.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.012 0.434 . . . . 72.32 110.623 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -121.85 108.4 13.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.873 0.869 . . . . 75.14 109.488 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.1 132.86 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.033 0.533 . . . . 34.12 110.093 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 40.8 t -104.14 116.94 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.308 0.643 . . . . 73.43 109.838 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -94.1 115.77 28.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.876 -0.787 . . . . 64.35 108.876 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -102.16 123.75 46.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.955 0.407 . . . . 61.23 110.419 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 75.0 t -117.07 108.3 24.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.686 -1.227 . . . . 72.02 107.686 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.5 m -97.84 146.54 25.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.326 -0.62 . . . . 74.21 109.326 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.531 HG21 HG21 ' B' ' 114' ' ' ILE . 72.5 t -132.58 136.34 56.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 124.464 1.106 . . . . 72.43 109.578 -171.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.39 149.5 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.426 1.09 . . . . 53.32 109.012 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.46 161.76 37.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.214 0.606 . . . . 72.41 110.359 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.4 p -148.48 147.42 29.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.595 0.591 . . . . 63.44 112.595 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.5 mt -124.19 107.06 10.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.689 -1.597 . . . . 72.11 106.689 172.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -111.39 3.46 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.285 -0.731 . . . . 71.45 111.347 -171.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.18 3.24 12.66 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.901 0.85 . . . . 62.31 111.665 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -114.25 167.19 10.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.708 0.403 . . . . 71.24 110.402 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -64.88 144.03 57.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.324 0.65 . . . . 61.44 110.467 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.425 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -100.69 -58.77 1.83 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.374 -0.973 . . . . 41.41 108.374 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -150.92 166.38 30.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 113.833 -1.53 . . . . 75.12 109.276 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -134.91 140.37 45.7 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.428 -1.323 . . . . 72.22 107.428 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.498 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.1 t -140.82 159.96 41.08 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.575 0.75 . . . . 74.33 109.146 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.33 137.45 4.21 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.942 0.897 . . . . 72.01 108.601 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.442 HG22 HD12 ' B' ' 21' ' ' ILE . 77.3 t -128.64 141.03 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.45 0.7 . . . . 73.03 109.179 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -124.63 91.61 3.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 72.5 108.992 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.434 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -89.15 102.17 14.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.875 -1.057 . . . . 60.31 108.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.499 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.57 142.82 16.36 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.775 -0.53 . . . . 44.1 111.775 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.74 128.43 4.44 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.407 -0.677 . . . . 43.4 111.407 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.426 HG13 ' HE1' ' B' ' 17' ' ' TYR . 44.7 mt -83.29 126.89 40.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -135.18 135.48 41.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.249 0.619 . . . . 74.55 109.623 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 20.2 m -87.43 100.46 12.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.033 -1.099 . . . . 61.2 108.033 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.6 122.34 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.709 0.804 . . . . 74.12 109.63 -170.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.22 172.33 18.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.13 0.972 . . . . 62.33 111.097 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -28.12 6.65 Favored Glycine 0 C--N 1.357 1.708 0 CA-C-N 116.046 -0.525 . . . . 75.01 112.832 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.4 HD11 ' O ' ' F' ' 173' ' ' LEU . 0.2 OUTLIER -56.93 157.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.039 1.336 . . . . 63.21 113.451 -175.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -161.32 143.15 11.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.535 -0.757 . . . . 72.32 109.866 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.49 -93.42 0.03 OUTLIER Glycine 0 C--N 1.362 1.979 0 O-C-N 124.324 1.015 . . . . 23.24 113.912 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.2 m -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.369 1.068 . . . . 73.44 110.604 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -67.55 -29.17 68.49 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.443 0.697 . . . . 60.34 111.505 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 52.8 tpp -67.02 -50.08 63.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.745 0.418 . . . . 63.14 110.495 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.31 -30.47 64.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.6 0.76 . . . . 71.04 111.834 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.69 -55.17 5.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.72 0.408 . . . . 71.04 110.024 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 42.8 t -69.35 -66.73 0.55 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.647 0.592 . . . . 75.42 110.819 -172.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.648 ' HB3' HD11 ' F' ' 177' ' ' LEU . 2.9 tt -71.3 -26.74 62.98 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.751 0.421 . . . . 65.25 110.277 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.01 -39.06 13.65 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 114.976 0.751 . . . . 72.12 114.976 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.62 -46.88 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.718 0.759 . . . . 72.05 112.059 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.487 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 88.2 t80 -64.61 -54.35 33.32 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.554 0.741 . . . . 71.02 112.607 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.471 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.3 m -61.6 -46.82 93.87 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.476 0.71 . . . . 72.52 111.424 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.2 Cg_exo -58.04 -36.98 97.61 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 121.843 1.696 . . . . 74.44 113.873 167.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -72.16 -21.18 61.48 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 122.872 0.469 . . . . 75.43 111.463 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.469 HG23 ' NH2' ' D' ' 111' ' ' ARG . 56.9 mt -64.2 -45.0 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.641 0.776 . . . . 72.41 109.901 167.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 28.2 mt -84.4 -11.02 57.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.319 -1.31 . . . . 75.3 111.37 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.498 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 63.4 t80 -63.26 -45.49 85.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.023 1.329 . . . . 74.45 113.934 -172.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.27 -36.05 81.64 Favored 'Trans proline' 0 C--N 1.374 1.878 0 CA-C-N 121.226 1.473 . . . . 64.35 112.657 173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.2 m-85 -65.6 -40.5 92.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.969 0.508 . . . . 74.13 110.764 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -47.94 72.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.847 0.459 . . . . 61.52 110.266 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -51.35 -49.21 61.89 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.67 1.188 . . . . 71.24 111.369 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -38.97 79.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.632 -1.167 . . . . 74.42 109.898 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -71.28 -34.18 70.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.91 -0.586 . . . . 74.01 111.33 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.531 HG21 HG21 ' B' ' 64' ' ' VAL . 73.2 mt -67.54 -52.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.854 0.462 . . . . 61.33 109.766 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.4 m -53.36 -33.11 52.35 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 123.941 0.775 . . . . 63.22 111.401 177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.0 t -65.8 -62.74 1.33 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.308 0.643 . . . . 62.32 110.648 172.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.52 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.8 mmt -61.25 -33.3 73.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.346 0.658 . . . . 65.31 112.449 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -76.96 -39.85 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.604 0.762 . . . . 74.03 110.693 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.3 p -66.39 -28.94 69.03 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.474 0.654 . . . . 44.25 111.15 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.52 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 84.2 mtt-85 -61.86 -31.78 72.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.523 -0.762 . . . . 74.24 110.205 174.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.58 12.85 58.04 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 119.425 -0.653 . . . . 73.5 114.145 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 17' ' ' TYR . 15.0 p 61.63 21.27 11.99 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.01 1.724 . . . . 64.33 111.965 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -105.08 159.66 28.63 Favored Pre-proline 0 CA--C 1.567 1.624 0 C-N-CA 123.801 0.84 . . . . 63.21 110.738 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.71 156.85 64.38 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 123.814 3.009 . . . . 63.51 115.541 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' C' ' 125' ' ' GLN . 5.1 pm0 -63.06 156.81 23.75 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.741 0.816 . . . . 72.22 112.709 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.8 96.8 6.49 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.334 -0.987 . . . . 75.15 108.334 163.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -89.08 93.55 9.63 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.196 -2.15 . . . . 64.31 105.196 165.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' B' ' 42' ' ' LEU . 1.8 tt -81.44 135.79 35.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.101 -0.703 . . . . 73.44 109.101 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.436 ' HB1' HD11 ' E' ' 204' ' ' ILE . . . -59.74 132.86 89.1 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 124.067 0.855 . . . . 73.35 111.512 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.99 81.19 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.498 2.132 . . . . 75.2 111.471 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -78.21 75.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.279 -0.873 . . . . 74.35 110.34 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.11 84.84 1.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.482 -0.781 . . . . 65.31 109.013 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.546 ' HA ' HD23 ' B' ' 136' ' ' LEU . 8.3 t80 -78.75 -6.19 55.22 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.478 -0.783 . . . . 63.42 111.063 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -53.28 -44.4 68.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.671 1.188 . . . . 73.44 111.014 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.42 -33.06 69.26 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.203 1.001 . . . . 73.35 112.242 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.605 HD21 HG22 ' E' ' 207' ' ' VAL . 3.3 mm? -75.66 -38.92 58.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.513 0.725 . . . . 64.32 110.07 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.44 -29.51 68.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.967 0.507 . . . . 34.43 111.184 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 92.8 mmm -65.75 -36.93 84.97 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.822 0.449 . . . . 74.45 111.457 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -100.72 -30.03 11.95 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.442 0.464 . . . . 74.03 112.154 -168.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.73 -45.3 52.88 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.852 -0.425 . . . . 73.02 109.852 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.49 21.36 5.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.299 0.64 . . . . 52.54 110.905 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -74.35 93.05 2.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.887 0.875 . . . . 74.51 109.901 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -154.53 147.75 24.85 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.288 -0.869 . . . . 72.31 109.109 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -104.18 101.57 11.3 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.491 0.663 . . . . 71.54 109.727 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' B' ' 1' ' ' MET . . . -153.23 83.76 1.2 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.659 -0.7 . . . . 64.04 109.793 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.58 141.85 10.43 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.012 -0.835 . . . . 74.51 111.012 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.69 144.07 26.84 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.252 0.621 . . . . 74.51 109.756 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.18 135.29 17.3 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.764 0.665 . . . . 74.14 111.916 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -148.83 127.81 12.71 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.695 -0.854 . . . . 74.21 108.695 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -76.82 -82.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.515 -0.92 . . . . 64.44 108.515 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 60.36 162.66 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.943 1.297 . . . . 64.52 113.175 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -122.82 140.0 53.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.118 -0.946 . . . . 74.22 108.87 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.71 107.65 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.84 -0.8 . . . . 73.42 108.84 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -118.36 136.72 53.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.111 0.964 . . . . 74.52 109.013 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.821 0.848 . . . . 43.35 109.232 -179.278 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' C' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.756 0.313 . . . . 45.11 111.043 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.8 p -149.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.306 0.642 . . . . 74.3 110.609 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.1 155.11 43.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.66 0.784 . . . . 75.34 110.586 -174.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -100.17 -55.43 2.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.671 0.788 . . . . 74.32 110.206 -173.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 56.8 77.96 0.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.745 1.218 . . . . 72.41 110.751 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.49 -82.2 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.284 -0.871 . . . . 72.32 109.969 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.3 m -155.19 93.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.333 0.653 . . . . 73.43 110.087 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -134.11 121.56 21.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.808 -1.182 . . . . 63.53 107.808 168.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.5 ttp 62.55 142.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 O-C-N 124.738 1.274 . . . . 75.43 112.039 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m -127.88 101.54 6.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.843 -0.799 . . . . 34.15 108.843 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' H' ' 206' ' ' ASP . 71.9 t80 -124.64 135.42 53.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.408 1.083 . . . . 70.53 108.352 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' C' ' 85' ' ' SER . 46.2 tt0 -146.35 105.28 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.09 0.556 . . . . 75.45 110.243 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.503 HD11 HD11 ' C' ' 16' ' ' ILE . 14.5 tt -72.14 129.91 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.43 0.692 . . . . 74.43 109.623 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -115.9 -49.16 2.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.919 0.487 . . . . 71.53 111.878 -172.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -162.13 133.18 5.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.493 -0.558 . . . . 73.32 109.493 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.503 HD11 HD11 ' C' ' 13' ' ' ILE . 64.0 mt -123.14 138.35 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.583 -0.895 . . . . 74.41 108.583 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.3 p90 -174.73 162.75 3.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.806 0.336 . . . . 74.43 111.612 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -81.52 125.76 30.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.483 0.713 . . . . 72.23 110.064 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -75.57 -49.1 19.62 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.184 -1.043 . . . . 73.15 108.184 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -136.81 147.15 46.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.24 -1.345 . . . . 74.2 110.428 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.5 mt -143.44 145.47 22.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 126.19 1.796 . . . . 63.43 106.622 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -161.03 149.25 15.9 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.256 0.551 . . . . 70.44 110.465 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' D' ' 21' ' ' ILE . 85.7 t80 -149.41 118.25 6.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.327 -1.36 . . . . 72.11 107.327 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.19 122.61 44.52 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.06 -0.719 . . . . 63.0 109.06 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.44 80.86 46.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.054 -1.091 . . . . 43.14 108.054 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.6 -26.43 16.5 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.207 1.938 . . . . 74.2 110.525 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.22 16.16 6.6 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.587 1.155 . . . . 60.1 110.759 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.11 99.99 Favored Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 113.649 0.981 . . . . 65.03 113.649 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.44 -26.5 3.99 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 121.79 1.66 . . . . 72.24 112.699 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -70.18 -33.47 71.78 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.383 1.073 . . . . 64.33 111.841 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.455 HG23 HD11 ' C' ' 68' ' ' LEU . 13.2 p -79.69 -18.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.447 1.099 . . . . 72.12 111.401 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.85 -28.44 66.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.293 1.037 . . . . 72.41 112.154 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -127.79 44.43 2.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 54.23 109.86 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -121.26 159.75 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.665 0.786 . . . . 62.21 110.389 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.16 120.32 11.25 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.709 0.63 . . . . 75.25 110.236 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -85.28 97.43 9.94 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.072 0.939 . . . . 75.24 109.905 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -140.56 62.57 19.05 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.417 -0.957 . . . . 74.55 108.417 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' C' ' 67' ' ' SER . 14.8 Cg_exo -69.47 97.98 0.64 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.858 1.705 . . . . 64.44 112.282 -175.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.89 77.6 9.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.57 -1.65 . . . . 75.4 107.494 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' C' ' 126' ' ' LEU . 19.6 m -89.84 110.73 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 113.687 -1.597 . . . . 72.11 110.36 -170.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -133.09 147.07 52.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 60.31 110.948 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' C' ' 128' ' ' LEU . 1.5 pp -105.38 165.73 10.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.356 0.598 . . . . 71.41 112.103 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -140.91 130.78 24.4 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.262 1.425 . . . . 71.44 107.531 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.95 118.43 36.95 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.247 0.619 . . . . 75.33 110.265 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 35.7 t70 -115.14 155.97 26.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.304 -0.999 . . . . 64.44 108.304 166.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -134.49 140.72 46.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.438 0.695 . . . . 74.25 110.29 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.3 38.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.29 1.036 . . . . 70.34 109.253 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -155.3 148.88 25.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.49 0.716 . . . . 61.15 109.274 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 38.3 t -144.86 128.29 16.93 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.635 0.774 . . . . 75.33 109.153 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -82.75 117.11 22.43 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.992 -0.744 . . . . 64.32 108.992 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' C' ' 57' ' ' GLU . 79.6 mt -92.48 -32.61 14.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.464 0.706 . . . . 72.23 110.368 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.34 -179.82 8.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.134 -0.939 . . . . 74.12 109.229 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.17 127.29 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 71.25 108.996 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.97 18.29 10.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.477 1.111 . . . . 74.01 112.461 -174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.28 115.16 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.568 -0.901 . . . . 60.13 108.568 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -116.16 169.57 9.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.055 0.931 . . . . 75.3 110.844 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.9 tt0 -127.45 133.24 49.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.924 -1.944 . . . . 61.34 107.99 173.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.42 127.89 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.101 -1.444 . . . . 72.45 107.101 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.5 HG22 ' HA2' ' C' ' 81' ' ' GLY . 61.7 t -126.46 114.23 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.234 -0.654 . . . . 70.54 109.234 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' C' ' 103' ' ' PRO . 18.6 mt -86.6 130.53 34.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.585 -0.524 . . . . 64.34 109.585 172.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.597 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 49.1 mtp180 -101.45 104.27 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.197 -1.038 . . . . 73.43 108.197 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.59 110.42 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.475 -1.305 . . . . 74.23 107.475 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -110.85 145.65 37.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.842 -0.799 . . . . 74.03 108.842 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.795 HG11 ' HG ' ' C' ' 126' ' ' LEU . 53.3 t -128.58 135.26 62.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.899 0.88 . . . . 65.54 109.224 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -117.92 138.11 52.37 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.989 -1.115 . . . . 73.52 107.989 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.99 132.79 55.13 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.269 -1.012 . . . . 44.54 108.269 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.7 m -132.96 164.21 27.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.833 0.708 . . . . 64.44 109.262 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.455 HD11 HG23 ' C' ' 31' ' ' VAL . 14.4 mt -124.04 29.08 6.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 106.926 -1.509 . . . . 74.33 106.926 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.82 -100.76 1.73 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.082 -0.963 . . . . 74.54 110.85 -169.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -89.67 -32.51 17.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.392 0.677 . . . . 71.24 110.107 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.65 120.84 32.05 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.616 0.766 . . . . 71.14 109.454 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -67.65 140.47 56.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.89 0.476 . . . . 74.34 111.026 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.43 -51.41 4.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.803 0.441 . . . . 64.21 109.931 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -168.5 177.27 5.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.944 0.898 . . . . 70.22 111.299 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.476 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -137.04 147.34 46.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.086 1.354 . . . . 73.14 107.391 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.476 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.0 t -148.99 153.48 37.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.349 0.66 . . . . 71.14 109.395 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -158.82 140.96 13.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.458 0.703 . . . . 71.11 109.905 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.98 119.26 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.714 0.806 . . . . 74.52 109.531 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.597 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 47.8 mt-30 -91.14 98.4 11.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.052 0.941 . . . . 64.33 109.623 172.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.473 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.2 tp-100 -88.78 107.82 19.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.617 0.767 . . . . 71.31 110.615 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.5 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -84.07 158.72 35.02 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.77 0.669 . . . . 75.4 113.041 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.64 117.29 0.77 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.481 -0.648 . . . . 33.23 111.481 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.457 HD12 ' CD1' ' C' ' 51' ' ' LEU . 15.0 mm -81.81 122.47 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.34 -0.615 . . . . 62.22 109.34 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -135.71 119.23 16.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.682 0.793 . . . . 75.23 109.149 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.581 ' HB3' ' HB3' ' C' ' 12' ' ' GLN . 41.1 t -77.08 128.0 33.68 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.765 -0.828 . . . . 72.14 108.765 170.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.469 HD11 HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -145.99 126.9 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.501 0.72 . . . . 64.34 110.433 -166.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.85 176.19 11.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.591 1.157 . . . . 72.22 110.176 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -50.96 4.0 Favored Glycine 0 N--CA 1.48 1.626 0 CA-C-O 121.295 0.386 . . . . 62.04 113.257 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.1 OUTLIER -64.83 156.34 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.448 1.499 . . . . 51.5 113.76 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -145.99 148.04 32.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.586 0.755 . . . . 74.3 109.24 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.38 -109.19 2.32 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.065 0.853 . . . . 35.11 114.345 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.646 HG21 ' HB3' ' C' ' 143' ' ' GLN . 56.6 p -53.99 -49.03 69.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 71.32 112.731 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 47.2 mt-30 -63.97 -46.62 83.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.122 0.569 . . . . 71.5 111.587 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.631 ' HB3' HG12 ' C' ' 89' ' ' ILE . 19.7 ptm -68.95 -37.22 78.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.053 0.221 . . . . 74.35 111.454 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -33.74 75.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.286 0.634 . . . . 65.2 111.185 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -75.8 -33.56 60.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.75 -0.659 . . . . 74.51 109.97 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -66.77 -60.97 2.21 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 123.559 0.744 . . . . 75.01 111.279 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.552 HD13 ' HB3' ' E' ' 175' ' ' PHE . 1.4 pt? -77.22 -18.43 57.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.173 -0.33 . . . . 71.23 111.275 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -25.83 61.13 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.115 -0.493 . . . . 51.51 113.892 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.03 -43.2 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.518 0.933 . . . . 61.15 113.518 -172.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.71 -65.27 0.7 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.26 0.624 . . . . 74.11 111.751 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 15.1 m -60.53 -43.1 91.65 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.827 0.851 . . . . 75.11 112.259 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.523 ' HB3' HD21 ' C' ' 60' ' ' LEU . 98.0 Cg_exo -51.02 -47.24 26.6 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.597 2.198 . . . . 74.24 114.771 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -69.05 -21.98 64.06 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 122.579 0.352 . . . . 74.4 111.485 -173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.5 mm -60.58 -45.53 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.563 0.745 . . . . 72.21 109.855 168.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 40.7 mt -85.8 -22.73 27.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.828 -1.078 . . . . 70.2 112.456 -170.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.88 -52.34 65.82 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.016 -0.992 . . . . 74.24 113.465 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.51 -31.88 70.93 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 121.599 1.532 . . . . 73.0 113.55 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -65.79 -47.88 73.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.04 0.536 . . . . 75.33 110.606 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.39 -41.9 96.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.444 0.698 . . . . 63.23 111.057 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.04 -50.13 75.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.687 1.195 . . . . 74.14 110.664 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.5 -33.96 76.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.517 0.727 . . . . 72.3 110.289 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.13 -36.21 74.63 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 122.688 0.395 . . . . 62.33 111.654 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -69.81 -43.36 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.578 -0.527 . . . . 74.11 109.578 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' GLN . 52.8 m -55.22 -38.62 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.255 1.022 . . . . 61.23 110.715 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -67.77 -53.65 25.52 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.638 -1.165 . . . . 50.22 110.272 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.717 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -49.79 -45.4 49.79 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.845 1.258 . . . . 73.42 112.921 -177.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.42 HG21 HD23 ' C' ' 126' ' ' LEU . 92.7 t -72.01 -40.66 67.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.748 -0.66 . . . . 74.5 111.346 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -61.83 -31.88 72.16 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.365 -0.834 . . . . 61.35 111.208 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.495 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.53 -34.99 79.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.866 0.866 . . . . 53.34 110.25 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.52 11.8 37.09 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 123.744 0.652 . . . . 75.33 113.687 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.582 HG23 ' HB3' ' D' ' 17' ' ' TYR . 44.7 p 59.81 27.58 16.91 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.949 1.699 . . . . 74.44 112.617 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -109.05 167.85 8.55 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.246 1.018 . . . . 73.15 110.704 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.78 118.12 4.92 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.255 2.637 . . . . 75.31 112.551 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.705 ' HB2' HG23 ' C' ' 115' ' ' THR . 9.1 pt20 -51.59 143.57 12.17 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.051 0.844 . . . . 74.54 111.709 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.795 ' HG ' HG11 ' C' ' 64' ' ' VAL . 2.5 mm? -97.58 59.66 1.53 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.726 1.25 . . . . 61.43 110.453 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' B' ' 122' ' ' THR . 32.1 t30 -95.61 83.85 3.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 112.927 -1.942 . . . . 75.44 107.414 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.517 HD12 ' HG ' ' C' ' 42' ' ' LEU . 21.7 mt -90.73 154.41 19.56 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.198 -0.91 . . . . 75.33 110.241 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.54 ' HB3' HD13 ' E' ' 187' ' ' ILE . . . -35.71 135.36 0.5 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 126.201 1.8 . . . . 73.45 115.107 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.77 93.73 0.44 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.636 2.224 . . . . 72.04 111.504 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.89 106.7 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.955 0.883 . . . . 64.21 111.759 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.48 71.69 0.75 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.773 0.829 . . . . 74.04 109.63 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -64.52 -29.12 70.16 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.974 -0.557 . . . . 71.53 111.085 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' C' ' 138' ' ' MET . 36.0 t70 -59.44 -23.44 62.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.491 0.716 . . . . 75.33 112.598 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.57 -32.77 63.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.042 0.449 . . . . 44.23 111.607 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.23 -42.73 25.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.975 0.91 . . . . 75.43 110.001 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.402 ' HB2' ' HA ' ' C' ' 134' ' ' ASP . 40.7 m-85 -70.4 -14.88 62.74 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.234 1.013 . . . . 73.31 112.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 89.6 mtp -61.97 -47.38 85.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.23 -0.655 . . . . 75.13 109.23 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -64.6 -36.83 85.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.99 0.916 . . . . 75.12 111.083 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -62.78 -82.09 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.911 0.885 . . . . 74.21 111.214 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.82 87.29 7.31 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.371 0.668 . . . . 64.34 111.464 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.97 120.46 24.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.665 1.186 . . . . 74.24 110.248 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.646 ' HB3' HG21 ' C' ' 92' ' ' THR . 52.5 tt0 -174.83 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.774 0.83 . . . . 74.42 109.232 171.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 139' ' ' ASN . 0.6 OUTLIER -173.18 128.97 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.925 0.89 . . . . 63.22 110.331 -175.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.63 84.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.215 0.606 . . . . 53.25 110.071 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.64 92.94 0.91 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.617 -0.593 . . . . 52.32 111.617 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.9 143.08 33.32 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.15 0.58 . . . . 72.13 110.548 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.73 119.72 3.1 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.835 -0.62 . . . . 73.01 111.892 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 54.4 p -93.88 129.6 40.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.162 0.585 . . . . 64.24 109.937 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -87.71 126.85 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.461 0.704 . . . . 74.33 110.328 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -81.99 174.04 11.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.029 0.532 . . . . 75.23 111.503 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -150.24 122.78 8.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.573 0.749 . . . . 64.44 110.037 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.18 135.63 56.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.387 -0.597 . . . . 70.35 109.387 168.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -148.28 -66.61 0.24 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.884 0.311 . . . . 73.31 111.053 -171.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.408 0 C-N-CA 123.343 0.657 . . . . 64.12 109.431 -179.002 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.624 0.25 . . . . 62.11 110.853 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' E' ' 206' ' ' ASP . 18.1 m -81.46 15.99 1.85 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.245 0.831 . . . . 71.31 113.245 -170.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.74 -42.12 16.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.757 0.823 . . . . 73.0 110.666 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -77.23 139.75 39.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.443 -0.799 . . . . 73.12 110.736 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -77.79 69.06 3.97 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.309 1.043 . . . . 73.34 109.34 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -153.15 179.51 8.66 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.608 1.163 . . . . 72.32 108.557 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m 80.51 -67.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.834 1.654 . . . . 75.45 111.057 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.489 ' HG2' ' H ' ' D' ' 9' ' ' MET . 21.1 tt0 -172.99 -170.93 0.69 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.513 0.725 . . . . 71.11 109.301 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.489 ' H ' ' HG2' ' D' ' 8' ' ' GLU . 6.7 ttp -29.76 135.37 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.509 1.524 . . . . 64.01 113.032 161.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.1 m -107.34 140.63 39.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.158 -0.682 . . . . 74.21 109.158 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.402 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 40.5 t80 -152.28 97.82 2.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 106.477 -1.675 . . . . 64.42 106.477 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 75.8 mt-30 -112.25 118.32 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.746 0.419 . . . . 53.13 110.814 -173.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.5 103.14 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 107.926 -1.139 . . . . 64.32 107.926 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.96 -50.06 8.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.581 0.173 . . . . 73.21 111.405 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -170.8 134.04 0.99 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.767 0.427 . . . . 75.43 110.479 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.23 130.66 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.582 ' HB3' HG23 ' C' ' 122' ' ' THR . 33.5 p90 -149.3 149.97 31.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.358 0.663 . . . . 73.25 111.895 -176.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.6 p -77.71 114.66 16.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.669 -0.696 . . . . 75.21 109.75 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -86.06 -20.25 29.06 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.915 0.486 . . . . 63.1 110.059 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.8 t70 -153.55 140.24 18.96 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.72 -1.127 . . . . 54.01 109.594 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.717 HD13 ' HE3' ' C' ' 117' ' ' MET . 96.3 mt -136.67 144.72 31.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 125.189 1.396 . . . . 73.23 107.554 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -154.76 133.62 12.22 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.959 0.787 . . . . 73.15 109.507 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.5 t80 -132.48 126.8 33.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.283 -1.747 . . . . 74.41 106.283 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -121.63 142.75 49.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.03 -1.1 . . . . 74.21 108.03 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.42 76.71 36.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 106.374 -1.713 . . . . 54.32 106.374 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.19 -34.15 28.83 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.822 2.348 . . . . 65.44 112.783 -169.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.457 ' O ' HG23 ' D' ' 31' ' ' VAL . 41.2 m-20 -116.13 23.3 12.28 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.091 0.956 . . . . 55.22 110.294 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -46.28 -50.47 38.55 Favored Pre-proline 0 CA--C 1.567 1.631 0 N-CA-C 116.462 2.023 . . . . 53.41 116.462 -167.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.86 -15.98 10.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 CA-C-N 122.137 1.799 . . . . 70.41 113.319 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -75.16 -26.87 59.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.668 1.187 . . . . 63.21 109.782 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 27' ' ' ASN . 70.4 t -80.02 -13.27 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.919 0.888 . . . . 52.43 110.648 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.46 -25.41 67.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.561 0.345 . . . . 71.32 110.543 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -77.12 -7.48 55.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 72.12 111.411 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -110.89 92.0 3.88 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.077 0.951 . . . . 75.53 109.478 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -97.41 77.76 2.65 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.097 0.559 . . . . 71.12 109.885 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -165.01 172.37 12.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.886 0.474 . . . . 72.23 110.141 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.423 ' HG2' ' H ' ' H' ' 192' ' ' GLY . 7.2 tp-100 -60.19 116.09 16.02 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.512 1.125 . . . . 74.24 110.965 172.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.75 123.94 12.43 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.026 1.817 . . . . 55.4 110.884 172.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -57.85 110.94 1.0 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.15 105.87 19.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.397 -0.819 . . . . 63.51 109.139 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.9 115.42 29.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.524 -1.658 . . . . 74.53 106.524 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.22 155.88 16.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.161 0.584 . . . . 61.12 109.972 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -149.47 132.28 16.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.131 0.572 . . . . 61.42 109.726 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -112.06 137.04 50.64 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.834 0.854 . . . . 74.32 109.655 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.633 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 3.8 t70 -133.57 154.84 50.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.931 1.292 . . . . 63.24 108.06 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.3 m -137.19 146.33 44.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.161 0.585 . . . . 75.23 110.294 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 167.03 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.389 1.075 . . . . 62.42 108.891 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -164.71 155.75 14.9 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.968 0.507 . . . . 75.33 110.844 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.1 p -158.75 132.99 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 65.23 109.323 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.44 133.8 48.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.391 0.676 . . . . 71.52 110.541 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' D' ' 57' ' ' GLU . 38.6 mt -102.16 -40.52 6.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.43 0.692 . . . . 75.4 110.31 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.98 -169.48 2.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.257 0.623 . . . . 65.12 111.222 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.71 111.48 1.64 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.241 -0.89 . . . . 61.44 110.648 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.799 ' H ' HD21 ' H' ' 173' ' ' LEU . 20.0 m-20 75.89 5.29 3.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.485 1.514 . . . . 72.31 110.739 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -108.57 121.19 61.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.216 0.606 . . . . 75.12 110.299 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.39 130.22 53.48 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.707 -1.22 . . . . 75.14 107.707 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' D' ' 51' ' ' LEU . 5.4 tm-20 -88.48 131.48 34.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.104 -1.813 . . . . 62.44 106.104 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.69 129.86 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.416 -0.957 . . . . 63.5 108.416 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -108.97 135.11 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.409 0.684 . . . . 74.34 110.604 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -115.74 124.08 49.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.789 -1.56 . . . . 74.13 106.789 171.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -106.77 99.6 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.72 -0.844 . . . . 71.31 108.72 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.87 122.52 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 74.43 108.136 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -121.43 134.37 55.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.357 -0.838 . . . . 50.51 109.635 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' D' ' 114' ' ' ILE . 86.2 t -124.58 102.77 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.79 0.836 . . . . 54.3 109.275 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -101.47 108.02 19.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.513 -0.921 . . . . 54.4 108.513 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.94 139.05 44.33 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.999 0.919 . . . . 54.03 109.131 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 79.2 p -143.39 138.93 29.74 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.077 0.551 . . . . 73.21 110.338 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -115.72 111.27 20.32 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.203 1.001 . . . . 74.25 109.656 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.03 10.94 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.517 0.511 . . . . 64.35 112.626 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 4.05 49.39 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.88 0.872 . . . . 73.2 110.95 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -131.32 147.87 52.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.513 0.725 . . . . 63.43 110.591 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -64.72 138.06 58.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.25 1.02 . . . . 50.11 111.277 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.11 -59.55 2.07 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.556 -0.905 . . . . 54.41 108.556 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -164.24 153.85 14.1 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.807 -1.088 . . . . 62.41 109.951 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 53.3 mt -113.41 154.47 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.019 . . . . 65.21 108.982 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.564 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.2 t -158.58 147.05 18.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.526 0.33 . . . . 74.44 110.436 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.52 121.31 5.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.896 0.878 . . . . 74.35 109.042 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.49 116.07 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 122.987 0.515 . . . . 75.53 109.846 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.726 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -90.11 87.85 7.04 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.638 0.732 . . . . 73.43 109.282 170.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.28 100.39 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.138 -1.392 . . . . 75.32 109.178 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.42 169.87 38.18 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.158 -0.377 . . . . 72.01 112.158 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.65 137.6 4.7 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 112.558 -0.217 . . . . 72.31 112.558 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.27 125.31 42.29 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.676 0.79 . . . . 72.14 109.653 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.07 142.63 50.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.654 0.782 . . . . 75.24 110.299 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 31.0 m -105.93 99.34 8.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.801 0.84 . . . . 54.03 108.796 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.69 138.4 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.423 1.089 . . . . 73.33 109.386 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.25 162.3 12.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.049 0.54 . . . . 54.44 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.51 85.06 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.979 -0.555 . . . . 72.4 113.665 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' D' ' 9' ' ' MET . 0.2 OUTLIER -126.74 169.04 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.501 0.72 . . . . 74.21 110.83 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -160.59 162.12 32.74 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.992 0.917 . . . . 72.43 109.54 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.67 -140.73 48.04 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.831 0.707 . . . . 72.45 114.035 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -62.22 -24.25 67.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.194 0.998 . . . . 72.43 111.909 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -61.47 -50.77 71.41 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.258 -0.645 . . . . 64.14 109.258 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.753 ' SD ' ' HG2' ' H' ' 174' ' ' MET . 5.3 ptm -66.4 -34.53 78.16 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.487 0.492 . . . . 75.44 110.507 -176.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.47 75.0 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.38 0.61 . . . . 55.24 111.294 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -69.32 -49.94 51.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 74.1 110.658 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -73.93 -38.39 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.848 -0.614 . . . . 74.41 111.672 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.523 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.6 tp -84.93 -29.67 24.96 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.353 0.661 . . . . 63.14 110.454 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.58 39.4 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.855 -0.611 . . . . 74.51 113.346 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -61.17 1.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.102 0.451 . . . . 74.14 111.705 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.33 -40.86 97.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.056 0.761 . . . . 74.54 113.056 -173.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 74.1 m -68.35 -47.4 37.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 CA-C-O 118.95 -0.547 . . . . 65.45 112.104 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.533 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.9 Cg_exo -59.45 -32.91 97.18 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 121.844 1.696 . . . . 61.31 113.267 168.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -64.38 -24.93 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.122 0.569 . . . . 73.04 111.717 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.41 -44.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.44 -0.578 . . . . 75.43 109.44 171.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' D' ' 60' ' ' LEU . 51.4 mt -70.86 -26.06 63.09 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.33 -0.85 . . . . 63.23 111.528 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.03 -44.9 91.06 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 115.076 1.51 . . . . 73.35 115.076 -166.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.72 -35.01 95.93 Favored 'Trans proline' 0 C--N 1.381 2.282 0 CA-C-N 122.039 1.764 . . . . 74.41 113.032 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -76.44 -35.38 58.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.708 0.803 . . . . 74.51 110.482 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -48.38 71.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.585 0.754 . . . . 52.31 110.025 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.469 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.9 ttp180 -56.52 -50.33 72.13 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 113.97 -1.468 . . . . 72.12 110.869 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.27 -45.44 94.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.085 0.866 . . . . 74.41 111.091 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.472 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.9 t -57.17 -39.83 76.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 71.14 111.05 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.564 HG23 ' SG ' ' D' ' 76' ' ' CYS . 76.6 mt -68.72 -56.98 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.465 0.706 . . . . 61.41 109.847 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -49.46 -45.27 46.52 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.921 1.289 . . . . 64.05 111.923 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 46.4 t -64.56 -45.52 86.74 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.893 -1.049 . . . . 75.52 110.258 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.6 mtm -63.22 -36.8 84.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.428 0.691 . . . . 70.15 111.801 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -66.88 -45.16 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 75.33 109.784 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -71.29 -27.23 63.27 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.69 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -69.98 -30.95 68.42 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.79 0.836 . . . . 74.33 109.643 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 8.74 63.95 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.818 0.698 . . . . 73.3 113.165 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.433 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.4 p 54.12 39.77 31.0 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.838 1.655 . . . . 72.15 112.313 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.538 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 38.9 m-85 -110.65 167.95 8.31 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.605 1.162 . . . . 74.53 108.861 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.21 155.84 62.91 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.392 2.061 . . . . 62.22 112.564 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.78 123.24 22.95 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.226 -0.657 . . . . 45.12 109.226 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.18 105.83 16.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.489 -0.93 . . . . 74.35 108.489 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 91.4 m-20 -97.6 88.86 4.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.915 -1.143 . . . . 42.41 107.915 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.55 HD12 ' HE1' ' G' ' 202' ' ' TYR . 26.3 tp -71.19 119.87 15.95 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.431 -0.804 . . . . 73.34 109.664 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.99 88.12 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.085 0.954 . . . . 72.42 112.288 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.32 106.8 1.18 Allowed 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.157 1.905 . . . . 65.0 110.796 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.06 109.95 30.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.371 -0.974 . . . . 63.51 108.371 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.85 79.25 6.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.415 -0.957 . . . . 73.03 108.415 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -21.02 60.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.807 -1.088 . . . . 74.13 109.393 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -52.92 -35.99 59.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.774 1.23 . . . . 72.2 110.736 172.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.58 81.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.072 0.949 . . . . 62.42 112.854 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.42 -48.57 79.08 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.405 0.622 . . . . 74.12 110.228 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -73.2 -30.13 63.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.892 -1.049 . . . . 72.03 110.519 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 39.7 ttm -55.85 -37.95 69.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.65 1.18 . . . . 64.21 110.877 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -55.82 -46.28 78.14 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.151 0.907 . . . . 75.52 111.116 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -69.82 -38.03 76.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.267 0.627 . . . . 75.1 111.315 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.3 -32.17 72.97 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.132 0.573 . . . . 72.12 111.523 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.16 2.06 56.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.01 0.524 . . . . 72.15 111.59 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -125.12 64.12 1.15 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.791 0.805 . . . . 74.42 108.857 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -168.51 -167.07 0.74 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.335 -1.302 . . . . 65.15 109.418 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.3 97.21 0.18 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.434 0.694 . . . . 73.22 111.007 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.81 40.34 0.1 OUTLIER Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.582 -1.007 . . . . 73.33 110.582 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.33 121.94 41.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.586 1.154 . . . . 74.44 110.065 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.02 49.13 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.815 -0.914 . . . . 71.11 110.815 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 40.9 p -61.36 95.55 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.943 0.897 . . . . 63.02 111.798 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.64 95.63 3.41 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.49 -0.929 . . . . 73.34 108.49 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.41 -62.28 1.78 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.51 1.124 . . . . 71.34 111.588 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -142.39 139.55 31.73 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.5 0.667 . . . . 70.02 111.414 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -121.97 173.12 7.73 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.03 1.332 . . . . 71.02 107.774 169.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.5 100.78 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.152 -0.314 . . . . 54.03 110.152 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.209 1.004 . . . . 55.45 108.637 -178.736 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.814 -0.439 . . . . 71.33 109.814 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 169' ' ' GLY . . . . . 0.478 ' HA3' ' SD ' ' E' ' 174' ' ' MET . . . -76.32 70.48 2.14 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 112.338 -0.305 . . . . 61.23 112.338 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.09 -52.34 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.618 1.167 . . . . 72.43 110.896 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 35.8 m -144.49 -44.84 0.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.762 0.825 . . . . 75.41 109.044 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.01 -171.14 3.44 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 53.25 110.288 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.419 HD23 ' O ' ' C' ' 89' ' ' ILE . 67.2 mt 68.54 -70.35 0.13 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.079 1.352 . . . . 72.52 109.341 -172.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.478 ' SD ' ' HA3' ' E' ' 169' ' ' GLY . 0.0 OUTLIER -69.03 124.13 22.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.857 0.863 . . . . 73.24 110.279 174.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.552 ' HB3' HD13 ' C' ' 98' ' ' LEU . 32.0 m-85 -62.06 98.04 0.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.908 0.883 . . . . 72.41 111.547 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -74.66 85.14 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.936 -1.135 . . . . 73.24 107.936 169.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 55.8 tp -104.37 100.65 10.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.654 0.782 . . . . 74.12 109.254 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -75.7 -75.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.861 0.464 . . . . 74.01 109.888 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 179' ' ' GLU . . . . . 0.481 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 29.3 tt0 178.38 -60.1 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.101 1.36 . . . . 71.21 109.53 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 180' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 98.6 Cg_endo -82.49 102.51 1.17 Allowed 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.581 1.52 . . . . 73.42 112.504 -173.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.45 -71.28 0.56 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.297 -1.001 . . . . 64.03 108.297 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -168.19 138.81 2.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.978 0.911 . . . . 75.55 109.229 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 54.1 m -122.47 133.51 54.6 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.222 -0.658 . . . . 71.51 109.222 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -80.03 127.65 76.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.415 0.686 . . . . 74.42 110.396 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -87.3 98.51 0.47 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.555 2.17 . . . . 72.0 110.936 169.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.52 174.22 9.95 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.737 -0.665 . . . . 71.4 111.114 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' F' ' 200' ' ' GLY . 21.3 pt -52.29 132.94 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.245 1.018 . . . . 73.2 111.684 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.25 86.3 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.705 0.802 . . . . 51.23 111.564 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 189' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' F' ' 200' ' ' GLY . . . 65.52 11.19 7.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.649 1.18 . . . . 64.24 113.462 172.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.54 152.68 37.74 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.714 0.806 . . . . 74.52 110.699 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 66.99 -162.95 45.45 Favored Glycine 0 C--N 1.344 1.002 0 O-C-N 123.561 0.538 . . . . 64.31 113.632 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 192' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' F' ' 194' ' ' ALA . . . 127.51 -65.45 0.57 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.122 -0.539 . . . . 52.32 113.017 172.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 193' ' ' TYR . . . . . 0.439 ' HB3' ' CD1' ' F' ' 193' ' ' TYR . 80.3 m-85 69.36 52.76 0.45 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 71.44 108.948 -160.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 194' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' F' ' 201' ' ' LYS . . . -69.93 -2.19 11.74 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.85 0.685 . . . . 75.31 112.85 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -146.35 132.1 18.97 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.463 0.705 . . . . 74.44 109.821 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 196' ' ' LYS . . . . . 0.466 ' HG3' ' HA2' ' F' ' 192' ' ' GLY . 46.4 mtpt -86.96 138.1 31.81 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.496 -1.298 . . . . 73.51 107.496 164.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -142.08 36.62 1.56 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.97 -1.492 . . . . 64.15 106.97 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.2 -24.4 34.93 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 112.805 -1.998 . . . . 52.2 111.142 -172.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -138.93 169.35 17.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.284 -0.871 . . . . 73.32 111.119 -169.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -71.79 91.67 0.51 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.736 -0.945 . . . . 41.43 110.736 169.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' F' ' 190' ' ' ASP . 18.8 ptmt -116.23 11.67 15.2 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.954 0.902 . . . . 74.15 111.465 -173.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -161.87 39.09 0.13 Allowed 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.823 0.82 . . . . 55.32 110.518 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -125.96 141.33 52.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.923 -0.769 . . . . 74.43 108.923 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.436 HD11 ' HB1' ' B' ' 129' ' ' ALA . 3.1 mp -89.89 -60.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.995 -1.113 . . . . 71.51 107.995 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 78.14 -27.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.727 1.211 . . . . 73.44 112.572 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 206' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' D' ' 2' ' ' SER . 3.9 m-20 -86.88 -13.73 44.0 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.72 -0.612 . . . . 65.54 110.798 164.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.605 HG22 HD21 ' B' ' 136' ' ' LEU . 95.0 t . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 107.094 -1.447 . . . . 65.03 107.094 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.754 0.787 . . . . 63.24 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -142.8 149.44 21.31 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 111.09 -0.804 . . . . 72.22 111.09 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -101.85 128.51 48.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.813 0.845 . . . . 74.04 109.559 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m 65.9 18.41 11.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.565 1.146 . . . . 74.3 113.282 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -89.04 92.18 9.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.893 0.477 . . . . 35.5 111.726 -176.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.4 ' O ' HD11 ' B' ' 89' ' ' ILE . 3.9 tt -155.72 -70.99 0.11 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.853 -1.166 . . . . 60.33 107.853 170.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 18.9 mmt -94.02 80.36 4.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.925 -0.398 . . . . 64.31 109.925 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 67.1 t80 66.82 114.89 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.433 1.493 . . . . 71.35 111.821 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -151.87 44.91 0.75 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.252 1.025 . . . . 64.53 109.212 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 177' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' B' ' 98' ' ' LEU . 6.5 mp -80.65 -59.19 2.78 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.505 -1.295 . . . . 72.15 107.505 172.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 178' ' ' GLN . . . . . 0.557 ' HG2' ' HG3' ' F' ' 179' ' ' GLU . 36.4 tt0 66.07 -74.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 70.11 111.5 175.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 179' ' ' GLU . . . . . 0.557 ' HG3' ' HG2' ' F' ' 178' ' ' GLN . 34.9 mt-10 -109.02 131.58 21.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.135 0.974 . . . . 74.44 109.005 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.18 111.6 2.06 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.431 2.088 . . . . 70.34 110.527 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -65.71 -43.31 89.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.04 0.536 . . . . 65.15 111.401 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -136.06 156.72 48.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.056 0.543 . . . . 74.03 109.934 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 42.6 p -117.64 130.1 56.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.065 0.946 . . . . 75.33 109.003 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -67.94 140.25 93.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.678 0.391 . . . . 74.31 110.714 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.26 109.52 2.23 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.221 1.948 . . . . 73.24 111.984 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.67 150.72 46.7 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.236 -0.893 . . . . 74.51 110.592 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 31.3 pt -86.42 160.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.403 0.681 . . . . 65.5 111.074 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.77 68.34 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.058 -0.519 . . . . 64.42 111.021 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . 62.05 156.11 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.273 1.429 . . . . 73.13 112.203 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 190' ' ' ASP . . . . . 0.455 ' HB3' ' HE3' ' E' ' 201' ' ' LYS . 29.7 t70 -167.01 147.08 5.52 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.218 -0.446 . . . . 55.14 110.455 -171.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -98.76 -124.12 5.04 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.399 -0.364 . . . . 55.4 113.468 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 192' ' ' GLY . . . . . 0.466 ' HA2' ' HG3' ' E' ' 196' ' ' LYS . . . -147.16 177.32 25.52 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.061 0.362 . . . . 62.33 113.009 -173.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 193' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' E' ' 193' ' ' TYR . 63.7 m-85 -83.76 -35.72 24.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.067 0.547 . . . . 75.24 110.848 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 194' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' E' ' 192' ' ' GLY . . . -96.44 153.3 17.91 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.98 1.104 . . . . 63.51 113.98 -168.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -175.78 -96.5 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 105.775 -1.935 . . . . 70.33 105.775 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt 62.06 7.75 2.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.307 1.595 . . . . 70.33 115.307 157.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 197' ' ' TYR . . . . . 0.407 ' OH ' HG13 ' B' ' 31' ' ' VAL . 17.3 m-85 59.79 83.55 0.13 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.783 1.233 . . . . 74.31 112.358 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 198' ' ' GLU . . . . . 0.454 ' HG2' ' H ' ' F' ' 199' ' ' ASN . 22.7 tt0 -149.1 168.76 22.32 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.645 0.778 . . . . 72.23 109.932 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 199' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' F' ' 198' ' ' GLU . 31.9 m-80 -63.69 111.38 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.067 0.947 . . . . 73.41 110.946 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 200' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' E' ' 187' ' ' ILE . . . 104.64 -170.91 18.72 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.815 -0.63 . . . . 70.22 112.626 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 201' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' E' ' 194' ' ' ALA . 2.7 mppt? 62.39 -159.5 0.32 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.04 0.936 . . . . 65.51 110.626 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -73.06 -7.59 51.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 120.958 0.408 . . . . 73.12 110.978 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -98.9 -173.76 2.6 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.125 0.97 . . . . 64.42 110.818 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 12.3 tt -142.43 149.18 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.691 1.196 . . . . 74.41 109.293 -175.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.65 139.07 17.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.973 0.509 . . . . 74.52 110.197 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 11.6 t70 71.35 -92.0 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.534 1.534 . . . . 71.01 111.577 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.261 1.71 0 C-N-CA 123.885 0.874 . . . . 62.32 109.874 179.161 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 tttp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.284 -0.265 . . . . 74.31 110.284 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.51 -76.74 0.78 Allowed Glycine 0 C--N 1.357 1.74 0 O-C-N 123.563 0.54 . . . . 62.13 111.822 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -74.04 169.18 18.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.922 0.889 . . . . 62.2 109.995 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 52.0 m 64.04 87.76 0.11 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.569 1.147 . . . . 62.03 110.348 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -169.44 -162.33 0.34 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.338 1.455 . . . . 61.14 108.855 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 73.86 -66.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.906 1.682 . . . . 73.14 110.874 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 18.6 mmt -122.26 106.9 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.27 1.028 . . . . 62.32 108.658 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 65.58 173.05 0.22 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.676 1.235 . . . . 70.42 112.222 -174.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 64.91 139.39 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.693 1.597 . . . . 71.24 113.14 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.32 143.3 29.03 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 106.484 -1.672 . . . . 72.35 106.484 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 178' ' ' GLN . . . . . 0.553 HE21 ' HG3' ' G' ' 179' ' ' GLU . 19.6 tp60 -66.26 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.815 -0.439 . . . . 72.22 109.815 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.553 ' HG3' HE21 ' G' ' 178' ' ' GLN . 49.7 mt-10 -153.17 154.61 31.07 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.179 0.992 . . . . 71.3 108.912 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.53 101.06 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.078 1.852 . . . . 65.53 111.441 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -67.61 -20.44 65.36 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.56 0.695 . . . . 74.32 109.82 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.35 -175.88 4.38 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.432 -1.258 . . . . 63.04 109.603 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 183' ' ' THR . . . . . 0.52 HG23 ' HD3' ' G' ' 185' ' ' PRO . 8.2 t -125.63 174.9 7.95 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.274 -0.639 . . . . 75.4 109.274 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -145.25 86.95 7.3 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.6 -0.889 . . . . 75.21 108.6 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 185' ' ' PRO . . . . . 0.52 ' HD3' HG23 ' G' ' 183' ' ' THR . 58.3 Cg_endo -71.11 104.84 1.59 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.841 2.361 . . . . 71.24 112.127 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.78 115.98 18.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.743 -0.662 . . . . 72.41 109.479 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -60.52 163.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 71.3 111.06 173.013 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -125.36 150.91 46.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.299 0.639 . . . . 42.55 110.528 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -73.01 114.64 11.39 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.79 0.436 . . . . 64.31 109.847 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -55.41 -61.52 2.28 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.019 0.824 . . . . 72.12 111.498 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 173.71 147.49 6.0 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-O 119.928 -0.373 . . . . 71.3 112.762 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.43 -151.86 26.5 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.875 -0.49 . . . . 22.32 111.875 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -155.07 -82.85 0.07 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.704 0.802 . . . . 71.03 109.169 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -174.09 108.54 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.113 0.965 . . . . 72.11 108.631 -173.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -84.33 112.77 20.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.981 -1.488 . . . . 72.42 106.981 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -68.77 90.21 0.41 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 123.909 0.755 . . . . 74.2 112.463 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.12 105.82 18.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.738 -1.119 . . . . 55.32 110.408 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.57 133.25 5.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.191 -1.411 . . . . 71.24 107.191 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -84.0 -32.27 25.04 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.05 0.54 . . . . 74.11 110.836 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.56 -85.19 0.74 Allowed Glycine 0 C--N 1.345 1.054 0 N-CA-C 109.429 -1.468 . . . . 75.41 109.429 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 201' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' G' ' 203' ' ' ASP . 36.5 ttpt -173.43 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.572 1.149 . . . . 65.22 110.07 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 202' ' ' TYR . . . . . 0.55 ' HE1' HD12 ' D' ' 128' ' ' LEU . 13.6 t80 70.98 48.43 0.38 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.589 1.555 . . . . 74.43 109.44 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 203' ' ' ASP . . . . . 0.52 ' O ' ' HE3' ' G' ' 201' ' ' LYS . 27.1 t70 62.63 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.605 1.562 . . . . 75.24 110.404 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.483 HD12 ' HG2' ' B' ' 12' ' ' GLN . 45.2 mt 48.74 88.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.309 1.444 . . . . 73.32 113.116 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 205' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' H' ' 186' ' ' LEU . 57.5 pttt -77.35 -179.75 5.91 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.217 -0.901 . . . . 55.43 109.683 168.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.01 -71.33 0.18 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.578 0.751 . . . . 74.23 110.224 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.985 1.314 . . . . 64.04 109.023 174.41 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.788 0.327 . . . . 73.31 110.664 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.96 -143.06 13.93 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.662 -0.975 . . . . 72.12 110.662 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -109.34 -30.39 8.0 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.817 0.847 . . . . 64.35 109.225 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 50.1 m 63.98 27.0 14.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.973 1.309 . . . . 65.14 111.615 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.37 75.74 10.2 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.816 0.847 . . . . 73.12 108.727 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.799 HD21 ' H ' ' D' ' 54' ' ' ASP . 4.1 mm? -109.82 81.66 1.47 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.05 0.929 . . . . 72.24 109.696 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.753 ' HG2' ' SD ' ' D' ' 94' ' ' MET . 0.2 OUTLIER -110.3 166.32 11.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.938 -1.483 . . . . 74.04 108.071 171.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -161.82 88.49 0.7 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.443 -0.947 . . . . 73.04 108.443 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -102.97 92.48 4.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 122.24 1.019 . . . . 63.33 108.492 173.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.22 21.76 0.65 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -65.2 -26.14 68.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.281 1.033 . . . . 74.21 111.583 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -133.47 147.3 64.21 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.043 0.937 . . . . 53.4 109.807 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.33 101.35 1.11 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.129 1.886 . . . . 73.45 110.708 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -59.77 -35.01 73.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 74.52 110.329 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.35 129.84 15.86 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.561 -1.2 . . . . 72.44 109.842 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -85.5 132.02 34.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.755 -0.831 . . . . 62.23 108.755 172.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -132.0 86.3 47.78 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.631 0.772 . . . . 71.21 111.111 -173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.98 115.31 3.99 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.753 2.302 . . . . 75.51 110.642 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 186' ' ' LEU . . . . . 0.479 ' O ' ' HE2' ' G' ' 205' ' ' LYS . 6.2 mp -67.85 -83.39 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.002 0.521 . . . . 74.21 111.066 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.428 HG21 ' HA ' ' G' ' 204' ' ' ILE . 2.3 pp -150.83 177.15 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.569 0.748 . . . . 64.45 111.406 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -118.85 -148.03 0.41 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.77 1.228 . . . . 51.13 107.747 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.68 141.89 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.458 0.703 . . . . 72.25 109.994 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.56 -178.04 3.44 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.27 -0.641 . . . . 73.03 109.27 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.22 -89.48 0.14 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.312 -0.715 . . . . 71.23 111.312 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 192' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' D' ' 37' ' ' GLN . . . 66.04 41.07 95.37 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.777 0.339 . . . . 65.41 113.281 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -99.92 148.41 24.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.214 0.606 . . . . 54.25 110.388 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.29 169.25 10.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.628 0.771 . . . . 75.33 110.028 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.436 ' HE2' ' HD3' ' D' ' 124' ' ' PRO . 3.2 m-30 -114.44 -55.07 2.53 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.665 0.386 . . . . 74.41 110.855 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.24 79.44 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.123 1.369 . . . . 72.35 109.098 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -63.12 81.23 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.809 -1.087 . . . . 63.32 111.418 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -80.54 82.49 6.54 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.626 0.727 . . . . 74.25 109.368 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -90.27 -165.94 1.47 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.801 -1.09 . . . . 74.22 111.454 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.43 73.41 1.37 Allowed Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.164 -0.774 . . . . 43.11 111.164 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -73.25 -12.33 60.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.993 0.917 . . . . 71.22 111.607 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -63.14 159.29 17.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.355 0.662 . . . . 74.33 111.089 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -86.31 124.33 32.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.917 -0.583 . . . . 75.33 109.879 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' C' ' 12' ' ' GLN . 3.4 mp -96.22 124.14 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.877 -0.786 . . . . 74.33 108.877 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.1 118.74 34.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.964 -1.495 . . . . 74.4 106.964 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 206' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' C' ' 11' ' ' PHE . 2.0 p-10 -53.44 -44.84 69.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.021 0.928 . . . . 73.11 111.531 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 136' ' ' LEU . 7.3 p . . . . . 0 C--O 1.254 1.327 0 C-N-CA 123.782 0.833 . . . . 71.33 109.214 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mmt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 108.599 -0.889 . . . . 75.34 108.599 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -94.41 8.68 41.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.873 . . . . 73.51 111.837 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -73.11 177.05 5.29 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.403 0.681 . . . . 71.55 111.122 -177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 65.64 15.47 10.06 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.253 1.021 . . . . 55.23 111.325 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.37 78.84 9.57 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.904 -1.147 . . . . 43.25 107.904 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -78.96 -15.36 58.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.393 -1.276 . . . . 73.34 111.26 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -83.63 -179.96 7.46 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.572 0.749 . . . . 73.33 109.987 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 88' ' ' GLY . 9.0 tp10 78.22 -54.39 0.49 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.362 1.465 . . . . 73.45 111.663 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 93' ' ' GLN . 56.2 mtm -67.32 136.0 54.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.6 0.76 . . . . 63.42 111.952 -175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -146.2 128.88 16.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.2 1.4 . . . . 61.33 108.796 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 55.9 t80 -131.88 147.85 52.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.444 0.697 . . . . 64.33 110.436 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 58.5 tp60 -145.44 134.05 22.14 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 123.67 0.606 . . . . 74.44 111.022 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.498 HD11 HG13 ' A' ' 16' ' ' ILE . 4.5 tp -92.76 128.93 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.011 0.924 . . . . 73.44 108.541 167.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -106.54 -41.87 5.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.463 0.305 . . . . 73.41 110.996 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -169.75 133.34 1.24 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 119.747 -0.168 . . . . 71.15 111.212 -171.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.819 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 67.9 mt -113.1 139.08 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.206 1.003 . . . . 72.34 109.017 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 29.9 p90 -165.3 175.53 9.12 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.008 0.818 . . . . 71.42 111.664 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.424 ' H ' ' HA2' ' B' ' 121' ' ' GLY . 75.8 p -100.71 118.99 37.94 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.37 -0.974 . . . . 75.23 108.37 170.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 25.0 mtpt -74.1 -34.37 63.92 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.011 -0.737 . . . . 75.34 109.011 171.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 29.8 t70 -145.03 141.87 29.27 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.257 -1.338 . . . . 53.51 110.241 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.38 142.2 44.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 106.772 -1.566 . . . . 50.43 106.772 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 138.28 21.06 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.395 0.678 . . . . 61.12 109.46 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.5 t80 -143.33 128.43 18.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.824 -1.547 . . . . 64.31 106.824 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -129.95 131.71 46.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.305 -0.628 . . . . 64.32 109.305 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.6 77.96 22.1 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 107.486 -1.301 . . . . 72.04 107.486 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.0 -35.57 33.87 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.798 2.332 . . . . 75.4 111.023 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 87.9 m-20 -95.25 25.71 4.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.17 0.988 . . . . 74.21 110.889 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.06 99.86 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.032 0.933 . . . . 74.12 112.221 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.83 -31.18 32.34 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 121.675 1.583 . . . . 71.31 112.106 173.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.6 m-70 -65.38 -30.97 71.85 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.707 0.803 . . . . 73.41 111.405 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' ASN . 48.1 t -58.54 -26.43 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 122.929 0.492 . . . . 65.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.95 -39.63 95.22 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.059 0.544 . . . . 73.42 110.431 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -74.28 -37.09 63.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.219 1.008 . . . . 75.51 110.336 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -82.34 160.07 22.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.208 -0.905 . . . . 72.31 111.28 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.42 141.54 35.2 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 108.266 -1.013 . . . . 72.24 108.266 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -79.93 82.69 5.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.203 0.525 . . . . 73.12 109.681 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' G' ' 193' ' ' TYR . 53.8 tt0 -132.73 72.91 76.91 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.161 -1.052 . . . . 71.12 108.161 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 52.8 Cg_endo -83.05 157.77 15.33 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.563 2.175 . . . . 73.23 111.583 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -123.38 108.29 12.56 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.141 -1.059 . . . . 73.35 108.141 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.679 HG23 HG13 ' A' ' 64' ' ' VAL . 7.3 p -65.87 135.14 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 123.706 0.629 . . . . 72.42 111.64 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 47.6 mtpt -104.51 145.25 30.56 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.009 0.924 . . . . 74.1 108.731 167.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HB2' HD21 ' G' ' 186' ' ' LEU . 4.6 mp -123.28 105.86 10.22 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.788 -1.19 . . . . 65.01 107.788 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.1 m-20 -115.88 102.76 9.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.766 -1.198 . . . . 61.51 107.766 173.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.96 122.65 43.19 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.84 -1.541 . . . . 54.41 106.84 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.11 154.12 49.79 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.742 -0.836 . . . . 70.03 108.742 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -106.83 157.68 17.56 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.502 0.668 . . . . 63.35 110.55 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -149.98 143.94 25.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.681 -1.229 . . . . 55.5 107.681 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 54.3 m -130.1 152.09 49.92 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.95 0.5 . . . . 72.33 110.025 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -158.27 121.09 3.79 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.272 0.629 . . . . 43.12 109.62 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.65 109.26 15.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.458 -0.942 . . . . 75.12 108.458 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.4 mt -86.11 -41.11 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.113 0.565 . . . . 72.05 111.128 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -154.43 -172.11 4.09 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.689 0.796 . . . . 33.42 110.266 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.71 110.58 4.36 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.341 0.656 . . . . 71.13 109.455 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.58 0.43 2.95 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.226 1.41 . . . . 73.2 112.636 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 85.0 t -98.94 113.14 32.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.549 -1.278 . . . . 71.23 107.549 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.467 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 0.2 OUTLIER -116.96 169.74 9.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -129.99 121.98 27.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.552 -0.907 . . . . 74.54 108.552 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.17 120.95 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.536 -1.653 . . . . 71.41 106.536 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 41.6 t -108.36 132.24 56.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.736 -0.839 . . . . 72.41 108.736 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -102.96 111.21 23.44 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.205 -1.406 . . . . 70.13 107.205 177.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.86 98.4 8.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.864 -1.161 . . . . 74.53 107.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 60' ' ' LEU . 4.0 t -96.96 142.08 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.255 -1.017 . . . . 23.42 108.255 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.7 m -135.62 127.03 28.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.467 -0.938 . . . . 75.25 108.467 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.679 HG13 HG23 ' A' ' 40' ' ' VAL . 55.2 t -125.24 107.75 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.723 1.209 . . . . 75.34 109.275 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 m -107.34 137.27 45.7 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.798 0.439 . . . . 72.54 109.943 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -121.03 122.36 39.93 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.931 -0.766 . . . . 74.43 108.931 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 67.2 m -118.81 130.78 55.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.0 0.52 . . . . 50.03 110.574 173.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -87.79 69.58 9.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.432 1.493 . . . . 71.41 107.884 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -94.14 1.32 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 114.95 -1.023 . . . . 73.43 111.23 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.58 -25.98 14.24 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.726 0.81 . . . . 73.22 111.966 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -111.81 128.19 56.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.115 0.566 . . . . 54.54 110.691 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -67.38 133.26 49.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.21 0.604 . . . . 72.34 111.294 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -56.64 3.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.613 1.165 . . . . 45.34 109.669 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -148.75 172.41 14.66 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.599 -1.182 . . . . 74.41 111.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -141.7 140.07 33.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.296 1.438 . . . . 53.34 107.733 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.6 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 29.9 m -128.04 140.59 51.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.988 -1.116 . . . . 71.52 107.988 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -148.85 118.31 6.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.255 -0.646 . . . . 73.32 109.255 168.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.14 110.6 23.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 123.752 0.821 . . . . 53.03 109.322 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.5 mt-30 -86.15 81.06 8.58 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.717 -0.846 . . . . 75.21 108.717 172.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.15 94.91 4.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.031 -0.986 . . . . 61.01 108.419 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -105.13 146.6 16.1 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 112.179 -0.368 . . . . 53.54 112.179 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.39 141.99 12.92 Favored Glycine 0 C--O 1.24 0.522 0 N-CA-C 111.433 -0.667 . . . . 75.1 111.433 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.421 HG13 ' HE1' ' A' ' 17' ' ' TYR . 50.6 mt -81.55 123.88 38.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.434 -0.95 . . . . 74.54 108.434 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.402 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -134.6 120.28 19.4 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.17 0.588 . . . . 71.3 109.743 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.634 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 24.0 m -83.6 103.25 12.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.881 -0.785 . . . . 72.41 108.881 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.478 HD12 HD11 ' A' ' 89' ' ' ILE . 45.2 pt -109.14 138.97 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.559 0.744 . . . . 71.41 110.709 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.5 153.79 33.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.206 -0.907 . . . . 72.3 109.344 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 8' ' ' GLU . . . 76.83 10.66 85.98 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 121.305 -0.474 . . . . 74.55 114.239 174.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 2.2 pp -107.37 130.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.513 -1.291 . . . . 64.44 107.513 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HG2' ' H ' ' G' ' 173' ' ' LEU . 43.7 mt-10 -153.34 168.29 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.699 -1.223 . . . . 74.53 107.699 -174.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.97 -117.85 2.41 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 114.73 0.652 . . . . 30.32 114.73 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -81.82 -27.22 33.74 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 63.01 111.159 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.456 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 47.6 mt-30 -64.65 -36.11 83.2 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.808 0.843 . . . . 75.22 110.091 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.48 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 59.0 ttm -69.05 -45.94 69.13 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.305 -0.861 . . . . 73.4 109.403 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.23 -26.79 68.95 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.286 -0.87 . . . . 62.43 112.228 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -70.53 -43.85 68.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.775 0.43 . . . . 75.53 110.315 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -70.46 -64.25 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.856 0.722 . . . . 65.01 110.981 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.95 -19.76 60.57 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.149 0.425 . . . . 73.23 112.149 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.35 -35.15 8.16 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 114.23 0.452 . . . . 63.42 114.23 -170.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -137.03 -48.01 0.6 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.793 0.294 . . . . 74.05 111.793 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.454 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.8 t80 -62.94 -61.44 2.39 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.407 0.683 . . . . 72.11 111.868 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.551 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.6 m -67.09 -37.45 13.57 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.72 0.808 . . . . 62.23 112.937 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.06 -44.05 48.4 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.149 1.9 . . . . 71.13 113.269 162.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -69.84 -23.43 63.3 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 71.34 111.664 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 102' ' ' CYS . 32.3 mm -65.77 -40.89 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.944 -0.762 . . . . 72.04 108.944 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.31 -23.06 26.41 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.364 1.066 . . . . 74.11 112.768 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -66.08 -42.84 53.86 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 114.249 1.203 . . . . 63.33 114.249 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.99 -34.56 99.2 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 121.938 1.758 . . . . 61.12 112.694 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -77.85 -39.0 44.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.761 0.825 . . . . 73.34 111.353 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.81 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.358 0.663 . . . . 75.13 109.548 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.6 ttm180 -48.59 -55.8 10.17 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.89 1.369 . . . . 74.1 110.717 176.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.458 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.0 tm-20 -66.07 -38.94 89.57 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.247 0.967 . . . . 63.25 111.18 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.583 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.2 t -62.37 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.221 0.608 . . . . 75.23 111.45 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.6 -46.49 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.152 0.981 . . . . 65.04 110.534 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' HE2' ' C' ' 109' ' ' TYR . 99.2 m -57.04 -43.98 82.48 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.949 1.299 . . . . 72.11 111.373 -174.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 29.0 t -68.68 -32.12 71.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.43 -0.805 . . . . 74.45 111.686 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.605 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 70.7 mtm -69.97 -38.28 76.04 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.581 0.352 . . . . 72.12 110.604 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -65.78 -48.51 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.559 0.743 . . . . 73.12 110.885 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.701 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 77.6 p -63.37 -35.61 80.96 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.516 0.674 . . . . 63.41 111.219 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -72.71 -20.5 61.21 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.3 -1.318 . . . . 74.45 110.656 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 16.39 37.87 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 119.413 -0.659 . . . . 75.13 113.295 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.504 HG21 ' HE ' ' B' ' 15' ' ' ARG . 0.5 OUTLIER 78.65 8.07 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 127.088 2.155 . . . . 75.43 112.082 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 119' ' ' SER . 19.0 m-85 -99.48 162.82 19.99 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.395 0.678 . . . . 74.45 110.127 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.98 125.93 13.18 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.857 1.704 . . . . 62.05 109.548 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.701 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 3.2 pt20 -61.72 147.54 45.77 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 123.554 0.534 . . . . 72.5 111.058 -173.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -121.77 113.0 19.07 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.984 -0.553 . . . . 71.32 110.118 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -110.72 111.68 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.388 -0.967 . . . . 65.21 108.388 174.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 40' ' ' VAL . 86.7 mt -73.18 144.84 46.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.038 0.535 . . . . 64.43 110.284 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 153.64 75.36 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.788 0.835 . . . . 51.23 111.701 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.47 138.58 12.35 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 121.922 1.748 . . . . 51.23 111.847 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' G' ' 186' ' ' LEU . 5.8 m -103.45 112.44 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.485 -0.931 . . . . 63.52 108.485 171.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.71 69.9 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.466 0.651 . . . . 71.3 110.472 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 39.9 t80 -76.21 -23.53 54.62 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.687 -0.688 . . . . 72.55 110.007 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.54 -38.31 84.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.986 0.515 . . . . 63.23 109.821 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.25 -56.8 6.49 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.56 1.144 . . . . 71.03 110.748 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.14 -30.07 70.78 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.391 -0.822 . . . . 71.42 112.345 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -69.28 -57.03 5.86 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.66 0.784 . . . . 75.14 110.048 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -61.34 -34.14 74.79 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.86 0.464 . . . . 64.33 110.875 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.1 -35.67 69.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.22 1.008 . . . . 73.23 111.307 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.524 ' HD2' HD22 ' A' ' 141' ' ' LEU . 90.4 t80 -73.5 -60.27 2.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.34 0.656 . . . . 63.34 111.825 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.524 HD22 ' HD2' ' A' ' 140' ' ' TYR . 4.4 mm? -54.12 -45.45 71.9 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.971 0.794 . . . . 74.24 112.159 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -148.61 -14.02 0.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 112.821 0.674 . . . . 64.44 112.821 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.433 HE21 ' HG3' ' C' ' 3' ' ' GLU . 0.6 OUTLIER 61.08 96.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.329 -1.36 . . . . 74.11 107.329 -158.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -145.91 153.76 41.19 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.893 -0.594 . . . . 72.21 110.649 -169.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.34 -178.49 5.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.207 1.003 . . . . 51.32 109.675 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.29 168.11 31.96 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.754 -0.203 . . . . 65.11 113.087 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' C' ' 141' ' ' LEU . 1.1 tm-20 -164.93 115.35 1.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.027 -1.472 . . . . 74.31 107.027 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.72 89.95 0.33 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.144 -0.383 . . . . 72.15 112.144 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 p -80.36 153.83 28.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.401 0.68 . . . . 45.11 111.352 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.11 167.1 15.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.154 -1.054 . . . . 73.33 108.154 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -127.33 155.08 44.13 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.177 -1.046 . . . . 55.51 108.177 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -119.91 156.79 30.08 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.328 -0.619 . . . . 75.31 109.328 172.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -80.47 163.04 24.08 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.736 0.814 . . . . 72.31 109.665 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.87 157.12 12.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.097 0.959 . . . . 73.12 111.748 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 N-CA-C 108.518 -0.919 . . . . 74.41 108.518 176.157 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.886 -0.413 . . . . 65.25 109.886 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.516 ' HA ' HG21 ' B' ' 92' ' ' THR . 53.4 m -149.31 85.27 1.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.503 1.121 . . . . 74.34 108.568 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.93 -177.77 3.24 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.933 -1.03 . . . . 72.43 110.994 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -75.82 110.07 9.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.414 -0.812 . . . . 72.31 110.599 178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.24 -173.4 2.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.515 1.126 . . . . 72.3 109.102 174.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -159.83 94.96 1.16 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.362 -0.607 . . . . 75.15 109.362 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.403 HG21 ' HA ' ' B' ' 89' ' ' ILE . 72.4 p -119.3 121.9 40.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.284 0.634 . . . . 70.35 109.604 176.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.19 -37.06 64.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.774 0.83 . . . . 75.54 110.32 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ptm 55.44 178.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.893 2.077 . . . . 75.13 116.091 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.7 m -148.35 139.0 22.86 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.722 -1.126 . . . . 74.35 108.567 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.44 123.45 13.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 64.14 109.82 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' G' ' 205' ' ' LYS . 1.8 mp0 -127.5 141.77 51.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.647 1.179 . . . . 73.31 109.83 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.6 HG13 ' HD3' ' D' ' 130' ' ' PRO . 61.4 mt -93.04 129.56 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.018 -1.104 . . . . 73.44 108.018 166.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -89.39 -40.92 12.42 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.581 0.55 . . . . 62.22 110.69 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.504 ' HE ' HG21 ' A' ' 122' ' ' THR . 68.8 ttt180 -167.55 150.46 6.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.774 0.43 . . . . 73.02 110.546 -170.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.11 145.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.998 -1.482 . . . . 73.35 106.998 172.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.1 p90 -170.62 162.21 7.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.685 0.394 . . . . 73.35 111.198 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 84.8 m -90.19 124.71 35.07 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.107 -0.701 . . . . 72.31 109.107 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.08 -45.19 11.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.899 -0.591 . . . . 64.45 109.505 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.516 ' HB3' HE21 ' B' ' 79' ' ' GLN . 19.4 t70 -148.92 146.05 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.889 -0.596 . . . . 74.34 111.807 -165.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 42.9 mm -138.35 150.01 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.463 1.505 . . . . 64.35 109.068 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -150.32 150.89 32.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.722 -0.672 . . . . 52.1 110.146 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 66.8 t80 -157.42 111.82 2.67 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.891 -1.522 . . . . 62.42 106.891 168.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -125.56 114.59 18.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 73.13 109.471 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.707 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.05 91.54 6.62 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.445 0.698 . . . . 53.44 109.503 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.84 -29.81 88.9 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.008 2.472 . . . . 61.25 112.62 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.45 31.27 6.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.873 0.869 . . . . 73.35 110.349 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -46.28 -55.59 13.31 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 125.115 1.366 . . . . 75.52 114.341 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.36 -13.91 10.82 Favored 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 121.751 1.634 . . . . 74.43 112.834 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -85.51 0.53 52.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.986 0.914 . . . . 72.45 111.841 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.47 -18.08 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 124.387 1.075 . . . . 63.25 111.008 170.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.55 -37.16 86.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.79 0.836 . . . . 64.44 110.825 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -85.85 -43.87 12.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.479 -0.782 . . . . 70.35 110.539 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 34' ' ' LYS . 23.9 mmtp -78.08 89.9 4.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.059 0.544 . . . . 70.43 109.989 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.403 ' HA ' ' CE2' ' F' ' 197' ' ' TYR . 12.0 p-10 -86.61 76.88 9.48 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.304 -0.862 . . . . 64.51 112.146 -171.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -173.1 161.85 4.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.572 -0.74 . . . . 64.32 110.281 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' F' ' 195' ' ' PHE . 34.4 tt0 -75.24 117.29 61.92 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.519 0.728 . . . . 73.02 109.329 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.4 151.5 79.09 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.7 2.267 . . . . 75.1 113.333 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.28 102.82 8.81 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.032 -0.985 . . . . 75.23 108.391 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.401 ' HB ' HD12 ' B' ' 126' ' ' LEU . 13.6 t -86.75 121.78 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.807 -0.812 . . . . 63.02 108.807 -175.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -130.52 133.84 46.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.095 0.958 . . . . 74.42 108.724 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.35 149.24 31.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.393 -0.595 . . . . 62.2 109.393 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -135.51 135.96 40.84 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.016 0.926 . . . . 64.05 109.313 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.29 146.76 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.813 0.845 . . . . 73.31 109.892 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.52 152.34 34.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.349 1.059 . . . . 61.44 108.275 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -137.27 137.93 39.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.184 0.594 . . . . 74.11 109.408 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.82 151.89 51.37 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.828 1.251 . . . . 61.13 107.961 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.0 m -132.11 161.89 32.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.096 0.558 . . . . 51.35 110.246 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -163.44 155.8 17.99 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.681 1.192 . . . . 62.41 108.399 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 10.1 tt0 -124.4 132.72 53.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.567 -0.531 . . . . 74.33 109.567 171.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.1 mt -100.7 -31.73 11.07 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.602 0.761 . . . . 75.44 111.342 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.31 -172.08 3.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.654 0.781 . . . . 64.12 111.326 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.36 107.19 1.56 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.034 -0.984 . . . . 72.44 111.119 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.0 16.41 7.0 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.651 1.181 . . . . 75.23 112.386 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 91.7 t -115.68 116.59 52.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.157 -1.423 . . . . 62.31 107.157 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 11.0 p90 -123.92 179.12 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.321 0.649 . . . . 65.52 109.894 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -142.44 134.18 26.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.556 -0.905 . . . . 73.23 108.556 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.72 125.91 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.142 -1.059 . . . . 72.12 108.142 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.08 113.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.594 -0.891 . . . . 74.34 108.594 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -93.57 118.46 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.755 -0.831 . . . . 72.43 108.755 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 35.1 ttm180 -105.12 120.77 42.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.157 0.583 . . . . 71.21 109.83 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.451 HG23 HD22 ' B' ' 60' ' ' LEU . 48.4 t -116.53 110.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.734 -1.21 . . . . 60.54 107.734 167.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -106.65 128.39 54.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.02 0.528 . . . . 64.21 109.796 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.7 HG21 HG21 ' B' ' 114' ' ' ILE . 97.2 t -115.39 128.84 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.216 1.006 . . . . 61.45 109.696 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -121.94 142.5 50.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.263 1.025 . . . . 71.53 109.562 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.07 163.87 28.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.176 0.991 . . . . 64.43 109.564 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.5 p -146.71 138.49 24.56 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.462 0.541 . . . . 73.35 112.462 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 39.3 mt -110.47 106.09 15.28 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.029 1.332 . . . . 70.24 107.982 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.46 -106.27 2.21 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.329 -0.462 . . . . 75.4 112.485 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.46 5.89 11.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.156 0.983 . . . . 54.34 110.732 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -127.22 171.47 11.42 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.091 0.956 . . . . 74.43 109.424 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 59.6 m -76.7 142.78 40.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.085 0.554 . . . . 72.03 111.31 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.469 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.56 -64.08 1.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.527 0.731 . . . . 70.33 109.33 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 32.7 p90 -147.5 162.02 39.9 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.005 -0.998 . . . . 75.12 110.6 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -130.0 154.09 47.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.239 1.416 . . . . 70.12 107.567 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.4 t -154.75 159.49 40.7 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.059 0.944 . . . . 63.21 108.675 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -164.67 141.04 5.99 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.655 0.782 . . . . 75.41 109.253 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 69.9 t -129.13 140.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.755 0.822 . . . . 64.42 108.948 171.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.516 HE21 ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -126.89 92.77 3.6 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.849 0.718 . . . . 74.32 109.164 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -89.86 101.82 14.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.272 -1.331 . . . . 62.24 109.048 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.11 15.46 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.896 -0.882 . . . . 72.42 110.896 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -141.75 125.95 2.87 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.167 -0.773 . . . . 72.31 111.167 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.91 126.43 40.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.719 0.808 . . . . 72.02 109.252 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -132.9 161.57 33.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.665 1.186 . . . . 74.43 109.293 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -134.03 127.38 32.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.492 1.117 . . . . 73.32 108.504 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.55 HG12 HD12 ' B' ' 89' ' ' ILE . 8.5 tt -139.1 135.98 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.512 -0.551 . . . . 72.34 109.512 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.33 158.57 36.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.716 0.806 . . . . 74.4 109.999 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.31 -30.3 10.69 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 111.797 -0.521 . . . . 65.02 111.797 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' B' ' 93' ' ' GLN . 0.1 OUTLIER -83.31 169.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.967 1.307 . . . . 73.13 111.087 175.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -152.16 143.68 23.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.992 0.917 . . . . 75.3 109.718 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -99.8 0.16 Allowed Glycine 0 C--N 1.35 1.331 0 O-C-N 123.917 0.761 . . . . 74.1 114.715 170.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.516 HG21 ' HA ' ' B' ' 2' ' ' SER . 86.1 m -64.27 -42.75 96.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 74.45 112.349 -170.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.625 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 1.4 mp0 -62.13 -45.07 95.08 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.229 0.612 . . . . 64.22 110.093 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -39.97 65.93 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.233 -0.894 . . . . 61.24 110.164 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.402 ' HB1' ' CE2' ' F' ' 181' ' ' TYR . . . -64.26 -27.56 69.13 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.252 0.621 . . . . 74.35 111.855 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -76.02 -40.58 53.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 70.43 110.501 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' B' ' 102' ' ' CYS . 49.6 t -66.2 -47.56 73.49 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.419 0.688 . . . . 64.42 109.674 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.65 -35.26 80.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.637 1.175 . . . . 73.52 110.837 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.69 2.14 87.78 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.375 -0.83 . . . . 52.41 114.172 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.99 -63.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.885 0.843 . . . . 63.4 112.732 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.8 -50.08 39.53 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.629 0.974 . . . . 72.43 113.629 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 61.4 m -58.44 -47.61 98.46 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.503 0.721 . . . . 63.23 112.081 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.03 -27.56 29.81 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 121.363 1.375 . . . . 73.51 112.898 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -64.84 -29.91 70.89 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.758 0.708 . . . . 64.4 110.515 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.517 HG23 ' NH2' ' D' ' 111' ' ' ARG . 63.7 mt -62.29 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.768 0.827 . . . . 62.24 110.372 172.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.488 ' HB2' HD12 ' B' ' 60' ' ' LEU . 39.2 mt -83.68 -11.85 56.66 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.882 -1.054 . . . . 75.22 111.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.554 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 32.3 t80 -63.46 -46.8 84.28 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.298 1.439 . . . . 51.13 112.994 -170.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.416 ' HB3' ' HD2' ' D' ' 109' ' ' TYR . 29.1 Cg_endo -60.95 -36.93 80.71 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.64 1.56 . . . . 63.24 112.764 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.22 -42.25 99.13 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.247 0.619 . . . . 70.34 110.587 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -41.47 73.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.358 0.663 . . . . 65.2 111.357 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -56.53 -58.92 5.98 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.571 1.149 . . . . 72.12 111.275 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.39 -35.79 81.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.397 -0.819 . . . . 62.21 110.387 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.408 ' HB3' HG21 ' B' ' 78' ' ' VAL . 36.8 t -64.64 -37.14 86.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.476 0.547 . . . . 73.43 112.476 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.7 HG21 HG21 ' B' ' 64' ' ' VAL . 79.3 mt -70.76 -47.9 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.918 0.487 . . . . 64.42 110.131 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.6 m -62.49 -23.75 67.1 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.533 -0.758 . . . . 71.43 110.833 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -73.27 -54.71 7.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.567 1.147 . . . . 71.51 109.985 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.503 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -64.93 -33.74 76.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.982 0.913 . . . . 70.3 113.163 -172.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.91 -30.15 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 122.901 0.48 . . . . 75.24 110.175 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' B' ' 125' ' ' GLN . 54.5 p -72.14 -32.18 66.67 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.481 0.658 . . . . 43.24 110.478 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.583 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 67.7 mtt-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.722 -1.127 . . . . 73.01 109.814 171.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 18' ' ' THR . . . -87.37 15.79 52.34 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.097 -0.835 . . . . 71.44 113.342 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t 56.69 14.07 1.63 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 126.97 2.108 . . . . 53.14 113.884 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -106.14 160.15 27.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.698 0.799 . . . . 73.21 111.309 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -52.77 101.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.782 2.988 . . . . 53.24 114.49 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.547 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 0.1 OUTLIER -68.86 155.45 40.21 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 113.356 -1.747 . . . . 71.53 110.293 176.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.401 HD12 ' HB ' ' B' ' 40' ' ' VAL . 2.6 tt -152.3 126.28 9.1 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.741 -0.837 . . . . 54.4 108.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -93.66 127.96 39.61 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.997 0.919 . . . . 62.42 108.661 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.571 HD11 HD21 ' F' ' 186' ' ' LEU . 1.7 tt -70.54 130.89 43.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.617 -0.512 . . . . 75.31 109.617 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.523 ' HB3' HG12 ' F' ' 187' ' ' ILE . . . -66.64 144.67 98.73 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.563 0.745 . . . . 60.21 111.042 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.469 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 57.8 Cg_endo -65.22 92.02 0.22 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.39 2.726 . . . . 75.03 113.431 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.485 HG11 HD12 ' F' ' 186' ' ' LEU . 19.6 m -84.95 108.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.953 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.444 ' HB3' HG21 ' D' ' 13' ' ' ILE . 52.5 t30 -109.84 105.93 15.32 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.188 0.595 . . . . 70.23 110.177 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.498 ' HD1' ' HB3' ' F' ' 184' ' ' TRP . 69.2 t80 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.803 0.841 . . . . 74.45 111.368 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.61 -36.77 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.364 0.665 . . . . 64.4 110.572 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.87 -40.57 84.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.955 0.902 . . . . 70.22 112.028 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.42 -40.81 73.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.358 0.663 . . . . 73.13 110.426 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.589 ' HA ' ' HD1' ' B' ' 140' ' ' TYR . 67.2 t80 -63.59 -31.25 72.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.892 0.877 . . . . 74.13 111.256 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 56.9 mtt -60.31 -36.99 79.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.435 0.694 . . . . 70.43 110.886 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.578 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 89.5 m-20 -77.43 -25.16 50.45 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.501 0.72 . . . . 73.42 111.621 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.589 ' HD1' ' HA ' ' B' ' 137' ' ' PHE . 58.6 m-85 -74.15 -32.3 63.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.604 0.362 . . . . 71.34 111.043 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 42.9 mt -113.54 27.67 9.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.085 0.554 . . . . 71.13 110.873 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.578 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 28.0 tt0 -66.64 100.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.17 0.988 . . . . 71.34 111.505 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 54.99 28.03 10.1 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.316 1.046 . . . . 74.13 111.599 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -75.15 80.46 2.3 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.174 0.99 . . . . 74.5 109.26 -175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.64 25.49 2.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.049 -0.978 . . . . 63.42 110.508 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.59 35.89 4.56 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.865 -0.894 . . . . 74.31 110.865 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.52 34.04 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.622 1.169 . . . . 74.12 109.085 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.45 85.64 0.08 OUTLIER Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.449 -0.796 . . . . 45.42 112.638 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -147.85 -178.53 6.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.643 1.177 . . . . 53.24 108.755 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.16 -160.54 0.14 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.211 1.004 . . . . 72.34 110.547 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.11 115.07 2.42 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.234 0.614 . . . . 74.33 111.159 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -125.28 -30.85 3.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.15 1.38 . . . . 55.41 110.178 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -86.23 18.26 3.24 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.626 0.77 . . . . 74.34 109.928 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.83 160.06 31.28 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.915 0.886 . . . . 72.23 111.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.538 -0.912 . . . . 43.25 108.538 179.82 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.181 -0.674 . . . . 52.51 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -78.17 89.97 4.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.636 -0.875 . . . . 61.24 108.636 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.433 ' HG3' HE21 ' A' ' 143' ' ' GLN . 0.3 OUTLIER -75.23 113.91 13.14 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.004 -0.998 . . . . 74.14 108.724 -173.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 86.65 4.79 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.089 -0.708 . . . . 73.04 109.089 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -166.33 145.75 5.9 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.399 -1.334 . . . . 72.22 107.399 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -67.73 -73.45 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.215 -0.661 . . . . 72.33 109.215 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m 51.54 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.211 1.404 . . . . 74.53 110.889 -168.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 79.52 -43.25 0.29 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.218 1.807 . . . . 74.24 112.39 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 64.36 115.38 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.591 1.557 . . . . 42.51 112.308 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 80.5 m -124.46 103.61 8.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.393 -1.336 . . . . 75.02 107.393 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -122.83 123.7 41.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.343 -1.355 . . . . 73.34 107.343 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.79 138.41 16.05 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.399 0.437 . . . . 64.5 110.733 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.17 142.35 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.869 0.867 . . . . 72.32 109.075 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.533 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 30.9 mm-40 -111.39 -35.73 5.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.416 0.686 . . . . 62.23 110.663 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 42.4 ttt180 -173.33 136.49 0.62 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.114 0.566 . . . . 65.23 109.654 -171.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -123.18 143.85 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.407 -1.331 . . . . 62.42 107.407 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.411 ' HB3' HG23 ' D' ' 122' ' ' THR . 39.2 p90 -177.71 168.85 2.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 75.54 110.72 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -87.56 111.86 21.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.372 -0.831 . . . . 50.34 109.323 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.38 -43.92 89.22 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.2 -0.667 . . . . 63.32 109.2 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -147.34 147.1 29.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.222 -1.354 . . . . 75.45 110.078 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.88 144.57 29.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 125.782 1.633 . . . . 73.42 106.729 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -153.33 151.02 29.5 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.31 0.576 . . . . 54.44 110.644 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -155.08 134.04 12.23 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.573 -1.194 . . . . 73.31 108.077 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.8 147.28 52.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.439 1.096 . . . . 74.43 108.268 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 84.87 6.32 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.544 0.737 . . . . 74.44 109.785 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.38 -27.97 46.97 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.989 2.459 . . . . 74.21 111.302 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.815 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 6.8 m-80 -95.25 18.56 12.15 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.797 -1.092 . . . . 55.51 111.551 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.29 88.98 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 118.613 0.642 . . . . 70.34 111.19 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -94.18 -26.33 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.743 1.629 . . . . 73.33 113.571 164.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.815 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 61.2 t60 -69.05 -24.41 64.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.734 1.213 . . . . 72.05 113.312 -170.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' C' ' 27' ' ' ASN . 8.8 p -74.99 -12.01 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 122.825 0.45 . . . . 73.53 111.854 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.67 -41.34 81.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.402 0.681 . . . . 74.14 112.189 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -112.12 48.11 1.01 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.071 0.939 . . . . 64.54 108.949 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.619 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.9 tppp? -124.33 164.05 20.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.455 -0.793 . . . . 73.35 109.481 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.42 105.79 8.78 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.859 -1.164 . . . . 70.53 107.859 166.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -84.0 73.35 10.37 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.917 0.887 . . . . 71.02 111.466 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -124.93 77.62 66.17 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.048 -0.723 . . . . 55.4 109.048 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.793 ' HG2' ' HG3' ' C' ' 124' ' ' PRO . 1.3 Cg_endo -86.51 137.4 4.95 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.366 2.711 . . . . 44.34 111.794 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.63 117.02 24.27 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.61 -1.256 . . . . 75.34 107.61 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.31 79.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 115.236 -0.893 . . . . 42.42 109.406 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.07 141.56 35.63 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.209 0.604 . . . . 54.03 110.847 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.1 165.91 14.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.785 0.834 . . . . 73.33 110.846 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -145.83 148.4 32.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.914 1.286 . . . . 71.01 107.594 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.415 HD11 HD21 ' C' ' 60' ' ' LEU . 15.6 tp -116.47 148.91 40.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.213 0.461 . . . . 75.41 111.042 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 12.9 m-20 -141.15 137.97 33.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.37 1.068 . . . . 73.42 109.17 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -113.97 126.22 54.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.502 -0.925 . . . . 64.45 108.502 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.96 165.29 25.04 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.38 1.072 . . . . 43.12 108.54 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 m -145.09 168.31 20.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.319 0.648 . . . . 71.11 110.441 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.19 128.0 4.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.729 1.211 . . . . 73.3 108.025 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -90.31 126.2 35.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.979 -0.749 . . . . 71.33 108.979 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.623 HD11 HD12 ' C' ' 83' ' ' ILE . 61.8 mt -97.93 -36.42 10.16 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.836 0.854 . . . . 61.12 110.18 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.99 -178.05 5.41 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.493 -0.776 . . . . 73.42 109.96 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -68.04 123.47 20.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.137 -1.061 . . . . 73.33 108.137 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' C' ' 85' ' ' SER . 21.6 m-20 73.06 -4.33 2.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.701 1.2 . . . . 73.32 112.823 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 98.01 6.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.91 0.884 . . . . 62.32 108.74 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.11 116.39 26.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.716 0.806 . . . . 75.21 110.481 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -82.83 121.92 27.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.985 -1.007 . . . . 74.2 109.484 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.85 124.56 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.98 -1.118 . . . . 64.24 107.98 170.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.06 103.41 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.016 -1.105 . . . . 73.24 108.016 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -93.01 110.07 21.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.193 0.997 . . . . 65.45 108.365 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 47.5 ttp180 -103.34 137.33 41.6 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.035 0.534 . . . . 72.5 109.893 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.3 130.17 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.324 -1.362 . . . . 70.21 107.324 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -120.23 121.04 37.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.849 -0.797 . . . . 44.12 108.849 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' C' ' 126' ' ' LEU . 25.6 t -98.73 138.5 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.966 0.907 . . . . 61.32 109.319 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -123.35 138.75 54.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.153 -1.385 . . . . 73.2 107.486 171.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.946 -1.501 . . . . 62.31 106.946 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -134.49 128.85 34.22 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 123.643 0.589 . . . . 71.22 110.68 -176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.619 HD13 ' HG2' ' C' ' 34' ' ' LYS . 17.1 mt -84.65 47.55 1.39 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.482 1.513 . . . . 73.31 108.811 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.27 -82.82 0.49 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.847 -0.901 . . . . 75.33 110.847 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.98 -31.78 3.59 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.674 1.19 . . . . 73.34 108.829 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.49 121.84 14.27 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.902 0.881 . . . . 72.15 109.874 170.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -74.59 122.0 22.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.749 0.704 . . . . 73.34 109.62 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' C' ' 27' ' ' ASN . . . -72.35 -51.32 21.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.064 0.946 . . . . 61.41 109.92 177.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -167.17 176.68 6.64 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.916 -0.583 . . . . 71.12 110.443 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.439 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -131.02 142.89 50.37 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.59 -1.263 . . . . 64.5 107.59 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -144.63 147.73 33.45 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.373 -0.973 . . . . 73.43 108.373 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.99 141.47 14.07 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.714 0.406 . . . . 64.2 110.389 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.86 115.47 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.313 1.045 . . . . 71.33 108.922 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 45.6 mt-30 -91.51 95.3 9.87 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.557 -0.905 . . . . 74.53 108.557 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.579 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -86.96 111.49 20.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.775 0.83 . . . . 71.51 109.905 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 145.18 17.6 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 112.389 -0.284 . . . . 43.15 112.389 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.13 124.03 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.268 -1.133 . . . . 71.44 110.268 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.623 HD12 HD11 ' C' ' 51' ' ' LEU . 8.1 mm -81.87 121.5 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.193 -1.04 . . . . 44.43 108.193 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.42 118.86 28.42 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.291 -0.633 . . . . 71.11 109.291 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' C' ' 54' ' ' ASP . 23.5 p -85.43 100.44 11.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.833 -0.803 . . . . 61.32 108.833 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.37 146.49 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.594 0.758 . . . . 72.22 111.251 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -164.93 151.05 10.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.17 0.988 . . . . 73.41 109.959 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 -38.75 3.14 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 114.042 0.377 . . . . 61.24 114.042 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.56 148.93 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.455 1.102 . . . . 74.34 111.082 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.521 ' HA ' ' HB3' ' E' ' 172' ' ' ALA . 6.9 pt-20 -148.85 152.92 37.31 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.856 0.687 . . . . 75.42 112.856 -170.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.83 -139.37 38.66 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 114.724 -1.126 . . . . 54.0 114.008 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -69.17 -20.37 64.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.837 0.855 . . . . 72.25 111.195 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -65.36 -43.28 91.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.922 0.889 . . . . 74.33 109.978 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 52.5 ttm -62.95 -47.35 83.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.916 -0.583 . . . . 72.23 109.958 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.47 72.67 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.86 0.725 . . . . 73.53 111.732 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -73.42 -31.89 64.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.663 0.785 . . . . 70.1 110.027 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.14 -35.62 48.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 52.04 110.989 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.998 0.919 . . . . 53.01 110.303 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 11.11 62.44 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 115.914 -0.585 . . . . 71.4 114.18 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.01 -61.58 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.488 0.644 . . . . 71.35 111.34 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -73.77 -46.53 45.06 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.898 0.703 . . . . 74.43 112.898 -172.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.495 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 82.8 m -60.9 -48.73 91.9 Favored Pre-proline 0 CA--C 1.563 1.47 0 CA-C-O 118.977 -0.535 . . . . 71.44 110.75 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 71.9 Cg_exo -57.04 -33.67 96.17 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.439 2.093 . . . . 71.33 114.081 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.46 -34.87 79.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.313 0.645 . . . . 62.4 111.193 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.455 HD12 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -64.92 -41.57 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.229 0.612 . . . . 64.2 110.331 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.2 mt -81.49 -22.28 38.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.216 -0.902 . . . . 65.31 112.088 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.72 -48.51 95.06 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 117.723 -1.132 . . . . 73.22 113.55 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.03 -39.54 84.92 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.195 1.93 . . . . 71.22 112.607 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.448 ' HE2' HG21 ' A' ' 115' ' ' THR . 87.4 m-85 -62.88 -52.31 63.58 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.845 -1.07 . . . . 74.44 111.952 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -70.18 -34.81 73.44 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.319 -0.4 . . . . 71.53 111.397 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.83 -51.03 67.13 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.257 1.423 . . . . 64.31 110.473 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.98 -36.44 69.81 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.507 -0.77 . . . . 74.23 110.195 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.16 -30.96 71.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.09 0.556 . . . . 64.11 111.378 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.577 HG21 HG21 ' C' ' 64' ' ' VAL . 98.1 mt -72.3 -45.49 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.0 -0.546 . . . . 75.23 109.871 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -56.76 -37.32 70.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.801 0.688 . . . . 73.41 110.423 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.7 t -59.76 -56.95 15.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.923 1.289 . . . . 64.14 110.45 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.686 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.17 -41.91 89.53 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.586 1.154 . . . . 74.0 112.917 -176.153 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' C' ' 126' ' ' LEU . 69.2 t -66.29 -41.59 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.424 0.689 . . . . 72.33 110.747 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 45.5 t -63.31 -35.96 82.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.145 -0.934 . . . . 75.11 110.993 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.5 mtt-85 -66.89 -37.92 85.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.979 -1.01 . . . . 70.24 110.122 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.15 0.84 82.7 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.283 -0.732 . . . . 74.34 113.328 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p 57.09 50.94 11.1 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.523 1.529 . . . . 74.43 111.492 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.42 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 26.9 m-85 -121.65 169.74 8.75 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.474 1.11 . . . . 74.53 110.693 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.793 ' HG3' ' HG2' ' C' ' 38' ' ' PRO . 26.9 Cg_endo -57.8 126.71 22.6 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.732 2.288 . . . . 61.54 110.905 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.547 ' HG3' ' HB2' ' B' ' 125' ' ' GLN . 87.5 mm-40 -58.99 132.44 54.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.148 0.979 . . . . 75.11 112.486 -168.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.775 ' HG ' HG11 ' C' ' 64' ' ' VAL . 1.7 mm? -108.02 72.18 0.84 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.779 -0.646 . . . . 73.14 109.968 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -126.53 89.02 2.93 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.035 -1.468 . . . . 65.02 107.035 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.823 ' HB3' HD13 ' E' ' 187' ' ' ILE . 31.9 mt -84.27 151.16 24.96 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.552 -1.203 . . . . 75.14 108.785 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.843 ' HB2' ' HA ' ' F' ' 203' ' ' ASP . . . -55.58 147.53 39.3 Favored Pre-proline 0 CA--C 1.546 0.791 0 O-C-N 124.281 0.988 . . . . 51.01 113.295 -172.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.819 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 88.0 Cg_exo -50.36 115.2 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.545 2.83 . . . . 43.13 112.583 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.16 78.91 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-O 121.632 0.729 . . . . 62.23 109.128 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.64 93.46 8.4 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.189 -0.914 . . . . 73.23 109.978 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -74.9 -11.87 60.23 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.389 -1.278 . . . . 72.24 111.443 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.28 -46.58 89.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.88 0.872 . . . . 63.33 112.667 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.75 95.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.168 0.587 . . . . 71.11 110.167 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 61.6 tp -58.43 -39.99 81.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.654 -1.157 . . . . 61.42 110.444 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -70.51 -37.02 74.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.601 1.161 . . . . 74.15 110.205 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.6 mmt -69.63 -28.95 66.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.457 0.703 . . . . 53.44 111.066 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.68 -39.78 84.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.694 0.397 . . . . 72.22 110.147 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -68.65 -85.51 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.488 0.715 . . . . 74.02 110.269 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 147' ' ' GLU . 4.5 pp -145.72 143.92 30.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.959 0.903 . . . . 75.22 110.066 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -91.96 96.75 10.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.511 0.724 . . . . 72.02 109.475 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.02 130.05 34.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.69 0.396 . . . . 75.32 109.958 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.424 ' HG3' ' H ' ' C' ' 144' ' ' GLN . 0.3 OUTLIER -79.44 173.01 13.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.726 0.81 . . . . 74.11 111.728 176.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.35 99.68 6.72 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.199 -1.037 . . . . 52.24 108.199 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.53 136.46 39.18 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.787 0.68 . . . . 43.21 112.589 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -144.64 -54.83 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.918 -1.141 . . . . 75.23 107.918 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.72 139.89 4.16 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.83 -0.623 . . . . 52.52 111.686 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 140' ' ' TYR . 85.6 m -151.68 141.55 21.99 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.247 0.619 . . . . 72.53 110.836 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -129.8 99.36 5.1 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.753 1.221 . . . . 72.54 108.509 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.65 143.98 50.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 75.44 110.152 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.99 103.22 4.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.977 0.911 . . . . 72.35 110.005 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.23 97.37 1.53 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.955 0.502 . . . . 71.34 109.792 173.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.43 136.45 39.44 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.216 1.006 . . . . 63.41 110.329 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 123.913 0.885 . . . . 73.34 109.332 179.613 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 110.088 -0.338 . . . . 61.13 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 45.1 p -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.878 0.871 . . . . 64.21 109.545 174.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.25 81.38 3.03 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.8 -0.815 . . . . 73.11 108.8 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -134.71 59.16 1.74 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.244 1.021 . . . . 72.43 109.161 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.716 HD22 ' HB2' ' D' ' 54' ' ' ASP . 11.8 p-10 -128.63 62.78 1.46 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.156 -0.929 . . . . 64.52 110.288 -173.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -159.23 88.26 0.87 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.743 -1.117 . . . . 75.32 108.82 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -166.31 -157.43 0.28 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.141 0.976 . . . . 74.1 108.4 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -69.63 -164.8 0.07 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.321 1.049 . . . . 73.51 110.725 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.3 ttp -33.67 125.97 0.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.346 1.058 . . . . 73.51 112.722 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m -138.4 141.57 39.59 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.72 0.808 . . . . 74.23 109.813 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 91.3 t80 -156.6 102.56 2.06 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.333 -1.358 . . . . 74.31 107.333 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 76.3 mt-30 -113.03 113.55 25.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.844 -0.799 . . . . 74.52 108.844 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' B' ' 132' ' ' ASN . 7.5 tt -91.43 98.31 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.581 -1.266 . . . . 64.35 107.581 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.53 -33.21 14.56 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.35 0.5 . . . . 51.23 112.35 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 75.2 ttt180 -170.53 122.42 0.63 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.059 -0.348 . . . . 74.13 110.059 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' B' ' 130' ' ' PRO . 35.4 mm -115.57 132.67 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.146 -1.057 . . . . 54.42 108.146 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 4.8 p90 -154.57 169.0 24.87 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.381 0.672 . . . . 73.12 112.024 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -97.7 119.59 36.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.016 -0.993 . . . . 62.13 108.815 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.02 -22.31 31.36 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.331 0.653 . . . . 72.24 110.2 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.3 t70 -160.85 139.5 10.07 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.102 0.961 . . . . 74.13 109.381 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.686 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.3 mt -142.25 143.73 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.479 1.112 . . . . 63.11 108.258 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 60.7 m -141.98 136.76 30.64 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.228 1.011 . . . . 43.34 109.187 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.527 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.9 t80 -143.22 110.99 5.93 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 106.445 -1.687 . . . . 73.02 106.445 165.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -122.31 115.12 21.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.353 -0.61 . . . . 74.41 109.353 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -116.66 80.44 10.58 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.476 -0.935 . . . . 74.51 108.476 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.76 -29.83 23.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.669 2.246 . . . . 53.43 112.266 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -111.49 18.03 19.51 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.721 -0.672 . . . . 51.1 109.661 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.486 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -39.4 -54.35 3.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 115.586 1.699 . . . . 64.34 115.586 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.412 ' HB3' HD11 ' C' ' 83' ' ' ILE . 44.4 Cg_endo -81.67 -13.55 10.64 Favored 'Trans proline' 0 C--N 1.382 2.32 0 CA-C-N 121.307 1.503 . . . . 73.23 113.439 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -76.44 -36.83 57.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.687 1.195 . . . . 70.44 109.462 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.611 HG13 HD12 ' D' ' 68' ' ' LEU . 35.7 t -65.56 -23.96 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 124.877 1.271 . . . . 75.01 111.324 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.41 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 74.3 t80 -45.9 -36.64 5.55 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.335 1.454 . . . . 62.12 113.47 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -79.1 -6.54 56.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.637 0.775 . . . . 72.52 112.518 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -109.57 112.69 24.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.787 0.835 . . . . 64.52 110.029 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.2 60.3 1.41 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.927 0.891 . . . . 44.12 110.932 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' H' ' 193' ' ' TYR . 20.1 m95 -124.89 158.12 34.28 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.484 -0.561 . . . . 64.05 109.484 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.406 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.4 tp60 -71.47 112.49 14.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.406 ' HD2' HE21 ' D' ' 37' ' ' GLN . 45.3 Cg_exo -56.79 114.42 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.671 0 C-N-CA 122.783 2.322 . . . . 51.55 112.663 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.25 109.94 3.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.146 -1.057 . . . . 74.44 108.146 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 m -108.33 106.6 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.031 0.919 . . . . 53.32 109.142 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -94.28 115.97 28.29 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.248 -1.39 . . . . 71.03 107.248 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.05 136.08 34.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.498 -0.927 . . . . 54.31 108.498 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.72 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.7 m-20 -107.69 153.8 22.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.152 0.981 . . . . 64.01 108.562 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.425 ' HB2' HD21 ' H' ' 186' ' ' LEU . 47.6 tp -126.97 132.47 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.157 -0.683 . . . . 75.22 109.157 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t70 -140.62 141.18 35.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.018 -1.105 . . . . 42.33 108.018 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.1 m -118.53 143.64 46.6 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.979 -0.749 . . . . 71.22 108.979 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.9 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.323 1.049 . . . . 70.23 108.317 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.5 p -170.57 157.66 5.93 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.988 0.515 . . . . 72.22 110.894 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -149.57 140.44 22.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.911 -0.774 . . . . 72.42 108.911 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.2 119.93 25.16 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 109.405 -0.591 . . . . 72.13 109.405 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.6 mt -95.02 -34.92 12.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.18 0.592 . . . . 73.23 109.853 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.33 -177.43 6.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.207 -0.906 . . . . 52.53 110.392 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -66.91 129.97 41.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.81 -1.086 . . . . 64.3 109.254 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.716 ' HB2' HD22 ' D' ' 5' ' ' ASN . 66.5 m-20 58.31 17.84 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.669 1.187 . . . . 72.44 113.125 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.18 125.59 72.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 123.603 0.761 . . . . 75.31 109.144 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -123.64 135.23 53.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.815 -0.809 . . . . 72.4 108.815 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.9 tt0 -86.36 111.61 20.66 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.129 -1.804 . . . . 53.1 106.129 161.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -100.37 120.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 108.079 -1.082 . . . . 70.32 108.079 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.582 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 54.4 t -101.64 130.3 51.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.923 -1.035 . . . . 61.22 109.726 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.38 126.02 51.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.463 -1.31 . . . . 75.4 107.463 172.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -112.54 100.9 9.1 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.563 -0.903 . . . . 64.15 108.563 173.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.86 127.97 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.894 -1.15 . . . . 73.24 107.894 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.72 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -116.94 148.48 41.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.467 -0.938 . . . . 64.32 108.467 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.66 131.11 71.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.108 0.963 . . . . 72.42 108.875 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -117.09 95.81 5.16 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.246 -1.39 . . . . 74.35 107.246 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.57 129.44 43.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.061 -0.718 . . . . 53.22 109.061 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.514 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 36.9 m -143.6 137.27 28.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.369 0.604 . . . . 42.52 110.83 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.611 HD12 HG13 ' D' ' 31' ' ' VAL . 38.2 mt -104.16 97.34 7.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.593 1.157 . . . . 72.3 109.077 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.85 -119.79 19.6 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.162 0.914 . . . . 73.42 113.114 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.65 25.17 3.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.443 0.697 . . . . 71.5 111.882 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -141.2 146.57 37.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.54 0.336 . . . . 75.03 110.572 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.9 m -71.78 121.59 19.2 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.89 0.744 . . . . 73.35 109.818 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.514 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -77.7 -59.86 2.61 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.484 -0.932 . . . . 75.23 108.484 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -160.95 163.03 32.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.901 -1.045 . . . . 73.43 110.494 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.48 150.32 41.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.639 -1.245 . . . . 74.32 107.639 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.6 t -157.21 144.0 18.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.788 0.435 . . . . 64.32 110.153 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.05 130.69 9.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.284 0.633 . . . . 62.34 110.253 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.86 118.38 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 71.25 110.006 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -89.87 85.94 6.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.515 0.726 . . . . 73.23 109.358 168.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.29 93.74 5.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.259 -0.882 . . . . 64.45 108.859 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.34 144.08 17.04 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.619 -0.593 . . . . 74.14 111.619 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.59 139.34 9.63 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 112.213 -0.355 . . . . 61.1 112.213 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.9 mt -88.89 122.82 40.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.646 0.778 . . . . 62.44 108.916 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' D' ' 12' ' ' GLN . 59.5 m-85 -130.44 125.84 35.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.301 0.641 . . . . 54.12 110.145 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.0 m -92.71 105.04 17.25 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.73 -1.211 . . . . 63.44 107.73 169.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.68 140.16 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.357 0.663 . . . . 44.44 109.458 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.53 ' HA ' HD21 ' H' ' 173' ' ' LEU . . . -165.44 169.42 15.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.756 0.823 . . . . 40.32 110.612 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.64 22.16 77.6 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-N 116.655 -0.248 . . . . 64.11 113.466 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -132.01 161.79 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.493 1.117 . . . . 43.42 109.877 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 149.23 26.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.96 0.504 . . . . 73.14 111.127 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.6 -107.72 0.41 Allowed Glycine 0 C--N 1.35 1.356 0 O-C-N 124.541 1.151 . . . . 32.03 115.552 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -71.84 -42.86 66.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.031 0.933 . . . . 72.24 111.362 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -65.13 -35.06 79.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.012 0.525 . . . . 74.11 110.571 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.577 ' SD ' ' HB3' ' H' ' 175' ' ' PHE . 40.4 ttm -61.29 -53.56 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.852 -1.067 . . . . 52.41 110.539 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.85 -19.42 61.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.453 0.701 . . . . 54.41 111.748 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.05 -43.92 61.36 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.35 1.06 . . . . 74.02 110.163 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.12 -51.98 6.26 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.965 -0.561 . . . . 63.22 111.141 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.637 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.0 tp -80.51 -30.2 37.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.594 0.358 . . . . 60.25 111.514 -171.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.71 -29.92 41.42 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.821 -0.433 . . . . 71.35 113.554 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.25 -44.37 1.58 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.434 0.617 . . . . 53.21 112.371 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -73.4 -40.96 63.9 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 111.905 0.335 . . . . 74.14 111.905 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 82.8 m -67.23 -43.13 43.45 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-O 118.827 -0.606 . . . . 71.13 112.519 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -65.72 -27.07 52.67 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 121.334 1.356 . . . . 71.21 112.905 166.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.57 -27.42 66.06 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 176.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 19.7 mm -67.55 -45.91 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.422 0.689 . . . . 74.21 109.619 169.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.52 -22.36 61.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.732 -0.667 . . . . 74.25 111.961 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.72 -41.14 20.16 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.023 1.119 . . . . 72.32 114.023 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' B' ' 105' ' ' ILE . 72.2 Cg_exo -55.11 -41.94 73.77 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.959 1.772 . . . . 62.24 113.053 169.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.416 ' HD2' ' HB3' ' B' ' 108' ' ' PRO . 69.8 m-85 -71.05 -38.18 72.53 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.419 -0.809 . . . . 71.03 111.021 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.24 -43.7 70.03 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.741 0.816 . . . . 71.32 110.598 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.517 ' NH2' HG23 ' B' ' 105' ' ' ILE . 25.6 ttp180 -57.17 -53.2 60.81 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.781 -1.1 . . . . 64.02 109.72 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.56 -41.27 89.77 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.322 1.014 . . . . 54.03 111.451 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.404 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 37.0 t -57.61 -43.95 85.1 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.567 0.542 . . . . 65.31 110.732 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -66.08 -49.53 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.651 0.78 . . . . 64.42 110.114 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -56.02 -43.92 78.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 73.45 111.744 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.7 t -67.25 -42.06 84.57 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.038 -0.983 . . . . 54.51 110.3 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.1 mtm -66.72 -34.04 76.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.959 0.504 . . . . 60.33 111.46 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.509 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.2 t -62.23 -47.96 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 123.759 0.662 . . . . 70.21 109.736 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.3 p -72.21 -30.87 65.35 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.915 -0.584 . . . . 45.33 111.262 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -69.02 -30.5 68.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.798 0.839 . . . . 61.55 110.237 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.75 12.21 60.0 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.782 0.676 . . . . 44.12 112.982 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 125' ' ' GLN . 30.2 p 59.58 28.69 18.16 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.956 1.702 . . . . 74.53 112.839 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.21 160.35 26.45 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.389 1.076 . . . . 72.4 108.928 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 126.54 16.65 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.719 2.28 . . . . 62.15 112.044 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -50.83 121.81 6.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.315 1.046 . . . . 71.03 111.678 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.16 96.8 6.62 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.573 0.749 . . . . 72.44 110.144 -170.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.94 84.75 2.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.409 1.084 . . . . 72.02 109.975 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.445 HD13 ' HB ' ' H' ' 187' ' ' ILE . 90.7 mt -74.84 157.29 35.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.698 -1.137 . . . . 73.42 111.636 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.594 ' H ' HD11 ' G' ' 204' ' ' ILE . . . -67.64 156.62 88.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.968 0.907 . . . . 43.13 110.593 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.6 ' HD3' HG13 ' B' ' 13' ' ' ILE . 1.0 OUTLIER -80.4 147.36 17.94 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.115 1.876 . . . . 74.13 110.379 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.46 108.11 24.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.699 0.761 . . . . 73.52 109.332 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -97.09 101.09 12.59 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.804 -1.184 . . . . 61.2 107.804 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -68.63 -27.08 65.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.079 -0.964 . . . . 65.31 111.255 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.28 -40.4 62.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.346 0.659 . . . . 74.12 110.771 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.18 89.49 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.081 -0.508 . . . . 74.22 109.918 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.64 -42.36 96.76 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.116 0.885 . . . . 64.52 111.478 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.446 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 26.8 t80 -58.34 -51.63 68.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.599 0.759 . . . . 64.42 110.184 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 79.1 mtm -63.66 -42.84 98.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.798 0.839 . . . . 75.11 111.152 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 15.1 m120 -56.19 -51.52 67.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.31 0.644 . . . . 73.41 109.922 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -62.08 -31.41 71.83 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.574 -1.194 . . . . 72.33 111.831 -172.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 89.3 mt -62.91 -35.86 81.48 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 74.42 110.633 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -90.07 8.26 33.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.715 0.806 . . . . 73.23 111.901 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 96.4 mt-30 -120.53 84.12 2.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.442 0.697 . . . . 54.11 109.55 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -152.84 8.92 0.44 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.875 -1.057 . . . . 72.44 110.689 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.22 99.0 3.17 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.192 0.597 . . . . 62.34 109.583 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.22 130.45 13.69 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.56 0.537 . . . . 63.31 112.794 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.46 154.21 22.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.977 0.911 . . . . 65.04 110.191 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.58 160.32 31.43 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.05 0.219 . . . . 70.34 112.745 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 34.3 p -130.89 136.38 48.56 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.775 0.83 . . . . 74.41 110.1 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -96.58 153.33 17.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.454 0.702 . . . . 71.24 109.849 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -87.76 162.12 17.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.724 0.809 . . . . 71.51 110.79 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.22 137.09 40.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.933 0.893 . . . . 63.33 109.397 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -100.89 110.35 22.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.8 0.84 . . . . 64.13 109.443 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -168.17 102.51 0.45 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.952 0.901 . . . . 75.32 109.185 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 C-N-CA 123.897 0.879 . . . . 71.1 108.774 179.082 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.086 -0.709 . . . . 71.33 109.086 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.72 166.58 33.44 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 123.55 0.531 . . . . 74.22 111.887 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -69.77 85.61 0.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.873 0.844 . . . . 71.51 110.165 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 35.9 p -159.52 132.26 6.77 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.072 -0.967 . . . . 55.51 109.849 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 172' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' C' ' 90' ' ' GLU . . . -96.48 123.99 40.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.451 0.7 . . . . 62.52 109.428 176.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.1 tt -148.63 -61.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.31 -1.367 . . . . 53.33 107.31 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 26.1 mmt -103.18 90.96 3.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.695 0.798 . . . . 72.14 110.854 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 20.3 t80 57.65 90.32 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.107 1.363 . . . . 55.14 111.722 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -122.87 105.75 10.28 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.074 -1.084 . . . . 72.52 108.074 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 45.3 tp -150.14 111.54 4.44 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.39 -1.337 . . . . 63.44 107.39 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -78.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 107.778 -1.193 . . . . 60.21 107.778 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 179' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 39.2 tt0 -179.99 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.354 1.062 . . . . 73.31 110.669 175.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 180' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 92.8 Cg_endo -89.75 89.37 0.36 Allowed 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 122.137 1.891 . . . . 74.33 112.604 -170.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -120.56 84.21 2.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.576 -0.898 . . . . 72.0 108.576 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 60.75 -162.55 0.27 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.092 0.957 . . . . 73.12 110.931 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 90.7 m -147.13 128.29 14.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.211 0.604 . . . . 73.22 109.587 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.452 ' HZ3' ' HB2' ' C' ' 103' ' ' PRO . 5.6 t90 -87.97 108.84 23.28 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 107.355 -1.35 . . . . 73.24 107.355 168.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -68.47 164.54 32.37 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.702 2.268 . . . . 61.55 112.169 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.21 146.56 44.15 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.58 0.752 . . . . 75.33 109.984 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' C' ' 128' ' ' LEU . 3.4 tt -68.78 99.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 109.432 -0.581 . . . . 73.42 109.432 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.3 87.86 4.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.957 -0.757 . . . . 61.24 108.957 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -83.91 14.02 4.43 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.742 -0.663 . . . . 73.23 111.334 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.54 135.61 55.34 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.848 -0.797 . . . . 62.11 108.848 166.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 102.74 -24.1 31.79 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.57 -1.012 . . . . 53.05 110.57 -164.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.07 61.84 3.3 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.29 -0.724 . . . . 71.22 111.29 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.78 -162.96 0.47 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.463 1.105 . . . . 72.21 110.497 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 73.82 140.54 0.06 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.151 1.38 . . . . 73.13 111.723 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -135.96 -54.3 0.76 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.779 0.832 . . . . 74.11 110.093 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 196' ' ' LYS . . . . . 0.513 ' HD3' ' HB3' ' E' ' 199' ' ' ASN . 37.5 ttmt 73.02 136.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.723 1.209 . . . . 64.53 110.289 -173.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 197' ' ' TYR . . . . . 0.404 ' CD1' ' HG3' ' E' ' 198' ' ' GLU . 34.7 t80 -119.06 -83.15 0.65 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 110.065 -0.346 . . . . 74.45 110.065 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 198' ' ' GLU . . . . . 0.404 ' HG3' ' CD1' ' E' ' 197' ' ' TYR . 49.8 mt-10 -95.73 89.82 5.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.848 0.459 . . . . 61.42 110.373 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 199' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' E' ' 196' ' ' LYS . 5.6 t30 -162.41 108.96 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.11 -1.07 . . . . 70.2 108.11 170.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 117.05 -151.51 18.19 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.959 -0.857 . . . . 72.11 110.959 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' E' ' 201' ' ' LYS . 0.2 OUTLIER -96.74 -10.66 26.35 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.089 0.444 . . . . 60.31 111.418 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -79.31 82.8 5.41 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.068 0.461 . . . . 65.11 110.738 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -175.8 145.45 0.68 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.896 1.678 . . . . 61.3 106.968 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.478 HG23 HG21 ' E' ' 207' ' ' VAL . 54.4 mt -92.96 92.06 3.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.754 0.788 . . . . 64.45 109.486 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.92 -64.64 0.69 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.844 -1.539 . . . . 71.44 106.844 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.4 87.84 2.59 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.585 0.754 . . . . 65.54 109.576 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.478 HG21 HG23 ' E' ' 204' ' ' ILE . 97.6 t . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 107.687 -1.227 . . . . 74.32 107.687 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 mttp . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.308 -0.627 . . . . 72.52 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.43 -56.13 4.5 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.457 -0.338 . . . . 44.22 112.711 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -84.72 170.11 13.59 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.344 0.658 . . . . 63.2 112.354 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 46.5 m 66.7 146.48 0.04 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.723 1.609 . . . . 71.34 112.255 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.54 99.16 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.867 -0.79 . . . . 54.15 108.867 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.49 179.79 2.79 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.81 -1.541 . . . . 75.33 108.411 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -151.81 -83.11 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.674 -0.491 . . . . 60.53 109.674 163.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.28 168.26 25.72 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 74.22 111.692 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -159.82 111.02 1.97 Allowed 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.196 -1.365 . . . . 71.13 107.941 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.22 98.37 0.6 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.737 0.815 . . . . 73.35 110.077 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -133.94 133.66 41.67 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.115 0.966 . . . . 71.32 109.011 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 70.9 161.03 0.16 Allowed Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 124.69 1.196 . . . . 74.43 112.233 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.15 -2.82 12.88 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.649 2.233 . . . . 72.33 112.769 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 181' ' ' TYR . . . . . 0.402 ' CE2' ' HB1' ' B' ' 95' ' ' ALA . 82.3 m-85 62.99 71.37 0.52 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 124.772 1.229 . . . . 74.12 109.872 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.48 -95.76 0.05 Allowed 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.633 -1.621 . . . . 74.34 111.469 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 14.7 t -177.88 146.89 0.44 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.515 1.126 . . . . 54.34 108.984 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.498 ' HB3' ' HD1' ' B' ' 133' ' ' PHE . 0.4 OUTLIER -163.02 93.96 1.15 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.0 0.92 . . . . 74.15 109.213 177.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.82 172.08 16.99 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.937 2.424 . . . . 74.25 112.928 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.571 HD21 HD11 ' B' ' 128' ' ' LEU . 6.2 tp -115.87 -163.4 0.89 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.776 0.83 . . . . 72.25 109.866 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' B' ' 129' ' ' ALA . 2.5 pp -130.41 168.77 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.38 1.072 . . . . 72.51 110.924 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.37 132.16 3.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.223 1.009 . . . . 75.32 108.577 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.19 167.76 13.33 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.419 0.628 . . . . 72.3 112.632 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -119.6 112.67 19.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.819 -1.178 . . . . 62.23 107.819 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.18 176.71 23.72 Favored Glycine 0 N--CA 1.47 0.912 0 O-C-N 123.178 0.299 . . . . 71.33 112.597 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 140.52 -171.15 24.14 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-O 119.776 -0.458 . . . . 65.45 112.334 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.91 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.485 1.514 . . . . 75.21 111.546 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.35 86.98 4.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.959 0.903 . . . . 75.01 110.525 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' B' ' 37' ' ' GLN . 47.9 t80 -150.7 144.76 25.38 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.402 -1.333 . . . . 71.1 107.402 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 196' ' ' LYS . . . . . 0.726 ' HD3' ' HA ' ' F' ' 205' ' ' LYS . 0.0 OUTLIER -65.68 89.44 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.26 0.624 . . . . 72.35 111.808 -168.209 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 197' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' B' ' 35' ' ' ASP . 59.2 m-85 -147.45 -12.27 0.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.491 1.517 . . . . 70.23 108.462 159.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -155.51 -53.41 0.09 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.169 0.988 . . . . 75.42 109.188 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -102.54 96.11 6.69 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.513 -0.921 . . . . 73.14 108.513 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.12 177.71 27.86 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 114.725 0.65 . . . . 75.32 114.725 -173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -153.36 -81.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.316 0.647 . . . . 73.35 109.816 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -105.36 11.65 32.52 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.996 0.519 . . . . 71.45 111.573 -166.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 203' ' ' ASP . . . . . 0.843 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 17.0 p-10 -156.21 147.02 21.98 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.547 0.739 . . . . 74.45 111.319 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.705 HG23 ' HB3' ' C' ' 129' ' ' ALA . 30.1 pt -81.71 158.74 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.161 0.985 . . . . 72.12 111.151 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 205' ' ' LYS . . . . . 0.726 ' HA ' ' HD3' ' F' ' 196' ' ' LYS . 97.9 mttt -75.78 -66.57 0.77 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.206 -0.664 . . . . 70.23 109.206 172.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -160.96 159.55 29.68 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.677 -0.692 . . . . 74.25 109.683 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.556 1.177 0 C-N-CA 123.972 0.909 . . . . 74.13 108.755 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.413 -0.217 . . . . 72.32 110.413 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.46 78.0 0.95 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.61 -0.596 . . . . 73.43 111.61 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.44 148.48 41.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.372 -0.603 . . . . 71.13 109.372 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 14.0 m -130.51 -41.6 1.2 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.407 1.083 . . . . 72.33 110.474 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.5 -64.87 0.29 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.348 0.659 . . . . 75.34 110.807 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.486 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 2.8 tt 65.08 -71.69 0.08 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.28 1.432 . . . . 32.43 109.901 -167.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 25.3 mmt -84.26 175.03 9.69 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.311 0.644 . . . . 72.53 110.375 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.434 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 43.0 p90 -149.5 167.34 26.52 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.031 0.532 . . . . 62.32 111.33 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.29 89.59 2.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.427 -1.323 . . . . 41.5 107.427 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.14 85.42 2.99 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.818 0.847 . . . . 71.31 110.894 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -100.67 1.32 40.47 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.62 0.768 . . . . 71.44 111.351 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.39 163.01 53.02 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.942 0.897 . . . . 70.33 109.409 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.64 137.5 64.32 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.358 2.039 . . . . 61.44 112.278 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -78.8 -167.56 1.15 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.782 0.833 . . . . 72.42 110.528 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.0 100.34 0.31 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.525 -0.917 . . . . 73.02 108.525 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 28.2 m -58.3 146.14 35.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.513 1.125 . . . . 75.15 111.599 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -131.35 144.98 55.67 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.567 0.747 . . . . 54.24 111.537 -169.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.03 158.02 27.01 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.835 3.023 . . . . 74.1 114.199 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 186' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 42' ' ' LEU . 9.1 tt -141.44 126.05 17.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.938 0.895 . . . . 71.5 108.6 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.404 HG13 HG13 ' A' ' 131' ' ' VAL . 2.4 pp -80.94 -171.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.78 1.232 . . . . 61.03 112.904 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.0 121.32 14.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.988 0.915 . . . . 75.44 109.331 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 189' ' ' ALA . . . . . 0.406 ' O ' HG11 ' A' ' 40' ' ' VAL . . . -140.68 104.52 4.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.122 0.569 . . . . 75.31 111.383 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 190' ' ' ASP . . . . . 0.528 ' HB2' HG12 ' A' ' 40' ' ' VAL . 14.7 t70 -152.6 146.62 25.34 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 73.34 108.787 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.37 17.5 2.89 Favored Glycine 0 N--CA 1.475 1.293 0 O-C-N 123.861 0.726 . . . . 73.23 111.933 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.72 3.2 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 123.161 0.41 . . . . 74.11 112.577 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 193' ' ' TYR . . . . . 0.442 ' HB3' ' HG2' ' H' ' 198' ' ' GLU . 59.5 t80 -137.63 -38.14 0.59 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.515 -0.92 . . . . 65.4 108.515 172.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -135.67 169.55 17.37 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.632 1.173 . . . . 74.22 108.917 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -167.81 -88.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.609 0.764 . . . . 75.25 109.386 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' G' ' 196' ' ' LYS . 0.0 OUTLIER -108.37 -33.88 6.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.555 0.742 . . . . 74.34 109.21 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -78.39 87.23 4.41 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.336 -0.847 . . . . 72.43 109.063 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -169.31 -56.65 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.969 -1.014 . . . . 73.44 109.171 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -158.01 169.69 24.0 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.208 -1.034 . . . . 64.15 108.208 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 69.48 67.56 1.9 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.821 -0.912 . . . . 43.3 110.821 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.52 -34.04 70.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.183 0.593 . . . . 73.25 111.315 -176.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 70.2 t80 68.28 -78.01 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.85 1.26 . . . . 74.02 110.568 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 11.4 t70 66.34 149.86 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.529 1.532 . . . . 61.14 111.087 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.594 HD11 ' H ' ' D' ' 129' ' ' ALA . 19.0 tt -149.94 4.45 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 121.335 0.588 . . . . 71.13 110.42 -172.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 205' ' ' LYS . . . . . 0.517 ' HA ' ' HG2' ' B' ' 12' ' ' GLN . 13.4 tmtt? -80.5 138.9 36.59 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.509 -0.923 . . . . 64.32 108.509 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 33.4 t70 74.16 110.42 0.07 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.728 1.611 . . . . 72.53 111.193 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 123.643 0.777 . . . . 62.22 109.807 177.108 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.936 -0.394 . . . . 72.42 109.936 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.93 75.4 1.27 Allowed Glycine 0 C--N 1.346 1.107 0 O-C-N 123.736 0.648 . . . . 33.13 113.087 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.81 76.64 5.3 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.151 -0.685 . . . . 74.4 109.151 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 33.6 t -154.58 55.93 0.68 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.296 0.638 . . . . 72.51 109.703 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -170.43 141.5 1.98 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.273 1.029 . . . . 33.24 109.125 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' D' ' 87' ' ' ALA . 1.6 tt -165.23 -68.78 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.2 -0.667 . . . . 62.41 109.2 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' D' ' 54' ' ' ASP . 30.9 mmt -92.58 92.25 7.94 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.658 -0.497 . . . . 74.33 109.658 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 175' ' ' PHE . . . . . 0.577 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 0.2 OUTLIER -86.96 -177.92 6.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.391 -0.822 . . . . 74.32 112.043 -173.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -128.05 137.89 52.35 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.373 1.069 . . . . 73.43 108.257 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.39 94.87 1.28 Allowed 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.241 -0.651 . . . . 62.21 109.241 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -81.93 -63.36 1.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.893 0.877 . . . . 74.54 110.803 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -141.52 151.87 61.89 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.928 0.891 . . . . 75.42 110.545 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.36 153.83 61.17 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.407 2.072 . . . . 70.32 111.586 170.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -102.09 -52.84 3.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.014 0.926 . . . . 75.11 109.849 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -137.89 172.17 13.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.333 1.053 . . . . 73.53 110.476 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 36.8 p -74.07 148.22 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.784 0.834 . . . . 54.04 110.43 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -109.86 92.27 12.33 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.78 0.832 . . . . 74.44 109.34 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.34 115.13 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.642 2.228 . . . . 65.04 112.149 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 186' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' D' ' 44' ' ' LEU . 3.1 mm? -85.51 -179.58 6.94 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.463 -0.94 . . . . 75.43 108.463 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' D' ' 128' ' ' LEU . 3.4 mp -78.21 94.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.668 -0.864 . . . . 74.04 108.668 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.39 90.95 2.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.723 -0.843 . . . . 43.43 108.723 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -79.21 161.53 26.32 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.378 -0.828 . . . . 70.04 111.471 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.17 170.28 8.4 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.925 0.89 . . . . 73.22 109.69 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -77.08 -141.36 1.32 Allowed Glycine 0 C--N 1.351 1.378 0 CA-C-N 116.433 -0.349 . . . . 65.13 113.147 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 129.05 -150.15 18.73 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.987 -0.845 . . . . 74.41 110.987 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' D' ' 36' ' ' TRP . 79.2 m-85 -129.46 -175.57 3.62 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.566 0.746 . . . . 75.13 111.142 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . 73.64 90.53 0.09 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.747 1.619 . . . . 73.43 111.237 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -153.14 41.27 0.56 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 104.2 -2.518 . . . . 75.41 104.2 169.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -93.47 117.46 30.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.287 -2.233 . . . . 74.44 110.17 -160.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.32 -8.66 59.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 64.43 109.938 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 198' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' G' ' 193' ' ' TYR . 10.0 tp10 65.73 -96.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.812 1.645 . . . . 71.34 110.834 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -154.38 178.41 10.06 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.521 1.129 . . . . 61.42 109.132 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.54 81.81 0.29 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.72 -0.952 . . . . 61.4 110.72 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.42 -54.38 47.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.953 1.301 . . . . 74.5 110.897 -171.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -73.98 0.37 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.15 -0.477 . . . . 72.33 111.187 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -162.01 -82.58 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.89 0.876 . . . . 73.11 108.675 -173.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 13.8 mt 51.87 54.62 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.875 1.27 . . . . 73.43 110.857 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -103.53 -58.67 1.84 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.784 -1.098 . . . . 63.24 111.144 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -168.36 163.93 12.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.057 0.543 . . . . 74.14 110.208 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--O 1.256 1.428 0 C-N-CA 123.944 0.898 . . . . 72.1 108.774 168.35 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 111.638 0.236 . . . . 70.52 111.638 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 t -149.16 39.62 0.84 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.749 -0.463 . . . . 71.32 109.749 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.18 149.99 44.02 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.7 -0.682 . . . . 61.21 111.038 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.84 164.73 29.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.339 0.655 . . . . 61.13 109.894 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -131.81 106.78 8.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 52.21 110.332 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -157.61 -66.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.283 0.633 . . . . 75.12 110.065 176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -145.3 163.38 34.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.502 0.721 . . . . 61.22 110.225 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.55 -66.79 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.955 -0.757 . . . . 72.23 108.955 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.53 153.52 47.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.479 0.712 . . . . 73.31 111.058 -174.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -159.67 144.04 14.94 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.862 1.265 . . . . 73.31 109.633 174.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -106.25 141.32 37.78 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.587 -0.894 . . . . 71.4 108.587 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 7.4 tp-100 -149.16 139.74 22.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.043 0.537 . . . . 64.23 110.854 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 tp -94.81 127.2 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.803 0.841 . . . . 64.53 109.396 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -103.09 -28.15 12.13 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 118.585 -0.721 . . . . 64.45 111.239 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -178.27 127.62 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.777 0.717 . . . . 74.55 111.154 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 64.2 mt -107.93 133.58 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.557 -0.905 . . . . 73.22 108.557 168.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.761 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 14.4 p90 -170.16 164.66 9.2 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.511 0.724 . . . . 74.21 110.664 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -85.97 117.69 24.98 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.77 -0.826 . . . . 63.32 108.77 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.6 mtpt -80.08 -29.95 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.345 -0.388 . . . . 64.31 110.145 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -153.97 148.12 25.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.54 0.525 . . . . 71.03 109.864 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.6 mt -138.74 145.4 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.969 1.307 . . . . 74.44 107.875 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 t -150.06 139.87 21.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.332 0.653 . . . . 63.23 109.761 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.7 t80 -145.22 112.26 6.01 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.415 -1.698 . . . . 64.25 106.415 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -123.02 109.99 14.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.243 -0.651 . . . . 61.34 109.243 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.28 86.49 9.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.79 -1.189 . . . . 71.24 107.79 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.02 -17.16 19.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.475 2.117 . . . . 72.13 111.343 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.99 31.12 6.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.269 1.027 . . . . 74.15 109.369 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.54 -45.63 98.76 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-N 115.165 -0.925 . . . . 74.42 112.82 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.44 -25.05 48.84 Favored 'Trans proline' 0 C--N 1.398 3.161 0 CA-C-N 121.517 1.577 . . . . 74.41 112.456 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -71.02 -26.32 63.06 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.128 0.571 . . . . 74.22 111.006 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.2 p -65.67 -12.69 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 118.455 0.571 . . . . 74.23 111.904 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.15 -39.29 75.44 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.87 0.468 . . . . 72.43 110.668 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HG3' ' HG2' ' A' ' 34' ' ' LYS . 9.1 pt20 -89.56 -38.71 13.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.308 0.643 . . . . 73.42 110.667 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 2.0 mmmp? -82.73 128.73 34.65 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.049 0.94 . . . . 63.42 109.219 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.03 153.21 32.54 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.127 -0.323 . . . . 75.32 110.127 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.683 ' HB3' ' HB2' ' G' ' 195' ' ' PHE . 73.9 t-105 -81.59 78.99 8.27 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.998 0.428 . . . . 64.14 110.654 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -124.64 82.34 59.63 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 107.459 -1.312 . . . . 70.53 107.459 168.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' H ' ' G' ' 193' ' ' TYR . 40.7 Cg_endo -84.8 158.58 11.98 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.324 2.016 . . . . 72.02 112.466 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.3 103.38 11.51 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.654 -1.98 . . . . 73.31 105.654 159.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.38 135.28 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 70.21 109.704 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 87.6 tttt -110.89 129.77 55.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.458 0.703 . . . . 52.24 109.114 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 128' ' ' LEU . 20.9 tp -97.2 109.74 22.43 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.149 -1.426 . . . . 74.02 107.149 166.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 25.5 t70 -105.74 139.76 39.83 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.068 -1.086 . . . . 62.01 108.068 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.13 128.08 41.1 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.689 -1.226 . . . . 65.44 107.689 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 28.0 t70 -140.7 159.23 42.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.224 1.01 . . . . 53.44 108.644 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.491 HG23 HD12 ' G' ' 177' ' ' LEU . 12.9 t -133.95 159.32 41.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.425 0.631 . . . . 73.24 111.063 -176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -141.51 150.14 41.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.224 1.409 . . . . 53.41 107.727 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -132.15 149.76 52.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.02 -0.363 . . . . 71.03 110.02 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -158.36 118.89 3.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.81 0.844 . . . . 64.12 108.729 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.27 117.09 21.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.327 -0.62 . . . . 74.41 109.327 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.35 -43.29 12.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.86 0.464 . . . . 62.32 110.715 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.82 -174.1 4.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.72 0.808 . . . . 65.13 110.163 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.9 121.5 18.21 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' H ' ' HB2' ' G' ' 171' ' ' SER . 2.0 m-20 73.25 -7.25 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.176 1.79 . . . . 74.35 111.807 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.5 t -104.78 120.67 55.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 124.433 1.093 . . . . 72.11 108.712 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 84' ' ' PHE . 7.8 p90 -135.34 170.51 15.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.218 -1.03 . . . . 72.51 108.218 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -131.23 136.8 48.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.28 -0.637 . . . . 72.3 109.28 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 75.4 t -114.42 121.29 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.62 -0.881 . . . . 62.34 108.62 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.8 t -100.5 125.99 54.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.982 -0.748 . . . . 72.25 108.982 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 114.93 26.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.343 -1.354 . . . . 74.0 107.343 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -92.39 99.56 12.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.633 -1.247 . . . . 61.42 107.633 170.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' HB1' ' A' ' 110' ' ' ALA . 11.9 t -94.62 135.12 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.83 -1.544 . . . . 73.0 106.83 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 31.8 m -134.09 123.34 24.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.538 0.685 . . . . 74.24 110.73 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.1 t -109.18 107.76 23.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.902 1.281 . . . . 65.51 108.779 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -108.23 112.79 25.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.623 -0.88 . . . . 71.31 108.623 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.74 116.85 28.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.417 -1.327 . . . . 63.44 107.417 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -123.31 132.12 53.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.018 0.437 . . . . 74.24 110.867 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 62.0 mt -87.24 84.25 7.26 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.879 1.271 . . . . 71.35 109.217 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -91.02 1.1 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.935 -1.03 . . . . 65.3 111.525 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.38 -29.94 7.6 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.426 0.69 . . . . 60.25 110.681 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.13 133.33 35.44 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.305 0.642 . . . . 74.43 109.673 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -69.85 135.97 50.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.802 0.441 . . . . 64.42 110.954 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -78.4 -56.4 4.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.762 -0.829 . . . . 70.13 108.762 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -164.36 174.62 10.85 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 113.97 -1.468 . . . . 74.31 110.26 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -138.58 116.6 11.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.752 -1.113 . . . . 75.25 108.741 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.625 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.5 m -103.56 139.65 38.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.514 -0.921 . . . . 60.33 108.514 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -146.88 117.88 7.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.616 -0.883 . . . . 75.11 108.616 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.04 113.84 39.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 123.766 0.827 . . . . 72.54 109.413 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 16.0 mp0 -84.6 85.28 7.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.491 -1.232 . . . . 74.32 108.352 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -83.79 92.38 7.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.109 -1.441 . . . . 74.33 107.109 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.87 142.83 18.67 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.409 -0.676 . . . . 75.13 111.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.593 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.32 122.03 2.2 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 110.759 -0.936 . . . . 71.31 110.759 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.4 mt -81.89 125.89 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 107.789 -1.189 . . . . 73.51 107.789 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 26.0 m-85 -128.59 164.58 22.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.36 0.664 . . . . 73.03 109.932 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 20.4 t -120.26 121.23 38.23 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.553 1.141 . . . . 75.43 109.212 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -138.55 150.1 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 123.378 0.671 . . . . 71.34 109.766 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' G' ' 168' ' ' LYS . . . 175.93 173.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.21 1.404 . . . . 50.34 110.211 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.96 88.67 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.952 0.783 . . . . 54.31 113.598 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.484 ' O ' HD21 ' G' ' 173' ' ' LEU . 1.3 pp -117.36 172.34 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.213 1.405 . . . . 73.11 109.427 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.6 tt0 -169.45 -177.63 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.814 0.846 . . . . 75.32 109.238 172.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.488 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.78 -142.81 42.62 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 123.44 0.543 . . . . 70.11 113.808 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -68.91 -18.95 64.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.835 0.854 . . . . 75.32 111.527 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -48.76 53.71 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.071 0.548 . . . . 74.55 109.586 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.604 ' SD ' HD23 ' G' ' 173' ' ' LEU . 9.2 ptm -69.55 -36.67 76.57 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.691 0.281 . . . . 53.13 110.316 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 94' ' ' MET . . . -71.06 -28.52 64.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.651 0.78 . . . . 60.11 111.221 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.27 -37.75 13.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.38 -0.373 . . . . 73.32 110.942 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.8 t -66.02 -52.98 44.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.905 0.482 . . . . 73.32 110.39 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.496 HD22 ' HE1' ' G' ' 175' ' ' PHE . 4.2 tt -76.33 -39.38 54.16 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.605 0.762 . . . . 72.33 109.853 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.99 -24.16 58.24 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.031 0.772 . . . . 60.44 115.031 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -42.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.927 0.864 . . . . 70.4 112.306 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 59.4 t80 -78.73 -36.75 42.84 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 122.966 0.506 . . . . 74.14 112.339 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -72.52 -41.05 7.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-O 118.551 -0.738 . . . . 74.24 111.446 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.88 -21.93 63.69 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 121.485 1.457 . . . . 61.4 113.129 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.07 -37.29 83.76 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 122.795 0.438 . . . . 75.1 109.977 174.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -57.93 -41.8 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 44.5 110.064 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.593 HD21 ' HA3' ' A' ' 82' ' ' GLY . 60.4 mt -80.12 -24.65 40.35 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.486 -1.233 . . . . 70.3 111.651 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.56 -39.49 48.76 Favored Pre-proline 0 CA--C 1.575 1.915 0 N-CA-C 114.782 1.401 . . . . 53.24 114.782 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.17 -40.11 72.64 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 122.273 1.982 . . . . 74.43 112.58 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' C' ' 108' ' ' PRO . 90.8 m-85 -77.13 -32.44 56.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.03 -0.986 . . . . 73.23 110.833 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -68.62 -43.44 76.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 55.54 109.77 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.625 HH12 HD12 ' C' ' 105' ' ' ILE . 36.8 ttm180 -55.32 -54.26 45.85 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.629 1.205 . . . . 74.13 110.054 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.99 -40.58 98.2 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.347 1.029 . . . . 74.33 111.432 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.513 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.1 t -59.82 -37.01 77.96 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.919 0.762 . . . . 54.04 111.023 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.596 HG21 HG21 ' A' ' 64' ' ' VAL . 78.6 mt -72.52 -54.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.638 0.775 . . . . 64.41 110.147 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.468 HG23 ' HG3' ' A' ' 125' ' ' GLN . 98.6 m -52.13 -37.04 53.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.797 1.639 . . . . 70.2 111.607 -174.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.09 -45.65 59.82 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.073 -0.967 . . . . 60.24 110.629 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.4 mtm -59.56 -41.47 90.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.107 0.48 . . . . 73.14 110.899 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.97 -46.97 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.828 1.251 . . . . 73.13 110.848 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -72.15 -30.66 65.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.699 0.4 . . . . 55.24 111.353 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.0 -26.94 63.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 70.31 110.418 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 7.77 57.72 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.897 -0.592 . . . . 73.05 113.342 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.7 m 66.98 30.85 7.34 Favored 'General case' 0 C--N 1.364 1.236 0 C-N-CA 124.671 1.188 . . . . 51.31 110.455 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -107.92 139.31 20.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.058 -1.089 . . . . 73.1 108.058 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 140.21 61.73 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.559 2.173 . . . . 63.41 112.609 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.468 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.0 tt0 -53.07 140.96 23.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.58 1.152 . . . . 62.15 112.163 -176.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.0 109.59 10.63 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.91 -1.145 . . . . 75.22 107.91 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -103.84 104.89 14.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.603 0.761 . . . . 70.44 108.96 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 42' ' ' LEU . 66.3 mt -72.48 116.95 13.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.294 -0.632 . . . . 70.02 109.294 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' HB3' HG21 ' G' ' 187' ' ' ILE . . . -57.66 149.27 52.8 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.522 1.129 . . . . 61.3 111.922 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HG3' HH22 ' A' ' 111' ' ' ARG . 5.4 Cg_exo -71.01 -176.75 1.95 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.573 2.182 . . . . 73.23 112.435 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -133.26 126.22 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.598 -0.89 . . . . 61.41 108.598 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.45 ' H ' HG11 ' H' ' 207' ' ' VAL . 17.0 p-10 -80.27 74.49 7.1 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.78 -0.822 . . . . 61.11 108.78 173.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -55.05 -43.44 73.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.674 0.79 . . . . 75.51 111.714 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.21 -40.15 74.74 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.62 1.168 . . . . 75.42 111.653 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' C' ' 8' ' ' GLU . . . -74.13 -39.38 63.36 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.672 -0.695 . . . . 62.04 110.957 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.476 HD13 ' HG2' ' G' ' 185' ' ' PRO . 88.5 mt -72.31 -23.81 61.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.709 0.804 . . . . 70.22 110.957 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.484 ' HE2' ' HD2' ' G' ' 182' ' ' PHE . 62.6 t80 -70.5 -52.75 19.74 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.497 -0.557 . . . . 74.43 109.497 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 tpp -55.26 -45.23 76.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.748 0.819 . . . . 65.55 110.356 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 42.0 t30 -60.76 -41.21 95.01 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.377 1.071 . . . . 73.5 111.333 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.86 -38.23 88.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.782 -0.645 . . . . 74.12 110.671 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 90.3 mt -66.58 -51.27 58.25 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.41 0.444 . . . . 74.52 111.274 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -175.88 -15.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.713 0.633 . . . . 61.44 111.286 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 25.0 tm0? 69.4 103.42 0.06 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.468 1.507 . . . . 64.34 112.078 176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -136.27 114.18 11.27 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.961 -1.125 . . . . 70.44 107.961 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.07 100.32 11.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.138 0.575 . . . . 73.52 110.188 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' C' ' 6' ' ' ASN . . . 85.08 63.55 1.58 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 116.661 -0.245 . . . . 54.54 113.396 173.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -69.48 -44.05 71.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.492 0.717 . . . . 75.0 109.574 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.73 165.81 12.78 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 114.875 -1.057 . . . . 54.12 112.205 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.1 t 179.2 -170.59 0.12 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.879 1.672 . . . . 72.45 107.931 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 65.98 40.97 3.86 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.506 1.146 . . . . 75.24 109.504 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.56 -3.13 35.91 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.68 -1.146 . . . . 73.5 111.71 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 77.65 -68.5 0.16 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.868 1.667 . . . . 75.45 111.078 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 177.57 -20.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.026 1.331 . . . . 54.23 110.184 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -145.8 148.59 33.09 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.021 0.929 . . . . 64.14 109.163 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 124.068 0.947 . . . . 64.4 108.634 178.748 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.164 -0.31 . . . . 61.5 110.164 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 16.8 m -83.11 86.97 6.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.258 -1.015 . . . . 72.32 108.258 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' F' ' 182' ' ' PHE . 18.9 mm-40 -86.54 81.94 8.1 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.437 0.637 . . . . 72.34 110.944 -171.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -115.51 -89.49 0.56 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.788 -1.096 . . . . 74.34 108.164 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.481 ' ND2' ' H ' ' B' ' 6' ' ' ASN . 5.7 t30 -179.37 -169.87 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.726 1.21 . . . . 74.21 109.029 173.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.481 ' H ' ' ND2' ' B' ' 5' ' ' ASN . 20.0 t-20 -154.49 92.08 1.46 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.0 0.818 . . . . 70.31 109.646 174.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.4 m -74.58 104.53 5.3 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.392 0.677 . . . . 63.44 110.21 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.663 ' HG3' ' H ' ' B' ' 9' ' ' MET . 8.8 tp10 -168.24 -159.26 0.27 Allowed 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 125.107 1.363 . . . . 73.4 107.632 -172.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.663 ' H ' ' HG3' ' B' ' 8' ' ' GLU . 19.8 ptm 65.55 176.23 0.21 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 126.911 2.084 . . . . 72.34 114.055 166.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p -136.65 141.89 43.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.22 1.008 . . . . 75.43 108.824 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.406 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 67.8 t80 -128.82 150.6 50.25 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.284 0.564 . . . . 75.41 111.899 -166.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 33.4 tp60 -142.54 123.63 14.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.054 1.342 . . . . 71.23 108.184 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.14 143.83 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.134 0.573 . . . . 75.33 109.984 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -116.94 -51.61 2.55 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.776 0.43 . . . . 74.32 110.841 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -162.53 143.65 10.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.405 0.282 . . . . 73.02 110.256 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -115.29 143.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.381 -1.34 . . . . 63.32 107.381 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -170.71 144.08 2.25 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.565 0.62 . . . . 70.3 111.716 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.3 m -75.25 121.72 22.59 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.976 -0.75 . . . . 70.14 108.976 172.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -88.73 -37.96 15.09 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.12 0.568 . . . . 75.41 110.312 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.6 t70 -152.89 144.08 23.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.283 -0.417 . . . . 72.5 112.071 -168.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -137.99 147.34 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.472 1.509 . . . . 65.55 108.492 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -150.58 150.69 31.52 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 73.23 108.78 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.9 t80 -160.19 114.7 2.24 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 106.625 -1.621 . . . . 72.31 106.625 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.78 113.91 20.34 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.607 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.96 89.23 4.24 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.649 -0.871 . . . . 64.34 108.649 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.46 -27.11 33.85 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.409 2.073 . . . . 74.44 112.035 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -123.3 30.59 6.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.372 1.069 . . . . 74.21 109.661 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.761 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -42.47 -52.07 10.74 Favored Pre-proline 0 CA--C 1.568 1.659 0 C-N-CA 125.525 1.53 . . . . 62.43 114.431 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.4 Cg_exo -72.16 -17.61 27.8 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.359 2.04 . . . . 72.1 112.802 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.43 2.97 56.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.491 1.116 . . . . 73.23 111.244 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.02 -27.95 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.807 0.443 . . . . 74.23 111.327 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -64.74 -41.03 96.23 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.247 0.619 . . . . 74.42 109.996 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -65.0 -29.6 70.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.562 1.145 . . . . 72.0 110.799 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' B' ' 68' ' ' LEU . 33.0 mmtp -108.85 96.72 6.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.317 1.047 . . . . 72.42 110.637 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.37 78.02 7.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.048 0.539 . . . . 74.54 111.287 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.6 170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.238 1.015 . . . . 64.2 109.727 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.539 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 48.9 tt0 -67.29 119.04 62.03 Favored Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 123.789 0.681 . . . . 65.15 109.653 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' 37' ' ' GLN . 12.3 Cg_endo -56.53 140.58 89.85 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.129 1.886 . . . . 62.43 110.842 167.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.815 ' HA ' ' HA3' ' F' ' 191' ' ' GLY . 36.3 mt-10 -67.04 100.45 0.75 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.708 -0.849 . . . . 73.51 108.708 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.09 120.84 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.758 -1.571 . . . . 65.41 106.758 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -144.08 126.68 16.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.577 -0.898 . . . . 75.33 108.577 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.5 HD13 HD11 ' B' ' 126' ' ' LEU . 1.8 pt? -129.29 159.02 37.45 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.982 0.513 . . . . 73.53 111.125 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -143.45 150.38 38.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.251 0.62 . . . . 74.11 110.77 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.13 144.03 29.29 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.726 1.21 . . . . 72.04 110.729 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.91 146.04 21.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 75.21 107.787 167.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.3 m -145.78 139.71 26.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.108 0.563 . . . . 73.42 110.004 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.31 134.76 18.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.101 0.96 . . . . 71.31 108.848 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -132.62 166.09 22.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.326 0.65 . . . . 53.44 110.343 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.1 p -153.09 137.19 16.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.645 0.778 . . . . 75.12 109.454 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -80.85 120.38 24.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.331 0.652 . . . . 75.44 110.539 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' B' ' 57' ' ' GLU . 38.4 mt -82.23 -50.03 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.754 0.822 . . . . 64.51 109.995 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.54 -171.11 3.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.272 1.029 . . . . 72.3 110.174 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.58 113.06 3.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.448 0.699 . . . . 61.12 110.56 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.4 m-20 71.06 -5.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.021 1.728 . . . . 45.12 112.694 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.68 116.62 46.72 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 108.15 -1.056 . . . . 53.31 108.15 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 155.33 50.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.172 -0.677 . . . . 75.25 109.172 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' B' ' 51' ' ' LEU . 6.9 tm-20 -111.68 112.28 23.87 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.342 -1.355 . . . . 75.42 107.342 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.95 127.21 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.964 0.905 . . . . 63.43 110.031 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -108.36 128.22 64.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.714 0.805 . . . . 70.42 109.282 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.44 109.11 20.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.794 -1.188 . . . . 74.22 107.794 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -93.41 119.25 32.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.838 0.455 . . . . 72.33 110.489 170.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.492 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.6 t -113.1 105.69 19.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.658 -1.238 . . . . 51.52 107.658 167.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -99.18 133.26 43.73 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.459 -0.571 . . . . 63.43 109.459 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.666 HG21 HG21 ' B' ' 114' ' ' ILE . 21.7 t -119.62 126.92 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.261 1.425 . . . . 63.51 109.069 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -114.72 149.13 37.31 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.426 1.09 . . . . 54.13 108.27 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.33 153.01 50.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.136 0.575 . . . . 63.13 109.736 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 33.5 p -146.13 141.23 27.31 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.606 0.566 . . . . 72.51 111.152 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' B' ' 34' ' ' LYS . 22.2 mt -130.17 99.82 5.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.253 1.421 . . . . 44.24 108.68 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -109.15 2.78 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.339 -0.391 . . . . 55.3 112.411 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -118.09 23.6 11.52 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.387 1.075 . . . . 74.22 110.555 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.86 160.72 42.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.116 0.566 . . . . 73.21 110.301 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -72.61 134.25 45.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.763 -0.653 . . . . 65.11 110.249 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.11 -58.07 2.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 50.2 109.271 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -153.19 173.54 15.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.787 -1.097 . . . . 63.31 109.779 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 73.2 mt -138.89 155.85 47.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.251 1.821 . . . . 71.11 106.473 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.565 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.4 t -160.49 159.59 30.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.81 0.844 . . . . 73.41 108.817 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.21 140.52 6.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.505 -0.924 . . . . 72.4 108.505 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.82 142.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.932 -1.136 . . . . 73.22 107.932 171.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -124.98 87.76 2.77 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.207 -1.035 . . . . 73.14 108.207 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 63.1 tp60 -81.94 100.87 9.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.455 -1.248 . . . . 71.33 109.129 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.43 175.22 35.8 Favored Glycine 0 C--O 1.241 0.534 0 N-CA-C 111.954 -0.458 . . . . 73.53 111.954 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.97 137.16 3.73 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.932 -0.467 . . . . 64.44 111.932 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 127.01 40.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.775 -0.824 . . . . 62.01 108.775 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -138.64 161.24 37.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.405 1.082 . . . . 64.3 109.581 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.0 m -132.39 133.6 44.13 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.777 1.231 . . . . 61.41 108.982 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.57 HG21 ' SG ' ' B' ' 97' ' ' CYS . 2.7 pp -139.18 147.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 122.876 0.47 . . . . 70.32 111.868 -171.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.92 170.58 16.32 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.986 0.915 . . . . 75.15 109.749 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.12 16.31 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.426 -0.352 . . . . 65.22 113.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.14 142.54 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.385 1.074 . . . . 51.34 112.848 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.716 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 14.1 pt-20 -160.73 142.07 12.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.324 1.05 . . . . 65.5 109.026 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.08 -106.15 0.76 Allowed Glycine 0 C--N 1.354 1.564 0 C-N-CA 123.081 0.372 . . . . 34.11 113.928 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.2 m -77.21 -30.27 54.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.768 1.227 . . . . 43.43 111.796 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.716 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 1.5 mp0 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.421 0.689 . . . . 73.41 110.793 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.606 ' HE2' ' HD2' ' F' ' 175' ' ' PHE . 41.9 mtp -70.44 -39.79 74.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.607 0.763 . . . . 62.31 110.057 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.53 64.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 71.2 111.397 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -62.52 -39.23 92.88 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.334 0.654 . . . . 74.32 110.934 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.57 ' SG ' HG21 ' B' ' 86' ' ' ILE . 44.9 t -61.12 -61.56 2.48 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.109 -0.95 . . . . 73.35 111.635 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.77 -18.4 25.0 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.575 0.583 . . . . 71.2 112.575 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.68 -26.72 11.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.232 0.333 . . . . 75.1 113.673 -173.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -55.96 1.86 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.371 0.508 . . . . 54.32 112.371 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -73.76 -60.06 2.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.524 0.33 . . . . 73.34 110.793 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.406 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 85.8 m -58.49 -46.18 99.63 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.196 -0.907 . . . . 71.44 112.225 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.9 -36.52 96.78 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.039 1.826 . . . . 64.4 113.759 172.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -66.87 -29.83 69.84 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 118.625 0.648 . . . . 74.02 110.849 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -63.04 -50.25 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.03 0.532 . . . . 75.14 109.877 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -79.34 -10.42 59.81 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.162 -1.381 . . . . 64.2 111.883 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.44 ' HE1' HD13 ' B' ' 128' ' ' LEU . 24.1 t80 -65.55 -49.67 60.77 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.654 1.181 . . . . 75.54 113.109 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 112' ' ' GLU . 25.1 Cg_exo -62.31 -35.72 71.8 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 121.494 1.463 . . . . 73.42 111.353 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' HE2' HG21 ' D' ' 115' ' ' THR . 72.9 m-85 -64.17 -48.6 75.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.069 0.947 . . . . 74.14 110.793 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.08 74.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.127 0.971 . . . . 61.42 110.734 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -67.46 -43.31 81.36 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.95 0.781 . . . . 74.35 110.381 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 108' ' ' PRO . 0.4 OUTLIER -69.26 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.131 0.972 . . . . 74.42 111.609 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.7 t -74.16 -39.05 63.5 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.8 -0.445 . . . . 71.42 109.8 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 64' ' ' VAL . 94.2 mt -62.82 -46.76 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.604 0.762 . . . . 64.55 110.078 173.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.429 HG23 ' OE1' ' C' ' 125' ' ' GLN . 44.1 m -50.41 -39.52 47.45 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.958 1.303 . . . . 75.41 110.701 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.8 t -66.34 -56.15 12.51 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 113.957 -1.474 . . . . 72.34 110.552 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.7 mmt -64.26 -38.13 89.95 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.659 0.615 . . . . 73.54 112.659 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.28 -46.41 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.421 1.088 . . . . 74.32 110.409 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.568 ' HB3' ' NE2' ' C' ' 125' ' ' GLN . 81.9 p -71.71 -25.28 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.568 -0.742 . . . . 60.32 111.465 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.513 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.1 mtt-85 -65.47 -39.44 91.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.158 0.583 . . . . 73.21 110.091 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.11 3.85 50.06 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.631 -0.713 . . . . 61.2 113.15 172.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p 59.72 48.98 8.65 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 126.512 1.925 . . . . 75.42 111.27 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -115.69 161.61 29.5 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-N 113.867 -1.515 . . . . 74.32 110.585 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.539 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 89.0 Cg_exo -53.2 177.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 125.031 3.82 . . . . 74.41 118.509 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.65 147.48 52.9 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 113.824 -1.534 . . . . 74.42 113.688 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.5 HD11 HD13 ' B' ' 42' ' ' LEU . 3.5 tm? -149.97 106.73 3.54 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.166 -1.379 . . . . 71.31 107.626 173.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -137.72 118.82 14.43 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.679 -1.23 . . . . 53.53 107.679 163.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.447 HD23 ' N ' ' B' ' 129' ' ' ALA . 2.2 tt -79.91 135.3 36.39 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.241 -0.652 . . . . 64.12 109.241 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.447 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -57.19 141.95 76.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.406 1.482 . . . . 70.31 113.078 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' D' ' 16' ' ' ILE . 61.4 Cg_endo -71.97 99.26 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.673 2.249 . . . . 73.14 111.818 171.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.28 105.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 109.24 -0.652 . . . . 50.25 109.24 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.406 ' ND2' HD13 ' D' ' 13' ' ' ILE . 45.8 t30 -70.1 117.66 11.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.391 0.677 . . . . 72.35 110.719 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -83.44 -31.15 26.75 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.574 0.75 . . . . 73.22 112.911 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.78 -46.88 73.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.878 0.871 . . . . 74.15 112.41 -167.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' B' ' 139' ' ' ASN . . . -57.71 -30.5 65.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.421 0.688 . . . . 64.23 112.264 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.46 -52.98 40.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.673 0.789 . . . . 65.21 110.455 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.76 -43.8 92.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.695 -0.684 . . . . 65.05 110.895 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.3 mmt -62.77 -36.05 81.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.53 0.732 . . . . 72.31 112.081 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 135' ' ' ALA . 1.9 t-20 -80.15 -40.34 27.54 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.145 -0.48 . . . . 63.4 110.391 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.73 -36.35 75.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.614 0.765 . . . . 73.32 110.816 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.49 33.63 2.87 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.886 0.874 . . . . 74.24 110.509 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -70.04 99.57 1.48 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.965 -1.124 . . . . 75.14 107.965 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -155.14 92.76 1.46 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.091 -0.707 . . . . 75.03 109.091 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -84.88 90.47 7.79 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.998 0.919 . . . . 72.11 109.069 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.54 77.64 2.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.812 -0.631 . . . . 63.44 109.396 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.91 105.72 0.18 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.872 -0.604 . . . . 34.22 112.158 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.23 13.15 2.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.537 1.135 . . . . 63.42 110.298 176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.29 114.27 5.37 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.857 -0.61 . . . . 74.34 112.871 -174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 1.8 t -125.58 125.43 43.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.262 1.025 . . . . 74.34 109.066 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -65.66 138.15 57.8 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.462 0.705 . . . . 63.04 111.48 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -147.27 107.51 4.05 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.285 -1.006 . . . . 73.24 108.285 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -120.04 61.05 0.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.468 1.107 . . . . 74.13 108.598 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -83.04 167.12 18.19 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.206 -1.361 . . . . 63.35 108.312 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.55 151.35 41.71 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.127 0.489 . . . . 71.5 111.222 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.11 0.964 . . . . 73.24 108.81 177.776 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 44.6 m -143.9 115.34 8.06 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.95 -1.13 . . . . 62.12 107.95 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.16 129.53 31.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.439 0.695 . . . . 73.4 110.303 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.2 102.51 15.24 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.951 -0.759 . . . . 71.21 108.951 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -145.8 82.38 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.936 -0.765 . . . . 63.13 108.936 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.611 ' HB3' ' HA2' ' A' ' 146' ' ' GLY . 42.6 m-80 -142.02 97.25 3.1 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.459 1.103 . . . . 71.24 108.614 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -167.58 164.84 14.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.823 . . . . 45.52 110.367 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' HB1' ' A' ' 135' ' ' ALA . 35.5 mt-10 -126.02 -64.02 1.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.819 0.848 . . . . 73.22 109.143 172.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 65.25 115.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 63.53 112.842 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 89.0 m -102.35 94.61 5.79 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.226 1.01 . . . . 71.44 109.404 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' H' ' 207' ' ' VAL . 58.6 t80 -107.83 163.74 12.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.635 1.174 . . . . 73.13 111.317 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.023 0.929 . . . . 70.03 109.213 161.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.548 HD11 HG13 ' C' ' 16' ' ' ILE . 5.5 tp -78.55 133.62 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.03 -0.73 . . . . 72.21 109.03 167.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -103.7 -47.93 4.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.552 0.741 . . . . 42.11 110.388 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -169.65 134.31 1.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.637 -0.256 . . . . 64.55 110.435 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.548 HG13 HD11 ' C' ' 13' ' ' ILE . 92.3 mt -122.34 135.25 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.451 -0.944 . . . . 75.33 108.451 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.693 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 10.3 p90 -171.63 157.1 4.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.244 0.545 . . . . 70.2 111.821 -172.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -82.02 118.43 22.99 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.289 -0.869 . . . . 51.41 109.813 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -69.76 -45.96 66.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.661 0.743 . . . . 71.11 109.216 172.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -146.29 146.41 30.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 113.882 -1.508 . . . . 65.3 108.956 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.3 mt -138.99 140.16 39.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.99 -1.485 . . . . 72.33 106.99 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -152.52 148.63 27.61 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.273 0.558 . . . . 45.21 110.213 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -154.36 107.83 2.91 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.376 -1.342 . . . . 73.0 107.376 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.43 112.09 20.19 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.415 -0.958 . . . . 74.53 108.415 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.22 95.93 32.74 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.403 1.081 . . . . 75.25 109.355 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.5 -39.88 33.85 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.793 2.328 . . . . 73.5 111.977 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -96.25 29.4 2.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.931 -1.031 . . . . 75.55 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.43 -48.34 97.13 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.684 -0.674 . . . . 51.45 112.412 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.58 -31.14 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 121.455 1.437 . . . . 63.23 113.387 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -71.13 -25.11 62.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.383 0.673 . . . . 70.03 112.415 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.93 -22.08 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.531 0.732 . . . . 72.1 111.546 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.44 -36.81 71.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.269 1.027 . . . . 65.4 111.12 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.86 45.94 1.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.996 0.903 . . . . 71.41 109.012 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.854 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -123.49 155.1 38.17 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.931 0.892 . . . . 70.42 110.859 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.41 115.38 8.61 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.363 -0.977 . . . . 71.33 108.363 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -80.46 71.18 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.092 0.957 . . . . 71.43 111.887 -173.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' E' ' 193' ' ' TYR . 25.8 tt0 -122.66 78.18 47.7 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.897 0.879 . . . . 75.31 109.821 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' E' ' 193' ' ' TYR . 15.4 Cg_exo -71.06 128.58 15.02 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.262 1.975 . . . . 74.32 111.152 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -87.7 107.36 18.6 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 70.23 106.785 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.31 113.65 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 124.113 0.883 . . . . 75.12 109.913 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.07 115.43 23.09 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.457 -1.312 . . . . 73.4 107.457 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.51 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.7 pt? -110.47 143.97 39.99 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.341 -0.985 . . . . 71.24 108.341 169.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.26 144.08 26.28 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.968 -0.752 . . . . 63.3 108.968 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.417 HD11 HD22 ' C' ' 60' ' ' LEU . 42.8 tp -113.89 123.94 51.0 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.588 0.555 . . . . 71.42 109.948 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -113.07 145.04 41.59 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.883 -1.525 . . . . 64.4 106.883 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -125.15 154.58 41.27 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.059 0.544 . . . . 64.13 110.001 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.6 161.51 39.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.499 1.119 . . . . 64.04 108.605 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.3 p -158.88 152.75 23.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.88 0.472 . . . . 54.2 110.978 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -156.84 130.28 8.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.721 0.808 . . . . 72.53 109.937 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -74.76 121.5 21.84 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.086 -0.709 . . . . 75.1 109.086 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' C' ' 57' ' ' GLU . 39.6 mt -94.98 -50.38 5.13 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.62 0.724 . . . . 74.42 110.864 -173.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -149.3 -172.19 4.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.749 -1.114 . . . . 74.25 109.945 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -69.96 113.89 7.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.852 0.461 . . . . 74.42 109.769 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 70.66 -0.38 2.97 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.674 1.589 . . . . 73.54 112.303 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 61.2 t -109.92 122.1 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 60.42 108.483 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -134.66 176.58 8.51 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.679 0.752 . . . . 72.51 109.711 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.701 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.7 tt0 -125.39 141.41 52.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.444 -1.253 . . . . 72.11 108.159 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.85 140.18 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.09 -1.078 . . . . 75.12 108.09 164.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.2 t -126.38 116.5 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.99 0.916 . . . . 74.53 109.465 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.417 HD22 HD11 ' C' ' 44' ' ' LEU . 15.2 mt -87.8 104.88 16.99 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 122.761 0.424 . . . . 63.53 110.261 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -86.81 101.46 13.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.107 -1.071 . . . . 74.44 108.107 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.1 t -99.84 132.0 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.645 -1.243 . . . . 62.24 107.645 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -122.92 123.12 40.23 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.502 -0.555 . . . . 73.42 109.502 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.643 HG21 HG21 ' C' ' 114' ' ' ILE . 92.7 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.369 1.067 . . . . 73.33 108.858 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -98.57 139.46 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.004 -1.11 . . . . 74.23 108.004 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.43 114.21 8.04 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.633 -0.877 . . . . 70.41 108.633 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.8 m -123.73 135.35 53.8 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.941 0.497 . . . . 70.42 111.015 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.854 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.3 mt -85.53 55.17 3.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.032 1.333 . . . . 75.55 109.148 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -110.18 3.81 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.943 -1.263 . . . . 74.55 109.943 -172.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.7 -23.72 17.45 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.876 . . . . 73.14 110.244 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -91.47 108.63 20.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.4 1.08 . . . . 72.03 110.027 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 59.0 m -70.19 122.65 19.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.304 0.642 . . . . 70.13 112.43 -171.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.643 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -67.77 -58.47 4.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.607 1.163 . . . . 51.11 110.254 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -154.53 176.2 12.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.587 -1.188 . . . . 71.01 111.05 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.79 109.75 5.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.578 -1.638 . . . . 75.33 106.578 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.516 ' SG ' HG23 ' C' ' 114' ' ' ILE . 43.6 t -107.45 146.25 31.97 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.528 -0.916 . . . . 74.52 108.528 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -158.24 129.77 6.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.807 -0.442 . . . . 71.21 109.807 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.24 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.309 1.044 . . . . 73.14 108.592 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.4 mt-30 -114.5 98.68 7.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 63.5 108.753 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -91.33 105.24 17.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.938 0.895 . . . . 75.15 110.26 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.78 151.45 22.33 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.311 0.382 . . . . 52.51 112.274 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.54 121.34 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.448 -0.661 . . . . 75.0 111.448 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.429 HD11 ' HB3' ' D' ' 29' ' ' PRO . 23.9 mm -82.69 127.8 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.747 -0.834 . . . . 75.12 108.747 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -136.23 126.03 25.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.335 0.654 . . . . 74.12 110.051 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.1 p -101.43 106.54 17.69 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.662 -0.866 . . . . 75.01 108.662 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.425 HD12 ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER -148.42 143.94 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.622 0.725 . . . . 72.22 111.369 -177.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.62 179.38 7.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.293 1.437 . . . . 54.24 109.716 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.72 52.74 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 114.618 0.607 . . . . 64.03 114.618 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -80.02 166.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.331 0.653 . . . . 70.22 111.865 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.576 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 14.6 pt-20 -165.36 147.6 7.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.157 0.983 . . . . 73.15 109.668 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.2 -110.89 2.22 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.486 0.554 . . . . 73.35 114.486 170.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 82.7 p -68.85 -37.75 79.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.422 1.089 . . . . 62.53 111.34 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.576 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 95.2 mt-30 -60.66 -42.19 96.52 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.568 0.747 . . . . 73.23 109.722 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.8 ttm -63.89 -47.31 81.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 65.31 111.053 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.295 -0.866 . . . . 74.24 110.854 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -74.68 -24.91 58.86 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.98 -0.554 . . . . 74.23 111.731 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' C' ' 86' ' ' ILE . 42.7 t -72.06 -62.71 1.33 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.84 0.456 . . . . 74.43 111.503 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 -6.86 24.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.764 -0.585 . . . . 70.02 112.433 -176.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.64 2.61 49.3 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.669 -0.517 . . . . 70.31 113.286 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.526 ' HA ' ' HZ3' ' E' ' 184' ' ' TRP . . . -154.56 -58.55 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.267 0.533 . . . . 75.31 111.858 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -65.4 -67.9 0.4 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.36 1.064 . . . . 74.44 112.212 -168.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -57.84 -43.98 99.05 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.299 1.039 . . . . 54.35 112.813 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.35 -34.18 55.89 Favored 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 121.638 1.559 . . . . 75.14 113.575 170.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -72.0 -19.14 61.91 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 118.76 0.709 . . . . 73.1 110.866 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.625 HD12 HH12 ' A' ' 111' ' ' ARG . 40.5 mm -66.08 -41.75 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.515 0.726 . . . . 73.44 109.551 167.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.53 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.1 mt -79.13 -28.1 42.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.26 -0.882 . . . . 62.33 112.053 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -53.74 -45.97 98.56 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.364 -1.303 . . . . 73.14 113.271 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.418 ' HG3' ' CD2' ' A' ' 109' ' ' TYR . 47.4 Cg_exo -53.96 -40.54 80.56 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 122.329 2.019 . . . . 72.11 113.274 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -69.21 -43.57 73.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.445 0.698 . . . . 53.22 110.651 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.82 98.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 71.33 110.718 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -57.94 -48.54 79.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.81 1.644 . . . . 73.54 110.751 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.434 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -72.35 -33.94 67.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.771 0.828 . . . . 65.42 110.541 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -65.03 -43.34 92.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.71 0.804 . . . . 54.33 110.466 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.643 HG21 HG21 ' C' ' 64' ' ' VAL . 87.9 mt -66.52 -50.03 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.212 0.605 . . . . 62.33 110.23 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.467 HG23 ' HB2' ' C' ' 125' ' ' GLN . 58.8 m -50.15 -44.28 52.5 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 124.555 1.16 . . . . 75.31 111.055 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.4 t -68.77 -46.82 67.76 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.484 -1.234 . . . . 75.4 110.012 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.602 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.75 -43.89 63.1 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.013 0.925 . . . . 63.54 112.229 178.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.1 t -66.1 -45.38 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.489 0.716 . . . . 63.54 110.668 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -70.47 -26.51 63.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.926 -0.579 . . . . 62.02 111.229 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.3 mtt-85 -65.99 -38.59 88.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.784 0.833 . . . . 74.23 110.413 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.69 3.7 63.09 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.755 -0.657 . . . . 54.11 112.826 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.5 p 63.32 33.42 14.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.349 1.86 . . . . 61.45 112.152 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.43 168.09 9.02 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.721 1.208 . . . . 71.12 109.609 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.48 106.51 0.6 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 122.386 2.058 . . . . 73.23 110.984 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' B' ' 119' ' ' SER . 18.7 pt20 -54.45 135.53 45.4 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.04 . . . . 72.22 111.842 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.01 89.67 3.71 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.402 0.62 . . . . 63.15 109.969 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -111.5 86.42 2.33 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.603 -1.629 . . . . 61.41 106.603 167.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.527 ' HB3' HD11 ' E' ' 187' ' ' ILE . 76.4 mt -87.52 153.8 21.13 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.261 -1.336 . . . . 73.24 109.985 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' E' ' 187' ' ' ILE . . . -45.25 127.84 5.85 Favored Pre-proline 0 CA--C 1.556 1.193 0 O-C-N 124.599 1.187 . . . . 52.01 112.817 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 37.0 Cg_endo -61.08 104.16 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.558 2.839 . . . . 61.03 113.054 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.68 91.66 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-O 121.955 0.883 . . . . 64.41 111.076 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -88.54 102.39 14.88 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.241 -1.022 . . . . 71.24 108.241 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.77 -36.9 82.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.877 0.871 . . . . 74.5 112.325 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.78 -43.28 80.11 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.3 0.64 . . . . 75.44 111.612 -170.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.19 93.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.168 0.587 . . . . 44.22 110.654 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.4 -31.54 69.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.017 0.927 . . . . 73.22 110.682 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -70.66 -45.02 65.88 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.994 0.917 . . . . 54.14 110.769 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.0 mtm -72.46 -33.26 66.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.959 -0.564 . . . . 72.22 110.535 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.38 -37.87 88.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.733 0.813 . . . . 73.22 110.251 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.57 -79.52 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.863 1.265 . . . . 71.1 110.839 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.97 -38.84 68.3 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.504 1.122 . . . . 71.51 110.454 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 69.64 9.81 7.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.284 1.434 . . . . 75.11 111.804 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 59.73 -81.12 0.02 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.63 1.572 . . . . 74.23 112.786 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.97 143.06 33.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.52 -0.918 . . . . 53.0 108.52 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.69 -179.75 4.91 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.608 0.718 . . . . 61.12 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.27 -140.71 5.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.902 -1.279 . . . . 73.45 109.902 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.5 -62.69 1.18 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 117.811 0.805 . . . . 75.43 110.415 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.74 78.46 1.41 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.977 -1.249 . . . . 43.15 109.977 -165.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.3 t -71.04 135.77 47.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.804 0.842 . . . . 44.33 110.255 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.64 113.5 25.32 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.787 -0.82 . . . . 72.53 108.787 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' G' ' 170' ' ' LYS . 11.6 mm-40 -100.33 -82.3 0.45 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.323 1.049 . . . . 74.55 111.083 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 m170 58.32 147.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.935 1.294 . . . . 72.31 113.474 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -109.09 87.14 2.42 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.773 -1.195 . . . . 73.11 107.773 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.02 -13.23 36.46 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.968 -1.014 . . . . 61.45 110.9 -174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.84 0.856 . . . . 64.32 110.6 -178.251 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' H' ' 172' ' ' ALA . 16.9 ptt? . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.352 0.596 . . . . 71.34 109.497 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 61.8 p -128.39 7.72 5.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.045 0.538 . . . . 54.13 112.094 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.55 134.06 38.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.354 0.662 . . . . 74.15 109.541 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -126.43 105.24 8.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.15 0.98 . . . . 75.45 109.631 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -75.16 143.78 43.08 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.572 -0.899 . . . . 65.42 108.572 165.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -69.04 99.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.736 -0.468 . . . . 74.22 109.736 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -122.0 136.79 54.95 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 125.019 1.327 . . . . 62.14 108.331 172.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -73.79 83.53 1.64 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.102 -0.703 . . . . 72.22 109.102 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttp -32.89 123.51 0.37 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.67 1.588 . . . . 71.22 112.937 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -120.14 138.94 53.3 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.763 0.825 . . . . 73.42 108.779 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -156.57 111.1 2.78 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.691 -1.226 . . . . 63.44 107.691 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.473 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 79.2 mt-30 -117.66 116.63 27.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.565 0.746 . . . . 71.14 110.312 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.406 HD13 ' ND2' ' B' ' 132' ' ' ASN . 1.7 mp -75.91 104.87 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.928 -1.508 . . . . 61.23 106.928 168.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.466 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 76.3 mt-30 -80.79 -41.9 22.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 119.106 -0.473 . . . . 75.13 110.759 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 177.96 144.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.686 0.616 . . . . 75.23 111.722 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.551 ' H ' ' HG3' ' B' ' 130' ' ' PRO . 2.0 mp -105.48 132.14 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 107.316 -1.364 . . . . 72.35 107.316 170.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -158.28 159.8 36.35 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.321 1.049 . . . . 74.53 109.628 -174.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -92.37 118.13 30.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 72.14 109.812 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -89.07 -32.75 17.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.758 -0.655 . . . . 72.43 109.827 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.8 t70 -146.06 134.02 21.4 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.118 -0.946 . . . . 63.43 108.902 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.602 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.3 mt -130.44 140.49 48.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.578 -1.268 . . . . 60.34 107.578 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -142.19 136.15 29.65 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.101 0.96 . . . . 73.34 108.837 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -144.31 119.83 10.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.558 -2.016 . . . . 72.43 105.558 166.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.69 134.29 54.96 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 108.973 -0.751 . . . . 72.42 108.973 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.53 82.22 47.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.758 -1.571 . . . . 74.31 106.758 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -65.91 -30.22 48.9 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.61 2.207 . . . . 71.44 112.043 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.7 24.9 12.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.726 -1.125 . . . . 52.54 109.898 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.693 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -41.22 -60.97 1.49 Allowed Pre-proline 0 CA--C 1.584 2.253 0 N-CA-C 116.018 1.859 . . . . 73.01 116.018 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.429 ' HB3' HD11 ' C' ' 83' ' ' ILE . 94.4 Cg_endo -79.6 -17.06 11.43 Favored 'Trans proline' 0 C--N 1.399 3.214 0 CA-C-N 122.923 2.08 . . . . 74.34 113.293 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -73.41 -39.22 65.23 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.989 1.316 . . . . 73.44 110.295 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.5 p -86.24 -7.86 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 124.296 1.038 . . . . 74.31 111.156 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.52 -25.34 59.71 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.363 1.065 . . . . 74.31 111.176 169.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.54 -14.21 62.85 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.232 1.013 . . . . 51.41 112.259 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.428 ' HB3' HD22 ' D' ' 68' ' ' LEU . 0.1 OUTLIER -96.92 106.28 18.57 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.854 0.862 . . . . 51.21 109.394 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' H' ' 196' ' ' LYS . 9.8 p-10 -112.7 50.08 0.89 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.579 1.152 . . . . 74.11 110.604 -171.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -146.59 177.51 9.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 75.42 110.509 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -62.05 113.98 10.16 Favored Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.058 0.943 . . . . 74.22 111.345 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HG3' HD21 ' D' ' 68' ' ' LEU . 15.4 Cg_exo -71.31 144.84 46.94 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.024 2.483 . . . . 55.14 113.037 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.87 142.69 47.94 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.489 -0.778 . . . . 73.13 109.053 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.523 HG13 HG13 ' D' ' 64' ' ' VAL . 95.7 t -124.95 118.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.21 108.385 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -112.67 118.26 34.55 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.24 -0.652 . . . . 64.13 109.24 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.642 HD21 HD22 ' D' ' 128' ' ' LEU . 5.7 mp -96.88 125.45 41.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.475 0.71 . . . . 75.32 109.696 -174.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.811 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.1 m-20 -107.06 126.86 52.9 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.459 -0.941 . . . . 73.01 108.459 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.58 132.23 40.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.258 0.623 . . . . 75.32 109.89 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.1 t70 -157.62 156.18 31.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 170.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -136.51 165.89 24.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.6 0.76 . . . . 63.42 109.794 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.99 177.57 10.03 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.889 1.275 . . . . 71.3 108.473 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -165.36 166.63 18.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.847 0.459 . . . . 73.43 111.249 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.6 p -154.24 131.69 11.28 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.292 1.037 . . . . 71.31 108.328 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.4 117.85 20.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.941 -0.762 . . . . 71.42 108.941 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.3 mt -92.27 -33.4 14.66 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.708 -0.478 . . . . 65.15 109.708 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.39 -177.04 5.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.538 0.735 . . . . 73.4 111.064 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -65.92 124.55 22.8 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.02 -0.991 . . . . 65.22 109.005 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 16.6 m-20 65.7 19.27 11.38 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.183 0.993 . . . . 64.34 111.821 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.24 119.93 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.735 0.814 . . . . 64.51 109.643 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.418 ' HE1' ' SD ' ' H' ' 174' ' ' MET . 20.1 m-85 -134.03 130.84 38.12 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.023 0.929 . . . . 71.12 108.668 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.424 ' HB2' HD11 ' D' ' 51' ' ' LEU . 4.2 tt0 -86.78 119.6 27.18 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.512 -1.292 . . . . 74.35 107.512 169.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -100.16 129.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.635 -1.246 . . . . 73.1 107.635 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.3 t -104.79 138.66 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 54.32 108.944 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -106.4 124.32 49.41 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.43 -1.322 . . . . 74.31 107.43 174.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.7 ttm-85 -99.5 98.99 9.82 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.544 -1.28 . . . . 72.11 107.544 173.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.611 HG21 ' HB1' ' D' ' 110' ' ' ALA . 9.3 t -100.51 112.72 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.397 -0.964 . . . . 75.24 108.397 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -114.5 145.76 41.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.791 -0.448 . . . . 72.32 109.791 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.523 HG13 HG13 ' D' ' 40' ' ' VAL . 39.3 t -133.95 105.17 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.889 1.276 . . . . 60.22 109.101 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -98.07 96.47 8.15 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.085 -1.08 . . . . 70.25 108.085 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.98 147.71 24.22 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.972 0.509 . . . . 44.12 110.131 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -137.23 133.49 35.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.346 0.593 . . . . 74.14 111.939 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.444 HD21 ' HG3' ' D' ' 38' ' ' PRO . 9.4 mt -119.69 108.87 14.97 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.008 1.323 . . . . 75.01 108.402 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.2 -118.41 4.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.724 -0.551 . . . . 75.01 111.724 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.75 4.72 15.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.534 0.734 . . . . 72.2 110.707 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -122.48 171.75 8.86 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.484 0.714 . . . . 71.45 110.549 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.8 m -68.18 123.76 21.6 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.938 -1.028 . . . . 73.12 110.734 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.751 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -73.35 -65.41 0.82 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.422 -0.955 . . . . 73.21 108.422 170.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -156.76 157.05 34.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.843 -1.072 . . . . 64.45 109.83 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.05 152.11 29.91 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.124 1.37 . . . . 70.34 108.608 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 39.3 t -157.85 143.39 17.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.487 0.715 . . . . 73.44 109.092 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.23 128.99 7.82 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.557 -0.535 . . . . 64.45 109.557 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.18 115.29 42.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.013 -0.736 . . . . 70.21 109.013 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.69 85.63 6.83 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.189 0.995 . . . . 41.33 108.627 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.461 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -80.04 96.9 6.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 113.324 -1.762 . . . . 75.2 108.241 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -97.72 144.14 17.11 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 112.061 -0.416 . . . . 70.55 112.061 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.61 137.64 7.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.366 -0.694 . . . . 50.13 111.366 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 62.0 mt -88.08 125.45 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.901 -0.777 . . . . 73.43 108.901 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -130.79 123.87 30.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.643 0.777 . . . . 74.55 109.62 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 66.5 m -80.77 106.23 12.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.611 -0.885 . . . . 62.03 108.611 170.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -108.23 103.55 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.998 0.904 . . . . 74.25 110.007 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -140.96 150.92 43.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.985 0.914 . . . . 71.54 109.711 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.6 14.83 75.22 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.093 0.246 . . . . 74.12 113.192 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.667 HD12 ' HG2' ' D' ' 94' ' ' MET . 24.7 pt -98.59 125.63 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.365 1.066 . . . . 65.11 108.708 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -140.67 172.83 12.15 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.228 0.537 . . . . 64.13 112.01 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.23 -143.9 47.92 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.31 -1.314 . . . . 74.34 113.684 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -85.32 -20.21 30.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.106 0.962 . . . . 62.4 110.724 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.82 -35.87 79.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.472 0.709 . . . . 63.44 110.627 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.667 ' HG2' HD12 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -58.33 -49.26 77.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.527 0.731 . . . . 71.35 110.69 175.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.01 94.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.309 -0.86 . . . . 71.33 111.047 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.25 -30.88 66.85 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.64 -0.709 . . . . 64.14 111.261 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.67 -48.35 64.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.822 0.449 . . . . 73.11 110.411 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.57 -36.5 65.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.141 0.576 . . . . 54.11 110.212 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.55 6.5 77.63 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.221 -0.766 . . . . 72.45 114.785 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -152.75 -57.92 0.14 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.364 1.082 . . . . 55.23 112.341 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -64.75 -51.7 60.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.183 0.593 . . . . 72.11 111.49 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.524 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 27.9 m -60.73 -47.93 94.5 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 118.498 -0.763 . . . . 75.44 111.357 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.2 Cg_exo -59.29 -31.38 94.98 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.418 2.078 . . . . 65.3 113.968 168.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.7 -31.29 70.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.861 0.465 . . . . 73.4 110.706 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.3 -33.82 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.505 0.722 . . . . 64.3 110.281 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.526 HD23 HG13 ' D' ' 16' ' ' ILE . 86.0 mt -76.95 -25.61 53.05 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.049 0.939 . . . . 73.4 111.731 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -63.74 -41.99 68.51 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 114.94 1.459 . . . . 64.1 114.94 -168.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.53 -41.85 71.71 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.106 1.87 . . . . 62.35 113.234 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.15 -30.74 38.95 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.134 -0.939 . . . . 65.3 110.365 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.611 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -63.89 -44.91 91.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.722 0.809 . . . . 72.42 110.179 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.0 -51.29 70.28 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 124.629 1.206 . . . . 64.44 110.515 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.2 -41.92 99.23 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.143 0.902 . . . . 73.43 110.559 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -56.51 -45.21 81.2 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 123.808 0.693 . . . . 63.04 110.356 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' D' ' 76' ' ' CYS . 77.4 mt -63.9 -54.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.024 0.828 . . . . 74.52 110.375 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.475 HG21 ' HE2' ' B' ' 109' ' ' TYR . 86.8 m -51.38 -46.74 62.89 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.152 1.381 . . . . 75.12 111.893 -171.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -65.53 -44.5 86.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.6 -1.182 . . . . 62.41 110.271 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.7 mtm -65.74 -32.71 74.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.03 0.532 . . . . 71.32 111.692 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -63.93 -48.26 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.77 0.828 . . . . 55.23 109.982 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -72.25 -28.63 63.27 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.983 -0.553 . . . . 64.1 110.937 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -69.81 -34.23 73.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.624 0.77 . . . . 74.44 110.041 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 8.65 64.16 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.982 -0.554 . . . . 64.32 113.001 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.8 p 61.27 30.62 19.26 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.956 1.702 . . . . 74.31 113.119 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 74.2 m-85 -100.9 163.43 18.05 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 124.708 1.203 . . . . 71.11 108.697 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 73.1 Cg_endo -71.12 143.21 43.78 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.212 1.942 . . . . 71.31 111.55 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -52.13 132.97 33.77 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.792 0.682 . . . . 75.11 111.384 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.454 HD13 HG21 ' D' ' 40' ' ' VAL . 29.4 tp -108.89 108.23 18.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.148 0.979 . . . . 71.33 109.715 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -102.12 102.75 13.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.395 0.678 . . . . 54.1 109.603 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.642 HD22 HD21 ' D' ' 42' ' ' LEU . 38.5 mt -72.75 118.47 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.125 -0.694 . . . . 75.45 109.125 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 125.09 79.25 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.341 0.656 . . . . 62.25 111.25 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -67.64 103.34 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.136 1.891 . . . . 72.34 110.605 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.44 HG23 HG22 ' G' ' 207' ' ' VAL . 2.8 p -106.84 110.12 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.107 0.956 . . . . 72.33 109.915 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -77.77 107.04 9.99 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.413 -1.267 . . . . 73.05 108.098 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.495 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 68.0 m-85 -68.04 -25.42 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.769 0.827 . . . . 73.21 111.285 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.48 -22.58 66.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.046 1.338 . . . . 71.44 112.305 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -45.27 79.84 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.503 0.721 . . . . 53.44 111.582 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.521 HD11 HG11 ' G' ' 207' ' ' VAL . 6.1 mp -75.31 -34.74 61.28 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.537 0.735 . . . . 74.24 111.065 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.3 -65.16 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.861 0.864 . . . . 73.42 109.588 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.37 -26.62 65.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.678 1.191 . . . . 74.44 112.354 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -62.0 -44.84 95.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.146 0.578 . . . . 73.54 110.483 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -63.05 -41.58 99.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.894 0.478 . . . . 70.44 110.765 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.7 -38.2 86.26 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.823 -0.626 . . . . 64.2 111.56 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -83.86 5.95 23.32 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.021 0.528 . . . . 73.44 111.277 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.95 49.06 1.36 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.637 -1.246 . . . . 72.12 107.637 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -139.33 13.69 2.59 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.073 -1.422 . . . . 62.14 108.814 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.98 146.09 24.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.112 0.965 . . . . 71.41 109.791 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.14 -148.86 5.96 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-O 120.076 -0.291 . . . . 74.04 112.572 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -149.71 138.19 20.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.088 0.555 . . . . 73.23 110.111 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.45 175.93 50.89 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.528 0.517 . . . . 63.21 112.803 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 34.4 m -75.92 102.53 5.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.943 0.497 . . . . 75.23 110.265 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -133.75 143.41 48.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.625 -0.88 . . . . 75.15 108.625 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -92.49 134.36 35.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.484 1.114 . . . . 71.11 110.506 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -103.03 109.48 21.05 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.912 -1.144 . . . . 74.13 107.912 166.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -73.41 139.49 45.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.421 0.451 . . . . 73.24 110.076 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.34 172.92 7.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.961 0.904 . . . . 74.44 110.313 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 N-CA-C 108.648 -0.871 . . . . 73.44 108.648 170.337 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.32 -0.252 . . . . 72.25 110.32 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.83 Favored Glycine 0 C--N 1.345 1.039 0 O-C-N 124.018 0.824 . . . . 61.12 111.222 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 66.79 129.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.126 1.371 . . . . 61.54 111.945 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 66.8 m -79.56 0.32 30.36 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.071 0.548 . . . . 71.0 112.055 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -162.07 156.89 22.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.369 0.668 . . . . 74.23 110.575 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.6 tt -156.48 -55.63 0.08 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 107.613 -1.254 . . . . 74.11 107.613 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.28 129.69 40.84 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.446 0.698 . . . . 71.14 109.428 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.607 ' HD2' ' HB2' ' E' ' 177' ' ' LEU . 12.9 p90 -73.5 152.52 40.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.856 -1.066 . . . . 72.15 111.236 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 176' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' E' ' 178' ' ' GLN . 29.7 p-10 -103.57 -38.01 7.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.554 0.742 . . . . 74.43 109.316 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 177' ' ' LEU . . . . . 0.607 ' HB2' ' HD2' ' E' ' 175' ' ' PHE . 0.6 OUTLIER 56.97 42.99 25.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.656 1.182 . . . . 75.33 109.749 -178.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 178' ' ' GLN . . . . . 0.425 ' HB2' ' ND2' ' E' ' 176' ' ' ASN . 0.1 OUTLIER -57.7 -53.55 56.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.634 0.774 . . . . 71.43 109.085 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -136.0 145.17 51.41 Favored Pre-proline 0 C--O 1.245 0.842 0 C-N-CA 124.416 1.086 . . . . 75.45 108.956 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.01 123.04 11.02 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.588 2.192 . . . . 74.24 110.506 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.89 -45.21 30.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.722 1.209 . . . . 74.05 111.434 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.68 136.28 38.94 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.298 -1.371 . . . . 72.55 107.298 168.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 24.4 p -68.92 134.67 49.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.447 0.699 . . . . 73.31 110.11 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.526 ' HZ3' ' HA ' ' C' ' 100' ' ' ALA . 8.2 t-105 -71.38 111.47 10.31 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.198 0.999 . . . . 71.42 109.881 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -87.84 117.23 1.11 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.701 2.267 . . . . 73.45 112.107 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.81 147.37 29.42 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' C' ' 128' ' ' LEU . 25.7 pt -61.09 149.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.363 0.665 . . . . 75.0 111.174 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.76 89.28 3.41 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.517 -0.92 . . . . 61.31 108.517 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.23 86.49 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.243 -0.89 . . . . 51.11 111.055 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 19.7 t0 73.16 -62.11 0.48 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.841 1.257 . . . . 63.0 111.912 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 99.37 -132.68 11.01 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-O 119.524 -0.598 . . . . 61.44 112.279 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.56 83.73 0.47 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.521 -0.632 . . . . 40.54 111.521 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 193' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' C' ' 37' ' ' GLN . 70.8 m-85 68.36 -89.39 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.144 1.378 . . . . 72.1 111.131 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 56.08 24.83 8.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.939 0.896 . . . . 74.15 110.918 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -171.25 158.35 5.39 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.068 0.947 . . . . 64.42 110.335 -171.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 196' ' ' LYS . . . . . 0.413 ' HD2' ' HD2' ' F' ' 193' ' ' TYR . 14.3 ptmm? -146.13 127.63 15.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.538 1.135 . . . . 71.4 108.32 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -92.85 -58.48 2.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.212 -1.033 . . . . 73.04 108.212 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 63.15 -170.28 0.18 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.227 1.411 . . . . 51.33 112.694 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -119.55 153.02 36.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.86 0.864 . . . . 74.03 109.767 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.49 -71.29 2.29 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.992 -0.443 . . . . 44.15 111.992 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 128.88 33.84 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.414 -0.587 . . . . 71.25 109.414 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 8.6 t80 58.06 25.26 12.14 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.853 1.261 . . . . 53.53 111.382 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.48 -61.62 1.77 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.276 1.031 . . . . 63.55 108.546 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 4.0 mt 63.39 89.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.803 1.641 . . . . 62.25 111.051 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -160.94 37.97 0.15 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 71.45 109.769 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.0 -50.84 0.44 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.614 -0.513 . . . . 64.42 109.614 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.256 1.44 0 C-N-CA 123.86 0.864 . . . . 73.33 110.959 -178.247 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 12.1 mptt . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.149 -0.686 . . . . 50.01 109.149 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.07 43.7 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.057 0.223 . . . . 72.33 112.572 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 170' ' ' LYS . . . . . 0.59 ' H ' ' HD3' ' F' ' 170' ' ' LYS . 0.0 OUTLIER -108.38 36.13 2.93 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.447 0.641 . . . . 71.02 111.424 -176.272 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 75.0 m -145.91 118.83 8.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.544 0.738 . . . . 64.21 109.355 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 172' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' B' ' 90' ' ' GLU . . . -154.45 147.44 24.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.017 0.927 . . . . 63.12 109.513 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -157.39 112.43 2.75 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.923 -1.14 . . . . 63.33 107.923 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.87 151.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.135 1.374 . . . . 64.1 113.047 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 175' ' ' PHE . . . . . 0.606 ' HD2' ' HE2' ' B' ' 94' ' ' MET . 21.8 p90 -152.66 171.56 17.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.234 -0.894 . . . . 61.43 111.649 -171.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -142.87 62.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.667 -1.605 . . . . 72.04 106.667 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? 61.87 96.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.799 1.239 . . . . 62.22 109.184 -170.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.97 -84.23 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 122.85 0.46 . . . . 62.32 109.962 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -149.85 146.04 19.89 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.116 1.366 . . . . 71.22 108.093 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.86 87.08 0.14 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.119 2.546 . . . . 73.02 112.71 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.89 110.18 19.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.927 0.891 . . . . 64.45 109.005 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 182' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' B' ' 3' ' ' GLU . 8.8 m-85 60.07 34.41 21.31 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 123.777 0.673 . . . . 64.32 110.459 172.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 19.4 m -57.42 -33.03 67.46 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.467 1.507 . . . . 45.44 113.309 -166.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 46.9 t90 72.39 98.39 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.471 1.108 . . . . 73.2 110.827 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.77 162.2 7.69 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.701 2.268 . . . . 73.22 112.992 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.62 -177.59 3.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.281 1.033 . . . . 74.41 109.614 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.1 160.52 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.066 0.546 . . . . 72.44 111.241 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 188' ' ' ALA . . . . . 0.474 ' HA ' HD23 ' B' ' 42' ' ' LEU . . . -81.9 161.26 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.657 0.783 . . . . 50.01 110.009 175.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.61 -165.52 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.31 0.644 . . . . 74.25 110.586 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -115.92 158.18 23.41 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.973 0.909 . . . . 72.25 110.4 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 191' ' ' GLY . . . . . 0.815 ' HA3' ' HA ' ' B' ' 39' ' ' GLU . . . -153.14 100.14 0.2 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.038 -0.528 . . . . 64.34 112.352 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.07 167.42 40.21 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.47 -0.628 . . . . 73.24 111.946 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 193' ' ' TYR . . . . . 0.413 ' HD2' ' HD2' ' E' ' 196' ' ' LYS . 89.1 m-85 51.18 -145.2 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.312 1.045 . . . . 71.32 110.056 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . 59.28 -160.12 0.28 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 123.897 0.879 . . . . 72.32 112.361 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 86.7 t80 65.56 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.655 1.182 . . . . 64.44 110.485 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 49.82 81.05 0.06 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.986 1.314 . . . . 72.44 112.072 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -67.85 87.08 0.24 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.449 -1.686 . . . . 64.11 106.449 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -145.82 -43.91 0.21 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.078 -0.51 . . . . 61.54 111.097 -163.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -177.42 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 123.911 0.757 . . . . 63.21 110.4 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.93 16.81 60.02 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.405 1.322 . . . . 54.35 116.405 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -87.38 -89.43 0.13 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.681 0.741 . . . . 70.44 109.581 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -104.54 34.03 3.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.181 -1.414 . . . . 74.24 107.181 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -155.37 -178.89 7.59 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.063 -1.426 . . . . 74.12 109.749 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 14.1 tt -133.69 136.21 54.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.488 -0.93 . . . . 64.31 108.488 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -149.57 161.74 41.55 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.467 -0.938 . . . . 75.4 108.467 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 29.9 t70 82.02 -26.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.398 1.479 . . . . 72.24 112.686 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.61 0.764 . . . . 64.11 109.939 177.893 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 168' ' ' LYS . . . . . 0.7 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 2.9 mppt? . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 108.303 -0.999 . . . . 74.21 108.303 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 73.1 -95.77 0.76 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.075 -0.966 . . . . 70.15 111.359 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 170' ' ' LYS . . . . . 0.462 ' HB3' ' H ' ' C' ' 151' ' ' GLU . 19.3 ptmt -71.93 150.94 43.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.515 0.726 . . . . 73.14 109.921 175.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 171' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 54' ' ' ASP . 69.5 p -89.09 44.33 1.21 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.465 0.706 . . . . 53.2 111.489 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . 62.08 -156.77 0.34 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.317 1.047 . . . . 70.21 111.197 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.604 HD23 ' SD ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -106.52 -50.72 3.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.859 -1.163 . . . . 75.04 107.859 -178.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 8.2 tpp 62.75 78.57 0.29 Allowed 'General case' 0 C--N 1.355 0.848 0 CA-C-N 113.624 -1.625 . . . . 64.2 110.754 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.496 ' HE1' HD22 ' A' ' 98' ' ' LEU . 1.3 p90 -76.0 162.1 28.35 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.441 -0.8 . . . . 75.3 111.913 -171.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -78.58 150.79 32.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.939 -1.028 . . . . 64.02 108.786 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 177' ' ' LEU . . . . . 0.491 HD12 HG23 ' A' ' 46' ' ' THR . 3.7 mm? -68.74 85.49 0.31 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.778 0.831 . . . . 63.11 111.268 -175.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -101.01 169.17 9.13 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.036 -0.984 . . . . 73.5 108.925 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.87 147.83 78.12 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-O 118.73 -0.653 . . . . 71.11 109.848 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -52.4 121.08 8.38 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.465 2.777 . . . . 75.14 113.552 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -45.35 -39.67 7.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.002 1.721 . . . . 75.0 112.179 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 182' ' ' PHE . . . . . 0.484 ' HD2' ' HE2' ' A' ' 137' ' ' PHE . 23.0 m-85 -126.11 116.11 20.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.721 -1.214 . . . . 72.11 107.721 166.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -71.16 107.21 4.07 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.824 0.702 . . . . 74.32 110.403 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 129.62 82.89 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.869 0.868 . . . . 74.43 109.89 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 185' ' ' PRO . . . . . 0.476 ' HG2' HD13 ' A' ' 136' ' ' LEU . 60.2 Cg_endo -72.45 146.89 45.51 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.286 1.99 . . . . 61.32 112.399 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.71 -179.33 3.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.057 0.943 . . . . 73.35 110.076 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.466 HG21 ' HB3' ' A' ' 129' ' ' ALA . 43.6 pt -68.57 166.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.89 0.876 . . . . 75.21 111.961 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.15 134.65 41.69 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 74.51 109.42 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.42 40.72 3.27 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.313 1.054 . . . . 63.32 108.385 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.51 21.64 1.75 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.92 -1.491 . . . . 74.44 112.308 -173.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 191' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' H' ' 201' ' ' LYS . . . -141.61 -160.29 8.26 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.81 -0.916 . . . . 72.14 110.81 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.82 -147.14 5.38 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.829 -0.224 . . . . 61.13 112.629 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 193' ' ' TYR . . . . . 0.537 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 46.2 m-85 -130.02 -166.19 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.184 1.394 . . . . 54.13 109.168 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 194' ' ' ALA . . . . . 0.665 ' HB3' ' HG2' ' H' ' 196' ' ' LYS . . . -145.7 157.58 43.94 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.021 0.928 . . . . 43.41 108.819 167.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.683 ' HB2' ' HB3' ' A' ' 36' ' ' TRP . 2.5 t80 -112.55 -47.57 3.07 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.686 0.794 . . . . 74.44 108.895 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' H' ' 196' ' ' LYS . 41.1 mtpt 65.36 76.23 0.34 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.795 1.638 . . . . 71.01 111.162 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -75.29 130.4 39.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.773 -1.103 . . . . 73.33 110.086 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.12 97.13 1.77 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.132 0.573 . . . . 73.32 109.521 169.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 68.14 162.87 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.989 1.315 . . . . 73.21 112.464 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.48 120.19 5.11 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.345 -0.702 . . . . 70.13 111.345 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 201' ' ' LYS . . . . . 0.713 ' HE3' ' HB2' ' H' ' 194' ' ' ALA . 3.6 mptp? -75.46 -38.8 59.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.5 0.72 . . . . 73.44 110.802 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -75.13 73.87 2.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.142 0.577 . . . . 72.4 109.444 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.68 80.52 7.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.911 0.862 . . . . 61.12 108.993 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.3 134.26 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 107.173 -1.417 . . . . 72.12 107.173 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.11 -59.34 1.81 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.172 -0.677 . . . . 71.43 109.172 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -152.62 99.23 2.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.755 0.822 . . . . 63.01 108.967 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 207' ' ' VAL . . . . . 0.521 HG11 HD11 ' D' ' 136' ' ' LEU . 21.8 t . . . . . 0 CA--C 1.571 1.783 0 C-N-CA 125.5 1.52 . . . . 63.43 111.455 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 109.282 -0.636 . . . . 74.05 109.282 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.12 -88.37 0.29 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.714 -0.555 . . . . 64.31 111.714 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -147.38 -80.67 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.695 0.798 . . . . 74.3 109.495 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.6 p 159.5 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.351 2.26 . . . . 73.15 107.349 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' D' ' 1' ' ' MET . . . -142.61 146.62 34.71 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.563 0.345 . . . . 52.43 111.037 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.74 -70.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.581 1.175 . . . . 50.4 108.157 174.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.465 ' HE2' ' HA ' ' H' ' 174' ' ' MET . 24.0 mmt -94.79 98.08 10.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.427 1.091 . . . . 74.1 109.807 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 60.3 -97.21 0.07 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.574 1.549 . . . . 64.13 111.5 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 60.05 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.549 1.14 . . . . 74.41 111.554 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp 62.88 93.9 0.05 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.807 1.243 . . . . 63.12 111.081 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 178' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' D' ' 1' ' ' MET . 18.6 mm100 -134.0 -175.22 3.77 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.626 0.77 . . . . 62.03 110.068 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 70.15 156.01 0.15 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 125.378 1.471 . . . . 72.23 112.992 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.07 111.91 3.18 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.476 2.118 . . . . 72.3 110.038 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -69.88 143.25 52.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.845 0.458 . . . . 74.15 110.461 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -64.49 107.56 1.41 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 108.739 -0.837 . . . . 73.02 108.739 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 34.0 p -65.67 97.66 0.33 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.638 0.775 . . . . 74.21 110.31 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -79.86 122.09 82.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.896 0.878 . . . . 72.23 110.25 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.24 130.04 37.34 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.947 2.431 . . . . 64.24 112.415 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.15 170.82 15.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 73.24 110.719 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.628 ' HB ' HD22 ' D' ' 42' ' ' LEU . 73.5 mt -72.63 123.78 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.632 0.773 . . . . 73.13 110.855 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -100.75 139.66 36.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.54 109.44 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.18 -88.3 0.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.057 0.543 . . . . 74.11 109.842 -177.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 59.48 -162.71 0.24 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.146 0.978 . . . . 71.12 111.846 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.11 155.25 7.39 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.699 -0.56 . . . . 54.3 111.699 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.43 -69.11 1.39 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 111.624 -0.59 . . . . 72.31 111.624 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.03 130.99 36.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.704 0.802 . . . . 74.42 109.43 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 194' ' ' ALA . . . . . 0.713 ' HB2' ' HE3' ' G' ' 201' ' ' LYS . . . -179.07 176.4 0.89 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.988 1.315 . . . . 71.35 109.396 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 54.5 t80 56.62 65.31 1.44 Allowed 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.579 1.175 . . . . 70.34 110.034 172.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 196' ' ' LYS . . . . . 0.665 ' HG2' ' HB3' ' G' ' 194' ' ' ALA . 0.1 OUTLIER -59.49 -47.43 85.52 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.479 -0.782 . . . . 55.05 109.956 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 2.9 t80 74.39 -58.66 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.778 1.299 . . . . 74.13 112.216 166.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -40.69 131.19 2.39 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.248 1.819 . . . . 64.34 112.295 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -67.55 127.35 32.41 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.242 1.017 . . . . 60.51 110.542 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.51 88.06 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 110.759 -0.936 . . . . 72.43 110.759 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 201' ' ' LYS . . . . . 0.495 ' HB3' ' HA3' ' G' ' 191' ' ' GLY . 1.5 tmtp? -173.69 113.52 0.21 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.044 -1.465 . . . . 74.42 107.044 171.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -162.43 70.12 0.28 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.467 0.651 . . . . 62.02 109.56 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -137.4 115.02 11.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.919 0.888 . . . . 54.1 109.535 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.509 HG22 ' H ' ' H' ' 206' ' ' ASP . 3.8 mp -93.57 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.402 -0.962 . . . . 72.12 108.402 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 65.76 23.01 11.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.114 1.366 . . . . 72.22 112.584 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 206' ' ' ASP . . . . . 0.509 ' H ' HG22 ' H' ' 204' ' ' ILE . 4.8 m-20 -117.3 -52.54 2.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.158 -1.423 . . . . 72.34 107.158 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' C' ' 11' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 126.132 1.773 . . . . 74.33 109.096 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.236 -0.283 . . . . 73.13 110.236 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 t -78.35 103.98 8.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.905 -0.776 . . . . 71.24 108.905 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -73.11 -170.83 0.81 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.024 0.93 . . . . 75.44 112.478 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -60.25 -66.09 0.58 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.148 0.979 . . . . 74.13 110.855 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -169.25 173.0 6.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.007 0.523 . . . . 75.53 110.497 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -140.45 156.81 46.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.137 0.975 . . . . 74.43 108.873 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -66.95 160.09 27.07 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.898 0.479 . . . . 63.21 109.766 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -51.22 -36.8 43.42 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.896 0.878 . . . . 65.44 111.238 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.474 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 20.7 ptt? -144.25 147.18 33.23 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.891 1.276 . . . . 73.53 107.808 173.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -139.51 141.39 37.33 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.183 0.516 . . . . 72.11 110.484 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -133.53 127.47 33.24 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 106.61 -1.626 . . . . 71.33 106.61 158.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -141.06 136.65 32.22 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.089 0.243 . . . . 74.33 110.681 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 13' ' ' ILE . 2.8 mp -92.64 104.03 15.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 107.491 -1.299 . . . . 73.1 107.491 174.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -81.28 -25.94 36.13 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 118.709 -0.662 . . . . 70.32 110.986 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.427 HH12 ' HA ' ' F' ' 203' ' ' ASP . 21.7 ttt85 -176.82 135.61 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.315 0.646 . . . . 65.35 110.711 173.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.5 136.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 123.765 0.826 . . . . 53.25 109.013 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.524 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 33.6 p90 -170.77 167.6 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.755 0.822 . . . . 65.3 110.863 -174.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -90.91 124.28 35.07 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 167.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -81.15 -33.34 33.2 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.352 -0.61 . . . . 52.3 109.352 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.5 t70 -148.23 140.84 24.49 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.797 -1.092 . . . . 74.33 109.911 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.1 mt -132.32 141.4 45.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.018 1.327 . . . . 62.11 107.442 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -149.65 130.85 14.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.127 -0.694 . . . . 75.3 109.127 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.7 t80 -132.46 135.85 46.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.7 -1.593 . . . . 74.0 106.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.11 152.63 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 75.43 108.29 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.84 79.35 46.02 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 106.541 -1.651 . . . . 73.24 106.541 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.9 -45.86 12.13 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.876 2.384 . . . . 73.34 112.094 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 28.2 m-80 -107.38 45.63 0.98 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.405 -0.816 . . . . 15.41 108.972 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -61.0 -50.16 85.95 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.187 0.995 . . . . 65.33 113.036 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -68.38 -7.99 21.73 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.823 1.682 . . . . 71.14 113.887 170.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.1 m80 -99.12 -13.4 19.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.766 0.826 . . . . 74.32 112.278 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -64.58 -23.02 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.896 0.316 . . . . 60.44 110.77 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.53 -34.92 74.83 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.078 0.951 . . . . 61.35 111.739 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -63.02 -54.71 34.0 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.555 0.742 . . . . 62.31 110.322 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HB2' HD13 ' A' ' 68' ' ' LEU . 33.8 mmtp -85.12 127.32 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.594 -1.185 . . . . 70.2 110.712 -172.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -66.8 136.36 55.33 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.785 -1.191 . . . . 74.12 107.785 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -60.05 100.78 0.1 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.453 1.095 . . . . 75.42 112.389 -163.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -127.35 76.51 76.52 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.633 1.173 . . . . 73.55 108.063 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.69 101.39 1.18 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.108 1.872 . . . . 74.33 111.642 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.01 94.67 9.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.674 -1.602 . . . . 54.45 106.674 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.8 m -84.37 129.76 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.832 -1.076 . . . . 63.44 111.666 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 3.0 mptp? -105.3 124.02 48.83 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.347 1.059 . . . . 63.22 108.577 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 128' ' ' LEU . 5.7 mp -97.52 120.96 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.574 1.15 . . . . 73.41 108.603 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 20.5 m-20 -117.57 111.27 18.99 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.279 -1.008 . . . . 75.24 108.279 167.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD11 HD21 ' A' ' 60' ' ' LEU . 29.7 tp -97.28 135.55 39.03 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.295 -1.002 . . . . 70.44 108.295 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 14.3 t70 -143.33 136.29 27.77 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -122.96 137.9 54.82 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.089 0.556 . . . . 75.42 109.643 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.43 153.17 52.06 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.444 1.098 . . . . 53.3 108.902 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.8 m -134.11 157.35 46.39 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.717 0.407 . . . . 54.45 110.69 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -149.82 119.45 6.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.981 0.912 . . . . 60.42 108.827 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -74.38 122.76 23.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.877 0.471 . . . . 75.22 109.986 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.77 -43.72 7.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.179 0.592 . . . . 73.31 110.154 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.81 -169.54 3.41 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 123.703 0.801 . . . . 74.22 109.991 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.64 126.25 30.64 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.757 -0.831 . . . . 71.22 108.757 169.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.687 ' HA ' ' HB2' ' G' ' 172' ' ' ALA . 17.4 m-20 69.44 -3.03 1.71 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.737 1.615 . . . . 70.35 112.653 -176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 41.1 t -115.4 120.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 N-CA-C 107.924 -1.139 . . . . 53.42 107.924 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.57 170.38 15.82 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.915 -1.143 . . . . 65.31 107.915 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 9.0 tm-20 -127.3 132.17 50.35 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.666 -1.235 . . . . 72.13 107.666 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.76 120.79 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.47 -0.937 . . . . 64.44 108.47 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 43.7 t -95.24 130.92 43.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 123.64 0.776 . . . . 72.44 109.047 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -105.09 107.54 18.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.896 -1.52 . . . . 74.41 106.896 170.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 24.3 ttp180 -100.06 100.79 11.71 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.39 -0.967 . . . . 74.03 108.39 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 t -94.74 137.57 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.834 -1.173 . . . . 75.14 107.834 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.9 m -128.66 126.79 40.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.505 -0.554 . . . . 54.12 109.505 173.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.1 t -122.06 109.5 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.675 1.19 . . . . 75.14 109.537 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 80.0 m -101.41 141.97 33.5 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.429 -0.952 . . . . 54.22 108.429 173.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.07 109.58 14.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.266 -1.013 . . . . 62.55 108.266 173.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 39.8 m -107.46 127.23 53.42 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.343 -0.614 . . . . 64.41 109.343 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 34' ' ' LYS . 22.3 mt -90.75 81.93 5.76 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.518 -1.66 . . . . 73.34 106.518 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.15 -86.4 1.1 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.16 -0.927 . . . . 75.42 110.881 -168.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.1 -19.25 4.4 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 70.12 110.452 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.08 108.02 18.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.855 0.862 . . . . 71.35 110.247 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.1 m -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.293 0.568 . . . . 63.33 111.442 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -54.09 7.69 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.92 1.288 . . . . 72.32 109.455 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -148.92 165.26 32.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.389 -1.278 . . . . 75.45 110.82 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.5 tp -130.89 145.2 51.94 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.666 -1.235 . . . . 73.03 107.666 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -134.54 140.39 46.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.77 0.828 . . . . 72.41 109.268 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.85 117.1 6.43 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.89 -0.781 . . . . 70.44 108.89 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.91 111.34 28.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.773 0.829 . . . . 62.32 109.038 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.6 mt-30 -88.42 82.57 6.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.118 -0.946 . . . . 63.03 109.119 173.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -75.95 93.6 3.26 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.154 -0.93 . . . . 73.14 108.842 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.39 148.9 19.54 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 116.179 -0.464 . . . . 70.43 112.06 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.06 123.97 1.73 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.74 -0.944 . . . . 51.33 110.74 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.4 mt -79.08 127.85 38.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.981 -1.118 . . . . 74.13 107.981 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.89 143.42 50.8 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.398 -0.593 . . . . 71.32 109.398 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 t -112.54 112.98 24.9 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.088 -1.078 . . . . 72.31 108.088 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -129.01 143.42 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.089 0.555 . . . . 72.54 110.011 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.06 175.39 2.29 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.208 1.003 . . . . 74.43 111.215 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 83.72 5.16 88.42 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.392 -0.822 . . . . 74.23 114.478 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -131.31 -179.62 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.337 1.055 . . . . 73.12 109.422 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.9 tt0 -168.37 177.2 5.47 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.085 0.554 . . . . 72.33 110.139 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.86 -121.28 22.74 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 114.969 0.748 . . . . 73.2 114.969 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.6 p -64.67 -30.92 71.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.899 0.88 . . . . 73.33 111.593 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.54 -42.1 71.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.549 0.739 . . . . 62.31 111.041 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -76.55 -30.24 57.0 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.507 -0.315 . . . . 55.12 110.701 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.76 63.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.147 0.579 . . . . 75.31 110.74 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -67.61 -48.56 66.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.174 0.99 . . . . 75.32 110.234 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 20.2 t -74.59 -63.0 1.34 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.544 -0.753 . . . . 71.2 111.001 -172.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 tt -62.36 -38.34 89.16 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.164 0.586 . . . . 75.35 110.698 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.15 -31.1 32.42 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 115.26 0.864 . . . . 72.14 115.26 -168.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -48.37 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.342 1.071 . . . . 54.42 112.569 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 86.4 t80 -66.66 -50.08 64.09 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.615 0.766 . . . . 74.03 112.697 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.426 ' HA ' HG12 ' A' ' 105' ' ' ILE . 63.6 m -72.16 -37.6 4.94 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.554 0.742 . . . . 62.25 112.634 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.65 -40.89 82.16 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.18 1.92 . . . . 71.22 112.478 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.27 -29.4 68.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.553 0.741 . . . . 72.32 111.419 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 102' ' ' CYS . 40.1 mm -60.66 -44.52 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.998 0.904 . . . . 62.11 109.855 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 82' ' ' GLY . 79.2 mt -77.21 -18.77 57.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.166 -1.379 . . . . 64.54 112.176 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -68.42 -41.86 25.62 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.444 1.276 . . . . 63.52 114.444 -168.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.81 -39.03 90.39 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 121.966 1.777 . . . . 72.11 112.906 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -75.1 -36.74 61.67 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.491 0.717 . . . . 75.22 111.608 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.93 -46.83 76.79 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.576 -0.527 . . . . 74.41 109.576 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttm105 -55.22 -47.09 75.81 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 124.552 1.158 . . . . 73.31 110.52 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.554 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 6.7 tm-20 -59.42 -48.69 80.68 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.136 0.897 . . . . 74.43 111.061 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.512 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 51.1 t -57.73 -46.49 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.067 -0.97 . . . . 74.14 111.213 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.5 mt -64.3 -53.19 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.525 0.73 . . . . 64.23 110.612 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 125' ' ' GLN . 60.7 m -53.46 -44.39 68.89 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.799 1.24 . . . . 61.2 112.009 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 43.3 t -72.46 -32.65 66.43 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.298 -0.865 . . . . 61.42 111.166 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -64.29 -43.3 95.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.483 0.713 . . . . 74.22 110.851 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.5 t -62.99 -49.27 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.627 1.171 . . . . 63.05 110.465 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.1 p -67.48 -26.04 66.17 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.846 -0.616 . . . . 24.3 111.6 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 116' ' ' SER . 26.4 ttm-85 -76.93 -26.06 53.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.272 1.029 . . . . 63.54 110.133 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 10.9 61.11 Favored Glycine 0 C--N 1.358 1.803 0 CA-C-N 115.887 -0.597 . . . . 74.14 112.618 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 67.66 36.49 3.63 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.815 1.293 . . . . 74.45 110.472 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -115.57 144.71 32.99 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 114.75 -1.114 . . . . 63.05 108.936 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.28 146.07 52.36 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.01 2.474 . . . . 72.01 113.275 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.595 ' HG3' HG23 ' A' ' 115' ' ' THR . 3.6 tt0 -59.07 140.92 55.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.135 0.974 . . . . 70.23 112.689 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.1 tp -124.86 114.16 18.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.935 0.894 . . . . 75.12 109.402 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -112.05 102.08 10.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.385 0.674 . . . . 63.42 109.505 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.75 127.11 31.54 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.867 -0.79 . . . . 72.03 108.867 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.4 132.03 95.24 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.784 0.834 . . . . 42.03 112.325 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -83.62 140.44 9.37 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.641 2.227 . . . . 32.5 112.153 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.556 HG23 HG23 ' H' ' 207' ' ' VAL . 2.3 p -116.67 125.3 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.96 0.904 . . . . 52.35 109.831 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -92.03 63.81 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 122.218 1.009 . . . . 71.35 110.536 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.58 -30.93 70.68 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 75.33 110.188 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.34 -34.25 77.55 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.766 -1.106 . . . . 63.2 110.588 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.95 -36.4 64.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.363 0.665 . . . . 74.44 110.837 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD11 HG22 ' H' ' 207' ' ' VAL . 88.1 mt -62.53 -33.62 75.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.384 0.673 . . . . 74.33 110.975 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -65.01 -46.89 79.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.11 0.564 . . . . 71.02 109.999 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.4 -49.01 79.26 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.704 0.627 . . . . 70.25 110.633 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HA ' ' HG2' ' A' ' 143' ' ' GLN . 19.9 t30 -53.53 -51.04 64.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.79 1.236 . . . . 73.41 111.528 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.63 -35.92 77.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.51 -0.768 . . . . 63.4 111.881 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.35 -54.39 20.99 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.478 0.486 . . . . 72.34 109.839 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.409 ' H ' ' H ' ' A' ' 143' ' ' GLN . 48.8 mt-30 -161.8 -17.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.799 0.84 . . . . 64.24 111.765 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER 59.19 80.39 0.19 Allowed 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.356 1.063 . . . . 63.33 109.721 -176.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -90.76 120.97 32.23 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.823 0.675 . . . . 72.41 112.823 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.83 178.78 4.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.124 1.369 . . . . 73.34 110.422 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.03 -39.13 0.73 Allowed Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.656 -0.578 . . . . 35.33 111.656 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 65.59 -80.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.826 1.251 . . . . 75.21 111.149 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.95 -124.81 10.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.797 -0.446 . . . . 75.32 113.159 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m 68.16 92.69 0.08 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.454 1.501 . . . . 60.4 111.824 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -149.52 4.23 0.59 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.411 1.085 . . . . 64.21 110.767 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -127.85 149.66 50.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.724 0.809 . . . . 73.55 110.283 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -133.72 -56.17 0.89 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.557 1.143 . . . . 72.32 109.171 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.75 81.83 0.11 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.544 1.137 . . . . 74.53 109.007 -170.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.41 124.1 23.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.427 -0.806 . . . . 61.0 109.95 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.265 0 N-CA-C 108.62 -0.881 . . . . 74.11 108.62 179.597 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.425 -0.584 . . . . 72.01 109.425 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.9 t -151.15 88.55 1.46 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.658 -0.867 . . . . 62.03 108.658 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.77 143.01 27.16 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.536 -0.756 . . . . 70.54 110.458 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -165.7 153.09 10.43 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.746 0.818 . . . . 61.44 109.201 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -138.28 158.99 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.241 0.616 . . . . 64.1 109.45 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -63.51 95.28 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.974 -0.75 . . . . 54.31 108.974 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.407 HG23 ' HA ' ' B' ' 89' ' ' ILE . 3.7 m -119.17 49.54 1.32 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.953 0.882 . . . . 75.53 108.705 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.919 -1.037 . . . . 70.34 108.641 168.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.5 ptm 56.85 170.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.416 2.286 . . . . 75.45 114.923 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p -135.55 127.79 30.09 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.918 -1.037 . . . . 72.45 108.255 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.91 120.67 21.78 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.538 -0.912 . . . . 64.15 108.538 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.56 138.3 29.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.722 0.296 . . . . 72.42 110.243 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.472 HD11 HG13 ' B' ' 16' ' ' ILE . 16.1 tt -82.56 144.48 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.263 1.025 . . . . 61.52 110.031 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -109.28 -49.16 3.15 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.192 0.597 . . . . 72.53 110.035 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.751 HH12 ' HE1' ' G' ' 197' ' ' TYR . 39.3 ttt180 -171.38 146.27 2.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.172 0.589 . . . . 74.43 110.458 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.472 HG13 HD11 ' B' ' 13' ' ' ILE . 51.1 mt -116.47 145.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.191 -1.04 . . . . 74.43 108.191 169.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -168.71 145.47 3.73 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.759 0.423 . . . . 64.33 110.305 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -74.06 122.16 22.24 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.872 -0.788 . . . . 64.44 108.872 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -91.49 -37.45 13.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.619 -0.719 . . . . 74.54 110.341 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.1 t70 -154.3 146.28 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.666 0.27 . . . . 71.52 111.622 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.436 HD11 ' SG ' ' B' ' 113' ' ' CYS . 43.4 mm -138.56 143.73 31.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 125.378 1.471 . . . . 52.42 109.158 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.4 t -141.1 129.21 22.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.862 1.265 . . . . 74.2 108.424 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -143.2 131.9 22.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.096 -1.446 . . . . 74.22 107.096 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -136.01 140.15 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.674 -1.232 . . . . 74.5 107.674 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.667 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -134.85 85.09 36.37 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 107.904 -1.147 . . . . 74.02 107.904 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.95 -29.48 57.64 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.88 2.387 . . . . 70.14 111.99 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.81 28.91 8.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.945 0.898 . . . . 63.44 109.961 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.667 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.2 -52.75 32.86 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 125.429 1.491 . . . . 70.35 113.509 168.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.1 Cg_exo -81.63 -11.74 11.46 Favored 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 122.547 2.165 . . . . 71.4 112.876 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -89.17 3.07 53.14 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.214 1.006 . . . . 72.52 111.576 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.1 -21.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.247 0.619 . . . . 74.23 111.266 169.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -64.76 -40.54 95.44 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.706 0.802 . . . . 61.34 110.16 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.29 -30.03 30.82 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.061 -0.972 . . . . 74.41 111.135 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.79 90.33 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.261 1.025 . . . . 71.52 109.729 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.49 77.35 9.44 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.8 0.84 . . . . 70.24 110.567 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -172.01 156.36 4.04 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.853 0.861 . . . . 74.22 109.419 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.449 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 28.1 tt0 -66.25 125.52 90.4 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.536 1.135 . . . . 50.42 110.778 169.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.25 129.16 20.94 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.129 1.886 . . . . 71.44 110.691 169.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 134.04 48.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 120.933 0.396 . . . . 61.01 109.94 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.437 HG21 ' O ' ' B' ' 124' ' ' PRO . 18.9 t -114.99 127.37 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.9 0.48 . . . . 71.23 111.282 -166.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -134.78 134.28 40.75 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.406 -0.961 . . . . 75.23 108.406 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.563 ' H ' HD23 ' B' ' 42' ' ' LEU . 1.2 pt? -119.5 140.43 50.49 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.962 -1.125 . . . . 74.23 107.962 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -136.81 142.64 42.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.432 0.693 . . . . 61.21 109.389 -167.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.4 ' HG ' HD21 ' B' ' 60' ' ' LEU . 6.6 tt -94.77 138.91 31.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.353 0.661 . . . . 74.34 110.391 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.74 135.83 31.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.564 1.145 . . . . 64.41 108.553 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.0 m -109.65 124.78 51.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.854 0.462 . . . . 73.1 110.646 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.05 156.37 38.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.197 0.999 . . . . 70.45 108.336 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 45.5 p -144.88 170.8 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.8 0.44 . . . . 63.45 110.684 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -150.49 143.66 24.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.614 0.766 . . . . 75.24 109.011 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -94.57 114.98 27.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.406 0.683 . . . . 75.51 110.025 173.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.2 -35.14 21.82 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.343 -0.614 . . . . 71.24 109.343 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.81 3.85 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.922 -1.036 . . . . 74.32 110.104 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.71 126.37 27.37 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.621 -1.172 . . . . 64.33 108.899 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 69.96 -4.36 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.592 1.157 . . . . 52.03 112.987 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.26 103.95 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.524 -0.917 . . . . 72.41 108.524 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' F' ' 175' ' ' PHE . 89.6 m-85 -123.99 137.78 54.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.2 0.524 . . . . 64.3 110.164 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -114.44 105.86 13.62 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.081 -1.451 . . . . 64.22 107.081 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 83.9 t -92.82 125.75 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.309 0.644 . . . . 62.1 109.541 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.2 t -103.04 117.42 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.599 0.76 . . . . 74.03 109.746 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.4 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -93.87 112.11 23.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.144 -0.687 . . . . 52.25 109.144 -177.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 41.9 ttm180 -94.7 114.24 26.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.953 0.501 . . . . 74.41 109.907 171.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.58 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.4 t -114.02 122.26 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.947 -1.131 . . . . 70.12 107.947 169.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -115.71 147.9 40.36 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.171 0.589 . . . . 42.53 110.378 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.613 HG21 HG21 ' B' ' 114' ' ' ILE . 44.5 t -127.3 127.14 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 75.35 109.582 -172.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.5 m -105.0 140.09 38.71 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.808 0.843 . . . . 71.44 109.281 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.4 22.62 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.097 0.959 . . . . 52.03 108.732 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.42 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 73.6 p -146.27 141.08 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.115 0.483 . . . . 53.31 111.529 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 65.6 mt -102.72 109.39 20.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.938 1.295 . . . . 75.15 108.678 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -111.88 3.5 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.02 -0.432 . . . . 42.3 112.02 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.17 10.21 18.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.044 0.938 . . . . 62.23 110.494 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -132.07 144.69 50.91 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.24 0.616 . . . . 74.14 109.821 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -66.91 134.77 52.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.203 0.601 . . . . 74.42 111.49 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -88.71 -58.86 2.4 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.679 -0.86 . . . . 53.14 108.679 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 158.81 39.36 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.318 -1.31 . . . . 74.44 109.925 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -136.37 124.0 22.34 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.18 1.392 . . . . 75.13 107.759 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.34 159.94 23.21 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -164.81 139.38 5.24 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.209 -1.034 . . . . 70.32 108.209 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 67.4 t -129.03 145.69 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 123.887 0.875 . . . . 75.3 108.722 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.9 mt-30 -124.43 85.9 2.48 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.545 -0.909 . . . . 73.11 108.545 174.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -82.67 101.63 10.96 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 114.432 -1.258 . . . . 74.24 109.877 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.65 161.22 29.53 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 121.181 -0.533 . . . . 72.25 112.018 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.11 126.45 1.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.361 -0.696 . . . . 70.11 111.361 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.89 128.12 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.956 -0.757 . . . . 51.32 108.956 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -132.85 163.46 29.04 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.685 1.194 . . . . 74.54 107.945 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 71.6 m -126.75 121.28 31.54 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.199 -1.037 . . . . 63.2 108.199 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.571 HD13 HD11 ' B' ' 89' ' ' ILE . 2.9 pp -128.28 147.03 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 73.24 110.263 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.04 162.63 40.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.547 0.739 . . . . 75.23 109.979 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.28 -28.98 8.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.261 0.464 . . . . 41.31 114.261 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.571 HD11 HD13 ' B' ' 86' ' ' ILE . 44.7 pt -67.83 162.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 60.1 112.865 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -165.35 159.68 17.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.1 -0.955 . . . . 73.3 111.596 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -130.32 50.11 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 124.014 0.821 . . . . 74.0 114.14 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.5 m -70.72 -25.31 62.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.933 0.893 . . . . 70.34 111.087 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.76 -26.91 67.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 74.44 110.623 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.534 ' SD ' ' HB1' ' F' ' 172' ' ' ALA . 18.1 ttt -72.67 -46.04 55.89 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.12 0.568 . . . . 74.03 110.522 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.84 67.14 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.438 -0.801 . . . . 74.1 111.192 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.17 -36.1 35.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.306 0.642 . . . . 72.3 110.716 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -74.74 -67.45 0.63 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.961 0.504 . . . . 73.21 111.914 -173.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.54 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.2 pp -94.27 -20.51 19.74 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.156 0.428 . . . . 75.33 112.156 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.68 -15.44 59.82 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.913 -0.382 . . . . 64.4 113.293 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.96 -52.53 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.206 0.503 . . . . 61.21 112.0 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -76.76 -37.28 56.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.963 0.357 . . . . 75.43 111.963 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 97.9 m -63.43 -51.44 67.58 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.607 -0.711 . . . . 72.32 111.566 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.449 ' HD3' HG11 ' B' ' 58' ' ' VAL . 36.5 Cg_endo -65.48 -17.53 57.65 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 121.763 1.642 . . . . 75.34 113.524 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.34 -42.04 75.83 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 122.864 0.466 . . . . 74.54 110.562 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.507 HG23 ' NH2' ' D' ' 111' ' ' ARG . 69.6 mt -58.92 -41.95 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.068 0.947 . . . . 72.11 110.194 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -84.71 -12.94 52.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.546 -1.206 . . . . 64.43 111.969 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -63.49 -45.14 83.46 Favored Pre-proline 0 C--N 1.359 0.984 0 CA-C-O 117.576 -1.202 . . . . 54.24 112.706 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.13 -42.83 61.96 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.305 2.004 . . . . 62.55 113.177 172.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -70.55 -45.22 65.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.147 -0.933 . . . . 73.32 111.027 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.06 82.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.632 0.773 . . . . 42.21 111.096 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.69 -60.86 3.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.751 1.22 . . . . 72.5 109.236 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.87 -34.53 74.77 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.076 0.86 . . . . 65.43 110.413 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.7 t -60.33 -51.05 71.19 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.203 0.601 . . . . 74.12 111.46 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.613 HG21 HG21 ' B' ' 64' ' ' VAL . 80.8 mt -58.64 -52.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.441 0.696 . . . . 72.44 109.962 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.657 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 2.0 m -64.29 -21.0 66.45 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.903 -1.499 . . . . 75.04 111.236 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -83.55 -40.3 19.3 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.706 1.202 . . . . 64.52 112.061 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.9 mmt -69.12 -39.49 78.87 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.287 0.494 . . . . 52.41 111.926 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.53 -26.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.127 0.571 . . . . 74.35 110.436 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.3 t -64.93 -30.99 72.01 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 74.42 110.321 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.512 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 66.6 mtt-85 -72.81 -33.66 66.36 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.527 0.731 . . . . 71.23 110.129 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.83 -2.56 81.99 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-N 115.753 -0.658 . . . . 55.43 112.833 171.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 17' ' ' TYR . 5.4 t 55.41 34.3 22.68 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.77 2.028 . . . . 73.25 112.694 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.91 157.67 35.47 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.075 0.95 . . . . 71.21 110.851 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.449 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.4 Cg_exo -71.84 87.82 0.82 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.302 2.668 . . . . 71.31 113.771 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.657 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 0.0 OUTLIER -71.78 159.78 33.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.329 0.652 . . . . 43.3 112.225 171.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.446 ' H ' ' NE2' ' B' ' 125' ' ' GLN . 33.1 tp -129.69 123.84 32.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.21 1.804 . . . . 75.02 107.542 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.48 HD21 ' HA ' ' C' ' 122' ' ' THR . 18.7 p-10 -91.5 110.24 21.55 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.09 -0.708 . . . . 71.31 109.09 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.5 137.74 54.64 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 72.3 110.621 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' E' ' 202' ' ' TYR . . . -63.24 141.78 97.78 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.057 0.943 . . . . 72.33 111.503 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.6 106.96 0.79 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.923 2.415 . . . . 44.03 112.74 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -73.89 106.71 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.986 -0.552 . . . . 64.13 110.025 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -79.08 94.75 5.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.263 0.554 . . . . 75.35 109.647 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -74.99 -28.75 60.67 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.161 -0.927 . . . . 71.24 111.25 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.36 -48.07 71.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.725 0.81 . . . . 62.44 111.698 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.19 68.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.853 0.721 . . . . 60.13 111.636 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.461 ' HG ' ' HE1' ' B' ' 140' ' ' TYR . 57.0 tp -70.26 -44.74 67.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.859 0.864 . . . . 73.22 110.261 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -69.63 -25.94 64.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.726 0.811 . . . . 73.11 111.676 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.8 mmt -60.99 -23.34 65.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.176 0.59 . . . . 74.55 111.904 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -81.94 -39.68 23.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.223 0.609 . . . . 74.34 110.237 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.461 ' HE1' ' HG ' ' B' ' 136' ' ' LEU . 44.3 m-85 -73.57 -37.33 65.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.639 0.776 . . . . 74.24 111.566 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.5 mt -90.9 11.75 21.69 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.882 0.873 . . . . 74.42 110.47 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 67.51 156.52 0.12 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.747 1.619 . . . . 70.12 112.188 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -104.1 166.0 10.69 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 65.1 110.914 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -162.07 164.53 28.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.451 1.1 . . . . 53.42 108.99 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.02 -55.1 0.08 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.627 0.371 . . . . 54.04 110.837 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.1 53.56 3.87 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.308 -0.717 . . . . 74.23 111.308 -173.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.17 149.9 31.48 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.234 1.014 . . . . 55.01 111.219 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 105.63 -135.58 12.7 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.311 -1.116 . . . . 72.23 110.311 -169.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.418 HG22 ' H ' ' D' ' 148' ' ' GLY . 1.4 m 58.45 31.03 20.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.293 1.037 . . . . 71.13 110.363 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.91 158.03 29.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.492 1.517 . . . . 74.01 112.623 -169.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 62.22 101.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.766 1.226 . . . . 74.24 112.208 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -166.95 112.18 0.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.781 -0.822 . . . . 75.41 108.781 167.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -66.73 155.19 38.75 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.516 -0.765 . . . . 63.24 110.611 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.61 147.67 24.45 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 75.24 110.33 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.804 0.842 . . . . 63.24 109.272 -179.198 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.959 -0.386 . . . . 74.31 109.959 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -77.96 138.5 38.88 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.503 0.721 . . . . 52.14 110.664 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -84.4 145.01 28.42 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.579 -0.526 . . . . 65.55 109.579 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -85.39 66.38 9.67 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.604 0.716 . . . . 72.04 110.755 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.18 12.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 114.626 -1.17 . . . . 72.45 109.035 173.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.37 151.36 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.665 0.786 . . . . 54.21 109.467 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.505 ' HB ' ' HA3' ' C' ' 88' ' ' GLY . 1.3 m -75.17 -2.14 26.45 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.307 0.643 . . . . 55.31 111.803 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 62.66 35.68 14.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.22 1.008 . . . . 63.43 110.988 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ttt 64.53 115.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.677 1.591 . . . . 74.5 111.814 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m -129.88 118.07 21.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.719 1.208 . . . . 64.31 109.102 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.745 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 53.9 t80 -117.17 127.46 54.14 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.428 -0.952 . . . . 62.3 108.428 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.11 135.04 35.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.427 -0.953 . . . . 74.11 108.427 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.543 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -93.68 114.67 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.377 0.608 . . . . 30.54 109.779 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.481 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.6 mm100 -82.04 -49.26 10.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 75.41 109.906 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.413 HH21 ' HG1' ' D' ' 122' ' ' THR . 71.0 ttt180 -173.55 145.63 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.7 -0.682 . . . . 74.33 109.988 -170.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.543 HG13 HD11 ' C' ' 13' ' ' ILE . 87.0 mt -128.12 144.63 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.503 -1.295 . . . . 45.41 107.503 171.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.455 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.0 p90 -174.71 166.57 3.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.452 0.644 . . . . 72.32 110.77 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -88.16 105.91 17.83 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.003 -0.999 . . . . 55.32 109.44 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -65.68 -36.28 83.19 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.547 0.689 . . . . 73.33 109.487 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.5 t70 -149.13 142.94 25.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.542 -1.208 . . . . 70.13 109.63 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -136.91 139.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.358 -1.719 . . . . 70.43 106.358 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.46 143.49 22.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.376 -0.602 . . . . 73.52 109.376 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -143.65 113.93 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.558 -1.275 . . . . 74.23 107.558 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -116.57 119.77 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.669 -0.864 . . . . 73.24 108.669 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.77 82.21 67.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.673 -1.232 . . . . 65.32 107.673 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.11 -37.29 33.2 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.572 2.181 . . . . 74.21 111.574 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.68 31.3 3.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.28 -1.327 . . . . 72.1 110.474 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 86.26 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 113.956 1.095 . . . . 75.31 113.956 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.18 -19.73 6.59 Favored 'Trans proline' 0 C--N 1.385 2.457 0 CA-C-N 121.298 1.499 . . . . 71.4 112.818 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.84 -33.53 70.76 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.189 0.996 . . . . 73.1 112.271 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.497 HG23 HD11 ' C' ' 68' ' ' LEU . 12.4 p -78.61 -10.63 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.064 0.946 . . . . 73.32 111.943 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -57.51 -40.63 79.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.852 0.861 . . . . 74.44 112.207 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -105.79 41.91 1.32 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.967 0.889 . . . . 71.24 109.248 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.3 tppp? -125.38 155.94 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.42 0.688 . . . . 70.05 110.443 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.56 127.11 31.57 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.332 0.653 . . . . 64.51 109.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.46 95.49 9.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.585 -0.734 . . . . 70.43 110.815 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.07 68.7 81.28 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.335 -0.987 . . . . 61.51 108.335 167.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.71 111.46 3.33 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.363 2.042 . . . . 74.5 110.57 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' E' ' 190' ' ' ASP . 38.2 mt-10 -85.09 92.82 8.47 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.649 -1.241 . . . . 74.42 107.649 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.428 HG21 HD22 ' C' ' 126' ' ' LEU . 40.1 t -81.58 86.16 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.225 -1.352 . . . . 72.12 110.633 -168.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -91.26 105.28 17.68 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.372 -1.344 . . . . 64.12 107.372 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.51 HD23 HD12 ' C' ' 128' ' ' LEU . 0.5 OUTLIER -87.85 160.71 17.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.367 0.603 . . . . 71.41 111.209 177.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.628 ' HA ' HD13 ' E' ' 186' ' ' LEU . 4.5 m-20 -137.05 144.18 43.06 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.737 1.215 . . . . 64.01 108.775 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 46.4 tp -131.45 105.34 7.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.489 -0.93 . . . . 73.4 108.489 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 20.0 t70 -113.33 140.15 48.26 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 74.12 109.26 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -114.4 134.08 55.25 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.18 0.592 . . . . 63.44 109.959 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.96 151.66 46.71 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.335 1.054 . . . . 64.1 108.407 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 73.8 m -138.42 149.21 45.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.261 0.625 . . . . 75.24 110.556 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -150.21 158.87 44.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.396 1.079 . . . . 62.14 109.503 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -102.51 138.91 38.8 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.198 -1.038 . . . . 61.44 108.198 168.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' C' ' 57' ' ' GLU . 89.3 mt -109.86 -37.03 5.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.523 0.729 . . . . 63.4 110.226 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 -167.51 1.71 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.228 0.611 . . . . 32.44 110.744 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.81 109.41 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.825 -1.079 . . . . 62.32 111.484 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.49 9.59 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.847 1.259 . . . . 72.24 111.968 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.28 118.78 54.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.535 1.134 . . . . 71.11 109.279 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.87 162.35 14.9 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.165 0.986 . . . . 72.44 110.322 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.9 tt0 -127.22 116.66 20.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.9 -1.045 . . . . 74.13 108.453 165.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -106.64 124.74 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.716 -1.216 . . . . 74.13 107.716 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.44 119.15 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.778 0.831 . . . . 63.14 109.341 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' C' ' 103' ' ' PRO . 38.5 mt -88.41 118.44 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.091 0.556 . . . . 74.45 110.683 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 33.4 mtm105 -82.65 105.23 13.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.687 -1.227 . . . . 75.41 107.687 164.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -109.12 117.23 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.878 -1.156 . . . . 61.43 107.878 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -123.12 126.01 46.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.858 0.463 . . . . 62.04 109.91 -171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.552 HG23 HD13 ' C' ' 114' ' ' ILE . 54.5 t -107.65 113.69 44.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.484 0.714 . . . . 44.45 109.109 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.424 HG23 HD23 ' C' ' 75' ' ' LEU . 5.8 m -99.48 140.37 33.76 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.311 -0.996 . . . . 70.31 108.311 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.8 108.66 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.925 -0.768 . . . . 51.51 108.925 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.2 m -130.17 140.65 50.74 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.202 0.525 . . . . 63.25 110.255 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.497 HD11 HG23 ' C' ' 31' ' ' VAL . 12.3 mt -93.39 40.75 1.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.337 1.455 . . . . 75.04 109.159 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.07 -112.36 4.12 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.125 -1.59 . . . . 73.33 109.125 -163.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.2 -27.53 19.48 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.336 0.655 . . . . 43.31 110.117 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.86 92.28 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.628 1.171 . . . . 64.31 110.393 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 117.97 12.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.387 0.613 . . . . 74.43 110.164 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.99 25.92 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.363 -1.289 . . . . 40.42 109.75 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -163.62 172.98 13.55 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.628 -0.715 . . . . 75.34 111.849 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.424 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -144.38 116.89 8.59 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.102 -1.444 . . . . 70.51 107.102 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -115.68 145.74 42.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.639 0.775 . . . . 72.41 109.492 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.11 135.6 20.64 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.703 0.401 . . . . 63.12 110.031 171.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.71 118.2 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.486 1.115 . . . . 71.15 108.798 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.9 mt-30 -90.14 93.71 9.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.83 -0.804 . . . . 70.14 108.83 172.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -83.2 107.87 16.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.445 -0.798 . . . . 74.24 109.921 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.56 146.33 18.11 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.165 -0.47 . . . . 41.41 112.21 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.45 126.3 3.13 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 111.129 -0.789 . . . . 63.0 111.129 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.0 mm -91.04 124.93 43.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.26 -1.015 . . . . 64.25 108.26 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.42 119.52 21.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.289 0.636 . . . . 62.42 109.468 -175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -87.6 100.02 12.48 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.28 -1.378 . . . . 65.51 107.28 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.476 HG13 ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -143.8 133.79 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.469 0.652 . . . . 74.33 110.904 -170.415 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.03 -177.22 5.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.074 1.35 . . . . 55.12 109.132 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.505 ' HA3' ' HB ' ' C' ' 7' ' ' THR . . . 87.63 -18.81 36.32 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 114.712 0.645 . . . . 55.0 114.712 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 158.1 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.015 0.926 . . . . 62.33 111.819 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -148.98 -173.61 4.41 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.409 -0.589 . . . . 72.42 109.409 171.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.43 -152.38 21.17 Favored Glycine 0 C--N 1.359 1.827 0 N-CA-C 114.3 0.48 . . . . 33.25 114.3 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -64.53 -32.11 73.62 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.3 0.64 . . . . 53.01 111.49 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.458 ' HB2' ' HA3' ' C' ' 146' ' ' GLY . 74.4 mt-30 -52.62 -32.57 42.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.849 0.86 . . . . 64.41 111.854 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.508 ' HG3' ' SD ' ' E' ' 174' ' ' MET . 38.1 ttm -58.67 -62.89 1.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.796 0.838 . . . . 73.44 111.417 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.43 ' HB1' ' CE2' ' E' ' 181' ' ' TYR . . . -71.2 -27.4 63.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.623 -0.717 . . . . 43.51 111.708 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -77.3 -22.99 51.13 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 71.5 110.314 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.7 t -71.96 -64.03 1.02 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.329 0.252 . . . . 61.42 110.44 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.471 ' HG ' HD12 ' E' ' 177' ' ' LEU . 2.5 pt? -79.24 -16.44 56.47 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 122.259 -0.275 . . . . 75.11 110.986 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.21 -26.05 27.05 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.691 0.636 . . . . 72.12 114.691 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.06 -40.2 0.25 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.489 0.922 . . . . 52.4 113.489 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -74.56 -48.64 25.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.048 0.539 . . . . 73.52 111.234 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.745 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 56.0 m -66.13 -45.1 61.85 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.313 0.645 . . . . 44.22 110.184 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.666 ' HB3' HD21 ' C' ' 60' ' ' LEU . 76.2 Cg_exo -52.38 -38.59 73.78 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.417 2.078 . . . . 75.33 115.01 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -63.66 -30.6 71.69 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 123.252 0.621 . . . . 74.32 111.209 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -65.62 -39.28 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.744 0.817 . . . . 71.3 110.489 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -88.94 -21.57 23.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.744 0.818 . . . . 71.1 112.353 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.77 -46.4 99.74 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.131 0.972 . . . . 73.24 113.039 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.554 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 23.7 Cg_exo -60.96 -40.14 55.04 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.872 1.714 . . . . 71.44 112.526 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -63.81 -46.15 86.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.571 0.748 . . . . 74.24 111.459 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.65 -43.46 93.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.369 0.668 . . . . 52.44 110.87 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -56.87 -50.88 71.14 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.011 1.324 . . . . 45.12 110.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.2 -41.41 85.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.785 0.834 . . . . 55.4 110.54 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.4 t -66.52 -30.87 71.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.539 0.735 . . . . 73.4 111.987 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.561 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.7 mt -72.58 -50.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.837 0.455 . . . . 60.4 110.086 173.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.538 HG22 ' NE2' ' C' ' 125' ' ' GLN . 10.3 m -61.99 -27.81 69.12 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.106 0.562 . . . . 74.14 110.67 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.3 t -60.73 -51.76 67.99 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.161 0.984 . . . . 73.42 110.076 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.493 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.86 -38.96 83.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.582 1.153 . . . . 51.34 112.618 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.63 -39.73 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.271 0.628 . . . . 73.33 110.25 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -60.23 -42.96 96.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.66 0.784 . . . . 64.43 110.89 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' C' ' 116' ' ' SER . 89.2 mtt-85 -63.12 -34.0 76.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.723 -0.671 . . . . 71.12 111.38 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.46 12.51 58.64 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.156 -0.802 . . . . 73.21 113.536 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.48 ' HA ' HD21 ' B' ' 127' ' ' ASN . 70.3 p 55.23 42.81 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.421 1.488 . . . . 75.43 112.277 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.6 154.27 44.74 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 107.972 -1.122 . . . . 75.14 107.972 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.72 148.15 36.27 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.322 2.015 . . . . 75.0 112.225 -171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.538 ' NE2' HG22 ' C' ' 115' ' ' THR . 12.8 mm100 -62.76 110.43 1.74 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.667 0.988 . . . . 74.23 113.667 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.428 HD22 HG21 ' C' ' 40' ' ' VAL . 65.1 mt -92.21 76.13 5.33 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.416 0.686 . . . . 72.31 109.884 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -92.31 89.41 6.83 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.01 -0.995 . . . . 63.25 109.356 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.51 HD12 HD23 ' C' ' 42' ' ' LEU . 12.7 mt -86.74 153.04 22.01 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.415 -1.266 . . . . 74.42 109.841 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.19 120.11 2.34 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 125.633 1.573 . . . . 74.22 113.633 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.62 94.48 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.666 2.244 . . . . 71.55 111.145 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.56 98.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-N 114.965 -1.016 . . . . 74.25 111.383 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.408 ' C ' HD21 ' C' ' 132' ' ' ASN . 0.2 OUTLIER -75.76 87.15 2.78 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.197 -0.91 . . . . 62.4 108.952 175.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' E' ' 182' ' ' PHE . 86.6 t80 -54.86 -39.17 68.34 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 64.44 112.631 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.39 -36.87 85.54 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.666 0.603 . . . . 53.34 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.71 83.89 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.739 0.649 . . . . 72.52 112.086 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.538 HD11 HG11 ' F' ' 207' ' ' VAL . 10.2 mp -64.83 -42.25 95.09 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.54 0.525 . . . . 74.15 110.088 176.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.6 -42.51 78.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.188 -0.301 . . . . 74.22 110.188 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.647 ' SD ' ' HG3' ' C' ' 142' ' ' GLN . 50.2 tpp -62.92 -35.15 79.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.332 1.053 . . . . 71.15 110.523 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -66.45 -52.48 45.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.119 1.368 . . . . 74.02 110.502 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.569 ' HB3' HD22 ' C' ' 141' ' ' LEU . 3.6 m-85 -69.93 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.389 1.075 . . . . 73.04 110.16 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' C' ' 140' ' ' TYR . 2.6 mm? -109.79 100.16 9.2 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.691 0.796 . . . . 72.41 109.902 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.647 ' HG3' ' SD ' ' C' ' 138' ' ' MET . 52.9 tt0 -75.18 -4.83 41.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.526 0.731 . . . . 63.01 111.39 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -72.83 77.93 1.14 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.713 0.805 . . . . 74.34 110.606 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -107.33 115.68 30.59 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.001 -1.111 . . . . 72.24 108.001 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.24 150.07 52.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 72.54 110.286 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' C' ' 93' ' ' GLN . . . 169.99 35.37 0.03 OUTLIER Glycine 0 CA--C 1.502 -0.746 0 C-N-CA 121.123 -0.561 . . . . 53.42 113.394 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -144.16 -162.63 1.51 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 106.821 -1.548 . . . . 62.24 106.821 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.46 41.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.997 0 N-CA-C 110.398 -1.081 . . . . 70.24 110.398 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 35.4 p -122.5 161.57 23.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.085 0.954 . . . . 71.01 110.576 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -140.57 -74.33 0.34 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.97 -1.863 . . . . 64.24 105.97 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.08 159.52 28.64 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.702 -0.681 . . . . 71.04 109.854 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -154.91 98.39 2.03 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.85 0.86 . . . . 62.43 108.972 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.41 149.65 31.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.767 -0.651 . . . . 55.34 110.02 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.52 113.07 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.039 0.837 . . . . 62.32 109.884 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 N-CA-C 108.17 -1.048 . . . . 75.41 108.17 178.649 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.35 -0.241 . . . . 61.54 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -143.13 27.52 1.59 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.596 0.758 . . . . 42.11 109.202 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.17 138.85 31.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.943 -0.571 . . . . 72.25 110.393 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.51 87.0 2.9 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.456 -0.942 . . . . 73.44 108.456 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -167.56 -152.84 0.13 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.707 -0.849 . . . . 55.22 108.707 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 71.41 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.701 1.6 . . . . 62.41 110.514 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p -134.47 161.65 34.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.274 1.03 . . . . 74.32 109.511 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.48 149.13 47.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.213 0.605 . . . . 73.3 110.013 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.2 ttp -34.72 130.01 0.41 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.107 0.963 . . . . 63.34 112.952 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -139.48 145.18 38.46 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.638 0.775 . . . . 42.42 109.067 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -154.37 105.68 2.69 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.862 -1.162 . . . . 75.12 107.862 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 74.9 mt-30 -117.34 115.94 26.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.992 0.517 . . . . 73.33 110.188 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -87.01 126.19 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.455 -0.943 . . . . 62.44 108.455 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.446 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.1 mt-30 -109.26 -47.53 3.39 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.114 0.413 . . . . 61.4 112.114 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -165.45 121.81 1.4 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.06 128.14 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.773 0.829 . . . . 71.55 109.057 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' C' ' 122' ' ' THR . 40.3 p90 -161.99 174.58 12.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.95 0.881 . . . . 73.22 111.52 -171.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.51 120.68 40.67 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.72 -1.127 . . . . 63.15 108.985 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -84.77 -37.59 20.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.541 -0.54 . . . . 55.53 109.541 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.8 137.96 24.13 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.078 -0.965 . . . . 75.34 109.088 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' C' ' 117' ' ' MET . 74.9 mt -131.44 139.68 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 73.33 108.08 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.97 134.36 33.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.139 0.975 . . . . 70.1 108.812 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -146.94 116.18 6.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.614 -1.625 . . . . 72.31 106.614 170.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -122.23 144.35 49.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 72.44 109.499 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.706 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -134.25 75.2 65.68 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.896 -1.15 . . . . 60.33 107.896 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.96 -27.18 10.32 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.748 2.299 . . . . 63.41 113.081 -170.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -115.21 27.08 9.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.449 0.699 . . . . 60.24 109.978 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.706 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.95 -56.15 30.98 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 115.272 1.582 . . . . 62.04 115.272 -167.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.96 -6.23 13.14 Favored 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-N 121.474 1.562 . . . . 73.22 112.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.75 -44.46 17.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.642 1.177 . . . . 63.53 110.094 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.18 2.42 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.061 0.545 . . . . 74.34 111.202 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.439 ' HA ' ' CE2' ' H' ' 197' ' ' TYR . 63.9 t80 -58.25 -33.82 69.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.137 0.975 . . . . 73.13 110.34 165.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.59 -23.46 58.74 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.622 -1.172 . . . . 75.12 111.004 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -88.62 79.03 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 72.13 110.419 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.616 ' HB2' ' HD3' ' H' ' 196' ' ' LYS . 6.3 p-10 -87.17 57.49 4.5 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.199 1.0 . . . . 72.11 110.894 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -125.86 175.87 7.35 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.884 1.274 . . . . 72.33 108.425 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -72.44 112.79 16.24 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 119.194 -0.431 . . . . 72.43 109.969 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.08 113.73 2.15 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.524 2.149 . . . . 61.13 111.889 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.77 112.42 6.21 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.09 0.869 . . . . 73.43 109.655 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 m -99.65 122.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 73.25 110.045 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -104.56 112.57 25.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 74.44 108.498 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.551 HD21 HD22 ' D' ' 128' ' ' LEU . 6.8 mp -95.22 142.25 27.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.345 0.658 . . . . 74.35 110.093 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.2 t70 -132.61 137.09 46.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.633 -0.877 . . . . 63.51 108.633 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.448 HD13 HD21 ' H' ' 186' ' ' LEU . 22.6 tp -115.12 129.59 56.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.295 -0.631 . . . . 73.34 109.295 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.98 148.02 44.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.289 1.035 . . . . 73.4 108.389 172.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.428 ' H ' ' HG3' ' H' ' 180' ' ' PRO . 88.6 m -128.97 150.59 50.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.166 0.987 . . . . 71.42 108.718 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.94 164.15 35.39 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.039 0.936 . . . . 62.33 109.755 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 96.5 p -167.43 155.33 9.12 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.5 0.72 . . . . 70.2 111.089 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -156.42 130.91 8.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.886 0.874 . . . . 70.51 109.031 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.74 126.13 27.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.836 0.454 . . . . 73.42 110.244 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.1 mt -98.69 -35.99 10.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.052 0.541 . . . . 72.12 110.183 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -159.25 -171.28 3.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.333 0.653 . . . . 72.43 111.186 -176.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.12 110.81 3.11 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.257 -0.883 . . . . 75.01 109.797 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 67.73 1.71 2.74 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.247 1.419 . . . . 71.43 112.707 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 52.2 t -110.24 134.16 53.3 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 123.87 0.868 . . . . 62.32 108.999 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -151.68 174.67 13.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.862 0.865 . . . . 71.03 109.08 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.0 tt0 -120.11 132.75 55.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.651 0.78 . . . . 73.41 109.127 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' D' ' 102' ' ' CYS . 58.5 t -100.24 132.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 108.045 -1.094 . . . . 65.1 108.045 168.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.0 t -111.12 136.15 48.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.48 -0.933 . . . . 63.13 108.48 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.87 127.49 56.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.138 -1.06 . . . . 74.33 108.138 179.119 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 35.3 ttm-85 -109.86 106.98 16.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.976 -0.749 . . . . 54.42 108.976 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -105.95 106.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 107.756 -1.201 . . . . 61.43 107.756 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 7.6 m -106.09 129.6 54.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.707 0.403 . . . . 54.43 110.183 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.64 102.89 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.719 1.208 . . . . 62.14 109.218 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -96.6 95.94 8.3 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.445 -0.946 . . . . 74.24 108.445 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 147.58 23.67 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.171 0.589 . . . . 62.1 110.495 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.568 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.4 p -155.8 129.16 8.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.564 0.697 . . . . 65.53 111.829 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 13.2 mt -92.51 98.33 11.39 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.695 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.04 -123.88 10.96 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.827 0.704 . . . . 73.43 112.133 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.92 5.98 37.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.17 0.588 . . . . 64.11 111.28 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -129.37 143.93 51.04 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.225 0.61 . . . . 54.01 110.8 -169.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.2 m -70.45 127.85 34.16 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.378 0.671 . . . . 73.43 110.982 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.568 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.67 -66.13 0.93 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.139 -1.059 . . . . 63.24 108.139 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.49 152.08 36.26 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.019 -0.991 . . . . 71.24 110.167 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.5 mt -104.93 147.11 28.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.573 -1.269 . . . . 73.35 107.573 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.5 t -156.92 143.4 18.26 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.87 -0.418 . . . . 55.21 109.87 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -157.15 141.23 16.26 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.505 -0.924 . . . . 64.32 108.505 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -135.51 116.64 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 71.51 109.555 175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -89.88 84.04 6.2 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.876 0.845 . . . . 72.24 108.889 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.41 ' O ' HD13 ' D' ' 106' ' ' LEU . 59.8 tp60 -79.88 100.33 7.98 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.208 -1.36 . . . . 64.11 109.292 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.58 143.87 16.47 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 111.683 -0.567 . . . . 54.52 111.683 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.97 139.26 6.82 Favored Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.279 -0.729 . . . . 72.2 111.279 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 49.0 mt -88.72 127.54 41.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 122.962 0.505 . . . . 63.52 109.91 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.68 146.27 52.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 72.22 109.49 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.5 m -116.32 105.14 12.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.356 0.663 . . . . 63.53 109.489 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.576 ' HB ' HD11 ' D' ' 89' ' ' ILE . 18.3 pt -109.33 142.4 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.413 0.551 . . . . 54.04 109.983 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.26 145.14 19.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.188 -0.915 . . . . 72.53 109.449 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.03 -10.05 61.79 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.108 0.403 . . . . 72.41 114.108 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.576 HD11 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -124.76 130.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.424 0.69 . . . . 72.24 110.368 -172.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.621 ' HG2' ' HG ' ' H' ' 173' ' ' LEU . 20.8 mt-10 -131.73 167.74 18.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.985 0.514 . . . . 61.34 111.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.43 -134.89 42.07 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.139 0.899 . . . . 53.31 113.208 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -66.39 -23.72 66.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.241 0.616 . . . . 63.43 111.608 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -66.52 -34.17 77.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.331 0.652 . . . . 65.43 110.912 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.524 ' HB3' HG12 ' D' ' 89' ' ' ILE . 3.2 ppp? -88.16 -27.76 21.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.433 0.293 . . . . 60.45 111.054 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.59 65.2 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.977 0.511 . . . . 71.3 111.879 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 8.0 t-160 -84.56 -10.74 57.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.696 0.799 . . . . 71.43 110.338 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.03 -45.61 9.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.348 0.659 . . . . 54.32 109.543 170.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.93 -39.29 72.76 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.015 0.926 . . . . 54.55 111.432 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.16 12.44 67.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.068 -0.515 . . . . 51.35 113.018 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.54 -75.88 0.17 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.988 0.515 . . . . 61.01 111.716 -176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -72.74 -44.69 61.34 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.948 0.721 . . . . 61.43 112.948 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.485 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 61.7 m -61.52 -48.44 90.48 Favored Pre-proline 0 CA--C 1.567 1.626 0 CA-C-O 118.771 -0.633 . . . . 62.04 112.162 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.549 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 10.0 Cg_exo -72.76 -18.89 24.59 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.036 1.824 . . . . 75.53 112.977 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.31 -28.73 64.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.795 0.438 . . . . 44.43 110.563 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.11 -41.78 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-O 121.598 0.713 . . . . 71.42 109.413 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.41 HD13 ' O ' ' D' ' 80' ' ' GLN . 92.4 mt -74.72 -20.91 59.65 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.863 -1.062 . . . . 64.41 111.722 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.16 -41.42 14.29 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.252 1.205 . . . . 64.01 114.252 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -56.14 -36.04 95.91 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 121.762 1.641 . . . . 53.3 112.881 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.13 -32.82 33.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.81 0.844 . . . . 73.34 111.552 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.6 -50.74 63.94 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.584 -0.524 . . . . 74.54 109.584 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.507 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.7 ttp180 -58.31 -50.27 74.23 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.031 -1.441 . . . . 75.1 110.51 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -63.06 -42.43 99.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.46 0.704 . . . . 72.41 111.643 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.2 t -59.47 -44.86 92.92 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.767 0.667 . . . . 72.24 110.944 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.436 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.3 mt -62.41 -57.24 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.612 0.765 . . . . 75.34 110.092 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.524 HG23 ' HG3' ' D' ' 125' ' ' GLN . 83.8 m -50.12 -43.83 51.93 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.533 1.533 . . . . 70.14 112.477 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.99 -44.66 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 70.34 110.486 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -64.48 -33.78 76.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.909 0.484 . . . . 74.14 111.43 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 79.4 t -64.61 -45.8 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.108 0.963 . . . . 52.12 110.049 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.03 -27.98 63.07 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.683 0.278 . . . . 61.34 111.085 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -71.68 -30.59 65.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.6 0.76 . . . . 72.21 110.138 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 6.64 80.11 Favored Glycine 0 C--N 1.358 1.781 0 O-C-N 123.66 0.6 . . . . 60.34 112.731 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.455 HG23 ' HB3' ' C' ' 17' ' ' TYR . 51.0 p 65.41 21.28 11.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.309 1.844 . . . . 71.51 113.09 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.26 164.89 18.01 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 124.82 1.248 . . . . 72.34 109.314 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.07 140.34 22.52 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.394 2.063 . . . . 63.42 112.266 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.524 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.8 tt0 -55.75 126.65 26.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 75.23 111.013 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.93 105.65 15.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.411 0.684 . . . . 75.13 109.209 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -98.48 92.81 5.83 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.718 -0.845 . . . . 73.12 108.718 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.551 HD22 HD21 ' D' ' 42' ' ' LEU . 76.3 mt -69.89 123.33 21.2 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.098 0.559 . . . . 75.14 109.555 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' H' ' 187' ' ' ILE . . . -56.21 133.05 75.33 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.254 0.621 . . . . 54.3 111.145 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.65 108.66 2.3 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 121.877 1.718 . . . . 63.14 110.17 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.7 107.25 22.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.809 -1.182 . . . . 73.41 107.809 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.42 93.0 5.67 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.141 -0.936 . . . . 75.23 108.682 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' H' ' 184' ' ' TRP . 76.1 t80 -62.2 -19.29 62.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.483 -1.235 . . . . 72.32 111.189 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' D' ' 138' ' ' MET . 0.5 OUTLIER -58.19 -69.31 0.18 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.421 -0.799 . . . . 54.43 109.593 171.158 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.22 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.36 0.527 . . . . 64.24 112.064 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.0 -35.54 78.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.287 1.035 . . . . 70.21 111.952 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -101.17 -25.47 14.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.602 0.761 . . . . 63.04 111.716 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 29.1 ttm -54.39 -38.63 66.38 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 124.47 1.108 . . . . 75.42 112.301 -170.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -64.34 -40.45 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.62 -1.173 . . . . 73.54 110.884 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -55.56 -44.3 76.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.934 0.894 . . . . 75.02 112.131 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -57.83 -50.41 73.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.02 0.438 . . . . 72.44 110.649 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -86.28 3.92 41.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.972 -1.013 . . . . 72.31 112.188 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -125.72 62.22 1.23 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.83 0.852 . . . . 55.45 109.731 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -144.02 160.0 41.63 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.207 1.003 . . . . 71.34 109.097 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.02 -50.44 28.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.542 0.737 . . . . 23.33 111.206 -172.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.37 -102.02 0.78 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.368 -0.693 . . . . 43.25 111.368 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.18 155.21 17.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.464 0.705 . . . . 53.3 110.35 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 148' ' ' GLY . . . . . 0.418 ' H ' HG22 ' B' ' 149' ' ' THR . . . 165.7 51.63 0.02 OUTLIER Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.972 -0.558 . . . . 42.52 111.734 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 90.9 m -134.11 122.71 23.29 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.448 -0.575 . . . . 25.33 109.448 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.96 81.04 2.17 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.706 0.802 . . . . 61.11 109.069 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.35 161.3 31.02 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.579 -1.192 . . . . 73.02 111.174 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -142.71 154.7 44.55 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.739 -1.119 . . . . 75.22 108.604 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.18 148.13 37.95 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.158 -0.682 . . . . 54.24 109.158 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -71.6 90.89 1.05 Allowed 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.242 1.02 . . . . 75.22 109.359 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.858 -1.065 . . . . 63.21 108.853 -177.306 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 108.653 -0.869 . . . . 74.43 108.653 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -75.39 -96.73 0.13 Allowed Glycine 0 C--N 1.349 1.288 0 N-CA-C 111.217 -0.753 . . . . 71.12 111.217 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -145.26 -72.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.722 0.809 . . . . 73.54 109.3 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 51.6 p -164.7 15.21 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.35 -0.841 . . . . 63.11 110.123 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 68.67 158.5 0.16 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.164 1.386 . . . . 52.32 110.855 -161.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.539 ' H ' HD23 ' E' ' 173' ' ' LEU . 2.3 pt? -85.02 37.13 0.65 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.536 0.734 . . . . 71.41 111.608 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.663 ' HG3' ' H ' ' E' ' 175' ' ' PHE . 12.2 ptt? -152.23 -96.45 0.05 Allowed 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.516 0.932 . . . . 73.31 113.516 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.663 ' H ' ' HG3' ' E' ' 174' ' ' MET . 4.8 t80 54.03 30.84 12.54 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.132 1.373 . . . . 74.4 110.463 -155.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.04 90.18 8.29 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 115.186 -0.915 . . . . 73.51 109.54 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 177' ' ' LEU . . . . . 0.471 HD12 ' HG ' ' C' ' 98' ' ' LEU . 1.7 tt -159.79 106.64 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.034 -1.469 . . . . 63.53 107.034 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -132.18 7.5 4.28 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.491 1.116 . . . . 71.34 109.036 172.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.0 151.27 4.75 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.541 1.537 . . . . 74.15 108.617 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.54 -8.3 22.32 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.091 2.527 . . . . 75.51 113.63 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 181' ' ' TYR . . . . . 0.43 ' CE2' ' HB1' ' C' ' 95' ' ' ALA . 94.7 m-85 66.0 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.247 1.419 . . . . 73.12 111.015 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 182' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' C' ' 133' ' ' PHE . 28.2 t80 -91.4 144.24 25.79 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.969 -1.123 . . . . 64.12 107.969 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 41.3 p -90.41 124.51 35.01 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.34 0.656 . . . . 75.41 111.454 -173.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.421 ' HA ' ' HD3' ' E' ' 185' ' ' PRO . 2.8 p90 -85.93 125.65 67.99 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.781 0.432 . . . . 71.22 110.045 169.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 185' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' E' ' 184' ' ' TRP . 8.3 Cg_exo -73.45 131.96 16.96 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.149 2.566 . . . . 72.24 112.115 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.628 HD13 ' HA ' ' C' ' 43' ' ' ASP . 73.7 mt -110.87 127.35 55.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.525 0.73 . . . . 60.23 109.707 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 pt -97.63 167.56 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.237 1.015 . . . . 71.24 111.971 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.24 81.79 2.04 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.066 0.946 . . . . 64.24 109.324 174.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.37 91.99 0.78 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.259 1.024 . . . . 75.12 111.979 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 190' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' C' ' 39' ' ' GLU . 6.8 p-10 -66.4 122.68 18.07 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.123 -0.695 . . . . 52.44 109.123 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.96 131.36 30.82 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.537 -0.591 . . . . 72.5 111.833 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.31 72.74 0.95 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 111.277 -0.729 . . . . 53.44 111.277 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 63.81 -85.48 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.907 1.683 . . . . 63.52 111.738 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 70.51 142.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.061 1.345 . . . . 73.32 111.71 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 66.64 171.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.205 1.402 . . . . 74.01 111.849 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -164.48 93.02 0.65 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.618 -0.882 . . . . 72.12 108.618 168.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.35 63.86 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.2 0.6 . . . . 71.44 110.117 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -113.04 5.6 17.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.089 0.556 . . . . 72.23 110.844 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -83.04 15.42 2.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.378 0.671 . . . . 62.25 111.633 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.37 85.96 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.362 -0.688 . . . . 45.12 113.18 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' E' ' 201' ' ' LYS . 1.1 tpmt? -170.98 -81.18 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.379 0.672 . . . . 72.35 111.367 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 202' ' ' TYR . . . . . 0.471 ' HB3' HG12 ' E' ' 204' ' ' ILE . 71.4 t80 -138.36 -169.69 2.65 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 107.681 -1.229 . . . . 71.14 107.681 -167.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.41 -24.0 66.21 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.423 0.689 . . . . 73.32 111.113 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' E' ' 202' ' ' TYR . 31.5 pt -81.63 166.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.322 0.582 . . . . 74.5 111.028 172.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -98.14 39.69 1.22 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.085 -0.962 . . . . 65.05 109.736 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.46 -159.76 0.31 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.299 1.04 . . . . 75.14 109.792 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.256 1.445 0 N-CA-C 109.219 -0.66 . . . . 72.52 109.219 176.128 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.365 0.126 . . . . 61.41 110.688 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.45 177.71 31.26 Favored Glycine 0 C--N 1.356 1.651 0 O-C-N 123.852 0.72 . . . . 72.42 113.06 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 32.66 4.7 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.585 -0.894 . . . . 64.51 108.585 172.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 45.4 m -70.23 86.8 0.58 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.05 0.94 . . . . 71.03 110.474 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 172' ' ' ALA . . . . . 0.534 ' HB1' ' SD ' ' B' ' 94' ' ' MET . . . -163.11 113.55 1.4 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.418 -0.956 . . . . 73.23 108.418 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.7 tt -170.14 -64.04 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.155 -1.424 . . . . 72.55 107.155 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 29.5 mmt -108.96 98.94 8.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.964 0.906 . . . . 71.24 110.194 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 175' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 20.8 t80 53.59 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.124 1.77 . . . . 73.2 113.72 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 56.7 t30 179.9 130.87 0.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.004 0.922 . . . . 71.31 109.936 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 mp -99.26 80.19 2.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.186 -1.413 . . . . 71.12 107.186 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -70.8 114.4 8.84 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.969 -1.014 . . . . 75.41 111.131 -174.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.99 118.72 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 125.391 1.476 . . . . 62.13 113.184 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.67 83.9 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.169 1.913 . . . . 74.04 110.755 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.46 -36.34 82.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.389 -0.823 . . . . 74.34 110.561 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.88 160.54 35.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 74.11 110.151 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 40.9 p -138.94 103.28 4.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.181 0.993 . . . . 61.12 109.254 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -72.82 123.92 90.14 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.004 0.522 . . . . 72.04 111.501 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -90.35 122.93 0.98 Allowed 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.12 2.547 . . . . 53.43 112.424 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.58 137.46 37.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.446 0.699 . . . . 71.13 110.229 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.427 HG12 HG22 ' E' ' 204' ' ' ILE . 2.8 pp -91.51 173.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.623 0.769 . . . . 73.33 112.979 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.34 165.89 20.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.85 1.26 . . . . 40.42 110.399 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.12 130.96 24.32 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.49 0.716 . . . . 35.24 109.906 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -129.45 15.11 6.06 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.433 1.093 . . . . 75.33 109.701 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.15 124.21 11.09 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.795 -0.639 . . . . 62.44 112.264 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.16 17.58 Favored Glycine 0 C--N 1.343 0.948 0 O-C-N 123.721 0.306 . . . . 52.11 113.415 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -83.41 -43.89 15.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.523 0.729 . . . . 72.23 109.644 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . 52.72 23.76 2.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.264 1.426 . . . . 73.01 114.633 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -147.88 132.03 17.35 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.859 0.864 . . . . 73.22 109.948 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 196' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' F' ' 198' ' ' GLU . 10.1 tmtt? -130.77 -21.61 2.73 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.638 1.175 . . . . 51.22 108.342 175.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 35.4 t80 76.91 4.67 3.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.092 1.757 . . . . 74.41 110.388 -169.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 198' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' F' ' 205' ' ' LYS . 42.5 mt-10 -142.46 155.54 45.08 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.813 0.845 . . . . 75.41 110.529 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 74.41 -1.61 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.161 1.784 . . . . 74.24 112.241 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 76.07 31.61 54.88 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.956 -0.458 . . . . 64.3 111.956 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.85 76.81 5.33 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.327 -0.99 . . . . 65.21 108.327 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 64.68 9.64 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.197 0.999 . . . . 54.5 110.696 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 203' ' ' ASP . . . . . 0.427 ' HA ' HH12 ' A' ' 15' ' ' ARG . 3.3 p30 -127.18 -156.74 0.77 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.319 1.448 . . . . 74.54 108.763 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 5.8 tt -155.48 121.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.381 0.672 . . . . 54.42 109.674 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 205' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' F' ' 198' ' ' GLU . 14.5 tmtt? -86.51 127.18 34.85 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.102 -1.073 . . . . 71.44 108.102 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.19 97.06 0.17 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.969 -0.752 . . . . 70.23 108.969 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.538 HG11 HD11 ' C' ' 136' ' ' LEU . 3.6 p . . . . . 0 CA--C 1.565 1.524 0 C-N-CA 125.264 1.425 . . . . 71.44 113.103 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.066 0.46 . . . . 73.31 110.012 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 169' ' ' GLY . . . . . 0.473 ' HA2' ' N ' ' G' ' 175' ' ' PHE . . . 90.6 -178.17 42.55 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.532 -0.758 . . . . 61.21 112.467 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -162.67 -40.48 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.564 0.346 . . . . 72.11 110.531 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 171' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' G' ' 175' ' ' PHE . 44.1 t -65.99 -69.29 0.31 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.977 0.511 . . . . 72.02 110.346 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 172' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . . . -110.76 -92.17 0.46 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.805 -0.813 . . . . 75.22 108.805 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.605 HD13 ' H ' ' G' ' 173' ' ' LEU . 0.0 OUTLIER -117.92 -8.26 10.79 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.409 1.084 . . . . 71.1 108.783 169.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' G' ' 175' ' ' PHE . 9.3 ptp -126.19 145.37 50.41 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 124.874 1.269 . . . . 72.31 108.973 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.473 ' N ' ' HA2' ' G' ' 169' ' ' GLY . 17.0 t80 170.41 72.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.443 1.497 . . . . 75.33 108.039 167.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -165.04 94.19 0.64 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.529 -0.915 . . . . 53.42 108.529 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -84.54 81.72 8.72 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.349 -0.612 . . . . 72.42 109.349 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -99.22 -168.92 1.69 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.37 -0.832 . . . . 62.14 109.469 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.33 111.64 5.46 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.283 0.633 . . . . 74.4 109.543 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.58 -177.08 3.23 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.88 2.387 . . . . 73.44 112.951 -172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -85.52 164.94 17.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.474 -0.785 . . . . 71.04 110.047 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 63.51 -165.16 0.24 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.493 1.117 . . . . 65.14 110.729 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.7 t -149.16 141.63 24.29 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.76 0.424 . . . . 71.43 110.461 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -148.73 88.45 5.24 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.088 -1.079 . . . . 75.24 108.088 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.75 3.32 7.41 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.116 2.544 . . . . 64.52 114.085 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 79.7 mt 64.82 -168.63 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.591 1.156 . . . . 74.04 111.426 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' H' ' 206' ' ' ASP . 2.3 pp -127.22 163.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.558 0.743 . . . . 63.14 110.773 174.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.64 164.55 15.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 71.13 109.52 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.54 116.96 10.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.552 0.741 . . . . 51.11 109.699 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.58 169.72 17.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.956 0.502 . . . . 72.15 111.162 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.4 130.76 10.13 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.765 -0.652 . . . . 64.25 112.592 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.02 -129.78 1.78 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.547 -1.021 . . . . 71.1 110.547 168.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -166.68 142.14 4.4 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.822 0.849 . . . . 74.32 109.152 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 194' ' ' ALA . . . . . 0.58 ' HB2' ' HA ' ' H' ' 198' ' ' GLU . . . -169.7 -168.64 0.8 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.069 0.948 . . . . 71.23 110.556 -172.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.708 ' H ' ' HB3' ' H' ' 196' ' ' LYS . 2.4 t80 29.37 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.665 2.386 . . . . 74.41 113.401 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.65 103.2 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.021 -0.99 . . . . 60.1 109.791 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 197' ' ' TYR . . . . . 0.751 ' HE1' HH12 ' B' ' 15' ' ' ARG . 54.6 m-85 -87.57 -97.72 0.08 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.537 0.735 . . . . 65.41 109.247 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 61.12 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.372 1.579 0 C-N-CA 124.963 1.305 . . . . 65.24 111.794 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -150.26 26.55 0.78 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.84 0.856 . . . . 73.54 110.629 175.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -76.31 132.03 12.26 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.078 -0.51 . . . . 73.15 112.453 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.31 157.28 38.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 62.04 110.255 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -70.56 94.56 1.0 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.725 -0.843 . . . . 73.12 108.725 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.23 112.67 4.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.382 1.073 . . . . 63.42 111.323 -174.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 11.5 tt -171.86 138.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 122.713 0.405 . . . . 74.4 111.61 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -151.05 116.81 5.48 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.924 -1.139 . . . . 72.31 107.924 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.22 -75.1 0.57 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.22 -1.03 . . . . 61.03 108.22 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.716 -0.659 . . . . 73.04 109.474 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.039 -0.356 . . . . 64.13 110.039 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.99 -80.37 0.36 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.126 -0.79 . . . . 52.51 111.126 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -127.62 132.16 49.81 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.813 0.845 . . . . 61.43 111.008 -177.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 47.4 p -79.36 157.14 27.69 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.132 -1.062 . . . . 65.44 108.132 159.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.02 -65.37 0.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.386 0.275 . . . . 44.44 110.923 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.621 ' HG ' ' HG2' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -172.73 156.79 3.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.319 0.648 . . . . 72.13 110.144 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 14.8 mmt -145.32 -179.45 6.65 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.632 1.173 . . . . 62.54 108.626 166.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -156.32 175.72 13.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.459 0.647 . . . . 74.24 111.078 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -128.23 10.37 6.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.103 1.361 . . . . 71.1 109.861 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 3.5 tt -65.75 97.67 0.35 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 108.319 -0.993 . . . . 75.53 108.319 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -125.47 30.4 5.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.76 1.224 . . . . 72.24 109.539 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -114.93 140.62 25.75 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.181 -1.372 . . . . 74.25 109.578 -171.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 180' ' ' PRO . . . . . 0.428 ' HG3' ' H ' ' D' ' 46' ' ' THR . 12.1 Cg_exo -70.23 77.6 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.885 2.39 . . . . 45.34 111.239 169.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.62 -61.55 1.37 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.231 -0.895 . . . . 62.34 110.032 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -104.08 33.5 3.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.37 0.668 . . . . 75.21 109.346 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 24.6 p -92.33 165.62 12.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.399 1.08 . . . . 74.23 111.241 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 184' ' ' TRP . . . . . 0.473 ' HH2' ' HB2' ' D' ' 103' ' ' PRO . 44.9 p90 -93.48 160.51 32.88 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.521 0.728 . . . . 73.23 111.821 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.47 139.51 16.36 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.221 1.947 . . . . 75.44 111.588 166.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 186' ' ' LEU . . . . . 0.448 HD21 HD13 ' D' ' 44' ' ' LEU . 76.3 mt -79.51 164.09 24.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.057 0.456 . . . . 64.35 110.674 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.529 HG12 ' HB3' ' D' ' 129' ' ' ALA . 2.5 pp -100.65 176.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.092 0.957 . . . . 74.32 111.262 -175.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.65 25.86 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.471 0.708 . . . . 51.43 110.812 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.5 167.94 20.85 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.34 1.056 . . . . 64.43 109.177 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -146.54 -53.03 0.23 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 120.919 0.39 . . . . 61.52 111.51 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.65 33.47 4.16 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.233 -0.44 . . . . 51.14 114.106 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.77 -55.16 5.06 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.25 -0.34 . . . . 62.23 112.25 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 60.71 22.45 12.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.852 1.261 . . . . 73.33 112.022 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -90.98 75.34 6.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.373 0.669 . . . . 65.22 110.849 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -164.28 124.13 2.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.04 0.536 . . . . 75.44 109.952 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 196' ' ' LYS . . . . . 0.708 ' HB3' ' H ' ' G' ' 195' ' ' PHE . 9.2 tppt? -175.03 108.25 0.1 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.775 -1.565 . . . . 64.13 106.775 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 197' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' D' ' 32' ' ' PHE . 46.1 m-85 -60.1 -68.08 0.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.674 0.609 . . . . 64.21 111.675 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 198' ' ' GLU . . . . . 0.58 ' HA ' ' HB2' ' G' ' 194' ' ' ALA . 1.2 tm-20 -172.94 139.95 0.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 106.773 -1.566 . . . . 75.55 106.773 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -123.71 -19.98 5.61 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.067 0.394 . . . . 44.22 111.928 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -89.54 16.06 57.23 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-O 119.335 -0.703 . . . . 63.01 114.685 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? 60.03 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.584 1.553 . . . . 62.42 112.281 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -84.7 54.5 3.07 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 122.396 1.093 . . . . 74.3 108.548 171.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -101.06 93.41 5.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.738 1.215 . . . . 65.31 109.027 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 46.6 mt -117.64 104.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.267 1.027 . . . . 75.53 110.147 -173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.59 168.41 10.2 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.582 -0.525 . . . . 74.43 109.582 170.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 206' ' ' ASP . . . . . 0.519 ' HB2' HG21 ' G' ' 187' ' ' ILE . 36.0 t70 -149.9 -56.34 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.764 -1.569 . . . . 52.5 106.764 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.556 HG23 HG23 ' A' ' 131' ' ' VAL . 31.1 t . . . . . 0 C--O 1.254 1.29 0 N-CA-C 106.535 -1.654 . . . . 63.13 106.535 163.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 mmt . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 108.605 -0.887 . . . . 70.33 108.605 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m 52.07 81.57 0.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.265 1.026 . . . . 75.12 112.044 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.59 128.78 20.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.625 -1.25 . . . . 64.53 107.625 174.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.69 152.94 16.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.163 0.585 . . . . 75.4 110.699 -170.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -162.54 107.41 1.16 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.2 -1.407 . . . . 50.35 107.2 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -157.23 -31.96 0.08 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.001 0.521 . . . . 74.31 111.473 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -80.09 77.43 6.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.364 0.602 . . . . 75.13 109.862 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -167.92 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.43 -0.804 . . . . 70.2 110.154 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.481 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -77.01 161.36 28.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.846 0.684 . . . . 73.3 112.846 -166.022 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -140.11 126.82 20.49 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.266 0.626 . . . . 60.52 109.328 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 45.3 t80 -127.38 141.68 51.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.204 1.002 . . . . 70.4 108.878 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 60.0 tp60 -152.66 137.35 16.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.999 0.52 . . . . 64.25 110.296 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.99 117.05 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.754 -1.202 . . . . 53.3 107.754 173.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -90.08 -40.73 12.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.443 0.297 . . . . 75.13 110.539 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -172.77 125.02 0.46 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.704 0.401 . . . . 51.2 110.693 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.891 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 71.6 mt -106.67 136.34 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.504 -0.925 . . . . 63.43 108.504 171.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 31.7 p90 -167.14 171.0 11.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.888 0.875 . . . . 72.54 110.101 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -92.38 130.29 38.1 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.498 -0.927 . . . . 75.43 108.498 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.6 mtpt -92.35 -42.94 9.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.61 -0.885 . . . . 65.05 108.61 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.4 t70 -135.09 135.03 40.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.921 -1.036 . . . . 63.41 110.083 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 117' ' ' MET . 82.5 mt -131.65 136.98 56.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.24 -1.393 . . . . 51.24 107.24 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -145.66 128.32 16.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.872 -0.418 . . . . 72.32 109.872 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 80.8 t80 -134.11 114.86 13.59 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.741 -1.578 . . . . 74.23 106.741 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 46.5 mt-10 -121.61 117.46 26.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.464 -0.569 . . . . 62.25 109.464 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.52 91.95 6.53 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 109.015 -0.735 . . . . 72.03 109.015 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 19.0 Cg_exo -67.39 -50.35 0.99 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.005 2.47 . . . . 71.4 111.854 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 40.1 m-80 -99.56 42.5 1.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.86 0.864 . . . . 73.34 109.86 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' B' ' 17' ' ' TYR . . . -59.19 -48.39 96.45 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.76 1.224 . . . . 74.02 114.144 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.88 -17.89 11.92 Favored 'Trans proline' 0 C--N 1.386 2.503 0 CA-C-N 121.168 1.453 . . . . 65.44 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -74.02 -38.79 63.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.14 111.546 -173.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.76 -14.15 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.758 0.823 . . . . 74.32 111.747 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.82 -39.63 89.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.487 0.715 . . . . 75.44 111.186 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -100.55 -30.28 11.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.604 0.762 . . . . 74.34 110.956 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.8 tmtp? -76.49 139.71 40.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.844 0.858 . . . . 73.32 108.95 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.1 m-20 -57.78 116.39 3.42 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.881 0.738 . . . . 72.43 109.793 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -79.17 80.45 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.191 0.996 . . . . 63.13 109.014 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -114.5 83.86 9.16 Favored Pre-proline 0 C--O 1.245 0.851 0 N-CA-C 107.404 -1.332 . . . . 63.41 107.404 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB2' HG13 ' A' ' 40' ' ' VAL . 73.2 Cg_endo -73.76 122.16 7.56 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.921 1.747 . . . . 72.24 112.125 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -94.93 85.31 4.34 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 105.857 -1.905 . . . . 71.43 105.857 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 38' ' ' PRO . 14.0 m -75.25 93.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.703 -1.589 . . . . 63.41 110.744 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -77.78 144.7 36.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.268 -1.787 . . . . 64.31 108.891 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.37 147.7 38.46 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.711 -1.131 . . . . 75.1 108.866 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.4 132.04 18.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.425 -0.954 . . . . 63.44 108.425 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.446 HD22 HD21 ' G' ' 186' ' ' LEU . 55.7 tp -99.46 119.24 37.68 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.695 -0.854 . . . . 74.42 108.695 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.78 155.66 50.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.775 -0.454 . . . . 72.12 109.775 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -118.15 162.89 17.47 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.374 0.67 . . . . 73.43 109.443 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.02 116.12 6.92 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.618 -1.253 . . . . 63.23 107.618 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 p -98.88 150.27 22.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.321 -0.251 . . . . 72.31 110.321 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -159.34 121.07 3.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.449 0.7 . . . . 72.42 109.458 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.72 131.17 35.82 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.962 -0.755 . . . . 61.52 108.962 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -104.45 -38.32 6.85 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.313 0.645 . . . . 51.1 110.454 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -154.23 -177.61 6.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.098 0.959 . . . . 73.22 109.776 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.26 128.11 34.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.336 -0.987 . . . . 72.31 108.336 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 69.96 2.73 4.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.151 0.981 . . . . 72.34 111.935 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 54.5 t -120.31 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 107.01 -1.478 . . . . 73.34 107.01 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.401 ' HB2' ' SD ' ' G' ' 174' ' ' MET . 6.6 t80 -128.38 128.67 44.95 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 72.13 108.95 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.25 115.09 28.34 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.861 -1.063 . . . . 52.53 109.168 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.42 119.73 53.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.047 0 N-CA-C 106.087 -1.82 . . . . 73.54 106.087 169.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -97.3 132.14 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.847 0.859 . . . . 55.33 108.938 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 115.37 27.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.726 -1.213 . . . . 53.5 107.726 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -105.3 100.74 10.31 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.03 -0.73 . . . . 70.43 109.03 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 114' ' ' ILE . 32.7 t -99.92 127.32 52.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.152 -1.055 . . . . 71.24 108.152 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -122.73 132.83 54.42 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.612 -0.514 . . . . 64.45 109.612 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 51.2 t -133.15 126.22 52.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 125.351 1.46 . . . . 61.24 108.569 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -118.66 137.03 53.58 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.44 109.437 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.66 111.8 23.49 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.049 -1.093 . . . . 72.31 108.049 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.9 m -108.46 131.29 54.94 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.973 0.416 . . . . 62.23 110.323 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 mt -105.14 43.1 1.14 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.699 -1.223 . . . . 74.04 107.699 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.98 -115.01 4.93 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.946 -1.261 . . . . 63.44 109.946 -168.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.41 -25.95 18.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.217 0.607 . . . . 73.44 110.411 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.64 99.6 5.85 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.84 -0.618 . . . . 74.33 110.015 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.9 m -68.75 127.45 33.11 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.206 -0.664 . . . . 74.41 109.206 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -52.05 8.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.881 0.873 . . . . 64.32 109.101 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.46 159.74 43.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.163 -1.38 . . . . 74.33 110.328 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -130.55 132.37 45.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.049 -1.463 . . . . 61.45 107.049 173.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.9 m -122.09 135.21 54.78 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.145 0.978 . . . . 73.34 108.792 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -148.27 116.49 6.5 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.003 -1.11 . . . . 72.13 108.003 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.6 t -123.92 118.71 54.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.87 -0.789 . . . . 71.35 108.87 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.1 mt-30 -97.15 88.23 4.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.904 -1.044 . . . . 74.24 108.451 172.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.2 tp-100 -75.7 98.94 4.21 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 114.541 -1.209 . . . . 74.53 107.936 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.01 143.74 18.34 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 112.042 -0.423 . . . . 64.11 112.042 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.27 120.83 1.96 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.878 -0.889 . . . . 71.45 110.878 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' B' ' 29' ' ' PRO . 50.2 mt -81.71 126.73 39.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.304 -1.369 . . . . 41.22 107.304 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 64.8 m-85 -134.8 128.83 33.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.552 -0.536 . . . . 73.33 109.552 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 12' ' ' GLN . 9.3 p -84.08 96.62 8.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.58 -0.896 . . . . 72.15 108.58 170.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 133.72 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 60.3 109.378 -169.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 175.61 4.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.594 0.757 . . . . 64.03 111.161 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 105.46 -22.86 31.54 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.433 -0.803 . . . . 33.42 113.314 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -110.25 150.84 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 53.2 110.152 -176.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.633 ' HA ' ' HB3' ' G' ' 172' ' ' ALA . 53.9 mt-10 -140.88 174.87 10.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.596 0.358 . . . . 75.35 110.834 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.6 -134.46 35.54 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.384 -0.371 . . . . 75.12 113.391 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -68.07 -21.79 64.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.814 0.846 . . . . 54.11 111.745 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -65.46 -35.76 81.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.676 0.79 . . . . 65.23 110.685 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 62.0 tpp -69.22 -39.89 78.29 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 116.201 -0.454 . . . . 72.2 109.972 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -28.59 69.67 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.937 0.495 . . . . 74.14 111.31 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -72.36 -61.76 1.68 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.408 0.683 . . . . 63.32 111.017 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 9.1 t -68.39 -43.3 77.6 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 52.13 110.773 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 tt -84.56 -41.2 16.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.023 0.929 . . . . 75.25 110.618 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.14 -36.19 28.33 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 114.822 0.689 . . . . 75.52 114.822 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.8 -44.44 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.939 0.496 . . . . 72.04 112.107 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.414 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -74.18 -53.62 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.909 0.883 . . . . 74.31 112.669 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.12 -40.79 30.72 Favored Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 113.206 0.817 . . . . 73.05 113.206 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.8 Cg_endo -66.7 -22.14 50.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 CA-C-N 121.05 1.411 . . . . 64.11 113.295 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.89 -31.17 68.83 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 118.269 0.486 . . . . 71.21 110.461 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.25 -33.07 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.786 0.803 . . . . 74.52 110.364 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 103' ' ' PRO . 86.5 mt -82.67 -23.64 34.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.866 1.266 . . . . 65.24 113.123 -174.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -62.3 -40.7 69.08 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.609 1.337 . . . . 71.24 114.609 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.52 -38.54 83.57 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 121.982 1.788 . . . . 35.13 112.992 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -82.56 -34.09 27.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.086 0.954 . . . . 74.42 111.515 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.06 78.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.063 0.545 . . . . 72.52 109.544 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.431 ' NH1' HD12 ' C' ' 105' ' ' ILE . 39.6 ttm180 -52.04 -52.7 49.23 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.709 1.256 . . . . 74.23 110.655 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.45 -45.74 92.99 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.403 1.064 . . . . 72.35 111.244 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -58.76 -45.35 89.95 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.771 0.669 . . . . 75.53 111.154 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 118' ' ' VAL . 86.7 mt -62.52 -51.58 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.903 0.752 . . . . 73.23 109.793 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -56.14 -41.28 75.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.267 1.027 . . . . 52.03 111.805 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.9 t -66.21 -47.88 72.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.345 0.658 . . . . 73.53 110.006 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 21' ' ' ILE . 13.5 mtp -55.59 -46.77 77.21 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.988 0.915 . . . . 71.41 111.048 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -60.1 -44.15 94.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.726 1.21 . . . . 73.11 111.17 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.4 t -68.38 -31.82 71.46 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.816 -0.629 . . . . 64.42 111.322 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 94.1 mtt-85 -74.16 -20.38 60.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.735 0.814 . . . . 53.21 110.844 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.04 11.55 57.03 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.511 0.507 . . . . 71.55 112.983 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' HH21 ' B' ' 15' ' ' ARG . 17.3 m 66.71 35.51 5.14 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.495 1.14 . . . . 54.44 110.323 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.31 149.68 50.11 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.162 -0.926 . . . . 74.53 109.54 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.21 157.78 47.85 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.718 2.278 . . . . 64.22 112.564 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.83 141.74 58.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.637 -1.165 . . . . 73.53 112.628 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -123.48 107.06 11.16 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.156 -1.424 . . . . 71.43 107.156 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.55 99.97 8.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.148 0.979 . . . . 70.42 109.387 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.91 148.32 40.21 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.699 0.8 . . . . 71.33 110.421 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.62 147.45 98.69 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.634 0.774 . . . . 63.24 111.817 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' HB3' HH22 ' A' ' 111' ' ' ARG . 71.7 Cg_endo -83.73 165.76 13.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.75 2.3 . . . . 75.21 112.801 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.41 114.68 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.744 -0.835 . . . . 72.11 108.744 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -99.98 63.82 1.2 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.948 -1.13 . . . . 71.35 107.948 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -70.27 -33.76 71.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.503 -1.226 . . . . 73.15 110.608 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -57.36 -44.27 84.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.224 1.009 . . . . 52.13 112.043 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.85 63.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.993 0.517 . . . . 74.44 110.601 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.68 -34.75 78.54 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.637 0.775 . . . . 71.44 110.871 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -67.52 -53.03 32.06 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.854 0.862 . . . . 75.35 109.667 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 59.6 mtp -55.84 -45.62 78.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.967 0.907 . . . . 72.15 110.866 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -52.75 -60.04 3.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.228 1.411 . . . . 62.03 110.908 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -64.43 -35.23 80.24 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.872 0.469 . . . . 75.52 111.57 -176.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.83 -48.78 67.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.712 -0.676 . . . . 74.22 110.257 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -167.18 -14.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.684 0.624 . . . . 73.25 112.684 -174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -92.58 20.34 6.44 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.585 0.354 . . . . 63.41 111.626 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -82.66 60.37 5.21 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 107.568 -1.271 . . . . 74.31 107.568 166.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.97 136.74 10.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.982 -1.008 . . . . 74.34 110.996 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.25 -163.91 11.91 Favored Glycine 0 C--O 1.247 0.956 0 N-CA-C 110.346 -1.102 . . . . 53.45 110.346 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -156.21 128.1 7.39 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.504 -0.554 . . . . 71.32 109.504 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.49 57.59 0.02 OUTLIER Glycine 0 C--O 1.245 0.806 0 O-C-N 123.22 0.325 . . . . 74.43 112.824 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.7 m -69.01 98.1 0.93 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.163 -0.68 . . . . 74.41 109.163 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -111.69 -16.73 13.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.593 1.157 . . . . 73.14 110.001 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.38 114.63 16.41 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.296 0.638 . . . . 63.11 110.644 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -166.13 112.92 0.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.356 1.063 . . . . 73.03 109.256 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -74.42 140.05 44.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.821 -0.436 . . . . 71.33 109.821 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.82 114.8 2.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.749 -1.204 . . . . 71.14 107.749 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 C-N-CA 123.472 0.709 . . . . 43.34 109.093 -178.101 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.041 -0.726 . . . . 64.55 109.041 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 62.3 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.175 1.39 . . . . 62.12 112.52 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.445 ' HG2' ' HA2' ' B' ' 148' ' ' GLY . 4.5 mp0 -93.34 -164.64 1.2 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.199 0.6 . . . . 73.42 110.627 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -109.03 24.67 12.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.0 0.92 . . . . 63.41 109.286 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' B' ' 3' ' ' GLU . 2.6 p-10 -77.07 -176.02 3.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.147 0.975 . . . . 74.03 112.028 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -149.88 175.97 11.17 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.274 -1.33 . . . . 54.24 107.978 173.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -157.81 165.53 35.07 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.941 -0.763 . . . . 61.43 108.941 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.444 ' HA ' HE22 ' B' ' 153' ' ' GLN . 1.9 mp0 -77.68 -37.75 49.02 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.544 0.738 . . . . 75.32 109.705 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm 50.53 -176.34 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.684 1.994 . . . . 74.21 113.781 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.8 m -146.07 127.05 14.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.424 -1.324 . . . . 74.34 107.424 172.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.9 140.95 38.54 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.813 -0.81 . . . . 71.13 108.813 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.6 140.26 18.93 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.631 0.582 . . . . 74.41 109.906 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 tt -95.09 133.03 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.939 0.896 . . . . 41.0 109.46 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -104.7 -50.55 3.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.814 0.446 . . . . 73.41 110.872 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.458 HH21 ' HB ' ' A' ' 122' ' ' THR . 63.3 ttt180 -158.57 140.36 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.657 0.383 . . . . 75.14 110.8 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -117.83 142.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.015 -1.105 . . . . 65.44 108.015 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.441 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 40.4 p90 -162.86 169.63 19.5 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.823 0.702 . . . . 73.02 110.69 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.8 m -99.2 123.23 43.32 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.065 -0.716 . . . . 72.33 109.065 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -77.21 -52.7 8.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.926 -0.579 . . . . 73.42 110.402 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -140.79 140.93 34.82 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.111 0.481 . . . . 71.02 111.919 -165.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mm -132.81 138.14 52.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.933 1.293 . . . . 72.31 108.396 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -143.1 135.98 27.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.063 -0.971 . . . . 62.44 108.509 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -153.35 111.85 3.67 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.851 -1.166 . . . . 74.11 107.851 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -119.83 118.66 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.594 -0.891 . . . . 64.22 108.594 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.793 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -115.89 86.88 17.11 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.721 0.808 . . . . 74.04 109.643 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.9 -50.57 2.16 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.868 2.379 . . . . 64.25 112.695 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -101.56 20.6 15.79 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.561 0.744 . . . . 72.24 111.435 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.793 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.6 -52.73 42.17 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 124.898 1.279 . . . . 54.0 112.932 168.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 83' ' ' ILE . 43.8 Cg_endo -74.62 -12.02 22.31 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 121.692 1.595 . . . . 64.54 113.207 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -96.01 1.12 52.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.759 0.824 . . . . 72.12 110.915 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.01 -22.92 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.817 1.247 . . . . 42.41 112.936 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.84 -42.05 78.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.915 0.886 . . . . 72.15 110.937 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -83.46 -12.47 56.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.5 1.12 . . . . 74.41 111.136 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -100.54 75.3 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.031 0.932 . . . . 74.24 109.284 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.12 76.04 9.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 71.54 110.899 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.48 158.51 1.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.89 1.276 . . . . 74.31 109.885 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.471 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 63.8 tt0 -83.93 130.89 53.3 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 74.32 108.729 173.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 50.3 Cg_endo -65.6 153.39 78.4 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.51 2.14 . . . . 64.2 112.746 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 42.8 mt-10 -69.76 100.82 1.57 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.944 . . . . 73.03 108.453 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' B' ' 126' ' ' LEU . 33.1 t -90.24 121.23 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 107.871 -1.159 . . . . 73.42 107.871 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -148.76 139.78 23.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.468 -1.308 . . . . 64.32 107.468 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.464 HD21 HD12 ' B' ' 126' ' ' LEU . 0.8 OUTLIER -128.11 163.03 25.52 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.711 0.767 . . . . 63.23 112.475 -171.626 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.45 ' HA ' HD13 ' F' ' 186' ' ' LEU . 10.0 m-20 -126.9 154.15 44.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.049 -1.432 . . . . 74.52 108.555 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.463 HD22 ' CZ2' ' F' ' 184' ' ' TRP . 2.5 tt -134.94 116.17 14.4 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.792 -1.559 . . . . 72.24 106.792 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -126.46 155.28 42.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.754 0.822 . . . . 74.43 110.044 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 29.2 m -111.4 136.69 50.18 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 64.13 110.394 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.583 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.15 154.06 36.7 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.688 1.195 . . . . 71.44 108.177 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 m -141.68 160.69 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.006 0.431 . . . . 54.34 111.338 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -162.99 163.38 26.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.108 1.363 . . . . 65.41 108.332 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.45 ' NE2' ' HG3' ' F' ' 174' ' ' MET . 59.3 tt0 -123.02 137.24 55.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.056 0.943 . . . . 74.44 109.193 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.15 -35.11 9.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.177 0.591 . . . . 73.53 111.117 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.46 -174.25 2.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.346 1.058 . . . . 74.15 110.316 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.05 119.09 14.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.347 -0.842 . . . . 62.15 109.823 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 67.02 12.46 8.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.659 1.184 . . . . 74.34 112.138 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -128.27 110.62 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.779 -1.193 . . . . 63.22 107.779 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.453 ' HB3' ' SD ' ' F' ' 174' ' ' MET . 2.8 p90 -122.31 163.96 18.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.137 -0.69 . . . . 75.2 109.137 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -137.93 110.46 7.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.681 -1.229 . . . . 71.31 107.681 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' B' ' 98' ' ' LEU . 24.4 m -107.77 150.66 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.211 0.529 . . . . 74.5 110.364 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 18.0 t -116.61 136.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 115.272 -0.876 . . . . 64.51 108.648 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -102.02 116.15 32.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.962 -1.125 . . . . 73.21 107.962 178.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -97.44 125.16 41.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.016 0.526 . . . . 61.22 109.98 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' B' ' 114' ' ' ILE . 12.7 t -125.7 116.86 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.486 -0.931 . . . . 74.4 108.486 166.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 38.0 m -99.08 152.13 20.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.452 1.101 . . . . 73.14 109.216 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' B' ' 42' ' ' LEU . 76.1 t -136.78 111.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.936 0.894 . . . . 71.03 109.242 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.2 m -92.31 138.41 31.54 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.514 0.725 . . . . 74.44 109.047 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.05 142.21 28.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.127 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -140.7 128.65 21.95 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.747 0.654 . . . . 73.53 111.824 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.8 99.04 11.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.951 -1.129 . . . . 54.14 107.951 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -112.81 3.79 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.341 -0.845 . . . . 54.21 111.467 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -108.26 1.32 21.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.091 0.956 . . . . 73.3 111.131 -176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.0 155.6 41.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.481 0.712 . . . . 72.14 110.213 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 130.72 44.17 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.034 0.534 . . . . 73.53 111.97 -173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.409 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -84.68 -58.85 2.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 60.24 108.72 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -161.55 162.93 30.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 113.536 -1.665 . . . . 63.31 109.352 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.4 mt -136.32 111.63 9.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.935 -1.506 . . . . 72.55 106.935 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -117.87 158.17 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.702 0.801 . . . . 62.14 109.068 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -165.68 146.69 7.0 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.003 -0.74 . . . . 71.34 109.003 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.15 144.5 37.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.566 -1.197 . . . . 70.42 108.353 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.1 mt-30 -127.36 93.46 3.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.547 -0.908 . . . . 71.13 108.547 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.407 ' O ' HD13 ' B' ' 106' ' ' LEU . 55.6 tp60 -86.08 102.66 14.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.95 -1.023 . . . . 62.11 109.449 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.57 148.87 20.76 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.759 -0.536 . . . . 71.44 111.759 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.25 126.09 2.16 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 117.27 0.535 . . . . 64.25 112.416 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.98 127.2 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.535 0.734 . . . . 63.5 109.079 173.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -139.72 170.18 16.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 70.31 109.041 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -133.68 131.72 39.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 74.34 108.874 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.691 HD12 ' SG ' ' B' ' 97' ' ' CYS . 7.1 tt -140.32 145.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.417 0.287 . . . . 71.1 110.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.3 39.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.767 0.827 . . . . 72.24 110.078 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.05 -31.6 4.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.18 -0.464 . . . . 64.22 114.149 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' B' ' 94' ' ' MET . 0.1 OUTLIER -71.54 170.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.13 0.972 . . . . 75.4 112.679 -177.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.487 ' HA ' ' HB1' ' F' ' 172' ' ' ALA . 13.8 pt-20 -164.12 160.25 21.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.326 0.65 . . . . 75.32 110.388 173.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.55 -128.74 47.57 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.469 0.48 . . . . 33.33 113.693 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 38.0 m -68.47 -21.88 64.59 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.367 0.667 . . . . 63.45 111.382 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' B' ' 90' ' ' GLU . 25.0 mt-30 -64.97 -31.7 73.06 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.907 0.483 . . . . 75.32 110.806 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.497 ' HB2' HG12 ' B' ' 89' ' ' ILE . 13.1 tpt -85.86 -46.3 10.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.457 -0.338 . . . . 64.32 110.574 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.67 66.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.781 0.833 . . . . 75.31 111.872 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.1 -38.67 75.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.638 0.775 . . . . 72.43 111.16 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' B' ' 86' ' ' ILE . 53.4 t -64.98 -68.37 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.882 0.31 . . . . 73.5 111.547 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.77 ' HB2' HG11 ' B' ' 58' ' ' VAL . 2.6 pt? -75.46 -18.02 59.98 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.785 0.266 . . . . 74.23 111.517 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.64 3.64 42.61 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-O 118.984 -0.898 . . . . 74.0 114.373 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.96 -50.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.076 0.938 . . . . 44.33 112.409 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -72.84 -46.57 52.27 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.557 0.743 . . . . 63.02 111.55 -170.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.0 -44.8 40.91 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 118.457 -0.782 . . . . 73.31 110.717 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.13 -45.35 21.8 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.033 1.822 . . . . 75.31 112.841 163.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -60.74 -36.52 79.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.509 0.724 . . . . 73.23 111.782 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.01 -48.37 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.358 0.663 . . . . 71.34 110.77 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 60' ' ' LEU . 44.2 mt -83.0 -11.48 58.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.911 -1.04 . . . . 71.02 111.575 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -62.22 -48.42 87.77 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 117.904 -1.046 . . . . 72.43 113.724 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.17 -36.07 98.17 Favored 'Trans proline' 0 C--N 1.373 1.851 0 CA-C-N 121.04 1.407 . . . . 44.31 112.267 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -66.28 -51.37 58.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 74.15 111.261 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.38 94.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.941 0.897 . . . . 63.33 110.832 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -56.58 -50.34 72.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.204 1.401 . . . . 75.41 111.292 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.5 -35.75 81.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.236 0.614 . . . . 71.33 110.374 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.5 t -72.22 -37.96 69.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.152 -0.476 . . . . 61.32 111.065 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' B' ' 62' ' ' VAL . 54.0 mt -60.59 -50.22 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.352 0.661 . . . . 60.23 109.222 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 72.5 m -48.2 -46.49 35.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.842 1.339 . . . . 63.2 110.532 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.1 t -61.89 -56.51 18.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.446 -1.252 . . . . 62.02 110.882 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 20.0 mmt -67.6 -38.36 83.86 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.752 0.821 . . . . 51.0 112.389 -170.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.91 -44.45 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.424 0.631 . . . . 75.52 109.944 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.485 ' OG ' HG21 ' C' ' 115' ' ' THR . 48.3 t -67.34 -25.16 65.85 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.648 -1.16 . . . . 72.0 112.222 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -70.94 -36.4 72.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.194 0.597 . . . . 63.35 109.933 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 6.75 56.59 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.662 0.601 . . . . 74.34 112.49 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.0 p 57.22 42.01 26.02 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.368 1.867 . . . . 72.11 111.457 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 48.3 m-85 -114.85 159.42 37.49 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.533 -1.212 . . . . 75.42 110.698 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.573 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 39.6 Cg_exo -60.53 104.56 0.26 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.58 2.853 . . . . 72.41 114.684 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.503 ' HG3' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -65.0 161.53 18.5 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.156 1.382 . . . . 61.21 111.447 171.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.464 HD12 HD21 ' B' ' 42' ' ' LEU . 1.1 tm? -132.29 117.99 18.89 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.395 -0.965 . . . . 72.3 108.395 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.41 94.85 10.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.132 -1.062 . . . . 62.11 108.132 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.444 HD23 ' N ' ' B' ' 129' ' ' ALA . 1.8 tt -58.4 138.99 56.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.681 -1.145 . . . . 72.12 110.565 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' E' ' 202' ' ' TYR . . . -51.51 148.98 8.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 70.33 112.228 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.499 ' HG3' HG12 ' D' ' 16' ' ' ILE . 80.1 Cg_endo -72.07 78.81 1.78 Allowed 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.331 2.021 . . . . 74.22 111.451 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.7 m -74.07 83.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.239 1.019 . . . . 74.22 110.691 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.58 111.33 7.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.807 -1.088 . . . . 42.04 108.891 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -75.45 -20.06 59.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.258 0.623 . . . . 74.41 110.91 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.07 -29.25 70.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.368 0.667 . . . . 72.0 110.824 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.63 81.72 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.653 0.596 . . . . 64.11 110.319 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -68.26 -34.29 75.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 62.35 110.872 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.588 ' HA ' HD13 ' B' ' 141' ' ' LEU . 60.3 m-85 -71.29 -36.32 71.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.596 0.358 . . . . 72.22 110.776 171.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' B' ' 142' ' ' GLN . 38.0 ttp -69.16 -29.53 67.57 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.318 1.047 . . . . 74.43 111.413 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -105.96 -42.65 5.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.642 -0.708 . . . . 54.23 111.028 -166.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -89.5 -37.9 14.42 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.599 0.36 . . . . 61.11 110.618 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.588 HD13 ' HA ' ' B' ' 137' ' ' PHE . 5.0 mp -107.14 -9.63 16.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.698 0.399 . . . . 75.05 111.565 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' B' ' 138' ' ' MET . 90.4 mt-30 67.24 -67.07 0.18 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.844 1.258 . . . . 65.33 111.963 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.42 172.35 8.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.494 0.718 . . . . 74.23 110.819 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -149.85 127.8 11.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 65.2 109.316 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.96 -165.98 0.09 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.734 1.213 . . . . 62.22 109.46 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 166.7 87.52 0.07 OUTLIER Glycine 0 C--N 1.35 1.356 0 N-CA-C 111.714 -0.554 . . . . 75.23 111.714 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.405 ' HB3' ' ND2' ' B' ' 5' ' ' ASN . 3.0 tm-20 -155.3 -64.4 0.12 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.305 -0.998 . . . . 75.14 108.305 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' B' ' 3' ' ' GLU . . . 126.54 -18.54 6.38 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.95 1.54 . . . . 43.13 116.95 166.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 46.6 p -105.17 -18.42 14.14 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.599 1.7 . . . . 42.23 111.967 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 62.7 90.14 0.08 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.612 1.165 . . . . 63.25 111.138 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -75.45 152.73 37.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 75.21 111.484 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -98.67 121.64 40.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.267 0.627 . . . . 71.42 109.878 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.444 HE22 ' HA ' ' B' ' 8' ' ' GLU . 15.9 mm-40 -84.54 132.19 34.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.721 -0.474 . . . . 72.14 109.721 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -108.75 -58.26 2.03 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.277 -1.379 . . . . 75.25 107.277 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.815 -1.084 . . . . 74.22 108.719 -178.649 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.2 mtt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 109.7 -0.482 . . . . 63.04 109.7 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 33.7 p -162.06 -79.86 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.14 107.801 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' C' ' 4' ' ' GLN . 19.5 tt0 58.18 -168.83 0.13 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 124.81 1.244 . . . . 74.15 111.348 171.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.506 ' H ' ' HG2' ' C' ' 3' ' ' GLU . 34.8 mt-30 69.76 105.45 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.763 1.225 . . . . 72.01 110.89 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.91 84.14 7.01 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.295 0.569 . . . . 70.2 110.428 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -76.06 -14.1 60.21 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.222 -0.899 . . . . 72.41 110.636 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -68.07 -52.92 29.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.024 0.93 . . . . 70.41 111.077 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.98 155.56 40.13 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.888 0.699 . . . . 75.1 112.888 -171.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 62.62 113.3 0.02 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.633 1.573 . . . . 74.11 110.916 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m -116.83 114.53 24.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.001 -0.74 . . . . 63.41 109.001 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -124.35 119.07 28.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -146.66 130.17 16.83 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.459 -0.941 . . . . 72.45 108.459 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 tp -78.81 137.89 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 109.477 -0.564 . . . . 72.44 109.477 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.5 mm100 -98.96 -47.33 5.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.273 0.629 . . . . 72.41 109.881 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.411 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 66.4 ttt180 -170.77 124.99 0.68 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.581 0.551 . . . . 74.44 110.48 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -109.35 141.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.665 -1.235 . . . . 74.22 107.665 169.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.455 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 6.8 p90 -179.39 164.94 1.38 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.438 0.695 . . . . 71.35 110.029 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -88.7 122.87 32.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 122.971 0.508 . . . . 71.25 109.913 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.595 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.8 mmtp -74.54 -50.56 17.6 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.069 0.938 . . . . 74.34 108.686 170.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.99 141.52 40.45 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.003 -1.453 . . . . 73.34 109.004 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 94.2 mt -137.28 139.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.808 -1.553 . . . . 65.12 106.808 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -149.85 146.3 27.04 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.557 -0.534 . . . . 74.33 109.557 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -152.48 108.84 3.41 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.162 -1.422 . . . . 75.24 107.162 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -116.47 118.68 33.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.91 -0.774 . . . . 61.43 108.91 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.49 86.94 5.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.28 -1.748 . . . . 72.53 106.28 167.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.55 -38.61 61.24 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 122.67 2.247 . . . . 43.42 110.989 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -99.9 44.79 1.01 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.394 -1.275 . . . . 52.3 109.064 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.462 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -59.26 -64.3 3.13 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.903 1.281 . . . . 61.33 112.694 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 61.3 Cg_endo -74.5 -12.47 22.62 Favored 'Trans proline' 0 C--N 1.382 2.319 0 CA-C-N 121.876 1.706 . . . . 53.42 112.203 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -67.7 -30.41 69.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.214 1.006 . . . . 73.42 109.907 174.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.824 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 2.9 p -69.51 -26.66 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 111.835 0.309 . . . . 70.33 111.835 -173.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.92 -40.15 72.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.651 1.18 . . . . 75.32 112.515 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -122.87 39.0 4.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.642 0.777 . . . . 65.34 109.889 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.824 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 31.7 ttpt -114.19 153.14 30.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 71.1 111.463 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.2 116.56 10.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.246 1.018 . . . . 54.14 110.539 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -87.2 101.7 13.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.378 1.071 . . . . 74.24 111.93 -173.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.47 HE22 ' HB3' ' C' ' 68' ' ' LEU . 0.1 OUTLIER -150.38 63.07 5.83 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 124.037 0.935 . . . . 75.1 109.683 168.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.26 122.09 6.87 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.099 2.532 . . . . 71.24 111.529 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.07 88.27 7.45 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.62 -1.252 . . . . 75.31 107.62 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.82 119.06 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.072 -1.422 . . . . 64.05 110.903 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -130.9 146.54 52.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.716 0.807 . . . . 71.12 110.396 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' C' ' 128' ' ' LEU . 56.1 tp -116.15 124.23 49.8 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.11 0.964 . . . . 70.41 109.201 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.522 ' HA ' HD13 ' E' ' 186' ' ' LEU . 8.9 m-20 -119.21 116.84 27.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.843 0.857 . . . . 74.12 109.664 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.562 ' H ' HD22 ' E' ' 186' ' ' LEU . 5.8 mp -101.2 126.96 47.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.317 -0.994 . . . . 65.52 108.317 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -134.4 151.46 51.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.294 1.038 . . . . 74.13 108.863 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 24.5 m -112.17 115.83 29.48 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.108 0.563 . . . . 74.01 110.311 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.67 147.76 44.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.246 -1.02 . . . . 74.45 108.246 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -163.08 145.15 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.744 0.418 . . . . 55.5 110.649 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.2 t -145.35 125.98 14.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.214 1.005 . . . . 52.22 108.413 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.01 126.09 30.35 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.843 -0.428 . . . . 62.02 109.843 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.636 HD11 HD12 ' C' ' 83' ' ' ILE . 87.3 mt -91.34 -52.2 4.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.401 0.681 . . . . 75.02 110.675 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.83 -170.77 3.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.921 0.888 . . . . 72.42 110.646 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.13 117.89 7.76 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.184 -0.673 . . . . 71.24 109.184 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 64.76 12.19 7.46 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 124.232 0.958 . . . . 73.42 112.186 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.4 t -121.74 122.93 68.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.621 -1.252 . . . . 72.55 107.621 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.42 ' OH ' ' HB3' ' C' ' 98' ' ' LEU . 0.1 OUTLIER -138.99 157.91 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 175.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -105.02 116.29 31.7 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.575 -1.193 . . . . 73.15 108.563 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.98 132.03 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.911 -1.144 . . . . 62.51 107.911 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.5 t -128.0 111.25 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.205 -1.406 . . . . 63.02 107.205 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.76 108.9 18.29 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.922 -1.51 . . . . 74.5 106.922 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -81.22 104.81 11.94 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.909 -1.145 . . . . 73.1 107.909 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.68 107.42 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.218 -0.66 . . . . 53.32 109.218 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -104.0 145.91 29.47 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.352 0.661 . . . . 72.43 109.285 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.612 HG21 HG21 ' C' ' 114' ' ' ILE . 38.9 t -140.54 117.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 124.706 1.202 . . . . 72.45 108.081 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -111.98 141.62 45.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.833 0.349 . . . . 63.14 110.097 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.37 103.17 6.29 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 107.155 -1.424 . . . . 64.42 107.155 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.1 m -125.55 137.9 53.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.163 0.506 . . . . 71.34 110.591 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.47 ' HB3' HE22 ' C' ' 37' ' ' GLN . 10.9 mt -89.51 37.55 0.87 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.859 1.264 . . . . 72.5 109.308 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.67 -115.47 5.11 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.213 -1.155 . . . . 72.34 110.213 -166.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.37 -31.48 16.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.582 0.753 . . . . 74.14 110.107 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.86 105.76 3.93 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.054 0.942 . . . . 62.41 108.922 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.06 135.61 37.76 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 122.27 -0.269 . . . . 62.24 110.95 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.55 -56.46 4.29 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.807 -0.812 . . . . 62.01 108.807 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -161.2 173.4 15.14 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.516 -0.765 . . . . 72.5 111.46 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.3 tm? -136.82 141.16 42.87 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.146 -1.428 . . . . 71.04 107.146 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' C' ' 114' ' ' ILE . 35.4 t -141.68 139.57 33.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.768 -1.197 . . . . 53.11 107.768 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.49 116.25 3.86 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.141 -0.689 . . . . 75.53 109.141 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -120.9 140.11 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.836 0.854 . . . . 71.22 109.623 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -107.7 109.02 20.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.941 0.896 . . . . 73.41 109.123 168.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.474 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -89.4 107.74 19.24 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.119 -0.697 . . . . 72.04 109.119 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.4 22.15 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.61 0.569 . . . . 53.03 112.033 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.43 116.83 0.77 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.694 -0.962 . . . . 64.5 110.694 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.636 HD12 HD11 ' C' ' 51' ' ' LEU . 13.7 mm -88.7 119.12 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.56 -0.904 . . . . 60.32 108.56 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 135.65 54.81 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.413 0.685 . . . . 75.0 109.725 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -103.47 99.66 9.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.845 -1.168 . . . . 60.34 107.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.82 156.23 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.096 0.558 . . . . 71.43 110.202 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.08 157.36 2.29 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.723 1.209 . . . . 71.23 108.949 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -18.27 54.26 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 120.333 -0.148 . . . . 73.44 113.178 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' C' ' 94' ' ' MET . 46.1 pt -76.31 165.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.126 0.57 . . . . 51.01 111.301 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.612 ' HG3' ' HA ' ' E' ' 171' ' ' SER . 37.5 tt0 -170.96 147.1 2.6 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.041 0.937 . . . . 70.14 108.911 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.72 -108.15 0.48 Allowed Glycine 0 C--N 1.362 1.997 0 O-C-N 124.108 0.88 . . . . 72.14 114.324 170.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.0 p -58.84 -47.61 84.24 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.663 1.185 . . . . 73.54 111.649 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.94 -32.33 73.51 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.101 0.56 . . . . 75.15 111.022 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.741 ' SD ' HD21 ' C' ' 98' ' ' LEU . 25.6 tpp -59.29 -55.37 35.65 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.536 0.523 . . . . 75.43 110.101 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.96 -34.6 78.47 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.644 -0.707 . . . . 74.41 112.229 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -77.78 -34.08 52.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.671 0.388 . . . . 75.23 111.772 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -68.8 -60.66 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.775 0.43 . . . . 62.52 110.755 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.741 HD21 ' SD ' ' C' ' 94' ' ' MET . 1.5 pp -94.43 -19.14 20.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.891 0.7 . . . . 75.22 112.891 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 6.73 73.76 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.785 -0.453 . . . . 71.5 113.326 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.69 -56.53 0.07 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.668 0.387 . . . . 61.01 111.873 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.53 -53.82 9.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.957 0.725 . . . . 71.25 112.957 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.35 -43.41 79.54 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 123.685 0.794 . . . . 61.0 112.456 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.04 -30.44 66.25 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 121.308 1.339 . . . . 65.13 112.706 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.64 -32.7 74.18 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.217 0.462 . . . . 72.31 110.315 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.431 HD12 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -60.22 -44.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.291 0.567 . . . . 70.15 109.903 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.8 mt -78.68 -21.12 48.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.9 -1.046 . . . . 61.42 111.926 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -56.69 -55.36 43.97 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 117.434 -1.27 . . . . 73.21 113.631 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.91 -30.7 84.15 Favored 'Trans proline' 0 C--N 1.377 2.03 0 CA-C-N 121.571 1.597 . . . . 42.32 112.732 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -63.39 -50.85 68.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.626 0.77 . . . . 75.01 110.83 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.42 -42.33 98.73 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.229 1.012 . . . . 70.32 111.225 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -61.12 -44.17 97.76 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.405 1.882 . . . . 61.1 110.521 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.2 -35.11 63.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.347 0.659 . . . . 64.11 110.3 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.5 t -64.1 -34.43 78.03 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.504 0.722 . . . . 71.35 111.357 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.612 HG21 HG21 ' C' ' 64' ' ' VAL . 97.3 mt -73.28 -45.01 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.805 0.842 . . . . 75.33 111.349 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.485 HG21 ' OG ' ' B' ' 119' ' ' SER . 28.4 m -57.83 -35.39 70.83 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.803 0.441 . . . . 75.42 111.787 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.1 -48.66 70.16 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.29 -0.633 . . . . 71.43 109.29 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.578 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.34 -39.46 70.03 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.872 1.269 . . . . 71.41 113.144 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' C' ' 126' ' ' LEU . 94.2 t -62.09 -48.23 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.218 0.532 . . . . 61.1 110.399 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.9 t -66.52 -28.66 68.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.079 -0.964 . . . . 54.42 111.843 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 84.6 mtt-85 -67.16 -40.62 86.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.068 -0.715 . . . . 73.41 109.068 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.65 5.04 66.13 Favored Glycine 0 C--N 1.358 1.789 0 O-C-N 124.038 0.836 . . . . 71.34 112.912 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 56.1 53.66 8.8 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.063 1.745 . . . . 71.31 111.939 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.508 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 56.4 m-85 -113.22 172.57 3.44 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 114.516 -1.22 . . . . 74.22 109.492 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 18.3 Cg_endo -56.59 171.49 0.96 Allowed 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.639 2.226 . . . . 70.14 113.327 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 9.0 tm0? -60.53 140.7 57.21 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.377 -0.972 . . . . 72.54 108.377 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.431 ' HB3' HG21 ' C' ' 118' ' ' VAL . 9.5 tp -151.03 83.34 1.33 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.975 0.893 . . . . 73.31 110.363 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.99 98.42 3.75 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.812 -1.54 . . . . 73.51 107.092 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' C' ' 42' ' ' LEU . 49.8 mt -78.5 149.26 33.17 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.636 -0.505 . . . . 63.33 109.636 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.86 155.5 82.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.926 0.89 . . . . 61.1 112.749 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.891 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 76.6 Cg_exo -54.74 132.5 52.09 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.926 3.084 . . . . 72.1 113.949 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.407 HG13 ' HB ' ' F' ' 207' ' ' VAL . 61.3 t -111.37 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.798 -1.186 . . . . 63.34 107.798 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -87.59 68.75 9.63 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.543 0.687 . . . . 71.43 110.0 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.402 ' HA ' HG11 ' F' ' 207' ' ' VAL . 71.5 t80 -72.09 -18.93 61.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.155 -0.929 . . . . 71.53 110.929 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.6 -32.27 71.4 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.353 0.661 . . . . 74.32 110.638 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.09 91.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.825 0.85 . . . . 73.32 111.356 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.94 -47.48 65.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.824 -0.806 . . . . 70.33 108.824 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -65.55 -24.84 67.2 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.68 1.192 . . . . 64.32 110.821 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.4 -59.33 4.48 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.231 1.012 . . . . 73.13 110.438 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.13 -35.02 78.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.856 0.862 . . . . 72.01 111.459 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -49.72 -80.58 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.559 1.544 . . . . 64.32 112.661 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.446 ' H ' HD22 ' C' ' 141' ' ' LEU . 1.7 mm? -72.25 92.25 1.37 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.176 -0.675 . . . . 73.45 109.176 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -103.9 -5.6 22.15 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.115 0.783 . . . . 73.22 113.115 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -79.64 140.54 37.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.915 0.325 . . . . 55.52 111.54 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.7 121.32 0.69 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.334 1.054 . . . . 74.43 108.872 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.34 -178.19 0.18 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.643 1.177 . . . . 60.13 112.858 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.71 37.27 1.85 Allowed Glycine 0 N--CA 1.473 1.131 0 CA-C-N 116.045 -0.525 . . . . 75.23 112.346 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.84 148.68 25.58 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.988 0.915 . . . . 71.43 109.065 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.37 162.96 36.76 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 121.683 -0.294 . . . . 72.15 113.522 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 12.4 t -86.94 175.08 8.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.45 0.7 . . . . 64.42 110.912 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.39 17.99 0.34 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.126 0.97 . . . . 74.41 110.067 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.25 120.97 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.696 0.798 . . . . 74.11 110.911 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -82.03 92.95 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.645 -0.872 . . . . 70.12 108.645 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -80.24 82.17 6.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.699 -0.852 . . . . 75.21 108.699 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.84 154.87 17.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.395 -0.821 . . . . 71.44 109.675 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 C-N-CA 123.588 0.755 . . . . 61.4 108.97 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.821 -0.436 . . . . 72.4 109.821 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -160.3 81.05 0.68 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.549 1.14 . . . . 75.54 108.28 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' H' ' 172' ' ' ALA . 0.4 OUTLIER -136.8 70.26 1.41 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.255 1.026 . . . . 51.02 109.464 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -121.55 74.75 1.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.868 -1.06 . . . . 74.33 108.438 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -171.97 -176.76 1.76 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.835 -1.075 . . . . 64.34 108.21 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.49 80.56 0.1 Allowed 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 109.009 -0.737 . . . . 71.33 109.009 167.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -165.2 76.78 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.414 1.086 . . . . 71.53 108.532 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.11 172.74 10.51 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 115.14 -0.936 . . . . 71.51 109.079 169.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.491 ' SD ' HG23 ' D' ' 89' ' ' ILE . 11.1 tpt -33.43 124.26 0.41 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.416 1.086 . . . . 52.03 112.659 169.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 79.7 m -141.52 137.29 31.93 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.141 0.976 . . . . 71.45 109.507 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.7 t80 -156.31 104.72 2.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.212 -1.403 . . . . 74.23 107.212 172.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -110.35 112.08 23.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.926 -1.138 . . . . 50.23 107.926 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 tt -80.36 98.63 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.102 -1.444 . . . . 72.25 107.102 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.66 -50.04 7.51 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.6 -167.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -162.3 119.08 2.03 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.663 -0.495 . . . . 74.55 109.663 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.499 HG12 ' HG3' ' B' ' 130' ' ' PRO . 28.3 mm -111.49 118.21 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.897 -1.149 . . . . 74.35 107.897 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.5 146.59 28.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.28 0.632 . . . . 71.21 111.232 -171.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 50.0 p -75.98 113.04 13.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.021 -0.99 . . . . 62.31 109.938 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -80.92 -36.03 31.59 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.415 -0.587 . . . . 62.42 109.415 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -144.77 137.59 26.56 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.081 -0.963 . . . . 72.54 109.617 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.521 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.2 mt -137.55 139.63 43.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.872 -1.159 . . . . 65.3 107.872 174.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -142.09 140.72 32.61 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -151.8 120.95 6.72 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.625 -1.621 . . . . 65.1 106.625 173.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.04 112.95 11.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 64.15 109.778 -175.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -110.45 84.18 3.75 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.682 0.793 . . . . 64.13 109.581 177.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 -26.97 11.44 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.051 2.5 . . . . 64.13 113.183 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -114.82 25.35 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.922 0.889 . . . . 74.51 109.847 -174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -58.72 -57.42 26.86 Favored Pre-proline 0 CA--C 1.564 1.497 0 N-CA-C 115.038 1.496 . . . . 74.12 115.038 -164.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 86.6 Cg_endo -78.42 -15.07 14.25 Favored 'Trans proline' 0 C--N 1.38 2.217 0 CA-C-N 122.06 1.771 . . . . 75.22 112.799 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.42 -44.24 68.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.041 0.936 . . . . 71.2 109.543 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.497 HG23 ' HD2' ' D' ' 34' ' ' LYS . 2.1 p -84.38 0.77 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.61 0.764 . . . . 75.35 110.981 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.411 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 84.2 t80 -63.36 -17.33 62.49 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.464 1.106 . . . . 73.4 111.169 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -81.32 -1.31 44.77 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.69 0.796 . . . . 75.21 112.104 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.497 ' HD2' HG23 ' D' ' 31' ' ' VAL . 96.5 mttt -121.8 113.27 19.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.877 0.871 . . . . 74.05 112.446 -167.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.98 79.84 2.24 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.222 1.011 . . . . 73.13 111.228 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.425 ' HB2' HD22 ' D' ' 68' ' ' LEU . 22.3 m95 -127.04 171.38 11.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.508 -0.745 . . . . 74.34 110.572 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.566 ' HG2' ' H ' ' H' ' 191' ' ' GLY . 6.7 tp-100 -85.04 120.55 73.68 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.605 -1.257 . . . . 75.2 107.605 164.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.403 ' O ' HG23 ' D' ' 40' ' ' VAL . 31.8 Cg_exo -57.4 114.5 1.97 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.977 1.784 . . . . 71.44 110.972 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -65.8 112.39 3.71 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 106.71 -1.589 . . . . 73.51 106.71 167.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.699 HG13 HG13 ' D' ' 64' ' ' VAL . 71.2 t -116.34 111.66 36.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 123.188 0.595 . . . . 61.3 109.591 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -87.21 133.67 33.63 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.961 -1.125 . . . . 74.12 107.961 169.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.15 127.41 53.79 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.706 -1.22 . . . . 75.43 107.706 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.2 t70 -112.76 125.18 54.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.228 -0.656 . . . . 54.53 109.228 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.643 ' HB2' HD11 ' H' ' 186' ' ' LEU . 62.0 tp -97.05 131.6 43.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.114 0.965 . . . . 71.21 109.758 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.0 t70 -147.59 155.45 41.84 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.631 -0.877 . . . . 51.24 108.631 168.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -146.28 151.36 37.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.384 0.674 . . . . 63.14 109.759 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.04 172.6 14.98 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.177 0.991 . . . . 74.14 108.853 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.2 p -163.76 163.68 23.97 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.729 0.412 . . . . 44.02 110.73 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 54.9 p -154.04 139.59 17.84 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.401 0.68 . . . . 74.41 109.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.15 122.98 25.1 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 110.207 -0.294 . . . . 71.23 110.207 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.0 mt -94.64 -35.99 11.96 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.631 0.582 . . . . 51.23 109.639 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.83 -176.6 5.34 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.038 0.935 . . . . 53.21 110.008 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.76 128.13 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.79 -0.641 . . . . 74.02 109.314 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.44 ' H ' HD11 ' H' ' 173' ' ' LEU . 3.4 m-20 61.08 26.42 16.35 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.933 0.893 . . . . 52.52 110.854 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -139.68 122.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 C-N-CA 124.105 0.962 . . . . 61.14 109.717 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.454 ' HE2' HD12 ' H' ' 173' ' ' LEU . 17.0 m-85 -136.07 137.37 41.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 72.33 108.948 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.495 ' HB2' HD11 ' D' ' 51' ' ' LEU . 20.5 tt0 -88.29 118.6 28.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.235 -1.024 . . . . 62.23 108.235 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.44 140.29 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.128 -1.064 . . . . 75.52 108.128 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.2 t -121.87 143.06 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.437 1.095 . . . . 72.42 108.997 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -119.74 126.83 52.03 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.511 -1.292 . . . . 72.13 107.511 174.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.3 ttm-85 -106.66 104.44 14.12 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.339 -0.986 . . . . 73.23 108.339 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 128.19 48.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.799 -1.186 . . . . 64.02 107.799 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.4 m -120.9 129.0 53.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.987 -0.375 . . . . 53.41 109.987 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.699 HG13 HG13 ' D' ' 40' ' ' VAL . 71.7 t -111.95 109.1 27.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 125.365 1.466 . . . . 71.11 109.318 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -102.17 93.75 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.397 -1.334 . . . . 65.12 107.397 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.92 144.01 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.586 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 18.5 m -142.87 135.72 27.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.451 0.469 . . . . 75.23 112.196 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 52.0 mt -116.65 125.44 51.77 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.87 0.868 . . . . 73.42 109.176 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.48 -113.09 4.11 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.143 -0.383 . . . . 34.42 112.143 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 7.01 10.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.273 0.629 . . . . 65.51 110.865 -176.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -129.42 174.62 9.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.37 0.668 . . . . 73.22 110.212 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -72.62 132.85 44.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.541 -0.754 . . . . 64.12 110.91 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.558 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -82.04 -57.98 3.17 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.62 -0.882 . . . . 72.34 108.62 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -164.8 165.53 20.52 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 113.623 -1.626 . . . . 74.11 108.921 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -122.77 153.45 39.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.452 -1.314 . . . . 61.41 107.452 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.571 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 40.1 t -158.7 146.91 18.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.742 0.417 . . . . 75.13 110.098 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.67 128.92 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.181 -0.674 . . . . 74.12 109.181 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.44 114.18 32.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.214 -0.662 . . . . 64.51 109.214 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.8 mt-30 -89.46 86.24 6.73 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.422 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.56 104.44 10.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 113.868 -1.515 . . . . 74.32 108.729 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.35 164.74 28.41 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 111.848 -0.501 . . . . 60.12 111.848 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.65 131.82 2.56 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.774 -0.531 . . . . 73.54 111.774 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -87.88 132.24 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.957 -0.757 . . . . 55.14 108.957 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.38 145.49 47.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.54 0.736 . . . . 72.43 110.075 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 67.0 m -96.34 136.91 36.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.019 -0.734 . . . . 71.25 109.019 167.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.35 126.49 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.401 1.081 . . . . 70.03 110.134 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -167.93 156.03 8.84 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.733 0.813 . . . . 64.41 110.066 175.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 88.18 -20.68 28.37 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 120.147 -0.252 . . . . 34.23 112.951 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.527 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -116.83 157.94 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.12 0.968 . . . . 74.4 109.295 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.756 ' HA ' ' HG2' ' H' ' 174' ' ' MET . 0.3 OUTLIER -160.85 175.0 13.04 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.03 0.381 . . . . 75.23 112.03 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -133.45 46.79 Favored Glycine 0 C--N 1.355 1.596 0 O-C-N 124.153 0.908 . . . . 63.13 114.073 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.853 0.861 . . . . 72.23 111.398 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -58.77 -45.28 90.14 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.056 0.943 . . . . 74.11 110.074 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.733 ' SD ' HD23 ' D' ' 98' ' ' LEU . 1.7 tmt? -81.85 -30.74 31.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.097 -0.956 . . . . 64.33 110.982 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.27 75.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.133 0.573 . . . . 71.03 110.93 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -73.52 -38.42 65.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.92 -0.582 . . . . 74.14 109.957 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.1 t -62.5 -49.2 76.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.055 0.542 . . . . 73.54 111.575 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.733 HD23 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -69.03 -29.59 67.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.21 0.604 . . . . 72.42 111.973 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.19 -18.05 37.97 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.684 0.615 . . . . 63.02 113.342 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -122.44 -65.17 1.13 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.859 0.464 . . . . 73.12 111.396 -175.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -67.66 -49.72 61.42 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.556 0.576 . . . . 73.35 112.556 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.494 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.4 m -61.85 -47.42 91.69 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.521 0.728 . . . . 31.25 111.837 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.562 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -61.25 -34.96 87.21 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.48 2.12 . . . . 73.41 112.854 169.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -64.73 -29.54 70.52 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.049 0.54 . . . . 62.41 110.718 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.95 -42.81 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.401 0.681 . . . . 73.25 110.388 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.422 HD13 ' O ' ' D' ' 80' ' ' GLN . 63.9 mt -72.46 -23.74 61.1 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.201 -0.909 . . . . 71.22 111.222 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -64.91 -42.5 63.04 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.609 1.337 . . . . 63.02 114.609 -170.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.35 -41.4 59.34 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.115 1.876 . . . . 75.41 113.552 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -77.99 -36.83 48.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.81 0.844 . . . . 75.41 111.303 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.54 82.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.312 0.645 . . . . 52.4 109.895 176.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -54.59 -54.64 38.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.84 1.256 . . . . 74.41 110.467 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.1 -40.33 94.4 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.301 1.001 . . . . 71.0 111.381 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.416 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.4 t -57.41 -44.7 84.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.388 0.43 . . . . 71.14 110.406 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.56 HG21 HG21 ' D' ' 64' ' ' VAL . 86.7 mt -63.09 -55.15 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.164 -0.925 . . . . 75.34 110.238 173.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' D' ' 125' ' ' GLN . 95.7 m -50.09 -48.48 53.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.306 1.442 . . . . 64.33 111.882 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.7 t -65.1 -41.91 94.51 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.76 -1.109 . . . . 71.03 109.932 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.51 -36.84 85.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.154 0.581 . . . . 72.23 111.251 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -62.36 -49.54 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.461 -0.791 . . . . 74.15 109.91 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -71.32 -27.63 63.53 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.167 0.587 . . . . 72.04 111.403 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -73.47 -31.07 63.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.846 0.859 . . . . 75.42 110.178 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.42 5.41 68.31 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.675 0.61 . . . . 53.31 112.16 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.0 p 60.94 27.57 17.42 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 126.554 1.942 . . . . 75.33 112.663 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.402 ' HA ' ' CZ ' ' H' ' 195' ' ' PHE . 66.9 m-85 -93.32 162.47 27.96 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.826 1.251 . . . . 74.14 109.728 173.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.423 ' HD3' ' CZ ' ' H' ' 195' ' ' PHE . 19.8 Cg_exo -66.56 134.85 36.93 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.979 2.453 . . . . 61.42 111.485 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' D' ' 115' ' ' THR . 47.6 tt0 -55.59 134.21 50.85 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 124.314 1.009 . . . . 70.31 111.988 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 tp -106.58 96.5 6.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.129 -0.693 . . . . 74.22 109.129 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -99.55 84.74 3.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.368 -0.604 . . . . 72.31 109.368 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.76 129.24 39.31 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.726 -0.67 . . . . 72.44 110.631 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' G' ' 204' ' ' ILE . . . -68.26 140.46 92.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 123.243 0.617 . . . . 55.33 111.613 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.5 Cg_endo -82.38 122.36 3.63 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.25 1.967 . . . . 63.34 109.689 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.2 m -107.47 134.82 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.188 0.518 . . . . 73.23 110.088 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -83.96 96.54 8.87 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.892 0.853 . . . . 71.44 109.716 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.528 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 80.8 m-85 -61.6 -21.74 64.6 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.943 -1.026 . . . . 73.34 112.033 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.85 -49.25 78.23 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.47 1.108 . . . . 73.22 111.587 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.22 74.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.532 -0.758 . . . . 75.43 111.041 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.56 -32.43 73.77 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.926 0.766 . . . . 73.02 110.215 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.499 ' HA ' ' HZ ' ' H' ' 182' ' ' PHE . 91.5 t80 -58.8 -56.24 24.71 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.041 0.536 . . . . 64.42 110.146 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 67.6 mtm -64.15 -42.6 96.7 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.279 -0.873 . . . . 63.44 110.691 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -62.92 -42.99 99.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 74.11 112.096 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -70.73 -39.86 73.12 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.585 0.754 . . . . 73.14 111.53 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 95.2 mt -59.79 -29.48 68.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.317 0.647 . . . . 64.11 111.856 -177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.33 0.36 49.5 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.627 0.771 . . . . 63.51 111.936 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -121.32 83.02 2.01 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.636 0.774 . . . . 75.44 109.593 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -164.12 18.2 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.391 0.615 . . . . 43.04 110.795 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.8 112.54 20.19 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.62 0.768 . . . . 41.32 109.896 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.27 153.69 25.49 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 122.919 0.137 . . . . 75.33 113.214 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.49 -162.7 1.61 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.026 0.931 . . . . 73.3 110.13 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.44 157.11 7.12 Favored Glycine 0 C--N 1.353 1.524 0 C-N-CA 122.579 0.133 . . . . 54.12 113.255 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.4 t -94.26 24.46 4.4 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.508 0.723 . . . . 64.5 109.794 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -76.71 134.37 39.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.647 0.779 . . . . 71.41 110.694 -175.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.68 102.25 4.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.221 0.608 . . . . 64.54 109.369 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -168.29 161.65 12.24 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.267 1.027 . . . . 75.13 109.515 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -84.76 83.2 8.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.41 -0.589 . . . . 74.42 109.41 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.27 95.45 3.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.155 0.982 . . . . 73.31 110.074 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.195 0 N-CA-C 109.062 -0.718 . . . . 64.32 109.062 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.242 -0.281 . . . . 61.45 110.242 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 162.35 66.39 0.02 OUTLIER Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.891 -0.483 . . . . 62.15 111.891 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.3 130.94 45.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.705 0.402 . . . . 71.22 110.639 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 171' ' ' SER . . . . . 0.612 ' HA ' ' HG3' ' C' ' 90' ' ' GLU . 52.3 m -65.63 122.17 16.64 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.132 0.895 . . . . 70.02 110.716 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.14 1.75 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.639 0.775 . . . . 73.1 109.089 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' E' ' 174' ' ' MET . 0.0 OUTLIER -89.05 -28.27 20.25 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.484 0.714 . . . . 64.23 112.749 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.455 ' HB2' HD22 ' E' ' 173' ' ' LEU . 0.0 OUTLIER -117.78 -75.42 0.58 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.908 0.483 . . . . 74.5 109.917 -172.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -165.91 89.78 0.43 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -115.29 35.31 4.43 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.031 0.92 . . . . 73.24 109.64 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.19 172.63 16.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.693 . . . . 75.11 109.703 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -122.89 -54.99 1.81 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.067 -0.716 . . . . 70.12 109.067 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -116.46 156.34 47.54 Favored Pre-proline 0 C--O 1.249 1.059 0 CA-C-N 114.986 -1.006 . . . . 72.1 109.254 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.17 164.43 33.99 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.267 1.978 . . . . 72.03 111.37 172.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.47 -35.24 67.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.692 0.797 . . . . 75.23 111.445 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -147.21 154.24 40.79 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.262 1.025 . . . . 70.14 108.826 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 13.4 t -80.85 157.25 25.74 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.958 0.503 . . . . 64.42 110.215 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.04 151.75 43.52 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.781 0.832 . . . . 65.15 111.914 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.51 136.86 56.74 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.996 2.464 . . . . 65.11 112.175 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.562 HD22 ' H ' ' C' ' 44' ' ' LEU . 67.5 mt -106.32 143.43 34.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 74.24 109.784 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 tt -91.06 146.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 122.999 0.52 . . . . 62.43 110.159 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.71 146.36 28.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.653 0.781 . . . . 75.22 109.232 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -108.39 128.22 54.58 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.924 -0.769 . . . . 73.12 108.924 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.04 132.64 51.17 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.89 0.744 . . . . 63.2 109.753 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.04 56.31 4.32 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.322 0.389 . . . . 63.31 113.191 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -76.0 76.48 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.906 -0.877 . . . . 72.33 110.906 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 57.06 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.263 1.425 . . . . 75.25 112.581 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 194' ' ' ALA . . . . . 0.656 ' HB2' ' HE2' ' F' ' 201' ' ' LYS . . . 60.72 -166.39 0.2 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.564 0.745 . . . . 55.41 110.336 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 9.4 t80 55.92 97.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.637 1.175 . . . . 75.44 112.565 169.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -66.82 93.39 0.26 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.51 -0.552 . . . . 74.44 109.51 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 69.32 7.36 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.054 -1.091 . . . . 74.55 108.054 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -60.94 -49.97 75.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.251 1.02 . . . . 72.14 109.774 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 199' ' ' ASN . . . . . 0.432 ' HB3' ' HA ' ' E' ' 202' ' ' TYR . 56.6 t-20 -169.37 133.8 1.41 Allowed 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.936 -1.505 . . . . 74.12 106.936 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.55 -22.57 66.01 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.512 0.507 . . . . 72.41 113.557 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -112.72 -8.55 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.384 0.674 . . . . 63.54 111.947 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 202' ' ' TYR . . . . . 0.548 ' CD2' ' HB2' ' B' ' 129' ' ' ALA . 87.8 m-85 63.92 -159.15 0.31 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.312 1.045 . . . . 64.44 110.371 -167.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.73 82.78 6.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.082 0.553 . . . . 74.11 110.755 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.25 99.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.696 0.799 . . . . 74.52 109.703 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -158.07 -57.28 0.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.413 -0.958 . . . . 63.21 108.413 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.64 -5.33 57.97 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.667 -1.151 . . . . 75.23 111.266 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.433 HG22 ' HG2' ' F' ' 185' ' ' PRO . 48.3 t . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 118.392 -0.813 . . . . 72.34 108.851 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.092 -0.336 . . . . 64.32 110.092 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.56 35.45 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 116.308 -0.405 . . . . 72.21 112.346 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -120.21 -69.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.129 0.572 . . . . 55.41 109.885 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 22.8 t -168.05 -151.59 0.11 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.812 -1.181 . . . . 72.15 107.812 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 172' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' B' ' 90' ' ' GLU . . . -68.65 -12.39 61.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.94 0.496 . . . . 73.5 112.011 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.2 146.63 24.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.725 0.81 . . . . 72.22 110.288 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' B' ' 56' ' ' TYR . 31.8 mmt 66.95 -75.88 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.386 1.474 . . . . 71.31 111.85 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.43 91.94 3.76 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.199 -0.667 . . . . 62.42 109.199 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -94.98 -47.25 6.49 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.329 0.652 . . . . 70.21 110.423 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.136 0.898 . . . . 71.03 113.217 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 60.82 20.09 10.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.712 1.205 . . . . 73.23 111.693 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.31 148.45 8.14 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.849 0.86 . . . . 73.34 109.102 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.8 97.87 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.677 2.252 . . . . 43.52 111.894 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -71.03 110.76 5.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.929 -0.578 . . . . 74.41 110.385 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 68.68 -65.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.923 1.689 . . . . 74.11 112.904 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 30.8 m 82.04 120.83 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.631 1.972 . . . . 74.54 111.455 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.463 ' CZ2' HD22 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -50.92 141.79 18.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 125.641 1.577 . . . . 74.51 112.615 175.14 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 185' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' F' ' 184' ' ' TRP . 19.9 Cg_exo -66.98 133.91 32.65 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.998 2.465 . . . . 62.24 112.228 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 43' ' ' ASP . 93.3 mt -99.86 115.71 30.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.828 0.851 . . . . 53.41 109.526 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.49 0.716 . . . . 43.43 111.469 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.52 139.7 33.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.889 0.876 . . . . 62.14 109.764 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.91 -31.31 20.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.376 0.671 . . . . 72.41 111.126 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 21.3 t70 70.55 158.82 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.795 1.238 . . . . 62.42 111.225 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.85 147.24 42.94 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.565 -0.289 . . . . 61.21 112.977 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.42 -153.51 6.55 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 111.705 -0.558 . . . . 44.05 111.705 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -133.1 8.35 4.03 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.521 0.728 . . . . 74.43 111.228 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.92 52.34 1.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 61.15 111.205 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' B' ' 37' ' ' GLN . 49.7 t80 -174.37 85.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.111 0.964 . . . . 71.13 108.853 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 196' ' ' LYS . . . . . 0.547 ' HE3' ' HB2' ' F' ' 199' ' ' ASN . 52.0 pttt -175.7 133.88 0.28 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.63 1.172 . . . . 64.44 108.705 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -51.34 -38.57 53.81 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.496 1.119 . . . . 64.11 113.216 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.77 -53.65 54.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 75.33 110.929 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 199' ' ' ASN . . . . . 0.547 ' HB2' ' HE3' ' F' ' 196' ' ' LYS . 10.4 t-20 -81.39 -12.39 58.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 74.01 110.395 -176.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.02 -152.19 21.19 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.235 -0.893 . . . . 63.02 111.716 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 201' ' ' LYS . . . . . 0.656 ' HE2' ' HB2' ' E' ' 194' ' ' ALA . 10.8 mptt 68.34 108.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.653 1.181 . . . . 71.31 111.695 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 202' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' C' ' 125' ' ' GLN . 0.9 OUTLIER 68.49 25.82 6.69 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.354 1.461 . . . . 65.44 111.297 166.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -120.95 -174.15 2.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.694 1.197 . . . . 72.41 109.888 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 21.3 tt -106.19 133.12 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 54.25 110.502 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -115.68 -60.97 1.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.258 0.623 . . . . 72.33 109.577 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.43 122.89 44.59 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.27 -0.877 . . . . 64.12 111.014 -173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' C' ' 131' ' ' VAL . 14.5 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.801 1.64 . . . . 73.33 110.867 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 6.5 mptt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 108.909 -0.774 . . . . 74.23 108.909 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.76 0.22 62.76 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 116.611 -0.268 . . . . 61.33 113.32 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -83.44 -14.05 53.41 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.662 -0.496 . . . . 72.5 109.662 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 17.5 m -78.3 157.97 29.01 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 124.491 1.116 . . . . 65.22 112.1 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 172' ' ' ALA . . . . . 0.633 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . . . -136.88 3.8 2.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.713 0.805 . . . . 73.3 111.485 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.504 HD13 ' HG2' ' G' ' 174' ' ' MET . 0.8 OUTLIER -59.18 109.53 0.87 Allowed 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.432 0.693 . . . . 64.0 109.643 -173.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.504 ' HG2' HD13 ' G' ' 173' ' ' LEU . 29.3 mmt 75.08 89.15 0.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.806 1.642 . . . . 73.52 110.8 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 71.96 -108.8 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 73.54 111.608 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 8.4 t30 63.63 7.18 2.96 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.768 . . . . 72.02 112.599 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 11.2 mp -57.04 -67.47 0.31 Allowed 'General case' 0 C--N 1.364 1.226 0 C-N-CA 123.079 0.552 . . . . 73.13 109.911 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 60.99 115.41 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.638 1.175 . . . . 65.32 111.287 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 68.9 123.64 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 125.108 1.363 . . . . 73.22 109.844 -168.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.47 113.52 1.53 Allowed 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.422 2.082 . . . . 50.11 111.206 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -111.7 125.42 53.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.251 0.62 . . . . 71.43 109.383 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 66.15 92.97 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.456 1.502 . . . . 72.52 111.711 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 34.0 p -123.33 127.96 49.26 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.537 -0.912 . . . . 73.14 108.537 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -100.5 142.78 25.27 Favored Pre-proline 0 C--O 1.244 0.772 0 C-N-CA 123.964 0.906 . . . . 72.1 110.309 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.35 117.99 2.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.58 2.187 . . . . 70.14 111.715 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 186' ' ' LEU . . . . . 0.446 HD21 HD22 ' A' ' 44' ' ' LEU . 3.8 mm? -73.06 151.2 41.79 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.454 -0.794 . . . . 71.53 109.678 173.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.67 175.49 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.491 0.716 . . . . 75.13 111.551 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.32 44.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.02 0.528 . . . . 51.54 109.581 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -104.28 121.87 44.23 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.983 -0.747 . . . . 75.31 108.983 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.14 -54.23 49.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.656 1.182 . . . . 74.34 111.395 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.65 -68.78 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.251 -1.139 . . . . 74.41 110.251 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.21 -11.12 70.99 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.56 -0.32 . . . . 64.31 113.607 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -163.19 155.7 18.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.059 0.543 . . . . 71.15 110.533 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -105.85 4.36 29.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.255 1.022 . . . . 64.54 110.408 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 68.41 -171.1 0.18 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.401 1.48 . . . . 71.34 110.396 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -140.58 90.95 2.39 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.412 -0.588 . . . . 74.01 109.412 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -105.48 -31.91 8.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.389 1.076 . . . . 73.33 110.006 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.47 -54.28 43.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.082 0.953 . . . . 71.41 111.051 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -119.97 39.15 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.354 -0.98 . . . . 63.32 108.354 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -141.8 65.25 0.5 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.481 -0.781 . . . . 70.14 111.606 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -115.04 148.97 38.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.976 0.91 . . . . 74.02 108.849 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -73.09 -33.24 65.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.601 0.76 . . . . 71.44 110.476 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.04 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.694 1.998 . . . . 73.35 113.681 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.509 HG21 ' HB2' ' D' ' 129' ' ' ALA . 63.4 mt -90.93 134.29 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.336 -0.847 . . . . 75.12 110.575 -175.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 205' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' H' ' 188' ' ' ALA . 12.2 mptt -93.61 105.52 17.56 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.365 -1.346 . . . . 72.14 107.365 170.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.48 162.34 29.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.571 0.748 . . . . 73.34 111.291 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.562 1.433 0 CA-C-O 118.386 -0.816 . . . . 63.21 109.967 175.918 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.324 -0.621 . . . . 73.44 109.324 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 179.59 -83.23 0.06 OUTLIER Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.606 -0.598 . . . . 52.43 111.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -114.2 18.61 16.95 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.149 0.58 . . . . 72.41 110.431 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 61.4 m 62.59 86.53 0.11 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.684 1.194 . . . . 61.33 111.683 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' D' ' 3' ' ' GLU . . . -89.18 23.35 2.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.69 -0.687 . . . . 65.22 111.238 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.454 HD12 ' HE2' ' D' ' 56' ' ' TYR . 3.7 mm? -61.44 144.63 53.82 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 121.989 0.899 . . . . 70.43 113.214 -166.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.756 ' HG2' ' HA ' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -161.97 168.46 22.81 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.057 -1.883 . . . . 61.45 108.492 -172.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -165.28 -68.51 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.297 -1.001 . . . . 74.11 108.297 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.9 -8.05 1.01 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.857 1.263 . . . . 63.52 113.728 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.56 73.05 10.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.429 0.633 . . . . 72.25 110.236 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.09 -35.15 10.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.243 -1.021 . . . . 72.13 108.243 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -108.42 140.59 21.9 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.074 -1.084 . . . . 74.22 108.074 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.6 -9.18 23.67 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.899 2.399 . . . . 72.33 114.235 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 65.43 -77.03 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.284 1.433 . . . . 73.25 109.524 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 182' ' ' PHE . . . . . 0.499 ' HZ ' ' HA ' ' D' ' 137' ' ' PHE . 45.1 p90 -165.16 152.47 10.9 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.655 1.182 . . . . 73.5 108.83 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 38.6 m -89.17 129.57 35.74 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.523 -0.547 . . . . 70.3 109.523 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 30.3 m-90 -73.64 138.08 77.26 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 122.933 0.493 . . . . 75.21 109.933 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.86 144.27 82.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.992 2.462 . . . . 73.24 111.818 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 186' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' D' ' 44' ' ' LEU . 89.7 mt -100.13 -164.51 1.13 Allowed 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.573 0.749 . . . . 74.11 111.026 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.522 ' H ' HD12 ' H' ' 187' ' ' ILE . 3.8 mp -73.08 104.31 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.831 0.852 . . . . 40.41 109.391 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 188' ' ' ALA . . . . . 0.57 ' HB3' ' HB2' ' G' ' 205' ' ' LYS . . . -72.08 85.18 1.01 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.21 -1.033 . . . . 65.41 108.21 168.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 189' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' H' ' 187' ' ' ILE . . . -105.0 123.61 48.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.029 -0.987 . . . . 45.2 110.187 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -164.46 136.44 4.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.422 0.689 . . . . 63.31 109.573 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 191' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' D' ' 37' ' ' GLN . . . -131.74 0.18 4.94 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 124.013 0.82 . . . . 71.21 112.989 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.06 -69.81 2.87 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 117.239 0.52 . . . . 73.21 112.874 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.17 149.6 52.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.86 0.864 . . . . 74.43 110.45 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -154.38 -164.4 1.83 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.721 1.608 . . . . 64.33 107.073 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.423 ' CZ ' ' HD3' ' D' ' 124' ' ' PRO . 0.1 OUTLIER 67.0 177.38 0.24 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.287 0.635 . . . . 75.22 111.742 178.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -172.47 85.15 0.07 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.801 -1.09 . . . . 73.33 109.22 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -86.35 93.96 9.24 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.451 -0.574 . . . . 74.43 109.451 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -140.3 26.7 2.16 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.663 0.744 . . . . 72.24 110.371 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -79.08 -42.67 25.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.53 -0.759 . . . . 61.34 109.642 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 67.15 -83.93 0.12 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.484 -0.78 . . . . 71.32 112.926 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 201' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' H' ' 203' ' ' ASP . 76.6 tttt -142.61 119.96 11.6 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.033 -1.099 . . . . 73.31 108.033 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.23 -32.32 72.98 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 71.1 110.848 172.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 203' ' ' ASP . . . . . 0.414 ' HA ' ' HE2' ' H' ' 201' ' ' LYS . 15.2 t70 69.9 5.31 5.19 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.986 1.314 . . . . 73.43 111.76 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 22.1 pt -80.83 140.5 16.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 123.883 0.873 . . . . 74.44 111.466 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -154.42 94.82 1.74 Allowed 'General case' 0 C--O 1.243 0.757 0 N-CA-C 106.254 -1.758 . . . . 72.55 106.254 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.0 -81.88 0.08 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 109.057 -0.719 . . . . 72.11 109.057 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.258 1.535 0 N-CA-C 106.944 -1.502 . . . . 72.23 106.944 171.934 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.0 mtp . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.168 -0.678 . . . . 74.2 109.168 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -147.38 123.0 10.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.124 -0.489 . . . . 64.22 110.82 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -102.42 113.4 26.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.443 -0.947 . . . . 71.43 108.443 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.81 -46.96 42.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.194 0.598 . . . . 74.31 111.067 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 61.87 91.47 0.06 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.599 1.16 . . . . 62.31 110.744 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -128.68 154.23 46.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 73.23 109.512 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 m -68.31 155.73 39.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.159 0.984 . . . . 73.21 110.121 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.93 79.82 0.31 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.649 0.78 . . . . 72.13 109.547 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.631 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 24.4 ptm -77.56 164.8 25.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 65.31 111.968 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.4 m -141.58 116.06 9.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.729 0.812 . . . . 51.43 109.365 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -115.83 126.93 54.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.957 -1.497 . . . . 74.35 106.957 165.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 4.1 tp60 -143.56 124.65 14.46 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.082 0.239 . . . . 64.54 110.632 -166.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.62 98.61 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.576 -0.898 . . . . 75.05 108.576 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -82.41 -30.64 30.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.915 -0.564 . . . . 73.51 111.535 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 179.22 121.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.458 0.703 . . . . 74.12 110.084 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.571 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 86.8 mt -105.84 130.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.846 -1.168 . . . . 72.21 107.846 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.813 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 22.6 p90 -171.95 152.44 2.96 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 124.193 0.933 . . . . 71.34 110.561 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -75.64 119.38 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.215 -0.661 . . . . 74.04 109.215 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -78.69 -46.28 19.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.136 -0.69 . . . . 60.44 109.136 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.46 136.73 41.53 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.889 -1.05 . . . . 71.3 109.383 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -129.06 140.72 48.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.354 -1.35 . . . . 74.13 107.354 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -142.96 128.72 19.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.452 0.701 . . . . 64.11 109.436 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 81.8 t80 -139.19 115.86 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.841 -1.541 . . . . 72.33 106.841 171.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -115.89 144.97 43.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.335 -0.987 . . . . 71.14 108.335 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.34 74.29 11.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.248 -1.39 . . . . 50.24 107.248 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.09 -23.34 24.93 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.543 2.162 . . . . 71.33 111.437 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 80.0 m-20 -110.4 33.54 4.44 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.858 -1.065 . . . . 53.4 109.79 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' B' ' 17' ' ' TYR . . . -59.5 -43.42 95.92 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.28 1.032 . . . . 75.22 113.126 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -69.63 -27.83 26.63 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.715 1.61 . . . . 72.24 113.023 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.6 m170 -72.6 -37.17 68.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.082 0.553 . . . . 72.44 111.077 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 68' ' ' LEU . 13.6 p -68.3 -23.11 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.903 0.881 . . . . 63.33 112.317 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.572 ' HD1' HH11 ' B' ' 15' ' ' ARG . 78.5 t80 -70.39 -35.65 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.882 0.373 . . . . 72.32 110.393 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -70.73 -46.04 63.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.451 -0.795 . . . . 74.54 109.658 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 3.7 mmmp? -73.17 151.92 41.32 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.425 -1.261 . . . . 64.43 111.201 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.72 136.1 47.06 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.583 -0.735 . . . . 70.42 109.421 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -75.41 84.68 2.53 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.736 0.779 . . . . 71.14 109.261 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -118.23 76.79 12.47 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.882 -1.053 . . . . 64.31 108.434 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.17 125.64 9.91 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.914 1.742 . . . . 61.41 111.627 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -97.26 89.98 4.95 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.706 -1.59 . . . . 75.41 106.706 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.452 HG23 ' HA2' ' G' ' 191' ' ' GLY . 62.0 t -70.72 92.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.529 -0.76 . . . . 64.31 110.5 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.39 115.29 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.452 -0.944 . . . . 51.05 108.452 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.49 151.54 19.9 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.771 -0.826 . . . . 61.03 108.771 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.5 t70 -143.37 147.78 35.2 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.357 -0.979 . . . . 65.03 108.357 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp -134.96 126.31 28.35 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.453 -0.943 . . . . 61.44 108.453 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -143.47 156.66 44.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.609 -0.886 . . . . 32.45 108.609 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -140.3 151.56 45.17 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.095 0.558 . . . . 61.12 110.149 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.7 153.58 49.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.999 1.32 . . . . 61.23 108.088 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.6 m -131.82 157.43 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.867 0.365 . . . . 74.22 110.663 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -148.24 120.69 8.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.657 -0.868 . . . . 75.32 108.657 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -81.99 105.22 12.92 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.772 -0.825 . . . . 74.44 108.772 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.18 -33.08 24.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.181 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.35 179.8 8.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.028 0.931 . . . . 65.31 109.736 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -70.35 125.03 25.62 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.843 -1.169 . . . . 54.11 107.843 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 75.11 -8.19 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.688 1.595 . . . . 73.54 112.785 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -107.45 110.6 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.683 -0.858 . . . . 71.32 108.683 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -133.65 123.67 25.44 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.271 -0.64 . . . . 71.14 109.271 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 28.0 tt0 -86.62 116.15 24.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.771 -0.649 . . . . 71.33 109.271 175.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.51 115.6 42.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 N-CA-C 107.233 -1.395 . . . . 55.21 107.233 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.3 t -98.78 136.6 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.694 0.798 . . . . 71.32 109.037 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.45 111.67 23.34 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.562 -1.273 . . . . 71.43 107.562 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.01 101.95 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.399 -0.963 . . . . 72.14 108.399 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.29 135.8 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.601 -1.259 . . . . 75.23 107.601 175.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 11.8 m -128.73 144.16 51.1 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.768 -0.456 . . . . 74.42 109.768 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 10.0 t -140.77 125.67 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.672 1.589 . . . . 75.33 107.793 -171.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -129.36 131.92 46.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.698 -0.482 . . . . 62.12 109.698 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.34 108.53 18.64 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.663 -0.866 . . . . 51.13 108.663 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.4 m -108.85 139.32 43.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.001 0.52 . . . . 74.11 110.17 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.647 HD11 HG23 ' A' ' 31' ' ' VAL . 6.2 mt -113.65 78.48 1.15 Allowed 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.273 -1.01 . . . . 63.42 108.273 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.54 -86.13 1.24 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.97 -0.852 . . . . 44.32 110.97 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -131.05 -8.09 3.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.423 1.089 . . . . 64.32 111.303 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -99.71 110.35 22.75 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.264 -0.643 . . . . 71.41 109.264 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.0 m -70.76 132.12 44.87 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 110.056 -0.349 . . . . 50.12 110.056 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 -60.53 2.33 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.07 0.948 . . . . 61.21 109.367 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -151.99 172.18 16.67 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 114.613 -1.176 . . . . 74.33 111.075 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.7 tp -132.57 147.43 52.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.903 1.281 . . . . 63.32 108.521 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -135.66 136.15 40.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.499 1.12 . . . . 71.23 109.145 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -147.37 129.28 15.34 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.489 -0.93 . . . . 75.54 108.489 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.21 109.56 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.959 -0.756 . . . . 71.22 108.959 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.57 82.84 8.09 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.186 -1.042 . . . . 74.13 108.186 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 41.8 tp60 -75.69 92.26 2.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.553 -1.203 . . . . 63.34 108.403 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.68 144.23 21.17 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.315 -0.714 . . . . 63.44 111.315 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.89 118.26 1.22 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 110.11 -1.196 . . . . 63.02 110.11 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.4 mt -81.25 124.12 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.581 -1.266 . . . . 44.41 107.581 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 49.4 m-85 -133.35 121.05 21.78 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.411 -0.588 . . . . 73.12 109.411 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 22.4 t -79.36 96.67 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.026 -1.101 . . . . 65.51 108.026 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.53 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -121.2 128.07 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.067 -0.97 . . . . 64.42 109.418 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -174.15 178.15 2.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.535 1.134 . . . . 72.45 110.43 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 85.69 4.38 85.29 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.928 -0.578 . . . . 65.01 113.951 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.526 HD11 HD11 ' G' ' 173' ' ' LEU . 2.0 pp -114.21 153.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.983 0.913 . . . . 63.42 109.546 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -144.33 168.94 18.9 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 109.27 -0.641 . . . . 62.53 109.27 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.557 ' HA2' ' H ' ' G' ' 170' ' ' LYS . . . 54.77 -127.29 40.24 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.727 0.642 . . . . 61.01 114.688 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.6 p -62.25 -26.36 68.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.43 1.092 . . . . 65.21 112.077 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -64.07 -36.41 83.92 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.903 0.881 . . . . 75.32 111.074 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.401 ' CB ' ' HB3' ' G' ' 172' ' ' ALA . 77.7 mtp -67.27 -45.38 76.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.622 0.769 . . . . 65.1 110.2 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.85 71.98 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.884 -1.053 . . . . 72.53 111.255 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -66.96 -44.32 80.82 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.966 0.906 . . . . 61.41 110.362 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 14.3 t -71.81 -63.24 1.17 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.624 0.577 . . . . 73.33 110.791 -171.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.552 ' HB2' HD23 ' G' ' 173' ' ' LEU . 49.2 tp -68.75 -38.39 80.08 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 120.555 0.217 . . . . 72.43 111.525 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.15 -9.33 84.21 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.347 -0.696 . . . . 25.33 114.715 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.32 -53.68 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.904 0.852 . . . . 71.43 112.743 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 89.9 t80 -72.99 -60.97 1.98 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.72 0.808 . . . . 72.41 113.156 -164.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 72.0 m -61.22 -39.72 66.16 Favored Pre-proline 0 CA--C 1.557 1.23 0 N-CA-C 113.761 1.023 . . . . 64.05 113.761 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.47 -33.56 68.4 Favored 'Trans proline' 0 C--N 1.382 2.341 0 CA-C-N 120.976 1.384 . . . . 62.14 112.87 167.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -72.87 -23.62 60.76 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 117.903 0.319 . . . . 60.44 111.212 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.12 -42.31 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.952 0.882 . . . . 52.35 109.305 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.1 -24.47 40.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.143 -1.39 . . . . 64.12 112.348 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.39 -41.91 86.15 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.923 1.082 . . . . 73.21 113.923 -171.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.89 -39.33 91.79 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.421 2.081 . . . . 65.24 113.313 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -76.27 -41.69 48.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.308 -0.86 . . . . 65.23 111.387 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.86 85.93 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 73.0 109.984 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.401 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.8 ttm180 -49.86 -59.08 4.19 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 124.897 1.373 . . . . 70.33 109.683 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 4.4 tm-20 -58.32 -40.97 83.5 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.428 1.08 . . . . 71.42 112.251 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.485 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.0 t -62.07 -47.6 83.94 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.503 0.502 . . . . 63.21 110.91 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.415 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 96.2 mt -61.47 -43.96 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.76 0.824 . . . . 60.13 110.464 175.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 125' ' ' GLN . 74.0 m -58.26 -42.75 87.12 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.909 1.284 . . . . 54.32 111.586 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -72.93 -41.5 64.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.314 -0.857 . . . . 33.11 110.888 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.0 mtm -58.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.653 0.381 . . . . 60.44 111.324 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.9 -42.99 96.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.974 0.796 . . . . 51.32 111.47 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.4 p -67.56 -29.0 68.26 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.106 0.479 . . . . 71.12 110.958 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.8 -31.55 64.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.713 0.805 . . . . 73.13 109.943 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 29.53 4.56 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.972 0.796 . . . . 74.32 113.623 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t 60.98 16.8 7.31 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.725 2.01 . . . . 70.14 114.994 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.18 159.36 52.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.618 -0.676 . . . . 72.42 111.962 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.18 139.76 90.91 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.82 2.346 . . . . 51.23 111.674 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.606 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.0 pt20 -55.44 151.64 9.9 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.576 1.173 . . . . 74.2 112.138 -173.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.02 97.46 5.62 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 71.31 108.997 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -124.6 101.82 7.31 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.522 1.129 . . . . 73.24 109.406 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.78 159.11 32.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.882 0.873 . . . . 74.42 112.006 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 152.37 95.98 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.895 0.878 . . . . 62.41 111.731 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -91.71 111.26 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.284 2.656 . . . . 74.42 112.191 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.441 HG13 ' HB ' ' H' ' 207' ' ' VAL . 49.6 t -100.84 111.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.961 -1.126 . . . . 75.4 107.961 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -96.14 73.06 2.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.079 0.942 . . . . 71.04 109.258 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.481 ' HZ ' ' HB2' ' G' ' 182' ' ' PHE . 71.5 t80 -71.21 -25.3 62.45 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.069 -1.423 . . . . 73.43 110.25 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -67.8 -40.23 83.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.977 0.911 . . . . 63.24 110.665 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.71 -30.33 67.94 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 115.616 -0.72 . . . . 72.03 110.082 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.08 -35.98 76.39 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 123.81 0.694 . . . . 65.41 111.25 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 74.8 m-85 -59.43 -51.88 67.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.227 -0.286 . . . . 73.13 110.227 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.5 mmt -58.36 -42.84 87.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.872 0.869 . . . . 75.24 111.731 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -76.03 -50.26 15.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.98 -1.009 . . . . 70.12 111.419 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -73.8 -31.7 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 119.132 -0.461 . . . . 62.32 112.205 -172.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -55.71 -52.53 63.58 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.261 0.624 . . . . 72.11 110.782 -170.63 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -152.05 -17.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.647 0.779 . . . . 62.41 111.044 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 48.05 81.43 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.697 1.199 . . . . 73.35 111.137 -171.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.37 156.97 47.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.969 0.507 . . . . 52.55 110.814 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.59 175.53 13.53 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.903 -1.044 . . . . 75.1 109.755 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.99 57.22 2.18 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.897 -0.481 . . . . 54.4 111.897 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' HB2' HE22 ' C' ' 142' ' ' GLN . 10.3 tp10 -76.78 142.63 40.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.294 0.638 . . . . 55.31 110.275 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.27 60.16 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 114.435 0.534 . . . . 74.33 114.435 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -100.64 122.15 42.82 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.329 0.564 . . . . 64.31 109.778 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.05 -29.4 23.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.577 0.751 . . . . 62.44 110.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.77 98.37 1.53 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.195 0.598 . . . . 73.14 109.585 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -99.45 21.61 11.9 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.877 -0.786 . . . . 73.25 108.877 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.1 101.83 0.93 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.202 -1.036 . . . . 74.22 108.202 172.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.51 128.71 34.74 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.665 -0.698 . . . . 74.31 109.979 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 123.779 0.832 . . . . 71.21 111.402 -176.316 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.577 -0.897 . . . . 74.4 108.577 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.516 ' HA ' HD12 ' F' ' 173' ' ' LEU . 33.4 p -61.32 93.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.846 0.858 . . . . 74.22 111.097 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.26 102.01 7.7 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.403 -1.332 . . . . 75.42 107.403 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -80.31 85.94 5.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.941 0.497 . . . . 44.54 110.885 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -106.99 147.67 29.61 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.102 -0.703 . . . . 72.04 109.102 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -73.62 83.21 1.55 Allowed 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 122.233 1.016 . . . . 74.02 110.937 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 144.95 43.78 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.633 -1.247 . . . . 73.24 107.633 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -84.79 64.67 8.71 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.417 -0.586 . . . . 63.23 109.417 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.3 ptm 47.78 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.033 2.133 . . . . 73.25 114.593 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -143.21 132.49 23.28 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.432 -1.322 . . . . 75.02 107.432 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.43 ' HA ' HG22 ' B' ' 86' ' ' ILE . 16.9 t80 -127.87 139.24 52.74 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -149.66 141.05 23.26 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.23 0.612 . . . . 63.43 109.789 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.447 HD11 HG13 ' B' ' 16' ' ' ILE . 7.2 tp -93.18 136.21 25.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 109.018 -0.734 . . . . 62.34 109.018 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.589 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.9 mm100 -104.95 -51.14 3.1 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.33 -0.619 . . . . 63.53 109.33 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.572 HH11 ' HD1' ' A' ' 32' ' ' PHE . 52.2 ttt180 -173.26 138.83 0.75 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.055 0.542 . . . . 75.23 110.543 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.447 HG13 HD11 ' B' ' 13' ' ' ILE . 55.8 mt -114.71 141.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.075 -1.083 . . . . 72.52 108.075 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 26.0 p90 -167.5 156.45 9.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.112 0.482 . . . . 75.43 111.957 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.9 m -81.57 125.83 31.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.31 -0.859 . . . . 74.0 108.685 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.436 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.36 -34.91 10.48 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.159 0.584 . . . . 71.42 111.301 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.6 t70 -153.95 132.82 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.743 -0.662 . . . . 65.23 109.942 -165.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.9 mm -135.94 138.31 47.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 124.102 0.961 . . . . 62.53 109.462 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.2 m -138.33 121.29 16.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.413 -1.267 . . . . 72.31 108.674 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.529 ' HZ ' ' HD2' ' B' ' 123' ' ' PHE . 83.3 t80 -130.65 108.59 10.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.652 -1.61 . . . . 72.24 106.652 163.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -122.45 114.67 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 63.4 108.746 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.21 87.15 3.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 74.14 108.867 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 35.7 Cg_endo -61.75 -41.12 40.52 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.173 2.582 . . . . 72.42 112.901 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -110.52 30.95 6.33 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.109 0.964 . . . . 63.44 109.912 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.813 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.66 -50.32 51.87 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 125.875 1.67 . . . . 62.03 115.057 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.89 -19.21 16.25 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.008 1.805 . . . . 73.41 112.445 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.04 5.01 53.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.923 1.289 . . . . 65.42 110.863 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.95 -28.85 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.548 0.739 . . . . 72.05 111.698 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -73.69 -33.51 64.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.38 0.672 . . . . 70.34 111.314 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.54 -20.38 63.69 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.135 0.974 . . . . 73.43 110.476 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -104.68 112.07 25.01 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.5 1.52 . . . . 64.1 111.379 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -93.54 77.97 4.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.229 0.612 . . . . 63.4 111.65 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 170.96 152.48 0.05 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 126.384 1.874 . . . . 72.34 109.307 161.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.436 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 0.6 OUTLIER -80.56 128.65 71.61 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 108.994 -0.743 . . . . 74.52 108.994 -177.041 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.519 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 10.6 Cg_endo -52.74 129.7 33.78 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.56 2.84 . . . . 53.1 114.048 -168.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.9 pt-20 -53.75 123.02 11.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.33 1.019 . . . . 52.43 110.358 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.442 HG21 ' HE3' ' E' ' 196' ' ' LYS . 21.8 t -85.41 124.1 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 107.973 -1.121 . . . . 74.31 107.973 -174.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -147.95 142.91 26.93 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.381 0.673 . . . . 75.11 109.598 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.55 164.59 21.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.67 0.788 . . . . 51.42 111.012 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.0 m-20 -140.25 144.26 36.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.166 1.386 . . . . 73.52 108.375 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tt -129.2 96.28 4.27 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.027 -1.101 . . . . 74.22 108.027 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.85 158.3 39.86 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.147 0.979 . . . . 74.42 109.156 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -139.63 137.4 35.26 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.02 0.438 . . . . 74.2 110.901 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.69 161.46 21.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.627 1.171 . . . . 62.12 108.377 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 p -146.14 167.44 23.43 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.278 0.231 . . . . 53.45 111.107 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -153.12 135.59 15.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.061 0.944 . . . . 64.23 109.192 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -84.89 132.88 34.33 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.71 0.804 . . . . 71.23 109.408 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -99.13 -41.9 7.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.125 0.57 . . . . 61.11 110.262 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -169.34 3.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.266 0.627 . . . . 70.42 110.871 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.39 119.05 19.73 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.322 -0.854 . . . . 73.34 110.22 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 59.99 21.98 11.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.85 1.26 . . . . 62.21 112.41 -172.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.04 117.28 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.477 1.111 . . . . 75.42 108.376 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -125.52 -177.79 4.02 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.339 0.59 . . . . 72.11 109.914 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -141.94 117.3 10.18 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.114 -1.81 . . . . 71.44 106.114 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.03 131.41 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 110.013 -0.366 . . . . 62.11 110.013 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -103.37 125.82 57.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.447 1.099 . . . . 72.53 109.253 176.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.409 HD22 HG23 ' B' ' 62' ' ' VAL . 0.3 OUTLIER -92.17 122.25 34.47 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.244 -1.391 . . . . 74.14 107.244 169.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -108.22 106.63 16.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.718 0.807 . . . . 74.03 108.849 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.409 HG23 HD22 ' B' ' 60' ' ' LEU . 31.6 t -106.53 122.39 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.806 -0.813 . . . . 63.33 108.806 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.2 m -114.59 152.44 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.354 0.409 . . . . 73.1 109.943 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 39.3 t -129.47 126.11 62.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.818 1.247 . . . . 73.12 107.947 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -109.55 136.1 49.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.766 -1.198 . . . . 70.13 107.766 170.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.483 -0.932 . . . . 72.12 108.483 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -138.69 136.2 35.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.244 0.545 . . . . 61.23 112.201 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.6 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 46.5 mt -95.05 99.05 11.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.742 1.217 . . . . 62.0 108.019 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -129.8 15.58 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 120.016 -0.325 . . . . 45.31 112.517 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -98.86 36.92 1.59 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.973 0.892 . . . . 65.13 108.838 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -153.98 142.95 21.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.656 -0.702 . . . . 72.42 109.396 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -66.07 136.91 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.154 0.582 . . . . 75.34 111.562 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.6 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.83 -60.62 1.77 Allowed 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.105 0.962 . . . . 75.05 109.227 177.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.435 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 26.3 p90 -157.6 160.58 38.24 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 113.361 -1.745 . . . . 62.52 108.863 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.6 mt -134.56 115.69 14.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.926 -1.509 . . . . 74.1 106.926 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -115.54 153.78 30.56 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.216 -1.031 . . . . 54.43 108.216 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.45 131.66 3.19 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.556 -0.905 . . . . 74.22 108.556 -174.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -122.63 142.66 38.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.485 -0.932 . . . . 74.11 108.485 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 71.4 mt-30 -125.29 90.22 3.19 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.462 -0.94 . . . . 62.13 108.462 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 59.8 tp60 -83.79 106.48 15.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.151 -1.386 . . . . 63.31 109.12 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.62 164.28 26.55 Favored Glycine 0 C--O 1.24 0.487 0 O-C-N 123.44 0.463 . . . . 64.41 112.838 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.85 126.86 1.6 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.828 -0.909 . . . . 62.21 110.828 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 20.1 mt -86.05 129.7 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.607 -0.886 . . . . 75.24 108.607 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -134.34 141.76 47.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.953 0.901 . . . . 62.14 108.9 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -116.92 114.04 23.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.645 0.778 . . . . 50.12 109.227 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.55 HD13 HD11 ' B' ' 89' ' ' ILE . 2.7 pp -135.93 149.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.957 0.903 . . . . 71.53 110.645 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.78 172.14 18.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.593 0.757 . . . . 70.14 110.119 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.11 -48.69 0.92 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.962 -0.354 . . . . 73.41 113.98 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.55 HD11 HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -73.23 162.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 117.21 0.505 . . . . 73.11 111.679 -177.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -152.3 153.65 34.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.28 0.632 . . . . 73.15 110.163 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.04 -136.56 25.53 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 123.888 0.756 . . . . 52.21 113.93 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -77.87 -16.98 57.85 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.249 1.02 . . . . 62.42 111.508 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.84 -39.69 59.25 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.682 0.793 . . . . 74.32 111.163 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' F' ' 172' ' ' ALA . 14.8 tpt -69.97 -33.66 72.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.79 -1.095 . . . . 54.24 111.746 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.423 ' HA ' ' ND2' ' F' ' 176' ' ' ASN . . . -62.5 -29.99 70.95 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.985 0.514 . . . . 71.41 111.527 177.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -73.44 -30.87 63.48 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.769 0.828 . . . . 64.32 111.385 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -79.22 -64.29 1.22 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.2 0.6 . . . . 62.44 110.817 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.64 -43.67 92.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 52.1 110.418 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.93 -2.13 86.47 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 118.788 -1.007 . . . . 74.11 114.992 -170.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.79 -52.38 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.642 1.221 . . . . 62.43 112.299 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -70.76 -44.11 67.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.419 0.287 . . . . 73.4 111.564 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -60.87 -47.89 94.37 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-O 118.765 -0.636 . . . . 74.12 111.593 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -47.48 -50.35 11.54 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.442 2.094 . . . . 75.42 113.967 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.9 -32.21 69.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.264 0.626 . . . . 71.2 112.507 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.427 HG23 ' NH2' ' D' ' 111' ' ' ARG . 60.6 mt -64.7 -48.1 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.484 0.714 . . . . 74.11 110.881 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.03 -9.32 56.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.044 0.938 . . . . 74.33 111.35 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.467 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 20.5 t80 -60.56 -48.56 93.13 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.255 1.422 . . . . 74.34 113.207 -172.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -38.14 54.79 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 121.732 1.622 . . . . 31.22 113.271 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.499 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 90.2 m-85 -61.62 -45.83 92.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.102 0.561 . . . . 72.01 110.602 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.99 94.2 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.095 0.958 . . . . 71.25 111.219 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.477 1.111 . . . . 64.13 111.431 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -37.35 83.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.259 -0.882 . . . . 62.42 110.015 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.8 t -66.16 -39.12 89.55 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.811 -0.631 . . . . 55.32 111.279 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.13 -51.98 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.738 0.415 . . . . 44.21 110.301 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.449 HG23 ' HB2' ' B' ' 125' ' ' GLN . 41.8 m -57.95 -27.36 63.34 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 123.899 0.749 . . . . 64.23 111.269 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -71.24 -62.28 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.35 0.66 . . . . 70.12 110.462 172.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.9 mmt -61.06 -39.97 91.89 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.488 0.715 . . . . 73.24 112.391 -170.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.425 HG11 ' O ' ' B' ' 124' ' ' PRO . 78.5 t -65.82 -43.04 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.611 -0.722 . . . . 73.2 111.144 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 63.2 p -69.65 -25.64 64.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.341 0.4 . . . . 73.34 111.394 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.485 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.1 mtt-85 -65.56 -36.89 85.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.564 -0.744 . . . . 72.34 110.023 174.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -81.13 7.17 60.84 Favored Glycine 0 C--N 1.356 1.69 0 O-C-N 124.04 0.838 . . . . 74.14 112.897 172.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.9 p 54.96 47.64 21.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.562 1.945 . . . . 61.32 111.504 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.529 ' HD2' ' HZ ' ' B' ' 23' ' ' PHE . 29.1 m-85 -120.36 166.62 14.77 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 114.016 -1.447 . . . . 64.2 110.781 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 36.7 Cg_endo -61.44 137.03 67.23 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.915 3.077 . . . . 73.55 115.334 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.541 ' NE2' ' HA ' ' C' ' 124' ' ' PRO . 13.6 pm0 -59.78 154.56 17.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.487 1.115 . . . . 75.1 112.648 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.44 95.96 4.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.079 -1.082 . . . . 44.25 108.079 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.423 HD22 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -92.58 90.62 7.21 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.973 -1.862 . . . . 64.23 105.973 172.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.467 HD22 ' HZ ' ' B' ' 107' ' ' PHE . 1.2 tt -67.88 133.98 50.06 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.414 -0.958 . . . . 54.24 108.414 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.69 107.55 0.85 Allowed Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 124.602 1.189 . . . . 63.31 111.269 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.411 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 95.9 Cg_endo -75.14 88.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.946 2.431 . . . . 63.22 112.494 -170.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.74 149.5 12.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.981 -1.009 . . . . 61.32 110.425 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -111.45 116.25 30.59 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.009 -1.108 . . . . 64.12 108.009 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -62.2 -28.91 70.01 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.907 0.883 . . . . 64.02 111.975 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' B' ' 138' ' ' MET . 19.6 t70 -56.11 -51.71 66.93 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.23 0.956 . . . . 61.21 111.358 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.76 64.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.93 0.892 . . . . 34.32 112.338 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.466 HD13 HG22 ' E' ' 207' ' ' VAL . 54.4 tp -69.94 -48.7 57.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.496 -0.774 . . . . 63.04 109.981 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.475 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 18.3 m-30 -76.6 -16.07 59.67 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.784 -0.644 . . . . 72.32 112.528 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' B' ' 134' ' ' ASP . 94.0 mtp -57.87 -33.97 69.27 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.916 0.886 . . . . 74.41 111.353 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -75.37 -29.54 59.92 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.103 -0.953 . . . . 71.22 110.697 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.475 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 97.3 m-85 -78.81 -17.0 56.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.595 0.758 . . . . 73.45 111.396 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.06 31.44 1.43 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.694 0.798 . . . . 53.52 111.071 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -45.73 78.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.676 0.791 . . . . 74.14 110.113 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -67.36 -23.86 65.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.17 0.588 . . . . 75.51 111.649 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -74.2 101.01 3.84 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.272 -0.64 . . . . 74.11 109.272 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.01 150.9 24.14 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.305 -0.861 . . . . 73.24 111.084 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.27 170.46 15.12 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 110.797 -0.921 . . . . 63.14 110.797 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.78 174.3 12.66 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.244 0.545 . . . . 54.13 111.737 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.62 -156.69 24.53 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.551 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.5 t -158.6 149.11 20.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 117.635 0.717 . . . . 31.15 110.824 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -92.65 110.24 21.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.644 -1.243 . . . . 72.24 107.644 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.92 129.53 56.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.238 -0.653 . . . . 72.04 109.238 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -77.28 172.43 13.29 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.352 0.661 . . . . 65.41 111.253 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -52.04 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.932 -1.507 . . . . 72.52 106.932 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 65.14 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.194 1.398 . . . . 61.04 112.089 173.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 124.899 1.279 . . . . 52.32 107.883 -174.249 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.307 0.099 . . . . 73.43 110.944 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -115.44 107.74 15.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.907 -1.146 . . . . 72.14 107.907 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -123.17 148.68 45.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.451 0.701 . . . . 75.42 109.632 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.7 159.83 29.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.601 -0.889 . . . . 64.13 108.601 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -157.13 159.7 38.09 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.714 -0.846 . . . . 70.21 108.714 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.491 ' HB2' ' HA2' ' C' ' 148' ' ' GLY . 11.8 m120 -55.99 115.44 2.41 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.913 0.885 . . . . 73.34 109.234 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 34.9 p -63.75 93.35 0.08 Allowed 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.164 0.915 . . . . 45.24 111.526 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -156.37 127.3 6.87 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.782 0.833 . . . . 74.31 109.117 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 53.8 ttp 59.55 113.96 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.203 1.401 . . . . 73.11 110.93 -171.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -121.12 89.02 3.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.538 -0.912 . . . . 64.44 108.538 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.593 ' HB3' ' HB3' ' H' ' 206' ' ' ASP . 2.3 t80 -102.51 127.97 49.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.062 -1.426 . . . . 71.55 108.732 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -141.3 131.09 24.26 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.25 -1.389 . . . . 73.35 107.25 167.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.676 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -68.61 117.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 106.621 -1.622 . . . . 65.14 106.621 168.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -83.99 -50.6 7.86 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.149 -0.478 . . . . 65.33 110.007 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -176.13 133.71 0.25 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.77 0.669 . . . . 64.52 110.37 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.676 HG13 HD11 ' C' ' 13' ' ' ILE . 96.2 mt -115.48 140.06 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.098 -1.075 . . . . 71.32 108.098 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.5 ' HB3' HG23 ' D' ' 122' ' ' THR . 30.5 p90 -177.91 147.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.703 0.401 . . . . 75.32 110.61 -173.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.495 HG21 ' SG ' ' C' ' 113' ' ' CYS . 77.3 p -72.89 121.67 20.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.388 -0.824 . . . . 73.53 109.896 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -76.18 -50.5 14.37 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.949 0.881 . . . . 71.34 108.667 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -135.0 136.96 42.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.763 -1.562 . . . . 73.4 108.952 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.8 mt -131.14 142.16 44.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.258 -1.756 . . . . 74.45 106.258 174.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -151.65 144.51 24.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.643 -0.503 . . . . 64.35 109.643 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -148.69 107.75 3.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.34 -1.356 . . . . 71.11 107.34 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.32 110.69 18.38 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.001 -0.74 . . . . 54.43 109.001 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.04 89.82 14.64 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.369 -0.974 . . . . 54.13 108.369 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.14 -39.67 22.73 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.554 2.169 . . . . 73.0 110.902 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -93.95 30.66 1.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.275 -1.33 . . . . 73.35 111.009 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -57.2 -48.26 97.68 Favored Pre-proline 0 CA--C 1.563 1.46 0 C-N-CA 123.388 0.675 . . . . 71.11 112.461 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.8 Cg_endo -88.42 -22.68 1.23 Allowed 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 122.034 1.823 . . . . 75.2 112.601 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -69.63 -25.48 63.95 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.573 1.149 . . . . 71.33 111.682 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.15 -13.65 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.729 0.811 . . . . 63.43 111.388 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -58.32 -40.55 82.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.213 0.605 . . . . 63.52 111.636 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -102.14 38.9 1.57 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.114 0.566 . . . . 75.43 110.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.479 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -126.65 162.27 26.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.563 0.745 . . . . 70.01 109.9 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.19 120.94 18.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.694 -0.854 . . . . 73.14 108.694 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.415 ' HD1' ' HB1' ' E' ' 194' ' ' ALA . 18.2 p90 -84.37 82.96 8.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.806 0.843 . . . . 60.41 110.943 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -139.67 70.48 37.59 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.854 -0.795 . . . . 75.05 108.854 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' C' ' 40' ' ' VAL . 3.2 Cg_exo -77.37 133.67 13.39 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.978 2.452 . . . . 75.45 112.231 -172.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.95 79.54 8.72 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.939 -1.504 . . . . 71.4 106.939 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.619 HG11 ' HG2' ' C' ' 124' ' ' PRO . 13.8 m -76.02 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.16 -1.382 . . . . 71.3 111.441 -170.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -97.0 136.13 38.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.17 -0.923 . . . . 75.01 110.25 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.592 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -114.43 140.99 48.25 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.656 -0.868 . . . . 61.31 108.656 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.08 119.65 33.96 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.718 0.807 . . . . 55.02 109.207 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.706 ' HG ' HD21 ' C' ' 60' ' ' LEU . 7.7 tt -85.9 114.14 22.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.779 -0.822 . . . . 63.32 108.779 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.456 ' O ' HD23 ' C' ' 60' ' ' LEU . 21.1 t70 -126.65 138.93 53.49 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.251 -1.018 . . . . 73.24 108.251 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -111.93 143.69 42.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.351 0.596 . . . . 72.41 110.541 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.94 150.38 50.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.542 1.137 . . . . 53.42 108.743 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -149.24 151.87 34.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.858 0.463 . . . . 64.53 110.048 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.1 t -160.58 140.42 11.09 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.376 -0.972 . . . . 65.22 108.376 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -86.96 137.55 32.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.916 0.388 . . . . 62.21 110.191 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.667 HD11 HD12 ' C' ' 83' ' ' ILE . 76.9 mt -101.38 -58.56 1.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.99 0.916 . . . . 73.51 109.348 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.74 -174.25 3.78 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.816 -1.084 . . . . 74.32 110.075 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -69.06 126.25 29.22 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.846 -1.07 . . . . 75.01 109.209 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.582 ' HA ' HD23 ' E' ' 173' ' ' LEU . 15.1 m-20 64.15 14.64 8.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.713 1.205 . . . . 75.54 111.898 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.77 104.48 11.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 124.447 1.099 . . . . 71.44 108.9 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.57 165.72 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.011 0.91 . . . . 73.25 110.203 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.02 119.22 27.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.844 -1.525 . . . . 75.14 107.416 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.02 120.03 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.881 -1.155 . . . . 63.42 107.881 172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.404 HG22 ' HA2' ' C' ' 81' ' ' GLY . 90.0 t -106.65 113.49 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.297 -1.001 . . . . 53.14 108.297 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.706 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -84.29 102.79 12.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.337 -1.357 . . . . 74.25 107.337 176.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 3.1 tmm_? -84.31 104.53 14.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.337 -0.986 . . . . 74.31 108.337 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.0 t -101.09 130.07 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.257 -1.016 . . . . 63.51 108.257 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 39.5 m -120.39 126.47 50.56 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.695 -0.854 . . . . 53.31 108.695 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.741 HG21 HG21 ' C' ' 114' ' ' ILE . 40.1 t -99.79 124.28 53.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.333 1.053 . . . . 72.34 109.868 177.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -100.51 143.97 30.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.483 -1.303 . . . . 71.5 107.483 167.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.55 120.93 18.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.469 -1.308 . . . . 74.42 107.469 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.7 m -128.47 156.63 42.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.714 0.769 . . . . 44.43 110.627 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' C' ' 34' ' ' LYS . 22.8 mt -116.94 34.18 5.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.206 -1.405 . . . . 71.22 107.206 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.38 -82.94 0.32 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.924 -1.271 . . . . 70.52 109.924 -169.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.65 -24.77 4.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.873 0.869 . . . . 72.24 109.989 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 7.8 tp10 -67.65 120.5 14.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.93 0.892 . . . . 71.11 110.103 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -74.38 123.17 24.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.711 -0.478 . . . . 45.43 109.711 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.29 -49.54 22.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.502 0.721 . . . . 62.24 109.229 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -166.85 173.37 9.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.891 -1.05 . . . . 72.43 110.183 172.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.432 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -130.24 143.11 50.58 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 106.595 -1.631 . . . . 64.24 106.595 170.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' C' ' 64' ' ' VAL . 43.0 t -144.32 155.28 43.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.552 -0.907 . . . . 63.13 108.552 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -157.41 129.87 7.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.86 0.464 . . . . 74.24 110.165 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.53 115.66 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 62.8 mt-30 -88.6 91.17 8.7 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.614 -1.254 . . . . 41.31 107.614 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -78.07 107.04 10.35 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.546 -0.752 . . . . 62.03 109.725 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -82.04 152.44 31.35 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.874 -0.491 . . . . 42.22 111.874 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.17 118.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.601 -0.999 . . . . 72.31 110.601 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.667 HD12 HD11 ' C' ' 51' ' ' LEU . 10.0 mm -84.55 128.91 38.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.462 -0.94 . . . . 54.41 108.462 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.13 128.49 28.18 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.443 -0.577 . . . . 70.22 109.443 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.3 p -79.38 119.24 22.12 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.573 -0.899 . . . . 71.23 108.573 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.66 120.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.718 0.807 . . . . 73.11 109.761 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.521 ' HB1' ' H ' ' E' ' 172' ' ' ALA . . . -167.32 157.57 11.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.004 0.922 . . . . 74.31 110.711 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' GLY . . . . . 0.557 ' H ' ' HB3' ' E' ' 172' ' ' ALA . . . 104.96 -18.7 42.57 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 123.129 0.268 . . . . 52.43 113.709 172.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.594 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -128.86 178.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.486 1.114 . . . . 74.55 110.625 -175.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.55 -172.97 4.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.465 -0.789 . . . . 74.33 109.775 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.86 -120.41 9.02 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.89 1.116 . . . . 63.13 115.89 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 78.7 p -74.3 -30.61 62.16 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.207 1.003 . . . . 71.44 111.459 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' C' ' 145' ' ' ALA . 1.4 mp0 -68.01 -43.25 79.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.88 -0.6 . . . . 63.42 109.818 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' C' ' 97' ' ' CYS . 11.2 ptm -78.3 -28.11 47.43 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.979 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.34 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.202 0.525 . . . . 72.24 110.407 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.79 -30.78 51.52 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.426 -0.807 . . . . 75.32 110.681 172.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' C' ' 94' ' ' MET . 48.7 t -81.53 -21.84 38.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.817 1.247 . . . . 73.33 113.521 -169.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.585 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.0 OUTLIER -139.04 -23.73 0.91 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 119.064 0.847 . . . . 64.42 111.997 172.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.51 -30.64 53.05 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 120.141 -0.255 . . . . 73.32 112.897 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.16 -42.11 2.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.017 0.527 . . . . 75.32 110.815 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.524 ' CE1' HG13 ' C' ' 105' ' ' ILE . 10.6 t80 -50.8 -71.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.927 0.891 . . . . 75.45 110.87 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 60.3 m -55.34 -45.81 99.8 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 113.558 -1.656 . . . . 74.3 113.71 -168.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.469 ' HB3' HD21 ' C' ' 44' ' ' LEU . 74.2 Cg_exo -55.78 -45.94 35.27 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.446 1.431 . . . . 73.14 113.313 168.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 81.1 m-20 -66.81 -25.56 66.51 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.519 0.728 . . . . 53.55 112.649 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.524 HG13 ' CE1' ' C' ' 101' ' ' TYR . 29.3 mm -85.55 -43.29 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.621 0.768 . . . . 74.51 110.611 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.22 -14.32 57.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.935 -0.575 . . . . 55.21 111.032 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.446 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 91.8 t80 -56.53 -54.35 54.39 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 117.705 -1.14 . . . . 71.44 111.761 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' C' ' 105' ' ' ILE . 32.5 Cg_exo -56.37 -40.33 85.36 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.338 2.025 . . . . 55.13 113.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.506 ' HE2' HG21 ' A' ' 115' ' ' THR . 84.2 m-85 -63.55 -52.35 61.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.045 0.938 . . . . 74.5 111.944 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.63 96.51 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 64.22 110.34 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -54.47 -47.85 72.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.973 1.709 . . . . 71.42 111.403 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.432 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -76.93 -37.58 55.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.964 0.505 . . . . 72.11 110.604 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' C' ' 18' ' ' THR . 25.6 t -65.85 -32.58 74.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.042 0.537 . . . . 72.43 111.494 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.741 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -72.31 -51.07 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.716 -0.675 . . . . 54.45 109.545 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m -51.12 -34.75 32.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.614 0.766 . . . . 72.54 111.562 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.9 t -59.4 -61.25 2.76 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.714 -1.13 . . . . 75.34 109.489 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.506 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.28 -45.24 54.27 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.514 1.526 . . . . 74.34 113.148 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.0 t -64.43 -46.71 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 53.23 110.43 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.988 -1.005 . . . . 62.1 111.43 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -69.1 -37.26 78.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.205 0.602 . . . . 72.13 109.861 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 6.7 72.57 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.884 0.74 . . . . 71.31 112.835 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.0 p 65.0 37.89 6.58 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.993 1.717 . . . . 60.43 111.982 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.578 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 60.0 m-85 -107.35 172.65 3.63 Favored Pre-proline 0 CA--C 1.572 1.821 0 C-N-CA 124.897 1.279 . . . . 54.31 109.803 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.619 ' HG2' HG11 ' C' ' 40' ' ' VAL . 73.8 Cg_endo -70.77 179.64 4.09 Favored 'Trans proline' 0 C--N 1.403 3.429 0 C-N-CA 122.49 2.126 . . . . 60.32 114.368 -171.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.41 ' HB2' ' CE1' ' F' ' 202' ' ' TYR . 28.2 mm-40 -60.37 125.73 24.78 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.609 -0.723 . . . . 74.14 112.025 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.41 2.61 36.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.408 0.683 . . . . 62.24 110.346 170.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 43.2 t-20 -88.46 82.8 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.719 -1.586 . . . . 72.34 106.719 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 73.1 mt -89.86 158.27 17.53 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 112.555 -2.111 . . . . 71.14 110.33 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' F' ' 204' ' ' ILE . . . -34.62 130.89 0.45 Allowed Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.854 1.661 . . . . 61.14 114.583 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.571 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 74.1 Cg_endo -71.77 109.01 2.55 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.164 2.576 . . . . 73.14 112.664 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.88 104.73 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.32 109.123 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 103.4 15.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.41 0.684 . . . . 63.42 109.902 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -79.39 -23.03 43.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.614 0.366 . . . . 63.32 111.349 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.444 ' HB2' ' ND2' ' C' ' 104' ' ' ASN . 3.9 t70 -60.78 -30.14 69.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.149 0.499 . . . . 75.44 110.779 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.14 96.96 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.139 -0.937 . . . . 75.14 111.563 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.582 HD11 HG21 ' F' ' 207' ' ' VAL . 74.7 mt -74.58 -34.05 62.79 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.66 0.784 . . . . 75.41 111.139 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.13 -32.63 48.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.23 1.012 . . . . 73.41 111.98 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.5 mtm -57.67 -45.08 86.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.972 0.909 . . . . 72.33 112.105 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -72.52 -37.7 68.27 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 110.448 -0.205 . . . . 72.21 110.448 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -68.01 -84.78 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 75.24 111.597 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 37.8 tp -106.95 120.72 42.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.274 -0.639 . . . . 40.21 109.274 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.48 HE22 ' HB2' ' A' ' 147' ' ' GLU . 96.4 mt-30 -82.16 156.9 24.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.29 0.636 . . . . 64.41 111.465 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -117.09 136.26 53.13 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.314 1.045 . . . . 74.14 109.348 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -103.76 -165.09 1.12 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.174 0.59 . . . . 70.43 109.673 170.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.423 ' HB3' ' HG2' ' C' ' 93' ' ' GLN . . . 63.25 -161.97 0.29 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.762 0.825 . . . . 60.5 111.782 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.5 30.6 Favored Glycine 0 C--N 1.348 1.221 0 C-N-CA 122.852 0.263 . . . . 75.54 112.837 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 98.71 0.23 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 74.44 109.509 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' C' ' 6' ' ' ASN . . . -166.72 124.8 1.26 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.527 -1.029 . . . . 63.11 110.527 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.1 t -167.66 92.76 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.48 0.712 . . . . 73.01 109.178 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -147.23 163.37 36.59 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.253 1.021 . . . . 72.41 110.752 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -167.05 121.91 1.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.959 -1.019 . . . . 64.22 110.0 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -159.74 26.31 0.18 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.39 1.076 . . . . 73.32 109.689 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -47.85 116.84 1.62 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.222 1.409 . . . . 75.45 112.453 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 -69.27 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.213 1.005 . . . . 64.1 108.894 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.351 0 N-CA-C 107.227 -1.397 . . . . 42.44 107.227 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.409 ' HA ' ' OE1' ' D' ' 12' ' ' GLN . 27.8 ttt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.807 -0.442 . . . . 62.22 109.807 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 83.1 p -157.66 149.3 21.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.81 0.844 . . . . 60.44 109.879 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -32.53 25.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.15 0.58 . . . . 64.33 109.981 168.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 63.14 -78.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.851 1.661 . . . . 71.21 110.688 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -174.7 179.18 1.75 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.317 0.647 . . . . 72.22 111.04 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -82.57 67.55 8.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.776 0.831 . . . . 75.01 109.435 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 96.4 m -149.82 -72.29 0.18 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.145 -1.057 . . . . 64.22 108.145 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -90.3 78.62 6.46 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.157 -1.053 . . . . 55.21 108.157 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.469 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 3.2 ptm -34.34 132.24 0.29 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.457 -1.247 . . . . 74.55 112.436 170.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -122.36 141.04 51.99 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.273 -0.64 . . . . 74.32 109.273 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -149.02 100.13 3.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.029 -1.471 . . . . 65.14 107.029 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' D' ' 1' ' ' MET . 1.1 mt-30 -121.58 150.97 40.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.356 -0.979 . . . . 75.43 108.356 -173.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 tp -102.81 137.16 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.156 -0.683 . . . . 64.53 109.156 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -99.3 -45.47 5.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.549 0.74 . . . . 74.35 109.507 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HD3' HD12 ' D' ' 83' ' ' ILE . 4.8 ptm180 -168.43 147.26 4.35 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.942 0.497 . . . . 73.12 111.104 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.476 HD12 HD23 ' D' ' 106' ' ' LEU . 48.0 mm -115.81 122.76 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 105.958 -1.867 . . . . 72.53 105.958 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 0.3 OUTLIER -155.69 156.27 34.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.098 0.951 . . . . 74.51 111.027 -169.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.403 HG21 HD11 ' D' ' 21' ' ' ILE . 73.3 p -91.86 116.99 29.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.945 -1.48 . . . . 72.23 109.152 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -85.84 -29.52 23.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.493 -0.776 . . . . 75.33 109.419 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.3 t70 -149.76 135.96 18.92 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.803 -1.09 . . . . 75.31 109.574 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.506 HD13 ' HE3' ' C' ' 117' ' ' MET . 60.6 mt -139.37 143.32 31.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.853 -1.165 . . . . 74.32 107.853 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -144.75 144.6 31.27 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.071 0.948 . . . . 52.21 108.861 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.634 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.4 t80 -145.6 129.63 17.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.53 -2.026 . . . . 73.0 105.53 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.3 mt-10 -133.07 136.03 45.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 73.43 108.498 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -131.0 75.27 78.81 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.032 -1.099 . . . . 62.3 108.032 174.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.0 -28.89 18.72 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.776 2.317 . . . . 74.23 112.571 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -114.37 32.76 5.72 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 123.726 0.811 . . . . 73.1 108.959 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -57.65 -58.31 19.23 Favored Pre-proline 0 N--CA 1.483 1.203 0 N-CA-C 114.543 1.312 . . . . 62.44 114.543 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.12 -4.08 13.59 Favored 'Trans proline' 0 C--N 1.381 2.256 0 CA-C-N 121.918 1.721 . . . . 74.14 112.637 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -84.25 -32.36 24.49 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.415 1.486 . . . . 43.32 109.107 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.411 HG13 ' CD1' ' D' ' 68' ' ' LEU . 2.1 t -65.57 -27.66 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.227 1.411 . . . . 63.41 111.952 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -62.43 -14.71 43.61 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 112.717 0.636 . . . . 74.34 112.717 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.908 0.883 . . . . 72.43 110.932 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -84.26 104.28 14.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.715 1.206 . . . . 60.4 109.904 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.34 75.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 74.35 111.763 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.41 ' HZ2' ' H ' ' D' ' 69' ' ' GLY . 1.6 p-90 -170.05 179.69 3.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.006 0.923 . . . . 73.15 109.924 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.626 HE21 ' HD2' ' D' ' 38' ' ' PRO . 37.8 tp60 -78.38 123.83 85.68 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.774 0.829 . . . . 72.35 108.787 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.626 ' HD2' HE21 ' D' ' 37' ' ' GLN . 39.7 Cg_exo -56.28 142.13 88.01 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.815 2.343 . . . . 72.22 115.006 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.16 112.24 2.3 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.652 -0.87 . . . . 74.34 108.652 167.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 22.5 m -103.33 117.29 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.579 0.704 . . . . 64.45 109.983 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -108.41 116.81 32.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.118 0.967 . . . . 74.41 108.756 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' D' ' 63' ' ' THR . 6.6 mp -104.64 135.72 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.283 0.364 . . . . 70.22 110.361 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.48 135.28 50.74 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.411 -0.813 . . . . 71.12 108.87 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.563 HD13 ' H ' ' H' ' 184' ' ' TRP . 5.3 tt -96.55 127.15 42.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.893 -1.151 . . . . 60.33 107.893 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.2 t70 -150.05 155.73 40.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.432 -0.951 . . . . 63.02 108.432 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.4 t -139.6 160.92 38.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.347 0.594 . . . . 65.0 110.167 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.69 176.74 10.1 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.019 1.328 . . . . 74.3 107.79 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' D' ' 56' ' ' TYR . 78.2 p -172.98 165.94 5.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.526 0.565 . . . . 74.13 112.526 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 4.4 m -152.11 140.72 20.77 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.017 0.927 . . . . 75.43 109.484 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -83.53 118.24 23.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.315 -0.995 . . . . 61.41 108.315 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' D' ' 57' ' ' GLU . 22.0 mt -99.79 -29.3 12.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.906 0.482 . . . . 64.0 110.177 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -165.13 -172.75 2.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.589 0.756 . . . . 54.32 111.029 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -71.41 120.24 16.71 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.979 -1.009 . . . . 64.1 109.082 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 62.28 18.08 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.47 1.108 . . . . 71.45 111.276 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 74.0 t -121.22 121.65 65.4 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 107.009 -1.478 . . . . 75.35 107.009 174.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' D' ' 48' ' ' SER . 12.4 t80 -144.64 128.27 17.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.909 -0.775 . . . . 73.5 108.909 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.4 tt0 -88.11 131.27 34.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.625 -0.88 . . . . 63.32 108.625 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.06 123.61 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.096 -1.446 . . . . 75.23 107.096 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.612 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 27.1 t -100.67 139.61 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 73.14 109.178 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.543 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -111.98 126.54 55.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.976 -1.12 . . . . 71.52 107.976 175.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.5 ttm-85 -102.92 101.62 11.65 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.715 -0.846 . . . . 70.14 108.715 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.9 t -102.91 121.85 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.706 -0.85 . . . . 34.41 108.706 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 23.7 m -125.7 130.92 52.51 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.397 0.679 . . . . 73.45 109.636 -171.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.489 HG21 HG21 ' D' ' 114' ' ' ILE . 32.1 t -120.8 103.66 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.677 1.191 . . . . 53.12 109.324 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -100.54 96.52 7.43 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.375 -0.972 . . . . 71.44 108.375 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 143.11 27.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.46 -0.791 . . . . 71.2 109.328 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.6 p -151.46 130.47 12.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.403 0.439 . . . . 44.54 111.867 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' D' ' 31' ' ' VAL . 21.3 mt -107.06 108.6 20.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.037 0.935 . . . . 61.42 110.283 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' GLY . . . . . 0.41 ' H ' ' HZ2' ' D' ' 36' ' ' TRP . . . 78.12 -115.15 4.14 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.562 -0.615 . . . . 74.21 111.562 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 4.51 15.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.909 0.884 . . . . 64.32 110.598 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -116.14 161.89 18.26 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.786 -0.45 . . . . 54.05 109.786 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.5 m -71.54 133.86 46.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.537 -0.756 . . . . 63.33 110.572 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.88 -64.91 1.07 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.441 -0.948 . . . . 45.13 108.441 173.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -156.15 147.7 22.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.4 -0.818 . . . . 75.41 109.971 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.1 mt -100.39 153.94 18.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.853 0.861 . . . . 73.33 108.952 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.6 t -159.31 143.72 15.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.284 0.633 . . . . 73.13 109.651 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.39 128.54 7.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.108 0.563 . . . . 65.14 109.845 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.455 HG22 HG23 ' D' ' 21' ' ' ILE . 88.0 t -127.46 114.66 37.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 123.98 0.912 . . . . 73.33 109.017 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.649 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.6 mt-30 -89.54 86.36 6.73 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.838 0.828 . . . . 70.35 108.879 170.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.433 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.8 tp-100 -79.73 98.9 7.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.969 -1.468 . . . . 72.42 108.66 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.5 154.91 23.71 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.822 -0.511 . . . . 73.13 111.822 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -149.18 131.16 3.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.695 -0.962 . . . . 54.15 110.695 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' D' ' 15' ' ' ARG . 59.3 mt -94.97 109.02 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.398 -0.594 . . . . 73.55 109.398 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -110.53 126.64 54.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.484 0.714 . . . . 72.2 110.385 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -79.56 97.19 6.37 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.735 -0.839 . . . . 75.24 108.735 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.68 130.24 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.224 0.61 . . . . 72.13 110.803 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.76 153.63 14.93 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.779 0.832 . . . . 65.52 109.945 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 84.96 5.39 86.19 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.393 -0.367 . . . . 74.02 113.302 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -119.32 126.33 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.898 0.879 . . . . 70.42 109.465 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 174.38 10.68 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 122.046 -0.409 . . . . 73.15 111.215 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -139.79 39.53 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.934 0.772 . . . . 71.23 113.358 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.9 p -69.27 -32.33 71.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.641 0.776 . . . . 52.42 111.464 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.22 -40.99 96.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.745 . . . . 71.23 110.619 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.406 ' HG3' HD21 ' H' ' 173' ' ' LEU . 1.2 tmt? -68.6 -55.86 10.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 74.53 110.754 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.64 69.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.453 0.701 . . . . 53.14 112.089 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -85.59 -35.36 21.07 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.466 0.707 . . . . 73.43 110.655 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -66.29 -41.83 89.22 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.662 0.268 . . . . 75.05 110.29 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 tt -78.06 -35.18 49.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.207 0.603 . . . . 74.43 110.065 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.42 -3.32 81.7 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.353 -0.693 . . . . 50.31 114.448 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -142.93 -57.28 0.43 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 117.974 0.887 . . . . 73.05 111.818 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -72.37 -41.77 66.0 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 112.288 0.477 . . . . 71.44 112.288 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 69.8 m -66.76 -44.97 55.11 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.109 0.564 . . . . 51.2 111.088 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.543 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.9 Cg_exo -55.73 -35.55 93.5 Favored 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.491 2.127 . . . . 55.12 113.402 165.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.48 -29.96 70.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.911 0.484 . . . . 54.41 111.161 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -68.35 -38.49 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.087 0.555 . . . . 64.32 109.619 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.476 HD23 HD12 ' D' ' 16' ' ' ILE . 94.3 mt -79.14 -22.9 44.44 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.311 1.045 . . . . 62.15 112.589 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -66.21 -40.8 38.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.161 1.171 . . . . 75.4 114.161 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.74 -39.23 92.36 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.054 1.836 . . . . 50.32 113.296 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -79.44 -33.17 42.72 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.895 0.878 . . . . 74.13 110.799 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.85 68.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.562 0.745 . . . . 72.25 109.899 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.427 ' NH2' HG23 ' B' ' 105' ' ' ILE . 27.6 ttp180 -52.39 -54.27 34.07 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.226 -1.352 . . . . 74.2 110.553 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.403 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.9 tm-20 -60.34 -45.45 93.4 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.472 1.107 . . . . 75.33 111.687 -175.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.439 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 42.7 t -54.82 -44.74 74.13 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.016 0.822 . . . . 73.33 110.961 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.489 HG21 HG21 ' D' ' 64' ' ' VAL . 77.0 mt -66.33 -53.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.203 -0.908 . . . . 50.13 110.885 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 54.0 m -53.85 -41.5 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.67 1.188 . . . . 65.41 111.567 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -67.57 -44.7 77.59 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 114.712 -1.131 . . . . 73.12 110.08 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.58 -32.58 74.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.977 0.511 . . . . 73.43 111.808 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.4 t -64.14 -46.51 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.298 0.639 . . . . 52.43 109.474 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -73.61 -27.78 61.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.704 -0.68 . . . . 62.44 111.35 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.24 -28.79 63.38 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.542 0.737 . . . . 74.04 110.118 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.04 10.06 70.0 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 123.83 0.706 . . . . 74.43 112.302 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.5 HG23 ' HB3' ' C' ' 17' ' ' TYR . 71.7 p 58.46 18.87 5.99 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.624 1.97 . . . . 71.04 113.691 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -86.58 152.07 54.0 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.889 -0.782 . . . . 54.14 108.889 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.05 133.02 55.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.732 2.288 . . . . 72.01 112.667 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -49.82 139.15 13.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.611 1.195 . . . . 65.42 112.376 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -120.35 102.4 8.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.822 . . . . 62.54 108.904 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -99.21 100.83 11.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.777 -0.823 . . . . 73.23 108.777 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 55.4 mt -72.02 136.0 46.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.616 0.572 . . . . 75.13 110.137 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.01 81.79 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.262 0.625 . . . . 64.24 110.998 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.39 96.79 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.407 2.071 . . . . 51.02 110.259 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -108.15 124.83 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.279 0.561 . . . . 71.42 110.153 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.8 113.7 18.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.375 -0.972 . . . . 73.21 108.375 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.453 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 91.8 m-85 -68.78 -15.77 63.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.167 0.587 . . . . 53.54 112.062 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.98 -41.88 90.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.55 0.74 . . . . 64.24 110.584 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.02 -53.45 49.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.635 -0.711 . . . . 73.13 109.174 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -57.3 -28.23 62.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.013 0.925 . . . . 71.12 112.116 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.562 ' HA ' ' HE1' ' H' ' 184' ' ' TRP . 66.5 t80 -62.55 -48.45 79.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.088 0.955 . . . . 64.22 110.643 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 71.6 mtm -74.22 -34.19 63.61 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.765 0.826 . . . . 74.43 111.066 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -78.67 -9.69 59.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.924 0.89 . . . . 73.53 111.75 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -69.36 -31.09 69.28 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.045 0.538 . . . . 64.5 110.501 171.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.46 -31.89 72.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.33 0.652 . . . . 71.2 111.297 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -90.99 25.28 2.48 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.448 0.699 . . . . 55.44 111.809 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -116.07 63.77 0.7 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.164 0.983 . . . . 75.44 108.804 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -140.66 77.63 1.61 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.818 -1.549 . . . . 72.42 106.818 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.28 93.5 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.531 -0.759 . . . . 60.24 109.907 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.25 -36.84 0.75 Allowed Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.574 -0.739 . . . . 33.23 112.108 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 147' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' D' ' 148' ' ' GLY . 15.1 tt0 -163.98 -172.04 2.67 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 122.907 0.483 . . . . 75.42 110.24 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 148' ' ' GLY . . . . . 0.441 ' H ' ' HG2' ' D' ' 147' ' ' GLU . . . -74.31 -92.58 0.14 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 114.263 0.465 . . . . 65.43 114.263 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.4 t -91.55 163.2 14.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.317 0.647 . . . . 74.02 111.324 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.06 123.93 48.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.496 0.718 . . . . 73.12 109.575 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -161.98 13.98 0.08 Allowed 'General case' 0 CA--C 1.551 0.991 0 O-C-N 124.032 0.832 . . . . 62.43 109.643 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m170 67.94 132.0 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.574 1.549 . . . . 72.41 111.408 -174.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.7 mp0 -56.84 107.67 0.42 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.685 1.194 . . . . 63.55 110.887 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.21 82.83 2.37 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.743 0.782 . . . . 74.22 109.934 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.394 0 CA-C-N 114.78 -1.1 . . . . 54.32 108.322 -178.725 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.607 0.241 . . . . 73.22 110.413 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.0 -178.46 49.98 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.687 -0.688 . . . . 75.53 112.424 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -139.16 80.53 1.79 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.525 -1.287 . . . . 65.13 107.525 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 23.3 p -66.02 115.28 5.9 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.126 -0.943 . . . . 74.33 110.725 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 172' ' ' ALA . . . . . 0.557 ' HB3' ' H ' ' C' ' 88' ' ' GLY . . . -164.64 85.62 0.43 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.521 1.128 . . . . 54.21 108.176 -175.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' C' ' 54' ' ' ASP . 1.8 tm? -88.54 140.03 29.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.205 -1.035 . . . . 52.14 108.205 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' E' ' 174' ' ' MET . 0.0 OUTLIER -146.66 -52.41 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.984 0.914 . . . . 74.24 109.986 -170.381 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 52.4 t80 43.58 78.81 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.755 1.622 . . . . 74.33 113.234 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -91.7 85.43 5.65 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.439 -0.948 . . . . 71.42 108.439 172.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 3.5 tt -158.92 81.56 0.79 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.312 -1.736 . . . . 72.31 106.312 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.85 -36.21 31.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.231 -1.349 . . . . 75.32 109.524 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -154.73 156.67 31.68 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.082 0.953 . . . . 72.24 109.443 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.04 97.12 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.041 1.827 . . . . 73.4 110.965 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -64.85 -28.22 69.4 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.526 0.73 . . . . 71.52 110.428 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.29 156.05 37.67 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.67 1.188 . . . . 74.22 108.875 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 40.7 m -147.55 147.23 29.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.497 -0.927 . . . . 64.25 108.497 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.504 ' HE1' HD13 ' C' ' 44' ' ' LEU . 45.1 p90 -93.97 155.28 40.37 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.52 0.728 . . . . 73.2 111.957 -175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.62 160.09 47.28 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.922 2.415 . . . . 75.41 111.562 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.7 -167.75 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.448 0.699 . . . . 64.14 110.715 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 13.5 tt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.935 0.494 . . . . 75.24 111.617 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . 59.21 78.46 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.296 1.038 . . . . 63.54 110.793 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.35 152.79 26.08 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.837 -0.62 . . . . 75.43 111.501 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -131.25 163.79 27.01 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.732 0.813 . . . . 73.02 109.585 -174.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -73.62 -100.21 0.08 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.023 -1.231 . . . . 51.21 110.023 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 72.82 -71.96 1.09 Allowed Glycine 0 C--N 1.343 0.932 0 O-C-N 123.843 0.379 . . . . 32.04 114.046 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.64 163.47 14.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.519 0.728 . . . . 64.13 111.528 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 194' ' ' ALA . . . . . 0.415 ' HB1' ' HD1' ' C' ' 36' ' ' TRP . . . -101.53 -158.61 0.68 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.265 1.026 . . . . 70.11 110.103 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 195' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' E' ' 197' ' ' TYR . 6.2 p90 -154.92 -162.76 1.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.255 0.622 . . . . 74.35 110.626 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 196' ' ' LYS . . . . . 0.451 ' HE2' ' HE2' ' F' ' 202' ' ' TYR . 3.4 mptp? -81.1 15.58 1.83 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.596 0.758 . . . . 74.32 112.582 -169.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 197' ' ' TYR . . . . . 0.413 ' HB2' ' CE2' ' E' ' 195' ' ' PHE . 0.2 OUTLIER -96.1 100.44 12.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.611 0.641 . . . . 74.02 109.557 172.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 198' ' ' GLU . . . . . 0.722 ' HB3' ' HD3' ' E' ' 201' ' ' LYS . 3.1 tm-20 -168.24 148.73 4.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.387 -2.079 . . . . 70.12 105.387 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -60.58 -29.76 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.532 0.733 . . . . 63.24 112.657 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -76.57 -16.29 80.86 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 122.96 0.314 . . . . 61.45 113.632 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.722 ' HD3' ' HB3' ' E' ' 198' ' ' GLU . 12.7 mptt -89.85 143.88 26.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.29 1.036 . . . . 60.32 109.864 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 54.14 36.74 25.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.388 1.075 . . . . 73.04 112.727 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.95 128.4 37.05 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.766 0.826 . . . . 74.24 112.229 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 13.1 pt -131.99 37.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.362 1.065 . . . . 70.54 109.896 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.32 -13.0 33.96 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.788 -0.642 . . . . 51.42 112.328 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.16 -54.96 28.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.514 1.126 . . . . 63.14 110.91 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.466 HG22 HD13 ' B' ' 136' ' ' LEU . 37.3 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.795 0.838 . . . . 63.13 109.643 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 120.656 0.265 . . . . 74.21 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.7 61.21 3.18 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.533 -0.758 . . . . 73.04 111.643 -175.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.31 140.65 20.52 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.888 0.475 . . . . 74.14 110.401 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 56.5 m 61.97 83.51 0.15 Allowed 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.887 1.275 . . . . 70.22 111.509 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 172' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . -66.2 -48.4 70.75 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.415 -0.811 . . . . 53.12 110.673 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' B' ' 2' ' ' SER . 63.0 mt -56.29 111.07 0.87 Allowed 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.257 0.973 . . . . 71.33 110.133 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 32.1 mmt 77.33 98.65 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.125 1.77 . . . . 71.34 110.993 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.37 80.95 0.19 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.107 1.363 . . . . 73.52 112.028 173.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 176' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' B' ' 95' ' ' ALA . 3.1 p-10 -86.91 9.58 18.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.054 0.941 . . . . 64.34 111.823 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.58 80.43 0.58 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.327 0.651 . . . . 75.31 109.425 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 177.88 -43.54 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.148 1.379 . . . . 71.34 107.659 -167.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -56.77 138.68 77.7 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.856 -1.066 . . . . 71.53 111.268 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.2 113.03 3.15 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.338 2.025 . . . . 74.55 111.305 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -130.01 112.52 13.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.199 0.6 . . . . 74.25 109.881 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -66.9 138.2 57.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.702 . . . . 75.52 110.48 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 7.5 m -94.51 155.74 16.78 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.517 0.727 . . . . 72.13 110.537 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.509 ' HB2' ' HG ' ' F' ' 186' ' ' LEU . 28.2 p90 -74.66 127.08 87.85 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.613 1.165 . . . . 75.42 111.304 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -99.73 24.47 0.19 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.672 2.914 . . . . 75.23 112.969 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' F' ' 184' ' ' TRP . 0.8 OUTLIER -90.13 170.72 10.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.59 0.756 . . . . 54.45 112.331 -175.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.509 HG13 HD13 ' F' ' 186' ' ' LEU . 57.7 mt 72.97 140.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 126.125 1.77 . . . . 71.03 113.204 173.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.21 -172.52 3.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.264 1.025 . . . . 63.24 109.476 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.3 -156.64 0.74 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.899 0.88 . . . . 75.24 108.671 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -161.91 154.63 20.11 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.452 0.569 . . . . 54.34 110.556 -175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -131.98 -174.26 13.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.137 -0.483 . . . . 72.12 113.625 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.49 -102.68 2.87 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 111.452 -0.659 . . . . 55.51 111.452 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 57.6 -169.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.497 1.119 . . . . 75.23 112.546 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -164.9 156.68 15.42 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.11 0.564 . . . . 40.54 111.292 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' F' ' 203' ' ' ASP . 97.4 m-85 -91.18 -159.85 0.67 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.856 0.862 . . . . 62.14 109.441 170.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -58.82 -9.76 1.99 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.266 1.026 . . . . 71.43 113.642 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -55.32 -36.95 66.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.319 0.647 . . . . 72.23 110.423 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.06 31.75 5.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.481 1.112 . . . . 73.21 109.608 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 66.22 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.223 1.409 . . . . 65.33 110.742 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -132.3 -166.34 11.52 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.744 -0.662 . . . . 70.1 112.899 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.65 -35.76 0.88 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.94 0.896 . . . . 63.12 110.73 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 202' ' ' TYR . . . . . 0.451 ' HE2' ' HE2' ' E' ' 196' ' ' LYS . 14.5 m-30 -89.88 34.03 0.85 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.809 0.844 . . . . 73.41 111.965 -165.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 203' ' ' ASP . . . . . 0.412 ' HB3' ' CD2' ' F' ' 195' ' ' PHE . 2.9 p30 -125.16 -146.89 0.36 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.013 1.325 . . . . 64.52 108.221 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.597 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 2.6 pp -131.66 156.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.384 0.611 . . . . 74.02 111.428 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -119.68 113.1 20.15 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.734 -1.21 . . . . 64.35 107.734 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -72.72 150.66 42.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.295 0.638 . . . . 74.44 109.773 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.582 HG21 HD11 ' C' ' 136' ' ' LEU . 4.3 p . . . . . 0 CA--C 1.565 1.546 0 CA-C-O 118.382 -0.818 . . . . 64.2 110.24 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.216 -1.031 . . . . 74.04 108.216 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.21 -95.7 0.13 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.308 -0.717 . . . . 75.35 111.308 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 170' ' ' LYS . . . . . 0.557 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 3.9 mptp? -116.05 124.78 51.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.385 -0.968 . . . . 63.43 108.385 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 31.6 p -88.21 63.24 7.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.78 0.832 . . . . 64.05 110.0 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 172' ' ' ALA . . . . . 0.401 ' HB3' ' CB ' ' A' ' 94' ' ' MET . . . -87.8 -168.05 2.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.248 -0.887 . . . . 64.33 110.176 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 98' ' ' LEU . 77.7 mt 64.1 179.82 0.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.023 0.929 . . . . 73.52 111.592 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 7.0 mmt 60.87 10.13 2.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.099 1.36 . . . . 73.33 112.587 171.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.54 -165.81 0.15 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.747 1.219 . . . . 72.25 111.526 -169.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 64.53 18.0 11.14 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.057 0.943 . . . . 60.02 110.604 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 177' ' ' LEU . . . . . 0.412 HD23 HD23 ' A' ' 98' ' ' LEU . 3.5 pp -73.34 159.37 33.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.231 0.612 . . . . 73.52 111.21 -175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -117.29 162.41 17.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.606 0.762 . . . . 75.32 110.044 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 69.6 137.31 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.216 1.407 . . . . 75.34 113.103 167.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.33 94.35 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.115 1.877 . . . . 55.12 109.542 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -53.8 110.84 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.07 0.948 . . . . 61.23 111.739 -174.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 182' ' ' PHE . . . . . 0.481 ' HB2' ' HZ ' ' A' ' 133' ' ' PHE . 28.5 m-85 54.49 33.98 20.05 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.085 1.354 . . . . 71.32 111.306 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 91.6 m 77.73 -50.08 0.51 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 126.554 1.942 . . . . 74.24 113.626 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 69.94 84.05 0.15 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.414 1.486 . . . . 63.54 109.353 -167.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.67 94.13 1.05 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.695 2.263 . . . . 73.12 110.84 170.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.14 131.69 34.75 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.507 -1.294 . . . . 63.52 107.507 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.84 152.57 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 120.738 0.304 . . . . 75.43 110.84 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -102.14 114.71 29.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.025 -0.732 . . . . 64.44 109.025 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -80.12 102.08 9.15 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.961 -0.755 . . . . 74.14 108.961 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.32 155.72 38.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.532 -0.758 . . . . 72.15 110.751 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 191' ' ' GLY . . . . . 0.452 ' HA2' HG23 ' A' ' 40' ' ' VAL . . . -78.69 74.25 2.15 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.117 -0.492 . . . . 64.13 113.07 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.3 123.14 28.9 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.024 -0.431 . . . . 54.41 112.024 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 193' ' ' TYR . . . . . 0.663 ' HB2' ' HB3' ' H' ' 198' ' ' GLU . 49.3 m-85 -87.66 39.06 0.86 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.198 0.999 . . . . 75.41 110.945 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.68 129.88 40.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.975 -0.75 . . . . 71.22 108.975 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.497 ' HE1' ' HZ1' ' G' ' 201' ' ' LYS . 62.8 t80 77.3 29.21 0.57 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 125.169 1.543 . . . . 63.44 110.726 -175.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' G' ' 193' ' ' TYR . 12.1 tmtt? -69.11 80.66 0.33 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.637 -0.875 . . . . 65.44 108.637 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -90.88 149.96 21.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.283 -0.871 . . . . 74.31 108.989 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -128.42 61.46 1.47 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.941 -0.763 . . . . 75.2 108.941 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 71.7 152.04 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.034 1.334 . . . . 62.32 111.54 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.5 119.36 2.89 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.956 -0.358 . . . . 74.24 112.51 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 201' ' ' LYS . . . . . 0.497 ' HZ1' ' HE1' ' G' ' 195' ' ' PHE . 35.0 mmtt -147.38 -59.79 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.382 0.673 . . . . 72.15 111.303 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -123.33 -70.23 0.78 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.776 -1.194 . . . . 73.35 107.776 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 54.85 25.63 6.9 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.303 1.223 . . . . 74.34 114.303 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 34.2 pt -89.42 144.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 120.787 0.327 . . . . 53.25 110.168 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -166.58 104.15 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.525 -0.916 . . . . 72.44 108.525 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -132.16 -90.62 0.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.11 -0.7 . . . . 65.35 109.11 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.568 1.673 0 C-N-CA 124.848 1.259 . . . . 73.0 111.156 -177.528 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 119.927 -0.082 . . . . 74.45 111.169 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.55 144.57 4.49 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.516 -0.234 . . . . 65.31 112.516 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -111.4 133.24 53.85 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.64 0.776 . . . . 75.1 109.605 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 47.7 m 67.85 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.752 1.221 . . . . 53.33 112.855 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.01 -66.56 0.88 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.198 0.599 . . . . 70.44 111.315 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.406 HD21 ' HG3' ' D' ' 94' ' ' MET . 0.0 OUTLIER -169.52 176.34 5.06 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.465 1.106 . . . . 64.31 108.586 -176.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.434 ' HA ' ' CE ' ' H' ' 174' ' ' MET . 1.0 OUTLIER -131.22 -58.65 1.0 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.606 0.965 . . . . 71.14 113.606 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -149.97 147.67 28.15 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 117.853 0.297 . . . . 75.24 111.764 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -158.02 119.2 3.51 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.282 1.033 . . . . 42.35 108.705 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -163.34 30.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.451 0.7 . . . . 74.45 109.453 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.39 -38.85 72.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.22 1.008 . . . . 73.53 111.599 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.18 138.98 24.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.589 0.755 . . . . 72.23 109.804 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.79 114.75 2.71 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.152 2.568 . . . . 51.54 112.721 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.96 120.98 34.96 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.588 -0.893 . . . . 75.12 108.588 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -67.47 150.23 49.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.986 0.515 . . . . 72.21 111.325 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 72.0 p -97.39 -176.72 3.59 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 109.144 -0.687 . . . . 74.23 109.144 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 184' ' ' TRP . . . . . 0.563 ' H ' HD13 ' D' ' 44' ' ' LEU . 16.3 m-90 -123.05 87.44 51.05 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 122.816 0.447 . . . . 74.21 110.592 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.94 122.59 2.26 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.799 2.332 . . . . 65.43 111.855 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -169.06 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.405 0.682 . . . . 75.13 111.42 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' D' ' 42' ' ' LEU . 15.6 tt -80.47 89.08 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 122.668 1.223 . . . . 74.04 110.447 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -147.23 83.56 1.56 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.238 -1.346 . . . . 55.32 108.263 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.17 133.32 33.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.174 -0.921 . . . . 62.4 110.243 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.55 157.34 32.12 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.537 -0.542 . . . . 61.44 109.537 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 191' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' D' ' 37' ' ' GLN . . . -95.73 154.56 20.97 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.918 -0.583 . . . . 63.01 112.739 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 192' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' D' ' 37' ' ' GLN . . . -116.11 177.05 16.79 Favored Glycine 0 C--N 1.346 1.112 0 C-N-CA 122.834 0.254 . . . . 72.44 112.671 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -80.87 89.92 5.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.174 0.59 . . . . 74.2 110.052 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.17 78.16 0.58 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.461 -0.791 . . . . 65.23 109.884 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.78 -47.43 0.13 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.679 -1.23 . . . . 75.03 107.679 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 tptt 39.84 81.04 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.51 1.924 . . . . 74.44 114.0 161.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -76.86 63.05 2.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.002 0.921 . . . . 54.35 110.513 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 198' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' G' ' 193' ' ' TYR . 2.1 mm-40 -81.5 103.67 11.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.099 -0.704 . . . . 74.11 109.099 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 63.94 35.37 10.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.282 1.033 . . . . 71.13 110.951 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.09 52.19 4.68 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.795 -0.639 . . . . 64.12 112.531 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -160.18 96.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 106.418 -1.697 . . . . 74.21 106.418 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -64.67 -34.42 78.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.866 0.866 . . . . 74.14 112.983 -172.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 15.5 t70 64.45 28.11 13.53 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.782 0.833 . . . . 74.41 111.048 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 15.5 pt -99.36 159.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.476 0.71 . . . . 63.01 110.94 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -97.89 163.24 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.633 0.773 . . . . 62.21 109.655 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 206' ' ' ASP . . . . . 0.593 ' HB3' ' HB3' ' C' ' 11' ' ' PHE . 3.3 p-10 -55.85 -59.17 5.25 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.31 1.044 . . . . 52.44 111.24 171.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.441 ' HB ' HG13 ' A' ' 131' ' ' VAL . 2.5 p . . . . . 0 C--O 1.26 1.614 0 N-CA-C 107.681 -1.229 . . . . 72.52 107.681 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 118.803 -0.618 . . . . 75.02 110.41 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t 65.69 164.75 0.17 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.137 1.375 . . . . 64.44 113.951 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -102.81 145.74 29.31 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.055 0.942 . . . . 73.13 109.718 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.47 ' HA ' ' HB3' ' A' ' 90' ' ' GLU . 19.8 mt-30 -126.08 135.05 51.27 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.63 0.772 . . . . 63.02 110.099 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.32 -76.75 0.31 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.021 -0.733 . . . . 44.41 109.021 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 t30 51.1 70.34 0.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.045 1.338 . . . . 72.33 112.096 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 p -125.01 -58.88 1.45 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.321 0.648 . . . . 72.1 109.594 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' C' ' 145' ' ' ALA . 2.2 tm-20 -145.81 127.58 15.31 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.618 -1.623 . . . . 74.1 106.618 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.433 ' HG2' HE22 ' C' ' 144' ' ' GLN . 26.8 ptt? -136.19 156.77 48.21 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.226 0.536 . . . . 73.42 112.408 -166.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -144.18 134.81 24.88 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.896 0.878 . . . . 65.01 109.344 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.485 ' HD2' HG22 ' A' ' 86' ' ' ILE . 36.2 t80 -121.32 130.01 53.41 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.767 -1.197 . . . . 72.3 107.767 166.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -144.52 123.39 12.7 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.997 0.186 . . . . 63.43 111.37 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.402 HD11 HG13 ' A' ' 16' ' ' ILE . 6.8 tp -68.7 130.95 34.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.956 -0.757 . . . . 63.55 108.956 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 15.5 mm100 -110.62 -39.97 4.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.928 -0.578 . . . . 65.04 109.919 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 27.1 ttt180 -173.58 144.29 1.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 119.871 -0.109 . . . . 74.21 110.755 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.556 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 71.7 mt -123.01 132.31 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.535 -1.283 . . . . 61.02 107.535 170.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 15.4 p90 -156.73 155.45 31.68 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.416 0.686 . . . . 73.5 110.633 -174.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -88.52 109.39 20.02 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.851 -0.613 . . . . 72.31 109.697 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -72.4 -32.53 66.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.165 0.507 . . . . 74.44 109.985 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.72 142.84 27.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.961 -1.018 . . . . 72.23 109.537 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.47 137.88 53.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.665 -1.605 . . . . 75.2 106.665 169.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -144.41 136.54 26.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.925 -0.769 . . . . 74.14 108.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.601 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.5 t80 -142.32 112.19 6.86 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 106.939 -1.504 . . . . 74.13 106.939 175.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 46.7 mt-10 -118.67 108.45 14.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.98 -0.748 . . . . 63.22 108.98 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.95 81.95 2.87 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.479 -1.304 . . . . 72.44 107.479 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.31 -19.07 20.04 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.153 1.902 . . . . 71.44 111.694 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 45.7 m-80 -120.65 38.5 4.0 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.014 0.925 . . . . 72.15 109.181 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.66 -44.47 99.5 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.073 -0.967 . . . . 74.11 112.632 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.85 -28.96 67.61 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.394 1.533 . . . . 73.54 112.856 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.1 m170 -82.19 -26.31 33.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.543 0.737 . . . . 64.41 112.158 -169.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG23 HD11 ' A' ' 68' ' ' LEU . 7.3 p -63.9 -19.2 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.202 0.525 . . . . 72.43 111.807 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -83.29 -39.78 20.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.725 0.81 . . . . 75.03 110.998 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.79 -28.22 58.29 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.92 0.488 . . . . 75.21 110.724 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.68 160.87 22.31 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.284 0.634 . . . . 74.55 110.099 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.32 144.88 26.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.245 -0.65 . . . . 60.1 109.245 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.2 t-105 -75.77 89.01 2.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.66 0.784 . . . . 64.44 110.557 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.3 tt0 -122.36 77.09 44.31 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 107.718 -1.215 . . . . 72.2 107.718 169.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -84.97 145.89 10.09 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.486 2.124 . . . . 43.23 113.174 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -98.86 104.61 16.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.19 -1.411 . . . . 65.14 107.19 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 t -80.64 116.14 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.802 0.841 . . . . 74.34 108.881 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 59.2 tttm -120.35 113.99 21.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.713 0.805 . . . . 70.04 109.391 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.681 HD21 HD22 ' A' ' 128' ' ' LEU . 10.5 mp -104.87 125.74 51.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.968 -0.752 . . . . 72.35 108.968 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.646 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.3 m-20 -117.05 128.57 55.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.175 -1.046 . . . . 64.41 108.175 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -115.2 121.02 41.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.263 0.625 . . . . 71.52 109.69 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -138.86 154.57 48.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.208 1.003 . . . . 74.43 109.037 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -140.05 153.2 46.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.487 0.715 . . . . 52.51 109.484 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.38 113.28 6.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.015 -0.735 . . . . 63.13 109.015 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.2 p -90.07 165.58 13.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.711 0.404 . . . . 74.45 110.33 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 47.8 t -166.46 157.34 12.64 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.227 1.011 . . . . 61.32 108.568 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.63 132.8 55.62 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.899 -0.778 . . . . 74.23 108.899 169.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 57' ' ' GLU . 70.3 mt -105.52 -37.45 6.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.885 0.874 . . . . 74.44 110.405 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.49 -175.14 5.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.727 0.811 . . . . 52.41 109.82 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.31 104.71 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.046 0.538 . . . . 62.31 110.398 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.634 ' H ' HD23 ' G' ' 173' ' ' LEU . 9.2 m-20 70.82 10.11 6.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.742 1.617 . . . . 65.33 112.432 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.07 112.42 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.0 -1.482 . . . . 52.04 107.0 170.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -117.74 150.18 39.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.502 0.721 . . . . 74.01 109.403 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 33.2 tt0 -111.11 118.31 35.66 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.48 -0.933 . . . . 71.13 108.48 171.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.8 115.57 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.916 -1.142 . . . . 73.34 107.916 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.629 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 53.7 t -98.01 137.52 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.387 0.675 . . . . 65.41 109.323 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.96 110.1 21.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.053 -1.462 . . . . 72.31 107.053 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -101.39 101.62 12.28 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.806 -0.813 . . . . 72.01 108.806 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -94.6 140.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.746 -1.205 . . . . 74.33 107.746 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 m -128.33 144.49 51.14 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.666 -0.864 . . . . 74.43 108.666 171.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 35.1 t -142.06 109.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.489 1.116 . . . . 32.21 108.543 -171.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -109.63 137.94 46.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.538 -0.541 . . . . 70.22 109.538 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.36 120.48 34.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.625 -1.25 . . . . 61.2 107.625 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -130.52 131.7 45.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.611 . . . . 74.44 110.866 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 31' ' ' VAL . 49.6 mt -87.12 83.64 7.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.02 1.328 . . . . 74.21 107.852 177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.93 -89.47 0.77 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.768 -0.651 . . . . 53.51 111.88 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.41 -28.67 9.24 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.771 0.828 . . . . 53.31 110.866 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.17 117.15 29.38 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.907 0.483 . . . . 74.25 111.144 -171.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -66.95 110.38 3.32 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.117 0.484 . . . . 74.33 112.021 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.73 -57.01 14.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.796 1.239 . . . . 73.12 110.221 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.21 173.6 16.73 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.732 0.777 . . . . 71.1 111.986 175.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 64.1 tp -141.25 144.04 34.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.504 1.522 . . . . 74.45 107.837 174.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -140.61 125.04 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.36 1.064 . . . . 63.44 108.769 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.99 116.52 8.09 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.929 0.491 . . . . 72.25 109.725 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.78 111.76 26.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.105 0.962 . . . . 72.23 109.021 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.05 79.66 9.55 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.027 -1.101 . . . . 73.23 108.027 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.44 90.29 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.931 1.292 . . . . 73.5 108.699 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.55 144.23 19.65 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 116.064 -0.516 . . . . 75.43 112.119 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.83 130.26 4.81 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 111.791 -0.524 . . . . 52.03 111.791 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 39.2 mt -82.14 125.27 39.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.53 -0.915 . . . . 74.3 108.53 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 21.0 m-85 -131.51 119.45 21.56 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.895 -1.15 . . . . 65.52 107.895 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -79.03 99.83 7.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.977 -0.749 . . . . 72.1 108.977 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.485 HG22 ' HD2' ' A' ' 11' ' ' PHE . 2.7 pp -112.61 153.48 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.354 0.662 . . . . 74.32 110.408 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.88 158.05 7.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.85 0.86 . . . . 73.14 110.231 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.1 -10.36 60.93 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 114.929 0.732 . . . . 75.41 114.929 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.32 138.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.244 0.618 . . . . 72.5 109.469 -179.003 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 4' ' ' GLN . 12.8 tt0 -148.21 175.7 10.84 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.535 -0.913 . . . . 73.55 108.535 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 63.45 -133.61 41.88 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.098 0.249 . . . . 64.22 112.953 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -73.43 -21.7 60.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.976 0.511 . . . . 53.31 111.113 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -71.14 -41.19 70.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 74.41 110.169 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' G' ' 175' ' ' PHE . 26.7 ttt -74.01 -38.8 63.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.681 -0.69 . . . . 63.13 109.936 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.21 69.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.648 -0.705 . . . . 75.52 111.545 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -77.12 -38.51 52.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.408 0.683 . . . . 63.33 109.964 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.4 -66.83 0.53 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.502 0.502 . . . . 72.02 110.649 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -82.24 -10.96 58.94 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.017 0.747 . . . . 72.03 113.017 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.97 2.99 25.69 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 118.947 -0.919 . . . . 74.3 114.469 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.23 -58.47 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.583 1.191 . . . . 64.35 112.051 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.473 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.9 t80 -67.06 -51.51 53.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.988 0.915 . . . . 75.5 111.737 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.0 m -71.73 -37.69 5.5 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.249 -0.882 . . . . 41.22 112.084 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.3 -39.57 72.27 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.911 1.741 . . . . 55.34 113.002 161.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.06 -24.27 61.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.619 0.768 . . . . 62.14 111.132 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 16' ' ' ILE . 47.8 mm -64.79 -43.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 109.149 -0.686 . . . . 53.5 109.149 169.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 82' ' ' GLY . 47.3 mt -75.8 -25.48 56.42 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.988 -1.006 . . . . 64.34 111.769 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -64.41 -40.35 50.23 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 114.381 1.252 . . . . 63.12 114.381 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.55 -31.57 86.97 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 121.873 1.716 . . . . 73.31 113.502 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -87.64 -29.91 20.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.549 0.74 . . . . 72.53 111.001 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.9 86.06 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.725 -0.843 . . . . 74.44 108.725 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.432 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -62.45 -44.44 96.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.362 1.065 . . . . 73.3 110.029 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' HH12 ' B' ' 120' ' ' ARG . 10.4 tt0 -49.66 -54.28 19.53 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.278 1.031 . . . . 71.04 110.927 176.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.14 -42.95 88.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.566 -1.197 . . . . 61.13 111.561 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 97.2 mt -67.01 -62.58 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.911 0.485 . . . . 72.13 110.415 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 125' ' ' GLN . 57.9 m -48.96 -35.37 14.97 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.004 1.322 . . . . 75.41 111.986 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.5 t -71.13 -49.65 41.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.027 -0.511 . . . . 42.3 110.875 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.601 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 58.5 mtm -56.33 -42.89 78.41 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.06 0.457 . . . . 71.14 110.847 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 114' ' ' ILE . 69.3 t -61.12 -49.16 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.912 1.285 . . . . 63.41 110.633 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.7 -30.96 68.73 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.615 0.366 . . . . 64.44 111.385 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.5 mtt-85 -71.08 -30.76 66.96 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.928 0.891 . . . . 72.53 110.532 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.0 6.34 49.47 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.021 -0.536 . . . . 53.12 113.507 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.454 ' HB ' HH21 ' B' ' 15' ' ' ARG . 37.8 m 74.06 7.84 4.76 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 125.413 1.485 . . . . 65.41 111.054 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.429 ' HE1' HG21 ' A' ' 31' ' ' VAL . 89.0 m-85 -81.71 159.02 67.39 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 123.493 0.717 . . . . 64.53 109.163 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.06 161.57 45.3 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.475 2.117 . . . . 65.44 111.614 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.5 tt0 -67.54 132.68 48.03 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.854 0.359 . . . . 74.33 110.551 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -111.69 106.62 15.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.93 0.892 . . . . 74.33 109.134 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.97 90.79 4.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.546 . . . . 63.51 110.335 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.681 HD22 HD21 ' A' ' 42' ' ' LEU . 48.4 mt -74.57 116.51 15.34 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.586 -0.894 . . . . 74.22 108.586 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 141.58 97.29 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 122.068 0.147 . . . . 53.34 111.242 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.12 121.23 8.63 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.193 1.928 . . . . 45.24 110.341 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.59 HG21 ' HG ' ' G' ' 186' ' ' LEU . 86.5 t -98.14 109.06 23.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.803 -1.184 . . . . 62.22 107.803 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -94.5 91.71 6.76 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.657 -1.156 . . . . 51.31 108.238 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -61.34 -28.59 69.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.945 -1.025 . . . . 71.4 110.814 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.67 -39.24 61.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.193 1.397 . . . . 74.34 112.047 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.31 -58.71 7.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.597 0.759 . . . . 64.22 110.945 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.28 -33.75 74.92 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.632 0.582 . . . . 72.41 111.537 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.421 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.6 t80 -65.73 -60.51 2.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.569 0.747 . . . . 73.21 110.508 -175.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.72 -41.99 99.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.939 0.775 . . . . 73.41 111.02 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 29.7 t30 -55.49 -51.45 66.94 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.544 1.153 . . . . 54.31 110.939 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -62.76 -39.88 95.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.597 0.759 . . . . 74.42 111.643 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 77.5 mt -67.39 -51.28 53.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.556 0.535 . . . . 73.23 111.533 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -176.93 22.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.565 0.541 . . . . 72.44 110.931 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 87.1 mt-30 52.55 48.46 22.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.917 0.865 . . . . 75.04 110.979 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -70.02 112.29 6.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.171 -1.377 . . . . 72.33 109.443 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.19 84.72 1.04 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.285 0.564 . . . . 63.15 110.124 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.19 39.85 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.316 -0.856 . . . . 62.55 112.914 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.38 99.8 6.68 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.371 -0.974 . . . . 75.41 108.371 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.96 72.3 0.11 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.601 -0.6 . . . . 73.11 111.601 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 m -76.19 85.95 3.03 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.303 0.573 . . . . 61.04 109.596 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 95.04 7.64 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.53 -0.915 . . . . 72.03 108.53 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.24 -36.7 12.46 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.178 0.991 . . . . 73.12 110.118 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 79.9 -44.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.004 1.722 . . . . 75.03 114.352 167.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -77.03 157.68 31.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.176 0.59 . . . . 74.35 111.584 -170.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.65 108.95 3.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.884 0.874 . . . . 75.13 110.255 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.734 0.813 . . . . 62.23 110.098 -176.505 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HG2' ' B' ' 3' ' ' GLU . 15.4 ptp . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.93 0.872 . . . . 65.43 110.244 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -88.21 66.98 8.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.788 -0.819 . . . . 71.44 108.788 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' B' ' 1' ' ' MET . 9.8 mm-40 -94.62 174.94 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.153 -0.931 . . . . 74.33 110.517 -174.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -117.74 163.98 15.68 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.603 0.761 . . . . 64.42 110.075 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -133.55 144.76 49.55 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.131 0.572 . . . . 73.23 109.985 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -122.0 -143.06 0.33 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.34 -0.985 . . . . 60.15 108.34 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.8 p -63.82 87.91 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.258 0.551 . . . . 62.11 109.625 169.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.9 -171.12 2.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.072 0.949 . . . . 71.24 110.424 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.2 ptm 54.67 178.23 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.316 1.846 . . . . 62.51 113.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -150.56 143.0 24.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.487 0.715 . . . . 63.01 110.176 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -139.44 134.0 31.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.273 -1.01 . . . . 73.21 108.273 171.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -149.62 108.35 3.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.251 -0.648 . . . . 74.12 109.251 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -78.47 133.97 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.524 0.73 . . . . 65.14 109.309 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -105.6 -50.09 3.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.674 0.39 . . . . 63.12 110.925 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.454 HH21 ' HB ' ' A' ' 122' ' ' THR . 45.9 ttt180 -159.99 146.34 15.86 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.456 0.17 . . . . 71.1 110.963 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.1 143.02 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.067 -1.457 . . . . 71.03 107.067 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.405 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.1 p90 -171.29 141.87 1.65 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 118.741 0.701 . . . . 73.13 111.198 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.6 m -74.15 118.55 17.24 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.739 -0.837 . . . . 74.14 108.739 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -86.71 -33.05 20.14 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.997 0.519 . . . . 74.05 110.524 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -158.21 143.46 16.63 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.867 0.321 . . . . 75.05 111.867 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 44.3 mm -131.88 142.35 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.823 1.249 . . . . 75.02 108.977 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.99 134.86 28.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.397 -0.964 . . . . 64.33 108.397 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -148.7 127.86 12.87 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 107.047 -1.464 . . . . 75.44 107.047 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.7 112.25 9.98 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.081 -1.081 . . . . 55.3 108.081 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -109.75 89.54 7.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.787 0.835 . . . . 73.43 108.954 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.7 -27.56 38.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.092 1.861 . . . . 72.45 111.696 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -113.82 29.44 8.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.626 0.77 . . . . 64.12 110.463 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -47.3 -48.45 55.85 Favored Pre-proline 0 CA--C 1.574 1.896 0 C-N-CA 124.905 1.282 . . . . 74.45 113.008 170.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.42 -25.48 3.8 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.044 1.83 . . . . 71.12 113.396 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.54 1.7 44.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.411 0.684 . . . . 73.41 111.923 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.47 -14.18 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.471 1.108 . . . . 44.14 111.237 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.09 -42.12 93.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.916 0.886 . . . . 72.53 110.408 169.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -75.56 -40.67 56.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.306 1.042 . . . . 72.33 110.289 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 32.1 mmtp -108.37 67.96 0.68 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.392 -1.276 . . . . 74.04 109.521 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.409 ' HB2' ' N ' ' F' ' 197' ' ' TYR . 8.5 p-10 -89.37 75.64 7.65 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.116 -0.947 . . . . 72.51 111.078 -173.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -169.61 170.95 7.82 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 126.098 1.759 . . . . 75.33 109.637 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.494 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 54.1 tt0 -67.57 122.06 81.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 123.318 0.647 . . . . 73.25 110.404 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.31 151.41 80.76 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.92 2.413 . . . . 62.45 113.377 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.41 106.63 6.11 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.836 -0.802 . . . . 74.12 108.836 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.77 131.94 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.242 1.017 . . . . 73.24 110.803 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -124.43 143.1 50.82 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.992 -0.744 . . . . 70.24 108.992 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.602 HD22 HD11 ' B' ' 126' ' ' LEU . 1.0 OUTLIER -129.3 140.99 51.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.881 0.372 . . . . 71.53 110.829 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.49 145.13 49.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.372 1.069 . . . . 75.15 109.558 -168.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.414 HD22 HD21 ' F' ' 186' ' ' LEU . 31.0 tp -93.96 131.82 39.04 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.4 0.68 . . . . 64.44 109.719 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.48 124.38 28.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.971 0.908 . . . . 75.44 108.695 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.4 m -112.55 113.95 26.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.758 0.423 . . . . 32.43 110.169 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.95 149.03 39.42 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.774 -1.195 . . . . 74.24 107.774 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -143.15 173.03 11.93 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.84 0.352 . . . . 74.12 110.544 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.3 p -157.32 173.99 16.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.383 1.073 . . . . 70.31 108.948 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -124.58 121.72 35.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.674 0.39 . . . . 73.24 110.566 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 70.8 mt -80.57 -44.35 19.16 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.158 0.583 . . . . 61.34 111.126 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 -173.2 4.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.917 0.887 . . . . 74.13 109.746 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -61.72 112.77 2.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.433 -0.803 . . . . 74.31 110.277 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.491 ' H ' HD21 ' F' ' 173' ' ' LEU . 4.2 m-20 70.52 0.28 3.19 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.922 1.689 . . . . 63.13 112.745 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.66 92.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 N-CA-C 107.543 -1.28 . . . . 74.22 107.543 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.26 171.05 8.96 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.29 0.636 . . . . 64.32 109.837 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.483 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 5.0 tm-20 -143.72 101.2 3.72 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.281 -1.377 . . . . 74.02 107.281 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.3 122.57 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.5 0.72 . . . . 64.2 110.304 -174.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 41.2 t -102.38 114.52 42.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.508 0.723 . . . . 73.54 109.532 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.5 OUTLIER -92.16 106.87 18.79 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.714 -1.217 . . . . 71.44 107.714 178.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -95.18 116.41 28.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.252 -0.647 . . . . 63.44 109.252 170.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.0 t -105.43 120.88 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.292 -1.374 . . . . 72.14 107.292 164.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -96.51 146.84 24.44 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 52.12 109.0 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.651 HG21 HG21 ' B' ' 114' ' ' ILE . 41.6 t -134.7 128.66 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.816 0.846 . . . . 71.21 109.461 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.5 m -123.61 138.78 54.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.111 -0.949 . . . . 73.51 108.543 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.71 149.82 37.75 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.498 0.719 . . . . 32.45 109.205 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.1 p -143.94 137.74 28.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.708 0.63 . . . . 64.35 110.25 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 38.8 mt -90.9 98.73 11.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.077 -1.823 . . . . 53.14 106.077 170.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.63 -129.68 14.09 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.538 -0.755 . . . . 65.15 111.686 -169.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -92.75 2.83 56.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.054 0.941 . . . . 74.42 111.021 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -115.65 138.09 51.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.244 1.018 . . . . 74.24 109.02 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 132.7 49.85 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.317 0.58 . . . . 65.33 111.846 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.477 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.87 -58.65 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.376 1.071 . . . . 73.24 109.073 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -157.82 157.03 32.53 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.275 -1.329 . . . . 74.1 110.544 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.3 mt -135.18 110.71 9.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 106.673 -1.603 . . . . 72.55 106.673 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.95 157.86 25.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.357 -0.608 . . . . 50.44 109.357 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -164.6 135.08 4.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.979 -0.749 . . . . 52.55 108.979 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.92 139.83 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.546 -0.752 . . . . 71.24 109.086 173.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -122.66 89.13 3.06 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.489 -0.93 . . . . 74.54 108.489 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.36 101.23 12.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.2 -1.037 . . . . 64.41 108.2 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.5 159.32 28.27 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.24 -0.744 . . . . 61.43 111.24 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.92 129.36 2.38 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 112.002 -0.439 . . . . 30.51 112.002 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.405 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.2 mt -85.15 124.13 39.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.578 -0.897 . . . . 74.45 108.578 174.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -136.33 158.11 45.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.162 0.985 . . . . 75.32 108.883 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -130.93 114.8 15.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.344 -0.613 . . . . 60.33 109.344 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.501 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.72 143.02 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.384 0.673 . . . . 74.12 110.003 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.03 167.86 29.19 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.98 0.912 . . . . 73.51 109.099 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.47 -70.19 1.22 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.847 -0.501 . . . . 72.4 111.847 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.431 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -57.62 141.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.823 0.449 . . . . 53.11 110.623 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' F' ' 174' ' ' MET . 31.0 tt0 -151.4 154.24 36.26 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.93 0.332 . . . . 75.52 110.593 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.21 -124.33 13.52 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.389 0.431 . . . . 71.34 112.7 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.6 m -65.76 -32.33 73.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.61 0.764 . . . . 75.34 110.121 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -69.38 -36.45 76.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.804 0.842 . . . . 52.41 110.512 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.718 ' SD ' ' HG2' ' F' ' 174' ' ' MET . 18.0 ttt -72.6 -45.6 58.28 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.96 -0.385 . . . . 64.51 109.96 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.92 66.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.87 0.468 . . . . 54.14 112.057 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -73.36 -33.2 64.94 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.686 0.794 . . . . 75.42 110.806 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -86.26 -67.42 0.81 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.284 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 16.8 tp -61.15 -32.36 72.08 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.597 1.159 . . . . 71.1 112.709 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.73 1.97 52.56 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.354 -0.692 . . . . 63.12 114.663 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.96 -52.2 0.33 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.904 0.852 . . . . 61.32 111.492 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -73.63 -46.8 44.62 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.017 0.527 . . . . 63.02 111.993 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.412 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 78.8 m -63.41 -44.16 81.36 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 118.814 -0.612 . . . . 63.54 111.207 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.7 Cg_exo -59.96 -36.53 89.69 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.893 1.729 . . . . 73.34 113.396 164.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.7 -31.04 71.16 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 122.835 0.454 . . . . 72.41 111.432 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.453 HG23 ' NH2' ' D' ' 111' ' ' ARG . 94.7 mt -61.41 -50.76 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.913 0.885 . . . . 75.42 109.964 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.439 ' HB2' HD12 ' B' ' 60' ' ' LEU . 46.4 mt -77.58 -11.51 59.87 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.487 1.115 . . . . 72.52 112.135 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -69.24 -44.06 26.02 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.883 1.273 . . . . 70.12 113.621 -165.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.64 -34.47 51.46 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 121.568 1.512 . . . . 75.21 112.344 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -63.71 -41.67 98.06 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.715 0.634 . . . . 75.44 110.136 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -69.03 -42.76 75.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.447 -0.797 . . . . 73.12 110.325 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -57.24 -54.71 43.7 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.643 1.177 . . . . 52.52 111.776 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.08 -38.81 91.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.176 0.99 . . . . 73.32 110.395 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.49 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -67.65 -32.91 73.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.6 -0.727 . . . . 71.54 111.78 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.651 HG21 HG21 ' B' ' 64' ' ' VAL . 74.5 mt -65.52 -55.64 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.466 -0.568 . . . . 63.24 109.466 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 5.0 m -56.93 -32.17 65.71 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.277 0.986 . . . . 62.44 110.983 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.62 -53.2 51.42 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.484 -1.235 . . . . 63.12 110.747 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.1 mmt -67.68 -32.01 72.38 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.663 0.385 . . . . 74.51 111.703 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.13 -42.75 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.237 1.015 . . . . 73.0 110.688 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.03 -25.32 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.94 0.496 . . . . 64.31 111.739 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 116' ' ' SER . 80.8 mtt-85 -66.85 -38.58 86.63 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.799 0.439 . . . . 75.51 109.848 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.41 4.21 56.37 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.263 -0.88 . . . . 73.41 113.148 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 66.8 p 59.44 50.73 7.25 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.921 1.688 . . . . 72.01 112.035 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.534 ' HA ' ' HZ ' ' F' ' 195' ' ' PHE . 59.6 m-85 -120.41 158.53 50.92 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.684 1.194 . . . . 72.25 109.795 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.494 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.2 Cg_exo -72.37 -174.65 1.49 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.57 2.847 . . . . 63.51 115.435 -166.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -58.85 130.66 48.05 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.839 -1.528 . . . . 74.23 112.118 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.602 HD11 HD22 ' B' ' 42' ' ' LEU . 59.0 tp -138.64 83.83 1.98 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.669 -1.234 . . . . 42.11 107.669 171.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.663 -1.236 . . . . 75.44 107.663 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.564 HD11 HD13 ' F' ' 186' ' ' LEU . 2.5 tt -87.0 130.62 34.38 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.581 -0.896 . . . . 75.0 108.581 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.43 34.76 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.236 0.615 . . . . 73.44 110.466 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.429 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 45.1 Cg_endo -67.06 131.86 26.45 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.192 1.928 . . . . 74.33 110.984 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.89 143.79 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 122.957 0.503 . . . . 63.45 110.384 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -86.99 111.83 21.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.735 0.814 . . . . 62.14 109.24 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -67.28 -27.89 67.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.95 0.9 . . . . 72.14 111.43 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.8 -44.69 40.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.261 1.025 . . . . 65.2 111.01 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.98 -34.19 74.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.096 -0.502 . . . . 71.01 111.064 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.502 HD22 ' HE1' ' F' ' 184' ' ' TRP . 5.5 tt -56.88 -48.54 77.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.947 0.899 . . . . 74.11 111.139 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -65.83 -33.6 76.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.794 0.838 . . . . 73.22 110.909 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -72.23 -37.23 69.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.192 0.597 . . . . 64.52 111.856 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -74.41 -20.25 60.12 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 120.561 0.219 . . . . 72.12 110.799 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -86.4 -42.83 13.32 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 72.04 109.995 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.94 37.15 2.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.844 0.858 . . . . 71.34 110.062 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.5 147.93 20.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.119 0.968 . . . . 62.21 111.698 171.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.12 117.63 10.3 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.602 -0.888 . . . . 74.14 108.602 -173.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.44 ' OE1' ' HB3' ' D' ' 8' ' ' GLU . 22.2 tt0 -148.63 79.69 1.43 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.044 -1.095 . . . . 72.12 108.044 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.57 148.52 48.08 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.68 -0.691 . . . . 73.21 112.255 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.14 -45.79 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.791 -1.095 . . . . 52.24 110.799 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -168.55 163.56 12.39 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.539 1.136 . . . . 75.25 110.026 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.67 141.92 13.1 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.286 -0.726 . . . . 72.14 111.286 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 152.22 34.48 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.704 0.801 . . . . 75.15 110.37 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.62 85.6 2.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.738 -0.838 . . . . 54.11 108.738 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' B' ' 153' ' ' GLN . 13.5 tp10 -164.19 153.68 14.03 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.496 -0.775 . . . . 70.11 109.714 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -133.29 83.29 2.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.845 0.858 . . . . 72.33 109.177 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.454 ' HG2' ' HG3' ' B' ' 151' ' ' GLU . 21.0 pt20 -158.63 163.69 36.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.749 0.819 . . . . 63.21 110.166 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -151.73 149.32 28.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.918 0.887 . . . . 74.35 109.321 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.663 0.785 . . . . 75.31 109.497 -177.825 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtm . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.294 -0.262 . . . . 65.24 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m 57.8 51.91 8.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.339 1.056 . . . . 71.54 112.327 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -66.53 -39.04 88.41 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 114.781 -1.099 . . . . 63.14 109.573 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.59 85.71 0.92 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.743 1.217 . . . . 72.33 108.504 168.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.98 -92.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.223 1.409 . . . . 65.34 111.32 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 97.7 6.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.016 -1.105 . . . . 73.13 108.016 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -111.69 -73.88 0.66 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.037 -1.098 . . . . 75.33 108.037 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 53.93 83.25 0.08 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.639 1.175 . . . . 75.3 112.499 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 64.18 115.4 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.093 1.357 . . . . 73.25 112.217 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m -115.56 111.71 21.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.818 1.247 . . . . 75.3 107.711 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.602 ' HA ' HG22 ' C' ' 86' ' ' ILE . 41.5 t80 -125.99 120.1 29.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.11 0.564 . . . . 75.23 109.841 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -139.02 128.94 25.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.64 0.376 . . . . 61.35 110.066 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.421 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.6 tp -80.99 136.83 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.388 -0.597 . . . . 70.55 109.388 170.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -106.65 -49.7 3.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.46 0.704 . . . . 73.21 110.17 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -160.73 136.47 8.16 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.144 -0.48 . . . . 74.01 110.313 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.83 143.52 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.338 -1.356 . . . . 73.54 107.338 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -171.5 162.66 6.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.33 0.586 . . . . 72.21 110.754 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -83.8 113.64 21.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.456 -0.793 . . . . 64.32 109.137 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -64.76 -46.9 80.23 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.987 -1.116 . . . . 72.22 107.987 167.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -142.8 141.61 31.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.42 -1.718 . . . . 71.44 109.791 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -140.73 143.43 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.388 -1.708 . . . . 53.22 106.388 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -155.69 151.6 27.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.745 0.418 . . . . 53.43 110.117 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -155.62 121.49 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.769 -1.197 . . . . 52.31 107.769 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.36 136.61 54.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.374 0.67 . . . . 61.15 109.804 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.59 77.93 8.56 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.843 -1.169 . . . . 63.04 107.843 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.53 -9.75 23.09 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.371 2.047 . . . . 61.1 111.943 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -109.38 19.43 19.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.716 1.206 . . . . 73.33 110.213 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -51.72 -49.8 81.13 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 124.903 1.281 . . . . 74.43 113.475 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.95 -30.12 1.43 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.421 1.414 . . . . 73.45 113.31 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -69.41 -28.06 65.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.524 0.729 . . . . 63.05 111.955 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.87 -12.29 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.217 0.607 . . . . 74.0 111.411 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.88 -31.67 72.74 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.888 0.875 . . . . 74.25 111.261 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.7 20.83 17.96 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.4 0.68 . . . . 61.02 110.146 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.812 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -100.83 158.27 16.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.095 0.558 . . . . 73.34 109.887 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -77.44 121.32 23.67 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.281 -1.007 . . . . 71.03 108.281 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -85.0 91.15 8.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.598 0.713 . . . . 74.0 110.434 -172.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -131.32 69.66 82.0 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.559 -1.2 . . . . 71.43 108.239 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.56 104.65 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.655 2.236 . . . . 63.14 111.933 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -86.99 118.01 26.08 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.753 -0.832 . . . . 61.55 108.753 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.467 HG11 HD21 ' C' ' 126' ' ' LEU . 48.2 t -80.2 128.29 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 74.33 111.448 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.36 104.31 7.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.688 1.195 . . . . 72.13 107.865 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.645 HD13 HD12 ' E' ' 186' ' ' LEU . 0.3 OUTLIER -86.65 165.83 15.83 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.838 0.352 . . . . 75.31 110.407 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.692 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -138.35 146.25 42.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.384 -1.339 . . . . 75.53 107.384 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.7 tp -138.2 102.26 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.921 -0.77 . . . . 72.3 108.921 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 7.1 m-20 -120.09 142.32 48.99 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.427 0.691 . . . . 73.12 109.758 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -114.88 117.56 31.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.137 -0.69 . . . . 63.03 109.137 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.92 153.9 24.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.718 -1.216 . . . . 54.14 107.718 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.3 p -164.34 154.17 14.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.934 0.397 . . . . 70.12 111.328 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 15.5 p -170.34 138.92 1.63 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.248 1.019 . . . . 73.24 109.174 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -80.32 135.99 36.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.955 0.502 . . . . 44.11 109.817 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.444 ' CD1' HD12 ' C' ' 83' ' ' ILE . 63.7 mt -104.57 -26.56 12.3 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.83 0.852 . . . . 73.52 111.591 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.23 -172.99 1.39 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.383 0.673 . . . . 41.05 110.955 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.28 105.92 0.67 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 123.985 0.803 . . . . 72.33 110.919 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.53 10.04 5.52 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.254 1.422 . . . . 54.33 112.519 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.41 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 108.234 -1.024 . . . . 74.34 108.234 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -108.31 158.67 17.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.124 0.97 . . . . 73.34 108.75 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.4 tt0 -126.07 127.78 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.281 -1.007 . . . . 73.14 108.281 172.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 81.1 t -117.93 129.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.939 -1.134 . . . . 61.32 107.939 170.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.09 107.48 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.336 -0.987 . . . . 64.03 108.336 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.472 HD22 HG22 ' C' ' 62' ' ' VAL . 0.9 OUTLIER -86.19 106.21 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.069 -1.086 . . . . 72.33 108.069 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 57.4 ttt180 -82.12 105.38 13.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.472 HG22 HD22 ' C' ' 60' ' ' LEU . 13.6 t -105.42 130.99 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.213 -1.032 . . . . 64.32 108.213 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 21.9 m -129.7 146.29 51.48 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.02 -0.733 . . . . 74.41 109.02 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.519 HG21 HG21 ' C' ' 114' ' ' ILE . 50.8 t -131.07 127.94 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.948 0.899 . . . . 72.5 108.655 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.484 HG23 HD23 ' C' ' 75' ' ' LEU . 4.2 m -123.2 109.16 13.64 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.657 -1.238 . . . . 72.42 107.657 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.67 121.14 41.14 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.056 -1.09 . . . . 54.31 108.056 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -129.8 133.05 46.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.282 0.563 . . . . 71.31 110.593 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.812 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -87.1 33.88 0.68 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 125.726 1.61 . . . . 74.14 110.085 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.77 -103.1 2.17 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.176 -0.769 . . . . 60.02 111.176 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.35 -31.61 17.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.427 0.691 . . . . 74.44 110.16 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 4.0 tp10 -79.21 120.22 23.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 75.32 109.2 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -77.56 122.36 25.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.15 -0.685 . . . . 64.41 109.15 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -71.15 -50.29 34.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 63.31 109.598 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -160.84 170.66 20.23 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.422 -1.263 . . . . 74.14 110.98 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.484 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -136.35 147.23 47.27 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.996 -1.483 . . . . 53.13 106.996 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.418 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -147.81 149.21 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.478 -0.934 . . . . 72.12 108.478 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -157.61 118.81 3.58 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.848 0.459 . . . . 75.33 109.884 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -121.64 112.47 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.517 0.727 . . . . 54.52 109.364 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.454 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 49.7 mt-30 -94.82 99.64 11.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.704 -0.85 . . . . 73.44 108.704 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.62 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.1 tp-100 -85.07 104.93 15.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 71.43 110.542 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.06 145.67 22.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.47 -0.332 . . . . 42.13 112.326 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.92 127.85 2.72 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.057 -0.417 . . . . 54.44 112.057 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.444 HD12 ' CD1' ' C' ' 51' ' ' LEU . 12.6 mm -91.19 125.03 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.606 0.762 . . . . 64.44 109.124 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.421 ' CE2' HD13 ' C' ' 13' ' ' ILE . 58.4 m-85 -133.69 118.31 17.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.864 -0.791 . . . . 72.01 108.864 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.1 p -85.69 97.37 10.09 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -125.22 135.48 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-O 121.531 0.682 . . . . 43.35 111.235 -174.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.95 -178.54 5.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.191 1.396 . . . . 73.4 107.905 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.74 -30.56 4.18 Favored Glycine 0 N--CA 1.477 1.419 0 C-N-CA 121.391 -0.433 . . . . 52.15 113.642 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.422 HG13 ' H ' ' C' ' 89' ' ' ILE . 2.4 pp -68.0 140.77 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.098 0.959 . . . . 64.11 111.764 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.485 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 41.3 tt0 -155.28 151.51 28.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.267 0.627 . . . . 72.21 110.447 -174.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.3 -115.99 6.79 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.063 0.227 . . . . 70.24 112.847 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -71.95 -29.93 64.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.242 0.617 . . . . 74.22 110.874 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 42.4 mt-30 -64.1 -35.17 79.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.862 0.865 . . . . 74.22 111.105 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.1 tpt -55.07 -36.93 66.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.892 0.877 . . . . 45.35 111.054 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.49 -47.44 11.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.636 0.774 . . . . 62.33 111.523 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -73.7 -34.61 64.93 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.482 0.713 . . . . 72.12 112.656 -167.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -63.6 -55.97 19.54 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.614 0.571 . . . . 75.14 111.233 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.743 HD11 HD11 ' E' ' 177' ' ' LEU . 1.0 OUTLIER -92.83 -16.69 25.01 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.198 0.599 . . . . 60.42 112.528 -175.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.414 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.95 -14.87 38.24 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.395 -0.67 . . . . 71.11 113.8 -172.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.08 -46.25 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.46 0.63 . . . . 70.35 111.979 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -74.7 -44.25 51.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.119 0.567 . . . . 63.41 111.972 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.511 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 73.2 m -67.63 -45.48 45.94 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.464 -0.779 . . . . 72.21 111.331 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.11 -36.65 96.63 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.249 1.966 . . . . 75.12 112.734 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -61.91 -33.44 74.24 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.546 0.738 . . . . 64.43 111.712 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.432 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -68.37 -39.31 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.165 0.586 . . . . 72.32 110.413 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.7 mt -80.84 -32.73 34.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.274 -0.876 . . . . 74.02 112.483 -171.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -54.19 -48.72 93.49 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 117.288 -1.339 . . . . 73.22 113.182 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -45.04 -43.19 15.86 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.974 2.449 . . . . 64.11 114.544 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -70.45 -45.32 66.01 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.285 0.634 . . . . 73.23 111.052 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.9 -37.01 81.19 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.117 0.567 . . . . 72.42 110.959 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -54.12 -51.08 65.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.341 1.456 . . . . 73.05 110.517 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.24 -32.03 66.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.224 -0.898 . . . . 64.53 110.92 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -74.6 -30.84 61.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.896 0.478 . . . . 73.51 111.609 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.519 HG21 HG21 ' C' ' 64' ' ' VAL . 94.3 mt -71.7 -46.31 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.572 -0.529 . . . . 73.22 109.572 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.521 HG23 ' HB2' ' C' ' 125' ' ' GLN . 54.2 m -51.28 -42.54 61.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 71.35 110.834 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -63.68 -52.56 60.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.811 -1.541 . . . . 55.44 110.219 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.469 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.93 -40.96 81.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.362 1.065 . . . . 73.31 113.162 -176.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.44 -46.44 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.283 0.633 . . . . 75.21 110.151 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -64.83 -27.69 69.05 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.001 -1.0 . . . . 71.03 111.648 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 76.6 mtt-85 -70.06 -37.26 75.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.616 0.767 . . . . 72.31 110.286 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.92 8.55 56.54 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.172 -0.793 . . . . 55.24 113.135 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 42.8 p 61.28 26.99 16.75 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 125.933 1.693 . . . . 74.14 112.664 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 51.5 m-85 -100.15 167.73 10.52 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.385 1.074 . . . . 72.44 109.606 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 45.0 Cg_endo -66.06 111.65 2.05 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 122.051 1.834 . . . . 54.32 111.682 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' C' ' 115' ' ' THR . 4.5 pp0? -47.47 143.32 3.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.569 1.147 . . . . 71.42 112.048 -173.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.467 HD21 HG11 ' C' ' 40' ' ' VAL . 1.2 tm? -111.13 91.25 3.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.21 0.529 . . . . 74.11 110.13 -173.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -129.95 92.33 3.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.866 -1.161 . . . . 64.1 107.866 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' E' ' 189' ' ' ALA . 61.6 mt -87.36 154.25 20.82 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.104 0.962 . . . . 72.14 111.442 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.72 136.27 13.28 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 124.42 1.075 . . . . 73.41 112.143 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.556 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 40.8 Cg_endo -63.85 108.4 0.9 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.989 2.46 . . . . 75.24 112.537 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.33 87.75 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.375 0.67 . . . . 71.12 109.492 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -79.77 101.59 8.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.945 -0.761 . . . . 43.31 108.945 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.88 -43.66 73.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.07 0.948 . . . . 72.53 111.096 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.07 -19.37 62.48 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.99 -1.004 . . . . 65.01 111.66 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.42 -48.51 64.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.623 0.369 . . . . 52.32 110.746 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -38.37 89.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.275 -0.421 . . . . 72.34 110.044 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.88 -29.82 70.79 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.767 0.827 . . . . 53.4 110.868 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -52.2 27.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.761 0.824 . . . . 70.53 110.967 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -69.17 -44.85 71.38 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.926 0.393 . . . . 74.44 110.715 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.91 -153.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 115.429 -0.805 . . . . 74.44 110.378 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.22 -70.62 0.11 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 125.488 1.515 . . . . 62.01 109.699 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.413 ' OE1' ' HG3' ' C' ' 144' ' ' GLN . 3.2 pp0? -88.32 -177.27 5.62 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.923 0.889 . . . . 72.35 110.92 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 97.44 2.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.552 -1.277 . . . . 75.32 107.552 172.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.433 HE22 ' HG2' ' A' ' 9' ' ' MET . 97.6 mt-30 -80.67 -72.13 0.43 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.783 0.433 . . . . 73.32 110.871 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . . . -155.59 -54.84 0.09 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.338 0.655 . . . . 72.45 109.954 172.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.59 -31.8 2.62 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.618 -0.265 . . . . 54.22 112.671 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 162.63 41.09 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.659 0.784 . . . . 75.13 110.268 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.8 -163.0 9.82 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.297 -1.521 . . . . 53.41 109.297 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 92.0 m -158.16 128.95 6.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.691 -0.855 . . . . 75.43 108.691 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -109.6 88.27 2.7 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 72.23 108.818 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -79.8 73.35 6.55 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.231 -1.026 . . . . 63.22 108.231 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -154.06 174.79 14.23 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.846 1.258 . . . . 72.14 109.045 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 73.71 -2.09 2.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.833 1.253 . . . . 62.21 112.689 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t70 51.53 54.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.959 1.362 . . . . 73.21 108.211 -166.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' ALA . . . . . 0.509 ' HB1' HD12 ' G' ' 173' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-N 113.428 -1.714 . . . . 65.42 111.323 -168.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.433 -0.318 . . . . 62.43 110.468 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m 73.65 173.63 0.28 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 125.283 1.433 . . . . 71.44 110.554 -164.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -77.52 -89.73 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.805 0.442 . . . . 70.34 110.901 -172.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 167.47 151.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.337 1.455 . . . . 75.23 109.087 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -160.02 140.73 12.07 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.755 -0.461 . . . . 33.2 109.755 165.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -103.68 98.29 8.18 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 52.02 108.506 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 23.8 p -76.13 -53.56 8.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.735 0.414 . . . . 55.1 109.92 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.44 ' HB3' ' OE1' ' B' ' 144' ' ' GLN . 8.8 pt-20 -161.39 45.56 0.18 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.263 -0.881 . . . . 55.11 110.165 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -30.61 131.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.209 1.559 . . . . 74.03 115.209 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -136.14 143.92 44.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.725 0.81 . . . . 73.1 109.11 168.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -150.47 94.05 2.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.26 -1.385 . . . . 52.52 107.26 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.449 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 80.9 mt-30 -112.11 131.89 55.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.644 0.778 . . . . 62.51 108.967 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.449 HG22 HD13 ' E' ' 204' ' ' ILE . 1.6 mp -80.04 138.68 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.231 -1.026 . . . . 75.13 108.231 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.579 ' HG2' ' HD3' ' E' ' 205' ' ' LYS . 52.8 mt-30 -106.04 -48.95 3.48 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 110.282 -0.266 . . . . 71.21 110.282 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 ttt85 -176.23 130.26 0.22 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.071 0.232 . . . . 74.13 111.618 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.429 ' HB ' ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -117.71 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.199 -1.037 . . . . 71.24 108.199 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -150.21 165.02 34.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.396 1.079 . . . . 73.51 110.546 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -90.85 113.55 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.289 -0.634 . . . . 74.34 109.289 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 44.3 mtpt -78.95 -31.64 45.16 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.133 0.492 . . . . 72.15 109.964 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -150.37 142.29 23.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.053 -0.976 . . . . 73.3 109.3 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.469 HD13 ' HE3' ' C' ' 117' ' ' MET . 63.1 mt -141.34 144.33 26.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.51 -1.293 . . . . 73.44 107.51 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -147.53 142.62 27.1 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.65 -0.87 . . . . 71.31 108.65 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.5 t80 -147.36 125.51 12.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.672 -1.603 . . . . 65.45 106.672 170.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.7 147.01 51.45 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.92 0.888 . . . . 75.44 108.707 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 78.43 37.08 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 107.498 -1.297 . . . . 74.24 107.498 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.21 -29.52 47.02 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.429 2.086 . . . . 52.4 112.275 -174.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -114.4 27.95 9.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.892 0.877 . . . . 52.43 110.139 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.12 -57.22 6.5 Favored Pre-proline 0 CA--C 1.576 1.974 0 N-CA-C 116.24 1.941 . . . . 54.21 116.24 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 83' ' ' ILE . 24.1 Cg_endo -87.97 -5.17 6.91 Favored 'Trans proline' 0 C--N 1.384 2.404 0 CA-C-N 122.321 1.865 . . . . 74.24 112.955 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -79.0 -30.95 44.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.11 1.364 . . . . 74.45 108.751 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' D' ' 123' ' ' PHE . 3.1 t -68.13 -28.59 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.81 1.244 . . . . 61.13 110.82 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -53.65 -23.41 11.18 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.44 0.696 . . . . 74.11 112.605 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -86.56 -0.03 55.31 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.644 0.778 . . . . 62.32 112.704 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.96 113.12 16.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.234 1.013 . . . . 73.43 110.764 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' H' ' 195' ' ' PHE . 7.7 p-10 -98.69 64.62 1.51 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.189 0.995 . . . . 65.12 110.874 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.507 ' HB2' HD22 ' D' ' 68' ' ' LEU . 14.5 m95 -126.18 173.79 8.99 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.858 0.863 . . . . 75.24 109.508 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -89.49 125.62 60.92 Favored Pre-proline 0 N--CA 1.476 0.842 0 N-CA-C 108.259 -1.015 . . . . 65.24 108.259 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.06 127.44 21.25 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.852 1.701 . . . . 75.1 111.588 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.4 OUTLIER -65.41 111.16 2.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.678 -1.23 . . . . 74.03 107.678 172.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.674 HG13 HG13 ' D' ' 64' ' ' VAL . 59.6 t -104.35 114.42 43.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 122.864 0.465 . . . . 72.13 110.36 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 4.7 tppp? -87.45 120.27 28.58 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.569 -0.741 . . . . 74.24 109.325 169.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.474 HD21 HD22 ' D' ' 128' ' ' LEU . 7.4 mp -96.27 111.72 23.7 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.486 -1.302 . . . . 64.03 107.486 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.6 t70 -109.47 119.6 39.95 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.227 -1.027 . . . . 51.22 108.227 175.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -96.58 131.12 43.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.298 0.639 . . . . 70.55 109.987 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.9 t70 -139.42 151.71 46.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.096 0.958 . . . . 62.11 108.528 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 155.98 44.76 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.401 0.68 . . . . 75.32 109.598 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.86 163.72 37.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.908 0.883 . . . . 62.21 109.096 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -150.12 153.17 35.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.113 0.565 . . . . 75.14 110.006 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.6 p -154.26 123.38 6.41 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.849 0.86 . . . . 55.34 109.005 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.99 121.07 22.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.891 0.476 . . . . 75.52 110.083 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.2 mt -89.38 -38.63 13.98 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.502 0.668 . . . . 64.4 109.393 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.16 -176.69 5.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.38 -1.282 . . . . 40.12 109.504 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 122.43 15.69 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.799 -0.637 . . . . 75.14 110.918 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 71.04 1.71 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.519 1.528 . . . . 62.43 112.55 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -110.04 123.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 124.198 0.999 . . . . 75.04 109.871 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.59 129.94 33.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.106 0.563 . . . . 64.45 109.998 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' D' ' 51' ' ' LEU . 9.3 tt0 -95.16 120.38 35.28 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.828 -1.175 . . . . 72.24 107.828 167.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.07 134.62 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.028 -0.731 . . . . 74.32 109.028 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.9 t -108.92 129.21 63.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.037 0.535 . . . . 73.05 110.029 -175.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.49 123.04 44.88 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.562 -1.273 . . . . 70.43 107.562 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.7 ttm-85 -108.8 102.84 11.84 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.876 -0.787 . . . . 74.43 108.876 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.82 107.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.114 -1.069 . . . . 73.3 108.114 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 45.6 m -97.68 136.1 38.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.922 -0.581 . . . . 63.12 109.603 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.674 HG13 HG13 ' D' ' 40' ' ' VAL . 53.4 t -126.67 103.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.825 1.25 . . . . 62.43 108.742 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 29.2 m -104.62 94.52 5.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.917 -1.142 . . . . 73.53 107.917 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.06 140.64 30.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.851 -0.613 . . . . 34.11 110.115 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.5 m -148.43 126.12 11.81 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.158 0.504 . . . . 65.54 111.577 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' D' ' 36' ' ' TRP . 26.2 mt -94.72 109.25 21.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.704 0.802 . . . . 70.0 109.634 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.25 -111.52 3.28 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.366 0.417 . . . . 61.03 112.283 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.57 7.96 12.78 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.367 0.667 . . . . 75.15 110.745 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.12 165.46 18.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.835 0.854 . . . . 73.12 109.302 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -75.8 136.37 40.24 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.278 0.631 . . . . 45.52 111.217 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.516 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.93 -1.137 . . . . 71.21 107.93 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.04 151.3 30.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.984 -1.007 . . . . 71.22 110.333 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.37 146.15 29.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.929 -1.137 . . . . 71.3 107.929 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.1 t -159.36 138.68 11.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.568 -0.53 . . . . 61.2 109.568 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.35 133.87 9.86 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.027 0.376 . . . . 74.11 110.602 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.8 118.13 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.175 0.59 . . . . 73.2 110.071 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.6 mt-30 -90.25 86.03 6.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.703 0.801 . . . . 72.24 109.24 170.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.16 95.16 6.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.661 1.185 . . . . 75.15 109.604 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.27 143.29 18.63 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 111.88 -0.488 . . . . 73.3 111.88 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.14 130.88 4.16 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.969 -0.453 . . . . 62.33 111.969 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 35.9 mt -90.47 133.6 31.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.693 0.797 . . . . 71.43 109.534 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -136.7 134.61 37.39 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.319 0.648 . . . . 75.2 110.176 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 40.0 m -82.46 104.36 12.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.984 -0.747 . . . . 72.45 108.984 166.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 134.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.282 1.033 . . . . 70.34 109.432 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.98 167.11 12.93 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.644 0.778 . . . . 73.01 111.39 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.13 -2.07 77.56 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 115.993 1.157 . . . . 72.41 115.993 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.441 HD12 ' HE2' ' D' ' 94' ' ' MET . 2.4 pp -123.18 169.99 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.353 1.061 . . . . 61.31 109.469 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.554 ' HB2' ' H ' ' H' ' 172' ' ' ALA . 2.6 pp20? -164.18 -173.37 3.11 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.568 0.581 . . . . 75.1 112.568 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 -145.14 31.16 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 123.932 0.777 . . . . 62.25 114.171 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.0 m -69.43 -27.19 65.05 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.363 0.665 . . . . 75.24 110.251 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -60.79 -43.41 98.16 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 110.223 -0.288 . . . . 74.12 110.223 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.441 ' HE2' HD12 ' D' ' 89' ' ' ILE . 50.3 ttm -68.08 -49.29 62.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.935 0.494 . . . . 74.32 111.118 176.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.22 96.52 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.5 0.72 . . . . 61.4 112.228 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -87.63 -25.02 23.76 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.558 -0.746 . . . . 73.14 110.744 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.442 HD21 HD12 ' H' ' 177' ' ' LEU . 27.3 tp -65.51 -42.79 91.67 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.151 -0.931 . . . . 61.21 111.05 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.54 -7.15 76.15 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.753 -0.658 . . . . 64.12 114.615 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.7 -62.75 0.55 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 117.672 0.736 . . . . 64.52 112.077 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -64.88 -47.01 79.4 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.562 0.579 . . . . 74.32 112.562 -167.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -65.25 -45.55 71.24 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.662 -0.685 . . . . 74.34 110.809 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.71 -38.86 77.61 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.266 1.978 . . . . 73.11 113.995 163.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -65.46 -27.73 68.72 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 122.852 0.461 . . . . 72.41 111.603 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.25 -44.88 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' D' ' 82' ' ' GLY . 65.0 mt -76.17 -20.26 57.71 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.829 -1.078 . . . . 65.03 111.732 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -68.25 -40.22 19.89 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 117.436 -1.269 . . . . 70.23 113.989 -168.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.95 -42.2 59.49 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.722 1.651 . . . . 62.43 112.771 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -76.73 -34.94 58.08 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.186 0.994 . . . . 73.41 110.982 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.91 51.91 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.465 0.706 . . . . 70.01 110.016 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -56.22 -47.73 77.87 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.818 1.324 . . . . 74.4 110.851 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.74 -46.78 88.16 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.236 0.96 . . . . 73.24 111.727 -175.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.6 t -55.73 -41.17 73.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.301 1.001 . . . . 75.11 110.349 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.491 HG21 HG21 ' D' ' 64' ' ' VAL . 67.8 mt -66.73 -53.75 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.347 1.029 . . . . 64.44 110.935 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.2 m -55.82 -39.2 71.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.555 1.142 . . . . 74.52 111.148 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.69 -46.23 76.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.573 -1.194 . . . . 52.15 110.261 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.1 mtm -66.23 -30.72 71.23 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.811 0.445 . . . . 64.23 112.097 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.8 t -64.37 -45.06 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 64.21 109.394 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -74.93 -24.32 58.47 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.258 -0.428 . . . . 62.11 111.458 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -74.16 -33.11 63.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.449 0.7 . . . . 74.41 109.938 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.11 4.58 85.81 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.976 -0.556 . . . . 63.13 112.531 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p 61.44 29.6 18.51 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.168 1.787 . . . . 62.01 113.349 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' D' ' 31' ' ' VAL . 97.3 m-85 -87.91 168.67 16.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.001 1.32 . . . . 60.32 109.451 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.56 140.1 38.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.792 2.328 . . . . 70.11 111.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -52.77 130.37 32.61 Favored 'General case' 0 C--O 1.243 0.763 0 O-C-N 124.057 0.848 . . . . 72.43 111.804 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -119.32 96.43 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.24 1.016 . . . . 64.01 109.401 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.73 98.34 9.18 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.672 -0.862 . . . . 72.41 108.672 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.474 HD22 HD21 ' D' ' 42' ' ' LEU . 75.5 mt -69.23 115.33 8.38 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.213 0.605 . . . . 75.31 109.692 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.84 135.77 87.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.264 0.625 . . . . 52.21 111.828 -172.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 11.2 Cg_endo -79.53 101.13 1.37 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.972 1.781 . . . . 71.22 110.029 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 114.27 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.058 0.943 . . . . 71.01 109.656 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -73.64 107.9 6.17 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.661 0.743 . . . . 60.55 109.588 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -62.64 -13.19 28.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.368 1.067 . . . . 71.55 112.101 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -64.39 -50.09 69.03 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.717 1.207 . . . . 62.23 111.118 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -42.35 96.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.877 0.736 . . . . 41.33 110.322 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.408 -0.815 . . . . 60.14 111.1 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -65.73 -57.9 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 73.25 111.155 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.37 -47.12 86.64 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.325 1.015 . . . . 64.21 111.005 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.3 -38.12 84.48 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.723 0.639 . . . . 73.34 111.881 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -58.04 -46.53 85.19 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.76 0.824 . . . . 73.21 111.132 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.82 -29.77 68.18 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.644 -0.707 . . . . 72.02 111.392 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -78.68 1.29 23.39 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.188 0.595 . . . . 75.22 111.998 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -122.8 91.39 3.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 75.21 109.136 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -144.07 -42.85 0.26 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.853 0.861 . . . . 73.0 110.071 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.93 129.13 37.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.337 0.655 . . . . 65.2 110.432 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.07 -175.58 39.47 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.627 0.58 . . . . 64.15 112.06 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.33 159.01 38.41 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.978 0.511 . . . . 55.4 110.525 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -135.23 162.77 24.85 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.653 -0.703 . . . . 74.54 111.67 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -116.79 140.71 49.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.275 0.559 . . . . 72.45 110.334 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.92 147.34 29.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.744 -0.836 . . . . 51.12 108.744 168.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -165.53 90.09 0.46 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.433 -0.951 . . . . 61.32 108.433 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -159.59 173.19 16.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.356 1.462 . . . . 74.33 108.746 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -159.02 156.13 28.75 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.62 0.768 . . . . 75.21 109.647 172.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -123.05 21.32 9.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.353 0.661 . . . . 75.35 109.345 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 C-N-CA 123.568 0.747 . . . . 37.69 110.147 178.914 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.263 -0.273 . . . . 73.33 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.32 26.39 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 O-C-N 123.726 0.641 . . . . 62.4 112.382 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -66.92 89.42 0.16 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.246 1.018 . . . . 72.11 110.872 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 56.8 p -175.88 -58.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.085 1.354 . . . . 54.21 108.349 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -159.42 166.17 31.61 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.126 1.371 . . . . 73.1 108.725 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.506 ' HB3' ' HE3' ' E' ' 174' ' ' MET . 87.7 mt 62.88 173.51 0.15 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.293 1.037 . . . . 72.41 111.923 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.506 ' HE3' ' HB3' ' E' ' 173' ' ' LEU . 29.8 mmt 55.98 30.73 16.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.806 1.642 . . . . 75.11 113.538 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 55.2 t80 66.79 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.995 1.318 . . . . 72.14 111.245 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -108.7 -81.25 0.57 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.434 0.694 . . . . 53.02 110.337 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 177' ' ' LEU . . . . . 0.743 HD11 HD11 ' C' ' 98' ' ' LEU . 6.1 mp 57.28 -151.73 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.47 1.108 . . . . 74.42 111.775 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 76.62 -62.47 0.41 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.983 1.313 . . . . 74.24 111.004 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 179' ' ' GLU . . . . . 0.43 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 26.1 tt0 -84.36 -58.37 0.37 Allowed Pre-proline 0 CA--C 1.56 1.353 0 CA-C-O 118.298 -0.858 . . . . 75.43 110.688 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 180' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 83.2 Cg_endo -83.16 102.36 1.06 Allowed 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.778 1.671 . . . . 73.35 111.544 172.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.77 113.96 2.85 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.347 -0.842 . . . . 74.31 108.747 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.25 134.83 34.25 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.034 -0.728 . . . . 75.32 109.034 -176.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 19.4 p -76.14 141.11 42.0 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.449 0.7 . . . . 21.42 110.772 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -83.79 125.36 73.44 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.752 0.821 . . . . 73.44 111.442 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -93.81 103.29 0.14 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.063 2.509 . . . . 73.14 111.846 166.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.645 HD12 HD13 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -120.68 156.59 31.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.94 0.896 . . . . 75.41 111.537 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.518 ' O ' HD11 ' C' ' 42' ' ' LEU . 37.4 pt -89.76 142.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.025 0.93 . . . . 54.11 111.313 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -102.96 74.16 1.29 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.124 -1.065 . . . . 62.42 108.124 165.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 189' ' ' ALA . . . . . 0.535 ' HB3' HD13 ' C' ' 128' ' ' LEU . . . -75.0 88.29 2.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.572 -0.74 . . . . 65.04 111.167 -174.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.66 -170.42 2.81 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.378 -1.283 . . . . 63.53 111.251 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -142.12 98.57 0.22 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.381 -1.088 . . . . 54.3 110.381 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.9 80.22 0.01 OUTLIER Glycine 0 C--N 1.355 1.639 0 O-C-N 124.513 0.772 . . . . 71.4 113.143 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 63.86 4.04 1.82 Allowed 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.615 1.566 . . . . 72.32 112.458 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.46 80.73 4.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.619 0.768 . . . . 75.24 111.028 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -164.75 146.37 8.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.182 1.393 . . . . 71.14 108.719 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -122.71 115.39 21.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 72.21 109.777 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -108.61 -57.99 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.602 0.761 . . . . 73.01 109.711 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -80.77 -40.48 25.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.689 -0.687 . . . . 70.33 110.911 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -85.38 123.07 30.42 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.964 -1.124 . . . . 62.22 107.964 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 115.21 -20.17 14.34 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 110.485 -1.046 . . . . 70.32 110.485 -164.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tptp 58.84 48.44 11.22 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 125.443 1.497 . . . . 73.03 111.247 172.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.86 78.13 5.31 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 121.853 0.835 . . . . 55.44 109.435 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -176.42 147.24 0.66 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.64 1.576 . . . . 73.25 107.95 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.449 HD13 HG22 ' D' ' 13' ' ' ILE . 3.1 mp -91.21 -87.05 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.912 -0.773 . . . . 75.2 108.912 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 205' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' D' ' 14' ' ' GLN . 13.9 mmmm 46.43 41.52 9.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.388 1.075 . . . . 75.35 113.776 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -152.7 -61.21 0.15 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.043 -1.095 . . . . 71.12 108.043 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . 0.251 10.7 p . . . . . 0 CA--C 1.571 1.773 0 C-N-CA 126.58 1.952 . . . . 72.3 113.915 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 8.3 mptt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.894 -0.409 . . . . 71.5 109.894 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.28 53.11 0.68 Allowed Glycine 0 N--CA 1.471 0.968 0 N-CA-C 111.426 -0.67 . . . . 45.24 111.426 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -170.77 168.55 7.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.051 0.941 . . . . 74.44 109.348 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 26.8 p -57.15 150.18 18.03 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.39 1.076 . . . . 71.24 111.987 170.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -145.08 114.07 6.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.581 0.753 . . . . 50.44 109.197 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.491 HD21 ' H ' ' B' ' 54' ' ' ASP . 85.6 mt -124.5 111.8 16.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.48 0.712 . . . . 72.41 111.519 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.718 ' HG2' ' SD ' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.68 89.74 1.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.1 0.96 . . . . 72.11 109.106 -175.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.46 78.11 8.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.598 0.713 . . . . 75.12 109.931 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -95.58 71.48 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.574 -0.739 . . . . 74.45 109.377 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 40.4 tp -80.47 -29.97 37.46 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.038 -0.983 . . . . 75.33 109.696 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -67.33 139.34 57.22 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.987 0.915 . . . . 75.55 112.349 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 59.34 83.81 0.21 Allowed Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 125.395 1.478 . . . . 71.14 111.741 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.55 128.55 16.39 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.152 2.568 . . . . 63.1 111.836 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -66.37 107.24 1.95 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.23 0.612 . . . . 75.14 110.105 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 65.92 100.52 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.942 1.297 . . . . 73.11 111.206 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 43.2 p -67.5 107.67 2.56 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.236 0.614 . . . . 73.42 109.646 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.502 ' HE1' HD22 ' B' ' 136' ' ' LEU . 5.3 m-90 -87.69 110.48 35.01 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.517 0.727 . . . . 72.31 110.549 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.74 2.28 8.66 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.492 2.128 . . . . 73.03 112.45 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.564 HD13 HD11 ' B' ' 128' ' ' LEU . 58.4 mt 63.69 -92.33 0.03 OUTLIER 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.523 1.529 . . . . 74.32 111.025 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' B' ' 128' ' ' LEU . 1.8 pp -161.85 -178.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.176 1.391 . . . . 74.2 109.327 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.31 167.06 31.62 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 62.2 109.73 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.45 120.2 27.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.188 0.995 . . . . 62.21 108.51 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.84 -7.87 38.47 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.228 0.825 . . . . 62.42 113.228 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.19 -162.43 46.15 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.427 -0.669 . . . . 72.52 111.427 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.91 -144.9 13.19 Favored Glycine 0 N--CA 1.467 0.746 0 CA-C-N 117.222 0.511 . . . . 62.43 112.461 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 193' ' ' TYR . . . . . 0.48 ' H ' ' HD1' ' F' ' 193' ' ' TYR . 0.4 OUTLIER -81.25 130.56 35.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.224 0.61 . . . . 73.23 111.001 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.61 -83.8 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.532 0.733 . . . . 62.13 110.601 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.534 ' HZ ' ' HA ' ' B' ' 123' ' ' PHE . 96.6 m-85 -54.52 -67.33 0.27 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.84 0.856 . . . . 73.33 112.663 -169.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 17.3 tptm 52.13 29.59 6.63 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 124.525 1.141 . . . . 62.12 111.035 -167.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 197' ' ' TYR . . . . . 0.409 ' N ' ' HB2' ' B' ' 35' ' ' ASP . 51.5 t80 50.19 -85.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.66 1.984 . . . . 72.33 113.191 -176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.22 -13.46 62.19 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.728 0.811 . . . . 63.45 112.339 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 199' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' F' ' 195' ' ' PHE . 27.9 t-20 -64.09 -29.52 70.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.725 0.81 . . . . 71.45 110.92 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.99 13.55 62.08 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 115.244 0.858 . . . . 62.43 115.244 169.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -71.34 92.85 1.08 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 117.163 0.481 . . . . 74.44 109.774 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 63.13 29.43 16.14 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.13 1.372 . . . . 65.21 109.612 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 203' ' ' ASP . . . . . 0.442 ' HB2' ' HD2' ' F' ' 195' ' ' PHE . 4.9 t0 -144.92 171.56 14.28 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.864 -1.516 . . . . 74.11 107.52 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 14.8 tt -67.68 141.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.28 0.562 . . . . 72.23 110.294 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -129.61 -77.69 0.55 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.428 0.691 . . . . 64.32 109.4 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.44 149.45 48.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.3 0.64 . . . . 74.2 109.73 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 124.949 1.3 . . . . 73.12 109.176 174.842 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 87.2 tttt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.224 -0.287 . . . . 72.43 110.224 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.59 -99.63 0.05 OUTLIER Glycine 0 C--N 1.361 1.959 0 O-C-N 124.341 1.025 . . . . 63.2 112.81 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 170' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' C' ' 155' ' ' ALA . 10.1 mttp -127.09 137.14 52.96 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.501 -0.926 . . . . 73.54 108.501 166.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 9.6 m -103.32 -33.28 9.18 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.161 0.984 . . . . 74.5 109.549 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.67 -78.67 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.063 0.945 . . . . 71.24 109.764 172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.634 HD23 ' H ' ' A' ' 54' ' ' ASP . 0.2 OUTLIER 65.66 104.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.794 1.637 . . . . 72.34 110.72 -175.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 33.0 mtm -139.76 -64.46 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.365 1.066 . . . . 71.42 109.201 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.415 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 44.4 t80 56.8 97.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.636 1.574 . . . . 72.45 112.751 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -118.66 119.57 34.85 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.881 -0.785 . . . . 71.32 108.881 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 tp -154.22 37.7 0.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.879 -1.156 . . . . 73.42 107.879 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.91 -22.17 64.18 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.537 -1.21 . . . . 54.33 112.846 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.37 152.73 69.86 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.158 0.983 . . . . 75.52 109.894 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 109.33 2.72 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.151 1.901 . . . . 60.21 109.69 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -67.88 -57.42 6.27 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.318 -0.855 . . . . 74.34 111.176 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.31 154.11 45.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.699 0.8 . . . . 71.15 109.698 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 17.8 p -80.81 140.29 35.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.416 -0.587 . . . . 61.21 109.416 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -145.29 86.01 7.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.326 0.651 . . . . 75.34 109.997 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 161.79 39.42 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.113 1.875 . . . . 74.34 112.015 174.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 186' ' ' LEU . . . . . 0.59 ' HG ' HG21 ' A' ' 131' ' ' VAL . 8.3 tt -135.22 156.15 49.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.852 -1.166 . . . . 73.03 107.852 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.654 HG21 HG23 ' H' ' 204' ' ' ILE . 34.7 pt -57.17 155.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.123 0.969 . . . . 64.02 112.669 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -112.21 -11.79 13.71 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.37 0.668 . . . . 65.44 111.19 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . 60.62 51.43 5.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.969 0.908 . . . . 64.24 111.735 175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.73 95.09 5.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.389 -0.823 . . . . 64.34 110.621 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 152.15 78.95 0.02 OUTLIER Glycine 0 C--N 1.346 1.128 0 C-N-CA 121.461 -0.399 . . . . 71.34 112.812 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.39 139.52 10.73 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.149 -0.78 . . . . 73.45 111.149 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -145.25 -18.98 0.49 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.451 0.7 . . . . 71.13 110.557 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.83 135.18 52.17 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.978 0.511 . . . . 75.5 111.579 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.427 ' HD1' ' N ' ' G' ' 196' ' ' LYS . 5.4 t80 -133.21 -127.18 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.25 -1.018 . . . . 65.33 108.25 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.427 ' N ' ' HD1' ' G' ' 195' ' ' PHE . 95.3 mttt -152.53 8.0 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.794 1.238 . . . . 75.11 109.965 -170.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.94 156.4 48.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.537 0.735 . . . . 73.54 109.521 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 198' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' H' ' 193' ' ' TYR . 1.0 OUTLIER -164.34 113.91 1.19 Allowed 'General case' 0 C--O 1.242 0.659 0 N-CA-C 105.839 -1.911 . . . . 61.42 105.839 168.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.79 176.15 0.26 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.6 1.188 . . . . 63.44 109.888 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.57 80.51 0.12 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.011 -0.836 . . . . 43.21 111.011 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 178.34 8.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.555 0.742 . . . . 75.41 110.878 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 55.6 t80 63.85 72.09 0.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.704 -0.85 . . . . 74.41 108.704 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.51 95.6 1.41 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.193 -0.912 . . . . 71.45 109.133 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.81 HG12 ' H ' ' G' ' 206' ' ' ASP . 5.5 tt -73.72 145.38 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-N 114.545 -1.207 . . . . 70.44 110.598 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.37 -16.86 61.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.924 0.889 . . . . 54.2 110.521 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 206' ' ' ASP . . . . . 0.81 ' H ' HG12 ' G' ' 204' ' ' ILE . 2.5 m-20 75.43 169.4 0.28 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.239 1.816 . . . . 62.22 110.29 -169.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.564 1.502 0 CA-C-O 118.531 -0.747 . . . . 44.44 110.269 -177.82 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.139 -0.689 . . . . 73.11 109.139 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.19 -96.21 0.61 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.992 -0.843 . . . . 62.11 110.992 -174.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -137.65 158.72 43.78 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.059 0.943 . . . . 73.42 109.155 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 171' ' ' SER . . . . . 0.5 ' HB2' ' HG ' ' H' ' 173' ' ' LEU . 89.9 p -164.98 110.07 0.92 Allowed 'General case' 0 CA--C 1.542 0.656 0 O-C-N 123.653 0.595 . . . . 65.11 110.4 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.554 ' H ' ' HB2' ' D' ' 90' ' ' GLU . . . -51.51 -66.38 0.39 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.099 0.96 . . . . 72.04 109.975 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' H' ' 171' ' ' SER . 76.7 mt 42.73 92.05 0.01 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 125.273 1.608 . . . . 71.34 114.082 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' H' ' 174' ' ' MET . 0.0 OUTLIER 72.01 156.6 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.752 1.221 . . . . 75.44 112.103 171.166 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.47 -167.56 0.53 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.29 0.636 . . . . 74.45 111.594 -161.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.28 -61.33 1.68 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.53 -1.285 . . . . 75.23 107.53 161.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 177' ' ' LEU . . . . . 0.442 HD12 HD21 ' D' ' 98' ' ' LEU . 17.7 tp -142.56 -81.99 0.2 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 106.217 -1.772 . . . . 72.43 106.217 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 162.21 -74.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.226 1.811 . . . . 64.13 106.324 178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -173.67 152.96 2.13 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 113.976 -1.465 . . . . 74.34 108.091 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.92 -14.75 32.61 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.262 1.974 . . . . 73.02 113.952 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 62.2 -171.42 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.922 0.889 . . . . 70.41 110.526 -169.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -85.28 0.04 53.22 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.985 -0.447 . . . . 74.32 111.312 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 33.2 p 58.88 172.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.882 1.673 . . . . 72.51 112.099 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -133.56 145.21 55.38 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.556 -0.715 . . . . 75.34 110.593 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.95 122.19 8.25 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.811 2.34 . . . . 62.05 111.925 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.18 -101.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.817 0.447 . . . . 70.4 110.277 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.69 152.17 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 107.622 -1.251 . . . . 43.02 107.622 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -130.17 92.51 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.838 -0.801 . . . . 44.54 108.838 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.55 81.06 5.94 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.285 0.634 . . . . 32.15 109.975 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.96 -29.14 9.18 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.66 -0.7 . . . . 51.41 111.998 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.73 169.56 37.23 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.499 0.5 . . . . 65.13 113.887 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 84.15 178.52 51.6 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.889 0.405 . . . . 44.44 113.005 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' G' ' 198' ' ' GLU . 96.3 m-85 -130.89 -176.04 3.87 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.215 0.606 . . . . 73.01 110.169 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.19 -170.24 1.26 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.462 0.705 . . . . 63.33 110.763 -177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' D' ' 35' ' ' ASP . 53.7 m-85 76.58 -51.76 0.59 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.482 1.513 . . . . 73.52 113.87 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp 61.0 40.13 15.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.969 0.907 . . . . 51.52 111.98 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -67.48 93.01 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.086 0.554 . . . . 74.04 110.988 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -135.91 -65.55 0.58 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.06 -1.459 . . . . 55.31 107.06 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -108.02 133.11 52.79 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.338 -0.616 . . . . 74.55 109.338 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.79 29.78 0.09 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.584 -1.006 . . . . 75.45 110.584 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -87.5 -38.59 15.91 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.505 0.722 . . . . 74.33 109.873 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 72.49 -11.64 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.446 1.499 . . . . 73.52 113.503 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 48.15 36.74 7.01 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.77 1.228 . . . . 63.15 113.049 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.654 HG23 HG21 ' G' ' 187' ' ' ILE . 85.6 mt -69.58 -50.32 51.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.121 -0.945 . . . . 73.02 109.857 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 65.22 -79.18 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.857 1.348 . . . . 64.45 110.016 -170.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -138.95 -77.33 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.008 0.432 . . . . 74.31 110.188 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 124.83 1.252 . . . . 71.52 109.693 -167.896 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.353 -0.61 . . . . 73.21 109.353 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m 63.71 -79.15 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.878 1.271 . . . . 73.15 111.52 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.73 6.38 2.65 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.536 1.534 . . . . 54.42 113.853 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -104.55 92.4 4.28 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.414 -0.958 . . . . 63.22 108.414 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -158.48 136.71 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.946 -0.57 . . . . 73.15 110.448 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -74.21 -25.0 59.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.34 1.056 . . . . 50.12 111.309 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -87.37 -11.65 48.68 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.606 0.362 . . . . 72.53 111.625 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.34 -15.37 35.82 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.056 0.542 . . . . 70.44 110.488 169.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.7 mtp -64.79 131.25 46.27 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.873 -0.788 . . . . 74.12 108.873 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 73.4 m -149.63 133.32 16.81 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.921 -1.141 . . . . 74.14 107.921 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -136.57 144.0 43.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.143 -0.688 . . . . 72.42 109.143 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.76 137.24 11.98 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.499 0.5 . . . . 74.44 110.999 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.39 119.86 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 N-CA-C 109.374 -0.602 . . . . 73.25 109.374 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -97.93 -37.23 9.88 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.401 0.681 . . . . 70.12 110.393 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt85 -172.95 141.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.806 0.442 . . . . 74.23 111.3 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.6 mt -116.61 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 108.352 -0.981 . . . . 71.22 108.352 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -166.24 155.53 11.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.713 0.805 . . . . 72.41 111.226 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -87.04 114.64 23.82 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.973 -0.751 . . . . 74.54 108.973 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 37.2 mtpt -76.72 -27.03 55.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.768 0.427 . . . . 73.33 109.986 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.9 t70 -154.59 140.75 18.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.414 -0.812 . . . . 65.53 109.466 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.8 mt -136.72 140.09 43.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.317 -1.364 . . . . 72.41 107.317 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.6 t -145.53 128.99 16.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.03 -0.729 . . . . 61.02 109.03 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 91.8 t80 -137.92 112.86 9.06 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.296 -1.742 . . . . 74.04 106.296 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -118.22 134.94 54.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.88 78.5 69.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 106.045 -1.835 . . . . 55.02 106.045 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.5 -24.49 26.21 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.186 1.924 . . . . 64.5 111.177 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -110.52 29.33 7.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.518 -1.219 . . . . 73.21 109.232 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.11 -43.64 97.51 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.283 1.033 . . . . 70.5 112.407 175.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.44 -25.57 70.67 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.231 1.475 . . . . 63.12 113.253 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -82.87 -13.77 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.022 0.529 . . . . 62.23 112.188 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.5 p -63.25 -18.17 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.468 0.577 . . . . 62.34 111.994 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.67 -40.26 20.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.921 0.888 . . . . 65.13 110.521 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.98 -25.82 31.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.987 0.515 . . . . 72.2 110.751 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.25 146.67 28.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.392 0.677 . . . . 73.31 111.184 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.65 122.04 18.33 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.547 -1.206 . . . . 54.24 108.602 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.592 ' HD1' ' HA ' ' G' ' 194' ' ' ALA . 74.4 t-105 -82.03 86.71 6.52 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.494 0.664 . . . . 71.11 110.165 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -124.45 83.42 57.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.487 -1.301 . . . . 74.01 107.487 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.65 119.29 5.13 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.519 2.146 . . . . 71.05 112.337 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.45 112.03 24.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.012 -1.107 . . . . 64.4 108.012 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.23 111.29 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.27 1.028 . . . . 71.2 110.729 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -101.82 140.35 36.22 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.836 -0.802 . . . . 74.42 108.836 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.54 131.52 55.18 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.425 -0.954 . . . . 73.15 108.425 171.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.662 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -117.9 128.95 55.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.047 -1.094 . . . . 72.5 108.047 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.8 tp -98.15 128.9 44.9 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.215 -0.661 . . . . 74.24 109.215 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -134.09 151.65 51.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.67 -0.863 . . . . 74.32 108.67 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.1 m -141.49 147.96 38.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.075 0.95 . . . . 73.44 108.493 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HA ' HD22 ' G' ' 177' ' ' LEU . . . -132.34 142.95 49.53 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.493 -0.929 . . . . 64.22 108.493 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.609 ' H ' ' HB2' ' G' ' 177' ' ' LEU . 18.7 m -132.67 150.15 52.2 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -159.79 151.43 20.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.999 0.919 . . . . 65.04 109.128 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -95.53 114.08 25.8 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.838 -0.801 . . . . 53.3 108.838 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 57' ' ' GLU . 83.8 mt -84.09 -43.59 14.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.723 0.409 . . . . 73.31 110.198 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.6 -178.16 6.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.027 0.931 . . . . 60.22 109.277 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.98 122.88 18.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.967 -0.753 . . . . 63.22 108.967 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 66.67 13.66 9.44 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.81 1.244 . . . . 72.13 112.133 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.33 125.54 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.494 -0.928 . . . . 75.35 108.494 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HB3' ' HG3' ' G' ' 174' ' ' MET . 0.1 OUTLIER -130.87 168.32 17.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.277 0.56 . . . . 71.41 110.212 176.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 51' ' ' LEU . 31.2 tt0 -127.34 121.78 31.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.159 -1.052 . . . . 72.15 108.159 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.51 119.02 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.778 -1.193 . . . . 74.2 107.778 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -99.16 135.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.79 0.836 . . . . 70.43 108.983 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.37 112.01 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.9 -1.518 . . . . 75.11 106.9 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.508 ' HD3' ' HG2' ' A' ' 79' ' ' GLN . 12.2 ttp180 -108.42 104.33 13.67 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.387 -0.597 . . . . 75.25 109.387 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.99 132.42 39.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.237 -1.023 . . . . 64.42 108.237 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.1 m -114.02 138.2 50.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.823 -0.806 . . . . 72.12 108.823 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 39.9 t -133.71 108.58 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 125.104 1.361 . . . . 75.24 108.382 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -106.02 140.48 38.94 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.568 -0.53 . . . . 74.44 109.568 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.9 117.27 27.67 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.172 -1.047 . . . . 73.34 108.172 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 m -113.88 127.56 56.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.189 0.596 . . . . 74.3 110.367 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.4 mt -93.41 53.46 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.292 1.437 . . . . 72.32 109.642 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.6 -84.93 0.97 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.119 -0.491 . . . . 74.25 112.147 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.04 -28.41 16.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.666 0.786 . . . . 72.31 111.724 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -123.39 133.69 54.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.714 0.806 . . . . 73.55 109.893 -169.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -71.34 136.89 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 120.916 0.388 . . . . 62.31 110.459 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -61.8 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.19 0.996 . . . . 61.44 109.214 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.83 167.64 26.85 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.34 -1.3 . . . . 60.43 110.297 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -134.43 140.36 46.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.806 1.242 . . . . 64.24 108.178 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.4 m -131.0 135.87 48.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.272 1.029 . . . . 53.31 108.973 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.17 123.45 8.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.602 0.361 . . . . 75.44 110.123 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.41 113.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.974 0.91 . . . . 74.21 109.749 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.508 ' HG2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 mt-30 -85.6 81.09 8.8 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.641 0.776 . . . . 73.51 108.916 172.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.74 90.53 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.154 0.982 . . . . 64.04 108.572 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.99 144.84 18.28 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 116.087 -0.506 . . . . 53.4 112.325 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.12 130.83 5.0 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 111.983 -0.447 . . . . 32.02 111.983 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -81.29 131.34 34.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 107.426 -1.324 . . . . 73.44 107.426 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . 37.7 m-85 -131.79 155.43 47.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.725 -0.843 . . . . 72.13 108.725 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -111.49 114.22 27.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.603 1.161 . . . . 72.52 108.035 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 tt -139.08 152.92 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 118.086 0.403 . . . . 73.35 111.033 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.82 169.34 13.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.374 1.069 . . . . 63.3 110.352 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.45 5.76 86.04 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 123.901 0.751 . . . . 73.21 114.701 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.05 153.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.154 0.981 . . . . 72.33 109.606 -177.06 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.23 170.48 22.38 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.165 0.586 . . . . 72.31 109.444 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.73 -125.3 34.59 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 123.701 0.667 . . . . 73.32 113.889 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.422 HG21 ' HG3' ' C' ' 147' ' ' GLU . 64.4 p -75.49 -21.39 58.08 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.731 0.812 . . . . 51.11 111.422 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.55 -40.16 92.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.004 0.522 . . . . 70.44 109.797 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -47.44 24.47 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.311 -0.859 . . . . 72.53 109.92 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -34.05 77.09 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.106 -0.952 . . . . 72.52 112.636 -172.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -78.89 -20.81 48.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.194 0.598 . . . . 55.53 110.855 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.532 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 49.4 t -80.42 -64.39 1.2 Allowed 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.413 0.285 . . . . 53.31 110.242 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.19 -37.12 84.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.961 0.504 . . . . 60.33 111.786 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.46 -15.11 64.62 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 114.92 0.728 . . . . 75.22 114.92 -172.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -140.88 -51.19 0.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.637 0.718 . . . . 74.54 112.656 -171.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.5 t80 -77.71 -51.69 10.17 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.216 0.607 . . . . 71.04 112.55 -168.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 67.7 m -70.84 -38.9 8.03 Favored Pre-proline 0 CA--C 1.569 1.688 0 C-N-CA 123.935 0.894 . . . . 74.22 113.112 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.37 -22.01 46.4 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.709 1.606 . . . . 62.23 112.434 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -71.42 -30.36 65.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.872 0.469 . . . . 73.22 110.492 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.03 -40.08 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.375 -0.602 . . . . 61.01 109.375 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 82' ' ' GLY . 36.1 mt -82.1 -21.85 36.54 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.077 -0.965 . . . . 74.3 112.253 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -65.53 -39.31 32.26 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.697 1.369 . . . . 74.33 114.697 -170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.65 -34.76 99.11 Favored 'Trans proline' 0 C--N 1.393 2.899 0 CA-C-N 122.153 1.805 . . . . 64.31 112.51 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -80.76 -36.66 31.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.815 0.846 . . . . 64.31 110.459 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.87 79.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.09 0.556 . . . . 54.44 109.927 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -52.0 -57.77 8.49 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.593 1.183 . . . . 74.12 109.286 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.77 -43.64 97.77 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.592 1.183 . . . . 71.31 111.793 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.628 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.8 t -57.64 -47.64 81.69 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.945 0.898 . . . . 70.33 110.832 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 64' ' ' VAL . 89.2 mt -64.34 -53.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.041 0.838 . . . . 74.31 110.463 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.3 m -50.25 -41.83 50.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.394 1.478 . . . . 74.01 111.505 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -72.78 -42.76 63.61 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.825 -1.08 . . . . 72.52 110.926 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.3 mtm -58.35 -42.61 87.25 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 74.1 110.86 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 81.8 t -60.12 -49.01 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.241 -1.345 . . . . 72.3 111.27 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 80.9 p -66.89 -31.41 71.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.887 0.475 . . . . 74.42 111.507 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.9 mtt-85 -68.7 -27.12 65.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.827 0.851 . . . . 72.21 111.358 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 13.06 53.24 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.628 -0.54 . . . . 71.01 113.545 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m 63.91 27.29 14.41 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.8 1.24 . . . . 72.24 110.871 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.36 150.0 37.97 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.555 -0.905 . . . . 71.11 108.555 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HB2' ' H ' ' G' ' 192' ' ' GLY . 60.8 Cg_endo -70.77 120.56 7.17 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.882 1.721 . . . . 73.23 109.674 176.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 10.8 pt20 -61.69 150.89 35.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.338 0.655 . . . . 63.42 111.719 -171.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.42 108.71 20.18 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.746 -0.835 . . . . 60.15 108.746 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -96.69 96.14 8.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.84 -1.17 . . . . 74.23 107.84 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.666 HD23 ' HB2' ' G' ' 189' ' ' ALA . 91.5 mt -65.72 148.63 51.44 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.473 -0.785 . . . . 72.23 110.58 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' H' ' 204' ' ' ILE . . . -79.92 162.84 60.83 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.013 0.525 . . . . 74.4 110.72 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.34 164.0 26.92 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.134 1.889 . . . . 64.44 111.924 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.01 114.13 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.997 0.919 . . . . 73.02 109.797 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.84 85.61 6.06 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.454 0.701 . . . . 72.31 109.476 173.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -57.07 -28.18 62.37 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.544 1.138 . . . . 74.33 111.869 173.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -74.4 -38.8 62.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.192 0.997 . . . . 72.14 110.317 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.46 80.7 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 116.277 -0.42 . . . . 55.22 110.038 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.426 HD22 ' HD3' ' G' ' 185' ' ' PRO . 42.2 tp -60.0 -37.95 81.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.314 1.046 . . . . 74.55 111.279 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 87.8 t80 -57.14 -52.12 66.57 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 123.754 0.659 . . . . 62.14 110.378 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.604 ' HB2' HE21 ' C' ' 4' ' ' GLN . 24.8 ptt? -80.63 -21.63 41.32 Favored 'General case' 0 CA--C 1.554 1.107 0 O-C-N 123.771 0.67 . . . . 73.11 111.739 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -77.77 -28.31 50.52 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.094 0.957 . . . . 70.52 110.276 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -85.71 -37.84 18.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.093 -0.503 . . . . 73.14 109.967 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -66.42 -43.18 86.42 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.301 0.64 . . . . 73.23 111.475 -177.121 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -147.7 -5.14 0.48 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.538 0.57 . . . . 73.43 112.538 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.66 130.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.701 1.2 . . . . 60.5 110.946 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.456 ' HA ' ' HG2' ' C' ' 4' ' ' GLN . 3.3 pp0? -78.32 147.94 34.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.808 0.443 . . . . 73.35 111.351 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.54 172.14 16.48 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.5 0.72 . . . . 72.22 110.299 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.74 -150.39 17.86 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.245 -0.888 . . . . 64.0 111.893 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.7 42.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.632 1.173 . . . . 72.32 108.636 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.62 77.45 0.1 OUTLIER Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.452 -0.795 . . . . 72.13 113.334 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 t -121.96 140.2 52.74 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.483 1.513 . . . . 71.02 107.966 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -162.5 132.84 4.69 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.507 -0.553 . . . . 74.21 109.507 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.93 95.11 8.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.335 1.054 . . . . 70.54 110.534 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -66.14 96.18 0.32 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.735 -0.469 . . . . 73.14 109.735 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -125.45 96.35 4.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.349 -0.982 . . . . 71.23 108.349 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.6 -39.41 45.62 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.887 -0.783 . . . . 73.35 108.887 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.499 1.519 . . . . 75.53 111.513 178.398 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 108.019 -1.104 . . . . 74.41 108.019 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.9 p -79.13 80.49 5.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.503 0.721 . . . . 62.11 111.001 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.17 -9.54 58.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.233 -0.894 . . . . 72.45 110.99 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -82.8 124.82 30.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.22 1.008 . . . . 64.41 109.475 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -84.06 169.89 14.46 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.288 0.635 . . . . 74.32 111.116 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -121.6 134.25 55.0 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.87 0.868 . . . . 63.22 109.523 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.597 HG21 ' HA ' ' B' ' 89' ' ' ILE . 87.3 m -77.72 120.72 23.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.104 0.562 . . . . 61.35 109.646 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.0 -49.63 76.93 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.121 0.888 . . . . 64.32 110.907 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 17.2 ptm 45.83 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 126.85 2.06 . . . . 74.0 115.208 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.3 t -154.14 142.73 20.79 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.756 -0.831 . . . . 70.11 108.756 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -133.44 144.67 49.64 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.21 0.604 . . . . 74.12 109.826 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -147.77 136.42 21.8 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.962 -1.017 . . . . 73.04 109.114 169.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.24 144.06 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.614 -0.884 . . . . 74.05 108.614 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.49 -49.36 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.412 0.285 . . . . 71.53 110.836 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -162.53 139.49 7.92 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.584 -0.154 . . . . 73.34 110.584 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.9 mt -115.28 137.83 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 106.744 -1.576 . . . . 71.24 106.744 170.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.47 ' HE1' HG13 ' B' ' 83' ' ' ILE . 16.2 p90 -165.65 144.91 6.34 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.66 0.6 . . . . 72.42 111.654 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.6 m -76.31 119.38 20.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.314 -0.857 . . . . 73.41 108.934 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -93.8 -26.96 16.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.383 0.673 . . . . 74.13 111.238 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.9 t70 -160.78 143.13 12.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.165 0.291 . . . . 72.0 110.78 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.3 mm -137.78 138.3 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.991 1.316 . . . . 60.41 108.992 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 7.9 t -137.91 138.76 39.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.22 -1.4 . . . . 35.41 107.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.8 t80 -160.62 114.53 2.11 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 107.753 -1.203 . . . . 73.21 107.753 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.8 147.89 42.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.811 -1.181 . . . . 74.22 107.811 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -131.85 81.92 61.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 106.911 -1.514 . . . . 72.53 106.911 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.55 -21.34 52.85 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.803 2.335 . . . . 73.22 113.094 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.33 30.47 6.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.917 0.887 . . . . 60.4 109.938 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.469 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -48.64 -50.54 59.12 Favored Pre-proline 0 CA--C 1.569 1.71 0 C-N-CA 124.752 1.221 . . . . 63.3 114.164 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.3 -16.77 6.9 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.87 1.713 . . . . 65.13 112.769 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.63 0.86 55.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.657 0.783 . . . . 63.11 110.817 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.24 -15.35 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 124.268 1.027 . . . . 45.24 111.385 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.81 -42.59 89.53 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.437 0.695 . . . . 74.03 110.607 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.68 -43.41 96.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.74 0.816 . . . . 62.22 110.85 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -103.2 76.42 1.44 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.631 -1.168 . . . . 71.24 109.989 -171.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' F' ' 196' ' ' LYS . 9.2 p-10 -95.28 76.71 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.557 -1.656 . . . . 74.24 110.368 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' B' ' 68' ' ' LEU . 2.4 p-90 -157.65 176.59 12.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.831 -1.077 . . . . 74.32 109.5 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.83 99.46 0.99 Allowed Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.878 0.871 . . . . 70.53 108.832 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.52 ' HB3' HD23 ' B' ' 68' ' ' LEU . 55.9 Cg_endo -67.15 161.36 43.2 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.234 1.956 . . . . 65.15 112.94 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.4 mt-10 -75.18 102.18 4.88 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.903 -1.044 . . . . 74.25 108.964 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 124' ' ' PRO . 8.0 t -92.21 119.03 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 N-CA-C 107.547 -1.279 . . . . 60.43 107.547 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -146.84 145.77 29.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.032 0.933 . . . . 62.41 108.992 -170.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.568 HD21 HD21 ' B' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 170.01 12.87 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.828 0.851 . . . . 70.43 111.003 -176.134 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.16 139.59 41.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.584 1.153 . . . . 62.11 109.335 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 129.73 36.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.838 . . . . 63.23 109.535 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -139.97 149.51 43.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.741 0.817 . . . . 55.32 109.601 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.525 ' H ' ' HG3' ' F' ' 180' ' ' PRO . 45.2 m -145.22 134.31 22.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.166 0.587 . . . . 61.15 110.02 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.88 149.27 43.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.747 1.219 . . . . 64.33 107.738 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -143.89 160.97 39.87 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.343 0.657 . . . . 71.15 110.678 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.3 p -163.12 140.15 7.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.694 0.797 . . . . 73.24 109.352 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 10.1 tt0 -82.64 134.43 35.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 74.05 109.871 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -92.87 -55.2 3.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.297 0.639 . . . . 64.45 110.028 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.59 -165.13 1.97 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.577 -0.738 . . . . 51.52 110.942 -170.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' F' ' 170' ' ' LYS . 13.7 m-20 -69.06 109.89 4.22 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.547 -0.752 . . . . 51.22 110.206 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.53 4.43 4.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.028 1.331 . . . . 64.53 111.908 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.94 114.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 124.734 1.214 . . . . 75.34 109.121 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 15.5 p90 -117.46 174.39 6.17 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.817 . . . . 75.22 109.224 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.17 117.66 8.55 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.469 -0.937 . . . . 71.43 108.469 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.13 127.47 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 62.11 109.585 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.7 t -101.38 113.77 38.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.989 0.915 . . . . 73.1 108.826 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.05 110.1 21.58 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.005 -1.48 . . . . 73.31 107.005 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.92 121.89 42.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.906 -0.405 . . . . 55.04 109.906 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.2 t -112.65 126.67 70.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.541 -1.281 . . . . 51.53 107.541 167.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 77' ' ' GLU . 5.1 m -121.43 127.06 50.76 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 110.062 -0.347 . . . . 61.31 110.062 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' B' ' 42' ' ' LEU . 38.6 t -99.04 127.9 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.995 . . . . 75.14 109.995 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -107.61 131.87 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.583 -1.189 . . . . 60.54 108.648 164.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -136.26 152.33 50.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.024 -0.732 . . . . 75.14 109.024 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.0 p -145.4 135.39 23.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.047 0.758 . . . . 75.32 113.047 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.52 HD23 ' HB3' ' B' ' 38' ' ' PRO . 75.9 mt -95.29 97.08 9.59 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.752 -1.567 . . . . 74.11 108.003 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . 0.459 ' H ' ' HZ2' ' B' ' 36' ' ' TRP . . . 71.86 -117.04 6.29 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.482 -0.647 . . . . 40.04 111.482 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -105.43 9.33 33.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.494 1.118 . . . . 61.53 110.427 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.71 151.09 34.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.045 1.338 . . . . 72.55 108.414 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.88 133.83 43.17 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.164 0.438 . . . . 71.53 110.726 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.4 -63.3 1.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.89 0.876 . . . . 72.51 108.952 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -157.27 160.36 38.52 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.639 -1.164 . . . . 73.3 109.392 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.87 113.86 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.963 -1.125 . . . . 64.23 107.963 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.494 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.9 t -115.41 161.11 19.01 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.526 -0.916 . . . . 74.31 108.526 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.76 135.62 3.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.416 -0.587 . . . . 72.13 109.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.4 t -126.62 144.04 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.819 . . . . 73.0 108.79 171.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -122.97 91.8 3.57 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.784 -0.821 . . . . 53.5 108.784 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -84.61 100.68 11.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.419 -0.81 . . . . 74.32 109.161 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.2 158.41 23.78 Favored Glycine 0 C--O 1.24 0.521 0 N-CA-C 111.459 -0.656 . . . . 52.12 111.459 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -155.37 128.9 2.38 Favored Glycine 0 C--O 1.237 0.297 0 N-CA-C 112.011 -0.436 . . . . 74.13 112.011 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.47 HG13 ' HE1' ' B' ' 17' ' ' TYR . 55.2 mt -85.32 125.64 40.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.516 -0.92 . . . . 73.24 108.516 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.415 ' HB2' ' CZ ' ' B' ' 56' ' ' TYR . 29.7 m-85 -137.89 170.3 16.29 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.196 0.999 . . . . 54.4 108.574 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 43.5 m -135.14 132.63 38.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.93 0.892 . . . . 71.12 110.327 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.451 HD13 HG12 ' B' ' 89' ' ' ILE . 2.8 pp -136.25 146.19 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 123.541 0.736 . . . . 72.33 111.02 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.91 28.24 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.126 1.37 . . . . 73.15 108.245 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.76 -27.83 4.69 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-O 119.931 -0.372 . . . . 62.33 113.811 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.597 ' HA ' HG21 ' B' ' 7' ' ' THR . 1.6 pp -53.24 142.99 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.626 1.17 . . . . 72.52 113.057 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -150.57 148.66 28.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.163 0.985 . . . . 73.35 110.434 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -136.09 49.94 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 124.387 1.054 . . . . 70.15 114.481 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -84.39 -19.21 33.92 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.746 0.818 . . . . 75.02 110.646 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.24 -21.73 63.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.101 0.56 . . . . 74.54 110.875 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.3 -42.49 93.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.375 0.67 . . . . 65.12 110.515 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -21.15 65.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 72.32 112.367 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.11 -42.02 89.76 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.257 0.623 . . . . 53.34 110.483 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.417 ' SG ' HG21 ' B' ' 86' ' ' ILE . 46.4 t -67.52 -57.06 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.096 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.36 -31.12 66.97 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.766 -0.652 . . . . 72.35 112.542 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.418 ' HA3' ' HD1' ' F' ' 182' ' ' PHE . . . -94.52 -9.59 58.78 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.37 -0.683 . . . . 73.21 114.627 -171.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.68 -48.1 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 117.636 0.718 . . . . 73.03 112.576 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -69.49 -48.44 60.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.657 0.383 . . . . 74.45 111.457 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 60.4 m -62.18 -48.91 86.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 118.216 -0.897 . . . . 74.15 110.793 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 95.7 Cg_exo -50.58 -44.7 38.75 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.416 2.077 . . . . 64.43 113.515 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.13 -34.86 75.66 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.299 1.039 . . . . 61.31 112.178 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.21 -49.28 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.355 0.662 . . . . 61.31 110.176 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' B' ' 82' ' ' GLY . 50.0 mt -76.55 -14.77 59.99 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.481 -1.236 . . . . 70.01 111.856 -174.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' B' ' 128' ' ' LEU . 27.3 t80 -62.06 -52.64 65.99 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.271 1.428 . . . . 75.11 113.249 -167.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.558 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 36.9 Cg_endo -62.23 -32.55 82.41 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.022 1.815 . . . . 50.32 113.17 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.457 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.2 m-85 -64.36 -46.29 84.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.153 0.581 . . . . 74.23 110.057 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.2 90.16 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.959 0.903 . . . . 54.3 110.468 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 31.9 mtp180 -52.3 -56.11 16.98 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.586 1.155 . . . . 73.32 111.871 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -32.51 64.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.284 -0.871 . . . . 74.11 110.676 -173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -69.69 -34.6 74.16 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.831 0.452 . . . . 70.21 111.008 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.453 HG21 HG21 ' B' ' 64' ' ' VAL . 58.2 mt -62.69 -58.95 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.773 -0.825 . . . . 73.33 108.773 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -51.69 -32.65 30.79 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 124.86 1.35 . . . . 75.03 112.263 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -64.47 -50.33 67.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.076 0.95 . . . . 72.21 110.345 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -71.14 -30.86 67.01 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.105 0.479 . . . . 75.15 111.43 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.9 t -70.48 -37.8 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.18 0.992 . . . . 72.22 110.978 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 96.2 p -67.35 -33.04 74.41 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.169 0.509 . . . . 61.24 110.955 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.628 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 58.6 mtt-85 -64.64 -35.26 80.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.399 -0.819 . . . . 71.44 110.292 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.31 10.45 71.26 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.971 -0.905 . . . . 54.42 113.817 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.468 ' HA ' ' OD1' ' C' ' 127' ' ' ASN . 62.8 p 59.23 34.92 23.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.569 1.548 . . . . 65.43 113.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 23.7 m-85 -117.86 164.84 17.97 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 124.211 1.004 . . . . 75.21 110.631 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.562 ' HB2' HG21 ' B' ' 40' ' ' VAL . 7.3 Cg_exo -75.45 137.72 21.11 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 123.693 2.929 . . . . 70.22 115.257 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.636 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.9 OUTLIER -66.81 159.0 29.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.517 1.527 . . . . 72.42 113.282 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -126.3 117.47 23.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.106 -1.072 . . . . 44.0 108.106 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' C' ' 122' ' ' THR . 3.8 m120 -92.11 97.51 10.97 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.042 -1.466 . . . . 72.33 107.042 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.63 HD23 ' H ' ' B' ' 129' ' ' ALA . 0.5 OUTLIER -66.18 148.19 52.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.258 0.481 . . . . 54.42 110.961 -170.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.63 ' H ' HD23 ' B' ' 128' ' ' LEU . . . -41.11 107.0 0.45 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 127.335 2.254 . . . . 60.0 113.783 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.08 54.33 4.57 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.726 2.284 . . . . 70.23 111.774 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.667 HG22 HD13 ' E' ' 204' ' ' ILE . 67.0 t -87.35 113.63 25.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 124.782 1.233 . . . . 71.34 109.034 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -69.8 98.47 1.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.045 -1.095 . . . . 73.23 108.045 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -61.33 -25.19 66.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.157 -0.929 . . . . 72.0 110.993 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.67 -38.84 61.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.744 1.618 . . . . 53.45 111.892 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.52 -30.66 70.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.704 0.802 . . . . 73.13 111.563 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.1 tt -68.75 -48.37 63.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.957 0.503 . . . . 55.35 109.685 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -62.6 -31.54 72.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.402 0.681 . . . . 73.41 111.684 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.71 -36.4 74.2 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.09 0.956 . . . . 75.13 111.496 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -94.82 -36.65 11.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.515 0.726 . . . . 71.15 111.412 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -72.66 -47.69 45.39 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.461 0.705 . . . . 74.4 110.961 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.92 -4.4 59.16 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.515 0.726 . . . . 71.32 112.116 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -149.35 -104.67 0.08 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 119.174 -0.441 . . . . 75.41 110.181 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -147.53 -82.38 0.13 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.582 0.628 . . . . 74.53 109.742 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -143.66 -67.1 0.35 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.121 -1.066 . . . . 74.13 108.121 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.51 160.18 4.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.352 1.061 . . . . 45.43 110.408 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.13 61.42 0.41 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.319 -0.401 . . . . 72.01 112.115 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.87 149.3 28.13 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.737 0.815 . . . . 74.32 110.002 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.72 74.76 1.26 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 123.551 0.532 . . . . 75.33 113.562 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.3 p -150.84 116.43 5.45 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 73.13 108.827 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.46 159.39 24.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.13 0.572 . . . . 71.44 111.079 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -166.58 109.05 0.72 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.987 0.915 . . . . 74.14 109.435 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -124.19 77.02 1.51 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.458 -1.312 . . . . 73.1 107.458 169.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 163.04 28.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.533 -0.758 . . . . 71.51 110.195 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -149.19 101.88 3.18 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.36 -0.607 . . . . 50.04 109.36 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.8 0.84 . . . . 52.44 108.821 -178.871 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.425 -0.583 . . . . 64.11 109.425 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 59.1 p -157.59 -43.45 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.508 0.723 . . . . 71.34 110.102 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.79 110.43 22.29 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.366 0.667 . . . . 72.25 109.62 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.604 HE21 ' HB2' ' A' ' 138' ' ' MET . 24.2 mp0 -75.08 -63.54 1.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.451 0.7 . . . . 75.0 109.373 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.02 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.017 1.327 . . . . 72.11 111.583 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -135.18 72.48 1.45 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.881 -0.785 . . . . 74.24 108.881 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -133.31 59.62 1.73 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.368 -0.833 . . . . 70.21 109.895 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.423 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 48.4 mt-10 -68.72 -63.4 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.256 -1.016 . . . . 42.54 108.256 172.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.5 ttt 56.08 109.71 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.514 1.925 . . . . 54.03 113.593 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.2 m -115.76 79.22 1.27 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.017 -1.475 . . . . 60.41 107.017 167.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -95.17 116.64 29.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.341 -1.726 . . . . 72.24 106.341 168.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -143.69 141.87 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.722 -0.844 . . . . 71.32 108.722 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.422 HD11 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -73.0 133.5 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 123.71 0.631 . . . . 62.35 109.435 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -113.29 -28.96 7.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.58 0.752 . . . . 71.34 110.107 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.43 ' NH2' ' HB ' ' D' ' 122' ' ' THR . 16.1 ttt85 -179.65 144.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 122.976 0.511 . . . . 72.45 110.605 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.422 HG13 HD11 ' C' ' 13' ' ' ILE . 51.7 mt -124.39 134.17 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.407 -1.331 . . . . 73.32 107.407 168.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.568 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.5 p90 -176.94 155.01 1.17 Allowed 'General case' 0 C--O 1.227 -0.122 0 O-C-N 123.997 0.81 . . . . 62.45 110.421 -174.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.23 120.94 22.19 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.629 0.772 . . . . 73.01 109.664 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.446 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 28.9 mmtp -70.55 -49.09 51.72 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 107.974 -1.121 . . . . 75.0 107.974 167.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -138.51 142.68 39.34 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.803 -1.544 . . . . 75.22 109.498 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.24 144.8 28.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.936 -1.505 . . . . 72.42 106.936 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.2 t -155.21 148.3 24.71 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.254 0.55 . . . . 61.4 110.593 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.4 t80 -147.8 125.96 12.18 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 114.694 -1.139 . . . . 74.52 107.926 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.36 139.25 51.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.361 1.064 . . . . 63.33 108.321 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 76.26 36.24 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 105.954 -1.869 . . . . 63.52 105.954 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.25 -19.68 29.03 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.369 2.046 . . . . 74.53 111.071 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.75 11.4 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.679 -1.146 . . . . 72.2 110.376 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.604 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.05 -61.73 3.07 Favored Pre-proline 0 CA--C 1.573 1.85 0 N-CA-C 114.064 1.135 . . . . 63.03 114.064 -165.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.9 Cg_exo -76.05 -23.49 12.09 Favored 'Trans proline' 0 C--N 1.387 2.594 0 CA-C-N 121.746 1.659 . . . . 71.23 112.28 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -71.09 -38.16 72.4 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.797 1.239 . . . . 73.13 111.894 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.36 -10.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.377 1.071 . . . . 74.11 111.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.578 ' HA ' ' HE2' ' E' ' 197' ' ' TYR . 73.2 t80 -55.09 -40.52 70.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.759 0.824 . . . . 75.4 111.7 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -116.52 38.78 3.33 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.997 0.903 . . . . 72.24 109.811 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.823 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -99.98 152.23 20.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.68 -0.638 . . . . 64.2 110.945 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.62 108.57 4.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.633 -1.247 . . . . 52.33 107.633 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -70.99 104.58 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.927 0.891 . . . . 74.24 110.68 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -134.47 49.88 4.38 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 124.174 0.99 . . . . 74.31 110.724 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 112.62 3.42 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.182 1.922 . . . . 73.42 112.302 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -86.0 95.08 9.39 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.579 -1.267 . . . . 63.23 107.579 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.734 ' HB ' ' HB3' ' E' ' 189' ' ' ALA . 76.0 t -80.7 89.63 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.095 -0.957 . . . . 74.13 110.118 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.88 139.14 31.24 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.837 -0.801 . . . . 63.25 108.837 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' C' ' 64' ' ' VAL . 0.6 OUTLIER -129.12 144.98 51.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.379 0.671 . . . . 54.34 109.633 172.041 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.46 139.19 53.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.796 1.239 . . . . 55.25 108.836 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.674 ' HG ' HD21 ' C' ' 60' ' ' LEU . 8.9 tt -114.21 135.7 53.76 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.629 0.772 . . . . 73.13 109.16 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -155.63 149.95 25.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.229 1.011 . . . . 74.41 108.835 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -112.16 152.11 28.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.466 0.65 . . . . 51.14 109.895 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.0 158.39 41.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.5 1.12 . . . . 75.43 108.173 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.4 t -153.26 148.84 27.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.899 0.38 . . . . 64.33 110.675 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -157.74 128.09 6.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.62 1.168 . . . . 74.12 108.917 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -81.41 131.22 35.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.312 -0.625 . . . . 73.32 109.312 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 HD12 ' C' ' 83' ' ' ILE . 84.2 mt -98.01 -40.1 8.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.542 0.737 . . . . 75.22 110.34 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.36 179.48 9.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.221 -0.899 . . . . 65.32 109.526 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.14 126.04 28.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.661 -0.866 . . . . 75.42 108.661 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.434 ' HA ' HG23 ' C' ' 86' ' ' ILE . 3.0 m-20 67.11 13.83 9.58 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.625 1.17 . . . . 64.54 112.606 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.68 117.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.405 1.082 . . . . 64.4 108.587 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 165.76 23.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.66 0.743 . . . . 72.5 109.547 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -126.57 136.63 52.8 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.328 1.051 . . . . 74.24 108.474 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.0 t -123.37 127.43 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.179 -1.415 . . . . 73.22 107.179 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.507 HG22 ' HA2' ' C' ' 81' ' ' GLY . 90.2 t -120.44 117.4 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.798 -0.815 . . . . 72.23 108.798 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.674 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -86.53 113.05 22.13 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.786 -0.82 . . . . 64.42 108.786 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -90.92 106.76 18.74 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.307 -0.998 . . . . 73.33 108.307 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.5 t -107.19 135.47 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.152 -1.055 . . . . 51.44 108.152 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -127.39 124.99 39.85 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.951 -0.388 . . . . 72.23 109.951 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.633 HG22 ' HB3' ' C' ' 42' ' ' LEU . 43.3 t -102.71 115.86 45.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 74.31 110.612 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -99.4 134.76 41.79 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.178 -1.045 . . . . 60.55 108.178 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.26 129.92 45.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.32 -0.993 . . . . 52.25 108.32 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 70.2 m -146.88 135.63 22.18 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.626 0.579 . . . . 70.44 111.146 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' C' ' 34' ' ' LYS . 5.9 mt -86.83 40.74 0.92 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.319 1.848 . . . . 74.22 109.413 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.42 -109.71 3.29 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.724 -0.95 . . . . 73.33 110.724 -168.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.25 -24.47 22.08 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.519 0.728 . . . . 72.2 110.136 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.531 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 6.9 tp10 -76.94 120.45 22.08 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.389 1.075 . . . . 62.23 110.027 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.1 m -66.65 125.36 25.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.958 0.799 . . . . 74.54 109.404 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -80.06 -51.9 8.46 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.842 -0.799 . . . . 72.52 108.842 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -164.81 175.29 9.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.777 -1.101 . . . . 74.12 109.863 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.406 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -134.33 144.81 48.5 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.677 -1.601 . . . . 65.35 106.677 170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.1 t -143.83 148.33 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.21 -1.033 . . . . 53.32 108.21 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.62 134.85 9.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.922 -0.77 . . . . 55.51 108.922 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.73 139.24 52.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.364 1.066 . . . . 75.4 108.521 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -116.4 90.34 3.31 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.116 -1.068 . . . . 75.42 108.116 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -79.56 106.6 11.7 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.675 -1.148 . . . . 75.25 109.991 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -82.72 148.41 26.05 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.371 0.419 . . . . 64.5 112.166 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.74 116.19 0.77 Allowed Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 110.795 -0.922 . . . . 74.33 110.795 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.632 HD12 HD11 ' C' ' 51' ' ' LEU . 10.9 mm -87.6 125.23 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.245 -1.02 . . . . 63.0 108.245 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -130.56 156.59 44.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.498 -0.927 . . . . 74.02 108.498 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -91.75 137.22 32.54 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.933 -0.766 . . . . 72.34 108.933 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.47 HD12 HD13 ' E' ' 173' ' ' LEU . 0.0 OUTLIER -108.52 134.67 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.655 -0.868 . . . . 71.41 108.655 172.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -178.39 153.56 0.75 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.574 0.75 . . . . 54.11 110.992 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.85 -36.53 3.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.652 1.021 . . . . 20.15 115.652 163.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' C' ' 94' ' ' MET . 1.6 pp -70.14 167.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.99 0.916 . . . . 73.42 112.282 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.43 148.57 4.64 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.935 -1.029 . . . . 73.35 108.676 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.43 -122.58 6.16 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.145 0.278 . . . . 74.03 113.444 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -77.31 -24.96 50.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.247 0.619 . . . . 62.11 112.575 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -41.75 98.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.79 0.436 . . . . 73.44 110.883 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.423 ' HB3' HD13 ' C' ' 89' ' ' ILE . 15.9 ptp -72.47 -27.37 62.25 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.298 -0.41 . . . . 72.13 111.816 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.94 76.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.491 0.716 . . . . 52.14 111.826 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -72.46 -24.57 61.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.063 0.545 . . . . 73.42 111.222 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 32.3 t -62.96 -63.46 1.2 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.537 0.523 . . . . 61.24 111.089 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.52 -23.92 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.49 0.586 . . . . 74.14 110.516 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.85 -24.44 76.63 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.486 -0.779 . . . . 64.15 113.521 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.401 ' HA ' ' CZ2' ' E' ' 184' ' ' TRP . . . -158.61 -38.01 0.06 Allowed 'General case' 0 C--N 1.358 0.967 0 N-CA-C 113.723 1.009 . . . . 61.12 113.723 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.21 -39.01 82.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.517 0.727 . . . . 64.03 112.057 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.82 -50.28 4.22 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.46 -0.781 . . . . 72.23 111.301 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.411 ' O ' HD12 ' C' ' 60' ' ' LEU . 34.3 Cg_endo -64.49 -23.16 64.84 Favored 'Trans proline' 0 C--N 1.398 3.183 0 C-N-CA 121.637 1.558 . . . . 75.55 113.306 175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -65.37 -36.13 83.05 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 122.984 0.514 . . . . 71.13 110.394 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.27 -41.52 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.895 0.878 . . . . 72.4 110.165 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 57.5 mt -86.64 -15.95 38.13 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.591 -1.186 . . . . 62.2 112.07 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -59.63 -51.58 80.03 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 117.617 -1.182 . . . . 70.22 113.182 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.94 -34.39 99.1 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 121.927 1.751 . . . . 74.45 112.596 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.64 -46.68 75.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.506 0.722 . . . . 73.3 110.864 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.59 94.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 40.14 110.402 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.19 -45.67 93.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.421 1.488 . . . . 72.23 110.716 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.59 -30.19 59.53 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.004 0.921 . . . . 63.11 110.324 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.1 t -68.67 -39.82 80.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.1 0.56 . . . . 44.32 110.481 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.58 HG21 HG21 ' C' ' 64' ' ' VAL . 86.4 mt -68.31 -45.06 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.064 0.546 . . . . 64.5 109.932 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.2 m -55.01 -38.87 68.46 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.634 0.774 . . . . 74.11 111.184 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -59.8 -60.6 3.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.187 -0.915 . . . . 71.42 109.716 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.524 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -48.2 -47.63 35.26 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.474 1.51 . . . . 73.22 113.349 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.622 HG11 HD23 ' C' ' 126' ' ' LEU . 53.5 t -70.69 -43.89 77.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.12 0.968 . . . . 75.24 111.796 -173.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.5 t -64.72 -30.57 71.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.889 -0.596 . . . . 64.51 110.793 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 75.2 mtt-85 -66.02 -32.53 74.06 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.816 -0.629 . . . . 73.5 110.564 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.28 12.3 60.9 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.526 0.516 . . . . 73.35 113.557 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.636 HG23 ' HB3' ' D' ' 17' ' ' TYR . 46.5 p 58.79 35.93 24.54 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.793 1.637 . . . . 71.22 112.922 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.418 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 41.5 m-85 -110.21 163.94 16.0 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.171 0.988 . . . . 71.33 110.504 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 32.7 Cg_endo -59.48 173.35 1.54 Allowed 'Trans proline' 0 C--N 1.402 3.361 0 C-N-CA 123.631 2.888 . . . . 64.41 114.905 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.636 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 5.7 mm-40 -60.68 136.26 58.01 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.393 -0.821 . . . . 73.42 111.732 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.622 HD23 HG11 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -112.32 24.81 12.15 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.278 -0.874 . . . . 53.12 111.683 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 7.1 p30 -92.56 84.0 5.01 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.523 1.63 . . . . 74.22 108.207 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' E' ' 187' ' ' ILE . 3.5 mm? -91.91 157.03 17.06 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.915 -1.038 . . . . 74.45 112.63 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' F' ' 204' ' ' ILE . . . -33.58 135.91 0.31 Allowed Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 126.542 1.937 . . . . 73.22 115.101 -174.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.75 109.99 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.851 2.367 . . . . 60.23 111.609 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.05 30.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.428 0.691 . . . . 74.34 111.381 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -71.2 103.8 2.9 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -67.17 -5.0 11.79 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.119 -0.946 . . . . 75.22 111.988 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' C' ' 137' ' ' PHE . 9.9 m-20 -63.46 -19.02 64.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.821 1.248 . . . . 65.13 112.999 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.24 89.28 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.468 0.651 . . . . 73.11 109.857 167.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.1 mt -87.9 -25.41 23.25 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.241 1.016 . . . . 71.31 111.739 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.583 ' HB3' ' HA ' ' C' ' 134' ' ' ASP . 77.2 t80 -64.54 -46.96 80.62 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.891 0.769 . . . . 74.33 111.278 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -32.89 74.84 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 123.38 0.425 . . . . 63.43 110.324 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -65.94 -38.57 88.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.135 1.374 . . . . 71.25 110.914 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.496 ' HB3' HD22 ' C' ' 141' ' ' LEU . 8.4 m-85 -71.03 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.939 0.896 . . . . 73.23 109.123 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' C' ' 140' ' ' TYR . 2.3 mm? -93.94 111.88 23.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.517 0.727 . . . . 75.54 110.034 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -72.24 143.38 48.82 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.419 0.687 . . . . 74.42 109.891 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.07 -28.41 63.31 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 74.01 112.121 -174.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 61.6 88.95 0.08 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.961 1.304 . . . . 73.42 110.044 -172.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.05 170.95 15.29 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.344 0.658 . . . . 53.45 111.671 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -129.27 175.79 18.75 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 110.219 -1.152 . . . . 45.33 110.219 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.422 ' HG3' HG21 ' A' ' 92' ' ' THR . 33.3 tt0 -152.45 109.11 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.875 -0.417 . . . . 52.21 109.875 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.94 165.11 33.31 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.423 -0.671 . . . . 71.11 111.423 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 24.3 m 62.29 82.79 0.17 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.496 1.118 . . . . 72.35 111.839 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.58 100.42 13.27 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.499 -1.667 . . . . 60.03 106.499 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -149.14 147.33 28.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.986 -0.746 . . . . 61.21 108.986 -167.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -128.49 8.84 5.97 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.789 1.033 . . . . 63.55 113.789 -166.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -73.19 -81.34 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.264 0.938 . . . . 71.3 109.834 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -158.09 172.17 18.9 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.406 1.082 . . . . 71.2 109.652 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.505 -0.77 . . . . 50.33 109.795 171.376 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.734 -0.469 . . . . 60.01 109.734 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.9 p -145.45 88.6 1.87 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.5 0.72 . . . . 60.11 109.686 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -105.88 111.54 24.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.269 -1.011 . . . . 72.12 108.269 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -146.69 117.22 7.51 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.656 0.782 . . . . 54.2 109.389 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.72 140.86 34.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.145 -1.057 . . . . 52.32 108.145 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -150.44 -51.33 0.13 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.448 0.699 . . . . 70.02 109.63 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -66.52 141.37 57.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.225 -0.898 . . . . 63.21 110.206 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -64.19 116.54 6.07 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.902 -1.147 . . . . 61.14 107.902 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.468 ' HG3' HG23 ' D' ' 89' ' ' ILE . 4.4 ttp -31.97 122.86 0.3 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.638 1.211 . . . . 63.54 112.464 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 47.7 m -116.46 141.21 48.47 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.633 -0.877 . . . . 73.35 108.633 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -153.49 99.53 2.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.378 -0.971 . . . . 75.22 108.378 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -123.58 114.4 19.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.77 0.828 . . . . 75.14 108.774 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.417 HG22 ' HD2' ' D' ' 84' ' ' PHE . 1.1 pp -78.75 127.05 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 107.157 -1.424 . . . . 73.25 107.157 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 78.3 mt-30 -85.09 -35.37 21.86 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.271 -0.27 . . . . 71.41 110.271 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.448 ' HB3' ' HE1' ' D' ' 17' ' ' TYR . 1.6 tpt180 -172.74 157.29 3.71 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.852 0.461 . . . . 64.35 110.514 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 19.7 mt -144.31 124.19 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.514 1.126 . . . . 64.44 108.038 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.636 ' HB3' HG23 ' C' ' 122' ' ' THR . 23.9 p90 -168.96 162.91 11.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.758 1.223 . . . . 72.21 109.996 -168.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.8 p -80.94 122.17 26.92 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.314 -0.857 . . . . 62.3 109.912 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 45.7 mtpt -86.09 -44.42 12.27 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 107.98 -1.118 . . . . 74.42 107.98 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.765 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.9 t70 -131.59 141.88 49.77 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.963 -1.017 . . . . 75.11 109.848 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.524 HD13 ' HE3' ' C' ' 117' ' ' MET . 55.4 mt -137.7 146.33 27.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.375 1.47 . . . . 74.14 107.778 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.1 140.5 17.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.498 0.666 . . . . 54.4 111.101 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.9 t80 -140.8 137.89 33.66 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.514 -1.662 . . . . 73.04 106.514 168.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.5 mt-10 -138.09 136.94 37.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.291 1.036 . . . . 73.15 108.489 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.11 74.17 10.97 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.959 -0.756 . . . . 71.23 108.959 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.71 -26.72 13.37 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.697 2.265 . . . . 73.33 112.407 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -99.46 -0.44 40.78 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.05 -0.977 . . . . 73.14 111.508 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.679 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.39 -57.87 4.13 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 116.071 1.878 . . . . 63.43 116.071 -163.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 67.1 Cg_endo -77.44 -25.18 8.47 Favored 'Trans proline' 0 C--N 1.387 2.59 0 CA-C-N 121.101 1.429 . . . . 62.45 113.221 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -87.14 -24.17 24.59 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.702 0.287 . . . . 74.12 110.585 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -8.93 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 123.495 0.718 . . . . 43.41 110.12 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -65.98 -38.17 87.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.774 0.829 . . . . 72.23 110.614 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -75.9 -2.1 28.6 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.81 0.338 . . . . 75.34 111.363 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -105.68 76.87 1.22 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.635 1.174 . . . . 65.51 107.975 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.62 95.19 8.27 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.015 -0.993 . . . . 73.12 112.325 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -150.05 176.13 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.401 -0.592 . . . . 75.23 109.401 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -73.3 114.12 28.45 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.139 0.976 . . . . 74.44 109.231 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.51 111.16 0.86 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.111 1.874 . . . . 73.04 110.421 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.66 111.17 2.28 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.862 -1.162 . . . . 70.21 107.862 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -98.35 121.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.352 0.661 . . . . 71.33 109.385 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -109.06 114.26 27.83 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.568 -1.271 . . . . 61.43 107.568 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -96.61 116.27 28.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.852 0.861 . . . . 74.54 108.968 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.41 125.87 52.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.712 -0.847 . . . . 63.1 108.712 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.71 129.82 42.8 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.423 -0.584 . . . . 64.35 109.423 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.5 t70 -144.55 152.82 41.11 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.147 -1.057 . . . . 54.13 108.147 172.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -145.19 157.31 44.11 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.326 0.651 . . . . 62.14 109.506 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.93 166.85 28.37 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.811 1.245 . . . . 71.23 107.793 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.48 ' OG ' HD11 ' H' ' 177' ' ' LEU . 68.9 p -168.1 166.01 13.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.828 0.451 . . . . 55.05 110.813 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.1 p -156.65 132.63 9.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.26 -0.882 . . . . 62.21 109.12 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -70.3 126.99 31.23 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.53 -0.544 . . . . 45.32 109.53 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.3 mt -91.45 -40.89 11.16 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.263 0.554 . . . . 65.01 109.824 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.22 -173.26 3.94 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.117 -0.947 . . . . 75.55 110.172 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.97 123.06 19.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.657 -0.701 . . . . 74.34 110.014 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 64.56 17.39 10.85 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.551 1.157 . . . . 75.31 112.242 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.12 123.47 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.563 0.745 . . . . 71.52 110.16 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.54 ' HE1' ' HG3' ' H' ' 174' ' ' MET . 12.0 m-85 -125.29 166.33 16.72 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.902 1.281 . . . . 71.14 108.419 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.5 tm-20 -130.6 126.93 37.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.737 -1.949 . . . . 64.31 105.737 168.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.86 133.23 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.189 0.996 . . . . 63.43 108.552 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.13 135.91 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.367 1.067 . . . . 65.13 110.079 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.46 126.6 52.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.212 -1.403 . . . . 72.34 107.212 171.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -104.51 102.95 12.57 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.883 -0.784 . . . . 73.55 108.883 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.5 t -95.18 119.39 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.373 -0.973 . . . . 63.33 108.373 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 32.0 m -115.76 136.92 52.58 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.677 -0.692 . . . . 74.12 110.164 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.482 HG21 HG21 ' D' ' 114' ' ' ILE . 76.4 t -126.76 102.3 9.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.897 1.279 . . . . 64.15 108.167 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -97.84 92.53 5.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.091 -1.448 . . . . 73.23 107.091 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.3 137.35 37.15 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.453 -0.943 . . . . 74.14 108.453 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.2 p -148.78 130.26 14.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.321 0.581 . . . . 75.44 111.782 -170.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 59.5 mt -98.31 107.67 20.18 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.694 1.198 . . . . 73.15 108.316 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.9 -134.58 22.05 Favored Glycine 0 C--N 1.343 0.932 0 O-C-N 123.536 0.523 . . . . 34.01 112.272 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.32 4.54 38.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.669 0.787 . . . . 43.23 111.943 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.08 162.73 30.1 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.836 0.454 . . . . 62.43 110.608 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.0 m -66.83 136.4 55.36 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.148 -0.933 . . . . 71.33 111.552 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -90.12 -56.44 3.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.931 -1.137 . . . . 62.24 107.931 169.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -162.62 144.42 10.47 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.201 -1.363 . . . . 54.44 109.802 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -110.53 111.52 22.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.832 0.853 . . . . 74.43 108.785 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG23 ' D' ' 114' ' ' ILE . 20.2 t -127.09 127.71 45.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.012 0.525 . . . . 63.11 109.936 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -148.38 139.77 23.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.431 0.692 . . . . 75.53 109.74 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' D' ' 113' ' ' CYS . 99.1 t -132.87 124.67 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.435 0.694 . . . . 64.03 109.678 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.765 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.8 mt-30 -91.74 88.32 6.64 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.751 -0.833 . . . . 74.43 108.751 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.405 ' O ' HD13 ' D' ' 106' ' ' LEU . 57.8 tp60 -80.05 109.71 14.75 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 114.401 -1.272 . . . . 74.23 108.353 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.07 166.8 21.33 Favored Glycine 0 C--O 1.241 0.545 0 N-CA-C 111.946 -0.462 . . . . 53.24 111.946 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.15 140.24 6.11 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.002 -0.839 . . . . 73.22 111.002 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 59.2 mt -88.71 126.25 41.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.81 -0.811 . . . . 71.13 108.81 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.417 ' HD2' HG22 ' D' ' 13' ' ' ILE . 69.3 m-85 -124.61 124.71 42.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.104 0.561 . . . . 72.03 109.965 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -93.28 111.34 22.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.052 0.941 . . . . 61.5 108.809 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.412 HD13 HD12 ' D' ' 98' ' ' LEU . 42.2 pt -116.68 142.98 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.237 0.615 . . . . 61.44 111.431 -172.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -157.93 160.64 37.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.858 1.263 . . . . 63.4 108.585 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.75 22.4 78.12 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 123.062 0.226 . . . . 52.1 113.404 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.662 HD13 ' HG2' ' D' ' 94' ' ' MET . 1.2 pp -113.1 148.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.311 1.044 . . . . 74.04 109.959 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' H' ' 172' ' ' ALA . 0.0 OUTLIER -144.27 146.41 32.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.34 0.656 . . . . 74.34 111.152 -176.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 35.45 -97.65 0.01 OUTLIER Glycine 0 C--N 1.359 1.828 0 N-CA-C 116.494 1.357 . . . . 62.04 116.494 169.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -64.25 -53.82 43.15 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.722 1.209 . . . . 60.24 110.934 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.46 -31.06 71.94 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.94 -1.027 . . . . 64.03 110.876 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.662 ' HG2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -71.96 -54.71 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.421 1.088 . . . . 53.04 109.915 -178.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.72 -25.79 68.36 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.835 -1.075 . . . . 65.14 111.563 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.67 -44.89 18.08 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.969 0.508 . . . . 65.21 111.01 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.9 -43.27 96.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.032 0.533 . . . . 72.55 111.033 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.412 HD12 HD13 ' D' ' 86' ' ' ILE . 6.7 tt -92.77 -33.39 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 72.14 110.682 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -20.73 57.36 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.401 0.52 . . . . 34.02 114.401 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.24 -49.86 1.1 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.577 0.689 . . . . 42.12 111.851 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -73.4 -45.01 57.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.868 0.467 . . . . 73.0 111.473 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 93.2 m -61.5 -48.04 91.64 Favored Pre-proline 0 CA--C 1.567 1.6 0 CA-C-O 118.286 -0.864 . . . . 34.14 111.637 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.58 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.8 Cg_exo -56.9 -38.17 96.55 Favored 'Trans proline' 0 C--N 1.399 3.228 0 C-N-CA 122.353 2.035 . . . . 64.3 113.366 168.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.91 -32.35 73.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.365 0.666 . . . . 70.53 111.251 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.65 -41.5 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.55 0.74 . . . . 55.41 110.259 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' D' ' 80' ' ' GLN . 61.7 mt -75.14 -23.52 57.83 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.152 -0.931 . . . . 74.04 111.607 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.403 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 66.4 t80 -60.64 -45.39 97.07 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.733 1.382 . . . . 73.33 114.733 -169.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.12 -42.63 58.15 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 122.118 1.879 . . . . 62.54 112.816 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -76.49 -35.65 58.25 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.921 -1.036 . . . . 71.31 110.724 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.57 78.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.896 0.878 . . . . 62.31 110.905 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -58.87 -55.09 39.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.448 1.093 . . . . 73.54 109.956 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.56 -40.32 86.9 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.273 0.983 . . . . 74.3 111.895 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.493 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -59.28 -42.71 91.86 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.02 0.825 . . . . 53.34 110.333 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.563 HG23 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -63.65 -52.02 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.018 0.927 . . . . 75.42 110.364 172.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.8 m -53.66 -43.61 68.96 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.361 1.464 . . . . 65.53 112.099 -172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -68.48 -43.05 77.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.011 -0.995 . . . . 44.4 110.377 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 76.7 mtm -66.35 -30.92 71.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.868 0.467 . . . . 55.54 111.964 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -71.02 -42.39 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.391 0.676 . . . . 75.12 110.397 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -71.06 -29.95 65.97 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 116.553 -0.294 . . . . 74.24 110.442 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -69.74 -28.67 65.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.762 0.825 . . . . 75.31 110.148 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 11.09 62.91 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.717 0.636 . . . . 74.1 112.922 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.568 HG23 ' HB3' ' C' ' 17' ' ' TYR . 75.1 p 56.06 25.12 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.292 1.837 . . . . 75.52 113.46 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.441 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 28.2 m-85 -103.34 166.22 12.18 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 125.055 1.342 . . . . 72.41 109.687 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 34.2 Cg_endo -59.23 124.71 16.19 Favored 'Trans proline' 0 C--N 1.394 2.933 0 C-N-CA 123.052 2.501 . . . . 75.23 112.791 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -55.16 119.64 5.8 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 123.883 0.74 . . . . 70.52 109.869 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.01 98.41 8.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.327 0.584 . . . . 73.1 109.831 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -99.13 86.3 3.41 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.006 -1.109 . . . . 74.41 108.006 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.403 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 1.0 OUTLIER -72.59 138.16 46.64 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.934 -1.03 . . . . 61.55 109.896 -173.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 131.5 95.21 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.993 0.517 . . . . 64.13 111.891 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.3 119.44 4.58 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.906 1.737 . . . . 72.4 110.072 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.75 120.22 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.63 0.728 . . . . 72.53 110.031 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -74.34 104.24 5.02 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.316 -0.994 . . . . 52.21 108.316 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -61.75 -32.87 73.15 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.403 1.081 . . . . 73.13 111.361 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.59 -40.55 73.2 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.707 0.803 . . . . 63.14 111.122 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.35 78.38 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.028 0.531 . . . . 65.54 110.729 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.604 HD13 ' HD2' ' H' ' 185' ' ' PRO . 87.0 mt -70.93 -45.18 64.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.344 0.658 . . . . 75.33 111.308 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.36 -58.18 9.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.051 0.54 . . . . 63.5 110.686 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtm -59.02 -52.86 63.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.892 0.877 . . . . 74.43 111.285 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.07 -33.41 70.77 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.583 0.753 . . . . 70.51 111.938 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -64.97 -43.26 93.23 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.972 0.909 . . . . 74.03 110.235 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.59 -39.06 32.56 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.9 0.88 . . . . 71.22 112.239 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.43 35.76 0.88 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.513 0.725 . . . . 72.32 111.351 -173.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -113.32 89.16 3.01 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.253 1.025 . . . . 72.13 108.309 -168.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.87 136.9 25.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.378 -1.712 . . . . 75.51 106.378 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.76 96.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.601 0.76 . . . . 72.41 110.179 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.61 51.97 0.05 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.111 -1.196 . . . . 43.43 110.111 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -63.16 152.63 36.82 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.165 0.986 . . . . 73.22 110.631 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.25 80.7 0.14 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.864 -0.894 . . . . 65.43 110.864 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 33.5 p -69.83 -32.26 70.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.15 0.98 . . . . 72.04 109.775 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.31 100.75 0.07 Allowed 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.911 -1.04 . . . . 71.52 109.572 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -175.85 1.85 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.616 0.767 . . . . 73.42 110.69 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -123.73 154.34 39.61 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.004 -0.435 . . . . 74.24 110.92 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -71.49 -175.69 1.36 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.757 0.823 . . . . 75.1 109.996 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.86 76.51 1.15 Allowed 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.533 0.682 . . . . 71.15 109.854 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 C-N-CA 124.969 1.308 . . . . 72.35 108.22 -172.888 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.075 -0.343 . . . . 74.54 110.075 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.12 96.93 0.49 Allowed Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.123 -1.191 . . . . 62.4 110.123 175.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.64 -19.92 52.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.42 1.088 . . . . 71.24 113.126 -168.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 69.2 m 64.18 39.36 7.59 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.597 0.759 . . . . 74.34 111.084 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.82 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 C-N-CA 124.547 1.139 . . . . 53.54 110.958 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.47 HD13 HD12 ' C' ' 86' ' ' ILE . 3.6 mm? 45.31 41.01 5.79 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 125.102 1.361 . . . . 65.54 114.372 167.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.4 ' HE3' HG12 ' C' ' 86' ' ' ILE . 53.0 mtt 56.69 53.47 8.35 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.83 0.852 . . . . 70.4 110.512 -174.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.47 -114.89 0.21 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.399 -0.963 . . . . 73.4 108.399 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 54.98 -103.01 0.16 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.384 1.074 . . . . 74.42 110.776 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.3 mp 53.83 178.7 0.02 OUTLIER 'General case' 0 C--N 1.366 1.291 0 C-N-CA 124.779 1.232 . . . . 74.45 113.434 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -167.39 -49.43 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 106.545 -1.65 . . . . 55.13 106.545 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -132.85 164.39 44.17 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 114.776 -1.102 . . . . 74.11 109.17 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.71 108.72 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.292 1.995 . . . . 71.23 110.442 164.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.65 -4.5 51.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.213 0.605 . . . . 73.13 111.27 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.49 140.92 51.13 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.138 0.975 . . . . 72.52 109.563 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 26.6 m -77.1 111.18 12.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.903 0.881 . . . . 74.24 110.148 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.401 ' CZ2' ' HA ' ' C' ' 100' ' ' ALA . 74.2 m95 -83.53 113.2 45.29 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.46 0.704 . . . . 75.3 109.697 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.88 143.97 37.83 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.183 1.922 . . . . 75.1 110.943 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 92.1 mt -119.85 110.29 16.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.204 -0.665 . . . . 73.14 109.204 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.584 HG13 ' HB3' ' C' ' 129' ' ' ALA . 0.0 OUTLIER -82.72 143.09 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.672 -0.862 . . . . 43.14 108.672 173.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 188' ' ' ALA . . . . . 0.409 ' N ' HD13 ' E' ' 187' ' ' ILE . . . -141.5 108.13 5.35 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.374 -0.973 . . . . 72.54 108.374 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 189' ' ' ALA . . . . . 0.734 ' HB3' ' HB ' ' C' ' 40' ' ' VAL . . . -65.61 121.11 14.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.73 0.812 . . . . 53.03 109.786 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.6 163.34 25.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.258 0.623 . . . . 64.34 111.235 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.37 160.67 31.69 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.877 -0.602 . . . . 45.12 113.606 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.34 146.4 6.73 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.782 -0.454 . . . . 72.44 112.466 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -114.9 106.14 13.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.901 0.88 . . . . 74.43 110.702 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -171.69 90.24 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.037 0.935 . . . . 71.23 110.203 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -147.3 160.38 42.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.94 0.896 . . . . 62.45 111.366 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -115.82 106.66 14.09 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.423 -1.325 . . . . 73.2 107.423 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 197' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' C' ' 32' ' ' PHE . 44.9 t80 -158.5 3.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.705 0.402 . . . . 75.44 111.827 -170.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -65.81 96.26 0.28 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.36 1.064 . . . . 72.14 110.564 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 63.56 -75.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.641 1.577 . . . . 74.54 111.289 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -127.69 -108.48 1.48 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.452 -1.459 . . . . 62.44 109.452 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 62.4 tttp 69.12 -59.63 0.47 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.188 1.795 . . . . 74.41 111.672 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 202' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' F' ' 187' ' ' ILE . 9.3 t80 -46.61 -49.49 18.9 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.569 1.148 . . . . 62.5 109.55 172.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.49 -167.6 2.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.068 0.547 . . . . 70.13 111.169 173.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.667 HD13 HG22 ' B' ' 131' ' ' VAL . 45.8 mm 73.67 -60.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.403 0 C-N-CA 125.888 1.675 . . . . 63.22 110.566 -171.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 28.8 tptp 71.59 -74.58 0.09 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.127 1.371 . . . . 75.32 110.183 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -165.92 -44.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.766 0.826 . . . . 55.42 109.308 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 CA--C 1.561 1.392 0 C-N-CA 124.859 1.263 . . . . 53.24 110.221 -175.296 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.155 -0.313 . . . . 64.11 110.155 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 123.76 -51.72 0.8 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.362 -1.495 . . . . 74.43 109.362 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 170' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' B' ' 53' ' ' ASP . 50.6 mttp -69.66 88.19 0.51 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.199 -1.038 . . . . 60.22 108.199 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 32.3 t -67.7 -45.25 75.64 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.563 1.145 . . . . 74.24 111.817 -165.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.78 134.13 45.99 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.635 0.585 . . . . 74.44 110.729 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.435 ' H ' HD23 ' F' ' 173' ' ' LEU . 2.4 pt? -62.23 106.17 0.7 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 124.212 0.945 . . . . 65.32 109.055 172.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.454 ' SD ' ' HB3' ' B' ' 56' ' ' TYR . 0.0 OUTLIER -106.41 -176.23 3.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.524 -0.762 . . . . 54.01 109.524 -174.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.51 156.23 45.12 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.264 1.025 . . . . 75.34 109.43 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -130.8 46.25 2.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.964 0.906 . . . . 71.2 109.493 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.57 119.66 8.5 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.114 0.565 . . . . 74.11 110.076 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.43 -17.63 15.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.945 0.498 . . . . 61.13 110.119 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.59 150.1 40.76 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.731 1.212 . . . . 73.03 110.096 -175.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 180' ' ' PRO . . . . . 0.525 ' HG3' ' H ' ' B' ' 46' ' ' THR . 3.9 Cg_exo -72.75 95.3 0.8 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.647 2.231 . . . . 73.42 110.553 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -61.07 -31.67 71.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.289 0.635 . . . . 73.34 110.45 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 182' ' ' PHE . . . . . 0.418 ' HD1' ' HA3' ' B' ' 99' ' ' GLY . 63.0 m-85 -116.33 81.4 1.61 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.517 0.727 . . . . 70.44 109.489 171.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 82.5 m -77.13 110.51 11.86 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.933 -0.766 . . . . 71.24 108.933 170.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -111.11 93.09 16.83 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.186 0.595 . . . . 74.14 109.625 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -88.02 128.82 2.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.58 2.187 . . . . 72.41 112.283 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.34 177.03 8.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.715 0.406 . . . . 74.14 111.76 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' E' ' 202' ' ' TYR . 64.3 mt 81.36 131.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 126.724 2.009 . . . . 75.33 112.534 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.08 87.95 2.13 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -89.72 111.66 22.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.649 -0.5 . . . . 70.31 109.649 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -139.11 163.03 33.48 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.78 0.832 . . . . 63.32 109.724 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.47 172.2 35.39 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.784 -0.644 . . . . 50.32 111.745 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -76.96 -110.64 0.14 Allowed Glycine 0 C--N 1.343 0.932 0 O-C-N 123.499 0.176 . . . . 72.21 112.755 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -112.96 74.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.636 0.774 . . . . 61.42 109.583 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -107.84 37.42 2.45 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.236 -0.893 . . . . 60.4 109.539 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.494 ' HD1' ' HB2' ' F' ' 202' ' ' TYR . 73.4 t80 -146.16 -81.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.796 -1.093 . . . . 64.34 108.698 -175.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 196' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 88.0 tttt 50.73 108.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.21 1.404 . . . . 73.35 113.177 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 197' ' ' TYR . . . . . 0.427 ' H ' ' HB2' ' B' ' 35' ' ' ASP . 3.2 t80 -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.436 0.694 . . . . 73.4 111.467 -172.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.46 -50.11 72.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 72.11 110.283 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -172.32 115.63 0.33 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.591 0.756 . . . . 75.0 109.635 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.9 -91.11 0.08 OUTLIER Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.733 -0.547 . . . . 61.22 111.733 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 201' ' ' LYS . . . . . 0.404 ' HB3' ' HB1' ' E' ' 189' ' ' ALA . 24.3 pttt -177.08 170.56 2.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.904 1.282 . . . . 74.21 111.071 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 202' ' ' TYR . . . . . 0.494 ' HB2' ' HD1' ' F' ' 195' ' ' PHE . 3.7 m-30 63.29 22.62 13.41 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 124.993 1.317 . . . . 74.44 110.071 -170.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -151.19 174.8 12.81 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 115.148 -0.933 . . . . 75.42 109.172 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.617 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 16.5 mt -93.08 93.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.295 0.569 . . . . 62.01 109.524 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -101.76 -21.11 14.69 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.486 -0.779 . . . . 71.32 110.789 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 206' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' E' ' 187' ' ' ILE . 18.7 m-20 -138.58 130.1 27.53 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.957 0.503 . . . . 72.34 109.758 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.558 1.25 0 C-N-CA 124.663 1.185 . . . . 55.34 109.201 170.766 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.238 0.471 0 CA-C-O 120.944 0.402 . . . . 73.23 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.68 175.35 43.02 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 116.172 -0.467 . . . . 52.45 112.511 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 170' ' ' LYS . . . . . 0.438 ' N ' ' HE2' ' G' ' 170' ' ' LYS . 0.0 OUTLIER -165.23 -158.49 0.39 Allowed 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.63 1.172 . . . . 64.42 107.86 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 31.2 t -56.09 96.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.994 -0.743 . . . . 70.2 108.994 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -174.27 -60.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.377 1.071 . . . . 62.13 109.696 -171.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.642 ' HB2' ' SD ' ' G' ' 174' ' ' MET . 0.6 OUTLIER -132.72 173.37 11.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.25 -1.341 . . . . 64.14 110.737 -170.032 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.642 ' SD ' ' HB2' ' G' ' 173' ' ' LEU . 0.0 OUTLIER 61.92 21.17 12.09 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.438 1.095 . . . . 72.11 113.481 171.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -64.36 157.98 24.84 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.046 0.538 . . . . 63.55 111.74 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -83.98 60.38 5.81 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.966 0.906 . . . . 63.15 109.299 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 177' ' ' LEU . . . . . 0.609 ' HB2' ' H ' ' A' ' 48' ' ' SER . 55.8 tp 55.45 94.25 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.215 1.406 . . . . 73.44 112.511 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 178' ' ' GLN . . . . . 0.498 ' HG2' ' HG3' ' G' ' 179' ' ' GLU . 48.6 tt0 -84.4 -75.87 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.602 -0.888 . . . . 63.22 108.602 171.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' G' ' 178' ' ' GLN . 43.3 mt-10 -146.57 150.2 39.49 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 124.222 1.009 . . . . 74.33 109.513 -172.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.9 -37.66 53.0 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.591 2.194 . . . . 42.32 112.024 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 60.5 t80 69.24 133.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.656 1.182 . . . . 74.24 111.746 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 33.4 t80 67.23 161.75 0.17 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.955 1.302 . . . . 63.14 110.859 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 39.2 p -76.48 143.07 40.72 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.999 0.52 . . . . 70.42 110.704 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 184' ' ' TRP . . . . . 0.447 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 29.3 t-105 -124.82 127.21 25.2 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 108.14 -1.059 . . . . 73.43 108.14 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 185' ' ' PRO . . . . . 0.584 ' HG3' HG23 ' H' ' 207' ' ' VAL . 87.5 Cg_endo -84.63 127.63 3.77 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.594 2.196 . . . . 61.41 112.185 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 91.7 mt -89.15 99.71 12.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.616 -0.883 . . . . 74.33 108.616 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 129' ' ' ALA . 1.9 pp -71.77 -178.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.13 0.972 . . . . 62.22 112.167 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.35 178.58 4.45 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.452 0.701 . . . . 74.33 111.03 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 189' ' ' ALA . . . . . 0.666 ' HB2' HD23 ' A' ' 128' ' ' LEU . . . -133.78 147.34 51.26 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.387 0.675 . . . . 43.32 111.644 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -86.65 153.09 22.03 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.896 0.878 . . . . 72.34 110.201 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.59 -170.15 23.8 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.414 -0.812 . . . . 75.23 111.306 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 192' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 124' ' ' PRO . . . -86.87 3.43 87.01 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 122.664 -0.315 . . . . 72.12 112.878 175.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 193' ' ' TYR . . . . . 0.408 ' HE1' ' HG3' ' H' ' 201' ' ' LYS . 77.5 t80 63.52 -80.69 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.075 1.75 . . . . 73.11 111.27 -172.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 194' ' ' ALA . . . . . 0.592 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . . . -148.45 155.54 41.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.316 0.579 . . . . 74.32 111.452 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.9 3.55 55.22 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.701 -1.136 . . . . 65.53 110.671 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 72.11 -59.63 0.55 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.584 1.554 . . . . 74.41 111.531 -169.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 72.21 143.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.161 1.384 . . . . 64.11 112.208 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 198' ' ' GLU . . . . . 0.43 ' HB3' ' HE3' ' G' ' 201' ' ' LYS . 5.0 tm-20 -167.5 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.173 -1.418 . . . . 74.05 107.173 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 9.0 t30 179.21 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.047 1.339 . . . . 64.5 108.269 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -88.67 61.22 3.85 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.581 -0.736 . . . . 71.4 112.398 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 201' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' G' ' 201' ' ' LYS . 11.4 mmpt? -89.02 -54.33 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.697 -0.853 . . . . 73.42 108.697 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -87.8 113.17 23.21 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.258 -1.386 . . . . 72.43 107.258 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.72 116.17 6.64 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.13 -1.063 . . . . 70.42 108.13 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 6.6 tp -126.33 99.65 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.739 0.78 . . . . 74.25 109.193 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.84 160.39 23.51 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.232 -0.895 . . . . 75.52 109.585 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.12 170.84 16.05 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.464 -0.569 . . . . 72.34 109.464 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.567 1.627 0 CA-C-O 118.517 -0.754 . . . . 74.5 111.183 -178.854 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 168' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' H' ' 168' ' ' LYS . 3.2 mptp? . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.201 -1.037 . . . . 72.11 108.201 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.69 85.84 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 O-C-N 124.076 0.86 . . . . 31.11 114.427 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -158.84 -67.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.541 0.736 . . . . 60.13 110.313 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 49.3 m -151.18 141.05 21.94 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.658 0.383 . . . . 73.22 111.076 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' D' ' 90' ' ' GLU . . . -104.25 -76.57 0.59 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.384 0.674 . . . . 54.4 110.509 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.667 ' HB3' ' SD ' ' H' ' 174' ' ' MET . 87.3 mt -85.09 126.47 33.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.787 -1.097 . . . . 74.14 110.193 -171.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' H' ' 173' ' ' LEU . 0.7 OUTLIER 69.08 147.43 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.084 1.354 . . . . 64.42 112.93 172.184 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.08 174.7 14.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.24 0.616 . . . . 73.13 110.835 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -116.46 27.52 9.15 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.643 0.777 . . . . 64.41 109.027 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 177' ' ' LEU . . . . . 0.48 HD11 ' OG ' ' D' ' 48' ' ' SER . 7.3 mp 64.81 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.144 1.378 . . . . 72.11 110.645 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.17 -66.08 0.66 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.759 -0.655 . . . . 53.2 111.711 -171.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.57 149.41 9.61 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.179 0.592 . . . . 64.01 110.138 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.76 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.757 2.305 . . . . 74.24 111.091 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.11 -43.61 78.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.881 0.873 . . . . 74.54 111.397 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -134.95 138.69 44.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.089 0.956 . . . . 71.13 109.069 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -97.88 -30.69 12.61 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.483 0.713 . . . . 72.53 110.196 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 66.59 136.1 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 125.545 1.538 . . . . 74.32 112.005 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 185' ' ' PRO . . . . . 0.604 ' HD2' HD13 ' D' ' 136' ' ' LEU . 64.1 Cg_endo -75.79 108.98 2.81 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.02 1.813 . . . . 74.43 112.233 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 mp -79.37 128.12 32.95 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.021 -0.733 . . . . 73.24 109.021 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.58 162.61 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.868 0.467 . . . . 75.2 110.917 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -149.58 -167.06 2.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.768 0.827 . . . . 73.24 109.5 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -157.26 133.88 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.104 0.562 . . . . 60.42 110.156 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.22 175.97 9.88 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.377 1.071 . . . . 73.0 108.646 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 68.6 -109.21 2.79 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.595 -0.602 . . . . 43.2 111.595 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.47 -61.85 4.67 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 114.343 0.497 . . . . 63.11 114.343 170.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 90.2 t80 63.32 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 74.45 110.271 -166.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -159.63 -171.73 3.41 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.699 0.8 . . . . 41.13 108.91 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 71.36 169.22 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.542 1.137 . . . . 55.35 112.14 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -153.91 -39.1 0.09 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.74 -0.664 . . . . 72.42 109.732 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 55.57 90.82 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.291 0.995 . . . . 65.5 112.31 170.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -129.03 126.1 38.75 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.831 -0.543 . . . . 72.11 111.246 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -85.45 80.19 9.18 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.035 -1.098 . . . . 73.03 108.035 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 164.8 -162.06 35.23 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.007 -0.997 . . . . 75.33 111.031 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 201' ' ' LYS . . . . . 0.408 ' HG3' ' HE1' ' G' ' 193' ' ' TYR . 6.8 tmtt? 61.71 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.179 1.392 . . . . 72.04 108.911 -171.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 64.79 82.52 0.18 Allowed 'General case' 0 C--N 1.355 0.836 0 N-CA-C 106.838 -1.541 . . . . 73.4 106.838 -167.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -109.19 158.75 17.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.14 -0.937 . . . . 74.35 110.517 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.554 HG12 ' HB2' ' A' ' 129' ' ' ALA . 3.8 mp -87.58 140.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.322 1.049 . . . . 65.11 109.976 -170.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.81 175.67 5.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.164 0.986 . . . . 72.52 110.708 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -64.67 143.56 57.84 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.481 -0.782 . . . . 71.23 110.053 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' G' ' 185' ' ' PRO . 2.5 p . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 118.224 -0.893 . . . . 74.4 110.69 -172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.664 0.269 . . . . 64.22 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -85.41 89.57 7.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.392 0.677 . . . . 71.13 110.52 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.37 116.92 29.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.79 0.836 . . . . 74.24 110.622 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -172.18 153.25 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.186 0.994 . . . . 75.41 110.45 -174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.562 ' ND2' ' HB2' ' C' ' 144' ' ' GLN . 6.1 p30 -160.09 121.23 3.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.044 -1.095 . . . . 63.31 108.044 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -142.04 172.93 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.597 0.759 . . . . 63.31 109.536 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.1 p -81.12 70.42 7.94 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.999 0.904 . . . . 72.22 108.932 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.12 174.22 10.42 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.398 1.079 . . . . 61.22 109.193 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.489 ' HG2' HG23 ' A' ' 89' ' ' ILE . 52.2 mtm 68.24 134.95 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.749 1.22 . . . . 71.53 111.071 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.2 m -146.46 122.0 10.41 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.674 -0.862 . . . . 75.11 108.674 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -126.59 116.57 21.24 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.07 -1.085 . . . . 75.51 108.07 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -137.55 110.66 7.79 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.701 0.8 . . . . 64.04 108.997 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -65.91 125.29 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 171.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -88.55 -33.4 17.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.152 -0.685 . . . . 61.21 109.152 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -172.61 145.31 1.54 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.34 0.4 . . . . 74.42 110.901 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.652 HD12 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -121.81 129.96 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.912 -1.144 . . . . 74.51 107.912 168.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 38.9 p90 -163.6 159.13 21.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.607 0.763 . . . . 74.43 110.751 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -84.92 118.53 24.58 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.354 -0.61 . . . . 74.04 109.354 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HZ1' ' HD3' ' B' ' 29' ' ' PRO . 23.6 mtpp -78.7 -40.64 33.2 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.752 -0.833 . . . . 55.22 108.752 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -136.42 142.17 43.65 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.985 -1.007 . . . . 75.01 110.234 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.492 HG21 ' SD ' ' B' ' 117' ' ' MET . 74.7 mt -139.84 140.72 35.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.56 1.544 . . . . 73.33 107.271 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -154.05 116.18 4.3 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 62.4 109.289 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 69.8 t80 -111.24 122.62 48.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.523 -1.658 . . . . 63.33 106.523 166.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.58 130.85 56.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.645 -0.872 . . . . 72.23 108.645 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.53 79.14 73.86 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.102 -1.814 . . . . 43.54 106.102 165.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.6 -27.25 45.81 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.439 2.093 . . . . 75.12 111.149 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -111.33 31.89 5.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.338 -1.301 . . . . 71.33 109.12 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.76 99.85 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.681 0.993 . . . . 71.21 113.681 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.52 -22.94 17.77 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 121.905 1.737 . . . . 54.33 113.415 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.45 -39.52 70.92 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.188 0.595 . . . . 75.15 111.011 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 73' ' ' ALA . 28.2 m -73.3 -15.64 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.352 0.661 . . . . 72.33 112.045 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' HD1' ' HD2' ' B' ' 15' ' ' ARG . 79.3 t80 -61.94 -38.92 90.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.784 0.834 . . . . 71.13 110.849 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -100.75 -13.26 18.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.239 0.616 . . . . 70.41 112.016 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.7 mmtp -83.29 150.71 25.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 117.977 0.353 . . . . 73.02 111.724 175.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.49 132.19 45.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.099 0.96 . . . . 63.5 109.895 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.537 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -77.63 93.44 4.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.216 0.531 . . . . 62.31 110.162 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' H ' HD22 ' A' ' 68' ' ' LEU . 8.5 tt0 -125.13 82.82 61.4 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.183 1.393 . . . . 75.34 107.745 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.4 114.32 3.77 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.537 2.158 . . . . 53.13 112.852 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -94.74 90.5 6.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.238 -1.764 . . . . 74.03 106.238 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.39 130.53 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.327 -0.851 . . . . 73.2 110.499 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.0 tttm -119.59 115.04 23.18 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.722 -1.214 . . . . 61.21 107.722 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.31 123.95 45.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.829 0.851 . . . . 73.11 109.222 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -118.84 109.21 15.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.989 0.916 . . . . 71.02 109.569 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.77 120.53 40.23 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.604 -0.887 . . . . 71.53 108.604 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -154.46 162.46 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.395 -0.594 . . . . 71.41 109.395 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -134.25 164.05 28.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.158 0.583 . . . . 72.35 110.842 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.79 108.27 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.826 -1.176 . . . . 73.24 107.826 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.8 m -109.9 152.44 25.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.135 0.574 . . . . 72.2 110.339 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.9 t -157.11 142.86 17.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.48 0.712 . . . . 53.02 110.062 -172.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -90.68 118.96 30.53 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.938 -0.764 . . . . 74.23 108.938 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 57' ' ' GLU . 71.3 mt -90.14 -39.64 12.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.086 0.555 . . . . 73.33 110.569 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -162.96 -174.09 3.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.789 0.836 . . . . 75.31 110.415 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.04 120.2 13.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.34 -0.985 . . . . 74.1 108.34 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 69.25 3.48 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.59 1.156 . . . . 41.13 112.811 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 21.2 t -115.32 114.59 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.821 -1.177 . . . . 70.35 107.821 176.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -142.58 133.05 25.02 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.488 -0.93 . . . . 74.15 108.488 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' HD11 ' A' ' 51' ' ' LEU . 75.4 tt0 -114.09 120.14 39.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.737 0.415 . . . . 73.54 110.55 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -100.69 121.81 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.114 -1.81 . . . . 73.42 106.114 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -106.18 134.97 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.975 -0.75 . . . . 72.2 108.975 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.421 HD11 ' HD1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -96.53 114.89 26.59 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.254 -1.017 . . . . 72.25 108.254 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -101.77 99.94 10.23 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.824 -0.806 . . . . 74.42 108.824 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.84 137.69 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 107.795 -1.187 . . . . 71.24 107.795 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.9 m -129.55 124.63 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.624 -0.88 . . . . 73.11 108.624 171.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.37 130.62 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 107.828 -1.175 . . . . 74.53 107.828 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 7.3 m -121.98 148.15 45.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.763 -1.569 . . . . 75.45 106.763 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.07 124.29 14.57 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.967 -1.123 . . . . 72.45 107.967 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 48.5 m -122.4 141.45 51.58 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 123.205 0.602 . . . . 73.11 110.298 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.537 HD21 ' CE3' ' A' ' 36' ' ' TRP . 51.1 mt -90.68 52.6 2.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.335 1.054 . . . . 74.04 109.791 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.14 -85.46 0.91 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.217 -0.901 . . . . 74.12 111.825 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -88.29 -31.09 19.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.443 0.697 . . . . 72.15 111.309 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.96 124.49 46.08 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 118.79 -0.624 . . . . 75.23 109.687 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.6 m -65.97 132.53 48.82 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.274 0.359 . . . . 65.24 110.797 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -75.51 -53.87 7.93 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.0 0.813 . . . . 44.13 109.697 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -164.06 169.77 17.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.583 -1.19 . . . . 74.23 111.304 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 tp -130.21 148.17 52.01 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.985 -1.461 . . . . 73.13 107.444 167.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -142.35 134.55 27.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.127 -1.064 . . . . 70.41 108.127 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -145.93 119.9 9.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.313 -0.995 . . . . 64.14 108.313 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.43 126.76 64.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.082 0.953 . . . . 75.32 109.635 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -104.99 90.15 3.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.044 -0.98 . . . . 74.01 108.781 172.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.408 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.0 tp-100 -76.83 97.64 4.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.929 -1.137 . . . . 64.41 107.929 173.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.82 143.52 20.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.122 -0.791 . . . . 71.25 111.122 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.61 120.87 1.74 Allowed Glycine 0 CA--C 1.495 -1.163 0 N-CA-C 110.304 -1.118 . . . . 71.14 110.304 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -83.96 125.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.791 -1.189 . . . . 75.52 107.791 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.57 118.03 23.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.197 0.999 . . . . 70.41 108.331 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -87.5 100.11 12.53 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.161 -1.422 . . . . 75.22 107.161 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.629 HG21 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -134.07 118.39 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.706 -0.679 . . . . 72.21 110.128 -168.219 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.8 177.67 11.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.727 1.211 . . . . 73.11 109.85 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.58 74.09 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 120.883 0.157 . . . . 43.02 112.958 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.507 HD13 ' HB2' ' A' ' 94' ' ' MET . 1.1 pp -129.45 161.35 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.311 1.444 . . . . 70.33 110.169 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.69 171.18 14.46 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.542 0.737 . . . . 70.44 109.965 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.13 -120.0 2.11 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.387 1.315 . . . . 53.51 116.387 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -76.21 -15.97 59.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.994 0.918 . . . . 63.32 112.695 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.53 -50.86 69.67 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.583 -0.525 . . . . 75.2 109.583 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.507 ' HB2' HD13 ' A' ' 89' ' ' ILE . 14.4 ttt -74.22 -32.71 63.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.114 -0.948 . . . . 65.13 110.756 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.74 92.31 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.123 0.487 . . . . 45.21 111.137 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.01 -37.99 78.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.778 0.831 . . . . 74.34 110.668 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.82 -63.38 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.514 -0.766 . . . . 72.34 110.198 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.629 HD21 HG21 ' A' ' 86' ' ' ILE . 53.8 mt -71.23 -22.78 61.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.251 0.62 . . . . 73.41 111.967 -176.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.6 -28.57 46.89 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.435 0.46 . . . . 71.03 113.887 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.93 -52.38 0.62 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.347 0.573 . . . . 72.24 112.397 -173.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -64.26 -54.42 33.58 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.328 0.651 . . . . 75.54 112.602 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' A' ' 98' ' ' LEU . 52.9 m -65.91 -46.45 64.86 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 123.839 0.856 . . . . 64.04 112.645 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -24.36 50.53 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 121.587 1.525 . . . . 72.44 112.852 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -74.32 -28.76 61.3 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.107 0.412 . . . . 73.34 111.032 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.421 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 19.6 mt -60.75 -43.07 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 121.369 0.604 . . . . 30.22 109.539 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.3 mt -70.53 -19.14 62.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.533 -1.212 . . . . 62.12 112.193 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.421 ' HD1' HD11 ' A' ' 60' ' ' LEU . 49.4 t80 -70.46 -42.49 15.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-O 117.563 -1.208 . . . . 74.44 113.6 -169.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 99.0 Cg_exo -49.43 -35.1 35.06 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.045 1.83 . . . . 55.3 114.022 168.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -84.74 -37.49 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.296 0.638 . . . . 62.55 111.439 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.33 -42.6 79.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.158 0.504 . . . . 71.44 109.984 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -53.37 -57.26 11.22 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.497 1.519 . . . . 75.32 109.909 171.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.35 -36.58 84.61 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.393 1.058 . . . . 62.04 111.671 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.23 -48.79 80.25 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.183 0.593 . . . . 43.12 110.026 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.89 -44.8 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 115.049 -0.978 . . . . 73.51 110.793 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 125' ' ' GLN . 60.2 m -57.55 -40.73 79.54 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.924 0.889 . . . . 74.45 111.116 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 t -69.0 -46.64 67.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.164 -0.925 . . . . 74.21 110.412 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.6 mtp -56.82 -40.69 76.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.764 0.825 . . . . 64.14 111.81 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.5 t -65.19 -46.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.506 1.123 . . . . 71.22 110.719 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -71.34 -26.49 62.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.598 0.359 . . . . 71.01 111.621 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.7 mtt-85 -73.2 -32.57 64.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.73 0.812 . . . . 73.24 110.082 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 4.4 60.25 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.999 -0.546 . . . . 50.03 112.901 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 m 68.07 44.19 1.5 Allowed 'General case' 0 C--N 1.36 1.052 0 CA-C-O 122.721 1.248 . . . . 64.32 110.268 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.9 149.13 50.22 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 114.769 -1.105 . . . . 74.14 108.955 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.29 141.58 93.34 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.087 1.858 . . . . 63.5 110.633 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.493 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -61.41 159.74 12.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.286 1.034 . . . . 61.33 112.448 -168.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.55 102.25 6.29 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 74.33 108.348 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -98.17 94.24 6.69 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.173 -0.676 . . . . 72.32 109.173 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 134.99 57.52 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.63 0.772 . . . . 65.54 110.906 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 139.45 91.74 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.162 0.585 . . . . 53.04 112.176 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.86 97.55 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.461 2.107 . . . . 72.22 109.991 177.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.13 112.76 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.647 -0.872 . . . . 72.02 108.647 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.57 87.84 3.47 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.806 -0.634 . . . . 72.43 110.434 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -66.87 -34.27 77.43 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.611 -0.722 . . . . 70.05 109.259 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 138' ' ' MET . 4.4 p-10 -55.67 -50.55 69.96 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.256 -0.884 . . . . 73.43 110.89 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.36 -37.69 88.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.084 0.553 . . . . 72.5 111.864 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.71 -51.62 68.59 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.006 -0.738 . . . . 75.32 109.006 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 140' ' ' TYR . 61.8 m-85 -76.13 -18.03 59.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.625 0.77 . . . . 72.43 112.778 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 88.4 mmm -61.22 -52.63 63.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.26 0.482 . . . . 73.24 109.919 170.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -73.93 -35.77 64.62 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 116.056 -0.52 . . . . 72.34 111.362 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 137' ' ' PHE . 77.1 t80 -63.6 -42.48 98.25 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.389 1.076 . . . . 74.31 110.906 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.26 -50.01 56.73 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.066 -0.516 . . . . 74.31 110.624 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -165.24 -18.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 112.533 0.568 . . . . 75.04 112.533 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' C' ' 145' ' ' ALA . 0.0 OUTLIER 46.98 84.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.636 0.774 . . . . 71.43 109.468 -172.128 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -169.58 139.86 2.12 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.99 -0.374 . . . . 72.24 109.99 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.18 -178.98 6.11 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.716 0.806 . . . . 71.4 109.85 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.37 144.02 12.26 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.748 -0.941 . . . . 63.34 110.748 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.51 93.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.027 0.931 . . . . 74.53 110.634 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.35 0.58 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.256 -0.883 . . . . 72.42 113.012 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -148.67 161.3 42.02 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.332 0.587 . . . . 71.4 111.29 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.94 -35.21 2.88 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.127 1.371 . . . . 71.2 109.687 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.74 162.0 30.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.139 0.976 . . . . 73.53 112.684 -170.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -142.3 143.03 32.61 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.837 1.255 . . . . 73.32 108.887 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.48 83.1 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.682 0.753 . . . . 75.52 109.453 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.14 83.8 6.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.401 -1.272 . . . . 72.33 109.92 -171.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.032 0.933 . . . . 74.33 109.214 -177.174 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.851 0.358 . . . . 55.25 110.948 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 63.6 p -101.16 21.95 13.14 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.227 0.611 . . . . 65.1 110.356 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.7 142.69 31.08 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.691 0.797 . . . . 65.31 109.722 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.433 ' HG2' ' HB2' ' D' ' 140' ' ' TYR . 2.9 pp0? -89.91 -3.75 57.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.267 0.627 . . . . 74.2 111.745 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -81.48 78.22 8.26 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.778 0.799 . . . . 72.22 109.084 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -143.6 -44.26 0.28 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.162 -0.926 . . . . 71.05 109.545 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m 56.56 69.51 0.73 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.668 1.187 . . . . 75.15 110.911 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.06 178.2 5.01 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.701 -1.136 . . . . 73.21 110.765 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.504 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 8.9 ptm 57.58 171.24 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 127.348 2.259 . . . . 45.53 113.699 -174.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t -162.24 142.51 10.02 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.294 0.637 . . . . 55.31 110.018 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -131.96 113.58 13.58 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.622 -1.251 . . . . 63.13 107.622 172.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 21.2 tp60 -127.87 98.66 5.23 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.388 0.613 . . . . 71.22 109.983 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 tt -78.61 119.68 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 115.393 -0.821 . . . . 72.23 109.733 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.85 -48.35 7.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.049 0.54 . . . . 74.45 110.562 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.466 ' HD2' ' HD1' ' A' ' 32' ' ' PHE . 55.2 ttt180 -165.26 142.91 5.99 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.484 -0.325 . . . . 72.14 110.563 -172.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.2 mt -114.5 142.93 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.449 -1.315 . . . . 65.42 107.449 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -164.83 158.44 17.4 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.031 0.443 . . . . 71.23 110.567 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.46 HG21 HD11 ' B' ' 21' ' ' ILE . 89.5 m -85.62 123.36 30.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.158 -0.682 . . . . 55.41 109.158 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.442 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 30.9 mtpt -88.09 -35.87 17.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.453 -0.794 . . . . 54.13 111.183 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -161.92 147.89 13.49 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.999 0.428 . . . . 63.14 111.013 -173.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.7 mm -142.33 145.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.101 1.76 . . . . 72.14 108.093 -175.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -154.44 148.43 25.69 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.676 0.61 . . . . 73.22 110.217 170.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 88.2 t80 -156.12 107.22 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.166 -1.42 . . . . 74.02 107.166 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.71 118.58 28.41 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.446 0.699 . . . . 72.41 109.793 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -112.12 87.89 9.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.429 1.092 . . . . 70.11 109.821 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 37.5 Cg_endo -63.67 -41.55 24.42 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.65 2.233 . . . . 75.52 113.072 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -106.27 31.51 5.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.58 0.752 . . . . 72.12 110.036 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -48.59 -48.11 69.17 Favored Pre-proline 0 CA--C 1.573 1.855 0 C-N-CA 125.217 1.407 . . . . 75.42 114.698 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HZ1' ' A' ' 19' ' ' LYS . 89.9 Cg_endo -92.66 -5.34 3.27 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.086 1.857 . . . . 54.22 113.087 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -98.4 -0.47 43.58 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.689 0.796 . . . . 64.52 110.814 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.99 -28.02 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.39 1.076 . . . . 71.13 111.089 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -71.23 -18.25 62.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.878 0.871 . . . . 74.25 112.519 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.33 -41.01 79.18 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.396 0.617 . . . . 74.14 109.887 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.519 ' HB2' HD13 ' B' ' 68' ' ' LEU . 81.4 mttt -108.73 106.74 16.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.58 -1.191 . . . . 72.42 108.465 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.44 79.28 1.91 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.74 0.781 . . . . 73.11 110.13 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.584 ' HA ' ' H ' ' F' ' 197' ' ' TYR . 10.0 t-105 -153.52 151.37 29.73 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.996 -1.483 . . . . 71.52 106.996 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -90.64 114.93 62.97 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.507 -1.664 . . . . 70.11 106.507 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.53 131.36 37.72 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.305 2.004 . . . . 63.22 111.978 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 120.41 14.05 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.914 0.759 . . . . 73.53 109.107 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.844 HG12 HD22 ' B' ' 126' ' ' LEU . 2.1 t -86.02 118.74 33.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 106.503 -1.666 . . . . 72.24 106.503 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -138.46 134.92 34.64 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.496 -0.557 . . . . 64.55 109.496 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' B' ' 126' ' ' LEU . 0.7 OUTLIER -128.96 156.63 43.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.248 0.619 . . . . 73.02 112.393 -169.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.19 141.32 48.03 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.932 1.293 . . . . 65.54 108.622 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.458 HD22 HD11 ' F' ' 186' ' ' LEU . 50.2 tp -85.61 136.57 33.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.655 0.782 . . . . 72.43 110.99 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.9 m-20 -129.77 144.27 51.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.988 -1.116 . . . . 74.24 107.988 172.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.9 m -130.18 125.64 35.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.296 0.638 . . . . 72.32 109.968 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -132.23 159.07 40.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.169 0.988 . . . . 63.11 109.11 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 62.1 m -143.01 168.91 18.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.071 0.549 . . . . 73.01 109.98 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.5 t -151.45 164.35 36.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.515 1.126 . . . . 74.12 108.408 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -124.05 124.11 41.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.082 0.553 . . . . 63.01 109.54 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.41 -28.55 16.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.342 0.657 . . . . 64.5 110.783 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.93 -171.48 0.75 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 62.34 111.223 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.48 113.14 4.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.615 -1.175 . . . . 74.21 110.152 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.779 ' H ' HD21 ' F' ' 173' ' ' LEU . 28.3 m-20 75.93 -5.15 2.23 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.773 2.029 . . . . 73.05 112.09 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 51.1 t -104.86 99.73 9.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 108.106 -1.072 . . . . 64.21 108.106 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.91 168.48 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.513 0.673 . . . . 75.34 110.062 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -138.41 100.06 4.01 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.402 -1.703 . . . . 63.31 106.402 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.46 128.82 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.197 0.599 . . . . 63.05 109.739 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 47.1 t -105.37 145.07 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.006 0.922 . . . . 73.04 109.815 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 112.96 18.99 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.443 -1.688 . . . . 75.04 106.443 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 34.0 ttm180 -102.83 130.84 49.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.06 -0.718 . . . . 65.45 109.06 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.489 HG11 HD12 ' B' ' 42' ' ' LEU . 50.7 t -121.14 108.83 23.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 107.218 -1.401 . . . . 71.22 107.218 169.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -98.28 136.79 37.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.167 0.508 . . . . 74.1 109.93 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 89.8 t -122.97 137.98 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.195 1.398 . . . . 71.14 110.705 -169.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 57.4 m -123.9 151.38 43.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.873 1.269 . . . . 71.31 109.038 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.04 146.87 31.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.686 0.795 . . . . 41.23 108.913 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 67.3 p -153.68 158.72 41.47 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 75.04 111.554 -171.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' B' ' 34' ' ' LYS . 72.6 mt -128.27 107.0 9.41 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.581 -1.266 . . . . 61.02 107.581 169.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.8 -110.6 3.21 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 123.422 0.451 . . . . 73.13 112.322 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -110.0 0.25 18.42 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.54 0.736 . . . . 75.24 111.517 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.61 159.19 28.36 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.504 -0.747 . . . . 65.24 111.358 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -73.9 139.08 44.72 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.434 -0.803 . . . . 51.41 110.488 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.96 -53.67 3.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.149 -1.056 . . . . 53.24 108.149 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.524 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 46.0 p90 -156.44 170.16 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.724 -1.125 . . . . 70.24 110.415 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.65 155.14 48.54 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.68 1.592 . . . . 65.22 107.939 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.589 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 54.1 t -152.91 158.67 42.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.125 -0.694 . . . . 73.45 109.125 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -155.76 137.94 14.69 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.723 -1.214 . . . . 74.01 107.723 171.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.0 146.38 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.303 0.641 . . . . 72.22 109.277 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -129.65 99.24 5.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.783 0.833 . . . . 64.12 108.969 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -91.42 106.47 18.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.42 -0.809 . . . . 70.43 109.394 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.92 168.11 21.15 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.839 -0.505 . . . . 62.24 111.839 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.45 129.86 2.11 Favored Glycine 0 C--O 1.236 0.28 0 N-CA-C 111.005 -0.838 . . . . 63.22 111.005 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -85.15 115.65 27.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.604 -0.887 . . . . 61.55 108.604 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.89 131.76 52.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.526 -0.916 . . . . 75.21 108.526 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -107.71 106.9 17.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.329 -0.989 . . . . 51.53 108.329 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -128.35 144.8 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.797 0.839 . . . . 75.42 111.277 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.73 171.92 19.43 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.348 1.059 . . . . 74.53 109.183 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.68 -48.33 2.06 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.368 -0.378 . . . . 73.11 112.733 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 163.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.533 0.733 . . . . 63.35 110.177 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 158.11 21.19 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.732 0.413 . . . . 45.04 111.529 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -113.72 5.45 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.858 0.724 . . . . 63.51 114.298 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.4 m -66.08 -38.29 87.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.318 1.047 . . . . 64.14 110.471 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.66 -31.32 66.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.674 -1.148 . . . . 75.12 110.002 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.5 tpt -70.39 -43.19 70.6 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.942 0.897 . . . . 63.45 109.945 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.63 67.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.196 -0.911 . . . . 72.32 111.278 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -83.51 -29.19 28.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.802 0.841 . . . . 70.43 110.561 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -68.98 -61.96 1.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.285 0.634 . . . . 54.23 110.789 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.73 -12.66 25.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.828 0.677 . . . . 73.23 112.828 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.68 1.42 42.19 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-O 119.92 -0.378 . . . . 52.12 113.66 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.1 -58.27 0.31 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.173 0.486 . . . . 53.42 111.114 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.409 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 52.7 t80 -74.66 -45.32 45.47 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.106 -0.497 . . . . 63.53 111.798 -172.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.558 ' HA ' HD12 ' B' ' 105' ' ' ILE . 99.8 m -63.64 -46.26 82.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.422 -0.799 . . . . 71.41 111.734 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.58 -39.19 92.47 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.777 1.651 . . . . 73.53 113.226 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.22 -30.54 71.66 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 123.014 0.525 . . . . 70.25 111.83 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' B' ' 102' ' ' CYS . 96.7 mt -64.43 -47.46 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.389 1.076 . . . . 73.05 110.41 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 mt -81.6 -12.62 58.67 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.345 -1.298 . . . . 60.33 111.384 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.471 ' HE2' ' HA ' ' B' ' 130' ' ' PRO . 26.1 t80 -63.29 -49.94 77.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.944 1.298 . . . . 72.2 113.084 -170.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.2 -33.25 95.0 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.867 1.711 . . . . 74.43 113.073 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 81.7 m-85 -66.11 -48.26 71.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.023 0.529 . . . . 71.22 110.837 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -40.88 97.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.954 0.902 . . . . 72.51 110.961 177.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.452 ' HE ' ' HB2' ' B' ' 127' ' ' ASN . 81.4 mtp180 -55.57 -52.61 63.17 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.317 1.047 . . . . 54.3 110.454 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.31 -39.83 92.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.197 -0.91 . . . . 65.41 111.33 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.6 t -70.74 -43.43 68.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.871 -0.604 . . . . 70.04 111.559 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.474 HD11 ' HB ' ' B' ' 62' ' ' VAL . 95.5 mt -63.11 -46.78 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 122.815 0.446 . . . . 74.22 110.474 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.409 HG21 ' CB ' ' C' ' 119' ' ' SER . 22.6 m -52.24 -41.18 62.57 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.81 0.693 . . . . 74.24 111.092 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.9 t -62.7 -53.92 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.927 -0.578 . . . . 71.52 110.383 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 21' ' ' ILE . 36.8 mmt -59.49 -44.58 93.04 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.208 0.603 . . . . 62.44 111.76 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.04 -40.47 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.513 1.125 . . . . 70.54 111.235 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 94.3 p -70.52 -31.91 69.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.422 -0.354 . . . . 53.31 110.834 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.1 mtt-85 -63.12 -27.73 69.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.321 0.648 . . . . 65.04 111.063 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.13 10.55 63.02 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 123.632 0.582 . . . . 52.33 113.059 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.2 p 64.62 44.06 4.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.749 2.019 . . . . 65.43 112.377 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.54 161.87 35.32 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.385 0.674 . . . . 73.34 110.908 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.49 ' HA ' ' OE1' ' C' ' 125' ' ' GLN . 32.1 Cg_exo -62.25 172.89 3.73 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.496 2.797 . . . . 65.13 114.326 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.691 ' HB3' ' HG3' ' C' ' 125' ' ' GLN . 12.9 pm0 -64.57 154.99 34.55 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 115.28 -0.873 . . . . 74.53 111.841 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.844 HD22 HG12 ' B' ' 40' ' ' VAL . 23.0 tp -142.48 83.98 1.84 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.477 -0.935 . . . . 63.51 108.477 165.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.452 ' HB2' ' HE ' ' B' ' 111' ' ' ARG . 6.2 p30 -115.84 106.31 13.69 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.037 -1.468 . . . . 74.24 107.037 170.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.634 ' HB2' HD11 ' B' ' 42' ' ' LEU . 4.0 tt -55.26 136.53 48.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.724 -1.125 . . . . 73.51 109.336 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -50.93 140.17 21.07 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 124.034 0.834 . . . . 52.34 110.985 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' D' ' 16' ' ' ILE . 25.8 Cg_exo -65.13 71.62 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.15 2.567 . . . . 74.53 113.242 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.62 85.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.298 -1.001 . . . . 63.52 108.298 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.496 ' ND2' HG23 ' D' ' 105' ' ' ILE . 2.1 m-20 -78.38 113.11 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.541 -0.911 . . . . 61.04 108.541 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.519 ' HZ ' ' HB2' ' F' ' 182' ' ' PHE . 74.0 t80 -55.64 -32.16 62.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.963 0.905 . . . . 75.54 110.709 175.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' B' ' 138' ' ' MET . 6.3 m-20 -56.78 -28.75 61.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.391 1.477 . . . . 74.4 112.155 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.55 71.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.617 0.767 . . . . 74.5 111.16 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.88 -46.34 85.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.248 1.019 . . . . 53.23 109.609 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.57 -32.68 71.75 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.891 -1.504 . . . . 73.43 111.186 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.518 ' O ' ' HG2' ' B' ' 142' ' ' GLN . 94.7 mmm -67.7 -36.29 80.36 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.772 0.429 . . . . 75.03 111.662 177.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -74.78 -38.03 62.26 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.643 0.377 . . . . 72.02 111.413 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -73.21 -41.59 63.61 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.789 -0.641 . . . . 75.01 110.7 -176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.16 19.38 5.88 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.085 0.772 . . . . 75.33 113.085 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' B' ' 138' ' ' MET . 11.6 pt20 -162.32 175.64 11.38 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.101 0.477 . . . . 54.13 111.468 168.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -147.36 -58.16 0.26 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.361 1.064 . . . . 70.44 108.575 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -80.82 -75.31 0.28 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.007 -0.997 . . . . 70.14 109.767 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 51.14 80.3 0.08 Allowed 'General case' 0 C--N 1.358 0.939 0 C-N-CA 124.737 1.215 . . . . 75.2 111.786 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' D' ' 90' ' ' GLU . . . -136.25 -84.68 0.17 Allowed Glycine 0 C--O 1.244 0.732 0 CA-C-N 115.327 -0.851 . . . . 64.32 111.33 -175.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 53.7 39.39 30.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.341 1.056 . . . . 72.4 110.809 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.99 118.43 12.1 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.946 -1.025 . . . . 31.24 112.088 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -59.39 107.61 0.59 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.568 1.147 . . . . 74.14 110.897 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 146.93 51.43 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.007 -0.738 . . . . 72.21 109.007 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 80.03 137.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 73.33 110.955 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -153.86 130.2 10.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.256 1.022 . . . . 64.23 108.848 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -129.01 110.09 11.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.071 0.948 . . . . 73.21 109.613 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -164.38 152.96 12.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.321 1.048 . . . . 73.3 109.649 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 124.937 1.295 . . . . 65.13 110.587 -175.237 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.44 ' HB2' ' HD1' ' G' ' 182' ' ' PHE . 1.2 mpt? . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.236 -0.653 . . . . 73.23 109.236 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 30.7 p -157.23 132.23 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.881 0.872 . . . . 74.22 109.402 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -122.53 8.15 9.55 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.244 0.545 . . . . 73.15 110.707 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -148.58 105.43 3.59 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 70.5 109.612 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -92.39 127.01 37.72 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.639 -1.245 . . . . 54.44 107.639 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.99 110.65 22.53 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.193 -0.669 . . . . 72.13 109.193 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -92.96 96.95 10.42 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.103 -0.703 . . . . 73.32 109.103 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.63 115.02 8.45 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.235 -1.024 . . . . 70.41 108.235 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.468 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.5 ttp 62.45 111.42 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.407 1.083 . . . . 73.5 110.979 -172.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -105.37 114.15 28.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.875 0.87 . . . . 75.15 109.109 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 72.8 t80 -96.36 131.94 42.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.611 -0.885 . . . . 75.11 108.611 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -139.83 124.4 18.19 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.147 0.579 . . . . 63.31 109.878 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -93.35 133.24 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.535 0.734 . . . . 73.01 109.262 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -105.17 -45.96 4.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.618 0.767 . . . . 71.03 110.371 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -167.81 124.35 1.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.999 -0.371 . . . . 73.3 109.999 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.22 135.45 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.552 -0.907 . . . . 75.11 108.552 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 27.3 p90 -173.45 163.13 4.39 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.176 0.59 . . . . 65.34 109.804 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -85.78 124.28 32.1 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.812 0.445 . . . . 71.42 110.374 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.601 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.2 mmtp -78.1 -49.95 12.94 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.869 0.842 . . . . 53.01 108.977 170.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -135.41 142.47 45.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.989 -1.459 . . . . 72.51 109.38 -169.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.4 mt -143.99 146.13 21.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.714 -1.587 . . . . 63.14 106.714 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -159.7 149.75 18.65 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.266 0.555 . . . . 55.25 110.42 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -142.65 116.5 9.3 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.614 -1.254 . . . . 75.55 107.614 171.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.57 126.21 52.97 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.847 0.859 . . . . 75.14 109.725 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 81.32 70.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 107.998 -1.112 . . . . 65.23 107.998 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.22 -25.74 42.75 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.131 2.554 . . . . 72.13 112.194 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.25 26.72 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.985 0.914 . . . . 71.22 110.44 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.479 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -46.16 -53.5 22.09 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.161 1.171 . . . . 44.43 114.161 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 59.9 Cg_endo -81.33 -18.74 8.29 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 121.566 1.511 . . . . 74.52 113.824 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.57 -49.26 42.24 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.303 0.641 . . . . 64.41 111.472 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -77.83 -13.37 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.802 1.241 . . . . 74.32 111.4 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.563 ' HE2' ' HD3' ' D' ' 15' ' ' ARG . 79.3 t80 -53.93 -43.06 69.46 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.322 1.049 . . . . 63.43 112.24 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -103.94 27.59 7.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.637 0.732 . . . . 71.14 110.046 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.11 165.18 11.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.404 0.682 . . . . 72.43 109.411 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.35 120.55 24.54 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.99 -0.744 . . . . 64.22 108.99 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -85.56 88.96 7.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.585 0.754 . . . . 71.24 110.688 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.457 ' H ' HD22 ' C' ' 68' ' ' LEU . 35.0 tt0 -128.75 74.32 80.69 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 107.768 -1.197 . . . . 75.24 107.768 169.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.82 143.21 4.18 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.503 2.802 . . . . 64.41 113.404 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.89 115.38 25.31 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.251 -1.018 . . . . 74.33 108.251 167.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.476 HG11 HD21 ' C' ' 128' ' ' LEU . 26.1 t -83.32 85.42 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.05 -0.722 . . . . 73.55 109.05 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -93.87 100.94 13.02 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.746 -1.205 . . . . 70.24 107.746 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.469 HD11 HD12 ' E' ' 186' ' ' LEU . 4.2 pp -90.27 154.53 19.65 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.144 -0.688 . . . . 74.54 109.144 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -120.9 145.33 47.77 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.437 1.095 . . . . 74.44 108.19 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.5 tp -117.73 134.45 54.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.749 0.82 . . . . 70.23 108.861 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.15 150.08 27.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.222 -1.029 . . . . 71.33 108.222 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 91.6 m -137.95 123.97 20.23 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.096 -0.705 . . . . 75.41 109.096 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.98 23.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.287 1.035 . . . . 54.21 108.497 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 p -145.27 144.37 30.74 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.748 0.419 . . . . 64.3 110.455 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -145.1 129.77 18.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.919 0.888 . . . . 72.11 109.109 -176.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -76.95 131.86 38.73 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.527 -0.546 . . . . 64.01 109.527 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.594 HD11 HD12 ' C' ' 83' ' ' ILE . 35.4 mt -106.46 -42.71 4.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.681 . . . . 63.53 109.568 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.78 -177.11 5.41 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.45 -1.25 . . . . 73.24 109.138 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.99 109.08 6.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.053 -0.522 . . . . 73.24 109.935 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.86 18.04 11.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.039 1.336 . . . . 75.21 112.222 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 48.1 t -121.93 114.48 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.66 -1.608 . . . . 74.11 106.66 169.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.433 ' HE2' HG12 ' C' ' 86' ' ' ILE . 43.6 p90 -134.64 -178.74 5.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.656 0.741 . . . . 64.34 110.95 -174.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' C' ' 51' ' ' LEU . 23.9 tt0 -126.34 113.24 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.877 -1.511 . . . . 74.13 108.904 -170.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.9 129.52 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.219 -1.03 . . . . 65.04 108.219 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.1 106.36 16.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.486 -1.302 . . . . 64.53 107.486 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.1 OUTLIER -86.13 103.09 14.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.066 -1.087 . . . . 71.01 108.066 -177.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -84.83 106.11 16.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.768 0.827 . . . . 72.24 109.349 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.84 130.73 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.313 -0.995 . . . . 54.53 108.313 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 5.8 m -116.8 148.31 41.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.041 -1.096 . . . . 64.43 108.041 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.702 HG21 HG21 ' C' ' 114' ' ' ILE . 46.1 t -132.91 110.43 15.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.872 -1.159 . . . . 62.13 107.872 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m -102.57 139.02 38.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.0 -0.741 . . . . 74.4 109.0 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.53 112.75 15.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.513 -1.291 . . . . 65.1 107.513 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -129.82 130.03 44.78 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.346 0.404 . . . . 55.43 110.256 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.457 HD22 ' H ' ' C' ' 37' ' ' GLN . 41.7 mt -87.29 27.88 1.01 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.961 1.304 . . . . 74.44 110.906 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.22 -103.1 1.92 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.933 -0.867 . . . . 62.53 110.933 -171.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.69 -29.37 18.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.979 0.512 . . . . 63.03 110.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.82 121.12 22.92 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.977 0.911 . . . . 72.02 110.146 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.2 m -80.81 124.76 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.789 -0.819 . . . . 74.13 108.789 166.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.69 -51.16 9.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.405 -0.816 . . . . 73.22 109.973 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -166.53 176.45 7.31 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.263 -0.881 . . . . 74.12 110.729 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -143.4 141.4 30.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.906 -1.516 . . . . 73.34 106.906 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.506 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -147.4 125.4 12.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.864 0.465 . . . . 73.35 109.896 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -129.66 133.55 47.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.878 0.471 . . . . 64.33 110.122 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.51 137.83 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.024 0.93 . . . . 74.42 108.56 168.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -112.15 102.09 10.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.294 1.037 . . . . 73.23 108.665 171.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -86.93 108.98 19.04 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.452 -0.794 . . . . 75.02 110.251 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 150.21 25.76 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 123.232 0.332 . . . . 50.4 112.305 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.36 119.33 0.93 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.31 -0.716 . . . . 75.2 111.31 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.594 HD12 HD11 ' C' ' 51' ' ' LEU . 11.7 mm -84.82 124.66 40.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.52 -0.918 . . . . 64.12 108.52 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -132.12 126.35 33.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.656 0.782 . . . . 75.25 110.014 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -96.08 134.98 38.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.912 -1.144 . . . . 35.51 107.912 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.452 HD13 HG12 ' C' ' 89' ' ' ILE . 2.7 pp -131.87 162.65 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.536 0.684 . . . . 43.44 111.911 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.92 29.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.29 -1.323 . . . . 34.31 108.096 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.36 49.17 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.528 -1.151 . . . . 72.41 114.991 173.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.456 ' O ' HG13 ' C' ' 89' ' ' ILE . 36.5 pt -62.1 98.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-N 118.489 1.144 . . . . 70.55 110.753 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.506 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 41.3 mt-10 -145.35 160.17 41.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.12 0.968 . . . . 74.41 109.294 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -115.07 7.51 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.844 0.715 . . . . 75.34 112.451 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 60.6 p -75.86 -36.35 59.62 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.376 0.67 . . . . 72.22 110.57 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.91 -32.77 69.85 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.92 0.888 . . . . 65.23 112.652 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 5.5 ptm -82.74 5.88 19.94 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.307 0.643 . . . . 71.44 112.149 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.15 -21.38 2.64 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 72.32 110.929 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.549 1.14 . . . . 64.04 110.207 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.468 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 43.7 t -72.18 -60.46 2.22 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.224 0.61 . . . . 74.25 111.008 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.434 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.3 pp -75.01 -14.47 60.61 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.003 0.521 . . . . 62.01 112.392 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.63 6.96 68.02 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.933 -0.37 . . . . 55.21 113.246 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.16 -63.54 0.11 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.082 0.441 . . . . 74.34 111.607 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -69.75 -50.79 40.04 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.984 0.913 . . . . 74.31 112.639 -169.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.466 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -59.7 -47.14 98.22 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 118.7 -0.667 . . . . 61.21 112.314 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 33.2 Cg_exo -63.56 -34.73 63.1 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.858 1.705 . . . . 71.53 113.28 171.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -69.69 -22.07 63.45 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.718 0.407 . . . . 65.43 111.314 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -69.35 -41.43 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.215 0.606 . . . . 70.13 109.965 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.1 mt -78.2 -20.15 52.43 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.911 -1.041 . . . . 73.4 111.366 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -57.79 -51.56 80.84 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 113.855 1.057 . . . . 74.44 113.855 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.48 -34.94 99.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.851 1.7 . . . . 75.11 112.606 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.45 -43.32 77.3 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.32 0.648 . . . . 73.13 111.243 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.65 91.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.634 0.773 . . . . 70.45 110.48 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.22 -58.98 6.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.843 1.657 . . . . 75.24 110.615 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -33.2 73.88 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.392 0.433 . . . . 71.54 110.65 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -63.05 -33.34 75.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.147 0.579 . . . . 74.5 111.559 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.702 HG21 HG21 ' C' ' 64' ' ' VAL . 91.4 mt -75.04 -47.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 63.31 109.98 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -28.5 67.2 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 115.252 -0.885 . . . . 31.24 111.183 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.1 t -70.74 -50.43 36.27 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.321 -0.854 . . . . 73.11 110.155 170.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.547 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.98 -38.47 73.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.112 0.965 . . . . 71.22 113.323 -175.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.92 -36.27 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.337 -0.392 . . . . 72.2 110.604 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.409 ' CB ' HG21 ' B' ' 115' ' ' THR . 39.6 p -76.36 -22.08 55.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.797 0.439 . . . . 71.12 111.298 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.463 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 82.8 mtt-85 -68.39 -36.39 79.09 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 73.05 109.512 171.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.8 3.51 49.84 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.084 -0.962 . . . . 54.31 112.604 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.443 HG23 ' HB3' ' D' ' 17' ' ' TYR . 67.9 p 56.22 21.36 5.22 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 126.765 2.026 . . . . 72.41 112.321 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -97.84 161.24 26.36 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.516 1.126 . . . . 74.22 108.865 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.05 107.99 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.674 2.25 . . . . 72.42 111.734 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.62 155.97 17.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.846 0.716 . . . . 72.22 112.067 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -117.11 91.94 3.72 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.394 -0.965 . . . . 62.43 108.394 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -90.73 88.98 7.3 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.995 -1.483 . . . . 72.51 106.995 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.476 HD21 HG11 ' C' ' 40' ' ' VAL . 48.7 mt -79.55 142.66 35.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.52 -1.218 . . . . 52.32 112.093 -164.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.43 96.72 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.924 -1.034 . . . . 63.11 111.116 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.652 ' HG3' HD12 ' A' ' 16' ' ' ILE . 86.2 Cg_endo -75.26 -171.9 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.81 2.34 . . . . 73.33 113.875 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.456 HG21 ' NE1' ' E' ' 184' ' ' TRP . 2.6 m -140.72 117.15 7.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 114.185 -1.371 . . . . 44.51 107.412 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.41 65.72 9.33 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.246 0.546 . . . . 71.41 109.656 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.423 ' CD1' ' HB3' ' E' ' 184' ' ' TRP . 59.4 t80 -66.43 -35.39 80.19 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.565 -0.902 . . . . 64.52 108.565 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' C' ' 138' ' ' MET . 4.1 p-10 -51.41 -59.85 3.79 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.53 1.144 . . . . 63.31 110.917 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.74 76.2 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.766 0.827 . . . . 71.51 112.173 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.9 tt -74.84 -41.17 60.39 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.475 0.71 . . . . 73.34 110.929 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -82.17 -25.64 34.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.077 0.951 . . . . 74.32 112.166 -169.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' C' ' 134' ' ' ASP . 23.9 mmt -71.86 -41.88 67.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.582 0.353 . . . . 72.33 110.581 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.77 -32.58 67.81 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 122.53 0.332 . . . . 73.25 110.577 177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.446 ' HD2' ' H ' ' C' ' 141' ' ' LEU . 0.3 OUTLIER -67.92 -155.99 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.819 1.248 . . . . 60.3 110.941 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.446 ' H ' ' HD2' ' C' ' 140' ' ' TYR . 91.7 mt 64.56 -75.1 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.983 1.313 . . . . 72.14 112.718 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.65 154.24 41.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.992 0.917 . . . . 75.44 109.083 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -116.01 154.34 30.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.633 1.173 . . . . 65.23 108.667 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.562 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 57.4 tp60 68.04 134.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.765 1.226 . . . . 73.44 113.006 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -159.08 166.72 30.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.334 0.654 . . . . 54.4 110.351 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.98 2.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.713 -0.676 . . . . 74.2 112.514 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.52 -155.15 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 106.725 -1.583 . . . . 64.33 106.725 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.9 98.22 2.03 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.722 -0.551 . . . . 73.54 111.722 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 46.1 p -75.92 166.95 22.76 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.514 0.726 . . . . 74.25 110.635 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.95 162.06 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.619 0.767 . . . . 60.34 109.883 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.13 -101.21 0.07 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.853 0.861 . . . . 63.34 109.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 m80 58.55 76.51 0.34 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.096 1.358 . . . . 74.5 112.523 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -124.57 111.95 16.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.595 -0.891 . . . . 74.1 108.595 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -89.39 145.21 25.49 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.515 0.726 . . . . 63.11 110.164 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.078 0 C-N-CA 123.283 0.633 . . . . 71.52 110.479 178.185 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.535 -0.542 . . . . 53.02 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 2' ' ' SER . . . . . 0.557 ' HB2' ' HG2' ' E' ' 201' ' ' LYS . 25.7 t -63.52 101.91 0.38 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.277 0.631 . . . . 71.2 109.966 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.64 -62.77 1.57 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.503 0.721 . . . . 75.41 110.605 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -106.32 153.13 22.63 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.909 0.884 . . . . 72.34 110.106 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -114.33 -161.09 0.75 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.587 0.755 . . . . 75.04 110.435 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -54.94 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.638 1.175 . . . . 52.14 110.657 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -104.51 -56.17 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.994 -0.743 . . . . 72.3 108.994 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.21 -140.64 0.25 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.312 . . . . 73.11 107.889 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.488 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 11.5 tpt -30.6 125.14 0.18 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.503 1.521 . . . . 74.02 113.568 170.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.1 m -148.62 139.79 23.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.582 1.153 . . . . 74.24 109.685 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.435 ' HD2' HG22 ' D' ' 86' ' ' ILE . 71.1 t80 -158.81 91.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.443 -1.317 . . . . 61.21 107.443 170.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.4 mt-30 -111.89 136.22 51.48 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.263 0.625 . . . . 75.51 109.707 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.49 HG22 HG21 ' E' ' 207' ' ' VAL . 0.0 OUTLIER -91.3 131.92 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.02 -1.104 . . . . 71.54 108.02 171.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -106.29 -49.0 3.44 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.718 0.407 . . . . 51.41 111.456 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.563 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 62.2 ttt180 -178.46 134.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 122.262 0.225 . . . . 53.54 111.282 -174.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.521 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 3.0 mp -123.23 130.07 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.742 -1.207 . . . . 73.4 107.742 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.443 ' HB3' HG23 ' C' ' 122' ' ' THR . 47.1 p90 -156.31 163.63 39.29 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 123.728 0.643 . . . . 75.2 111.842 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.02 110.11 10.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.736 -1.12 . . . . 74.13 109.634 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.479 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 46.0 mtpt -77.57 -32.81 54.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.86 -0.609 . . . . 73.24 109.734 172.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.744 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -146.4 138.41 24.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.79 -1.095 . . . . 43.15 109.718 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.547 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.2 mt -137.15 147.75 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.528 1.131 . . . . 65.31 108.411 171.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -147.63 143.75 27.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.878 0.871 . . . . 63.4 108.668 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.3 t80 -147.54 124.98 11.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.919 -1.882 . . . . 74.41 105.919 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.61 142.01 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.735 0.814 . . . . 52.13 108.817 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -135.46 77.65 52.75 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 107.431 -1.322 . . . . 71.13 107.431 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.38 -28.89 17.54 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.748 2.299 . . . . 64.21 112.36 -172.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 50.8 m-20 -114.46 28.66 8.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.424 1.089 . . . . 65.13 109.338 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.554 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.25 -47.96 95.32 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.714 1.746 . . . . 33.42 115.714 -170.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 61.1 Cg_endo -80.94 -15.47 10.54 Favored 'Trans proline' 0 C--N 1.379 2.149 0 CA-C-N 122.021 1.757 . . . . 72.33 112.138 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 1.1 t60 -68.41 -32.07 71.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.93 0.892 . . . . 65.33 108.918 167.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' D' ' 28' ' ' ALA . 12.9 t -68.08 -23.33 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.265 1.026 . . . . 73.44 111.499 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -55.66 -32.92 63.63 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 122.677 0.391 . . . . 74.03 111.67 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -73.85 -27.56 61.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.572 0.749 . . . . 74.01 111.42 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -97.12 111.21 23.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.839 0.856 . . . . 70.1 111.704 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' H' ' 197' ' ' TYR . 7.9 p-10 -108.02 52.32 0.72 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.947 1.299 . . . . 71.43 111.148 -176.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -126.01 165.34 18.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.713 0.805 . . . . 62.13 108.94 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.56 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 59.4 tp60 -81.61 122.05 80.27 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.641 -0.503 . . . . 75.43 109.641 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.58 126.21 18.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.691 2.261 . . . . 70.32 112.013 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.85 119.71 12.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.411 0.684 . . . . 74.54 109.206 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.8 107.19 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.22 0.608 . . . . 61.43 109.669 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 46.9 mmtm -98.82 114.46 27.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.425 0.69 . . . . 74.24 109.28 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.72 131.59 43.26 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.215 -0.661 . . . . 64.21 109.215 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.63 123.18 42.18 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.626 -1.25 . . . . 61.34 107.626 171.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -95.42 130.24 42.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.038 0.535 . . . . 61.52 109.893 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.8 t70 -138.35 150.43 46.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.433 -1.321 . . . . 55.0 107.433 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -145.31 157.11 44.12 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.271 -0.64 . . . . 71.03 109.271 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.01 167.57 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.062 0.945 . . . . 70.12 108.835 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.2 p -164.92 155.91 14.57 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.058 0.543 . . . . 73.13 110.571 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 19.5 p -164.55 132.29 3.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.04 0.936 . . . . 70.21 109.4 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.46 131.59 45.54 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.078 0.551 . . . . 73.31 111.309 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' D' ' 57' ' ' GLU . 64.7 mt -103.65 -37.72 7.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.632 0.773 . . . . 72.05 110.93 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -158.43 -167.54 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.356 0.662 . . . . 21.21 110.929 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -70.87 112.93 7.43 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.25 -0.887 . . . . 53.11 110.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.41 ' HA ' HD23 ' H' ' 173' ' ' LEU . 28.9 m-20 70.76 -2.62 2.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.579 1.552 . . . . 64.25 112.313 -176.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 82.5 t -109.88 133.43 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.204 1.002 . . . . 73.44 109.434 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.03 154.08 36.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 74.31 109.306 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.1 tt0 -92.2 134.87 34.47 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.801 0.841 . . . . 65.22 109.346 176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.86 124.3 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.832 -1.173 . . . . 64.21 107.832 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.7 t -105.82 138.55 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.201 0.601 . . . . 65.22 109.448 175.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -113.11 123.85 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.948 -1.13 . . . . 54.21 107.948 176.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.6 ttm-85 -106.64 103.65 13.15 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.813 -0.81 . . . . 75.4 108.813 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.02 123.07 52.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.756 -0.831 . . . . 71.24 108.756 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -114.6 139.14 49.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.538 0.735 . . . . 60.11 109.599 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.478 HG21 HG21 ' D' ' 114' ' ' ILE . 50.8 t -131.67 100.6 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.804 1.242 . . . . 60.13 108.376 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.7 m -95.02 94.05 7.75 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.16 -1.422 . . . . 73.23 107.16 170.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.06 134.2 40.72 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.577 -0.897 . . . . 51.12 108.577 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.453 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 16.6 p -148.57 129.88 14.69 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.074 0.464 . . . . 62.22 111.524 -170.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 41.5 mt -95.16 104.71 16.6 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.569 1.147 . . . . 73.0 110.867 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.15 -110.91 3.6 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.556 0.535 . . . . 74.21 112.523 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.22 7.26 35.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 63.42 111.632 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.38 150.15 48.77 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.212 0.605 . . . . 54.33 110.326 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -73.22 132.55 43.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.27 0.628 . . . . 73.1 110.362 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -86.98 -57.68 2.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.547 0.739 . . . . 70.14 109.192 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.81 152.89 14.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.801 -1.091 . . . . 63.03 110.245 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -117.52 120.4 37.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.282 1.033 . . . . 63.23 108.788 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.5 t -133.07 142.0 48.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.415 0.686 . . . . 71.51 110.004 -175.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -156.5 129.65 7.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.916 0.486 . . . . 63.42 110.257 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.49 HG22 HG23 ' D' ' 21' ' ' ILE . 84.8 t -128.37 122.72 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.989 0.916 . . . . 62.31 110.051 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.744 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -93.01 87.55 5.8 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.673 0.749 . . . . 74.51 109.531 169.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.425 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.3 tp-100 -80.27 96.62 6.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.19 -1.368 . . . . 61.33 108.954 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.92 157.76 29.92 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.812 -0.515 . . . . 63.53 111.812 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 138.44 5.45 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.946 -0.462 . . . . 74.23 111.946 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.0 mt -91.85 132.97 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 123.762 0.825 . . . . 61.03 109.941 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.1 150.1 52.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.499 0.72 . . . . 72.33 110.602 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.7 m -116.55 101.34 8.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.315 1.046 . . . . 63.22 109.248 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.463 ' HB ' HD11 ' D' ' 89' ' ' ILE . 39.2 pt -109.33 132.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.031 0.443 . . . . 74.12 110.747 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.98 165.77 26.97 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.971 0.909 . . . . 61.02 109.469 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.738 ' H ' ' HB3' ' H' ' 172' ' ' ALA . . . 81.78 -21.6 6.45 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 114.198 0.439 . . . . 71.45 114.198 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.485 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -107.01 169.37 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.272 1.029 . . . . 75.35 109.308 175.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.509 ' O ' ' HA2' ' B' ' 146' ' ' GLY . 1.1 pp20? -170.78 -168.63 0.69 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 71.35 110.895 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.65 -141.9 29.2 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.243 -0.435 . . . . 35.13 113.837 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.9 m -82.68 -25.67 32.79 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.383 0.673 . . . . 74.44 111.339 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -63.46 -48.88 75.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.011 0.524 . . . . 70.42 109.788 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -66.06 -31.77 72.84 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.426 0.454 . . . . 70.24 110.95 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.77 98.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.202 0.601 . . . . 74.15 111.212 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.522 ' HE1' ' HA ' ' D' ' 134' ' ' ASP . 8.9 t-160 -79.22 -37.71 37.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.432 -0.349 . . . . 74.45 110.224 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.87 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.322 0.649 . . . . 30.0 111.481 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.534 HD22 HD13 ' H' ' 177' ' ' LEU . 5.2 tt -75.78 -50.68 14.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.763 0.825 . . . . 74.03 109.042 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.01 14.1 65.08 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.868 -0.605 . . . . 61.02 114.398 -170.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -56.67 0.2 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.548 0.674 . . . . 43.12 111.618 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -72.09 -43.24 65.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.695 0.628 . . . . 72.53 112.695 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 98.8 m -63.37 -46.41 84.71 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 118.747 -0.644 . . . . 51.45 111.084 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.0 Cg_exo -58.82 -31.52 95.39 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 122.608 2.205 . . . . 64.54 114.013 166.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -65.86 -34.94 79.3 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.149 0.58 . . . . 74.21 110.757 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.496 HG23 ' ND2' ' B' ' 132' ' ' ASN . 37.3 mm -63.48 -39.76 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.382 0.673 . . . . 73.53 110.29 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.425 HD13 ' O ' ' D' ' 80' ' ' GLN . 84.5 mt -74.24 -21.24 59.86 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.374 -0.83 . . . . 74.23 111.672 -175.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -67.9 -40.72 24.64 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 114.584 1.327 . . . . 65.22 114.584 -168.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.412 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 98.2 Cg_exo -49.72 -38.54 46.57 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 121.982 1.788 . . . . 71.25 113.586 170.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -83.87 -29.81 26.93 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.74 -1.118 . . . . 71.13 110.834 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.79 -49.73 64.9 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.31 0.644 . . . . 74.11 110.346 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.1 ttp-105 -50.98 -56.61 11.62 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.809 1.318 . . . . 71.52 110.273 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.97 -44.39 94.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.619 1.2 . . . . 64.04 111.595 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.463 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 40.8 t -56.3 -44.03 79.48 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.88 0.738 . . . . 63.42 111.075 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.478 HG21 HG21 ' D' ' 64' ' ' VAL . 74.2 mt -67.85 -53.28 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.883 . . . . 74.14 110.382 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -51.56 -43.64 62.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.071 1.348 . . . . 60.13 112.265 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.9 t -69.71 -41.56 75.2 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.149 -0.932 . . . . 74.5 110.525 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.5 mtm -64.36 -35.1 79.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.028 0.531 . . . . 65.23 111.534 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.3 t -61.53 -48.15 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.221 -0.9 . . . . 54.32 110.319 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.7 p -73.98 -23.02 59.41 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.079 -0.51 . . . . 70.12 111.604 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -73.97 -36.28 64.55 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.726 0.81 . . . . 74.25 110.235 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 2.48 71.66 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.714 0.634 . . . . 71.4 112.07 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 62.29 30.76 17.56 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.85 2.06 . . . . 71.31 112.45 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -88.92 168.64 15.07 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 125.232 1.413 . . . . 75.34 108.077 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.36 153.89 27.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.706 1.604 . . . . 54.24 110.884 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.48 132.31 47.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.174 0.19 . . . . 71.41 110.816 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.76 113.03 22.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.735 -0.839 . . . . 70.45 108.735 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.35 88.85 4.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.795 -1.187 . . . . 63.55 107.795 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.53 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 75.9 mt -63.56 114.56 4.01 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.568 -0.742 . . . . 55.53 109.425 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.55 137.92 89.45 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.215 0.82 . . . . 73.15 113.215 -168.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.409 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 60.0 Cg_endo -80.3 104.87 1.68 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.618 2.212 . . . . 63.4 110.55 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' D' ' 133' ' ' PHE . 53.1 t -109.43 111.32 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.954 -1.021 . . . . 73.42 110.542 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -95.62 70.89 3.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.405 1.098 . . . . 62.13 108.267 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.401 ' HB2' HG12 ' D' ' 131' ' ' VAL . 18.4 t80 -82.92 -8.87 59.53 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.021 -1.445 . . . . 73.43 109.971 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.522 ' HA ' ' HE1' ' D' ' 96' ' ' HIS . 7.9 t0 -66.22 -40.91 90.64 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.921 0.888 . . . . 54.53 109.317 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.45 66.02 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.97 0.908 . . . . 74.22 112.687 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.65 -48.91 79.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.54 0.736 . . . . 73.24 109.936 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.409 ' HB2' ' CE1' ' D' ' 96' ' ' HIS . 91.3 m-85 -75.49 -29.13 59.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.549 -0.75 . . . . 72.43 112.34 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 56.8 mtm -65.03 -35.96 82.86 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 120.663 0.268 . . . . 73.12 110.927 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.9 -27.79 57.81 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.108 0.563 . . . . 74.23 110.593 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.433 ' HB2' ' HG2' ' B' ' 4' ' ' GLN . 71.7 t80 -80.5 -25.17 38.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 72.11 111.498 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -36.44 84.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.196 0.998 . . . . 70.43 110.234 -172.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -90.01 21.54 3.63 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.586 -0.734 . . . . 72.44 111.76 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.9 71.7 0.83 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.929 -1.137 . . . . 71.43 107.929 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.47 156.12 39.95 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.96 -1.473 . . . . 75.31 108.72 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 106.77 1.36 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.274 0.629 . . . . 72.51 109.862 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.0 -105.47 1.2 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 123.943 0.777 . . . . 40.13 113.918 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -85.22 147.25 26.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.61 0.764 . . . . 74.34 111.122 -175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.62 70.5 2.93 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.32 -0.712 . . . . 30.25 111.32 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 22.7 p -65.61 93.51 0.17 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.785 0.834 . . . . 73.23 111.278 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 175.41 -35.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.871 1.668 . . . . 43.31 108.189 -172.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 55.44 -100.24 0.11 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.526 1.53 . . . . 61.13 111.937 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.1 m80 62.34 155.11 0.04 OUTLIER 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.739 1.215 . . . . 74.4 111.955 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 57.04 39.49 29.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.863 0.865 . . . . 75.31 110.357 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.01 -45.84 93.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.677 -1.147 . . . . 72.02 111.389 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.596 -0.716 . . . . 73.44 109.11 177.451 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.18 -0.674 . . . . 74.12 109.18 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -78.96 67.52 3.22 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 112.387 -0.285 . . . . 71.41 112.387 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -132.27 41.1 3.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.117 0.967 . . . . 71.54 109.673 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 66.9 m -134.98 136.94 42.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.13 -0.941 . . . . 63.22 109.458 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 172' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' E' ' 175' ' ' PHE . . . -80.56 -161.67 0.4 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.815 0.846 . . . . 72.43 110.869 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.81 -26.35 67.24 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.336 0.516 . . . . 72.11 110.375 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -144.17 -36.04 0.35 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.812 0.845 . . . . 73.31 110.88 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.727 ' HB3' ' HB3' ' E' ' 172' ' ' ALA . 41.2 t80 -56.52 106.86 0.32 Allowed 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.074 0.549 . . . . 74.33 110.884 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -137.96 99.41 3.89 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.84 -1.541 . . . . 74.14 106.84 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 52.5 tp -112.08 102.6 10.8 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.05 -64.11 1.25 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.117 -1.438 . . . . 74.13 107.117 174.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -147.16 137.69 12.57 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.435 1.094 . . . . 64.41 109.396 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.39 108.48 2.38 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.479 2.119 . . . . 73.43 111.05 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -82.01 7.29 13.6 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.348 0.659 . . . . 74.44 112.08 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -118.24 125.7 50.67 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.956 0.902 . . . . 74.33 109.188 170.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 9.6 t -136.84 163.88 29.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.144 0.978 . . . . 75.04 109.006 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.456 ' NE1' HG21 ' C' ' 131' ' ' VAL . 27.3 p90 -108.18 161.56 22.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 123.834 0.854 . . . . 74.34 110.141 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.47 108.4 1.39 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.131 1.887 . . . . 75.3 111.753 169.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.469 HD12 HD11 ' C' ' 42' ' ' LEU . 4.0 mm? -73.47 128.57 35.87 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 61.32 109.677 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -100.87 154.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.283 0.633 . . . . 63.23 111.526 -170.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.0 149.43 30.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.843 0.857 . . . . 70.24 109.348 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.24 122.83 25.62 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.673 -0.491 . . . . 75.12 109.673 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 190' ' ' ASP . . . . . 0.486 ' HB2' ' HZ1' ' F' ' 205' ' ' LYS . 18.0 t70 -95.22 160.87 14.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.906 0.882 . . . . 71.22 110.979 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 191' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' F' ' 199' ' ' ASN . . . 89.13 101.88 1.03 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.111 -0.495 . . . . 65.34 112.866 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.13 -177.46 50.84 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 123.662 0.272 . . . . 72.52 112.781 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -162.11 -172.18 3.13 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.346 1.058 . . . . 72.35 109.535 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.89 -67.6 0.9 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.27 0.628 . . . . 72.32 110.03 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 19.4 t80 52.41 30.34 8.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.923 1.289 . . . . 64.22 112.451 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -71.75 133.08 45.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.485 0.714 . . . . 73.02 109.884 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -90.58 136.38 33.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.42 -0.585 . . . . 62.21 109.42 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -38.0 62.58 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.627 -0.508 . . . . 73.04 109.627 169.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 12.0 t30 64.95 157.3 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.973 1.309 . . . . 74.0 113.227 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 102.53 -103.13 2.39 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 111.014 -0.834 . . . . 42.0 111.014 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.557 ' HG2' ' HB2' ' D' ' 2' ' ' SER . 18.5 tptt -89.82 74.89 7.38 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.769 -1.197 . . . . 54.23 107.769 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -77.11 81.09 3.62 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.723 -1.126 . . . . 73.41 109.422 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 203' ' ' ASP . . . . . 0.501 ' HB2' HG22 ' F' ' 187' ' ' ILE . 12.8 m-20 73.73 -59.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.106 1.762 . . . . 53.54 111.827 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.44 HG22 ' HB2' ' F' ' 185' ' ' PRO . 28.7 pt -60.21 103.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 71.13 111.936 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -84.94 -33.12 22.73 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.667 -1.151 . . . . 72.04 110.048 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.41 91.14 8.34 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.603 -0.888 . . . . 74.5 108.603 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.49 HG21 HG22 ' D' ' 13' ' ' ILE . 7.6 p . . . . . 0 CA--C 1.559 1.32 0 C-N-CA 124.497 1.119 . . . . 71.43 109.557 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.543 -0.54 . . . . 74.45 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.66 82.72 1.21 Allowed Glycine 0 C--N 1.347 1.189 0 N-CA-C 111.643 -0.583 . . . . 74.25 111.643 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -67.24 -69.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.679 0.792 . . . . 65.44 110.917 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 55.5 m 64.27 178.67 0.17 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.336 1.055 . . . . 61.13 112.422 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -127.88 78.38 1.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.044 -1.095 . . . . 61.24 108.044 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.779 HD21 ' H ' ' B' ' 54' ' ' ASP . 62.4 mt -110.81 80.48 1.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.802 0.811 . . . . 74.01 109.581 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.66 52.08 2.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.464 -1.244 . . . . 51.12 109.076 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.68 91.45 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.606 -1.179 . . . . 73.0 109.992 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -148.64 104.19 3.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.687 0.795 . . . . 62.2 108.978 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.23 -50.01 4.09 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.537 0.735 . . . . 72.54 109.5 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 54.26 80.44 0.12 Allowed 'General case' 0 C--N 1.355 0.837 0 O-C-N 124.802 1.314 . . . . 63.24 111.446 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 66.5 172.71 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 124.171 0.988 . . . . 75.42 111.898 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.2 99.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 121.829 1.686 . . . . 74.4 111.888 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -56.57 -32.34 65.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.653 1.181 . . . . 73.23 110.906 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 182' ' ' PHE . . . . . 0.519 ' HB2' ' HZ ' ' B' ' 133' ' ' PHE . 77.0 m-85 -137.27 155.41 49.51 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.224 -1.028 . . . . 72.24 108.224 160.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 79.5 m -70.87 129.7 39.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.272 0.629 . . . . 62.42 110.974 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -115.67 92.73 34.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 107.948 -1.13 . . . . 63.33 107.948 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 185' ' ' PRO . . . . . 0.44 ' HB2' HG22 ' E' ' 204' ' ' ILE . 3.6 Cg_exo -75.54 156.98 40.68 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.829 2.352 . . . . 71.34 112.358 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.458 HD11 HD22 ' B' ' 44' ' ' LEU . 3.1 mm? -119.02 178.32 4.54 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.915 0.886 . . . . 71.04 110.306 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' E' ' 203' ' ' ASP . 2.6 pp -110.89 154.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.2 0.6 . . . . 74.42 111.26 -175.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.51 56.35 1.53 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.922 0.889 . . . . 61.24 111.055 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 189' ' ' ALA . . . . . 0.412 ' H ' HD12 ' F' ' 187' ' ' ILE . . . 62.38 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.167 1.387 . . . . 65.1 111.748 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -138.55 -29.7 0.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.135 1.374 . . . . 64.33 109.325 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 143.89 -21.92 2.14 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.495 -1.042 . . . . 44.13 110.495 -166.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.94 81.56 Favored Glycine 0 C--N 1.356 1.658 0 C-N-CA 123.881 0.753 . . . . 64.52 112.911 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.41 11.02 3.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.592 0.96 . . . . 74.22 113.592 -166.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.3 -15.97 55.71 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.987 -0.746 . . . . 41.11 108.987 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -75.59 138.01 41.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.558 1.543 . . . . 71.44 111.668 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 196' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' F' ' 198' ' ' GLU . 39.3 ttpt 179.51 133.99 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.491 1.516 . . . . 73.24 108.029 171.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 197' ' ' TYR . . . . . 0.584 ' H ' ' HA ' ' B' ' 36' ' ' TRP . 1.6 t80 -87.44 77.38 8.87 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 106.803 -1.555 . . . . 41.51 106.803 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 198' ' ' GLU . . . . . 0.432 ' HB2' ' HE3' ' F' ' 196' ' ' LYS . 40.1 tt0 -69.68 -67.03 0.51 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.729 -1.123 . . . . 74.31 109.958 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 199' ' ' ASN . . . . . 0.438 ' O ' ' HA3' ' E' ' 191' ' ' GLY . 15.5 m120 -145.68 158.35 43.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.176 1.39 . . . . 74.42 107.574 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 58.82 -97.7 0.09 OUTLIER Glycine 0 CA--C 1.532 1.112 0 O-C-N 123.874 0.734 . . . . 53.34 114.684 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 55.32 76.66 0.25 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.255 1.422 . . . . 65.45 111.55 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 62.0 39.29 13.47 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.798 1.239 . . . . 64.43 110.672 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.34 152.72 24.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.648 -1.16 . . . . 73.3 112.324 -172.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.04 97.72 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 107.882 -1.155 . . . . 60.43 107.882 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 205' ' ' LYS . . . . . 0.486 ' HZ1' ' HB2' ' E' ' 190' ' ' ASP . 0.0 OUTLIER -73.77 -55.34 6.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.539 -0.755 . . . . 61.52 112.227 -169.509 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.84 -86.52 0.64 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 119.296 -0.383 . . . . 63.12 111.575 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 C--O 1.255 1.355 0 CA-C-N 118.479 0.581 . . . . 73.35 109.893 -177.182 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.65 136.91 9.34 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.644 -0.583 . . . . 71.55 111.644 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -75.15 86.53 2.4 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 72.53 110.139 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 32.0 t -71.55 117.32 12.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.518 -0.764 . . . . 75.2 110.489 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -165.64 -39.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.427 1.091 . . . . 75.23 109.622 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.89 124.66 23.08 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.258 1.023 . . . . 64.04 111.551 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.39 47.4 3.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.368 1.067 . . . . 65.42 111.617 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.4 168.88 3.23 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.42 -0.809 . . . . 71.02 112.022 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -68.89 -42.9 76.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.672 0.789 . . . . 74.23 111.478 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 5.6 tt 68.3 95.54 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.714 1.206 . . . . 71.45 109.13 -173.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -153.65 -23.13 0.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.071 0.549 . . . . 75.42 110.652 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.5 139.99 94.59 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.108 0.563 . . . . 73.13 110.619 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 131.71 24.85 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.927 2.418 . . . . 73.34 112.258 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -82.9 -167.98 1.87 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.578 0.751 . . . . 72.15 110.656 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 182' ' ' PHE . . . . . 0.44 ' HD1' ' HB2' ' C' ' 1' ' ' MET . 74.0 m-85 -56.02 -71.56 0.09 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.027 0.931 . . . . 74.22 111.674 -173.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 14.7 t 177.69 162.59 0.57 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.979 1.312 . . . . 44.23 109.286 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.23 89.11 2.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.277 0.631 . . . . 73.13 111.344 172.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 -36.33 1.39 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.204 2.603 . . . . 62.43 114.063 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.88 -172.86 0.17 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.66 1.184 . . . . 72.43 112.57 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.418 HG21 HG23 ' H' ' 204' ' ' ILE . 39.0 pt -73.83 165.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.735 0.814 . . . . 75.32 110.938 175.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -134.93 146.21 48.92 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.584 0.754 . . . . 73.23 109.838 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.54 135.0 20.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.477 0.711 . . . . 50.43 110.35 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -153.14 132.17 12.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.932 -0.766 . . . . 74.04 108.932 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 82.46 -170.46 50.51 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.054 -0.521 . . . . 40.55 113.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 125.45 84.54 0.56 Allowed Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.581 -1.008 . . . . 64.14 110.581 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -76.91 70.84 3.39 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.858 0.837 . . . . 75.33 109.662 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -122.27 176.69 5.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.08 1.352 . . . . 31.0 108.343 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 41.3 t80 52.73 31.47 10.44 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.467 1.127 . . . . 72.02 109.925 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.23 118.86 11.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.763 -1.562 . . . . 52.15 110.558 -163.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -71.15 85.06 0.74 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 124.361 1.038 . . . . 71.33 110.633 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -87.28 -53.92 4.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.76 -0.83 . . . . 74.41 108.76 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -159.43 161.6 35.57 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.449 -0.796 . . . . 63.24 109.129 174.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.14 16.52 0.05 OUTLIER Glycine 0 N--CA 1.471 0.98 0 CA-C-O 120.149 -0.25 . . . . 74.04 113.09 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -78.3 109.58 12.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.537 -0.542 . . . . 60.31 109.537 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.42 97.63 0.43 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.437 -0.949 . . . . 64.13 108.437 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.65 87.05 0.48 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.92 0.888 . . . . 53.43 111.815 -169.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.775 HG13 HG21 ' H' ' 187' ' ' ILE . 1.7 mp -108.36 132.36 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.758 1.223 . . . . 73.51 108.247 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.09 -40.65 4.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.903 0.881 . . . . 63.55 110.218 -175.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -99.46 178.53 4.85 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.237 1.015 . . . . 71.12 111.761 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 123.586 0.754 . . . . 73.33 111.095 -179.724 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.2 -0.667 . . . . 64.43 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 112.39 0.05 OUTLIER Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.833 -0.621 . . . . 62.11 113.858 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -75.91 128.93 36.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.473 -0.936 . . . . 73.33 108.473 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.0 m -80.82 -58.61 3.02 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.827 -0.805 . . . . 64.42 108.827 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.738 ' HB3' ' H ' ' D' ' 88' ' ' GLY . . . -161.66 54.05 0.25 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.204 -0.907 . . . . 73.3 109.761 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' D' ' 54' ' ' ASP . 3.1 tm? -76.31 121.49 23.05 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 107.748 -1.205 . . . . 71.05 107.748 169.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.24 63.18 1.33 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.474 1.11 . . . . 64.11 109.495 -170.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -63.47 86.92 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.267 0.627 . . . . 74.21 110.24 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -115.74 84.58 2.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.161 0.984 . . . . 74.51 109.555 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 177' ' ' LEU . . . . . 0.534 HD13 HD22 ' D' ' 98' ' ' LEU . 6.6 tt -156.35 132.54 9.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.05 -0.722 . . . . 60.45 109.05 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.98 93.9 2.6 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.727 1.211 . . . . 52.54 107.761 172.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 64.48 169.46 0.1 OUTLIER Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 124.615 1.166 . . . . 63.11 112.573 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.91 122.73 11.39 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.992 1.794 . . . . 72.05 111.184 168.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.25 -53.05 6.36 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.598 0.759 . . . . 74.41 110.752 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -118.66 14.33 13.49 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.776 0.83 . . . . 71.33 111.97 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 183' ' ' THR . . . . . 0.488 HG22 ' HD3' ' H' ' 185' ' ' PRO . 20.2 m 70.05 150.9 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.046 1.339 . . . . 75.21 112.749 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -147.44 82.91 7.93 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.117 0.567 . . . . 74.24 109.484 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 185' ' ' PRO . . . . . 0.488 ' HD3' HG22 ' H' ' 183' ' ' THR . 74.0 Cg_endo -77.13 144.91 24.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.275 2.65 . . . . 74.13 113.487 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.29 -173.53 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.865 0.866 . . . . 74.42 110.52 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.775 HG21 HG13 ' G' ' 204' ' ' ILE . 2.4 pp -73.67 170.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.854 0.861 . . . . 71.51 113.107 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.75 -22.23 19.49 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.226 -0.897 . . . . 72.42 111.371 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . 62.21 5.36 1.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.816 1.246 . . . . 60.02 113.495 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -94.7 132.96 38.89 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.243 1.017 . . . . 72.11 108.57 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 147.99 78.86 0.03 OUTLIER Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.44 -0.664 . . . . 72.42 111.44 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.14 174.98 44.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.47 -0.252 . . . . 71.44 112.47 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.56 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 21.3 t80 -174.07 91.45 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.376 . . . . 63.15 107.743 173.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.27 15.65 2.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.537 0.735 . . . . 65.03 110.787 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -103.66 27.51 7.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.955 0.502 . . . . 73.52 109.672 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -79.59 105.36 10.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.108 -0.701 . . . . 53.15 109.108 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 197' ' ' TYR . . . . . 0.512 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 0.5 OUTLIER -150.15 115.93 5.57 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.197 0.999 . . . . 73.24 109.603 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.29 58.09 0.76 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.868 0.867 . . . . 75.32 109.054 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 33.1 t30 62.91 88.89 0.09 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.596 -1.261 . . . . 64.54 107.596 -165.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.9 -61.01 7.93 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.887 0.742 . . . . 30.25 113.542 -168.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -175.1 -44.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.182 0.593 . . . . 63.52 110.314 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -59.01 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 125.018 1.449 . . . . 73.42 111.742 -166.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -102.8 139.93 37.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.907 -1.146 . . . . 74.13 107.907 172.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.418 HG23 HG21 ' G' ' 187' ' ' ILE . 91.7 mt -103.89 135.69 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.507 0.723 . . . . 74.31 109.405 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.25 112.34 3.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.935 -1.505 . . . . 73.32 106.935 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -162.59 -58.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.827 0.285 . . . . 73.1 111.306 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.624 0.77 . . . . 63.32 109.185 -178.403 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 110.436 -0.209 . . . . 72.11 110.436 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -76.59 105.58 7.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.207 0.603 . . . . 74.24 110.024 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 49.0 mt-10 -146.24 124.47 12.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.505 0.722 . . . . 64.42 109.827 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -91.95 72.29 5.6 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.729 0.776 . . . . 74.14 110.343 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' MET . 60.6 m-80 -90.1 44.87 1.23 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.151 -0.931 . . . . 62.54 110.183 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -60.15 -40.36 89.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.381 0.672 . . . . 60.33 111.444 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 155' ' ' ALA . 71.1 p -128.59 38.36 3.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.966 0.907 . . . . 45.22 108.661 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.96 26.81 6.07 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.687 -0.857 . . . . 74.12 108.687 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.486 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -154.8 158.25 39.16 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.672 1.189 . . . . 33.53 108.61 173.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -142.17 137.91 31.18 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.631 0.772 . . . . 75.14 109.947 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 52.4 t80 -135.96 129.17 31.72 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.596 -1.261 . . . . 65.0 107.596 170.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -148.82 123.41 9.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.266 0.469 . . . . 62.12 112.266 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 16' ' ' ILE . 3.4 tp -75.19 118.26 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.949 -1.023 . . . . 63.52 109.056 168.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.9 -20.75 13.34 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.292 0.637 . . . . 71.34 111.048 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -178.41 127.16 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.249 0.477 . . . . 74.31 111.157 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 13' ' ' ILE . 48.3 mt -106.48 132.22 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.761 -0.829 . . . . 74.15 108.761 169.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -148.45 171.84 15.42 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.27 1.428 . . . . 74.23 109.931 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -102.15 123.49 46.09 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.959 -0.756 . . . . 74.11 108.959 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -81.53 -32.19 32.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.387 0.675 . . . . 61.25 110.556 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.7 t70 -150.1 144.34 25.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.13 110.083 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.454 HG23 ' SD ' ' A' ' 117' ' ' MET . 61.6 mt -137.38 130.3 43.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.852 -1.536 . . . . 53.03 106.852 171.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -140.33 116.17 10.3 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.113 -1.069 . . . . 71.14 108.113 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.4 t80 -126.68 109.2 11.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 106.667 -1.605 . . . . 71.22 106.667 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.97 108.91 15.85 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.403 -0.962 . . . . 75.54 108.403 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -106.76 89.48 4.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.335 -0.987 . . . . 61.32 108.335 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.59 -43.45 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.446 2.098 . . . . 63.23 112.794 -172.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.6 m-80 -101.42 29.27 4.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.24 0.616 . . . . 73.25 109.891 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -50.79 -48.65 82.99 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 124.359 1.064 . . . . 52.41 113.163 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 21.8 Cg_exo -67.84 -26.39 38.37 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 121.688 1.592 . . . . 62.21 112.517 176.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.52 -28.4 60.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.625 -0.716 . . . . 73.12 110.857 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.734 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 41.4 t -58.79 -20.34 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 123.667 0.787 . . . . 62.01 111.645 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.48 ' HE1' ' HB3' ' G' ' 201' ' ' LYS . 66.5 t80 -59.77 -41.4 90.98 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.262 1.025 . . . . 75.24 111.776 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -101.27 -22.21 14.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.246 0.618 . . . . 70.51 111.436 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.9 mmmt -69.88 134.72 48.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.269 0.627 . . . . 72.24 110.001 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.42 131.94 44.84 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.339 -0.846 . . . . 65.25 109.087 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HA ' HD22 ' A' ' 68' ' ' LEU . 75.4 t-105 -80.79 90.6 5.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.479 0.656 . . . . 75.44 110.006 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -121.22 83.97 39.85 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 106.866 -1.531 . . . . 74.2 106.866 165.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.05 132.24 16.51 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.295 1.996 . . . . 43.43 111.389 -171.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -94.49 91.51 6.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.097 -1.446 . . . . 74.13 107.097 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' G' ' 189' ' ' ALA . 5.3 p -65.34 98.59 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 124.612 1.195 . . . . 62.05 111.586 -170.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 20.2 tptm -100.42 130.52 46.52 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.428 -1.26 . . . . 72.21 108.763 175.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -131.67 114.08 14.37 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.41 0.684 . . . . 60.15 109.367 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -108.08 137.56 45.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.394 1.078 . . . . 73.21 108.535 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.8 tp -119.0 118.9 32.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.747 -0.835 . . . . 64.42 108.747 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -128.58 149.99 50.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.012 0.925 . . . . 60.23 108.953 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -140.63 151.25 44.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.378 0.671 . . . . 74.43 109.858 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -142.53 155.29 45.0 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.226 1.01 . . . . 62.01 109.38 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 p -125.6 159.81 31.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.602 0.761 . . . . 64.24 110.329 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -159.12 122.43 3.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.683 0.793 . . . . 74.01 109.68 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -79.84 111.9 16.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.755 0.422 . . . . 51.31 109.869 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.5 mt -88.52 -34.16 17.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.124 0.569 . . . . 45.22 110.667 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -161.58 -172.38 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.437 1.095 . . . . 54.13 109.937 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.19 107.41 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 54.21 109.522 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 68.56 3.66 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.219 1.408 . . . . 70.21 112.87 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.5 t -99.64 115.04 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.351 -1.351 . . . . 75.45 107.351 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -123.2 167.04 14.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.67 0.747 . . . . 74.34 110.745 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' A' ' 51' ' ' LEU . 19.3 tt0 -128.59 126.26 39.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.043 -1.435 . . . . 65.31 107.143 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -106.48 122.05 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.464 -1.31 . . . . 74.0 107.464 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.51 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.5 t -97.51 139.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 124.313 1.045 . . . . 72.52 108.291 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.12 112.77 19.1 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.434 -1.321 . . . . 71.3 107.434 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -109.75 103.03 11.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.658 0.742 . . . . 74.22 109.752 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.49 136.12 28.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.703 -1.135 . . . . 75.22 108.414 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.8 m -123.5 128.97 50.53 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.039 0.447 . . . . 73.2 110.276 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.5 t -125.33 110.5 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 74.41 109.394 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -107.73 138.59 43.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.19 0.45 . . . . 74.24 109.827 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.48 105.85 12.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.286 -1.376 . . . . 74.54 107.286 168.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 47.6 m -106.42 126.52 52.35 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.552 -0.536 . . . . 72.31 109.552 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 36' ' ' TRP . 17.0 mt -93.27 80.84 4.44 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.137 -1.431 . . . . 72.2 107.137 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -89.24 0.86 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.951 -1.022 . . . . 54.42 111.285 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -121.5 -15.06 8.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.167 0.987 . . . . 71.04 110.477 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 4.8 mp0 -97.16 101.74 13.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.404 1.082 . . . . 55.42 109.83 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.4 m -66.17 127.19 31.19 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.263 0.554 . . . . 53.14 111.192 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -74.28 -55.06 6.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.738 1.215 . . . . 62.25 108.986 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.22 164.87 35.6 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.749 -1.114 . . . . 64.33 111.125 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.21 143.38 50.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.3 1.44 . . . . 71.02 107.224 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.8 m -130.11 136.05 48.9 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 123.712 0.805 . . . . 73.41 108.855 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -148.57 115.72 6.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.582 -0.896 . . . . 63.3 108.582 173.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.89 112.84 30.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.652 0.781 . . . . 73.23 109.518 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -86.67 84.49 7.38 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.751 -0.833 . . . . 64.41 108.751 172.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.53 93.3 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.588 -0.893 . . . . 74.54 108.588 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.37 148.44 20.08 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.413 -0.675 . . . . 73.12 111.413 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 131.92 4.03 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.865 -0.894 . . . . 64.13 110.865 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.78 121.33 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.662 -0.866 . . . . 64.5 108.662 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' HD13 ' A' ' 13' ' ' ILE . 34.5 m-85 -130.87 117.33 19.14 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.723 -1.214 . . . . 74.52 107.723 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 p -79.15 115.8 19.03 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.416 -0.957 . . . . 75.43 108.416 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.471 ' HB ' HD11 ' A' ' 89' ' ' ILE . 44.4 pt -118.37 142.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.481 0.712 . . . . 72.4 110.594 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.81 155.74 17.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.099 0.96 . . . . 54.45 109.628 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 76.17 9.48 85.54 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.616 0.606 . . . . 53.52 114.616 173.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB ' ' A' ' 86' ' ' ILE . 1.3 pp -119.61 132.58 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 117.409 0.604 . . . . 74.24 110.678 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' G' ' 172' ' ' ALA . 50.6 mt-10 -151.76 173.39 14.79 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.373 1.069 . . . . 64.41 110.217 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.19 -136.26 51.13 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.602 0.564 . . . . 61.12 113.896 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -70.34 -25.95 63.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.759 0.824 . . . . 73.22 111.371 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -65.29 -43.35 91.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 62.1 110.492 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.532 ' HE1' ' H ' ' G' ' 175' ' ' PHE . 28.0 ttt -76.11 -38.17 57.21 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.874 -0.603 . . . . 65.21 110.64 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.26 67.83 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.797 0.439 . . . . 63.22 111.489 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -71.72 -39.44 70.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.949 0.9 . . . . 75.04 110.473 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.604 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 t -77.36 -65.87 0.9 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.65 -0.704 . . . . 65.33 110.222 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 ' HG3' ' A' ' 94' ' ' MET . 3.8 mm? -73.54 -17.95 61.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.745 0.818 . . . . 74.11 112.365 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.29 -16.91 54.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.852 -0.416 . . . . 61.23 113.964 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -55.7 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.403 0.601 . . . . 62.22 111.75 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 92.1 t80 -66.79 -61.05 2.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.904 0.882 . . . . 42.31 113.361 -168.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.604 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 79.1 m -62.78 -40.91 68.33 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.157 -0.925 . . . . 60.04 113.372 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -63.79 -32.53 67.29 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 121.098 1.428 . . . . 72.12 112.868 168.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -72.02 -24.64 61.59 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 117.945 0.339 . . . . 63.14 111.204 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -57.74 -43.26 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.638 0.733 . . . . 73.43 109.406 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 mt -77.49 -21.84 52.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.146 -1.388 . . . . 74.44 112.27 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -64.61 -41.35 57.04 Favored Pre-proline 0 CA--C 1.562 1.424 0 CA-C-O 117.475 -1.25 . . . . 75.53 114.116 -168.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.69 -31.26 91.54 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.119 1.879 . . . . 74.21 113.26 172.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.95 -41.07 21.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.616 0.766 . . . . 72.03 110.924 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.53 87.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.947 0.499 . . . . 73.11 110.061 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.471 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.9 ttm180 -50.51 -58.79 4.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.867 1.267 . . . . 54.13 110.154 173.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.19 -40.55 96.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.516 1.135 . . . . 74.52 111.754 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.6 t -57.59 -48.43 79.42 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 123.854 0.721 . . . . 61.3 110.1 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 64' ' ' VAL . 95.1 mt -62.16 -51.16 75.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 O-C-N 124.306 1.004 . . . . 65.3 110.203 175.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.8 m -53.0 -42.72 65.87 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.81 1.244 . . . . 70.4 111.621 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.91 -47.01 66.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.969 -1.014 . . . . 61.13 109.985 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.454 ' SD ' HG23 ' A' ' 21' ' ' ILE . 15.6 mtp -53.45 -45.61 69.57 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.856 0.862 . . . . 72.45 111.394 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 114' ' ' ILE . 73.8 t -61.09 -49.11 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.076 1.351 . . . . 74.24 111.046 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -68.48 -28.84 67.39 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.899 0.479 . . . . 70.22 111.454 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.3 -27.59 64.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.694 0.798 . . . . 70.22 110.976 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.96 11.96 58.83 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 119.498 -0.612 . . . . 71.41 113.776 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.48 ' HB ' HH21 ' B' ' 15' ' ' ARG . 11.9 m 65.18 32.53 10.04 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.351 1.072 . . . . 74.24 110.316 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.424 ' HE1' HG11 ' A' ' 31' ' ' VAL . 65.2 m-85 -109.4 152.69 42.83 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 115.106 -0.952 . . . . 74.12 109.101 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 149.57 80.23 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.103 1.868 . . . . 65.33 111.319 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HG23 ' A' ' 115' ' ' THR . 29.5 tt0 -56.7 142.29 40.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.699 0.8 . . . . 73.33 111.313 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp -133.8 101.79 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.57 0.748 . . . . 71.13 109.434 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.528 ' HB2' HD22 ' H' ' 199' ' ' ASN . 10.9 m120 -98.63 100.7 11.95 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.61 117.85 6.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 75.14 109.928 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.94 150.36 50.03 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.345 0.658 . . . . 62.43 111.859 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.71 160.86 7.75 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.378 2.052 . . . . 73.31 112.763 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.89 114.3 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.806 -1.183 . . . . 72.03 107.806 165.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 29.1 m-20 -98.8 63.41 1.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.648 0.737 . . . . 64.24 109.945 176.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -77.08 -32.5 56.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.24 -0.891 . . . . 73.52 109.035 173.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.57 -42.23 99.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.078 -0.964 . . . . 72.44 110.659 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -75.61 -26.43 57.81 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.86 0.725 . . . . 63.21 110.965 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.8 tp -73.07 -44.68 60.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.307 0.643 . . . . 64.15 110.658 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.438 ' HE2' HD23 ' A' ' 141' ' ' LEU . 45.9 t80 -84.66 -23.68 29.34 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.043 -0.526 . . . . 75.43 111.487 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -32.76 72.43 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.559 0.618 . . . . 65.12 110.004 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -52.28 -61.22 2.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.378 1.049 . . . . 74.55 109.292 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -63.53 -31.59 72.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.611 -0.722 . . . . 62.44 112.477 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.438 HD23 ' HE2' ' A' ' 137' ' ' PHE . 2.3 tm? -61.3 -51.11 70.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.262 0.625 . . . . 75.24 109.388 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -176.79 -12.54 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.898 0.749 . . . . 61.13 112.378 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -68.53 -17.84 64.24 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.168 0.433 . . . . 74.11 112.168 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' C' ' 143' ' ' GLN . 49.4 tt0 -70.22 -23.42 62.93 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 64.23 110.178 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' C' ' 147' ' ' GLU . . . -83.68 53.59 2.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.543 0.737 . . . . 71.34 109.745 169.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.01 59.62 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.955 -0.566 . . . . 62.42 112.312 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -78.38 -27.94 46.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.127 0.971 . . . . 74.12 109.412 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.01 119.59 0.44 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.623 -0.717 . . . . 60.24 111.44 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -136.85 100.02 4.19 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.816 -1.179 . . . . 64.45 107.816 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.82 127.09 31.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.385 -0.825 . . . . 75.23 110.205 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.66 111.28 3.51 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 105.393 -2.077 . . . . 72.3 105.393 173.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -71.48 -97.92 0.01 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-O 118.255 -0.878 . . . . 60.12 109.817 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 42.5 -89.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.927 1.291 . . . . 75.1 112.066 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 168.06 -63.88 0.0 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 126.656 1.983 . . . . 60.31 106.585 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 7' ' ' THR . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.309 -1.314 . . . . 50.13 108.492 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 108.743 -0.836 . . . . 62.22 108.743 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 94.72 0.76 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.775 0.83 . . . . 65.51 110.513 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -81.02 155.33 26.42 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.901 -0.778 . . . . 72.31 108.901 169.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 65.57 111.46 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.689 1.196 . . . . 75.24 110.555 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -68.89 -5.75 23.08 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.376 0.67 . . . . 72.51 112.546 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.32 73.53 1.84 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.87 0.868 . . . . 74.44 109.799 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.6 m -105.68 106.03 16.35 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.351 -1.352 . . . . 64.02 107.351 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -61.03 -50.95 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.711 0.805 . . . . 65.34 110.426 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.574 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.0 ptm 50.36 171.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.908 2.083 . . . . 72.24 115.071 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.2 p -142.13 134.97 28.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 63.13 109.089 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -139.97 117.17 11.22 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.834 -0.802 . . . . 72.15 108.834 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.1 tp60 -128.03 103.5 7.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.191 0.596 . . . . 75.43 109.797 176.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' D' ' 129' ' ' ALA . 12.5 tt -67.92 121.63 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 108.819 -0.808 . . . . 74.41 108.819 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -101.1 -47.38 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.86 0.464 . . . . 71.32 110.715 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.48 HH21 ' HB ' ' A' ' 122' ' ' THR . 66.9 ttt180 -163.25 135.59 5.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.098 -171.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.15 138.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 106.805 -1.554 . . . . 64.23 106.805 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.507 ' HE1' HG13 ' B' ' 83' ' ' ILE . 15.1 p90 -164.78 146.35 8.02 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 123.711 0.632 . . . . 64.32 111.178 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -74.64 116.84 15.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.864 -0.791 . . . . 75.4 108.864 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -89.48 -30.18 18.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.26 0.624 . . . . 73.21 111.158 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.5 t70 -158.25 142.89 16.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.091 -0.504 . . . . 60.32 110.376 -171.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.9 mm -138.29 141.46 37.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 125.336 1.455 . . . . 65.23 108.071 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -140.49 133.17 28.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.73 -1.123 . . . . 75.35 108.073 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.1 t80 -142.43 127.43 18.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.447 -1.686 . . . . 73.22 106.447 164.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.57 147.05 49.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.446 -1.316 . . . . 64.35 107.446 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -141.31 81.74 15.26 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 105.829 -1.915 . . . . 51.42 105.829 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.87 -29.08 76.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.574 2.183 . . . . 72.1 111.13 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.25 30.7 6.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.66 -1.155 . . . . 42.34 110.435 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.45 -52.45 29.63 Favored Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 124.734 1.214 . . . . 71.24 111.972 169.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.25 -16.84 9.43 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.007 1.804 . . . . 72.32 113.072 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -87.59 3.15 48.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.339 0.656 . . . . 71.21 111.419 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.494 HG12 HD11 ' B' ' 68' ' ' LEU . 22.0 m -67.04 -17.12 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.644 0.778 . . . . 74.1 110.766 166.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -71.33 -31.28 67.21 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.403 1.081 . . . . 74.41 110.123 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.18 -42.65 15.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.351 0.66 . . . . 72.12 109.383 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -91.45 78.52 5.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.076 0.95 . . . . 45.43 109.377 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.682 ' HB3' ' HA ' ' F' ' 196' ' ' LYS . 24.0 m-20 -83.11 74.87 9.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.42 -1.264 . . . . 75.44 110.471 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -179.46 171.64 1.24 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.199 1.0 . . . . 74.1 109.471 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -71.15 135.57 84.79 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.181 0.992 . . . . 70.45 111.276 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.54 157.41 48.89 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.135 1.89 . . . . 73.0 111.742 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 52.5 mt-10 -70.2 102.19 2.04 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.826 -1.176 . . . . 61.33 107.826 167.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.5 136.6 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.436 -0.95 . . . . 71.11 108.436 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -136.68 141.45 43.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.62 0.768 . . . . 65.14 109.23 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' B' ' 126' ' ' LEU . 2.8 pp -104.83 142.23 35.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.475 0.71 . . . . 74.33 109.366 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.543 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.2 m-20 -139.6 155.71 47.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.687 1.595 . . . . 61.34 106.916 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 165.09 36.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.944 0.402 . . . . 64.43 110.327 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.53 141.51 13.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.346 1.058 . . . . 75.22 109.057 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.577 HG21 ' HA2' ' B' ' 99' ' ' GLY . 88.8 m -108.57 120.06 41.34 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.251 0.621 . . . . 73.14 109.361 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.33 153.82 32.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.765 1.226 . . . . 64.14 108.539 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -142.99 163.41 32.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.096 0.558 . . . . 75.14 110.889 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -154.03 170.59 20.75 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.05 1.34 . . . . 72.13 109.222 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 9.8 tt0 -125.79 135.36 51.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.786 0.834 . . . . 72.55 109.818 169.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 59.3 mt -100.62 -44.75 5.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.677 0.791 . . . . 71.23 110.767 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -147.8 179.23 7.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.944 -1.025 . . . . 74.44 109.733 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.11 119.29 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.526 -0.761 . . . . 65.1 109.851 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' B' ' 85' ' ' SER . 16.6 m-20 70.76 -6.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.144 1.778 . . . . 75.12 112.674 -174.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.0 t -104.58 94.95 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.131 -1.062 . . . . 62.34 108.131 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.464 ' HE2' HD22 ' F' ' 173' ' ' LEU . 8.0 m-85 -94.93 169.39 10.16 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.435 0.694 . . . . 61.32 109.517 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 6.8 tm-20 -142.89 101.72 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.518 -1.289 . . . . 71.43 107.518 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.87 125.12 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.446 -0.576 . . . . 73.3 109.446 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.8 t -102.98 111.58 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.569 0.748 . . . . 74.02 109.605 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.37 112.09 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.381 -0.97 . . . . 74.42 108.381 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -96.44 131.45 43.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.592 -1.186 . . . . 71.02 109.708 173.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -126.89 120.29 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.579 -1.267 . . . . 72.53 107.579 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.4 m -109.48 153.97 23.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.494 1.117 . . . . 51.41 109.805 -174.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 85.1 t -133.33 126.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.631 1.172 . . . . 72.44 108.766 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 43.2 m -112.8 143.22 44.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.679 0.792 . . . . 73.21 109.335 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.7 151.37 34.79 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.56 0.344 . . . . 73.33 110.81 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.4 p -144.37 133.39 22.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.099 0.56 . . . . 75.05 111.203 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.494 HD11 HG12 ' B' ' 31' ' ' VAL . 41.8 mt -100.87 99.67 10.2 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 73.21 108.365 171.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.68 -120.01 6.73 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.018 -0.833 . . . . 24.33 111.018 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.17 6.0 35.37 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.803 0.841 . . . . 75.51 112.191 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -115.19 165.57 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.44 0.696 . . . . 64.43 109.793 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -77.82 133.14 38.26 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.121 0.568 . . . . 73.25 111.111 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.46 -60.2 2.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.64 0.776 . . . . 74.11 109.291 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.5 150.98 21.91 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.533 -1.212 . . . . 72.23 110.041 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.45 114.22 15.87 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.215 1.006 . . . . 74.41 108.729 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.544 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 51.4 t -115.38 157.94 23.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.766 -0.827 . . . . 71.12 108.766 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.88 135.97 2.85 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.451 -0.944 . . . . 71.1 108.451 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.74 143.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.51 -0.922 . . . . 35.31 108.51 172.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -127.15 89.25 2.94 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.68 -0.859 . . . . 73.14 108.68 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -83.45 104.71 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.939 -1.028 . . . . 62.21 108.506 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.21 162.52 29.71 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.574 -0.61 . . . . 72.52 111.574 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.09 128.81 2.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.519 -0.632 . . . . 64.12 111.519 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.507 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.8 mt -85.72 118.39 32.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.748 -0.834 . . . . 71.14 108.748 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.69 134.71 43.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.773 0.829 . . . . 75.13 109.375 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 43.2 m -97.58 113.85 25.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.268 0.627 . . . . 62.24 109.993 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 137.47 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.772 0.829 . . . . 64.44 111.608 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.41 173.09 17.17 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.698 1.199 . . . . 72.52 108.782 165.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 86.53 -44.29 3.32 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-O 120.279 -0.179 . . . . 75.21 112.771 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.91 152.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.876 0.87 . . . . 74.44 110.654 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 1.1 tm-20 -155.93 144.25 20.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 120.406 0.146 . . . . 64.53 110.64 -174.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.39 -114.36 6.12 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.707 0.67 . . . . 73.15 114.034 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -67.01 -31.13 71.48 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.867 0.867 . . . . 74.13 110.996 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 92.1 mt-30 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.34 0.656 . . . . 73.54 110.475 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.575 ' SD ' ' HB2' ' F' ' 174' ' ' MET . 26.2 ttt -73.11 -37.86 66.53 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.767 -0.651 . . . . 64.42 110.681 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.84 -24.85 67.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 71.01 111.121 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -88.75 -23.38 22.92 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.048 0.939 . . . . 73.23 110.985 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.64 -67.66 0.64 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.716 0.406 . . . . 74.21 109.926 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.59 -18.4 58.66 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.034 0.383 . . . . 73.1 112.034 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.577 ' HA2' HG21 ' B' ' 46' ' ' THR . . . -90.11 -20.19 43.49 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.769 -0.462 . . . . 73.42 114.043 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.42 -52.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.766 0.654 . . . . 61.35 112.766 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -67.22 -50.17 61.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.104 0.561 . . . . 74.34 111.401 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.68 -47.41 82.17 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 118.236 -0.888 . . . . 65.33 110.42 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.8 -43.03 36.04 Favored 'Trans proline' 0 C--N 1.404 3.495 0 C-N-CA 122.296 1.998 . . . . 72.44 114.463 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -31.42 72.31 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.257 0.623 . . . . 73.21 111.867 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.9 -45.69 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.547 0.739 . . . . 72.43 110.372 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.24 -16.38 33.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.009 -0.996 . . . . 72.34 111.786 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.14 -44.17 95.73 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 125.773 1.629 . . . . 61.35 113.757 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.0 Cg_endo -58.59 -40.32 74.93 Favored 'Trans proline' 0 C--N 1.4 3.286 0 C-N-CA 121.873 1.715 . . . . 74.05 112.494 174.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.444 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.8 m-85 -63.79 -44.09 94.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.17 0.588 . . . . 74.44 110.33 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.445 0.698 . . . . 62.0 111.045 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.52 -47.2 87.21 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.966 1.307 . . . . 74.1 111.063 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.82 -40.41 75.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.643 0.777 . . . . 62.42 110.0 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.7 t -67.45 -35.24 78.82 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 115.797 -0.638 . . . . 62.5 111.218 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.485 HG21 HG21 ' B' ' 64' ' ' VAL . 52.1 mt -62.81 -57.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.167 0.587 . . . . 74.51 109.548 174.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.406 HG21 ' HB2' ' C' ' 119' ' ' SER . 90.1 m -59.84 -26.43 65.8 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.328 1.018 . . . . 70.53 111.183 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.6 t -66.03 -58.79 4.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.528 0.731 . . . . 75.33 109.852 171.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.2 mmt -62.79 -39.05 93.03 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.99 0.516 . . . . 61.25 112.267 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.0 -41.82 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.498 1.119 . . . . 63.3 110.631 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -72.69 -25.64 61.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.661 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.9 mtt-85 -65.32 -38.63 90.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.509 -0.552 . . . . 72.34 109.509 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 1.55 62.86 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.908 -0.587 . . . . 73.23 113.191 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.9 p 63.25 39.99 9.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 61.12 111.816 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -112.74 159.26 35.01 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.937 1.295 . . . . 72.22 111.207 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.41 141.46 95.64 Favored 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 123.745 2.964 . . . . 71.44 115.181 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' C' ' 124' ' ' PRO . 0.9 OUTLIER -65.61 160.39 22.66 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 126.322 1.849 . . . . 64.12 113.701 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.552 HD13 ' HB3' ' B' ' 42' ' ' LEU . 24.3 mt -127.54 102.46 6.87 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.254 -0.885 . . . . 74.01 110.004 163.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -91.05 100.24 13.13 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.542 -1.281 . . . . 74.24 107.542 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.87 136.33 33.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.112 0.565 . . . . 61.23 112.236 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.54 142.26 74.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.708 0.803 . . . . 72.42 110.324 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.419 ' HG2' HG21 ' D' ' 13' ' ' ILE . 29.0 Cg_endo -64.24 100.4 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.156 1.904 . . . . 74.45 111.396 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' F' ' 184' ' ' TRP . 7.5 m -75.5 71.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.024 0.916 . . . . 74.2 109.189 168.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.1 93.2 1.77 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.962 -1.125 . . . . 75.32 107.962 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.4 -21.88 66.78 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.031 -1.44 . . . . 71.34 111.886 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.43 -36.88 65.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.505 0.722 . . . . 74.43 110.642 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.38 -24.81 67.33 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.433 0.693 . . . . 63.22 111.478 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.69 -46.61 86.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.039 0.936 . . . . 64.44 110.353 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.88 -17.82 59.65 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.702 -0.681 . . . . 72.21 111.879 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.82 0.282 . . . . 72.33 111.254 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -86.56 -32.96 20.39 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.876 0.471 . . . . 75.03 111.69 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -89.76 -34.08 16.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.731 0.412 . . . . 73.13 112.11 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -105.95 23.94 13.16 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.031 0.533 . . . . 72.13 110.788 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.31 -43.73 88.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.405 0.282 . . . . 73.12 110.324 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? 56.46 23.91 7.98 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.481 1.112 . . . . 71.43 111.82 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -130.83 130.28 43.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.035 0.934 . . . . 75.34 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' D' ' 5' ' ' ASN . . . -83.29 136.39 34.39 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.428 0.691 . . . . 74.15 109.552 174.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.85 -173.07 49.52 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.261 0.351 . . . . 45.11 112.915 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.2 163.66 39.48 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.679 0.792 . . . . 52.33 109.858 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.29 -54.37 0.25 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.727 -0.669 . . . . 74.43 111.805 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.3 m 48.82 64.23 1.8 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.682 1.193 . . . . 74.13 110.221 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.15 92.95 1.39 Allowed 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.372 -0.831 . . . . 65.3 109.781 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.07 162.38 16.81 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.006 0.922 . . . . 74.05 109.263 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -111.1 163.23 14.09 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.977 0.511 . . . . 75.44 111.117 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -104.99 115.94 31.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.039 0.936 . . . . 71.53 108.948 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -128.39 140.37 51.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.769 0.828 . . . . 72.35 108.975 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.903 0.881 . . . . 75.3 109.09 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 40.1 ttp . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.791 -0.818 . . . . 70.12 108.791 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -71.74 96.84 1.67 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 74.12 109.714 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.86 78.2 3.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.721 -1.214 . . . . 64.3 107.721 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -143.56 49.86 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.243 -1.344 . . . . 74.12 107.508 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -59.76 -21.78 61.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.64 -1.618 . . . . 75.41 112.89 -173.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -164.25 130.19 2.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.077 0.551 . . . . 73.3 110.391 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -136.44 -51.93 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.696 -1.594 . . . . 64.03 106.696 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -167.87 100.37 0.47 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.404 -1.271 . . . . 64.42 107.739 168.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.793 ' HG3' HG22 ' C' ' 89' ' ' ILE . 24.6 ttt 60.62 111.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.547 1.539 . . . . 75.21 111.621 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m -122.25 118.84 29.51 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.148 0.979 . . . . 73.33 109.571 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -117.65 125.16 50.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.504 1.122 . . . . 73.5 108.159 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.686 ' HG3' HD13 ' H' ' 204' ' ' ILE . 53.7 tt0 -137.14 112.16 9.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.054 0.542 . . . . 72.03 109.601 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.458 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -64.47 130.87 30.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-N 115.862 -0.608 . . . . 73.2 109.926 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.551 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.3 mm100 -103.75 -51.51 3.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.085 -0.709 . . . . 74.31 109.085 174.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.421 ' NH2' ' HD1' ' H' ' 197' ' ' TYR . 28.4 ttt85 -166.53 155.96 11.28 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.439 0.162 . . . . 71.52 111.439 -174.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.458 HG13 HD11 ' C' ' 13' ' ' ILE . 93.9 mt -138.19 137.48 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.608 1.163 . . . . 63.52 108.128 173.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.569 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.5 p90 -171.84 155.04 3.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.524 0.678 . . . . 74.44 111.786 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -78.72 117.99 20.37 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.67 -1.15 . . . . 74.33 108.461 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 17.4 mtmt -92.61 -38.57 11.81 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.903 -0.777 . . . . 74.4 108.903 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.9 t70 -133.9 134.89 43.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.683 -1.144 . . . . 74.21 108.729 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -138.82 141.02 37.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.078 -1.453 . . . . 52.15 107.078 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -151.95 150.22 29.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.394 0.616 . . . . 51.41 109.823 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -150.83 113.33 4.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.889 -1.523 . . . . 64.42 106.889 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -115.16 111.15 20.57 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.883 -0.784 . . . . 73.31 108.883 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.02 75.69 53.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.09 0.956 . . . . 53.54 108.711 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.54 -24.35 30.77 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.092 1.862 . . . . 72.24 110.465 168.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -92.23 19.12 7.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.18 0.992 . . . . 75.21 110.731 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.2 94.76 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.908 0.883 . . . . 75.24 113.353 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.63 -25.92 7.52 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 121.46 1.44 . . . . 74.0 112.06 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.48 -32.98 72.21 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.088 1.355 . . . . 72.53 111.29 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.507 HG23 HD11 ' C' ' 68' ' ' LEU . 12.6 p -72.05 -24.24 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.809 0.844 . . . . 74.42 111.689 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.31 -39.15 93.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.199 0.6 . . . . 75.12 111.139 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -100.74 39.9 1.33 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.752 0.821 . . . . 62.33 109.858 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.768 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -124.72 173.86 8.27 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.36 0.664 . . . . 72.54 110.459 -176.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.27 115.42 25.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.041 -1.096 . . . . 74.21 108.041 167.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.13 68.02 10.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.832 0.853 . . . . 75.11 111.839 -167.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.725 ' HG3' ' HA2' ' E' ' 192' ' ' GLY . 53.8 tt0 -125.73 79.26 68.28 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.251 -1.018 . . . . 70.11 108.251 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.487 ' HB2' HG13 ' C' ' 40' ' ' VAL . 18.8 Cg_endo -89.42 137.57 3.02 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.472 2.115 . . . . 71.13 111.285 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.25 79.8 9.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.37 -1.344 . . . . 72.32 107.37 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.623 ' HB ' HD11 ' C' ' 126' ' ' LEU . 17.2 m -84.21 111.29 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.314 -1.766 . . . . 34.4 110.166 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -136.83 140.27 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.608 0.363 . . . . 74.3 110.104 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.549 HD12 HD11 ' E' ' 186' ' ' LEU . 3.4 pp -88.47 155.36 19.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.964 0.506 . . . . 73.51 109.796 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -144.31 125.27 14.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.689 -0.486 . . . . 51.52 109.689 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.625 ' HB2' ' HE1' ' E' ' 184' ' ' TRP . 7.4 mp -92.11 120.2 32.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.112 0.965 . . . . 73.44 110.229 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.438 ' O ' HD23 ' C' ' 60' ' ' LEU . 30.4 t70 -117.32 146.8 43.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.707 1.203 . . . . 54.13 109.27 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.8 m -112.83 118.25 34.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.393 0.677 . . . . 75.3 110.592 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.87 160.29 29.14 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.88 1.272 . . . . 73.3 108.352 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -161.34 154.13 20.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.835 0.854 . . . . 70.32 110.077 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.1 p -147.75 143.45 27.56 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.592 1.157 . . . . 63.43 109.379 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -85.28 136.4 33.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.351 0.66 . . . . 71.52 110.351 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.617 HD11 HD12 ' C' ' 83' ' ' ILE . 85.8 mt -107.24 -39.66 5.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.871 0.868 . . . . 74.54 109.731 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.1 -178.54 7.06 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.587 -1.188 . . . . 73.01 109.752 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -73.33 119.99 18.33 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.678 -1.146 . . . . 73.02 108.462 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.495 ' H ' ' HB2' ' E' ' 172' ' ' ALA . 14.7 m-20 66.22 19.66 11.08 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.81 1.244 . . . . 75.43 111.256 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 48.4 t -135.14 105.79 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 107.314 -1.365 . . . . 62.15 107.314 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.476 ' CE2' ' SD ' ' E' ' 174' ' ' MET . 93.1 m-85 -123.09 166.57 14.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.456 0.703 . . . . 71.33 110.78 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.86 110.71 13.98 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.261 -1.336 . . . . 72.21 108.537 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.44 HG11 ' HD3' ' C' ' 103' ' ' PRO . 59.9 t -96.08 136.1 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.435 -1.32 . . . . 72.5 107.435 174.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.8 t -128.41 107.01 15.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.096 0.959 . . . . 74.35 108.92 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.492 HD12 ' O ' ' C' ' 103' ' ' PRO . 0.4 OUTLIER -87.35 108.09 18.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.951 -1.129 . . . . 72.31 107.951 176.23 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -89.64 104.94 17.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.121 -0.696 . . . . 71.54 109.121 173.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.25 -1.019 . . . . 72.11 108.25 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -103.39 121.91 43.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.161 0.584 . . . . 72.43 109.503 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.744 HG21 HG21 ' C' ' 114' ' ' ILE . 88.5 t -102.34 136.44 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.762 1.225 . . . . 72.43 109.984 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 54.8 m -122.79 140.42 52.93 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.819 0.848 . . . . 74.25 109.044 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 117.87 17.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.036 -1.098 . . . . 64.34 108.036 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -135.0 131.78 37.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.481 0.658 . . . . 75.15 110.76 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.768 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.3 mt -89.61 41.97 1.07 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.423 1.889 . . . . 71.01 109.479 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.26 -109.11 3.29 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.529 -1.028 . . . . 73.3 110.529 -169.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -91.83 -31.4 15.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.622 0.769 . . . . 75.44 110.584 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -75.53 119.43 19.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.683 1.193 . . . . 61.35 109.074 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -75.79 124.96 28.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.772 -0.455 . . . . 71.11 109.772 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.6 -51.99 13.01 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.078 -0.712 . . . . 55.04 109.078 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -166.69 174.87 8.32 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 115.174 -0.921 . . . . 63.11 110.351 173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.6 tm? -133.14 146.79 51.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.329 -1.73 . . . . 62.24 106.329 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.583 ' SG ' HG23 ' C' ' 114' ' ' ILE . 44.7 t -145.53 146.4 31.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.447 -0.946 . . . . 53.2 108.447 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.28 130.32 6.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.072 0.396 . . . . 72.24 110.698 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.87 134.55 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.232 1.013 . . . . 62.43 109.236 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.679 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.6 mt-30 -107.18 97.73 7.46 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.648 1.179 . . . . 70.52 108.361 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 61.6 tp60 -82.71 101.24 10.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.526 -0.761 . . . . 74.44 109.027 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.02 145.38 20.67 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.948 -0.861 . . . . 64.13 110.948 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.26 122.65 1.54 Allowed Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.508 -1.037 . . . . 54.44 110.508 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.617 HD12 HD11 ' C' ' 51' ' ' LEU . 7.7 mm -84.02 128.15 39.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.246 -1.02 . . . . 75.14 108.246 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -134.69 120.92 20.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.653 0.781 . . . . 72.42 109.412 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -78.85 116.74 19.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.631 -1.248 . . . . 65.03 107.631 168.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.573 HG12 HD12 ' C' ' 89' ' ' ILE . 1.5 tt -133.58 114.46 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 C-N-CA 123.937 0.895 . . . . 65.12 109.743 -170.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.23 41.88 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.582 0.753 . . . . 54.12 110.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.7 -19.02 35.28 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 114.217 0.447 . . . . 63.25 114.217 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.793 HG22 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -63.39 130.85 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 125.053 1.341 . . . . 65.13 111.283 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.465 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 44.9 mt-10 -147.29 147.2 30.13 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.809 0.443 . . . . 75.41 110.719 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.63 -136.99 18.2 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.828 -0.624 . . . . 41.01 112.825 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.449 ' HB ' ' HZ ' ' C' ' 137' ' ' PHE . 37.5 p -66.28 -19.51 65.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.67 0.788 . . . . 75.12 111.357 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -64.19 -49.5 71.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.609 0.764 . . . . 61.21 110.604 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.465 ' HE2' ' HA ' ' C' ' 90' ' ' GLU . 15.3 ptp -71.38 -32.8 68.9 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.776 0.262 . . . . 54.2 110.652 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.9 94.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.933 0.893 . . . . 54.31 111.705 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -83.4 -30.92 26.98 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.046 -0.525 . . . . 62.5 111.031 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.16 -58.16 8.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.424 0.289 . . . . 63.45 110.575 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -82.31 -38.39 24.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.784 0.434 . . . . 75.14 110.517 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.74 10.23 75.07 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.001 -0.888 . . . . 71.14 115.029 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.92 -49.03 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.365 1.083 . . . . 60.2 112.452 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.401 ' O ' HG12 ' C' ' 105' ' ' ILE . 82.5 t80 -76.14 -49.26 17.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.314 0.646 . . . . 72.52 111.079 -171.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 99.4 m -59.35 -48.03 96.87 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.218 -0.896 . . . . 52.23 111.639 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.492 ' O ' HD12 ' C' ' 60' ' ' LEU . 39.5 Cg_endo -66.75 -27.29 44.68 Favored 'Trans proline' 0 C--N 1.399 3.234 0 C-N-CA 121.487 1.458 . . . . 73.31 112.781 172.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.91 -35.58 81.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.224 0.465 . . . . 54.21 110.974 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.471 HD12 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -65.01 -36.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.507 0.723 . . . . 74.04 110.092 174.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.6 mt -85.47 -19.68 30.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.165 0.986 . . . . 64.32 112.455 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.9 -53.0 70.32 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.256 -1.354 . . . . 62.13 112.68 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.85 -33.85 97.52 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 121.94 1.76 . . . . 72.44 112.273 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.446 ' HE2' HG21 ' A' ' 115' ' ' THR . 89.6 m-85 -67.81 -50.48 56.6 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.005 0.922 . . . . 73.24 111.187 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -62.3 -41.4 98.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 64.35 110.392 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -57.76 -48.13 80.51 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.988 1.715 . . . . 73.1 110.902 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -74.89 -33.06 61.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.249 0.62 . . . . 73.21 110.581 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.1 t -63.85 -33.78 76.46 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.322 0.649 . . . . 63.05 110.824 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.744 HG21 HG21 ' C' ' 64' ' ' VAL . 96.8 mt -75.98 -46.35 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.096 -0.957 . . . . 73.33 110.507 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -55.92 -35.99 67.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.524 0.73 . . . . 62.33 110.851 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 44.6 t -60.62 -57.56 12.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.26 -1.336 . . . . 75.23 109.89 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.546 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.62 -39.39 70.76 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.907 1.283 . . . . 60.44 113.538 -177.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' C' ' 123' ' ' PHE . 77.5 t -68.33 -44.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.09 0.956 . . . . 62.13 110.439 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.406 ' HB2' HG21 ' B' ' 115' ' ' THR . 40.3 t -63.03 -34.99 78.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.272 -0.876 . . . . 73.01 111.086 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.546 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 67.0 mtt-85 -64.83 -45.13 87.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.07 -0.968 . . . . 74.21 109.925 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.47 69.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.402 -0.817 . . . . 63.23 113.447 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 65.91 34.46 7.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.867 1.667 . . . . 55.25 113.23 170.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.517 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 87.1 m-85 -97.9 169.98 7.75 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 124.417 1.087 . . . . 62.13 109.802 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.533 ' HA ' HE21 ' B' ' 125' ' ' GLN . 72.1 Cg_endo -70.71 175.32 9.05 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.6 2.2 . . . . 73.42 112.803 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -60.23 130.64 47.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.859 0.464 . . . . 63.3 112.121 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.623 HD11 ' HB ' ' C' ' 40' ' ' VAL . 1.5 mm? -122.81 18.48 10.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.42 1.088 . . . . 72.43 110.857 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -90.44 81.15 6.0 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.001 -1.481 . . . . 63.25 107.001 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.71 101.71 14.11 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.196 -1.366 . . . . 71.2 111.088 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.614 ' HB3' HD13 ' E' ' 187' ' ' ILE . . . 54.03 175.63 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 115.399 1.629 . . . . 74.22 115.399 162.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -91.58 -172.33 0.44 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.449 2.099 . . . . 72.23 113.334 165.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.48 122.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.765 0.826 . . . . 63.13 109.81 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -114.9 102.78 10.29 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.937 0.895 . . . . 72.14 109.276 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -82.49 -21.02 35.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.819 0.448 . . . . 74.42 111.77 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.88 -29.84 68.59 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.795 0.838 . . . . 74.41 111.768 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.53 97.37 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.728 0.811 . . . . 63.23 110.926 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 68.8 mt -80.01 -28.05 39.45 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.906 0.882 . . . . 64.34 111.495 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.449 ' HZ ' ' HB ' ' C' ' 92' ' ' THR . 84.1 t80 -71.3 -45.68 62.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.13 0.572 . . . . 71.42 110.175 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.542 ' HA ' ' HG3' ' C' ' 142' ' ' GLN . 0.0 OUTLIER -68.86 -28.38 66.66 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.518 0.512 . . . . 73.21 110.664 178.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.18 -46.05 88.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.523 1.129 . . . . 73.35 109.848 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -71.73 -85.59 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.761 0.824 . . . . 73.21 110.907 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 55.8 tp -148.31 130.67 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.055 0.942 . . . . 72.53 108.809 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.542 ' HG3' ' HA ' ' C' ' 138' ' ' MET . 9.3 mp0 -101.99 -77.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 74.4 109.449 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 144' ' ' GLN . 21.0 mm-40 -145.17 108.41 4.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.683 1.193 . . . . 64.44 107.92 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.54 101.9 13.62 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.672 -1.233 . . . . 75.54 107.672 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.06 -68.91 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.742 0.417 . . . . 71.53 110.403 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.97 174.71 25.21 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 116.664 -0.244 . . . . 65.31 113.497 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 145' ' ' ALA . 2.9 tm-20 -152.36 156.91 40.5 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.69 -1.226 . . . . 74.12 107.69 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.44 -54.53 0.28 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.195 -0.762 . . . . 75.14 111.195 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -74.9 86.99 2.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.544 0.738 . . . . 73.03 109.876 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.06 92.21 3.35 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.011 -1.107 . . . . 74.43 108.011 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.14 104.59 13.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.454 -0.943 . . . . 61.21 108.454 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -90.11 63.76 5.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.742 0.782 . . . . 75.15 110.136 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -95.97 92.6 6.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.506 -0.77 . . . . 74.13 109.077 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -136.1 140.81 44.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.217 1.007 . . . . 74.44 108.477 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 N-CA-C 109.326 -0.62 . . . . 73.21 109.326 177.111 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 111.743 0.275 . . . . 71.22 111.743 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m -131.15 88.08 2.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.192 0.597 . . . . 71.23 109.482 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.22 8.54 3.92 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.581 0.752 . . . . 74.11 112.308 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -60.7 2.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.038 1.335 . . . . 63.12 109.622 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' D' ' 8' ' ' GLU . 89.7 m-20 -91.74 75.75 5.71 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.665 -0.865 . . . . 64.54 108.665 171.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -75.01 -17.59 60.5 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.084 -0.962 . . . . 70.54 111.203 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -108.56 26.37 10.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.264 1.025 . . . . 72.04 110.726 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' D' ' 5' ' ' ASN . 10.3 tp10 -70.75 -94.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.393 0.677 . . . . 71.51 110.787 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.471 ' HG3' HG13 ' D' ' 89' ' ' ILE . 20.2 ttp -37.97 134.48 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.42 1.088 . . . . 74.13 112.947 171.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.4 m -130.46 138.17 50.16 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.783 -0.451 . . . . 63.52 109.783 172.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' D' ' 85' ' ' SER . 73.5 t80 -156.73 93.06 1.34 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.968 1.307 . . . . 64.21 107.651 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.82 146.75 45.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.811 -0.631 . . . . 74.54 110.149 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.419 HG21 ' HG2' ' B' ' 130' ' ' PRO . 2.2 mp -83.12 125.83 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 71.31 108.688 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.0 -46.42 4.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.059 0.544 . . . . 75.11 111.403 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.444 ' NH1' ' HE2' ' E' ' 202' ' ' TYR . 7.9 tpt180 -166.45 122.44 1.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.919 -0.562 . . . . 42.45 110.938 -169.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.27 124.1 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.627 -1.249 . . . . 74.22 107.627 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -158.98 152.77 23.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 73.12 111.895 -168.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -86.49 117.8 25.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.162 -0.926 . . . . 61.13 109.087 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -88.67 -23.28 23.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.759 -0.655 . . . . 60.51 110.183 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.5 t70 -158.53 133.92 8.69 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.258 -0.883 . . . . 62.12 109.416 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.53 HD13 ' HE3' ' C' ' 117' ' ' MET . 76.7 mt -137.61 143.68 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.347 1.059 . . . . 60.44 108.386 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -142.12 143.96 33.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.958 1.303 . . . . 74.53 108.023 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.9 t80 -151.49 110.82 3.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.511 -2.033 . . . . 64.41 105.511 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -128.12 108.22 10.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.164 -0.68 . . . . 73.31 109.164 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.46 91.15 4.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 106.896 -1.52 . . . . 73.43 106.896 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 -24.96 11.95 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.426 2.084 . . . . 51.21 112.24 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -112.7 36.03 3.62 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 124.186 0.994 . . . . 72.23 108.419 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.569 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -59.96 -50.18 87.69 Favored Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.974 1.472 . . . . 44.12 114.974 -166.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.401 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.8 Cg_endo -83.98 -4.84 10.52 Favored 'Trans proline' 0 C--N 1.392 2.854 0 CA-C-N 121.803 1.68 . . . . 75.14 113.076 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.52 -37.04 23.58 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.288 1.035 . . . . 72.35 109.231 178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' D' ' 73' ' ' ALA . 33.1 m -83.63 -4.24 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.864 0.865 . . . . 63.45 111.534 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.94 -25.73 67.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.671 0.788 . . . . 70.34 109.965 165.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -83.19 0.07 47.03 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.135 0.974 . . . . 52.43 111.447 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -116.94 86.23 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.536 1.134 . . . . 72.23 109.641 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.81 51.53 2.17 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.805 0.812 . . . . 64.41 110.186 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -130.15 -175.95 3.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.934 0.894 . . . . 73.05 109.222 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.468 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 33.9 tp60 -79.68 116.88 64.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 122.968 0.507 . . . . 65.11 110.293 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 13.9 Cg_exo -67.52 87.92 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.999 1.799 . . . . 74.23 109.375 169.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.88 120.66 14.53 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.539 -0.755 . . . . 61.24 110.548 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.659 HG13 HG13 ' D' ' 64' ' ' VAL . 84.8 t -95.83 117.65 40.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 114.991 -1.004 . . . . 73.54 110.291 -167.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.3 mmtt -89.58 115.2 26.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.712 -1.218 . . . . 74.31 107.712 171.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.51 124.53 37.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.218 -1.03 . . . . 73.14 108.218 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.8 t70 -116.59 125.39 51.76 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.388 -0.967 . . . . 53.2 108.388 174.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.61 132.3 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.749 0.82 . . . . 75.32 109.744 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.0 t70 -143.04 118.31 10.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.252 -1.388 . . . . 63.14 107.252 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -120.02 145.02 47.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.046 0.538 . . . . 63.1 110.27 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.29 43.94 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.17 0.988 . . . . 72.11 109.087 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -147.65 156.06 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.778 0.831 . . . . 65.23 109.521 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 63.4 p -151.77 127.27 10.04 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.329 0.651 . . . . 60.25 109.985 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -69.49 119.58 13.96 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.666 -0.494 . . . . 72.25 109.666 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' D' ' 57' ' ' GLU . 52.7 mt -92.35 -34.02 14.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.009 0.523 . . . . 75.33 110.348 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.84 -171.68 3.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.152 0.981 . . . . 75.22 109.856 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.12 109.59 1.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.036 0.534 . . . . 62.23 109.837 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.689 ' HA ' HD23 ' H' ' 173' ' ' LEU . 2.5 m-20 64.85 11.16 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.067 1.347 . . . . 73.12 113.193 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.89 133.27 58.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.386 . . . . 51.25 107.259 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.66 174.35 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.322 0.582 . . . . 71.14 109.822 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.8 tt0 -124.86 147.83 48.57 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 124.251 1.02 . . . . 72.44 108.511 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -120.15 125.57 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.521 -1.289 . . . . 73.15 107.521 167.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.423 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 82.4 t -103.54 126.81 57.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.019 0.928 . . . . 64.35 108.691 174.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.2 122.08 46.79 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.712 -1.218 . . . . 74.43 107.712 178.288 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.8 ttm-85 -109.47 99.97 9.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.298 -1.001 . . . . 53.2 108.298 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.08 126.68 44.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.19 -1.411 . . . . 33.41 107.19 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.0 m -120.44 127.22 52.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.585 0.707 . . . . 63.21 110.351 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.659 HG13 HG13 ' D' ' 40' ' ' VAL . 17.3 t -112.43 107.29 22.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 126.151 1.78 . . . . 75.2 109.144 -175.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 22.6 m -107.6 93.07 4.34 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.7 -1.222 . . . . 61.21 107.7 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.5 137.59 34.34 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.151 -0.685 . . . . 64.24 109.151 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.514 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 43.4 m -137.68 134.4 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 70.5 111.48 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.491 HD12 ' HB ' ' D' ' 31' ' ' VAL . 21.7 mt -108.08 107.05 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.004 1.322 . . . . 75.21 110.397 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.55 -112.29 3.67 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.936 -0.466 . . . . 74.12 111.936 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.86 6.3 17.87 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.089 0.955 . . . . 74.12 111.002 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -124.17 168.32 13.07 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.659 0.784 . . . . 64.11 110.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -81.31 126.6 31.77 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.312 0.645 . . . . 74.11 110.283 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG11 ' D' ' 31' ' ' VAL . . . -78.05 -67.17 0.76 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.783 0.833 . . . . 53.31 109.243 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.08 153.68 32.31 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 115.169 -0.923 . . . . 74.41 110.117 173.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.5 mt -109.66 152.75 25.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.623 -1.251 . . . . 61.42 107.623 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.571 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 42.0 t -158.9 146.73 17.86 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.528 0.731 . . . . 70.14 109.095 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -156.1 128.95 7.9 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.302 -0.629 . . . . 71.32 109.302 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.78 115.58 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.03 0.532 . . . . 64.45 109.708 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.537 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.9 mt-30 -90.36 89.1 7.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.571 0.749 . . . . 74.24 109.817 170.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -81.31 100.39 9.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.684 -1.144 . . . . 75.04 108.838 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -95.6 144.62 17.35 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.491 -0.644 . . . . 63.32 111.491 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.82 130.52 3.93 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.317 -0.713 . . . . 62.31 111.317 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.6 mt -89.73 124.86 42.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 124.249 1.02 . . . . 72.43 109.011 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.91 168.77 16.76 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.047 1.339 . . . . 71.44 108.973 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.6 m -114.07 137.0 52.31 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.765 0.826 . . . . 73.24 109.637 171.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.44 125.44 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.296 0.638 . . . . 60.24 109.939 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' H' ' 171' ' ' SER . . . -162.32 164.64 27.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.343 0.657 . . . . 71.21 110.602 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.04 -20.63 19.63 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 123.837 0.71 . . . . 73.42 114.788 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.471 HG13 ' HG3' ' D' ' 9' ' ' MET . 2.1 pp -133.49 163.3 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.993 0.917 . . . . 65.33 110.555 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -143.95 -176.12 4.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.08 0.952 . . . . 72.02 110.414 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.33 -133.54 20.05 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.347 -0.842 . . . . 74.2 113.565 171.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.1 m -59.3 -39.7 83.87 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.463 1.105 . . . . 70.33 111.812 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -58.62 -45.29 89.51 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.038 0.935 . . . . 73.11 111.604 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 3.4 ppp? -81.64 -39.26 24.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.547 0.339 . . . . 61.53 111.513 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.471 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.5 -40.3 92.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 73.52 111.272 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -78.96 -26.37 43.48 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.288 -0.869 . . . . 73.13 110.735 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.3 t -68.73 -52.5 30.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.437 0.295 . . . . 41.44 110.861 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' D' ' 94' ' ' MET . 1.7 pp -76.82 -18.34 58.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.096 0.406 . . . . 70.3 112.096 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.16 0.03 68.49 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.241 -0.755 . . . . 44.03 113.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.535 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -151.53 -61.56 0.17 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.081 0.94 . . . . 74.32 112.421 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -67.05 -48.88 66.95 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.533 0.733 . . . . 75.52 112.631 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 23.4 m -66.05 -42.7 53.19 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.384 0.674 . . . . 73.22 112.264 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 49.4 Cg_exo -59.15 -35.62 97.39 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.168 1.912 . . . . 70.41 112.762 166.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -65.85 -28.69 69.17 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.126 0.571 . . . . 73.02 111.356 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -65.97 -40.96 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.231 0.612 . . . . 75.53 110.011 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.431 HD21 ' HA3' ' D' ' 82' ' ' GLY . 77.1 mt -75.57 -23.01 56.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.021 -0.99 . . . . 73.14 111.762 -174.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -64.14 -40.9 57.5 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 117.495 -1.241 . . . . 70.44 113.904 -171.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.46 -41.9 42.85 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.224 1.949 . . . . 74.1 113.719 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.2 m-85 -78.09 -38.69 43.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.749 0.82 . . . . 73.14 111.422 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.04 95.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.152 0.581 . . . . 73.02 109.913 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -57.14 -56.82 16.81 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 124.875 1.27 . . . . 72.54 109.732 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.11 -39.62 90.67 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.325 1.016 . . . . 70.53 111.837 -172.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -45.36 88.35 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.743 0.652 . . . . 74.01 110.408 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.553 HG21 HG21 ' D' ' 64' ' ' VAL . 84.2 mt -64.51 -53.66 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.124 0.97 . . . . 50.44 110.155 174.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.0 m -52.4 -41.18 62.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.99 1.716 . . . . 71.11 111.546 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -69.7 -44.9 69.46 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.685 -1.143 . . . . 61.21 110.105 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.72 -30.21 70.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.963 0.505 . . . . 72.15 112.007 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.5 t -65.57 -47.37 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.805 0.842 . . . . 73.53 109.75 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -72.18 -29.08 63.66 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.047 -0.524 . . . . 44.51 110.744 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -70.18 -30.91 68.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.651 0.78 . . . . 55.24 110.166 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 10.46 63.99 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 115.788 -0.642 . . . . 51.44 112.797 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.535 HG23 ' HB3' ' C' ' 17' ' ' TYR . 40.7 p 64.01 18.53 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.663 1.985 . . . . 74.11 113.841 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 88.0 m-85 -88.28 164.71 31.93 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.036 0.934 . . . . 74.25 108.875 171.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.42 140.89 71.89 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.707 2.271 . . . . 72.21 111.012 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.5 118.18 7.2 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 109.521 -0.548 . . . . 72.43 109.521 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.3 101.76 11.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.377 0.671 . . . . 64.23 109.689 -171.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -98.8 96.12 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.508 -0.923 . . . . 63.25 108.508 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 129.63 40.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.939 0.896 . . . . 74.23 110.758 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -57.44 132.07 81.57 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.717 0.807 . . . . 75.23 111.121 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.44 114.25 3.87 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 121.962 1.775 . . . . 70.32 110.656 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.8 t -106.03 107.09 21.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.033 -1.099 . . . . 65.35 108.033 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -80.74 106.03 12.43 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.722 -1.214 . . . . 74.53 107.722 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.535 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 51.4 m-85 -66.06 -38.02 87.27 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.038 -0.983 . . . . 73.33 110.546 -175.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.98 -42.34 94.64 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.105 -0.952 . . . . 54.21 110.667 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.55 -53.08 62.37 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.066 0.854 . . . . 74.22 111.045 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.584 HD13 ' HD2' ' H' ' 185' ' ' PRO . 77.3 mt -63.66 -33.28 75.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.402 0.681 . . . . 52.32 112.257 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -62.78 -47.67 82.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.65 0.78 . . . . 75.44 110.477 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 71.9 mtm -73.37 -44.22 59.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.589 -0.732 . . . . 61.11 111.299 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -64.75 -43.11 94.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.539 0.736 . . . . 63.34 111.154 -175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -65.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.72 0.638 . . . . 74.2 110.913 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.07 -36.47 82.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.955 0.902 . . . . 72.44 109.725 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -79.16 5.44 12.07 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.95 0.9 . . . . 73.5 111.86 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.52 92.09 3.71 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.279 1.032 . . . . 75.04 108.834 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -141.27 14.99 2.22 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.671 0.788 . . . . 45.51 109.655 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.37 131.63 2.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.964 0.905 . . . . 74.4 109.364 174.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.1 124.02 7.71 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.921 -0.872 . . . . 72.52 110.921 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.31 148.15 40.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.398 0.679 . . . . 74.5 110.481 -174.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.19 39.9 0.1 Allowed Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.901 -0.59 . . . . 70.42 111.925 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 19.5 m -80.81 87.17 5.9 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.603 0.761 . . . . 73.2 110.534 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -163.3 164.22 24.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.07 0.948 . . . . 73.33 108.765 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 66.36 144.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.049 1.34 . . . . 73.34 111.908 -171.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -139.29 163.17 33.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.071 0.949 . . . . 73.11 109.351 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -135.29 114.87 12.67 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.392 1.077 . . . . 72.41 109.153 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.42 102.74 6.1 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.251 0.62 . . . . 65.1 109.624 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 123.831 0.853 . . . . 62.22 110.867 -177.749 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 109.635 -0.506 . . . . 72.42 109.635 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.81 142.88 4.64 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.475 0.484 . . . . 60.42 112.019 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -72.0 121.38 19.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.296 0.638 . . . . 55.2 110.795 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 51.6 m -84.51 144.73 28.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.906 -0.775 . . . . 53.12 108.906 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 172' ' ' ALA . . . . . 0.582 ' HB1' ' SD ' ' E' ' 174' ' ' MET . . . -69.55 154.13 42.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.929 0.492 . . . . 62.11 111.475 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.637 HD22 ' HE3' ' E' ' 174' ' ' MET . 0.0 OUTLIER -114.93 7.13 15.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.806 0.842 . . . . 63.1 112.75 -169.541 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.637 ' HE3' HD22 ' E' ' 173' ' ' LEU . 1.0 OUTLIER -122.33 -165.92 1.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.377 0.671 . . . . 63.41 109.335 -176.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 19.9 t80 72.37 34.02 1.39 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.752 1.221 . . . . 72.22 110.966 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -62.67 -47.59 83.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.052 -1.092 . . . . 72.14 108.052 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 1.6 tt 52.32 70.58 0.55 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.46 1.504 . . . . 72.34 110.821 171.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -93.13 73.74 4.66 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.258 -1.015 . . . . 75.23 108.258 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 67.29 170.17 0.11 Allowed Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.65 1.18 . . . . 71.44 111.621 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.63 79.57 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.272 1.981 . . . . 74.43 110.564 165.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -70.67 -25.3 62.92 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.23 -0.896 . . . . 72.43 111.581 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.04 118.4 36.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.136 -0.69 . . . . 75.11 109.136 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 49.9 p -131.48 146.17 52.11 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.479 1.112 . . . . 71.23 110.627 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.625 ' HE1' ' HB2' ' C' ' 44' ' ' LEU . 2.8 p90 -101.16 143.51 26.74 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.944 1.298 . . . . 74.22 109.144 175.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.57 -41.27 26.16 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.795 2.33 . . . . 63.42 111.831 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.549 HD11 HD12 ' C' ' 42' ' ' LEU . 2.6 tm? 70.54 138.91 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.365 1.466 . . . . 74.42 110.308 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' C' ' 129' ' ' ALA . 45.0 pt -55.76 142.23 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 124.116 0.966 . . . . 73.25 112.498 -174.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.76 91.84 4.17 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.86 -1.163 . . . . 74.21 107.86 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.28 128.63 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.896 0.478 . . . . 72.25 110.65 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -53.17 -45.51 68.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 72.21 112.443 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.38 -170.23 54.88 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.925 -0.579 . . . . 74.51 112.124 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 192' ' ' GLY . . . . . 0.725 ' HA2' ' HG3' ' C' ' 37' ' ' GLN . . . 130.98 -161.45 23.49 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 117.314 0.557 . . . . 43.51 113.048 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -82.84 162.42 21.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.921 0.889 . . . . 73.11 111.265 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -164.33 10.02 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.789 0.835 . . . . 75.14 111.432 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -136.96 134.26 36.5 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.751 0.821 . . . . 74.32 109.928 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -119.64 82.13 1.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.209 -1.404 . . . . 74.12 107.209 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 197' ' ' TYR . . . . . 0.532 ' HA ' ' HB3' ' E' ' 201' ' ' LYS . 59.1 m-85 -74.46 1.88 10.83 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.317 0.647 . . . . 75.5 112.716 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -108.86 -7.03 15.55 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.47 0.708 . . . . 63.42 110.683 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -134.98 -76.3 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 63.14 110.804 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -85.68 24.23 7.85 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 114.333 0.493 . . . . 60.01 114.333 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' E' ' 197' ' ' TYR . 63.3 pttt -66.42 -179.65 0.85 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.822 1.249 . . . . 72.13 112.426 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 202' ' ' TYR . . . . . 0.444 ' HE2' ' NH1' ' D' ' 15' ' ' ARG . 44.5 m-85 -74.69 77.79 2.04 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.77 -1.196 . . . . 62.34 107.77 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.51 95.42 2.25 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.829 -0.434 . . . . 75.42 109.829 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 14.0 tt -131.15 137.67 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.274 1.029 . . . . 72.1 109.114 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 3.32 1.56 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.856 1.262 . . . . 72.51 109.724 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.99 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.701 1.2 . . . . 74.01 109.261 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.484 1.241 0 C-N-CA 124.835 1.254 . . . . 74.3 109.441 -172.942 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.292 -0.262 . . . . 53.21 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.19 -62.49 3.19 Favored Glycine 0 C--N 1.345 1.067 0 O-C-N 123.74 0.65 . . . . 62.24 113.354 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -91.75 98.63 11.73 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.653 0.781 . . . . 61.22 111.683 -171.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 1.4 m 60.19 -85.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.625 1.57 . . . . 75.0 112.227 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.02 96.76 0.62 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.133 -1.062 . . . . 63.45 108.133 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.464 HD22 ' HE2' ' B' ' 56' ' ' TYR . 58.2 mt -117.48 96.22 5.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.563 0.697 . . . . 71.05 111.108 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.575 ' HB2' ' SD ' ' B' ' 94' ' ' MET . 2.8 mpp? -99.09 178.6 4.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.749 1.22 . . . . 73.42 108.45 173.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -172.95 89.87 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.528 -0.545 . . . . 71.24 109.528 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -138.04 84.97 2.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.756 0.822 . . . . 74.24 109.936 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 32.4 tp -88.64 59.52 5.16 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.621 -1.252 . . . . 75.03 107.621 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -102.82 -73.79 0.65 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.88 -1.055 . . . . 73.51 110.146 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -94.99 109.18 42.86 Favored Pre-proline 0 C--O 1.243 0.731 0 C-N-CA 123.573 0.749 . . . . 71.15 110.564 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.54 94.43 0.94 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.172 1.914 . . . . 53.04 110.244 170.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -62.28 104.26 0.47 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.56 -0.745 . . . . 73.11 109.226 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 69.01 163.45 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.704 1.601 . . . . 74.42 110.546 -166.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 30.6 p -140.18 151.43 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.789 -0.57 . . . . 64.24 111.001 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.406 ' HB2' ' HB ' ' B' ' 131' ' ' VAL . 38.3 p90 -71.0 152.37 94.94 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.044 1.338 . . . . 62.24 110.864 176.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.52 160.29 41.73 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.738 2.292 . . . . 74.11 112.488 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.6 147.42 25.97 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.627 -0.879 . . . . 74.03 108.627 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.401 HG22 ' O ' ' F' ' 188' ' ' ALA . 3.9 mp -98.94 154.57 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 108.674 -0.862 . . . . 72.22 108.674 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 188' ' ' ALA . . . . . 0.401 ' O ' HG22 ' F' ' 187' ' ' ILE . . . -82.25 -179.23 7.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.21 0.604 . . . . 64.34 110.819 172.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.32 19.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.395 0.678 . . . . 65.33 109.818 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -92.82 -82.5 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.525 0.73 . . . . 73.21 111.189 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.96 -105.75 0.6 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 111.631 -0.588 . . . . 50.42 111.631 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -144.56 -145.94 4.41 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.795 -0.522 . . . . 50.24 111.795 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -97.9 -84.19 0.39 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 117.039 0.419 . . . . 75.43 109.979 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -134.67 -22.64 1.66 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.724 0.81 . . . . 45.3 110.503 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 63.98 -84.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.294 1.438 . . . . 72.33 110.339 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 196' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' B' ' 35' ' ' ASP . 31.2 ttpt 56.43 20.03 4.49 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.889 1.275 . . . . 75.01 111.379 -171.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 58.8 t80 68.07 -58.33 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.026 1.731 . . . . 74.35 111.553 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.94 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.406 1.482 . . . . 73.21 111.746 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 199' ' ' ASN . . . . . 0.537 HD22 ' HB3' ' F' ' 205' ' ' LYS . 64.5 m-80 -57.34 94.9 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 CA-C-O 122.122 0.963 . . . . 64.25 112.358 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -164.7 32.39 0.25 Allowed Glycine 0 C--O 1.244 0.778 0 CA-C-N 113.638 -1.619 . . . . 75.22 109.615 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 75.33 143.34 0.08 Allowed 'General case' 0 C--N 1.363 1.191 0 C-N-CA 126.605 1.962 . . . . 74.32 111.847 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 63.94 37.96 9.08 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.568 1.547 . . . . 74.2 109.575 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.7 -176.68 3.67 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.57 -1.65 . . . . 73.12 111.999 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 2.9 tp -132.1 -44.51 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.282 -1.326 . . . . 72.45 109.158 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 205' ' ' LYS . . . . . 0.537 ' HB3' HD22 ' F' ' 199' ' ' ASN . 21.2 ptmt 46.57 -74.0 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 126.414 1.886 . . . . 74.2 113.0 -167.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.91 152.22 5.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.384 1.074 . . . . 62.54 108.839 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.564 1.485 0 C-N-CA 124.531 1.133 . . . . 65.23 111.635 -179.54 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' G' G ' 168' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' G' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 121.407 0.623 . . . . 72.23 109.559 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.27 -149.64 19.32 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.428 -0.669 . . . . 73.54 111.428 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.63 113.64 24.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.88 -0.785 . . . . 74.05 108.88 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 66.5 p -65.5 142.12 58.24 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.846 0.859 . . . . 74.31 110.972 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 172' ' ' ALA . . . . . 0.592 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . . . -139.47 -101.58 0.16 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 117.88 -1.057 . . . . 64.24 110.836 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 77.1 mt 66.3 -67.09 0.16 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.822 1.249 . . . . 63.22 113.241 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 36.2 mmt -93.16 40.68 1.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.33 1.052 . . . . 74.41 112.375 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.532 ' H ' ' HE1' ' A' ' 94' ' ' MET . 53.5 t80 60.59 94.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.243 1.417 . . . . 71.33 110.707 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 176' ' ' ASN . . . . . 0.51 ' OD1' ' HG2' ' G' ' 178' ' ' GLN . 24.4 t-20 -108.65 -77.93 0.59 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.846 0.858 . . . . 74.14 109.702 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.59 65.76 1.42 Allowed 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.194 0.998 . . . . 75.15 110.805 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 178' ' ' GLN . . . . . 0.51 ' HG2' ' OD1' ' G' ' 176' ' ' ASN . 14.9 mm100 -56.42 -40.97 75.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.323 0.649 . . . . 72.04 111.518 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.22 143.83 29.05 Favored Pre-proline 0 C--O 1.245 0.821 0 C-N-CA 124.532 1.133 . . . . 71.44 108.738 -173.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.78 90.36 1.06 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.473 2.115 . . . . 63.34 111.404 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.98 -49.7 73.67 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.513 0.725 . . . . 75.25 110.358 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -96.07 90.09 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.742 -1.117 . . . . 64.42 109.979 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 33.6 p -88.14 80.13 7.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.103 -0.953 . . . . 74.54 108.786 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -102.27 135.66 19.57 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 116.021 -0.536 . . . . 63.42 111.003 -174.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.02 166.9 18.52 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.674 2.25 . . . . 75.15 112.894 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.86 163.59 14.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.951 -1.022 . . . . 61.15 110.413 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.4 ' H ' HG13 ' G' ' 187' ' ' ILE . 2.9 pp -73.64 169.77 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.799 -1.092 . . . . 70.51 111.241 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -131.7 176.15 8.58 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.602 0.761 . . . . 74.14 109.454 171.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 189' ' ' ALA . . . . . 0.4 ' HB3' HG21 ' A' ' 40' ' ' VAL . . . -113.91 104.74 12.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.225 0.61 . . . . 52.43 109.952 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 190' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' H' ' 201' ' ' LYS . 25.5 t70 -85.55 -58.31 2.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.559 0.744 . . . . 72.53 110.306 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.62 97.18 1.92 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.324 -0.398 . . . . 72.42 112.381 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.11 36.05 0.17 Allowed Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.733 0.267 . . . . 70.31 113.361 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.03 88.2 2.09 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.169 0.988 . . . . 75.31 109.192 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -165.58 -26.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.284 0.846 . . . . 73.34 113.284 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -80.39 53.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 75.45 109.222 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . 7.0 mtpm? -83.99 30.2 0.52 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.29 -0.881 . . . . 74.01 111.562 -170.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 60.01 176.14 0.09 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 125.466 1.507 . . . . 65.4 111.928 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -160.62 -63.73 0.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.603 -0.888 . . . . 74.34 108.603 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.16 -56.96 3.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.279 -0.873 . . . . 74.2 111.994 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.18 -67.88 0.52 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.163 -0.775 . . . . 63.02 111.163 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 201' ' ' LYS . . . . . 0.48 ' HB3' ' HE1' ' A' ' 32' ' ' PHE . 25.0 pttm -146.88 176.99 9.47 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.619 0.723 . . . . 74.24 111.924 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.11 100.9 6.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.468 -1.242 . . . . 74.43 109.312 170.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.26 95.87 6.44 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.954 0.501 . . . . 55.54 110.718 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.94 -18.07 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 N-CA-C 108.149 -1.056 . . . . 72.22 108.149 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt 74.38 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.218 1.807 . . . . 71.31 111.137 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -141.55 170.09 16.38 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.881 0.872 . . . . 74.45 110.318 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 207' ' ' VAL . . . . . 0.581 HG12 HD21 ' D' ' 136' ' ' LEU . 50.0 t . . . . . 0 CA--C 1.557 1.223 0 C-N-CA 124.308 1.043 . . . . 73.12 108.813 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 20.6 tptm . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 108.919 -0.771 . . . . 61.13 108.919 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.02 65.07 3.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.154 0.407 . . . . 61.12 112.697 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -169.93 102.18 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.648 1.579 . . . . 74.14 108.356 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 171' ' ' SER . . . . . 0.528 ' HB2' ' HB1' ' D' ' 87' ' ' ALA . 56.7 m -151.74 -59.47 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.43 0.692 . . . . 51.21 111.242 -173.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.01 76.99 1.55 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.286 -0.635 . . . . 60.33 109.286 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' D' ' 54' ' ' ASP . 2.8 tm? -78.56 129.88 35.32 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.493 -0.928 . . . . 75.34 108.493 176.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.88 29.08 0.6 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 109.739 -168.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.18 102.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.423 1.089 . . . . 65.15 111.305 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -144.76 96.54 2.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.333 1.053 . . . . 61.32 109.348 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 43.9 tp -112.56 93.96 4.69 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.853 -1.165 . . . . 72.54 107.853 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -81.1 -69.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.416 -0.811 . . . . 73.35 109.525 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.9 147.36 23.97 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.853 1.261 . . . . 75.15 108.814 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.09 113.87 3.2 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.764 2.31 . . . . 64.21 110.666 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -70.43 130.84 42.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.17 0.588 . . . . 72.43 111.358 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 65.6 -176.02 0.18 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.237 1.415 . . . . 53.14 111.04 -174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 85.7 m -129.63 125.97 37.33 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.36 0.664 . . . . 72.33 109.638 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 184' ' ' TRP . . . . . 0.405 ' HA ' ' HD3' ' H' ' 185' ' ' PRO . 5.8 m-90 -98.62 123.63 49.23 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.694 0.798 . . . . 74.12 109.566 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 185' ' ' PRO . . . . . 0.584 ' HD2' HD13 ' D' ' 136' ' ' LEU . 46.4 Cg_exo -58.09 126.02 20.32 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.424 2.749 . . . . 64.23 114.031 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 72.2 mt -85.54 137.61 32.76 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.045 0.938 . . . . 53.14 109.212 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 pt -72.91 148.02 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.446 0.698 . . . . 74.22 111.233 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.66 156.41 17.09 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.682 0.793 . . . . 70.32 109.882 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.33 127.1 31.72 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.776 0.831 . . . . 61.33 109.81 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.76 127.62 32.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.468 0.707 . . . . 75.1 109.439 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.9 95.2 0.19 Allowed Glycine 0 C--N 1.348 1.212 0 O-C-N 123.846 0.716 . . . . 60.22 111.452 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.16 15.39 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 124.073 0.514 . . . . 61.4 114.335 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.439 ' H ' ' HE2' ' H' ' 195' ' ' PHE . 47.6 m-85 63.53 8.96 3.89 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.933 1.293 . . . . 75.52 112.464 -175.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.91 81.57 2.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.576 -1.268 . . . . 43.22 107.576 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.439 ' HE2' ' H ' ' H' ' 193' ' ' TYR . 90.2 m-85 -130.88 -92.42 0.42 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.36 0.664 . . . . 74.22 109.461 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 43.37 77.49 0.06 Allowed 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.23 1.012 . . . . 72.3 110.01 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 197' ' ' TYR . . . . . 0.421 ' HD1' ' NH2' ' C' ' 15' ' ' ARG . 69.9 m-85 -45.18 96.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.388 1.075 . . . . 75.51 113.416 -166.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.23 175.7 2.55 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.894 1.278 . . . . 73.53 110.299 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 199' ' ' ASN . . . . . 0.528 HD22 ' HB2' ' A' ' 127' ' ' ASN . 4.6 t-20 70.34 96.44 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.254 1.022 . . . . 71.23 109.746 -176.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.72 169.49 15.54 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 110.171 -1.172 . . . . 73.31 110.171 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 201' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' G' ' 190' ' ' ASP . 44.1 tttp 61.91 36.24 15.93 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.591 0.756 . . . . 73.15 111.101 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.28 165.84 24.29 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.246 0.618 . . . . 72.22 111.568 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.99 102.49 10.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.152 0.981 . . . . 74.0 109.511 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.686 HD13 ' HG3' ' C' ' 12' ' ' GLN . 4.2 mp -123.25 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.921 -0.77 . . . . 71.24 108.921 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 205' ' ' LYS . . . . . 0.478 ' HE2' ' H ' ' H' ' 207' ' ' VAL . 5.0 ptmt -62.64 -75.91 0.07 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.648 0.779 . . . . 73.14 110.162 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 206' ' ' ASP . . . . . 0.468 ' H ' ' HG3' ' H' ' 205' ' ' LYS . 1.6 m-20 -155.21 -73.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 106.319 -1.734 . . . . 75.41 106.319 -174.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.478 ' H ' ' HE2' ' H' ' 205' ' ' LYS . 4.3 m . . . . . 0 CA--C 1.568 1.637 0 C-N-CA 125.019 1.328 . . . . 74.22 108.503 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 mmt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 112.036 0.384 . . . . 64.24 112.036 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -161.28 72.68 0.43 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 122.931 0.492 . . . . 53.04 110.954 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -169.1 -79.52 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.233 1.013 . . . . 71.23 109.197 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -161.02 -162.58 0.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.676 0.791 . . . . 62.01 109.29 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.711 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 14.5 t-20 82.37 -57.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 126.467 1.907 . . . . 74.11 109.932 -172.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' H ' ' H ' ' C' ' 146' ' ' GLY . 7.7 t-20 67.33 170.63 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.225 1.41 . . . . 73.34 111.578 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -84.87 -59.3 2.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.818 0.847 . . . . 72.43 109.418 171.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -81.5 -69.17 0.63 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.208 1.003 . . . . 62.12 110.52 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 ppp? 179.93 152.52 0.46 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.296 1.038 . . . . 61.43 109.826 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.3 m -144.63 139.82 28.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.985 0.914 . . . . 55.42 108.638 171.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.2 t80 -109.2 149.99 28.58 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.748 -0.834 . . . . 72.12 108.748 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 51.0 tp60 -148.68 114.77 5.79 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.289 -0.263 . . . . 75.25 110.289 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.45 HD11 HG13 ' A' ' 16' ' ' ILE . 2.3 tp -72.1 90.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.907 -1.516 . . . . 74.22 106.907 164.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -82.98 -22.69 33.61 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.698 -1.137 . . . . 73.53 110.611 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -176.88 145.23 0.49 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.07 0.395 . . . . 72.44 111.297 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.3 mt -106.12 139.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.606 -1.627 . . . . 73.22 106.606 162.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.0 p90 -169.03 135.9 1.8 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.951 0.9 . . . . 63.52 109.712 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.7 p -77.71 118.02 19.67 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.141 -0.482 . . . . 61.4 109.799 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -84.15 -27.05 28.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.764 -0.653 . . . . 75.21 110.114 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -151.8 138.0 18.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.026 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.9 mt -132.69 139.23 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.981 -1.489 . . . . 75.1 106.981 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -152.34 110.53 3.7 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.076 0.465 . . . . 75.53 110.501 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 72.6 t80 -109.71 120.49 42.64 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 106.397 -1.705 . . . . 73.44 106.397 169.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -119.14 130.71 55.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.36 -0.978 . . . . 50.22 108.36 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.65 19.49 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.529 -1.286 . . . . 65.1 107.529 172.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.31 -15.94 28.12 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.648 2.232 . . . . 62.41 112.129 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -113.44 28.49 8.74 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 124.188 0.995 . . . . 73.34 109.544 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -58.41 -45.68 99.67 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 113.962 1.097 . . . . 61.45 113.962 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.79 -32.75 8.85 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 121.538 1.492 . . . . 55.04 112.333 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -74.27 -20.36 60.17 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.75 1.22 . . . . 75.41 111.678 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 28' ' ' ALA . 5.2 p -75.32 -20.53 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.366 0.666 . . . . 75.02 112.097 -170.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.65 -29.85 65.08 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.019 -0.537 . . . . 71.44 110.224 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -71.14 -28.83 64.57 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.148 0.979 . . . . 71.4 110.72 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -72.98 142.65 47.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 73.23 111.484 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -73.08 115.31 12.25 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.489 -1.301 . . . . 71.42 107.489 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.59 ' CD1' ' HA ' ' G' ' 196' ' ' LYS . 63.8 t-105 -84.43 96.48 9.1 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.431 0.634 . . . . 74.55 110.867 -170.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' G' ' 192' ' ' GLY . 38.9 tt0 -137.25 80.0 35.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 106.515 -1.661 . . . . 62.24 106.515 168.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.31 148.54 16.63 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.393 2.062 . . . . 73.3 112.544 -170.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' HA ' ' HA2' ' G' ' 192' ' ' GLY . 42.5 tt0 -98.37 92.82 5.87 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.25 -1.389 . . . . 75.31 107.25 171.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' G' ' 190' ' ' ASP . 7.1 p -65.32 124.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.062 -0.972 . . . . 72.55 109.207 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -124.06 117.62 25.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.778 0.831 . . . . 74.43 109.321 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.4 tp -97.21 129.38 44.56 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.753 -0.832 . . . . 72.23 108.753 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.755 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.7 m-20 -115.19 134.35 55.23 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.273 1.029 . . . . 73.1 108.567 172.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -113.3 125.23 54.06 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.755 0.822 . . . . 74.01 109.246 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.27 145.52 37.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.334 0.653 . . . . 51.03 109.596 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.3 m -135.63 133.11 37.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 75.14 109.313 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 117.04 17.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.213 1.005 . . . . 40.32 109.439 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.3 p -118.47 153.27 34.42 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.46 0.704 . . . . 74.44 111.964 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -168.02 153.1 6.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.786 1.234 . . . . 73.53 109.523 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.4 138.6 32.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.887 -0.412 . . . . 70.25 109.887 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 55' ' ' VAL . 98.1 mt -107.5 -39.56 5.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.851 0.86 . . . . 75.41 111.134 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.95 -170.7 3.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.268 0.627 . . . . 64.3 110.305 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.42 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 26.1 t70 -66.96 113.18 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.248 1.019 . . . . 75.43 110.444 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 66.87 -4.29 0.81 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.488 1.515 . . . . 53.5 113.571 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 72.6 t -97.59 117.45 42.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.087 0.955 . . . . 65.25 108.439 -172.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HE2' HD21 ' G' ' 173' ' ' LEU . 26.0 m-85 -119.66 168.76 10.73 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.117 0.967 . . . . 70.11 109.367 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.9 tt0 -130.67 130.84 44.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.541 -1.209 . . . . 62.54 108.459 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 111.94 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.477 -1.675 . . . . 65.32 106.477 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.2 t -98.35 131.57 45.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.898 -0.778 . . . . 62.14 108.898 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -101.28 108.57 20.25 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.073 -1.454 . . . . 73.15 107.073 177.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.02 101.47 12.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.356 -0.979 . . . . 74.3 108.356 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' HB1' ' A' ' 110' ' ' ALA . 9.9 t -98.62 145.06 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.677 -1.147 . . . . 71.15 108.286 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 42.5 m -133.11 137.52 46.34 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.735 -0.469 . . . . 72.15 109.735 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.12 107.74 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.675 1.19 . . . . 75.23 107.998 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 24.6 m -103.13 138.48 39.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.777 -0.823 . . . . 71.44 108.777 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.09 102.81 9.32 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.603 -1.629 . . . . 55.25 106.603 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 52.5 m -108.45 124.0 49.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.339 0.59 . . . . 74.14 109.677 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 73' ' ' ALA . 14.7 mt -90.02 80.46 6.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.105 -1.443 . . . . 75.42 107.105 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -89.27 0.84 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.177 -0.919 . . . . 63.2 111.442 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -114.8 -26.39 7.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.451 0.7 . . . . 73.31 110.759 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -99.58 124.48 44.82 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.976 -0.379 . . . . 65.0 109.976 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 74.6 m -76.4 137.7 39.91 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.406 0.682 . . . . 43.25 111.437 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -78.87 -62.56 1.66 Allowed 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.815 1.246 . . . . 70.25 109.615 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -144.04 151.68 39.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.442 -1.254 . . . . 64.53 109.61 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.8 tp -126.09 115.56 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.038 1.335 . . . . 72.51 108.409 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.1 m -103.99 139.33 39.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.792 0.837 . . . . 63.33 108.94 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -145.1 133.21 21.47 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.887 -1.524 . . . . 74.13 106.887 167.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -135.71 120.92 28.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.781 -0.822 . . . . 61.02 108.781 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.34 79.5 5.0 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.745 -1.205 . . . . 62.21 107.745 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 106' ' ' LEU . 7.0 tp-100 -76.65 93.93 3.7 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 106.917 -1.512 . . . . 73.35 106.917 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.07 160.07 19.39 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.746 -0.264 . . . . 72.51 113.0 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.59 138.86 6.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 112.197 -0.361 . . . . 44.52 112.197 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.561 HG13 ' HE1' ' A' ' 17' ' ' TYR . 74.8 mt -81.76 125.47 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.892 -1.151 . . . . 73.42 107.892 169.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 57.3 m-85 -131.26 117.84 19.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.897 -1.149 . . . . 63.4 107.897 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 18.9 m -81.37 114.34 20.07 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.171 -1.048 . . . . 64.24 108.171 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.7 140.12 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.403 0.681 . . . . 72.23 110.971 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.711 ' HB3' ' HA ' ' A' ' 5' ' ' ASN . . . -178.75 168.53 1.69 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.679 1.592 . . . . 60.44 108.924 172.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.08 -27.51 7.02 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-N 116.161 -0.472 . . . . 73.41 112.889 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.54 179.85 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.907 1.283 . . . . 71.11 110.114 -170.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.63 174.12 15.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.012 0.525 . . . . 73.34 110.068 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.91 -128.12 28.55 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.819 -0.628 . . . . 62.42 113.753 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 p -67.5 -29.82 69.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.263 1.025 . . . . 64.22 111.516 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.65 -36.64 70.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.608 0.568 . . . . 62.43 110.934 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.616 ' SD ' ' HG2' ' G' ' 174' ' ' MET . 23.2 ttt -74.1 -37.31 64.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.003 -0.369 . . . . 62.03 110.003 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.21 68.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.007 0.523 . . . . 40.15 111.016 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -74.92 -52.19 11.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.667 0.787 . . . . 74.45 110.282 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.1 t -65.21 -62.19 1.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.957 0.785 . . . . 53.54 110.553 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -65.66 -38.77 90.27 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.971 0.908 . . . . 63.13 111.957 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.78 -28.52 38.14 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 115.238 0.855 . . . . 51.35 115.238 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 -40.61 0.6 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.165 0.983 . . . . 24.11 112.423 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 56.1 t80 -74.89 -39.44 61.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.582 0.753 . . . . 62.13 112.296 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -79.58 -39.8 1.37 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 123.235 0.614 . . . . 74.24 111.752 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 53.1 Cg_exo -54.91 -30.15 67.36 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.372 2.048 . . . . 65.12 112.98 164.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.81 -24.26 66.15 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.755 0.822 . . . . 62.32 111.553 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 13' ' ' ILE . 47.3 mm -67.55 -42.5 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.913 0.864 . . . . 73.3 109.757 172.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 80' ' ' GLN . 44.3 mt -86.99 -15.98 37.13 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.272 -1.331 . . . . 71.13 112.25 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.36 -41.31 17.15 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-O 118.054 -0.974 . . . . 74.33 113.418 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.78 -35.28 80.02 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.81 1.673 . . . . 71.05 112.007 171.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.467 ' CE1' ' HD3' ' C' ' 111' ' ' ARG . 41.6 m-85 -77.0 -29.68 55.57 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.641 0.776 . . . . 72.51 112.213 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -72.36 -47.02 52.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.786 -0.82 . . . . 74.11 108.786 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.0 ttm180 -49.51 -50.13 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.048 1.467 . . . . 53.15 110.561 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.66 -40.47 73.0 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.36 1.038 . . . . 73.14 111.596 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.582 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.5 t -62.83 -41.83 99.49 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.483 0.489 . . . . 54.1 110.598 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.3 mt -65.97 -51.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.259 -0.882 . . . . 65.22 109.658 174.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.1 m -55.36 -39.75 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.077 0.951 . . . . 74.22 111.259 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.1 t -66.73 -45.22 79.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 123.776 0.673 . . . . 73.15 110.342 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 34.1 mtm -63.13 -40.32 97.24 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.73 0.412 . . . . 70.21 111.146 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.7 t -61.1 -50.29 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.499 1.12 . . . . 72.35 110.149 177.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 94.8 p -70.98 -25.92 62.91 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.796 -0.638 . . . . 71.24 111.633 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 116' ' ' SER . 37.7 ttm-85 -79.04 -28.9 43.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.35 1.06 . . . . 74.55 109.461 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.21 9.77 56.38 Favored Glycine 0 C--N 1.356 1.672 0 CA-C-N 115.196 -0.911 . . . . 61.3 112.825 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.448 HG22 ' NH2' ' B' ' 15' ' ' ARG . 31.1 m 69.22 33.65 3.22 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 123.476 1.607 . . . . 60.22 111.122 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 119' ' ' SER . 75.7 m-85 -101.89 158.2 32.23 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 113.994 -1.457 . . . . 74.33 107.135 161.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.84 -174.1 0.56 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.974 1.783 . . . . 72.25 112.004 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -76.01 141.59 42.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.893 0.477 . . . . 75.43 112.135 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.08 94.13 3.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.455 -1.313 . . . . 63.34 107.455 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.11 110.86 22.63 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.331 0.652 . . . . 74.21 110.242 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.4 mt -74.15 145.37 44.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.378 -0.828 . . . . 75.14 110.949 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' G' ' 187' ' ' ILE . . . -67.12 146.39 98.98 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.096 0.559 . . . . 73.43 111.396 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.48 141.0 45.12 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.284 1.989 . . . . 73.15 111.721 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.23 108.74 22.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 108.457 -0.942 . . . . 74.02 108.457 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -109.18 74.75 0.92 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 72.31 109.06 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.667 -0.697 . . . . 71.24 110.641 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.83 -33.53 75.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.011 0.434 . . . . 65.41 109.952 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.82 31.5 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 115.265 -0.88 . . . . 71.32 110.673 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' H' ' 206' ' ' ASP . 9.4 tt -49.71 -45.56 49.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.991 0.916 . . . . 70.43 111.721 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.3 t80 -57.17 -55.25 37.2 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.447 1.092 . . . . 72.22 111.137 -176.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -70.72 -37.38 73.5 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.562 0.539 . . . . 71.3 111.156 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -65.57 -33.92 77.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.377 0.671 . . . . 74.53 110.278 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.59 -42.76 98.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.62 0.768 . . . . 71.31 110.49 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 81.6 mt -62.26 -52.06 65.23 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.787 0.679 . . . . 52.04 110.875 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 178.61 -5.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.909 0.756 . . . . 71.01 112.725 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.13 102.51 0.38 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.437 0.637 . . . . 72.34 110.14 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.789 ' HA ' ' HG2' ' C' ' 8' ' ' GLU . 0.6 OUTLIER -147.92 -43.41 0.16 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.236 1.415 . . . . 74.25 109.079 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.83 77.8 10.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.46 -0.791 . . . . 50.15 111.402 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.96 43.91 3.19 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.496 -1.042 . . . . 52.21 110.496 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.22 86.56 3.66 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.332 1.053 . . . . 75.13 110.523 -170.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.03 -39.21 4.93 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.704 -1.358 . . . . 61.55 109.704 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 65.6 m 71.47 107.08 0.06 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.765 1.626 . . . . 70.11 111.159 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 77.85 59.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.911 1.285 . . . . 72.24 111.102 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.74 108.44 19.69 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.808 -1.087 . . . . 74.45 109.316 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -169.11 167.03 10.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.84 0.856 . . . . 63.41 109.357 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.98 107.07 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.603 1.161 . . . . 75.04 109.516 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.81 -62.77 1.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.499 0.72 . . . . 55.41 109.992 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 124.035 0.934 . . . . 52.43 109.249 179.151 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 109.77 -0.455 . . . . 75.4 109.77 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -142.99 26.86 1.66 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.803 0.841 . . . . 55.55 110.312 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 131.62 50.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.587 0.755 . . . . 73.12 111.031 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -161.26 92.11 0.89 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.946 0.898 . . . . 52.34 108.843 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -79.31 -6.43 56.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.615 0.766 . . . . 74.04 110.796 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -60.29 135.82 57.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.676 1.19 . . . . 73.24 110.222 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -153.26 162.14 41.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.998 0.519 . . . . 41.5 110.811 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 68.22 -74.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.737 1.615 . . . . 44.55 111.668 -173.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.543 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 9.2 ptm 54.79 171.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.849 2.06 . . . . 71.34 113.659 -171.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -167.04 143.5 4.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 115.107 -0.951 . . . . 63.24 109.201 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -148.75 125.21 10.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.407 -1.331 . . . . 74.1 107.407 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -144.96 140.76 28.45 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.312 -0.625 . . . . 71.52 109.312 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.531 HD11 HG13 ' B' ' 16' ' ' ILE . 10.8 tt -90.75 144.07 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.521 0.728 . . . . 72.42 109.459 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.66 -44.59 3.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.959 0.504 . . . . 74.4 109.772 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.448 ' NH2' HG22 ' A' ' 122' ' ' THR . 19.7 ttt180 -169.6 146.22 3.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.3 0.24 . . . . 74.51 110.76 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.531 HG13 HD11 ' B' ' 13' ' ' ILE . 94.2 mt -120.42 144.49 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.378 -1.342 . . . . 61.41 107.378 173.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -169.37 158.98 8.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.69 0.677 . . . . 74.13 112.176 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.8 m -83.54 127.67 33.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.191 -0.913 . . . . 53.55 108.835 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -96.37 -36.62 10.79 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.666 0.786 . . . . 72.42 110.885 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -161.74 145.3 12.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.352 -0.385 . . . . 73.21 110.375 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.411 HD11 ' SG ' ' B' ' 113' ' ' CYS . 37.3 mm -137.2 138.93 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.682 1.193 . . . . 72.5 109.8 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 74.0 m -134.81 125.52 27.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.144 1.378 . . . . 74.43 108.492 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -142.78 108.2 5.04 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.54 -1.282 . . . . 75.11 107.54 167.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -119.2 122.99 43.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 45.2 108.462 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.11 89.43 14.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.991 0.917 . . . . 61.2 109.278 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.3 -32.04 73.11 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.194 2.596 . . . . 72.21 113.136 -172.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -117.96 32.09 6.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.911 0.884 . . . . 34.42 110.122 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.55 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -45.91 -54.76 15.16 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 125.646 1.578 . . . . 41.21 113.829 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.2 Cg_exo -68.77 -24.36 34.63 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 122.511 2.141 . . . . 74.32 112.881 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -89.19 1.79 55.15 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.777 -1.101 . . . . 63.52 111.786 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.31 -23.88 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.927 0.491 . . . . 52.13 110.462 170.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -63.62 -38.85 92.69 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.543 0.737 . . . . 74.53 110.416 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -82.88 -41.75 18.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.927 0.891 . . . . 74.32 110.296 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -85.38 70.66 10.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.686 1.194 . . . . 73.03 109.032 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.53 74.58 9.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.263 1.03 . . . . 61.13 110.798 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -167.08 154.07 8.7 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.235 -1.394 . . . . 75.3 107.235 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.739 ' HB3' ' HB3' ' F' ' 194' ' ' ALA . 0.0 OUTLIER -64.07 127.74 92.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.049 0.54 . . . . 73.34 110.226 175.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.69 151.79 81.72 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.257 1.972 . . . . 72.23 112.164 167.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 2.8 pt-20 -61.01 102.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.035 -0.984 . . . . 62.42 109.303 169.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.0 t -88.46 116.51 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.896 -1.15 . . . . 72.11 107.896 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -138.96 138.27 37.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.308 0.643 . . . . 72.32 109.275 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.553 HD23 HG13 ' F' ' 187' ' ' ILE . 0.8 OUTLIER -118.71 147.35 43.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 74.15 110.14 -168.14 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.26 149.5 52.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.214 1.406 . . . . 75.4 108.054 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.67 135.41 51.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.437 -0.579 . . . . 65.42 109.437 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -136.57 154.19 50.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.158 1.383 . . . . 65.41 108.363 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -132.03 139.94 48.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.986 0.514 . . . . 65.25 110.508 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.7 160.8 37.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 74.24 108.551 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -142.32 162.85 34.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.082 0.553 . . . . 72.25 110.588 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -153.35 168.2 26.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.821 1.248 . . . . 74.25 108.526 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -123.3 130.73 53.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.262 0.625 . . . . 63.01 111.134 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 65.7 mt -97.81 -49.86 4.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.469 0.708 . . . . 70.33 110.183 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.51 -170.89 3.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.501 -0.772 . . . . 71.02 110.387 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -65.71 116.19 6.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.702 -1.136 . . . . 73.33 109.704 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.809 ' H ' HD21 ' F' ' 173' ' ' LEU . 1.9 m-20 72.62 2.78 4.48 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.817 1.647 . . . . 65.04 111.605 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 95.51 3.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 124.291 1.036 . . . . 64.51 108.33 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.467 ' HB2' HD12 ' B' ' 86' ' ' ILE . 0.1 OUTLIER -94.58 139.02 31.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.842 177.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.45 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.2 tm-20 -103.65 95.99 6.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 106.622 -1.622 . . . . 64.43 106.622 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.29 123.1 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.267 -0.642 . . . . 65.42 109.267 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.6 t -102.31 123.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.568 0.747 . . . . 73.03 109.482 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -93.13 126.67 38.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.259 -1.386 . . . . 52.51 107.259 173.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.409 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 29.3 ttt180 -119.41 104.36 10.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.19 -0.67 . . . . 74.11 109.19 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.5 120.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.571 -0.9 . . . . 61.31 108.571 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -109.39 150.5 27.97 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.065 -0.717 . . . . 63.02 109.065 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.555 HG21 HG21 ' B' ' 114' ' ' ILE . 90.3 t -139.32 122.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.865 0.866 . . . . 73.31 109.279 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 79.8 m -113.76 138.78 49.78 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.638 0.775 . . . . 73.5 109.27 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.3 147.03 28.85 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.887 -1.052 . . . . 70.1 109.071 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 9.2 m -143.77 135.27 26.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.497 0.554 . . . . 61.35 112.497 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 50.0 mt -88.47 101.39 13.87 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.69 -1.596 . . . . 62.22 106.69 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -111.25 3.22 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.053 -0.819 . . . . 52.23 111.053 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.85 4.88 12.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.319 1.048 . . . . 72.0 110.734 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.75 139.07 50.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.578 1.151 . . . . 75.54 108.098 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -61.98 133.49 55.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.11 0.564 . . . . 71.53 112.141 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.95 -61.19 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.5 1.12 . . . . 74.01 109.176 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.02 167.1 28.7 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.456 -1.702 . . . . 71.04 109.618 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.69 118.86 11.35 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.661 1.585 . . . . 72.43 106.726 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -119.4 153.42 35.23 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.436 -0.579 . . . . 72.34 109.436 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.23 134.85 7.6 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.161 -1.052 . . . . 52.43 108.161 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -123.39 143.02 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 123.604 0.762 . . . . 72.22 109.738 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.4 mt-30 -118.15 90.93 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.653 -0.869 . . . . 70.13 108.653 171.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.8 tp-100 -89.88 100.8 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.339 -0.985 . . . . 72.24 108.339 175.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.68 163.69 29.85 Favored Glycine 0 C--O 1.242 0.643 0 N-CA-C 111.75 -0.54 . . . . 71.22 111.75 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.97 130.8 2.84 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.597 -0.601 . . . . 30.22 111.597 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -86.39 116.31 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.725 0.81 . . . . 74.11 109.195 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -133.87 134.59 42.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.212 1.005 . . . . 73.2 109.183 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 41.8 m -95.34 110.86 22.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.768 0.827 . . . . 61.4 110.028 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -118.69 138.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.146 0.978 . . . . 71.14 110.606 -177.161 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.98 167.64 27.47 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.598 0.759 . . . . 44.13 109.744 167.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.25 -41.65 3.01 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 123.549 0.53 . . . . 51.21 113.045 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.409 ' H ' HG13 ' B' ' 89' ' ' ILE . 2.2 pp -63.42 156.14 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.308 1.043 . . . . 74.52 110.872 169.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.06 154.98 7.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.146 0.578 . . . . 72.1 109.732 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.75 -113.33 5.77 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.25 0.452 . . . . 75.42 113.444 170.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 -36.94 74.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.599 0.76 . . . . 70.42 110.643 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.48 -46.39 86.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.782 0.433 . . . . 61.32 110.731 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ttt -68.47 -40.87 80.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.017 -0.538 . . . . 61.54 110.326 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.65 70.34 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.324 0.649 . . . . 64.3 111.434 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -74.11 -36.33 64.2 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.585 0.754 . . . . 72.11 109.513 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.06 -68.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.791 -0.64 . . . . 61.23 110.446 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.76 -20.32 61.9 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.138 0.421 . . . . 72.42 112.138 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.46 -6.7 52.78 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.144 -0.809 . . . . 72.11 114.528 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.62 -42.54 0.14 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.255 1.028 . . . . 50.53 112.716 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -79.9 -53.04 7.13 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.932 0.333 . . . . 74.04 111.538 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.405 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 61.7 m -57.69 -45.56 99.82 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.648 0.779 . . . . 62.12 110.991 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 79.9 Cg_exo -50.14 -46.93 26.03 Favored 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.512 2.142 . . . . 74.13 113.582 164.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.4 -35.6 70.24 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.624 0.769 . . . . 74.2 112.098 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.459 HG23 ' NH2' ' D' ' 111' ' ' ARG . 82.6 mt -65.13 -49.11 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.637 0.775 . . . . 65.43 110.332 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 80' ' ' GLN . 50.8 mt -78.92 -12.65 60.04 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.684 -1.144 . . . . 73.21 111.966 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.432 ' HZ ' HD12 ' B' ' 128' ' ' LEU . 22.1 t80 -67.77 -46.11 44.59 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.06 1.344 . . . . 70.11 113.451 -166.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.47 -33.67 78.34 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.554 1.503 . . . . 70.1 112.203 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -65.8 -45.2 83.23 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.088 0.555 . . . . 64.13 110.531 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.79 77.79 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.318 0.647 . . . . 71.23 110.912 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -57.57 -53.41 58.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.04 0.936 . . . . 72.02 110.275 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.7 tm-20 -68.0 -29.79 68.89 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.046 0.842 . . . . 53.32 110.387 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 117' ' ' MET . 33.7 t -68.22 -45.63 72.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.158 0.583 . . . . 64.12 111.182 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.555 HG21 HG21 ' B' ' 64' ' ' VAL . 95.0 mt -63.11 -44.25 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 64.13 109.847 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.639 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . 32.6 m -66.34 -23.29 66.33 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.829 -1.078 . . . . 74.43 111.534 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.2 t -75.59 -40.87 55.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 72.1 110.627 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.4 mmt -79.29 -38.46 35.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.849 0.685 . . . . 74.3 112.849 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.798 ' HB ' ' HG3' ' B' ' 125' ' ' GLN . 95.5 t -75.62 -27.14 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.326 0.65 . . . . 52.12 110.77 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.451 ' HB3' HG21 ' C' ' 115' ' ' THR . 91.9 p -66.72 -37.67 85.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.027 0.441 . . . . 63.33 110.248 174.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.582 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 60.5 mtt-85 -63.57 -40.3 96.62 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.147 -0.933 . . . . 65.41 110.508 175.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.94 80.93 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.716 0.635 . . . . 45.43 113.199 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p 62.38 33.45 16.32 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.548 1.939 . . . . 61.33 112.874 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.37 -177.17 0.58 Allowed Pre-proline 0 CA--C 1.568 1.635 0 CA-C-N 114.284 -1.325 . . . . 70.14 109.024 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.542 ' HB2' HG21 ' B' ' 40' ' ' VAL . 3.9 Cg_exo -81.87 116.72 2.86 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.853 2.369 . . . . 73.15 112.964 169.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.798 ' HG3' ' HB ' ' B' ' 118' ' ' VAL . 0.5 OUTLIER -72.02 164.01 26.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.908 0.883 . . . . 71.22 111.324 164.369 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.436 ' HB3' HD21 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -137.26 127.16 25.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.205 -1.035 . . . . 62.3 108.205 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -91.71 102.81 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.816 -1.179 . . . . 73.31 107.816 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.752 HD11 HD22 ' F' ' 186' ' ' LEU . 0.3 OUTLIER -66.08 139.34 58.17 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 110.361 -0.237 . . . . 54.55 110.361 -170.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.66 148.23 98.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.768 0.827 . . . . 70.2 111.118 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.405 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 93.4 Cg_endo -74.33 97.07 1.0 Allowed 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.22 1.946 . . . . 65.25 111.239 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.91 110.95 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.263 -0.643 . . . . 71.54 109.263 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -72.68 97.07 2.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.23 0.612 . . . . 74.01 109.452 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -70.82 -13.46 62.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.636 0.774 . . . . 70.43 112.17 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -76.31 -66.13 0.84 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.882 0.873 . . . . 33.32 111.287 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.65 -11.43 59.87 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.146 0.579 . . . . 61.3 111.673 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' F' ' 184' ' ' TRP . 10.5 tt -48.15 -55.27 10.74 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.74 1.216 . . . . 74.24 110.718 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.21 -41.61 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.889 0.876 . . . . 73.41 110.667 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -36.18 82.63 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.486 0.714 . . . . 71.54 110.651 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -73.79 -32.47 63.78 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.991 0.517 . . . . 63.02 110.522 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -67.34 -32.87 74.12 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.978 0.511 . . . . 72.3 110.837 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.83 5.39 28.93 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.689 0.796 . . . . 73.03 111.402 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -118.76 -179.23 3.74 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.29 1.036 . . . . 74.32 110.109 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.01 99.96 3.56 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.152 -1.055 . . . . 54.4 108.152 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.42 115.39 17.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.018 0.927 . . . . 74.31 110.306 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.12 156.62 22.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.465 1.106 . . . . 72.02 109.449 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.16 -33.13 0.08 OUTLIER Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.595 -0.558 . . . . 42.12 114.011 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 72.7 160.01 0.22 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.025 1.33 . . . . 73.34 111.384 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.9 -177.87 41.11 Favored Glycine 0 N--CA 1.473 1.13 0 CA-C-N 115.999 -0.546 . . . . 73.23 112.206 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.9 m 60.9 82.78 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.446 1.098 . . . . 75.23 110.815 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.15 -45.55 5.87 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.275 1.03 . . . . 74.23 110.581 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.76 93.04 0.03 OUTLIER 'General case' 0 C--N 1.358 0.955 0 O-C-N 124.3 1.0 . . . . 74.02 111.533 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -83.01 90.54 7.03 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.617 -1.623 . . . . 71.53 106.617 167.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -68.32 119.78 13.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.403 -0.591 . . . . 72.54 109.403 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.04 154.87 41.34 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.566 -0.743 . . . . 63.12 109.898 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.604 0.761 . . . . 72.43 109.07 -179.643 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 108.929 -0.767 . . . . 75.41 108.929 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 41.4 m -85.9 -64.42 1.16 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.629 0.372 . . . . 64.4 110.767 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 57.82 -80.72 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.209 1.403 . . . . 73.21 111.623 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -160.69 -81.38 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.012 -0.736 . . . . 74.12 109.012 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -173.04 93.04 0.1 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.531 -0.915 . . . . 72.41 108.531 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -71.15 -25.1 62.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.615 0.766 . . . . 62.0 112.039 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -90.95 -146.92 0.2 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.874 1.27 . . . . 61.03 109.833 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.789 ' HG2' ' HA ' ' A' ' 144' ' ' GLN . 15.8 tp10 -150.54 152.42 34.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.913 0.779 . . . . 64.25 110.691 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.56 111.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.772 1.629 . . . . 64.32 109.529 -173.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 75.2 m -107.85 97.22 6.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.012 -0.54 . . . . 75.31 109.596 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.532 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 48.4 t80 -92.84 119.76 32.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.676 -1.231 . . . . 72.41 107.676 169.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -137.1 117.95 14.15 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 109.255 -0.646 . . . . 73.31 109.255 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.412 HD11 HG13 ' C' ' 16' ' ' ILE . 6.5 tp -70.53 131.44 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 109.437 -0.579 . . . . 72.41 109.437 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.501 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.1 mm100 -96.15 -48.69 5.55 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.37 -0.832 . . . . 74.24 108.989 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.467 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 61.9 ttt180 -176.37 133.95 0.24 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.387 -0.824 . . . . 72.03 109.787 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.412 HG13 HD11 ' C' ' 13' ' ' ILE . 80.9 mt -108.64 150.32 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.767 -1.197 . . . . 75.32 107.767 170.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.516 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 28.9 p90 -179.62 154.29 0.6 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.74 . . . . 74.2 109.471 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.437 HG21 HD11 ' C' ' 21' ' ' ILE . 75.2 p -74.87 118.4 17.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.763 -0.828 . . . . 52.24 108.763 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.59 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -69.92 -43.3 71.96 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.315 -0.994 . . . . 61.25 108.315 176.085 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.6 t70 -154.02 138.89 17.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.425 -1.716 . . . . 75.04 108.928 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.437 HD11 HG21 ' C' ' 18' ' ' THR . 97.8 mt -129.3 145.72 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.714 -1.217 . . . . 64.11 107.714 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -153.23 150.06 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.527 0.679 . . . . 70.32 110.0 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -143.91 127.19 16.71 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.815 -1.55 . . . . 73.4 106.815 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 48.5 mt-10 -116.47 125.12 51.52 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.118 -0.697 . . . . 61.43 109.118 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.68 74.91 38.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.626 1.17 . . . . 74.12 108.189 171.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.98 -28.57 49.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.306 2.004 . . . . 74.45 110.452 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 93.1 m-20 -97.9 24.83 6.51 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.768 -1.106 . . . . 74.41 111.094 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HA ' ' HZ ' ' C' ' 123' ' ' PHE . . . -57.09 -48.28 97.68 Favored Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.454 0.701 . . . . 64.2 111.74 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' C' ' 32' ' ' PHE . 56.4 Cg_endo -86.82 -25.46 1.16 Allowed 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.164 1.909 . . . . 75.41 113.27 168.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.427 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 83.0 t60 -70.01 -23.39 63.12 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.64 0.776 . . . . 74.43 112.627 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.616 HG11 ' HE1' ' C' ' 123' ' ' PHE . 9.9 p -78.03 1.3 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 124.278 1.031 . . . . 74.04 112.189 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' C' ' 29' ' ' PRO . 36.5 t80 -49.34 -43.45 43.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.72 1.608 . . . . 72.14 113.913 -171.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -128.65 48.81 2.27 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.364 -0.976 . . . . 72.31 108.364 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.89 155.31 19.46 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.834 -0.621 . . . . 75.52 109.63 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.27 118.39 12.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.776 . . . . 73.22 109.97 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -78.48 94.57 4.97 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.72 0.808 . . . . 74.03 110.755 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.33 54.06 2.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 114.986 -1.006 . . . . 64.22 110.082 171.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.32 97.88 0.17 Allowed 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.09 1.86 . . . . 73.44 111.715 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.636 ' HG2' ' HA ' ' E' ' 190' ' ' ASP . 2.4 tm-20 -84.24 108.83 17.33 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.401 -1.703 . . . . 75.43 106.401 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.68 HG11 ' HG ' ' C' ' 126' ' ' LEU . 46.4 t -94.02 102.64 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 113.897 -1.501 . . . . 63.15 110.218 -166.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.87 112.52 24.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.3 0.64 . . . . 70.31 110.442 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.704 HD11 HD12 ' C' ' 128' ' ' LEU . 7.0 mp -91.24 141.01 29.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.733 -0.84 . . . . 74.53 108.733 172.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -143.18 138.48 29.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.899 0.88 . . . . 63.25 109.476 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' E' ' 186' ' ' LEU . 0.0 OUTLIER -109.79 127.23 54.52 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.321 -0.622 . . . . 63.43 109.321 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.73 145.36 48.47 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.353 1.461 . . . . 74.04 108.276 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.2 t -123.67 139.45 53.98 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.275 0.559 . . . . 72.33 109.66 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.47 147.61 34.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.997 1.319 . . . . 75.31 107.682 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -145.75 155.43 42.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.937 0.398 . . . . 74.51 111.346 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.0 m -142.62 136.42 29.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.266 1.027 . . . . 60.2 108.527 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -84.66 116.76 23.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.554 -0.906 . . . . 71.45 108.554 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.581 HD11 HD12 ' C' ' 83' ' ' ILE . 76.4 mt -91.0 -34.4 15.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.752 -0.658 . . . . 72.01 109.579 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.75 -174.19 2.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.101 -0.954 . . . . 52.32 110.004 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.25 122.49 22.04 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.38 -0.827 . . . . 45.33 109.256 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 65.4 11.4 7.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.09 1.356 . . . . 74.3 112.406 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.23 110.67 30.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 108.18 -1.044 . . . . 70.33 108.18 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -127.03 129.82 48.8 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.631 -0.713 . . . . 75.22 109.623 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.27 109.92 16.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.241 -1.345 . . . . 73.23 108.462 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 64.8 t -97.68 114.7 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.102 -1.073 . . . . 73.21 108.102 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.8 105.34 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.676 -0.861 . . . . 63.12 108.676 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -96.7 104.4 16.39 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.754 -1.202 . . . . 65.31 107.754 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -85.8 116.48 24.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.627 0.771 . . . . 74.33 109.957 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.8 t -101.54 127.92 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.71 -1.218 . . . . 64.25 107.71 168.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.8 m -124.61 124.23 41.77 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.087 -0.709 . . . . 71.42 109.087 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.544 HG22 ' HG ' ' C' ' 42' ' ' LEU . 38.3 t -110.58 131.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 72.23 109.447 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 25.9 m -116.52 149.69 39.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.233 -1.395 . . . . 65.3 107.233 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.52 130.94 41.05 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.768 -1.197 . . . . 75.04 107.768 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.6 m -133.54 161.64 34.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.485 0.66 . . . . 42.4 110.693 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 mt -128.45 28.5 5.44 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.647 1.579 . . . . 75.54 108.016 -173.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.41 -113.85 2.62 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.349 -1.9 . . . . 75.3 108.349 -165.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.5 -27.12 19.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.204 0.601 . . . . 62.43 109.717 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.6 117.98 9.54 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 124.658 1.183 . . . . 72.55 110.214 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -79.17 126.43 30.73 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.523 -0.547 . . . . 71.23 109.523 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.03 -52.13 11.85 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.593 0.757 . . . . 54.52 109.011 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.408 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 43.1 p90 -164.18 172.68 13.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.535 -1.211 . . . . 64.14 110.129 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -137.72 145.13 42.14 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.754 -1.573 . . . . 74.4 106.754 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.469 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.6 t -144.18 144.54 31.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.572 -0.899 . . . . 74.53 108.572 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.05 125.68 9.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.404 -0.591 . . . . 75.21 109.404 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' C' ' 110' ' ' ALA . 75.0 t -126.66 114.66 38.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.263 1.025 . . . . 72.52 108.424 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -96.81 87.51 4.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.62 -0.881 . . . . 52.41 108.62 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -85.14 119.81 25.95 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.075 -0.966 . . . . 42.51 109.542 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.59 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -114.05 153.77 17.38 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 123.453 0.471 . . . . 62.54 112.507 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.31 130.98 3.74 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.969 -1.252 . . . . 63.41 109.969 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.581 HD12 HD11 ' C' ' 51' ' ' LEU . 18.6 mm -88.56 119.01 35.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.764 -1.199 . . . . 71.35 107.764 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.58 122.88 39.3 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.39 -0.967 . . . . 71.14 108.39 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -90.19 100.4 13.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.886 -1.524 . . . . 73.2 106.886 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.57 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -122.72 133.45 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.697 0.799 . . . . 72.34 110.818 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.33 177.39 11.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.547 -0.751 . . . . 72.54 110.921 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.08 -63.69 2.07 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.641 -0.709 . . . . 32.53 112.731 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.611 HD11 ' SD ' ' E' ' 174' ' ' MET . 3.0 mp 61.67 123.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 125.161 1.384 . . . . 65.11 112.787 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.88 156.76 20.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.253 0.834 . . . . 62.31 113.253 172.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.93 48.61 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 114.31 -1.314 . . . . 55.31 113.766 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.8 p -78.07 -17.82 56.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.172 0.989 . . . . 62.13 111.366 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.69 -31.96 68.71 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.569 0.748 . . . . 65.14 111.944 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.6 tpt -45.77 -54.13 8.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.941 0.719 . . . . 43.25 112.941 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.26 -34.32 18.98 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.622 0.369 . . . . 53.52 111.378 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -74.6 -20.05 60.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.127 0.788 . . . . 72.21 113.127 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -68.02 -62.19 1.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.136 0.425 . . . . 73.35 110.696 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.471 ' H ' HD23 ' C' ' 98' ' ' LEU . 2.7 pt? -79.89 -20.3 46.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.239 -0.437 . . . . 54.43 111.294 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.67 -30.22 30.25 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.369 0.507 . . . . 54.34 114.369 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.2 -35.29 0.18 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.223 0.823 . . . . 52.23 113.223 -173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -73.38 -56.83 4.54 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.17 0.588 . . . . 73.11 111.169 -169.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 36.9 m -61.63 -46.36 93.61 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 123.73 0.812 . . . . 61.33 111.226 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 84.2 Cg_exo -53.44 -34.39 71.45 Favored 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 122.798 2.332 . . . . 60.43 114.61 167.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.6 -30.36 69.08 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.821 0.849 . . . . 62.15 111.365 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.427 HG23 ' NH1' ' A' ' 111' ' ' ARG . 46.2 mm -68.05 -29.88 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 123.199 0.6 . . . . 44.12 110.206 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.9 mt -93.05 -29.71 15.67 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.304 1.042 . . . . 63.43 112.567 -173.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -56.96 -38.32 67.38 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.79 -1.1 . . . . 52.34 113.956 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.17 -50.9 12.37 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.079 2.519 . . . . 75.01 113.897 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -62.05 -36.7 82.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.989 -1.005 . . . . 75.45 110.873 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.483 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -76.44 -40.0 51.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.459 -0.791 . . . . 54.2 111.2 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' CE1' ' A' ' 109' ' ' TYR . 29.1 ttt180 -58.15 -36.95 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.782 0.833 . . . . 74.22 111.142 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -44.96 25.18 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.197 0.599 . . . . 53.1 110.872 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.05 -30.17 71.11 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.325 0.65 . . . . 61.31 112.597 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.53 HD13 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -67.33 -49.91 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.339 0.655 . . . . 52.53 109.98 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.46 HG23 ' HB2' ' C' ' 125' ' ' GLN . 90.5 m -54.0 -42.74 69.36 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.253 0.971 . . . . 61.11 110.951 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.6 t -62.34 -49.26 76.3 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.168 -1.378 . . . . 65.23 110.754 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.554 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -63.19 -39.49 94.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.883 0.873 . . . . 72.32 112.373 -177.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.03 -41.85 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.152 0.581 . . . . 60.35 110.886 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.441 ' CB ' HG21 ' B' ' 115' ' ' THR . 28.2 t -59.8 -35.74 75.3 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.439 -1.255 . . . . 73.53 111.851 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.554 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 73.6 mtt-85 -68.91 -38.6 79.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.313 -0.858 . . . . 72.44 110.895 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.22 4.66 66.25 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.699 -0.682 . . . . 75.25 112.85 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 60.51 38.31 19.11 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.829 1.652 . . . . 63.44 112.207 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.616 ' HE1' HG11 ' C' ' 31' ' ' VAL . 43.9 m-85 -106.57 163.53 16.79 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.206 -1.361 . . . . 60.25 109.821 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.475 ' HD3' ' HE2' ' E' ' 195' ' ' PHE . 31.7 Cg_endo -61.34 104.45 0.3 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.263 1.975 . . . . 75.34 111.181 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.792 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -56.07 150.77 13.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.237 1.415 . . . . 74.24 112.746 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.68 ' HG ' HG11 ' C' ' 40' ' ' VAL . 1.9 mm? -129.45 99.87 5.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.807 0.443 . . . . 74.24 110.737 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -109.32 84.63 1.96 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.37 -1.715 . . . . 71.32 106.37 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.704 HD12 HD11 ' C' ' 42' ' ' LEU . 55.4 mt -90.02 156.68 18.24 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.337 -1.301 . . . . 53.52 111.848 -172.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.522 ' HB2' ' HA ' ' F' ' 204' ' ' ILE . . . -34.62 121.98 0.55 Allowed Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.218 1.807 . . . . 54.3 113.65 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HG3' HD12 ' A' ' 16' ' ' ILE . 74.4 Cg_endo -71.29 110.24 2.79 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.73 2.287 . . . . 63.42 111.559 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' E' ' 186' ' ' LEU . 86.0 t -76.0 94.32 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.94 -0.763 . . . . 71.4 108.94 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.56 104.67 3.37 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -55.9 -45.41 78.65 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.075 1.484 . . . . 74.01 112.761 -170.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.76 -29.87 25.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.302 -0.408 . . . . 65.33 111.73 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.057 0.143 . . . . 64.21 111.041 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.06 -46.11 90.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.986 0.514 . . . . 71.44 110.534 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -63.6 -39.78 95.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.623 0.769 . . . . 73.24 111.391 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt -66.09 -47.6 73.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.452 1.101 . . . . 72.41 111.377 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -72.35 -41.77 66.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 73.02 111.085 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.07 -155.04 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.803 -0.635 . . . . 75.42 109.727 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 18.1 tp 61.72 9.88 3.1 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.662 1.185 . . . . 52.52 111.529 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -172.51 158.69 4.29 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.949 1.3 . . . . 74.03 108.716 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.78 74.9 1.47 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.922 0.489 . . . . 70.21 109.908 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -124.16 151.26 44.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.715 0.806 . . . . 74.41 109.106 168.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.42 148.23 16.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.817 0.847 . . . . 71.42 109.92 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.44 ' H ' ' H ' ' A' ' 6' ' ' ASN . . . -96.0 -126.44 5.06 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.636 -0.711 . . . . 75.42 113.273 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.04 -23.42 0.3 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.967 0.728 . . . . 74.3 112.967 -158.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.09 -123.72 7.36 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-O 119.995 -0.336 . . . . 74.15 113.184 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.3 m 68.34 101.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.04 1.736 . . . . 63.44 111.214 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 29.9 mt-10 -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.584 1.153 . . . . 73.11 112.574 -170.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -168.84 143.9 3.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.479 1.112 . . . . 71.42 108.921 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.592 ' HA ' ' HB3' ' G' ' 175' ' ' PHE . 4.5 p-80 -154.63 122.28 5.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.972 0.909 . . . . 74.0 109.738 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -83.79 -39.23 20.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.082 0.553 . . . . 74.24 110.071 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.41 164.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.165 1.386 . . . . 54.43 112.741 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.339 1.056 . . . . 53.41 109.289 -173.908 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.071 -0.344 . . . . 61.51 110.071 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.6 p -157.7 137.71 12.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.749 0.419 . . . . 74.33 111.017 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.66 126.61 30.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.702 0.801 . . . . 53.31 109.023 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -76.83 98.59 4.89 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.812 0.845 . . . . 74.12 110.606 -171.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -178.64 167.48 1.76 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.753 1.621 . . . . 54.34 106.844 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -73.45 74.58 1.42 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.661 1.22 . . . . 75.24 108.682 168.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 16.6 m -84.15 169.76 14.5 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 113.773 -1.558 . . . . 23.42 109.303 -175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.38 135.25 57.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 119.075 -0.488 . . . . 73.34 109.883 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.427 ' HG3' HG22 ' D' ' 89' ' ' ILE . 3.2 ttp -29.4 122.99 0.15 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 125.603 1.814 . . . . 62.1 114.059 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m -134.46 142.61 47.15 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.007 0.432 . . . . 45.42 109.946 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -145.97 94.5 2.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 106.431 -1.692 . . . . 74.01 106.431 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -129.47 139.45 51.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.306 0.642 . . . . 71.34 109.468 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.48 142.81 12.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.152 0.581 . . . . 71.01 109.738 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 56.9 mt-30 -103.36 -43.93 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.15 0.58 . . . . 70.23 110.683 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.542 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 55.6 ttt180 -170.13 148.72 3.4 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 111.784 0.29 . . . . 73.25 111.784 -169.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.405 ' HB ' ' HG3' ' B' ' 130' ' ' PRO . 1.1 mp -120.68 144.2 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 106.205 -1.776 . . . . 74.02 106.205 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.542 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 16.3 p90 -165.9 151.07 8.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.478 0.656 . . . . 75.43 111.226 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -86.95 113.05 22.39 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.033 -0.985 . . . . 50.22 109.082 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -81.06 -28.84 35.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.978 -0.555 . . . . 71.04 110.289 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -151.82 136.44 17.0 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.788 -1.096 . . . . 71.22 109.131 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' C' ' 117' ' ' MET . 96.7 mt -130.81 138.3 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.694 -1.224 . . . . 62.14 107.694 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -141.59 137.11 31.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.138 0.975 . . . . 73.2 109.053 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.2 t80 -145.52 114.23 6.82 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.263 -1.755 . . . . 60.13 106.263 170.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 38.3 mt-10 -122.26 111.09 16.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.228 0.611 . . . . 75.44 109.707 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.91 88.99 5.97 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.331 -0.989 . . . . 74.41 108.331 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.48 -33.94 1.64 Allowed 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 122.634 2.223 . . . . 71.52 113.295 -173.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -101.26 28.25 5.55 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.944 0.897 . . . . 73.5 109.317 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -51.58 -55.22 31.43 Favored Pre-proline 0 CA--C 1.574 1.893 0 N-CA-C 116.149 1.907 . . . . 64.32 116.149 -165.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.2 -16.24 11.09 Favored 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 122.049 1.768 . . . . 73.25 113.43 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -72.64 -44.78 61.46 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.066 0.946 . . . . 65.35 109.81 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.3 p -82.93 -0.27 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.818 -172.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 80.2 t80 -57.82 -29.84 65.26 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.1 0.96 . . . . 74.12 111.098 164.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -78.95 4.36 14.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.705 0.802 . . . . 70.13 111.543 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -108.3 110.24 21.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.285 1.034 . . . . 62.13 108.717 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.587 ' HB2' ' HA ' ' H' ' 196' ' ' LYS . 5.3 p-10 -112.59 48.83 0.97 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.343 1.057 . . . . 74.24 111.793 -164.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -154.29 -174.55 5.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.533 0.733 . . . . 73.22 110.403 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.418 ' HG2' ' HA3' ' H' ' 191' ' ' GLY . 60.1 tp60 -72.24 126.8 90.97 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.147 0.579 . . . . 64.14 110.893 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 17.4 Cg_exo -68.06 134.13 30.92 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.548 2.165 . . . . 64.22 111.898 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 38.1 mt-10 -60.14 115.08 3.21 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.218 0.949 . . . . 74.31 108.95 170.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.4 HG21 HD13 ' D' ' 126' ' ' LEU . 57.6 t -95.12 107.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.099 -1.075 . . . . 75.41 108.099 -176.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' D' ' 65' ' ' THR . 0.2 OUTLIER -88.07 119.23 28.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.569 -1.271 . . . . 61.5 107.569 171.511 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.19 141.86 29.05 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.448 -0.945 . . . . 62.33 108.448 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -144.44 130.43 19.42 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.503 -0.925 . . . . 75.52 108.503 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.3 135.53 52.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.511 0.725 . . . . 61.43 109.958 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -144.67 156.96 44.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.505 1.122 . . . . 64.43 108.894 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -139.04 164.53 29.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 53.35 109.55 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 174.21 14.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.44 1.096 . . . . 73.52 108.594 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 95.8 p -164.14 157.57 18.25 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.006 0.432 . . . . 74.01 110.82 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.3 p -151.29 129.99 12.33 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.155 -0.93 . . . . 63.05 108.948 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.5 116.81 15.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.635 -0.505 . . . . 75.44 109.635 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' D' ' 57' ' ' GLU . 81.7 mt -92.64 -35.28 13.6 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.359 0.664 . . . . 74.43 109.709 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.99 -177.47 6.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.279 -0.873 . . . . 53.52 110.133 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.08 125.16 27.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.162 -1.051 . . . . 75.23 108.162 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.42 16.43 10.19 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.267 1.027 . . . . 75.31 112.271 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 65.2 t -136.72 127.19 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.569 1.147 . . . . 73.15 108.089 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.29 152.62 34.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.194 0.521 . . . . 74.22 110.102 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.6 tt0 -88.58 131.48 34.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.989 -1.005 . . . . 70.05 109.109 175.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.65 131.68 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.618 -1.253 . . . . 73.41 107.618 167.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 58.4 t -106.29 133.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.953 -0.758 . . . . 71.4 108.953 173.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -104.58 125.34 50.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.645 -1.613 . . . . 64.12 106.645 172.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.9 ttm-85 -106.97 100.2 9.72 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.211 -1.033 . . . . 71.14 108.211 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.79 121.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.298 -1.371 . . . . 62.02 107.298 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.0 m -124.84 128.99 49.54 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.454 0.645 . . . . 64.42 109.965 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.2 t -120.84 132.18 71.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.223 1.409 . . . . 75.11 109.171 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' D' ' 41' ' ' LYS . 89.0 m -128.65 98.75 5.11 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.649 -1.241 . . . . 74.44 107.649 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.13 141.95 28.9 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.869 -0.605 . . . . 62.31 109.599 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.7 p -143.14 129.13 19.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.41 0.443 . . . . 74.22 111.227 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 mt -108.99 99.76 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 73.13 108.751 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.87 -132.05 10.81 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.476 0.485 . . . . 60.03 111.972 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.94 5.03 52.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.463 0.705 . . . . 73.22 111.569 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -123.68 167.46 13.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.77 . . . . 71.4 110.557 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.9 m -77.68 132.01 37.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.2 -0.909 . . . . 72.45 110.293 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.53 -65.8 0.97 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.815 0.846 . . . . 74.52 108.73 176.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -154.75 170.39 21.71 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.202 -0.908 . . . . 75.12 110.116 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.0 mt -128.12 153.46 46.83 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.42 -1.326 . . . . 73.44 107.42 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.0 t -158.58 144.1 16.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.841 0.456 . . . . 71.43 110.253 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.34 124.44 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.244 -0.65 . . . . 75.11 109.244 170.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -125.75 116.2 45.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.47 0.708 . . . . 73.32 109.862 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -91.85 86.89 6.04 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.705 0.764 . . . . 74.14 109.809 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.421 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.1 tp-100 -80.72 98.36 7.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.112 1.365 . . . . 74.54 109.736 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.99 158.99 26.25 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.117 -0.393 . . . . 32.23 112.117 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.65 140.31 6.85 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.842 -0.503 . . . . 52.3 111.842 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.9 mt -91.55 120.89 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.518 0.727 . . . . 62.42 109.786 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -118.77 126.42 51.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 72.23 110.407 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 75.2 m -91.31 101.53 14.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.487 1.115 . . . . 63.45 109.541 171.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.87 141.76 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.072 0.549 . . . . 55.43 110.814 -177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.5 162.74 14.61 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.632 1.173 . . . . 73.22 109.129 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.79 77.52 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.356 0.41 . . . . 64.42 113.233 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' D' ' 94' ' ' MET . 0.1 OUTLIER -123.26 130.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 124.097 0.959 . . . . 73.15 109.462 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' H' ' 172' ' ' ALA . 47.4 mt-10 -142.89 170.77 15.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.894 0.878 . . . . 74.45 110.357 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.15 -141.98 33.6 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.211 -0.904 . . . . 71.42 113.569 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 92' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' D' ' 95' ' ' ALA . 16.9 p -75.32 -16.06 60.44 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.716 0.807 . . . . 62.32 111.948 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -60.85 -48.29 82.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.345 0.658 . . . . 75.33 109.992 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.672 ' HG3' HD23 ' D' ' 98' ' ' LEU . 11.2 tpt -80.97 -41.16 23.26 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.38 -0.827 . . . . 72.43 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' D' ' 92' ' ' THR . . . -57.78 -39.92 78.6 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 62.23 112.143 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 80.4 t60 -76.84 -27.07 54.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.625 0.77 . . . . 71.41 110.69 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 37.3 t -75.33 -51.51 13.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.448 0.299 . . . . 73.51 111.273 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.672 HD23 ' HG3' ' D' ' 94' ' ' MET . 4.1 pp -67.38 -32.72 73.82 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.573 0.749 . . . . 74.41 112.217 -172.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.67 13.56 42.37 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.543 -0.587 . . . . 72.34 113.877 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -156.55 -59.86 0.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.35 0.575 . . . . 71.43 111.946 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.455 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 70.3 t80 -73.69 -42.29 61.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.888 0.699 . . . . 64.25 112.888 -168.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 76.0 m -67.04 -44.8 51.56 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.92 -0.562 . . . . 51.24 111.18 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.5 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.3 Cg_exo -56.74 -32.62 91.86 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.127 1.885 . . . . 65.21 113.663 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.18 -35.96 82.49 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.435 0.694 . . . . 75.44 111.272 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.87 -41.78 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.387 0.675 . . . . 62.51 110.208 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.421 HD13 ' O ' ' D' ' 80' ' ' GLN . 86.8 mt -75.06 -21.22 59.13 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.955 -1.021 . . . . 74.23 111.757 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -64.9 -44.61 72.76 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.784 1.402 . . . . 61.24 114.784 -167.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.37 -39.53 86.89 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.244 1.963 . . . . 73.1 113.279 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -78.0 -37.69 46.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.014 -0.993 . . . . 71.23 110.932 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.41 90.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 70.33 110.694 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.459 ' NH2' HG23 ' B' ' 105' ' ' ILE . 40.1 ttp180 -57.47 -49.89 74.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.113 1.365 . . . . 64.31 111.009 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.17 -41.5 99.23 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.277 0.986 . . . . 53.12 111.648 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.464 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 45.0 t -56.58 -40.17 74.76 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.926 0.766 . . . . 75.24 110.896 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.484 HG12 ' SG ' ' D' ' 76' ' ' CYS . 39.8 mt -69.14 -50.36 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.088 -0.96 . . . . 72.14 110.087 175.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.442 HG23 ' HG3' ' D' ' 125' ' ' GLN . 20.2 m -52.05 -42.43 63.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.678 1.191 . . . . 72.15 111.981 -175.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -70.54 -43.45 69.52 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.894 -1.048 . . . . 73.42 110.948 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.7 mtm -64.62 -30.32 71.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.694 0.398 . . . . 54.21 111.615 178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.4 t -66.17 -47.9 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.862 0.726 . . . . 73.44 110.346 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.3 p -71.43 -27.67 63.45 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.656 0.383 . . . . 71.04 111.061 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -75.9 -32.77 59.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.791 0.837 . . . . 65.44 109.795 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.64 -4.88 89.45 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 115.718 -0.674 . . . . 61.42 112.119 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 67.88 33.13 4.86 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.496 1.918 . . . . 70.52 113.117 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -102.6 166.22 12.37 Favored Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.806 1.242 . . . . 72.15 109.949 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.417 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 35.4 Cg_exo -60.01 140.15 91.28 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 123.278 2.652 . . . . 73.32 112.889 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' D' ' 115' ' ' THR . 24.1 tt0 -52.18 140.06 22.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.087 0.867 . . . . 74.01 111.897 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.4 HD13 HG21 ' D' ' 40' ' ' VAL . 46.1 tp -128.3 106.12 8.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.634 -0.712 . . . . 73.02 109.519 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.0 106.29 8.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.832 0.853 . . . . 74.11 109.021 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.26 151.23 45.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 73.3 110.72 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.83 136.63 95.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.462 0.705 . . . . 50.04 111.16 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -69.5 113.11 3.22 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.005 1.804 . . . . 73.13 109.461 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.52 104.43 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.174 0.987 . . . . 70.1 109.663 -171.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -92.81 105.62 17.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 105.913 -1.884 . . . . 73.54 105.913 174.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -68.15 -27.27 66.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.055 0.942 . . . . 65.12 112.106 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.64 -57.16 9.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.197 0.999 . . . . 72.01 109.276 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.15 67.62 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 114.649 -1.159 . . . . 63.23 111.723 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.65 -44.2 94.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.734 1.213 . . . . 65.41 110.894 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -64.8 -51.34 62.74 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.71 0.632 . . . . 73.21 110.365 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 74.3 mtm -65.49 -30.03 70.75 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.47 -0.786 . . . . 40.11 111.521 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -76.35 -36.89 57.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 70.2 110.283 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.72 -46.09 88.15 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.706 0.802 . . . . 74.11 111.349 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.49 -29.45 65.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.33 -0.85 . . . . 61.41 112.118 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.65 6.19 44.93 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.48 0.312 . . . . 72.11 111.819 177.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -118.27 84.12 2.12 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.373 0.669 . . . . 73.24 109.685 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -153.09 94.8 1.88 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.664 -1.236 . . . . 72.45 107.664 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.12 165.42 15.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.918 0.887 . . . . 52.23 109.457 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.96 -174.38 48.67 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 116.053 -0.521 . . . . 72.15 113.391 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.93 147.83 27.67 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.223 1.009 . . . . 62.42 108.896 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.74 63.91 4.38 Favored Glycine 0 C--N 1.344 1.013 0 O-C-N 123.26 0.35 . . . . 44.03 112.988 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -80.97 115.0 20.22 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.433 0.693 . . . . 62.2 109.72 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.59 177.48 6.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.657 0.783 . . . . 74.34 111.183 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.52 159.45 22.83 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.012 -0.54 . . . . 71.42 110.36 173.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.59 149.16 5.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.589 0.755 . . . . 73.42 110.018 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -79.76 167.98 19.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.823 -0.626 . . . . 73.21 110.035 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -145.02 -85.21 0.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.761 -0.459 . . . . 65.33 109.761 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 107.836 -1.172 . . . . 71.43 107.836 -176.617 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.485 0.183 . . . . 71.34 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -123.9 35.08 3.37 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.224 -0.75 . . . . 51.35 111.224 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.16 104.95 17.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.771 0.828 . . . . 73.52 109.442 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 21.3 p -76.85 -174.77 3.2 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.532 0.733 . . . . 64.54 110.866 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.84 139.89 58.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.095 0.558 . . . . 61.22 110.308 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.03 102.74 2.99 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.722 -0.844 . . . . 64.51 108.722 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.611 ' SD ' HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -65.44 76.23 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.435 1.094 . . . . 54.45 112.685 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.442 ' HA ' HD13 ' C' ' 98' ' ' LEU . 12.9 t80 -165.07 57.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.201 1.001 . . . . 73.51 108.458 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -147.85 103.08 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 114.086 -1.415 . . . . 64.22 108.612 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.61 -168.51 1.58 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.187 -1.042 . . . . 61.05 108.187 168.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -161.37 -66.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.351 -1.351 . . . . 71.43 107.351 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -120.24 159.37 47.81 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.781 1.232 . . . . 74.32 107.742 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.09 148.3 89.87 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.596 2.197 . . . . 73.41 112.645 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -74.58 -178.08 3.43 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.398 -0.964 . . . . 73.13 108.398 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -48.84 108.44 0.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.333 0.653 . . . . 73.11 110.337 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 44.8 p -58.51 126.26 26.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.382 1.073 . . . . 75.1 110.898 -174.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -103.91 96.48 9.36 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.02 0.928 . . . . 74.12 109.877 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.55 112.73 3.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.075 1.85 . . . . 62.23 110.998 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' C' ' 44' ' ' LEU . 21.9 mt -67.52 137.8 56.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 109.324 -0.621 . . . . 63.32 109.324 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.68 147.08 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 123.825 0.703 . . . . 75.44 112.267 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -118.44 100.46 7.48 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.557 0.743 . . . . 64.42 109.536 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 189' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' C' ' 40' ' ' VAL . . . -70.84 95.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.395 0.678 . . . . 43.0 110.888 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 190' ' ' ASP . . . . . 0.636 ' HA ' ' HG2' ' C' ' 39' ' ' GLU . 35.0 t70 -70.27 151.75 44.97 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.846 0.858 . . . . 61.41 111.531 -174.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.4 -114.38 3.34 Favored Glycine 0 C--N 1.354 1.555 0 O-C-N 124.021 0.826 . . . . 72.24 113.758 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 192' ' ' GLY . . . . . 0.479 ' HA3' ' HE2' ' F' ' 201' ' ' LYS . . . 67.98 82.2 0.16 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.623 -0.543 . . . . 52.32 111.924 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -50.09 -43.15 51.3 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.411 1.084 . . . . 64.42 112.245 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 69.02 -74.98 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.914 1.286 . . . . 50.34 111.737 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 195' ' ' PHE . . . . . 0.475 ' HE2' ' HD3' ' C' ' 124' ' ' PRO . 2.3 p90 -150.92 178.27 9.32 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.316 0.646 . . . . 65.05 110.547 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -119.96 150.76 40.0 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.899 0.88 . . . . 74.41 109.498 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -153.71 112.46 3.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.011 0.924 . . . . 74.31 110.041 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.18 114.96 8.18 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 107.572 -1.27 . . . . 75.34 107.572 164.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 73.31 159.65 0.22 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.44 1.096 . . . . 71.54 111.524 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.7 69.24 1.21 Allowed Glycine 0 C--N 1.351 1.403 0 CA-C-N 116.221 -0.445 . . . . 74.04 112.58 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' E' ' 204' ' ' ILE . 79.6 tttt -139.95 15.75 2.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.165 0.986 . . . . 74.25 109.36 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.47 -36.59 80.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.389 1.075 . . . . 73.51 111.337 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 203' ' ' ASP . . . . . 0.735 ' HB2' ' H ' ' F' ' 187' ' ' ILE . 13.3 p-10 -150.91 -46.51 0.12 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.116 -0.947 . . . . 64.2 110.005 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' E' ' 201' ' ' LYS . 0.2 OUTLIER -85.21 167.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.455 -0.572 . . . . 65.23 109.455 172.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -132.07 -55.8 0.98 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.385 -1.339 . . . . 75.23 107.385 172.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.35 122.76 23.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.844 -1.525 . . . . 61.31 108.187 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.254 1.318 0 C-N-CA 123.022 0.529 . . . . 45.45 110.409 -172.415 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.594 -0.521 . . . . 75.41 109.594 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.07 -58.16 5.05 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 116.216 -0.447 . . . . 72.13 112.072 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -117.16 153.89 32.03 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.937 1.295 . . . . 51.43 109.3 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 41.2 p -171.82 105.06 0.19 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.348 1.059 . . . . 64.2 109.043 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -135.67 76.71 1.63 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.805 0.842 . . . . 64.41 109.422 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.809 HD21 ' H ' ' B' ' 54' ' ' ASP . 2.3 mm? -122.32 33.34 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.393 1.077 . . . . 42.11 109.982 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.99 -51.66 5.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.007 1.723 . . . . 53.14 113.275 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 50.4 t80 54.58 80.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.45 1.1 . . . . 74.24 111.372 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -78.24 -74.82 0.25 Allowed 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.339 -0.615 . . . . 45.32 109.339 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 tp 54.64 31.01 14.32 Favored 'General case' 0 CA--C 1.559 1.31 0 O-C-N 124.204 0.94 . . . . 75.4 110.07 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -83.97 136.24 34.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.187 -0.915 . . . . 75.33 109.866 -172.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 70.5 136.48 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.675 1.59 . . . . 75.33 111.726 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 102.13 1.2 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.575 2.183 . . . . 75.54 110.819 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -63.78 170.21 3.54 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.659 0.784 . . . . 65.25 111.543 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -61.3 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.118 0.967 . . . . 74.32 110.86 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 13.0 m -75.76 150.18 37.83 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.171 -0.922 . . . . 74.12 110.207 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.492 ' HB3' HD11 ' B' ' 136' ' ' LEU . 32.6 p90 -96.26 109.78 49.06 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.846 0.858 . . . . 63.12 110.549 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.12 137.1 10.59 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.49 2.127 . . . . 71.51 111.197 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.752 HD22 HD11 ' B' ' 128' ' ' LEU . 1.0 OUTLIER -150.69 161.56 42.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.597 0.713 . . . . 73.41 112.624 -172.506 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.735 ' H ' ' HB2' ' E' ' 203' ' ' ASP . 49.0 mm 77.37 133.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 127.069 2.148 . . . . 72.02 113.288 167.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.62 45.17 1.29 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.765 1.226 . . . . 31.24 108.466 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.92 33.47 0.94 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.195 0.998 . . . . 55.32 112.08 -173.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -93.84 130.7 39.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.163 0.985 . . . . 41.52 110.038 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 71.96 87.59 0.15 Allowed Glycine 0 C--N 1.353 1.498 0 O-C-N 123.161 0.288 . . . . 72.52 112.882 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -130.37 -137.88 4.24 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.257 -0.737 . . . . 73.44 111.257 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.16 117.01 14.13 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 117.563 0.682 . . . . 72.32 111.465 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 194' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' B' ' 37' ' ' GLN . . . -175.55 178.64 1.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.603 1.161 . . . . 52.04 111.621 170.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 64.28 76.57 0.34 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.939 1.695 . . . . 72.45 112.065 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.58 102.81 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.255 -1.387 . . . . 72.15 107.255 169.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.54 -4.63 27.91 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.08 0.952 . . . . 74.53 112.713 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.38 5.13 51.8 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.038 0.935 . . . . 53.53 110.839 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -139.42 -43.94 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.051 0.54 . . . . 51.14 112.37 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.07 29.89 7.36 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 114.285 0.474 . . . . 74.24 114.285 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 201' ' ' LYS . . . . . 0.479 ' HE2' ' HA3' ' E' ' 192' ' ' GLY . 6.9 mmtm -91.53 93.33 8.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.123 0.569 . . . . 71.4 109.563 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 74.48 15.52 3.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.109 1.364 . . . . 64.43 111.724 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -136.67 -163.56 1.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.479 0.712 . . . . 63.2 111.075 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.522 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 3.8 tp -108.14 110.21 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.076 0.951 . . . . 74.22 109.506 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -89.44 151.36 22.06 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.796 -0.816 . . . . 74.13 108.796 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.23 122.49 11.9 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.158 0.583 . . . . 64.44 110.152 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.751 0.821 . . . . 73.0 110.913 -176.934 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.651 -0.5 . . . . 62.14 109.651 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -179.76 109.02 0.25 Allowed Glycine 0 C--N 1.35 1.36 0 C-N-CA 121.474 -0.393 . . . . 53.41 113.534 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -87.74 -51.97 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.556 0.743 . . . . 72.34 109.601 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 35.5 m 58.26 74.71 0.42 Allowed 'General case' 0 C--N 1.356 0.874 0 O-C-N 124.766 1.291 . . . . 71.22 109.982 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.38 17.45 2.6 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.174 -0.921 . . . . 74.44 111.661 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.431 HD21 ' HE2' ' A' ' 56' ' ' TYR . 2.5 tm? -83.96 117.15 23.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.175 0.99 . . . . 65.41 108.466 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.616 ' HG2' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -137.12 163.45 30.8 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.943 0.897 . . . . 62.14 110.245 -170.613 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.592 ' HB3' ' HA ' ' C' ' 152' ' ' HIS . 33.7 t80 -170.88 77.81 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.787 0.835 . . . . 74.3 109.703 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -96.07 -65.53 0.96 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.356 -0.609 . . . . 75.31 109.356 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 30.5 tp 54.6 80.41 0.12 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.938 1.295 . . . . 61.31 109.563 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -103.72 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.746 0.818 . . . . 60.31 110.619 -173.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.6 153.57 40.54 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.789 0.836 . . . . 71.5 110.104 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.38 -169.8 0.57 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.935 2.424 . . . . 65.11 111.759 166.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -151.67 142.45 22.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.657 -0.497 . . . . 72.13 109.657 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 9.0 t80 59.82 -157.28 0.33 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.196 0.998 . . . . 63.1 109.993 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -132.26 140.14 48.52 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.554 0.742 . . . . 72.03 109.139 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -149.47 124.29 4.8 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 122.999 0.52 . . . . 73.14 111.203 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.91 -179.54 1.85 Allowed 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.684 2.256 . . . . 74.44 110.658 164.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.81 -173.63 2.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.842 -0.799 . . . . 41.05 108.842 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 129' ' ' ALA . 45.3 pt -62.78 -23.52 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 55.41 111.425 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . 59.94 69.8 0.68 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.59 1.156 . . . . 61.35 110.293 -174.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -81.35 70.5 8.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.861 -1.063 . . . . 71.3 108.681 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 190' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 35.9 t70 -147.63 101.88 3.38 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.259 -1.337 . . . . 73.45 107.86 -174.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.8 6.96 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.617 0.573 . . . . 72.5 111.797 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 192' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 39' ' ' GLU . . . -93.49 21.54 40.27 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.264 -0.742 . . . . 65.24 113.807 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -158.75 84.76 0.82 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.081 0.944 . . . . 51.33 109.628 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 194' ' ' ALA . . . . . 0.446 ' HB1' ' HA2' ' H' ' 200' ' ' GLY . . . -168.89 145.49 3.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.798 0.839 . . . . 62.45 108.87 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 35.3 t80 70.0 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.44 1.087 . . . . 75.52 110.319 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 3.9 ttmp? -137.29 138.38 39.98 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.646 -0.659 . . . . 65.22 112.203 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 166.89 17.95 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 124.004 0.815 . . . . 75.42 111.103 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 198' ' ' GLU . . . . . 0.768 ' HA ' ' HA ' ' H' ' 195' ' ' PHE . 0.0 OUTLIER -73.85 -179.92 3.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.613 -0.721 . . . . 71.21 111.296 174.31 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -130.79 49.33 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.209 -1.034 . . . . 64.24 108.209 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.78 81.44 0.23 Allowed Glycine 0 C--N 1.354 1.552 0 CA-C-N 114.562 -1.199 . . . . 45.42 112.574 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -77.08 -34.73 56.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.105 0.962 . . . . 72.11 110.495 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.72 95.62 0.04 OUTLIER 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.623 1.202 . . . . 72.23 109.867 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.23 38.16 0.8 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.213 1.005 . . . . 74.45 110.744 -173.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.34 131.54 61.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.26 1.024 . . . . 53.02 109.81 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -155.35 127.24 7.53 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.864 0.866 . . . . 51.25 108.669 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -168.47 -53.41 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.488 -1.301 . . . . 64.22 107.488 -172.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.482 -1.235 . . . . 75.43 107.678 170.093 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 110.354 -0.239 . . . . 74.12 110.354 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.49 98.72 0.95 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 116.077 -0.51 . . . . 72.44 112.057 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.83 -40.7 79.33 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.815 -0.809 . . . . 62.42 108.815 168.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 34.2 p -131.7 155.44 47.64 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.067 1.347 . . . . 71.33 108.621 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' D' ' 90' ' ' GLU . . . -163.7 127.52 2.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.365 0.666 . . . . 74.04 110.305 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.13 -156.33 0.69 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.49 1.116 . . . . 73.02 109.075 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' H' ' 174' ' ' MET . 1.0 OUTLIER -61.01 94.97 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.888 1.275 . . . . 63.44 111.562 -171.368 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 40.1 t80 69.2 104.28 0.06 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.578 1.551 . . . . 71.14 111.609 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.99 105.39 2.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.1 0.96 . . . . 74.44 109.02 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.09 100.73 10.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.172 -1.047 . . . . 72.42 108.172 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -104.49 -43.0 5.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 70.25 110.516 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.42 115.36 5.34 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.24 1.016 . . . . 65.43 108.988 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.58 95.78 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.777 2.318 . . . . 74.01 112.23 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -81.25 125.18 30.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.819 0.848 . . . . 75.21 109.593 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 10.4 t80 68.23 165.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.86 1.264 . . . . 75.13 111.303 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.6 t -134.66 161.61 34.64 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.722 -0.611 . . . . 41.13 111.216 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -107.46 121.41 44.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.358 1.063 . . . . 74.13 109.965 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.85 107.09 2.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.208 1.939 . . . . 74.54 111.241 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.01 98.5 0.97 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.819 -0.628 . . . . 63.3 109.703 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.453 HD13 ' H ' ' H' ' 187' ' ' ILE . 0.2 OUTLIER -56.66 110.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 C-N-CA 124.694 1.198 . . . . 74.14 113.031 -171.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.54 97.48 7.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.447 1.099 . . . . 62.33 109.239 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -85.87 140.43 30.4 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.41 0.684 . . . . 62.34 111.382 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -72.74 -29.44 63.35 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.502 0.721 . . . . 74.24 109.853 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 191' ' ' GLY . . . . . 0.418 ' HA3' ' HG2' ' D' ' 37' ' ' GLN . . . 76.34 -86.07 0.92 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 123.8 0.687 . . . . 31.22 111.566 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.09 156.09 21.79 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.281 -0.328 . . . . 63.22 112.281 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -84.9 -10.23 57.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.5 0.72 . . . . 72.15 111.303 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.69 39.87 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.843 0.857 . . . . 63.14 110.459 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.768 ' HA ' ' HA ' ' G' ' 198' ' ' GLU . 4.7 t80 -164.88 -65.87 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.426 1.09 . . . . 64.11 109.027 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 196' ' ' LYS . . . . . 0.587 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 74.9 mmtt 62.42 -162.91 0.27 Allowed 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.224 0.952 . . . . 63.32 110.889 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -149.73 -77.68 0.14 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.999 -0.741 . . . . 73.44 108.999 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 55.61 -165.67 0.12 Allowed 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.536 -1.211 . . . . 73.11 111.351 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -163.73 -34.55 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.633 1.173 . . . . 33.54 107.945 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 200' ' ' GLY . . . . . 0.446 ' HA2' ' HB1' ' G' ' 194' ' ' ALA . . . 120.37 105.79 2.07 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 114.36 -1.291 . . . . 73.51 109.941 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.59 92.0 2.37 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.117 -1.068 . . . . 73.34 108.117 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -75.74 164.43 26.27 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.178 -1.374 . . . . 73.44 109.164 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.93 45.54 1.22 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 122.148 0.975 . . . . 72.44 109.277 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.25 105.17 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 114.219 -1.355 . . . . 75.2 111.721 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 205' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' H' ' 205' ' ' LYS . 1.7 mppt? -133.32 18.62 4.01 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.718 -1.216 . . . . 63.14 107.718 162.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 206' ' ' ASP . . . . . 0.428 ' HA ' HD12 ' A' ' 136' ' ' LEU . 6.3 p-10 -81.94 14.11 2.94 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.169 0.987 . . . . 55.01 112.687 -172.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 C--O 1.255 1.369 0 C-N-CA 124.561 1.144 . . . . 73.34 108.018 178.783 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttm . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.128 -0.693 . . . . 64.34 109.128 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -84.3 85.57 7.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.827 0.851 . . . . 54.2 109.014 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -73.34 93.4 1.91 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.571 0.749 . . . . 72.01 110.216 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -59.44 132.15 53.13 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.348 1.059 . . . . 64.4 110.838 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -139.33 106.89 5.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.483 0.713 . . . . 74.4 109.287 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.638 ' HA ' ' HA2' ' C' ' 146' ' ' GLY . 20.4 t-20 -101.37 93.46 5.42 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.985 0.514 . . . . 72.23 109.904 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.3 p -80.76 -75.78 0.26 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.844 -0.799 . . . . 60.55 108.844 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.56 ' HG3' ' HG3' ' A' ' 9' ' ' MET . 12.0 tp10 -130.38 -83.22 0.54 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.167 -0.679 . . . . 64.4 109.167 -174.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.56 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -176.36 158.54 1.87 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 64.34 110.244 -174.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -152.84 145.02 23.87 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.29 1.036 . . . . 73.01 110.282 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -98.54 139.82 33.69 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.098 -0.955 . . . . 72.44 108.513 162.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.1 tp60 -156.39 137.37 13.55 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 112.329 0.492 . . . . 74.1 112.329 174.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 83' ' ' ILE . 7.9 tp -80.02 134.63 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.531 0.732 . . . . 73.24 110.149 169.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' O ' HD13 ' F' ' 204' ' ' ILE . 0.9 OUTLIER -101.77 -40.25 7.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.957 -0.757 . . . . 71.04 108.957 174.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' NH1' ' HA ' ' F' ' 203' ' ' ASP . 20.7 ttt180 -173.75 127.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.999 -0.524 . . . . 74.34 110.948 -171.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.05 133.75 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.614 -0.884 . . . . 72.42 108.614 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 34.0 p90 -169.04 170.34 8.94 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.899 0.88 . . . . 74.34 110.578 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.8 p -93.39 120.08 33.26 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.32 -0.992 . . . . 73.45 108.32 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.7 mtpt -86.94 -42.94 12.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.204 -0.665 . . . . 75.5 109.204 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 12.0 t70 -135.16 128.51 32.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.145 -0.934 . . . . 70.54 108.499 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -122.95 143.28 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.952 -1.129 . . . . 64.3 107.952 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -143.5 125.91 15.73 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.798 -0.816 . . . . 70.03 108.798 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.9 t80 -131.1 129.87 42.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.586 -1.635 . . . . 72.52 106.586 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.91 138.83 47.09 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.313 -0.625 . . . . 72.11 109.313 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 76.18 11.39 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.385 -1.339 . . . . 72.03 107.385 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.53 -24.07 16.53 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.296 1.998 . . . . 63.34 111.202 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.03 25.76 7.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.078 0.951 . . . . 73.13 109.104 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -59.2 -47.64 97.93 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 124.389 1.075 . . . . 11.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 52.8 Cg_exo -61.17 -27.99 84.68 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.982 1.788 . . . . 70.02 113.738 171.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -76.07 -48.79 19.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.7 0.8 . . . . 62.22 112.134 -173.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.596 HG23 HD11 ' A' ' 68' ' ' LEU . 7.4 p -57.11 -27.21 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.975 0.91 . . . . 64.2 112.362 -175.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.45 -36.32 75.73 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.381 1.072 . . . . 73.44 112.328 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.72 -12.39 20.02 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.063 0.545 . . . . 61.24 111.363 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 4.6 mmmp? -83.51 143.23 30.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.729 0.812 . . . . 55.31 111.972 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.47 143.59 57.69 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 124.324 1.015 . . . . 74.41 110.578 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CE3' HD21 ' A' ' 68' ' ' LEU . 65.9 t-105 -93.0 86.69 5.5 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.758 0.79 . . . . 75.24 110.326 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -125.55 79.8 66.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 107.058 -1.46 . . . . 62.35 107.058 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 142.38 11.86 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.326 2.017 . . . . 72.31 112.928 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.55 86.04 3.49 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.257 -1.757 . . . . 64.31 106.257 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' G' ' 189' ' ' ALA . 19.7 t -76.49 93.76 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.02 -0.991 . . . . 74.31 108.966 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.3 tttt -79.22 124.42 28.35 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.55 -0.75 . . . . 63.53 109.096 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.415 ' HG ' HD21 ' A' ' 128' ' ' LEU . 2.4 mm? -107.38 112.25 24.97 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.01 -1.107 . . . . 71.33 108.01 170.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 28.9 t70 -105.17 129.86 53.47 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.647 -0.872 . . . . 75.22 108.647 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.675 ' HB2' HD11 ' G' ' 186' ' ' LEU . 31.1 tp -106.04 131.93 52.73 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.174 -0.676 . . . . 73.4 109.174 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -143.0 152.61 42.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.131 -1.063 . . . . 74.32 108.131 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -138.01 156.59 47.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.929 0.892 . . . . 63.41 109.313 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 153.75 34.42 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.139 0.975 . . . . 51.24 108.797 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.46 152.43 51.52 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.896 0.478 . . . . 74.51 110.754 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -149.94 121.19 7.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.998 0.919 . . . . 62.42 109.046 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.37 -0.604 . . . . 74.13 109.37 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -88.58 -43.38 11.42 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.581 -0.736 . . . . 75.01 111.048 -175.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 -174.87 4.7 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.411 -0.813 . . . . 74.34 110.577 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -75.53 123.33 25.28 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.359 -0.837 . . . . 73.13 108.825 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' HA ' HD21 ' G' ' 173' ' ' LEU . 20.5 m-20 72.33 14.78 5.38 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.304 1.442 . . . . 73.21 111.77 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.26 114.13 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.771 0.828 . . . . 73.31 110.381 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -124.26 126.14 45.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.742 0.817 . . . . 72.23 108.992 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 33.8 tt0 -90.34 120.43 31.46 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.406 1.082 . . . . 60.15 109.152 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.523 HG21 ' HG ' ' A' ' 98' ' ' LEU . 21.5 t -102.61 116.71 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.73 -1.211 . . . . 53.2 107.73 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.0 t -99.23 126.28 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.038 -0.727 . . . . 73.54 109.038 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.27 115.67 31.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.349 -1.352 . . . . 75.01 107.349 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -108.83 105.38 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.42 0.628 . . . . 74.11 109.742 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -101.99 133.51 45.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.778 -1.101 . . . . 72.33 108.152 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.2 m -121.69 118.23 28.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.372 0.606 . . . . 73.34 110.528 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.7 t -105.6 107.08 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.701 -1.136 . . . . 62.41 108.931 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 12.4 m -106.51 131.78 53.28 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.625 -0.88 . . . . 61.42 108.625 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.78 107.78 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.073 -1.084 . . . . 72.24 108.073 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 44.8 m -115.24 126.98 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.643 0.377 . . . . 63.1 110.392 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.596 HD11 HG23 ' A' ' 31' ' ' VAL . 18.9 mt -88.97 58.95 4.8 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.093 -1.077 . . . . 75.54 108.093 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.36 -89.0 0.71 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-N 114.999 -1.001 . . . . 64.33 112.136 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -92.92 -28.1 16.67 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.049 0.94 . . . . 72.14 110.709 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.706 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -107.54 103.53 12.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.592 0.757 . . . . 75.5 109.631 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 91.8 m -66.03 130.34 42.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.638 0.654 . . . . 74.4 109.576 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.25 -56.3 4.57 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.806 0.843 . . . . 65.44 109.831 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.5 172.92 16.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.83 -1.077 . . . . 64.23 111.36 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -132.09 144.42 50.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.138 -1.392 . . . . 71.14 108.276 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.6 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -136.82 139.82 42.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.895 0.878 . . . . 72.14 108.665 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.465 ' HG2' ' OE1' ' A' ' 79' ' ' GLN . 43.6 tt0 -149.77 120.22 7.41 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.465 -0.568 . . . . 73.35 109.465 173.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.65 113.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.457 0.703 . . . . 70.02 110.485 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.465 ' OE1' ' HG2' ' A' ' 77' ' ' GLU . 1.7 mp0 -89.0 80.48 7.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.388 1.475 . . . . 74.24 108.36 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.36 94.27 3.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.713 -1.13 . . . . 73.14 108.879 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.88 140.74 19.65 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.409 -0.677 . . . . 52.4 111.409 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.672 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.89 122.22 1.88 Allowed Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.417 -1.073 . . . . 73.21 110.417 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.0 mt -83.74 125.91 40.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.685 -0.857 . . . . 63.21 108.685 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CE2' HD13 ' A' ' 13' ' ' ILE . 53.1 m-85 -128.36 120.47 27.06 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.079 -0.711 . . . . 64.24 109.079 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.3 t -81.27 102.17 10.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.504 0.722 . . . . 54.32 109.295 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 149.84 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.375 0.67 . . . . 63.53 110.402 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.07 177.06 2.01 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.708 1.203 . . . . 43.32 109.58 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' G' ' 172' ' ' ALA . . . 90.36 -34.35 4.19 Favored Glycine 0 N--CA 1.473 1.122 0 CA-C-N 116.126 -0.488 . . . . 73.44 114.076 173.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.55 HG23 ' HG2' ' A' ' 9' ' ' MET . 1.6 pp -110.55 150.85 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.97 0.908 . . . . 71.24 108.772 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.626 ' HA ' ' SD ' ' G' ' 174' ' ' MET . 44.8 mt-10 -136.37 176.94 8.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.121 0.568 . . . . 74.51 112.065 -171.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.41 -126.71 40.52 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.118 -0.947 . . . . 74.25 113.089 172.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.505 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 40.9 p -71.45 -15.06 62.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.689 0.796 . . . . 71.35 112.568 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -72.15 -45.65 59.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.475 0.71 . . . . 63.4 110.584 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.97 -28.99 29.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.443 0.697 . . . . 74.43 109.981 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -72.93 -22.99 60.64 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.195 0.598 . . . . 62.11 111.177 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -65.89 -46.55 77.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.906 0.882 . . . . 74.43 109.616 169.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.4 m -60.55 -64.72 0.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.711 -1.131 . . . . 63.32 110.318 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.523 ' HG ' HG21 ' A' ' 58' ' ' VAL . 9.7 mp -73.8 -9.91 59.14 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.898 0.703 . . . . 63.21 112.898 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.89 -29.4 13.1 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.795 -0.447 . . . . 52.1 113.747 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.504 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -145.33 -44.47 0.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.876 0.695 . . . . 72.42 112.876 -172.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.9 t80 -78.32 -60.44 2.37 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.246 0.618 . . . . 44.2 112.318 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 97' ' ' CYS . 59.1 m -66.64 -37.9 16.99 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 114.325 1.231 . . . . 64.21 114.325 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.51 -27.05 69.97 Favored 'Trans proline' 0 C--N 1.391 2.767 0 CA-C-N 121.391 1.533 . . . . 65.44 112.664 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.0 -26.5 61.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.974 0.509 . . . . 75.02 110.149 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -64.78 -43.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.311 0.576 . . . . 63.13 109.568 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.672 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.4 mt -76.85 -26.45 54.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.093 -0.958 . . . . 71.23 112.031 -175.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -64.32 -36.67 20.12 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.52 1.304 . . . . 62.44 114.52 -168.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 -34.37 95.03 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.074 1.849 . . . . 43.55 113.292 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -85.65 -36.29 20.39 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.667 0.787 . . . . 73.02 111.149 -174.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.89 85.03 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.377 -0.601 . . . . 65.42 109.377 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -53.16 -56.48 16.05 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.798 1.311 . . . . 63.51 109.492 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.8 -41.84 87.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.156 0.982 . . . . 74.02 111.8 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.476 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 48.3 t -62.5 -50.5 71.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.357 0.663 . . . . 74.32 110.674 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.554 HG21 HG21 ' A' ' 64' ' ' VAL . 89.7 mt -61.83 -51.22 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.92 0.763 . . . . 61.13 110.451 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.6 m -51.57 -45.16 63.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.923 1.289 . . . . 72.34 111.4 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -73.41 -41.49 63.23 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.841 -1.072 . . . . 50.15 110.833 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.5 mtp -55.13 -43.47 74.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.652 0.781 . . . . 50.15 111.424 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 54.5 t -65.08 -45.81 93.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.523 -1.217 . . . . 51.3 111.103 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.69 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.2 p -69.18 -32.52 71.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.383 0.273 . . . . 42.22 111.595 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.54 -28.43 67.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.614 0.766 . . . . 74.52 110.829 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.96 67.14 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.475 0.484 . . . . 63.11 113.496 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.481 ' HB ' HH21 ' B' ' 15' ' ' ARG . 9.5 m 64.07 43.24 5.2 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.74 1.216 . . . . 71.31 110.525 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.4 156.63 50.82 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 114.908 -1.042 . . . . 73.11 108.918 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.27 115.56 3.39 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.98 1.787 . . . . 70.0 110.395 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 8.5 pt20 -62.92 143.18 57.92 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.422 0.451 . . . . 62.44 110.222 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.84 122.16 46.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.88 -0.785 . . . . 73.55 108.88 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -97.11 94.15 6.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.415 HD21 ' HG ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -68.05 126.18 28.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.274 -0.875 . . . . 75.41 109.893 -172.019 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.479 ' HB3' HD13 ' G' ' 187' ' ' ILE . . . -66.08 128.13 93.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 O-C-N 123.466 0.479 . . . . 52.52 110.537 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 4.8 Cg_exo -79.19 123.74 5.71 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.615 2.21 . . . . 74.34 111.567 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.4 112.43 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.129 -1.063 . . . . 73.11 108.129 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -90.91 72.26 6.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.082 -1.081 . . . . 63.22 108.082 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -62.85 -29.66 70.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.032 -0.985 . . . . 63.14 111.103 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.95 -29.74 69.68 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.278 1.031 . . . . 75.23 111.933 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.31 93.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.924 0.489 . . . . 71.11 110.568 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.16 -38.55 60.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.38 -0.827 . . . . 74.24 110.047 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t80 -55.55 -50.18 70.7 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.623 1.169 . . . . 62.42 110.951 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.7 mmt -61.83 -44.58 96.55 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 73.03 111.469 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -65.02 -33.39 75.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.261 0.624 . . . . 75.3 111.567 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -74.12 -37.11 64.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.437 -0.801 . . . . 65.44 110.634 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 65.0 mt -67.51 -49.73 62.08 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.373 0.42 . . . . 73.14 111.059 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -165.74 -17.04 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.453 0.538 . . . . 75.34 112.453 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 62.15 105.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.603 1.161 . . . . 53.52 110.103 -172.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.8 -60.82 2.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.965 0.506 . . . . 70.51 111.53 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.86 34.89 16.77 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.362 1.065 . . . . 52.11 111.068 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.3 -110.96 1.65 Allowed Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.714 -0.676 . . . . 52.44 112.383 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 53.17 70.88 0.54 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.92 1.288 . . . . 63.04 110.891 -177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.36 72.8 0.08 OUTLIER Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.166 -0.47 . . . . 43.03 112.609 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 61.0 p -94.29 -62.63 1.3 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.6 -0.889 . . . . 70.32 108.6 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 73.9 -29.83 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.03 1.732 . . . . 75.04 112.643 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.42 109.64 0.58 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.806 1.242 . . . . 74.21 109.593 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 170.33 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.272 1.829 . . . . 63.32 108.715 166.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -97.16 0.49 48.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.679 0.792 . . . . 72.23 110.667 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.51 118.66 11.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.828 0.851 . . . . 74.3 110.435 -173.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.844 0.857 . . . . 37.78 109.003 175.851 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.864 -0.791 . . . . 71.23 108.864 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -74.0 -5.85 43.84 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.744 0.818 . . . . 53.52 111.716 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.566 ' HA ' HD21 ' D' ' 141' ' ' LEU . 9.8 pt-20 -60.87 -17.59 51.19 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.864 0.865 . . . . 75.21 112.099 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.09 166.12 8.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.681 0.792 . . . . 74.43 111.376 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' D' ' 138' ' ' MET . 9.6 p30 -137.86 154.7 49.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.87 0.468 . . . . 72.11 110.777 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' D' ' 135' ' ' ALA . 5.8 m-20 -112.26 41.64 1.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.584 -0.895 . . . . 62.32 108.584 169.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -84.13 60.78 6.11 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 123.101 1.429 . . . . 62.33 107.562 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.559 ' HG2' ' H ' ' B' ' 9' ' ' MET . 23.6 tt0 -161.41 177.18 10.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.957 -1.929 . . . . 71.44 106.58 -170.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.663 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 17.9 ptm 56.13 176.45 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.931 1.693 . . . . 73.23 113.285 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.2 m -150.96 125.99 9.84 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.423 -1.325 . . . . 74.12 107.423 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -143.18 132.22 22.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.485 -0.932 . . . . 74.33 108.485 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -154.12 140.93 19.12 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.396 0.435 . . . . 53.13 111.702 173.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.56 HD13 HD11 ' B' ' 16' ' ' ILE . 58.8 mt -84.66 115.04 25.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.45 -0.944 . . . . 74.33 108.45 168.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -87.9 -35.07 17.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.604 0.565 . . . . 71.15 110.039 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.481 HH21 ' HB ' ' A' ' 122' ' ' THR . 70.8 ttt180 -167.27 137.73 2.98 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.139 -0.482 . . . . 72.23 110.045 -177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.56 HD11 HD13 ' B' ' 13' ' ' ILE . 98.0 mt -116.98 135.95 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.934 -1.506 . . . . 61.43 106.934 169.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -168.99 152.04 5.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.274 0.559 . . . . 64.23 111.479 -170.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.2 m -83.04 121.48 27.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.343 -0.984 . . . . 70.15 108.343 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -92.24 -32.88 14.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.102 0.561 . . . . 73.34 110.773 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 25.7 t70 -155.95 142.42 18.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.981 -0.554 . . . . 75.45 110.851 -168.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 34.4 mm -138.87 142.08 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 62.45 108.881 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 41.4 t -141.36 133.76 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.451 -1.25 . . . . 52.33 107.856 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.0 t80 -147.34 107.54 4.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.493 -1.299 . . . . 71.02 107.493 171.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.45 120.97 39.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.127 0.971 . . . . 64.41 108.656 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -119.23 87.19 34.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.959 0.904 . . . . 62.52 109.857 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 -48.83 4.66 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.904 2.403 . . . . 64.14 112.672 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -104.11 28.57 6.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.204 0.602 . . . . 73.33 110.66 -177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -49.99 -51.66 59.58 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.885 1.274 . . . . 70.34 113.411 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 97.2 Cg_endo -86.98 -13.06 4.73 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.435 2.09 . . . . 53.44 113.394 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -89.27 2.97 53.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.378 0.671 . . . . 73.24 111.078 -174.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -62.66 -16.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.973 1.309 . . . . 72.22 111.942 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.893 0.877 . . . . 75.25 111.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.14 -45.91 72.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.775 -0.648 . . . . 62.13 110.806 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.07 81.61 1.47 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.721 0.809 . . . . 74.03 109.511 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -80.24 74.11 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.114 0.959 . . . . 70.43 111.41 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -159.29 174.28 15.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.997 1.319 . . . . 75.33 109.745 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -75.74 129.97 80.09 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 115.284 -0.871 . . . . 75.2 109.757 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.15 153.41 69.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.341 2.028 . . . . 72.4 111.723 167.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.3 mt-10 -65.65 99.79 0.47 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.05 -1.092 . . . . 73.04 108.05 172.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' 126' ' ' LEU . 21.7 t -87.18 117.43 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.413 -1.328 . . . . 54.21 107.413 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -151.67 132.86 14.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.066 -0.716 . . . . 65.45 109.066 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' B' ' 64' ' ' VAL . 1.5 pt? -128.92 164.55 22.89 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.032 0.444 . . . . 74.42 111.877 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -149.49 149.93 31.54 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.963 -1.017 . . . . 63.04 109.556 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.425 ' HB2' HD11 ' F' ' 186' ' ' LEU . 7.9 tt -107.14 136.69 46.56 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 52.45 111.121 -170.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 1.2 m-20 -123.61 150.92 43.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.223 1.409 . . . . 71.44 107.574 172.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -136.41 134.19 37.5 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.77 147.38 27.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.348 1.059 . . . . 72.41 108.237 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -142.65 162.54 35.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.843 0.457 . . . . 54.34 110.555 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -154.33 166.4 33.33 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.566 1.146 . . . . 70.44 109.064 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -115.05 132.67 56.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.858 0.463 . . . . 73.41 110.373 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.93 -48.19 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.859 0.864 . . . . 74.25 110.063 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.86 -175.81 5.48 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.797 -1.092 . . . . 53.43 109.779 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -61.43 122.05 14.19 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.241 -0.89 . . . . 74.42 109.455 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 71.69 -5.29 1.69 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.23 1.412 . . . . 73.3 111.882 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -109.64 100.21 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.301 1.04 . . . . 75.13 108.715 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.49 172.44 6.97 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.623 0.769 . . . . 71.03 110.814 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -144.04 115.45 8.05 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.903 -1.517 . . . . 71.52 106.903 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' B' ' 98' ' ' LEU . 43.3 t -117.33 125.6 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.54 0.736 . . . . 53.03 109.805 -173.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.6 t -106.29 121.16 58.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.993 0.917 . . . . 65.44 110.319 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -93.81 114.47 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 107.653 -1.24 . . . . 72.42 107.653 170.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.0 ttm180 -100.64 112.56 24.96 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.11 118.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.11 -1.071 . . . . 61.45 108.11 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.2 m -115.9 137.08 52.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.616 0.766 . . . . 72.12 109.812 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' B' ' 42' ' ' LEU . 94.1 t -111.85 119.99 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.842 1.257 . . . . 74.22 110.453 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 67.5 m -89.67 140.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.896 -1.15 . . . . 63.41 107.896 165.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.54 143.61 26.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.013 -0.366 . . . . 63.23 110.013 175.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.6 p -156.03 135.2 12.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.687 0.625 . . . . 75.33 112.687 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -92.88 99.1 11.82 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.548 -1.279 . . . . 64.32 107.548 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.44 -130.93 41.13 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.65 0.594 . . . . 43.01 112.494 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -90.89 44.92 1.22 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.025 0.93 . . . . 74.22 110.091 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.06 139.02 13.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.455 0.702 . . . . 72.13 109.42 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.0 m -72.85 133.12 44.3 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.021 0.529 . . . . 71.43 110.466 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 -56.18 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.839 0.856 . . . . 71.43 109.281 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -152.85 165.93 33.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.301 -1.318 . . . . 60.01 109.83 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -140.73 121.07 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.419 -1.697 . . . . 73.3 106.419 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.548 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.4 t -116.31 158.96 22.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.319 -0.993 . . . . 64.33 108.319 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.3 tt0 -165.88 130.36 2.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.131 -0.692 . . . . 74.21 109.131 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -124.33 142.93 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.229 -1.026 . . . . 60.33 108.229 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -122.05 87.22 2.71 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.126 -1.065 . . . . 72.24 108.126 172.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 63.2 tp60 -80.59 101.05 8.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.235 -1.348 . . . . 64.23 108.539 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.66 171.13 37.53 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.404 -0.678 . . . . 75.33 111.404 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.92 131.61 2.46 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.2 -0.76 . . . . 71.53 111.2 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.12 122.87 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.376 -1.342 . . . . 62.32 107.376 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -129.85 129.73 44.34 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.653 -1.24 . . . . 75.22 107.653 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -97.41 102.65 14.47 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.216 -0.661 . . . . 64.41 109.216 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.36 138.41 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.177 0.991 . . . . 71.42 110.901 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.8 172.06 19.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.449 1.099 . . . . 45.35 109.585 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 89.64 -43.28 2.99 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-N 116.173 -0.467 . . . . 62.21 112.859 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 163.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.934 0.894 . . . . 75.33 111.019 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 9.9 pt-20 -159.37 143.82 15.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.005 0.522 . . . . 74.33 110.873 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.11 -104.36 0.45 Allowed Glycine 0 C--N 1.353 1.515 0 O-C-N 124.226 0.954 . . . . 44.12 114.121 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.3 m -65.88 -41.35 91.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.231 1.012 . . . . 63.11 110.258 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.419 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 72.6 mt-30 -61.33 -40.56 94.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.475 -0.784 . . . . 75.3 111.035 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.574 ' SD ' ' SD ' ' F' ' 174' ' ' MET . 20.2 ttt -71.52 -40.7 69.93 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.509 0.505 . . . . 72.11 110.676 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.3 66.96 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.466 -0.788 . . . . 71.21 111.692 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -93.73 -21.22 19.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.973 0.909 . . . . 74.33 110.648 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -79.17 -67.2 0.78 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.563 -0.532 . . . . 75.14 109.563 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' B' ' 58' ' ' VAL . 2.2 pp -95.34 -4.85 44.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.177 0.806 . . . . 70.43 113.177 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -3.21 56.59 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 120.04 -0.311 . . . . 73.53 112.665 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.05 -56.51 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.013 0.375 . . . . 71.02 112.013 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -74.78 -41.26 60.35 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.106 0.41 . . . . 75.51 112.106 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 85.6 m -68.9 -45.72 31.68 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.698 -0.668 . . . . 73.35 110.532 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.6 Cg_exo -55.69 -31.54 80.28 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.132 1.888 . . . . 73.52 113.895 165.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.97 -40.79 87.53 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 122.886 0.474 . . . . 72.42 110.173 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.489 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -58.57 -49.17 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.66 0.784 . . . . 65.41 109.871 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.71 -9.64 59.67 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.781 -1.1 . . . . 71.22 112.005 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.512 ' HZ ' HD13 ' B' ' 128' ' ' LEU . 76.9 t80 -64.94 -51.06 59.18 Favored Pre-proline 0 N--CA 1.484 1.256 0 CA-C-O 117.991 -1.004 . . . . 74.12 113.402 -172.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.79 -35.8 87.14 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.788 1.658 . . . . 74.25 112.174 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.51 ' HE2' HG21 ' D' ' 115' ' ' THR . 88.7 m-85 -64.17 -47.87 78.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.745 0.818 . . . . 74.21 110.858 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.61 91.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.379 -0.828 . . . . 54.14 110.467 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -65.1 -45.0 86.99 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.375 1.07 . . . . 64.42 109.948 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.08 -37.82 69.52 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.148 -0.933 . . . . 72.11 110.132 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG2' ' B' ' 117' ' ' MET . 10.0 t -64.97 -35.69 82.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.945 0.498 . . . . 75.3 110.993 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' B' ' 64' ' ' VAL . 73.3 mt -64.7 -53.31 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.22 0.608 . . . . 72.01 109.778 173.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -56.74 -31.55 64.68 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.139 0.899 . . . . 52.01 110.892 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -64.38 -53.26 51.42 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 114.805 -1.089 . . . . 72.32 110.111 172.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.4 mmt -66.53 -33.84 76.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.065 0.394 . . . . 72.02 112.065 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.25 -40.86 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.731 0.812 . . . . 44.41 109.906 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.6 p -73.03 -29.31 62.89 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.022 -0.535 . . . . 75.35 111.642 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' HA ' ' A' ' 113' ' ' CYS . 72.5 mtt-85 -65.73 -36.9 84.92 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.46 -0.791 . . . . 72.41 109.484 172.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.98 3.61 69.88 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 124.024 0.827 . . . . 75.31 113.5 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.4 p 59.56 29.67 19.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.824 1.65 . . . . 73.11 112.748 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 63.7 m-85 -102.24 155.51 36.39 Favored Pre-proline 0 N--CA 1.488 1.461 0 C-N-CA 124.206 1.003 . . . . 73.42 111.278 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.65 178.85 0.83 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.731 2.954 . . . . 74.04 115.662 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.619 HE22 ' HB1' ' F' ' 189' ' ' ALA . 1.4 pp0? -64.93 152.85 42.13 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.56 -1.655 . . . . 61.11 114.573 -162.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.579 HD21 HD13 ' B' ' 42' ' ' LEU . 26.6 tp -149.32 106.08 3.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.003 -1.453 . . . . 75.22 108.861 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.52 92.36 2.9 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.588 -1.264 . . . . 73.24 107.588 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' F' ' 186' ' ' LEU . 2.4 tt -58.95 141.45 53.68 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.745 -1.116 . . . . 64.32 109.649 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.619 ' H ' HD11 ' F' ' 187' ' ' ILE . . . -57.46 106.48 0.69 Allowed Pre-proline 0 N--CA 1.477 0.912 0 O-C-N 124.359 1.037 . . . . 65.33 110.831 173.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.648 ' HB2' ' HB ' ' D' ' 16' ' ' ILE . 6.1 Cg_exo -79.3 123.16 5.42 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.662 2.241 . . . . 72.21 109.739 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' D' ' 13' ' ' ILE . 10.0 p -155.44 155.34 5.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 123.694 0.621 . . . . 54.13 109.732 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.536 ' H ' HD12 ' D' ' 13' ' ' ILE . 2.7 t-20 -69.09 114.47 7.39 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 107.784 -1.191 . . . . 75.41 107.784 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -50.12 -35.64 26.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.507 1.123 . . . . 43.22 112.015 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.93 -45.45 70.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.398 1.079 . . . . 64.41 110.917 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.25 80.05 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.792 0.437 . . . . 75.23 110.749 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.2 tt -71.29 -34.67 70.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.368 0.667 . . . . 52.45 110.094 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -63.13 -48.38 78.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.203 0.601 . . . . 73.45 110.38 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -37.9 87.61 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.807 0.813 . . . . 64.52 109.387 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.58 1.79 54.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.702 -1.136 . . . . 74.25 111.545 -175.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -89.88 -41.71 11.64 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.767 -0.457 . . . . 72.43 109.767 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 9.87 25.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.346 0.658 . . . . 43.55 112.037 -176.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.73 177.47 8.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.124 0.57 . . . . 61.34 111.155 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -143.71 84.01 1.78 Allowed 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.541 -1.281 . . . . 74.04 107.541 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -167.65 105.22 0.52 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.436 -0.802 . . . . 64.54 108.915 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.2 111.37 5.09 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.867 -0.79 . . . . 23.24 108.867 171.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.44 93.33 0.11 Allowed Glycine 0 C--N 1.342 0.913 0 O-C-N 123.701 0.626 . . . . 55.02 111.894 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.75 159.59 27.85 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.279 -0.637 . . . . 53.12 109.279 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.68 125.19 3.12 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.558 -1.017 . . . . 42.22 110.558 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.7 t -159.65 -178.06 6.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.098 -0.705 . . . . 71.42 109.098 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -155.38 145.0 21.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.044 -1.095 . . . . 60.13 108.044 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.5 5.67 1.23 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.161 0.584 . . . . 74.2 111.582 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -87.46 97.98 11.13 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.472 -0.566 . . . . 72.45 109.472 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -87.93 120.41 29.24 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.985 0.514 . . . . 72.41 109.988 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.41 -28.77 66.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.779 0.832 . . . . 52.33 111.371 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 124.083 0.953 . . . . 62.24 110.397 -177.6 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtm . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.613 -0.232 . . . . 74.44 110.891 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 34.6 m 66.27 115.9 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.333 1.453 . . . . 74.44 111.524 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -88.92 110.08 20.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.949 0.9 . . . . 70.05 110.003 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.3 20.94 9.66 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.585 1.154 . . . . 75.34 109.246 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -150.98 158.82 44.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.887 0.875 . . . . 71.12 108.702 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -71.99 70.41 0.77 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 122.569 1.176 . . . . 62.42 111.196 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.4 m -152.1 86.4 1.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.13 1.372 . . . . 72.34 107.847 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.01 -56.28 0.14 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.276 -1.379 . . . . 44.13 107.276 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 53.8 ttm 64.53 112.65 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.616 1.566 . . . . 74.44 111.176 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 38.9 m -104.78 103.96 13.66 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.553 -1.277 . . . . 52.24 107.553 167.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -120.94 119.01 31.35 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.133 -1.432 . . . . 71.24 107.133 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -146.13 136.3 23.71 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 171.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.429 HD12 ' O ' ' C' ' 83' ' ' ILE . 5.5 tp -80.47 132.17 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.369 -0.832 . . . . 72.3 108.79 169.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 76.2 mm-40 -99.59 -45.61 5.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.263 -0.881 . . . . 61.45 109.866 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -165.41 122.03 1.44 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.512 -0.767 . . . . 71.01 109.174 -170.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 56.1 mt -112.95 134.53 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.319 -1.363 . . . . 74.04 107.319 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.485 ' HB3' HG23 ' D' ' 122' ' ' THR . 18.9 p90 -173.71 168.86 4.32 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 123.816 0.698 . . . . 73.04 110.636 -173.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -91.3 128.29 37.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.26 -0.882 . . . . 65.15 109.615 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.469 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 30.0 mmtp -80.01 -52.79 7.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.577 0.703 . . . . 71.05 109.413 170.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 28.9 t70 -135.75 115.09 12.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.6 -1.182 . . . . 75.21 109.267 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 54.8 mt -111.27 139.46 35.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.515 -1.661 . . . . 74.32 106.515 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -152.74 142.51 22.01 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.276 0.56 . . . . 41.24 109.819 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -132.48 133.77 44.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.322 -1.362 . . . . 55.35 107.322 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -125.89 127.55 46.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.954 -1.128 . . . . 73.23 107.954 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -145.7 76.61 12.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.867 -1.16 . . . . 63.01 107.867 170.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.62 -27.57 22.2 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.486 2.124 . . . . 63.44 110.785 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -106.56 29.12 7.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.484 1.113 . . . . 43.54 109.558 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -58.59 -50.67 86.76 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.072 1.138 . . . . 63.54 114.072 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.21 -15.99 4.28 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.367 1.378 . . . . 53.52 112.356 171.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -72.12 -29.65 64.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.429 1.092 . . . . 73.52 111.548 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.626 HG23 HD11 ' C' ' 68' ' ' LEU . 14.7 p -79.03 -18.15 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.69 0.796 . . . . 73.31 111.842 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -53.99 -41.65 68.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.487 1.115 . . . . 71.24 112.201 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 52.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.509 -0.922 . . . . 71.3 108.509 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.521 ' HG2' ' HG2' ' C' ' 71' ' ' GLU . 0.1 OUTLIER -125.56 164.92 19.48 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.816 -0.552 . . . . 63.43 110.337 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.34 104.06 1.77 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.542 -0.91 . . . . 63.22 108.542 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.93 88.46 7.44 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.252 1.025 . . . . 62.53 112.616 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -133.1 71.43 77.46 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.62 1.168 . . . . 73.34 108.611 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.33 127.26 12.44 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.473 2.115 . . . . 73.13 111.638 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.712 ' HA ' ' HA2' ' E' ' 191' ' ' GLY . 42.1 tt0 -87.09 112.91 22.37 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 62.21 108.525 173.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.483 HG21 HD21 ' C' ' 126' ' ' LEU . 21.8 t -79.88 80.49 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.141 -0.936 . . . . 44.22 108.691 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.497 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 25.5 tptp -90.95 102.03 14.79 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.585 -0.894 . . . . 65.32 108.585 -175.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.91 152.54 22.0 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.605 -0.725 . . . . 72.11 109.817 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.56 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 4.6 m-20 -139.75 136.36 34.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.075 0.95 . . . . 73.34 109.336 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.58 HD22 HD11 ' E' ' 186' ' ' LEU . 42.0 tp -112.8 108.88 18.04 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.768 0.827 . . . . 71.41 109.283 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 14.4 t70 -113.77 148.05 37.22 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.64 -1.245 . . . . 72.31 107.64 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 63.2 m -126.97 126.38 43.1 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.934 0.494 . . . . 62.14 109.884 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.13 146.32 45.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.11 -1.07 . . . . 75.14 108.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -149.37 143.66 25.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.77 0.828 . . . . 63.34 109.049 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 34.8 p -154.66 129.28 9.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.369 0.667 . . . . 60.33 110.45 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.29 133.95 42.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 110.037 -0.357 . . . . 75.13 110.037 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 47.8 mt -98.66 -52.92 3.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.96 0.904 . . . . 71.14 110.417 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.92 -170.78 3.55 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.304 -0.862 . . . . 74.4 110.581 -170.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.44 109.64 3.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.135 0.974 . . . . 54.32 110.1 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 67.74 -4.02 1.04 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.911 1.285 . . . . 72.52 112.762 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.9 t -92.93 111.96 25.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 N-CA-C 108.308 -0.997 . . . . 72.4 108.308 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -119.04 157.88 26.93 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.197 0.999 . . . . 63.03 108.433 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.62 139.44 53.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.578 -0.897 . . . . 72.3 108.578 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.57 116.84 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.307 -1.368 . . . . 74.12 107.307 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.81 105.54 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.523 -0.917 . . . . 62.23 108.523 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.11 122.16 29.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.841 -1.17 . . . . 74.33 107.841 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 60.0 mtp180 -105.44 114.04 27.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.834 0.854 . . . . 72.25 110.036 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.53 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.9 t -106.91 128.24 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.1 -0.704 . . . . 72.45 109.1 172.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 14.3 m -111.59 138.14 48.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.473 -0.936 . . . . 50.33 108.473 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.668 HG21 HG21 ' C' ' 114' ' ' ILE . 97.5 t -123.19 112.22 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.957 -1.127 . . . . 63.4 107.957 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.75 142.57 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.86 -0.793 . . . . 53.31 108.86 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.17 102.9 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.758 -1.571 . . . . 74.22 106.758 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -136.77 142.82 42.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.38 0.61 . . . . 44.1 111.275 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.626 HD11 HG23 ' C' ' 31' ' ' VAL . 17.6 mt -94.02 30.62 1.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.405 1.482 . . . . 62.44 109.369 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.93 -110.58 2.81 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 109.773 -1.331 . . . . 62.43 109.773 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 -22.45 19.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.071 0.548 . . . . 74.42 110.513 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.521 ' HG2' ' HG2' ' C' ' 34' ' ' LYS . 11.4 tp10 -79.58 90.1 5.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.03 0.932 . . . . 74.13 109.706 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -73.04 123.25 23.16 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 120.953 0.406 . . . . 61.13 110.987 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.24 26.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.68 1.192 . . . . 74.42 109.779 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.08 168.57 24.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.223 -0.899 . . . . 71.35 110.896 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -136.44 136.52 39.58 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.311 -1.737 . . . . 44.04 106.311 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -146.8 113.05 5.87 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.097 0.408 . . . . 61.23 109.989 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -118.43 133.21 56.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.546 -0.538 . . . . 54.54 109.546 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.409 HG22 HG23 ' C' ' 21' ' ' ILE . 54.9 t -119.3 143.36 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.508 -0.923 . . . . 74.42 108.508 169.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -119.57 94.44 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.246 -1.02 . . . . 63.42 108.246 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -81.77 106.49 13.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.783 0.833 . . . . 73.02 110.822 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.01 146.8 23.27 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.201 -0.454 . . . . 64.11 112.542 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.16 120.72 1.29 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.23 -0.748 . . . . 55.31 111.23 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 14.8 mm -90.97 115.51 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.18 -0.674 . . . . 64.24 109.18 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -120.9 117.37 27.19 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.642 -0.873 . . . . 55.01 108.642 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -88.46 104.75 17.09 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.608 -1.256 . . . . 61.11 107.608 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' C' ' 10' ' ' THR . 1.8 pp -130.97 138.25 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.296 0.638 . . . . 71.23 112.038 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.74 163.02 18.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.813 1.245 . . . . 55.14 109.83 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 -26.2 7.88 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.293 -0.412 . . . . 63.1 113.287 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.597 HD11 ' SD ' ' E' ' 174' ' ' MET . 0.2 OUTLIER -67.98 145.62 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.443 1.097 . . . . 74.42 110.213 176.097 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 0.4 OUTLIER -155.41 146.11 22.22 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.767 -0.457 . . . . 75.12 109.767 -179.078 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.84 -121.61 23.9 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.459 0.475 . . . . 65.05 113.513 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 36.1 p -64.16 -25.9 68.29 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.015 0.926 . . . . 64.24 111.875 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.419 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 47.6 mt-30 -59.54 -56.03 27.06 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.263 0.625 . . . . 74.01 109.839 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.502 ' HB3' HG12 ' C' ' 89' ' ' ILE . 14.3 ptp -77.58 -28.19 51.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.847 0.459 . . . . 64.31 111.897 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.53 -45.48 75.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.34 0.656 . . . . 74.34 110.802 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -78.76 -33.98 46.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.073 -0.512 . . . . 63.3 110.259 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 38.8 t -63.82 -59.99 3.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.96 0.504 . . . . 41.42 111.047 -177.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 tt -71.63 -35.84 70.54 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.521 -0.548 . . . . 53.14 109.521 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.66 -4.68 90.22 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.163 -0.798 . . . . 53.22 114.882 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -155.08 -60.47 0.11 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.396 1.098 . . . . 61.52 112.143 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -60.68 -60.54 3.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.006 0.923 . . . . 73.43 113.26 -165.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 64.7 m -59.72 -47.71 96.87 Favored Pre-proline 0 CA--C 1.564 1.512 0 N-CA-C 113.181 0.808 . . . . 73.23 113.181 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.24 -32.05 42.95 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 120.982 1.386 . . . . 74.52 113.014 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -67.78 -27.88 67.13 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.958 0.503 . . . . 62.22 110.625 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.83 -42.61 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 65.12 110.15 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.465 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -78.87 -21.63 47.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.427 -0.806 . . . . 51.52 112.342 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -55.64 -51.98 75.73 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 117.799 -1.096 . . . . 73.14 113.881 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.28 -33.97 92.57 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.026 1.817 . . . . 70.44 113.508 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.89 -45.92 66.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 63.23 110.807 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.02 90.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.446 0.698 . . . . 44.22 110.382 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -54.47 -53.23 57.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.742 1.617 . . . . 72.01 111.127 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.4 -34.34 75.85 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.618 0.767 . . . . 72.42 110.65 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.6 t -70.45 -33.88 71.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.381 0.673 . . . . 73.1 112.107 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.668 HG21 HG21 ' C' ' 64' ' ' VAL . 92.5 mt -72.58 -49.08 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.014 0.526 . . . . 72.35 109.742 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.567 HG23 ' HB2' ' C' ' 125' ' ' GLN . 99.3 m -57.12 -33.98 67.9 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.158 0.911 . . . . 73.42 111.321 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.5 t -58.66 -57.36 13.33 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.57 -1.195 . . . . 63.23 109.743 170.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.413 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.22 -42.53 86.45 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.159 1.384 . . . . 75.21 113.914 -175.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.19 -47.33 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 123.635 0.584 . . . . 72.24 109.836 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -72.29 -22.56 61.18 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.888 -1.051 . . . . 74.25 111.777 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 86.0 mtt-85 -71.06 -39.26 72.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.118 0.567 . . . . 71.34 109.863 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' D' ' 17' ' ' TYR . . . -79.95 5.26 62.77 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.893 0.746 . . . . 63.42 112.591 171.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.68 ' HB ' HH21 ' D' ' 15' ' ' ARG . 43.0 p 58.04 38.71 26.7 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 74.23 112.143 174.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -102.32 164.15 16.28 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.046 1.338 . . . . 74.23 108.792 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.49 102.54 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.08 1.853 . . . . 72.45 112.336 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.567 ' HB2' HG23 ' C' ' 115' ' ' THR . 1.4 pp0? -60.63 140.87 57.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.154 0.582 . . . . 74.13 110.267 177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.483 HD21 HG21 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -112.2 144.2 41.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.237 0.615 . . . . 72.1 110.912 -173.319 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -118.21 93.3 4.08 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' E' ' 187' ' ' ILE . 77.9 mt -75.87 133.04 40.67 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.684 -1.144 . . . . 74.42 107.95 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.29 146.99 77.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 124.293 0.996 . . . . 74.51 111.09 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.21 100.63 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.117 2.545 . . . . 74.2 112.728 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.28 82.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.378 -0.828 . . . . 63.33 109.635 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.86 105.49 17.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.49 -1.3 . . . . 64.35 107.49 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -50.86 -41.14 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.424 0.69 . . . . 70.21 112.176 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -57.7 -35.53 70.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.243 1.017 . . . . 64.33 111.974 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 13' ' ' ILE . . . -62.96 -43.97 97.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.556 0.742 . . . . 52.22 111.523 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.549 HD11 HG11 ' F' ' 207' ' ' VAL . 6.1 mp -77.24 -28.52 53.69 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.52 0.728 . . . . 53.02 110.595 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.21 -47.5 79.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.245 1.018 . . . . 74.23 109.793 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 97.3 mmm -69.41 -47.8 63.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.636 -0.711 . . . . 64.34 110.159 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.07 -41.94 65.34 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.597 1.159 . . . . 74.03 111.551 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -70.51 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.873 -1.058 . . . . 70.32 110.667 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.54 -19.14 64.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.907 1.283 . . . . 71.14 114.111 -160.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -66.23 155.02 38.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.932 0.493 . . . . 72.15 110.039 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -83.15 59.71 5.11 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.695 0.798 . . . . 63.03 112.007 -171.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 67.96 152.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.875 1.67 . . . . 72.52 112.607 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.71 153.97 42.64 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.252 -0.886 . . . . 74.41 111.582 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 6' ' ' ASN . . . -128.34 84.16 0.33 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.7 -0.682 . . . . 72.23 111.726 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.72 165.37 23.15 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.787 0.803 . . . . 73.31 112.527 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.07 -153.3 12.19 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 114.444 -1.253 . . . . 61.41 109.992 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.0 t -171.54 129.36 0.68 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.915 -0.772 . . . . 75.35 108.915 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.539 ' HB3' ' HB2' ' G' ' 173' ' ' LEU . 43.2 tt0 -177.78 144.12 0.35 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.284 0.634 . . . . 64.22 110.329 -171.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -109.01 175.26 5.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.332 -0.988 . . . . 61.15 108.332 166.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.528 ' CG ' ' HA ' ' G' ' 174' ' ' MET . 49.8 p-80 -155.27 162.06 40.98 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 122.17 -0.332 . . . . 51.45 111.64 -174.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? 58.52 -76.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.486 1.741 . . . . 75.13 112.306 164.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.0 t70 69.14 88.98 0.11 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.204 1.402 . . . . 62.41 110.04 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.998 0 CA-C-N 115.19 -0.914 . . . . 72.13 110.814 178.475 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 108.049 -1.093 . . . . 74.21 108.049 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 22.2 m 67.78 25.96 7.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.877 1.271 . . . . 44.42 111.294 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -79.08 125.78 29.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.449 -0.575 . . . . 74.21 109.449 174.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -71.52 170.78 12.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.584 0.754 . . . . 74.02 109.266 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.23 84.0 0.75 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.501 0.667 . . . . 45.14 109.604 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.53 4.84 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.552 1.141 . . . . 75.23 109.556 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.552 ' HG1' ' N ' ' H' ' 168' ' ' LYS . 46.5 m -115.64 169.23 9.35 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.064 1.345 . . . . 65.23 108.911 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -76.97 57.32 1.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.668 0.787 . . . . 75.35 111.949 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.9 ttp -34.67 125.92 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.421 1.488 . . . . 71.41 112.643 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -135.61 141.54 45.1 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.685 0.794 . . . . 62.04 109.238 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 63.9 t80 -162.58 89.26 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.354 -2.091 . . . . 71.42 105.354 174.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -131.13 144.83 51.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.908 -1.145 . . . . 60.31 107.908 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.593 HD13 HD11 ' D' ' 16' ' ' ILE . 47.8 mt -104.12 120.17 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 117.676 0.216 . . . . 64.04 111.452 -170.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.34 -28.47 34.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.593 0.757 . . . . 73.13 111.39 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.68 HH21 ' HB ' ' C' ' 122' ' ' THR . 14.1 tpt180 177.89 156.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.691 0.396 . . . . 74.24 110.242 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' B' ' 130' ' ' PRO . 17.8 mt -141.14 127.52 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 106.439 -1.689 . . . . 73.35 106.439 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' HA2' ' C' ' 121' ' ' GLY . 47.3 p90 -165.71 173.35 10.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.053 0.93 . . . . 74.52 110.906 -172.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.084 -1.417 . . . . 74.33 109.606 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -82.25 -17.95 44.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.104 -0.702 . . . . 74.35 109.104 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -158.17 135.92 10.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.117 1.367 . . . . 75.43 109.03 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.573 HG23 HG22 ' D' ' 78' ' ' VAL . 21.1 mt -137.61 145.27 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.877 -1.157 . . . . 63.04 107.877 170.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -144.02 141.29 30.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.391 0.676 . . . . 61.41 110.224 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.1 t80 -147.53 122.61 10.13 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 105.842 -1.91 . . . . 74.11 105.842 169.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.16 123.47 28.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.118 -1.438 . . . . 64.44 107.118 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -122.04 78.33 41.91 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.545 -0.909 . . . . 62.24 108.545 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.24 -41.81 6.54 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.116 2.544 . . . . 73.43 112.963 -165.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -106.47 17.9 22.7 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 123.884 0.873 . . . . 75.15 110.231 -175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.61 -51.29 11.94 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 116.369 1.988 . . . . 32.0 116.369 -164.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 14.9 Cg_endo -88.05 -14.38 3.45 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.807 1.671 . . . . 64.15 113.92 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -75.72 -40.57 55.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.417 1.087 . . . . 62.43 109.034 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.02 -1.07 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 114.702 -1.135 . . . . 75.21 110.257 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.17 -34.95 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.918 1.287 . . . . 74.11 110.578 164.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.95 -12.76 61.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.806 1.243 . . . . 72.42 112.156 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -89.94 101.93 14.63 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.097 0.959 . . . . 62.34 109.188 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.545 ' HB2' ' HA ' ' H' ' 196' ' ' LYS . 10.7 p-10 -99.37 52.56 0.95 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.145 0.978 . . . . 71.55 111.234 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.45 -169.46 3.22 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.489 -0.778 . . . . 72.33 109.246 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -78.07 118.27 71.14 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.243 1.017 . . . . 73.24 111.528 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' D' ' 68' ' ' LEU . 17.0 Cg_exo -65.47 97.39 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.304 2.003 . . . . 65.24 109.682 167.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.63 115.51 4.79 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 124.337 1.023 . . . . 74.43 109.847 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.405 HG21 HD11 ' D' ' 126' ' ' LEU . 16.7 m -97.09 113.31 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.908 0.861 . . . . 45.24 109.555 -174.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.564 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.8 tmtt? -88.3 118.56 27.99 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.175 -1.417 . . . . 75.11 107.175 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.472 HD21 HD22 ' D' ' 128' ' ' LEU . 10.2 mp -94.27 144.33 25.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.623 -0.88 . . . . 72.31 108.623 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 24.6 t70 -145.27 118.66 9.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.142 -0.936 . . . . 64.21 108.839 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.514 HD22 HD11 ' H' ' 186' ' ' LEU . 48.5 tp -96.79 130.39 44.05 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.342 0.657 . . . . 73.11 109.869 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -147.09 157.43 43.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.144 -1.058 . . . . 61.21 108.144 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -146.41 166.28 26.86 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.939 0.495 . . . . 72.33 110.479 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 166.72 31.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.457 1.103 . . . . 64.45 109.484 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -149.12 153.85 38.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.268 0.627 . . . . 61.11 109.743 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.5 126.83 9.26 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.502 0.721 . . . . 72.22 109.138 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' D' ' 55' ' ' VAL . 52.2 tt0 -71.84 119.27 15.78 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.536 -0.542 . . . . 73.43 109.536 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.15 -38.1 12.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.2 0.524 . . . . 72.13 110.12 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.08 174.4 11.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.803 -1.09 . . . . 55.13 109.561 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.67 133.25 45.54 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.245 -0.889 . . . . 74.01 109.534 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.88 15.4 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.797 1.239 . . . . 74.04 112.057 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' D' ' 50' ' ' GLN . 87.6 t -130.54 129.6 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.221 0.608 . . . . 71.12 110.784 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.14 129.36 41.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.016 0.926 . . . . 72.5 109.066 171.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -95.48 111.58 23.46 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.709 -0.848 . . . . 71.25 108.709 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 41.5 t -100.52 124.37 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.27 -1.011 . . . . 63.22 108.27 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.9 t -101.06 135.27 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.754 0.822 . . . . 71.42 109.282 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.65 43.66 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.897 -1.149 . . . . 72.24 107.897 175.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -98.75 108.37 21.04 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.641 HG21 ' HB1' ' D' ' 110' ' ' ALA . 48.1 t -105.35 116.66 49.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.966 -1.124 . . . . 55.32 107.966 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.6 m -111.81 137.1 50.22 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.156 0.503 . . . . 72.35 109.892 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 100.01 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.129 1.372 . . . . 74.23 107.885 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 40.3 m -96.51 94.59 7.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.409 -1.33 . . . . 71.32 107.409 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.83 141.23 30.28 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.577 -0.527 . . . . 72.4 109.577 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.88 137.46 18.79 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.502 0.501 . . . . 72.53 111.798 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' D' ' 38' ' ' PRO . 12.1 mt -110.53 107.85 17.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.919 1.288 . . . . 74.0 109.059 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -143.55 37.27 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.553 0.533 . . . . 75.2 112.183 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 8.24 15.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.629 0.772 . . . . 73.05 111.866 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -121.78 157.13 31.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.371 0.668 . . . . 62.45 109.894 178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.3 m -73.05 141.02 47.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.67 -0.695 . . . . 63.02 110.534 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.56 -58.36 2.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.873 -1.158 . . . . 73.54 107.873 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -160.45 143.19 13.2 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 115.405 -0.816 . . . . 72.14 110.902 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.09 111.03 23.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.159 0.984 . . . . 74.12 109.209 171.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.556 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.5 t -125.06 133.72 52.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.427 0.691 . . . . 73.35 109.509 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -154.99 135.25 13.18 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.275 -0.639 . . . . 75.31 109.275 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.573 HG22 HG23 ' D' ' 21' ' ' ILE . 97.6 t -127.23 142.32 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.686 0.795 . . . . 73.51 109.191 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.617 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 62.2 mt-30 -115.25 91.42 3.6 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.757 0.823 . . . . 75.14 109.078 171.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.61 93.04 6.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.899 -1.501 . . . . 61.12 108.861 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.32 141.26 18.94 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.282 -0.727 . . . . 74.35 111.282 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.53 130.57 4.63 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.558 -1.017 . . . . 51.1 110.558 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.63 121.01 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.069 -1.085 . . . . 71.12 108.069 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.5 122.6 35.64 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.584 0.754 . . . . 74.33 109.591 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -75.87 103.1 5.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.118 -0.697 . . . . 73.44 109.118 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.82 136.78 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.406 0.683 . . . . 74.24 110.546 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.88 160.95 12.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.215 1.006 . . . . 61.14 109.062 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.5 14.14 74.6 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 121.807 -0.235 . . . . 73.14 113.61 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.602 HD13 ' SD ' ' D' ' 94' ' ' MET . 1.8 pp -114.34 143.17 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 73.12 110.248 -174.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' H' ' 172' ' ' ALA . 0.3 OUTLIER -170.13 177.4 4.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.719 0.807 . . . . 64.31 110.084 175.214 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.84 -137.87 39.29 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.561 0.538 . . . . 75.23 112.709 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.8 m -68.63 -30.73 69.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.384 1.074 . . . . 72.44 111.692 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.48 -49.3 75.95 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.49 0.716 . . . . 74.31 110.559 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.602 ' SD ' HD13 ' D' ' 89' ' ' ILE . 10.0 tpt -76.5 -33.53 58.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.1 0.56 . . . . 73.24 111.245 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.48 80.42 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.677 0.751 . . . . 73.32 110.633 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -80.15 -38.65 30.99 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.382 -1.281 . . . . 71.41 110.738 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 43.5 t -63.4 -45.11 92.55 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.082 0.553 . . . . 52.15 111.486 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.01 -54.11 6.35 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.743 0.817 . . . . 74.34 110.73 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.11 -4.7 83.94 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 115.005 0.762 . . . . 71.22 115.005 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.44 -49.74 0.41 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.992 0.896 . . . . 71.14 112.126 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.414 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 56.9 t80 -76.04 -37.39 58.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.795 0.438 . . . . 70.41 111.582 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 72.1 m -65.06 -50.07 63.66 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.539 -0.743 . . . . 45.44 110.386 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 88.3 Cg_exo -51.22 -36.02 54.82 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.299 1.999 . . . . 72.02 114.254 167.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.37 -40.15 93.18 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.488 0.715 . . . . 55.14 111.022 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.81 -43.28 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.674 0.79 . . . . 74.52 110.348 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.2 -20.41 59.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.122 -0.944 . . . . 64.13 111.867 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -66.34 -41.4 41.69 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.469 1.285 . . . . 74.44 114.469 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.44 -45.18 41.52 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.937 1.758 . . . . 54.04 112.846 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -75.06 -35.83 61.85 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.892 0.877 . . . . 73.24 111.219 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.641 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.04 -52.44 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.094 0.957 . . . . 65.23 110.243 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.489 ' NH2' HG23 ' B' ' 105' ' ' ILE . 33.9 ttp180 -57.37 -49.84 74.87 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.231 -1.35 . . . . 71.03 109.993 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.47 -41.5 89.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.501 1.126 . . . . 64.43 111.775 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.444 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 36.6 t -57.96 -44.05 86.79 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.899 0.749 . . . . 55.24 110.689 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.556 HG23 ' SG ' ' D' ' 76' ' ' CYS . 71.1 mt -67.81 -49.16 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.68 0.792 . . . . 71.14 110.498 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.51 HG21 ' HE2' ' B' ' 109' ' ' TYR . 91.1 m -52.42 -48.11 65.92 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.379 1.472 . . . . 74.32 112.095 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -67.91 -41.24 82.96 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.369 -1.287 . . . . 73.25 110.533 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -65.15 -34.79 79.23 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.818 0.447 . . . . 73.2 111.964 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.3 t -66.4 -44.18 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 123.718 0.637 . . . . 74.42 110.295 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -71.8 -31.59 66.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.353 -0.385 . . . . 72.12 110.783 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -69.02 -27.65 65.87 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.747 0.819 . . . . 71.24 110.06 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.24 11.26 68.14 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.873 0.733 . . . . 60.11 112.901 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.485 HG23 ' HB3' ' C' ' 17' ' ' TYR . 42.2 p 56.02 33.8 22.51 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.829 1.651 . . . . 72.13 113.08 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 39.1 m-85 -110.98 166.37 10.89 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 125.141 1.376 . . . . 73.41 109.725 175.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 41.5 Cg_endo -61.42 123.46 12.82 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.046 2.497 . . . . 72.31 112.167 -176.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -52.06 122.21 8.09 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.051 0.844 . . . . 71.04 110.397 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.405 HD11 HG21 ' D' ' 40' ' ' VAL . 36.8 tp -103.9 93.91 5.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.391 0.615 . . . . 51.14 109.658 -166.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -100.53 82.44 2.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.01 -0.996 . . . . 70.53 108.481 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.472 HD22 HD21 ' D' ' 42' ' ' LEU . 95.9 mt -67.4 139.54 57.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.16 -0.927 . . . . 73.23 110.669 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 143.83 98.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.426 0.691 . . . . 52.04 110.779 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.36 142.18 14.74 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.059 1.839 . . . . 73.24 110.233 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.43 HG22 HG23 ' H' ' 187' ' ' ILE . 38.7 t -106.76 108.78 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 107.967 -1.124 . . . . 62.11 107.967 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -77.8 88.33 4.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.223 -1.399 . . . . 75.54 107.223 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.01 -33.59 70.9 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.916 -1.038 . . . . 75.33 111.202 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.47 -49.48 76.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.48 1.112 . . . . 73.03 110.664 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' B' ' 6' ' ' ASN . . . -57.46 -52.35 65.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.122 0.889 . . . . 72.43 111.929 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.478 HD23 ' HD2' ' H' ' 185' ' ' PRO . 9.2 mp -70.41 -28.29 64.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.767 0.827 . . . . 72.5 111.892 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.51 -55.45 11.71 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.132 0.973 . . . . 72.41 110.245 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.407 ' HB3' ' HA ' ' B' ' 5' ' ' ASN . 73.1 mtm -73.38 -20.37 60.77 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.592 -0.731 . . . . 71.52 111.472 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -67.6 -40.24 84.76 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.317 0.647 . . . . 64.21 110.243 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' H' ' 182' ' ' PHE . 45.3 t80 -68.23 -26.99 65.97 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.833 -0.621 . . . . 74.41 110.844 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' B' ' 3' ' ' GLU . 20.3 tp -67.86 -44.16 77.75 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.779 0.832 . . . . 63.42 111.399 175.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.45 26.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.678 0.391 . . . . 74.22 111.797 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -117.18 46.96 1.58 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.354 -1.35 . . . . 74.44 107.354 175.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -151.23 -58.37 0.16 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 113.77 -1.559 . . . . 75.21 107.928 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.94 112.29 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.511 -0.768 . . . . 54.32 109.468 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.35 112.62 0.49 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.055 -0.818 . . . . 30.14 111.055 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.86 93.07 1.66 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.357 0.663 . . . . 74.54 109.673 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.71 112.47 0.7 Allowed Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.849 -1.301 . . . . 74.11 109.849 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 18.3 m -85.3 51.97 2.32 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.366 1.079 . . . . 72.1 110.296 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.7 162.19 33.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.763 1.225 . . . . 73.33 108.481 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.6 88.15 3.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.541 . . . . 61.21 110.83 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -114.05 142.17 46.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.302 0.641 . . . . 74.41 110.284 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.79 -166.7 1.47 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.474 1.11 . . . . 72.53 110.315 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.53 -55.91 15.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.519 0.728 . . . . 73.43 111.783 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.603 0.761 . . . . 64.34 109.449 -176.742 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.697 -0.483 . . . . 63.11 109.697 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.48 140.12 15.77 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.234 -0.439 . . . . 74.32 112.495 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.98 -11.45 50.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.97 0.908 . . . . 52.15 110.333 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 56.2 m -67.22 156.24 36.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.07 0.948 . . . . 53.31 111.754 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.43 79.22 2.48 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.291 -0.868 . . . . 45.21 109.574 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.406 ' HA ' ' HE2' ' E' ' 174' ' ' MET . 81.7 mt -114.5 97.58 6.38 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.542 -0.754 . . . . 75.13 110.028 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.597 ' SD ' HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -57.12 96.34 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.607 -1.179 . . . . 72.11 111.32 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -162.01 11.54 0.08 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.312 -0.858 . . . . 65.24 109.7 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.03 -67.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.244 1.018 . . . . 72.55 110.29 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.6 mp 60.07 39.0 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.095 0.958 . . . . 72.14 112.731 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -69.51 -19.86 63.72 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.537 0.335 . . . . 52.44 111.652 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.64 116.81 6.41 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.881 0.872 . . . . 74.11 110.685 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.73 149.28 11.16 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.697 2.265 . . . . 52.23 111.438 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -101.72 137.63 39.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.021 0.528 . . . . 74.11 109.649 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 61.71 -90.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.188 1.395 . . . . 71.21 110.686 -170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t 174.86 -23.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.3 1.04 . . . . 72.31 111.083 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 2.3 t90 67.3 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.363 1.173 0 C-N-CA 124.836 1.254 . . . . 75.33 108.373 -161.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.93 113.23 3.74 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.569 2.179 . . . . 73.3 111.835 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.58 HD11 HD22 ' C' ' 44' ' ' LEU . 3.8 mm? -81.87 175.26 10.56 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.508 0.723 . . . . 65.12 111.436 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' C' ' 128' ' ' LEU . 34.1 pt -115.82 -177.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 61.54 110.999 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.26 126.66 10.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.424 0.69 . . . . 61.31 110.378 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -91.82 1.87 56.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.621 0.768 . . . . 75.51 111.88 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 29.2 t70 75.16 162.98 0.26 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.851 1.661 . . . . 72.13 113.097 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 191' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' C' ' 39' ' ' GLU . . . -102.53 63.5 0.46 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.372 -0.831 . . . . 63.22 112.243 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.62 -165.22 23.48 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 112.696 -0.162 . . . . 71.3 112.696 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -70.39 120.21 15.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.562 0.745 . . . . 75.24 109.956 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -154.54 76.28 1.02 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.64 0.776 . . . . 51.32 109.957 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -170.52 160.37 7.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.02 -0.733 . . . . 73.21 109.02 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 196' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' E' ' 196' ' ' LYS . 0.0 OUTLIER -156.16 69.44 0.64 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.088 0.947 . . . . 65.44 112.153 -168.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -142.63 4.63 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.464 0.705 . . . . 73.5 111.006 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.34 -51.73 2.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.767 -0.827 . . . . 73.41 108.767 -175.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -52.08 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.235 1.414 . . . . 65.4 113.358 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.53 55.41 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 115.316 -0.856 . . . . 52.43 113.768 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm 66.91 153.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.76 1.624 . . . . 72.41 110.884 -167.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -91.66 41.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.609 0.718 . . . . 64.53 109.189 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 55.29 29.71 13.4 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.367 1.067 . . . . 54.43 111.461 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.46 122.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 108.974 -0.75 . . . . 72.14 108.974 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 46.4 tptt 179.88 -56.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.77 0.828 . . . . 73.5 110.371 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.41 -15.91 63.08 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.699 1.199 . . . . 70.23 112.586 -168.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.561 1.392 0 C-N-CA 123.908 0.883 . . . . 54.34 109.137 172.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.474 -0.195 . . . . 71.12 110.474 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.1 102.59 0.33 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.919 -0.582 . . . . 71.53 112.945 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.03 179.88 6.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.279 -0.637 . . . . 72.43 109.279 164.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 98.8 p -59.54 154.73 16.76 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.903 -0.777 . . . . 72.54 108.903 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.19 84.7 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.625 0.726 . . . . 73.14 110.077 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tt -137.61 128.16 26.7 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.532 -1.284 . . . . 72.21 107.532 -167.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.574 ' SD ' ' SD ' ' B' ' 94' ' ' MET . 0.0 OUTLIER -154.14 177.08 11.49 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.362 1.465 . . . . 72.34 108.106 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -164.25 -87.77 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.493 -0.558 . . . . 71.24 109.493 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 53.16 23.73 3.24 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.539 1.135 . . . . 74.44 112.867 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.4 tt -107.34 116.42 31.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.072 0.549 . . . . 74.43 109.741 -173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -144.52 9.14 1.37 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.544 1.138 . . . . 65.32 109.079 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.24 128.48 25.36 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.398 1.079 . . . . 74.42 109.787 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.5 102.79 1.53 Allowed 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 121.964 1.776 . . . . 70.22 111.317 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -66.66 179.16 1.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.534 0.733 . . . . 72.23 110.432 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.18 94.45 0.08 Allowed 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.578 0.704 . . . . 72.0 109.651 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 22.2 p -71.96 120.95 18.28 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.113 -1.403 . . . . 54.12 108.238 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 -68.68 115.97 35.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.807 0.692 . . . . 74.34 109.841 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.17 104.57 0.21 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.965 2.443 . . . . 63.34 112.534 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' B' ' 128' ' ' LEU . 73.6 mt -65.86 144.25 56.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.517 -1.219 . . . . 73.52 110.344 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.619 HD11 ' H ' ' B' ' 129' ' ' ALA . 2.7 pp -89.11 158.87 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.455 . . . . 75.12 111.522 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.06 178.1 7.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.564 0.746 . . . . 62.53 111.211 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 189' ' ' ALA . . . . . 0.619 ' HB1' HE22 ' B' ' 125' ' ' GLN . . . -120.9 88.35 2.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.676 0.79 . . . . 45.4 110.199 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -100.26 145.15 28.43 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.416 0.687 . . . . 63.51 109.216 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 115.68 -158.27 14.5 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.621 -0.718 . . . . 64.51 112.527 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.41 -79.78 1.48 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.685 -1.366 . . . . 64.45 109.685 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 66.01 29.2 10.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.856 1.262 . . . . 72.5 111.004 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 194' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' F' ' 199' ' ' ASN . . . -95.36 83.91 3.93 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.684 -1.144 . . . . 41.4 108.754 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -162.91 -175.46 4.4 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.899 -1.046 . . . . 75.22 108.601 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 48.0 tttp 77.61 42.94 0.11 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.301 1.441 . . . . 64.21 111.637 165.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 59.05 17.27 5.35 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.403 1.081 . . . . 73.32 113.464 167.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -137.98 -55.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.625 -0.88 . . . . 74.42 108.625 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 199' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' F' ' 194' ' ' ALA . 4.1 m-20 -93.57 14.06 20.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.521 0.728 . . . . 74.25 109.229 168.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.68 -126.22 0.34 Allowed Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.348 0.899 . . . . 35.31 115.348 -166.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 81.72 -30.48 0.11 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.974 1.71 . . . . 63.14 110.48 -165.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 202' ' ' TYR . . . . . 0.435 ' HE1' HD23 ' C' ' 126' ' ' LEU . 0.8 OUTLIER -61.58 -22.88 65.59 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.668 1.187 . . . . 75.54 109.835 163.6 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' F' F ' 203' ' ' ASP . . . . . 0.48 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -106.76 -89.46 0.44 Allowed 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.324 1.449 . . . . 74.4 109.996 174.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 14' ' ' GLN . 7.1 tp -178.32 141.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.765 1.626 . . . . 74.3 108.088 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -159.83 100.93 1.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.634 -0.876 . . . . 75.5 108.634 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t70 66.93 -75.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.94 1.296 . . . . 75.12 108.662 -167.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.549 HG11 HD11 ' C' ' 136' ' ' LEU . 5.2 p . . . . . 0 C--O 1.255 1.384 0 N-CA-C 106.402 -1.703 . . . . 75.11 106.402 162.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 110.434 -0.209 . . . . 74.44 110.434 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.17 -44.36 3.15 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 123.237 0.336 . . . . 72.34 112.405 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.42 138.42 58.26 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.492 1.517 . . . . 73.24 111.287 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 30.2 t -74.45 153.92 38.97 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.163 0.585 . . . . 74.4 109.617 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 172' ' ' ALA . . . . . 0.629 ' HB3' ' H ' ' A' ' 88' ' ' GLY . . . -151.11 76.85 1.25 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.304 -0.628 . . . . 75.14 109.304 -174.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 54' ' ' ASP . 71.4 mt -123.63 95.22 4.5 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.037 -1.097 . . . . 73.0 108.037 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.626 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -155.27 162.81 40.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.032 -1.44 . . . . 75.32 110.467 -167.631 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -176.86 112.6 0.09 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.39 -1.337 . . . . 74.44 107.39 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 176' ' ' ASN . . . . . 0.508 ' HB3' ' HG3' ' G' ' 180' ' ' PRO . 27.3 t-20 -52.46 -51.88 57.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.48 1.112 . . . . 54.53 111.012 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tt 76.08 -20.92 0.33 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.018 1.327 . . . . 75.43 112.741 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -85.68 46.8 1.35 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.372 1.069 . . . . 74.14 111.1 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.4 68.04 3.89 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.091 1.356 . . . . 73.41 112.794 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 180' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' G' ' 176' ' ' ASN . 69.2 Cg_endo -83.83 4.45 6.98 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 122.921 2.414 . . . . 71.31 112.476 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -106.11 163.39 12.82 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.583 1.153 . . . . 74.22 109.762 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -77.73 167.31 21.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.406 0.682 . . . . 54.04 110.894 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 10.9 t -68.75 129.27 39.44 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.725 -0.67 . . . . 75.33 111.407 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 184' ' ' TRP . . . . . 0.504 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 3.2 t-105 -92.39 118.94 68.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 74.23 109.444 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -85.44 113.08 1.38 Allowed 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.485 2.123 . . . . 63.55 112.428 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 186' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 44' ' ' LEU . 96.9 mt -90.2 158.73 17.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.239 0.616 . . . . 74.03 110.21 175.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 129' ' ' ALA . 33.6 pt -77.13 89.03 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 121.471 0.653 . . . . 73.14 111.327 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.49 98.93 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.437 -0.579 . . . . 55.35 109.437 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 189' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -99.27 94.98 6.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.55 0.74 . . . . 74.54 110.051 -172.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -108.13 105.26 14.91 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.914 -0.772 . . . . 60.05 108.914 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 117.15 -153.55 17.25 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.749 -0.94 . . . . 74.21 110.749 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.65 66.13 0.72 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.477 -1.049 . . . . 61.31 110.477 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -70.43 107.75 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.078 0.551 . . . . 74.15 111.138 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.8 -179.59 4.74 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.999 0.92 . . . . 51.03 108.545 170.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.405 ' HD1' ' HB1' ' H' ' 194' ' ' ALA . 70.3 m-85 61.74 -84.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.39 1.076 . . . . 74.11 111.234 -174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 65.25 31.48 10.65 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.037 0.935 . . . . 54.23 110.1 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 80.51 7.7 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.742 -1.117 . . . . 64.45 111.016 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.71 -27.19 67.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.818 0.847 . . . . 65.1 111.568 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.09 163.7 28.67 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.777 1.231 . . . . 54.42 108.224 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.44 93.76 0.63 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-O 120.329 -0.151 . . . . 51.21 113.46 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 201' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' H' ' 193' ' ' TYR . 4.0 mptp? -96.31 151.58 19.39 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.156 -0.683 . . . . 52.43 109.156 170.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 24.7 t80 63.54 29.78 15.23 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.539 1.161 . . . . 72.11 109.451 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 93.14 6.16 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.986 -1.461 . . . . 74.12 108.867 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.79 107.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.28 -0.637 . . . . 75.1 109.28 -175.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.11 59.77 5.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.24 1.016 . . . . 61.42 111.134 -171.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 t70 71.08 174.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.401 1.48 . . . . 73.11 111.885 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.567 1.598 0 C-N-CA 123.939 0.896 . . . . 51.35 110.719 179.408 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' H' H ' 168' ' ' LYS . . . . . 0.552 ' N ' ' HG1' ' D' ' 7' ' ' THR . 59.3 mttm . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.134 -0.321 . . . . 73.35 110.134 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.25 112.09 0.32 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.406 -0.678 . . . . 72.34 111.406 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 170' ' ' LYS . . . . . 0.435 ' HD2' HD11 ' H' ' 173' ' ' LEU . 57.5 pttt -150.09 156.36 41.51 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.43 1.092 . . . . 64.32 108.418 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 15.9 m -136.22 -29.56 0.98 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.358 0.663 . . . . 63.55 110.408 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' D' ' 90' ' ' GLU . . . -122.08 147.64 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.941 0.896 . . . . 65.13 109.384 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.435 HD11 ' HD2' ' H' ' 170' ' ' LYS . 28.9 mt -156.16 -66.52 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.695 1.198 . . . . 74.03 109.883 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.54 99.21 3.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.008 0.923 . . . . 72.43 112.464 -168.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 34.1 t80 59.01 35.05 23.88 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.148 1.379 . . . . 60.43 111.327 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.07 101.17 13.89 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.008 -0.542 . . . . 71.54 110.104 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.19 -13.42 59.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.141 0.576 . . . . 75.32 110.405 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 178' ' ' GLN . . . . . 0.509 ' HG3' ' H ' ' H' ' 179' ' ' GLU . 9.6 tp60 63.47 -172.09 0.17 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 125.042 1.337 . . . . 72.13 110.808 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 179' ' ' GLU . . . . . 0.509 ' H ' ' HG3' ' H' ' 178' ' ' GLN . 3.4 mp0 -64.78 148.68 97.03 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 123.563 0.745 . . . . 55.13 110.82 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.62 96.59 0.36 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.61 2.206 . . . . 74.21 111.907 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -78.89 -151.99 0.06 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.777 0.831 . . . . 73.1 110.934 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 182' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' D' ' 140' ' ' TYR . 29.4 m-85 -63.68 140.97 58.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.881 0.872 . . . . 74.23 111.479 -173.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 35.6 p -82.84 150.53 26.51 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.218 0.607 . . . . 73.32 111.272 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -137.1 98.76 10.22 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.442 1.097 . . . . 73.2 109.695 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 185' ' ' PRO . . . . . 0.478 ' HD2' HD23 ' D' ' 136' ' ' LEU . 18.1 Cg_exo -69.45 160.03 51.36 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.551 2.167 . . . . 71.11 112.667 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 186' ' ' LEU . . . . . 0.514 HD11 HD22 ' D' ' 44' ' ' LEU . 3.0 mm? -93.82 169.91 9.95 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.877 0.471 . . . . 71.55 109.826 174.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.43 HG23 HG22 ' D' ' 131' ' ' VAL . 2.7 pp -70.57 171.84 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.679 0.792 . . . . 74.24 112.276 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.82 150.54 51.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.66 0.784 . . . . 63.12 110.456 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -94.73 133.79 38.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.808 0.843 . . . . 62.34 110.082 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.44 157.15 30.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.37 0.668 . . . . 74.52 110.05 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.62 103.85 0.69 Allowed Glycine 0 C--N 1.348 1.21 0 O-C-N 123.801 0.688 . . . . 42.24 112.654 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.53 152.09 26.05 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 123.021 0.343 . . . . 65.05 113.416 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.588 ' HB3' ' HG2' ' G' ' 201' ' ' LYS . 91.2 t80 -168.73 105.32 0.43 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.92 1.288 . . . . 75.42 107.866 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 194' ' ' ALA . . . . . 0.405 ' HB1' ' HD1' ' G' ' 195' ' ' PHE . . . -171.21 56.09 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.624 1.17 . . . . 44.42 109.038 -177.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -142.07 151.53 42.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.015 0.526 . . . . 73.23 111.98 -168.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 196' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 1.4 tmtm? -158.45 -46.69 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 O-C-N 123.895 0.747 . . . . 72.13 110.506 168.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 68.83 -64.85 0.31 Allowed 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.787 1.235 . . . . 72.1 110.882 -171.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.16 165.91 6.68 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.348 1.059 . . . . 74.01 108.614 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 81.79 5.24 1.23 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.427 1.491 . . . . 70.31 111.327 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -132.84 30.01 3.15 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 122.851 0.262 . . . . 75.44 112.925 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -102.35 148.27 25.68 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.65 0.78 . . . . 73.52 109.848 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -97.84 -48.39 5.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.169 0.587 . . . . 72.11 111.951 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 64.48 93.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.2 1.4 . . . . 74.44 110.822 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 34.2 pt -118.86 136.71 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.288 0.635 . . . . 64.23 110.836 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -137.69 151.33 48.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.43 1.492 . . . . 71.04 109.162 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 23.6 t70 60.71 110.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.646 1.216 . . . . 70.44 112.856 166.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.564 1.5 0 C-N-CA 122.918 0.487 . . . . 72.44 110.591 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.332 -0.618 . . . . 51.4 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m 65.98 17.53 10.82 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.975 1.31 . . . . 73.23 112.855 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.15 156.27 19.77 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 52.45 111.066 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.492 ' HB3' ' HA3' ' G' ' 169' ' ' GLY . 12.3 pt20 -157.43 175.32 14.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.112 0.965 . . . . 73.11 109.498 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -98.88 -62.24 1.26 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.176 0.99 . . . . 73.55 108.717 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -161.9 171.43 17.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.453 -0.794 . . . . 74.45 110.556 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 p -104.02 -162.16 0.88 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.054 0.942 . . . . 74.04 109.851 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.4 84.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.426 1.09 . . . . 74.12 109.815 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.481 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 24.3 ptt? -83.14 139.37 33.23 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.488 0.661 . . . . 73.13 112.348 -175.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.516 HG21 ' H ' ' C' ' 145' ' ' ALA . 72.3 m -145.1 105.75 4.12 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.401 -1.272 . . . . 64.12 108.29 173.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 72.1 t80 -95.38 142.39 27.82 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.658 -0.867 . . . . 64.42 108.658 168.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.486 ' OE1' ' HB1' ' C' ' 135' ' ' ALA . 6.0 tp60 -162.14 137.26 7.15 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.678 0.611 . . . . 72.01 112.501 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.438 HD13 ' CE2' ' A' ' 84' ' ' PHE . 3.8 tp -75.96 121.6 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.516 1.126 . . . . 74.22 109.16 170.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.487 ' O ' HG21 ' F' ' 204' ' ' ILE . 15.5 mm100 -107.09 -13.8 15.08 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-O 117.781 -1.105 . . . . 65.44 112.163 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 178.38 126.58 0.05 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 119.193 0.906 . . . . 74.1 110.691 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.483 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 77.2 mt -106.44 131.62 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.015 -1.105 . . . . 61.41 108.015 172.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -158.67 170.06 23.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.6 0.714 . . . . 75.11 111.136 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -99.5 114.31 27.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.795 -1.093 . . . . 72.43 108.71 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -77.65 -38.77 47.08 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.84 136.13 32.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.592 -1.186 . . . . 73.31 109.343 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.1 mt -129.95 130.34 66.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.107 -1.442 . . . . 74.32 107.107 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -136.32 106.1 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.523 -0.917 . . . . 72.15 108.523 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.1 t80 -120.65 110.09 16.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.178 -1.786 . . . . 70.24 106.178 167.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -119.43 127.11 52.79 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.278 0.631 . . . . 73.05 109.379 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -126.24 79.4 70.07 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.648 -1.241 . . . . 74.42 107.648 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.07 -22.07 23.21 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.889 2.393 . . . . 65.13 112.372 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -119.07 33.12 5.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.179 0.992 . . . . 61.51 109.048 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.16 -44.69 99.83 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.773 1.229 . . . . 63.05 113.331 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.47 -29.68 71.38 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.463 1.442 . . . . 70.34 112.555 173.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -76.62 -28.73 56.21 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.516 -0.766 . . . . 73.11 111.828 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.6 p -61.74 -23.08 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 118.193 0.451 . . . . 73.35 112.143 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.61 -39.65 67.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.176 0.99 . . . . 75.3 110.869 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -88.39 -19.59 26.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 71.41 110.744 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.38 148.83 33.53 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.419 0.688 . . . . 72.34 110.289 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.36 127.47 32.78 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 74.24 108.327 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.484 ' NE1' ' HB3' ' G' ' 195' ' ' PHE . 25.3 t-105 -86.26 84.94 7.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.578 0.704 . . . . 73.32 110.182 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 80.32 68.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.283 -1.377 . . . . 71.32 107.283 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' G' ' 194' ' ' ALA . 75.9 Cg_endo -81.67 153.26 17.58 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.929 2.419 . . . . 74.42 113.154 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -96.06 90.72 5.64 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.001 -1.111 . . . . 71.1 108.001 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 m -69.98 93.18 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.381 1.086 . . . . 64.01 109.532 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -103.34 121.0 41.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.751 -1.113 . . . . 71.14 109.951 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.34 132.33 43.17 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.044 0.937 . . . . 71.51 109.348 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.722 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.4 m-20 -126.56 132.45 51.32 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.025 0.93 . . . . 73.15 108.754 176.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD22 HD11 ' G' ' 186' ' ' LEU . 54.5 tp -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.746 -0.835 . . . . 74.35 108.746 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -134.29 145.42 49.07 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.679 -0.489 . . . . 70.24 109.679 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 m -109.42 121.38 45.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.865 0.866 . . . . 72.11 108.864 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.97 123.37 27.23 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 107.412 -1.329 . . . . 72.33 107.412 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.6 m -133.16 152.63 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.661 0.384 . . . . 60.54 110.704 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -149.96 130.84 14.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.838 0.855 . . . . 63.05 109.311 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -87.79 117.82 26.89 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.866 -0.791 . . . . 74.4 108.866 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 57' ' ' GLU . 54.9 mt -84.63 -44.57 13.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.543 0.737 . . . . 73.14 110.696 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.47 -171.94 4.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.692 0.797 . . . . 63.13 109.923 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -59.96 102.75 0.17 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.375 0.67 . . . . 74.02 110.39 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 65.3 12.11 7.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.823 1.249 . . . . 73.12 112.997 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.4 t -99.83 113.82 36.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.859 -1.534 . . . . 55.33 106.859 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' G' ' 174' ' ' MET . 5.9 m-30 -108.82 165.91 11.21 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.199 1.0 . . . . 74.13 111.3 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 51' ' ' LEU . 28.0 tt0 -131.26 118.59 20.6 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 112.574 -2.103 . . . . 74.34 106.862 164.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.61 117.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.344 -1.724 . . . . 63.14 106.344 170.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.4 t -97.9 127.99 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.114 -0.698 . . . . 53.21 109.114 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 109.85 21.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.427 -1.323 . . . . 74.14 107.427 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -106.01 106.74 17.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.019 -0.991 . . . . 73.2 109.559 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.95 133.47 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 114.95 -1.023 . . . . 75.4 108.553 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.722 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.8 m -117.69 131.71 56.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.912 -0.773 . . . . 75.14 108.912 173.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 37.1 t -126.21 111.42 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.869 1.268 . . . . 53.34 108.263 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 m -102.26 145.1 29.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.578 -0.527 . . . . 72.54 109.578 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.43 109.94 7.98 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.233 -1.025 . . . . 72.25 108.233 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.7 m -126.81 145.69 50.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.275 0.559 . . . . 75.15 110.363 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.442 HD21 ' CE3' ' A' ' 36' ' ' TRP . 49.1 mt -107.84 51.56 0.74 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.542 1.537 . . . . 73.15 108.031 -175.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.93 -85.44 0.89 Allowed Glycine 0 C--N 1.349 1.282 0 CA-C-N 114.569 -1.196 . . . . 33.15 111.483 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -89.92 -24.73 21.25 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.131 0.973 . . . . 75.12 111.846 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -118.15 107.03 13.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.086 0.554 . . . . 75.4 110.392 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.2 123.44 20.72 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 118.525 0.602 . . . . 72.54 109.889 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.39 -54.73 6.33 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.852 -1.067 . . . . 70.44 109.648 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.5 172.48 17.14 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.467 -1.242 . . . . 74.41 110.912 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.6 141.31 33.46 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.114 -1.403 . . . . 51.5 107.364 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.544 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 54.9 m -140.16 99.78 3.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.285 -0.635 . . . . 61.21 109.285 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -121.58 122.86 40.61 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.508 -0.923 . . . . 64.2 108.508 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.47 131.13 70.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.511 0.725 . . . . 71.23 109.293 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -104.59 93.44 4.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.931 -1.031 . . . . 64.4 109.434 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -81.67 92.88 6.66 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.112 -1.069 . . . . 65.34 108.112 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.12 143.7 20.51 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.242 -0.743 . . . . 54.13 111.242 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.82 129.92 4.49 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.491 -0.644 . . . . 72.21 111.491 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -78.53 129.5 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 107.648 -1.242 . . . . 65.22 107.648 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' CE2' HD13 ' A' ' 13' ' ' ILE . 49.5 m-85 -133.49 121.72 22.59 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.134 -0.691 . . . . 62.44 109.134 174.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.9 t -74.3 115.27 13.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.591 -1.262 . . . . 64.51 107.591 169.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -137.78 119.06 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.682 0.793 . . . . 71.23 109.729 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.01 161.6 28.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.931 0.893 . . . . 61.23 109.849 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 78.3 5.24 87.48 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.646 0.591 . . . . 63.31 114.399 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.34 166.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.753 . . . . 72.2 108.972 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -172.74 175.97 3.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.343 -0.614 . . . . 64.25 109.343 -168.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.42 -126.01 38.04 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.813 0.695 . . . . 74.34 114.437 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.3 p -82.47 -20.39 36.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.689 0.796 . . . . 73.34 110.98 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.96 -43.45 98.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.012 0.925 . . . . 71.24 111.006 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -49.48 67.07 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.879 0.737 . . . . 74.35 110.352 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.95 71.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.354 0.662 . . . . 62.13 111.534 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -71.56 -41.8 68.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.732 0.813 . . . . 64.4 110.528 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.67 -65.25 0.81 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.029 0.532 . . . . 64.24 110.489 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.62 -40.58 84.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.222 0.609 . . . . 74.22 111.046 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.78 -38.81 49.28 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.601 0.563 . . . . 51.04 113.793 -168.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 133' ' ' PHE . . . -126.55 -53.53 1.46 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.124 0.462 . . . . 40.31 112.149 -171.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.437 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 82.9 t80 -63.7 -42.27 97.99 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.011 0.924 . . . . 74.4 112.862 -171.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' CE2' ' A' ' 11' ' ' PHE . 73.7 m -77.62 -41.43 2.26 Favored Pre-proline 0 CA--C 1.557 1.243 0 N-CA-C 113.048 0.758 . . . . 72.33 113.048 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.76 -23.64 55.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 CA-C-N 121.139 1.442 . . . . 65.01 112.544 166.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -70.8 -24.92 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.966 0.506 . . . . 73.31 111.463 172.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.73 -42.82 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.968 0.89 . . . . 70.33 109.299 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.511 HD21 ' HA3' ' A' ' 82' ' ' GLY . 25.1 mt -84.06 -27.72 28.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.421 -1.263 . . . . 62.03 112.444 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -61.92 -40.74 71.6 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 114.504 1.298 . . . . 73.23 114.504 -171.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.89 -36.22 82.57 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.963 1.775 . . . . 71.45 113.057 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' C' ' 108' ' ' PRO . 87.5 m-85 -81.56 -35.33 30.39 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.181 -0.918 . . . . 75.42 111.352 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.49 80.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.886 0.474 . . . . 62.01 110.566 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm105 -56.46 -54.83 41.14 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 114.796 -1.093 . . . . 50.12 109.216 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.27 -41.33 88.61 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.393 1.058 . . . . 70.21 111.564 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.0 t -57.78 -50.98 71.42 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.742 0.651 . . . . 73.12 110.102 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.449 HG21 HG21 ' A' ' 64' ' ' VAL . 96.5 mt -63.57 -42.72 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.937 0.895 . . . . 72.25 111.306 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.43 HG21 ' HE2' ' C' ' 109' ' ' TYR . 90.7 m -57.35 -45.19 84.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.243 1.017 . . . . 73.4 110.616 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -70.93 -41.41 71.22 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.702 -1.135 . . . . 73.44 110.054 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 19.4 mtp -57.66 -46.14 84.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.864 0.866 . . . . 75.41 111.67 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.05 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.961 0.904 . . . . 73.32 110.67 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 82.5 p -69.66 -33.07 72.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.406 0.282 . . . . 35.04 111.62 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.598 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.7 mtt-85 -68.65 -27.31 65.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.48 0.712 . . . . 63.13 110.789 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.75 9.88 58.21 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.502 0.501 . . . . 61.44 113.2 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m 69.31 42.17 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.869 1.319 . . . . 65.54 110.584 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' SER . 90.5 m-85 -120.66 156.48 55.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.837 -1.074 . . . . 64.22 109.523 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.19 124.65 16.07 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.565 1.51 . . . . 72.02 109.789 166.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 19.7 pt20 -60.69 146.38 45.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.827 0.451 . . . . 73.12 111.34 -174.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -114.22 105.8 13.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.008 -0.542 . . . . 62.12 110.19 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -118.28 93.22 4.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 74.44 109.742 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.502 ' HB3' HD11 ' G' ' 187' ' ' ILE . 96.8 mt -73.02 160.66 31.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.697 -1.138 . . . . 71.04 110.824 176.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' C' ' 13' ' ' ILE . . . -68.84 145.3 96.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.279 0.632 . . . . 54.43 112.441 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.25 114.5 4.01 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.118 1.879 . . . . 75.02 110.818 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 109.19 23.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.797 -1.557 . . . . 74.22 106.797 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -104.53 92.03 4.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.982 0.913 . . . . 72.53 110.358 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 136' ' ' LEU . 93.2 m-85 -66.5 -21.44 66.17 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.988 -1.005 . . . . 74.51 111.67 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.47 -51.18 70.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.308 1.043 . . . . 72.24 110.434 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.76 49.57 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.517 -0.765 . . . . 53.43 110.629 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 133' ' ' PHE . 46.3 tp -53.45 -39.38 64.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.359 1.063 . . . . 74.24 111.852 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 86.9 t80 -57.65 -56.78 17.53 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.838 0.711 . . . . 71.34 110.504 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.5 mtm -67.63 -36.03 80.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.71 0.804 . . . . 74.02 111.352 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -58.61 -58.02 10.42 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.268 1.427 . . . . 74.11 109.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -69.01 -30.93 69.43 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.14 -0.936 . . . . 65.3 111.261 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -61.57 -38.32 87.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.972 0.909 . . . . 73.42 110.968 -176.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -148.5 29.98 0.84 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.984 0.735 . . . . 64.11 112.984 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -34.54 71.31 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.365 0.53 . . . . 74.31 109.838 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -59.47 -39.89 85.17 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.856 0.862 . . . . 75.21 111.229 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.89 83.96 1.15 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.088 0.555 . . . . 62.04 110.723 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.24 161.35 19.11 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.588 -0.733 . . . . 72.32 111.534 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 5' ' ' ASN . 11.0 tp10 -166.26 147.77 6.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.218 0.607 . . . . 64.23 109.684 176.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.77 153.37 6.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.933 -0.467 . . . . 62.01 111.933 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -153.26 152.92 31.71 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.541 0.686 . . . . 74.44 110.578 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.702 ' H ' HG21 ' C' ' 92' ' ' THR . 29.9 mt-10 -121.36 -12.23 8.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.408 1.483 . . . . 72.41 109.612 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.444 ' HB2' HG22 ' C' ' 92' ' ' THR . 35.4 tt0 -88.82 94.45 9.93 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.09 0.956 . . . . 74.04 111.922 -163.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -179.5 76.14 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.862 0.865 . . . . 74.3 109.677 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.488 ' HB3' ' HG3' ' E' ' 180' ' ' PRO . 40.3 tt0 -176.89 23.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.192 0.597 . . . . 71.3 109.745 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.85 90.47 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.136 0.974 . . . . 73.53 112.314 -167.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.452 0 C-N-CA 125.978 1.711 . . . . 37.83 106.91 175.709 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 110.172 -0.307 . . . . 51.11 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -141.77 150.13 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.752 . . . . 70.15 109.853 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -83.5 116.59 22.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.182 0.593 . . . . 74.32 111.811 -172.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -77.52 -12.97 60.02 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.226 1.01 . . . . 74.02 110.605 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -65.66 131.36 46.15 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.582 0.753 . . . . 65.3 110.061 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -143.64 167.17 22.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.719 0.808 . . . . 72.43 110.145 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -133.43 138.43 46.22 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.275 -1.009 . . . . 44.01 108.275 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -44.78 95.89 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.647 0.779 . . . . 64.11 110.93 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.598 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.1 ptm 55.67 168.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.197 2.199 . . . . 73.54 114.589 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -176.74 145.05 0.51 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.224 -1.353 . . . . 50.34 109.017 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.02 156.43 39.96 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.382 -0.372 . . . . 73.04 111.177 162.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.412 HE22 HD13 ' G' ' 204' ' ' ILE . 22.2 tp60 -122.78 111.37 16.62 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.75 -1.204 . . . . 73.4 107.75 176.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 tt -61.34 101.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.914 -1.494 . . . . 72.12 109.318 170.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -78.4 -33.25 48.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.677 -0.692 . . . . 71.2 109.672 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -173.19 141.36 0.94 Allowed 'General case' 0 C--N 1.361 1.089 0 O-C-N 123.354 0.409 . . . . 70.04 110.761 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.36 136.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 106.545 -1.65 . . . . 61.14 106.545 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -166.04 148.65 7.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.099 0.476 . . . . 73.43 111.069 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.616 HG21 HD11 ' B' ' 21' ' ' ILE . 86.3 m -76.92 117.42 18.5 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.712 -0.847 . . . . 73.43 108.712 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -88.38 -25.61 22.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.152 0.581 . . . . 52.23 110.633 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 15.8 t70 -158.55 143.54 16.24 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.347 0.594 . . . . 75.43 111.845 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.616 HD11 HG21 ' B' ' 18' ' ' THR . 39.9 mm -134.18 138.59 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 C-N-CA 125.897 1.679 . . . . 72.32 106.867 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -146.62 133.4 20.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.606 -0.887 . . . . 74.04 108.606 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.2 115.59 6.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.395 -1.335 . . . . 74.33 107.395 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.06 127.16 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -122.51 86.95 48.98 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 108.383 -0.969 . . . . 60.51 108.383 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.28 -19.2 50.36 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.916 2.41 . . . . 62.13 111.928 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.491 HD21 ' HB2' ' C' ' 154' ' ' ASP . 33.4 m-80 -126.6 30.58 5.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.021 0.928 . . . . 70.41 110.739 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.05 -49.51 50.23 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 124.55 1.14 . . . . 72.21 112.894 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.64 -24.46 1.86 Allowed 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 121.8 1.666 . . . . 72.44 113.699 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -76.56 -5.36 47.34 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.354 0.662 . . . . 72.32 112.356 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.14 -13.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.849 0.86 . . . . 72.43 110.653 170.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.519 ' HZ ' ' HG3' ' C' ' 147' ' ' GLU . 65.3 t80 -57.2 -41.95 80.36 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.223 1.009 . . . . 75.41 110.78 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.503 ' OE1' ' HB3' ' C' ' 150' ' ' GLU . 17.3 mm100 -75.75 -37.99 58.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.933 -1.031 . . . . 72.43 110.714 -173.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.406 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 77.5 mttt -107.93 89.03 2.87 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.462 -0.79 . . . . 64.34 109.71 -174.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.75 76.21 10.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.846 1.258 . . . . 73.14 112.025 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -172.93 156.23 3.3 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.357 0.663 . . . . 73.25 110.468 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -58.29 119.21 33.56 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.537 1.135 . . . . 61.33 111.473 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 37.8 Cg_endo -65.92 163.64 30.24 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.906 2.404 . . . . 72.44 112.018 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -76.08 100.92 5.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.724 -1.213 . . . . 73.15 107.724 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.496 HG12 HD13 ' B' ' 126' ' ' LEU . 16.8 t -88.6 120.6 37.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.361 -1.348 . . . . 71.2 107.361 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -145.31 144.6 30.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.017 0.527 . . . . 64.32 110.276 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.528 HD21 ' HG ' ' B' ' 128' ' ' LEU . 1.9 pt? -115.81 160.24 20.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 70.35 110.065 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.24 138.18 44.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.455 1.102 . . . . 64.33 108.721 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -90.96 134.34 34.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.248 0.619 . . . . 75.12 109.574 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.32 150.05 34.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.973 0.909 . . . . 74.31 108.609 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.3 m -142.92 113.42 7.37 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.105 -0.702 . . . . 75.01 109.105 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.75 120.81 32.84 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.384 -1.339 . . . . 70.11 107.384 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -132.92 172.26 12.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.941 0.496 . . . . 63.04 111.368 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.3 p -152.77 179.08 8.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.864 0.866 . . . . 74.25 109.999 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -122.13 121.74 37.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.629 0.771 . . . . 71.24 110.083 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 81.4 mt -79.03 -44.8 21.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.619 0.767 . . . . 74.05 110.642 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.18 -172.01 3.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.56 -0.745 . . . . 35.32 110.911 -172.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.87 111.95 1.66 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.767 -1.106 . . . . 75.23 110.265 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 70.43 -5.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.047 1.739 . . . . 52.04 112.932 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.85 93.17 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.054 -1.091 . . . . 65.23 108.054 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.13 141.07 30.7 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.898 -1.046 . . . . 73.31 110.005 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.657 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.7 tm-20 -105.2 100.15 9.74 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.888 -1.523 . . . . 64.4 106.888 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.64 117.68 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.25 0.62 . . . . 73.33 109.822 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.94 121.1 55.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 109.286 -0.635 . . . . 73.14 109.286 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.06 118.08 30.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.05 -1.463 . . . . 72.33 107.05 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -106.45 116.45 31.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.494 0.717 . . . . 71.25 109.355 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.3 t -109.7 119.04 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.145 -1.057 . . . . 74.35 108.145 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -116.32 125.82 52.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.988 0.515 . . . . 71.3 110.21 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.666 HG21 HG21 ' B' ' 114' ' ' ILE . 77.8 t -107.72 137.43 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.729 1.212 . . . . 71.13 110.898 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.3 m -124.41 146.85 48.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.212 1.005 . . . . 74.21 109.923 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 156.26 42.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.066 0.946 . . . . 73.21 109.402 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.7 p -153.1 142.61 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.655 0.613 . . . . 75.22 112.655 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.1 mt -118.56 98.18 6.12 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.629 -0.878 . . . . 73.11 108.629 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.87 -110.44 2.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 122.954 0.311 . . . . 52.0 113.05 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -88.48 4.97 44.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.843 0.857 . . . . 61.1 110.285 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 68' ' ' LEU . 1.2 mp0 -114.4 153.07 30.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.79 1.236 . . . . 65.41 109.998 -167.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -87.43 129.24 35.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 162.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.47 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -83.17 -55.8 4.14 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.849 -0.797 . . . . 43.33 108.849 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.1 150.29 20.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.804 -1.089 . . . . 71.44 110.694 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -124.88 113.87 18.44 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.505 1.522 . . . . 53.41 107.643 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.521 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.7 t -116.29 160.1 20.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.407 -0.961 . . . . 72.33 108.407 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.02 131.84 3.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.628 -0.878 . . . . 73.41 108.628 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.52 142.78 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.715 -0.846 . . . . 75.21 108.715 172.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.5 mt-30 -120.73 97.91 5.77 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.183 -0.917 . . . . 63.32 109.071 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -87.77 101.29 13.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.12 154.49 24.47 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 111.16 -0.776 . . . . 71.45 111.16 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.73 126.16 2.01 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.673 -1.371 . . . . 55.4 109.673 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.657 HG12 ' HG2' ' B' ' 57' ' ' GLU . 27.9 mt -85.25 115.89 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.114 -1.069 . . . . 73.15 108.114 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -124.93 132.47 53.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.798 -1.556 . . . . 74.25 106.798 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -88.97 88.63 7.66 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.025 -1.102 . . . . 62.43 108.025 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.68 129.83 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.935 0.494 . . . . 65.22 110.626 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.28 170.99 20.67 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.966 -1.015 . . . . 53.02 110.249 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 92.52 -49.35 2.62 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 75.21 112.219 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.615 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -72.12 152.28 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.871 0.468 . . . . 74.51 111.316 174.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -160.4 172.48 17.2 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.848 -1.069 . . . . 63.01 108.97 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.93 -125.42 38.97 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.616 0.572 . . . . 61.12 113.747 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.0 m -74.57 -27.51 60.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.744 0.818 . . . . 54.34 111.109 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -68.9 -40.19 79.28 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.682 0.793 . . . . 71.33 109.881 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -41.91 59.92 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.045 -0.525 . . . . 54.5 110.116 176.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.73 62.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.149 0.98 . . . . 75.11 111.649 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.428 ' CE1' ' HA ' ' B' ' 134' ' ' ASP . 39.0 t-80 -93.34 -13.1 28.52 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.061 -0.972 . . . . 74.44 111.191 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.31 -64.32 1.01 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.623 0.369 . . . . 70.24 110.195 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.414 HD21 HD13 ' F' ' 177' ' ' LEU . 0.0 OUTLIER -74.36 -15.83 60.93 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.146 0.178 . . . . 50.12 111.167 -176.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 -6.08 53.67 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.227 -0.763 . . . . 73.43 114.198 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -149.5 -47.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.399 1.1 . . . . 60.2 112.875 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -73.21 -54.02 9.48 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.052 0.541 . . . . 74.3 111.254 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 68.1 m -63.01 -45.3 86.65 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.529 0.732 . . . . 60.23 111.335 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -50.78 -45.0 38.05 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.416 2.077 . . . . 73.02 113.893 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 123.176 0.591 . . . . 62.13 112.057 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.525 HG23 ' NH2' ' D' ' 111' ' ' ARG . 79.5 mt -71.57 -47.98 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.659 0.784 . . . . 70.54 110.863 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -80.3 -20.88 43.33 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.233 -0.894 . . . . 61.11 112.298 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 64.5 t80 -64.71 -45.78 75.82 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.653 -1.165 . . . . 64.24 113.387 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 19.1 Cg_endo -56.72 -37.64 97.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 CA-C-N 121.581 1.6 . . . . 55.02 113.076 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.81 -49.6 65.29 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.31 0.644 . . . . 75.14 110.973 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.99 -42.39 98.34 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.717 0.807 . . . . 64.24 111.181 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.436 ' NH2' HG22 ' C' ' 122' ' ' THR . 50.1 ttt180 -58.87 -55.22 37.92 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.681 1.593 . . . . 70.41 110.96 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -38.5 90.88 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.487 0.715 . . . . 74.12 109.918 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.598 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.8 t -67.69 -42.08 82.64 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.745 -0.662 . . . . 60.22 112.103 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 64' ' ' VAL . 96.8 mt -62.52 -50.61 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.696 -0.483 . . . . 60.13 109.696 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 86.7 m -55.59 -31.52 62.3 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.092 0.87 . . . . 75.53 111.183 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.9 t -66.05 -52.56 47.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.572 0.749 . . . . 72.21 110.403 172.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.6 mmt -67.36 -36.14 80.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.55 0.574 . . . . 64.42 112.55 -172.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.94 -42.02 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.639 0.776 . . . . 74.02 110.475 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.763 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 90.3 p -71.73 -30.31 65.47 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.469 -0.787 . . . . 63.44 111.872 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -63.44 -33.7 76.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 65.15 110.368 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.77 9.0 58.05 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.839 0.712 . . . . 71.3 113.329 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.9 p 56.15 27.97 12.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.892 1.677 . . . . 42.24 112.466 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.86 158.66 32.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.249 -0.887 . . . . 71.01 110.578 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.576 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 38.8 Cg_exo -61.98 179.73 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.484 2.789 . . . . 72.43 115.999 -171.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.63 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -62.84 150.21 42.29 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 113.894 -1.503 . . . . 71.13 114.347 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.496 HD13 HG12 ' B' ' 40' ' ' VAL . 53.3 tp -141.61 86.04 1.98 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.008 -1.478 . . . . 63.02 107.008 167.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' C' ' 119' ' ' SER . 7.1 m120 -116.11 90.62 3.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.485 -1.302 . . . . 75.04 107.485 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.528 ' HG ' HD21 ' B' ' 42' ' ' LEU . 1.9 tm? -84.88 138.01 32.79 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.512 -0.922 . . . . 73.43 108.512 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.433 ' HB2' ' NH1' ' D' ' 15' ' ' ARG . . . -67.62 107.24 1.64 Allowed Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 124.357 1.035 . . . . 75.13 109.913 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 129.71 25.28 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.09 1.86 . . . . 63.43 110.925 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.516 ' HA ' HD13 ' D' ' 13' ' ' ILE . 30.2 m -118.36 140.52 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.277 0.631 . . . . 71.34 110.522 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.715 ' H ' HG21 ' D' ' 13' ' ' ILE . 15.6 m-20 -69.76 104.97 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.256 -0.883 . . . . 73.42 109.093 170.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -64.19 -14.37 54.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 120.858 0.361 . . . . 72.23 110.427 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.428 ' HA ' ' CE1' ' B' ' 96' ' ' HIS . 29.1 t70 -79.56 -55.12 5.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.085 0.954 . . . . 74.44 111.361 172.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.16 77.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.225 0.61 . . . . 73.35 111.64 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.98 -44.12 85.83 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.963 0.505 . . . . 73.05 110.266 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.5 -45.21 94.62 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.412 0.685 . . . . 72.23 110.425 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -58.41 -38.81 78.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.301 1.04 . . . . 74.43 110.088 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -77.08 -29.11 54.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.407 -1.269 . . . . 73.24 111.05 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -69.5 -23.19 63.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.357 0.663 . . . . 64.14 111.206 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.26 -6.47 15.52 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 74.11 111.888 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -167.44 101.79 0.51 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.14 0.576 . . . . 70.33 110.907 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -132.02 101.96 5.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.918 -1.141 . . . . 75.53 107.918 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.695 ' HG2' ' HA ' ' D' ' 8' ' ' GLU . 7.5 tp60 -106.23 -58.5 1.91 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.83 -0.804 . . . . 70.45 108.83 175.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.98 92.88 0.05 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.328 1.451 . . . . 61.24 111.522 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.98 -169.09 23.72 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.313 -0.403 . . . . 74.41 113.079 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.76 93.37 3.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 122.101 0.953 . . . . 74.54 111.747 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -85.3 -166.12 41.37 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 114.961 -1.018 . . . . 75.5 111.196 165.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.3 t -163.63 150.58 12.21 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.341 0.57 . . . . 72.24 110.564 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -173.14 107.0 0.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.399 0.68 . . . . 71.54 110.098 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.27 95.51 2.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.406 -0.59 . . . . 54.31 109.406 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -78.64 100.85 7.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.437 0.637 . . . . 63.25 109.987 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -87.91 97.23 10.82 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.103 -0.499 . . . . 62.51 109.752 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.79 168.46 25.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.03 0.932 . . . . 71.14 109.846 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.132 -0.937 . . . . 63.24 108.784 176.377 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.651 -0.87 . . . . 72.24 108.651 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 88.5 p 53.39 -172.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.659 1.584 . . . . 71.43 112.375 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.524 ' HG3' HG22 ' C' ' 7' ' ' THR . 24.9 tt0 -87.58 121.64 30.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.804 -1.184 . . . . 73.34 107.804 166.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -87.18 84.96 7.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 73.53 109.13 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 16.4 t-20 76.74 -70.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.634 1.974 . . . . 74.52 111.33 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -156.2 139.15 15.36 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.146 -0.687 . . . . 53.24 109.146 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.524 HG22 ' HG3' ' C' ' 3' ' ' GLU . 6.5 t -158.33 177.14 11.59 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-O 121.42 0.629 . . . . 73.24 110.995 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -160.25 -36.48 0.05 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.754 1.622 . . . . 42.32 107.141 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 63.69 112.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 126.294 1.838 . . . . 73.35 111.163 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 74.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.054 -1.091 . . . . 74.35 108.054 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.591 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 8.0 t80 -100.28 119.67 38.75 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.104 -0.702 . . . . 61.1 109.104 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -141.25 119.25 11.93 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.948 -0.76 . . . . 64.22 108.948 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.679 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -74.28 127.35 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 108.682 -0.859 . . . . 72.34 108.682 171.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 11.5 mm100 -96.36 -49.52 5.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.096 0.558 . . . . 71.25 110.36 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -162.65 123.29 2.44 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.971 -0.381 . . . . 72.23 109.971 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.679 HG13 HD11 ' C' ' 13' ' ' ILE . 76.6 mt -113.69 135.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.038 -1.097 . . . . 72.11 108.038 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.9 p90 -174.5 158.29 2.79 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 124.132 0.895 . . . . 64.4 110.866 -172.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -80.3 136.71 36.48 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.376 -0.829 . . . . 70.34 109.487 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -89.55 -51.39 5.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.27 1.033 . . . . 72.32 108.846 171.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 25.9 t70 -134.91 132.91 39.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.134 -1.848 . . . . 52.44 108.2 -171.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.4 mt -129.29 140.52 48.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.728 -1.582 . . . . 73.11 106.728 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -148.71 145.02 27.48 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.402 -0.592 . . . . 74.43 109.402 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.72 111.64 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.032 -1.47 . . . . 75.35 107.032 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.06 117.87 31.79 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.832 -1.173 . . . . 62.11 107.832 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.36 87.84 8.16 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 108.112 -1.07 . . . . 71.32 108.112 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.3 3.41 7.49 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.05 2.5 . . . . 62.42 111.709 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.3 12.56 8.21 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 124.246 1.019 . . . . 73.01 109.936 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.39 -49.43 82.18 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.737 1.014 . . . . 75.25 113.737 -171.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.53 -27.87 0.54 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.666 1.578 . . . . 54.11 113.449 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -70.12 -25.74 63.63 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.205 1.002 . . . . 63.11 112.905 -173.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.57 -6.86 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.328 1.051 . . . . 71.41 111.564 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -56.95 -41.7 78.75 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.357 1.063 . . . . 72.4 112.638 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -100.42 4.24 43.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.702 0.801 . . . . 53.31 110.606 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.496 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.5 OUTLIER -87.68 168.21 13.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.058 0.543 . . . . 62.13 111.76 -168.449 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.08 113.53 10.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.008 -0.738 . . . . 63.45 109.008 167.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -86.78 65.21 8.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.497 0.719 . . . . 65.03 110.157 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -135.57 78.98 48.74 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.414 -0.958 . . . . 73.21 108.414 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.96 167.57 26.77 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.826 2.351 . . . . 53.03 112.448 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -122.83 109.25 13.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.971 -1.122 . . . . 73.03 107.971 171.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.568 HG11 HD11 ' C' ' 126' ' ' LEU . 97.6 t -78.45 103.11 5.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.829 -0.804 . . . . 65.22 108.829 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -91.66 116.33 28.79 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.522 -1.288 . . . . 60.4 107.522 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.418 HD12 HG12 ' C' ' 40' ' ' VAL . 9.2 mp -85.93 149.1 25.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.974 0.51 . . . . 73.42 109.84 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.35 142.29 25.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.847 0.859 . . . . 74.21 108.976 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -135.17 136.02 41.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.897 -0.779 . . . . 74.23 108.897 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 28.0 t70 -141.18 145.9 36.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.991 -1.114 . . . . 71.42 107.991 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -114.2 137.5 51.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.096 0.558 . . . . 55.41 110.472 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.28 47.13 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.444 1.097 . . . . 35.11 108.589 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 70.2 p -160.22 150.53 18.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.741 0.416 . . . . 74.25 110.95 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.3 t -149.43 133.24 16.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.554 0.742 . . . . 75.03 109.511 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -77.98 139.03 39.14 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.602 -0.518 . . . . 74.23 109.602 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.585 HD11 HD12 ' C' ' 83' ' ' ILE . 53.1 mt -114.65 -30.52 6.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.773 0.829 . . . . 73.03 110.893 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.33 -175.07 4.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.25 1.02 . . . . 74.34 110.142 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.39 100.16 0.34 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.445 -0.798 . . . . 24.33 110.223 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.425 ' HA ' ' SD ' ' E' ' 174' ' ' MET . 0.9 OUTLIER 64.75 9.25 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.273 1.429 . . . . 75.31 113.843 -177.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 89.9 t -100.41 117.95 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.635 -1.617 . . . . 62.42 106.635 164.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.407 ' HB3' ' SD ' ' E' ' 174' ' ' MET . 1.2 p90 -137.06 -178.1 5.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.852 -0.796 . . . . 73.35 108.852 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -128.51 138.9 52.49 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.336 1.055 . . . . 63.43 109.829 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.69 127.72 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.767 -1.197 . . . . 72.22 107.767 168.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 111.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.913 0.885 . . . . 40.01 109.123 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' C' ' 103' ' ' PRO . 54.4 mt -87.53 109.06 19.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.077 0.551 . . . . 71.35 110.316 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 79.6 ttt180 -85.38 102.03 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.308 -0.997 . . . . 73.42 108.308 172.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.46 124.13 55.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.913 -1.143 . . . . 52.23 107.913 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -124.99 142.34 51.55 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.407 0.622 . . . . 71.14 109.769 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.531 HG11 HD22 ' C' ' 126' ' ' LEU . 70.6 t -135.52 130.22 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.442 1.097 . . . . 65.53 108.93 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.6 m -112.35 141.41 46.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.112 -1.07 . . . . 75.03 108.112 172.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.54 125.52 45.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.475 -1.306 . . . . 74.13 107.475 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -135.58 131.31 35.74 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.102 0.477 . . . . 65.32 110.5 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.496 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.7 mt -86.6 35.13 0.66 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.602 1.561 . . . . 65.42 109.321 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.57 -112.01 3.57 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 110.743 -0.943 . . . . 53.21 110.743 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.56 -31.52 18.6 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.632 0.773 . . . . 74.01 109.67 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -70.03 121.98 18.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.807 1.243 . . . . 74.41 110.363 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.5 m -80.05 131.66 35.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.765 0.257 . . . . 72.3 110.33 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.23 -53.89 4.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.112 0.565 . . . . 64.05 110.005 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -162.28 176.7 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.568 0.747 . . . . 73.01 111.07 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.482 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -136.73 143.96 43.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.656 -1.609 . . . . 63.3 106.656 171.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.482 ' N ' HD13 ' C' ' 75' ' ' LEU . 39.1 t -144.69 141.49 29.35 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.394 -0.965 . . . . 64.44 108.394 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.22 131.66 10.41 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.677 -0.49 . . . . 63.33 109.677 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.76 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.401 1.08 . . . . 64.21 108.305 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -121.1 96.84 5.26 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.232 1.013 . . . . 72.14 108.335 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.28 105.13 15.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.272 0.629 . . . . 74.21 110.556 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.45 150.57 25.86 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 123.668 0.605 . . . . 63.25 112.566 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.54 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -155.72 117.74 0.8 Allowed Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 111.47 -0.652 . . . . 64.21 111.47 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.585 HD12 HD11 ' C' ' 51' ' ' LEU . 9.5 mm -80.99 128.63 38.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 N-CA-C 108.733 -0.84 . . . . 52.33 108.733 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -135.11 131.17 36.57 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.193 0.597 . . . . 73.41 110.101 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -92.0 122.42 34.49 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.389 -1.337 . . . . 50.53 107.389 164.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 40.8 pt -113.71 -142.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 118.379 -0.819 . . . . 74.2 109.175 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 97.78 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.896 2.079 . . . . 72.2 110.596 176.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -39.56 3.1 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.316 -0.714 . . . . 64.45 111.316 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.416 HG13 ' H ' ' C' ' 89' ' ' ILE . 2.2 pp -77.65 162.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 124.366 1.066 . . . . 75.32 111.166 169.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -168.77 157.65 8.49 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.133 0.573 . . . . 65.4 110.462 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.07 -119.45 8.01 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-N 116.011 -0.541 . . . . 74.33 112.88 170.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.702 HG21 ' H ' ' A' ' 150' ' ' GLU . 60.3 p -57.64 -44.0 85.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.119 0.968 . . . . 72.12 111.036 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.13 -46.72 87.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.531 -1.213 . . . . 70.33 110.519 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.1 ttt -69.98 -41.94 73.76 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.676 -0.693 . . . . 74.34 110.957 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.1 76.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.976 0.51 . . . . 71.2 110.908 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.456 ' HA ' ' OH ' ' E' ' 181' ' ' TYR . 62.1 m170 -84.31 -21.48 30.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.672 0.789 . . . . 72.11 112.148 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 97.9 m -73.88 -59.75 2.57 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.701 0.401 . . . . 74.42 109.997 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.69 -26.3 68.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.179 0.991 . . . . 70.11 111.827 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 -22.44 42.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.375 -0.68 . . . . 75.02 114.295 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.84 -50.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.077 0.938 . . . . 64.5 113.428 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.457 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 85.4 t80 -69.87 -55.64 9.21 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 112.482 0.549 . . . . 74.25 112.482 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.591 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 32.0 m -60.9 -45.11 96.64 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.544 0.738 . . . . 52.45 111.277 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' C' ' 60' ' ' LEU . 91.5 Cg_exo -53.08 -40.37 76.96 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.591 2.194 . . . . 74.32 114.912 167.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.341 0.656 . . . . 72.01 111.511 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.455 HG23 ' NH1' ' A' ' 111' ' ' ARG . 51.4 mm -62.87 -42.4 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.471 -0.786 . . . . 72.22 110.554 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA3' ' C' ' 82' ' ' GLY . 73.8 mt -82.79 -25.43 32.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.988 0.915 . . . . 73.32 112.544 -171.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.16 -51.49 74.7 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.753 1.02 . . . . 73.11 113.753 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.423 ' HB3' ' CD2' ' A' ' 109' ' ' TYR . 19.5 Cg_endo -58.32 -33.95 98.19 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.837 1.691 . . . . 72.54 113.665 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.43 ' HE2' HG21 ' A' ' 115' ' ' THR . 86.5 m-85 -67.65 -47.73 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.436 0.694 . . . . 72.25 110.812 177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.84 92.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.762 0.825 . . . . 71.02 110.677 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.47 -53.26 59.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.678 1.591 . . . . 62.22 110.726 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.43 -30.94 70.81 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.699 0.799 . . . . 65.44 110.513 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.77 -38.04 87.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 74.21 110.655 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.458 HG23 ' SG ' ' C' ' 76' ' ' CYS . 61.0 mt -73.24 -42.07 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.021 -0.536 . . . . 73.12 110.385 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -55.94 -44.24 78.21 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.496 0.719 . . . . 53.42 110.928 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 85.6 p -70.58 -47.41 60.36 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.248 -0.887 . . . . 70.23 110.462 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.512 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -54.22 -45.77 72.34 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.319 1.048 . . . . 74.44 112.768 -177.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 -42.86 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.673 0.608 . . . . 74.13 110.509 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.417 ' HA ' ' ND2' ' B' ' 127' ' ' ASN . 37.6 t -67.82 -27.78 67.01 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.318 -0.855 . . . . 63.14 112.373 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.5 mtt-85 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.245 0.618 . . . . 72.53 109.575 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.96 7.96 64.78 Favored Glycine 0 C--N 1.36 1.895 0 O-C-N 123.794 0.684 . . . . 71.13 112.951 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.436 HG22 ' NH2' ' B' ' 111' ' ' ARG . 17.3 p 63.37 16.18 9.31 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 127.369 2.268 . . . . 74.21 113.586 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.91 153.38 63.73 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 107.894 -1.15 . . . . 71.54 107.894 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.493 ' HB2' ' OH ' ' F' ' 202' ' ' TYR . 17.0 Cg_endo -51.98 118.56 4.63 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.969 2.446 . . . . 63.42 112.088 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.63 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 9.1 pt20 -44.77 146.89 0.7 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 124.906 1.282 . . . . 63.52 112.434 -172.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.568 HD11 HG11 ' C' ' 40' ' ' VAL . 14.7 tp -109.59 79.83 1.25 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.71 0.767 . . . . 74.42 112.845 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.763 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 6.9 p-10 -97.47 90.3 5.0 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.572 -1.195 . . . . 72.12 109.564 172.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 66.9 mt -74.83 146.0 42.37 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.478 -1.237 . . . . 72.24 109.465 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.03 130.03 92.83 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.339 0.399 . . . . 52.51 110.334 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.483 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 42.6 Cg_endo -65.61 101.31 0.44 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.955 2.437 . . . . 60.2 112.27 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.647 ' HB ' HD11 ' C' ' 136' ' ' LEU . 31.2 m -84.66 130.01 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.504 -0.771 . . . . 73.42 111.153 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -97.32 105.28 17.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.659 -1.238 . . . . 73.05 107.659 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' C' ' 136' ' ' LEU . 57.3 t80 -48.14 -44.93 32.61 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.575 1.15 . . . . 72.34 113.529 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.96 -41.32 91.39 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.484 0.49 . . . . 43.11 110.327 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.486 ' HB1' ' OE1' ' A' ' 12' ' ' GLN . . . -62.93 -38.13 89.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.837 0.855 . . . . 73.24 111.951 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.647 HD11 ' HB ' ' C' ' 131' ' ' VAL . 65.9 mt -64.57 -38.99 92.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.624 0.77 . . . . 73.24 110.646 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -71.58 -42.9 67.22 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.263 -0.88 . . . . 73.22 110.728 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 70.8 mtm -63.74 -50.18 70.11 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.294 0.638 . . . . 74.45 110.678 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -57.55 -36.07 71.16 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.896 0.879 . . . . 73.44 112.025 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -58.61 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.303 0.641 . . . . 64.43 110.011 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.07 -27.96 68.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.863 0.865 . . . . 73.25 112.707 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.27 116.16 18.71 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.41 -0.959 . . . . 72.53 108.41 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.28 154.02 36.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.376 0.67 . . . . 71.14 112.525 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.414 ' HA ' HG21 ' A' ' 10' ' ' THR . 39.8 tt0 -88.45 151.23 22.7 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.241 -0.436 . . . . 52.24 110.249 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.516 ' H ' HG21 ' A' ' 10' ' ' THR . . . -74.28 157.42 35.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.537 0.735 . . . . 60.22 110.216 170.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.63 163.17 53.52 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 114.159 0.424 . . . . 51.53 114.159 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.519 ' HG3' ' HZ ' ' B' ' 32' ' ' PHE . 0.0 OUTLIER -84.44 177.27 8.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.644 0.778 . . . . 74.02 110.939 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.96 168.95 23.1 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.916 -0.584 . . . . 72.01 111.927 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p -77.2 133.24 38.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.635 0.774 . . . . 61.14 111.091 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.503 ' HB3' ' OE1' ' B' ' 33' ' ' GLN . 11.6 tt0 -121.71 149.91 42.56 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.442 1.097 . . . . 71.24 108.676 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -98.17 142.96 29.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.103 0.561 . . . . 72.22 110.944 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -112.1 139.17 47.84 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.986 0.914 . . . . 74.22 108.594 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -149.85 97.27 2.57 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.583 0.706 . . . . 75.54 109.571 -176.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 154' ' ' ASP . . . . . 0.491 ' HB2' HD21 ' B' ' 27' ' ' ASN . 9.4 t70 -135.77 79.01 1.75 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.834 -1.172 . . . . 74.35 107.834 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.046 -0.979 . . . . 37.83 110.117 -179.177 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.826 -0.435 . . . . 34.15 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -119.79 144.98 47.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.686 0.794 . . . . 72.31 109.517 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.83 158.62 32.13 Favored 'General case' 0 C--O 1.241 0.645 0 O-C-N 123.681 0.613 . . . . 62.42 110.143 170.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.57 134.37 54.94 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.497 -0.927 . . . . 71.43 108.497 168.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -126.93 89.87 3.06 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.04 -1.096 . . . . 63.01 108.04 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.55 179.82 5.26 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.306 -0.861 . . . . 72.35 109.305 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -65.18 -9.87 26.72 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.533 0.733 . . . . 51.25 112.126 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.695 ' HA ' ' HG2' ' B' ' 144' ' ' GLN . 1.2 mp0 -51.81 -43.74 63.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.023 0.529 . . . . 74.24 111.976 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.566 ' SD ' HG23 ' D' ' 89' ' ' ILE . 13.3 tpt -33.83 121.29 0.44 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 125.082 1.489 . . . . 72.32 112.878 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m -151.76 143.18 23.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.674 1.19 . . . . 71.44 108.535 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.452 ' CZ ' ' SG ' ' D' ' 102' ' ' CYS . 43.4 t80 -157.31 126.48 5.92 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.658 ' HB3' HG12 ' E' ' 207' ' ' VAL . 47.7 mt-30 -140.08 158.11 44.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.143 0.577 . . . . 74.04 110.205 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.715 HG21 ' H ' ' B' ' 132' ' ' ASN . 10.5 tt -104.39 144.18 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.25 1.02 . . . . 74.52 110.191 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.44 -45.88 3.0 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.382 0.273 . . . . 73.22 111.624 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.433 ' NH1' ' HB2' ' B' ' 129' ' ' ALA . 12.7 tpt180 -169.79 130.75 1.04 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 119.33 -0.367 . . . . 70.31 110.923 -171.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.557 HG12 HD11 ' D' ' 13' ' ' ILE . 32.9 mm -116.73 130.37 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.206 -0.664 . . . . 65.04 109.206 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.09 158.79 39.59 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.741 0.817 . . . . 75.25 111.731 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -88.09 116.35 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.358 -0.608 . . . . 72.53 109.358 172.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.17 -29.13 26.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.109 175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.2 t70 -149.99 137.58 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.114 -0.948 . . . . 65.33 109.746 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.512 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.7 mt -133.57 139.54 48.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.333 -1.358 . . . . 61.34 107.333 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -147.94 112.0 5.17 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.502 0.501 . . . . 44.04 110.012 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.559 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.6 t80 -109.73 122.22 46.99 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 105.674 -1.973 . . . . 71.21 105.674 167.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -132.97 109.28 9.46 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.598 -0.89 . . . . 63.41 108.598 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.73 83.45 4.57 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.75 -0.834 . . . . 52.5 108.75 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.75 -27.61 31.46 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.494 2.129 . . . . 62.31 112.074 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -114.14 35.59 4.09 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 124.588 1.155 . . . . 61.41 109.238 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.57 -58.76 16.74 Favored Pre-proline 0 CA--C 1.576 1.963 0 N-CA-C 114.947 1.462 . . . . 75.13 114.947 -164.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.2 Cg_endo -81.68 -14.31 10.24 Favored 'Trans proline' 0 C--N 1.389 2.708 0 CA-C-N 122.384 1.887 . . . . 62.41 113.027 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -68.67 -42.27 78.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.824 0.85 . . . . 62.12 109.934 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' D' ' 73' ' ' ALA . 1.0 OUTLIER -85.76 -2.37 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.082 -0.963 . . . . 63.52 110.226 -172.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -56.4 -35.37 67.7 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 73.41 111.005 164.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -65.42 -29.06 69.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 71.5 111.146 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.463 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -91.74 74.19 5.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.228 1.011 . . . . 75.01 110.189 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.499 ' O ' ' HD2' ' H' ' 196' ' ' LYS . 11.9 p-10 -87.42 79.46 8.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.079 0.942 . . . . 65.14 109.001 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -134.17 178.16 7.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.139 1.376 . . . . 71.24 108.168 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 59.0 tp60 -75.68 118.38 70.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 118.547 0.612 . . . . 73.32 109.446 170.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.26 109.52 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.225 1.95 . . . . 52.54 111.182 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.49 113.64 3.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.135 -1.061 . . . . 72.4 108.135 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.568 HG13 HG13 ' D' ' 64' ' ' VAL . 97.5 t -95.76 106.2 17.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.616 -0.883 . . . . 75.24 108.616 -172.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.78 110.35 20.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.124 -1.806 . . . . 73.51 106.124 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.669 HD21 ' HA ' ' H' ' 188' ' ' ALA . 3.9 pp -94.66 157.22 16.06 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.04 -1.096 . . . . 72.24 108.04 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 11.4 t70 -146.18 132.37 19.42 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.899 -0.408 . . . . 62.13 109.899 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' H' ' 186' ' ' LEU . 61.2 tp -102.31 130.5 49.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.168 0.987 . . . . 72.43 109.036 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -147.44 150.19 34.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.846 . . . . 53.2 108.914 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.6 t -126.42 159.33 33.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.256 0.622 . . . . 72.13 110.4 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.13 161.64 42.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 75.11 108.958 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 67.5 p -162.31 153.4 17.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.977 0.511 . . . . 64.24 110.936 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -155.47 147.81 23.8 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.717 0.807 . . . . 45.35 109.644 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -82.35 118.08 22.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.274 -0.639 . . . . 73.52 109.274 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.687 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.0 mt -92.66 -33.49 14.35 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.074 -0.343 . . . . 75.24 110.074 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.52 -177.96 2.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.282 1.033 . . . . 75.24 109.809 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.03 124.44 21.6 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.407 0.683 . . . . 53.14 109.977 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 65.0 14.25 9.22 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.036 1.334 . . . . 74.53 112.487 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -119.22 128.9 75.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.624 0.77 . . . . 72.01 109.404 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.35 149.78 50.37 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.848 0.859 . . . . 75.4 109.733 174.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.687 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.9 tt0 -109.38 117.47 34.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.299 -1.371 . . . . 73.42 107.299 163.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.27 129.75 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.528 -1.286 . . . . 73.42 107.528 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 40.7 t -113.19 132.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.67 -0.863 . . . . 62.11 108.67 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -108.62 126.05 52.53 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.949 -1.13 . . . . 63.15 107.949 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 40.7 ttm-85 -101.01 105.06 16.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.211 -1.033 . . . . 72.02 108.211 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.13 120.78 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.586 -1.264 . . . . 52.44 107.586 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.5 m -117.73 147.02 43.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.258 0.623 . . . . 65.11 109.452 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.568 HG13 HG13 ' D' ' 40' ' ' VAL . 69.2 t -133.87 100.57 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.014 1.326 . . . . 70.33 107.822 176.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -91.97 89.96 7.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.594 -2.002 . . . . 62.55 105.594 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' D' ' 74' ' ' PHE . . . -100.0 132.6 45.26 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.895 -1.048 . . . . 54.54 108.389 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.502 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 71.5 m -141.15 137.36 32.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 122.113 0.959 . . . . 73.15 111.814 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 54.8 mt -100.19 100.53 11.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.363 -1.744 . . . . 41.12 109.669 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.1 -123.6 10.68 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.835 -0.621 . . . . 71.22 111.957 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.92 4.21 53.46 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.353 0.661 . . . . 73.43 110.941 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.71 144.74 46.04 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.195 0.598 . . . . 62.41 110.026 -171.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -72.03 128.94 37.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.482 0.488 . . . . 70.33 110.208 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -78.33 -61.09 2.12 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.587 -0.894 . . . . 73.23 108.587 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' D' ' 118' ' ' VAL . 0.5 OUTLIER -159.59 177.62 10.71 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 113.859 -1.519 . . . . 74.12 108.329 171.507 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -134.34 107.47 7.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 73.01 106.447 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.597 ' SG ' HG12 ' D' ' 114' ' ' ILE . 1.9 t -113.77 146.29 40.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.836 0.454 . . . . 63.12 111.763 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.32 136.53 11.88 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.26 1.024 . . . . 73.24 109.158 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.36 116.26 24.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.998 -0.742 . . . . 71.34 108.998 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -91.89 88.21 6.53 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.703 0.764 . . . . 72.14 109.518 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.442 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -82.09 104.19 12.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.239 -1.346 . . . . 74.15 109.034 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.95 155.36 23.03 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.444 -0.662 . . . . 21.34 111.444 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.419 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -159.08 132.03 2.93 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.574 -0.61 . . . . 50.33 111.574 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.51 134.15 28.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 109.141 -0.689 . . . . 73.23 109.141 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.37 148.5 46.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 72.01 110.06 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 30.7 m -90.58 135.54 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.92 0.888 . . . . 65.2 109.138 170.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 5.0 tt -138.08 117.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 123.87 0.868 . . . . 71.41 110.166 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.27 146.29 5.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 44.31 110.103 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.81 0.27 59.04 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 113.737 0.255 . . . . 63.24 113.737 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.566 HG23 ' SD ' ' D' ' 9' ' ' MET . 1.8 pp -103.06 164.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.098 0.959 . . . . 75.54 110.831 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.54 164.21 5.5 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.132 0.895 . . . . 75.51 110.31 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.58 -127.09 38.86 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 115.566 -0.743 . . . . 65.45 113.986 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.6 p -77.1 -27.31 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.777 0.831 . . . . 61.35 111.54 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -48.01 82.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.938 0.895 . . . . 64.25 110.846 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.649 ' SD ' ' HB1' ' H' ' 172' ' ' ALA . 25.3 ptm -68.73 -41.27 79.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.0 -0.545 . . . . 73.21 111.714 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.15 72.25 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.484 0.714 . . . . 73.21 111.104 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -81.16 -37.47 28.72 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.348 -0.842 . . . . 72.0 110.453 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -66.0 -49.79 66.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.166 0.586 . . . . 74.14 111.879 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.821 HD11 HD11 ' H' ' 177' ' ' LEU . 4.5 pp -83.82 -26.32 29.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.541 0.336 . . . . 74.03 111.23 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.31 -27.75 29.63 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.304 0.378 . . . . 64.5 113.447 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -115.76 -60.06 1.92 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.155 0.582 . . . . 75.34 110.469 -174.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.419 ' O ' HG12 ' D' ' 105' ' ' ILE . 86.4 t80 -63.54 -49.61 72.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.733 0.413 . . . . 71.12 111.995 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 60.9 m -58.24 -51.58 80.74 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-O 118.642 -0.694 . . . . 72.23 112.494 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 39.3 Cg_exo -64.91 -32.79 54.26 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 121.66 1.574 . . . . 72.34 112.827 173.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.58 -32.17 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.971 0.508 . . . . 70.41 111.148 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.419 HG12 ' O ' ' D' ' 101' ' ' TYR . 38.2 mm -71.37 -35.68 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.756 0.822 . . . . 72.34 110.997 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' D' ' 80' ' ' GLN . 66.7 mt -75.04 -19.84 59.84 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.399 -0.819 . . . . 64.04 110.827 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -68.32 -42.5 29.35 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.294 1.22 . . . . 62.44 114.294 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -56.15 -40.42 84.96 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.069 1.846 . . . . 73.05 113.401 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -77.96 -35.0 50.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.052 0.941 . . . . 72.44 111.25 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.59 -42.87 77.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.467 0.707 . . . . 65.24 109.841 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.525 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.7 ttp180 -62.43 -46.62 87.7 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.438 -1.255 . . . . 74.14 109.888 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.92 -46.8 89.23 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.963 0.79 . . . . 71.51 110.743 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.426 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.8 t -59.23 -40.98 87.6 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.587 0.555 . . . . 62.32 110.678 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.597 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.8 mt -59.92 -57.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.915 0.486 . . . . 71.3 109.87 171.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 55.9 m -52.53 -44.49 65.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.36 1.464 . . . . 72.41 111.709 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.45 -44.55 78.39 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.528 -1.215 . . . . 44.32 110.07 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.7 mtm -66.01 -38.47 88.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.74 0.416 . . . . 71.32 111.411 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' D' ' 74' ' ' PHE . 98.6 t -62.53 -45.27 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 O-C-N 124.141 0.901 . . . . 62.33 109.795 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -71.45 -32.8 68.75 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.933 0.493 . . . . 74.33 111.03 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -70.08 -27.15 64.38 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.577 0.751 . . . . 74.23 109.949 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.17 11.89 70.8 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.918 0.761 . . . . 53.32 112.83 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.478 HG23 ' HB3' ' C' ' 17' ' ' TYR . 55.8 p 58.26 32.08 21.61 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.863 1.665 . . . . 42.51 113.356 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.431 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 84.9 m-85 -101.92 165.06 14.61 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.233 1.013 . . . . 73.13 108.296 168.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 57.3 Cg_endo -67.41 149.72 80.6 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.487 2.124 . . . . 61.34 112.423 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -59.19 126.92 29.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.294 0.637 . . . . 64.31 111.091 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.472 HD13 HG21 ' D' ' 40' ' ' VAL . 60.4 tp -107.79 96.48 6.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.529 0.732 . . . . 72.22 110.458 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -103.89 95.04 5.75 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.478 -0.564 . . . . 73.12 109.478 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' D' ' 128' ' ' LEU . 0.8 OUTLIER -73.96 134.28 43.1 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.227 -0.657 . . . . 73.31 109.227 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.86 138.53 87.07 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.812 0.845 . . . . 65.42 111.569 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -83.6 103.8 1.1 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.306 2.004 . . . . 53.24 110.889 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -107.71 110.92 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.708 0.766 . . . . 60.1 110.415 -171.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.45 116.41 28.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.045 -0.98 . . . . 71.53 109.648 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.431 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 79.5 m-85 -63.72 -12.38 34.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.269 0.628 . . . . 63.22 111.127 175.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.62 -57.23 13.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.39 1.076 . . . . 60.33 110.962 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.06 85.44 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.589 0.555 . . . . 51.54 111.635 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -70.54 -41.13 72.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.612 0.765 . . . . 63.3 111.61 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -71.71 -54.51 10.08 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 74.22 110.313 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mtm -61.07 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.337 0.655 . . . . 73.13 111.397 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -51.49 -38.02 51.96 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.04 0.936 . . . . 72.42 111.938 175.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -77.33 -42.23 37.5 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.597 0.759 . . . . 74.44 110.826 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.39 -29.87 47.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.03 0.752 . . . . 73.32 113.03 -171.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -89.07 30.34 0.96 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.098 0.559 . . . . 64.42 111.677 -172.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -119.72 51.35 1.18 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.192 0.997 . . . . 71.21 108.886 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -163.93 10.8 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.957 -1.02 . . . . 71.42 111.093 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.72 -54.69 2.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.547 0.739 . . . . 74.44 110.379 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.14 -122.08 6.3 Favored Glycine 0 C--O 1.239 0.451 0 CA-C-N 115.001 -1.0 . . . . 74.11 111.558 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.48 138.96 40.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.249 -1.019 . . . . 65.33 108.249 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.32 -124.97 0.21 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.73 0.644 . . . . 42.42 112.342 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 91.1 m -153.68 145.45 23.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.843 0.857 . . . . 52.53 109.246 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.33 119.96 7.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.665 0.786 . . . . 71.21 110.529 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.69 123.75 18.81 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.344 1.028 . . . . 53.42 109.317 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -62.55 141.25 58.53 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.856 0.723 . . . . 54.24 110.139 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -59.92 103.03 0.18 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.417 1.087 . . . . 75.11 109.406 -177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.82 151.32 35.95 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.692 0.797 . . . . 74.34 111.065 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.389 0 C-N-CA 123.995 0.918 . . . . 61.14 109.393 179.159 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 23.8 pttm . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 122.215 1.007 . . . . 71.01 110.056 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.7 -16.12 79.24 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.61 -1.177 . . . . 72.23 112.719 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 62.07 -162.45 0.28 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.983 1.313 . . . . 72.42 111.653 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 18.9 m -49.98 104.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 75.14 111.896 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.85 -59.3 1.95 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 75.4 110.325 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.88 145.57 13.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.102 0.561 . . . . 61.45 110.274 -174.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' C' ' 54' ' ' ASP . 0.1 OUTLIER -122.26 131.82 54.11 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 122.3 -0.25 . . . . 75.22 111.007 -176.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 56.6 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.084 1.754 . . . . 73.33 114.314 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -159.72 90.77 0.94 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.085 -1.45 . . . . 74.03 107.085 165.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.02 83.37 2.88 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.166 -0.925 . . . . 75.42 108.662 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -90.25 -158.62 0.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.81 -1.086 . . . . 73.43 109.166 170.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 73.76 137.67 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.64 1.176 . . . . 63.23 111.341 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 180' ' ' PRO . . . . . 0.488 ' HG3' ' HB3' ' A' ' 153' ' ' GLN . 29.7 Cg_endo -60.44 -43.54 33.18 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.478 2.119 . . . . 61.34 111.56 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 181' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' C' ' 96' ' ' HIS . 0.8 OUTLIER 64.55 -169.83 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.557 1.143 . . . . 71.12 111.04 -171.882 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -128.18 168.34 15.57 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.323 -0.992 . . . . 65.44 108.323 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 25.8 m -63.79 -18.94 64.6 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.817 0.847 . . . . 74.13 112.622 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 67.84 89.65 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.216 1.406 . . . . 71.13 108.746 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 185' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' C' ' 136' ' ' LEU . 51.2 Cg_exo -57.25 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.223 2.616 . . . . 71.01 114.085 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.93 125.34 33.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.81 -0.811 . . . . 71.52 108.81 172.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 31.5 pt -71.3 167.73 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.517 0.727 . . . . 55.52 111.255 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.05 128.28 54.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.134 -1.062 . . . . 70.22 108.134 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -99.58 -19.33 16.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.595 0.358 . . . . 52.52 111.34 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 190' ' ' ASP . . . . . 0.421 ' O ' HG23 ' C' ' 40' ' ' VAL . 2.6 m-20 59.05 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.806 1.242 . . . . 72.42 112.192 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.62 -35.65 2.3 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.423 -1.071 . . . . 74.23 110.423 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.52 -83.67 0.2 Allowed Glycine 0 C--N 1.35 1.346 0 O-C-N 124.304 0.649 . . . . 52.54 113.826 171.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -166.81 107.05 0.63 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.898 0.879 . . . . 63.24 108.839 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 194' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' E' ' 195' ' ' PHE . . . -172.09 123.0 0.49 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 60.1 109.858 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 195' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' E' ' 194' ' ' ALA . 0.6 OUTLIER 170.36 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.257 -1.386 . . . . 64.35 107.257 171.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 196' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' F' ' 190' ' ' ASP . 3.3 tppp? 67.08 106.03 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.407 1.483 . . . . 71.33 113.634 169.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.77 -168.37 1.77 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.919 1.287 . . . . 74.15 108.802 167.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 58.93 83.35 0.13 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.223 1.009 . . . . 72.3 109.519 -175.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 199' ' ' ASN . . . . . 0.595 ' HA ' ' HA ' ' E' ' 205' ' ' LYS . 38.6 t30 64.01 -73.9 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.012 1.325 . . . . 75.15 110.827 -170.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.4 79.4 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.517 -0.765 . . . . 64.14 112.722 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.1 17.82 7.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.236 1.014 . . . . 73.35 111.416 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.61 150.54 21.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.277 -1.009 . . . . 73.52 108.277 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.26 -13.24 57.9 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.295 0.638 . . . . 75.14 111.792 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.486 HG23 HG23 ' E' ' 207' ' ' VAL . 9.3 mt -57.37 -61.54 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.458 1.103 . . . . 71.24 110.47 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 205' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' E' ' 199' ' ' ASN . 77.0 mttt 60.84 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.292 1.037 . . . . 74.0 110.968 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.76 -30.59 1.82 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.596 1.159 . . . . 72.34 109.243 173.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.658 HG12 ' HB3' ' D' ' 12' ' ' GLN . 2.9 t . . . . . 0 C--O 1.254 1.337 0 C-N-CA 126.2 1.8 . . . . 64.43 109.099 -168.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.52 -0.548 . . . . 61.43 109.52 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -155.85 73.64 0.24 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.751 -0.939 . . . . 74.11 110.751 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -105.47 172.67 6.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.841 0.856 . . . . 70.32 110.129 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -81.06 -159.25 0.24 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.538 -0.912 . . . . 64.3 108.538 164.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.55 61.97 4.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.622 -0.674 . . . . 64.23 109.698 171.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -132.91 123.83 26.73 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.406 -1.331 . . . . 75.13 107.406 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.99 142.79 6.21 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.481 -1.236 . . . . 32.15 108.456 -172.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.28 103.09 2.15 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.129 -1.063 . . . . 71.04 108.129 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.62 -76.3 0.6 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.885 -0.783 . . . . 75.1 108.885 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 177' ' ' LEU . . . . . 0.414 HD13 HD21 ' B' ' 98' ' ' LEU . 32.1 tp 55.64 27.8 11.06 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.545 1.138 . . . . 74.12 110.796 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -104.07 -24.73 13.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.899 -1.046 . . . . 62.02 110.763 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.62 142.75 28.18 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 124.867 1.267 . . . . 72.21 109.185 -174.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.06 98.87 0.74 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.777 2.318 . . . . 64.0 110.954 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -60.35 -42.73 96.34 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.515 -0.766 . . . . 73.44 110.499 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.341 -0.845 . . . . 73.51 109.826 171.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 26.4 m 60.75 84.87 0.12 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.446 1.098 . . . . 73.53 110.341 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -69.8 121.09 81.49 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.406 0.682 . . . . 70.33 111.02 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -70.44 106.51 1.8 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.795 2.33 . . . . 74.32 111.454 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.81 120.5 21.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.11 -0.495 . . . . 61.3 110.07 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.428 ' H ' HD13 ' F' ' 187' ' ' ILE . 0.2 OUTLIER -64.54 171.39 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.474 1.11 . . . . 73.34 111.362 172.065 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.37 -91.72 0.46 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.922 0.489 . . . . 73.34 110.874 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -176.44 112.46 0.1 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.538 -1.282 . . . . 63.32 107.538 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 190' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' E' ' 196' ' ' LYS . 31.7 t70 -74.31 90.91 2.15 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 120.803 0.335 . . . . 64.03 110.554 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 70.38 -172.34 41.93 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.062 -0.972 . . . . 65.44 114.147 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.33 129.02 1.33 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.522 -0.631 . . . . 31.12 111.522 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.68 28.77 8.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.928 0.891 . . . . 73.43 109.255 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.4 -0.28 28.53 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.919 0.888 . . . . 70.04 111.936 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' F' ' 201' ' ' LYS . 42.8 t80 -137.87 135.1 35.83 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.637 0.775 . . . . 74.41 109.215 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.08 115.9 1.35 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.553 1.158 . . . . 74.12 108.462 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.98 145.03 56.87 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.595 0.56 . . . . 73.14 110.533 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 79.46 -45.86 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.914 1.685 . . . . 73.42 111.057 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -61.68 -54.53 41.5 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.604 1.162 . . . . 72.33 111.272 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.13 -171.96 20.85 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 111.36 -0.696 . . . . 73.22 111.36 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 201' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' F' ' 195' ' ' PHE . 43.2 mtmt 69.91 106.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.983 1.313 . . . . 75.03 110.593 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 202' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' C' ' 124' ' ' PRO . 21.6 m-30 56.11 21.12 4.88 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 124.27 1.028 . . . . 74.51 111.597 -172.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -138.39 151.1 47.19 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.205 -1.361 . . . . 71.43 108.05 -172.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.487 HG21 ' O ' ' A' ' 14' ' ' GLN . 8.2 tp -65.75 -37.02 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.404 -1.271 . . . . 62.32 111.429 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.11 147.93 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.108 1.363 . . . . 73.0 109.269 -165.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.2 85.71 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.293 0.568 . . . . 72.32 110.465 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.246 0.905 0 C-N-CA 123.658 0.783 . . . . 63.42 109.409 -179.308 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.438 0.161 . . . . 74.05 110.632 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' G' G ' 169' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 4' ' ' GLN . . . -87.34 -132.4 3.59 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.089 -0.505 . . . . 42.41 114.096 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -148.09 -88.07 0.09 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.611 0.764 . . . . 74.32 110.002 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 59.3 p -178.4 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.879 0.872 . . . . 71.13 110.091 -167.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -138.96 71.75 1.39 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.921 0.888 . . . . 72.54 109.297 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' G' ' 173' ' ' LEU . 10.6 mt -154.72 143.62 20.9 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.944 -1.025 . . . . 74.11 109.196 171.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.492 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 34.8 mmt 55.62 64.63 1.69 Allowed 'General case' 0 C--O 1.243 0.736 0 O-C-N 124.493 1.121 . . . . 44.51 110.525 -175.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 55.98 -94.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 112.584 -2.098 . . . . 55.52 109.679 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 65.0 t30 55.89 28.53 12.67 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.7 1.2 . . . . 71.41 112.015 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.67 86.25 0.21 Allowed 'General case' 0 C--N 1.358 0.939 0 N-CA-C 108.699 -0.852 . . . . 63.52 108.699 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -64.97 -54.21 34.12 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 109.049 -0.723 . . . . 71.53 109.049 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.93 138.1 26.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.845 -1.07 . . . . 73.33 108.51 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.66 -6.0 17.98 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.849 2.366 . . . . 74.12 113.274 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 67.78 -75.9 0.06 Allowed 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.608 1.563 . . . . 73.24 110.439 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.87 179.95 6.93 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.042 0.937 . . . . 72.44 110.997 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 20.6 m -128.49 159.69 34.65 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.033 0.933 . . . . 64.04 108.544 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -97.99 105.15 25.91 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.498 0.719 . . . . 75.1 110.608 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.12 -58.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.332 2.021 . . . . 62.31 112.621 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 186' ' ' LEU . . . . . 0.596 HD11 HD22 ' A' ' 44' ' ' LEU . 6.7 mp 60.83 176.71 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.299 1.44 . . . . 62.31 111.569 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.679 ' HA ' ' HB2' ' H' ' 206' ' ' ASP . 36.0 pt -68.99 150.86 10.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.052 -0.522 . . . . 72.34 110.575 171.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.7 -2.14 28.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.529 -0.76 . . . . 71.52 112.007 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . 66.61 -76.22 0.05 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.799 1.64 . . . . 64.24 110.986 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -57.81 131.02 49.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.116 0.966 . . . . 63.32 111.798 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.24 21.19 9.44 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.006 -0.543 . . . . 54.45 111.771 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.51 -50.69 4.07 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 123.044 0.354 . . . . 54.24 112.725 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -87.78 46.26 1.36 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.039 0.935 . . . . 75.23 110.125 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 194' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 38' ' ' PRO . . . -80.3 81.57 6.52 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.573 -0.739 . . . . 74.21 110.034 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.484 ' HB3' ' NE1' ' A' ' 36' ' ' TRP . 2.0 m-30 68.32 153.55 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.73 1.212 . . . . 71.25 113.26 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -163.89 139.45 6.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.466 0.706 . . . . 55.45 110.129 170.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' G' G ' 197' ' ' TYR . . . . . 0.432 ' H ' ' HB3' ' A' ' 36' ' ' TRP . 2.6 m-30 -78.06 155.55 30.56 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.306 0.574 . . . . 63.33 110.651 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -114.13 147.21 39.19 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.893 -1.049 . . . . 75.35 108.171 172.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.65 24.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.495 0.924 . . . . 71.21 113.495 -168.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.7 -42.31 62.38 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.65 -0.528 . . . . 72.24 113.468 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 74.16 -38.73 0.4 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.606 1.563 . . . . 55.44 113.731 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 56.8 t80 68.67 66.76 0.3 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.801 1.241 . . . . 74.12 110.063 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -103.69 138.27 40.57 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.679 -1.146 . . . . 72.33 109.001 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.412 HD13 HE22 ' B' ' 12' ' ' GLN . 3.4 mp -97.4 -70.04 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 107.779 -1.193 . . . . 70.43 107.779 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 176.11 -71.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.275 1.83 . . . . 74.41 107.187 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.92 -79.92 0.13 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.676 1.19 . . . . 71.15 108.586 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 CA--C 1.565 1.55 0 C-N-CA 124.231 1.012 . . . . 70.23 108.646 -173.741 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 109.537 -0.542 . . . . 72.2 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 162.83 -152.64 22.9 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.758 -0.937 . . . . 73.01 110.758 -174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -111.98 -79.64 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.067 0.547 . . . . 71.42 110.014 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.8 t -169.47 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.341 0.656 . . . . 71.54 109.729 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.649 ' HB1' ' SD ' ' D' ' 94' ' ' MET . . . -139.91 114.77 9.53 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.993 0.517 . . . . 63.22 111.445 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 32.8 mt -135.56 -49.69 0.72 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.61 1.164 . . . . 63.2 109.21 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.52 166.02 20.66 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.716 -0.674 . . . . 74.04 109.822 173.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -49.57 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.807 1.643 . . . . 74.43 111.958 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -89.98 -81.79 0.28 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.955 0.902 . . . . 74.15 109.696 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 177' ' ' LEU . . . . . 0.821 HD11 HD11 ' D' ' 98' ' ' LEU . 6.0 mp 55.99 34.51 23.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.6 1.16 . . . . 64.54 111.579 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -62.18 -48.32 80.59 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.841 0.856 . . . . 64.23 111.21 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -80.02 140.4 53.75 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 115.846 -0.615 . . . . 73.3 110.297 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.26 99.98 0.25 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.528 2.152 . . . . 75.11 110.788 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -78.24 81.8 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.069 -0.514 . . . . 75.41 110.069 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 55.88 -99.88 0.1 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.718 1.207 . . . . 75.31 111.194 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 183' ' ' THR . . . . . 0.588 HG23 ' HD3' ' H' ' 185' ' ' PRO . 15.3 t -178.08 -36.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.627 1.171 . . . . 73.13 109.461 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 36.09 76.17 0.46 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 126.443 1.897 . . . . 74.35 114.213 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 185' ' ' PRO . . . . . 0.588 ' HD3' HG23 ' H' ' 183' ' ' THR . 93.4 Cg_endo -77.27 141.75 20.75 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.464 2.11 . . . . 74.35 112.566 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 186' ' ' LEU . . . . . 0.437 ' HB2' HD22 ' D' ' 44' ' ' LEU . 5.7 tt -81.86 136.52 35.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.827 -1.175 . . . . 64.12 107.827 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.9 164.02 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.436 0.695 . . . . 73.1 112.282 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 188' ' ' ALA . . . . . 0.669 ' HA ' HD21 ' D' ' 42' ' ' LEU . . . -107.61 -178.71 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.181 0.592 . . . . 71.14 110.952 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.26 86.41 1.55 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.464 0.705 . . . . 70.34 109.425 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.96 105.22 15.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.19 -1.041 . . . . 71.33 108.19 171.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.93 -164.98 35.62 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 123.628 0.58 . . . . 63.1 112.455 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.35 171.9 45.88 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 112.024 -0.431 . . . . 65.53 112.024 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.526 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 43.4 t80 -176.87 98.35 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.373 -1.343 . . . . 70.43 107.373 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.91 102.94 0.31 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.115 0.966 . . . . 70.03 109.63 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.425 ' CD1' ' HD3' ' D' ' 124' ' ' PRO . 32.6 t80 -178.28 -13.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.989 0.916 . . . . 64.35 110.86 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 196' ' ' LYS . . . . . 0.499 ' HD2' ' O ' ' D' ' 35' ' ' ASP . 2.0 mmmp? -51.27 115.0 1.37 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.325 1.05 . . . . 74.1 111.531 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 197' ' ' TYR . . . . . 0.43 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 36.4 m-85 -84.16 -177.17 6.57 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.425 1.09 . . . . 74.21 110.671 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -138.69 160.16 40.32 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.769 -0.65 . . . . 63.23 109.531 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.71 143.52 31.8 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.327 -0.851 . . . . 70.05 109.746 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.79 2.87 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.608 -0.551 . . . . 64.15 113.05 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 77.8 tttt 64.84 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.364 1.213 0 C-N-CA 124.861 1.264 . . . . 75.3 109.318 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.57 141.13 31.95 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.407 1.483 . . . . 74.12 107.046 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -101.15 100.69 11.28 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.752 -0.462 . . . . 54.52 109.752 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.3 90.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.525 0.73 . . . . 73.23 109.438 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -94.01 -29.7 15.09 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.791 -1.095 . . . . 75.15 109.521 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 206' ' ' ASP . . . . . 0.679 ' HB2' ' HA ' ' G' ' 187' ' ' ILE . 4.2 m-20 -99.99 129.7 46.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.614 -1.175 . . . . 54.12 111.062 -166.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.251 1.152 0 N-CA-C 106.363 -1.717 . . . . 74.13 106.363 165.453 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 111.207 0.077 . . . . 75.51 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -126.46 -27.67 3.14 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.27 0.47 . . . . 73.11 112.27 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -76.54 113.5 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.878 0.37 . . . . 74.1 110.959 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -114.83 130.25 56.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 61.0 108.636 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -114.44 136.19 53.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.981 0.512 . . . . 61.22 111.16 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -169.56 113.09 0.51 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.806 1.242 . . . . 74.24 108.661 170.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -141.67 -52.56 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.149 -1.056 . . . . 74.33 108.149 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -84.43 169.25 14.75 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.702 -1.135 . . . . 74.21 108.33 166.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -171.33 134.19 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.082 0.553 . . . . 72.03 110.348 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -156.69 135.6 11.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.255 1.022 . . . . 63.14 109.618 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.543 ' HB3' ' SD ' ' C' ' 138' ' ' MET . 50.5 t80 -136.32 136.96 40.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 75.1 108.72 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -151.18 125.88 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.864 -0.153 . . . . 73.4 110.965 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -76.26 132.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.44 108.385 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 79.6 mm-40 -103.85 -38.61 6.96 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 123.88 0.737 . . . . 72.13 109.906 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -168.94 141.84 2.78 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 112.074 0.398 . . . . 75.01 112.074 -171.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.455 HD13 ' CD2' ' A' ' 109' ' ' TYR . 74.4 mt -106.71 142.47 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 124.932 1.293 . . . . 63.53 107.516 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.411 ' HE1' HG13 ' A' ' 83' ' ' ILE . 15.3 p90 -166.21 146.22 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.723 0.773 . . . . 75.43 111.003 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 p -88.46 105.06 17.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.845 -1.07 . . . . 73.11 109.321 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.1 mtpt -76.06 -28.21 57.54 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.857 -0.423 . . . . 74.13 109.857 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.3 t70 -148.77 130.77 15.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.87 -1.059 . . . . 73.12 109.67 174.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -122.84 136.36 59.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 105.983 -1.858 . . . . 65.43 105.983 167.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.82 108.26 3.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.831 0.348 . . . . 72.35 110.649 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.727 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.9 t80 -109.83 131.0 55.46 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.035 -1.468 . . . . 64.01 107.035 171.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.62 131.6 41.58 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.441 -0.948 . . . . 53.13 108.441 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -146.8 72.67 12.51 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.913 -0.773 . . . . 64.2 108.913 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.44 -13.22 25.2 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.509 2.139 . . . . 73.24 111.853 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -118.04 25.53 10.28 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.762 0.825 . . . . 74.23 109.296 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.37 -46.47 99.8 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.166 0.987 . . . . 72.14 112.898 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.03 -18.08 18.96 Favored 'Trans proline' 0 C--N 1.391 2.812 0 CA-C-N 120.933 1.369 . . . . 51.33 113.208 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.95 -18.99 61.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.249 0.62 . . . . 73.42 111.938 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 8.6 p -64.69 -18.39 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 112.783 0.66 . . . . 44.43 112.783 -176.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -71.45 -40.32 70.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.965 0.506 . . . . 65.0 110.604 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -86.68 -19.54 29.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.658 -0.701 . . . . 74.3 110.713 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 29.8 mmmt -81.97 151.0 27.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.12 0.568 . . . . 74.11 111.29 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.717 ' HB3' ' HE1' ' G' ' 193' ' ' TYR . 9.5 m-20 -80.5 124.01 28.57 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.931 -1.031 . . . . 54.43 108.714 168.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.477 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.4 t-105 -76.13 87.42 3.01 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.115 0.483 . . . . 75.15 110.54 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.86 80.66 70.63 Favored Pre-proline 0 C--O 1.245 0.837 0 C-N-CA 124.505 1.122 . . . . 74.24 108.035 169.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' G' ' 192' ' ' GLY . 94.3 Cg_endo -79.45 129.41 8.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.269 1.979 . . . . 62.41 111.804 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.79 84.17 3.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 105.626 -1.99 . . . . 74.35 105.626 172.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -77.19 93.85 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.344 -1.298 . . . . 55.04 109.854 -172.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.88 116.11 23.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 113.976 -1.466 . . . . 61.54 110.867 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD23 HD23 ' A' ' 128' ' ' LEU . 6.6 mp -97.38 106.94 19.34 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.45 -1.25 . . . . 70.42 107.882 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.2 t70 -107.47 147.26 30.7 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.793 1.237 . . . . 63.15 109.364 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -129.8 137.61 50.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.013 0.925 . . . . 70.4 109.528 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -144.41 145.8 32.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.31 0.644 . . . . 72.33 109.485 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.8 m -107.19 125.93 51.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.619 0.768 . . . . 72.13 110.032 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.78 138.32 45.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.999 0.92 . . . . 55.24 108.825 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -135.65 162.46 32.67 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.434 0.693 . . . . 74.03 110.341 172.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 t -161.34 123.27 2.97 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.047 0.939 . . . . 72.01 108.661 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.08 146.26 39.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.812 -0.44 . . . . 62.2 109.812 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 57' ' ' GLU . 49.9 mt -117.35 -34.92 4.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.507 0.723 . . . . 74.31 111.355 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.1 -175.28 5.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.987 0.915 . . . . 75.51 109.441 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.09 121.13 17.72 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.735 -0.839 . . . . 73.44 108.735 173.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.94 9.86 7.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.388 1.475 . . . . 70.51 113.013 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 71.1 t -124.12 122.24 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.152 -1.055 . . . . 64.44 108.152 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -140.84 170.47 15.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.998 -0.741 . . . . 74.32 108.998 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' A' ' 51' ' ' LEU . 23.0 tt0 -126.51 140.08 52.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.174 0.99 . . . . 74.31 108.75 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -117.48 124.86 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 107.138 -1.43 . . . . 74.54 107.138 164.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -98.29 127.04 51.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 172.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.86 109.47 21.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.843 -1.54 . . . . 60.13 106.843 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -98.52 100.33 11.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.267 -1.012 . . . . 74.34 108.267 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.81 117.14 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.582 -1.19 . . . . 44.3 108.756 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.1 m -112.74 128.01 56.3 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.55 -0.537 . . . . 71.12 109.55 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 25.2 t -120.28 107.54 21.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 107.948 -1.13 . . . . 63.2 107.948 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.0 m -102.16 141.35 35.14 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.318 -0.993 . . . . 71.22 108.318 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.19 106.88 10.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.068 -1.086 . . . . 63.21 108.068 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -108.97 125.96 52.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.049 0.54 . . . . 63.22 110.467 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD21 ' CE3' ' A' ' 36' ' ' TRP . 46.7 mt -88.46 62.33 6.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.47 -1.307 . . . . 73.55 107.47 171.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.39 1.32 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.57 -1.196 . . . . 43.4 111.371 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.01 -20.26 27.47 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.969 0.908 . . . . 75.14 111.161 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -109.2 118.86 37.82 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.351 -0.611 . . . . 75.3 109.351 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -73.18 130.17 39.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.559 0.618 . . . . 73.4 110.129 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.75 4.19 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.78 -0.822 . . . . 53.1 108.78 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.19 168.6 26.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.167 -1.379 . . . . 54.23 110.558 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.4 116.91 11.36 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.545 1.138 . . . . 73.05 108.733 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.4 m -104.31 138.82 40.19 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 124.319 1.048 . . . . 75.35 108.893 172.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -148.04 117.33 6.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.255 -1.017 . . . . 74.3 108.255 171.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -122.81 111.48 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 109.316 -0.624 . . . . 73.14 109.316 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.0 mt-30 -86.42 82.19 8.05 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.89 -1.05 . . . . 74.23 108.732 170.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' HG3' HD22 ' A' ' 106' ' ' LEU . 45.3 tp60 -77.96 95.63 4.85 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.358 -1.292 . . . . 61.15 109.405 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.14 154.53 29.02 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 112.057 -0.417 . . . . 51.52 112.057 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.57 131.8 3.0 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 112.136 -0.385 . . . . 52.04 112.136 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 37.0 mt -81.6 128.28 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.446 -0.946 . . . . 64.35 108.446 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.38 154.32 48.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -119.26 119.44 34.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.649 1.18 . . . . 64.41 108.051 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 89' ' ' ILE . 2.9 pp -122.17 158.79 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.019 0.438 . . . . 73.2 111.098 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 151.91 8.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.591 -1.186 . . . . 64.53 109.094 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.23 83.82 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 115.26 0.864 . . . . 73.45 115.26 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.481 HD11 HD13 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -115.88 136.58 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.538 0.669 . . . . 75.55 110.357 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -144.75 172.37 13.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.836 0.455 . . . . 61.31 111.54 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -120.67 23.77 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.899 -0.591 . . . . 71.11 113.31 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.7 p -79.58 -16.38 55.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.779 0.832 . . . . 71.0 111.832 -174.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.75 -42.43 90.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.767 0.827 . . . . 74.21 109.263 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 98' ' ' LEU . 43.5 tpp -67.1 -38.37 85.55 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.976 -1.011 . . . . 75.11 110.509 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.44 81.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.704 0.802 . . . . 51.34 111.969 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -84.17 -36.67 22.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.766 0.426 . . . . 63.43 111.095 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -71.95 -64.73 0.88 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.703 0.401 . . . . 65.12 110.669 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.417 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 7.4 tt -68.42 -34.54 76.18 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 72.1 110.324 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -5.59 78.19 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 119.077 -0.846 . . . . 44.13 114.968 -172.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.84 -55.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.534 1.167 . . . . 63.14 112.742 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 81.1 t80 -68.9 -45.74 70.14 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.882 0.697 . . . . 73.41 112.882 -169.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -73.58 -37.42 3.53 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.05 0.54 . . . . 53.34 112.315 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -48.84 -33.68 26.05 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.503 2.136 . . . . 71.15 113.901 162.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.19 -16.55 64.03 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.576 0.75 . . . . 75.43 111.991 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.409 HG23 HD21 ' C' ' 132' ' ' ASN . 47.7 mm -74.63 -44.3 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 122.002 0.906 . . . . 61.41 109.639 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.493 HD22 ' HG3' ' A' ' 80' ' ' GLN . 89.0 mt -85.74 -19.26 31.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.164 -1.38 . . . . 73.54 112.33 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.44 -44.24 25.04 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.215 -0.898 . . . . 73.35 112.483 -173.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.37 -35.26 98.87 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 121.996 1.797 . . . . 63.11 113.062 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.455 ' CD2' HD13 ' A' ' 16' ' ' ILE . 27.7 m-85 -82.77 -31.81 28.1 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.107 0.78 . . . . 71.5 113.107 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 -47.84 61.28 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.515 -0.92 . . . . 72.44 108.515 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -46.74 -59.7 2.87 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 125.331 1.644 . . . . 74.24 109.559 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.7 tm-20 -64.24 -38.35 90.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.433 1.083 . . . . 64.15 111.895 -172.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 117' ' ' MET . 44.8 t -62.12 -46.43 89.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.659 0.384 . . . . 71.12 110.471 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 118' ' ' VAL . 34.1 mt -62.33 -47.19 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.882 0.873 . . . . 72.24 110.13 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.592 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.5 m -55.68 -42.77 75.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.097 1.359 . . . . 61.33 110.71 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -68.87 -39.18 79.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.583 -1.189 . . . . 71.43 110.321 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -66.79 -35.56 80.36 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.425 0.29 . . . . 74.22 111.299 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -66.37 -40.09 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.478 0.711 . . . . 72.24 110.292 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.6 p -73.47 -34.3 65.28 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.36 -0.382 . . . . 62.23 111.259 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.12 -23.98 63.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.512 0.725 . . . . 71.22 110.261 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 31.04 3.55 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 123.743 0.687 . . . . 61.45 113.522 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 14.7 t 58.68 15.96 4.06 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.943 2.097 . . . . 71.21 114.683 173.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' SER . 42.0 m-85 -123.49 159.82 53.5 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.174 0.589 . . . . 74.4 111.066 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.61 135.63 57.91 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.447 2.098 . . . . 75.32 110.141 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 3.4 pt20 -57.84 153.27 14.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.064 0.946 . . . . 71.24 111.709 -174.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.18 112.17 24.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.162 -1.051 . . . . 61.34 108.162 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -97.31 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.316 -0.994 . . . . 64.03 108.316 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.443 HD23 HD23 ' A' ' 42' ' ' LEU . 5.8 mp -69.0 142.12 54.72 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.744 -0.662 . . . . 75.1 109.622 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.1 74.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 122.704 0.401 . . . . 50.43 110.453 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.455 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 16.8 Cg_exo -68.05 124.78 12.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.459 2.106 . . . . 75.23 109.995 170.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.0 m -97.12 111.9 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 122.077 0.942 . . . . 74.25 108.951 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.91 86.46 2.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.167 -1.378 . . . . 65.24 109.396 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -51.78 -37.62 52.23 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.148 1.379 . . . . 73.24 112.951 -171.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.55 -47.51 47.64 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.294 -0.867 . . . . 65.51 110.996 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.27 -20.18 60.23 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 116.034 -0.53 . . . . 63.3 110.972 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.53 -35.47 60.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.028 0.931 . . . . 72.21 109.017 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.02 -45.36 87.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.835 0.854 . . . . 75.41 109.877 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 84.1 mmm -74.52 -29.49 61.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.752 -0.658 . . . . 73.43 111.163 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -70.0 -27.13 64.44 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.643 0.777 . . . . 75.54 110.552 174.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -81.27 -38.21 27.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.245 -0.65 . . . . 70.1 109.245 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.86 -47.43 74.96 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.099 0.959 . . . . 64.23 110.75 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.69 10.85 0.96 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.388 0.275 . . . . 54.34 111.043 -171.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 71.19 149.72 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.134 0.973 . . . . 60.24 111.734 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -77.51 171.71 14.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.125 0.57 . . . . 70.34 111.24 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.85 149.48 21.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.434 0.693 . . . . 64.44 109.906 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.97 152.07 6.32 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 110.844 -0.903 . . . . 64.3 110.844 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -138.27 114.21 9.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.441 0.696 . . . . 71.13 109.331 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.0 151.58 27.51 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.375 -0.69 . . . . 75.03 111.375 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.9 p -116.23 160.53 20.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.842 0.857 . . . . 74.42 109.342 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -112.28 52.8 0.75 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.602 0.715 . . . . 63.51 109.11 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.673 ' HG3' ' HG2' ' E' ' 170' ' ' LYS . 61.0 mm-40 -81.85 85.24 6.69 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.461 -0.79 . . . . 74.12 110.391 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -112.42 113.12 25.14 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.547 -1.279 . . . . 74.15 107.547 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -59.44 -43.15 93.2 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.331 0.586 . . . . 74.12 109.863 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -164.14 -62.02 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.577 -1.192 . . . . 74.32 108.329 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 CA-C-N 114.771 -1.104 . . . . 51.5 108.654 -179.912 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' B' ' 1' ' ' MET . 2.7 mpp? . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 109.484 -0.561 . . . . 55.43 109.484 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -169.51 11.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.634 1.174 . . . . 73.1 110.974 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.0 168.35 10.32 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.316 0.487 . . . . 75.4 112.316 -169.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -83.84 123.48 29.95 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.854 -0.612 . . . . 72.41 111.017 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -148.37 167.13 26.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.182 0.593 . . . . 74.03 110.522 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -124.93 148.5 48.32 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.053 0.941 . . . . 73.42 108.748 172.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -162.99 178.4 8.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.581 0.752 . . . . 72.0 110.346 -175.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -72.33 -27.69 62.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.298 1.039 . . . . 74.24 111.1 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ptm 55.48 -173.61 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.434 1.893 . . . . 72.24 114.158 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -132.45 102.57 5.78 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.534 1.134 . . . . 61.31 107.982 173.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.615 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 31.5 t80 -122.07 134.82 54.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.69 -0.855 . . . . 73.32 108.69 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' G' ' 204' ' ' ILE . 0.8 OUTLIER -165.87 141.45 4.93 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.79 0.681 . . . . 72.14 109.248 178.296 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.616 HD13 HD11 ' B' ' 16' ' ' ILE . 78.4 mt -86.22 121.05 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.93 0.492 . . . . 72.51 110.326 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -80.65 -36.72 32.14 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.662 0.601 . . . . 73.04 111.249 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -171.32 142.44 1.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.994 0.518 . . . . 65.23 109.949 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.616 HD11 HD13 ' B' ' 13' ' ' ILE . 90.1 mt -121.26 140.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.911 -1.144 . . . . 74.33 107.911 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 31.5 p90 -165.53 152.23 10.07 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.896 0.747 . . . . 74.21 111.079 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -75.42 123.98 26.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.262 -1.014 . . . . 72.34 108.262 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -92.54 -37.11 12.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.988 0.515 . . . . 74.22 109.679 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.0 t70 -148.84 147.96 29.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.531 -0.759 . . . . 75.54 110.712 -170.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.479 HD13 HG13 ' B' ' 78' ' ' VAL . 36.7 mm -143.11 143.41 24.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.504 1.521 . . . . 72.12 107.79 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 55.6 m -149.09 131.73 15.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.203 -0.908 . . . . 63.34 108.706 168.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -140.08 106.95 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.228 -1.768 . . . . 74.33 106.228 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.52 110.6 15.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.665 -0.865 . . . . 75.44 108.665 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 74' ' ' PHE . . . -108.42 88.56 5.11 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.499 1.12 . . . . 73.41 109.205 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.68 -30.21 59.94 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.084 2.523 . . . . 74.13 112.374 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -118.45 31.39 6.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 71.22 110.22 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.63 -52.24 32.11 Favored Pre-proline 0 CA--C 1.572 1.799 0 C-N-CA 125.327 1.451 . . . . 75.14 113.648 173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 96.0 Cg_endo -77.7 -12.57 16.57 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.814 1.676 . . . . 70.4 113.142 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -86.98 1.12 53.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.897 0.879 . . . . 74.52 111.803 -175.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.13 -14.03 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 123.653 0.781 . . . . 73.34 110.334 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -65.76 -41.27 92.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.798 0.439 . . . . 73.03 110.266 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -47.27 12.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.327 -0.62 . . . . 73.54 109.327 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.38 67.82 9.57 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.12 -1.067 . . . . 75.41 108.12 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.21 75.56 9.13 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.432 -1.258 . . . . 63.12 111.442 -168.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -177.27 172.44 1.89 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.255 -1.339 . . . . 62.22 108.216 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.627 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 3.9 pt20 -71.05 134.84 85.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.322 0.649 . . . . 65.51 111.731 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.88 156.12 60.04 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.549 2.166 . . . . 73.35 112.461 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 27.2 mt-10 -70.31 98.86 1.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.372 -0.973 . . . . 63.52 108.372 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.606 ' HB ' HD13 ' B' ' 126' ' ' LEU . 16.4 m -87.67 122.55 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 74.52 109.445 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -153.22 130.31 11.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.476 1.11 . . . . 70.25 109.645 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.71 HD22 HD11 ' B' ' 126' ' ' LEU . 1.4 pt? -130.81 164.98 23.97 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.993 0.738 . . . . 64.15 112.993 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.96 141.19 38.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.188 1.395 . . . . 72.34 109.79 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -94.68 124.85 38.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 74.23 108.988 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -124.36 156.14 37.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.862 1.265 . . . . 65.45 108.427 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.2 t -129.4 140.85 51.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.616 0.722 . . . . 71.54 111.518 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 161.6 32.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.738 1.615 . . . . 64.03 107.981 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -143.12 165.77 26.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.46 0.648 . . . . 64.35 111.525 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.7 t -152.09 157.83 42.15 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.149 1.38 . . . . 55.2 108.379 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -123.66 129.01 50.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.17 -39.48 12.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.319 0.648 . . . . 71.01 110.125 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 179.96 8.1 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.517 1.127 . . . . 70.25 109.826 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.29 121.25 9.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.342 0.657 . . . . 71.45 109.517 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 66.17 -5.74 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 126.04 1.736 . . . . 43.14 113.712 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.71 86.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.945 -1.502 . . . . 54.23 106.945 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -95.82 168.71 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.609 . . . . 73.34 110.183 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -145.38 97.64 3.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.833 -1.544 . . . . 64.13 106.833 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.34 130.24 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.946 -0.761 . . . . 73.43 108.946 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.1 t -106.89 124.03 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.645 0.778 . . . . 72.41 109.734 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 1.0 OUTLIER -93.68 121.41 35.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.11 -1.07 . . . . 74.05 108.11 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -113.11 113.46 25.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.221 0.608 . . . . 71.11 109.821 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.574 ' HB ' HD11 ' B' ' 114' ' ' ILE . 47.9 t -104.93 125.48 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 62.23 108.546 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -98.64 137.66 36.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.784 -0.821 . . . . 73.13 108.784 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' B' ' 114' ' ' ILE . 50.6 t -128.67 123.76 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.774 -0.825 . . . . 50.01 108.774 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.7 m -108.07 139.07 43.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.023 0.929 . . . . 74.33 109.637 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.33 143.28 30.9 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.438 0.695 . . . . 41.21 109.216 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -151.46 134.13 15.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.462 0.541 . . . . 73.34 112.462 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -107.41 104.23 13.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.943 1.297 . . . . 62.32 108.758 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.96 -113.88 5.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.813 -0.437 . . . . 65.41 112.523 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -97.94 2.76 49.4 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.325 0.65 . . . . 71.34 111.502 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -130.81 157.68 42.21 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.556 0.342 . . . . 70.21 111.864 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.2 m -76.04 133.69 40.29 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.786 -0.643 . . . . 71.42 110.669 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.34 -55.77 3.29 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.533 0.733 . . . . 74.31 109.701 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 30.8 p90 -154.01 162.34 41.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.26 -0.882 . . . . 73.24 109.956 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.7 mt -142.25 116.05 9.24 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.075 1.35 . . . . 72.33 107.453 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -117.79 120.49 38.09 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.528 -0.545 . . . . 33.43 109.528 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -123.37 124.2 42.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.434 -0.95 . . . . 70.24 108.434 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.479 HG13 HD13 ' B' ' 21' ' ' ILE . 55.3 t -121.47 146.0 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.314 -0.995 . . . . 71.2 108.314 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.8 mt-30 -127.06 99.28 5.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.14 109.255 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.533 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 49.2 tp60 -92.41 104.22 16.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.144 -1.389 . . . . 74.44 108.751 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.44 159.27 25.99 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 112.142 -0.383 . . . . 74.33 112.142 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -156.19 127.98 2.12 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.837 -0.905 . . . . 51.34 110.837 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.84 125.0 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.608 -0.886 . . . . 73.21 108.608 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.88 136.73 47.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.298 1.039 . . . . 63.22 109.979 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 5.7 m -90.22 110.48 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.043 -1.095 . . . . 62.44 108.043 172.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 38.3 pt -126.68 109.19 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.824 0.821 . . . . 72.43 110.553 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.5 170.71 20.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.645 -1.162 . . . . 64.22 109.441 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' F' ' 172' ' ' ALA . . . 99.53 -49.14 1.21 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 111.413 -0.675 . . . . 65.22 111.413 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 165.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.755 0.822 . . . . 71.1 111.387 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.778 ' HA ' ' SD ' ' F' ' 174' ' ' MET . 38.0 tt0 -163.7 144.87 9.03 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.89 0.744 . . . . 73.22 110.561 169.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.51 -110.44 3.13 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.555 -0.748 . . . . 73.23 113.031 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 m -65.26 -44.92 86.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 65.4 112.309 -170.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.9 -22.4 61.5 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.573 -0.74 . . . . 72.43 112.126 -167.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.599 ' SD ' ' HB2' ' F' ' 174' ' ' MET . 17.4 ttt -72.15 -38.73 69.13 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.405 -0.22 . . . . 75.44 110.405 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.53 74.26 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.945 0.498 . . . . 40.01 110.845 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 59.2 t-80 -74.45 -20.51 60.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.687 0.795 . . . . 74.14 110.848 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -86.92 -67.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.131 0.573 . . . . 61.55 111.289 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.435 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.5 pp -74.19 -24.26 59.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.126 0.57 . . . . 64.35 112.301 -172.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.37 72.94 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.905 -0.386 . . . . 52.24 113.35 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -145.37 -69.92 0.28 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.502 0.556 . . . . 72.55 112.502 -173.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -74.03 -39.53 63.49 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.318 0.386 . . . . 63.33 111.562 -168.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.615 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 61.0 m -61.98 -50.33 81.34 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.865 -0.588 . . . . 53.53 111.522 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.64 -25.82 28.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.427 1.418 . . . . 64.11 113.415 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.83 -33.03 74.78 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.281 0.562 . . . . 74.35 110.962 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.442 HD13 HD11 ' B' ' 13' ' ' ILE . 59.6 mt -65.67 -44.9 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.257 1.023 . . . . 74.44 110.89 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' B' ' 82' ' ' GLY . 44.9 mt -81.33 -12.9 58.89 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.126 -0.943 . . . . 62.14 111.017 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -60.01 -49.94 88.75 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.755 -1.117 . . . . 72.2 112.093 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.49 -41.38 77.51 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.887 1.725 . . . . 41.01 113.011 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.533 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.2 m-85 -65.99 -50.22 65.06 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.483 0.713 . . . . 74.11 112.204 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.73 81.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.759 0.824 . . . . 70.12 110.847 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -56.09 -48.6 75.81 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.379 1.472 . . . . 65.15 110.299 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.63 -36.36 80.66 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.399 0.68 . . . . 61.35 110.428 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.0 t -68.51 -45.02 73.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.752 0.421 . . . . 72.31 111.82 -174.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.574 HD11 ' HB ' ' B' ' 62' ' ' VAL . 92.1 mt -59.22 -50.77 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.955 0.902 . . . . 71.24 110.429 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.436 HG21 ' OG ' ' C' ' 119' ' ' SER . 86.9 m -58.26 -33.06 68.98 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 124.481 1.113 . . . . 65.25 111.175 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.7 t -69.75 -35.18 74.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.219 1.008 . . . . 74.44 111.357 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -79.24 -33.21 43.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.862 0.465 . . . . 72.04 111.481 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.56 -31.9 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.675 0.79 . . . . 74.14 110.748 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.505 ' HB3' HG21 ' C' ' 115' ' ' THR . 80.7 p -68.48 -33.45 74.18 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 116.03 -0.532 . . . . 55.01 112.068 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.454 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 83.7 mtt-85 -65.55 -36.96 85.34 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.011 -0.995 . . . . 72.31 110.96 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.89 9.09 63.9 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.508 -0.769 . . . . 71.13 113.85 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p 63.84 12.66 6.92 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.436 1.894 . . . . 74.44 113.192 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.498 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 58.3 m-85 -77.99 170.98 13.74 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.915 0.886 . . . . 74.3 110.269 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.627 ' HG3' ' HB2' ' B' ' 37' ' ' GLN . 62.5 Cg_endo -77.18 -169.11 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.101 1.867 . . . . 64.05 114.718 -170.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' C' ' 125' ' ' GLN . 17.7 pt20 -64.92 142.11 58.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.945 -1.48 . . . . 61.23 112.434 177.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.71 HD11 HD22 ' B' ' 42' ' ' LEU . 32.5 tp -151.57 98.34 2.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.334 -0.848 . . . . 72.0 108.895 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -134.65 126.04 28.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.644 . . . . 75.22 109.769 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.493 HD13 ' HG ' ' F' ' 186' ' ' LEU . 39.0 mt -77.01 151.17 35.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.875 0.87 . . . . 73.34 111.807 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.69 106.54 15.77 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.981 -0.748 . . . . 64.14 108.981 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.2 113.47 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.026 2.484 . . . . 64.32 112.938 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.515 HG23 ' HE1' ' F' ' 184' ' ' TRP . 30.7 m -102.23 153.84 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.52 0.728 . . . . 73.55 110.152 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.447 ' HB2' HD12 ' D' ' 13' ' ' ILE . 50.2 t-20 -110.55 115.83 30.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.635 0.774 . . . . 70.22 110.562 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.525 ' HD1' ' HB2' ' F' ' 184' ' ' TRP . 54.4 t80 -66.32 -42.24 88.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.973 0.509 . . . . 74.34 111.201 175.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.12 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 110.021 -0.363 . . . . 73.33 110.021 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.53 -42.54 98.98 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.875 0.734 . . . . 72.52 110.922 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' B' ' 140' ' ' TYR . 9.4 tt -53.74 -47.73 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.538 0.735 . . . . 71.2 110.16 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -68.77 -37.8 79.6 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.683 1.193 . . . . 64.04 111.208 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.7 mmt -69.13 -38.29 78.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 73.04 110.613 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -92.28 -0.58 57.39 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.839 -0.619 . . . . 74.12 111.188 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' B' ' 136' ' ' LEU . 0.3 OUTLIER -87.7 -37.56 16.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.227 0.611 . . . . 74.01 109.352 172.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.01 4.25 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.225 0.61 . . . . 74.21 111.02 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.625 ' HG3' ' HB3' ' D' ' 8' ' ' GLU . 36.3 tt0 -71.85 148.63 45.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.249 0.62 . . . . 73.44 109.636 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -94.01 -91.98 0.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.746 -0.835 . . . . 73.32 108.746 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -153.45 132.51 12.57 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.066 0.947 . . . . 61.33 109.947 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.77 143.01 49.04 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.739 1.216 . . . . 73.24 108.858 174.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.51 66.77 0.21 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.274 -0.73 . . . . 52.21 111.274 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -161.39 176.47 11.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.841 0.857 . . . . 71.34 110.365 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.68 31.61 12.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.257 -0.429 . . . . 63.11 113.098 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -71.82 88.1 1.01 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.311 -0.626 . . . . 62.13 109.311 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.84 98.67 7.18 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.106 -1.072 . . . . 72.33 108.106 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -122.18 39.17 3.96 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 73.42 110.305 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -118.65 79.39 1.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.501 -0.555 . . . . 75.42 109.501 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 105.77 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.543 0.737 . . . . 74.32 109.931 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.38 95.27 2.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.149 0.58 . . . . 52.31 109.796 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.243 0 C-N-CA 123.399 0.68 . . . . 74.33 109.354 176.427 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.048 0.451 . . . . 72.03 110.713 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.0 t -138.71 91.05 2.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.354 -1.35 . . . . 63.34 107.354 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' C' ' 4' ' ' GLN . 6.1 tp10 -82.97 -164.72 0.91 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.967 0.907 . . . . 73.5 109.814 -177.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.464 ' H ' ' HG3' ' C' ' 3' ' ' GLU . 2.4 mp0 77.16 76.28 0.08 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.497 1.519 . . . . 44.32 109.444 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 m120 64.87 25.32 12.82 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.337 -1.301 . . . . 51.24 113.074 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -61.66 99.77 0.12 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.081 0.952 . . . . 73.12 112.416 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.2 m -110.23 99.37 8.44 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.016 0.926 . . . . 73.51 109.201 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.37 104.04 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.987 0.515 . . . . 53.13 110.048 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.2 ttt 64.22 115.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.254 1.422 . . . . 62.12 112.219 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.3 m -103.6 111.59 24.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.569 0.748 . . . . 75.53 109.484 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -104.34 140.3 38.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.702 0.801 . . . . 63.54 108.892 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -150.02 140.09 22.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.869 0.366 . . . . 74.04 111.305 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -93.34 141.49 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.232 1.013 . . . . 72.42 109.578 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.519 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.7 mm-40 -108.49 -49.11 3.22 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.37 0.668 . . . . 74.3 110.087 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.555 HH11 ' HD1' ' D' ' 32' ' ' PHE . 63.5 ttt180 -170.57 125.39 0.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.608 0.363 . . . . 74.25 110.354 -173.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 73.0 mt -109.6 141.73 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.344 -1.354 . . . . 63.1 107.344 176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.544 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 40.6 p90 -176.94 156.69 1.36 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.037 0.836 . . . . 74.52 110.768 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -78.73 123.34 27.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.428 -0.806 . . . . 72.34 109.954 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.58 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -81.16 -44.87 17.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.007 -0.738 . . . . 52.14 109.007 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -149.87 134.19 17.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.41 -1.268 . . . . 70.42 109.606 -171.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.0 mt -134.15 145.07 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.519 1.128 . . . . 74.12 108.499 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -156.24 151.99 27.22 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.223 0.535 . . . . 73.21 111.154 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -152.94 108.52 3.29 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.152 -1.425 . . . . 71.01 107.152 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.18 114.88 25.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.449 0.7 . . . . 70.03 110.298 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.72 83.44 62.3 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.609 1.163 . . . . 75.54 109.333 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.29 -23.15 24.5 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.412 2.074 . . . . 72.55 111.46 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -93.54 15.28 16.43 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.25 1.42 . . . . 70.44 109.535 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' D' ' 17' ' ' TYR . . . -56.95 -49.0 96.48 Favored Pre-proline 0 CA--C 1.567 1.616 0 N-CA-C 113.991 1.108 . . . . 51.21 113.991 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.98 -29.57 6.62 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.041 1.407 . . . . 71.44 113.132 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -70.25 -39.84 74.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.198 0.599 . . . . 75.2 111.739 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.443 HG23 HD11 ' C' ' 68' ' ' LEU . 10.5 p -71.18 -12.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.672 0.789 . . . . 51.1 111.16 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.97 -41.0 77.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 110.562 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -100.57 48.54 0.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.033 0.92 . . . . 74.32 109.842 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.622 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -125.52 158.75 33.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.803 0.841 . . . . 75.14 110.12 177.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.85 107.2 9.0 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 106.766 -1.568 . . . . 54.01 106.766 164.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.01 90.01 3.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.824 -0.625 . . . . 74.21 111.962 -164.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -137.75 65.55 46.64 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.969 0.908 . . . . 73.31 109.071 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' E' ' 192' ' ' GLY . 28.9 Cg_exo -65.13 133.36 35.15 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.284 1.99 . . . . 75.05 111.727 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' C' ' 66' ' ' ALA . 29.4 tt0 -83.76 86.45 7.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.875 -1.158 . . . . 70.25 107.875 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -74.47 79.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.513 -1.221 . . . . 60.52 110.332 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' E' ' 189' ' ' ALA . 41.5 tttp -92.74 134.23 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.054 -1.43 . . . . 72.31 110.003 -174.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.424 HD23 HD13 ' C' ' 128' ' ' LEU . 1.4 pp -87.72 167.25 14.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.727 0.811 . . . . 73.51 111.867 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.97 148.3 18.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.709 0.804 . . . . 75.25 109.429 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 tt -123.9 139.02 54.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.277 0.631 . . . . 63.35 109.86 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 14.0 m-20 -136.39 150.68 48.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.769 1.228 . . . . 53.52 109.156 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -115.0 143.56 44.99 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.572 0.749 . . . . 73.44 109.342 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.23 154.66 41.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.187 0.995 . . . . 60.3 108.328 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -163.77 152.96 14.21 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.849 0.357 . . . . 72.52 111.063 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -151.48 130.92 12.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.28 1.032 . . . . 24.41 109.043 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.549 ' HB2' ' HE2' ' E' ' 175' ' ' PHE . 60.5 tt0 -75.85 129.06 36.41 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.723 -0.473 . . . . 60.11 109.723 175.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 47.0 mt -104.77 -36.23 7.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.504 0.722 . . . . 73.35 110.018 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -173.44 4.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.685 -1.143 . . . . 70.14 108.948 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -76.14 124.35 27.3 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.43 -0.804 . . . . 63.21 109.798 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.7 ' H ' ' HB2' ' E' ' 172' ' ' ALA . 3.1 m-20 63.34 12.24 6.09 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.416 1.086 . . . . 65.13 112.483 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.31 130.28 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.874 1.27 . . . . 50.03 108.36 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.2 152.13 36.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.58 0.705 . . . . 74.12 111.458 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.439 ' HB2' HD11 ' C' ' 51' ' ' LEU . 27.6 tt0 -83.61 125.42 31.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.234 1.414 . . . . 71.2 109.448 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.9 t -112.37 130.57 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.99 -1.115 . . . . 75.35 107.99 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.4 107.69 19.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.865 0.866 . . . . 64.21 108.752 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' C' ' 103' ' ' PRO . 3.1 tm? -92.07 108.3 19.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.39 -1.337 . . . . 64.34 107.39 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.9 ttp180 -89.67 128.65 36.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.069 -0.514 . . . . 75.34 109.951 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.577 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.9 t -117.99 118.94 59.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.734 -1.21 . . . . 72.53 107.734 168.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 32.4 m -110.67 146.49 36.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 72.55 109.393 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.556 HG21 HG21 ' C' ' 114' ' ' ILE . 63.8 t -129.94 115.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.747 1.219 . . . . 65.34 109.131 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -98.67 143.44 29.04 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.481 -0.933 . . . . 62.52 108.481 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' C' ' 39' ' ' GLU . . . -127.67 121.08 29.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.485 -0.561 . . . . 63.45 109.485 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.0 m -137.96 131.73 31.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.316 0.579 . . . . 73.1 111.38 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.622 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.9 mt -87.79 41.12 0.97 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.192 1.397 . . . . 73.32 109.685 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.91 -102.66 2.28 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.287 -1.125 . . . . 54.23 110.287 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -92.35 -31.87 15.19 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.952 0.501 . . . . 64.32 110.152 174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.584 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 3.8 tp10 -66.8 119.0 11.1 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.702 1.201 . . . . 72.51 109.758 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.2 m -73.06 124.63 25.9 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.174 -0.676 . . . . 75.22 109.174 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.64 -47.91 10.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.377 -0.601 . . . . 73.32 109.377 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -171.44 177.22 3.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.864 0.866 . . . . 74.51 110.76 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.426 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -132.43 144.6 50.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.484 -1.672 . . . . 64.21 106.484 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.426 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.4 t -140.04 143.02 36.18 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.829 -1.545 . . . . 74.1 106.829 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.72 135.07 9.25 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.146 0.498 . . . . 73.32 110.274 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.33 135.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.864 -1.062 . . . . 61.12 108.341 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -115.84 94.01 4.5 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.362 -1.348 . . . . 73.41 107.362 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -89.83 115.17 26.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.849 -1.068 . . . . 75.13 110.11 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.58 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -108.4 157.4 15.3 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.014 -0.539 . . . . 63.31 113.28 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -158.0 133.76 3.62 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.93 -1.268 . . . . 53.32 109.93 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 20.8 mm -91.59 122.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.907 -1.146 . . . . 74.11 107.907 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.01 130.74 52.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.966 0.506 . . . . 75.5 110.052 -173.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.6 t -104.97 119.31 38.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.3 -1.0 . . . . 71.12 108.3 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.17 150.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.017 0.927 . . . . 65.44 110.24 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.66 149.57 28.56 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.813 0.845 . . . . 74.44 109.579 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.38 60.22 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.195 -0.457 . . . . 63.2 113.212 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.613 HD11 ' HG3' ' E' ' 174' ' ' MET . 48.0 pt -63.22 139.34 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.849 0.86 . . . . 62.1 112.0 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.636 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 44.7 tt0 -163.97 145.24 8.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.145 0.978 . . . . 73.44 108.767 175.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -112.92 3.09 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.211 0.944 . . . . 34.32 113.127 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -56.59 -46.25 80.94 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 73.31 111.326 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.636 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 96.9 mt-30 -61.52 -31.13 71.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.431 0.693 . . . . 75.1 111.921 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 48.2 ttm -84.74 -44.06 13.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.633 0.373 . . . . 73.13 110.776 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.25 -39.49 65.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.418 0.687 . . . . 71.44 111.364 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -69.82 -31.95 70.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.756 0.822 . . . . 72.42 110.368 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 45.7 t -80.87 -61.9 1.83 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.886 0.474 . . . . 73.34 110.419 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.9 -40.36 91.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.146 0.978 . . . . 73.3 110.271 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.3 2.97 68.81 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.074 -0.848 . . . . 54.04 114.622 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.06 -59.41 0.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.404 1.102 . . . . 72.33 112.768 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 77.0 t80 -71.96 -48.49 44.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.062 0.764 . . . . 73.04 113.062 -166.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.56 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -60.35 -48.97 92.54 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.692 0.397 . . . . 75.25 110.57 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 54.2 Cg_exo -59.62 -30.47 92.37 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.277 1.985 . . . . 74.35 114.258 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.648 0.779 . . . . 52.44 110.846 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.48 -36.76 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.246 0.618 . . . . 73.33 110.168 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.1 mt -83.44 -25.84 30.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.513 -0.767 . . . . 74.41 111.86 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.98 -40.15 83.02 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 124.324 1.05 . . . . 75.42 113.609 -175.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.3 -53.63 6.78 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.692 2.262 . . . . 65.25 113.792 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.592 ' HE2' HG21 ' A' ' 115' ' ' THR . 53.7 m-85 -63.5 -34.42 77.74 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.58 -1.191 . . . . 73.33 110.793 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.81 -45.24 62.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.402 0.681 . . . . 54.3 110.853 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.83 -37.74 69.11 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.384 1.074 . . . . 72.0 110.647 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.454 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -77.94 -43.15 30.74 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.262 0.625 . . . . 72.04 111.075 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.56 -33.28 75.31 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.755 0.65 . . . . 73.14 112.755 -170.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' C' ' 62' ' ' VAL . 70.4 mt -67.64 -49.08 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.871 0.469 . . . . 60.4 109.821 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.676 HG23 ' HB2' ' C' ' 125' ' ' GLN . 57.4 m -54.8 -37.16 65.74 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.251 -1.341 . . . . 74.11 111.603 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.1 t -57.42 -58.11 9.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.906 -1.043 . . . . 62.43 109.98 174.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -41.68 85.85 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.325 1.05 . . . . 71.12 113.195 -176.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.04 -42.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 122.594 0.358 . . . . 64.12 110.385 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.436 ' OG ' HG21 ' B' ' 115' ' ' THR . 38.1 t -71.78 -20.15 61.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.545 -0.752 . . . . 55.42 111.588 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.5 mtt-85 -73.98 -40.12 63.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.108 0.563 . . . . 71.2 110.051 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.02 -5.64 71.21 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.53 0.519 . . . . 71.44 111.909 167.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p 65.37 23.05 12.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.491 2.316 . . . . 63.33 112.357 173.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.85 164.21 49.9 Favored Pre-proline 0 CA--C 1.548 0.865 0 CA-C-N 114.805 -1.089 . . . . 75.52 108.491 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.17 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.775 2.317 . . . . 73.21 113.072 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.676 ' HB2' HG23 ' C' ' 115' ' ' THR . 2.6 pt20 -49.78 133.29 21.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.806 1.242 . . . . 75.02 111.295 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.405 ' HG ' ' HG ' ' C' ' 128' ' ' LEU . 28.2 tp -90.9 82.33 5.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.519 0.676 . . . . 51.43 110.359 -170.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -94.59 85.94 4.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.058 -0.974 . . . . 73.03 108.867 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.424 HD13 HD23 ' C' ' 42' ' ' LEU . 93.7 mt -87.85 144.28 26.67 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.416 0.627 . . . . 61.43 111.714 -176.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.18 153.35 90.51 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 114.203 -1.362 . . . . 71.45 109.417 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.446 ' HB3' HD12 ' A' ' 16' ' ' ILE . 53.5 Cg_endo -64.47 142.19 77.23 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.783 2.322 . . . . 71.34 114.737 -168.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' E' ' 186' ' ' LEU . 3.0 t -104.08 84.11 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 107.54 -1.282 . . . . 62.33 107.54 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.409 HD21 HG23 ' A' ' 105' ' ' ILE . 8.9 m120 -86.1 99.99 11.88 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.48 0.657 . . . . 74.22 110.456 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -68.67 -29.45 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.421 -1.263 . . . . 74.23 110.873 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.86 -37.21 86.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.87 0.868 . . . . 71.21 111.076 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.4 77.8 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.708 0.803 . . . . 45.12 110.65 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' C' ' 140' ' ' TYR . 7.6 mp -72.94 -22.17 60.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.957 -1.019 . . . . 72.02 111.094 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -79.36 -48.32 14.25 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.758 . . . . 70.44 110.662 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.543 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 4.6 ppp? -76.45 -27.71 56.29 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.28 0.632 . . . . 61.4 111.011 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -70.95 -37.43 72.81 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.877 0.471 . . . . 72.03 110.73 169.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' C' ' 136' ' ' LEU . 4.7 t80 -72.17 -159.42 0.05 Allowed 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 109.818 -0.438 . . . . 74.31 109.818 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 51.17 23.54 1.64 Allowed 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.362 0.665 . . . . 55.11 110.797 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -174.97 115.65 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.354 1.062 . . . . 62.5 108.622 -164.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -76.26 -43.79 40.29 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.98 0.419 . . . . 74.54 110.323 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -81.3 90.95 6.16 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.8 -0.636 . . . . 70.53 110.05 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.3 -68.2 0.44 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.478 -0.564 . . . . 55.21 109.478 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.54 -26.77 3.3 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.471 -0.627 . . . . 53.35 114.491 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 66.0 -178.83 0.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.126 0.971 . . . . 74.31 112.11 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.88 139.05 29.24 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.568 -0.742 . . . . 75.13 112.187 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.4 m -137.26 12.84 3.04 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.217 0.607 . . . . 71.25 110.612 -174.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.1 157.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 74.11 112.067 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.434 ' HB3' ' SD ' ' G' ' 174' ' ' MET . 0.0 OUTLIER -123.42 -179.13 4.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.219 1.007 . . . . 65.15 109.596 174.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -145.1 68.85 1.24 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.002 -1.11 . . . . 70.55 108.002 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -157.22 120.77 4.14 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.586 -0.734 . . . . 72.41 110.908 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -103.34 -49.98 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.836 0.855 . . . . 73.35 110.289 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.636 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 -178.437 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.733 -0.84 . . . . 73.52 108.733 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -78.3 84.05 4.51 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.445 0.698 . . . . 72.22 110.61 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -82.08 104.51 12.48 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.283 -0.871 . . . . 74.23 109.192 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -74.5 85.21 2.03 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.46 0.704 . . . . 52.41 110.097 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -82.52 58.95 4.4 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 72.1 110.582 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -123.43 86.13 2.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.752 0.787 . . . . 73.14 109.828 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -164.89 157.36 16.13 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 113.927 -1.488 . . . . 74.44 108.216 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.625 ' HB3' ' HG3' ' B' ' 142' ' ' GLN . 32.2 mm-40 -83.14 71.24 10.17 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.1 0.56 . . . . 65.53 111.358 -172.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.563 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm -33.72 137.17 0.1 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.164 1.385 . . . . 73.45 113.575 170.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.4 m -125.6 142.46 51.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.115 0.966 . . . . 75.21 108.712 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -144.68 127.12 15.92 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.576 -1.268 . . . . 54.4 107.576 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 58.5 mt-30 -132.89 143.63 49.64 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.099 0.96 . . . . 63.44 108.68 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' B' ' 132' ' ' ASN . 38.5 mt -103.41 115.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.622 -0.881 . . . . 72.41 108.622 170.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -83.74 -44.33 14.55 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 110.152 -0.314 . . . . 70.34 110.152 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -165.11 141.1 5.51 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 111.52 0.193 . . . . 73.33 111.52 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 38.7 mm -120.47 126.05 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.309 -0.997 . . . . 73.51 108.309 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' C' ' 28' ' ' ALA . 2.0 p90 -167.86 154.83 8.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.627 0.771 . . . . 72.44 111.534 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.44 HG21 HD11 ' D' ' 21' ' ' ILE . 81.3 p -79.55 118.87 21.79 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.401 -0.818 . . . . 63.33 110.604 -176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.37 -23.0 30.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.515 -0.766 . . . . 65.24 110.862 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.614 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 35.1 t70 -160.04 132.1 6.25 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.852 0.72 . . . . 65.15 109.696 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.591 HD13 ' HE3' ' C' ' 117' ' ' MET . 96.6 mt -132.48 135.73 57.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.089 -1.449 . . . . 73.22 107.089 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -138.61 132.15 30.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.574 -1.269 . . . . 70.14 107.574 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.545 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -145.14 112.17 5.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.923 -1.51 . . . . 65.2 106.923 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.9 112.19 18.01 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.691 0.796 . . . . 51.13 108.983 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.1 82.47 2.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 107.843 -1.169 . . . . 63.22 107.843 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.38 -30.5 5.24 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.424 2.083 . . . . 75.3 112.479 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.43 ' O ' HG23 ' D' ' 31' ' ' VAL . 88.8 m-20 -108.29 38.91 2.09 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.679 1.192 . . . . 72.3 108.962 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.544 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.19 -53.39 65.49 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 115.147 1.536 . . . . 70.3 115.147 -169.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.76 -7.21 14.53 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 122.191 1.818 . . . . 70.34 112.364 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -84.4 -24.67 29.53 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.372 1.469 . . . . 72.32 109.055 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 27' ' ' ASN . 13.4 t -66.25 -29.68 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.946 0.898 . . . . 72.11 110.135 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.555 ' HD1' HH11 ' C' ' 15' ' ' ARG . 91.7 t80 -51.25 -31.75 22.04 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.434 -0.803 . . . . 64.12 112.599 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -75.42 -17.51 60.16 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.777 0.831 . . . . 74.21 112.42 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' D' ' 71' ' ' GLU . 92.3 mttt -122.55 110.79 16.01 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.337 0.655 . . . . 73.33 110.583 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -110.82 81.75 1.48 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.243 1.017 . . . . 63.32 110.672 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -150.81 174.96 12.47 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.203 -0.908 . . . . 73.41 109.143 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.545 ' H ' ' HA ' ' H' ' 193' ' ' TYR . 59.9 tp60 -71.73 117.58 58.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 119.494 -0.289 . . . . 73.3 110.278 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.466 ' HG3' HD21 ' D' ' 68' ' ' LEU . 77.6 Cg_exo -55.65 130.5 40.78 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.993 2.462 . . . . 71.15 112.411 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.35 122.27 15.27 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.755 -0.831 . . . . 51.12 108.755 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -98.45 112.08 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.108 0.563 . . . . 65.32 109.541 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 3.2 mppt? -99.32 120.05 38.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.984 -1.117 . . . . 73.44 107.984 170.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.06 121.18 39.67 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.092 -1.077 . . . . 75.41 108.092 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.471 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.3 t70 -119.4 135.61 54.66 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.837 -0.801 . . . . 75.34 108.837 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.44 HD11 HD21 ' D' ' 60' ' ' LEU . 29.1 tp -111.97 129.76 56.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.084 0.554 . . . . 74.35 109.852 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -139.12 152.42 47.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.335 1.054 . . . . 63.51 108.477 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -146.21 162.76 37.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.075 0.55 . . . . 73.54 110.295 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.36 147.66 27.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.334 1.054 . . . . 64.51 108.86 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 48.9 m -144.48 152.03 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.878 0.37 . . . . 70.05 111.061 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.1 p -163.13 125.99 2.7 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.303 1.041 . . . . 71.31 108.842 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -72.86 123.84 24.21 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.834 0.454 . . . . 63.23 111.106 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.8 mt -96.53 -29.41 13.9 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.536 0.734 . . . . 74.04 111.503 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.4 -172.49 3.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.507 0.723 . . . . 71.04 110.592 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -64.47 116.62 6.3 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.971 -0.559 . . . . 72.2 110.025 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 69.51 0.43 2.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.925 1.29 . . . . 65.33 112.365 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.95 131.56 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.844 0.857 . . . . 64.55 110.117 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.47 154.2 42.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.332 0.653 . . . . 65.31 109.734 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.603 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -95.16 118.56 32.15 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.643 0.777 . . . . 75.45 109.39 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.9 119.21 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.519 -0.919 . . . . 65.34 108.519 169.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.8 t -98.11 138.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.949 -1.13 . . . . 75.21 107.949 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.561 HD13 HG23 ' D' ' 62' ' ' VAL . 0.3 OUTLIER -125.55 116.19 21.37 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.973 -0.751 . . . . 72.3 108.973 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.1 ttm180 -97.75 110.52 23.07 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.613 -0.722 . . . . 74.45 109.244 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.561 HG23 HD13 ' D' ' 60' ' ' LEU . 65.8 t -99.59 123.28 52.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.061 -1.088 . . . . 75.44 108.061 170.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.491 HG23 ' HG3' ' D' ' 77' ' ' GLU . 70.4 m -122.29 130.42 53.14 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.324 -0.853 . . . . 45.25 110.145 -172.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.53 HG21 HG21 ' D' ' 114' ' ' ILE . 37.6 t -120.67 101.58 10.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 113.699 -1.591 . . . . 40.15 107.281 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 11.2 m -94.3 111.36 23.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.206 -1.405 . . . . 61.22 107.206 169.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.65 135.09 54.53 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.088 -0.708 . . . . 73.43 109.088 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.9 p -139.1 148.92 43.94 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.807 -0.633 . . . . 55.3 110.022 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.466 HD21 ' HG3' ' D' ' 38' ' ' PRO . 85.9 mt -109.96 92.06 3.9 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.376 -0.601 . . . . 74.51 109.376 169.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.27 -121.23 20.4 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.421 -0.809 . . . . 31.41 111.893 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -84.4 27.77 0.68 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.957 0.903 . . . . 62.04 112.127 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.537 ' HB2' ' NZ ' ' D' ' 34' ' ' LYS . 5.2 tp10 -135.63 135.64 40.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 118.889 -0.577 . . . . 61.42 110.048 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -73.85 113.17 10.7 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.905 -0.776 . . . . 54.42 108.905 167.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -76.23 -61.46 1.94 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.173 -0.677 . . . . 63.33 109.173 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.57 154.23 15.99 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.361 -1.29 . . . . 63.11 110.016 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.13 149.52 29.21 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.111 -1.44 . . . . 63.02 107.111 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.2 t -155.35 103.38 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.547 -0.538 . . . . 71.11 109.547 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' D' ' 63' ' ' THR . 5.2 mp0 -121.96 121.71 37.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.133 0.973 . . . . 64.14 108.667 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.43 114.18 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.758 -0.46 . . . . 73.04 109.758 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.78 91.25 8.55 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.639 0.776 . . . . 70.11 109.268 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -79.17 98.56 6.63 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.962 -1.017 . . . . 74.35 108.962 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.05 142.92 20.14 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.079 -0.808 . . . . 14.53 111.079 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.16 130.12 3.61 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.689 -0.964 . . . . 62.41 110.689 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.73 128.72 42.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.502 -0.925 . . . . 70.1 108.502 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -134.06 148.38 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.091 0.556 . . . . 73.03 110.489 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 46.1 m -104.94 105.78 15.98 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.566 -0.902 . . . . 74.42 108.566 170.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.1 pt -109.57 145.38 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 118.488 0.585 . . . . 63.14 110.634 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.15 169.3 21.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.697 -1.138 . . . . 62.22 109.43 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 72.67 23.8 77.26 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 121.576 -0.345 . . . . 72.1 112.584 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.434 HD13 ' HB2' ' D' ' 94' ' ' MET . 2.2 pp -124.46 146.16 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.749 0.82 . . . . 32.12 110.755 -172.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.29 171.49 17.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 75.51 110.177 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.98 -134.48 31.69 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.941 0.776 . . . . 54.34 114.73 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -81.04 -13.25 58.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.269 0.628 . . . . 74.13 110.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -67.9 -36.69 80.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.235 0.614 . . . . 70.42 110.468 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.434 ' HB2' HD13 ' D' ' 89' ' ' ILE . 2.0 ppp? -70.45 -35.08 73.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.455 -0.572 . . . . 74.1 109.455 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.85 76.02 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 115.038 -0.983 . . . . 54.32 111.285 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -72.28 -37.68 68.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.25 0.62 . . . . 51.41 110.974 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.85 -38.96 76.63 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.043 0.537 . . . . 72.03 110.811 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.67 -45.86 20.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.662 0.785 . . . . 64.21 110.416 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.61 -26.9 40.72 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.626 -0.715 . . . . 70.23 114.009 -168.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.93 -51.02 2.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.142 0.471 . . . . 73.24 111.903 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -73.74 -47.29 40.32 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.282 0.475 . . . . 74.22 112.282 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 73.6 m -60.5 -47.84 95.18 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 118.976 -0.535 . . . . 61.4 111.274 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.8 Cg_exo -55.32 -37.0 94.89 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.447 2.098 . . . . 74.21 114.043 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.98 -29.61 70.54 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.099 0.56 . . . . 71.01 111.02 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 44.6 mm -75.34 -46.3 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.351 0.66 . . . . 70.11 110.409 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.81 -17.27 59.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.202 -0.908 . . . . 71.51 111.822 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.0 -47.6 52.33 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.256 1.022 . . . . 71.54 112.859 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 83.2 Cg_exo -49.42 -44.98 32.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.565 2.177 . . . . 73.13 113.945 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -73.71 -37.08 65.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.319 0.648 . . . . 74.31 111.918 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' D' ' 62' ' ' VAL . . . -64.36 -53.38 49.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.212 0.605 . . . . 74.34 110.764 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.602 HH12 ' HB3' ' D' ' 130' ' ' PRO . 8.7 ptt180 -67.13 -30.85 70.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.703 -1.135 . . . . 64.54 110.898 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.419 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.3 tm-20 -67.82 -45.71 73.92 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.09 0.868 . . . . 75.33 110.446 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.696 0.622 . . . . 22.24 110.4 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' D' ' 64' ' ' VAL . 96.5 mt -58.25 -54.83 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 114.889 -1.051 . . . . 74.41 110.562 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.611 HG23 ' HG3' ' D' ' 125' ' ' GLN . 27.6 m -51.2 -48.24 62.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.878 1.271 . . . . 73.34 111.145 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -66.93 -44.78 79.79 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.464 -1.244 . . . . 62.54 110.176 -173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.5 mtm -65.47 -34.03 77.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.903 0.481 . . . . 73.14 111.405 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.657 HG13 ' HB2' ' D' ' 123' ' ' PHE . 56.5 t -64.91 -49.63 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.597 0.759 . . . . 74.33 110.454 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 90.4 p -69.29 -31.6 70.21 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.959 0.504 . . . . 65.53 111.066 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -70.43 -31.46 68.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.929 0.892 . . . . 75.12 109.945 173.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.85 64.13 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.536 -0.756 . . . . 73.31 113.202 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 125' ' ' GLN . 66.8 p 56.92 28.18 14.22 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.866 1.667 . . . . 75.35 113.112 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.657 ' HB2' HG13 ' D' ' 118' ' ' VAL . 20.4 m-85 -100.9 164.36 16.25 Favored Pre-proline 0 CA--C 1.561 1.396 0 N-CA-C 108.474 -0.936 . . . . 73.44 108.474 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 63.2 Cg_endo -68.77 133.53 27.69 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.311 2.007 . . . . 72.21 112.196 -175.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' D' ' 115' ' ' THR . 57.2 tt0 -56.58 129.91 42.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.688 0.795 . . . . 64.23 111.227 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -121.99 97.99 5.74 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.031 0.443 . . . . 64.25 110.121 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -99.43 105.05 16.95 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.218 -1.401 . . . . 72.43 107.218 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.82 115.0 12.75 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.888 -0.412 . . . . 70.31 109.888 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.11 86.83 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.543 0.737 . . . . 64.31 111.05 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.602 ' HB3' HH12 ' D' ' 111' ' ' ARG . 73.1 Cg_endo -79.82 108.72 2.3 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.581 2.187 . . . . 75.04 109.997 -174.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -104.26 113.26 40.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.3 91.37 0.17 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.731 -1.581 . . . . 52.34 106.731 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.68 -24.51 63.99 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 115.797 -0.638 . . . . 75.3 110.609 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.55 -40.51 19.1 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.336 1.054 . . . . 64.01 111.521 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.75 -50.37 72.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.784 0.833 . . . . 64.43 111.142 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 29.4 tp -72.76 -22.53 60.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.535 -0.757 . . . . 72.24 110.846 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 83.2 t80 -76.58 -44.37 34.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.438 1.095 . . . . 70.21 109.188 -177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 74.7 mtm -61.81 -39.89 93.35 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.846 0.716 . . . . 71.34 110.305 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -70.62 -27.85 64.39 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.549 -0.751 . . . . 63.33 111.11 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -76.37 -31.14 57.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.052 0.541 . . . . 63.22 110.882 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 74.4 mt -65.21 -27.12 68.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.107 0.563 . . . . 73.51 110.324 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.93 3.87 11.17 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 61.43 111.727 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.483 ' HG2' ' H ' ' D' ' 148' ' ' GLY . 47.2 mt-30 -118.17 73.35 0.9 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.196 0.998 . . . . 73.51 108.988 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -144.25 6.42 1.31 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.996 -1.002 . . . . 75.14 110.75 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.9 -58.38 0.05 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.66 -1.237 . . . . 72.3 107.66 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 146' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' D' ' 143' ' ' GLN . . . -110.9 -168.66 19.11 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.099 -0.955 . . . . 42.43 110.886 167.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -101.92 144.1 30.97 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.083 0.553 . . . . 70.31 110.907 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 148' ' ' GLY . . . . . 0.483 ' H ' ' HG2' ' D' ' 143' ' ' GLN . . . -88.05 158.56 29.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.858 -0.897 . . . . 74.25 110.858 172.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -120.09 129.82 54.37 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 117.349 0.575 . . . . 61.31 111.336 -172.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.415 -2.068 . . . . 62.21 105.415 168.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -85.04 -77.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.985 0.514 . . . . 72.24 110.523 -166.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -175.57 166.54 3.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.578 0.751 . . . . 75.14 110.724 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -105.93 124.11 49.06 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.474 -1.676 . . . . 60.33 106.474 161.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.26 -41.62 98.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.679 0.792 . . . . 71.15 111.981 -173.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 C-N-CA 124.004 0.922 . . . . 72.41 109.038 179.148 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.09 -0.707 . . . . 74.22 109.09 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.25 -78.89 0.66 Allowed Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.807 -1.317 . . . . 41.01 109.807 -165.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 170' ' ' LYS . . . . . 0.673 ' HG2' ' HG3' ' A' ' 151' ' ' GLU . 10.5 mptt -117.16 -166.92 1.23 Allowed 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.163 -1.051 . . . . 64.21 108.163 168.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m 61.8 19.77 10.86 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.389 1.076 . . . . 71.24 112.386 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 172' ' ' ALA . . . . . 0.7 ' HB2' ' H ' ' C' ' 54' ' ' ASP . . . 61.14 165.04 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.309 1.444 . . . . 65.41 113.392 -175.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.486 HD22 ' SD ' ' E' ' 174' ' ' MET . 0.0 OUTLIER -124.31 20.07 8.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.552 1.141 . . . . 75.11 109.844 172.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.695 ' SD ' ' HB1' ' E' ' 172' ' ' ALA . 0.1 OUTLIER -84.95 -177.55 6.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.48 1.112 . . . . 65.14 111.733 -169.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.549 ' HE2' ' HB2' ' C' ' 50' ' ' GLN . 56.7 m-85 59.46 81.04 0.18 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.731 1.212 . . . . 72.14 110.865 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -146.42 -63.11 0.31 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.538 -0.756 . . . . 73.31 109.186 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.89 -2.84 0.84 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.702 1.201 . . . . 63.11 113.096 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 178' ' ' GLN . . . . . 0.574 ' HG3' ' HG3' ' E' ' 179' ' ' GLU . 55.6 tp60 55.31 -81.94 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.16 1.784 . . . . 74.11 112.16 -173.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 179' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' E' ' 178' ' ' GLN . 49.2 mt-10 -135.99 144.23 47.52 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 124.417 1.087 . . . . 54.25 108.654 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.87 95.13 0.29 Allowed 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.617 2.211 . . . . 72.41 111.833 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -76.35 -173.24 2.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.633 0.773 . . . . 74.12 110.466 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -56.56 143.73 34.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.513 0.725 . . . . 75.52 111.444 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 10.9 t -82.98 -178.14 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.036 0.535 . . . . 63.25 111.434 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -138.01 84.93 20.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 124.186 0.994 . . . . 73.14 109.471 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -84.16 153.59 12.62 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.223 2.615 . . . . 65.33 113.91 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 186' ' ' LEU . . . . . 0.639 ' HA ' HG11 ' C' ' 131' ' ' VAL . 95.9 mt -84.98 171.01 12.46 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.492 -0.777 . . . . 44.13 110.889 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.572 HG23 HG22 ' C' ' 131' ' ' VAL . 30.4 pt -68.13 162.02 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.616 0.766 . . . . 53.54 111.834 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.41 105.03 10.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.912 -0.585 . . . . 51.23 109.644 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 189' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' C' ' 41' ' ' LYS . . . -118.54 105.0 11.2 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.965 0.906 . . . . 63.33 108.808 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -142.66 88.27 2.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.428 0.691 . . . . 74.14 109.785 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.51 123.6 2.0 Favored Glycine 0 C--N 1.354 1.535 0 C-N-CA 121.277 -0.487 . . . . 72.34 113.71 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 192' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' C' ' 38' ' ' PRO . . . -125.86 83.99 0.35 Allowed Glycine 0 C--N 1.341 0.829 0 N-CA-C 108.88 -1.688 . . . . 72.31 108.88 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.96 129.42 34.46 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.34 0.656 . . . . 72.14 111.692 -164.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 194' ' ' ALA . . . . . 0.426 ' HB2' ' HD2' ' F' ' 193' ' ' TYR . . . 75.14 112.02 0.07 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.753 1.621 . . . . 71.4 113.151 173.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -91.75 150.58 21.03 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.601 -1.259 . . . . 74.14 107.601 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.16 76.53 2.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.676 0.79 . . . . 62.25 110.584 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -136.05 127.46 28.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.61 1.164 . . . . 74.25 109.336 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 198' ' ' GLU . . . . . 0.523 ' N ' ' HB2' ' E' ' 202' ' ' TYR . 22.6 mt-10 60.85 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.554 1.542 . . . . 71.25 113.608 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -56.66 114.49 2.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.737 1.215 . . . . 63.34 110.153 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 101.51 21.65 11.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.705 -0.68 . . . . 74.44 112.292 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? 58.48 71.85 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.371 1.468 . . . . 42.43 111.119 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 202' ' ' TYR . . . . . 0.523 ' HB2' ' N ' ' E' ' 198' ' ' GLU . 96.3 m-85 -120.58 15.27 11.95 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.796 -1.093 . . . . 73.34 109.791 172.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.54 130.0 38.31 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.646 0.778 . . . . 72.3 108.991 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.452 HG23 HG23 ' E' ' 207' ' ' VAL . 89.0 mt -122.88 99.5 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.964 0.906 . . . . 75.14 109.529 -172.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -121.68 -30.33 4.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.54 0.736 . . . . 64.2 111.146 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.31 -29.78 60.14 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.525 0.33 . . . . 32.1 111.327 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.452 HG23 HG23 ' E' ' 204' ' ' ILE . 16.6 m . . . . . 0 C--O 1.254 1.314 0 CA-C-O 121.499 0.666 . . . . 70.02 109.968 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.604 -0.517 . . . . 52.22 109.604 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.91 97.74 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.949 0.781 . . . . 32.34 111.873 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.29 99.7 4.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.21 0.604 . . . . 73.12 109.623 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 12.6 m -87.35 130.43 34.64 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 64.54 109.529 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 172' ' ' ALA . . . . . 0.446 ' HB3' ' H ' ' B' ' 88' ' ' GLY . . . -74.6 79.09 1.99 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.7 0.762 . . . . 73.11 109.594 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -136.2 132.5 35.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.636 -1.616 . . . . 62.51 106.636 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.778 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 4.1 mtm -142.01 -48.35 0.37 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.052 0.39 . . . . 62.24 112.052 -169.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 14.3 t80 58.79 50.74 8.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.925 0.89 . . . . 70.33 108.957 -162.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -66.91 95.43 0.37 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.593 -1.185 . . . . 54.44 109.523 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 177' ' ' LEU . . . . . 0.643 HD23 ' H ' ' F' ' 178' ' ' GLN . 1.4 tt -153.91 157.66 39.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.279 -0.873 . . . . 74.22 108.779 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 178' ' ' GLN . . . . . 0.643 ' H ' HD23 ' F' ' 177' ' ' LEU . 8.8 mm-40 71.18 86.77 0.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.338 1.455 . . . . 73.14 110.034 -175.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.02 160.67 18.85 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 114.429 -1.259 . . . . 73.43 108.863 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.06 53.82 4.92 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.67 2.247 . . . . 73.25 111.377 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -66.58 171.69 4.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.057 0.543 . . . . 74.32 110.112 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -59.98 100.33 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.863 -0.792 . . . . 75.02 108.863 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 183' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' F' ' 185' ' ' PRO . 62.9 p -59.34 111.42 1.36 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.082 0.553 . . . . 75.44 109.567 -176.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.525 ' HB2' ' HD1' ' B' ' 133' ' ' PHE . 30.2 t90 -109.53 93.9 15.05 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 123.344 0.658 . . . . 74.12 109.521 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 185' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' F' ' 183' ' ' THR . 83.1 Cg_endo -98.84 -152.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 123.19 2.593 . . . . 74.44 109.985 170.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.493 ' HG ' HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -131.7 171.8 13.05 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.342 -0.984 . . . . 72.04 108.342 170.629 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.4 164.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.858 -0.423 . . . . 62.02 109.858 171.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.46 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.912 -0.773 . . . . 50.03 108.912 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 189' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 40' ' ' VAL . . . 176.45 146.39 0.09 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.2 1.0 . . . . 63.11 110.025 175.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -160.66 154.1 22.03 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.214 1.006 . . . . 73.34 109.245 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 106.08 59.51 0.61 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 110.53 -1.028 . . . . 55.45 110.53 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.85 97.86 0.77 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.52 -0.34 . . . . 54.42 112.298 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 193' ' ' TYR . . . . . 0.426 ' HD2' ' HB2' ' E' ' 194' ' ' ALA . 45.5 m-85 -129.4 21.18 5.65 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.387 0.675 . . . . 73.43 110.013 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.04 -171.34 2.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.654 0.782 . . . . 65.51 110.162 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 63.5 93.53 0.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.844 0.858 . . . . 73.42 109.351 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -76.49 -57.6 3.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.359 -0.978 . . . . 64.13 108.359 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 46.7 t80 62.87 147.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.746 1.218 . . . . 71.52 110.139 -171.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 62.57 23.11 13.73 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.11 0.957 . . . . 75.1 109.287 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -167.0 -71.12 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.387 -0.824 . . . . 61.45 110.204 -169.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.04 21.1 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.508 -0.607 . . . . 73.54 112.443 -175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.73 95.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.901 1.28 . . . . 75.45 112.304 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 69.48 -68.79 0.18 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.552 1.541 . . . . 75.52 110.644 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.48 171.84 14.52 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.667 0.787 . . . . 62.43 109.154 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.638 HG13 ' H ' ' F' ' 205' ' ' LYS . 3.5 pt -133.26 -77.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.792 0.837 . . . . 71.33 108.847 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 205' ' ' LYS . . . . . 0.638 ' H ' HG13 ' F' ' 204' ' ' ILE . 87.6 tttt 153.17 -54.4 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.045 2.138 . . . . 64.22 107.065 -173.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -143.44 -80.61 0.2 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.013 -1.449 . . . . 63.13 108.025 -171.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' F' ' 204' ' ' ILE . 61.3 t . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 107.018 -1.475 . . . . 73.41 107.018 166.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.91 -0.404 . . . . 74.12 109.91 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.26 -47.19 3.78 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 112.328 -0.309 . . . . 70.02 112.328 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 170' ' ' LYS . . . . . 0.413 ' HD2' ' H ' ' G' ' 170' ' ' LYS . 0.0 OUTLIER -132.18 -179.09 5.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.757 1.223 . . . . 74.52 108.755 173.419 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 49.9 m -65.57 94.48 0.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.721 0.808 . . . . 72.44 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -176.51 176.61 1.56 Allowed 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.947 0.899 . . . . 43.32 111.606 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 85.5 mt 70.11 102.1 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.568 1.547 . . . . 70.2 112.34 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' G' ' 174' ' ' MET . 0.9 OUTLIER 78.03 -33.07 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.237 1.815 . . . . 74.33 112.787 171.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -164.81 -167.64 1.28 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.059 0.944 . . . . 74.12 108.573 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 69.88 104.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.067 1.347 . . . . 74.3 110.355 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.63 -17.77 0.69 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.666 0.786 . . . . 64.22 110.166 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 59.76 -82.59 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.72 1.608 . . . . 71.42 112.683 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.29 85.51 56.57 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.61 -1.255 . . . . 75.11 107.61 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.89 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.806 2.338 . . . . 75.34 112.418 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -170.84 170.07 6.6 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 125.44 1.496 . . . . 75.34 107.562 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -57.87 138.94 55.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.043 0.537 . . . . 74.4 110.814 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 31.8 m -72.58 131.39 42.4 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 74.32 109.216 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -63.39 134.46 95.86 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 123.766 0.666 . . . . 64.13 110.382 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -52.06 113.09 1.03 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.931 2.421 . . . . 62.24 112.413 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.29 156.55 34.04 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.844 -0.616 . . . . 73.21 111.209 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 79.3 mt -66.54 112.03 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.164 -0.926 . . . . 73.4 109.66 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.23 -58.39 7.32 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.206 0.941 . . . . 64.41 110.755 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 189' ' ' ALA . . . . . 0.677 ' HA ' ' HB3' ' H' ' 203' ' ' ASP . . . 49.55 69.35 0.6 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.496 1.118 . . . . 52.44 112.234 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -68.13 -27.19 66.24 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.63 -0.714 . . . . 64.03 111.124 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 81.05 -141.3 22.28 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.581 -0.736 . . . . 74.4 112.279 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 192' ' ' GLY . . . . . 0.455 ' O ' ' HD2' ' A' ' 38' ' ' PRO . . . 147.83 -164.63 28.85 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.535 -0.626 . . . . 64.04 111.535 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 193' ' ' TYR . . . . . 0.717 ' HE1' ' HB3' ' A' ' 35' ' ' ASP . 81.2 m-85 -82.72 148.25 27.99 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.428 . . . . 63.2 112.009 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 194' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' H' ' 197' ' ' TYR . . . -151.29 -70.33 0.17 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.641 -1.163 . . . . 71.13 108.321 174.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.57 132.43 34.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.66 0.784 . . . . 73.45 111.597 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -173.4 112.85 0.21 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.192 -1.411 . . . . 73.5 107.192 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -139.41 108.02 5.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.403 0.681 . . . . 74.12 110.112 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.78 -153.57 0.49 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.456 1.102 . . . . 74.24 109.228 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 8.4 t30 76.5 -72.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.599 1.56 . . . . 60.02 111.056 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.04 138.15 4.01 Favored Glycine 0 C--O 1.246 0.858 0 N-CA-C 110.167 -1.173 . . . . 43.42 110.167 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -155.53 -176.59 6.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.266 0.533 . . . . 70.32 109.917 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -60.72 94.61 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.847 -1.538 . . . . 73.23 106.847 159.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -72.47 -61.19 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.876 -1.056 . . . . 74.41 111.116 -165.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.401 ' O ' ' HG2' ' B' ' 12' ' ' GLN . 8.4 tp -174.38 -39.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.377 -1.283 . . . . 64.53 108.634 -170.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 205' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' G' ' 205' ' ' LYS . 18.7 pttp -79.77 -127.63 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.674 1.59 . . . . 75.2 109.356 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 68.51 29.58 5.56 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.032 0.933 . . . . 72.22 111.258 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.533 -1.212 . . . . 75.23 109.3 174.707 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 25.9 pttm . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 111.307 0.114 . . . . 73.22 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.39 71.94 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.124 0.393 . . . . 75.44 113.407 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 170' ' ' LYS . . . . . 0.449 ' HB2' ' ND2' ' H' ' 176' ' ' ASN . 0.1 OUTLIER -78.05 151.65 33.37 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.728 0.811 . . . . 62.13 110.532 173.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 48.4 t -160.85 -59.64 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.755 0.422 . . . . 64.4 110.114 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -162.26 175.84 11.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.271 1.029 . . . . 61.11 109.945 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 1.1 tt 70.14 106.98 0.06 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.859 1.264 . . . . 72.15 109.418 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 17.2 mmt 65.21 93.55 0.06 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.903 1.281 . . . . 71.54 110.231 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.48 -155.27 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.696 1.198 . . . . 64.41 110.197 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 176' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' H' ' 170' ' ' LYS . 4.9 m120 69.1 80.33 0.19 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.567 1.147 . . . . 74.31 109.453 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 177' ' ' LEU . . . . . 0.41 ' H ' ' H ' ' H' ' 178' ' ' GLN . 2.4 pt? -163.51 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.598 -0.728 . . . . 73.34 111.448 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 178' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' H' ' 177' ' ' LEU . 53.1 tt0 -66.55 -35.97 81.53 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.399 0.68 . . . . 72.13 112.009 -173.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -64.01 -50.48 69.19 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.675 -0.679 . . . . 62.55 111.654 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.09 5.67 6.08 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.187 1.924 . . . . 72.11 113.694 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -100.85 -179.56 4.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.552 0.741 . . . . 72.02 111.284 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -149.07 174.27 12.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.602 1.161 . . . . 75.33 109.789 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 69.1 p -70.3 99.69 1.59 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.852 -0.796 . . . . 75.13 108.852 174.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -66.0 112.06 8.02 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.068 0.947 . . . . 75.15 112.074 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.66 107.31 2.42 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.376 2.051 . . . . 75.52 110.665 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.49 -71.24 0.19 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.527 0.731 . . . . 71.23 110.916 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 80.3 mt -140.45 137.0 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.231 1.012 . . . . 45.41 108.569 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.75 75.0 9.71 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.768 -0.827 . . . . 72.24 108.768 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.9 154.87 31.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.317 -0.856 . . . . 53.2 110.542 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.64 -77.11 0.42 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.155 0.582 . . . . 71.44 109.511 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.46 -80.03 1.18 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.774 -0.53 . . . . 53.31 111.774 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.73 -65.94 3.11 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.797 0.351 . . . . 72.53 112.626 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.545 ' HA ' ' H ' ' D' ' 37' ' ' GLN . 24.7 p90 -140.03 125.13 18.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.495 0.718 . . . . 71.12 109.118 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -167.28 -42.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.349 1.059 . . . . 41.43 108.735 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -67.44 96.94 0.54 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.574 -1.194 . . . . 73.01 110.22 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -120.32 112.24 18.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.002 0.921 . . . . 72.24 109.099 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 197' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' D' ' 32' ' ' PHE . 4.0 p90 -138.23 155.0 49.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.691 0.396 . . . . 63.41 110.155 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 198' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' H' ' 200' ' ' GLY . 11.6 pt-20 -170.02 -154.26 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.272 1.029 . . . . 75.25 108.417 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.43 1.59 9.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.551 0.741 . . . . 70.32 112.138 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 200' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' H' ' 198' ' ' GLU . . . -78.44 60.78 3.97 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 121.098 0.277 . . . . 71.44 112.489 174.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.47 -19.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.871 1.268 . . . . 75.4 110.293 -175.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -170.5 147.43 2.94 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.925 0.89 . . . . 63.34 109.778 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 203' ' ' ASP . . . . . 0.677 ' HB3' ' HA ' ' G' ' 189' ' ' ALA . 22.6 t70 -148.83 147.53 28.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.939 0.495 . . . . 72.14 111.188 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.17 104.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.379 1.472 . . . . 54.04 108.724 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.94 32.58 5.52 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.145 0.578 . . . . 74.42 111.019 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -125.71 -53.39 1.56 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.992 -0.744 . . . . 74.33 108.992 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.15 0.98 . . . . 73.23 108.692 172.109 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.778 -0.452 . . . . 74.34 109.778 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -152.33 -43.93 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.964 1.306 . . . . 75.41 108.049 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -81.81 169.52 16.79 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.474 -0.784 . . . . 64.22 109.565 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -72.12 -45.04 62.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 171.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -75.89 119.82 20.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.379 -0.828 . . . . 74.1 109.56 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -135.19 91.56 2.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.062 0.945 . . . . 62.43 109.237 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m 62.07 78.41 0.29 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.324 1.05 . . . . 65.31 110.385 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.15 95.71 5.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.195 -0.912 . . . . 72.32 109.089 -173.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtt -88.97 175.45 7.41 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.664 -0.698 . . . . 53.14 109.661 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.9 m -140.34 109.16 5.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.212 -1.033 . . . . 65.41 108.212 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.508 ' HB3' ' SD ' ' C' ' 138' ' ' MET . 60.3 t80 -135.04 135.91 41.67 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.287 -1.005 . . . . 63.4 108.287 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.48 135.7 15.79 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 116.134 -0.485 . . . . 61.34 110.2 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' C' ' 135' ' ' ALA . 3.7 mp -79.82 117.73 26.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.667 -0.864 . . . . 55.23 108.667 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -89.27 -39.65 13.35 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.155 0.582 . . . . 72.34 109.701 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -172.71 123.78 0.45 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.307 0.243 . . . . 74.1 111.078 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.82 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 85.6 mt -108.17 132.73 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 123.611 0.764 . . . . 74.31 109.208 173.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.702 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 9.3 p90 -167.73 170.74 10.65 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.047 0.939 . . . . 63.15 110.13 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -88.46 134.86 33.73 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.694 -0.854 . . . . 75.24 108.694 171.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 46.9 mtpt -94.44 -43.32 8.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.927 -0.768 . . . . 62.21 108.927 170.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 28.1 t70 -137.54 129.5 28.91 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.709 -1.132 . . . . 74.21 109.604 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -124.36 136.15 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.416 -1.328 . . . . 61.54 107.416 170.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -145.89 112.75 6.03 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 123.519 0.512 . . . . 62.31 109.725 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.567 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 77.7 t80 -114.23 111.78 22.08 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 106.609 -1.626 . . . . 65.01 106.609 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.76 110.19 16.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.976 -0.75 . . . . 75.01 108.976 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.47 93.04 7.75 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.566 -1.272 . . . . 70.14 107.566 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.46 -41.01 7.02 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.457 2.105 . . . . 65.1 111.182 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 78.0 m-20 -100.56 37.51 1.68 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.651 -1.159 . . . . 75.22 109.303 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.34 73.2 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.131 -0.938 . . . . 74.44 113.43 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.33 -27.93 10.92 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 121.541 1.586 . . . . 71.04 112.924 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 14.3 t60 -67.58 -26.26 66.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.761 1.224 . . . . 62.34 112.151 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 HD11 ' A' ' 68' ' ' LEU . 12.0 p -55.75 -30.18 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.517 1.127 . . . . 74.14 112.908 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.6 -34.46 75.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.892 0.877 . . . . 73.23 111.21 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -69.64 -32.03 70.47 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.282 1.033 . . . . 75.21 110.267 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -79.14 162.32 25.88 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.683 -1.144 . . . . 74.45 111.06 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.1 143.08 30.79 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 108.316 -0.994 . . . . 74.35 108.316 164.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.547 ' H ' ' HA ' ' G' ' 196' ' ' LYS . 62.8 t-105 -83.68 83.88 7.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.756 0.789 . . . . 75.02 110.038 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.67 69.77 16.97 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.416 1.086 . . . . 73.42 108.318 176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.27 110.02 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.534 2.156 . . . . 73.25 112.704 -170.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.671 ' HA ' ' HA2' ' G' ' 191' ' ' GLY . 44.8 tt0 -94.11 114.4 26.53 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.634 -1.247 . . . . 74.02 107.634 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 65' ' ' THR . 22.8 m -87.63 118.25 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.066 -0.97 . . . . 63.03 110.877 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 64.1 tttm -85.33 116.74 23.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.198 -0.91 . . . . 64.13 108.753 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.34 123.51 41.19 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.863 -0.608 . . . . 51.44 110.206 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.1 m-20 -115.32 122.92 47.37 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.061 -1.089 . . . . 71.41 108.061 170.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD23 ' HE2' ' A' ' 133' ' ' PHE . 34.1 tp -124.21 121.23 34.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.033 -0.729 . . . . 71.43 109.033 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.15 146.06 34.89 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.893 0.877 . . . . 73.34 110.017 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -109.29 150.11 28.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.405 0.682 . . . . 73.33 109.811 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.28 154.17 49.04 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.767 1.227 . . . . 54.34 108.085 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -130.55 152.79 49.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.86 0.464 . . . . 70.33 110.454 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.9 t -154.66 119.38 4.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.213 1.005 . . . . 62.42 108.537 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -91.47 118.67 30.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.183 -1.043 . . . . 62.34 108.183 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 57' ' ' GLU . 40.5 mt -93.24 -33.27 14.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.751 0.82 . . . . 71.52 110.129 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.97 -169.97 1.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.307 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.68 106.31 0.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.898 1.279 . . . . 72.34 109.964 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.96 8.18 6.3 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.541 1.136 . . . . 74.44 112.515 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.36 19.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.736 -1.209 . . . . 71.43 107.736 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.554 ' HE1' ' HB2' ' G' ' 175' ' ' PHE . 9.2 m-85 -122.32 123.32 41.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.442 -0.799 . . . . 71.15 109.592 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.9 tt0 -93.64 128.07 39.64 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.878 -1.055 . . . . 64.43 108.796 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.8 t -101.3 124.86 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.75 . . . . 74.34 106.276 166.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.9 t -101.83 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.725 -0.843 . . . . 45.02 108.725 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -102.85 107.05 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.127 -1.064 . . . . 63.54 108.127 -175.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -103.68 110.53 22.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.952 0.901 . . . . 74.1 109.984 -173.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.01 132.07 66.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.97 -1.013 . . . . 75.23 108.729 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.1 m -121.92 123.22 41.19 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.533 -0.543 . . . . 75.51 109.533 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 114' ' ' ILE . 52.4 t -116.69 107.23 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.727 1.211 . . . . 65.44 108.453 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.8 m -102.2 149.81 23.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.132 -1.062 . . . . 44.25 108.132 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.19 122.67 30.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.623 -0.51 . . . . 64.31 109.623 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -117.74 126.61 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.238 0.615 . . . . 75.1 110.39 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD11 HG23 ' A' ' 31' ' ' VAL . 28.8 mt -92.92 82.42 4.66 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.791 -1.559 . . . . 65.51 106.791 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -83.63 1.0 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.177 -1.169 . . . . 50.53 110.177 -167.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.93 -18.2 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.472 1.109 . . . . 75.45 110.321 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.44 108.86 12.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.41 1.084 . . . . 73.43 110.505 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 m -66.16 119.15 10.95 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.967 0.348 . . . . 72.43 111.106 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.09 -50.89 17.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.184 0.994 . . . . 64.43 109.336 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -159.9 173.15 16.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 113.607 -1.633 . . . . 71.23 110.174 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 76' ' ' CYS . 19.0 tp -141.1 141.2 34.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.737 1.215 . . . . 60.4 107.811 173.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.567 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 36.2 m -132.25 141.51 49.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.854 0.862 . . . . 71.13 108.877 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.99 121.39 9.65 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.568 -0.901 . . . . 70.13 108.568 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.49 112.38 29.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.524 0.73 . . . . 74.43 109.542 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -88.73 87.2 7.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.536 -1.211 . . . . 71.11 109.086 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -77.15 95.55 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.716 -1.129 . . . . 75.25 109.29 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.82 142.95 19.56 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.912 -0.475 . . . . 65.43 111.912 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.43 122.66 2.33 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 110.865 -0.894 . . . . 72.34 110.865 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.3 mt -79.76 131.0 35.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.726 -1.212 . . . . 62.02 107.726 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD2' ' HA ' ' A' ' 13' ' ' ILE . 39.2 m-85 -135.9 138.34 42.32 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.197 0.599 . . . . 75.41 109.577 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.9 m -87.62 121.46 30.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 63.51 108.94 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.37 136.09 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.57 0.748 . . . . 72.23 111.26 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.27 174.31 3.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.711 1.204 . . . . 54.5 110.155 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.41 9.62 86.73 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-N 116.509 -0.314 . . . . 54.32 113.833 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 94' ' ' MET . 1.8 pp -120.22 149.4 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.311 1.044 . . . . 64.31 111.02 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.8 174.55 10.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.597 0.759 . . . . 74.33 110.634 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.43 -140.43 40.12 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 115.683 1.033 . . . . 75.24 115.683 167.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -78.63 -12.04 60.0 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.308 1.043 . . . . 71.53 111.064 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -36.9 79.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.752 0.821 . . . . 63.44 110.091 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.519 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 26.2 ptm -75.69 -20.15 58.61 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.397 -0.365 . . . . 74.22 111.191 174.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' HA ' HD21 ' G' ' 177' ' ' LEU . . . -66.05 -23.8 66.61 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.781 0.432 . . . . 73.0 111.553 177.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' CD2' ' HB2' ' A' ' 134' ' ' ASP . 10.8 t-160 -62.86 -45.0 94.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 72.22 110.522 169.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 41.9 t -68.85 -64.52 0.85 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.704 0.802 . . . . 72.52 111.601 -173.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.58 -26.1 61.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.557 0.343 . . . . 74.33 111.688 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.05 -34.15 11.21 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 114.659 0.624 . . . . 52.22 114.659 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.99 -39.25 0.41 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.96 0.88 . . . . 74.42 113.067 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.1 t80 -69.8 -58.96 3.26 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.844 0.458 . . . . 75.32 111.632 -174.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -67.19 -37.46 13.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.748 0.819 . . . . 75.42 112.66 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.17 -43.56 47.85 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.124 1.883 . . . . 75.13 113.309 162.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.3 -25.43 62.43 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.17 0.588 . . . . 75.5 111.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.0 mm -62.33 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.595 0.712 . . . . 74.44 109.176 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.566 HD21 ' HA3' ' A' ' 82' ' ' GLY . 45.5 mt -81.12 -18.74 45.4 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.584 -1.189 . . . . 52.43 112.061 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.481 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 51.4 t80 -63.42 -42.54 74.7 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 113.966 1.098 . . . . 75.21 113.966 -171.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.514 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 73.6 Cg_exo -55.13 -33.19 83.06 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 122.101 1.867 . . . . 73.5 113.785 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.94 -40.14 24.99 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.265 -0.88 . . . . 73.43 111.317 -175.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.06 -41.14 82.42 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.457 0.303 . . . . 63.22 110.586 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.523 ' NH1' HG23 ' C' ' 105' ' ' ILE . 34.0 ttm180 -51.98 -55.72 18.67 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.528 1.142 . . . . 75.33 109.537 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.45 -42.17 99.27 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.676 1.235 . . . . 75.35 111.845 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.466 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.5 t -57.54 -50.21 73.82 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.967 0.792 . . . . 72.11 110.302 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.1 mt -62.63 -46.5 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.141 -0.936 . . . . 64.33 110.667 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' HE2' ' C' ' 109' ' ' TYR . 82.0 m -54.41 -44.49 72.41 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.253 1.021 . . . . 64.4 110.902 -176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.2 t -72.13 -34.81 68.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.547 -1.206 . . . . 73.22 111.035 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.9 mtp -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.516 0.726 . . . . 65.12 111.193 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -59.97 -52.08 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.008 0.923 . . . . 75.54 110.064 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 71.1 p -68.04 -26.71 66.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.17 -0.923 . . . . 75.12 112.151 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.9 ttm-85 -72.81 -25.49 61.16 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.877 0.871 . . . . 60.3 109.985 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 22.16 12.03 Favored Glycine 0 C--N 1.358 1.791 0 CA-C-N 116.027 -0.533 . . . . 62.11 113.06 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t 55.96 27.86 11.82 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 127.154 2.182 . . . . 74.33 113.664 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 119' ' ' SER . 36.1 m-85 -98.48 153.15 38.11 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.398 0.679 . . . . 63.23 110.191 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.74 118.94 5.78 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.501 2.134 . . . . 74.1 111.14 166.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 3.3 pt20 -64.23 150.35 46.09 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.391 0.676 . . . . 43.21 112.345 -171.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -109.21 101.24 10.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 109.029 -0.73 . . . . 62.35 109.029 -171.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.468 ' ND2' ' HB ' ' C' ' 16' ' ' ILE . 10.9 m120 -98.2 84.7 3.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.735 -0.839 . . . . 71.14 108.735 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.481 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -59.43 139.95 56.61 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.875 0.87 . . . . 74.11 110.017 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' HD13 ' A' ' 128' ' ' LEU . . . -60.78 132.71 91.74 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.316 0.647 . . . . 62.14 111.852 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.456 ' HB3' ' NH2' ' A' ' 111' ' ' ARG . 39.8 Cg_endo -72.07 101.73 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.396 2.064 . . . . 73.21 111.483 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -101.03 111.52 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 122.389 1.09 . . . . 73.34 110.711 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -99.16 70.03 1.75 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.965 -1.471 . . . . 70.14 108.526 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.498 ' HE2' HD23 ' A' ' 44' ' ' LEU . 21.7 m-85 -57.18 -33.16 67.17 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 75.33 112.289 -175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 96' ' ' HIS . 9.8 p-10 -74.98 -36.32 62.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.657 0.783 . . . . 61.12 111.001 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.41 -29.37 52.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.454 0.702 . . . . 74.14 110.828 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.79 -38.32 76.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.709 1.204 . . . . 74.31 108.924 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.04 -22.14 29.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.602 -0.727 . . . . 73.43 111.073 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -61.26 -46.54 89.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.504 0.722 . . . . 71.24 111.067 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -68.4 -17.66 64.27 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.902 -0.59 . . . . 70.21 111.499 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -91.85 -35.51 14.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.887 0.875 . . . . 73.31 111.289 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.1 -23.2 67.23 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.36 1.464 . . . . 74.04 110.648 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -146.31 33.77 0.98 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.451 -0.944 . . . . 75.32 108.451 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.17 97.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.02 1.728 . . . . 62.13 114.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -174.44 123.05 0.28 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.97 1.308 . . . . 52.12 107.723 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.93 120.17 18.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.243 0.617 . . . . 71.15 110.544 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.8 39.47 0.43 Allowed Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.79 -0.524 . . . . 60.34 111.79 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.32 141.34 34.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.127 0.571 . . . . 72.32 110.455 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.69 49.87 0.2 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.455 -1.058 . . . . 33.55 110.455 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.7 p -89.31 109.42 20.32 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.384 0.673 . . . . 63.04 109.232 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.86 78.48 3.45 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.038 0.935 . . . . 73.25 109.478 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -97.21 78.62 2.76 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.441 0.696 . . . . 72.31 109.864 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -88.8 -45.8 9.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.225 -1.028 . . . . 74.22 108.225 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.93 131.55 43.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.292 0.637 . . . . 72.12 109.343 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' C' ' 141' ' ' LEU . 4.1 p-10 -97.38 -26.2 14.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.261 0.624 . . . . 70.01 111.095 -175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 O-C-N 124.074 0.859 . . . . 72.14 109.22 -176.023 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.427 -0.583 . . . . 73.3 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -153.42 117.84 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.491 0.716 . . . . 62.31 109.57 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.3 103.75 7.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.518 0.727 . . . . 71.24 109.284 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.82 88.78 1.2 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.014 -1.476 . . . . 63.13 107.014 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.97 -21.25 66.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.617 -1.174 . . . . 72.23 112.073 -174.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -87.92 66.81 8.84 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.757 0.789 . . . . 74.32 108.893 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -95.03 150.82 19.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.83 -0.623 . . . . 63.31 110.595 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.34 -29.45 57.24 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.483 0.713 . . . . 75.25 109.759 173.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.625 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.9 ptm 55.98 172.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.272 2.229 . . . . 74.12 114.575 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -157.37 130.09 7.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.681 1.193 . . . . 71.33 107.8 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -137.21 140.48 41.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.179 -0.674 . . . . 71.44 109.179 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 6.7 tp-100 -142.68 115.46 8.68 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.171 -0.677 . . . . 51.41 109.171 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.409 HD11 HG13 ' B' ' 16' ' ' ILE . 6.8 tp -68.88 127.6 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.953 -0.758 . . . . 63.22 108.953 171.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.78 -45.55 3.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.873 0.469 . . . . 63.23 110.332 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -167.09 143.74 4.48 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.329 0.393 . . . . 63.13 110.689 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.409 HG13 HD11 ' B' ' 13' ' ' ILE . 92.8 mt -120.04 143.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.442 -1.318 . . . . 73.5 107.442 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.445 ' HE1' HG13 ' B' ' 83' ' ' ILE . 22.1 p90 -173.19 156.27 3.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.167 0.508 . . . . 73.51 111.461 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -84.1 128.98 34.91 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.93 -0.767 . . . . 63.11 108.93 169.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.5 mtpt -90.41 -43.49 10.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.496 0.718 . . . . 75.3 109.738 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.0 t70 -148.19 142.44 26.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.316 -0.856 . . . . 74.34 111.323 -172.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 41.3 mm -128.27 135.36 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 124.768 1.227 . . . . 63.12 108.878 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.8 t -130.39 128.83 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.611 -1.177 . . . . 75.11 108.067 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 72.5 t80 -150.08 110.33 4.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.793 -1.558 . . . . 75.22 106.793 171.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.41 113.93 18.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.979 -1.119 . . . . 71.03 107.979 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.07 89.64 5.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.703 0.801 . . . . 73.24 108.903 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 44.7 Cg_endo -63.57 -38.28 42.48 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.25 2.634 . . . . 74.1 112.844 -171.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.33 30.69 6.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.302 1.041 . . . . 75.02 109.559 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.702 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.4 -50.02 51.0 Favored Pre-proline 0 CA--C 1.566 1.57 0 N-CA-C 114.856 1.428 . . . . 32.43 114.856 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.9 Cg_endo -77.68 -23.28 9.8 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.871 1.714 . . . . 43.32 112.738 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -78.38 -8.29 58.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.568 0.747 . . . . 75.35 111.437 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.01 -24.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.074 0.95 . . . . 71.33 111.027 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -66.13 -43.49 86.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.665 0.386 . . . . 71.12 110.975 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -72.54 -36.59 68.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.709 0.804 . . . . 62.34 110.049 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.38 76.6 10.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.651 0.739 . . . . 72.11 109.786 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.79 79.34 6.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.595 -1.184 . . . . 55.52 110.641 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -173.29 156.95 3.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.142 0.977 . . . . 72.02 109.482 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -58.54 128.38 83.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.881 0.872 . . . . 75.25 110.699 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -66.01 152.6 80.91 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.19 1.26 . . . . 73.34 110.281 168.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.27 101.66 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.026 -1.101 . . . . 74.12 108.026 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.594 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.2 t -84.58 123.21 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.143 -1.428 . . . . 42.34 107.143 -174.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 64' ' ' VAL . 1.5 tmtp? -145.83 113.97 6.59 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.629 -0.508 . . . . 61.45 109.629 -174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.71 148.48 23.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.646 0.779 . . . . 74.5 109.157 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.39 150.33 43.76 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.13 -1.063 . . . . 53.14 108.13 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.401 HD12 HG11 ' B' ' 131' ' ' VAL . 5.5 tt -109.92 125.73 53.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.351 0.66 . . . . 74.44 109.257 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -134.46 136.19 43.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.884 -1.154 . . . . 73.24 107.884 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -108.41 146.16 33.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.274 0.559 . . . . 62.14 109.957 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.75 159.17 42.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.5 1.12 . . . . 71.4 108.405 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.519 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 81.2 p -143.54 162.35 36.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.945 0.402 . . . . 43.22 110.94 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -160.48 154.36 22.75 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.781 1.233 . . . . 75.0 108.91 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -121.76 135.07 54.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.166 0.587 . . . . 75.15 109.657 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.5 mt -100.66 -47.9 4.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.474 0.71 . . . . 75.24 109.517 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.06 -175.39 5.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.99 -1.005 . . . . 60.21 110.295 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -71.83 130.11 40.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.736 -1.12 . . . . 70.13 109.072 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 66.07 -8.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.47 1.508 . . . . 64.32 112.743 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.02 94.18 2.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 107.942 -1.133 . . . . 63.43 107.942 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.519 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 2.8 t80 -98.12 165.32 11.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.701 -1.136 . . . . 74.31 109.134 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.8 106.01 4.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.548 -1.278 . . . . 70.02 107.548 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 56.7 t -97.94 131.5 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.205 0.602 . . . . 71.24 109.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 34.7 t -108.92 125.28 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.716 0.806 . . . . 53.14 109.726 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.455 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.25 130.95 40.31 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.511 -1.292 . . . . 64.4 107.511 172.167 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -121.26 106.74 11.77 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.681 . . . . 71.32 109.497 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.1 124.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.537 -0.912 . . . . 75.42 108.537 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.1 m -120.35 146.91 45.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.398 . . . . 63.15 110.931 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 55.1 t -116.88 120.1 64.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 124.644 1.177 . . . . 75.51 109.577 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.3 m -99.24 127.93 45.29 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.981 -1.488 . . . . 74.31 106.981 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.59 132.43 18.03 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.582 -0.896 . . . . 72.14 108.582 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -148.55 139.31 22.88 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.587 0.554 . . . . 51.44 111.803 -170.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 51.2 mt -100.24 100.28 11.08 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.054 1.342 . . . . 74.44 109.587 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.66 -111.18 3.61 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.801 -0.52 . . . . 73.45 111.801 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -108.16 4.43 24.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.566 0.747 . . . . 43.34 111.536 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -121.07 160.31 23.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.693 0.797 . . . . 73.43 109.843 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.9 m -78.74 136.99 37.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.738 0.415 . . . . 65.33 110.515 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -82.33 -61.42 1.9 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.412 1.101 . . . . 65.42 109.024 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' B' ' 76' ' ' CYS . 1.2 p90 -154.17 171.79 18.61 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 112.892 -1.958 . . . . 72.23 107.623 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -136.57 110.17 8.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.907 -1.886 . . . . 74.04 105.907 167.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.484 ' HB2' ' HD1' ' B' ' 23' ' ' PHE . 1.8 t -113.76 160.22 18.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.094 -0.503 . . . . 71.31 110.292 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.2 tt0 -164.98 143.73 6.59 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.653 -1.24 . . . . 75.24 107.653 -170.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.16 144.01 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.786 0.834 . . . . 73.13 108.871 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.69 92.53 3.73 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.748 0.819 . . . . 74.23 108.911 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -88.54 100.73 13.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.736 -1.12 . . . . 74.24 108.809 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.39 174.52 33.74 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 111.838 -0.505 . . . . 74.02 111.838 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.29 136.5 4.07 Favored Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.729 -0.548 . . . . 74.34 111.729 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.445 HG13 ' HE1' ' B' ' 17' ' ' TYR . 34.5 mt -86.15 124.88 40.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.445 -0.946 . . . . 72.23 108.445 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -138.61 131.53 29.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.976 -1.12 . . . . 74.01 107.976 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 75.1 m -91.03 107.37 19.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.716 -0.476 . . . . 75.12 109.716 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.505 ' HB ' HD11 ' B' ' 89' ' ' ILE . 24.7 pt -106.24 142.85 18.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.358 -0.837 . . . . 70.41 110.817 -176.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.38 166.13 33.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.313 1.045 . . . . 52.11 108.739 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.63 -53.33 4.84 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.924 -0.375 . . . . 53.3 113.523 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.5 pp -51.98 126.07 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.036 0.934 . . . . 73.11 112.474 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.561 ' HB3' ' HG ' ' F' ' 173' ' ' LEU . 10.2 pt-20 -159.36 154.36 24.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 73.01 110.768 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.33 -122.93 22.19 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.578 -0.737 . . . . 74.35 112.188 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -68.52 -31.27 70.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.66 0.784 . . . . 72.03 110.936 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -72.8 -34.85 67.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.642 0.777 . . . . 74.34 110.763 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.447 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 54.1 ttm -62.79 -49.23 75.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.527 -0.761 . . . . 75.13 109.36 171.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.0 -28.79 69.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.697 0.799 . . . . 65.41 112.071 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -69.83 -44.73 69.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 74.33 110.034 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 45.5 t -63.91 -59.47 4.47 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.753 0.821 . . . . 62.44 111.535 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.449 HD12 ' N ' ' B' ' 99' ' ' GLY . 4.2 pp -71.12 -28.66 64.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.475 0.71 . . . . 75.13 112.486 -175.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.449 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -94.42 -38.41 5.04 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.478 -0.328 . . . . 22.12 113.521 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 104' ' ' ASN . . . -125.9 -45.17 1.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 118.984 -0.531 . . . . 52.41 112.223 -171.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.454 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 93.0 t80 -71.04 -63.86 1.02 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.17 0.441 . . . . 74.53 111.819 -169.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.46 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 58.1 m -58.32 -45.99 99.67 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.777 -0.63 . . . . 73.13 111.1 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.3 Cg_exo -54.04 -38.91 87.15 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.314 2.009 . . . . 65.22 114.228 167.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 14.1 t-20 -68.52 -30.14 68.88 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.576 0.626 . . . . 64.12 111.49 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.8 -50.18 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.528 0.68 . . . . 74.24 109.206 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.41 -13.5 59.91 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 113.841 -1.527 . . . . 74.42 111.963 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 55.2 t80 -67.56 -49.3 41.38 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 117.821 -1.085 . . . . 70.5 113.792 -166.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.21 -32.42 90.63 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.45 1.433 . . . . 71.45 112.231 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -65.23 -49.85 68.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 71.3 110.531 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.55 99.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.873 0.869 . . . . 73.14 111.15 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -61.28 -49.14 78.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.53 1.532 . . . . 73.51 111.265 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -36.85 77.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.512 -0.551 . . . . 74.42 109.512 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 37.9 t -62.18 -39.27 92.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.326 0.65 . . . . 73.41 112.217 -178.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mt -63.51 -51.84 65.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.716 -0.476 . . . . 63.23 109.716 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.9 m -61.52 -24.42 66.61 Favored 'General case' 0 CA--C 1.561 1.371 0 O-C-N 124.31 1.006 . . . . 74.12 111.438 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.4 t -69.74 -58.59 3.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.971 0.909 . . . . 64.15 109.884 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.483 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.4 mmt -65.9 -28.08 68.68 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.309 0.576 . . . . 71.43 111.477 -176.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -52.35 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.726 1.61 . . . . 65.41 109.548 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 96.7 p -65.97 -31.6 72.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.015 0.526 . . . . 71.51 111.007 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 79.8 mtt-85 -62.17 -39.85 94.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.406 0.682 . . . . 65.24 110.721 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 9.21 71.15 Favored Glycine 0 C--N 1.353 1.475 0 O-C-N 123.349 0.406 . . . . 62.04 113.489 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p 58.95 30.7 20.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.406 1.882 . . . . 71.41 112.362 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.84 161.53 35.6 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.749 1.22 . . . . 65.3 110.899 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.594 ' HB2' HG21 ' B' ' 40' ' ' VAL . 14.8 Cg_exo -74.89 145.46 31.94 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 124.157 3.238 . . . . 73.22 115.46 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.485 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.4 OUTLIER -67.41 143.13 56.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.25 1.42 . . . . 75.23 111.936 177.2 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.28 113.73 4.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.95 -1.13 . . . . 74.13 107.95 163.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -89.01 116.02 26.99 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.147 -1.057 . . . . 65.2 108.147 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.65 ' HA ' HD12 ' F' ' 187' ' ' ILE . 2.3 tt -66.34 137.48 56.94 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.853 0.721 . . . . 74.44 110.063 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.505 ' HB2' ' HE2' ' E' ' 202' ' ' TYR . . . -55.11 152.89 13.5 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 126.138 1.775 . . . . 70.23 113.539 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.646 ' HG3' HD11 ' D' ' 16' ' ' ILE . 92.6 Cg_endo -69.72 103.98 1.24 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.807 2.338 . . . . 72.44 110.701 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.401 HG11 HD12 ' B' ' 44' ' ' LEU . 16.6 m -85.29 52.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 122.374 1.083 . . . . 61.24 111.096 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.46 71.27 4.92 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.402 -1.333 . . . . 73.43 107.402 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -66.47 -31.1 71.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.308 -1.315 . . . . 73.5 110.974 -171.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.42 -42.95 88.37 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.212 0.945 . . . . 73.33 111.301 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -48.76 76.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.457 0.703 . . . . 55.04 111.481 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.15 -47.91 75.39 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.756 0.823 . . . . 43.54 110.136 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -62.75 -29.79 70.95 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.399 1.08 . . . . 73.41 111.565 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' B' ' 142' ' ' GLN . 1.4 tmt? -67.49 -37.18 82.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.244 0.618 . . . . 72.12 110.931 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -92.2 -18.21 23.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.972 0.509 . . . . 70.12 111.515 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -88.49 -48.38 7.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.666 0.386 . . . . 74.4 110.686 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.423 HD13 ' O ' ' B' ' 141' ' ' LEU . 2.0 tm? -90.02 -8.98 50.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.5 0.72 . . . . 74.04 109.778 -176.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' B' ' 138' ' ' MET . 6.3 tp-100 -132.88 108.41 8.92 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 70.11 108.872 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -78.23 125.84 29.94 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.143 -1.058 . . . . 73.53 108.143 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.54 144.66 50.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.783 0.833 . . . . 72.02 108.936 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.08 152.16 40.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.549 0.74 . . . . 64.22 111.087 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.51 2.75 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.958 -0.457 . . . . 70.4 111.958 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLU . . . . . 0.43 ' HG3' ' HB1' ' D' ' 87' ' ' ALA . 10.5 pt-20 -152.65 162.73 40.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.593 1.157 . . . . 71.35 108.756 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.71 171.36 12.96 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 112.268 -0.333 . . . . 54.4 112.268 -176.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.2 t -79.54 32.3 0.24 Allowed 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.782 1.03 . . . . 71.52 113.782 -168.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.55 80.73 4.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.767 -1.197 . . . . 75.34 107.767 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.46 89.9 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.7 0.8 . . . . 75.05 112.528 -166.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' HIS . . . . . 0.462 ' H ' HG21 ' D' ' 7' ' ' THR . 40.8 m170 -93.64 146.51 23.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.219 1.008 . . . . 74.33 109.897 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -88.8 5.41 43.73 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.107 0.963 . . . . 54.45 111.177 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.23 157.36 16.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.816 0.847 . . . . 64.25 110.646 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.019 0.928 . . . . 62.3 111.041 -174.969 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 108.619 -0.882 . . . . 72.34 108.619 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -161.31 176.68 10.93 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.683 -1.144 . . . . 61.52 109.809 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.59 22.39 4.69 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.175 0.99 . . . . 70.12 110.781 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -52.95 140.89 23.5 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.921 0.888 . . . . 74.24 110.883 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -81.45 66.59 7.07 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.085 0.945 . . . . 74.45 110.429 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -146.73 170.44 16.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.209 1.404 . . . . 61.35 107.946 -177.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.7 p -76.8 135.5 38.94 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.698 0.399 . . . . 64.41 110.615 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -33.28 59.56 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.555 1.142 . . . . 73.01 112.396 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.618 ' HG3' HG22 ' C' ' 89' ' ' ILE . 23.7 ttt 64.81 114.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 74.32 111.413 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m -96.04 117.41 30.62 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.167 0.587 . . . . 43.23 110.49 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.501 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 44.0 t80 -125.31 118.64 26.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.953 -1.128 . . . . 74.55 107.953 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.442 ' NE2' ' HG2' ' C' ' 14' ' ' GLN . 11.9 tm0? -136.12 127.57 28.58 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 117.943 0.338 . . . . 75.34 110.235 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -89.15 129.03 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.224 -0.658 . . . . 73.31 109.224 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.442 ' HG2' ' NE2' ' C' ' 12' ' ' GLN . 5.5 mt-30 -99.99 -42.2 6.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.413 0.685 . . . . 73.14 110.42 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.498 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 60.6 ttt180 -174.6 128.19 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.153 0.581 . . . . 75.33 110.11 -168.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.468 ' HB ' ' ND2' ' A' ' 127' ' ' ASN . 68.2 mt -112.85 142.1 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.961 -1.126 . . . . 64.41 107.961 172.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.556 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 26.2 p90 -177.84 161.37 1.59 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.824 0.703 . . . . 72.25 110.909 -175.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.464 HG21 ' SG ' ' C' ' 113' ' ' CYS . 64.9 p -80.41 120.32 24.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.609 0.764 . . . . 75.3 109.701 175.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.2 OUTLIER -74.02 -49.87 22.36 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.862 0.839 . . . . 74.32 108.964 178.177 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' C' ' 79' ' ' GLN . 25.0 m-20 -141.91 122.07 13.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.417 -1.72 . . . . 51.01 108.16 -174.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.2 mt -112.63 143.62 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 107.412 -1.329 . . . . 73.24 107.412 169.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.19 145.98 21.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.098 0.475 . . . . 53.34 110.214 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' D' ' 21' ' ' ILE . 91.8 t80 -148.21 123.99 10.56 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.562 -1.273 . . . . 55.11 107.562 176.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.06 115.35 24.11 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.14 0.976 . . . . 73.34 109.306 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.32 78.55 27.06 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 108.042 -1.095 . . . . 55.15 108.042 166.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.52 -15.34 24.73 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.373 2.049 . . . . 71.43 111.559 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -112.31 25.41 11.55 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 124.276 1.03 . . . . 51.25 109.945 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.33 77.01 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 114.435 1.272 . . . . 64.11 114.435 -172.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.69 -27.13 9.2 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 121.922 1.748 . . . . 71.21 112.45 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.84 -33.81 72.79 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.211 1.404 . . . . 71.41 111.395 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.705 HG13 HD11 ' C' ' 68' ' ' LEU . 53.5 t -79.9 -22.78 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 124.78 1.232 . . . . 73.34 111.487 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.65 -40.87 93.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.215 0.606 . . . . 70.34 111.78 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -101.97 45.69 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.415 0.686 . . . . 71.11 109.944 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.83 168.33 13.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.636 0.775 . . . . 62.12 110.019 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -74.08 115.41 13.52 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.032 -0.729 . . . . 72.33 109.032 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.51 ' HE1' ' HB3' ' E' ' 194' ' ' ALA . 51.7 t-105 -85.25 93.94 8.8 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.659 0.784 . . . . 60.42 111.842 -167.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.49 73.39 20.5 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.148 0.979 . . . . 74.31 109.773 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 120.76 4.97 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.999 2.466 . . . . 61.13 112.408 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' C' ' 67' ' ' SER . 8.8 pt-20 -86.49 91.37 8.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.222 1.01 . . . . 63.42 109.346 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.755 ' HB ' HD13 ' C' ' 126' ' ' LEU . 26.2 m -82.03 89.01 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 122.532 1.158 . . . . 65.53 110.449 -173.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -109.61 142.04 41.29 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.691 -1.141 . . . . 73.3 109.507 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.416 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -129.85 160.78 32.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.895 0.478 . . . . 74.42 111.17 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -133.41 146.58 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.719 1.208 . . . . 62.1 109.053 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.578 ' HG ' HD21 ' C' ' 60' ' ' LEU . 6.0 tt -112.39 109.77 19.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.657 -1.238 . . . . 72.41 107.657 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 24.0 t70 -112.97 141.7 46.5 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.039 -1.097 . . . . 74.31 108.039 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 43.5 m -113.94 111.63 22.0 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.786 -0.82 . . . . 45.13 108.786 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.47 158.86 18.65 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.934 1.294 . . . . 71.12 108.971 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 p -165.69 154.48 11.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.789 0.436 . . . . 70.25 111.198 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -145.6 160.91 40.97 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.737 0.815 . . . . 52.4 109.172 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.68 121.83 35.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.494 -0.558 . . . . 54.34 109.494 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.615 HD11 HD12 ' C' ' 83' ' ' ILE . 61.6 mt -88.3 -53.06 4.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.561 -0.903 . . . . 63.21 108.561 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.16 -171.26 3.79 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.852 -1.067 . . . . 71.43 110.328 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.91 118.92 17.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.065 -0.97 . . . . 75.22 108.779 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 69.51 -0.55 2.55 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.805 1.242 . . . . 74.44 113.189 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.71 114.64 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.059 -0.719 . . . . 70.31 109.059 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -128.13 140.07 52.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.835 0.826 . . . . 75.04 110.839 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -85.24 109.3 18.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.373 -1.739 . . . . 64.44 108.138 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.32 115.97 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.714 -1.217 . . . . 74.41 107.714 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.6 114.07 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.695 0.798 . . . . 62.42 109.973 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.578 HD21 ' HG ' ' C' ' 44' ' ' LEU . 1.3 tt -86.58 106.44 17.56 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.97 -1.493 . . . . 73.0 106.97 169.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 45.0 mtp180 -87.61 106.51 18.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 74.1 109.738 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' C' ' 114' ' ' ILE . 8.2 t -100.19 120.63 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.85 -0.796 . . . . 64.24 108.85 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 86.0 m -104.35 145.42 30.28 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.454 -0.943 . . . . 73.22 108.454 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.545 HG21 HD21 ' C' ' 126' ' ' LEU . 46.8 t -136.88 127.56 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.846 0.858 . . . . 65.52 109.637 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.1 m -118.17 146.15 44.41 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.39 -0.967 . . . . 72.32 108.39 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.273 -1.01 . . . . 71.15 108.273 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 70.6 m -143.25 168.18 20.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.047 0.939 . . . . 63.54 110.058 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.705 HD11 HG13 ' C' ' 31' ' ' VAL . 13.2 mt -111.56 37.5 2.88 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.466 -1.309 . . . . 73.13 107.466 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 -79.13 0.29 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 109.473 -1.451 . . . . 71.53 109.473 -166.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -128.13 -28.02 2.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.153 0.981 . . . . 61.25 110.016 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.93 98.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.986 0.914 . . . . 65.01 109.499 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.8 m -65.4 117.1 7.44 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.156 0.503 . . . . 62.43 110.43 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.12 -50.33 28.86 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.406 -1.27 . . . . 73.32 109.026 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -161.87 166.09 26.79 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.36 -0.836 . . . . 61.12 111.103 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -122.65 146.75 47.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.831 -1.915 . . . . 75.3 105.831 167.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.614 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -152.6 153.35 33.19 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.37 -0.604 . . . . 74.2 109.37 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.25 128.52 6.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.834 0.453 . . . . 63.33 110.329 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.81 114.06 44.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.158 -1.053 . . . . 74.42 108.158 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' C' ' 20' ' ' ASP . 49.6 mt-30 -87.99 90.78 8.52 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.347 -1.353 . . . . 73.13 107.347 169.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 69.1 tp60 -79.8 132.48 36.15 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.36 -0.836 . . . . 72.23 109.539 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -119.72 152.94 16.96 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 123.376 0.422 . . . . 73.02 112.767 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.12 126.64 2.22 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 109.321 -1.512 . . . . 71.33 109.321 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.615 HD12 HD11 ' C' ' 51' ' ' LEU . 19.3 mm -88.26 113.12 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 42.23 108.092 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -123.91 119.16 28.81 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.056 -1.09 . . . . 72.43 108.056 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -84.89 108.79 17.71 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.944 -0.761 . . . . 62.1 108.944 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.408 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.2 pp -112.19 132.41 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.871 0.869 . . . . 75.41 109.617 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.05 135.63 16.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.573 0.749 . . . . 42.53 109.962 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -19.62 27.87 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.352 0.408 . . . . 63.32 113.078 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.618 HG22 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -60.09 127.85 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.726 1.21 . . . . 54.43 111.552 -174.766 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -157.99 170.11 23.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.437 0.695 . . . . 70.25 110.451 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.22 -154.09 53.04 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.781 -0.645 . . . . 71.43 113.485 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -69.89 -24.54 63.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.627 0.771 . . . . 51.51 112.151 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -58.17 -53.35 59.26 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.516 0.51 . . . . 72.12 109.864 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.42 -42.98 99.85 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.995 0.918 . . . . 74.1 111.773 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.55 84.3 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.024 0.827 . . . . 72.53 111.393 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -84.51 -26.59 27.99 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.134 -0.484 . . . . 55.23 110.845 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -70.11 -61.07 1.92 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.009 0.524 . . . . 72.1 111.361 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.482 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.6 pp -88.35 -18.6 28.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.663 0.245 . . . . 61.41 111.663 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.12 -29.69 27.55 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.433 0.458 . . . . 43.34 113.199 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.74 -46.5 0.96 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.72 0.408 . . . . 60.14 112.095 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.461 ' O ' HG12 ' C' ' 105' ' ' ILE . 56.5 t80 -76.3 -39.32 54.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.542 0.737 . . . . 71.41 112.101 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.501 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 67.7 m -68.74 -46.79 33.81 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.919 -0.563 . . . . 72.52 110.032 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 58.1 Cg_exo -57.4 -34.31 97.73 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 121.884 1.723 . . . . 54.51 113.281 166.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.25 -35.87 82.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 123.412 0.685 . . . . 74.52 111.112 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.523 HG23 ' NH1' ' A' ' 111' ' ' ARG . 23.2 mm -62.99 -43.0 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.629 -0.714 . . . . 72.5 109.777 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.573 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.8 mt -81.49 -21.56 38.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.672 -1.149 . . . . 71.22 112.582 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.75 -48.53 92.79 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-O 117.695 -1.145 . . . . 71.24 113.557 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 -33.91 97.83 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.704 1.603 . . . . 75.43 112.484 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.466 ' HE2' HG21 ' A' ' 115' ' ' THR . 87.5 m-85 -64.17 -52.78 57.33 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.775 . . . . 73.45 110.872 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.09 -38.77 89.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.482 . . . . 72.53 111.218 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -54.68 -47.29 73.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.222 1.409 . . . . 72.01 111.126 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -77.57 -36.23 52.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 74.51 110.285 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.464 ' SG ' HG21 ' C' ' 18' ' ' THR . 41.6 t -67.02 -37.55 84.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.621 0.768 . . . . 70.14 112.046 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.614 HG23 ' SG ' ' C' ' 76' ' ' CYS . 74.7 mt -71.63 -47.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.225 -0.657 . . . . 62.31 109.225 175.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.6 m -54.82 -33.61 61.81 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 124.036 0.835 . . . . 62.41 111.355 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -61.64 -57.03 13.63 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.46 -0.791 . . . . 71.12 109.972 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.77 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.97 -43.2 63.44 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.817 1.247 . . . . 61.14 112.999 177.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 114' ' ' ILE . 77.2 t -64.56 -47.38 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.508 1.123 . . . . 65.52 110.701 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -31.96 73.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.885 -1.052 . . . . 75.34 111.037 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.3 mtt-85 -66.95 -34.48 77.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.401 0.68 . . . . 73.52 110.441 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.23 81.65 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 60.12 113.262 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 15.9 p 67.96 29.51 6.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.789 2.036 . . . . 71.32 112.819 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.87 153.23 37.85 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.123 0.969 . . . . 62.4 109.844 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.52 173.97 1.81 Allowed 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.872 3.048 . . . . 73.44 114.803 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 38.4 mm-40 -59.31 122.95 15.18 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 115.892 -0.594 . . . . 73.11 111.17 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.755 HD13 ' HB ' ' C' ' 40' ' ' VAL . 51.5 tp -107.06 17.21 23.3 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.4 -1.273 . . . . 71.35 109.198 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -87.37 84.02 7.25 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.111 -1.811 . . . . 74.54 106.111 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.42 153.47 21.42 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 113.437 -1.711 . . . . 61.14 108.91 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.83 133.26 14.46 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.253 1.021 . . . . 72.31 112.726 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.82 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 54.1 Cg_exo -43.46 129.47 6.61 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 124.525 3.483 . . . . 64.34 114.304 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.06 81.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.882 -0.785 . . . . 64.41 108.882 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -83.47 98.38 9.5 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.705 -0.68 . . . . 63.14 109.321 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.06 -38.97 75.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.182 -0.917 . . . . 74.53 110.872 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.11 -27.83 69.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.395 0.678 . . . . 72.31 111.459 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -67.5 -41.97 83.61 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.009 0.524 . . . . 61.12 110.623 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.14 -38.84 80.64 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.535 0.522 . . . . 73.1 111.395 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.22 -43.55 98.58 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.244 0.617 . . . . 73.1 111.068 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.508 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 62.8 mtt -75.49 -30.51 59.9 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.715 0.806 . . . . 63.25 111.26 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -70.59 -36.95 73.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.534 1.134 . . . . 74.35 110.65 177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -69.29 -82.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.893 1.277 . . . . 75.54 110.778 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 154' ' ' ASP . 2.2 pp -85.87 172.22 10.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.147 0.579 . . . . 75.33 112.214 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 64.57 -97.01 0.05 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.329 1.451 . . . . 71.45 111.868 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -177.98 148.66 0.53 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.48 0.712 . . . . 74.01 110.3 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -137.39 98.1 3.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.474 1.11 . . . . 70.44 108.328 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.6 147.2 25.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.371 0.668 . . . . 62.3 110.787 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.16 177.78 50.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.793 -0.639 . . . . 61.2 111.906 172.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.66 -36.7 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.844 0.457 . . . . 74.22 111.285 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.73 165.4 49.57 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.87 0.15 . . . . 75.32 113.234 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 94.5 m -147.19 114.17 6.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.708 0.803 . . . . 75.24 109.487 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.55 125.74 4.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.587 0.755 . . . . 74.43 110.111 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 121.45 20.31 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.109 -0.7 . . . . 75.14 109.109 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -162.36 132.21 4.56 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.073 -1.084 . . . . 73.41 108.073 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -122.55 178.4 5.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.158 0.983 . . . . 73.4 109.31 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -160.36 -164.86 1.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.311 -0.996 . . . . 73.15 108.311 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.767 -0.635 . . . . 75.24 109.794 175.777 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.79 0.328 . . . . 72.4 110.461 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.1 m -147.84 102.63 3.43 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.97 0.908 . . . . 74.13 108.97 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.98 147.47 35.23 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.819 0.848 . . . . 73.31 108.946 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 177.63 2.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.757 0.423 . . . . 63.2 110.942 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -151.18 -179.47 7.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.222 -1.029 . . . . 73.35 108.222 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -65.21 88.04 0.07 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.864 -0.421 . . . . 71.22 109.864 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.462 HG21 ' H ' ' B' ' 152' ' ' HIS . 17.5 p 45.68 -139.7 0.44 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.694 1.598 . . . . 70.23 113.324 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.85 171.92 9.77 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.819 0.736 . . . . 70.04 112.246 -166.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.2 tpt -29.15 125.72 0.12 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.839 2.056 . . . . 74.33 114.299 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.5 m -141.22 143.75 34.34 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.348 0.659 . . . . 73.13 111.022 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -145.03 103.38 3.87 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.527 -1.286 . . . . 64.02 107.527 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.99 139.88 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.681 1.192 . . . . 65.11 108.989 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 tt -105.28 135.23 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 70.42 109.871 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.74 -46.64 4.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -158.27 146.72 18.77 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.214 0.206 . . . . 73.31 110.475 -171.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.646 HD11 ' HG3' ' B' ' 130' ' ' PRO . 1.0 OUTLIER -140.01 134.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.634 -1.247 . . . . 73.43 107.634 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -159.97 156.74 27.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.515 0.726 . . . . 72.21 110.677 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 55.7 p -85.14 110.07 18.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.483 -0.932 . . . . 63.4 108.483 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -75.93 -26.6 57.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.127 0.489 . . . . 63.31 110.171 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.08 133.82 12.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.699 -1.137 . . . . 74.04 109.011 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.77 HD13 ' HE3' ' C' ' 117' ' ' MET . 92.9 mt -132.68 132.2 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.785 -1.561 . . . . 70.15 106.785 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -137.94 138.22 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.166 -0.679 . . . . 53.22 109.166 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -145.15 109.94 5.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.403 -2.073 . . . . 73.3 105.403 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.07 113.93 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.928 -0.767 . . . . 74.03 108.928 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.9 83.71 3.02 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.66 -23.61 22.72 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.377 2.051 . . . . 75.34 112.011 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -106.65 20.07 19.56 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 124.415 1.086 . . . . 74.03 110.256 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.5 -63.93 0.98 Allowed Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.963 1.468 . . . . 63.42 114.963 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.19 -17.8 11.54 Favored 'Trans proline' 0 C--N 1.387 2.572 0 CA-C-N 122.221 1.829 . . . . 61.43 113.331 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.79 -52.33 51.7 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.29 1.036 . . . . 45.53 110.319 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -84.15 -1.02 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 124.234 1.014 . . . . 74.23 110.463 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.498 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.8 t80 -54.57 -35.55 63.41 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.117 1.367 . . . . 71.54 111.161 165.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -70.9 -11.8 61.17 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.947 -1.024 . . . . 72.4 111.944 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.597 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 9.6 ttmt -106.78 114.05 27.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.364 0.665 . . . . 71.14 110.715 -173.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -101.56 56.58 0.83 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.147 1.379 . . . . 73.21 112.875 -167.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -125.82 173.97 8.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.609 0.764 . . . . 71.33 109.221 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.625 ' HG2' ' HA3' ' H' ' 191' ' ' GLY . 55.3 tp60 -88.07 124.06 67.55 Favored Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 121.59 -0.694 . . . . 51.55 109.322 172.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.46 110.58 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.772 2.314 . . . . 73.21 112.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -68.82 113.02 5.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.193 0.997 . . . . 71.2 109.098 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.628 HG13 HG13 ' D' ' 64' ' ' VAL . 73.9 t -99.27 124.29 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.813 0.845 . . . . 71.25 110.763 -169.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -96.34 108.56 21.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.499 -1.667 . . . . 72.31 106.499 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.24 113.62 25.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.328 -0.99 . . . . 72.31 108.328 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.3 t70 -109.17 132.44 54.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.74 -0.837 . . . . 63.13 108.74 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.46 131.88 54.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.776 -1.194 . . . . 65.42 107.776 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.3 t70 -145.09 154.26 42.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.943 0.897 . . . . 54.03 108.786 173.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -126.66 164.6 20.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.225 0.61 . . . . 73.22 110.312 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.655 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.21 164.02 39.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 52.34 109.45 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 m -154.46 160.39 41.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.041 0.536 . . . . 63.44 110.928 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -157.1 120.02 4.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.161 0.984 . . . . 74.33 109.373 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -79.53 117.61 20.63 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.359 -0.608 . . . . 71.34 109.359 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.9 mt -99.81 -34.39 10.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.744 0.418 . . . . 73.54 110.85 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.6 -171.83 3.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.132 0.973 . . . . 75.33 109.773 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.04 118.48 11.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.754 0.821 . . . . 61.43 110.479 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 61.95 13.32 5.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.86 1.264 . . . . 72.22 112.669 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.45 122.64 66.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.032 -1.099 . . . . 74.11 108.032 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -151.71 145.88 25.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.517 0.675 . . . . 72.23 110.556 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.2 tt0 -86.67 125.27 33.75 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.887 -1.506 . . . . 71.32 108.744 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.05 137.78 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.623 -1.251 . . . . 72.12 107.623 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.655 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.6 t -115.19 145.29 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.366 1.066 . . . . 70.32 109.144 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.02 122.33 43.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.116 -1.068 . . . . 55.33 108.116 173.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 36.2 ttm-85 -96.07 100.38 12.05 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.46 -0.941 . . . . 72.03 108.46 172.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.51 107.11 18.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.246 -1.02 . . . . 71.31 108.246 171.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -98.65 131.86 44.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.049 0.452 . . . . 70.31 109.884 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.628 HG13 HG13 ' D' ' 40' ' ' VAL . 54.2 t -127.22 101.42 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.857 1.263 . . . . 73.43 108.104 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.7 m -101.92 94.38 5.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.286 -1.375 . . . . 74.32 107.286 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.02 143.62 27.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.734 -0.469 . . . . 65.42 109.734 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 38.4 p -146.76 133.3 19.77 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 121.199 0.523 . . . . 74.4 111.041 -173.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 55.4 mt -100.2 102.23 13.46 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.522 -1.288 . . . . 73.11 107.522 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -130.56 11.65 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.713 -0.676 . . . . 64.21 112.32 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.13 6.52 48.32 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.628 0.771 . . . . 75.54 111.403 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.597 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 8.9 tp10 -121.73 148.16 44.98 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.052 0.941 . . . . 72.44 109.56 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 76.3 m -65.82 131.38 46.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.363 0.665 . . . . 73.05 110.702 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.518 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -86.41 -59.55 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.483 -0.932 . . . . 62.41 108.483 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -160.7 150.39 17.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 113.925 -1.489 . . . . 74.13 109.558 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.33 146.65 29.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.781 -1.192 . . . . 74.15 107.781 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.586 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.1 t -158.73 137.94 11.48 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.704 -0.48 . . . . 65.15 109.704 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -156.88 129.36 7.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.664 -0.495 . . . . 43.05 109.664 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.12 116.1 43.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.672 0.789 . . . . 74.11 109.391 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -89.98 90.21 8.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.453 -0.794 . . . . 70.03 108.933 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.419 ' O ' HD13 ' D' ' 106' ' ' LEU . 8.2 tp-100 -80.28 104.37 10.79 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 114.769 -1.105 . . . . 74.54 109.089 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.91 145.03 16.88 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.634 -0.586 . . . . 72.44 111.634 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.1 139.1 7.68 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 110.661 -0.975 . . . . 71.0 110.661 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.23 130.77 37.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.709 0.804 . . . . 74.14 109.159 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.15 125.19 34.43 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.72 0.408 . . . . 51.2 110.331 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 24.4 m -84.88 93.23 8.47 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.171 -1.048 . . . . 74.44 108.171 165.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.594 HD11 HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -129.32 134.72 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.521 0.728 . . . . 73.21 109.641 -171.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' B' ' 147' ' ' GLU . . . -163.66 159.55 21.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.502 1.121 . . . . 71.25 109.841 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.62 -19.53 14.26 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.091 0.797 . . . . 50.11 115.091 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' D' ' 94' ' ' MET . 2.2 pp -108.96 161.78 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.397 0.679 . . . . 64.14 111.014 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 2.6 pt-20 -158.03 -175.44 5.35 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.5 0.72 . . . . 60.21 110.851 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -132.05 47.54 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 123.653 0.644 . . . . 74.2 114.014 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -66.35 -28.73 68.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.764 0.826 . . . . 74.22 111.254 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -68.8 -33.31 73.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.464 0.706 . . . . 75.11 111.094 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.638 ' HA ' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -70.34 -47.51 60.71 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.567 -0.531 . . . . 72.33 109.567 177.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.85 72.94 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.46 -0.791 . . . . 71.13 111.151 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -72.26 -37.81 68.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.063 0.945 . . . . 71.51 111.11 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -72.17 -51.41 21.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.036 0.535 . . . . 71.24 111.394 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 tt -72.9 -36.36 67.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.019 0.528 . . . . 62.54 110.168 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.23 -23.85 62.46 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 114.304 0.481 . . . . 74.2 114.304 -174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.53 -56.34 1.01 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.502 0.651 . . . . 53.43 112.274 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -67.46 -46.46 72.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.307 0.854 . . . . 73.33 113.307 -166.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.7 -44.67 43.73 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.972 -0.537 . . . . 74.31 111.229 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.603 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 85.5 Cg_exo -53.68 -35.78 79.17 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 122.953 2.435 . . . . 50.41 114.119 165.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -61.85 -31.93 72.23 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.399 0.68 . . . . 73.21 112.097 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -72.51 -40.08 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.671 . . . . 71.22 110.351 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.419 HD13 ' O ' ' D' ' 80' ' ' GLN . 83.8 mt -75.25 -24.93 57.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.882 -1.054 . . . . 64.22 111.252 -175.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -61.69 -42.46 83.6 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.876 1.436 . . . . 75.04 114.876 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.15 -46.87 28.63 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.267 1.978 . . . . 64.41 113.752 171.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.0 -37.21 69.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.511 -0.768 . . . . 72.25 111.226 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.78 79.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.744 0.818 . . . . 41.45 110.6 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -57.08 -50.67 72.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 70.14 110.956 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -67.91 -39.62 83.54 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.039 0.837 . . . . 72.43 111.39 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.4 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.0 t -57.64 -40.99 80.5 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.732 0.645 . . . . 70.44 110.486 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.586 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -68.45 -52.15 39.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.86 -1.064 . . . . 61.13 110.388 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -50.82 -43.46 58.96 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.123 . . . . 70.41 111.673 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -67.45 -45.86 74.76 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.676 -1.147 . . . . 62.14 110.33 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.06 -34.04 77.12 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.005 0.522 . . . . 75.41 111.947 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.57 -46.23 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.666 0.786 . . . . 73.31 110.252 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.7 p -70.74 -29.13 65.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.68 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -70.05 -32.69 70.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.6 0.76 . . . . 63.02 109.622 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 11.1 60.95 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.617 0.573 . . . . 64.42 113.069 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.445 HG23 ' HB3' ' C' ' 17' ' ' TYR . 41.4 p 60.27 20.5 9.95 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.402 1.881 . . . . 75.05 114.057 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.461 ' HB2' HG13 ' D' ' 118' ' ' VAL . 79.7 m-85 -93.97 159.05 35.22 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 107.758 -1.201 . . . . 72.55 107.758 171.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' H' ' 195' ' ' PHE . 72.4 Cg_endo -70.91 154.1 63.33 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.994 1.796 . . . . 64.15 111.672 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -50.97 120.14 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.872 0.869 . . . . 72.52 111.438 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.467 HD21 HG21 ' D' ' 40' ' ' VAL . 2.4 tm? -109.57 91.78 3.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.446 -1.316 . . . . 72.34 107.446 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -108.85 106.2 16.09 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.077 -0.965 . . . . 72.45 109.62 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.668 ' HB3' HD13 ' H' ' 187' ' ' ILE . 62.5 mt -65.76 134.68 53.67 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.796 -1.093 . . . . 74.11 110.911 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.68 130.98 85.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.782 0.833 . . . . 75.3 111.611 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.85 95.93 0.98 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.497 2.131 . . . . 75.52 110.548 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.52 HG21 HG21 ' G' ' 207' ' ' VAL . 7.6 p -129.66 139.94 50.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.174 -0.921 . . . . 61.23 110.447 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -69.64 116.12 9.67 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.912 -1.144 . . . . 74.15 107.912 166.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.404 ' HD1' HD21 ' H' ' 186' ' ' LEU . 12.6 m-85 -53.17 -33.11 51.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.063 0.945 . . . . 74.45 112.542 -177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -67.82 -24.08 65.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.575 1.15 . . . . 74.31 112.277 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.98 70.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.037 0.535 . . . . 61.42 111.523 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.89 -40.53 72.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.29 0.636 . . . . 71.23 110.434 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.605 ' HB2' ' HE1' ' H' ' 184' ' ' TRP . 63.2 t80 -59.01 -33.16 70.4 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.195 0.998 . . . . 74.32 111.198 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.1 mmt -54.64 -52.87 60.93 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.325 0.65 . . . . 72.24 109.87 175.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -65.97 -50.09 65.57 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 113.968 -1.469 . . . . 72.55 110.924 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -51.6 -34.76 38.7 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.763 1.225 . . . . 74.01 113.848 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.96 -47.74 17.87 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.061 0.545 . . . . 72.2 110.739 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.09 13.94 4.65 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.215 0.606 . . . . 72.13 112.503 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -118.92 90.18 3.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.305 0.642 . . . . 73.45 109.272 -171.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -143.51 -19.18 0.61 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.418 1.087 . . . . 74.24 110.195 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.91 142.18 28.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.921 0.888 . . . . 61.3 110.439 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.4 44.56 1.16 Allowed Glycine 0 N--CA 1.471 0.978 0 N-CA-C 111.269 -0.732 . . . . 72.23 111.269 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.5 86.43 6.34 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.036 0.934 . . . . 71.42 110.748 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.33 38.8 0.24 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.021 -0.991 . . . . 33.41 110.998 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.3 t -81.57 85.2 6.57 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.917 0.887 . . . . 71.51 110.83 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -173.64 141.32 0.84 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.497 1.119 . . . . 64.34 109.824 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -163.21 -96.55 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.585 -1.265 . . . . 65.43 107.585 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -159.3 132.42 7.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.543 1.537 . . . . 74.44 107.012 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -137.21 82.37 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.992 -1.114 . . . . 70.33 107.992 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -134.98 101.99 5.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.814 0.846 . . . . 72.05 109.012 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 C-N-CA 124.137 0.975 . . . . 71.01 108.686 177.31 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.2 -0.296 . . . . 75.02 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -92.34 -122.61 3.06 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.407 -0.677 . . . . 52.32 111.407 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -131.86 142.84 49.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.207 1.003 . . . . 72.14 108.871 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 72.3 m -154.92 114.28 3.68 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.963 1.305 . . . . 72.51 107.763 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 65.15 -170.07 0.2 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.247 1.019 . . . . 72.41 110.904 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 66.55 -76.11 0.05 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.079 1.351 . . . . 63.21 109.53 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 30.8 mmt -86.61 69.91 10.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.378 0.671 . . . . 73.44 110.093 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 53.75 -90.73 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.496 1.518 . . . . 73.51 112.784 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 54.75 58.18 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.229 1.014 . . . . 62.43 110.398 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.19 70.19 7.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.206 -0.906 . . . . 62.34 108.973 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.79 -61.18 2.09 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.384 -0.969 . . . . 64.55 108.384 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.26 154.5 54.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.913 0.885 . . . . 73.4 110.24 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.92 173.98 11.2 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.679 2.253 . . . . 75.52 112.605 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -112.83 162.31 15.94 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.081 0.952 . . . . 70.24 109.562 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.02 122.71 12.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.22 1.008 . . . . 72.44 108.789 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 32.7 m -73.66 124.45 26.0 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.17 0.588 . . . . 73.12 111.403 -171.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -75.66 155.98 85.05 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.812 0.845 . . . . 74.33 111.528 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.69 169.24 22.7 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.654 2.236 . . . . 62.45 112.26 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -129.23 118.98 23.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.066 -1.087 . . . . 74.44 108.066 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.17 139.28 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.912 -1.144 . . . . 74.43 107.912 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.38 31.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.807 0.843 . . . . 64.25 109.151 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -107.99 134.39 50.96 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.593 -0.521 . . . . 50.13 109.593 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.44 -169.17 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.124 0.97 . . . . 45.43 111.61 -174.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.39 -68.31 1.74 Allowed Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.912 -0.585 . . . . 71.45 113.041 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 55.7 -125.33 36.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 124.13 0.547 . . . . 32.41 112.52 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -145.83 -176.13 5.01 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.469 1.108 . . . . 73.43 108.672 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 194' ' ' ALA . . . . . 0.51 ' HB3' ' HE1' ' C' ' 36' ' ' TRP . . . -165.97 -63.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.578 0.751 . . . . 75.5 109.283 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -113.55 -175.05 2.59 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.083 0.953 . . . . 64.24 110.023 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -150.87 139.91 21.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.646 1.178 . . . . 74.02 108.935 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 197' ' ' TYR . . . . . 0.655 ' HA ' ' HA ' ' E' ' 201' ' ' LYS . 65.1 m-85 -128.11 -41.41 1.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.665 0.617 . . . . 75.21 112.665 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.54 -14.87 56.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.057 0.143 . . . . 62.41 111.211 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -146.26 113.0 6.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 72.9 49.5 16.92 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 123.545 0.528 . . . . 71.4 112.618 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 201' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' E' ' 197' ' ' TYR . 23.3 ttmm -49.29 -50.11 40.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.905 1.282 . . . . 64.33 112.97 -171.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 202' ' ' TYR . . . . . 0.505 ' HE2' ' HB2' ' B' ' 129' ' ' ALA . 60.1 t80 -173.99 -52.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.019 -0.992 . . . . 63.03 108.859 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 203' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' F' ' 188' ' ' ALA . 18.3 t0 69.32 107.9 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.342 1.457 . . . . 74.11 112.571 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.57 HD12 ' HB ' ' E' ' 207' ' ' VAL . 17.1 pt -121.31 13.91 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.938 1.295 . . . . 60.41 109.945 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.27 -73.66 0.09 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.702 1.601 . . . . 73.41 110.382 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -168.45 101.49 0.42 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.712 -0.848 . . . . 62.53 108.712 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.57 ' HB ' HD12 ' E' ' 204' ' ' ILE . 57.5 t . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.934 . . . . 73.5 108.539 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 60.4 mttp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.223 -0.658 . . . . 62.31 109.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.03 100.48 0.35 Allowed Glycine 0 C--N 1.346 1.123 0 O-C-N 123.503 0.502 . . . . 64.23 112.863 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -80.46 74.37 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.475 -0.565 . . . . 73.33 109.475 172.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 80.1 p -167.01 -176.05 3.25 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.882 0.873 . . . . 45.42 109.791 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 162.59 21.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.157 0.583 . . . . 61.41 110.384 168.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -103.34 89.8 3.5 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.28 0.632 . . . . 71.51 109.3 -171.401 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.9 138.3 38.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.655 -0.869 . . . . 74.03 108.655 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.07 176.3 8.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.759 0.824 . . . . 73.11 111.719 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.8 108.0 11.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.89 -1.522 . . . . 73.34 106.89 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.69 115.89 9.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.907 0.483 . . . . 70.23 112.038 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -165.47 44.13 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.51 -1.292 . . . . 71.11 107.51 167.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.13 149.3 91.95 Favored Pre-proline 0 N--CA 1.483 1.178 0 CA-C-N 115.527 -0.761 . . . . 64.1 111.318 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.14 89.3 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.612 2.208 . . . . 65.24 111.633 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.6 150.66 26.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.794 0.837 . . . . 63.53 110.423 176.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -90.56 -173.83 3.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.777 0.831 . . . . 53.11 110.749 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 25.5 p -63.09 102.26 0.36 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.758 0.823 . . . . 64.32 112.114 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -69.05 -41.72 19.73 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.863 0.865 . . . . 73.32 112.168 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.49 81.84 0.73 Allowed 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 121.679 1.586 . . . . 70.42 111.967 170.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' F' ' 186' ' ' LEU . 2.4 pp -96.92 -26.59 15.0 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.122 0.969 . . . . 73.22 110.484 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' B' ' 128' ' ' LEU . 6.0 tt -60.71 130.79 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.694 1.197 . . . . 73.33 111.996 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 188' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' E' ' 203' ' ' ASP . . . -114.65 161.81 17.61 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.725 0.81 . . . . 71.44 109.552 169.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.02 100.28 2.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.586 0.754 . . . . 73.32 109.618 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.96 11.03 37.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.852 0.861 . . . . 64.25 109.993 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.81 143.91 42.64 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.609 -0.597 . . . . 55.01 111.609 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -165.84 55.99 0.25 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.219 -0.753 . . . . 62.35 111.219 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.6 -175.31 4.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 74.34 111.264 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 194' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' F' ' 201' ' ' LYS . . . 75.58 -66.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.818 1.647 . . . . 74.24 111.998 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.81 104.17 0.17 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.229 1.412 . . . . 61.31 111.935 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -154.78 105.21 2.57 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.68 1.192 . . . . 64.42 109.333 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 197' ' ' TYR . . . . . 0.588 ' HA ' ' HB2' ' F' ' 203' ' ' ASP . 53.8 m-85 -69.26 81.69 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.404 0.682 . . . . 63.23 110.803 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 176.78 -68.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.794 1.237 . . . . 74.2 107.956 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -153.04 95.7 1.99 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.568 -1.197 . . . . 64.02 108.587 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 178.14 -106.27 0.21 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.881 -0.599 . . . . 75.04 112.023 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 201' ' ' LYS . . . . . 0.486 ' HB3' ' HB1' ' F' ' 194' ' ' ALA . 34.1 ttmt -163.52 163.64 24.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.83 -0.804 . . . . 73.44 108.83 -170.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 202' ' ' TYR . . . . . 0.442 ' HE2' ' HB3' ' B' ' 124' ' ' PRO . 2.2 m-30 63.0 17.19 9.9 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 124.489 1.116 . . . . 73.35 110.853 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 203' ' ' ASP . . . . . 0.588 ' HB2' ' HA ' ' F' ' 197' ' ' TYR . 14.2 p-10 -124.39 171.63 9.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.591 0.756 . . . . 74.22 112.449 -163.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.425 ' H ' ' HD1' ' F' ' 197' ' ' TYR . 7.2 tp -94.7 135.66 28.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 114.704 -1.135 . . . . 71.33 108.264 167.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -118.28 -178.56 3.54 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.635 -0.876 . . . . 63.32 108.635 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 161.62 28.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.663 0.385 . . . . 75.45 110.25 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.507 0.723 . . . . 73.11 109.586 -176.402 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.846 -0.428 . . . . 74.23 109.846 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -169.43 -146.19 4.95 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.057 -0.817 . . . . 35.51 111.057 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.77 20.69 11.61 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.942 0.897 . . . . 63.41 111.75 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 66.4 m -141.25 165.59 27.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.51 1.124 . . . . 71.04 109.288 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.36 45.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.832 0.453 . . . . 53.13 111.655 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 2.7 tt -177.0 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.114 -1.439 . . . . 64.33 107.114 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 30.2 mmt -76.1 174.98 9.37 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.069 -0.969 . . . . 65.31 110.85 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.554 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 17.5 t80 -56.74 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.008 0.923 . . . . 73.22 112.138 -167.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -90.24 0.87 57.0 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.948 -1.024 . . . . 71.24 110.64 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 177' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 95' ' ' ALA . 5.1 mp -87.79 165.54 15.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.372 -0.603 . . . . 74.43 109.372 172.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -138.84 -64.68 0.51 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.255 -1.387 . . . . 75.13 107.255 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -170.47 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.489 0 C-N-CA 123.945 0.898 . . . . 71.11 111.41 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -78.35 76.64 4.33 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.51 2.14 . . . . 74.3 111.732 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -138.02 123.07 19.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.539 1.136 . . . . 64.12 108.286 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 63.94 -172.9 0.17 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 124.493 1.12 . . . . 71.43 110.974 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 69.3 p -89.81 -32.2 17.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.067 -0.396 . . . . 62.34 111.074 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 54.88 80.31 0.3 Allowed Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.942 1.297 . . . . 64.43 110.95 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.76 167.26 24.95 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.244 1.963 . . . . 65.31 112.402 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -154.1 135.39 14.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.672 -0.862 . . . . 65.04 108.672 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -82.88 131.32 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.415 0.686 . . . . 75.43 110.968 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.24 86.37 3.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 73.13 110.097 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.39 130.86 48.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.93 0.892 . . . . 62.33 112.349 -173.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.3 174.69 7.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 73.41 113.278 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 191' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 39' ' ' GLU . . . -113.91 123.96 6.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 114.574 -1.194 . . . . 74.21 112.059 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.49 153.29 51.15 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.057 -0.417 . . . . 73.2 112.057 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -141.91 14.39 2.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.534 0.734 . . . . 72.0 109.818 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 194' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' H' ' 196' ' ' LYS . . . -120.14 170.05 9.66 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.01 0.924 . . . . 71.32 110.365 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.422 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 58.5 t80 66.99 21.39 10.3 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.658 1.183 . . . . 64.02 110.582 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.547 ' HA ' ' H ' ' A' ' 36' ' ' TRP . 9.7 mtmp? -64.05 128.0 33.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 70.44 110.711 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.19 83.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.134 0.974 . . . . 73.21 110.494 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.27 -6.73 4.3 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.938 0.895 . . . . 53.33 111.148 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -141.26 162.52 35.29 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.25 0.62 . . . . 73.45 109.828 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -64.42 125.64 31.77 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.782 0.676 . . . . 72.2 112.596 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -90.25 -60.73 1.85 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.589 0.355 . . . . 71.41 110.73 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -109.68 -67.8 0.96 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.481 -0.933 . . . . 74.22 108.481 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 18.3 t70 58.63 106.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.412 1.485 . . . . 73.52 112.784 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.65 110.83 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.988 0.915 . . . . 71.52 109.547 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -81.5 97.43 7.79 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.473 -0.936 . . . . 64.12 108.473 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 63.48 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.669 1.188 . . . . 74.41 110.111 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 207' ' ' VAL . . . . . 0.52 HG21 HG21 ' D' ' 131' ' ' VAL . 1.1 p . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 125.426 1.49 . . . . 63.42 107.751 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 56.8 tptt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.14 -0.689 . . . . 62.42 109.14 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.17 178.6 19.55 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.521 0.513 . . . . 51.01 112.949 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -86.54 67.76 9.98 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 108.923 -0.769 . . . . 72.53 108.923 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 33.5 t -90.64 60.96 4.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.159 0.984 . . . . 62.04 110.164 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -174.37 -157.13 0.07 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.959 1.303 . . . . 63.03 109.004 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.497 ' H ' ' HG3' ' D' ' 94' ' ' MET . 49.0 mt 71.94 117.2 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.195 1.398 . . . . 71.01 111.407 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' H' ' 174' ' ' MET . 0.0 OUTLIER 54.86 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.01 1.324 . . . . 71.53 111.661 170.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 74.0 110.38 0.07 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.897 1.679 . . . . 74.21 110.36 -172.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 176' ' ' ASN . . . . . 0.504 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 64.8 t30 -153.45 177.28 11.07 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.428 -1.323 . . . . 62.41 107.428 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 6.7 tt 77.9 87.06 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.478 1.111 . . . . 74.23 108.818 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.4 -48.15 2.52 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.282 -1.007 . . . . 73.44 108.282 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -95.24 -48.46 0.26 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.402 1.081 . . . . 74.31 112.449 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.05 159.18 34.01 Favored 'Trans proline' 0 C--N 1.393 2.887 0 CA-C-N 121.511 1.575 . . . . 73.52 112.349 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 63.26 178.05 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.905 1.282 . . . . 74.53 113.426 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -168.23 175.5 6.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.144 1.378 . . . . 73.31 108.54 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 76.8 p -81.57 122.98 28.26 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.075 -0.713 . . . . 73.52 109.075 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 184' ' ' TRP . . . . . 0.605 ' HE1' ' HB2' ' D' ' 137' ' ' PHE . 16.3 m-90 -83.57 118.33 71.19 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.789 0.835 . . . . 75.34 110.295 -171.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.72 102.24 1.0 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.672 2.248 . . . . 43.52 111.796 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 186' ' ' LEU . . . . . 0.404 HD21 ' HD1' ' D' ' 133' ' ' PHE . 1.0 OUTLIER -141.54 173.97 11.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.59 0.756 . . . . 73.32 111.372 -177.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.668 HD13 ' HB3' ' D' ' 128' ' ' LEU . 76.2 mt 70.18 83.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 125.1 1.36 . . . . 73.54 110.46 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.11 92.47 9.16 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.874 -1.057 . . . . 62.43 108.921 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.37 41.03 0.91 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.697 1.199 . . . . 75.03 111.131 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.01 99.07 5.94 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.856 0.863 . . . . 74.21 109.576 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 191' ' ' GLY . . . . . 0.625 ' HA3' ' HG2' ' D' ' 37' ' ' GLN . . . -100.63 -169.97 28.93 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.251 -0.431 . . . . 71.24 112.05 175.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -120.53 -105.69 2.04 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.611 0.205 . . . . 72.44 113.278 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.86 -159.3 0.85 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.81 0.844 . . . . 60.45 111.163 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . 67.99 80.2 0.21 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 125.237 1.415 . . . . 35.11 111.073 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 195' ' ' PHE . . . . . 0.515 ' CE1' ' HD3' ' D' ' 124' ' ' PRO . 40.1 t80 -162.22 33.74 0.12 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.884 0.849 . . . . 71.02 109.25 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 196' ' ' LYS . . . . . 0.532 ' HB2' ' HB1' ' G' ' 194' ' ' ALA . 0.2 OUTLIER -73.83 -0.58 16.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.493 0.553 . . . . 72.52 112.493 -173.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 61.34 -160.69 0.3 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 123.671 0.788 . . . . 75.11 111.284 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 113.34 3.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.009 -1.478 . . . . 72.12 107.009 170.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -72.85 117.93 15.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.32 -0.993 . . . . 74.44 108.32 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.0 110.17 2.28 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.644 1.215 . . . . 51.32 114.827 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -95.95 -72.57 0.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.006 -0.739 . . . . 74.52 109.006 174.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 60.6 20.06 9.96 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.303 1.041 . . . . 71.23 112.707 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 33.5 t70 67.05 66.86 0.42 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.458 1.103 . . . . 72.42 111.542 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.86 112.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.345 -0.983 . . . . 73.41 108.345 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -118.94 -38.98 2.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.4 0.28 . . . . 73.0 111.569 -166.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -137.55 -52.49 0.65 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.563 -0.903 . . . . 63.42 108.563 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.299 0 N-CA-C 108.095 -1.076 . . . . 71.13 108.095 172.072 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.887 -0.412 . . . . 54.42 109.887 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.6 p -112.26 110.57 20.88 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.803 -1.184 . . . . 63.13 107.803 171.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.61 ' HB3' ' HA3' ' C' ' 146' ' ' GLY . 42.5 mt-10 -76.04 82.9 2.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 61.24 110.335 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -92.76 166.77 12.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.759 -1.109 . . . . 71.13 110.049 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 64.09 66.98 0.62 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.258 1.023 . . . . 73.14 109.888 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -67.31 136.37 54.76 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-N 114.447 -1.251 . . . . 65.35 109.07 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -159.32 157.29 30.18 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.397 0.679 . . . . 73.44 109.562 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.03 146.04 51.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.904 0.881 . . . . 61.23 109.615 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -137.9 166.74 23.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.55 0.74 . . . . 74.43 110.733 -173.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.1 m -141.37 132.5 26.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.643 0.777 . . . . 74.35 109.204 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.5 136.63 54.71 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.116 0.966 . . . . 62.11 109.76 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' NE2' ' HB ' ' F' ' 207' ' ' VAL . 56.7 tp60 -147.69 136.83 22.27 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.375 0.422 . . . . 72.22 111.279 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.3 110.29 12.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.073 0.949 . . . . 74.44 108.44 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.86 -41.04 16.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.322 0.649 . . . . 74.2 109.275 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.495 ' HA ' HD13 ' F' ' 204' ' ' ILE . 12.2 ttt180 -161.32 141.08 10.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.014 0.526 . . . . 53.1 110.211 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -124.53 135.91 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.003 -1.11 . . . . 71.23 108.003 167.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.678 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 18.3 p90 -170.56 171.88 6.18 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.042 0.839 . . . . 62.24 110.645 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -94.54 124.19 38.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.896 -0.779 . . . . 61.41 108.896 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.3 mtpt -82.63 -43.54 16.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.021 -0.733 . . . . 72.3 109.021 172.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.0 t70 -135.79 143.97 45.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.281 -1.327 . . . . 54.41 110.041 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.434 HG23 ' SD ' ' A' ' 117' ' ' MET . 83.3 mt -139.81 141.51 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 125.982 1.713 . . . . 74.13 106.624 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.35 123.24 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.48 -0.563 . . . . 65.25 109.48 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 85.0 t80 -121.74 126.52 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.823 -1.547 . . . . 74.13 106.823 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -123.56 126.57 46.91 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.896 -0.779 . . . . 74.14 108.896 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.03 70.98 14.77 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.236 1.014 . . . . 72.34 108.347 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.73 -26.31 27.85 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.053 1.835 . . . . 65.55 110.12 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 31' ' ' VAL . 81.9 m-20 -99.8 22.7 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.734 -1.121 . . . . 71.23 110.767 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.42 97.62 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.594 -0.717 . . . . 51.23 112.425 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.6 -21.38 22.21 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.898 1.732 . . . . 70.54 113.495 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.0 m170 -71.09 -36.51 72.25 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.867 0.467 . . . . 74.01 110.452 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 27' ' ' ASN . 73.4 t -56.34 -35.88 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.174 0.99 . . . . 71.44 112.87 -174.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.15 -35.17 80.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.322 0.649 . . . . 75.25 110.726 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -75.07 -37.9 61.48 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.126 0.97 . . . . 71.52 110.102 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -82.15 156.84 24.27 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.217 -0.901 . . . . 73.52 110.641 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -72.4 125.8 28.29 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.924 -0.769 . . . . 61.44 108.924 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.526 ' HD1' ' H ' ' G' ' 194' ' ' ALA . 77.4 t-105 -78.17 81.07 4.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.498 0.666 . . . . 74.21 110.949 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -118.09 84.34 21.59 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.822 -1.547 . . . . 64.14 106.822 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.63 115.3 4.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.255 1.97 . . . . 75.45 111.256 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -95.69 90.87 5.84 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.835 -1.542 . . . . 72.43 106.835 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 46.9 t -84.47 112.59 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.734 -1.121 . . . . 54.32 111.381 -168.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 12.6 mptt -80.08 146.07 32.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.06 0.944 . . . . 64.33 108.534 167.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.23 114.82 10.52 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.448 0.699 . . . . 70.5 109.539 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 26.0 m-20 -108.8 141.56 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.402 0.681 . . . . 75.33 109.384 173.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.3 tp -133.68 119.44 19.35 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.942 -1.132 . . . . 73.14 107.942 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 30.9 t70 -141.81 151.54 42.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.432 0.693 . . . . 72.33 110.018 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -131.35 150.13 52.27 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.894 0.877 . . . . 74.11 109.876 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . . . -147.34 152.53 38.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.73 1.212 . . . . 54.51 108.466 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.686 ' HB2' HD11 ' A' ' 98' ' ' LEU . 8.5 t -133.29 160.47 37.21 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.138 0.426 . . . . 73.11 111.345 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -149.57 120.42 7.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.212 1.005 . . . . 55.21 108.82 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -74.07 104.13 4.78 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.784 -0.821 . . . . 74.44 108.784 175.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.75 -32.61 27.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.114 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.65 -175.69 5.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.932 0.893 . . . . 63.43 109.705 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.71 125.23 24.12 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.16 -0.681 . . . . 71.44 109.16 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 70.44 -8.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.622 1.569 . . . . 73.42 112.44 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.78 110.94 28.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.996 -0.742 . . . . 73.15 108.996 -174.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.28 124.47 40.4 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.362 1.065 . . . . 71.25 108.562 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.33 127.19 35.48 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.202 -1.036 . . . . 74.34 108.202 168.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.97 121.86 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.242 -1.022 . . . . 60.33 108.242 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.6 t -103.33 130.21 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.199 0.6 . . . . 75.22 109.555 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -101.38 117.81 35.71 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.213 1.005 . . . . 73.04 108.668 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' NH2' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -91.9 106.12 18.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.071 -0.714 . . . . 74.42 109.071 169.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' HB1' ' A' ' 110' ' ' ALA . 17.7 t -105.92 126.97 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.527 -1.286 . . . . 30.41 107.527 169.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -122.92 134.23 54.36 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.731 -0.47 . . . . 64.53 109.731 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.5 t -130.36 107.31 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.352 1.461 . . . . 72.32 107.791 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 36.3 m -113.2 122.27 46.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.369 -0.604 . . . . 74.01 109.369 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.5 117.96 35.65 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.682 -1.229 . . . . 64.32 107.682 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.7 m -117.76 126.77 53.05 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.827 0.451 . . . . 32.01 109.846 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.485 HD21 ' CE3' ' A' ' 36' ' ' TRP . 66.6 mt -89.37 70.3 8.11 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.529 -1.285 . . . . 75.41 107.529 176.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -85.29 0.95 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.42 -1.263 . . . . 43.52 110.733 -168.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.04 -25.17 5.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.94 0.896 . . . . 72.12 110.961 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.83 107.26 12.48 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.26 -0.645 . . . . 63.1 109.26 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -62.1 127.35 30.97 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.903 0.382 . . . . 65.53 110.16 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -53.52 6.51 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.125 0.97 . . . . 34.11 108.695 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.14 167.24 30.39 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 113.867 -1.515 . . . . 75.22 110.236 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -129.78 144.12 51.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.33 1.452 . . . . 71.24 107.861 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.4 m -134.19 138.18 44.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.872 0.869 . . . . 74.3 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.96 123.69 10.53 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.486 -0.931 . . . . 72.13 108.486 168.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.89 119.86 55.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.713 -0.847 . . . . 72.11 108.713 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 73.6 mt-30 -95.3 90.08 5.71 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.761 -1.109 . . . . 62.31 108.948 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 60.9 tp60 -81.17 96.66 7.29 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.346 -1.297 . . . . 64.13 107.724 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.54 143.24 17.12 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.923 -0.871 . . . . 55.53 110.923 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.93 121.54 1.57 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.706 -0.958 . . . . 72.11 110.706 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.5 mt -82.91 129.11 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.102 -1.073 . . . . 65.32 108.102 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -137.78 163.91 30.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.691 1.197 . . . . 73.14 109.208 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 p -110.29 120.18 41.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.119 0.568 . . . . 73.1 109.65 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 119.6 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.865 0.866 . . . . 75.53 110.327 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.81 160.97 4.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.8 1.64 . . . . 61.12 108.711 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.33 11.83 40.73 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 112.633 -0.187 . . . . 62.12 112.633 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' G' ' 173' ' ' LEU . 0.1 OUTLIER -115.79 169.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.669 1.188 . . . . 70.41 110.655 -173.09 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -167.79 173.95 7.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.194 -0.669 . . . . 73.04 109.194 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.84 -130.97 49.5 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 116.627 -0.26 . . . . 75.32 113.198 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.7 p -79.15 -15.01 58.74 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.693 0.797 . . . . 71.44 112.308 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.35 -36.94 69.36 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.047 0.939 . . . . 75.51 111.082 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -40.86 39.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.469 -0.787 . . . . 73.3 110.523 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.47 67.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 72.31 111.319 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -75.19 -44.2 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.82 0.848 . . . . 61.3 110.563 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.0 t -74.6 -64.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.913 -0.585 . . . . 42.11 109.938 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 48' ' ' SER . 65.5 tp -64.52 -41.74 96.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.674 0.789 . . . . 71.11 112.713 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.12 -36.86 44.62 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.234 -0.439 . . . . 73.41 113.464 -173.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -119.63 -54.38 2.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.43 0.53 . . . . 71.32 112.43 -170.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.446 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.4 t80 -74.27 -55.95 5.45 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.38 0.881 . . . . 73.14 113.38 -163.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 86.2 m -66.61 -38.18 18.3 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.589 0.959 . . . . 62.41 113.589 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.0 -26.24 43.68 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.627 1.551 . . . . 72.33 112.563 167.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.51 -26.61 61.84 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.765 0.426 . . . . 71.22 110.849 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -59.97 -42.3 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.873 0.844 . . . . 73.21 109.685 170.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.1 mt -78.56 -19.41 52.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.116 -1.402 . . . . 65.32 112.167 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 34.0 t80 -64.6 -39.85 44.12 Favored Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.197 1.184 . . . . 70.01 114.197 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.58 -40.64 83.05 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.318 2.012 . . . . 63.43 113.282 170.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -75.58 -36.76 60.28 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.295 -0.866 . . . . 54.5 111.15 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.48 -48.34 75.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.519 0.728 . . . . 72.35 109.747 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -52.89 -50.79 63.16 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 124.706 1.254 . . . . 70.11 110.755 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -60.95 -46.72 89.57 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.536 1.148 . . . . 63.3 111.721 -175.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.467 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -59.04 -43.5 91.64 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.194 0.934 . . . . 71.22 110.752 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 118' ' ' VAL . 91.1 mt -63.31 -53.89 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 123.963 0.789 . . . . 74.52 110.293 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 125' ' ' GLN . 61.6 m -51.59 -45.71 63.24 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.697 1.199 . . . . 71.53 111.188 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -66.96 -45.54 77.44 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.647 -1.16 . . . . 73.12 110.352 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' HG23 ' A' ' 21' ' ' ILE . 12.0 mtp -55.22 -44.7 75.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.762 0.825 . . . . 73.5 111.719 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -64.07 -46.95 92.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.207 1.003 . . . . 73.31 110.817 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.5 p -70.85 -28.59 64.7 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 115.802 -0.635 . . . . 73.03 110.784 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.509 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.8 mtt-85 -72.26 -33.57 67.59 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.022 0.929 . . . . 75.13 110.098 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.36 68.37 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.485 -0.779 . . . . 54.44 112.763 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m 69.28 40.34 1.52 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.774 1.229 . . . . 71.42 110.096 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.15 145.24 39.64 Favored Pre-proline 0 C--O 1.245 0.852 0 CA-C-N 115.356 -0.838 . . . . 70.41 109.208 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -51.99 114.39 1.6 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.025 2.484 . . . . 73.11 112.096 172.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.641 ' HB2' HG23 ' A' ' 115' ' ' THR . 19.1 pt20 -63.19 156.13 26.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.088 -0.96 . . . . 73.14 111.945 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.39 118.68 37.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.772 -1.104 . . . . 31.53 108.881 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 79.0 m-20 -98.72 84.51 3.14 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.315 -1.365 . . . . 73.3 107.315 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.478 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -69.35 141.14 54.28 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.262 -0.881 . . . . 73.11 109.453 -174.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' H' ' 204' ' ' ILE . . . -64.9 129.41 94.43 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 122.629 0.372 . . . . 73.13 111.569 -175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.66 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.559 2.173 . . . . 63.33 110.807 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.71 114.42 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.886 -1.052 . . . . 64.02 109.25 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -87.99 104.9 17.08 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.706 -1.22 . . . . 70.35 107.706 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -59.82 -31.66 69.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.533 1.145 . . . . 75.21 111.184 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.652 ' HA ' ' HE2' ' G' ' 182' ' ' PHE . 27.6 t70 -77.6 -53.45 7.57 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 115.461 -0.79 . . . . 71.23 111.105 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.81 92.49 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.031 0.832 . . . . 64.32 112.523 -169.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' H' ' 207' ' ' VAL . 53.0 tp -62.23 -41.14 98.13 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.07 0.462 . . . . 74.32 111.085 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.433 ' O ' HD13 ' A' ' 141' ' ' LEU . 40.5 t80 -80.57 -32.22 36.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.632 -0.713 . . . . 71.03 110.791 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.7 ttt -65.28 -40.41 93.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.093 0.957 . . . . 75.23 110.4 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' C' ' 8' ' ' GLU . 87.0 m-20 -63.13 -31.95 73.21 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.239 -0.891 . . . . 74.22 110.988 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.19 -40.49 71.17 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.841 -0.618 . . . . 70.3 110.89 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 137' ' ' PHE . 6.1 mp -61.17 -48.94 79.26 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.679 . . . . 74.41 111.599 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.497 ' HB3' ' NE2' ' A' ' 144' ' ' GLN . 23.6 tm0? -170.98 -18.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 123.729 0.643 . . . . 75.43 110.744 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.425 ' HG3' ' HG3' ' C' ' 8' ' ' GLU . 0.6 OUTLIER 58.89 94.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.974 0.91 . . . . 72.21 109.552 -171.508 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 142' ' ' GLN . 24.7 mp0 -87.7 91.81 8.88 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.876 0.471 . . . . 72.04 109.809 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.28 136.9 48.16 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.212 -0.662 . . . . 74.32 109.212 172.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.29 90.07 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.52 -0.632 . . . . 72.25 111.52 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.11 152.29 35.89 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.282 -0.636 . . . . 70.23 109.282 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.64 37.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.875 -0.89 . . . . 45.52 110.875 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.1 t -112.33 149.68 32.08 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.292 0.637 . . . . 40.14 110.524 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 20.94 0.59 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.5 1.12 . . . . 62.21 108.766 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.09 110.14 17.76 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.744 0.783 . . . . 75.02 110.478 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -108.35 82.34 1.61 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.99 0.916 . . . . 53.03 108.915 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -100.29 137.11 39.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.274 0.559 . . . . 75.13 110.329 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -151.95 31.31 0.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.486 1.114 . . . . 54.51 108.917 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 CA-C-N 114.492 -1.231 . . . . 61.5 110.972 -177.759 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.317 -0.623 . . . . 64.51 109.317 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -77.49 80.2 3.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.221 0.609 . . . . 65.23 110.482 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -74.4 106.5 6.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.956 0.902 . . . . 75.4 110.18 -171.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -122.84 87.83 2.82 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 107.201 -1.407 . . . . 70.33 107.201 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 70.15 156.03 0.14 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 124.474 1.109 . . . . 75.24 110.882 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.53 147.47 45.95 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.628 -0.508 . . . . 73.24 109.628 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -136.54 -34.54 0.76 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.88 1.272 . . . . 75.34 108.785 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.58 98.85 0.28 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 123.433 0.693 . . . . 73.04 109.769 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.531 ' HB3' HG23 ' B' ' 89' ' ' ILE . 13.6 ptm 49.49 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.898 2.079 . . . . 62.24 114.556 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -146.8 137.15 23.66 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.983 -1.117 . . . . 71.01 107.983 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -137.28 137.0 38.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.804 -0.813 . . . . 72.45 108.804 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -147.72 126.66 12.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.886 0.475 . . . . 74.41 109.975 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -91.47 139.87 17.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 108.918 -0.771 . . . . 70.44 108.918 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -110.79 -44.27 3.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.838 0.455 . . . . 62.43 110.516 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -172.44 139.95 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.506 0.322 . . . . 72.21 110.219 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.47 146.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.06 -1.089 . . . . 74.14 108.06 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -167.2 164.87 15.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.619 0.723 . . . . 74.4 111.583 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.2 m -90.04 120.01 30.87 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.286 -1.005 . . . . 74.03 108.286 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -90.43 -24.88 20.62 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.842 0.457 . . . . 72.3 111.301 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.0 t70 -158.62 144.65 16.88 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.94 0.4 . . . . 73.14 111.829 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.476 HD11 ' SG ' ' B' ' 113' ' ' CYS . 42.8 mm -132.96 141.22 45.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.117 1.367 . . . . 75.12 108.755 173.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 38.3 m -137.87 122.25 18.29 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.219 1.407 . . . . 71.21 108.388 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 65.8 t80 -134.97 110.02 8.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.083 -1.821 . . . . 73.25 106.083 165.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -125.66 111.23 14.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.977 -1.12 . . . . 75.12 107.977 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.662 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.06 89.37 5.52 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.012 0.925 . . . . 50.53 109.162 177.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.68 -26.67 19.25 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.416 2.077 . . . . 63.3 111.831 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -117.62 24.58 10.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.317 1.047 . . . . 74.12 109.313 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.678 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.04 -53.2 13.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 125.905 1.682 . . . . 64.13 114.498 173.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.0 Cg_exo -74.84 -18.23 19.32 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.541 2.161 . . . . 75.02 112.185 -177.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.89 2.53 54.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.706 -1.134 . . . . 71.32 111.811 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.04 -18.13 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.172 0.589 . . . . 72.5 110.503 168.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -73.51 -34.48 65.3 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.683 -0.488 . . . . 64.23 109.683 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.11 -45.56 26.51 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.423 0.63 . . . . 75.11 109.4 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 27.3 mmtp -94.57 68.91 3.48 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.858 1.263 . . . . 64.42 109.191 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.16 75.86 3.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.314 -1.312 . . . . 64.02 110.905 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -162.25 151.95 16.18 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.474 -1.306 . . . . 63.23 107.474 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.458 ' HB2' ' N ' ' F' ' 195' ' ' PHE . 22.7 tt0 -88.08 119.37 70.37 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.472 -0.566 . . . . 71.5 109.472 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.656 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 68.8 Cg_endo -68.63 144.4 60.16 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.963 1.776 . . . . 73.3 111.817 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 109.03 2.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.075 -0.966 . . . . 71.25 108.71 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.519 HG23 ' HA2' ' F' ' 191' ' ' GLY . 1.1 t -84.79 123.07 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 108.983 -0.747 . . . . 72.33 108.983 -167.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -124.44 147.09 48.54 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.38 1.072 . . . . 75.2 109.659 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.641 ' H ' HD13 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -109.24 167.13 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.319 0.648 . . . . 71.24 111.605 179.028 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.9 t70 -153.51 139.98 18.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.892 1.277 . . . . 73.53 108.731 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.61 132.98 53.41 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.328 0.651 . . . . 74.33 109.36 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -146.81 151.63 37.42 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.551 1.141 . . . . 74.13 109.079 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.0 m -139.28 121.84 16.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.835 0.454 . . . . 64.42 110.02 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.91 160.42 19.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.64 1.176 . . . . 51.21 108.854 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -144.21 163.95 32.16 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.298 0.639 . . . . 73.21 110.601 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 7.3 p -159.97 137.3 9.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.094 0.958 . . . . 73.3 109.853 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -84.12 129.9 34.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.535 0.734 . . . . 73.42 110.402 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.53 -42.91 8.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.196 0.598 . . . . 74.2 109.479 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.41 -171.23 3.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.078 0.951 . . . . 54.42 110.04 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.55 112.93 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.859 -1.064 . . . . 62.34 110.252 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 69.49 -0.5 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.564 1.546 . . . . 74.45 112.979 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -104.83 104.7 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.377 -1.342 . . . . 50.24 107.377 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -124.09 149.77 45.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.395 0.678 . . . . 74.02 109.542 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.83 112.59 21.31 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.498 1.119 . . . . 71.41 108.665 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.85 118.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.429 -0.952 . . . . 73.3 108.429 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 50.5 t -102.42 109.33 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.394 -0.965 . . . . 71.0 108.394 175.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -93.75 117.06 29.6 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.576 -0.898 . . . . 72.44 108.576 -175.077 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.04 117.28 34.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.161 0.584 . . . . 73.42 110.128 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.51 HG11 HD11 ' B' ' 128' ' ' LEU . 11.8 t -116.19 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.989 -1.115 . . . . 72.32 107.989 169.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 6.7 m -115.31 150.45 36.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.52 0.728 . . . . 44.0 109.567 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.442 HG23 HD13 ' B' ' 114' ' ' ILE . 34.8 t -129.43 130.57 67.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.637 1.175 . . . . 61.3 109.139 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -126.12 140.81 52.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.181 0.992 . . . . 75.31 110.351 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.844 ' HB3' ' HE2' ' B' ' 74' ' ' PHE . . . -150.63 161.78 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.045 -0.724 . . . . 64.11 109.045 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.9 p -146.91 141.46 26.57 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.45 0.643 . . . . 63.23 112.022 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 34.5 mt -91.89 98.85 11.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.831 -1.174 . . . . 70.54 107.831 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.14 -107.73 2.3 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.44 -1.064 . . . . 71.43 110.44 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.0 8.63 10.45 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.82 0.848 . . . . 73.54 110.376 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -112.39 142.97 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.192 -0.67 . . . . 72.2 109.192 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -56.55 126.05 24.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.765 0.826 . . . . 73.14 110.742 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.26 -59.62 2.7 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 122.222 1.011 . . . . 65.23 109.065 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.844 ' HE2' ' HB3' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -154.53 178.66 9.83 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 113.006 -1.906 . . . . 73.41 107.08 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.72 136.81 29.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.931 -1.137 . . . . 65.23 107.931 164.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 50.6 t -131.83 147.56 52.49 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.589 -0.893 . . . . 71.34 108.589 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.0 tt0 -163.66 134.72 4.62 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.807 -0.812 . . . . 71.43 108.807 -173.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -125.21 146.7 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.325 1.05 . . . . 71.4 109.014 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 78.4 mt-30 -126.05 88.95 2.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.382 -0.969 . . . . 72.05 108.382 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.528 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 43.7 tp60 -85.07 100.86 11.98 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.899 -1.046 . . . . 71.4 109.523 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.79 156.46 25.55 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.693 -0.563 . . . . 55.21 111.693 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.83 130.22 2.38 Favored Glycine 0 C--O 1.239 0.456 0 N-CA-C 111.568 -0.613 . . . . 60.21 111.568 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.61 127.26 40.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.609 0.764 . . . . 62.21 109.401 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -134.22 158.21 44.28 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.773 1.229 . . . . 75.01 108.665 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -132.51 121.95 24.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.407 -0.96 . . . . 63.32 108.407 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.623 HG13 ' SG ' ' B' ' 97' ' ' CYS . 0.2 OUTLIER -133.24 141.65 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.568 -0.901 . . . . 74.13 108.568 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.469 ' N ' HD13 ' B' ' 86' ' ' ILE . . . -158.94 174.88 14.29 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.078 0.951 . . . . 71.34 109.487 169.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.14 -54.98 0.53 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.27 0.462 . . . . 45.05 112.275 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' B' ' 9' ' ' MET . 2.1 pp -78.85 170.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.506 0.722 . . . . 55.24 112.589 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.7 162.87 40.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.559 0.744 . . . . 73.2 110.634 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.73 -129.38 24.61 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.473 -0.785 . . . . 44.43 113.771 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -67.61 -28.5 67.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.355 1.062 . . . . 54.03 111.167 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.68 -18.43 65.37 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.62 0.768 . . . . 65.21 112.09 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.4 tpt -68.97 -39.95 79.13 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.991 0.516 . . . . 71.22 110.156 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.47 -21.32 66.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.295 -0.866 . . . . 62.44 111.587 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -65.14 -40.83 94.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.411 0.685 . . . . 62.44 110.849 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.623 ' SG ' HG13 ' B' ' 86' ' ' ILE . 53.9 t -75.23 -69.91 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.852 -0.613 . . . . 74.31 111.128 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.589 HD13 ' H ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -88.79 -8.33 54.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 112.313 0.486 . . . . 73.45 112.313 -171.441 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.23 3.42 54.82 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.691 -0.505 . . . . 71.4 112.769 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.09 -67.9 0.18 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 117.142 0.471 . . . . 72.53 111.424 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -68.05 -50.85 52.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.819 0.674 . . . . 75.54 112.819 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.551 ' HA ' HD12 ' B' ' 105' ' ' ILE . 62.5 m -62.25 -43.4 85.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.921 0.888 . . . . 72.35 113.206 -173.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -39.4 49.23 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 121.476 1.451 . . . . 64.54 112.365 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -65.73 -18.33 65.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.761 0.652 . . . . 75.03 112.761 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.592 HG23 ' NH2' ' D' ' 111' ' ' ARG . 96.4 mt -69.83 -44.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.513 0.725 . . . . 75.14 109.988 170.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.483 ' HB2' HD12 ' B' ' 60' ' ' LEU . 30.9 mt -84.85 -18.19 35.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.754 -1.112 . . . . 63.31 111.437 -173.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.427 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 36.0 t80 -61.87 -40.95 73.86 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 124.736 1.214 . . . . 71.01 113.197 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.443 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 14.9 Cg_endo -56.71 -45.77 34.46 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.533 2.155 . . . . 61.45 113.479 169.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.528 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 85.1 m-85 -64.82 -42.71 94.76 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.073 0.549 . . . . 74.44 110.42 -177.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -39.99 89.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.651 0.78 . . . . 74.52 110.843 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' B' ' 128' ' ' LEU . 26.8 ttt180 -58.55 -52.91 63.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.402 1.081 . . . . 63.1 111.486 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -38.14 88.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.108 -0.951 . . . . 73.15 109.779 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.509 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 5.8 t -68.18 -36.84 80.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.477 -0.783 . . . . 74.12 111.474 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.442 HD13 HG23 ' B' ' 64' ' ' VAL . 53.5 mt -62.7 -60.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.364 1.215 0 N-CA-C 109.351 -0.611 . . . . 65.2 109.351 176.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.8 m -53.55 -38.04 63.46 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 124.724 1.265 . . . . 71.3 110.754 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.7 t -55.88 -54.23 47.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.133 0.973 . . . . 73.04 111.391 174.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.505 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 16.8 mmt -66.29 -37.2 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.902 0.481 . . . . 73.24 111.462 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.498 HG22 ' HE1' ' B' ' 74' ' ' PHE . 91.1 t -63.74 -40.28 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.534 1.133 . . . . 71.35 110.577 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.4 m -65.32 -35.88 82.33 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.47 -1.241 . . . . 74.33 111.826 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 75.4 mtt-85 -65.22 -41.73 94.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.258 -0.883 . . . . 71.32 110.168 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.59 -1.48 82.87 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.875 0.734 . . . . 44.32 113.895 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p 60.0 49.84 7.25 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.74 1.616 . . . . 74.24 111.62 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -118.49 161.36 35.87 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 114.264 -1.335 . . . . 73.52 110.071 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.38 145.6 72.08 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.325 2.683 . . . . 74.44 114.89 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' C' ' 124' ' ' PRO . 3.9 pt20 -66.63 158.83 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.206 1.403 . . . . 74.42 113.803 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.11 104.27 7.46 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.671 -1.603 . . . . 70.42 106.671 162.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -90.05 93.1 9.25 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.371 -0.974 . . . . 65.51 108.371 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' B' ' 111' ' ' ARG . 40.0 mt -57.29 135.27 56.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.116 0.967 . . . . 70.25 113.478 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.2 117.51 58.24 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 114.621 -1.172 . . . . 65.22 108.625 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -65.67 151.1 85.54 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.399 2.733 . . . . 63.34 112.702 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 114.67 -1.15 . . . . 71.21 108.117 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.34 65.75 9.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.669 -0.863 . . . . 64.4 108.669 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.81 -26.95 63.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.198 -0.91 . . . . 71.23 109.383 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.31 -39.8 88.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.489 1.116 . . . . 74.43 110.136 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.2 -44.0 48.81 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.975 0.91 . . . . 51.21 110.982 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.464 ' HB2' HG21 ' E' ' 207' ' ' VAL . 48.3 tp -61.51 -35.41 77.63 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.701 0.8 . . . . 72.44 111.082 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -61.23 -39.86 91.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.88 1.272 . . . . 74.2 110.792 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 50.0 mtt -61.88 -42.92 99.64 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.903 0.752 . . . . 74.04 109.985 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -75.97 -29.57 58.3 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.993 -1.003 . . . . 41.54 110.981 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -64.65 -36.34 83.96 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.731 0.645 . . . . 75.02 109.95 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -90.76 35.66 0.89 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.807 0.843 . . . . 74.14 111.091 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 62.33 42.25 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.641 1.176 . . . . 74.31 111.825 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 62.61 -157.84 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.423 1.089 . . . . 74.54 110.918 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.468 ' NE2' ' SD ' ' D' ' 138' ' ' MET . 11.1 pt20 -149.67 -163.63 1.83 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.428 0.691 . . . . 72.23 109.718 -176.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' D' ' 138' ' ' MET . . . -67.46 -3.2 7.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.139 0.976 . . . . 61.44 113.487 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' D' ' 137' ' ' PHE . . . -73.65 62.09 1.97 Allowed Glycine 0 C--N 1.355 1.607 0 C-N-CA 123.273 0.463 . . . . 52.1 112.557 173.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.38 6.67 4.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.391 1.476 . . . . 73.31 109.495 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.31 71.8 2.92 Favored Glycine 0 C--N 1.358 1.79 0 N-CA-C 110.912 -0.875 . . . . 74.24 110.912 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.722 ' HA ' ' HB2' ' D' ' 93' ' ' GLN . 41.2 p -74.82 -64.87 0.95 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.749 0.82 . . . . 64.51 111.123 -172.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 55.23 88.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.395 1.078 . . . . 73.23 111.945 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -61.43 117.07 5.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.517 0.727 . . . . 72.43 110.38 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -165.74 99.89 0.68 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.223 -1.028 . . . . 73.42 108.223 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.501 HE21 ' N ' ' H' ' 168' ' ' LYS . 47.8 mt-30 -121.17 -62.19 1.46 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.757 0.823 . . . . 62.34 109.217 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.7 -74.72 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.646 0.778 . . . . 75.24 110.473 -174.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.965 0 C-N-CA 124.201 1.0 . . . . 45.42 108.742 -177.897 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.854 -0.795 . . . . 54.22 108.854 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.4 m -134.46 169.51 17.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.821 0.848 . . . . 74.55 110.386 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.63 96.06 2.96 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.53 -0.915 . . . . 55.51 108.53 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.96 113.27 22.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.157 0.583 . . . . 74.23 109.854 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -167.04 118.63 0.92 Allowed 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.729 -1.212 . . . . 43.04 107.729 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -160.09 133.92 7.18 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.899 -0.778 . . . . 74.13 108.899 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -84.58 -12.67 53.63 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 60.22 112.022 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 0.2 OUTLIER -86.2 112.7 21.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.742 -0.836 . . . . 73.41 108.742 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.4 ttp 63.03 115.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.385 1.474 . . . . 72.33 112.369 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -116.53 118.95 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.732 1.213 . . . . 64.22 108.19 170.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -120.83 137.31 54.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.054 0.542 . . . . 65.25 109.552 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.459 ' HG3' HG13 ' H' ' 204' ' ' ILE . 54.1 tt0 -148.6 124.16 10.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.707 0.803 . . . . 61.42 108.942 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 tp -78.57 133.57 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.037 -0.727 . . . . 72.04 109.037 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -103.17 -51.06 3.33 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.583 0.753 . . . . 73.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.513 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 57.4 ttt180 -165.1 123.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.231 -168.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -112.3 132.02 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.522 -0.918 . . . . 72.2 108.522 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.546 ' HB3' HG23 ' D' ' 122' ' ' THR . 22.1 p90 -173.19 148.03 1.63 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.126 0.891 . . . . 73.34 110.597 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -74.42 124.8 27.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 75.21 110.121 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -74.79 -48.94 22.69 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.288 1.042 . . . . 73.22 109.053 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 29.1 t70 -139.31 136.02 34.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.923 -1.49 . . . . 51.32 109.284 -167.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.8 mt -137.31 143.7 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 106.902 -1.518 . . . . 72.51 106.902 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -154.21 150.8 28.46 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.335 0.588 . . . . 71.43 109.79 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.427 ' HZ ' ' HD2' ' C' ' 123' ' ' PHE . 79.4 t80 -150.99 110.54 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.496 -1.298 . . . . 74.12 107.496 173.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.07 124.85 50.26 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.597 0.759 . . . . 74.41 109.337 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.27 84.0 48.7 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 107.7 -1.222 . . . . 74.12 107.7 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.89 -25.71 38.67 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.471 2.114 . . . . 64.31 111.69 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.3 20.74 17.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.338 1.055 . . . . 71.41 110.412 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.86 -49.96 90.77 Favored Pre-proline 0 CA--C 1.569 1.711 0 N-CA-C 114.723 1.379 . . . . 73.41 114.723 -172.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 -30.89 10.87 Favored 'Trans proline' 0 C--N 1.387 2.569 0 CA-C-N 121.58 1.6 . . . . 75.14 112.723 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -68.83 -49.57 57.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.976 0.91 . . . . 61.33 111.423 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.45 HG23 HD11 ' C' ' 68' ' ' LEU . 14.3 p -59.51 -18.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.344 1.458 . . . . 60.24 112.932 -169.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.64 -33.56 71.68 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.172 0.989 . . . . 74.2 112.311 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.47 5.34 52.11 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.769 0.655 . . . . 72.11 112.769 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -87.6 163.88 16.37 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.562 -0.532 . . . . 73.53 109.562 176.136 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.61 107.07 1.3 Allowed 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.762 -1.199 . . . . 74.13 107.762 164.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -82.15 83.61 7.3 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.328 1.061 . . . . 72.41 110.348 -171.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.56 72.75 81.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 115.036 -0.983 . . . . 72.21 108.823 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.06 127.65 15.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.416 2.077 . . . . 74.5 111.153 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.46 ' HA ' ' H ' ' E' ' 191' ' ' GLY . 41.8 mt-10 -86.06 76.72 9.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.377 -1.342 . . . . 74.01 107.377 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.19 85.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 123.055 1.407 . . . . 64.22 110.833 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 140.47 48.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.907 -1.497 . . . . 73.21 107.46 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.484 HD12 HD12 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -128.48 155.94 44.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.159 0.583 . . . . 74.44 110.767 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.21 128.06 53.86 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.695 1.198 . . . . 63.5 108.118 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.589 ' HB3' ' HE1' ' E' ' 184' ' ' TRP . 7.5 tp -106.02 101.26 10.77 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.138 0.575 . . . . 73.54 109.507 -173.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.469 ' O ' HD23 ' C' ' 60' ' ' LEU . 10.3 t70 -113.91 139.03 49.54 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.62 1.168 . . . . 72.42 109.781 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.0 t -119.08 131.35 55.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.281 0.632 . . . . 73.11 109.631 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.39 151.72 32.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.357 1.063 . . . . 72.32 108.974 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -143.57 143.59 31.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.079 0.552 . . . . 72.33 110.404 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -153.21 156.46 38.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.569 1.148 . . . . 75.13 108.528 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.573 ' HB2' ' H ' ' E' ' 172' ' ' ALA . 63.5 tt0 -103.79 117.95 35.55 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.342 -0.614 . . . . 75.44 109.342 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' C' ' 57' ' ' GLU . 56.7 mt -86.52 -36.63 18.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.369 0.668 . . . . 73.23 110.093 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.75 -176.37 5.5 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.077 -0.965 . . . . 54.1 110.69 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.87 102.45 0.47 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.429 -1.26 . . . . 74.02 110.322 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 13.0 m-20 64.57 13.04 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.968 1.307 . . . . 71.14 113.581 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 98.9 t -106.03 107.74 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 107.973 -1.121 . . . . 74.11 107.973 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' C' ' 86' ' ' ILE . 7.9 m-30 -114.89 146.05 41.53 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.48 -0.933 . . . . 72.0 108.48 -174.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.6 tt0 -109.08 124.13 50.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.206 1.002 . . . . 71.32 108.557 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.809 HG21 ' HB2' ' C' ' 98' ' ' LEU . 92.8 t -119.38 124.55 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.189 -1.041 . . . . 31.33 108.189 172.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.9 115.43 47.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.581 1.152 . . . . 71.33 108.764 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.469 HD23 ' O ' ' C' ' 45' ' ' ASP . 0.9 OUTLIER -86.27 105.25 16.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.356 -0.979 . . . . 64.12 108.356 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.12 106.45 16.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.242 0.617 . . . . 72.02 109.481 172.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.577 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.9 t -100.7 130.66 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.113 -1.069 . . . . 62.44 108.113 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -125.25 122.59 37.39 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.48 -0.563 . . . . 72.42 109.48 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.66 HG21 HG21 ' C' ' 114' ' ' ILE . 71.5 t -98.63 113.55 33.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.424 1.09 . . . . 64.12 109.302 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -99.34 134.46 42.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.401 -0.963 . . . . 50.12 108.401 171.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.16 124.53 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.676 0.79 . . . . 64.13 108.952 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.7 m -133.54 170.98 14.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.944 0.898 . . . . 75.04 110.136 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.652 HD13 ' HG2' ' C' ' 34' ' ' LYS . 27.8 mt -127.89 22.95 6.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.666 1.186 . . . . 74.01 108.551 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.24 -96.62 0.99 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.027 -1.229 . . . . 50.05 110.027 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -91.48 -30.94 16.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.44 110.744 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -85.69 121.99 29.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.145 0.978 . . . . 74.2 110.87 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -69.62 125.5 26.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.471 -0.566 . . . . 75.44 109.471 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -49.09 12.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.247 0.619 . . . . 21.51 109.782 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -171.27 177.09 3.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.976 0.91 . . . . 54.31 110.699 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -140.99 139.23 34.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.738 -1.579 . . . . 74.23 106.738 174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -137.24 154.51 50.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.643 -0.873 . . . . 71.02 108.643 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.09 143.98 18.46 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.85 0.46 . . . . 74.03 109.831 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' C' ' 113' ' ' CYS . 19.6 t -142.99 114.28 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.857 1.263 . . . . 74.42 108.171 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 42.1 mt-30 -93.36 95.53 9.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.546 0.739 . . . . 71.14 109.308 169.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -83.17 104.61 13.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.779 -1.1 . . . . 45.11 109.829 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.73 146.63 22.41 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.4 0.437 . . . . 52.32 112.327 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.97 124.78 2.64 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.879 -0.888 . . . . 55.45 110.879 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.487 HG12 ' HE1' ' C' ' 17' ' ' TYR . 26.1 mm -93.72 118.04 38.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.3 -1.0 . . . . 63.53 108.3 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.46 118.55 28.61 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.526 -0.916 . . . . 72.23 108.526 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -95.75 102.84 14.68 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.183 -1.043 . . . . 74.34 108.183 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.7 pp -114.44 -177.76 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.744 0.818 . . . . 70.22 110.648 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 176.91 153.01 0.21 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.584 1.554 . . . . 65.0 108.657 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.32 -17.61 46.84 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 114.597 0.599 . . . . 64.14 114.597 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 pt -57.43 133.09 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.833 0.853 . . . . 70.02 111.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.582 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 8.8 pt-20 -145.0 -177.9 5.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.643 0.777 . . . . 73.53 109.356 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.59 -124.53 23.31 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 124.042 0.839 . . . . 54.31 113.779 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -83.55 -18.48 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.817 0.847 . . . . 64.32 112.255 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.428 ' H ' ' NE2' ' C' ' 93' ' ' GLN . 1.3 mp0 -69.23 -40.43 77.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.004 0.522 . . . . 63.14 110.501 -172.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.582 ' HE3' ' HA ' ' C' ' 90' ' ' GLU . 11.3 ptp -63.57 -35.4 80.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.579 0.352 . . . . 63.41 111.422 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.54 ' HB1' ' HE1' ' E' ' 181' ' ' TYR . . . -76.22 -38.17 56.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.797 0.839 . . . . 74.44 111.245 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -77.96 -37.81 46.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.088 0.955 . . . . 61.15 111.23 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.53 -49.98 75.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.118 0.967 . . . . 73.13 111.277 -169.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.809 ' HB2' HG21 ' C' ' 58' ' ' VAL . 3.4 pp -108.88 -11.1 15.05 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.055 0.391 . . . . 51.12 112.055 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.17 -28.98 35.1 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.238 -0.201 . . . . 34.43 112.918 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.09 -45.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.009 0.524 . . . . 75.04 111.481 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -74.43 -47.24 34.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.743 0.817 . . . . 74.54 112.364 -172.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.539 ' HB2' ' HA ' ' C' ' 98' ' ' LEU . 97.7 m -65.78 -46.49 66.25 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 118.518 -0.753 . . . . 63.2 112.443 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.426 ' O ' HD12 ' C' ' 60' ' ' LEU . 37.8 Cg_endo -66.26 -23.1 52.49 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 121.135 1.441 . . . . 61.22 112.397 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.23 -31.72 70.48 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.349 0.522 . . . . 75.25 110.191 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' C' ' 102' ' ' CYS . 26.8 mm -62.89 -44.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.63 0.772 . . . . 61.43 109.592 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 66.4 mt -82.4 -18.15 42.95 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.766 0.826 . . . . 74.22 112.454 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.12 -47.56 90.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.46 -1.257 . . . . 70.35 112.955 -174.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.75 -38.63 92.3 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.021 1.814 . . . . 44.54 112.304 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.495 ' HB3' ' NE2' ' C' ' 80' ' ' GLN . 87.9 m-85 -63.46 -50.78 68.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.962 0.905 . . . . 63.15 111.318 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.96 -37.5 81.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.763 -0.653 . . . . 65.13 110.952 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.78 -50.41 70.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 61.44 110.053 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.11 -38.22 75.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.86 0.864 . . . . 71.42 110.854 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.422 ' HB3' HG11 ' C' ' 78' ' ' VAL . 9.1 t -64.98 -34.02 77.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.177 0.591 . . . . 73.34 110.89 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.66 HG21 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -70.66 -50.8 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 115.772 -0.649 . . . . 74.42 109.661 173.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.406 HG23 ' H ' ' C' ' 126' ' ' LEU . 27.4 m -58.3 -34.77 70.92 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.957 0.786 . . . . 75.42 111.403 -173.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.9 p -67.88 -51.66 45.52 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.776 -0.647 . . . . 50.22 109.382 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.579 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.1 -41.41 62.41 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.859 1.264 . . . . 61.21 112.664 179.013 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.53 HG11 HD23 ' C' ' 126' ' ' LEU . 88.1 t -72.05 -41.21 67.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.091 -0.959 . . . . 61.14 110.397 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.42 -29.89 70.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.396 0.679 . . . . 72.51 111.271 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 61.5 mtt-85 -67.66 -44.14 78.59 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.634 -0.876 . . . . 73.33 108.634 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.85 -1.94 85.3 Favored Glycine 0 C--N 1.36 1.911 0 O-C-N 124.139 0.9 . . . . 63.33 113.434 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.1 p 66.84 41.84 2.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.877 1.671 . . . . 71.05 112.317 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HD2' ' HZ ' ' C' ' 23' ' ' PHE . 65.8 m-85 -114.41 163.89 17.93 Favored Pre-proline 0 CA--C 1.565 1.531 0 C-N-CA 124.958 1.303 . . . . 65.03 109.961 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.485 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 96.0 Cg_exo -49.41 151.77 6.59 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 124.341 3.36 . . . . 74.42 116.228 -175.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -48.46 132.37 16.92 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.648 1.179 . . . . 75.24 112.011 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.53 HD23 HG11 ' C' ' 118' ' ' VAL . 0.5 OUTLIER -111.47 23.52 13.86 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.536 -0.756 . . . . 72.13 111.521 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -90.71 79.5 6.04 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-O 123.788 1.756 . . . . 64.23 106.951 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' E' ' 189' ' ' ALA . 82.3 mt -90.12 151.67 21.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.648 -1.615 . . . . 72.23 110.185 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.447 ' HB1' HG13 ' F' ' 204' ' ' ILE . . . -35.54 113.19 0.5 Allowed Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 126.231 1.812 . . . . 63.43 114.319 -173.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.37 99.07 0.88 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.315 2.01 . . . . 64.03 111.816 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.35 97.96 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 115.214 -0.903 . . . . 74.21 110.524 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.51 68.11 10.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 71.41 109.821 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -51.05 -44.15 61.07 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.966 -1.47 . . . . 73.24 111.931 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.79 -35.26 76.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.253 1.021 . . . . 72.2 111.574 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.69 84.53 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.501 -0.772 . . . . 44.15 111.055 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.04 -48.21 82.83 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.869 -0.605 . . . . 65.02 110.234 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -68.77 -28.9 67.2 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.975 0.797 . . . . 64.34 111.449 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -50.6 35.07 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 123.854 0.721 . . . . 61.45 110.617 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -70.28 -30.9 68.04 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.677 0.391 . . . . 63.21 111.121 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.29 -149.68 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.29 1.436 . . . . 73.23 110.919 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 84.9 mt 64.84 95.47 0.05 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 123.974 0.909 . . . . 52.33 109.874 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -50.25 121.69 5.9 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.585 1.554 . . . . 65.33 111.381 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -140.17 165.84 26.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.817 0.847 . . . . 64.32 109.586 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -103.5 -23.33 13.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.733 0.813 . . . . 74.31 111.098 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.19 -159.76 0.31 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.389 1.076 . . . . 74.3 111.209 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 3' ' ' GLU . . . 166.45 69.59 0.03 OUTLIER Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.136 -0.786 . . . . 63.0 111.136 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -158.48 142.39 15.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.984 0.514 . . . . 74.32 110.407 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 170.6 141.02 3.17 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.456 -0.793 . . . . 21.41 111.651 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 91.6 m -148.82 86.13 1.51 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.224 -1.028 . . . . 71.23 108.224 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -86.76 110.9 20.23 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.319 -0.993 . . . . 74.5 108.319 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.16 175.33 13.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.959 0.903 . . . . 64.12 110.084 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -169.54 168.78 9.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.414 1.086 . . . . 73.35 110.041 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -126.37 102.29 7.08 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.55 0.74 . . . . 64.11 110.144 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -173.69 156.35 2.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.789 1.236 . . . . 61.24 109.825 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.988 0.915 . . . . 63.23 108.876 -177.206 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.635 0.255 . . . . 73.23 110.769 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.8 p -115.18 5.76 14.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.651 0.78 . . . . 75.34 109.484 164.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.72 128.06 49.59 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.327 1.051 . . . . 74.41 109.0 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' D' ' 6' ' ' ASN . 9.3 tt0 -77.29 133.12 38.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.771 0.828 . . . . 71.03 110.574 177.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -63.23 -35.05 79.04 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.142 0.977 . . . . 72.41 111.636 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.455 ' H ' ' HG2' ' D' ' 4' ' ' GLN . 28.8 t-20 60.75 -89.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.382 1.473 . . . . 62.53 110.551 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -163.12 99.21 0.95 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.563 0.697 . . . . 73.14 109.588 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 57.88 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.381 1.472 . . . . 75.54 111.025 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.8 ttp -36.35 126.35 0.8 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.36 1.064 . . . . 74.44 111.945 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 31.7 m -128.05 138.91 52.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.055 . . . . 73.24 108.15 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.418 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 73.2 t80 -169.74 91.14 0.21 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.314 -1.365 . . . . 71.41 107.314 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -126.09 153.37 44.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.77 0.828 . . . . 63.0 109.501 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.478 HG23 HD13 ' E' ' 204' ' ' ILE . 10.4 tp -103.53 142.84 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.201 0.6 . . . . 73.03 109.559 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.2 -45.39 2.94 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.781 0.833 . . . . 72.11 110.633 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -154.58 129.45 9.41 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 120.429 0.157 . . . . 75.01 111.19 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.536 HD12 ' N ' ' D' ' 16' ' ' ILE . 0.6 OUTLIER -121.28 112.16 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 106.256 -1.757 . . . . 72.51 106.256 -177.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -159.66 142.07 13.6 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 123.703 0.627 . . . . 72.13 111.704 -164.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.7 p -79.86 115.05 19.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.716 -1.129 . . . . 72.22 109.32 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -89.31 -28.83 19.59 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.007 -0.542 . . . . 72.5 110.365 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.5 t70 -147.08 133.49 19.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.324 -0.853 . . . . 65.41 109.582 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.579 HD13 ' HE3' ' C' ' 117' ' ' MET . 88.4 mt -133.5 139.5 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.688 1.195 . . . . 70.03 108.089 173.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -146.45 118.69 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.908 0.883 . . . . 71.14 109.289 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.7 t80 -124.93 131.96 53.35 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.247 -1.39 . . . . 73.05 107.247 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -137.97 118.63 14.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 75.24 108.803 -173.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -115.96 89.87 26.02 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.722 -0.844 . . . . 70.22 108.722 175.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.87 -63.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.333 2.688 . . . . 70.25 113.134 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 10.2 m-80 -98.35 41.07 1.15 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.607 -1.257 . . . . 72.15 107.607 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' D' ' 31' ' ' VAL . . . -56.75 -53.0 69.37 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.154 1.168 . . . . 62.14 114.154 -168.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.01 -8.45 15.47 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 122.394 1.891 . . . . 71.01 113.072 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 6.3 t-160 -74.27 -34.66 63.64 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 108.288 -1.004 . . . . 72.33 108.288 168.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.526 HG11 ' HE1' ' D' ' 123' ' ' PHE . 53.2 t -66.99 -26.63 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.512 1.125 . . . . 55.01 111.421 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.435 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.6 t80 -60.87 -34.53 74.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.032 0.444 . . . . 74.45 110.419 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -82.74 -33.2 27.54 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.462 -0.79 . . . . 65.03 110.289 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -91.94 90.86 7.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.737 0.815 . . . . 54.22 109.876 -173.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.85 59.27 3.62 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.39 1.076 . . . . 60.1 112.514 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.438 ' HB2' HD22 ' D' ' 68' ' ' LEU . 24.9 m95 -126.47 174.1 8.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.858 -0.793 . . . . 73.44 108.858 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.822 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 8.2 tp-100 -85.17 118.13 70.19 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 122.128 -0.358 . . . . 43.22 110.236 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.74 109.31 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.248 1.966 . . . . 74.45 110.633 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 52.2 mt-10 -62.51 111.85 2.22 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.953 0.783 . . . . 74.53 109.037 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.516 HG21 HD13 ' D' ' 126' ' ' LEU . 3.7 m -98.06 107.28 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.427 1.091 . . . . 60.31 109.267 -172.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -105.33 148.02 27.51 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.571 -0.74 . . . . 72.34 109.878 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -119.43 129.96 55.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.708 -0.678 . . . . 72.45 110.362 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 28.1 t70 -119.11 128.26 54.14 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.376 -0.972 . . . . 71.01 108.376 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -97.46 132.89 42.73 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.488 0.715 . . . . 73.34 110.03 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -146.96 156.3 42.95 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.939 -1.134 . . . . 62.14 107.939 169.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -144.57 164.39 31.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.218 0.533 . . . . 40.53 109.873 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 163.86 37.05 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.942 1.297 . . . . 70.12 108.277 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -167.13 153.47 8.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.903 0.382 . . . . 63.24 111.772 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.8 p -158.86 141.44 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.133 0.973 . . . . 71.31 109.716 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -81.75 124.06 29.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 74.42 110.856 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.7 mt -98.22 -35.71 10.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.589 0.756 . . . . 73.5 110.792 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -172.07 4.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.226 0.61 . . . . 73.43 111.085 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.53 112.56 4.18 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.288 1.035 . . . . 75.23 110.732 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.68 ' HA ' HD21 ' H' ' 173' ' ' LEU . 27.5 m-20 69.19 3.63 4.19 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.944 1.698 . . . . 71.12 112.847 -174.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.2 t -109.14 118.27 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.297 0.639 . . . . 52.41 110.438 -173.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.81 130.26 45.09 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.092 1.357 . . . . 73.23 108.354 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.7 tt0 -87.08 111.87 21.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.702 -1.221 . . . . 75.32 107.702 169.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -100.09 121.01 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.961 -1.496 . . . . 72.41 106.961 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.548 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 44.3 t -99.58 132.55 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.788 0.835 . . . . 75.12 109.231 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.4 OUTLIER -105.06 128.0 53.13 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.646 -1.242 . . . . 73.1 107.646 176.075 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 31.8 ttm-85 -107.49 99.99 9.45 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.572 0.749 . . . . 74.25 109.138 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.24 122.49 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.425 -0.954 . . . . 61.11 108.425 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.8 m -114.9 142.37 46.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.638 -0.71 . . . . 55.14 109.61 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.786 HG21 HG21 ' D' ' 114' ' ' ILE . 81.1 t -130.78 127.45 61.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.127 1.371 . . . . 65.02 108.637 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -123.7 94.76 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.086 -1.079 . . . . 54.44 108.086 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -98.06 127.37 43.96 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.661 -0.866 . . . . 72.22 108.661 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.484 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.4 m -140.63 139.52 34.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.392 0.615 . . . . 73.23 111.298 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' D' ' 36' ' ' TRP . 36.1 mt -110.52 116.98 32.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.284 1.434 . . . . 71.13 109.228 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.68 -129.05 44.15 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 120.14 -0.256 . . . . 41.43 112.894 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.81 4.06 50.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.504 0.721 . . . . 75.01 112.126 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' D' ' 68' ' ' LEU . 11.8 pt-20 -124.15 154.48 39.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.129 0.572 . . . . 71.33 110.174 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 33.9 m -74.47 136.13 42.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.286 -0.635 . . . . 71.13 109.286 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.46 -57.43 3.15 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.829 -1.175 . . . . 74.34 107.829 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' D' ' 118' ' ' VAL . 49.0 p90 -161.3 149.3 15.44 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 114.696 -1.138 . . . . 73.35 110.202 169.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -100.75 150.63 22.58 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.505 -0.924 . . . . 74.24 108.505 166.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.695 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.4 t -158.1 132.54 8.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.34 0.4 . . . . 65.24 109.922 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.87 132.81 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.553 0.741 . . . . 74.21 109.25 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -132.19 119.76 41.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.701 0.801 . . . . 72.11 109.687 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.88 88.2 7.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.729 0.812 . . . . 74.23 109.491 171.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.87 102.33 9.99 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 114.466 -1.243 . . . . 63.01 109.153 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.89 145.27 18.59 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.438 -0.665 . . . . 70.14 111.438 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.99 130.62 4.75 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.809 -0.916 . . . . 73.41 110.809 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.41 ' O ' HD12 ' D' ' 13' ' ' ILE . 56.1 mt -90.13 115.78 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.677 -0.86 . . . . 74.44 108.677 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -117.58 152.42 35.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.431 1.092 . . . . 53.45 109.71 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -116.23 95.02 4.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.033 -1.099 . . . . 72.14 108.033 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.479 HD12 ' H ' ' D' ' 86' ' ' ILE . 0.1 OUTLIER -110.3 138.71 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.468 0.707 . . . . 72.03 110.038 -171.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 169.76 13.89 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.786 1.235 . . . . 53.13 109.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.21 21.76 56.18 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.56 -0.291 . . . . 70.15 112.397 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.459 HD11 HD12 ' H' ' 173' ' ' LEU . 2.4 pp -125.01 161.04 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.485 1.114 . . . . 65.1 110.404 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.561 ' HG3' ' HB ' ' B' ' 149' ' ' THR . 6.6 pt-20 -166.63 165.98 16.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.59 0.756 . . . . 74.53 110.467 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 60.35 -134.54 50.21 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 124.026 0.829 . . . . 74.12 114.178 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -79.39 -14.11 59.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.012 0.925 . . . . 55.13 112.527 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.722 ' HB2' ' HA ' ' B' ' 149' ' ' THR . 27.3 tp60 -63.89 -34.17 77.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.459 0.704 . . . . 72.43 111.564 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 22.3 ptp -71.38 -28.04 63.76 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.521 0.513 . . . . 63.31 111.038 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.81 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.568 0.747 . . . . 42.01 110.002 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 82.1 t60 -72.8 -32.9 65.88 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.058 -0.974 . . . . 63.41 110.542 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.82 -50.15 32.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.968 0.507 . . . . 60.14 110.517 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' H' ' 174' ' ' MET . 7.8 tt -72.03 -46.02 58.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.105 0.562 . . . . 75.35 110.182 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.55 84.56 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.378 -0.679 . . . . 54.4 114.344 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -148.92 -63.75 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.881 0.84 . . . . 54.41 112.071 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -68.68 -44.54 73.78 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 113.474 0.916 . . . . 73.14 113.474 -165.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 56.1 m -67.22 -45.26 50.44 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 118.971 -0.538 . . . . 61.44 111.772 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.7 Cg_exo -53.7 -32.91 67.44 Favored 'Trans proline' 0 C--N 1.394 2.921 0 C-N-CA 122.931 2.421 . . . . 62.32 114.347 168.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -60.64 -28.12 68.31 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 122.786 0.434 . . . . 73.3 112.107 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.22 -42.13 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.604 0.716 . . . . 65.34 110.041 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.1 mt -76.33 -21.68 55.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 61.12 111.999 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -62.83 -42.98 81.5 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 117.693 -1.146 . . . . 74.12 113.623 -171.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.73 -43.85 44.0 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.061 1.841 . . . . 63.35 113.492 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 82.6 m-85 -74.22 -39.06 63.36 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.943 0.897 . . . . 64.12 112.044 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.95 80.54 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.604 0.761 . . . . 42.13 109.95 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.592 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.9 ttp180 -60.94 -48.82 80.04 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 124.353 1.033 . . . . 71.23 110.055 174.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 5.1 tm-20 -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.063 0.945 . . . . 62.44 111.956 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -58.64 -41.3 85.68 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.939 0.774 . . . . 75.15 111.147 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.786 HG21 HG21 ' D' ' 64' ' ' VAL . 65.1 mt -63.37 -56.28 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.021 0.928 . . . . 74.44 109.701 174.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 82.4 m -51.82 -40.1 59.88 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.095 1.758 . . . . 71.04 111.853 -175.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.3 t -69.64 -45.04 69.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.531 -1.213 . . . . 72.04 110.226 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.2 mtm -67.0 -31.67 72.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.947 0.499 . . . . 71.41 111.847 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.496 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.7 t -62.14 -49.12 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.688 0.795 . . . . 53.13 109.677 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -72.79 -28.88 62.85 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.733 -0.667 . . . . 62.34 111.139 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.74 -25.22 61.97 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.518 0.727 . . . . 74.14 110.056 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 121' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.9 11.43 70.58 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.791 0.682 . . . . 42.35 112.828 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.546 HG23 ' HB3' ' C' ' 17' ' ' TYR . 76.8 p 61.25 14.94 5.99 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.331 1.853 . . . . 75.22 113.661 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.526 ' HE1' HG11 ' D' ' 31' ' ' VAL . 62.0 m-85 -87.27 159.57 50.36 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.97 0.908 . . . . 63.32 109.804 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.35 127.53 20.27 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.928 2.419 . . . . 64.53 111.961 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -52.28 132.29 33.8 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.097 0.873 . . . . 73.11 111.318 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.516 HD13 HG21 ' D' ' 40' ' ' VAL . 42.4 tp -108.3 115.52 30.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.521 0.728 . . . . 51.33 110.122 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -113.41 100.78 8.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.364 0.666 . . . . 43.31 109.701 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 68.1 mt -74.49 148.51 40.93 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.928 -1.033 . . . . 62.44 110.138 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' G' ' 204' ' ' ILE . . . -60.99 125.42 83.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 123.787 0.68 . . . . 73.43 110.523 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.68 99.07 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.44 2.093 . . . . 63.04 109.271 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.07 119.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.107 -0.951 . . . . 31.24 110.95 -167.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -103.47 107.2 17.94 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.649 -1.241 . . . . 63.31 107.649 167.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.586 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 13.3 m-85 -67.74 -21.31 65.28 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.48 0.712 . . . . 71.54 111.893 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 -23.92 61.75 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 73.34 111.05 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.67 -33.25 69.91 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.82 0.448 . . . . 74.23 111.873 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' H' ' 185' ' ' PRO . 52.3 mt -84.01 -17.5 40.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.9 0.88 . . . . 55.14 111.81 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.448 ' HE2' ' HA2' ' B' ' 146' ' ' GLY . 82.4 t80 -76.38 -47.26 23.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.826 0.85 . . . . 74.53 109.629 173.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.615 ' HG2' ' HB3' ' B' ' 145' ' ' ALA . 78.5 mtm -62.47 -42.44 99.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.276 -0.874 . . . . 63.11 110.131 174.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' D' ' 143' ' ' GLN . 18.6 t30 -61.4 -45.34 94.73 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.032 0.833 . . . . 65.32 110.436 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -47.54 -48.88 27.49 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.194 0.934 . . . . 64.34 111.238 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.589 HD12 ' HB1' ' B' ' 145' ' ' ALA . 81.3 mt -71.4 -47.39 56.39 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.081 -0.963 . . . . 71.14 111.79 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -84.4 2.91 38.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.669 0.618 . . . . 62.21 112.669 -173.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' D' ' 139' ' ' ASN . 5.8 tm0? -115.2 93.1 4.15 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.937 -1.505 . . . . 54.24 106.937 -175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -158.9 13.84 0.16 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.66 -1.155 . . . . 75.22 110.211 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.23 105.85 3.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.671 0.789 . . . . 71.51 109.65 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.81 97.46 0.15 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 111.657 -0.577 . . . . 64.02 111.657 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.34 96.65 9.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.148 -0.686 . . . . 73.25 109.148 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.61 63.12 4.5 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.325 -0.398 . . . . 70.31 112.352 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.1 p -71.58 94.71 1.34 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.898 0.879 . . . . 50.24 109.422 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.06 112.71 7.59 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.786 -0.82 . . . . 73.15 108.786 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.71 -165.5 1.2 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.311 1.044 . . . . 63.34 111.609 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -137.85 168.16 20.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.068 0.947 . . . . 71.11 109.753 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -78.85 153.95 30.19 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.343 1.057 . . . . 72.43 109.888 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.17 78.41 0.96 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.931 -0.766 . . . . 73.35 108.931 170.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.767 1.227 . . . . 74.34 108.652 -178.085 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.207 -0.664 . . . . 74.3 109.207 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.06 82.56 0.75 Allowed Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.552 -0.619 . . . . 63.4 111.552 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.16 115.98 24.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.319 1.048 . . . . 74.22 110.574 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 30.4 t -113.47 89.94 3.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.758 -0.83 . . . . 74.43 108.758 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 172' ' ' ALA . . . . . 0.573 ' H ' ' HB2' ' C' ' 50' ' ' GLN . . . 65.41 178.43 0.2 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.569 1.148 . . . . 30.42 112.301 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.487 HD12 ' HG2' ' E' ' 174' ' ' MET . 2.4 pp -114.96 7.0 15.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.965 0.506 . . . . 72.1 112.152 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.487 ' HG2' HD12 ' E' ' 173' ' ' LEU . 18.2 ptt? -168.56 -4.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.504 0.722 . . . . 71.24 111.842 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' C' ' 98' ' ' LEU . 55.2 t80 -120.78 151.66 39.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 75.32 110.884 -174.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.08 147.59 11.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.763 1.225 . . . . 71.52 108.404 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.15 106.5 2.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.838 0.855 . . . . 61.33 109.771 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -127.12 137.38 52.98 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.199 1.0 . . . . 61.3 110.693 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 67.98 162.57 0.14 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 125.129 1.372 . . . . 71.34 113.774 169.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.62 120.58 7.21 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.989 1.793 . . . . 71.11 111.117 175.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 181' ' ' TYR . . . . . 0.54 ' HE1' ' HB1' ' C' ' 95' ' ' ALA . 99.1 m-85 -76.72 -180.0 5.7 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.583 -0.735 . . . . 74.32 110.031 176.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.96 155.64 30.34 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.868 0.467 . . . . 72.42 110.0 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 6.9 t -50.46 129.19 21.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.95 0.9 . . . . 72.51 111.869 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 184' ' ' TRP . . . . . 0.589 ' HE1' ' HB3' ' C' ' 44' ' ' LEU . 19.4 t-105 -112.4 91.1 15.69 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 74.33 108.282 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.06 110.33 2.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.737 2.291 . . . . 54.04 111.304 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.07 68.42 5.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.682 0.793 . . . . 73.41 109.652 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 tt 34.18 -71.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.666 0 C-N-CA 127.809 2.444 . . . . 74.41 116.614 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . 79.28 99.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.275 1.83 . . . . 61.24 110.482 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 189' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' C' ' 128' ' ' LEU . . . -136.2 36.88 2.76 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.367 1.067 . . . . 74.42 109.807 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.54 145.54 48.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.739 1.215 . . . . 71.24 111.645 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 191' ' ' GLY . . . . . 0.46 ' H ' ' HA ' ' C' ' 39' ' ' GLU . . . 67.86 60.3 5.82 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.738 0.649 . . . . 74.32 113.511 177.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.07 76.21 0.59 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 111.445 -0.662 . . . . 73.4 111.445 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -88.53 106.44 18.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.571 1.148 . . . . 74.33 110.205 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.99 -171.59 3.49 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.139 0.975 . . . . 55.42 110.314 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 66.7 173.63 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.705 1.202 . . . . 71.52 113.468 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -151.9 73.9 1.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 108.153 -1.055 . . . . 63.35 108.153 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -86.18 26.29 1.05 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.874 0.87 . . . . 62.0 111.27 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.27 -36.41 79.97 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.184 0.594 . . . . 74.11 110.931 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -136.91 -61.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.599 0.759 . . . . 53.31 109.549 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.11 105.97 0.25 Allowed Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.192 -0.458 . . . . 74.02 112.432 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -73.95 111.69 9.36 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 107.239 -1.393 . . . . 74.03 107.239 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 202' ' ' TYR . . . . . 0.431 ' HB3' HG13 ' F' ' 187' ' ' ILE . 42.4 m-85 69.74 92.74 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.246 1.418 . . . . 75.14 109.243 -169.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.26 91.19 1.29 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.018 0.527 . . . . 44.01 110.774 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.478 HD13 HG23 ' D' ' 13' ' ' ILE . 47.3 mt -79.63 82.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.526 -0.916 . . . . 72.54 108.526 175.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -78.28 -44.98 23.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.633 -1.167 . . . . 72.34 110.548 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -111.31 120.92 43.86 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.197 -0.911 . . . . 73.05 109.329 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' B' ' 136' ' ' LEU . 9.6 m . . . . . 0 CA--C 1.575 1.912 0 C-N-CA 126.477 1.911 . . . . 52.04 114.563 172.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.1 99.89 0.17 Allowed Glycine 0 C--N 1.348 1.198 0 N-CA-C 110.854 -0.899 . . . . 35.34 110.854 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 106.69 9.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.721 0.808 . . . . 60.11 110.038 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -143.8 -163.25 1.62 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.958 1.303 . . . . 72.25 108.16 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.69 -70.55 0.25 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.051 0.387 . . . . 44.32 110.171 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -164.29 40.89 0.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.248 0.547 . . . . 63.11 111.763 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' F' ' 174' ' ' MET . 0.0 OUTLIER -71.0 87.93 0.75 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.585 0.754 . . . . 54.22 112.181 -173.347 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 23.6 p90 43.13 -165.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 126.84 2.056 . . . . 73.31 115.792 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -166.2 -36.0 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.389 1.075 . . . . 74.14 109.826 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp 57.9 67.43 0.96 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.882 1.273 . . . . 72.34 110.329 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -133.89 11.92 3.98 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.854 -1.066 . . . . 34.25 109.267 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -168.81 134.88 1.47 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.793 0.837 . . . . 54.25 109.939 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.82 89.36 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.619 2.213 . . . . 63.35 111.393 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.3 118.2 29.61 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.167 -0.679 . . . . 74.23 109.167 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 68.86 144.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.327 1.451 . . . . 73.33 111.705 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 17.6 p -138.86 103.02 4.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.874 0.87 . . . . 74.41 109.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.02 130.82 74.41 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.754 0.822 . . . . 74.01 111.167 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.59 132.19 9.79 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.085 1.857 . . . . 75.44 111.974 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.12 -172.12 3.37 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.261 0.624 . . . . 71.31 110.608 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.557 ' H ' HD13 ' F' ' 187' ' ' ILE . 0.2 OUTLIER -117.26 154.75 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.258 1.023 . . . . 75.12 110.072 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.75 169.83 9.74 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.694 0.798 . . . . 40.2 109.924 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -160.49 143.98 13.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.027 -0.533 . . . . 43.24 110.776 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -108.73 165.2 11.73 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.455 1.102 . . . . 44.44 108.339 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 191' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' B' ' 40' ' ' VAL . . . -65.6 -37.88 94.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.395 0.435 . . . . 64.45 112.847 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 104.08 -72.34 0.26 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.57 -0.612 . . . . 71.24 111.57 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -140.0 140.27 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.921 0.888 . . . . 71.15 109.299 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.46 154.72 39.51 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.553 1.141 . . . . 74.25 113.73 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.458 ' N ' ' HB2' ' B' ' 37' ' ' GLN . 17.5 m-85 -53.51 136.54 38.13 Favored 'General case' 0 C--N 1.376 1.748 0 C-N-CA 124.242 1.017 . . . . 74.31 109.722 173.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -127.54 127.2 43.54 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.749 -0.463 . . . . 74.34 109.749 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -82.54 -3.33 55.78 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.035 1.334 . . . . 70.14 109.758 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -81.75 96.72 7.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.549 -1.649 . . . . 65.13 106.549 167.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 70.42 167.22 0.3 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.969 1.308 . . . . 72.13 110.78 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 200' ' ' GLY . . . . . 0.487 ' H ' ' HA ' ' E' ' 189' ' ' ALA . . . -81.46 62.77 4.45 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.901 -0.59 . . . . 74.34 112.328 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -79.51 79.74 5.95 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 108.193 -1.04 . . . . 75.21 108.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 75.45 -42.62 0.48 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.592 1.557 . . . . 74.25 111.499 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -80.59 -174.54 4.74 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.122 1.369 . . . . 54.22 109.834 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 204' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 15' ' ' ARG . 13.6 tt -122.84 121.19 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.048 0.939 . . . . 51.13 109.453 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 -55.31 3.82 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.432 -0.804 . . . . 65.04 110.612 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -151.14 166.07 31.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.413 1.085 . . . . 65.3 108.827 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.473 ' HB ' ' NE2' ' A' ' 12' ' ' GLN . 21.3 t . . . . . 0 C--O 1.252 1.232 0 N-CA-C 107.322 -1.362 . . . . 71.34 107.322 171.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.117 -0.327 . . . . 44.34 110.117 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 149.45 -46.96 0.64 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.548 -1.021 . . . . 53.44 110.548 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 170' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' G' ' 178' ' ' GLN . 26.7 tptp 47.88 68.82 0.6 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.44 1.496 . . . . 74.33 110.521 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 171' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' G' ' 177' ' ' LEU . 49.3 p -152.49 157.95 41.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.184 -0.916 . . . . 74.44 111.735 -170.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.99 -174.33 2.64 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.932 1.293 . . . . 75.33 108.06 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 89' ' ' ILE . 1.3 pt? -58.62 170.55 0.76 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.676 0.79 . . . . 73.21 112.361 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 32.1 mmt 74.3 14.61 3.68 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.504 1.522 . . . . 75.13 111.302 -173.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.412 ' CD1' HD21 ' A' ' 98' ' ' LEU . 29.8 t80 63.8 106.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.272 1.429 . . . . 70.21 111.075 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -132.73 -87.22 0.44 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.317 -0.623 . . . . 54.31 109.317 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 177' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' G' ' 171' ' ' SER . 6.9 mp 57.9 89.94 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.931 1.292 . . . . 73.43 112.194 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 178' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' G' ' 170' ' ' LYS . 28.5 mm-40 -91.94 -64.25 1.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.054 0.454 . . . . 73.4 110.374 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.34 132.56 28.79 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.835 0.854 . . . . 75.34 110.325 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.53 135.92 63.95 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.027 2.485 . . . . 72.1 111.583 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -146.11 167.15 24.12 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.265 0.626 . . . . 74.43 110.518 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 182' ' ' PHE . . . . . 0.652 ' HE2' ' HA ' ' A' ' 134' ' ' ASP . 9.7 t80 72.38 27.81 2.41 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.558 1.543 . . . . 75.13 110.646 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 90.8 m 76.91 -49.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.135 1.774 . . . . 74.11 112.598 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 184' ' ' TRP . . . . . 0.406 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 75.7 t-105 58.66 69.11 1.5 Allowed Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 124.716 1.206 . . . . 74.14 110.703 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.55 139.64 31.6 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.162 2.575 . . . . 72.32 112.69 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 64.9 mt -142.88 141.47 31.54 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.709 0.804 . . . . 75.23 111.083 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 187' ' ' ILE . . . . . 0.578 HD13 ' H ' ' G' ' 187' ' ' ILE . 0.2 OUTLIER -84.01 165.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.726 0.81 . . . . 72.54 110.65 170.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.82 128.33 55.73 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.833 0.853 . . . . 35.33 109.284 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -80.46 149.21 30.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.283 0.633 . . . . 54.24 110.291 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -135.15 -86.75 0.38 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.433 0.693 . . . . 71.25 109.554 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 146.2 -173.32 26.53 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 112.044 -0.422 . . . . 63.34 112.044 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 192' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' H' ' 199' ' ' ASN . . . -152.34 125.86 1.91 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.526 -0.63 . . . . 55.42 111.526 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -74.05 89.44 1.95 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.581 0.705 . . . . 71.12 109.324 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 194' ' ' ALA . . . . . 0.526 ' H ' ' HD1' ' A' ' 36' ' ' TRP . . . -102.86 -166.01 1.23 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.714 1.205 . . . . 75.42 108.782 171.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.4 ' HA ' ' HB1' ' H' ' 194' ' ' ALA . 18.3 m-85 55.79 78.55 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.877 0.871 . . . . 72.11 110.725 -173.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 196' ' ' LYS . . . . . 0.449 ' H ' ' HA ' ' H' ' 194' ' ' ALA . 33.3 tttp -70.91 93.79 1.01 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.818 -1.179 . . . . 74.02 107.818 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.53 75.88 1.97 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.719 0.808 . . . . 72.44 110.787 -176.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -99.72 39.1 1.35 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.389 1.076 . . . . 74.53 109.902 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 68.06 110.08 0.05 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.95 1.3 . . . . 61.21 109.297 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.73 -127.79 0.05 OUTLIER Glycine 0 C--N 1.352 1.427 0 CA-C-O 119.363 -0.687 . . . . 44.41 112.095 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 60.1 114.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.236 1.014 . . . . 70.52 111.281 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 202' ' ' TYR . . . . . 0.637 ' HB3' HG23 ' G' ' 204' ' ' ILE . 24.5 m-85 -59.7 -29.11 67.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.498 0.719 . . . . 72.44 112.038 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 14.1 t70 57.54 38.59 28.01 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.773 1.273 . . . . 63.43 110.081 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 204' ' ' ILE . . . . . 0.637 HG23 ' HB3' ' G' ' 202' ' ' TYR . 4.5 pt -83.44 40.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.912 -1.494 . . . . 71.43 111.113 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 205' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' H' ' 187' ' ' ILE . 45.5 mtpt 59.71 -171.13 0.13 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 124.493 1.117 . . . . 73.4 111.627 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -92.58 -84.32 0.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.933 -1.136 . . . . 74.43 107.933 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 207' ' ' VAL . . . . . 0.434 HG12 HD11 ' D' ' 136' ' ' LEU . 36.2 t . . . . . 0 C--O 1.259 1.604 0 N-CA-C 107.911 -1.144 . . . . 61.1 107.911 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 168' ' ' LYS . . . . . 0.501 ' N ' HE21 ' B' ' 153' ' ' GLN . 29.9 mmmt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 110.229 -0.286 . . . . 71.5 110.229 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.91 -133.25 24.67 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 124.105 0.878 . . . . 62.31 111.828 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -104.65 -9.41 18.24 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.88 0.872 . . . . 73.24 111.371 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 36.6 m -80.87 78.42 7.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.23 0.612 . . . . 51.51 110.121 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -96.45 78.86 3.04 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.023 -0.535 . . . . 72.42 110.222 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.68 HD21 ' HA ' ' D' ' 54' ' ' ASP . 15.8 tp -168.86 86.06 0.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 105.929 -1.878 . . . . 70.12 105.929 173.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 174' ' ' MET . . . . . 0.45 ' HB3' HD12 ' D' ' 98' ' ' LEU . 3.0 mpp? 63.73 176.27 0.17 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.086 0.954 . . . . 74.41 112.27 -171.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 69.44 0.41 2.9 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.264 1.425 . . . . 65.23 113.3 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.83 54.39 3.0 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.995 0.902 . . . . 73.43 109.973 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.48 101.75 14.42 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.357 -1.349 . . . . 71.44 107.357 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -79.81 -105.6 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.353 -0.61 . . . . 73.33 109.353 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 179' ' ' GLU . . . . . 0.458 ' H ' ' HD2' ' H' ' 180' ' ' PRO . 47.6 mt-10 -151.59 -54.75 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.615 1.166 . . . . 63.24 109.428 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 180' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' H' ' 179' ' ' GLU . 96.3 Cg_endo -79.07 99.19 1.24 Allowed 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 121.437 1.425 . . . . 74.51 112.935 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -155.23 136.85 14.27 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.277 -1.008 . . . . 73.21 108.277 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.78 126.23 27.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.192 0.597 . . . . 71.03 111.074 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.9 t -91.67 -173.25 3.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.609 0.764 . . . . 72.34 110.588 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -115.51 152.18 46.83 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.192 0.997 . . . . 75.5 109.395 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 185' ' ' PRO . . . . . 0.616 ' HD2' HD13 ' D' ' 136' ' ' LEU . 72.7 Cg_endo -74.37 138.16 24.31 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.377 2.052 . . . . 74.34 111.885 166.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.65 169.34 15.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.404 0.681 . . . . 75.31 110.605 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' G' ' 205' ' ' LYS . 37.5 pt -82.92 179.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.9 0.88 . . . . 64.21 111.39 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.68 -168.64 1.67 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.807 0.843 . . . . 73.35 109.423 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -169.53 125.98 0.88 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.115 0.566 . . . . 73.42 111.26 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -165.25 152.32 10.64 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.201 1.0 . . . . 65.2 109.538 174.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.57 160.13 13.48 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 111.313 -0.715 . . . . 73.51 111.313 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.41 31.26 2.96 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 114.292 0.477 . . . . 73.25 114.292 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.822 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 98.5 m-85 62.88 14.61 7.58 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.397 1.479 . . . . 74.51 113.811 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 194' ' ' ALA . . . . . 0.449 ' HA ' ' H ' ' G' ' 196' ' ' LYS . . . -74.22 103.47 4.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 74.21 110.994 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.79 -83.99 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 109.538 -0.542 . . . . 75.12 109.538 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 196' ' ' LYS . . . . . 0.424 ' HG3' ' HB2' ' G' ' 196' ' ' LYS . 22.1 mtpp 72.18 -64.51 0.39 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.131 1.772 . . . . 73.0 115.344 170.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 57.8 21.13 7.16 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 123.455 0.702 . . . . 73.21 111.449 -168.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.22 83.54 6.8 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.249 -0.649 . . . . 61.34 109.249 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 199' ' ' ASN . . . . . 0.447 ' HA ' ' HA2' ' G' ' 192' ' ' GLY . 94.5 m-20 -69.57 121.73 17.67 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.181 -0.918 . . . . 63.34 109.123 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.93 -60.24 9.39 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.284 0.99 . . . . 74.43 111.532 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -124.71 -74.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.401 -1.703 . . . . 54.01 106.401 167.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 16.6 t80 53.37 24.19 3.74 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.386 1.474 . . . . 64.11 112.07 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.46 80.02 5.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.58 1.181 . . . . 54.44 109.166 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 129' ' ' ALA . 6.6 pt -74.97 81.46 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 114.183 -1.371 . . . . 75.24 110.988 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.1 142.37 33.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.489 -1.232 . . . . 71.25 110.441 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -173.41 -60.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.875 1.359 . . . . 72.35 108.05 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 136' ' ' LEU . 46.8 t . . . . . 0 C--O 1.252 1.236 0 CA-C-N 114.297 -1.319 . . . . 71.35 107.953 175.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.798 -0.815 . . . . 74.21 108.798 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -77.27 108.66 10.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.954 0.901 . . . . 75.23 110.501 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -142.12 96.81 3.02 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.261 -1.385 . . . . 74.2 107.261 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.64 125.1 50.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.751 0.821 . . . . 70.21 110.911 -171.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -91.16 87.01 6.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.858 -0.793 . . . . 70.34 108.858 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -140.55 106.9 5.26 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.81 -1.181 . . . . 74.4 107.81 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.483 HG22 ' H ' ' C' ' 143' ' ' GLN . 6.6 m -124.02 5.25 8.63 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.244 -0.65 . . . . 71.34 109.244 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' C' ' 145' ' ' ALA . 6.6 mp0 -92.47 36.28 1.0 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.345 1.058 . . . . 73.0 110.953 -171.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -82.88 177.09 8.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.488 0.715 . . . . 71.23 109.82 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m -147.45 101.27 3.35 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.868 -1.53 . . . . 64.34 106.868 162.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 32.5 t80 -136.43 128.58 29.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.049 0.54 . . . . 72.51 109.845 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -155.6 134.56 12.08 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.481 0.488 . . . . 74.12 110.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' C' ' 135' ' ' ALA . 1.8 mp -79.69 116.22 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.917 -1.142 . . . . 72.14 107.917 172.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.53 -39.36 46.33 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.674 -0.491 . . . . 73.54 109.674 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.8 ttt85 -169.51 136.89 1.73 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.541 0.526 . . . . 72.33 110.921 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.37 130.77 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.809 -1.182 . . . . 62.5 107.809 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 3.2 p90 -168.23 151.65 5.77 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.923 0.765 . . . . 73.02 110.77 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -80.71 117.62 21.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.612 -0.884 . . . . 54.44 108.612 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.4 mtpt -76.26 -33.47 59.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.446 0.641 . . . . 73.54 109.495 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.2 t70 -150.85 140.78 21.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.229 -1.35 . . . . 72.35 109.797 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.0 mt -137.69 142.7 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.958 1.303 . . . . 65.13 108.022 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 m -152.34 112.73 4.09 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 123.621 0.769 . . . . 65.41 110.514 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 73.5 t80 -109.98 127.72 54.96 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 105.843 -1.91 . . . . 53.53 105.843 164.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.9 143.19 51.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.787 -0.82 . . . . 74.42 108.787 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -147.86 73.48 11.34 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 106.595 -1.631 . . . . 34.43 106.595 171.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.7 -28.15 44.3 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.86 2.373 . . . . 73.35 111.435 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -111.04 32.79 5.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.285 1.034 . . . . 75.21 109.017 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -57.52 -52.4 74.56 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 118.357 -0.83 . . . . 61.45 111.947 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 53.1 Cg_exo -53.52 -33.4 67.86 Favored 'Trans proline' 0 C--N 1.403 3.417 0 C-N-CA 122.119 1.879 . . . . 51.33 113.565 173.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 10.4 m170 -67.61 -35.29 78.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.542 0.737 . . . . 73.25 111.269 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.52 -34.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.366 0.666 . . . . 73.21 111.367 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -80.71 -22.21 40.53 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.355 -0.838 . . . . 75.2 111.996 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -92.9 -23.56 18.73 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.808 0.443 . . . . 72.4 109.981 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 5.3 tmtp? -81.41 163.89 22.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.626 1.17 . . . . 75.42 109.693 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -76.61 138.88 40.38 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.124 -1.065 . . . . 60.33 108.124 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -91.5 79.71 5.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.771 0.796 . . . . 55.45 109.977 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -127.89 82.47 68.33 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.114 -1.439 . . . . 70.43 107.114 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.53 166.15 12.12 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.866 2.377 . . . . 63.31 112.545 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -112.33 99.96 8.42 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.533 -1.284 . . . . 73.23 107.533 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.79 94.32 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.482 1.113 . . . . 70.1 110.1 -171.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.5 tttt -80.33 124.79 29.16 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.357 -0.838 . . . . 73.55 109.555 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -103.98 108.75 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.007 -0.738 . . . . 75.45 109.007 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 16.1 t70 -108.34 117.87 35.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.992 0.917 . . . . 73.41 108.617 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -99.79 121.0 40.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.68 -1.23 . . . . 74.14 107.68 171.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -119.09 148.57 42.9 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.084 -1.45 . . . . 52.24 107.084 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -149.77 146.15 27.02 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 73.21 110.4 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 151.94 46.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.674 1.19 . . . . 54.23 108.959 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -135.1 161.93 33.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.971 0.508 . . . . 51.34 111.438 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -168.65 131.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.116 0.966 . . . . 73.31 109.751 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -77.06 115.69 17.08 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.103 -0.703 . . . . 72.33 109.103 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.45 -43.11 17.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 70.42 110.294 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.64 -173.66 4.24 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.967 -1.015 . . . . 35.03 110.487 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.81 114.59 5.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.37 0.668 . . . . 72.35 110.882 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.497 ' H ' ' HA ' ' G' ' 171' ' ' SER . 11.9 m-20 68.29 -0.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.508 1.523 . . . . 54.25 111.994 -177.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.3 t -105.18 101.86 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.568 -1.271 . . . . 41.23 107.568 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -119.03 154.0 33.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.375 -1.284 . . . . 72.21 107.756 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -124.24 123.94 41.35 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.694 -0.854 . . . . 42.04 108.694 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.61 116.29 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.802 -1.555 . . . . 75.42 106.802 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 66.0 t -96.72 132.93 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.794 -0.817 . . . . 72.04 108.794 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 112.52 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.622 -1.621 . . . . 73.22 106.622 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 23.1 ttp180 -109.63 102.34 11.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.277 -0.638 . . . . 73.3 109.277 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.75 127.93 45.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.976 -1.12 . . . . 74.03 107.976 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.7 m -116.34 122.56 45.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.044 -0.725 . . . . 53.5 109.044 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 46.5 t -116.51 106.27 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.794 1.238 . . . . 64.42 107.896 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 20.8 m -104.39 139.71 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.731 -0.84 . . . . 74.03 108.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.38 125.21 38.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.066 -1.457 . . . . 52.42 107.066 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 m -129.99 128.79 42.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.194 0.598 . . . . 63.1 110.066 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 57.0 mt -87.63 75.62 9.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.13 -1.063 . . . . 75.33 108.13 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.72 -99.66 1.38 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.427 -0.806 . . . . 50.31 112.064 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.16 -18.47 16.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.77 0.828 . . . . 62.43 111.324 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -112.37 134.51 53.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.436 0.694 . . . . 64.32 109.939 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -68.82 136.73 53.18 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.078 0.551 . . . . 74.21 111.42 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -83.01 -59.88 2.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.379 1.072 . . . . 64.13 109.334 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.97 174.8 14.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.22 -0.9 . . . . 75.23 110.337 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 tp -141.32 141.23 33.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.283 1.433 . . . . 64.11 107.891 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.3 m -129.62 135.87 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.999 -1.111 . . . . 51.42 107.999 171.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.42 116.07 6.3 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.684 -0.858 . . . . 61.53 108.684 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 t -129.59 112.74 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.651 0.781 . . . . 73.21 109.899 -173.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.3 mt-30 -83.64 87.66 7.04 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.844 -0.799 . . . . 61.24 108.844 168.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.7 tp-100 -77.11 92.96 3.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.264 -1.384 . . . . 73.42 107.264 169.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.76 143.38 21.47 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.739 -0.944 . . . . 64.35 110.739 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.17 123.01 2.1 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 110.677 -0.969 . . . . 74.12 110.677 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.6 mt -90.92 121.8 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.345 -0.983 . . . . 72.41 108.345 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 28.6 m-85 -129.73 152.59 49.06 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.518 0.727 . . . . 53.2 109.948 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.8 m -91.49 121.71 33.43 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.604 0.762 . . . . 72.12 109.25 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 94' ' ' MET . 5.8 tt -116.96 119.95 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.614 -0.513 . . . . 74.33 109.614 173.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.94 172.28 1.67 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.631 1.572 . . . . 75.11 108.895 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.44 -32.15 3.97 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 116.79 -0.187 . . . . 55.3 112.784 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.12 170.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.475 1.11 . . . . 73.11 109.206 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.0 tt0 -164.29 175.68 9.84 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.493 0.495 . . . . 75.12 110.275 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.45 -130.85 37.9 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.674 -0.694 . . . . 72.13 113.172 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 t -62.32 -27.73 69.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.241 1.016 . . . . 54.45 111.772 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -68.16 -48.89 64.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.502 0.721 . . . . 75.35 110.861 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.64 ' HB2' HD11 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -75.59 -30.49 59.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.893 0.477 . . . . 72.13 111.116 -177.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.26 67.76 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.731 0.812 . . . . 41.14 110.612 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.437 ' CE1' ' HA ' ' A' ' 134' ' ' ASP . 11.1 t-80 -76.61 -31.5 57.49 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.028 -0.987 . . . . 72.41 110.178 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.6 m -71.85 -66.13 0.68 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 123.029 0.532 . . . . 64.21 111.531 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' G' ' 175' ' ' PHE . 7.0 tt -67.74 -29.41 68.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.325 0.65 . . . . 53.34 111.044 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.44 -19.97 57.54 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.682 -1.065 . . . . 45.32 114.721 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.35 -48.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.201 1.5 . . . . 70.13 113.911 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 44.9 t80 -66.76 -47.87 70.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.123 0.969 . . . . 71.43 111.879 -173.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.33 -41.83 8.45 Favored Pre-proline 0 CA--C 1.565 1.555 0 C-N-CA 123.494 0.717 . . . . 64.55 112.163 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.98 -31.78 65.3 Favored 'Trans proline' 0 C--N 1.393 2.876 0 C-N-CA 122.22 1.946 . . . . 24.12 113.919 163.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -68.74 -34.6 75.87 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.563 0.745 . . . . 62.14 110.283 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.07 -42.72 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.705 0.802 . . . . 75.55 110.172 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.5 mt -76.49 -24.77 53.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.553 -1.203 . . . . 71.12 112.462 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.13 -40.18 50.95 Favored Pre-proline 0 CA--C 1.563 1.474 0 N-CA-C 114.46 1.281 . . . . 72.23 114.46 -168.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -55.08 -38.78 93.29 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.97 1.78 . . . . 72.13 113.344 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -77.65 -38.84 46.88 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.756 0.823 . . . . 72.41 111.644 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.19 77.34 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.971 0.509 . . . . 44.44 110.178 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.1 ttm180 -55.57 -51.19 67.94 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.472 1.108 . . . . 70.43 110.025 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.4 tm-20 -64.0 -41.48 97.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.125 0.891 . . . . 75.14 111.401 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.89 -42.02 98.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.838 0.712 . . . . 54.11 111.005 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.416 HG21 HG21 ' A' ' 64' ' ' VAL . 91.5 mt -66.74 -51.48 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.384 0.674 . . . . 70.52 110.528 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.694 HG23 ' HB2' ' A' ' 125' ' ' GLN . 52.4 m -52.78 -44.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.624 1.17 . . . . 70.45 110.907 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 37.8 t -64.77 -41.06 96.17 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.403 -1.271 . . . . 65.43 110.907 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 32.2 mtm -67.87 -41.31 83.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.96 0.504 . . . . 75.14 111.541 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.4 -50.34 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.792 0.837 . . . . 62.3 110.095 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 90.5 p -67.09 -32.05 72.95 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.224 -0.898 . . . . 74.51 111.105 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 116' ' ' SER . 26.9 ttm-85 -75.24 -27.44 59.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.596 1.159 . . . . 71.45 110.206 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.18 8.86 62.43 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.62 -0.718 . . . . 74.11 112.86 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' D' ' 125' ' ' GLN . 9.4 m 67.07 29.63 7.83 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.794 1.238 . . . . 73.0 110.831 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.51 151.09 41.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 114.479 -1.237 . . . . 75.0 107.905 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.76 121.53 8.43 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.784 1.656 . . . . 75.13 110.104 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.694 ' HB2' HG23 ' A' ' 115' ' ' THR . 18.5 pt20 -60.87 155.4 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.554 0.741 . . . . 65.45 111.873 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.12 122.08 26.05 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.828 -0.805 . . . . 73.42 108.828 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.432 ' ND2' ' HB ' ' C' ' 16' ' ' ILE . 2.3 m-20 -103.54 95.32 5.98 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.758 -1.201 . . . . 74.32 107.758 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 131.86 46.79 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.381 -0.6 . . . . 71.45 109.381 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.51 128.02 89.38 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 123.676 0.79 . . . . 54.23 111.886 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.01 110.24 3.08 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.025 1.817 . . . . 73.14 110.83 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.1 t -99.35 114.79 38.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.041 -1.096 . . . . 74.13 108.041 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 135' ' ' ALA . 7.6 p30 -76.16 107.03 8.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.155 0.502 . . . . 74.24 110.117 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' G' ' 184' ' ' TRP . 65.3 t80 -76.85 -21.81 54.45 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.3 0.571 . . . . 72.44 109.484 171.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.437 ' HA ' ' CE1' ' A' ' 96' ' ' HIS . 2.2 p-10 -66.0 -49.04 69.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.588 1.155 . . . . 74.44 111.724 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.524 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . . . -89.06 -26.13 21.56 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.276 0.473 . . . . 61.51 112.276 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' H' ' 207' ' ' VAL . 6.9 tt -63.12 -32.43 73.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 123.015 0.526 . . . . 64.15 109.865 171.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.439 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 50.2 t80 -58.18 -48.01 81.62 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.632 0.773 . . . . 65.44 111.006 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' C' ' 5' ' ' ASN . 52.1 mtm -73.65 -38.0 65.14 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.457 0.703 . . . . 72.41 110.658 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 53.7 t-20 -51.62 -38.6 55.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.693 1.197 . . . . 72.13 110.311 173.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -70.61 -42.79 70.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.493 -0.776 . . . . 62.24 111.45 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 84.2 mt -62.68 -49.59 74.52 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.581 0.551 . . . . 61.41 111.529 -172.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -162.75 13.18 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.879 0.326 . . . . 72.13 111.879 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.4 tt0 78.76 -52.26 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.143 1.377 . . . . 73.24 111.793 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 72.88 -77.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.117 1.367 . . . . 70.44 112.234 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.98 79.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.21 0.604 . . . . 72.52 111.198 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.26 -79.41 0.3 Allowed Glycine 0 C--N 1.345 1.068 0 O-C-N 123.956 0.785 . . . . 63.22 111.186 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -156.12 138.74 15.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.119 0.967 . . . . 72.13 109.498 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' C' ' 90' ' ' GLU . . . -107.63 -73.4 0.82 Allowed Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.163 -1.175 . . . . 52.32 110.163 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 m 56.17 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.961 1.705 . . . . 63.12 114.721 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.44 96.06 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.982 0.513 . . . . 73.15 111.219 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -176.53 140.44 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.634 1.174 . . . . 75.14 108.782 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.559 ' HA ' ' HA ' ' E' ' 174' ' ' MET . 25.1 t-80 -156.54 137.37 13.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.297 0.639 . . . . 74.0 110.274 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -112.12 131.24 55.56 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.405 -0.961 . . . . 61.33 108.405 171.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.99 -61.94 1.95 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.628 0.771 . . . . 74.42 109.919 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.188 0 N-CA-C 107.747 -1.205 . . . . 71.21 107.747 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.854 -0.424 . . . . 74.33 109.854 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -155.75 87.4 1.08 Allowed 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.077 0.951 . . . . 72.04 108.684 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -76.48 170.72 15.85 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.116 -0.493 . . . . 75.03 110.744 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 61.06 70.33 0.62 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.34 1.056 . . . . 73.54 111.074 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -69.69 126.8 30.81 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.881 -0.6 . . . . 73.44 109.553 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -138.73 106.08 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.958 -0.756 . . . . 74.42 108.958 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -160.85 143.81 12.97 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.473 -0.785 . . . . 74.33 109.792 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.65 -18.35 33.48 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.562 0.745 . . . . 74.11 109.74 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.477 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 20.2 ptm 52.69 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.379 2.272 . . . . 73.3 114.519 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -137.56 128.38 27.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.035 0.934 . . . . 65.52 109.304 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -129.67 128.52 42.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 71.1 109.565 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -135.43 114.63 12.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.568 0.747 . . . . 72.12 109.042 173.136 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' D' ' 129' ' ' ALA . 8.7 tt -89.91 107.12 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 108.118 -1.067 . . . . 62.33 108.118 171.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.58 -40.9 20.25 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 115.774 -0.648 . . . . 74.42 110.61 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.436 HH21 HG22 ' A' ' 122' ' ' THR . 16.3 ttt180 -170.33 145.11 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.104 0.253 . . . . 70.24 111.123 -173.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.53 149.83 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.492 -1.299 . . . . 74.23 107.492 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' B' ' 83' ' ' ILE . 23.4 p90 -171.42 150.01 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.172 0.511 . . . . 73.35 111.208 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -76.0 121.45 22.75 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.552 -0.907 . . . . 62.3 108.552 169.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.51 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.8 mtpt -88.98 -39.7 13.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.352 0.661 . . . . 63.12 109.865 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.05 148.04 27.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.08 -0.509 . . . . 74.54 110.62 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.405 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 46.0 mm -142.19 139.42 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.916 1.686 . . . . 72.42 107.462 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -141.22 136.03 31.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.182 -1.044 . . . . 60.52 108.182 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -143.72 120.94 11.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.009 -1.478 . . . . 71.11 107.009 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 23.1 mt-10 -128.76 112.0 13.72 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.447 -0.946 . . . . 73.2 108.447 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -114.44 88.65 16.1 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.7 -0.852 . . . . 73.55 108.7 176.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.08 -29.84 88.18 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.625 2.217 . . . . 61.32 112.059 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -119.99 29.41 7.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.345 1.058 . . . . 73.23 110.232 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -47.43 -50.07 51.1 Favored Pre-proline 0 CA--C 1.575 1.941 0 C-N-CA 125.236 1.414 . . . . 62.51 114.658 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.453 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 62.6 Cg_endo -81.14 -13.46 11.3 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.708 1.605 . . . . 72.11 113.422 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -94.39 2.9 55.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.419 0.687 . . . . 72.0 111.875 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.411 HG23 HD11 ' B' ' 68' ' ' LEU . 10.6 p -64.02 -17.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.626 0.771 . . . . 74.21 110.896 169.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.44 -37.47 83.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.163 0.985 . . . . 64.2 111.065 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.45 -45.36 39.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.772 0.829 . . . . 71.11 110.391 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -94.39 67.62 3.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 73.22 109.513 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -81.44 76.51 8.36 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.122 0.963 . . . . 73.32 110.871 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -158.68 167.62 29.03 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.896 1.278 . . . . 65.13 109.897 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.41 121.94 75.19 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 115.89 -0.595 . . . . 65.53 109.476 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.02 150.31 48.29 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.213 1.942 . . . . 61.14 110.899 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.78 114.13 9.55 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.867 -0.79 . . . . 65.32 108.867 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.548 HG12 HD22 ' B' ' 42' ' ' LEU . 23.5 t -85.15 117.06 29.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 107.41 -1.33 . . . . 65.31 107.41 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -140.3 102.1 4.28 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.235 -1.024 . . . . 74.11 108.235 -170.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.582 ' HG ' HD21 ' B' ' 128' ' ' LEU . 1.1 pt? -127.85 138.69 52.78 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.197 -1.365 . . . . 72.24 109.652 -170.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -126.51 148.73 49.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.843 0.857 . . . . 70.1 111.067 -170.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.566 ' HG ' HD21 ' B' ' 60' ' ' LEU . 7.6 tt -89.42 131.44 35.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.241 1.017 . . . . 73.45 109.016 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -122.89 137.45 54.94 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.858 -1.534 . . . . 72.41 106.858 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.472 HG21 ' HA2' ' B' ' 99' ' ' GLY . 85.2 m -107.42 120.37 41.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.08 -0.711 . . . . 74.45 109.08 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.446 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.62 153.74 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.437 1.095 . . . . 61.42 108.129 170.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 49.5 m -143.86 172.0 13.45 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.112 0.482 . . . . 52.02 110.599 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -154.44 167.29 30.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.79 1.236 . . . . 65.2 108.591 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -123.43 130.47 52.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.054 0.541 . . . . 73.23 109.772 171.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -100.82 -40.4 7.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 63.23 110.654 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.69 -169.92 3.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.063 0.545 . . . . 73.13 111.375 -174.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.401 ' O ' HG23 ' B' ' 55' ' ' VAL . 1.1 m-20 -57.62 111.3 1.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.754 -1.112 . . . . 60.21 110.967 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.486 ' H ' HD11 ' F' ' 173' ' ' LEU . 10.2 m-20 68.65 0.78 2.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.033 1.333 . . . . 73.15 112.186 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 53' ' ' ASP . 95.8 t -101.08 101.06 11.57 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.231 -1.025 . . . . 43.45 108.231 -172.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.584 ' HE2' HD21 ' F' ' 173' ' ' LEU . 17.7 m-85 -108.97 136.42 48.53 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.484 -0.78 . . . . 74.55 109.969 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -105.92 96.76 6.71 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.97 -1.492 . . . . 64.04 106.97 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 64.4 t -87.08 122.83 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.746 0.818 . . . . 63.32 109.577 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -101.68 113.68 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.798 0.839 . . . . 51.51 109.263 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.566 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -91.77 105.94 18.1 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.811 -1.181 . . . . 64.14 107.811 177.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -97.8 108.66 21.42 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.336 -0.847 . . . . 65.02 109.497 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' B' ' 114' ' ' ILE . 18.3 t -105.41 113.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.925 -1.139 . . . . 74.24 107.925 170.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -104.4 150.89 24.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.534 0.733 . . . . 71.43 109.276 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 26.1 t -134.66 133.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.984 0.913 . . . . 61.12 110.341 -167.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.9 m -125.15 149.09 48.24 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.604 0.762 . . . . 71.14 109.253 170.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.07 147.45 29.56 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.731 0.812 . . . . 70.2 108.972 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.0 p -144.64 129.15 18.02 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.499 0.499 . . . . 74.35 111.325 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 37.0 mt -95.61 104.73 16.65 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.752 1.221 . . . . 62.4 108.3 171.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.39 -127.88 21.06 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 123.744 0.652 . . . . 71.45 111.631 -174.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -96.56 17.16 16.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.706 0.802 . . . . 62.05 111.485 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -134.84 146.76 49.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.51 0.724 . . . . 74.45 109.724 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.7 m -63.78 135.65 56.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.177 0.591 . . . . 74.34 111.04 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.92 -59.7 1.99 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.931 0.892 . . . . 63.24 108.906 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -156.54 171.35 20.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 113.962 -1.472 . . . . 64.41 109.585 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.4 mt -139.94 154.69 47.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.882 1.673 . . . . 75.23 106.99 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.2 t -159.7 160.42 34.08 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.156 -0.683 . . . . 74.53 109.156 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.42 136.83 3.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.233 -1.025 . . . . 75.23 108.233 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 97.1 t -124.18 143.82 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.973 -0.751 . . . . 74.14 108.973 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -124.0 102.08 7.57 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.531 -0.914 . . . . 74.15 108.531 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -92.16 100.11 12.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.218 -1.03 . . . . 65.32 108.218 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.51 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.88 146.64 18.51 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.146 -0.782 . . . . 74.13 111.146 177.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.81 127.75 3.39 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 110.758 -0.937 . . . . 71.14 110.758 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.455 HG13 ' HE1' ' B' ' 17' ' ' TYR . 50.3 mt -84.45 115.7 26.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.25 -1.018 . . . . 63.33 108.25 176.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.52 164.39 19.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.303 1.041 . . . . 72.23 108.849 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 16.4 m -132.43 103.68 6.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.452 -0.944 . . . . 75.55 108.452 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.556 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -115.88 134.71 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.214 0.606 . . . . 75.11 110.739 -177.214 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 172.76 18.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.466 1.106 . . . . 61.15 108.553 172.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.35 -55.01 3.55 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.703 -0.559 . . . . 62.23 111.703 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.52 154.45 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.255 1.022 . . . . 74.42 111.996 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.75 166.24 26.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.501 0.72 . . . . 73.14 110.355 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.61 -127.1 43.84 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.737 0.648 . . . . 43.14 113.71 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -65.16 -30.24 71.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.106 0.963 . . . . 62.15 111.149 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -74.07 -34.98 64.21 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.513 -0.767 . . . . 74.25 110.71 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.764 ' HG2' ' SD ' ' F' ' 174' ' ' MET . 12.3 tpt -66.56 -47.99 71.09 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.018 -0.537 . . . . 64.21 110.241 172.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.522 ' HB1' ' NE2' ' F' ' 178' ' ' GLN . . . -56.53 -42.04 77.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.11 0.881 . . . . 63.12 110.844 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -65.78 -34.53 78.38 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.51 0.724 . . . . 64.0 110.666 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -67.04 -67.9 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.637 0.375 . . . . 75.44 111.528 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' F' ' 177' ' ' LEU . 0.0 OUTLIER -73.39 -17.64 61.25 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 118.106 0.412 . . . . 74.12 112.076 -171.487 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' HB3' ' F' ' 178' ' ' GLN . . . -108.74 2.27 32.09 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.48 -0.622 . . . . 64.32 114.607 -174.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -49.06 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 117.948 0.874 . . . . 74.12 111.387 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -72.45 -50.63 24.77 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.697 0.399 . . . . 65.01 111.471 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.24 -46.46 79.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 118.435 -0.793 . . . . 74.1 111.183 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -51.58 -41.32 61.43 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.153 1.902 . . . . 71.43 113.835 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.84 -36.84 84.54 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 123.478 0.711 . . . . 75.14 111.689 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.44 HG23 ' NH2' ' D' ' 111' ' ' ARG . 64.9 mt -62.35 -47.25 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.625 0.77 . . . . 74.25 110.418 174.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.11 -10.54 54.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.804 -1.089 . . . . 61.41 111.692 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -64.88 -49.76 66.79 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 117.411 -1.28 . . . . 73.43 113.312 -171.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -58.73 -34.64 99.08 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 121.944 1.762 . . . . 73.13 112.341 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.422 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.0 m-85 -64.31 -52.56 57.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.388 0.675 . . . . 75.41 110.358 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.86 81.94 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.764 0.825 . . . . 62.33 111.329 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.694 HH22 HG22 ' C' ' 122' ' ' THR . 53.6 ttt180 -67.61 -49.95 60.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.223 1.409 . . . . 74.32 110.414 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -34.96 78.99 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.939 0.775 . . . . 74.51 110.191 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.1 t -67.37 -45.49 76.11 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.066 0.546 . . . . 74.32 111.787 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' B' ' 62' ' ' VAL . 81.5 mt -59.35 -46.36 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.143 0.577 . . . . 55.42 110.196 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.626 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 34.2 m -53.58 -50.15 66.21 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.673 1.233 . . . . 62.2 110.045 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.5 t -59.42 -50.72 72.86 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.303 1.041 . . . . 63.21 111.852 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.559 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 20.7 mmt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.165 0.586 . . . . 73.34 112.494 -170.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.91 -32.33 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.089 0.556 . . . . 74.34 110.846 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.5 m -64.22 -30.02 71.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.555 0.742 . . . . 54.54 111.276 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 80.2 mtt-85 -68.69 -39.78 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.861 0.864 . . . . 63.45 109.844 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.32 66.47 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.838 0.711 . . . . 73.14 113.198 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p 60.55 44.95 11.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.194 1.797 . . . . 44.21 111.96 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -119.01 144.91 36.81 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 114.718 -1.128 . . . . 75.24 109.785 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' F' ' 195' ' ' PHE . 20.9 Cg_exo -68.1 94.76 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.736 2.957 . . . . 74.3 113.718 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.626 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 3.3 mm-40 -68.21 160.79 28.5 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.332 1.063 . . . . 72.42 113.163 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.416 HD22 HD11 ' F' ' 187' ' ' ILE . 4.5 tt -143.02 124.83 15.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.074 -2.195 . . . . 62.01 105.074 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -87.03 136.19 33.01 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.918 -0.771 . . . . 72.3 108.918 -171.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.582 HD21 ' HG ' ' B' ' 42' ' ' LEU . 38.1 mt -58.13 144.78 39.17 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.54 0.525 . . . . 54.41 112.296 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.643 ' HB1' HG12 ' E' ' 204' ' ' ILE . . . -66.69 108.56 2.47 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.629 1.206 . . . . 42.23 109.912 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.457 ' HG2' ' H ' ' D' ' 16' ' ' ILE . 73.1 Cg_endo -73.59 113.55 3.81 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.505 2.137 . . . . 73.05 111.185 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.08 142.77 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.405 0.682 . . . . 74.41 110.663 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -79.38 118.61 21.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.565 1.146 . . . . 70.1 109.91 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -67.38 -25.8 66.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.448 0.699 . . . . 52.31 111.702 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.12 -29.57 65.42 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.461 0.704 . . . . 75.45 111.223 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.49 95.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.139 0.576 . . . . 55.41 110.509 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.0 -40.26 95.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.409 -0.814 . . . . 74.04 110.546 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -66.45 -39.9 89.13 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.923 . . . . 75.24 110.588 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.0 mtt -65.13 -38.73 91.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.568 0.747 . . . . 61.4 111.245 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -88.07 -19.2 27.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.546 -0.752 . . . . 74.32 110.636 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -87.01 -35.35 18.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.998 0.519 . . . . 74.44 110.658 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.34 1.6 56.99 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.056 0.542 . . . . 60.41 110.662 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -70.37 100.28 1.72 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.623 -0.88 . . . . 64.24 108.623 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -97.55 -12.55 22.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.051 0.94 . . . . 71.11 110.422 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.444 ' HB3' ' HG3' ' D' ' 8' ' ' GLU . 21.5 mp0 -76.46 97.72 4.39 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.517 -0.92 . . . . 70.12 108.517 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.69 121.26 26.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.712 0.805 . . . . 72.44 109.391 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.05 -168.92 41.88 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.521 0.513 . . . . 72.0 112.169 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -143.27 178.47 7.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.276 0.631 . . . . 62.3 110.791 -171.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -164.31 82.63 0.11 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 115.557 -0.747 . . . . 75.03 111.815 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -112.89 132.68 55.21 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 108.696 -0.853 . . . . 72.14 108.696 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -140.77 155.15 46.48 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.527 0.731 . . . . 74.15 109.83 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.78 108.47 0.58 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.978 0.911 . . . . 64.41 109.55 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -65.28 93.5 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.842 0.857 . . . . 55.22 109.002 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -55.7 -72.83 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.93 0.892 . . . . 74.42 111.85 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.98 130.93 38.39 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.689 -0.856 . . . . 75.24 108.689 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 O-C-N 123.919 0.762 . . . . 71.21 110.302 178.207 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.272 -0.64 . . . . 75.31 109.272 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -75.3 -169.92 1.08 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.055 0.942 . . . . 63.44 111.795 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -80.79 17.0 1.24 Allowed 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.161 0.984 . . . . 71.02 112.448 -167.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -76.34 73.1 3.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.94 0.896 . . . . 54.3 108.956 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.456 ' HA ' ' SD ' ' A' ' 138' ' ' MET . 1.0 OUTLIER -123.12 134.17 54.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.739 1.215 . . . . 64.44 108.067 176.722 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 76.88 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.726 1.611 . . . . 71.25 112.979 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -59.37 135.05 57.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.671 1.188 . . . . 53.43 111.69 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.78 -61.0 1.45 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.376 -0.972 . . . . 72.51 108.376 166.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 55.5 ttp 64.67 136.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.283 1.433 . . . . 72.21 112.311 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 61.4 m -115.67 96.69 5.74 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.595 -1.261 . . . . 75.41 107.595 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HA ' HG22 ' C' ' 86' ' ' ILE . 37.7 t80 -91.02 132.43 36.0 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.442 -1.254 . . . . 71.21 108.27 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -136.23 102.08 4.88 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.988 -1.115 . . . . 61.42 107.988 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.532 HD11 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -70.44 131.45 34.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 115.456 -0.793 . . . . 73.21 109.242 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.502 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.4 mm100 -105.21 -49.37 3.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.305 0.642 . . . . 65.44 109.857 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.519 HH11 ' HB2' ' D' ' 32' ' ' PHE . 73.5 ttt180 -173.62 132.25 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.692 -0.685 . . . . 72.43 110.34 -169.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.532 HG13 HD11 ' C' ' 13' ' ' ILE . 84.0 mt -118.93 136.26 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.266 -1.013 . . . . 75.24 108.266 170.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.667 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 8.4 p90 -171.53 172.02 5.22 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.355 1.035 . . . . 75.04 110.081 -173.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -93.17 118.98 31.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.521 -0.763 . . . . 74.32 109.384 176.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.414 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 17.4 mmtp -65.83 -47.11 76.09 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.124 -1.065 . . . . 74.24 108.124 168.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.5 t70 -141.52 147.09 37.21 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.472 -1.694 . . . . 72.33 110.008 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -135.1 144.73 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.767 1.627 . . . . 72.44 106.876 172.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -150.73 146.45 26.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.508 0.671 . . . . 74.22 110.706 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -151.64 118.45 5.79 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.566 -1.642 . . . . 65.34 106.566 167.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.62 133.08 56.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.72 -1.215 . . . . 54.51 107.72 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.88 85.22 39.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.376 -1.342 . . . . 74.12 107.376 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.16 -3.37 12.75 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.619 2.213 . . . . 75.21 112.183 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.62 18.24 8.78 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 123.921 0.889 . . . . 74.34 109.764 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -47.01 -50.85 43.87 Favored Pre-proline 0 CA--C 1.575 1.905 0 N-CA-C 114.309 1.226 . . . . 72.11 114.309 -169.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 85.2 Cg_endo -86.68 -27.88 0.68 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.713 1.608 . . . . 75.05 114.107 171.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -71.09 -24.62 62.35 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.474 0.71 . . . . 55.15 112.471 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.444 HG23 HD11 ' C' ' 68' ' ' LEU . 14.4 p -75.28 -18.19 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.593 1.157 . . . . 43.44 110.922 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' D' ' 14' ' ' GLN . 42.6 t80 -59.74 -38.48 81.85 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.845 0.858 . . . . 74.22 110.81 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 5.48 51.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.283 0.633 . . . . 73.42 112.395 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.72 ' HE2' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -98.33 164.55 12.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.575 0.35 . . . . 55.32 111.866 -167.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.95 117.37 8.93 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.266 -1.013 . . . . 73.3 108.266 165.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -84.96 67.01 10.03 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.223 1.011 . . . . 73.23 111.242 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -125.07 78.52 66.37 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 124.582 1.153 . . . . 71.44 109.261 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.5 106.6 1.88 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.542 2.161 . . . . 73.2 111.422 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -84.17 120.36 26.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.098 -1.445 . . . . 72.24 107.098 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.474 HG13 HG13 ' C' ' 64' ' ' VAL . 95.6 t -96.86 148.84 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.885 -1.052 . . . . 70.1 110.959 -166.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -133.53 114.98 14.18 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.834 -1.543 . . . . 61.21 106.834 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' C' ' 128' ' ' LEU . 5.4 mp -86.44 152.73 22.44 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.64 -0.874 . . . . 63.23 108.64 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.2 t70 -154.63 148.6 25.7 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.052 -0.721 . . . . 75.44 109.052 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 tt -149.78 120.59 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.013 -0.736 . . . . 54.32 109.013 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 11.7 m-20 -121.81 144.7 48.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.739 1.216 . . . . 75.41 108.656 176.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -113.01 132.8 55.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.18 -0.674 . . . . 63.4 109.18 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.17 157.32 38.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 64.24 109.044 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.0 p -144.87 150.35 36.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.886 -0.597 . . . . 75.22 110.008 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -156.32 143.16 18.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.792 1.237 . . . . 74.22 107.906 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -105.09 132.67 51.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.133 0.492 . . . . 71.25 109.692 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.61 HD11 HD12 ' C' ' 83' ' ' ILE . 69.0 mt -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.453 -0.794 . . . . 73.24 111.252 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -172.89 4.31 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.204 0.526 . . . . 60.12 111.174 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.94 112.79 2.73 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.331 -1.304 . . . . 43.54 110.312 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.706 ' HA ' HD21 ' E' ' 173' ' ' LEU . 18.5 m-20 60.87 23.87 13.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.643 1.177 . . . . 74.14 112.782 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -114.91 116.24 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.894 . . . . 62.34 109.284 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.09 159.97 15.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.06 0.933 . . . . 74.42 110.083 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.05 124.22 36.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.517 -1.674 . . . . 52.31 107.26 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.7 125.74 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.573 -1.269 . . . . 52.31 107.573 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.56 105.59 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.412 HD22 ' O ' ' C' ' 45' ' ' ASP . 2.4 tm? -91.33 112.61 24.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.216 -1.031 . . . . 55.14 108.216 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.4 ttp180 -91.68 110.76 22.1 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.823 0.849 . . . . 72.21 109.991 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.48 124.23 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 108.161 -1.051 . . . . 71.12 108.161 173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 7.5 m -123.44 137.05 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.491 -0.559 . . . . 75.52 109.491 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.522 HG21 HG21 ' C' ' 114' ' ' ILE . 56.1 t -125.17 115.74 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.861 1.264 . . . . 41.33 108.889 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.48 144.35 28.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.209 -1.034 . . . . 55.24 108.209 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.99 37.28 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.361 -0.607 . . . . 63.21 109.361 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -137.76 138.4 39.23 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.479 0.487 . . . . 54.02 110.665 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.65 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.1 mt -86.93 43.82 1.12 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.083 1.353 . . . . 62.02 109.356 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.96 -113.17 4.37 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.517 -1.033 . . . . 73.2 110.517 -170.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.77 -10.03 41.45 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.678 0.791 . . . . 73.45 110.883 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.72 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 8.3 tp10 -90.11 128.89 36.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.308 1.443 . . . . 63.52 110.049 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 16.3 m -64.82 129.34 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.853 0.751 . . . . 75.21 109.908 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.534 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -83.36 -54.73 4.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.128 -0.694 . . . . 72.31 109.128 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -168.57 178.51 4.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.401 -1.272 . . . . 74.14 110.31 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -141.09 146.22 36.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 106.423 -1.695 . . . . 70.43 106.423 175.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.451 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -146.66 145.89 30.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.912 -1.144 . . . . 71.4 107.912 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.29 136.85 11.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.563 -0.532 . . . . 53.43 109.563 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' C' ' 110' ' ' ALA . 53.6 t -134.87 112.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.038 0.935 . . . . 61.23 108.507 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.7 mt-30 -92.71 89.51 6.69 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.822 -0.807 . . . . 65.44 108.822 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 63.3 tp60 -82.59 109.82 17.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.016 -0.993 . . . . 43.34 109.767 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 144.95 17.48 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.34 0.4 . . . . 71.11 112.434 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.607 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.29 128.29 3.35 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 110.358 -1.097 . . . . 71.23 110.358 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.61 HD12 HD11 ' C' ' 51' ' ' LEU . 11.8 mm -95.19 118.69 41.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.032 -1.099 . . . . 75.04 108.032 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.47 117.13 20.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.502 -0.925 . . . . 55.13 108.502 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -98.58 107.29 19.7 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.179 -1.045 . . . . 75.21 108.179 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.8 pp -131.7 154.31 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.036 0.534 . . . . 73.45 111.065 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.25 177.46 3.59 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.483 -1.235 . . . . 63.02 109.468 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -36.53 3.69 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 116.515 -0.312 . . . . 71.32 112.46 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.409 ' H ' HG13 ' C' ' 89' ' ' ILE . 2.5 pp -75.6 -173.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.477 1.111 . . . . 75.15 111.402 176.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.449 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 4.0 tm-20 -168.54 147.11 4.22 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.41 0.522 . . . . 50.21 112.41 -174.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.601 ' H ' ' HG2' ' E' ' 174' ' ' MET . . . 54.24 -116.02 5.85 Favored Glycine 0 C--N 1.354 1.564 0 C-N-CA 124.113 0.863 . . . . 53.1 115.001 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.2 p -69.07 -24.82 64.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.378 0.671 . . . . 54.1 111.914 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.449 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 44.4 mt-30 -56.46 -39.38 73.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.274 0.63 . . . . 74.14 110.237 174.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.582 ' HE2' ' SD ' ' E' ' 174' ' ' MET . 54.8 tpp -65.46 -44.4 87.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.558 0.743 . . . . 74.41 110.243 173.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' E' ' 177' ' ' LEU . . . -64.62 -26.42 68.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.553 0.741 . . . . 65.23 112.431 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -88.14 -33.51 18.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.518 0.727 . . . . 73.24 111.34 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -67.68 -61.58 1.82 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.19 0.596 . . . . 75.4 110.953 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.11 -6.64 47.56 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.191 0.441 . . . . 70.0 112.191 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.44 -29.67 21.26 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.919 -0.378 . . . . 70.11 113.527 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 -43.47 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.154 0.477 . . . . 62.11 111.778 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -72.29 -49.91 31.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.228 0.455 . . . . 71.14 112.228 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.05 -45.66 80.01 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.808 -0.615 . . . . 51.41 112.461 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.15 -23.1 60.65 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 121.877 1.718 . . . . 71.33 113.798 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -67.86 -39.74 83.72 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.352 0.661 . . . . 73.23 109.602 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.46 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.5 mm -61.61 -40.36 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 75.35 110.126 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.607 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -76.87 -27.03 54.89 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.129 -0.941 . . . . 74.43 112.288 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 51.2 t80 -57.67 -47.75 98.4 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 117.285 -1.341 . . . . 74.31 114.11 -170.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.78 -39.49 91.03 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.032 1.821 . . . . 73.31 112.863 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -63.48 -43.83 96.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.066 0.947 . . . . 75.14 111.3 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -76.04 -35.47 59.47 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.897 -0.592 . . . . 73.32 111.605 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -60.45 -47.39 86.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.275 1.43 . . . . 64.41 110.214 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -39.59 87.3 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.365 -0.834 . . . . 61.12 109.959 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.7 t -66.02 -27.99 68.53 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.398 0.679 . . . . 60.35 112.329 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.522 HG21 HG21 ' C' ' 64' ' ' VAL . 78.2 mt -73.12 -49.08 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.938 0.495 . . . . 64.21 110.113 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -58.18 -34.85 70.79 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.028 0.931 . . . . 61.11 111.143 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -62.58 -55.0 31.26 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.912 -1.495 . . . . 73.51 109.79 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.503 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -59.48 -36.92 76.94 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.802 1.241 . . . . 73.44 113.443 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.02 -41.37 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.848 0.459 . . . . 71.1 110.769 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.9 t -66.6 -30.25 70.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.278 -0.873 . . . . 63.05 110.986 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.503 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 89.4 mtt-85 -70.23 -33.46 71.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.535 0.734 . . . . 73.34 110.315 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.14 7.38 63.81 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-N 115.668 -0.696 . . . . 53.04 112.966 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.694 HG22 HH22 ' B' ' 111' ' ' ARG . 17.2 p 62.1 21.27 12.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.897 2.079 . . . . 72.02 113.488 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.31 166.4 15.51 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.168 0.987 . . . . 75.33 110.239 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.78 105.7 0.39 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.296 1.997 . . . . 71.13 111.236 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.34 141.38 36.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.863 1.265 . . . . 72.54 111.418 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.76 118.14 36.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.631 0.372 . . . . 62.14 111.376 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -98.33 85.01 3.32 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.385 -0.969 . . . . 53.3 108.385 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.419 HD13 ' HG ' ' C' ' 42' ' ' LEU . 53.5 mt -78.36 142.63 37.52 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.882 -1.054 . . . . 43.23 109.15 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 141.4 94.11 Favored Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 123.934 0.894 . . . . 63.33 112.721 -169.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' C' ' 107' ' ' PHE . 82.6 Cg_endo -75.36 102.37 1.59 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.785 2.323 . . . . 73.11 111.521 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.2 t -69.19 91.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.295 0.638 . . . . 63.41 110.818 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -83.83 105.91 15.1 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.084 -0.962 . . . . 74.31 110.134 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -52.22 -44.32 64.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.416 0.686 . . . . 72.52 111.229 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.48 -48.27 81.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.582 1.153 . . . . 73.5 111.066 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.683 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -66.3 -50.22 64.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.617 -0.72 . . . . 54.51 111.054 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.638 HD12 HG21 ' F' ' 207' ' ' VAL . 7.4 tt -58.53 -39.61 80.64 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.204 1.002 . . . . 71.34 110.963 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -70.31 -42.74 71.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.393 0.677 . . . . 75.05 110.304 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.422 ' HB3' ' NE2' ' C' ' 142' ' ' GLN . 18.9 mmt -74.63 -26.68 60.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.95 0.9 . . . . 72.03 111.354 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -70.55 -46.92 62.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.125 0.97 . . . . 73.24 109.456 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -73.18 -84.2 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.001 -1.0 . . . . 75.51 110.329 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.603 ' H ' HD23 ' C' ' 141' ' ' LEU . 1.8 pt? -100.53 106.59 18.13 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.834 0.826 . . . . 72.33 110.884 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.422 ' NE2' ' HB3' ' C' ' 138' ' ' MET . 34.2 tt0 -167.61 139.31 3.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.728 1.211 . . . . 70.54 108.167 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.483 ' H ' HG22 ' A' ' 7' ' ' THR . 6.0 tp-100 -76.2 114.35 14.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.114 -0.699 . . . . 73.01 109.114 175.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.85 96.62 1.02 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.292 -0.632 . . . . 72.14 109.292 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' ' 8' ' ' GLU . . . -75.33 -57.49 3.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.14 -0.689 . . . . 53.44 109.14 172.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.42 -143.1 30.06 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.147 -0.933 . . . . 31.24 111.235 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 62.41 130.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.019 1.728 . . . . 74.21 112.752 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.32 144.79 6.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.136 -0.786 . . . . 62.43 111.136 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.513 ' H ' HD12 ' G' ' 173' ' ' LEU . 10.0 t -111.37 136.72 50.1 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.824 -1.176 . . . . 61.21 107.824 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' C' ' 151' ' ' GLU . 31.7 tt0 -68.73 125.06 25.38 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.967 0.507 . . . . 72.3 111.027 -174.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' C' ' 150' ' ' GLU . 0.4 OUTLIER -69.94 153.9 42.65 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 108.573 -0.899 . . . . 72.33 108.573 169.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -48.67 -61.35 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.52 0.728 . . . . 75.35 110.703 172.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 179.68 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.936 1.294 . . . . 72.15 109.652 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.7 t70 58.63 83.13 0.13 Allowed 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.945 1.403 . . . . 62.42 109.516 -170.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 123.917 0.887 . . . . 72.24 108.972 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtp . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.316 -0.624 . . . . 71.21 109.316 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -158.78 121.85 3.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.461 -0.94 . . . . 52.23 108.461 -174.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.83 42.94 2.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.527 0.731 . . . . 72.03 110.064 -167.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -69.91 -71.52 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.229 0.612 . . . . 65.42 111.069 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -172.44 134.8 0.69 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.759 0.823 . . . . 72.04 109.804 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.482 HD22 HD21 ' H' ' 173' ' ' LEU . 25.0 t30 -171.89 74.78 0.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.445 -1.687 . . . . 70.01 106.445 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -105.64 -160.88 0.77 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.943 -1.48 . . . . 73.44 109.665 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' B' ' 144' ' ' GLN . 3.6 mp0 60.84 50.82 5.06 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 123.719 0.808 . . . . 73.43 109.162 -171.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.534 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 6.0 ptm -30.11 131.01 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.91 2.084 . . . . 63.22 115.707 -171.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.5 m -130.31 139.47 50.71 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 62.41 108.468 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.83 100.07 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.896 -1.52 . . . . 73.33 106.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.557 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.0 mt-30 -118.31 153.73 33.49 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.421 -0.955 . . . . 64.35 108.421 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.1 141.44 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.881 -1.525 . . . . 72.54 106.881 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.448 ' HB3' ' CZ ' ' C' ' 32' ' ' PHE . 69.8 mt-30 -109.89 -35.2 6.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.84 0.456 . . . . 64.4 110.008 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -173.77 124.06 0.36 Allowed 'General case' 0 C--N 1.367 1.326 0 O-C-N 123.272 0.358 . . . . 74.24 111.028 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' B' ' 130' ' ' PRO . 38.4 mm -110.87 118.92 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 72.42 109.075 175.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' C' ' 122' ' ' THR . 9.0 p90 -149.6 175.96 11.07 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.909 0.861 . . . . 75.45 111.82 -171.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.44 HG21 HD11 ' D' ' 21' ' ' ILE . 72.2 p -98.99 119.03 37.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.238 -1.347 . . . . 62.43 109.733 175.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -84.49 -38.75 19.71 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.902 -0.59 . . . . 74.42 110.207 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.99 136.38 23.96 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.871 -0.788 . . . . 42.01 108.871 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.478 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.9 mt -130.16 132.35 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.885 -1.524 . . . . 73.51 106.885 172.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -145.44 114.96 7.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 123.394 0.434 . . . . 64.54 110.244 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.4 t80 -111.39 120.25 41.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.751 -1.574 . . . . 73.41 106.751 167.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.85 119.38 25.53 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.62 94.57 10.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 109.114 -0.699 . . . . 70.33 109.114 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.27 -57.4 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.15 2.567 . . . . 70.43 112.727 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -92.57 22.09 4.93 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.634 -0.698 . . . . 63.44 111.055 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.667 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -28.19 -64.24 0.16 Allowed Pre-proline 0 CA--C 1.577 2.018 0 N-CA-C 117.401 2.371 . . . . 70.03 117.401 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -82.95 -19.62 5.73 Favored 'Trans proline' 0 C--N 1.389 2.661 0 CA-C-N 122.491 1.925 . . . . 74.41 113.57 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -70.01 -40.99 74.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.346 1.058 . . . . 73.25 109.727 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.9 p -86.09 -0.87 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 C-N-CA 123.537 0.735 . . . . 74.32 111.249 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.519 ' HB2' HH11 ' C' ' 15' ' ' ARG . 82.3 t80 -62.1 -30.82 71.28 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.961 0.504 . . . . 53.33 110.665 164.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -68.44 -15.47 63.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 71.35 111.429 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.95 99.95 12.49 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.264 1.026 . . . . 73.42 109.739 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -96.88 50.75 1.11 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.33 1.052 . . . . 74.21 110.561 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -127.22 159.55 33.96 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.511 -0.922 . . . . 72.01 108.511 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -63.43 112.61 7.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.815 0.846 . . . . 60.14 109.96 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' D' ' 68' ' ' LEU . 25.8 Cg_exo -61.47 118.23 5.09 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.652 2.235 . . . . 71.35 111.671 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 51.3 mt-10 -60.38 115.56 3.64 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.235 0.959 . . . . 75.44 110.243 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.602 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -96.14 110.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 122.12 0.962 . . . . 74.11 109.027 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -97.2 107.34 19.84 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.668 -1.604 . . . . 72.21 106.668 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.584 HD22 HD22 ' D' ' 128' ' ' LEU . 55.3 tp -97.14 113.71 25.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.248 -0.649 . . . . 72.51 109.248 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.8 t70 -113.6 148.74 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.503 -0.554 . . . . 62.11 109.503 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 tp -119.88 135.05 55.03 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.686 0.794 . . . . 72.4 110.543 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -144.05 142.95 30.94 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.155 -1.054 . . . . 74.42 108.155 168.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -120.89 166.54 13.66 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.45 0.7 . . . . 74.04 109.279 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.74 169.3 24.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.183 0.993 . . . . 62.53 109.015 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 13.3 p -165.0 155.8 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.947 0.404 . . . . 74.54 111.738 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -152.75 135.7 15.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 51.11 109.147 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.35 118.06 22.34 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.394 -0.595 . . . . 70.01 109.394 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' D' ' 57' ' ' GLU . 34.6 mt -95.19 -34.31 12.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.196 0.598 . . . . 60.31 110.267 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.45 -173.43 4.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.03 0.932 . . . . 70.53 110.357 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.58 120.62 14.29 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.316 -0.856 . . . . 75.21 109.519 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 63.46 14.43 7.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.742 1.217 . . . . 61.21 112.178 -176.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.87 119.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.225 -0.657 . . . . 74.15 109.225 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -133.08 130.48 39.39 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.243 1.017 . . . . 73.5 108.376 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.49 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.1 tt0 -87.18 112.71 22.24 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.949 -1.13 . . . . 75.52 107.949 169.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.32 124.13 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.006 -1.479 . . . . 73.2 107.006 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 32.8 t -105.02 135.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.691 0.797 . . . . 70.24 109.024 -177.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 121.18 44.6 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.923 -1.14 . . . . 64.41 107.923 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.4 ttm-85 -103.68 102.28 12.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.835 -1.172 . . . . 64.14 107.835 173.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.571 HG21 ' HB1' ' D' ' 110' ' ' ALA . 19.8 t -98.44 120.61 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.664 -0.865 . . . . 71.45 108.664 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.1 m -108.04 137.41 46.09 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.187 0.595 . . . . 72.3 109.931 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.602 HG13 HG23 ' D' ' 40' ' ' VAL . 50.7 t -136.89 108.04 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 61.24 108.054 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.9 m -101.07 126.94 47.8 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.317 -0.994 . . . . 54.21 108.317 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -111.94 141.44 45.58 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.323 -0.621 . . . . 53.21 109.323 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 57.5 p -145.13 141.99 29.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.708 0.63 . . . . 73.41 111.016 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' D' ' 38' ' ' PRO . 39.9 mt -136.35 112.51 9.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.777 1.231 . . . . 74.21 109.456 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.12 -109.72 2.97 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.368 -0.693 . . . . 72.24 111.368 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -122.54 4.09 9.6 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.495 0.718 . . . . 65.43 110.588 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.7 153.09 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.316 0.646 . . . . 72.45 110.601 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -76.53 116.61 17.37 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 122.774 0.429 . . . . 70.23 110.42 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -69.5 -56.58 6.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.541 -0.754 . . . . 73.44 111.026 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.96 174.06 15.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.43 -0.804 . . . . 64.43 110.654 170.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.36 145.19 51.73 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.88 -1.526 . . . . 73.12 106.88 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.523 ' SG ' HG23 ' D' ' 114' ' ' ILE . 53.0 t -157.79 121.21 4.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.863 -0.792 . . . . 72.13 108.863 -174.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.83 129.03 10.46 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.468 -0.567 . . . . 70.42 109.468 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.94 121.2 53.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.875 0.87 . . . . 63.22 109.577 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -87.84 85.01 6.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.387 -0.968 . . . . 74.2 108.387 167.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -79.98 97.8 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.324 -0.991 . . . . 60.12 108.324 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.59 143.72 16.74 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.859 -0.496 . . . . 42.14 111.859 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.43 131.48 4.86 Favored Glycine 0 CA--C 1.505 -0.532 0 N-CA-C 111.421 -0.672 . . . . 53.32 111.421 -175.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -90.31 125.72 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.574 -0.899 . . . . 71.04 108.574 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.5 127.86 43.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.942 0.897 . . . . 72.12 109.684 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 49.0 m -81.82 93.18 6.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.256 -1.016 . . . . 53.42 108.256 165.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.52 128.36 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.968 1.707 . . . . 64.42 109.751 -172.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 164.99 20.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 72.53 109.958 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 83.07 11.54 80.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.092 -0.504 . . . . 71.44 114.182 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.17 168.35 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.457 0.703 . . . . 74.12 110.571 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.521 ' HB2' ' H ' ' H' ' 172' ' ' ALA . 5.7 pt-20 -162.51 146.61 11.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.894 -1.048 . . . . 73.34 109.815 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.716 ' H ' ' HB3' ' H' ' 172' ' ' ALA . . . 42.88 -107.61 0.12 Allowed Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.307 1.004 . . . . 60.24 114.915 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 92' ' ' THR . . . . . 0.436 ' H ' ' HA3' ' H' ' 169' ' ' GLY . 9.7 m -67.27 -38.58 85.33 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.492 0.717 . . . . 62.45 110.937 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.72 -31.95 73.28 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.77 0.828 . . . . 72.43 110.573 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 45.1 ttm -67.74 -50.77 55.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.682 0.793 . . . . 64.23 110.284 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.24 62.69 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.829 -0.623 . . . . 63.53 111.303 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -79.51 -32.37 42.33 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.398 0.679 . . . . 72.33 110.31 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.2 t -78.27 -52.75 8.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 117.729 0.24 . . . . 55.2 110.356 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.41 -18.52 31.56 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.658 0.383 . . . . 74.31 111.788 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.68 -8.98 29.54 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.266 -0.741 . . . . 61.24 114.254 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.33 -55.21 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.027 0.914 . . . . 65.04 112.329 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -76.34 -50.94 12.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.096 0.559 . . . . 70.45 111.994 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 106' ' ' LEU . 71.0 m -60.96 -46.19 96.69 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 118.438 -0.791 . . . . 74.43 110.478 176.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.96 -39.57 59.27 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.263 1.976 . . . . 65.42 114.019 163.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.03 -26.61 65.07 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.353 0.661 . . . . 63.15 110.753 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -72.56 -38.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.892 0.877 . . . . 74.51 110.387 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.53 HD21 ' HA3' ' D' ' 82' ' ' GLY . 42.3 mt -79.64 -17.89 52.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.032 -0.986 . . . . 55.21 111.209 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -68.69 -38.64 12.46 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.18 1.178 . . . . 62.42 114.18 -171.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.34 -46.78 29.93 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.101 1.868 . . . . 74.05 113.095 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.86 -33.21 68.24 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.158 -0.928 . . . . 65.14 111.123 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -67.61 -54.24 21.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.927 0.891 . . . . 72.21 110.152 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -50.56 -46.5 57.65 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.987 1.43 . . . . 74.0 110.811 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -66.43 -46.07 77.7 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.175 0.922 . . . . 72.3 111.732 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.95 -41.71 92.44 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.737 0.648 . . . . 72.2 110.709 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.523 HG23 ' SG ' ' D' ' 76' ' ' CYS . 81.7 mt -59.45 -56.99 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.365 1.066 . . . . 51.53 110.671 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.633 HG23 ' HG3' ' D' ' 125' ' ' GLN . 54.9 m -53.93 -41.37 67.63 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.276 1.43 . . . . 75.31 111.865 -174.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -67.82 -42.59 81.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.923 -1.035 . . . . 73.13 109.958 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.444 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.6 mtm -71.11 -28.07 64.05 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.887 0.475 . . . . 64.34 111.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.42 -42.74 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.438 0.695 . . . . 64.41 110.135 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -74.38 -26.53 60.17 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.972 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -76.09 -24.16 55.02 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.458 0.703 . . . . 72.23 109.826 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.72 12.24 66.15 Favored Glycine 0 C--N 1.352 1.432 0 O-C-N 123.654 0.596 . . . . 74.33 112.258 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.595 HG23 ' HB3' ' C' ' 17' ' ' TYR . 80.6 p 62.95 9.98 4.09 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 127.385 2.274 . . . . 71.43 114.6 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.467 ' HZ ' HG13 ' D' ' 31' ' ' VAL . 41.9 m-85 -89.37 156.42 48.34 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.172 0.589 . . . . 74.31 110.65 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.89 141.37 89.52 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.714 2.276 . . . . 74.21 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.633 ' HG3' HG23 ' D' ' 115' ' ' THR . 28.2 tt0 -54.51 145.55 18.32 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.686 1.194 . . . . 74.34 112.107 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 114.8 15.74 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.065 -1.087 . . . . 71.43 108.065 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -100.78 93.24 5.46 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.12 -0.696 . . . . 72.32 109.12 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.584 HD22 HD22 ' D' ' 42' ' ' LEU . 89.0 mt -59.0 115.48 3.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.25 0.62 . . . . 72.23 110.92 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -65.3 127.84 93.26 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.773 0.429 . . . . 74.54 111.867 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.28 102.01 1.52 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 75.05 110.399 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.01 130.0 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.537 -0.756 . . . . 73.2 109.71 -174.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -92.64 116.37 28.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.4 -0.963 . . . . 75.24 108.4 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -63.62 -14.74 54.6 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 119.58 -0.248 . . . . 71.52 111.148 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.56 -50.37 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.875 1.27 . . . . 74.23 111.127 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.76 54.6 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.405 1.066 . . . . 65.23 110.706 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.524 HD21 HG21 ' G' ' 207' ' ' VAL . 2.7 mm? -71.52 -25.01 62.07 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.105 0.562 . . . . 64.35 112.001 -174.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.28 -49.71 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.261 1.024 . . . . 72.43 109.613 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.46 -46.13 50.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.621 0.768 . . . . 72.42 110.731 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -62.1 -31.28 71.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.603 0.761 . . . . 72.32 112.125 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -55.44 -40.38 71.46 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.475 0.484 . . . . 75.04 110.901 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.89 -46.97 10.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.14 0.576 . . . . 71.43 112.106 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.3 4.97 32.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.043 0.757 . . . . 65.44 113.043 -170.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -117.21 90.3 3.3 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.509 -0.923 . . . . 63.11 108.509 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.67 17.59 1.82 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.079 -1.419 . . . . 63.02 109.188 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.54 14.73 23.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.993 0.917 . . . . 74.44 111.371 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.77 -16.68 59.49 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.632 0.634 . . . . 60.5 114.231 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -63.24 91.59 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.77 0.795 . . . . 74.4 109.978 168.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.47 -128.99 2.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-O 119.146 -0.808 . . . . 62.34 111.431 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 30.8 m 59.2 85.51 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.642 1.177 . . . . 40.22 109.496 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 63.2 -167.82 0.21 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.187 0.995 . . . . 73.23 111.316 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 103.38 1.71 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.121 -0.696 . . . . 64.12 109.121 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -113.23 115.94 28.99 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.614 0.766 . . . . 75.04 108.965 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -76.88 94.69 3.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.563 -0.532 . . . . 74.1 109.563 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.76 136.35 36.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.183 0.593 . . . . 74.04 109.968 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 C-N-CA 123.837 0.855 . . . . 73.12 110.356 -178.677 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.368 -0.604 . . . . 62.32 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 169' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' E' ' 173' ' ' LEU . . . 163.19 -123.7 1.21 Allowed Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.366 -0.686 . . . . 41.31 111.555 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? 66.75 -76.8 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.233 1.413 . . . . 62.24 109.66 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -78.5 82.15 4.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.589 0.756 . . . . 74.03 109.018 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 62.57 -128.22 0.62 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.276 0.985 . . . . 71.33 110.599 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.706 HD21 ' HA ' ' C' ' 54' ' ' ASP . 44.0 mt 61.86 74.83 0.43 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 124.468 1.107 . . . . 70.22 110.838 172.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 174' ' ' MET . . . . . 0.601 ' HG2' ' H ' ' C' ' 91' ' ' GLY . 1.0 OUTLIER -81.01 -42.64 20.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.883 -1.508 . . . . 73.22 110.281 -172.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 32.5 t80 56.99 -85.12 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.601 1.16 . . . . 72.12 109.67 -164.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.94 25.72 4.84 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.153 0.981 . . . . 72.13 112.774 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 177' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' C' ' 95' ' ' ALA . 6.5 mp -101.26 128.68 47.29 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.785 -0.82 . . . . 74.01 108.785 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -145.06 99.38 3.32 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.272 -1.381 . . . . 75.34 107.272 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 69.48 151.74 0.13 Allowed Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 125.664 1.585 . . . . 72.13 111.496 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.95 103.05 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.319 2.013 . . . . 61.34 110.991 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -61.21 -30.43 70.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.74 0.816 . . . . 75.02 111.987 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -135.39 114.21 11.95 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.15 -1.056 . . . . 72.14 108.15 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 33.6 m -79.93 139.73 36.96 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.558 0.743 . . . . 72.23 109.918 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -112.05 94.96 27.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 N-CA-C 109.029 -0.73 . . . . 73.22 109.029 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.98 124.95 15.41 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.716 2.277 . . . . 74.31 112.824 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.05 165.06 16.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 74.01 109.863 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 46.2 pt -68.99 148.65 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.027 0.441 . . . . 74.41 111.634 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -77.62 123.52 26.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.373 -0.973 . . . . 64.13 108.373 167.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.74 -88.21 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 O-C-N 123.862 0.726 . . . . 60.52 111.707 -173.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 27.6 t70 44.62 -90.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.301 1.44 . . . . 63.53 112.01 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 51.66 -90.7 0.01 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 124.992 1.282 . . . . 72.14 115.841 167.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 192' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' F' ' 194' ' ' ALA . . . -74.11 96.37 0.88 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.704 -0.748 . . . . 74.51 113.153 -174.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -87.08 -24.46 24.56 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.431 0.692 . . . . 65.25 110.174 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 194' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' F' ' 193' ' ' TYR . . . -106.94 130.23 54.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.049 0.54 . . . . 63.13 111.254 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -144.72 150.18 36.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.913 1.285 . . . . 75.04 108.507 175.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.71 110.02 21.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.221 -0.659 . . . . 63.04 109.221 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -142.25 116.5 9.51 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.43 -1.693 . . . . 73.05 106.43 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 198' ' ' GLU . . . . . 0.558 ' HG2' ' H ' ' E' ' 199' ' ' ASN . 17.5 tt0 67.41 -171.04 0.19 Allowed 'General case' 0 CA--C 1.571 1.777 0 O-C-N 124.139 0.899 . . . . 75.53 110.526 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 199' ' ' ASN . . . . . 0.558 ' H ' ' HG2' ' E' ' 198' ' ' GLU . 21.5 t-20 69.97 105.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.384 1.474 . . . . 74.1 111.828 171.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.76 -67.24 3.46 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 111.342 -0.703 . . . . 62.42 111.342 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.94 171.21 19.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.277 1.031 . . . . 73.44 108.543 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 49.4 t80 76.75 18.07 1.68 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.571 1.548 . . . . 64.31 109.187 -169.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -87.91 -31.34 19.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.86 1.664 . . . . 73.34 110.65 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.643 HG12 ' HB1' ' B' ' 129' ' ' ALA . 8.0 mt 71.41 -8.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 126.142 1.777 . . . . 62.12 112.027 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.36 -11.68 59.87 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.235 1.014 . . . . 75.13 110.605 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.59 67.98 6.64 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.45 1.1 . . . . 64.55 110.152 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 75.3 t . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.638 1.175 . . . . 73.24 108.835 -178.038 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.638 -0.134 . . . . 64.24 110.638 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -156.58 -135.59 1.98 Allowed Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.535 -0.592 . . . . 64.55 111.757 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.61 0.764 . . . . 61.12 110.93 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 39.7 m -75.62 1.19 15.09 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.545 0.738 . . . . 61.32 111.643 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -95.48 15.84 18.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.57 0.748 . . . . 73.41 110.729 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.584 HD21 ' HE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -63.83 124.51 21.68 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.289 -0.634 . . . . 73.14 109.289 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.764 ' SD ' ' HG2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -153.61 178.83 9.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.146 1.378 . . . . 63.53 109.206 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -149.25 140.65 23.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.349 0.659 . . . . 64.44 109.629 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -157.2 109.2 2.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.96 -1.126 . . . . 64.53 107.96 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 177' ' ' LEU . . . . . 0.459 ' HA ' HD21 ' B' ' 98' ' ' LEU . 38.8 tp -67.06 100.53 0.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.785 -0.45 . . . . 74.34 109.785 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 178' ' ' GLN . . . . . 0.581 ' HB3' ' HA3' ' B' ' 99' ' ' GLY . 6.9 tp-100 -69.39 116.87 10.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.29 0.636 . . . . 71.3 110.202 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 179' ' ' GLU . . . . . 0.632 ' H ' ' HD2' ' F' ' 180' ' ' PRO . 34.7 mt-10 -128.73 -50.34 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.145 0.978 . . . . 63.02 111.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 180' ' ' PRO . . . . . 0.632 ' HD2' ' H ' ' F' ' 179' ' ' GLU . 85.6 Cg_endo -74.76 -159.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.4 3.246 0 C-N-CA 121.923 1.749 . . . . 73.2 112.687 177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 68.5 135.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.237 1.415 . . . . 64.12 112.705 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 69.13 -71.48 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.253 1.421 . . . . 72.31 113.118 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 15.5 m 69.92 105.21 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.094 1.358 . . . . 64.1 110.121 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.541 ' HE1' ' HB3' ' B' ' 44' ' ' LEU . 4.6 p90 -87.17 110.08 30.4 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.221 1.008 . . . . 71.04 111.589 -173.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.76 77.13 4.0 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.411 2.074 . . . . 63.13 111.734 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.571 HD13 HD22 ' B' ' 128' ' ' LEU . 0.5 OUTLIER -97.16 10.9 38.13 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.061 0.763 . . . . 42.45 113.061 -174.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.416 HD11 HD22 ' B' ' 126' ' ' LEU . 7.7 tp -158.87 169.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 110.052 -0.351 . . . . 74.11 110.052 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.29 -19.86 0.13 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 62.13 111.422 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . 61.11 -146.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.903 0.881 . . . . 61.25 109.897 -170.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 34.2 t70 73.78 158.88 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.436 1.094 . . . . 75.42 112.109 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 65.51 11.68 53.85 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 115.549 0.979 . . . . 52.21 115.549 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.52 108.54 3.66 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.733 -0.547 . . . . 61.04 111.733 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 193' ' ' TYR . . . . . 0.439 ' HB2' ' HB3' ' E' ' 194' ' ' ALA . 64.9 m-85 -138.64 87.8 2.25 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 123.795 0.838 . . . . 62.32 108.946 173.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 194' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' E' ' 192' ' ' GLY . . . -130.95 -8.17 3.92 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.447 -1.251 . . . . 52.03 111.289 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 195' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' B' ' 124' ' ' PRO . 56.8 t80 -91.57 106.69 18.67 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.69 0.796 . . . . 63.43 109.531 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -144.93 136.22 25.11 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.799 -1.185 . . . . 70.01 107.799 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -71.45 -55.01 8.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 70.01 108.202 171.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.84 112.64 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.011 -0.737 . . . . 73.01 109.011 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 16.4 m120 60.73 83.09 0.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.182 0.993 . . . . 71.3 109.841 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.04 127.17 2.07 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.906 -0.588 . . . . 65.25 112.102 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 201' ' ' LYS . . . . . 0.422 ' HG3' ' CD1' ' F' ' 202' ' ' TYR . 39.7 pttt -92.93 -6.54 48.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.089 0.956 . . . . 71.42 111.002 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 202' ' ' TYR . . . . . 0.422 ' CD1' ' HG3' ' F' ' 201' ' ' LYS . 2.8 m-30 -103.91 1.91 31.88 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.177 0.991 . . . . 74.11 110.975 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -137.47 165.73 25.55 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.016 0.526 . . . . 74.35 109.716 -171.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 10.1 tt -101.69 119.93 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.543 1.137 . . . . 54.04 109.863 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -78.78 -47.77 16.12 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.404 0.621 . . . . 74.22 109.702 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -144.34 -55.48 0.35 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.228 -1.397 . . . . 53.13 107.228 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.638 HG21 HD12 ' C' ' 136' ' ' LEU . 28.2 m . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 125.132 1.373 . . . . 74.41 109.157 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 6.4 mptt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 108.676 -0.861 . . . . 63.34 108.676 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -66.25 83.88 0.1 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.691 -0.564 . . . . 51.3 111.691 173.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -126.44 -86.66 0.6 Allowed 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.592 1.157 . . . . 73.23 108.19 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 171' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' A' ' 54' ' ' ASP . 16.8 t 66.06 176.8 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.722 1.209 . . . . 60.03 113.581 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 172' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 86' ' ' ILE . . . -102.97 -175.08 2.7 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.81 -0.811 . . . . 65.03 108.81 166.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 173' ' ' LEU . . . . . 0.513 HD12 ' H ' ' C' ' 149' ' ' THR . 0.0 OUTLIER -133.91 23.08 3.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.277 0.631 . . . . 73.51 111.895 -169.002 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' G' G ' 174' ' ' MET . . . . . 0.572 ' SD ' ' HG2' ' A' ' 94' ' ' MET . 7.5 ptt? -159.28 151.85 21.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.864 0.69 . . . . 64.4 112.864 -161.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.562 ' HA ' HD13 ' A' ' 98' ' ' LEU . 57.7 m-85 -137.85 -61.93 0.61 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.246 1.418 . . . . 75.05 108.778 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 73.81 -4.1 2.34 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.987 1.715 . . . . 74.05 112.038 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.0 -25.03 64.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.329 0.652 . . . . 75.53 111.62 -172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 178' ' ' GLN . . . . . 0.572 ' HG2' ' HG3' ' G' ' 179' ' ' GLU . 27.4 tt0 -49.65 -49.82 45.74 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.237 1.015 . . . . 75.13 110.961 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 179' ' ' GLU . . . . . 0.572 ' HG3' ' HG2' ' G' ' 178' ' ' GLN . 31.0 mt-10 -134.06 101.31 12.6 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.415 1.086 . . . . 75.31 108.157 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.54 106.84 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.731 2.287 . . . . 55.45 110.746 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -52.88 -35.87 58.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.731 1.212 . . . . 55.31 113.22 -172.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -94.46 -24.12 17.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.691 0.796 . . . . 72.24 110.974 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 56.8 m 69.73 126.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.715 1.206 . . . . 70.01 112.671 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 184' ' ' TRP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 1.5 p-90 -146.91 91.65 5.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.488 0.715 . . . . 63.22 110.622 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.24 -19.55 19.71 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.657 2.238 . . . . 65.31 112.946 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 79.2 mt 61.15 -176.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.21 1.404 . . . . 74.15 112.689 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -92.91 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.557 -0.747 . . . . 75.4 110.592 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -136.81 178.8 6.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.061 0.945 . . . . 41.5 109.179 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -125.42 171.71 10.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.542 0.737 . . . . 72.02 110.624 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -127.48 -60.48 1.18 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.111 0.564 . . . . 64.4 109.591 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.3 -110.67 0.46 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.047 -0.421 . . . . 53.32 112.047 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 192' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' H' ' 200' ' ' GLY . . . 89.85 46.33 4.26 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.753 -0.539 . . . . 73.33 111.753 -176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.48 -174.52 2.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.171 0.989 . . . . 72.11 109.424 175.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -157.57 -65.65 0.09 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.443 0.534 . . . . 23.03 112.443 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 64.07 172.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.579 1.152 . . . . 71.43 112.127 -168.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -136.91 93.0 2.79 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.603 -0.517 . . . . 71.35 109.603 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -115.0 73.4 0.83 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.666 0.786 . . . . 74.25 110.15 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.46 -3.38 55.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.701 -0.681 . . . . 71.2 109.206 164.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -158.03 -173.16 4.21 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.167 1.387 . . . . 75.24 109.596 -167.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -81.95 -15.56 74.71 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.634 -0.536 . . . . 41.23 112.91 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.68 -0.55 3.13 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.775 1.23 . . . . 74.24 112.685 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.96 22.59 0.38 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 107.308 -1.368 . . . . 73.51 107.308 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.65 106.45 4.07 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.439 -1.255 . . . . 73.04 111.742 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 11.0 pt -129.92 118.69 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.15 -1.426 . . . . 71.03 107.15 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.19 -34.3 14.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.459 1.104 . . . . 71.03 113.638 -165.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.43 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.194 -1.039 . . . . 71.22 108.194 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 207' ' ' VAL . . . . . 0.524 HG21 HD21 ' D' ' 136' ' ' LEU . 4.2 p . . . . . 0 CA--C 1.556 1.177 0 C-N-CA 123.928 0.891 . . . . 73.01 108.946 174.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 46.7 tptt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.159 -0.682 . . . . 74.11 109.159 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' H' H ' 169' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' D' ' 92' ' ' THR . . . -125.29 -152.49 8.25 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 112.282 -0.327 . . . . 62.14 112.282 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -79.89 140.2 36.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.232 -1.025 . . . . 62.21 108.232 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 14.8 p -65.66 85.01 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.833 0.825 . . . . 62.41 110.73 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.716 ' HB3' ' H ' ' D' ' 91' ' ' GLY . . . -115.74 -173.68 2.39 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.053 1.341 . . . . 75.43 110.016 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 173' ' ' LEU . . . . . 0.482 HD21 HD22 ' D' ' 6' ' ' ASN . 1.5 tt -157.77 -74.19 0.09 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 122.841 0.456 . . . . 73.51 109.922 -176.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 27.4 mmt -81.62 159.61 23.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.753 0.421 . . . . 62.22 111.218 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -46.78 103.04 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 O-C-N 125.031 1.457 . . . . 65.34 112.493 -166.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -107.98 -66.6 1.02 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.562 1.145 . . . . 73.1 108.599 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 21.3 tp 59.93 22.6 11.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.681 1.192 . . . . 73.43 111.655 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -88.69 6.97 35.98 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.647 0.779 . . . . 75.11 111.381 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -79.11 116.69 62.06 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.706 0.802 . . . . 64.51 110.438 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.11 110.82 1.32 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.4 2.067 . . . . 73.51 111.518 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.636 -0.875 . . . . 72.41 108.636 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -63.82 -71.82 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.201 0.6 . . . . 75.31 110.861 -172.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.1 p -145.64 164.17 32.58 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.216 1.007 . . . . 73.31 108.619 174.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -113.31 92.03 21.39 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 107.995 -1.113 . . . . 70.44 107.995 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.64 88.08 1.17 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.153 2.569 . . . . 74.15 111.874 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.86 125.94 30.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.784 -0.821 . . . . 72.14 108.784 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 24.4 pt -62.03 138.98 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 124.234 0.959 . . . . 75.53 111.366 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.44 1.01 43.77 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.485 -0.779 . . . . 73.12 110.389 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . 75.92 -65.67 0.31 Allowed 'General case' 0 C--N 1.363 1.153 0 C-N-CA 126.029 1.732 . . . . 54.14 112.485 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 65.15 -172.12 0.18 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.745 1.218 . . . . 74.2 111.186 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.3 100.43 0.14 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.84 -0.618 . . . . 21.32 112.621 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -174.74 100.34 0.15 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 112.245 -0.342 . . . . 72.42 112.245 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.63 -54.39 3.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.793 -0.817 . . . . 74.4 108.793 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.45 -174.25 2.17 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.267 -1.333 . . . . 72.24 109.266 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -172.63 -15.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.931 0.769 . . . . 63.11 111.579 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 68.52 94.51 0.07 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.849 0.86 . . . . 73.23 109.141 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 197' ' ' TYR . . . . . 0.447 ' HE2' ' HA ' ' D' ' 32' ' ' PHE . 10.3 t80 -80.83 -30.32 35.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.453 1.101 . . . . 74.51 111.869 -170.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -85.47 178.52 7.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.226 1.01 . . . . 70.23 111.65 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 199' ' ' ASN . . . . . 0.411 ' HB3' ' CD2' ' H' ' 202' ' ' TYR . 93.2 m-20 -92.41 -170.8 2.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.309 1.043 . . . . 74.24 109.862 172.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 200' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' G' ' 192' ' ' GLY . . . -147.9 -79.03 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.296 -0.321 . . . . 55.31 112.296 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.11 68.14 9.88 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.651 0.78 . . . . 75.21 109.945 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 202' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' H' ' 199' ' ' ASN . 79.4 m-85 -136.75 92.44 2.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 74.02 108.809 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.18 82.12 8.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.465 -0.789 . . . . 63.12 109.128 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.46 73.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 107.883 -1.155 . . . . 53.03 107.883 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -122.87 24.91 8.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.221 -1.354 . . . . 73.31 109.864 -171.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.1 -172.07 2.36 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.69 0.796 . . . . 64.23 109.803 -177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 136' ' ' LEU . 7.0 m . . . . . 0 C--O 1.257 1.456 0 C-N-CA 123.018 0.527 . . . . 64.41 110.594 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 111.376 0.139 . . . . 73.53 111.376 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -132.33 40.17 3.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 73.02 109.215 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.64 120.23 12.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.508 0.723 . . . . 74.53 110.879 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.26 102.11 0.81 Allowed 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.007 0.817 . . . . 61.14 109.043 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -73.95 72.35 1.6 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.003 0.906 . . . . 72.22 110.583 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -69.71 103.43 2.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.987 -1.006 . . . . 62.22 108.301 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -83.9 30.61 0.5 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 70.12 111.635 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -54.36 -44.58 72.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.252 1.421 . . . . 73.05 109.829 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.88 167.18 17.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.657 -1.156 . . . . 75.12 112.238 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.7 m -149.43 143.88 26.0 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.114 0.965 . . . . 75.3 109.52 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.473 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 65.3 t80 -128.13 147.35 50.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.053 0.941 . . . . 72.2 109.676 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -158.93 137.37 10.8 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 120.74 0.305 . . . . 75.25 111.394 173.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' C' ' 132' ' ' ASN . 13.5 mm -74.78 118.73 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.427 -0.953 . . . . 72.52 108.427 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -89.25 -38.39 14.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.685 -0.487 . . . . 74.1 109.685 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.98 153.24 4.64 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 123.39 0.432 . . . . 74.01 111.259 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' C' ' 130' ' ' PRO . 98.3 mt -137.02 126.68 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.731 1.613 . . . . 54.25 106.814 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -154.61 157.11 37.71 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.461 1.104 . . . . 70.0 109.598 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.56 HG21 ' SG ' ' A' ' 113' ' ' CYS . 45.3 p -86.99 117.17 25.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.881 -0.785 . . . . 71.31 108.881 170.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 42.0 mtpt -83.56 -22.35 32.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.43 0.292 . . . . 71.03 110.284 173.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.4 t70 -153.8 140.02 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.681 -0.691 . . . . 75.22 109.667 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 40.8 mt -136.64 133.18 48.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.953 -1.499 . . . . 73.32 106.953 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -145.37 107.59 4.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.156 -0.683 . . . . 33.42 109.156 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.2 t80 -119.25 110.32 16.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.872 -1.529 . . . . 73.13 106.872 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 40.6 mt-10 -116.95 108.21 15.5 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.756 -1.572 . . . . 70.4 106.756 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.68 83.05 0.72 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 106.946 -1.502 . . . . 72.12 106.946 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 13.7 Cg_exo -68.69 -31.63 25.57 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.726 2.284 . . . . 72.35 111.704 -168.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 27.7 m-80 -118.24 39.99 3.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.059 -0.973 . . . . 61.43 108.807 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.23 -50.0 87.17 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.083 -0.962 . . . . 75.11 113.203 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 -24.67 22.33 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 121.775 1.65 . . . . 45.12 113.132 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -69.76 -24.45 63.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.408 0.683 . . . . 70.02 111.802 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG11 ' HE1' ' A' ' 123' ' ' PHE . 88.6 t -57.21 -33.26 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.401 0.68 . . . . 43.34 111.465 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -64.05 -32.13 73.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.748 0.819 . . . . 72.41 111.224 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -80.49 -27.04 37.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.352 1.061 . . . . 64.23 110.255 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -82.67 162.07 21.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 75.33 112.362 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.92 129.29 34.72 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.363 -1.347 . . . . 71.21 107.363 163.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.1 t-105 -77.32 84.17 3.76 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.745 0.784 . . . . 72.35 110.329 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -132.01 77.11 72.34 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.204 -1.406 . . . . 74.14 107.204 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.8 146.17 37.59 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.102 1.868 . . . . 64.34 112.077 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -96.34 86.12 4.12 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.39 -1.708 . . . . 75.15 106.39 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.01 102.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.54 -1.209 . . . . 62.54 110.823 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -111.49 146.18 37.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.918 0.887 . . . . 73.31 110.184 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.01 153.19 37.68 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.76 0.824 . . . . 62.51 110.659 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.0 t70 -142.9 113.82 7.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.883 0.873 . . . . 54.21 108.66 174.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -98.84 119.97 38.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.5 -0.926 . . . . 45.04 108.5 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.3 142.87 39.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 74.44 109.952 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -110.03 144.76 38.13 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.817 0.847 . . . . 70.4 108.815 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.34 113.63 12.81 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.077 -1.083 . . . . 23.44 108.077 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 35.5 p -88.04 151.02 23.06 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.268 0.627 . . . . 64.32 111.062 -172.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.0 t -163.0 136.72 5.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.207 1.003 . . . . 64.11 109.098 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.64 124.53 52.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.029 0.531 . . . . 72.22 109.75 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.82 -43.16 12.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.33 0.652 . . . . 73.4 110.055 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.28 175.43 13.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.638 -1.164 . . . . 73.42 109.676 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.06 119.1 11.44 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.609 -0.886 . . . . 74.42 108.609 173.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 78.26 -7.66 1.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.778 1.631 . . . . 72.21 113.19 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.83 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.786 -1.19 . . . . 74.21 107.786 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' A' ' 48' ' ' SER . 9.3 t80 -117.24 155.33 29.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.844 -0.798 . . . . 71.14 108.844 -171.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -127.23 113.77 16.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.315 -0.994 . . . . 71.04 108.315 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.09 117.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.863 -1.532 . . . . 71.14 106.863 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.6 t -98.36 131.87 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -102.12 112.27 24.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.261 -1.385 . . . . 72.11 107.261 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -101.87 99.98 10.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.439 -0.948 . . . . 75.24 108.439 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -98.0 132.94 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.991 -1.114 . . . . 74.34 107.991 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 18.7 m -128.77 137.69 51.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.169 0.509 . . . . 72.32 110.096 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.729 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.3 t -130.94 125.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.354 1.462 . . . . 61.44 108.695 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -118.58 150.64 39.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.684 0.394 . . . . 71.44 110.097 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.02 112.17 8.02 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.593 -0.892 . . . . 64.23 108.593 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -113.01 126.39 55.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.356 0.598 . . . . 64.34 110.411 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.0 mt -89.18 75.6 7.82 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.025 1.33 . . . . 71.21 108.652 175.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -82.91 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 111.07 -0.812 . . . . 45.23 111.07 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 -19.1 5.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.457 1.103 . . . . 71.24 111.742 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.68 126.94 36.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.031 0.933 . . . . 70.31 109.305 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -77.16 127.59 32.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.148 0.885 . . . . 74.44 110.388 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -77.9 -55.74 5.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.081 0.952 . . . . 71.33 108.818 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -157.66 169.34 24.88 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.895 -1.502 . . . . 72.12 110.429 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 tp -141.17 138.11 33.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.39 -1.277 . . . . 64.44 108.164 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.2 m -128.82 140.6 51.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.038 0.935 . . . . 73.32 109.531 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -149.42 133.53 17.23 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.388 -0.967 . . . . 74.24 108.388 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.81 110.52 12.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.504 -0.924 . . . . 74.43 108.504 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.2 mt-30 -88.88 79.57 7.33 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.147 -1.057 . . . . 75.53 108.147 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.06 92.77 3.21 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.032 -0.985 . . . . 75.13 108.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.47 146.48 20.88 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.363 -0.38 . . . . 72.11 112.704 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.1 135.89 6.72 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.789 0.295 . . . . 64.53 112.409 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.7 mt -82.27 126.92 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.332 -0.988 . . . . 74.23 108.332 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.464 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.1 m-85 -133.18 121.0 21.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.876 -0.787 . . . . 71.45 108.876 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -78.31 113.36 16.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.644 -0.873 . . . . 41.45 108.644 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.31 133.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.559 0.744 . . . . 65.14 110.188 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.04 144.84 14.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.804 0.841 . . . . 75.41 109.698 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.37 9.21 86.79 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.783 0.677 . . . . 65.43 113.961 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' SD ' ' A' ' 94' ' ' MET . 0.9 OUTLIER -109.89 131.44 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.124 -0.695 . . . . 73.13 109.124 -173.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -147.22 176.33 10.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.073 0.949 . . . . 53.24 109.727 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 -114.98 3.89 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 124.185 0.928 . . . . 71.13 113.994 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.2 p -82.3 -27.29 32.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.51 1.124 . . . . 60.34 111.17 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.57 -42.55 67.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.896 0.879 . . . . 63.32 110.523 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.635 ' SD ' HD13 ' A' ' 89' ' ' ILE . 10.6 tpt -78.52 -34.65 47.15 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.174 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.06 -29.18 70.34 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.004 0.43 . . . . 52.13 111.313 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -70.71 -56.16 7.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.295 -0.866 . . . . 74.43 109.709 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 77.3 m -65.48 -65.53 0.66 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 123.867 0.729 . . . . 52.32 111.978 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' G' ' 175' ' ' PHE . 59.4 tp -63.04 -33.73 76.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.334 1.053 . . . . 73.13 112.114 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.9 -37.26 9.44 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.66 0.624 . . . . 50.15 114.66 -170.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.31 -50.38 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 117.948 0.874 . . . . 64.44 113.348 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 90.1 t80 -68.06 -63.14 1.12 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.435 0.694 . . . . 71.21 111.7 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -61.81 -37.49 40.25 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 123.748 0.819 . . . . 63.44 113.209 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.84 -49.82 16.0 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.217 1.945 . . . . 62.11 113.081 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -73.93 -15.65 61.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.429 0.692 . . . . 73.34 112.007 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 13' ' ' ILE . 48.1 mm -62.14 -42.67 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.731 0.777 . . . . 64.33 109.505 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 60' ' ' LEU . 52.3 mt -75.31 -21.62 58.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.423 -1.262 . . . . 73.12 112.156 -173.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -67.05 -40.65 30.23 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 114.429 1.27 . . . . 74.12 114.429 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.27 -41.31 77.88 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.173 1.915 . . . . 75.34 112.813 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -72.95 -36.85 67.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.493 0.717 . . . . 71.44 110.976 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.46 94.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.471 0.708 . . . . 75.4 109.944 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 44.6 ttm105 -55.6 -48.98 73.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.618 1.199 . . . . 62.14 110.798 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -45.25 90.99 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.837 0.711 . . . . 64.12 110.301 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.56 ' SG ' HG21 ' A' ' 18' ' ' THR . 42.1 t -61.37 -24.41 66.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.338 -0.846 . . . . 52.32 112.468 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 64' ' ' VAL . 94.9 mt -85.02 -53.0 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.574 0.749 . . . . 62.24 110.002 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -55.3 -40.95 71.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.67 1.188 . . . . 74.01 112.216 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.2 t -60.98 -45.55 94.35 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.025 -0.989 . . . . 73.02 111.025 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.667 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.9 mtm -64.4 -46.03 85.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.389 0.675 . . . . 74.25 111.313 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -58.5 -51.02 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.572 -1.195 . . . . 75.0 110.846 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 24.1 t -68.05 -25.86 65.57 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.195 -0.912 . . . . 61.13 111.419 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -78.83 -26.0 44.18 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.421 1.088 . . . . 74.55 110.657 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 13.0 54.14 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-N 115.698 -0.683 . . . . 73.32 112.618 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.512 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 7.0 m 67.98 40.31 2.31 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 124.792 1.237 . . . . 74.33 110.336 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.45 ' HE1' HG11 ' A' ' 31' ' ' VAL . 48.0 m-85 -119.37 157.15 52.14 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.647 -1.161 . . . . 75.34 108.782 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.484 ' HD3' ' HE2' ' G' ' 195' ' ' PHE . 69.3 Cg_endo -70.37 148.47 61.18 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.155 1.904 . . . . 62.44 111.298 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.6 tt0 -60.01 139.89 57.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.525 0.73 . . . . 75.12 111.413 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.3 114.75 15.41 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.89 -0.781 . . . . 73.02 108.89 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -109.9 105.77 15.08 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.53 128.32 35.16 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.082 -0.71 . . . . 51.24 109.082 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.8 97.45 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.516 0.727 . . . . 50.42 111.01 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.56 143.99 35.18 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.237 1.958 . . . . 54.21 110.978 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.55 109.68 25.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.042 -1.466 . . . . 64.22 107.042 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -99.95 74.7 1.82 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.402 -1.332 . . . . 65.41 107.402 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -64.44 -29.62 70.67 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.419 -1.264 . . . . 75.11 110.439 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.02 -50.17 69.7 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.54 1.136 . . . . 70.04 110.905 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.94 -52.42 65.12 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.49 0.494 . . . . 73.41 110.861 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.42 -46.37 73.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.319 0.648 . . . . 62.53 111.868 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.36 -61.79 2.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.062 -0.972 . . . . 62.43 110.351 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 25.7 mmt -58.97 -50.46 73.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.941 0.776 . . . . 65.24 111.685 -172.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 91.3 m-20 -53.16 -51.37 62.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.07 0.856 . . . . 65.34 111.262 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -65.9 -38.25 88.24 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.14 -0.936 . . . . 72.25 111.547 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.02 -49.76 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.934 -0.576 . . . . 75.32 111.403 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -176.17 -13.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.63 0.974 . . . . 61.21 113.63 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 19.9 tp60 -82.44 74.79 9.39 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.074 0.94 . . . . 63.54 110.346 -174.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -78.78 -35.97 43.6 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.547 -1.206 . . . . 63.51 111.478 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.62 103.65 1.38 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.445 0.698 . . . . 70.4 109.738 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.43 69.23 3.37 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.618 -0.593 . . . . 75.02 111.618 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -54.46 121.81 9.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.751 1.22 . . . . 75.41 111.421 -172.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' N ' HG21 ' C' ' 92' ' ' THR . . . -77.15 148.88 35.05 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.411 -0.813 . . . . 52.33 113.507 -167.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 m -122.11 108.7 13.65 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.881 0.873 . . . . 75.43 109.229 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.446 ' HA ' ' HE1' ' E' ' 182' ' ' PHE . 0.3 OUTLIER -74.77 95.17 2.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.679 -1.23 . . . . 73.25 107.679 173.651 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -119.25 87.62 2.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.307 -0.998 . . . . 64.11 108.307 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -74.27 127.17 32.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.127 0.971 . . . . 70.1 110.66 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -161.49 144.12 12.14 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.823 0.849 . . . . 72.21 109.198 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.37 168.21 15.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.01 0.924 . . . . 55.24 110.304 173.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 N-CA-C 108.774 -0.824 . . . . 37.76 108.774 177.182 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.635 0.255 . . . . 71.34 110.686 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -144.35 89.95 2.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.023 0.929 . . . . 71.24 108.661 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.05 -176.99 6.21 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.296 1.038 . . . . 61.5 109.761 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.41 ' HB2' ' HA3' ' B' ' 91' ' ' GLY . 34.7 mm-40 66.44 119.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.18 1.392 . . . . 73.2 111.079 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -138.06 140.69 40.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.233 0.613 . . . . 73.2 109.624 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -146.22 89.33 1.86 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.852 -1.166 . . . . 75.44 107.852 173.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.5 m -83.99 76.67 10.03 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.541 -0.754 . . . . 62.33 110.922 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.21 -68.72 0.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.737 -1.579 . . . . 61.15 106.737 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.539 ' HG2' ' N ' ' B' ' 10' ' ' THR . 25.4 ttt 64.52 166.63 0.16 Allowed 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.697 1.599 . . . . 60.23 114.371 166.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.539 ' N ' ' HG2' ' B' ' 9' ' ' MET . 18.9 p -146.8 120.66 9.3 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 125.599 1.559 . . . . 74.22 106.979 169.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -124.5 113.17 17.75 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.997 -0.742 . . . . 73.53 108.997 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.52 130.45 34.63 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.969 -0.752 . . . . 72.43 108.969 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.543 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -85.36 120.34 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.633 -1.247 . . . . 73.4 107.633 178.394 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -90.3 -42.47 10.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 75.21 110.451 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.512 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 48.3 ttt180 -168.5 137.41 2.28 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.041 -0.527 . . . . 64.42 109.728 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.543 HG13 HD11 ' B' ' 13' ' ' ILE . 69.4 mt -113.33 133.98 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.468 -1.678 . . . . 71.53 106.468 168.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.458 ' HE1' HG13 ' B' ' 83' ' ' ILE . 29.9 p90 -164.85 146.81 8.11 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.013 0.82 . . . . 74.02 110.973 -173.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.4 m -74.9 121.92 22.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.403 -0.817 . . . . 75.14 109.707 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -93.99 -31.66 14.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.335 0.654 . . . . 73.33 110.907 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.6 t70 -153.03 141.16 20.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.689 -0.687 . . . . 63.03 110.409 -170.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.483 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 36.0 mm -136.96 142.92 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.551 1.54 . . . . 61.22 107.831 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -148.1 133.62 18.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.222 -1.029 . . . . 34.25 108.222 172.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -150.41 127.73 11.36 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.334 -1.358 . . . . 75.25 107.334 169.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.24 155.97 41.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.523 1.129 . . . . 64.43 108.507 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -149.34 79.86 8.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.597 -1.26 . . . . 71.32 107.597 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.75 -23.44 30.83 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.989 2.459 . . . . 62.23 112.3 -173.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 93.1 m-20 -124.97 31.11 5.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.194 0.998 . . . . 72.31 109.854 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.573 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.6 -47.91 69.67 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 124.967 1.307 . . . . 70.15 113.772 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.47 -23.05 10.29 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.024 1.816 . . . . 72.32 113.551 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 69.4 m-70 -78.42 3.45 15.77 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.973 0.909 . . . . 72.4 112.894 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.38 -18.88 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 123.425 0.69 . . . . 73.21 111.192 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -83.48 -28.06 29.0 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.894 0.477 . . . . 65.4 110.344 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.78 -42.48 70.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.12 0.968 . . . . 74.24 109.866 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.72 113.07 26.31 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.322 1.049 . . . . 54.21 109.53 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -72.9 80.78 1.17 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.166 0.586 . . . . 73.2 110.221 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -170.02 151.35 4.01 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.044 -1.095 . . . . 74.43 108.044 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -95.0 127.86 41.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.547 -0.74 . . . . 64.44 109.651 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.518 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 25.1 Cg_endo -60.02 121.97 10.65 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.995 2.463 . . . . 63.23 112.169 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 109.25 2.61 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.784 0.677 . . . . 74.42 109.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' B' ' 125' ' ' GLN . 6.2 t -85.5 117.16 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.054 -0.721 . . . . 75.23 109.054 -168.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -136.28 144.22 44.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.291 0.636 . . . . 61.13 110.465 -169.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.781 ' HB3' HG13 ' F' ' 187' ' ' ILE . 8.6 tt -126.45 152.49 46.34 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.069 0.948 . . . . 74.13 109.874 -164.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.477 ' N ' HD23 ' B' ' 42' ' ' LEU . 29.5 t70 -137.11 140.85 42.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.753 1.221 . . . . 65.33 110.04 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.16 127.97 56.09 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.058 0.943 . . . . 60.2 109.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -140.62 152.76 45.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.865 1.266 . . . . 70.11 108.984 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.5 m -145.62 134.4 22.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.007 0.523 . . . . 52.11 110.601 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.66 162.97 30.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.071 1.348 . . . . 63.13 108.894 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.1 m -135.62 163.39 30.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.922 0.489 . . . . 74.23 110.369 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.37 139.21 18.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.888 0.875 . . . . 74.22 109.025 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -82.07 132.05 35.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.476 0.711 . . . . 71.14 109.408 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.0 mt -89.58 -53.08 4.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.792 -0.818 . . . . 64.3 108.792 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.39 -172.36 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.424 -0.807 . . . . 74.35 110.6 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.39 116.84 7.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.319 -0.855 . . . . 72.33 110.078 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.741 ' H ' HD23 ' F' ' 173' ' ' LEU . 12.2 m-20 65.12 13.2 8.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.028 1.731 . . . . 75.23 112.602 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.29 100.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.232 1.013 . . . . 75.13 108.603 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -97.28 165.95 11.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.608 0.718 . . . . 75.4 109.847 171.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -144.61 104.63 4.06 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.316 -1.364 . . . . 73.44 107.316 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.63 123.4 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.711 0.804 . . . . 72.31 109.507 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.2 t -105.54 120.82 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 75.51 109.8 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.3 119.82 34.47 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.909 -1.145 . . . . 75.42 107.909 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -107.9 110.3 22.02 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.294 0.638 . . . . 73.22 110.394 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.2 115.15 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.237 -1.023 . . . . 34.02 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -110.68 129.37 55.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.941 0.497 . . . . 73.3 109.862 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.568 HG21 HG21 ' B' ' 114' ' ' ILE . 54.5 t -119.36 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.274 1.03 . . . . 74.02 110.317 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 37.7 m -114.7 150.56 35.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 74.33 109.726 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -147.28 146.78 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.232 -1.025 . . . . 71.34 108.232 167.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -148.2 139.48 23.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.351 0.596 . . . . 63.41 111.476 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 46.8 mt -113.42 118.4 34.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.329 1.051 . . . . 71.52 109.348 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.52 -111.92 3.77 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.864 0.728 . . . . 44.4 112.605 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 4.89 21.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.71 0.804 . . . . 75.31 111.712 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -139.21 175.48 9.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.604 0.362 . . . . 72.55 110.84 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -69.69 150.0 47.45 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.196 0.998 . . . . 75.32 111.0 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.401 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -105.89 -57.4 2.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.987 -1.116 . . . . 71.04 107.987 169.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.447 ' HZ ' HG13 ' B' ' 40' ' ' VAL . 5.5 p90 -147.41 159.66 43.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.574 -1.193 . . . . 73.02 109.575 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.8 mt -127.55 157.99 38.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.163 1.385 . . . . 73.43 108.67 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' B' ' 114' ' ' ILE . 16.4 t -156.77 158.05 36.15 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.495 -0.557 . . . . 40.21 109.495 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.54 132.55 2.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.622 1.169 . . . . 71.24 108.236 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' B' ' 21' ' ' ILE . 56.0 t -128.11 147.36 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.036 -0.727 . . . . 75.33 109.036 174.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 19.5 mt-30 -126.8 93.3 3.74 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.883 0.849 . . . . 75.21 109.291 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -86.11 100.25 12.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.59 -1.641 . . . . 73.34 109.65 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.65 164.48 26.64 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 111.966 -0.454 . . . . 72.44 111.966 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.25 126.24 1.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.047 -0.821 . . . . 71.31 111.047 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.458 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.3 mt -84.56 127.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.369 -0.975 . . . . 74.05 108.369 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.66 131.5 39.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.148 -1.427 . . . . 72.33 107.148 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -96.25 102.53 14.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.551 -0.907 . . . . 61.14 108.551 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' B' ' 10' ' ' THR . 2.8 pp -122.94 139.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 115.669 -0.696 . . . . 75.11 110.584 -175.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.65 173.66 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.076 1.351 . . . . 51.3 107.852 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.03 -51.12 2.83 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 122.633 0.159 . . . . 74.13 112.893 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.532 HD13 ' HG2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -51.28 143.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.958 0.903 . . . . 71.44 111.178 172.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 144.26 24.82 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.644 -0.502 . . . . 74.0 109.644 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' B' ' 4' ' ' GLN . . . 62.25 -110.9 3.54 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 124.518 1.136 . . . . 73.2 113.335 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -64.13 -47.79 78.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.297 0.639 . . . . 75.34 110.046 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.505 ' HB3' HG22 ' B' ' 89' ' ' ILE . 89.1 mt-30 -63.58 -35.3 80.04 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 124.664 1.227 . . . . 75.35 111.484 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.532 ' HG2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -67.25 -56.8 8.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.364 -0.835 . . . . 71.11 110.24 -177.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -16.66 61.85 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.169 -0.923 . . . . 71.31 111.673 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -73.05 -39.17 66.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.098 0.959 . . . . 73.1 109.795 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -67.6 -63.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.102 -0.953 . . . . 54.32 110.969 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -77.82 -15.18 59.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 122.126 -0.359 . . . . 75.15 111.736 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.06 35.81 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.508 0.505 . . . . 61.43 113.711 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.55 -44.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.344 0.572 . . . . 64.43 112.535 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.97 -47.88 70.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.435 0.694 . . . . 73.11 112.282 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m -65.28 -50.49 59.11 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 123.583 0.753 . . . . 64.42 111.87 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.73 -24.09 55.2 Favored 'Trans proline' 0 C--N 1.398 3.162 0 C-N-CA 121.568 1.512 . . . . 55.22 113.291 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.06 -36.86 85.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.364 0.602 . . . . 75.43 110.904 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.412 HG23 ' NH2' ' D' ' 111' ' ' ARG . 66.7 mt -61.05 -46.7 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.61 1.164 . . . . 75.33 110.564 173.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.52 -10.95 58.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.491 -1.231 . . . . 63.52 111.701 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -63.28 -52.18 63.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.587 1.155 . . . . 71.15 113.153 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.9 -31.88 66.8 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 121.772 1.648 . . . . 74.52 112.964 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.472 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.7 m-85 -63.81 -51.11 66.23 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.912 0.485 . . . . 74.24 110.845 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.53 91.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.288 1.035 . . . . 72.12 111.72 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -58.29 -63.07 1.4 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.197 0.936 . . . . 70.11 109.419 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.49 -29.2 66.07 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.207 1.003 . . . . 73.51 111.311 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.483 ' SG ' ' CD1' ' B' ' 21' ' ' ILE . 23.9 t -62.87 -60.22 3.77 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.473 0.709 . . . . 45.33 112.307 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.699 HG23 ' SG ' ' B' ' 76' ' ' CYS . 85.3 mt -57.82 -44.57 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.084 0.954 . . . . 73.52 110.388 176.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.572 HG23 ' HB3' ' B' ' 125' ' ' GLN . 22.8 m -64.61 -25.3 67.9 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.463 -1.699 . . . . 54.33 111.435 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -80.52 -31.38 37.12 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.469 0.708 . . . . 62.33 110.839 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.4 mmt -71.65 -42.71 67.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.224 0.609 . . . . 62.42 111.647 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' B' ' 125' ' ' GLN . 96.4 t -73.91 -27.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.532 0.733 . . . . 61.04 110.615 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.428 ' OG ' HG21 ' C' ' 115' ' ' THR . 34.0 t -56.94 -34.52 68.08 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.8 0.84 . . . . 61.45 111.063 171.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.481 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 53.3 mtt-85 -80.12 -35.54 36.58 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.85 -1.068 . . . . 74.12 110.359 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.68 1.69 36.19 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.849 0.718 . . . . 60.23 112.597 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 70.22 25.26 4.63 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 127.115 2.166 . . . . 73.24 113.598 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.434 ' O ' HG12 ' B' ' 118' ' ' VAL . 65.2 m-85 -120.32 149.12 48.95 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.765 0.826 . . . . 71.11 109.253 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.03 101.73 1.17 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.674 2.249 . . . . 75.43 112.303 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.717 ' HA ' HG11 ' B' ' 40' ' ' VAL . 0.0 OUTLIER -65.15 157.17 29.42 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.047 -0.978 . . . . 74.51 110.096 170.2 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 44.7 tp -110.11 129.34 55.71 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.406 1.882 . . . . 60.12 108.296 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.98 125.61 32.84 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 106.548 -1.649 . . . . 73.24 106.548 173.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.647 HD21 ' HB2' ' F' ' 186' ' ' LEU . 0.9 OUTLIER -52.73 134.33 36.38 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.877 1.361 . . . . 74.53 109.08 -175.326 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -38.35 103.02 0.26 Allowed Pre-proline 0 C--N 1.361 1.095 0 O-C-N 125.824 1.953 . . . . 74.34 111.236 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.487 ' HG3' HG21 ' C' ' 122' ' ' THR . 57.1 Cg_endo -67.89 99.76 0.57 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.516 2.144 . . . . 65.14 110.843 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -147.94 115.18 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.455 -1.313 . . . . 72.43 107.455 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.91 103.1 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.683 -1.228 . . . . 43.32 107.683 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.539 ' HA ' HD23 ' B' ' 136' ' ' LEU . 64.9 t80 -65.75 -14.95 62.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.41 1.084 . . . . 73.5 111.937 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.2 -28.55 69.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.637 1.175 . . . . 74.3 111.037 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.5 -35.46 77.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.562 0.745 . . . . 74.05 111.004 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' B' ' 133' ' ' PHE . 4.2 mm? -66.15 -27.58 68.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.566 0.747 . . . . 74.41 111.354 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -62.84 -46.81 86.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.739 . . . . 72.23 109.959 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -67.03 -35.59 80.25 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.644 -1.162 . . . . 50.03 110.555 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -74.64 -35.09 62.88 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.656 0.783 . . . . 71.34 111.148 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -68.93 -43.92 74.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.754 0.822 . . . . 64.4 110.55 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -93.42 0.0 56.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.742 -0.663 . . . . 74.12 112.384 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.65 82.98 4.04 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.936 0.494 . . . . 64.14 109.751 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -155.65 120.89 4.85 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.818 1.247 . . . . 63.44 109.799 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -139.79 -87.29 0.21 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.966 0.906 . . . . 71.22 109.387 168.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.79 166.82 13.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.576 0.75 . . . . 72.5 109.453 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.92 94.81 0.1 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.359 -0.696 . . . . 53.51 111.359 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.56 139.45 31.43 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.106 0.562 . . . . 73.25 109.89 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLY . . . . . 0.572 ' HA3' ' SD ' ' D' ' 1' ' ' MET . . . -118.38 96.09 0.66 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.937 -0.574 . . . . 71.24 111.954 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -132.97 137.74 46.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.967 0.907 . . . . 75.52 109.947 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.45 148.46 22.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.774 0.83 . . . . 70.15 109.69 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.71 167.7 10.75 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.737 0.648 . . . . 63.22 111.022 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.41 143.52 50.52 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.804 0.842 . . . . 72.02 110.656 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -113.22 15.2 19.42 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.761 1.224 . . . . 75.33 108.975 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.88 161.43 21.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.167 0.987 . . . . 73.03 111.067 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 C-N-CA 123.582 0.753 . . . . 75.43 109.771 174.194 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 110.291 -0.262 . . . . 61.05 110.291 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -138.55 -54.11 0.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.619 1.168 . . . . 50.13 108.968 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -107.12 89.97 3.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.621 0.768 . . . . 73.11 109.384 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 170.43 16.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.709 1.204 . . . . 71.14 109.951 177.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 67.12 120.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.739 1.216 . . . . 71.43 109.825 -174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.82 -49.08 77.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.2 0.6 . . . . 72.33 110.52 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.8 m 73.76 -18.22 0.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.877 1.271 . . . . 73.23 112.765 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.65 148.67 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.503 0.721 . . . . 75.22 110.689 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.664 ' HG3' HG22 ' C' ' 89' ' ' ILE . 25.3 ttt 60.42 111.69 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.391 1.476 . . . . 72.51 109.482 -164.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.778 ' HB ' ' HG2' ' H' ' 205' ' ' LYS . 73.5 p -123.6 119.47 29.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.039 0.536 . . . . 65.12 109.745 -173.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.758 ' HA ' HG22 ' C' ' 86' ' ' ILE . 46.7 t80 -118.69 124.58 47.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.38 0.672 . . . . 73.44 109.673 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -139.35 124.94 19.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.328 0.651 . . . . 54.44 109.471 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.578 HD11 HG13 ' C' ' 16' ' ' ILE . 6.0 tp -82.01 134.19 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.945 -0.761 . . . . 75.21 108.945 170.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.554 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.7 mm100 -97.82 -51.43 4.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.281 0.632 . . . . 71.15 109.986 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.58 HH11 ' HD1' ' D' ' 32' ' ' PHE . 34.3 ttt180 -176.07 126.83 0.21 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.57 -0.741 . . . . 70.04 110.055 -166.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.578 HG13 HD11 ' C' ' 13' ' ' ILE . 97.4 mt -113.32 135.0 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.762 0.825 . . . . 71.42 108.847 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.754 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.1 p90 -169.74 153.99 5.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.24 0.543 . . . . 63.33 110.067 -174.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -74.75 115.08 13.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.966 -1.016 . . . . 73.24 109.976 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -66.09 -39.32 89.92 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.819 -0.808 . . . . 75.14 108.819 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -151.44 147.48 26.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.448 -1.251 . . . . 53.11 110.434 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -136.34 145.08 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.053 1.741 . . . . 73.43 106.789 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -154.7 148.82 25.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.987 0.422 . . . . 75.22 110.269 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -153.58 108.61 3.16 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.584 -1.265 . . . . 75.0 107.584 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -117.57 121.33 40.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.571 0.748 . . . . 71.21 109.687 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.82 85.93 56.57 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.472 1.109 . . . . 65.01 108.533 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.68 -16.58 16.54 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.56 2.173 . . . . 71.41 112.006 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.458 ' ND2' ' HB3' ' C' ' 30' ' ' HIS . 0.2 OUTLIER -99.51 19.64 15.31 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.933 1.293 . . . . 73.5 108.949 178.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.638 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -54.37 -52.13 71.95 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.332 1.053 . . . . 74.12 113.487 -172.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 6.2 Cg_exo -80.35 -31.31 1.68 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.923 1.749 . . . . 65.52 112.915 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.458 ' HB3' ' ND2' ' C' ' 27' ' ' ASN . 52.1 t-80 -70.22 -30.8 67.97 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.425 1.09 . . . . 75.13 112.827 -173.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.26 -17.62 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.78 0.832 . . . . 73.15 111.796 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -59.79 -32.0 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.621 0.768 . . . . 75.3 111.781 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.63 6.48 34.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.613 0.765 . . . . 71.35 111.875 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.841 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.14 143.25 38.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.446 0.699 . . . . 73.12 110.205 -176.455 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 129.65 39.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.548 -0.908 . . . . 74.2 108.548 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.591 ' HB3' ' HB3' ' E' ' 194' ' ' ALA . 75.6 m95 -84.61 84.41 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.736 0.779 . . . . 73.31 111.808 -165.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -132.42 78.64 67.37 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 114.44 -1.255 . . . . 74.21 108.082 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' C' ' 67' ' ' SER . 5.6 Cg_exo -82.79 146.44 13.16 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.647 2.231 . . . . 54.43 112.455 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -85.79 109.83 18.94 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.403 -1.332 . . . . 70.21 107.403 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 t -78.54 97.4 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 124.378 1.049 . . . . 61.43 109.44 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 92.9 mttt -99.45 104.28 16.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.579 0.752 . . . . 51.1 109.552 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.66 129.81 45.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.703 -0.851 . . . . 74.4 108.703 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -131.63 137.2 48.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.687 0.795 . . . . 73.24 109.201 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.57 113.78 20.27 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.988 -0.745 . . . . 64.12 108.988 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.54 143.77 43.98 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.195 -0.669 . . . . 62.13 109.195 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -114.64 128.3 56.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 73.02 110.842 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 161.93 19.36 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.983 1.313 . . . . 74.25 108.615 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.6 p -153.32 150.36 28.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.024 0.53 . . . . 75.41 111.137 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -146.0 143.02 29.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.663 1.185 . . . . 63.54 108.981 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -101.16 115.43 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.212 -1.403 . . . . 75.21 107.212 166.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 HD12 ' C' ' 83' ' ' ILE . 32.8 mt -87.43 -28.02 22.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.053 0.541 . . . . 72.4 109.944 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.5 -174.95 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.587 1.155 . . . . 62.23 109.442 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 120.73 12.43 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.261 -0.881 . . . . 74.13 109.077 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 65.76 7.06 4.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.893 1.277 . . . . 64.41 112.822 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.26 107.72 23.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.568 -1.271 . . . . 72.23 107.568 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -107.76 148.76 29.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.238 1.015 . . . . 64.23 109.591 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -128.13 110.37 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.183 -0.917 . . . . 75.2 108.796 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -100.14 125.63 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.654 -1.61 . . . . 60.44 106.654 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.54 104.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.453 -0.943 . . . . 50.41 108.453 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -91.78 104.54 16.97 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.029 -1.101 . . . . 72.01 108.029 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 16.4 mtm180 -84.18 137.49 33.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.657 -1.156 . . . . 75.25 108.425 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -126.94 132.28 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.873 -1.158 . . . . 74.33 107.873 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -121.73 122.51 39.71 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.986 -0.746 . . . . 73.02 108.986 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.533 HG23 HD13 ' C' ' 114' ' ' ILE . 71.1 t -110.84 111.48 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.9 m -100.1 146.12 27.17 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.679 -0.86 . . . . 63.13 108.679 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.96 124.72 33.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.101 -1.074 . . . . 64.35 108.101 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.2 m -126.61 168.54 14.17 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.895 0.878 . . . . 51.42 109.255 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.841 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.9 mt -128.89 26.42 5.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.378 1.071 . . . . 71.21 108.912 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.06 -92.8 0.68 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.74 -1.344 . . . . 73.4 109.74 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 -13.57 16.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.002 0.921 . . . . 75.11 111.12 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.25 120.57 40.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.984 0.913 . . . . 74.04 109.689 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -70.65 132.3 45.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.017 0.372 . . . . 62.41 110.673 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -51.65 7.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.151 -0.685 . . . . 61.43 109.151 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -169.79 177.48 4.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.787 0.835 . . . . 71.52 111.167 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.455 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -134.02 146.89 50.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.745 1.218 . . . . 50.54 107.91 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.2 t -150.67 145.55 25.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.789 0.836 . . . . 74.24 109.381 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.09 136.35 15.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.362 0.665 . . . . 62.43 109.529 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -130.48 114.77 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.027 0.931 . . . . 74.02 108.964 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 15.1 mt-30 -91.63 96.16 10.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.688 -0.856 . . . . 65.13 108.688 176.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.596 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -87.77 111.93 21.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.9 0.48 . . . . 72.54 110.598 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.92 146.93 18.36 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 112.044 -0.422 . . . . 52.44 112.044 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.05 123.8 2.1 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 110.198 -1.161 . . . . 61.35 110.198 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.7 mm -92.36 125.31 44.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.8 -1.185 . . . . 65.33 107.8 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.87 119.68 26.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.486 -0.931 . . . . 75.2 108.486 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -89.31 97.48 11.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.408 -1.33 . . . . 44.13 107.408 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.758 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.2 pp -135.89 137.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 115.753 -0.658 . . . . 70.42 110.151 -170.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.29 166.08 32.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.926 0.89 . . . . 54.12 110.605 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -26.27 7.81 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.812 -0.631 . . . . 52.15 113.103 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.709 HG12 ' HG2' ' C' ' 94' ' ' MET . 0.2 OUTLIER -65.61 134.9 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.401 1.08 . . . . 73.04 110.08 178.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -159.23 157.61 31.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.74 0.416 . . . . 73.3 110.241 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -134.51 40.67 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.826 0.704 . . . . 70.13 111.744 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 148' ' ' GLY . 46.7 p -74.65 -18.68 60.5 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.68 . . . . 71.33 111.809 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -64.84 -40.89 95.9 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.552 0.741 . . . . 74.55 109.598 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.709 ' HG2' HG12 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -67.18 -50.52 60.76 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.583 -1.19 . . . . 73.43 109.026 178.516 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.86 77.64 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.162 0.985 . . . . 63.42 112.988 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -73.04 -39.11 66.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 63.44 110.494 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.4 t -73.47 -34.75 65.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.163 0.585 . . . . 72.04 110.974 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.406 HD22 ' SD ' ' C' ' 94' ' ' MET . 47.0 tp -86.31 -56.93 3.21 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.571 1.148 . . . . 72.13 111.687 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.49 11.39 68.67 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.869 -0.605 . . . . 51.23 114.554 -168.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -56.25 0.23 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.458 0.629 . . . . 74.11 111.215 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -66.72 -60.06 3.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.303 0.641 . . . . 71.01 111.989 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.36 -47.8 98.13 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.05 0.94 . . . . 62.43 113.159 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.73 -20.05 35.47 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.975 1.783 . . . . 71.23 113.356 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.26 -22.68 47.95 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.406 0.682 . . . . 61.11 110.467 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.47 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.0 mm -69.91 -33.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.082 0.553 . . . . 54.12 109.52 169.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.7 mt -89.9 -25.15 21.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.085 0.954 . . . . 72.23 112.613 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -58.45 -45.38 99.69 Favored Pre-proline 0 CA--C 1.558 1.253 0 CA-C-O 117.859 -1.067 . . . . 72.12 113.136 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.41 -43.67 56.58 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.112 1.875 . . . . 53.32 112.633 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -63.37 -44.84 93.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.051 0.54 . . . . 75.13 111.569 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -73.21 -37.2 66.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.065 -0.516 . . . . 62.14 111.682 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.95 -58.51 7.08 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 124.258 0.974 . . . . 73.22 108.97 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.68 66.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.222 1.409 . . . . 65.33 112.631 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 17.0 t -74.73 -38.71 62.21 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.048 0.539 . . . . 73.32 111.95 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.56 HG23 ' SG ' ' C' ' 76' ' ' CYS . 93.3 mt -67.14 -47.23 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 123.59 0.756 . . . . 73.22 109.737 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.663 HG23 ' HB3' ' C' ' 125' ' ' GLN . 91.8 m -56.61 -37.45 70.7 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.435 -1.257 . . . . 74.12 111.359 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.1 t -62.84 -49.28 75.51 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 114.91 -1.041 . . . . 61.32 110.251 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.624 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.73 -35.67 70.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.176 0.991 . . . . 73.15 112.96 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.78 -45.61 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.078 0.551 . . . . 70.34 110.414 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 54.1 p -70.48 -26.44 63.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.661 -0.7 . . . . 74.44 111.02 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.9 mtt-85 -66.6 -33.79 76.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 72.34 110.595 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.96 11.55 47.54 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.945 0.778 . . . . 42.42 112.826 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.664 HG23 ' HB3' ' D' ' 17' ' ' TYR . 43.9 p 57.93 28.2 15.79 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.826 2.05 . . . . 74.02 112.485 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -102.04 150.26 37.29 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.826 0.85 . . . . 73.04 108.899 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.729 ' HG3' ' HB1' ' E' ' 194' ' ' ALA . 36.8 Cg_endo -62.5 130.74 31.02 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.029 2.486 . . . . 72.14 110.708 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.663 ' HB3' HG23 ' C' ' 115' ' ' THR . 37.6 mt-30 -61.01 153.74 24.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.167 0.987 . . . . 64.22 113.001 -170.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.43 67.42 0.84 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.348 -0.842 . . . . 53.11 109.704 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.527 ' HB3' HG21 ' C' ' 115' ' ' THR . 1.9 p-10 -90.69 80.99 5.86 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.407 -1.331 . . . . 65.43 107.407 167.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.542 ' HB3' HD13 ' E' ' 187' ' ' ILE . 2.0 mm? -95.24 103.89 15.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.866 -1.515 . . . . 71.33 110.607 -170.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.497 ' HB3' HD12 ' E' ' 187' ' ' ILE . . . 63.11 155.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.385 1.624 . . . . 42.24 115.385 166.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.563 ' HG3' ' H ' ' A' ' 16' ' ' ILE . 69.5 Cg_endo -91.29 102.89 0.25 Allowed 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.774 2.316 . . . . 73.02 111.317 161.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 t -82.45 79.93 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.01 -0.737 . . . . 61.45 109.01 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.518 ' HB3' HG13 ' A' ' 13' ' ' ILE . 28.7 t-20 -82.16 107.19 14.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.454 -0.794 . . . . 73.4 109.378 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' E' ' 183' ' ' THR . 29.9 m-85 -68.9 -21.74 64.21 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.195 1.398 . . . . 75.01 112.899 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.19 -43.44 33.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.936 0.894 . . . . 62.33 112.386 -169.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.52 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.925 0.713 . . . . 74.04 112.925 -172.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.25 -30.1 64.55 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.481 -0.327 . . . . 53.15 111.208 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -70.52 -33.6 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.421 0.288 . . . . 74.34 110.528 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.5 mtp -65.76 -34.65 78.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.075 0.55 . . . . 73.42 110.489 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -65.95 -36.2 82.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.354 0.662 . . . . 63.03 110.747 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.34 -87.47 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.211 0.604 . . . . 72.51 110.717 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -129.93 139.01 51.19 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.648 0.779 . . . . 65.22 110.404 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -162.9 163.67 26.26 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.055 0.942 . . . . 71.13 110.698 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -150.57 95.9 2.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.007 0.923 . . . . 70.53 108.991 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.93 24.01 0.95 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.143 0.977 . . . . 74.32 109.866 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.99 143.14 47.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.615 0.766 . . . . 74.34 110.424 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.12 -68.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.895 0 N-CA-C 110.464 -1.055 . . . . 62.51 110.464 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -168.53 -70.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.307 0.643 . . . . 52.41 109.416 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 168.79 -135.17 3.49 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.648 -0.581 . . . . 54.2 111.648 -173.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -134.41 -77.03 0.46 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.847 0.859 . . . . 73.14 110.087 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -172.87 161.98 4.68 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.847 0.859 . . . . 54.42 108.882 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.94 137.92 58.41 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.213 0.605 . . . . 73.51 110.15 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -88.85 169.22 11.78 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.457 -0.572 . . . . 74.14 109.457 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -163.1 115.26 1.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.313 -0.995 . . . . 75.13 108.313 172.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.75 96.89 9.67 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.244 -1.021 . . . . 71.31 108.244 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 N-CA-C 108.647 -0.871 . . . . 75.22 108.647 -178.454 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.572 ' SD ' ' HA3' ' B' ' 148' ' ' GLY . 56.3 mtp . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.251 0.548 . . . . 73.23 109.561 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -153.14 -165.03 2.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.649 1.18 . . . . 72.12 108.706 -173.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -42.82 67.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.324 0.65 . . . . 54.25 111.579 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 52.06 -90.27 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.51 1.524 . . . . 74.55 112.979 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.95 -70.99 0.51 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.7 -1.222 . . . . 72.41 107.7 170.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -171.75 87.02 0.09 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.433 1.093 . . . . 72.43 108.434 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -162.28 -179.84 7.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.488 0.715 . . . . 75.33 109.865 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 77.99 -58.26 0.46 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.566 1.546 . . . . 74.44 112.317 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.432 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 4.0 ttp -30.09 123.68 0.17 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.149 1.78 . . . . 63.53 113.187 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -125.79 145.51 50.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.953 0.901 . . . . 64.34 109.425 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.515 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 76.6 t80 -159.39 89.57 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.441 -1.318 . . . . 73.44 107.441 171.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.8 142.85 45.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.227 1.011 . . . . 70.41 108.468 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -103.06 110.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.085 0.554 . . . . 53.4 110.963 -170.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.92 -43.48 22.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.81 0.444 . . . . 64.33 111.577 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.429 ' HD2' ' HG2' ' B' ' 130' ' ' PRO . 6.2 tpt180 -166.32 148.61 6.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.038 0.384 . . . . 62.31 112.038 -165.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.86 128.39 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.986 -1.116 . . . . 74.3 107.986 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.664 ' HB3' HG23 ' C' ' 122' ' ' THR . 11.4 p90 -163.32 164.01 24.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.584 0.706 . . . . 73.5 111.41 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -77.93 107.94 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.588 -1.187 . . . . 52.41 109.642 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 46.8 mtpt -77.23 -35.82 55.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.114 -0.494 . . . . 75.21 109.727 173.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -145.03 136.79 25.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.034 -0.984 . . . . 74.23 109.229 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.624 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.1 mt -135.06 145.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.427 1.091 . . . . 75.52 108.371 175.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -149.32 132.43 16.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.989 -1.005 . . . . 64.31 108.606 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.3 t80 -137.01 117.49 13.75 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 106.333 -1.729 . . . . 74.45 106.333 167.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.23 133.61 54.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.729 -0.841 . . . . 72.21 108.729 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.54 84.66 19.35 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.214 -1.402 . . . . 62.23 107.214 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.87 -38.8 56.33 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.665 2.243 . . . . 72.1 112.295 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 25.3 m-80 -114.38 31.18 6.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.165 0.986 . . . . 74.24 109.275 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.754 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -35.16 -55.64 1.0 Allowed Pre-proline 0 CA--C 1.588 2.411 0 N-CA-C 117.487 2.403 . . . . 64.42 117.487 -172.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.87 -12.88 8.3 Favored 'Trans proline' 0 C--N 1.399 3.198 0 CA-C-N 122.595 1.963 . . . . 64.23 114.512 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -74.42 -35.69 63.4 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.423 1.089 . . . . 75.32 109.762 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.647 HG13 HD12 ' D' ' 68' ' ' LEU . 72.3 t -70.43 -34.26 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.527 1.131 . . . . 75.14 110.938 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.58 ' HD1' HH11 ' C' ' 15' ' ' ARG . 3.4 t80 -48.67 -36.68 16.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.446 1.499 . . . . 72.34 112.342 171.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -81.41 7.83 10.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.111 0.964 . . . . 75.44 113.116 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.565 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 86.8 mttt -121.66 114.3 20.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.534 0.734 . . . . 74.12 110.164 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -95.82 73.62 3.09 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.109 -0.7 . . . . 74.23 109.109 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.67 ' HB2' HD22 ' D' ' 68' ' ' LEU . 6.7 m95 -125.8 157.43 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.05 -1.833 . . . . 73.13 106.05 174.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.424 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 32.1 tp60 -77.79 113.18 30.19 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.826 0.739 . . . . 71.12 109.258 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.424 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 44.6 Cg_exo -58.74 107.1 0.32 Allowed 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.963 2.442 . . . . 65.34 112.517 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.65 112.32 3.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.474 1.109 . . . . 71.52 108.736 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.437 HG22 ' OH ' ' G' ' 202' ' ' TYR . 34.5 m -96.8 113.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 122.205 1.002 . . . . 70.32 108.527 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 71.6 mmtt -92.71 120.48 33.15 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.633 -1.247 . . . . 75.12 107.633 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.549 HD22 ' HB ' ' H' ' 187' ' ' ILE . 7.3 mp -94.58 121.65 36.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.602 -0.518 . . . . 72.32 109.602 -175.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 6.5 t70 -111.22 135.56 51.57 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.045 -1.465 . . . . 72.32 107.045 169.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -130.77 130.17 43.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.532 -0.914 . . . . 74.0 108.532 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.46 153.72 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.753 -1.203 . . . . 51.33 107.753 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -143.57 149.19 37.04 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.218 -0.66 . . . . 64.43 109.218 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.1 167.54 25.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.095 -0.957 . . . . 41.41 108.458 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -155.13 156.65 36.16 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.937 0.399 . . . . 60.23 110.445 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -155.09 139.45 16.73 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.104 0.962 . . . . 64.21 109.143 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -76.84 129.01 35.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.672 0.389 . . . . 65.01 110.037 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -97.69 -39.25 9.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.975 0.51 . . . . 75.35 110.102 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.01 -176.03 5.59 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.489 0.716 . . . . 72.54 110.353 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.03 121.64 11.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.043 -0.981 . . . . 71.12 110.309 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 66.85 3.6 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.473 1.509 . . . . 70.13 112.036 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -111.74 120.27 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.481 0.712 . . . . 70.33 110.171 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' H' ' 175' ' ' PHE . 65.4 m-85 -131.21 129.06 41.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.648 1.179 . . . . 72.2 107.933 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.75 116.85 29.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.923 0.889 . . . . 52.12 108.887 173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.01 124.71 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 107.781 -1.192 . . . . 72.32 107.781 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.608 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.2 t -101.27 144.21 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.517 1.127 . . . . 45.01 109.331 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.615 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -118.05 128.87 55.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.196 -1.038 . . . . 64.52 108.196 175.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -109.41 106.87 16.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.255 1.022 . . . . 74.01 109.158 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.27 128.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.567 -1.272 . . . . 53.02 107.567 166.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.3 m -125.42 124.05 40.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.264 0.555 . . . . 54.35 109.7 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.442 HG21 HG21 ' D' ' 114' ' ' ILE . 69.0 t -106.59 101.93 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 125.002 1.321 . . . . 63.23 108.493 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 8.2 m -94.94 93.59 7.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.647 -1.242 . . . . 70.14 107.647 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.44 138.79 33.5 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.944 -0.762 . . . . 73.15 108.944 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.4 p -148.39 138.78 22.68 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.456 0.473 . . . . 73.43 112.128 -176.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' D' ' 36' ' ' TRP . 66.2 mt -107.48 110.58 22.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.773 1.229 . . . . 73.2 109.971 172.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.51 17.47 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.421 0.451 . . . . 71.21 112.997 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.68 6.25 46.58 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.407 0.683 . . . . 54.41 111.408 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.565 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 7.4 tp10 -140.04 149.36 43.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.391 0.676 . . . . 74.0 110.668 -166.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.8 m -70.44 138.42 51.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.057 0.943 . . . . 73.41 111.512 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -87.6 -63.13 1.35 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.561 1.144 . . . . 62.21 108.188 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -155.03 161.62 41.29 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.181 -0.918 . . . . 73.13 110.739 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -117.59 138.05 52.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.271 -1.331 . . . . 72.23 107.498 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.1 t -149.35 139.42 22.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.834 -0.802 . . . . 74.55 108.834 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.434 ' HB2' HG23 ' D' ' 63' ' ' THR . 43.0 tt0 -156.12 131.88 9.71 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.117 -0.697 . . . . 75.11 109.117 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.22 118.11 26.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 123.492 0.717 . . . . 74.32 109.282 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.701 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.0 mt-30 -90.08 85.47 6.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.912 0.863 . . . . 52.13 108.871 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.92 95.92 6.23 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.685 -1.598 . . . . 70.52 108.901 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.28 145.65 18.2 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 112.299 -0.32 . . . . 71.44 112.299 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.99 131.29 4.68 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.588 -0.605 . . . . 72.41 111.588 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -90.88 131.39 38.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.903 -0.777 . . . . 43.24 108.903 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.26 142.64 48.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.94 0.496 . . . . 72.13 110.867 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -89.44 95.9 10.48 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.668 -0.864 . . . . 73.21 108.668 166.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.522 HD11 HG12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -122.04 134.46 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.146 0.978 . . . . 74.31 110.171 -173.193 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.33 171.1 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.256 1.023 . . . . 53.23 109.951 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.76 22.95 77.68 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.237 -0.438 . . . . 32.32 113.881 172.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.522 HG12 HD11 ' D' ' 86' ' ' ILE . 1.8 pp -103.99 158.08 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.201 1.0 . . . . 63.24 110.866 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.86 171.68 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.424 0.69 . . . . 65.03 110.643 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.8 -138.06 34.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.098 0.874 . . . . 60.24 114.912 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -72.55 -28.69 62.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.043 0.937 . . . . 73.14 110.954 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -63.87 -29.11 70.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.927 0.891 . . . . 60.04 111.652 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.554 ' SD ' ' HB3' ' H' ' 172' ' ' ALA . 24.2 ttt -59.93 -53.82 53.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.232 0.613 . . . . 73.41 110.525 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.95 64.5 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.419 -0.81 . . . . 73.33 111.205 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -69.12 -33.35 73.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.326 1.05 . . . . 75.11 110.316 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 46.5 t -78.93 -51.41 9.69 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.574 -0.739 . . . . 74.22 110.58 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.21 -49.48 27.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.284 0.633 . . . . 60.41 110.834 -171.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.34 -26.4 61.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.792 -0.64 . . . . 65.41 114.457 -172.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.18 -58.13 1.89 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.452 0.626 . . . . 63.44 112.063 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 76.8 t80 -68.73 -34.08 75.01 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.165 0.802 . . . . 75.4 113.165 -168.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.518 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 43.6 m -72.13 -48.92 10.2 Favored Pre-proline 0 CA--C 1.563 1.476 0 CA-C-O 118.977 -0.535 . . . . 75.15 110.995 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.615 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 71.0 Cg_exo -56.55 -30.97 84.89 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 122.49 2.126 . . . . 71.34 114.431 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.24 -29.32 69.77 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.039 0.536 . . . . 74.25 111.971 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -68.27 -38.98 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 73.42 110.595 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.94 -25.37 40.49 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.063 -0.971 . . . . 71.13 111.651 -170.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.65 -41.82 80.22 Favored Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 114.231 1.197 . . . . 63.21 114.231 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -50.1 -39.99 50.9 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.214 1.942 . . . . 75.45 114.19 171.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.19 -36.01 27.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.729 0.812 . . . . 71.53 111.109 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -44.19 96.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.445 0.698 . . . . 75.41 110.36 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.412 ' NH2' HG23 ' B' ' 105' ' ' ILE . 30.8 ttp180 -55.89 -54.97 38.23 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 124.965 1.415 . . . . 73.42 110.215 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.158 0.911 . . . . 72.35 111.837 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.427 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 43.0 t -59.7 -42.51 93.17 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.547 0.529 . . . . 74.53 110.96 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.491 HG23 ' SG ' ' D' ' 76' ' ' CYS . 83.4 mt -62.26 -55.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 115.123 -0.944 . . . . 73.41 110.338 172.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 97.1 m -53.44 -40.11 64.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.554 1.541 . . . . 74.34 112.4 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -71.73 -40.77 69.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.159 -0.928 . . . . 73.33 110.695 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.3 mtm -69.08 -31.09 69.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.864 0.465 . . . . 72.42 111.637 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.0 t -63.23 -46.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.622 0.769 . . . . 72.45 109.714 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -74.43 -29.19 61.4 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 116.009 -0.541 . . . . 74.54 111.506 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -74.12 -23.24 59.27 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.83 0.852 . . . . 64.54 110.479 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.36 12.19 65.57 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.725 -0.67 . . . . 60.15 112.43 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p 62.26 22.42 13.17 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 126.319 1.848 . . . . 73.34 113.972 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -97.99 161.26 26.16 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.265 1.026 . . . . 72.21 109.551 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.25 140.02 47.68 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.106 2.537 . . . . 74.53 111.625 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.08 119.39 8.26 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.547 0.739 . . . . 72.04 110.618 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.76 103.87 12.76 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.316 -0.994 . . . . 70.22 108.316 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -103.82 99.78 9.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 54.31 109.328 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.48 HD22 HD21 ' D' ' 42' ' ' LEU . 95.5 mt -71.29 126.88 30.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.29 0.636 . . . . 74.54 110.473 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.37 138.64 96.36 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 123.184 0.594 . . . . 54.41 111.064 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 2.1 Cg_endo -74.78 96.59 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.946 1.764 . . . . 73.41 109.647 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 85.5 t -106.97 109.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.014 -1.106 . . . . 72.42 108.014 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -79.44 117.99 20.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.588 -0.733 . . . . 71.2 109.137 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -46.89 -33.0 4.17 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.841 1.256 . . . . 65.23 113.136 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.78 -36.39 80.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.038 0.935 . . . . 74.35 111.535 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.6 98.74 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.584 . . . . 61.33 111.108 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -67.6 -41.14 84.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.236 0.615 . . . . 71.02 110.262 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.99 -46.33 85.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.925 0.89 . . . . 74.32 110.804 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 77.8 mtm -65.96 -57.43 7.84 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.637 0.586 . . . . 73.21 110.481 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -57.93 -31.54 66.91 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.816 0.846 . . . . 73.43 111.885 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -58.59 -53.64 56.11 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.536 0.734 . . . . 72.42 110.38 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.94 -32.84 74.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.556 0.742 . . . . 65.41 111.502 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' D' ' 138' ' ' MET . 43.9 mt-30 -77.41 3.52 13.08 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.295 0.638 . . . . 75.33 112.309 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.82 90.11 3.21 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.702 0.801 . . . . 62.2 109.504 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -161.85 -65.97 0.05 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.413 1.085 . . . . 75.51 108.663 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.87 132.52 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.886 1.275 . . . . 64.23 108.21 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.4 57.03 0.3 Allowed Glycine 0 C--N 1.345 1.028 0 O-C-N 123.209 0.318 . . . . 62.51 112.78 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.9 179.02 7.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.998 -0.371 . . . . 71.31 109.998 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 82.32 0.62 Allowed Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.776 -0.53 . . . . 72.34 111.776 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.6 t -133.48 9.94 4.03 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.389 1.076 . . . . 25.41 109.037 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.98 111.2 2.4 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.048 0.939 . . . . 73.21 111.315 -170.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.81 163.57 27.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.892 1.277 . . . . 64.45 111.256 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -147.74 -65.9 0.26 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.239 0.615 . . . . 72.31 110.439 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -69.98 126.15 28.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.313 0.645 . . . . 74.21 111.158 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -112.87 145.38 40.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.747 0.819 . . . . 63.43 110.049 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.806 1.642 . . . . 55.44 110.708 -176.408 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 56.0 mttm . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.048 -0.723 . . . . 65.11 109.048 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.36 66.84 3.81 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.459 0.474 . . . . 43.43 112.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 8.34 21.33 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.638 1.175 . . . . 71.13 110.847 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 44.3 p -136.45 -67.83 0.5 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.255 0.622 . . . . 64.15 110.787 -166.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 172' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' E' ' 175' ' ' PHE . . . -169.22 -175.95 2.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.583 0.753 . . . . 73.42 111.026 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 173' ' ' LEU . . . . . 0.427 HD22 ' H ' ' E' ' 173' ' ' LEU . 1.6 mm? -76.87 -30.63 56.34 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.771 -1.104 . . . . 70.31 109.961 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -57.36 1.17 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.741 1.216 . . . . 64.13 109.268 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 175' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' E' ' 172' ' ' ALA . 16.0 t80 62.19 86.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.442 1.497 . . . . 73.54 111.422 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 176' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' C' ' 94' ' ' MET . 22.1 m-80 -93.49 103.31 15.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.451 -0.944 . . . . 73.31 108.451 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 177' ' ' LEU . . . . . 0.473 ' HG ' ' H ' ' E' ' 178' ' ' GLN . 11.8 tp -167.42 -169.38 1.21 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.343 -0.984 . . . . 74.05 108.343 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 178' ' ' GLN . . . . . 0.473 ' H ' ' HG ' ' E' ' 177' ' ' LEU . 2.0 mp0 78.23 -41.39 0.32 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.627 1.571 . . . . 71.13 111.862 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.29 150.22 43.76 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.081 1.352 . . . . 64.12 111.319 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.87 85.12 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.754 2.302 . . . . 51.32 112.536 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -94.51 96.91 9.78 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.545 -1.28 . . . . 72.52 107.545 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 182' ' ' PHE . . . . . 0.446 ' HE1' ' HA ' ' A' ' 150' ' ' GLU . 10.9 p90 -78.4 65.56 3.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.354 1.062 . . . . 74.51 110.803 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 183' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' C' ' 133' ' ' PHE . 13.5 t -132.11 6.27 4.22 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.759 -1.11 . . . . 75.5 109.958 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -118.06 87.07 27.51 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 122.954 0.502 . . . . 74.32 110.014 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.16 154.93 19.32 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.427 2.084 . . . . 65.2 112.371 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.52 151.62 34.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.923 -1.14 . . . . 64.32 107.923 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 187' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' C' ' 128' ' ' LEU . 2.7 tt -80.78 134.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.663 0.385 . . . . 71.54 110.052 175.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.44 83.62 1.84 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.906 0.882 . . . . 44.34 109.326 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.16 95.73 4.33 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.734 -0.839 . . . . 74.54 108.734 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -68.36 105.96 2.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.903 0.881 . . . . 74.04 110.585 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 60.39 -124.41 35.77 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 124.1 0.875 . . . . 72.4 111.663 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 139.53 171.48 12.29 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.761 -0.536 . . . . 52.13 111.761 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 193' ' ' TYR . . . . . 0.523 ' HE2' ' HB1' ' F' ' 194' ' ' ALA . 53.7 t80 -146.78 160.52 42.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.494 -0.928 . . . . 70.4 108.494 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 194' ' ' ALA . . . . . 0.729 ' HB1' ' HG3' ' C' ' 124' ' ' PRO . . . -134.45 -78.9 0.46 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.037 0.535 . . . . 74.11 110.4 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -165.77 178.08 6.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.576 0.703 . . . . 74.24 111.894 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -109.65 121.74 45.9 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.321 1.448 . . . . 61.2 109.06 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.06 104.35 11.49 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.196 -0.668 . . . . 71.02 109.196 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.7 171.3 8.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.925 0.89 . . . . 61.22 109.702 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -90.16 8.59 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.32 0.648 . . . . 64.14 110.934 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -151.97 -131.09 1.69 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 109.985 -1.246 . . . . 51.21 109.985 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.84 -74.9 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.198 1.399 . . . . 65.31 110.057 -173.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -81.95 -172.82 4.13 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.31 1.044 . . . . 74.42 110.645 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -77.18 -145.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 106.982 -1.488 . . . . 72.51 106.982 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 204' ' ' ILE . . . . . 0.507 ' HA ' HG22 ' E' ' 207' ' ' VAL . 17.4 mm 55.96 32.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.444 1.116 . . . . 73.42 109.15 -170.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -73.81 -51.62 15.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.276 -1.329 . . . . 72.2 109.119 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -137.58 64.29 1.52 Allowed 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 73.13 109.118 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' E' ' 204' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 124.584 1.154 . . . . 74.34 109.808 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.784 0.326 . . . . 72.15 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.51 -61.3 1.77 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.812 -0.631 . . . . 24.42 112.124 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -78.83 124.77 28.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.174 0.59 . . . . 71.03 110.142 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 4.3 m -82.53 -63.12 1.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.388 1.075 . . . . 70.24 109.178 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.2 68.61 1.19 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 45.42 108.551 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 173' ' ' LEU . . . . . 0.741 HD23 ' H ' ' B' ' 54' ' ' ASP . 1.4 tm? -98.63 101.1 12.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.21 -1.359 . . . . 52.54 107.791 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 174' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' F' ' 174' ' ' MET . 0.0 OUTLIER -156.38 108.62 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.529 0.731 . . . . 73.3 109.174 174.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -158.83 121.71 3.7 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.019 0.528 . . . . 75.52 110.135 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.04 130.47 19.93 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.994 -1.854 . . . . 62.21 105.994 170.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.79 -71.27 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.559 0.537 . . . . 74.05 109.614 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 61.91 -71.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.096 1.359 . . . . 70.13 111.606 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -108.82 136.28 20.02 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 107.757 -1.201 . . . . 71.11 107.757 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.69 143.11 60.67 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 70.0 110.162 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.2 -57.81 11.24 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.253 -0.647 . . . . 74.23 109.253 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -148.01 143.71 27.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.622 1.169 . . . . 73.02 108.606 166.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 69.5 p -72.14 144.72 48.5 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.297 -0.631 . . . . 72.53 109.297 172.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 184' ' ' TRP . . . . . 0.524 ' CD1' HD11 ' F' ' 186' ' ' LEU . 8.3 t90 -142.65 65.02 16.39 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 122.63 0.372 . . . . 72.42 110.026 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -98.04 132.96 0.3 Allowed 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.762 2.975 . . . . 71.31 112.876 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 186' ' ' LEU . . . . . 0.647 ' HB2' HD21 ' B' ' 128' ' ' LEU . 0.8 OUTLIER -138.92 -165.1 1.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.086 0.555 . . . . 73.41 110.913 -175.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' F' F ' 187' ' ' ILE . . . . . 0.781 HG13 ' HB3' ' B' ' 42' ' ' LEU . 29.8 mm 69.53 134.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 127.041 2.136 . . . . 75.15 112.985 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.01 35.55 1.74 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.668 -0.696 . . . . 62.14 110.65 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.88 64.25 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.52 0.728 . . . . 15.4 111.963 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.08 -49.82 70.71 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.808 1.243 . . . . 64.11 110.897 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -95.59 10.81 68.82 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.87 -0.605 . . . . 62.22 112.941 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.22 87.26 0.32 Allowed Glycine 0 C--N 1.35 1.356 0 C-N-CA 123.216 0.436 . . . . 34.41 112.178 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -72.89 89.83 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.906 0.882 . . . . 73.35 109.69 -177.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 194' ' ' ALA . . . . . 0.523 ' HB1' ' HE2' ' E' ' 193' ' ' TYR . . . -170.71 -37.74 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.402 1.081 . . . . 63.31 108.69 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.32 108.01 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.994 -1.003 . . . . 72.21 110.173 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -159.55 155.68 26.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.641 1.176 . . . . 71.45 108.91 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -78.98 -42.48 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.815 0.446 . . . . 73.24 110.717 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -80.62 66.4 6.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.376 0.671 . . . . 65.51 111.058 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -166.67 -73.45 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.061 0.544 . . . . 74.21 109.812 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -136.94 84.52 0.25 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.896 -0.882 . . . . 73.24 110.896 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.96 117.1 9.37 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.77 0.828 . . . . 71.32 111.409 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -75.97 -29.0 58.1 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.863 0.84 . . . . 63.24 109.403 167.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.91 130.83 36.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 113.943 -1.48 . . . . 61.1 110.099 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.38 107.48 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 73.12 108.685 167.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -63.14 -38.97 93.28 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.063 -0.971 . . . . 72.23 109.72 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -159.85 159.91 33.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.251 1.021 . . . . 74.23 108.738 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.258 1.518 0 CA-C-O 118.11 -0.948 . . . . 70.51 109.604 175.124 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.607 -0.886 . . . . 75.41 108.607 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.86 -165.49 15.39 Favored Glycine 0 C--N 1.344 0.991 0 O-C-N 123.587 0.554 . . . . 74.54 113.587 173.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 170' ' ' LYS . . . . . 0.544 ' HG2' ' H ' ' G' ' 171' ' ' SER . 33.5 ttpt -177.07 -170.11 0.28 Allowed 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.445 1.498 . . . . 62.25 107.494 -172.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 171' ' ' SER . . . . . 0.544 ' H ' ' HG2' ' G' ' 170' ' ' LYS . 32.3 t 68.41 10.38 7.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.893 0.877 . . . . 61.44 111.932 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -165.87 -46.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.535 0.734 . . . . 53.34 109.353 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.47 125.41 21.93 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 124.107 0.88 . . . . 63.14 110.377 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 30.0 mmt 72.77 -71.41 0.14 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.089 1.756 . . . . 72.55 109.793 -173.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 175' ' ' PHE . . . . . 0.43 ' CD1' HD21 ' A' ' 98' ' ' LEU . 26.7 t80 -148.46 -86.36 0.09 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.966 -0.753 . . . . 71.02 108.966 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 14.4 m120 49.84 26.41 1.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.009 1.324 . . . . 53.33 113.282 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.5 109.78 4.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.473 0.709 . . . . 75.41 110.319 -172.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -139.46 134.98 33.07 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.67 -1.233 . . . . 64.14 107.67 177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 84.58 0.18 Allowed Pre-proline 0 CA--C 1.557 1.216 0 O-C-N 124.559 1.162 . . . . 74.04 109.513 -165.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.42 138.03 53.43 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.409 2.739 . . . . 74.05 112.607 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -72.19 95.16 1.63 Allowed 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.694 0.798 . . . . 72.42 109.219 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 68.86 -179.38 0.23 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.234 1.414 . . . . 75.12 111.26 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 76.8 p -109.87 -5.9 15.38 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.601 0.76 . . . . 63.45 111.048 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 67.61 100.91 0.04 OUTLIER Pre-proline 0 C--N 1.366 1.307 0 C-N-CA 125.115 1.366 . . . . 64.3 110.886 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.52 117.08 3.34 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.351 2.034 . . . . 74.02 111.457 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.16 -175.84 5.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.401 0.68 . . . . 63.13 110.27 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.99 146.59 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.489 0.716 . . . . 72.44 109.421 167.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -100.06 85.08 2.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.442 0.697 . . . . 50.53 109.539 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 189' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' H' ' 204' ' ' ILE . . . -86.36 108.02 18.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.415 -0.811 . . . . 65.12 109.631 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -146.64 174.69 11.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.412 0.685 . . . . 71.32 110.002 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 90.1 113.33 1.53 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.469 -1.052 . . . . 71.34 110.469 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -145.79 116.61 0.91 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.58 -0.566 . . . . 60.32 111.941 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -170.29 130.19 0.91 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.492 1.117 . . . . 65.15 108.849 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -156.54 171.58 20.05 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.448 0.699 . . . . 60.54 110.231 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 195' ' ' PHE . . . . . 0.484 ' HE2' ' HD3' ' A' ' 124' ' ' PRO . 25.8 m-85 60.65 -166.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.477 1.111 . . . . 64.14 111.269 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -136.79 92.91 2.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.817 0.847 . . . . 75.14 109.439 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -83.5 69.51 10.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.857 0.863 . . . . 73.41 108.875 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.76 -65.47 1.17 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.182 0.993 . . . . 75.52 108.72 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -169.4 141.58 2.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.417 1.087 . . . . 72.31 109.01 174.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 160.64 141.02 3.02 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.684 -0.566 . . . . 74.24 111.684 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.93 -39.55 5.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.448 0.699 . . . . 74.41 111.324 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 202' ' ' TYR . . . . . 0.437 ' OH ' HG22 ' D' ' 40' ' ' VAL . 37.3 t80 63.8 106.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.963 1.305 . . . . 74.52 108.396 -167.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.12 85.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 113.502 0.927 . . . . 74.03 113.502 -161.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mt -130.88 44.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 106.416 -1.698 . . . . 75.31 106.416 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -67.32 163.31 20.92 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.607 -1.179 . . . . 71.42 112.053 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -55.06 103.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.987 0.915 . . . . 60.24 111.471 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.797 1.639 . . . . 63.03 111.791 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 55.6 tptt . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.79 -0.448 . . . . 73.54 109.79 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 165.45 35.92 0.02 OUTLIER Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.445 -0.343 . . . . 42.34 113.29 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -95.16 152.95 17.9 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.685 -0.857 . . . . 71.42 108.685 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 40.2 m -75.19 76.02 2.33 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.932 0.893 . . . . 60.05 109.922 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 172' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' H' ' 176' ' ' ASN . . . -74.68 -38.97 62.27 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.672 -1.149 . . . . 63.4 110.823 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 72.11 -73.77 0.09 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.419 1.488 . . . . 64.43 111.201 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 25.2 mmt -91.51 75.56 5.91 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.602 0.761 . . . . 75.21 111.569 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 175' ' ' PHE . . . . . 0.452 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 49.8 t80 54.37 94.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.139 1.776 . . . . 73.24 113.779 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 176' ' ' ASN . . . . . 0.682 ' HB3' ' HB1' ' H' ' 172' ' ' ALA . 28.0 t-20 -171.62 98.83 0.19 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.954 0.902 . . . . 72.34 109.113 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.3 107.61 19.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.074 -1.454 . . . . 73.35 107.074 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -66.03 93.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.397 0.679 . . . . 72.34 110.796 -171.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . 0.315 1.2 mp0 34.99 -85.12 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.346 0 C-N-CA 127.857 2.463 . . . . 73.45 116.015 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.19 133.19 32.08 Favored 'Trans proline' 0 C--N 1.401 3.322 0 CA-C-N 124.036 2.477 . . . . 53.01 112.138 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -107.86 -79.19 0.58 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.468 -0.938 . . . . 73.14 108.468 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 15.4 t80 178.6 153.04 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.531 1.133 . . . . 61.11 108.312 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 15.2 t -78.12 148.15 34.31 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.567 0.747 . . . . 72.33 110.996 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 184' ' ' TRP . . . . . 0.53 ' HB2' HD13 ' H' ' 186' ' ' LEU . 0.1 OUTLIER -149.27 115.54 3.65 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 122.911 0.484 . . . . 50.45 111.768 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.74 -63.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.219 2.613 . . . . 65.21 111.907 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 186' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' H' ' 184' ' ' TRP . 10.2 mp 59.23 86.08 0.09 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.384 1.473 . . . . 63.4 112.803 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 187' ' ' ILE . . . . . 0.549 ' HB ' HD22 ' D' ' 42' ' ' LEU . 56.8 mt 64.97 108.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.767 1.627 . . . . 63.21 112.469 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -112.75 66.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.98 145.57 48.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.877 -1.056 . . . . 74.13 112.84 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.27 172.57 18.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.952 0.901 . . . . 75.45 110.309 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 191' ' ' GLY . . . . . 0.402 ' HA3' ' HG2' ' D' ' 37' ' ' GLN . . . -160.71 -152.3 6.53 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 111.241 -0.744 . . . . 75.1 111.241 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -135.23 -62.31 0.06 OUTLIER Glycine 0 C--N 1.351 1.388 0 CA-C-N 117.585 0.693 . . . . 55.21 112.73 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 193' ' ' TYR . . . . . 0.444 ' HE1' ' HB2' ' H' ' 196' ' ' LYS . 3.2 t80 -158.89 118.54 3.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.464 0.706 . . . . 75.42 109.129 -175.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.49 25.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.993 0.917 . . . . 75.3 110.338 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -122.22 23.57 9.78 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.18 0.992 . . . . 73.21 110.058 -168.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 196' ' ' LYS . . . . . 0.444 ' HB2' ' HE1' ' H' ' 193' ' ' TYR . 6.6 tmtm? -73.84 105.59 5.18 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.605 -0.725 . . . . 62.04 110.396 -171.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.2 179.34 7.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.048 0.939 . . . . 71.1 111.537 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.109 1.363 . . . . 60.42 111.834 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.85 1.55 52.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.136 -0.938 . . . . 74.5 110.433 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 80.59 -59.45 4.66 Favored Glycine 0 C--N 1.361 1.932 0 O-C-N 123.754 0.659 . . . . 52.22 111.455 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -110.19 118.9 37.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.919 1.288 . . . . 73.35 107.593 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 67.9 t80 179.63 89.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.286 -1.376 . . . . 75.55 107.286 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -132.58 96.42 3.83 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.174 0.59 . . . . 72.22 110.562 -169.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 204' ' ' ILE . . . . . 0.508 HD13 ' HB2' ' G' ' 189' ' ' ALA . 15.6 pt -142.9 112.32 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.466 1.107 . . . . 73.13 109.27 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 205' ' ' LYS . . . . . 0.778 ' HG2' ' HB ' ' C' ' 10' ' ' THR . 41.3 ttmt -147.16 -61.84 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.905 0.482 . . . . 73.23 110.906 -173.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.22 164.43 16.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.943 -0.571 . . . . 74.22 110.758 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.559 1.301 0 CA-C-O 117.962 -1.018 . . . . 73.14 109.885 -176.597 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 107.815 -1.18 . . . . 72.13 107.815 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -100.86 118.43 36.9 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.97 -0.752 . . . . 64.24 108.97 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.408 ' H ' HG22 ' A' ' 86' ' ' ILE . 52.3 tp60 -141.29 123.51 15.65 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.436 0.46 . . . . 62.42 110.908 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.47 128.9 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.66 -1.237 . . . . 71.14 107.66 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 85' ' ' SER . 86.8 mm-40 -97.29 -28.91 13.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.472 -0.775 . . . . 72.23 111.341 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -175.85 127.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 123.428 0.455 . . . . 73.12 111.182 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.795 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 65.1 mt -107.74 133.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.359 -0.978 . . . . 53.42 108.359 168.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' HE1' HG13 ' A' ' 83' ' ' ILE . 17.0 p90 -165.26 154.43 12.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.034 0.934 . . . . 75.22 110.139 -174.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -81.14 121.15 25.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.316 -0.624 . . . . 63.52 109.316 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.2 mtpt -88.45 -24.57 22.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.623 0.369 . . . . 74.41 111.146 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 13.8 t70 -153.52 143.71 22.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.424 0.631 . . . . 71.42 109.955 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.08 131.66 41.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 106.325 -1.731 . . . . 72.54 106.325 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.0 t -146.27 114.14 6.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.488 . . . . 71.33 109.684 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 88.8 t80 -116.11 120.33 38.7 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.242 -1.392 . . . . 74.53 107.242 172.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -119.95 130.8 54.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.365 -0.606 . . . . 73.51 109.365 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -140.84 76.03 23.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.844 -1.169 . . . . 73.03 107.844 172.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 -20.43 21.74 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.639 2.226 . . . . 72.05 112.028 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -110.63 25.24 11.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.981 0.912 . . . . 71.1 109.179 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.529 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.99 -49.69 89.96 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.536 0.734 . . . . 72.1 112.882 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 30.7 Cg_endo -68.8 -22.6 36.6 Favored 'Trans proline' 0 C--N 1.387 2.566 0 CA-C-N 121.293 1.498 . . . . 63.04 112.287 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -81.63 -20.54 39.47 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.971 1.309 . . . . 74.23 111.293 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 28' ' ' ALA . 4.0 p -64.52 -29.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.708 0.803 . . . . 61.34 111.592 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -62.7 -32.47 73.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.302 1.041 . . . . 74.44 111.597 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -72.26 -35.46 68.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.003 -0.999 . . . . 73.35 110.365 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 1.5 mmmp? -83.95 153.15 24.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.929 0.891 . . . . 74.01 110.808 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.06 144.69 32.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.383 0.673 . . . . 75.42 109.99 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -86.77 86.39 7.32 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.83 0.824 . . . . 74.41 110.247 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -131.96 82.63 59.02 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.951 -1.5 . . . . 74.32 106.951 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.62 127.42 7.21 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.635 2.223 . . . . 73.52 113.368 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 106.02 18.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.945 -1.502 . . . . 71.32 106.945 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.4 130.21 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 116.23 -0.441 . . . . 65.32 111.183 -171.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 59.9 mtpt -109.26 144.96 36.7 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 74.14 110.504 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD22 ' A' ' 128' ' ' LEU . 7.9 mp -126.01 112.27 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.691 -1.595 . . . . 71.33 107.603 171.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.633 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.1 m-20 -104.09 110.1 22.15 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.209 -1.404 . . . . 73.52 107.209 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.1 tp -96.52 127.32 42.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.185 -0.672 . . . . 74.12 109.185 -174.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.63 162.09 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.191 0.596 . . . . 73.2 109.815 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -149.51 164.59 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.962 0.905 . . . . 71.23 110.261 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . . . -148.68 154.13 39.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.634 1.174 . . . . 75.21 108.96 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 50.8 m -125.33 152.08 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.821 0.448 . . . . 73.34 110.264 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -150.14 138.59 20.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.953 0.901 . . . . 64.02 109.147 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -97.32 113.42 25.05 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.577 -0.527 . . . . 64.31 109.577 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.19 -32.03 17.65 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.815 -0.629 . . . . 71.33 110.538 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.61 -173.86 3.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.671 0.788 . . . . 64.54 110.549 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.71 115.8 5.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.52 0.728 . . . . 62.04 109.285 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 71.69 -6.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.103 1.361 . . . . 71.01 112.613 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 56.4 t -99.11 112.48 31.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 64.13 108.055 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -122.62 167.31 13.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.227 -0.897 . . . . 73.23 110.27 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 48' ' ' SER . 35.4 tt0 -131.67 125.65 32.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.894 -1.503 . . . . 71.52 108.004 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.8 113.88 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.586 -1.264 . . . . 61.12 107.586 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -100.35 127.3 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.403 0.681 . . . . 73.43 109.836 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -96.49 118.55 33.24 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.944 -1.132 . . . . 73.2 107.944 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -96.39 101.85 13.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.002 -0.74 . . . . 72.51 109.002 170.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 18.3 t -95.64 128.66 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 107.387 -1.338 . . . . 74.22 107.387 169.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.8 m -117.84 132.03 56.48 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.844 -0.798 . . . . 73.31 108.844 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 114' ' ' ILE . 54.9 t -126.83 109.52 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.689 1.196 . . . . 73.14 108.308 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 2.6 m -115.79 132.91 56.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.349 -0.611 . . . . 51.52 109.349 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.4 105.04 12.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.103 -1.444 . . . . 73.32 107.103 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -109.56 123.52 49.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.84 -0.43 . . . . 75.51 109.84 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.94 75.12 7.25 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.017 -1.105 . . . . 72.44 108.017 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.74 -105.52 1.96 Allowed Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.922 -0.871 . . . . 65.43 110.922 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.58 13.48 25.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.579 0.752 . . . . 73.44 110.693 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.611 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -120.31 114.08 21.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.533 -0.746 . . . . 72.45 109.76 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -73.46 132.09 42.54 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.46 1.027 . . . . 75.24 110.726 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.63 -54.14 4.73 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.318 1.047 . . . . 71.0 108.942 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -157.3 173.34 17.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.593 -1.185 . . . . 70.52 111.233 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -142.79 142.94 31.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.678 1.591 . . . . 63.22 107.555 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 34.1 m -143.74 99.56 3.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.158 0.583 . . . . 74.53 109.838 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 40.3 tt0 -109.14 121.47 45.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.077 0.551 . . . . 75.2 109.98 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 t -122.69 119.29 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.935 0.894 . . . . 51.22 109.355 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 46.0 mt-30 -85.58 91.91 8.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.523 -0.762 . . . . 74.34 109.125 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.11 97.5 10.35 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.207 -1.034 . . . . 75.11 108.207 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.74 144.16 18.06 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 112.173 -0.371 . . . . 72.45 112.173 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.62 125.43 3.0 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.281 -0.728 . . . . 65.34 111.281 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.423 HG13 ' HE1' ' A' ' 17' ' ' TYR . 47.2 mt -80.36 129.71 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.625 -0.88 . . . . 75.42 108.625 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.7 120.85 27.26 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.268 -1.012 . . . . 64.52 108.268 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB3' HE21 ' A' ' 14' ' ' GLN . 33.5 t -105.39 94.22 5.1 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.437 -0.949 . . . . 74.13 108.437 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 12' ' ' GLN . 1.5 pp -134.93 165.06 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.381 1.073 . . . . 64.34 108.4 -170.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.36 178.85 8.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.191 0.596 . . . . 72.04 111.073 170.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.86 67.66 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.739 -0.664 . . . . 71.23 114.522 170.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -113.6 147.71 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.203 0.601 . . . . 73.2 111.624 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -157.79 -170.25 3.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.98 1.312 . . . . 73.52 110.573 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 73.86 -149.41 41.31 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.996 0.808 . . . . 74.01 114.722 175.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.9 p -83.31 -23.43 32.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.577 1.151 . . . . 71.32 111.261 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -71.39 -35.45 71.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.488 1.115 . . . . 74.24 110.648 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 27.7 ptm -62.24 -39.6 93.37 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.199 0.312 . . . . 72.44 110.3 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.5 94.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.48 0.712 . . . . 71.44 110.569 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -57.99 -45.67 86.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.923 0.889 . . . . 73.4 111.488 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.43 -54.27 7.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.315 -0.402 . . . . 74.25 111.334 -173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.0 -23.97 65.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.513 0.597 . . . . 72.44 111.449 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.85 -21.1 48.08 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-O 119.596 -0.558 . . . . 62.31 113.827 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -136.56 -54.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.654 0.727 . . . . 72.13 112.746 -173.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -72.81 -48.94 33.69 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.727 0.811 . . . . 73.45 112.475 -167.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.91 -46.8 75.13 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.258 1.023 . . . . 70.41 112.072 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.58 -20.82 40.51 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.588 1.525 . . . . 75.1 113.119 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 40.4 t-20 -67.85 -36.06 79.64 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.871 0.469 . . . . 73.11 109.829 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.0 mm -56.26 -43.18 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.677 0.791 . . . . 73.13 110.393 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 82' ' ' GLY . 53.3 mt -81.46 -21.85 38.49 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.995 -1.002 . . . . 61.24 111.527 -172.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.411 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 29.3 t80 -66.14 -39.43 28.56 Favored Pre-proline 0 CA--C 1.56 1.35 0 N-CA-C 114.696 1.369 . . . . 73.01 114.696 -167.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HB3' HD13 ' C' ' 105' ' ' ILE . 12.2 Cg_endo -57.13 -40.05 86.14 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 121.878 1.718 . . . . 63.4 112.525 172.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.43 -35.38 63.37 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.552 0.741 . . . . 70.11 110.957 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.81 64.67 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.119 0.568 . . . . 72.01 110.153 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.8 ttm105 -51.41 -51.4 55.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.787 1.235 . . . . 71.2 110.333 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.82 -48.41 80.73 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.456 1.097 . . . . 72.13 111.362 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.413 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.1 t -54.18 -45.78 72.21 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.375 1.047 . . . . 72.5 110.698 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.663 HG21 HG21 ' A' ' 64' ' ' VAL . 9.0 mt -64.29 -53.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.051 -0.977 . . . . 53.31 110.901 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 125' ' ' GLN . 66.1 m -53.22 -39.57 63.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 72.42 111.371 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -71.4 -42.11 68.77 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.192 -0.913 . . . . 75.54 109.807 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.9 mtp -57.79 -41.94 83.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.826 0.85 . . . . 70.31 111.215 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.5 t -61.02 -50.19 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.415 1.086 . . . . 74.04 110.387 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 82.2 p -72.1 -27.18 62.48 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.734 -0.666 . . . . 73.5 111.784 -175.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.531 HH12 ' HG3' ' B' ' 112' ' ' GLU . 76.8 mtt-85 -73.11 -24.74 60.66 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.442 0.697 . . . . 65.42 110.335 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.41 14.83 48.94 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-O 119.833 -0.426 . . . . 60.45 113.133 171.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.489 HG22 HH21 ' B' ' 15' ' ' ARG . 1.8 t 62.83 15.21 8.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 127.331 2.252 . . . . 73.42 113.42 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -91.91 157.75 40.86 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.319 0.648 . . . . 71.03 109.855 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.22 151.99 76.35 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.68 2.253 . . . . 75.44 111.977 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.493 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.1 tt0 -57.46 137.21 56.47 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.487 0.492 . . . . 55.2 110.818 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.4 tp -117.07 112.61 21.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.027 -0.988 . . . . 53.41 108.667 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.71 102.37 14.11 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.125 -1.065 . . . . 73.24 108.125 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.457 HD22 HD21 ' A' ' 42' ' ' LEU . 61.1 mt -71.35 117.98 13.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.05 -0.722 . . . . 75.45 109.05 177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.48 128.84 94.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.285 0.366 . . . . 71.13 110.605 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HB3' HH22 ' A' ' 111' ' ' ARG . 57.9 Cg_endo -72.9 136.97 26.04 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 121.833 1.688 . . . . 44.43 110.584 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 39.7 t -97.88 113.7 33.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.23 -1.396 . . . . 62.11 107.23 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.89 63.94 8.35 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.887 1.327 . . . . 73.13 109.215 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 113.822 -1.536 . . . . 75.31 110.064 179.354 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.248 0.991 0 N-CA-C 109.566 -0.531 . . . . 72.52 109.566 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 41.3 t80 -137.33 153.92 50.16 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.735 0.814 . . . . 63.02 108.916 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.635 ' HA ' HE21 ' B' ' 12' ' ' GLN . 0.0 OUTLIER -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.424 0.69 . . . . 71.23 111.381 170.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tp -86.95 133.77 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.019 0.528 . . . . 45.21 109.699 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -101.64 -37.85 8.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.869 0.468 . . . . 65.33 109.841 170.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.489 HH21 HG22 ' A' ' 122' ' ' THR . 68.2 ttt180 -167.36 137.51 2.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.678 0.391 . . . . 73.51 111.006 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.81 141.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.653 -1.61 . . . . 70.31 106.653 169.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -172.06 144.17 1.64 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.961 0.41 . . . . 74.45 111.701 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.599 HG21 HD11 ' B' ' 21' ' ' ILE . 16.4 m -76.07 128.18 34.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.534 -0.913 . . . . 54.51 108.534 170.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.48 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 42.1 mtpt -98.4 -40.99 8.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.502 0.721 . . . . 72.02 109.564 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 30.7 t70 -138.77 143.27 38.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.34 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.599 HD11 HG21 ' B' ' 18' ' ' THR . 34.7 mm -131.32 142.88 42.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 125.309 1.443 . . . . 73.03 107.758 170.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.7 m -144.4 129.09 18.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.825 -1.08 . . . . 61.01 108.798 168.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 75.0 t80 -138.79 106.7 5.67 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.125 -2.176 . . . . 75.41 105.125 164.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -119.64 108.55 14.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.205 -1.406 . . . . 73.11 107.205 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.497 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.04 89.26 6.44 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.561 1.144 . . . . 75.2 108.461 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.75 -44.2 6.14 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.714 2.276 . . . . 74.54 111.695 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 41.0 m-80 -105.98 32.17 4.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.349 1.059 . . . . 53.34 109.414 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.497 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.19 -46.42 55.69 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 125.022 1.329 . . . . 74.23 113.929 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 38.4 Cg_endo -69.89 -23.15 30.53 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 121.56 1.507 . . . . 54.23 113.32 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 0.3 OUTLIER -78.63 -2.77 40.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.408 0.683 . . . . 74.05 111.415 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.82 -20.96 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.115 0.566 . . . . 74.23 110.593 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -84.36 -21.48 30.88 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.709 0.803 . . . . 63.41 110.422 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -87.83 -22.84 24.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.408 0.683 . . . . 72.45 111.659 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -107.04 99.88 9.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.976 0.91 . . . . 74.15 111.09 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.02 76.55 8.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.579 0.752 . . . . 74.12 109.359 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 t90 179.88 159.04 0.75 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.106 0.962 . . . . 72.4 109.667 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.56 137.81 85.98 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.081 0.953 . . . . 71.4 112.066 175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.68 141.0 48.56 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.376 1.384 . . . . 73.42 110.271 163.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 44.6 mm-40 -75.21 99.24 3.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.247 -1.02 . . . . 75.25 108.247 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.403 ' HB ' ' HG ' ' B' ' 126' ' ' LEU . 14.1 t -97.57 118.21 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.763 -1.199 . . . . 72.11 107.763 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 134.29 46.41 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.666 -1.235 . . . . 72.22 107.666 -165.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.534 HD23 HD22 ' B' ' 128' ' ' LEU . 1.8 pp -86.67 162.49 17.89 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.086 0.773 . . . . 71.33 113.086 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.0 m-20 -146.94 131.75 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.002 -1.481 . . . . 71.44 107.002 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.13 142.83 34.22 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.229 -1.026 . . . . 42.33 108.229 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -145.11 140.31 27.94 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.305 -0.628 . . . . 73.31 109.305 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 48.3 m -108.93 111.43 23.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.512 0.725 . . . . 62.04 109.886 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.48 128.65 47.27 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 107.813 -1.181 . . . . 72.12 107.813 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.8 m -142.7 165.37 27.56 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.853 -0.529 . . . . 72.04 110.075 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.3 p -152.61 159.52 43.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 72.04 109.499 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -106.54 121.27 43.97 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.688 0.795 . . . . 75.31 109.5 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 85.5 mt -82.99 -43.1 16.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.251 0.62 . . . . 53.41 110.095 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -158.53 -177.07 6.27 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.381 -0.827 . . . . 71.42 111.019 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.23 112.54 5.87 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 113.76 -1.564 . . . . 72.35 109.096 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 73.61 8.26 5.02 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.924 1.29 . . . . 52.4 112.584 -176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 48.5 t -119.34 96.08 4.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.988 0.915 . . . . 72.21 108.635 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -99.21 169.61 9.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.713 0.768 . . . . 71.35 110.964 175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.436 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.5 tm-20 -142.7 96.77 2.99 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.581 -1.637 . . . . 74.1 106.581 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 79.1 t -94.86 122.58 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.194 -0.669 . . . . 75.13 109.194 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 32.5 t -103.44 118.91 51.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.309 -0.86 . . . . 73.22 109.226 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.479 HD22 HG23 ' B' ' 62' ' ' VAL . 1.9 tt -92.03 112.33 24.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.263 -1.384 . . . . 70.33 107.263 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -104.17 111.79 24.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.463 -0.79 . . . . 73.15 109.655 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' B' ' 114' ' ' ILE . 67.1 t -105.4 112.42 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.941 -1.133 . . . . 74.12 107.941 170.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 8.8 m -98.44 152.08 19.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.801 -0.815 . . . . 73.55 108.801 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.562 HG21 HG21 ' B' ' 114' ' ' ILE . 84.9 t -141.6 126.49 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.422 1.089 . . . . 71.03 108.326 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -114.26 135.32 54.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.666 0.786 . . . . 51.34 109.388 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.28 146.18 44.39 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.081 0.552 . . . . 61.23 110.231 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -149.87 129.87 13.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.27 0.557 . . . . 72.33 112.255 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 65.7 mt -95.15 104.84 16.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.727 1.211 . . . . 72.54 109.605 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.05 -110.1 3.28 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.702 0.626 . . . . 74.43 113.047 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.7 3.57 37.16 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.106 1.362 . . . . 71.21 109.62 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.29 154.24 39.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.125 0.97 . . . . 61.32 109.879 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -73.53 137.88 44.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.13 0.572 . . . . 61.42 109.931 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.657 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.73 -61.98 1.48 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.784 0.834 . . . . 72.54 108.869 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.26 166.78 32.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.984 -1.462 . . . . 74.41 109.501 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.13 111.12 6.31 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.846 -1.539 . . . . 51.21 106.846 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -116.7 158.69 23.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.043 -0.725 . . . . 73.42 109.043 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -166.26 127.63 1.8 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.092 -1.077 . . . . 75.01 108.092 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.74 142.6 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.782 -0.451 . . . . 75.31 109.782 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -120.38 95.99 4.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.126 -0.943 . . . . 73.21 109.361 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -86.59 103.67 15.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.097 -0.956 . . . . 73.32 109.251 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.13 159.48 28.83 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 111.598 -0.601 . . . . 71.45 111.598 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.17 127.42 1.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.75 -0.94 . . . . 73.31 110.75 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.4 mt -85.41 113.2 23.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.609 -0.886 . . . . 73.43 108.609 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -118.82 133.74 55.63 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.177 -0.675 . . . . 75.24 109.177 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -93.49 110.29 21.87 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.108 -1.071 . . . . 71.12 108.108 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.632 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -121.19 134.68 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.306 0.642 . . . . 75.41 109.74 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.87 33.68 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.152 0.981 . . . . 42.35 108.986 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.31 -44.98 3.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 122.863 0.268 . . . . 64.53 113.261 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.1 136.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.918 0.887 . . . . 64.24 111.655 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.551 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 10.8 pt-20 -151.67 146.97 26.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.744 0.418 . . . . 74.2 110.561 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.23 -105.83 0.79 Allowed Glycine 0 C--N 1.35 1.334 0 O-C-N 124.037 0.835 . . . . 74.21 113.469 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.1 m -79.65 -31.72 41.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.923 0.889 . . . . 72.13 110.846 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.551 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 21.1 mt-30 -60.88 -48.74 80.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.315 0.646 . . . . 63.22 110.107 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.452 ' HA ' ' SG ' ' B' ' 97' ' ' CYS . 10.3 ptm -72.82 -36.85 67.61 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.158 -0.928 . . . . 64.12 110.137 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.73 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.066 0.546 . . . . 72.53 111.286 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -75.27 -35.84 61.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.096 0.958 . . . . 72.53 111.139 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' B' ' 94' ' ' MET . 27.3 p -78.66 -56.91 4.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 110.466 -0.198 . . . . 75.21 110.466 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.6 -22.75 64.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.249 0.62 . . . . 70.04 111.49 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.38 -0.39 40.6 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.246 -0.752 . . . . 23.41 114.584 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.95 -49.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.384 1.092 . . . . 75.2 112.319 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -72.22 -58.5 3.36 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.69 0.396 . . . . 75.45 111.193 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.06 -45.97 99.72 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 124.009 0.923 . . . . 62.04 111.956 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.72 -54.89 4.69 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.145 1.897 . . . . 52.41 112.349 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -63.56 -14.78 54.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.803 1.038 . . . . 60.12 113.803 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 75.4 mt -78.65 -48.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.738 -0.467 . . . . 63.21 109.738 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.01 -20.7 48.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.215 1.006 . . . . 60.35 111.785 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.87 -44.78 80.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.503 1.521 . . . . 72.32 112.517 -171.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.473 ' HA ' HH11 ' B' ' 111' ' ' ARG . 35.1 Cg_exo -56.69 -39.78 88.97 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 121.984 1.789 . . . . 72.31 112.94 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.8 m-85 -69.21 -41.62 76.84 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.138 0.575 . . . . 74.22 110.94 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.6 87.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.783 0.433 . . . . 71.33 110.121 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.473 HH11 ' HA ' ' B' ' 108' ' ' PRO . 28.9 mtp-105 -52.84 -63.41 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.778 1.231 . . . . 65.15 110.743 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.531 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.7 tp10 -55.28 -37.42 67.29 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.728 1.211 . . . . 63.32 111.493 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.538 ' O ' ' HG2' ' B' ' 117' ' ' MET . 2.0 t -72.57 -46.4 54.58 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 119.642 -0.218 . . . . 61.04 110.965 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.562 HG21 HG21 ' B' ' 64' ' ' VAL . 83.4 mt -60.02 -57.27 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.625 0.77 . . . . 55.33 110.668 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.466 HG23 ' H ' ' B' ' 126' ' ' LEU . 5.9 m -60.24 -28.19 67.82 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.123 0.889 . . . . 71.44 110.744 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.9 t -68.69 -53.12 24.13 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.476 0.711 . . . . 65.55 110.821 171.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.5 mmt -61.85 -37.69 85.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.004 0.522 . . . . 53.53 111.318 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.14 -49.46 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.859 1.264 . . . . 52.15 110.438 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.499 ' HB2' ' HA ' ' C' ' 126' ' ' LEU . 87.4 p -73.69 -22.99 59.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 64.14 112.258 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.8 mtt-85 -65.21 -32.37 74.01 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.472 0.709 . . . . 72.51 110.523 175.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 17.23 35.09 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.569 -0.741 . . . . 50.34 112.474 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 60.93 35.96 18.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.452 1.901 . . . . 73.5 112.648 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.32 159.37 29.52 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 124.24 1.016 . . . . 75.11 109.555 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.81 -175.06 2.49 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.948 2.432 . . . . 41.04 115.408 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.487 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 1.0 OUTLIER -65.58 133.43 51.16 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.971 1.308 . . . . 62.01 112.743 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.466 ' H ' HG23 ' B' ' 115' ' ' THR . 0.2 OUTLIER -153.72 86.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.199 -1.037 . . . . 63.33 108.199 163.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -102.62 136.89 41.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.643 -1.243 . . . . 73.53 107.643 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.534 HD22 HD23 ' B' ' 42' ' ' LEU . 10.8 mt -74.9 125.07 28.06 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.679 -0.489 . . . . 72.55 109.679 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -71.01 137.58 84.88 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.054 0.542 . . . . 73.11 110.7 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 12.8 Cg_exo -72.42 143.48 38.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.591 2.861 . . . . 74.1 113.138 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.53 128.35 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.259 0.624 . . . . 75.24 109.464 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.566 HD21 HG13 ' D' ' 105' ' ' ILE . 5.2 m-20 -83.62 81.59 8.68 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.167 0.587 . . . . 73.54 109.82 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 N--CA 1.471 0.583 0 CA-C-N 115.192 -0.913 . . . . 74.21 111.322 175.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.245 0.854 0 N-CA-C 107.455 -1.313 . . . . 74.11 107.455 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.661 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 53.3 t80 -98.64 127.1 44.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.797 -0.816 . . . . 74.23 108.797 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -138.2 126.57 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.618 -0.512 . . . . 62.14 109.618 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -80.75 140.31 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.047 0.939 . . . . 72.51 109.004 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.463 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -111.55 -51.44 2.86 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.913 0.387 . . . . 71.42 110.218 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 50.2 ttt180 -167.88 140.53 3.16 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.536 -0.756 . . . . 73.43 109.445 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mt -122.27 146.95 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.316 -0.994 . . . . 63.05 108.316 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.565 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 24.5 p90 -175.65 158.27 2.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.275 0.559 . . . . 73.43 111.284 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -77.16 118.54 19.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.2 -0.909 . . . . 74.34 109.153 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -77.46 -47.72 18.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.423 -0.955 . . . . 72.23 108.423 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -137.3 137.33 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.207 -1.361 . . . . 73.42 109.054 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.7 mt -134.68 145.45 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.969 -1.493 . . . . 72.1 106.969 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -159.37 150.23 19.64 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.223 0.535 . . . . 73.54 109.918 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -139.47 122.67 16.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.875 -1.157 . . . . 71.21 107.875 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.62 111.07 18.69 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.818 0.847 . . . . 71.05 109.182 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.44 84.06 60.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.201 -1.407 . . . . 52.22 107.201 167.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.49 -31.8 60.53 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.927 2.418 . . . . 71.22 111.892 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.484 ' O ' HG13 ' C' ' 31' ' ' VAL . 66.7 m-20 -96.89 24.96 5.66 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.342 1.057 . . . . 53.11 110.456 -176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.408 ' O ' HG22 ' C' ' 31' ' ' VAL . . . -54.96 -42.74 97.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 115.26 1.578 . . . . 72.11 115.26 -169.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -68.41 -41.97 5.95 Favored 'Trans proline' 0 C--N 1.384 2.44 0 CA-C-N 121.478 1.563 . . . . 64.43 112.082 169.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -64.02 -23.04 67.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.615 1.566 . . . . 73.03 113.131 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.544 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 15.8 m -57.63 -17.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.6 0.963 . . . . 64.53 113.6 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -59.66 -22.81 62.44 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.503 1.121 . . . . 71.52 112.436 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.6 22.53 5.92 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.428 0.529 . . . . 73.21 112.428 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -88.21 172.71 9.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.87 0.843 . . . . 74.33 111.337 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.416 ' O ' HD22 ' C' ' 68' ' ' LEU . 34.8 t70 -91.59 134.74 34.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.148 -1.387 . . . . 75.42 109.535 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -89.31 81.93 6.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.216 0.607 . . . . 73.32 111.33 172.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -159.1 69.66 3.4 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.133 0.573 . . . . 72.55 109.896 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' C' ' 67' ' ' SER . 42.1 Cg_endo -91.45 157.58 3.65 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.729 2.286 . . . . 75.32 113.368 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.92 76.77 7.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.078 -1.419 . . . . 65.01 108.798 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 m -73.39 96.35 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 122.141 0.972 . . . . 72.12 110.091 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 14.5 ptmm? -128.71 137.86 51.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.382 -1.281 . . . . 60.14 110.458 -173.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.92 139.47 36.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.833 0.853 . . . . 64.32 109.896 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -120.25 106.65 12.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.377 0.671 . . . . 72.13 109.77 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.94 108.96 19.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.402 0.681 . . . . 63.21 109.503 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -113.74 129.48 56.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.004 1.322 . . . . 74.11 108.116 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 36.3 m -111.38 116.92 31.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.988 0.515 . . . . 64.43 110.712 -167.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.11 162.85 27.88 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.336 1.054 . . . . 70.21 109.423 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.0 m -148.56 165.8 30.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.133 0.973 . . . . 63.11 109.641 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -154.65 131.92 11.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.518 0.727 . . . . 74.31 109.511 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.34 120.03 19.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.149 0.579 . . . . 43.11 110.271 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' C' ' 57' ' ' GLU . 57.0 mt -94.2 -37.18 11.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.132 0.573 . . . . 60.22 109.508 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.07 -171.42 2.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.102 -0.954 . . . . 71.35 110.277 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.43 123.31 25.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.129 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 68.18 1.26 2.75 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.791 1.236 . . . . 61.11 112.906 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.98 112.71 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.067 -1.086 . . . . 74.41 108.067 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.37 133.9 43.04 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.91 -0.774 . . . . 74.31 108.91 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.621 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.7 tt0 -93.26 117.64 30.31 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.768 0.827 . . . . 70.43 109.77 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.37 118.27 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.144 -1.058 . . . . 73.43 108.144 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.35 106.44 20.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.165 -1.05 . . . . 64.42 108.165 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -99.67 109.69 22.15 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.096 -1.076 . . . . 74.21 108.096 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 31.1 ttm180 -81.24 110.2 16.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.889 0.875 . . . . 64.32 108.952 174.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 t -100.02 130.08 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.41 -1.33 . . . . 62.12 107.41 169.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -129.16 117.07 20.18 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.414 -0.587 . . . . 65.34 109.414 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.563 HG23 HD13 ' C' ' 114' ' ' ILE . 60.0 t -101.09 112.07 32.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.427 -0.953 . . . . 74.0 108.427 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.433 HG23 HD23 ' C' ' 75' ' ' LEU . 5.0 m -99.4 146.62 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.363 -0.835 . . . . 64.23 109.039 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.89 110.93 6.28 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 22.3 m -135.41 140.05 44.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.913 0.485 . . . . 21.21 110.438 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.722 HD12 ' HG3' ' C' ' 71' ' ' GLU . 6.5 mt -111.02 14.07 21.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.657 1.183 . . . . 71.24 110.667 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.86 -104.54 0.93 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.598 -1.001 . . . . 54.33 110.598 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -93.06 -33.01 14.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.437 0.695 . . . . 73.44 109.316 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.722 ' HG3' HD12 ' C' ' 68' ' ' LEU . 3.8 tp10 -76.84 119.75 21.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.199 1.4 . . . . 74.23 109.137 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -86.29 134.1 33.77 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.029 -0.73 . . . . 64.1 109.029 174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -75.08 -58.24 3.4 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.485 -0.561 . . . . 74.14 109.485 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.84 175.27 3.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.137 -0.938 . . . . 72.13 110.652 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.433 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -141.77 143.11 33.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.732 -1.581 . . . . 74.43 106.732 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.8 t -145.72 143.18 29.6 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.451 -0.944 . . . . 72.55 108.451 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -150.99 130.4 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.81 0.444 . . . . 74.45 109.979 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.98 115.07 23.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.291 1.036 . . . . 71.02 108.527 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 62.4 mt-30 -90.98 92.34 8.71 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.161 -1.051 . . . . 63.31 108.161 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.533 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -81.38 110.96 17.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.737 -1.12 . . . . 64.53 110.004 -176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.6 146.08 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.782 -0.527 . . . . 61.3 111.782 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.62 120.42 1.57 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.889 -0.885 . . . . 64.53 110.889 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.478 HD12 HD11 ' C' ' 51' ' ' LEU . 11.0 mm -81.28 122.06 35.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.25 -1.018 . . . . 55.54 108.25 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -132.16 120.92 22.92 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.597 -0.89 . . . . 73.02 108.597 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.8 t -89.67 109.55 20.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.398 -0.964 . . . . 65.1 108.398 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -131.49 148.09 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.455 0.702 . . . . 75.34 111.036 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.8 152.75 9.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.796 1.238 . . . . 73.15 108.818 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.95 -16.38 58.65 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.967 -0.352 . . . . 74.33 113.176 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 42.4 pt . . . . . 0 CA--C 1.549 0.906 0 C-N-CA 123.95 0.9 . . . . 65.45 110.325 178.321 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 119.943 -0.075 . . . . 72.13 111.161 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.425 ' HG3' ' N ' ' C' ' 95' ' ' ALA . 10.4 ptp -64.36 -48.02 77.11 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.295 0.372 . . . . 74.33 110.259 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' C' ' 94' ' ' MET . . . -71.29 -25.15 62.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.63 0.772 . . . . 60.11 111.195 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -79.22 -29.79 42.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 60.33 110.108 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -80.51 -66.77 0.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 116.577 -0.283 . . . . 63.42 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -3.78 58.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.766 -0.584 . . . . 50.34 112.259 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.81 9.28 25.6 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.894 -0.392 . . . . 44.02 113.791 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.29 -59.45 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.06 0.544 . . . . 64.53 110.207 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.403 ' O ' HG12 ' C' ' 105' ' ' ILE . 81.0 t80 -66.55 -54.53 22.63 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.721 0.808 . . . . 33.42 112.565 -171.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.661 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 20.7 m -62.76 -45.84 88.03 Favored Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 123.594 0.758 . . . . 44.32 111.505 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.6 Cg_exo -57.64 -32.07 93.56 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.067 1.844 . . . . 64.21 113.752 168.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' C' ' 108' ' ' PRO . 25.9 t-20 -74.83 -23.55 58.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.544 0.738 . . . . 64.52 110.822 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 108' ' ' PRO . 46.0 mm -69.96 -33.26 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.196 0.598 . . . . 73.55 109.41 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' C' ' 82' ' ' GLY . 80.5 mt -88.26 -23.66 23.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.132 0.973 . . . . 63.53 111.951 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.55 -49.39 91.3 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.455 1.102 . . . . 73.33 113.339 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' C' ' 104' ' ' ASN . 16.0 Cg_exo -65.69 -38.57 23.84 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.979 1.786 . . . . 73.42 112.152 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -61.76 -49.5 76.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.777 0.831 . . . . 74.02 111.197 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.84 -42.41 94.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.031 -0.986 . . . . 74.52 110.607 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.503 HH12 ' HG3' ' C' ' 130' ' ' PRO . 57.0 ttp180 -61.56 -42.44 98.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.554 1.142 . . . . 70.14 109.953 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.55 -35.89 65.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.721 0.809 . . . . 74.52 109.929 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.489 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 40.7 t -69.19 -29.85 67.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.637 0.375 . . . . 71.25 111.174 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.563 HD13 HG23 ' C' ' 64' ' ' VAL . 66.3 mt -72.28 -47.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 61.41 109.539 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -56.73 -31.99 65.1 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.382 1.073 . . . . 51.31 111.283 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -64.82 -56.5 13.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.578 1.151 . . . . 53.4 109.662 174.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.81 -38.07 77.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.603 1.161 . . . . 72.05 112.581 -177.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.7 t -69.83 -40.02 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.176 0.591 . . . . 65.42 110.252 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.543 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 34.1 t -62.93 -38.12 89.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.452 0.644 . . . . 73.41 110.628 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 51.0 mtt-85 -67.07 -37.51 84.13 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 114.534 -1.212 . . . . 72.1 110.404 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 7.2 57.2 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 123.637 0.586 . . . . 61.23 113.248 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 60.57 26.78 16.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 126.38 1.872 . . . . 44.44 113.168 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.481 ' HB2' HG13 ' C' ' 118' ' ' VAL . 67.2 m-85 -97.73 156.02 36.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 123.283 0.633 . . . . 63.1 109.632 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.85 78.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.747 2.965 . . . . 71.55 114.405 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.543 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 0.0 OUTLIER -65.63 155.16 36.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.518 1.127 . . . . 62.42 112.497 173.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 119' ' ' SER . 2.0 pt? -168.13 162.16 12.86 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.111 -1.404 . . . . 75.21 108.934 165.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -88.22 100.79 13.25 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.455 -1.683 . . . . 73.25 106.455 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.04 149.81 35.73 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 124.48 1.112 . . . . 64.43 111.124 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.73 122.48 16.54 Favored Pre-proline 0 CA--C 1.551 1.014 0 O-C-N 124.841 1.338 . . . . 71.24 111.853 -175.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.795 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 71.9 Cg_exo -52.68 120.6 7.78 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.552 2.835 . . . . 72.21 112.846 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.5 m -77.48 91.42 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.037 0.922 . . . . 63.45 109.712 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -77.01 82.61 3.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.176 -0.92 . . . . 72.42 110.693 -173.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 t80 . . . . . 0 N--CA 1.476 0.851 0 CA-C-N 115.034 -0.985 . . . . 71.14 111.054 178.855 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.241 0.614 0 N-CA-C 108.503 -0.925 . . . . 64.14 108.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -154.61 98.12 2.05 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -112.56 143.05 44.37 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.476 -0.935 . . . . 73.24 108.476 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.7 tt -104.38 101.47 12.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.994 -1.113 . . . . 71.41 107.994 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.54 -46.6 31.13 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.894 -0.593 . . . . 75.12 111.808 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.464 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 32.4 ttt180 -170.68 126.68 0.74 Allowed 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.167 0.292 . . . . 72.31 111.067 -167.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.95 123.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.581 0.752 . . . . 72.21 109.002 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.464 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 15.8 p90 -147.29 160.69 42.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.675 0.79 . . . . 74.11 111.724 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -91.53 122.42 34.1 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.12 -0.946 . . . . 70.0 108.828 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -86.46 -45.56 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.636 -0.876 . . . . 72.53 108.636 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -130.75 133.84 46.37 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 113.692 -1.594 . . . . 74.12 109.082 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.551 HD13 ' HE3' ' C' ' 117' ' ' MET . 83.0 mt -134.29 145.55 32.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.603 -1.258 . . . . 74.3 107.603 170.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -148.84 144.64 27.06 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.715 0.806 . . . . 75.12 109.393 171.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.575 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -146.04 132.2 19.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.146 -1.798 . . . . 74.44 106.146 170.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.49 134.18 43.16 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.055 -1.091 . . . . 75.24 108.055 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.63 89.6 48.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.738 -1.208 . . . . 74.42 107.738 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.39 -51.92 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.053 2.502 . . . . 71.35 112.974 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -96.7 38.91 1.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.494 -0.928 . . . . 73.13 108.494 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.565 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.84 -52.58 63.44 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 115.329 1.603 . . . . 72.41 115.329 -164.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.98 -15.8 7.86 Favored 'Trans proline' 0 C--N 1.388 2.607 0 CA-C-N 121.302 1.501 . . . . 64.51 113.534 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -69.56 -38.96 77.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.659 1.183 . . . . 64.14 109.119 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 t -68.97 -29.57 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 125.426 1.491 . . . . 74.24 110.836 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.423 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 49.8 t80 -63.16 -36.02 82.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.137 0.575 . . . . 75.14 110.84 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.47 -1.83 56.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.984 0.914 . . . . 73.43 111.566 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -119.8 78.4 1.32 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.953 0.901 . . . . 71.3 109.407 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -80.81 85.93 6.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.154 0.582 . . . . 74.42 112.388 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -139.85 177.34 8.03 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.371 1.069 . . . . 74.25 108.759 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -87.18 119.11 70.8 Favored Pre-proline 0 CA--C 1.554 1.128 0 O-C-N 121.985 -0.447 . . . . 72.52 110.16 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.27 113.4 2.85 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.854 2.369 . . . . 64.14 112.255 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.19 114.03 12.07 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.835 -0.802 . . . . 74.13 108.835 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' D' ' 66' ' ' ALA . 31.5 m -99.76 134.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.834 0.854 . . . . 63.24 110.934 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 39.5 mmtm -97.12 110.8 23.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.453 -0.944 . . . . 71.35 108.453 171.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.573 ' HG ' HD11 ' D' ' 128' ' ' LEU . 1.8 mm? -97.14 115.43 27.52 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.041 -1.096 . . . . 62.52 108.041 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.81 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -107.24 119.53 39.65 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.434 -0.95 . . . . 71.02 108.434 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.9 129.45 41.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.041 -0.725 . . . . 60.52 109.041 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.9 t70 -152.44 151.11 30.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 64.3 108.595 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -133.22 163.03 30.2 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.51 0.724 . . . . 70.42 110.047 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.2 166.97 28.27 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 74.04 109.652 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -152.2 154.25 35.43 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.105 0.562 . . . . 63.21 110.444 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -157.22 119.03 3.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.193 0.997 . . . . 71.13 108.859 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -70.85 128.22 35.26 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.688 0.395 . . . . 63.04 110.211 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.5 mt -103.57 -29.1 11.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.318 0.647 . . . . 63.3 110.166 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -165.8 -176.63 3.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.297 1.039 . . . . 72.55 110.017 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.54 121.02 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.579 -0.897 . . . . 53.33 108.579 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 63.89 16.82 10.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.4 1.08 . . . . 71.15 112.756 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 79.6 t -131.2 128.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.283 1.033 . . . . 71.31 108.765 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' D' ' 86' ' ' ILE . 0.0 OUTLIER -151.41 161.67 42.3 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 72.53 110.674 176.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -103.01 120.55 40.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 124.531 1.132 . . . . 70.34 108.848 173.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.65 123.09 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.403 -1.332 . . . . 43.35 107.403 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 29.7 t -102.75 133.93 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.883 -0.784 . . . . 63.55 108.883 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.24 111.08 22.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.219 -1.03 . . . . 72.21 108.219 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.0 ttm-85 -86.84 110.53 20.02 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 109.144 -0.688 . . . . 75.23 109.144 171.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -108.56 103.83 16.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.87 -1.159 . . . . 65.14 107.87 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.81 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -96.04 146.5 24.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.957 -0.757 . . . . 71.42 108.957 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 81.2 t -138.21 123.18 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.818 1.247 . . . . 74.42 108.368 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 60.6 m -125.63 97.78 5.3 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 71.04 108.644 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -94.16 137.62 33.14 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.49 0.716 . . . . 71.15 109.385 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.8 m -137.06 149.53 47.47 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.142 0.577 . . . . 53.41 110.694 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -132.58 117.42 17.93 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.047 1.339 . . . . 71.32 107.999 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.26 -112.43 4.68 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.695 -0.562 . . . . 74.43 111.695 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 4.48 13.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.768 0.827 . . . . 73.15 110.815 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -118.62 170.9 8.58 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.308 0.643 . . . . 74.33 110.511 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -79.95 138.04 37.0 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.851 -0.613 . . . . 72.44 109.986 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.05 -56.74 2.96 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.704 0.802 . . . . 72.05 109.069 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -163.59 163.6 24.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.878 -1.055 . . . . 71.34 109.828 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.1 mt -118.82 153.04 35.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.048 1.339 . . . . 74.45 108.25 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.541 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 44.3 t -159.31 144.96 16.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.115 0.566 . . . . 64.04 109.988 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -156.83 139.71 15.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.61 . . . . 64.31 109.382 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.61 119.89 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 123.653 0.781 . . . . 75.03 108.936 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.2 mt-30 -97.47 87.84 4.22 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.768 0.827 . . . . 74.51 108.956 173.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -80.64 97.75 7.37 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.819 -1.537 . . . . 72.45 109.588 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.53 141.59 16.73 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.578 -0.609 . . . . 72.01 111.578 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.3 131.42 4.86 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.847 -0.501 . . . . 72.24 111.847 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -90.04 125.35 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.956 -0.757 . . . . 74.44 108.956 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -129.6 128.8 43.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.255 1.022 . . . . 74.45 109.493 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 6.0 m -88.29 95.18 10.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.054 0.942 . . . . 73.51 108.682 172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.465 HG12 ' CE1' ' D' ' 56' ' ' TYR . 2.7 pp -109.42 140.23 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.66 0.384 . . . . 75.45 110.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.32 165.41 19.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.003 0.921 . . . . 74.03 109.113 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.36 23.83 76.45 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 121.529 0.516 . . . . 74.44 112.262 -174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.47 HD13 ' SD ' ' D' ' 94' ' ' MET . 2.3 pp -109.18 147.16 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.967 1.307 . . . . 70.23 110.238 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -168.58 150.46 4.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.923 0.489 . . . . 73.21 111.332 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.05 -139.75 48.25 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.015 0.822 . . . . 70.22 114.959 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 12.6 p -68.54 -18.69 64.41 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.544 0.738 . . . . 72.23 111.739 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.84 -47.85 61.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.518 0.727 . . . . 72.25 109.573 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.47 ' SD ' HD13 ' D' ' 89' ' ' ILE . 9.3 tpt -58.34 -53.06 62.6 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.94 0.775 . . . . 62.52 110.553 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.17 86.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.956 0.785 . . . . 34.21 111.424 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -70.86 -47.09 61.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.409 0.683 . . . . 51.44 111.526 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.155 0.582 . . . . 55.02 110.589 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.03 -48.39 18.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.137 0.975 . . . . 65.42 110.34 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.45 -14.31 60.22 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.772 -0.649 . . . . 71.42 114.231 -169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.15 -60.97 1.32 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.025 0.53 . . . . 62.42 110.99 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -64.56 -47.45 78.69 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.818 0.673 . . . . 72.33 112.818 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.463 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 94.9 m -62.29 -50.17 80.84 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 118.8 -0.619 . . . . 74.12 111.246 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 60.1 Cg_exo -58.77 -31.0 94.19 Favored 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 122.542 2.161 . . . . 73.41 113.94 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.04 -32.9 74.65 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.09 0.556 . . . . 74.03 110.419 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.566 HG13 HD21 ' B' ' 132' ' ' ASN . 47.7 mm -69.9 -43.22 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.516 0.726 . . . . 70.23 110.21 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.448 HD21 ' HA3' ' D' ' 82' ' ' GLY . 90.7 mt -73.36 -19.5 60.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.183 -0.917 . . . . 75.13 111.772 -175.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -69.09 -44.33 27.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 N-CA-C 113.887 1.069 . . . . 75.23 113.887 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.03 -34.52 87.38 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 121.927 1.752 . . . . 74.31 113.237 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.2 -33.87 32.66 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 75.42 111.441 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.33 66.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.16 0.584 . . . . 50.13 109.71 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -58.82 -49.31 78.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.089 1.356 . . . . 64.12 110.596 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.45 -43.41 94.37 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.172 0.92 . . . . 75.15 110.881 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.3 t -56.09 -41.59 75.42 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.628 0.58 . . . . 25.34 110.737 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' D' ' 118' ' ' VAL . 78.8 mt -70.91 -44.59 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.153 -0.931 . . . . 55.42 110.782 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.513 HG23 ' HG3' ' D' ' 125' ' ' GLN . 74.2 m -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.015 0.926 . . . . 75.33 110.598 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.31 -48.08 71.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.511 -1.222 . . . . 33.43 110.305 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.44 -32.76 74.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.008 0.523 . . . . 63.25 112.126 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.3 t -67.42 -45.73 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.566 -0.743 . . . . 65.53 109.531 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.8 p -71.76 -23.17 61.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.625 0.37 . . . . 72.24 111.548 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.489 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.4 mtt-85 -77.6 -34.35 53.48 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.094 0.958 . . . . 71.14 109.85 175.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -0.01 79.93 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.587 -0.733 . . . . 32.3 111.926 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p 61.5 42.31 11.52 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.313 1.845 . . . . 41.44 111.552 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.417 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 37.1 m-85 -111.56 167.82 8.52 Favored Pre-proline 0 CA--C 1.56 1.347 0 CA-C-N 113.078 -1.874 . . . . 75.2 107.878 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 93.1 Cg_endo -75.17 140.37 24.91 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.996 1.797 . . . . 75.44 112.053 -171.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.513 ' HG3' HG23 ' D' ' 115' ' ' THR . 25.6 tt0 -45.61 123.78 4.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.502 1.121 . . . . 75.13 112.338 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.51 HD11 HG21 ' D' ' 40' ' ' VAL . 42.1 tp -108.56 93.02 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.524 -0.762 . . . . 65.1 109.021 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -115.53 106.0 13.44 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.03 0.932 . . . . 61.01 109.039 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.573 HD11 ' HG ' ' D' ' 42' ' ' LEU . 3.6 mm? -62.44 125.51 24.16 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.337 -0.847 . . . . 72.41 110.135 174.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.531 ' HB1' HE22 ' B' ' 12' ' ' GLN . . . -55.7 128.46 69.33 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 124.538 1.149 . . . . 60.45 110.562 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -73.59 95.23 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.307 2.671 . . . . 74.34 112.335 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 91.2 t -102.12 118.74 49.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.508 -1.293 . . . . 64.12 107.508 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 . . . . . 0 CA--C 1.544 0.746 0 CA-C-O 121.752 0.787 . . . . 62.42 109.215 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 C--O 1.245 0.841 0 N-CA-C 109.552 -0.536 . . . . 74.34 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.74 135.78 48.12 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.663 0.785 . . . . 53.21 108.956 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -160.52 141.17 11.7 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.647 0.592 . . . . 64.22 112.582 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.36 117.71 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 107.867 -1.16 . . . . 63.51 107.867 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 2.1 mp0 -84.69 -30.6 24.67 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.128 -0.463 . . . . 64.33 110.053 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -175.9 146.91 0.74 Allowed 'General case' 0 C--N 1.371 1.535 0 O-C-N 123.851 0.72 . . . . 64.3 111.046 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.86 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 96.5 mt -129.65 128.23 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.497 -1.297 . . . . 74.44 107.497 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -156.81 166.43 33.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.178 0.991 . . . . 75.13 110.656 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -92.26 119.0 31.44 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.921 -0.77 . . . . 51.21 108.921 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -82.62 -26.28 32.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.002 -0.37 . . . . 61.45 110.002 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.6 t70 -152.94 143.0 22.32 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.261 -0.881 . . . . 75.33 110.35 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.436 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 85.7 mt -138.39 140.88 39.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 C-N-CA 125.536 1.534 . . . . 64.44 106.926 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -149.15 126.68 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.753 0.658 . . . . 74.11 109.624 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 90.1 t80 -130.9 131.97 44.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.405 -1.332 . . . . 72.33 107.405 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.6 131.86 41.9 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -123.39 87.84 51.69 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.61 -1.256 . . . . 74.41 107.61 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.77 -22.76 42.74 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.672 2.248 . . . . 73.13 112.925 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -120.42 38.78 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.615 0.766 . . . . 73.24 109.448 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -59.41 -48.24 96.32 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.125 0.97 . . . . 64.23 113.055 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 10.1 Cg_exo -73.53 -42.04 0.99 Allowed 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.085 1.857 . . . . 43.41 112.266 168.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -62.8 -19.89 64.48 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.055 1.342 . . . . 73.24 112.792 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.66 -24.12 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.279 0.631 . . . . 60.35 111.814 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -54.98 -32.24 61.44 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.971 0.908 . . . . 73.32 112.698 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -86.21 -48.53 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.965 0.906 . . . . 64.4 110.359 -175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -78.91 128.56 33.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.802 -1.09 . . . . 62.43 112.038 -169.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.56 134.75 57.31 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.482 1.113 . . . . 72.22 111.246 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.581 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 46.6 t-105 -84.49 80.46 9.22 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.906 0.754 . . . . 74.34 111.231 -173.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.92 75.92 74.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.675 -1.231 . . . . 70.1 107.675 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.01 155.96 11.33 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.745 2.296 . . . . 72.3 113.336 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.27 105.76 17.94 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.317 -1.364 . . . . 70.05 107.317 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 65' ' ' THR . 36.0 t -87.24 98.78 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.878 -0.416 . . . . 31.3 109.878 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 85.0 tttt -81.72 130.86 35.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.446 0.698 . . . . 74.41 109.897 175.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.554 HD21 HD22 ' A' ' 128' ' ' LEU . 5.7 mp -114.67 110.87 20.43 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.754 -0.832 . . . . 64.52 108.754 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.9 t70 -112.92 130.96 55.93 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.984 -1.117 . . . . 63.5 107.984 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.9 tp -117.54 131.27 56.72 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 73.22 109.307 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.68 146.74 40.03 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.945 -0.761 . . . . 71.14 108.945 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -147.55 143.13 27.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.283 -0.636 . . . . 64.44 109.283 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.54 134.11 15.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.63 0.772 . . . . 75.12 109.116 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 20.7 m -88.73 162.66 16.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.133 0.573 . . . . 74.35 110.556 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -149.86 141.15 23.19 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.536 1.134 . . . . 64.31 108.004 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -91.66 133.43 35.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.886 -0.413 . . . . 63.24 109.886 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 57' ' ' GLU . 42.5 mt -118.43 -35.32 3.8 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.803 0.841 . . . . 74.42 109.144 171.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.632 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.04 179.57 7.52 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.599 -1.182 . . . . 62.21 109.848 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.11 122.89 21.74 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.27 -1.011 . . . . 72.42 108.27 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 70.77 -6.38 1.26 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.699 1.199 . . . . 75.32 112.925 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.5 t -105.3 111.07 33.14 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 N-CA-C 108.088 -1.078 . . . . 65.12 108.088 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.1 m-30 -119.11 128.12 54.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 64.32 109.796 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 51' ' ' LEU . 13.1 tt0 -82.66 112.22 19.34 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.326 -1.361 . . . . 72.15 107.326 166.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.0 t -100.7 115.62 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.854 -1.535 . . . . 71.12 106.854 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.669 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.7 t -96.29 129.44 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.388 -0.597 . . . . 70.01 109.388 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 111.39 23.67 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.112 -1.44 . . . . 71.02 107.112 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -100.49 102.75 14.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.665 -0.865 . . . . 71.12 108.665 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.4 128.53 46.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.101 -1.074 . . . . 75.13 108.101 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.8 m -113.94 135.99 53.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.848 -0.797 . . . . 73.43 108.848 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -132.49 136.95 55.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 125.568 1.547 . . . . 62.35 107.135 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.7 m -141.63 138.3 32.46 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.99 127.56 45.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.676 -1.601 . . . . 73.34 106.676 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -139.95 131.97 27.85 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.349 0.595 . . . . 63.54 111.688 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.3 mt -89.62 78.19 7.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.577 -1.268 . . . . 73.23 107.577 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -117.04 4.36 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.081 -0.963 . . . . 65.44 111.184 -173.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -87.87 -25.22 23.39 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.522 0.729 . . . . 65.52 110.297 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -79.93 106.8 12.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.078 0.951 . . . . 70.14 109.371 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -65.62 129.92 41.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.238 0.542 . . . . 75.25 111.139 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.28 -52.94 7.11 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.592 1.157 . . . . 71.23 109.004 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -158.25 155.26 28.61 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.464 -0.789 . . . . 62.44 111.396 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -117.94 146.35 44.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.972 1.309 . . . . 75.02 108.422 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 80.9 m -144.93 131.12 19.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.563 1.145 . . . . 23.45 108.85 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.74 128.6 14.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.191 -0.67 . . . . 62.24 109.191 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -130.29 110.4 19.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.437 -0.949 . . . . 73.44 108.437 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.7 mt-30 -86.34 81.01 8.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.7 -0.852 . . . . 72.4 108.7 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.87 93.58 3.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.2 -1.364 . . . . 71.21 109.046 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.16 143.7 16.77 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.766 -0.534 . . . . 74.33 111.766 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.51 131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.044 -0.823 . . . . 34.44 111.044 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 17.3 mt -81.14 128.8 38.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 70.42 108.849 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -136.21 131.0 34.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.086 0.554 . . . . 71.34 110.699 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -83.5 119.67 24.97 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.052 -1.092 . . . . 74.02 108.052 168.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.32 122.48 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 75.23 110.096 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.17 162.95 28.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.632 0.773 . . . . 75.12 109.961 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.05 81.54 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.132 -0.485 . . . . 51.2 112.948 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.46 137.2 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.187 0.995 . . . . 61.1 109.808 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 20.2 tt0 -137.07 -179.11 5.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 73.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 48.95 -124.24 12.3 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 124.02 0.819 . . . . 51.44 114.94 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -79.11 -16.61 56.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.543 0.737 . . . . 50.43 111.608 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.69 -39.88 61.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.679 0.392 . . . . 71.44 110.369 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.05 36.61 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.299 0.24 . . . . 73.14 110.838 175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.7 -30.01 67.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.501 . . . . 62.22 110.072 171.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.48 -44.11 45.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.86 0.864 . . . . 73.13 110.319 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.17 -63.91 1.08 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.259 0.623 . . . . 70.1 111.566 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 tt -71.12 -46.2 62.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.511 0.724 . . . . 64.12 111.031 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.69 -18.25 79.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.742 0.657 . . . . 25.41 114.742 -169.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.56 -51.78 0.69 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.578 0.689 . . . . 74.11 112.205 -172.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.24 -37.29 71.98 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.328 0.651 . . . . 74.01 112.441 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.31 -45.79 13.81 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-O 118.355 -0.831 . . . . 54.01 113.028 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.78 -22.66 68.88 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 121.531 1.487 . . . . 65.24 112.578 168.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -79.38 -22.43 44.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.038 0.535 . . . . 71.13 111.79 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.72 -36.97 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.627 -0.879 . . . . 71.31 108.627 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' A' ' 82' ' ' GLY . 44.1 mt -85.8 -18.31 33.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.115 . . . . 73.14 112.568 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -66.25 -42.62 50.57 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-O 117.709 -1.139 . . . . 75.22 114.013 -171.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.21 -35.27 86.25 Favored 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 121.951 1.733 . . . . 74.51 112.745 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -74.07 -40.8 62.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.654 0.781 . . . . 72.55 111.343 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.22 75.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.332 0.653 . . . . 42.33 109.8 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.584 ' NH1' HG23 ' C' ' 105' ' ' ILE . 34.5 ttm180 -52.11 -55.21 22.27 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.65 1.218 . . . . 73.04 109.893 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.46 -40.65 97.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.204 0.94 . . . . 74.44 111.3 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.604 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -61.87 -35.69 79.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.983 0.513 . . . . 72.21 111.207 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 64' ' ' VAL . 95.6 mt -72.62 -51.02 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 75.31 109.644 173.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 125' ' ' GLN . 97.9 m -53.41 -37.17 62.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.318 1.447 . . . . 64.24 111.227 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.7 t -69.47 -49.65 52.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.927 -1.033 . . . . 54.22 110.118 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 60.7 mtm -57.83 -44.84 86.71 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.346 0.658 . . . . 71.23 110.984 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.3 t -58.73 -48.84 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.386 -1.279 . . . . 75.51 110.608 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -68.78 -29.53 67.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.744 -0.662 . . . . 44.33 111.544 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -73.93 -28.59 61.6 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.64 0.776 . . . . 72.3 110.529 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.89 10.67 51.36 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.954 0.784 . . . . 71.54 112.801 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.452 HG23 ' HB3' ' D' ' 125' ' ' GLN . 3.7 m 66.34 26.05 10.32 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.794 1.238 . . . . 74.04 110.467 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -103.33 157.73 33.23 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.019 -0.991 . . . . 64.13 108.852 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.581 ' HG3' ' HE1' ' A' ' 36' ' ' TRP . 73.1 Cg_endo -68.8 147.54 69.22 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.093 1.862 . . . . 71.13 111.744 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.4 tt0 -58.13 128.88 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 123.949 0.78 . . . . 70.35 110.878 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -108.98 101.32 10.42 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.895 -0.78 . . . . 74.23 108.895 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.471 ' HB3' HD13 ' C' ' 13' ' ' ILE . 92.4 m-20 -98.41 105.18 17.29 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.901 -0.777 . . . . 54.5 108.901 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.554 HD22 HD21 ' A' ' 42' ' ' LEU . 46.0 mt -72.96 139.12 46.51 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.537 -0.756 . . . . 63.43 109.218 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.03 138.03 90.97 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.667 0.604 . . . . 45.52 110.433 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 16.1 Cg_endo -76.57 96.93 1.1 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 121.611 1.541 . . . . 63.43 109.143 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 m -97.94 112.07 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.977 -1.01 . . . . 75.44 108.37 -171.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -103.91 109.98 21.94 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.797 -1.092 . . . . 55.44 108.325 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.4 t80 . . . . . 0 CA--C 1.543 0.704 0 C-N-CA 123.53 0.732 . . . . 72.44 111.281 -179.888 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 108.568 -0.901 . . . . 74.24 108.568 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -142.84 131.31 22.34 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 73.14 107.5 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -160.55 139.97 10.79 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.991 0.807 . . . . 75.11 110.021 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.652 HD11 HG13 ' B' ' 16' ' ' ILE . 16.9 tt -95.93 145.23 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.377 1.071 . . . . 71.43 109.836 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.18 -35.07 8.16 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 119.658 -0.21 . . . . 53.41 111.037 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.439 HH21 ' HB ' ' A' ' 122' ' ' THR . 23.0 ttt180 -173.53 144.76 1.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.502 0.321 . . . . 75.24 111.565 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.652 HG13 HD11 ' B' ' 13' ' ' ILE . 60.9 mt -118.94 138.11 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.182 -1.414 . . . . 74.14 107.182 165.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -167.3 142.12 3.89 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.341 1.026 . . . . 74.22 109.339 -170.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.4 m -75.16 118.8 18.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.476 -0.935 . . . . 74.33 108.476 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -85.14 -34.64 22.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.824 -0.625 . . . . 72.54 110.832 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.03 145.92 15.54 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.407 0.442 . . . . 70.03 110.924 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 40.5 mm -135.63 142.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.431 1.092 . . . . 54.03 109.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -136.61 127.93 28.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.921 1.289 . . . . 72.12 108.569 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.42 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.4 t80 -144.38 109.5 5.07 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.873 -1.528 . . . . 72.24 106.873 165.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -123.42 113.35 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.469 -0.937 . . . . 44.42 108.469 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.33 90.02 5.36 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.662 1.185 . . . . 64.23 108.965 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.86 -25.18 53.01 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.285 1.99 . . . . 63.35 111.759 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 92.4 m-20 -121.28 31.46 6.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.441 1.097 . . . . 72.21 110.064 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -46.87 -48.52 51.32 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 125.399 1.48 . . . . 71.51 113.476 172.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.05 -17.83 17.02 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.855 1.703 . . . . 74.31 113.396 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 2.0 m-70 -82.6 -1.24 50.25 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.206 0.817 . . . . 75.11 113.206 -171.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 28' ' ' ALA . 7.2 p -79.84 -25.99 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.239 0.542 . . . . 54.45 109.812 166.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -78.96 -32.01 45.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.564 ' HA ' HE21 ' B' ' 33' ' ' GLN . 0.0 OUTLIER -71.43 -45.0 63.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.146 -0.479 . . . . 61.21 110.716 177.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -108.08 110.46 22.14 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.234 1.014 . . . . 72.22 109.252 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -74.12 79.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.136 0.575 . . . . 71.23 111.487 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -162.15 151.09 15.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.194 -1.41 . . . . 75.55 107.194 169.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -92.23 133.17 30.53 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.08 0.952 . . . . 42.42 109.443 173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 158.26 35.6 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.023 2.482 . . . . 73.01 113.818 -169.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.27 107.95 12.41 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.917 -0.771 . . . . 71.42 108.917 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.549 HG12 HD23 ' B' ' 126' ' ' LEU . 17.7 t -95.28 123.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.576 0.751 . . . . 73.42 109.12 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -136.85 145.31 44.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.624 0.77 . . . . 72.14 110.845 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.701 HD21 HD23 ' B' ' 128' ' ' LEU . 2.4 pt? -116.8 166.54 12.02 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.365 0.666 . . . . 73.33 111.572 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -150.14 154.35 37.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.225 1.41 . . . . 74.3 108.142 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -94.54 148.99 21.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.166 0.586 . . . . 63.21 111.106 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -141.79 154.59 45.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.855 1.262 . . . . 72.44 108.943 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 72.0 p -122.92 134.8 54.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.547 . . . . 74.5 110.468 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.34 32.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.241 -1.022 . . . . 72.1 108.241 170.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.2 p -147.93 167.7 24.18 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.801 0.334 . . . . 71.24 111.367 172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.1 p -151.32 136.55 17.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.378 1.071 . . . . 73.34 108.69 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.84 129.69 35.12 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.471 -0.566 . . . . 62.02 109.471 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 mt -95.58 -47.21 6.32 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.442 -0.577 . . . . 75.02 109.442 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.26 -172.93 4.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.984 0.913 . . . . 74.53 110.179 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 103.07 0.3 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.09 -0.959 . . . . 74.43 110.148 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.52 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 4.9 m-20 65.38 12.82 8.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.917 1.287 . . . . 74.44 113.094 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -104.59 86.51 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 105.999 -1.852 . . . . 61.33 105.999 166.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -109.39 141.6 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.877 0.846 . . . . 75.23 109.762 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -103.54 115.84 31.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.058 -1.428 . . . . 73.44 107.994 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.98 127.73 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.881 0.472 . . . . 73.35 109.784 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -102.03 115.97 44.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.168 0.987 . . . . 72.22 108.612 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 109.6 20.96 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.8 -1.185 . . . . 75.04 107.8 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -99.99 126.03 46.11 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.738 -0.468 . . . . 74.41 109.738 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.4 t -118.25 126.83 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.153 -1.055 . . . . 52.12 108.153 171.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 29.1 m -97.13 149.64 21.75 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.548 0.739 . . . . 73.14 109.147 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.727 HG21 HG21 ' B' ' 114' ' ' ILE . 55.6 t -135.33 132.73 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.266 1.026 . . . . 65.41 109.358 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -124.16 139.22 54.14 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.444 -0.947 . . . . 73.41 108.444 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.38 149.63 36.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.797 0.839 . . . . 64.44 109.072 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.7 p -144.95 132.65 21.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.367 0.877 . . . . 71.41 113.367 -174.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 27.6 mt -95.6 104.73 16.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.151 1.38 . . . . 61.34 108.495 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.75 -103.38 1.11 Allowed Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.042 -1.075 . . . . 54.53 111.18 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.18 3.55 11.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.47 1.508 . . . . 65.32 111.799 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.404 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 23.7 pt-20 -116.29 161.49 18.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.978 0.511 . . . . 61.53 111.15 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -77.65 113.28 15.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.066 0.547 . . . . 74.15 110.554 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.475 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -68.25 -59.39 3.24 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.872 -0.788 . . . . 73.33 108.872 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.02 168.47 27.15 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.117 -0.947 . . . . 73.44 111.425 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -130.39 113.28 14.14 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.743 -1.577 . . . . 63.04 106.743 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.0 t -118.11 153.14 34.27 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.893 -0.78 . . . . 71.14 108.893 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.82 132.8 3.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.88 144.07 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.709 0.803 . . . . 73.3 109.065 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -121.75 84.35 2.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.509 -0.923 . . . . 63.52 108.509 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.26 99.88 9.57 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 114.716 -1.129 . . . . 74.52 108.835 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.69 159.75 26.05 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.809 -0.517 . . . . 65.41 111.809 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.62 129.27 2.02 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.09 -0.804 . . . . 74.23 111.09 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.3 mt -86.64 130.71 36.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 N-CA-C 109.381 -0.6 . . . . 70.21 109.381 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -131.37 146.19 52.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.23 0.538 . . . . 73.21 110.205 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -127.92 112.83 15.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.883 1.273 . . . . 72.21 108.354 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 5.1 tt -139.48 140.54 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.638 0.775 . . . . 63.01 110.476 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 173.52 16.87 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.745 0.418 . . . . 25.42 111.532 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.59 -69.59 1.03 Allowed Glycine 0 C--N 1.351 1.392 0 C-N-CA 124.023 0.82 . . . . 64.12 112.886 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.518 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -74.51 169.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.627 0.771 . . . . 75.25 111.559 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.88 -171.93 2.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.178 0.591 . . . . 73.05 111.552 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.47 -105.81 1.62 Allowed Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.13 -0.941 . . . . 75.04 112.837 172.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -77.73 -33.07 53.09 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 64.35 110.828 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -75.74 -38.85 58.11 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.184 0.593 . . . . 71.02 111.321 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptm -67.91 -34.43 76.62 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 120.871 0.367 . . . . 74.45 110.323 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.13 80.23 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.825 0.85 . . . . 75.53 110.899 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -71.32 -30.22 65.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.041 -0.981 . . . . 74.22 110.93 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.62 -69.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.169 0.293 . . . . 72.13 110.935 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.86 -19.78 60.62 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 111.928 0.344 . . . . 72.43 111.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.95 -25.65 44.32 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.574 0.546 . . . . 62.32 114.033 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -47.16 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.165 0.802 . . . . 75.31 113.165 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.03 -49.14 20.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.067 0.547 . . . . 74.25 111.955 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.4 m -60.45 -46.97 97.48 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.964 0.905 . . . . 42.13 111.91 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.76 -30.9 49.65 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 121.229 1.286 . . . . 70.53 112.951 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.83 -27.7 68.44 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.747 0.703 . . . . 75.21 111.22 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.472 HG23 ' NH2' ' D' ' 111' ' ' ARG . 70.3 mt -64.51 -43.61 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 64.44 110.192 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.76 -14.54 47.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.09 0.956 . . . . 75.44 111.784 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' B' ' 128' ' ' LEU . 33.7 t80 -60.19 -47.26 97.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.063 1.345 . . . . 74.01 113.192 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' D' ' 112' ' ' GLU . 18.6 Cg_endo -58.06 -35.97 98.34 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.06 1.84 . . . . 74.4 113.706 174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 65.4 m-85 -69.7 -46.14 66.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 75.51 110.802 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.459 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.693 0.797 . . . . 71.21 110.345 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.444 ' NH2' ' HG3' ' B' ' 130' ' ' PRO . 33.4 mtp180 -50.48 -54.94 18.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.43 1.092 . . . . 75.33 110.789 173.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.8 -33.85 76.53 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.982 -1.008 . . . . 63.11 110.681 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -72.88 -41.15 65.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.098 0.559 . . . . 61.23 111.259 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.727 HG21 HG21 ' B' ' 64' ' ' VAL . 52.7 mt -65.6 -48.14 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.869 . . . . 74.23 108.652 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -51.51 -35.97 42.63 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 124.536 1.148 . . . . 61.24 111.177 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.9 t -69.24 -55.03 11.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.626 0.77 . . . . 62.21 110.826 175.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.465 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 18.0 mmt -65.67 -33.37 75.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.016 0.526 . . . . 72.32 111.901 -172.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.53 -41.42 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.055 0.942 . . . . 73.11 110.374 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.475 ' HB3' HE22 ' C' ' 125' ' ' GLN . 90.0 p -70.1 -26.05 63.79 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.27 0.557 . . . . 71.45 112.149 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.604 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 80.1 mtt-85 -68.6 -34.01 75.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.365 -0.834 . . . . 44.23 110.441 175.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.6 13.09 54.11 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.847 0.717 . . . . 72.43 112.738 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.25 42.21 12.32 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.554 1.942 . . . . 62.15 112.497 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.602 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 71.3 m-85 -120.32 172.78 4.27 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 114.167 -1.378 . . . . 75.1 109.333 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 85.3 Cg_endo -73.08 -167.55 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.965 2.444 . . . . 74.41 116.107 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -66.89 155.58 38.02 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.758 -1.564 . . . . 62.41 111.054 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' B' ' 42' ' ' LEU . 3.4 tm? -135.23 84.91 2.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.974 -2.232 . . . . 74.32 104.974 163.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -123.58 95.4 4.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.287 -1.375 . . . . 74.25 107.287 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.701 HD23 HD21 ' B' ' 42' ' ' LEU . 2.7 tm? -64.29 145.38 56.11 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.17 -0.923 . . . . 72.53 109.863 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -53.46 110.6 2.12 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 124.633 1.208 . . . . 74.22 110.426 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.687 ' HB2' HD13 ' D' ' 16' ' ' ILE . 10.3 Cg_exo -65.61 132.67 31.64 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.152 1.901 . . . . 73.24 110.319 -173.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.63 137.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.061 -0.348 . . . . 75.43 110.061 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -87.07 117.73 25.99 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.801 0.841 . . . . 50.23 109.015 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 47.3 t80 . . . . . 0 N--CA 1.485 1.292 0 C-N-CA 124.531 1.132 . . . . 73.21 113.1 -174.138 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 C--O 1.24 0.605 0 N-CA-C 109.743 -0.466 . . . . 71.42 109.743 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.434 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 0.5 OUTLIER -120.91 163.53 18.08 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 116.04 -0.527 . . . . 72.33 109.79 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -136.12 129.76 32.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.005 -0.998 . . . . 71.41 108.993 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 127' ' ' ASN . 17.7 tt -66.19 137.79 24.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.253 1.021 . . . . 61.23 110.178 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 92.0 mm-40 -111.79 -45.45 3.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.202 -0.454 . . . . 64.15 110.101 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -174.98 142.02 0.62 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.604 0.565 . . . . 75.13 110.974 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.22 138.21 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.771 -1.196 . . . . 73.14 107.771 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.45 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -171.46 161.51 6.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.318 0.58 . . . . 71.34 110.95 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -86.36 105.0 16.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.03 -0.986 . . . . 74.32 109.01 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -67.46 -46.64 72.43 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.754 0.787 . . . . 64.2 109.426 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.4 t70 -136.12 145.25 45.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.224 -1.353 . . . . 52.23 109.441 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.7 mt -140.3 144.31 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.292 -1.373 . . . . 72.33 107.292 175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.4 t -152.71 145.73 24.54 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.337 0.589 . . . . 72.01 110.198 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -149.15 120.79 8.03 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.373 -1.343 . . . . 71.14 107.373 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -126.01 124.11 39.98 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.482 -0.932 . . . . 71.55 108.482 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -111.39 89.72 10.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.172 -1.047 . . . . 72.03 108.172 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.88 -31.41 93.75 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.473 2.782 . . . . 53.52 112.926 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.432 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 87.2 m-20 -119.04 36.03 4.61 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 114.53 -1.214 . . . . 73.45 109.668 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' C' ' 25' ' ' ALA . . . -49.79 -48.6 77.0 Favored Pre-proline 0 CA--C 1.572 1.82 0 N-CA-C 114.213 1.19 . . . . 73.34 114.213 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.37 -29.54 1.46 Allowed 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.782 1.655 . . . . 40.42 113.069 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.432 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 41.3 t60 -69.59 -31.36 69.47 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.803 1.241 . . . . 72.22 112.328 -171.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.606 HG23 HD11 ' C' ' 68' ' ' LEU . 12.8 p -79.66 -19.3 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.836 1.254 . . . . 73.54 112.074 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.34 -39.24 69.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.01 0.924 . . . . 60.12 112.518 -171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -113.41 45.95 1.33 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.941 0.877 . . . . 72.21 109.389 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 167.71 12.58 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.298 -0.631 . . . . 73.05 109.298 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.15 116.97 4.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.911 -0.774 . . . . 72.12 108.911 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -84.8 68.9 10.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.788 0.68 . . . . 74.05 111.428 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -140.59 79.33 20.11 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.508 0.723 . . . . 74.1 109.512 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -79.45 135.81 12.07 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.437 2.091 . . . . 54.1 109.963 173.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.56 118.74 24.01 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.003 -1.11 . . . . 64.14 108.003 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.628 HG11 HD21 ' C' ' 128' ' ' LEU . 24.7 t -65.46 95.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.095 1.497 . . . . 72.1 108.822 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 0.5 OUTLIER -110.95 116.13 30.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.241 -1.022 . . . . 73.05 108.241 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.62 137.54 54.87 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.107 -1.071 . . . . 72.31 108.107 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -147.81 145.44 28.75 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.328 0.651 . . . . 65.24 109.398 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.7 tp -113.6 132.56 55.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 64.32 110.275 -176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.686 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 4.3 m-20 -114.65 134.77 54.81 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 106.869 -1.53 . . . . 73.23 106.869 171.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -114.2 132.12 56.22 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.943 0.402 . . . . 73.34 110.391 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.06 147.15 45.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.984 0.914 . . . . 64.14 108.982 173.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -139.6 144.01 37.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.473 0.709 . . . . 74.11 109.805 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -146.23 134.26 21.48 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.832 0.853 . . . . 74.11 109.407 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -74.94 147.5 40.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.468 -0.938 . . . . 65.31 108.468 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.56 HD11 HD12 ' C' ' 83' ' ' ILE . 86.5 mt -118.25 -37.57 3.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.849 0.86 . . . . 74.43 110.401 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.39 -168.8 1.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.155 0.582 . . . . 73.13 110.858 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.47 116.26 5.41 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.197 -0.91 . . . . 73.41 109.419 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 62.09 18.11 9.71 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 124.549 1.14 . . . . 71.11 112.324 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' C' ' 51' ' ' LEU . 67.8 t -120.86 107.47 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.567 0.747 . . . . 71.23 109.299 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.89 161.53 14.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.847 0.832 . . . . 73.13 110.757 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.547 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.2 tt0 -127.82 126.1 41.03 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.412 -1.722 . . . . 74.33 107.673 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 123.38 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.332 -0.618 . . . . 72.44 109.332 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.67 111.44 34.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.36 1.064 . . . . 73.21 108.668 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.99 100.01 12.3 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.055 -0.72 . . . . 74.02 109.055 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 41.2 ttm180 -82.33 100.09 9.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.85 -1.537 . . . . 73.51 106.85 171.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.5 t -103.16 113.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.495 -1.298 . . . . 64.42 107.495 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.8 m -118.71 131.52 56.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.883 -0.598 . . . . 71.03 110.106 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.606 HG21 HG21 ' C' ' 114' ' ' ILE . 55.2 t -114.89 131.39 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.668 1.187 . . . . 64.41 110.242 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 9.4 m -110.22 146.58 35.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 164.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 110.74 8.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.677 -1.231 . . . . 74.33 107.677 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -135.19 133.34 38.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.364 0.602 . . . . 74.02 111.449 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.606 HD11 HG23 ' C' ' 31' ' ' VAL . 4.0 mt -85.5 14.58 5.37 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 125.195 1.398 . . . . 65.34 110.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.75 -96.28 0.48 Allowed Glycine 0 C--N 1.35 1.357 0 N-CA-C 110.505 -1.038 . . . . 74.15 110.505 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.32 -25.77 15.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.23 1.012 . . . . 73.11 109.55 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -87.71 116.94 26.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.211 1.004 . . . . 75.43 108.523 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -86.31 129.36 34.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.477 0.581 . . . . 62.2 110.256 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.66 -52.78 9.01 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.76 0.824 . . . . 74.12 109.843 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -163.39 175.13 11.11 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.553 0.692 . . . . 75.15 111.391 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.461 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -133.1 146.77 51.94 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.503 -1.666 . . . . 62.35 106.503 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.607 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.5 t -150.99 150.82 31.23 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.312 -0.625 . . . . 75.02 109.312 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.27 140.45 10.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.952 0.501 . . . . 52.04 109.929 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -135.35 134.05 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.344 -0.984 . . . . 51.52 108.344 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.706 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -109.63 92.68 4.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.088 -0.708 . . . . 75.04 109.088 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -81.21 107.32 13.9 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.556 -1.202 . . . . 71.32 109.934 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.63 145.35 18.3 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.449 -0.661 . . . . 70.52 111.449 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.484 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.22 117.24 0.98 Allowed Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.069 -0.812 . . . . 71.35 111.069 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.56 HD12 HD11 ' C' ' 51' ' ' LEU . 6.7 mm -86.53 126.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 N-CA-C 108.843 -0.799 . . . . 74.25 108.843 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -136.68 122.6 20.1 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.442 -0.947 . . . . 73.14 108.442 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -76.74 96.58 4.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.753 -0.832 . . . . 71.35 108.753 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.652 HD13 ' HE3' ' C' ' 94' ' ' MET . 2.7 pp -96.45 136.02 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.327 1.051 . . . . 73.41 111.131 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.42 -169.35 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.64 0.776 . . . . 65.1 110.018 172.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.39 -60.11 0.69 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.93 -0.468 . . . . 55.04 111.93 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.656 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.337 1.055 . . . . 54.22 112.356 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 108.413 -0.958 . . . . 64.32 108.413 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.652 ' HE3' HD13 ' C' ' 86' ' ' ILE . 34.7 tpp -71.14 -44.81 64.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.175 -0.92 . . . . 73.13 110.064 169.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.16 -29.19 70.18 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.223 0.609 . . . . 54.11 112.21 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -83.01 -45.29 14.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.29 0.636 . . . . 73.54 110.309 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -66.55 -60.4 2.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.487 -0.779 . . . . 73.12 110.18 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.543 ' HB2' ' SD ' ' C' ' 94' ' ' MET . 14.6 tp -64.84 -21.42 66.79 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.605 1.162 . . . . 64.14 111.329 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.87 -29.54 38.21 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.99 -0.55 . . . . 75.42 114.379 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.6 -42.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.765 0.782 . . . . 65.14 112.767 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 63.9 t80 -71.21 -49.39 43.95 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.177 0.591 . . . . 73.34 112.13 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 22.0 m -61.96 -47.97 89.84 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 123.053 0.541 . . . . 62.11 110.782 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 79.6 Cg_exo -56.11 -37.25 96.7 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 122.1 1.867 . . . . 41.35 114.429 169.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.47 -27.79 69.22 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.841 0.456 . . . . 60.21 111.254 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.584 HG23 ' NH1' ' A' ' 111' ' ' ARG . 43.6 mm -65.39 -46.55 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.722 -0.672 . . . . 73.42 109.831 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.484 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.6 mt -79.89 -24.18 41.35 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.088 -0.96 . . . . 73.42 112.351 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.57 -50.57 86.15 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-O 117.592 -1.195 . . . . 74.15 113.608 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.65 -32.6 93.43 Favored 'Trans proline' 0 C--N 1.384 2.422 0 CA-C-N 121.589 1.603 . . . . 71.42 112.96 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -65.54 -47.63 75.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.12 0.568 . . . . 75.51 110.519 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.67 96.58 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.895 0.878 . . . . 74.43 111.166 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -62.89 -52.64 62.29 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.464 1.506 . . . . 74.0 110.123 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -68.98 -27.49 65.76 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.673 0.608 . . . . 72.11 110.441 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -64.42 -51.18 64.48 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.941 -0.392 . . . . 71.41 109.941 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.607 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -61.54 -49.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 123.431 0.457 . . . . 75.34 110.104 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -43.81 -45.07 7.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.121 1.369 . . . . 74.32 111.493 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -68.14 -51.69 43.19 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 113.561 -1.654 . . . . 35.25 110.703 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.493 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 13.8 mmm -57.49 -40.35 78.44 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.951 0.9 . . . . 64.02 112.245 -173.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' C' ' 126' ' ' LEU . 98.9 t -64.78 -44.73 96.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.128 -0.942 . . . . 61.45 110.782 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.3 t -66.16 -26.56 67.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.059 -0.973 . . . . 73.35 111.021 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.1 mtt-85 -68.41 -32.74 72.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.769 0.828 . . . . 45.22 110.541 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 9.75 67.49 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 115.856 -0.611 . . . . 53.33 113.014 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 6.3 p 61.93 24.31 14.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.449 1.9 . . . . 73.44 113.122 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.89 158.7 32.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 109.208 -0.664 . . . . 75.35 109.208 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.75 115.98 2.9 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.331 2.021 . . . . 72.54 110.556 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.475 HE22 ' HB3' ' B' ' 119' ' ' SER . 3.4 pt20 -45.91 147.29 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.705 1.253 . . . . 70.35 112.591 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.553 ' HB2' HG21 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -98.32 76.23 2.3 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.513 -0.921 . . . . 71.2 108.513 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -110.52 89.43 3.03 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.701 -1.222 . . . . 61.43 107.701 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.628 HD21 HG11 ' C' ' 40' ' ' VAL . 30.4 mt -84.68 151.94 24.11 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.656 0.741 . . . . 70.04 110.248 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.59 156.02 46.26 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 112.858 -1.974 . . . . 51.04 113.071 -172.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.86 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 38.3 Cg_endo -60.52 125.1 16.5 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 124.138 3.225 . . . . 75.44 113.956 -173.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.03 111.69 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.304 0.642 . . . . 64.32 110.364 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -115.73 108.43 16.35 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.501 1.121 . . . . 63.21 109.162 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.498 1.935 0 C-N-CA 123.784 0.834 . . . . 74.11 112.488 179.674 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.1 m . . . . . 0 C--O 1.236 0.354 0 N-CA-C 108.143 -1.058 . . . . 72.43 108.143 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 48.3 t80 -157.9 99.08 1.67 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.698 -1.223 . . . . 70.31 107.698 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.46 157.58 46.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.248 -1.019 . . . . 64.34 108.248 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.657 HG12 HD11 ' D' ' 16' ' ' ILE . 6.7 tp -98.18 140.5 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 123.197 0.599 . . . . 72.54 110.439 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -106.9 -33.04 7.65 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.579 0.752 . . . . 75.33 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -173.07 142.78 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 119.418 -0.325 . . . . 73.43 110.819 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' B' ' 130' ' ' PRO . 3.6 mp -121.11 130.12 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.291 -1.374 . . . . 63.23 107.291 171.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -155.75 160.63 40.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.598 0.759 . . . . 72.53 110.679 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -86.43 118.31 25.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 71.31 109.567 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -86.88 -31.12 20.92 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.3 -0.409 . . . . 53.35 110.397 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.691 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.6 t70 -149.79 135.08 18.16 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.173 -0.921 . . . . 61.42 108.956 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.472 HD13 ' SG ' ' D' ' 113' ' ' CYS . 84.3 mt -135.53 139.06 47.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.912 -1.144 . . . . 51.13 107.912 175.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -142.66 131.5 22.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.823 0.849 . . . . 71.23 108.755 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.8 t80 -134.4 117.52 16.41 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.162 -1.792 . . . . 74.42 106.162 167.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.4 122.95 32.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.311 0.644 . . . . 64.31 109.753 -170.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.05 88.81 18.11 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.595 -0.891 . . . . 71.15 108.595 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.67 -37.14 12.86 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.869 2.379 . . . . 64.11 113.243 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -112.4 35.03 3.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.935 -0.765 . . . . 73.54 108.935 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.83 -64.36 0.88 Allowed Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.973 1.471 . . . . 33.13 114.973 -163.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.15 -9.43 16.54 Favored 'Trans proline' 0 C--N 1.381 2.279 0 CA-C-N 122.3 1.857 . . . . 75.22 113.14 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -84.45 -38.68 19.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 71.12 110.599 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.3 p -81.66 -12.29 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.979 0.418 . . . . 63.22 111.414 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.84 -7.57 53.86 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.257 0.465 . . . . 72.14 112.257 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.39 -20.8 59.93 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.513 0.725 . . . . 71.13 110.653 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.94 76.01 10.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.853 1.261 . . . . 61.12 110.083 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -84.96 67.89 10.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.152 0.977 . . . . 62.41 111.578 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -147.4 -179.43 6.84 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.634 1.174 . . . . 74.44 108.553 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -66.65 122.1 80.46 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.673 0.389 . . . . 55.45 111.444 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HG3' HD21 ' D' ' 68' ' ' LEU . 7.7 Cg_exo -75.75 133.75 15.84 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.281 2.654 . . . . 72.25 111.631 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -88.66 132.39 34.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.704 -0.48 . . . . 73.31 109.704 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.89 140.07 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.785 0.834 . . . . 74.12 110.004 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 75.2 mmtt -116.0 112.92 22.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.49 1.116 . . . . 64.04 108.033 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.745 HD21 HD22 ' D' ' 128' ' ' LEU . 10.0 mp -95.79 119.79 34.92 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.478 -0.564 . . . . 73.05 109.478 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -113.17 141.75 46.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.236 -1.024 . . . . 72.14 108.236 173.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -118.61 130.96 56.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.473 0.709 . . . . 72.22 110.142 -171.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.6 t70 -139.23 146.14 40.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.079 0.952 . . . . 65.14 108.687 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 49.0 m -141.86 143.98 33.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.63 -0.878 . . . . 60.54 108.63 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.97 162.96 38.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.065 0.946 . . . . 62.24 108.806 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -151.87 155.65 38.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.492 0.317 . . . . 51.4 111.535 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.0 p -155.37 126.92 7.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.63 1.172 . . . . 53.3 109.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.51 123.55 24.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.622 0.769 . . . . 70.34 111.121 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.6 mt -90.63 -33.52 15.81 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.328 0.393 . . . . 72.23 110.588 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.17 -170.11 0.94 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.06 0.544 . . . . 74.24 111.82 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.22 121.99 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.825 0.85 . . . . 60.42 110.043 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 64.42 4.33 2.18 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.346 1.458 . . . . 74.44 112.212 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.04 124.82 67.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.93 0.892 . . . . 62.11 108.833 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.74 128.98 23.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.735 -1.209 . . . . 74.53 107.735 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.426 ' HB2' HD11 ' D' ' 51' ' ' LEU . 16.8 tt0 -92.54 129.99 38.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.171 -1.048 . . . . 70.23 108.171 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.77 124.85 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.179 -1.045 . . . . 75.31 108.179 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.6 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -100.53 142.14 16.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.373 0.669 . . . . 74.45 109.594 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' CB ' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.44 120.91 39.58 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.932 -1.136 . . . . 73.32 107.932 177.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.4 ttm-85 -104.25 101.02 10.75 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.629 -0.878 . . . . 74.51 108.629 174.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -92.29 107.35 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.167 -1.049 . . . . 73.15 108.167 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 35.4 m -97.23 137.21 36.59 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.597 -0.728 . . . . 52.21 109.228 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 67.5 t -128.94 127.37 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.857 -1.164 . . . . 64.22 107.857 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 86.7 m -125.96 105.72 9.11 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.395 -0.965 . . . . 74.14 108.395 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.51 142.15 35.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.419 -0.809 . . . . 74.43 108.973 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.6 m -145.25 132.78 20.83 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.659 0.599 . . . . 51.13 111.229 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' D' ' 38' ' ' PRO . 13.8 mt -106.24 112.67 25.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.466 -1.243 . . . . 74.25 109.458 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.94 -113.57 4.61 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.263 -0.426 . . . . 71.25 112.085 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 3.99 18.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.169 0.587 . . . . 74.43 111.452 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -121.36 161.69 21.66 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.732 0.413 . . . . 73.31 110.124 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -78.12 125.11 28.87 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.206 0.603 . . . . 61.15 110.624 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.726 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.09 -64.14 1.12 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.822 0.849 . . . . 44.22 109.124 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -155.42 164.35 38.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.596 -0.729 . . . . 61.02 111.435 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.22 110.08 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.978 -1.489 . . . . 65.24 106.978 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.573 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.2 t -122.12 116.37 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.241 -0.651 . . . . 70.13 109.241 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -144.07 125.88 15.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.201 0.6 . . . . 72.01 109.82 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' D' ' 113' ' ' CYS . 84.4 t -127.75 116.22 42.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.742 0.817 . . . . 54.3 109.569 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.691 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.5 mt-30 -89.52 86.71 6.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.896 0.855 . . . . 74.32 109.232 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.405 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.5 tp-100 -80.25 100.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.056 -1.429 . . . . 63.2 109.56 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.79 144.36 17.13 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.922 -0.471 . . . . 72.53 111.922 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.16 139.28 9.12 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.711 -0.556 . . . . 61.24 111.711 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.81 127.71 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.161 -1.052 . . . . 53.44 108.161 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.17 153.33 41.7 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.844 0.857 . . . . 71.43 110.09 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -107.44 94.1 4.91 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.973 -1.121 . . . . 73.11 107.973 169.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tt -116.31 137.33 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.97 0.908 . . . . 72.54 110.079 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.17 155.76 11.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.051 0.94 . . . . 63.15 110.305 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.47 22.36 73.08 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 116.602 1.401 . . . . 75.31 116.602 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' D' ' 94' ' ' MET . 0.9 OUTLIER -121.16 152.22 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.281 0.632 . . . . 52.01 110.704 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -161.65 164.79 29.03 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 114.854 -1.066 . . . . 75.41 109.699 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.38 -129.2 36.86 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.443 -0.799 . . . . 74.13 113.362 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -70.96 -31.51 68.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.244 1.018 . . . . 73.32 111.635 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -70.73 -34.7 72.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 72.14 110.437 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.497 ' HG2' HD13 ' D' ' 89' ' ' ILE . 1.1 tmt? -74.57 -29.58 61.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.025 0.53 . . . . 64.31 110.22 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -38.89 91.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.285 0.634 . . . . 75.1 110.782 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.4 -29.07 41.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.247 -0.888 . . . . 73.44 111.313 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -78.6 -53.12 7.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.636 0.375 . . . . 61.42 111.027 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.57 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 52.8 tp -92.11 -48.28 6.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.109 0.564 . . . . 52.22 110.89 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.53 -14.13 82.3 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.403 0.44 . . . . 63.34 113.875 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.83 -55.88 1.06 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.877 0.471 . . . . 70.22 111.589 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -75.68 -37.03 59.9 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.908 0.707 . . . . 72.22 112.908 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 73.6 m -59.08 -52.9 71.47 Favored Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 118.851 -0.595 . . . . 73.4 111.441 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.406 ' CB ' ' HG ' ' D' ' 60' ' ' LEU . 37.5 Cg_endo -66.65 -23.41 49.26 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.81 1.673 . . . . 73.51 113.221 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.59 -37.81 85.69 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.745 0.418 . . . . 74.44 110.785 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -61.31 -43.02 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.596 0.758 . . . . 75.21 110.177 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' D' ' 80' ' ' GLN . 65.5 mt -79.91 -17.46 53.03 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.03 -0.986 . . . . 72.02 112.031 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -66.77 -43.65 50.13 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.139 1.163 . . . . 73.45 114.139 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.51 -33.78 79.54 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 121.951 1.768 . . . . 61.2 112.932 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -88.62 -26.24 22.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.709 -1.132 . . . . 73.14 111.03 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.34 72.36 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.903 0.859 . . . . 64.22 109.102 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.472 ' NH2' HG23 ' B' ' 105' ' ' ILE . 41.3 ttp180 -61.41 -41.33 96.97 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 113.4 -1.727 . . . . 72.41 110.709 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 108' ' ' PRO . 9.6 tt0 -43.73 -54.64 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.779 1.232 . . . . 62.51 111.874 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' D' ' 21' ' ' ILE . 42.6 t -70.05 -48.31 58.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.604 -1.18 . . . . 63.43 111.083 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.573 HG23 ' SG ' ' D' ' 76' ' ' CYS . 45.5 mt -56.44 -58.73 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.812 0.845 . . . . 71.13 110.901 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -52.0 -42.87 63.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.8 1.24 . . . . 71.01 112.295 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.2 -41.55 66.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.193 -0.912 . . . . 71.51 110.923 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 57.8 mtm -68.46 -32.14 71.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.811 0.444 . . . . 63.24 111.424 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -61.84 -45.55 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 123.804 0.69 . . . . 64.32 109.896 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.4 -29.14 62.4 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.938 -0.574 . . . . 73.12 111.11 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -71.54 -33.05 68.82 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.697 0.799 . . . . 75.0 110.723 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.32 3.75 80.14 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.667 -0.697 . . . . 61.03 112.213 173.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 64.81 26.16 12.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.801 2.04 . . . . 74.11 112.933 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -91.94 161.9 32.28 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 114.556 -1.202 . . . . 71.21 108.818 167.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.64 126.97 17.01 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 122.287 1.991 . . . . 72.1 111.519 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.452 ' HB3' HG23 ' A' ' 122' ' ' THR . 51.5 tt0 -53.38 128.03 27.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.364 1.066 . . . . 74.11 111.827 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.7 tp -115.01 97.86 6.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.643 -0.708 . . . . 62.34 110.203 -166.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.49 ' OD1' ' HB ' ' B' ' 16' ' ' ILE . 46.6 m-80 -99.42 99.05 9.92 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.998 -0.742 . . . . 72.31 108.998 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.745 HD22 HD21 ' D' ' 42' ' ' LEU . 48.2 mt -66.85 120.99 14.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.039 0.936 . . . . 73.43 111.146 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.83 137.66 96.86 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.367 0.667 . . . . 74.5 111.978 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 3.2 Cg_exo -73.91 122.34 7.62 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.557 2.171 . . . . 73.31 110.446 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -107.86 120.52 59.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.25 0.62 . . . . 70.24 109.473 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 . . . . . 0 CA--C 1.542 0.64 0 CA-C-N 115.076 -0.965 . . . . 62.42 108.413 177.086 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 m . . . . . 0 C--O 1.24 0.592 0 N-CA-C 109.488 -0.56 . . . . 75.23 109.488 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HE1' ' HG ' ' A' ' 102' ' ' CYS . 67.2 t80 -129.05 140.01 51.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.742 -1.207 . . . . 71.5 107.742 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 27.3 tp60 -149.79 130.51 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.685 0.394 . . . . 70.01 110.162 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.79 112.83 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.549 -1.278 . . . . 73.33 107.549 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.461 ' NE2' ' HB2' ' A' ' 85' ' ' SER . 8.0 mm-40 -87.88 -38.03 15.98 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.104 0.252 . . . . 70.34 110.94 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -171.95 124.32 0.53 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.954 0.502 . . . . 71.41 110.798 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 80.4 mt -108.6 135.78 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 74.3 108.767 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.635 ' HB3' HG23 ' B' ' 122' ' ' THR . 16.9 p90 -170.5 176.35 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.915 0.759 . . . . 70.43 111.489 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -98.78 128.95 45.16 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.114 -0.698 . . . . 62.35 109.114 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -92.5 -38.04 12.17 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.207 -0.664 . . . . 75.52 109.207 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -135.86 136.53 40.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.601 -1.181 . . . . 75.44 109.502 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.2 mt -135.97 139.52 45.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.949 -1.5 . . . . 62.12 106.949 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 t -149.28 122.78 9.11 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 123.474 0.484 . . . . 65.23 110.222 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.3 t80 -119.9 114.54 22.23 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.522 -1.658 . . . . 75.34 106.522 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.35 117.62 29.02 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.402 -0.592 . . . . 73.11 109.402 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.67 81.56 67.21 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 108.145 -1.057 . . . . 72.31 108.145 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.32 -35.03 42.15 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.563 2.175 . . . . 60.41 111.628 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.0 m-20 -104.98 31.54 4.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.26 -0.882 . . . . 74.43 109.62 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.41 99.66 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.299 1.039 . . . . 54.23 112.684 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.01 -26.24 11.08 Favored 'Trans proline' 0 C--N 1.38 2.23 0 CA-C-N 121.277 1.492 . . . . 63.4 113.721 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -70.7 -23.01 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.38 0.672 . . . . 61.5 112.357 -173.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.608 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.6 p -61.19 -20.39 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.15 0.58 . . . . 74.01 111.27 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.6 -39.57 91.69 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.246 1.018 . . . . 63.31 111.693 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.91 -28.27 17.38 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.679 0.392 . . . . 60.12 110.961 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.63 149.86 28.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.061 0.544 . . . . 64.43 111.204 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.5 147.36 41.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.443 0.697 . . . . 71.51 110.337 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.462 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.7 t-105 -93.81 76.96 4.23 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.605 0.717 . . . . 63.3 110.183 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -121.75 82.45 41.84 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 106.309 -1.737 . . . . 61.32 106.309 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.12 136.99 9.36 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.691 2.261 . . . . 52.41 113.082 -170.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.34 84.32 3.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.456 -1.683 . . . . 65.23 106.456 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.25 101.06 4.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 114.193 -1.367 . . . . 75.53 108.971 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -79.32 114.55 18.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.534 -0.913 . . . . 73.2 108.534 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.7 116.48 28.93 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.187 -1.412 . . . . 74.32 107.187 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.1 t70 -126.25 138.9 53.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.824 -0.806 . . . . 62.22 108.824 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.3 tp -130.38 120.03 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.995 -0.743 . . . . 71.21 108.995 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -135.65 157.15 47.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.676 0.79 . . . . 73.13 109.522 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -127.75 159.63 34.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.691 0.796 . . . . 64.11 109.662 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.39 136.06 21.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.694 1.198 . . . . 74.31 107.97 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.6 m -107.86 160.11 16.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 52.4 110.312 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -157.74 150.28 22.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.962 0.905 . . . . 54.45 109.385 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.01 140.25 47.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.239 -1.023 . . . . 74.34 108.239 170.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -115.59 -37.68 3.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.567 0.747 . . . . 74.33 110.569 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -158.15 -179.28 7.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.912 0.885 . . . . 74.2 110.318 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.28 114.52 3.22 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.633 -0.712 . . . . 65.33 109.262 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 69.15 0.99 3.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.893 1.277 . . . . 55.14 113.402 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 23.9 t -106.73 108.62 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.885 -1.154 . . . . 64.32 107.885 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 160.64 26.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.059 -0.719 . . . . 70.43 109.059 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.87 134.69 47.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.77 0.828 . . . . 70.12 108.948 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.5 t -118.13 122.23 69.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.321 -1.363 . . . . 64.31 107.321 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -98.69 134.74 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.727 0.811 . . . . 43.44 109.429 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.05 114.15 28.02 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.889 -1.152 . . . . 74.34 107.889 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.18 100.47 10.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.146 -0.687 . . . . 71.21 109.146 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 t -99.66 141.7 16.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.461 -0.94 . . . . 71.31 108.461 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 19.5 m -130.99 133.7 46.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.111 0.481 . . . . 65.41 110.533 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.5 t -130.62 109.48 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.341 1.457 . . . . 75.11 107.741 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -112.11 128.42 56.21 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.117 -0.697 . . . . 65.33 109.117 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.67 13.91 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.792 -0.818 . . . . 60.24 108.792 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 30.9 m -114.93 126.61 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.001 0.52 . . . . 74.22 110.051 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD21 ' CE3' ' A' ' 36' ' ' TRP . 25.7 mt -89.73 65.27 6.77 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.855 -1.165 . . . . 53.2 107.855 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 -101.8 1.23 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.101 -0.954 . . . . 75.03 110.999 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -88.36 -27.4 21.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.428 1.091 . . . . 74.02 110.126 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -98.05 94.79 7.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 71.24 110.08 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 92.6 m -67.41 125.58 26.58 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.839 0.745 . . . . 54.23 111.03 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.35 -56.85 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.83 0.852 . . . . 74.52 109.769 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -161.07 174.84 13.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.493 -1.23 . . . . 71.32 111.781 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -139.11 130.53 27.04 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.955 -1.498 . . . . 71.21 106.955 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.514 ' HB3' HG23 ' A' ' 114' ' ' ILE . 74.8 m -130.27 101.77 5.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.463 1.105 . . . . 64.44 109.761 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.44 121.56 29.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.836 -0.801 . . . . 71.01 108.836 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.4 t -129.49 129.62 66.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 123.458 0.703 . . . . 45.42 109.391 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.9 mt-30 -102.51 90.65 3.93 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.497 -0.774 . . . . 73.41 109.49 171.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -77.08 95.46 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.39 -1.277 . . . . 70.01 108.614 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.97 143.18 19.57 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 112.138 -0.385 . . . . 74.31 112.138 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.48 122.35 1.94 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 111.598 -0.601 . . . . 72.33 111.598 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -80.89 125.56 39.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.083 -1.08 . . . . 71.34 108.083 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -132.1 132.45 43.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.593 0.757 . . . . 74.23 110.582 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 33.4 t -80.24 122.79 27.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.451 -0.944 . . . . 72.54 108.451 166.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 tp -129.44 146.52 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.141 -0.688 . . . . 64.52 109.141 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.88 162.14 7.33 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.048 0.939 . . . . 61.1 110.978 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.03 7.61 88.35 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 115.688 1.035 . . . . 65.34 115.688 168.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' H ' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -114.66 141.13 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.818 0.809 . . . . 55.02 109.864 -174.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.402 ' H ' ' NE2' ' A' ' 93' ' ' GLN . 45.7 mt-10 -146.25 170.31 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.874 0.47 . . . . 73.41 110.345 173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 -115.8 4.99 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.18 0.925 . . . . 42.03 114.22 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.2 p -68.3 -34.16 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.363 1.065 . . . . 72.2 111.653 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 90' ' ' GLU . 44.5 mt-30 -57.97 -44.38 87.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.956 0.902 . . . . 74.25 110.839 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.0 tpt -76.61 -40.68 48.69 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.869 -0.605 . . . . 70.41 111.022 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.44 71.89 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.322 0.582 . . . . 63.42 111.066 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -79.25 -41.82 27.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.104 0.962 . . . . 73.22 111.097 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 23.3 t -74.24 -63.6 1.19 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.772 0.429 . . . . 71.32 110.233 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.06 -33.34 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.928 0.891 . . . . 75.22 111.57 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.78 -10.46 63.04 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 115.239 0.855 . . . . 63.14 115.239 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.15 -55.47 0.32 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.971 0.886 . . . . 72.13 111.799 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.24 -60.07 2.9 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.53 0.567 . . . . 73.22 112.53 -168.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.402 ' HG ' ' HE1' ' A' ' 11' ' ' PHE . 30.5 m -55.88 -48.24 97.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.573 0.749 . . . . 71.43 112.865 -176.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.2 Cg_endo -67.82 -28.95 35.89 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 120.702 1.287 . . . . 60.13 113.809 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.79 -19.9 51.08 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.295 0.952 . . . . 63.54 111.807 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.54 -38.57 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.216 1.007 . . . . 75.03 109.497 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.515 HD21 ' HA3' ' A' ' 82' ' ' GLY . 51.7 mt -75.94 -18.97 59.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.017 -1.447 . . . . 74.04 112.124 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 38.9 t80 -65.87 -40.53 39.55 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.462 1.282 . . . . 75.42 114.462 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.91 -39.65 83.8 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.154 1.903 . . . . 63.51 113.444 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -80.68 -33.84 35.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.389 -0.823 . . . . 75.42 111.546 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.85 81.5 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.02 -0.733 . . . . 71.31 109.02 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -52.15 -53.93 36.96 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.624 -1.171 . . . . 65.34 110.566 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.6 tm-20 -61.14 -41.19 96.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.044 0.84 . . . . 75.14 111.315 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.79 -47.63 84.28 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.892 -0.595 . . . . 71.42 110.714 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 76' ' ' CYS . 97.8 mt -63.11 -47.71 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.133 0.973 . . . . 64.0 110.717 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.545 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.7 m -60.68 -41.88 95.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.523 1.129 . . . . 51.13 111.56 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.01 -43.39 78.95 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.684 -0.689 . . . . 60.22 110.602 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -55.65 -43.84 76.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.617 0.767 . . . . 70.43 111.453 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.41 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.938 0.895 . . . . 74.31 111.113 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -70.36 -26.97 63.97 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.292 -0.413 . . . . 42.23 111.294 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -73.93 -32.1 63.36 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.712 0.805 . . . . 71.05 109.952 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.51 -1.62 71.57 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.958 0.786 . . . . 72.24 112.875 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.8 m 67.81 40.28 2.44 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.87 1.319 . . . . 55.44 110.071 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.608 ' HE1' HG11 ' A' ' 31' ' ' VAL . 43.9 m-85 -116.72 152.31 48.27 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 114.524 -1.217 . . . . 73.5 109.579 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 135.69 60.96 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.114 2.543 . . . . 74.41 113.459 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.5 tt0 -58.74 139.5 56.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 54.31 112.304 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 tp -117.08 115.08 24.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.136 -0.69 . . . . 70.15 109.136 176.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -100.3 93.65 5.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.683 -0.858 . . . . 74.3 108.683 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -65.89 135.33 54.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.45 0.7 . . . . 53.35 109.9 -176.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.79 131.07 91.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 122.957 0.503 . . . . 74.01 111.897 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.39 110.77 2.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.596 2.197 . . . . 70.31 111.709 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.14 110.78 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.248 -1.019 . . . . 52.54 108.248 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -110.82 72.22 0.77 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.231 1.012 . . . . 74.22 112.749 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 73.02 110.732 169.068 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.244 0.788 0 N-CA-C 109.313 -0.625 . . . . 75.2 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.22 131.6 30.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.014 0.925 . . . . 72.01 108.9 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 24.4 tm0? -142.47 134.36 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.728 -1.212 . . . . 74.23 107.728 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -97.3 118.37 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 32.51 109.874 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.18 -53.56 4.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.692 0.282 . . . . 74.33 110.973 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 43.8 ttt180 -161.17 141.04 10.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.412 -0.358 . . . . 74.43 110.57 -169.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -115.8 143.64 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 107.96 -1.126 . . . . 74.44 107.96 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.426 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.9 p90 -168.9 158.22 8.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.356 0.598 . . . . 75.45 111.553 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -83.89 127.82 34.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.248 -0.887 . . . . 75.1 108.648 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.499 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -96.09 -41.2 8.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.165 0.586 . . . . 71.32 109.713 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.7 t70 -147.42 139.29 24.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.851 -0.613 . . . . 71.01 110.597 -168.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.442 HD12 HG22 ' B' ' 78' ' ' VAL . 42.2 mm -138.07 137.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.81 1.244 . . . . 53.02 108.811 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -138.8 125.09 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.05 -1.092 . . . . 55.22 108.05 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.6 t80 -137.59 108.05 6.52 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.17 -1.419 . . . . 60.21 107.17 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.81 117.83 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.438 -0.949 . . . . 75.4 108.438 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.823 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -112.82 87.89 10.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.796 0.838 . . . . 75.0 109.504 -176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 -38.24 10.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.075 2.517 . . . . 74.54 112.736 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.43 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 66.1 m-20 -111.74 29.07 8.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.445 0.698 . . . . 74.21 109.622 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.823 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.12 -54.58 23.66 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.787 1.235 . . . . 74.53 113.107 172.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 5.6 Cg_exo -76.22 -19.17 15.63 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.036 1.824 . . . . 64.32 111.754 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.43 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 80.7 m-70 -85.43 3.03 41.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.312 1.045 . . . . 71.15 111.408 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -69.45 -14.94 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 CA-C-O 121.419 0.628 . . . . 70.41 109.736 163.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -70.58 -28.77 65.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.754 0.821 . . . . 72.21 109.832 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.62 -39.7 18.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.314 0.646 . . . . 73.0 109.609 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -102.51 75.23 1.44 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.292 1.037 . . . . 62.33 109.955 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.49 76.44 5.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.824 0.849 . . . . 73.43 110.648 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -163.7 160.32 22.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.762 0.825 . . . . 74.12 109.403 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -69.84 118.61 64.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.208 1.003 . . . . 74.22 109.518 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.76 152.0 82.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.176 1.918 . . . . 55.11 113.026 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.24 119.06 13.87 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.473 -0.785 . . . . 71.54 109.033 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 t -85.01 119.66 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.466 -1.309 . . . . 73.12 107.466 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -134.73 138.59 44.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' B' ' 128' ' ' LEU . 0.0 OUTLIER -128.57 166.42 18.87 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.783 0.833 . . . . 71.35 111.542 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 121.24 1.55 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.423 -0.954 . . . . 71.12 108.423 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.1 163.74 21.81 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.361 0.6 . . . . 63.13 110.724 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -161.06 135.89 7.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.477 1.111 . . . . 74.13 108.447 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -108.65 119.68 40.24 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.843 0.354 . . . . 74.41 110.376 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.48 159.26 22.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.141 0.976 . . . . 73.01 108.711 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.497 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 73.9 m -144.39 162.69 35.84 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.178 -0.326 . . . . 71.22 111.464 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.1 t -157.12 137.9 13.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.078 0.951 . . . . 71.4 109.62 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -105.51 131.07 53.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.338 -0.616 . . . . 64.44 109.338 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -98.36 -41.75 7.68 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.455 0.645 . . . . 73.44 109.472 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.84 10.87 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.596 -1.184 . . . . 63.25 109.358 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -76.57 134.17 39.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 70.51 108.414 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.3 -3.63 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.934 1.294 . . . . 62.45 111.811 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.54 95.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.298 1.039 . . . . 71.35 108.354 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.497 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 8.4 t80 -113.83 139.54 49.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.012 0.434 . . . . 72.32 110.623 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -121.85 108.4 13.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.873 0.869 . . . . 75.14 109.488 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.1 132.86 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.033 0.533 . . . . 34.12 110.093 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 40.8 t -104.14 116.94 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.308 0.643 . . . . 73.43 109.838 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -94.1 115.77 28.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.876 -0.787 . . . . 64.35 108.876 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -102.16 123.75 46.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.955 0.407 . . . . 61.23 110.419 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 75.0 t -117.07 108.3 24.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.686 -1.227 . . . . 72.02 107.686 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.5 m -97.84 146.54 25.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.326 -0.62 . . . . 74.21 109.326 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.531 HG21 HG21 ' B' ' 114' ' ' ILE . 72.5 t -132.58 136.34 56.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 124.464 1.106 . . . . 72.43 109.578 -171.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.39 149.5 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.426 1.09 . . . . 53.32 109.012 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.46 161.76 37.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.214 0.606 . . . . 72.41 110.359 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.4 p -148.48 147.42 29.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.595 0.591 . . . . 63.44 112.595 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.5 mt -124.19 107.06 10.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.689 -1.597 . . . . 72.11 106.689 172.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -111.39 3.46 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.285 -0.731 . . . . 71.45 111.347 -171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.18 3.24 12.66 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.901 0.85 . . . . 62.31 111.665 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -114.25 167.19 10.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.708 0.403 . . . . 71.24 110.402 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -64.88 144.03 57.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.324 0.65 . . . . 61.44 110.467 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.425 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -100.69 -58.77 1.83 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.374 -0.973 . . . . 41.41 108.374 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -150.92 166.38 30.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 113.833 -1.53 . . . . 75.12 109.276 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -134.91 140.37 45.7 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.428 -1.323 . . . . 72.22 107.428 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.498 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.1 t -140.82 159.96 41.08 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.575 0.75 . . . . 74.33 109.146 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.33 137.45 4.21 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.942 0.897 . . . . 72.01 108.601 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.442 HG22 HD12 ' B' ' 21' ' ' ILE . 77.3 t -128.64 141.03 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.45 0.7 . . . . 73.03 109.179 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -124.63 91.61 3.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 72.5 108.992 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.434 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -89.15 102.17 14.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.875 -1.057 . . . . 60.31 108.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.499 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.57 142.82 16.36 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.775 -0.53 . . . . 44.1 111.775 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.74 128.43 4.44 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.407 -0.677 . . . . 43.4 111.407 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.426 HG13 ' HE1' ' B' ' 17' ' ' TYR . 44.7 mt -83.29 126.89 40.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -135.18 135.48 41.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.249 0.619 . . . . 74.55 109.623 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 20.2 m -87.43 100.46 12.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.033 -1.099 . . . . 61.2 108.033 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.6 122.34 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.709 0.804 . . . . 74.12 109.63 -170.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.22 172.33 18.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.13 0.972 . . . . 62.33 111.097 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -28.12 6.65 Favored Glycine 0 C--N 1.357 1.708 0 CA-C-N 116.046 -0.525 . . . . 75.01 112.832 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.93 157.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.039 1.336 . . . . 63.21 113.451 -175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -161.32 143.15 11.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.535 -0.757 . . . . 72.32 109.866 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.49 -93.42 0.03 OUTLIER Glycine 0 C--N 1.362 1.979 0 O-C-N 124.324 1.015 . . . . 23.24 113.912 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.2 m -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.369 1.068 . . . . 73.44 110.604 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -67.55 -29.17 68.49 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.443 0.697 . . . . 60.34 111.505 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 52.8 tpp -67.02 -50.08 63.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.745 0.418 . . . . 63.14 110.495 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.31 -30.47 64.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.6 0.76 . . . . 71.04 111.834 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.69 -55.17 5.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.72 0.408 . . . . 71.04 110.024 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 42.8 t -69.35 -66.73 0.55 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.647 0.592 . . . . 75.42 110.819 -172.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tt -71.3 -26.74 62.98 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.751 0.421 . . . . 65.25 110.277 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.01 -39.06 13.65 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 114.976 0.751 . . . . 72.12 114.976 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.62 -46.88 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.718 0.759 . . . . 72.05 112.059 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.487 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 88.2 t80 -64.61 -54.35 33.32 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.554 0.741 . . . . 71.02 112.607 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.471 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.3 m -61.6 -46.82 93.87 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.476 0.71 . . . . 72.52 111.424 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.2 Cg_exo -58.04 -36.98 97.61 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 121.843 1.696 . . . . 74.44 113.873 167.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -72.16 -21.18 61.48 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 122.872 0.469 . . . . 75.43 111.463 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.469 HG23 ' NH2' ' D' ' 111' ' ' ARG . 56.9 mt -64.2 -45.0 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.641 0.776 . . . . 72.41 109.901 167.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 28.2 mt -84.4 -11.02 57.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.319 -1.31 . . . . 75.3 111.37 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.498 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 63.4 t80 -63.26 -45.49 85.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.023 1.329 . . . . 74.45 113.934 -172.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.27 -36.05 81.64 Favored 'Trans proline' 0 C--N 1.374 1.878 0 CA-C-N 121.226 1.473 . . . . 64.35 112.657 173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.2 m-85 -65.6 -40.5 92.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.969 0.508 . . . . 74.13 110.764 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -47.94 72.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.847 0.459 . . . . 61.52 110.266 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -51.35 -49.21 61.89 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.67 1.188 . . . . 71.24 111.369 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -38.97 79.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.632 -1.167 . . . . 74.42 109.898 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -71.28 -34.18 70.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.91 -0.586 . . . . 74.01 111.33 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.531 HG21 HG21 ' B' ' 64' ' ' VAL . 73.2 mt -67.54 -52.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.854 0.462 . . . . 61.33 109.766 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.4 HG23 HE21 ' C' ' 125' ' ' GLN . 24.4 m -53.36 -33.11 52.35 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 123.941 0.775 . . . . 63.22 111.401 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.0 t -65.8 -62.74 1.33 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.308 0.643 . . . . 62.32 110.648 172.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.52 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.8 mmt -61.25 -33.3 73.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.346 0.658 . . . . 65.31 112.449 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -76.96 -39.85 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.604 0.762 . . . . 74.03 110.693 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.494 ' HB3' HE22 ' C' ' 125' ' ' GLN . 91.3 p -66.39 -28.94 69.03 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.474 0.654 . . . . 44.25 111.15 176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.52 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 84.2 mtt-85 -61.86 -31.78 72.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.523 -0.762 . . . . 74.24 110.205 174.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.58 12.85 58.04 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 119.425 -0.653 . . . . 73.5 114.145 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 17' ' ' TYR . 15.0 p 61.63 21.27 11.99 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.01 1.724 . . . . 64.33 111.965 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -105.08 159.66 28.63 Favored Pre-proline 0 CA--C 1.567 1.624 0 C-N-CA 123.801 0.84 . . . . 63.21 110.738 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.71 156.85 64.38 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 123.814 3.009 . . . . 63.51 115.541 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' C' ' 125' ' ' GLN . 5.1 pm0 -63.06 156.81 23.75 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.741 0.816 . . . . 72.22 112.709 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.8 96.8 6.49 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.334 -0.987 . . . . 75.15 108.334 163.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -89.08 93.55 9.63 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.196 -2.15 . . . . 64.31 105.196 165.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' B' ' 42' ' ' LEU . 1.8 tt -81.44 135.79 35.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.101 -0.703 . . . . 73.44 109.101 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.74 132.86 89.1 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 124.067 0.855 . . . . 73.35 111.512 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.99 81.19 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.498 2.132 . . . . 75.2 111.471 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -78.21 75.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.279 -0.873 . . . . 74.35 110.34 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.11 84.84 1.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.482 -0.781 . . . . 65.31 109.013 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 CA--C 1.546 0.808 0 CA-C-N 115.478 -0.783 . . . . 63.42 111.063 -175.229 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 108.843 -0.799 . . . . 34.15 108.843 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -124.64 135.42 53.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.408 1.083 . . . . 70.53 108.352 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' C' ' 85' ' ' SER . 46.2 tt0 -146.35 105.28 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.09 0.556 . . . . 75.45 110.243 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.503 HD11 HD11 ' C' ' 16' ' ' ILE . 14.5 tt -72.14 129.91 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.43 0.692 . . . . 74.43 109.623 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.439 ' NE2' HE21 ' C' ' 12' ' ' GLN . 22.9 mm-40 -115.9 -49.16 2.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.919 0.487 . . . . 71.53 111.878 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -162.13 133.18 5.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.493 -0.558 . . . . 73.32 109.493 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.503 HD11 HD11 ' C' ' 13' ' ' ILE . 64.0 mt -123.14 138.35 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.583 -0.895 . . . . 74.41 108.583 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.3 p90 -174.73 162.75 3.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.806 0.336 . . . . 74.43 111.612 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -81.52 125.76 30.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.483 0.713 . . . . 72.23 110.064 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -75.57 -49.1 19.62 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.184 -1.043 . . . . 73.15 108.184 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -136.81 147.15 46.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.24 -1.345 . . . . 74.2 110.428 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.5 mt -143.44 145.47 22.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 126.19 1.796 . . . . 63.43 106.622 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -161.03 149.25 15.9 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.256 0.551 . . . . 70.44 110.465 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' D' ' 21' ' ' ILE . 85.7 t80 -149.41 118.25 6.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.327 -1.36 . . . . 72.11 107.327 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.19 122.61 44.52 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.06 -0.719 . . . . 63.0 109.06 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.44 80.86 46.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.054 -1.091 . . . . 43.14 108.054 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.6 -26.43 16.5 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.207 1.938 . . . . 74.2 110.525 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.22 16.16 6.6 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.587 1.155 . . . . 60.1 110.759 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.11 99.99 Favored Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 113.649 0.981 . . . . 65.03 113.649 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.44 -26.5 3.99 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 121.79 1.66 . . . . 72.24 112.699 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -70.18 -33.47 71.78 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.383 1.073 . . . . 64.33 111.841 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.455 HG23 HD11 ' C' ' 68' ' ' LEU . 13.2 p -79.69 -18.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.447 1.099 . . . . 72.12 111.401 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.85 -28.44 66.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.293 1.037 . . . . 72.41 112.154 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -127.79 44.43 2.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 54.23 109.86 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -121.26 159.75 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.665 0.786 . . . . 62.21 110.389 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.16 120.32 11.25 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.709 0.63 . . . . 75.25 110.236 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -85.28 97.43 9.94 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.072 0.939 . . . . 75.24 109.905 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -140.56 62.57 19.05 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.417 -0.957 . . . . 74.55 108.417 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' C' ' 67' ' ' SER . 14.8 Cg_exo -69.47 97.98 0.64 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.858 1.705 . . . . 64.44 112.282 -175.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.89 77.6 9.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.57 -1.65 . . . . 75.4 107.494 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' C' ' 126' ' ' LEU . 19.6 m -89.84 110.73 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 113.687 -1.597 . . . . 72.11 110.36 -170.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -133.09 147.07 52.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 60.31 110.948 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' C' ' 128' ' ' LEU . 1.5 pp -105.38 165.73 10.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.356 0.598 . . . . 71.41 112.103 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -140.91 130.78 24.4 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.262 1.425 . . . . 71.44 107.531 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.95 118.43 36.95 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.247 0.619 . . . . 75.33 110.265 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 35.7 t70 -115.14 155.97 26.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.304 -0.999 . . . . 64.44 108.304 166.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -134.49 140.72 46.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.438 0.695 . . . . 74.25 110.29 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.3 38.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.29 1.036 . . . . 70.34 109.253 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -155.3 148.88 25.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.49 0.716 . . . . 61.15 109.274 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 38.3 t -144.86 128.29 16.93 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.635 0.774 . . . . 75.33 109.153 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -82.75 117.11 22.43 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.992 -0.744 . . . . 64.32 108.992 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' C' ' 57' ' ' GLU . 79.6 mt -92.48 -32.61 14.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.464 0.706 . . . . 72.23 110.368 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.34 -179.82 8.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.134 -0.939 . . . . 74.12 109.229 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.17 127.29 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 71.25 108.996 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.97 18.29 10.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.477 1.111 . . . . 74.01 112.461 -174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.28 115.16 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.568 -0.901 . . . . 60.13 108.568 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -116.16 169.57 9.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.055 0.931 . . . . 75.3 110.844 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.9 tt0 -127.45 133.24 49.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.924 -1.944 . . . . 61.34 107.99 173.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.42 127.89 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.101 -1.444 . . . . 72.45 107.101 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.5 HG22 ' HA2' ' C' ' 81' ' ' GLY . 61.7 t -126.46 114.23 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.234 -0.654 . . . . 70.54 109.234 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' C' ' 103' ' ' PRO . 18.6 mt -86.6 130.53 34.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.585 -0.524 . . . . 64.34 109.585 172.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.597 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 49.1 mtp180 -101.45 104.27 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.197 -1.038 . . . . 73.43 108.197 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.59 110.42 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.475 -1.305 . . . . 74.23 107.475 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -110.85 145.65 37.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.842 -0.799 . . . . 74.03 108.842 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.795 HG11 ' HG ' ' C' ' 126' ' ' LEU . 53.3 t -128.58 135.26 62.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.899 0.88 . . . . 65.54 109.224 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -117.92 138.11 52.37 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.989 -1.115 . . . . 73.52 107.989 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.99 132.79 55.13 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.269 -1.012 . . . . 44.54 108.269 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.7 m -132.96 164.21 27.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.833 0.708 . . . . 64.44 109.262 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.455 HD11 HG23 ' C' ' 31' ' ' VAL . 14.4 mt -124.04 29.08 6.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 106.926 -1.509 . . . . 74.33 106.926 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.82 -100.76 1.73 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.082 -0.963 . . . . 74.54 110.85 -169.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -89.67 -32.51 17.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.392 0.677 . . . . 71.24 110.107 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.65 120.84 32.05 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.616 0.766 . . . . 71.14 109.454 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -67.65 140.47 56.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.89 0.476 . . . . 74.34 111.026 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.43 -51.41 4.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.803 0.441 . . . . 64.21 109.931 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -168.5 177.27 5.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.944 0.898 . . . . 70.22 111.299 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.476 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -137.04 147.34 46.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.086 1.354 . . . . 73.14 107.391 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.476 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.0 t -148.99 153.48 37.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.349 0.66 . . . . 71.14 109.395 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -158.82 140.96 13.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.458 0.703 . . . . 71.11 109.905 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.98 119.26 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.714 0.806 . . . . 74.52 109.531 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.597 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 47.8 mt-30 -91.14 98.4 11.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.052 0.941 . . . . 64.33 109.623 172.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.473 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.2 tp-100 -88.78 107.82 19.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.617 0.767 . . . . 71.31 110.615 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.5 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -84.07 158.72 35.02 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.77 0.669 . . . . 75.4 113.041 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.64 117.29 0.77 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.481 -0.648 . . . . 33.23 111.481 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.457 HD12 ' CD1' ' C' ' 51' ' ' LEU . 15.0 mm -81.81 122.47 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.34 -0.615 . . . . 62.22 109.34 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -135.71 119.23 16.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.682 0.793 . . . . 75.23 109.149 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.581 ' HB3' ' HB3' ' C' ' 12' ' ' GLN . 41.1 t -77.08 128.0 33.68 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.765 -0.828 . . . . 72.14 108.765 170.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.469 HD11 HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -145.99 126.9 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.501 0.72 . . . . 64.34 110.433 -166.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.85 176.19 11.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.591 1.157 . . . . 72.22 110.176 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -50.96 4.0 Favored Glycine 0 N--CA 1.48 1.626 0 CA-C-O 121.295 0.386 . . . . 62.04 113.257 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 125.448 1.499 . . . . 51.5 113.76 -172.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 47.2 mt-30 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 111.587 0.217 . . . . 71.5 111.587 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.631 ' HB3' HG12 ' C' ' 89' ' ' ILE . 19.7 ptm -68.95 -37.22 78.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.053 0.221 . . . . 74.35 111.454 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -33.74 75.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.286 0.634 . . . . 65.2 111.185 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -75.8 -33.56 60.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.75 -0.659 . . . . 74.51 109.97 176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -66.77 -60.97 2.21 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 123.559 0.744 . . . . 75.01 111.279 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -77.22 -18.43 57.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.173 -0.33 . . . . 71.23 111.275 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -25.83 61.13 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.115 -0.493 . . . . 51.51 113.892 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.03 -43.2 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.518 0.933 . . . . 61.15 113.518 -172.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.71 -65.27 0.7 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.26 0.624 . . . . 74.11 111.751 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 15.1 m -60.53 -43.1 91.65 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.827 0.851 . . . . 75.11 112.259 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.523 ' HB3' HD21 ' C' ' 60' ' ' LEU . 98.0 Cg_exo -51.02 -47.24 26.6 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.597 2.198 . . . . 74.24 114.771 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.05 -21.98 64.06 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 122.579 0.352 . . . . 74.4 111.485 -173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.5 mm -60.58 -45.53 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.563 0.745 . . . . 72.21 109.855 168.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 40.7 mt -85.8 -22.73 27.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.828 -1.078 . . . . 70.2 112.456 -170.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.88 -52.34 65.82 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.016 -0.992 . . . . 74.24 113.465 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.51 -31.88 70.93 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 121.599 1.532 . . . . 73.0 113.55 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -65.79 -47.88 73.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.04 0.536 . . . . 75.33 110.606 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.39 -41.9 96.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.444 0.698 . . . . 63.23 111.057 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.04 -50.13 75.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.687 1.195 . . . . 74.14 110.664 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.5 -33.96 76.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.517 0.727 . . . . 72.3 110.289 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.13 -36.21 74.63 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 122.688 0.395 . . . . 62.33 111.654 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -69.81 -43.36 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.578 -0.527 . . . . 74.11 109.578 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' GLN . 52.8 m -55.22 -38.62 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.255 1.022 . . . . 61.23 110.715 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -67.77 -53.65 25.52 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.638 -1.165 . . . . 50.22 110.272 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.717 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -49.79 -45.4 49.79 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.845 1.258 . . . . 73.42 112.921 -177.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.42 HG21 HD23 ' C' ' 126' ' ' LEU . 92.7 t -72.01 -40.66 67.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.748 -0.66 . . . . 74.5 111.346 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -61.83 -31.88 72.16 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.365 -0.834 . . . . 61.35 111.208 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.495 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.53 -34.99 79.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.866 0.866 . . . . 53.34 110.25 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.52 11.8 37.09 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 123.744 0.652 . . . . 75.33 113.687 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.582 HG23 ' HB3' ' D' ' 17' ' ' TYR . 44.7 p 59.81 27.58 16.91 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.949 1.699 . . . . 74.44 112.617 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -109.05 167.85 8.55 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.246 1.018 . . . . 73.15 110.704 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.78 118.12 4.92 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.255 2.637 . . . . 75.31 112.551 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.705 ' HB2' HG23 ' C' ' 115' ' ' THR . 3.6 pt20 -51.59 143.57 12.17 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.051 0.844 . . . . 74.54 111.709 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.795 ' HG ' HG11 ' C' ' 64' ' ' VAL . 2.5 mm? -97.58 59.66 1.53 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.726 1.25 . . . . 61.43 110.453 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' B' ' 122' ' ' THR . 32.1 t30 -95.61 83.85 3.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 112.927 -1.942 . . . . 75.44 107.414 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.517 HD12 ' HG ' ' C' ' 42' ' ' LEU . 21.7 mt -90.73 154.41 19.56 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.198 -0.91 . . . . 75.33 110.241 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -35.71 135.36 0.5 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 126.201 1.8 . . . . 73.45 115.107 -176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.77 93.73 0.44 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.636 2.224 . . . . 72.04 111.504 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.89 106.7 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.955 0.883 . . . . 64.21 111.759 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.48 71.69 0.75 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.773 0.829 . . . . 74.04 109.63 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 N--CA 1.485 1.291 0 CA-C-N 115.974 -0.557 . . . . 71.53 111.085 176.251 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.1 m . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 109.158 -0.682 . . . . 74.21 109.158 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.402 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 40.5 t80 -152.28 97.82 2.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 106.477 -1.675 . . . . 64.42 106.477 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 75.8 mt-30 -112.25 118.32 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.746 0.419 . . . . 53.13 110.814 -173.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.5 103.14 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 107.926 -1.139 . . . . 64.32 107.926 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.96 -50.06 8.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.581 0.173 . . . . 73.21 111.405 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -170.8 134.04 0.99 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.767 0.427 . . . . 75.43 110.479 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.23 130.66 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.582 ' HB3' HG23 ' C' ' 122' ' ' THR . 33.5 p90 -149.3 149.97 31.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.358 0.663 . . . . 73.25 111.895 -176.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.6 p -77.71 114.66 16.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.669 -0.696 . . . . 75.21 109.75 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -86.06 -20.25 29.06 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.915 0.486 . . . . 63.1 110.059 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.8 t70 -153.55 140.24 18.96 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.72 -1.127 . . . . 54.01 109.594 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.717 HD13 ' HE3' ' C' ' 117' ' ' MET . 96.3 mt -136.67 144.72 31.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 125.189 1.396 . . . . 73.23 107.554 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -154.76 133.62 12.22 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.959 0.787 . . . . 73.15 109.507 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.5 t80 -132.48 126.8 33.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.283 -1.747 . . . . 74.41 106.283 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -121.63 142.75 49.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.03 -1.1 . . . . 74.21 108.03 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.42 76.71 36.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 106.374 -1.713 . . . . 54.32 106.374 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.19 -34.15 28.83 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.822 2.348 . . . . 65.44 112.783 -169.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.457 ' O ' HG23 ' D' ' 31' ' ' VAL . 41.2 m-20 -116.13 23.3 12.28 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.091 0.956 . . . . 55.22 110.294 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -46.28 -50.47 38.55 Favored Pre-proline 0 CA--C 1.567 1.631 0 N-CA-C 116.462 2.023 . . . . 53.41 116.462 -167.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.86 -15.98 10.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 CA-C-N 122.137 1.799 . . . . 70.41 113.319 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -75.16 -26.87 59.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.668 1.187 . . . . 63.21 109.782 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 27' ' ' ASN . 70.4 t -80.02 -13.27 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.919 0.888 . . . . 52.43 110.648 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.46 -25.41 67.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.561 0.345 . . . . 71.32 110.543 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.12 -7.48 55.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 72.12 111.411 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -110.89 92.0 3.88 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.077 0.951 . . . . 75.53 109.478 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -97.41 77.76 2.65 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.097 0.559 . . . . 71.12 109.885 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -165.01 172.37 12.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.886 0.474 . . . . 72.23 110.141 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -60.19 116.09 16.02 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.512 1.125 . . . . 74.24 110.965 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.75 123.94 12.43 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.026 1.817 . . . . 55.4 110.884 172.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -57.85 110.94 1.0 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.15 105.87 19.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.397 -0.819 . . . . 63.51 109.139 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.9 115.42 29.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.524 -1.658 . . . . 74.53 106.524 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.22 155.88 16.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.161 0.584 . . . . 61.12 109.972 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -149.47 132.28 16.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.131 0.572 . . . . 61.42 109.726 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -112.06 137.04 50.64 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.834 0.854 . . . . 74.32 109.655 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.633 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 3.8 t70 -133.57 154.84 50.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.931 1.292 . . . . 63.24 108.06 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.3 m -137.19 146.33 44.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.161 0.585 . . . . 75.23 110.294 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 167.03 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.389 1.075 . . . . 62.42 108.891 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -164.71 155.75 14.9 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.968 0.507 . . . . 75.33 110.844 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.1 p -158.75 132.99 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 65.23 109.323 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.44 133.8 48.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.391 0.676 . . . . 71.52 110.541 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' D' ' 57' ' ' GLU . 38.6 mt -102.16 -40.52 6.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.43 0.692 . . . . 75.4 110.31 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.98 -169.48 2.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.257 0.623 . . . . 65.12 111.222 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.71 111.48 1.64 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.241 -0.89 . . . . 61.44 110.648 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 75.89 5.29 3.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.485 1.514 . . . . 72.31 110.739 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -108.57 121.19 61.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.216 0.606 . . . . 75.12 110.299 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.39 130.22 53.48 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.707 -1.22 . . . . 75.14 107.707 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' D' ' 51' ' ' LEU . 5.4 tm-20 -88.48 131.48 34.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.104 -1.813 . . . . 62.44 106.104 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.69 129.86 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.416 -0.957 . . . . 63.5 108.416 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -108.97 135.11 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.409 0.684 . . . . 74.34 110.604 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -115.74 124.08 49.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.789 -1.56 . . . . 74.13 106.789 171.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -106.77 99.6 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.72 -0.844 . . . . 71.31 108.72 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.87 122.52 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 74.43 108.136 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -121.43 134.37 55.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.357 -0.838 . . . . 50.51 109.635 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' D' ' 114' ' ' ILE . 86.2 t -124.58 102.77 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.79 0.836 . . . . 54.3 109.275 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -101.47 108.02 19.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.513 -0.921 . . . . 54.4 108.513 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.94 139.05 44.33 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.999 0.919 . . . . 54.03 109.131 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 79.2 p -143.39 138.93 29.74 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.077 0.551 . . . . 73.21 110.338 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -115.72 111.27 20.32 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.203 1.001 . . . . 74.25 109.656 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.03 10.94 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.517 0.511 . . . . 64.35 112.626 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 4.05 49.39 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.88 0.872 . . . . 73.2 110.95 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -131.32 147.87 52.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.513 0.725 . . . . 63.43 110.591 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -64.72 138.06 58.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.25 1.02 . . . . 50.11 111.277 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.11 -59.55 2.07 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.556 -0.905 . . . . 54.41 108.556 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -164.24 153.85 14.1 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.807 -1.088 . . . . 62.41 109.951 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 53.3 mt -113.41 154.47 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.019 . . . . 65.21 108.982 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.564 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.2 t -158.58 147.05 18.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.526 0.33 . . . . 74.44 110.436 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.52 121.31 5.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.896 0.878 . . . . 74.35 109.042 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.49 116.07 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 122.987 0.515 . . . . 75.53 109.846 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.726 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -90.11 87.85 7.04 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.638 0.732 . . . . 73.43 109.282 170.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.28 100.39 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.138 -1.392 . . . . 75.32 109.178 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.42 169.87 38.18 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.158 -0.377 . . . . 72.01 112.158 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.65 137.6 4.7 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 112.558 -0.217 . . . . 72.31 112.558 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.27 125.31 42.29 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.676 0.79 . . . . 72.14 109.653 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.07 142.63 50.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.654 0.782 . . . . 75.24 110.299 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 31.0 m -105.93 99.34 8.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.801 0.84 . . . . 54.03 108.796 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.69 138.4 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.423 1.089 . . . . 73.33 109.386 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.25 162.3 12.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.049 0.54 . . . . 54.44 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.51 85.06 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.979 -0.555 . . . . 72.4 113.665 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.419 ' H ' HD13 ' D' ' 89' ' ' ILE . 0.2 OUTLIER -126.74 169.04 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.501 0.72 . . . . 74.21 110.83 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -160.59 162.12 32.74 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.992 0.917 . . . . 72.43 109.54 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.67 -140.73 48.04 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.831 0.707 . . . . 72.45 114.035 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -62.22 -24.25 67.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.194 0.998 . . . . 72.43 111.909 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -61.47 -50.77 71.41 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.258 -0.645 . . . . 64.14 109.258 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 5.3 ptm -66.4 -34.53 78.16 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.487 0.492 . . . . 75.44 110.507 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.47 75.0 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.38 0.61 . . . . 55.24 111.294 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -69.32 -49.94 51.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 74.1 110.658 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -73.93 -38.39 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.848 -0.614 . . . . 74.41 111.672 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.523 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.6 tp -84.93 -29.67 24.96 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.353 0.661 . . . . 63.14 110.454 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.58 39.4 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.855 -0.611 . . . . 74.51 113.346 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -61.17 1.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.102 0.451 . . . . 74.14 111.705 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.33 -40.86 97.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.056 0.761 . . . . 74.54 113.056 -173.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 74.1 m -68.35 -47.4 37.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 CA-C-O 118.95 -0.547 . . . . 65.45 112.104 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.533 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.9 Cg_exo -59.45 -32.91 97.18 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 121.844 1.696 . . . . 61.31 113.267 168.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -64.38 -24.93 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.122 0.569 . . . . 73.04 111.717 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.41 -44.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.44 -0.578 . . . . 75.43 109.44 171.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' D' ' 60' ' ' LEU . 51.4 mt -70.86 -26.06 63.09 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.33 -0.85 . . . . 63.23 111.528 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.03 -44.9 91.06 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 115.076 1.51 . . . . 73.35 115.076 -166.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.72 -35.01 95.93 Favored 'Trans proline' 0 C--N 1.381 2.282 0 CA-C-N 122.039 1.764 . . . . 74.41 113.032 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -76.44 -35.38 58.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.708 0.803 . . . . 74.51 110.482 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -48.38 71.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.585 0.754 . . . . 52.31 110.025 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.469 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.9 ttp180 -56.52 -50.33 72.13 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 113.97 -1.468 . . . . 72.12 110.869 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.27 -45.44 94.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.085 0.866 . . . . 74.41 111.091 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.472 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.9 t -57.17 -39.83 76.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 71.14 111.05 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.564 HG23 ' SG ' ' D' ' 76' ' ' CYS . 76.6 mt -68.72 -56.98 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.465 0.706 . . . . 61.41 109.847 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -49.46 -45.27 46.52 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.921 1.289 . . . . 64.05 111.923 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 46.4 t -64.56 -45.52 86.74 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.893 -1.049 . . . . 75.52 110.258 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.6 mtm -63.22 -36.8 84.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.428 0.691 . . . . 70.15 111.801 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -66.88 -45.16 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 75.33 109.784 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -71.29 -27.23 63.27 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.69 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -69.98 -30.95 68.42 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.79 0.836 . . . . 74.33 109.643 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 8.74 63.95 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.818 0.698 . . . . 73.3 113.165 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.433 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.4 p 54.12 39.77 31.0 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.838 1.655 . . . . 72.15 112.313 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.538 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 38.9 m-85 -110.65 167.95 8.31 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.605 1.162 . . . . 74.53 108.861 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.21 155.84 62.91 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.392 2.061 . . . . 62.22 112.564 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.78 123.24 22.95 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.226 -0.657 . . . . 45.12 109.226 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.18 105.83 16.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.489 -0.93 . . . . 74.35 108.489 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 91.4 m-20 -97.6 88.86 4.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.915 -1.143 . . . . 42.41 107.915 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 26.3 tp -71.19 119.87 15.95 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.431 -0.804 . . . . 73.34 109.664 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.99 88.12 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.085 0.954 . . . . 72.42 112.288 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.32 106.8 1.18 Allowed 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.157 1.905 . . . . 65.0 110.796 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.06 109.95 30.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.371 -0.974 . . . . 63.51 108.371 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 108.415 -0.957 . . . . 73.03 108.415 175.349 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.551 1.002 0 N-CA-C 108.796 -0.816 . . . . 61.33 108.796 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 55.9 t80 -131.88 147.85 52.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.444 0.697 . . . . 64.33 110.436 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 58.5 tp60 -145.44 134.05 22.14 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 123.67 0.606 . . . . 74.44 111.022 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.498 HD11 HG13 ' A' ' 16' ' ' ILE . 4.5 tp -92.76 128.93 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.011 0.924 . . . . 73.44 108.541 167.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -106.54 -41.87 5.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.463 0.305 . . . . 73.41 110.996 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -169.75 133.34 1.24 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 119.747 -0.168 . . . . 71.15 111.212 -171.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.819 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 67.9 mt -113.1 139.08 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.206 1.003 . . . . 72.34 109.017 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 29.9 p90 -165.3 175.53 9.12 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.008 0.818 . . . . 71.42 111.664 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.424 ' H ' ' HA2' ' B' ' 121' ' ' GLY . 75.8 p -100.71 118.99 37.94 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.37 -0.974 . . . . 75.23 108.37 170.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 25.0 mtpt -74.1 -34.37 63.92 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.011 -0.737 . . . . 75.34 109.011 171.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 29.8 t70 -145.03 141.87 29.27 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.257 -1.338 . . . . 53.51 110.241 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.38 142.2 44.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 106.772 -1.566 . . . . 50.43 106.772 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 138.28 21.06 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.395 0.678 . . . . 61.12 109.46 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.5 t80 -143.33 128.43 18.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.824 -1.547 . . . . 64.31 106.824 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -129.95 131.71 46.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.305 -0.628 . . . . 64.32 109.305 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.6 77.96 22.1 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 107.486 -1.301 . . . . 72.04 107.486 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.0 -35.57 33.87 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.798 2.332 . . . . 75.4 111.023 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 87.9 m-20 -95.25 25.71 4.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.17 0.988 . . . . 74.21 110.889 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.06 99.86 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.032 0.933 . . . . 74.12 112.221 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.83 -31.18 32.34 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 121.675 1.583 . . . . 71.31 112.106 173.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.6 m-70 -65.38 -30.97 71.85 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.707 0.803 . . . . 73.41 111.405 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' ASN . 48.1 t -58.54 -26.43 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 122.929 0.492 . . . . 65.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.95 -39.63 95.22 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.059 0.544 . . . . 73.42 110.431 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -74.28 -37.09 63.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.219 1.008 . . . . 75.51 110.336 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -82.34 160.07 22.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.208 -0.905 . . . . 72.31 111.28 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.42 141.54 35.2 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 108.266 -1.013 . . . . 72.24 108.266 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -79.93 82.69 5.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.203 0.525 . . . . 73.12 109.681 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -132.73 72.91 76.91 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.161 -1.052 . . . . 71.12 108.161 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 52.8 Cg_endo -83.05 157.77 15.33 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.563 2.175 . . . . 73.23 111.583 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -123.38 108.29 12.56 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.141 -1.059 . . . . 73.35 108.141 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.679 HG23 HG13 ' A' ' 64' ' ' VAL . 7.3 p -65.87 135.14 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 123.706 0.629 . . . . 72.42 111.64 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 47.6 mtpt -104.51 145.25 30.56 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.009 0.924 . . . . 74.1 108.731 167.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 mp -123.28 105.86 10.22 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.788 -1.19 . . . . 65.01 107.788 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.1 m-20 -115.88 102.76 9.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.766 -1.198 . . . . 61.51 107.766 173.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.96 122.65 43.19 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.84 -1.541 . . . . 54.41 106.84 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.11 154.12 49.79 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.742 -0.836 . . . . 70.03 108.742 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -106.83 157.68 17.56 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.502 0.668 . . . . 63.35 110.55 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -149.98 143.94 25.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.681 -1.229 . . . . 55.5 107.681 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 54.3 m -130.1 152.09 49.92 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.95 0.5 . . . . 72.33 110.025 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -158.27 121.09 3.79 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.272 0.629 . . . . 43.12 109.62 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.65 109.26 15.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.458 -0.942 . . . . 75.12 108.458 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.4 mt -86.11 -41.11 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.113 0.565 . . . . 72.05 111.128 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -154.43 -172.11 4.09 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.689 0.796 . . . . 33.42 110.266 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.71 110.58 4.36 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.341 0.656 . . . . 71.13 109.455 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.58 0.43 2.95 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.226 1.41 . . . . 73.2 112.636 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 85.0 t -98.94 113.14 32.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.549 -1.278 . . . . 71.23 107.549 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.467 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 0.2 OUTLIER -116.96 169.74 9.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -129.99 121.98 27.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.552 -0.907 . . . . 74.54 108.552 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.17 120.95 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.536 -1.653 . . . . 71.41 106.536 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 41.6 t -108.36 132.24 56.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.736 -0.839 . . . . 72.41 108.736 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -102.96 111.21 23.44 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.205 -1.406 . . . . 70.13 107.205 177.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.86 98.4 8.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.864 -1.161 . . . . 74.53 107.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 60' ' ' LEU . 4.0 t -96.96 142.08 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.255 -1.017 . . . . 23.42 108.255 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.7 m -135.62 127.03 28.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.467 -0.938 . . . . 75.25 108.467 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.679 HG13 HG23 ' A' ' 40' ' ' VAL . 55.2 t -125.24 107.75 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.723 1.209 . . . . 75.34 109.275 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 m -107.34 137.27 45.7 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.798 0.439 . . . . 72.54 109.943 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -121.03 122.36 39.93 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.931 -0.766 . . . . 74.43 108.931 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 67.2 m -118.81 130.78 55.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.0 0.52 . . . . 50.03 110.574 173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -87.79 69.58 9.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.432 1.493 . . . . 71.41 107.884 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -94.14 1.32 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 114.95 -1.023 . . . . 73.43 111.23 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.58 -25.98 14.24 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.726 0.81 . . . . 73.22 111.966 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -111.81 128.19 56.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.115 0.566 . . . . 54.54 110.691 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -67.38 133.26 49.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.21 0.604 . . . . 72.34 111.294 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -56.64 3.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.613 1.165 . . . . 45.34 109.669 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -148.75 172.41 14.66 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.599 -1.182 . . . . 74.41 111.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -141.7 140.07 33.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.296 1.438 . . . . 53.34 107.733 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.6 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 29.9 m -128.04 140.59 51.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.988 -1.116 . . . . 71.52 107.988 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -148.85 118.31 6.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.255 -0.646 . . . . 73.32 109.255 168.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.14 110.6 23.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 123.752 0.821 . . . . 53.03 109.322 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.5 mt-30 -86.15 81.06 8.58 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.717 -0.846 . . . . 75.21 108.717 172.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.15 94.91 4.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.031 -0.986 . . . . 61.01 108.419 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -105.13 146.6 16.1 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 112.179 -0.368 . . . . 53.54 112.179 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.39 141.99 12.92 Favored Glycine 0 C--O 1.24 0.522 0 N-CA-C 111.433 -0.667 . . . . 75.1 111.433 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.421 HG13 ' HE1' ' A' ' 17' ' ' TYR . 50.6 mt -81.55 123.88 38.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.434 -0.95 . . . . 74.54 108.434 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.402 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -134.6 120.28 19.4 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.17 0.588 . . . . 71.3 109.743 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.634 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 24.0 m -83.6 103.25 12.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.881 -0.785 . . . . 72.41 108.881 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.478 HD12 HD11 ' A' ' 89' ' ' ILE . 45.2 pt -109.14 138.97 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.559 0.744 . . . . 71.41 110.709 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.5 153.79 33.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.206 -0.907 . . . . 72.3 109.344 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.66 85.98 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 121.305 -0.474 . . . . 74.55 114.239 174.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 2.2 pp -107.37 130.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.513 -1.291 . . . . 64.44 107.513 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -153.34 168.29 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.699 -1.223 . . . . 74.53 107.699 -174.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.97 -117.85 2.41 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 114.73 0.652 . . . . 30.32 114.73 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -81.82 -27.22 33.74 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 63.01 111.159 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -64.65 -36.11 83.2 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.808 0.843 . . . . 75.22 110.091 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.48 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 59.0 ttm -69.05 -45.94 69.13 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.305 -0.861 . . . . 73.4 109.403 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.23 -26.79 68.95 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.286 -0.87 . . . . 62.43 112.228 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -70.53 -43.85 68.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.775 0.43 . . . . 75.53 110.315 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -70.46 -64.25 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.856 0.722 . . . . 65.01 110.981 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.95 -19.76 60.57 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.149 0.425 . . . . 73.23 112.149 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.35 -35.15 8.16 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 114.23 0.452 . . . . 63.42 114.23 -170.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -137.03 -48.01 0.6 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.793 0.294 . . . . 74.05 111.793 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.454 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.8 t80 -62.94 -61.44 2.39 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.407 0.683 . . . . 72.11 111.868 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.551 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.6 m -67.09 -37.45 13.57 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.72 0.808 . . . . 62.23 112.937 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.06 -44.05 48.4 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.149 1.9 . . . . 71.13 113.269 162.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -69.84 -23.43 63.3 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 71.34 111.664 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 102' ' ' CYS . 32.3 mm -65.77 -40.89 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.944 -0.762 . . . . 72.04 108.944 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.31 -23.06 26.41 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.364 1.066 . . . . 74.11 112.768 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -66.08 -42.84 53.86 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 114.249 1.203 . . . . 63.33 114.249 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.99 -34.56 99.2 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 121.938 1.758 . . . . 61.12 112.694 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -77.85 -39.0 44.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.761 0.825 . . . . 73.34 111.353 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.81 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.358 0.663 . . . . 75.13 109.548 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.6 ttm180 -48.59 -55.8 10.17 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.89 1.369 . . . . 74.1 110.717 176.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.458 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.0 tm-20 -66.07 -38.94 89.57 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.247 0.967 . . . . 63.25 111.18 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.583 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.2 t -62.37 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.221 0.608 . . . . 75.23 111.45 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.6 -46.49 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.152 0.981 . . . . 65.04 110.534 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' HE2' ' C' ' 109' ' ' TYR . 99.2 m -57.04 -43.98 82.48 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.949 1.299 . . . . 72.11 111.373 -174.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 29.0 t -68.68 -32.12 71.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.43 -0.805 . . . . 74.45 111.686 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.605 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 70.7 mtm -69.97 -38.28 76.04 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.581 0.352 . . . . 72.12 110.604 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -65.78 -48.51 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.559 0.743 . . . . 73.12 110.885 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.701 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 77.6 p -63.37 -35.61 80.96 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.516 0.674 . . . . 63.41 111.219 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -72.71 -20.5 61.21 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.3 -1.318 . . . . 74.45 110.656 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 16.39 37.87 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 119.413 -0.659 . . . . 75.13 113.295 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.504 HG21 ' HE ' ' B' ' 15' ' ' ARG . 0.5 OUTLIER 78.65 8.07 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 127.088 2.155 . . . . 75.43 112.082 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 119' ' ' SER . 19.0 m-85 -99.48 162.82 19.99 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.395 0.678 . . . . 74.45 110.127 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.98 125.93 13.18 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.857 1.704 . . . . 62.05 109.548 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.701 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 9.9 pt20 -61.72 147.54 45.77 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 123.554 0.534 . . . . 72.5 111.058 -173.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -121.77 113.0 19.07 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.984 -0.553 . . . . 71.32 110.118 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -110.72 111.68 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.388 -0.967 . . . . 65.21 108.388 174.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 40' ' ' VAL . 86.7 mt -73.18 144.84 46.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.038 0.535 . . . . 64.43 110.284 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 153.64 75.36 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.788 0.835 . . . . 51.23 111.701 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.47 138.58 12.35 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 121.922 1.748 . . . . 51.23 111.847 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 m -103.45 112.44 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.485 -0.931 . . . . 63.52 108.485 171.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.71 69.9 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.466 0.651 . . . . 71.3 110.472 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 39.9 t80 . . . . . 0 C--O 1.218 -0.582 0 CA-C-N 115.687 -0.688 . . . . 72.55 110.007 173.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 108.567 -0.901 . . . . 74.35 108.567 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.44 123.45 13.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 64.14 109.82 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -127.5 141.77 51.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.647 1.179 . . . . 73.31 109.83 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.6 HG13 ' HD3' ' D' ' 130' ' ' PRO . 61.4 mt -93.04 129.56 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.018 -1.104 . . . . 73.44 108.018 166.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -89.39 -40.92 12.42 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.581 0.55 . . . . 62.22 110.69 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.504 ' HE ' HG21 ' A' ' 122' ' ' THR . 68.8 ttt180 -167.55 150.46 6.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.774 0.43 . . . . 73.02 110.546 -170.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.422 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 82.8 mt -132.11 145.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.998 -1.482 . . . . 73.35 106.998 172.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.1 p90 -170.62 162.21 7.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.685 0.394 . . . . 73.35 111.198 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 84.8 m -90.19 124.71 35.07 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.107 -0.701 . . . . 72.31 109.107 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.08 -45.19 11.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.899 -0.591 . . . . 64.45 109.505 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.516 ' HB3' HE21 ' B' ' 79' ' ' GLN . 19.4 t70 -148.92 146.05 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.889 -0.596 . . . . 74.34 111.807 -165.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 42.9 mm -138.35 150.01 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.463 1.505 . . . . 64.35 109.068 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -150.32 150.89 32.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.722 -0.672 . . . . 52.1 110.146 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 66.8 t80 -157.42 111.82 2.67 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.891 -1.522 . . . . 62.42 106.891 168.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -125.56 114.59 18.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 73.13 109.471 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.707 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.05 91.54 6.62 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.445 0.698 . . . . 53.44 109.503 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.84 -29.81 88.9 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.008 2.472 . . . . 61.25 112.62 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.45 31.27 6.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.873 0.869 . . . . 73.35 110.349 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -46.28 -55.59 13.31 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 125.115 1.366 . . . . 75.52 114.341 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.36 -13.91 10.82 Favored 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 121.751 1.634 . . . . 74.43 112.834 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -85.51 0.53 52.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.986 0.914 . . . . 72.45 111.841 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.47 -18.08 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 124.387 1.075 . . . . 63.25 111.008 170.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.55 -37.16 86.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.79 0.836 . . . . 64.44 110.825 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -85.85 -43.87 12.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.479 -0.782 . . . . 70.35 110.539 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 34' ' ' LYS . 23.9 mmtp -78.08 89.9 4.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.059 0.544 . . . . 70.43 109.989 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -86.61 76.88 9.48 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.304 -0.862 . . . . 64.51 112.146 -171.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -173.1 161.85 4.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.572 -0.74 . . . . 64.32 110.281 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -75.24 117.29 61.92 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.519 0.728 . . . . 73.02 109.329 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.4 151.5 79.09 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.7 2.267 . . . . 75.1 113.333 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.28 102.82 8.81 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.032 -0.985 . . . . 75.23 108.391 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.401 ' HB ' HD12 ' B' ' 126' ' ' LEU . 13.6 t -86.75 121.78 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.807 -0.812 . . . . 63.02 108.807 -175.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -130.52 133.84 46.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.095 0.958 . . . . 74.42 108.724 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.35 149.24 31.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.393 -0.595 . . . . 62.2 109.393 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -135.51 135.96 40.84 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.016 0.926 . . . . 64.05 109.313 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.29 146.76 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.813 0.845 . . . . 73.31 109.892 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.52 152.34 34.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.349 1.059 . . . . 61.44 108.275 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -137.27 137.93 39.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.184 0.594 . . . . 74.11 109.408 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.82 151.89 51.37 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.828 1.251 . . . . 61.13 107.961 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.0 m -132.11 161.89 32.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.096 0.558 . . . . 51.35 110.246 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -163.44 155.8 17.99 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.681 1.192 . . . . 62.41 108.399 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.5 tt0 -124.4 132.72 53.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.567 -0.531 . . . . 74.33 109.567 171.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.1 mt -100.7 -31.73 11.07 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.602 0.761 . . . . 75.44 111.342 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.31 -172.08 3.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.654 0.781 . . . . 64.12 111.326 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.36 107.19 1.56 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.034 -0.984 . . . . 72.44 111.119 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.0 16.41 7.0 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.651 1.181 . . . . 75.23 112.386 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 91.7 t -115.68 116.59 52.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.157 -1.423 . . . . 62.31 107.157 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 11.0 p90 -123.92 179.12 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.321 0.649 . . . . 65.52 109.894 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -142.44 134.18 26.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.556 -0.905 . . . . 73.23 108.556 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.72 125.91 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.142 -1.059 . . . . 72.12 108.142 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.08 113.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.594 -0.891 . . . . 74.34 108.594 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -93.57 118.46 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.755 -0.831 . . . . 72.43 108.755 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 35.1 ttm180 -105.12 120.77 42.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.157 0.583 . . . . 71.21 109.83 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.451 HG23 HD22 ' B' ' 60' ' ' LEU . 48.4 t -116.53 110.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.734 -1.21 . . . . 60.54 107.734 167.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -106.65 128.39 54.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.02 0.528 . . . . 64.21 109.796 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.7 HG21 HG21 ' B' ' 114' ' ' ILE . 97.2 t -115.39 128.84 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.216 1.006 . . . . 61.45 109.696 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -121.94 142.5 50.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.263 1.025 . . . . 71.53 109.562 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.07 163.87 28.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.176 0.991 . . . . 64.43 109.564 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.5 p -146.71 138.49 24.56 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.462 0.541 . . . . 73.35 112.462 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 39.3 mt -110.47 106.09 15.28 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.029 1.332 . . . . 70.24 107.982 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.46 -106.27 2.21 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.329 -0.462 . . . . 75.4 112.485 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.46 5.89 11.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.156 0.983 . . . . 54.34 110.732 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -127.22 171.47 11.42 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.091 0.956 . . . . 74.43 109.424 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 59.6 m -76.7 142.78 40.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.085 0.554 . . . . 72.03 111.31 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.469 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.56 -64.08 1.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.527 0.731 . . . . 70.33 109.33 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 32.7 p90 -147.5 162.02 39.9 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.005 -0.998 . . . . 75.12 110.6 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -130.0 154.09 47.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.239 1.416 . . . . 70.12 107.567 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.4 t -154.75 159.49 40.7 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.059 0.944 . . . . 63.21 108.675 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -164.67 141.04 5.99 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.655 0.782 . . . . 75.41 109.253 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 69.9 t -129.13 140.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.755 0.822 . . . . 64.42 108.948 171.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.516 HE21 ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -126.89 92.77 3.6 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.849 0.718 . . . . 74.32 109.164 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -89.86 101.82 14.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.272 -1.331 . . . . 62.24 109.048 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.11 15.46 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.896 -0.882 . . . . 72.42 110.896 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -141.75 125.95 2.87 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.167 -0.773 . . . . 72.31 111.167 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.91 126.43 40.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.719 0.808 . . . . 72.02 109.252 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -132.9 161.57 33.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.665 1.186 . . . . 74.43 109.293 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -134.03 127.38 32.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.492 1.117 . . . . 73.32 108.504 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.55 HG12 HD12 ' B' ' 89' ' ' ILE . 8.5 tt -139.1 135.98 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.512 -0.551 . . . . 72.34 109.512 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.33 158.57 36.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.716 0.806 . . . . 74.4 109.999 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.31 -30.3 10.69 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 111.797 -0.521 . . . . 65.02 111.797 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' B' ' 93' ' ' GLN . 0.1 OUTLIER -83.31 169.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.967 1.307 . . . . 73.13 111.087 175.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -152.16 143.68 23.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.992 0.917 . . . . 75.3 109.718 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -99.8 0.16 Allowed Glycine 0 C--N 1.35 1.331 0 O-C-N 123.917 0.761 . . . . 74.1 114.715 170.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . 0.406 ' HB ' ' NE2' ' B' ' 93' ' ' GLN . 86.1 m -64.27 -42.75 96.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 74.45 112.349 -170.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.625 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 1.4 mp0 -62.13 -45.07 95.08 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.229 0.612 . . . . 64.22 110.093 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -39.97 65.93 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.233 -0.894 . . . . 61.24 110.164 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.56 69.13 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.252 0.621 . . . . 74.35 111.855 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -76.02 -40.58 53.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 70.43 110.501 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' B' ' 102' ' ' CYS . 49.6 t -66.2 -47.56 73.49 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.419 0.688 . . . . 64.42 109.674 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.65 -35.26 80.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.637 1.175 . . . . 73.52 110.837 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.69 2.14 87.78 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.375 -0.83 . . . . 52.41 114.172 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.99 -63.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.885 0.843 . . . . 63.4 112.732 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.8 -50.08 39.53 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.629 0.974 . . . . 72.43 113.629 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 61.4 m -58.44 -47.61 98.46 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.503 0.721 . . . . 63.23 112.081 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.03 -27.56 29.81 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 121.363 1.375 . . . . 73.51 112.898 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -64.84 -29.91 70.89 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.758 0.708 . . . . 64.4 110.515 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.517 HG23 ' NH2' ' D' ' 111' ' ' ARG . 63.7 mt -62.29 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.768 0.827 . . . . 62.24 110.372 172.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.488 ' HB2' HD12 ' B' ' 60' ' ' LEU . 39.2 mt -83.68 -11.85 56.66 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.882 -1.054 . . . . 75.22 111.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.554 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 32.3 t80 -63.46 -46.8 84.28 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.298 1.439 . . . . 51.13 112.994 -170.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.416 ' HB3' ' HD2' ' D' ' 109' ' ' TYR . 29.1 Cg_endo -60.95 -36.93 80.71 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.64 1.56 . . . . 63.24 112.764 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.22 -42.25 99.13 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.247 0.619 . . . . 70.34 110.587 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -41.47 73.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.358 0.663 . . . . 65.2 111.357 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -56.53 -58.92 5.98 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.571 1.149 . . . . 72.12 111.275 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.39 -35.79 81.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.397 -0.819 . . . . 62.21 110.387 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.408 ' HB3' HG21 ' B' ' 78' ' ' VAL . 36.8 t -64.64 -37.14 86.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.476 0.547 . . . . 73.43 112.476 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.7 HG21 HG21 ' B' ' 64' ' ' VAL . 79.3 mt -70.76 -47.9 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.918 0.487 . . . . 64.42 110.131 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.6 m -62.49 -23.75 67.1 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.533 -0.758 . . . . 71.43 110.833 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -73.27 -54.71 7.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.567 1.147 . . . . 71.51 109.985 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.503 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -64.93 -33.74 76.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.982 0.913 . . . . 70.3 113.163 -172.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.91 -30.15 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 122.901 0.48 . . . . 75.24 110.175 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' B' ' 125' ' ' GLN . 54.5 p -72.14 -32.18 66.67 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.481 0.658 . . . . 43.24 110.478 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.583 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 67.7 mtt-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.722 -1.127 . . . . 73.01 109.814 171.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 18' ' ' THR . . . -87.37 15.79 52.34 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.097 -0.835 . . . . 71.44 113.342 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t 56.69 14.07 1.63 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 126.97 2.108 . . . . 53.14 113.884 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -106.14 160.15 27.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.698 0.799 . . . . 73.21 111.309 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -52.77 101.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.782 2.988 . . . . 53.24 114.49 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.547 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 0.1 OUTLIER -68.86 155.45 40.21 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 113.356 -1.747 . . . . 71.53 110.293 176.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.401 HD12 ' HB ' ' B' ' 40' ' ' VAL . 2.6 tt -152.3 126.28 9.1 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.741 -0.837 . . . . 54.4 108.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -93.66 127.96 39.61 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.997 0.919 . . . . 62.42 108.661 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.554 HD22 ' HZ ' ' B' ' 107' ' ' PHE . 1.7 tt -70.54 130.89 43.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.617 -0.512 . . . . 75.31 109.617 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.64 144.67 98.73 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.563 0.745 . . . . 60.21 111.042 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.469 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 57.8 Cg_endo -65.22 92.02 0.22 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.39 2.726 . . . . 75.03 113.431 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 19.6 m -84.95 108.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.953 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.444 ' HB3' HG21 ' D' ' 13' ' ' ILE . 52.5 t30 -109.84 105.93 15.32 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.188 0.595 . . . . 70.23 110.177 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 69.2 t80 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 123.803 0.841 . . . . 74.45 111.368 176.421 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 80.5 m . . . . . 0 CA--C 1.528 0.134 0 N-CA-C 107.393 -1.336 . . . . 75.02 107.393 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -122.83 123.7 41.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.343 -1.355 . . . . 73.34 107.343 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.79 138.41 16.05 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.399 0.437 . . . . 64.5 110.733 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.17 142.35 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.869 0.867 . . . . 72.32 109.075 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.533 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 30.9 mm-40 -111.39 -35.73 5.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.416 0.686 . . . . 62.23 110.663 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 42.4 ttt180 -173.33 136.49 0.62 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.114 0.566 . . . . 65.23 109.654 -171.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -123.18 143.85 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.407 -1.331 . . . . 62.42 107.407 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.411 ' HB3' HG23 ' D' ' 122' ' ' THR . 39.2 p90 -177.71 168.85 2.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 75.54 110.72 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -87.56 111.86 21.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.372 -0.831 . . . . 50.34 109.323 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.38 -43.92 89.22 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.2 -0.667 . . . . 63.32 109.2 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -147.34 147.1 29.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.222 -1.354 . . . . 75.45 110.078 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.88 144.57 29.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 125.782 1.633 . . . . 73.42 106.729 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -153.33 151.02 29.5 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.31 0.576 . . . . 54.44 110.644 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -155.08 134.04 12.23 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.573 -1.194 . . . . 73.31 108.077 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.8 147.28 52.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.439 1.096 . . . . 74.43 108.268 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 84.87 6.32 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.544 0.737 . . . . 74.44 109.785 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.38 -27.97 46.97 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.989 2.459 . . . . 74.21 111.302 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.815 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 6.8 m-80 -95.25 18.56 12.15 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.797 -1.092 . . . . 55.51 111.551 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.29 88.98 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 118.613 0.642 . . . . 70.34 111.19 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -94.18 -26.33 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.743 1.629 . . . . 73.33 113.571 164.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.815 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 61.2 t60 -69.05 -24.41 64.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.734 1.213 . . . . 72.05 113.312 -170.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' C' ' 27' ' ' ASN . 8.8 p -74.99 -12.01 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 122.825 0.45 . . . . 73.53 111.854 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.67 -41.34 81.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.402 0.681 . . . . 74.14 112.189 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -112.12 48.11 1.01 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.071 0.939 . . . . 64.54 108.949 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.619 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.9 tppp? -124.33 164.05 20.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.455 -0.793 . . . . 73.35 109.481 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.42 105.79 8.78 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.859 -1.164 . . . . 70.53 107.859 166.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -84.0 73.35 10.37 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.917 0.887 . . . . 71.02 111.466 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -124.93 77.62 66.17 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.048 -0.723 . . . . 55.4 109.048 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.793 ' HG2' ' HG3' ' C' ' 124' ' ' PRO . 1.3 Cg_endo -86.51 137.4 4.95 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.366 2.711 . . . . 44.34 111.794 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.63 117.02 24.27 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.61 -1.256 . . . . 75.34 107.61 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.31 79.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 115.236 -0.893 . . . . 42.42 109.406 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.07 141.56 35.63 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.209 0.604 . . . . 54.03 110.847 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.1 165.91 14.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.785 0.834 . . . . 73.33 110.846 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -145.83 148.4 32.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.914 1.286 . . . . 71.01 107.594 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.415 HD11 HD21 ' C' ' 60' ' ' LEU . 15.6 tp -116.47 148.91 40.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.213 0.461 . . . . 75.41 111.042 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 12.9 m-20 -141.15 137.97 33.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.37 1.068 . . . . 73.42 109.17 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -113.97 126.22 54.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.502 -0.925 . . . . 64.45 108.502 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.96 165.29 25.04 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.38 1.072 . . . . 43.12 108.54 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 m -145.09 168.31 20.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.319 0.648 . . . . 71.11 110.441 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.19 128.0 4.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.729 1.211 . . . . 73.3 108.025 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -90.31 126.2 35.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.979 -0.749 . . . . 71.33 108.979 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.623 HD11 HD12 ' C' ' 83' ' ' ILE . 61.8 mt -97.93 -36.42 10.16 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.836 0.854 . . . . 61.12 110.18 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.99 -178.05 5.41 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.493 -0.776 . . . . 73.42 109.96 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -68.04 123.47 20.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.137 -1.061 . . . . 73.33 108.137 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' C' ' 85' ' ' SER . 21.6 m-20 73.06 -4.33 2.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.701 1.2 . . . . 73.32 112.823 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 98.01 6.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.91 0.884 . . . . 62.32 108.74 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.11 116.39 26.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.716 0.806 . . . . 75.21 110.481 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -82.83 121.92 27.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.985 -1.007 . . . . 74.2 109.484 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.85 124.56 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.98 -1.118 . . . . 64.24 107.98 170.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.06 103.41 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.016 -1.105 . . . . 73.24 108.016 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -93.01 110.07 21.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.193 0.997 . . . . 65.45 108.365 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 47.5 ttp180 -103.34 137.33 41.6 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.035 0.534 . . . . 72.5 109.893 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.3 130.17 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.324 -1.362 . . . . 70.21 107.324 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -120.23 121.04 37.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.849 -0.797 . . . . 44.12 108.849 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' C' ' 126' ' ' LEU . 25.6 t -98.73 138.5 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.966 0.907 . . . . 61.32 109.319 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -123.35 138.75 54.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.153 -1.385 . . . . 73.2 107.486 171.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.946 -1.501 . . . . 62.31 106.946 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -134.49 128.85 34.22 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 123.643 0.589 . . . . 71.22 110.68 -176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.619 HD13 ' HG2' ' C' ' 34' ' ' LYS . 17.1 mt -84.65 47.55 1.39 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.482 1.513 . . . . 73.31 108.811 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.27 -82.82 0.49 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.847 -0.901 . . . . 75.33 110.847 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.98 -31.78 3.59 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.674 1.19 . . . . 73.34 108.829 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.49 121.84 14.27 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.902 0.881 . . . . 72.15 109.874 170.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -74.59 122.0 22.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.749 0.704 . . . . 73.34 109.62 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' C' ' 27' ' ' ASN . . . -72.35 -51.32 21.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.064 0.946 . . . . 61.41 109.92 177.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -167.17 176.68 6.64 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.916 -0.583 . . . . 71.12 110.443 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.439 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -131.02 142.89 50.37 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.59 -1.263 . . . . 64.5 107.59 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -144.63 147.73 33.45 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.373 -0.973 . . . . 73.43 108.373 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.99 141.47 14.07 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.714 0.406 . . . . 64.2 110.389 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.86 115.47 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.313 1.045 . . . . 71.33 108.922 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 45.6 mt-30 -91.51 95.3 9.87 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.557 -0.905 . . . . 74.53 108.557 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.579 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -86.96 111.49 20.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.775 0.83 . . . . 71.51 109.905 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 145.18 17.6 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 112.389 -0.284 . . . . 43.15 112.389 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.13 124.03 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.268 -1.133 . . . . 71.44 110.268 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.623 HD12 HD11 ' C' ' 51' ' ' LEU . 8.1 mm -81.87 121.5 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.193 -1.04 . . . . 44.43 108.193 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.42 118.86 28.42 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.291 -0.633 . . . . 71.11 109.291 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' C' ' 54' ' ' ASP . 23.5 p -85.43 100.44 11.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.833 -0.803 . . . . 61.32 108.833 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.37 146.49 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.594 0.758 . . . . 72.22 111.251 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -164.93 151.05 10.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.17 0.988 . . . . 73.41 109.959 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 -38.75 3.14 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 114.042 0.377 . . . . 61.24 114.042 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.048 0 C-N-CA 124.455 1.102 . . . . 74.34 111.082 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.978 -0.379 . . . . 74.33 109.978 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 52.5 ttm -62.95 -47.35 83.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.916 -0.583 . . . . 72.23 109.958 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.47 72.67 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.86 0.725 . . . . 73.53 111.732 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -73.42 -31.89 64.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.663 0.785 . . . . 70.1 110.027 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.14 -35.62 48.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 52.04 110.989 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.998 0.919 . . . . 53.01 110.303 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 11.11 62.44 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 115.914 -0.585 . . . . 71.4 114.18 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.01 -61.58 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.488 0.644 . . . . 71.35 111.34 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -73.77 -46.53 45.06 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.898 0.703 . . . . 74.43 112.898 -172.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.495 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 82.8 m -60.9 -48.73 91.9 Favored Pre-proline 0 CA--C 1.563 1.47 0 CA-C-O 118.977 -0.535 . . . . 71.44 110.75 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 71.9 Cg_exo -57.04 -33.67 96.17 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.439 2.093 . . . . 71.33 114.081 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.46 -34.87 79.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.313 0.645 . . . . 62.4 111.193 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.455 HD12 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -64.92 -41.57 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.229 0.612 . . . . 64.2 110.331 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.2 mt -81.49 -22.28 38.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.216 -0.902 . . . . 65.31 112.088 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.72 -48.51 95.06 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 117.723 -1.132 . . . . 73.22 113.55 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.03 -39.54 84.92 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.195 1.93 . . . . 71.22 112.607 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.448 ' HE2' HG21 ' A' ' 115' ' ' THR . 87.4 m-85 -62.88 -52.31 63.58 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.845 -1.07 . . . . 74.44 111.952 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -70.18 -34.81 73.44 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.319 -0.4 . . . . 71.53 111.397 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.83 -51.03 67.13 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.257 1.423 . . . . 64.31 110.473 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.98 -36.44 69.81 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.507 -0.77 . . . . 74.23 110.195 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.16 -30.96 71.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.09 0.556 . . . . 64.11 111.378 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.577 HG21 HG21 ' C' ' 64' ' ' VAL . 98.1 mt -72.3 -45.49 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.0 -0.546 . . . . 75.23 109.871 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -56.76 -37.32 70.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.801 0.688 . . . . 73.41 110.423 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.7 t -59.76 -56.95 15.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.923 1.289 . . . . 64.14 110.45 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.686 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.17 -41.91 89.53 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.586 1.154 . . . . 74.0 112.917 -176.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' C' ' 126' ' ' LEU . 69.2 t -66.29 -41.59 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.424 0.689 . . . . 72.33 110.747 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.615 ' HB2' HE22 ' C' ' 125' ' ' GLN . 45.5 t -63.31 -35.96 82.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.145 -0.934 . . . . 75.11 110.993 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.5 mtt-85 -66.89 -37.92 85.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.979 -1.01 . . . . 70.24 110.122 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.15 0.84 82.7 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.283 -0.732 . . . . 74.34 113.328 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p 57.09 50.94 11.1 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.523 1.529 . . . . 74.43 111.492 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.42 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 26.9 m-85 -121.65 169.74 8.75 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.474 1.11 . . . . 74.53 110.693 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.793 ' HG3' ' HG2' ' C' ' 38' ' ' PRO . 26.9 Cg_endo -57.8 126.71 22.6 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.732 2.288 . . . . 61.54 110.905 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.615 HE22 ' HB2' ' C' ' 119' ' ' SER . 15.5 mm100 -58.99 132.44 54.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.148 0.979 . . . . 75.11 112.486 -168.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.775 ' HG ' HG11 ' C' ' 64' ' ' VAL . 1.7 mm? -108.02 72.18 0.84 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.779 -0.646 . . . . 73.14 109.968 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -126.53 89.02 2.93 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.035 -1.468 . . . . 65.02 107.035 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 31.9 mt -84.27 151.16 24.96 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.552 -1.203 . . . . 75.14 108.785 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.58 147.53 39.3 Favored Pre-proline 0 CA--C 1.546 0.791 0 O-C-N 124.281 0.988 . . . . 51.01 113.295 -172.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.819 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 88.0 Cg_exo -50.36 115.2 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.545 2.83 . . . . 43.13 112.583 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.16 78.91 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-O 121.632 0.729 . . . . 62.23 109.128 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.64 93.46 8.4 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.189 -0.914 . . . . 73.23 109.978 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 33.4 p90 . . . . . 0 CA--C 1.544 0.718 0 CA-C-N 114.389 -1.278 . . . . 72.24 111.443 179.663 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m . . . . . 0 C--O 1.244 0.797 0 N-CA-C 109.813 -0.44 . . . . 74.23 109.813 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 91.3 t80 -156.6 102.56 2.06 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.333 -1.358 . . . . 74.31 107.333 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 76.3 mt-30 -113.03 113.55 25.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.844 -0.799 . . . . 74.52 108.844 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' B' ' 132' ' ' ASN . 7.5 tt -91.43 98.31 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.581 -1.266 . . . . 64.35 107.581 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.53 -33.21 14.56 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.35 0.5 . . . . 51.23 112.35 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 75.2 ttt180 -170.53 122.42 0.63 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.059 -0.348 . . . . 74.13 110.059 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' B' ' 130' ' ' PRO . 35.4 mm -115.57 132.67 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.146 -1.057 . . . . 54.42 108.146 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 4.8 p90 -154.57 169.0 24.87 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.381 0.672 . . . . 73.12 112.024 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -97.7 119.59 36.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.016 -0.993 . . . . 62.13 108.815 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.02 -22.31 31.36 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.331 0.653 . . . . 72.24 110.2 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.3 t70 -160.85 139.5 10.07 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.102 0.961 . . . . 74.13 109.381 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.686 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.3 mt -142.25 143.73 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.479 1.112 . . . . 63.11 108.258 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 60.7 m -141.98 136.76 30.64 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.228 1.011 . . . . 43.34 109.187 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.527 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.9 t80 -143.22 110.99 5.93 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 106.445 -1.687 . . . . 73.02 106.445 165.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -122.31 115.12 21.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.353 -0.61 . . . . 74.41 109.353 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -116.66 80.44 10.58 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.476 -0.935 . . . . 74.51 108.476 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.76 -29.83 23.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.669 2.246 . . . . 53.43 112.266 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -111.49 18.03 19.51 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.721 -0.672 . . . . 51.1 109.661 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.486 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -39.4 -54.35 3.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 115.586 1.699 . . . . 64.34 115.586 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.412 ' HB3' HD11 ' C' ' 83' ' ' ILE . 44.4 Cg_endo -81.67 -13.55 10.64 Favored 'Trans proline' 0 C--N 1.382 2.32 0 CA-C-N 121.307 1.503 . . . . 73.23 113.439 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -76.44 -36.83 57.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.687 1.195 . . . . 70.44 109.462 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.611 HG13 HD12 ' D' ' 68' ' ' LEU . 35.7 t -65.56 -23.96 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 124.877 1.271 . . . . 75.01 111.324 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.41 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 74.3 t80 -45.9 -36.64 5.55 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.335 1.454 . . . . 62.12 113.47 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -79.1 -6.54 56.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.637 0.775 . . . . 72.52 112.518 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -109.57 112.69 24.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.787 0.835 . . . . 64.52 110.029 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.2 60.3 1.41 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.927 0.891 . . . . 44.12 110.932 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.605 ' HB2' HD22 ' D' ' 68' ' ' LEU . 20.1 m95 -124.89 158.12 34.28 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.484 -0.561 . . . . 64.05 109.484 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.406 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.4 tp60 -71.47 112.49 14.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.406 ' HD2' HE21 ' D' ' 37' ' ' GLN . 45.3 Cg_exo -56.79 114.42 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.671 0 C-N-CA 122.783 2.322 . . . . 51.55 112.663 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.25 109.94 3.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.146 -1.057 . . . . 74.44 108.146 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 m -108.33 106.6 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.031 0.919 . . . . 53.32 109.142 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -94.28 115.97 28.29 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.248 -1.39 . . . . 71.03 107.248 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.05 136.08 34.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.498 -0.927 . . . . 54.31 108.498 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.72 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.7 m-20 -107.69 153.8 22.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.152 0.981 . . . . 64.01 108.562 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.6 tp -126.97 132.47 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.157 -0.683 . . . . 75.22 109.157 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t70 -140.62 141.18 35.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.018 -1.105 . . . . 42.33 108.018 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.1 m -118.53 143.64 46.6 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.979 -0.749 . . . . 71.22 108.979 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.9 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.323 1.049 . . . . 70.23 108.317 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.5 p -170.57 157.66 5.93 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.988 0.515 . . . . 72.22 110.894 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -149.57 140.44 22.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.911 -0.774 . . . . 72.42 108.911 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.2 119.93 25.16 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 109.405 -0.591 . . . . 72.13 109.405 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.6 mt -95.02 -34.92 12.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.18 0.592 . . . . 73.23 109.853 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.33 -177.43 6.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.207 -0.906 . . . . 52.53 110.392 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -66.91 129.97 41.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.81 -1.086 . . . . 64.3 109.254 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 58.31 17.84 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.669 1.187 . . . . 72.44 113.125 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.18 125.59 72.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 123.603 0.761 . . . . 75.31 109.144 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -123.64 135.23 53.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.815 -0.809 . . . . 72.4 108.815 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.9 tt0 -86.36 111.61 20.66 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.129 -1.804 . . . . 53.1 106.129 161.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -100.37 120.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 108.079 -1.082 . . . . 70.32 108.079 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.582 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 54.4 t -101.64 130.3 51.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.923 -1.035 . . . . 61.22 109.726 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.38 126.02 51.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.463 -1.31 . . . . 75.4 107.463 172.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -112.54 100.9 9.1 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.563 -0.903 . . . . 64.15 108.563 173.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.86 127.97 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.894 -1.15 . . . . 73.24 107.894 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.72 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -116.94 148.48 41.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.467 -0.938 . . . . 64.32 108.467 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.66 131.11 71.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.108 0.963 . . . . 72.42 108.875 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -117.09 95.81 5.16 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.246 -1.39 . . . . 74.35 107.246 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.57 129.44 43.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.061 -0.718 . . . . 53.22 109.061 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.514 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 36.9 m -143.6 137.27 28.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.369 0.604 . . . . 42.52 110.83 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.611 HD12 HG13 ' D' ' 31' ' ' VAL . 38.2 mt -104.16 97.34 7.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.593 1.157 . . . . 72.3 109.077 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.85 -119.79 19.6 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.162 0.914 . . . . 73.42 113.114 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.65 25.17 3.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.443 0.697 . . . . 71.5 111.882 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -141.2 146.57 37.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.54 0.336 . . . . 75.03 110.572 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.9 m -71.78 121.59 19.2 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.89 0.744 . . . . 73.35 109.818 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.514 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -77.7 -59.86 2.61 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.484 -0.932 . . . . 75.23 108.484 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -160.95 163.03 32.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.901 -1.045 . . . . 73.43 110.494 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.48 150.32 41.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.639 -1.245 . . . . 74.32 107.639 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.6 t -157.21 144.0 18.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.788 0.435 . . . . 64.32 110.153 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.05 130.69 9.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.284 0.633 . . . . 62.34 110.253 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.86 118.38 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 71.25 110.006 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.9 mt-30 -89.87 85.94 6.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.515 0.726 . . . . 73.23 109.358 168.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.29 93.74 5.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.259 -0.882 . . . . 64.45 108.859 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.34 144.08 17.04 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.619 -0.593 . . . . 74.14 111.619 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.59 139.34 9.63 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 112.213 -0.355 . . . . 61.1 112.213 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.9 mt -88.89 122.82 40.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.646 0.778 . . . . 62.44 108.916 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' D' ' 12' ' ' GLN . 59.5 m-85 -130.44 125.84 35.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.301 0.641 . . . . 54.12 110.145 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.0 m -92.71 105.04 17.25 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.73 -1.211 . . . . 63.44 107.73 169.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.68 140.16 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.357 0.663 . . . . 44.44 109.458 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.44 169.42 15.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.756 0.823 . . . . 40.32 110.612 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.64 22.16 77.6 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-N 116.655 -0.248 . . . . 64.11 113.466 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -132.01 161.79 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.493 1.117 . . . . 43.42 109.877 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 149.23 26.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.96 0.504 . . . . 73.14 111.127 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.6 -107.72 0.41 Allowed Glycine 0 C--N 1.35 1.356 0 O-C-N 124.541 1.151 . . . . 32.03 115.552 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -71.84 -42.86 66.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.031 0.933 . . . . 72.24 111.362 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -65.13 -35.06 79.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.012 0.525 . . . . 74.11 110.571 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 40.4 ttm -61.29 -53.56 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.852 -1.067 . . . . 52.41 110.539 175.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.85 -19.42 61.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.453 0.701 . . . . 54.41 111.748 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.05 -43.92 61.36 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.35 1.06 . . . . 74.02 110.163 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.12 -51.98 6.26 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.965 -0.561 . . . . 63.22 111.141 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.637 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.0 tp -80.51 -30.2 37.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.594 0.358 . . . . 60.25 111.514 -171.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.71 -29.92 41.42 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.821 -0.433 . . . . 71.35 113.554 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.25 -44.37 1.58 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.434 0.617 . . . . 53.21 112.371 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -73.4 -40.96 63.9 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 111.905 0.335 . . . . 74.14 111.905 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 82.8 m -67.23 -43.13 43.45 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-O 118.827 -0.606 . . . . 71.13 112.519 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -65.72 -27.07 52.67 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 121.334 1.356 . . . . 71.21 112.905 166.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -68.57 -27.42 66.06 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 19.7 mm -67.55 -45.91 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.422 0.689 . . . . 74.21 109.619 169.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.52 -22.36 61.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.732 -0.667 . . . . 74.25 111.961 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.72 -41.14 20.16 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.023 1.119 . . . . 72.32 114.023 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' B' ' 105' ' ' ILE . 72.2 Cg_exo -55.11 -41.94 73.77 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.959 1.772 . . . . 62.24 113.053 169.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.416 ' HD2' ' HB3' ' B' ' 108' ' ' PRO . 69.8 m-85 -71.05 -38.18 72.53 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.419 -0.809 . . . . 71.03 111.021 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.24 -43.7 70.03 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.741 0.816 . . . . 71.32 110.598 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.517 ' NH2' HG23 ' B' ' 105' ' ' ILE . 25.6 ttp180 -57.17 -53.2 60.81 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.781 -1.1 . . . . 64.02 109.72 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.56 -41.27 89.77 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.322 1.014 . . . . 54.03 111.451 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.404 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 37.0 t -57.61 -43.95 85.1 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.567 0.542 . . . . 65.31 110.732 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -66.08 -49.53 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.651 0.78 . . . . 64.42 110.114 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -56.02 -43.92 78.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 73.45 111.744 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.7 t -67.25 -42.06 84.57 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.038 -0.983 . . . . 54.51 110.3 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.1 mtm -66.72 -34.04 76.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.959 0.504 . . . . 60.33 111.46 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.509 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.2 t -62.23 -47.96 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 123.759 0.662 . . . . 70.21 109.736 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.3 p -72.21 -30.87 65.35 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.915 -0.584 . . . . 45.33 111.262 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -69.02 -30.5 68.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.798 0.839 . . . . 61.55 110.237 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.75 12.21 60.0 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.782 0.676 . . . . 44.12 112.982 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 125' ' ' GLN . 30.2 p 59.58 28.69 18.16 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.956 1.702 . . . . 74.53 112.839 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.21 160.35 26.45 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.389 1.076 . . . . 72.4 108.928 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 126.54 16.65 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.719 2.28 . . . . 62.15 112.044 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.5 HE21 ' ND2' ' D' ' 127' ' ' ASN . 30.6 tt0 -50.83 121.81 6.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.315 1.046 . . . . 71.03 111.678 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.16 96.8 6.62 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.573 0.749 . . . . 72.44 110.144 -170.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.5 ' ND2' HE21 ' D' ' 125' ' ' GLN . 1.9 p30 -116.94 84.75 2.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.409 1.084 . . . . 72.02 109.975 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.84 157.29 35.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.698 -1.137 . . . . 73.42 111.636 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.64 156.62 88.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.968 0.907 . . . . 43.13 110.593 176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.6 ' HD3' HG13 ' B' ' 13' ' ' ILE . 1.0 OUTLIER -80.4 147.36 17.94 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.115 1.876 . . . . 74.13 110.379 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.46 108.11 24.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.699 0.761 . . . . 73.52 109.332 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 . . . . . 0 C--O 1.242 0.68 0 N-CA-C 107.804 -1.184 . . . . 61.2 107.804 175.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.633 -0.506 . . . . 73.31 109.633 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -106.25 141.32 37.78 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.587 -0.894 . . . . 71.4 108.587 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 7.4 tp-100 -149.16 139.74 22.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.043 0.537 . . . . 64.23 110.854 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 tp -94.81 127.2 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.803 0.841 . . . . 64.53 109.396 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.448 ' NE2' HG21 ' A' ' 83' ' ' ILE . 27.7 tt0 -103.09 -28.15 12.13 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 118.585 -0.721 . . . . 64.45 111.239 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -178.27 127.62 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.777 0.717 . . . . 74.55 111.154 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 64.2 mt -107.93 133.58 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.557 -0.905 . . . . 73.22 108.557 168.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.761 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 14.4 p90 -170.16 164.66 9.2 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.511 0.724 . . . . 74.21 110.664 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -85.97 117.69 24.98 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.77 -0.826 . . . . 63.32 108.77 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.6 mtpt -80.08 -29.95 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.345 -0.388 . . . . 64.31 110.145 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -153.97 148.12 25.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.54 0.525 . . . . 71.03 109.864 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.6 mt -138.74 145.4 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.969 1.307 . . . . 74.44 107.875 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 t -150.06 139.87 21.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.332 0.653 . . . . 63.23 109.761 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.7 t80 -145.22 112.26 6.01 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.415 -1.698 . . . . 64.25 106.415 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -123.02 109.99 14.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.243 -0.651 . . . . 61.34 109.243 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.28 86.49 9.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.79 -1.189 . . . . 71.24 107.79 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.02 -17.16 19.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.475 2.117 . . . . 72.13 111.343 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.99 31.12 6.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.269 1.027 . . . . 74.15 109.369 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.54 -45.63 98.76 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-N 115.165 -0.925 . . . . 74.42 112.82 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.44 -25.05 48.84 Favored 'Trans proline' 0 C--N 1.398 3.161 0 CA-C-N 121.517 1.577 . . . . 74.41 112.456 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -71.02 -26.32 63.06 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.128 0.571 . . . . 74.22 111.006 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.2 p -65.67 -12.69 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 118.455 0.571 . . . . 74.23 111.904 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.15 -39.29 75.44 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.87 0.468 . . . . 72.43 110.668 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HG3' ' HG2' ' A' ' 34' ' ' LYS . 9.1 pt20 -89.56 -38.71 13.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.308 0.643 . . . . 73.42 110.667 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 2.0 mmmp? -82.73 128.73 34.65 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.049 0.94 . . . . 63.42 109.219 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.03 153.21 32.54 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.127 -0.323 . . . . 75.32 110.127 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' CE3' HD21 ' A' ' 68' ' ' LEU . 73.9 t-105 -81.59 78.99 8.27 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.998 0.428 . . . . 64.14 110.654 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -124.64 82.34 59.63 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 107.459 -1.312 . . . . 70.53 107.459 168.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -84.8 158.58 11.98 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.324 2.016 . . . . 72.02 112.466 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.3 103.38 11.51 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.654 -1.98 . . . . 73.31 105.654 159.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.38 135.28 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 70.21 109.704 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 87.6 tttt -110.89 129.77 55.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.458 0.703 . . . . 52.24 109.114 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 128' ' ' LEU . 20.9 tp -97.2 109.74 22.43 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.149 -1.426 . . . . 74.02 107.149 166.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 25.5 t70 -105.74 139.76 39.83 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.068 -1.086 . . . . 62.01 108.068 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.13 128.08 41.1 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.689 -1.226 . . . . 65.44 107.689 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 28.0 t70 -140.7 159.23 42.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.224 1.01 . . . . 53.44 108.644 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 t -133.95 159.32 41.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.425 0.631 . . . . 73.24 111.063 -176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -141.51 150.14 41.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.224 1.409 . . . . 53.41 107.727 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -132.15 149.76 52.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.02 -0.363 . . . . 71.03 110.02 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -158.36 118.89 3.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.81 0.844 . . . . 64.12 108.729 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.27 117.09 21.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.327 -0.62 . . . . 74.41 109.327 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.35 -43.29 12.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.86 0.464 . . . . 62.32 110.715 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.82 -174.1 4.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.72 0.808 . . . . 65.13 110.163 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.9 121.5 18.21 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.25 -7.25 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.176 1.79 . . . . 74.35 111.807 -175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.5 t -104.78 120.67 55.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 124.433 1.093 . . . . 72.11 108.712 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 84' ' ' PHE . 7.8 p90 -135.34 170.51 15.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.218 -1.03 . . . . 72.51 108.218 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -131.23 136.8 48.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.28 -0.637 . . . . 72.3 109.28 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 75.4 t -114.42 121.29 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.62 -0.881 . . . . 62.34 108.62 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.8 t -100.5 125.99 54.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.982 -0.748 . . . . 72.25 108.982 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 114.93 26.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.343 -1.354 . . . . 74.0 107.343 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -92.39 99.56 12.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.633 -1.247 . . . . 61.42 107.633 170.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' HB1' ' A' ' 110' ' ' ALA . 11.9 t -94.62 135.12 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.83 -1.544 . . . . 73.0 106.83 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 31.8 m -134.09 123.34 24.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.538 0.685 . . . . 74.24 110.73 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.1 t -109.18 107.76 23.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.902 1.281 . . . . 65.51 108.779 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -108.23 112.79 25.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.623 -0.88 . . . . 71.31 108.623 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.74 116.85 28.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.417 -1.327 . . . . 63.44 107.417 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -123.31 132.12 53.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.018 0.437 . . . . 74.24 110.867 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 62.0 mt -87.24 84.25 7.26 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.879 1.271 . . . . 71.35 109.217 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -91.02 1.1 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.935 -1.03 . . . . 65.3 111.525 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.38 -29.94 7.6 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.426 0.69 . . . . 60.25 110.681 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.13 133.33 35.44 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.305 0.642 . . . . 74.43 109.673 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -69.85 135.97 50.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.802 0.441 . . . . 64.42 110.954 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -78.4 -56.4 4.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.762 -0.829 . . . . 70.13 108.762 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -164.36 174.62 10.85 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 113.97 -1.468 . . . . 74.31 110.26 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -138.58 116.6 11.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.752 -1.113 . . . . 75.25 108.741 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.625 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.5 m -103.56 139.65 38.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.514 -0.921 . . . . 60.33 108.514 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -146.88 117.88 7.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.616 -0.883 . . . . 75.11 108.616 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.04 113.84 39.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 123.766 0.827 . . . . 72.54 109.413 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 16.0 mp0 -84.6 85.28 7.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.491 -1.232 . . . . 74.32 108.352 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -83.79 92.38 7.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.109 -1.441 . . . . 74.33 107.109 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.87 142.83 18.67 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.409 -0.676 . . . . 75.13 111.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.593 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.32 122.03 2.2 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 110.759 -0.936 . . . . 71.31 110.759 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.448 HG21 ' NE2' ' A' ' 14' ' ' GLN . 39.4 mt -81.89 125.89 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 107.789 -1.189 . . . . 73.51 107.789 172.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 26.0 m-85 -128.59 164.58 22.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.36 0.664 . . . . 73.03 109.932 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 20.4 t -120.26 121.23 38.23 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.553 1.141 . . . . 75.43 109.212 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -138.55 150.1 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 123.378 0.671 . . . . 71.34 109.766 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.93 173.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.21 1.404 . . . . 50.34 110.211 167.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.96 88.67 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.952 0.783 . . . . 54.31 113.598 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -117.36 172.34 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.213 1.405 . . . . 73.11 109.427 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.6 tt0 -169.45 -177.63 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.814 0.846 . . . . 75.32 109.238 172.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.488 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.78 -142.81 42.62 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 123.44 0.543 . . . . 70.11 113.808 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -68.91 -18.95 64.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.835 0.854 . . . . 75.32 111.527 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -48.76 53.71 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.071 0.548 . . . . 74.55 109.586 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.43 ' HG3' ' N ' ' A' ' 95' ' ' ALA . 9.2 ptm -69.55 -36.67 76.57 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.691 0.281 . . . . 53.13 110.316 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 94' ' ' MET . . . -71.06 -28.52 64.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.651 0.78 . . . . 60.11 111.221 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.27 -37.75 13.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.38 -0.373 . . . . 73.32 110.942 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.8 t -66.02 -52.98 44.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.905 0.482 . . . . 73.32 110.39 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 tt -76.33 -39.38 54.16 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.605 0.762 . . . . 72.33 109.853 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.99 -24.16 58.24 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.031 0.772 . . . . 60.44 115.031 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -42.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.927 0.864 . . . . 70.4 112.306 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 59.4 t80 -78.73 -36.75 42.84 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 122.966 0.506 . . . . 74.14 112.339 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -72.52 -41.05 7.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-O 118.551 -0.738 . . . . 74.24 111.446 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.88 -21.93 63.69 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 121.485 1.457 . . . . 61.4 113.129 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -67.07 -37.29 83.76 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 122.795 0.438 . . . . 75.1 109.977 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -57.93 -41.8 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 44.5 110.064 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.593 HD21 ' HA3' ' A' ' 82' ' ' GLY . 60.4 mt -80.12 -24.65 40.35 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.486 -1.233 . . . . 70.3 111.651 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.56 -39.49 48.76 Favored Pre-proline 0 CA--C 1.575 1.915 0 N-CA-C 114.782 1.401 . . . . 53.24 114.782 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.17 -40.11 72.64 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 122.273 1.982 . . . . 74.43 112.58 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' C' ' 108' ' ' PRO . 90.8 m-85 -77.13 -32.44 56.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.03 -0.986 . . . . 73.23 110.833 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -68.62 -43.44 76.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 55.54 109.77 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.625 HH12 HD12 ' C' ' 105' ' ' ILE . 36.8 ttm180 -55.32 -54.26 45.85 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.629 1.205 . . . . 74.13 110.054 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.99 -40.58 98.2 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.347 1.029 . . . . 74.33 111.432 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.513 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.1 t -59.82 -37.01 77.96 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.919 0.762 . . . . 54.04 111.023 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.596 HG21 HG21 ' A' ' 64' ' ' VAL . 78.6 mt -72.52 -54.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.638 0.775 . . . . 64.41 110.147 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.468 HG23 ' HG3' ' A' ' 125' ' ' GLN . 98.6 m -52.13 -37.04 53.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.797 1.639 . . . . 70.2 111.607 -174.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.09 -45.65 59.82 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.073 -0.967 . . . . 60.24 110.629 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.4 mtm -59.56 -41.47 90.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.107 0.48 . . . . 73.14 110.899 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.97 -46.97 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.828 1.251 . . . . 73.13 110.848 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -72.15 -30.66 65.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.699 0.4 . . . . 55.24 111.353 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.0 -26.94 63.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 70.31 110.418 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 7.77 57.72 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.897 -0.592 . . . . 73.05 113.342 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.7 m 66.98 30.85 7.34 Favored 'General case' 0 C--N 1.364 1.236 0 C-N-CA 124.671 1.188 . . . . 51.31 110.455 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -107.92 139.31 20.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.058 -1.089 . . . . 73.1 108.058 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 140.21 61.73 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.559 2.173 . . . . 63.41 112.609 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.468 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.0 tt0 -53.07 140.96 23.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.58 1.152 . . . . 62.15 112.163 -176.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.0 109.59 10.63 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.91 -1.145 . . . . 75.22 107.91 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -103.84 104.89 14.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.603 0.761 . . . . 70.44 108.96 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 42' ' ' LEU . 66.3 mt -72.48 116.95 13.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.294 -0.632 . . . . 70.02 109.294 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.66 149.27 52.8 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.522 1.129 . . . . 61.3 111.922 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HG3' HH22 ' A' ' 111' ' ' ARG . 5.4 Cg_exo -71.01 -176.75 1.95 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.573 2.182 . . . . 73.23 112.435 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -133.26 126.22 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.598 -0.89 . . . . 61.41 108.598 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -80.27 74.49 7.1 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.78 -0.822 . . . . 61.11 108.78 173.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.481 1.099 0 C-N-CA 123.674 0.79 . . . . 75.51 111.714 -174.671 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 108.824 -0.806 . . . . 75.43 108.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.406 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 67.8 t80 -128.82 150.6 50.25 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.284 0.564 . . . . 75.41 111.899 -166.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 33.4 tp60 -142.54 123.63 14.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.054 1.342 . . . . 71.23 108.184 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.14 143.83 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.134 0.573 . . . . 75.33 109.984 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -116.94 -51.61 2.55 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.776 0.43 . . . . 74.32 110.841 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -162.53 143.65 10.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.405 0.282 . . . . 73.02 110.256 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -115.29 143.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.381 -1.34 . . . . 63.32 107.381 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -170.71 144.08 2.25 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.565 0.62 . . . . 70.3 111.716 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.3 m -75.25 121.72 22.59 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.976 -0.75 . . . . 70.14 108.976 172.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -88.73 -37.96 15.09 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.12 0.568 . . . . 75.41 110.312 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.6 t70 -152.89 144.08 23.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.283 -0.417 . . . . 72.5 112.071 -168.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -137.99 147.34 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.472 1.509 . . . . 65.55 108.492 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -150.58 150.69 31.52 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 73.23 108.78 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.9 t80 -160.19 114.7 2.24 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 106.625 -1.621 . . . . 72.31 106.625 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.78 113.91 20.34 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.607 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.96 89.23 4.24 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.649 -0.871 . . . . 64.34 108.649 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.46 -27.11 33.85 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.409 2.073 . . . . 74.44 112.035 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -123.3 30.59 6.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.372 1.069 . . . . 74.21 109.661 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.761 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -42.47 -52.07 10.74 Favored Pre-proline 0 CA--C 1.568 1.659 0 C-N-CA 125.525 1.53 . . . . 62.43 114.431 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.4 Cg_exo -72.16 -17.61 27.8 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.359 2.04 . . . . 72.1 112.802 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.43 2.97 56.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.491 1.116 . . . . 73.23 111.244 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.02 -27.95 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.807 0.443 . . . . 74.23 111.327 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -64.74 -41.03 96.23 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.247 0.619 . . . . 74.42 109.996 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -65.0 -29.6 70.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.562 1.145 . . . . 72.0 110.799 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' B' ' 68' ' ' LEU . 33.0 mmtp -108.85 96.72 6.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.317 1.047 . . . . 72.42 110.637 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.37 78.02 7.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.048 0.539 . . . . 74.54 111.287 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.6 170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.238 1.015 . . . . 64.2 109.727 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.539 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 48.9 tt0 -67.29 119.04 62.03 Favored Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 123.789 0.681 . . . . 65.15 109.653 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' 37' ' ' GLN . 12.3 Cg_endo -56.53 140.58 89.85 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.129 1.886 . . . . 62.43 110.842 167.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 36.3 mt-10 -67.04 100.45 0.75 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.708 -0.849 . . . . 73.51 108.708 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.09 120.84 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.758 -1.571 . . . . 65.41 106.758 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -144.08 126.68 16.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.577 -0.898 . . . . 75.33 108.577 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.5 HD13 HD11 ' B' ' 126' ' ' LEU . 1.8 pt? -129.29 159.02 37.45 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.982 0.513 . . . . 73.53 111.125 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -143.45 150.38 38.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.251 0.62 . . . . 74.11 110.77 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.13 144.03 29.29 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.726 1.21 . . . . 72.04 110.729 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.91 146.04 21.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 75.21 107.787 167.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.3 m -145.78 139.71 26.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.108 0.563 . . . . 73.42 110.004 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.31 134.76 18.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.101 0.96 . . . . 71.31 108.848 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -132.62 166.09 22.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.326 0.65 . . . . 53.44 110.343 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.1 p -153.09 137.19 16.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.645 0.778 . . . . 75.12 109.454 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -80.85 120.38 24.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.331 0.652 . . . . 75.44 110.539 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' B' ' 57' ' ' GLU . 38.4 mt -82.23 -50.03 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.754 0.822 . . . . 64.51 109.995 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.54 -171.11 3.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.272 1.029 . . . . 72.3 110.174 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.58 113.06 3.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.448 0.699 . . . . 61.12 110.56 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.4 m-20 71.06 -5.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.021 1.728 . . . . 45.12 112.694 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.68 116.62 46.72 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 108.15 -1.056 . . . . 53.31 108.15 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 155.33 50.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.172 -0.677 . . . . 75.25 109.172 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' B' ' 51' ' ' LEU . 6.9 tm-20 -111.68 112.28 23.87 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.342 -1.355 . . . . 75.42 107.342 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.95 127.21 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.964 0.905 . . . . 63.43 110.031 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -108.36 128.22 64.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.714 0.805 . . . . 70.42 109.282 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.44 109.11 20.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.794 -1.188 . . . . 74.22 107.794 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -93.41 119.25 32.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.838 0.455 . . . . 72.33 110.489 170.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.492 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.6 t -113.1 105.69 19.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.658 -1.238 . . . . 51.52 107.658 167.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -99.18 133.26 43.73 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.459 -0.571 . . . . 63.43 109.459 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.666 HG21 HG21 ' B' ' 114' ' ' ILE . 21.7 t -119.62 126.92 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.261 1.425 . . . . 63.51 109.069 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -114.72 149.13 37.31 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.426 1.09 . . . . 54.13 108.27 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.33 153.01 50.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.136 0.575 . . . . 63.13 109.736 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 33.5 p -146.13 141.23 27.31 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.606 0.566 . . . . 72.51 111.152 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' B' ' 34' ' ' LYS . 22.2 mt -130.17 99.82 5.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.253 1.421 . . . . 44.24 108.68 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -109.15 2.78 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.339 -0.391 . . . . 55.3 112.411 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -118.09 23.6 11.52 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.387 1.075 . . . . 74.22 110.555 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.86 160.72 42.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.116 0.566 . . . . 73.21 110.301 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -72.61 134.25 45.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.763 -0.653 . . . . 65.11 110.249 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.11 -58.07 2.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 50.2 109.271 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -153.19 173.54 15.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.787 -1.097 . . . . 63.31 109.779 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 73.2 mt -138.89 155.85 47.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.251 1.821 . . . . 71.11 106.473 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.565 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.4 t -160.49 159.59 30.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.81 0.844 . . . . 73.41 108.817 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.21 140.52 6.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.505 -0.924 . . . . 72.4 108.505 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.82 142.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.932 -1.136 . . . . 73.22 107.932 171.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -124.98 87.76 2.77 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.207 -1.035 . . . . 73.14 108.207 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -81.94 100.87 9.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.455 -1.248 . . . . 71.33 109.129 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.43 175.22 35.8 Favored Glycine 0 C--O 1.241 0.534 0 N-CA-C 111.954 -0.458 . . . . 73.53 111.954 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.97 137.16 3.73 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.932 -0.467 . . . . 64.44 111.932 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 127.01 40.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.775 -0.824 . . . . 62.01 108.775 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -138.64 161.24 37.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.405 1.082 . . . . 64.3 109.581 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.0 m -132.39 133.6 44.13 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.777 1.231 . . . . 61.41 108.982 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.57 HG21 ' SG ' ' B' ' 97' ' ' CYS . 2.7 pp -139.18 147.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 122.876 0.47 . . . . 70.32 111.868 -171.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.92 170.58 16.32 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.986 0.915 . . . . 75.15 109.749 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.12 16.31 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.426 -0.352 . . . . 65.22 113.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.14 142.54 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.385 1.074 . . . . 51.34 112.848 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.716 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 14.1 pt-20 -160.73 142.07 12.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.324 1.05 . . . . 65.5 109.026 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.08 -106.15 0.76 Allowed Glycine 0 C--N 1.354 1.564 0 C-N-CA 123.081 0.372 . . . . 34.11 113.928 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.2 m -77.21 -30.27 54.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.768 1.227 . . . . 43.43 111.796 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.716 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 1.5 mp0 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.421 0.689 . . . . 73.41 110.793 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 41.9 mtp -70.44 -39.79 74.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.607 0.763 . . . . 62.31 110.057 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.53 64.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 71.2 111.397 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.52 -39.23 92.88 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.334 0.654 . . . . 74.32 110.934 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.57 ' SG ' HG21 ' B' ' 86' ' ' ILE . 44.9 t -61.12 -61.56 2.48 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.109 -0.95 . . . . 73.35 111.635 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.77 -18.4 25.0 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.575 0.583 . . . . 71.2 112.575 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.68 -26.72 11.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.232 0.333 . . . . 75.1 113.673 -173.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -55.96 1.86 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.371 0.508 . . . . 54.32 112.371 -171.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -73.76 -60.06 2.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.524 0.33 . . . . 73.34 110.793 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.406 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 85.8 m -58.49 -46.18 99.63 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.196 -0.907 . . . . 71.44 112.225 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.9 -36.52 96.78 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.039 1.826 . . . . 64.4 113.759 172.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -66.87 -29.83 69.84 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 118.625 0.648 . . . . 74.02 110.849 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -63.04 -50.25 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.03 0.532 . . . . 75.14 109.877 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -79.34 -10.42 59.81 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.162 -1.381 . . . . 64.2 111.883 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.44 ' HE1' HD13 ' B' ' 128' ' ' LEU . 24.1 t80 -65.55 -49.67 60.77 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.654 1.181 . . . . 75.54 113.109 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 112' ' ' GLU . 25.1 Cg_exo -62.31 -35.72 71.8 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 121.494 1.463 . . . . 73.42 111.353 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.475 ' HE2' HG21 ' D' ' 115' ' ' THR . 72.9 m-85 -64.17 -48.6 75.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.069 0.947 . . . . 74.14 110.793 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.08 74.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.127 0.971 . . . . 61.42 110.734 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -67.46 -43.31 81.36 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.95 0.781 . . . . 74.35 110.381 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 108' ' ' PRO . 0.4 OUTLIER -69.26 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.131 0.972 . . . . 74.42 111.609 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.7 t -74.16 -39.05 63.5 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.8 -0.445 . . . . 71.42 109.8 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 64' ' ' VAL . 94.2 mt -62.82 -46.76 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.604 0.762 . . . . 64.55 110.078 173.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.429 HG23 ' OE1' ' C' ' 125' ' ' GLN . 44.1 m -50.41 -39.52 47.45 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.958 1.303 . . . . 75.41 110.701 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.8 t -66.34 -56.15 12.51 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 113.957 -1.474 . . . . 72.34 110.552 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.7 mmt -64.26 -38.13 89.95 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.659 0.615 . . . . 73.54 112.659 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.28 -46.41 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.421 1.088 . . . . 74.32 110.409 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.568 ' HB3' ' NE2' ' C' ' 125' ' ' GLN . 81.9 p -71.71 -25.28 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.568 -0.742 . . . . 60.32 111.465 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.513 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.1 mtt-85 -65.47 -39.44 91.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.158 0.583 . . . . 73.21 110.091 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.11 3.85 50.06 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.631 -0.713 . . . . 61.2 113.15 172.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p 59.72 48.98 8.65 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 126.512 1.925 . . . . 75.42 111.27 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -115.69 161.61 29.5 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-N 113.867 -1.515 . . . . 74.32 110.585 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.539 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 89.0 Cg_exo -53.2 177.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 125.031 3.82 . . . . 74.41 118.509 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.65 147.48 52.9 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 113.824 -1.534 . . . . 74.42 113.688 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.5 HD11 HD13 ' B' ' 42' ' ' LEU . 3.5 tm? -149.97 106.73 3.54 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.166 -1.379 . . . . 71.31 107.626 173.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -137.72 118.82 14.43 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.679 -1.23 . . . . 53.53 107.679 163.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.447 HD23 ' N ' ' B' ' 129' ' ' ALA . 2.2 tt -79.91 135.3 36.39 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.241 -0.652 . . . . 64.12 109.241 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.447 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -57.19 141.95 76.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.406 1.482 . . . . 70.31 113.078 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' D' ' 16' ' ' ILE . 61.4 Cg_endo -71.97 99.26 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.673 2.249 . . . . 73.14 111.818 171.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.28 105.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 109.24 -0.652 . . . . 50.25 109.24 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.406 ' ND2' HD13 ' D' ' 13' ' ' ILE . 45.8 t30 -70.1 117.66 11.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.391 0.677 . . . . 72.35 110.719 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 19.2 p90 . . . . . 0 CA--C 1.555 1.173 0 C-N-CA 123.574 0.75 . . . . 73.22 112.911 177.793 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 89.0 m . . . . . 0 CA--C 1.547 0.861 0 N-CA-C 109.404 -0.591 . . . . 71.44 109.404 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -107.83 163.74 12.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.635 1.174 . . . . 73.13 111.317 -169.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.023 0.929 . . . . 70.03 109.213 161.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.548 HD11 HG13 ' C' ' 16' ' ' ILE . 5.5 tp -78.55 133.62 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.03 -0.73 . . . . 72.21 109.03 167.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -103.7 -47.93 4.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.552 0.741 . . . . 42.11 110.388 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -169.65 134.31 1.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.637 -0.256 . . . . 64.55 110.435 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.548 HG13 HD11 ' C' ' 13' ' ' ILE . 92.3 mt -122.34 135.25 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.451 -0.944 . . . . 75.33 108.451 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.693 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 10.3 p90 -171.63 157.1 4.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.244 0.545 . . . . 70.2 111.821 -172.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -82.02 118.43 22.99 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.289 -0.869 . . . . 51.41 109.813 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -69.76 -45.96 66.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.661 0.743 . . . . 71.11 109.216 172.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -146.29 146.41 30.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 113.882 -1.508 . . . . 65.3 108.956 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.3 mt -138.99 140.16 39.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.99 -1.485 . . . . 72.33 106.99 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -152.52 148.63 27.61 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.273 0.558 . . . . 45.21 110.213 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -154.36 107.83 2.91 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.376 -1.342 . . . . 73.0 107.376 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.43 112.09 20.19 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.415 -0.958 . . . . 74.53 108.415 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.22 95.93 32.74 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.403 1.081 . . . . 75.25 109.355 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.5 -39.88 33.85 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.793 2.328 . . . . 73.5 111.977 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -96.25 29.4 2.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.931 -1.031 . . . . 75.55 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.43 -48.34 97.13 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.684 -0.674 . . . . 51.45 112.412 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.58 -31.14 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 121.455 1.437 . . . . 63.23 113.387 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -71.13 -25.11 62.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.383 0.673 . . . . 70.03 112.415 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.93 -22.08 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.531 0.732 . . . . 72.1 111.546 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.44 -36.81 71.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.269 1.027 . . . . 65.4 111.12 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.86 45.94 1.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.996 0.903 . . . . 71.41 109.012 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.854 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -123.49 155.1 38.17 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.931 0.892 . . . . 70.42 110.859 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.41 115.38 8.61 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.363 -0.977 . . . . 71.33 108.363 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -80.46 71.18 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.092 0.957 . . . . 71.43 111.887 -173.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.434 ' O ' ' HA ' ' C' ' 68' ' ' LEU . 25.8 tt0 -122.66 78.18 47.7 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.897 0.879 . . . . 75.31 109.821 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -71.06 128.58 15.02 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.262 1.975 . . . . 74.32 111.152 172.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -87.7 107.36 18.6 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 70.23 106.785 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.31 113.65 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 124.113 0.883 . . . . 75.12 109.913 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.07 115.43 23.09 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.457 -1.312 . . . . 73.4 107.457 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.51 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.7 pt? -110.47 143.97 39.99 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.341 -0.985 . . . . 71.24 108.341 169.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.26 144.08 26.28 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.968 -0.752 . . . . 63.3 108.968 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.417 HD11 HD22 ' C' ' 60' ' ' LEU . 42.8 tp -113.89 123.94 51.0 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.588 0.555 . . . . 71.42 109.948 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -113.07 145.04 41.59 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.883 -1.525 . . . . 64.4 106.883 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -125.15 154.58 41.27 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.059 0.544 . . . . 64.13 110.001 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.6 161.51 39.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.499 1.119 . . . . 64.04 108.605 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.3 p -158.88 152.75 23.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.88 0.472 . . . . 54.2 110.978 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -156.84 130.28 8.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.721 0.808 . . . . 72.53 109.937 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -74.76 121.5 21.84 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.086 -0.709 . . . . 75.1 109.086 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' C' ' 57' ' ' GLU . 39.6 mt -94.98 -50.38 5.13 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.62 0.724 . . . . 74.42 110.864 -173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -149.3 -172.19 4.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.749 -1.114 . . . . 74.25 109.945 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -69.96 113.89 7.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.852 0.461 . . . . 74.42 109.769 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 70.66 -0.38 2.97 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.674 1.589 . . . . 73.54 112.303 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 61.2 t -109.92 122.1 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 60.42 108.483 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -134.66 176.58 8.51 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.679 0.752 . . . . 72.51 109.711 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.701 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.7 tt0 -125.39 141.41 52.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.444 -1.253 . . . . 72.11 108.159 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.85 140.18 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.09 -1.078 . . . . 75.12 108.09 164.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.2 t -126.38 116.5 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.99 0.916 . . . . 74.53 109.465 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.417 HD22 HD11 ' C' ' 44' ' ' LEU . 15.2 mt -87.8 104.88 16.99 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 122.761 0.424 . . . . 63.53 110.261 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -86.81 101.46 13.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.107 -1.071 . . . . 74.44 108.107 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.1 t -99.84 132.0 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.645 -1.243 . . . . 62.24 107.645 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -122.92 123.12 40.23 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.502 -0.555 . . . . 73.42 109.502 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.643 HG21 HG21 ' C' ' 114' ' ' ILE . 92.7 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.369 1.067 . . . . 73.33 108.858 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -98.57 139.46 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.004 -1.11 . . . . 74.23 108.004 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.43 114.21 8.04 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.633 -0.877 . . . . 70.41 108.633 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.8 m -123.73 135.35 53.8 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.941 0.497 . . . . 70.42 111.015 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.854 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.3 mt -85.53 55.17 3.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.032 1.333 . . . . 75.55 109.148 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -110.18 3.81 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.943 -1.263 . . . . 74.55 109.943 -172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.7 -23.72 17.45 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.876 . . . . 73.14 110.244 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -91.47 108.63 20.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.4 1.08 . . . . 72.03 110.027 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 59.0 m -70.19 122.65 19.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.304 0.642 . . . . 70.13 112.43 -171.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.643 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -67.77 -58.47 4.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.607 1.163 . . . . 51.11 110.254 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -154.53 176.2 12.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.587 -1.188 . . . . 71.01 111.05 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.79 109.75 5.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.578 -1.638 . . . . 75.33 106.578 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.516 ' SG ' HG23 ' C' ' 114' ' ' ILE . 43.6 t -107.45 146.25 31.97 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.528 -0.916 . . . . 74.52 108.528 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -158.24 129.77 6.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.807 -0.442 . . . . 71.21 109.807 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.24 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.309 1.044 . . . . 73.14 108.592 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.4 mt-30 -114.5 98.68 7.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 63.5 108.753 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -91.33 105.24 17.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.938 0.895 . . . . 75.15 110.26 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.78 151.45 22.33 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.311 0.382 . . . . 52.51 112.274 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.54 121.34 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.448 -0.661 . . . . 75.0 111.448 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.429 HD11 ' HB3' ' D' ' 29' ' ' PRO . 23.9 mm -82.69 127.8 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.747 -0.834 . . . . 75.12 108.747 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -136.23 126.03 25.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.335 0.654 . . . . 74.12 110.051 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.1 p -101.43 106.54 17.69 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.662 -0.866 . . . . 75.01 108.662 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.425 HD12 ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER -148.42 143.94 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.622 0.725 . . . . 72.22 111.369 -177.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.62 179.38 7.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.293 1.437 . . . . 54.24 109.716 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.72 52.74 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 114.618 0.607 . . . . 64.03 114.618 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 123.331 0.653 . . . . 70.22 111.865 -179.647 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.722 -0.473 . . . . 73.23 109.722 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.8 ttm -63.89 -47.31 81.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 65.31 111.053 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.295 -0.866 . . . . 74.24 110.854 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -74.68 -24.91 58.86 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.98 -0.554 . . . . 74.23 111.731 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' C' ' 86' ' ' ILE . 42.7 t -72.06 -62.71 1.33 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.84 0.456 . . . . 74.43 111.503 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 -6.86 24.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.764 -0.585 . . . . 70.02 112.433 -176.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.64 2.61 49.3 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.669 -0.517 . . . . 70.31 113.286 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.56 -58.55 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.267 0.533 . . . . 75.31 111.858 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -65.4 -67.9 0.4 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.36 1.064 . . . . 74.44 112.212 -168.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -57.84 -43.98 99.05 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.299 1.039 . . . . 54.35 112.813 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.35 -34.18 55.89 Favored 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 121.638 1.559 . . . . 75.14 113.575 170.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -72.0 -19.14 61.91 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 118.76 0.709 . . . . 73.1 110.866 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.625 HD12 HH12 ' A' ' 111' ' ' ARG . 40.5 mm -66.08 -41.75 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.515 0.726 . . . . 73.44 109.551 167.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.53 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.1 mt -79.13 -28.1 42.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.26 -0.882 . . . . 62.33 112.053 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -53.74 -45.97 98.56 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.364 -1.303 . . . . 73.14 113.271 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.418 ' HG3' ' CD2' ' A' ' 109' ' ' TYR . 47.4 Cg_exo -53.96 -40.54 80.56 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 122.329 2.019 . . . . 72.11 113.274 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -69.21 -43.57 73.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.445 0.698 . . . . 53.22 110.651 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.82 98.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 71.33 110.718 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -57.94 -48.54 79.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.81 1.644 . . . . 73.54 110.751 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.434 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -72.35 -33.94 67.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.771 0.828 . . . . 65.42 110.541 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -65.03 -43.34 92.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.71 0.804 . . . . 54.33 110.466 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.643 HG21 HG21 ' C' ' 64' ' ' VAL . 87.9 mt -66.52 -50.03 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.212 0.605 . . . . 62.33 110.23 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.467 HG23 ' HB2' ' C' ' 125' ' ' GLN . 58.8 m -50.15 -44.28 52.5 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 124.555 1.16 . . . . 75.31 111.055 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.4 t -68.77 -46.82 67.76 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.484 -1.234 . . . . 75.4 110.012 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.602 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.75 -43.89 63.1 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.013 0.925 . . . . 63.54 112.229 178.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.1 t -66.1 -45.38 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.489 0.716 . . . . 63.54 110.668 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -70.47 -26.51 63.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.926 -0.579 . . . . 62.02 111.229 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.3 mtt-85 -65.99 -38.59 88.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.784 0.833 . . . . 74.23 110.413 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.69 3.7 63.09 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.755 -0.657 . . . . 54.11 112.826 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.5 p 63.32 33.42 14.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.349 1.86 . . . . 61.45 112.152 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.43 168.09 9.02 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.721 1.208 . . . . 71.12 109.609 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.48 106.51 0.6 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 122.386 2.058 . . . . 73.23 110.984 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' B' ' 119' ' ' SER . 18.7 pt20 -54.45 135.53 45.4 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.04 . . . . 72.22 111.842 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.01 89.67 3.71 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.402 0.62 . . . . 63.15 109.969 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -111.5 86.42 2.33 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.603 -1.629 . . . . 61.41 106.603 167.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 76.4 mt -87.52 153.8 21.13 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.261 -1.336 . . . . 73.24 109.985 -174.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.25 127.84 5.85 Favored Pre-proline 0 CA--C 1.556 1.193 0 O-C-N 124.599 1.187 . . . . 52.01 112.817 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 37.0 Cg_endo -61.08 104.16 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.558 2.839 . . . . 61.03 113.054 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.68 91.66 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-O 121.955 0.883 . . . . 64.41 111.076 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -88.54 102.39 14.88 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.241 -1.022 . . . . 71.24 108.241 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 64.8 t80 . . . . . 0 CA--C 1.547 0.865 0 C-N-CA 123.877 0.871 . . . . 74.5 112.325 -173.509 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m . . . . . 0 C--O 1.238 0.455 0 N-CA-C 108.779 -0.823 . . . . 73.42 108.779 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -156.57 111.1 2.78 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.691 -1.226 . . . . 63.44 107.691 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.473 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 79.2 mt-30 -117.66 116.63 27.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.565 0.746 . . . . 71.14 110.312 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.406 HD13 ' ND2' ' B' ' 132' ' ' ASN . 1.7 mp -75.91 104.87 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.928 -1.508 . . . . 61.23 106.928 168.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.466 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 76.3 mt-30 -80.79 -41.9 22.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 119.106 -0.473 . . . . 75.13 110.759 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 177.96 144.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.686 0.616 . . . . 75.23 111.722 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.551 ' H ' ' HG3' ' B' ' 130' ' ' PRO . 2.0 mp -105.48 132.14 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 107.316 -1.364 . . . . 72.35 107.316 170.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -158.28 159.8 36.35 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.321 1.049 . . . . 74.53 109.628 -174.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -92.37 118.13 30.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 72.14 109.812 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -89.07 -32.75 17.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.758 -0.655 . . . . 72.43 109.827 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.8 t70 -146.06 134.02 21.4 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.118 -0.946 . . . . 63.43 108.902 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.602 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.3 mt -130.44 140.49 48.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.578 -1.268 . . . . 60.34 107.578 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -142.19 136.15 29.65 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.101 0.96 . . . . 73.34 108.837 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -144.31 119.83 10.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.558 -2.016 . . . . 72.43 105.558 166.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.69 134.29 54.96 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 108.973 -0.751 . . . . 72.42 108.973 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.53 82.22 47.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.758 -1.571 . . . . 74.31 106.758 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -65.91 -30.22 48.9 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.61 2.207 . . . . 71.44 112.043 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.7 24.9 12.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.726 -1.125 . . . . 52.54 109.898 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.693 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -41.22 -60.97 1.49 Allowed Pre-proline 0 CA--C 1.584 2.253 0 N-CA-C 116.018 1.859 . . . . 73.01 116.018 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.429 ' HB3' HD11 ' C' ' 83' ' ' ILE . 94.4 Cg_endo -79.6 -17.06 11.43 Favored 'Trans proline' 0 C--N 1.399 3.214 0 CA-C-N 122.923 2.08 . . . . 74.34 113.293 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -73.41 -39.22 65.23 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.989 1.316 . . . . 73.44 110.295 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.5 p -86.24 -7.86 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 124.296 1.038 . . . . 74.31 111.156 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.52 -25.34 59.71 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.363 1.065 . . . . 74.31 111.176 169.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.54 -14.21 62.85 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.232 1.013 . . . . 51.41 112.259 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.428 ' HB3' HD22 ' D' ' 68' ' ' LEU . 0.1 OUTLIER -96.92 106.28 18.57 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.854 0.862 . . . . 51.21 109.394 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -112.7 50.08 0.89 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.579 1.152 . . . . 74.11 110.604 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -146.59 177.51 9.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 75.42 110.509 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -62.05 113.98 10.16 Favored Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.058 0.943 . . . . 74.22 111.345 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HG3' HD21 ' D' ' 68' ' ' LEU . 15.4 Cg_exo -71.31 144.84 46.94 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.024 2.483 . . . . 55.14 113.037 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.87 142.69 47.94 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.489 -0.778 . . . . 73.13 109.053 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.523 HG13 HG13 ' D' ' 64' ' ' VAL . 95.7 t -124.95 118.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.21 108.385 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -112.67 118.26 34.55 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.24 -0.652 . . . . 64.13 109.24 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.642 HD21 HD22 ' D' ' 128' ' ' LEU . 5.7 mp -96.88 125.45 41.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.475 0.71 . . . . 75.32 109.696 -174.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.811 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.1 m-20 -107.06 126.86 52.9 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.459 -0.941 . . . . 73.01 108.459 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.58 132.23 40.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.258 0.623 . . . . 75.32 109.89 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.1 t70 -157.62 156.18 31.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 170.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -136.51 165.89 24.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.6 0.76 . . . . 63.42 109.794 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.99 177.57 10.03 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.889 1.275 . . . . 71.3 108.473 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -165.36 166.63 18.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.847 0.459 . . . . 73.43 111.249 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.6 p -154.24 131.69 11.28 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.292 1.037 . . . . 71.31 108.328 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.4 117.85 20.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.941 -0.762 . . . . 71.42 108.941 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.3 mt -92.27 -33.4 14.66 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.708 -0.478 . . . . 65.15 109.708 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.39 -177.04 5.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.538 0.735 . . . . 73.4 111.064 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -65.92 124.55 22.8 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.02 -0.991 . . . . 65.22 109.005 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 16.6 m-20 65.7 19.27 11.38 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.183 0.993 . . . . 64.34 111.821 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.24 119.93 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.735 0.814 . . . . 64.51 109.643 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -134.03 130.84 38.12 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.023 0.929 . . . . 71.12 108.668 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.424 ' HB2' HD11 ' D' ' 51' ' ' LEU . 4.2 tt0 -86.78 119.6 27.18 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.512 -1.292 . . . . 74.35 107.512 169.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -100.16 129.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.635 -1.246 . . . . 73.1 107.635 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.3 t -104.79 138.66 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 54.32 108.944 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -106.4 124.32 49.41 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.43 -1.322 . . . . 74.31 107.43 174.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.7 ttm-85 -99.5 98.99 9.82 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.544 -1.28 . . . . 72.11 107.544 173.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.611 HG21 ' HB1' ' D' ' 110' ' ' ALA . 9.3 t -100.51 112.72 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.397 -0.964 . . . . 75.24 108.397 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -114.5 145.76 41.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.791 -0.448 . . . . 72.32 109.791 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.523 HG13 HG13 ' D' ' 40' ' ' VAL . 39.3 t -133.95 105.17 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.889 1.276 . . . . 60.22 109.101 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -98.07 96.47 8.15 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.085 -1.08 . . . . 70.25 108.085 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.98 147.71 24.22 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.972 0.509 . . . . 44.12 110.131 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -137.23 133.49 35.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.346 0.593 . . . . 74.14 111.939 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.444 HD21 ' HG3' ' D' ' 38' ' ' PRO . 9.4 mt -119.69 108.87 14.97 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.008 1.323 . . . . 75.01 108.402 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.2 -118.41 4.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.724 -0.551 . . . . 75.01 111.724 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.75 4.72 15.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.534 0.734 . . . . 72.2 110.707 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -122.48 171.75 8.86 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.484 0.714 . . . . 71.45 110.549 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.8 m -68.18 123.76 21.6 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.938 -1.028 . . . . 73.12 110.734 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.751 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -73.35 -65.41 0.82 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.422 -0.955 . . . . 73.21 108.422 170.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -156.76 157.05 34.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.843 -1.072 . . . . 64.45 109.83 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.05 152.11 29.91 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.124 1.37 . . . . 70.34 108.608 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 39.3 t -157.85 143.39 17.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.487 0.715 . . . . 73.44 109.092 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.23 128.99 7.82 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.557 -0.535 . . . . 64.45 109.557 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.18 115.29 42.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.013 -0.736 . . . . 70.21 109.013 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.69 85.63 6.83 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.189 0.995 . . . . 41.33 108.627 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.461 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -80.04 96.9 6.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 113.324 -1.762 . . . . 75.2 108.241 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -97.72 144.14 17.11 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 112.061 -0.416 . . . . 70.55 112.061 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.61 137.64 7.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.366 -0.694 . . . . 50.13 111.366 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 62.0 mt -88.08 125.45 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.901 -0.777 . . . . 73.43 108.901 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -130.79 123.87 30.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.643 0.777 . . . . 74.55 109.62 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 66.5 m -80.77 106.23 12.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.611 -0.885 . . . . 62.03 108.611 170.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -108.23 103.55 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.998 0.904 . . . . 74.25 110.007 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -140.96 150.92 43.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.985 0.914 . . . . 71.54 109.711 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.6 14.83 75.22 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.093 0.246 . . . . 74.12 113.192 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.667 HD12 ' HG2' ' D' ' 94' ' ' MET . 24.7 pt -98.59 125.63 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.365 1.066 . . . . 65.11 108.708 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -140.67 172.83 12.15 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.228 0.537 . . . . 64.13 112.01 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.23 -143.9 47.92 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.31 -1.314 . . . . 74.34 113.684 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -85.32 -20.21 30.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.106 0.962 . . . . 62.4 110.724 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.82 -35.87 79.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.472 0.709 . . . . 63.44 110.627 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.667 ' HG2' HD12 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -58.33 -49.26 77.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.527 0.731 . . . . 71.35 110.69 175.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.01 94.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.309 -0.86 . . . . 71.33 111.047 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.25 -30.88 66.85 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.64 -0.709 . . . . 64.14 111.261 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.67 -48.35 64.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.822 0.449 . . . . 73.11 110.411 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.57 -36.5 65.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.141 0.576 . . . . 54.11 110.212 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.55 6.5 77.63 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.221 -0.766 . . . . 72.45 114.785 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.75 -57.92 0.14 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.364 1.082 . . . . 55.23 112.341 -178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -64.75 -51.7 60.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.183 0.593 . . . . 72.11 111.49 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.524 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 27.9 m -60.73 -47.93 94.5 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 118.498 -0.763 . . . . 75.44 111.357 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.2 Cg_exo -59.29 -31.38 94.98 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.418 2.078 . . . . 65.3 113.968 168.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.7 -31.29 70.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.861 0.465 . . . . 73.4 110.706 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.3 -33.82 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.505 0.722 . . . . 64.3 110.281 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.526 HD23 HG13 ' D' ' 16' ' ' ILE . 86.0 mt -76.95 -25.61 53.05 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.049 0.939 . . . . 73.4 111.731 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -63.74 -41.99 68.51 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 114.94 1.459 . . . . 64.1 114.94 -168.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.53 -41.85 71.71 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.106 1.87 . . . . 62.35 113.234 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.15 -30.74 38.95 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.134 -0.939 . . . . 65.3 110.365 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.611 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -63.89 -44.91 91.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.722 0.809 . . . . 72.42 110.179 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.0 -51.29 70.28 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 124.629 1.206 . . . . 64.44 110.515 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.2 -41.92 99.23 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.143 0.902 . . . . 73.43 110.559 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -56.51 -45.21 81.2 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 123.808 0.693 . . . . 63.04 110.356 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' D' ' 76' ' ' CYS . 77.4 mt -63.9 -54.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.024 0.828 . . . . 74.52 110.375 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.475 HG21 ' HE2' ' B' ' 109' ' ' TYR . 86.8 m -51.38 -46.74 62.89 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.152 1.381 . . . . 75.12 111.893 -171.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -65.53 -44.5 86.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.6 -1.182 . . . . 62.41 110.271 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.7 mtm -65.74 -32.71 74.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.03 0.532 . . . . 71.32 111.692 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -63.93 -48.26 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.77 0.828 . . . . 55.23 109.982 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -72.25 -28.63 63.27 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.983 -0.553 . . . . 64.1 110.937 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -69.81 -34.23 73.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.624 0.77 . . . . 74.44 110.041 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 8.65 64.16 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.982 -0.554 . . . . 64.32 113.001 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.8 p 61.27 30.62 19.26 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.956 1.702 . . . . 74.31 113.119 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 74.2 m-85 -100.9 163.43 18.05 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 124.708 1.203 . . . . 71.11 108.697 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 73.1 Cg_endo -71.12 143.21 43.78 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.212 1.942 . . . . 71.31 111.55 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -52.13 132.97 33.77 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.792 0.682 . . . . 75.11 111.384 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.454 HD13 HG21 ' D' ' 40' ' ' VAL . 29.4 tp -108.89 108.23 18.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.148 0.979 . . . . 71.33 109.715 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -102.12 102.75 13.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.395 0.678 . . . . 54.1 109.603 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.642 HD22 HD21 ' D' ' 42' ' ' LEU . 38.5 mt -72.75 118.47 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.125 -0.694 . . . . 75.45 109.125 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 125.09 79.25 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.341 0.656 . . . . 62.25 111.25 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -67.64 103.34 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.136 1.891 . . . . 72.34 110.605 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -106.84 110.12 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.107 0.956 . . . . 72.33 109.915 -178.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 16.2 t30 . . . . . 0 CA--C 1.539 0.527 0 CA-C-N 114.413 -1.267 . . . . 73.05 108.098 173.876 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 121.183 0.516 . . . . 72.11 110.484 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -133.53 127.47 33.24 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 106.61 -1.626 . . . . 71.33 106.61 158.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -141.06 136.65 32.22 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.089 0.243 . . . . 74.33 110.681 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 13' ' ' ILE . 2.8 mp -92.64 104.03 15.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 107.491 -1.299 . . . . 73.1 107.491 174.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -81.28 -25.94 36.13 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 118.709 -0.662 . . . . 70.32 110.986 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.409 HH21 HG23 ' B' ' 122' ' ' THR . 21.7 ttt85 -176.82 135.61 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.315 0.646 . . . . 65.35 110.711 173.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.5 136.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 123.765 0.826 . . . . 53.25 109.013 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.524 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 33.6 p90 -170.77 167.6 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.755 0.822 . . . . 65.3 110.863 -174.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -90.91 124.28 35.07 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 167.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -81.15 -33.34 33.2 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.352 -0.61 . . . . 52.3 109.352 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.5 t70 -148.23 140.84 24.49 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.797 -1.092 . . . . 74.33 109.911 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.1 mt -132.32 141.4 45.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.018 1.327 . . . . 62.11 107.442 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -149.65 130.85 14.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.127 -0.694 . . . . 75.3 109.127 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.7 t80 -132.46 135.85 46.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.7 -1.593 . . . . 74.0 106.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.11 152.63 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 75.43 108.29 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.84 79.35 46.02 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 106.541 -1.651 . . . . 73.24 106.541 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.9 -45.86 12.13 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.876 2.384 . . . . 73.34 112.094 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 28.2 m-80 -107.38 45.63 0.98 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.405 -0.816 . . . . 15.41 108.972 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -61.0 -50.16 85.95 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.187 0.995 . . . . 65.33 113.036 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -68.38 -7.99 21.73 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.823 1.682 . . . . 71.14 113.887 170.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.1 m80 -99.12 -13.4 19.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.766 0.826 . . . . 74.32 112.278 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -64.58 -23.02 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.896 0.316 . . . . 60.44 110.77 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.53 -34.92 74.83 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.078 0.951 . . . . 61.35 111.739 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -63.02 -54.71 34.0 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.555 0.742 . . . . 62.31 110.322 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HB2' HD13 ' A' ' 68' ' ' LEU . 33.8 mmtp -85.12 127.32 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.594 -1.185 . . . . 70.2 110.712 -172.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -66.8 136.36 55.33 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.785 -1.191 . . . . 74.12 107.785 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -60.05 100.78 0.1 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.453 1.095 . . . . 75.42 112.389 -163.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -127.35 76.51 76.52 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.633 1.173 . . . . 73.55 108.063 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.69 101.39 1.18 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.108 1.872 . . . . 74.33 111.642 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.01 94.67 9.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.674 -1.602 . . . . 54.45 106.674 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.8 m -84.37 129.76 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.832 -1.076 . . . . 63.44 111.666 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 3.0 mptp? -105.3 124.02 48.83 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.347 1.059 . . . . 63.22 108.577 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 128' ' ' LEU . 5.7 mp -97.52 120.96 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.574 1.15 . . . . 73.41 108.603 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 20.5 m-20 -117.57 111.27 18.99 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.279 -1.008 . . . . 75.24 108.279 167.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD11 HD21 ' A' ' 60' ' ' LEU . 29.7 tp -97.28 135.55 39.03 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.295 -1.002 . . . . 70.44 108.295 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 14.3 t70 -143.33 136.29 27.77 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -122.96 137.9 54.82 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.089 0.556 . . . . 75.42 109.643 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.43 153.17 52.06 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.444 1.098 . . . . 53.3 108.902 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.8 m -134.11 157.35 46.39 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.717 0.407 . . . . 54.45 110.69 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -149.82 119.45 6.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.981 0.912 . . . . 60.42 108.827 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -74.38 122.76 23.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.877 0.471 . . . . 75.22 109.986 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.77 -43.72 7.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.179 0.592 . . . . 73.31 110.154 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.81 -169.54 3.41 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 123.703 0.801 . . . . 74.22 109.991 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.64 126.25 30.64 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.757 -0.831 . . . . 71.22 108.757 169.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 69.44 -3.03 1.71 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.737 1.615 . . . . 70.35 112.653 -176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 41.1 t -115.4 120.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 N-CA-C 107.924 -1.139 . . . . 53.42 107.924 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.57 170.38 15.82 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.915 -1.143 . . . . 65.31 107.915 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 9.0 tm-20 -127.3 132.17 50.35 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.666 -1.235 . . . . 72.13 107.666 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.76 120.79 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.47 -0.937 . . . . 64.44 108.47 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 43.7 t -95.24 130.92 43.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 123.64 0.776 . . . . 72.44 109.047 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -105.09 107.54 18.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.896 -1.52 . . . . 74.41 106.896 170.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 24.3 ttp180 -100.06 100.79 11.71 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.39 -0.967 . . . . 74.03 108.39 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 t -94.74 137.57 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.834 -1.173 . . . . 75.14 107.834 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.9 m -128.66 126.79 40.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.505 -0.554 . . . . 54.12 109.505 173.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.1 t -122.06 109.5 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.675 1.19 . . . . 75.14 109.537 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 80.0 m -101.41 141.97 33.5 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.429 -0.952 . . . . 54.22 108.429 173.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.07 109.58 14.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.266 -1.013 . . . . 62.55 108.266 173.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 39.8 m -107.46 127.23 53.42 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.343 -0.614 . . . . 64.41 109.343 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 34' ' ' LYS . 22.3 mt -90.75 81.93 5.76 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.518 -1.66 . . . . 73.34 106.518 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.15 -86.4 1.1 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.16 -0.927 . . . . 75.42 110.881 -168.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.1 -19.25 4.4 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 70.12 110.452 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.08 108.02 18.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.855 0.862 . . . . 71.35 110.247 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.1 m -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.293 0.568 . . . . 63.33 111.442 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -54.09 7.69 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.92 1.288 . . . . 72.32 109.455 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -148.92 165.26 32.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.389 -1.278 . . . . 75.45 110.82 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.5 tp -130.89 145.2 51.94 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.666 -1.235 . . . . 73.03 107.666 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -134.54 140.39 46.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.77 0.828 . . . . 72.41 109.268 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.85 117.1 6.43 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.89 -0.781 . . . . 70.44 108.89 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.91 111.34 28.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.773 0.829 . . . . 62.32 109.038 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.6 mt-30 -88.42 82.57 6.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.118 -0.946 . . . . 63.03 109.119 173.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -75.95 93.6 3.26 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.154 -0.93 . . . . 73.14 108.842 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.39 148.9 19.54 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 116.179 -0.464 . . . . 70.43 112.06 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.06 123.97 1.73 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.74 -0.944 . . . . 51.33 110.74 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.4 mt -79.08 127.85 38.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.981 -1.118 . . . . 74.13 107.981 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.89 143.42 50.8 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.398 -0.593 . . . . 71.32 109.398 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 t -112.54 112.98 24.9 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.088 -1.078 . . . . 72.31 108.088 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -129.01 143.42 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.089 0.555 . . . . 72.54 110.011 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.06 175.39 2.29 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.208 1.003 . . . . 74.43 111.215 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.72 5.16 88.42 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.392 -0.822 . . . . 74.23 114.478 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -131.31 -179.62 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.337 1.055 . . . . 73.12 109.422 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.9 tt0 -168.37 177.2 5.47 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.085 0.554 . . . . 72.33 110.139 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.86 -121.28 22.74 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 114.969 0.748 . . . . 73.2 114.969 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.6 p -64.67 -30.92 71.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.899 0.88 . . . . 73.33 111.593 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.54 -42.1 71.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.549 0.739 . . . . 62.31 111.041 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -76.55 -30.24 57.0 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.507 -0.315 . . . . 55.12 110.701 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.76 63.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.147 0.579 . . . . 75.31 110.74 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -67.61 -48.56 66.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.174 0.99 . . . . 75.32 110.234 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 20.2 t -74.59 -63.0 1.34 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.544 -0.753 . . . . 71.2 111.001 -172.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 tt -62.36 -38.34 89.16 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.164 0.586 . . . . 75.35 110.698 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.15 -31.1 32.42 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 115.26 0.864 . . . . 72.14 115.26 -168.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -48.37 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.342 1.071 . . . . 54.42 112.569 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 86.4 t80 -66.66 -50.08 64.09 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.615 0.766 . . . . 74.03 112.697 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.426 ' HA ' HG12 ' A' ' 105' ' ' ILE . 63.6 m -72.16 -37.6 4.94 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.554 0.742 . . . . 62.25 112.634 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.65 -40.89 82.16 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.18 1.92 . . . . 71.22 112.478 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.27 -29.4 68.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.553 0.741 . . . . 72.32 111.419 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.744 HD12 HD21 ' C' ' 132' ' ' ASN . 40.1 mm -60.66 -44.52 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.998 0.904 . . . . 62.11 109.855 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 82' ' ' GLY . 79.2 mt -77.21 -18.77 57.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.166 -1.379 . . . . 64.54 112.176 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -68.42 -41.86 25.62 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.444 1.276 . . . . 63.52 114.444 -168.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.81 -39.03 90.39 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 121.966 1.777 . . . . 72.11 112.906 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -75.1 -36.74 61.67 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.491 0.717 . . . . 75.22 111.608 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.93 -46.83 76.79 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.576 -0.527 . . . . 74.41 109.576 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttm105 -55.22 -47.09 75.81 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 124.552 1.158 . . . . 73.31 110.52 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.554 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 6.7 tm-20 -59.42 -48.69 80.68 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.136 0.897 . . . . 74.43 111.061 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.512 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 51.1 t -57.73 -46.49 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.067 -0.97 . . . . 74.14 111.213 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.5 mt -64.3 -53.19 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.525 0.73 . . . . 64.23 110.612 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 125' ' ' GLN . 60.7 m -53.46 -44.39 68.89 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.799 1.24 . . . . 61.2 112.009 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 43.3 t -72.46 -32.65 66.43 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.298 -0.865 . . . . 61.42 111.166 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -64.29 -43.3 95.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.483 0.713 . . . . 74.22 110.851 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.5 t -62.99 -49.27 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.627 1.171 . . . . 63.05 110.465 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.1 p -67.48 -26.04 66.17 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.846 -0.616 . . . . 24.3 111.6 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 116' ' ' SER . 26.4 ttm-85 -76.93 -26.06 53.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.272 1.029 . . . . 63.54 110.133 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 10.9 61.11 Favored Glycine 0 C--N 1.358 1.803 0 CA-C-N 115.887 -0.597 . . . . 74.14 112.618 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 67.66 36.49 3.63 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.815 1.293 . . . . 74.45 110.472 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -115.57 144.71 32.99 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 114.75 -1.114 . . . . 63.05 108.936 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.28 146.07 52.36 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.01 2.474 . . . . 72.01 113.275 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.595 ' HG3' HG23 ' A' ' 115' ' ' THR . 3.6 tt0 -59.07 140.92 55.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.135 0.974 . . . . 70.23 112.689 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.1 tp -124.86 114.16 18.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.935 0.894 . . . . 75.12 109.402 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -112.05 102.08 10.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.385 0.674 . . . . 63.42 109.505 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.75 127.11 31.54 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.867 -0.79 . . . . 72.03 108.867 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.4 132.03 95.24 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.784 0.834 . . . . 42.03 112.325 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -83.62 140.44 9.37 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.641 2.227 . . . . 32.5 112.153 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 p -116.67 125.3 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.96 0.904 . . . . 52.35 109.831 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -92.03 63.81 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 122.218 1.009 . . . . 71.35 110.536 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.2 t80 . . . . . 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 75.33 110.188 176.305 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p . . . . . 0 C--O 1.238 0.475 0 N-CA-C 108.255 -1.017 . . . . 72.45 108.255 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.91 120.67 21.78 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.538 -0.912 . . . . 64.15 108.538 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.56 138.3 29.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.722 0.296 . . . . 72.42 110.243 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.472 HD11 HG13 ' B' ' 16' ' ' ILE . 16.1 tt -82.56 144.48 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.263 1.025 . . . . 61.52 110.031 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -109.28 -49.16 3.15 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.192 0.597 . . . . 72.53 110.035 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.3 ttt180 -171.38 146.27 2.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.172 0.589 . . . . 74.43 110.458 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.472 HG13 HD11 ' B' ' 13' ' ' ILE . 51.1 mt -116.47 145.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.191 -1.04 . . . . 74.43 108.191 169.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -168.71 145.47 3.73 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.759 0.423 . . . . 64.33 110.305 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -74.06 122.16 22.24 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.872 -0.788 . . . . 64.44 108.872 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -91.49 -37.45 13.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.619 -0.719 . . . . 74.54 110.341 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.1 t70 -154.3 146.28 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.666 0.27 . . . . 71.52 111.622 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.436 HD11 ' SG ' ' B' ' 113' ' ' CYS . 43.4 mm -138.56 143.73 31.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 125.378 1.471 . . . . 52.42 109.158 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.4 t -141.1 129.21 22.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.862 1.265 . . . . 74.2 108.424 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -143.2 131.9 22.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.096 -1.446 . . . . 74.22 107.096 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -136.01 140.15 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.674 -1.232 . . . . 74.5 107.674 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.667 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -134.85 85.09 36.37 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 107.904 -1.147 . . . . 74.02 107.904 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.95 -29.48 57.64 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.88 2.387 . . . . 70.14 111.99 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.81 28.91 8.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.945 0.898 . . . . 63.44 109.961 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.667 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.2 -52.75 32.86 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 125.429 1.491 . . . . 70.35 113.509 168.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.1 Cg_exo -81.63 -11.74 11.46 Favored 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 122.547 2.165 . . . . 71.4 112.876 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -89.17 3.07 53.14 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.214 1.006 . . . . 72.52 111.576 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.1 -21.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.247 0.619 . . . . 74.23 111.266 169.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -64.76 -40.54 95.44 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.706 0.802 . . . . 61.34 110.16 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.29 -30.03 30.82 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.061 -0.972 . . . . 74.41 111.135 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.79 90.33 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.261 1.025 . . . . 71.52 109.729 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.49 77.35 9.44 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.8 0.84 . . . . 70.24 110.567 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -172.01 156.36 4.04 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.853 0.861 . . . . 74.22 109.419 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.449 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 28.1 tt0 -66.25 125.52 90.4 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.536 1.135 . . . . 50.42 110.778 169.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.25 129.16 20.94 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.129 1.886 . . . . 71.44 110.691 169.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 134.04 48.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 120.933 0.396 . . . . 61.01 109.94 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.437 HG21 ' O ' ' B' ' 124' ' ' PRO . 18.9 t -114.99 127.37 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.9 0.48 . . . . 71.23 111.282 -166.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -134.78 134.28 40.75 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.406 -0.961 . . . . 75.23 108.406 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.563 ' H ' HD23 ' B' ' 42' ' ' LEU . 1.2 pt? -119.5 140.43 50.49 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.962 -1.125 . . . . 74.23 107.962 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -136.81 142.64 42.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.432 0.693 . . . . 61.21 109.389 -167.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.4 ' HG ' HD21 ' B' ' 60' ' ' LEU . 6.6 tt -94.77 138.91 31.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.353 0.661 . . . . 74.34 110.391 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.74 135.83 31.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.564 1.145 . . . . 64.41 108.553 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.0 m -109.65 124.78 51.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.854 0.462 . . . . 73.1 110.646 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.05 156.37 38.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.197 0.999 . . . . 70.45 108.336 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 45.5 p -144.88 170.8 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.8 0.44 . . . . 63.45 110.684 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -150.49 143.66 24.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.614 0.766 . . . . 75.24 109.011 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -94.57 114.98 27.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.406 0.683 . . . . 75.51 110.025 173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.2 -35.14 21.82 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.343 -0.614 . . . . 71.24 109.343 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.81 3.85 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.922 -1.036 . . . . 74.32 110.104 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.71 126.37 27.37 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.621 -1.172 . . . . 64.33 108.899 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 69.96 -4.36 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.592 1.157 . . . . 52.03 112.987 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.26 103.95 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.524 -0.917 . . . . 72.41 108.524 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -123.99 137.78 54.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.2 0.524 . . . . 64.3 110.164 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -114.44 105.86 13.62 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.081 -1.451 . . . . 64.22 107.081 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 83.9 t -92.82 125.75 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.309 0.644 . . . . 62.1 109.541 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.2 t -103.04 117.42 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.599 0.76 . . . . 74.03 109.746 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.4 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -93.87 112.11 23.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.144 -0.687 . . . . 52.25 109.144 -177.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 41.9 ttm180 -94.7 114.24 26.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.953 0.501 . . . . 74.41 109.907 171.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.58 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.4 t -114.02 122.26 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.947 -1.131 . . . . 70.12 107.947 169.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -115.71 147.9 40.36 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.171 0.589 . . . . 42.53 110.378 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.613 HG21 HG21 ' B' ' 114' ' ' ILE . 44.5 t -127.3 127.14 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 75.35 109.582 -172.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.5 m -105.0 140.09 38.71 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.808 0.843 . . . . 71.44 109.281 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.4 22.62 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.097 0.959 . . . . 52.03 108.732 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.42 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 73.6 p -146.27 141.08 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.115 0.483 . . . . 53.31 111.529 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 65.6 mt -102.72 109.39 20.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.938 1.295 . . . . 75.15 108.678 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -111.88 3.5 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.02 -0.432 . . . . 42.3 112.02 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.17 10.21 18.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.044 0.938 . . . . 62.23 110.494 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -132.07 144.69 50.91 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.24 0.616 . . . . 74.14 109.821 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -66.91 134.77 52.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.203 0.601 . . . . 74.42 111.49 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -88.71 -58.86 2.4 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.679 -0.86 . . . . 53.14 108.679 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 158.81 39.36 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.318 -1.31 . . . . 74.44 109.925 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -136.37 124.0 22.34 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.18 1.392 . . . . 75.13 107.759 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.34 159.94 23.21 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -164.81 139.38 5.24 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.209 -1.034 . . . . 70.32 108.209 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 67.4 t -129.03 145.69 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 123.887 0.875 . . . . 75.3 108.722 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.9 mt-30 -124.43 85.9 2.48 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.545 -0.909 . . . . 73.11 108.545 174.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -82.67 101.63 10.96 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 114.432 -1.258 . . . . 74.24 109.877 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.65 161.22 29.53 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 121.181 -0.533 . . . . 72.25 112.018 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.11 126.45 1.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.361 -0.696 . . . . 70.11 111.361 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.89 128.12 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.956 -0.757 . . . . 51.32 108.956 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -132.85 163.46 29.04 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.685 1.194 . . . . 74.54 107.945 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 71.6 m -126.75 121.28 31.54 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.199 -1.037 . . . . 63.2 108.199 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.571 HD13 HD11 ' B' ' 89' ' ' ILE . 2.9 pp -128.28 147.03 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 73.24 110.263 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.04 162.63 40.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.547 0.739 . . . . 75.23 109.979 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.28 -28.98 8.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.261 0.464 . . . . 41.31 114.261 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.571 HD11 HD13 ' B' ' 86' ' ' ILE . 44.7 pt -67.83 162.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 60.1 112.865 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -165.35 159.68 17.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.1 -0.955 . . . . 73.3 111.596 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -130.32 50.11 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 124.014 0.821 . . . . 74.0 114.14 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.5 m -70.72 -25.31 62.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.933 0.893 . . . . 70.34 111.087 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.76 -26.91 67.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 74.44 110.623 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.474 ' HG3' HD12 ' B' ' 89' ' ' ILE . 18.1 ttt -72.67 -46.04 55.89 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.12 0.568 . . . . 74.03 110.522 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.84 67.14 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.438 -0.801 . . . . 74.1 111.192 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.17 -36.1 35.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.306 0.642 . . . . 72.3 110.716 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -74.74 -67.45 0.63 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.961 0.504 . . . . 73.21 111.914 -173.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.54 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.2 pp -94.27 -20.51 19.74 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.156 0.428 . . . . 75.33 112.156 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.68 -15.44 59.82 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.913 -0.382 . . . . 64.4 113.293 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.96 -52.53 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.206 0.503 . . . . 61.21 112.0 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -76.76 -37.28 56.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.963 0.357 . . . . 75.43 111.963 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 97.9 m -63.43 -51.44 67.58 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.607 -0.711 . . . . 72.32 111.566 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.449 ' HD3' HG11 ' B' ' 58' ' ' VAL . 36.5 Cg_endo -65.48 -17.53 57.65 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 121.763 1.642 . . . . 75.34 113.524 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.34 -42.04 75.83 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 122.864 0.466 . . . . 74.54 110.562 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.507 HG23 ' NH2' ' D' ' 111' ' ' ARG . 69.6 mt -58.92 -41.95 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.068 0.947 . . . . 72.11 110.194 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -84.71 -12.94 52.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.546 -1.206 . . . . 64.43 111.969 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -63.49 -45.14 83.46 Favored Pre-proline 0 C--N 1.359 0.984 0 CA-C-O 117.576 -1.202 . . . . 54.24 112.706 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.13 -42.83 61.96 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.305 2.004 . . . . 62.55 113.177 172.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -70.55 -45.22 65.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.147 -0.933 . . . . 73.32 111.027 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.06 82.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.632 0.773 . . . . 42.21 111.096 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.69 -60.86 3.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.751 1.22 . . . . 72.5 109.236 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.87 -34.53 74.77 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.076 0.86 . . . . 65.43 110.413 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.7 t -60.33 -51.05 71.19 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.203 0.601 . . . . 74.12 111.46 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.613 HG21 HG21 ' B' ' 64' ' ' VAL . 80.8 mt -58.64 -52.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.441 0.696 . . . . 72.44 109.962 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.657 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 2.0 m -64.29 -21.0 66.45 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.903 -1.499 . . . . 75.04 111.236 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -83.55 -40.3 19.3 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.706 1.202 . . . . 64.52 112.061 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.9 mmt -69.12 -39.49 78.87 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.287 0.494 . . . . 52.41 111.926 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.53 -26.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.127 0.571 . . . . 74.35 110.436 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.3 t -64.93 -30.99 72.01 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 74.42 110.321 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.512 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 66.6 mtt-85 -72.81 -33.66 66.36 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.527 0.731 . . . . 71.23 110.129 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.83 -2.56 81.99 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-N 115.753 -0.658 . . . . 55.43 112.833 171.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 17' ' ' TYR . 5.4 t 55.41 34.3 22.68 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.77 2.028 . . . . 73.25 112.694 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.91 157.67 35.47 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.075 0.95 . . . . 71.21 110.851 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.449 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.4 Cg_exo -71.84 87.82 0.82 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.302 2.668 . . . . 71.31 113.771 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.657 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 0.0 OUTLIER -71.78 159.78 33.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.329 0.652 . . . . 43.3 112.225 171.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.446 ' H ' ' NE2' ' B' ' 125' ' ' GLN . 33.1 tp -129.69 123.84 32.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.21 1.804 . . . . 75.02 107.542 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.48 HD21 ' HA ' ' C' ' 122' ' ' THR . 18.7 p-10 -91.5 110.24 21.55 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.09 -0.708 . . . . 71.31 109.09 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.5 137.74 54.64 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 72.3 110.621 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.24 141.78 97.78 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.057 0.943 . . . . 72.33 111.503 176.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.6 106.96 0.79 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.923 2.415 . . . . 44.03 112.74 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -73.89 106.71 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.986 -0.552 . . . . 64.13 110.025 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -79.08 94.75 5.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.263 0.554 . . . . 75.35 109.647 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 23.6 p90 . . . . . 0 CA--C 1.546 0.809 0 CA-C-N 115.161 -0.927 . . . . 71.24 111.25 177.63 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m . . . . . 0 N--CA 1.467 0.39 0 N-CA-C 109.102 -0.703 . . . . 64.31 109.102 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.745 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 53.9 t80 -117.17 127.46 54.14 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.428 -0.952 . . . . 62.3 108.428 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -138.11 135.04 35.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.427 -0.953 . . . . 74.11 108.427 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.543 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -93.68 114.67 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.377 0.608 . . . . 30.54 109.779 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.481 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.0 mm-40 -82.04 -49.26 10.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 75.41 109.906 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.413 HH21 ' HG1' ' D' ' 122' ' ' THR . 71.0 ttt180 -173.55 145.63 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.7 -0.682 . . . . 74.33 109.988 -170.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.543 HG13 HD11 ' C' ' 13' ' ' ILE . 87.0 mt -128.12 144.63 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.503 -1.295 . . . . 45.41 107.503 171.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.455 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.0 p90 -174.71 166.57 3.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.452 0.644 . . . . 72.32 110.77 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -88.16 105.91 17.83 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.003 -0.999 . . . . 55.32 109.44 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -65.68 -36.28 83.19 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.547 0.689 . . . . 73.33 109.487 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.5 t70 -149.13 142.94 25.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.542 -1.208 . . . . 70.13 109.63 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -136.91 139.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.358 -1.719 . . . . 70.43 106.358 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.46 143.49 22.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.376 -0.602 . . . . 73.52 109.376 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -143.65 113.93 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.558 -1.275 . . . . 74.23 107.558 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -116.57 119.77 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.669 -0.864 . . . . 73.24 108.669 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.77 82.21 67.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.673 -1.232 . . . . 65.32 107.673 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.11 -37.29 33.2 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.572 2.181 . . . . 74.21 111.574 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.68 31.3 3.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.28 -1.327 . . . . 72.1 110.474 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 86.26 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 113.956 1.095 . . . . 75.31 113.956 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.18 -19.73 6.59 Favored 'Trans proline' 0 C--N 1.385 2.457 0 CA-C-N 121.298 1.499 . . . . 71.4 112.818 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.84 -33.53 70.76 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.189 0.996 . . . . 73.1 112.271 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.497 HG23 HD11 ' C' ' 68' ' ' LEU . 12.4 p -78.61 -10.63 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.064 0.946 . . . . 73.32 111.943 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -57.51 -40.63 79.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.852 0.861 . . . . 74.44 112.207 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -105.79 41.91 1.32 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.967 0.889 . . . . 71.24 109.248 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.3 tppp? -125.38 155.94 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.42 0.688 . . . . 70.05 110.443 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.56 127.11 31.57 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.332 0.653 . . . . 64.51 109.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.46 95.49 9.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.585 -0.734 . . . . 70.43 110.815 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.07 68.7 81.28 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.335 -0.987 . . . . 61.51 108.335 167.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.71 111.46 3.33 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.363 2.042 . . . . 74.5 110.57 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -85.09 92.82 8.47 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.649 -1.241 . . . . 74.42 107.649 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.428 HG21 HD22 ' C' ' 126' ' ' LEU . 40.1 t -81.58 86.16 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.225 -1.352 . . . . 72.12 110.633 -168.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -91.26 105.28 17.68 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.372 -1.344 . . . . 64.12 107.372 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.51 HD23 HD12 ' C' ' 128' ' ' LEU . 0.5 OUTLIER -87.85 160.71 17.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.367 0.603 . . . . 71.41 111.209 177.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -137.05 144.18 43.06 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.737 1.215 . . . . 64.01 108.775 175.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 46.4 tp -131.45 105.34 7.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.489 -0.93 . . . . 73.4 108.489 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 20.0 t70 -113.33 140.15 48.26 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 74.12 109.26 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -114.4 134.08 55.25 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.18 0.592 . . . . 63.44 109.959 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.96 151.66 46.71 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.335 1.054 . . . . 64.1 108.407 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 73.8 m -138.42 149.21 45.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.261 0.625 . . . . 75.24 110.556 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -150.21 158.87 44.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.396 1.079 . . . . 62.14 109.503 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -102.51 138.91 38.8 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.198 -1.038 . . . . 61.44 108.198 168.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' C' ' 57' ' ' GLU . 89.3 mt -109.86 -37.03 5.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.523 0.729 . . . . 63.4 110.226 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 -167.51 1.71 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.228 0.611 . . . . 32.44 110.744 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.81 109.41 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.825 -1.079 . . . . 62.32 111.484 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.49 9.59 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.847 1.259 . . . . 72.24 111.968 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.28 118.78 54.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.535 1.134 . . . . 71.11 109.279 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.87 162.35 14.9 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.165 0.986 . . . . 72.44 110.322 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.9 tt0 -127.22 116.66 20.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.9 -1.045 . . . . 74.13 108.453 165.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -106.64 124.74 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.716 -1.216 . . . . 74.13 107.716 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.44 119.15 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.778 0.831 . . . . 63.14 109.341 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' C' ' 103' ' ' PRO . 38.5 mt -88.41 118.44 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.091 0.556 . . . . 74.45 110.683 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 33.4 mtm105 -82.65 105.23 13.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.687 -1.227 . . . . 75.41 107.687 164.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -109.12 117.23 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.878 -1.156 . . . . 61.43 107.878 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -123.12 126.01 46.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.858 0.463 . . . . 62.04 109.91 -171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.552 HG23 HD13 ' C' ' 114' ' ' ILE . 54.5 t -107.65 113.69 44.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.484 0.714 . . . . 44.45 109.109 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.424 HG23 HD23 ' C' ' 75' ' ' LEU . 5.8 m -99.48 140.37 33.76 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.311 -0.996 . . . . 70.31 108.311 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.8 108.66 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.925 -0.768 . . . . 51.51 108.925 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.2 m -130.17 140.65 50.74 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.202 0.525 . . . . 63.25 110.255 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.497 HD11 HG23 ' C' ' 31' ' ' VAL . 12.3 mt -93.39 40.75 1.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.337 1.455 . . . . 75.04 109.159 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.07 -112.36 4.12 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.125 -1.59 . . . . 73.33 109.125 -163.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.2 -27.53 19.48 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.336 0.655 . . . . 43.31 110.117 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.86 92.28 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.628 1.171 . . . . 64.31 110.393 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 117.97 12.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.387 0.613 . . . . 74.43 110.164 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.99 25.92 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.363 -1.289 . . . . 40.42 109.75 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -163.62 172.98 13.55 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.628 -0.715 . . . . 75.34 111.849 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.424 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -144.38 116.89 8.59 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.102 -1.444 . . . . 70.51 107.102 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -115.68 145.74 42.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.639 0.775 . . . . 72.41 109.492 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.11 135.6 20.64 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.703 0.401 . . . . 63.12 110.031 171.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.71 118.2 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.486 1.115 . . . . 71.15 108.798 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.9 mt-30 -90.14 93.71 9.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.83 -0.804 . . . . 70.14 108.83 172.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -83.2 107.87 16.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.445 -0.798 . . . . 74.24 109.921 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.56 146.33 18.11 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.165 -0.47 . . . . 41.41 112.21 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.45 126.3 3.13 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 111.129 -0.789 . . . . 63.0 111.129 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.0 mm -91.04 124.93 43.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.26 -1.015 . . . . 64.25 108.26 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.42 119.52 21.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.289 0.636 . . . . 62.42 109.468 -175.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -87.6 100.02 12.48 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.28 -1.378 . . . . 65.51 107.28 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.476 HG13 ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -143.8 133.79 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.469 0.652 . . . . 74.33 110.904 -170.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.03 -177.22 5.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.074 1.35 . . . . 55.12 109.132 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -18.81 36.32 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 114.712 0.645 . . . . 55.0 114.712 174.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.015 0.926 . . . . 62.33 111.819 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 111.854 0.316 . . . . 64.41 111.854 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 38.1 ttm -58.67 -62.89 1.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.796 0.838 . . . . 73.44 111.417 177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -27.4 63.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.623 -0.717 . . . . 43.51 111.708 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -77.3 -22.99 51.13 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 71.5 110.314 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.7 t -71.96 -64.03 1.02 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.329 0.252 . . . . 61.42 110.44 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -79.24 -16.44 56.47 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 122.259 -0.275 . . . . 75.11 110.986 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.21 -26.05 27.05 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.691 0.636 . . . . 72.12 114.691 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.06 -40.2 0.25 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.489 0.922 . . . . 52.4 113.489 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -74.56 -48.64 25.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.048 0.539 . . . . 73.52 111.234 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.745 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 56.0 m -66.13 -45.1 61.85 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.313 0.645 . . . . 44.22 110.184 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.666 ' HB3' HD21 ' C' ' 60' ' ' LEU . 76.2 Cg_exo -52.38 -38.59 73.78 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.417 2.078 . . . . 75.33 115.01 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -63.66 -30.6 71.69 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 123.252 0.621 . . . . 74.32 111.209 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -65.62 -39.28 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.744 0.817 . . . . 71.3 110.489 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -88.94 -21.57 23.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.744 0.818 . . . . 71.1 112.353 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.77 -46.4 99.74 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.131 0.972 . . . . 73.24 113.039 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.554 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 23.7 Cg_exo -60.96 -40.14 55.04 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.872 1.714 . . . . 71.44 112.526 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -63.81 -46.15 86.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.571 0.748 . . . . 74.24 111.459 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.65 -43.46 93.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.369 0.668 . . . . 52.44 110.87 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -56.87 -50.88 71.14 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.011 1.324 . . . . 45.12 110.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.2 -41.41 85.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.785 0.834 . . . . 55.4 110.54 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.4 t -66.52 -30.87 71.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.539 0.735 . . . . 73.4 111.987 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.561 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.7 mt -72.58 -50.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.837 0.455 . . . . 60.4 110.086 173.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.538 HG22 ' NE2' ' C' ' 125' ' ' GLN . 10.3 m -61.99 -27.81 69.12 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.106 0.562 . . . . 74.14 110.67 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.3 t -60.73 -51.76 67.99 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.161 0.984 . . . . 73.42 110.076 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.493 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.86 -38.96 83.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.582 1.153 . . . . 51.34 112.618 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.63 -39.73 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.271 0.628 . . . . 73.33 110.25 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -60.23 -42.96 96.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.66 0.784 . . . . 64.43 110.89 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' C' ' 116' ' ' SER . 89.2 mtt-85 -63.12 -34.0 76.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.723 -0.671 . . . . 71.12 111.38 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.46 12.51 58.64 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.156 -0.802 . . . . 73.21 113.536 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.48 ' HA ' HD21 ' B' ' 127' ' ' ASN . 70.3 p 55.23 42.81 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.421 1.488 . . . . 75.43 112.277 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.6 154.27 44.74 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 107.972 -1.122 . . . . 75.14 107.972 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.72 148.15 36.27 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.322 2.015 . . . . 75.0 112.225 -171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.538 ' NE2' HG22 ' C' ' 115' ' ' THR . 12.8 mm100 -62.76 110.43 1.74 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.667 0.988 . . . . 74.23 113.667 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.428 HD22 HG21 ' C' ' 40' ' ' VAL . 65.1 mt -92.21 76.13 5.33 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.416 0.686 . . . . 72.31 109.884 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -92.31 89.41 6.83 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.01 -0.995 . . . . 63.25 109.356 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.51 HD12 HD23 ' C' ' 42' ' ' LEU . 12.7 mt -86.74 153.04 22.01 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.415 -1.266 . . . . 74.42 109.841 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.19 120.11 2.34 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 125.633 1.573 . . . . 74.22 113.633 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.62 94.48 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.666 2.244 . . . . 71.55 111.145 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.56 98.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-N 114.965 -1.016 . . . . 74.25 111.383 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.744 HD21 HD12 ' A' ' 105' ' ' ILE . 57.3 t-20 -75.76 87.15 2.78 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.197 -0.91 . . . . 62.4 108.952 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.6 t80 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 64.44 112.631 -176.577 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m . . . . . 0 C--O 1.238 0.464 0 N-CA-C 109.067 -0.716 . . . . 42.42 109.067 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -154.37 105.68 2.69 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.862 -1.162 . . . . 75.12 107.862 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 74.9 mt-30 -117.34 115.94 26.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.992 0.517 . . . . 73.33 110.188 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -87.01 126.19 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.455 -0.943 . . . . 62.44 108.455 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.446 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.1 mt-30 -109.26 -47.53 3.39 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.114 0.413 . . . . 61.4 112.114 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -165.45 121.81 1.4 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.06 128.14 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.773 0.829 . . . . 71.55 109.057 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' C' ' 122' ' ' THR . 40.3 p90 -161.99 174.58 12.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.95 0.881 . . . . 73.22 111.52 -171.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.51 120.68 40.67 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.72 -1.127 . . . . 63.15 108.985 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -84.77 -37.59 20.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.541 -0.54 . . . . 55.53 109.541 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.8 137.96 24.13 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.078 -0.965 . . . . 75.34 109.088 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' C' ' 117' ' ' MET . 74.9 mt -131.44 139.68 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 73.33 108.08 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.97 134.36 33.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.139 0.975 . . . . 70.1 108.812 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -146.94 116.18 6.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.614 -1.625 . . . . 72.31 106.614 170.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -122.23 144.35 49.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 72.44 109.499 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.706 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -134.25 75.2 65.68 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.896 -1.15 . . . . 60.33 107.896 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.96 -27.18 10.32 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.748 2.299 . . . . 63.41 113.081 -170.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.21 27.08 9.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.449 0.699 . . . . 60.24 109.978 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.706 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.95 -56.15 30.98 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 115.272 1.582 . . . . 62.04 115.272 -167.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.96 -6.23 13.14 Favored 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-N 121.474 1.562 . . . . 73.22 112.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -81.75 -44.46 17.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.642 1.177 . . . . 63.53 110.094 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.18 2.42 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.061 0.545 . . . . 74.34 111.202 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -58.25 -33.82 69.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.137 0.975 . . . . 73.13 110.34 165.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.59 -23.46 58.74 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.622 -1.172 . . . . 75.12 111.004 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -88.62 79.03 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 72.13 110.419 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -87.17 57.49 4.5 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.199 1.0 . . . . 72.11 110.894 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -125.86 175.87 7.35 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.884 1.274 . . . . 72.33 108.425 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -72.44 112.79 16.24 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 119.194 -0.431 . . . . 72.43 109.969 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.08 113.73 2.15 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.524 2.149 . . . . 61.13 111.889 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.77 112.42 6.21 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.09 0.869 . . . . 73.43 109.655 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 m -99.65 122.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 73.25 110.045 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -104.56 112.57 25.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 74.44 108.498 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.551 HD21 HD22 ' D' ' 128' ' ' LEU . 6.8 mp -95.22 142.25 27.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.345 0.658 . . . . 74.35 110.093 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.2 t70 -132.61 137.09 46.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.633 -0.877 . . . . 63.51 108.633 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 22.6 tp -115.12 129.59 56.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.295 -0.631 . . . . 73.34 109.295 178.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.98 148.02 44.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.289 1.035 . . . . 73.4 108.389 172.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 88.6 m -128.97 150.59 50.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.166 0.987 . . . . 71.42 108.718 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.94 164.15 35.39 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.039 0.936 . . . . 62.33 109.755 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 96.5 p -167.43 155.33 9.12 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.5 0.72 . . . . 70.2 111.089 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -156.42 130.91 8.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.886 0.874 . . . . 70.51 109.031 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.74 126.13 27.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.836 0.454 . . . . 73.42 110.244 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.1 mt -98.69 -35.99 10.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.052 0.541 . . . . 72.12 110.183 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -159.25 -171.28 3.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.333 0.653 . . . . 72.43 111.186 -176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.12 110.81 3.11 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.257 -0.883 . . . . 75.01 109.797 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 67.73 1.71 2.74 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.247 1.419 . . . . 71.43 112.707 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 52.2 t -110.24 134.16 53.3 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 123.87 0.868 . . . . 62.32 108.999 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -151.68 174.67 13.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.862 0.865 . . . . 71.03 109.08 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.0 tt0 -120.11 132.75 55.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.651 0.78 . . . . 73.41 109.127 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' D' ' 102' ' ' CYS . 58.5 t -100.24 132.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 108.045 -1.094 . . . . 65.1 108.045 168.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.0 t -111.12 136.15 48.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.48 -0.933 . . . . 63.13 108.48 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.87 127.49 56.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.138 -1.06 . . . . 74.33 108.138 179.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 35.3 ttm-85 -109.86 106.98 16.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.976 -0.749 . . . . 54.42 108.976 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -105.95 106.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 107.756 -1.201 . . . . 61.43 107.756 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 7.6 m -106.09 129.6 54.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.707 0.403 . . . . 54.43 110.183 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.64 102.89 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.719 1.208 . . . . 62.14 109.218 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -96.6 95.94 8.3 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.445 -0.946 . . . . 74.24 108.445 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 147.58 23.67 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.171 0.589 . . . . 62.1 110.495 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.568 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.4 p -155.8 129.16 8.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.564 0.697 . . . . 65.53 111.829 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 13.2 mt -92.51 98.33 11.39 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.695 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.04 -123.88 10.96 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.827 0.704 . . . . 73.43 112.133 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.92 5.98 37.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.17 0.588 . . . . 64.11 111.28 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -129.37 143.93 51.04 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.225 0.61 . . . . 54.01 110.8 -169.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.2 m -70.45 127.85 34.16 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.378 0.671 . . . . 73.43 110.982 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.568 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.67 -66.13 0.93 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.139 -1.059 . . . . 63.24 108.139 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.49 152.08 36.26 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.019 -0.991 . . . . 71.24 110.167 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.5 mt -104.93 147.11 28.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.573 -1.269 . . . . 73.35 107.573 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.5 t -156.92 143.4 18.26 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.87 -0.418 . . . . 55.21 109.87 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -157.15 141.23 16.26 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.505 -0.924 . . . . 64.32 108.505 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -135.51 116.64 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 71.51 109.555 175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -89.88 84.04 6.2 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.876 0.845 . . . . 72.24 108.889 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.41 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.88 100.33 7.98 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.208 -1.36 . . . . 64.11 109.292 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.58 143.87 16.47 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 111.683 -0.567 . . . . 54.52 111.683 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.97 139.26 6.82 Favored Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.279 -0.729 . . . . 72.2 111.279 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 49.0 mt -88.72 127.54 41.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 122.962 0.505 . . . . 63.52 109.91 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.68 146.27 52.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 72.22 109.49 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.5 m -116.32 105.14 12.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.356 0.663 . . . . 63.53 109.489 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.576 ' HB ' HD11 ' D' ' 89' ' ' ILE . 18.3 pt -109.33 142.4 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.413 0.551 . . . . 54.04 109.983 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.26 145.14 19.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.188 -0.915 . . . . 72.53 109.449 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.03 -10.05 61.79 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.108 0.403 . . . . 72.41 114.108 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.576 HD11 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -124.76 130.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.424 0.69 . . . . 72.24 110.368 -172.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -131.73 167.74 18.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.985 0.514 . . . . 61.34 111.173 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.43 -134.89 42.07 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.139 0.899 . . . . 53.31 113.208 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -66.39 -23.72 66.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.241 0.616 . . . . 63.43 111.608 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.407 ' NE2' HG22 ' D' ' 89' ' ' ILE . 45.9 tt0 -66.52 -34.17 77.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.331 0.652 . . . . 65.43 110.912 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.524 ' HB3' HG12 ' D' ' 89' ' ' ILE . 3.2 ppp? -88.16 -27.76 21.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.433 0.293 . . . . 60.45 111.054 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.59 65.2 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.977 0.511 . . . . 71.3 111.879 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 8.0 t-160 -84.56 -10.74 57.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.696 0.799 . . . . 71.43 110.338 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.03 -45.61 9.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.348 0.659 . . . . 54.32 109.543 170.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.93 -39.29 72.76 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.015 0.926 . . . . 54.55 111.432 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.16 12.44 67.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.068 -0.515 . . . . 51.35 113.018 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.54 -75.88 0.17 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.988 0.515 . . . . 61.01 111.716 -176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -72.74 -44.69 61.34 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.948 0.721 . . . . 61.43 112.948 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.485 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 61.7 m -61.52 -48.44 90.48 Favored Pre-proline 0 CA--C 1.567 1.626 0 CA-C-O 118.771 -0.633 . . . . 62.04 112.162 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.549 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 10.0 Cg_exo -72.76 -18.89 24.59 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.036 1.824 . . . . 75.53 112.977 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.31 -28.73 64.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.795 0.438 . . . . 44.43 110.563 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.11 -41.78 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-O 121.598 0.713 . . . . 71.42 109.413 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.41 HD13 ' O ' ' D' ' 80' ' ' GLN . 92.4 mt -74.72 -20.91 59.65 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.863 -1.062 . . . . 64.41 111.722 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.16 -41.42 14.29 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.252 1.205 . . . . 64.01 114.252 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -56.14 -36.04 95.91 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 121.762 1.641 . . . . 53.3 112.881 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.13 -32.82 33.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.81 0.844 . . . . 73.34 111.552 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.6 -50.74 63.94 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.584 -0.524 . . . . 74.54 109.584 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.507 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.7 ttp180 -58.31 -50.27 74.23 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.031 -1.441 . . . . 75.1 110.51 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -63.06 -42.43 99.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.46 0.704 . . . . 72.41 111.643 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.2 t -59.47 -44.86 92.92 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.767 0.667 . . . . 72.24 110.944 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.436 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.3 mt -62.41 -57.24 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.612 0.765 . . . . 75.34 110.092 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.524 HG23 ' HG3' ' D' ' 125' ' ' GLN . 83.8 m -50.12 -43.83 51.93 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.533 1.533 . . . . 70.14 112.477 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.99 -44.66 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 70.34 110.486 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -64.48 -33.78 76.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.909 0.484 . . . . 74.14 111.43 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 79.4 t -64.61 -45.8 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.108 0.963 . . . . 52.12 110.049 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.03 -27.98 63.07 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.683 0.278 . . . . 61.34 111.085 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -71.68 -30.59 65.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.6 0.76 . . . . 72.21 110.138 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 6.64 80.11 Favored Glycine 0 C--N 1.358 1.781 0 O-C-N 123.66 0.6 . . . . 60.34 112.731 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.455 HG23 ' HB3' ' C' ' 17' ' ' TYR . 51.0 p 65.41 21.28 11.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.309 1.844 . . . . 71.51 113.09 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.26 164.89 18.01 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 124.82 1.248 . . . . 72.34 109.314 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.07 140.34 22.52 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.394 2.063 . . . . 63.42 112.266 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.524 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.8 tt0 -55.75 126.65 26.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 75.23 111.013 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.93 105.65 15.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.411 0.684 . . . . 75.13 109.209 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -98.48 92.81 5.83 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.718 -0.845 . . . . 73.12 108.718 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.551 HD22 HD21 ' D' ' 42' ' ' LEU . 76.3 mt -69.89 123.33 21.2 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.098 0.559 . . . . 75.14 109.555 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -56.21 133.05 75.33 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.254 0.621 . . . . 54.3 111.145 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.65 108.66 2.3 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 121.877 1.718 . . . . 63.14 110.17 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.7 107.25 22.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.809 -1.182 . . . . 73.41 107.809 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 . . . . . 0 C--O 1.241 0.649 0 CA-C-N 115.141 -0.936 . . . . 75.23 108.682 178.035 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.239 0.52 0 N-CA-C 109.328 -0.619 . . . . 60.52 109.328 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 45.3 t80 -127.38 141.68 51.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.204 1.002 . . . . 70.4 108.878 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 60.0 tp60 -152.66 137.35 16.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.999 0.52 . . . . 64.25 110.296 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.99 117.05 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.754 -1.202 . . . . 53.3 107.754 173.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -90.08 -40.73 12.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.443 0.297 . . . . 75.13 110.539 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -172.77 125.02 0.46 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.704 0.401 . . . . 51.2 110.693 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.891 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 71.6 mt -106.67 136.34 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.504 -0.925 . . . . 63.43 108.504 171.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 31.7 p90 -167.14 171.0 11.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.888 0.875 . . . . 72.54 110.101 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -92.38 130.29 38.1 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.498 -0.927 . . . . 75.43 108.498 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.6 mtpt -92.35 -42.94 9.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.61 -0.885 . . . . 65.05 108.61 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.4 t70 -135.09 135.03 40.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.921 -1.036 . . . . 63.41 110.083 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 117' ' ' MET . 82.5 mt -131.65 136.98 56.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.24 -1.393 . . . . 51.24 107.24 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -145.66 128.32 16.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.872 -0.418 . . . . 72.32 109.872 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 80.8 t80 -134.11 114.86 13.59 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.741 -1.578 . . . . 74.23 106.741 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 46.5 mt-10 -121.61 117.46 26.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.464 -0.569 . . . . 62.25 109.464 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.52 91.95 6.53 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 109.015 -0.735 . . . . 72.03 109.015 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 19.0 Cg_exo -67.39 -50.35 0.99 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.005 2.47 . . . . 71.4 111.854 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 40.1 m-80 -99.56 42.5 1.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.86 0.864 . . . . 73.34 109.86 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' B' ' 17' ' ' TYR . . . -59.19 -48.39 96.45 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.76 1.224 . . . . 74.02 114.144 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.88 -17.89 11.92 Favored 'Trans proline' 0 C--N 1.386 2.503 0 CA-C-N 121.168 1.453 . . . . 65.44 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -74.02 -38.79 63.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.14 111.546 -173.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.76 -14.15 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.758 0.823 . . . . 74.32 111.747 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.82 -39.63 89.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.487 0.715 . . . . 75.44 111.186 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -100.55 -30.28 11.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.604 0.762 . . . . 74.34 110.956 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.8 tmtp? -76.49 139.71 40.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.844 0.858 . . . . 73.32 108.95 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.1 m-20 -57.78 116.39 3.42 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.881 0.738 . . . . 72.43 109.793 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -79.17 80.45 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.191 0.996 . . . . 63.13 109.014 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -114.5 83.86 9.16 Favored Pre-proline 0 C--O 1.245 0.851 0 N-CA-C 107.404 -1.332 . . . . 63.41 107.404 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB2' HG13 ' A' ' 40' ' ' VAL . 73.2 Cg_endo -73.76 122.16 7.56 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.921 1.747 . . . . 72.24 112.125 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -94.93 85.31 4.34 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 105.857 -1.905 . . . . 71.43 105.857 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 38' ' ' PRO . 14.0 m -75.25 93.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.703 -1.589 . . . . 63.41 110.744 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -77.78 144.7 36.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.268 -1.787 . . . . 64.31 108.891 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.37 147.7 38.46 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.711 -1.131 . . . . 75.1 108.866 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.4 132.04 18.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.425 -0.954 . . . . 63.44 108.425 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.7 tp -99.46 119.24 37.68 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.695 -0.854 . . . . 74.42 108.695 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.78 155.66 50.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.775 -0.454 . . . . 72.12 109.775 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -118.15 162.89 17.47 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.374 0.67 . . . . 73.43 109.443 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.02 116.12 6.92 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.618 -1.253 . . . . 63.23 107.618 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 p -98.88 150.27 22.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.321 -0.251 . . . . 72.31 110.321 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -159.34 121.07 3.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.449 0.7 . . . . 72.42 109.458 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.72 131.17 35.82 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.962 -0.755 . . . . 61.52 108.962 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -104.45 -38.32 6.85 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.313 0.645 . . . . 51.1 110.454 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -154.23 -177.61 6.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.098 0.959 . . . . 73.22 109.776 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.26 128.11 34.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.336 -0.987 . . . . 72.31 108.336 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 69.96 2.73 4.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.151 0.981 . . . . 72.34 111.935 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 54.5 t -120.31 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 107.01 -1.478 . . . . 73.34 107.01 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -128.38 128.67 44.95 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 72.13 108.95 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.25 115.09 28.34 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.861 -1.063 . . . . 52.53 109.168 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.42 119.73 53.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.047 0 N-CA-C 106.087 -1.82 . . . . 73.54 106.087 169.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -97.3 132.14 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.847 0.859 . . . . 55.33 108.938 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 115.37 27.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.726 -1.213 . . . . 53.5 107.726 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -105.3 100.74 10.31 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.03 -0.73 . . . . 70.43 109.03 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 114' ' ' ILE . 32.7 t -99.92 127.32 52.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.152 -1.055 . . . . 71.24 108.152 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -122.73 132.83 54.42 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.612 -0.514 . . . . 64.45 109.612 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 51.2 t -133.15 126.22 52.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 125.351 1.46 . . . . 61.24 108.569 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -118.66 137.03 53.58 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.44 109.437 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.66 111.8 23.49 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.049 -1.093 . . . . 72.31 108.049 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.9 m -108.46 131.29 54.94 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.973 0.416 . . . . 62.23 110.323 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 mt -105.14 43.1 1.14 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.699 -1.223 . . . . 74.04 107.699 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.98 -115.01 4.93 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.946 -1.261 . . . . 63.44 109.946 -168.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.41 -25.95 18.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.217 0.607 . . . . 73.44 110.411 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.64 99.6 5.85 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.84 -0.618 . . . . 74.33 110.015 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.9 m -68.75 127.45 33.11 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.206 -0.664 . . . . 74.41 109.206 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -52.05 8.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.881 0.873 . . . . 64.32 109.101 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.46 159.74 43.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.163 -1.38 . . . . 74.33 110.328 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -130.55 132.37 45.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.049 -1.463 . . . . 61.45 107.049 173.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.9 m -122.09 135.21 54.78 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.145 0.978 . . . . 73.34 108.792 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -148.27 116.49 6.5 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.003 -1.11 . . . . 72.13 108.003 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.6 t -123.92 118.71 54.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.87 -0.789 . . . . 71.35 108.87 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.1 mt-30 -97.15 88.23 4.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.904 -1.044 . . . . 74.24 108.451 172.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.2 tp-100 -75.7 98.94 4.21 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 114.541 -1.209 . . . . 74.53 107.936 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.01 143.74 18.34 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 112.042 -0.423 . . . . 64.11 112.042 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.27 120.83 1.96 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.878 -0.889 . . . . 71.45 110.878 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' B' ' 29' ' ' PRO . 50.2 mt -81.71 126.73 39.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.304 -1.369 . . . . 41.22 107.304 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 64.8 m-85 -134.8 128.83 33.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.552 -0.536 . . . . 73.33 109.552 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 12' ' ' GLN . 9.3 p -84.08 96.62 8.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.58 -0.896 . . . . 72.15 108.58 170.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 133.72 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 60.3 109.378 -169.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 175.61 4.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.594 0.757 . . . . 64.03 111.161 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.46 -22.86 31.54 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.433 -0.803 . . . . 33.42 113.314 172.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -110.25 150.84 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 53.2 110.152 -176.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -140.88 174.87 10.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.596 0.358 . . . . 75.35 110.834 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.6 -134.46 35.54 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.384 -0.371 . . . . 75.12 113.391 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -68.07 -21.79 64.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.814 0.846 . . . . 54.11 111.745 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -65.46 -35.76 81.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.676 0.79 . . . . 65.23 110.685 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 62.0 tpp -69.22 -39.89 78.29 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 116.201 -0.454 . . . . 72.2 109.972 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -28.59 69.67 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.937 0.495 . . . . 74.14 111.31 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -72.36 -61.76 1.68 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.408 0.683 . . . . 63.32 111.017 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 9.1 t -68.39 -43.3 77.6 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 52.13 110.773 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 tt -84.56 -41.2 16.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.023 0.929 . . . . 75.25 110.618 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.14 -36.19 28.33 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 114.822 0.689 . . . . 75.52 114.822 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.8 -44.44 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.939 0.496 . . . . 72.04 112.107 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.414 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -74.18 -53.62 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.909 0.883 . . . . 74.31 112.669 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.12 -40.79 30.72 Favored Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 113.206 0.817 . . . . 73.05 113.206 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.8 Cg_endo -66.7 -22.14 50.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 CA-C-N 121.05 1.411 . . . . 64.11 113.295 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.89 -31.17 68.83 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 118.269 0.486 . . . . 71.21 110.461 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.25 -33.07 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.786 0.803 . . . . 74.52 110.364 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 103' ' ' PRO . 86.5 mt -82.67 -23.64 34.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.866 1.266 . . . . 65.24 113.123 -174.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -62.3 -40.7 69.08 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.609 1.337 . . . . 71.24 114.609 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.52 -38.54 83.57 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 121.982 1.788 . . . . 35.13 112.992 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -82.56 -34.09 27.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.086 0.954 . . . . 74.42 111.515 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.06 78.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.063 0.545 . . . . 72.52 109.544 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.431 ' NH1' HD12 ' C' ' 105' ' ' ILE . 39.6 ttm180 -52.04 -52.7 49.23 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.709 1.256 . . . . 74.23 110.655 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.45 -45.74 92.99 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.403 1.064 . . . . 72.35 111.244 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -58.76 -45.35 89.95 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.771 0.669 . . . . 75.53 111.154 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 118' ' ' VAL . 86.7 mt -62.52 -51.58 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.903 0.752 . . . . 73.23 109.793 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -56.14 -41.28 75.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.267 1.027 . . . . 52.03 111.805 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.9 t -66.21 -47.88 72.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.345 0.658 . . . . 73.53 110.006 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 21' ' ' ILE . 13.5 mtp -55.59 -46.77 77.21 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.988 0.915 . . . . 71.41 111.048 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -60.1 -44.15 94.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.726 1.21 . . . . 73.11 111.17 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.4 t -68.38 -31.82 71.46 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.816 -0.629 . . . . 64.42 111.322 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 94.1 mtt-85 -74.16 -20.38 60.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.735 0.814 . . . . 53.21 110.844 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.04 11.55 57.03 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.511 0.507 . . . . 71.55 112.983 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' HH21 ' B' ' 15' ' ' ARG . 17.3 m 66.71 35.51 5.14 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.495 1.14 . . . . 54.44 110.323 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.31 149.68 50.11 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.162 -0.926 . . . . 74.53 109.54 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.21 157.78 47.85 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.718 2.278 . . . . 64.22 112.564 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.83 141.74 58.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.637 -1.165 . . . . 73.53 112.628 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -123.48 107.06 11.16 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.156 -1.424 . . . . 71.43 107.156 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.55 99.97 8.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.148 0.979 . . . . 70.42 109.387 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.91 148.32 40.21 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.699 0.8 . . . . 71.33 110.421 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.62 147.45 98.69 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.634 0.774 . . . . 63.24 111.817 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.426 ' HB3' HH22 ' A' ' 111' ' ' ARG . 71.7 Cg_endo -83.73 165.76 13.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.75 2.3 . . . . 75.21 112.801 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.41 114.68 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.744 -0.835 . . . . 72.11 108.744 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -99.98 63.82 1.2 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.948 -1.13 . . . . 71.35 107.948 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 t80 . . . . . 0 N--CA 1.479 0.991 0 CA-C-N 114.503 -1.226 . . . . 73.15 110.608 -176.512 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.8 m . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.424 -1.324 . . . . 74.34 107.424 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.9 140.95 38.54 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.813 -0.81 . . . . 71.13 108.813 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.6 140.26 18.93 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.631 0.582 . . . . 74.41 109.906 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 tt -95.09 133.03 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.939 0.896 . . . . 41.0 109.46 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -104.7 -50.55 3.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.814 0.446 . . . . 73.41 110.872 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.458 HH21 ' HB ' ' A' ' 122' ' ' THR . 63.3 ttt180 -158.57 140.36 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.657 0.383 . . . . 75.14 110.8 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -117.83 142.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.015 -1.105 . . . . 65.44 108.015 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.441 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 40.4 p90 -162.86 169.63 19.5 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.823 0.702 . . . . 73.02 110.69 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.8 m -99.2 123.23 43.32 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.065 -0.716 . . . . 72.33 109.065 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -77.21 -52.7 8.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.926 -0.579 . . . . 73.42 110.402 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -140.79 140.93 34.82 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.111 0.481 . . . . 71.02 111.919 -165.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mm -132.81 138.14 52.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.933 1.293 . . . . 72.31 108.396 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -143.1 135.98 27.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.063 -0.971 . . . . 62.44 108.509 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -153.35 111.85 3.67 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.851 -1.166 . . . . 74.11 107.851 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -119.83 118.66 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.594 -0.891 . . . . 64.22 108.594 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.793 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -115.89 86.88 17.11 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.721 0.808 . . . . 74.04 109.643 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.9 -50.57 2.16 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.868 2.379 . . . . 64.25 112.695 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.456 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 88.8 m-20 -101.56 20.6 15.79 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.561 0.744 . . . . 72.24 111.435 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.793 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.6 -52.73 42.17 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 124.898 1.279 . . . . 54.0 112.932 168.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 83' ' ' ILE . 43.8 Cg_endo -74.62 -12.02 22.31 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 121.692 1.595 . . . . 64.54 113.207 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.456 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 82.8 m-70 -96.01 1.12 52.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.759 0.824 . . . . 72.12 110.915 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.01 -22.92 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.817 1.247 . . . . 42.41 112.936 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.84 -42.05 78.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.915 0.886 . . . . 72.15 110.937 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -83.46 -12.47 56.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.5 1.12 . . . . 74.41 111.136 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -100.54 75.3 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.031 0.932 . . . . 74.24 109.284 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.12 76.04 9.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 71.54 110.899 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.48 158.51 1.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.89 1.276 . . . . 74.31 109.885 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.471 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 63.8 tt0 -83.93 130.89 53.3 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 74.32 108.729 173.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 50.3 Cg_endo -65.6 153.39 78.4 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.51 2.14 . . . . 64.2 112.746 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 42.8 mt-10 -69.76 100.82 1.57 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.944 . . . . 73.03 108.453 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' B' ' 126' ' ' LEU . 33.1 t -90.24 121.23 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 107.871 -1.159 . . . . 73.42 107.871 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -148.76 139.78 23.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.468 -1.308 . . . . 64.32 107.468 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.464 HD21 HD12 ' B' ' 126' ' ' LEU . 0.8 OUTLIER -128.11 163.03 25.52 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.711 0.767 . . . . 63.23 112.475 -171.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -126.9 154.15 44.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.049 -1.432 . . . . 74.52 108.555 177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.451 HD21 HD21 ' B' ' 60' ' ' LEU . 2.5 tt -134.94 116.17 14.4 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.792 -1.559 . . . . 72.24 106.792 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -126.46 155.28 42.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.754 0.822 . . . . 74.43 110.044 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 29.2 m -111.4 136.69 50.18 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 64.13 110.394 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.583 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.15 154.06 36.7 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.688 1.195 . . . . 71.44 108.177 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 m -141.68 160.69 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.006 0.431 . . . . 54.34 111.338 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -162.99 163.38 26.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.108 1.363 . . . . 65.41 108.332 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -123.02 137.24 55.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.056 0.943 . . . . 74.44 109.193 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.15 -35.11 9.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.177 0.591 . . . . 73.53 111.117 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.46 -174.25 2.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.346 1.058 . . . . 74.15 110.316 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.05 119.09 14.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.347 -0.842 . . . . 62.15 109.823 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 67.02 12.46 8.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.659 1.184 . . . . 74.34 112.138 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -128.27 110.62 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.779 -1.193 . . . . 63.22 107.779 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -122.31 163.96 18.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.137 -0.69 . . . . 75.2 109.137 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -137.93 110.46 7.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.681 -1.229 . . . . 71.31 107.681 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' B' ' 98' ' ' LEU . 24.4 m -107.77 150.66 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.211 0.529 . . . . 74.5 110.364 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 18.0 t -116.61 136.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 115.272 -0.876 . . . . 64.51 108.648 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -102.02 116.15 32.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.962 -1.125 . . . . 73.21 107.962 178.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -97.44 125.16 41.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.016 0.526 . . . . 61.22 109.98 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' B' ' 114' ' ' ILE . 12.7 t -125.7 116.86 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.486 -0.931 . . . . 74.4 108.486 166.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 38.0 m -99.08 152.13 20.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.452 1.101 . . . . 73.14 109.216 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' B' ' 42' ' ' LEU . 76.1 t -136.78 111.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.936 0.894 . . . . 71.03 109.242 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.2 m -92.31 138.41 31.54 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.514 0.725 . . . . 74.44 109.047 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.05 142.21 28.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.127 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -140.7 128.65 21.95 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.747 0.654 . . . . 73.53 111.824 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.8 99.04 11.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.951 -1.129 . . . . 54.14 107.951 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -112.81 3.79 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.341 -0.845 . . . . 54.21 111.467 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -108.26 1.32 21.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.091 0.956 . . . . 73.3 111.131 -176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.0 155.6 41.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.481 0.712 . . . . 72.14 110.213 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 130.72 44.17 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.034 0.534 . . . . 73.53 111.97 -173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.409 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -84.68 -58.85 2.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 60.24 108.72 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -161.55 162.93 30.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 113.536 -1.665 . . . . 63.31 109.352 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.4 mt -136.32 111.63 9.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.935 -1.506 . . . . 72.55 106.935 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -117.87 158.17 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.702 0.801 . . . . 62.14 109.068 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -165.68 146.69 7.0 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.003 -0.74 . . . . 71.34 109.003 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.15 144.5 37.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.566 -1.197 . . . . 70.42 108.353 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.1 mt-30 -127.36 93.46 3.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.547 -0.908 . . . . 71.13 108.547 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.407 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.2 tp-100 -86.08 102.66 14.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.95 -1.023 . . . . 62.11 109.449 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.57 148.87 20.76 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.759 -0.536 . . . . 71.44 111.759 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.25 126.09 2.16 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 117.27 0.535 . . . . 64.25 112.416 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.98 127.2 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.535 0.734 . . . . 63.5 109.079 173.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -139.72 170.18 16.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 70.31 109.041 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -133.68 131.72 39.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 74.34 108.874 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.691 HD12 ' SG ' ' B' ' 97' ' ' CYS . 7.1 tt -140.32 145.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.417 0.287 . . . . 71.1 110.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.3 39.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.767 0.827 . . . . 72.24 110.078 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.05 -31.6 4.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.18 -0.464 . . . . 64.22 114.149 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' B' ' 94' ' ' MET . 0.1 OUTLIER -71.54 170.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.13 0.972 . . . . 75.4 112.679 -177.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 93' ' ' GLN . 13.8 pt-20 -164.12 160.25 21.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.326 0.65 . . . . 75.32 110.388 173.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.55 -128.74 47.57 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.469 0.48 . . . . 33.33 113.693 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 38.0 m -68.47 -21.88 64.59 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.367 0.667 . . . . 63.45 111.382 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' B' ' 90' ' ' GLU . 25.0 mt-30 -64.97 -31.7 73.06 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.907 0.483 . . . . 75.32 110.806 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.497 ' HB2' HG12 ' B' ' 89' ' ' ILE . 13.1 tpt -85.86 -46.3 10.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.457 -0.338 . . . . 64.32 110.574 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.67 66.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.781 0.833 . . . . 75.31 111.872 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.1 -38.67 75.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.638 0.775 . . . . 72.43 111.16 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' B' ' 86' ' ' ILE . 53.4 t -64.98 -68.37 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.882 0.31 . . . . 73.5 111.547 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.77 ' HB2' HG11 ' B' ' 58' ' ' VAL . 2.6 pt? -75.46 -18.02 59.98 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.785 0.266 . . . . 74.23 111.517 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.64 3.64 42.61 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-O 118.984 -0.898 . . . . 74.0 114.373 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.96 -50.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.076 0.938 . . . . 44.33 112.409 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -72.84 -46.57 52.27 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.557 0.743 . . . . 63.02 111.55 -170.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.0 -44.8 40.91 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 118.457 -0.782 . . . . 73.31 110.717 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.13 -45.35 21.8 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.033 1.822 . . . . 75.31 112.841 163.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -60.74 -36.52 79.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.509 0.724 . . . . 73.23 111.782 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.01 -48.37 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.358 0.663 . . . . 71.34 110.77 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 60' ' ' LEU . 44.2 mt -83.0 -11.48 58.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.911 -1.04 . . . . 71.02 111.575 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -62.22 -48.42 87.77 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 117.904 -1.046 . . . . 72.43 113.724 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.17 -36.07 98.17 Favored 'Trans proline' 0 C--N 1.373 1.851 0 CA-C-N 121.04 1.407 . . . . 44.31 112.267 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -66.28 -51.37 58.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 74.15 111.261 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.38 94.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.941 0.897 . . . . 63.33 110.832 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -56.58 -50.34 72.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.204 1.401 . . . . 75.41 111.292 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.5 -35.75 81.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.236 0.614 . . . . 71.33 110.374 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.5 t -72.22 -37.96 69.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.152 -0.476 . . . . 61.32 111.065 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' B' ' 62' ' ' VAL . 54.0 mt -60.59 -50.22 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.352 0.661 . . . . 60.23 109.222 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 72.5 m -48.2 -46.49 35.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.842 1.339 . . . . 63.2 110.532 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.1 t -61.89 -56.51 18.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.446 -1.252 . . . . 62.02 110.882 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 20.0 mmt -67.6 -38.36 83.86 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.752 0.821 . . . . 51.0 112.389 -170.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.91 -44.45 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.424 0.631 . . . . 75.52 109.944 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.485 ' OG ' HG21 ' C' ' 115' ' ' THR . 48.3 t -67.34 -25.16 65.85 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.648 -1.16 . . . . 72.0 112.222 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -70.94 -36.4 72.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.194 0.597 . . . . 63.35 109.933 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 6.75 56.59 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.662 0.601 . . . . 74.34 112.49 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.0 p 57.22 42.01 26.02 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.368 1.867 . . . . 72.11 111.457 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 48.3 m-85 -114.85 159.42 37.49 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.533 -1.212 . . . . 75.42 110.698 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.573 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 39.6 Cg_exo -60.53 104.56 0.26 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.58 2.853 . . . . 72.41 114.684 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.503 ' HG3' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -65.0 161.53 18.5 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.156 1.382 . . . . 61.21 111.447 171.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.464 HD12 HD21 ' B' ' 42' ' ' LEU . 1.1 tm? -132.29 117.99 18.89 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.395 -0.965 . . . . 72.3 108.395 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.41 94.85 10.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.132 -1.062 . . . . 62.11 108.132 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.444 HD23 ' N ' ' B' ' 129' ' ' ALA . 1.8 tt -58.4 138.99 56.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.681 -1.145 . . . . 72.12 110.565 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.444 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -51.51 148.98 8.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 70.33 112.228 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.499 ' HG3' HG12 ' D' ' 16' ' ' ILE . 80.1 Cg_endo -72.07 78.81 1.78 Allowed 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.331 2.021 . . . . 74.22 111.451 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.7 m -74.07 83.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.239 1.019 . . . . 74.22 110.691 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.58 111.33 7.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.807 -1.088 . . . . 42.04 108.891 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.8 t80 . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.258 0.623 . . . . 74.41 110.91 -177.454 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 109.001 -0.74 . . . . 63.41 109.001 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -124.35 119.07 28.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -146.66 130.17 16.83 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.459 -0.941 . . . . 72.45 108.459 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 tp -78.81 137.89 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 109.477 -0.564 . . . . 72.44 109.477 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.9 mm-40 -98.96 -47.33 5.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.273 0.629 . . . . 72.41 109.881 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.411 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 66.4 ttt180 -170.77 124.99 0.68 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.581 0.551 . . . . 74.44 110.48 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -109.35 141.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.665 -1.235 . . . . 74.22 107.665 169.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.455 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 6.8 p90 -179.39 164.94 1.38 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.438 0.695 . . . . 71.35 110.029 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -88.7 122.87 32.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 122.971 0.508 . . . . 71.25 109.913 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.595 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.8 mmtp -74.54 -50.56 17.6 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.069 0.938 . . . . 74.34 108.686 170.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.99 141.52 40.45 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.003 -1.453 . . . . 73.34 109.004 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 94.2 mt -137.28 139.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.808 -1.553 . . . . 65.12 106.808 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -149.85 146.3 27.04 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.557 -0.534 . . . . 74.33 109.557 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -152.48 108.84 3.41 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.162 -1.422 . . . . 75.24 107.162 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -116.47 118.68 33.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.91 -0.774 . . . . 61.43 108.91 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.49 86.94 5.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.28 -1.748 . . . . 72.53 106.28 167.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.55 -38.61 61.24 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 122.67 2.247 . . . . 43.42 110.989 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -99.9 44.79 1.01 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.394 -1.275 . . . . 52.3 109.064 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.462 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -59.26 -64.3 3.13 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.903 1.281 . . . . 61.33 112.694 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 61.3 Cg_endo -74.5 -12.47 22.62 Favored 'Trans proline' 0 C--N 1.382 2.319 0 CA-C-N 121.876 1.706 . . . . 53.42 112.203 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.512 ' CD2' ' HD3' ' C' ' 34' ' ' LYS . 3.5 t-160 -67.7 -30.41 69.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.214 1.006 . . . . 73.42 109.907 174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.824 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 2.9 p -69.51 -26.66 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 111.835 0.309 . . . . 70.33 111.835 -173.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.92 -40.15 72.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.651 1.18 . . . . 75.32 112.515 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -122.87 39.0 4.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.642 0.777 . . . . 65.34 109.889 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.824 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 31.7 ttpt -114.19 153.14 30.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 71.1 111.463 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.2 116.56 10.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.246 1.018 . . . . 54.14 110.539 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -87.2 101.7 13.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.378 1.071 . . . . 74.24 111.93 -173.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.47 HE22 ' HB3' ' C' ' 68' ' ' LEU . 0.1 OUTLIER -150.38 63.07 5.83 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 124.037 0.935 . . . . 75.1 109.683 168.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.26 122.09 6.87 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.099 2.532 . . . . 71.24 111.529 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.07 88.27 7.45 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.62 -1.252 . . . . 75.31 107.62 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.82 119.06 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.072 -1.422 . . . . 64.05 110.903 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -130.9 146.54 52.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.716 0.807 . . . . 71.12 110.396 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' C' ' 128' ' ' LEU . 56.1 tp -116.15 124.23 49.8 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.11 0.964 . . . . 70.41 109.201 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -119.21 116.84 27.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.843 0.857 . . . . 74.12 109.664 -173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -101.2 126.96 47.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.317 -0.994 . . . . 65.52 108.317 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -134.4 151.46 51.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.294 1.038 . . . . 74.13 108.863 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 24.5 m -112.17 115.83 29.48 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.108 0.563 . . . . 74.01 110.311 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.67 147.76 44.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.246 -1.02 . . . . 74.45 108.246 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -163.08 145.15 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.744 0.418 . . . . 55.5 110.649 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.2 t -145.35 125.98 14.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.214 1.005 . . . . 52.22 108.413 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.01 126.09 30.35 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.843 -0.428 . . . . 62.02 109.843 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.636 HD11 HD12 ' C' ' 83' ' ' ILE . 87.3 mt -91.34 -52.2 4.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.401 0.681 . . . . 75.02 110.675 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.83 -170.77 3.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.921 0.888 . . . . 72.42 110.646 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.13 117.89 7.76 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.184 -0.673 . . . . 71.24 109.184 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 64.76 12.19 7.46 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 124.232 0.958 . . . . 73.42 112.186 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.4 t -121.74 122.93 68.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.621 -1.252 . . . . 72.55 107.621 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.42 ' OH ' ' HB3' ' C' ' 98' ' ' LEU . 0.1 OUTLIER -138.99 157.91 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 175.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -105.02 116.29 31.7 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.575 -1.193 . . . . 73.15 108.563 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.98 132.03 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.911 -1.144 . . . . 62.51 107.911 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.5 t -128.0 111.25 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.205 -1.406 . . . . 63.02 107.205 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.76 108.9 18.29 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.922 -1.51 . . . . 74.5 106.922 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -81.22 104.81 11.94 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.909 -1.145 . . . . 73.1 107.909 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.68 107.42 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.218 -0.66 . . . . 53.32 109.218 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -104.0 145.91 29.47 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.352 0.661 . . . . 72.43 109.285 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.612 HG21 HG21 ' C' ' 114' ' ' ILE . 38.9 t -140.54 117.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 124.706 1.202 . . . . 72.45 108.081 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -111.98 141.62 45.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.833 0.349 . . . . 63.14 110.097 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.37 103.17 6.29 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 107.155 -1.424 . . . . 64.42 107.155 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.1 m -125.55 137.9 53.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.163 0.506 . . . . 71.34 110.591 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.47 ' HB3' HE22 ' C' ' 37' ' ' GLN . 10.9 mt -89.51 37.55 0.87 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.859 1.264 . . . . 72.5 109.308 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.67 -115.47 5.11 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.213 -1.155 . . . . 72.34 110.213 -166.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.37 -31.48 16.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.582 0.753 . . . . 74.14 110.107 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.86 105.76 3.93 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.054 0.942 . . . . 62.41 108.922 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.06 135.61 37.76 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 122.27 -0.269 . . . . 62.24 110.95 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.55 -56.46 4.29 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.807 -0.812 . . . . 62.01 108.807 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -161.2 173.4 15.14 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.516 -0.765 . . . . 72.5 111.46 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.3 tm? -136.82 141.16 42.87 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.146 -1.428 . . . . 71.04 107.146 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' C' ' 114' ' ' ILE . 35.4 t -141.68 139.57 33.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.768 -1.197 . . . . 53.11 107.768 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.49 116.25 3.86 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.141 -0.689 . . . . 75.53 109.141 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -120.9 140.11 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.836 0.854 . . . . 71.22 109.623 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -107.7 109.02 20.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.941 0.896 . . . . 73.41 109.123 168.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.474 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -89.4 107.74 19.24 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.119 -0.697 . . . . 72.04 109.119 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.4 22.15 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.61 0.569 . . . . 53.03 112.033 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.43 116.83 0.77 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.694 -0.962 . . . . 64.5 110.694 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.636 HD12 HD11 ' C' ' 51' ' ' LEU . 13.7 mm -88.7 119.12 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.56 -0.904 . . . . 60.32 108.56 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 135.65 54.81 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.413 0.685 . . . . 75.0 109.725 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -103.47 99.66 9.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.845 -1.168 . . . . 60.34 107.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.82 156.23 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.096 0.558 . . . . 71.43 110.202 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.08 157.36 2.29 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.723 1.209 . . . . 71.23 108.949 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -18.27 54.26 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 120.333 -0.148 . . . . 73.44 113.178 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' C' ' 94' ' ' MET . 46.1 pt . . . . . 0 CA--C 1.544 0.731 0 C-N-CA 123.126 0.57 . . . . 51.01 111.301 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 119.657 -0.211 . . . . 75.15 111.022 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.741 ' SD ' HD21 ' C' ' 98' ' ' LEU . 25.6 tpp -59.29 -55.37 35.65 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.536 0.523 . . . . 75.43 110.101 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.96 -34.6 78.47 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.644 -0.707 . . . . 74.41 112.229 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -77.78 -34.08 52.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.671 0.388 . . . . 75.23 111.772 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -68.8 -60.66 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.775 0.43 . . . . 62.52 110.755 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.741 HD21 ' SD ' ' C' ' 94' ' ' MET . 1.5 pp -94.43 -19.14 20.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.891 0.7 . . . . 75.22 112.891 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 6.73 73.76 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.785 -0.453 . . . . 71.5 113.326 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.69 -56.53 0.07 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.668 0.387 . . . . 61.01 111.873 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.53 -53.82 9.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.957 0.725 . . . . 71.25 112.957 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.35 -43.41 79.54 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 123.685 0.794 . . . . 61.0 112.456 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.04 -30.44 66.25 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 121.308 1.339 . . . . 65.13 112.706 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.413 HD21 ' ND2' ' C' ' 132' ' ' ASN . 46.8 t-20 -66.64 -32.7 74.18 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.217 0.462 . . . . 72.31 110.315 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.431 HD12 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -60.22 -44.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.291 0.567 . . . . 70.15 109.903 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.8 mt -78.68 -21.12 48.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.9 -1.046 . . . . 61.42 111.926 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -56.69 -55.36 43.97 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 117.434 -1.27 . . . . 73.21 113.631 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.91 -30.7 84.15 Favored 'Trans proline' 0 C--N 1.377 2.03 0 CA-C-N 121.571 1.597 . . . . 42.32 112.732 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -63.39 -50.85 68.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.626 0.77 . . . . 75.01 110.83 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.42 -42.33 98.73 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.229 1.012 . . . . 70.32 111.225 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -61.12 -44.17 97.76 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.405 1.882 . . . . 61.1 110.521 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.2 -35.11 63.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.347 0.659 . . . . 64.11 110.3 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.5 t -64.1 -34.43 78.03 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.504 0.722 . . . . 71.35 111.357 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.612 HG21 HG21 ' C' ' 64' ' ' VAL . 97.3 mt -73.28 -45.01 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.805 0.842 . . . . 75.33 111.349 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.485 HG21 ' OG ' ' B' ' 119' ' ' SER . 28.4 m -57.83 -35.39 70.83 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.803 0.441 . . . . 75.42 111.787 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.1 -48.66 70.16 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.29 -0.633 . . . . 71.43 109.29 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.578 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.34 -39.46 70.03 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.872 1.269 . . . . 71.41 113.144 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' C' ' 126' ' ' LEU . 94.2 t -62.09 -48.23 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.218 0.532 . . . . 61.1 110.399 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.9 t -66.52 -28.66 68.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.079 -0.964 . . . . 54.42 111.843 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 84.6 mtt-85 -67.16 -40.62 86.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.068 -0.715 . . . . 73.41 109.068 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.65 5.04 66.13 Favored Glycine 0 C--N 1.358 1.789 0 O-C-N 124.038 0.836 . . . . 71.34 112.912 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 56.1 53.66 8.8 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.063 1.745 . . . . 71.31 111.939 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.508 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 56.4 m-85 -113.22 172.57 3.44 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 114.516 -1.22 . . . . 74.22 109.492 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 18.3 Cg_endo -56.59 171.49 0.96 Allowed 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.639 2.226 . . . . 70.14 113.327 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 9.0 tm0? -60.53 140.7 57.21 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.377 -0.972 . . . . 72.54 108.377 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.431 ' HB3' HG21 ' C' ' 118' ' ' VAL . 9.5 tp -151.03 83.34 1.33 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.975 0.893 . . . . 73.31 110.363 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.99 98.42 3.75 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.812 -1.54 . . . . 73.51 107.092 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' C' ' 42' ' ' LEU . 49.8 mt -78.5 149.26 33.17 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.636 -0.505 . . . . 63.33 109.636 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.86 155.5 82.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.926 0.89 . . . . 61.1 112.749 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.891 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 76.6 Cg_exo -54.74 132.5 52.09 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.926 3.084 . . . . 72.1 113.949 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -111.37 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.798 -1.186 . . . . 63.34 107.798 174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.413 ' ND2' HD21 ' C' ' 104' ' ' ASN . 11.5 m120 -87.59 68.75 9.63 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.543 0.687 . . . . 71.43 110.0 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.155 -0.929 . . . . 71.53 110.929 177.687 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 79.7 m . . . . . 0 C--O 1.244 0.792 0 N-CA-C 109.507 -0.553 . . . . 71.45 109.507 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.7 t80 -156.31 104.72 2.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.212 -1.403 . . . . 74.23 107.212 172.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -110.35 112.08 23.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.926 -1.138 . . . . 50.23 107.926 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 tt -80.36 98.63 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.102 -1.444 . . . . 72.25 107.102 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.66 -50.04 7.51 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.6 -167.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -162.3 119.08 2.03 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.663 -0.495 . . . . 74.55 109.663 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.499 HG12 ' HG3' ' B' ' 130' ' ' PRO . 28.3 mm -111.49 118.21 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.897 -1.149 . . . . 74.35 107.897 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.5 146.59 28.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.28 0.632 . . . . 71.21 111.232 -171.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 50.0 p -75.98 113.04 13.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.021 -0.99 . . . . 62.31 109.938 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -80.92 -36.03 31.59 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.415 -0.587 . . . . 62.42 109.415 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -144.77 137.59 26.56 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.081 -0.963 . . . . 72.54 109.617 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.521 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.2 mt -137.55 139.63 43.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.872 -1.159 . . . . 65.3 107.872 174.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -142.09 140.72 32.61 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -151.8 120.95 6.72 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.625 -1.621 . . . . 65.1 106.625 173.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.04 112.95 11.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 64.15 109.778 -175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -110.45 84.18 3.75 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.682 0.793 . . . . 64.13 109.581 177.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 -26.97 11.44 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.051 2.5 . . . . 64.13 113.183 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -114.82 25.35 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.922 0.889 . . . . 74.51 109.847 -174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -58.72 -57.42 26.86 Favored Pre-proline 0 CA--C 1.564 1.497 0 N-CA-C 115.038 1.496 . . . . 74.12 115.038 -164.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 86.6 Cg_endo -78.42 -15.07 14.25 Favored 'Trans proline' 0 C--N 1.38 2.217 0 CA-C-N 122.06 1.771 . . . . 75.22 112.799 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.42 -44.24 68.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.041 0.936 . . . . 71.2 109.543 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.497 HG23 ' HD2' ' D' ' 34' ' ' LYS . 2.1 p -84.38 0.77 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.61 0.764 . . . . 75.35 110.981 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.411 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 84.2 t80 -63.36 -17.33 62.49 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.464 1.106 . . . . 73.4 111.169 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -81.32 -1.31 44.77 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.69 0.796 . . . . 75.21 112.104 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.497 ' HD2' HG23 ' D' ' 31' ' ' VAL . 96.5 mttt -121.8 113.27 19.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.877 0.871 . . . . 74.05 112.446 -167.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.98 79.84 2.24 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.222 1.011 . . . . 73.13 111.228 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.425 ' HB2' HD22 ' D' ' 68' ' ' LEU . 22.3 m95 -127.04 171.38 11.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.508 -0.745 . . . . 74.34 110.572 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.476 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 29.4 tp60 -85.04 120.55 73.68 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.605 -1.257 . . . . 75.2 107.605 164.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.476 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 31.8 Cg_exo -57.4 114.5 1.97 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.977 1.784 . . . . 71.44 110.972 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -65.8 112.39 3.71 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 106.71 -1.589 . . . . 73.51 106.71 167.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.699 HG13 HG13 ' D' ' 64' ' ' VAL . 71.2 t -116.34 111.66 36.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 123.188 0.595 . . . . 61.3 109.591 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -87.21 133.67 33.63 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.961 -1.125 . . . . 74.12 107.961 169.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.15 127.41 53.79 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.706 -1.22 . . . . 75.43 107.706 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.2 t70 -112.76 125.18 54.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.228 -0.656 . . . . 54.53 109.228 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 62.0 tp -97.05 131.6 43.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.114 0.965 . . . . 71.21 109.758 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.0 t70 -147.59 155.45 41.84 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.631 -0.877 . . . . 51.24 108.631 168.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -146.28 151.36 37.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.384 0.674 . . . . 63.14 109.759 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.04 172.6 14.98 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.177 0.991 . . . . 74.14 108.853 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.2 p -163.76 163.68 23.97 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.729 0.412 . . . . 44.02 110.73 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 54.9 p -154.04 139.59 17.84 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.401 0.68 . . . . 74.41 109.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.15 122.98 25.1 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 110.207 -0.294 . . . . 71.23 110.207 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.0 mt -94.64 -35.99 11.96 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.631 0.582 . . . . 51.23 109.639 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.83 -176.6 5.34 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.038 0.935 . . . . 53.21 110.008 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.76 128.13 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.79 -0.641 . . . . 74.02 109.314 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 61.08 26.42 16.35 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.933 0.893 . . . . 52.52 110.854 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -139.68 122.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 C-N-CA 124.105 0.962 . . . . 61.14 109.717 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -136.07 137.37 41.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 72.33 108.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.495 ' HB2' HD11 ' D' ' 51' ' ' LEU . 20.5 tt0 -88.29 118.6 28.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.235 -1.024 . . . . 62.23 108.235 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.44 140.29 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.128 -1.064 . . . . 75.52 108.128 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.2 t -121.87 143.06 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.437 1.095 . . . . 72.42 108.997 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -119.74 126.83 52.03 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.511 -1.292 . . . . 72.13 107.511 174.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.3 ttm-85 -106.66 104.44 14.12 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.339 -0.986 . . . . 73.23 108.339 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 128.19 48.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.799 -1.186 . . . . 64.02 107.799 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.4 m -120.9 129.0 53.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.987 -0.375 . . . . 53.41 109.987 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.699 HG13 HG13 ' D' ' 40' ' ' VAL . 71.7 t -111.95 109.1 27.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 125.365 1.466 . . . . 71.11 109.318 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -102.17 93.75 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.397 -1.334 . . . . 65.12 107.397 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.92 144.01 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.586 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 18.5 m -142.87 135.72 27.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.451 0.469 . . . . 75.23 112.196 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 52.0 mt -116.65 125.44 51.77 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.87 0.868 . . . . 73.42 109.176 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.48 -113.09 4.11 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.143 -0.383 . . . . 34.42 112.143 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 7.01 10.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.273 0.629 . . . . 65.51 110.865 -176.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -129.42 174.62 9.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.37 0.668 . . . . 73.22 110.212 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -72.62 132.85 44.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.541 -0.754 . . . . 64.12 110.91 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.558 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -82.04 -57.98 3.17 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.62 -0.882 . . . . 72.34 108.62 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -164.8 165.53 20.52 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 113.623 -1.626 . . . . 74.11 108.921 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -122.77 153.45 39.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.452 -1.314 . . . . 61.41 107.452 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.571 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 40.1 t -158.7 146.91 18.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.742 0.417 . . . . 75.13 110.098 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.67 128.92 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.181 -0.674 . . . . 74.12 109.181 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.44 114.18 32.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.214 -0.662 . . . . 64.51 109.214 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.8 mt-30 -89.46 86.24 6.73 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.422 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.56 104.44 10.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 113.868 -1.515 . . . . 74.32 108.729 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.35 164.74 28.41 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 111.848 -0.501 . . . . 60.12 111.848 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.65 131.82 2.56 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.774 -0.531 . . . . 73.54 111.774 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -87.88 132.24 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.957 -0.757 . . . . 55.14 108.957 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.38 145.49 47.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.54 0.736 . . . . 72.43 110.075 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 67.0 m -96.34 136.91 36.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.019 -0.734 . . . . 71.25 109.019 167.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.35 126.49 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.401 1.081 . . . . 70.03 110.134 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -167.93 156.03 8.84 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.733 0.813 . . . . 64.41 110.066 175.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.18 -20.68 28.37 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 120.147 -0.252 . . . . 34.23 112.951 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.527 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -116.83 157.94 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.12 0.968 . . . . 74.4 109.295 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.85 175.0 13.04 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.03 0.381 . . . . 75.23 112.03 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -133.45 46.79 Favored Glycine 0 C--N 1.355 1.596 0 O-C-N 124.153 0.908 . . . . 63.13 114.073 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.853 0.861 . . . . 72.23 111.398 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -58.77 -45.28 90.14 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.056 0.943 . . . . 74.11 110.074 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.733 ' SD ' HD23 ' D' ' 98' ' ' LEU . 1.7 tmt? -81.85 -30.74 31.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.097 -0.956 . . . . 64.33 110.982 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.27 75.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.133 0.573 . . . . 71.03 110.93 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -73.52 -38.42 65.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.92 -0.582 . . . . 74.14 109.957 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.1 t -62.5 -49.2 76.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.055 0.542 . . . . 73.54 111.575 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.733 HD23 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -69.03 -29.59 67.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.21 0.604 . . . . 72.42 111.973 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.19 -18.05 37.97 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.684 0.615 . . . . 63.02 113.342 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -122.44 -65.17 1.13 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.859 0.464 . . . . 73.12 111.396 -175.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -67.66 -49.72 61.42 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.556 0.576 . . . . 73.35 112.556 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.494 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.4 m -61.85 -47.42 91.69 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.521 0.728 . . . . 31.25 111.837 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.562 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -61.25 -34.96 87.21 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.48 2.12 . . . . 73.41 112.854 169.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -64.73 -29.54 70.52 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.049 0.54 . . . . 62.41 110.718 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.95 -42.81 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.401 0.681 . . . . 73.25 110.388 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.422 HD13 ' O ' ' D' ' 80' ' ' GLN . 63.9 mt -72.46 -23.74 61.1 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.201 -0.909 . . . . 71.22 111.222 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -64.91 -42.5 63.04 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.609 1.337 . . . . 63.02 114.609 -170.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.35 -41.4 59.34 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.115 1.876 . . . . 75.41 113.552 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -77.99 -36.83 48.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.81 0.844 . . . . 75.41 111.303 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.54 82.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.312 0.645 . . . . 52.4 109.895 176.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -54.59 -54.64 38.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.84 1.256 . . . . 74.41 110.467 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.1 -40.33 94.4 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.301 1.001 . . . . 71.0 111.381 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.416 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.4 t -57.41 -44.7 84.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.388 0.43 . . . . 71.14 110.406 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.56 HG21 HG21 ' D' ' 64' ' ' VAL . 86.7 mt -63.09 -55.15 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.164 -0.925 . . . . 75.34 110.238 173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' D' ' 125' ' ' GLN . 95.7 m -50.09 -48.48 53.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.306 1.442 . . . . 64.33 111.882 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.7 t -65.1 -41.91 94.51 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.76 -1.109 . . . . 71.03 109.932 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.51 -36.84 85.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.154 0.581 . . . . 72.23 111.251 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -62.36 -49.54 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.461 -0.791 . . . . 74.15 109.91 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -71.32 -27.63 63.53 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.167 0.587 . . . . 72.04 111.403 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -73.47 -31.07 63.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.846 0.859 . . . . 75.42 110.178 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.42 5.41 68.31 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.675 0.61 . . . . 53.31 112.16 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.0 p 60.94 27.57 17.42 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 126.554 1.942 . . . . 75.33 112.663 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -93.32 162.47 27.96 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.826 1.251 . . . . 74.14 109.728 173.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -66.56 134.85 36.93 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.979 2.453 . . . . 61.42 111.485 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' D' ' 115' ' ' THR . 47.6 tt0 -55.59 134.21 50.85 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 124.314 1.009 . . . . 70.31 111.988 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 tp -106.58 96.5 6.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.129 -0.693 . . . . 74.22 109.129 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -99.55 84.74 3.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.368 -0.604 . . . . 72.31 109.368 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.76 129.24 39.31 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.726 -0.67 . . . . 72.44 110.631 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -68.26 140.46 92.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 123.243 0.617 . . . . 55.33 111.613 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.5 Cg_endo -82.38 122.36 3.63 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.25 1.967 . . . . 63.34 109.689 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.2 m -107.47 134.82 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.188 0.518 . . . . 73.23 110.088 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 . . . . . 0 CA--C 1.546 0.801 0 CA-C-O 121.892 0.853 . . . . 71.44 109.716 176.112 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.4 m . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.365 -0.606 . . . . 51.43 109.365 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -115.83 126.93 54.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.957 -1.497 . . . . 74.35 106.957 165.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 4.1 tp60 -143.56 124.65 14.46 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.082 0.239 . . . . 64.54 110.632 -166.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.62 98.61 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.576 -0.898 . . . . 75.05 108.576 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -82.41 -30.64 30.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.915 -0.564 . . . . 73.51 111.535 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 179.22 121.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.458 0.703 . . . . 74.12 110.084 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.571 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 86.8 mt -105.84 130.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.846 -1.168 . . . . 72.21 107.846 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.813 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 22.6 p90 -171.95 152.44 2.96 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 124.193 0.933 . . . . 71.34 110.561 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -75.64 119.38 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.215 -0.661 . . . . 74.04 109.215 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -78.69 -46.28 19.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.136 -0.69 . . . . 60.44 109.136 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.46 136.73 41.53 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.889 -1.05 . . . . 71.3 109.383 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -129.06 140.72 48.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.354 -1.35 . . . . 74.13 107.354 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -142.96 128.72 19.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.452 0.701 . . . . 64.11 109.436 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 81.8 t80 -139.19 115.86 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.841 -1.541 . . . . 72.33 106.841 171.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -115.89 144.97 43.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.335 -0.987 . . . . 71.14 108.335 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.34 74.29 11.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.248 -1.39 . . . . 50.24 107.248 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.09 -23.34 24.93 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.543 2.162 . . . . 71.33 111.437 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 80.0 m-20 -110.4 33.54 4.44 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.858 -1.065 . . . . 53.4 109.79 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' B' ' 17' ' ' TYR . . . -59.5 -43.42 95.92 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.28 1.032 . . . . 75.22 113.126 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -69.63 -27.83 26.63 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.715 1.61 . . . . 72.24 113.023 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.6 m170 -72.6 -37.17 68.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.082 0.553 . . . . 72.44 111.077 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 68' ' ' LEU . 13.6 p -68.3 -23.11 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.903 0.881 . . . . 63.33 112.317 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.572 ' HD1' HH11 ' B' ' 15' ' ' ARG . 78.5 t80 -70.39 -35.65 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.882 0.373 . . . . 72.32 110.393 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.73 -46.04 63.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.451 -0.795 . . . . 74.54 109.658 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 3.7 mmmp? -73.17 151.92 41.32 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.425 -1.261 . . . . 64.43 111.201 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.72 136.1 47.06 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.583 -0.735 . . . . 70.42 109.421 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -75.41 84.68 2.53 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.736 0.779 . . . . 71.14 109.261 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -118.23 76.79 12.47 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.882 -1.053 . . . . 64.31 108.434 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.17 125.64 9.91 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.914 1.742 . . . . 61.41 111.627 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -97.26 89.98 4.95 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.706 -1.59 . . . . 75.41 106.706 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.72 92.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.529 -0.76 . . . . 64.31 110.5 -169.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.39 115.29 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.452 -0.944 . . . . 51.05 108.452 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.49 151.54 19.9 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.771 -0.826 . . . . 61.03 108.771 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.5 t70 -143.37 147.78 35.2 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.357 -0.979 . . . . 65.03 108.357 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp -134.96 126.31 28.35 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.453 -0.943 . . . . 61.44 108.453 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -143.47 156.66 44.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.609 -0.886 . . . . 32.45 108.609 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -140.3 151.56 45.17 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.095 0.558 . . . . 61.12 110.149 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.7 153.58 49.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.999 1.32 . . . . 61.23 108.088 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.6 m -131.82 157.43 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.867 0.365 . . . . 74.22 110.663 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -148.24 120.69 8.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.657 -0.868 . . . . 75.32 108.657 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -81.99 105.22 12.92 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.772 -0.825 . . . . 74.44 108.772 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.18 -33.08 24.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.181 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.35 179.8 8.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.028 0.931 . . . . 65.31 109.736 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -70.35 125.03 25.62 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.843 -1.169 . . . . 54.11 107.843 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 75.11 -8.19 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.688 1.595 . . . . 73.54 112.785 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -107.45 110.6 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.683 -0.858 . . . . 71.32 108.683 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -133.65 123.67 25.44 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.271 -0.64 . . . . 71.14 109.271 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 28.0 tt0 -86.62 116.15 24.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.771 -0.649 . . . . 71.33 109.271 175.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.51 115.6 42.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 N-CA-C 107.233 -1.395 . . . . 55.21 107.233 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.3 t -98.78 136.6 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.694 0.798 . . . . 71.32 109.037 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.45 111.67 23.34 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.562 -1.273 . . . . 71.43 107.562 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.01 101.95 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.399 -0.963 . . . . 72.14 108.399 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.29 135.8 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.601 -1.259 . . . . 75.23 107.601 175.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 11.8 m -128.73 144.16 51.1 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.768 -0.456 . . . . 74.42 109.768 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 10.0 t -140.77 125.67 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.672 1.589 . . . . 75.33 107.793 -171.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -129.36 131.92 46.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.698 -0.482 . . . . 62.12 109.698 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.34 108.53 18.64 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.663 -0.866 . . . . 51.13 108.663 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.4 m -108.85 139.32 43.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.001 0.52 . . . . 74.11 110.17 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.647 HD11 HG23 ' A' ' 31' ' ' VAL . 6.2 mt -113.65 78.48 1.15 Allowed 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.273 -1.01 . . . . 63.42 108.273 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.54 -86.13 1.24 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.97 -0.852 . . . . 44.32 110.97 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -131.05 -8.09 3.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.423 1.089 . . . . 64.32 111.303 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -99.71 110.35 22.75 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.264 -0.643 . . . . 71.41 109.264 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.0 m -70.76 132.12 44.87 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 110.056 -0.349 . . . . 50.12 110.056 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 -60.53 2.33 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.07 0.948 . . . . 61.21 109.367 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -151.99 172.18 16.67 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 114.613 -1.176 . . . . 74.33 111.075 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.7 tp -132.57 147.43 52.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.903 1.281 . . . . 63.32 108.521 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -135.66 136.15 40.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.499 1.12 . . . . 71.23 109.145 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -147.37 129.28 15.34 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.489 -0.93 . . . . 75.54 108.489 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.21 109.56 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.959 -0.756 . . . . 71.22 108.959 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.57 82.84 8.09 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.186 -1.042 . . . . 74.13 108.186 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -75.69 92.26 2.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.553 -1.203 . . . . 63.34 108.403 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.68 144.23 21.17 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.315 -0.714 . . . . 63.44 111.315 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.89 118.26 1.22 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 110.11 -1.196 . . . . 63.02 110.11 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.4 mt -81.25 124.12 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.581 -1.266 . . . . 44.41 107.581 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 49.4 m-85 -133.35 121.05 21.78 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.411 -0.588 . . . . 73.12 109.411 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 22.4 t -79.36 96.67 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.026 -1.101 . . . . 65.51 108.026 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.53 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -121.2 128.07 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.067 -0.97 . . . . 64.42 109.418 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -174.15 178.15 2.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.535 1.134 . . . . 72.45 110.43 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.69 4.38 85.29 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.928 -0.578 . . . . 65.01 113.951 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -114.21 153.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.983 0.913 . . . . 63.42 109.546 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -144.33 168.94 18.9 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 109.27 -0.641 . . . . 62.53 109.27 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.77 -127.29 40.24 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.727 0.642 . . . . 61.01 114.688 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.6 p -62.25 -26.36 68.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.43 1.092 . . . . 65.21 112.077 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -64.07 -36.41 83.92 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.903 0.881 . . . . 75.32 111.074 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 77.7 mtp -67.27 -45.38 76.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.622 0.769 . . . . 65.1 110.2 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.85 71.98 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.884 -1.053 . . . . 72.53 111.255 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -66.96 -44.32 80.82 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.966 0.906 . . . . 61.41 110.362 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 14.3 t -71.81 -63.24 1.17 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.624 0.577 . . . . 73.33 110.791 -171.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.2 tp -68.75 -38.39 80.08 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 120.555 0.217 . . . . 72.43 111.525 -177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.15 -9.33 84.21 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.347 -0.696 . . . . 25.33 114.715 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.32 -53.68 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.904 0.852 . . . . 71.43 112.743 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 89.9 t80 -72.99 -60.97 1.98 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.72 0.808 . . . . 72.41 113.156 -164.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 72.0 m -61.22 -39.72 66.16 Favored Pre-proline 0 CA--C 1.557 1.23 0 N-CA-C 113.761 1.023 . . . . 64.05 113.761 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.47 -33.56 68.4 Favored 'Trans proline' 0 C--N 1.382 2.341 0 CA-C-N 120.976 1.384 . . . . 62.14 112.87 167.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -72.87 -23.62 60.76 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 117.903 0.319 . . . . 60.44 111.212 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.12 -42.31 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.952 0.882 . . . . 52.35 109.305 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.1 -24.47 40.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.143 -1.39 . . . . 64.12 112.348 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.39 -41.91 86.15 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.923 1.082 . . . . 73.21 113.923 -171.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.89 -39.33 91.79 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.421 2.081 . . . . 65.24 113.313 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -76.27 -41.69 48.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.308 -0.86 . . . . 65.23 111.387 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.86 85.93 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 73.0 109.984 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.401 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.8 ttm180 -49.86 -59.08 4.19 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 124.897 1.373 . . . . 70.33 109.683 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 4.4 tm-20 -58.32 -40.97 83.5 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.428 1.08 . . . . 71.42 112.251 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.485 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.0 t -62.07 -47.6 83.94 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.503 0.502 . . . . 63.21 110.91 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.415 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 96.2 mt -61.47 -43.96 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.76 0.824 . . . . 60.13 110.464 175.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 125' ' ' GLN . 74.0 m -58.26 -42.75 87.12 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.909 1.284 . . . . 54.32 111.586 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -72.93 -41.5 64.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.314 -0.857 . . . . 33.11 110.888 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.0 mtm -58.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.653 0.381 . . . . 60.44 111.324 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.9 -42.99 96.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.974 0.796 . . . . 51.32 111.47 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.4 p -67.56 -29.0 68.26 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.106 0.479 . . . . 71.12 110.958 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.8 -31.55 64.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.713 0.805 . . . . 73.13 109.943 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 29.53 4.56 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.972 0.796 . . . . 74.32 113.623 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t 60.98 16.8 7.31 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.725 2.01 . . . . 70.14 114.994 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.18 159.36 52.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.618 -0.676 . . . . 72.42 111.962 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.18 139.76 90.91 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.82 2.346 . . . . 51.23 111.674 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.606 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.0 pt20 -55.44 151.64 9.9 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.576 1.173 . . . . 74.2 112.138 -173.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.02 97.46 5.62 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 71.31 108.997 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -124.6 101.82 7.31 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.522 1.129 . . . . 73.24 109.406 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.78 159.11 32.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.882 0.873 . . . . 74.42 112.006 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 152.37 95.98 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.895 0.878 . . . . 62.41 111.731 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -91.71 111.26 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.284 2.656 . . . . 74.42 112.191 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 49.6 t -100.84 111.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.961 -1.126 . . . . 75.4 107.961 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -96.14 73.06 2.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.079 0.942 . . . . 71.04 109.258 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 71.5 t80 . . . . . 0 CA--C 1.547 0.828 0 CA-C-N 114.069 -1.423 . . . . 73.43 110.25 176.62 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 C--O 1.238 0.45 0 N-CA-C 107.432 -1.322 . . . . 75.02 107.432 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.43 ' HA ' HG22 ' B' ' 86' ' ' ILE . 16.9 t80 -127.87 139.24 52.74 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -149.66 141.05 23.26 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.23 0.612 . . . . 63.43 109.789 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.447 HD11 HG13 ' B' ' 16' ' ' ILE . 7.2 tp -93.18 136.21 25.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 109.018 -0.734 . . . . 62.34 109.018 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.589 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.9 mm100 -104.95 -51.14 3.1 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.33 -0.619 . . . . 63.53 109.33 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.572 HH11 ' HD1' ' A' ' 32' ' ' PHE . 52.2 ttt180 -173.26 138.83 0.75 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.055 0.542 . . . . 75.23 110.543 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.447 HG13 HD11 ' B' ' 13' ' ' ILE . 55.8 mt -114.71 141.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.075 -1.083 . . . . 72.52 108.075 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 26.0 p90 -167.5 156.45 9.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.112 0.482 . . . . 75.43 111.957 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.9 m -81.57 125.83 31.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.31 -0.859 . . . . 74.0 108.685 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.436 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.36 -34.91 10.48 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.159 0.584 . . . . 71.42 111.301 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.6 t70 -153.95 132.82 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.743 -0.662 . . . . 65.23 109.942 -165.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.9 mm -135.94 138.31 47.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 124.102 0.961 . . . . 62.53 109.462 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.2 m -138.33 121.29 16.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.413 -1.267 . . . . 72.31 108.674 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.529 ' HZ ' ' HD2' ' B' ' 123' ' ' PHE . 83.3 t80 -130.65 108.59 10.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.652 -1.61 . . . . 72.24 106.652 163.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -122.45 114.67 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 63.4 108.746 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.21 87.15 3.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 74.14 108.867 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 35.7 Cg_endo -61.75 -41.12 40.52 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.173 2.582 . . . . 72.42 112.901 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -110.52 30.95 6.33 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.109 0.964 . . . . 63.44 109.912 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.813 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.66 -50.32 51.87 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 125.875 1.67 . . . . 62.03 115.057 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.89 -19.21 16.25 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.008 1.805 . . . . 73.41 112.445 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.04 5.01 53.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.923 1.289 . . . . 65.42 110.863 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.95 -28.85 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.548 0.739 . . . . 72.05 111.698 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -73.69 -33.51 64.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.38 0.672 . . . . 70.34 111.314 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.54 -20.38 63.69 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.135 0.974 . . . . 73.43 110.476 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -104.68 112.07 25.01 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.5 1.52 . . . . 64.1 111.379 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -93.54 77.97 4.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.229 0.612 . . . . 63.4 111.65 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 170.96 152.48 0.05 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 126.384 1.874 . . . . 72.34 109.307 161.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.436 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 0.6 OUTLIER -80.56 128.65 71.61 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 108.994 -0.743 . . . . 74.52 108.994 -177.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.519 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 10.6 Cg_endo -52.74 129.7 33.78 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.56 2.84 . . . . 53.1 114.048 -168.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.9 pt-20 -53.75 123.02 11.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.33 1.019 . . . . 52.43 110.358 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.41 124.1 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 107.973 -1.121 . . . . 74.31 107.973 -174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -147.95 142.91 26.93 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.381 0.673 . . . . 75.11 109.598 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.55 164.59 21.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.67 0.788 . . . . 51.42 111.012 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.0 m-20 -140.25 144.26 36.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.166 1.386 . . . . 73.52 108.375 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tt -129.2 96.28 4.27 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.027 -1.101 . . . . 74.22 108.027 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.85 158.3 39.86 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.147 0.979 . . . . 74.42 109.156 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -139.63 137.4 35.26 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.02 0.438 . . . . 74.2 110.901 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.69 161.46 21.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.627 1.171 . . . . 62.12 108.377 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 p -146.14 167.44 23.43 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.278 0.231 . . . . 53.45 111.107 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -153.12 135.59 15.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.061 0.944 . . . . 64.23 109.192 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -84.89 132.88 34.33 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.71 0.804 . . . . 71.23 109.408 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -99.13 -41.9 7.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.125 0.57 . . . . 61.11 110.262 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -169.34 3.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.266 0.627 . . . . 70.42 110.871 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.39 119.05 19.73 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.322 -0.854 . . . . 73.34 110.22 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 59.99 21.98 11.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.85 1.26 . . . . 62.21 112.41 -172.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.04 117.28 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.477 1.111 . . . . 75.42 108.376 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -125.52 -177.79 4.02 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.339 0.59 . . . . 72.11 109.914 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -141.94 117.3 10.18 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.114 -1.81 . . . . 71.44 106.114 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.03 131.41 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 110.013 -0.366 . . . . 62.11 110.013 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -103.37 125.82 57.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.447 1.099 . . . . 72.53 109.253 176.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.409 HD22 HG23 ' B' ' 62' ' ' VAL . 0.3 OUTLIER -92.17 122.25 34.47 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.244 -1.391 . . . . 74.14 107.244 169.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -108.22 106.63 16.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.718 0.807 . . . . 74.03 108.849 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.409 HG23 HD22 ' B' ' 60' ' ' LEU . 31.6 t -106.53 122.39 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.806 -0.813 . . . . 63.33 108.806 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.2 m -114.59 152.44 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.354 0.409 . . . . 73.1 109.943 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 39.3 t -129.47 126.11 62.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.818 1.247 . . . . 73.12 107.947 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -109.55 136.1 49.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.766 -1.198 . . . . 70.13 107.766 170.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.483 -0.932 . . . . 72.12 108.483 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -138.69 136.2 35.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.244 0.545 . . . . 61.23 112.201 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.6 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 46.5 mt -95.05 99.05 11.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.742 1.217 . . . . 62.0 108.019 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -129.8 15.58 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 120.016 -0.325 . . . . 45.31 112.517 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -98.86 36.92 1.59 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.973 0.892 . . . . 65.13 108.838 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -153.98 142.95 21.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.656 -0.702 . . . . 72.42 109.396 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -66.07 136.91 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.154 0.582 . . . . 75.34 111.562 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.6 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.83 -60.62 1.77 Allowed 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.105 0.962 . . . . 75.05 109.227 177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.435 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 26.3 p90 -157.6 160.58 38.24 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 113.361 -1.745 . . . . 62.52 108.863 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.6 mt -134.56 115.69 14.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.926 -1.509 . . . . 74.1 106.926 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -115.54 153.78 30.56 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.216 -1.031 . . . . 54.43 108.216 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.45 131.66 3.19 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.556 -0.905 . . . . 74.22 108.556 -174.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -122.63 142.66 38.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.485 -0.932 . . . . 74.11 108.485 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.4 mt-30 -125.29 90.22 3.19 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.462 -0.94 . . . . 62.13 108.462 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -83.79 106.48 15.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.151 -1.386 . . . . 63.31 109.12 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.62 164.28 26.55 Favored Glycine 0 C--O 1.24 0.487 0 O-C-N 123.44 0.463 . . . . 64.41 112.838 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.85 126.86 1.6 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.828 -0.909 . . . . 62.21 110.828 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 20.1 mt -86.05 129.7 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.607 -0.886 . . . . 75.24 108.607 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -134.34 141.76 47.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.953 0.901 . . . . 62.14 108.9 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -116.92 114.04 23.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.645 0.778 . . . . 50.12 109.227 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.55 HD13 HD11 ' B' ' 89' ' ' ILE . 2.7 pp -135.93 149.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.957 0.903 . . . . 71.53 110.645 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.78 172.14 18.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.593 0.757 . . . . 70.14 110.119 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.11 -48.69 0.92 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.962 -0.354 . . . . 73.41 113.98 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.55 HD11 HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -73.23 162.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 117.21 0.505 . . . . 73.11 111.679 -177.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -152.3 153.65 34.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.28 0.632 . . . . 73.15 110.163 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.04 -136.56 25.53 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 123.888 0.756 . . . . 52.21 113.93 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -77.87 -16.98 57.85 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.249 1.02 . . . . 62.42 111.508 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.84 -39.69 59.25 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.682 0.793 . . . . 74.32 111.163 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 14.8 tpt -69.97 -33.66 72.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.79 -1.095 . . . . 54.24 111.746 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.99 70.95 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.985 0.514 . . . . 71.41 111.527 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -73.44 -30.87 63.48 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.769 0.828 . . . . 64.32 111.385 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -79.22 -64.29 1.22 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.2 0.6 . . . . 62.44 110.817 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.64 -43.67 92.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 52.1 110.418 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.93 -2.13 86.47 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 118.788 -1.007 . . . . 74.11 114.992 -170.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.79 -52.38 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.642 1.221 . . . . 62.43 112.299 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -70.76 -44.11 67.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.419 0.287 . . . . 73.4 111.564 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -60.87 -47.89 94.37 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-O 118.765 -0.636 . . . . 74.12 111.593 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -47.48 -50.35 11.54 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.442 2.094 . . . . 75.42 113.967 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.9 -32.21 69.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.264 0.626 . . . . 71.2 112.507 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.427 HG23 ' NH2' ' D' ' 111' ' ' ARG . 60.6 mt -64.7 -48.1 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.484 0.714 . . . . 74.11 110.881 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.03 -9.32 56.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.044 0.938 . . . . 74.33 111.35 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.467 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 20.5 t80 -60.56 -48.56 93.13 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.255 1.422 . . . . 74.34 113.207 -172.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -38.14 54.79 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 121.732 1.622 . . . . 31.22 113.271 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.499 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 90.2 m-85 -61.62 -45.83 92.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.102 0.561 . . . . 72.01 110.602 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.99 94.2 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.095 0.958 . . . . 71.25 111.219 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.477 1.111 . . . . 64.13 111.431 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -37.35 83.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.259 -0.882 . . . . 62.42 110.015 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.8 t -66.16 -39.12 89.55 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.811 -0.631 . . . . 55.32 111.279 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.13 -51.98 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.738 0.415 . . . . 44.21 110.301 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.449 HG23 ' HB2' ' B' ' 125' ' ' GLN . 41.8 m -57.95 -27.36 63.34 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 123.899 0.749 . . . . 64.23 111.269 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -71.24 -62.28 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.35 0.66 . . . . 70.12 110.462 172.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.9 mmt -61.06 -39.97 91.89 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.488 0.715 . . . . 73.24 112.391 -170.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.425 HG11 ' O ' ' B' ' 124' ' ' PRO . 78.5 t -65.82 -43.04 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.611 -0.722 . . . . 73.2 111.144 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 63.2 p -69.65 -25.64 64.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.341 0.4 . . . . 73.34 111.394 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.485 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.1 mtt-85 -65.56 -36.89 85.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.564 -0.744 . . . . 72.34 110.023 174.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -81.13 7.17 60.84 Favored Glycine 0 C--N 1.356 1.69 0 O-C-N 124.04 0.838 . . . . 74.14 112.897 172.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.9 p 54.96 47.64 21.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.562 1.945 . . . . 61.32 111.504 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.529 ' HD2' ' HZ ' ' B' ' 23' ' ' PHE . 29.1 m-85 -120.36 166.62 14.77 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 114.016 -1.447 . . . . 64.2 110.781 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 36.7 Cg_endo -61.44 137.03 67.23 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.915 3.077 . . . . 73.55 115.334 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.541 ' NE2' ' HA ' ' C' ' 124' ' ' PRO . 13.6 pm0 -59.78 154.56 17.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.487 1.115 . . . . 75.1 112.648 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.44 95.96 4.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.079 -1.082 . . . . 44.25 108.079 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.423 HD22 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -92.58 90.62 7.21 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.973 -1.862 . . . . 64.23 105.973 172.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.467 HD22 ' HZ ' ' B' ' 107' ' ' PHE . 1.2 tt -67.88 133.98 50.06 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.414 -0.958 . . . . 54.24 108.414 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.69 107.55 0.85 Allowed Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 124.602 1.189 . . . . 63.31 111.269 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.411 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 95.9 Cg_endo -75.14 88.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.946 2.431 . . . . 63.22 112.494 -170.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.74 149.5 12.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.981 -1.009 . . . . 61.32 110.425 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -111.45 116.25 30.59 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.009 -1.108 . . . . 64.12 108.009 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 123.907 0.883 . . . . 64.02 111.975 -174.595 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.24 0.605 0 N-CA-C 108.538 -0.912 . . . . 64.44 108.538 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.439 ' CD1' ' SG ' ' C' ' 97' ' ' CYS . 2.3 t80 -102.51 127.97 49.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.062 -1.426 . . . . 71.55 108.732 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -141.3 131.09 24.26 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.25 -1.389 . . . . 73.35 107.25 167.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.676 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -68.61 117.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 106.621 -1.622 . . . . 65.14 106.621 168.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -83.99 -50.6 7.86 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.149 -0.478 . . . . 65.33 110.007 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -176.13 133.71 0.25 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.77 0.669 . . . . 64.52 110.37 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.676 HG13 HD11 ' C' ' 13' ' ' ILE . 96.2 mt -115.48 140.06 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.098 -1.075 . . . . 71.32 108.098 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.5 ' HB3' HG23 ' D' ' 122' ' ' THR . 30.5 p90 -177.91 147.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.703 0.401 . . . . 75.32 110.61 -173.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.495 HG21 ' SG ' ' C' ' 113' ' ' CYS . 77.3 p -72.89 121.67 20.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.388 -0.824 . . . . 73.53 109.896 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -76.18 -50.5 14.37 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.949 0.881 . . . . 71.34 108.667 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -135.0 136.96 42.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.763 -1.562 . . . . 73.4 108.952 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.8 mt -131.14 142.16 44.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.258 -1.756 . . . . 74.45 106.258 174.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -151.65 144.51 24.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.643 -0.503 . . . . 64.35 109.643 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -148.69 107.75 3.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.34 -1.356 . . . . 71.11 107.34 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.32 110.69 18.38 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.001 -0.74 . . . . 54.43 109.001 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.04 89.82 14.64 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.369 -0.974 . . . . 54.13 108.369 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.14 -39.67 22.73 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.554 2.169 . . . . 73.0 110.902 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -93.95 30.66 1.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.275 -1.33 . . . . 73.35 111.009 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -57.2 -48.26 97.68 Favored Pre-proline 0 CA--C 1.563 1.46 0 C-N-CA 123.388 0.675 . . . . 71.11 112.461 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.8 Cg_endo -88.42 -22.68 1.23 Allowed 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 122.034 1.823 . . . . 75.2 112.601 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -69.63 -25.48 63.95 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.573 1.149 . . . . 71.33 111.682 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.15 -13.65 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.729 0.811 . . . . 63.43 111.388 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -58.32 -40.55 82.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.213 0.605 . . . . 63.52 111.636 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -102.14 38.9 1.57 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.114 0.566 . . . . 75.43 110.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.479 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -126.65 162.27 26.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.563 0.745 . . . . 70.01 109.9 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.19 120.94 18.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.694 -0.854 . . . . 73.14 108.694 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 p90 -84.37 82.96 8.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.806 0.843 . . . . 60.41 110.943 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -139.67 70.48 37.59 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.854 -0.795 . . . . 75.05 108.854 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' C' ' 40' ' ' VAL . 3.2 Cg_exo -77.37 133.67 13.39 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.978 2.452 . . . . 75.45 112.231 -172.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.95 79.54 8.72 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.939 -1.504 . . . . 71.4 106.939 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.619 HG11 ' HG2' ' C' ' 124' ' ' PRO . 13.8 m -76.02 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.16 -1.382 . . . . 71.3 111.441 -170.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -97.0 136.13 38.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.17 -0.923 . . . . 75.01 110.25 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.592 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -114.43 140.99 48.25 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.656 -0.868 . . . . 61.31 108.656 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.08 119.65 33.96 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.718 0.807 . . . . 55.02 109.207 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.706 ' HG ' HD21 ' C' ' 60' ' ' LEU . 7.7 tt -85.9 114.14 22.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.779 -0.822 . . . . 63.32 108.779 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.456 ' O ' HD23 ' C' ' 60' ' ' LEU . 21.1 t70 -126.65 138.93 53.49 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.251 -1.018 . . . . 73.24 108.251 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -111.93 143.69 42.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.351 0.596 . . . . 72.41 110.541 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.94 150.38 50.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.542 1.137 . . . . 53.42 108.743 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -149.24 151.87 34.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.858 0.463 . . . . 64.53 110.048 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.1 t -160.58 140.42 11.09 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.376 -0.972 . . . . 65.22 108.376 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -86.96 137.55 32.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.916 0.388 . . . . 62.21 110.191 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.667 HD11 HD12 ' C' ' 83' ' ' ILE . 76.9 mt -101.38 -58.56 1.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.99 0.916 . . . . 73.51 109.348 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.74 -174.25 3.78 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.816 -1.084 . . . . 74.32 110.075 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -69.06 126.25 29.22 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.846 -1.07 . . . . 75.01 109.209 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 15.1 m-20 64.15 14.64 8.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.713 1.205 . . . . 75.54 111.898 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.77 104.48 11.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 124.447 1.099 . . . . 71.44 108.9 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.57 165.72 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.011 0.91 . . . . 73.25 110.203 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.02 119.22 27.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.844 -1.525 . . . . 75.14 107.416 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.02 120.03 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.881 -1.155 . . . . 63.42 107.881 172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.404 HG22 ' HA2' ' C' ' 81' ' ' GLY . 90.0 t -106.65 113.49 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.297 -1.001 . . . . 53.14 108.297 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.706 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -84.29 102.79 12.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.337 -1.357 . . . . 74.25 107.337 176.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 3.1 tmm_? -84.31 104.53 14.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.337 -0.986 . . . . 74.31 108.337 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.0 t -101.09 130.07 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.257 -1.016 . . . . 63.51 108.257 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 39.5 m -120.39 126.47 50.56 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.695 -0.854 . . . . 53.31 108.695 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.741 HG21 HG21 ' C' ' 114' ' ' ILE . 40.1 t -99.79 124.28 53.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.333 1.053 . . . . 72.34 109.868 177.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -100.51 143.97 30.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.483 -1.303 . . . . 71.5 107.483 167.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.55 120.93 18.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.469 -1.308 . . . . 74.42 107.469 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.7 m -128.47 156.63 42.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.714 0.769 . . . . 44.43 110.627 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' C' ' 34' ' ' LYS . 22.8 mt -116.94 34.18 5.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.206 -1.405 . . . . 71.22 107.206 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.38 -82.94 0.32 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.924 -1.271 . . . . 70.52 109.924 -169.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.65 -24.77 4.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.873 0.869 . . . . 72.24 109.989 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 7.8 tp10 -67.65 120.5 14.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.93 0.892 . . . . 71.11 110.103 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -74.38 123.17 24.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.711 -0.478 . . . . 45.43 109.711 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.29 -49.54 22.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.502 0.721 . . . . 62.24 109.229 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -166.85 173.37 9.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.891 -1.05 . . . . 72.43 110.183 172.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.432 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -130.24 143.11 50.58 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 106.595 -1.631 . . . . 64.24 106.595 170.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' C' ' 64' ' ' VAL . 43.0 t -144.32 155.28 43.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.552 -0.907 . . . . 63.13 108.552 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -157.41 129.87 7.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.86 0.464 . . . . 74.24 110.165 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.53 115.66 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 62.8 mt-30 -88.6 91.17 8.7 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.614 -1.254 . . . . 41.31 107.614 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -78.07 107.04 10.35 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.546 -0.752 . . . . 62.03 109.725 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -82.04 152.44 31.35 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.874 -0.491 . . . . 42.22 111.874 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.17 118.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.601 -0.999 . . . . 72.31 110.601 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.667 HD12 HD11 ' C' ' 51' ' ' LEU . 10.0 mm -84.55 128.91 38.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.462 -0.94 . . . . 54.41 108.462 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.13 128.49 28.18 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.443 -0.577 . . . . 70.22 109.443 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.3 p -79.38 119.24 22.12 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.573 -0.899 . . . . 71.23 108.573 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.66 120.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.718 0.807 . . . . 73.11 109.761 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -167.32 157.57 11.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.004 0.922 . . . . 74.31 110.711 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.96 -18.7 42.57 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 123.129 0.268 . . . . 52.43 113.709 172.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.594 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.146 0 C-N-CA 124.486 1.114 . . . . 74.55 110.625 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.818 -0.438 . . . . 63.42 109.818 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' C' ' 97' ' ' CYS . 11.2 ptm -78.3 -28.11 47.43 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.979 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.34 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.202 0.525 . . . . 72.24 110.407 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.79 -30.78 51.52 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.426 -0.807 . . . . 75.32 110.681 172.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' C' ' 94' ' ' MET . 48.7 t -81.53 -21.84 38.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.817 1.247 . . . . 73.33 113.521 -169.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.585 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.0 OUTLIER -139.04 -23.73 0.91 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 119.064 0.847 . . . . 64.42 111.997 172.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.51 -30.64 53.05 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 120.141 -0.255 . . . . 73.32 112.897 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.16 -42.11 2.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.017 0.527 . . . . 75.32 110.815 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.524 ' CE1' HG13 ' C' ' 105' ' ' ILE . 10.6 t80 -50.8 -71.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.927 0.891 . . . . 75.45 110.87 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 60.3 m -55.34 -45.81 99.8 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 113.558 -1.656 . . . . 74.3 113.71 -168.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.469 ' HB3' HD21 ' C' ' 44' ' ' LEU . 74.2 Cg_exo -55.78 -45.94 35.27 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.446 1.431 . . . . 73.14 113.313 168.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.81 -25.56 66.51 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.519 0.728 . . . . 53.55 112.649 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.524 HG13 ' CE1' ' C' ' 101' ' ' TYR . 29.3 mm -85.55 -43.29 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.621 0.768 . . . . 74.51 110.611 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.22 -14.32 57.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.935 -0.575 . . . . 55.21 111.032 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.446 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 91.8 t80 -56.53 -54.35 54.39 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 117.705 -1.14 . . . . 71.44 111.761 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' C' ' 105' ' ' ILE . 32.5 Cg_exo -56.37 -40.33 85.36 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.338 2.025 . . . . 55.13 113.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.506 ' HE2' HG21 ' A' ' 115' ' ' THR . 84.2 m-85 -63.55 -52.35 61.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.045 0.938 . . . . 74.5 111.944 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.63 96.51 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 64.22 110.34 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -54.47 -47.85 72.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.973 1.709 . . . . 71.42 111.403 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.432 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -76.93 -37.58 55.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.964 0.505 . . . . 72.11 110.604 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' C' ' 18' ' ' THR . 25.6 t -65.85 -32.58 74.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.042 0.537 . . . . 72.43 111.494 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.741 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -72.31 -51.07 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.716 -0.675 . . . . 54.45 109.545 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m -51.12 -34.75 32.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.614 0.766 . . . . 72.54 111.562 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.9 t -59.4 -61.25 2.76 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.714 -1.13 . . . . 75.34 109.489 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.506 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.28 -45.24 54.27 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.514 1.526 . . . . 74.34 113.148 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.0 t -64.43 -46.71 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 53.23 110.43 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.988 -1.005 . . . . 62.1 111.43 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -69.1 -37.26 78.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.205 0.602 . . . . 72.13 109.861 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 6.7 72.57 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.884 0.74 . . . . 71.31 112.835 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.0 p 65.0 37.89 6.58 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.993 1.717 . . . . 60.43 111.982 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.578 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 60.0 m-85 -107.35 172.65 3.63 Favored Pre-proline 0 CA--C 1.572 1.821 0 C-N-CA 124.897 1.279 . . . . 54.31 109.803 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.619 ' HG2' HG11 ' C' ' 40' ' ' VAL . 73.8 Cg_endo -70.77 179.64 4.09 Favored 'Trans proline' 0 C--N 1.403 3.429 0 C-N-CA 122.49 2.126 . . . . 60.32 114.368 -171.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.405 ' HG2' ' HB3' ' B' ' 125' ' ' GLN . 28.2 mm-40 -60.37 125.73 24.78 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.609 -0.723 . . . . 74.14 112.025 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.41 2.61 36.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.408 0.683 . . . . 62.24 110.346 170.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 43.2 t-20 -88.46 82.8 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.719 -1.586 . . . . 72.34 106.719 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 73.1 mt -89.86 158.27 17.53 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 112.555 -2.111 . . . . 71.14 110.33 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -34.62 130.89 0.45 Allowed Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.854 1.661 . . . . 61.14 114.583 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.571 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 74.1 Cg_endo -71.77 109.01 2.55 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.164 2.576 . . . . 73.14 112.664 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.88 104.73 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.32 109.123 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 103.4 15.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.41 0.684 . . . . 63.42 109.902 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.3 t80 . . . . . 0 N--CA 1.477 0.902 0 C-N-CA 122.614 0.366 . . . . 63.32 111.349 175.565 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.241 0.612 0 N-CA-C 109.273 -0.64 . . . . 74.32 109.273 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -149.02 100.13 3.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.029 -1.471 . . . . 65.14 107.029 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -121.58 150.97 40.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.356 -0.979 . . . . 75.43 108.356 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 tp -102.81 137.16 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.156 -0.683 . . . . 64.53 109.156 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -99.3 -45.47 5.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.549 0.74 . . . . 74.35 109.507 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HD3' HD12 ' D' ' 83' ' ' ILE . 4.8 ptm180 -168.43 147.26 4.35 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.942 0.497 . . . . 73.12 111.104 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.476 HD12 HD23 ' D' ' 106' ' ' LEU . 48.0 mm -115.81 122.76 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 105.958 -1.867 . . . . 72.53 105.958 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 0.3 OUTLIER -155.69 156.27 34.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.098 0.951 . . . . 74.51 111.027 -169.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.403 HG21 HD11 ' D' ' 21' ' ' ILE . 73.3 p -91.86 116.99 29.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.945 -1.48 . . . . 72.23 109.152 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -85.84 -29.52 23.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.493 -0.776 . . . . 75.33 109.419 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.3 t70 -149.76 135.96 18.92 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.803 -1.09 . . . . 75.31 109.574 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.506 HD13 ' HE3' ' C' ' 117' ' ' MET . 60.6 mt -139.37 143.32 31.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.853 -1.165 . . . . 74.32 107.853 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -144.75 144.6 31.27 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.071 0.948 . . . . 52.21 108.861 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.634 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.4 t80 -145.6 129.63 17.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.53 -2.026 . . . . 73.0 105.53 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.3 mt-10 -133.07 136.03 45.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 73.43 108.498 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -131.0 75.27 78.81 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.032 -1.099 . . . . 62.3 108.032 174.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.0 -28.89 18.72 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.776 2.317 . . . . 74.23 112.571 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -114.37 32.76 5.72 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 123.726 0.811 . . . . 73.1 108.959 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -57.65 -58.31 19.23 Favored Pre-proline 0 N--CA 1.483 1.203 0 N-CA-C 114.543 1.312 . . . . 62.44 114.543 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.12 -4.08 13.59 Favored 'Trans proline' 0 C--N 1.381 2.256 0 CA-C-N 121.918 1.721 . . . . 74.14 112.637 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -84.25 -32.36 24.49 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.415 1.486 . . . . 43.32 109.107 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.411 HG13 ' CD1' ' D' ' 68' ' ' LEU . 2.1 t -65.57 -27.66 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.227 1.411 . . . . 63.41 111.952 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -62.43 -14.71 43.61 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 112.717 0.636 . . . . 74.34 112.717 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.908 0.883 . . . . 72.43 110.932 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -84.26 104.28 14.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.715 1.206 . . . . 60.4 109.904 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.34 75.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 74.35 111.763 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.41 ' HZ2' ' H ' ' D' ' 69' ' ' GLY . 1.6 p-90 -170.05 179.69 3.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.006 0.923 . . . . 73.15 109.924 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.626 HE21 ' HD2' ' D' ' 38' ' ' PRO . 37.8 tp60 -78.38 123.83 85.68 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.774 0.829 . . . . 72.35 108.787 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.626 ' HD2' HE21 ' D' ' 37' ' ' GLN . 39.7 Cg_exo -56.28 142.13 88.01 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.815 2.343 . . . . 72.22 115.006 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.16 112.24 2.3 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.652 -0.87 . . . . 74.34 108.652 167.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 22.5 m -103.33 117.29 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.579 0.704 . . . . 64.45 109.983 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -108.41 116.81 32.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.118 0.967 . . . . 74.41 108.756 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' D' ' 63' ' ' THR . 6.6 mp -104.64 135.72 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.283 0.364 . . . . 70.22 110.361 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.48 135.28 50.74 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.411 -0.813 . . . . 71.12 108.87 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 tt -96.55 127.15 42.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.893 -1.151 . . . . 60.33 107.893 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.2 t70 -150.05 155.73 40.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.432 -0.951 . . . . 63.02 108.432 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.4 t -139.6 160.92 38.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.347 0.594 . . . . 65.0 110.167 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.69 176.74 10.1 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.019 1.328 . . . . 74.3 107.79 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' D' ' 56' ' ' TYR . 78.2 p -172.98 165.94 5.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.526 0.565 . . . . 74.13 112.526 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 4.4 m -152.11 140.72 20.77 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.017 0.927 . . . . 75.43 109.484 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -83.53 118.24 23.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.315 -0.995 . . . . 61.41 108.315 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' D' ' 57' ' ' GLU . 22.0 mt -99.79 -29.3 12.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.906 0.482 . . . . 64.0 110.177 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -165.13 -172.75 2.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.589 0.756 . . . . 54.32 111.029 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -71.41 120.24 16.71 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.979 -1.009 . . . . 64.1 109.082 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 62.28 18.08 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.47 1.108 . . . . 71.45 111.276 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 74.0 t -121.22 121.65 65.4 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 107.009 -1.478 . . . . 75.35 107.009 174.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' D' ' 48' ' ' SER . 12.4 t80 -144.64 128.27 17.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.909 -0.775 . . . . 73.5 108.909 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.4 tt0 -88.11 131.27 34.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.625 -0.88 . . . . 63.32 108.625 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.06 123.61 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.096 -1.446 . . . . 75.23 107.096 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.612 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 27.1 t -100.67 139.61 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 73.14 109.178 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.543 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -111.98 126.54 55.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.976 -1.12 . . . . 71.52 107.976 175.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.5 ttm-85 -102.92 101.62 11.65 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.715 -0.846 . . . . 70.14 108.715 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.9 t -102.91 121.85 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.706 -0.85 . . . . 34.41 108.706 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 23.7 m -125.7 130.92 52.51 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.397 0.679 . . . . 73.45 109.636 -171.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.489 HG21 HG21 ' D' ' 114' ' ' ILE . 32.1 t -120.8 103.66 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.677 1.191 . . . . 53.12 109.324 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -100.54 96.52 7.43 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.375 -0.972 . . . . 71.44 108.375 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 143.11 27.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.46 -0.791 . . . . 71.2 109.328 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.6 p -151.46 130.47 12.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.403 0.439 . . . . 44.54 111.867 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' D' ' 31' ' ' VAL . 21.3 mt -107.06 108.6 20.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.037 0.935 . . . . 61.42 110.283 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . 0.41 ' H ' ' HZ2' ' D' ' 36' ' ' TRP . . . 78.12 -115.15 4.14 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.562 -0.615 . . . . 74.21 111.562 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 4.51 15.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.909 0.884 . . . . 64.32 110.598 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -116.14 161.89 18.26 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.786 -0.45 . . . . 54.05 109.786 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.5 m -71.54 133.86 46.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.537 -0.756 . . . . 63.33 110.572 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.88 -64.91 1.07 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.441 -0.948 . . . . 45.13 108.441 173.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -156.15 147.7 22.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.4 -0.818 . . . . 75.41 109.971 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.1 mt -100.39 153.94 18.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.853 0.861 . . . . 73.33 108.952 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.6 t -159.31 143.72 15.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.284 0.633 . . . . 73.13 109.651 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.39 128.54 7.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.108 0.563 . . . . 65.14 109.845 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.455 HG22 HG23 ' D' ' 21' ' ' ILE . 88.0 t -127.46 114.66 37.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 123.98 0.912 . . . . 73.33 109.017 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.649 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.6 mt-30 -89.54 86.36 6.73 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.838 0.828 . . . . 70.35 108.879 170.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.433 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.8 tp-100 -79.73 98.9 7.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.969 -1.468 . . . . 72.42 108.66 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.5 154.91 23.71 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.822 -0.511 . . . . 73.13 111.822 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -149.18 131.16 3.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.695 -0.962 . . . . 54.15 110.695 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' D' ' 15' ' ' ARG . 59.3 mt -94.97 109.02 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.398 -0.594 . . . . 73.55 109.398 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -110.53 126.64 54.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.484 0.714 . . . . 72.2 110.385 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -79.56 97.19 6.37 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.735 -0.839 . . . . 75.24 108.735 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.68 130.24 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.224 0.61 . . . . 72.13 110.803 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.76 153.63 14.93 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.779 0.832 . . . . 65.52 109.945 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.96 5.39 86.19 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.393 -0.367 . . . . 74.02 113.302 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -119.32 126.33 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.898 0.879 . . . . 70.42 109.465 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 174.38 10.68 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 122.046 -0.409 . . . . 73.15 111.215 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -139.79 39.53 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.934 0.772 . . . . 71.23 113.358 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.9 p -69.27 -32.33 71.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.641 0.776 . . . . 52.42 111.464 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.22 -40.99 96.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.745 . . . . 71.23 110.619 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -68.6 -55.86 10.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 74.53 110.754 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.64 69.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.453 0.701 . . . . 53.14 112.089 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -85.59 -35.36 21.07 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.466 0.707 . . . . 73.43 110.655 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -66.29 -41.83 89.22 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.662 0.268 . . . . 75.05 110.29 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 tt -78.06 -35.18 49.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.207 0.603 . . . . 74.43 110.065 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.42 -3.32 81.7 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.353 -0.693 . . . . 50.31 114.448 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -57.28 0.43 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 117.974 0.887 . . . . 73.05 111.818 -176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -72.37 -41.77 66.0 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 112.288 0.477 . . . . 71.44 112.288 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 69.8 m -66.76 -44.97 55.11 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.109 0.564 . . . . 51.2 111.088 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.543 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.9 Cg_exo -55.73 -35.55 93.5 Favored 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.491 2.127 . . . . 55.12 113.402 165.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.48 -29.96 70.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.911 0.484 . . . . 54.41 111.161 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -68.35 -38.49 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.087 0.555 . . . . 64.32 109.619 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.476 HD23 HD12 ' D' ' 16' ' ' ILE . 94.3 mt -79.14 -22.9 44.44 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.311 1.045 . . . . 62.15 112.589 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -66.21 -40.8 38.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.161 1.171 . . . . 75.4 114.161 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.74 -39.23 92.36 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.054 1.836 . . . . 50.32 113.296 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -79.44 -33.17 42.72 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.895 0.878 . . . . 74.13 110.799 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.85 68.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.562 0.745 . . . . 72.25 109.899 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.427 ' NH2' HG23 ' B' ' 105' ' ' ILE . 27.6 ttp180 -52.39 -54.27 34.07 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.226 -1.352 . . . . 74.2 110.553 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.403 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.9 tm-20 -60.34 -45.45 93.4 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.472 1.107 . . . . 75.33 111.687 -175.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.439 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 42.7 t -54.82 -44.74 74.13 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.016 0.822 . . . . 73.33 110.961 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.489 HG21 HG21 ' D' ' 64' ' ' VAL . 77.0 mt -66.33 -53.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.203 -0.908 . . . . 50.13 110.885 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 54.0 m -53.85 -41.5 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.67 1.188 . . . . 65.41 111.567 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -67.57 -44.7 77.59 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 114.712 -1.131 . . . . 73.12 110.08 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.58 -32.58 74.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.977 0.511 . . . . 73.43 111.808 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.4 t -64.14 -46.51 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.298 0.639 . . . . 52.43 109.474 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -73.61 -27.78 61.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.704 -0.68 . . . . 62.44 111.35 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.24 -28.79 63.38 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.542 0.737 . . . . 74.04 110.118 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.04 10.06 70.0 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 123.83 0.706 . . . . 74.43 112.302 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.5 HG23 ' HB3' ' C' ' 17' ' ' TYR . 71.7 p 58.46 18.87 5.99 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.624 1.97 . . . . 71.04 113.691 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -86.58 152.07 54.0 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.889 -0.782 . . . . 54.14 108.889 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.05 133.02 55.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.732 2.288 . . . . 72.01 112.667 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -49.82 139.15 13.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.611 1.195 . . . . 65.42 112.376 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -120.35 102.4 8.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.822 . . . . 62.54 108.904 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -99.21 100.83 11.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.777 -0.823 . . . . 73.23 108.777 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 55.4 mt -72.02 136.0 46.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.616 0.572 . . . . 75.13 110.137 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.01 81.79 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.262 0.625 . . . . 64.24 110.998 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.39 96.79 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.407 2.071 . . . . 51.02 110.259 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -108.15 124.83 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.279 0.561 . . . . 71.42 110.153 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 108.375 -0.972 . . . . 73.21 108.375 174.554 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 109.344 -0.613 . . . . 65.01 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.485 ' HD2' HG22 ' A' ' 86' ' ' ILE . 36.2 t80 -121.32 130.01 53.41 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.767 -1.197 . . . . 72.3 107.767 166.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -144.52 123.39 12.7 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.997 0.186 . . . . 63.43 111.37 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.402 HD11 HG13 ' A' ' 16' ' ' ILE . 6.8 tp -68.7 130.95 34.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.956 -0.757 . . . . 63.55 108.956 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 28.1 mm-40 -110.62 -39.97 4.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.928 -0.578 . . . . 65.04 109.919 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 27.1 ttt180 -173.58 144.29 1.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 119.871 -0.109 . . . . 74.21 110.755 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.556 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 71.7 mt -123.01 132.31 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.535 -1.283 . . . . 61.02 107.535 170.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 15.4 p90 -156.73 155.45 31.68 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.416 0.686 . . . . 73.5 110.633 -174.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -88.52 109.39 20.02 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.851 -0.613 . . . . 72.31 109.697 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -72.4 -32.53 66.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.165 0.507 . . . . 74.44 109.985 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.72 142.84 27.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.961 -1.018 . . . . 72.23 109.537 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.47 137.88 53.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.665 -1.605 . . . . 75.2 106.665 169.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -144.41 136.54 26.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.925 -0.769 . . . . 74.14 108.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.601 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.5 t80 -142.32 112.19 6.86 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 106.939 -1.504 . . . . 74.13 106.939 175.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 46.7 mt-10 -118.67 108.45 14.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.98 -0.748 . . . . 63.22 108.98 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.95 81.95 2.87 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.479 -1.304 . . . . 72.44 107.479 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.31 -19.07 20.04 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.153 1.902 . . . . 71.44 111.694 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 45.7 m-80 -120.65 38.5 4.0 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.014 0.925 . . . . 72.15 109.181 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.66 -44.47 99.5 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.073 -0.967 . . . . 74.11 112.632 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.85 -28.96 67.61 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.394 1.533 . . . . 73.54 112.856 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.1 m170 -82.19 -26.31 33.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.543 0.737 . . . . 64.41 112.158 -169.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG23 HD11 ' A' ' 68' ' ' LEU . 7.3 p -63.9 -19.2 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.202 0.525 . . . . 72.43 111.807 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -83.29 -39.78 20.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.725 0.81 . . . . 75.03 110.998 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.79 -28.22 58.29 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.92 0.488 . . . . 75.21 110.724 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.68 160.87 22.31 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.284 0.634 . . . . 74.55 110.099 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.32 144.88 26.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.245 -0.65 . . . . 60.1 109.245 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.2 t-105 -75.77 89.01 2.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.66 0.784 . . . . 64.44 110.557 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.3 tt0 -122.36 77.09 44.31 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 107.718 -1.215 . . . . 72.2 107.718 169.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -84.97 145.89 10.09 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.486 2.124 . . . . 43.23 113.174 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -98.86 104.61 16.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.19 -1.411 . . . . 65.14 107.19 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 t -80.64 116.14 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.802 0.841 . . . . 74.34 108.881 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 59.2 tttm -120.35 113.99 21.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.713 0.805 . . . . 70.04 109.391 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.681 HD21 HD22 ' A' ' 128' ' ' LEU . 10.5 mp -104.87 125.74 51.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.968 -0.752 . . . . 72.35 108.968 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.646 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.3 m-20 -117.05 128.57 55.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.175 -1.046 . . . . 64.41 108.175 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -115.2 121.02 41.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.263 0.625 . . . . 71.52 109.69 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -138.86 154.57 48.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.208 1.003 . . . . 74.43 109.037 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -140.05 153.2 46.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.487 0.715 . . . . 52.51 109.484 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.38 113.28 6.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.015 -0.735 . . . . 63.13 109.015 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.2 p -90.07 165.58 13.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.711 0.404 . . . . 74.45 110.33 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 47.8 t -166.46 157.34 12.64 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.227 1.011 . . . . 61.32 108.568 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.63 132.8 55.62 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.899 -0.778 . . . . 74.23 108.899 169.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 57' ' ' GLU . 70.3 mt -105.52 -37.45 6.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.885 0.874 . . . . 74.44 110.405 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.49 -175.14 5.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.727 0.811 . . . . 52.41 109.82 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.31 104.71 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.046 0.538 . . . . 62.31 110.398 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 70.82 10.11 6.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.742 1.617 . . . . 65.33 112.432 176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.07 112.42 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.0 -1.482 . . . . 52.04 107.0 170.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -117.74 150.18 39.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.502 0.721 . . . . 74.01 109.403 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 33.2 tt0 -111.11 118.31 35.66 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.48 -0.933 . . . . 71.13 108.48 171.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.8 115.57 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.916 -1.142 . . . . 73.34 107.916 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.629 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 53.7 t -98.01 137.52 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.387 0.675 . . . . 65.41 109.323 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.96 110.1 21.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.053 -1.462 . . . . 72.31 107.053 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -101.39 101.62 12.28 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.806 -0.813 . . . . 72.01 108.806 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -94.6 140.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.746 -1.205 . . . . 74.33 107.746 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 m -128.33 144.49 51.14 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.666 -0.864 . . . . 74.43 108.666 171.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 35.1 t -142.06 109.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.489 1.116 . . . . 32.21 108.543 -171.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -109.63 137.94 46.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.538 -0.541 . . . . 70.22 109.538 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.36 120.48 34.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.625 -1.25 . . . . 61.2 107.625 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -130.52 131.7 45.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.611 . . . . 74.44 110.866 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 31' ' ' VAL . 49.6 mt -87.12 83.64 7.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.02 1.328 . . . . 74.21 107.852 177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.93 -89.47 0.77 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.768 -0.651 . . . . 53.51 111.88 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.41 -28.67 9.24 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.771 0.828 . . . . 53.31 110.866 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.17 117.15 29.38 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.907 0.483 . . . . 74.25 111.144 -171.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -66.95 110.38 3.32 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.117 0.484 . . . . 74.33 112.021 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.73 -57.01 14.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.796 1.239 . . . . 73.12 110.221 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.21 173.6 16.73 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.732 0.777 . . . . 71.1 111.986 175.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 64.1 tp -141.25 144.04 34.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.504 1.522 . . . . 74.45 107.837 174.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -140.61 125.04 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.36 1.064 . . . . 63.44 108.769 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.99 116.52 8.09 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.929 0.491 . . . . 72.25 109.725 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.78 111.76 26.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.105 0.962 . . . . 72.23 109.021 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.05 79.66 9.55 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.027 -1.101 . . . . 73.23 108.027 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.44 90.29 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.931 1.292 . . . . 73.5 108.699 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.55 144.23 19.65 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 116.064 -0.516 . . . . 75.43 112.119 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.83 130.26 4.81 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 111.791 -0.524 . . . . 52.03 111.791 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 39.2 mt -82.14 125.27 39.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.53 -0.915 . . . . 74.3 108.53 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 21.0 m-85 -131.51 119.45 21.56 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.895 -1.15 . . . . 65.52 107.895 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -79.03 99.83 7.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.977 -0.749 . . . . 72.1 108.977 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.485 HG22 ' HD2' ' A' ' 11' ' ' PHE . 2.7 pp -112.61 153.48 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.354 0.662 . . . . 74.32 110.408 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.88 158.05 7.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.85 0.86 . . . . 73.14 110.231 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.1 -10.36 60.93 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 114.929 0.732 . . . . 75.41 114.929 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.32 138.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.244 0.618 . . . . 72.5 109.469 -179.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 12.8 tt0 -148.21 175.7 10.84 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.535 -0.913 . . . . 73.55 108.535 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 63.45 -133.61 41.88 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.098 0.249 . . . . 64.22 112.953 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -73.43 -21.7 60.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.976 0.511 . . . . 53.31 111.113 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -71.14 -41.19 70.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 74.41 110.169 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.7 ttt -74.01 -38.8 63.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.681 -0.69 . . . . 63.13 109.936 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.21 69.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.648 -0.705 . . . . 75.52 111.545 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -77.12 -38.51 52.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.408 0.683 . . . . 63.33 109.964 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.4 -66.83 0.53 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.502 0.502 . . . . 72.02 110.649 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -82.24 -10.96 58.94 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.017 0.747 . . . . 72.03 113.017 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.97 2.99 25.69 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 118.947 -0.919 . . . . 74.3 114.469 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.23 -58.47 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.583 1.191 . . . . 64.35 112.051 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.473 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.9 t80 -67.06 -51.51 53.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.988 0.915 . . . . 75.5 111.737 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.0 m -71.73 -37.69 5.5 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.249 -0.882 . . . . 41.22 112.084 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.3 -39.57 72.27 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.911 1.741 . . . . 55.34 113.002 161.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.06 -24.27 61.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.619 0.768 . . . . 62.14 111.132 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 16' ' ' ILE . 47.8 mm -64.79 -43.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 109.149 -0.686 . . . . 53.5 109.149 169.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 82' ' ' GLY . 47.3 mt -75.8 -25.48 56.42 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.988 -1.006 . . . . 64.34 111.769 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -64.41 -40.35 50.23 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 114.381 1.252 . . . . 63.12 114.381 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.55 -31.57 86.97 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 121.873 1.716 . . . . 73.31 113.502 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -87.64 -29.91 20.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.549 0.74 . . . . 72.53 111.001 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.9 86.06 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.725 -0.843 . . . . 74.44 108.725 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.432 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -62.45 -44.44 96.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.362 1.065 . . . . 73.3 110.029 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' HH12 ' B' ' 120' ' ' ARG . 10.4 tt0 -49.66 -54.28 19.53 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.278 1.031 . . . . 71.04 110.927 176.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.14 -42.95 88.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.566 -1.197 . . . . 61.13 111.561 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 97.2 mt -67.01 -62.58 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.911 0.485 . . . . 72.13 110.415 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 125' ' ' GLN . 57.9 m -48.96 -35.37 14.97 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.004 1.322 . . . . 75.41 111.986 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.5 t -71.13 -49.65 41.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.027 -0.511 . . . . 42.3 110.875 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.601 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 58.5 mtm -56.33 -42.89 78.41 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.06 0.457 . . . . 71.14 110.847 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 114' ' ' ILE . 69.3 t -61.12 -49.16 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.912 1.285 . . . . 63.41 110.633 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.7 -30.96 68.73 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.615 0.366 . . . . 64.44 111.385 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.5 mtt-85 -71.08 -30.76 66.96 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.928 0.891 . . . . 72.53 110.532 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.0 6.34 49.47 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.021 -0.536 . . . . 53.12 113.507 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.454 ' HB ' HH21 ' B' ' 15' ' ' ARG . 37.8 m 74.06 7.84 4.76 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 125.413 1.485 . . . . 65.41 111.054 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.429 ' HE1' HG21 ' A' ' 31' ' ' VAL . 89.0 m-85 -81.71 159.02 67.39 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 123.493 0.717 . . . . 64.53 109.163 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.06 161.57 45.3 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.475 2.117 . . . . 65.44 111.614 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.5 tt0 -67.54 132.68 48.03 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.854 0.359 . . . . 74.33 110.551 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -111.69 106.62 15.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.93 0.892 . . . . 74.33 109.134 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.97 90.79 4.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.546 . . . . 63.51 110.335 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.681 HD22 HD21 ' A' ' 42' ' ' LEU . 48.4 mt -74.57 116.51 15.34 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.586 -0.894 . . . . 74.22 108.586 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 141.58 97.29 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 122.068 0.147 . . . . 53.34 111.242 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.12 121.23 8.63 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.193 1.928 . . . . 45.24 110.341 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 86.5 t -98.14 109.06 23.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.803 -1.184 . . . . 62.22 107.803 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.5 91.71 6.76 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.657 -1.156 . . . . 51.31 108.238 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.477 0.875 0 CA-C-N 114.945 -1.025 . . . . 71.4 110.814 -178.648 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 110.176 -0.305 . . . . 63.01 110.176 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -139.44 134.0 31.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.273 -1.01 . . . . 73.21 108.273 171.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -149.62 108.35 3.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.251 -0.648 . . . . 74.12 109.251 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -78.47 133.97 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.524 0.73 . . . . 65.14 109.309 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -105.6 -50.09 3.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.674 0.39 . . . . 63.12 110.925 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.454 HH21 ' HB ' ' A' ' 122' ' ' THR . 45.9 ttt180 -159.99 146.34 15.86 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.456 0.17 . . . . 71.1 110.963 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.1 143.02 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.067 -1.457 . . . . 71.03 107.067 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.405 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.1 p90 -171.29 141.87 1.65 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 118.741 0.701 . . . . 73.13 111.198 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.6 m -74.15 118.55 17.24 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.739 -0.837 . . . . 74.14 108.739 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -86.71 -33.05 20.14 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.997 0.519 . . . . 74.05 110.524 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -158.21 143.46 16.63 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.867 0.321 . . . . 75.05 111.867 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 44.3 mm -131.88 142.35 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.823 1.249 . . . . 75.02 108.977 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.99 134.86 28.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.397 -0.964 . . . . 64.33 108.397 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -148.7 127.86 12.87 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 107.047 -1.464 . . . . 75.44 107.047 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.7 112.25 9.98 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.081 -1.081 . . . . 55.3 108.081 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -109.75 89.54 7.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.787 0.835 . . . . 73.43 108.954 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.7 -27.56 38.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.092 1.861 . . . . 72.45 111.696 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -113.82 29.44 8.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.626 0.77 . . . . 64.12 110.463 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -47.3 -48.45 55.85 Favored Pre-proline 0 CA--C 1.574 1.896 0 C-N-CA 124.905 1.282 . . . . 74.45 113.008 170.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.42 -25.48 3.8 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.044 1.83 . . . . 71.12 113.396 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.54 1.7 44.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.411 0.684 . . . . 73.41 111.923 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.47 -14.18 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.471 1.108 . . . . 44.14 111.237 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.09 -42.12 93.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.916 0.886 . . . . 72.53 110.408 169.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -75.56 -40.67 56.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.306 1.042 . . . . 72.33 110.289 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 32.1 mmtp -108.37 67.96 0.68 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.392 -1.276 . . . . 74.04 109.521 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.37 75.64 7.65 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.116 -0.947 . . . . 72.51 111.078 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -169.61 170.95 7.82 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 126.098 1.759 . . . . 75.33 109.637 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.494 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 54.1 tt0 -67.57 122.06 81.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 123.318 0.647 . . . . 73.25 110.404 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.31 151.41 80.76 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.92 2.413 . . . . 62.45 113.377 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.41 106.63 6.11 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.836 -0.802 . . . . 74.12 108.836 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.77 131.94 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.242 1.017 . . . . 73.24 110.803 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -124.43 143.1 50.82 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.992 -0.744 . . . . 70.24 108.992 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.602 HD22 HD11 ' B' ' 126' ' ' LEU . 1.0 OUTLIER -129.3 140.99 51.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.881 0.372 . . . . 71.53 110.829 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.49 145.13 49.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.372 1.069 . . . . 75.15 109.558 -168.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 31.0 tp -93.96 131.82 39.04 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.4 0.68 . . . . 64.44 109.719 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.48 124.38 28.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.971 0.908 . . . . 75.44 108.695 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.4 m -112.55 113.95 26.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.758 0.423 . . . . 32.43 110.169 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.95 149.03 39.42 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.774 -1.195 . . . . 74.24 107.774 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -143.15 173.03 11.93 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.84 0.352 . . . . 74.12 110.544 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.3 p -157.32 173.99 16.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.383 1.073 . . . . 70.31 108.948 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -124.58 121.72 35.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.674 0.39 . . . . 73.24 110.566 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 70.8 mt -80.57 -44.35 19.16 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.158 0.583 . . . . 61.34 111.126 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 -173.2 4.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.917 0.887 . . . . 74.13 109.746 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -61.72 112.77 2.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.433 -0.803 . . . . 74.31 110.277 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.52 0.28 3.19 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.922 1.689 . . . . 63.13 112.745 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.66 92.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 N-CA-C 107.543 -1.28 . . . . 74.22 107.543 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.26 171.05 8.96 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.29 0.636 . . . . 64.32 109.837 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.483 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 5.0 tm-20 -143.72 101.2 3.72 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.281 -1.377 . . . . 74.02 107.281 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.3 122.57 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.5 0.72 . . . . 64.2 110.304 -174.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 41.2 t -102.38 114.52 42.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.508 0.723 . . . . 73.54 109.532 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.5 OUTLIER -92.16 106.87 18.79 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.714 -1.217 . . . . 71.44 107.714 178.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -95.18 116.41 28.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.252 -0.647 . . . . 63.44 109.252 170.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.0 t -105.43 120.88 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.292 -1.374 . . . . 72.14 107.292 164.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -96.51 146.84 24.44 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 52.12 109.0 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.651 HG21 HG21 ' B' ' 114' ' ' ILE . 41.6 t -134.7 128.66 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.816 0.846 . . . . 71.21 109.461 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.5 m -123.61 138.78 54.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.111 -0.949 . . . . 73.51 108.543 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.71 149.82 37.75 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.498 0.719 . . . . 32.45 109.205 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.1 p -143.94 137.74 28.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.708 0.63 . . . . 64.35 110.25 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 38.8 mt -90.9 98.73 11.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.077 -1.823 . . . . 53.14 106.077 170.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.63 -129.68 14.09 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.538 -0.755 . . . . 65.15 111.686 -169.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -92.75 2.83 56.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.054 0.941 . . . . 74.42 111.021 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -115.65 138.09 51.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.244 1.018 . . . . 74.24 109.02 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 132.7 49.85 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.317 0.58 . . . . 65.33 111.846 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.477 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.87 -58.65 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.376 1.071 . . . . 73.24 109.073 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -157.82 157.03 32.53 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.275 -1.329 . . . . 74.1 110.544 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.3 mt -135.18 110.71 9.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 106.673 -1.603 . . . . 72.55 106.673 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.95 157.86 25.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.357 -0.608 . . . . 50.44 109.357 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -164.6 135.08 4.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.979 -0.749 . . . . 52.55 108.979 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.92 139.83 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.546 -0.752 . . . . 71.24 109.086 173.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -122.66 89.13 3.06 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.489 -0.93 . . . . 74.54 108.489 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.36 101.23 12.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.2 -1.037 . . . . 64.41 108.2 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.5 159.32 28.27 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.24 -0.744 . . . . 61.43 111.24 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.92 129.36 2.38 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 112.002 -0.439 . . . . 30.51 112.002 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.405 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.2 mt -85.15 124.13 39.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.578 -0.897 . . . . 74.45 108.578 174.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -136.33 158.11 45.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.162 0.985 . . . . 75.32 108.883 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -130.93 114.8 15.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.344 -0.613 . . . . 60.33 109.344 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.501 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.72 143.02 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.384 0.673 . . . . 74.12 110.003 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.03 167.86 29.19 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.98 0.912 . . . . 73.51 109.099 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.47 -70.19 1.22 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.847 -0.501 . . . . 72.4 111.847 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.431 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -57.62 141.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.823 0.449 . . . . 53.11 110.623 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 31.0 tt0 -151.4 154.24 36.26 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.93 0.332 . . . . 75.52 110.593 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.21 -124.33 13.52 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.389 0.431 . . . . 71.34 112.7 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.6 m -65.76 -32.33 73.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.61 0.764 . . . . 75.34 110.121 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -69.38 -36.45 76.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.804 0.842 . . . . 52.41 110.512 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.4 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 18.0 ttt -72.6 -45.6 58.28 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.96 -0.385 . . . . 64.51 109.96 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.92 66.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.87 0.468 . . . . 54.14 112.057 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -73.36 -33.2 64.94 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.686 0.794 . . . . 75.42 110.806 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -86.26 -67.42 0.81 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.284 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 16.8 tp -61.15 -32.36 72.08 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.597 1.159 . . . . 71.1 112.709 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.73 1.97 52.56 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.354 -0.692 . . . . 63.12 114.663 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.96 -52.2 0.33 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.904 0.852 . . . . 61.32 111.492 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -73.63 -46.8 44.62 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.017 0.527 . . . . 63.02 111.993 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.412 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 78.8 m -63.41 -44.16 81.36 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 118.814 -0.612 . . . . 63.54 111.207 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.7 Cg_exo -59.96 -36.53 89.69 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.893 1.729 . . . . 73.34 113.396 164.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.7 -31.04 71.16 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 122.835 0.454 . . . . 72.41 111.432 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.453 HG23 ' NH2' ' D' ' 111' ' ' ARG . 94.7 mt -61.41 -50.76 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.913 0.885 . . . . 75.42 109.964 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.439 ' HB2' HD12 ' B' ' 60' ' ' LEU . 46.4 mt -77.58 -11.51 59.87 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.487 1.115 . . . . 72.52 112.135 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -69.24 -44.06 26.02 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.883 1.273 . . . . 70.12 113.621 -165.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.64 -34.47 51.46 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 121.568 1.512 . . . . 75.21 112.344 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -63.71 -41.67 98.06 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.715 0.634 . . . . 75.44 110.136 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -69.03 -42.76 75.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.447 -0.797 . . . . 73.12 110.325 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -57.24 -54.71 43.7 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.643 1.177 . . . . 52.52 111.776 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.08 -38.81 91.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.176 0.99 . . . . 73.32 110.395 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.49 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -67.65 -32.91 73.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.6 -0.727 . . . . 71.54 111.78 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.651 HG21 HG21 ' B' ' 64' ' ' VAL . 74.5 mt -65.52 -55.64 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.466 -0.568 . . . . 63.24 109.466 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 5.0 m -56.93 -32.17 65.71 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.277 0.986 . . . . 62.44 110.983 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.62 -53.2 51.42 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.484 -1.235 . . . . 63.12 110.747 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.1 mmt -67.68 -32.01 72.38 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.663 0.385 . . . . 74.51 111.703 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.13 -42.75 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.237 1.015 . . . . 73.0 110.688 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.03 -25.32 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.94 0.496 . . . . 64.31 111.739 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 116' ' ' SER . 80.8 mtt-85 -66.85 -38.58 86.63 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.799 0.439 . . . . 75.51 109.848 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.41 4.21 56.37 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.263 -0.88 . . . . 73.41 113.148 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 66.8 p 59.44 50.73 7.25 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.921 1.688 . . . . 72.01 112.035 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -120.41 158.53 50.92 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.684 1.194 . . . . 72.25 109.795 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.494 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.2 Cg_exo -72.37 -174.65 1.49 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.57 2.847 . . . . 63.51 115.435 -166.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -58.85 130.66 48.05 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.839 -1.528 . . . . 74.23 112.118 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.602 HD11 HD22 ' B' ' 42' ' ' LEU . 59.0 tp -138.64 83.83 1.98 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.669 -1.234 . . . . 42.11 107.669 171.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.663 -1.236 . . . . 75.44 107.663 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.5 tt -87.0 130.62 34.38 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.581 -0.896 . . . . 75.0 108.581 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.43 34.76 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.236 0.615 . . . . 73.44 110.466 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.429 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 45.1 Cg_endo -67.06 131.86 26.45 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.192 1.928 . . . . 74.33 110.984 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.89 143.79 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 122.957 0.503 . . . . 63.45 110.384 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -86.99 111.83 21.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.735 0.814 . . . . 62.14 109.24 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.481 1.119 0 C-N-CA 123.95 0.9 . . . . 72.14 111.43 -177.395 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 107.711 -1.218 . . . . 75.3 107.711 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.602 ' HA ' HG22 ' C' ' 86' ' ' ILE . 41.5 t80 -125.99 120.1 29.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.11 0.564 . . . . 75.23 109.841 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -139.02 128.94 25.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.64 0.376 . . . . 61.35 110.066 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.421 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.6 tp -80.99 136.83 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.388 -0.597 . . . . 70.55 109.388 170.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.65 -49.7 3.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.46 0.704 . . . . 73.21 110.17 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -160.73 136.47 8.16 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.144 -0.48 . . . . 74.01 110.313 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.83 143.52 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.338 -1.356 . . . . 73.54 107.338 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -171.5 162.66 6.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.33 0.586 . . . . 72.21 110.754 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -83.8 113.64 21.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.456 -0.793 . . . . 64.32 109.137 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -64.76 -46.9 80.23 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.987 -1.116 . . . . 72.22 107.987 167.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -142.8 141.61 31.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.42 -1.718 . . . . 71.44 109.791 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -140.73 143.43 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.388 -1.708 . . . . 53.22 106.388 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -155.69 151.6 27.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.745 0.418 . . . . 53.43 110.117 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -155.62 121.49 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.769 -1.197 . . . . 52.31 107.769 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.36 136.61 54.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.374 0.67 . . . . 61.15 109.804 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.59 77.93 8.56 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.843 -1.169 . . . . 63.04 107.843 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.53 -9.75 23.09 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.371 2.047 . . . . 61.1 111.943 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -109.38 19.43 19.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.716 1.206 . . . . 73.33 110.213 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -51.72 -49.8 81.13 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 124.903 1.281 . . . . 74.43 113.475 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.95 -30.12 1.43 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.421 1.414 . . . . 73.45 113.31 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -69.41 -28.06 65.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.524 0.729 . . . . 63.05 111.955 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.87 -12.29 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.217 0.607 . . . . 74.0 111.411 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.88 -31.67 72.74 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.888 0.875 . . . . 74.25 111.261 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.7 20.83 17.96 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.4 0.68 . . . . 61.02 110.146 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.812 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -100.83 158.27 16.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.095 0.558 . . . . 73.34 109.887 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -77.44 121.32 23.67 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.281 -1.007 . . . . 71.03 108.281 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -85.0 91.15 8.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.598 0.713 . . . . 74.0 110.434 -172.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -131.32 69.66 82.0 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.559 -1.2 . . . . 71.43 108.239 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.56 104.65 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.655 2.236 . . . . 63.14 111.933 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -86.99 118.01 26.08 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.753 -0.832 . . . . 61.55 108.753 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.467 HG11 HD21 ' C' ' 126' ' ' LEU . 48.2 t -80.2 128.29 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 74.33 111.448 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.36 104.31 7.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.688 1.195 . . . . 72.13 107.865 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.511 HD23 HD12 ' C' ' 128' ' ' LEU . 0.3 OUTLIER -86.65 165.83 15.83 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.838 0.352 . . . . 75.31 110.407 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.692 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -138.35 146.25 42.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.384 -1.339 . . . . 75.53 107.384 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.7 tp -138.2 102.26 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.921 -0.77 . . . . 72.3 108.921 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 7.1 m-20 -120.09 142.32 48.99 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.427 0.691 . . . . 73.12 109.758 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -114.88 117.56 31.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.137 -0.69 . . . . 63.03 109.137 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.92 153.9 24.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.718 -1.216 . . . . 54.14 107.718 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.3 p -164.34 154.17 14.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.934 0.397 . . . . 70.12 111.328 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 15.5 p -170.34 138.92 1.63 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.248 1.019 . . . . 73.24 109.174 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -80.32 135.99 36.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.955 0.502 . . . . 44.11 109.817 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.444 ' CD1' HD12 ' C' ' 83' ' ' ILE . 63.7 mt -104.57 -26.56 12.3 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.83 0.852 . . . . 73.52 111.591 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.23 -172.99 1.39 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.383 0.673 . . . . 41.05 110.955 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.28 105.92 0.67 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 123.985 0.803 . . . . 72.33 110.919 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.53 10.04 5.52 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.254 1.422 . . . . 54.33 112.519 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.41 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 108.234 -1.024 . . . . 74.34 108.234 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -108.31 158.67 17.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.124 0.97 . . . . 73.34 108.75 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.4 tt0 -126.07 127.78 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.281 -1.007 . . . . 73.14 108.281 172.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 81.1 t -117.93 129.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.939 -1.134 . . . . 61.32 107.939 170.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.09 107.48 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.336 -0.987 . . . . 64.03 108.336 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.472 HD22 HG22 ' C' ' 62' ' ' VAL . 0.9 OUTLIER -86.19 106.21 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.069 -1.086 . . . . 72.33 108.069 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 57.4 ttt180 -82.12 105.38 13.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.472 HG22 HD22 ' C' ' 60' ' ' LEU . 13.6 t -105.42 130.99 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.213 -1.032 . . . . 64.32 108.213 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 21.9 m -129.7 146.29 51.48 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.02 -0.733 . . . . 74.41 109.02 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.519 HG21 HG21 ' C' ' 114' ' ' ILE . 50.8 t -131.07 127.94 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.948 0.899 . . . . 72.5 108.655 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.484 HG23 HD23 ' C' ' 75' ' ' LEU . 4.2 m -123.2 109.16 13.64 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.657 -1.238 . . . . 72.42 107.657 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.67 121.14 41.14 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.056 -1.09 . . . . 54.31 108.056 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -129.8 133.05 46.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.282 0.563 . . . . 71.31 110.593 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.812 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -87.1 33.88 0.68 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 125.726 1.61 . . . . 74.14 110.085 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.77 -103.1 2.17 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.176 -0.769 . . . . 60.02 111.176 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.35 -31.61 17.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.427 0.691 . . . . 74.44 110.16 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 4.0 tp10 -79.21 120.22 23.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 75.32 109.2 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -77.56 122.36 25.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.15 -0.685 . . . . 64.41 109.15 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -71.15 -50.29 34.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 63.31 109.598 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -160.84 170.66 20.23 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.422 -1.263 . . . . 74.14 110.98 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.484 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -136.35 147.23 47.27 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.996 -1.483 . . . . 53.13 106.996 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.418 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -147.81 149.21 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.478 -0.934 . . . . 72.12 108.478 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -157.61 118.81 3.58 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.848 0.459 . . . . 75.33 109.884 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -121.64 112.47 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.517 0.727 . . . . 54.52 109.364 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.454 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 49.7 mt-30 -94.82 99.64 11.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.704 -0.85 . . . . 73.44 108.704 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.62 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.1 tp-100 -85.07 104.93 15.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 71.43 110.542 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.06 145.67 22.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.47 -0.332 . . . . 42.13 112.326 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.92 127.85 2.72 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.057 -0.417 . . . . 54.44 112.057 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.444 HD12 ' CD1' ' C' ' 51' ' ' LEU . 12.6 mm -91.19 125.03 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.606 0.762 . . . . 64.44 109.124 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.421 ' CE2' HD13 ' C' ' 13' ' ' ILE . 58.4 m-85 -133.69 118.31 17.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.864 -0.791 . . . . 72.01 108.864 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.1 p -85.69 97.37 10.09 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -125.22 135.48 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-O 121.531 0.682 . . . . 43.35 111.235 -174.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.95 -178.54 5.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.191 1.396 . . . . 73.4 107.905 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.74 -30.56 4.18 Favored Glycine 0 N--CA 1.477 1.419 0 C-N-CA 121.391 -0.433 . . . . 52.15 113.642 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.422 HG13 ' H ' ' C' ' 89' ' ' ILE . 2.4 pp . . . . . 0 CA--C 1.549 0.918 0 C-N-CA 124.098 0.959 . . . . 64.11 111.764 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.345 0.117 . . . . 74.22 111.105 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.1 tpt -55.07 -36.93 66.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.892 0.877 . . . . 45.35 111.054 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.49 -47.44 11.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.636 0.774 . . . . 62.33 111.523 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -73.7 -34.61 64.93 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.482 0.713 . . . . 72.12 112.656 -167.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -63.6 -55.97 19.54 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.614 0.571 . . . . 75.14 111.233 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.414 HD12 ' N ' ' C' ' 99' ' ' GLY . 1.0 OUTLIER -92.83 -16.69 25.01 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.198 0.599 . . . . 60.42 112.528 -175.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.414 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.95 -14.87 38.24 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.395 -0.67 . . . . 71.11 113.8 -172.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.08 -46.25 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.46 0.63 . . . . 70.35 111.979 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -74.7 -44.25 51.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.119 0.567 . . . . 63.41 111.972 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.511 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 73.2 m -67.63 -45.48 45.94 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.464 -0.779 . . . . 72.21 111.331 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.11 -36.65 96.63 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.249 1.966 . . . . 75.12 112.734 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -61.91 -33.44 74.24 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.546 0.738 . . . . 64.43 111.712 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.432 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -68.37 -39.31 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.165 0.586 . . . . 72.32 110.413 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.7 mt -80.84 -32.73 34.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.274 -0.876 . . . . 74.02 112.483 -171.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -54.19 -48.72 93.49 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 117.288 -1.339 . . . . 73.22 113.182 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -45.04 -43.19 15.86 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.974 2.449 . . . . 64.11 114.544 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -70.45 -45.32 66.01 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.285 0.634 . . . . 73.23 111.052 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.9 -37.01 81.19 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.117 0.567 . . . . 72.42 110.959 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -54.12 -51.08 65.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.341 1.456 . . . . 73.05 110.517 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.24 -32.03 66.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.224 -0.898 . . . . 64.53 110.92 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -74.6 -30.84 61.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.896 0.478 . . . . 73.51 111.609 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.519 HG21 HG21 ' C' ' 64' ' ' VAL . 94.3 mt -71.7 -46.31 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.572 -0.529 . . . . 73.22 109.572 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.521 HG23 ' HB2' ' C' ' 125' ' ' GLN . 54.2 m -51.28 -42.54 61.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 71.35 110.834 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -63.68 -52.56 60.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.811 -1.541 . . . . 55.44 110.219 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.469 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.93 -40.96 81.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.362 1.065 . . . . 73.31 113.162 -176.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.44 -46.44 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.283 0.633 . . . . 75.21 110.151 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -64.83 -27.69 69.05 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.001 -1.0 . . . . 71.03 111.648 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 76.6 mtt-85 -70.06 -37.26 75.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.616 0.767 . . . . 72.31 110.286 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.92 8.55 56.54 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.172 -0.793 . . . . 55.24 113.135 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 42.8 p 61.28 26.99 16.75 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 125.933 1.693 . . . . 74.14 112.664 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 51.5 m-85 -100.15 167.73 10.52 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.385 1.074 . . . . 72.44 109.606 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 45.0 Cg_endo -66.06 111.65 2.05 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 122.051 1.834 . . . . 54.32 111.682 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' C' ' 115' ' ' THR . 0.0 OUTLIER -47.47 143.32 3.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.569 1.147 . . . . 71.42 112.048 -173.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.467 HD21 HG11 ' C' ' 40' ' ' VAL . 1.2 tm? -111.13 91.25 3.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.21 0.529 . . . . 74.11 110.13 -173.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -129.95 92.33 3.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.866 -1.161 . . . . 64.1 107.866 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.511 HD12 HD23 ' C' ' 42' ' ' LEU . 61.6 mt -87.36 154.25 20.82 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.104 0.962 . . . . 72.14 111.442 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.72 136.27 13.28 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 124.42 1.075 . . . . 73.41 112.143 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.556 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 40.8 Cg_endo -63.85 108.4 0.9 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.989 2.46 . . . . 75.24 112.537 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.33 87.75 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.375 0.67 . . . . 71.12 109.492 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.77 101.59 8.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.945 -0.761 . . . . 43.31 108.945 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.3 t80 . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 124.07 0.948 . . . . 72.53 111.096 179.433 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 CA--C 1.54 0.574 0 N-CA-C 109.11 -0.7 . . . . 73.1 109.11 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -150.47 94.05 2.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.26 -1.385 . . . . 52.52 107.26 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.449 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 80.9 mt-30 -112.11 131.89 55.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.644 0.778 . . . . 62.51 108.967 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -80.04 138.68 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.231 -1.026 . . . . 75.13 108.231 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.41 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 52.8 mt-30 -106.04 -48.95 3.48 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 110.282 -0.266 . . . . 71.21 110.282 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 ttt85 -176.23 130.26 0.22 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.071 0.232 . . . . 74.13 111.618 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.429 ' HB ' ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -117.71 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.199 -1.037 . . . . 71.24 108.199 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -150.21 165.02 34.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.396 1.079 . . . . 73.51 110.546 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -90.85 113.55 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.289 -0.634 . . . . 74.34 109.289 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 44.3 mtpt -78.95 -31.64 45.16 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.133 0.492 . . . . 72.15 109.964 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -150.37 142.29 23.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.053 -0.976 . . . . 73.3 109.3 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.469 HD13 ' HE3' ' C' ' 117' ' ' MET . 63.1 mt -141.34 144.33 26.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.51 -1.293 . . . . 73.44 107.51 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -147.53 142.62 27.1 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.65 -0.87 . . . . 71.31 108.65 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.5 t80 -147.36 125.51 12.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.672 -1.603 . . . . 65.45 106.672 170.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.7 147.01 51.45 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.92 0.888 . . . . 75.44 108.707 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 78.43 37.08 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 107.498 -1.297 . . . . 74.24 107.498 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.21 -29.52 47.02 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.429 2.086 . . . . 52.4 112.275 -174.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -114.4 27.95 9.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.892 0.877 . . . . 52.43 110.139 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.12 -57.22 6.5 Favored Pre-proline 0 CA--C 1.576 1.974 0 N-CA-C 116.24 1.941 . . . . 54.21 116.24 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 83' ' ' ILE . 24.1 Cg_endo -87.97 -5.17 6.91 Favored 'Trans proline' 0 C--N 1.384 2.404 0 CA-C-N 122.321 1.865 . . . . 74.24 112.955 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.453 ' HA ' HE21 ' D' ' 33' ' ' GLN . 13.6 t-160 -79.0 -30.95 44.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.11 1.364 . . . . 74.45 108.751 171.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' D' ' 123' ' ' PHE . 3.1 t -68.13 -28.59 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.81 1.244 . . . . 61.13 110.82 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -53.65 -23.41 11.18 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.44 0.696 . . . . 74.11 112.605 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' D' ' 30' ' ' HIS . 41.2 mt-30 -86.56 -0.03 55.31 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.644 0.778 . . . . 62.32 112.704 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.96 113.12 16.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.234 1.013 . . . . 73.43 110.764 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -98.69 64.62 1.51 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.189 0.995 . . . . 65.12 110.874 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.507 ' HB2' HD22 ' D' ' 68' ' ' LEU . 14.5 m95 -126.18 173.79 8.99 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.858 0.863 . . . . 75.24 109.508 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -89.49 125.62 60.92 Favored Pre-proline 0 N--CA 1.476 0.842 0 N-CA-C 108.259 -1.015 . . . . 65.24 108.259 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.06 127.44 21.25 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.852 1.701 . . . . 75.1 111.588 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.4 OUTLIER -65.41 111.16 2.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.678 -1.23 . . . . 74.03 107.678 172.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.674 HG13 HG13 ' D' ' 64' ' ' VAL . 59.6 t -104.35 114.42 43.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 122.864 0.465 . . . . 72.13 110.36 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 4.7 tppp? -87.45 120.27 28.58 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.569 -0.741 . . . . 74.24 109.325 169.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.474 HD21 HD22 ' D' ' 128' ' ' LEU . 7.4 mp -96.27 111.72 23.7 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.486 -1.302 . . . . 64.03 107.486 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.6 t70 -109.47 119.6 39.95 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.227 -1.027 . . . . 51.22 108.227 175.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -96.58 131.12 43.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.298 0.639 . . . . 70.55 109.987 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.9 t70 -139.42 151.71 46.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.096 0.958 . . . . 62.11 108.528 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 155.98 44.76 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.401 0.68 . . . . 75.32 109.598 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.86 163.72 37.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.908 0.883 . . . . 62.21 109.096 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -150.12 153.17 35.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.113 0.565 . . . . 75.14 110.006 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.6 p -154.26 123.38 6.41 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.849 0.86 . . . . 55.34 109.005 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.99 121.07 22.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.891 0.476 . . . . 75.52 110.083 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.2 mt -89.38 -38.63 13.98 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.502 0.668 . . . . 64.4 109.393 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.16 -176.69 5.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.38 -1.282 . . . . 40.12 109.504 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 122.43 15.69 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.799 -0.637 . . . . 75.14 110.918 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 71.04 1.71 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.519 1.528 . . . . 62.43 112.55 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -110.04 123.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 124.198 0.999 . . . . 75.04 109.871 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.59 129.94 33.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.106 0.563 . . . . 64.45 109.998 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' D' ' 51' ' ' LEU . 9.3 tt0 -95.16 120.38 35.28 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.828 -1.175 . . . . 72.24 107.828 167.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.07 134.62 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.028 -0.731 . . . . 74.32 109.028 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.9 t -108.92 129.21 63.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.037 0.535 . . . . 73.05 110.029 -175.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.49 123.04 44.88 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.562 -1.273 . . . . 70.43 107.562 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.7 ttm-85 -108.8 102.84 11.84 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.876 -0.787 . . . . 74.43 108.876 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.82 107.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.114 -1.069 . . . . 73.3 108.114 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 45.6 m -97.68 136.1 38.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.922 -0.581 . . . . 63.12 109.603 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.674 HG13 HG13 ' D' ' 40' ' ' VAL . 53.4 t -126.67 103.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.825 1.25 . . . . 62.43 108.742 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 29.2 m -104.62 94.52 5.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.917 -1.142 . . . . 73.53 107.917 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.06 140.64 30.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.851 -0.613 . . . . 34.11 110.115 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.5 m -148.43 126.12 11.81 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.158 0.504 . . . . 65.54 111.577 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' D' ' 36' ' ' TRP . 26.2 mt -94.72 109.25 21.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.704 0.802 . . . . 70.0 109.634 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.25 -111.52 3.28 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.366 0.417 . . . . 61.03 112.283 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.57 7.96 12.78 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.367 0.667 . . . . 75.15 110.745 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.12 165.46 18.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.835 0.854 . . . . 73.12 109.302 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -75.8 136.37 40.24 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.278 0.631 . . . . 45.52 111.217 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.516 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.93 -1.137 . . . . 71.21 107.93 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.04 151.3 30.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.984 -1.007 . . . . 71.22 110.333 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.37 146.15 29.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.929 -1.137 . . . . 71.3 107.929 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.1 t -159.36 138.68 11.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.568 -0.53 . . . . 61.2 109.568 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.35 133.87 9.86 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.027 0.376 . . . . 74.11 110.602 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.8 118.13 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.175 0.59 . . . . 73.2 110.071 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.6 mt-30 -90.25 86.03 6.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.703 0.801 . . . . 72.24 109.24 170.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.16 95.16 6.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.661 1.185 . . . . 75.15 109.604 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.27 143.29 18.63 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 111.88 -0.488 . . . . 73.3 111.88 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.14 130.88 4.16 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.969 -0.453 . . . . 62.33 111.969 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 35.9 mt -90.47 133.6 31.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.693 0.797 . . . . 71.43 109.534 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -136.7 134.61 37.39 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.319 0.648 . . . . 75.2 110.176 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 40.0 m -82.46 104.36 12.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.984 -0.747 . . . . 72.45 108.984 166.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 134.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.282 1.033 . . . . 70.34 109.432 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.98 167.11 12.93 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.644 0.778 . . . . 73.01 111.39 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.13 -2.07 77.56 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 115.993 1.157 . . . . 72.41 115.993 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.449 HD12 ' HE3' ' D' ' 94' ' ' MET . 2.4 pp -123.18 169.99 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.353 1.061 . . . . 61.31 109.469 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -164.18 -173.37 3.11 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.568 0.581 . . . . 75.1 112.568 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 -145.14 31.16 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 123.932 0.777 . . . . 62.25 114.171 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.0 m -69.43 -27.19 65.05 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.363 0.665 . . . . 75.24 110.251 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -60.79 -43.41 98.16 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 110.223 -0.288 . . . . 74.12 110.223 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.449 ' HE3' HD12 ' D' ' 89' ' ' ILE . 50.3 ttm -68.08 -49.29 62.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.935 0.494 . . . . 74.32 111.118 176.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.22 96.52 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.5 0.72 . . . . 61.4 112.228 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -87.63 -25.02 23.76 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.558 -0.746 . . . . 73.14 110.744 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 27.3 tp -65.51 -42.79 91.67 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.151 -0.931 . . . . 61.21 111.05 178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.54 -7.15 76.15 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.753 -0.658 . . . . 64.12 114.615 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.7 -62.75 0.55 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 117.672 0.736 . . . . 64.52 112.077 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -64.88 -47.01 79.4 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.562 0.579 . . . . 74.32 112.562 -167.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -65.25 -45.55 71.24 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.662 -0.685 . . . . 74.34 110.809 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.71 -38.86 77.61 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.266 1.978 . . . . 73.11 113.995 163.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -65.46 -27.73 68.72 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 122.852 0.461 . . . . 72.41 111.603 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.25 -44.88 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' D' ' 82' ' ' GLY . 65.0 mt -76.17 -20.26 57.71 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.829 -1.078 . . . . 65.03 111.732 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -68.25 -40.22 19.89 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 117.436 -1.269 . . . . 70.23 113.989 -168.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.95 -42.2 59.49 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.722 1.651 . . . . 62.43 112.771 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -76.73 -34.94 58.08 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.186 0.994 . . . . 73.41 110.982 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.91 51.91 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.465 0.706 . . . . 70.01 110.016 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -56.22 -47.73 77.87 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.818 1.324 . . . . 74.4 110.851 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.74 -46.78 88.16 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.236 0.96 . . . . 73.24 111.727 -175.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.6 t -55.73 -41.17 73.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.301 1.001 . . . . 75.11 110.349 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.491 HG21 HG21 ' D' ' 64' ' ' VAL . 67.8 mt -66.73 -53.75 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.347 1.029 . . . . 64.44 110.935 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.2 m -55.82 -39.2 71.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.555 1.142 . . . . 74.52 111.148 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.69 -46.23 76.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.573 -1.194 . . . . 52.15 110.261 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.1 mtm -66.23 -30.72 71.23 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.811 0.445 . . . . 64.23 112.097 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.8 t -64.37 -45.06 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 64.21 109.394 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -74.93 -24.32 58.47 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.258 -0.428 . . . . 62.11 111.458 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -74.16 -33.11 63.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.449 0.7 . . . . 74.41 109.938 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.11 4.58 85.81 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.976 -0.556 . . . . 63.13 112.531 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p 61.44 29.6 18.51 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.168 1.787 . . . . 62.01 113.349 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' D' ' 31' ' ' VAL . 97.3 m-85 -87.91 168.67 16.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.001 1.32 . . . . 60.32 109.451 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.56 140.1 38.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.792 2.328 . . . . 70.11 111.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.77 130.37 32.61 Favored 'General case' 0 C--O 1.243 0.763 0 O-C-N 124.057 0.848 . . . . 72.43 111.804 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -119.32 96.43 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.24 1.016 . . . . 64.01 109.401 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.73 98.34 9.18 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.672 -0.862 . . . . 72.41 108.672 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.474 HD22 HD21 ' D' ' 42' ' ' LEU . 75.5 mt -69.23 115.33 8.38 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.213 0.605 . . . . 75.31 109.692 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.84 135.77 87.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.264 0.625 . . . . 52.21 111.828 -172.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 11.2 Cg_endo -79.53 101.13 1.37 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.972 1.781 . . . . 71.22 110.029 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 114.27 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.058 0.943 . . . . 71.01 109.656 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 121.661 0.743 . . . . 60.55 109.588 -179.885 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 73.4 m . . . . . 0 C--O 1.217 -0.622 0 N-CA-C 107.921 -1.141 . . . . 74.14 107.921 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -136.57 144.0 43.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.143 -0.688 . . . . 72.42 109.143 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.76 137.24 11.98 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.499 0.5 . . . . 74.44 110.999 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.39 119.86 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 N-CA-C 109.374 -0.602 . . . . 73.25 109.374 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -97.93 -37.23 9.88 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.401 0.681 . . . . 70.12 110.393 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt85 -172.95 141.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.806 0.442 . . . . 74.23 111.3 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.6 mt -116.61 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 108.352 -0.981 . . . . 71.22 108.352 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -166.24 155.53 11.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.713 0.805 . . . . 72.41 111.226 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -87.04 114.64 23.82 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.973 -0.751 . . . . 74.54 108.973 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 37.2 mtpt -76.72 -27.03 55.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.768 0.427 . . . . 73.33 109.986 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.9 t70 -154.59 140.75 18.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.414 -0.812 . . . . 65.53 109.466 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.8 mt -136.72 140.09 43.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.317 -1.364 . . . . 72.41 107.317 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.6 t -145.53 128.99 16.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.03 -0.729 . . . . 61.02 109.03 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 91.8 t80 -137.92 112.86 9.06 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.296 -1.742 . . . . 74.04 106.296 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -118.22 134.94 54.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.88 78.5 69.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 106.045 -1.835 . . . . 55.02 106.045 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.5 -24.49 26.21 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.186 1.924 . . . . 64.5 111.177 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -110.52 29.33 7.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.518 -1.219 . . . . 73.21 109.232 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.11 -43.64 97.51 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.283 1.033 . . . . 70.5 112.407 175.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.44 -25.57 70.67 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.231 1.475 . . . . 63.12 113.253 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -82.87 -13.77 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.022 0.529 . . . . 62.23 112.188 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.5 p -63.25 -18.17 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.468 0.577 . . . . 62.34 111.994 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.67 -40.26 20.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.921 0.888 . . . . 65.13 110.521 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.98 -25.82 31.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.987 0.515 . . . . 72.2 110.751 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.25 146.67 28.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.392 0.677 . . . . 73.31 111.184 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.65 122.04 18.33 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.547 -1.206 . . . . 54.24 108.602 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.468 ' CE3' HD21 ' A' ' 68' ' ' LEU . 74.4 t-105 -82.03 86.71 6.52 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.494 0.664 . . . . 71.11 110.165 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -124.45 83.42 57.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.487 -1.301 . . . . 74.01 107.487 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.65 119.29 5.13 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.519 2.146 . . . . 71.05 112.337 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.45 112.03 24.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.012 -1.107 . . . . 64.4 108.012 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.23 111.29 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.27 1.028 . . . . 71.2 110.729 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -101.82 140.35 36.22 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.836 -0.802 . . . . 74.42 108.836 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.54 131.52 55.18 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.425 -0.954 . . . . 73.15 108.425 171.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.662 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -117.9 128.95 55.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.047 -1.094 . . . . 72.5 108.047 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.8 tp -98.15 128.9 44.9 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.215 -0.661 . . . . 74.24 109.215 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -134.09 151.65 51.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.67 -0.863 . . . . 74.32 108.67 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.1 m -141.49 147.96 38.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.075 0.95 . . . . 73.44 108.493 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -132.34 142.95 49.53 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.493 -0.929 . . . . 64.22 108.493 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.7 m -132.67 150.15 52.2 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 176.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -159.79 151.43 20.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.999 0.919 . . . . 65.04 109.128 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -95.53 114.08 25.8 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.838 -0.801 . . . . 53.3 108.838 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 57' ' ' GLU . 83.8 mt -84.09 -43.59 14.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.723 0.409 . . . . 73.31 110.198 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.6 -178.16 6.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.027 0.931 . . . . 60.22 109.277 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.98 122.88 18.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.967 -0.753 . . . . 63.22 108.967 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 66.67 13.66 9.44 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.81 1.244 . . . . 72.13 112.133 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.33 125.54 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.494 -0.928 . . . . 75.35 108.494 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -130.87 168.32 17.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.277 0.56 . . . . 71.41 110.212 176.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 51' ' ' LEU . 31.2 tt0 -127.34 121.78 31.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.159 -1.052 . . . . 72.15 108.159 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.51 119.02 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.778 -1.193 . . . . 74.2 107.778 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -99.16 135.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.79 0.836 . . . . 70.43 108.983 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.37 112.01 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.9 -1.518 . . . . 75.11 106.9 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.508 ' HD3' ' HG2' ' A' ' 79' ' ' GLN . 12.2 ttp180 -108.42 104.33 13.67 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.387 -0.597 . . . . 75.25 109.387 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.99 132.42 39.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.237 -1.023 . . . . 64.42 108.237 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.1 m -114.02 138.2 50.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.823 -0.806 . . . . 72.12 108.823 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 39.9 t -133.71 108.58 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 125.104 1.361 . . . . 75.24 108.382 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -106.02 140.48 38.94 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.568 -0.53 . . . . 74.44 109.568 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.9 117.27 27.67 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.172 -1.047 . . . . 73.34 108.172 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 m -113.88 127.56 56.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.189 0.596 . . . . 74.3 110.367 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.4 mt -93.41 53.46 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.292 1.437 . . . . 72.32 109.642 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.6 -84.93 0.97 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.119 -0.491 . . . . 74.25 112.147 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.04 -28.41 16.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.666 0.786 . . . . 72.31 111.724 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -123.39 133.69 54.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.714 0.806 . . . . 73.55 109.893 -169.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -71.34 136.89 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 120.916 0.388 . . . . 62.31 110.459 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -61.8 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.19 0.996 . . . . 61.44 109.214 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.83 167.64 26.85 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.34 -1.3 . . . . 60.43 110.297 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -134.43 140.36 46.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.806 1.242 . . . . 64.24 108.178 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.4 m -131.0 135.87 48.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.272 1.029 . . . . 53.31 108.973 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.17 123.45 8.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.602 0.361 . . . . 75.44 110.123 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.41 113.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.974 0.91 . . . . 74.21 109.749 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.508 ' HG2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 mt-30 -85.6 81.09 8.8 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.641 0.776 . . . . 73.51 108.916 172.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.74 90.53 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.154 0.982 . . . . 64.04 108.572 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.99 144.84 18.28 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 116.087 -0.506 . . . . 53.4 112.325 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.12 130.83 5.0 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 111.983 -0.447 . . . . 32.02 111.983 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -81.29 131.34 34.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 107.426 -1.324 . . . . 73.44 107.426 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . 37.7 m-85 -131.79 155.43 47.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.725 -0.843 . . . . 72.13 108.725 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -111.49 114.22 27.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.603 1.161 . . . . 72.52 108.035 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 tt -139.08 152.92 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 118.086 0.403 . . . . 73.35 111.033 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.82 169.34 13.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.374 1.069 . . . . 63.3 110.352 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.45 5.76 86.04 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 123.901 0.751 . . . . 73.21 114.701 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.05 153.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.154 0.981 . . . . 72.33 109.606 -177.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.23 170.48 22.38 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.165 0.586 . . . . 72.31 109.444 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.73 -125.3 34.59 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 123.701 0.667 . . . . 73.32 113.889 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.4 p -75.49 -21.39 58.08 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.731 0.812 . . . . 51.11 111.422 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.55 -40.16 92.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.004 0.522 . . . . 70.44 109.797 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -47.44 24.47 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.311 -0.859 . . . . 72.53 109.92 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -34.05 77.09 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.106 -0.952 . . . . 72.52 112.636 -172.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -78.89 -20.81 48.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.194 0.598 . . . . 55.53 110.855 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.532 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 49.4 t -80.42 -64.39 1.2 Allowed 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.413 0.285 . . . . 53.31 110.242 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.19 -37.12 84.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.961 0.504 . . . . 60.33 111.786 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.46 -15.11 64.62 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 114.92 0.728 . . . . 75.22 114.92 -172.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.88 -51.19 0.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.637 0.718 . . . . 74.54 112.656 -171.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.5 t80 -77.71 -51.69 10.17 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.216 0.607 . . . . 71.04 112.55 -168.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 67.7 m -70.84 -38.9 8.03 Favored Pre-proline 0 CA--C 1.569 1.688 0 C-N-CA 123.935 0.894 . . . . 74.22 113.112 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.37 -22.01 46.4 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.709 1.606 . . . . 62.23 112.434 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -71.42 -30.36 65.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.872 0.469 . . . . 73.22 110.492 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.03 -40.08 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.375 -0.602 . . . . 61.01 109.375 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 82' ' ' GLY . 36.1 mt -82.1 -21.85 36.54 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.077 -0.965 . . . . 74.3 112.253 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -65.53 -39.31 32.26 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.697 1.369 . . . . 74.33 114.697 -170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.65 -34.76 99.11 Favored 'Trans proline' 0 C--N 1.393 2.899 0 CA-C-N 122.153 1.805 . . . . 64.31 112.51 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -80.76 -36.66 31.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.815 0.846 . . . . 64.31 110.459 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.87 79.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.09 0.556 . . . . 54.44 109.927 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -52.0 -57.77 8.49 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.593 1.183 . . . . 74.12 109.286 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.77 -43.64 97.77 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.592 1.183 . . . . 71.31 111.793 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.628 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.8 t -57.64 -47.64 81.69 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.945 0.898 . . . . 70.33 110.832 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 64' ' ' VAL . 89.2 mt -64.34 -53.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.041 0.838 . . . . 74.31 110.463 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.3 m -50.25 -41.83 50.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.394 1.478 . . . . 74.01 111.505 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -72.78 -42.76 63.61 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.825 -1.08 . . . . 72.52 110.926 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.3 mtm -58.35 -42.61 87.25 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 74.1 110.86 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 81.8 t -60.12 -49.01 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.241 -1.345 . . . . 72.3 111.27 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 80.9 p -66.89 -31.41 71.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.887 0.475 . . . . 74.42 111.507 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.9 mtt-85 -68.7 -27.12 65.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.827 0.851 . . . . 72.21 111.358 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 13.06 53.24 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.628 -0.54 . . . . 71.01 113.545 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m 63.91 27.29 14.41 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.8 1.24 . . . . 72.24 110.871 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.36 150.0 37.97 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.555 -0.905 . . . . 71.11 108.555 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HD2' ' CZ2' ' A' ' 36' ' ' TRP . 60.8 Cg_endo -70.77 120.56 7.17 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.882 1.721 . . . . 73.23 109.674 176.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 10.8 pt20 -61.69 150.89 35.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.338 0.655 . . . . 63.42 111.719 -171.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.42 108.71 20.18 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.746 -0.835 . . . . 60.15 108.746 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -96.69 96.14 8.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.84 -1.17 . . . . 74.23 107.84 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.5 mt -65.72 148.63 51.44 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.473 -0.785 . . . . 72.23 110.58 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.92 162.84 60.83 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.013 0.525 . . . . 74.4 110.72 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.34 164.0 26.92 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.134 1.889 . . . . 64.44 111.924 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.01 114.13 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.997 0.919 . . . . 73.02 109.797 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.84 85.61 6.06 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.454 0.701 . . . . 72.31 109.476 173.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 124.544 1.138 . . . . 74.33 111.869 173.945 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.244 0.77 0 N-CA-C 108.756 -0.831 . . . . 70.11 108.756 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -133.44 144.67 49.64 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.21 0.604 . . . . 74.12 109.826 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -147.77 136.42 21.8 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.962 -1.017 . . . . 73.04 109.114 169.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.24 144.06 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.614 -0.884 . . . . 74.05 108.614 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.49 -49.36 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.412 0.285 . . . . 71.53 110.836 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -162.53 139.49 7.92 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.584 -0.154 . . . . 73.34 110.584 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.467 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 93.9 mt -115.28 137.83 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 106.744 -1.576 . . . . 71.24 106.744 170.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.47 ' HE1' HG13 ' B' ' 83' ' ' ILE . 16.2 p90 -165.65 144.91 6.34 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.66 0.6 . . . . 72.42 111.654 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.6 m -76.31 119.38 20.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.314 -0.857 . . . . 73.41 108.934 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -93.8 -26.96 16.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.383 0.673 . . . . 74.13 111.238 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.9 t70 -160.78 143.13 12.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.165 0.291 . . . . 72.0 110.78 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.3 mm -137.78 138.3 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.991 1.316 . . . . 60.41 108.992 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 7.9 t -137.91 138.76 39.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.22 -1.4 . . . . 35.41 107.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.8 t80 -160.62 114.53 2.11 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 107.753 -1.203 . . . . 73.21 107.753 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.8 147.89 42.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.811 -1.181 . . . . 74.22 107.811 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -131.85 81.92 61.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 106.911 -1.514 . . . . 72.53 106.911 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.55 -21.34 52.85 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.803 2.335 . . . . 73.22 113.094 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.33 30.47 6.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.917 0.887 . . . . 60.4 109.938 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.469 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -48.64 -50.54 59.12 Favored Pre-proline 0 CA--C 1.569 1.71 0 C-N-CA 124.752 1.221 . . . . 63.3 114.164 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.3 -16.77 6.9 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.87 1.713 . . . . 65.13 112.769 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.63 0.86 55.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.657 0.783 . . . . 63.11 110.817 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.24 -15.35 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 124.268 1.027 . . . . 45.24 111.385 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.81 -42.59 89.53 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.437 0.695 . . . . 74.03 110.607 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.68 -43.41 96.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.74 0.816 . . . . 62.22 110.85 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -103.2 76.42 1.44 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.631 -1.168 . . . . 71.24 109.989 -171.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -95.28 76.71 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.557 -1.656 . . . . 74.24 110.368 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' B' ' 68' ' ' LEU . 2.4 p-90 -157.65 176.59 12.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.831 -1.077 . . . . 74.32 109.5 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.83 99.46 0.99 Allowed Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.878 0.871 . . . . 70.53 108.832 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.52 ' HB3' HD23 ' B' ' 68' ' ' LEU . 55.9 Cg_endo -67.15 161.36 43.2 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.234 1.956 . . . . 65.15 112.94 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.4 mt-10 -75.18 102.18 4.88 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.903 -1.044 . . . . 74.25 108.964 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 124' ' ' PRO . 8.0 t -92.21 119.03 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 N-CA-C 107.547 -1.279 . . . . 60.43 107.547 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -146.84 145.77 29.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.032 0.933 . . . . 62.41 108.992 -170.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.568 HD21 HD21 ' B' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 170.01 12.87 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.828 0.851 . . . . 70.43 111.003 -176.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.16 139.59 41.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.584 1.153 . . . . 62.11 109.335 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 129.73 36.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.838 . . . . 63.23 109.535 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -139.97 149.51 43.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.741 0.817 . . . . 55.32 109.601 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -145.22 134.31 22.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.166 0.587 . . . . 61.15 110.02 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.88 149.27 43.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.747 1.219 . . . . 64.33 107.738 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -143.89 160.97 39.87 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.343 0.657 . . . . 71.15 110.678 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.3 p -163.12 140.15 7.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.694 0.797 . . . . 73.24 109.352 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.8 tt0 -82.64 134.43 35.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 74.05 109.871 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -92.87 -55.2 3.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.297 0.639 . . . . 64.45 110.028 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.59 -165.13 1.97 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.577 -0.738 . . . . 51.52 110.942 -170.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -69.06 109.89 4.22 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.547 -0.752 . . . . 51.22 110.206 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.53 4.43 4.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.028 1.331 . . . . 64.53 111.908 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.94 114.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 124.734 1.214 . . . . 75.34 109.121 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 15.5 p90 -117.46 174.39 6.17 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.817 . . . . 75.22 109.224 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.17 117.66 8.55 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.469 -0.937 . . . . 71.43 108.469 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.13 127.47 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 62.11 109.585 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.7 t -101.38 113.77 38.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.989 0.915 . . . . 73.1 108.826 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.05 110.1 21.58 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.005 -1.48 . . . . 73.31 107.005 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.92 121.89 42.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.906 -0.405 . . . . 55.04 109.906 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.2 t -112.65 126.67 70.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.541 -1.281 . . . . 51.53 107.541 167.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 77' ' ' GLU . 5.1 m -121.43 127.06 50.76 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 110.062 -0.347 . . . . 61.31 110.062 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' B' ' 42' ' ' LEU . 38.6 t -99.04 127.9 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.995 . . . . 75.14 109.995 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -107.61 131.87 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.583 -1.189 . . . . 60.54 108.648 164.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -136.26 152.33 50.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.024 -0.732 . . . . 75.14 109.024 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.0 p -145.4 135.39 23.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.047 0.758 . . . . 75.32 113.047 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.52 HD23 ' HB3' ' B' ' 38' ' ' PRO . 75.9 mt -95.29 97.08 9.59 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.752 -1.567 . . . . 74.11 108.003 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . 0.459 ' H ' ' HZ2' ' B' ' 36' ' ' TRP . . . 71.86 -117.04 6.29 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.482 -0.647 . . . . 40.04 111.482 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -105.43 9.33 33.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.494 1.118 . . . . 61.53 110.427 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.71 151.09 34.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.045 1.338 . . . . 72.55 108.414 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.88 133.83 43.17 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.164 0.438 . . . . 71.53 110.726 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.4 -63.3 1.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.89 0.876 . . . . 72.51 108.952 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -157.27 160.36 38.52 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.639 -1.164 . . . . 73.3 109.392 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.87 113.86 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.963 -1.125 . . . . 64.23 107.963 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.494 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.9 t -115.41 161.11 19.01 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.526 -0.916 . . . . 74.31 108.526 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.76 135.62 3.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.416 -0.587 . . . . 72.13 109.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.4 t -126.62 144.04 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.819 . . . . 73.0 108.79 171.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -122.97 91.8 3.57 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.784 -0.821 . . . . 53.5 108.784 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -84.61 100.68 11.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.419 -0.81 . . . . 74.32 109.161 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.2 158.41 23.78 Favored Glycine 0 C--O 1.24 0.521 0 N-CA-C 111.459 -0.656 . . . . 52.12 111.459 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -155.37 128.9 2.38 Favored Glycine 0 C--O 1.237 0.297 0 N-CA-C 112.011 -0.436 . . . . 74.13 112.011 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.47 HG13 ' HE1' ' B' ' 17' ' ' TYR . 55.2 mt -85.32 125.64 40.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.516 -0.92 . . . . 73.24 108.516 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.415 ' HB2' ' CZ ' ' B' ' 56' ' ' TYR . 29.7 m-85 -137.89 170.3 16.29 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.196 0.999 . . . . 54.4 108.574 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 43.5 m -135.14 132.63 38.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.93 0.892 . . . . 71.12 110.327 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.451 HD13 HG12 ' B' ' 89' ' ' ILE . 2.8 pp -136.25 146.19 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 123.541 0.736 . . . . 72.33 111.02 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.91 28.24 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.126 1.37 . . . . 73.15 108.245 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.76 -27.83 4.69 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-O 119.931 -0.372 . . . . 62.33 113.811 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.451 HG12 HD13 ' B' ' 86' ' ' ILE . 1.6 pp -53.24 142.99 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.626 1.17 . . . . 72.52 113.057 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -150.57 148.66 28.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.163 0.985 . . . . 73.35 110.434 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -136.09 49.94 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 124.387 1.054 . . . . 70.15 114.481 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -84.39 -19.21 33.92 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.746 0.818 . . . . 75.02 110.646 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.24 -21.73 63.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.101 0.56 . . . . 74.54 110.875 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.3 -42.49 93.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.375 0.67 . . . . 65.12 110.515 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -21.15 65.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 72.32 112.367 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.11 -42.02 89.76 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.257 0.623 . . . . 53.34 110.483 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.417 ' SG ' HG21 ' B' ' 86' ' ' ILE . 46.4 t -67.52 -57.06 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.096 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.36 -31.12 66.97 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.766 -0.652 . . . . 72.35 112.542 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.52 -9.59 58.78 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.37 -0.683 . . . . 73.21 114.627 -171.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.68 -48.1 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 117.636 0.718 . . . . 73.03 112.576 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -69.49 -48.44 60.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.657 0.383 . . . . 74.45 111.457 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 60.4 m -62.18 -48.91 86.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 118.216 -0.897 . . . . 74.15 110.793 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 95.7 Cg_exo -50.58 -44.7 38.75 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.416 2.077 . . . . 64.43 113.515 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.13 -34.86 75.66 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.299 1.039 . . . . 61.31 112.178 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.21 -49.28 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.355 0.662 . . . . 61.31 110.176 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' B' ' 82' ' ' GLY . 50.0 mt -76.55 -14.77 59.99 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.481 -1.236 . . . . 70.01 111.856 -174.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' B' ' 128' ' ' LEU . 27.3 t80 -62.06 -52.64 65.99 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.271 1.428 . . . . 75.11 113.249 -167.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.558 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 36.9 Cg_endo -62.23 -32.55 82.41 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.022 1.815 . . . . 50.32 113.17 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.457 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.2 m-85 -64.36 -46.29 84.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.153 0.581 . . . . 74.23 110.057 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.2 90.16 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.959 0.903 . . . . 54.3 110.468 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 31.9 mtp180 -52.3 -56.11 16.98 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.586 1.155 . . . . 73.32 111.871 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -32.51 64.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.284 -0.871 . . . . 74.11 110.676 -173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -69.69 -34.6 74.16 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.831 0.452 . . . . 70.21 111.008 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.453 HG21 HG21 ' B' ' 64' ' ' VAL . 58.2 mt -62.69 -58.95 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.773 -0.825 . . . . 73.33 108.773 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -51.69 -32.65 30.79 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 124.86 1.35 . . . . 75.03 112.263 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -64.47 -50.33 67.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.076 0.95 . . . . 72.21 110.345 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -71.14 -30.86 67.01 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.105 0.479 . . . . 75.15 111.43 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.9 t -70.48 -37.8 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.18 0.992 . . . . 72.22 110.978 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 96.2 p -67.35 -33.04 74.41 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.169 0.509 . . . . 61.24 110.955 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.628 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 58.6 mtt-85 -64.64 -35.26 80.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.399 -0.819 . . . . 71.44 110.292 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.31 10.45 71.26 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.971 -0.905 . . . . 54.42 113.817 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.468 ' HA ' ' OD1' ' C' ' 127' ' ' ASN . 62.8 p 59.23 34.92 23.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.569 1.548 . . . . 65.43 113.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 23.7 m-85 -117.86 164.84 17.97 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 124.211 1.004 . . . . 75.21 110.631 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.562 ' HB2' HG21 ' B' ' 40' ' ' VAL . 7.3 Cg_exo -75.45 137.72 21.11 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 123.693 2.929 . . . . 70.22 115.257 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.636 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.9 OUTLIER -66.81 159.0 29.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.517 1.527 . . . . 72.42 113.282 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -126.3 117.47 23.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.106 -1.072 . . . . 44.0 108.106 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' C' ' 122' ' ' THR . 3.8 m120 -92.11 97.51 10.97 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.042 -1.466 . . . . 72.33 107.042 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.63 HD23 ' H ' ' B' ' 129' ' ' ALA . 0.5 OUTLIER -66.18 148.19 52.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.258 0.481 . . . . 54.42 110.961 -170.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.63 ' H ' HD23 ' B' ' 128' ' ' LEU . . . -41.11 107.0 0.45 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 127.335 2.254 . . . . 60.0 113.783 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.08 54.33 4.57 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.726 2.284 . . . . 70.23 111.774 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.616 HG23 ' HB1' ' B' ' 129' ' ' ALA . 67.0 t -87.35 113.63 25.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 124.782 1.233 . . . . 71.34 109.034 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -69.8 98.47 1.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.045 -1.095 . . . . 73.23 108.045 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.475 0.779 0 CA-C-N 115.157 -0.929 . . . . 72.0 110.993 -175.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.2 m . . . . . 0 C--O 1.237 0.414 0 N-CA-C 107.017 -1.475 . . . . 60.41 107.017 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -95.17 116.64 29.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.341 -1.726 . . . . 72.24 106.341 168.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -143.69 141.87 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.722 -0.844 . . . . 71.32 108.722 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.422 HD11 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -73.0 133.5 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 123.71 0.631 . . . . 62.35 109.435 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -113.29 -28.96 7.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.58 0.752 . . . . 71.34 110.107 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.43 ' NH2' ' HB ' ' D' ' 122' ' ' THR . 16.1 ttt85 -179.65 144.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 122.976 0.511 . . . . 72.45 110.605 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.422 HG13 HD11 ' C' ' 13' ' ' ILE . 51.7 mt -124.39 134.17 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.407 -1.331 . . . . 73.32 107.407 168.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.568 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.5 p90 -176.94 155.01 1.17 Allowed 'General case' 0 C--O 1.227 -0.122 0 O-C-N 123.997 0.81 . . . . 62.45 110.421 -174.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.23 120.94 22.19 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.629 0.772 . . . . 73.01 109.664 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.446 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 28.9 mmtp -70.55 -49.09 51.72 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 107.974 -1.121 . . . . 75.0 107.974 167.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -138.51 142.68 39.34 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.803 -1.544 . . . . 75.22 109.498 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.24 144.8 28.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.936 -1.505 . . . . 72.42 106.936 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.2 t -155.21 148.3 24.71 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.254 0.55 . . . . 61.4 110.593 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.4 t80 -147.8 125.96 12.18 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 114.694 -1.139 . . . . 74.52 107.926 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.36 139.25 51.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.361 1.064 . . . . 63.33 108.321 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 76.26 36.24 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 105.954 -1.869 . . . . 63.52 105.954 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.25 -19.68 29.03 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.369 2.046 . . . . 74.53 111.071 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.75 11.4 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.679 -1.146 . . . . 72.2 110.376 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.604 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.05 -61.73 3.07 Favored Pre-proline 0 CA--C 1.573 1.85 0 N-CA-C 114.064 1.135 . . . . 63.03 114.064 -165.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.9 Cg_exo -76.05 -23.49 12.09 Favored 'Trans proline' 0 C--N 1.387 2.594 0 CA-C-N 121.746 1.659 . . . . 71.23 112.28 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -71.09 -38.16 72.4 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.797 1.239 . . . . 73.13 111.894 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.36 -10.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.377 1.071 . . . . 74.11 111.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.09 -40.52 70.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.759 0.824 . . . . 75.4 111.7 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.548 ' HA ' HE21 ' C' ' 33' ' ' GLN . 0.0 OUTLIER -116.52 38.78 3.33 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.997 0.903 . . . . 72.24 109.811 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.823 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -99.98 152.23 20.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.68 -0.638 . . . . 64.2 110.945 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.62 108.57 4.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.633 -1.247 . . . . 52.33 107.633 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -70.99 104.58 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.927 0.891 . . . . 74.24 110.68 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -134.47 49.88 4.38 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 124.174 0.99 . . . . 74.31 110.724 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 112.62 3.42 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.182 1.922 . . . . 73.42 112.302 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -86.0 95.08 9.39 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.579 -1.267 . . . . 63.23 107.579 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 76.0 t -80.7 89.63 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.095 -0.957 . . . . 74.13 110.118 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.88 139.14 31.24 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.837 -0.801 . . . . 63.25 108.837 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' C' ' 64' ' ' VAL . 0.6 OUTLIER -129.12 144.98 51.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.379 0.671 . . . . 54.34 109.633 172.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.46 139.19 53.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.796 1.239 . . . . 55.25 108.836 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.674 ' HG ' HD21 ' C' ' 60' ' ' LEU . 8.9 tt -114.21 135.7 53.76 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.629 0.772 . . . . 73.13 109.16 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -155.63 149.95 25.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.229 1.011 . . . . 74.41 108.835 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -112.16 152.11 28.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.466 0.65 . . . . 51.14 109.895 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.0 158.39 41.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.5 1.12 . . . . 75.43 108.173 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.4 t -153.26 148.84 27.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.899 0.38 . . . . 64.33 110.675 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -157.74 128.09 6.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.62 1.168 . . . . 74.12 108.917 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -81.41 131.22 35.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.312 -0.625 . . . . 73.32 109.312 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 HD12 ' C' ' 83' ' ' ILE . 84.2 mt -98.01 -40.1 8.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.542 0.737 . . . . 75.22 110.34 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.36 179.48 9.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.221 -0.899 . . . . 65.32 109.526 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.14 126.04 28.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.661 -0.866 . . . . 75.42 108.661 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.434 ' HA ' HG23 ' C' ' 86' ' ' ILE . 3.0 m-20 67.11 13.83 9.58 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.625 1.17 . . . . 64.54 112.606 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.68 117.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.405 1.082 . . . . 64.4 108.587 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 165.76 23.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.66 0.743 . . . . 72.5 109.547 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -126.57 136.63 52.8 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.328 1.051 . . . . 74.24 108.474 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.0 t -123.37 127.43 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.179 -1.415 . . . . 73.22 107.179 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.507 HG22 ' HA2' ' C' ' 81' ' ' GLY . 90.2 t -120.44 117.4 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.798 -0.815 . . . . 72.23 108.798 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.674 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -86.53 113.05 22.13 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.786 -0.82 . . . . 64.42 108.786 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -90.92 106.76 18.74 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.307 -0.998 . . . . 73.33 108.307 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.5 t -107.19 135.47 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.152 -1.055 . . . . 51.44 108.152 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -127.39 124.99 39.85 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.951 -0.388 . . . . 72.23 109.951 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.633 HG22 ' HB3' ' C' ' 42' ' ' LEU . 43.3 t -102.71 115.86 45.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 74.31 110.612 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -99.4 134.76 41.79 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.178 -1.045 . . . . 60.55 108.178 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.26 129.92 45.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.32 -0.993 . . . . 52.25 108.32 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 70.2 m -146.88 135.63 22.18 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.626 0.579 . . . . 70.44 111.146 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' C' ' 34' ' ' LYS . 5.9 mt -86.83 40.74 0.92 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.319 1.848 . . . . 74.22 109.413 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.42 -109.71 3.29 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.724 -0.95 . . . . 73.33 110.724 -168.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.25 -24.47 22.08 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.519 0.728 . . . . 72.2 110.136 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.531 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 6.9 tp10 -76.94 120.45 22.08 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.389 1.075 . . . . 62.23 110.027 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.1 m -66.65 125.36 25.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.958 0.799 . . . . 74.54 109.404 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -80.06 -51.9 8.46 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.842 -0.799 . . . . 72.52 108.842 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -164.81 175.29 9.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.777 -1.101 . . . . 74.12 109.863 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.406 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -134.33 144.81 48.5 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.677 -1.601 . . . . 65.35 106.677 170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.1 t -143.83 148.33 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.21 -1.033 . . . . 53.32 108.21 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.62 134.85 9.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.922 -0.77 . . . . 55.51 108.922 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.73 139.24 52.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.364 1.066 . . . . 75.4 108.521 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -116.4 90.34 3.31 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.116 -1.068 . . . . 75.42 108.116 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -79.56 106.6 11.7 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.675 -1.148 . . . . 75.25 109.991 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -82.72 148.41 26.05 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.371 0.419 . . . . 64.5 112.166 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.74 116.19 0.77 Allowed Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 110.795 -0.922 . . . . 74.33 110.795 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.632 HD12 HD11 ' C' ' 51' ' ' LEU . 10.9 mm -87.6 125.23 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.245 -1.02 . . . . 63.0 108.245 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -130.56 156.59 44.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.498 -0.927 . . . . 74.02 108.498 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -91.75 137.22 32.54 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.933 -0.766 . . . . 72.34 108.933 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' C' ' 54' ' ' ASP . 0.0 OUTLIER -108.52 134.67 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.655 -0.868 . . . . 71.41 108.655 172.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -178.39 153.56 0.75 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.574 0.75 . . . . 54.11 110.992 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.85 -36.53 3.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.652 1.021 . . . . 20.15 115.652 163.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' C' ' 94' ' ' MET . 1.6 pp . . . . . 0 N--CA 1.482 1.135 0 C-N-CA 123.99 0.916 . . . . 73.42 112.282 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.537 0.208 . . . . 73.44 110.883 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.423 ' HB3' HD13 ' C' ' 89' ' ' ILE . 15.9 ptp -72.47 -27.37 62.25 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.298 -0.41 . . . . 72.13 111.816 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.94 76.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.491 0.716 . . . . 52.14 111.826 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -72.46 -24.57 61.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.063 0.545 . . . . 73.42 111.222 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 32.3 t -62.96 -63.46 1.2 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.537 0.523 . . . . 61.24 111.089 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.52 -23.92 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.49 0.586 . . . . 74.14 110.516 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.85 -24.44 76.63 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.486 -0.779 . . . . 64.15 113.521 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.61 -38.01 0.06 Allowed 'General case' 0 C--N 1.358 0.967 0 N-CA-C 113.723 1.009 . . . . 61.12 113.723 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.21 -39.01 82.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.517 0.727 . . . . 64.03 112.057 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.82 -50.28 4.22 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.46 -0.781 . . . . 72.23 111.301 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.411 ' O ' HD12 ' C' ' 60' ' ' LEU . 34.3 Cg_endo -64.49 -23.16 64.84 Favored 'Trans proline' 0 C--N 1.398 3.183 0 C-N-CA 121.637 1.558 . . . . 75.55 113.306 175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -65.37 -36.13 83.05 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 122.984 0.514 . . . . 71.13 110.394 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.27 -41.52 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.895 0.878 . . . . 72.4 110.165 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 57.5 mt -86.64 -15.95 38.13 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.591 -1.186 . . . . 62.2 112.07 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -59.63 -51.58 80.03 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 117.617 -1.182 . . . . 70.22 113.182 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.94 -34.39 99.1 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 121.927 1.751 . . . . 74.45 112.596 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.64 -46.68 75.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.506 0.722 . . . . 73.3 110.864 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.59 94.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 40.14 110.402 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.19 -45.67 93.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.421 1.488 . . . . 72.23 110.716 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.59 -30.19 59.53 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.004 0.921 . . . . 63.11 110.324 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.1 t -68.67 -39.82 80.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.1 0.56 . . . . 44.32 110.481 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.58 HG21 HG21 ' C' ' 64' ' ' VAL . 86.4 mt -68.31 -45.06 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.064 0.546 . . . . 64.5 109.932 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.2 m -55.01 -38.87 68.46 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.634 0.774 . . . . 74.11 111.184 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -59.8 -60.6 3.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.187 -0.915 . . . . 71.42 109.716 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.524 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -48.2 -47.63 35.26 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.474 1.51 . . . . 73.22 113.349 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.622 HG11 HD23 ' C' ' 126' ' ' LEU . 53.5 t -70.69 -43.89 77.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.12 0.968 . . . . 75.24 111.796 -173.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.5 t -64.72 -30.57 71.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.889 -0.596 . . . . 64.51 110.793 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 75.2 mtt-85 -66.02 -32.53 74.06 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.816 -0.629 . . . . 73.5 110.564 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.28 12.3 60.9 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.526 0.516 . . . . 73.35 113.557 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.636 HG23 ' HB3' ' D' ' 17' ' ' TYR . 46.5 p 58.79 35.93 24.54 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.793 1.637 . . . . 71.22 112.922 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.418 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 41.5 m-85 -110.21 163.94 16.0 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.171 0.988 . . . . 71.33 110.504 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 32.7 Cg_endo -59.48 173.35 1.54 Allowed 'Trans proline' 0 C--N 1.402 3.361 0 C-N-CA 123.631 2.888 . . . . 64.41 114.905 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.636 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 5.7 mm-40 -60.68 136.26 58.01 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.393 -0.821 . . . . 73.42 111.732 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.622 HD23 HG11 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -112.32 24.81 12.15 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.278 -0.874 . . . . 53.12 111.683 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 7.1 p30 -92.56 84.0 5.01 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.523 1.63 . . . . 74.22 108.207 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' C' ' 128' ' ' LEU . 3.5 mm? -91.91 157.03 17.06 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.915 -1.038 . . . . 74.45 112.63 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -33.58 135.91 0.31 Allowed Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 126.542 1.937 . . . . 73.22 115.101 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.75 109.99 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.851 2.367 . . . . 60.23 111.609 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.05 30.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.428 0.691 . . . . 74.34 111.381 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -71.2 103.8 2.9 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 p90 . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 115.119 -0.946 . . . . 75.22 111.988 -175.418 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 47.7 m . . . . . 0 C--O 1.237 0.397 0 N-CA-C 108.633 -0.877 . . . . 73.35 108.633 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -153.49 99.53 2.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.378 -0.971 . . . . 75.22 108.378 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -123.58 114.4 19.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.77 0.828 . . . . 75.14 108.774 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.417 HG22 ' HD2' ' D' ' 84' ' ' PHE . 1.1 pp -78.75 127.05 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 107.157 -1.424 . . . . 73.25 107.157 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 78.3 mt-30 -85.09 -35.37 21.86 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.271 -0.27 . . . . 71.41 110.271 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.448 ' HB3' ' HE1' ' D' ' 17' ' ' TYR . 1.6 tpt180 -172.74 157.29 3.71 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.852 0.461 . . . . 64.35 110.514 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 19.7 mt -144.31 124.19 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.514 1.126 . . . . 64.44 108.038 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.636 ' HB3' HG23 ' C' ' 122' ' ' THR . 23.9 p90 -168.96 162.91 11.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.758 1.223 . . . . 72.21 109.996 -168.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.8 p -80.94 122.17 26.92 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.314 -0.857 . . . . 62.3 109.912 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 45.7 mtpt -86.09 -44.42 12.27 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 107.98 -1.118 . . . . 74.42 107.98 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.765 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.9 t70 -131.59 141.88 49.77 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.963 -1.017 . . . . 75.11 109.848 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.524 HD13 ' HE3' ' C' ' 117' ' ' MET . 55.4 mt -137.7 146.33 27.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.375 1.47 . . . . 74.14 107.778 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.1 140.5 17.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.498 0.666 . . . . 54.4 111.101 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.9 t80 -140.8 137.89 33.66 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.514 -1.662 . . . . 73.04 106.514 168.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.5 mt-10 -138.09 136.94 37.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.291 1.036 . . . . 73.15 108.489 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.11 74.17 10.97 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.959 -0.756 . . . . 71.23 108.959 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.71 -26.72 13.37 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.697 2.265 . . . . 73.33 112.407 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -99.46 -0.44 40.78 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.05 -0.977 . . . . 73.14 111.508 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.679 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.39 -57.87 4.13 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 116.071 1.878 . . . . 63.43 116.071 -163.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 67.1 Cg_endo -77.44 -25.18 8.47 Favored 'Trans proline' 0 C--N 1.387 2.59 0 CA-C-N 121.101 1.429 . . . . 62.45 113.221 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -87.14 -24.17 24.59 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.702 0.287 . . . . 74.12 110.585 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -8.93 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 123.495 0.718 . . . . 43.41 110.12 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -65.98 -38.17 87.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.774 0.829 . . . . 72.23 110.614 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -75.9 -2.1 28.6 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.81 0.338 . . . . 75.34 111.363 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -105.68 76.87 1.22 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.635 1.174 . . . . 65.51 107.975 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.62 95.19 8.27 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.015 -0.993 . . . . 73.12 112.325 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -150.05 176.13 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.401 -0.592 . . . . 75.23 109.401 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -73.3 114.12 28.45 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.139 0.976 . . . . 74.44 109.231 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.51 111.16 0.86 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.111 1.874 . . . . 73.04 110.421 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.66 111.17 2.28 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.862 -1.162 . . . . 70.21 107.862 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -98.35 121.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.352 0.661 . . . . 71.33 109.385 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -109.06 114.26 27.83 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.568 -1.271 . . . . 61.43 107.568 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -96.61 116.27 28.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.852 0.861 . . . . 74.54 108.968 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.41 125.87 52.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.712 -0.847 . . . . 63.1 108.712 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.71 129.82 42.8 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.423 -0.584 . . . . 64.35 109.423 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.5 t70 -144.55 152.82 41.11 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.147 -1.057 . . . . 54.13 108.147 172.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -145.19 157.31 44.11 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.326 0.651 . . . . 62.14 109.506 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.93 166.85 28.37 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.811 1.245 . . . . 71.23 107.793 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 68.9 p -168.1 166.01 13.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.828 0.451 . . . . 55.05 110.813 175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.1 p -156.65 132.63 9.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.26 -0.882 . . . . 62.21 109.12 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -70.3 126.99 31.23 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.53 -0.544 . . . . 45.32 109.53 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.3 mt -91.45 -40.89 11.16 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.263 0.554 . . . . 65.01 109.824 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.22 -173.26 3.94 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.117 -0.947 . . . . 75.55 110.172 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.97 123.06 19.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.657 -0.701 . . . . 74.34 110.014 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 64.56 17.39 10.85 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.551 1.157 . . . . 75.31 112.242 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.12 123.47 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.563 0.745 . . . . 71.52 110.16 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -125.29 166.33 16.72 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.902 1.281 . . . . 71.14 108.419 173.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.5 tm-20 -130.6 126.93 37.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.737 -1.949 . . . . 64.31 105.737 168.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.86 133.23 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.189 0.996 . . . . 63.43 108.552 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.13 135.91 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.367 1.067 . . . . 65.13 110.079 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.46 126.6 52.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.212 -1.403 . . . . 72.34 107.212 171.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -104.51 102.95 12.57 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.883 -0.784 . . . . 73.55 108.883 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.5 t -95.18 119.39 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.373 -0.973 . . . . 63.33 108.373 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 32.0 m -115.76 136.92 52.58 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.677 -0.692 . . . . 74.12 110.164 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.482 HG21 HG21 ' D' ' 114' ' ' ILE . 76.4 t -126.76 102.3 9.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.897 1.279 . . . . 64.15 108.167 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -97.84 92.53 5.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.091 -1.448 . . . . 73.23 107.091 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.3 137.35 37.15 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.453 -0.943 . . . . 74.14 108.453 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.2 p -148.78 130.26 14.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.321 0.581 . . . . 75.44 111.782 -170.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 59.5 mt -98.31 107.67 20.18 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.694 1.198 . . . . 73.15 108.316 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.9 -134.58 22.05 Favored Glycine 0 C--N 1.343 0.932 0 O-C-N 123.536 0.523 . . . . 34.01 112.272 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.32 4.54 38.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.669 0.787 . . . . 43.23 111.943 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.08 162.73 30.1 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.836 0.454 . . . . 62.43 110.608 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.0 m -66.83 136.4 55.36 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.148 -0.933 . . . . 71.33 111.552 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -90.12 -56.44 3.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.931 -1.137 . . . . 62.24 107.931 169.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -162.62 144.42 10.47 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.201 -1.363 . . . . 54.44 109.802 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -110.53 111.52 22.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.832 0.853 . . . . 74.43 108.785 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG23 ' D' ' 114' ' ' ILE . 20.2 t -127.09 127.71 45.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.012 0.525 . . . . 63.11 109.936 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -148.38 139.77 23.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.431 0.692 . . . . 75.53 109.74 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' D' ' 113' ' ' CYS . 99.1 t -132.87 124.67 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.435 0.694 . . . . 64.03 109.678 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.765 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.8 mt-30 -91.74 88.32 6.64 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.751 -0.833 . . . . 74.43 108.751 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.405 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.2 tp-100 -80.05 109.71 14.75 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 114.401 -1.272 . . . . 74.23 108.353 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.07 166.8 21.33 Favored Glycine 0 C--O 1.241 0.545 0 N-CA-C 111.946 -0.462 . . . . 53.24 111.946 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.15 140.24 6.11 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.002 -0.839 . . . . 73.22 111.002 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 59.2 mt -88.71 126.25 41.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.81 -0.811 . . . . 71.13 108.81 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.417 ' HD2' HG22 ' D' ' 13' ' ' ILE . 69.3 m-85 -124.61 124.71 42.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.104 0.561 . . . . 72.03 109.965 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -93.28 111.34 22.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.052 0.941 . . . . 61.5 108.809 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.412 HD13 HD12 ' D' ' 98' ' ' LEU . 42.2 pt -116.68 142.98 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.237 0.615 . . . . 61.44 111.431 -172.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -157.93 160.64 37.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.858 1.263 . . . . 63.4 108.585 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.75 22.4 78.12 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 123.062 0.226 . . . . 52.1 113.404 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.662 HD13 ' HG2' ' D' ' 94' ' ' MET . 1.2 pp -113.1 148.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.311 1.044 . . . . 74.04 109.959 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.27 146.41 32.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.34 0.656 . . . . 74.34 111.152 -176.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 35.45 -97.65 0.01 OUTLIER Glycine 0 C--N 1.359 1.828 0 N-CA-C 116.494 1.357 . . . . 62.04 116.494 169.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -64.25 -53.82 43.15 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.722 1.209 . . . . 60.24 110.934 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.46 -31.06 71.94 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.94 -1.027 . . . . 64.03 110.876 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.662 ' HG2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -71.96 -54.71 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.421 1.088 . . . . 53.04 109.915 -178.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.72 -25.79 68.36 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.835 -1.075 . . . . 65.14 111.563 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.67 -44.89 18.08 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.969 0.508 . . . . 65.21 111.01 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.9 -43.27 96.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.032 0.533 . . . . 72.55 111.033 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.412 HD12 HD13 ' D' ' 86' ' ' ILE . 6.7 tt -92.77 -33.39 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 72.14 110.682 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -20.73 57.36 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.401 0.52 . . . . 34.02 114.401 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.24 -49.86 1.1 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.577 0.689 . . . . 42.12 111.851 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -73.4 -45.01 57.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.868 0.467 . . . . 73.0 111.473 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 93.2 m -61.5 -48.04 91.64 Favored Pre-proline 0 CA--C 1.567 1.6 0 CA-C-O 118.286 -0.864 . . . . 34.14 111.637 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.58 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.8 Cg_exo -56.9 -38.17 96.55 Favored 'Trans proline' 0 C--N 1.399 3.228 0 C-N-CA 122.353 2.035 . . . . 64.3 113.366 168.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.91 -32.35 73.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.365 0.666 . . . . 70.53 111.251 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.65 -41.5 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.55 0.74 . . . . 55.41 110.259 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' D' ' 80' ' ' GLN . 61.7 mt -75.14 -23.52 57.83 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.152 -0.931 . . . . 74.04 111.607 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.403 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 66.4 t80 -60.64 -45.39 97.07 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.733 1.382 . . . . 73.33 114.733 -169.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.12 -42.63 58.15 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 122.118 1.879 . . . . 62.54 112.816 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -76.49 -35.65 58.25 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.921 -1.036 . . . . 71.31 110.724 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.57 78.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.896 0.878 . . . . 62.31 110.905 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -58.87 -55.09 39.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.448 1.093 . . . . 73.54 109.956 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.56 -40.32 86.9 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.273 0.983 . . . . 74.3 111.895 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.493 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -59.28 -42.71 91.86 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.02 0.825 . . . . 53.34 110.333 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.563 HG23 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -63.65 -52.02 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.018 0.927 . . . . 75.42 110.364 172.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.8 m -53.66 -43.61 68.96 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.361 1.464 . . . . 65.53 112.099 -172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -68.48 -43.05 77.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.011 -0.995 . . . . 44.4 110.377 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 76.7 mtm -66.35 -30.92 71.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.868 0.467 . . . . 55.54 111.964 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -71.02 -42.39 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.391 0.676 . . . . 75.12 110.397 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -71.06 -29.95 65.97 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 116.553 -0.294 . . . . 74.24 110.442 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -69.74 -28.67 65.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.762 0.825 . . . . 75.31 110.148 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 11.09 62.91 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.717 0.636 . . . . 74.1 112.922 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.568 HG23 ' HB3' ' C' ' 17' ' ' TYR . 75.1 p 56.06 25.12 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.292 1.837 . . . . 75.52 113.46 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.441 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 28.2 m-85 -103.34 166.22 12.18 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 125.055 1.342 . . . . 72.41 109.687 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 34.2 Cg_endo -59.23 124.71 16.19 Favored 'Trans proline' 0 C--N 1.394 2.933 0 C-N-CA 123.052 2.501 . . . . 75.23 112.791 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -55.16 119.64 5.8 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 123.883 0.74 . . . . 70.52 109.869 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.01 98.41 8.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.327 0.584 . . . . 73.1 109.831 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.467 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 79.6 m-20 -99.13 86.3 3.41 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.006 -1.109 . . . . 74.41 108.006 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.403 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 1.0 OUTLIER -72.59 138.16 46.64 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.934 -1.03 . . . . 61.55 109.896 -173.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 131.5 95.21 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.993 0.517 . . . . 64.13 111.891 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.3 119.44 4.58 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.906 1.737 . . . . 72.4 110.072 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.75 120.22 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.63 0.728 . . . . 72.53 110.031 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 . . . . . 0 CA--C 1.543 0.679 0 N-CA-C 108.316 -0.994 . . . . 52.21 108.316 176.43 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.2 m . . . . . 0 C--O 1.235 0.338 0 N-CA-C 108.674 -0.862 . . . . 75.11 108.674 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -126.59 116.57 21.24 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.07 -1.085 . . . . 75.51 108.07 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -137.55 110.66 7.79 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.701 0.8 . . . . 64.04 108.997 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -65.91 125.29 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 171.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -88.55 -33.4 17.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.152 -0.685 . . . . 61.21 109.152 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -172.61 145.31 1.54 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.34 0.4 . . . . 74.42 110.901 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.652 HD12 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -121.81 129.96 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.912 -1.144 . . . . 74.51 107.912 168.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 38.9 p90 -163.6 159.13 21.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.607 0.763 . . . . 74.43 110.751 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -84.92 118.53 24.58 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.354 -0.61 . . . . 74.04 109.354 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HZ1' ' HD3' ' B' ' 29' ' ' PRO . 23.6 mtpp -78.7 -40.64 33.2 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.752 -0.833 . . . . 55.22 108.752 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -136.42 142.17 43.65 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.985 -1.007 . . . . 75.01 110.234 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.492 HG21 ' SD ' ' B' ' 117' ' ' MET . 74.7 mt -139.84 140.72 35.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.56 1.544 . . . . 73.33 107.271 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -154.05 116.18 4.3 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 62.4 109.289 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 69.8 t80 -111.24 122.62 48.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.523 -1.658 . . . . 63.33 106.523 166.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.58 130.85 56.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.645 -0.872 . . . . 72.23 108.645 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.53 79.14 73.86 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.102 -1.814 . . . . 43.54 106.102 165.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.6 -27.25 45.81 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.439 2.093 . . . . 75.12 111.149 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -111.33 31.89 5.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.338 -1.301 . . . . 71.33 109.12 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.76 99.85 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.681 0.993 . . . . 71.21 113.681 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.52 -22.94 17.77 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 121.905 1.737 . . . . 54.33 113.415 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.45 -39.52 70.92 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.188 0.595 . . . . 75.15 111.011 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 73' ' ' ALA . 28.2 m -73.3 -15.64 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.352 0.661 . . . . 72.33 112.045 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' HD1' ' HD2' ' B' ' 15' ' ' ARG . 79.3 t80 -61.94 -38.92 90.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.784 0.834 . . . . 71.13 110.849 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -100.75 -13.26 18.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.239 0.616 . . . . 70.41 112.016 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.7 mmtp -83.29 150.71 25.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 117.977 0.353 . . . . 73.02 111.724 175.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.49 132.19 45.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.099 0.96 . . . . 63.5 109.895 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.537 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -77.63 93.44 4.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.216 0.531 . . . . 62.31 110.162 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' H ' HD22 ' A' ' 68' ' ' LEU . 8.5 tt0 -125.13 82.82 61.4 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.183 1.393 . . . . 75.34 107.745 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.4 114.32 3.77 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.537 2.158 . . . . 53.13 112.852 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -94.74 90.5 6.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.238 -1.764 . . . . 74.03 106.238 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.39 130.53 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.327 -0.851 . . . . 73.2 110.499 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.0 tttm -119.59 115.04 23.18 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.722 -1.214 . . . . 61.21 107.722 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.31 123.95 45.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.829 0.851 . . . . 73.11 109.222 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -118.84 109.21 15.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.989 0.916 . . . . 71.02 109.569 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.77 120.53 40.23 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.604 -0.887 . . . . 71.53 108.604 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -154.46 162.46 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.395 -0.594 . . . . 71.41 109.395 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -134.25 164.05 28.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.158 0.583 . . . . 72.35 110.842 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.79 108.27 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.826 -1.176 . . . . 73.24 107.826 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.8 m -109.9 152.44 25.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.135 0.574 . . . . 72.2 110.339 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.9 t -157.11 142.86 17.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.48 0.712 . . . . 53.02 110.062 -172.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -90.68 118.96 30.53 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.938 -0.764 . . . . 74.23 108.938 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 57' ' ' GLU . 71.3 mt -90.14 -39.64 12.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.086 0.555 . . . . 73.33 110.569 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -162.96 -174.09 3.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.789 0.836 . . . . 75.31 110.415 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.04 120.2 13.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.34 -0.985 . . . . 74.1 108.34 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 69.25 3.48 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.59 1.156 . . . . 41.13 112.811 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 21.2 t -115.32 114.59 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.821 -1.177 . . . . 70.35 107.821 176.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -142.58 133.05 25.02 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.488 -0.93 . . . . 74.15 108.488 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' HD11 ' A' ' 51' ' ' LEU . 75.4 tt0 -114.09 120.14 39.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.737 0.415 . . . . 73.54 110.55 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -100.69 121.81 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.114 -1.81 . . . . 73.42 106.114 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -106.18 134.97 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.975 -0.75 . . . . 72.2 108.975 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.421 HD11 ' HD1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -96.53 114.89 26.59 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.254 -1.017 . . . . 72.25 108.254 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -101.77 99.94 10.23 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.824 -0.806 . . . . 74.42 108.824 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.84 137.69 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 107.795 -1.187 . . . . 71.24 107.795 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.9 m -129.55 124.63 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.624 -0.88 . . . . 73.11 108.624 171.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.37 130.62 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 107.828 -1.175 . . . . 74.53 107.828 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 7.3 m -121.98 148.15 45.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.763 -1.569 . . . . 75.45 106.763 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.07 124.29 14.57 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.967 -1.123 . . . . 72.45 107.967 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 48.5 m -122.4 141.45 51.58 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 123.205 0.602 . . . . 73.11 110.298 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.537 HD21 ' CE3' ' A' ' 36' ' ' TRP . 51.1 mt -90.68 52.6 2.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.335 1.054 . . . . 74.04 109.791 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.14 -85.46 0.91 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.217 -0.901 . . . . 74.12 111.825 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -88.29 -31.09 19.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.443 0.697 . . . . 72.15 111.309 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.96 124.49 46.08 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 118.79 -0.624 . . . . 75.23 109.687 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.6 m -65.97 132.53 48.82 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.274 0.359 . . . . 65.24 110.797 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -75.51 -53.87 7.93 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.0 0.813 . . . . 44.13 109.697 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -164.06 169.77 17.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.583 -1.19 . . . . 74.23 111.304 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 tp -130.21 148.17 52.01 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.985 -1.461 . . . . 73.13 107.444 167.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -142.35 134.55 27.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.127 -1.064 . . . . 70.41 108.127 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -145.93 119.9 9.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.313 -0.995 . . . . 64.14 108.313 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.43 126.76 64.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.082 0.953 . . . . 75.32 109.635 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -104.99 90.15 3.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.044 -0.98 . . . . 74.01 108.781 172.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.408 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.0 tp-100 -76.83 97.64 4.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.929 -1.137 . . . . 64.41 107.929 173.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.82 143.52 20.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.122 -0.791 . . . . 71.25 111.122 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.61 120.87 1.74 Allowed Glycine 0 CA--C 1.495 -1.163 0 N-CA-C 110.304 -1.118 . . . . 71.14 110.304 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -83.96 125.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.791 -1.189 . . . . 75.52 107.791 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.57 118.03 23.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.197 0.999 . . . . 70.41 108.331 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -87.5 100.11 12.53 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.161 -1.422 . . . . 75.22 107.161 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.629 HG21 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -134.07 118.39 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.706 -0.679 . . . . 72.21 110.128 -168.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.8 177.67 11.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.727 1.211 . . . . 73.11 109.85 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.58 74.09 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 120.883 0.157 . . . . 43.02 112.958 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.507 HD13 ' HB2' ' A' ' 94' ' ' MET . 1.1 pp -129.45 161.35 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.311 1.444 . . . . 70.33 110.169 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.69 171.18 14.46 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.542 0.737 . . . . 70.44 109.965 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.13 -120.0 2.11 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.387 1.315 . . . . 53.51 116.387 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -76.21 -15.97 59.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.994 0.918 . . . . 63.32 112.695 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.53 -50.86 69.67 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.583 -0.525 . . . . 75.2 109.583 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.507 ' HB2' HD13 ' A' ' 89' ' ' ILE . 14.4 ttt -74.22 -32.71 63.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.114 -0.948 . . . . 65.13 110.756 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.74 92.31 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.123 0.487 . . . . 45.21 111.137 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.01 -37.99 78.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.778 0.831 . . . . 74.34 110.668 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.82 -63.38 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.514 -0.766 . . . . 72.34 110.198 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.629 HD21 HG21 ' A' ' 86' ' ' ILE . 53.8 mt -71.23 -22.78 61.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.251 0.62 . . . . 73.41 111.967 -176.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.6 -28.57 46.89 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.435 0.46 . . . . 71.03 113.887 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.93 -52.38 0.62 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.347 0.573 . . . . 72.24 112.397 -173.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -64.26 -54.42 33.58 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.328 0.651 . . . . 75.54 112.602 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' A' ' 98' ' ' LEU . 52.9 m -65.91 -46.45 64.86 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 123.839 0.856 . . . . 64.04 112.645 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -24.36 50.53 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 121.587 1.525 . . . . 72.44 112.852 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -74.32 -28.76 61.3 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.107 0.412 . . . . 73.34 111.032 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.421 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 19.6 mt -60.75 -43.07 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 121.369 0.604 . . . . 30.22 109.539 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.3 mt -70.53 -19.14 62.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.533 -1.212 . . . . 62.12 112.193 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.421 ' HD1' HD11 ' A' ' 60' ' ' LEU . 49.4 t80 -70.46 -42.49 15.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-O 117.563 -1.208 . . . . 74.44 113.6 -169.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 99.0 Cg_exo -49.43 -35.1 35.06 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.045 1.83 . . . . 55.3 114.022 168.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -84.74 -37.49 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.296 0.638 . . . . 62.55 111.439 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.33 -42.6 79.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.158 0.504 . . . . 71.44 109.984 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -53.37 -57.26 11.22 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.497 1.519 . . . . 75.32 109.909 171.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.35 -36.58 84.61 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.393 1.058 . . . . 62.04 111.671 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.23 -48.79 80.25 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.183 0.593 . . . . 43.12 110.026 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.89 -44.8 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 115.049 -0.978 . . . . 73.51 110.793 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 125' ' ' GLN . 60.2 m -57.55 -40.73 79.54 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.924 0.889 . . . . 74.45 111.116 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 t -69.0 -46.64 67.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.164 -0.925 . . . . 74.21 110.412 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.6 mtp -56.82 -40.69 76.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.764 0.825 . . . . 64.14 111.81 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.5 t -65.19 -46.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.506 1.123 . . . . 71.22 110.719 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -71.34 -26.49 62.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.598 0.359 . . . . 71.01 111.621 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.7 mtt-85 -73.2 -32.57 64.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.73 0.812 . . . . 73.24 110.082 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 4.4 60.25 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.999 -0.546 . . . . 50.03 112.901 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 m 68.07 44.19 1.5 Allowed 'General case' 0 C--N 1.36 1.052 0 CA-C-O 122.721 1.248 . . . . 64.32 110.268 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.9 149.13 50.22 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 114.769 -1.105 . . . . 74.14 108.955 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.29 141.58 93.34 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.087 1.858 . . . . 63.5 110.633 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.493 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -61.41 159.74 12.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.286 1.034 . . . . 61.33 112.448 -168.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.55 102.25 6.29 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 74.33 108.348 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -98.17 94.24 6.69 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.173 -0.676 . . . . 72.32 109.173 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 134.99 57.52 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.63 0.772 . . . . 65.54 110.906 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 139.45 91.74 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.162 0.585 . . . . 53.04 112.176 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.86 97.55 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.461 2.107 . . . . 72.22 109.991 177.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.13 112.76 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.647 -0.872 . . . . 72.02 108.647 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.57 87.84 3.47 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.806 -0.634 . . . . 72.43 110.434 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 . . . . . 0 N--CA 1.475 0.813 0 CA-C-N 115.611 -0.722 . . . . 70.05 109.259 169.499 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 CA--C 1.547 0.828 0 N-CA-C 110.018 -0.364 . . . . 55.31 110.018 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -131.96 113.58 13.58 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.622 -1.251 . . . . 63.13 107.622 172.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 21.2 tp60 -127.87 98.66 5.23 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.388 0.613 . . . . 71.22 109.983 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 tt -78.61 119.68 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 115.393 -0.821 . . . . 72.23 109.733 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.85 -48.35 7.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.049 0.54 . . . . 74.45 110.562 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.466 ' HD2' ' HD1' ' A' ' 32' ' ' PHE . 55.2 ttt180 -165.26 142.91 5.99 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.484 -0.325 . . . . 72.14 110.563 -172.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.2 mt -114.5 142.93 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.449 -1.315 . . . . 65.42 107.449 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -164.83 158.44 17.4 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.031 0.443 . . . . 71.23 110.567 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.46 HG21 HD11 ' B' ' 21' ' ' ILE . 89.5 m -85.62 123.36 30.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.158 -0.682 . . . . 55.41 109.158 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.442 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 30.9 mtpt -88.09 -35.87 17.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.453 -0.794 . . . . 54.13 111.183 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -161.92 147.89 13.49 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.999 0.428 . . . . 63.14 111.013 -173.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.7 mm -142.33 145.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.101 1.76 . . . . 72.14 108.093 -175.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -154.44 148.43 25.69 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.676 0.61 . . . . 73.22 110.217 170.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 88.2 t80 -156.12 107.22 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.166 -1.42 . . . . 74.02 107.166 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.71 118.58 28.41 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.446 0.699 . . . . 72.41 109.793 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -112.12 87.89 9.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.429 1.092 . . . . 70.11 109.821 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 37.5 Cg_endo -63.67 -41.55 24.42 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.65 2.233 . . . . 75.52 113.072 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -106.27 31.51 5.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.58 0.752 . . . . 72.12 110.036 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -48.59 -48.11 69.17 Favored Pre-proline 0 CA--C 1.573 1.855 0 C-N-CA 125.217 1.407 . . . . 75.42 114.698 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HZ1' ' A' ' 19' ' ' LYS . 89.9 Cg_endo -92.66 -5.34 3.27 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.086 1.857 . . . . 54.22 113.087 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -98.4 -0.47 43.58 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.689 0.796 . . . . 64.52 110.814 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.99 -28.02 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.39 1.076 . . . . 71.13 111.089 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -71.23 -18.25 62.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.878 0.871 . . . . 74.25 112.519 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.33 -41.01 79.18 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.396 0.617 . . . . 74.14 109.887 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.519 ' HB2' HD13 ' B' ' 68' ' ' LEU . 81.4 mttt -108.73 106.74 16.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.58 -1.191 . . . . 72.42 108.465 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.44 79.28 1.91 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.74 0.781 . . . . 73.11 110.13 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -153.52 151.37 29.73 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.996 -1.483 . . . . 71.52 106.996 173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -90.64 114.93 62.97 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.507 -1.664 . . . . 70.11 106.507 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.53 131.36 37.72 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.305 2.004 . . . . 63.22 111.978 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 120.41 14.05 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.914 0.759 . . . . 73.53 109.107 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.844 HG12 HD22 ' B' ' 126' ' ' LEU . 2.1 t -86.02 118.74 33.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 106.503 -1.666 . . . . 72.24 106.503 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -138.46 134.92 34.64 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.496 -0.557 . . . . 64.55 109.496 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' B' ' 126' ' ' LEU . 0.7 OUTLIER -128.96 156.63 43.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.248 0.619 . . . . 73.02 112.393 -169.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.19 141.32 48.03 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.932 1.293 . . . . 65.54 108.622 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.2 tp -85.61 136.57 33.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.655 0.782 . . . . 72.43 110.99 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.9 m-20 -129.77 144.27 51.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.988 -1.116 . . . . 74.24 107.988 172.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.9 m -130.18 125.64 35.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.296 0.638 . . . . 72.32 109.968 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -132.23 159.07 40.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.169 0.988 . . . . 63.11 109.11 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 62.1 m -143.01 168.91 18.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.071 0.549 . . . . 73.01 109.98 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.5 t -151.45 164.35 36.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.515 1.126 . . . . 74.12 108.408 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -124.05 124.11 41.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.082 0.553 . . . . 63.01 109.54 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.41 -28.55 16.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.342 0.657 . . . . 64.5 110.783 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.93 -171.48 0.75 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 62.34 111.223 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.48 113.14 4.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.615 -1.175 . . . . 74.21 110.152 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 75.93 -5.15 2.23 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.773 2.029 . . . . 73.05 112.09 -177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 51.1 t -104.86 99.73 9.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 108.106 -1.072 . . . . 64.21 108.106 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.91 168.48 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.513 0.673 . . . . 75.34 110.062 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -138.41 100.06 4.01 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.402 -1.703 . . . . 63.31 106.402 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.46 128.82 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.197 0.599 . . . . 63.05 109.739 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 47.1 t -105.37 145.07 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.006 0.922 . . . . 73.04 109.815 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 112.96 18.99 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.443 -1.688 . . . . 75.04 106.443 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 34.0 ttm180 -102.83 130.84 49.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.06 -0.718 . . . . 65.45 109.06 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.489 HG11 HD12 ' B' ' 42' ' ' LEU . 50.7 t -121.14 108.83 23.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 107.218 -1.401 . . . . 71.22 107.218 169.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -98.28 136.79 37.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.167 0.508 . . . . 74.1 109.93 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 89.8 t -122.97 137.98 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.195 1.398 . . . . 71.14 110.705 -169.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 57.4 m -123.9 151.38 43.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.873 1.269 . . . . 71.31 109.038 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.04 146.87 31.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.686 0.795 . . . . 41.23 108.913 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 67.3 p -153.68 158.72 41.47 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 75.04 111.554 -171.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' B' ' 34' ' ' LYS . 72.6 mt -128.27 107.0 9.41 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.581 -1.266 . . . . 61.02 107.581 169.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.8 -110.6 3.21 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 123.422 0.451 . . . . 73.13 112.322 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -110.0 0.25 18.42 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.54 0.736 . . . . 75.24 111.517 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.61 159.19 28.36 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.504 -0.747 . . . . 65.24 111.358 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -73.9 139.08 44.72 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.434 -0.803 . . . . 51.41 110.488 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.96 -53.67 3.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.149 -1.056 . . . . 53.24 108.149 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.524 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 46.0 p90 -156.44 170.16 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.724 -1.125 . . . . 70.24 110.415 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.65 155.14 48.54 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.68 1.592 . . . . 65.22 107.939 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.589 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 54.1 t -152.91 158.67 42.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.125 -0.694 . . . . 73.45 109.125 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -155.76 137.94 14.69 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.723 -1.214 . . . . 74.01 107.723 171.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.0 146.38 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.303 0.641 . . . . 72.22 109.277 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -129.65 99.24 5.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.783 0.833 . . . . 64.12 108.969 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -91.42 106.47 18.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.42 -0.809 . . . . 70.43 109.394 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.92 168.11 21.15 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.839 -0.505 . . . . 62.24 111.839 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.45 129.86 2.11 Favored Glycine 0 C--O 1.236 0.28 0 N-CA-C 111.005 -0.838 . . . . 63.22 111.005 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -85.15 115.65 27.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.604 -0.887 . . . . 61.55 108.604 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.89 131.76 52.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.526 -0.916 . . . . 75.21 108.526 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -107.71 106.9 17.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.329 -0.989 . . . . 51.53 108.329 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -128.35 144.8 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.797 0.839 . . . . 75.42 111.277 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.73 171.92 19.43 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.348 1.059 . . . . 74.53 109.183 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.68 -48.33 2.06 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.368 -0.378 . . . . 73.11 112.733 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 163.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.533 0.733 . . . . 63.35 110.177 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 158.11 21.19 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.732 0.413 . . . . 45.04 111.529 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -113.72 5.45 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.858 0.724 . . . . 63.51 114.298 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.4 m -66.08 -38.29 87.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.318 1.047 . . . . 64.14 110.471 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.66 -31.32 66.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.674 -1.148 . . . . 75.12 110.002 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.5 tpt -70.39 -43.19 70.6 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.942 0.897 . . . . 63.45 109.945 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.63 67.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.196 -0.911 . . . . 72.32 111.278 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -83.51 -29.19 28.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.802 0.841 . . . . 70.43 110.561 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -68.98 -61.96 1.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.285 0.634 . . . . 54.23 110.789 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.73 -12.66 25.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.828 0.677 . . . . 73.23 112.828 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.68 1.42 42.19 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-O 119.92 -0.378 . . . . 52.12 113.66 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.1 -58.27 0.31 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.173 0.486 . . . . 53.42 111.114 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.409 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 52.7 t80 -74.66 -45.32 45.47 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.106 -0.497 . . . . 63.53 111.798 -172.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.558 ' HA ' HD12 ' B' ' 105' ' ' ILE . 99.8 m -63.64 -46.26 82.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.422 -0.799 . . . . 71.41 111.734 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.58 -39.19 92.47 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.777 1.651 . . . . 73.53 113.226 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.22 -30.54 71.66 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 123.014 0.525 . . . . 70.25 111.83 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' B' ' 102' ' ' CYS . 96.7 mt -64.43 -47.46 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.389 1.076 . . . . 73.05 110.41 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 mt -81.6 -12.62 58.67 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.345 -1.298 . . . . 60.33 111.384 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.471 ' HE2' ' HA ' ' B' ' 130' ' ' PRO . 26.1 t80 -63.29 -49.94 77.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.944 1.298 . . . . 72.2 113.084 -170.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.2 -33.25 95.0 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.867 1.711 . . . . 74.43 113.073 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 81.7 m-85 -66.11 -48.26 71.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.023 0.529 . . . . 71.22 110.837 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -40.88 97.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.954 0.902 . . . . 72.51 110.961 177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.452 ' HE ' ' HB2' ' B' ' 127' ' ' ASN . 81.4 mtp180 -55.57 -52.61 63.17 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.317 1.047 . . . . 54.3 110.454 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.31 -39.83 92.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.197 -0.91 . . . . 65.41 111.33 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.6 t -70.74 -43.43 68.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.871 -0.604 . . . . 70.04 111.559 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.474 HD11 ' HB ' ' B' ' 62' ' ' VAL . 95.5 mt -63.11 -46.78 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 122.815 0.446 . . . . 74.22 110.474 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.409 HG21 ' CB ' ' C' ' 119' ' ' SER . 22.6 m -52.24 -41.18 62.57 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.81 0.693 . . . . 74.24 111.092 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.9 t -62.7 -53.92 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.927 -0.578 . . . . 71.52 110.383 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 21' ' ' ILE . 36.8 mmt -59.49 -44.58 93.04 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.208 0.603 . . . . 62.44 111.76 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.04 -40.47 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.513 1.125 . . . . 70.54 111.235 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 94.3 p -70.52 -31.91 69.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.422 -0.354 . . . . 53.31 110.834 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.1 mtt-85 -63.12 -27.73 69.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.321 0.648 . . . . 65.04 111.063 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.13 10.55 63.02 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 123.632 0.582 . . . . 52.33 113.059 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.2 p 64.62 44.06 4.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.749 2.019 . . . . 65.43 112.377 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.54 161.87 35.32 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.385 0.674 . . . . 73.34 110.908 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.49 ' HA ' ' OE1' ' C' ' 125' ' ' GLN . 32.1 Cg_exo -62.25 172.89 3.73 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.496 2.797 . . . . 65.13 114.326 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.691 ' HB3' ' HG3' ' C' ' 125' ' ' GLN . 12.9 pm0 -64.57 154.99 34.55 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 115.28 -0.873 . . . . 74.53 111.841 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.844 HD22 HG12 ' B' ' 40' ' ' VAL . 23.0 tp -142.48 83.98 1.84 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.477 -0.935 . . . . 63.51 108.477 165.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.452 ' HB2' ' HE ' ' B' ' 111' ' ' ARG . 6.2 p30 -115.84 106.31 13.69 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.037 -1.468 . . . . 74.24 107.037 170.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.634 ' HB2' HD11 ' B' ' 42' ' ' LEU . 4.0 tt -55.26 136.53 48.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.724 -1.125 . . . . 73.51 109.336 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -50.93 140.17 21.07 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 124.034 0.834 . . . . 52.34 110.985 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' D' ' 16' ' ' ILE . 25.8 Cg_exo -65.13 71.62 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.15 2.567 . . . . 74.53 113.242 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.62 85.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.298 -1.001 . . . . 63.52 108.298 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.496 ' ND2' HG23 ' D' ' 105' ' ' ILE . 2.1 m-20 -78.38 113.11 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.541 -0.911 . . . . 61.04 108.541 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 123.963 0.905 . . . . 75.54 110.709 175.018 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m . . . . . 0 C--O 1.239 0.545 0 N-CA-C 109.109 -0.7 . . . . 75.15 109.109 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 72.8 t80 -96.36 131.94 42.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.611 -0.885 . . . . 75.11 108.611 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -139.83 124.4 18.19 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.147 0.579 . . . . 63.31 109.878 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -93.35 133.24 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.535 0.734 . . . . 73.01 109.262 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -105.17 -45.96 4.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.618 0.767 . . . . 71.03 110.371 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -167.81 124.35 1.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.999 -0.371 . . . . 73.3 109.999 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.22 135.45 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.552 -0.907 . . . . 75.11 108.552 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 27.3 p90 -173.45 163.13 4.39 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.176 0.59 . . . . 65.34 109.804 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -85.78 124.28 32.1 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.812 0.445 . . . . 71.42 110.374 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.601 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.2 mmtp -78.1 -49.95 12.94 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.869 0.842 . . . . 53.01 108.977 170.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -135.41 142.47 45.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.989 -1.459 . . . . 72.51 109.38 -169.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.4 mt -143.99 146.13 21.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.714 -1.587 . . . . 63.14 106.714 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -159.7 149.75 18.65 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.266 0.555 . . . . 55.25 110.42 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -142.65 116.5 9.3 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.614 -1.254 . . . . 75.55 107.614 171.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.57 126.21 52.97 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.847 0.859 . . . . 75.14 109.725 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 81.32 70.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 107.998 -1.112 . . . . 65.23 107.998 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.22 -25.74 42.75 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.131 2.554 . . . . 72.13 112.194 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.25 26.72 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.985 0.914 . . . . 71.22 110.44 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.479 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -46.16 -53.5 22.09 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.161 1.171 . . . . 44.43 114.161 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 59.9 Cg_endo -81.33 -18.74 8.29 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 121.566 1.511 . . . . 74.52 113.824 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.57 -49.26 42.24 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.303 0.641 . . . . 64.41 111.472 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -77.83 -13.37 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.802 1.241 . . . . 74.32 111.4 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.563 ' HE2' ' HD3' ' D' ' 15' ' ' ARG . 79.3 t80 -53.93 -43.06 69.46 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.322 1.049 . . . . 63.43 112.24 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -103.94 27.59 7.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.637 0.732 . . . . 71.14 110.046 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.11 165.18 11.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.404 0.682 . . . . 72.43 109.411 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.35 120.55 24.54 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.99 -0.744 . . . . 64.22 108.99 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -85.56 88.96 7.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.585 0.754 . . . . 71.24 110.688 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.457 ' H ' HD22 ' C' ' 68' ' ' LEU . 35.0 tt0 -128.75 74.32 80.69 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 107.768 -1.197 . . . . 75.24 107.768 169.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.82 143.21 4.18 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.503 2.802 . . . . 64.41 113.404 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.89 115.38 25.31 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.251 -1.018 . . . . 74.33 108.251 167.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.476 HG11 HD21 ' C' ' 128' ' ' LEU . 26.1 t -83.32 85.42 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.05 -0.722 . . . . 73.55 109.05 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -93.87 100.94 13.02 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.746 -1.205 . . . . 70.24 107.746 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.433 HD22 HD13 ' C' ' 128' ' ' LEU . 4.2 pp -90.27 154.53 19.65 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.144 -0.688 . . . . 74.54 109.144 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -120.9 145.33 47.77 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.437 1.095 . . . . 74.44 108.19 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.5 tp -117.73 134.45 54.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.749 0.82 . . . . 70.23 108.861 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.15 150.08 27.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.222 -1.029 . . . . 71.33 108.222 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 91.6 m -137.95 123.97 20.23 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.096 -0.705 . . . . 75.41 109.096 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.98 23.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.287 1.035 . . . . 54.21 108.497 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 p -145.27 144.37 30.74 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.748 0.419 . . . . 64.3 110.455 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -145.1 129.77 18.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.919 0.888 . . . . 72.11 109.109 -176.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -76.95 131.86 38.73 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.527 -0.546 . . . . 64.01 109.527 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.594 HD11 HD12 ' C' ' 83' ' ' ILE . 35.4 mt -106.46 -42.71 4.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.681 . . . . 63.53 109.568 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.78 -177.11 5.41 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.45 -1.25 . . . . 73.24 109.138 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.99 109.08 6.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.053 -0.522 . . . . 73.24 109.935 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.86 18.04 11.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.039 1.336 . . . . 75.21 112.222 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 48.1 t -121.93 114.48 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.66 -1.608 . . . . 74.11 106.66 169.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.433 ' HE2' HG12 ' C' ' 86' ' ' ILE . 43.6 p90 -134.64 -178.74 5.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.656 0.741 . . . . 64.34 110.95 -174.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' C' ' 51' ' ' LEU . 23.9 tt0 -126.34 113.24 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.877 -1.511 . . . . 74.13 108.904 -170.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.9 129.52 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.219 -1.03 . . . . 65.04 108.219 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.1 106.36 16.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.486 -1.302 . . . . 64.53 107.486 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.1 OUTLIER -86.13 103.09 14.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.066 -1.087 . . . . 71.01 108.066 -177.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -84.83 106.11 16.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.768 0.827 . . . . 72.24 109.349 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.84 130.73 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.313 -0.995 . . . . 54.53 108.313 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 5.8 m -116.8 148.31 41.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.041 -1.096 . . . . 64.43 108.041 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.702 HG21 HG21 ' C' ' 114' ' ' ILE . 46.1 t -132.91 110.43 15.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.872 -1.159 . . . . 62.13 107.872 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m -102.57 139.02 38.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.0 -0.741 . . . . 74.4 109.0 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.53 112.75 15.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.513 -1.291 . . . . 65.1 107.513 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -129.82 130.03 44.78 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.346 0.404 . . . . 55.43 110.256 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.457 HD22 ' H ' ' C' ' 37' ' ' GLN . 41.7 mt -87.29 27.88 1.01 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.961 1.304 . . . . 74.44 110.906 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.22 -103.1 1.92 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.933 -0.867 . . . . 62.53 110.933 -171.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.69 -29.37 18.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.979 0.512 . . . . 63.03 110.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.82 121.12 22.92 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.977 0.911 . . . . 72.02 110.146 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.2 m -80.81 124.76 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.789 -0.819 . . . . 74.13 108.789 166.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.69 -51.16 9.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.405 -0.816 . . . . 73.22 109.973 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -166.53 176.45 7.31 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.263 -0.881 . . . . 74.12 110.729 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -143.4 141.4 30.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.906 -1.516 . . . . 73.34 106.906 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.506 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -147.4 125.4 12.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.864 0.465 . . . . 73.35 109.896 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -129.66 133.55 47.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.878 0.471 . . . . 64.33 110.122 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.51 137.83 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.024 0.93 . . . . 74.42 108.56 168.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -112.15 102.09 10.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.294 1.037 . . . . 73.23 108.665 171.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -86.93 108.98 19.04 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.452 -0.794 . . . . 75.02 110.251 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 150.21 25.76 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 123.232 0.332 . . . . 50.4 112.305 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.36 119.33 0.93 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.31 -0.716 . . . . 75.2 111.31 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.594 HD12 HD11 ' C' ' 51' ' ' LEU . 11.7 mm -84.82 124.66 40.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.52 -0.918 . . . . 64.12 108.52 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -132.12 126.35 33.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.656 0.782 . . . . 75.25 110.014 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -96.08 134.98 38.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.912 -1.144 . . . . 35.51 107.912 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.452 HD13 HG12 ' C' ' 89' ' ' ILE . 2.7 pp -131.87 162.65 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.536 0.684 . . . . 43.44 111.911 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.92 29.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.29 -1.323 . . . . 34.31 108.096 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.36 49.17 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.528 -1.151 . . . . 72.41 114.991 173.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.456 ' O ' HG13 ' C' ' 89' ' ' ILE . 36.5 pt . . . . . 0 C--N 1.366 1.321 0 CA-C-N 118.489 1.144 . . . . 70.55 110.753 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 112.652 0.612 . . . . 65.23 112.652 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.5 ptm -82.74 5.88 19.94 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.307 0.643 . . . . 71.44 112.149 -177.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.15 -21.38 2.64 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 72.32 110.929 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.549 1.14 . . . . 64.04 110.207 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -72.18 -60.46 2.22 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.224 0.61 . . . . 74.25 111.008 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.434 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.3 pp -75.01 -14.47 60.61 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.003 0.521 . . . . 62.01 112.392 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.63 6.96 68.02 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.933 -0.37 . . . . 55.21 113.246 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.16 -63.54 0.11 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.082 0.441 . . . . 74.34 111.607 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -69.75 -50.79 40.04 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.984 0.913 . . . . 74.31 112.639 -169.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.466 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -59.7 -47.14 98.22 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 118.7 -0.667 . . . . 61.21 112.314 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 33.2 Cg_exo -63.56 -34.73 63.1 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.858 1.705 . . . . 71.53 113.28 171.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -69.69 -22.07 63.45 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.718 0.407 . . . . 65.43 111.314 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -69.35 -41.43 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.215 0.606 . . . . 70.13 109.965 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.1 mt -78.2 -20.15 52.43 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.911 -1.041 . . . . 73.4 111.366 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -57.79 -51.56 80.84 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 113.855 1.057 . . . . 74.44 113.855 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.48 -34.94 99.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.851 1.7 . . . . 75.11 112.606 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.45 -43.32 77.3 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.32 0.648 . . . . 73.13 111.243 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.65 91.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.634 0.773 . . . . 70.45 110.48 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.22 -58.98 6.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.843 1.657 . . . . 75.24 110.615 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -33.2 73.88 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.392 0.433 . . . . 71.54 110.65 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -63.05 -33.34 75.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.147 0.579 . . . . 74.5 111.559 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.702 HG21 HG21 ' C' ' 64' ' ' VAL . 91.4 mt -75.04 -47.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 63.31 109.98 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -28.5 67.2 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 115.252 -0.885 . . . . 31.24 111.183 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.1 t -70.74 -50.43 36.27 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.321 -0.854 . . . . 73.11 110.155 170.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.547 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.98 -38.47 73.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.112 0.965 . . . . 71.22 113.323 -175.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.92 -36.27 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.337 -0.392 . . . . 72.2 110.604 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.409 ' CB ' HG21 ' B' ' 115' ' ' THR . 39.6 p -76.36 -22.08 55.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.797 0.439 . . . . 71.12 111.298 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.463 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 82.8 mtt-85 -68.39 -36.39 79.09 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 73.05 109.512 171.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.8 3.51 49.84 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.084 -0.962 . . . . 54.31 112.604 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.443 HG23 ' HB3' ' D' ' 17' ' ' TYR . 67.9 p 56.22 21.36 5.22 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 126.765 2.026 . . . . 72.41 112.321 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -97.84 161.24 26.36 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.516 1.126 . . . . 74.22 108.865 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.05 107.99 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.674 2.25 . . . . 72.42 111.734 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.62 155.97 17.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.846 0.716 . . . . 72.22 112.067 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -117.11 91.94 3.72 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.394 -0.965 . . . . 62.43 108.394 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -90.73 88.98 7.3 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.995 -1.483 . . . . 72.51 106.995 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.476 HD21 HG11 ' C' ' 40' ' ' VAL . 48.7 mt -79.55 142.66 35.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.52 -1.218 . . . . 52.32 112.093 -164.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.43 96.72 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.924 -1.034 . . . . 63.11 111.116 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.652 ' HG3' HD12 ' A' ' 16' ' ' ILE . 86.2 Cg_endo -75.26 -171.9 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.81 2.34 . . . . 73.33 113.875 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.72 117.15 7.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 114.185 -1.371 . . . . 44.51 107.412 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.41 65.72 9.33 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.246 0.546 . . . . 71.41 109.656 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 t80 . . . . . 0 C--O 1.215 -0.758 0 N-CA-C 108.565 -0.902 . . . . 64.52 108.565 179.09 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 109.685 -0.487 . . . . 74.24 109.685 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.435 ' HD2' HG22 ' D' ' 86' ' ' ILE . 71.1 t80 -158.81 91.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.443 -1.317 . . . . 61.21 107.443 170.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.4 mt-30 -111.89 136.22 51.48 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.263 0.625 . . . . 75.51 109.707 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.3 131.92 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.02 -1.104 . . . . 71.54 108.02 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -106.29 -49.0 3.44 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.718 0.407 . . . . 51.41 111.456 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.563 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 62.2 ttt180 -178.46 134.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 122.262 0.225 . . . . 53.54 111.282 -174.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.521 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 3.0 mp -123.23 130.07 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.742 -1.207 . . . . 73.4 107.742 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.443 ' HB3' HG23 ' C' ' 122' ' ' THR . 47.1 p90 -156.31 163.63 39.29 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 123.728 0.643 . . . . 75.2 111.842 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.02 110.11 10.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.736 -1.12 . . . . 74.13 109.634 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.479 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 46.0 mtpt -77.57 -32.81 54.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.86 -0.609 . . . . 73.24 109.734 172.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.744 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -146.4 138.41 24.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.79 -1.095 . . . . 43.15 109.718 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.547 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.2 mt -137.15 147.75 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.528 1.131 . . . . 65.31 108.411 171.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -147.63 143.75 27.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.878 0.871 . . . . 63.4 108.668 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.3 t80 -147.54 124.98 11.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.919 -1.882 . . . . 74.41 105.919 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.61 142.01 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.735 0.814 . . . . 52.13 108.817 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -135.46 77.65 52.75 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 107.431 -1.322 . . . . 71.13 107.431 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.38 -28.89 17.54 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.748 2.299 . . . . 64.21 112.36 -172.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 50.8 m-20 -114.46 28.66 8.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.424 1.089 . . . . 65.13 109.338 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.554 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.25 -47.96 95.32 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.714 1.746 . . . . 33.42 115.714 -170.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 61.1 Cg_endo -80.94 -15.47 10.54 Favored 'Trans proline' 0 C--N 1.379 2.149 0 CA-C-N 122.021 1.757 . . . . 72.33 112.138 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.8 t-160 -68.41 -32.07 71.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.93 0.892 . . . . 65.33 108.918 167.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' D' ' 28' ' ' ALA . 12.9 t -68.08 -23.33 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.265 1.026 . . . . 73.44 111.499 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -55.66 -32.92 63.63 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 122.677 0.391 . . . . 74.03 111.67 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.85 -27.56 61.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.572 0.749 . . . . 74.01 111.42 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -97.12 111.21 23.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.839 0.856 . . . . 70.1 111.704 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -108.02 52.32 0.72 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.947 1.299 . . . . 71.43 111.148 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -126.01 165.34 18.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.713 0.805 . . . . 62.13 108.94 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -81.61 122.05 80.27 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.641 -0.503 . . . . 75.43 109.641 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.58 126.21 18.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.691 2.261 . . . . 70.32 112.013 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.85 119.71 12.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.411 0.684 . . . . 74.54 109.206 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.8 107.19 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.22 0.608 . . . . 61.43 109.669 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 46.9 mmtm -98.82 114.46 27.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.425 0.69 . . . . 74.24 109.28 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.72 131.59 43.26 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.215 -0.661 . . . . 64.21 109.215 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.63 123.18 42.18 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.626 -1.25 . . . . 61.34 107.626 171.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -95.42 130.24 42.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.038 0.535 . . . . 61.52 109.893 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.8 t70 -138.35 150.43 46.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.433 -1.321 . . . . 55.0 107.433 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -145.31 157.11 44.12 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.271 -0.64 . . . . 71.03 109.271 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.01 167.57 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.062 0.945 . . . . 70.12 108.835 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.2 p -164.92 155.91 14.57 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.058 0.543 . . . . 73.13 110.571 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 19.5 p -164.55 132.29 3.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.04 0.936 . . . . 70.21 109.4 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.46 131.59 45.54 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.078 0.551 . . . . 73.31 111.309 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' D' ' 57' ' ' GLU . 64.7 mt -103.65 -37.72 7.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.632 0.773 . . . . 72.05 110.93 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -158.43 -167.54 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.356 0.662 . . . . 21.21 110.929 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -70.87 112.93 7.43 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.25 -0.887 . . . . 53.11 110.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 70.76 -2.62 2.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.579 1.552 . . . . 64.25 112.313 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 82.5 t -109.88 133.43 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.204 1.002 . . . . 73.44 109.434 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.03 154.08 36.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 74.31 109.306 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.1 tt0 -92.2 134.87 34.47 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.801 0.841 . . . . 65.22 109.346 176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.86 124.3 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.832 -1.173 . . . . 64.21 107.832 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.7 t -105.82 138.55 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.201 0.601 . . . . 65.22 109.448 175.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -113.11 123.85 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.948 -1.13 . . . . 54.21 107.948 176.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.6 ttm-85 -106.64 103.65 13.15 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.813 -0.81 . . . . 75.4 108.813 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.02 123.07 52.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.756 -0.831 . . . . 71.24 108.756 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -114.6 139.14 49.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.538 0.735 . . . . 60.11 109.599 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.478 HG21 HG21 ' D' ' 114' ' ' ILE . 50.8 t -131.67 100.6 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.804 1.242 . . . . 60.13 108.376 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.7 m -95.02 94.05 7.75 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.16 -1.422 . . . . 73.23 107.16 170.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.06 134.2 40.72 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.577 -0.897 . . . . 51.12 108.577 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.453 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 16.6 p -148.57 129.88 14.69 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.074 0.464 . . . . 62.22 111.524 -170.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 41.5 mt -95.16 104.71 16.6 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.569 1.147 . . . . 73.0 110.867 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.15 -110.91 3.6 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.556 0.535 . . . . 74.21 112.523 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.22 7.26 35.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 63.42 111.632 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.38 150.15 48.77 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.212 0.605 . . . . 54.33 110.326 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -73.22 132.55 43.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.27 0.628 . . . . 73.1 110.362 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -86.98 -57.68 2.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.547 0.739 . . . . 70.14 109.192 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.81 152.89 14.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.801 -1.091 . . . . 63.03 110.245 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -117.52 120.4 37.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.282 1.033 . . . . 63.23 108.788 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.5 t -133.07 142.0 48.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.415 0.686 . . . . 71.51 110.004 -175.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -156.5 129.65 7.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.916 0.486 . . . . 63.42 110.257 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.49 HG22 HG23 ' D' ' 21' ' ' ILE . 84.8 t -128.37 122.72 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.989 0.916 . . . . 62.31 110.051 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.744 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -93.01 87.55 5.8 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.673 0.749 . . . . 74.51 109.531 169.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.425 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.3 tp-100 -80.27 96.62 6.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.19 -1.368 . . . . 61.33 108.954 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.92 157.76 29.92 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.812 -0.515 . . . . 63.53 111.812 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 138.44 5.45 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.946 -0.462 . . . . 74.23 111.946 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.0 mt -91.85 132.97 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 123.762 0.825 . . . . 61.03 109.941 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.1 150.1 52.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.499 0.72 . . . . 72.33 110.602 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.7 m -116.55 101.34 8.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.315 1.046 . . . . 63.22 109.248 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.463 ' HB ' HD11 ' D' ' 89' ' ' ILE . 39.2 pt -109.33 132.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.031 0.443 . . . . 74.12 110.747 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.98 165.77 26.97 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.971 0.909 . . . . 61.02 109.469 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.78 -21.6 6.45 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 114.198 0.439 . . . . 71.45 114.198 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.485 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -107.01 169.37 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.272 1.029 . . . . 75.35 109.308 175.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -170.78 -168.63 0.69 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 71.35 110.895 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.65 -141.9 29.2 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.243 -0.435 . . . . 35.13 113.837 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.9 m -82.68 -25.67 32.79 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.383 0.673 . . . . 74.44 111.339 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -63.46 -48.88 75.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.011 0.524 . . . . 70.42 109.788 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -66.06 -31.77 72.84 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.426 0.454 . . . . 70.24 110.95 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.77 98.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.202 0.601 . . . . 74.15 111.212 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -79.22 -37.71 37.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.432 -0.349 . . . . 74.45 110.224 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.87 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.322 0.649 . . . . 30.0 111.481 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.2 tt -75.78 -50.68 14.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.763 0.825 . . . . 74.03 109.042 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.01 14.1 65.08 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.868 -0.605 . . . . 61.02 114.398 -170.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -56.67 0.2 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.548 0.674 . . . . 43.12 111.618 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -72.09 -43.24 65.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.695 0.628 . . . . 72.53 112.695 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 98.8 m -63.37 -46.41 84.71 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 118.747 -0.644 . . . . 51.45 111.084 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.0 Cg_exo -58.82 -31.52 95.39 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 122.608 2.205 . . . . 64.54 114.013 166.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -65.86 -34.94 79.3 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.149 0.58 . . . . 74.21 110.757 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.496 HG23 ' ND2' ' B' ' 132' ' ' ASN . 37.3 mm -63.48 -39.76 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.382 0.673 . . . . 73.53 110.29 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.425 HD13 ' O ' ' D' ' 80' ' ' GLN . 84.5 mt -74.24 -21.24 59.86 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.374 -0.83 . . . . 74.23 111.672 -175.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -67.9 -40.72 24.64 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 114.584 1.327 . . . . 65.22 114.584 -168.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.412 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 98.2 Cg_exo -49.72 -38.54 46.57 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 121.982 1.788 . . . . 71.25 113.586 170.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -83.87 -29.81 26.93 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.74 -1.118 . . . . 71.13 110.834 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.79 -49.73 64.9 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.31 0.644 . . . . 74.11 110.346 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.1 ttp-105 -50.98 -56.61 11.62 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.809 1.318 . . . . 71.52 110.273 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.97 -44.39 94.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.619 1.2 . . . . 64.04 111.595 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.463 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 40.8 t -56.3 -44.03 79.48 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.88 0.738 . . . . 63.42 111.075 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.478 HG21 HG21 ' D' ' 64' ' ' VAL . 74.2 mt -67.85 -53.28 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.883 . . . . 74.14 110.382 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -51.56 -43.64 62.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.071 1.348 . . . . 60.13 112.265 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.9 t -69.71 -41.56 75.2 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.149 -0.932 . . . . 74.5 110.525 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.5 mtm -64.36 -35.1 79.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.028 0.531 . . . . 65.23 111.534 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.3 t -61.53 -48.15 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.221 -0.9 . . . . 54.32 110.319 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.7 p -73.98 -23.02 59.41 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.079 -0.51 . . . . 70.12 111.604 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -73.97 -36.28 64.55 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.726 0.81 . . . . 74.25 110.235 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 2.48 71.66 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.714 0.634 . . . . 71.4 112.07 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 62.29 30.76 17.56 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.85 2.06 . . . . 71.31 112.45 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -88.92 168.64 15.07 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 125.232 1.413 . . . . 75.34 108.077 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.36 153.89 27.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.706 1.604 . . . . 54.24 110.884 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.48 132.31 47.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.174 0.19 . . . . 71.41 110.816 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.76 113.03 22.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.735 -0.839 . . . . 70.45 108.735 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.35 88.85 4.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.795 -1.187 . . . . 63.55 107.795 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.53 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 75.9 mt -63.56 114.56 4.01 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.568 -0.742 . . . . 55.53 109.425 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.55 137.92 89.45 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.215 0.82 . . . . 73.15 113.215 -168.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.409 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 60.0 Cg_endo -80.3 104.87 1.68 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.618 2.212 . . . . 63.4 110.55 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.43 111.32 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.954 -1.021 . . . . 73.42 110.542 -169.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--O 1.242 0.66 0 CA-C-O 122.405 1.098 . . . . 62.13 108.267 177.328 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.238 0.497 0 CA-C-O 121.018 0.437 . . . . 75.14 109.947 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 52.4 t80 -135.96 129.17 31.72 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.596 -1.261 . . . . 65.0 107.596 170.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -148.82 123.41 9.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.266 0.469 . . . . 62.12 112.266 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 16' ' ' ILE . 3.4 tp -75.19 118.26 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.949 -1.023 . . . . 63.52 109.056 168.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.9 -20.75 13.34 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.292 0.637 . . . . 71.34 111.048 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -178.41 127.16 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.249 0.477 . . . . 74.31 111.157 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 13' ' ' ILE . 48.3 mt -106.48 132.22 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.761 -0.829 . . . . 74.15 108.761 169.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -148.45 171.84 15.42 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.27 1.428 . . . . 74.23 109.931 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -102.15 123.49 46.09 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.959 -0.756 . . . . 74.11 108.959 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -81.53 -32.19 32.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.387 0.675 . . . . 61.25 110.556 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.7 t70 -150.1 144.34 25.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.13 110.083 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.454 HG23 ' SD ' ' A' ' 117' ' ' MET . 61.6 mt -137.38 130.3 43.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.852 -1.536 . . . . 53.03 106.852 171.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -140.33 116.17 10.3 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.113 -1.069 . . . . 71.14 108.113 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.4 t80 -126.68 109.2 11.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 106.667 -1.605 . . . . 71.22 106.667 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.97 108.91 15.85 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.403 -0.962 . . . . 75.54 108.403 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -106.76 89.48 4.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.335 -0.987 . . . . 61.32 108.335 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.59 -43.45 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.446 2.098 . . . . 63.23 112.794 -172.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.6 m-80 -101.42 29.27 4.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.24 0.616 . . . . 73.25 109.891 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.483 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -50.79 -48.65 82.99 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 124.359 1.064 . . . . 52.41 113.163 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 21.8 Cg_exo -67.84 -26.39 38.37 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 121.688 1.592 . . . . 62.21 112.517 176.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.52 -28.4 60.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.625 -0.716 . . . . 73.12 110.857 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.734 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 41.4 t -58.79 -20.34 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 123.667 0.787 . . . . 62.01 111.645 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.77 -41.4 90.98 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.262 1.025 . . . . 75.24 111.776 175.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -101.27 -22.21 14.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.246 0.618 . . . . 70.51 111.436 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.9 mmmt -69.88 134.72 48.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.269 0.627 . . . . 72.24 110.001 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.42 131.94 44.84 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.339 -0.846 . . . . 65.25 109.087 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HA ' HD22 ' A' ' 68' ' ' LEU . 75.4 t-105 -80.79 90.6 5.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.479 0.656 . . . . 75.44 110.006 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -121.22 83.97 39.85 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 106.866 -1.531 . . . . 74.2 106.866 165.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.05 132.24 16.51 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.295 1.996 . . . . 43.43 111.389 -171.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -94.49 91.51 6.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.097 -1.446 . . . . 74.13 107.097 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.34 98.59 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 124.612 1.195 . . . . 62.05 111.586 -170.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 20.2 tptm -100.42 130.52 46.52 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.428 -1.26 . . . . 72.21 108.763 175.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -131.67 114.08 14.37 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.41 0.684 . . . . 60.15 109.367 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -108.08 137.56 45.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.394 1.078 . . . . 73.21 108.535 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.8 tp -119.0 118.9 32.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.747 -0.835 . . . . 64.42 108.747 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -128.58 149.99 50.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.012 0.925 . . . . 60.23 108.953 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -140.63 151.25 44.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.378 0.671 . . . . 74.43 109.858 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -142.53 155.29 45.0 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.226 1.01 . . . . 62.01 109.38 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 p -125.6 159.81 31.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.602 0.761 . . . . 64.24 110.329 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -159.12 122.43 3.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.683 0.793 . . . . 74.01 109.68 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -79.84 111.9 16.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.755 0.422 . . . . 51.31 109.869 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.5 mt -88.52 -34.16 17.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.124 0.569 . . . . 45.22 110.667 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -161.58 -172.38 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.437 1.095 . . . . 54.13 109.937 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.19 107.41 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 54.21 109.522 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 68.56 3.66 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.219 1.408 . . . . 70.21 112.87 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.5 t -99.64 115.04 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.351 -1.351 . . . . 75.45 107.351 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -123.2 167.04 14.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.67 0.747 . . . . 74.34 110.745 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' A' ' 51' ' ' LEU . 19.3 tt0 -128.59 126.26 39.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.043 -1.435 . . . . 65.31 107.143 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -106.48 122.05 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.464 -1.31 . . . . 74.0 107.464 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.51 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.5 t -97.51 139.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 124.313 1.045 . . . . 72.52 108.291 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.12 112.77 19.1 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.434 -1.321 . . . . 71.3 107.434 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -109.75 103.03 11.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.658 0.742 . . . . 74.22 109.752 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.49 136.12 28.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.703 -1.135 . . . . 75.22 108.414 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.8 m -123.5 128.97 50.53 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.039 0.447 . . . . 73.2 110.276 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.5 t -125.33 110.5 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 74.41 109.394 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -107.73 138.59 43.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.19 0.45 . . . . 74.24 109.827 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.48 105.85 12.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.286 -1.376 . . . . 74.54 107.286 168.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 47.6 m -106.42 126.52 52.35 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.552 -0.536 . . . . 72.31 109.552 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 36' ' ' TRP . 17.0 mt -93.27 80.84 4.44 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.137 -1.431 . . . . 72.2 107.137 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -89.24 0.86 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.951 -1.022 . . . . 54.42 111.285 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -121.5 -15.06 8.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.167 0.987 . . . . 71.04 110.477 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 4.8 mp0 -97.16 101.74 13.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.404 1.082 . . . . 55.42 109.83 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.4 m -66.17 127.19 31.19 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.263 0.554 . . . . 53.14 111.192 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -74.28 -55.06 6.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.738 1.215 . . . . 62.25 108.986 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.22 164.87 35.6 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.749 -1.114 . . . . 64.33 111.125 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.21 143.38 50.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.3 1.44 . . . . 71.02 107.224 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.8 m -130.11 136.05 48.9 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 123.712 0.805 . . . . 73.41 108.855 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -148.57 115.72 6.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.582 -0.896 . . . . 63.3 108.582 173.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.89 112.84 30.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.652 0.781 . . . . 73.23 109.518 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -86.67 84.49 7.38 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.751 -0.833 . . . . 64.41 108.751 172.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.53 93.3 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.588 -0.893 . . . . 74.54 108.588 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.37 148.44 20.08 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.413 -0.675 . . . . 73.12 111.413 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 131.92 4.03 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.865 -0.894 . . . . 64.13 110.865 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.78 121.33 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.662 -0.866 . . . . 64.5 108.662 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' HD13 ' A' ' 13' ' ' ILE . 34.5 m-85 -130.87 117.33 19.14 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.723 -1.214 . . . . 74.52 107.723 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 p -79.15 115.8 19.03 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.416 -0.957 . . . . 75.43 108.416 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.471 ' HB ' HD11 ' A' ' 89' ' ' ILE . 44.4 pt -118.37 142.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.481 0.712 . . . . 72.4 110.594 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.81 155.74 17.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.099 0.96 . . . . 54.45 109.628 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.17 9.48 85.54 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.616 0.606 . . . . 53.52 114.616 173.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB ' ' A' ' 86' ' ' ILE . 1.3 pp -119.61 132.58 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 117.409 0.604 . . . . 74.24 110.678 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -151.76 173.39 14.79 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.373 1.069 . . . . 64.41 110.217 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.19 -136.26 51.13 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.602 0.564 . . . . 61.12 113.896 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -70.34 -25.95 63.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.759 0.824 . . . . 73.22 111.371 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -65.29 -43.35 91.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 62.1 110.492 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.426 ' HG3' HD23 ' A' ' 98' ' ' LEU . 28.0 ttt -76.11 -38.17 57.21 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.874 -0.603 . . . . 65.21 110.64 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.26 67.83 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.797 0.439 . . . . 63.22 111.489 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -71.72 -39.44 70.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.949 0.9 . . . . 75.04 110.473 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.604 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 t -77.36 -65.87 0.9 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.65 -0.704 . . . . 65.33 110.222 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 ' HG3' ' A' ' 94' ' ' MET . 3.8 mm? -73.54 -17.95 61.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.745 0.818 . . . . 74.11 112.365 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.29 -16.91 54.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.852 -0.416 . . . . 61.23 113.964 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -55.7 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.403 0.601 . . . . 62.22 111.75 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 92.1 t80 -66.79 -61.05 2.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.904 0.882 . . . . 42.31 113.361 -168.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.604 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 79.1 m -62.78 -40.91 68.33 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.157 -0.925 . . . . 60.04 113.372 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -63.79 -32.53 67.29 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 121.098 1.428 . . . . 72.12 112.868 168.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -72.02 -24.64 61.59 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 117.945 0.339 . . . . 63.14 111.204 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -57.74 -43.26 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.638 0.733 . . . . 73.43 109.406 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 mt -77.49 -21.84 52.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.146 -1.388 . . . . 74.44 112.27 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -64.61 -41.35 57.04 Favored Pre-proline 0 CA--C 1.562 1.424 0 CA-C-O 117.475 -1.25 . . . . 75.53 114.116 -168.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.69 -31.26 91.54 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.119 1.879 . . . . 74.21 113.26 172.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.95 -41.07 21.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.616 0.766 . . . . 72.03 110.924 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.53 87.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.947 0.499 . . . . 73.11 110.061 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.471 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.9 ttm180 -50.51 -58.79 4.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.867 1.267 . . . . 54.13 110.154 173.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.19 -40.55 96.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.516 1.135 . . . . 74.52 111.754 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.6 t -57.59 -48.43 79.42 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 123.854 0.721 . . . . 61.3 110.1 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 64' ' ' VAL . 95.1 mt -62.16 -51.16 75.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 O-C-N 124.306 1.004 . . . . 65.3 110.203 175.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.8 m -53.0 -42.72 65.87 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.81 1.244 . . . . 70.4 111.621 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.91 -47.01 66.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.969 -1.014 . . . . 61.13 109.985 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.454 ' SD ' HG23 ' A' ' 21' ' ' ILE . 15.6 mtp -53.45 -45.61 69.57 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.856 0.862 . . . . 72.45 111.394 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 114' ' ' ILE . 73.8 t -61.09 -49.11 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.076 1.351 . . . . 74.24 111.046 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -68.48 -28.84 67.39 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.899 0.479 . . . . 70.22 111.454 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.3 -27.59 64.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.694 0.798 . . . . 70.22 110.976 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.96 11.96 58.83 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 119.498 -0.612 . . . . 71.41 113.776 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.48 ' HB ' HH21 ' B' ' 15' ' ' ARG . 11.9 m 65.18 32.53 10.04 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.351 1.072 . . . . 74.24 110.316 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.424 ' HE1' HG11 ' A' ' 31' ' ' VAL . 65.2 m-85 -109.4 152.69 42.83 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 115.106 -0.952 . . . . 74.12 109.101 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 149.57 80.23 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.103 1.868 . . . . 65.33 111.319 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.7 tt0 -56.7 142.29 40.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.699 0.8 . . . . 73.33 111.313 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp -133.8 101.79 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.57 0.748 . . . . 71.13 109.434 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -98.63 100.7 11.95 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.61 117.85 6.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 75.14 109.928 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.94 150.36 50.03 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.345 0.658 . . . . 62.43 111.859 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.71 160.86 7.75 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.378 2.052 . . . . 73.31 112.763 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.89 114.3 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.806 -1.183 . . . . 72.03 107.806 165.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -98.8 63.41 1.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.648 0.737 . . . . 64.24 109.945 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 t80 . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 115.24 -0.891 . . . . 73.52 109.035 173.323 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.2 p . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 109.089 -0.708 . . . . 63.13 109.089 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -139.97 117.17 11.22 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.834 -0.802 . . . . 72.15 108.834 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -128.03 103.5 7.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.191 0.596 . . . . 75.43 109.797 176.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' D' ' 129' ' ' ALA . 12.5 tt -67.92 121.63 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 108.819 -0.808 . . . . 74.41 108.819 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -101.1 -47.38 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.86 0.464 . . . . 71.32 110.715 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.48 HH21 ' HB ' ' A' ' 122' ' ' THR . 66.9 ttt180 -163.25 135.59 5.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.098 -171.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.15 138.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 106.805 -1.554 . . . . 64.23 106.805 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.507 ' HE1' HG13 ' B' ' 83' ' ' ILE . 15.1 p90 -164.78 146.35 8.02 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 123.711 0.632 . . . . 64.32 111.178 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -74.64 116.84 15.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.864 -0.791 . . . . 75.4 108.864 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -89.48 -30.18 18.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.26 0.624 . . . . 73.21 111.158 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.5 t70 -158.25 142.89 16.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.091 -0.504 . . . . 60.32 110.376 -171.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.9 mm -138.29 141.46 37.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 125.336 1.455 . . . . 65.23 108.071 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -140.49 133.17 28.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.73 -1.123 . . . . 75.35 108.073 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.1 t80 -142.43 127.43 18.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.447 -1.686 . . . . 73.22 106.447 164.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.57 147.05 49.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.446 -1.316 . . . . 64.35 107.446 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -141.31 81.74 15.26 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 105.829 -1.915 . . . . 51.42 105.829 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.87 -29.08 76.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.574 2.183 . . . . 72.1 111.13 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.25 30.7 6.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.66 -1.155 . . . . 42.34 110.435 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.45 -52.45 29.63 Favored Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 124.734 1.214 . . . . 71.24 111.972 169.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.25 -16.84 9.43 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.007 1.804 . . . . 72.32 113.072 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -87.59 3.15 48.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.339 0.656 . . . . 71.21 111.419 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.494 HG12 HD11 ' B' ' 68' ' ' LEU . 22.0 m -67.04 -17.12 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.644 0.778 . . . . 74.1 110.766 166.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -71.33 -31.28 67.21 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.403 1.081 . . . . 74.41 110.123 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.18 -42.65 15.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.351 0.66 . . . . 72.12 109.383 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -91.45 78.52 5.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.076 0.95 . . . . 45.43 109.377 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -83.11 74.87 9.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.42 -1.264 . . . . 75.44 110.471 -173.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -179.46 171.64 1.24 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.199 1.0 . . . . 74.1 109.471 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -71.15 135.57 84.79 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.181 0.992 . . . . 70.45 111.276 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.54 157.41 48.89 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.135 1.89 . . . . 73.0 111.742 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 52.5 mt-10 -70.2 102.19 2.04 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.826 -1.176 . . . . 61.33 107.826 167.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.5 136.6 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.436 -0.95 . . . . 71.11 108.436 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -136.68 141.45 43.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.62 0.768 . . . . 65.14 109.23 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' B' ' 126' ' ' LEU . 2.8 pp -104.83 142.23 35.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.475 0.71 . . . . 74.33 109.366 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.543 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.2 m-20 -139.6 155.71 47.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.687 1.595 . . . . 61.34 106.916 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 165.09 36.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.944 0.402 . . . . 64.43 110.327 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.53 141.51 13.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.346 1.058 . . . . 75.22 109.057 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . 0.577 HG21 ' HA2' ' B' ' 99' ' ' GLY . 88.8 m -108.57 120.06 41.34 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.251 0.621 . . . . 73.14 109.361 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.33 153.82 32.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.765 1.226 . . . . 64.14 108.539 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -142.99 163.41 32.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.096 0.558 . . . . 75.14 110.889 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -154.03 170.59 20.75 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.05 1.34 . . . . 72.13 109.222 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 64.0 tt0 -125.79 135.36 51.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.786 0.834 . . . . 72.55 109.818 169.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 59.3 mt -100.62 -44.75 5.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.677 0.791 . . . . 71.23 110.767 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -147.8 179.23 7.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.944 -1.025 . . . . 74.44 109.733 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.11 119.29 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.526 -0.761 . . . . 65.1 109.851 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' B' ' 85' ' ' SER . 16.6 m-20 70.76 -6.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.144 1.778 . . . . 75.12 112.674 -174.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.0 t -104.58 94.95 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.131 -1.062 . . . . 62.34 108.131 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 8.0 m-85 -94.93 169.39 10.16 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.435 0.694 . . . . 61.32 109.517 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 6.8 tm-20 -142.89 101.72 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.518 -1.289 . . . . 71.43 107.518 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.87 125.12 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.446 -0.576 . . . . 73.3 109.446 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.8 t -102.98 111.58 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.569 0.748 . . . . 74.02 109.605 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.37 112.09 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.381 -0.97 . . . . 74.42 108.381 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -96.44 131.45 43.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.592 -1.186 . . . . 71.02 109.708 173.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -126.89 120.29 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.579 -1.267 . . . . 72.53 107.579 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.4 m -109.48 153.97 23.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.494 1.117 . . . . 51.41 109.805 -174.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 85.1 t -133.33 126.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.631 1.172 . . . . 72.44 108.766 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 43.2 m -112.8 143.22 44.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.679 0.792 . . . . 73.21 109.335 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.7 151.37 34.79 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.56 0.344 . . . . 73.33 110.81 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.4 p -144.37 133.39 22.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.099 0.56 . . . . 75.05 111.203 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.494 HD11 HG12 ' B' ' 31' ' ' VAL . 41.8 mt -100.87 99.67 10.2 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 73.21 108.365 171.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.68 -120.01 6.73 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.018 -0.833 . . . . 24.33 111.018 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.17 6.0 35.37 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.803 0.841 . . . . 75.51 112.191 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -115.19 165.57 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.44 0.696 . . . . 64.43 109.793 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -77.82 133.14 38.26 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.121 0.568 . . . . 73.25 111.111 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.46 -60.2 2.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.64 0.776 . . . . 74.11 109.291 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.5 150.98 21.91 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.533 -1.212 . . . . 72.23 110.041 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.45 114.22 15.87 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.215 1.006 . . . . 74.41 108.729 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.544 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 51.4 t -115.38 157.94 23.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.766 -0.827 . . . . 71.12 108.766 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.88 135.97 2.85 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.451 -0.944 . . . . 71.1 108.451 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.74 143.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.51 -0.922 . . . . 35.31 108.51 172.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -127.15 89.25 2.94 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.68 -0.859 . . . . 73.14 108.68 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -83.45 104.71 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.939 -1.028 . . . . 62.21 108.506 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.21 162.52 29.71 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.574 -0.61 . . . . 72.52 111.574 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.09 128.81 2.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.519 -0.632 . . . . 64.12 111.519 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.507 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.8 mt -85.72 118.39 32.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.748 -0.834 . . . . 71.14 108.748 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.69 134.71 43.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.773 0.829 . . . . 75.13 109.375 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 43.2 m -97.58 113.85 25.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.268 0.627 . . . . 62.24 109.993 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 137.47 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.772 0.829 . . . . 64.44 111.608 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.41 173.09 17.17 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.698 1.199 . . . . 72.52 108.782 165.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.53 -44.29 3.32 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-O 120.279 -0.179 . . . . 75.21 112.771 177.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.91 152.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.876 0.87 . . . . 74.44 110.654 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 1.1 tm-20 -155.93 144.25 20.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 120.406 0.146 . . . . 64.53 110.64 -174.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.39 -114.36 6.12 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.707 0.67 . . . . 73.15 114.034 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -67.01 -31.13 71.48 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.867 0.867 . . . . 74.13 110.996 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 92.1 mt-30 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.34 0.656 . . . . 73.54 110.475 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 26.2 ttt -73.11 -37.86 66.53 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.767 -0.651 . . . . 64.42 110.681 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.84 -24.85 67.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 71.01 111.121 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -88.75 -23.38 22.92 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.048 0.939 . . . . 73.23 110.985 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.64 -67.66 0.64 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.716 0.406 . . . . 74.21 109.926 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.59 -18.4 58.66 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.034 0.383 . . . . 73.1 112.034 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.577 ' HA2' HG21 ' B' ' 46' ' ' THR . . . -90.11 -20.19 43.49 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.769 -0.462 . . . . 73.42 114.043 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.42 -52.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.766 0.654 . . . . 61.35 112.766 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -67.22 -50.17 61.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.104 0.561 . . . . 74.34 111.401 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.68 -47.41 82.17 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 118.236 -0.888 . . . . 65.33 110.42 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.8 -43.03 36.04 Favored 'Trans proline' 0 C--N 1.404 3.495 0 C-N-CA 122.296 1.998 . . . . 72.44 114.463 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -31.42 72.31 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.257 0.623 . . . . 73.21 111.867 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.9 -45.69 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.547 0.739 . . . . 72.43 110.372 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.24 -16.38 33.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.009 -0.996 . . . . 72.34 111.786 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.14 -44.17 95.73 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 125.773 1.629 . . . . 61.35 113.757 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.0 Cg_endo -58.59 -40.32 74.93 Favored 'Trans proline' 0 C--N 1.4 3.286 0 C-N-CA 121.873 1.715 . . . . 74.05 112.494 174.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.444 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.8 m-85 -63.79 -44.09 94.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.17 0.588 . . . . 74.44 110.33 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.445 0.698 . . . . 62.0 111.045 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.52 -47.2 87.21 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.966 1.307 . . . . 74.1 111.063 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.82 -40.41 75.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.643 0.777 . . . . 62.42 110.0 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.7 t -67.45 -35.24 78.82 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 115.797 -0.638 . . . . 62.5 111.218 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.485 HG21 HG21 ' B' ' 64' ' ' VAL . 52.1 mt -62.81 -57.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.167 0.587 . . . . 74.51 109.548 174.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.406 HG21 ' HB2' ' C' ' 119' ' ' SER . 90.1 m -59.84 -26.43 65.8 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.328 1.018 . . . . 70.53 111.183 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.6 t -66.03 -58.79 4.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.528 0.731 . . . . 75.33 109.852 171.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.2 mmt -62.79 -39.05 93.03 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.99 0.516 . . . . 61.25 112.267 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.0 -41.82 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.498 1.119 . . . . 63.3 110.631 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -72.69 -25.64 61.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.661 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.9 mtt-85 -65.32 -38.63 90.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.509 -0.552 . . . . 72.34 109.509 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 1.55 62.86 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.908 -0.587 . . . . 73.23 113.191 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.9 p 63.25 39.99 9.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 61.12 111.816 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -112.74 159.26 35.01 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.937 1.295 . . . . 72.22 111.207 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.41 141.46 95.64 Favored 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 123.745 2.964 . . . . 71.44 115.181 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' C' ' 124' ' ' PRO . 0.9 OUTLIER -65.61 160.39 22.66 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 126.322 1.849 . . . . 64.12 113.701 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.552 HD13 ' HB3' ' B' ' 42' ' ' LEU . 24.3 mt -127.54 102.46 6.87 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.254 -0.885 . . . . 74.01 110.004 163.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -91.05 100.24 13.13 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.542 -1.281 . . . . 74.24 107.542 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.87 136.33 33.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.112 0.565 . . . . 61.23 112.236 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.54 142.26 74.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.708 0.803 . . . . 72.42 110.324 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.419 ' HG2' HG21 ' D' ' 13' ' ' ILE . 29.0 Cg_endo -64.24 100.4 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.156 1.904 . . . . 74.45 111.396 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.5 m -75.5 71.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.024 0.916 . . . . 74.2 109.189 168.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.1 93.2 1.77 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.962 -1.125 . . . . 75.32 107.962 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.6 t80 . . . . . 0 CA--C 1.546 0.804 0 CA-C-N 114.031 -1.44 . . . . 71.34 111.886 -172.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 C--O 1.24 0.587 0 N-CA-C 109.571 -0.529 . . . . 73.33 109.571 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -117.65 125.16 50.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.504 1.122 . . . . 73.5 108.159 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -137.14 112.16 9.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.054 0.542 . . . . 72.03 109.601 -177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.458 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -64.47 130.87 30.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-N 115.862 -0.608 . . . . 73.2 109.926 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.551 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -103.75 -51.51 3.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.085 -0.709 . . . . 74.31 109.085 174.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -166.53 155.96 11.28 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.439 0.162 . . . . 71.52 111.439 -174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.458 HG13 HD11 ' C' ' 13' ' ' ILE . 93.9 mt -138.19 137.48 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.608 1.163 . . . . 63.52 108.128 173.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.569 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.5 p90 -171.84 155.04 3.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.524 0.678 . . . . 74.44 111.786 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -78.72 117.99 20.37 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.67 -1.15 . . . . 74.33 108.461 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 17.4 mtmt -92.61 -38.57 11.81 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.903 -0.777 . . . . 74.4 108.903 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.9 t70 -133.9 134.89 43.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.683 -1.144 . . . . 74.21 108.729 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -138.82 141.02 37.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.078 -1.453 . . . . 52.15 107.078 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -151.95 150.22 29.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.394 0.616 . . . . 51.41 109.823 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -150.83 113.33 4.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.889 -1.523 . . . . 64.42 106.889 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -115.16 111.15 20.57 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.883 -0.784 . . . . 73.31 108.883 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.02 75.69 53.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.09 0.956 . . . . 53.54 108.711 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.54 -24.35 30.77 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.092 1.862 . . . . 72.24 110.465 168.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -92.23 19.12 7.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.18 0.992 . . . . 75.21 110.731 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.2 94.76 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.908 0.883 . . . . 75.24 113.353 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.63 -25.92 7.52 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 121.46 1.44 . . . . 74.0 112.06 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -69.48 -32.98 72.21 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.088 1.355 . . . . 72.53 111.29 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.507 HG23 HD11 ' C' ' 68' ' ' LEU . 12.6 p -72.05 -24.24 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.809 0.844 . . . . 74.42 111.689 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.31 -39.15 93.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.199 0.6 . . . . 75.12 111.139 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -100.74 39.9 1.33 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.752 0.821 . . . . 62.33 109.858 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.768 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -124.72 173.86 8.27 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.36 0.664 . . . . 72.54 110.459 -176.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.27 115.42 25.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.041 -1.096 . . . . 74.21 108.041 167.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.13 68.02 10.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.832 0.853 . . . . 75.11 111.839 -167.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -125.73 79.26 68.28 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.251 -1.018 . . . . 70.11 108.251 170.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.487 ' HB2' HG13 ' C' ' 40' ' ' VAL . 18.8 Cg_endo -89.42 137.57 3.02 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.472 2.115 . . . . 71.13 111.285 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.25 79.8 9.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.37 -1.344 . . . . 72.32 107.37 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.623 ' HB ' HD11 ' C' ' 126' ' ' LEU . 17.2 m -84.21 111.29 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.314 -1.766 . . . . 34.4 110.166 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -136.83 140.27 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.608 0.363 . . . . 74.3 110.104 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.468 ' HA ' HG22 ' C' ' 64' ' ' VAL . 3.4 pp -88.47 155.36 19.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.964 0.506 . . . . 73.51 109.796 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -144.31 125.27 14.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.689 -0.486 . . . . 51.52 109.689 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.11 120.2 32.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.112 0.965 . . . . 73.44 110.229 -175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.438 ' O ' HD23 ' C' ' 60' ' ' LEU . 30.4 t70 -117.32 146.8 43.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.707 1.203 . . . . 54.13 109.27 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.8 m -112.83 118.25 34.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.393 0.677 . . . . 75.3 110.592 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.87 160.29 29.14 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.88 1.272 . . . . 73.3 108.352 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -161.34 154.13 20.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.835 0.854 . . . . 70.32 110.077 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.1 p -147.75 143.45 27.56 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.592 1.157 . . . . 63.43 109.379 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -85.28 136.4 33.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.351 0.66 . . . . 71.52 110.351 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.617 HD11 HD12 ' C' ' 83' ' ' ILE . 85.8 mt -107.24 -39.66 5.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.871 0.868 . . . . 74.54 109.731 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.1 -178.54 7.06 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.587 -1.188 . . . . 73.01 109.752 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -73.33 119.99 18.33 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.678 -1.146 . . . . 73.02 108.462 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 66.22 19.66 11.08 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.81 1.244 . . . . 75.43 111.256 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 48.4 t -135.14 105.79 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 107.314 -1.365 . . . . 62.15 107.314 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -123.09 166.57 14.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.456 0.703 . . . . 71.33 110.78 -175.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.86 110.71 13.98 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.261 -1.336 . . . . 72.21 108.537 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.44 HG11 ' HD3' ' C' ' 103' ' ' PRO . 59.9 t -96.08 136.1 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.435 -1.32 . . . . 72.5 107.435 174.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.8 t -128.41 107.01 15.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.096 0.959 . . . . 74.35 108.92 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.492 HD12 ' O ' ' C' ' 103' ' ' PRO . 0.4 OUTLIER -87.35 108.09 18.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.951 -1.129 . . . . 72.31 107.951 176.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -89.64 104.94 17.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.121 -0.696 . . . . 71.54 109.121 173.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.25 -1.019 . . . . 72.11 108.25 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -103.39 121.91 43.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.161 0.584 . . . . 72.43 109.503 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.744 HG21 HG21 ' C' ' 114' ' ' ILE . 88.5 t -102.34 136.44 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.762 1.225 . . . . 72.43 109.984 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 54.8 m -122.79 140.42 52.93 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.819 0.848 . . . . 74.25 109.044 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 117.87 17.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.036 -1.098 . . . . 64.34 108.036 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -135.0 131.78 37.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.481 0.658 . . . . 75.15 110.76 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.768 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.3 mt -89.61 41.97 1.07 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.423 1.889 . . . . 71.01 109.479 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.26 -109.11 3.29 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.529 -1.028 . . . . 73.3 110.529 -169.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -91.83 -31.4 15.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.622 0.769 . . . . 75.44 110.584 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -75.53 119.43 19.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.683 1.193 . . . . 61.35 109.074 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -75.79 124.96 28.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.772 -0.455 . . . . 71.11 109.772 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.6 -51.99 13.01 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.078 -0.712 . . . . 55.04 109.078 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -166.69 174.87 8.32 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 115.174 -0.921 . . . . 63.11 110.351 173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.6 tm? -133.14 146.79 51.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.329 -1.73 . . . . 62.24 106.329 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.583 ' SG ' HG23 ' C' ' 114' ' ' ILE . 44.7 t -145.53 146.4 31.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.447 -0.946 . . . . 53.2 108.447 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.28 130.32 6.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.072 0.396 . . . . 72.24 110.698 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.87 134.55 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.232 1.013 . . . . 62.43 109.236 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.679 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.6 mt-30 -107.18 97.73 7.46 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.648 1.179 . . . . 70.52 108.361 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.8 tp-100 -82.71 101.24 10.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.526 -0.761 . . . . 74.44 109.027 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.02 145.38 20.67 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.948 -0.861 . . . . 64.13 110.948 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.26 122.65 1.54 Allowed Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.508 -1.037 . . . . 54.44 110.508 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.617 HD12 HD11 ' C' ' 51' ' ' LEU . 7.7 mm -84.02 128.15 39.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.246 -1.02 . . . . 75.14 108.246 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -134.69 120.92 20.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.653 0.781 . . . . 72.42 109.412 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -78.85 116.74 19.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.631 -1.248 . . . . 65.03 107.631 168.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.573 HG12 HD12 ' C' ' 89' ' ' ILE . 1.5 tt -133.58 114.46 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 C-N-CA 123.937 0.895 . . . . 65.12 109.743 -170.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.23 41.88 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.582 0.753 . . . . 54.12 110.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.7 -19.02 35.28 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 114.217 0.447 . . . . 63.25 114.217 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.573 HD12 HG12 ' C' ' 86' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 125.053 1.341 . . . . 65.13 111.283 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 119.273 -0.394 . . . . 61.21 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 15.3 ptp -71.38 -32.8 68.9 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.776 0.262 . . . . 54.2 110.652 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.9 94.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.933 0.893 . . . . 54.31 111.705 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -83.4 -30.92 26.98 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.046 -0.525 . . . . 62.5 111.031 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.16 -58.16 8.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.424 0.289 . . . . 63.45 110.575 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -82.31 -38.39 24.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.784 0.434 . . . . 75.14 110.517 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.74 10.23 75.07 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.001 -0.888 . . . . 71.14 115.029 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.92 -49.03 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.365 1.083 . . . . 60.2 112.452 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.401 ' O ' HG12 ' C' ' 105' ' ' ILE . 82.5 t80 -76.14 -49.26 17.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.314 0.646 . . . . 72.52 111.079 -171.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 99.4 m -59.35 -48.03 96.87 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.218 -0.896 . . . . 52.23 111.639 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.492 ' O ' HD12 ' C' ' 60' ' ' LEU . 39.5 Cg_endo -66.75 -27.29 44.68 Favored 'Trans proline' 0 C--N 1.399 3.234 0 C-N-CA 121.487 1.458 . . . . 73.31 112.781 172.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.91 -35.58 81.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.224 0.465 . . . . 54.21 110.974 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.471 HD12 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -65.01 -36.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.507 0.723 . . . . 74.04 110.092 174.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.6 mt -85.47 -19.68 30.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.165 0.986 . . . . 64.32 112.455 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.9 -53.0 70.32 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.256 -1.354 . . . . 62.13 112.68 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.85 -33.85 97.52 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 121.94 1.76 . . . . 72.44 112.273 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.446 ' HE2' HG21 ' A' ' 115' ' ' THR . 89.6 m-85 -67.81 -50.48 56.6 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.005 0.922 . . . . 73.24 111.187 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -62.3 -41.4 98.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 64.35 110.392 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -57.76 -48.13 80.51 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.988 1.715 . . . . 73.1 110.902 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -74.89 -33.06 61.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.249 0.62 . . . . 73.21 110.581 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.1 t -63.85 -33.78 76.46 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.322 0.649 . . . . 63.05 110.824 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.744 HG21 HG21 ' C' ' 64' ' ' VAL . 96.8 mt -75.98 -46.35 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.096 -0.957 . . . . 73.33 110.507 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -55.92 -35.99 67.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.524 0.73 . . . . 62.33 110.851 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 44.6 t -60.62 -57.56 12.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.26 -1.336 . . . . 75.23 109.89 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.546 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.62 -39.39 70.76 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.907 1.283 . . . . 60.44 113.538 -177.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' C' ' 123' ' ' PHE . 77.5 t -68.33 -44.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.09 0.956 . . . . 62.13 110.439 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.406 ' HB2' HG21 ' B' ' 115' ' ' THR . 40.3 t -63.03 -34.99 78.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.272 -0.876 . . . . 73.01 111.086 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.546 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 67.0 mtt-85 -64.83 -45.13 87.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.07 -0.968 . . . . 74.21 109.925 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.47 69.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.402 -0.817 . . . . 63.23 113.447 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 65.91 34.46 7.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.867 1.667 . . . . 55.25 113.23 170.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.517 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 87.1 m-85 -97.9 169.98 7.75 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 124.417 1.087 . . . . 62.13 109.802 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.533 ' HA ' HE21 ' B' ' 125' ' ' GLN . 72.1 Cg_endo -70.71 175.32 9.05 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.6 2.2 . . . . 73.42 112.803 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -60.23 130.64 47.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.859 0.464 . . . . 63.3 112.121 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.623 HD11 ' HB ' ' C' ' 40' ' ' VAL . 1.5 mm? -122.81 18.48 10.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.42 1.088 . . . . 72.43 110.857 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -90.44 81.15 6.0 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.001 -1.481 . . . . 63.25 107.001 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.71 101.71 14.11 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.196 -1.366 . . . . 71.2 111.088 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . 54.03 175.63 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 115.399 1.629 . . . . 74.22 115.399 162.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -91.58 -172.33 0.44 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.449 2.099 . . . . 72.23 113.334 165.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.48 122.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.765 0.826 . . . . 63.13 109.81 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -114.9 102.78 10.29 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.937 0.895 . . . . 72.14 109.276 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 t80 . . . . . 0 N--CA 1.479 1.023 0 C-N-CA 122.819 0.448 . . . . 74.42 111.77 177.587 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.4 m . . . . . 0 C--O 1.24 0.567 0 N-CA-C 109.783 -0.451 . . . . 63.52 109.783 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' D' ' 85' ' ' SER . 73.5 t80 -156.73 93.06 1.34 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.968 1.307 . . . . 64.21 107.651 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.82 146.75 45.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.811 -0.631 . . . . 74.54 110.149 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.419 HG21 ' HG2' ' B' ' 130' ' ' PRO . 2.2 mp -83.12 125.83 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 71.31 108.688 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.0 -46.42 4.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.059 0.544 . . . . 75.11 111.403 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -166.45 122.44 1.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.919 -0.562 . . . . 42.45 110.938 -169.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.27 124.1 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.627 -1.249 . . . . 74.22 107.627 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -158.98 152.77 23.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 73.12 111.895 -168.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -86.49 117.8 25.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.162 -0.926 . . . . 61.13 109.087 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -88.67 -23.28 23.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.759 -0.655 . . . . 60.51 110.183 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.5 t70 -158.53 133.92 8.69 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.258 -0.883 . . . . 62.12 109.416 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.53 HD13 ' HE3' ' C' ' 117' ' ' MET . 76.7 mt -137.61 143.68 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.347 1.059 . . . . 60.44 108.386 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -142.12 143.96 33.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.958 1.303 . . . . 74.53 108.023 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.9 t80 -151.49 110.82 3.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.511 -2.033 . . . . 64.41 105.511 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -128.12 108.22 10.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.164 -0.68 . . . . 73.31 109.164 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.46 91.15 4.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 106.896 -1.52 . . . . 73.43 106.896 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 -24.96 11.95 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.426 2.084 . . . . 51.21 112.24 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -112.7 36.03 3.62 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 124.186 0.994 . . . . 72.23 108.419 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.569 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -59.96 -50.18 87.69 Favored Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.974 1.472 . . . . 44.12 114.974 -166.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.401 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.8 Cg_endo -83.98 -4.84 10.52 Favored 'Trans proline' 0 C--N 1.392 2.854 0 CA-C-N 121.803 1.68 . . . . 75.14 113.076 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -83.52 -37.04 23.58 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.288 1.035 . . . . 72.35 109.231 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' D' ' 73' ' ' ALA . 33.1 m -83.63 -4.24 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.864 0.865 . . . . 63.45 111.534 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.94 -25.73 67.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.671 0.788 . . . . 70.34 109.965 165.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -83.19 0.07 47.03 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.135 0.974 . . . . 52.43 111.447 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -116.94 86.23 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.536 1.134 . . . . 72.23 109.641 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.81 51.53 2.17 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.805 0.812 . . . . 64.41 110.186 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -130.15 -175.95 3.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.934 0.894 . . . . 73.05 109.222 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.468 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 33.9 tp60 -79.68 116.88 64.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 122.968 0.507 . . . . 65.11 110.293 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 13.9 Cg_exo -67.52 87.92 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.999 1.799 . . . . 74.23 109.375 169.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.88 120.66 14.53 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.539 -0.755 . . . . 61.24 110.548 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.659 HG13 HG13 ' D' ' 64' ' ' VAL . 84.8 t -95.83 117.65 40.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 114.991 -1.004 . . . . 73.54 110.291 -167.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.3 mmtt -89.58 115.2 26.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.712 -1.218 . . . . 74.31 107.712 171.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.51 124.53 37.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.218 -1.03 . . . . 73.14 108.218 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.8 t70 -116.59 125.39 51.76 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.388 -0.967 . . . . 53.2 108.388 174.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.61 132.3 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.749 0.82 . . . . 75.32 109.744 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.0 t70 -143.04 118.31 10.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.252 -1.388 . . . . 63.14 107.252 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -120.02 145.02 47.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.046 0.538 . . . . 63.1 110.27 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.29 43.94 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.17 0.988 . . . . 72.11 109.087 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -147.65 156.06 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.778 0.831 . . . . 65.23 109.521 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 63.4 p -151.77 127.27 10.04 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.329 0.651 . . . . 60.25 109.985 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -69.49 119.58 13.96 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.666 -0.494 . . . . 72.25 109.666 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' D' ' 57' ' ' GLU . 52.7 mt -92.35 -34.02 14.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.009 0.523 . . . . 75.33 110.348 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.84 -171.68 3.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.152 0.981 . . . . 75.22 109.856 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.12 109.59 1.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.036 0.534 . . . . 62.23 109.837 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 64.85 11.16 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.067 1.347 . . . . 73.12 113.193 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.89 133.27 58.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.386 . . . . 51.25 107.259 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.66 174.35 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.322 0.582 . . . . 71.14 109.822 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.8 tt0 -124.86 147.83 48.57 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 124.251 1.02 . . . . 72.44 108.511 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -120.15 125.57 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.521 -1.289 . . . . 73.15 107.521 167.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.423 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 82.4 t -103.54 126.81 57.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.019 0.928 . . . . 64.35 108.691 174.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.2 122.08 46.79 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.712 -1.218 . . . . 74.43 107.712 178.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.8 ttm-85 -109.47 99.97 9.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.298 -1.001 . . . . 53.2 108.298 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.08 126.68 44.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.19 -1.411 . . . . 33.41 107.19 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.0 m -120.44 127.22 52.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.585 0.707 . . . . 63.21 110.351 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.659 HG13 HG13 ' D' ' 40' ' ' VAL . 17.3 t -112.43 107.29 22.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 126.151 1.78 . . . . 75.2 109.144 -175.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 22.6 m -107.6 93.07 4.34 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.7 -1.222 . . . . 61.21 107.7 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.5 137.59 34.34 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.151 -0.685 . . . . 64.24 109.151 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.514 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 43.4 m -137.68 134.4 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 70.5 111.48 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.491 HD12 ' HB ' ' D' ' 31' ' ' VAL . 21.7 mt -108.08 107.05 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.004 1.322 . . . . 75.21 110.397 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.55 -112.29 3.67 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.936 -0.466 . . . . 74.12 111.936 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.86 6.3 17.87 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.089 0.955 . . . . 74.12 111.002 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -124.17 168.32 13.07 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.659 0.784 . . . . 64.11 110.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -81.31 126.6 31.77 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.312 0.645 . . . . 74.11 110.283 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG11 ' D' ' 31' ' ' VAL . . . -78.05 -67.17 0.76 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.783 0.833 . . . . 53.31 109.243 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.08 153.68 32.31 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 115.169 -0.923 . . . . 74.41 110.117 173.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.5 mt -109.66 152.75 25.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.623 -1.251 . . . . 61.42 107.623 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.571 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 42.0 t -158.9 146.73 17.86 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.528 0.731 . . . . 70.14 109.095 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -156.1 128.95 7.9 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.302 -0.629 . . . . 71.32 109.302 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.78 115.58 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.03 0.532 . . . . 64.45 109.708 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.537 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.9 mt-30 -90.36 89.1 7.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.571 0.749 . . . . 74.24 109.817 170.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -81.31 100.39 9.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.684 -1.144 . . . . 75.04 108.838 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -95.6 144.62 17.35 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.491 -0.644 . . . . 63.32 111.491 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.82 130.52 3.93 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.317 -0.713 . . . . 62.31 111.317 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.6 mt -89.73 124.86 42.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 124.249 1.02 . . . . 72.43 109.011 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.91 168.77 16.76 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.047 1.339 . . . . 71.44 108.973 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.6 m -114.07 137.0 52.31 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.765 0.826 . . . . 73.24 109.637 171.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.44 125.44 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.296 0.638 . . . . 60.24 109.939 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.32 164.64 27.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.343 0.657 . . . . 71.21 110.602 -176.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.04 -20.63 19.63 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 123.837 0.71 . . . . 73.42 114.788 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.49 163.3 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.993 0.917 . . . . 65.33 110.555 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -143.95 -176.12 4.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.08 0.952 . . . . 72.02 110.414 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.33 -133.54 20.05 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.347 -0.842 . . . . 74.2 113.565 171.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.1 m -59.3 -39.7 83.87 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.463 1.105 . . . . 70.33 111.812 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -58.62 -45.29 89.51 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.038 0.935 . . . . 73.11 111.604 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 3.4 ppp? -81.64 -39.26 24.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.547 0.339 . . . . 61.53 111.513 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.471 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.5 -40.3 92.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 73.52 111.272 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -78.96 -26.37 43.48 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.288 -0.869 . . . . 73.13 110.735 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.3 t -68.73 -52.5 30.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.437 0.295 . . . . 41.44 110.861 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' D' ' 94' ' ' MET . 1.7 pp -76.82 -18.34 58.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.096 0.406 . . . . 70.3 112.096 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.16 0.03 68.49 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.241 -0.755 . . . . 44.03 113.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.53 -61.56 0.17 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.081 0.94 . . . . 74.32 112.421 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -67.05 -48.88 66.95 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.533 0.733 . . . . 75.52 112.631 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 23.4 m -66.05 -42.7 53.19 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.384 0.674 . . . . 73.22 112.264 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 49.4 Cg_exo -59.15 -35.62 97.39 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.168 1.912 . . . . 70.41 112.762 166.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.85 -28.69 69.17 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.126 0.571 . . . . 73.02 111.356 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -65.97 -40.96 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.231 0.612 . . . . 75.53 110.011 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.431 HD21 ' HA3' ' D' ' 82' ' ' GLY . 77.1 mt -75.57 -23.01 56.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.021 -0.99 . . . . 73.14 111.762 -174.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -64.14 -40.9 57.5 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 117.495 -1.241 . . . . 70.44 113.904 -171.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.46 -41.9 42.85 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.224 1.949 . . . . 74.1 113.719 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.2 m-85 -78.09 -38.69 43.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.749 0.82 . . . . 73.14 111.422 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.04 95.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.152 0.581 . . . . 73.02 109.913 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -57.14 -56.82 16.81 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 124.875 1.27 . . . . 72.54 109.732 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.11 -39.62 90.67 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.325 1.016 . . . . 70.53 111.837 -172.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -45.36 88.35 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.743 0.652 . . . . 74.01 110.408 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.553 HG21 HG21 ' D' ' 64' ' ' VAL . 84.2 mt -64.51 -53.66 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.124 0.97 . . . . 50.44 110.155 174.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.0 m -52.4 -41.18 62.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.99 1.716 . . . . 71.11 111.546 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -69.7 -44.9 69.46 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.685 -1.143 . . . . 61.21 110.105 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.72 -30.21 70.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.963 0.505 . . . . 72.15 112.007 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.5 t -65.57 -47.37 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.805 0.842 . . . . 73.53 109.75 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -72.18 -29.08 63.66 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.047 -0.524 . . . . 44.51 110.744 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -70.18 -30.91 68.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.651 0.78 . . . . 55.24 110.166 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 10.46 63.99 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 115.788 -0.642 . . . . 51.44 112.797 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.535 HG23 ' HB3' ' C' ' 17' ' ' TYR . 40.7 p 64.01 18.53 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.663 1.985 . . . . 74.11 113.841 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 88.0 m-85 -88.28 164.71 31.93 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.036 0.934 . . . . 74.25 108.875 171.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.42 140.89 71.89 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.707 2.271 . . . . 72.21 111.012 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.5 118.18 7.2 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 109.521 -0.548 . . . . 72.43 109.521 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.3 101.76 11.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.377 0.671 . . . . 64.23 109.689 -171.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -98.8 96.12 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.508 -0.923 . . . . 63.25 108.508 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 129.63 40.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.939 0.896 . . . . 74.23 110.758 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -57.44 132.07 81.57 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.717 0.807 . . . . 75.23 111.121 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.44 114.25 3.87 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 121.962 1.775 . . . . 70.32 110.656 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.8 t -106.03 107.09 21.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.033 -1.099 . . . . 65.35 108.033 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 . . . . . 0 C--O 1.24 0.597 0 N-CA-C 107.722 -1.214 . . . . 74.53 107.722 177.014 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.3 m . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 108.638 -0.875 . . . . 55.42 108.638 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.2 t80 -109.2 149.99 28.58 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.748 -0.834 . . . . 72.12 108.748 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 51.0 tp60 -148.68 114.77 5.79 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.289 -0.263 . . . . 75.25 110.289 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.45 HD11 HG13 ' A' ' 16' ' ' ILE . 2.3 tp -72.1 90.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.907 -1.516 . . . . 74.22 106.907 164.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -82.98 -22.69 33.61 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.698 -1.137 . . . . 73.53 110.611 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -176.88 145.23 0.49 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.07 0.395 . . . . 72.44 111.297 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.3 mt -106.12 139.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.606 -1.627 . . . . 73.22 106.606 162.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.0 p90 -169.03 135.9 1.8 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.951 0.9 . . . . 63.52 109.712 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.7 p -77.71 118.02 19.67 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.141 -0.482 . . . . 61.4 109.799 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -84.15 -27.05 28.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.764 -0.653 . . . . 75.21 110.114 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -151.8 138.0 18.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.026 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.9 mt -132.69 139.23 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.981 -1.489 . . . . 75.1 106.981 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -152.34 110.53 3.7 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.076 0.465 . . . . 75.53 110.501 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 72.6 t80 -109.71 120.49 42.64 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 106.397 -1.705 . . . . 73.44 106.397 169.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -119.14 130.71 55.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.36 -0.978 . . . . 50.22 108.36 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.65 19.49 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.529 -1.286 . . . . 65.1 107.529 172.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.31 -15.94 28.12 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.648 2.232 . . . . 62.41 112.129 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -113.44 28.49 8.74 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 124.188 0.995 . . . . 73.34 109.544 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -58.41 -45.68 99.67 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 113.962 1.097 . . . . 61.45 113.962 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.79 -32.75 8.85 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 121.538 1.492 . . . . 55.04 112.333 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -74.27 -20.36 60.17 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.75 1.22 . . . . 75.41 111.678 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 28' ' ' ALA . 5.2 p -75.32 -20.53 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.366 0.666 . . . . 75.02 112.097 -170.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.65 -29.85 65.08 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.019 -0.537 . . . . 71.44 110.224 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -71.14 -28.83 64.57 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.148 0.979 . . . . 71.4 110.72 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -72.98 142.65 47.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 73.23 111.484 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -73.08 115.31 12.25 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.489 -1.301 . . . . 71.42 107.489 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -84.43 96.48 9.1 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.431 0.634 . . . . 74.55 110.867 -170.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -137.25 80.0 35.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 106.515 -1.661 . . . . 62.24 106.515 168.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.31 148.54 16.63 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.393 2.062 . . . . 73.3 112.544 -170.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.37 92.82 5.87 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.25 -1.389 . . . . 75.31 107.25 171.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 p -65.32 124.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.062 -0.972 . . . . 72.55 109.207 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -124.06 117.62 25.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.778 0.831 . . . . 74.43 109.321 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.4 tp -97.21 129.38 44.56 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.753 -0.832 . . . . 72.23 108.753 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.755 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.7 m-20 -115.19 134.35 55.23 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.273 1.029 . . . . 73.1 108.567 172.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -113.3 125.23 54.06 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.755 0.822 . . . . 74.01 109.246 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.27 145.52 37.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.334 0.653 . . . . 51.03 109.596 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.3 m -135.63 133.11 37.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 75.14 109.313 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 117.04 17.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.213 1.005 . . . . 40.32 109.439 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.3 p -118.47 153.27 34.42 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.46 0.704 . . . . 74.44 111.964 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -168.02 153.1 6.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.786 1.234 . . . . 73.53 109.523 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.4 138.6 32.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.887 -0.412 . . . . 70.25 109.887 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 55' ' ' VAL . 98.1 mt -107.5 -39.56 5.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.851 0.86 . . . . 75.41 111.134 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.95 -170.7 3.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.268 0.627 . . . . 64.3 110.305 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -66.96 113.18 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.248 1.019 . . . . 75.43 110.444 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 66.87 -4.29 0.81 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.488 1.515 . . . . 53.5 113.571 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 72.6 t -97.59 117.45 42.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.087 0.955 . . . . 65.25 108.439 -172.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -119.66 168.76 10.73 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.117 0.967 . . . . 70.11 109.367 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.9 tt0 -130.67 130.84 44.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.541 -1.209 . . . . 62.54 108.459 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 111.94 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.477 -1.675 . . . . 65.32 106.477 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.2 t -98.35 131.57 45.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.898 -0.778 . . . . 62.14 108.898 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -101.28 108.57 20.25 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.073 -1.454 . . . . 73.15 107.073 177.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.02 101.47 12.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.356 -0.979 . . . . 74.3 108.356 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' HB1' ' A' ' 110' ' ' ALA . 9.9 t -98.62 145.06 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.677 -1.147 . . . . 71.15 108.286 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 42.5 m -133.11 137.52 46.34 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.735 -0.469 . . . . 72.15 109.735 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.12 107.74 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.675 1.19 . . . . 75.23 107.998 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 24.6 m -103.13 138.48 39.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.777 -0.823 . . . . 71.44 108.777 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.09 102.81 9.32 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.603 -1.629 . . . . 55.25 106.603 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 52.5 m -108.45 124.0 49.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.339 0.59 . . . . 74.14 109.677 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 73' ' ' ALA . 14.7 mt -90.02 80.46 6.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.105 -1.443 . . . . 75.42 107.105 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -89.27 0.84 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.177 -0.919 . . . . 63.2 111.442 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -114.8 -26.39 7.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.451 0.7 . . . . 73.31 110.759 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -99.58 124.48 44.82 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.976 -0.379 . . . . 65.0 109.976 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 74.6 m -76.4 137.7 39.91 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.406 0.682 . . . . 43.25 111.437 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -78.87 -62.56 1.66 Allowed 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.815 1.246 . . . . 70.25 109.615 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -144.04 151.68 39.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.442 -1.254 . . . . 64.53 109.61 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.8 tp -126.09 115.56 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.038 1.335 . . . . 72.51 108.409 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.1 m -103.99 139.33 39.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.792 0.837 . . . . 63.33 108.94 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -145.1 133.21 21.47 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.887 -1.524 . . . . 74.13 106.887 167.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -135.71 120.92 28.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.781 -0.822 . . . . 61.02 108.781 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.34 79.5 5.0 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.745 -1.205 . . . . 62.21 107.745 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 106' ' ' LEU . 7.0 tp-100 -76.65 93.93 3.7 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 106.917 -1.512 . . . . 73.35 106.917 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.07 160.07 19.39 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.746 -0.264 . . . . 72.51 113.0 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.59 138.86 6.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 112.197 -0.361 . . . . 44.52 112.197 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.561 HG13 ' HE1' ' A' ' 17' ' ' TYR . 74.8 mt -81.76 125.47 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.892 -1.151 . . . . 73.42 107.892 169.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 57.3 m-85 -131.26 117.84 19.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.897 -1.149 . . . . 63.4 107.897 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 18.9 m -81.37 114.34 20.07 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.171 -1.048 . . . . 64.24 108.171 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.7 140.12 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.403 0.681 . . . . 72.23 110.971 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -178.75 168.53 1.69 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.679 1.592 . . . . 60.44 108.924 172.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.08 -27.51 7.02 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-N 116.161 -0.472 . . . . 73.41 112.889 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.54 179.85 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.907 1.283 . . . . 71.11 110.114 -170.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.63 174.12 15.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.012 0.525 . . . . 73.34 110.068 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.91 -128.12 28.55 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.819 -0.628 . . . . 62.42 113.753 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 p -67.5 -29.82 69.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.263 1.025 . . . . 64.22 111.516 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.65 -36.64 70.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.608 0.568 . . . . 62.43 110.934 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.2 ttt -74.1 -37.31 64.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.003 -0.369 . . . . 62.03 110.003 173.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.21 68.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.007 0.523 . . . . 40.15 111.016 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -74.92 -52.19 11.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.667 0.787 . . . . 74.45 110.282 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.1 t -65.21 -62.19 1.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.957 0.785 . . . . 53.54 110.553 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -65.66 -38.77 90.27 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.971 0.908 . . . . 63.13 111.957 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.78 -28.52 38.14 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 115.238 0.855 . . . . 51.35 115.238 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 -40.61 0.6 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.165 0.983 . . . . 24.11 112.423 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 56.1 t80 -74.89 -39.44 61.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.582 0.753 . . . . 62.13 112.296 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -79.58 -39.8 1.37 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 123.235 0.614 . . . . 74.24 111.752 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 53.1 Cg_exo -54.91 -30.15 67.36 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.372 2.048 . . . . 65.12 112.98 164.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.81 -24.26 66.15 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.755 0.822 . . . . 62.32 111.553 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 13' ' ' ILE . 47.3 mm -67.55 -42.5 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.913 0.864 . . . . 73.3 109.757 172.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 80' ' ' GLN . 44.3 mt -86.99 -15.98 37.13 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.272 -1.331 . . . . 71.13 112.25 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.36 -41.31 17.15 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-O 118.054 -0.974 . . . . 74.33 113.418 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.78 -35.28 80.02 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.81 1.673 . . . . 71.05 112.007 171.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.467 ' CE1' ' HD3' ' C' ' 111' ' ' ARG . 41.6 m-85 -77.0 -29.68 55.57 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.641 0.776 . . . . 72.51 112.213 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -72.36 -47.02 52.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.786 -0.82 . . . . 74.11 108.786 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.0 ttm180 -49.51 -50.13 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.048 1.467 . . . . 53.15 110.561 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.66 -40.47 73.0 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.36 1.038 . . . . 73.14 111.596 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.582 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.5 t -62.83 -41.83 99.49 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.483 0.489 . . . . 54.1 110.598 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.3 mt -65.97 -51.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.259 -0.882 . . . . 65.22 109.658 174.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.1 m -55.36 -39.75 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.077 0.951 . . . . 74.22 111.259 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.1 t -66.73 -45.22 79.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 123.776 0.673 . . . . 73.15 110.342 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 34.1 mtm -63.13 -40.32 97.24 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.73 0.412 . . . . 70.21 111.146 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.7 t -61.1 -50.29 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.499 1.12 . . . . 72.35 110.149 177.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 94.8 p -70.98 -25.92 62.91 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.796 -0.638 . . . . 71.24 111.633 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 116' ' ' SER . 37.7 ttm-85 -79.04 -28.9 43.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.35 1.06 . . . . 74.55 109.461 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.21 9.77 56.38 Favored Glycine 0 C--N 1.356 1.672 0 CA-C-N 115.196 -0.911 . . . . 61.3 112.825 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.448 HG22 ' NH2' ' B' ' 15' ' ' ARG . 31.1 m 69.22 33.65 3.22 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 123.476 1.607 . . . . 60.22 111.122 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 119' ' ' SER . 75.7 m-85 -101.89 158.2 32.23 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 113.994 -1.457 . . . . 74.33 107.135 161.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.84 -174.1 0.56 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.974 1.783 . . . . 72.25 112.004 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -76.01 141.59 42.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.893 0.477 . . . . 75.43 112.135 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.08 94.13 3.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.455 -1.313 . . . . 63.34 107.455 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.11 110.86 22.63 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.331 0.652 . . . . 74.21 110.242 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.4 mt -74.15 145.37 44.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.378 -0.828 . . . . 75.14 110.949 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.12 146.39 98.98 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.096 0.559 . . . . 73.43 111.396 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.48 141.0 45.12 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.284 1.989 . . . . 73.15 111.721 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.23 108.74 22.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 108.457 -0.942 . . . . 74.02 108.457 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -109.18 74.75 0.92 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 72.31 109.06 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.475 0.802 0 CA-C-N 115.667 -0.697 . . . . 71.24 110.641 177.263 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.245 0.841 0 N-CA-C 109.201 -0.666 . . . . 63.24 109.201 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -148.75 125.21 10.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.407 -1.331 . . . . 74.1 107.407 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -144.96 140.76 28.45 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.312 -0.625 . . . . 71.52 109.312 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.531 HD11 HG13 ' B' ' 16' ' ' ILE . 10.8 tt -90.75 144.07 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.521 0.728 . . . . 72.42 109.459 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.66 -44.59 3.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.959 0.504 . . . . 74.4 109.772 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.448 ' NH2' HG22 ' A' ' 122' ' ' THR . 19.7 ttt180 -169.6 146.22 3.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.3 0.24 . . . . 74.51 110.76 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.531 HG13 HD11 ' B' ' 13' ' ' ILE . 94.2 mt -120.42 144.49 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.378 -1.342 . . . . 61.41 107.378 173.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -169.37 158.98 8.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.69 0.677 . . . . 74.13 112.176 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.8 m -83.54 127.67 33.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.191 -0.913 . . . . 53.55 108.835 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -96.37 -36.62 10.79 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.666 0.786 . . . . 72.42 110.885 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -161.74 145.3 12.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.352 -0.385 . . . . 73.21 110.375 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.411 HD11 ' SG ' ' B' ' 113' ' ' CYS . 37.3 mm -137.2 138.93 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.682 1.193 . . . . 72.5 109.8 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 74.0 m -134.81 125.52 27.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.144 1.378 . . . . 74.43 108.492 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -142.78 108.2 5.04 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.54 -1.282 . . . . 75.11 107.54 167.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -119.2 122.99 43.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 45.2 108.462 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.11 89.43 14.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.991 0.917 . . . . 61.2 109.278 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.3 -32.04 73.11 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.194 2.596 . . . . 72.21 113.136 -172.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -117.96 32.09 6.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.911 0.884 . . . . 34.42 110.122 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.55 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -45.91 -54.76 15.16 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 125.646 1.578 . . . . 41.21 113.829 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.2 Cg_exo -68.77 -24.36 34.63 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 122.511 2.141 . . . . 74.32 112.881 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -89.19 1.79 55.15 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.777 -1.101 . . . . 63.52 111.786 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.31 -23.88 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.927 0.491 . . . . 52.13 110.462 170.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -63.62 -38.85 92.69 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.543 0.737 . . . . 74.53 110.416 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -82.88 -41.75 18.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.927 0.891 . . . . 74.32 110.296 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -85.38 70.66 10.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.686 1.194 . . . . 73.03 109.032 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.53 74.58 9.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.263 1.03 . . . . 61.13 110.798 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -167.08 154.07 8.7 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.235 -1.394 . . . . 75.3 107.235 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.07 127.74 92.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.049 0.54 . . . . 73.34 110.226 175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.69 151.79 81.72 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.257 1.972 . . . . 72.23 112.164 167.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 2.8 pt-20 -61.01 102.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.035 -0.984 . . . . 62.42 109.303 169.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.0 t -88.46 116.51 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.896 -1.15 . . . . 72.11 107.896 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -138.96 138.27 37.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.308 0.643 . . . . 72.32 109.275 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.459 ' HG ' HD23 ' B' ' 128' ' ' LEU . 0.8 OUTLIER -118.71 147.35 43.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 74.15 110.14 -168.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.26 149.5 52.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.214 1.406 . . . . 75.4 108.054 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.67 135.41 51.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.437 -0.579 . . . . 65.42 109.437 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -136.57 154.19 50.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.158 1.383 . . . . 65.41 108.363 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -132.03 139.94 48.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.986 0.514 . . . . 65.25 110.508 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.7 160.8 37.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 74.24 108.551 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -142.32 162.85 34.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.082 0.553 . . . . 72.25 110.588 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -153.35 168.2 26.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.821 1.248 . . . . 74.25 108.526 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -123.3 130.73 53.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.262 0.625 . . . . 63.01 111.134 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 65.7 mt -97.81 -49.86 4.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.469 0.708 . . . . 70.33 110.183 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.51 -170.89 3.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.501 -0.772 . . . . 71.02 110.387 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -65.71 116.19 6.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.702 -1.136 . . . . 73.33 109.704 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' B' ' 85' ' ' SER . 1.9 m-20 72.62 2.78 4.48 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.817 1.647 . . . . 65.04 111.605 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 95.51 3.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 124.291 1.036 . . . . 64.51 108.33 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.467 ' HB2' HD12 ' B' ' 86' ' ' ILE . 0.1 OUTLIER -94.58 139.02 31.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.842 177.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.45 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.2 tm-20 -103.65 95.99 6.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 106.622 -1.622 . . . . 64.43 106.622 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.29 123.1 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.267 -0.642 . . . . 65.42 109.267 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.6 t -102.31 123.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.568 0.747 . . . . 73.03 109.482 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -93.13 126.67 38.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.259 -1.386 . . . . 52.51 107.259 173.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.409 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 29.3 ttt180 -119.41 104.36 10.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.19 -0.67 . . . . 74.11 109.19 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.5 120.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.571 -0.9 . . . . 61.31 108.571 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -109.39 150.5 27.97 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.065 -0.717 . . . . 63.02 109.065 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.555 HG21 HG21 ' B' ' 114' ' ' ILE . 90.3 t -139.32 122.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.865 0.866 . . . . 73.31 109.279 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 79.8 m -113.76 138.78 49.78 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.638 0.775 . . . . 73.5 109.27 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.3 147.03 28.85 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.887 -1.052 . . . . 70.1 109.071 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 9.2 m -143.77 135.27 26.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.497 0.554 . . . . 61.35 112.497 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 50.0 mt -88.47 101.39 13.87 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.69 -1.596 . . . . 62.22 106.69 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -111.25 3.22 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.053 -0.819 . . . . 52.23 111.053 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.85 4.88 12.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.319 1.048 . . . . 72.0 110.734 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.75 139.07 50.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.578 1.151 . . . . 75.54 108.098 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -61.98 133.49 55.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.11 0.564 . . . . 71.53 112.141 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.95 -61.19 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.5 1.12 . . . . 74.01 109.176 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.02 167.1 28.7 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.456 -1.702 . . . . 71.04 109.618 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.69 118.86 11.35 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.661 1.585 . . . . 72.43 106.726 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -119.4 153.42 35.23 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.436 -0.579 . . . . 72.34 109.436 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.23 134.85 7.6 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.161 -1.052 . . . . 52.43 108.161 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -123.39 143.02 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 123.604 0.762 . . . . 72.22 109.738 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.4 mt-30 -118.15 90.93 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.653 -0.869 . . . . 70.13 108.653 171.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.8 tp-100 -89.88 100.8 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.339 -0.985 . . . . 72.24 108.339 175.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.68 163.69 29.85 Favored Glycine 0 C--O 1.242 0.643 0 N-CA-C 111.75 -0.54 . . . . 71.22 111.75 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.97 130.8 2.84 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.597 -0.601 . . . . 30.22 111.597 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -86.39 116.31 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.725 0.81 . . . . 74.11 109.195 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -133.87 134.59 42.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.212 1.005 . . . . 73.2 109.183 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 41.8 m -95.34 110.86 22.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.768 0.827 . . . . 61.4 110.028 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -118.69 138.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.146 0.978 . . . . 71.14 110.606 -177.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.98 167.64 27.47 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.598 0.759 . . . . 44.13 109.744 167.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.25 -41.65 3.01 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 123.549 0.53 . . . . 51.21 113.045 176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.409 ' H ' HG13 ' B' ' 89' ' ' ILE . 2.2 pp -63.42 156.14 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.308 1.043 . . . . 74.52 110.872 169.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.06 154.98 7.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.146 0.578 . . . . 72.1 109.732 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.75 -113.33 5.77 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.25 0.452 . . . . 75.42 113.444 170.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 -36.94 74.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.599 0.76 . . . . 70.42 110.643 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.48 -46.39 86.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.782 0.433 . . . . 61.32 110.731 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ttt -68.47 -40.87 80.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.017 -0.538 . . . . 61.54 110.326 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.65 70.34 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.324 0.649 . . . . 64.3 111.434 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -74.11 -36.33 64.2 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.585 0.754 . . . . 72.11 109.513 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.06 -68.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.791 -0.64 . . . . 61.23 110.446 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.76 -20.32 61.9 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.138 0.421 . . . . 72.42 112.138 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.46 -6.7 52.78 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.144 -0.809 . . . . 72.11 114.528 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.62 -42.54 0.14 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.255 1.028 . . . . 50.53 112.716 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -79.9 -53.04 7.13 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.932 0.333 . . . . 74.04 111.538 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.405 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 61.7 m -57.69 -45.56 99.82 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.648 0.779 . . . . 62.12 110.991 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 79.9 Cg_exo -50.14 -46.93 26.03 Favored 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.512 2.142 . . . . 74.13 113.582 164.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.4 -35.6 70.24 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.624 0.769 . . . . 74.2 112.098 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.459 HG23 ' NH2' ' D' ' 111' ' ' ARG . 82.6 mt -65.13 -49.11 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.637 0.775 . . . . 65.43 110.332 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 80' ' ' GLN . 50.8 mt -78.92 -12.65 60.04 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.684 -1.144 . . . . 73.21 111.966 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.432 ' HZ ' HD12 ' B' ' 128' ' ' LEU . 22.1 t80 -67.77 -46.11 44.59 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.06 1.344 . . . . 70.11 113.451 -166.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.47 -33.67 78.34 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.554 1.503 . . . . 70.1 112.203 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -65.8 -45.2 83.23 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.088 0.555 . . . . 64.13 110.531 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.79 77.79 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.318 0.647 . . . . 71.23 110.912 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -57.57 -53.41 58.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.04 0.936 . . . . 72.02 110.275 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.7 tm-20 -68.0 -29.79 68.89 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.046 0.842 . . . . 53.32 110.387 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 117' ' ' MET . 33.7 t -68.22 -45.63 72.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.158 0.583 . . . . 64.12 111.182 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.555 HG21 HG21 ' B' ' 64' ' ' VAL . 95.0 mt -63.11 -44.25 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 64.13 109.847 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.639 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . 32.6 m -66.34 -23.29 66.33 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.829 -1.078 . . . . 74.43 111.534 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.2 t -75.59 -40.87 55.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 72.1 110.627 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.4 mmt -79.29 -38.46 35.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.849 0.685 . . . . 74.3 112.849 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.798 ' HB ' ' HG3' ' B' ' 125' ' ' GLN . 95.5 t -75.62 -27.14 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.326 0.65 . . . . 52.12 110.77 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.451 ' HB3' HG21 ' C' ' 115' ' ' THR . 91.9 p -66.72 -37.67 85.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.027 0.441 . . . . 63.33 110.248 174.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.582 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 60.5 mtt-85 -63.57 -40.3 96.62 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.147 -0.933 . . . . 65.41 110.508 175.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.94 80.93 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.716 0.635 . . . . 45.43 113.199 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p 62.38 33.45 16.32 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.548 1.939 . . . . 61.33 112.874 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.37 -177.17 0.58 Allowed Pre-proline 0 CA--C 1.568 1.635 0 CA-C-N 114.284 -1.325 . . . . 70.14 109.024 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.542 ' HB2' HG21 ' B' ' 40' ' ' VAL . 3.9 Cg_exo -81.87 116.72 2.86 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.853 2.369 . . . . 73.15 112.964 169.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.798 ' HG3' ' HB ' ' B' ' 118' ' ' VAL . 0.5 OUTLIER -72.02 164.01 26.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.908 0.883 . . . . 71.22 111.324 164.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.436 ' HB3' HD21 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -137.26 127.16 25.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.205 -1.035 . . . . 62.3 108.205 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -91.71 102.81 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.816 -1.179 . . . . 73.31 107.816 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.459 HD23 ' HG ' ' B' ' 42' ' ' LEU . 0.3 OUTLIER -66.08 139.34 58.17 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 110.361 -0.237 . . . . 54.55 110.361 -170.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.66 148.23 98.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.768 0.827 . . . . 70.2 111.118 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.405 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 93.4 Cg_endo -74.33 97.07 1.0 Allowed 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.22 1.946 . . . . 65.25 111.239 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.91 110.95 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.263 -0.643 . . . . 71.54 109.263 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -72.68 97.07 2.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.23 0.612 . . . . 74.01 109.452 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 N--CA 1.478 0.946 0 C-N-CA 123.636 0.774 . . . . 70.43 112.17 -175.728 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.236 0.356 0 N-CA-C 109.596 -0.52 . . . . 75.31 109.596 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.532 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 48.4 t80 -92.84 119.76 32.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.676 -1.231 . . . . 72.41 107.676 169.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -137.1 117.95 14.15 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 109.255 -0.646 . . . . 73.31 109.255 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.412 HD11 HG13 ' C' ' 16' ' ' ILE . 6.5 tp -70.53 131.44 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 109.437 -0.579 . . . . 72.41 109.437 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.501 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.9 mm-40 -96.15 -48.69 5.55 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.37 -0.832 . . . . 74.24 108.989 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.467 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 61.9 ttt180 -176.37 133.95 0.24 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.387 -0.824 . . . . 72.03 109.787 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.412 HG13 HD11 ' C' ' 13' ' ' ILE . 80.9 mt -108.64 150.32 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.767 -1.197 . . . . 75.32 107.767 170.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.516 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 28.9 p90 -179.62 154.29 0.6 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.74 . . . . 74.2 109.471 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.437 HG21 HD11 ' C' ' 21' ' ' ILE . 75.2 p -74.87 118.4 17.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.763 -0.828 . . . . 52.24 108.763 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.59 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -69.92 -43.3 71.96 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.315 -0.994 . . . . 61.25 108.315 176.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.6 t70 -154.02 138.89 17.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.425 -1.716 . . . . 75.04 108.928 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.437 HD11 HG21 ' C' ' 18' ' ' THR . 97.8 mt -129.3 145.72 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.714 -1.217 . . . . 64.11 107.714 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -153.23 150.06 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.527 0.679 . . . . 70.32 110.0 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -143.91 127.19 16.71 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.815 -1.55 . . . . 73.4 106.815 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 48.5 mt-10 -116.47 125.12 51.52 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.118 -0.697 . . . . 61.43 109.118 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.68 74.91 38.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.626 1.17 . . . . 74.12 108.189 171.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.98 -28.57 49.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.306 2.004 . . . . 74.45 110.452 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 93.1 m-20 -97.9 24.83 6.51 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.768 -1.106 . . . . 74.41 111.094 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HA ' ' HZ ' ' C' ' 123' ' ' PHE . . . -57.09 -48.28 97.68 Favored Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.454 0.701 . . . . 64.2 111.74 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' C' ' 32' ' ' PHE . 56.4 Cg_endo -86.82 -25.46 1.16 Allowed 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.164 1.909 . . . . 75.41 113.27 168.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.427 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 83.0 t60 -70.01 -23.39 63.12 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.64 0.776 . . . . 74.43 112.627 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.616 HG11 ' HE1' ' C' ' 123' ' ' PHE . 9.9 p -78.03 1.3 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 124.278 1.031 . . . . 74.04 112.189 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' C' ' 29' ' ' PRO . 36.5 t80 -49.34 -43.45 43.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.72 1.608 . . . . 72.14 113.913 -171.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -128.65 48.81 2.27 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.364 -0.976 . . . . 72.31 108.364 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.89 155.31 19.46 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.834 -0.621 . . . . 75.52 109.63 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.27 118.39 12.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.776 . . . . 73.22 109.97 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -78.48 94.57 4.97 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.72 0.808 . . . . 74.03 110.755 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.33 54.06 2.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 114.986 -1.006 . . . . 64.22 110.082 171.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.32 97.88 0.17 Allowed 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.09 1.86 . . . . 73.44 111.715 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -84.24 108.83 17.33 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.401 -1.703 . . . . 75.43 106.401 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.68 HG11 ' HG ' ' C' ' 126' ' ' LEU . 46.4 t -94.02 102.64 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 113.897 -1.501 . . . . 63.15 110.218 -166.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.87 112.52 24.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.3 0.64 . . . . 70.31 110.442 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.704 HD11 HD12 ' C' ' 128' ' ' LEU . 7.0 mp -91.24 141.01 29.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.733 -0.84 . . . . 74.53 108.733 172.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -143.18 138.48 29.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.899 0.88 . . . . 63.25 109.476 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.79 127.23 54.52 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.321 -0.622 . . . . 63.43 109.321 177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.73 145.36 48.47 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.353 1.461 . . . . 74.04 108.276 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.2 t -123.67 139.45 53.98 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.275 0.559 . . . . 72.33 109.66 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.47 147.61 34.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.997 1.319 . . . . 75.31 107.682 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -145.75 155.43 42.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.937 0.398 . . . . 74.51 111.346 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.0 m -142.62 136.42 29.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.266 1.027 . . . . 60.2 108.527 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -84.66 116.76 23.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.554 -0.906 . . . . 71.45 108.554 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.581 HD11 HD12 ' C' ' 83' ' ' ILE . 76.4 mt -91.0 -34.4 15.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.752 -0.658 . . . . 72.01 109.579 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.75 -174.19 2.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.101 -0.954 . . . . 52.32 110.004 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.25 122.49 22.04 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.38 -0.827 . . . . 45.33 109.256 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 65.4 11.4 7.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.09 1.356 . . . . 74.3 112.406 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.23 110.67 30.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 108.18 -1.044 . . . . 70.33 108.18 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -127.03 129.82 48.8 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.631 -0.713 . . . . 75.22 109.623 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.27 109.92 16.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.241 -1.345 . . . . 73.23 108.462 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 64.8 t -97.68 114.7 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.102 -1.073 . . . . 73.21 108.102 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.8 105.34 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.676 -0.861 . . . . 63.12 108.676 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -96.7 104.4 16.39 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.754 -1.202 . . . . 65.31 107.754 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -85.8 116.48 24.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.627 0.771 . . . . 74.33 109.957 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.8 t -101.54 127.92 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.71 -1.218 . . . . 64.25 107.71 168.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.8 m -124.61 124.23 41.77 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.087 -0.709 . . . . 71.42 109.087 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.544 HG22 ' HG ' ' C' ' 42' ' ' LEU . 38.3 t -110.58 131.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 72.23 109.447 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 25.9 m -116.52 149.69 39.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.233 -1.395 . . . . 65.3 107.233 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.52 130.94 41.05 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.768 -1.197 . . . . 75.04 107.768 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.6 m -133.54 161.64 34.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.485 0.66 . . . . 42.4 110.693 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 mt -128.45 28.5 5.44 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.647 1.579 . . . . 75.54 108.016 -173.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.41 -113.85 2.62 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.349 -1.9 . . . . 75.3 108.349 -165.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.5 -27.12 19.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.204 0.601 . . . . 62.43 109.717 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.6 117.98 9.54 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 124.658 1.183 . . . . 72.55 110.214 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -79.17 126.43 30.73 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.523 -0.547 . . . . 71.23 109.523 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.03 -52.13 11.85 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.593 0.757 . . . . 54.52 109.011 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.408 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 43.1 p90 -164.18 172.68 13.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.535 -1.211 . . . . 64.14 110.129 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -137.72 145.13 42.14 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.754 -1.573 . . . . 74.4 106.754 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.469 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.6 t -144.18 144.54 31.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.572 -0.899 . . . . 74.53 108.572 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.05 125.68 9.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.404 -0.591 . . . . 75.21 109.404 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' C' ' 110' ' ' ALA . 75.0 t -126.66 114.66 38.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.263 1.025 . . . . 72.52 108.424 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -96.81 87.51 4.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.62 -0.881 . . . . 52.41 108.62 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -85.14 119.81 25.95 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.075 -0.966 . . . . 42.51 109.542 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.59 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -114.05 153.77 17.38 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 123.453 0.471 . . . . 62.54 112.507 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.31 130.98 3.74 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.969 -1.252 . . . . 63.41 109.969 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.581 HD12 HD11 ' C' ' 51' ' ' LEU . 18.6 mm -88.56 119.01 35.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.764 -1.199 . . . . 71.35 107.764 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.58 122.88 39.3 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.39 -0.967 . . . . 71.14 108.39 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -90.19 100.4 13.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.886 -1.524 . . . . 73.2 106.886 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.57 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -122.72 133.45 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.697 0.799 . . . . 72.34 110.818 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.33 177.39 11.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.547 -0.751 . . . . 72.54 110.921 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.08 -63.69 2.07 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.641 -0.709 . . . . 32.53 112.731 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.5 2.032 0 C-N-CA 125.161 1.384 . . . . 65.11 112.787 176.06 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 118.851 -0.595 . . . . 65.14 111.944 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.6 tpt -45.77 -54.13 8.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.941 0.719 . . . . 43.25 112.941 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.26 -34.32 18.98 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.622 0.369 . . . . 53.52 111.378 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -74.6 -20.05 60.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.127 0.788 . . . . 72.21 113.127 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -68.02 -62.19 1.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.136 0.425 . . . . 73.35 110.696 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.471 ' H ' HD23 ' C' ' 98' ' ' LEU . 2.7 pt? -79.89 -20.3 46.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.239 -0.437 . . . . 54.43 111.294 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.67 -30.22 30.25 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.369 0.507 . . . . 54.34 114.369 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.2 -35.29 0.18 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.223 0.823 . . . . 52.23 113.223 -173.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -73.38 -56.83 4.54 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.17 0.588 . . . . 73.11 111.169 -169.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 36.9 m -61.63 -46.36 93.61 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 123.73 0.812 . . . . 61.33 111.226 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 84.2 Cg_exo -53.44 -34.39 71.45 Favored 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 122.798 2.332 . . . . 60.43 114.61 167.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.6 -30.36 69.08 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.821 0.849 . . . . 62.15 111.365 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.427 HG23 ' NH1' ' A' ' 111' ' ' ARG . 46.2 mm -68.05 -29.88 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 123.199 0.6 . . . . 44.12 110.206 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.9 mt -93.05 -29.71 15.67 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.304 1.042 . . . . 63.43 112.567 -173.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -56.96 -38.32 67.38 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.79 -1.1 . . . . 52.34 113.956 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.17 -50.9 12.37 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.079 2.519 . . . . 75.01 113.897 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -62.05 -36.7 82.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.989 -1.005 . . . . 75.45 110.873 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.483 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -76.44 -40.0 51.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.459 -0.791 . . . . 54.2 111.2 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' CE1' ' A' ' 109' ' ' TYR . 29.1 ttt180 -58.15 -36.95 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.782 0.833 . . . . 74.22 111.142 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -44.96 25.18 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.197 0.599 . . . . 53.1 110.872 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.05 -30.17 71.11 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.325 0.65 . . . . 61.31 112.597 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.53 HD13 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -67.33 -49.91 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.339 0.655 . . . . 52.53 109.98 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.46 HG23 ' HB2' ' C' ' 125' ' ' GLN . 90.5 m -54.0 -42.74 69.36 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.253 0.971 . . . . 61.11 110.951 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.6 t -62.34 -49.26 76.3 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.168 -1.378 . . . . 65.23 110.754 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.554 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -63.19 -39.49 94.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.883 0.873 . . . . 72.32 112.373 -177.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.03 -41.85 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.152 0.581 . . . . 60.35 110.886 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.441 ' CB ' HG21 ' B' ' 115' ' ' THR . 28.2 t -59.8 -35.74 75.3 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.439 -1.255 . . . . 73.53 111.851 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.554 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 73.6 mtt-85 -68.91 -38.6 79.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.313 -0.858 . . . . 72.44 110.895 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.22 4.66 66.25 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.699 -0.682 . . . . 75.25 112.85 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 60.51 38.31 19.11 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.829 1.652 . . . . 63.44 112.207 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.616 ' HE1' HG11 ' C' ' 31' ' ' VAL . 43.9 m-85 -106.57 163.53 16.79 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.206 -1.361 . . . . 60.25 109.821 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.34 104.45 0.3 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.263 1.975 . . . . 75.34 111.181 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.792 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -56.07 150.77 13.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.237 1.415 . . . . 74.24 112.746 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.68 ' HG ' HG11 ' C' ' 40' ' ' VAL . 1.9 mm? -129.45 99.87 5.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.807 0.443 . . . . 74.24 110.737 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -109.32 84.63 1.96 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.37 -1.715 . . . . 71.32 106.37 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.704 HD12 HD11 ' C' ' 42' ' ' LEU . 55.4 mt -90.02 156.68 18.24 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.337 -1.301 . . . . 53.52 111.848 -172.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -34.62 121.98 0.55 Allowed Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.218 1.807 . . . . 54.3 113.65 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HG3' HD12 ' A' ' 16' ' ' ILE . 74.4 Cg_endo -71.29 110.24 2.79 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.73 2.287 . . . . 63.42 111.559 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 86.0 t -76.0 94.32 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.94 -0.763 . . . . 71.4 108.94 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.56 104.67 3.37 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 CA--C 1.549 0.934 0 O-C-N 125.075 1.484 . . . . 74.01 112.761 -170.241 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.237 0.396 0 CA-C-O 121.007 0.432 . . . . 45.42 109.946 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -145.97 94.5 2.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 106.431 -1.692 . . . . 74.01 106.431 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -129.47 139.45 51.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.306 0.642 . . . . 71.34 109.468 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.48 142.81 12.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.152 0.581 . . . . 71.01 109.738 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 56.9 mt-30 -103.36 -43.93 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.15 0.58 . . . . 70.23 110.683 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.542 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 55.6 ttt180 -170.13 148.72 3.4 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 111.784 0.29 . . . . 73.25 111.784 -169.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.405 ' HB ' ' HG3' ' B' ' 130' ' ' PRO . 1.1 mp -120.68 144.2 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 106.205 -1.776 . . . . 74.02 106.205 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.542 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 16.3 p90 -165.9 151.07 8.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.478 0.656 . . . . 75.43 111.226 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -86.95 113.05 22.39 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.033 -0.985 . . . . 50.22 109.082 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -81.06 -28.84 35.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.978 -0.555 . . . . 71.04 110.289 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -151.82 136.44 17.0 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.788 -1.096 . . . . 71.22 109.131 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' C' ' 117' ' ' MET . 96.7 mt -130.81 138.3 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.694 -1.224 . . . . 62.14 107.694 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -141.59 137.11 31.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.138 0.975 . . . . 73.2 109.053 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.2 t80 -145.52 114.23 6.82 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.263 -1.755 . . . . 60.13 106.263 170.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 38.3 mt-10 -122.26 111.09 16.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.228 0.611 . . . . 75.44 109.707 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.91 88.99 5.97 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.331 -0.989 . . . . 74.41 108.331 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.48 -33.94 1.64 Allowed 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 122.634 2.223 . . . . 71.52 113.295 -173.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -101.26 28.25 5.55 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.944 0.897 . . . . 73.5 109.317 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -51.58 -55.22 31.43 Favored Pre-proline 0 CA--C 1.574 1.893 0 N-CA-C 116.149 1.907 . . . . 64.32 116.149 -165.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.2 -16.24 11.09 Favored 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 122.049 1.768 . . . . 73.25 113.43 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -72.64 -44.78 61.46 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.066 0.946 . . . . 65.35 109.81 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.3 p -82.93 -0.27 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.818 -172.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 80.2 t80 -57.82 -29.84 65.26 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.1 0.96 . . . . 74.12 111.098 164.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -78.95 4.36 14.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.705 0.802 . . . . 70.13 111.543 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -108.3 110.24 21.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.285 1.034 . . . . 62.13 108.717 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -112.59 48.83 0.97 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.343 1.057 . . . . 74.24 111.793 -164.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -154.29 -174.55 5.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.533 0.733 . . . . 73.22 110.403 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -72.24 126.8 90.97 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.147 0.579 . . . . 64.14 110.893 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 17.4 Cg_exo -68.06 134.13 30.92 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.548 2.165 . . . . 64.22 111.898 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 38.1 mt-10 -60.14 115.08 3.21 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.218 0.949 . . . . 74.31 108.95 170.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.4 HG21 HD13 ' D' ' 126' ' ' LEU . 57.6 t -95.12 107.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.099 -1.075 . . . . 75.41 108.099 -176.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' D' ' 65' ' ' THR . 0.2 OUTLIER -88.07 119.23 28.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.569 -1.271 . . . . 61.5 107.569 171.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.19 141.86 29.05 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.448 -0.945 . . . . 62.33 108.448 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -144.44 130.43 19.42 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.503 -0.925 . . . . 75.52 108.503 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.3 135.53 52.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.511 0.725 . . . . 61.43 109.958 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -144.67 156.96 44.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.505 1.122 . . . . 64.43 108.894 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -139.04 164.53 29.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 53.35 109.55 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 174.21 14.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.44 1.096 . . . . 73.52 108.594 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 95.8 p -164.14 157.57 18.25 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.006 0.432 . . . . 74.01 110.82 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.3 p -151.29 129.99 12.33 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.155 -0.93 . . . . 63.05 108.948 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.5 116.81 15.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.635 -0.505 . . . . 75.44 109.635 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' D' ' 57' ' ' GLU . 81.7 mt -92.64 -35.28 13.6 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.359 0.664 . . . . 74.43 109.709 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.99 -177.47 6.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.279 -0.873 . . . . 53.52 110.133 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.08 125.16 27.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.162 -1.051 . . . . 75.23 108.162 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.42 16.43 10.19 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.267 1.027 . . . . 75.31 112.271 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 65.2 t -136.72 127.19 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.569 1.147 . . . . 73.15 108.089 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.29 152.62 34.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.194 0.521 . . . . 74.22 110.102 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.6 tt0 -88.58 131.48 34.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.989 -1.005 . . . . 70.05 109.109 175.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.65 131.68 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.618 -1.253 . . . . 73.41 107.618 167.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 58.4 t -106.29 133.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.953 -0.758 . . . . 71.4 108.953 173.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -104.58 125.34 50.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.645 -1.613 . . . . 64.12 106.645 172.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.9 ttm-85 -106.97 100.2 9.72 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.211 -1.033 . . . . 71.14 108.211 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.79 121.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.298 -1.371 . . . . 62.02 107.298 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.0 m -124.84 128.99 49.54 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.454 0.645 . . . . 64.42 109.965 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.2 t -120.84 132.18 71.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.223 1.409 . . . . 75.11 109.171 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' D' ' 41' ' ' LYS . 89.0 m -128.65 98.75 5.11 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.649 -1.241 . . . . 74.44 107.649 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.13 141.95 28.9 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.869 -0.605 . . . . 62.31 109.599 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.7 p -143.14 129.13 19.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.41 0.443 . . . . 74.22 111.227 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 mt -108.99 99.76 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 73.13 108.751 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.87 -132.05 10.81 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.476 0.485 . . . . 60.03 111.972 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.94 5.03 52.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.463 0.705 . . . . 73.22 111.569 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -123.68 167.46 13.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.77 . . . . 71.4 110.557 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.9 m -77.68 132.01 37.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.2 -0.909 . . . . 72.45 110.293 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.53 -65.8 0.97 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.815 0.846 . . . . 74.52 108.73 176.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -154.75 170.39 21.71 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.202 -0.908 . . . . 75.12 110.116 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.0 mt -128.12 153.46 46.83 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.42 -1.326 . . . . 73.44 107.42 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.0 t -158.58 144.1 16.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.841 0.456 . . . . 71.43 110.253 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.34 124.44 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.244 -0.65 . . . . 75.11 109.244 170.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -125.75 116.2 45.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.47 0.708 . . . . 73.32 109.862 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -91.85 86.89 6.04 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.705 0.764 . . . . 74.14 109.809 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.421 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.1 tp-100 -80.72 98.36 7.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.112 1.365 . . . . 74.54 109.736 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.99 158.99 26.25 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.117 -0.393 . . . . 32.23 112.117 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.65 140.31 6.85 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.842 -0.503 . . . . 52.3 111.842 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.9 mt -91.55 120.89 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.518 0.727 . . . . 62.42 109.786 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -118.77 126.42 51.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 72.23 110.407 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 75.2 m -91.31 101.53 14.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.487 1.115 . . . . 63.45 109.541 171.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.87 141.76 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.072 0.549 . . . . 55.43 110.814 -177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.5 162.74 14.61 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.632 1.173 . . . . 73.22 109.129 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.79 77.52 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.356 0.41 . . . . 64.42 113.233 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' D' ' 94' ' ' MET . 0.1 OUTLIER -123.26 130.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 124.097 0.959 . . . . 73.15 109.462 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -142.89 170.77 15.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.894 0.878 . . . . 74.45 110.357 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.15 -141.98 33.6 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.211 -0.904 . . . . 71.42 113.569 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' D' ' 95' ' ' ALA . 16.9 p -75.32 -16.06 60.44 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.716 0.807 . . . . 62.32 111.948 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -60.85 -48.29 82.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.345 0.658 . . . . 75.33 109.992 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.672 ' HG3' HD23 ' D' ' 98' ' ' LEU . 11.2 tpt -80.97 -41.16 23.26 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.38 -0.827 . . . . 72.43 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' D' ' 92' ' ' THR . . . -57.78 -39.92 78.6 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 62.23 112.143 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 80.4 t60 -76.84 -27.07 54.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.625 0.77 . . . . 71.41 110.69 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 37.3 t -75.33 -51.51 13.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.448 0.299 . . . . 73.51 111.273 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.672 HD23 ' HG3' ' D' ' 94' ' ' MET . 4.1 pp -67.38 -32.72 73.82 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.573 0.749 . . . . 74.41 112.217 -172.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.67 13.56 42.37 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.543 -0.587 . . . . 72.34 113.877 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -156.55 -59.86 0.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.35 0.575 . . . . 71.43 111.946 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.455 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 70.3 t80 -73.69 -42.29 61.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.888 0.699 . . . . 64.25 112.888 -168.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 76.0 m -67.04 -44.8 51.56 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.92 -0.562 . . . . 51.24 111.18 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.5 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.3 Cg_exo -56.74 -32.62 91.86 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.127 1.885 . . . . 65.21 113.663 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.18 -35.96 82.49 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.435 0.694 . . . . 75.44 111.272 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.87 -41.78 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.387 0.675 . . . . 62.51 110.208 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.421 HD13 ' O ' ' D' ' 80' ' ' GLN . 86.8 mt -75.06 -21.22 59.13 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.955 -1.021 . . . . 74.23 111.757 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -64.9 -44.61 72.76 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.784 1.402 . . . . 61.24 114.784 -167.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.37 -39.53 86.89 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.244 1.963 . . . . 73.1 113.279 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -78.0 -37.69 46.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.014 -0.993 . . . . 71.23 110.932 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.41 90.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 70.33 110.694 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.459 ' NH2' HG23 ' B' ' 105' ' ' ILE . 40.1 ttp180 -57.47 -49.89 74.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.113 1.365 . . . . 64.31 111.009 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.17 -41.5 99.23 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.277 0.986 . . . . 53.12 111.648 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.464 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 45.0 t -56.58 -40.17 74.76 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.926 0.766 . . . . 75.24 110.896 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.484 HG12 ' SG ' ' D' ' 76' ' ' CYS . 39.8 mt -69.14 -50.36 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.088 -0.96 . . . . 72.14 110.087 175.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.442 HG23 ' HG3' ' D' ' 125' ' ' GLN . 20.2 m -52.05 -42.43 63.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.678 1.191 . . . . 72.15 111.981 -175.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -70.54 -43.45 69.52 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.894 -1.048 . . . . 73.42 110.948 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.7 mtm -64.62 -30.32 71.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.694 0.398 . . . . 54.21 111.615 178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.4 t -66.17 -47.9 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.862 0.726 . . . . 73.44 110.346 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.3 p -71.43 -27.67 63.45 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.656 0.383 . . . . 71.04 111.061 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -75.9 -32.77 59.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.791 0.837 . . . . 65.44 109.795 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.64 -4.88 89.45 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 115.718 -0.674 . . . . 61.42 112.119 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 67.88 33.13 4.86 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.496 1.918 . . . . 70.52 113.117 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -102.6 166.22 12.37 Favored Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.806 1.242 . . . . 72.15 109.949 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.417 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 35.4 Cg_exo -60.01 140.15 91.28 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 123.278 2.652 . . . . 73.32 112.889 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' D' ' 115' ' ' THR . 29.4 tt0 -52.18 140.06 22.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.087 0.867 . . . . 74.01 111.897 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.4 HD13 HG21 ' D' ' 40' ' ' VAL . 46.1 tp -128.3 106.12 8.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.634 -0.712 . . . . 73.02 109.519 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.433 HD22 ' HB ' ' B' ' 16' ' ' ILE . 8.1 p30 -130.0 106.29 8.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.832 0.853 . . . . 74.11 109.021 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.26 151.23 45.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 73.3 110.72 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.83 136.63 95.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.462 0.705 . . . . 50.04 111.16 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -69.5 113.11 3.22 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.005 1.804 . . . . 73.13 109.461 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.52 104.43 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.174 0.987 . . . . 70.1 109.663 -171.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.319 0 N-CA-C 105.913 -1.884 . . . . 73.54 105.913 174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.898 0.38 . . . . 73.01 110.282 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -98.54 139.82 33.69 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.098 -0.955 . . . . 72.44 108.513 162.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.658 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -156.39 137.37 13.55 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 112.329 0.492 . . . . 74.1 112.329 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 83' ' ' ILE . 7.9 tp -80.02 134.63 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.531 0.732 . . . . 73.24 110.149 169.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.413 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.9 OUTLIER -101.77 -40.25 7.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.957 -0.757 . . . . 71.04 108.957 174.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt180 -173.75 127.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.999 -0.524 . . . . 74.34 110.948 -171.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.05 133.75 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.614 -0.884 . . . . 72.42 108.614 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 34.0 p90 -169.04 170.34 8.94 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.899 0.88 . . . . 74.34 110.578 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.8 p -93.39 120.08 33.26 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.32 -0.992 . . . . 73.45 108.32 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.7 mtpt -86.94 -42.94 12.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.204 -0.665 . . . . 75.5 109.204 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 12.0 t70 -135.16 128.51 32.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.145 -0.934 . . . . 70.54 108.499 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -122.95 143.28 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.952 -1.129 . . . . 64.3 107.952 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -143.5 125.91 15.73 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.798 -0.816 . . . . 70.03 108.798 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.9 t80 -131.1 129.87 42.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.586 -1.635 . . . . 72.52 106.586 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.91 138.83 47.09 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.313 -0.625 . . . . 72.11 109.313 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 76.18 11.39 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.385 -1.339 . . . . 72.03 107.385 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.53 -24.07 16.53 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.296 1.998 . . . . 63.34 111.202 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.03 25.76 7.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.078 0.951 . . . . 73.13 109.104 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -59.2 -47.64 97.93 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 124.389 1.075 . . . . 11.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 52.8 Cg_exo -61.17 -27.99 84.68 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.982 1.788 . . . . 70.02 113.738 171.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -76.07 -48.79 19.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.7 0.8 . . . . 62.22 112.134 -173.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.596 HG23 HD11 ' A' ' 68' ' ' LEU . 7.4 p -57.11 -27.21 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.975 0.91 . . . . 64.2 112.362 -175.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.45 -36.32 75.73 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.381 1.072 . . . . 73.44 112.328 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.72 -12.39 20.02 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.063 0.545 . . . . 61.24 111.363 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 4.6 mmmp? -83.51 143.23 30.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.729 0.812 . . . . 55.31 111.972 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.47 143.59 57.69 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 124.324 1.015 . . . . 74.41 110.578 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CE3' HD21 ' A' ' 68' ' ' LEU . 65.9 t-105 -93.0 86.69 5.5 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.758 0.79 . . . . 75.24 110.326 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -125.55 79.8 66.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 107.058 -1.46 . . . . 62.35 107.058 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 142.38 11.86 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.326 2.017 . . . . 72.31 112.928 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.55 86.04 3.49 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.257 -1.757 . . . . 64.31 106.257 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 t -76.49 93.76 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.02 -0.991 . . . . 74.31 108.966 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.3 tttt -79.22 124.42 28.35 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.55 -0.75 . . . . 63.53 109.096 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.415 ' HG ' HD21 ' A' ' 128' ' ' LEU . 2.4 mm? -107.38 112.25 24.97 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.01 -1.107 . . . . 71.33 108.01 170.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 28.9 t70 -105.17 129.86 53.47 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.647 -0.872 . . . . 75.22 108.647 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.1 tp -106.04 131.93 52.73 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.174 -0.676 . . . . 73.4 109.174 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -143.0 152.61 42.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.131 -1.063 . . . . 74.32 108.131 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -138.01 156.59 47.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.929 0.892 . . . . 63.41 109.313 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 153.75 34.42 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.139 0.975 . . . . 51.24 108.797 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.46 152.43 51.52 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.896 0.478 . . . . 74.51 110.754 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -149.94 121.19 7.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.998 0.919 . . . . 62.42 109.046 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.37 -0.604 . . . . 74.13 109.37 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -88.58 -43.38 11.42 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.581 -0.736 . . . . 75.01 111.048 -175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 -174.87 4.7 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.411 -0.813 . . . . 74.34 110.577 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -75.53 123.33 25.28 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.359 -0.837 . . . . 73.13 108.825 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 72.33 14.78 5.38 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.304 1.442 . . . . 73.21 111.77 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.26 114.13 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.771 0.828 . . . . 73.31 110.381 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -124.26 126.14 45.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.742 0.817 . . . . 72.23 108.992 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 33.8 tt0 -90.34 120.43 31.46 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.406 1.082 . . . . 60.15 109.152 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.523 HG21 ' HG ' ' A' ' 98' ' ' LEU . 21.5 t -102.61 116.71 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.73 -1.211 . . . . 53.2 107.73 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.0 t -99.23 126.28 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.038 -0.727 . . . . 73.54 109.038 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.27 115.67 31.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.349 -1.352 . . . . 75.01 107.349 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -108.83 105.38 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.42 0.628 . . . . 74.11 109.742 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -101.99 133.51 45.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.778 -1.101 . . . . 72.33 108.152 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.2 m -121.69 118.23 28.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.372 0.606 . . . . 73.34 110.528 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.7 t -105.6 107.08 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.701 -1.136 . . . . 62.41 108.931 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 12.4 m -106.51 131.78 53.28 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.625 -0.88 . . . . 61.42 108.625 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.78 107.78 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.073 -1.084 . . . . 72.24 108.073 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 44.8 m -115.24 126.98 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.643 0.377 . . . . 63.1 110.392 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.596 HD11 HG23 ' A' ' 31' ' ' VAL . 18.9 mt -88.97 58.95 4.8 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.093 -1.077 . . . . 75.54 108.093 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.36 -89.0 0.71 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-N 114.999 -1.001 . . . . 64.33 112.136 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -92.92 -28.1 16.67 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.049 0.94 . . . . 72.14 110.709 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.706 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -107.54 103.53 12.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.592 0.757 . . . . 75.5 109.631 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 91.8 m -66.03 130.34 42.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.638 0.654 . . . . 74.4 109.576 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.25 -56.3 4.57 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.806 0.843 . . . . 65.44 109.831 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.5 172.92 16.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.83 -1.077 . . . . 64.23 111.36 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -132.09 144.42 50.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.138 -1.392 . . . . 71.14 108.276 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.6 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -136.82 139.82 42.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.895 0.878 . . . . 72.14 108.665 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.465 ' HG2' ' OE1' ' A' ' 79' ' ' GLN . 43.6 tt0 -149.77 120.22 7.41 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.465 -0.568 . . . . 73.35 109.465 173.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.65 113.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.457 0.703 . . . . 70.02 110.485 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.465 ' OE1' ' HG2' ' A' ' 77' ' ' GLU . 1.7 mp0 -89.0 80.48 7.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.388 1.475 . . . . 74.24 108.36 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.36 94.27 3.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.713 -1.13 . . . . 73.14 108.879 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.88 140.74 19.65 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.409 -0.677 . . . . 52.4 111.409 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.672 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.89 122.22 1.88 Allowed Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.417 -1.073 . . . . 73.21 110.417 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.0 mt -83.74 125.91 40.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.685 -0.857 . . . . 63.21 108.685 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CE2' HD13 ' A' ' 13' ' ' ILE . 53.1 m-85 -128.36 120.47 27.06 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.079 -0.711 . . . . 64.24 109.079 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.3 t -81.27 102.17 10.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.504 0.722 . . . . 54.32 109.295 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 149.84 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.375 0.67 . . . . 63.53 110.402 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.07 177.06 2.01 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.708 1.203 . . . . 43.32 109.58 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.36 -34.35 4.19 Favored Glycine 0 N--CA 1.473 1.122 0 CA-C-N 116.126 -0.488 . . . . 73.44 114.076 173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.55 150.85 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.97 0.908 . . . . 71.24 108.772 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -136.37 176.94 8.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.121 0.568 . . . . 74.51 112.065 -171.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.41 -126.71 40.52 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.118 -0.947 . . . . 74.25 113.089 172.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.505 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 40.9 p -71.45 -15.06 62.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.689 0.796 . . . . 71.35 112.568 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -72.15 -45.65 59.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.475 0.71 . . . . 63.4 110.584 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.97 -28.99 29.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.443 0.697 . . . . 74.43 109.981 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -72.93 -22.99 60.64 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.195 0.598 . . . . 62.11 111.177 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -65.89 -46.55 77.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.906 0.882 . . . . 74.43 109.616 169.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.4 m -60.55 -64.72 0.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.711 -1.131 . . . . 63.32 110.318 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.523 ' HG ' HG21 ' A' ' 58' ' ' VAL . 9.7 mp -73.8 -9.91 59.14 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.898 0.703 . . . . 63.21 112.898 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.89 -29.4 13.1 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.795 -0.447 . . . . 52.1 113.747 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.33 -44.47 0.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.876 0.695 . . . . 72.42 112.876 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.9 t80 -78.32 -60.44 2.37 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.246 0.618 . . . . 44.2 112.318 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 97' ' ' CYS . 59.1 m -66.64 -37.9 16.99 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 114.325 1.231 . . . . 64.21 114.325 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.51 -27.05 69.97 Favored 'Trans proline' 0 C--N 1.391 2.767 0 CA-C-N 121.391 1.533 . . . . 65.44 112.664 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -73.0 -26.5 61.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.974 0.509 . . . . 75.02 110.149 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -64.78 -43.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.311 0.576 . . . . 63.13 109.568 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.672 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.4 mt -76.85 -26.45 54.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.093 -0.958 . . . . 71.23 112.031 -175.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -64.32 -36.67 20.12 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.52 1.304 . . . . 62.44 114.52 -168.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 -34.37 95.03 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.074 1.849 . . . . 43.55 113.292 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -85.65 -36.29 20.39 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.667 0.787 . . . . 73.02 111.149 -174.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.89 85.03 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.377 -0.601 . . . . 65.42 109.377 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -53.16 -56.48 16.05 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.798 1.311 . . . . 63.51 109.492 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.8 -41.84 87.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.156 0.982 . . . . 74.02 111.8 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.476 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 48.3 t -62.5 -50.5 71.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.357 0.663 . . . . 74.32 110.674 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.554 HG21 HG21 ' A' ' 64' ' ' VAL . 89.7 mt -61.83 -51.22 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.92 0.763 . . . . 61.13 110.451 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.6 m -51.57 -45.16 63.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.923 1.289 . . . . 72.34 111.4 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -73.41 -41.49 63.23 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.841 -1.072 . . . . 50.15 110.833 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.5 mtp -55.13 -43.47 74.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.652 0.781 . . . . 50.15 111.424 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 54.5 t -65.08 -45.81 93.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.523 -1.217 . . . . 51.3 111.103 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.69 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.2 p -69.18 -32.52 71.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.383 0.273 . . . . 42.22 111.595 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.54 -28.43 67.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.614 0.766 . . . . 74.52 110.829 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.96 67.14 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.475 0.484 . . . . 63.11 113.496 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.481 ' HB ' HH21 ' B' ' 15' ' ' ARG . 9.5 m 64.07 43.24 5.2 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.74 1.216 . . . . 71.31 110.525 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.4 156.63 50.82 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 114.908 -1.042 . . . . 73.11 108.918 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.27 115.56 3.39 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.98 1.787 . . . . 70.0 110.395 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 8.5 pt20 -62.92 143.18 57.92 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.422 0.451 . . . . 62.44 110.222 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.84 122.16 46.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.88 -0.785 . . . . 73.55 108.88 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -97.11 94.15 6.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.415 HD21 ' HG ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -68.05 126.18 28.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.274 -0.875 . . . . 75.41 109.893 -172.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -66.08 128.13 93.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 O-C-N 123.466 0.479 . . . . 52.52 110.537 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 4.8 Cg_exo -79.19 123.74 5.71 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.615 2.21 . . . . 74.34 111.567 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.4 112.43 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.129 -1.063 . . . . 73.11 108.129 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -90.91 72.26 6.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.082 -1.081 . . . . 63.22 108.082 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 t80 . . . . . 0 N--CA 1.477 0.884 0 CA-C-N 115.032 -0.985 . . . . 63.14 111.103 -178.164 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.2 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.423 -1.325 . . . . 74.12 107.423 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -143.18 132.22 22.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.485 -0.932 . . . . 74.33 108.485 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -154.12 140.93 19.12 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.396 0.435 . . . . 53.13 111.702 173.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.56 HD13 HD11 ' B' ' 16' ' ' ILE . 58.8 mt -84.66 115.04 25.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.45 -0.944 . . . . 74.33 108.45 168.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -87.9 -35.07 17.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.604 0.565 . . . . 71.15 110.039 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.481 HH21 ' HB ' ' A' ' 122' ' ' THR . 70.8 ttt180 -167.27 137.73 2.98 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.139 -0.482 . . . . 72.23 110.045 -177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.56 HD11 HD13 ' B' ' 13' ' ' ILE . 98.0 mt -116.98 135.95 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.934 -1.506 . . . . 61.43 106.934 169.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -168.99 152.04 5.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.274 0.559 . . . . 64.23 111.479 -170.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.2 m -83.04 121.48 27.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.343 -0.984 . . . . 70.15 108.343 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -92.24 -32.88 14.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.102 0.561 . . . . 73.34 110.773 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 25.7 t70 -155.95 142.42 18.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.981 -0.554 . . . . 75.45 110.851 -168.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 34.4 mm -138.87 142.08 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 62.45 108.881 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 41.4 t -141.36 133.76 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.451 -1.25 . . . . 52.33 107.856 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.0 t80 -147.34 107.54 4.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.493 -1.299 . . . . 71.02 107.493 171.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.45 120.97 39.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.127 0.971 . . . . 64.41 108.656 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -119.23 87.19 34.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.959 0.904 . . . . 62.52 109.857 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 -48.83 4.66 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.904 2.403 . . . . 64.14 112.672 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.488 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 28.1 m-80 -104.11 28.57 6.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.204 0.602 . . . . 73.33 110.66 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -49.99 -51.66 59.58 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.885 1.274 . . . . 70.34 113.411 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 97.2 Cg_endo -86.98 -13.06 4.73 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.435 2.09 . . . . 53.44 113.394 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.488 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 88.3 m-70 -89.27 2.97 53.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.378 0.671 . . . . 73.24 111.078 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -62.66 -16.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.973 1.309 . . . . 72.22 111.942 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.893 0.877 . . . . 75.25 111.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.14 -45.91 72.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.775 -0.648 . . . . 62.13 110.806 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.07 81.61 1.47 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.721 0.809 . . . . 74.03 109.511 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -80.24 74.11 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.114 0.959 . . . . 70.43 111.41 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -159.29 174.28 15.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.997 1.319 . . . . 75.33 109.745 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.74 129.97 80.09 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 115.284 -0.871 . . . . 75.2 109.757 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.15 153.41 69.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.341 2.028 . . . . 72.4 111.723 167.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.3 mt-10 -65.65 99.79 0.47 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.05 -1.092 . . . . 73.04 108.05 172.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' 126' ' ' LEU . 21.7 t -87.18 117.43 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.413 -1.328 . . . . 54.21 107.413 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -151.67 132.86 14.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.066 -0.716 . . . . 65.45 109.066 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' B' ' 64' ' ' VAL . 1.5 pt? -128.92 164.55 22.89 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.032 0.444 . . . . 74.42 111.877 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -149.49 149.93 31.54 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.963 -1.017 . . . . 63.04 109.556 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.9 tt -107.14 136.69 46.56 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 52.45 111.121 -170.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 1.2 m-20 -123.61 150.92 43.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.223 1.409 . . . . 71.44 107.574 172.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -136.41 134.19 37.5 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.77 147.38 27.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.348 1.059 . . . . 72.41 108.237 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -142.65 162.54 35.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.843 0.457 . . . . 54.34 110.555 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -154.33 166.4 33.33 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.566 1.146 . . . . 70.44 109.064 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -115.05 132.67 56.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.858 0.463 . . . . 73.41 110.373 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.93 -48.19 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.859 0.864 . . . . 74.25 110.063 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.86 -175.81 5.48 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.797 -1.092 . . . . 53.43 109.779 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -61.43 122.05 14.19 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.241 -0.89 . . . . 74.42 109.455 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 71.69 -5.29 1.69 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.23 1.412 . . . . 73.3 111.882 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -109.64 100.21 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.301 1.04 . . . . 75.13 108.715 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.49 172.44 6.97 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.623 0.769 . . . . 71.03 110.814 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -144.04 115.45 8.05 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.903 -1.517 . . . . 71.52 106.903 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' B' ' 98' ' ' LEU . 43.3 t -117.33 125.6 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.54 0.736 . . . . 53.03 109.805 -173.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.6 t -106.29 121.16 58.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.993 0.917 . . . . 65.44 110.319 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -93.81 114.47 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 107.653 -1.24 . . . . 72.42 107.653 170.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.0 ttm180 -100.64 112.56 24.96 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.11 118.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.11 -1.071 . . . . 61.45 108.11 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.2 m -115.9 137.08 52.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.616 0.766 . . . . 72.12 109.812 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' B' ' 42' ' ' LEU . 94.1 t -111.85 119.99 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.842 1.257 . . . . 74.22 110.453 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 67.5 m -89.67 140.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.896 -1.15 . . . . 63.41 107.896 165.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.54 143.61 26.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.013 -0.366 . . . . 63.23 110.013 175.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.6 p -156.03 135.2 12.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.687 0.625 . . . . 75.33 112.687 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -92.88 99.1 11.82 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.548 -1.279 . . . . 64.32 107.548 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.44 -130.93 41.13 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.65 0.594 . . . . 43.01 112.494 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -90.89 44.92 1.22 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.025 0.93 . . . . 74.22 110.091 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.06 139.02 13.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.455 0.702 . . . . 72.13 109.42 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.0 m -72.85 133.12 44.3 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.021 0.529 . . . . 71.43 110.466 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 -56.18 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.839 0.856 . . . . 71.43 109.281 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -152.85 165.93 33.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.301 -1.318 . . . . 60.01 109.83 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -140.73 121.07 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.419 -1.697 . . . . 73.3 106.419 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.548 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.4 t -116.31 158.96 22.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.319 -0.993 . . . . 64.33 108.319 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.3 tt0 -165.88 130.36 2.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.131 -0.692 . . . . 74.21 109.131 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -124.33 142.93 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.229 -1.026 . . . . 60.33 108.229 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -122.05 87.22 2.71 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.126 -1.065 . . . . 72.24 108.126 172.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -80.59 101.05 8.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.235 -1.348 . . . . 64.23 108.539 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.66 171.13 37.53 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.404 -0.678 . . . . 75.33 111.404 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.92 131.61 2.46 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.2 -0.76 . . . . 71.53 111.2 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.12 122.87 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.376 -1.342 . . . . 62.32 107.376 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -129.85 129.73 44.34 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.653 -1.24 . . . . 75.22 107.653 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -97.41 102.65 14.47 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.216 -0.661 . . . . 64.41 109.216 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.36 138.41 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.177 0.991 . . . . 71.42 110.901 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.8 172.06 19.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.449 1.099 . . . . 45.35 109.585 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.64 -43.28 2.99 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-N 116.173 -0.467 . . . . 62.21 112.859 177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 163.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.934 0.894 . . . . 75.33 111.019 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 9.9 pt-20 -159.37 143.82 15.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.005 0.522 . . . . 74.33 110.873 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.11 -104.36 0.45 Allowed Glycine 0 C--N 1.353 1.515 0 O-C-N 124.226 0.954 . . . . 44.12 114.121 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.3 m -65.88 -41.35 91.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.231 1.012 . . . . 63.11 110.258 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.419 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 72.6 mt-30 -61.33 -40.56 94.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.475 -0.784 . . . . 75.3 111.035 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.2 ttt -71.52 -40.7 69.93 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.509 0.505 . . . . 72.11 110.676 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.3 66.96 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.466 -0.788 . . . . 71.21 111.692 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -93.73 -21.22 19.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.973 0.909 . . . . 74.33 110.648 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -79.17 -67.2 0.78 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.563 -0.532 . . . . 75.14 109.563 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' B' ' 58' ' ' VAL . 2.2 pp -95.34 -4.85 44.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.177 0.806 . . . . 70.43 113.177 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -3.21 56.59 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 120.04 -0.311 . . . . 73.53 112.665 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.05 -56.51 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.013 0.375 . . . . 71.02 112.013 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -74.78 -41.26 60.35 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.106 0.41 . . . . 75.51 112.106 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 85.6 m -68.9 -45.72 31.68 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.698 -0.668 . . . . 73.35 110.532 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.6 Cg_exo -55.69 -31.54 80.28 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.132 1.888 . . . . 73.52 113.895 165.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.455 HD22 ' HE1' ' B' ' 133' ' ' PHE . 54.6 t-20 -66.97 -40.79 87.53 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 122.886 0.474 . . . . 72.42 110.173 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.489 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -58.57 -49.17 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.66 0.784 . . . . 65.41 109.871 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.71 -9.64 59.67 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.781 -1.1 . . . . 71.22 112.005 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.512 ' HZ ' HD13 ' B' ' 128' ' ' LEU . 76.9 t80 -64.94 -51.06 59.18 Favored Pre-proline 0 N--CA 1.484 1.256 0 CA-C-O 117.991 -1.004 . . . . 74.12 113.402 -172.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.79 -35.8 87.14 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.788 1.658 . . . . 74.25 112.174 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.51 ' HE2' HG21 ' D' ' 115' ' ' THR . 88.7 m-85 -64.17 -47.87 78.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.745 0.818 . . . . 74.21 110.858 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.61 91.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.379 -0.828 . . . . 54.14 110.467 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -65.1 -45.0 86.99 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.375 1.07 . . . . 64.42 109.948 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.08 -37.82 69.52 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.148 -0.933 . . . . 72.11 110.132 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG2' ' B' ' 117' ' ' MET . 10.0 t -64.97 -35.69 82.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.945 0.498 . . . . 75.3 110.993 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' B' ' 64' ' ' VAL . 73.3 mt -64.7 -53.31 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.22 0.608 . . . . 72.01 109.778 173.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -56.74 -31.55 64.68 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.139 0.899 . . . . 52.01 110.892 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -64.38 -53.26 51.42 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 114.805 -1.089 . . . . 72.32 110.111 172.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.4 mmt -66.53 -33.84 76.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.065 0.394 . . . . 72.02 112.065 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.25 -40.86 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.731 0.812 . . . . 44.41 109.906 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.6 p -73.03 -29.31 62.89 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.022 -0.535 . . . . 75.35 111.642 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' HA ' ' A' ' 113' ' ' CYS . 72.5 mtt-85 -65.73 -36.9 84.92 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.46 -0.791 . . . . 72.41 109.484 172.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.98 3.61 69.88 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 124.024 0.827 . . . . 75.31 113.5 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.4 p 59.56 29.67 19.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.824 1.65 . . . . 73.11 112.748 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 63.7 m-85 -102.24 155.51 36.39 Favored Pre-proline 0 N--CA 1.488 1.461 0 C-N-CA 124.206 1.003 . . . . 73.42 111.278 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.65 178.85 0.83 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.731 2.954 . . . . 74.04 115.662 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -64.93 152.85 42.13 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.56 -1.655 . . . . 61.11 114.573 -162.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.579 HD21 HD13 ' B' ' 42' ' ' LEU . 26.6 tp -149.32 106.08 3.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.003 -1.453 . . . . 75.22 108.861 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.52 92.36 2.9 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.588 -1.264 . . . . 73.24 107.588 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.522 HD12 HD11 ' B' ' 42' ' ' LEU . 2.4 tt -58.95 141.45 53.68 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.745 -1.116 . . . . 64.32 109.649 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.45 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -57.46 106.48 0.69 Allowed Pre-proline 0 N--CA 1.477 0.912 0 O-C-N 124.359 1.037 . . . . 65.33 110.831 173.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.648 ' HB2' ' HB ' ' D' ' 16' ' ' ILE . 6.1 Cg_exo -79.3 123.16 5.42 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.662 2.241 . . . . 72.21 109.739 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' D' ' 13' ' ' ILE . 10.0 p -155.44 155.34 5.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 123.694 0.621 . . . . 54.13 109.732 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.536 ' H ' HD12 ' D' ' 13' ' ' ILE . 32.6 t30 -69.09 114.47 7.39 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 107.784 -1.191 . . . . 75.41 107.784 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.455 ' HE1' HD22 ' B' ' 104' ' ' ASN . 46.3 p90 . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 124.507 1.123 . . . . 43.22 112.015 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 38.9 m . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 107.553 -1.277 . . . . 52.24 107.553 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -120.94 119.01 31.35 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.133 -1.432 . . . . 71.24 107.133 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -146.13 136.3 23.71 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 171.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.429 HD12 ' O ' ' C' ' 83' ' ' ILE . 5.5 tp -80.47 132.17 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.369 -0.832 . . . . 72.3 108.79 169.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 76.2 mm-40 -99.59 -45.61 5.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.263 -0.881 . . . . 61.45 109.866 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -165.41 122.03 1.44 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.512 -0.767 . . . . 71.01 109.174 -170.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 56.1 mt -112.95 134.53 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.319 -1.363 . . . . 74.04 107.319 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.485 ' HB3' HG23 ' D' ' 122' ' ' THR . 18.9 p90 -173.71 168.86 4.32 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 123.816 0.698 . . . . 73.04 110.636 -173.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -91.3 128.29 37.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.26 -0.882 . . . . 65.15 109.615 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.469 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 30.0 mmtp -80.01 -52.79 7.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.577 0.703 . . . . 71.05 109.413 170.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 28.9 t70 -135.75 115.09 12.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.6 -1.182 . . . . 75.21 109.267 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 54.8 mt -111.27 139.46 35.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.515 -1.661 . . . . 74.32 106.515 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -152.74 142.51 22.01 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.276 0.56 . . . . 41.24 109.819 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -132.48 133.77 44.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.322 -1.362 . . . . 55.35 107.322 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -125.89 127.55 46.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.954 -1.128 . . . . 73.23 107.954 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -145.7 76.61 12.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.867 -1.16 . . . . 63.01 107.867 170.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.62 -27.57 22.2 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.486 2.124 . . . . 63.44 110.785 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -106.56 29.12 7.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.484 1.113 . . . . 43.54 109.558 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -58.59 -50.67 86.76 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.072 1.138 . . . . 63.54 114.072 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.21 -15.99 4.28 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.367 1.378 . . . . 53.52 112.356 171.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -72.12 -29.65 64.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.429 1.092 . . . . 73.52 111.548 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.626 HG23 HD11 ' C' ' 68' ' ' LEU . 14.7 p -79.03 -18.15 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.69 0.796 . . . . 73.31 111.842 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -53.99 -41.65 68.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.487 1.115 . . . . 71.24 112.201 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 52.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.509 -0.922 . . . . 71.3 108.509 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.521 ' HG2' ' HG2' ' C' ' 71' ' ' GLU . 0.1 OUTLIER -125.56 164.92 19.48 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.816 -0.552 . . . . 63.43 110.337 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.34 104.06 1.77 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.542 -0.91 . . . . 63.22 108.542 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.93 88.46 7.44 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.252 1.025 . . . . 62.53 112.616 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -133.1 71.43 77.46 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.62 1.168 . . . . 73.34 108.611 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.33 127.26 12.44 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.473 2.115 . . . . 73.13 111.638 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -87.09 112.91 22.37 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 62.21 108.525 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.483 HG21 HD21 ' C' ' 126' ' ' LEU . 21.8 t -79.88 80.49 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.141 -0.936 . . . . 44.22 108.691 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.497 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 25.5 tptp -90.95 102.03 14.79 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.585 -0.894 . . . . 65.32 108.585 -175.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.91 152.54 22.0 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.605 -0.725 . . . . 72.11 109.817 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.56 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 4.6 m-20 -139.75 136.36 34.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.075 0.95 . . . . 73.34 109.336 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 42.0 tp -112.8 108.88 18.04 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.768 0.827 . . . . 71.41 109.283 178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 14.4 t70 -113.77 148.05 37.22 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.64 -1.245 . . . . 72.31 107.64 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 63.2 m -126.97 126.38 43.1 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.934 0.494 . . . . 62.14 109.884 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.13 146.32 45.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.11 -1.07 . . . . 75.14 108.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -149.37 143.66 25.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.77 0.828 . . . . 63.34 109.049 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 34.8 p -154.66 129.28 9.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.369 0.667 . . . . 60.33 110.45 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.29 133.95 42.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 110.037 -0.357 . . . . 75.13 110.037 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 47.8 mt -98.66 -52.92 3.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.96 0.904 . . . . 71.14 110.417 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.92 -170.78 3.55 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.304 -0.862 . . . . 74.4 110.581 -170.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.44 109.64 3.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.135 0.974 . . . . 54.32 110.1 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 67.74 -4.02 1.04 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.911 1.285 . . . . 72.52 112.762 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.9 t -92.93 111.96 25.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 N-CA-C 108.308 -0.997 . . . . 72.4 108.308 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -119.04 157.88 26.93 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.197 0.999 . . . . 63.03 108.433 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.62 139.44 53.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.578 -0.897 . . . . 72.3 108.578 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.57 116.84 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.307 -1.368 . . . . 74.12 107.307 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.81 105.54 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.523 -0.917 . . . . 62.23 108.523 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.11 122.16 29.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.841 -1.17 . . . . 74.33 107.841 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 60.0 mtp180 -105.44 114.04 27.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.834 0.854 . . . . 72.25 110.036 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.53 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.9 t -106.91 128.24 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.1 -0.704 . . . . 72.45 109.1 172.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 14.3 m -111.59 138.14 48.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.473 -0.936 . . . . 50.33 108.473 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.668 HG21 HG21 ' C' ' 114' ' ' ILE . 97.5 t -123.19 112.22 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.957 -1.127 . . . . 63.4 107.957 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.75 142.57 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.86 -0.793 . . . . 53.31 108.86 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.17 102.9 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.758 -1.571 . . . . 74.22 106.758 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -136.77 142.82 42.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.38 0.61 . . . . 44.1 111.275 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.626 HD11 HG23 ' C' ' 31' ' ' VAL . 17.6 mt -94.02 30.62 1.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.405 1.482 . . . . 62.44 109.369 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.93 -110.58 2.81 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 109.773 -1.331 . . . . 62.43 109.773 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 -22.45 19.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.071 0.548 . . . . 74.42 110.513 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.521 ' HG2' ' HG2' ' C' ' 34' ' ' LYS . 11.4 tp10 -79.58 90.1 5.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.03 0.932 . . . . 74.13 109.706 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -73.04 123.25 23.16 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 120.953 0.406 . . . . 61.13 110.987 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.24 26.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.68 1.192 . . . . 74.42 109.779 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.08 168.57 24.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.223 -0.899 . . . . 71.35 110.896 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -136.44 136.52 39.58 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.311 -1.737 . . . . 44.04 106.311 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -146.8 113.05 5.87 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.097 0.408 . . . . 61.23 109.989 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -118.43 133.21 56.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.546 -0.538 . . . . 54.54 109.546 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.409 HG22 HG23 ' C' ' 21' ' ' ILE . 54.9 t -119.3 143.36 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.508 -0.923 . . . . 74.42 108.508 169.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -119.57 94.44 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.246 -1.02 . . . . 63.42 108.246 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -81.77 106.49 13.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.783 0.833 . . . . 73.02 110.822 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.01 146.8 23.27 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.201 -0.454 . . . . 64.11 112.542 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.16 120.72 1.29 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.23 -0.748 . . . . 55.31 111.23 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 14.8 mm -90.97 115.51 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.18 -0.674 . . . . 64.24 109.18 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -120.9 117.37 27.19 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.642 -0.873 . . . . 55.01 108.642 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -88.46 104.75 17.09 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.608 -1.256 . . . . 61.11 107.608 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' C' ' 10' ' ' THR . 1.8 pp -130.97 138.25 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.296 0.638 . . . . 71.23 112.038 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.74 163.02 18.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.813 1.245 . . . . 55.14 109.83 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 -26.2 7.88 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.293 -0.412 . . . . 63.1 113.287 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.443 1.097 . . . . 74.42 110.213 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.839 -0.43 . . . . 74.01 109.839 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.502 ' HB3' HG12 ' C' ' 89' ' ' ILE . 14.3 ptp -77.58 -28.19 51.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.847 0.459 . . . . 64.31 111.897 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.53 -45.48 75.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.34 0.656 . . . . 74.34 110.802 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -78.76 -33.98 46.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.073 -0.512 . . . . 63.3 110.259 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 38.8 t -63.82 -59.99 3.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.96 0.504 . . . . 41.42 111.047 -177.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 tt -71.63 -35.84 70.54 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.521 -0.548 . . . . 53.14 109.521 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.66 -4.68 90.22 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.163 -0.798 . . . . 53.22 114.882 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -155.08 -60.47 0.11 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.396 1.098 . . . . 61.52 112.143 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -60.68 -60.54 3.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.006 0.923 . . . . 73.43 113.26 -165.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 64.7 m -59.72 -47.71 96.87 Favored Pre-proline 0 CA--C 1.564 1.512 0 N-CA-C 113.181 0.808 . . . . 73.23 113.181 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.24 -32.05 42.95 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 120.982 1.386 . . . . 74.52 113.014 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -67.78 -27.88 67.13 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.958 0.503 . . . . 62.22 110.625 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.83 -42.61 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 65.12 110.15 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.465 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -78.87 -21.63 47.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.427 -0.806 . . . . 51.52 112.342 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -55.64 -51.98 75.73 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 117.799 -1.096 . . . . 73.14 113.881 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.28 -33.97 92.57 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.026 1.817 . . . . 70.44 113.508 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.89 -45.92 66.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 63.23 110.807 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.02 90.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.446 0.698 . . . . 44.22 110.382 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -54.47 -53.23 57.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.742 1.617 . . . . 72.01 111.127 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.4 -34.34 75.85 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.618 0.767 . . . . 72.42 110.65 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.6 t -70.45 -33.88 71.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.381 0.673 . . . . 73.1 112.107 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.668 HG21 HG21 ' C' ' 64' ' ' VAL . 92.5 mt -72.58 -49.08 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.014 0.526 . . . . 72.35 109.742 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.567 HG23 ' HB2' ' C' ' 125' ' ' GLN . 99.3 m -57.12 -33.98 67.9 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.158 0.911 . . . . 73.42 111.321 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.5 t -58.66 -57.36 13.33 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.57 -1.195 . . . . 63.23 109.743 170.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.413 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.22 -42.53 86.45 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.159 1.384 . . . . 75.21 113.914 -175.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.19 -47.33 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 123.635 0.584 . . . . 72.24 109.836 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -72.29 -22.56 61.18 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.888 -1.051 . . . . 74.25 111.777 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 86.0 mtt-85 -71.06 -39.26 72.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.118 0.567 . . . . 71.34 109.863 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' D' ' 17' ' ' TYR . . . -79.95 5.26 62.77 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.893 0.746 . . . . 63.42 112.591 171.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.68 ' HB ' HH21 ' D' ' 15' ' ' ARG . 43.0 p 58.04 38.71 26.7 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 74.23 112.143 174.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -102.32 164.15 16.28 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.046 1.338 . . . . 74.23 108.792 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.49 102.54 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.08 1.853 . . . . 72.45 112.336 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.567 ' HB2' HG23 ' C' ' 115' ' ' THR . 0.0 OUTLIER -60.63 140.87 57.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.154 0.582 . . . . 74.13 110.267 177.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.483 HD21 HG21 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -112.2 144.2 41.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.237 0.615 . . . . 72.1 110.912 -173.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -118.21 93.3 4.08 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 77.9 mt -75.87 133.04 40.67 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.684 -1.144 . . . . 74.42 107.95 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.29 146.99 77.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 124.293 0.996 . . . . 74.51 111.09 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.21 100.63 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.117 2.545 . . . . 74.2 112.728 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.28 82.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.378 -0.828 . . . . 63.33 109.635 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.86 105.49 17.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.49 -1.3 . . . . 64.35 107.49 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 t80 . . . . . 0 N--CA 1.488 1.474 0 C-N-CA 123.424 0.69 . . . . 70.21 112.176 -176.995 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.241 0.65 0 N-CA-C 109.238 -0.653 . . . . 62.04 109.238 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 63.9 t80 -162.58 89.26 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.354 -2.091 . . . . 71.42 105.354 174.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -131.13 144.83 51.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.908 -1.145 . . . . 60.31 107.908 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.593 HD13 HD11 ' D' ' 16' ' ' ILE . 47.8 mt -104.12 120.17 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 117.676 0.216 . . . . 64.04 111.452 -170.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.34 -28.47 34.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.593 0.757 . . . . 73.13 111.39 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.68 HH21 ' HB ' ' C' ' 122' ' ' THR . 14.1 tpt180 177.89 156.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.691 0.396 . . . . 74.24 110.242 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' B' ' 130' ' ' PRO . 17.8 mt -141.14 127.52 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 106.439 -1.689 . . . . 73.35 106.439 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' HA2' ' C' ' 121' ' ' GLY . 47.3 p90 -165.71 173.35 10.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.053 0.93 . . . . 74.52 110.906 -172.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.084 -1.417 . . . . 74.33 109.606 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -82.25 -17.95 44.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.104 -0.702 . . . . 74.35 109.104 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -158.17 135.92 10.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.117 1.367 . . . . 75.43 109.03 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.573 HG23 HG22 ' D' ' 78' ' ' VAL . 21.1 mt -137.61 145.27 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.877 -1.157 . . . . 63.04 107.877 170.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -144.02 141.29 30.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.391 0.676 . . . . 61.41 110.224 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.1 t80 -147.53 122.61 10.13 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 105.842 -1.91 . . . . 74.11 105.842 169.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.16 123.47 28.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.118 -1.438 . . . . 64.44 107.118 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -122.04 78.33 41.91 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.545 -0.909 . . . . 62.24 108.545 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.24 -41.81 6.54 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.116 2.544 . . . . 73.43 112.963 -165.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 58.0 m-20 -106.47 17.9 22.7 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 123.884 0.873 . . . . 75.15 110.231 -175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.61 -51.29 11.94 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 116.369 1.988 . . . . 32.0 116.369 -164.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 14.9 Cg_endo -88.05 -14.38 3.45 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.807 1.671 . . . . 64.15 113.92 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -75.72 -40.57 55.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.417 1.087 . . . . 62.43 109.034 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.02 -1.07 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 114.702 -1.135 . . . . 75.21 110.257 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.17 -34.95 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.918 1.287 . . . . 74.11 110.578 164.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.95 -12.76 61.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.806 1.243 . . . . 72.42 112.156 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -89.94 101.93 14.63 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.097 0.959 . . . . 62.34 109.188 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -99.37 52.56 0.95 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.145 0.978 . . . . 71.55 111.234 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.45 -169.46 3.22 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.489 -0.778 . . . . 72.33 109.246 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -78.07 118.27 71.14 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.243 1.017 . . . . 73.24 111.528 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' D' ' 68' ' ' LEU . 17.0 Cg_exo -65.47 97.39 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.304 2.003 . . . . 65.24 109.682 167.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.63 115.51 4.79 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 124.337 1.023 . . . . 74.43 109.847 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.405 HG21 HD11 ' D' ' 126' ' ' LEU . 16.7 m -97.09 113.31 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.908 0.861 . . . . 45.24 109.555 -174.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.564 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.8 tmtt? -88.3 118.56 27.99 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.175 -1.417 . . . . 75.11 107.175 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.472 HD21 HD22 ' D' ' 128' ' ' LEU . 10.2 mp -94.27 144.33 25.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.623 -0.88 . . . . 72.31 108.623 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 24.6 t70 -145.27 118.66 9.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.142 -0.936 . . . . 64.21 108.839 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -96.79 130.39 44.05 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.342 0.657 . . . . 73.11 109.869 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -147.09 157.43 43.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.144 -1.058 . . . . 61.21 108.144 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -146.41 166.28 26.86 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.939 0.495 . . . . 72.33 110.479 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 166.72 31.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.457 1.103 . . . . 64.45 109.484 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -149.12 153.85 38.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.268 0.627 . . . . 61.11 109.743 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.5 126.83 9.26 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.502 0.721 . . . . 72.22 109.138 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' D' ' 55' ' ' VAL . 52.2 tt0 -71.84 119.27 15.78 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.536 -0.542 . . . . 73.43 109.536 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.15 -38.1 12.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.2 0.524 . . . . 72.13 110.12 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.08 174.4 11.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.803 -1.09 . . . . 55.13 109.561 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.67 133.25 45.54 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.245 -0.889 . . . . 74.01 109.534 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.88 15.4 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.797 1.239 . . . . 74.04 112.057 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' D' ' 50' ' ' GLN . 87.6 t -130.54 129.6 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.221 0.608 . . . . 71.12 110.784 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.14 129.36 41.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.016 0.926 . . . . 72.5 109.066 171.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -95.48 111.58 23.46 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.709 -0.848 . . . . 71.25 108.709 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 41.5 t -100.52 124.37 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.27 -1.011 . . . . 63.22 108.27 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.9 t -101.06 135.27 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.754 0.822 . . . . 71.42 109.282 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.65 43.66 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.897 -1.149 . . . . 72.24 107.897 175.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -98.75 108.37 21.04 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.641 HG21 ' HB1' ' D' ' 110' ' ' ALA . 48.1 t -105.35 116.66 49.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.966 -1.124 . . . . 55.32 107.966 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.6 m -111.81 137.1 50.22 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.156 0.503 . . . . 72.35 109.892 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 100.01 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.129 1.372 . . . . 74.23 107.885 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 40.3 m -96.51 94.59 7.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.409 -1.33 . . . . 71.32 107.409 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.83 141.23 30.28 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.577 -0.527 . . . . 72.4 109.577 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.88 137.46 18.79 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.502 0.501 . . . . 72.53 111.798 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' D' ' 38' ' ' PRO . 12.1 mt -110.53 107.85 17.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.919 1.288 . . . . 74.0 109.059 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -143.55 37.27 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.553 0.533 . . . . 75.2 112.183 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 8.24 15.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.629 0.772 . . . . 73.05 111.866 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.432 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.7 pt-20 -121.78 157.13 31.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.371 0.668 . . . . 62.45 109.894 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.3 m -73.05 141.02 47.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.67 -0.695 . . . . 63.02 110.534 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.56 -58.36 2.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.873 -1.158 . . . . 73.54 107.873 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -160.45 143.19 13.2 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 115.405 -0.816 . . . . 72.14 110.902 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.09 111.03 23.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.159 0.984 . . . . 74.12 109.209 171.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.556 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.5 t -125.06 133.72 52.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.427 0.691 . . . . 73.35 109.509 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -154.99 135.25 13.18 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.275 -0.639 . . . . 75.31 109.275 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.573 HG22 HG23 ' D' ' 21' ' ' ILE . 97.6 t -127.23 142.32 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.686 0.795 . . . . 73.51 109.191 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.617 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 16.2 mt-30 -115.25 91.42 3.6 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.757 0.823 . . . . 75.14 109.078 171.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.61 93.04 6.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.899 -1.501 . . . . 61.12 108.861 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.32 141.26 18.94 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.282 -0.727 . . . . 74.35 111.282 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.53 130.57 4.63 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.558 -1.017 . . . . 51.1 110.558 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.63 121.01 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.069 -1.085 . . . . 71.12 108.069 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.5 122.6 35.64 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.584 0.754 . . . . 74.33 109.591 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -75.87 103.1 5.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.118 -0.697 . . . . 73.44 109.118 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.82 136.78 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.406 0.683 . . . . 74.24 110.546 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.88 160.95 12.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.215 1.006 . . . . 61.14 109.062 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.5 14.14 74.6 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 121.807 -0.235 . . . . 73.14 113.61 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.602 HD13 ' SD ' ' D' ' 94' ' ' MET . 1.8 pp -114.34 143.17 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 73.12 110.248 -174.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -170.13 177.4 4.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.719 0.807 . . . . 64.31 110.084 175.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.84 -137.87 39.29 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.561 0.538 . . . . 75.23 112.709 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.8 m -68.63 -30.73 69.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.384 1.074 . . . . 72.44 111.692 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.48 -49.3 75.95 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.49 0.716 . . . . 74.31 110.559 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.602 ' SD ' HD13 ' D' ' 89' ' ' ILE . 10.0 tpt -76.5 -33.53 58.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.1 0.56 . . . . 73.24 111.245 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.48 80.42 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.677 0.751 . . . . 73.32 110.633 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -80.15 -38.65 30.99 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.382 -1.281 . . . . 71.41 110.738 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 43.5 t -63.4 -45.11 92.55 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.082 0.553 . . . . 52.15 111.486 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.01 -54.11 6.35 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.743 0.817 . . . . 74.34 110.73 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.11 -4.7 83.94 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 115.005 0.762 . . . . 71.22 115.005 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.44 -49.74 0.41 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.992 0.896 . . . . 71.14 112.126 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.414 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 56.9 t80 -76.04 -37.39 58.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.795 0.438 . . . . 70.41 111.582 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 72.1 m -65.06 -50.07 63.66 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.539 -0.743 . . . . 45.44 110.386 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 88.3 Cg_exo -51.22 -36.02 54.82 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.299 1.999 . . . . 72.02 114.254 167.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.37 -40.15 93.18 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.488 0.715 . . . . 55.14 111.022 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.81 -43.28 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.674 0.79 . . . . 74.52 110.348 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.2 -20.41 59.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.122 -0.944 . . . . 64.13 111.867 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -66.34 -41.4 41.69 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.469 1.285 . . . . 74.44 114.469 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.44 -45.18 41.52 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.937 1.758 . . . . 54.04 112.846 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -75.06 -35.83 61.85 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.892 0.877 . . . . 73.24 111.219 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.641 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.04 -52.44 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.094 0.957 . . . . 65.23 110.243 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.489 ' NH2' HG23 ' B' ' 105' ' ' ILE . 33.9 ttp180 -57.37 -49.84 74.87 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.231 -1.35 . . . . 71.03 109.993 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.47 -41.5 89.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.501 1.126 . . . . 64.43 111.775 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.444 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 36.6 t -57.96 -44.05 86.79 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.899 0.749 . . . . 55.24 110.689 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.556 HG23 ' SG ' ' D' ' 76' ' ' CYS . 71.1 mt -67.81 -49.16 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.68 0.792 . . . . 71.14 110.498 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.51 HG21 ' HE2' ' B' ' 109' ' ' TYR . 91.1 m -52.42 -48.11 65.92 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.379 1.472 . . . . 74.32 112.095 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -67.91 -41.24 82.96 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.369 -1.287 . . . . 73.25 110.533 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -65.15 -34.79 79.23 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.818 0.447 . . . . 73.2 111.964 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.3 t -66.4 -44.18 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 123.718 0.637 . . . . 74.42 110.295 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -71.8 -31.59 66.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.353 -0.385 . . . . 72.12 110.783 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -69.02 -27.65 65.87 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.747 0.819 . . . . 71.24 110.06 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.24 11.26 68.14 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.873 0.733 . . . . 60.11 112.901 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.485 HG23 ' HB3' ' C' ' 17' ' ' TYR . 42.2 p 56.02 33.8 22.51 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.829 1.651 . . . . 72.13 113.08 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 39.1 m-85 -110.98 166.37 10.89 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 125.141 1.376 . . . . 73.41 109.725 175.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 41.5 Cg_endo -61.42 123.46 12.82 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.046 2.497 . . . . 72.31 112.167 -176.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -52.06 122.21 8.09 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.051 0.844 . . . . 71.04 110.397 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.405 HD11 HG21 ' D' ' 40' ' ' VAL . 36.8 tp -103.9 93.91 5.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.391 0.615 . . . . 51.14 109.658 -166.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 86.9 m-20 -100.53 82.44 2.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.01 -0.996 . . . . 70.53 108.481 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.472 HD22 HD21 ' D' ' 42' ' ' LEU . 95.9 mt -67.4 139.54 57.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.16 -0.927 . . . . 73.23 110.669 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 143.83 98.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.426 0.691 . . . . 52.04 110.779 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.36 142.18 14.74 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.059 1.839 . . . . 73.24 110.233 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 38.7 t -106.76 108.78 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 107.967 -1.124 . . . . 62.11 107.967 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 . . . . . 0 C--O 1.239 0.549 0 N-CA-C 107.223 -1.399 . . . . 75.54 107.223 174.843 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.3 m . . . . . 0 C--O 1.24 0.601 0 N-CA-C 108.29 -1.004 . . . . 64.12 108.29 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 72.1 t80 -95.38 142.39 27.82 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.658 -0.867 . . . . 64.42 108.658 168.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.406 ' HG3' HE21 ' A' ' 14' ' ' GLN . 6.0 tp60 -162.14 137.26 7.15 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.678 0.611 . . . . 72.01 112.501 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.438 HD13 ' CE2' ' A' ' 84' ' ' PHE . 3.8 tp -75.96 121.6 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.516 1.126 . . . . 74.22 109.16 170.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.406 HE21 ' HG3' ' A' ' 12' ' ' GLN . 24.3 mm-40 -107.09 -13.8 15.08 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-O 117.781 -1.105 . . . . 65.44 112.163 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 178.38 126.58 0.05 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 119.193 0.906 . . . . 74.1 110.691 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.483 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 77.2 mt -106.44 131.62 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.015 -1.105 . . . . 61.41 108.015 172.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -158.67 170.06 23.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.6 0.714 . . . . 75.11 111.136 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -99.5 114.31 27.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.795 -1.093 . . . . 72.43 108.71 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -77.65 -38.77 47.08 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.84 136.13 32.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.592 -1.186 . . . . 73.31 109.343 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.1 mt -129.95 130.34 66.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.107 -1.442 . . . . 74.32 107.107 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -136.32 106.1 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.523 -0.917 . . . . 72.15 108.523 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.1 t80 -120.65 110.09 16.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.178 -1.786 . . . . 70.24 106.178 167.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -119.43 127.11 52.79 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.278 0.631 . . . . 73.05 109.379 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -126.24 79.4 70.07 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.648 -1.241 . . . . 74.42 107.648 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.07 -22.07 23.21 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.889 2.393 . . . . 65.13 112.372 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -119.07 33.12 5.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.179 0.992 . . . . 61.51 109.048 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.16 -44.69 99.83 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.773 1.229 . . . . 63.05 113.331 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.47 -29.68 71.38 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.463 1.442 . . . . 70.34 112.555 173.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -76.62 -28.73 56.21 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.516 -0.766 . . . . 73.11 111.828 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.6 p -61.74 -23.08 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 118.193 0.451 . . . . 73.35 112.143 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.61 -39.65 67.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.176 0.99 . . . . 75.3 110.869 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -88.39 -19.59 26.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 71.41 110.744 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.38 148.83 33.53 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.419 0.688 . . . . 72.34 110.289 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.36 127.47 32.78 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 74.24 108.327 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.442 ' CE3' HD21 ' A' ' 68' ' ' LEU . 25.3 t-105 -86.26 84.94 7.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.578 0.704 . . . . 73.32 110.182 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 80.32 68.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.283 -1.377 . . . . 71.32 107.283 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -81.67 153.26 17.58 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.929 2.419 . . . . 74.42 113.154 -177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -96.06 90.72 5.64 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.001 -1.111 . . . . 71.1 108.001 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 m -69.98 93.18 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.381 1.086 . . . . 64.01 109.532 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -103.34 121.0 41.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.751 -1.113 . . . . 71.14 109.951 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.34 132.33 43.17 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.044 0.937 . . . . 71.51 109.348 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.722 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.4 m-20 -126.56 132.45 51.32 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.025 0.93 . . . . 73.15 108.754 176.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.746 -0.835 . . . . 74.35 108.746 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -134.29 145.42 49.07 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.679 -0.489 . . . . 70.24 109.679 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 m -109.42 121.38 45.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.865 0.866 . . . . 72.11 108.864 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.97 123.37 27.23 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 107.412 -1.329 . . . . 72.33 107.412 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.6 m -133.16 152.63 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.661 0.384 . . . . 60.54 110.704 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -149.96 130.84 14.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.838 0.855 . . . . 63.05 109.311 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -87.79 117.82 26.89 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.866 -0.791 . . . . 74.4 108.866 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 57' ' ' GLU . 54.9 mt -84.63 -44.57 13.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.543 0.737 . . . . 73.14 110.696 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.47 -171.94 4.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.692 0.797 . . . . 63.13 109.923 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -59.96 102.75 0.17 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.375 0.67 . . . . 74.02 110.39 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 65.3 12.11 7.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.823 1.249 . . . . 73.12 112.997 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.4 t -99.83 113.82 36.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.859 -1.534 . . . . 55.33 106.859 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -108.82 165.91 11.21 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.199 1.0 . . . . 74.13 111.3 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 51' ' ' LEU . 28.0 tt0 -131.26 118.59 20.6 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 112.574 -2.103 . . . . 74.34 106.862 164.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.61 117.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.344 -1.724 . . . . 63.14 106.344 170.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.4 t -97.9 127.99 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.114 -0.698 . . . . 53.21 109.114 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 109.85 21.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.427 -1.323 . . . . 74.14 107.427 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -106.01 106.74 17.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.019 -0.991 . . . . 73.2 109.559 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.95 133.47 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 114.95 -1.023 . . . . 75.4 108.553 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.722 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.8 m -117.69 131.71 56.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.912 -0.773 . . . . 75.14 108.912 173.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 37.1 t -126.21 111.42 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.869 1.268 . . . . 53.34 108.263 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 m -102.26 145.1 29.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.578 -0.527 . . . . 72.54 109.578 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.43 109.94 7.98 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.233 -1.025 . . . . 72.25 108.233 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.7 m -126.81 145.69 50.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.275 0.559 . . . . 75.15 110.363 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.442 HD21 ' CE3' ' A' ' 36' ' ' TRP . 49.1 mt -107.84 51.56 0.74 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.542 1.537 . . . . 73.15 108.031 -175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.93 -85.44 0.89 Allowed Glycine 0 C--N 1.349 1.282 0 CA-C-N 114.569 -1.196 . . . . 33.15 111.483 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -89.92 -24.73 21.25 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.131 0.973 . . . . 75.12 111.846 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -118.15 107.03 13.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.086 0.554 . . . . 75.4 110.392 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.2 123.44 20.72 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 118.525 0.602 . . . . 72.54 109.889 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.39 -54.73 6.33 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.852 -1.067 . . . . 70.44 109.648 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.5 172.48 17.14 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.467 -1.242 . . . . 74.41 110.912 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.6 141.31 33.46 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.114 -1.403 . . . . 51.5 107.364 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.544 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 54.9 m -140.16 99.78 3.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.285 -0.635 . . . . 61.21 109.285 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -121.58 122.86 40.61 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.508 -0.923 . . . . 64.2 108.508 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.47 131.13 70.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.511 0.725 . . . . 71.23 109.293 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -104.59 93.44 4.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.931 -1.031 . . . . 64.4 109.434 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -81.67 92.88 6.66 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.112 -1.069 . . . . 65.34 108.112 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.12 143.7 20.51 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.242 -0.743 . . . . 54.13 111.242 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.82 129.92 4.49 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.491 -0.644 . . . . 72.21 111.491 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -78.53 129.5 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 107.648 -1.242 . . . . 65.22 107.648 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.438 ' CE2' HD13 ' A' ' 13' ' ' ILE . 49.5 m-85 -133.49 121.72 22.59 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.134 -0.691 . . . . 62.44 109.134 174.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.9 t -74.3 115.27 13.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.591 -1.262 . . . . 64.51 107.591 169.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -137.78 119.06 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.682 0.793 . . . . 71.23 109.729 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.01 161.6 28.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.931 0.893 . . . . 61.23 109.849 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.3 5.24 87.48 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.646 0.591 . . . . 63.31 114.399 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.34 166.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.753 . . . . 72.2 108.972 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -172.74 175.97 3.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.343 -0.614 . . . . 64.25 109.343 -168.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.42 -126.01 38.04 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.813 0.695 . . . . 74.34 114.437 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.3 p -82.47 -20.39 36.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.689 0.796 . . . . 73.34 110.98 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.96 -43.45 98.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.012 0.925 . . . . 71.24 111.006 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -49.48 67.07 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.879 0.737 . . . . 74.35 110.352 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.95 71.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.354 0.662 . . . . 62.13 111.534 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -71.56 -41.8 68.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.732 0.813 . . . . 64.4 110.528 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.67 -65.25 0.81 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.029 0.532 . . . . 64.24 110.489 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.62 -40.58 84.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.222 0.609 . . . . 74.22 111.046 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.78 -38.81 49.28 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.601 0.563 . . . . 51.04 113.793 -168.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 133' ' ' PHE . . . -126.55 -53.53 1.46 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.124 0.462 . . . . 40.31 112.149 -171.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.437 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 82.9 t80 -63.7 -42.27 97.99 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.011 0.924 . . . . 74.4 112.862 -171.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' CE2' ' A' ' 11' ' ' PHE . 73.7 m -77.62 -41.43 2.26 Favored Pre-proline 0 CA--C 1.557 1.243 0 N-CA-C 113.048 0.758 . . . . 72.33 113.048 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.76 -23.64 55.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 CA-C-N 121.139 1.442 . . . . 65.01 112.544 166.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -70.8 -24.92 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.966 0.506 . . . . 73.31 111.463 172.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.73 -42.82 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.968 0.89 . . . . 70.33 109.299 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.511 HD21 ' HA3' ' A' ' 82' ' ' GLY . 25.1 mt -84.06 -27.72 28.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.421 -1.263 . . . . 62.03 112.444 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -61.92 -40.74 71.6 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 114.504 1.298 . . . . 73.23 114.504 -171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.89 -36.22 82.57 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.963 1.775 . . . . 71.45 113.057 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' C' ' 108' ' ' PRO . 87.5 m-85 -81.56 -35.33 30.39 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.181 -0.918 . . . . 75.42 111.352 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.49 80.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.886 0.474 . . . . 62.01 110.566 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm105 -56.46 -54.83 41.14 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 114.796 -1.093 . . . . 50.12 109.216 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.27 -41.33 88.61 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.393 1.058 . . . . 70.21 111.564 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.0 t -57.78 -50.98 71.42 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.742 0.651 . . . . 73.12 110.102 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.449 HG21 HG21 ' A' ' 64' ' ' VAL . 96.5 mt -63.57 -42.72 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.937 0.895 . . . . 72.25 111.306 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.43 HG21 ' HE2' ' C' ' 109' ' ' TYR . 90.7 m -57.35 -45.19 84.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.243 1.017 . . . . 73.4 110.616 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -70.93 -41.41 71.22 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.702 -1.135 . . . . 73.44 110.054 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 19.4 mtp -57.66 -46.14 84.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.864 0.866 . . . . 75.41 111.67 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.05 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.961 0.904 . . . . 73.32 110.67 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 82.5 p -69.66 -33.07 72.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.406 0.282 . . . . 35.04 111.62 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.598 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.7 mtt-85 -68.65 -27.31 65.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.48 0.712 . . . . 63.13 110.789 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.75 9.88 58.21 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.502 0.501 . . . . 61.44 113.2 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m 69.31 42.17 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.869 1.319 . . . . 65.54 110.584 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' SER . 90.5 m-85 -120.66 156.48 55.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.837 -1.074 . . . . 64.22 109.523 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.19 124.65 16.07 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.565 1.51 . . . . 72.02 109.789 166.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 19.7 pt20 -60.69 146.38 45.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.827 0.451 . . . . 73.12 111.34 -174.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -114.22 105.8 13.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.008 -0.542 . . . . 62.12 110.19 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -118.28 93.22 4.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 74.44 109.742 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.02 160.66 31.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.697 -1.138 . . . . 71.04 110.824 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' C' ' 13' ' ' ILE . . . -68.84 145.3 96.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.279 0.632 . . . . 54.43 112.441 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.25 114.5 4.01 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.118 1.879 . . . . 75.02 110.818 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 109.19 23.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.797 -1.557 . . . . 74.22 106.797 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -104.53 92.03 4.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.982 0.913 . . . . 72.53 110.358 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.516 ' HB2' ' HB1' ' A' ' 100' ' ' ALA . 93.2 m-85 . . . . . 0 N--CA 1.481 1.094 0 CA-C-N 114.988 -1.005 . . . . 74.51 111.67 178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.245 0.829 0 N-CA-C 109.017 -0.735 . . . . 50.34 109.017 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.02 156.43 39.96 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.382 -0.372 . . . . 73.04 111.177 162.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -122.78 111.37 16.62 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.75 -1.204 . . . . 73.4 107.75 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 tt -61.34 101.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.914 -1.494 . . . . 72.12 109.318 170.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -78.4 -33.25 48.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.677 -0.692 . . . . 71.2 109.672 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -173.19 141.36 0.94 Allowed 'General case' 0 C--N 1.361 1.089 0 O-C-N 123.354 0.409 . . . . 70.04 110.761 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.36 136.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 106.545 -1.65 . . . . 61.14 106.545 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -166.04 148.65 7.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.099 0.476 . . . . 73.43 111.069 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.616 HG21 HD11 ' B' ' 21' ' ' ILE . 86.3 m -76.92 117.42 18.5 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.712 -0.847 . . . . 73.43 108.712 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -88.38 -25.61 22.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.152 0.581 . . . . 52.23 110.633 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 15.8 t70 -158.55 143.54 16.24 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.347 0.594 . . . . 75.43 111.845 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.616 HD11 HG21 ' B' ' 18' ' ' THR . 39.9 mm -134.18 138.59 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 C-N-CA 125.897 1.679 . . . . 72.32 106.867 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -146.62 133.4 20.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.606 -0.887 . . . . 74.04 108.606 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.2 115.59 6.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.395 -1.335 . . . . 74.33 107.395 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.06 127.16 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -122.51 86.95 48.98 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 108.383 -0.969 . . . . 60.51 108.383 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.28 -19.2 50.36 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.916 2.41 . . . . 62.13 111.928 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -126.6 30.58 5.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.021 0.928 . . . . 70.41 110.739 179.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.05 -49.51 50.23 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 124.55 1.14 . . . . 72.21 112.894 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.64 -24.46 1.86 Allowed 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 121.8 1.666 . . . . 72.44 113.699 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -76.56 -5.36 47.34 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.354 0.662 . . . . 72.32 112.356 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.14 -13.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.849 0.86 . . . . 72.43 110.653 170.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -57.2 -41.95 80.36 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.223 1.009 . . . . 75.41 110.78 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -75.75 -37.99 58.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.933 -1.031 . . . . 72.43 110.714 -173.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.406 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 77.5 mttt -107.93 89.03 2.87 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.462 -0.79 . . . . 64.34 109.71 -174.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.75 76.21 10.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.846 1.258 . . . . 73.14 112.025 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -172.93 156.23 3.3 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.357 0.663 . . . . 73.25 110.468 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -58.29 119.21 33.56 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.537 1.135 . . . . 61.33 111.473 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 37.8 Cg_endo -65.92 163.64 30.24 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.906 2.404 . . . . 72.44 112.018 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -76.08 100.92 5.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.724 -1.213 . . . . 73.15 107.724 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.496 HG12 HD13 ' B' ' 126' ' ' LEU . 16.8 t -88.6 120.6 37.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.361 -1.348 . . . . 71.2 107.361 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -145.31 144.6 30.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.017 0.527 . . . . 64.32 110.276 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.528 HD21 ' HG ' ' B' ' 128' ' ' LEU . 1.9 pt? -115.81 160.24 20.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 70.35 110.065 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.24 138.18 44.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.455 1.102 . . . . 64.33 108.721 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -90.96 134.34 34.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.248 0.619 . . . . 75.12 109.574 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.32 150.05 34.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.973 0.909 . . . . 74.31 108.609 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.3 m -142.92 113.42 7.37 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.105 -0.702 . . . . 75.01 109.105 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.75 120.81 32.84 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.384 -1.339 . . . . 70.11 107.384 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -132.92 172.26 12.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.941 0.496 . . . . 63.04 111.368 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.3 p -152.77 179.08 8.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.864 0.866 . . . . 74.25 109.999 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -122.13 121.74 37.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.629 0.771 . . . . 71.24 110.083 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 81.4 mt -79.03 -44.8 21.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.619 0.767 . . . . 74.05 110.642 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.18 -172.01 3.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.56 -0.745 . . . . 35.32 110.911 -172.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.87 111.95 1.66 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.767 -1.106 . . . . 75.23 110.265 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 70.43 -5.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.047 1.739 . . . . 52.04 112.932 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.85 93.17 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.054 -1.091 . . . . 65.23 108.054 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.13 141.07 30.7 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.898 -1.046 . . . . 73.31 110.005 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.657 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.7 tm-20 -105.2 100.15 9.74 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.888 -1.523 . . . . 64.4 106.888 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.64 117.68 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.25 0.62 . . . . 73.33 109.822 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.94 121.1 55.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 109.286 -0.635 . . . . 73.14 109.286 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.06 118.08 30.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.05 -1.463 . . . . 72.33 107.05 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -106.45 116.45 31.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.494 0.717 . . . . 71.25 109.355 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.3 t -109.7 119.04 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.145 -1.057 . . . . 74.35 108.145 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -116.32 125.82 52.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.988 0.515 . . . . 71.3 110.21 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.666 HG21 HG21 ' B' ' 114' ' ' ILE . 77.8 t -107.72 137.43 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.729 1.212 . . . . 71.13 110.898 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.3 m -124.41 146.85 48.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.212 1.005 . . . . 74.21 109.923 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 156.26 42.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.066 0.946 . . . . 73.21 109.402 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.7 p -153.1 142.61 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.655 0.613 . . . . 75.22 112.655 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.1 mt -118.56 98.18 6.12 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.629 -0.878 . . . . 73.11 108.629 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.87 -110.44 2.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 122.954 0.311 . . . . 52.0 113.05 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -88.48 4.97 44.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.843 0.857 . . . . 61.1 110.285 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 68' ' ' LEU . 1.2 mp0 -114.4 153.07 30.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.79 1.236 . . . . 65.41 109.998 -167.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -87.43 129.24 35.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 162.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.47 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -83.17 -55.8 4.14 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.849 -0.797 . . . . 43.33 108.849 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.1 150.29 20.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.804 -1.089 . . . . 71.44 110.694 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -124.88 113.87 18.44 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.505 1.522 . . . . 53.41 107.643 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.521 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.7 t -116.29 160.1 20.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.407 -0.961 . . . . 72.33 108.407 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.02 131.84 3.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.628 -0.878 . . . . 73.41 108.628 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.52 142.78 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.715 -0.846 . . . . 75.21 108.715 172.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.5 mt-30 -120.73 97.91 5.77 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.183 -0.917 . . . . 63.32 109.071 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -87.77 101.29 13.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.12 154.49 24.47 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 111.16 -0.776 . . . . 71.45 111.16 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.73 126.16 2.01 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.673 -1.371 . . . . 55.4 109.673 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.657 HG12 ' HG2' ' B' ' 57' ' ' GLU . 27.9 mt -85.25 115.89 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.114 -1.069 . . . . 73.15 108.114 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -124.93 132.47 53.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.798 -1.556 . . . . 74.25 106.798 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -88.97 88.63 7.66 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.025 -1.102 . . . . 62.43 108.025 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.68 129.83 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.935 0.494 . . . . 65.22 110.626 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.28 170.99 20.67 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.966 -1.015 . . . . 53.02 110.249 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.52 -49.35 2.62 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 75.21 112.219 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.615 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -72.12 152.28 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.871 0.468 . . . . 74.51 111.316 174.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -160.4 172.48 17.2 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.848 -1.069 . . . . 63.01 108.97 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.93 -125.42 38.97 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.616 0.572 . . . . 61.12 113.747 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.0 m -74.57 -27.51 60.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.744 0.818 . . . . 54.34 111.109 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -68.9 -40.19 79.28 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.682 0.793 . . . . 71.33 109.881 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -41.91 59.92 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.045 -0.525 . . . . 54.5 110.116 176.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.73 62.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.149 0.98 . . . . 75.11 111.649 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 39.0 t-80 -93.34 -13.1 28.52 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.061 -0.972 . . . . 74.44 111.191 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.31 -64.32 1.01 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.623 0.369 . . . . 70.24 110.195 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -15.83 60.93 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.146 0.178 . . . . 50.12 111.167 -176.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 -6.08 53.67 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.227 -0.763 . . . . 73.43 114.198 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -149.5 -47.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.399 1.1 . . . . 60.2 112.875 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -73.21 -54.02 9.48 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.052 0.541 . . . . 74.3 111.254 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 68.1 m -63.01 -45.3 86.65 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.529 0.732 . . . . 60.23 111.335 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -50.78 -45.0 38.05 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.416 2.077 . . . . 73.02 113.893 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 123.176 0.591 . . . . 62.13 112.057 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.525 HG23 ' NH2' ' D' ' 111' ' ' ARG . 79.5 mt -71.57 -47.98 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.659 0.784 . . . . 70.54 110.863 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -80.3 -20.88 43.33 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.233 -0.894 . . . . 61.11 112.298 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 64.5 t80 -64.71 -45.78 75.82 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.653 -1.165 . . . . 64.24 113.387 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 19.1 Cg_endo -56.72 -37.64 97.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 CA-C-N 121.581 1.6 . . . . 55.02 113.076 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.81 -49.6 65.29 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.31 0.644 . . . . 75.14 110.973 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.99 -42.39 98.34 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.717 0.807 . . . . 64.24 111.181 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.436 ' NH2' HG22 ' C' ' 122' ' ' THR . 50.1 ttt180 -58.87 -55.22 37.92 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.681 1.593 . . . . 70.41 110.96 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -38.5 90.88 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.487 0.715 . . . . 74.12 109.918 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.598 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.8 t -67.69 -42.08 82.64 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.745 -0.662 . . . . 60.22 112.103 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 64' ' ' VAL . 96.8 mt -62.52 -50.61 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.696 -0.483 . . . . 60.13 109.696 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.523 HG23 HE21 ' C' ' 125' ' ' GLN . 86.7 m -55.59 -31.52 62.3 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.092 0.87 . . . . 75.53 111.183 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.9 t -66.05 -52.56 47.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.572 0.749 . . . . 72.21 110.403 172.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.6 mmt -67.36 -36.14 80.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.55 0.574 . . . . 64.42 112.55 -172.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.94 -42.02 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.639 0.776 . . . . 74.02 110.475 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.763 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 90.3 p -71.73 -30.31 65.47 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.469 -0.787 . . . . 63.44 111.872 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -63.44 -33.7 76.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 65.15 110.368 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.77 9.0 58.05 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.839 0.712 . . . . 71.3 113.329 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.9 p 56.15 27.97 12.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.892 1.677 . . . . 42.24 112.466 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.86 158.66 32.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.249 -0.887 . . . . 71.01 110.578 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.576 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 38.8 Cg_exo -61.98 179.73 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.484 2.789 . . . . 72.43 115.999 -171.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.63 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -62.84 150.21 42.29 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 113.894 -1.503 . . . . 71.13 114.347 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.496 HD13 HG12 ' B' ' 40' ' ' VAL . 53.3 tp -141.61 86.04 1.98 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.008 -1.478 . . . . 63.02 107.008 167.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' C' ' 119' ' ' SER . 7.1 m120 -116.11 90.62 3.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.485 -1.302 . . . . 75.04 107.485 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.528 ' HG ' HD21 ' B' ' 42' ' ' LEU . 1.9 tm? -84.88 138.01 32.79 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.512 -0.922 . . . . 73.43 108.512 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.433 ' HB2' ' NH1' ' D' ' 15' ' ' ARG . . . -67.62 107.24 1.64 Allowed Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 124.357 1.035 . . . . 75.13 109.913 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 129.71 25.28 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.09 1.86 . . . . 63.43 110.925 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.516 ' HA ' HD13 ' D' ' 13' ' ' ILE . 30.2 m -118.36 140.52 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.277 0.631 . . . . 71.34 110.522 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.715 ' H ' HG21 ' D' ' 13' ' ' ILE . 15.6 m-20 -69.76 104.97 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.256 -0.883 . . . . 73.42 109.093 170.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 . . . . . 0 CA--C 1.554 1.104 0 CA-C-O 120.858 0.361 . . . . 72.23 110.427 172.843 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 108.054 -1.091 . . . . 74.35 108.054 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.591 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 8.0 t80 -100.28 119.67 38.75 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.104 -0.702 . . . . 61.1 109.104 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -141.25 119.25 11.93 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.948 -0.76 . . . . 64.22 108.948 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.679 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -74.28 127.35 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 108.682 -0.859 . . . . 72.34 108.682 171.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 77.1 mm-40 -96.36 -49.52 5.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.096 0.558 . . . . 71.25 110.36 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -162.65 123.29 2.44 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.971 -0.381 . . . . 72.23 109.971 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.679 HG13 HD11 ' C' ' 13' ' ' ILE . 76.6 mt -113.69 135.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.038 -1.097 . . . . 72.11 108.038 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.9 p90 -174.5 158.29 2.79 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 124.132 0.895 . . . . 64.4 110.866 -172.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -80.3 136.71 36.48 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.376 -0.829 . . . . 70.34 109.487 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -89.55 -51.39 5.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.27 1.033 . . . . 72.32 108.846 171.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 25.9 t70 -134.91 132.91 39.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.134 -1.848 . . . . 52.44 108.2 -171.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.4 mt -129.29 140.52 48.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.728 -1.582 . . . . 73.11 106.728 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -148.71 145.02 27.48 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.402 -0.592 . . . . 74.43 109.402 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.72 111.64 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.032 -1.47 . . . . 75.35 107.032 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.06 117.87 31.79 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.832 -1.173 . . . . 62.11 107.832 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.36 87.84 8.16 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 108.112 -1.07 . . . . 71.32 108.112 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.3 3.41 7.49 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.05 2.5 . . . . 62.42 111.709 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.3 12.56 8.21 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 124.246 1.019 . . . . 73.01 109.936 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.39 -49.43 82.18 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.737 1.014 . . . . 75.25 113.737 -171.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.53 -27.87 0.54 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.666 1.578 . . . . 54.11 113.449 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -70.12 -25.74 63.63 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.205 1.002 . . . . 63.11 112.905 -173.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.57 -6.86 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.328 1.051 . . . . 71.41 111.564 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -56.95 -41.7 78.75 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.357 1.063 . . . . 72.4 112.638 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -100.42 4.24 43.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.702 0.801 . . . . 53.31 110.606 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.496 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.5 OUTLIER -87.68 168.21 13.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.058 0.543 . . . . 62.13 111.76 -168.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.08 113.53 10.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.008 -0.738 . . . . 63.45 109.008 167.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -86.78 65.21 8.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.497 0.719 . . . . 65.03 110.157 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -135.57 78.98 48.74 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.414 -0.958 . . . . 73.21 108.414 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.96 167.57 26.77 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.826 2.351 . . . . 53.03 112.448 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -122.83 109.25 13.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.971 -1.122 . . . . 73.03 107.971 171.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.568 HG11 HD11 ' C' ' 126' ' ' LEU . 97.6 t -78.45 103.11 5.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.829 -0.804 . . . . 65.22 108.829 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -91.66 116.33 28.79 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.522 -1.288 . . . . 60.4 107.522 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.418 HD12 HG12 ' C' ' 40' ' ' VAL . 9.2 mp -85.93 149.1 25.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.974 0.51 . . . . 73.42 109.84 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.35 142.29 25.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.847 0.859 . . . . 74.21 108.976 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -135.17 136.02 41.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.897 -0.779 . . . . 74.23 108.897 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 28.0 t70 -141.18 145.9 36.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.991 -1.114 . . . . 71.42 107.991 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -114.2 137.5 51.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.096 0.558 . . . . 55.41 110.472 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.28 47.13 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.444 1.097 . . . . 35.11 108.589 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 70.2 p -160.22 150.53 18.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.741 0.416 . . . . 74.25 110.95 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.3 t -149.43 133.24 16.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.554 0.742 . . . . 75.03 109.511 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -77.98 139.03 39.14 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.602 -0.518 . . . . 74.23 109.602 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.585 HD11 HD12 ' C' ' 83' ' ' ILE . 53.1 mt -114.65 -30.52 6.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.773 0.829 . . . . 73.03 110.893 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.33 -175.07 4.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.25 1.02 . . . . 74.34 110.142 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.39 100.16 0.34 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.445 -0.798 . . . . 24.33 110.223 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 64.75 9.25 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.273 1.429 . . . . 75.31 113.843 -177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 89.9 t -100.41 117.95 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.635 -1.617 . . . . 62.42 106.635 164.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -137.06 -178.1 5.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.852 -0.796 . . . . 73.35 108.852 -176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -128.51 138.9 52.49 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.336 1.055 . . . . 63.43 109.829 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.69 127.72 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.767 -1.197 . . . . 72.22 107.767 168.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 111.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.913 0.885 . . . . 40.01 109.123 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' C' ' 103' ' ' PRO . 54.4 mt -87.53 109.06 19.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.077 0.551 . . . . 71.35 110.316 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 79.6 ttt180 -85.38 102.03 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.308 -0.997 . . . . 73.42 108.308 172.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.46 124.13 55.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.913 -1.143 . . . . 52.23 107.913 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -124.99 142.34 51.55 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.407 0.622 . . . . 71.14 109.769 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.531 HG11 HD22 ' C' ' 126' ' ' LEU . 70.6 t -135.52 130.22 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.442 1.097 . . . . 65.53 108.93 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.6 m -112.35 141.41 46.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.112 -1.07 . . . . 75.03 108.112 172.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.54 125.52 45.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.475 -1.306 . . . . 74.13 107.475 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -135.58 131.31 35.74 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.102 0.477 . . . . 65.32 110.5 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.496 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.7 mt -86.6 35.13 0.66 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.602 1.561 . . . . 65.42 109.321 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.57 -112.01 3.57 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 110.743 -0.943 . . . . 53.21 110.743 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.56 -31.52 18.6 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.632 0.773 . . . . 74.01 109.67 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -70.03 121.98 18.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.807 1.243 . . . . 74.41 110.363 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.5 m -80.05 131.66 35.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.765 0.257 . . . . 72.3 110.33 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.23 -53.89 4.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.112 0.565 . . . . 64.05 110.005 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -162.28 176.7 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.568 0.747 . . . . 73.01 111.07 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.482 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -136.73 143.96 43.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.656 -1.609 . . . . 63.3 106.656 171.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.482 ' N ' HD13 ' C' ' 75' ' ' LEU . 39.1 t -144.69 141.49 29.35 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.394 -0.965 . . . . 64.44 108.394 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.22 131.66 10.41 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.677 -0.49 . . . . 63.33 109.677 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.76 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.401 1.08 . . . . 64.21 108.305 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -121.1 96.84 5.26 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.232 1.013 . . . . 72.14 108.335 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.28 105.13 15.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.272 0.629 . . . . 74.21 110.556 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.45 150.57 25.86 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 123.668 0.605 . . . . 63.25 112.566 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.54 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -155.72 117.74 0.8 Allowed Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 111.47 -0.652 . . . . 64.21 111.47 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.585 HD12 HD11 ' C' ' 51' ' ' LEU . 9.5 mm -80.99 128.63 38.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 N-CA-C 108.733 -0.84 . . . . 52.33 108.733 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -135.11 131.17 36.57 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.193 0.597 . . . . 73.41 110.101 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -92.0 122.42 34.49 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.389 -1.337 . . . . 50.53 107.389 164.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 40.8 pt -113.71 -142.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 118.379 -0.819 . . . . 74.2 109.175 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 97.78 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.896 2.079 . . . . 72.2 110.596 176.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -39.56 3.1 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.316 -0.714 . . . . 64.45 111.316 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.416 HG13 ' H ' ' C' ' 89' ' ' ILE . 2.2 pp . . . . . 0 CA--C 1.551 1.018 0 C-N-CA 124.366 1.066 . . . . 75.32 111.166 169.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.684 0.278 . . . . 70.33 110.519 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.1 ttt -69.98 -41.94 73.76 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.676 -0.693 . . . . 74.34 110.957 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.1 76.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.976 0.51 . . . . 71.2 110.908 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -84.31 -21.48 30.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.672 0.789 . . . . 72.11 112.148 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 97.9 m -73.88 -59.75 2.57 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.701 0.401 . . . . 74.42 109.997 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.69 -26.3 68.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.179 0.991 . . . . 70.11 111.827 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 -22.44 42.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.375 -0.68 . . . . 75.02 114.295 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.84 -50.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.077 0.938 . . . . 64.5 113.428 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.457 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 85.4 t80 -69.87 -55.64 9.21 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 112.482 0.549 . . . . 74.25 112.482 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.591 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 32.0 m -60.9 -45.11 96.64 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.544 0.738 . . . . 52.45 111.277 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' C' ' 60' ' ' LEU . 91.5 Cg_exo -53.08 -40.37 76.96 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.591 2.194 . . . . 74.32 114.912 167.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.341 0.656 . . . . 72.01 111.511 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.455 HG23 ' NH1' ' A' ' 111' ' ' ARG . 51.4 mm -62.87 -42.4 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.471 -0.786 . . . . 72.22 110.554 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA3' ' C' ' 82' ' ' GLY . 73.8 mt -82.79 -25.43 32.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.988 0.915 . . . . 73.32 112.544 -171.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.16 -51.49 74.7 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.753 1.02 . . . . 73.11 113.753 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.423 ' HB3' ' CD2' ' A' ' 109' ' ' TYR . 19.5 Cg_endo -58.32 -33.95 98.19 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.837 1.691 . . . . 72.54 113.665 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.43 ' HE2' HG21 ' A' ' 115' ' ' THR . 86.5 m-85 -67.65 -47.73 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.436 0.694 . . . . 72.25 110.812 177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.84 92.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.762 0.825 . . . . 71.02 110.677 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.47 -53.26 59.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.678 1.591 . . . . 62.22 110.726 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.43 -30.94 70.81 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.699 0.799 . . . . 65.44 110.513 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.77 -38.04 87.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 74.21 110.655 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.458 HG23 ' SG ' ' C' ' 76' ' ' CYS . 61.0 mt -73.24 -42.07 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.021 -0.536 . . . . 73.12 110.385 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -55.94 -44.24 78.21 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.496 0.719 . . . . 53.42 110.928 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 85.6 p -70.58 -47.41 60.36 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.248 -0.887 . . . . 70.23 110.462 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.512 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -54.22 -45.77 72.34 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.319 1.048 . . . . 74.44 112.768 -177.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 -42.86 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.673 0.608 . . . . 74.13 110.509 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.417 ' HA ' ' ND2' ' B' ' 127' ' ' ASN . 37.6 t -67.82 -27.78 67.01 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.318 -0.855 . . . . 63.14 112.373 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.5 mtt-85 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.245 0.618 . . . . 72.53 109.575 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.96 7.96 64.78 Favored Glycine 0 C--N 1.36 1.895 0 O-C-N 123.794 0.684 . . . . 71.13 112.951 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.436 HG22 ' NH2' ' B' ' 111' ' ' ARG . 17.3 p 63.37 16.18 9.31 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 127.369 2.268 . . . . 74.21 113.586 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.91 153.38 63.73 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 107.894 -1.15 . . . . 71.54 107.894 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -51.98 118.56 4.63 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.969 2.446 . . . . 63.42 112.088 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.63 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 3.5 pt20 -44.77 146.89 0.7 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 124.906 1.282 . . . . 63.52 112.434 -172.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.568 HD11 HG11 ' C' ' 40' ' ' VAL . 14.7 tp -109.59 79.83 1.25 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.71 0.767 . . . . 74.42 112.845 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.763 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 6.9 p-10 -97.47 90.3 5.0 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.572 -1.195 . . . . 72.12 109.564 172.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 66.9 mt -74.83 146.0 42.37 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.478 -1.237 . . . . 72.24 109.465 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.03 130.03 92.83 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.339 0.399 . . . . 52.51 110.334 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.483 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 42.6 Cg_endo -65.61 101.31 0.44 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.955 2.437 . . . . 60.2 112.27 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 31.2 m -84.66 130.01 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.504 -0.771 . . . . 73.42 111.153 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -97.32 105.28 17.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.659 -1.238 . . . . 73.05 107.659 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.3 t80 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 124.575 1.15 . . . . 72.34 113.529 -176.14 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m . . . . . 0 C--O 1.242 0.679 0 N-CA-C 108.535 -0.913 . . . . 71.44 108.535 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.452 ' CZ ' ' SG ' ' D' ' 102' ' ' CYS . 43.4 t80 -157.31 126.48 5.92 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.7 mt-30 -140.08 158.11 44.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.143 0.577 . . . . 74.04 110.205 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.715 HG21 ' H ' ' B' ' 132' ' ' ASN . 10.5 tt -104.39 144.18 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.25 1.02 . . . . 74.52 110.191 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.44 -45.88 3.0 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.382 0.273 . . . . 73.22 111.624 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.433 ' NH1' ' HB2' ' B' ' 129' ' ' ALA . 12.7 tpt180 -169.79 130.75 1.04 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 119.33 -0.367 . . . . 70.31 110.923 -171.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.557 HG12 HD11 ' D' ' 13' ' ' ILE . 32.9 mm -116.73 130.37 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.206 -0.664 . . . . 65.04 109.206 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.09 158.79 39.59 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.741 0.817 . . . . 75.25 111.731 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -88.09 116.35 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.358 -0.608 . . . . 72.53 109.358 172.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.17 -29.13 26.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.109 175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.2 t70 -149.99 137.58 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.114 -0.948 . . . . 65.33 109.746 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.512 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.7 mt -133.57 139.54 48.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.333 -1.358 . . . . 61.34 107.333 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -147.94 112.0 5.17 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.502 0.501 . . . . 44.04 110.012 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.559 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.6 t80 -109.73 122.22 46.99 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 105.674 -1.973 . . . . 71.21 105.674 167.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -132.97 109.28 9.46 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.598 -0.89 . . . . 63.41 108.598 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.73 83.45 4.57 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.75 -0.834 . . . . 52.5 108.75 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.75 -27.61 31.46 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.494 2.129 . . . . 62.31 112.074 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -114.14 35.59 4.09 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 124.588 1.155 . . . . 61.41 109.238 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.57 -58.76 16.74 Favored Pre-proline 0 CA--C 1.576 1.963 0 N-CA-C 114.947 1.462 . . . . 75.13 114.947 -164.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.2 Cg_endo -81.68 -14.31 10.24 Favored 'Trans proline' 0 C--N 1.389 2.708 0 CA-C-N 122.384 1.887 . . . . 62.41 113.027 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -68.67 -42.27 78.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.824 0.85 . . . . 62.12 109.934 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' D' ' 73' ' ' ALA . 1.0 OUTLIER -85.76 -2.37 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.082 -0.963 . . . . 63.52 110.226 -172.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -56.4 -35.37 67.7 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 73.41 111.005 164.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -65.42 -29.06 69.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 71.5 111.146 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.463 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -91.74 74.19 5.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.228 1.011 . . . . 75.01 110.189 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -87.42 79.46 8.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.079 0.942 . . . . 65.14 109.001 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -134.17 178.16 7.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.139 1.376 . . . . 71.24 108.168 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -75.68 118.38 70.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 118.547 0.612 . . . . 73.32 109.446 170.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.26 109.52 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.225 1.95 . . . . 52.54 111.182 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.49 113.64 3.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.135 -1.061 . . . . 72.4 108.135 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.568 HG13 HG13 ' D' ' 64' ' ' VAL . 97.5 t -95.76 106.2 17.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.616 -0.883 . . . . 75.24 108.616 -172.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.78 110.35 20.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.124 -1.806 . . . . 73.51 106.124 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.9 pp -94.66 157.22 16.06 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.04 -1.096 . . . . 72.24 108.04 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 11.4 t70 -146.18 132.37 19.42 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.899 -0.408 . . . . 62.13 109.899 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -102.31 130.5 49.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.168 0.987 . . . . 72.43 109.036 176.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -147.44 150.19 34.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.846 . . . . 53.2 108.914 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.6 t -126.42 159.33 33.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.256 0.622 . . . . 72.13 110.4 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.13 161.64 42.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 75.11 108.958 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 67.5 p -162.31 153.4 17.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.977 0.511 . . . . 64.24 110.936 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -155.47 147.81 23.8 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.717 0.807 . . . . 45.35 109.644 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -82.35 118.08 22.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.274 -0.639 . . . . 73.52 109.274 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.687 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.0 mt -92.66 -33.49 14.35 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.074 -0.343 . . . . 75.24 110.074 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.52 -177.96 2.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.282 1.033 . . . . 75.24 109.809 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.03 124.44 21.6 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.407 0.683 . . . . 53.14 109.977 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 65.0 14.25 9.22 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.036 1.334 . . . . 74.53 112.487 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -119.22 128.9 75.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.624 0.77 . . . . 72.01 109.404 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.35 149.78 50.37 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.848 0.859 . . . . 75.4 109.733 174.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.687 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.9 tt0 -109.38 117.47 34.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.299 -1.371 . . . . 73.42 107.299 163.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.27 129.75 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.528 -1.286 . . . . 73.42 107.528 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 40.7 t -113.19 132.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.67 -0.863 . . . . 62.11 108.67 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -108.62 126.05 52.53 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.949 -1.13 . . . . 63.15 107.949 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 40.7 ttm-85 -101.01 105.06 16.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.211 -1.033 . . . . 72.02 108.211 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.13 120.78 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.586 -1.264 . . . . 52.44 107.586 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.5 m -117.73 147.02 43.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.258 0.623 . . . . 65.11 109.452 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.568 HG13 HG13 ' D' ' 40' ' ' VAL . 69.2 t -133.87 100.57 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.014 1.326 . . . . 70.33 107.822 176.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -91.97 89.96 7.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.594 -2.002 . . . . 62.55 105.594 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' D' ' 74' ' ' PHE . . . -100.0 132.6 45.26 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.895 -1.048 . . . . 54.54 108.389 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.502 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 71.5 m -141.15 137.36 32.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 122.113 0.959 . . . . 73.15 111.814 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 54.8 mt -100.19 100.53 11.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.363 -1.744 . . . . 41.12 109.669 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.1 -123.6 10.68 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.835 -0.621 . . . . 71.22 111.957 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.92 4.21 53.46 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.353 0.661 . . . . 73.43 110.941 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.71 144.74 46.04 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.195 0.598 . . . . 62.41 110.026 -171.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -72.03 128.94 37.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.482 0.488 . . . . 70.33 110.208 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -78.33 -61.09 2.12 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.587 -0.894 . . . . 73.23 108.587 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' D' ' 118' ' ' VAL . 0.5 OUTLIER -159.59 177.62 10.71 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 113.859 -1.519 . . . . 74.12 108.329 171.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -134.34 107.47 7.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 73.01 106.447 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.597 ' SG ' HG12 ' D' ' 114' ' ' ILE . 1.9 t -113.77 146.29 40.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.836 0.454 . . . . 63.12 111.763 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.32 136.53 11.88 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.26 1.024 . . . . 73.24 109.158 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.36 116.26 24.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.998 -0.742 . . . . 71.34 108.998 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -91.89 88.21 6.53 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.703 0.764 . . . . 72.14 109.518 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.442 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -82.09 104.19 12.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.239 -1.346 . . . . 74.15 109.034 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.95 155.36 23.03 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.444 -0.662 . . . . 21.34 111.444 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.419 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -159.08 132.03 2.93 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.574 -0.61 . . . . 50.33 111.574 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.51 134.15 28.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 109.141 -0.689 . . . . 73.23 109.141 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.37 148.5 46.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 72.01 110.06 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 30.7 m -90.58 135.54 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.92 0.888 . . . . 65.2 109.138 170.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 5.0 tt -138.08 117.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 123.87 0.868 . . . . 71.41 110.166 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.27 146.29 5.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 44.31 110.103 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.81 0.27 59.04 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 113.737 0.255 . . . . 63.24 113.737 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 94' ' ' MET . 1.8 pp -103.06 164.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.098 0.959 . . . . 75.54 110.831 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.54 164.21 5.5 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.132 0.895 . . . . 75.51 110.31 173.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.58 -127.09 38.86 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 115.566 -0.743 . . . . 65.45 113.986 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.6 p -77.1 -27.31 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.777 0.831 . . . . 61.35 111.54 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -48.01 82.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.938 0.895 . . . . 64.25 110.846 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.48 ' HB3' ' HB ' ' D' ' 89' ' ' ILE . 25.3 ptm -68.73 -41.27 79.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.0 -0.545 . . . . 73.21 111.714 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.15 72.25 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.484 0.714 . . . . 73.21 111.104 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -81.16 -37.47 28.72 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.348 -0.842 . . . . 72.0 110.453 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -66.0 -49.79 66.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.166 0.586 . . . . 74.14 111.879 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.766 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 4.5 pp -83.82 -26.32 29.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.541 0.336 . . . . 74.03 111.23 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.31 -27.75 29.63 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.304 0.378 . . . . 64.5 113.447 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.76 -60.06 1.92 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.155 0.582 . . . . 75.34 110.469 -174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.419 ' O ' HG12 ' D' ' 105' ' ' ILE . 86.4 t80 -63.54 -49.61 72.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.733 0.413 . . . . 71.12 111.995 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 60.9 m -58.24 -51.58 80.74 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-O 118.642 -0.694 . . . . 72.23 112.494 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 39.3 Cg_exo -64.91 -32.79 54.26 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 121.66 1.574 . . . . 72.34 112.827 173.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.58 -32.17 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.971 0.508 . . . . 70.41 111.148 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.419 HG12 ' O ' ' D' ' 101' ' ' TYR . 38.2 mm -71.37 -35.68 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.756 0.822 . . . . 72.34 110.997 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' D' ' 80' ' ' GLN . 66.7 mt -75.04 -19.84 59.84 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.399 -0.819 . . . . 64.04 110.827 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -68.32 -42.5 29.35 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.294 1.22 . . . . 62.44 114.294 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -56.15 -40.42 84.96 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.069 1.846 . . . . 73.05 113.401 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -77.96 -35.0 50.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.052 0.941 . . . . 72.44 111.25 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.59 -42.87 77.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.467 0.707 . . . . 65.24 109.841 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.525 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.7 ttp180 -62.43 -46.62 87.7 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.438 -1.255 . . . . 74.14 109.888 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.92 -46.8 89.23 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.963 0.79 . . . . 71.51 110.743 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.426 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.8 t -59.23 -40.98 87.6 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.587 0.555 . . . . 62.32 110.678 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.597 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.8 mt -59.92 -57.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.915 0.486 . . . . 71.3 109.87 171.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 55.9 m -52.53 -44.49 65.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.36 1.464 . . . . 72.41 111.709 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.45 -44.55 78.39 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.528 -1.215 . . . . 44.32 110.07 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.7 mtm -66.01 -38.47 88.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.74 0.416 . . . . 71.32 111.411 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' D' ' 74' ' ' PHE . 98.6 t -62.53 -45.27 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 O-C-N 124.141 0.901 . . . . 62.33 109.795 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -71.45 -32.8 68.75 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.933 0.493 . . . . 74.33 111.03 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -70.08 -27.15 64.38 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.577 0.751 . . . . 74.23 109.949 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.17 11.89 70.8 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.918 0.761 . . . . 53.32 112.83 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.478 HG23 ' HB3' ' C' ' 17' ' ' TYR . 55.8 p 58.26 32.08 21.61 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.863 1.665 . . . . 42.51 113.356 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.431 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 84.9 m-85 -101.92 165.06 14.61 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.233 1.013 . . . . 73.13 108.296 168.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 57.3 Cg_endo -67.41 149.72 80.6 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.487 2.124 . . . . 61.34 112.423 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -59.19 126.92 29.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.294 0.637 . . . . 64.31 111.091 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.472 HD13 HG21 ' D' ' 40' ' ' VAL . 60.4 tp -107.79 96.48 6.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.529 0.732 . . . . 72.22 110.458 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -103.89 95.04 5.75 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.478 -0.564 . . . . 73.12 109.478 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' D' ' 128' ' ' LEU . 0.8 OUTLIER -73.96 134.28 43.1 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.227 -0.657 . . . . 73.31 109.227 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.86 138.53 87.07 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.812 0.845 . . . . 65.42 111.569 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -83.6 103.8 1.1 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.306 2.004 . . . . 53.24 110.889 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -107.71 110.92 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.708 0.766 . . . . 60.1 110.415 -171.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 . . . . . 0 C--O 1.243 0.711 0 CA-C-N 115.045 -0.98 . . . . 71.53 109.648 175.191 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 CA--C 1.542 0.658 0 N-CA-C 109.618 -0.512 . . . . 63.14 109.618 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.422 ' CD1' ' HE2' ' A' ' 101' ' ' TYR . 50.5 t80 -136.32 136.96 40.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 75.1 108.72 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -151.18 125.88 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.864 -0.153 . . . . 73.4 110.965 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -76.26 132.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.44 108.385 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 79.6 mm-40 -103.85 -38.61 6.96 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 123.88 0.737 . . . . 72.13 109.906 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -168.94 141.84 2.78 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 112.074 0.398 . . . . 75.01 112.074 -171.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.455 HD13 ' CD2' ' A' ' 109' ' ' TYR . 74.4 mt -106.71 142.47 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 124.932 1.293 . . . . 63.53 107.516 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.411 ' HE1' HG13 ' A' ' 83' ' ' ILE . 15.3 p90 -166.21 146.22 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.723 0.773 . . . . 75.43 111.003 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 p -88.46 105.06 17.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.845 -1.07 . . . . 73.11 109.321 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.1 mtpt -76.06 -28.21 57.54 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.857 -0.423 . . . . 74.13 109.857 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.3 t70 -148.77 130.77 15.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.87 -1.059 . . . . 73.12 109.67 174.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -122.84 136.36 59.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 105.983 -1.858 . . . . 65.43 105.983 167.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.82 108.26 3.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.831 0.348 . . . . 72.35 110.649 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.727 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.9 t80 -109.83 131.0 55.46 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.035 -1.468 . . . . 64.01 107.035 171.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.62 131.6 41.58 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.441 -0.948 . . . . 53.13 108.441 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -146.8 72.67 12.51 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.913 -0.773 . . . . 64.2 108.913 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.44 -13.22 25.2 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.509 2.139 . . . . 73.24 111.853 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -118.04 25.53 10.28 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.762 0.825 . . . . 74.23 109.296 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.37 -46.47 99.8 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.166 0.987 . . . . 72.14 112.898 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.03 -18.08 18.96 Favored 'Trans proline' 0 C--N 1.391 2.812 0 CA-C-N 120.933 1.369 . . . . 51.33 113.208 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.95 -18.99 61.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.249 0.62 . . . . 73.42 111.938 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 8.6 p -64.69 -18.39 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 112.783 0.66 . . . . 44.43 112.783 -176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -71.45 -40.32 70.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.965 0.506 . . . . 65.0 110.604 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -86.68 -19.54 29.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.658 -0.701 . . . . 74.3 110.713 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 29.8 mmmt -81.97 151.0 27.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.12 0.568 . . . . 74.11 111.29 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -80.5 124.01 28.57 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.931 -1.031 . . . . 54.43 108.714 168.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.477 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.4 t-105 -76.13 87.42 3.01 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.115 0.483 . . . . 75.15 110.54 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.86 80.66 70.63 Favored Pre-proline 0 C--O 1.245 0.837 0 C-N-CA 124.505 1.122 . . . . 74.24 108.035 169.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -79.45 129.41 8.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.269 1.979 . . . . 62.41 111.804 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.79 84.17 3.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 105.626 -1.99 . . . . 74.35 105.626 172.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -77.19 93.85 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.344 -1.298 . . . . 55.04 109.854 -172.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.88 116.11 23.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 113.976 -1.466 . . . . 61.54 110.867 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.443 HD23 HD23 ' A' ' 128' ' ' LEU . 6.6 mp -97.38 106.94 19.34 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.45 -1.25 . . . . 70.42 107.882 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.2 t70 -107.47 147.26 30.7 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.793 1.237 . . . . 63.15 109.364 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -129.8 137.61 50.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.013 0.925 . . . . 70.4 109.528 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -144.41 145.8 32.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.31 0.644 . . . . 72.33 109.485 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.8 m -107.19 125.93 51.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.619 0.768 . . . . 72.13 110.032 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.78 138.32 45.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.999 0.92 . . . . 55.24 108.825 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -135.65 162.46 32.67 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.434 0.693 . . . . 74.03 110.341 172.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 t -161.34 123.27 2.97 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.047 0.939 . . . . 72.01 108.661 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.08 146.26 39.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.812 -0.44 . . . . 62.2 109.812 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 57' ' ' GLU . 49.9 mt -117.35 -34.92 4.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.507 0.723 . . . . 74.31 111.355 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.1 -175.28 5.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.987 0.915 . . . . 75.51 109.441 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.09 121.13 17.72 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.735 -0.839 . . . . 73.44 108.735 173.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.94 9.86 7.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.388 1.475 . . . . 70.51 113.013 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 71.1 t -124.12 122.24 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.152 -1.055 . . . . 64.44 108.152 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -140.84 170.47 15.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.998 -0.741 . . . . 74.32 108.998 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' A' ' 51' ' ' LEU . 23.0 tt0 -126.51 140.08 52.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.174 0.99 . . . . 74.31 108.75 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -117.48 124.86 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 107.138 -1.43 . . . . 74.54 107.138 164.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -98.29 127.04 51.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 172.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.86 109.47 21.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.843 -1.54 . . . . 60.13 106.843 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -98.52 100.33 11.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.267 -1.012 . . . . 74.34 108.267 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.81 117.14 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.582 -1.19 . . . . 44.3 108.756 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.1 m -112.74 128.01 56.3 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.55 -0.537 . . . . 71.12 109.55 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 25.2 t -120.28 107.54 21.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 107.948 -1.13 . . . . 63.2 107.948 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.0 m -102.16 141.35 35.14 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.318 -0.993 . . . . 71.22 108.318 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.19 106.88 10.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.068 -1.086 . . . . 63.21 108.068 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -108.97 125.96 52.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.049 0.54 . . . . 63.22 110.467 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.477 HD21 ' CE3' ' A' ' 36' ' ' TRP . 46.7 mt -88.46 62.33 6.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.47 -1.307 . . . . 73.55 107.47 171.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.39 1.32 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.57 -1.196 . . . . 43.4 111.371 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.01 -20.26 27.47 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.969 0.908 . . . . 75.14 111.161 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -109.2 118.86 37.82 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.351 -0.611 . . . . 75.3 109.351 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -73.18 130.17 39.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.559 0.618 . . . . 73.4 110.129 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.75 4.19 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.78 -0.822 . . . . 53.1 108.78 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.19 168.6 26.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.167 -1.379 . . . . 54.23 110.558 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.4 116.91 11.36 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.545 1.138 . . . . 73.05 108.733 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.4 m -104.31 138.82 40.19 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 124.319 1.048 . . . . 75.35 108.893 172.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -148.04 117.33 6.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.255 -1.017 . . . . 74.3 108.255 171.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -122.81 111.48 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 109.316 -0.624 . . . . 73.14 109.316 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.0 mt-30 -86.42 82.19 8.05 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.89 -1.05 . . . . 74.23 108.732 170.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' HG3' HD22 ' A' ' 106' ' ' LEU . 6.2 tp-100 -77.96 95.63 4.85 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.358 -1.292 . . . . 61.15 109.405 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.14 154.53 29.02 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 112.057 -0.417 . . . . 51.52 112.057 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.57 131.8 3.0 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 112.136 -0.385 . . . . 52.04 112.136 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 37.0 mt -81.6 128.28 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.446 -0.946 . . . . 64.35 108.446 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.38 154.32 48.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -119.26 119.44 34.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.649 1.18 . . . . 64.41 108.051 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 89' ' ' ILE . 2.9 pp -122.17 158.79 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.019 0.438 . . . . 73.2 111.098 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 151.91 8.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.591 -1.186 . . . . 64.53 109.094 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.23 83.82 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 115.26 0.864 . . . . 73.45 115.26 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.481 HD11 HD13 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -115.88 136.58 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.538 0.669 . . . . 75.55 110.357 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -144.75 172.37 13.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.836 0.455 . . . . 61.31 111.54 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -120.67 23.77 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.899 -0.591 . . . . 71.11 113.31 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.7 p -79.58 -16.38 55.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.779 0.832 . . . . 71.0 111.832 -174.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.75 -42.43 90.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.767 0.827 . . . . 74.21 109.263 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 98' ' ' LEU . 43.5 tpp -67.1 -38.37 85.55 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.976 -1.011 . . . . 75.11 110.509 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.44 81.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.704 0.802 . . . . 51.34 111.969 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -84.17 -36.67 22.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.766 0.426 . . . . 63.43 111.095 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -71.95 -64.73 0.88 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.703 0.401 . . . . 65.12 110.669 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.417 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 7.4 tt -68.42 -34.54 76.18 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 72.1 110.324 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -5.59 78.19 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 119.077 -0.846 . . . . 44.13 114.968 -172.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.84 -55.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.534 1.167 . . . . 63.14 112.742 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 81.1 t80 -68.9 -45.74 70.14 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.882 0.697 . . . . 73.41 112.882 -169.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -73.58 -37.42 3.53 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.05 0.54 . . . . 53.34 112.315 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -48.84 -33.68 26.05 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.503 2.136 . . . . 71.15 113.901 162.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.19 -16.55 64.03 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.576 0.75 . . . . 75.43 111.991 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.409 HG23 HD21 ' C' ' 132' ' ' ASN . 47.7 mm -74.63 -44.3 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 122.002 0.906 . . . . 61.41 109.639 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.493 HD22 ' HG3' ' A' ' 80' ' ' GLN . 89.0 mt -85.74 -19.26 31.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.164 -1.38 . . . . 73.54 112.33 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.44 -44.24 25.04 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.215 -0.898 . . . . 73.35 112.483 -173.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.37 -35.26 98.87 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 121.996 1.797 . . . . 63.11 113.062 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.455 ' CD2' HD13 ' A' ' 16' ' ' ILE . 27.7 m-85 -82.77 -31.81 28.1 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.107 0.78 . . . . 71.5 113.107 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 -47.84 61.28 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.515 -0.92 . . . . 72.44 108.515 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -46.74 -59.7 2.87 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 125.331 1.644 . . . . 74.24 109.559 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.7 tm-20 -64.24 -38.35 90.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.433 1.083 . . . . 64.15 111.895 -172.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 117' ' ' MET . 44.8 t -62.12 -46.43 89.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.659 0.384 . . . . 71.12 110.471 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 118' ' ' VAL . 34.1 mt -62.33 -47.19 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.882 0.873 . . . . 72.24 110.13 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.592 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.5 m -55.68 -42.77 75.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.097 1.359 . . . . 61.33 110.71 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -68.87 -39.18 79.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.583 -1.189 . . . . 71.43 110.321 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -66.79 -35.56 80.36 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.425 0.29 . . . . 74.22 111.299 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -66.37 -40.09 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.478 0.711 . . . . 72.24 110.292 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.6 p -73.47 -34.3 65.28 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.36 -0.382 . . . . 62.23 111.259 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.12 -23.98 63.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.512 0.725 . . . . 71.22 110.261 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 31.04 3.55 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 123.743 0.687 . . . . 61.45 113.522 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 14.7 t 58.68 15.96 4.06 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.943 2.097 . . . . 71.21 114.683 173.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' SER . 42.0 m-85 -123.49 159.82 53.5 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.174 0.589 . . . . 74.4 111.066 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.61 135.63 57.91 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.447 2.098 . . . . 75.32 110.141 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 12.7 pt20 -57.84 153.27 14.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.064 0.946 . . . . 71.24 111.709 -174.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.18 112.17 24.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.162 -1.051 . . . . 61.34 108.162 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' C' ' 16' ' ' ILE . 76.6 m-20 -97.31 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.316 -0.994 . . . . 64.03 108.316 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.443 HD23 HD23 ' A' ' 42' ' ' LEU . 5.8 mp -69.0 142.12 54.72 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.744 -0.662 . . . . 75.1 109.622 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.1 74.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 122.704 0.401 . . . . 50.43 110.453 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.455 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 16.8 Cg_exo -68.05 124.78 12.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.459 2.106 . . . . 75.23 109.995 170.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.0 m -97.12 111.9 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 122.077 0.942 . . . . 74.25 108.951 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.91 86.46 2.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.167 -1.378 . . . . 65.24 109.396 177.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.489 1.497 0 C-N-CA 125.148 1.379 . . . . 73.24 112.951 -171.498 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--O 1.241 0.649 0 N-CA-C 107.982 -1.118 . . . . 61.31 107.982 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.615 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 31.5 t80 -122.07 134.82 54.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.69 -0.855 . . . . 73.32 108.69 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -165.87 141.45 4.93 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.79 0.681 . . . . 72.14 109.248 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.616 HD13 HD11 ' B' ' 16' ' ' ILE . 78.4 mt -86.22 121.05 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.93 0.492 . . . . 72.51 110.326 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -80.65 -36.72 32.14 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.662 0.601 . . . . 73.04 111.249 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -171.32 142.44 1.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.994 0.518 . . . . 65.23 109.949 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.616 HD11 HD13 ' B' ' 13' ' ' ILE . 90.1 mt -121.26 140.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.911 -1.144 . . . . 74.33 107.911 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 31.5 p90 -165.53 152.23 10.07 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.896 0.747 . . . . 74.21 111.079 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -75.42 123.98 26.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.262 -1.014 . . . . 72.34 108.262 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -92.54 -37.11 12.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.988 0.515 . . . . 74.22 109.679 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.0 t70 -148.84 147.96 29.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.531 -0.759 . . . . 75.54 110.712 -170.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.479 HD13 HG13 ' B' ' 78' ' ' VAL . 36.7 mm -143.11 143.41 24.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.504 1.521 . . . . 72.12 107.79 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 55.6 m -149.09 131.73 15.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.203 -0.908 . . . . 63.34 108.706 168.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -140.08 106.95 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.228 -1.768 . . . . 74.33 106.228 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.52 110.6 15.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.665 -0.865 . . . . 75.44 108.665 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 74' ' ' PHE . . . -108.42 88.56 5.11 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.499 1.12 . . . . 73.41 109.205 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.68 -30.21 59.94 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.084 2.523 . . . . 74.13 112.374 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -118.45 31.39 6.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 71.22 110.22 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.63 -52.24 32.11 Favored Pre-proline 0 CA--C 1.572 1.799 0 C-N-CA 125.327 1.451 . . . . 75.14 113.648 173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 96.0 Cg_endo -77.7 -12.57 16.57 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.814 1.676 . . . . 70.4 113.142 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -86.98 1.12 53.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.897 0.879 . . . . 74.52 111.803 -175.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.13 -14.03 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 123.653 0.781 . . . . 73.34 110.334 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -65.76 -41.27 92.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.798 0.439 . . . . 73.03 110.266 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -47.27 12.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.327 -0.62 . . . . 73.54 109.327 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.38 67.82 9.57 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.12 -1.067 . . . . 75.41 108.12 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.21 75.56 9.13 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.432 -1.258 . . . . 63.12 111.442 -168.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -177.27 172.44 1.89 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.255 -1.339 . . . . 62.22 108.216 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.627 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 3.9 pt20 -71.05 134.84 85.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.322 0.649 . . . . 65.51 111.731 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.88 156.12 60.04 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.549 2.166 . . . . 73.35 112.461 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 27.2 mt-10 -70.31 98.86 1.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.372 -0.973 . . . . 63.52 108.372 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.606 ' HB ' HD13 ' B' ' 126' ' ' LEU . 16.4 m -87.67 122.55 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 74.52 109.445 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -153.22 130.31 11.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.476 1.11 . . . . 70.25 109.645 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.71 HD22 HD11 ' B' ' 126' ' ' LEU . 1.4 pt? -130.81 164.98 23.97 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.993 0.738 . . . . 64.15 112.993 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.96 141.19 38.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.188 1.395 . . . . 72.34 109.79 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -94.68 124.85 38.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 74.23 108.988 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -124.36 156.14 37.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.862 1.265 . . . . 65.45 108.427 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.2 t -129.4 140.85 51.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.616 0.722 . . . . 71.54 111.518 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 161.6 32.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.738 1.615 . . . . 64.03 107.981 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -143.12 165.77 26.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.46 0.648 . . . . 64.35 111.525 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.7 t -152.09 157.83 42.15 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.149 1.38 . . . . 55.2 108.379 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -123.66 129.01 50.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.17 -39.48 12.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.319 0.648 . . . . 71.01 110.125 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 179.96 8.1 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.517 1.127 . . . . 70.25 109.826 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.29 121.25 9.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.342 0.657 . . . . 71.45 109.517 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 66.17 -5.74 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 126.04 1.736 . . . . 43.14 113.712 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.71 86.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.945 -1.502 . . . . 54.23 106.945 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -95.82 168.71 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.609 . . . . 73.34 110.183 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -145.38 97.64 3.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.833 -1.544 . . . . 64.13 106.833 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.34 130.24 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.946 -0.761 . . . . 73.43 108.946 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.1 t -106.89 124.03 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.645 0.778 . . . . 72.41 109.734 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 1.0 OUTLIER -93.68 121.41 35.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.11 -1.07 . . . . 74.05 108.11 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -113.11 113.46 25.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.221 0.608 . . . . 71.11 109.821 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.574 ' HB ' HD11 ' B' ' 114' ' ' ILE . 47.9 t -104.93 125.48 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 62.23 108.546 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -98.64 137.66 36.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.784 -0.821 . . . . 73.13 108.784 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' B' ' 114' ' ' ILE . 50.6 t -128.67 123.76 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.774 -0.825 . . . . 50.01 108.774 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.7 m -108.07 139.07 43.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.023 0.929 . . . . 74.33 109.637 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.33 143.28 30.9 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.438 0.695 . . . . 41.21 109.216 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -151.46 134.13 15.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.462 0.541 . . . . 73.34 112.462 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -107.41 104.23 13.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.943 1.297 . . . . 62.32 108.758 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.96 -113.88 5.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.813 -0.437 . . . . 65.41 112.523 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -97.94 2.76 49.4 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.325 0.65 . . . . 71.34 111.502 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -130.81 157.68 42.21 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.556 0.342 . . . . 70.21 111.864 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.2 m -76.04 133.69 40.29 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.786 -0.643 . . . . 71.42 110.669 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.34 -55.77 3.29 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.533 0.733 . . . . 74.31 109.701 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 30.8 p90 -154.01 162.34 41.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.26 -0.882 . . . . 73.24 109.956 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.7 mt -142.25 116.05 9.24 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.075 1.35 . . . . 72.33 107.453 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -117.79 120.49 38.09 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.528 -0.545 . . . . 33.43 109.528 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -123.37 124.2 42.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.434 -0.95 . . . . 70.24 108.434 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.479 HG13 HD13 ' B' ' 21' ' ' ILE . 55.3 t -121.47 146.0 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.314 -0.995 . . . . 71.2 108.314 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.8 mt-30 -127.06 99.28 5.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.14 109.255 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.533 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -92.41 104.22 16.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.144 -1.389 . . . . 74.44 108.751 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.44 159.27 25.99 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 112.142 -0.383 . . . . 74.33 112.142 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -156.19 127.98 2.12 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.837 -0.905 . . . . 51.34 110.837 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.84 125.0 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.608 -0.886 . . . . 73.21 108.608 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.88 136.73 47.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.298 1.039 . . . . 63.22 109.979 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 5.7 m -90.22 110.48 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.043 -1.095 . . . . 62.44 108.043 172.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 38.3 pt -126.68 109.19 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.824 0.821 . . . . 72.43 110.553 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.5 170.71 20.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.645 -1.162 . . . . 64.22 109.441 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.53 -49.14 1.21 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 111.413 -0.675 . . . . 65.22 111.413 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 165.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.755 0.822 . . . . 71.1 111.387 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -163.7 144.87 9.03 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.89 0.744 . . . . 73.22 110.561 169.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.51 -110.44 3.13 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.555 -0.748 . . . . 73.23 113.031 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 m -65.26 -44.92 86.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 65.4 112.309 -170.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.9 -22.4 61.5 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.573 -0.74 . . . . 72.43 112.126 -167.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.416 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 17.4 ttt -72.15 -38.73 69.13 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.405 -0.22 . . . . 75.44 110.405 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.53 74.26 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.945 0.498 . . . . 40.01 110.845 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 59.2 t-80 -74.45 -20.51 60.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.687 0.795 . . . . 74.14 110.848 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -86.92 -67.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.131 0.573 . . . . 61.55 111.289 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.435 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.5 pp -74.19 -24.26 59.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.126 0.57 . . . . 64.35 112.301 -172.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.37 72.94 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.905 -0.386 . . . . 52.24 113.35 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -145.37 -69.92 0.28 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.502 0.556 . . . . 72.55 112.502 -173.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -74.03 -39.53 63.49 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.318 0.386 . . . . 63.33 111.562 -168.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.615 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 61.0 m -61.98 -50.33 81.34 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.865 -0.588 . . . . 53.53 111.522 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.64 -25.82 28.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.427 1.418 . . . . 64.11 113.415 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.83 -33.03 74.78 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.281 0.562 . . . . 74.35 110.962 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.442 HD13 HD11 ' B' ' 13' ' ' ILE . 59.6 mt -65.67 -44.9 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.257 1.023 . . . . 74.44 110.89 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' B' ' 82' ' ' GLY . 44.9 mt -81.33 -12.9 58.89 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.126 -0.943 . . . . 62.14 111.017 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -60.01 -49.94 88.75 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.755 -1.117 . . . . 72.2 112.093 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.49 -41.38 77.51 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.887 1.725 . . . . 41.01 113.011 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.533 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.2 m-85 -65.99 -50.22 65.06 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.483 0.713 . . . . 74.11 112.204 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.73 81.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.759 0.824 . . . . 70.12 110.847 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -56.09 -48.6 75.81 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.379 1.472 . . . . 65.15 110.299 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.63 -36.36 80.66 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.399 0.68 . . . . 61.35 110.428 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.0 t -68.51 -45.02 73.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.752 0.421 . . . . 72.31 111.82 -174.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.574 HD11 ' HB ' ' B' ' 62' ' ' VAL . 92.1 mt -59.22 -50.77 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.955 0.902 . . . . 71.24 110.429 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.436 HG21 ' OG ' ' C' ' 119' ' ' SER . 86.9 m -58.26 -33.06 68.98 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 124.481 1.113 . . . . 65.25 111.175 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.7 t -69.75 -35.18 74.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.219 1.008 . . . . 74.44 111.357 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -79.24 -33.21 43.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.862 0.465 . . . . 72.04 111.481 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.56 -31.9 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.675 0.79 . . . . 74.14 110.748 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.505 ' HB3' HG21 ' C' ' 115' ' ' THR . 80.7 p -68.48 -33.45 74.18 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 116.03 -0.532 . . . . 55.01 112.068 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.454 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 83.7 mtt-85 -65.55 -36.96 85.34 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.011 -0.995 . . . . 72.31 110.96 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.89 9.09 63.9 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.508 -0.769 . . . . 71.13 113.85 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p 63.84 12.66 6.92 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.436 1.894 . . . . 74.44 113.192 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.498 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 58.3 m-85 -77.99 170.98 13.74 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.915 0.886 . . . . 74.3 110.269 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.627 ' HG3' ' HB2' ' B' ' 37' ' ' GLN . 62.5 Cg_endo -77.18 -169.11 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.101 1.867 . . . . 64.05 114.718 -170.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' C' ' 125' ' ' GLN . 17.7 pt20 -64.92 142.11 58.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.945 -1.48 . . . . 61.23 112.434 177.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.71 HD11 HD22 ' B' ' 42' ' ' LEU . 32.5 tp -151.57 98.34 2.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.334 -0.848 . . . . 72.0 108.895 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -134.65 126.04 28.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.644 . . . . 75.22 109.769 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 39.0 mt -77.01 151.17 35.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.875 0.87 . . . . 73.34 111.807 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.69 106.54 15.77 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.981 -0.748 . . . . 64.14 108.981 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.2 113.47 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.026 2.484 . . . . 64.32 112.938 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.23 153.84 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.52 0.728 . . . . 73.55 110.152 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.447 ' HB2' HD12 ' D' ' 13' ' ' ILE . 50.2 t-20 -110.55 115.83 30.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.635 0.774 . . . . 70.22 110.562 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.48 1.055 0 C-N-CA 122.973 0.509 . . . . 74.34 111.201 175.188 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.3 m . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 109.484 -0.561 . . . . 75.53 109.484 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -104.34 140.3 38.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.702 0.801 . . . . 63.54 108.892 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -150.02 140.09 22.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.869 0.366 . . . . 74.04 111.305 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -93.34 141.49 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.232 1.013 . . . . 72.42 109.578 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.519 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.7 mm-40 -108.49 -49.11 3.22 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.37 0.668 . . . . 74.3 110.087 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.555 HH11 ' HD1' ' D' ' 32' ' ' PHE . 63.5 ttt180 -170.57 125.39 0.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.608 0.363 . . . . 74.25 110.354 -173.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.525 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 73.0 mt -109.6 141.73 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.344 -1.354 . . . . 63.1 107.344 176.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.544 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 40.6 p90 -176.94 156.69 1.36 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.037 0.836 . . . . 74.52 110.768 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -78.73 123.34 27.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.428 -0.806 . . . . 72.34 109.954 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.58 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -81.16 -44.87 17.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.007 -0.738 . . . . 52.14 109.007 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -149.87 134.19 17.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.41 -1.268 . . . . 70.42 109.606 -171.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.0 mt -134.15 145.07 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.519 1.128 . . . . 74.12 108.499 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -156.24 151.99 27.22 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.223 0.535 . . . . 73.21 111.154 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -152.94 108.52 3.29 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.152 -1.425 . . . . 71.01 107.152 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.18 114.88 25.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.449 0.7 . . . . 70.03 110.298 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.72 83.44 62.3 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.609 1.163 . . . . 75.54 109.333 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.29 -23.15 24.5 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.412 2.074 . . . . 72.55 111.46 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -93.54 15.28 16.43 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.25 1.42 . . . . 70.44 109.535 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' D' ' 17' ' ' TYR . . . -56.95 -49.0 96.48 Favored Pre-proline 0 CA--C 1.567 1.616 0 N-CA-C 113.991 1.108 . . . . 51.21 113.991 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.98 -29.57 6.62 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.041 1.407 . . . . 71.44 113.132 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -70.25 -39.84 74.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.198 0.599 . . . . 75.2 111.739 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.443 HG23 HD11 ' C' ' 68' ' ' LEU . 10.5 p -71.18 -12.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.672 0.789 . . . . 51.1 111.16 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.97 -41.0 77.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 110.562 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -100.57 48.54 0.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.033 0.92 . . . . 74.32 109.842 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.622 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -125.52 158.75 33.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.803 0.841 . . . . 75.14 110.12 177.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.85 107.2 9.0 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 106.766 -1.568 . . . . 54.01 106.766 164.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.01 90.01 3.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.824 -0.625 . . . . 74.21 111.962 -164.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -137.75 65.55 46.64 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.969 0.908 . . . . 73.31 109.071 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -65.13 133.36 35.15 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.284 1.99 . . . . 75.05 111.727 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' C' ' 66' ' ' ALA . 29.4 tt0 -83.76 86.45 7.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.875 -1.158 . . . . 70.25 107.875 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -74.47 79.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.513 -1.221 . . . . 60.52 110.332 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 41.5 tttp -92.74 134.23 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.054 -1.43 . . . . 72.31 110.003 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.424 HD23 HD13 ' C' ' 128' ' ' LEU . 1.4 pp -87.72 167.25 14.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.727 0.811 . . . . 73.51 111.867 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.97 148.3 18.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.709 0.804 . . . . 75.25 109.429 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 tt -123.9 139.02 54.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.277 0.631 . . . . 63.35 109.86 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 14.0 m-20 -136.39 150.68 48.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.769 1.228 . . . . 53.52 109.156 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -115.0 143.56 44.99 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.572 0.749 . . . . 73.44 109.342 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.23 154.66 41.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.187 0.995 . . . . 60.3 108.328 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -163.77 152.96 14.21 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.849 0.357 . . . . 72.52 111.063 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -151.48 130.92 12.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.28 1.032 . . . . 24.41 109.043 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -75.85 129.06 36.41 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.723 -0.473 . . . . 60.11 109.723 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 47.0 mt -104.77 -36.23 7.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.504 0.722 . . . . 73.35 110.018 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -173.44 4.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.685 -1.143 . . . . 70.14 108.948 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -76.14 124.35 27.3 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.43 -0.804 . . . . 63.21 109.798 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 63.34 12.24 6.09 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.416 1.086 . . . . 65.13 112.483 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.31 130.28 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.874 1.27 . . . . 50.03 108.36 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.2 152.13 36.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.58 0.705 . . . . 74.12 111.458 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.439 ' HB2' HD11 ' C' ' 51' ' ' LEU . 27.6 tt0 -83.61 125.42 31.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.234 1.414 . . . . 71.2 109.448 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.9 t -112.37 130.57 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.99 -1.115 . . . . 75.35 107.99 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.4 107.69 19.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.865 0.866 . . . . 64.21 108.752 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' C' ' 103' ' ' PRO . 3.1 tm? -92.07 108.3 19.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.39 -1.337 . . . . 64.34 107.39 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.9 ttp180 -89.67 128.65 36.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.069 -0.514 . . . . 75.34 109.951 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.577 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.9 t -117.99 118.94 59.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.734 -1.21 . . . . 72.53 107.734 168.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 32.4 m -110.67 146.49 36.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 72.55 109.393 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.556 HG21 HG21 ' C' ' 114' ' ' ILE . 63.8 t -129.94 115.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.747 1.219 . . . . 65.34 109.131 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -98.67 143.44 29.04 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.481 -0.933 . . . . 62.52 108.481 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' C' ' 39' ' ' GLU . . . -127.67 121.08 29.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.485 -0.561 . . . . 63.45 109.485 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.0 m -137.96 131.73 31.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.316 0.579 . . . . 73.1 111.38 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.622 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.9 mt -87.79 41.12 0.97 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.192 1.397 . . . . 73.32 109.685 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.91 -102.66 2.28 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.287 -1.125 . . . . 54.23 110.287 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -92.35 -31.87 15.19 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.952 0.501 . . . . 64.32 110.152 174.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.584 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 3.8 tp10 -66.8 119.0 11.1 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.702 1.201 . . . . 72.51 109.758 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.2 m -73.06 124.63 25.9 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.174 -0.676 . . . . 75.22 109.174 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.64 -47.91 10.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.377 -0.601 . . . . 73.32 109.377 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -171.44 177.22 3.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.864 0.866 . . . . 74.51 110.76 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.426 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -132.43 144.6 50.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.484 -1.672 . . . . 64.21 106.484 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.426 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.4 t -140.04 143.02 36.18 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.829 -1.545 . . . . 74.1 106.829 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.72 135.07 9.25 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.146 0.498 . . . . 73.32 110.274 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.33 135.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.864 -1.062 . . . . 61.12 108.341 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -115.84 94.01 4.5 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.362 -1.348 . . . . 73.41 107.362 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -89.83 115.17 26.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.849 -1.068 . . . . 75.13 110.11 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.58 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -108.4 157.4 15.3 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.014 -0.539 . . . . 63.31 113.28 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -158.0 133.76 3.62 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.93 -1.268 . . . . 53.32 109.93 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 20.8 mm -91.59 122.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.907 -1.146 . . . . 74.11 107.907 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.01 130.74 52.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.966 0.506 . . . . 75.5 110.052 -173.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.6 t -104.97 119.31 38.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.3 -1.0 . . . . 71.12 108.3 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.17 150.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.017 0.927 . . . . 65.44 110.24 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.66 149.57 28.56 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.813 0.845 . . . . 74.44 109.579 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.38 60.22 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.195 -0.457 . . . . 63.2 113.212 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 48.0 pt . . . . . 0 CA--C 1.551 0.995 0 C-N-CA 123.849 0.86 . . . . 62.1 112.0 -175.628 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 111.921 0.341 . . . . 75.1 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 48.2 ttm -84.74 -44.06 13.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.633 0.373 . . . . 73.13 110.776 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.25 -39.49 65.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.418 0.687 . . . . 71.44 111.364 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -69.82 -31.95 70.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.756 0.822 . . . . 72.42 110.368 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 45.7 t -80.87 -61.9 1.83 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.886 0.474 . . . . 73.34 110.419 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.9 -40.36 91.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.146 0.978 . . . . 73.3 110.271 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.3 2.97 68.81 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.074 -0.848 . . . . 54.04 114.622 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.06 -59.41 0.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.404 1.102 . . . . 72.33 112.768 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 77.0 t80 -71.96 -48.49 44.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.062 0.764 . . . . 73.04 113.062 -166.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.56 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -60.35 -48.97 92.54 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.692 0.397 . . . . 75.25 110.57 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 54.2 Cg_exo -59.62 -30.47 92.37 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.277 1.985 . . . . 74.35 114.258 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.648 0.779 . . . . 52.44 110.846 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.48 -36.76 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.246 0.618 . . . . 73.33 110.168 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.1 mt -83.44 -25.84 30.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.513 -0.767 . . . . 74.41 111.86 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.98 -40.15 83.02 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 124.324 1.05 . . . . 75.42 113.609 -175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.3 -53.63 6.78 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.692 2.262 . . . . 65.25 113.792 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.592 ' HE2' HG21 ' A' ' 115' ' ' THR . 53.7 m-85 -63.5 -34.42 77.74 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.58 -1.191 . . . . 73.33 110.793 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.81 -45.24 62.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.402 0.681 . . . . 54.3 110.853 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.83 -37.74 69.11 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.384 1.074 . . . . 72.0 110.647 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.454 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -77.94 -43.15 30.74 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.262 0.625 . . . . 72.04 111.075 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.56 -33.28 75.31 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.755 0.65 . . . . 73.14 112.755 -170.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' C' ' 62' ' ' VAL . 70.4 mt -67.64 -49.08 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.871 0.469 . . . . 60.4 109.821 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.676 HG23 ' HB2' ' C' ' 125' ' ' GLN . 57.4 m -54.8 -37.16 65.74 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.251 -1.341 . . . . 74.11 111.603 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.1 t -57.42 -58.11 9.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.906 -1.043 . . . . 62.43 109.98 174.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -41.68 85.85 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.325 1.05 . . . . 71.12 113.195 -176.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.04 -42.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 122.594 0.358 . . . . 64.12 110.385 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.436 ' OG ' HG21 ' B' ' 115' ' ' THR . 38.1 t -71.78 -20.15 61.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.545 -0.752 . . . . 55.42 111.588 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.5 mtt-85 -73.98 -40.12 63.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.108 0.563 . . . . 71.2 110.051 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.02 -5.64 71.21 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.53 0.519 . . . . 71.44 111.909 167.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p 65.37 23.05 12.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.491 2.316 . . . . 63.33 112.357 173.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.85 164.21 49.9 Favored Pre-proline 0 CA--C 1.548 0.865 0 CA-C-N 114.805 -1.089 . . . . 75.52 108.491 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.17 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.775 2.317 . . . . 73.21 113.072 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.676 ' HB2' HG23 ' C' ' 115' ' ' THR . 2.6 pt20 -49.78 133.29 21.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.806 1.242 . . . . 75.02 111.295 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.405 ' HG ' ' HG ' ' C' ' 128' ' ' LEU . 28.2 tp -90.9 82.33 5.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.519 0.676 . . . . 51.43 110.359 -170.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -94.59 85.94 4.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.058 -0.974 . . . . 73.03 108.867 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.424 HD13 HD23 ' C' ' 42' ' ' LEU . 93.7 mt -87.85 144.28 26.67 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.416 0.627 . . . . 61.43 111.714 -176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.18 153.35 90.51 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 114.203 -1.362 . . . . 71.45 109.417 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.446 ' HB3' HD12 ' A' ' 16' ' ' ILE . 53.5 Cg_endo -64.47 142.19 77.23 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.783 2.322 . . . . 71.34 114.737 -168.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.08 84.11 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 107.54 -1.282 . . . . 62.33 107.54 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.409 HD21 HG23 ' A' ' 105' ' ' ILE . 8.9 m120 -86.1 99.99 11.88 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.48 0.657 . . . . 74.22 110.456 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 N--CA 1.473 0.712 0 CA-C-N 114.421 -1.263 . . . . 74.23 110.873 -178.459 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.4 m . . . . . 0 C--O 1.238 0.467 0 N-CA-C 108.712 -0.848 . . . . 75.21 108.712 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -144.68 127.12 15.92 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.576 -1.268 . . . . 54.4 107.576 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 58.5 mt-30 -132.89 143.63 49.64 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.099 0.96 . . . . 63.44 108.68 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' B' ' 132' ' ' ASN . 38.5 mt -103.41 115.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.622 -0.881 . . . . 72.41 108.622 170.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -83.74 -44.33 14.55 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 110.152 -0.314 . . . . 70.34 110.152 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -165.11 141.1 5.51 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 111.52 0.193 . . . . 73.33 111.52 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 38.7 mm -120.47 126.05 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.309 -0.997 . . . . 73.51 108.309 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' C' ' 28' ' ' ALA . 2.0 p90 -167.86 154.83 8.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.627 0.771 . . . . 72.44 111.534 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.44 HG21 HD11 ' D' ' 21' ' ' ILE . 81.3 p -79.55 118.87 21.79 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.401 -0.818 . . . . 63.33 110.604 -176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.37 -23.0 30.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.515 -0.766 . . . . 65.24 110.862 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.614 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 35.1 t70 -160.04 132.1 6.25 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.852 0.72 . . . . 65.15 109.696 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.591 HD13 ' HE3' ' C' ' 117' ' ' MET . 96.6 mt -132.48 135.73 57.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.089 -1.449 . . . . 73.22 107.089 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -138.61 132.15 30.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.574 -1.269 . . . . 70.14 107.574 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.545 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -145.14 112.17 5.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.923 -1.51 . . . . 65.2 106.923 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.9 112.19 18.01 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.691 0.796 . . . . 51.13 108.983 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.1 82.47 2.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 107.843 -1.169 . . . . 63.22 107.843 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.38 -30.5 5.24 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.424 2.083 . . . . 75.3 112.479 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.43 ' O ' HG23 ' D' ' 31' ' ' VAL . 88.8 m-20 -108.29 38.91 2.09 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.679 1.192 . . . . 72.3 108.962 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.544 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.19 -53.39 65.49 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 115.147 1.536 . . . . 70.3 115.147 -169.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.76 -7.21 14.53 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 122.191 1.818 . . . . 70.34 112.364 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -84.4 -24.67 29.53 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.372 1.469 . . . . 72.32 109.055 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 27' ' ' ASN . 13.4 t -66.25 -29.68 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.946 0.898 . . . . 72.11 110.135 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.555 ' HD1' HH11 ' C' ' 15' ' ' ARG . 91.7 t80 -51.25 -31.75 22.04 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.434 -0.803 . . . . 64.12 112.599 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -75.42 -17.51 60.16 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.777 0.831 . . . . 74.21 112.42 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' D' ' 71' ' ' GLU . 92.3 mttt -122.55 110.79 16.01 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.337 0.655 . . . . 73.33 110.583 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -110.82 81.75 1.48 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.243 1.017 . . . . 63.32 110.672 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -150.81 174.96 12.47 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.203 -0.908 . . . . 73.41 109.143 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -71.73 117.58 58.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 119.494 -0.289 . . . . 73.3 110.278 -178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.466 ' HG3' HD21 ' D' ' 68' ' ' LEU . 77.6 Cg_exo -55.65 130.5 40.78 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.993 2.462 . . . . 71.15 112.411 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.35 122.27 15.27 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.755 -0.831 . . . . 51.12 108.755 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -98.45 112.08 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.108 0.563 . . . . 65.32 109.541 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 3.2 mppt? -99.32 120.05 38.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.984 -1.117 . . . . 73.44 107.984 170.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.06 121.18 39.67 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.092 -1.077 . . . . 75.41 108.092 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.471 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.3 t70 -119.4 135.61 54.66 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.837 -0.801 . . . . 75.34 108.837 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.44 HD11 HD21 ' D' ' 60' ' ' LEU . 29.1 tp -111.97 129.76 56.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.084 0.554 . . . . 74.35 109.852 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -139.12 152.42 47.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.335 1.054 . . . . 63.51 108.477 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -146.21 162.76 37.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.075 0.55 . . . . 73.54 110.295 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.36 147.66 27.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.334 1.054 . . . . 64.51 108.86 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 48.9 m -144.48 152.03 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.878 0.37 . . . . 70.05 111.061 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.1 p -163.13 125.99 2.7 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.303 1.041 . . . . 71.31 108.842 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -72.86 123.84 24.21 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.834 0.454 . . . . 63.23 111.106 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.8 mt -96.53 -29.41 13.9 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.536 0.734 . . . . 74.04 111.503 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.4 -172.49 3.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.507 0.723 . . . . 71.04 110.592 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -64.47 116.62 6.3 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.971 -0.559 . . . . 72.2 110.025 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 69.51 0.43 2.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.925 1.29 . . . . 65.33 112.365 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.95 131.56 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.844 0.857 . . . . 64.55 110.117 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.47 154.2 42.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.332 0.653 . . . . 65.31 109.734 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.603 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -95.16 118.56 32.15 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.643 0.777 . . . . 75.45 109.39 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.9 119.21 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.519 -0.919 . . . . 65.34 108.519 169.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.8 t -98.11 138.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.949 -1.13 . . . . 75.21 107.949 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.561 HD13 HG23 ' D' ' 62' ' ' VAL . 0.3 OUTLIER -125.55 116.19 21.37 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.973 -0.751 . . . . 72.3 108.973 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.1 ttm180 -97.75 110.52 23.07 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.613 -0.722 . . . . 74.45 109.244 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.561 HG23 HD13 ' D' ' 60' ' ' LEU . 65.8 t -99.59 123.28 52.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.061 -1.088 . . . . 75.44 108.061 170.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.491 HG23 ' HG3' ' D' ' 77' ' ' GLU . 70.4 m -122.29 130.42 53.14 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.324 -0.853 . . . . 45.25 110.145 -172.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.53 HG21 HG21 ' D' ' 114' ' ' ILE . 37.6 t -120.67 101.58 10.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 113.699 -1.591 . . . . 40.15 107.281 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 11.2 m -94.3 111.36 23.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.206 -1.405 . . . . 61.22 107.206 169.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.65 135.09 54.53 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.088 -0.708 . . . . 73.43 109.088 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.9 p -139.1 148.92 43.94 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.807 -0.633 . . . . 55.3 110.022 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.466 HD21 ' HG3' ' D' ' 38' ' ' PRO . 85.9 mt -109.96 92.06 3.9 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.376 -0.601 . . . . 74.51 109.376 169.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.27 -121.23 20.4 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.421 -0.809 . . . . 31.41 111.893 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -84.4 27.77 0.68 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.957 0.903 . . . . 62.04 112.127 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.537 ' HB2' ' NZ ' ' D' ' 34' ' ' LYS . 5.2 tp10 -135.63 135.64 40.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 118.889 -0.577 . . . . 61.42 110.048 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -73.85 113.17 10.7 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.905 -0.776 . . . . 54.42 108.905 167.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -76.23 -61.46 1.94 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.173 -0.677 . . . . 63.33 109.173 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.57 154.23 15.99 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.361 -1.29 . . . . 63.11 110.016 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.13 149.52 29.21 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.111 -1.44 . . . . 63.02 107.111 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.2 t -155.35 103.38 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.547 -0.538 . . . . 71.11 109.547 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' D' ' 63' ' ' THR . 5.2 mp0 -121.96 121.71 37.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.133 0.973 . . . . 64.14 108.667 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.43 114.18 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.758 -0.46 . . . . 73.04 109.758 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.78 91.25 8.55 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.639 0.776 . . . . 70.11 109.268 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -79.17 98.56 6.63 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.962 -1.017 . . . . 74.35 108.962 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.05 142.92 20.14 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.079 -0.808 . . . . 14.53 111.079 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.16 130.12 3.61 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.689 -0.964 . . . . 62.41 110.689 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.73 128.72 42.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.502 -0.925 . . . . 70.1 108.502 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -134.06 148.38 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.091 0.556 . . . . 73.03 110.489 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 46.1 m -104.94 105.78 15.98 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.566 -0.902 . . . . 74.42 108.566 170.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.1 pt -109.57 145.38 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 118.488 0.585 . . . . 63.14 110.634 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.15 169.3 21.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.697 -1.138 . . . . 62.22 109.43 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.67 23.8 77.26 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 121.576 -0.345 . . . . 72.1 112.584 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.434 HD13 ' HB2' ' D' ' 94' ' ' MET . 2.2 pp -124.46 146.16 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.749 0.82 . . . . 32.12 110.755 -172.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.29 171.49 17.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 75.51 110.177 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.98 -134.48 31.69 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.941 0.776 . . . . 54.34 114.73 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -81.04 -13.25 58.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.269 0.628 . . . . 74.13 110.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -67.9 -36.69 80.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.235 0.614 . . . . 70.42 110.468 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.434 ' HB2' HD13 ' D' ' 89' ' ' ILE . 2.0 ppp? -70.45 -35.08 73.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.455 -0.572 . . . . 74.1 109.455 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.85 76.02 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 115.038 -0.983 . . . . 54.32 111.285 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -72.28 -37.68 68.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.25 0.62 . . . . 51.41 110.974 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.85 -38.96 76.63 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.043 0.537 . . . . 72.03 110.811 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.67 -45.86 20.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.662 0.785 . . . . 64.21 110.416 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.61 -26.9 40.72 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.626 -0.715 . . . . 70.23 114.009 -168.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.93 -51.02 2.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.142 0.471 . . . . 73.24 111.903 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -73.74 -47.29 40.32 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.282 0.475 . . . . 74.22 112.282 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 73.6 m -60.5 -47.84 95.18 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 118.976 -0.535 . . . . 61.4 111.274 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.8 Cg_exo -55.32 -37.0 94.89 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.447 2.098 . . . . 74.21 114.043 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.98 -29.61 70.54 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.099 0.56 . . . . 71.01 111.02 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 44.6 mm -75.34 -46.3 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.351 0.66 . . . . 70.11 110.409 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.81 -17.27 59.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.202 -0.908 . . . . 71.51 111.822 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.0 -47.6 52.33 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.256 1.022 . . . . 71.54 112.859 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 83.2 Cg_exo -49.42 -44.98 32.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.565 2.177 . . . . 73.13 113.945 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -73.71 -37.08 65.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.319 0.648 . . . . 74.31 111.918 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' D' ' 62' ' ' VAL . . . -64.36 -53.38 49.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.212 0.605 . . . . 74.34 110.764 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.602 HH12 ' HB3' ' D' ' 130' ' ' PRO . 8.7 ptt180 -67.13 -30.85 70.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.703 -1.135 . . . . 64.54 110.898 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.419 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.3 tm-20 -67.82 -45.71 73.92 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.09 0.868 . . . . 75.33 110.446 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.696 0.622 . . . . 22.24 110.4 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' D' ' 64' ' ' VAL . 96.5 mt -58.25 -54.83 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 114.889 -1.051 . . . . 74.41 110.562 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.611 HG23 ' HG3' ' D' ' 125' ' ' GLN . 27.6 m -51.2 -48.24 62.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.878 1.271 . . . . 73.34 111.145 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -66.93 -44.78 79.79 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.464 -1.244 . . . . 62.54 110.176 -173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.5 mtm -65.47 -34.03 77.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.903 0.481 . . . . 73.14 111.405 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.657 HG13 ' HB2' ' D' ' 123' ' ' PHE . 56.5 t -64.91 -49.63 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.597 0.759 . . . . 74.33 110.454 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 90.4 p -69.29 -31.6 70.21 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.959 0.504 . . . . 65.53 111.066 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -70.43 -31.46 68.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.929 0.892 . . . . 75.12 109.945 173.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.85 64.13 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.536 -0.756 . . . . 73.31 113.202 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 125' ' ' GLN . 66.8 p 56.92 28.18 14.22 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.866 1.667 . . . . 75.35 113.112 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.657 ' HB2' HG13 ' D' ' 118' ' ' VAL . 20.4 m-85 -100.9 164.36 16.25 Favored Pre-proline 0 CA--C 1.561 1.396 0 N-CA-C 108.474 -0.936 . . . . 73.44 108.474 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 63.2 Cg_endo -68.77 133.53 27.69 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.311 2.007 . . . . 72.21 112.196 -175.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' D' ' 115' ' ' THR . 57.2 tt0 -56.58 129.91 42.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.688 0.795 . . . . 64.23 111.227 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -121.99 97.99 5.74 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.031 0.443 . . . . 64.25 110.121 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -99.43 105.05 16.95 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.218 -1.401 . . . . 72.43 107.218 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.82 115.0 12.75 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.888 -0.412 . . . . 70.31 109.888 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.11 86.83 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.543 0.737 . . . . 64.31 111.05 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.602 ' HB3' HH12 ' D' ' 111' ' ' ARG . 73.1 Cg_endo -79.82 108.72 2.3 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.581 2.187 . . . . 75.04 109.997 -174.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -104.26 113.26 40.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t30 . . . . . 0 C--O 1.241 0.611 0 N-CA-C 106.731 -1.581 . . . . 52.34 106.731 169.01 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.235 0.311 0 N-CA-C 108.212 -1.033 . . . . 65.41 108.212 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.412 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 60.3 t80 -135.04 135.91 41.67 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.287 -1.005 . . . . 63.4 108.287 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.48 135.7 15.79 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 116.134 -0.485 . . . . 61.34 110.2 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.454 ' HA ' ' HD2' ' A' ' 84' ' ' PHE . 3.7 mp -79.82 117.73 26.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.667 -0.864 . . . . 55.23 108.667 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -89.27 -39.65 13.35 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.155 0.582 . . . . 72.34 109.701 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -172.71 123.78 0.45 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.307 0.243 . . . . 74.1 111.078 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.82 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 85.6 mt -108.17 132.73 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 123.611 0.764 . . . . 74.31 109.208 173.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.702 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 9.3 p90 -167.73 170.74 10.65 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.047 0.939 . . . . 63.15 110.13 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -88.46 134.86 33.73 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.694 -0.854 . . . . 75.24 108.694 171.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 46.9 mtpt -94.44 -43.32 8.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.927 -0.768 . . . . 62.21 108.927 170.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 28.1 t70 -137.54 129.5 28.91 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.709 -1.132 . . . . 74.21 109.604 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -124.36 136.15 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.416 -1.328 . . . . 61.54 107.416 170.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -145.89 112.75 6.03 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 123.519 0.512 . . . . 62.31 109.725 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.567 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 77.7 t80 -114.23 111.78 22.08 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 106.609 -1.626 . . . . 65.01 106.609 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.76 110.19 16.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.976 -0.75 . . . . 75.01 108.976 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.47 93.04 7.75 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.566 -1.272 . . . . 70.14 107.566 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.46 -41.01 7.02 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.457 2.105 . . . . 65.1 111.182 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 78.0 m-20 -100.56 37.51 1.68 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.651 -1.159 . . . . 75.22 109.303 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.34 73.2 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.131 -0.938 . . . . 74.44 113.43 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.33 -27.93 10.92 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 121.541 1.586 . . . . 71.04 112.924 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 14.3 t60 -67.58 -26.26 66.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.761 1.224 . . . . 62.34 112.151 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 HD11 ' A' ' 68' ' ' LEU . 12.0 p -55.75 -30.18 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.517 1.127 . . . . 74.14 112.908 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.6 -34.46 75.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.892 0.877 . . . . 73.23 111.21 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -69.64 -32.03 70.47 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.282 1.033 . . . . 75.21 110.267 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -79.14 162.32 25.88 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.683 -1.144 . . . . 74.45 111.06 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.1 143.08 30.79 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 108.316 -0.994 . . . . 74.35 108.316 164.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -83.68 83.88 7.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.756 0.789 . . . . 75.02 110.038 -177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.67 69.77 16.97 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.416 1.086 . . . . 73.42 108.318 176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.27 110.02 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.534 2.156 . . . . 73.25 112.704 -170.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -94.11 114.4 26.53 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.634 -1.247 . . . . 74.02 107.634 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 65' ' ' THR . 22.8 m -87.63 118.25 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.066 -0.97 . . . . 63.03 110.877 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 64.1 tttm -85.33 116.74 23.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.198 -0.91 . . . . 64.13 108.753 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.34 123.51 41.19 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.863 -0.608 . . . . 51.44 110.206 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.537 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.1 m-20 -115.32 122.92 47.37 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.061 -1.089 . . . . 71.41 108.061 170.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.498 HD23 ' HE2' ' A' ' 133' ' ' PHE . 34.1 tp -124.21 121.23 34.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.033 -0.729 . . . . 71.43 109.033 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.15 146.06 34.89 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.893 0.877 . . . . 73.34 110.017 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -109.29 150.11 28.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.405 0.682 . . . . 73.33 109.811 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.28 154.17 49.04 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.767 1.227 . . . . 54.34 108.085 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -130.55 152.79 49.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.86 0.464 . . . . 70.33 110.454 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.9 t -154.66 119.38 4.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.213 1.005 . . . . 62.42 108.537 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -91.47 118.67 30.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.183 -1.043 . . . . 62.34 108.183 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 57' ' ' GLU . 40.5 mt -93.24 -33.27 14.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.751 0.82 . . . . 71.52 110.129 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.97 -169.97 1.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.307 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.68 106.31 0.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.898 1.279 . . . . 72.34 109.964 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.96 8.18 6.3 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.541 1.136 . . . . 74.44 112.515 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.36 19.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.736 -1.209 . . . . 71.43 107.736 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -122.32 123.32 41.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.442 -0.799 . . . . 71.15 109.592 -175.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.9 tt0 -93.64 128.07 39.64 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.878 -1.055 . . . . 64.43 108.796 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.8 t -101.3 124.86 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.75 . . . . 74.34 106.276 166.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.9 t -101.83 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.725 -0.843 . . . . 45.02 108.725 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -102.85 107.05 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.127 -1.064 . . . . 63.54 108.127 -175.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -103.68 110.53 22.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.952 0.901 . . . . 74.1 109.984 -173.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.01 132.07 66.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.97 -1.013 . . . . 75.23 108.729 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.1 m -121.92 123.22 41.19 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.533 -0.543 . . . . 75.51 109.533 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 114' ' ' ILE . 52.4 t -116.69 107.23 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.727 1.211 . . . . 65.44 108.453 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.8 m -102.2 149.81 23.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.132 -1.062 . . . . 44.25 108.132 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.19 122.67 30.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.623 -0.51 . . . . 64.31 109.623 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -117.74 126.61 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.238 0.615 . . . . 75.1 110.39 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD11 HG23 ' A' ' 31' ' ' VAL . 28.8 mt -92.92 82.42 4.66 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.791 -1.559 . . . . 65.51 106.791 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -83.63 1.0 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.177 -1.169 . . . . 50.53 110.177 -167.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.93 -18.2 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.472 1.109 . . . . 75.45 110.321 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.44 108.86 12.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.41 1.084 . . . . 73.43 110.505 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 m -66.16 119.15 10.95 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.967 0.348 . . . . 72.43 111.106 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.09 -50.89 17.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.184 0.994 . . . . 64.43 109.336 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -159.9 173.15 16.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 113.607 -1.633 . . . . 71.23 110.174 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 76' ' ' CYS . 19.0 tp -141.1 141.2 34.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.737 1.215 . . . . 60.4 107.811 173.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.567 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 36.2 m -132.25 141.51 49.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.854 0.862 . . . . 71.13 108.877 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.99 121.39 9.65 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.568 -0.901 . . . . 70.13 108.568 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.49 112.38 29.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.524 0.73 . . . . 74.43 109.542 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -88.73 87.2 7.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.536 -1.211 . . . . 71.11 109.086 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -77.15 95.55 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.716 -1.129 . . . . 75.25 109.29 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.82 142.95 19.56 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.912 -0.475 . . . . 65.43 111.912 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.43 122.66 2.33 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 110.865 -0.894 . . . . 72.34 110.865 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.3 mt -79.76 131.0 35.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.726 -1.212 . . . . 62.02 107.726 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD2' ' HA ' ' A' ' 13' ' ' ILE . 39.2 m-85 -135.9 138.34 42.32 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.197 0.599 . . . . 75.41 109.577 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.9 m -87.62 121.46 30.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 63.51 108.94 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.37 136.09 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.57 0.748 . . . . 72.23 111.26 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.27 174.31 3.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.711 1.204 . . . . 54.5 110.155 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.41 9.62 86.73 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-N 116.509 -0.314 . . . . 54.32 113.833 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 94' ' ' MET . 1.8 pp -120.22 149.4 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.311 1.044 . . . . 64.31 111.02 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.8 174.55 10.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.597 0.759 . . . . 74.33 110.634 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.43 -140.43 40.12 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 115.683 1.033 . . . . 75.24 115.683 167.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -78.63 -12.04 60.0 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.308 1.043 . . . . 71.53 111.064 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -36.9 79.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.752 0.821 . . . . 63.44 110.091 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.519 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 26.2 ptm -75.69 -20.15 58.61 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.397 -0.365 . . . . 74.22 111.191 174.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -23.8 66.61 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.781 0.432 . . . . 73.0 111.553 177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -62.86 -45.0 94.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 72.22 110.522 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 41.9 t -68.85 -64.52 0.85 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.704 0.802 . . . . 72.52 111.601 -173.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.58 -26.1 61.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.557 0.343 . . . . 74.33 111.688 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.05 -34.15 11.21 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 114.659 0.624 . . . . 52.22 114.659 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.99 -39.25 0.41 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.96 0.88 . . . . 74.42 113.067 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.1 t80 -69.8 -58.96 3.26 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.844 0.458 . . . . 75.32 111.632 -174.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -67.19 -37.46 13.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.748 0.819 . . . . 75.42 112.66 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.17 -43.56 47.85 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.124 1.883 . . . . 75.13 113.309 162.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.3 -25.43 62.43 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.17 0.588 . . . . 75.5 111.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.0 mm -62.33 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.595 0.712 . . . . 74.44 109.176 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.566 HD21 ' HA3' ' A' ' 82' ' ' GLY . 45.5 mt -81.12 -18.74 45.4 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.584 -1.189 . . . . 52.43 112.061 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.481 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 51.4 t80 -63.42 -42.54 74.7 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 113.966 1.098 . . . . 75.21 113.966 -171.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.514 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 73.6 Cg_exo -55.13 -33.19 83.06 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 122.101 1.867 . . . . 73.5 113.785 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.94 -40.14 24.99 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.265 -0.88 . . . . 73.43 111.317 -175.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.06 -41.14 82.42 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.457 0.303 . . . . 63.22 110.586 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.523 ' NH1' HG23 ' C' ' 105' ' ' ILE . 34.0 ttm180 -51.98 -55.72 18.67 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.528 1.142 . . . . 75.33 109.537 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.45 -42.17 99.27 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.676 1.235 . . . . 75.35 111.845 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.466 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.5 t -57.54 -50.21 73.82 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.967 0.792 . . . . 72.11 110.302 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.1 mt -62.63 -46.5 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.141 -0.936 . . . . 64.33 110.667 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' HE2' ' C' ' 109' ' ' TYR . 82.0 m -54.41 -44.49 72.41 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.253 1.021 . . . . 64.4 110.902 -176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.2 t -72.13 -34.81 68.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.547 -1.206 . . . . 73.22 111.035 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.9 mtp -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.516 0.726 . . . . 65.12 111.193 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -59.97 -52.08 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.008 0.923 . . . . 75.54 110.064 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 71.1 p -68.04 -26.71 66.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.17 -0.923 . . . . 75.12 112.151 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.9 ttm-85 -72.81 -25.49 61.16 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.877 0.871 . . . . 60.3 109.985 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 22.16 12.03 Favored Glycine 0 C--N 1.358 1.791 0 CA-C-N 116.027 -0.533 . . . . 62.11 113.06 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t 55.96 27.86 11.82 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 127.154 2.182 . . . . 74.33 113.664 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 119' ' ' SER . 36.1 m-85 -98.48 153.15 38.11 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.398 0.679 . . . . 63.23 110.191 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.74 118.94 5.78 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.501 2.134 . . . . 74.1 111.14 166.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 11.9 pt20 -64.23 150.35 46.09 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.391 0.676 . . . . 43.21 112.345 -171.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -109.21 101.24 10.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 109.029 -0.73 . . . . 62.35 109.029 -171.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -98.2 84.7 3.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.735 -0.839 . . . . 71.14 108.735 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.481 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -59.43 139.95 56.61 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.875 0.87 . . . . 74.11 110.017 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' HD13 ' A' ' 128' ' ' LEU . . . -60.78 132.71 91.74 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.316 0.647 . . . . 62.14 111.852 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.456 ' HB3' ' NH2' ' A' ' 111' ' ' ARG . 39.8 Cg_endo -72.07 101.73 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.396 2.064 . . . . 73.21 111.483 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -101.03 111.52 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 122.389 1.09 . . . . 73.34 110.711 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -99.16 70.03 1.75 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.965 -1.471 . . . . 70.14 108.526 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.498 ' HE2' HD23 ' A' ' 44' ' ' LEU . 21.7 m-85 . . . . . 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 75.33 112.289 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m . . . . . 0 C--O 1.242 0.688 0 N-CA-C 107.8 -1.185 . . . . 71.33 107.8 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -137.21 140.48 41.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.179 -0.674 . . . . 71.44 109.179 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 23.9 tp60 -142.68 115.46 8.68 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.171 -0.677 . . . . 51.41 109.171 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.409 HD11 HG13 ' B' ' 16' ' ' ILE . 6.8 tp -68.88 127.6 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.953 -0.758 . . . . 63.22 108.953 171.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.78 -45.55 3.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.873 0.469 . . . . 63.23 110.332 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -167.09 143.74 4.48 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.329 0.393 . . . . 63.13 110.689 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.409 HG13 HD11 ' B' ' 13' ' ' ILE . 92.8 mt -120.04 143.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.442 -1.318 . . . . 73.5 107.442 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.445 ' HE1' HG13 ' B' ' 83' ' ' ILE . 22.1 p90 -173.19 156.27 3.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.167 0.508 . . . . 73.51 111.461 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -84.1 128.98 34.91 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.93 -0.767 . . . . 63.11 108.93 169.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.5 mtpt -90.41 -43.49 10.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.496 0.718 . . . . 75.3 109.738 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.0 t70 -148.19 142.44 26.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.316 -0.856 . . . . 74.34 111.323 -172.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 41.3 mm -128.27 135.36 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 124.768 1.227 . . . . 63.12 108.878 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.8 t -130.39 128.83 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.611 -1.177 . . . . 75.11 108.067 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 72.5 t80 -150.08 110.33 4.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.793 -1.558 . . . . 75.22 106.793 171.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.41 113.93 18.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.979 -1.119 . . . . 71.03 107.979 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.07 89.64 5.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.703 0.801 . . . . 73.24 108.903 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 44.7 Cg_endo -63.57 -38.28 42.48 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.25 2.634 . . . . 74.1 112.844 -171.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.33 30.69 6.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.302 1.041 . . . . 75.02 109.559 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.702 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.4 -50.02 51.0 Favored Pre-proline 0 CA--C 1.566 1.57 0 N-CA-C 114.856 1.428 . . . . 32.43 114.856 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.9 Cg_endo -77.68 -23.28 9.8 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.871 1.714 . . . . 43.32 112.738 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.464 ' HA ' ' NE2' ' B' ' 33' ' ' GLN . 77.0 m80 -78.38 -8.29 58.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.568 0.747 . . . . 75.35 111.437 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.01 -24.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.074 0.95 . . . . 71.33 111.027 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -66.13 -43.49 86.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.665 0.386 . . . . 71.12 110.975 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' B' ' 30' ' ' HIS . 2.1 mp0 -72.54 -36.59 68.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.709 0.804 . . . . 62.34 110.049 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.38 76.6 10.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.651 0.739 . . . . 72.11 109.786 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.79 79.34 6.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.595 -1.184 . . . . 55.52 110.641 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -173.29 156.95 3.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.142 0.977 . . . . 72.02 109.482 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -58.54 128.38 83.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.881 0.872 . . . . 75.25 110.699 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -66.01 152.6 80.91 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.19 1.26 . . . . 73.34 110.281 168.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.27 101.66 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.026 -1.101 . . . . 74.12 108.026 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.594 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.2 t -84.58 123.21 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.143 -1.428 . . . . 42.34 107.143 -174.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 64' ' ' VAL . 1.5 tmtp? -145.83 113.97 6.59 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.629 -0.508 . . . . 61.45 109.629 -174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.71 148.48 23.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.646 0.779 . . . . 74.5 109.157 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.39 150.33 43.76 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.13 -1.063 . . . . 53.14 108.13 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.401 HD12 HG11 ' B' ' 131' ' ' VAL . 5.5 tt -109.92 125.73 53.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.351 0.66 . . . . 74.44 109.257 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -134.46 136.19 43.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.884 -1.154 . . . . 73.24 107.884 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -108.41 146.16 33.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.274 0.559 . . . . 62.14 109.957 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.75 159.17 42.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.5 1.12 . . . . 71.4 108.405 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.519 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 81.2 p -143.54 162.35 36.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.945 0.402 . . . . 43.22 110.94 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -160.48 154.36 22.75 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.781 1.233 . . . . 75.0 108.91 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -121.76 135.07 54.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.166 0.587 . . . . 75.15 109.657 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.5 mt -100.66 -47.9 4.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.474 0.71 . . . . 75.24 109.517 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.06 -175.39 5.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.99 -1.005 . . . . 60.21 110.295 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -71.83 130.11 40.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.736 -1.12 . . . . 70.13 109.072 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 66.07 -8.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.47 1.508 . . . . 64.32 112.743 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.02 94.18 2.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 107.942 -1.133 . . . . 63.43 107.942 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.519 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 2.8 t80 -98.12 165.32 11.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.701 -1.136 . . . . 74.31 109.134 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.8 106.01 4.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.548 -1.278 . . . . 70.02 107.548 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 56.7 t -97.94 131.5 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.205 0.602 . . . . 71.24 109.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 34.7 t -108.92 125.28 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.716 0.806 . . . . 53.14 109.726 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.455 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.25 130.95 40.31 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.511 -1.292 . . . . 64.4 107.511 172.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -121.26 106.74 11.77 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.681 . . . . 71.32 109.497 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.1 124.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.537 -0.912 . . . . 75.42 108.537 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.1 m -120.35 146.91 45.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.398 . . . . 63.15 110.931 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 55.1 t -116.88 120.1 64.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 124.644 1.177 . . . . 75.51 109.577 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.3 m -99.24 127.93 45.29 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.981 -1.488 . . . . 74.31 106.981 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.59 132.43 18.03 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.582 -0.896 . . . . 72.14 108.582 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -148.55 139.31 22.88 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.587 0.554 . . . . 51.44 111.803 -170.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 51.2 mt -100.24 100.28 11.08 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.054 1.342 . . . . 74.44 109.587 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.66 -111.18 3.61 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.801 -0.52 . . . . 73.45 111.801 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -108.16 4.43 24.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.566 0.747 . . . . 43.34 111.536 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -121.07 160.31 23.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.693 0.797 . . . . 73.43 109.843 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.9 m -78.74 136.99 37.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.738 0.415 . . . . 65.33 110.515 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -82.33 -61.42 1.9 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.412 1.101 . . . . 65.42 109.024 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' B' ' 76' ' ' CYS . 1.2 p90 -154.17 171.79 18.61 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 112.892 -1.958 . . . . 72.23 107.623 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -136.57 110.17 8.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.907 -1.886 . . . . 74.04 105.907 167.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.484 ' HB2' ' HD1' ' B' ' 23' ' ' PHE . 1.8 t -113.76 160.22 18.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.094 -0.503 . . . . 71.31 110.292 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.2 tt0 -164.98 143.73 6.59 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.653 -1.24 . . . . 75.24 107.653 -170.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.16 144.01 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.786 0.834 . . . . 73.13 108.871 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.69 92.53 3.73 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.748 0.819 . . . . 74.23 108.911 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -88.54 100.73 13.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.736 -1.12 . . . . 74.24 108.809 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.39 174.52 33.74 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 111.838 -0.505 . . . . 74.02 111.838 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.29 136.5 4.07 Favored Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.729 -0.548 . . . . 74.34 111.729 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.445 HG13 ' HE1' ' B' ' 17' ' ' TYR . 34.5 mt -86.15 124.88 40.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.445 -0.946 . . . . 72.23 108.445 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -138.61 131.53 29.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.976 -1.12 . . . . 74.01 107.976 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 75.1 m -91.03 107.37 19.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.716 -0.476 . . . . 75.12 109.716 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.505 ' HB ' HD11 ' B' ' 89' ' ' ILE . 24.7 pt -106.24 142.85 18.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.358 -0.837 . . . . 70.41 110.817 -176.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.38 166.13 33.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.313 1.045 . . . . 52.11 108.739 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.63 -53.33 4.84 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.924 -0.375 . . . . 53.3 113.523 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.5 pp -51.98 126.07 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.036 0.934 . . . . 73.11 112.474 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.447 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 10.2 pt-20 -159.36 154.36 24.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 73.01 110.768 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.33 -122.93 22.19 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.578 -0.737 . . . . 74.35 112.188 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -68.52 -31.27 70.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.66 0.784 . . . . 72.03 110.936 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -72.8 -34.85 67.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.642 0.777 . . . . 74.34 110.763 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.447 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 54.1 ttm -62.79 -49.23 75.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.527 -0.761 . . . . 75.13 109.36 171.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.0 -28.79 69.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.697 0.799 . . . . 65.41 112.071 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -69.83 -44.73 69.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 74.33 110.034 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 45.5 t -63.91 -59.47 4.47 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.753 0.821 . . . . 62.44 111.535 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.449 HD12 ' N ' ' B' ' 99' ' ' GLY . 4.2 pp -71.12 -28.66 64.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.475 0.71 . . . . 75.13 112.486 -175.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.449 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -94.42 -38.41 5.04 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.478 -0.328 . . . . 22.12 113.521 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 104' ' ' ASN . . . -125.9 -45.17 1.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 118.984 -0.531 . . . . 52.41 112.223 -171.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.454 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 93.0 t80 -71.04 -63.86 1.02 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.17 0.441 . . . . 74.53 111.819 -169.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.46 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 58.1 m -58.32 -45.99 99.67 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.777 -0.63 . . . . 73.13 111.1 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.3 Cg_exo -54.04 -38.91 87.15 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.314 2.009 . . . . 65.22 114.228 167.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 14.1 t-20 -68.52 -30.14 68.88 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.576 0.626 . . . . 64.12 111.49 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.8 -50.18 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.528 0.68 . . . . 74.24 109.206 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.41 -13.5 59.91 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 113.841 -1.527 . . . . 74.42 111.963 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 55.2 t80 -67.56 -49.3 41.38 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 117.821 -1.085 . . . . 70.5 113.792 -166.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.21 -32.42 90.63 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.45 1.433 . . . . 71.45 112.231 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -65.23 -49.85 68.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 71.3 110.531 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.55 99.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.873 0.869 . . . . 73.14 111.15 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -61.28 -49.14 78.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.53 1.532 . . . . 73.51 111.265 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -36.85 77.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.512 -0.551 . . . . 74.42 109.512 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 37.9 t -62.18 -39.27 92.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.326 0.65 . . . . 73.41 112.217 -178.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mt -63.51 -51.84 65.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.716 -0.476 . . . . 63.23 109.716 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.9 m -61.52 -24.42 66.61 Favored 'General case' 0 CA--C 1.561 1.371 0 O-C-N 124.31 1.006 . . . . 74.12 111.438 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.4 t -69.74 -58.59 3.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.971 0.909 . . . . 64.15 109.884 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.483 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.4 mmt -65.9 -28.08 68.68 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.309 0.576 . . . . 71.43 111.477 -176.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -52.35 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.726 1.61 . . . . 65.41 109.548 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 96.7 p -65.97 -31.6 72.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.015 0.526 . . . . 71.51 111.007 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 79.8 mtt-85 -62.17 -39.85 94.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.406 0.682 . . . . 65.24 110.721 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 9.21 71.15 Favored Glycine 0 C--N 1.353 1.475 0 O-C-N 123.349 0.406 . . . . 62.04 113.489 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p 58.95 30.7 20.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.406 1.882 . . . . 71.41 112.362 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.84 161.53 35.6 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.749 1.22 . . . . 65.3 110.899 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.594 ' HB2' HG21 ' B' ' 40' ' ' VAL . 14.8 Cg_exo -74.89 145.46 31.94 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 124.157 3.238 . . . . 73.22 115.46 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.485 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.4 OUTLIER -67.41 143.13 56.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.25 1.42 . . . . 75.23 111.936 177.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.28 113.73 4.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.95 -1.13 . . . . 74.13 107.95 163.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -89.01 116.02 26.99 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.147 -1.057 . . . . 65.2 108.147 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 129' ' ' ALA . 2.3 tt -66.34 137.48 56.94 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.853 0.721 . . . . 74.44 110.063 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.475 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -55.11 152.89 13.5 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 126.138 1.775 . . . . 70.23 113.539 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.646 ' HG3' HD11 ' D' ' 16' ' ' ILE . 92.6 Cg_endo -69.72 103.98 1.24 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.807 2.338 . . . . 72.44 110.701 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.401 HG11 HD12 ' B' ' 44' ' ' LEU . 16.6 m -85.29 52.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 122.374 1.083 . . . . 61.24 111.096 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.46 71.27 4.92 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.402 -1.333 . . . . 73.43 107.402 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 t80 . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 114.308 -1.315 . . . . 73.5 110.974 -171.42 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m . . . . . 0 C--O 1.245 0.826 0 N-CA-C 110.49 -0.189 . . . . 43.23 110.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.501 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 44.0 t80 -125.31 118.64 26.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.953 -1.128 . . . . 74.55 107.953 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.442 ' NE2' ' HG2' ' C' ' 14' ' ' GLN . 11.9 tm0? -136.12 127.57 28.58 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 117.943 0.338 . . . . 75.34 110.235 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -89.15 129.03 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.224 -0.658 . . . . 73.31 109.224 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.442 ' HG2' ' NE2' ' C' ' 12' ' ' GLN . 5.5 mt-30 -99.99 -42.2 6.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.413 0.685 . . . . 73.14 110.42 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.498 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 60.6 ttt180 -174.6 128.19 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.153 0.581 . . . . 75.33 110.11 -168.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.85 142.1 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.961 -1.126 . . . . 64.41 107.961 172.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.556 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 26.2 p90 -177.84 161.37 1.59 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.824 0.703 . . . . 72.25 110.909 -175.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.464 HG21 ' SG ' ' C' ' 113' ' ' CYS . 64.9 p -80.41 120.32 24.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.609 0.764 . . . . 75.3 109.701 175.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.2 OUTLIER -74.02 -49.87 22.36 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.862 0.839 . . . . 74.32 108.964 178.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' C' ' 79' ' ' GLN . 25.0 m-20 -141.91 122.07 13.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.417 -1.72 . . . . 51.01 108.16 -174.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.2 mt -112.63 143.62 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 107.412 -1.329 . . . . 73.24 107.412 169.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.19 145.98 21.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.098 0.475 . . . . 53.34 110.214 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' D' ' 21' ' ' ILE . 91.8 t80 -148.21 123.99 10.56 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.562 -1.273 . . . . 55.11 107.562 176.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.06 115.35 24.11 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.14 0.976 . . . . 73.34 109.306 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.32 78.55 27.06 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 108.042 -1.095 . . . . 55.15 108.042 166.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.52 -15.34 24.73 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.373 2.049 . . . . 71.43 111.559 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -112.31 25.41 11.55 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 124.276 1.03 . . . . 51.25 109.945 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.33 77.01 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 114.435 1.272 . . . . 64.11 114.435 -172.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.69 -27.13 9.2 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 121.922 1.748 . . . . 71.21 112.45 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.84 -33.81 72.79 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.211 1.404 . . . . 71.41 111.395 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.705 HG13 HD11 ' C' ' 68' ' ' LEU . 53.5 t -79.9 -22.78 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 124.78 1.232 . . . . 73.34 111.487 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.65 -40.87 93.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.215 0.606 . . . . 70.34 111.78 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -101.97 45.69 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.415 0.686 . . . . 71.11 109.944 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.83 168.33 13.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.636 0.775 . . . . 62.12 110.019 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -74.08 115.41 13.52 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.032 -0.729 . . . . 72.33 109.032 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.472 ' HZ3' HG12 ' C' ' 31' ' ' VAL . 51.7 t-105 -85.25 93.94 8.8 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.659 0.784 . . . . 60.42 111.842 -167.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.49 73.39 20.5 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.148 0.979 . . . . 74.31 109.773 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 120.76 4.97 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.999 2.466 . . . . 61.13 112.408 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' C' ' 67' ' ' SER . 8.8 pt-20 -86.49 91.37 8.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.222 1.01 . . . . 63.42 109.346 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.755 ' HB ' HD13 ' C' ' 126' ' ' LEU . 26.2 m -82.03 89.01 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 122.532 1.158 . . . . 65.53 110.449 -173.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -109.61 142.04 41.29 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.691 -1.141 . . . . 73.3 109.507 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.416 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -129.85 160.78 32.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.895 0.478 . . . . 74.42 111.17 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -133.41 146.58 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.719 1.208 . . . . 62.1 109.053 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.578 ' HG ' HD21 ' C' ' 60' ' ' LEU . 6.0 tt -112.39 109.77 19.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.657 -1.238 . . . . 72.41 107.657 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 24.0 t70 -112.97 141.7 46.5 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.039 -1.097 . . . . 74.31 108.039 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 43.5 m -113.94 111.63 22.0 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.786 -0.82 . . . . 45.13 108.786 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.47 158.86 18.65 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.934 1.294 . . . . 71.12 108.971 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 p -165.69 154.48 11.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.789 0.436 . . . . 70.25 111.198 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -145.6 160.91 40.97 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.737 0.815 . . . . 52.4 109.172 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.68 121.83 35.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.494 -0.558 . . . . 54.34 109.494 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.615 HD11 HD12 ' C' ' 83' ' ' ILE . 61.6 mt -88.3 -53.06 4.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.561 -0.903 . . . . 63.21 108.561 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.16 -171.26 3.79 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.852 -1.067 . . . . 71.43 110.328 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.91 118.92 17.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.065 -0.97 . . . . 75.22 108.779 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 69.51 -0.55 2.55 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.805 1.242 . . . . 74.44 113.189 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.71 114.64 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.059 -0.719 . . . . 70.31 109.059 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -128.13 140.07 52.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.835 0.826 . . . . 75.04 110.839 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -85.24 109.3 18.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.373 -1.739 . . . . 64.44 108.138 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.32 115.97 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.714 -1.217 . . . . 74.41 107.714 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.6 114.07 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.695 0.798 . . . . 62.42 109.973 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.578 HD21 ' HG ' ' C' ' 44' ' ' LEU . 1.3 tt -86.58 106.44 17.56 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.97 -1.493 . . . . 73.0 106.97 169.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 45.0 mtp180 -87.61 106.51 18.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 74.1 109.738 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' C' ' 114' ' ' ILE . 8.2 t -100.19 120.63 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.85 -0.796 . . . . 64.24 108.85 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 86.0 m -104.35 145.42 30.28 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.454 -0.943 . . . . 73.22 108.454 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.545 HG21 HD21 ' C' ' 126' ' ' LEU . 46.8 t -136.88 127.56 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.846 0.858 . . . . 65.52 109.637 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.1 m -118.17 146.15 44.41 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.39 -0.967 . . . . 72.32 108.39 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.273 -1.01 . . . . 71.15 108.273 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 70.6 m -143.25 168.18 20.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.047 0.939 . . . . 63.54 110.058 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.705 HD11 HG13 ' C' ' 31' ' ' VAL . 13.2 mt -111.56 37.5 2.88 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.466 -1.309 . . . . 73.13 107.466 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 -79.13 0.29 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 109.473 -1.451 . . . . 71.53 109.473 -166.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -128.13 -28.02 2.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.153 0.981 . . . . 61.25 110.016 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.93 98.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.986 0.914 . . . . 65.01 109.499 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.8 m -65.4 117.1 7.44 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.156 0.503 . . . . 62.43 110.43 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.12 -50.33 28.86 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.406 -1.27 . . . . 73.32 109.026 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -161.87 166.09 26.79 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.36 -0.836 . . . . 61.12 111.103 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -122.65 146.75 47.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.831 -1.915 . . . . 75.3 105.831 167.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.614 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -152.6 153.35 33.19 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.37 -0.604 . . . . 74.2 109.37 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.25 128.52 6.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.834 0.453 . . . . 63.33 110.329 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.81 114.06 44.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.158 -1.053 . . . . 74.42 108.158 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' C' ' 20' ' ' ASP . 49.6 mt-30 -87.99 90.78 8.52 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.347 -1.353 . . . . 73.13 107.347 169.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.8 tp-100 -79.8 132.48 36.15 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.36 -0.836 . . . . 72.23 109.539 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -119.72 152.94 16.96 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 123.376 0.422 . . . . 73.02 112.767 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.12 126.64 2.22 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 109.321 -1.512 . . . . 71.33 109.321 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.615 HD12 HD11 ' C' ' 51' ' ' LEU . 19.3 mm -88.26 113.12 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 42.23 108.092 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -123.91 119.16 28.81 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.056 -1.09 . . . . 72.43 108.056 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -84.89 108.79 17.71 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.944 -0.761 . . . . 62.1 108.944 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.408 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.2 pp -112.19 132.41 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.871 0.869 . . . . 75.41 109.617 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.05 135.63 16.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.573 0.749 . . . . 42.53 109.962 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -19.62 27.87 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.352 0.408 . . . . 63.32 113.078 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.555 1.137 0 C-N-CA 124.726 1.21 . . . . 54.43 111.552 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 109.864 -0.421 . . . . 72.12 109.864 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.42 -42.98 99.85 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.995 0.918 . . . . 74.1 111.773 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.55 84.3 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.024 0.827 . . . . 72.53 111.393 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -84.51 -26.59 27.99 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.134 -0.484 . . . . 55.23 110.845 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -70.11 -61.07 1.92 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.009 0.524 . . . . 72.1 111.361 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.482 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.6 pp -88.35 -18.6 28.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.663 0.245 . . . . 61.41 111.663 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.12 -29.69 27.55 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.433 0.458 . . . . 43.34 113.199 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.74 -46.5 0.96 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.72 0.408 . . . . 60.14 112.095 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.461 ' O ' HG12 ' C' ' 105' ' ' ILE . 56.5 t80 -76.3 -39.32 54.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.542 0.737 . . . . 71.41 112.101 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.501 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 67.7 m -68.74 -46.79 33.81 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.919 -0.563 . . . . 72.52 110.032 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 58.1 Cg_exo -57.4 -34.31 97.73 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 121.884 1.723 . . . . 54.51 113.281 166.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.25 -35.87 82.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 123.412 0.685 . . . . 74.52 111.112 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.523 HG23 ' NH1' ' A' ' 111' ' ' ARG . 23.2 mm -62.99 -43.0 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.629 -0.714 . . . . 72.5 109.777 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.573 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.8 mt -81.49 -21.56 38.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.672 -1.149 . . . . 71.22 112.582 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.75 -48.53 92.79 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-O 117.695 -1.145 . . . . 71.24 113.557 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 -33.91 97.83 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.704 1.603 . . . . 75.43 112.484 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.466 ' HE2' HG21 ' A' ' 115' ' ' THR . 87.5 m-85 -64.17 -52.78 57.33 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.775 . . . . 73.45 110.872 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.09 -38.77 89.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.482 . . . . 72.53 111.218 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -54.68 -47.29 73.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.222 1.409 . . . . 72.01 111.126 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -77.57 -36.23 52.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 74.51 110.285 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.464 ' SG ' HG21 ' C' ' 18' ' ' THR . 41.6 t -67.02 -37.55 84.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.621 0.768 . . . . 70.14 112.046 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.614 HG23 ' SG ' ' C' ' 76' ' ' CYS . 74.7 mt -71.63 -47.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.225 -0.657 . . . . 62.31 109.225 175.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.6 m -54.82 -33.61 61.81 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 124.036 0.835 . . . . 62.41 111.355 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -61.64 -57.03 13.63 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.46 -0.791 . . . . 71.12 109.972 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.77 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.97 -43.2 63.44 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.817 1.247 . . . . 61.14 112.999 177.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 114' ' ' ILE . 77.2 t -64.56 -47.38 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.508 1.123 . . . . 65.52 110.701 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -31.96 73.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.885 -1.052 . . . . 75.34 111.037 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.3 mtt-85 -66.95 -34.48 77.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.401 0.68 . . . . 73.52 110.441 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.23 81.65 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 60.12 113.262 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 15.9 p 67.96 29.51 6.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.789 2.036 . . . . 71.32 112.819 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.87 153.23 37.85 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.123 0.969 . . . . 62.4 109.844 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.52 173.97 1.81 Allowed 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.872 3.048 . . . . 73.44 114.803 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 38.4 mm-40 -59.31 122.95 15.18 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 115.892 -0.594 . . . . 73.11 111.17 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.755 HD13 ' HB ' ' C' ' 40' ' ' VAL . 51.5 tp -107.06 17.21 23.3 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.4 -1.273 . . . . 71.35 109.198 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -87.37 84.02 7.25 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.111 -1.811 . . . . 74.54 106.111 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.42 153.47 21.42 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 113.437 -1.711 . . . . 61.14 108.91 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.83 133.26 14.46 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.253 1.021 . . . . 72.31 112.726 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.82 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 54.1 Cg_exo -43.46 129.47 6.61 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 124.525 3.483 . . . . 64.34 114.304 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.06 81.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.882 -0.785 . . . . 64.41 108.882 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.502 HD21 ' HB2' ' C' ' 130' ' ' PRO . 46.0 m-80 -83.47 98.38 9.5 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.705 -0.68 . . . . 63.14 109.321 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 CA--C 1.548 0.869 0 CA-C-N 115.182 -0.917 . . . . 74.53 110.872 -178.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.23 0.538 . . . . 73.13 111.022 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -145.03 103.38 3.87 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.527 -1.286 . . . . 64.02 107.527 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.99 139.88 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.681 1.192 . . . . 65.11 108.989 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 tt -105.28 135.23 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 70.42 109.871 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.74 -46.64 4.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -158.27 146.72 18.77 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.214 0.206 . . . . 73.31 110.475 -171.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.646 HD11 ' HG3' ' B' ' 130' ' ' PRO . 1.0 OUTLIER -140.01 134.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.634 -1.247 . . . . 73.43 107.634 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -159.97 156.74 27.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.515 0.726 . . . . 72.21 110.677 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 55.7 p -85.14 110.07 18.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.483 -0.932 . . . . 63.4 108.483 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -75.93 -26.6 57.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.127 0.489 . . . . 63.31 110.171 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.08 133.82 12.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.699 -1.137 . . . . 74.04 109.011 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.77 HD13 ' HE3' ' C' ' 117' ' ' MET . 92.9 mt -132.68 132.2 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.785 -1.561 . . . . 70.15 106.785 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -137.94 138.22 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.166 -0.679 . . . . 53.22 109.166 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -145.15 109.94 5.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.403 -2.073 . . . . 73.3 105.403 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.07 113.93 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.928 -0.767 . . . . 74.03 108.928 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.9 83.71 3.02 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.66 -23.61 22.72 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.377 2.051 . . . . 75.34 112.011 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -106.65 20.07 19.56 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 124.415 1.086 . . . . 74.03 110.256 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.5 -63.93 0.98 Allowed Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.963 1.468 . . . . 63.42 114.963 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.19 -17.8 11.54 Favored 'Trans proline' 0 C--N 1.387 2.572 0 CA-C-N 122.221 1.829 . . . . 61.43 113.331 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.79 -52.33 51.7 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.29 1.036 . . . . 45.53 110.319 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -84.15 -1.02 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 124.234 1.014 . . . . 74.23 110.463 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.498 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.8 t80 -54.57 -35.55 63.41 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.117 1.367 . . . . 71.54 111.161 165.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -70.9 -11.8 61.17 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.947 -1.024 . . . . 72.4 111.944 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.597 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 9.6 ttmt -106.78 114.05 27.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.364 0.665 . . . . 71.14 110.715 -173.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -101.56 56.58 0.83 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.147 1.379 . . . . 73.21 112.875 -167.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -125.82 173.97 8.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.609 0.764 . . . . 71.33 109.221 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -88.07 124.06 67.55 Favored Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 121.59 -0.694 . . . . 51.55 109.322 172.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.46 110.58 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.772 2.314 . . . . 73.21 112.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -68.82 113.02 5.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.193 0.997 . . . . 71.2 109.098 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.628 HG13 HG13 ' D' ' 64' ' ' VAL . 73.9 t -99.27 124.29 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.813 0.845 . . . . 71.25 110.763 -169.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -96.34 108.56 21.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.499 -1.667 . . . . 72.31 106.499 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.24 113.62 25.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.328 -0.99 . . . . 72.31 108.328 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.3 t70 -109.17 132.44 54.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.74 -0.837 . . . . 63.13 108.74 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.46 131.88 54.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.776 -1.194 . . . . 65.42 107.776 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.3 t70 -145.09 154.26 42.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.943 0.897 . . . . 54.03 108.786 173.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -126.66 164.6 20.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.225 0.61 . . . . 73.22 110.312 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.655 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.21 164.02 39.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 52.34 109.45 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 m -154.46 160.39 41.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.041 0.536 . . . . 63.44 110.928 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -157.1 120.02 4.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.161 0.984 . . . . 74.33 109.373 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -79.53 117.61 20.63 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.359 -0.608 . . . . 71.34 109.359 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.9 mt -99.81 -34.39 10.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.744 0.418 . . . . 73.54 110.85 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.6 -171.83 3.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.132 0.973 . . . . 75.33 109.773 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.04 118.48 11.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.754 0.821 . . . . 61.43 110.479 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 61.95 13.32 5.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.86 1.264 . . . . 72.22 112.669 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.45 122.64 66.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.032 -1.099 . . . . 74.11 108.032 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -151.71 145.88 25.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.517 0.675 . . . . 72.23 110.556 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.2 tt0 -86.67 125.27 33.75 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.887 -1.506 . . . . 71.32 108.744 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.05 137.78 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.623 -1.251 . . . . 72.12 107.623 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.655 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.6 t -115.19 145.29 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.366 1.066 . . . . 70.32 109.144 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.02 122.33 43.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.116 -1.068 . . . . 55.33 108.116 173.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 36.2 ttm-85 -96.07 100.38 12.05 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.46 -0.941 . . . . 72.03 108.46 172.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.51 107.11 18.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.246 -1.02 . . . . 71.31 108.246 171.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -98.65 131.86 44.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.049 0.452 . . . . 70.31 109.884 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.628 HG13 HG13 ' D' ' 40' ' ' VAL . 54.2 t -127.22 101.42 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.857 1.263 . . . . 73.43 108.104 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.7 m -101.92 94.38 5.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.286 -1.375 . . . . 74.32 107.286 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.02 143.62 27.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.734 -0.469 . . . . 65.42 109.734 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 38.4 p -146.76 133.3 19.77 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 121.199 0.523 . . . . 74.4 111.041 -173.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 55.4 mt -100.2 102.23 13.46 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.522 -1.288 . . . . 73.11 107.522 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -130.56 11.65 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.713 -0.676 . . . . 64.21 112.32 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.13 6.52 48.32 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.628 0.771 . . . . 75.54 111.403 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.597 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 8.9 tp10 -121.73 148.16 44.98 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.052 0.941 . . . . 72.44 109.56 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 76.3 m -65.82 131.38 46.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.363 0.665 . . . . 73.05 110.702 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.518 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -86.41 -59.55 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.483 -0.932 . . . . 62.41 108.483 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -160.7 150.39 17.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 113.925 -1.489 . . . . 74.13 109.558 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.33 146.65 29.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.781 -1.192 . . . . 74.15 107.781 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.586 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.1 t -158.73 137.94 11.48 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.704 -0.48 . . . . 65.15 109.704 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -156.88 129.36 7.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.664 -0.495 . . . . 43.05 109.664 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.12 116.1 43.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.672 0.789 . . . . 74.11 109.391 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -89.98 90.21 8.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.453 -0.794 . . . . 70.03 108.933 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.419 ' O ' HD13 ' D' ' 106' ' ' LEU . 8.2 tp-100 -80.28 104.37 10.79 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 114.769 -1.105 . . . . 74.54 109.089 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.91 145.03 16.88 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.634 -0.586 . . . . 72.44 111.634 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.1 139.1 7.68 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 110.661 -0.975 . . . . 71.0 110.661 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.23 130.77 37.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.709 0.804 . . . . 74.14 109.159 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.15 125.19 34.43 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.72 0.408 . . . . 51.2 110.331 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 24.4 m -84.88 93.23 8.47 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.171 -1.048 . . . . 74.44 108.171 165.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.594 HD11 HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -129.32 134.72 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.521 0.728 . . . . 73.21 109.641 -171.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.66 159.55 21.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.502 1.121 . . . . 71.25 109.841 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.62 -19.53 14.26 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.091 0.797 . . . . 50.11 115.091 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' D' ' 94' ' ' MET . 2.2 pp -108.96 161.78 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.397 0.679 . . . . 64.14 111.014 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 2.6 pt-20 -158.03 -175.44 5.35 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.5 0.72 . . . . 60.21 110.851 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -132.05 47.54 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 123.653 0.644 . . . . 74.2 114.014 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -66.35 -28.73 68.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.764 0.826 . . . . 74.22 111.254 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -68.8 -33.31 73.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.464 0.706 . . . . 75.11 111.094 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.638 ' HA ' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -70.34 -47.51 60.71 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.567 -0.531 . . . . 72.33 109.567 177.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.85 72.94 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.46 -0.791 . . . . 71.13 111.151 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -72.26 -37.81 68.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.063 0.945 . . . . 71.51 111.11 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -72.17 -51.41 21.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.036 0.535 . . . . 71.24 111.394 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 tt -72.9 -36.36 67.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.019 0.528 . . . . 62.54 110.168 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.23 -23.85 62.46 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 114.304 0.481 . . . . 74.2 114.304 -174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.53 -56.34 1.01 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.502 0.651 . . . . 53.43 112.274 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -67.46 -46.46 72.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.307 0.854 . . . . 73.33 113.307 -166.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.7 -44.67 43.73 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.972 -0.537 . . . . 74.31 111.229 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.603 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 85.5 Cg_exo -53.68 -35.78 79.17 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 122.953 2.435 . . . . 50.41 114.119 165.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -61.85 -31.93 72.23 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.399 0.68 . . . . 73.21 112.097 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -72.51 -40.08 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.671 . . . . 71.22 110.351 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.419 HD13 ' O ' ' D' ' 80' ' ' GLN . 83.8 mt -75.25 -24.93 57.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.882 -1.054 . . . . 64.22 111.252 -175.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -61.69 -42.46 83.6 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.876 1.436 . . . . 75.04 114.876 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.15 -46.87 28.63 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.267 1.978 . . . . 64.41 113.752 171.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.0 -37.21 69.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.511 -0.768 . . . . 72.25 111.226 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.78 79.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.744 0.818 . . . . 41.45 110.6 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -57.08 -50.67 72.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 70.14 110.956 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -67.91 -39.62 83.54 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.039 0.837 . . . . 72.43 111.39 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.4 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.0 t -57.64 -40.99 80.5 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.732 0.645 . . . . 70.44 110.486 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.586 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -68.45 -52.15 39.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.86 -1.064 . . . . 61.13 110.388 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -50.82 -43.46 58.96 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.123 . . . . 70.41 111.673 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -67.45 -45.86 74.76 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.676 -1.147 . . . . 62.14 110.33 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.06 -34.04 77.12 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.005 0.522 . . . . 75.41 111.947 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.57 -46.23 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.666 0.786 . . . . 73.31 110.252 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.7 p -70.74 -29.13 65.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.68 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -70.05 -32.69 70.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.6 0.76 . . . . 63.02 109.622 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 11.1 60.95 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.617 0.573 . . . . 64.42 113.069 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.445 HG23 ' HB3' ' C' ' 17' ' ' TYR . 41.4 p 60.27 20.5 9.95 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.402 1.881 . . . . 75.05 114.057 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.461 ' HB2' HG13 ' D' ' 118' ' ' VAL . 79.7 m-85 -93.97 159.05 35.22 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 107.758 -1.201 . . . . 72.55 107.758 171.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.91 154.1 63.33 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.994 1.796 . . . . 64.15 111.672 -172.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -50.97 120.14 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.872 0.869 . . . . 72.52 111.438 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.467 HD21 HG21 ' D' ' 40' ' ' VAL . 2.4 tm? -109.57 91.78 3.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.446 -1.316 . . . . 72.34 107.446 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -108.85 106.2 16.09 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.077 -0.965 . . . . 72.45 109.62 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 62.5 mt -65.76 134.68 53.67 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.796 -1.093 . . . . 74.11 110.911 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.68 130.98 85.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.782 0.833 . . . . 75.3 111.611 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.85 95.93 0.98 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.497 2.131 . . . . 75.52 110.548 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.66 139.94 50.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.174 -0.921 . . . . 61.23 110.447 -175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 . . . . . 0 C--O 1.237 0.407 0 N-CA-C 107.912 -1.144 . . . . 74.15 107.912 166.831 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 109.204 -0.665 . . . . 74.35 109.204 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.5 136.63 54.71 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.116 0.966 . . . . 62.11 109.76 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -147.69 136.83 22.27 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.375 0.422 . . . . 72.22 111.279 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.3 110.29 12.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.073 0.949 . . . . 74.44 108.44 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.86 -41.04 16.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.322 0.649 . . . . 74.2 109.275 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -161.32 141.08 10.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.014 0.526 . . . . 53.1 110.211 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -124.53 135.91 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.003 -1.11 . . . . 71.23 108.003 167.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.678 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 18.3 p90 -170.56 171.88 6.18 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.042 0.839 . . . . 62.24 110.645 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -94.54 124.19 38.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.896 -0.779 . . . . 61.41 108.896 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.3 mtpt -82.63 -43.54 16.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.021 -0.733 . . . . 72.3 109.021 172.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.0 t70 -135.79 143.97 45.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.281 -1.327 . . . . 54.41 110.041 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.434 HG23 ' SD ' ' A' ' 117' ' ' MET . 83.3 mt -139.81 141.51 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 125.982 1.713 . . . . 74.13 106.624 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.35 123.24 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.48 -0.563 . . . . 65.25 109.48 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 85.0 t80 -121.74 126.52 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.823 -1.547 . . . . 74.13 106.823 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -123.56 126.57 46.91 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.896 -0.779 . . . . 74.14 108.896 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.03 70.98 14.77 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.236 1.014 . . . . 72.34 108.347 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.73 -26.31 27.85 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.053 1.835 . . . . 65.55 110.12 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 31' ' ' VAL . 81.9 m-20 -99.8 22.7 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.734 -1.121 . . . . 71.23 110.767 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.42 97.62 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.594 -0.717 . . . . 51.23 112.425 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.6 -21.38 22.21 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.898 1.732 . . . . 70.54 113.495 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.0 m170 -71.09 -36.51 72.25 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.867 0.467 . . . . 74.01 110.452 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 27' ' ' ASN . 73.4 t -56.34 -35.88 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.174 0.99 . . . . 71.44 112.87 -174.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.15 -35.17 80.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.322 0.649 . . . . 75.25 110.726 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -75.07 -37.9 61.48 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.126 0.97 . . . . 71.52 110.102 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -82.15 156.84 24.27 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.217 -0.901 . . . . 73.52 110.641 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -72.4 125.8 28.29 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.924 -0.769 . . . . 61.44 108.924 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.485 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -78.17 81.07 4.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.498 0.666 . . . . 74.21 110.949 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -118.09 84.34 21.59 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.822 -1.547 . . . . 64.14 106.822 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.63 115.3 4.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.255 1.97 . . . . 75.45 111.256 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -95.69 90.87 5.84 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.835 -1.542 . . . . 72.43 106.835 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 46.9 t -84.47 112.59 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.734 -1.121 . . . . 54.32 111.381 -168.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 12.6 mptt -80.08 146.07 32.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.06 0.944 . . . . 64.33 108.534 167.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.23 114.82 10.52 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.448 0.699 . . . . 70.5 109.539 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 26.0 m-20 -108.8 141.56 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.402 0.681 . . . . 75.33 109.384 173.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.3 tp -133.68 119.44 19.35 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.942 -1.132 . . . . 73.14 107.942 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 30.9 t70 -141.81 151.54 42.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.432 0.693 . . . . 72.33 110.018 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -131.35 150.13 52.27 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.894 0.877 . . . . 74.11 109.876 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . . . -147.34 152.53 38.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.73 1.212 . . . . 54.51 108.466 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.686 ' HB2' HD11 ' A' ' 98' ' ' LEU . 8.5 t -133.29 160.47 37.21 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.138 0.426 . . . . 73.11 111.345 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -149.57 120.42 7.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.212 1.005 . . . . 55.21 108.82 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -74.07 104.13 4.78 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.784 -0.821 . . . . 74.44 108.784 175.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.75 -32.61 27.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.114 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.65 -175.69 5.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.932 0.893 . . . . 63.43 109.705 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.71 125.23 24.12 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.16 -0.681 . . . . 71.44 109.16 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 70.44 -8.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.622 1.569 . . . . 73.42 112.44 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.78 110.94 28.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.996 -0.742 . . . . 73.15 108.996 -174.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.28 124.47 40.4 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.362 1.065 . . . . 71.25 108.562 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.33 127.19 35.48 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.202 -1.036 . . . . 74.34 108.202 168.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.97 121.86 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.242 -1.022 . . . . 60.33 108.242 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.6 t -103.33 130.21 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.199 0.6 . . . . 75.22 109.555 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -101.38 117.81 35.71 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.213 1.005 . . . . 73.04 108.668 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.405 ' NH2' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -91.9 106.12 18.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.071 -0.714 . . . . 74.42 109.071 169.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' HB1' ' A' ' 110' ' ' ALA . 17.7 t -105.92 126.97 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.527 -1.286 . . . . 30.41 107.527 169.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -122.92 134.23 54.36 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.731 -0.47 . . . . 64.53 109.731 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.5 t -130.36 107.31 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.352 1.461 . . . . 72.32 107.791 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 36.3 m -113.2 122.27 46.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.369 -0.604 . . . . 74.01 109.369 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.5 117.96 35.65 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.682 -1.229 . . . . 64.32 107.682 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.7 m -117.76 126.77 53.05 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.827 0.451 . . . . 32.01 109.846 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.485 HD21 ' CE3' ' A' ' 36' ' ' TRP . 66.6 mt -89.37 70.3 8.11 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.529 -1.285 . . . . 75.41 107.529 176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -85.29 0.95 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.42 -1.263 . . . . 43.52 110.733 -168.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.04 -25.17 5.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.94 0.896 . . . . 72.12 110.961 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.83 107.26 12.48 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.26 -0.645 . . . . 63.1 109.26 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -62.1 127.35 30.97 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.903 0.382 . . . . 65.53 110.16 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -53.52 6.51 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.125 0.97 . . . . 34.11 108.695 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.14 167.24 30.39 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 113.867 -1.515 . . . . 75.22 110.236 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -129.78 144.12 51.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.33 1.452 . . . . 71.24 107.861 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.4 m -134.19 138.18 44.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.872 0.869 . . . . 74.3 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.96 123.69 10.53 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.486 -0.931 . . . . 72.13 108.486 168.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.89 119.86 55.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.713 -0.847 . . . . 72.11 108.713 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 73.6 mt-30 -95.3 90.08 5.71 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.761 -1.109 . . . . 62.31 108.948 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.1 tp-100 -81.17 96.66 7.29 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.346 -1.297 . . . . 64.13 107.724 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.54 143.24 17.12 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.923 -0.871 . . . . 55.53 110.923 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.93 121.54 1.57 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.706 -0.958 . . . . 72.11 110.706 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.5 mt -82.91 129.11 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.102 -1.073 . . . . 65.32 108.102 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -137.78 163.91 30.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.691 1.197 . . . . 73.14 109.208 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 p -110.29 120.18 41.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.119 0.568 . . . . 73.1 109.65 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 119.6 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.865 0.866 . . . . 75.53 110.327 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.81 160.97 4.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.8 1.64 . . . . 61.12 108.711 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.33 11.83 40.73 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 112.633 -0.187 . . . . 62.12 112.633 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.559 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -115.79 169.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.669 1.188 . . . . 70.41 110.655 -173.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -167.79 173.95 7.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.194 -0.669 . . . . 73.04 109.194 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.84 -130.97 49.5 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 116.627 -0.26 . . . . 75.32 113.198 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.7 p -79.15 -15.01 58.74 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.693 0.797 . . . . 71.44 112.308 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.35 -36.94 69.36 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.047 0.939 . . . . 75.51 111.082 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -40.86 39.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.469 -0.787 . . . . 73.3 110.523 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.47 67.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 72.31 111.319 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -75.19 -44.2 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.82 0.848 . . . . 61.3 110.563 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.0 t -74.6 -64.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.913 -0.585 . . . . 42.11 109.938 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 48' ' ' SER . 65.5 tp -64.52 -41.74 96.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.674 0.789 . . . . 71.11 112.713 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.12 -36.86 44.62 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.234 -0.439 . . . . 73.41 113.464 -173.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.63 -54.38 2.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.43 0.53 . . . . 71.32 112.43 -170.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.446 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.4 t80 -74.27 -55.95 5.45 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.38 0.881 . . . . 73.14 113.38 -163.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 86.2 m -66.61 -38.18 18.3 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.589 0.959 . . . . 62.41 113.589 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.0 -26.24 43.68 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.627 1.551 . . . . 72.33 112.563 167.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.51 -26.61 61.84 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.765 0.426 . . . . 71.22 110.849 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -59.97 -42.3 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.873 0.844 . . . . 73.21 109.685 170.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.1 mt -78.56 -19.41 52.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.116 -1.402 . . . . 65.32 112.167 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.478 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 34.0 t80 -64.6 -39.85 44.12 Favored Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.197 1.184 . . . . 70.01 114.197 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.58 -40.64 83.05 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.318 2.012 . . . . 63.43 113.282 170.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -75.58 -36.76 60.28 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.295 -0.866 . . . . 54.5 111.15 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.48 -48.34 75.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.519 0.728 . . . . 72.35 109.747 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -52.89 -50.79 63.16 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 124.706 1.254 . . . . 70.11 110.755 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -60.95 -46.72 89.57 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.536 1.148 . . . . 63.3 111.721 -175.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.467 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -59.04 -43.5 91.64 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.194 0.934 . . . . 71.22 110.752 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 118' ' ' VAL . 91.1 mt -63.31 -53.89 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 123.963 0.789 . . . . 74.52 110.293 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 125' ' ' GLN . 61.6 m -51.59 -45.71 63.24 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.697 1.199 . . . . 71.53 111.188 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -66.96 -45.54 77.44 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.647 -1.16 . . . . 73.12 110.352 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' HG23 ' A' ' 21' ' ' ILE . 12.0 mtp -55.22 -44.7 75.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.762 0.825 . . . . 73.5 111.719 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -64.07 -46.95 92.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.207 1.003 . . . . 73.31 110.817 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.5 p -70.85 -28.59 64.7 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 115.802 -0.635 . . . . 73.03 110.784 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.509 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.8 mtt-85 -72.26 -33.57 67.59 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.022 0.929 . . . . 75.13 110.098 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.36 68.37 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.485 -0.779 . . . . 54.44 112.763 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m 69.28 40.34 1.52 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.774 1.229 . . . . 71.42 110.096 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.15 145.24 39.64 Favored Pre-proline 0 C--O 1.245 0.852 0 CA-C-N 115.356 -0.838 . . . . 70.41 109.208 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -51.99 114.39 1.6 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.025 2.484 . . . . 73.11 112.096 172.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.641 ' HB2' HG23 ' A' ' 115' ' ' THR . 19.1 pt20 -63.19 156.13 26.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.088 -0.96 . . . . 73.14 111.945 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.39 118.68 37.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.772 -1.104 . . . . 31.53 108.881 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 79.0 m-20 -98.72 84.51 3.14 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.315 -1.365 . . . . 73.3 107.315 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.478 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -69.35 141.14 54.28 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.262 -0.881 . . . . 73.11 109.453 -174.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.9 129.41 94.43 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 122.629 0.372 . . . . 73.13 111.569 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.66 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.559 2.173 . . . . 63.33 110.807 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.71 114.42 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.886 -1.052 . . . . 64.02 109.25 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -87.99 104.9 17.08 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.706 -1.22 . . . . 70.35 107.706 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 . . . . . 0 N--CA 1.477 0.888 0 O-C-N 124.533 1.145 . . . . 75.21 111.184 -175.07 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 107.983 -1.117 . . . . 71.01 107.983 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -137.28 137.0 38.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.804 -0.813 . . . . 72.45 108.804 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -147.72 126.66 12.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.886 0.475 . . . . 74.41 109.975 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -91.47 139.87 17.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 108.918 -0.771 . . . . 70.44 108.918 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -110.79 -44.27 3.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.838 0.455 . . . . 62.43 110.516 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -172.44 139.95 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.506 0.322 . . . . 72.21 110.219 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.47 146.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.06 -1.089 . . . . 74.14 108.06 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -167.2 164.87 15.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.619 0.723 . . . . 74.4 111.583 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.2 m -90.04 120.01 30.87 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.286 -1.005 . . . . 74.03 108.286 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -90.43 -24.88 20.62 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.842 0.457 . . . . 72.3 111.301 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.0 t70 -158.62 144.65 16.88 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.94 0.4 . . . . 73.14 111.829 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.476 HD11 ' SG ' ' B' ' 113' ' ' CYS . 42.8 mm -132.96 141.22 45.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.117 1.367 . . . . 75.12 108.755 173.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 38.3 m -137.87 122.25 18.29 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.219 1.407 . . . . 71.21 108.388 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 65.8 t80 -134.97 110.02 8.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.083 -1.821 . . . . 73.25 106.083 165.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -125.66 111.23 14.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.977 -1.12 . . . . 75.12 107.977 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.662 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.06 89.37 5.52 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.012 0.925 . . . . 50.53 109.162 177.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.68 -26.67 19.25 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.416 2.077 . . . . 63.3 111.831 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -117.62 24.58 10.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.317 1.047 . . . . 74.12 109.313 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.678 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.04 -53.2 13.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 125.905 1.682 . . . . 64.13 114.498 173.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.0 Cg_exo -74.84 -18.23 19.32 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.541 2.161 . . . . 75.02 112.185 -177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.89 2.53 54.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.706 -1.134 . . . . 71.32 111.811 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.04 -18.13 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.172 0.589 . . . . 72.5 110.503 168.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -73.51 -34.48 65.3 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.683 -0.488 . . . . 64.23 109.683 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.11 -45.56 26.51 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.423 0.63 . . . . 75.11 109.4 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 27.3 mmtp -94.57 68.91 3.48 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.858 1.263 . . . . 64.42 109.191 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.16 75.86 3.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.314 -1.312 . . . . 64.02 110.905 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -162.25 151.95 16.18 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.474 -1.306 . . . . 63.23 107.474 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -88.08 119.37 70.37 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.472 -0.566 . . . . 71.5 109.472 -178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.656 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 68.8 Cg_endo -68.63 144.4 60.16 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.963 1.776 . . . . 73.3 111.817 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 109.03 2.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.075 -0.966 . . . . 71.25 108.71 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -84.79 123.07 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 108.983 -0.747 . . . . 72.33 108.983 -167.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -124.44 147.09 48.54 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.38 1.072 . . . . 75.2 109.659 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.641 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -109.24 167.13 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.319 0.648 . . . . 71.24 111.605 179.028 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.9 t70 -153.51 139.98 18.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.892 1.277 . . . . 73.53 108.731 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.61 132.98 53.41 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.328 0.651 . . . . 74.33 109.36 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -146.81 151.63 37.42 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.551 1.141 . . . . 74.13 109.079 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.0 m -139.28 121.84 16.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.835 0.454 . . . . 64.42 110.02 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.91 160.42 19.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.64 1.176 . . . . 51.21 108.854 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -144.21 163.95 32.16 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.298 0.639 . . . . 73.21 110.601 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 7.3 p -159.97 137.3 9.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.094 0.958 . . . . 73.3 109.853 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -84.12 129.9 34.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.535 0.734 . . . . 73.42 110.402 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.53 -42.91 8.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.196 0.598 . . . . 74.2 109.479 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.41 -171.23 3.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.078 0.951 . . . . 54.42 110.04 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.55 112.93 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.859 -1.064 . . . . 62.34 110.252 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 69.49 -0.5 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.564 1.546 . . . . 74.45 112.979 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -104.83 104.7 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.377 -1.342 . . . . 50.24 107.377 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -124.09 149.77 45.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.395 0.678 . . . . 74.02 109.542 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.83 112.59 21.31 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.498 1.119 . . . . 71.41 108.665 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.85 118.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.429 -0.952 . . . . 73.3 108.429 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 50.5 t -102.42 109.33 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.394 -0.965 . . . . 71.0 108.394 175.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -93.75 117.06 29.6 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.576 -0.898 . . . . 72.44 108.576 -175.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.04 117.28 34.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.161 0.584 . . . . 73.42 110.128 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.51 HG11 HD11 ' B' ' 128' ' ' LEU . 11.8 t -116.19 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.989 -1.115 . . . . 72.32 107.989 169.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 6.7 m -115.31 150.45 36.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.52 0.728 . . . . 44.0 109.567 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.442 HG23 HD13 ' B' ' 114' ' ' ILE . 34.8 t -129.43 130.57 67.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.637 1.175 . . . . 61.3 109.139 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -126.12 140.81 52.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.181 0.992 . . . . 75.31 110.351 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.844 ' HB3' ' HE2' ' B' ' 74' ' ' PHE . . . -150.63 161.78 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.045 -0.724 . . . . 64.11 109.045 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.9 p -146.91 141.46 26.57 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.45 0.643 . . . . 63.23 112.022 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 34.5 mt -91.89 98.85 11.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.831 -1.174 . . . . 70.54 107.831 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.14 -107.73 2.3 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.44 -1.064 . . . . 71.43 110.44 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.0 8.63 10.45 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.82 0.848 . . . . 73.54 110.376 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -112.39 142.97 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.192 -0.67 . . . . 72.2 109.192 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -56.55 126.05 24.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.765 0.826 . . . . 73.14 110.742 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.26 -59.62 2.7 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 122.222 1.011 . . . . 65.23 109.065 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.844 ' HE2' ' HB3' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -154.53 178.66 9.83 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 113.006 -1.906 . . . . 73.41 107.08 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.72 136.81 29.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.931 -1.137 . . . . 65.23 107.931 164.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 50.6 t -131.83 147.56 52.49 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.589 -0.893 . . . . 71.34 108.589 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.0 tt0 -163.66 134.72 4.62 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.807 -0.812 . . . . 71.43 108.807 -173.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -125.21 146.7 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.325 1.05 . . . . 71.4 109.014 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.3 mt-30 -126.05 88.95 2.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.382 -0.969 . . . . 72.05 108.382 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.528 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.7 tp-100 -85.07 100.86 11.98 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.899 -1.046 . . . . 71.4 109.523 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.79 156.46 25.55 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.693 -0.563 . . . . 55.21 111.693 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.83 130.22 2.38 Favored Glycine 0 C--O 1.239 0.456 0 N-CA-C 111.568 -0.613 . . . . 60.21 111.568 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.61 127.26 40.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.609 0.764 . . . . 62.21 109.401 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -134.22 158.21 44.28 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.773 1.229 . . . . 75.01 108.665 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -132.51 121.95 24.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.407 -0.96 . . . . 63.32 108.407 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.623 HG13 ' SG ' ' B' ' 97' ' ' CYS . 0.2 OUTLIER -133.24 141.65 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.568 -0.901 . . . . 74.13 108.568 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.469 ' N ' HD13 ' B' ' 86' ' ' ILE . . . -158.94 174.88 14.29 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.078 0.951 . . . . 71.34 109.487 169.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.14 -54.98 0.53 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.27 0.462 . . . . 45.05 112.275 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -78.85 170.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.506 0.722 . . . . 55.24 112.589 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.7 162.87 40.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.559 0.744 . . . . 73.2 110.634 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.73 -129.38 24.61 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.473 -0.785 . . . . 44.43 113.771 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -67.61 -28.5 67.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.355 1.062 . . . . 54.03 111.167 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.68 -18.43 65.37 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.62 0.768 . . . . 65.21 112.09 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.4 tpt -68.97 -39.95 79.13 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.991 0.516 . . . . 71.22 110.156 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.47 -21.32 66.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.295 -0.866 . . . . 62.44 111.587 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -65.14 -40.83 94.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.411 0.685 . . . . 62.44 110.849 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.623 ' SG ' HG13 ' B' ' 86' ' ' ILE . 53.9 t -75.23 -69.91 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.852 -0.613 . . . . 74.31 111.128 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.589 HD13 ' H ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -88.79 -8.33 54.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 112.313 0.486 . . . . 73.45 112.313 -171.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.23 3.42 54.82 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.691 -0.505 . . . . 71.4 112.769 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.09 -67.9 0.18 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 117.142 0.471 . . . . 72.53 111.424 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -68.05 -50.85 52.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.819 0.674 . . . . 75.54 112.819 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.551 ' HA ' HD12 ' B' ' 105' ' ' ILE . 62.5 m -62.25 -43.4 85.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.921 0.888 . . . . 72.35 113.206 -173.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -39.4 49.23 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 121.476 1.451 . . . . 64.54 112.365 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -65.73 -18.33 65.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.761 0.652 . . . . 75.03 112.761 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.592 HG23 ' NH2' ' D' ' 111' ' ' ARG . 96.4 mt -69.83 -44.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.513 0.725 . . . . 75.14 109.988 170.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.483 ' HB2' HD12 ' B' ' 60' ' ' LEU . 30.9 mt -84.85 -18.19 35.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.754 -1.112 . . . . 63.31 111.437 -173.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.427 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 36.0 t80 -61.87 -40.95 73.86 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 124.736 1.214 . . . . 71.01 113.197 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.443 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 14.9 Cg_endo -56.71 -45.77 34.46 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.533 2.155 . . . . 61.45 113.479 169.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.528 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 85.1 m-85 -64.82 -42.71 94.76 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.073 0.549 . . . . 74.44 110.42 -177.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -39.99 89.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.651 0.78 . . . . 74.52 110.843 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' B' ' 128' ' ' LEU . 26.8 ttt180 -58.55 -52.91 63.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.402 1.081 . . . . 63.1 111.486 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -38.14 88.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.108 -0.951 . . . . 73.15 109.779 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.509 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 5.8 t -68.18 -36.84 80.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.477 -0.783 . . . . 74.12 111.474 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.442 HD13 HG23 ' B' ' 64' ' ' VAL . 53.5 mt -62.7 -60.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.364 1.215 0 N-CA-C 109.351 -0.611 . . . . 65.2 109.351 176.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.8 m -53.55 -38.04 63.46 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 124.724 1.265 . . . . 71.3 110.754 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.7 t -55.88 -54.23 47.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.133 0.973 . . . . 73.04 111.391 174.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.505 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 16.8 mmt -66.29 -37.2 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.902 0.481 . . . . 73.24 111.462 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.498 HG22 ' HE1' ' B' ' 74' ' ' PHE . 91.1 t -63.74 -40.28 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.534 1.133 . . . . 71.35 110.577 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.4 m -65.32 -35.88 82.33 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.47 -1.241 . . . . 74.33 111.826 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 75.4 mtt-85 -65.22 -41.73 94.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.258 -0.883 . . . . 71.32 110.168 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.59 -1.48 82.87 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.875 0.734 . . . . 44.32 113.895 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p 60.0 49.84 7.25 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.74 1.616 . . . . 74.24 111.62 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -118.49 161.36 35.87 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 114.264 -1.335 . . . . 73.52 110.071 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.38 145.6 72.08 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.325 2.683 . . . . 74.44 114.89 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' C' ' 124' ' ' PRO . 3.9 pt20 -66.63 158.83 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.206 1.403 . . . . 74.42 113.803 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.11 104.27 7.46 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.671 -1.603 . . . . 70.42 106.671 162.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -90.05 93.1 9.25 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.371 -0.974 . . . . 65.51 108.371 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' B' ' 111' ' ' ARG . 40.0 mt -57.29 135.27 56.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.116 0.967 . . . . 70.25 113.478 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.2 117.51 58.24 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 114.621 -1.172 . . . . 65.22 108.625 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -65.67 151.1 85.54 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.399 2.733 . . . . 63.34 112.702 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 114.67 -1.15 . . . . 71.21 108.117 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.34 65.75 9.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.669 -0.863 . . . . 64.4 108.669 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 t80 . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 115.198 -0.91 . . . . 71.23 109.383 178.728 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 C--O 1.234 0.286 0 N-CA-C 108.19 -1.041 . . . . 64.22 108.19 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -120.83 137.31 54.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.054 0.542 . . . . 65.25 109.552 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -148.6 124.16 10.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.707 0.803 . . . . 61.42 108.942 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 tp -78.57 133.57 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.037 -0.727 . . . . 72.04 109.037 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -103.17 -51.06 3.33 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.583 0.753 . . . . 73.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.513 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 57.4 ttt180 -165.1 123.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.231 -168.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -112.3 132.02 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.522 -0.918 . . . . 72.2 108.522 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.546 ' HB3' HG23 ' D' ' 122' ' ' THR . 22.1 p90 -173.19 148.03 1.63 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.126 0.891 . . . . 73.34 110.597 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -74.42 124.8 27.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 75.21 110.121 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -74.79 -48.94 22.69 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.288 1.042 . . . . 73.22 109.053 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 29.1 t70 -139.31 136.02 34.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.923 -1.49 . . . . 51.32 109.284 -167.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.8 mt -137.31 143.7 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 106.902 -1.518 . . . . 72.51 106.902 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -154.21 150.8 28.46 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.335 0.588 . . . . 71.43 109.79 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.427 ' HZ ' ' HD2' ' C' ' 123' ' ' PHE . 79.4 t80 -150.99 110.54 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.496 -1.298 . . . . 74.12 107.496 173.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.07 124.85 50.26 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.597 0.759 . . . . 74.41 109.337 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.27 84.0 48.7 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 107.7 -1.222 . . . . 74.12 107.7 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.89 -25.71 38.67 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.471 2.114 . . . . 64.31 111.69 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.3 20.74 17.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.338 1.055 . . . . 71.41 110.412 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.86 -49.96 90.77 Favored Pre-proline 0 CA--C 1.569 1.711 0 N-CA-C 114.723 1.379 . . . . 73.41 114.723 -172.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 -30.89 10.87 Favored 'Trans proline' 0 C--N 1.387 2.569 0 CA-C-N 121.58 1.6 . . . . 75.14 112.723 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -68.83 -49.57 57.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.976 0.91 . . . . 61.33 111.423 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.45 HG23 HD11 ' C' ' 68' ' ' LEU . 14.3 p -59.51 -18.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.344 1.458 . . . . 60.24 112.932 -169.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.64 -33.56 71.68 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.172 0.989 . . . . 74.2 112.311 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.47 5.34 52.11 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.769 0.655 . . . . 72.11 112.769 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -87.6 163.88 16.37 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.562 -0.532 . . . . 73.53 109.562 176.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.61 107.07 1.3 Allowed 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.762 -1.199 . . . . 74.13 107.762 164.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -82.15 83.61 7.3 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.328 1.061 . . . . 72.41 110.348 -171.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.56 72.75 81.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 115.036 -0.983 . . . . 72.21 108.823 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.06 127.65 15.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.416 2.077 . . . . 74.5 111.153 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -86.06 76.72 9.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.377 -1.342 . . . . 74.01 107.377 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.19 85.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 123.055 1.407 . . . . 64.22 110.833 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 140.47 48.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.907 -1.497 . . . . 73.21 107.46 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.484 HD12 HD12 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -128.48 155.94 44.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.159 0.583 . . . . 74.44 110.767 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.21 128.06 53.86 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.695 1.198 . . . . 63.5 108.118 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tp -106.02 101.26 10.77 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.138 0.575 . . . . 73.54 109.507 -173.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.469 ' O ' HD23 ' C' ' 60' ' ' LEU . 10.3 t70 -113.91 139.03 49.54 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.62 1.168 . . . . 72.42 109.781 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.0 t -119.08 131.35 55.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.281 0.632 . . . . 73.11 109.631 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.39 151.72 32.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.357 1.063 . . . . 72.32 108.974 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -143.57 143.59 31.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.079 0.552 . . . . 72.33 110.404 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -153.21 156.46 38.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.569 1.148 . . . . 75.13 108.528 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -103.79 117.95 35.55 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.342 -0.614 . . . . 75.44 109.342 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' C' ' 57' ' ' GLU . 56.7 mt -86.52 -36.63 18.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.369 0.668 . . . . 73.23 110.093 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.75 -176.37 5.5 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.077 -0.965 . . . . 54.1 110.69 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.87 102.45 0.47 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.429 -1.26 . . . . 74.02 110.322 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 13.0 m-20 64.57 13.04 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.968 1.307 . . . . 71.14 113.581 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 98.9 t -106.03 107.74 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 107.973 -1.121 . . . . 74.11 107.973 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' C' ' 86' ' ' ILE . 7.9 m-30 -114.89 146.05 41.53 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.48 -0.933 . . . . 72.0 108.48 -174.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.6 tt0 -109.08 124.13 50.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.206 1.002 . . . . 71.32 108.557 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.809 HG21 ' HB2' ' C' ' 98' ' ' LEU . 92.8 t -119.38 124.55 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.189 -1.041 . . . . 31.33 108.189 172.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.9 115.43 47.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.581 1.152 . . . . 71.33 108.764 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.469 HD23 ' O ' ' C' ' 45' ' ' ASP . 0.9 OUTLIER -86.27 105.25 16.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.356 -0.979 . . . . 64.12 108.356 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.12 106.45 16.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.242 0.617 . . . . 72.02 109.481 172.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.577 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.9 t -100.7 130.66 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.113 -1.069 . . . . 62.44 108.113 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -125.25 122.59 37.39 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.48 -0.563 . . . . 72.42 109.48 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.66 HG21 HG21 ' C' ' 114' ' ' ILE . 71.5 t -98.63 113.55 33.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.424 1.09 . . . . 64.12 109.302 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -99.34 134.46 42.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.401 -0.963 . . . . 50.12 108.401 171.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.16 124.53 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.676 0.79 . . . . 64.13 108.952 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.7 m -133.54 170.98 14.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.944 0.898 . . . . 75.04 110.136 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.652 HD13 ' HG2' ' C' ' 34' ' ' LYS . 27.8 mt -127.89 22.95 6.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.666 1.186 . . . . 74.01 108.551 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.24 -96.62 0.99 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.027 -1.229 . . . . 50.05 110.027 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -91.48 -30.94 16.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.44 110.744 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -85.69 121.99 29.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.145 0.978 . . . . 74.2 110.87 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -69.62 125.5 26.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.471 -0.566 . . . . 75.44 109.471 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -49.09 12.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.247 0.619 . . . . 21.51 109.782 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -171.27 177.09 3.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.976 0.91 . . . . 54.31 110.699 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -140.99 139.23 34.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.738 -1.579 . . . . 74.23 106.738 174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -137.24 154.51 50.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.643 -0.873 . . . . 71.02 108.643 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.09 143.98 18.46 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.85 0.46 . . . . 74.03 109.831 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' C' ' 113' ' ' CYS . 19.6 t -142.99 114.28 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.857 1.263 . . . . 74.42 108.171 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 42.1 mt-30 -93.36 95.53 9.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.546 0.739 . . . . 71.14 109.308 169.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -83.17 104.61 13.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.779 -1.1 . . . . 45.11 109.829 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.73 146.63 22.41 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.4 0.437 . . . . 52.32 112.327 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.97 124.78 2.64 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.879 -0.888 . . . . 55.45 110.879 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.487 HG12 ' HE1' ' C' ' 17' ' ' TYR . 26.1 mm -93.72 118.04 38.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.3 -1.0 . . . . 63.53 108.3 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.46 118.55 28.61 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.526 -0.916 . . . . 72.23 108.526 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -95.75 102.84 14.68 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.183 -1.043 . . . . 74.34 108.183 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.7 pp -114.44 -177.76 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.744 0.818 . . . . 70.22 110.648 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 176.91 153.01 0.21 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.584 1.554 . . . . 65.0 108.657 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.32 -17.61 46.84 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 114.597 0.599 . . . . 64.14 114.597 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 pt . . . . . 0 CA--C 1.553 1.088 0 C-N-CA 123.833 0.853 . . . . 70.02 111.052 -179.331 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 119.663 -0.208 . . . . 63.14 110.501 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.3 ptp -63.57 -35.4 80.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.579 0.352 . . . . 63.41 111.422 178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -76.22 -38.17 56.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.797 0.839 . . . . 74.44 111.245 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -77.96 -37.81 46.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.088 0.955 . . . . 61.15 111.23 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.53 -49.98 75.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.118 0.967 . . . . 73.13 111.277 -169.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.809 ' HB2' HG21 ' C' ' 58' ' ' VAL . 3.4 pp -108.88 -11.1 15.05 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.055 0.391 . . . . 51.12 112.055 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.17 -28.98 35.1 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.238 -0.201 . . . . 34.43 112.918 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.09 -45.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.009 0.524 . . . . 75.04 111.481 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -74.43 -47.24 34.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.743 0.817 . . . . 74.54 112.364 -172.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.539 ' HB2' ' HA ' ' C' ' 98' ' ' LEU . 97.7 m -65.78 -46.49 66.25 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 118.518 -0.753 . . . . 63.2 112.443 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.426 ' O ' HD12 ' C' ' 60' ' ' LEU . 37.8 Cg_endo -66.26 -23.1 52.49 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 121.135 1.441 . . . . 61.22 112.397 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.23 -31.72 70.48 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.349 0.522 . . . . 75.25 110.191 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' C' ' 102' ' ' CYS . 26.8 mm -62.89 -44.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.63 0.772 . . . . 61.43 109.592 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 66.4 mt -82.4 -18.15 42.95 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.766 0.826 . . . . 74.22 112.454 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.12 -47.56 90.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.46 -1.257 . . . . 70.35 112.955 -174.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.75 -38.63 92.3 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.021 1.814 . . . . 44.54 112.304 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.495 ' HB3' ' NE2' ' C' ' 80' ' ' GLN . 87.9 m-85 -63.46 -50.78 68.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.962 0.905 . . . . 63.15 111.318 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.96 -37.5 81.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.763 -0.653 . . . . 65.13 110.952 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.78 -50.41 70.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 61.44 110.053 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.11 -38.22 75.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.86 0.864 . . . . 71.42 110.854 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.422 ' HB3' HG11 ' C' ' 78' ' ' VAL . 9.1 t -64.98 -34.02 77.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.177 0.591 . . . . 73.34 110.89 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.66 HG21 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -70.66 -50.8 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 115.772 -0.649 . . . . 74.42 109.661 173.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.406 HG23 ' H ' ' C' ' 126' ' ' LEU . 27.4 m -58.3 -34.77 70.92 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.957 0.786 . . . . 75.42 111.403 -173.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.9 p -67.88 -51.66 45.52 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.776 -0.647 . . . . 50.22 109.382 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.579 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.1 -41.41 62.41 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.859 1.264 . . . . 61.21 112.664 179.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.53 HG11 HD23 ' C' ' 126' ' ' LEU . 88.1 t -72.05 -41.21 67.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.091 -0.959 . . . . 61.14 110.397 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.42 -29.89 70.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.396 0.679 . . . . 72.51 111.271 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 61.5 mtt-85 -67.66 -44.14 78.59 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.634 -0.876 . . . . 73.33 108.634 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.85 -1.94 85.3 Favored Glycine 0 C--N 1.36 1.911 0 O-C-N 124.139 0.9 . . . . 63.33 113.434 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.1 p 66.84 41.84 2.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.877 1.671 . . . . 71.05 112.317 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HD2' ' HZ ' ' C' ' 23' ' ' PHE . 65.8 m-85 -114.41 163.89 17.93 Favored Pre-proline 0 CA--C 1.565 1.531 0 C-N-CA 124.958 1.303 . . . . 65.03 109.961 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.485 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 96.0 Cg_exo -49.41 151.77 6.59 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 124.341 3.36 . . . . 74.42 116.228 -175.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -48.46 132.37 16.92 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.648 1.179 . . . . 75.24 112.011 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.53 HD23 HG11 ' C' ' 118' ' ' VAL . 0.5 OUTLIER -111.47 23.52 13.86 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.536 -0.756 . . . . 72.13 111.521 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -90.71 79.5 6.04 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-O 123.788 1.756 . . . . 64.23 106.951 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.484 HD12 HD12 ' C' ' 42' ' ' LEU . 82.3 mt -90.12 151.67 21.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.648 -1.615 . . . . 72.23 110.185 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -35.54 113.19 0.5 Allowed Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 126.231 1.812 . . . . 63.43 114.319 -173.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.37 99.07 0.88 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.315 2.01 . . . . 64.03 111.816 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.35 97.96 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 115.214 -0.903 . . . . 74.21 110.524 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.51 68.11 10.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 71.41 109.821 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 18.8 p90 . . . . . 0 CA--C 1.546 0.807 0 CA-C-N 113.966 -1.47 . . . . 73.24 111.931 -179.813 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.15 -1.055 . . . . 73.24 108.15 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.418 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 73.2 t80 -169.74 91.14 0.21 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.314 -1.365 . . . . 71.41 107.314 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -126.09 153.37 44.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.77 0.828 . . . . 63.0 109.501 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.41 HD12 ' O ' ' D' ' 83' ' ' ILE . 10.4 tp -103.53 142.84 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.201 0.6 . . . . 73.03 109.559 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.2 -45.39 2.94 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.781 0.833 . . . . 72.11 110.633 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -154.58 129.45 9.41 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 120.429 0.157 . . . . 75.01 111.19 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.536 HD12 ' N ' ' D' ' 16' ' ' ILE . 0.6 OUTLIER -121.28 112.16 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 106.256 -1.757 . . . . 72.51 106.256 -177.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -159.66 142.07 13.6 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 123.703 0.627 . . . . 72.13 111.704 -164.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.7 p -79.86 115.05 19.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.716 -1.129 . . . . 72.22 109.32 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -89.31 -28.83 19.59 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.007 -0.542 . . . . 72.5 110.365 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.5 t70 -147.08 133.49 19.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.324 -0.853 . . . . 65.41 109.582 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.579 HD13 ' HE3' ' C' ' 117' ' ' MET . 88.4 mt -133.5 139.5 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.688 1.195 . . . . 70.03 108.089 173.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -146.45 118.69 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.908 0.883 . . . . 71.14 109.289 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.7 t80 -124.93 131.96 53.35 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.247 -1.39 . . . . 73.05 107.247 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -137.97 118.63 14.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 75.24 108.803 -173.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -115.96 89.87 26.02 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.722 -0.844 . . . . 70.22 108.722 175.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.87 -63.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.333 2.688 . . . . 70.25 113.134 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 10.2 m-80 -98.35 41.07 1.15 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.607 -1.257 . . . . 72.15 107.607 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' D' ' 31' ' ' VAL . . . -56.75 -53.0 69.37 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.154 1.168 . . . . 62.14 114.154 -168.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.01 -8.45 15.47 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 122.394 1.891 . . . . 71.01 113.072 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.486 ' HA ' HE21 ' D' ' 33' ' ' GLN . 6.3 t-160 -74.27 -34.66 63.64 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 108.288 -1.004 . . . . 72.33 108.288 168.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.526 HG11 ' HE1' ' D' ' 123' ' ' PHE . 53.2 t -66.99 -26.63 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.512 1.125 . . . . 55.01 111.421 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.435 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.6 t80 -60.87 -34.53 74.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.032 0.444 . . . . 74.45 110.419 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.486 HE21 ' HA ' ' D' ' 30' ' ' HIS . 40.7 mt-30 -82.74 -33.2 27.54 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.462 -0.79 . . . . 65.03 110.289 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -91.94 90.86 7.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.737 0.815 . . . . 54.22 109.876 -173.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.85 59.27 3.62 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.39 1.076 . . . . 60.1 112.514 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.438 ' HB2' HD22 ' D' ' 68' ' ' LEU . 24.9 m95 -126.47 174.1 8.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.858 -0.793 . . . . 73.44 108.858 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -85.17 118.13 70.19 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 122.128 -0.358 . . . . 43.22 110.236 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.74 109.31 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.248 1.966 . . . . 74.45 110.633 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 52.2 mt-10 -62.51 111.85 2.22 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.953 0.783 . . . . 74.53 109.037 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.516 HG21 HD13 ' D' ' 126' ' ' LEU . 3.7 m -98.06 107.28 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.427 1.091 . . . . 60.31 109.267 -172.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -105.33 148.02 27.51 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.571 -0.74 . . . . 72.34 109.878 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -119.43 129.96 55.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.708 -0.678 . . . . 72.45 110.362 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 28.1 t70 -119.11 128.26 54.14 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.376 -0.972 . . . . 71.01 108.376 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -97.46 132.89 42.73 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.488 0.715 . . . . 73.34 110.03 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -146.96 156.3 42.95 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.939 -1.134 . . . . 62.14 107.939 169.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -144.57 164.39 31.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.218 0.533 . . . . 40.53 109.873 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 163.86 37.05 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.942 1.297 . . . . 70.12 108.277 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -167.13 153.47 8.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.903 0.382 . . . . 63.24 111.772 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.8 p -158.86 141.44 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.133 0.973 . . . . 71.31 109.716 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -81.75 124.06 29.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 74.42 110.856 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.7 mt -98.22 -35.71 10.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.589 0.756 . . . . 73.5 110.792 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -172.07 4.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.226 0.61 . . . . 73.43 111.085 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.53 112.56 4.18 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.288 1.035 . . . . 75.23 110.732 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 69.19 3.63 4.19 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.944 1.698 . . . . 71.12 112.847 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.2 t -109.14 118.27 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.297 0.639 . . . . 52.41 110.438 -173.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.81 130.26 45.09 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.092 1.357 . . . . 73.23 108.354 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.7 tt0 -87.08 111.87 21.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.702 -1.221 . . . . 75.32 107.702 169.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -100.09 121.01 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.961 -1.496 . . . . 72.41 106.961 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.548 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 44.3 t -99.58 132.55 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.788 0.835 . . . . 75.12 109.231 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.4 OUTLIER -105.06 128.0 53.13 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.646 -1.242 . . . . 73.1 107.646 176.075 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 31.8 ttm-85 -107.49 99.99 9.45 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.572 0.749 . . . . 74.25 109.138 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.24 122.49 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.425 -0.954 . . . . 61.11 108.425 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.8 m -114.9 142.37 46.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.638 -0.71 . . . . 55.14 109.61 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.786 HG21 HG21 ' D' ' 114' ' ' ILE . 81.1 t -130.78 127.45 61.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.127 1.371 . . . . 65.02 108.637 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -123.7 94.76 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.086 -1.079 . . . . 54.44 108.086 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -98.06 127.37 43.96 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.661 -0.866 . . . . 72.22 108.661 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.484 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.4 m -140.63 139.52 34.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.392 0.615 . . . . 73.23 111.298 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' D' ' 36' ' ' TRP . 36.1 mt -110.52 116.98 32.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.284 1.434 . . . . 71.13 109.228 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.68 -129.05 44.15 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 120.14 -0.256 . . . . 41.43 112.894 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.81 4.06 50.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.504 0.721 . . . . 75.01 112.126 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' D' ' 68' ' ' LEU . 11.8 pt-20 -124.15 154.48 39.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.129 0.572 . . . . 71.33 110.174 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 33.9 m -74.47 136.13 42.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.286 -0.635 . . . . 71.13 109.286 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.46 -57.43 3.15 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.829 -1.175 . . . . 74.34 107.829 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' D' ' 118' ' ' VAL . 49.0 p90 -161.3 149.3 15.44 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 114.696 -1.138 . . . . 73.35 110.202 169.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -100.75 150.63 22.58 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.505 -0.924 . . . . 74.24 108.505 166.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.695 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.4 t -158.1 132.54 8.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.34 0.4 . . . . 65.24 109.922 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.87 132.81 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.553 0.741 . . . . 74.21 109.25 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -132.19 119.76 41.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.701 0.801 . . . . 72.11 109.687 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.88 88.2 7.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.729 0.812 . . . . 74.23 109.491 171.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.87 102.33 9.99 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 114.466 -1.243 . . . . 63.01 109.153 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.89 145.27 18.59 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.438 -0.665 . . . . 70.14 111.438 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.99 130.62 4.75 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.809 -0.916 . . . . 73.41 110.809 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.41 ' O ' HD12 ' D' ' 13' ' ' ILE . 56.1 mt -90.13 115.78 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.677 -0.86 . . . . 74.44 108.677 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -117.58 152.42 35.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.431 1.092 . . . . 53.45 109.71 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -116.23 95.02 4.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.033 -1.099 . . . . 72.14 108.033 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.479 ' H ' HD12 ' D' ' 86' ' ' ILE . 0.1 OUTLIER -110.3 138.71 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.468 0.707 . . . . 72.03 110.038 -171.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 169.76 13.89 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.786 1.235 . . . . 53.13 109.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.21 21.76 56.18 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.56 -0.291 . . . . 70.15 112.397 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -125.01 161.04 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.485 1.114 . . . . 65.1 110.404 -176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -166.63 165.98 16.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.59 0.756 . . . . 74.53 110.467 175.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 60.35 -134.54 50.21 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 124.026 0.829 . . . . 74.12 114.178 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -79.39 -14.11 59.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.012 0.925 . . . . 55.13 112.527 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -63.89 -34.17 77.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.459 0.704 . . . . 72.43 111.564 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 22.3 ptp -71.38 -28.04 63.76 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.521 0.513 . . . . 63.31 111.038 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.81 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.568 0.747 . . . . 42.01 110.002 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 82.1 t60 -72.8 -32.9 65.88 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.058 -0.974 . . . . 63.41 110.542 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.82 -50.15 32.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.968 0.507 . . . . 60.14 110.517 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 tt -72.03 -46.02 58.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.105 0.562 . . . . 75.35 110.182 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.55 84.56 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.378 -0.679 . . . . 54.4 114.344 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.92 -63.75 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.881 0.84 . . . . 54.41 112.071 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -68.68 -44.54 73.78 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 113.474 0.916 . . . . 73.14 113.474 -165.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 56.1 m -67.22 -45.26 50.44 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 118.971 -0.538 . . . . 61.44 111.772 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.7 Cg_exo -53.7 -32.91 67.44 Favored 'Trans proline' 0 C--N 1.394 2.921 0 C-N-CA 122.931 2.421 . . . . 62.32 114.347 168.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.64 -28.12 68.31 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 122.786 0.434 . . . . 73.3 112.107 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.22 -42.13 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.604 0.716 . . . . 65.34 110.041 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.1 mt -76.33 -21.68 55.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 61.12 111.999 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -62.83 -42.98 81.5 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 117.693 -1.146 . . . . 74.12 113.623 -171.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.73 -43.85 44.0 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.061 1.841 . . . . 63.35 113.492 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 82.6 m-85 -74.22 -39.06 63.36 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.943 0.897 . . . . 64.12 112.044 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.95 80.54 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.604 0.761 . . . . 42.13 109.95 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.592 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.9 ttp180 -60.94 -48.82 80.04 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 124.353 1.033 . . . . 71.23 110.055 174.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 5.1 tm-20 -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.063 0.945 . . . . 62.44 111.956 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -58.64 -41.3 85.68 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.939 0.774 . . . . 75.15 111.147 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.786 HG21 HG21 ' D' ' 64' ' ' VAL . 65.1 mt -63.37 -56.28 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.021 0.928 . . . . 74.44 109.701 174.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 82.4 m -51.82 -40.1 59.88 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.095 1.758 . . . . 71.04 111.853 -175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.3 t -69.64 -45.04 69.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.531 -1.213 . . . . 72.04 110.226 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.2 mtm -67.0 -31.67 72.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.947 0.499 . . . . 71.41 111.847 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.496 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.7 t -62.14 -49.12 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.688 0.795 . . . . 53.13 109.677 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -72.79 -28.88 62.85 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.733 -0.667 . . . . 62.34 111.139 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.74 -25.22 61.97 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.518 0.727 . . . . 74.14 110.056 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.9 11.43 70.58 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.791 0.682 . . . . 42.35 112.828 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.546 HG23 ' HB3' ' C' ' 17' ' ' TYR . 76.8 p 61.25 14.94 5.99 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.331 1.853 . . . . 75.22 113.661 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.526 ' HE1' HG11 ' D' ' 31' ' ' VAL . 62.0 m-85 -87.27 159.57 50.36 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.97 0.908 . . . . 63.32 109.804 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.35 127.53 20.27 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.928 2.419 . . . . 64.53 111.961 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -52.28 132.29 33.8 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.097 0.873 . . . . 73.11 111.318 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.516 HD13 HG21 ' D' ' 40' ' ' VAL . 42.4 tp -108.3 115.52 30.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.521 0.728 . . . . 51.33 110.122 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -113.41 100.78 8.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.364 0.666 . . . . 43.31 109.701 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 68.1 mt -74.49 148.51 40.93 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.928 -1.033 . . . . 62.44 110.138 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.99 125.42 83.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 123.787 0.68 . . . . 73.43 110.523 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.68 99.07 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.44 2.093 . . . . 63.04 109.271 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.07 119.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.107 -0.951 . . . . 31.24 110.95 -167.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 38.7 t30 . . . . . 0 C--O 1.236 0.387 0 N-CA-C 107.649 -1.241 . . . . 63.31 107.649 167.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m . . . . . 0 C--O 1.239 0.527 0 N-CA-C 106.868 -1.53 . . . . 64.34 106.868 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 32.5 t80 -136.43 128.58 29.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.049 0.54 . . . . 72.51 109.845 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -155.6 134.56 12.08 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.481 0.488 . . . . 74.12 110.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -79.69 116.22 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.917 -1.142 . . . . 72.14 107.917 172.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.53 -39.36 46.33 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.674 -0.491 . . . . 73.54 109.674 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.8 ttt85 -169.51 136.89 1.73 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.541 0.526 . . . . 72.33 110.921 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.37 130.77 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.809 -1.182 . . . . 62.5 107.809 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 3.2 p90 -168.23 151.65 5.77 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.923 0.765 . . . . 73.02 110.77 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -80.71 117.62 21.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.612 -0.884 . . . . 54.44 108.612 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.4 mtpt -76.26 -33.47 59.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.446 0.641 . . . . 73.54 109.495 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.2 t70 -150.85 140.78 21.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.229 -1.35 . . . . 72.35 109.797 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.0 mt -137.69 142.7 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.958 1.303 . . . . 65.13 108.022 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 m -152.34 112.73 4.09 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 123.621 0.769 . . . . 65.41 110.514 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 73.5 t80 -109.98 127.72 54.96 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 105.843 -1.91 . . . . 53.53 105.843 164.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.9 143.19 51.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.787 -0.82 . . . . 74.42 108.787 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -147.86 73.48 11.34 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 106.595 -1.631 . . . . 34.43 106.595 171.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.7 -28.15 44.3 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.86 2.373 . . . . 73.35 111.435 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -111.04 32.79 5.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.285 1.034 . . . . 75.21 109.017 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -57.52 -52.4 74.56 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 118.357 -0.83 . . . . 61.45 111.947 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 53.1 Cg_exo -53.52 -33.4 67.86 Favored 'Trans proline' 0 C--N 1.403 3.417 0 C-N-CA 122.119 1.879 . . . . 51.33 113.565 173.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 10.4 m170 -67.61 -35.29 78.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.542 0.737 . . . . 73.25 111.269 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.52 -34.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.366 0.666 . . . . 73.21 111.367 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -80.71 -22.21 40.53 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.355 -0.838 . . . . 75.2 111.996 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -92.9 -23.56 18.73 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.808 0.443 . . . . 72.4 109.981 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 5.3 tmtp? -81.41 163.89 22.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.626 1.17 . . . . 75.42 109.693 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -76.61 138.88 40.38 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.124 -1.065 . . . . 60.33 108.124 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -91.5 79.71 5.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.771 0.796 . . . . 55.45 109.977 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -127.89 82.47 68.33 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.114 -1.439 . . . . 70.43 107.114 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.53 166.15 12.12 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.866 2.377 . . . . 63.31 112.545 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -112.33 99.96 8.42 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.533 -1.284 . . . . 73.23 107.533 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.79 94.32 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.482 1.113 . . . . 70.1 110.1 -171.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.5 tttt -80.33 124.79 29.16 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.357 -0.838 . . . . 73.55 109.555 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -103.98 108.75 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.007 -0.738 . . . . 75.45 109.007 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 16.1 t70 -108.34 117.87 35.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.992 0.917 . . . . 73.41 108.617 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -99.79 121.0 40.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.68 -1.23 . . . . 74.14 107.68 171.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -119.09 148.57 42.9 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.084 -1.45 . . . . 52.24 107.084 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -149.77 146.15 27.02 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 73.21 110.4 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 151.94 46.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.674 1.19 . . . . 54.23 108.959 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -135.1 161.93 33.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.971 0.508 . . . . 51.34 111.438 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -168.65 131.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.116 0.966 . . . . 73.31 109.751 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.06 115.69 17.08 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.103 -0.703 . . . . 72.33 109.103 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.45 -43.11 17.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 70.42 110.294 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.64 -173.66 4.24 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.967 -1.015 . . . . 35.03 110.487 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.81 114.59 5.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.37 0.668 . . . . 72.35 110.882 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 85' ' ' SER . 11.9 m-20 68.29 -0.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.508 1.523 . . . . 54.25 111.994 -177.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.3 t -105.18 101.86 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.568 -1.271 . . . . 41.23 107.568 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -119.03 154.0 33.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.375 -1.284 . . . . 72.21 107.756 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -124.24 123.94 41.35 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.694 -0.854 . . . . 42.04 108.694 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.61 116.29 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.802 -1.555 . . . . 75.42 106.802 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 66.0 t -96.72 132.93 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.794 -0.817 . . . . 72.04 108.794 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 112.52 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.622 -1.621 . . . . 73.22 106.622 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 23.1 ttp180 -109.63 102.34 11.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.277 -0.638 . . . . 73.3 109.277 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.75 127.93 45.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.976 -1.12 . . . . 74.03 107.976 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.7 m -116.34 122.56 45.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.044 -0.725 . . . . 53.5 109.044 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 46.5 t -116.51 106.27 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.794 1.238 . . . . 64.42 107.896 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 20.8 m -104.39 139.71 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.731 -0.84 . . . . 74.03 108.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.38 125.21 38.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.066 -1.457 . . . . 52.42 107.066 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 m -129.99 128.79 42.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.194 0.598 . . . . 63.1 110.066 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 57.0 mt -87.63 75.62 9.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.13 -1.063 . . . . 75.33 108.13 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.72 -99.66 1.38 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.427 -0.806 . . . . 50.31 112.064 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.16 -18.47 16.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.77 0.828 . . . . 62.43 111.324 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -112.37 134.51 53.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.436 0.694 . . . . 64.32 109.939 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -68.82 136.73 53.18 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.078 0.551 . . . . 74.21 111.42 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -83.01 -59.88 2.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.379 1.072 . . . . 64.13 109.334 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.97 174.8 14.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.22 -0.9 . . . . 75.23 110.337 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 tp -141.32 141.23 33.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.283 1.433 . . . . 64.11 107.891 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.3 m -129.62 135.87 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.999 -1.111 . . . . 51.42 107.999 171.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.42 116.07 6.3 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.684 -0.858 . . . . 61.53 108.684 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 t -129.59 112.74 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.651 0.781 . . . . 73.21 109.899 -173.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.3 mt-30 -83.64 87.66 7.04 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.844 -0.799 . . . . 61.24 108.844 168.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.7 tp-100 -77.11 92.96 3.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.264 -1.384 . . . . 73.42 107.264 169.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.76 143.38 21.47 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.739 -0.944 . . . . 64.35 110.739 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.17 123.01 2.1 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 110.677 -0.969 . . . . 74.12 110.677 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.6 mt -90.92 121.8 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.345 -0.983 . . . . 72.41 108.345 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 28.6 m-85 -129.73 152.59 49.06 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.518 0.727 . . . . 53.2 109.948 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.8 m -91.49 121.71 33.43 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.604 0.762 . . . . 72.12 109.25 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 94' ' ' MET . 5.8 tt -116.96 119.95 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.614 -0.513 . . . . 74.33 109.614 173.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.94 172.28 1.67 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.631 1.572 . . . . 75.11 108.895 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.44 -32.15 3.97 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 116.79 -0.187 . . . . 55.3 112.784 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.12 170.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.475 1.11 . . . . 73.11 109.206 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.0 tt0 -164.29 175.68 9.84 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.493 0.495 . . . . 75.12 110.275 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.45 -130.85 37.9 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.674 -0.694 . . . . 72.13 113.172 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 t -62.32 -27.73 69.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.241 1.016 . . . . 54.45 111.772 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -68.16 -48.89 64.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.502 0.721 . . . . 75.35 110.861 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.64 ' HB2' HD11 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -75.59 -30.49 59.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.893 0.477 . . . . 72.13 111.116 -177.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.26 67.76 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.731 0.812 . . . . 41.14 110.612 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 11.1 t-80 -76.61 -31.5 57.49 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.028 -0.987 . . . . 72.41 110.178 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.6 m -71.85 -66.13 0.68 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 123.029 0.532 . . . . 64.21 111.531 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 tt -67.74 -29.41 68.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.325 0.65 . . . . 53.34 111.044 -172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.44 -19.97 57.54 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.682 -1.065 . . . . 45.32 114.721 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.35 -48.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.201 1.5 . . . . 70.13 113.911 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 44.9 t80 -66.76 -47.87 70.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.123 0.969 . . . . 71.43 111.879 -173.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.33 -41.83 8.45 Favored Pre-proline 0 CA--C 1.565 1.555 0 C-N-CA 123.494 0.717 . . . . 64.55 112.163 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.98 -31.78 65.3 Favored 'Trans proline' 0 C--N 1.393 2.876 0 C-N-CA 122.22 1.946 . . . . 24.12 113.919 163.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -68.74 -34.6 75.87 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.563 0.745 . . . . 62.14 110.283 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.07 -42.72 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.705 0.802 . . . . 75.55 110.172 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.5 mt -76.49 -24.77 53.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.553 -1.203 . . . . 71.12 112.462 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.13 -40.18 50.95 Favored Pre-proline 0 CA--C 1.563 1.474 0 N-CA-C 114.46 1.281 . . . . 72.23 114.46 -168.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -55.08 -38.78 93.29 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.97 1.78 . . . . 72.13 113.344 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -77.65 -38.84 46.88 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.756 0.823 . . . . 72.41 111.644 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.19 77.34 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.971 0.509 . . . . 44.44 110.178 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.1 ttm180 -55.57 -51.19 67.94 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.472 1.108 . . . . 70.43 110.025 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.4 tm-20 -64.0 -41.48 97.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.125 0.891 . . . . 75.14 111.401 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.89 -42.02 98.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.838 0.712 . . . . 54.11 111.005 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.416 HG21 HG21 ' A' ' 64' ' ' VAL . 91.5 mt -66.74 -51.48 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.384 0.674 . . . . 70.52 110.528 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.694 HG23 ' HB2' ' A' ' 125' ' ' GLN . 52.4 m -52.78 -44.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.624 1.17 . . . . 70.45 110.907 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 37.8 t -64.77 -41.06 96.17 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.403 -1.271 . . . . 65.43 110.907 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 32.2 mtm -67.87 -41.31 83.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.96 0.504 . . . . 75.14 111.541 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.4 -50.34 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.792 0.837 . . . . 62.3 110.095 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 90.5 p -67.09 -32.05 72.95 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.224 -0.898 . . . . 74.51 111.105 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 116' ' ' SER . 26.9 ttm-85 -75.24 -27.44 59.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.596 1.159 . . . . 71.45 110.206 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.18 8.86 62.43 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.62 -0.718 . . . . 74.11 112.86 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' D' ' 125' ' ' GLN . 9.4 m 67.07 29.63 7.83 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.794 1.238 . . . . 73.0 110.831 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.51 151.09 41.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 114.479 -1.237 . . . . 75.0 107.905 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.76 121.53 8.43 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.784 1.656 . . . . 75.13 110.104 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.694 ' HB2' HG23 ' A' ' 115' ' ' THR . 18.5 pt20 -60.87 155.4 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.554 0.741 . . . . 65.45 111.873 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.12 122.08 26.05 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.828 -0.805 . . . . 73.42 108.828 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.432 ' ND2' ' HB ' ' C' ' 16' ' ' ILE . 2.3 m-20 -103.54 95.32 5.98 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.758 -1.201 . . . . 74.32 107.758 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 131.86 46.79 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.381 -0.6 . . . . 71.45 109.381 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.51 128.02 89.38 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 123.676 0.79 . . . . 54.23 111.886 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.01 110.24 3.08 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.025 1.817 . . . . 73.14 110.83 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.1 t -99.35 114.79 38.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.041 -1.096 . . . . 74.13 108.041 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -76.16 107.03 8.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.155 0.502 . . . . 74.24 110.117 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 65.3 t80 . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 121.3 0.571 . . . . 72.44 109.484 171.501 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.241 0.627 0 N-CA-C 109.304 -0.628 . . . . 65.52 109.304 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -129.67 128.52 42.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 71.1 109.565 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -135.43 114.63 12.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.568 0.747 . . . . 72.12 109.042 173.136 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' D' ' 129' ' ' ALA . 8.7 tt -89.91 107.12 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 108.118 -1.067 . . . . 62.33 108.118 171.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.58 -40.9 20.25 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 115.774 -0.648 . . . . 74.42 110.61 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.436 HH21 HG22 ' A' ' 122' ' ' THR . 16.3 ttt180 -170.33 145.11 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.104 0.253 . . . . 70.24 111.123 -173.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.53 149.83 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.492 -1.299 . . . . 74.23 107.492 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' B' ' 83' ' ' ILE . 23.4 p90 -171.42 150.01 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.172 0.511 . . . . 73.35 111.208 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -76.0 121.45 22.75 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.552 -0.907 . . . . 62.3 108.552 169.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.51 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.8 mtpt -88.98 -39.7 13.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.352 0.661 . . . . 63.12 109.865 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.05 148.04 27.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.08 -0.509 . . . . 74.54 110.62 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.405 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 46.0 mm -142.19 139.42 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.916 1.686 . . . . 72.42 107.462 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -141.22 136.03 31.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.182 -1.044 . . . . 60.52 108.182 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -143.72 120.94 11.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.009 -1.478 . . . . 71.11 107.009 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 23.1 mt-10 -128.76 112.0 13.72 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.447 -0.946 . . . . 73.2 108.447 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -114.44 88.65 16.1 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.7 -0.852 . . . . 73.55 108.7 176.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.08 -29.84 88.18 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.625 2.217 . . . . 61.32 112.059 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -119.99 29.41 7.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.345 1.058 . . . . 73.23 110.232 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -47.43 -50.07 51.1 Favored Pre-proline 0 CA--C 1.575 1.941 0 C-N-CA 125.236 1.414 . . . . 62.51 114.658 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.453 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 62.6 Cg_endo -81.14 -13.46 11.3 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.708 1.605 . . . . 72.11 113.422 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -94.39 2.9 55.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.419 0.687 . . . . 72.0 111.875 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.411 HG23 HD11 ' B' ' 68' ' ' LEU . 10.6 p -64.02 -17.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.626 0.771 . . . . 74.21 110.896 169.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.44 -37.47 83.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.163 0.985 . . . . 64.2 111.065 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.45 -45.36 39.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.772 0.829 . . . . 71.11 110.391 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -94.39 67.62 3.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 73.22 109.513 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -81.44 76.51 8.36 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.122 0.963 . . . . 73.32 110.871 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -158.68 167.62 29.03 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.896 1.278 . . . . 65.13 109.897 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.41 121.94 75.19 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 115.89 -0.595 . . . . 65.53 109.476 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.02 150.31 48.29 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.213 1.942 . . . . 61.14 110.899 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.78 114.13 9.55 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.867 -0.79 . . . . 65.32 108.867 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.548 HG12 HD22 ' B' ' 42' ' ' LEU . 23.5 t -85.15 117.06 29.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 107.41 -1.33 . . . . 65.31 107.41 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -140.3 102.1 4.28 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.235 -1.024 . . . . 74.11 108.235 -170.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.582 ' HG ' HD21 ' B' ' 128' ' ' LEU . 1.1 pt? -127.85 138.69 52.78 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.197 -1.365 . . . . 72.24 109.652 -170.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -126.51 148.73 49.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.843 0.857 . . . . 70.1 111.067 -170.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.566 ' HG ' HD21 ' B' ' 60' ' ' LEU . 7.6 tt -89.42 131.44 35.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.241 1.017 . . . . 73.45 109.016 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -122.89 137.45 54.94 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.858 -1.534 . . . . 72.41 106.858 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . 0.472 HG21 ' HA2' ' B' ' 99' ' ' GLY . 85.2 m -107.42 120.37 41.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.08 -0.711 . . . . 74.45 109.08 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.446 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.62 153.74 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.437 1.095 . . . . 61.42 108.129 170.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 49.5 m -143.86 172.0 13.45 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.112 0.482 . . . . 52.02 110.599 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -154.44 167.29 30.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.79 1.236 . . . . 65.2 108.591 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -123.43 130.47 52.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.054 0.541 . . . . 73.23 109.772 171.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -100.82 -40.4 7.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 63.23 110.654 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.69 -169.92 3.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.063 0.545 . . . . 73.13 111.375 -174.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . 0.401 ' O ' HG23 ' B' ' 55' ' ' VAL . 1.1 m-20 -57.62 111.3 1.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.754 -1.112 . . . . 60.21 110.967 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 68.65 0.78 2.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.033 1.333 . . . . 73.15 112.186 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 53' ' ' ASP . 95.8 t -101.08 101.06 11.57 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.231 -1.025 . . . . 43.45 108.231 -172.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -108.97 136.42 48.53 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.484 -0.78 . . . . 74.55 109.969 178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -105.92 96.76 6.71 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.97 -1.492 . . . . 64.04 106.97 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 64.4 t -87.08 122.83 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.746 0.818 . . . . 63.32 109.577 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -101.68 113.68 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.798 0.839 . . . . 51.51 109.263 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.566 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -91.77 105.94 18.1 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.811 -1.181 . . . . 64.14 107.811 177.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -97.8 108.66 21.42 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.336 -0.847 . . . . 65.02 109.497 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' B' ' 114' ' ' ILE . 18.3 t -105.41 113.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.925 -1.139 . . . . 74.24 107.925 170.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -104.4 150.89 24.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.534 0.733 . . . . 71.43 109.276 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 26.1 t -134.66 133.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.984 0.913 . . . . 61.12 110.341 -167.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.9 m -125.15 149.09 48.24 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.604 0.762 . . . . 71.14 109.253 170.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.07 147.45 29.56 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.731 0.812 . . . . 70.2 108.972 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.0 p -144.64 129.15 18.02 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.499 0.499 . . . . 74.35 111.325 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 37.0 mt -95.61 104.73 16.65 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.752 1.221 . . . . 62.4 108.3 171.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.39 -127.88 21.06 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 123.744 0.652 . . . . 71.45 111.631 -174.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -96.56 17.16 16.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.706 0.802 . . . . 62.05 111.485 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -134.84 146.76 49.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.51 0.724 . . . . 74.45 109.724 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.7 m -63.78 135.65 56.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.177 0.591 . . . . 74.34 111.04 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.92 -59.7 1.99 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.931 0.892 . . . . 63.24 108.906 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -156.54 171.35 20.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 113.962 -1.472 . . . . 64.41 109.585 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.4 mt -139.94 154.69 47.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.882 1.673 . . . . 75.23 106.99 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.2 t -159.7 160.42 34.08 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.156 -0.683 . . . . 74.53 109.156 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.42 136.83 3.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.233 -1.025 . . . . 75.23 108.233 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 97.1 t -124.18 143.82 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.973 -0.751 . . . . 74.14 108.973 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -124.0 102.08 7.57 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.531 -0.914 . . . . 74.15 108.531 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -92.16 100.11 12.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.218 -1.03 . . . . 65.32 108.218 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.51 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.88 146.64 18.51 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.146 -0.782 . . . . 74.13 111.146 177.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.81 127.75 3.39 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 110.758 -0.937 . . . . 71.14 110.758 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.455 HG13 ' HE1' ' B' ' 17' ' ' TYR . 50.3 mt -84.45 115.7 26.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.25 -1.018 . . . . 63.33 108.25 176.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.52 164.39 19.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.303 1.041 . . . . 72.23 108.849 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 16.4 m -132.43 103.68 6.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.452 -0.944 . . . . 75.55 108.452 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.556 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -115.88 134.71 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.214 0.606 . . . . 75.11 110.739 -177.214 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 172.76 18.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.466 1.106 . . . . 61.15 108.553 172.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.35 -55.01 3.55 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.703 -0.559 . . . . 62.23 111.703 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.52 154.45 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.255 1.022 . . . . 74.42 111.996 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.75 166.24 26.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.501 0.72 . . . . 73.14 110.355 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.61 -127.1 43.84 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.737 0.648 . . . . 43.14 113.71 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -65.16 -30.24 71.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.106 0.963 . . . . 62.15 111.149 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -74.07 -34.98 64.21 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.513 -0.767 . . . . 74.25 110.71 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 12.3 tpt -66.56 -47.99 71.09 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.018 -0.537 . . . . 64.21 110.241 172.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.04 77.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.11 0.881 . . . . 63.12 110.844 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -65.78 -34.53 78.38 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.51 0.724 . . . . 64.0 110.666 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -67.04 -67.9 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.637 0.375 . . . . 75.44 111.528 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -17.64 61.25 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 118.106 0.412 . . . . 74.12 112.076 -171.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.472 ' HA2' HG21 ' B' ' 46' ' ' THR . . . -108.74 2.27 32.09 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.48 -0.622 . . . . 64.32 114.607 -174.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -49.06 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 117.948 0.874 . . . . 74.12 111.387 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -72.45 -50.63 24.77 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.697 0.399 . . . . 65.01 111.471 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.24 -46.46 79.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 118.435 -0.793 . . . . 74.1 111.183 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -51.58 -41.32 61.43 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.153 1.902 . . . . 71.43 113.835 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.84 -36.84 84.54 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 123.478 0.711 . . . . 75.14 111.689 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.44 HG23 ' NH2' ' D' ' 111' ' ' ARG . 64.9 mt -62.35 -47.25 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.625 0.77 . . . . 74.25 110.418 174.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.11 -10.54 54.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.804 -1.089 . . . . 61.41 111.692 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -64.88 -49.76 66.79 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 117.411 -1.28 . . . . 73.43 113.312 -171.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -58.73 -34.64 99.08 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 121.944 1.762 . . . . 73.13 112.341 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.422 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.0 m-85 -64.31 -52.56 57.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.388 0.675 . . . . 75.41 110.358 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.86 81.94 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.764 0.825 . . . . 62.33 111.329 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.694 HH22 HG22 ' C' ' 122' ' ' THR . 53.6 ttt180 -67.61 -49.95 60.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.223 1.409 . . . . 74.32 110.414 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -34.96 78.99 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.939 0.775 . . . . 74.51 110.191 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.1 t -67.37 -45.49 76.11 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.066 0.546 . . . . 74.32 111.787 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' B' ' 62' ' ' VAL . 81.5 mt -59.35 -46.36 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.143 0.577 . . . . 55.42 110.196 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.626 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 34.2 m -53.58 -50.15 66.21 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.673 1.233 . . . . 62.2 110.045 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.5 t -59.42 -50.72 72.86 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.303 1.041 . . . . 63.21 111.852 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.559 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 20.7 mmt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.165 0.586 . . . . 73.34 112.494 -170.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.91 -32.33 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.089 0.556 . . . . 74.34 110.846 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.5 m -64.22 -30.02 71.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.555 0.742 . . . . 54.54 111.276 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 80.2 mtt-85 -68.69 -39.78 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.861 0.864 . . . . 63.45 109.844 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.32 66.47 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.838 0.711 . . . . 73.14 113.198 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p 60.55 44.95 11.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.194 1.797 . . . . 44.21 111.96 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -119.01 144.91 36.81 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 114.718 -1.128 . . . . 75.24 109.785 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -68.1 94.76 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.736 2.957 . . . . 74.3 113.718 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.626 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 3.3 mm-40 -68.21 160.79 28.5 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.332 1.063 . . . . 72.42 113.163 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.5 tt -143.02 124.83 15.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.074 -2.195 . . . . 62.01 105.074 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -87.03 136.19 33.01 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.918 -0.771 . . . . 72.3 108.918 -171.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.582 HD21 ' HG ' ' B' ' 42' ' ' LEU . 38.1 mt -58.13 144.78 39.17 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.54 0.525 . . . . 54.41 112.296 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.69 108.56 2.47 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.629 1.206 . . . . 42.23 109.912 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.457 ' HG2' ' H ' ' D' ' 16' ' ' ILE . 73.1 Cg_endo -73.59 113.55 3.81 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.505 2.137 . . . . 73.05 111.185 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.08 142.77 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.405 0.682 . . . . 74.41 110.663 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -79.38 118.61 21.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.565 1.146 . . . . 70.1 109.91 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 . . . . . 0 CA--C 1.553 1.081 0 C-N-CA 123.448 0.699 . . . . 52.31 111.702 179.312 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.241 0.617 0 N-CA-C 107.595 -1.261 . . . . 75.41 107.595 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HA ' HG22 ' C' ' 86' ' ' ILE . 37.7 t80 -91.02 132.43 36.0 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.442 -1.254 . . . . 71.21 108.27 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.409 ' HG2' ' NE2' ' C' ' 14' ' ' GLN . 25.4 tt0 -136.23 102.08 4.88 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.988 -1.115 . . . . 61.42 107.988 -178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.532 HD11 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -70.44 131.45 34.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 115.456 -0.793 . . . . 73.21 109.242 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.502 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 22.8 mm-40 -105.21 -49.37 3.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.305 0.642 . . . . 65.44 109.857 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.519 HH11 ' HB2' ' D' ' 32' ' ' PHE . 73.5 ttt180 -173.62 132.25 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.692 -0.685 . . . . 72.43 110.34 -169.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.532 HG13 HD11 ' C' ' 13' ' ' ILE . 84.0 mt -118.93 136.26 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.266 -1.013 . . . . 75.24 108.266 170.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.667 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 8.4 p90 -171.53 172.02 5.22 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.355 1.035 . . . . 75.04 110.081 -173.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -93.17 118.98 31.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.521 -0.763 . . . . 74.32 109.384 176.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.414 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 17.4 mmtp -65.83 -47.11 76.09 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.124 -1.065 . . . . 74.24 108.124 168.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.5 t70 -141.52 147.09 37.21 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.472 -1.694 . . . . 72.33 110.008 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -135.1 144.73 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.767 1.627 . . . . 72.44 106.876 172.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -150.73 146.45 26.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.508 0.671 . . . . 74.22 110.706 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -151.64 118.45 5.79 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.566 -1.642 . . . . 65.34 106.566 167.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.62 133.08 56.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.72 -1.215 . . . . 54.51 107.72 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.88 85.22 39.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.376 -1.342 . . . . 74.12 107.376 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.16 -3.37 12.75 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.619 2.213 . . . . 75.21 112.183 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.62 18.24 8.78 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 123.921 0.889 . . . . 74.34 109.764 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -47.01 -50.85 43.87 Favored Pre-proline 0 CA--C 1.575 1.905 0 N-CA-C 114.309 1.226 . . . . 72.11 114.309 -169.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 85.2 Cg_endo -86.68 -27.88 0.68 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.713 1.608 . . . . 75.05 114.107 171.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -71.09 -24.62 62.35 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.474 0.71 . . . . 55.15 112.471 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.444 HG23 HD11 ' C' ' 68' ' ' LEU . 14.4 p -75.28 -18.19 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.593 1.157 . . . . 43.44 110.922 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' D' ' 14' ' ' GLN . 42.6 t80 -59.74 -38.48 81.85 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.845 0.858 . . . . 74.22 110.81 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 5.48 51.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.283 0.633 . . . . 73.42 112.395 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.72 ' HE2' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -98.33 164.55 12.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.575 0.35 . . . . 55.32 111.866 -167.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.95 117.37 8.93 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.266 -1.013 . . . . 73.3 108.266 165.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -84.96 67.01 10.03 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.223 1.011 . . . . 73.23 111.242 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -125.07 78.52 66.37 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 124.582 1.153 . . . . 71.44 109.261 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.5 106.6 1.88 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.542 2.161 . . . . 73.2 111.422 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -84.17 120.36 26.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.098 -1.445 . . . . 72.24 107.098 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.474 HG13 HG13 ' C' ' 64' ' ' VAL . 95.6 t -96.86 148.84 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.885 -1.052 . . . . 70.1 110.959 -166.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -133.53 114.98 14.18 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.834 -1.543 . . . . 61.21 106.834 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' C' ' 128' ' ' LEU . 5.4 mp -86.44 152.73 22.44 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.64 -0.874 . . . . 63.23 108.64 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.2 t70 -154.63 148.6 25.7 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.052 -0.721 . . . . 75.44 109.052 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 tt -149.78 120.59 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.013 -0.736 . . . . 54.32 109.013 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 11.7 m-20 -121.81 144.7 48.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.739 1.216 . . . . 75.41 108.656 176.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -113.01 132.8 55.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.18 -0.674 . . . . 63.4 109.18 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.17 157.32 38.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 64.24 109.044 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.0 p -144.87 150.35 36.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.886 -0.597 . . . . 75.22 110.008 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -156.32 143.16 18.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.792 1.237 . . . . 74.22 107.906 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -105.09 132.67 51.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.133 0.492 . . . . 71.25 109.692 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.61 HD11 HD12 ' C' ' 83' ' ' ILE . 69.0 mt -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.453 -0.794 . . . . 73.24 111.252 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -172.89 4.31 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.204 0.526 . . . . 60.12 111.174 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.94 112.79 2.73 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.331 -1.304 . . . . 43.54 110.312 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 60.87 23.87 13.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.643 1.177 . . . . 74.14 112.782 -178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -114.91 116.24 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.894 . . . . 62.34 109.284 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.09 159.97 15.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.06 0.933 . . . . 74.42 110.083 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.05 124.22 36.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.517 -1.674 . . . . 52.31 107.26 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.7 125.74 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.573 -1.269 . . . . 52.31 107.573 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.56 105.59 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.412 HD22 ' O ' ' C' ' 45' ' ' ASP . 2.4 tm? -91.33 112.61 24.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.216 -1.031 . . . . 55.14 108.216 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.4 ttp180 -91.68 110.76 22.1 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.823 0.849 . . . . 72.21 109.991 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.48 124.23 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 108.161 -1.051 . . . . 71.12 108.161 173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 7.5 m -123.44 137.05 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.491 -0.559 . . . . 75.52 109.491 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.522 HG21 HG21 ' C' ' 114' ' ' ILE . 56.1 t -125.17 115.74 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.861 1.264 . . . . 41.33 108.889 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.48 144.35 28.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.209 -1.034 . . . . 55.24 108.209 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.99 37.28 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.361 -0.607 . . . . 63.21 109.361 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -137.76 138.4 39.23 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.479 0.487 . . . . 54.02 110.665 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.65 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.1 mt -86.93 43.82 1.12 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.083 1.353 . . . . 62.02 109.356 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.96 -113.17 4.37 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.517 -1.033 . . . . 73.2 110.517 -170.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.77 -10.03 41.45 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.678 0.791 . . . . 73.45 110.883 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.72 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 8.3 tp10 -90.11 128.89 36.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.308 1.443 . . . . 63.52 110.049 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 16.3 m -64.82 129.34 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.853 0.751 . . . . 75.21 109.908 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.534 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -83.36 -54.73 4.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.128 -0.694 . . . . 72.31 109.128 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -168.57 178.51 4.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.401 -1.272 . . . . 74.14 110.31 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -141.09 146.22 36.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 106.423 -1.695 . . . . 70.43 106.423 175.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.451 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -146.66 145.89 30.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.912 -1.144 . . . . 71.4 107.912 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.29 136.85 11.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.563 -0.532 . . . . 53.43 109.563 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' C' ' 110' ' ' ALA . 53.6 t -134.87 112.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.038 0.935 . . . . 61.23 108.507 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.7 mt-30 -92.71 89.51 6.69 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.822 -0.807 . . . . 65.44 108.822 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.2 tp-100 -82.59 109.82 17.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.016 -0.993 . . . . 43.34 109.767 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 144.95 17.48 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.34 0.4 . . . . 71.11 112.434 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.607 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.29 128.29 3.35 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 110.358 -1.097 . . . . 71.23 110.358 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.61 HD12 HD11 ' C' ' 51' ' ' LEU . 11.8 mm -95.19 118.69 41.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.032 -1.099 . . . . 75.04 108.032 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.47 117.13 20.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.502 -0.925 . . . . 55.13 108.502 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -98.58 107.29 19.7 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.179 -1.045 . . . . 75.21 108.179 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.8 pp -131.7 154.31 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.036 0.534 . . . . 73.45 111.065 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.25 177.46 3.59 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.483 -1.235 . . . . 63.02 109.468 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -36.53 3.69 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 116.515 -0.312 . . . . 71.32 112.46 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.409 ' H ' HG13 ' C' ' 89' ' ' ILE . 2.5 pp . . . . . 0 N--CA 1.486 1.349 0 C-N-CA 124.477 1.111 . . . . 75.15 111.402 176.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 110.237 -0.282 . . . . 74.14 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 54.8 tpp -65.46 -44.4 87.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.558 0.743 . . . . 74.41 110.243 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -26.42 68.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.553 0.741 . . . . 65.23 112.431 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -88.14 -33.51 18.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.518 0.727 . . . . 73.24 111.34 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -67.68 -61.58 1.82 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.19 0.596 . . . . 75.4 110.953 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.11 -6.64 47.56 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.191 0.441 . . . . 70.0 112.191 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.44 -29.67 21.26 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.919 -0.378 . . . . 70.11 113.527 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 -43.47 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.154 0.477 . . . . 62.11 111.778 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -72.29 -49.91 31.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.228 0.455 . . . . 71.14 112.228 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.05 -45.66 80.01 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.808 -0.615 . . . . 51.41 112.461 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.15 -23.1 60.65 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 121.877 1.718 . . . . 71.33 113.798 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -67.86 -39.74 83.72 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.352 0.661 . . . . 73.23 109.602 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.46 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.5 mm -61.61 -40.36 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 75.35 110.126 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.607 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -76.87 -27.03 54.89 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.129 -0.941 . . . . 74.43 112.288 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 51.2 t80 -57.67 -47.75 98.4 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 117.285 -1.341 . . . . 74.31 114.11 -170.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.78 -39.49 91.03 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.032 1.821 . . . . 73.31 112.863 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -63.48 -43.83 96.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.066 0.947 . . . . 75.14 111.3 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -76.04 -35.47 59.47 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.897 -0.592 . . . . 73.32 111.605 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -60.45 -47.39 86.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.275 1.43 . . . . 64.41 110.214 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -39.59 87.3 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.365 -0.834 . . . . 61.12 109.959 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.7 t -66.02 -27.99 68.53 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.398 0.679 . . . . 60.35 112.329 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.522 HG21 HG21 ' C' ' 64' ' ' VAL . 78.2 mt -73.12 -49.08 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.938 0.495 . . . . 64.21 110.113 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -58.18 -34.85 70.79 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.028 0.931 . . . . 61.11 111.143 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -62.58 -55.0 31.26 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.912 -1.495 . . . . 73.51 109.79 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.503 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -59.48 -36.92 76.94 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.802 1.241 . . . . 73.44 113.443 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.02 -41.37 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.848 0.459 . . . . 71.1 110.769 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.9 t -66.6 -30.25 70.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.278 -0.873 . . . . 63.05 110.986 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.503 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 89.4 mtt-85 -70.23 -33.46 71.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.535 0.734 . . . . 73.34 110.315 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.14 7.38 63.81 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-N 115.668 -0.696 . . . . 53.04 112.966 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.694 HG22 HH22 ' B' ' 111' ' ' ARG . 17.2 p 62.1 21.27 12.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.897 2.079 . . . . 72.02 113.488 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.31 166.4 15.51 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.168 0.987 . . . . 75.33 110.239 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.78 105.7 0.39 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.296 1.997 . . . . 71.13 111.236 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.487 HE22 ' ND2' ' C' ' 127' ' ' ASN . 0.0 OUTLIER -55.34 141.38 36.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.863 1.265 . . . . 72.54 111.418 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.76 118.14 36.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.631 0.372 . . . . 62.14 111.376 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.487 ' ND2' HE22 ' C' ' 125' ' ' GLN . 12.4 m120 -98.33 85.01 3.32 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.385 -0.969 . . . . 53.3 108.385 169.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.419 HD13 ' HG ' ' C' ' 42' ' ' LEU . 53.5 mt -78.36 142.63 37.52 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.882 -1.054 . . . . 43.23 109.15 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 141.4 94.11 Favored Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 123.934 0.894 . . . . 63.33 112.721 -169.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' C' ' 107' ' ' PHE . 82.6 Cg_endo -75.36 102.37 1.59 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.785 2.323 . . . . 73.11 111.521 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.2 t -69.19 91.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.295 0.638 . . . . 63.41 110.818 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -83.83 105.91 15.1 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.084 -0.962 . . . . 74.31 110.134 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 . . . . . 0 N--CA 1.483 1.183 0 C-N-CA 123.416 0.686 . . . . 72.52 111.229 175.066 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 62.41 108.468 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.83 100.07 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.896 -1.52 . . . . 73.33 106.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.557 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.0 mt-30 -118.31 153.73 33.49 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.421 -0.955 . . . . 64.35 108.421 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.1 141.44 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.881 -1.525 . . . . 72.54 106.881 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.448 ' HB3' ' CZ ' ' C' ' 32' ' ' PHE . 69.8 mt-30 -109.89 -35.2 6.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.84 0.456 . . . . 64.4 110.008 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -173.77 124.06 0.36 Allowed 'General case' 0 C--N 1.367 1.326 0 O-C-N 123.272 0.358 . . . . 74.24 111.028 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' B' ' 130' ' ' PRO . 38.4 mm -110.87 118.92 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 72.42 109.075 175.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' C' ' 122' ' ' THR . 9.0 p90 -149.6 175.96 11.07 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.909 0.861 . . . . 75.45 111.82 -171.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.44 HG21 HD11 ' D' ' 21' ' ' ILE . 72.2 p -98.99 119.03 37.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.238 -1.347 . . . . 62.43 109.733 175.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -84.49 -38.75 19.71 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.902 -0.59 . . . . 74.42 110.207 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.99 136.38 23.96 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.871 -0.788 . . . . 42.01 108.871 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.478 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.9 mt -130.16 132.35 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.885 -1.524 . . . . 73.51 106.885 172.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -145.44 114.96 7.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 123.394 0.434 . . . . 64.54 110.244 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.4 t80 -111.39 120.25 41.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.751 -1.574 . . . . 73.41 106.751 167.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.85 119.38 25.53 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.62 94.57 10.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 109.114 -0.699 . . . . 70.33 109.114 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.27 -57.4 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.15 2.567 . . . . 70.43 112.727 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -92.57 22.09 4.93 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.634 -0.698 . . . . 63.44 111.055 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.667 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -28.19 -64.24 0.16 Allowed Pre-proline 0 CA--C 1.577 2.018 0 N-CA-C 117.401 2.371 . . . . 70.03 117.401 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -82.95 -19.62 5.73 Favored 'Trans proline' 0 C--N 1.389 2.661 0 CA-C-N 122.491 1.925 . . . . 74.41 113.57 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -70.01 -40.99 74.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.346 1.058 . . . . 73.25 109.727 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.9 p -86.09 -0.87 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 C-N-CA 123.537 0.735 . . . . 74.32 111.249 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.519 ' HB2' HH11 ' C' ' 15' ' ' ARG . 82.3 t80 -62.1 -30.82 71.28 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.961 0.504 . . . . 53.33 110.665 164.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.44 -15.47 63.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 71.35 111.429 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.95 99.95 12.49 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.264 1.026 . . . . 73.42 109.739 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -96.88 50.75 1.11 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.33 1.052 . . . . 74.21 110.561 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -127.22 159.55 33.96 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.511 -0.922 . . . . 72.01 108.511 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -63.43 112.61 7.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.815 0.846 . . . . 60.14 109.96 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' D' ' 68' ' ' LEU . 25.8 Cg_exo -61.47 118.23 5.09 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.652 2.235 . . . . 71.35 111.671 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 51.3 mt-10 -60.38 115.56 3.64 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.235 0.959 . . . . 75.44 110.243 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.602 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -96.14 110.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 122.12 0.962 . . . . 74.11 109.027 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -97.2 107.34 19.84 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.668 -1.604 . . . . 72.21 106.668 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.584 HD22 HD22 ' D' ' 128' ' ' LEU . 55.3 tp -97.14 113.71 25.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.248 -0.649 . . . . 72.51 109.248 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.8 t70 -113.6 148.74 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.503 -0.554 . . . . 62.11 109.503 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 tp -119.88 135.05 55.03 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.686 0.794 . . . . 72.4 110.543 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -144.05 142.95 30.94 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.155 -1.054 . . . . 74.42 108.155 168.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -120.89 166.54 13.66 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.45 0.7 . . . . 74.04 109.279 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.74 169.3 24.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.183 0.993 . . . . 62.53 109.015 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 13.3 p -165.0 155.8 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.947 0.404 . . . . 74.54 111.738 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -152.75 135.7 15.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 51.11 109.147 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.35 118.06 22.34 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.394 -0.595 . . . . 70.01 109.394 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' D' ' 57' ' ' GLU . 34.6 mt -95.19 -34.31 12.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.196 0.598 . . . . 60.31 110.267 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.45 -173.43 4.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.03 0.932 . . . . 70.53 110.357 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.58 120.62 14.29 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.316 -0.856 . . . . 75.21 109.519 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 63.46 14.43 7.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.742 1.217 . . . . 61.21 112.178 -176.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.87 119.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.225 -0.657 . . . . 74.15 109.225 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -133.08 130.48 39.39 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.243 1.017 . . . . 73.5 108.376 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.49 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.1 tt0 -87.18 112.71 22.24 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.949 -1.13 . . . . 75.52 107.949 169.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.32 124.13 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.006 -1.479 . . . . 73.2 107.006 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 32.8 t -105.02 135.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.691 0.797 . . . . 70.24 109.024 -177.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 121.18 44.6 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.923 -1.14 . . . . 64.41 107.923 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.4 ttm-85 -103.68 102.28 12.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.835 -1.172 . . . . 64.14 107.835 173.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.571 HG21 ' HB1' ' D' ' 110' ' ' ALA . 19.8 t -98.44 120.61 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.664 -0.865 . . . . 71.45 108.664 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.1 m -108.04 137.41 46.09 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.187 0.595 . . . . 72.3 109.931 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.602 HG13 HG23 ' D' ' 40' ' ' VAL . 50.7 t -136.89 108.04 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 61.24 108.054 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.9 m -101.07 126.94 47.8 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.317 -0.994 . . . . 54.21 108.317 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -111.94 141.44 45.58 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.323 -0.621 . . . . 53.21 109.323 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 57.5 p -145.13 141.99 29.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.708 0.63 . . . . 73.41 111.016 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' D' ' 38' ' ' PRO . 39.9 mt -136.35 112.51 9.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.777 1.231 . . . . 74.21 109.456 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.12 -109.72 2.97 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.368 -0.693 . . . . 72.24 111.368 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -122.54 4.09 9.6 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.495 0.718 . . . . 65.43 110.588 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.7 153.09 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.316 0.646 . . . . 72.45 110.601 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -76.53 116.61 17.37 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 122.774 0.429 . . . . 70.23 110.42 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -69.5 -56.58 6.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.541 -0.754 . . . . 73.44 111.026 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.96 174.06 15.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.43 -0.804 . . . . 64.43 110.654 170.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.36 145.19 51.73 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.88 -1.526 . . . . 73.12 106.88 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.523 ' SG ' HG23 ' D' ' 114' ' ' ILE . 53.0 t -157.79 121.21 4.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.863 -0.792 . . . . 72.13 108.863 -174.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.83 129.03 10.46 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.468 -0.567 . . . . 70.42 109.468 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.94 121.2 53.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.875 0.87 . . . . 63.22 109.577 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -87.84 85.01 6.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.387 -0.968 . . . . 74.2 108.387 167.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -79.98 97.8 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.324 -0.991 . . . . 60.12 108.324 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.59 143.72 16.74 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.859 -0.496 . . . . 42.14 111.859 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.43 131.48 4.86 Favored Glycine 0 CA--C 1.505 -0.532 0 N-CA-C 111.421 -0.672 . . . . 53.32 111.421 -175.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -90.31 125.72 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.574 -0.899 . . . . 71.04 108.574 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.5 127.86 43.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.942 0.897 . . . . 72.12 109.684 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 49.0 m -81.82 93.18 6.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.256 -1.016 . . . . 53.42 108.256 165.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.52 128.36 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.968 1.707 . . . . 64.42 109.751 -172.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 164.99 20.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 72.53 109.958 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.07 11.54 80.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.092 -0.504 . . . . 71.44 114.182 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.17 168.35 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.457 0.703 . . . . 74.12 110.571 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -162.51 146.61 11.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.894 -1.048 . . . . 73.34 109.815 -176.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.88 -107.61 0.12 Allowed Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.307 1.004 . . . . 60.24 114.915 169.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -67.27 -38.58 85.33 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.492 0.717 . . . . 62.45 110.937 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.72 -31.95 73.28 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.77 0.828 . . . . 72.43 110.573 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 45.1 ttm -67.74 -50.77 55.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.682 0.793 . . . . 64.23 110.284 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.24 62.69 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.829 -0.623 . . . . 63.53 111.303 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -79.51 -32.37 42.33 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.398 0.679 . . . . 72.33 110.31 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.2 t -78.27 -52.75 8.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 117.729 0.24 . . . . 55.2 110.356 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.41 -18.52 31.56 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.658 0.383 . . . . 74.31 111.788 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.68 -8.98 29.54 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.266 -0.741 . . . . 61.24 114.254 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.33 -55.21 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.027 0.914 . . . . 65.04 112.329 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -76.34 -50.94 12.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.096 0.559 . . . . 70.45 111.994 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 106' ' ' LEU . 71.0 m -60.96 -46.19 96.69 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 118.438 -0.791 . . . . 74.43 110.478 176.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.96 -39.57 59.27 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.263 1.976 . . . . 65.42 114.019 163.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.03 -26.61 65.07 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.353 0.661 . . . . 63.15 110.753 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -72.56 -38.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.892 0.877 . . . . 74.51 110.387 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.53 HD21 ' HA3' ' D' ' 82' ' ' GLY . 42.3 mt -79.64 -17.89 52.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.032 -0.986 . . . . 55.21 111.209 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -68.69 -38.64 12.46 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.18 1.178 . . . . 62.42 114.18 -171.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.34 -46.78 29.93 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.101 1.868 . . . . 74.05 113.095 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.86 -33.21 68.24 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.158 -0.928 . . . . 65.14 111.123 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -67.61 -54.24 21.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.927 0.891 . . . . 72.21 110.152 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -50.56 -46.5 57.65 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.987 1.43 . . . . 74.0 110.811 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -66.43 -46.07 77.7 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.175 0.922 . . . . 72.3 111.732 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.95 -41.71 92.44 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.737 0.648 . . . . 72.2 110.709 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.523 HG23 ' SG ' ' D' ' 76' ' ' CYS . 81.7 mt -59.45 -56.99 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.365 1.066 . . . . 51.53 110.671 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.633 HG23 ' HG3' ' D' ' 125' ' ' GLN . 54.9 m -53.93 -41.37 67.63 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.276 1.43 . . . . 75.31 111.865 -174.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -67.82 -42.59 81.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.923 -1.035 . . . . 73.13 109.958 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.444 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.6 mtm -71.11 -28.07 64.05 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.887 0.475 . . . . 64.34 111.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.42 -42.74 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.438 0.695 . . . . 64.41 110.135 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -74.38 -26.53 60.17 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.972 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -76.09 -24.16 55.02 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.458 0.703 . . . . 72.23 109.826 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.72 12.24 66.15 Favored Glycine 0 C--N 1.352 1.432 0 O-C-N 123.654 0.596 . . . . 74.33 112.258 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.595 HG23 ' HB3' ' C' ' 17' ' ' TYR . 80.6 p 62.95 9.98 4.09 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 127.385 2.274 . . . . 71.43 114.6 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.467 ' HZ ' HG13 ' D' ' 31' ' ' VAL . 41.9 m-85 -89.37 156.42 48.34 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.172 0.589 . . . . 74.31 110.65 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.89 141.37 89.52 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.714 2.276 . . . . 74.21 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.633 ' HG3' HG23 ' D' ' 115' ' ' THR . 28.2 tt0 -54.51 145.55 18.32 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.686 1.194 . . . . 74.34 112.107 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 114.8 15.74 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.065 -1.087 . . . . 71.43 108.065 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -100.78 93.24 5.46 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.12 -0.696 . . . . 72.32 109.12 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.584 HD22 HD22 ' D' ' 42' ' ' LEU . 89.0 mt -59.0 115.48 3.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.25 0.62 . . . . 72.23 110.92 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -65.3 127.84 93.26 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.773 0.429 . . . . 74.54 111.867 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.28 102.01 1.52 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 75.05 110.399 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.01 130.0 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.537 -0.756 . . . . 73.2 109.71 -174.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 . . . . . 0 C--O 1.242 0.706 0 N-CA-C 108.4 -0.963 . . . . 75.24 108.4 173.853 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.7 m . . . . . 0 CA--C 1.548 0.889 0 N-CA-C 109.52 -0.548 . . . . 75.3 109.52 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.473 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 65.3 t80 -128.13 147.35 50.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.053 0.941 . . . . 72.2 109.676 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -158.93 137.37 10.8 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 120.74 0.305 . . . . 75.25 111.394 173.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' C' ' 132' ' ' ASN . 13.5 mm -74.78 118.73 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.427 -0.953 . . . . 72.52 108.427 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -89.25 -38.39 14.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.685 -0.487 . . . . 74.1 109.685 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.98 153.24 4.64 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 123.39 0.432 . . . . 74.01 111.259 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' C' ' 130' ' ' PRO . 98.3 mt -137.02 126.68 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.731 1.613 . . . . 54.25 106.814 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -154.61 157.11 37.71 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.461 1.104 . . . . 70.0 109.598 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.56 HG21 ' SG ' ' A' ' 113' ' ' CYS . 45.3 p -86.99 117.17 25.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.881 -0.785 . . . . 71.31 108.881 170.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 42.0 mtpt -83.56 -22.35 32.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.43 0.292 . . . . 71.03 110.284 173.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.4 t70 -153.8 140.02 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.681 -0.691 . . . . 75.22 109.667 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 40.8 mt -136.64 133.18 48.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.953 -1.499 . . . . 73.32 106.953 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -145.37 107.59 4.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.156 -0.683 . . . . 33.42 109.156 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.2 t80 -119.25 110.32 16.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.872 -1.529 . . . . 73.13 106.872 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 40.6 mt-10 -116.95 108.21 15.5 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.756 -1.572 . . . . 70.4 106.756 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.68 83.05 0.72 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 106.946 -1.502 . . . . 72.12 106.946 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 13.7 Cg_exo -68.69 -31.63 25.57 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.726 2.284 . . . . 72.35 111.704 -168.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 27.7 m-80 -118.24 39.99 3.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.059 -0.973 . . . . 61.43 108.807 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.23 -50.0 87.17 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.083 -0.962 . . . . 75.11 113.203 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 -24.67 22.33 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 121.775 1.65 . . . . 45.12 113.132 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -69.76 -24.45 63.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.408 0.683 . . . . 70.02 111.802 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG11 ' HE1' ' A' ' 123' ' ' PHE . 88.6 t -57.21 -33.26 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.401 0.68 . . . . 43.34 111.465 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -64.05 -32.13 73.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.748 0.819 . . . . 72.41 111.224 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -80.49 -27.04 37.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.352 1.061 . . . . 64.23 110.255 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -82.67 162.07 21.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 75.33 112.362 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.92 129.29 34.72 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.363 -1.347 . . . . 71.21 107.363 163.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.1 t-105 -77.32 84.17 3.76 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.745 0.784 . . . . 72.35 110.329 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -132.01 77.11 72.34 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.204 -1.406 . . . . 74.14 107.204 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.8 146.17 37.59 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.102 1.868 . . . . 64.34 112.077 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -96.34 86.12 4.12 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.39 -1.708 . . . . 75.15 106.39 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.01 102.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.54 -1.209 . . . . 62.54 110.823 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -111.49 146.18 37.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.918 0.887 . . . . 73.31 110.184 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.01 153.19 37.68 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.76 0.824 . . . . 62.51 110.659 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.0 t70 -142.9 113.82 7.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.883 0.873 . . . . 54.21 108.66 174.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -98.84 119.97 38.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.5 -0.926 . . . . 45.04 108.5 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.3 142.87 39.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 74.44 109.952 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -110.03 144.76 38.13 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.817 0.847 . . . . 70.4 108.815 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.34 113.63 12.81 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.077 -1.083 . . . . 23.44 108.077 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 35.5 p -88.04 151.02 23.06 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.268 0.627 . . . . 64.32 111.062 -172.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.0 t -163.0 136.72 5.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.207 1.003 . . . . 64.11 109.098 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.64 124.53 52.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.029 0.531 . . . . 72.22 109.75 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.82 -43.16 12.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.33 0.652 . . . . 73.4 110.055 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.28 175.43 13.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.638 -1.164 . . . . 73.42 109.676 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.06 119.1 11.44 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.609 -0.886 . . . . 74.42 108.609 173.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 78.26 -7.66 1.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.778 1.631 . . . . 72.21 113.19 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.83 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.786 -1.19 . . . . 74.21 107.786 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' A' ' 48' ' ' SER . 9.3 t80 -117.24 155.33 29.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.844 -0.798 . . . . 71.14 108.844 -171.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -127.23 113.77 16.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.315 -0.994 . . . . 71.04 108.315 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.09 117.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.863 -1.532 . . . . 71.14 106.863 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.6 t -98.36 131.87 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -102.12 112.27 24.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.261 -1.385 . . . . 72.11 107.261 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -101.87 99.98 10.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.439 -0.948 . . . . 75.24 108.439 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -98.0 132.94 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.991 -1.114 . . . . 74.34 107.991 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 18.7 m -128.77 137.69 51.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.169 0.509 . . . . 72.32 110.096 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.729 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.3 t -130.94 125.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.354 1.462 . . . . 61.44 108.695 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -118.58 150.64 39.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.684 0.394 . . . . 71.44 110.097 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.02 112.17 8.02 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.593 -0.892 . . . . 64.23 108.593 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -113.01 126.39 55.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.356 0.598 . . . . 64.34 110.411 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.0 mt -89.18 75.6 7.82 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.025 1.33 . . . . 71.21 108.652 175.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -82.91 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 111.07 -0.812 . . . . 45.23 111.07 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 -19.1 5.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.457 1.103 . . . . 71.24 111.742 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.68 126.94 36.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.031 0.933 . . . . 70.31 109.305 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -77.16 127.59 32.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.148 0.885 . . . . 74.44 110.388 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -77.9 -55.74 5.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.081 0.952 . . . . 71.33 108.818 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -157.66 169.34 24.88 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.895 -1.502 . . . . 72.12 110.429 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 tp -141.17 138.11 33.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.39 -1.277 . . . . 64.44 108.164 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.2 m -128.82 140.6 51.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.038 0.935 . . . . 73.32 109.531 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -149.42 133.53 17.23 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.388 -0.967 . . . . 74.24 108.388 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.81 110.52 12.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.504 -0.924 . . . . 74.43 108.504 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.2 mt-30 -88.88 79.57 7.33 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.147 -1.057 . . . . 75.53 108.147 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.06 92.77 3.21 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.032 -0.985 . . . . 75.13 108.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.47 146.48 20.88 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.363 -0.38 . . . . 72.11 112.704 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.1 135.89 6.72 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.789 0.295 . . . . 64.53 112.409 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.7 mt -82.27 126.92 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.332 -0.988 . . . . 74.23 108.332 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.464 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.1 m-85 -133.18 121.0 21.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.876 -0.787 . . . . 71.45 108.876 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -78.31 113.36 16.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.644 -0.873 . . . . 41.45 108.644 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.31 133.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.559 0.744 . . . . 65.14 110.188 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.04 144.84 14.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.804 0.841 . . . . 75.41 109.698 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.37 9.21 86.79 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.783 0.677 . . . . 65.43 113.961 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' SD ' ' A' ' 94' ' ' MET . 0.9 OUTLIER -109.89 131.44 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.124 -0.695 . . . . 73.13 109.124 -173.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -147.22 176.33 10.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.073 0.949 . . . . 53.24 109.727 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 -114.98 3.89 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 124.185 0.928 . . . . 71.13 113.994 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.2 p -82.3 -27.29 32.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.51 1.124 . . . . 60.34 111.17 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.57 -42.55 67.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.896 0.879 . . . . 63.32 110.523 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.635 ' SD ' HD13 ' A' ' 89' ' ' ILE . 10.6 tpt -78.52 -34.65 47.15 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.174 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.06 -29.18 70.34 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.004 0.43 . . . . 52.13 111.313 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -70.71 -56.16 7.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.295 -0.866 . . . . 74.43 109.709 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 77.3 m -65.48 -65.53 0.66 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 123.867 0.729 . . . . 52.32 111.978 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.04 -33.73 76.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.334 1.053 . . . . 73.13 112.114 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.9 -37.26 9.44 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.66 0.624 . . . . 50.15 114.66 -170.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.31 -50.38 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 117.948 0.874 . . . . 64.44 113.348 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 90.1 t80 -68.06 -63.14 1.12 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.435 0.694 . . . . 71.21 111.7 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -61.81 -37.49 40.25 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 123.748 0.819 . . . . 63.44 113.209 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.84 -49.82 16.0 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.217 1.945 . . . . 62.11 113.081 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -73.93 -15.65 61.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.429 0.692 . . . . 73.34 112.007 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 13' ' ' ILE . 48.1 mm -62.14 -42.67 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.731 0.777 . . . . 64.33 109.505 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 60' ' ' LEU . 52.3 mt -75.31 -21.62 58.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.423 -1.262 . . . . 73.12 112.156 -173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -67.05 -40.65 30.23 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 114.429 1.27 . . . . 74.12 114.429 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.27 -41.31 77.88 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.173 1.915 . . . . 75.34 112.813 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -72.95 -36.85 67.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.493 0.717 . . . . 71.44 110.976 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.46 94.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.471 0.708 . . . . 75.4 109.944 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 44.6 ttm105 -55.6 -48.98 73.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.618 1.199 . . . . 62.14 110.798 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -45.25 90.99 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.837 0.711 . . . . 64.12 110.301 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.56 ' SG ' HG21 ' A' ' 18' ' ' THR . 42.1 t -61.37 -24.41 66.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.338 -0.846 . . . . 52.32 112.468 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 64' ' ' VAL . 94.9 mt -85.02 -53.0 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.574 0.749 . . . . 62.24 110.002 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -55.3 -40.95 71.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.67 1.188 . . . . 74.01 112.216 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.2 t -60.98 -45.55 94.35 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.025 -0.989 . . . . 73.02 111.025 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.667 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.9 mtm -64.4 -46.03 85.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.389 0.675 . . . . 74.25 111.313 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -58.5 -51.02 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.572 -1.195 . . . . 75.0 110.846 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 24.1 t -68.05 -25.86 65.57 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.195 -0.912 . . . . 61.13 111.419 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -78.83 -26.0 44.18 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.421 1.088 . . . . 74.55 110.657 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 13.0 54.14 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-N 115.698 -0.683 . . . . 73.32 112.618 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.512 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 7.0 m 67.98 40.31 2.31 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 124.792 1.237 . . . . 74.33 110.336 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.45 ' HE1' HG11 ' A' ' 31' ' ' VAL . 48.0 m-85 -119.37 157.15 52.14 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.647 -1.161 . . . . 75.34 108.782 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -70.37 148.47 61.18 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.155 1.904 . . . . 62.44 111.298 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.6 tt0 -60.01 139.89 57.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.525 0.73 . . . . 75.12 111.413 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.3 114.75 15.41 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.89 -0.781 . . . . 73.02 108.89 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -109.9 105.77 15.08 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.53 128.32 35.16 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.082 -0.71 . . . . 51.24 109.082 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.8 97.45 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.516 0.727 . . . . 50.42 111.01 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.56 143.99 35.18 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.237 1.958 . . . . 54.21 110.978 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.55 109.68 25.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.042 -1.466 . . . . 64.22 107.042 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -99.95 74.7 1.82 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.402 -1.332 . . . . 65.41 107.402 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.474 0.733 0 CA-C-N 114.419 -1.264 . . . . 75.11 110.439 179.819 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 18.9 p . . . . . 0 CA--C 1.54 0.577 0 N-CA-C 106.979 -1.489 . . . . 74.22 106.979 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -124.5 113.17 17.75 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.997 -0.742 . . . . 73.53 108.997 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.52 130.45 34.63 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.969 -0.752 . . . . 72.43 108.969 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.543 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -85.36 120.34 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.633 -1.247 . . . . 73.4 107.633 178.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -90.3 -42.47 10.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 75.21 110.451 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.512 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 48.3 ttt180 -168.5 137.41 2.28 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.041 -0.527 . . . . 64.42 109.728 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.543 HG13 HD11 ' B' ' 13' ' ' ILE . 69.4 mt -113.33 133.98 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.468 -1.678 . . . . 71.53 106.468 168.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.458 ' HE1' HG13 ' B' ' 83' ' ' ILE . 29.9 p90 -164.85 146.81 8.11 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.013 0.82 . . . . 74.02 110.973 -173.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.4 m -74.9 121.92 22.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.403 -0.817 . . . . 75.14 109.707 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -93.99 -31.66 14.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.335 0.654 . . . . 73.33 110.907 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.6 t70 -153.03 141.16 20.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.689 -0.687 . . . . 63.03 110.409 -170.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.483 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 36.0 mm -136.96 142.92 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.551 1.54 . . . . 61.22 107.831 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -148.1 133.62 18.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.222 -1.029 . . . . 34.25 108.222 172.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -150.41 127.73 11.36 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.334 -1.358 . . . . 75.25 107.334 169.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.24 155.97 41.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.523 1.129 . . . . 64.43 108.507 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -149.34 79.86 8.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.597 -1.26 . . . . 71.32 107.597 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.75 -23.44 30.83 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.989 2.459 . . . . 62.23 112.3 -173.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 93.1 m-20 -124.97 31.11 5.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.194 0.998 . . . . 72.31 109.854 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.573 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.6 -47.91 69.67 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 124.967 1.307 . . . . 70.15 113.772 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.47 -23.05 10.29 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.024 1.816 . . . . 72.32 113.551 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 69.4 m-70 -78.42 3.45 15.77 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.973 0.909 . . . . 72.4 112.894 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.38 -18.88 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 123.425 0.69 . . . . 73.21 111.192 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -83.48 -28.06 29.0 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.894 0.477 . . . . 65.4 110.344 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.78 -42.48 70.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.12 0.968 . . . . 74.24 109.866 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.72 113.07 26.31 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.322 1.049 . . . . 54.21 109.53 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -72.9 80.78 1.17 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.166 0.586 . . . . 73.2 110.221 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -170.02 151.35 4.01 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.044 -1.095 . . . . 74.43 108.044 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -95.0 127.86 41.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.547 -0.74 . . . . 64.44 109.651 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.518 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 25.1 Cg_endo -60.02 121.97 10.65 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.995 2.463 . . . . 63.23 112.169 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 109.25 2.61 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.784 0.677 . . . . 74.42 109.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' B' ' 125' ' ' GLN . 6.2 t -85.5 117.16 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.054 -0.721 . . . . 75.23 109.054 -168.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -136.28 144.22 44.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.291 0.636 . . . . 61.13 110.465 -169.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.477 HD23 ' N ' ' B' ' 43' ' ' ASP . 8.6 tt -126.45 152.49 46.34 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.069 0.948 . . . . 74.13 109.874 -164.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.477 ' N ' HD23 ' B' ' 42' ' ' LEU . 29.5 t70 -137.11 140.85 42.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.753 1.221 . . . . 65.33 110.04 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.16 127.97 56.09 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.058 0.943 . . . . 60.2 109.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -140.62 152.76 45.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.865 1.266 . . . . 70.11 108.984 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.5 m -145.62 134.4 22.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.007 0.523 . . . . 52.11 110.601 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.66 162.97 30.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.071 1.348 . . . . 63.13 108.894 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.1 m -135.62 163.39 30.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.922 0.489 . . . . 74.23 110.369 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.37 139.21 18.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.888 0.875 . . . . 74.22 109.025 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -82.07 132.05 35.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.476 0.711 . . . . 71.14 109.408 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.0 mt -89.58 -53.08 4.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.792 -0.818 . . . . 64.3 108.792 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.39 -172.36 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.424 -0.807 . . . . 74.35 110.6 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.39 116.84 7.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.319 -0.855 . . . . 72.33 110.078 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 65.12 13.2 8.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.028 1.731 . . . . 75.23 112.602 -178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.29 100.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.232 1.013 . . . . 75.13 108.603 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -97.28 165.95 11.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.608 0.718 . . . . 75.4 109.847 171.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -144.61 104.63 4.06 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.316 -1.364 . . . . 73.44 107.316 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.63 123.4 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.711 0.804 . . . . 72.31 109.507 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.2 t -105.54 120.82 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 75.51 109.8 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.3 119.82 34.47 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.909 -1.145 . . . . 75.42 107.909 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -107.9 110.3 22.02 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.294 0.638 . . . . 73.22 110.394 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.2 115.15 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.237 -1.023 . . . . 34.02 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -110.68 129.37 55.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.941 0.497 . . . . 73.3 109.862 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.568 HG21 HG21 ' B' ' 114' ' ' ILE . 54.5 t -119.36 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.274 1.03 . . . . 74.02 110.317 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 37.7 m -114.7 150.56 35.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 74.33 109.726 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -147.28 146.78 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.232 -1.025 . . . . 71.34 108.232 167.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -148.2 139.48 23.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.351 0.596 . . . . 63.41 111.476 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 46.8 mt -113.42 118.4 34.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.329 1.051 . . . . 71.52 109.348 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.52 -111.92 3.77 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.864 0.728 . . . . 44.4 112.605 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 4.89 21.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.71 0.804 . . . . 75.31 111.712 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -139.21 175.48 9.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.604 0.362 . . . . 72.55 110.84 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -69.69 150.0 47.45 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.196 0.998 . . . . 75.32 111.0 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.401 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -105.89 -57.4 2.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.987 -1.116 . . . . 71.04 107.987 169.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.447 ' HZ ' HG13 ' B' ' 40' ' ' VAL . 5.5 p90 -147.41 159.66 43.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.574 -1.193 . . . . 73.02 109.575 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.8 mt -127.55 157.99 38.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.163 1.385 . . . . 73.43 108.67 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' B' ' 114' ' ' ILE . 16.4 t -156.77 158.05 36.15 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.495 -0.557 . . . . 40.21 109.495 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.54 132.55 2.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.622 1.169 . . . . 71.24 108.236 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' B' ' 21' ' ' ILE . 56.0 t -128.11 147.36 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.036 -0.727 . . . . 75.33 109.036 174.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 19.5 mt-30 -126.8 93.3 3.74 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.883 0.849 . . . . 75.21 109.291 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -86.11 100.25 12.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.59 -1.641 . . . . 73.34 109.65 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.65 164.48 26.64 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 111.966 -0.454 . . . . 72.44 111.966 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.25 126.24 1.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.047 -0.821 . . . . 71.31 111.047 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.458 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.3 mt -84.56 127.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.369 -0.975 . . . . 74.05 108.369 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.66 131.5 39.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.148 -1.427 . . . . 72.33 107.148 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -96.25 102.53 14.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.551 -0.907 . . . . 61.14 108.551 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' B' ' 10' ' ' THR . 2.8 pp -122.94 139.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 115.669 -0.696 . . . . 75.11 110.584 -175.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.65 173.66 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.076 1.351 . . . . 51.3 107.852 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.03 -51.12 2.83 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 122.633 0.159 . . . . 74.13 112.893 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.532 HD13 ' HG2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -51.28 143.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.958 0.903 . . . . 71.44 111.178 172.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 144.26 24.82 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.644 -0.502 . . . . 74.0 109.644 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.25 -110.9 3.54 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 124.518 1.136 . . . . 73.2 113.335 174.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -64.13 -47.79 78.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.297 0.639 . . . . 75.34 110.046 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.505 ' HB3' HG22 ' B' ' 89' ' ' ILE . 89.1 mt-30 -63.58 -35.3 80.04 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 124.664 1.227 . . . . 75.35 111.484 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.532 ' HG2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -67.25 -56.8 8.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.364 -0.835 . . . . 71.11 110.24 -177.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -16.66 61.85 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.169 -0.923 . . . . 71.31 111.673 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -73.05 -39.17 66.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.098 0.959 . . . . 73.1 109.795 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -67.6 -63.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.102 -0.953 . . . . 54.32 110.969 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -77.82 -15.18 59.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 122.126 -0.359 . . . . 75.15 111.736 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.06 35.81 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.508 0.505 . . . . 61.43 113.711 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.55 -44.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.344 0.572 . . . . 64.43 112.535 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.97 -47.88 70.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.435 0.694 . . . . 73.11 112.282 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m -65.28 -50.49 59.11 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 123.583 0.753 . . . . 64.42 111.87 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.73 -24.09 55.2 Favored 'Trans proline' 0 C--N 1.398 3.162 0 C-N-CA 121.568 1.512 . . . . 55.22 113.291 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.06 -36.86 85.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.364 0.602 . . . . 75.43 110.904 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.412 HG23 ' NH2' ' D' ' 111' ' ' ARG . 66.7 mt -61.05 -46.7 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.61 1.164 . . . . 75.33 110.564 173.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.52 -10.95 58.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.491 -1.231 . . . . 63.52 111.701 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -63.28 -52.18 63.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.587 1.155 . . . . 71.15 113.153 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.9 -31.88 66.8 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 121.772 1.648 . . . . 74.52 112.964 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.472 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.7 m-85 -63.81 -51.11 66.23 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.912 0.485 . . . . 74.24 110.845 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.53 91.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.288 1.035 . . . . 72.12 111.72 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -58.29 -63.07 1.4 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.197 0.936 . . . . 70.11 109.419 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.49 -29.2 66.07 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.207 1.003 . . . . 73.51 111.311 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.483 ' SG ' ' CD1' ' B' ' 21' ' ' ILE . 23.9 t -62.87 -60.22 3.77 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.473 0.709 . . . . 45.33 112.307 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.699 HG23 ' SG ' ' B' ' 76' ' ' CYS . 85.3 mt -57.82 -44.57 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.084 0.954 . . . . 73.52 110.388 176.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.572 HG23 ' HB3' ' B' ' 125' ' ' GLN . 22.8 m -64.61 -25.3 67.9 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.463 -1.699 . . . . 54.33 111.435 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -80.52 -31.38 37.12 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.469 0.708 . . . . 62.33 110.839 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.4 mmt -71.65 -42.71 67.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.224 0.609 . . . . 62.42 111.647 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' B' ' 125' ' ' GLN . 96.4 t -73.91 -27.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.532 0.733 . . . . 61.04 110.615 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.428 ' OG ' HG21 ' C' ' 115' ' ' THR . 34.0 t -56.94 -34.52 68.08 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.8 0.84 . . . . 61.45 111.063 171.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.481 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 53.3 mtt-85 -80.12 -35.54 36.58 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.85 -1.068 . . . . 74.12 110.359 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.68 1.69 36.19 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.849 0.718 . . . . 60.23 112.597 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 70.22 25.26 4.63 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 127.115 2.166 . . . . 73.24 113.598 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.434 ' O ' HG12 ' B' ' 118' ' ' VAL . 65.2 m-85 -120.32 149.12 48.95 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.765 0.826 . . . . 71.11 109.253 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.401 ' HA ' HE21 ' C' ' 125' ' ' GLN . 84.4 Cg_endo -82.03 101.73 1.17 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.674 2.249 . . . . 75.43 112.303 177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.717 ' HA ' HG11 ' B' ' 40' ' ' VAL . 0.0 OUTLIER -65.15 157.17 29.42 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.047 -0.978 . . . . 74.51 110.096 170.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 44.7 tp -110.11 129.34 55.71 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.406 1.882 . . . . 60.12 108.296 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.98 125.61 32.84 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 106.548 -1.649 . . . . 73.24 106.548 173.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.426 ' HG ' HD22 ' B' ' 42' ' ' LEU . 0.9 OUTLIER -52.73 134.33 36.38 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.877 1.361 . . . . 74.53 109.08 -175.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -38.35 103.02 0.26 Allowed Pre-proline 0 C--N 1.361 1.095 0 O-C-N 125.824 1.953 . . . . 74.34 111.236 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.487 ' HG3' HG21 ' C' ' 122' ' ' THR . 57.1 Cg_endo -67.89 99.76 0.57 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.516 2.144 . . . . 65.14 110.843 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -147.94 115.18 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.455 -1.313 . . . . 72.43 107.455 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.91 103.1 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.683 -1.228 . . . . 43.32 107.683 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 64.9 t80 . . . . . 0 CA--C 1.552 1.027 0 C-N-CA 124.41 1.084 . . . . 73.5 111.937 -177.552 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 73.5 p . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.745 -0.465 . . . . 65.12 109.745 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.758 ' HA ' HG22 ' C' ' 86' ' ' ILE . 46.7 t80 -118.69 124.58 47.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.38 0.672 . . . . 73.44 109.673 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -139.35 124.94 19.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.328 0.651 . . . . 54.44 109.471 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.578 HD11 HG13 ' C' ' 16' ' ' ILE . 6.0 tp -82.01 134.19 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.945 -0.761 . . . . 75.21 108.945 170.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.554 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.6 mm-40 -97.82 -51.43 4.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.281 0.632 . . . . 71.15 109.986 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.58 HH11 ' HD1' ' D' ' 32' ' ' PHE . 34.3 ttt180 -176.07 126.83 0.21 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.57 -0.741 . . . . 70.04 110.055 -166.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.578 HG13 HD11 ' C' ' 13' ' ' ILE . 97.4 mt -113.32 135.0 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.762 0.825 . . . . 71.42 108.847 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.754 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.1 p90 -169.74 153.99 5.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.24 0.543 . . . . 63.33 110.067 -174.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -74.75 115.08 13.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.966 -1.016 . . . . 73.24 109.976 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -66.09 -39.32 89.92 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.819 -0.808 . . . . 75.14 108.819 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -151.44 147.48 26.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.448 -1.251 . . . . 53.11 110.434 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -136.34 145.08 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.053 1.741 . . . . 73.43 106.789 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -154.7 148.82 25.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.987 0.422 . . . . 75.22 110.269 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -153.58 108.61 3.16 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.584 -1.265 . . . . 75.0 107.584 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -117.57 121.33 40.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.571 0.748 . . . . 71.21 109.687 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.82 85.93 56.57 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.472 1.109 . . . . 65.01 108.533 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.68 -16.58 16.54 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.56 2.173 . . . . 71.41 112.006 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -99.51 19.64 15.31 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.933 1.293 . . . . 73.5 108.949 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.638 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -54.37 -52.13 71.95 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.332 1.053 . . . . 74.12 113.487 -172.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 6.2 Cg_exo -80.35 -31.31 1.68 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.923 1.749 . . . . 65.52 112.915 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.22 -30.8 67.97 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.425 1.09 . . . . 75.13 112.827 -173.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.26 -17.62 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.78 0.832 . . . . 73.15 111.796 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -59.79 -32.0 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.621 0.768 . . . . 75.3 111.781 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.63 6.48 34.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.613 0.765 . . . . 71.35 111.875 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.841 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.14 143.25 38.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.446 0.699 . . . . 73.12 110.205 -176.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 129.65 39.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.548 -0.908 . . . . 74.2 108.548 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -84.61 84.41 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.736 0.779 . . . . 73.31 111.808 -165.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -132.42 78.64 67.37 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 114.44 -1.255 . . . . 74.21 108.082 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' C' ' 67' ' ' SER . 5.6 Cg_exo -82.79 146.44 13.16 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.647 2.231 . . . . 54.43 112.455 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -85.79 109.83 18.94 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.403 -1.332 . . . . 70.21 107.403 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 t -78.54 97.4 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 124.378 1.049 . . . . 61.43 109.44 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 92.9 mttt -99.45 104.28 16.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.579 0.752 . . . . 51.1 109.552 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.66 129.81 45.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.703 -0.851 . . . . 74.4 108.703 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -131.63 137.2 48.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.687 0.795 . . . . 73.24 109.201 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.57 113.78 20.27 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.988 -0.745 . . . . 64.12 108.988 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.54 143.77 43.98 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.195 -0.669 . . . . 62.13 109.195 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -114.64 128.3 56.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 73.02 110.842 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 161.93 19.36 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.983 1.313 . . . . 74.25 108.615 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.6 p -153.32 150.36 28.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.024 0.53 . . . . 75.41 111.137 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -146.0 143.02 29.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.663 1.185 . . . . 63.54 108.981 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -101.16 115.43 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.212 -1.403 . . . . 75.21 107.212 166.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 HD12 ' C' ' 83' ' ' ILE . 32.8 mt -87.43 -28.02 22.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.053 0.541 . . . . 72.4 109.944 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.5 -174.95 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.587 1.155 . . . . 62.23 109.442 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 120.73 12.43 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.261 -0.881 . . . . 74.13 109.077 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 65.76 7.06 4.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.893 1.277 . . . . 64.41 112.822 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.26 107.72 23.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.568 -1.271 . . . . 72.23 107.568 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -107.76 148.76 29.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.238 1.015 . . . . 64.23 109.591 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -128.13 110.37 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.183 -0.917 . . . . 75.2 108.796 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -100.14 125.63 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.654 -1.61 . . . . 60.44 106.654 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.54 104.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.453 -0.943 . . . . 50.41 108.453 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -91.78 104.54 16.97 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.029 -1.101 . . . . 72.01 108.029 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 16.4 mtm180 -84.18 137.49 33.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.657 -1.156 . . . . 75.25 108.425 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -126.94 132.28 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.873 -1.158 . . . . 74.33 107.873 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -121.73 122.51 39.71 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.986 -0.746 . . . . 73.02 108.986 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.533 HG23 HD13 ' C' ' 114' ' ' ILE . 71.1 t -110.84 111.48 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.9 m -100.1 146.12 27.17 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.679 -0.86 . . . . 63.13 108.679 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.96 124.72 33.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.101 -1.074 . . . . 64.35 108.101 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.2 m -126.61 168.54 14.17 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.895 0.878 . . . . 51.42 109.255 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.841 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.9 mt -128.89 26.42 5.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.378 1.071 . . . . 71.21 108.912 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.06 -92.8 0.68 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.74 -1.344 . . . . 73.4 109.74 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 -13.57 16.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.002 0.921 . . . . 75.11 111.12 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.25 120.57 40.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.984 0.913 . . . . 74.04 109.689 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -70.65 132.3 45.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.017 0.372 . . . . 62.41 110.673 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -51.65 7.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.151 -0.685 . . . . 61.43 109.151 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -169.79 177.48 4.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.787 0.835 . . . . 71.52 111.167 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.455 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -134.02 146.89 50.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.745 1.218 . . . . 50.54 107.91 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.2 t -150.67 145.55 25.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.789 0.836 . . . . 74.24 109.381 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.09 136.35 15.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.362 0.665 . . . . 62.43 109.529 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -130.48 114.77 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.027 0.931 . . . . 74.02 108.964 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 15.1 mt-30 -91.63 96.16 10.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.688 -0.856 . . . . 65.13 108.688 176.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.596 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -87.77 111.93 21.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.9 0.48 . . . . 72.54 110.598 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.92 146.93 18.36 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 112.044 -0.422 . . . . 52.44 112.044 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.05 123.8 2.1 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 110.198 -1.161 . . . . 61.35 110.198 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.7 mm -92.36 125.31 44.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.8 -1.185 . . . . 65.33 107.8 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.87 119.68 26.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.486 -0.931 . . . . 75.2 108.486 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -89.31 97.48 11.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.408 -1.33 . . . . 44.13 107.408 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.758 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.2 pp -135.89 137.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 115.753 -0.658 . . . . 70.42 110.151 -170.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.29 166.08 32.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.926 0.89 . . . . 54.12 110.605 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -26.27 7.81 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.812 -0.631 . . . . 52.15 113.103 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.709 HG12 ' HG2' ' C' ' 94' ' ' MET . 0.2 OUTLIER . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 124.401 1.08 . . . . 73.04 110.08 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.598 -0.519 . . . . 74.55 109.598 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.709 ' HG2' HG12 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -67.18 -50.52 60.76 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.583 -1.19 . . . . 73.43 109.026 178.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.86 77.64 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.162 0.985 . . . . 63.42 112.988 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -73.04 -39.11 66.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 63.44 110.494 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.4 t -73.47 -34.75 65.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.163 0.585 . . . . 72.04 110.974 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.406 HD22 ' SD ' ' C' ' 94' ' ' MET . 47.0 tp -86.31 -56.93 3.21 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.571 1.148 . . . . 72.13 111.687 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.49 11.39 68.67 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.869 -0.605 . . . . 51.23 114.554 -168.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -56.25 0.23 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.458 0.629 . . . . 74.11 111.215 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -66.72 -60.06 3.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.303 0.641 . . . . 71.01 111.989 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.36 -47.8 98.13 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.05 0.94 . . . . 62.43 113.159 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.73 -20.05 35.47 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.975 1.783 . . . . 71.23 113.356 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.26 -22.68 47.95 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.406 0.682 . . . . 61.11 110.467 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.47 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.0 mm -69.91 -33.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.082 0.553 . . . . 54.12 109.52 169.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.7 mt -89.9 -25.15 21.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.085 0.954 . . . . 72.23 112.613 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -58.45 -45.38 99.69 Favored Pre-proline 0 CA--C 1.558 1.253 0 CA-C-O 117.859 -1.067 . . . . 72.12 113.136 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.41 -43.67 56.58 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.112 1.875 . . . . 53.32 112.633 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -63.37 -44.84 93.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.051 0.54 . . . . 75.13 111.569 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -73.21 -37.2 66.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.065 -0.516 . . . . 62.14 111.682 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.95 -58.51 7.08 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 124.258 0.974 . . . . 73.22 108.97 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.68 66.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.222 1.409 . . . . 65.33 112.631 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 17.0 t -74.73 -38.71 62.21 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.048 0.539 . . . . 73.32 111.95 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.56 HG23 ' SG ' ' C' ' 76' ' ' CYS . 93.3 mt -67.14 -47.23 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 123.59 0.756 . . . . 73.22 109.737 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.663 HG23 ' HB3' ' C' ' 125' ' ' GLN . 91.8 m -56.61 -37.45 70.7 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.435 -1.257 . . . . 74.12 111.359 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.1 t -62.84 -49.28 75.51 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 114.91 -1.041 . . . . 61.32 110.251 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.624 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.73 -35.67 70.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.176 0.991 . . . . 73.15 112.96 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.78 -45.61 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.078 0.551 . . . . 70.34 110.414 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 54.1 p -70.48 -26.44 63.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.661 -0.7 . . . . 74.44 111.02 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.9 mtt-85 -66.6 -33.79 76.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 72.34 110.595 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.96 11.55 47.54 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.945 0.778 . . . . 42.42 112.826 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.664 HG23 ' HB3' ' D' ' 17' ' ' TYR . 43.9 p 57.93 28.2 15.79 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.826 2.05 . . . . 74.02 112.485 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -102.04 150.26 37.29 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.826 0.85 . . . . 73.04 108.899 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.5 130.74 31.02 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.029 2.486 . . . . 72.14 110.708 175.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.663 ' HB3' HG23 ' C' ' 115' ' ' THR . 31.4 mt-30 -61.01 153.74 24.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.167 0.987 . . . . 64.22 113.001 -170.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.43 67.42 0.84 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.348 -0.842 . . . . 53.11 109.704 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.527 ' HB3' HG21 ' C' ' 115' ' ' THR . 1.9 p-10 -90.69 80.99 5.86 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.407 -1.331 . . . . 65.43 107.407 167.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -95.24 103.89 15.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.866 -1.515 . . . . 71.33 110.607 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . 63.11 155.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.385 1.624 . . . . 42.24 115.385 166.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.563 ' HG3' ' H ' ' A' ' 16' ' ' ILE . 69.5 Cg_endo -91.29 102.89 0.25 Allowed 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.774 2.316 . . . . 73.02 111.317 161.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 t -82.45 79.93 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.01 -0.737 . . . . 61.45 109.01 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.518 ' HB3' HG13 ' A' ' 13' ' ' ILE . 28.7 t-20 -82.16 107.19 14.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.454 -0.794 . . . . 73.4 109.378 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 CA--C 1.552 1.045 0 C-N-CA 125.195 1.398 . . . . 75.01 112.899 -172.207 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 C--O 1.236 0.36 0 N-CA-C 109.425 -0.583 . . . . 64.34 109.425 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.515 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 76.6 t80 -159.39 89.57 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.441 -1.318 . . . . 73.44 107.441 171.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.8 142.85 45.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.227 1.011 . . . . 70.41 108.468 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -103.06 110.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.085 0.554 . . . . 53.4 110.963 -170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.92 -43.48 22.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.81 0.444 . . . . 64.33 111.577 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.429 ' HD2' ' HG2' ' B' ' 130' ' ' PRO . 6.2 tpt180 -166.32 148.61 6.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.038 0.384 . . . . 62.31 112.038 -165.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.86 128.39 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.986 -1.116 . . . . 74.3 107.986 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.664 ' HB3' HG23 ' C' ' 122' ' ' THR . 11.4 p90 -163.32 164.01 24.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.584 0.706 . . . . 73.5 111.41 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -77.93 107.94 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.588 -1.187 . . . . 52.41 109.642 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 46.8 mtpt -77.23 -35.82 55.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.114 -0.494 . . . . 75.21 109.727 173.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -145.03 136.79 25.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.034 -0.984 . . . . 74.23 109.229 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.624 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.1 mt -135.06 145.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.427 1.091 . . . . 75.52 108.371 175.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -149.32 132.43 16.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.989 -1.005 . . . . 64.31 108.606 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.3 t80 -137.01 117.49 13.75 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 106.333 -1.729 . . . . 74.45 106.333 167.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.23 133.61 54.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.729 -0.841 . . . . 72.21 108.729 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.54 84.66 19.35 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.214 -1.402 . . . . 62.23 107.214 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.87 -38.8 56.33 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.665 2.243 . . . . 72.1 112.295 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 25.3 m-80 -114.38 31.18 6.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.165 0.986 . . . . 74.24 109.275 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.754 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -35.16 -55.64 1.0 Allowed Pre-proline 0 CA--C 1.588 2.411 0 N-CA-C 117.487 2.403 . . . . 64.42 117.487 -172.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.87 -12.88 8.3 Favored 'Trans proline' 0 C--N 1.399 3.198 0 CA-C-N 122.595 1.963 . . . . 64.23 114.512 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -74.42 -35.69 63.4 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.423 1.089 . . . . 75.32 109.762 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.647 HG13 HD12 ' D' ' 68' ' ' LEU . 72.3 t -70.43 -34.26 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.527 1.131 . . . . 75.14 110.938 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.58 ' HD1' HH11 ' C' ' 15' ' ' ARG . 3.4 t80 -48.67 -36.68 16.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.446 1.499 . . . . 72.34 112.342 171.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.463 HE21 ' HA ' ' D' ' 30' ' ' HIS . 50.8 mt-30 -81.41 7.83 10.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.111 0.964 . . . . 75.44 113.116 -173.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.565 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 86.8 mttt -121.66 114.3 20.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.534 0.734 . . . . 74.12 110.164 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -95.82 73.62 3.09 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.109 -0.7 . . . . 74.23 109.109 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.67 ' HB2' HD22 ' D' ' 68' ' ' LEU . 6.7 m95 -125.8 157.43 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.05 -1.833 . . . . 73.13 106.05 174.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.424 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 32.1 tp60 -77.79 113.18 30.19 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.826 0.739 . . . . 71.12 109.258 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.424 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 44.6 Cg_exo -58.74 107.1 0.32 Allowed 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.963 2.442 . . . . 65.34 112.517 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.65 112.32 3.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.474 1.109 . . . . 71.52 108.736 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 34.5 m -96.8 113.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 122.205 1.002 . . . . 70.32 108.527 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 71.6 mmtt -92.71 120.48 33.15 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.633 -1.247 . . . . 75.12 107.633 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.48 HD21 HD22 ' D' ' 128' ' ' LEU . 7.3 mp -94.58 121.65 36.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.602 -0.518 . . . . 72.32 109.602 -175.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 6.5 t70 -111.22 135.56 51.57 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.045 -1.465 . . . . 72.32 107.045 169.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -130.77 130.17 43.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.532 -0.914 . . . . 74.0 108.532 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.46 153.72 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.753 -1.203 . . . . 51.33 107.753 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -143.57 149.19 37.04 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.218 -0.66 . . . . 64.43 109.218 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.1 167.54 25.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.095 -0.957 . . . . 41.41 108.458 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -155.13 156.65 36.16 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.937 0.399 . . . . 60.23 110.445 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -155.09 139.45 16.73 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.104 0.962 . . . . 64.21 109.143 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -76.84 129.01 35.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.672 0.389 . . . . 65.01 110.037 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -97.69 -39.25 9.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.975 0.51 . . . . 75.35 110.102 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.01 -176.03 5.59 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.489 0.716 . . . . 72.54 110.353 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.03 121.64 11.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.043 -0.981 . . . . 71.12 110.309 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 66.85 3.6 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.473 1.509 . . . . 70.13 112.036 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -111.74 120.27 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.481 0.712 . . . . 70.33 110.171 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -131.21 129.06 41.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.648 1.179 . . . . 72.2 107.933 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.75 116.85 29.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.923 0.889 . . . . 52.12 108.887 173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.01 124.71 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 107.781 -1.192 . . . . 72.32 107.781 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.608 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.2 t -101.27 144.21 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.517 1.127 . . . . 45.01 109.331 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.615 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -118.05 128.87 55.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.196 -1.038 . . . . 64.52 108.196 175.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -109.41 106.87 16.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.255 1.022 . . . . 74.01 109.158 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.27 128.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.567 -1.272 . . . . 53.02 107.567 166.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.3 m -125.42 124.05 40.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.264 0.555 . . . . 54.35 109.7 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.442 HG21 HG21 ' D' ' 114' ' ' ILE . 69.0 t -106.59 101.93 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 125.002 1.321 . . . . 63.23 108.493 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 8.2 m -94.94 93.59 7.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.647 -1.242 . . . . 70.14 107.647 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.44 138.79 33.5 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.944 -0.762 . . . . 73.15 108.944 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.4 p -148.39 138.78 22.68 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.456 0.473 . . . . 73.43 112.128 -176.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' D' ' 36' ' ' TRP . 66.2 mt -107.48 110.58 22.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.773 1.229 . . . . 73.2 109.971 172.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.51 17.47 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.421 0.451 . . . . 71.21 112.997 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.68 6.25 46.58 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.407 0.683 . . . . 54.41 111.408 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.565 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 7.4 tp10 -140.04 149.36 43.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.391 0.676 . . . . 74.0 110.668 -166.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.8 m -70.44 138.42 51.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.057 0.943 . . . . 73.41 111.512 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -87.6 -63.13 1.35 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.561 1.144 . . . . 62.21 108.188 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -155.03 161.62 41.29 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.181 -0.918 . . . . 73.13 110.739 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -117.59 138.05 52.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.271 -1.331 . . . . 72.23 107.498 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.1 t -149.35 139.42 22.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.834 -0.802 . . . . 74.55 108.834 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.434 ' HB2' HG23 ' D' ' 63' ' ' THR . 43.0 tt0 -156.12 131.88 9.71 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.117 -0.697 . . . . 75.11 109.117 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.22 118.11 26.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 123.492 0.717 . . . . 74.32 109.282 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.701 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.0 mt-30 -90.08 85.47 6.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.912 0.863 . . . . 52.13 108.871 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.92 95.92 6.23 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.685 -1.598 . . . . 70.52 108.901 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.28 145.65 18.2 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 112.299 -0.32 . . . . 71.44 112.299 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.99 131.29 4.68 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.588 -0.605 . . . . 72.41 111.588 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -90.88 131.39 38.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.903 -0.777 . . . . 43.24 108.903 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.26 142.64 48.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.94 0.496 . . . . 72.13 110.867 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -89.44 95.9 10.48 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.668 -0.864 . . . . 73.21 108.668 166.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.522 HD11 HG12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -122.04 134.46 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.146 0.978 . . . . 74.31 110.171 -173.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.33 171.1 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.256 1.023 . . . . 53.23 109.951 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.76 22.95 77.68 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.237 -0.438 . . . . 32.32 113.881 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.522 HG12 HD11 ' D' ' 86' ' ' ILE . 1.8 pp -103.99 158.08 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.201 1.0 . . . . 63.24 110.866 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.86 171.68 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.424 0.69 . . . . 65.03 110.643 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.8 -138.06 34.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.098 0.874 . . . . 60.24 114.912 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -72.55 -28.69 62.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.043 0.937 . . . . 73.14 110.954 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -63.87 -29.11 70.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.927 0.891 . . . . 60.04 111.652 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.412 ' HG3' HD13 ' D' ' 89' ' ' ILE . 24.2 ttt -59.93 -53.82 53.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.232 0.613 . . . . 73.41 110.525 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.95 64.5 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.419 -0.81 . . . . 73.33 111.205 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -69.12 -33.35 73.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.326 1.05 . . . . 75.11 110.316 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 46.5 t -78.93 -51.41 9.69 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.574 -0.739 . . . . 74.22 110.58 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.21 -49.48 27.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.284 0.633 . . . . 60.41 110.834 -171.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.34 -26.4 61.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.792 -0.64 . . . . 65.41 114.457 -172.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.18 -58.13 1.89 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.452 0.626 . . . . 63.44 112.063 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 76.8 t80 -68.73 -34.08 75.01 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.165 0.802 . . . . 75.4 113.165 -168.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.518 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 43.6 m -72.13 -48.92 10.2 Favored Pre-proline 0 CA--C 1.563 1.476 0 CA-C-O 118.977 -0.535 . . . . 75.15 110.995 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.615 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 71.0 Cg_exo -56.55 -30.97 84.89 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 122.49 2.126 . . . . 71.34 114.431 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.24 -29.32 69.77 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.039 0.536 . . . . 74.25 111.971 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -68.27 -38.98 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 73.42 110.595 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.94 -25.37 40.49 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.063 -0.971 . . . . 71.13 111.651 -170.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.65 -41.82 80.22 Favored Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 114.231 1.197 . . . . 63.21 114.231 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -50.1 -39.99 50.9 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.214 1.942 . . . . 75.45 114.19 171.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.19 -36.01 27.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.729 0.812 . . . . 71.53 111.109 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -44.19 96.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.445 0.698 . . . . 75.41 110.36 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.412 ' NH2' HG23 ' B' ' 105' ' ' ILE . 30.8 ttp180 -55.89 -54.97 38.23 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 124.965 1.415 . . . . 73.42 110.215 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.158 0.911 . . . . 72.35 111.837 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.427 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 43.0 t -59.7 -42.51 93.17 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.547 0.529 . . . . 74.53 110.96 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.491 HG23 ' SG ' ' D' ' 76' ' ' CYS . 83.4 mt -62.26 -55.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 115.123 -0.944 . . . . 73.41 110.338 172.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 97.1 m -53.44 -40.11 64.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.554 1.541 . . . . 74.34 112.4 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -71.73 -40.77 69.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.159 -0.928 . . . . 73.33 110.695 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.3 mtm -69.08 -31.09 69.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.864 0.465 . . . . 72.42 111.637 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.0 t -63.23 -46.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.622 0.769 . . . . 72.45 109.714 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -74.43 -29.19 61.4 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 116.009 -0.541 . . . . 74.54 111.506 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -74.12 -23.24 59.27 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.83 0.852 . . . . 64.54 110.479 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.36 12.19 65.57 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.725 -0.67 . . . . 60.15 112.43 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p 62.26 22.42 13.17 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 126.319 1.848 . . . . 73.34 113.972 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -97.99 161.26 26.16 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.265 1.026 . . . . 72.21 109.551 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.25 140.02 47.68 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.106 2.537 . . . . 74.53 111.625 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.08 119.39 8.26 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.547 0.739 . . . . 72.04 110.618 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.76 103.87 12.76 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.316 -0.994 . . . . 70.22 108.316 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -103.82 99.78 9.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 54.31 109.328 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.48 HD22 HD21 ' D' ' 42' ' ' LEU . 95.5 mt -71.29 126.88 30.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.29 0.636 . . . . 74.54 110.473 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.37 138.64 96.36 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 123.184 0.594 . . . . 54.41 111.064 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 2.1 Cg_endo -74.78 96.59 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.946 1.764 . . . . 73.41 109.647 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 85.5 t -106.97 109.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.014 -1.106 . . . . 72.42 108.014 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p30 . . . . . 0 C--O 1.24 0.604 0 CA-C-N 115.588 -0.733 . . . . 71.2 109.137 -174.169 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 tpt . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 108.666 -0.864 . . . . 62.2 108.666 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.5 m -76.92 -18.87 58.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.419 0.688 . . . . 54.2 111.632 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.9 80.58 0.9 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.617 0.767 . . . . 74.33 109.828 174.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -103.8 77.33 1.45 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.732 -1.211 . . . . 54.42 107.732 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -160.76 137.16 8.59 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 114.342 -1.299 . . . . 61.42 107.51 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -73.88 140.64 45.83 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 123.304 0.377 . . . . 72.45 110.301 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 9' ' ' MET . 10.2 t -88.31 -163.96 1.05 Allowed 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 108.669 -0.863 . . . . 74.2 108.669 173.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.23 -7.14 33.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.21 0.604 . . . . 55.01 112.455 -178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.542 ' SD ' ' HA2' ' G' ' 169' ' ' GLY . 46.9 mtt -77.46 131.23 37.86 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.587 0.755 . . . . 72.44 110.207 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -164.44 136.33 4.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.875 1.27 . . . . 72.13 107.815 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -100.86 118.43 36.9 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.97 -0.752 . . . . 64.24 108.97 175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.408 ' H ' HG22 ' A' ' 86' ' ' ILE . 52.3 tp60 -141.29 123.51 15.65 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 123.436 0.46 . . . . 62.42 110.908 -174.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.47 128.9 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 107.66 -1.237 . . . . 71.14 107.66 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 85' ' ' SER . 86.8 mm-40 -97.29 -28.91 13.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.472 -0.775 . . . . 72.23 111.341 177.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -175.85 127.6 0.23 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 123.428 0.455 . . . . 73.12 111.182 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.795 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 65.1 mt -107.74 133.89 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.359 -0.978 . . . . 53.42 108.359 168.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' HE1' HG13 ' A' ' 83' ' ' ILE . 17.0 p90 -165.26 154.43 12.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.034 0.934 . . . . 75.22 110.139 -174.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -81.14 121.15 25.75 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 109.316 -0.624 . . . . 63.52 109.316 173.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.2 mtpt -88.45 -24.57 22.96 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 122.623 0.369 . . . . 74.41 111.146 174.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.615 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 13.8 t70 -153.52 143.71 22.24 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.424 0.631 . . . . 71.42 109.955 175.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.9 mt -138.08 131.66 41.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 106.325 -1.731 . . . . 72.54 106.325 174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.0 t -146.27 114.14 6.49 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.488 . . . . 71.33 109.684 -177.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.477 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 88.8 t80 -116.11 120.33 38.7 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 107.242 -1.392 . . . . 74.53 107.242 172.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -119.95 130.8 54.96 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.365 -0.606 . . . . 73.51 109.365 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -140.84 76.03 23.86 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.844 -1.169 . . . . 73.03 107.844 172.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.08 -20.43 21.74 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.639 2.226 . . . . 72.05 112.028 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -110.63 25.24 11.99 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.981 0.912 . . . . 71.1 109.179 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.529 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.99 -49.69 89.96 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 123.536 0.734 . . . . 72.1 112.882 179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 30.7 Cg_endo -68.8 -22.6 36.6 Favored 'Trans proline' 0 C--N 1.387 2.566 0 CA-C-N 121.293 1.498 . . . . 63.04 112.287 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -81.63 -20.54 39.47 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.971 1.309 . . . . 74.23 111.293 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 28' ' ' ALA . 4.0 p -64.52 -29.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 123.708 0.803 . . . . 61.34 111.592 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -62.7 -32.47 73.57 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.302 1.041 . . . . 74.44 111.597 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -72.26 -35.46 68.78 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.003 -0.999 . . . . 73.35 110.365 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.611 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 1.5 mmmp? -83.95 153.15 24.08 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.929 0.891 . . . . 74.01 110.808 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -80.06 144.69 32.94 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.383 0.673 . . . . 75.42 109.99 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -86.77 86.39 7.32 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.83 0.824 . . . . 74.41 110.247 -178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -131.96 82.63 59.02 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.951 -1.5 . . . . 74.32 106.951 168.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.62 127.42 7.21 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.635 2.223 . . . . 73.52 113.368 -173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.06 106.02 18.28 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 106.945 -1.502 . . . . 71.32 106.945 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.4 130.21 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 116.23 -0.441 . . . . 65.32 111.183 -171.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 59.9 mtpt -109.26 144.96 36.7 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.471 1.109 . . . . 74.14 110.504 171.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD21 HD22 ' A' ' 128' ' ' LEU . 7.9 mp -126.01 112.27 15.7 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.691 -1.595 . . . . 71.33 107.603 171.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.633 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.1 m-20 -104.09 110.1 22.15 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 107.209 -1.404 . . . . 73.52 107.209 175.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.519 HD22 HD11 ' G' ' 186' ' ' LEU . 58.1 tp -96.52 127.32 42.41 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.185 -0.672 . . . . 74.12 109.185 -174.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.63 162.09 40.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.191 0.596 . . . . 73.2 109.815 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.416 HG23 ' HE1' ' G' ' 175' ' ' PHE . 9.3 t -149.51 164.59 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.962 0.905 . . . . 71.23 110.261 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.419 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . . . -148.68 154.13 39.21 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.634 1.174 . . . . 75.21 108.96 177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 57' ' ' GLU . 50.8 m -125.33 152.08 45.2 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.821 0.448 . . . . 73.34 110.264 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.8 t -150.14 138.59 20.57 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.953 0.901 . . . . 64.02 109.147 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -97.32 113.42 25.05 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.577 -0.527 . . . . 64.31 109.577 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.9 mt -89.19 -32.03 17.65 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.815 -0.629 . . . . 71.33 110.538 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -163.61 -173.86 3.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.671 0.788 . . . . 64.54 110.549 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.71 115.8 5.62 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.52 0.728 . . . . 62.04 109.285 175.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 71.69 -6.2 1.48 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.103 1.361 . . . . 71.01 112.613 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 56.4 t -99.11 112.48 31.37 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 64.13 108.055 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -122.62 167.31 13.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.227 -0.897 . . . . 73.23 110.27 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 48' ' ' SER . 35.4 tt0 -131.67 125.65 32.65 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.894 -1.503 . . . . 71.52 108.004 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.8 113.88 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.586 -1.264 . . . . 61.12 107.586 171.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.9 t -100.35 127.3 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 123.403 0.681 . . . . 73.43 109.836 178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.3 OUTLIER -96.49 118.55 33.24 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.944 -1.132 . . . . 73.2 107.944 -178.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.57 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -96.39 101.85 13.55 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.002 -0.74 . . . . 72.51 109.002 170.042 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 18.3 t -95.64 128.66 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 107.387 -1.338 . . . . 74.22 107.387 169.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.633 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.8 m -117.84 132.03 56.48 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.844 -0.798 . . . . 73.31 108.844 172.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG21 HG21 ' A' ' 114' ' ' ILE . 54.9 t -126.83 109.52 21.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 124.689 1.196 . . . . 73.14 108.308 -173.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 2.6 m -115.79 132.91 56.5 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.349 -0.611 . . . . 51.52 109.349 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.4 105.04 12.66 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.103 -1.444 . . . . 73.32 107.103 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -109.56 123.52 49.56 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.84 -0.43 . . . . 75.51 109.84 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -89.94 75.12 7.25 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.017 -1.105 . . . . 72.44 108.017 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.74 -105.52 1.96 Allowed Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.922 -0.871 . . . . 65.43 110.922 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -108.58 13.48 25.24 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.579 0.752 . . . . 73.44 110.693 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.611 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 5.1 tp10 -120.31 114.08 21.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 118.533 -0.746 . . . . 72.45 109.76 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.1 m -73.46 132.09 42.54 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.46 1.027 . . . . 75.24 110.726 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.63 -54.14 4.73 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.318 1.047 . . . . 71.0 108.942 176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -157.3 173.34 17.1 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.593 -1.185 . . . . 70.52 111.233 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -142.79 142.94 31.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.678 1.591 . . . . 63.22 107.555 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.58 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 34.1 m -143.74 99.56 3.43 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.158 0.583 . . . . 74.53 109.838 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 40.3 tt0 -109.14 121.47 45.23 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.077 0.551 . . . . 75.2 109.98 174.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 t -122.69 119.29 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.935 0.894 . . . . 51.22 109.355 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 46.0 mt-30 -85.58 91.91 8.39 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.523 -0.762 . . . . 74.34 109.125 167.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.11 97.5 10.35 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.207 -1.034 . . . . 75.11 108.207 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.74 144.16 18.06 Favored Glycine 0 C--N 1.342 0.884 0 N-CA-C 112.173 -0.371 . . . . 72.45 112.173 -178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.62 125.43 3.0 Favored Glycine 0 C--N 1.332 0.34 0 N-CA-C 111.281 -0.728 . . . . 65.34 111.281 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.423 HG13 ' HE1' ' A' ' 17' ' ' TYR . 47.2 mt -80.36 129.71 37.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.625 -0.88 . . . . 75.42 108.625 173.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -128.7 120.85 27.26 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 108.268 -1.012 . . . . 64.52 108.268 173.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB3' HE21 ' A' ' 14' ' ' GLN . 33.5 t -105.39 94.22 5.1 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.437 -0.949 . . . . 74.13 108.437 178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.428 HD11 HD22 ' G' ' 173' ' ' LEU . 1.5 pp -134.93 165.06 32.16 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.895 0 C-N-CA 124.381 1.073 . . . . 64.34 108.4 -170.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 9' ' ' MET . . . -161.36 178.85 8.79 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.191 0.596 . . . . 72.04 111.073 170.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.95 3.86 67.66 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.739 -0.664 . . . . 71.23 114.522 170.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -113.6 147.71 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 123.203 0.601 . . . . 73.2 111.624 -171.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -157.79 -170.25 3.12 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.98 1.312 . . . . 73.52 110.573 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' A' ' 94' ' ' MET . . . 73.86 -149.41 41.31 Favored Glycine 0 C--N 1.352 1.445 0 C-N-CA 123.996 0.808 . . . . 74.01 114.722 175.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.9 p -83.31 -23.43 32.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.577 1.151 . . . . 71.32 111.261 -176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -71.39 -35.45 71.04 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.488 1.115 . . . . 74.24 110.648 -176.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 91' ' ' GLY . 27.7 ptm -62.24 -39.6 93.37 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.199 0.312 . . . . 72.44 110.3 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -39.5 94.44 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.48 0.712 . . . . 71.44 110.569 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -57.99 -45.67 86.41 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.923 0.889 . . . . 73.4 111.488 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.537 ' HB3' ' HB2' ' G' ' 172' ' ' ALA . 42.0 t -75.43 -54.27 7.32 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 116.315 -0.402 . . . . 74.25 111.334 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -68.0 -23.97 65.07 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 118.513 0.597 . . . . 72.44 111.449 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.85 -21.1 48.08 Favored Glycine 0 C--N 1.349 1.296 0 CA-C-O 119.596 -0.558 . . . . 62.31 113.827 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -136.56 -54.58 0.73 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 117.654 0.727 . . . . 72.13 112.746 -173.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -72.81 -48.94 33.69 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.727 0.811 . . . . 73.45 112.475 -167.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.91 -46.8 75.13 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.258 1.023 . . . . 70.41 112.072 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.58 -20.82 40.51 Favored 'Trans proline' 0 C--N 1.395 2.991 0 C-N-CA 121.588 1.525 . . . . 75.1 113.119 171.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 40.4 t-20 -67.85 -36.06 79.64 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 122.871 0.469 . . . . 73.11 109.829 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.0 mm -56.26 -43.18 76.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 123.677 0.791 . . . . 73.13 110.393 171.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' A' ' 82' ' ' GLY . 53.3 mt -81.46 -21.85 38.49 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.995 -1.002 . . . . 61.24 111.527 -172.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.411 ' N ' ' HD2' ' A' ' 108' ' ' PRO . 29.3 t80 -66.14 -39.43 28.56 Favored Pre-proline 0 CA--C 1.56 1.35 0 N-CA-C 114.696 1.369 . . . . 73.01 114.696 -167.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HB3' HD13 ' C' ' 105' ' ' ILE . 12.2 Cg_endo -57.13 -40.05 86.14 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 121.878 1.718 . . . . 63.4 112.525 172.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.43 -35.38 63.37 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.552 0.741 . . . . 70.11 110.957 -177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.02 -48.81 64.67 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.119 0.568 . . . . 72.01 110.153 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.8 ttm105 -51.41 -51.4 55.09 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.787 1.235 . . . . 71.2 110.333 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.82 -48.41 80.73 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 124.456 1.097 . . . . 72.13 111.362 -177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.413 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 37.1 t -54.18 -45.78 72.21 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.375 1.047 . . . . 72.5 110.698 -177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.663 HG21 HG21 ' A' ' 64' ' ' VAL . 9.0 mt -64.29 -53.22 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.051 -0.977 . . . . 53.31 110.901 175.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.493 HG23 ' HG3' ' A' ' 125' ' ' GLN . 66.1 m -53.22 -39.57 63.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.948 0.899 . . . . 72.42 111.371 -174.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.5 t -71.4 -42.11 68.77 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.192 -0.913 . . . . 75.54 109.807 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.9 mtp -57.79 -41.94 83.15 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.826 0.85 . . . . 70.31 111.215 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.5 t -61.02 -50.19 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 124.415 1.086 . . . . 74.04 110.387 178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 82.2 p -72.1 -27.18 62.48 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.734 -0.666 . . . . 73.5 111.784 -175.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.531 HH12 ' HG3' ' B' ' 112' ' ' GLU . 76.8 mtt-85 -73.11 -24.74 60.66 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.442 0.697 . . . . 65.42 110.335 174.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 122' ' ' THR . . . -85.41 14.83 48.94 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-O 119.833 -0.426 . . . . 60.45 113.133 171.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.489 HG22 HH21 ' B' ' 15' ' ' ARG . 1.8 t 62.83 15.21 8.03 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 127.331 2.252 . . . . 73.42 113.42 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -91.91 157.75 40.86 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.319 0.648 . . . . 71.03 109.855 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.421 ' HB3' ' HE1' ' G' ' 195' ' ' PHE . 59.0 Cg_endo -68.22 151.99 76.35 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.68 2.253 . . . . 75.44 111.977 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.493 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.1 tt0 -57.46 137.21 56.47 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 123.487 0.492 . . . . 55.2 110.818 176.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.4 tp -117.07 112.61 21.15 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.027 -0.988 . . . . 53.41 108.667 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.71 102.37 14.11 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.125 -1.065 . . . . 73.24 108.125 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.457 HD22 HD21 ' A' ' 42' ' ' LEU . 61.1 mt -71.35 117.98 13.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.05 -0.722 . . . . 75.45 109.05 177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.455 ' O ' HD13 ' G' ' 187' ' ' ILE . . . -65.48 128.84 94.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 123.285 0.366 . . . . 71.13 110.605 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HB3' HH22 ' A' ' 111' ' ' ARG . 57.9 Cg_endo -72.9 136.97 26.04 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 121.833 1.688 . . . . 44.43 110.584 176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.566 HG22 HG23 ' G' ' 187' ' ' ILE . 39.7 t -97.88 113.7 33.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.23 -1.396 . . . . 62.11 107.23 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.89 63.94 8.35 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 122.887 1.327 . . . . 73.13 109.215 -176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.17 -24.37 64.05 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 113.822 -1.536 . . . . 75.31 110.064 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.01 -50.05 74.95 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.956 0.902 . . . . 61.22 110.385 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.55 -40.28 92.67 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.814 0.696 . . . . 43.2 111.168 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.14 -38.36 79.47 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.721 0.808 . . . . 65.32 110.925 177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -73.01 -37.9 66.77 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.98 0.912 . . . . 75.13 109.979 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -70.05 -28.87 65.81 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.183 0.593 . . . . 75.14 111.746 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 91.1 m-20 -59.37 -32.6 70.28 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.364 0.666 . . . . 72.34 110.82 175.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.92 -39.63 42.26 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 114.69 -1.141 . . . . 62.33 110.858 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.646 HD13 ' HA ' ' C' ' 149' ' ' THR . 98.5 mt -67.29 -49.51 63.97 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.454 0.701 . . . . 65.2 112.08 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -169.21 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.91 0.484 . . . . 64.04 110.612 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 25.2 tp60 65.02 -85.33 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.449 1.099 . . . . 73.31 110.325 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.405 ' OE1' ' HB2' ' C' ' 5' ' ' ASN . 23.3 tm0? -173.07 130.25 0.48 Allowed 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.99 -0.744 . . . . 41.42 108.99 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.44 124.11 11.84 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.52 1.128 . . . . 54.32 108.411 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.79 73.2 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.788 -0.525 . . . . 72.23 111.788 -177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -88.84 101.13 13.73 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.341 0.656 . . . . 73.42 109.251 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.3 140.87 23.35 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 116.016 -0.538 . . . . 74.2 112.112 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.3 m -143.27 101.03 3.73 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.433 -0.58 . . . . 71.1 109.433 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -80.01 143.61 33.95 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.611 0.764 . . . . 73.32 109.707 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -164.18 -66.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.952 -1.129 . . . . 72.25 107.952 176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.598 ' HB2' ' HB3' ' C' ' 140' ' ' TYR . 51.3 m80 -65.87 97.87 0.37 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 109.363 -0.606 . . . . 73.13 109.363 175.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.33 -64.89 0.76 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 114.357 -1.292 . . . . 70.53 110.782 -171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -159.75 142.48 13.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.016 -0.538 . . . . 45.3 111.177 -171.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.467 1.107 . . . . 73.22 108.746 174.517 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 108.852 -0.795 . . . . 74.14 108.852 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.589 ' H ' HD12 ' F' ' 173' ' ' LEU . 35.2 m -98.27 153.92 18.17 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.751 0.821 . . . . 72.11 109.923 -177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -140.16 90.65 2.39 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.606 0.762 . . . . 64.45 109.116 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -154.22 -39.07 0.09 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.151 0.981 . . . . 73.43 109.652 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.1 71.13 0.18 Allowed 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.691 1.197 . . . . 61.41 111.314 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -169.7 75.36 0.09 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.411 -0.813 . . . . 72.44 109.337 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.1 m -147.82 153.13 38.77 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.125 0.57 . . . . 52.23 110.159 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -56.65 -32.12 65.05 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.991 1.316 . . . . 43.44 112.941 -175.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.555 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 10.2 ptm 57.65 175.42 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 126.24 1.816 . . . . 73.23 113.699 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.5 t -168.54 146.26 4.03 Favored 'General case' 0 C--O 1.248 0.991 0 C-N-CA 124.137 0.975 . . . . 72.52 109.566 174.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 41.3 t80 -137.33 153.92 50.16 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 123.735 0.814 . . . . 63.02 108.916 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.635 HE21 ' HA ' ' B' ' 12' ' ' GLN . 0.0 OUTLIER -166.68 141.16 4.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.424 0.69 . . . . 71.23 111.381 170.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tp -86.95 133.77 29.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 123.019 0.528 . . . . 45.21 109.699 169.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -101.64 -37.85 8.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.869 0.468 . . . . 65.33 109.841 170.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.489 HH21 HG22 ' A' ' 122' ' ' THR . 68.2 ttt180 -167.36 137.51 2.89 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.678 0.391 . . . . 73.51 111.006 -177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -113.81 141.58 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 106.653 -1.61 . . . . 70.31 106.653 169.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -172.06 144.17 1.64 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.961 0.41 . . . . 74.45 111.701 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.599 HG21 HD11 ' B' ' 21' ' ' ILE . 16.4 m -76.07 128.18 34.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.534 -0.913 . . . . 54.51 108.534 170.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.48 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 42.1 mtpt -98.4 -40.99 8.02 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.502 0.721 . . . . 72.02 109.564 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 30.7 t70 -138.77 143.27 38.9 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.34 -176.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.599 HD11 HG21 ' B' ' 18' ' ' THR . 34.7 mm -131.32 142.88 42.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 C-N-CA 125.309 1.443 . . . . 73.03 107.758 170.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 68.7 m -144.4 129.09 18.21 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.825 -1.08 . . . . 61.01 108.798 168.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 75.0 t80 -138.79 106.7 5.67 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.125 -2.176 . . . . 75.41 105.125 164.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -119.64 108.55 14.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.205 -1.406 . . . . 73.11 107.205 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.497 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.04 89.26 6.44 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.561 1.144 . . . . 75.2 108.461 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.75 -44.2 6.14 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.714 2.276 . . . . 74.54 111.695 -174.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.402 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 41.0 m-80 -105.98 32.17 4.57 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.349 1.059 . . . . 53.34 109.414 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.497 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.19 -46.42 55.69 Favored Pre-proline 0 CA--C 1.564 1.496 0 C-N-CA 125.022 1.329 . . . . 74.23 113.929 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 38.4 Cg_endo -69.89 -23.15 30.53 Favored 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 121.56 1.507 . . . . 54.23 113.32 175.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.402 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 0.3 OUTLIER -78.63 -2.77 40.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.408 0.683 . . . . 74.05 111.415 -177.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.82 -20.96 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.115 0.566 . . . . 74.23 110.593 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -84.36 -21.48 30.88 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.709 0.803 . . . . 63.41 110.422 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -87.83 -22.84 24.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.408 0.683 . . . . 72.45 111.659 172.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -107.04 99.88 9.41 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.976 0.91 . . . . 74.15 111.09 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -88.02 76.55 8.57 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.579 0.752 . . . . 74.12 109.359 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 t90 179.88 159.04 0.75 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.106 0.962 . . . . 72.4 109.667 175.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' F' ' 193' ' ' TYR . 7.4 pt20 -58.56 137.81 85.98 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.081 0.953 . . . . 71.4 112.066 175.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.68 141.0 48.56 Favored 'Trans proline' 0 C--N 1.365 1.415 0 C-N-CA 121.376 1.384 . . . . 73.42 110.271 163.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 44.6 mm-40 -75.21 99.24 3.95 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.247 -1.02 . . . . 75.25 108.247 171.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.403 ' HB ' ' HG ' ' B' ' 126' ' ' LEU . 14.1 t -97.57 118.21 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.763 -1.199 . . . . 72.11 107.763 -174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.13 134.29 46.41 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.666 -1.235 . . . . 72.22 107.666 -165.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.534 HD23 HD22 ' B' ' 128' ' ' LEU . 1.8 pp -86.67 162.49 17.89 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.086 0.773 . . . . 71.33 113.086 -172.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.499 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.0 m-20 -146.94 131.75 18.01 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.002 -1.481 . . . . 71.44 107.002 171.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.4 tp -105.13 142.83 34.22 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.229 -1.026 . . . . 42.33 108.229 170.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -145.11 140.31 27.94 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.305 -0.628 . . . . 73.31 109.305 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 48.3 m -108.93 111.43 23.11 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.512 0.725 . . . . 62.04 109.886 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.48 128.65 47.27 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 107.813 -1.181 . . . . 72.12 107.813 174.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.636 ' HB2' HD11 ' F' ' 177' ' ' LEU . 26.8 m -142.7 165.37 27.56 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 121.853 -0.529 . . . . 72.04 110.075 177.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.3 p -152.61 159.52 43.23 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.449 -0.796 . . . . 72.04 109.499 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.449 ' NE2' ' SD ' ' F' ' 174' ' ' MET . 56.1 tt0 -106.54 121.27 43.97 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.688 0.795 . . . . 75.31 109.5 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.436 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 85.5 mt -82.99 -43.1 16.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.251 0.62 . . . . 53.41 110.095 175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -158.53 -177.07 6.27 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.381 -0.827 . . . . 71.42 111.019 -177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.23 112.54 5.87 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 113.76 -1.564 . . . . 72.35 109.096 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.417 ' HA ' ' HE3' ' F' ' 174' ' ' MET . 63.5 m-20 73.61 8.26 5.02 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.924 1.29 . . . . 52.4 112.584 -176.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 48.5 t -119.34 96.08 4.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.988 0.915 . . . . 72.21 108.635 177.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.45 ' HE2' ' SD ' ' F' ' 174' ' ' MET . 17.0 m-85 -99.21 169.61 9.26 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.713 0.768 . . . . 71.35 110.964 175.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.436 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.5 tm-20 -142.7 96.77 2.99 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 106.581 -1.637 . . . . 74.1 106.581 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 79.1 t -94.86 122.58 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 109.194 -0.669 . . . . 75.13 109.194 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 32.5 t -103.44 118.91 51.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 115.309 -0.86 . . . . 73.22 109.226 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.479 HD22 HG23 ' B' ' 62' ' ' VAL . 1.9 tt -92.03 112.33 24.22 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.263 -1.384 . . . . 70.33 107.263 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -104.17 111.79 24.53 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.463 -0.79 . . . . 73.15 109.655 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' B' ' 114' ' ' ILE . 67.1 t -105.4 112.42 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 107.941 -1.133 . . . . 74.12 107.941 170.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 8.8 m -98.44 152.08 19.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.801 -0.815 . . . . 73.55 108.801 175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.562 HG21 HG21 ' B' ' 114' ' ' ILE . 84.9 t -141.6 126.49 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.422 1.089 . . . . 71.03 108.326 -170.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.1 m -114.26 135.32 54.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.666 0.786 . . . . 51.34 109.388 175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.28 146.18 44.39 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.081 0.552 . . . . 61.23 110.231 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -149.87 129.87 13.47 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.27 0.557 . . . . 72.33 112.255 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 65.7 mt -95.15 104.84 16.74 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.727 1.211 . . . . 72.54 109.605 174.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.05 -110.1 3.28 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.702 0.626 . . . . 74.43 113.047 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -102.7 3.57 37.16 Favored 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.106 1.362 . . . . 71.21 109.62 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -123.29 154.24 39.12 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.125 0.97 . . . . 61.32 109.879 -172.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -73.53 137.88 44.67 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.13 0.572 . . . . 61.42 109.931 174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.657 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.73 -61.98 1.48 Allowed 'General case' 0 C--O 1.24 0.605 0 C-N-CA 123.784 0.834 . . . . 72.54 108.869 176.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -154.26 166.78 32.09 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 113.984 -1.462 . . . . 74.41 109.501 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -142.13 111.12 6.31 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.846 -1.539 . . . . 51.21 106.846 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -116.7 158.69 23.41 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.043 -0.725 . . . . 73.42 109.043 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -166.26 127.63 1.8 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.092 -1.077 . . . . 75.01 108.092 -178.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -123.74 142.6 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 109.782 -0.451 . . . . 75.31 109.782 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.491 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -120.38 95.99 4.96 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.126 -0.943 . . . . 73.21 109.361 174.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -86.59 103.67 15.3 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.097 -0.956 . . . . 73.32 109.251 174.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.13 159.48 28.83 Favored Glycine 0 C--O 1.242 0.616 0 N-CA-C 111.598 -0.601 . . . . 71.45 111.598 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.17 127.42 1.83 Allowed Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.75 -0.94 . . . . 73.31 110.75 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 50.4 mt -85.41 113.2 23.36 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.609 -0.886 . . . . 73.43 108.609 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -118.82 133.74 55.63 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.177 -0.675 . . . . 75.24 109.177 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.9 m -93.49 110.29 21.87 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.108 -1.071 . . . . 71.12 108.108 175.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.632 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -121.19 134.68 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 123.306 0.642 . . . . 75.41 109.74 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.07 157.87 33.68 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.152 0.981 . . . . 42.35 108.986 174.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.31 -44.98 3.37 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 122.863 0.268 . . . . 64.53 113.261 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.632 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.1 136.39 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 C-N-CA 123.918 0.887 . . . . 64.24 111.655 175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.551 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 10.8 pt-20 -151.67 146.97 26.17 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.744 0.418 . . . . 74.2 110.561 -173.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.23 -105.83 0.79 Allowed Glycine 0 C--N 1.35 1.334 0 O-C-N 124.037 0.835 . . . . 74.21 113.469 175.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.443 HG21 HD11 ' B' ' 141' ' ' LEU . 22.1 m -79.65 -31.72 41.5 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.923 0.889 . . . . 72.13 110.846 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.551 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 21.1 mt-30 -60.88 -48.74 80.41 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.315 0.646 . . . . 63.22 110.107 177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.452 ' HA ' ' SG ' ' B' ' 97' ' ' CYS . 10.3 ptm -72.82 -36.85 67.61 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 115.158 -0.928 . . . . 64.12 110.137 -176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.73 70.95 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.066 0.546 . . . . 72.53 111.286 176.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -75.27 -35.84 61.29 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.096 0.958 . . . . 72.53 111.139 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' B' ' 94' ' ' MET . 27.3 p -78.66 -56.91 4.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 110.466 -0.198 . . . . 75.21 110.466 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.6 -22.75 64.43 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.249 0.62 . . . . 70.04 111.49 -177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.38 -0.39 40.6 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.246 -0.752 . . . . 23.41 114.584 -174.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.598 ' HA ' ' HZ3' ' F' ' 184' ' ' TRP . . . -147.95 -49.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 118.384 1.092 . . . . 75.2 112.319 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -72.22 -58.5 3.36 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 122.69 0.396 . . . . 75.45 111.193 -172.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 75.6 m -58.06 -45.97 99.72 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 124.009 0.923 . . . . 62.04 111.956 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -50.72 -54.89 4.69 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.145 1.897 . . . . 52.41 112.349 168.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -63.56 -14.78 54.65 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 113.803 1.038 . . . . 60.12 113.803 -176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 75.4 mt -78.65 -48.9 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 109.738 -0.467 . . . . 63.21 109.738 170.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.5 mt -79.01 -20.7 48.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.215 1.006 . . . . 60.35 111.785 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -63.87 -44.78 80.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.503 1.521 . . . . 72.32 112.517 -171.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.473 ' HA ' HH11 ' B' ' 111' ' ' ARG . 35.1 Cg_exo -56.69 -39.78 88.97 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 121.984 1.789 . . . . 72.31 112.94 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 84.8 m-85 -69.21 -41.62 76.84 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.138 0.575 . . . . 74.22 110.94 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.89 -43.6 87.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.783 0.433 . . . . 71.33 110.121 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.473 HH11 ' HA ' ' B' ' 108' ' ' PRO . 28.9 mtp-105 -52.84 -63.41 1.15 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.778 1.231 . . . . 65.15 110.743 174.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.531 ' HG3' HH12 ' A' ' 120' ' ' ARG . 13.7 tp10 -55.28 -37.42 67.29 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.728 1.211 . . . . 63.32 111.493 -177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.538 ' O ' ' HG2' ' B' ' 117' ' ' MET . 2.0 t -72.57 -46.4 54.58 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 119.642 -0.218 . . . . 61.04 110.965 -177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.562 HG21 HG21 ' B' ' 64' ' ' VAL . 83.4 mt -60.02 -57.27 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 123.625 0.77 . . . . 55.33 110.668 176.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.466 HG23 ' H ' ' B' ' 126' ' ' LEU . 5.9 m -60.24 -28.19 67.82 Favored 'General case' 0 CA--C 1.559 1.304 0 O-C-N 124.123 0.889 . . . . 71.44 110.744 -173.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.9 t -68.69 -53.12 24.13 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.476 0.711 . . . . 65.55 110.821 171.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.5 mmt -61.85 -37.69 85.45 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.004 0.522 . . . . 53.53 111.318 -176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 51.9 t -58.14 -49.46 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.859 1.264 . . . . 52.15 110.438 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.499 ' HB2' ' HA ' ' C' ' 126' ' ' LEU . 87.4 p -73.69 -22.99 59.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.308 -0.86 . . . . 64.14 112.258 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.5 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.8 mtt-85 -65.21 -32.37 74.01 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.472 0.709 . . . . 72.51 110.523 175.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.39 17.23 35.09 Favored Glycine 0 C--N 1.354 1.541 0 CA-C-N 115.569 -0.741 . . . . 50.34 112.474 172.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 60.93 35.96 18.95 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.452 1.901 . . . . 73.5 112.648 176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -103.32 159.37 29.52 Favored Pre-proline 0 CA--C 1.562 1.421 0 C-N-CA 124.24 1.016 . . . . 75.11 109.555 172.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.81 -175.06 2.49 Favored 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 122.948 2.432 . . . . 41.04 115.408 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.487 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 1.0 OUTLIER -65.58 133.43 51.16 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.971 1.308 . . . . 62.01 112.743 -177.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.466 ' H ' HG23 ' B' ' 115' ' ' THR . 0.2 OUTLIER -153.72 86.42 1.2 Allowed 'General case' 0 CA--C 1.549 0.937 0 N-CA-C 108.199 -1.037 . . . . 63.33 108.199 163.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -102.62 136.89 41.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.643 -1.243 . . . . 73.53 107.643 170.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.534 HD22 HD23 ' B' ' 42' ' ' LEU . 10.8 mt -74.9 125.07 28.06 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.679 -0.489 . . . . 72.55 109.679 -175.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -71.01 137.58 84.88 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 123.054 0.542 . . . . 73.11 110.7 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 12.8 Cg_exo -72.42 143.48 38.9 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 123.591 2.861 . . . . 74.1 113.138 -175.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 17.0 t -119.53 128.35 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.259 0.624 . . . . 75.24 109.464 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.566 HD21 HG13 ' D' ' 105' ' ' ILE . 5.2 m-20 -83.62 81.59 8.68 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.167 0.587 . . . . 73.54 109.82 175.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' F' ' 181' ' ' TYR . 54.9 m-85 -68.45 -29.44 68.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.192 -0.913 . . . . 74.21 111.322 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -60.42 -42.16 95.45 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 124.046 0.841 . . . . 71.53 110.619 176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.31 82.89 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.454 0.702 . . . . 62.5 111.142 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.46 -40.78 76.95 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.675 -0.693 . . . . 62.34 109.599 176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.451 ' HB2' ' OH ' ' F' ' 181' ' ' TYR . 86.6 t80 -62.62 -42.56 99.66 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 125.302 1.441 . . . . 75.12 111.743 -175.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.427 ' SD ' ' HG3' ' B' ' 143' ' ' GLN . 25.5 mmt -62.43 -31.9 72.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.598 0.759 . . . . 61.15 111.368 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.12 -30.2 20.01 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.392 0.677 . . . . 63.42 110.892 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -64.59 -42.44 95.59 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.957 0.903 . . . . 63.44 110.297 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.443 HD11 HG21 ' B' ' 92' ' ' THR . 72.8 mt -101.91 3.98 39.66 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.874 -0.603 . . . . 75.14 111.684 177.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 55.31 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.488 1.115 . . . . 73.13 112.215 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.427 ' HG3' ' SD ' ' B' ' 138' ' ' MET . 29.6 mm-40 -100.34 -32.21 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 122.122 -0.361 . . . . 71.34 111.535 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 64.01 -163.79 0.26 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.167 0.987 . . . . 55.42 111.476 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.26 176.51 5.43 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.556 0.742 . . . . 72.5 110.869 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.17 84.46 0.93 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.474 -0.65 . . . . 50.03 111.474 174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -59.94 123.26 16.49 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.163 0.985 . . . . 73.11 111.35 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.6 -98.02 0.11 Allowed Glycine 0 C--N 1.348 1.225 0 O-C-N 123.29 0.369 . . . . 63.24 112.488 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -156.23 137.63 13.94 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.618 0.767 . . . . 55.22 109.557 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -83.2 150.22 26.34 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.62 0.768 . . . . 63.45 111.296 -174.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.16 154.94 19.98 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.633 0.773 . . . . 64.35 110.52 172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -104.03 -49.93 3.5 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.536 0.734 . . . . 61.15 110.438 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 68.29 142.66 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.198 1.399 . . . . 74.14 110.417 -169.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -137.94 94.86 2.94 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 121.931 -0.481 . . . . 71.32 109.986 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' H' ' 168' ' ' LYS . . . . . . . . 0 C--O 1.248 0.976 0 C-N-CA 125.154 1.381 . . . . 54.22 108.042 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 85.0 mtp . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 111.548 0.203 . . . . 63.31 111.548 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -165.37 92.09 0.54 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.535 0.734 . . . . 74.14 109.473 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -83.07 99.15 9.69 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.283 -0.636 . . . . 73.5 109.283 175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -60.22 125.55 24.09 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.554 -0.748 . . . . 63.2 110.845 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.405 ' HB2' ' OE1' ' A' ' 144' ' ' GLN . 10.1 m120 -103.69 -18.13 14.83 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.956 -0.757 . . . . 74.32 108.956 172.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 54.53 35.07 22.58 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.058 1.343 . . . . 75.53 110.36 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -70.37 117.38 11.85 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.297 -0.865 . . . . 61.33 109.718 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -70.21 -64.61 0.86 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.851 -1.068 . . . . 44.53 109.78 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ttt 63.19 116.78 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.707 1.203 . . . . 61.21 111.96 -175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -122.79 105.3 9.92 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 107.455 -1.313 . . . . 74.11 107.455 172.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.661 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 53.3 t80 -98.64 127.1 44.44 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 108.797 -0.816 . . . . 74.23 108.797 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -138.2 126.57 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.618 -0.512 . . . . 62.14 109.618 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 16.4 tt -80.75 140.31 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.047 0.939 . . . . 72.51 109.004 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.463 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.3 mm-40 -111.55 -51.44 2.86 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.913 0.387 . . . . 71.42 110.218 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.423 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 50.2 ttt180 -167.88 140.53 3.16 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.536 -0.756 . . . . 73.43 109.445 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 mt -122.27 146.95 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.316 -0.994 . . . . 63.05 108.316 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.565 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 24.5 p90 -175.65 158.27 2.16 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.275 0.559 . . . . 73.43 111.284 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -77.16 118.54 19.79 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.2 -0.909 . . . . 74.34 109.153 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 17.6 mmmt -77.46 -47.72 18.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.423 -0.955 . . . . 72.23 108.423 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -137.3 137.33 38.87 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.207 -1.361 . . . . 73.42 109.054 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.7 mt -134.68 145.45 32.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 106.969 -1.493 . . . . 72.1 106.969 175.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.0 t -159.37 150.23 19.64 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.223 0.535 . . . . 73.54 109.918 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -139.47 122.67 16.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.875 -1.157 . . . . 71.21 107.875 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -117.62 111.07 18.69 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.818 0.847 . . . . 71.05 109.182 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.44 84.06 60.6 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 107.201 -1.407 . . . . 52.22 107.201 167.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.49 -31.8 60.53 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.927 2.418 . . . . 71.22 111.892 -178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.484 ' O ' HG13 ' C' ' 31' ' ' VAL . 66.7 m-20 -96.89 24.96 5.66 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.342 1.057 . . . . 53.11 110.456 -176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.408 ' O ' HG22 ' C' ' 31' ' ' VAL . . . -54.96 -42.74 97.35 Favored Pre-proline 0 N--CA 1.493 1.723 0 N-CA-C 115.26 1.578 . . . . 72.11 115.26 -169.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -68.41 -41.97 5.95 Favored 'Trans proline' 0 C--N 1.384 2.44 0 CA-C-N 121.478 1.563 . . . . 64.43 112.082 169.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -64.02 -23.04 67.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.615 1.566 . . . . 73.03 113.131 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.544 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 15.8 m -57.63 -17.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 113.6 0.963 . . . . 64.53 113.6 -178.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -59.66 -22.81 62.44 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.503 1.121 . . . . 71.52 112.436 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.6 22.53 5.92 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 112.428 0.529 . . . . 73.21 112.428 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -88.21 172.71 9.27 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.87 0.843 . . . . 74.33 111.337 -178.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.416 ' O ' HD22 ' C' ' 68' ' ' LEU . 34.8 t70 -91.59 134.74 34.41 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.148 -1.387 . . . . 75.42 109.535 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.515 ' HB2' ' HB2' ' E' ' 195' ' ' PHE . 19.0 t-105 -89.31 81.93 6.59 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.216 0.607 . . . . 73.32 111.33 172.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -159.1 69.66 3.4 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 123.133 0.573 . . . . 72.55 109.896 169.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.641 ' HD2' ' HA3' ' E' ' 191' ' ' GLY . 42.1 Cg_endo -91.45 157.58 3.65 Favored 'Trans proline' 0 C--N 1.384 2.408 0 C-N-CA 122.729 2.286 . . . . 75.32 113.368 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.92 76.77 7.84 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.078 -1.419 . . . . 65.01 108.798 168.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 13.0 m -73.39 96.35 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-O 122.141 0.972 . . . . 72.12 110.091 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 14.5 ptmm? -128.71 137.86 51.83 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.382 -1.281 . . . . 60.14 110.458 -173.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.92 139.47 36.57 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.833 0.853 . . . . 64.32 109.896 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.477 ' HA ' HD22 ' E' ' 186' ' ' LEU . 6.4 m-20 -120.25 106.65 12.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.377 0.671 . . . . 72.13 109.77 -174.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.409 ' HB2' ' NE1' ' E' ' 184' ' ' TRP . 5.9 mp -86.94 108.96 19.04 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.402 0.681 . . . . 63.21 109.503 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -113.74 129.48 56.57 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.004 1.322 . . . . 74.11 108.116 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 36.3 m -111.38 116.92 31.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.988 0.515 . . . . 64.43 110.712 -167.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.11 162.85 27.88 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.336 1.054 . . . . 70.21 109.423 172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.0 m -148.56 165.8 30.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.133 0.973 . . . . 63.11 109.641 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 62.3 p -154.65 131.92 11.1 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.518 0.727 . . . . 74.31 109.511 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.34 120.03 19.35 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.149 0.579 . . . . 43.11 110.271 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' C' ' 57' ' ' GLU . 57.0 mt -94.2 -37.18 11.68 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.132 0.573 . . . . 60.22 109.508 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.07 -171.42 2.64 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.102 -0.954 . . . . 71.35 110.277 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -75.43 123.31 25.19 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.662 -0.699 . . . . 64.03 109.129 176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 68.18 1.26 2.75 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.791 1.236 . . . . 61.11 112.906 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -116.98 112.71 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 108.067 -1.086 . . . . 74.41 108.067 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -133.37 133.9 43.04 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.91 -0.774 . . . . 74.31 108.91 -174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.621 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.7 tt0 -93.26 117.64 30.31 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.768 0.827 . . . . 70.43 109.77 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.37 118.27 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.144 -1.058 . . . . 73.43 108.144 174.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.35 106.44 20.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 N-CA-C 108.165 -1.05 . . . . 64.42 108.165 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -99.67 109.69 22.15 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.096 -1.076 . . . . 74.21 108.096 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 31.1 ttm180 -81.24 110.2 16.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.889 0.875 . . . . 64.32 108.952 174.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 t -100.02 130.08 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 107.41 -1.33 . . . . 62.12 107.41 169.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -129.16 117.07 20.18 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.414 -0.587 . . . . 65.34 109.414 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.563 HG23 HD13 ' C' ' 114' ' ' ILE . 60.0 t -101.09 112.07 32.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 N-CA-C 108.427 -0.953 . . . . 74.0 108.427 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.433 HG23 HD23 ' C' ' 75' ' ' LEU . 5.0 m -99.4 146.62 26.11 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.363 -0.835 . . . . 64.23 109.039 177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.89 110.93 6.28 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.288 -1.004 . . . . 61.43 108.288 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 22.3 m -135.41 140.05 44.64 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.913 0.485 . . . . 21.21 110.438 -173.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.722 HD12 ' HG3' ' C' ' 71' ' ' GLU . 6.5 mt -111.02 14.07 21.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.657 1.183 . . . . 71.24 110.667 -170.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.86 -104.54 0.93 Allowed Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.598 -1.001 . . . . 54.33 110.598 -172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -93.06 -33.01 14.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.437 0.695 . . . . 73.44 109.316 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.722 ' HG3' HD12 ' C' ' 68' ' ' LEU . 3.8 tp10 -76.84 119.75 21.03 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.199 1.4 . . . . 74.23 109.137 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -86.29 134.1 33.77 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 109.029 -0.73 . . . . 64.1 109.029 174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -75.08 -58.24 3.4 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.485 -0.561 . . . . 74.14 109.485 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.84 175.27 3.96 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.137 -0.938 . . . . 72.13 110.652 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.433 HD23 HG23 ' C' ' 65' ' ' THR . 2.7 tm? -141.77 143.11 33.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.732 -1.581 . . . . 74.43 106.732 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.8 t -145.72 143.18 29.6 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.451 -0.944 . . . . 72.55 108.451 175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -150.99 130.4 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 122.81 0.444 . . . . 74.45 109.979 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.98 115.07 23.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 124.291 1.036 . . . . 71.02 108.527 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 62.4 mt-30 -90.98 92.34 8.71 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.161 -1.051 . . . . 63.31 108.161 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.533 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -81.38 110.96 17.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.737 -1.12 . . . . 64.53 110.004 -176.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.6 146.08 18.05 Favored Glycine 0 C--N 1.337 0.606 0 N-CA-C 111.782 -0.527 . . . . 61.3 111.782 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.62 120.42 1.57 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 110.889 -0.885 . . . . 64.53 110.889 -177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.478 HD12 HD11 ' C' ' 51' ' ' LEU . 11.0 mm -81.28 122.06 35.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.25 -1.018 . . . . 55.54 108.25 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -132.16 120.92 22.92 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.597 -0.89 . . . . 73.02 108.597 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.8 t -89.67 109.55 20.51 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.398 -0.964 . . . . 65.1 108.398 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -131.49 148.09 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.455 0.702 . . . . 75.34 111.036 -175.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.8 152.75 9.98 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.796 1.238 . . . . 73.15 108.818 176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.95 -16.38 58.65 Favored Glycine 0 N--CA 1.475 1.247 0 CA-C-O 119.967 -0.352 . . . . 74.33 113.176 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 42.4 pt -59.98 131.43 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 123.95 0.9 . . . . 65.45 110.325 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -161.6 164.97 29.05 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.591 0.357 . . . . 72.31 110.407 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.01 -137.65 26.99 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.705 0.628 . . . . 71.0 111.902 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -79.32 -23.62 43.36 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.092 0.557 . . . . 72.33 110.787 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.91 -32.3 73.46 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 123.88 0.737 . . . . 72.13 111.161 -171.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.425 ' HG3' ' N ' ' C' ' 95' ' ' ALA . 10.4 ptp -64.36 -48.02 77.11 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.295 0.372 . . . . 74.33 110.259 174.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' C' ' 94' ' ' MET . . . -71.29 -25.15 62.32 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.63 0.772 . . . . 60.11 111.195 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -79.22 -29.79 42.95 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 60.33 110.108 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -80.51 -66.77 0.84 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 116.577 -0.283 . . . . 63.42 110.794 -177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.38 -3.78 58.51 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.766 -0.584 . . . . 50.34 112.259 -173.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.81 9.28 25.6 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.894 -0.392 . . . . 44.02 113.791 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.29 -59.45 0.08 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.06 0.544 . . . . 64.53 110.207 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.403 ' O ' HG12 ' C' ' 105' ' ' ILE . 81.0 t80 -66.55 -54.53 22.63 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.721 0.808 . . . . 33.42 112.565 -171.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.661 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 20.7 m -62.76 -45.84 88.03 Favored Pre-proline 0 CA--C 1.561 1.402 0 C-N-CA 123.594 0.758 . . . . 44.32 111.505 -177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.6 Cg_exo -57.64 -32.07 93.56 Favored 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.067 1.844 . . . . 64.21 113.752 168.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' C' ' 108' ' ' PRO . 25.9 t-20 -74.83 -23.55 58.47 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 123.544 0.738 . . . . 64.52 110.822 178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 108' ' ' PRO . 46.0 mm -69.96 -33.26 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.196 0.598 . . . . 73.55 109.41 171.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' C' ' 82' ' ' GLY . 80.5 mt -88.26 -23.66 23.44 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.132 0.973 . . . . 63.53 111.951 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.55 -49.39 91.3 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.455 1.102 . . . . 73.33 113.339 -176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' C' ' 104' ' ' ASN . 16.0 Cg_exo -65.69 -38.57 23.84 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 121.979 1.786 . . . . 73.42 112.152 -176.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -61.76 -49.5 76.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.777 0.831 . . . . 74.02 111.197 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.84 -42.41 94.94 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.031 -0.986 . . . . 74.52 110.607 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.503 HH12 ' HG3' ' C' ' 130' ' ' PRO . 57.0 ttp180 -61.56 -42.44 98.84 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.554 1.142 . . . . 70.14 109.953 -178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.55 -35.89 65.56 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.721 0.809 . . . . 74.52 109.929 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.489 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 40.7 t -69.19 -29.85 67.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.637 0.375 . . . . 71.25 111.174 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.563 HD13 HG23 ' C' ' 64' ' ' VAL . 66.3 mt -72.28 -47.51 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 61.41 109.539 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 91.0 m -56.73 -31.99 65.1 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.382 1.073 . . . . 51.31 111.283 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -64.82 -56.5 13.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.578 1.151 . . . . 53.4 109.662 174.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.81 -38.07 77.79 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.603 1.161 . . . . 72.05 112.581 -177.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.481 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.7 t -69.83 -40.02 78.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 123.176 0.591 . . . . 65.42 110.252 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.543 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 34.1 t -62.93 -38.12 89.73 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.452 0.644 . . . . 73.41 110.628 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.461 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 51.0 mtt-85 -67.07 -37.51 84.13 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-N 114.534 -1.212 . . . . 72.1 110.404 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.11 7.2 57.2 Favored Glycine 0 C--N 1.353 1.504 0 O-C-N 123.637 0.586 . . . . 61.23 113.248 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 50.7 p 60.57 26.78 16.45 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 126.38 1.872 . . . . 44.44 113.168 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.481 ' HB2' HG13 ' C' ' 118' ' ' VAL . 67.2 m-85 -97.73 156.02 36.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 123.283 0.633 . . . . 63.1 109.632 176.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -60.85 78.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 123.747 2.965 . . . . 71.55 114.405 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.543 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 0.0 OUTLIER -65.63 155.16 36.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.518 1.127 . . . . 62.42 112.497 173.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 119' ' ' SER . 2.0 pt? -168.13 162.16 12.86 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 114.111 -1.404 . . . . 75.21 108.934 165.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -88.22 100.79 13.25 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 106.455 -1.683 . . . . 73.25 106.455 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 89.1 mt -61.04 149.81 35.73 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 124.48 1.112 . . . . 64.43 111.124 -170.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.412 ' HB1' HD12 ' F' ' 204' ' ' ILE . . . -50.73 122.48 16.54 Favored Pre-proline 0 CA--C 1.551 1.014 0 O-C-N 124.841 1.338 . . . . 71.24 111.853 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.795 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 71.9 Cg_exo -52.68 120.6 7.78 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.552 2.835 . . . . 72.21 112.846 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.5 m -77.48 91.42 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 CA-C-O 122.037 0.922 . . . . 63.45 109.712 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.55 HD22 HG21 ' F' ' 207' ' ' VAL . 47.5 m-80 -77.01 82.61 3.53 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.176 -0.92 . . . . 72.42 110.693 -173.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -66.45 -42.31 87.82 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.034 -0.985 . . . . 71.14 111.054 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -56.51 -49.97 73.17 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.027 0.931 . . . . 44.41 111.373 -178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.23 -46.45 85.89 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 123.873 0.733 . . . . 54.04 111.583 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.08 -51.45 69.07 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.095 0.872 . . . . 63.03 110.595 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -57.26 -52.32 65.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.429 1.092 . . . . 73.01 111.972 -176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 96.5 mmm -65.42 -31.72 72.97 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.742 0.817 . . . . 72.22 111.126 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -70.74 -41.87 71.26 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.285 1.034 . . . . 64.24 110.422 176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.598 ' HB3' ' HB2' ' A' ' 152' ' ' HIS . 11.5 m-85 -71.9 -89.62 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.403 1.081 . . . . 63.43 112.223 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 96.2 mt 48.47 -133.97 1.32 Allowed 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 124.594 1.157 . . . . 73.03 112.308 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -161.07 -67.05 0.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.54 -1.282 . . . . 75.01 107.54 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -86.88 163.38 17.21 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 113.848 -1.524 . . . . 51.25 108.702 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -72.89 -0.4 13.47 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.082 0.553 . . . . 74.24 111.852 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 75.33 -64.32 0.38 Allowed 'General case' 0 C--N 1.365 1.256 0 C-N-CA 126.183 1.793 . . . . 62.31 110.563 177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 161.34 -173.27 37.73 Favored Glycine 0 C--O 1.24 0.52 0 CA-C-N 115.807 -0.633 . . . . 65.41 111.928 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.33 63.53 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.794 0.807 . . . . 74.14 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.41 -35.9 9.16 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 114.413 -1.267 . . . . 53.31 112.262 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.646 ' HA ' HD13 ' A' ' 141' ' ' LEU . 9.1 t -81.57 16.48 1.71 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.379 1.072 . . . . 52.24 112.187 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -96.08 95.09 7.94 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 123.693 0.797 . . . . 51.33 110.547 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -164.72 145.7 7.83 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.369 -0.974 . . . . 74.43 108.369 166.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -70.41 -90.17 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.388 1.075 . . . . 72.33 110.753 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 161.94 174.71 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.06 1.744 . . . . 62.52 107.99 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -125.61 -76.88 0.58 Allowed 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.594 -0.891 . . . . 73.21 108.594 171.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.503 -0.925 . . . . 63.43 108.503 178.756 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.435 ' SD ' ' HD2' ' E' ' 205' ' ' LYS . 1.2 tmt? . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.113 -0.699 . . . . 74.14 109.113 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -160.81 98.67 1.22 Allowed 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.535 -1.283 . . . . 70.33 107.535 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' D' ' 85' ' ' SER . 1.4 pm0 -143.71 126.73 16.39 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.152 0.981 . . . . 75.22 109.489 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -108.3 164.06 12.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.214 1.005 . . . . 62.51 109.947 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -70.23 -22.18 62.93 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 123.777 0.673 . . . . 72.41 111.658 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -73.01 82.4 1.23 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.677 0.791 . . . . 74.34 109.272 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -174.95 157.21 2.33 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.607 -1.179 . . . . 62.5 109.813 -175.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -82.33 -168.8 2.12 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.901 0.88 . . . . 74.22 109.06 167.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.526 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.6 ttp -34.94 123.29 0.57 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 123.944 0.898 . . . . 73.24 112.788 175.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 62.2 m -138.01 144.77 41.22 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.503 -0.925 . . . . 64.14 108.503 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -154.61 98.12 2.05 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -112.56 143.05 44.37 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.476 -0.935 . . . . 73.24 108.476 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 9.7 tt -104.38 101.47 12.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 107.994 -1.113 . . . . 71.41 107.994 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.54 -46.6 31.13 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.894 -0.593 . . . . 75.12 111.808 -171.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.464 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 32.4 ttt180 -170.68 126.68 0.74 Allowed 'General case' 0 N--CA 1.479 0.999 0 O-C-N 123.167 0.292 . . . . 72.31 111.067 -167.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 41.1 mm -115.95 123.44 71.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.581 0.752 . . . . 72.21 109.002 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.464 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 15.8 p90 -147.29 160.69 42.22 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.675 0.79 . . . . 74.11 111.724 -176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -91.53 122.42 34.1 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.12 -0.946 . . . . 70.0 108.828 171.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -86.46 -45.56 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.636 -0.876 . . . . 72.53 108.636 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -130.75 133.84 46.37 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 113.692 -1.594 . . . . 74.12 109.082 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.551 HD13 ' HE3' ' C' ' 117' ' ' MET . 83.0 mt -134.29 145.55 32.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 107.603 -1.258 . . . . 74.3 107.603 170.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.0 t -148.84 144.64 27.06 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.715 0.806 . . . . 75.12 109.393 171.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.575 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -146.04 132.2 19.4 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.146 -1.798 . . . . 74.44 106.146 170.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -133.49 134.18 43.16 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.055 -1.091 . . . . 75.24 108.055 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.63 89.6 48.83 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.738 -1.208 . . . . 74.42 107.738 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.39 -51.92 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.053 2.502 . . . . 71.35 112.974 -173.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -96.7 38.91 1.19 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.494 -0.928 . . . . 73.13 108.494 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.565 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.84 -52.58 63.44 Favored Pre-proline 0 CA--C 1.573 1.843 0 N-CA-C 115.329 1.603 . . . . 72.41 115.329 -164.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -82.98 -15.8 7.86 Favored 'Trans proline' 0 C--N 1.388 2.607 0 CA-C-N 121.302 1.501 . . . . 64.51 113.534 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -69.56 -38.96 77.66 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.659 1.183 . . . . 64.14 109.119 174.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 14.5 t -68.97 -29.57 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 125.426 1.491 . . . . 74.24 110.836 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.423 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 49.8 t80 -63.16 -36.02 82.22 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.137 0.575 . . . . 75.14 110.84 172.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -84.47 -1.83 56.3 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.984 0.914 . . . . 73.43 111.566 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -119.8 78.4 1.32 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.953 0.901 . . . . 71.3 109.407 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.635 ' HA ' ' HD2' ' H' ' 195' ' ' PHE . 8.0 p-10 -80.81 85.93 6.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.154 0.582 . . . . 74.42 112.388 -171.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -139.85 177.34 8.03 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.371 1.069 . . . . 74.25 108.759 172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -87.18 119.11 70.8 Favored Pre-proline 0 CA--C 1.554 1.128 0 O-C-N 121.985 -0.447 . . . . 72.52 110.16 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.27 113.4 2.85 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.854 2.369 . . . . 64.14 112.255 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -74.19 114.03 12.07 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.835 -0.802 . . . . 74.13 108.835 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' D' ' 66' ' ' ALA . 31.5 m -99.76 134.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 123.834 0.854 . . . . 63.24 110.934 -174.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 39.5 mmtm -97.12 110.8 23.27 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.453 -0.944 . . . . 71.35 108.453 171.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' H' ' 188' ' ' ALA . 1.8 mm? -97.14 115.43 27.52 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.041 -1.096 . . . . 62.52 108.041 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.81 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 3.7 m-20 -107.24 119.53 39.65 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.434 -0.95 . . . . 71.02 108.434 -177.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 tp -94.9 129.45 41.92 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.041 -0.725 . . . . 60.52 109.041 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.9 t70 -152.44 151.11 30.38 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.149 0.98 . . . . 64.3 108.595 175.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -133.22 163.03 30.2 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.51 0.724 . . . . 70.42 110.047 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.2 166.97 28.27 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.109 0.964 . . . . 74.04 109.652 -178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 52.3 p -152.2 154.25 35.43 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.105 0.562 . . . . 63.21 110.444 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -157.22 119.03 3.76 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.193 0.997 . . . . 71.13 108.859 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -70.85 128.22 35.26 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.688 0.395 . . . . 63.04 110.211 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' D' ' 57' ' ' GLU . 40.5 mt -103.57 -29.1 11.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.318 0.647 . . . . 63.3 110.166 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -165.8 -176.63 3.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.297 1.039 . . . . 72.55 110.017 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -67.54 121.02 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.579 -0.897 . . . . 53.33 108.579 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 63.89 16.82 10.13 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.4 1.08 . . . . 71.15 112.756 -178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.53 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 79.6 t -131.2 128.59 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.283 1.033 . . . . 71.31 108.765 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.465 ' CE1' HG12 ' D' ' 86' ' ' ILE . 0.0 OUTLIER -151.41 161.67 42.3 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.021 0.439 . . . . 72.53 110.674 176.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' D' ' 51' ' ' LEU . 26.9 tt0 -103.01 120.55 40.85 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 124.531 1.132 . . . . 70.34 108.848 173.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -99.65 123.09 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.403 -1.332 . . . . 43.35 107.403 169.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 29.7 t -102.75 133.93 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 N-CA-C 108.883 -0.784 . . . . 63.55 108.883 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.24 111.08 22.47 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.219 -1.03 . . . . 72.21 108.219 179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.0 ttm-85 -86.84 110.53 20.02 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 109.144 -0.688 . . . . 75.23 109.144 171.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.0 t -108.56 103.83 16.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.87 -1.159 . . . . 65.14 107.87 168.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.81 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -96.04 146.5 24.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.957 -0.757 . . . . 71.42 108.957 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 81.2 t -138.21 123.18 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 124.818 1.247 . . . . 74.42 108.368 -177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 60.6 m -125.63 97.78 5.3 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.644 -0.873 . . . . 71.04 108.644 177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -94.16 137.62 33.14 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.49 0.716 . . . . 71.15 109.385 -174.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.8 m -137.06 149.53 47.47 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.142 0.577 . . . . 53.41 110.694 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 14.1 mt -132.58 117.42 17.93 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 125.047 1.339 . . . . 71.32 107.999 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.26 -112.43 4.68 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.695 -0.562 . . . . 74.43 111.695 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.04 4.48 13.73 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.768 0.827 . . . . 73.15 110.815 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -118.62 170.9 8.58 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.308 0.643 . . . . 74.33 110.511 -176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -79.95 138.04 37.0 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.851 -0.613 . . . . 72.44 109.986 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.05 -56.74 2.96 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.704 0.802 . . . . 72.05 109.069 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -163.59 163.6 24.44 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.878 -1.055 . . . . 71.34 109.828 172.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 78.1 mt -118.82 153.04 35.13 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.048 1.339 . . . . 74.45 108.25 173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.541 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 44.3 t -159.31 144.96 16.09 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.115 0.566 . . . . 64.04 109.988 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -156.83 139.71 15.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.226 0.61 . . . . 64.31 109.382 171.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.8 t -134.61 119.89 30.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 123.653 0.781 . . . . 75.03 108.936 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.2 mt-30 -97.47 87.84 4.22 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.768 0.827 . . . . 74.51 108.956 173.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -80.64 97.75 7.37 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 113.819 -1.537 . . . . 72.45 109.588 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.53 141.59 16.73 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.578 -0.609 . . . . 72.01 111.578 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.3 131.42 4.86 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 111.847 -0.501 . . . . 72.24 111.847 -176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.3 mt -90.04 125.35 42.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 108.956 -0.757 . . . . 74.44 108.956 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -129.6 128.8 43.42 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.255 1.022 . . . . 74.45 109.493 -177.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.493 ' HB3' ' HG3' ' D' ' 3' ' ' GLU . 6.0 m -88.29 95.18 10.08 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.054 0.942 . . . . 73.51 108.682 172.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.465 HG12 ' CE1' ' D' ' 56' ' ' TYR . 2.7 pp -109.42 140.23 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 122.66 0.384 . . . . 75.45 110.389 -175.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.32 165.41 19.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.003 0.921 . . . . 74.03 109.113 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.36 23.83 76.45 Favored Glycine 0 N--CA 1.477 1.393 0 CA-C-O 121.529 0.516 . . . . 74.44 112.262 -174.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.47 HD13 ' SD ' ' D' ' 94' ' ' MET . 2.3 pp -109.18 147.16 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.967 1.307 . . . . 70.23 110.238 -173.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -168.58 150.46 4.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.923 0.489 . . . . 73.21 111.332 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.05 -139.75 48.25 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 124.015 0.822 . . . . 70.22 114.959 173.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . 0.618 ' HB ' HD22 ' D' ' 141' ' ' LEU . 12.6 p -68.54 -18.69 64.41 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.544 0.738 . . . . 72.23 111.739 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' D' ' 147' ' ' GLU . 0.6 OUTLIER -69.84 -47.85 61.15 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.518 0.727 . . . . 72.25 109.573 175.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.47 ' SD ' HD13 ' D' ' 89' ' ' ILE . 9.3 tpt -58.34 -53.06 62.6 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.94 0.775 . . . . 62.52 110.553 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.64 -40.17 86.79 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.956 0.785 . . . . 34.21 111.424 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.434 ' HE1' ' HB3' ' D' ' 137' ' ' PHE . 83.5 t60 -70.86 -47.09 61.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.409 0.683 . . . . 51.44 111.526 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.91 -30.53 71.14 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.155 0.582 . . . . 55.02 110.589 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 tt -77.03 -48.39 18.03 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.137 0.975 . . . . 65.42 110.34 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.45 -14.31 60.22 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 115.772 -0.649 . . . . 71.42 114.231 -169.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.15 -60.97 1.32 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.025 0.53 . . . . 62.42 110.99 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -64.56 -47.45 78.69 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 112.818 0.673 . . . . 72.33 112.818 -173.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.463 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 94.9 m -62.29 -50.17 80.84 Favored Pre-proline 0 CA--C 1.57 1.714 0 CA-C-O 118.8 -0.619 . . . . 74.12 111.246 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 60.1 Cg_exo -58.77 -31.0 94.19 Favored 'Trans proline' 0 C--N 1.393 2.898 0 C-N-CA 122.542 2.161 . . . . 73.41 113.94 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -66.04 -32.9 74.65 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.09 0.556 . . . . 74.03 110.419 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.566 HG13 HD21 ' B' ' 132' ' ' ASN . 47.7 mm -69.9 -43.22 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.516 0.726 . . . . 70.23 110.21 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.448 HD21 ' HA3' ' D' ' 82' ' ' GLY . 90.7 mt -73.36 -19.5 60.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.183 -0.917 . . . . 75.13 111.772 -175.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -69.09 -44.33 27.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 N-CA-C 113.887 1.069 . . . . 75.23 113.887 -169.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -55.03 -34.52 87.38 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 121.927 1.752 . . . . 74.31 113.237 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -81.2 -33.87 32.66 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.175 0.99 . . . . 75.42 111.441 -176.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.73 -46.33 66.17 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.16 0.584 . . . . 50.13 109.71 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -58.82 -49.31 78.2 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.089 1.356 . . . . 64.12 110.596 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.45 -43.41 94.37 Favored 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.172 0.92 . . . . 75.15 110.881 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.461 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.3 t -56.09 -41.59 75.42 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.628 0.58 . . . . 25.34 110.737 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' D' ' 118' ' ' VAL . 78.8 mt -70.91 -44.59 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.153 -0.931 . . . . 55.42 110.782 176.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.513 HG23 ' HG3' ' D' ' 125' ' ' GLN . 74.2 m -55.07 -42.65 73.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.015 0.926 . . . . 75.33 110.598 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.31 -48.08 71.48 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 114.511 -1.222 . . . . 33.43 110.305 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.44 -32.76 74.52 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.008 0.523 . . . . 63.25 112.126 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.3 t -67.42 -45.73 85.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 CA-C-N 115.566 -0.743 . . . . 65.53 109.531 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.8 p -71.76 -23.17 61.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.625 0.37 . . . . 72.24 111.548 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.489 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 84.4 mtt-85 -77.6 -34.35 53.48 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.094 0.958 . . . . 71.14 109.85 175.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.89 -0.01 79.93 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-N 115.587 -0.733 . . . . 32.3 111.926 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.4 p 61.5 42.31 11.52 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.313 1.845 . . . . 41.44 111.552 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.417 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 37.1 m-85 -111.56 167.82 8.52 Favored Pre-proline 0 CA--C 1.56 1.347 0 CA-C-N 113.078 -1.874 . . . . 75.2 107.878 174.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.479 ' HD3' ' HE1' ' H' ' 195' ' ' PHE . 93.1 Cg_endo -75.17 140.37 24.91 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.996 1.797 . . . . 75.44 112.053 -171.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.513 ' HG3' HG23 ' D' ' 115' ' ' THR . 25.6 tt0 -45.61 123.78 4.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.502 1.121 . . . . 75.13 112.338 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.51 HD11 HG21 ' D' ' 40' ' ' VAL . 42.1 tp -108.56 93.02 4.3 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.524 -0.762 . . . . 65.1 109.021 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -115.53 106.0 13.44 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.03 0.932 . . . . 61.01 109.039 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.573 HD11 ' HG ' ' D' ' 42' ' ' LEU . 3.6 mm? -62.44 125.51 24.16 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.337 -0.847 . . . . 72.41 110.135 174.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.531 ' HB1' HE22 ' B' ' 12' ' ' GLN . . . -55.7 128.46 69.33 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 124.538 1.149 . . . . 60.45 110.562 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -73.59 95.23 0.86 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.307 2.671 . . . . 74.34 112.335 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 91.2 t -102.12 118.74 49.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 107.508 -1.293 . . . . 64.12 107.508 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -80.07 79.04 6.67 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 121.752 0.787 . . . . 62.42 109.215 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -68.16 -20.57 64.89 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.482 -1.236 . . . . 74.51 111.392 176.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.4 -56.02 13.03 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 109.092 -0.707 . . . . 75.11 109.092 176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.74 -30.88 71.07 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.461 0.705 . . . . 50.11 112.011 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 56.0 tp -61.61 -48.46 80.79 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.849 0.859 . . . . 64.32 111.037 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.434 ' HB3' ' HE1' ' D' ' 96' ' ' HIS . 39.3 t80 -83.18 -26.6 30.72 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.531 0.733 . . . . 73.31 111.04 -178.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 44.1 ttm -51.32 -38.57 53.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.24 1.416 . . . . 71.41 112.504 -176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -67.57 -31.69 71.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-N 115.802 -0.635 . . . . 64.55 111.091 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -74.92 -22.73 58.44 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.706 0.802 . . . . 73.22 111.831 -176.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.618 HD22 ' HB ' ' D' ' 92' ' ' THR . 82.3 mt -61.87 -53.32 57.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.829 0.852 . . . . 72.52 111.503 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -79.23 5.55 11.99 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.159 -0.928 . . . . 73.12 111.978 -177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -122.05 46.25 2.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.929 0.892 . . . . 61.01 109.317 173.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -168.33 -178.67 3.68 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.836 0.854 . . . . 64.42 110.427 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.07 128.44 35.53 Favored 'General case' 0 C--N 1.351 0.663 0 N-CA-C 108.957 -0.757 . . . . 55.14 108.957 166.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.99 144.24 3.87 Favored Glycine 0 C--O 1.238 0.386 0 N-CA-C 109.996 -1.242 . . . . 64.34 109.996 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . 0.411 ' HG2' ' HB2' ' D' ' 93' ' ' GLN . 16.7 mt-10 67.15 111.09 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.067 0.947 . . . . 62.13 110.14 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.35 -157.02 3.27 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 116.147 -0.479 . . . . 63.35 113.117 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.0 m 63.27 101.28 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.126 0.971 . . . . 74.52 109.813 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.68 145.94 32.54 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.116 0.966 . . . . 62.02 112.377 -169.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 -173.49 0.64 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.454 0.701 . . . . 74.31 111.353 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 64.3 t60 75.59 14.33 2.83 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.646 1.178 . . . . 73.25 110.384 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.76 81.5 7.77 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.019 -1.474 . . . . 75.21 107.019 173.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -173.64 159.64 3.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.457 1.103 . . . . 75.31 109.83 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.253 0 C-N-CA 123.697 0.799 . . . . 74.44 109.31 177.269 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' E' ' 169' ' ' GLY . 8.8 tmtt? . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 108.369 -0.975 . . . . 54.52 108.369 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . 0.43 ' N ' ' HD3' ' E' ' 168' ' ' LYS . . . 104.71 -130.66 10.32 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 110.873 -0.891 . . . . 74.43 110.873 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' E' ' 175' ' ' PHE . 20.5 ptmt -159.73 136.21 9.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.62 0.768 . . . . 75.11 111.163 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 34.2 m -124.12 31.67 5.74 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.108 0.963 . . . . 52.45 109.468 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -145.15 176.1 9.77 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.766 -1.106 . . . . 64.1 109.388 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -63.41 -30.86 71.92 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.264 0.554 . . . . 33.13 110.377 170.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 14.3 ptt? -147.48 120.15 8.6 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.931 1.292 . . . . 70.12 108.512 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' E' ' 170' ' ' LYS . 38.0 t80 -174.33 126.63 0.34 Allowed 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 106.71 -1.589 . . . . 73.25 106.71 -175.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -138.64 -73.08 0.4 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.069 -0.715 . . . . 75.41 109.069 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp 59.45 79.05 0.24 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 124.271 1.028 . . . . 52.01 111.46 173.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -136.95 -59.16 0.71 Allowed 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 109.4 -0.593 . . . . 74.44 109.4 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' E' ' 180' ' ' PRO . 20.5 mp0 -74.53 -57.22 2.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.488 0.715 . . . . 64.03 110.901 -174.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' E' ' 179' ' ' GLU . 66.2 Cg_endo -81.24 4.0 7.35 Favored 'Trans proline' 0 C--N 1.397 3.118 0 C-N-CA 121.747 1.631 . . . . 63.14 112.521 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -98.2 88.44 4.19 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.227 -1.027 . . . . 72.11 108.227 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -83.98 165.87 18.27 Favored 'General case' 0 C--O 1.246 0.892 0 N-CA-C 109.494 -0.558 . . . . 75.52 109.494 177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 23.5 p -81.01 112.05 18.05 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.852 0.461 . . . . 53.14 110.122 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.409 ' NE1' ' HB2' ' C' ' 44' ' ' LEU . 0.6 OUTLIER -70.77 148.21 94.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.997 -0.547 . . . . 71.32 110.2 170.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.16 141.78 98.45 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.38 2.054 . . . . 62.43 111.161 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' C' ' 43' ' ' ASP . 88.0 mt -103.73 7.21 37.23 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.489 0.716 . . . . 65.43 110.568 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 3.6 tt 59.6 164.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 126.527 1.931 . . . . 74.03 112.282 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -169.02 93.03 0.29 Allowed 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.753 -0.832 . . . . 61.24 108.753 174.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' F' ' 201' ' ' LYS . . . -97.48 128.2 44.05 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.766 -0.652 . . . . 54.3 109.508 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -83.33 128.59 34.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.773 0.829 . . . . 71.11 109.272 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . 0.641 ' HA3' ' HD2' ' C' ' 38' ' ' PRO . . . -79.83 16.0 13.12 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 115.021 0.768 . . . . 54.11 115.021 -175.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.48 -107.2 2.9 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 118.168 0.984 . . . . 32.51 111.631 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 51.2 t80 179.9 131.25 0.09 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.0 0.92 . . . . 65.24 109.558 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 63.68 125.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.112 1.365 . . . . 73.43 113.334 172.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . 0.515 ' HB2' ' HB2' ' C' ' 36' ' ' TRP . 0.2 OUTLIER -96.08 163.09 13.26 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.977 -0.452 . . . . 74.2 110.141 -178.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -72.94 84.09 1.24 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 108.905 -0.776 . . . . 73.33 108.905 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -136.92 112.22 9.17 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.579 1.152 . . . . 73.04 108.213 174.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -174.42 -68.48 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.549 0.74 . . . . 71.01 109.128 176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -92.79 -48.52 6.52 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.789 0.836 . . . . 74.02 109.628 173.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 85.32 123.37 1.25 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.79 -0.524 . . . . 75.52 111.79 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -136.34 12.14 3.26 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.131 0.572 . . . . 72.31 111.398 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' F' ' 190' ' ' ASP . 24.1 t80 -122.84 -12.6 8.01 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.34 0.656 . . . . 73.04 110.556 -175.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.37 179.52 7.81 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.166 0.987 . . . . 60.1 110.722 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 50.0 mm -109.81 103.26 15.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 CA-C-O 121.313 0.578 . . . . 64.33 110.445 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . 0.435 ' HD2' ' SD ' ' D' ' 1' ' ' MET . 81.7 tttt -126.7 131.75 51.31 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.995 -1.113 . . . . 74.31 107.995 169.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -163.94 -50.63 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.456 0.702 . . . . 74.41 109.393 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 CA--C 1.554 1.097 0 CA-C-N 114.937 -1.029 . . . . 73.52 109.733 178.637 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 21.8 pttp . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.692 -0.485 . . . . 74.12 109.692 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.32 128.87 1.18 Allowed Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.175 -0.466 . . . . 72.35 112.086 -176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -113.42 -162.42 0.8 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.616 0.767 . . . . 64.52 109.407 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 9.4 m 67.56 174.39 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.259 1.024 . . . . 51.12 110.748 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . 0.555 ' HB1' HD22 ' F' ' 173' ' ' LEU . . . -82.17 -86.56 0.1 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 121.921 -0.487 . . . . 71.42 111.018 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.589 HD12 ' H ' ' B' ' 2' ' ' SER . 2.4 mm? -122.79 -66.47 1.02 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.934 -0.479 . . . . 74.4 111.307 -172.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.45 ' SD ' ' HE2' ' B' ' 56' ' ' TYR . 20.5 mmt 74.86 168.74 0.29 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.567 1.547 . . . . 75.42 111.054 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . 0.491 ' HD1' ' H ' ' F' ' 177' ' ' LEU . 43.5 p90 -159.57 164.87 33.88 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.528 0.731 . . . . 73.34 110.873 -177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -118.12 27.36 9.03 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.003 0.921 . . . . 73.24 109.274 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' B' ' 48' ' ' SER . 7.0 mp 66.82 70.81 0.39 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.936 1.295 . . . . 64.44 109.977 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -89.82 102.61 15.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.534 -0.757 . . . . 75.3 109.589 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 55.6 83.96 0.22 Allowed Pre-proline 0 CA--C 1.555 1.157 0 O-C-N 124.578 1.174 . . . . 64.01 111.896 171.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.58 90.69 0.1 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.068 2.512 . . . . 55.31 112.253 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . 0.451 ' OH ' ' HB2' ' B' ' 137' ' ' PHE . 9.7 t80 68.11 -177.55 0.21 Allowed 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 125.172 1.389 . . . . 73.24 112.208 176.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -87.25 57.17 4.32 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.59 1.156 . . . . 75.32 109.84 173.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 26.5 m 69.93 146.17 0.06 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.905 1.282 . . . . 75.42 112.014 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.598 ' HZ3' ' HA ' ' B' ' 100' ' ' ALA . 4.2 t-105 -125.7 85.64 58.69 Favored Pre-proline 0 CA--C 1.554 1.098 0 N-CA-C 108.693 -0.855 . . . . 73.33 108.693 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . 0.409 ' HD2' ' HE2' ' B' ' 133' ' ' PHE . 72.1 Cg_endo -76.79 149.84 30.05 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.606 2.204 . . . . 63.11 112.52 171.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.425 HD21 ' HE1' ' F' ' 184' ' ' TRP . 79.0 mt -142.51 168.72 19.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.582 1.153 . . . . 74.42 109.857 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.507 ' H ' HD13 ' F' ' 187' ' ' ILE . 0.2 OUTLIER -76.23 154.48 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 123.199 0.6 . . . . 74.13 110.163 175.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -78.11 -71.37 0.43 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.683 0.393 . . . . 62.23 110.468 -178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -169.48 143.51 2.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.128 0.971 . . . . 71.35 109.828 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' E' ' 202' ' ' TYR . 29.7 t70 -173.33 161.6 4.21 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.946 0.779 . . . . 72.3 110.259 174.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.78 -37.93 0.32 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.741 -0.944 . . . . 62.32 110.741 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.56 34.0 36.89 Favored Glycine 0 C--N 1.345 1.046 0 CA-C-N 115.351 -0.424 . . . . 74.2 112.884 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . 0.488 ' HB2' ' HB3' ' B' ' 37' ' ' GLN . 63.7 m-85 -75.14 171.96 13.22 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.978 0.911 . . . . 74.14 111.699 -178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -165.17 171.74 13.36 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.488 1.115 . . . . 60.32 108.894 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -107.09 -86.12 0.5 Allowed 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 119.264 -0.398 . . . . 73.03 111.441 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 13.1 mptt 70.73 100.57 0.06 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.315 1.046 . . . . 64.44 109.984 -169.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . 0.482 ' HD1' ' HB2' ' F' ' 203' ' ' ASP . 23.3 m-85 -74.35 -18.83 60.63 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.868 0.467 . . . . 72.43 110.434 173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -82.66 75.4 9.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.977 0.511 . . . . 73.01 109.786 175.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 64.2 23.9 13.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.521 1.129 . . . . 60.34 112.664 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -86.71 -116.2 1.0 Allowed Glycine 0 C--N 1.349 1.256 0 CA-C-O 119.678 -0.512 . . . . 65.11 112.511 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.412 ' HA ' ' HB1' ' E' ' 189' ' ' ALA . 36.9 pttt -155.73 153.59 30.15 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.617 0.767 . . . . 73.12 109.887 -168.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 63.81 8.74 3.99 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.721 1.208 . . . . 74.25 111.81 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . 0.482 ' HB2' ' HD1' ' F' ' 197' ' ' TYR . 5.1 p-10 -106.74 -169.58 1.58 Allowed 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.757 1.223 . . . . 75.24 109.139 -172.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.412 HD12 ' HB1' ' C' ' 129' ' ' ALA . 10.9 tt -157.98 100.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 106.894 -1.521 . . . . 72.33 106.894 167.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -82.87 36.18 0.49 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.143 -1.39 . . . . 71.45 112.228 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 22.6 t70 71.42 124.74 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.26 1.424 . . . . 71.35 111.28 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.55 HG21 HD22 ' C' ' 132' ' ' ASN . 54.1 t . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.708 -0.663 . . . . 62.4 109.675 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.893 -0.41 . . . . 74.1 109.893 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . 0.542 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 82.58 177.4 51.91 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.567 0.542 . . . . 45.21 113.189 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -147.18 2.61 0.77 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.613 0.765 . . . . 64.12 109.544 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 34.9 p -162.49 177.86 9.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.291 0.636 . . . . 72.32 111.12 -167.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 97' ' ' CYS . . . -158.62 136.03 10.1 Favored 'General case' 0 C--N 1.355 0.806 0 CA-C-O 121.116 0.484 . . . . 73.44 112.065 172.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.685 ' HG ' ' HG3' ' G' ' 174' ' ' MET . 1.2 pt? -125.21 -174.03 2.96 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 125.074 1.35 . . . . 65.03 107.415 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.685 ' HG3' ' HG ' ' G' ' 173' ' ' LEU . 29.1 mtt 64.06 -166.45 0.23 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.259 0.624 . . . . 73.22 109.617 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.416 ' HE1' HG23 ' A' ' 46' ' ' THR . 8.7 t80 -129.86 -71.15 0.62 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 107.947 -1.131 . . . . 63.42 107.947 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 55.3 t30 42.85 75.52 0.09 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.449 1.499 . . . . 63.42 113.119 171.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 mp -78.84 75.9 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.423 -0.954 . . . . 71.1 108.423 172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -65.69 -47.03 76.81 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 113.716 -1.584 . . . . 72.22 110.704 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -149.16 137.62 11.91 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.317 1.047 . . . . 71.01 109.177 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.78 87.1 1.16 Allowed 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.078 2.519 . . . . 74.45 110.972 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -73.12 131.05 41.59 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.191 -0.913 . . . . 74.41 109.258 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 60.64 -165.91 0.21 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.208 1.003 . . . . 75.21 112.597 174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.8 t -130.27 140.18 50.7 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 123.787 0.835 . . . . 53.11 109.312 174.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . 0.477 ' HD1' ' H ' ' G' ' 186' ' ' LEU . 4.5 t90 -135.22 92.13 18.36 Favored Pre-proline 0 CA--C 1.544 0.75 0 N-CA-C 107.098 -1.445 . . . . 75.34 107.098 176.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -81.91 0.5 9.8 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.788 2.325 . . . . 74.13 113.598 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . 0.519 HD11 HD22 ' A' ' 44' ' ' LEU . 4.5 mm? 62.81 -167.67 0.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.995 . . . . 71.21 110.903 -175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.633 HD12 ' HE1' ' H' ' 202' ' ' TYR . 13.9 pt -93.5 131.73 39.66 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.918 0.887 . . . . 74.32 109.96 176.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.62 91.52 2.87 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.545 -0.909 . . . . 74.2 108.545 173.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -72.65 83.25 1.14 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.556 -0.747 . . . . 75.54 111.213 -174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -144.32 125.66 14.77 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.889 -1.152 . . . . 73.33 107.889 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -125.3 -146.95 6.9 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 123.212 0.32 . . . . 33.43 113.668 -172.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.63 54.79 0.74 Allowed Glycine 0 C--N 1.345 1.046 0 C-N-CA 123.36 0.505 . . . . 53.02 112.273 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 66.64 -178.72 0.2 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.52 1.128 . . . . 71.14 112.998 172.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -152.1 -162.72 1.57 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.558 1.143 . . . . 74.42 108.403 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.456 ' HB3' ' O ' ' H' ' 195' ' ' PHE . 24.3 p90 -61.98 104.63 0.48 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 121.111 0.482 . . . . 72.1 109.806 171.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.66 53.55 2.58 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.72 0.772 . . . . 53.34 109.508 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 61.05 -77.3 0.02 OUTLIER 'General case' 0 C--N 1.358 0.96 0 C-N-CA 126.053 1.741 . . . . 72.2 112.297 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 66.77 120.82 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.611 1.164 . . . . 73.13 109.852 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -66.27 86.76 0.11 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 121.41 0.624 . . . . 51.13 111.066 -172.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . 0.46 ' HA3' ' HA2' ' H' ' 192' ' ' GLY . . . -97.83 -176.35 33.7 Favored Glycine 0 C--O 1.244 0.761 0 CA-C-N 114.866 -1.061 . . . . 63.35 110.642 171.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -144.48 150.09 37.05 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 122.902 0.481 . . . . 71.44 110.029 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . 0.439 ' HE1' ' HB2' ' D' ' 129' ' ' ALA . 82.1 t80 -117.2 0.85 12.4 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.35 1.06 . . . . 61.11 109.882 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 36.6 t70 69.44 92.97 0.08 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 124.991 1.316 . . . . 74.32 109.492 -172.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.573 HG23 ' HG2' ' B' ' 12' ' ' GLN . 39.9 mm -93.75 92.6 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.172 -0.922 . . . . 63.21 111.622 -167.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 17.1 mttp 168.38 131.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.15 2.18 . . . . 63.5 108.251 171.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -90.05 -77.93 0.38 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.902 0.481 . . . . 54.33 109.996 172.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 C--O 1.245 0.835 0 N-CA-C 107.618 -1.253 . . . . 41.22 107.618 -177.081 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' B' ' 155' ' ' ALA . 47.2 mmtm . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 110.128 -0.323 . . . . 64.44 110.128 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -61.29 120.73 23.83 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 123.845 0.716 . . . . 62.01 113.27 -176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.91 169.33 23.7 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.203 0.601 . . . . 72.55 110.356 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 51.8 m -107.84 -176.1 2.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.845 0.858 . . . . 50.51 110.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.29 84.46 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.268 0.627 . . . . 65.2 110.539 172.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.55 112.27 24.63 Favored 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.152 -0.931 . . . . 65.11 109.766 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 18.9 mmt 64.69 -178.44 0.17 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.049 1.34 . . . . 70.41 112.987 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -162.19 178.01 9.14 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.825 0.85 . . . . 72.43 109.446 175.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' H' ' 178' ' ' GLN . 3.9 p-10 -109.43 137.52 47.16 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.012 -1.107 . . . . 75.0 108.012 167.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 38.5 tp -77.33 77.53 3.86 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.753 0.787 . . . . 72.42 109.725 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . 0.447 ' HG3' ' HG2' ' H' ' 179' ' ' GLU . 4.2 pt20 -81.92 -26.47 34.04 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 115.131 -0.94 . . . . 61.0 110.515 177.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . 0.447 ' HG2' ' HG3' ' H' ' 178' ' ' GLN . 17.2 pt-20 -169.43 158.47 7.13 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.349 1.059 . . . . 73.54 109.796 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.44 -176.83 2.68 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 122.712 2.274 . . . . 53.13 111.391 164.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -166.72 -51.75 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 108.771 -0.826 . . . . 65.42 108.771 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -85.13 86.47 7.38 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.925 -1.034 . . . . 43.03 109.831 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 36.0 m -140.06 100.8 4.01 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.534 -0.757 . . . . 74.01 109.305 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 29.4 m-90 -95.13 139.29 21.99 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 123.576 0.751 . . . . 70.11 110.293 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.33 115.05 3.29 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.692 2.261 . . . . 72.34 111.498 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.48 152.14 45.21 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.051 -0.522 . . . . 71.43 110.834 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.468 HG12 ' HB3' ' D' ' 129' ' ' ALA . 2.3 pp -60.47 -24.81 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 114.523 1.305 . . . . 73.22 114.523 -169.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . 0.598 ' HA ' HD23 ' D' ' 42' ' ' LEU . . . 67.84 170.98 0.27 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.613 1.165 . . . . 52.01 112.821 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.11 171.87 10.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.677 -0.692 . . . . 74.1 109.461 170.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -136.94 169.82 17.12 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.354 -0.98 . . . . 74.52 108.354 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.33 81.04 0.2 Allowed Glycine 0 C--N 1.346 1.129 0 O-C-N 123.355 0.41 . . . . 74.03 113.445 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . 0.46 ' HA2' ' HA3' ' G' ' 200' ' ' GLY . . . -97.03 -142.06 12.91 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 110.325 -1.11 . . . . 72.3 110.325 170.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -165.67 129.96 2.31 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.197 0.498 . . . . 72.0 109.741 171.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.22 36.86 0.14 Allowed 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.92 0.762 . . . . 65.1 110.079 175.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.635 ' HD2' ' HA ' ' D' ' 35' ' ' ASP . 0.4 OUTLIER -109.06 -170.3 1.64 Allowed 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.844 0.857 . . . . 71.44 110.422 178.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm 68.04 89.11 0.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.872 0.869 . . . . 42.12 109.205 -173.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -109.2 70.36 0.73 Allowed 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.363 -0.977 . . . . 73.24 108.363 -176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 74.41 163.01 0.26 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 124.369 1.043 . . . . 71.54 110.544 -170.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 30.2 p30 -162.62 -34.08 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.858 0.863 . . . . 73.01 109.732 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -100.27 51.28 1.04 Allowed Glycine 0 C--N 1.348 1.209 0 N-CA-C 110.949 -0.86 . . . . 35.12 110.949 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.75 119.38 3.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.894 1.278 . . . . 74.35 112.406 -175.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . 0.633 ' HE1' HD12 ' G' ' 187' ' ' ILE . 37.5 p90 -61.28 140.37 57.98 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 114.826 -1.079 . . . . 73.13 111.524 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.05 170.83 13.5 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.191 0.596 . . . . 74.43 110.702 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.521 ' HA ' HG22 ' G' ' 187' ' ' ILE . 2.4 mp -86.44 -62.48 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 108.379 -0.971 . . . . 65.45 108.379 178.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -173.18 -63.17 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.75 0.82 . . . . 71.41 109.655 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t70 179.35 -41.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.051 1.34 . . . . 74.15 107.753 -167.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 6.1 m . . . . . 0 C--O 1.255 1.348 0 CA-C-N 114.433 -1.258 . . . . 74.23 109.859 170.73 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 154' ' ' ASP . 16.3 ptm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.802 -0.444 . . . . 73.4 109.802 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.5 t -129.27 -31.63 2.06 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.429 0.692 . . . . 73.3 110.742 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' C' ' 141' ' ' LEU . 37.2 tt0 66.23 -76.35 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.514 1.525 . . . . 73.23 109.685 -170.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 55.7 93.49 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.706 1.203 . . . . 74.32 111.839 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' C' ' 142' ' ' GLN . 45.7 m-80 -71.32 85.88 0.8 Allowed 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.284 0.564 . . . . 61.41 111.037 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -79.6 154.27 28.85 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.889 1.276 . . . . 50.12 108.761 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.6 t -136.14 30.92 2.98 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.292 0.567 . . . . 61.42 110.686 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -66.61 -56.2 11.81 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.807 0.813 . . . . 74.34 110.305 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ttt -152.54 159.29 43.3 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.357 -1.292 . . . . 64.15 108.24 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 m -140.2 123.66 17.05 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 109.552 -0.536 . . . . 74.34 109.552 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -130.74 135.78 48.12 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.663 0.785 . . . . 53.21 108.956 173.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -160.52 141.17 11.7 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 123.647 0.592 . . . . 64.22 112.582 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.36 117.71 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 107.867 -1.16 . . . . 63.51 107.867 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 2.1 mp0 -84.69 -30.6 24.67 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 119.128 -0.463 . . . . 64.33 110.053 171.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 15.2 ttt85 -175.9 146.91 0.74 Allowed 'General case' 0 C--N 1.371 1.535 0 O-C-N 123.851 0.72 . . . . 64.3 111.046 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.86 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 96.5 mt -129.65 128.23 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 N-CA-C 107.497 -1.297 . . . . 74.44 107.497 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -156.81 166.43 33.39 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.178 0.991 . . . . 75.13 110.656 -172.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.9 p -92.26 119.0 31.44 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.921 -0.77 . . . . 51.21 108.921 168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.7 mtpt -82.62 -26.28 32.38 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 110.002 -0.37 . . . . 61.45 110.002 172.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.6 t70 -152.94 143.0 22.32 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.261 -0.881 . . . . 75.33 110.35 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.436 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 85.7 mt -138.39 140.88 39.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.931 0 C-N-CA 125.536 1.534 . . . . 64.44 106.926 172.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -149.15 126.68 11.61 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.753 0.658 . . . . 74.11 109.624 175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 90.1 t80 -130.9 131.97 44.83 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.405 -1.332 . . . . 72.33 107.405 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.6 131.86 41.9 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.049 -1.093 . . . . 73.34 108.049 174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.464 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -123.39 87.84 51.69 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 107.61 -1.256 . . . . 74.41 107.61 170.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.77 -22.76 42.74 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.672 2.248 . . . . 73.13 112.925 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -120.42 38.78 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.615 0.766 . . . . 73.24 109.448 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.464 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -59.41 -48.24 96.32 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.125 0.97 . . . . 64.23 113.055 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 10.1 Cg_exo -73.53 -42.04 0.99 Allowed 'Trans proline' 0 C--N 1.395 3.014 0 C-N-CA 122.085 1.857 . . . . 43.41 112.266 168.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -62.8 -19.89 64.48 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 125.055 1.342 . . . . 73.24 112.792 -173.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.66 -24.12 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 C-N-CA 123.279 0.631 . . . . 60.35 111.814 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -54.98 -32.24 61.44 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 123.971 0.908 . . . . 73.32 112.698 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -86.21 -48.53 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.965 0.906 . . . . 64.4 110.359 -175.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -78.91 128.56 33.48 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.802 -1.09 . . . . 62.43 112.038 -169.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.56 134.75 57.31 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.482 1.113 . . . . 72.22 111.246 177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.581 ' HE1' ' HG3' ' A' ' 124' ' ' PRO . 46.6 t-105 -84.49 80.46 9.22 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.906 0.754 . . . . 74.34 111.231 -173.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -131.92 75.92 74.74 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 107.675 -1.231 . . . . 70.1 107.675 174.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.01 155.96 11.33 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.745 2.296 . . . . 72.3 113.336 -174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -98.27 105.76 17.94 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 107.317 -1.364 . . . . 70.05 107.317 167.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' G' ' 189' ' ' ALA . 36.0 t -87.24 98.78 7.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 N-CA-C 109.878 -0.416 . . . . 31.3 109.878 -176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 85.0 tttt -81.72 130.86 35.2 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.446 0.698 . . . . 74.41 109.897 175.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD22 ' HB ' ' G' ' 187' ' ' ILE . 5.7 mp -114.67 110.87 20.43 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.754 -0.832 . . . . 64.52 108.754 174.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.9 t70 -112.92 130.96 55.93 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.984 -1.117 . . . . 63.5 107.984 176.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.9 tp -117.54 131.27 56.72 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.307 -0.627 . . . . 73.22 109.307 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -139.68 146.74 40.03 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.945 -0.761 . . . . 71.14 108.945 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -147.55 143.13 27.57 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 109.283 -0.636 . . . . 64.44 109.283 173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.54 134.11 15.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.63 0.772 . . . . 75.12 109.116 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . 20.7 m -88.73 162.66 16.13 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.133 0.573 . . . . 74.35 110.556 -177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.7 t -149.86 141.15 23.19 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.536 1.134 . . . . 64.31 108.004 -174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -91.66 133.43 35.58 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.886 -0.413 . . . . 63.24 109.886 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 57' ' ' GLU . 42.5 mt -118.43 -35.32 3.8 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.803 0.841 . . . . 74.42 109.144 171.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.632 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.04 179.57 7.52 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.599 -1.182 . . . . 62.21 109.848 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -72.11 122.89 21.74 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 108.27 -1.011 . . . . 72.42 108.27 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 70.77 -6.38 1.26 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 124.699 1.199 . . . . 75.32 112.925 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.5 t -105.3 111.07 33.14 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 N-CA-C 108.088 -1.078 . . . . 65.12 108.088 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' G' ' 171' ' ' SER . 21.1 m-30 -119.11 128.12 54.0 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.065 -0.516 . . . . 64.32 109.796 -175.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 51' ' ' LEU . 13.1 tt0 -82.66 112.22 19.34 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.326 -1.361 . . . . 72.15 107.326 166.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.0 t -100.7 115.62 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.854 -1.535 . . . . 71.12 106.854 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.669 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.7 t -96.29 129.44 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 109.388 -0.597 . . . . 70.01 109.388 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.23 111.39 23.67 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.112 -1.44 . . . . 71.02 107.112 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 20.7 ttp180 -100.49 102.75 14.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.665 -0.865 . . . . 71.12 108.665 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -95.4 128.53 46.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 108.101 -1.074 . . . . 75.13 108.101 173.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.603 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 28.8 m -113.94 135.99 53.39 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.848 -0.797 . . . . 73.43 108.848 172.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.586 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 52.9 t -132.49 136.95 55.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 125.568 1.547 . . . . 62.35 107.135 -175.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.7 m -141.63 138.3 32.46 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 109.245 -0.65 . . . . 74.51 109.245 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.99 127.56 45.0 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 106.676 -1.601 . . . . 73.34 106.676 171.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 68.7 m -139.95 131.97 27.85 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.349 0.595 . . . . 63.54 111.688 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 25.3 mt -89.62 78.19 7.05 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.577 -1.268 . . . . 73.23 107.577 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.58 -117.04 4.36 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.081 -0.963 . . . . 65.44 111.184 -173.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -87.87 -25.22 23.39 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.522 0.729 . . . . 65.52 110.297 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -79.93 106.8 12.22 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.078 0.951 . . . . 70.14 109.371 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 54.7 m -65.62 129.92 41.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.238 0.542 . . . . 75.25 111.139 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.28 -52.94 7.11 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.592 1.157 . . . . 71.23 109.004 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -158.25 155.26 28.61 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.464 -0.789 . . . . 62.44 111.396 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.7 tp -117.94 146.35 44.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.972 1.309 . . . . 75.02 108.422 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 80.9 m -144.93 131.12 19.48 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.563 1.145 . . . . 23.45 108.85 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.74 128.6 14.38 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.191 -0.67 . . . . 62.24 109.191 173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.8 t -130.29 110.4 19.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.437 -0.949 . . . . 73.44 108.437 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.7 mt-30 -86.34 81.01 8.51 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.7 -0.852 . . . . 72.4 108.7 174.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -76.87 93.58 3.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.2 -1.364 . . . . 71.21 109.046 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.16 143.7 16.77 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 111.766 -0.534 . . . . 74.33 111.766 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.51 131.64 4.92 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 111.044 -0.823 . . . . 34.44 111.044 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 17.3 mt -81.14 128.8 38.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 70.42 108.849 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -136.21 131.0 34.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.086 0.554 . . . . 71.34 110.699 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -83.5 119.67 24.97 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.052 -1.092 . . . . 74.02 108.052 168.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.32 122.48 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.598 0.759 . . . . 75.23 110.096 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.17 162.95 28.61 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.632 0.773 . . . . 75.12 109.961 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.05 81.54 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-N 116.132 -0.485 . . . . 51.2 112.948 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.46 137.2 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 124.187 0.995 . . . . 61.1 109.808 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 20.2 tt0 -137.07 -179.11 5.51 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.526 -0.916 . . . . 73.0 108.526 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 48.95 -124.24 12.3 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 124.02 0.819 . . . . 51.44 114.94 175.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -79.11 -16.61 56.46 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.543 0.737 . . . . 50.43 111.608 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.69 -39.88 61.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.679 0.392 . . . . 71.44 110.369 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -24.05 36.61 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.299 0.24 . . . . 73.14 110.838 175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.7 -30.01 67.56 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.153 0.501 . . . . 62.22 110.072 171.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.48 -44.11 45.71 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.86 0.864 . . . . 73.13 110.319 174.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.17 -63.91 1.08 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.259 0.623 . . . . 70.1 111.566 -175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 tt -71.12 -46.2 62.1 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.511 0.724 . . . . 64.12 111.031 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.69 -18.25 79.13 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 114.742 0.657 . . . . 25.41 114.742 -169.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.56 -51.78 0.69 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.578 0.689 . . . . 74.11 112.205 -172.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -71.24 -37.29 71.98 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.328 0.651 . . . . 74.01 112.441 -172.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.31 -45.79 13.81 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-O 118.355 -0.831 . . . . 54.01 113.028 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -59.78 -22.66 68.88 Favored 'Trans proline' 0 C--N 1.381 2.272 0 C-N-CA 121.531 1.487 . . . . 65.24 112.578 168.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -79.38 -22.43 44.37 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.038 0.535 . . . . 71.13 111.79 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -68.72 -36.97 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 108.627 -0.879 . . . . 71.31 108.627 167.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' A' ' 82' ' ' GLY . 44.1 mt -85.8 -18.31 33.3 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.486 1.115 . . . . 73.14 112.568 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -66.25 -42.62 50.57 Favored Pre-proline 0 N--CA 1.484 1.245 0 CA-C-O 117.709 -1.139 . . . . 75.22 114.013 -171.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.21 -35.27 86.25 Favored 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 121.951 1.733 . . . . 74.51 112.745 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -74.07 -40.8 62.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.654 0.781 . . . . 72.55 111.343 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -46.22 75.77 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.332 0.653 . . . . 42.33 109.8 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.584 ' NH1' HG23 ' C' ' 105' ' ' ILE . 34.5 ttm180 -52.11 -55.21 22.27 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.65 1.218 . . . . 73.04 109.893 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -63.46 -40.65 97.7 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 124.204 0.94 . . . . 74.44 111.3 -175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.604 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.1 t -61.87 -35.69 79.06 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.983 0.513 . . . . 72.21 111.207 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.491 HG21 HG21 ' A' ' 64' ' ' VAL . 95.6 mt -72.62 -51.02 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.579 0.752 . . . . 75.31 109.644 173.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.495 HG23 ' HG3' ' A' ' 125' ' ' GLN . 97.9 m -53.41 -37.17 62.27 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.318 1.447 . . . . 64.24 111.227 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 15.7 t -69.47 -49.65 52.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.927 -1.033 . . . . 54.22 110.118 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 60.7 mtm -57.83 -44.84 86.71 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.346 0.658 . . . . 71.23 110.984 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.3 t -58.73 -48.84 84.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.386 -1.279 . . . . 75.51 110.608 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 t -68.78 -29.53 67.92 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.744 -0.662 . . . . 44.33 111.544 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -73.93 -28.59 61.6 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.64 0.776 . . . . 72.3 110.529 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.89 10.67 51.36 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 123.954 0.784 . . . . 71.54 112.801 174.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.452 HG23 ' HB3' ' D' ' 125' ' ' GLN . 3.7 m 66.34 26.05 10.32 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 124.794 1.238 . . . . 74.04 110.467 177.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -103.33 157.73 33.23 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 115.019 -0.991 . . . . 64.13 108.852 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.581 ' HG3' ' HE1' ' A' ' 36' ' ' TRP . 73.1 Cg_endo -68.8 147.54 69.22 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 122.093 1.862 . . . . 71.13 111.744 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.4 tt0 -58.13 128.88 39.32 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 123.949 0.78 . . . . 70.35 110.878 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -108.98 101.32 10.42 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 108.895 -0.78 . . . . 74.23 108.895 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.471 ' HB3' HD13 ' C' ' 13' ' ' ILE . 92.4 m-20 -98.41 105.18 17.29 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.901 -0.777 . . . . 54.5 108.901 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.554 HD22 HD21 ' A' ' 42' ' ' LEU . 46.0 mt -72.96 139.12 46.51 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.537 -0.756 . . . . 63.43 109.218 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' H' ' 204' ' ' ILE . . . -60.03 138.03 90.97 Favored Pre-proline 0 N--CA 1.471 0.623 0 O-C-N 123.667 0.604 . . . . 45.52 110.433 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 16.1 Cg_endo -76.57 96.93 1.1 Allowed 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 121.611 1.541 . . . . 63.43 109.143 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.499 HG12 HG21 ' H' ' 207' ' ' VAL . 14.1 m -97.94 112.07 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.977 -1.01 . . . . 75.44 108.37 -171.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -103.91 109.98 21.94 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.797 -1.092 . . . . 55.44 108.325 -178.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -59.59 -36.34 76.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.53 0.732 . . . . 72.44 111.281 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -60.05 -45.38 93.03 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 123.878 0.736 . . . . 73.01 110.441 176.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.88 -48.51 81.42 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 114.995 -1.002 . . . . 53.31 110.653 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.1 tp -69.81 -26.58 64.31 Favored 'General case' 0 CA--C 1.549 0.926 0 O-C-N 124.055 0.847 . . . . 73.04 111.481 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -70.21 -59.8 2.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.381 0.672 . . . . 65.0 109.292 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.3 mmt -60.35 -32.36 71.19 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.213 0.605 . . . . 73.21 111.033 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 56.3 t-20 -59.42 -55.23 37.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.589 1.156 . . . . 73.51 109.86 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -64.71 -37.15 86.62 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.458 -0.792 . . . . 74.44 110.997 -175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.99 -49.37 70.53 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.839 0.456 . . . . 64.43 110.979 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -167.95 -4.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 112.795 0.665 . . . . 72.14 112.795 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 45.6 mt-30 62.04 76.14 0.38 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.41 1.084 . . . . 72.31 109.526 -165.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -101.9 107.24 18.34 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.234 -0.893 . . . . 71.42 109.486 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.576 ' HB2' ' HB3' ' C' ' 8' ' ' GLU . . . -145.25 111.96 5.86 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.952 0.901 . . . . 51.21 109.483 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.76 16.56 0.04 OUTLIER Glycine 0 C--N 1.342 0.886 0 CA-C-N 116.137 -0.483 . . . . 70.24 112.578 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.12 120.66 17.01 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.614 -0.513 . . . . 73.12 109.614 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.71 66.17 0.36 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.121 -0.49 . . . . 41.04 112.196 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 61.8 p -124.74 86.2 2.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.29 0.567 . . . . 73.21 110.545 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.61 124.82 9.41 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.004 -1.11 . . . . 74.42 108.004 166.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.417 ' H ' ' H ' ' A' ' 152' ' ' HIS . 36.1 tt0 -161.14 -31.81 0.05 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.53 108.861 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.417 ' H ' ' H ' ' A' ' 151' ' ' GLU . 14.5 p-80 -59.89 -39.32 84.92 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 124.098 0.874 . . . . 73.52 111.765 -169.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 44.76 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 125.48 1.512 . . . . 71.23 113.137 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 64.8 m-20 -69.8 -44.79 69.34 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 110.405 -0.22 . . . . 73.33 110.405 177.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.068 0 O-C-N 125.059 1.474 . . . . 64.12 110.877 178.801 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.685 ' SD ' ' HB3' ' D' ' 153' ' ' GLN . 27.8 ttt . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.086 0.469 . . . . 72.12 109.755 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 t -132.65 94.31 3.38 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.475 -1.306 . . . . 70.41 107.475 174.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.512 ' H ' ' HA ' ' D' ' 150' ' ' GLU . 15.5 mm-40 -75.37 91.29 2.71 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.272 -0.877 . . . . 72.05 110.847 -172.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -148.89 152.32 36.22 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.244 0.545 . . . . 60.33 111.173 -176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -116.12 69.9 0.75 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.009 -1.108 . . . . 64.34 108.009 173.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -142.1 168.21 20.29 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.311 -1.313 . . . . 75.02 109.477 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.595 HG21 ' HB3' ' D' ' 138' ' ' MET . 2.4 t -131.71 146.04 51.96 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 107.54 -1.281 . . . . 74.44 107.54 167.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -160.42 -82.74 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.793 -1.188 . . . . 75.2 107.793 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.49 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.7 ptm 47.78 171.42 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 126.5 1.92 . . . . 74.25 115.527 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.9 p -148.13 140.65 24.46 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.465 -1.243 . . . . 74.24 108.568 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -142.84 131.31 22.34 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 73.14 107.5 165.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -160.55 139.97 10.79 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 123.991 0.807 . . . . 75.11 110.021 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.652 HD11 HG13 ' B' ' 16' ' ' ILE . 16.9 tt -95.93 145.23 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.377 1.071 . . . . 71.43 109.836 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -104.18 -35.07 8.16 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 119.658 -0.21 . . . . 53.41 111.037 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.439 HH21 ' HB ' ' A' ' 122' ' ' THR . 23.0 ttt180 -173.53 144.76 1.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 122.502 0.321 . . . . 75.24 111.565 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.652 HG13 HD11 ' B' ' 13' ' ' ILE . 60.9 mt -118.94 138.11 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.182 -1.414 . . . . 74.14 107.182 165.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -167.3 142.12 3.89 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 124.341 1.026 . . . . 74.22 109.339 -170.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.4 m -75.16 118.8 18.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.476 -0.935 . . . . 74.33 108.476 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -85.14 -34.64 22.09 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.824 -0.625 . . . . 72.54 110.832 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.03 145.92 15.54 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 123.407 0.442 . . . . 70.03 110.924 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 40.5 mm -135.63 142.08 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.431 1.092 . . . . 54.03 109.877 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 75.6 m -136.61 127.93 28.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.921 1.289 . . . . 72.12 108.569 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.42 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.4 t80 -144.38 109.5 5.07 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 106.873 -1.528 . . . . 72.24 106.873 165.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -123.42 113.35 18.68 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.469 -0.937 . . . . 44.42 108.469 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.33 90.02 5.36 Favored Pre-proline 0 C--O 1.242 0.688 0 C-N-CA 124.662 1.185 . . . . 64.23 108.965 178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.86 -25.18 53.01 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.285 1.99 . . . . 63.35 111.759 -178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 92.4 m-20 -121.28 31.46 6.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.441 1.097 . . . . 72.21 110.064 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -46.87 -48.52 51.32 Favored Pre-proline 0 N--CA 1.492 1.628 0 C-N-CA 125.399 1.48 . . . . 71.51 113.476 172.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.05 -17.83 17.02 Favored 'Trans proline' 0 C--N 1.385 2.478 0 C-N-CA 121.855 1.703 . . . . 74.31 113.396 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.465 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 2.0 m-70 -82.6 -1.24 50.25 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.206 0.817 . . . . 75.11 113.206 -171.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 28' ' ' ALA . 7.2 p -79.84 -25.99 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 121.239 0.542 . . . . 54.45 109.812 166.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -78.96 -32.01 45.26 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.564 ' HA ' HE21 ' B' ' 33' ' ' GLN . 0.0 OUTLIER -71.43 -45.0 63.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.146 -0.479 . . . . 61.21 110.716 177.518 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -108.08 110.46 22.14 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.234 1.014 . . . . 72.22 109.252 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -74.12 79.24 1.75 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.136 0.575 . . . . 71.23 111.487 -177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -162.15 151.09 15.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.194 -1.41 . . . . 75.55 107.194 169.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.59 ' HG3' ' HA ' ' F' ' 197' ' ' TYR . 72.9 mt-30 -92.23 133.17 30.53 Favored Pre-proline 0 CA--C 1.555 1.141 0 C-N-CA 124.08 0.952 . . . . 42.42 109.443 173.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -76.68 158.26 35.6 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 123.023 2.482 . . . . 73.01 113.818 -169.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.27 107.95 12.41 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.917 -0.771 . . . . 71.42 108.917 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.549 HG12 HD23 ' B' ' 126' ' ' LEU . 17.7 t -95.28 123.51 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.576 0.751 . . . . 73.42 109.12 -173.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -136.85 145.31 44.28 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.624 0.77 . . . . 72.14 110.845 -176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.701 HD21 HD23 ' B' ' 128' ' ' LEU . 2.4 pt? -116.8 166.54 12.02 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.365 0.666 . . . . 73.33 111.572 173.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -150.14 154.35 37.89 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.225 1.41 . . . . 74.3 108.142 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -94.54 148.99 21.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.166 0.586 . . . . 63.21 111.106 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -141.79 154.59 45.33 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.855 1.262 . . . . 72.44 108.943 168.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 72.0 p -122.92 134.8 54.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.547 . . . . 74.5 110.468 -178.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.19 144.34 32.14 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.241 -1.022 . . . . 72.1 108.241 170.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 13.2 p -147.93 167.7 24.18 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.801 0.334 . . . . 71.24 111.367 172.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.1 p -151.32 136.55 17.57 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.378 1.071 . . . . 73.34 108.69 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.84 129.69 35.12 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.471 -0.566 . . . . 62.02 109.471 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 26.9 mt -95.58 -47.21 6.32 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.442 -0.577 . . . . 75.02 109.442 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.26 -172.93 4.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.984 0.913 . . . . 74.53 110.179 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 103.07 0.3 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 115.09 -0.959 . . . . 74.43 110.148 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.52 ' HB3' ' O ' ' B' ' 86' ' ' ILE . 4.9 m-20 65.38 12.82 8.4 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.917 1.287 . . . . 74.44 113.094 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -104.59 86.51 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 105.999 -1.852 . . . . 61.33 105.999 166.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.489 ' HE1' ' HG3' ' F' ' 174' ' ' MET . 17.1 p90 -109.39 141.6 41.54 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.877 0.846 . . . . 75.23 109.762 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -103.54 115.84 31.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.058 -1.428 . . . . 73.44 107.994 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.9 t -97.98 127.73 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 122.881 0.472 . . . . 73.35 109.784 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -102.03 115.97 44.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.168 0.987 . . . . 72.22 108.612 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 109.6 20.96 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.8 -1.185 . . . . 75.04 107.8 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -99.99 126.03 46.11 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.738 -0.468 . . . . 74.41 109.738 172.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.4 t -118.25 126.83 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 108.153 -1.055 . . . . 52.12 108.153 171.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 29.1 m -97.13 149.64 21.75 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.548 0.739 . . . . 73.14 109.147 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.727 HG21 HG21 ' B' ' 114' ' ' ILE . 55.6 t -135.33 132.73 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.266 1.026 . . . . 65.41 109.358 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -124.16 139.22 54.14 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.444 -0.947 . . . . 73.41 108.444 170.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.38 149.63 36.44 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.797 0.839 . . . . 64.44 109.072 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.475 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.7 p -144.95 132.65 21.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.367 0.877 . . . . 71.41 113.367 -174.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 27.6 mt -95.6 104.73 16.66 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.151 1.38 . . . . 61.34 108.495 173.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.75 -103.38 1.11 Allowed Glycine 0 C--N 1.339 0.699 0 C-N-CA 120.042 -1.075 . . . . 54.53 111.18 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.18 3.55 11.39 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.47 1.508 . . . . 65.32 111.799 -176.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.451 ' HB3' ' HG3' ' C' ' 153' ' ' GLN . 23.7 pt-20 -116.29 161.49 18.92 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 122.978 0.511 . . . . 61.53 111.15 -178.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 55.2 m -77.65 113.28 15.33 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.066 0.547 . . . . 74.15 110.554 177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.475 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -68.25 -59.39 3.24 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.872 -0.788 . . . . 73.33 108.872 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -156.02 168.47 27.15 Favored 'General case' 0 C--O 1.243 0.76 0 CA-C-N 115.117 -0.947 . . . . 73.44 111.425 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -130.39 113.28 14.14 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.743 -1.577 . . . . 63.04 106.743 173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.445 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.0 t -118.11 153.14 34.27 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.893 -0.78 . . . . 71.14 108.893 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -164.82 132.8 3.26 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 109.158 -0.682 . . . . 70.31 109.158 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -122.88 144.07 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.709 0.803 . . . . 73.3 109.065 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -121.75 84.35 2.23 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.509 -0.923 . . . . 63.52 108.509 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -82.26 99.88 9.57 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 114.716 -1.129 . . . . 74.52 108.835 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.69 159.75 26.05 Favored Glycine 0 C--O 1.244 0.723 0 N-CA-C 111.809 -0.517 . . . . 65.41 111.809 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.62 129.27 2.02 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 111.09 -0.804 . . . . 74.23 111.09 -176.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.3 mt -86.64 130.71 36.31 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 N-CA-C 109.381 -0.6 . . . . 70.21 109.381 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -131.37 146.19 52.16 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.23 0.538 . . . . 73.21 110.205 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.9 m -127.92 112.83 15.12 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.883 1.273 . . . . 72.21 108.354 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.52 ' O ' ' HB3' ' B' ' 54' ' ' ASP . 5.1 tt -139.48 140.54 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.638 0.775 . . . . 63.01 110.476 -171.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.84 173.52 16.87 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 122.745 0.418 . . . . 25.42 111.532 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.587 ' H ' ' HB2' ' F' ' 172' ' ' ALA . . . 95.59 -69.59 1.03 Allowed Glycine 0 C--N 1.351 1.392 0 C-N-CA 124.023 0.82 . . . . 64.12 112.886 176.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.518 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -74.51 169.55 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.627 0.771 . . . . 75.25 111.559 -179.127 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -162.88 -171.93 2.88 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.178 0.591 . . . . 73.05 111.552 -174.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.47 -105.81 1.62 Allowed Glycine 0 C--N 1.353 1.51 0 CA-C-N 115.13 -0.941 . . . . 75.04 112.837 172.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -77.73 -33.07 53.09 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.855 0.862 . . . . 64.35 110.828 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -75.74 -38.85 58.11 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.184 0.593 . . . . 71.02 111.321 -175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptm -67.91 -34.43 76.62 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 120.871 0.367 . . . . 74.45 110.323 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 -45.13 80.23 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 123.825 0.85 . . . . 75.53 110.899 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -71.32 -30.22 65.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.041 -0.981 . . . . 74.22 110.93 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.62 -69.08 0.32 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.169 0.293 . . . . 72.13 110.935 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.86 -19.78 60.62 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 111.928 0.344 . . . . 72.43 111.928 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.95 -25.65 44.32 Favored Glycine 0 C--N 1.348 1.232 0 O-C-N 123.574 0.546 . . . . 62.32 114.033 -177.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.93 -47.16 0.21 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 113.165 0.802 . . . . 75.31 113.165 -171.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -75.03 -49.14 20.76 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.067 0.547 . . . . 74.25 111.955 -167.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.4 m -60.45 -46.97 97.48 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.964 0.905 . . . . 42.13 111.91 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.76 -30.9 49.65 Favored 'Trans proline' 0 C--N 1.387 2.596 0 C-N-CA 121.229 1.286 . . . . 70.53 112.951 169.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.83 -27.7 68.44 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-N 118.747 0.703 . . . . 75.21 111.22 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.472 HG23 ' NH2' ' D' ' 111' ' ' ARG . 70.3 mt -64.51 -43.61 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.625 0.77 . . . . 64.44 110.192 171.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.76 -14.54 47.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.09 0.956 . . . . 75.44 111.784 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.56 ' HZ ' HD12 ' B' ' 128' ' ' LEU . 33.7 t80 -60.19 -47.26 97.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.063 1.345 . . . . 74.01 113.192 -173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.529 ' HB2' ' HB2' ' D' ' 112' ' ' GLU . 18.6 Cg_endo -58.06 -35.97 98.34 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 122.06 1.84 . . . . 74.4 113.706 174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.473 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 65.4 m-85 -69.7 -46.14 66.68 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.297 0.639 . . . . 75.51 110.802 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.459 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -62.43 -43.78 97.99 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.693 0.797 . . . . 71.21 110.345 178.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.444 ' NH2' ' HG3' ' B' ' 130' ' ' PRO . 33.4 mtp180 -50.48 -54.94 18.37 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.43 1.092 . . . . 75.33 110.789 173.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -66.8 -33.85 76.53 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.982 -1.008 . . . . 63.11 110.681 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.462 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.6 t -72.88 -41.15 65.0 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.098 0.559 . . . . 61.23 111.259 -175.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.727 HG21 HG21 ' B' ' 64' ' ' VAL . 52.7 mt -65.6 -48.14 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.652 -0.869 . . . . 74.23 108.652 176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 15.3 m -51.51 -35.97 42.63 Favored 'General case' 0 CA--C 1.561 1.392 0 O-C-N 124.536 1.148 . . . . 61.24 111.177 177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.9 t -69.24 -55.03 11.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.626 0.77 . . . . 62.21 110.826 175.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.465 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 18.0 mmt -65.67 -33.37 75.74 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.016 0.526 . . . . 72.32 111.901 -172.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.53 -41.42 80.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.055 0.942 . . . . 73.11 110.374 178.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.475 ' HB3' HE22 ' C' ' 125' ' ' GLN . 90.0 p -70.1 -26.05 63.79 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.27 0.557 . . . . 71.45 112.149 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.604 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 80.1 mtt-85 -68.6 -34.01 75.03 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.365 -0.834 . . . . 44.23 110.441 175.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.6 13.09 54.11 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 123.847 0.717 . . . . 72.43 112.738 172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 61.25 42.21 12.32 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.554 1.942 . . . . 62.15 112.497 177.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.602 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 71.3 m-85 -120.32 172.78 4.27 Favored Pre-proline 0 CA--C 1.572 1.804 0 CA-C-N 114.167 -1.378 . . . . 75.1 109.333 173.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.602 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 85.3 Cg_endo -73.08 -167.55 0.36 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.965 2.444 . . . . 74.41 116.107 -172.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -66.89 155.58 38.02 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 113.758 -1.564 . . . . 62.41 111.054 167.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' B' ' 42' ' ' LEU . 3.4 tm? -135.23 84.91 2.13 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 104.974 -2.232 . . . . 74.32 104.974 163.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -123.58 95.4 4.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.287 -1.375 . . . . 74.25 107.287 -175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.701 HD23 HD21 ' B' ' 42' ' ' LEU . 2.7 tm? -64.29 145.38 56.11 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.17 -0.923 . . . . 72.53 109.863 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -53.46 110.6 2.12 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 124.633 1.208 . . . . 74.22 110.426 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.687 ' HB2' HD13 ' D' ' 16' ' ' ILE . 10.3 Cg_exo -65.61 132.67 31.64 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.152 1.901 . . . . 73.24 110.319 -173.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.9 p -159.63 137.21 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 110.061 -0.348 . . . . 75.43 110.061 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -87.07 117.73 25.99 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 123.801 0.841 . . . . 50.23 109.015 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.489 ' HZ ' ' HB2' ' F' ' 182' ' ' PHE . 47.3 t80 -61.06 -16.45 43.96 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.531 1.132 . . . . 73.21 113.1 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.462 ' O ' ' HG2' ' B' ' 138' ' ' MET . 7.1 m-20 -55.06 -36.41 65.54 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 122.968 0.507 . . . . 64.43 112.011 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.22 -49.25 64.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.956 0.902 . . . . 63.23 111.837 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.05 -43.92 95.05 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.181 -0.918 . . . . 71.05 110.092 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -67.21 -35.85 80.47 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.725 -1.125 . . . . 72.33 111.092 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 24.6 mmt -65.69 -37.6 86.92 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.909 0.484 . . . . 75.23 110.147 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -76.4 -17.61 59.27 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.612 0.765 . . . . 74.43 112.076 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -73.18 -30.98 63.94 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.149 0.58 . . . . 71.5 110.977 178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -109.19 12.96 24.69 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.534 0.734 . . . . 70.5 111.255 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' B' ' 138' ' ' MET . 8.7 tt0 -96.47 142.91 27.99 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.423 0.689 . . . . 65.12 111.471 -173.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -136.11 172.32 13.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.882 0.873 . . . . 74.24 109.485 172.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.511 ' HA ' ' HG2' ' D' ' 8' ' ' GLU . 4.8 pm0 -157.32 140.69 15.57 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.465 0.706 . . . . 73.43 110.011 177.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.92 18.09 0.1 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.608 0.763 . . . . 73.2 111.079 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.401 ' HA3' ' HB ' ' D' ' 7' ' ' THR . . . -98.0 -147.8 22.83 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-N 116.338 -0.392 . . . . 72.04 113.631 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -141.63 144.33 34.11 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.803 0.841 . . . . 72.31 109.896 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.68 113.64 3.95 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.323 -1.111 . . . . 73.45 110.323 172.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' D' ' 4' ' ' GLN . 18.4 p -72.24 -177.92 2.3 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.917 0.487 . . . . 71.35 110.883 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -145.95 103.37 3.74 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.914 -0.491 . . . . 75.3 110.174 -169.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -167.18 93.79 0.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 106.718 -1.586 . . . . 60.15 106.718 168.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -132.11 64.65 1.59 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.899 -0.778 . . . . 73.14 108.899 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.9 92.51 9.03 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 107.268 -1.382 . . . . 70.44 107.268 172.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -114.74 -175.38 2.67 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.774 0.83 . . . . 75.44 110.238 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 N-CA-C 109.213 -0.662 . . . . 61.13 109.213 175.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 108.433 -0.951 . . . . 73.33 108.433 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 57.9 m 63.27 78.81 0.28 Allowed 'General case' 0 C--N 1.353 0.755 0 O-C-N 124.449 1.093 . . . . 71.23 109.11 -169.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -69.77 -31.65 69.71 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.882 -1.054 . . . . 65.12 110.87 -172.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -67.8 92.85 0.36 Allowed 'General case' 0 CA--C 1.55 0.945 0 CA-C-O 122.128 0.966 . . . . 63.43 109.916 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -91.88 -65.0 1.04 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.573 -0.899 . . . . 61.31 108.573 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -167.38 52.3 0.07 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 107.205 -1.406 . . . . 73.42 107.205 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -128.89 136.43 50.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.811 . . . . 63.44 110.813 -170.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 145' ' ' ALA . 43.6 tt0 -144.08 -77.28 0.22 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.975 0.91 . . . . 63.52 108.55 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.421 ' HG2' ' HB2' ' C' ' 97' ' ' CYS . 4.3 mpp? 59.53 114.97 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.125 1.37 . . . . 70.44 111.432 -175.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.9 m -116.68 93.99 4.43 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.764 -0.653 . . . . 71.42 109.743 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.434 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 0.5 OUTLIER -120.91 163.53 18.08 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 116.04 -0.527 . . . . 72.33 109.79 167.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -136.12 129.76 32.3 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.005 -0.998 . . . . 71.41 108.993 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 127' ' ' ASN . 17.7 tt -66.19 137.79 24.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 124.253 1.021 . . . . 61.23 110.178 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 92.0 mm-40 -111.79 -45.45 3.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.202 -0.454 . . . . 64.15 110.101 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.585 HH22 ' HD1' ' H' ' 197' ' ' TYR . 18.9 ttt180 -174.98 142.02 0.62 Allowed 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.604 0.565 . . . . 75.13 110.974 -178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.22 138.21 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 107.771 -1.196 . . . . 73.14 107.771 175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.45 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -171.46 161.51 6.35 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.318 0.58 . . . . 71.34 110.95 -176.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -86.36 105.0 16.4 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.03 -0.986 . . . . 74.32 109.01 174.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.2 mtmt -67.46 -46.64 72.43 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.754 0.787 . . . . 64.2 109.426 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.4 t70 -136.12 145.25 45.67 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 114.224 -1.353 . . . . 52.23 109.441 -177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.7 mt -140.3 144.31 27.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 107.292 -1.373 . . . . 72.33 107.292 175.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.4 t -152.71 145.73 24.54 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.337 0.589 . . . . 72.01 110.198 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -149.15 120.79 8.03 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 107.373 -1.343 . . . . 71.14 107.373 169.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -126.01 124.11 39.98 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 108.482 -0.932 . . . . 71.55 108.482 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -111.39 89.72 10.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 N-CA-C 108.172 -1.047 . . . . 72.03 108.172 174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -59.88 -31.41 93.75 Favored 'Trans proline' 0 C--N 1.385 2.459 0 C-N-CA 123.473 2.782 . . . . 53.52 112.926 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.432 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 87.2 m-20 -119.04 36.03 4.61 Favored 'General case' 0 C--O 1.213 -0.852 0 CA-C-N 114.53 -1.214 . . . . 73.45 109.668 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' C' ' 25' ' ' ALA . . . -49.79 -48.6 77.0 Favored Pre-proline 0 CA--C 1.572 1.82 0 N-CA-C 114.213 1.19 . . . . 73.34 114.213 -175.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -82.37 -29.54 1.46 Allowed 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 121.782 1.655 . . . . 40.42 113.069 171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.432 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 41.3 t60 -69.59 -31.36 69.47 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.803 1.241 . . . . 72.22 112.328 -171.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.606 HG23 HD11 ' C' ' 68' ' ' LEU . 12.8 p -79.66 -19.3 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 C-N-CA 124.836 1.254 . . . . 73.54 112.074 -176.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -55.34 -39.24 69.78 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.01 0.924 . . . . 60.12 112.518 -171.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -113.41 45.95 1.33 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.941 0.877 . . . . 72.21 109.389 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.6 167.71 12.58 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.298 -0.631 . . . . 73.05 109.298 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.15 116.97 4.59 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 108.911 -0.774 . . . . 72.12 108.911 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -84.8 68.9 10.63 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 123.788 0.68 . . . . 74.05 111.428 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -140.59 79.33 20.11 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.508 0.723 . . . . 74.1 109.512 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.629 ' HD2' ' HB2' ' E' ' 193' ' ' TYR . 3.9 Cg_exo -79.45 135.81 12.07 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.437 2.091 . . . . 54.1 109.963 173.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -83.56 118.74 24.01 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.003 -1.11 . . . . 64.14 108.003 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.628 HG11 HD21 ' C' ' 128' ' ' LEU . 24.7 t -65.46 95.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 O-C-N 125.095 1.497 . . . . 72.1 108.822 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 0.5 OUTLIER -110.95 116.13 30.68 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.241 -1.022 . . . . 73.05 108.241 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 54.4 tp -122.62 137.54 54.87 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 108.107 -1.071 . . . . 72.31 108.107 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -147.81 145.44 28.75 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.328 0.651 . . . . 65.24 109.398 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.599 ' HB2' HD22 ' E' ' 186' ' ' LEU . 48.7 tp -113.6 132.56 55.69 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 64.32 110.275 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.686 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 4.3 m-20 -114.65 134.77 54.81 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 106.869 -1.53 . . . . 73.23 106.869 171.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -114.2 132.12 56.22 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.943 0.402 . . . . 73.34 110.391 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.06 147.15 45.95 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.984 0.914 . . . . 64.14 108.982 173.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -139.6 144.01 37.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.473 0.709 . . . . 74.11 109.805 -176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.0 t -146.23 134.26 21.48 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.832 0.853 . . . . 74.11 109.407 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -74.94 147.5 40.85 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.468 -0.938 . . . . 65.31 108.468 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.56 HD11 HD12 ' C' ' 83' ' ' ILE . 86.5 mt -118.25 -37.57 3.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.849 0.86 . . . . 74.43 110.401 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.39 -168.8 1.44 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.155 0.582 . . . . 73.13 110.858 -175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.47 116.26 5.41 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.197 -0.91 . . . . 73.41 109.419 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.631 ' HA ' HD23 ' E' ' 173' ' ' LEU . 20.2 m-20 62.09 18.11 9.71 Favored 'General case' 0 C--O 1.204 -1.293 0 C-N-CA 124.549 1.14 . . . . 71.11 112.324 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' C' ' 51' ' ' LEU . 67.8 t -120.86 107.47 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.567 0.747 . . . . 71.23 109.299 -177.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.89 161.53 14.11 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.847 0.832 . . . . 73.13 110.757 172.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.547 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.2 tt0 -127.82 126.1 41.03 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.412 -1.722 . . . . 74.33 107.673 169.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.81 123.38 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 109.332 -0.618 . . . . 72.44 109.332 171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.67 111.44 34.22 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 124.36 1.064 . . . . 73.21 108.668 -178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.99 100.01 12.3 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.055 -0.72 . . . . 74.02 109.055 174.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.686 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 41.2 ttm180 -82.33 100.09 9.75 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.85 -1.537 . . . . 73.51 106.85 171.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.5 t -103.16 113.57 40.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.495 -1.298 . . . . 64.42 107.495 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 12.8 m -118.71 131.52 56.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.883 -0.598 . . . . 71.03 110.106 -168.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.606 HG21 HG21 ' C' ' 114' ' ' ILE . 55.2 t -114.89 131.39 67.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.668 1.187 . . . . 64.41 110.242 177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 9.4 m -110.22 146.58 35.34 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.066 -1.087 . . . . 73.21 108.066 164.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 110.74 8.77 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.677 -1.231 . . . . 74.33 107.677 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -135.19 133.34 38.97 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.364 0.602 . . . . 74.02 111.449 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.606 HD11 HG23 ' C' ' 31' ' ' VAL . 4.0 mt -85.5 14.58 5.37 Favored 'General case' 0 CA--C 1.561 1.385 0 C-N-CA 125.195 1.398 . . . . 65.34 110.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.75 -96.28 0.48 Allowed Glycine 0 C--N 1.35 1.357 0 N-CA-C 110.505 -1.038 . . . . 74.15 110.505 -176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -97.32 -25.77 15.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.23 1.012 . . . . 73.11 109.55 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -87.71 116.94 26.19 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.211 1.004 . . . . 75.43 108.523 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 31.6 m -86.31 129.36 34.88 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.477 0.581 . . . . 62.2 110.256 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.66 -52.78 9.01 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.76 0.824 . . . . 74.12 109.843 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -163.39 175.13 11.11 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.553 0.692 . . . . 75.15 111.391 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.461 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -133.1 146.77 51.94 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.503 -1.666 . . . . 62.35 106.503 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.607 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.5 t -150.99 150.82 31.23 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.312 -0.625 . . . . 75.02 109.312 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -161.27 140.45 10.18 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.952 0.501 . . . . 52.04 109.929 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 75.2 t -135.35 134.05 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.344 -0.984 . . . . 51.52 108.344 174.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.706 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.9 mt-30 -109.63 92.68 4.15 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.088 -0.708 . . . . 75.04 109.088 176.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -81.21 107.32 13.9 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 114.556 -1.202 . . . . 71.32 109.934 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.63 145.35 18.3 Favored Glycine 0 C--O 1.243 0.71 0 N-CA-C 111.449 -0.661 . . . . 70.52 111.449 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.484 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.22 117.24 0.98 Allowed Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 111.069 -0.812 . . . . 71.35 111.069 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.56 HD12 HD11 ' C' ' 51' ' ' LEU . 6.7 mm -86.53 126.61 40.73 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 N-CA-C 108.843 -0.799 . . . . 74.25 108.843 177.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -136.68 122.6 20.1 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.442 -0.947 . . . . 73.14 108.442 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -76.74 96.58 4.26 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 108.753 -0.832 . . . . 71.35 108.753 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.652 HD13 ' HE3' ' C' ' 94' ' ' MET . 2.7 pp -96.45 136.02 28.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.327 1.051 . . . . 73.41 111.131 -173.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.42 -169.35 0.7 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.64 0.776 . . . . 65.1 110.018 172.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.39 -60.11 0.69 Allowed Glycine 0 C--N 1.346 1.129 0 N-CA-C 111.93 -0.468 . . . . 55.04 111.93 176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.656 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -100.55 -167.6 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.337 1.055 . . . . 54.22 112.356 -171.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 174.57 11.89 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.09 0.956 . . . . 52.24 110.132 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.85 -120.0 8.43 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 116.583 1.393 . . . . 61.53 116.583 163.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -26.2 61.75 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.26 1.024 . . . . 71.42 111.763 -173.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -36.94 72.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.413 -0.958 . . . . 64.32 108.413 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.652 ' HE3' HD13 ' C' ' 86' ' ' ILE . 34.7 tpp -71.14 -44.81 64.8 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.175 -0.92 . . . . 73.13 110.064 169.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.16 -29.19 70.18 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.223 0.609 . . . . 54.11 112.21 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -83.01 -45.29 14.24 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.29 0.636 . . . . 73.54 110.309 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.421 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 53.5 t -66.55 -60.4 2.76 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.487 -0.779 . . . . 73.12 110.18 -177.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.543 ' HB2' ' SD ' ' C' ' 94' ' ' MET . 14.6 tp -64.84 -21.42 66.79 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.605 1.162 . . . . 64.14 111.329 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.87 -29.54 38.21 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.99 -0.55 . . . . 75.42 114.379 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.6 -42.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 117.765 0.782 . . . . 65.14 112.767 -174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.41 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 63.9 t80 -71.21 -49.39 43.95 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.177 0.591 . . . . 73.34 112.13 -174.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.523 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 22.0 m -61.96 -47.97 89.84 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 123.053 0.541 . . . . 62.11 110.782 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 79.6 Cg_exo -56.11 -37.25 96.7 Favored 'Trans proline' 0 C--N 1.389 2.685 0 C-N-CA 122.1 1.867 . . . . 41.35 114.429 169.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -64.47 -27.79 69.22 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 122.841 0.456 . . . . 60.21 111.254 -177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.584 HG23 ' NH1' ' A' ' 111' ' ' ARG . 43.6 mm -65.39 -46.55 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 115.722 -0.672 . . . . 73.42 109.831 173.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.484 HD21 ' HA3' ' C' ' 82' ' ' GLY . 69.6 mt -79.89 -24.18 41.35 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.088 -0.96 . . . . 73.42 112.351 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -55.57 -50.57 86.15 Favored Pre-proline 0 CA--C 1.555 1.155 0 CA-C-O 117.592 -1.195 . . . . 74.15 113.608 -170.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -60.65 -32.6 93.43 Favored 'Trans proline' 0 C--N 1.384 2.422 0 CA-C-N 121.589 1.603 . . . . 71.42 112.96 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -65.54 -47.63 75.22 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.12 0.568 . . . . 75.51 110.519 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.67 96.58 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.895 0.878 . . . . 74.43 111.166 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -62.89 -52.64 62.29 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.464 1.506 . . . . 74.0 110.123 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -68.98 -27.49 65.76 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.673 0.608 . . . . 72.11 110.441 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.9 t -64.42 -51.18 64.48 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.941 -0.392 . . . . 71.41 109.941 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.607 HG23 ' SG ' ' C' ' 76' ' ' CYS . 63.5 mt -61.54 -49.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 123.431 0.457 . . . . 75.34 110.104 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -43.81 -45.07 7.17 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.121 1.369 . . . . 74.32 111.493 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.7 t -68.14 -51.69 43.19 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 113.561 -1.654 . . . . 35.25 110.703 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.493 ' HB3' ' HB2' ' C' ' 23' ' ' PHE . 13.8 mmm -57.49 -40.35 78.44 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.951 0.9 . . . . 64.02 112.245 -173.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.553 HG21 ' HB2' ' C' ' 126' ' ' LEU . 98.9 t -64.78 -44.73 96.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.128 -0.942 . . . . 61.45 110.782 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.3 t -66.16 -26.56 67.48 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.059 -0.973 . . . . 73.35 111.021 -177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.1 mtt-85 -68.41 -32.74 72.99 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.769 0.828 . . . . 45.22 110.541 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 9.75 67.49 Favored Glycine 0 C--N 1.354 1.582 0 CA-C-N 115.856 -0.611 . . . . 53.33 113.014 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 6.3 p 61.93 24.31 14.45 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.449 1.9 . . . . 73.44 113.122 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -97.89 158.7 32.44 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 109.208 -0.664 . . . . 75.35 109.208 174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -57.75 115.98 2.9 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.331 2.021 . . . . 72.54 110.556 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.475 HE22 ' HB3' ' B' ' 119' ' ' SER . 3.4 pt20 -45.91 147.29 1.02 Allowed 'General case' 0 N--CA 1.48 1.039 0 O-C-N 124.705 1.253 . . . . 70.35 112.591 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.553 ' HB2' HG21 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -98.32 76.23 2.3 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.513 -0.921 . . . . 71.2 108.513 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -110.52 89.43 3.03 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.701 -1.222 . . . . 61.43 107.701 169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.628 HD21 HG11 ' C' ' 40' ' ' VAL . 30.4 mt -84.68 151.94 24.11 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.656 0.741 . . . . 70.04 110.248 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.558 ' HB1' ' HB ' ' F' ' 204' ' ' ILE . . . -60.59 156.02 46.26 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 112.858 -1.974 . . . . 51.04 113.071 -172.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.86 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 38.3 Cg_endo -60.52 125.1 16.5 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 124.138 3.225 . . . . 75.44 113.956 -173.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -112.03 111.69 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.304 0.642 . . . . 64.32 110.364 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -115.73 108.43 16.35 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.501 1.121 . . . . 63.21 109.162 174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -52.49 -40.75 62.73 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 123.784 0.834 . . . . 74.11 112.488 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.38 -34.82 74.43 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 124.119 0.887 . . . . 75.52 110.419 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.36 -45.69 75.56 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.795 0.838 . . . . 71.12 111.062 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.407 HD12 ' HB ' ' F' ' 207' ' ' VAL . 10.4 tt -61.11 -38.4 86.19 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.632 0.773 . . . . 65.44 110.298 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -70.96 -42.38 69.82 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.701 0.801 . . . . 75.31 110.823 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 68.1 mtt -74.3 -29.69 61.74 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.503 0.721 . . . . 74.44 111.439 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -70.38 -37.13 74.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.999 0.92 . . . . 72.41 109.324 173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -161.61 0.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.383 -0.826 . . . . 74.41 109.864 174.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 3' ' ' GLU . 3.5 mm? 45.11 30.01 0.56 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.343 0.657 . . . . 64.23 111.703 -170.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.663 HE21 ' HB2' ' C' ' 144' ' ' GLN . 54.2 tt0 175.72 154.26 0.17 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 125.144 1.377 . . . . 73.13 108.937 -171.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -131.81 112.83 12.83 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.617 -1.623 . . . . 70.25 106.617 167.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.663 ' HB2' HE21 ' C' ' 142' ' ' GLN . 27.7 tt0 -127.65 131.48 49.85 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.281 0.632 . . . . 73.21 109.841 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.43 141.19 41.47 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.496 0.719 . . . . 62.33 110.742 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.15 178.21 22.68 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 111.458 -0.657 . . . . 35.43 111.458 173.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -139.45 127.48 22.32 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.895 0.478 . . . . 72.3 109.966 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.98 161.04 30.24 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 123.876 0.735 . . . . 42.35 112.663 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.1 p -138.71 176.05 9.03 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.705 0.802 . . . . 61.03 111.147 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.73 -28.93 9.87 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.875 0.87 . . . . 71.31 110.003 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 57.93 -134.35 1.1 Allowed 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.936 1.294 . . . . 63.14 109.183 -173.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -142.92 140.92 31.35 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 119.21 0.914 . . . . 71.13 110.839 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.451 ' HG3' ' HB3' ' B' ' 71' ' ' GLU . 2.1 mp0 -62.97 101.72 0.3 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.521 1.128 . . . . 63.0 109.709 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.17 -46.73 76.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.603 0.761 . . . . 74.13 110.398 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.864 0 CA-C-N 114.98 -1.009 . . . . 44.35 110.4 177.454 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 122.355 1.074 . . . . 62.15 109.989 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -163.87 -168.15 1.55 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 114.588 -1.187 . . . . 62.52 108.394 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -75.57 123.62 25.8 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.358 0.663 . . . . 62.12 110.38 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.568 ' HG2' ' H ' ' D' ' 5' ' ' ASN . 25.5 tt0 -178.21 -156.37 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 106.5 -1.667 . . . . 72.34 106.5 173.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.568 ' H ' ' HG2' ' D' ' 4' ' ' GLN . 1.4 p-10 -68.54 79.91 0.27 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 119.253 0.933 . . . . 72.24 110.711 172.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -73.76 128.61 35.99 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.587 -0.894 . . . . 64.53 108.587 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.401 ' HB ' ' HA3' ' B' ' 146' ' ' GLY . 6.1 m -70.25 138.24 51.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 110.044 -0.354 . . . . 75.22 110.044 -170.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' B' ' 144' ' ' GLN . 5.5 mp0 64.52 84.74 0.15 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.055 1.342 . . . . 74.05 109.644 -165.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.416 ' HG3' HG23 ' D' ' 89' ' ' ILE . 8.8 ttp -30.32 127.5 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.187 1.395 . . . . 75.34 113.519 171.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.1 m -106.82 137.62 44.53 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.143 -1.058 . . . . 72.43 108.143 167.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.405 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 48.3 t80 -157.9 99.08 1.67 Allowed 'General case' 0 C--O 1.241 0.621 0 N-CA-C 107.698 -1.223 . . . . 70.31 107.698 178.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -134.46 157.58 46.1 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.248 -1.019 . . . . 64.34 108.248 176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.657 HG12 HD11 ' D' ' 16' ' ' ILE . 6.7 tp -98.18 140.5 17.97 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 123.197 0.599 . . . . 72.54 110.439 -173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -106.9 -33.04 7.65 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.579 0.752 . . . . 75.33 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -173.07 142.78 1.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 119.418 -0.325 . . . . 73.43 110.819 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' B' ' 130' ' ' PRO . 3.6 mp -121.11 130.12 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.291 -1.374 . . . . 63.23 107.291 171.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -155.75 160.63 40.47 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.598 0.759 . . . . 72.53 110.679 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -86.43 118.31 25.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.692 -0.686 . . . . 71.31 109.567 172.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -86.88 -31.12 20.92 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.3 -0.409 . . . . 53.35 110.397 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.691 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.6 t70 -149.79 135.08 18.16 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.173 -0.921 . . . . 61.42 108.956 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.472 HD13 ' SG ' ' D' ' 113' ' ' CYS . 84.3 mt -135.53 139.06 47.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.912 -1.144 . . . . 51.13 107.912 175.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -142.66 131.5 22.84 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.823 0.849 . . . . 71.23 108.755 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.8 t80 -134.4 117.52 16.41 Favored 'General case' 0 C--O 1.218 -0.56 0 N-CA-C 106.162 -1.792 . . . . 74.42 106.162 167.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -128.4 122.95 32.6 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.311 0.644 . . . . 64.31 109.753 -170.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.05 88.81 18.11 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.595 -0.891 . . . . 71.15 108.595 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.67 -37.14 12.86 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.869 2.379 . . . . 64.11 113.243 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -112.4 35.03 3.97 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.935 -0.765 . . . . 73.54 108.935 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.45 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.83 -64.36 0.88 Allowed Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.973 1.471 . . . . 33.13 114.973 -163.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.15 -9.43 16.54 Favored 'Trans proline' 0 C--N 1.381 2.279 0 CA-C-N 122.3 1.857 . . . . 75.22 113.14 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -84.45 -38.68 19.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.668 1.187 . . . . 71.12 110.599 176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.726 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.3 p -81.66 -12.29 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.979 0.418 . . . . 63.22 111.414 -169.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.84 -7.57 53.86 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.257 0.465 . . . . 72.14 112.257 174.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -74.39 -20.8 59.93 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.513 0.725 . . . . 71.13 110.653 173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -83.94 76.01 10.08 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.853 1.261 . . . . 61.12 110.083 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -84.96 67.89 10.35 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.152 0.977 . . . . 62.41 111.578 -175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -147.4 -179.43 6.84 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.634 1.174 . . . . 74.44 108.553 171.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -66.65 122.1 80.46 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 122.673 0.389 . . . . 55.45 111.444 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HG3' HD21 ' D' ' 68' ' ' LEU . 7.7 Cg_exo -75.75 133.75 15.84 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.281 2.654 . . . . 72.25 111.631 171.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.569 ' HA ' ' HB3' ' H' ' 189' ' ' ALA . 57.4 tt0 -88.66 132.39 34.59 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.704 -0.48 . . . . 73.31 109.704 172.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.89 140.07 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 123.785 0.834 . . . . 74.12 110.004 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 75.2 mmtt -116.0 112.92 22.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.49 1.116 . . . . 64.04 108.033 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.745 HD21 HD22 ' D' ' 128' ' ' LEU . 10.0 mp -95.79 119.79 34.92 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.478 -0.564 . . . . 73.05 109.478 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.432 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -113.17 141.75 46.58 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.236 -1.024 . . . . 72.14 108.236 173.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 50.1 tp -118.61 130.96 56.17 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.473 0.709 . . . . 72.22 110.142 -171.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.578 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.6 t70 -139.23 146.14 40.09 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.079 0.952 . . . . 65.14 108.687 174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 49.0 m -141.86 143.98 33.63 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.63 -0.878 . . . . 60.54 108.63 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.97 162.96 38.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.065 0.946 . . . . 62.24 108.806 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.9 m -151.87 155.65 38.55 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.492 0.317 . . . . 51.4 111.535 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 52.0 p -155.37 126.92 7.35 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.63 1.172 . . . . 53.3 109.483 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.51 123.55 24.15 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.622 0.769 . . . . 70.34 111.121 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.6 mt -90.63 -33.52 15.81 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.328 0.393 . . . . 72.23 110.588 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.17 -170.11 0.94 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.06 0.544 . . . . 74.24 111.82 -175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.22 121.99 16.05 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.825 0.85 . . . . 60.42 110.043 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 64.42 4.33 2.18 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.346 1.458 . . . . 74.44 112.212 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.4 t -110.04 124.82 67.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.93 0.892 . . . . 62.11 108.833 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.74 128.98 23.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.735 -1.209 . . . . 74.53 107.735 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.426 ' HB2' HD11 ' D' ' 51' ' ' LEU . 16.8 tt0 -92.54 129.99 38.31 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.171 -1.048 . . . . 70.23 108.171 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.77 124.85 73.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 108.179 -1.045 . . . . 75.31 108.179 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.6 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -100.53 142.14 16.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 123.373 0.669 . . . . 74.45 109.594 175.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.406 ' HG ' ' CB ' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.44 120.91 39.58 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.932 -1.136 . . . . 73.32 107.932 177.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.4 ttm-85 -104.25 101.02 10.75 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.629 -0.878 . . . . 74.51 108.629 174.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 84.5 t -92.29 107.35 18.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.167 -1.049 . . . . 73.15 108.167 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 35.4 m -97.23 137.21 36.59 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.597 -0.728 . . . . 52.21 109.228 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 67.5 t -128.94 127.37 66.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 107.857 -1.164 . . . . 64.22 107.857 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 86.7 m -125.96 105.72 9.11 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.395 -0.965 . . . . 74.14 108.395 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.51 142.15 35.77 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.419 -0.809 . . . . 74.43 108.973 -174.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 67.6 m -145.25 132.78 20.83 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 123.659 0.599 . . . . 51.13 111.229 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' D' ' 38' ' ' PRO . 13.8 mt -106.24 112.67 25.79 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.466 -1.243 . . . . 74.25 109.458 174.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.94 -113.57 4.61 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 116.263 -0.426 . . . . 71.25 112.085 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.48 3.99 18.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.169 0.587 . . . . 74.43 111.452 -178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -121.36 161.69 21.66 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.732 0.413 . . . . 73.31 110.124 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -78.12 125.11 28.87 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.206 0.603 . . . . 61.15 110.624 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.726 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -75.09 -64.14 1.12 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.822 0.849 . . . . 44.22 109.124 176.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -155.42 164.35 38.83 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.596 -0.729 . . . . 61.02 111.435 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.22 110.08 12.49 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 106.978 -1.489 . . . . 65.24 106.978 176.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.573 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.2 t -122.12 116.37 24.1 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.241 -0.651 . . . . 70.13 109.241 -174.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -144.07 125.88 15.21 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.201 0.6 . . . . 72.01 109.82 -173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' D' ' 113' ' ' CYS . 84.4 t -127.75 116.22 42.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 123.742 0.817 . . . . 54.3 109.569 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.691 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.5 mt-30 -89.52 86.71 6.82 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.896 0.855 . . . . 74.32 109.232 172.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.405 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.5 tp-100 -80.25 100.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.056 -1.429 . . . . 63.2 109.56 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.6 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.79 144.36 17.13 Favored Glycine 0 N--CA 1.467 0.732 0 N-CA-C 111.922 -0.471 . . . . 72.53 111.922 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.16 139.28 9.12 Favored Glycine 0 C--N 1.333 0.406 0 N-CA-C 111.711 -0.556 . . . . 61.24 111.711 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -88.81 127.71 41.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.161 -1.052 . . . . 53.44 108.161 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.17 153.33 41.7 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.844 0.857 . . . . 71.43 110.09 -177.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 67.1 m -107.44 94.1 4.91 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 107.973 -1.121 . . . . 73.11 107.973 169.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 9.7 tt -116.31 137.33 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.97 0.908 . . . . 72.54 110.079 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.17 155.76 11.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.051 0.94 . . . . 63.15 110.305 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.504 ' H ' HD21 ' H' ' 173' ' ' LEU . . . 76.47 22.36 73.08 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 116.602 1.401 . . . . 75.31 116.602 167.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.497 HD13 ' HG2' ' D' ' 94' ' ' MET . 0.9 OUTLIER -121.16 152.22 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.281 0.632 . . . . 52.01 110.704 177.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' H' ' 171' ' ' SER . 7.3 pt-20 -161.65 164.79 29.03 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-N 114.854 -1.066 . . . . 75.41 109.699 177.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.38 -129.2 36.86 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.443 -0.799 . . . . 74.13 113.362 177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 30.7 m -70.96 -31.51 68.1 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.244 1.018 . . . . 73.32 111.635 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -70.73 -34.7 72.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.692 0.797 . . . . 72.14 110.437 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.497 ' HG2' HD13 ' D' ' 89' ' ' ILE . 1.1 tmt? -74.57 -29.58 61.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.025 0.53 . . . . 64.31 110.22 177.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.22 -38.89 91.82 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.285 0.634 . . . . 75.1 110.782 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -79.4 -29.07 41.86 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.247 -0.888 . . . . 73.44 111.313 177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -78.6 -53.12 7.52 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.636 0.375 . . . . 61.42 111.027 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.57 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 52.8 tp -92.11 -48.28 6.81 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.109 0.564 . . . . 52.22 110.89 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.53 -14.13 82.3 Favored Glycine 0 C--N 1.347 1.158 0 O-C-N 123.403 0.44 . . . . 63.34 113.875 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.83 -55.88 1.06 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.877 0.471 . . . . 70.22 111.589 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -75.68 -37.03 59.9 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.908 0.707 . . . . 72.22 112.908 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 73.6 m -59.08 -52.9 71.47 Favored Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 118.851 -0.595 . . . . 73.4 111.441 177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.406 ' CB ' ' HG ' ' D' ' 60' ' ' LEU . 37.5 Cg_endo -66.65 -23.41 49.26 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 121.81 1.673 . . . . 73.51 113.221 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -66.59 -37.81 85.69 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.745 0.418 . . . . 74.44 110.785 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -61.31 -43.02 95.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.596 0.758 . . . . 75.21 110.177 173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' D' ' 80' ' ' GLN . 65.5 mt -79.91 -17.46 53.03 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.03 -0.986 . . . . 72.02 112.031 -172.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -66.77 -43.65 50.13 Favored Pre-proline 0 N--CA 1.487 1.411 0 N-CA-C 114.139 1.163 . . . . 73.45 114.139 -170.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -54.51 -33.78 79.54 Favored 'Trans proline' 0 C--N 1.384 2.442 0 C-N-CA 121.951 1.768 . . . . 61.2 112.932 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -88.62 -26.24 22.01 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.709 -1.132 . . . . 73.14 111.03 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.81 -47.34 72.36 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.903 0.859 . . . . 64.22 109.102 170.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.472 ' NH2' HG23 ' B' ' 105' ' ' ILE . 41.3 ttp180 -61.41 -41.33 96.97 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 113.4 -1.727 . . . . 72.41 110.709 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' B' ' 108' ' ' PRO . 9.6 tt0 -43.73 -54.64 4.97 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.779 1.232 . . . . 62.51 111.874 176.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' D' ' 21' ' ' ILE . 42.6 t -70.05 -48.31 58.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.604 -1.18 . . . . 63.43 111.083 -174.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.573 HG23 ' SG ' ' D' ' 76' ' ' CYS . 45.5 mt -56.44 -58.73 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.812 0.845 . . . . 71.13 110.901 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 41.7 m -52.0 -42.87 63.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.8 1.24 . . . . 71.01 112.295 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.2 -41.55 66.83 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.193 -0.912 . . . . 71.51 110.923 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 57.8 mtm -68.46 -32.14 71.93 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.811 0.444 . . . . 63.24 111.424 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -61.84 -45.55 98.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 O-C-N 123.804 0.69 . . . . 64.32 109.896 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.4 -29.14 62.4 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.938 -0.574 . . . . 73.12 111.11 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -71.54 -33.05 68.82 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.697 0.799 . . . . 75.0 110.723 175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.32 3.75 80.14 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.667 -0.697 . . . . 61.03 112.213 173.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 64.81 26.16 12.94 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 126.801 2.04 . . . . 74.11 112.933 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.445 ' HD1' ' HH ' ' H' ' 197' ' ' TYR . 97.2 m-85 -91.94 161.9 32.28 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 114.556 -1.202 . . . . 71.21 108.818 167.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.64 126.97 17.01 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 122.287 1.991 . . . . 72.1 111.519 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.452 ' HB3' HG23 ' A' ' 122' ' ' THR . 51.5 tt0 -53.38 128.03 27.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.364 1.066 . . . . 74.11 111.827 -174.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.7 tp -115.01 97.86 6.47 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.643 -0.708 . . . . 62.34 110.203 -166.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.49 ' OD1' ' HB ' ' B' ' 16' ' ' ILE . 46.6 m-80 -99.42 99.05 9.92 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.998 -0.742 . . . . 72.31 108.998 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.745 HD22 HD21 ' D' ' 42' ' ' LEU . 48.2 mt -66.85 120.99 14.49 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.039 0.936 . . . . 73.43 111.146 -174.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.83 137.66 96.86 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 123.367 0.667 . . . . 74.5 111.978 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 3.2 Cg_exo -73.91 122.34 7.62 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.557 2.171 . . . . 73.31 110.446 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.502 HG23 HG11 ' G' ' 207' ' ' VAL . 2.5 p -107.86 120.52 59.36 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.25 0.62 . . . . 70.24 109.473 -177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -77.41 105.87 8.81 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.076 -0.965 . . . . 62.42 108.413 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -66.26 -30.28 70.68 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.767 0.827 . . . . 72.43 111.822 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -75.63 -29.86 59.31 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.662 -0.699 . . . . 75.0 110.632 -178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.67 -33.73 68.65 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.715 0.806 . . . . 52.42 111.808 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.473 HD21 ' HD2' ' H' ' 185' ' ' PRO . 7.7 mp -69.67 -41.8 75.02 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.154 0.582 . . . . 63.43 111.514 178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.416 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 43.0 t80 -59.56 -46.93 87.48 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 123.755 0.659 . . . . 73.24 109.345 178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.595 ' HB3' HG21 ' B' ' 7' ' ' THR . 75.8 mtm -65.28 -38.88 91.62 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.905 -1.043 . . . . 64.31 111.095 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -65.57 -24.98 67.22 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.899 0.879 . . . . 70.14 110.741 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -78.22 -36.68 46.81 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 116.097 -0.501 . . . . 75.13 110.176 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 45.0 mt -73.35 -28.25 61.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.299 0.64 . . . . 74.3 112.084 -176.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -79.3 30.62 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.772 0.656 . . . . 72.54 112.772 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -117.4 45.93 1.81 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.282 -1.007 . . . . 71.43 108.282 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -177.3 -61.85 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.171 1.388 . . . . 72.3 108.264 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.98 120.63 20.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.472 0.709 . . . . 23.33 110.606 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.7 104.05 0.25 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 111.778 -0.529 . . . . 64.24 111.778 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.98 119.87 11.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.521 0.729 . . . . 65.43 109.68 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.25 113.53 1.38 Allowed Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.083 -0.807 . . . . 71.32 111.083 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.2 t -144.6 58.28 1.31 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.664 0.786 . . . . 74.2 109.311 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . 0.512 ' HA ' ' H ' ' B' ' 3' ' ' GLU . 10.8 pt-20 -62.3 111.48 2.01 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-O 121.311 0.577 . . . . 74.11 110.665 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -77.78 117.18 18.91 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.211 -0.904 . . . . 73.34 109.552 -176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -63.42 110.76 2.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.533 1.133 . . . . 74.5 109.055 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.685 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 11.9 pt20 -75.9 -30.57 58.85 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.368 0.667 . . . . 60.04 112.114 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.39 93.11 0.21 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.847 0.859 . . . . 74.3 110.957 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 C-N-CA 124.039 0.935 . . . . 72.14 110.298 179.494 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 110.057 -0.349 . . . . 72.15 110.057 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -90.48 150.87 21.03 Favored Glycine 0 C--N 1.344 0.984 0 O-C-N 123.8 0.687 . . . . 74.54 112.374 -176.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -85.9 133.77 33.93 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 109.56 -0.533 . . . . 74.21 109.56 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 6.0 p -66.17 105.76 1.48 Allowed 'General case' 0 CA--C 1.542 0.639 0 O-C-N 124.195 0.935 . . . . 74.31 111.608 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -101.75 31.16 3.96 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.463 1.105 . . . . 73.42 108.949 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.631 HD23 ' HA ' ' C' ' 54' ' ' ASP . 3.1 tm? -68.7 117.82 10.9 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.48 -0.782 . . . . 74.31 109.867 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.55 -167.49 2.63 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.764 1.226 . . . . 70.3 108.762 176.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -144.02 -67.0 0.34 Allowed 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.985 -1.117 . . . . 73.22 107.985 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 58.02 19.55 6.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.913 1.285 . . . . 75.22 113.38 171.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 51.8 tp -97.5 104.05 16.04 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.098 -1.075 . . . . 70.22 108.098 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -74.55 -68.46 0.53 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.134 -0.691 . . . . 64.21 109.134 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -129.09 159.9 66.5 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.768 0.827 . . . . 73.51 109.454 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.16 91.56 0.17 Allowed 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.301 2.001 . . . . 65.44 110.043 167.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -53.06 142.22 20.57 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.075 1.35 . . . . 73.34 111.007 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 8.5 t80 62.87 104.53 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.346 1.058 . . . . 73.33 109.363 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 28.6 m -53.39 102.41 0.06 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 123.352 0.661 . . . . 63.31 111.541 -175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 22.6 t90 -107.83 107.35 60.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.293 1.037 . . . . 73.23 108.545 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -87.32 31.71 0.44 Allowed 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 123.211 2.607 . . . . 71.13 112.286 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.599 HD22 ' HB2' ' C' ' 44' ' ' LEU . 39.2 tp 57.3 -85.88 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.242 1.417 . . . . 72.34 110.254 -173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 15.1 tt -142.97 145.18 23.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.739 0 C-N-CA 124.052 0.941 . . . . 71.21 109.127 -178.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -77.34 76.07 3.89 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.383 -0.599 . . . . 61.41 109.383 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -76.1 93.76 3.37 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.459 -0.791 . . . . 71.25 109.456 177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -143.65 150.16 38.34 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.174 -0.921 . . . . 74.31 109.24 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.04 -52.16 0.71 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.686 -0.566 . . . . 74.13 111.686 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 80.68 137.64 1.98 Allowed Glycine 0 C--N 1.345 1.034 0 O-C-N 123.845 0.38 . . . . 52.12 113.502 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . 0.629 ' HB2' ' HD2' ' C' ' 38' ' ' PRO . 31.5 m-85 -69.76 173.5 6.16 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.798 0.839 . . . . 74.14 112.431 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.22 128.81 14.1 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.126 -1.064 . . . . 64.22 108.126 167.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -152.63 176.65 11.51 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 123.475 0.484 . . . . 73.32 111.103 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . 0.552 ' HB2' ' HB3' ' E' ' 199' ' ' ASN . 73.3 mmtt -121.05 122.74 40.74 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 124.586 1.154 . . . . 74.11 108.051 172.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.94 100.52 2.97 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.51 -1.293 . . . . 74.44 107.51 164.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . 0.584 ' HB3' ' HG2' ' E' ' 201' ' ' LYS . 42.0 mt-10 75.35 97.97 0.07 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.612 1.565 . . . . 75.24 111.165 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' E' ' 196' ' ' LYS . 4.1 p-10 -119.1 120.79 38.19 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.005 0.922 . . . . 62.43 110.057 178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 53.86 34.43 51.36 Favored Glycine 0 C--N 1.36 1.885 0 O-C-N 123.635 0.584 . . . . 54.33 113.083 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.584 ' HG2' ' HB3' ' E' ' 198' ' ' GLU . 0.0 OUTLIER -73.62 163.27 28.24 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.575 0.954 . . . . 74.33 113.575 -167.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -85.11 1.69 46.76 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.714 1.206 . . . . 71.12 111.135 172.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 20.6 t0 73.63 127.37 0.04 OUTLIER 'General case' 0 C--N 1.36 1.042 0 C-N-CA 126.556 1.942 . . . . 64.54 109.642 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 11.9 tt -99.32 -37.21 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.093 0.557 . . . . 73.35 109.519 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -70.85 -18.72 62.69 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.451 1.101 . . . . 73.33 111.691 -177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -144.56 106.04 4.25 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.675 -0.491 . . . . 71.21 109.675 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.075 1.35 . . . . 75.12 108.0 175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 57.5 tptt . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.731 -0.47 . . . . 74.24 109.731 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.26 108.46 2.07 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.138 -0.812 . . . . 32.01 112.392 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 22.9 tptm 69.25 -69.37 0.16 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 126.02 1.728 . . . . 71.51 111.239 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 56.0 p -66.58 167.08 11.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.52 1.128 . . . . 42.41 110.917 172.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . 0.587 ' HB2' ' H ' ' B' ' 88' ' ' GLY . . . -117.93 -97.8 0.46 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.29 0.636 . . . . 53.23 111.675 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.411 HD13 ' HB1' ' F' ' 172' ' ' ALA . 0.0 OUTLIER -163.48 -6.24 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 113.853 1.057 . . . . 74.12 113.853 -166.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.499 ' SD ' HD13 ' B' ' 86' ' ' ILE . 20.6 ptp -106.42 109.29 21.17 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.697 1.369 . . . . 63.22 114.697 -159.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -161.26 85.94 0.67 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.29 -1.004 . . . . 74.44 108.29 157.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -177.48 135.35 0.19 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.215 1.006 . . . . 50.31 108.431 174.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 58.2 tp -86.63 135.45 33.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.706 0.802 . . . . 72.4 109.73 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -83.34 122.81 28.95 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.132 0.973 . . . . 74.13 109.714 -176.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -64.12 -49.92 71.24 Favored Pre-proline 0 CA--C 1.564 1.491 0 O-C-N 124.52 1.138 . . . . 75.21 112.158 -176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.45 93.85 0.99 Allowed 'Trans proline' 0 C--N 1.391 2.813 0 C-N-CA 121.449 1.433 . . . . 74.55 111.082 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -133.81 167.31 20.78 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.566 -0.743 . . . . 70.53 109.15 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . 0.489 ' HB2' ' HZ ' ' B' ' 133' ' ' PHE . 52.2 m-85 -85.43 141.43 29.97 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.191 0.596 . . . . 72.54 110.27 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 89.5 m -71.54 139.15 49.36 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.722 0.809 . . . . 73.3 110.431 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -109.25 98.41 31.13 Favored Pre-proline 0 CA--C 1.552 1.022 0 N-CA-C 108.023 -1.103 . . . . 73.34 108.023 177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -79.01 124.05 5.94 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.731 2.288 . . . . 74.34 112.331 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 66.2 mt -112.46 127.43 56.04 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.567 0.747 . . . . 64.31 109.044 176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' E' ' 201' ' ' LYS . 2.6 pp -93.84 -175.53 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.481 0.712 . . . . 73.11 111.811 -176.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -93.67 142.75 27.0 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.544 0.738 . . . . 54.34 110.622 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.62 83.14 4.82 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.827 0.851 . . . . 52.52 109.429 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 1.1 t70 63.29 -171.59 0.17 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.277 1.431 . . . . 75.01 111.912 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 141.12 -142.92 12.61 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.336 -1.106 . . . . 61.44 110.336 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 65.04 -89.92 0.1 OUTLIER Glycine 0 C--N 1.352 1.443 0 O-C-N 124.03 0.489 . . . . 55.11 113.424 173.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -142.15 -26.62 0.64 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.654 0.782 . . . . 72.4 110.603 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -65.06 -35.98 82.89 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.257 0.623 . . . . 73.41 111.146 -177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' B' ' 37' ' ' GLN . 2.1 t80 -82.95 118.87 23.78 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.9 -0.778 . . . . 70.35 108.9 176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -159.83 152.21 20.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.373 0.669 . . . . 72.14 109.904 -172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . 0.59 ' HA ' ' HG3' ' B' ' 37' ' ' GLN . 3.6 t80 -58.78 -44.99 90.82 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.297 1.039 . . . . 73.51 113.413 -164.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -64.55 -24.05 67.47 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.96 0.504 . . . . 63.44 111.471 -174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -80.57 90.61 5.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.836 0.854 . . . . 75.34 110.166 -175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.44 79.93 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 114.809 -1.087 . . . . 53.12 113.463 -177.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 70.63 -70.71 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.717 1.607 . . . . 62.22 112.48 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . 0.48 ' HE2' ' HB3' ' B' ' 124' ' ' PRO . 4.5 m-30 57.81 40.69 25.88 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.178 0.991 . . . . 70.32 109.839 -168.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -159.18 148.43 18.54 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.624 -1.171 . . . . 74.33 109.625 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.558 ' HB ' ' HB1' ' C' ' 129' ' ' ALA . 7.2 tp -85.7 82.32 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.93 -1.137 . . . . 72.35 107.93 173.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -62.08 123.7 18.83 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.71 -1.132 . . . . 62.43 108.265 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -30.47 110.79 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 127.222 2.209 . . . . 75.52 113.692 -167.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.407 ' HB ' HD12 ' C' ' 136' ' ' LEU . 2.4 m . . . . . 0 CA--C 1.565 1.527 0 C-N-CA 123.953 0.901 . . . . 72.44 111.954 -174.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' G' ' 168' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.264 -0.643 . . . . 74.41 109.264 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.46 115.28 6.23 Favored Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.812 -0.515 . . . . 51.33 111.812 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 96.1 mttt 62.75 22.64 13.5 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.898 1.279 . . . . 63.41 112.439 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . 0.415 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 34.9 p -161.76 139.69 9.03 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.375 -0.83 . . . . 73.5 109.468 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.45 -78.51 0.06 Allowed 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.95 -0.389 . . . . 74.21 109.95 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.459 HD23 ' SD ' ' G' ' 174' ' ' MET . 2.0 pt? -158.93 16.25 0.18 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.446 1.098 . . . . 73.42 108.942 170.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.459 ' SD ' HD23 ' G' ' 173' ' ' LEU . 0.0 OUTLIER -174.69 165.97 3.74 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.284 1.434 . . . . 70.2 108.964 -173.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -169.45 -48.01 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.181 0.592 . . . . 75.02 109.99 173.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -74.04 104.64 4.95 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.883 -0.784 . . . . 75.24 108.883 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 52.3 tp -80.63 93.62 6.16 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.496 -0.927 . . . . 72.24 108.496 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -81.8 102.91 11.11 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.201 -0.909 . . . . 54.34 110.765 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 74.27 149.28 0.12 Allowed Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 125.555 1.542 . . . . 72.12 113.294 171.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.28 95.33 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.747 2.298 . . . . 75.35 110.658 169.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -60.6 -29.11 69.0 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.591 0.756 . . . . 75.23 111.437 -175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -128.2 154.59 45.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.615 0.766 . . . . 75.21 110.252 167.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 19.3 p -92.51 128.93 38.54 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.01 0.924 . . . . 74.31 108.978 171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -126.49 114.5 23.11 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.213 0.605 . . . . 71.33 109.58 -172.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -64.99 154.15 74.79 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.053 2.502 . . . . 73.21 112.898 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 95.9 mt -128.93 51.37 2.04 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.868 0.867 . . . . 71.44 111.068 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.569 ' HB ' HD22 ' A' ' 42' ' ' LEU . 4.8 mp 60.31 -75.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 124.684 1.193 . . . . 71.12 111.747 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . 70.33 97.84 0.06 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 125.494 1.518 . . . . 61.13 109.875 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -112.01 161.35 16.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.82 -0.627 . . . . 61.44 111.648 -170.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -161.85 152.74 17.88 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.255 -0.884 . . . . 74.03 109.65 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 71.32 -146.33 40.66 Favored Glycine 0 C--N 1.345 1.064 0 O-C-N 123.643 0.59 . . . . 72.44 113.53 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.2 67.65 1.17 Allowed Glycine 0 C--N 1.348 1.211 0 N-CA-C 111.763 -0.535 . . . . 73.35 111.763 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -68.72 89.46 0.39 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.216 0.607 . . . . 74.24 110.335 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.94 -74.89 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.032 -0.729 . . . . 51.33 109.032 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -88.57 108.35 19.38 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.927 -0.768 . . . . 75.14 108.927 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -70.21 112.2 6.39 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.838 -0.801 . . . . 74.33 108.838 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -99.83 149.55 23.26 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.111 0.565 . . . . 73.54 110.413 176.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -171.71 -33.69 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.122 1.369 . . . . 70.22 109.167 -176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -163.26 -178.17 5.8 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.403 1.081 . . . . 62.44 108.481 -174.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.25 128.53 46.06 Favored Glycine 0 C--N 1.353 1.52 0 N-CA-C 112.159 -0.377 . . . . 61.4 112.159 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -102.86 -11.15 18.48 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.758 0.823 . . . . 64.1 110.699 -174.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -139.0 121.28 15.92 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.394 -0.965 . . . . 74.31 108.394 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -169.78 -27.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.211 0.944 . . . . 65.33 110.42 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 2.7 mp 62.39 -78.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.11 0.964 . . . . 74.31 108.926 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 3.8 ptpp? 179.24 -61.52 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.285 1.834 . . . . 73.31 108.074 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 4.2 p30 178.3 -174.43 0.16 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.342 1.457 . . . . 74.42 108.949 -173.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . 0.502 HG11 HG23 ' D' ' 131' ' ' VAL . 60.7 t . . . . . 0 CA--C 1.553 1.06 0 N-CA-C 108.062 -1.088 . . . . 72.15 108.062 172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.685 -0.858 . . . . 75.42 108.685 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -171.52 128.61 1.62 Allowed Glycine 0 C--N 1.347 1.156 0 C-N-CA 121.444 -0.408 . . . . 53.45 112.832 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -77.99 130.69 36.82 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.365 -0.976 . . . . 71.13 108.365 175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . 0.435 ' H ' ' HB2' ' D' ' 90' ' ' GLU . 42.5 m 60.65 27.72 17.43 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.262 0.977 . . . . 54.21 111.641 -173.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.66 -59.1 4.65 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 115.658 -0.701 . . . . 75.01 111.203 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.504 HD21 ' H ' ' D' ' 88' ' ' GLY . 1.6 tm? 63.49 -75.5 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.458 1.503 . . . . 74.13 111.621 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 24.5 mmt -86.64 -57.33 3.03 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.82 0.848 . . . . 63.4 111.373 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -167.44 135.64 2.5 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.327 -0.62 . . . . 75.24 109.327 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -153.48 -70.61 0.14 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.466 -1.309 . . . . 73.3 107.466 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . 0.536 HD11 HD23 ' D' ' 98' ' ' LEU . 8.5 mp 56.96 27.79 13.71 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.582 1.153 . . . . 71.04 112.94 171.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -79.41 -44.71 20.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.402 0.681 . . . . 73.43 110.524 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -76.02 141.45 71.21 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.74 -0.664 . . . . 63.42 109.921 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -83.93 164.19 13.66 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 122.708 2.272 . . . . 74.24 113.128 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.56 -169.3 2.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.07 0.948 . . . . 74.25 110.277 174.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -69.96 130.19 41.54 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.655 0.782 . . . . 64.25 110.433 178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 47.5 p -70.48 161.32 30.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.064 0.546 . . . . 73.41 109.616 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -128.07 117.85 20.6 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.238 0.615 . . . . 71.22 109.964 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . 0.473 ' HD2' HD21 ' D' ' 136' ' ' LEU . 63.9 Cg_endo -73.71 117.06 4.89 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 122.817 2.345 . . . . 72.4 112.065 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 mp -81.64 145.32 30.65 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 108.605 -0.887 . . . . 72.25 108.605 170.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.406 HG13 ' H ' ' H' ' 187' ' ' ILE . 2.6 pp -64.19 170.06 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 123.988 0.915 . . . . 65.1 112.273 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -161.63 170.36 19.9 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.938 0.495 . . . . 74.1 110.938 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' D' ' 39' ' ' GLU . . . -87.07 132.26 33.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.35 0.66 . . . . 54.51 109.503 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -137.82 128.25 26.42 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.787 0.835 . . . . 72.44 109.759 -174.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 57.78 -115.96 7.55 Favored Glycine 0 C--N 1.353 1.523 0 O-C-N 124.507 1.129 . . . . 73.13 113.433 175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 69.97 -89.85 0.32 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 124.055 0.503 . . . . 72.11 112.741 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 58.74 19.4 6.83 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.966 1.306 . . . . 73.12 112.422 -174.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.5 39.9 1.27 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.464 1.106 . . . . 63.11 109.303 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -138.6 142.13 39.16 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.693 0.797 . . . . 73.31 109.289 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.16 154.88 43.61 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.12 1.368 . . . . 71.04 108.147 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . 0.585 ' HD1' HH22 ' C' ' 15' ' ' ARG . 55.7 m-85 -93.6 -29.04 15.67 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.883 0.473 . . . . 70.21 111.124 176.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . 0.583 ' HG3' HD22 ' H' ' 199' ' ' ASN . 8.5 tp10 60.61 -89.06 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 124.113 0.965 . . . . 54.33 109.743 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . 0.583 HD22 ' HG3' ' H' ' 198' ' ' GLU . 0.1 OUTLIER 165.74 158.48 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 126.928 2.091 . . . . 72.22 107.355 174.593 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -87.37 46.1 3.46 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 112.194 -0.363 . . . . 22.43 112.194 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . 0.491 ' HG3' HD12 ' H' ' 204' ' ' ILE . 60.6 tttm -165.43 108.99 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.549 1.14 . . . . 73.35 108.599 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -72.0 -60.28 2.31 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 120.857 0.361 . . . . 75.25 110.314 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -151.93 -68.76 0.17 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.622 -0.881 . . . . 73.51 108.622 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' A' ' 129' ' ' ALA . 14.1 mt 56.17 74.14 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 125.502 1.521 . . . . 73.55 110.685 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -88.0 -21.16 24.98 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.174 0.989 . . . . 74.51 110.515 177.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -70.04 -39.26 75.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.286 1.034 . . . . 70.13 112.259 -171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.499 HG21 HG12 ' A' ' 131' ' ' VAL . 82.4 t . . . . . 0 C--O 1.255 1.35 0 C-N-CA 124.254 1.022 . . . . 75.42 108.445 177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 mtm . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 109.442 -0.577 . . . . 55.52 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.7 m -87.26 99.42 11.95 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.187 -1.042 . . . . 70.43 108.187 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -145.91 123.91 12.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.121 0.568 . . . . 65.55 111.039 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -91.15 60.12 4.17 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.023 -1.103 . . . . 74.51 108.023 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -138.07 147.13 43.76 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.317 -0.856 . . . . 55.13 109.813 -176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -144.23 143.67 31.16 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 107.848 -1.167 . . . . 53.54 107.848 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 p -85.58 60.25 6.13 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.747 0.784 . . . . 73.14 110.542 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -97.53 -164.74 1.17 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.537 1.135 . . . . 71.44 110.354 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.576 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 25.0 ptm -55.19 148.42 14.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.9 0.88 . . . . 53.54 112.257 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.9 m -140.54 130.7 24.91 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.77 0.828 . . . . 75.23 109.488 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' HE1' ' HG ' ' A' ' 102' ' ' CYS . 67.2 t80 -129.05 140.01 51.79 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.742 -1.207 . . . . 71.5 107.742 173.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 27.3 tp60 -149.79 130.51 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.685 0.394 . . . . 70.01 110.162 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.79 112.83 16.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.549 -1.278 . . . . 73.33 107.549 172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.461 ' NE2' ' HB2' ' A' ' 85' ' ' SER . 8.0 mm-40 -87.88 -38.03 15.98 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.104 0.252 . . . . 70.34 110.94 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -171.95 124.32 0.53 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.954 0.502 . . . . 71.41 110.798 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 80.4 mt -108.6 135.78 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.767 -0.827 . . . . 74.3 108.767 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.635 ' HB3' HG23 ' B' ' 122' ' ' THR . 16.9 p90 -170.5 176.35 4.4 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.915 0.759 . . . . 70.43 111.489 -178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.2 p -98.78 128.95 45.16 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.114 -0.698 . . . . 62.35 109.114 172.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 40.5 mtpt -92.5 -38.04 12.17 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.207 -0.664 . . . . 75.52 109.207 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.675 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -135.86 136.53 40.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.601 -1.181 . . . . 75.44 109.502 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.2 mt -135.97 139.52 45.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.949 -1.5 . . . . 62.12 106.949 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.3 t -149.28 122.78 9.11 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 123.474 0.484 . . . . 65.23 110.222 173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.3 t80 -119.9 114.54 22.23 Favored 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 106.522 -1.658 . . . . 75.34 106.522 170.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -119.35 117.62 29.02 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.402 -0.592 . . . . 73.11 109.402 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.67 81.56 67.21 Favored Pre-proline 0 CA--C 1.54 0.571 0 N-CA-C 108.145 -1.057 . . . . 72.31 108.145 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.32 -35.03 42.15 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.563 2.175 . . . . 60.41 111.628 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.0 m-20 -104.98 31.54 4.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.26 -0.882 . . . . 74.43 109.62 -177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.41 99.66 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.299 1.039 . . . . 54.23 112.684 177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.01 -26.24 11.08 Favored 'Trans proline' 0 C--N 1.38 2.23 0 CA-C-N 121.277 1.492 . . . . 63.4 113.721 170.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.9 OUTLIER -70.7 -23.01 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 123.38 0.672 . . . . 61.5 112.357 -173.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.608 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.6 p -61.19 -20.39 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 123.15 0.58 . . . . 74.01 111.27 176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -61.6 -39.57 91.69 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.246 1.018 . . . . 63.31 111.693 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -91.91 -28.27 17.38 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.679 0.392 . . . . 60.12 110.961 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.63 149.86 28.37 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.061 0.544 . . . . 64.43 111.204 -174.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.5 147.36 41.93 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.443 0.697 . . . . 71.51 110.337 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.462 ' CE3' HD21 ' A' ' 68' ' ' LEU . 63.7 t-105 -93.81 76.96 4.23 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.605 0.717 . . . . 63.3 110.183 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -121.75 82.45 41.84 Favored Pre-proline 0 CA--C 1.545 0.756 0 N-CA-C 106.309 -1.737 . . . . 61.32 106.309 169.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -82.12 136.99 9.36 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 122.691 2.261 . . . . 52.41 113.082 -170.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.34 84.32 3.71 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 106.456 -1.683 . . . . 65.23 106.456 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.9 t -79.25 101.06 4.27 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 CA-C-N 114.193 -1.367 . . . . 75.53 108.971 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -79.32 114.55 18.35 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.534 -0.913 . . . . 73.2 108.534 170.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.7 116.48 28.93 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.187 -1.412 . . . . 74.32 107.187 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.1 t70 -126.25 138.9 53.66 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.824 -0.806 . . . . 62.22 108.824 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.3 tp -130.38 120.03 23.66 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.995 -0.743 . . . . 71.21 108.995 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -135.65 157.15 47.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.676 0.79 . . . . 73.13 109.522 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -127.75 159.63 34.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.691 0.796 . . . . 64.11 109.662 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.39 136.06 21.94 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.694 1.198 . . . . 74.31 107.97 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.6 m -107.86 160.11 16.0 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.035 0.534 . . . . 52.4 110.312 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.3 t -157.74 150.28 22.68 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.962 0.905 . . . . 54.45 109.385 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -113.01 140.25 47.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.239 -1.023 . . . . 74.34 108.239 170.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.3 mt -115.59 -37.68 3.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.567 0.747 . . . . 74.33 110.569 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -158.15 -179.28 7.97 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.912 0.885 . . . . 74.2 110.318 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -61.28 114.52 3.22 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.633 -0.712 . . . . 65.33 109.262 169.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 69.15 0.99 3.04 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.893 1.277 . . . . 55.14 113.402 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 23.9 t -106.73 108.62 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 107.885 -1.154 . . . . 64.32 107.885 172.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -123.14 160.64 26.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.059 -0.719 . . . . 70.43 109.059 -177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -130.87 134.69 47.02 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 123.77 0.828 . . . . 70.12 108.948 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 56.5 t -118.13 122.23 69.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 107.321 -1.363 . . . . 64.31 107.321 170.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -98.69 134.74 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 123.727 0.811 . . . . 43.44 109.429 176.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.05 114.15 28.02 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.889 -1.152 . . . . 74.34 107.889 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.18 100.47 10.69 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.146 -0.687 . . . . 71.21 109.146 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.9 t -99.66 141.7 16.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.461 -0.94 . . . . 71.31 108.461 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 19.5 m -130.99 133.7 46.02 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.111 0.481 . . . . 65.41 110.533 176.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 37.5 t -130.62 109.48 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 125.341 1.457 . . . . 75.11 107.741 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.0 m -112.11 128.42 56.21 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.117 -0.697 . . . . 65.33 109.117 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.31 106.67 13.91 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.792 -0.818 . . . . 60.24 108.792 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.619 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 30.9 m -114.93 126.61 54.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.001 0.52 . . . . 74.22 110.051 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.462 HD21 ' CE3' ' A' ' 36' ' ' TRP . 25.7 mt -89.73 65.27 6.77 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 107.855 -1.165 . . . . 53.2 107.855 177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 -101.8 1.23 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.101 -0.954 . . . . 75.03 110.999 -175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -88.36 -27.4 21.64 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.428 1.091 . . . . 74.02 110.126 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -98.05 94.79 7.04 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.717 0.807 . . . . 71.24 110.08 -172.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 92.6 m -67.41 125.58 26.58 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.839 0.745 . . . . 54.23 111.03 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.35 -56.85 4.51 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.83 0.852 . . . . 74.52 109.769 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -161.07 174.84 13.13 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.493 -1.23 . . . . 71.32 111.781 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 31.3 tp -139.11 130.53 27.04 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.955 -1.498 . . . . 71.21 106.955 173.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.514 ' HB3' HG23 ' A' ' 114' ' ' ILE . 74.8 m -130.27 101.77 5.92 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 124.463 1.105 . . . . 64.44 109.761 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -128.44 121.56 29.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.836 -0.801 . . . . 71.01 108.836 -177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.4 t -129.49 129.62 66.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 C-N-CA 123.458 0.703 . . . . 45.42 109.391 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.675 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.9 mt-30 -102.51 90.65 3.93 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 115.497 -0.774 . . . . 73.41 109.49 171.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -77.08 95.46 4.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.39 -1.277 . . . . 70.01 108.614 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.97 143.18 19.57 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 112.138 -0.385 . . . . 74.31 112.138 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.48 122.35 1.94 Allowed Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 111.598 -0.601 . . . . 72.33 111.598 -177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 43.9 mt -80.89 125.56 39.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.083 -1.08 . . . . 71.34 108.083 174.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -132.1 132.45 43.3 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.593 0.757 . . . . 74.23 110.582 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 33.4 t -80.24 122.79 27.3 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.451 -0.944 . . . . 72.54 108.451 166.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.8 tp -129.44 146.52 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.141 -0.688 . . . . 64.52 109.141 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.88 162.14 7.33 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.048 0.939 . . . . 61.1 110.978 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 79.03 7.61 88.35 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 115.688 1.035 . . . . 65.34 115.688 168.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' H ' HD13 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -114.66 141.13 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 CA-C-N 117.818 0.809 . . . . 55.02 109.864 -174.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.402 ' H ' ' NE2' ' A' ' 93' ' ' GLN . 45.7 mt-10 -146.25 170.31 17.01 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.874 0.47 . . . . 73.41 110.345 173.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.17 -115.8 4.99 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 124.18 0.925 . . . . 42.03 114.22 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.2 p -68.3 -34.16 75.64 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.363 1.065 . . . . 72.2 111.653 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 90' ' ' GLU . 44.5 mt-30 -57.97 -44.38 87.02 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.956 0.902 . . . . 74.25 110.839 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.0 tpt -76.61 -40.68 48.69 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 115.869 -0.605 . . . . 70.41 111.022 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.44 71.89 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 121.322 0.582 . . . . 63.42 111.066 176.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.473 ' HE1' ' HA ' ' A' ' 134' ' ' ASP . 65.9 t60 -79.25 -41.82 27.3 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.104 0.962 . . . . 73.22 111.097 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 23.3 t -74.24 -63.6 1.19 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.772 0.429 . . . . 71.32 110.233 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.06 -33.34 74.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.928 0.891 . . . . 75.22 111.57 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.78 -10.46 63.04 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 115.239 0.855 . . . . 63.14 115.239 -173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.15 -55.47 0.32 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.971 0.886 . . . . 72.13 111.799 -176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.24 -60.07 2.9 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.53 0.567 . . . . 73.22 112.53 -168.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.402 ' HG ' ' HE1' ' A' ' 11' ' ' PHE . 30.5 m -55.88 -48.24 97.06 Favored Pre-proline 0 CA--C 1.558 1.281 0 C-N-CA 123.573 0.749 . . . . 71.43 112.865 -176.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 106' ' ' LEU . 47.2 Cg_endo -67.82 -28.95 35.89 Favored 'Trans proline' 0 C--N 1.38 2.196 0 CA-C-N 120.702 1.287 . . . . 60.13 113.809 174.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -78.79 -19.9 51.08 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.295 0.952 . . . . 63.54 111.807 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -58.54 -38.57 71.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 122.216 1.007 . . . . 75.03 109.497 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.515 HD21 ' HA3' ' A' ' 82' ' ' GLY . 51.7 mt -75.94 -18.97 59.13 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.017 -1.447 . . . . 74.04 112.124 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 38.9 t80 -65.87 -40.53 39.55 Favored Pre-proline 0 CA--C 1.565 1.541 0 N-CA-C 114.462 1.282 . . . . 75.42 114.462 -169.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.91 -39.65 83.8 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 122.154 1.903 . . . . 63.51 113.444 170.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -80.68 -33.84 35.17 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.389 -0.823 . . . . 75.42 111.546 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.85 81.5 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 109.02 -0.733 . . . . 71.31 109.02 175.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttm105 -52.15 -53.93 36.96 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-N 114.624 -1.171 . . . . 65.34 110.566 176.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.42 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.6 tm-20 -61.14 -41.19 96.29 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.044 0.84 . . . . 75.14 111.315 -174.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.79 -47.63 84.28 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.892 -0.595 . . . . 71.42 110.714 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.514 HG23 ' HB3' ' A' ' 76' ' ' CYS . 97.8 mt -63.11 -47.71 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.133 0.973 . . . . 64.0 110.717 179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.545 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.7 m -60.68 -41.88 95.98 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.523 1.129 . . . . 51.13 111.56 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.01 -43.39 78.95 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.684 -0.689 . . . . 60.22 110.602 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -55.65 -43.84 76.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.617 0.767 . . . . 70.43 111.453 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.41 -48.19 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.938 0.895 . . . . 74.31 111.113 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -70.36 -26.97 63.97 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 116.292 -0.413 . . . . 42.23 111.294 -176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -73.93 -32.1 63.36 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.712 0.805 . . . . 71.05 109.952 173.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.51 -1.62 71.57 Favored Glycine 0 C--N 1.352 1.464 0 O-C-N 123.958 0.786 . . . . 72.24 112.875 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.8 m 67.81 40.28 2.44 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 122.87 1.319 . . . . 55.44 110.071 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.608 ' HE1' HG11 ' A' ' 31' ' ' VAL . 43.9 m-85 -116.72 152.31 48.27 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 114.524 -1.217 . . . . 73.5 109.579 176.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.32 135.69 60.96 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.114 2.543 . . . . 74.41 113.459 178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.545 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.5 tt0 -58.74 139.5 56.11 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.62 0.768 . . . . 54.31 112.304 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.9 tp -117.08 115.08 24.68 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 109.136 -0.69 . . . . 70.15 109.136 176.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -100.3 93.65 5.79 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.683 -0.858 . . . . 74.3 108.683 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -65.89 135.33 54.64 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.45 0.7 . . . . 53.35 109.9 -176.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.489 ' HB3' HD12 ' G' ' 187' ' ' ILE . . . -68.79 131.07 91.32 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 122.957 0.503 . . . . 74.01 111.897 -175.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -78.39 110.77 2.91 Favored 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 122.596 2.197 . . . . 70.31 111.709 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.14 110.78 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 108.248 -1.019 . . . . 52.54 108.248 175.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 14.8 m120 -110.82 72.22 0.77 Allowed 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.231 1.012 . . . . 74.22 112.749 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -70.84 -24.24 62.49 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.0 0.429 . . . . 73.02 110.732 169.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.473 ' HA ' ' HE1' ' A' ' 96' ' ' HIS . 19.1 p-10 -69.0 -47.77 64.71 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.687 -0.688 . . . . 75.11 110.437 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -69.0 -49.39 58.23 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.442 0.697 . . . . 74.14 111.491 -173.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.494 ' HB2' HG11 ' H' ' 207' ' ' VAL . 54.0 tp -57.3 -43.1 82.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 123.563 0.539 . . . . 52.41 111.107 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 44.8 t80 -70.28 -38.13 75.0 Favored 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 115.675 -0.693 . . . . 64.24 110.934 -177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 94.9 mmm -63.72 -42.53 97.91 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 118.003 0.365 . . . . 72.23 110.046 175.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.555 ' HB3' ' NE2' ' C' ' 144' ' ' GLN . 96.0 m-20 -66.28 -18.54 65.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.432 1.093 . . . . 73.42 111.987 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -95.92 -42.03 8.5 Favored 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.91 0.884 . . . . 75.01 111.215 173.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.465 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -67.67 -27.25 66.68 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 124.966 1.306 . . . . 62.35 111.094 -167.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -141.31 31.72 1.72 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.691 -1.226 . . . . 61.52 107.691 -172.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.403 HE22 ' HB2' ' C' ' 145' ' ' ALA . 29.8 tt0 -55.96 -24.36 37.91 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 113.995 -1.457 . . . . 73.3 112.257 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.58 87.91 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.721 0.809 . . . . 71.4 109.457 168.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -89.68 166.11 13.8 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 114.907 -1.042 . . . . 53.53 110.593 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.03 118.63 0.97 Allowed Glycine 0 C--O 1.238 0.369 0 N-CA-C 111.201 -0.76 . . . . 70.11 111.201 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -76.85 149.84 36.11 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.608 -0.516 . . . . 71.35 109.608 170.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.32 100.04 0.14 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 109.792 -1.323 . . . . 73.12 109.792 -176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.6 t -148.92 168.89 21.83 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.217 0.607 . . . . 64.45 110.095 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -140.72 123.49 16.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.136 0.975 . . . . 73.01 108.858 176.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -84.58 148.43 26.48 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 109.531 -0.544 . . . . 73.15 109.531 173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -166.8 -166.98 0.89 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.73 1.212 . . . . 74.34 109.367 174.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -145.87 154.56 42.11 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.788 0.835 . . . . 64.42 110.267 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.59 75.95 6.23 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.537 0.735 . . . . 74.54 109.864 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.523 0 C-N-CA 123.451 0.7 . . . . 63.22 109.301 -177.553 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.436 ' HG3' ' HA ' ' B' ' 145' ' ' ALA . 26.6 mmt . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.425 -0.583 . . . . 71.13 109.425 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -67.2 119.96 12.97 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 122.964 0.506 . . . . 71.45 110.449 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.14 109.86 1.43 Allowed 'General case' 0 C--N 1.351 0.637 0 N-CA-C 108.98 -0.748 . . . . 74.15 108.98 171.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.93 150.53 30.95 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.889 -0.782 . . . . 62.05 108.889 -176.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -72.27 128.71 36.49 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.485 -1.302 . . . . 75.12 107.485 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -81.21 71.59 8.2 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.855 0.835 . . . . 73.42 110.098 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.4 t -92.1 69.45 5.31 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 123.317 1.532 . . . . 64.53 107.71 172.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -112.96 159.27 19.27 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 113.44 -1.709 . . . . 61.24 109.571 -169.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 21.8 ptm 51.11 -175.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 126.503 1.921 . . . . 63.11 113.358 -173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -151.34 140.48 21.21 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.748 -0.66 . . . . 75.2 109.313 170.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -138.22 131.6 30.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.014 0.925 . . . . 72.01 108.9 176.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 24.4 tm0? -142.47 134.36 27.08 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.728 -1.212 . . . . 74.23 107.728 178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 tt -97.3 118.37 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 32.51 109.874 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -90.18 -53.56 4.41 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.692 0.282 . . . . 74.33 110.973 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.492 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 43.8 ttt180 -161.17 141.04 10.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.412 -0.358 . . . . 74.43 110.57 -169.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.6 mt -115.8 143.64 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 107.96 -1.126 . . . . 74.44 107.96 171.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.426 ' HE1' HG13 ' B' ' 83' ' ' ILE . 32.9 p90 -168.9 158.22 8.64 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.356 0.598 . . . . 75.45 111.553 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.2 m -83.89 127.82 34.11 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.248 -0.887 . . . . 75.1 108.648 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.499 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.1 mtpt -96.09 -41.2 8.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.165 0.586 . . . . 71.32 109.713 177.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.7 t70 -147.42 139.29 24.19 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.851 -0.613 . . . . 71.01 110.597 -168.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.442 HD12 HG22 ' B' ' 78' ' ' VAL . 42.2 mm -138.07 137.92 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.81 1.244 . . . . 53.02 108.811 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -138.8 125.09 20.31 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.05 -1.092 . . . . 55.22 108.05 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 84.6 t80 -137.59 108.05 6.52 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.17 -1.419 . . . . 60.21 107.17 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -121.81 117.83 27.52 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 108.438 -0.949 . . . . 75.4 108.438 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.823 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -112.82 87.89 10.81 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 123.796 0.838 . . . . 75.0 109.504 -176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.88 -38.24 10.2 Favored 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 123.075 2.517 . . . . 74.54 112.736 -174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.43 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 66.1 m-20 -111.74 29.07 8.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.445 0.698 . . . . 74.21 109.622 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.823 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.12 -54.58 23.66 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.787 1.235 . . . . 74.53 113.107 172.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 5.6 Cg_exo -76.22 -19.17 15.63 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.036 1.824 . . . . 64.32 111.754 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.43 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 80.7 m-70 -85.43 3.03 41.97 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.312 1.045 . . . . 71.15 111.408 -174.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.407 HG13 ' OH ' ' F' ' 197' ' ' TYR . 9.7 p -69.45 -14.94 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.298 0 CA-C-O 121.419 0.628 . . . . 70.41 109.736 163.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -70.58 -28.77 65.14 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.754 0.821 . . . . 72.21 109.832 171.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -84.62 -39.7 18.36 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.314 0.646 . . . . 73.0 109.609 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -102.51 75.23 1.44 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.292 1.037 . . . . 62.33 109.955 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -78.49 76.44 5.0 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.824 0.849 . . . . 73.43 110.648 -174.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -163.7 160.32 22.52 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.762 0.825 . . . . 74.12 109.403 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -69.84 118.61 64.8 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.208 1.003 . . . . 74.22 109.518 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.76 152.0 82.82 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.176 1.918 . . . . 55.11 113.026 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.24 119.06 13.87 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.473 -0.785 . . . . 71.54 109.033 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.6 t -85.01 119.66 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 107.466 -1.309 . . . . 73.12 107.466 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -134.73 138.59 44.5 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 -176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' B' ' 128' ' ' LEU . 0.0 OUTLIER -128.57 166.42 18.87 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.783 0.833 . . . . 71.35 111.542 -176.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 121.24 1.55 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.423 -0.954 . . . . 71.12 108.423 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.1 163.74 21.81 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.361 0.6 . . . . 63.13 110.724 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -161.06 135.89 7.44 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.477 1.111 . . . . 74.13 108.447 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 21.7 m -108.65 119.68 40.24 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.843 0.354 . . . . 74.41 110.376 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -116.48 159.26 22.31 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.141 0.976 . . . . 73.01 108.711 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.497 ' HB3' ' HE1' ' B' ' 56' ' ' TYR . 73.9 m -144.39 162.69 35.84 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 122.178 -0.326 . . . . 71.22 111.464 -177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 13.1 t -157.12 137.9 13.28 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.078 0.951 . . . . 71.4 109.62 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -105.51 131.07 53.37 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.338 -0.616 . . . . 64.44 109.338 173.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 39.3 mt -98.36 -41.75 7.68 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.455 0.645 . . . . 73.44 109.472 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.84 10.87 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 114.596 -1.184 . . . . 63.25 109.358 176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -76.57 134.17 39.47 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.878 -1.055 . . . . 70.51 108.414 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 73.3 -3.63 2.41 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.934 1.294 . . . . 62.45 111.811 -174.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 91.6 t -124.54 95.13 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.298 1.039 . . . . 71.35 108.354 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.497 ' HE1' ' HB3' ' B' ' 48' ' ' SER . 8.4 t80 -113.83 139.54 49.07 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.012 0.434 . . . . 72.32 110.623 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -121.85 108.4 13.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.873 0.869 . . . . 75.14 109.488 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.6 t -94.1 132.86 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.033 0.533 . . . . 34.12 110.093 -173.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 40.8 t -104.14 116.94 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.308 0.643 . . . . 73.43 109.838 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -94.1 115.77 28.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.876 -0.787 . . . . 64.35 108.876 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -102.16 123.75 46.55 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.955 0.407 . . . . 61.23 110.419 171.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 75.0 t -117.07 108.3 24.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.686 -1.227 . . . . 72.02 107.686 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.5 m -97.84 146.54 25.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.326 -0.62 . . . . 74.21 109.326 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.531 HG21 HG21 ' B' ' 114' ' ' ILE . 72.5 t -132.58 136.34 56.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 124.464 1.106 . . . . 72.43 109.578 -171.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.4 m -125.39 149.5 48.1 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.426 1.09 . . . . 53.32 109.012 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.46 161.76 37.22 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.214 0.606 . . . . 72.41 110.359 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.4 p -148.48 147.42 29.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.595 0.591 . . . . 63.44 112.595 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.425 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 44.5 mt -124.19 107.06 10.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 106.689 -1.597 . . . . 72.11 106.689 172.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -111.39 3.46 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 119.285 -0.731 . . . . 71.45 111.347 -171.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -117.18 3.24 12.66 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.901 0.85 . . . . 62.31 111.665 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pm0 -114.25 167.19 10.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.708 0.403 . . . . 71.24 110.402 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 11.4 m -64.88 144.03 57.54 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.324 0.65 . . . . 61.44 110.467 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.425 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -100.69 -58.77 1.83 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.374 -0.973 . . . . 41.41 108.374 173.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -150.92 166.38 30.78 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 113.833 -1.53 . . . . 75.12 109.276 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.9 mt -134.91 140.37 45.7 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.428 -1.323 . . . . 72.22 107.428 174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.498 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.1 t -140.82 159.96 41.08 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.575 0.75 . . . . 74.33 109.146 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -165.33 137.45 4.21 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.942 0.897 . . . . 72.01 108.601 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.442 HG22 HD12 ' B' ' 21' ' ' ILE . 77.3 t -128.64 141.03 47.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.45 0.7 . . . . 73.03 109.179 174.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.1 mt-30 -124.63 91.61 3.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 72.5 108.992 174.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.434 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.0 tp-100 -89.15 102.17 14.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.875 -1.057 . . . . 60.31 108.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.499 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -96.57 142.82 16.36 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.775 -0.53 . . . . 44.1 111.775 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.74 128.43 4.44 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 111.407 -0.677 . . . . 43.4 111.407 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.426 HG13 ' HE1' ' B' ' 17' ' ' TYR . 44.7 mt -83.29 126.89 40.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 N-CA-C 108.72 -0.844 . . . . 74.23 108.72 177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -135.18 135.48 41.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.249 0.619 . . . . 74.55 109.623 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 20.2 m -87.43 100.46 12.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.033 -1.099 . . . . 61.2 108.033 170.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.6 122.34 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.709 0.804 . . . . 74.12 109.63 -170.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.22 172.33 18.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.13 0.972 . . . . 62.33 111.097 -176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -28.12 6.65 Favored Glycine 0 C--N 1.357 1.708 0 CA-C-N 116.046 -0.525 . . . . 75.01 112.832 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.4 HD11 ' O ' ' F' ' 173' ' ' LEU . 0.2 OUTLIER -56.93 157.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.039 1.336 . . . . 63.21 113.451 -175.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -161.32 143.15 11.83 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.535 -0.757 . . . . 72.32 109.866 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.49 -93.42 0.03 OUTLIER Glycine 0 C--N 1.362 1.979 0 O-C-N 124.324 1.015 . . . . 23.24 113.912 169.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.2 m -64.16 -52.85 57.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.369 1.068 . . . . 73.44 110.604 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -67.55 -29.17 68.49 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.443 0.697 . . . . 60.34 111.505 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 52.8 tpp -67.02 -50.08 63.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.745 0.418 . . . . 63.14 110.495 175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.31 -30.47 64.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.6 0.76 . . . . 71.04 111.834 -177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -78.69 -55.17 5.39 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.72 0.408 . . . . 71.04 110.024 -177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 42.8 t -69.35 -66.73 0.55 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.647 0.592 . . . . 75.42 110.819 -172.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.648 ' HB3' HD11 ' F' ' 177' ' ' LEU . 2.9 tt -71.3 -26.74 62.98 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.751 0.421 . . . . 65.25 110.277 -173.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.01 -39.06 13.65 Favored Glycine 0 C--N 1.353 1.476 0 N-CA-C 114.976 0.751 . . . . 72.12 114.976 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.62 -46.88 1.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 117.718 0.759 . . . . 72.05 112.059 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.487 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 88.2 t80 -64.61 -54.35 33.32 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.554 0.741 . . . . 71.02 112.607 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.471 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.3 m -61.6 -46.82 93.87 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 123.476 0.71 . . . . 72.52 111.424 -178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.2 Cg_exo -58.04 -36.98 97.61 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 121.843 1.696 . . . . 74.44 113.873 167.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -72.16 -21.18 61.48 Favored 'General case' 0 N--CA 1.5 2.052 0 C-N-CA 122.872 0.469 . . . . 75.43 111.463 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.469 HG23 ' NH2' ' D' ' 111' ' ' ARG . 56.9 mt -64.2 -45.0 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.641 0.776 . . . . 72.41 109.901 167.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 28.2 mt -84.4 -11.02 57.02 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.319 -1.31 . . . . 75.3 111.37 -173.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.498 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 63.4 t80 -63.26 -45.49 85.09 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 125.023 1.329 . . . . 74.45 113.934 -172.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.27 -36.05 81.64 Favored 'Trans proline' 0 C--N 1.374 1.878 0 CA-C-N 121.226 1.473 . . . . 64.35 112.657 173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.434 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.2 m-85 -65.6 -40.5 92.74 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.969 0.508 . . . . 74.13 110.764 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -47.94 72.02 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.847 0.459 . . . . 61.52 110.266 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -51.35 -49.21 61.89 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.67 1.188 . . . . 71.24 111.369 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.04 -38.97 79.43 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.632 -1.167 . . . . 74.42 109.898 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -71.28 -34.18 70.43 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.91 -0.586 . . . . 74.01 111.33 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.531 HG21 HG21 ' B' ' 64' ' ' VAL . 73.2 mt -67.54 -52.85 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 122.854 0.462 . . . . 61.33 109.766 176.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.4 HG23 HE21 ' C' ' 125' ' ' GLN . 24.4 m -53.36 -33.11 52.35 Favored 'General case' 0 CA--C 1.552 1.041 0 O-C-N 123.941 0.775 . . . . 63.22 111.401 177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.0 t -65.8 -62.74 1.33 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.308 0.643 . . . . 62.32 110.648 172.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.52 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.8 mmt -61.25 -33.3 73.3 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 123.346 0.658 . . . . 65.31 112.449 -171.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 80.5 t -76.96 -39.85 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.604 0.762 . . . . 74.03 110.693 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.494 ' HB3' HE22 ' C' ' 125' ' ' GLN . 91.3 p -66.39 -28.94 69.03 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.474 0.654 . . . . 44.25 111.15 176.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.52 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 84.2 mtt-85 -61.86 -31.78 72.07 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.523 -0.762 . . . . 74.24 110.205 174.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.551 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.58 12.85 58.04 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-O 119.425 -0.653 . . . . 73.5 114.145 174.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 17' ' ' TYR . 15.0 p 61.63 21.27 11.99 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 126.01 1.724 . . . . 64.33 111.965 -174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -105.08 159.66 28.63 Favored Pre-proline 0 CA--C 1.567 1.624 0 C-N-CA 123.801 0.84 . . . . 63.21 110.738 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.71 156.85 64.38 Favored 'Trans proline' 0 C--N 1.392 2.848 0 C-N-CA 123.814 3.009 . . . . 63.51 115.541 -169.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' C' ' 125' ' ' GLN . 5.1 pm0 -63.06 156.81 23.75 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.741 0.816 . . . . 72.22 112.709 -179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.8 96.8 6.49 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.334 -0.987 . . . . 75.15 108.334 163.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -89.08 93.55 9.63 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.196 -2.15 . . . . 64.31 105.196 165.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.601 ' HG ' ' HG ' ' B' ' 42' ' ' LEU . 1.8 tt -81.44 135.79 35.65 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.101 -0.703 . . . . 73.44 109.101 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.436 ' HB1' HD11 ' E' ' 204' ' ' ILE . . . -59.74 132.86 89.1 Favored Pre-proline 0 CA--C 1.538 0.507 0 O-C-N 124.067 0.855 . . . . 73.35 111.512 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.99 81.19 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.701 0 C-N-CA 122.498 2.132 . . . . 75.2 111.471 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -78.21 75.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.279 -0.873 . . . . 74.35 110.34 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -74.11 84.84 1.83 Allowed 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.482 -0.781 . . . . 65.31 109.013 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.546 ' HA ' HD23 ' B' ' 136' ' ' LEU . 8.3 t80 -78.75 -6.19 55.22 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.478 -0.783 . . . . 63.42 111.063 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -53.28 -44.4 68.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.671 1.188 . . . . 73.44 111.014 170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.42 -33.06 69.26 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.203 1.001 . . . . 73.35 112.242 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.605 HD21 HG22 ' E' ' 207' ' ' VAL . 3.3 mm? -75.66 -38.92 58.41 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.513 0.725 . . . . 64.32 110.07 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.44 -29.51 68.18 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.967 0.507 . . . . 34.43 111.184 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 92.8 mmm -65.75 -36.93 84.97 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.822 0.449 . . . . 74.45 111.457 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -100.72 -30.03 11.95 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.442 0.464 . . . . 74.03 112.154 -168.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -73.73 -45.3 52.88 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.852 -0.425 . . . . 73.02 109.852 176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -92.49 21.36 5.42 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.299 0.64 . . . . 52.54 110.905 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -74.35 93.05 2.35 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.887 0.875 . . . . 74.51 109.901 178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -154.53 147.75 24.85 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.288 -0.869 . . . . 72.31 109.109 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -104.18 101.57 11.3 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.491 0.663 . . . . 71.54 109.727 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.436 ' HA ' ' HG3' ' B' ' 1' ' ' MET . . . -153.23 83.76 1.2 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.659 -0.7 . . . . 64.04 109.793 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.58 141.85 10.43 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.012 -0.835 . . . . 74.51 111.012 -178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.69 144.07 26.84 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.252 0.621 . . . . 74.51 109.756 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.18 135.29 17.3 Favored Glycine 0 C--N 1.338 0.659 0 O-C-N 123.764 0.665 . . . . 74.14 111.916 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -148.83 127.81 12.71 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.695 -0.854 . . . . 74.21 108.695 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.4 tm-20 -76.82 -82.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.515 -0.92 . . . . 64.44 108.515 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 60.36 162.66 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.943 1.297 . . . . 64.52 113.175 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -122.82 140.0 53.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.118 -0.946 . . . . 74.22 108.87 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.71 107.65 1.23 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.84 -0.8 . . . . 73.42 108.84 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -118.36 136.72 53.57 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.111 0.964 . . . . 74.52 109.013 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 C-N-CA 123.821 0.848 . . . . 43.35 109.232 -179.278 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' C' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.756 0.313 . . . . 45.11 111.043 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.8 p -149.27 44.54 0.96 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 123.306 0.642 . . . . 74.3 110.609 -174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.1 155.11 43.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.66 0.784 . . . . 75.34 110.586 -174.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -100.17 -55.43 2.62 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.671 0.788 . . . . 74.32 110.206 -173.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 56.8 77.96 0.24 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.745 1.218 . . . . 72.41 110.751 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -87.49 -82.2 0.22 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.284 -0.871 . . . . 72.32 109.969 -176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.3 m -155.19 93.14 1.49 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.333 0.653 . . . . 73.43 110.087 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -134.11 121.56 21.64 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 107.808 -1.182 . . . . 63.53 107.808 168.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.5 ttp 62.55 142.24 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 O-C-N 124.738 1.274 . . . . 75.43 112.039 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 41.6 m -127.88 101.54 6.38 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.843 -0.799 . . . . 34.15 108.843 172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' H' ' 206' ' ' ASP . 71.9 t80 -124.64 135.42 53.06 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.408 1.083 . . . . 70.53 108.352 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.581 ' HB3' ' HB3' ' C' ' 85' ' ' SER . 46.2 tt0 -146.35 105.28 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.09 0.556 . . . . 75.45 110.243 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.503 HD11 HD11 ' C' ' 16' ' ' ILE . 14.5 tt -72.14 129.91 35.47 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.43 0.692 . . . . 74.43 109.623 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.439 ' NE2' HE21 ' C' ' 12' ' ' GLN . 22.9 mm-40 -115.9 -49.16 2.72 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.919 0.487 . . . . 71.53 111.878 -172.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -162.13 133.18 5.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.493 -0.558 . . . . 73.32 109.493 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.503 HD11 HD11 ' C' ' 13' ' ' ILE . 64.0 mt -123.14 138.35 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.583 -0.895 . . . . 74.41 108.583 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.433 ' HB3' HG23 ' D' ' 122' ' ' THR . 26.3 p90 -174.73 162.75 3.34 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.806 0.336 . . . . 74.43 111.612 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.8 p -81.52 125.76 30.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.483 0.713 . . . . 72.23 110.064 175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -75.57 -49.1 19.62 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.184 -1.043 . . . . 73.15 108.184 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -136.81 147.15 46.42 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.24 -1.345 . . . . 74.2 110.428 -172.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.5 mt -143.44 145.47 22.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 C-N-CA 126.19 1.796 . . . . 63.43 106.622 176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -161.03 149.25 15.9 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.256 0.551 . . . . 70.44 110.465 172.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' D' ' 21' ' ' ILE . 85.7 t80 -149.41 118.25 6.66 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 107.327 -1.36 . . . . 72.11 107.327 173.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -117.19 122.61 44.52 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.06 -0.719 . . . . 63.0 109.06 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.44 80.86 46.36 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 108.054 -1.091 . . . . 43.14 108.054 167.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.6 -26.43 16.5 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.207 1.938 . . . . 74.2 110.525 173.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -88.22 16.16 6.6 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.587 1.155 . . . . 60.1 110.759 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.11 99.99 Favored Pre-proline 0 CA--C 1.566 1.561 0 N-CA-C 113.649 0.981 . . . . 65.03 113.649 -177.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -80.44 -26.5 3.99 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 121.79 1.66 . . . . 72.24 112.699 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 56.3 t60 -70.18 -33.47 71.78 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.383 1.073 . . . . 64.33 111.841 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.455 HG23 HD11 ' C' ' 68' ' ' LEU . 13.2 p -79.69 -18.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 124.447 1.099 . . . . 72.12 111.401 -178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -58.85 -28.44 66.07 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.293 1.037 . . . . 72.41 112.154 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -127.79 44.43 2.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.77 0.828 . . . . 54.23 109.86 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -121.26 159.75 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.665 0.786 . . . . 62.21 110.389 -174.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -63.16 120.32 11.25 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 123.709 0.63 . . . . 75.25 110.236 173.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.2 p90 -85.28 97.43 9.94 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 122.072 0.939 . . . . 75.24 109.905 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -140.56 62.57 19.05 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.417 -0.957 . . . . 74.55 108.417 174.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' C' ' 67' ' ' SER . 14.8 Cg_exo -69.47 97.98 0.64 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.858 1.705 . . . . 64.44 112.282 -175.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -85.89 77.6 9.67 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 113.57 -1.65 . . . . 75.4 107.494 174.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' C' ' 126' ' ' LEU . 19.6 m -89.84 110.73 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.005 0 CA-C-N 113.687 -1.597 . . . . 72.11 110.36 -170.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -133.09 147.07 52.15 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.843 0.857 . . . . 60.31 110.948 -171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.517 ' HG ' HD12 ' C' ' 128' ' ' LEU . 1.5 pp -105.38 165.73 10.92 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.356 0.598 . . . . 71.41 112.103 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -140.91 130.78 24.4 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.262 1.425 . . . . 71.44 107.531 174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 55.8 tp -100.95 118.43 36.95 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.247 0.619 . . . . 75.33 110.265 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 35.7 t70 -115.14 155.97 26.13 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.304 -0.999 . . . . 64.44 108.304 166.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -134.49 140.72 46.41 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.438 0.695 . . . . 74.25 110.29 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.3 38.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.29 1.036 . . . . 70.34 109.253 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.7 p -155.3 148.88 25.2 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.49 0.716 . . . . 61.15 109.274 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 38.3 t -144.86 128.29 16.93 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.635 0.774 . . . . 75.33 109.153 -174.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -82.75 117.11 22.43 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.992 -0.744 . . . . 64.32 108.992 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' C' ' 57' ' ' GLU . 79.6 mt -92.48 -32.61 14.82 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.464 0.706 . . . . 72.23 110.368 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.34 -179.82 8.46 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.134 -0.939 . . . . 74.12 109.229 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.17 127.29 32.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.553 -0.749 . . . . 71.25 108.996 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 62.97 18.29 10.75 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.477 1.111 . . . . 74.01 112.461 -174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.28 115.16 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.568 -0.901 . . . . 60.13 108.568 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -116.16 169.57 9.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.055 0.931 . . . . 75.3 110.844 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.9 tt0 -127.45 133.24 49.94 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 112.924 -1.944 . . . . 61.34 107.99 173.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.42 127.89 72.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 107.101 -1.444 . . . . 72.45 107.101 170.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.5 HG22 ' HA2' ' C' ' 81' ' ' GLY . 61.7 t -126.46 114.23 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 109.234 -0.654 . . . . 70.54 109.234 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' C' ' 103' ' ' PRO . 18.6 mt -86.6 130.53 34.45 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.585 -0.524 . . . . 64.34 109.585 172.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.597 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 49.1 mtp180 -101.45 104.27 15.21 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.197 -1.038 . . . . 73.43 108.197 170.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 t -105.59 110.42 31.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.475 -1.305 . . . . 74.23 107.475 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -110.85 145.65 37.86 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.842 -0.799 . . . . 74.03 108.842 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.795 HG11 ' HG ' ' C' ' 126' ' ' LEU . 53.3 t -128.58 135.26 62.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 123.899 0.88 . . . . 65.54 109.224 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -117.92 138.11 52.37 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 107.989 -1.115 . . . . 73.52 107.989 170.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.99 132.79 55.13 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 108.269 -1.012 . . . . 44.54 108.269 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.7 m -132.96 164.21 27.48 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.833 0.708 . . . . 64.44 109.262 -179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.455 HD11 HG23 ' C' ' 31' ' ' VAL . 14.4 mt -124.04 29.08 6.56 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 106.926 -1.509 . . . . 74.33 106.926 177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.82 -100.76 1.73 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.082 -0.963 . . . . 74.54 110.85 -169.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -89.67 -32.51 17.02 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.392 0.677 . . . . 71.24 110.107 176.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.65 120.84 32.05 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.616 0.766 . . . . 71.14 109.454 -172.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 39.2 m -67.65 140.47 56.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.89 0.476 . . . . 74.34 111.026 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.43 -51.41 4.99 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 122.803 0.441 . . . . 64.21 109.931 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -168.5 177.27 5.34 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.944 0.898 . . . . 70.22 111.299 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.476 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -137.04 147.34 46.13 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.086 1.354 . . . . 73.14 107.391 175.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.476 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.0 t -148.99 153.48 37.99 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.349 0.66 . . . . 71.14 109.395 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -158.82 140.96 13.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.458 0.703 . . . . 71.11 109.905 172.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -131.98 119.26 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 123.714 0.806 . . . . 74.52 109.531 171.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.597 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 47.8 mt-30 -91.14 98.4 11.72 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.052 0.941 . . . . 64.33 109.623 172.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.473 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.2 tp-100 -88.78 107.82 19.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.617 0.767 . . . . 71.31 110.615 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.5 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -84.07 158.72 35.02 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.77 0.669 . . . . 75.4 113.041 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.64 117.29 0.77 Allowed Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.481 -0.648 . . . . 33.23 111.481 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.457 HD12 ' CD1' ' C' ' 51' ' ' LEU . 15.0 mm -81.81 122.47 36.75 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 N-CA-C 109.34 -0.615 . . . . 62.22 109.34 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -135.71 119.23 16.95 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.682 0.793 . . . . 75.23 109.149 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.581 ' HB3' ' HB3' ' C' ' 12' ' ' GLN . 41.1 t -77.08 128.0 33.68 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.765 -0.828 . . . . 72.14 108.765 170.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.469 HD11 HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -145.99 126.9 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 123.501 0.72 . . . . 64.34 110.433 -166.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.85 176.19 11.11 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.591 1.157 . . . . 72.22 110.176 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -50.96 4.0 Favored Glycine 0 N--CA 1.48 1.626 0 CA-C-O 121.295 0.386 . . . . 62.04 113.257 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.631 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.1 OUTLIER -64.83 156.34 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.448 1.499 . . . . 51.5 113.76 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -145.99 148.04 32.32 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.586 0.755 . . . . 74.3 109.24 171.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.38 -109.19 2.32 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 124.065 0.853 . . . . 35.11 114.345 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.646 HG21 ' HB3' ' C' ' 143' ' ' GLN . 56.6 p -53.99 -49.03 69.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.863 1.265 . . . . 71.32 112.731 -175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 47.2 mt-30 -63.97 -46.62 83.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.122 0.569 . . . . 71.5 111.587 -176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.631 ' HB3' HG12 ' C' ' 89' ' ' ILE . 19.7 ptm -68.95 -37.22 78.7 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.053 0.221 . . . . 74.35 111.454 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.66 -33.74 75.53 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.286 0.634 . . . . 65.2 111.185 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.475 ' HE1' ' HA ' ' C' ' 138' ' ' MET . 4.1 t60 -75.8 -33.56 60.14 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.75 -0.659 . . . . 74.51 109.97 176.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 18.8 t -66.77 -60.97 2.21 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 123.559 0.744 . . . . 75.01 111.279 -173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.552 HD13 ' HB3' ' E' ' 175' ' ' PHE . 1.4 pt? -77.22 -18.43 57.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 122.173 -0.33 . . . . 71.23 111.275 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.11 -25.83 61.13 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 116.115 -0.493 . . . . 51.51 113.892 -173.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.03 -43.2 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.518 0.933 . . . . 61.15 113.518 -172.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -63.71 -65.27 0.7 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.26 0.624 . . . . 74.11 111.751 -172.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 15.1 m -60.53 -43.1 91.65 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 123.827 0.851 . . . . 75.11 112.259 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.523 ' HB3' HD21 ' C' ' 60' ' ' LEU . 98.0 Cg_exo -51.02 -47.24 26.6 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.597 2.198 . . . . 74.24 114.771 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -69.05 -21.98 64.06 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 122.579 0.352 . . . . 74.4 111.485 -173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.5 mm -60.58 -45.53 97.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.563 0.745 . . . . 72.21 109.855 168.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 40.7 mt -85.8 -22.73 27.51 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.828 -1.078 . . . . 70.2 112.456 -170.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -52.88 -52.34 65.82 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-O 118.016 -0.992 . . . . 74.24 113.465 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.51 -31.88 70.93 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 121.599 1.532 . . . . 73.0 113.55 -178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -65.79 -47.88 73.62 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.04 0.536 . . . . 75.33 110.606 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.39 -41.9 96.41 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.444 0.698 . . . . 63.23 111.057 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -59.04 -50.13 75.27 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.687 1.195 . . . . 74.14 110.664 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.5 -33.96 76.16 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.517 0.727 . . . . 72.3 110.289 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.13 -36.21 74.63 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 122.688 0.395 . . . . 62.33 111.654 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -69.81 -43.36 79.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 109.578 -0.527 . . . . 74.11 109.578 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.705 HG23 ' HB2' ' C' ' 125' ' ' GLN . 52.8 m -55.22 -38.62 68.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.255 1.022 . . . . 61.23 110.715 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -67.77 -53.65 25.52 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.638 -1.165 . . . . 50.22 110.272 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.717 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.1 OUTLIER -49.79 -45.4 49.79 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 124.845 1.258 . . . . 73.42 112.921 -177.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.42 HG21 HD23 ' C' ' 126' ' ' LEU . 92.7 t -72.01 -40.66 67.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 CA-C-N 115.748 -0.66 . . . . 74.5 111.346 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.2 t -61.83 -31.88 72.16 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.365 -0.834 . . . . 61.35 111.208 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.495 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 74.6 mtt-85 -66.53 -34.99 79.14 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.866 0.866 . . . . 53.34 110.25 175.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.52 11.8 37.09 Favored Glycine 0 C--N 1.352 1.471 0 O-C-N 123.744 0.652 . . . . 75.33 113.687 175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.582 HG23 ' HB3' ' D' ' 17' ' ' TYR . 44.7 p 59.81 27.58 16.91 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.949 1.699 . . . . 74.44 112.617 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -109.05 167.85 8.55 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 124.246 1.018 . . . . 73.15 110.704 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -56.78 118.12 4.92 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 123.255 2.637 . . . . 75.31 112.551 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.705 ' HB2' HG23 ' C' ' 115' ' ' THR . 3.6 pt20 -51.59 143.57 12.17 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 124.051 0.844 . . . . 74.54 111.709 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.795 ' HG ' HG11 ' C' ' 64' ' ' VAL . 2.5 mm? -97.58 59.66 1.53 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 122.726 1.25 . . . . 61.43 110.453 -177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.534 HD21 ' HA ' ' B' ' 122' ' ' THR . 32.1 t30 -95.61 83.85 3.85 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 112.927 -1.942 . . . . 75.44 107.414 172.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.517 HD12 ' HG ' ' C' ' 42' ' ' LEU . 21.7 mt -90.73 154.41 19.56 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-N 115.198 -0.91 . . . . 75.33 110.241 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.54 ' HB3' HD13 ' E' ' 187' ' ' ILE . . . -35.71 135.36 0.5 Allowed Pre-proline 0 N--CA 1.49 1.551 0 C-N-CA 126.201 1.8 . . . . 73.45 115.107 -176.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.77 93.73 0.44 Allowed 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.636 2.224 . . . . 72.04 111.504 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 m -81.89 106.7 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 CA-C-O 121.955 0.883 . . . . 64.21 111.759 -174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.48 71.69 0.75 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.773 0.829 . . . . 74.04 109.63 176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -64.52 -29.12 70.16 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 115.974 -0.557 . . . . 71.53 111.085 176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' C' ' 138' ' ' MET . 36.0 t70 -59.44 -23.44 62.7 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.491 0.716 . . . . 75.33 112.598 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.57 -32.77 63.29 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 121.042 0.449 . . . . 44.23 111.607 175.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 65.6 mt -79.23 -42.73 25.29 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.975 0.91 . . . . 75.43 110.001 175.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.402 ' HB2' ' HA ' ' C' ' 134' ' ' ASP . 40.7 m-85 -70.4 -14.88 62.74 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.234 1.013 . . . . 73.31 112.684 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.475 ' HA ' ' HE1' ' C' ' 96' ' ' HIS . 89.6 mtp -61.97 -47.38 85.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.23 -0.655 . . . . 75.13 109.23 171.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -64.6 -36.83 85.51 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.99 0.916 . . . . 75.12 111.083 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -62.78 -82.09 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.911 0.885 . . . . 74.21 111.214 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 18.3 tp -84.82 87.29 7.31 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 123.371 0.668 . . . . 64.34 111.464 -167.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -129.97 120.46 24.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.665 1.186 . . . . 74.24 110.248 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.646 ' HB3' HG21 ' C' ' 92' ' ' THR . 52.5 tt0 -174.83 82.46 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.774 0.83 . . . . 74.42 109.232 171.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 139' ' ' ASN . 0.6 OUTLIER -173.18 128.97 0.46 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.925 0.89 . . . . 63.22 110.331 -175.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.403 ' HB2' HE22 ' A' ' 143' ' ' GLN . . . -162.63 84.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.215 0.606 . . . . 53.25 110.071 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.64 92.94 0.91 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.617 -0.593 . . . . 52.32 111.617 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -103.9 143.08 33.32 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.15 0.58 . . . . 72.13 110.548 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.73 119.72 3.1 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 115.835 -0.62 . . . . 73.01 111.892 175.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 54.4 p -93.88 129.6 40.24 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.162 0.585 . . . . 64.24 109.937 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -87.71 126.85 35.21 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.461 0.704 . . . . 74.33 110.328 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -81.99 174.04 11.63 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.029 0.532 . . . . 75.23 111.503 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -150.24 122.78 8.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.573 0.749 . . . . 64.44 110.037 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -64.18 135.63 56.48 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.387 -0.597 . . . . 70.35 109.387 168.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -148.28 -66.61 0.24 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.884 0.311 . . . . 73.31 111.053 -171.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.408 0 C-N-CA 123.343 0.657 . . . . 64.12 109.431 -179.002 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.624 0.25 . . . . 62.11 110.853 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' E' ' 206' ' ' ASP . 18.1 m -81.46 15.99 1.85 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.245 0.831 . . . . 71.31 113.245 -170.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.74 -42.12 16.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.757 0.823 . . . . 73.0 110.666 -177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -77.23 139.75 39.93 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.443 -0.799 . . . . 73.12 110.736 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -77.79 69.06 3.97 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.309 1.043 . . . . 73.34 109.34 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -153.15 179.51 8.66 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.608 1.163 . . . . 72.32 108.557 -170.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m 80.51 -67.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.834 1.654 . . . . 75.45 111.057 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.489 ' HG2' ' H ' ' D' ' 9' ' ' MET . 21.1 tt0 -172.99 -170.93 0.69 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.513 0.725 . . . . 71.11 109.301 -176.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.489 ' H ' ' HG2' ' D' ' 8' ' ' GLU . 6.7 ttp -29.76 135.37 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.509 1.524 . . . . 64.01 113.032 161.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.1 m -107.34 140.63 39.96 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.158 -0.682 . . . . 74.21 109.158 171.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.402 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 40.5 t80 -152.28 97.82 2.33 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 106.477 -1.675 . . . . 64.42 106.477 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.581 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 75.8 mt-30 -112.25 118.32 34.98 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.746 0.419 . . . . 53.13 110.814 -173.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -84.5 103.14 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 107.926 -1.139 . . . . 64.32 107.926 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -83.96 -50.06 8.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.581 0.173 . . . . 73.21 111.405 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -170.8 134.04 0.99 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.767 0.427 . . . . 75.43 110.479 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.23 130.66 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 N-CA-C 107.855 -1.165 . . . . 72.34 107.855 173.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.582 ' HB3' HG23 ' C' ' 122' ' ' THR . 33.5 p90 -149.3 149.97 31.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.358 0.663 . . . . 73.25 111.895 -176.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.6 p -77.71 114.66 16.78 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.669 -0.696 . . . . 75.21 109.75 174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -86.06 -20.25 29.06 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.915 0.486 . . . . 63.1 110.059 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.8 t70 -153.55 140.24 18.96 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.72 -1.127 . . . . 54.01 109.594 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.717 HD13 ' HE3' ' C' ' 117' ' ' MET . 96.3 mt -136.67 144.72 31.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.844 0 C-N-CA 125.189 1.396 . . . . 73.23 107.554 174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -154.76 133.62 12.22 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 123.959 0.787 . . . . 73.15 109.507 169.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.5 t80 -132.48 126.8 33.83 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.283 -1.747 . . . . 74.41 106.283 165.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -121.63 142.75 49.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.03 -1.1 . . . . 74.21 108.03 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.574 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -138.42 76.71 36.5 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 106.374 -1.713 . . . . 54.32 106.374 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.19 -34.15 28.83 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.822 2.348 . . . . 65.44 112.783 -169.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.457 ' O ' HG23 ' D' ' 31' ' ' VAL . 41.2 m-20 -116.13 23.3 12.28 Favored 'General case' 0 C--O 1.214 -0.799 0 C-N-CA 124.091 0.956 . . . . 55.22 110.294 -174.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.574 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -46.28 -50.47 38.55 Favored Pre-proline 0 CA--C 1.567 1.631 0 N-CA-C 116.462 2.023 . . . . 53.41 116.462 -167.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -80.86 -15.98 10.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 CA-C-N 122.137 1.799 . . . . 70.41 113.319 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -75.16 -26.87 59.42 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.668 1.187 . . . . 63.21 109.782 170.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 27' ' ' ASN . 70.4 t -80.02 -13.27 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.919 0.888 . . . . 52.43 110.648 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.46 -25.41 67.49 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.561 0.345 . . . . 71.32 110.543 168.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -77.12 -7.48 55.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.502 0.721 . . . . 72.12 111.411 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -110.89 92.0 3.88 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.077 0.951 . . . . 75.53 109.478 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -97.41 77.76 2.65 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.097 0.559 . . . . 71.12 109.885 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 t90 -165.01 172.37 12.81 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.886 0.474 . . . . 72.23 110.141 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.423 ' HG2' ' H ' ' H' ' 192' ' ' GLY . 28.7 tp60 -60.19 116.09 16.02 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 124.512 1.125 . . . . 74.24 110.965 172.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.75 123.94 12.43 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.026 1.817 . . . . 55.4 110.884 172.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -57.85 110.94 1.0 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 172.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.15 105.87 19.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.397 -0.819 . . . . 63.51 109.139 -174.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.9 115.42 29.6 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 106.524 -1.658 . . . . 74.53 106.524 177.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.22 155.88 16.55 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.161 0.584 . . . . 61.12 109.972 -176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -149.47 132.28 16.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.131 0.572 . . . . 61.42 109.726 174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.9 mp -112.06 137.04 50.64 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.834 0.854 . . . . 74.32 109.655 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.633 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 3.8 t70 -133.57 154.84 50.55 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.931 1.292 . . . . 63.24 108.06 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 45.3 m -137.19 146.33 44.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.161 0.585 . . . . 75.23 110.294 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.05 167.03 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.389 1.075 . . . . 62.42 108.891 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -164.71 155.75 14.9 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.968 0.507 . . . . 75.33 110.844 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 49.1 p -158.75 132.99 7.85 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 65.23 109.323 177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -69.44 133.8 48.19 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.391 0.676 . . . . 71.52 110.541 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' D' ' 57' ' ' GLU . 38.6 mt -102.16 -40.52 6.77 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.43 0.692 . . . . 75.4 110.31 176.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.98 -169.48 2.54 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.257 0.623 . . . . 65.12 111.222 -172.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.71 111.48 1.64 Allowed 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.241 -0.89 . . . . 61.44 110.648 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.799 ' H ' HD21 ' H' ' 173' ' ' LEU . 20.0 m-20 75.89 5.29 3.86 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.485 1.514 . . . . 72.31 110.739 173.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.4 t -108.57 121.19 61.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 123.216 0.606 . . . . 75.12 110.299 -175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.39 130.22 53.48 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.707 -1.22 . . . . 75.14 107.707 171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.482 ' HB2' HD11 ' D' ' 51' ' ' LEU . 5.4 tm-20 -88.48 131.48 34.88 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.104 -1.813 . . . . 62.44 106.104 166.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.69 129.86 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 N-CA-C 108.416 -0.957 . . . . 63.5 108.416 -173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 61.8 t -108.97 135.11 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.409 0.684 . . . . 74.34 110.604 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.533 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -115.74 124.08 49.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 106.789 -1.56 . . . . 74.13 106.789 171.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.633 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -106.77 99.6 9.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.72 -0.844 . . . . 71.31 108.72 177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.7 t -91.87 122.52 43.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.136 -1.061 . . . . 74.43 108.136 171.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 29.7 m -121.43 134.37 55.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.357 -0.838 . . . . 50.51 109.635 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' D' ' 114' ' ' ILE . 86.2 t -124.58 102.77 11.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 123.79 0.836 . . . . 54.3 109.275 -177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -101.47 108.02 19.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.513 -0.921 . . . . 54.4 108.513 173.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.94 139.05 44.33 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.999 0.919 . . . . 54.03 109.131 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 79.2 p -143.39 138.93 29.74 Favored 'General case' 0 N--CA 1.461 0.089 0 C-N-CA 123.077 0.551 . . . . 73.21 110.338 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -115.72 111.27 20.32 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.203 1.001 . . . . 74.25 109.656 175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.6 -132.03 10.94 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.517 0.511 . . . . 64.35 112.626 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 4.05 49.39 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.88 0.872 . . . . 73.2 110.95 175.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -131.32 147.87 52.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.513 0.725 . . . . 63.43 110.591 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -64.72 138.06 58.17 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.25 1.02 . . . . 50.11 111.277 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.45 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.11 -59.55 2.07 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.556 -0.905 . . . . 54.41 108.556 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -164.24 153.85 14.1 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.807 -1.088 . . . . 62.41 109.951 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 53.3 mt -113.41 154.47 26.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.249 1.019 . . . . 65.21 108.982 176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.564 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.2 t -158.58 147.05 18.54 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.526 0.33 . . . . 74.44 110.436 174.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -154.52 121.31 5.51 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.896 0.878 . . . . 74.35 109.042 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 95.1 t -124.49 116.07 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 122.987 0.515 . . . . 75.53 109.846 177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.726 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -90.11 87.85 7.04 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.638 0.732 . . . . 73.43 109.282 170.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.28 100.39 8.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 114.138 -1.392 . . . . 75.32 109.178 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.42 169.87 38.18 Favored Glycine 0 CA--C 1.529 0.936 0 N-CA-C 112.158 -0.377 . . . . 72.01 112.158 175.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.65 137.6 4.7 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 112.558 -0.217 . . . . 72.31 112.558 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.27 125.31 42.29 Favored 'Isoleucine or valine' 0 C--O 1.246 0.92 0 C-N-CA 123.676 0.79 . . . . 72.14 109.653 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -129.07 142.63 50.84 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.654 0.782 . . . . 75.24 110.299 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 31.0 m -105.93 99.34 8.94 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.801 0.84 . . . . 54.03 108.796 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -105.69 138.4 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.423 1.089 . . . . 73.33 109.386 -176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.25 162.3 12.67 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.049 0.54 . . . . 54.44 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 7.51 85.06 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.979 -0.555 . . . . 72.4 113.665 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.485 HG23 ' HG3' ' D' ' 9' ' ' MET . 0.2 OUTLIER -126.74 169.04 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.501 0.72 . . . . 74.21 110.83 178.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -160.59 162.12 32.74 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.992 0.917 . . . . 72.43 109.54 -176.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.67 -140.73 48.04 Favored Glycine 0 C--N 1.35 1.321 0 O-C-N 123.831 0.707 . . . . 72.45 114.035 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -62.22 -24.25 67.12 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.194 0.998 . . . . 72.43 111.909 -172.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -61.47 -50.77 71.41 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.258 -0.645 . . . . 64.14 109.258 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.753 ' SD ' ' HG2' ' H' ' 174' ' ' MET . 5.3 ptm -66.4 -34.53 78.16 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.487 0.492 . . . . 75.44 110.507 -176.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.17 -34.47 75.0 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.38 0.61 . . . . 55.24 111.294 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -69.32 -49.94 51.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.539 1.135 . . . . 74.1 110.658 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.1 t -73.93 -38.39 64.29 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.848 -0.614 . . . . 74.41 111.672 -173.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.523 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.6 tp -84.93 -29.67 24.96 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.353 0.661 . . . . 63.14 110.454 -176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.32 -27.58 39.4 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.855 -0.611 . . . . 74.51 113.346 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.98 -61.17 1.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 117.102 0.451 . . . . 74.14 111.705 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.33 -40.86 97.74 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 113.056 0.761 . . . . 74.54 113.056 -173.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.523 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 74.1 m -68.35 -47.4 37.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 CA-C-O 118.95 -0.547 . . . . 65.45 112.104 -177.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.533 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.9 Cg_exo -59.45 -32.91 97.18 Favored 'Trans proline' 0 C--N 1.382 2.292 0 C-N-CA 121.844 1.696 . . . . 61.31 113.267 168.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -64.38 -24.93 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.122 0.569 . . . . 73.04 111.717 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -70.41 -44.95 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.44 -0.578 . . . . 75.43 109.44 171.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' D' ' 60' ' ' LEU . 51.4 mt -70.86 -26.06 63.09 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.33 -0.85 . . . . 63.23 111.528 -175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -62.03 -44.9 91.06 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 115.076 1.51 . . . . 73.35 115.076 -166.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.72 -35.01 95.93 Favored 'Trans proline' 0 C--N 1.381 2.282 0 CA-C-N 122.039 1.764 . . . . 74.41 113.032 174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -76.44 -35.38 58.53 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.708 0.803 . . . . 74.51 110.482 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.06 -48.38 71.2 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.585 0.754 . . . . 52.31 110.025 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.469 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.9 ttp180 -56.52 -50.33 72.13 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-N 113.97 -1.468 . . . . 72.12 110.869 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.27 -45.44 94.49 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.085 0.866 . . . . 74.41 111.091 -176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.472 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.9 t -57.17 -39.83 76.08 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.801 0.688 . . . . 71.14 111.05 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.564 HG23 ' SG ' ' D' ' 76' ' ' CYS . 76.6 mt -68.72 -56.98 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.465 0.706 . . . . 61.41 109.847 174.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.2 m -49.46 -45.27 46.52 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.921 1.289 . . . . 64.05 111.923 -173.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 46.4 t -64.56 -45.52 86.74 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.893 -1.049 . . . . 75.52 110.258 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.6 mtm -63.22 -36.8 84.86 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.428 0.691 . . . . 70.15 111.801 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -66.88 -45.16 88.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 115.55 -0.75 . . . . 75.33 109.784 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -71.29 -27.23 63.27 Favored 'General case' 0 CA--C 1.554 1.107 0 CA-C-N 116.302 -0.408 . . . . 71.43 110.69 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -69.98 -30.95 68.42 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.79 0.836 . . . . 74.33 109.643 171.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 8.74 63.95 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 123.818 0.698 . . . . 73.3 113.165 174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.433 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.4 p 54.12 39.77 31.0 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.838 1.655 . . . . 72.15 112.313 -178.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.538 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 38.9 m-85 -110.65 167.95 8.31 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.605 1.162 . . . . 74.53 108.861 175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.21 155.84 62.91 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 122.392 2.061 . . . . 62.22 112.564 -173.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -72.78 123.24 22.95 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.226 -0.657 . . . . 45.12 109.226 172.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -103.18 105.83 16.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.489 -0.93 . . . . 74.35 108.489 174.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 91.4 m-20 -97.6 88.86 4.47 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.915 -1.143 . . . . 42.41 107.915 176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.55 HD12 ' HE1' ' G' ' 202' ' ' TYR . 26.3 tp -71.19 119.87 15.95 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.431 -0.804 . . . . 73.34 109.664 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.99 88.12 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.085 0.954 . . . . 72.42 112.288 -171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -84.32 106.8 1.18 Allowed 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.157 1.905 . . . . 65.0 110.796 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -107.06 109.95 30.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 N-CA-C 108.371 -0.974 . . . . 63.51 108.371 -176.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -79.85 79.25 6.39 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.415 -0.957 . . . . 73.03 108.415 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.91 -21.02 60.97 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 114.807 -1.088 . . . . 74.13 109.393 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -52.92 -35.99 59.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.774 1.23 . . . . 72.2 110.736 172.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.71 -36.58 81.33 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.072 0.949 . . . . 62.42 112.854 -176.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.42 -48.57 79.08 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.405 0.622 . . . . 74.12 110.228 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -73.2 -30.13 63.31 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.892 -1.049 . . . . 72.03 110.519 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 39.7 ttm -55.85 -37.95 69.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.65 1.18 . . . . 64.21 110.877 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -55.82 -46.28 78.14 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.151 0.907 . . . . 75.52 111.116 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -69.82 -38.03 76.44 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.267 0.627 . . . . 75.1 111.315 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.3 -32.17 72.97 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.132 0.573 . . . . 72.12 111.523 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -91.16 2.06 56.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.01 0.524 . . . . 72.15 111.59 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -125.12 64.12 1.15 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.791 0.805 . . . . 74.42 108.857 -178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -168.51 -167.07 0.74 Allowed 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.335 -1.302 . . . . 65.15 109.418 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.3 97.21 0.18 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.434 0.694 . . . . 73.22 111.007 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.81 40.34 0.1 OUTLIER Glycine 0 C--N 1.339 0.73 0 N-CA-C 110.582 -1.007 . . . . 73.33 110.582 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -99.33 121.94 41.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.586 1.154 . . . . 74.44 110.065 -174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.02 49.13 0.02 OUTLIER Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.815 -0.914 . . . . 71.11 110.815 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 40.9 p -61.36 95.55 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.943 0.897 . . . . 63.02 111.798 -173.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -75.64 95.63 3.41 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.49 -0.929 . . . . 73.34 108.49 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -55.41 -62.28 1.78 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.51 1.124 . . . . 71.34 111.588 -173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -142.39 139.55 31.73 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.5 0.667 . . . . 70.02 111.414 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -121.97 173.12 7.73 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.03 1.332 . . . . 71.02 107.774 169.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.5 100.78 0.53 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 110.152 -0.314 . . . . 54.03 110.152 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.209 1.004 . . . . 55.45 108.637 -178.736 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.814 -0.439 . . . . 71.33 109.814 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . 0.478 ' HA3' ' SD ' ' E' ' 174' ' ' MET . . . -76.32 70.48 2.14 Favored Glycine 0 C--N 1.354 1.58 0 N-CA-C 112.338 -0.305 . . . . 61.23 112.338 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.09 -52.34 65.75 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.618 1.167 . . . . 72.43 110.896 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 35.8 m -144.49 -44.84 0.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.762 0.825 . . . . 75.41 109.044 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.01 -171.14 3.44 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.317 -0.856 . . . . 53.25 110.288 170.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.419 HD23 ' O ' ' C' ' 89' ' ' ILE . 67.2 mt 68.54 -70.35 0.13 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.079 1.352 . . . . 72.52 109.341 -172.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.478 ' SD ' ' HA3' ' E' ' 169' ' ' GLY . 0.0 OUTLIER -69.03 124.13 22.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.857 0.863 . . . . 73.24 110.279 174.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.552 ' HB3' HD13 ' C' ' 98' ' ' LEU . 32.0 m-85 -62.06 98.04 0.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.908 0.883 . . . . 72.41 111.547 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -74.66 85.14 2.11 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.936 -1.135 . . . . 73.24 107.936 169.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 55.8 tp -104.37 100.65 10.36 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.654 0.782 . . . . 74.12 109.254 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -75.7 -75.47 0.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.861 0.464 . . . . 74.01 109.888 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . 0.481 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 29.3 tt0 178.38 -60.1 0.0 OUTLIER Pre-proline 0 CA--C 1.559 1.305 0 C-N-CA 125.101 1.36 . . . . 71.21 109.53 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 98.6 Cg_endo -82.49 102.51 1.17 Allowed 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.581 1.52 . . . . 73.42 112.504 -173.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -131.45 -71.28 0.56 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.297 -1.001 . . . . 64.03 108.297 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -168.19 138.81 2.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.978 0.911 . . . . 75.55 109.229 176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 54.1 m -122.47 133.51 54.6 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.222 -0.658 . . . . 71.51 109.222 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -80.03 127.65 76.3 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.415 0.686 . . . . 74.42 110.396 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -87.3 98.51 0.47 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.555 2.17 . . . . 72.0 110.936 169.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 mp -75.52 174.22 9.95 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.737 -0.665 . . . . 71.4 111.114 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.566 HD12 ' HA2' ' F' ' 200' ' ' GLY . 21.3 pt -52.29 132.94 14.33 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.245 1.018 . . . . 73.2 111.684 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -59.56 -47.25 86.3 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.705 0.802 . . . . 51.23 111.564 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' F' ' 200' ' ' GLY . . . 65.52 11.19 7.24 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.649 1.18 . . . . 64.24 113.462 172.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.54 152.68 37.74 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.714 0.806 . . . . 74.52 110.699 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 66.99 -162.95 45.45 Favored Glycine 0 C--N 1.344 1.002 0 O-C-N 123.561 0.538 . . . . 64.31 113.632 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' F' ' 194' ' ' ALA . . . 127.51 -65.45 0.57 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 115.122 -0.539 . . . . 52.32 113.017 172.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . 0.439 ' HB3' ' CD1' ' F' ' 193' ' ' TYR . 80.3 m-85 69.36 52.76 0.45 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.121 0.969 . . . . 71.44 108.948 -160.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' F' ' 201' ' ' LYS . . . -69.93 -2.19 11.74 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 112.85 0.685 . . . . 75.31 112.85 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -146.35 132.1 18.97 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.463 0.705 . . . . 74.44 109.821 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . 0.466 ' HG3' ' HA2' ' F' ' 192' ' ' GLY . 46.4 mtpt -86.96 138.1 31.81 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.496 -1.298 . . . . 73.51 107.496 164.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -142.08 36.62 1.56 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 106.97 -1.492 . . . . 64.15 106.97 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -82.2 -24.4 34.93 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 112.805 -1.998 . . . . 52.2 111.142 -172.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -138.93 169.35 17.95 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.284 -0.871 . . . . 73.32 111.119 -169.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -71.79 91.67 0.51 Allowed Glycine 0 C--N 1.346 1.088 0 N-CA-C 110.736 -0.945 . . . . 41.43 110.736 169.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' F' ' 190' ' ' ASP . 18.8 ptmt -116.23 11.67 15.2 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.954 0.902 . . . . 74.15 111.465 -173.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -161.87 39.09 0.13 Allowed 'General case' 0 CA--C 1.556 1.208 0 CA-C-O 121.823 0.82 . . . . 55.32 110.518 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -125.96 141.33 52.02 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.923 -0.769 . . . . 74.43 108.923 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.436 HD11 ' HB1' ' B' ' 129' ' ' ALA . 3.1 mp -89.89 -60.28 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.995 -1.113 . . . . 71.51 107.995 176.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 78.14 -27.51 0.17 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.727 1.211 . . . . 73.44 112.572 168.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' D' ' 2' ' ' SER . 3.9 m-20 -86.88 -13.73 44.0 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.72 -0.612 . . . . 65.54 110.798 164.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.605 HG22 HD21 ' B' ' 136' ' ' LEU . 95.0 t . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 107.094 -1.447 . . . . 65.03 107.094 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.754 0.787 . . . . 63.24 110.41 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -142.8 149.44 21.31 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 111.09 -0.804 . . . . 72.22 111.09 178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -101.85 128.51 48.19 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.813 0.845 . . . . 74.04 109.559 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 19.9 m 65.9 18.41 11.08 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.565 1.146 . . . . 74.3 113.282 172.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . 0.483 ' HB2' HD22 ' F' ' 176' ' ' ASN . . . -89.04 92.18 9.12 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.893 0.477 . . . . 35.5 111.726 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.4 ' O ' HD11 ' B' ' 89' ' ' ILE . 3.9 tt -155.72 -70.99 0.11 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 107.853 -1.166 . . . . 60.33 107.853 170.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 18.9 mmt -94.02 80.36 4.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.925 -0.398 . . . . 64.31 109.925 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 67.1 t80 66.82 114.89 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.433 1.493 . . . . 71.35 111.821 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . 0.483 HD22 ' HB2' ' F' ' 172' ' ' ALA . 66.1 t30 -151.87 44.91 0.75 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.252 1.025 . . . . 64.53 109.212 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' B' ' 98' ' ' LEU . 6.5 mp -80.65 -59.19 2.78 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.505 -1.295 . . . . 72.15 107.505 172.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . 0.557 ' HG2' ' HG3' ' F' ' 179' ' ' GLU . 36.4 tt0 66.07 -74.56 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.583 1.553 . . . . 70.11 111.5 175.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . 0.557 ' HG3' ' HG2' ' F' ' 178' ' ' GLN . 34.9 mt-10 -109.02 131.58 21.71 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.135 0.974 . . . . 74.44 109.005 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.18 111.6 2.06 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.431 2.088 . . . . 70.34 110.527 175.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -65.71 -43.31 89.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.04 0.536 . . . . 65.15 111.401 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -136.06 156.72 48.31 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.056 0.543 . . . . 74.03 109.934 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 42.6 p -117.64 130.1 56.16 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.065 0.946 . . . . 75.33 109.003 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -67.94 140.25 93.64 Favored Pre-proline 0 N--CA 1.484 1.231 0 C-N-CA 122.678 0.391 . . . . 74.31 110.714 175.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.26 109.52 2.23 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.221 1.948 . . . . 73.24 111.984 175.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.67 150.72 46.7 Favored 'General case' 0 CA--C 1.552 1.019 0 CA-C-N 115.236 -0.893 . . . . 74.51 110.592 176.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 31.3 pt -86.42 160.9 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.403 0.681 . . . . 65.5 111.074 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.77 68.34 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 116.058 -0.519 . . . . 64.42 111.021 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . 62.05 156.11 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.273 1.429 . . . . 73.13 112.203 -174.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . 0.455 ' HB3' ' HE3' ' E' ' 201' ' ' LYS . 29.7 t70 -167.01 147.08 5.52 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 116.218 -0.446 . . . . 55.14 110.455 -171.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -98.76 -124.12 5.04 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 116.399 -0.364 . . . . 55.4 113.468 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . 0.466 ' HA2' ' HG3' ' E' ' 196' ' ' LYS . . . -147.16 177.32 25.52 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 123.061 0.362 . . . . 62.33 113.009 -173.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . 0.439 ' CD1' ' HB3' ' E' ' 193' ' ' TYR . 63.7 m-85 -83.76 -35.72 24.15 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.067 0.547 . . . . 75.24 110.848 -178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' E' ' 192' ' ' GLY . . . -96.44 153.3 17.91 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 113.98 1.104 . . . . 63.51 113.98 -168.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -175.78 -96.5 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 105.775 -1.935 . . . . 70.33 105.775 170.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt 62.06 7.75 2.28 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.307 1.595 . . . . 70.33 115.307 157.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . 0.407 ' OH ' HG13 ' B' ' 31' ' ' VAL . 17.3 m-85 59.79 83.55 0.13 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.783 1.233 . . . . 74.31 112.358 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . 0.454 ' HG2' ' H ' ' F' ' 199' ' ' ASN . 22.7 tt0 -149.1 168.76 22.32 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.645 0.778 . . . . 72.23 109.932 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . 0.454 ' H ' ' HG2' ' F' ' 198' ' ' GLU . 31.9 m-80 -63.69 111.38 2.38 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.067 0.947 . . . . 73.41 110.946 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . 0.566 ' HA2' HD12 ' E' ' 187' ' ' ILE . . . 104.64 -170.91 18.72 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.815 -0.63 . . . . 70.22 112.626 177.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.417 ' HG3' ' HB2' ' E' ' 194' ' ' ALA . 2.7 mppt? 62.39 -159.5 0.32 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.04 0.936 . . . . 65.51 110.626 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -73.06 -7.59 51.97 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 120.958 0.408 . . . . 73.12 110.978 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -98.9 -173.76 2.6 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.125 0.97 . . . . 64.42 110.818 -174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 12.3 tt -142.43 149.18 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.691 1.196 . . . . 74.41 109.293 -175.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -153.65 139.07 17.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 122.973 0.509 . . . . 74.52 110.197 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 11.6 t70 71.35 -92.0 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.534 1.534 . . . . 71.01 111.577 172.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.261 1.71 0 C-N-CA 123.885 0.874 . . . . 62.32 109.874 179.161 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 62.3 tttp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.284 -0.265 . . . . 74.31 110.284 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.51 -76.74 0.78 Allowed Glycine 0 C--N 1.357 1.74 0 O-C-N 123.563 0.54 . . . . 62.13 111.822 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -74.04 169.18 18.02 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.922 0.889 . . . . 62.2 109.995 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 52.0 m 64.04 87.76 0.11 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.569 1.147 . . . . 62.03 110.348 -170.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -169.44 -162.33 0.34 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.338 1.455 . . . . 61.14 108.855 -175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 73.86 -66.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.906 1.682 . . . . 73.14 110.874 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 18.6 mmt -122.26 106.9 11.53 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.27 1.028 . . . . 62.32 108.658 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 65.58 173.05 0.22 Allowed 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.676 1.235 . . . . 70.42 112.222 -174.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 64.91 139.39 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.693 1.597 . . . . 71.24 113.14 176.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -146.32 143.3 29.03 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 106.484 -1.672 . . . . 72.35 106.484 174.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . 0.553 HE21 ' HG3' ' G' ' 179' ' ' GLU . 19.6 tp60 -66.26 -85.06 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.815 -0.439 . . . . 72.22 109.815 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.553 ' HG3' HE21 ' G' ' 178' ' ' GLN . 49.7 mt-10 -153.17 154.61 31.07 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.179 0.992 . . . . 71.3 108.912 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.53 101.06 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.078 1.852 . . . . 65.53 111.441 167.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -67.61 -20.44 65.36 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.56 0.695 . . . . 74.32 109.82 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -91.35 -175.88 4.38 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.432 -1.258 . . . . 63.04 109.603 173.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . 0.52 HG23 ' HD3' ' G' ' 185' ' ' PRO . 8.2 t -125.63 174.9 7.95 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 109.274 -0.639 . . . . 75.4 109.274 172.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -145.25 86.95 7.3 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.6 -0.889 . . . . 75.21 108.6 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . 0.52 ' HD3' HG23 ' G' ' 183' ' ' THR . 58.3 Cg_endo -71.11 104.84 1.59 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.841 2.361 . . . . 71.24 112.127 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 91.2 mt -78.78 115.98 18.83 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.743 -0.662 . . . . 72.41 109.479 174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.489 HD12 ' HB3' ' A' ' 129' ' ' ALA . 0.2 OUTLIER -60.52 163.0 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.507 0.723 . . . . 71.3 111.06 173.013 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -125.36 150.91 46.76 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.299 0.639 . . . . 42.55 110.528 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -73.01 114.64 11.39 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.79 0.436 . . . . 64.31 109.847 176.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -55.41 -61.52 2.28 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.019 0.824 . . . . 72.12 111.498 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 173.71 147.49 6.0 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-O 119.928 -0.373 . . . . 71.3 112.762 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.43 -151.86 26.5 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.875 -0.49 . . . . 22.32 111.875 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -155.07 -82.85 0.07 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.704 0.802 . . . . 71.03 109.169 177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -174.09 108.54 0.14 Allowed 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.113 0.965 . . . . 72.11 108.631 -173.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -84.33 112.77 20.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 106.981 -1.488 . . . . 72.42 106.981 178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -68.77 90.21 0.41 Allowed 'General case' 0 CA--C 1.545 0.766 0 O-C-N 123.909 0.755 . . . . 74.2 112.463 -164.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -91.12 105.82 18.08 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.738 -1.119 . . . . 55.32 110.408 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.57 133.25 5.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.191 -1.411 . . . . 71.24 107.191 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -84.0 -32.27 25.04 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.05 0.54 . . . . 74.11 110.836 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 74.56 -85.19 0.74 Allowed Glycine 0 C--N 1.345 1.054 0 N-CA-C 109.429 -1.468 . . . . 75.41 109.429 -166.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . 0.52 ' HE3' ' O ' ' G' ' 203' ' ' ASP . 36.5 ttpt -173.43 -22.46 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.572 1.149 . . . . 65.22 110.07 171.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . 0.55 ' HE1' HD12 ' D' ' 128' ' ' LEU . 13.6 t80 70.98 48.43 0.38 Allowed 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.589 1.555 . . . . 74.43 109.44 -178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . 0.52 ' O ' ' HE3' ' G' ' 201' ' ' LYS . 27.1 t70 62.63 -87.37 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.605 1.562 . . . . 75.24 110.404 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.483 HD12 ' HG2' ' B' ' 12' ' ' GLN . 45.2 mt 48.74 88.93 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 125.309 1.444 . . . . 73.32 113.116 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' H' ' 186' ' ' LEU . 57.5 pttt -77.35 -179.75 5.91 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 115.217 -0.901 . . . . 55.43 109.683 168.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -64.01 -71.33 0.18 Allowed 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 123.578 0.751 . . . . 74.23 110.224 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.559 1.309 0 C-N-CA 124.985 1.314 . . . . 64.04 109.023 174.41 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.788 0.327 . . . . 73.31 110.664 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 137.96 -143.06 13.93 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.662 -0.975 . . . . 72.12 110.662 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -109.34 -30.39 8.0 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.817 0.847 . . . . 64.35 109.225 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 50.1 m 63.98 27.0 14.26 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.973 1.309 . . . . 65.14 111.615 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.37 75.74 10.2 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.816 0.847 . . . . 73.12 108.727 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.799 HD21 ' H ' ' D' ' 54' ' ' ASP . 4.1 mm? -109.82 81.66 1.47 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 122.05 0.929 . . . . 72.24 109.696 -178.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.753 ' HG2' ' SD ' ' D' ' 94' ' ' MET . 0.2 OUTLIER -110.3 166.32 11.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.938 -1.483 . . . . 74.04 108.071 171.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -161.82 88.49 0.7 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.443 -0.947 . . . . 73.04 108.443 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -102.97 92.48 4.58 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-O 122.24 1.019 . . . . 63.33 108.492 173.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.22 21.76 0.65 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 108.092 -1.077 . . . . 73.14 108.092 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -65.2 -26.14 68.01 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.281 1.033 . . . . 74.21 111.583 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -133.47 147.3 64.21 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.043 0.937 . . . . 53.4 109.807 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.33 101.35 1.11 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.129 1.886 . . . . 73.45 110.708 170.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -59.77 -35.01 73.74 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.595 0.758 . . . . 74.52 110.329 176.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.35 129.84 15.86 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.561 -1.2 . . . . 72.44 109.842 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -85.5 132.02 34.27 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.755 -0.831 . . . . 62.23 108.755 172.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -132.0 86.3 47.78 Favored Pre-proline 0 CA--C 1.559 1.289 0 C-N-CA 123.631 0.772 . . . . 71.21 111.111 -173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.98 115.31 3.99 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.753 2.302 . . . . 75.51 110.642 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . 0.479 ' O ' ' HE2' ' G' ' 205' ' ' LYS . 6.2 mp -67.85 -83.39 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.002 0.521 . . . . 74.21 111.066 -172.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.428 HG21 ' HA ' ' G' ' 204' ' ' ILE . 2.3 pp -150.83 177.15 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.569 0.748 . . . . 64.45 111.406 -176.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -118.85 -148.03 0.41 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.77 1.228 . . . . 51.13 107.747 171.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -153.68 141.89 20.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.458 0.703 . . . . 72.25 109.994 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -118.56 -178.04 3.44 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 109.27 -0.641 . . . . 73.03 109.27 171.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.22 -89.48 0.14 Allowed Glycine 0 C--N 1.339 0.716 0 N-CA-C 111.312 -0.715 . . . . 71.23 111.312 177.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . 0.423 ' H ' ' HG2' ' D' ' 37' ' ' GLN . . . 66.04 41.07 95.37 Favored Glycine 0 C--N 1.347 1.19 0 O-C-N 123.777 0.339 . . . . 65.41 113.281 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -99.92 148.41 24.51 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.214 0.606 . . . . 54.25 110.388 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -68.29 169.25 10.86 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.628 0.771 . . . . 75.33 110.028 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.436 ' HE2' ' HD3' ' D' ' 124' ' ' PRO . 3.2 m-30 -114.44 -55.07 2.53 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.665 0.386 . . . . 74.41 110.855 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt 62.24 79.44 0.26 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.123 1.369 . . . . 72.35 109.098 -173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -63.12 81.23 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 114.809 -1.087 . . . . 63.32 111.418 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -80.54 82.49 6.54 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.626 0.727 . . . . 74.25 109.368 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -90.27 -165.94 1.47 Allowed 'General case' 0 C--O 1.246 0.885 0 CA-C-N 114.801 -1.09 . . . . 74.22 111.454 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -74.43 73.41 1.37 Allowed Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.164 -0.774 . . . . 43.11 111.164 171.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -73.25 -12.33 60.82 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.993 0.917 . . . . 71.22 111.607 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -63.14 159.29 17.79 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.355 0.662 . . . . 74.33 111.089 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -86.31 124.33 32.56 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.917 -0.583 . . . . 75.33 109.879 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.506 ' HB ' ' HA ' ' C' ' 12' ' ' GLN . 3.4 mp -96.22 124.14 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 108.877 -0.786 . . . . 74.33 108.877 177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.1 118.74 34.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.964 -1.495 . . . . 74.4 106.964 170.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' C' ' 11' ' ' PHE . 2.0 p-10 -53.44 -44.84 69.17 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.021 0.928 . . . . 73.11 111.531 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 136' ' ' LEU . 7.3 p . . . . . 0 C--O 1.254 1.327 0 C-N-CA 123.782 0.833 . . . . 71.33 109.214 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mmt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 108.599 -0.889 . . . . 75.34 108.599 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 m -94.41 8.68 41.19 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.873 . . . . 73.51 111.837 -176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.535 ' HB3' HE22 ' A' ' 144' ' ' GLN . 2.6 mp0 -73.11 177.05 5.29 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.403 0.681 . . . . 71.55 111.122 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 65.64 15.47 10.06 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.253 1.021 . . . . 55.23 111.325 -175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -83.37 78.84 9.57 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.904 -1.147 . . . . 43.25 107.904 175.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -78.96 -15.36 58.39 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.393 -1.276 . . . . 73.34 111.26 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -83.63 -179.96 7.46 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.572 0.749 . . . . 73.33 109.987 172.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 88' ' ' GLY . 9.0 tp10 78.22 -54.39 0.49 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.362 1.465 . . . . 73.45 111.663 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.456 ' SD ' ' HB3' ' A' ' 93' ' ' GLN . 56.2 mtm -67.32 136.0 54.16 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.6 0.76 . . . . 63.42 111.952 -175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -146.2 128.88 16.17 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.2 1.4 . . . . 61.33 108.796 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 55.9 t80 -131.88 147.85 52.5 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.444 0.697 . . . . 64.33 110.436 -175.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 58.5 tp60 -145.44 134.05 22.14 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 123.67 0.606 . . . . 74.44 111.022 175.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.498 HD11 HG13 ' A' ' 16' ' ' ILE . 4.5 tp -92.76 128.93 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 124.011 0.924 . . . . 73.44 108.541 167.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -106.54 -41.87 5.16 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.463 0.305 . . . . 73.41 110.996 174.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -169.75 133.34 1.24 Allowed 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 119.747 -0.168 . . . . 71.15 111.212 -171.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.819 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 67.9 mt -113.1 139.08 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.206 1.003 . . . . 72.34 109.017 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 29.9 p90 -165.3 175.53 9.12 Favored 'General case' 0 C--N 1.347 0.471 0 O-C-N 124.008 0.818 . . . . 71.42 111.664 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.424 ' H ' ' HA2' ' B' ' 121' ' ' GLY . 75.8 p -100.71 118.99 37.94 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.37 -0.974 . . . . 75.23 108.37 170.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 25.0 mtpt -74.1 -34.37 63.92 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.011 -0.737 . . . . 75.34 109.011 171.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 29.8 t70 -145.03 141.87 29.27 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.257 -1.338 . . . . 53.51 110.241 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 77.8 mt -130.38 142.2 44.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 N-CA-C 106.772 -1.566 . . . . 50.43 106.772 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 138.28 21.06 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.395 0.678 . . . . 61.12 109.46 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.605 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.5 t80 -143.33 128.43 18.62 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.824 -1.547 . . . . 64.31 106.824 171.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -129.95 131.71 46.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.305 -0.628 . . . . 64.32 109.305 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.6 77.96 22.1 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 107.486 -1.301 . . . . 72.04 107.486 172.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -66.0 -35.57 33.87 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.798 2.332 . . . . 75.4 111.023 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 31' ' ' VAL . 87.9 m-20 -95.25 25.71 4.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.17 0.988 . . . . 74.21 110.889 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.44 -46.06 99.86 Favored Pre-proline 0 CA--C 1.563 1.452 0 C-N-CA 124.032 0.933 . . . . 74.12 112.221 174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.83 -31.18 32.34 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 121.675 1.583 . . . . 71.31 112.106 173.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.431 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 14.6 m-70 -65.38 -30.97 71.85 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.707 0.803 . . . . 73.41 111.405 -176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 27' ' ' ASN . 48.1 t -58.54 -26.43 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 122.929 0.492 . . . . 65.0 111.376 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -62.95 -39.63 95.22 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.059 0.544 . . . . 73.42 110.431 175.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -74.28 -37.09 63.78 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.219 1.008 . . . . 75.51 110.336 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 30' ' ' HIS . 0.7 OUTLIER -82.34 160.07 22.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 115.208 -0.905 . . . . 72.31 111.28 -174.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -80.42 141.54 35.2 Favored 'General case' 0 C--O 1.246 0.891 0 N-CA-C 108.266 -1.013 . . . . 72.24 108.266 167.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -79.93 82.69 5.97 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.203 0.525 . . . . 73.12 109.681 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.437 ' HG3' ' HA ' ' G' ' 193' ' ' TYR . 53.8 tt0 -132.73 72.91 76.91 Favored Pre-proline 0 C--O 1.244 0.774 0 N-CA-C 108.161 -1.052 . . . . 71.12 108.161 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 52.8 Cg_endo -83.05 157.77 15.33 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.563 2.175 . . . . 73.23 111.583 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -123.38 108.29 12.56 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.141 -1.059 . . . . 73.35 108.141 172.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.679 HG23 HG13 ' A' ' 64' ' ' VAL . 7.3 p -65.87 135.14 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 O-C-N 123.706 0.629 . . . . 72.42 111.64 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 47.6 mtpt -104.51 145.25 30.56 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.009 0.924 . . . . 74.1 108.731 167.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HB2' HD21 ' G' ' 186' ' ' LEU . 4.6 mp -123.28 105.86 10.22 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.788 -1.19 . . . . 65.01 107.788 179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.585 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 2.1 m-20 -115.88 102.76 9.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.766 -1.198 . . . . 61.51 107.766 173.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.6 mp -99.96 122.65 43.19 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 106.84 -1.541 . . . . 54.41 106.84 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -132.11 154.12 49.79 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.742 -0.836 . . . . 70.03 108.742 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -106.83 157.68 17.56 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.502 0.668 . . . . 63.35 110.55 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -149.98 143.94 25.52 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.681 -1.229 . . . . 55.5 107.681 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.467 ' HB3' ' HE1' ' A' ' 56' ' ' TYR . 54.3 m -130.1 152.09 49.92 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.95 0.5 . . . . 72.33 110.025 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -158.27 121.09 3.79 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.272 0.629 . . . . 43.12 109.62 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -80.65 109.26 15.02 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.458 -0.942 . . . . 75.12 108.458 174.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 74.4 mt -86.11 -41.11 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.113 0.565 . . . . 72.05 111.128 -175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -154.43 -172.11 4.09 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.689 0.796 . . . . 33.42 110.266 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -68.71 110.58 4.36 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.341 0.656 . . . . 71.13 109.455 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 69.58 0.43 2.95 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 125.226 1.41 . . . . 73.2 112.636 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 85.0 t -98.94 113.14 32.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 107.549 -1.278 . . . . 71.23 107.549 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.467 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 0.2 OUTLIER -116.96 169.74 9.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -129.99 121.98 27.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.552 -0.907 . . . . 74.54 108.552 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -104.17 120.95 55.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 106.536 -1.653 . . . . 71.41 106.536 168.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.693 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 41.6 t -108.36 132.24 56.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 N-CA-C 108.736 -0.839 . . . . 72.41 108.736 177.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 HD22 HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -102.96 111.21 23.44 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.205 -1.406 . . . . 70.13 107.205 177.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.86 98.4 8.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.864 -1.161 . . . . 74.53 107.864 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 60' ' ' LEU . 4.0 t -96.96 142.08 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.255 -1.017 . . . . 23.42 108.255 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.585 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.7 m -135.62 127.03 28.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.467 -0.938 . . . . 75.25 108.467 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.679 HG13 HG23 ' A' ' 40' ' ' VAL . 55.2 t -125.24 107.75 18.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.723 1.209 . . . . 75.34 109.275 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 41.2 m -107.34 137.27 45.7 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.798 0.439 . . . . 72.54 109.943 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -121.03 122.36 39.93 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 108.931 -0.766 . . . . 74.43 108.931 175.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.551 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 67.2 m -118.81 130.78 55.96 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.0 0.52 . . . . 50.03 110.574 173.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -87.79 69.58 9.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.432 1.493 . . . . 71.41 107.884 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -94.14 1.32 Allowed Glycine 0 C--N 1.343 0.95 0 CA-C-N 114.95 -1.023 . . . . 73.43 111.23 -172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.58 -25.98 14.24 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.726 0.81 . . . . 73.22 111.966 -174.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -111.81 128.19 56.04 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.115 0.566 . . . . 54.54 110.691 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -67.38 133.26 49.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.21 0.604 . . . . 72.34 111.294 176.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.25 -56.64 3.65 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.613 1.165 . . . . 45.34 109.669 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -148.75 172.41 14.66 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.599 -1.182 . . . . 74.41 111.124 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 23.6 tp -141.7 140.07 33.09 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.296 1.438 . . . . 53.34 107.733 176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.6 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 29.9 m -128.04 140.59 51.88 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.988 -1.116 . . . . 71.52 107.988 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -148.85 118.31 6.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.255 -0.646 . . . . 73.32 109.255 168.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.3 t -127.14 110.6 23.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 123.752 0.821 . . . . 53.03 109.322 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 52.5 mt-30 -86.15 81.06 8.58 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.717 -0.846 . . . . 75.21 108.717 172.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.15 94.91 4.15 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.031 -0.986 . . . . 61.01 108.419 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -105.13 146.6 16.1 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 112.179 -0.368 . . . . 53.54 112.179 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.39 141.99 12.92 Favored Glycine 0 C--O 1.24 0.522 0 N-CA-C 111.433 -0.667 . . . . 75.1 111.433 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.421 HG13 ' HE1' ' A' ' 17' ' ' TYR . 50.6 mt -81.55 123.88 38.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.966 0 N-CA-C 108.434 -0.95 . . . . 74.54 108.434 173.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.402 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 38.7 m-85 -134.6 120.28 19.4 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.17 0.588 . . . . 71.3 109.743 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.634 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 24.0 m -83.6 103.25 12.77 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 108.881 -0.785 . . . . 72.41 108.881 174.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.478 HD12 HD11 ' A' ' 89' ' ' ILE . 45.2 pt -109.14 138.97 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.559 0.744 . . . . 71.41 110.709 -176.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.5 153.79 33.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.206 -0.907 . . . . 72.3 109.344 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 8' ' ' GLU . . . 76.83 10.66 85.98 Favored Glycine 0 C--N 1.342 0.886 0 C-N-CA 121.305 -0.474 . . . . 74.55 114.239 174.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.48 ' HB ' ' HA ' ' A' ' 94' ' ' MET . 2.2 pp -107.37 130.09 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.513 -1.291 . . . . 64.44 107.513 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HG2' ' H ' ' G' ' 173' ' ' LEU . 43.7 mt-10 -153.34 168.29 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.699 -1.223 . . . . 74.53 107.699 -174.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 44.97 -117.85 2.41 Favored Glycine 0 CA--C 1.54 1.595 0 N-CA-C 114.73 0.652 . . . . 30.32 114.73 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 75.7 p -81.82 -27.22 33.74 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.013 0.925 . . . . 63.01 111.159 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.456 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 47.6 mt-30 -64.65 -36.11 83.2 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.808 0.843 . . . . 75.22 110.091 177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.48 ' HA ' ' HB ' ' A' ' 89' ' ' ILE . 59.0 ttm -69.05 -45.94 69.13 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.305 -0.861 . . . . 73.4 109.403 175.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.23 -26.79 68.95 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.286 -0.87 . . . . 62.43 112.228 -177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -70.53 -43.85 68.73 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.775 0.43 . . . . 75.53 110.315 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -70.46 -64.25 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 O-C-N 123.856 0.722 . . . . 65.01 110.981 -174.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.95 -19.76 60.57 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 112.149 0.425 . . . . 73.23 112.149 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.35 -35.15 8.16 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 114.23 0.452 . . . . 63.42 114.23 -170.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -137.03 -48.01 0.6 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.793 0.294 . . . . 74.05 111.793 -174.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.454 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.8 t80 -62.94 -61.44 2.39 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.407 0.683 . . . . 72.11 111.868 -170.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.551 ' HA ' HG12 ' A' ' 105' ' ' ILE . 77.6 m -67.09 -37.45 13.57 Favored Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 123.72 0.808 . . . . 62.23 112.937 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.06 -44.05 48.4 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.149 1.9 . . . . 71.13 113.269 162.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -69.84 -23.43 63.3 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 123.809 0.844 . . . . 71.34 111.664 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.551 HG12 ' HA ' ' A' ' 102' ' ' CYS . 32.3 mm -65.77 -40.89 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 108.944 -0.762 . . . . 72.04 108.944 171.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.31 -23.06 26.41 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.364 1.066 . . . . 74.11 112.768 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -66.08 -42.84 53.86 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 114.249 1.203 . . . . 63.33 114.249 -168.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -58.99 -34.56 99.2 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 121.938 1.758 . . . . 61.12 112.694 173.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -77.85 -39.0 44.84 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.761 0.825 . . . . 73.34 111.353 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.81 79.69 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.358 0.663 . . . . 75.13 109.548 175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.6 ttm180 -48.59 -55.8 10.17 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.89 1.369 . . . . 74.1 110.717 176.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.458 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.0 tm-20 -66.07 -38.94 89.57 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 124.247 0.967 . . . . 63.25 111.18 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.583 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.2 t -62.37 -34.55 76.91 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.221 0.608 . . . . 75.23 111.45 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.9 mt -76.6 -46.49 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.152 0.981 . . . . 65.04 110.534 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' HE2' ' C' ' 109' ' ' TYR . 99.2 m -57.04 -43.98 82.48 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.949 1.299 . . . . 72.11 111.373 -174.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 29.0 t -68.68 -32.12 71.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.43 -0.805 . . . . 74.45 111.686 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.605 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 70.7 mtm -69.97 -38.28 76.04 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.581 0.352 . . . . 72.12 110.604 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.0 t -65.78 -48.51 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.559 0.743 . . . . 73.12 110.885 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.701 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 77.6 p -63.37 -35.61 80.96 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.516 0.674 . . . . 63.41 111.219 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -72.71 -20.5 61.21 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.3 -1.318 . . . . 74.45 110.656 -176.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 16.39 37.87 Favored Glycine 0 C--N 1.358 1.757 0 CA-C-O 119.413 -0.659 . . . . 75.13 113.295 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.504 HG21 ' HE ' ' B' ' 15' ' ' ARG . 0.5 OUTLIER 78.65 8.07 2.15 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 127.088 2.155 . . . . 75.43 112.082 177.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 119' ' ' SER . 19.0 m-85 -99.48 162.82 19.99 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 123.395 0.678 . . . . 74.45 110.127 -173.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.98 125.93 13.18 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 121.857 1.704 . . . . 62.05 109.548 170.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.701 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 9.9 pt20 -61.72 147.54 45.77 Favored 'General case' 0 C--O 1.245 0.823 0 O-C-N 123.554 0.534 . . . . 72.5 111.058 -173.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 58.2 tp -121.77 113.0 19.07 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.984 -0.553 . . . . 71.32 110.118 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -110.72 111.68 23.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.388 -0.967 . . . . 65.21 108.388 174.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.67 HD21 HG21 ' A' ' 40' ' ' VAL . 86.7 mt -73.18 144.84 46.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.038 0.535 . . . . 64.43 110.284 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.38 153.64 75.36 Favored Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 123.788 0.835 . . . . 51.23 111.701 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -80.47 138.58 12.35 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 121.922 1.748 . . . . 51.23 111.847 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.521 HG11 ' HA ' ' G' ' 186' ' ' LEU . 5.8 m -103.45 112.44 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.485 -0.931 . . . . 63.52 108.485 171.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.71 69.9 0.91 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.466 0.651 . . . . 71.3 110.472 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.536 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 39.9 t80 -76.21 -23.53 54.62 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 115.687 -0.688 . . . . 72.55 110.007 173.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -60.54 -38.31 84.05 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.986 0.515 . . . . 63.23 109.821 174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.25 -56.8 6.49 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.56 1.144 . . . . 71.03 110.748 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.14 -30.07 70.78 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.391 -0.822 . . . . 71.42 112.345 -176.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -69.28 -57.03 5.86 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.66 0.784 . . . . 75.14 110.048 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -61.34 -34.14 74.79 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.86 0.464 . . . . 64.33 110.875 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -72.1 -35.67 69.25 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.22 1.008 . . . . 73.23 111.307 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.524 ' HD2' HD22 ' A' ' 141' ' ' LEU . 90.4 t80 -73.5 -60.27 2.33 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.34 0.656 . . . . 63.34 111.825 -174.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.524 HD22 ' HD2' ' A' ' 140' ' ' TYR . 4.4 mm? -54.12 -45.45 71.9 Favored 'General case' 0 N--CA 1.483 1.201 0 O-C-N 123.971 0.794 . . . . 74.24 112.159 -167.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -148.61 -14.02 0.33 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 112.821 0.674 . . . . 64.44 112.821 172.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.433 HE21 ' HG3' ' C' ' 3' ' ' GLU . 0.6 OUTLIER 61.08 96.77 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.329 -1.36 . . . . 74.11 107.329 -158.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.535 HE22 ' HB3' ' A' ' 3' ' ' GLU . 10.8 pt20 -145.91 153.76 41.19 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.893 -0.594 . . . . 72.21 110.649 -169.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.34 -178.49 5.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.207 1.003 . . . . 51.32 109.675 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.29 168.11 31.96 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.754 -0.203 . . . . 65.11 113.087 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' C' ' 141' ' ' LEU . 1.1 tm-20 -164.93 115.35 1.14 Allowed 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 107.027 -1.472 . . . . 74.31 107.027 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.72 89.95 0.33 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 112.144 -0.383 . . . . 72.15 112.144 -176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 p -80.36 153.83 28.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.401 0.68 . . . . 45.11 111.352 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -125.11 167.1 15.26 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.154 -1.054 . . . . 73.33 108.154 176.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -127.33 155.08 44.13 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 108.177 -1.046 . . . . 55.51 108.177 168.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -119.91 156.79 30.08 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 109.328 -0.619 . . . . 75.31 109.328 172.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -80.47 163.04 24.08 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.736 0.814 . . . . 72.31 109.665 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.87 157.12 12.98 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.097 0.959 . . . . 73.12 111.748 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 N-CA-C 108.518 -0.919 . . . . 74.41 108.518 176.157 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.886 -0.413 . . . . 65.25 109.886 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.516 ' HA ' HG21 ' B' ' 92' ' ' THR . 53.4 m -149.31 85.27 1.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.503 1.121 . . . . 74.34 108.568 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.93 -177.77 3.24 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.933 -1.03 . . . . 72.43 110.994 -172.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.507 ' NE2' ' HB3' ' B' ' 144' ' ' GLN . 88.6 mm-40 -75.82 110.07 9.94 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.414 -0.812 . . . . 72.31 110.599 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -119.24 -173.4 2.5 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.515 1.126 . . . . 72.3 109.102 174.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -159.83 94.96 1.16 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.362 -0.607 . . . . 75.15 109.362 172.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.403 HG21 ' HA ' ' B' ' 89' ' ' ILE . 72.4 p -119.3 121.9 40.66 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.284 0.634 . . . . 70.35 109.604 176.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.19 -37.06 64.02 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.774 0.83 . . . . 75.54 110.32 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 23.7 ptm 55.44 178.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 126.893 2.077 . . . . 75.13 116.091 165.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 24.7 m -148.35 139.0 22.86 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.722 -1.126 . . . . 74.35 108.567 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -143.44 123.45 13.59 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.469 0.708 . . . . 64.14 109.82 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.517 ' HG2' ' HA ' ' G' ' 205' ' ' LYS . 1.8 mp0 -127.5 141.77 51.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.647 1.179 . . . . 73.31 109.83 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.6 HG13 ' HD3' ' D' ' 130' ' ' PRO . 61.4 mt -93.04 129.56 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 108.018 -1.104 . . . . 73.44 108.018 166.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -89.39 -40.92 12.42 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.581 0.55 . . . . 62.22 110.69 173.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.504 ' HE ' HG21 ' A' ' 122' ' ' THR . 68.8 ttt180 -167.55 150.46 6.04 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.774 0.43 . . . . 73.02 110.546 -170.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.422 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 82.8 mt -132.11 145.42 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.998 -1.482 . . . . 73.35 106.998 172.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 36.1 p90 -170.62 162.21 7.85 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.685 0.394 . . . . 73.35 111.198 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 84.8 m -90.19 124.71 35.07 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.107 -0.701 . . . . 72.31 109.107 171.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.08 -45.19 11.63 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.899 -0.591 . . . . 64.45 109.505 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.516 ' HB3' HE21 ' B' ' 79' ' ' GLN . 19.4 t70 -148.92 146.05 27.7 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.889 -0.596 . . . . 74.34 111.807 -165.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 42.9 mm -138.35 150.01 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.463 1.505 . . . . 64.35 109.068 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -150.32 150.89 32.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.722 -0.672 . . . . 52.1 110.146 169.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 66.8 t80 -157.42 111.82 2.67 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 106.891 -1.522 . . . . 62.42 106.891 168.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -125.56 114.59 18.95 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.24 0.616 . . . . 73.13 109.471 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.707 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -107.05 91.54 6.62 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.445 0.698 . . . . 53.44 109.503 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -60.84 -29.81 88.9 Favored 'Trans proline' 0 C--N 1.383 2.366 0 C-N-CA 123.008 2.472 . . . . 61.25 112.62 -176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -121.45 31.27 6.38 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.873 0.869 . . . . 73.35 110.349 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.707 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -46.28 -55.59 13.31 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 125.115 1.366 . . . . 75.52 114.341 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.36 -13.91 10.82 Favored 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 121.751 1.634 . . . . 74.43 112.834 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -85.51 0.53 52.12 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.986 0.914 . . . . 72.45 111.841 -171.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 p -67.47 -18.08 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 C-N-CA 124.387 1.075 . . . . 63.25 111.008 170.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -64.55 -37.16 86.61 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.79 0.836 . . . . 64.44 110.825 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -85.85 -43.87 12.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.479 -0.782 . . . . 70.35 110.539 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 34' ' ' LYS . 23.9 mmtp -78.08 89.9 4.22 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.059 0.544 . . . . 70.43 109.989 177.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.403 ' HA ' ' CE2' ' F' ' 197' ' ' TYR . 12.0 p-10 -86.61 76.88 9.48 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.304 -0.862 . . . . 64.51 112.146 -171.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -173.1 161.85 4.42 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.572 -0.74 . . . . 64.32 110.281 170.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.469 ' HB2' ' HB2' ' F' ' 195' ' ' PHE . 34.4 tt0 -75.24 117.29 61.92 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.519 0.728 . . . . 73.02 109.329 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -61.4 151.5 79.09 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.7 2.267 . . . . 75.1 113.333 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.28 102.82 8.81 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.032 -0.985 . . . . 75.23 108.391 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.401 ' HB ' HD12 ' B' ' 126' ' ' LEU . 13.6 t -86.75 121.78 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 N-CA-C 108.807 -0.812 . . . . 63.02 108.807 -175.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -130.52 133.84 46.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.095 0.958 . . . . 74.42 108.724 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -111.35 149.24 31.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.393 -0.595 . . . . 62.2 109.393 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -135.51 135.96 40.84 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.016 0.926 . . . . 64.05 109.313 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 35.7 tp -99.29 146.76 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.813 0.845 . . . . 73.31 109.892 -175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.52 152.34 34.03 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.349 1.059 . . . . 61.44 108.275 177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.0 t -137.27 137.93 39.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.184 0.594 . . . . 74.11 109.408 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.82 151.89 51.37 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.828 1.251 . . . . 61.13 107.961 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 12.0 m -132.11 161.89 32.18 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.096 0.558 . . . . 51.35 110.246 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -163.44 155.8 17.99 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.681 1.192 . . . . 62.41 108.399 -176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.5 tt0 -124.4 132.72 53.53 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 109.567 -0.531 . . . . 74.33 109.567 171.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.1 mt -100.7 -31.73 11.07 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.602 0.761 . . . . 75.44 111.342 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.31 -172.08 3.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.654 0.781 . . . . 64.12 111.326 -172.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.36 107.19 1.56 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.034 -0.984 . . . . 72.44 111.119 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 61.0 16.41 7.0 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.651 1.181 . . . . 75.23 112.386 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 91.7 t -115.68 116.59 52.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 N-CA-C 107.157 -1.423 . . . . 62.31 107.157 174.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 11.0 p90 -123.92 179.12 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.321 0.649 . . . . 65.52 109.894 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -142.44 134.18 26.89 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.556 -0.905 . . . . 73.23 108.556 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.72 125.91 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 108.142 -1.059 . . . . 72.12 108.142 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.08 113.01 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.594 -0.891 . . . . 74.34 108.594 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -93.57 118.46 31.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.755 -0.831 . . . . 72.43 108.755 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 35.1 ttm180 -105.12 120.77 42.33 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.157 0.583 . . . . 71.21 109.83 173.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.451 HG23 HD22 ' B' ' 60' ' ' LEU . 48.4 t -116.53 110.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 107.734 -1.21 . . . . 60.54 107.734 167.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -106.65 128.39 54.13 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.02 0.528 . . . . 64.21 109.796 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.7 HG21 HG21 ' B' ' 114' ' ' ILE . 97.2 t -115.39 128.84 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.216 1.006 . . . . 61.45 109.696 -174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.7 m -121.94 142.5 50.22 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.263 1.025 . . . . 71.53 109.562 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.07 163.87 28.6 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.176 0.991 . . . . 64.43 109.564 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 27.5 p -146.71 138.49 24.56 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.462 0.541 . . . . 73.35 112.462 -175.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.469 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 39.3 mt -110.47 106.09 15.28 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.029 1.332 . . . . 70.24 107.982 171.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.46 -106.27 2.21 Favored Glycine 0 C--N 1.344 1.015 0 C-N-CA 121.329 -0.462 . . . . 75.4 112.485 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.46 5.89 11.12 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.156 0.983 . . . . 54.34 110.732 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -127.22 171.47 11.42 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.091 0.956 . . . . 74.43 109.424 -177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 59.6 m -76.7 142.78 40.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.085 0.554 . . . . 72.03 111.31 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.469 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -93.56 -64.08 1.13 Allowed 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.527 0.731 . . . . 70.33 109.33 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 32.7 p90 -147.5 162.02 39.9 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.005 -0.998 . . . . 75.12 110.6 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.0 mt -130.0 154.09 47.74 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.239 1.416 . . . . 70.12 107.567 175.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.476 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.4 t -154.75 159.49 40.7 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.059 0.944 . . . . 63.21 108.675 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -164.67 141.04 5.99 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.655 0.782 . . . . 75.41 109.253 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 69.9 t -129.13 140.78 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 C-N-CA 123.755 0.822 . . . . 64.42 108.948 171.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.516 HE21 ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -126.89 92.77 3.6 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.849 0.718 . . . . 74.32 109.164 175.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -89.86 101.82 14.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.272 -1.331 . . . . 62.24 109.048 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.11 15.46 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.896 -0.882 . . . . 72.42 110.896 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -141.75 125.95 2.87 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 111.167 -0.773 . . . . 72.31 111.167 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.91 126.43 40.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 123.719 0.808 . . . . 72.02 109.252 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -132.9 161.57 33.88 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.665 1.186 . . . . 74.43 109.293 -176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 49.4 m -134.03 127.38 32.14 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 124.492 1.117 . . . . 73.32 108.504 175.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.55 HG12 HD12 ' B' ' 89' ' ' ILE . 8.5 tt -139.1 135.98 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 109.512 -0.551 . . . . 72.34 109.512 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.33 158.57 36.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.716 0.806 . . . . 74.4 109.999 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 102.31 -30.3 10.69 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 111.797 -0.521 . . . . 65.02 111.797 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' B' ' 93' ' ' GLN . 0.1 OUTLIER -83.31 169.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.967 1.307 . . . . 73.13 111.087 175.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -152.16 143.68 23.46 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.992 0.917 . . . . 75.3 109.718 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -99.8 0.16 Allowed Glycine 0 C--N 1.35 1.331 0 O-C-N 123.917 0.761 . . . . 74.1 114.715 170.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.516 HG21 ' HA ' ' B' ' 2' ' ' SER . 86.1 m -64.27 -42.75 96.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.882 0.873 . . . . 74.45 112.349 -170.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.625 ' HB2' ' HB ' ' B' ' 89' ' ' ILE . 1.4 mp0 -62.13 -45.07 95.08 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 123.229 0.612 . . . . 64.22 110.093 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -72.9 -39.97 65.93 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.233 -0.894 . . . . 61.24 110.164 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.402 ' HB1' ' CE2' ' F' ' 181' ' ' TYR . . . -64.26 -27.56 69.13 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.252 0.621 . . . . 74.35 111.855 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 13.2 t60 -76.02 -40.58 53.23 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.786 0.834 . . . . 70.43 110.501 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' B' ' 102' ' ' CYS . 49.6 t -66.2 -47.56 73.49 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.419 0.688 . . . . 64.42 109.674 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 56.0 tp -64.65 -35.26 80.46 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.637 1.175 . . . . 73.52 110.837 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.69 2.14 87.78 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.375 -0.83 . . . . 52.41 114.172 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.99 -63.81 0.12 Allowed 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 117.885 0.843 . . . . 63.4 112.732 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -70.8 -50.08 39.53 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.629 0.974 . . . . 72.43 113.629 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.498 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 61.4 m -58.44 -47.61 98.46 Favored Pre-proline 0 CA--C 1.56 1.365 0 C-N-CA 123.503 0.721 . . . . 63.23 112.081 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.03 -27.56 29.81 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 121.363 1.375 . . . . 73.51 112.898 170.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -64.84 -29.91 70.89 Favored 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 118.758 0.708 . . . . 64.4 110.515 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.517 HG23 ' NH2' ' D' ' 111' ' ' ARG . 63.7 mt -62.29 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.768 0.827 . . . . 62.24 110.372 172.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.488 ' HB2' HD12 ' B' ' 60' ' ' LEU . 39.2 mt -83.68 -11.85 56.66 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.882 -1.054 . . . . 75.22 111.419 -174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.554 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 32.3 t80 -63.46 -46.8 84.28 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.298 1.439 . . . . 51.13 112.994 -170.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.416 ' HB3' ' HD2' ' D' ' 109' ' ' TYR . 29.1 Cg_endo -60.95 -36.93 80.71 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.64 1.56 . . . . 63.24 112.764 174.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.22 -42.25 99.13 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.247 0.619 . . . . 70.34 110.587 177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.21 -41.47 73.59 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.358 0.663 . . . . 65.2 111.357 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -56.53 -58.92 5.98 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.571 1.149 . . . . 72.12 111.275 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.39 -35.79 81.57 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.397 -0.819 . . . . 62.21 110.387 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.408 ' HB3' HG21 ' B' ' 78' ' ' VAL . 36.8 t -64.64 -37.14 86.56 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.476 0.547 . . . . 73.43 112.476 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.7 HG21 HG21 ' B' ' 64' ' ' VAL . 79.3 mt -70.76 -47.9 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 122.918 0.487 . . . . 64.42 110.131 176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.6 m -62.49 -23.75 67.1 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 115.533 -0.758 . . . . 71.43 110.833 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.2 t -73.27 -54.71 7.72 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.567 1.147 . . . . 71.51 109.985 170.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.503 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 0.0 OUTLIER -64.93 -33.74 76.74 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.982 0.913 . . . . 70.3 113.163 -172.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.8 t -76.91 -30.15 18.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 122.901 0.48 . . . . 75.24 110.175 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' B' ' 125' ' ' GLN . 54.5 p -72.14 -32.18 66.67 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 121.481 0.658 . . . . 43.24 110.478 177.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.583 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 67.7 mtt-85 -64.62 -35.82 82.26 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.722 -1.127 . . . . 73.01 109.814 171.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 18' ' ' THR . . . -87.37 15.79 52.34 Favored Glycine 0 C--N 1.35 1.337 0 CA-C-O 119.097 -0.835 . . . . 71.44 113.342 176.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t 56.69 14.07 1.63 Allowed 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 126.97 2.108 . . . . 53.14 113.884 173.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -106.14 160.15 27.19 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 123.698 0.799 . . . . 73.21 111.309 -172.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -52.77 101.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 123.782 2.988 . . . . 53.24 114.49 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.547 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 0.1 OUTLIER -68.86 155.45 40.21 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 113.356 -1.747 . . . . 71.53 110.293 176.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.401 HD12 ' HB ' ' B' ' 40' ' ' VAL . 2.6 tt -152.3 126.28 9.1 Favored 'General case' 0 C--O 1.245 0.833 0 N-CA-C 108.741 -0.837 . . . . 54.4 108.741 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -93.66 127.96 39.61 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.997 0.919 . . . . 62.42 108.661 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.571 HD11 HD21 ' F' ' 186' ' ' LEU . 1.7 tt -70.54 130.89 43.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.617 -0.512 . . . . 75.31 109.617 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.523 ' HB3' HG12 ' F' ' 187' ' ' ILE . . . -66.64 144.67 98.73 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.563 0.745 . . . . 60.21 111.042 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.469 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 57.8 Cg_endo -65.22 92.02 0.22 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 123.39 2.726 . . . . 75.03 113.431 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.485 HG11 HD12 ' F' ' 186' ' ' LEU . 19.6 m -84.95 108.48 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-N 115.449 -0.796 . . . . 74.44 109.953 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.444 ' HB3' HG21 ' D' ' 13' ' ' ILE . 52.5 t30 -109.84 105.93 15.32 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.188 0.595 . . . . 70.23 110.177 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.498 ' HD1' ' HB3' ' F' ' 184' ' ' TRP . 69.2 t80 -69.72 -28.18 65.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.803 0.841 . . . . 74.45 111.368 176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.61 -36.77 76.96 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.364 0.665 . . . . 64.4 110.572 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.87 -40.57 84.76 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.955 0.902 . . . . 70.22 112.028 177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.42 -40.81 73.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.358 0.663 . . . . 73.13 110.426 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.589 ' HA ' ' HD1' ' B' ' 140' ' ' TYR . 67.2 t80 -63.59 -31.25 72.35 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.892 0.877 . . . . 74.13 111.256 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 56.9 mtt -60.31 -36.99 79.18 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.435 0.694 . . . . 70.43 110.886 174.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.578 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 18.2 m120 -77.43 -25.16 50.45 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.501 0.72 . . . . 73.42 111.621 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.589 ' HD1' ' HA ' ' B' ' 137' ' ' PHE . 58.6 m-85 -74.15 -32.3 63.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 122.604 0.362 . . . . 71.34 111.043 176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.444 ' HB3' HE22 ' B' ' 4' ' ' GLN . 42.9 mt -113.54 27.67 9.38 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.085 0.554 . . . . 71.13 110.873 176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.578 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 28.0 tt0 -66.64 100.85 0.72 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.17 0.988 . . . . 71.34 111.505 -176.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 54.99 28.03 10.1 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.316 1.046 . . . . 74.13 111.599 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.507 ' HB3' ' NE2' ' B' ' 4' ' ' GLN . 33.3 tt0 -75.15 80.46 2.3 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.174 0.99 . . . . 74.5 109.26 -175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.64 25.49 2.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.049 -0.978 . . . . 63.42 110.508 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -110.59 35.89 4.56 Favored Glycine 0 C--N 1.347 1.152 0 N-CA-C 110.865 -0.894 . . . . 74.31 110.865 172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -165.52 34.04 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.622 1.169 . . . . 74.12 109.085 -174.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.45 85.64 0.08 OUTLIER Glycine 0 C--N 1.348 1.202 0 CA-C-N 115.449 -0.796 . . . . 45.42 112.638 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -147.85 -178.53 6.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.643 1.177 . . . . 53.24 108.755 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -76.16 -160.54 0.14 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.211 1.004 . . . . 72.34 110.547 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.11 115.07 2.42 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.234 0.614 . . . . 74.33 111.159 -177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -125.28 -30.85 3.11 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.15 1.38 . . . . 55.41 110.178 -175.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -86.23 18.26 3.24 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.626 0.77 . . . . 74.34 109.928 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -68.83 160.06 31.28 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.915 0.886 . . . . 72.23 111.552 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 N-CA-C 108.538 -0.912 . . . . 43.25 108.538 179.82 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mtm . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.181 -0.674 . . . . 52.51 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -78.17 89.97 4.27 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.636 -0.875 . . . . 61.24 108.636 177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.433 ' HG3' HE21 ' A' ' 143' ' ' GLN . 0.3 OUTLIER -75.23 113.91 13.14 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.004 -0.998 . . . . 74.14 108.724 -173.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.91 86.65 4.79 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 109.089 -0.708 . . . . 73.04 109.089 -175.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -166.33 145.75 5.9 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.399 -1.334 . . . . 72.22 107.399 172.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -67.73 -73.45 0.14 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.215 -0.661 . . . . 72.33 109.215 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.4 m 51.54 -75.05 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.211 1.404 . . . . 74.53 110.889 -168.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 79.52 -43.25 0.29 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.218 1.807 . . . . 74.24 112.39 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 64.36 115.38 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.591 1.557 . . . . 42.51 112.308 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 80.5 m -124.46 103.61 8.28 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.393 -1.336 . . . . 75.02 107.393 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -122.83 123.7 41.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 107.343 -1.355 . . . . 73.34 107.343 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -154.79 138.41 16.05 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 123.399 0.437 . . . . 64.5 110.733 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 8.5 tp -82.17 142.35 13.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.869 0.867 . . . . 72.32 109.075 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.533 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 30.9 mm-40 -111.39 -35.73 5.75 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.416 0.686 . . . . 62.23 110.663 176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.41 ' NH1' ' HB2' ' D' ' 32' ' ' PHE . 42.4 ttt180 -173.33 136.49 0.62 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.114 0.566 . . . . 65.23 109.654 -171.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -123.18 143.85 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 N-CA-C 107.407 -1.331 . . . . 62.42 107.407 172.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.411 ' HB3' HG23 ' D' ' 122' ' ' THR . 39.2 p90 -177.71 168.85 2.13 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.53 0.732 . . . . 75.54 110.72 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.5 p -87.56 111.86 21.66 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.372 -0.831 . . . . 50.34 109.323 174.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.38 -43.92 89.22 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.2 -0.667 . . . . 63.32 109.2 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.5 t70 -147.34 147.1 29.97 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 114.222 -1.354 . . . . 75.45 110.078 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.5 mt -138.88 144.57 29.38 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 C-N-CA 125.782 1.633 . . . . 73.42 106.729 175.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -153.33 151.02 29.5 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-O 121.31 0.576 . . . . 54.44 110.644 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -155.08 134.04 12.23 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.573 -1.194 . . . . 73.31 108.077 174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.8 147.28 52.31 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.439 1.096 . . . . 74.43 108.268 175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 84.87 6.32 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.544 0.737 . . . . 74.44 109.785 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.38 -27.97 46.97 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.989 2.459 . . . . 74.21 111.302 171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.815 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 6.8 m-80 -95.25 18.56 12.15 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.797 -1.092 . . . . 55.51 111.551 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.29 88.98 Favored Pre-proline 0 CA--C 1.564 1.492 0 CA-C-N 118.613 0.642 . . . . 70.34 111.19 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -94.18 -26.33 0.14 Allowed 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 121.743 1.629 . . . . 73.33 113.571 164.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.815 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 61.2 t60 -69.05 -24.41 64.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.734 1.213 . . . . 72.05 113.312 -170.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' C' ' 27' ' ' ASN . 8.8 p -74.99 -12.01 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 122.825 0.45 . . . . 73.53 111.854 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -57.67 -41.34 81.33 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.402 0.681 . . . . 74.14 112.189 -174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -112.12 48.11 1.01 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 122.071 0.939 . . . . 64.54 108.949 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.619 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.9 tppp? -124.33 164.05 20.43 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.455 -0.793 . . . . 73.35 109.481 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -77.42 105.79 8.78 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.859 -1.164 . . . . 70.53 107.859 166.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -84.0 73.35 10.37 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 123.917 0.887 . . . . 71.02 111.466 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -124.93 77.62 66.17 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.048 -0.723 . . . . 55.4 109.048 172.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.793 ' HG2' ' HG3' ' C' ' 124' ' ' PRO . 1.3 Cg_endo -86.51 137.4 4.95 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.366 2.711 . . . . 44.34 111.794 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.63 117.02 24.27 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.61 -1.256 . . . . 75.34 107.61 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 m -82.31 79.45 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 115.236 -0.893 . . . . 42.42 109.406 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.07 141.56 35.63 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.209 0.604 . . . . 54.03 110.847 -171.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -121.1 165.91 14.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.785 0.834 . . . . 73.33 110.846 171.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -145.83 148.4 32.86 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.914 1.286 . . . . 71.01 107.594 175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.415 HD11 HD21 ' C' ' 60' ' ' LEU . 15.6 tp -116.47 148.91 40.31 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 118.213 0.461 . . . . 75.41 111.042 -172.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.674 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 12.9 m-20 -141.15 137.97 33.11 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.37 1.068 . . . . 73.42 109.17 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.7 m -113.97 126.22 54.9 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.502 -0.925 . . . . 64.45 108.502 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.96 165.29 25.04 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.38 1.072 . . . . 43.12 108.54 174.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 m -145.09 168.31 20.63 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.319 0.648 . . . . 71.11 110.441 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.19 128.0 4.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.729 1.211 . . . . 73.3 108.025 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -90.31 126.2 35.77 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.979 -0.749 . . . . 71.33 108.979 175.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.623 HD11 HD12 ' C' ' 83' ' ' ILE . 61.8 mt -97.93 -36.42 10.16 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.836 0.854 . . . . 61.12 110.18 177.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.99 -178.05 5.41 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.493 -0.776 . . . . 73.42 109.96 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -68.04 123.47 20.72 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.137 -1.061 . . . . 73.33 108.137 175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' C' ' 85' ' ' SER . 21.6 m-20 73.06 -4.33 2.2 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.701 1.2 . . . . 73.32 112.823 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.4 t -107.48 98.01 6.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.91 0.884 . . . . 62.32 108.74 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.11 116.39 26.27 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.716 0.806 . . . . 75.21 110.481 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -82.83 121.92 27.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 114.985 -1.007 . . . . 74.2 109.484 172.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 76.6 t -100.85 124.56 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 107.98 -1.118 . . . . 64.24 107.98 170.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 59.7 t -104.06 103.41 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 108.016 -1.105 . . . . 73.24 108.016 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -93.01 110.07 21.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.193 0.997 . . . . 65.45 108.365 178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.674 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 47.5 ttp180 -103.34 137.33 41.6 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.035 0.534 . . . . 72.5 109.893 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.469 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.3 130.17 74.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 107.324 -1.362 . . . . 70.21 107.324 171.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -120.23 121.04 37.84 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.849 -0.797 . . . . 44.12 108.849 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' C' ' 126' ' ' LEU . 25.6 t -98.73 138.5 23.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 C-N-CA 123.966 0.907 . . . . 61.32 109.319 176.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.2 m -123.35 138.75 54.54 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.153 -1.385 . . . . 73.2 107.486 171.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.13 127.74 46.23 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.946 -1.501 . . . . 62.31 106.946 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 15.6 m -134.49 128.85 34.22 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 123.643 0.589 . . . . 71.22 110.68 -176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.619 HD13 ' HG2' ' C' ' 34' ' ' LYS . 17.1 mt -84.65 47.55 1.39 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.482 1.513 . . . . 73.31 108.811 171.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.27 -82.82 0.49 Allowed Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.847 -0.901 . . . . 75.33 110.847 -174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -122.98 -31.78 3.59 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.674 1.19 . . . . 73.34 108.829 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -62.49 121.84 14.27 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.902 0.881 . . . . 72.15 109.874 170.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 19.0 m -74.59 122.0 22.47 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 118.749 0.704 . . . . 73.34 109.62 174.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' C' ' 27' ' ' ASN . . . -72.35 -51.32 21.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.064 0.946 . . . . 61.41 109.92 177.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -167.17 176.68 6.64 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.916 -0.583 . . . . 71.12 110.443 175.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.439 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -131.02 142.89 50.37 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.59 -1.263 . . . . 64.5 107.59 174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -144.63 147.73 33.45 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.373 -0.973 . . . . 73.43 108.373 176.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -158.99 141.47 14.07 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.714 0.406 . . . . 64.2 110.389 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -139.86 115.47 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.313 1.045 . . . . 71.33 108.922 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 45.6 mt-30 -91.51 95.3 9.87 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.557 -0.905 . . . . 74.53 108.557 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.579 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -86.96 111.49 20.89 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.775 0.83 . . . . 71.51 109.905 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.9 145.18 17.6 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 112.389 -0.284 . . . . 43.15 112.389 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.498 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -141.13 124.03 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 110.268 -1.133 . . . . 71.44 110.268 177.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.623 HD12 HD11 ' C' ' 51' ' ' LEU . 8.1 mm -81.87 121.5 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.193 -1.04 . . . . 44.43 108.193 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -123.42 118.86 28.42 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.291 -0.633 . . . . 71.11 109.291 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' C' ' 54' ' ' ASP . 23.5 p -85.43 100.44 11.87 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 108.833 -0.803 . . . . 61.32 108.833 173.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.37 146.49 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.594 0.758 . . . . 72.22 111.251 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -164.93 151.05 10.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.17 0.988 . . . . 73.41 109.959 -176.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.58 -38.75 3.14 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 114.042 0.377 . . . . 61.24 114.042 169.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.56 148.93 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.455 1.102 . . . . 74.34 111.082 -179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.521 ' HA ' ' HB3' ' E' ' 172' ' ' ALA . 6.9 pt-20 -148.85 152.92 37.31 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.856 0.687 . . . . 75.42 112.856 -170.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.83 -139.37 38.66 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-N 114.724 -1.126 . . . . 54.0 114.008 173.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 81.2 p -69.17 -20.37 64.01 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.837 0.855 . . . . 72.25 111.195 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -65.36 -43.28 91.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.922 0.889 . . . . 74.33 109.978 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 52.5 ttm -62.95 -47.35 83.6 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.916 -0.583 . . . . 72.23 109.958 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.47 72.67 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.86 0.725 . . . . 73.53 111.732 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -73.42 -31.89 64.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.663 0.785 . . . . 70.1 110.027 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.14 -35.62 48.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.463 0.705 . . . . 52.04 110.989 176.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.2 -52.62 6.11 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.998 0.919 . . . . 53.01 110.303 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 11.11 62.44 Favored Glycine 0 N--CA 1.47 0.935 0 CA-C-N 115.914 -0.585 . . . . 71.4 114.18 -171.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.01 -61.58 0.39 Allowed 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.488 0.644 . . . . 71.35 111.34 -176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -73.77 -46.53 45.06 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 112.898 0.703 . . . . 74.43 112.898 -172.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.495 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 82.8 m -60.9 -48.73 91.9 Favored Pre-proline 0 CA--C 1.563 1.47 0 CA-C-O 118.977 -0.535 . . . . 71.44 110.75 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 71.9 Cg_exo -57.04 -33.67 96.17 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 122.439 2.093 . . . . 71.33 114.081 170.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.46 -34.87 79.3 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.313 0.645 . . . . 62.4 111.193 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.455 HD12 ' NH1' ' A' ' 111' ' ' ARG . 37.9 mm -64.92 -41.57 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.229 0.612 . . . . 64.2 110.331 174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.498 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.2 mt -81.49 -22.28 38.12 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.216 -0.902 . . . . 65.31 112.088 -173.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -59.72 -48.51 95.06 Favored Pre-proline 0 CA--C 1.559 1.32 0 CA-C-O 117.723 -1.132 . . . . 73.22 113.55 -173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.03 -39.54 84.92 Favored 'Trans proline' 0 C--N 1.389 2.661 0 C-N-CA 122.195 1.93 . . . . 71.22 112.607 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.448 ' HE2' HG21 ' A' ' 115' ' ' THR . 87.4 m-85 -62.88 -52.31 63.58 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.845 -1.07 . . . . 74.44 111.952 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -70.18 -34.81 73.44 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 116.319 -0.4 . . . . 71.53 111.397 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttt180 -54.83 -51.03 67.13 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.257 1.423 . . . . 64.31 110.473 175.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -71.98 -36.44 69.81 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.507 -0.77 . . . . 74.23 110.195 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.8 t -65.16 -30.96 71.92 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.09 0.556 . . . . 64.11 111.378 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.577 HG21 HG21 ' C' ' 64' ' ' VAL . 98.1 mt -72.3 -45.49 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 116.0 -0.546 . . . . 75.23 109.871 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 7.2 m -56.76 -37.32 70.89 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.801 0.688 . . . . 73.41 110.423 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 47.7 t -59.76 -56.95 15.46 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.923 1.289 . . . . 64.14 110.45 175.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.686 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.17 -41.91 89.53 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.586 1.154 . . . . 74.0 112.917 -176.153 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.668 HG21 ' HB2' ' C' ' 126' ' ' LEU . 69.2 t -66.29 -41.59 89.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.424 0.689 . . . . 72.33 110.747 177.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.615 ' HB2' HE22 ' C' ' 125' ' ' GLN . 45.5 t -63.31 -35.96 82.11 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.145 -0.934 . . . . 75.11 110.993 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 75.5 mtt-85 -66.89 -37.92 85.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.979 -1.01 . . . . 70.24 110.122 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.15 0.84 82.7 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.283 -0.732 . . . . 74.34 113.328 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p 57.09 50.94 11.1 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.523 1.529 . . . . 74.43 111.492 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.42 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 26.9 m-85 -121.65 169.74 8.75 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.474 1.11 . . . . 74.53 110.693 -176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.793 ' HG3' ' HG2' ' C' ' 38' ' ' PRO . 26.9 Cg_endo -57.8 126.71 22.6 Favored 'Trans proline' 0 C--N 1.399 3.197 0 C-N-CA 122.732 2.288 . . . . 61.54 110.905 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.615 HE22 ' HB2' ' C' ' 119' ' ' SER . 15.5 mm100 -58.99 132.44 54.04 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.148 0.979 . . . . 75.11 112.486 -168.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.775 ' HG ' HG11 ' C' ' 64' ' ' VAL . 1.7 mm? -108.02 72.18 0.84 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.779 -0.646 . . . . 73.14 109.968 -176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -126.53 89.02 2.93 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.035 -1.468 . . . . 65.02 107.035 167.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.823 ' HB3' HD13 ' E' ' 187' ' ' ILE . 31.9 mt -84.27 151.16 24.96 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.552 -1.203 . . . . 75.14 108.785 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.843 ' HB2' ' HA ' ' F' ' 203' ' ' ASP . . . -55.58 147.53 39.3 Favored Pre-proline 0 CA--C 1.546 0.791 0 O-C-N 124.281 0.988 . . . . 51.01 113.295 -172.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.819 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 88.0 Cg_exo -50.36 115.2 1.78 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.545 2.83 . . . . 43.13 112.583 171.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -83.16 78.91 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.737 0 CA-C-O 121.632 0.729 . . . . 62.23 109.128 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -84.64 93.46 8.4 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.189 -0.914 . . . . 73.23 109.978 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -74.9 -11.87 60.23 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.389 -1.278 . . . . 72.24 111.443 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -61.28 -46.58 89.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.88 0.872 . . . . 63.33 112.667 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.86 -43.75 95.17 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.168 0.587 . . . . 71.11 110.167 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 61.6 tp -58.43 -39.99 81.29 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.654 -1.157 . . . . 61.42 110.444 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -70.51 -37.02 74.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.601 1.161 . . . . 74.15 110.205 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 25.6 mmt -69.63 -28.95 66.35 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.457 0.703 . . . . 53.44 111.066 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -67.68 -39.78 84.45 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.694 0.397 . . . . 72.22 110.147 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -68.65 -85.51 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.488 0.715 . . . . 74.02 110.269 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.407 ' HB3' ' HG2' ' A' ' 147' ' ' GLU . 4.5 pp -145.72 143.92 30.05 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.959 0.903 . . . . 75.22 110.066 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -91.96 96.75 10.55 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.511 0.724 . . . . 72.02 109.475 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.02 130.05 34.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.69 0.396 . . . . 75.32 109.958 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.424 ' HG3' ' H ' ' C' ' 144' ' ' GLN . 0.3 OUTLIER -79.44 173.01 13.01 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.726 0.81 . . . . 74.11 111.728 176.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.35 99.68 6.72 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.199 -1.037 . . . . 52.24 108.199 170.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.53 136.46 39.18 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.787 0.68 . . . . 43.21 112.589 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -144.64 -54.83 0.33 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.918 -1.141 . . . . 75.23 107.918 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.72 139.89 4.16 Favored Glycine 0 N--CA 1.471 0.968 0 CA-C-N 115.83 -0.623 . . . . 52.52 111.686 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 140' ' ' TYR . 85.6 m -151.68 141.55 21.99 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.247 0.619 . . . . 72.53 110.836 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -129.8 99.36 5.1 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.753 1.221 . . . . 72.54 108.509 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.65 143.98 50.03 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.023 0.529 . . . . 75.44 110.152 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -140.99 103.22 4.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.977 0.911 . . . . 72.35 110.005 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -71.23 97.37 1.53 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.955 0.502 . . . . 71.34 109.792 173.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -76.43 136.45 39.44 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.216 1.006 . . . . 63.41 110.329 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 C-N-CA 123.913 0.885 . . . . 73.34 109.332 179.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 110.088 -0.338 . . . . 61.13 110.088 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 45.1 p -128.84 139.92 51.93 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.878 0.871 . . . . 64.21 109.545 174.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.25 81.38 3.03 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 108.8 -0.815 . . . . 73.11 108.8 174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -134.71 59.16 1.74 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.244 1.021 . . . . 72.43 109.161 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.716 HD22 ' HB2' ' D' ' 54' ' ' ASP . 11.8 p-10 -128.63 62.78 1.46 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.156 -0.929 . . . . 64.52 110.288 -173.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -159.23 88.26 0.87 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.743 -1.117 . . . . 75.32 108.82 175.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -166.31 -157.43 0.28 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.141 0.976 . . . . 74.1 108.4 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -69.63 -164.8 0.07 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.321 1.049 . . . . 73.51 110.725 171.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.3 ttp -33.67 125.97 0.41 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.346 1.058 . . . . 73.51 112.722 171.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 85.5 m -138.4 141.57 39.59 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.72 0.808 . . . . 74.23 109.813 -174.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 91.3 t80 -156.6 102.56 2.06 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.333 -1.358 . . . . 74.31 107.333 175.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 76.3 mt-30 -113.03 113.55 25.62 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.844 -0.799 . . . . 74.52 108.844 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' B' ' 132' ' ' ASN . 7.5 tt -91.43 98.31 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 107.581 -1.266 . . . . 64.35 107.581 175.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.53 -33.21 14.56 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 112.35 0.5 . . . . 51.23 112.35 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 75.2 ttt180 -170.53 122.42 0.63 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 110.059 -0.348 . . . . 74.13 110.059 -174.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.451 HG12 ' HG3' ' B' ' 130' ' ' PRO . 35.4 mm -115.57 132.67 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 108.146 -1.057 . . . . 54.42 108.146 178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 4.8 p90 -154.57 169.0 24.87 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.381 0.672 . . . . 73.12 112.024 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.2 p -97.7 119.59 36.55 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.016 -0.993 . . . . 62.13 108.815 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -84.02 -22.31 31.36 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.331 0.653 . . . . 72.24 110.2 174.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.3 t70 -160.85 139.5 10.07 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.102 0.961 . . . . 74.13 109.381 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.686 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.3 mt -142.25 143.73 25.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.479 1.112 . . . . 63.11 108.258 176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 60.7 m -141.98 136.76 30.64 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.228 1.011 . . . . 43.34 109.187 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.527 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 92.9 t80 -143.22 110.99 5.93 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 106.445 -1.687 . . . . 73.02 106.445 165.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -122.31 115.12 21.77 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 109.353 -0.61 . . . . 74.41 109.353 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -116.66 80.44 10.58 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.476 -0.935 . . . . 74.51 108.476 176.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.76 -29.83 23.24 Favored 'Trans proline' 0 C--N 1.383 2.374 0 C-N-CA 122.669 2.246 . . . . 53.43 112.266 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -111.49 18.03 19.51 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.721 -0.672 . . . . 51.1 109.661 -176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.486 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -39.4 -54.35 3.73 Favored Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 115.586 1.699 . . . . 64.34 115.586 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.412 ' HB3' HD11 ' C' ' 83' ' ' ILE . 44.4 Cg_endo -81.67 -13.55 10.64 Favored 'Trans proline' 0 C--N 1.382 2.32 0 CA-C-N 121.307 1.503 . . . . 73.23 113.439 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -76.44 -36.83 57.73 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.687 1.195 . . . . 70.44 109.462 172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.611 HG13 HD12 ' D' ' 68' ' ' LEU . 35.7 t -65.56 -23.96 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 C-N-CA 124.877 1.271 . . . . 75.01 111.324 -177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.41 ' HB2' ' NH1' ' C' ' 15' ' ' ARG . 74.3 t80 -45.9 -36.64 5.55 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.335 1.454 . . . . 62.12 113.47 170.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -79.1 -6.54 56.69 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.637 0.775 . . . . 72.52 112.518 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -109.57 112.69 24.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.787 0.835 . . . . 64.52 110.029 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -98.2 60.3 1.41 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.927 0.891 . . . . 44.12 110.932 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.627 ' HA ' ' HA ' ' H' ' 193' ' ' TYR . 20.1 m95 -124.89 158.12 34.28 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.484 -0.561 . . . . 64.05 109.484 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.406 HE21 ' HD2' ' D' ' 38' ' ' PRO . 28.4 tp60 -71.47 112.49 14.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.787 -0.82 . . . . 73.05 108.787 175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.406 ' HD2' HE21 ' D' ' 37' ' ' GLN . 45.3 Cg_exo -56.79 114.42 1.91 Allowed 'Trans proline' 0 C--N 1.389 2.671 0 C-N-CA 122.783 2.322 . . . . 51.55 112.663 -178.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -67.25 109.94 3.3 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.146 -1.057 . . . . 74.44 108.146 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 18.1 m -108.33 106.6 20.98 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 CA-C-O 122.031 0.919 . . . . 53.32 109.142 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -94.28 115.97 28.29 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.248 -1.39 . . . . 71.03 107.248 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.05 136.08 34.72 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.498 -0.927 . . . . 54.31 108.498 -177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.72 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.7 m-20 -107.69 153.8 22.4 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.152 0.981 . . . . 64.01 108.562 174.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.425 ' HB2' HD21 ' H' ' 186' ' ' LEU . 47.6 tp -126.97 132.47 50.81 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.157 -0.683 . . . . 75.22 109.157 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.5 t70 -140.62 141.18 35.14 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.018 -1.105 . . . . 42.33 108.018 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 22.1 m -118.53 143.64 46.6 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.979 -0.749 . . . . 71.22 108.979 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.9 27.72 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.323 1.049 . . . . 70.23 108.317 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.5 p -170.57 157.66 5.93 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.988 0.515 . . . . 72.22 110.894 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -149.57 140.44 22.79 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.911 -0.774 . . . . 72.42 108.911 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -83.2 119.93 25.16 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 109.405 -0.591 . . . . 72.13 109.405 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.529 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.6 mt -95.02 -34.92 12.16 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.18 0.592 . . . . 73.23 109.853 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.33 -177.43 6.59 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.207 -0.906 . . . . 52.53 110.392 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -66.91 129.97 41.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.81 -1.086 . . . . 64.3 109.254 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.716 ' HB2' HD22 ' D' ' 5' ' ' ASN . 66.5 m-20 58.31 17.84 5.02 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.669 1.187 . . . . 72.44 113.125 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.18 125.59 72.21 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 C-N-CA 123.603 0.761 . . . . 75.31 109.144 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -123.64 135.23 53.8 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.815 -0.809 . . . . 72.4 108.815 170.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.529 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.9 tt0 -86.36 111.61 20.66 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 106.129 -1.804 . . . . 53.1 106.129 161.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -100.37 120.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 N-CA-C 108.079 -1.082 . . . . 70.32 108.079 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.582 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 54.4 t -101.64 130.3 51.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-N 114.923 -1.035 . . . . 61.22 109.726 -176.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.38 126.02 51.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.463 -1.31 . . . . 75.4 107.463 172.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -112.54 100.9 9.1 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.563 -0.903 . . . . 64.15 108.563 173.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 49.1 t -92.86 127.97 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.894 -1.15 . . . . 73.24 107.894 169.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.72 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -116.94 148.48 41.35 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.467 -0.938 . . . . 64.32 108.467 175.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 79.1 t -126.66 131.11 71.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 124.108 0.963 . . . . 72.42 108.875 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.9 m -117.09 95.81 5.16 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.246 -1.39 . . . . 74.35 107.246 172.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.57 129.44 43.96 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.061 -0.718 . . . . 53.22 109.061 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.514 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 36.9 m -143.6 137.27 28.23 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-O 121.369 0.604 . . . . 42.52 110.83 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.611 HD12 HG13 ' D' ' 31' ' ' VAL . 38.2 mt -104.16 97.34 7.32 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.593 1.157 . . . . 72.3 109.077 173.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.85 -119.79 19.6 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.162 0.914 . . . . 73.42 113.114 -177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.65 25.17 3.65 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.443 0.697 . . . . 71.5 111.882 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -141.2 146.57 37.09 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.54 0.336 . . . . 75.03 110.572 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 34.9 m -71.78 121.59 19.2 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.89 0.744 . . . . 73.35 109.818 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.514 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -77.7 -59.86 2.61 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.484 -0.932 . . . . 75.23 108.484 177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -160.95 163.03 32.1 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 114.901 -1.045 . . . . 73.43 110.494 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -120.48 150.32 41.0 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.639 -1.245 . . . . 74.32 107.639 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.567 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.6 t -157.21 144.0 18.32 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.788 0.435 . . . . 64.32 110.153 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -156.05 130.69 9.0 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.284 0.633 . . . . 62.34 110.253 174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -133.86 118.38 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 123.462 0.705 . . . . 71.25 110.006 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.9 mt-30 -89.87 85.94 6.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.515 0.726 . . . . 73.23 109.358 168.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.29 93.74 5.97 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.259 -0.882 . . . . 64.45 108.859 174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -98.34 144.08 17.04 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.619 -0.593 . . . . 74.14 111.619 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.59 139.34 9.63 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 112.213 -0.355 . . . . 61.1 112.213 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.9 mt -88.89 122.82 40.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.646 0.778 . . . . 62.44 108.916 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' D' ' 12' ' ' GLN . 59.5 m-85 -130.44 125.84 35.47 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.301 0.641 . . . . 54.12 110.145 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.527 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.0 m -92.71 105.04 17.25 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 107.73 -1.211 . . . . 63.44 107.73 169.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tt -113.68 140.16 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 123.357 0.663 . . . . 44.44 109.458 -173.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.53 ' HA ' HD21 ' H' ' 173' ' ' LEU . . . -165.44 169.42 15.63 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.756 0.823 . . . . 40.32 110.612 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.64 22.16 77.6 Favored Glycine 0 N--CA 1.475 1.289 0 CA-C-N 116.655 -0.248 . . . . 64.11 113.466 176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -132.01 161.79 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.493 1.117 . . . . 43.42 109.877 -176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.19 149.23 26.82 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.96 0.504 . . . . 73.14 111.127 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.6 -107.72 0.41 Allowed Glycine 0 C--N 1.35 1.356 0 O-C-N 124.541 1.151 . . . . 32.03 115.552 169.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.7 p -71.84 -42.86 66.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.031 0.933 . . . . 72.24 111.362 -175.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -65.13 -35.06 79.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.012 0.525 . . . . 74.11 110.571 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.577 ' SD ' ' HB3' ' H' ' 175' ' ' PHE . 40.4 ttm -61.29 -53.56 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 114.852 -1.067 . . . . 52.41 110.539 175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.85 -19.42 61.97 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.453 0.701 . . . . 54.41 111.748 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -73.05 -43.92 61.36 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.35 1.06 . . . . 74.02 110.163 178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -85.12 -51.98 6.26 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.965 -0.561 . . . . 63.22 111.141 -177.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.637 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 18.0 tp -80.51 -30.2 37.27 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.594 0.358 . . . . 60.25 111.514 -171.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.71 -29.92 41.42 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 119.821 -0.433 . . . . 71.35 113.554 -174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.25 -44.37 1.58 Allowed 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 117.434 0.617 . . . . 53.21 112.371 -171.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -73.4 -40.96 63.9 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 111.905 0.335 . . . . 74.14 111.905 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 82.8 m -67.23 -43.13 43.45 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-O 118.827 -0.606 . . . . 71.13 112.519 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -65.72 -27.07 52.67 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 121.334 1.356 . . . . 71.21 112.905 166.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -68.57 -27.42 66.06 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 109.732 -0.47 . . . . 74.14 109.732 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 19.7 mm -67.55 -45.91 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 123.422 0.689 . . . . 74.21 109.619 169.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 91.8 mt -71.52 -22.36 61.79 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.732 -0.667 . . . . 74.25 111.961 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -68.72 -41.14 20.16 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.023 1.119 . . . . 72.32 114.023 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' B' ' 105' ' ' ILE . 72.2 Cg_exo -55.11 -41.94 73.77 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 121.959 1.772 . . . . 62.24 113.053 169.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.416 ' HD2' ' HB3' ' B' ' 108' ' ' PRO . 69.8 m-85 -71.05 -38.18 72.53 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.419 -0.809 . . . . 71.03 111.021 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.24 -43.7 70.03 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.741 0.816 . . . . 71.32 110.598 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.517 ' NH2' HG23 ' B' ' 105' ' ' ILE . 25.6 ttp180 -57.17 -53.2 60.81 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.781 -1.1 . . . . 64.02 109.72 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.56 -41.27 89.77 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.322 1.014 . . . . 54.03 111.451 -175.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.404 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 37.0 t -57.61 -43.95 85.1 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.567 0.542 . . . . 65.31 110.732 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.567 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -66.08 -49.53 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.651 0.78 . . . . 64.42 110.114 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 91.4 m -56.02 -43.92 78.2 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 73.45 111.744 -172.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.7 t -67.25 -42.06 84.57 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.038 -0.983 . . . . 54.51 110.3 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 74.1 mtm -66.72 -34.04 76.97 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.959 0.504 . . . . 60.33 111.46 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.509 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.2 t -62.23 -47.96 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 123.759 0.662 . . . . 70.21 109.736 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.3 p -72.21 -30.87 65.35 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 115.915 -0.584 . . . . 45.33 111.262 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.4 mtt-85 -69.02 -30.5 68.89 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.798 0.839 . . . . 61.55 110.237 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.75 12.21 60.0 Favored Glycine 0 C--N 1.352 1.42 0 O-C-N 123.782 0.676 . . . . 44.12 112.982 176.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 125' ' ' GLN . 30.2 p 59.58 28.69 18.16 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 125.956 1.702 . . . . 74.53 112.839 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.21 160.35 26.45 Favored Pre-proline 0 CA--C 1.558 1.262 0 C-N-CA 124.389 1.076 . . . . 72.4 108.928 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.07 126.54 16.65 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.719 2.28 . . . . 62.15 112.044 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.5 HE21 ' ND2' ' D' ' 127' ' ' ASN . 30.6 tt0 -50.83 121.81 6.48 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 124.315 1.046 . . . . 71.03 111.678 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.16 96.8 6.62 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.573 0.749 . . . . 72.44 110.144 -170.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.5 ' ND2' HE21 ' D' ' 125' ' ' GLN . 1.9 p30 -116.94 84.75 2.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.409 1.084 . . . . 72.02 109.975 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.445 HD13 ' HB ' ' H' ' 187' ' ' ILE . 90.7 mt -74.84 157.29 35.36 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.698 -1.137 . . . . 73.42 111.636 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.594 ' H ' HD11 ' G' ' 204' ' ' ILE . . . -67.64 156.62 88.49 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.968 0.907 . . . . 43.13 110.593 176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.6 ' HD3' HG13 ' B' ' 13' ' ' ILE . 1.0 OUTLIER -80.4 147.36 17.94 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.115 1.876 . . . . 74.13 110.379 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 m -107.46 108.11 24.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-O 121.699 0.761 . . . . 73.52 109.332 -177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -97.09 101.09 12.59 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.804 -1.184 . . . . 61.2 107.804 175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -68.63 -27.08 65.7 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.079 -0.964 . . . . 65.31 111.255 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -74.28 -40.4 62.32 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.346 0.659 . . . . 74.12 110.771 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.18 89.49 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 116.081 -0.508 . . . . 74.22 109.918 176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.5 tp -60.64 -42.36 96.76 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 124.116 0.885 . . . . 64.52 111.478 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.446 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 26.8 t80 -58.34 -51.63 68.99 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.599 0.759 . . . . 64.42 110.184 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 79.1 mtm -63.66 -42.84 98.02 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.798 0.839 . . . . 75.11 111.152 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.4 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 15.1 m120 -56.19 -51.52 67.75 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.31 0.644 . . . . 73.41 109.922 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -62.08 -31.41 71.83 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.574 -1.194 . . . . 72.33 111.831 -172.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 89.3 mt -62.91 -35.86 81.48 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.036 0.534 . . . . 74.42 110.633 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -90.07 8.26 33.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.715 0.806 . . . . 73.23 111.901 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 96.4 mt-30 -120.53 84.12 2.17 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.442 0.697 . . . . 54.11 109.55 -177.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -152.84 8.92 0.44 Allowed 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 114.875 -1.057 . . . . 72.44 110.689 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.22 99.0 3.17 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.192 0.597 . . . . 62.34 109.583 -174.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.22 130.45 13.69 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.56 0.537 . . . . 63.31 112.794 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -109.46 154.21 22.97 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.977 0.911 . . . . 65.04 110.191 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.58 160.32 31.43 Favored Glycine 0 C--N 1.342 0.905 0 O-C-N 123.05 0.219 . . . . 70.34 112.745 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 34.3 p -130.89 136.38 48.56 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.775 0.83 . . . . 74.41 110.1 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -96.58 153.33 17.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.454 0.702 . . . . 71.24 109.849 175.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -87.76 162.12 17.21 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.724 0.809 . . . . 71.51 110.79 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -102.22 137.09 40.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.933 0.893 . . . . 63.33 109.397 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -100.89 110.35 22.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.8 0.84 . . . . 64.13 109.443 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -168.17 102.51 0.45 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.952 0.901 . . . . 75.32 109.185 173.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.267 0 C-N-CA 123.897 0.879 . . . . 71.1 108.774 179.082 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 109.086 -0.709 . . . . 71.33 109.086 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.72 166.58 33.44 Favored Glycine 0 C--N 1.339 0.744 0 O-C-N 123.55 0.531 . . . . 74.22 111.887 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -69.77 85.61 0.48 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.873 0.844 . . . . 71.51 110.165 175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 35.9 p -159.52 132.26 6.77 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.072 -0.967 . . . . 55.51 109.849 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' C' ' 90' ' ' GLU . . . -96.48 123.99 40.32 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.451 0.7 . . . . 62.52 109.428 176.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.1 tt -148.63 -61.81 0.24 Allowed 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.31 -1.367 . . . . 53.33 107.31 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 26.1 mmt -103.18 90.96 3.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.695 0.798 . . . . 72.14 110.854 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 20.3 t80 57.65 90.32 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.107 1.363 . . . . 55.14 111.722 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -122.87 105.75 10.28 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 108.074 -1.084 . . . . 72.52 108.074 176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 45.3 tp -150.14 111.54 4.44 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.39 -1.337 . . . . 63.44 107.39 -174.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.58 -78.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 107.778 -1.193 . . . . 60.21 107.778 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 39.2 tt0 -179.99 -61.9 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.354 1.062 . . . . 73.31 110.669 175.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 92.8 Cg_endo -89.75 89.37 0.36 Allowed 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 122.137 1.891 . . . . 74.33 112.604 -170.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -120.56 84.21 2.19 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.576 -0.898 . . . . 72.0 108.576 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 60.75 -162.55 0.27 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.092 0.957 . . . . 73.12 110.931 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 90.7 m -147.13 128.29 14.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.211 0.604 . . . . 73.22 109.587 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.452 ' HZ3' ' HB2' ' C' ' 103' ' ' PRO . 5.6 t90 -87.97 108.84 23.28 Favored Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 107.355 -1.35 . . . . 73.24 107.355 168.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -68.47 164.54 32.37 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.702 2.268 . . . . 61.55 112.169 176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.21 146.56 44.15 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.58 0.752 . . . . 75.33 109.984 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' C' ' 128' ' ' LEU . 3.4 tt -68.78 99.68 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 109.432 -0.581 . . . . 73.42 109.432 172.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.3 87.86 4.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.957 -0.757 . . . . 61.24 108.957 170.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -83.91 14.02 4.43 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.742 -0.663 . . . . 73.23 111.334 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -65.54 135.61 55.34 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 108.848 -0.797 . . . . 62.11 108.848 166.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 102.74 -24.1 31.79 Favored Glycine 0 N--CA 1.469 0.88 0 N-CA-C 110.57 -1.012 . . . . 53.05 110.57 -164.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -90.07 61.84 3.3 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.29 -0.724 . . . . 71.22 111.29 171.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -79.78 -162.96 0.47 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.463 1.105 . . . . 72.21 110.497 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 73.82 140.54 0.06 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 125.151 1.38 . . . . 73.13 111.723 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -135.96 -54.3 0.76 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.779 0.832 . . . . 74.11 110.093 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . 0.513 ' HD3' ' HB3' ' E' ' 199' ' ' ASN . 37.5 ttmt 73.02 136.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.723 1.209 . . . . 64.53 110.289 -173.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . 0.404 ' CD1' ' HG3' ' E' ' 198' ' ' GLU . 34.7 t80 -119.06 -83.15 0.65 Allowed 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 110.065 -0.346 . . . . 74.45 110.065 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . 0.404 ' HG3' ' CD1' ' E' ' 197' ' ' TYR . 49.8 mt-10 -95.73 89.82 5.45 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.848 0.459 . . . . 61.42 110.373 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . 0.513 ' HB3' ' HD3' ' E' ' 196' ' ' LYS . 5.6 t30 -162.41 108.96 1.26 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.11 -1.07 . . . . 70.2 108.11 170.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 117.05 -151.51 18.19 Favored Glycine 0 C--N 1.34 0.798 0 N-CA-C 110.959 -0.857 . . . . 72.11 110.959 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.592 ' HE3' ' HA ' ' E' ' 201' ' ' LYS . 0.2 OUTLIER -96.74 -10.66 26.35 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.089 0.444 . . . . 60.31 111.418 -178.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -79.31 82.8 5.41 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.068 0.461 . . . . 65.11 110.738 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -175.8 145.45 0.68 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.896 1.678 . . . . 61.3 106.968 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.478 HG23 HG21 ' E' ' 207' ' ' VAL . 54.4 mt -92.96 92.06 3.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 CA-C-O 121.754 0.788 . . . . 64.45 109.486 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.92 -64.64 0.69 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.844 -1.539 . . . . 71.44 106.844 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.4 87.84 2.59 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 123.585 0.754 . . . . 65.54 109.576 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.478 HG21 HG23 ' E' ' 204' ' ' ILE . 97.6 t . . . . . 0 CA--C 1.55 0.966 0 N-CA-C 107.687 -1.227 . . . . 74.32 107.687 177.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 54.7 mttp . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.308 -0.627 . . . . 72.52 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.43 -56.13 4.5 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.457 -0.338 . . . . 44.22 112.711 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -84.72 170.11 13.59 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.344 0.658 . . . . 63.2 112.354 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 46.5 m 66.7 146.48 0.04 OUTLIER 'General case' 0 C--N 1.359 0.995 0 C-N-CA 125.723 1.609 . . . . 71.34 112.255 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.54 99.16 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.867 -0.79 . . . . 54.15 108.867 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -171.49 179.79 2.79 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.81 -1.541 . . . . 75.33 108.411 175.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' B' ' 56' ' ' TYR . 0.5 OUTLIER -151.81 -83.11 0.09 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.674 -0.491 . . . . 60.53 109.674 163.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -160.28 168.26 25.72 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.302 0.572 . . . . 74.22 111.692 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -159.82 111.02 1.97 Allowed 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.196 -1.365 . . . . 71.13 107.941 176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.22 98.37 0.6 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.737 0.815 . . . . 73.35 110.077 -176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -133.94 133.66 41.67 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.115 0.966 . . . . 71.32 109.011 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 70.9 161.03 0.16 Allowed Pre-proline 0 N--CA 1.488 1.462 0 C-N-CA 124.69 1.196 . . . . 74.43 112.233 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.15 -2.82 12.88 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.649 2.233 . . . . 72.33 112.769 173.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . 0.402 ' CE2' ' HB1' ' B' ' 95' ' ' ALA . 82.3 m-85 62.99 71.37 0.52 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 124.772 1.229 . . . . 74.12 109.872 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 54.48 -95.76 0.05 Allowed 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 113.633 -1.621 . . . . 74.34 111.469 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 14.7 t -177.88 146.89 0.44 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.515 1.126 . . . . 54.34 108.984 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.498 ' HB3' ' HD1' ' B' ' 133' ' ' PHE . 0.4 OUTLIER -163.02 93.96 1.15 Allowed Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 124.0 0.92 . . . . 74.15 109.213 177.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.82 172.08 16.99 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.937 2.424 . . . . 74.25 112.928 -176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.571 HD21 HD11 ' B' ' 128' ' ' LEU . 6.2 tp -115.87 -163.4 0.89 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.776 0.83 . . . . 72.25 109.866 -176.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' B' ' 129' ' ' ALA . 2.5 pp -130.41 168.77 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.38 1.072 . . . . 72.51 110.924 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -164.37 132.16 3.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.223 1.009 . . . . 75.32 108.577 175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -88.19 167.76 13.33 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-O 121.419 0.628 . . . . 72.3 112.632 -173.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -119.6 112.67 19.62 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.819 -1.178 . . . . 62.23 107.819 174.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -104.18 176.71 23.72 Favored Glycine 0 N--CA 1.47 0.912 0 O-C-N 123.178 0.299 . . . . 71.33 112.597 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 140.52 -171.15 24.14 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-O 119.776 -0.458 . . . . 65.45 112.334 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.91 -78.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.485 1.514 . . . . 75.21 111.546 -176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.35 86.98 4.39 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.959 0.903 . . . . 75.01 110.525 -176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.469 ' HB2' ' HB2' ' B' ' 37' ' ' GLN . 47.9 t80 -150.7 144.76 25.38 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 107.402 -1.333 . . . . 71.1 107.402 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . 0.726 ' HD3' ' HA ' ' F' ' 205' ' ' LYS . 0.0 OUTLIER -65.68 89.44 0.11 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.26 0.624 . . . . 72.35 111.808 -168.209 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' B' ' 35' ' ' ASP . 59.2 m-85 -147.45 -12.27 0.4 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.491 1.517 . . . . 70.23 108.462 159.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -155.51 -53.41 0.09 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.169 0.988 . . . . 75.42 109.188 162.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -102.54 96.11 6.69 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.513 -0.921 . . . . 73.14 108.513 177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.12 177.71 27.86 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 114.725 0.65 . . . . 75.32 114.725 -173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -153.36 -81.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.316 0.647 . . . . 73.35 109.816 176.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -105.36 11.65 32.52 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.996 0.519 . . . . 71.45 111.573 -166.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . 0.843 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 17.0 p-10 -156.21 147.02 21.98 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.547 0.739 . . . . 74.45 111.319 -177.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.705 HG23 ' HB3' ' C' ' 129' ' ' ALA . 30.1 pt -81.71 158.74 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.161 0.985 . . . . 72.12 111.151 -178.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . 0.726 ' HA ' ' HD3' ' F' ' 196' ' ' LYS . 97.9 mttt -75.78 -66.57 0.77 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.206 -0.664 . . . . 70.23 109.206 172.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -160.96 159.55 29.68 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.677 -0.692 . . . . 74.25 109.683 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.556 1.177 0 C-N-CA 123.972 0.909 . . . . 74.13 108.755 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 110.413 -0.217 . . . . 72.32 110.413 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.46 78.0 0.95 Allowed Glycine 0 C--N 1.35 1.319 0 N-CA-C 111.61 -0.596 . . . . 73.43 111.61 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.44 148.48 41.25 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.372 -0.603 . . . . 71.13 109.372 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 14.0 m -130.51 -41.6 1.2 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.407 1.083 . . . . 72.33 110.474 -175.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.5 -64.87 0.29 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.348 0.659 . . . . 75.34 110.807 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.486 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 2.8 tt 65.08 -71.69 0.08 Allowed 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 125.28 1.432 . . . . 32.43 109.901 -167.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 25.3 mmt -84.26 175.03 9.69 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.311 0.644 . . . . 72.53 110.375 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.434 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 43.0 p90 -149.5 167.34 26.52 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.031 0.532 . . . . 62.32 111.33 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.29 89.59 2.44 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.427 -1.323 . . . . 41.5 107.427 171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 20.0 tp -76.14 85.42 2.99 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.818 0.847 . . . . 71.31 110.894 -172.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -100.67 1.32 40.47 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 123.62 0.768 . . . . 71.44 111.351 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -136.39 163.01 53.02 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.942 0.897 . . . . 70.33 109.409 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.64 137.5 64.32 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.358 2.039 . . . . 61.44 112.278 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -78.8 -167.56 1.15 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.782 0.833 . . . . 72.42 110.528 173.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.0 100.34 0.31 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.525 -0.917 . . . . 73.02 108.525 175.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 28.2 m -58.3 146.14 35.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.513 1.125 . . . . 75.15 111.599 -173.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -131.35 144.98 55.67 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.567 0.747 . . . . 54.24 111.537 -169.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -59.03 158.02 27.01 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 123.835 3.023 . . . . 74.1 114.199 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 42' ' ' LEU . 9.1 tt -141.44 126.05 17.88 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.938 0.895 . . . . 71.5 108.6 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.404 HG13 HG13 ' A' ' 131' ' ' VAL . 2.4 pp -80.94 -171.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 124.78 1.232 . . . . 61.03 112.904 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -140.0 121.32 14.94 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.988 0.915 . . . . 75.44 109.331 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . 0.406 ' O ' HG11 ' A' ' 40' ' ' VAL . . . -140.68 104.52 4.74 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.122 0.569 . . . . 75.31 111.383 -175.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . 0.528 ' HB2' HG12 ' A' ' 40' ' ' VAL . 14.7 t70 -152.6 146.62 25.34 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 73.34 108.787 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -140.37 17.5 2.89 Favored Glycine 0 N--CA 1.475 1.293 0 O-C-N 123.861 0.726 . . . . 73.23 111.933 177.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -91.22 104.72 3.2 Favored Glycine 0 C--N 1.342 0.908 0 C-N-CA 123.161 0.41 . . . . 74.11 112.577 -176.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . 0.442 ' HB3' ' HG2' ' H' ' 198' ' ' GLU . 59.5 t80 -137.63 -38.14 0.59 Allowed 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.515 -0.92 . . . . 65.4 108.515 172.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -135.67 169.55 17.37 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 124.632 1.173 . . . . 74.22 108.917 172.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -167.81 -88.31 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.609 0.764 . . . . 75.25 109.386 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' G' ' 196' ' ' LYS . 0.0 OUTLIER -108.37 -33.88 6.96 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.555 0.742 . . . . 74.34 109.21 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -78.39 87.23 4.41 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.336 -0.847 . . . . 72.43 109.063 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -169.31 -56.65 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.969 -1.014 . . . . 73.44 109.171 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -158.01 169.69 24.0 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 108.208 -1.034 . . . . 64.15 108.208 -172.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 69.48 67.56 1.9 Allowed Glycine 0 C--N 1.341 0.809 0 N-CA-C 110.821 -0.912 . . . . 43.3 110.821 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -58.52 -34.04 70.53 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.183 0.593 . . . . 73.25 111.315 -176.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 70.2 t80 68.28 -78.01 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.85 1.26 . . . . 74.02 110.568 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 11.4 t70 66.34 149.86 0.05 Allowed 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 125.529 1.532 . . . . 61.14 111.087 -175.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.594 HD11 ' H ' ' D' ' 129' ' ' ALA . 19.0 tt -149.94 4.45 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-O 121.335 0.588 . . . . 71.13 110.42 -172.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . 0.517 ' HA ' ' HG2' ' B' ' 12' ' ' GLN . 13.4 tmtt? -80.5 138.9 36.59 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.509 -0.923 . . . . 64.32 108.509 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 33.4 t70 74.16 110.42 0.07 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.728 1.611 . . . . 72.53 111.193 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.56 1.34 0 C-N-CA 123.643 0.777 . . . . 62.22 109.807 177.108 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.936 -0.394 . . . . 72.42 109.936 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.93 75.4 1.27 Allowed Glycine 0 C--N 1.346 1.107 0 O-C-N 123.736 0.648 . . . . 33.13 113.087 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.81 76.64 5.3 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.151 -0.685 . . . . 74.4 109.151 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 33.6 t -154.58 55.93 0.68 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.296 0.638 . . . . 72.51 109.703 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -170.43 141.5 1.98 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.273 1.029 . . . . 33.24 109.125 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' D' ' 87' ' ' ALA . 1.6 tt -165.23 -68.78 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 109.2 -0.667 . . . . 62.41 109.2 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' D' ' 54' ' ' ASP . 30.9 mmt -92.58 92.25 7.94 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.658 -0.497 . . . . 74.33 109.658 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . 0.577 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 0.2 OUTLIER -86.96 -177.92 6.17 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.391 -0.822 . . . . 74.32 112.043 -173.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -128.05 137.89 52.35 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.373 1.069 . . . . 73.43 108.257 171.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -71.39 94.87 1.28 Allowed 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.241 -0.651 . . . . 62.21 109.241 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -81.93 -63.36 1.4 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.893 0.877 . . . . 74.54 110.803 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -141.52 151.87 61.89 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.928 0.891 . . . . 75.42 110.545 -173.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.36 153.83 61.17 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.407 2.072 . . . . 70.32 111.586 170.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -102.09 -52.84 3.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.014 0.926 . . . . 75.11 109.849 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -137.89 172.17 13.33 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.333 1.053 . . . . 73.53 110.476 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 36.8 p -74.07 148.22 42.1 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.784 0.834 . . . . 54.04 110.43 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 m95 -109.86 92.27 12.33 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.78 0.832 . . . . 74.44 109.34 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -86.34 115.13 1.33 Allowed 'Trans proline' 0 C--N 1.365 1.43 0 C-N-CA 122.642 2.228 . . . . 65.04 112.149 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' D' ' 44' ' ' LEU . 3.1 mm? -85.51 -179.58 6.94 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.463 -0.94 . . . . 75.43 108.463 169.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.445 ' HB ' HD13 ' D' ' 128' ' ' LEU . 3.4 mp -78.21 94.23 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 108.668 -0.864 . . . . 74.04 108.668 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.39 90.95 2.69 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.723 -0.843 . . . . 43.43 108.723 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -79.21 161.53 26.32 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 115.378 -0.828 . . . . 70.04 111.471 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -114.17 170.28 8.4 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.925 0.89 . . . . 73.22 109.69 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -77.08 -141.36 1.32 Allowed Glycine 0 C--N 1.351 1.378 0 CA-C-N 116.433 -0.349 . . . . 65.13 113.147 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 129.05 -150.15 18.73 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.987 -0.845 . . . . 74.41 110.987 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' D' ' 36' ' ' TRP . 79.2 m-85 -129.46 -175.57 3.62 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.566 0.746 . . . . 75.13 111.142 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . 73.64 90.53 0.09 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.747 1.619 . . . . 73.43 111.237 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -153.14 41.27 0.56 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 104.2 -2.518 . . . . 75.41 104.2 169.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -93.47 117.46 30.11 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 112.287 -2.233 . . . . 74.44 110.17 -160.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -82.32 -8.66 59.64 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 64.43 109.938 171.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' G' ' 193' ' ' TYR . 10.0 tp10 65.73 -96.72 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.812 1.645 . . . . 71.34 110.834 176.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -154.38 178.41 10.06 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.521 1.129 . . . . 61.42 109.132 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.54 81.81 0.29 Allowed Glycine 0 C--N 1.351 1.371 0 N-CA-C 110.72 -0.952 . . . . 61.4 110.72 171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -57.42 -54.38 47.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.953 1.301 . . . . 74.5 110.897 -171.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -73.98 0.37 Allowed 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.15 -0.477 . . . . 72.33 111.187 -176.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -162.01 -82.58 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.89 0.876 . . . . 73.11 108.675 -173.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 13.8 mt 51.87 54.62 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.374 0 C-N-CA 124.875 1.27 . . . . 73.43 110.857 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -103.53 -58.67 1.84 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.784 -1.098 . . . . 63.24 111.144 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -168.36 163.93 12.85 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.057 0.543 . . . . 74.14 110.208 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--O 1.256 1.428 0 C-N-CA 123.944 0.898 . . . . 72.1 108.774 168.35 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 111.638 0.236 . . . . 70.52 111.638 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 t -149.16 39.62 0.84 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 109.749 -0.463 . . . . 71.32 109.749 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.18 149.99 44.02 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.7 -0.682 . . . . 61.21 111.038 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -143.84 164.73 29.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.339 0.655 . . . . 61.13 109.894 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -131.81 106.78 8.32 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.603 0.761 . . . . 52.21 110.332 -176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.449 HD21 HE22 ' C' ' 142' ' ' GLN . 58.2 t30 -157.61 -66.61 0.09 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.283 0.633 . . . . 75.12 110.065 176.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 t -145.3 163.38 34.67 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.502 0.721 . . . . 61.22 110.225 -173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -74.55 -66.79 0.69 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.955 -0.757 . . . . 72.23 108.955 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.53 153.52 47.93 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.479 0.712 . . . . 73.31 111.058 -174.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -159.67 144.04 14.94 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.862 1.265 . . . . 73.31 109.633 174.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -106.25 141.32 37.78 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.587 -0.894 . . . . 71.4 108.587 170.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 7.4 tp-100 -149.16 139.74 22.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.043 0.537 . . . . 64.23 110.854 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.3 tp -94.81 127.2 46.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 123.803 0.841 . . . . 64.53 109.396 175.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.448 ' NE2' HG21 ' A' ' 83' ' ' ILE . 27.7 tt0 -103.09 -28.15 12.13 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 118.585 -0.721 . . . . 64.45 111.239 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -178.27 127.62 0.12 Allowed 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 118.777 0.717 . . . . 74.55 111.154 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.547 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 64.2 mt -107.93 133.58 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.557 -0.905 . . . . 73.22 108.557 168.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.761 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 14.4 p90 -170.16 164.66 9.2 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.511 0.724 . . . . 74.21 110.664 -176.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.6 p -85.97 117.69 24.98 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 108.77 -0.826 . . . . 63.32 108.77 172.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.557 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.6 mtpt -80.08 -29.95 39.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.345 -0.388 . . . . 64.31 110.145 171.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.6 t70 -153.97 148.12 25.79 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.54 0.525 . . . . 71.03 109.864 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.6 mt -138.74 145.4 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.969 1.307 . . . . 74.44 107.875 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.3 t -150.06 139.87 21.8 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.332 0.653 . . . . 63.23 109.761 173.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.529 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.7 t80 -145.22 112.26 6.01 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 106.415 -1.698 . . . . 64.25 106.415 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -123.02 109.99 14.8 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.243 -0.651 . . . . 61.34 109.243 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.28 86.49 9.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.79 -1.189 . . . . 71.24 107.79 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.02 -17.16 19.71 Favored 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.475 2.117 . . . . 72.13 111.343 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.99 31.12 6.65 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.269 1.027 . . . . 74.15 109.369 177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.465 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.54 -45.63 98.76 Favored Pre-proline 0 CA--C 1.565 1.523 0 CA-C-N 115.165 -0.925 . . . . 74.42 112.82 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -66.44 -25.05 48.84 Favored 'Trans proline' 0 C--N 1.398 3.161 0 CA-C-N 121.517 1.577 . . . . 74.41 112.456 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.4 m170 -71.02 -26.32 63.06 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.128 0.571 . . . . 74.22 111.006 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.2 p -65.67 -12.69 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 118.455 0.571 . . . . 74.23 111.904 -175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -70.15 -39.29 75.44 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 122.87 0.468 . . . . 72.43 110.668 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.459 ' HG3' ' HG2' ' A' ' 34' ' ' LYS . 9.1 pt20 -89.56 -38.71 13.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.308 0.643 . . . . 73.42 110.667 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.459 ' HG2' ' HG3' ' A' ' 33' ' ' GLN . 2.0 mmmp? -82.73 128.73 34.65 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.049 0.94 . . . . 63.42 109.219 -177.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.03 153.21 32.54 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 110.127 -0.323 . . . . 75.32 110.127 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.683 ' HB3' ' HB2' ' G' ' 195' ' ' PHE . 73.9 t-105 -81.59 78.99 8.27 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.998 0.428 . . . . 64.14 110.654 -177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -124.64 82.34 59.63 Favored Pre-proline 0 C--O 1.243 0.727 0 N-CA-C 107.459 -1.312 . . . . 70.53 107.459 168.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' H ' ' G' ' 193' ' ' TYR . 40.7 Cg_endo -84.8 158.58 11.98 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.324 2.016 . . . . 72.02 112.466 -176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -112.3 103.38 11.51 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 105.654 -1.98 . . . . 73.31 105.654 159.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.0 t -86.38 135.28 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.458 0.703 . . . . 70.21 109.704 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 87.6 tttt -110.89 129.77 55.77 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.458 0.703 . . . . 52.24 109.114 173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 128' ' ' LEU . 20.9 tp -97.2 109.74 22.43 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.149 -1.426 . . . . 74.02 107.149 166.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 25.5 t70 -105.74 139.76 39.83 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.068 -1.086 . . . . 62.01 108.068 173.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.13 128.08 41.1 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 107.689 -1.226 . . . . 65.44 107.689 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.557 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 28.0 t70 -140.7 159.23 42.65 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.224 1.01 . . . . 53.44 108.644 176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.491 HG23 HD12 ' G' ' 177' ' ' LEU . 12.9 t -133.95 159.32 41.07 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.425 0.631 . . . . 73.24 111.063 -176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -141.51 150.14 41.78 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.224 1.409 . . . . 53.41 107.727 173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -132.15 149.76 52.32 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 110.02 -0.363 . . . . 71.03 110.02 172.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -158.36 118.89 3.33 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.81 0.844 . . . . 64.12 108.729 179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -81.27 117.09 21.49 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.327 -0.62 . . . . 74.41 109.327 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.35 -43.29 12.99 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 122.86 0.464 . . . . 62.32 110.715 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.82 -174.1 4.46 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.72 0.808 . . . . 65.13 110.163 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -70.9 121.5 18.21 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 109.556 -0.535 . . . . 73.23 109.556 175.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' H ' ' HB2' ' G' ' 171' ' ' SER . 2.0 m-20 73.25 -7.25 1.56 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 126.176 1.79 . . . . 74.35 111.807 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.5 t -104.78 120.67 55.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 124.433 1.093 . . . . 72.11 108.712 -177.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 84' ' ' PHE . 7.8 p90 -135.34 170.51 15.82 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.218 -1.03 . . . . 72.51 108.218 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -131.23 136.8 48.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.28 -0.637 . . . . 72.3 109.28 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 75.4 t -114.42 121.29 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.62 -0.881 . . . . 62.34 108.62 170.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.8 t -100.5 125.99 54.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.982 -0.748 . . . . 72.25 108.982 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.82 114.93 26.6 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.343 -1.354 . . . . 74.0 107.343 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -92.39 99.56 12.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.633 -1.247 . . . . 61.42 107.633 170.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' HB1' ' A' ' 110' ' ' ALA . 11.9 t -94.62 135.12 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.83 -1.544 . . . . 73.0 106.83 171.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 31.8 m -134.09 123.34 24.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.538 0.685 . . . . 74.24 110.73 178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.625 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.1 t -109.18 107.76 23.65 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 C-N-CA 124.902 1.281 . . . . 65.51 108.779 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 m -108.23 112.79 25.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.623 -0.88 . . . . 71.31 108.623 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.74 116.85 28.3 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 107.417 -1.327 . . . . 63.44 107.417 -173.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.6 m -123.31 132.12 53.89 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.018 0.437 . . . . 74.24 110.867 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 62.0 mt -87.24 84.25 7.26 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.879 1.271 . . . . 71.35 109.217 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -91.02 1.1 Allowed Glycine 0 C--N 1.342 0.916 0 CA-C-N 114.935 -1.03 . . . . 65.3 111.525 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -111.38 -29.94 7.6 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.426 0.69 . . . . 60.25 110.681 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.13 133.33 35.44 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.305 0.642 . . . . 74.43 109.673 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.7 m -69.85 135.97 50.2 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 122.802 0.441 . . . . 64.42 110.954 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -78.4 -56.4 4.47 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.762 -0.829 . . . . 70.13 108.762 174.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -164.36 174.62 10.85 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 113.97 -1.468 . . . . 74.31 110.26 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -138.58 116.6 11.68 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.752 -1.113 . . . . 75.25 108.741 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.625 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.5 m -103.56 139.65 38.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.514 -0.921 . . . . 60.33 108.514 176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -146.88 117.88 7.71 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.616 -0.883 . . . . 75.11 108.616 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.8 t -123.04 113.84 39.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 C-N-CA 123.766 0.827 . . . . 72.54 109.413 -178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 16.0 mp0 -84.6 85.28 7.44 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 114.491 -1.232 . . . . 74.32 108.352 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -83.79 92.38 7.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 107.109 -1.441 . . . . 74.33 107.109 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.87 142.83 18.67 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.409 -0.676 . . . . 75.13 111.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.593 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.32 122.03 2.2 Favored Glycine 0 CA--C 1.499 -0.953 0 N-CA-C 110.759 -0.936 . . . . 71.31 110.759 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.448 HG21 ' NE2' ' A' ' 14' ' ' GLN . 39.4 mt -81.89 125.89 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 107.789 -1.189 . . . . 73.51 107.789 172.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 26.0 m-85 -128.59 164.58 22.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.36 0.664 . . . . 73.03 109.932 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 20.4 t -120.26 121.23 38.23 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.553 1.141 . . . . 75.43 109.212 173.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -138.55 150.1 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 123.378 0.671 . . . . 71.34 109.766 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.7 ' HB3' ' HB2' ' G' ' 168' ' ' LYS . . . 175.93 173.22 0.34 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.21 1.404 . . . . 50.34 110.211 167.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.69 6.96 88.67 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.952 0.783 . . . . 54.31 113.598 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.484 ' O ' HD21 ' G' ' 173' ' ' LEU . 1.3 pp -117.36 172.34 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.213 1.405 . . . . 73.11 109.427 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.488 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.6 tt0 -169.45 -177.63 2.85 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.814 0.846 . . . . 75.32 109.238 172.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.488 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 66.78 -142.81 42.62 Favored Glycine 0 C--N 1.346 1.107 0 C-N-CA 123.44 0.543 . . . . 70.11 113.808 172.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.9 t -68.91 -18.95 64.19 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.835 0.854 . . . . 75.32 111.527 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.57 -48.76 53.71 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 123.071 0.548 . . . . 74.55 109.586 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.604 ' SD ' HD23 ' G' ' 173' ' ' LEU . 9.2 ptm -69.55 -36.67 76.57 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 120.691 0.281 . . . . 53.13 110.316 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' N ' ' HG3' ' A' ' 94' ' ' MET . . . -71.06 -28.52 64.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.651 0.78 . . . . 60.11 111.221 -173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -90.27 -37.75 13.88 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.38 -0.373 . . . . 73.32 110.942 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.8 t -66.02 -52.98 44.3 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.905 0.482 . . . . 73.32 110.39 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.496 HD22 ' HE1' ' G' ' 175' ' ' PHE . 4.2 tt -76.33 -39.38 54.16 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 123.605 0.762 . . . . 72.33 109.853 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.99 -24.16 58.24 Favored Glycine 0 CA--C 1.535 1.293 0 N-CA-C 115.031 0.772 . . . . 60.44 115.031 -170.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.7 -42.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 117.927 0.864 . . . . 70.4 112.306 -173.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 59.4 t80 -78.73 -36.75 42.84 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 122.966 0.506 . . . . 74.14 112.339 -174.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.4 m -72.52 -41.05 7.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-O 118.551 -0.738 . . . . 74.24 111.446 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.88 -21.93 63.69 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 121.485 1.457 . . . . 61.4 113.129 165.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -67.07 -37.29 83.76 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 122.795 0.438 . . . . 75.1 109.977 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.9 mm -57.93 -41.8 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 121.618 0.723 . . . . 44.5 110.064 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.593 HD21 ' HA3' ' A' ' 82' ' ' GLY . 60.4 mt -80.12 -24.65 40.35 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.486 -1.233 . . . . 70.3 111.651 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -63.56 -39.49 48.76 Favored Pre-proline 0 CA--C 1.575 1.915 0 N-CA-C 114.782 1.401 . . . . 53.24 114.782 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.17 -40.11 72.64 Favored 'Trans proline' 0 C--N 1.398 3.146 0 C-N-CA 122.273 1.982 . . . . 74.43 112.58 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CD2' ' HG3' ' C' ' 108' ' ' PRO . 90.8 m-85 -77.13 -32.44 56.4 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.03 -0.986 . . . . 73.23 110.833 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -68.62 -43.44 76.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.536 0.734 . . . . 55.54 109.77 174.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.625 HH12 HD12 ' C' ' 105' ' ' ILE . 36.8 ttm180 -55.32 -54.26 45.85 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 124.629 1.205 . . . . 74.13 110.054 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -62.99 -40.58 98.2 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.347 1.029 . . . . 74.33 111.432 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.513 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.1 t -59.82 -37.01 77.96 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 123.919 0.762 . . . . 54.04 111.023 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.596 HG21 HG21 ' A' ' 64' ' ' VAL . 78.6 mt -72.52 -54.91 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.638 0.775 . . . . 64.41 110.147 175.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.468 HG23 ' HG3' ' A' ' 125' ' ' GLN . 98.6 m -52.13 -37.04 53.06 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.797 1.639 . . . . 70.2 111.607 -174.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.7 t -72.09 -45.65 59.82 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.073 -0.967 . . . . 60.24 110.629 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.529 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 50.4 mtm -59.56 -41.47 90.24 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.107 0.48 . . . . 73.14 110.899 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.97 -46.97 95.3 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 124.828 1.251 . . . . 73.13 110.848 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.9 p -72.15 -30.66 65.23 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.699 0.4 . . . . 55.24 111.353 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.0 -26.94 63.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.792 0.837 . . . . 70.31 110.418 175.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.75 7.77 57.72 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 115.897 -0.592 . . . . 73.05 113.342 175.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.7 m 66.98 30.85 7.34 Favored 'General case' 0 C--N 1.364 1.236 0 C-N-CA 124.671 1.188 . . . . 51.31 110.455 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -107.92 139.31 20.53 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.058 -1.089 . . . . 73.1 108.058 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -53.2 140.21 61.73 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.559 2.173 . . . . 63.41 112.609 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.468 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.0 tt0 -53.07 140.96 23.92 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.58 1.152 . . . . 62.15 112.163 -176.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.0 109.59 10.63 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 107.91 -1.145 . . . . 75.22 107.91 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -103.84 104.89 14.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.603 0.761 . . . . 70.44 108.96 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 42' ' ' LEU . 66.3 mt -72.48 116.95 13.54 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 109.294 -0.632 . . . . 70.02 109.294 172.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' HB3' HG21 ' G' ' 187' ' ' ILE . . . -57.66 149.27 52.8 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.522 1.129 . . . . 61.3 111.922 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.471 ' HG3' HH22 ' A' ' 111' ' ' ARG . 5.4 Cg_exo -71.01 -176.75 1.95 Allowed 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.573 2.182 . . . . 73.23 112.435 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -133.26 126.22 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.598 -0.89 . . . . 61.41 108.598 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.45 ' H ' HG11 ' H' ' 207' ' ' VAL . 17.0 p-10 -80.27 74.49 7.1 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.78 -0.822 . . . . 61.11 108.78 173.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -55.05 -43.44 73.8 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.674 0.79 . . . . 75.51 111.714 -174.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.21 -40.15 74.74 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.62 1.168 . . . . 75.42 111.653 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' C' ' 8' ' ' GLU . . . -74.13 -39.38 63.36 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.672 -0.695 . . . . 62.04 110.957 -178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.476 HD13 ' HG2' ' G' ' 185' ' ' PRO . 88.5 mt -72.31 -23.81 61.22 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.709 0.804 . . . . 70.22 110.957 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.484 ' HE2' ' HD2' ' G' ' 182' ' ' PHE . 62.6 t80 -70.5 -52.75 19.74 Favored 'General case' 0 C--N 1.352 0.703 0 N-CA-C 109.497 -0.557 . . . . 74.43 109.497 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 tpp -55.26 -45.23 76.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.748 0.819 . . . . 65.55 110.356 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.481 ' HA ' ' HB2' ' A' ' 143' ' ' GLN . 42.0 t30 -60.76 -41.21 95.01 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.377 1.071 . . . . 73.5 111.333 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -65.86 -38.23 88.29 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.782 -0.645 . . . . 74.12 110.671 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 90.3 mt -66.58 -51.27 58.25 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.41 0.444 . . . . 74.52 111.274 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -175.88 -15.46 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.713 0.633 . . . . 61.44 111.286 -178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 139' ' ' ASN . 25.0 tm0? 69.4 103.42 0.06 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.468 1.507 . . . . 64.34 112.078 176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -136.27 114.18 11.27 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.961 -1.125 . . . . 70.44 107.961 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.07 100.32 11.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.138 0.575 . . . . 73.52 110.188 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.611 ' HA2' ' HB3' ' C' ' 6' ' ' ASN . . . 85.08 63.55 1.58 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 116.661 -0.245 . . . . 54.54 113.396 173.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -69.48 -44.05 71.94 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.492 0.717 . . . . 75.0 109.574 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.73 165.81 12.78 Favored Glycine 0 C--N 1.341 0.86 0 CA-C-N 114.875 -1.057 . . . . 54.12 112.205 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.1 t 179.2 -170.59 0.12 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 125.879 1.672 . . . . 72.45 107.931 176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 65.98 40.97 3.86 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 122.506 1.146 . . . . 75.24 109.504 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -76.56 -3.13 35.91 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 114.68 -1.146 . . . . 73.5 111.71 -175.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 m-70 77.65 -68.5 0.16 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.868 1.667 . . . . 75.45 111.078 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 177.57 -20.02 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 125.026 1.331 . . . . 54.23 110.184 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -145.8 148.59 33.09 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.021 0.929 . . . . 64.14 109.163 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 124.068 0.947 . . . . 64.4 108.634 178.748 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 110.164 -0.31 . . . . 61.5 110.164 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 16.8 m -83.11 86.97 6.92 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 108.258 -1.015 . . . . 72.32 108.258 176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.541 ' HA ' ' HA ' ' F' ' 182' ' ' PHE . 18.9 mm-40 -86.54 81.94 8.1 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.437 0.637 . . . . 72.34 110.944 -171.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -115.51 -89.49 0.56 Allowed 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.788 -1.096 . . . . 74.34 108.164 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.428 HD21 ' HB1' ' B' ' 100' ' ' ALA . 3.0 t-20 -179.37 -169.87 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.726 1.21 . . . . 74.21 109.029 173.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.542 ' ND2' ' HG3' ' B' ' 93' ' ' GLN . 4.4 t30 -154.49 92.08 1.46 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.0 0.818 . . . . 70.31 109.646 174.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.4 m -74.58 104.53 5.3 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.392 0.677 . . . . 63.44 110.21 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.663 ' HG3' ' H ' ' B' ' 9' ' ' MET . 8.8 tp10 -168.24 -159.26 0.27 Allowed 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 125.107 1.363 . . . . 73.4 107.632 -172.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.663 ' H ' ' HG3' ' B' ' 8' ' ' GLU . 19.8 ptm 65.55 176.23 0.21 Allowed 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 126.911 2.084 . . . . 72.34 114.055 166.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.1 p -136.65 141.89 43.19 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.22 1.008 . . . . 75.43 108.824 -177.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.406 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 67.8 t80 -128.82 150.6 50.25 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.284 0.564 . . . . 75.41 111.899 -166.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 33.4 tp60 -142.54 123.63 14.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.054 1.342 . . . . 71.23 108.184 176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.14 143.83 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.134 0.573 . . . . 75.33 109.984 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -116.94 -51.61 2.55 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.776 0.43 . . . . 74.32 110.841 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -162.53 143.65 10.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.405 0.282 . . . . 73.02 110.256 -173.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -115.29 143.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 N-CA-C 107.381 -1.34 . . . . 63.32 107.381 171.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -170.71 144.08 2.25 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.565 0.62 . . . . 70.3 111.716 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.3 m -75.25 121.72 22.59 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.976 -0.75 . . . . 70.14 108.976 172.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -88.73 -37.96 15.09 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.12 0.568 . . . . 75.41 110.312 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.6 t70 -152.89 144.08 23.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.283 -0.417 . . . . 72.5 112.071 -168.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -137.99 147.34 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.472 1.509 . . . . 65.55 108.492 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 15.7 t -150.58 150.69 31.52 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.06 0.944 . . . . 73.23 108.78 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 85.9 t80 -160.19 114.7 2.24 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 106.625 -1.621 . . . . 72.31 106.625 174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.78 113.91 20.34 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 109.198 -0.667 . . . . 64.22 109.198 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.607 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.96 89.23 4.24 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.649 -0.871 . . . . 64.34 108.649 174.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.46 -27.11 33.85 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.409 2.073 . . . . 74.44 112.035 -175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -123.3 30.59 6.25 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.372 1.069 . . . . 74.21 109.661 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.761 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -42.47 -52.07 10.74 Favored Pre-proline 0 CA--C 1.568 1.659 0 C-N-CA 125.525 1.53 . . . . 62.43 114.431 172.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 10.4 Cg_exo -72.16 -17.61 27.8 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.359 2.04 . . . . 72.1 112.802 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -92.43 2.97 56.36 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.491 1.116 . . . . 73.23 111.244 -174.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.02 -27.95 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.807 0.443 . . . . 74.23 111.327 171.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -64.74 -41.03 96.23 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.247 0.619 . . . . 74.42 109.996 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -65.0 -29.6 70.53 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.562 1.145 . . . . 72.0 110.799 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' B' ' 68' ' ' LEU . 33.0 mmtp -108.85 96.72 6.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.317 1.047 . . . . 72.42 110.637 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -89.37 78.02 7.27 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.048 0.539 . . . . 74.54 111.287 -174.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.6 170.24 2.95 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 124.238 1.015 . . . . 64.2 109.727 171.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.539 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 48.9 tt0 -67.29 119.04 62.03 Favored Pre-proline 0 N--CA 1.476 0.868 0 O-C-N 123.789 0.681 . . . . 65.15 109.653 173.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' 37' ' ' GLN . 12.3 Cg_endo -56.53 140.58 89.85 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.129 1.886 . . . . 62.43 110.842 167.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.815 ' HA ' ' HA3' ' F' ' 191' ' ' GLY . 36.3 mt-10 -67.04 100.45 0.75 Allowed 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.708 -0.849 . . . . 73.51 108.708 176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.09 120.84 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 106.758 -1.571 . . . . 65.41 106.758 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -144.08 126.68 16.02 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 108.577 -0.898 . . . . 75.33 108.577 -172.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.5 HD13 HD11 ' B' ' 126' ' ' LEU . 1.8 pt? -129.29 159.02 37.45 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.982 0.513 . . . . 73.53 111.125 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -143.45 150.38 38.93 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.251 0.62 . . . . 74.11 110.77 -170.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.8 tp -84.13 144.03 29.29 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.726 1.21 . . . . 72.04 110.729 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -155.91 146.04 21.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.833 1.253 . . . . 75.21 107.787 167.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.3 m -145.78 139.71 26.62 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.108 0.563 . . . . 73.42 110.004 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.31 134.76 18.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.101 0.96 . . . . 71.31 108.848 175.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -132.62 166.09 22.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.326 0.65 . . . . 53.44 110.343 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 52.1 p -153.09 137.19 16.4 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.645 0.778 . . . . 75.12 109.454 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -80.85 120.38 24.62 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.331 0.652 . . . . 75.44 110.539 -173.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' B' ' 57' ' ' GLU . 38.4 mt -82.23 -50.03 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.754 0.822 . . . . 64.51 109.995 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.54 -171.11 3.72 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.272 1.029 . . . . 72.3 110.174 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.58 113.06 3.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.448 0.699 . . . . 61.12 110.56 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.4 m-20 71.06 -5.8 1.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 126.021 1.728 . . . . 45.12 112.694 -175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.3 t -102.68 116.62 46.72 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 108.15 -1.056 . . . . 53.31 108.15 -174.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.57 155.33 50.08 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.172 -0.677 . . . . 75.25 109.172 178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' B' ' 51' ' ' LEU . 6.9 tm-20 -111.68 112.28 23.87 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 107.342 -1.355 . . . . 75.42 107.342 -174.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -97.95 127.21 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.964 0.905 . . . . 63.43 110.031 -176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -108.36 128.22 64.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 123.714 0.805 . . . . 70.42 109.282 176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.44 109.11 20.97 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.794 -1.188 . . . . 74.22 107.794 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -93.41 119.25 32.29 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 122.838 0.455 . . . . 72.33 110.489 170.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.492 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.6 t -113.1 105.69 19.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.658 -1.238 . . . . 51.52 107.658 167.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -99.18 133.26 43.73 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.459 -0.571 . . . . 63.43 109.459 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.666 HG21 HG21 ' B' ' 114' ' ' ILE . 21.7 t -119.62 126.92 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.261 1.425 . . . . 63.51 109.069 -173.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -114.72 149.13 37.31 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 124.426 1.09 . . . . 54.13 108.27 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -137.33 153.01 50.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.136 0.575 . . . . 63.13 109.736 174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 33.5 p -146.13 141.23 27.31 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 123.606 0.566 . . . . 72.51 111.152 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' B' ' 34' ' ' LYS . 22.2 mt -130.17 99.82 5.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.253 1.421 . . . . 44.24 108.68 176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -109.15 2.78 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 116.339 -0.391 . . . . 55.3 112.411 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -118.09 23.6 11.52 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.387 1.075 . . . . 74.22 110.555 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -147.86 160.72 42.47 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.116 0.566 . . . . 73.21 110.301 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -72.61 134.25 45.07 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.763 -0.653 . . . . 65.11 110.249 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.11 -58.07 2.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.517 0.727 . . . . 50.2 109.271 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -153.19 173.54 15.4 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.787 -1.097 . . . . 63.31 109.779 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 73.2 mt -138.89 155.85 47.76 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.251 1.821 . . . . 71.11 106.473 175.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.565 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.4 t -160.49 159.59 30.99 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.81 0.844 . . . . 73.41 108.817 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -164.21 140.52 6.37 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 108.505 -0.924 . . . . 72.4 108.505 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.82 142.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.932 -1.136 . . . . 73.22 107.932 171.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.4 mt-30 -124.98 87.76 2.77 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.207 -1.035 . . . . 73.14 108.207 174.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -81.94 100.87 9.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 114.455 -1.248 . . . . 71.33 109.129 178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.43 175.22 35.8 Favored Glycine 0 C--O 1.241 0.534 0 N-CA-C 111.954 -0.458 . . . . 73.53 111.954 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -174.97 137.16 3.73 Favored Glycine 0 N--CA 1.449 -0.457 0 N-CA-C 111.932 -0.467 . . . . 64.44 111.932 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 70.7 mt -86.07 127.01 40.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 108.775 -0.824 . . . . 62.01 108.775 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -138.64 161.24 37.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.405 1.082 . . . . 64.3 109.581 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.0 m -132.39 133.6 44.13 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.777 1.231 . . . . 61.41 108.982 174.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.57 HG21 ' SG ' ' B' ' 97' ' ' CYS . 2.7 pp -139.18 147.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 122.876 0.47 . . . . 70.32 111.868 -171.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.92 170.58 16.32 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 123.986 0.915 . . . . 75.15 109.749 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.95 -26.12 16.31 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.426 -0.352 . . . . 65.22 113.482 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.14 142.54 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.037 0 C-N-CA 124.385 1.074 . . . . 51.34 112.848 -172.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.716 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 14.1 pt-20 -160.73 142.07 12.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.324 1.05 . . . . 65.5 109.026 169.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.08 -106.15 0.76 Allowed Glycine 0 C--N 1.354 1.564 0 C-N-CA 123.081 0.372 . . . . 34.11 113.928 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 55.2 m -77.21 -30.27 54.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.768 1.227 . . . . 43.43 111.796 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.716 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 1.5 mp0 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.421 0.689 . . . . 73.41 110.793 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.606 ' HE2' ' HD2' ' F' ' 175' ' ' PHE . 41.9 mtp -70.44 -39.79 74.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.607 0.763 . . . . 62.31 110.057 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.53 64.04 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 71.2 111.397 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.52 -39.23 92.88 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.334 0.654 . . . . 74.32 110.934 170.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.57 ' SG ' HG21 ' B' ' 86' ' ' ILE . 44.9 t -61.12 -61.56 2.48 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.109 -0.95 . . . . 73.35 111.635 -170.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -90.77 -18.4 25.0 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.575 0.583 . . . . 71.2 112.575 -176.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.68 -26.72 11.36 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.232 0.333 . . . . 75.1 113.673 -173.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' B' ' 5' ' ' ASN . . . -121.98 -55.96 1.86 Allowed 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.371 0.508 . . . . 54.32 112.371 -171.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -73.76 -60.06 2.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 122.524 0.33 . . . . 73.34 110.793 -169.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.406 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 85.8 m -58.49 -46.18 99.63 Favored Pre-proline 0 CA--C 1.565 1.53 0 CA-C-O 118.196 -0.907 . . . . 71.44 112.225 -177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -58.9 -36.52 96.78 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.039 1.826 . . . . 64.4 113.759 172.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -66.87 -29.83 69.84 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 118.625 0.648 . . . . 74.02 110.849 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.7 mt -63.04 -50.25 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.03 0.532 . . . . 75.14 109.877 169.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 59.5 mt -79.34 -10.42 59.81 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.162 -1.381 . . . . 64.2 111.883 -173.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.44 ' HE1' HD13 ' B' ' 128' ' ' LEU . 24.1 t80 -65.55 -49.67 60.77 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 124.654 1.181 . . . . 75.54 113.109 -171.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 112' ' ' GLU . 25.1 Cg_exo -62.31 -35.72 71.8 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 121.494 1.463 . . . . 73.42 111.353 177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.475 ' HE2' HG21 ' D' ' 115' ' ' THR . 72.9 m-85 -64.17 -48.6 75.35 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.069 0.947 . . . . 74.14 110.793 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.66 -49.08 74.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.127 0.971 . . . . 61.42 110.734 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -67.46 -43.31 81.36 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.95 0.781 . . . . 74.35 110.381 -174.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 108' ' ' PRO . 0.4 OUTLIER -69.26 -24.52 63.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.131 0.972 . . . . 74.42 111.609 178.63 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.7 t -74.16 -39.05 63.5 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 109.8 -0.445 . . . . 71.42 109.8 176.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 64' ' ' VAL . 94.2 mt -62.82 -46.76 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.604 0.762 . . . . 64.55 110.078 173.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.429 HG23 ' OE1' ' C' ' 125' ' ' GLN . 44.1 m -50.41 -39.52 47.45 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.958 1.303 . . . . 75.41 110.701 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.8 t -66.34 -56.15 12.51 Favored 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 113.957 -1.474 . . . . 72.34 110.552 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.7 mmt -64.26 -38.13 89.95 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 112.659 0.615 . . . . 73.54 112.659 -170.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 60.0 t -62.28 -46.41 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.421 1.088 . . . . 74.32 110.409 175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.568 ' HB3' ' NE2' ' C' ' 125' ' ' GLN . 81.9 p -71.71 -25.28 62.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.568 -0.742 . . . . 60.32 111.465 -177.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.513 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 81.1 mtt-85 -65.47 -39.44 91.96 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.158 0.583 . . . . 73.21 110.091 175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.11 3.85 50.06 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.631 -0.713 . . . . 61.2 113.15 172.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 33.0 p 59.72 48.98 8.65 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 126.512 1.925 . . . . 75.42 111.27 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -115.69 161.61 29.5 Favored Pre-proline 0 CA--C 1.568 1.654 0 CA-C-N 113.867 -1.515 . . . . 74.32 110.585 -178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.539 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 89.0 Cg_exo -53.2 177.13 0.07 OUTLIER 'Trans proline' 0 C--N 1.396 3.027 0 C-N-CA 125.031 3.82 . . . . 74.41 118.509 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -64.65 147.48 52.9 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 113.824 -1.534 . . . . 74.42 113.688 -177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.5 HD11 HD13 ' B' ' 42' ' ' LEU . 3.5 tm? -149.97 106.73 3.54 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.166 -1.379 . . . . 71.31 107.626 173.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -137.72 118.82 14.43 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.679 -1.23 . . . . 53.53 107.679 163.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.447 HD23 ' N ' ' B' ' 129' ' ' ALA . 2.2 tt -79.91 135.3 36.39 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.241 -0.652 . . . . 64.12 109.241 -174.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.447 ' N ' HD23 ' B' ' 128' ' ' LEU . . . -57.19 141.95 76.09 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.406 1.482 . . . . 70.31 113.078 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' D' ' 16' ' ' ILE . 61.4 Cg_endo -71.97 99.26 0.97 Allowed 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.673 2.249 . . . . 73.14 111.818 171.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -86.28 105.89 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 109.24 -0.652 . . . . 50.25 109.24 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.406 ' ND2' HD13 ' D' ' 13' ' ' ILE . 45.8 t30 -70.1 117.66 11.96 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.391 0.677 . . . . 72.35 110.719 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -83.44 -31.15 26.75 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 123.574 0.75 . . . . 73.22 112.911 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -66.78 -46.88 73.89 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.878 0.871 . . . . 74.15 112.41 -167.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' B' ' 139' ' ' ASN . . . -57.71 -30.5 65.58 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.421 0.688 . . . . 64.23 112.264 -175.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.46 -52.98 40.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.673 0.789 . . . . 65.21 110.455 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -64.76 -43.8 92.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.695 -0.684 . . . . 65.05 110.895 -177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.3 mmt -62.77 -36.05 81.83 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.53 0.732 . . . . 72.31 112.081 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 135' ' ' ALA . 1.9 t-20 -80.15 -40.34 27.54 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.145 -0.48 . . . . 63.4 110.391 -173.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -69.73 -36.35 75.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.614 0.765 . . . . 73.32 110.816 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -101.49 33.63 2.87 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.886 0.874 . . . . 74.24 110.509 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -70.04 99.57 1.48 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 107.965 -1.124 . . . . 75.14 107.965 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -155.14 92.76 1.46 Allowed 'General case' 0 C--O 1.24 0.572 0 N-CA-C 109.091 -0.707 . . . . 75.03 109.091 175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -84.88 90.47 7.79 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.998 0.919 . . . . 72.11 109.069 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.54 77.64 2.94 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.812 -0.631 . . . . 63.44 109.396 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 169.91 105.72 0.18 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.872 -0.604 . . . . 34.22 112.158 -177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -141.23 13.15 2.2 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.537 1.135 . . . . 63.42 110.298 176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.29 114.27 5.37 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.857 -0.61 . . . . 74.34 112.871 -174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 1.8 t -125.58 125.43 43.17 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.262 1.025 . . . . 74.34 109.066 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -65.66 138.15 57.8 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.462 0.705 . . . . 63.04 111.48 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -147.27 107.51 4.05 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.285 -1.006 . . . . 73.24 108.285 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 65.1 m-70 -120.04 61.05 0.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.468 1.107 . . . . 74.13 108.598 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -83.04 167.12 18.19 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.206 -1.361 . . . . 63.35 108.312 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.55 151.35 41.71 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.127 0.489 . . . . 71.5 111.222 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.11 0.964 . . . . 73.24 108.81 177.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.556 -0.535 . . . . 75.33 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 44.6 m -143.9 115.34 8.06 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.95 -1.13 . . . . 62.12 107.95 175.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.16 129.53 31.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.439 0.695 . . . . 73.4 110.303 -172.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -91.2 102.51 15.24 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.951 -0.759 . . . . 71.21 108.951 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -145.8 82.38 1.62 Allowed 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.936 -0.765 . . . . 63.13 108.936 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.611 ' HB3' ' HA2' ' A' ' 146' ' ' GLY . 42.6 m-80 -142.02 97.25 3.1 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.459 1.103 . . . . 71.24 108.614 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 12.0 t -167.58 164.84 14.72 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.756 0.823 . . . . 45.52 110.367 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.519 ' HA ' ' HB1' ' A' ' 135' ' ' ALA . 35.5 mt-10 -126.02 -64.02 1.07 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.819 0.848 . . . . 73.22 109.143 172.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 65.25 115.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.575 1.15 . . . . 63.53 112.842 173.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 89.0 m -102.35 94.61 5.79 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.226 1.01 . . . . 71.44 109.404 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' H' ' 207' ' ' VAL . 58.6 t80 -107.83 163.74 12.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.635 1.174 . . . . 73.13 111.317 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -167.57 135.35 2.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.023 0.929 . . . . 70.03 109.213 161.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.548 HD11 HG13 ' C' ' 16' ' ' ILE . 5.5 tp -78.55 133.62 29.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.03 -0.73 . . . . 72.21 109.03 167.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -103.7 -47.93 4.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.552 0.741 . . . . 42.11 110.388 176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -169.65 134.31 1.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 116.637 -0.256 . . . . 64.55 110.435 -170.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.548 HG13 HD11 ' C' ' 13' ' ' ILE . 92.3 mt -122.34 135.25 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.451 -0.944 . . . . 75.33 108.451 173.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.693 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 10.3 p90 -171.63 157.1 4.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.244 0.545 . . . . 70.2 111.821 -172.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -82.02 118.43 22.99 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.289 -0.869 . . . . 51.41 109.813 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.4 mmtp -69.76 -45.96 66.89 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.661 0.743 . . . . 71.11 109.216 172.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.7 t70 -146.29 146.41 30.71 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 113.882 -1.508 . . . . 65.3 108.956 -173.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.3 mt -138.99 140.16 39.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.99 -1.485 . . . . 72.33 106.99 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.1 t -152.52 148.63 27.61 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.273 0.558 . . . . 45.21 110.213 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -154.36 107.83 2.91 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 107.376 -1.342 . . . . 73.0 107.376 174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -117.43 112.09 20.19 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.415 -0.958 . . . . 74.53 108.415 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.22 95.93 32.74 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.403 1.081 . . . . 75.25 109.355 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -63.5 -39.88 33.85 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.793 2.328 . . . . 73.5 111.977 177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -96.25 29.4 2.85 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 114.931 -1.031 . . . . 75.55 111.202 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.43 -48.34 97.13 Favored Pre-proline 0 CA--C 1.573 1.843 0 CA-C-O 118.684 -0.674 . . . . 51.45 112.412 176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -86.58 -31.14 0.3 Allowed 'Trans proline' 0 C--N 1.394 2.967 0 C-N-CA 121.455 1.437 . . . . 63.23 113.387 170.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -71.13 -25.11 62.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.383 0.673 . . . . 70.03 112.415 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.93 -22.08 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 123.531 0.732 . . . . 72.1 111.546 176.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -57.44 -36.81 71.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.269 1.027 . . . . 65.4 111.12 -176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.86 45.94 1.75 Allowed 'General case' 0 CA--C 1.556 1.202 0 CA-C-O 121.996 0.903 . . . . 71.41 109.012 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.854 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -123.49 155.1 38.17 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.931 0.892 . . . . 70.42 110.859 -178.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -69.41 115.38 8.61 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.363 -0.977 . . . . 71.33 108.363 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -80.46 71.18 7.27 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.092 0.957 . . . . 71.43 111.887 -173.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' E' ' 193' ' ' TYR . 25.8 tt0 -122.66 78.18 47.7 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.897 0.879 . . . . 75.31 109.821 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' E' ' 193' ' ' TYR . 15.4 Cg_exo -71.06 128.58 15.02 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.262 1.975 . . . . 74.32 111.152 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -87.7 107.36 18.6 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 106.785 -1.561 . . . . 70.23 106.785 173.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 48.8 t -73.31 113.65 11.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 O-C-N 124.113 0.883 . . . . 75.12 109.913 -175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -121.07 115.43 23.09 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.457 -1.312 . . . . 73.4 107.457 176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.51 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.7 pt? -110.47 143.97 39.99 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.341 -0.985 . . . . 71.24 108.341 169.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -149.26 144.08 26.28 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.968 -0.752 . . . . 63.3 108.968 174.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.417 HD11 HD22 ' C' ' 60' ' ' LEU . 42.8 tp -113.89 123.94 51.0 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 123.588 0.555 . . . . 71.42 109.948 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -113.07 145.04 41.59 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.883 -1.525 . . . . 64.4 106.883 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -125.15 154.58 41.27 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.059 0.544 . . . . 64.13 110.001 -176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.6 161.51 39.64 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.499 1.119 . . . . 64.04 108.605 176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.3 p -158.88 152.75 23.36 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.88 0.472 . . . . 54.2 110.978 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.9 p -156.84 130.28 8.07 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.721 0.808 . . . . 72.53 109.937 176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -74.76 121.5 21.84 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.086 -0.709 . . . . 75.1 109.086 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' C' ' 57' ' ' GLU . 39.6 mt -94.98 -50.38 5.13 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.62 0.724 . . . . 74.42 110.864 -173.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -149.3 -172.19 4.07 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.749 -1.114 . . . . 74.25 109.945 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -69.96 113.89 7.61 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.852 0.461 . . . . 74.42 109.769 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 70.66 -0.38 2.97 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.674 1.589 . . . . 73.54 112.303 -177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 61.2 t -109.92 122.1 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.032 0.933 . . . . 60.42 108.483 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -134.66 176.58 8.51 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.679 0.752 . . . . 72.51 109.711 174.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.701 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.7 tt0 -125.39 141.41 52.08 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.444 -1.253 . . . . 72.11 108.159 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.85 140.18 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.09 -1.078 . . . . 75.12 108.09 164.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.2 t -126.38 116.5 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.99 0.916 . . . . 74.53 109.465 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.417 HD22 HD11 ' C' ' 44' ' ' LEU . 15.2 mt -87.8 104.88 16.99 Favored 'General case' 0 C--N 1.349 0.548 0 C-N-CA 122.761 0.424 . . . . 63.53 110.261 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -86.81 101.46 13.37 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.107 -1.071 . . . . 74.44 108.107 171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.1 t -99.84 132.0 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 N-CA-C 107.645 -1.243 . . . . 62.24 107.645 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -122.92 123.12 40.23 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.502 -0.555 . . . . 73.42 109.502 177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.643 HG21 HG21 ' C' ' 114' ' ' ILE . 92.7 t -103.34 113.75 41.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.369 1.067 . . . . 73.33 108.858 174.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -98.57 139.46 34.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.004 -1.11 . . . . 74.23 108.004 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.43 114.21 8.04 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.633 -0.877 . . . . 70.41 108.633 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.8 m -123.73 135.35 53.8 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.941 0.497 . . . . 70.42 111.015 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.854 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.3 mt -85.53 55.17 3.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.032 1.333 . . . . 75.55 109.148 177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.3 -110.18 3.81 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.943 -1.263 . . . . 74.55 109.943 -172.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -94.7 -23.72 17.45 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.876 . . . . 73.14 110.244 174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -91.47 108.63 20.03 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.4 1.08 . . . . 72.03 110.027 -175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 59.0 m -70.19 122.65 19.89 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.304 0.642 . . . . 70.13 112.43 -171.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.643 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -67.77 -58.47 4.57 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.607 1.163 . . . . 51.11 110.254 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -154.53 176.2 12.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 114.587 -1.188 . . . . 71.01 111.05 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -144.79 109.75 5.07 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 106.578 -1.638 . . . . 75.33 106.578 175.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.516 ' SG ' HG23 ' C' ' 114' ' ' ILE . 43.6 t -107.45 146.25 31.97 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.528 -0.916 . . . . 74.52 108.528 178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -158.24 129.77 6.65 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.807 -0.442 . . . . 71.21 109.807 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 71.9 t -130.24 138.88 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.309 1.044 . . . . 73.14 108.592 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.4 mt-30 -114.5 98.68 7.04 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.303 1.041 . . . . 63.5 108.753 175.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -91.33 105.24 17.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.938 0.895 . . . . 75.15 110.26 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.78 151.45 22.33 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.311 0.382 . . . . 52.51 112.274 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.54 121.34 1.27 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 111.448 -0.661 . . . . 75.0 111.448 179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.429 HD11 ' HB3' ' D' ' 29' ' ' PRO . 23.9 mm -82.69 127.8 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.747 -0.834 . . . . 75.12 108.747 174.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -136.23 126.03 25.69 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.335 0.654 . . . . 74.12 110.051 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.1 p -101.43 106.54 17.69 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.662 -0.866 . . . . 75.01 108.662 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.425 HD12 ' SG ' ' C' ' 97' ' ' CYS . 0.0 OUTLIER -148.42 143.94 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 121.622 0.725 . . . . 72.22 111.369 -177.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.62 179.38 7.47 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.293 1.437 . . . . 54.24 109.716 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -18.72 52.74 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 114.618 0.607 . . . . 64.03 114.618 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -80.02 166.61 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.331 0.653 . . . . 70.22 111.865 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.576 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 14.6 pt-20 -165.36 147.6 7.74 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.157 0.983 . . . . 73.15 109.668 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.2 -110.89 2.22 Favored Glycine 0 C--N 1.352 1.44 0 N-CA-C 114.486 0.554 . . . . 73.35 114.486 170.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 82.7 p -68.85 -37.75 79.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.422 1.089 . . . . 62.53 111.34 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.576 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 22.2 mt-30 -60.66 -42.19 96.52 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.568 0.747 . . . . 73.23 109.722 174.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 41.8 ttm -63.89 -47.31 81.13 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.976 0.911 . . . . 65.31 111.053 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.295 -0.866 . . . . 74.24 110.854 -177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -74.68 -24.91 58.86 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.98 -0.554 . . . . 74.23 111.731 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' C' ' 86' ' ' ILE . 42.7 t -72.06 -62.71 1.33 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.84 0.456 . . . . 74.43 111.503 -176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.84 -6.86 24.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.764 -0.585 . . . . 70.02 112.433 -176.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.64 2.61 49.3 Favored Glycine 0 C--N 1.347 1.155 0 CA-C-O 119.669 -0.517 . . . . 70.31 113.286 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.526 ' HA ' ' HZ3' ' E' ' 184' ' ' TRP . . . -154.56 -58.55 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.267 0.533 . . . . 75.31 111.858 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -65.4 -67.9 0.4 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.36 1.064 . . . . 74.44 112.212 -168.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -57.84 -43.98 99.05 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.299 1.039 . . . . 54.35 112.813 -175.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.35 -34.18 55.89 Favored 'Trans proline' 0 C--N 1.39 2.721 0 C-N-CA 121.638 1.559 . . . . 75.14 113.575 170.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -72.0 -19.14 61.91 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 118.76 0.709 . . . . 73.1 110.866 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.625 HD12 HH12 ' A' ' 111' ' ' ARG . 40.5 mm -66.08 -41.75 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.515 0.726 . . . . 73.44 109.551 167.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.53 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.1 mt -79.13 -28.1 42.85 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.26 -0.882 . . . . 62.33 112.053 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -53.74 -45.97 98.56 Favored Pre-proline 0 CA--C 1.564 1.51 0 CA-C-O 117.364 -1.303 . . . . 73.14 113.271 -174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.418 ' HG3' ' CD2' ' A' ' 109' ' ' TYR . 47.4 Cg_exo -53.96 -40.54 80.56 Favored 'Trans proline' 0 C--N 1.398 3.164 0 C-N-CA 122.329 2.019 . . . . 72.11 113.274 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -69.21 -43.57 73.83 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.445 0.698 . . . . 53.22 110.651 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.82 98.73 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 71.33 110.718 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -57.94 -48.54 79.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.81 1.644 . . . . 73.54 110.751 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.434 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -72.35 -33.94 67.64 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.771 0.828 . . . . 65.42 110.541 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.0 t -65.03 -43.34 92.71 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.71 0.804 . . . . 54.33 110.466 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.643 HG21 HG21 ' C' ' 64' ' ' VAL . 87.9 mt -66.52 -50.03 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.212 0.605 . . . . 62.33 110.23 176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.467 HG23 ' HB2' ' C' ' 125' ' ' GLN . 58.8 m -50.15 -44.28 52.5 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 124.555 1.16 . . . . 75.31 111.055 -176.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.4 t -68.77 -46.82 67.76 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.484 -1.234 . . . . 75.4 110.012 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.602 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.75 -43.89 63.1 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.013 0.925 . . . . 63.54 112.229 178.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 114' ' ' ILE . 62.1 t -66.1 -45.38 90.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.489 0.716 . . . . 63.54 110.668 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -70.47 -26.51 63.66 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.926 -0.579 . . . . 62.02 111.229 -175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.3 mtt-85 -65.99 -38.59 88.88 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.784 0.833 . . . . 74.23 110.413 174.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.69 3.7 63.09 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 115.755 -0.657 . . . . 54.11 112.826 172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 25.5 p 63.32 33.42 14.0 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.349 1.86 . . . . 61.45 112.152 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.43 168.09 9.02 Favored Pre-proline 0 CA--C 1.56 1.337 0 C-N-CA 124.721 1.208 . . . . 71.12 109.609 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.48 106.51 0.6 Allowed 'Trans proline' 0 C--N 1.392 2.837 0 C-N-CA 122.386 2.058 . . . . 73.23 110.984 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' B' ' 119' ' ' SER . 18.7 pt20 -54.45 135.53 45.4 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.301 1.04 . . . . 72.22 111.842 -177.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.01 89.67 3.71 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.402 0.62 . . . . 63.15 109.969 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -111.5 86.42 2.33 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.603 -1.629 . . . . 61.41 106.603 167.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.527 ' HB3' HD11 ' E' ' 187' ' ' ILE . 76.4 mt -87.52 153.8 21.13 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.261 -1.336 . . . . 73.24 109.985 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' E' ' 187' ' ' ILE . . . -45.25 127.84 5.85 Favored Pre-proline 0 CA--C 1.556 1.193 0 O-C-N 124.599 1.187 . . . . 52.01 112.817 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.547 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 37.0 Cg_endo -61.08 104.16 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.558 2.839 . . . . 61.03 113.054 -176.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 10.6 m -70.68 91.66 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.354 0 CA-C-O 121.955 0.883 . . . . 64.41 111.076 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -88.54 102.39 14.88 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.241 -1.022 . . . . 71.24 108.241 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.77 -36.9 82.39 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.877 0.871 . . . . 74.5 112.325 -173.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.78 -43.28 80.11 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.3 0.64 . . . . 75.44 111.612 -170.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.26 -39.19 93.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.168 0.587 . . . . 44.22 110.654 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.4 -31.54 69.98 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.017 0.927 . . . . 73.22 110.682 177.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -70.66 -45.02 65.88 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.994 0.917 . . . . 54.14 110.769 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.0 mtm -72.46 -33.26 66.91 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.959 -0.564 . . . . 72.22 110.535 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -65.38 -37.87 88.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.733 0.813 . . . . 73.22 110.251 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.57 -79.52 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.863 1.265 . . . . 71.1 110.839 177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.97 -38.84 68.3 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.504 1.122 . . . . 71.51 110.454 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.449 HE22 HD21 ' A' ' 6' ' ' ASN . 44.4 tt0 69.64 9.81 7.35 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.284 1.434 . . . . 75.11 111.804 176.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 59.73 -81.12 0.02 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.63 1.572 . . . . 74.23 112.786 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.97 143.06 33.03 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.52 -0.918 . . . . 53.0 108.52 -174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.69 -179.75 4.91 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.608 0.718 . . . . 61.12 111.18 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.27 -140.71 5.57 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.902 -1.279 . . . . 73.45 109.902 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -125.5 -62.69 1.18 Allowed 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 117.811 0.805 . . . . 75.43 110.415 174.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.74 78.46 1.41 Allowed Glycine 0 C--N 1.342 0.899 0 N-CA-C 109.977 -1.249 . . . . 43.15 109.977 -165.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.3 t -71.04 135.77 47.96 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.804 0.842 . . . . 44.33 110.255 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.64 113.5 25.32 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.787 -0.82 . . . . 72.53 108.787 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.462 ' H ' ' HB3' ' G' ' 170' ' ' LYS . 11.6 mm-40 -100.33 -82.3 0.45 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.323 1.049 . . . . 74.55 111.083 -177.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 m170 58.32 147.78 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 124.935 1.294 . . . . 72.31 113.474 -172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -109.09 87.14 2.42 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.773 -1.195 . . . . 73.11 107.773 168.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -90.02 -13.23 36.46 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.968 -1.014 . . . . 61.45 110.9 -174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.06 0 C-N-CA 123.84 0.856 . . . . 64.32 110.6 -178.251 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' H' ' 172' ' ' ALA . 16.9 ptt? . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 121.352 0.596 . . . . 71.34 109.497 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 61.8 p -128.39 7.72 5.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.045 0.538 . . . . 54.13 112.094 -175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.55 134.06 38.85 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.354 0.662 . . . . 74.15 109.541 175.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -126.43 105.24 8.63 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.15 0.98 . . . . 75.45 109.631 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.509 HD22 HG23 ' D' ' 7' ' ' THR . 3.8 t30 -75.16 143.78 43.08 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.572 -0.899 . . . . 65.42 108.572 165.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -69.04 99.49 1.1 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.736 -0.468 . . . . 74.22 109.736 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.509 HG23 HD22 ' D' ' 5' ' ' ASN . 5.0 p -122.0 136.79 54.95 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 125.019 1.327 . . . . 62.14 108.331 172.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -73.79 83.53 1.64 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.102 -0.703 . . . . 72.22 109.102 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.8 ttp -32.89 123.51 0.37 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.67 1.588 . . . . 71.22 112.937 178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -120.14 138.94 53.3 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.763 0.825 . . . . 73.42 108.779 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -156.57 111.1 2.78 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.691 -1.226 . . . . 63.44 107.691 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.473 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 79.2 mt-30 -117.66 116.63 27.45 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.565 0.746 . . . . 71.14 110.312 -177.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.406 HD13 ' ND2' ' B' ' 132' ' ' ASN . 1.7 mp -75.91 104.87 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.928 -1.508 . . . . 61.23 106.928 168.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.466 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 76.3 mt-30 -80.79 -41.9 22.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 119.106 -0.473 . . . . 75.13 110.759 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 34.9 ttp-105 177.96 144.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 123.686 0.616 . . . . 75.23 111.722 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.551 ' H ' ' HG3' ' B' ' 130' ' ' PRO . 2.0 mp -105.48 132.14 53.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 107.316 -1.364 . . . . 72.35 107.316 170.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -158.28 159.8 36.35 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.321 1.049 . . . . 74.53 109.628 -174.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -92.37 118.13 30.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.99 -0.55 . . . . 72.14 109.812 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -89.07 -32.75 17.4 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.758 -0.655 . . . . 72.43 109.827 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 30.8 t70 -146.06 134.02 21.4 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.118 -0.946 . . . . 63.43 108.902 178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.602 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.3 mt -130.44 140.49 48.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.578 -1.268 . . . . 60.34 107.578 172.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.1 t -142.19 136.15 29.65 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.101 0.96 . . . . 73.34 108.837 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.517 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -144.31 119.83 10.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 105.558 -2.016 . . . . 72.43 105.558 166.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -121.69 134.29 54.96 Favored 'General case' 0 C--O 1.22 -0.482 0 N-CA-C 108.973 -0.751 . . . . 72.42 108.973 175.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.53 82.22 47.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 106.758 -1.571 . . . . 74.31 106.758 170.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -65.91 -30.22 48.9 Favored 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.61 2.207 . . . . 71.44 112.043 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -110.7 24.9 12.38 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 114.726 -1.125 . . . . 52.54 109.898 -178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.693 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -41.22 -60.97 1.49 Allowed Pre-proline 0 CA--C 1.584 2.253 0 N-CA-C 116.018 1.859 . . . . 73.01 116.018 -170.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.429 ' HB3' HD11 ' C' ' 83' ' ' ILE . 94.4 Cg_endo -79.6 -17.06 11.43 Favored 'Trans proline' 0 C--N 1.399 3.214 0 CA-C-N 122.923 2.08 . . . . 74.34 113.293 176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -73.41 -39.22 65.23 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.989 1.316 . . . . 73.44 110.295 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.751 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.5 p -86.24 -7.86 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 C-N-CA 124.296 1.038 . . . . 74.31 111.156 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -57.52 -25.34 59.71 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.363 1.065 . . . . 74.31 111.176 169.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -68.54 -14.21 62.85 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.232 1.013 . . . . 51.41 112.259 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.428 ' HB3' HD22 ' D' ' 68' ' ' LEU . 0.1 OUTLIER -96.92 106.28 18.57 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.854 0.862 . . . . 51.21 109.394 179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' H' ' 196' ' ' LYS . 9.8 p-10 -112.7 50.08 0.89 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.579 1.152 . . . . 74.11 110.604 -171.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -146.59 177.51 9.01 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.009 0.924 . . . . 75.42 110.509 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -62.05 113.98 10.16 Favored Pre-proline 0 N--CA 1.486 1.364 0 C-N-CA 124.058 0.943 . . . . 74.22 111.345 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HG3' HD21 ' D' ' 68' ' ' LEU . 15.4 Cg_exo -71.31 144.84 46.94 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 123.024 2.483 . . . . 55.14 113.037 173.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -72.87 142.69 47.94 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.489 -0.778 . . . . 73.13 109.053 164.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.523 HG13 HG13 ' D' ' 64' ' ' VAL . 95.7 t -124.95 118.08 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.21 108.385 169.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -112.67 118.26 34.55 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.24 -0.652 . . . . 64.13 109.24 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.642 HD21 HD22 ' D' ' 128' ' ' LEU . 5.7 mp -96.88 125.45 41.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.475 0.71 . . . . 75.32 109.696 -174.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.811 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.1 m-20 -107.06 126.86 52.9 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.459 -0.941 . . . . 73.01 108.459 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.58 132.23 40.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.258 0.623 . . . . 75.32 109.89 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.1 t70 -157.62 156.18 31.39 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 170.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -136.51 165.89 24.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.6 0.76 . . . . 63.42 109.794 176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.531 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.99 177.57 10.03 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.889 1.275 . . . . 71.3 108.473 178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 61.4 p -165.36 166.63 18.46 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.847 0.459 . . . . 73.43 111.249 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.6 p -154.24 131.69 11.28 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 124.292 1.037 . . . . 71.31 108.328 171.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.4 117.85 20.02 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.941 -0.762 . . . . 71.42 108.941 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.424 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.3 mt -92.27 -33.4 14.66 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.708 -0.478 . . . . 65.15 109.708 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.39 -177.04 5.06 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.538 0.735 . . . . 73.4 111.064 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -65.92 124.55 22.8 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.02 -0.991 . . . . 65.22 109.005 174.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 16.6 m-20 65.7 19.27 11.38 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.183 0.993 . . . . 64.34 111.821 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.24 119.93 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.735 0.814 . . . . 64.51 109.643 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.418 ' HE1' ' SD ' ' H' ' 174' ' ' MET . 20.1 m-85 -134.03 130.84 38.12 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.023 0.929 . . . . 71.12 108.668 175.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.424 ' HB2' HD11 ' D' ' 51' ' ' LEU . 4.2 tt0 -86.78 119.6 27.18 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.512 -1.292 . . . . 74.35 107.512 169.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -100.16 129.1 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.635 -1.246 . . . . 73.1 107.635 176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.3 t -104.79 138.66 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 124.04 0.936 . . . . 54.32 108.944 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -106.4 124.32 49.41 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.43 -1.322 . . . . 74.31 107.43 174.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.7 ttm-85 -99.5 98.99 9.82 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 107.544 -1.28 . . . . 72.11 107.544 173.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.611 HG21 ' HB1' ' D' ' 110' ' ' ALA . 9.3 t -100.51 112.72 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.397 -0.964 . . . . 75.24 108.397 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.811 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -114.5 145.76 41.51 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 109.791 -0.448 . . . . 72.32 109.791 -175.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.523 HG13 HG13 ' D' ' 40' ' ' VAL . 39.3 t -133.95 105.17 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.889 1.276 . . . . 60.22 109.101 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 10.0 m -98.07 96.47 8.15 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.085 -1.08 . . . . 70.25 108.085 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.98 147.71 24.22 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.972 0.509 . . . . 44.12 110.131 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -137.23 133.49 35.17 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.346 0.593 . . . . 74.14 111.939 -176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.444 HD21 ' HG3' ' D' ' 38' ' ' PRO . 9.4 mt -119.69 108.87 14.97 Favored 'General case' 0 C--O 1.244 0.795 0 C-N-CA 125.008 1.323 . . . . 75.01 108.402 173.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.2 -118.41 4.62 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.724 -0.551 . . . . 75.01 111.724 -177.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.75 4.72 15.06 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.534 0.734 . . . . 72.2 110.707 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -122.48 171.75 8.86 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.484 0.714 . . . . 71.45 110.549 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 82.8 m -68.18 123.76 21.6 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.938 -1.028 . . . . 73.12 110.734 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.751 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -73.35 -65.41 0.82 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.422 -0.955 . . . . 73.21 108.422 170.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -156.76 157.05 34.35 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.843 -1.072 . . . . 64.45 109.83 172.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -113.05 152.11 29.91 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 125.124 1.37 . . . . 70.34 108.608 171.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 39.3 t -157.85 143.39 17.05 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.487 0.715 . . . . 73.44 109.092 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -156.23 128.99 7.82 Favored 'General case' 0 C--O 1.223 -0.321 0 N-CA-C 109.557 -0.535 . . . . 64.45 109.557 172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -126.18 115.29 42.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 109.013 -0.736 . . . . 70.21 109.013 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.1 mt-30 -88.69 85.63 6.83 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.189 0.995 . . . . 41.33 108.627 170.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.461 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -80.04 96.9 6.6 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 113.324 -1.762 . . . . 75.2 108.241 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -97.72 144.14 17.11 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 112.061 -0.416 . . . . 70.55 112.061 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.61 137.64 7.37 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 111.366 -0.694 . . . . 50.13 111.366 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 62.0 mt -88.08 125.45 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.901 -0.777 . . . . 73.43 108.901 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -130.79 123.87 30.1 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.643 0.777 . . . . 74.55 109.62 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 66.5 m -80.77 106.23 12.62 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.611 -0.885 . . . . 62.03 108.611 170.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.7 pt -108.23 103.55 15.66 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.998 0.904 . . . . 74.25 110.007 -174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -140.96 150.92 43.73 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.985 0.914 . . . . 71.54 109.711 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.6 14.83 75.22 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.093 0.246 . . . . 74.12 113.192 176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.667 HD12 ' HG2' ' D' ' 94' ' ' MET . 24.7 pt -98.59 125.63 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.365 1.066 . . . . 65.11 108.708 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -140.67 172.83 12.15 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 121.228 0.537 . . . . 64.13 112.01 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.23 -143.9 47.92 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.31 -1.314 . . . . 74.34 113.684 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 28.6 m -85.32 -20.21 30.33 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.106 0.962 . . . . 62.4 110.724 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -61.82 -35.87 79.49 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.472 0.709 . . . . 63.44 110.627 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.667 ' HG2' HD12 ' D' ' 89' ' ' ILE . 0.3 OUTLIER -58.33 -49.26 77.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.527 0.731 . . . . 71.35 110.69 175.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.86 -43.01 94.9 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 115.309 -0.86 . . . . 71.33 111.047 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -71.25 -30.88 66.85 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.64 -0.709 . . . . 64.14 111.261 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -68.67 -48.35 64.18 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.822 0.449 . . . . 73.11 110.411 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -73.57 -36.5 65.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.141 0.576 . . . . 54.11 110.212 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.55 6.5 77.63 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.221 -0.766 . . . . 72.45 114.785 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -152.75 -57.92 0.14 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 118.364 1.082 . . . . 55.23 112.341 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -64.75 -51.7 60.93 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.183 0.593 . . . . 72.11 111.49 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.524 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 27.9 m -60.73 -47.93 94.5 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-O 118.498 -0.763 . . . . 75.44 111.357 -177.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.2 Cg_exo -59.29 -31.38 94.98 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.418 2.078 . . . . 65.3 113.968 168.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -68.7 -31.29 70.28 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.861 0.465 . . . . 73.4 110.706 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.3 -33.82 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.505 0.722 . . . . 64.3 110.281 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.526 HD23 HG13 ' D' ' 16' ' ' ILE . 86.0 mt -76.95 -25.61 53.05 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.049 0.939 . . . . 73.4 111.731 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -63.74 -41.99 68.51 Favored Pre-proline 0 CA--C 1.572 1.792 0 N-CA-C 114.94 1.459 . . . . 64.1 114.94 -168.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.53 -41.85 71.71 Favored 'Trans proline' 0 C--N 1.399 3.214 0 C-N-CA 122.106 1.87 . . . . 62.35 113.234 176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -80.15 -30.74 38.95 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.134 -0.939 . . . . 65.3 110.365 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.611 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -63.89 -44.91 91.6 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.722 0.809 . . . . 72.42 110.179 172.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -58.0 -51.29 70.28 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 124.629 1.206 . . . . 64.44 110.515 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -63.2 -41.92 99.23 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 124.143 0.902 . . . . 73.43 110.559 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -56.51 -45.21 81.2 Favored 'General case' 0 C--N 1.349 0.58 0 O-C-N 123.808 0.693 . . . . 63.04 110.356 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.457 HG12 ' SG ' ' D' ' 76' ' ' CYS . 77.4 mt -63.9 -54.94 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 O-C-N 124.024 0.828 . . . . 74.52 110.375 173.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.475 HG21 ' HE2' ' B' ' 109' ' ' TYR . 86.8 m -51.38 -46.74 62.89 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.152 1.381 . . . . 75.12 111.893 -171.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -65.53 -44.5 86.71 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.6 -1.182 . . . . 62.41 110.271 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.7 mtm -65.74 -32.71 74.42 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.03 0.532 . . . . 71.32 111.692 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -63.93 -48.26 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.77 0.828 . . . . 55.23 109.982 175.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -72.25 -28.63 63.27 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.983 -0.553 . . . . 64.1 110.937 -177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -69.81 -34.23 73.42 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.624 0.77 . . . . 74.44 110.041 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.48 8.65 64.16 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 115.982 -0.554 . . . . 64.32 113.001 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 70.8 p 61.27 30.62 19.26 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.956 1.702 . . . . 74.31 113.119 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.401 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 74.2 m-85 -100.9 163.43 18.05 Favored Pre-proline 0 CA--C 1.563 1.478 0 C-N-CA 124.708 1.203 . . . . 71.11 108.697 171.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 73.1 Cg_endo -71.12 143.21 43.78 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.212 1.942 . . . . 71.31 111.55 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -52.13 132.97 33.77 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.792 0.682 . . . . 75.11 111.384 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.454 HD13 HG21 ' D' ' 40' ' ' VAL . 29.4 tp -108.89 108.23 18.92 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.148 0.979 . . . . 71.33 109.715 -178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -102.12 102.75 13.25 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.395 0.678 . . . . 54.1 109.603 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.642 HD22 HD21 ' D' ' 42' ' ' LEU . 38.5 mt -72.75 118.47 15.72 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.125 -0.694 . . . . 75.45 109.125 177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.76 125.09 79.25 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.341 0.656 . . . . 62.25 111.25 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -67.64 103.34 0.82 Allowed 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.136 1.891 . . . . 72.34 110.605 178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.44 HG23 HG22 ' G' ' 207' ' ' VAL . 2.8 p -106.84 110.12 30.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-O 122.107 0.956 . . . . 72.33 109.915 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -77.77 107.04 9.99 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.413 -1.267 . . . . 73.05 108.098 173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.495 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 68.0 m-85 -68.04 -25.42 65.36 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.769 0.827 . . . . 73.21 111.285 -176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.48 -22.58 66.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.046 1.338 . . . . 71.44 112.305 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.19 -45.27 79.84 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.503 0.721 . . . . 53.44 111.582 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.521 HD11 HG11 ' G' ' 207' ' ' VAL . 6.1 mp -75.31 -34.74 61.28 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.537 0.735 . . . . 74.24 111.065 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -63.3 -65.16 0.72 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.861 0.864 . . . . 73.42 109.588 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 72.5 mtm -59.37 -26.62 65.24 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.678 1.191 . . . . 74.44 112.354 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -62.0 -44.84 95.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.146 0.578 . . . . 73.54 110.483 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -63.05 -41.58 99.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.894 0.478 . . . . 70.44 110.765 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -66.7 -38.2 86.26 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.823 -0.626 . . . . 64.2 111.56 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -83.86 5.95 23.32 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.021 0.528 . . . . 73.44 111.277 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -118.95 49.06 1.36 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 107.637 -1.246 . . . . 72.12 107.637 172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -139.33 13.69 2.59 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 114.073 -1.422 . . . . 62.14 108.814 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.98 146.09 24.89 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.112 0.965 . . . . 71.41 109.791 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -169.14 -148.86 5.96 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-O 120.076 -0.291 . . . . 74.04 112.572 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -149.71 138.19 20.73 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.088 0.555 . . . . 73.23 110.111 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.45 175.93 50.89 Favored Glycine 0 C--N 1.344 1.021 0 O-C-N 123.528 0.517 . . . . 63.21 112.803 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 34.4 m -75.92 102.53 5.6 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.943 0.497 . . . . 75.23 110.265 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -133.75 143.41 48.43 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.625 -0.88 . . . . 75.15 108.625 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -92.49 134.36 35.04 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.484 1.114 . . . . 71.11 110.506 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -103.03 109.48 21.05 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.912 -1.144 . . . . 74.13 107.912 166.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -73.41 139.49 45.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.421 0.451 . . . . 73.24 110.076 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.34 172.92 7.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.961 0.904 . . . . 74.44 110.313 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 N-CA-C 108.648 -0.871 . . . . 73.44 108.648 170.337 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 110.32 -0.252 . . . . 72.25 110.32 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.43 -153.88 23.83 Favored Glycine 0 C--N 1.345 1.039 0 O-C-N 124.018 0.824 . . . . 61.12 111.222 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 66.79 129.79 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.126 1.371 . . . . 61.54 111.945 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 66.8 m -79.56 0.32 30.36 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.071 0.548 . . . . 71.0 112.055 -177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -162.07 156.89 22.64 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.369 0.668 . . . . 74.23 110.575 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.6 tt -156.48 -55.63 0.08 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 107.613 -1.254 . . . . 74.11 107.613 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.28 129.69 40.84 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.446 0.698 . . . . 71.14 109.428 171.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.607 ' HD2' ' HB2' ' E' ' 177' ' ' LEU . 12.9 p90 -73.5 152.52 40.66 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.856 -1.066 . . . . 72.15 111.236 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . 0.425 ' ND2' ' HB2' ' E' ' 178' ' ' GLN . 29.7 p-10 -103.57 -38.01 7.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.554 0.742 . . . . 74.43 109.316 167.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . 0.607 ' HB2' ' HD2' ' E' ' 175' ' ' PHE . 0.6 OUTLIER 56.97 42.99 25.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.656 1.182 . . . . 75.33 109.749 -178.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . 0.425 ' HB2' ' ND2' ' E' ' 176' ' ' ASN . 0.1 OUTLIER -57.7 -53.55 56.93 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.634 0.774 . . . . 71.43 109.085 -178.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -136.0 145.17 51.41 Favored Pre-proline 0 C--O 1.245 0.842 0 C-N-CA 124.416 1.086 . . . . 75.45 108.956 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.01 123.04 11.02 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.588 2.192 . . . . 74.24 110.506 171.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.89 -45.21 30.25 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.722 1.209 . . . . 74.05 111.434 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -136.68 136.28 38.94 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.298 -1.371 . . . . 72.55 107.298 168.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 24.4 p -68.92 134.67 49.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.447 0.699 . . . . 73.31 110.11 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.526 ' HZ3' ' HA ' ' C' ' 100' ' ' ALA . 8.2 t-105 -71.38 111.47 10.31 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 124.198 0.999 . . . . 71.42 109.881 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -87.84 117.23 1.11 Allowed 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 122.701 2.267 . . . . 73.45 112.107 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.81 147.37 29.42 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.325 -0.991 . . . . 75.42 108.325 171.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' C' ' 128' ' ' LEU . 25.7 pt -61.09 149.12 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.363 0.665 . . . . 75.0 111.174 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.76 89.28 3.41 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.517 -0.92 . . . . 61.31 108.517 174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.23 86.49 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 115.243 -0.89 . . . . 51.11 111.055 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 19.7 t0 73.16 -62.11 0.48 Allowed 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.841 1.257 . . . . 63.0 111.912 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 99.37 -132.68 11.01 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-O 119.524 -0.598 . . . . 61.44 112.279 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 76.56 83.73 0.47 Allowed Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.521 -0.632 . . . . 40.54 111.521 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' C' ' 37' ' ' GLN . 70.8 m-85 68.36 -89.39 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.144 1.378 . . . . 72.1 111.131 -177.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 56.08 24.83 8.27 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.939 0.896 . . . . 74.15 110.918 -169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -171.25 158.35 5.39 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.068 0.947 . . . . 64.42 110.335 -171.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . 0.413 ' HD2' ' HD2' ' F' ' 193' ' ' TYR . 14.3 ptmm? -146.13 127.63 15.05 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.538 1.135 . . . . 71.4 108.32 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -92.85 -58.48 2.32 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.212 -1.033 . . . . 73.04 108.212 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 63.15 -170.28 0.18 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.227 1.411 . . . . 51.33 112.694 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -119.55 153.02 36.04 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.86 0.864 . . . . 74.03 109.767 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 89.49 -71.29 2.29 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.992 -0.443 . . . . 44.15 111.992 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.1 128.88 33.84 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.414 -0.587 . . . . 71.25 109.414 175.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 8.6 t80 58.06 25.26 12.14 Favored 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 124.853 1.261 . . . . 53.53 111.382 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.48 -61.62 1.77 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.276 1.031 . . . . 63.55 108.546 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 4.0 mt 63.39 89.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 125.803 1.641 . . . . 62.25 111.051 173.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -160.94 37.97 0.15 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.597 0.759 . . . . 71.45 109.769 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.0 -50.84 0.44 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.614 -0.513 . . . . 64.42 109.614 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.256 1.44 0 C-N-CA 123.86 0.864 . . . . 73.33 110.959 -178.247 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 12.1 mptt . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 109.149 -0.686 . . . . 50.01 109.149 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.75 171.07 43.7 Favored Glycine 0 C--N 1.345 1.079 0 O-C-N 123.057 0.223 . . . . 72.33 112.572 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . 0.59 ' H ' ' HD3' ' F' ' 170' ' ' LYS . 0.0 OUTLIER -108.38 36.13 2.93 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.447 0.641 . . . . 71.02 111.424 -176.272 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 75.0 m -145.91 118.83 8.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.544 0.738 . . . . 64.21 109.355 170.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . 0.541 ' HB3' ' HA ' ' B' ' 90' ' ' GLU . . . -154.45 147.44 24.58 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.017 0.927 . . . . 63.12 109.513 178.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -157.39 112.43 2.75 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.923 -1.14 . . . . 63.33 107.923 -177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 66.87 151.58 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.135 1.374 . . . . 64.1 113.047 -177.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . 0.606 ' HD2' ' HE2' ' B' ' 94' ' ' MET . 21.8 p90 -152.66 171.56 17.98 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.234 -0.894 . . . . 61.43 111.649 -171.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -142.87 62.69 1.4 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.667 -1.605 . . . . 72.04 106.667 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 1.2 tm? 61.87 96.29 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.799 1.239 . . . . 62.22 109.184 -170.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -66.97 -84.23 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 122.85 0.46 . . . . 62.32 109.962 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -149.85 146.04 19.89 Favored Pre-proline 0 N--CA 1.476 0.849 0 C-N-CA 125.116 1.366 . . . . 71.22 108.093 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.86 87.08 0.14 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.119 2.546 . . . . 73.02 112.71 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -113.89 110.18 19.69 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.927 0.891 . . . . 64.45 109.005 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' B' ' 3' ' ' GLU . 8.8 m-85 60.07 34.41 21.31 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 123.777 0.673 . . . . 64.32 110.459 172.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 19.4 m -57.42 -33.03 67.46 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.467 1.507 . . . . 45.44 113.309 -166.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 46.9 t90 72.39 98.39 0.04 OUTLIER Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.471 1.108 . . . . 73.2 110.827 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -87.77 162.2 7.69 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.701 2.268 . . . . 73.22 112.992 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -101.62 -177.59 3.47 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.281 1.033 . . . . 74.41 109.614 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -123.1 160.52 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.066 0.546 . . . . 72.44 111.241 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . 0.474 ' HA ' HD23 ' B' ' 42' ' ' LEU . . . -81.9 161.26 23.19 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.657 0.783 . . . . 50.01 110.009 175.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -87.61 -165.52 1.33 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.31 0.644 . . . . 74.25 110.586 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -115.92 158.18 23.41 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.973 0.909 . . . . 72.25 110.4 -176.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . 0.815 ' HA3' ' HA ' ' B' ' 39' ' ' GLU . . . -153.14 100.14 0.2 Allowed Glycine 0 C--N 1.347 1.168 0 CA-C-N 116.038 -0.528 . . . . 64.34 112.352 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.07 167.42 40.21 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-O 119.47 -0.628 . . . . 73.24 111.946 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . 0.413 ' HD2' ' HD2' ' E' ' 196' ' ' LYS . 89.1 m-85 51.18 -145.2 0.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.312 1.045 . . . . 71.32 110.056 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . 59.28 -160.12 0.28 Allowed 'General case' 0 C--N 1.363 1.172 0 C-N-CA 123.897 0.879 . . . . 72.32 112.361 164.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 86.7 t80 65.56 -82.23 0.03 OUTLIER 'General case' 0 C--N 1.359 1.02 0 C-N-CA 124.655 1.182 . . . . 64.44 110.485 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp 49.82 81.05 0.06 Allowed 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.986 1.314 . . . . 72.44 112.072 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -67.85 87.08 0.24 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 106.449 -1.686 . . . . 64.11 106.449 167.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -145.82 -43.91 0.21 Allowed 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.078 -0.51 . . . . 61.54 111.097 -163.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -177.42 90.65 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 O-C-N 123.911 0.757 . . . . 63.21 110.4 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.93 16.81 60.02 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.405 1.322 . . . . 54.35 116.405 165.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -87.38 -89.43 0.13 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 117.681 0.741 . . . . 70.44 109.581 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -104.54 34.03 3.3 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.181 -1.414 . . . . 74.24 107.181 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -155.37 -178.89 7.59 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.063 -1.426 . . . . 74.12 109.749 -171.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 14.1 tt -133.69 136.21 54.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.488 -0.93 . . . . 64.31 108.488 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -149.57 161.74 41.55 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.467 -0.938 . . . . 75.4 108.467 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 29.9 t70 82.02 -26.6 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.398 1.479 . . . . 72.24 112.686 173.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--O 1.251 1.148 0 C-N-CA 123.61 0.764 . . . . 64.11 109.939 177.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . 0.7 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 2.9 mppt? . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 108.303 -0.999 . . . . 74.21 108.303 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 73.1 -95.77 0.76 Allowed Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.075 -0.966 . . . . 70.15 111.359 -173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . 0.462 ' HB3' ' H ' ' C' ' 151' ' ' GLU . 19.3 ptmt -71.93 150.94 43.69 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.515 0.726 . . . . 73.14 109.921 175.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . 0.484 ' HB2' ' H ' ' A' ' 54' ' ' ASP . 69.5 p -89.09 44.33 1.21 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.465 0.706 . . . . 53.2 111.489 -175.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . 62.08 -156.77 0.34 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.317 1.047 . . . . 70.21 111.197 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.604 HD23 ' SD ' ' A' ' 94' ' ' MET . 0.3 OUTLIER -106.52 -50.72 3.08 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.859 -1.163 . . . . 75.04 107.859 -178.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 8.2 tpp 62.75 78.57 0.29 Allowed 'General case' 0 C--N 1.355 0.848 0 CA-C-N 113.624 -1.625 . . . . 64.2 110.754 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.496 ' HE1' HD22 ' A' ' 98' ' ' LEU . 1.3 p90 -76.0 162.1 28.35 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.441 -0.8 . . . . 75.3 111.913 -171.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -78.58 150.79 32.69 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 114.939 -1.028 . . . . 64.02 108.786 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . 0.491 HD12 HG23 ' A' ' 46' ' ' THR . 3.7 mm? -68.74 85.49 0.31 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.778 0.831 . . . . 63.11 111.268 -175.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -101.01 169.17 9.13 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.036 -0.984 . . . . 73.5 108.925 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.87 147.83 78.12 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-O 118.73 -0.653 . . . . 71.11 109.848 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_exo -52.4 121.08 8.38 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 123.465 2.777 . . . . 75.14 113.552 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -45.35 -39.67 7.05 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 126.002 1.721 . . . . 75.0 112.179 176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . 0.484 ' HD2' ' HE2' ' A' ' 137' ' ' PHE . 23.0 m-85 -126.11 116.11 20.86 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.721 -1.214 . . . . 72.11 107.721 166.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -71.16 107.21 4.07 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 123.824 0.702 . . . . 74.32 110.403 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.88 129.62 82.89 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.869 0.868 . . . . 74.43 109.89 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . 0.476 ' HG2' HD13 ' A' ' 136' ' ' LEU . 60.2 Cg_endo -72.45 146.89 45.51 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.286 1.99 . . . . 61.32 112.399 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.71 -179.33 3.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.057 0.943 . . . . 73.35 110.076 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.466 HG21 ' HB3' ' A' ' 129' ' ' ALA . 43.6 pt -68.57 166.37 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.89 0.876 . . . . 75.21 111.961 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.15 134.65 41.69 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.517 0.727 . . . . 74.51 109.42 171.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.42 40.72 3.27 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.313 1.054 . . . . 63.32 108.385 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -85.51 21.64 1.75 Allowed 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.92 -1.491 . . . . 74.44 112.308 -173.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' H' ' 201' ' ' LYS . . . -141.61 -160.29 8.26 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.81 -0.916 . . . . 72.14 110.81 177.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -169.82 -147.14 5.38 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.829 -0.224 . . . . 61.13 112.629 -178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . 0.537 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 46.2 m-85 -130.02 -166.19 1.64 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.184 1.394 . . . . 54.13 109.168 -175.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . 0.665 ' HB3' ' HG2' ' H' ' 196' ' ' LYS . . . -145.7 157.58 43.94 Favored 'General case' 0 C--O 1.244 0.802 0 C-N-CA 124.021 0.928 . . . . 43.41 108.819 167.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.683 ' HB2' ' HB3' ' A' ' 36' ' ' TRP . 2.5 t80 -112.55 -47.57 3.07 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.686 0.794 . . . . 74.44 108.895 -179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.414 ' HG3' ' HB2' ' H' ' 196' ' ' LYS . 41.1 mtpt 65.36 76.23 0.34 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.795 1.638 . . . . 71.01 111.162 -174.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -75.29 130.4 39.01 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.773 -1.103 . . . . 73.33 110.086 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.12 97.13 1.77 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.132 0.573 . . . . 73.32 109.521 169.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 68.14 162.87 0.2 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.989 1.315 . . . . 73.21 112.464 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -80.48 120.19 5.11 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 111.345 -0.702 . . . . 70.13 111.345 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . 0.713 ' HE3' ' HB2' ' H' ' 194' ' ' ALA . 3.6 mptp? -75.46 -38.8 59.41 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.5 0.72 . . . . 73.44 110.802 -173.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -75.13 73.87 2.28 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.142 0.577 . . . . 72.4 109.444 174.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.68 80.52 7.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.911 0.862 . . . . 61.12 108.993 -177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.3 134.26 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 107.173 -1.417 . . . . 72.12 107.173 175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.11 -59.34 1.81 Allowed 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 109.172 -0.677 . . . . 71.43 109.172 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -152.62 99.23 2.44 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.755 0.822 . . . . 63.01 108.967 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . 0.521 HG11 HD11 ' D' ' 136' ' ' LEU . 21.8 t . . . . . 0 CA--C 1.571 1.783 0 C-N-CA 125.5 1.52 . . . . 63.43 111.455 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 84.7 tttt . . . . . 0 N--CA 1.474 0.765 0 N-CA-C 109.282 -0.636 . . . . 74.05 109.282 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.12 -88.37 0.29 Allowed Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.714 -0.555 . . . . 64.31 111.714 177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -147.38 -80.67 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.695 0.798 . . . . 74.3 109.495 -176.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.6 p 159.5 177.62 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.351 2.26 . . . . 73.15 107.349 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.573 ' HB2' ' SD ' ' D' ' 1' ' ' MET . . . -142.61 146.62 34.71 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.563 0.345 . . . . 52.43 111.037 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.74 -70.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 O-C-N 124.581 1.175 . . . . 50.4 108.157 174.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.465 ' HE2' ' HA ' ' H' ' 174' ' ' MET . 24.0 mmt -94.79 98.08 10.5 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.427 1.091 . . . . 74.1 109.807 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 60.3 -97.21 0.07 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.574 1.549 . . . . 64.13 111.5 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 60.05 -76.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.549 1.14 . . . . 74.41 111.554 -171.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp 62.88 93.9 0.05 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.807 1.243 . . . . 63.12 111.081 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . 0.464 ' HB2' ' HG2' ' D' ' 1' ' ' MET . 18.6 mm100 -134.0 -175.22 3.77 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.626 0.77 . . . . 62.03 110.068 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 70.15 156.01 0.15 Allowed Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 125.378 1.471 . . . . 72.23 112.992 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.07 111.91 3.18 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.476 2.118 . . . . 72.3 110.038 170.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -69.88 143.25 52.85 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.845 0.458 . . . . 74.15 110.461 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -64.49 107.56 1.41 Allowed 'General case' 0 C--O 1.219 -0.503 0 N-CA-C 108.739 -0.837 . . . . 73.02 108.739 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 34.0 p -65.67 97.66 0.33 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.638 0.775 . . . . 74.21 110.31 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -79.86 122.09 82.96 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.896 0.878 . . . . 72.23 110.25 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.24 130.04 37.34 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.947 2.431 . . . . 64.24 112.415 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 86.0 mt -77.15 170.82 15.85 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.425 0.69 . . . . 73.24 110.719 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.628 ' HB ' HD22 ' D' ' 42' ' ' LEU . 73.5 mt -72.63 123.78 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.632 0.773 . . . . 73.13 110.855 -175.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -100.75 139.66 36.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.088 0.955 . . . . 73.54 109.44 176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.18 -88.3 0.5 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.057 0.543 . . . . 74.11 109.842 -177.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 59.48 -162.71 0.24 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.146 0.978 . . . . 71.12 111.846 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.11 155.25 7.39 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 111.699 -0.56 . . . . 54.3 111.699 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -83.43 -69.11 1.39 Allowed Glycine 0 C--N 1.339 0.749 0 N-CA-C 111.624 -0.59 . . . . 72.31 111.624 176.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -135.03 130.99 36.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.704 0.802 . . . . 74.42 109.43 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . 0.713 ' HB2' ' HE3' ' G' ' 201' ' ' LYS . . . -179.07 176.4 0.89 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.988 1.315 . . . . 71.35 109.396 175.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 54.5 t80 56.62 65.31 1.44 Allowed 'General case' 0 C--N 1.355 0.843 0 O-C-N 124.579 1.175 . . . . 70.34 110.034 172.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . 0.665 ' HG2' ' HB3' ' G' ' 194' ' ' ALA . 0.1 OUTLIER -59.49 -47.43 85.52 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.479 -0.782 . . . . 55.05 109.956 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 2.9 t80 74.39 -58.66 0.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.778 1.299 . . . . 74.13 112.216 166.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -40.69 131.19 2.39 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.248 1.819 . . . . 64.34 112.295 170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 -67.55 127.35 32.41 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 124.242 1.017 . . . . 60.51 110.542 -175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.14 -40.51 88.06 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 110.759 -0.936 . . . . 72.43 110.759 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . 0.495 ' HB3' ' HA3' ' G' ' 191' ' ' GLY . 1.5 tmtp? -173.69 113.52 0.21 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.044 -1.465 . . . . 74.42 107.044 171.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -162.43 70.12 0.28 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.467 0.651 . . . . 62.02 109.56 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -137.4 115.02 11.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.919 0.888 . . . . 54.1 109.535 174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.509 HG22 ' H ' ' H' ' 206' ' ' ASP . 3.8 mp -93.57 -59.94 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.402 -0.962 . . . . 72.12 108.402 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt 65.76 23.01 11.51 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 125.114 1.366 . . . . 72.22 112.584 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . 0.509 ' H ' HG22 ' H' ' 204' ' ' ILE . 4.8 m-20 -117.3 -52.54 2.49 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.158 -1.423 . . . . 72.34 107.158 172.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' C' ' 11' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 C-N-CA 126.132 1.773 . . . . 74.33 109.096 173.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 110.236 -0.283 . . . . 73.13 110.236 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 t -78.35 103.98 8.64 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 108.905 -0.776 . . . . 71.24 108.905 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -73.11 -170.83 0.81 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.024 0.93 . . . . 75.44 112.478 -173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -60.25 -66.09 0.58 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.148 0.979 . . . . 74.13 110.855 -175.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -169.25 173.0 6.93 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.007 0.523 . . . . 75.53 110.497 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -140.45 156.81 46.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.137 0.975 . . . . 74.43 108.873 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -66.95 160.09 27.07 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 122.898 0.479 . . . . 63.21 109.766 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -51.22 -36.8 43.42 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.896 0.878 . . . . 65.44 111.238 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.474 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 20.7 ptt? -144.25 147.18 33.23 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.891 1.276 . . . . 73.53 107.808 173.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.7 p -139.51 141.39 37.33 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.183 0.516 . . . . 72.11 110.484 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -133.53 127.47 33.24 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 106.61 -1.626 . . . . 71.33 106.61 158.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tp60 -141.06 136.65 32.22 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 123.089 0.243 . . . . 74.33 110.681 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 13' ' ' ILE . 2.8 mp -92.64 104.03 15.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 N-CA-C 107.491 -1.299 . . . . 73.1 107.491 174.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -81.28 -25.94 36.13 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 118.709 -0.662 . . . . 70.32 110.986 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.427 HH12 ' HA ' ' F' ' 203' ' ' ASP . 21.7 ttt85 -176.82 135.61 0.22 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.315 0.646 . . . . 65.35 110.711 173.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.5 136.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 123.765 0.826 . . . . 53.25 109.013 170.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.524 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 33.6 p90 -170.77 167.6 7.6 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.755 0.822 . . . . 65.3 110.863 -174.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -90.91 124.28 35.07 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.48 -0.933 . . . . 74.44 108.48 167.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HG2' ' HE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -81.15 -33.34 33.2 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.352 -0.61 . . . . 52.3 109.352 171.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.546 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 18.5 t70 -148.23 140.84 24.49 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.797 -1.092 . . . . 74.33 109.911 -178.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 72.1 mt -132.32 141.4 45.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.018 1.327 . . . . 62.11 107.442 171.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.4 t -149.65 130.85 14.53 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.127 -0.694 . . . . 75.3 109.127 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.7 t80 -132.46 135.85 46.32 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.7 -1.593 . . . . 74.0 106.7 172.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.11 152.63 50.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.29 -1.004 . . . . 75.43 108.29 175.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.84 79.35 46.02 Favored Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 106.541 -1.651 . . . . 73.24 106.541 170.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.9 -45.86 12.13 Favored 'Trans proline' 0 C--N 1.382 2.337 0 C-N-CA 122.876 2.384 . . . . 73.34 112.094 -170.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.645 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 28.2 m-80 -107.38 45.63 0.98 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.405 -0.816 . . . . 15.41 108.972 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -61.0 -50.16 85.95 Favored Pre-proline 0 CA--C 1.566 1.589 0 C-N-CA 124.187 0.995 . . . . 65.33 113.036 178.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 27.9 Cg_exo -68.38 -7.99 21.73 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 121.823 1.682 . . . . 71.14 113.887 170.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.645 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.1 m80 -99.12 -13.4 19.81 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.766 0.826 . . . . 74.32 112.278 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.7 p -64.58 -23.02 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 117.896 0.316 . . . . 60.44 110.77 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.53 -34.92 74.83 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.078 0.951 . . . . 61.35 111.739 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -63.02 -54.71 34.0 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.555 0.742 . . . . 62.31 110.322 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HB2' HD13 ' A' ' 68' ' ' LEU . 33.8 mmtp -85.12 127.32 34.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.594 -1.185 . . . . 70.2 110.712 -172.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -66.8 136.36 55.33 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.785 -1.191 . . . . 74.12 107.785 165.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -60.05 100.78 0.1 Allowed 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.453 1.095 . . . . 75.42 112.389 -163.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -127.35 76.51 76.52 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 124.633 1.173 . . . . 73.55 108.063 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.69 101.39 1.18 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.108 1.872 . . . . 74.33 111.642 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -92.01 94.67 9.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.674 -1.602 . . . . 54.45 106.674 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.8 m -84.37 129.76 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.832 -1.076 . . . . 63.44 111.666 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 3.0 mptp? -105.3 124.02 48.83 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 124.347 1.059 . . . . 63.22 108.577 176.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 128' ' ' LEU . 5.7 mp -97.52 120.96 38.85 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.574 1.15 . . . . 73.41 108.603 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 20.5 m-20 -117.57 111.27 18.99 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.279 -1.008 . . . . 75.24 108.279 167.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD11 HD21 ' A' ' 60' ' ' LEU . 29.7 tp -97.28 135.55 39.03 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.295 -1.002 . . . . 70.44 108.295 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 14.3 t70 -143.33 136.29 27.77 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.354 -0.98 . . . . 72.21 108.354 178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -122.96 137.9 54.82 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.089 0.556 . . . . 75.42 109.643 176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -134.43 153.17 52.06 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.444 1.098 . . . . 53.3 108.902 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.8 m -134.11 157.35 46.39 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.717 0.407 . . . . 54.45 110.69 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.0 t -149.82 119.45 6.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.981 0.912 . . . . 60.42 108.827 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -74.38 122.76 23.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.877 0.471 . . . . 75.22 109.986 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.2 mt -96.77 -43.72 7.4 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.179 0.592 . . . . 73.31 110.154 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.81 -169.54 3.41 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 123.703 0.801 . . . . 74.22 109.991 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.64 126.25 30.64 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 108.757 -0.831 . . . . 71.22 108.757 169.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.687 ' HA ' ' HB2' ' G' ' 172' ' ' ALA . 17.4 m-20 69.44 -3.03 1.71 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.737 1.615 . . . . 70.35 112.653 -176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 41.1 t -115.4 120.98 66.23 Favored 'Isoleucine or valine' 0 C--N 1.351 0.654 0 N-CA-C 107.924 -1.139 . . . . 53.42 107.924 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.57 170.38 15.82 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.915 -1.143 . . . . 65.31 107.915 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 9.0 tm-20 -127.3 132.17 50.35 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 107.666 -1.235 . . . . 72.13 107.666 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.76 120.79 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 108.47 -0.937 . . . . 64.44 108.47 -176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 43.7 t -95.24 130.92 43.33 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 C-N-CA 123.64 0.776 . . . . 72.44 109.047 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.419 HD21 HD11 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -105.09 107.54 18.57 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.896 -1.52 . . . . 74.41 106.896 170.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 24.3 ttp180 -100.06 100.79 11.71 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.39 -0.967 . . . . 74.03 108.39 177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.9 t -94.74 137.57 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.834 -1.173 . . . . 75.14 107.834 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.9 m -128.66 126.79 40.88 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.505 -0.554 . . . . 54.12 109.505 173.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.584 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.1 t -122.06 109.5 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 124.675 1.19 . . . . 75.14 109.537 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 80.0 m -101.41 141.97 33.5 Favored 'General case' 0 C--O 1.214 -0.767 0 N-CA-C 108.429 -0.952 . . . . 54.22 108.429 173.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.07 109.58 14.73 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.266 -1.013 . . . . 62.55 108.266 173.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 39.8 m -107.46 127.23 53.42 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 109.343 -0.614 . . . . 64.41 109.343 177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 HD13 ' HB2' ' A' ' 34' ' ' LYS . 22.3 mt -90.75 81.93 5.76 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.518 -1.66 . . . . 73.34 106.518 175.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.15 -86.4 1.1 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.16 -0.927 . . . . 75.42 110.881 -168.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -127.1 -19.25 4.4 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.99 0.916 . . . . 70.12 110.452 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -86.08 108.02 18.09 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.855 0.862 . . . . 71.35 110.247 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.1 m -73.22 125.0 26.75 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.293 0.568 . . . . 63.33 111.442 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.25 -54.09 7.69 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.92 1.288 . . . . 72.32 109.455 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -148.92 165.26 32.1 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.389 -1.278 . . . . 75.45 110.82 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 35.5 tp -130.89 145.2 51.94 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.666 -1.235 . . . . 73.03 107.666 170.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -134.54 140.39 46.11 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.77 0.828 . . . . 72.41 109.268 176.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -148.85 117.1 6.43 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.89 -0.781 . . . . 70.44 108.89 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.91 111.34 28.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.773 0.829 . . . . 62.32 109.038 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.546 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.6 mt-30 -88.42 82.57 6.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.118 -0.946 . . . . 63.03 109.119 173.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -75.95 93.6 3.26 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.154 -0.93 . . . . 73.14 108.842 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.39 148.9 19.54 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 116.179 -0.464 . . . . 70.43 112.06 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -149.06 123.97 1.73 Allowed Glycine 0 CA--C 1.501 -0.784 0 N-CA-C 110.74 -0.944 . . . . 51.33 110.74 -174.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.4 mt -79.08 127.85 38.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.981 -1.118 . . . . 74.13 107.981 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -129.89 143.42 50.8 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.398 -0.593 . . . . 71.32 109.398 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.4 t -112.54 112.98 24.9 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.088 -1.078 . . . . 72.31 108.088 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -129.01 143.42 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.089 0.555 . . . . 72.54 110.011 -173.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.06 175.39 2.29 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.208 1.003 . . . . 74.43 111.215 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 83.72 5.16 88.42 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.392 -0.822 . . . . 74.23 114.478 175.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.502 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -131.31 -179.62 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 124.337 1.055 . . . . 73.12 109.422 -176.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 16.9 tt0 -168.37 177.2 5.47 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.085 0.554 . . . . 72.33 110.139 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.86 -121.28 22.74 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 114.969 0.748 . . . . 73.2 114.969 172.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.6 p -64.67 -30.92 71.95 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.899 0.88 . . . . 73.33 111.593 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.54 -42.1 71.63 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.549 0.739 . . . . 62.31 111.041 -177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -76.55 -30.24 57.0 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.507 -0.315 . . . . 55.12 110.701 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.58 -30.76 63.22 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.147 0.579 . . . . 75.31 110.74 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -67.61 -48.56 66.45 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.174 0.99 . . . . 75.32 110.234 174.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 20.2 t -74.59 -63.0 1.34 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.544 -0.753 . . . . 71.2 111.001 -172.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.0 tt -62.36 -38.34 89.16 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.164 0.586 . . . . 75.35 110.698 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.15 -31.1 32.42 Favored Glycine 0 C--N 1.348 1.243 0 N-CA-C 115.26 0.864 . . . . 72.14 115.26 -168.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -48.37 0.83 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 118.342 1.071 . . . . 54.42 112.569 -172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.514 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 86.4 t80 -66.66 -50.08 64.09 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.615 0.766 . . . . 74.03 112.697 -173.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.426 ' HA ' HG12 ' A' ' 105' ' ' ILE . 63.6 m -72.16 -37.6 4.94 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.554 0.742 . . . . 62.25 112.634 -176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -54.65 -40.89 82.16 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.18 1.92 . . . . 71.22 112.478 163.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -68.27 -29.4 68.18 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.553 0.741 . . . . 72.32 111.419 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.744 HD12 HD21 ' C' ' 132' ' ' ASN . 40.1 mm -60.66 -44.52 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-O 121.998 0.904 . . . . 62.11 109.855 173.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 82' ' ' GLY . 79.2 mt -77.21 -18.77 57.46 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.166 -1.379 . . . . 64.54 112.176 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -68.42 -41.86 25.62 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.444 1.276 . . . . 63.52 114.444 -168.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.81 -39.03 90.39 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 121.966 1.777 . . . . 72.11 112.906 171.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -75.1 -36.74 61.67 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.491 0.717 . . . . 75.22 111.608 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.93 -46.83 76.79 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.576 -0.527 . . . . 74.41 109.576 174.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 40.8 ttm105 -55.22 -47.09 75.81 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 124.552 1.158 . . . . 73.31 110.52 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.554 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 6.7 tm-20 -59.42 -48.69 80.68 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.136 0.897 . . . . 74.43 111.061 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.512 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 51.1 t -57.73 -46.49 84.37 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.067 -0.97 . . . . 74.14 111.213 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.5 mt -64.3 -53.19 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.525 0.73 . . . . 64.23 110.612 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 125' ' ' GLN . 60.7 m -53.46 -44.39 68.89 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.799 1.24 . . . . 61.2 112.009 -176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 43.3 t -72.46 -32.65 66.43 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.298 -0.865 . . . . 61.42 111.166 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.9 mtp -64.29 -43.3 95.2 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.483 0.713 . . . . 74.22 110.851 173.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.5 t -62.99 -49.27 84.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 124.627 1.171 . . . . 63.05 110.465 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.1 p -67.48 -26.04 66.17 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 115.846 -0.616 . . . . 24.3 111.6 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.529 ' HB2' ' O ' ' A' ' 116' ' ' SER . 26.4 ttm-85 -76.93 -26.06 53.64 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.272 1.029 . . . . 63.54 110.133 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 10.9 61.11 Favored Glycine 0 C--N 1.358 1.803 0 CA-C-N 115.887 -0.597 . . . . 74.14 112.618 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 67.66 36.49 3.63 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 122.815 1.293 . . . . 74.45 110.472 176.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -115.57 144.71 32.99 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 114.75 -1.114 . . . . 63.05 108.936 175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -54.28 146.07 52.36 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.01 2.474 . . . . 72.01 113.275 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.595 ' HG3' HG23 ' A' ' 115' ' ' THR . 3.6 tt0 -59.07 140.92 55.29 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.135 0.974 . . . . 70.23 112.689 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 42.1 tp -124.86 114.16 18.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.935 0.894 . . . . 75.12 109.402 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -112.05 102.08 10.32 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.385 0.674 . . . . 63.42 109.505 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.436 HD21 HD21 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -70.75 127.11 31.54 Favored 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 108.867 -0.79 . . . . 72.03 108.867 179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.4 132.03 95.24 Favored Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 123.784 0.834 . . . . 42.03 112.325 -172.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -83.62 140.44 9.37 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.641 2.227 . . . . 32.5 112.153 175.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.556 HG23 HG23 ' H' ' 207' ' ' VAL . 2.3 p -116.67 125.3 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.96 0.904 . . . . 52.35 109.831 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.531 HD22 ' HB3' ' A' ' 135' ' ' ALA . 4.5 p-10 -92.03 63.81 4.5 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 122.218 1.009 . . . . 71.35 110.536 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -67.58 -30.93 70.68 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 114.775 -1.102 . . . . 75.33 110.188 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -66.34 -34.25 77.55 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.766 -1.106 . . . . 63.2 110.588 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.531 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -73.95 -36.4 64.63 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.363 0.665 . . . . 74.44 110.837 177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.401 HD11 HG22 ' H' ' 207' ' ' VAL . 88.1 mt -62.53 -33.62 75.28 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.384 0.673 . . . . 74.33 110.975 175.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -65.01 -46.89 79.47 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.11 0.564 . . . . 71.02 109.999 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.9 mmt -60.4 -49.01 79.26 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.704 0.627 . . . . 70.25 110.633 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.446 ' HA ' ' HG2' ' A' ' 143' ' ' GLN . 19.9 t30 -53.53 -51.04 64.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.79 1.236 . . . . 73.41 111.528 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -68.63 -35.92 77.93 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.51 -0.768 . . . . 63.4 111.881 -176.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.35 -54.39 20.99 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.478 0.486 . . . . 72.34 109.839 -172.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.409 ' H ' ' H ' ' A' ' 143' ' ' GLN . 48.8 mt-30 -161.8 -17.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.799 0.84 . . . . 64.24 111.765 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.446 ' HG2' ' HA ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER 59.19 80.39 0.19 Allowed 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.356 1.063 . . . . 63.33 109.721 -176.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -90.76 120.97 32.23 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.823 0.675 . . . . 72.41 112.823 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.83 178.78 4.25 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.124 1.369 . . . . 73.34 110.422 176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.03 -39.13 0.73 Allowed Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.656 -0.578 . . . . 35.33 111.656 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 65.59 -80.87 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.826 1.251 . . . . 75.21 111.149 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.95 -124.81 10.59 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.797 -0.446 . . . . 75.32 113.159 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m 68.16 92.69 0.08 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.454 1.501 . . . . 60.4 111.824 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -149.52 4.23 0.59 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.411 1.085 . . . . 64.21 110.767 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -127.85 149.66 50.19 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.724 0.809 . . . . 73.55 110.283 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -133.72 -56.17 0.89 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.557 1.143 . . . . 72.32 109.171 171.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.75 81.83 0.11 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.544 1.137 . . . . 74.53 109.007 -170.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -71.41 124.1 23.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.427 -0.806 . . . . 61.0 109.95 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.265 0 N-CA-C 108.62 -0.881 . . . . 74.11 108.62 179.597 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 54.2 mtm . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.425 -0.584 . . . . 72.01 109.425 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 37.9 t -151.15 88.55 1.46 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.658 -0.867 . . . . 62.03 108.658 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -90.77 143.01 27.16 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.536 -0.756 . . . . 70.54 110.458 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -165.7 153.09 10.43 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.746 0.818 . . . . 61.44 109.201 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -138.28 158.99 43.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.241 0.616 . . . . 64.1 109.45 175.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -63.51 95.28 0.1 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 108.974 -0.75 . . . . 54.31 108.974 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.407 HG23 ' HA ' ' B' ' 89' ' ' ILE . 3.7 m -119.17 49.54 1.32 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.953 0.882 . . . . 75.53 108.705 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -63.56 -36.26 83.2 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.919 -1.037 . . . . 70.34 108.641 168.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.5 ptm 56.85 170.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 127.416 2.286 . . . . 75.45 114.923 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.3 p -135.55 127.79 30.09 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.918 -1.037 . . . . 72.45 108.255 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.91 120.67 21.78 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.538 -0.912 . . . . 64.15 108.538 177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.56 138.3 29.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.722 0.296 . . . . 72.42 110.243 174.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.472 HD11 HG13 ' B' ' 16' ' ' ILE . 16.1 tt -82.56 144.48 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 124.263 1.025 . . . . 61.52 110.031 -178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -109.28 -49.16 3.15 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.192 0.597 . . . . 72.53 110.035 177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.751 HH12 ' HE1' ' G' ' 197' ' ' TYR . 39.3 ttt180 -171.38 146.27 2.26 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.172 0.589 . . . . 74.43 110.458 -176.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.472 HG13 HD11 ' B' ' 13' ' ' ILE . 51.1 mt -116.47 145.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.191 -1.04 . . . . 74.43 108.191 169.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -168.71 145.47 3.73 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.759 0.423 . . . . 64.33 110.305 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -74.06 122.16 22.24 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.872 -0.788 . . . . 64.44 108.872 172.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -91.49 -37.45 13.14 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.619 -0.719 . . . . 74.54 110.341 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.1 t70 -154.3 146.28 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.666 0.27 . . . . 71.52 111.622 -171.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.436 HD11 ' SG ' ' B' ' 113' ' ' CYS . 43.4 mm -138.56 143.73 31.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 125.378 1.471 . . . . 52.42 109.158 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.511 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 38.4 t -141.1 129.21 22.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.862 1.265 . . . . 74.2 108.424 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -143.2 131.9 22.57 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.096 -1.446 . . . . 74.22 107.096 166.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -136.01 140.15 43.66 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.674 -1.232 . . . . 74.5 107.674 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.667 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -134.85 85.09 36.37 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 107.904 -1.147 . . . . 74.02 107.904 174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.95 -29.48 57.64 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.88 2.387 . . . . 70.14 111.99 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.81 28.91 8.01 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.945 0.898 . . . . 63.44 109.961 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.667 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.2 -52.75 32.86 Favored Pre-proline 0 CA--C 1.564 1.519 0 C-N-CA 125.429 1.491 . . . . 70.35 113.509 168.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.1 Cg_exo -81.63 -11.74 11.46 Favored 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 122.547 2.165 . . . . 71.4 112.876 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -89.17 3.07 53.14 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.214 1.006 . . . . 72.52 111.576 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 34.1 m -65.1 -21.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.247 0.619 . . . . 74.23 111.266 169.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -64.76 -40.54 95.44 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.706 0.802 . . . . 61.34 110.16 172.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -82.29 -30.03 30.82 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.061 -0.972 . . . . 74.41 111.135 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.79 90.33 3.29 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.261 1.025 . . . . 71.52 109.729 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -86.49 77.35 9.44 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.8 0.84 . . . . 70.24 110.567 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 t-105 -172.01 156.36 4.04 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.853 0.861 . . . . 74.22 109.419 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.449 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 28.1 tt0 -66.25 125.52 90.4 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.536 1.135 . . . . 50.42 110.778 169.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.25 129.16 20.94 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.129 1.886 . . . . 71.44 110.691 169.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.7 134.04 48.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 120.933 0.396 . . . . 61.01 109.94 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.437 HG21 ' O ' ' B' ' 124' ' ' PRO . 18.9 t -114.99 127.37 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 122.9 0.48 . . . . 71.23 111.282 -166.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -134.78 134.28 40.75 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 108.406 -0.961 . . . . 75.23 108.406 166.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.563 ' H ' HD23 ' B' ' 42' ' ' LEU . 1.2 pt? -119.5 140.43 50.49 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.962 -1.125 . . . . 74.23 107.962 173.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -136.81 142.64 42.91 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.432 0.693 . . . . 61.21 109.389 -167.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.4 ' HG ' HD21 ' B' ' 60' ' ' LEU . 6.6 tt -94.77 138.91 31.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.353 0.661 . . . . 74.34 110.391 -169.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -140.74 135.83 31.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.564 1.145 . . . . 64.41 108.553 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 28.0 m -109.65 124.78 51.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.854 0.462 . . . . 73.1 110.646 -172.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.05 156.37 38.3 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.197 0.999 . . . . 70.45 108.336 170.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 45.5 p -144.88 170.8 15.44 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.8 0.44 . . . . 63.45 110.684 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 58.7 p -150.49 143.66 24.87 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.614 0.766 . . . . 75.24 109.011 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -94.57 114.98 27.03 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.406 0.683 . . . . 75.51 110.025 173.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.2 -35.14 21.82 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.343 -0.614 . . . . 71.24 109.343 173.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -175.81 3.85 Favored 'General case' 0 C--O 1.245 0.833 0 CA-C-N 114.922 -1.036 . . . . 74.32 110.104 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.71 126.37 27.37 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.621 -1.172 . . . . 64.33 108.899 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 69.96 -4.36 1.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 124.592 1.157 . . . . 52.03 112.987 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 80.1 t -114.26 103.95 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.524 -0.917 . . . . 72.41 108.524 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' F' ' 175' ' ' PHE . 89.6 m-85 -123.99 137.78 54.55 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.2 0.524 . . . . 64.3 110.164 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -114.44 105.86 13.62 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.081 -1.451 . . . . 64.22 107.081 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 83.9 t -92.82 125.75 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.309 0.644 . . . . 62.1 109.541 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.2 t -103.04 117.42 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 123.599 0.76 . . . . 74.03 109.746 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.4 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -93.87 112.11 23.92 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 109.144 -0.687 . . . . 52.25 109.144 -177.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' B' ' 78' ' ' VAL . 41.9 ttm180 -94.7 114.24 26.14 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 122.953 0.501 . . . . 74.41 109.907 171.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.58 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.4 t -114.02 122.26 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 107.947 -1.131 . . . . 70.12 107.947 169.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 3.7 m -115.71 147.9 40.36 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.171 0.589 . . . . 42.53 110.378 -173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.613 HG21 HG21 ' B' ' 114' ' ' ILE . 44.5 t -127.3 127.14 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.436 1.094 . . . . 75.35 109.582 -172.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.5 m -105.0 140.09 38.71 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.808 0.843 . . . . 71.44 109.281 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.84 139.4 22.62 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.097 0.959 . . . . 52.03 108.732 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.42 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 73.6 p -146.27 141.08 26.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.115 0.483 . . . . 53.31 111.529 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 65.6 mt -102.72 109.39 20.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.938 1.295 . . . . 75.15 108.678 174.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -111.88 3.5 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 112.02 -0.432 . . . . 42.3 112.02 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -113.17 10.21 18.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.044 0.938 . . . . 62.23 110.494 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -132.07 144.69 50.91 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.24 0.616 . . . . 74.14 109.821 -172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.4 m -66.91 134.77 52.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.203 0.601 . . . . 74.42 111.49 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -88.71 -58.86 2.4 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.679 -0.86 . . . . 53.14 108.679 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -155.29 158.81 39.36 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.318 -1.31 . . . . 74.44 109.925 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -136.37 124.0 22.34 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.18 1.392 . . . . 75.13 107.759 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.34 159.94 23.21 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.458 -0.571 . . . . 73.41 109.458 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.511 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.0 tt0 -164.81 139.38 5.24 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.209 -1.034 . . . . 70.32 108.209 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' B' ' 61' ' ' ARG . 67.4 t -129.03 145.69 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 123.887 0.875 . . . . 75.3 108.722 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.506 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.9 mt-30 -124.43 85.9 2.48 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.545 -0.909 . . . . 73.11 108.545 174.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -82.67 101.63 10.96 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 114.432 -1.258 . . . . 74.24 109.877 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.65 161.22 29.53 Favored Glycine 0 C--O 1.241 0.538 0 C-N-CA 121.181 -0.533 . . . . 72.25 112.018 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -160.11 126.45 1.63 Allowed Glycine 0 N--CA 1.451 -0.314 0 N-CA-C 111.361 -0.696 . . . . 70.11 111.361 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.89 128.12 39.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.956 -0.757 . . . . 51.32 108.956 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -132.85 163.46 29.04 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.685 1.194 . . . . 74.54 107.945 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 71.6 m -126.75 121.28 31.54 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.199 -1.037 . . . . 63.2 108.199 172.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.571 HD13 HD11 ' B' ' 89' ' ' ILE . 2.9 pp -128.28 147.03 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 73.24 110.263 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.04 162.63 40.28 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.547 0.739 . . . . 75.23 109.979 172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.28 -28.98 8.09 Favored Glycine 0 C--N 1.353 1.505 0 N-CA-C 114.261 0.464 . . . . 41.31 114.261 174.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.571 HD11 HD13 ' B' ' 86' ' ' ILE . 44.7 pt -67.83 162.43 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.905 0.882 . . . . 60.1 112.865 -175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -165.35 159.68 17.41 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.1 -0.955 . . . . 73.3 111.596 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.45 -130.32 50.11 Favored Glycine 0 C--N 1.352 1.426 0 O-C-N 124.014 0.821 . . . . 74.0 114.14 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 35.5 m -70.72 -25.31 62.89 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.933 0.893 . . . . 70.34 111.087 178.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -66.76 -26.91 67.21 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.999 0.52 . . . . 74.44 110.623 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.534 ' SD ' ' HB1' ' F' ' 172' ' ' ALA . 18.1 ttt -72.67 -46.04 55.89 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.12 0.568 . . . . 74.03 110.522 174.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.84 67.14 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.438 -0.801 . . . . 74.1 111.192 176.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -80.17 -36.1 35.56 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.306 0.642 . . . . 72.3 110.716 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -74.74 -67.45 0.63 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.961 0.504 . . . . 73.21 111.914 -173.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.54 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.2 pp -94.27 -20.51 19.74 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.156 0.428 . . . . 75.33 112.156 -174.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.68 -15.44 59.82 Favored Glycine 0 C--N 1.346 1.085 0 CA-C-O 119.913 -0.382 . . . . 64.4 113.293 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.96 -52.53 0.79 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 117.206 0.503 . . . . 61.21 112.0 -174.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -76.76 -37.28 56.18 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 111.963 0.357 . . . . 75.43 111.963 -172.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.54 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 97.9 m -63.43 -51.44 67.58 Favored Pre-proline 0 CA--C 1.561 1.389 0 CA-C-O 118.607 -0.711 . . . . 72.32 111.566 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.449 ' HD3' HG11 ' B' ' 58' ' ' VAL . 36.5 Cg_endo -65.48 -17.53 57.65 Favored 'Trans proline' 0 C--N 1.394 2.944 0 C-N-CA 121.763 1.642 . . . . 75.34 113.524 172.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -69.34 -42.04 75.83 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 122.864 0.466 . . . . 74.54 110.562 174.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.507 HG23 ' NH2' ' D' ' 111' ' ' ARG . 69.6 mt -58.92 -41.95 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.068 0.947 . . . . 72.11 110.194 173.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 53.8 mt -84.71 -12.94 52.79 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 114.546 -1.206 . . . . 64.43 111.969 -173.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -63.49 -45.14 83.46 Favored Pre-proline 0 C--N 1.359 0.984 0 CA-C-O 117.576 -1.202 . . . . 54.24 112.706 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -53.13 -42.83 61.96 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.305 2.004 . . . . 62.55 113.177 172.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -70.55 -45.22 65.89 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.147 -0.933 . . . . 73.32 111.027 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.06 82.64 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.632 0.773 . . . . 42.21 111.096 177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -59.69 -60.86 3.17 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.751 1.22 . . . . 72.5 109.236 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -60.87 -34.53 74.77 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.076 0.86 . . . . 65.43 110.413 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.7 t -60.33 -51.05 71.19 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.203 0.601 . . . . 74.12 111.46 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.613 HG21 HG21 ' B' ' 64' ' ' VAL . 80.8 mt -58.64 -52.01 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.441 0.696 . . . . 72.44 109.962 176.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.657 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 2.0 m -64.29 -21.0 66.45 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.903 -1.499 . . . . 75.04 111.236 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -83.55 -40.3 19.3 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 124.706 1.202 . . . . 64.52 112.061 171.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.9 mmt -69.12 -39.49 78.87 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-N 118.287 0.494 . . . . 52.41 111.926 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -74.53 -26.6 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 123.127 0.571 . . . . 74.35 110.436 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 38.3 t -64.93 -30.99 72.01 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.485 0.714 . . . . 74.42 110.321 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.512 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 66.6 mtt-85 -72.81 -33.66 66.36 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.527 0.731 . . . . 71.23 110.129 173.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.83 -2.56 81.99 Favored Glycine 0 C--N 1.356 1.684 0 CA-C-N 115.753 -0.658 . . . . 55.43 112.833 171.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.498 HG22 ' HB3' ' A' ' 17' ' ' TYR . 5.4 t 55.41 34.3 22.68 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.77 2.028 . . . . 73.25 112.694 177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -107.91 157.67 35.47 Favored Pre-proline 0 CA--C 1.559 1.304 0 C-N-CA 124.075 0.95 . . . . 71.21 110.851 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.449 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.4 Cg_exo -71.84 87.82 0.82 Allowed 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 123.302 2.668 . . . . 71.31 113.771 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.657 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 0.0 OUTLIER -71.78 159.78 33.73 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.329 0.652 . . . . 43.3 112.225 171.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.446 ' H ' ' NE2' ' B' ' 125' ' ' GLN . 33.1 tp -129.69 123.84 32.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 126.21 1.804 . . . . 75.02 107.542 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.48 HD21 ' HA ' ' C' ' 122' ' ' THR . 18.7 p-10 -91.5 110.24 21.55 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.09 -0.708 . . . . 71.31 109.09 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.5 137.74 54.64 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.989 0.516 . . . . 72.3 110.621 -174.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' E' ' 202' ' ' TYR . . . -63.24 141.78 97.78 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.057 0.943 . . . . 72.33 111.503 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -64.6 106.96 0.79 Allowed 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 122.923 2.415 . . . . 44.03 112.74 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 m -73.89 106.71 3.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-N 115.986 -0.552 . . . . 64.13 110.025 173.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -79.08 94.75 5.38 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.263 0.554 . . . . 75.35 109.647 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -74.99 -28.75 60.67 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.161 -0.927 . . . . 71.24 111.25 177.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -66.36 -48.07 71.38 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.725 0.81 . . . . 62.44 111.698 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.81 -31.19 68.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.853 0.721 . . . . 60.13 111.636 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.461 ' HG ' ' HE1' ' B' ' 140' ' ' TYR . 57.0 tp -70.26 -44.74 67.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.859 0.864 . . . . 73.22 110.261 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -69.63 -25.94 64.18 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.726 0.811 . . . . 73.11 111.676 -177.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.8 mmt -60.99 -23.34 65.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.176 0.59 . . . . 74.55 111.904 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.489 ' N ' HD22 ' B' ' 139' ' ' ASN . 0.8 OUTLIER -81.94 -39.68 23.38 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.223 0.609 . . . . 74.34 110.237 178.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.461 ' HE1' ' HG ' ' B' ' 136' ' ' LEU . 44.3 m-85 -73.57 -37.33 65.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.639 0.776 . . . . 74.24 111.566 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.5 mt -90.9 11.75 21.69 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.882 0.873 . . . . 74.42 110.47 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 67.51 156.52 0.12 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.747 1.619 . . . . 70.12 112.188 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -104.1 166.0 10.69 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.486 0.714 . . . . 65.1 110.914 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -162.07 164.53 28.07 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.451 1.1 . . . . 53.42 108.99 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.02 -55.1 0.08 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 122.627 0.371 . . . . 54.04 110.837 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.1 53.56 3.87 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.308 -0.717 . . . . 74.23 111.308 -173.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.17 149.9 31.48 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.234 1.014 . . . . 55.01 111.219 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 105.63 -135.58 12.7 Favored Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.311 -1.116 . . . . 72.23 110.311 -169.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.418 HG22 ' H ' ' D' ' 148' ' ' GLY . 1.4 m 58.45 31.03 20.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.293 1.037 . . . . 71.13 110.363 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.91 158.03 29.07 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.492 1.517 . . . . 74.01 112.623 -169.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 62.22 101.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.766 1.226 . . . . 74.24 112.208 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -166.95 112.18 0.76 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 108.781 -0.822 . . . . 75.41 108.781 167.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -66.73 155.19 38.75 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.516 -0.765 . . . . 63.24 110.611 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -88.61 147.67 24.45 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 75.24 110.33 177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.804 0.842 . . . . 63.24 109.272 -179.198 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.0 mmt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.959 -0.386 . . . . 74.31 109.959 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p -77.96 138.5 38.88 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.503 0.721 . . . . 52.14 110.664 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -84.4 145.01 28.42 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.579 -0.526 . . . . 65.55 109.579 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -85.39 66.38 9.67 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.604 0.716 . . . . 72.04 110.755 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -159.18 12.47 0.14 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 114.626 -1.17 . . . . 72.45 109.035 173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.37 151.36 23.15 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.665 0.786 . . . . 54.21 109.467 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.505 ' HB ' ' HA3' ' C' ' 88' ' ' GLY . 1.3 m -75.17 -2.14 26.45 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.307 0.643 . . . . 55.31 111.803 -176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 62.66 35.68 14.0 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.22 1.008 . . . . 63.43 110.988 171.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ttt 64.53 115.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.677 1.591 . . . . 74.5 111.814 -174.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 53.4 m -129.88 118.07 21.14 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.719 1.208 . . . . 64.31 109.102 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.745 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 53.9 t80 -117.17 127.46 54.14 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.428 -0.952 . . . . 62.3 108.428 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.486 ' NE2' ' H ' ' H' ' 204' ' ' ILE . 9.7 tm0? -138.11 135.04 35.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 108.427 -0.953 . . . . 74.11 108.427 177.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.543 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -93.68 114.67 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-O 121.377 0.608 . . . . 30.54 109.779 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.481 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.0 mm-40 -82.04 -49.26 10.42 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.275 -0.875 . . . . 75.41 109.906 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.413 HH21 ' HG1' ' D' ' 122' ' ' THR . 71.0 ttt180 -173.55 145.63 1.24 Allowed 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.7 -0.682 . . . . 74.33 109.988 -170.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.543 HG13 HD11 ' C' ' 13' ' ' ILE . 87.0 mt -128.12 144.63 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.503 -1.295 . . . . 45.41 107.503 171.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.455 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.0 p90 -174.71 166.57 3.76 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.452 0.644 . . . . 72.32 110.77 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -88.16 105.91 17.83 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.003 -0.999 . . . . 55.32 109.44 174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mmmt -65.68 -36.28 83.19 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.547 0.689 . . . . 73.33 109.487 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.5 t70 -149.13 142.94 25.65 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.542 -1.208 . . . . 70.13 109.63 -178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -136.91 139.58 44.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 106.358 -1.719 . . . . 70.43 106.358 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -153.46 143.49 22.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.376 -0.602 . . . . 73.52 109.376 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -143.65 113.93 7.4 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.558 -1.275 . . . . 74.23 107.558 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -116.57 119.77 36.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.669 -0.864 . . . . 73.24 108.669 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.77 82.21 67.73 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 107.673 -1.232 . . . . 65.32 107.673 175.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.11 -37.29 33.2 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.572 2.181 . . . . 74.21 111.574 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.68 31.3 3.56 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.28 -1.327 . . . . 72.1 110.474 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.31 -50.76 86.26 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 113.956 1.095 . . . . 75.31 113.956 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -82.18 -19.73 6.59 Favored 'Trans proline' 0 C--N 1.385 2.457 0 CA-C-N 121.298 1.499 . . . . 71.4 112.818 171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.84 -33.53 70.76 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.189 0.996 . . . . 73.1 112.271 -178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.497 HG23 HD11 ' C' ' 68' ' ' LEU . 12.4 p -78.61 -10.63 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.064 0.946 . . . . 73.32 111.943 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -57.51 -40.63 79.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.852 0.861 . . . . 74.44 112.207 -174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -105.79 41.91 1.32 Allowed 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.967 0.889 . . . . 71.24 109.248 -178.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' C' ' 68' ' ' LEU . 1.3 tppp? -125.38 155.94 39.55 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.42 0.688 . . . . 70.05 110.443 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -72.56 127.11 31.57 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 123.332 0.653 . . . . 64.51 109.465 171.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -85.46 95.49 9.29 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.585 -0.734 . . . . 70.43 110.815 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -130.07 68.7 81.28 Favored Pre-proline 0 N--CA 1.481 1.122 0 N-CA-C 108.335 -0.987 . . . . 61.51 108.335 167.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.71 111.46 3.33 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.363 2.042 . . . . 74.5 110.57 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' E' ' 190' ' ' ASP . 38.2 mt-10 -85.09 92.82 8.47 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.649 -1.241 . . . . 74.42 107.649 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.428 HG21 HD22 ' C' ' 126' ' ' LEU . 40.1 t -81.58 86.16 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 CA-C-N 114.225 -1.352 . . . . 72.12 110.633 -168.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -91.26 105.28 17.68 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.372 -1.344 . . . . 64.12 107.372 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.51 HD23 HD12 ' C' ' 128' ' ' LEU . 0.5 OUTLIER -87.85 160.71 17.88 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.367 0.603 . . . . 71.41 111.209 177.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.628 ' HA ' HD13 ' E' ' 186' ' ' LEU . 4.5 m-20 -137.05 144.18 43.06 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.737 1.215 . . . . 64.01 108.775 175.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 46.4 tp -131.45 105.34 7.53 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.489 -0.93 . . . . 73.4 108.489 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 20.0 t70 -113.33 140.15 48.26 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 74.12 109.26 177.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -114.4 134.08 55.25 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.18 0.592 . . . . 63.44 109.959 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.96 151.66 46.71 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.335 1.054 . . . . 64.1 108.407 174.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 73.8 m -138.42 149.21 45.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.261 0.625 . . . . 75.24 110.556 -178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.6 t -150.21 158.87 44.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.396 1.079 . . . . 62.14 109.503 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -102.51 138.91 38.8 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.198 -1.038 . . . . 61.44 108.198 168.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' C' ' 57' ' ' GLU . 89.3 mt -109.86 -37.03 5.74 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.523 0.729 . . . . 63.4 110.226 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.78 -167.51 1.71 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.228 0.611 . . . . 32.44 110.744 -175.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -59.81 109.41 0.93 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.825 -1.079 . . . . 62.32 111.484 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 64.49 9.59 5.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.847 1.259 . . . . 72.24 111.968 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.28 118.78 54.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 C-N-CA 124.535 1.134 . . . . 71.11 109.279 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -110.87 162.35 14.9 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.165 0.986 . . . . 72.44 110.322 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.9 tt0 -127.22 116.66 20.94 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 114.9 -1.045 . . . . 74.13 108.453 165.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.2 t -106.64 124.74 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 107.716 -1.216 . . . . 74.13 107.716 173.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.44 119.15 60.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 123.778 0.831 . . . . 63.14 109.341 -177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' C' ' 103' ' ' PRO . 38.5 mt -88.41 118.44 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.091 0.556 . . . . 74.45 110.683 174.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 33.4 mtm105 -82.65 105.23 13.51 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 107.687 -1.227 . . . . 75.41 107.687 164.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -109.12 117.23 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.878 -1.156 . . . . 61.43 107.878 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.3 m -123.12 126.01 46.24 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.858 0.463 . . . . 62.04 109.91 -171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.552 HG23 HD13 ' C' ' 114' ' ' ILE . 54.5 t -107.65 113.69 44.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.484 0.714 . . . . 44.45 109.109 175.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.424 HG23 HD23 ' C' ' 75' ' ' LEU . 5.8 m -99.48 140.37 33.76 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.311 -0.996 . . . . 70.31 108.311 175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.8 108.66 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.925 -0.768 . . . . 51.51 108.925 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.2 m -130.17 140.65 50.74 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.202 0.525 . . . . 63.25 110.255 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.497 HD11 HG23 ' C' ' 31' ' ' VAL . 12.3 mt -93.39 40.75 1.07 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.337 1.455 . . . . 75.04 109.159 -177.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.07 -112.36 4.12 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.125 -1.59 . . . . 73.33 109.125 -163.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -90.2 -27.53 19.48 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.336 0.655 . . . . 43.31 110.117 176.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -72.86 92.28 1.59 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.628 1.171 . . . . 64.31 110.393 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 45.5 m -70.12 117.97 12.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.387 0.613 . . . . 74.43 110.164 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.92 -45.99 25.92 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 114.363 -1.289 . . . . 40.42 109.75 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -163.62 172.98 13.55 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.628 -0.715 . . . . 75.34 111.849 175.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.424 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -144.38 116.89 8.59 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 107.102 -1.444 . . . . 70.51 107.102 175.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -115.68 145.74 42.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.639 0.775 . . . . 72.41 109.492 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.11 135.6 20.64 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.703 0.401 . . . . 63.12 110.031 171.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.71 118.2 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.486 1.115 . . . . 71.15 108.798 172.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.9 mt-30 -90.14 93.71 9.48 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.83 -0.804 . . . . 70.14 108.83 172.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -83.2 107.87 16.05 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.445 -0.798 . . . . 74.24 109.921 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.56 146.33 18.11 Favored Glycine 0 C--N 1.337 0.626 0 CA-C-N 116.165 -0.47 . . . . 41.41 112.21 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.45 126.3 3.13 Favored Glycine 0 CA--C 1.507 -0.447 0 N-CA-C 111.129 -0.789 . . . . 63.0 111.129 177.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.0 mm -91.04 124.93 43.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.26 -1.015 . . . . 64.25 108.26 176.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -131.42 119.52 21.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.289 0.636 . . . . 62.42 109.468 -175.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.1 t -87.6 100.02 12.48 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.28 -1.378 . . . . 65.51 107.28 169.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.476 HG13 ' HD1' ' C' ' 11' ' ' PHE . 0.0 OUTLIER -143.8 133.79 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-O 121.469 0.652 . . . . 74.33 110.904 -170.415 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.03 -177.22 5.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.074 1.35 . . . . 55.12 109.132 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.505 ' HA3' ' HB ' ' C' ' 7' ' ' THR . . . 87.63 -18.81 36.32 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 114.712 0.645 . . . . 55.0 114.712 174.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.62 158.1 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 124.015 0.926 . . . . 62.33 111.819 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -148.98 -173.61 4.41 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.409 -0.589 . . . . 72.42 109.409 171.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.43 -152.38 21.17 Favored Glycine 0 C--N 1.359 1.827 0 N-CA-C 114.3 0.48 . . . . 33.25 114.3 177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.6 p -64.53 -32.11 73.62 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.3 0.64 . . . . 53.01 111.49 175.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.534 HE22 ' HG3' ' C' ' 147' ' ' GLU . 27.0 mt-30 -52.62 -32.57 42.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.849 0.86 . . . . 64.41 111.854 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.508 ' HG3' ' SD ' ' E' ' 174' ' ' MET . 38.1 ttm -58.67 -62.89 1.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.796 0.838 . . . . 73.44 111.417 177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.43 ' HB1' ' CE2' ' E' ' 181' ' ' TYR . . . -71.2 -27.4 63.48 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.623 -0.717 . . . . 43.51 111.708 -175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -77.3 -22.99 51.13 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.913 0.885 . . . . 71.5 110.314 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 44.7 t -71.96 -64.03 1.02 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 122.329 0.252 . . . . 61.42 110.44 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.471 ' HG ' HD12 ' E' ' 177' ' ' LEU . 2.5 pt? -79.24 -16.44 56.47 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 122.259 -0.275 . . . . 75.11 110.986 -177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.21 -26.05 27.05 Favored Glycine 0 C--N 1.352 1.459 0 N-CA-C 114.691 0.636 . . . . 72.12 114.691 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.06 -40.2 0.25 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.489 0.922 . . . . 52.4 113.489 -170.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -74.56 -48.64 25.63 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.048 0.539 . . . . 73.52 111.234 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.745 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 56.0 m -66.13 -45.1 61.85 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.313 0.645 . . . . 44.22 110.184 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.666 ' HB3' HD21 ' C' ' 60' ' ' LEU . 76.2 Cg_exo -52.38 -38.59 73.78 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.417 2.078 . . . . 75.33 115.01 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -63.66 -30.6 71.69 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 123.252 0.621 . . . . 74.32 111.209 -178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -65.62 -39.28 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 123.744 0.817 . . . . 71.3 110.489 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.1 mt -88.94 -21.57 23.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.744 0.818 . . . . 71.1 112.353 -170.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.77 -46.4 99.74 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.131 0.972 . . . . 73.24 113.039 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.554 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 23.7 Cg_exo -60.96 -40.14 55.04 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.872 1.714 . . . . 71.44 112.526 177.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -63.81 -46.15 86.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.571 0.748 . . . . 74.24 111.459 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.65 -43.46 93.54 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.369 0.668 . . . . 52.44 110.87 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -56.87 -50.88 71.14 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.011 1.324 . . . . 45.12 110.308 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -67.2 -41.41 85.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.785 0.834 . . . . 55.4 110.54 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 24.4 t -66.52 -30.87 71.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.539 0.735 . . . . 73.4 111.987 -176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.561 HG23 ' SG ' ' C' ' 76' ' ' CYS . 96.7 mt -72.58 -50.98 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 122.837 0.455 . . . . 60.4 110.086 173.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.538 HG22 ' NE2' ' C' ' 125' ' ' GLN . 10.3 m -61.99 -27.81 69.12 Favored 'General case' 0 CA--C 1.56 1.341 0 C-N-CA 123.106 0.562 . . . . 74.14 110.67 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.3 t -60.73 -51.76 67.99 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.161 0.984 . . . . 73.42 110.076 168.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.493 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.86 -38.96 83.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.582 1.153 . . . . 51.34 112.618 179.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.63 -39.73 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.271 0.628 . . . . 73.33 110.25 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 45.4 t -60.23 -42.96 96.32 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.66 0.784 . . . . 64.43 110.89 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' C' ' 116' ' ' SER . 89.2 mtt-85 -63.12 -34.0 76.66 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.723 -0.671 . . . . 71.12 111.38 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.46 12.51 58.64 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 119.156 -0.802 . . . . 73.21 113.536 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.48 ' HA ' HD21 ' B' ' 127' ' ' ASN . 70.3 p 55.23 42.81 30.14 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.421 1.488 . . . . 75.43 112.277 -178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -112.6 154.27 44.74 Favored Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 107.972 -1.122 . . . . 75.14 107.972 172.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.72 148.15 36.27 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.322 2.015 . . . . 75.0 112.225 -171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.538 ' NE2' HG22 ' C' ' 115' ' ' THR . 12.8 mm100 -62.76 110.43 1.74 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.667 0.988 . . . . 74.23 113.667 -170.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.428 HD22 HG21 ' C' ' 40' ' ' VAL . 65.1 mt -92.21 76.13 5.33 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.416 0.686 . . . . 72.31 109.884 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -92.31 89.41 6.83 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.01 -0.995 . . . . 63.25 109.356 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.51 HD12 HD23 ' C' ' 42' ' ' LEU . 12.7 mt -86.74 153.04 22.01 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 114.415 -1.266 . . . . 74.42 109.841 -176.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -42.19 120.11 2.34 Favored Pre-proline 0 CA--C 1.556 1.191 0 C-N-CA 125.633 1.573 . . . . 74.22 113.633 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.62 94.48 0.44 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.666 2.244 . . . . 71.55 111.145 176.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 m -69.56 98.9 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-N 114.965 -1.016 . . . . 74.25 111.383 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.744 HD21 HD12 ' A' ' 105' ' ' ILE . 57.3 t-20 -75.76 87.15 2.78 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.197 -0.91 . . . . 62.4 108.952 175.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' E' ' 182' ' ' PHE . 86.6 t80 -54.86 -39.17 68.34 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.674 1.19 . . . . 64.44 112.631 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -64.39 -36.87 85.54 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.666 0.603 . . . . 53.34 111.096 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.1 -36.71 83.89 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.739 0.649 . . . . 72.52 112.086 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.538 HD11 HG11 ' F' ' 207' ' ' VAL . 10.2 mp -64.83 -42.25 95.09 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.54 0.525 . . . . 74.15 110.088 176.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -68.6 -42.51 78.07 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 110.188 -0.301 . . . . 74.22 110.188 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.647 ' SD ' ' HG3' ' C' ' 142' ' ' GLN . 50.2 tpp -62.92 -35.15 79.14 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.332 1.053 . . . . 71.15 110.523 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -66.45 -52.48 45.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.119 1.368 . . . . 74.02 110.502 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.569 ' HB3' HD22 ' C' ' 141' ' ' LEU . 3.6 m-85 -69.93 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.389 1.075 . . . . 73.04 110.16 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.569 HD22 ' HB3' ' C' ' 140' ' ' TYR . 2.6 mm? -109.79 100.16 9.2 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.691 0.796 . . . . 72.41 109.902 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.647 ' HG3' ' SD ' ' C' ' 138' ' ' MET . 52.9 tt0 -75.18 -4.83 41.11 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.526 0.731 . . . . 63.01 111.39 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -72.83 77.93 1.14 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.713 0.805 . . . . 74.34 110.606 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -107.33 115.68 30.59 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.001 -1.111 . . . . 72.24 108.001 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.24 150.07 52.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.917 0.887 . . . . 72.54 110.286 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' C' ' 93' ' ' GLN . . . 169.99 35.37 0.03 OUTLIER Glycine 0 CA--C 1.502 -0.746 0 C-N-CA 121.123 -0.561 . . . . 53.42 113.394 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.534 ' HG3' HE22 ' C' ' 93' ' ' GLN . 39.6 mt-10 -144.16 -162.63 1.51 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 106.821 -1.548 . . . . 62.24 106.821 170.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.46 41.15 0.02 OUTLIER Glycine 0 N--CA 1.471 0.997 0 N-CA-C 110.398 -1.081 . . . . 70.24 110.398 178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 35.4 p -122.5 161.57 23.36 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.085 0.954 . . . . 71.01 110.576 -169.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -140.57 -74.33 0.34 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 105.97 -1.863 . . . . 64.24 105.97 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -78.08 159.52 28.64 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.702 -0.681 . . . . 71.04 109.854 170.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 3.9 p-80 -154.91 98.39 2.03 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.85 0.86 . . . . 62.43 108.972 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -149.41 149.65 31.16 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.767 -0.651 . . . . 55.34 110.02 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.52 113.07 3.07 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 124.039 0.837 . . . . 62.32 109.884 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.901 0 N-CA-C 108.17 -1.048 . . . . 75.41 108.17 178.649 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.35 -0.241 . . . . 61.54 110.35 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 70.1 m -143.13 27.52 1.59 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.596 0.758 . . . . 42.11 109.202 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.17 138.85 31.08 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.943 -0.571 . . . . 72.25 110.393 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.51 87.0 2.9 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 108.456 -0.942 . . . . 73.44 108.456 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -167.56 -152.84 0.13 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.707 -0.849 . . . . 55.22 108.707 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 71.41 -79.33 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.701 1.6 . . . . 62.41 110.514 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p -134.47 161.65 34.45 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.274 1.03 . . . . 74.32 109.511 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -70.48 149.13 47.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.213 0.605 . . . . 73.3 110.013 171.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.2 ttp -34.72 130.01 0.41 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.107 0.963 . . . . 63.34 112.952 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -139.48 145.18 38.46 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.638 0.775 . . . . 42.42 109.067 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -154.37 105.68 2.69 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.862 -1.162 . . . . 75.12 107.862 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.514 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 74.9 mt-30 -117.34 115.94 26.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.992 0.517 . . . . 73.33 110.188 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.9 tt -87.01 126.19 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 N-CA-C 108.455 -0.943 . . . . 62.44 108.455 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.446 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.1 mt-30 -109.26 -47.53 3.39 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 112.114 0.413 . . . . 61.4 112.114 -172.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -165.45 121.81 1.4 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 39.6 mm -116.06 128.14 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.773 0.829 . . . . 71.55 109.057 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.407 ' HB3' HG23 ' C' ' 122' ' ' THR . 40.3 p90 -161.99 174.58 12.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.95 0.881 . . . . 73.22 111.52 -171.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -101.51 120.68 40.67 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.72 -1.127 . . . . 63.15 108.985 177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -84.77 -37.59 20.64 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.541 -0.54 . . . . 55.53 109.541 177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -146.8 137.96 24.13 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.078 -0.965 . . . . 75.34 109.088 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' C' ' 117' ' ' MET . 74.9 mt -131.44 139.68 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 73.33 108.08 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -138.97 134.36 33.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.139 0.975 . . . . 70.1 108.812 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -146.94 116.18 6.98 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 106.614 -1.625 . . . . 72.31 106.614 170.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -122.23 144.35 49.03 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.528 0.731 . . . . 72.44 109.499 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.706 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -134.25 75.2 65.68 Favored Pre-proline 0 C--O 1.241 0.645 0 N-CA-C 107.896 -1.15 . . . . 60.33 107.896 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.96 -27.18 10.32 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.748 2.299 . . . . 63.41 113.081 -170.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -115.21 27.08 9.62 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.449 0.699 . . . . 60.24 109.978 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.706 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.95 -56.15 30.98 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 115.272 1.582 . . . . 62.04 115.272 -167.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -80.96 -6.23 13.14 Favored 'Trans proline' 0 C--N 1.376 2.015 0 CA-C-N 121.474 1.562 . . . . 73.22 112.903 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 10.5 t-160 -81.75 -44.46 17.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.642 1.177 . . . . 63.53 110.094 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 35.2 m -81.18 2.42 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.061 0.545 . . . . 74.34 111.202 -178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.439 ' HA ' ' CE2' ' H' ' 197' ' ' TYR . 63.9 t80 -58.25 -33.82 69.79 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.137 0.975 . . . . 73.13 110.34 165.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.59 -23.46 58.74 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.622 -1.172 . . . . 75.12 111.004 177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.468 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -88.62 79.03 7.65 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.273 1.029 . . . . 72.13 110.419 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.616 ' HB2' ' HD3' ' H' ' 196' ' ' LYS . 6.3 p-10 -87.17 57.49 4.5 Favored 'General case' 0 CA--C 1.561 1.371 0 C-N-CA 124.199 1.0 . . . . 72.11 110.894 179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -125.86 175.87 7.35 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.884 1.274 . . . . 72.33 108.425 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -72.44 112.79 16.24 Favored Pre-proline 0 N--CA 1.485 1.315 0 CA-C-O 119.194 -0.431 . . . . 72.43 109.969 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -63.08 113.73 2.15 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.524 2.149 . . . . 61.13 111.889 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -69.77 112.42 6.21 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 124.09 0.869 . . . . 73.43 109.655 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.5 m -99.65 122.16 51.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.713 0.805 . . . . 73.25 110.045 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -104.56 112.57 25.69 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 74.44 108.498 176.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.551 HD21 HD22 ' D' ' 128' ' ' LEU . 6.8 mp -95.22 142.25 27.86 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.345 0.658 . . . . 74.35 110.093 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.431 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.2 t70 -132.61 137.09 46.91 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.633 -0.877 . . . . 63.51 108.633 174.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.448 HD13 HD21 ' H' ' 186' ' ' LEU . 22.6 tp -115.12 129.59 56.71 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.295 -0.631 . . . . 73.34 109.295 178.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.98 148.02 44.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.289 1.035 . . . . 73.4 108.389 172.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.428 ' H ' ' HG3' ' H' ' 180' ' ' PRO . 88.6 m -128.97 150.59 50.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.166 0.987 . . . . 71.42 108.718 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.94 164.15 35.39 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.039 0.936 . . . . 62.33 109.755 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 96.5 p -167.43 155.33 9.12 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.5 0.72 . . . . 70.2 111.089 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.1 p -156.42 130.91 8.8 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.886 0.874 . . . . 70.51 109.031 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.74 126.13 27.49 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.836 0.454 . . . . 73.42 110.244 177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.1 mt -98.69 -35.99 10.0 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.052 0.541 . . . . 72.12 110.183 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -159.25 -171.28 3.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.333 0.653 . . . . 72.43 111.186 -176.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -66.12 110.81 3.11 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.257 -0.883 . . . . 75.01 109.797 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 67.73 1.71 2.74 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 125.247 1.419 . . . . 71.43 112.707 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 52.2 t -110.24 134.16 53.3 Favored 'Isoleucine or valine' 0 C--N 1.346 0.437 0 C-N-CA 123.87 0.868 . . . . 62.32 108.999 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -151.68 174.67 13.22 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.862 0.865 . . . . 71.03 109.08 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.0 tt0 -120.11 132.75 55.53 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.651 0.78 . . . . 73.41 109.127 176.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' D' ' 102' ' ' CYS . 58.5 t -100.24 132.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 108.045 -1.094 . . . . 65.1 108.045 168.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 47.0 t -111.12 136.15 48.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.48 -0.933 . . . . 63.13 108.48 171.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.549 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -113.87 127.49 56.01 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.138 -1.06 . . . . 74.33 108.138 179.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 35.3 ttm-85 -109.86 106.98 16.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.976 -0.749 . . . . 54.42 108.976 174.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.2 t -105.95 106.74 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 107.756 -1.201 . . . . 61.43 107.756 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 7.6 m -106.09 129.6 54.15 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.707 0.403 . . . . 54.43 110.183 -178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 63.4 t -119.64 102.89 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.719 1.208 . . . . 62.14 109.218 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 55.7 m -96.6 95.94 8.3 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.445 -0.946 . . . . 74.24 108.445 173.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 147.58 23.67 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.171 0.589 . . . . 62.1 110.495 -176.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.568 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.4 p -155.8 129.16 8.26 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.564 0.697 . . . . 65.53 111.829 -175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 13.2 mt -92.51 98.33 11.39 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.695 178.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.04 -123.88 10.96 Favored Glycine 0 C--N 1.347 1.163 0 O-C-N 123.827 0.704 . . . . 73.43 112.133 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.92 5.98 37.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.17 0.588 . . . . 64.11 111.28 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -129.37 143.93 51.04 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.225 0.61 . . . . 54.01 110.8 -169.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.2 m -70.45 127.85 34.16 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.378 0.671 . . . . 73.43 110.982 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.568 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.67 -66.13 0.93 Allowed 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.139 -1.059 . . . . 63.24 108.139 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -148.49 152.08 36.26 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.019 -0.991 . . . . 71.24 110.167 172.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.5 mt -104.93 147.11 28.13 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.573 -1.269 . . . . 73.35 107.573 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.5 t -156.92 143.4 18.26 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.87 -0.418 . . . . 55.21 109.87 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -157.15 141.23 16.26 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.505 -0.924 . . . . 64.32 108.505 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -135.51 116.64 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.202 0.601 . . . . 71.51 109.555 175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -89.88 84.04 6.2 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.876 0.845 . . . . 72.24 108.889 171.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.41 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.88 100.33 7.98 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.208 -1.36 . . . . 64.11 109.292 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.58 143.87 16.47 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 111.683 -0.567 . . . . 54.52 111.683 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.97 139.26 6.82 Favored Glycine 0 C--O 1.239 0.413 0 N-CA-C 111.279 -0.729 . . . . 72.2 111.279 -175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 49.0 mt -88.72 127.54 41.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 122.962 0.505 . . . . 63.52 109.91 -175.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -130.68 146.27 52.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.67 0.788 . . . . 72.22 109.49 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 20.5 m -116.32 105.14 12.21 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.356 0.663 . . . . 63.53 109.489 176.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.576 ' HB ' HD11 ' D' ' 89' ' ' ILE . 18.3 pt -109.33 142.4 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 CA-C-N 118.413 0.551 . . . . 54.04 109.983 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.26 145.14 19.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.188 -0.915 . . . . 72.53 109.449 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.03 -10.05 61.79 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 114.108 0.403 . . . . 72.41 114.108 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.576 HD11 ' HB ' ' D' ' 86' ' ' ILE . 0.2 OUTLIER -124.76 130.85 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.424 0.69 . . . . 72.24 110.368 -172.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.621 ' HG2' ' HG ' ' H' ' 173' ' ' LEU . 20.8 mt-10 -131.73 167.74 18.98 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.985 0.514 . . . . 61.34 111.173 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.43 -134.89 42.07 Favored Glycine 0 C--N 1.352 1.433 0 O-C-N 124.139 0.899 . . . . 53.31 113.208 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 14.7 t -66.39 -23.72 66.37 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.241 0.616 . . . . 63.43 111.608 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.407 ' NE2' HG22 ' D' ' 89' ' ' ILE . 45.9 tt0 -66.52 -34.17 77.32 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.331 0.652 . . . . 65.43 110.912 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.524 ' HB3' HG12 ' D' ' 89' ' ' ILE . 3.2 ppp? -88.16 -27.76 21.65 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.433 0.293 . . . . 60.45 111.054 173.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.13 -30.59 65.2 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.977 0.511 . . . . 71.3 111.879 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 8.0 t-160 -84.56 -10.74 57.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.696 0.799 . . . . 71.43 110.338 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -89.03 -45.61 9.5 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.348 0.659 . . . . 54.32 109.543 170.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 46.6 tp -70.93 -39.29 72.76 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.015 0.926 . . . . 54.55 111.432 -178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.16 12.44 67.83 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.068 -0.515 . . . . 51.35 113.018 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.54 -75.88 0.17 Allowed 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.988 0.515 . . . . 61.01 111.716 -176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -72.74 -44.69 61.34 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.948 0.721 . . . . 61.43 112.948 -163.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.485 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 61.7 m -61.52 -48.44 90.48 Favored Pre-proline 0 CA--C 1.567 1.626 0 CA-C-O 118.771 -0.633 . . . . 62.04 112.162 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.549 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 10.0 Cg_exo -72.76 -18.89 24.59 Favored 'Trans proline' 0 C--N 1.395 3.015 0 C-N-CA 122.036 1.824 . . . . 75.53 112.977 171.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -71.31 -28.73 64.31 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 122.795 0.438 . . . . 44.43 110.563 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.11 -41.78 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-O 121.598 0.713 . . . . 71.42 109.413 169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.41 HD13 ' O ' ' D' ' 80' ' ' GLN . 92.4 mt -74.72 -20.91 59.65 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.863 -1.062 . . . . 64.41 111.722 -176.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -70.16 -41.42 14.29 Favored Pre-proline 0 CA--C 1.556 1.205 0 N-CA-C 114.252 1.205 . . . . 64.01 114.252 -169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -56.14 -36.04 95.91 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 121.762 1.641 . . . . 53.3 112.881 171.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -81.13 -32.82 33.58 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.81 0.844 . . . . 73.34 111.552 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.6 -50.74 63.94 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.584 -0.524 . . . . 74.54 109.584 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.507 ' NH2' HG23 ' B' ' 105' ' ' ILE . 38.7 ttp180 -58.31 -50.27 74.23 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 114.031 -1.441 . . . . 75.1 110.51 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -63.06 -42.43 99.68 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.46 0.704 . . . . 72.41 111.643 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.2 t -59.47 -44.86 92.92 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.767 0.667 . . . . 72.24 110.944 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.436 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.3 mt -62.41 -57.24 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.612 0.765 . . . . 75.34 110.092 174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.524 HG23 ' HG3' ' D' ' 125' ' ' GLN . 83.8 m -50.12 -43.83 51.93 Favored 'General case' 0 C--O 1.246 0.876 0 C-N-CA 125.533 1.533 . . . . 70.14 112.477 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 48.4 t -67.99 -44.66 76.09 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.255 -0.884 . . . . 70.34 110.486 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -64.48 -33.78 76.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.909 0.484 . . . . 74.14 111.43 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 79.4 t -64.61 -45.8 94.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 124.108 0.963 . . . . 52.12 110.049 177.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.03 -27.98 63.07 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 120.683 0.278 . . . . 61.34 111.085 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -71.68 -30.59 65.86 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.6 0.76 . . . . 72.21 110.138 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 6.64 80.11 Favored Glycine 0 C--N 1.358 1.781 0 O-C-N 123.66 0.6 . . . . 60.34 112.731 175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.455 HG23 ' HB3' ' C' ' 17' ' ' TYR . 51.0 p 65.41 21.28 11.87 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.309 1.844 . . . . 71.51 113.09 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -95.26 164.89 18.01 Favored Pre-proline 0 CA--C 1.563 1.445 0 C-N-CA 124.82 1.248 . . . . 72.34 109.314 175.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.07 140.34 22.52 Favored 'Trans proline' 0 C--N 1.389 2.688 0 C-N-CA 122.394 2.063 . . . . 63.42 112.266 -170.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.524 ' HG3' HG23 ' D' ' 115' ' ' THR . 32.8 tt0 -55.75 126.65 26.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.365 0.666 . . . . 75.23 111.013 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.6 tp -107.93 105.65 15.54 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.411 0.684 . . . . 75.13 109.209 -178.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -98.48 92.81 5.83 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.718 -0.845 . . . . 73.12 108.718 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.551 HD22 HD21 ' D' ' 42' ' ' LEU . 76.3 mt -69.89 123.33 21.2 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.098 0.559 . . . . 75.14 109.555 176.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.529 ' HB3' HG12 ' H' ' 187' ' ' ILE . . . -56.21 133.05 75.33 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.254 0.621 . . . . 54.3 111.145 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.65 108.66 2.3 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 121.877 1.718 . . . . 63.14 110.17 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.7 107.25 22.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.809 -1.182 . . . . 73.41 107.809 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -99.42 93.0 5.67 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.141 -0.936 . . . . 75.23 108.682 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.455 ' HB2' ' HB3' ' H' ' 184' ' ' TRP . 76.1 t80 -62.2 -19.29 62.97 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.483 -1.235 . . . . 72.32 111.189 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' D' ' 138' ' ' MET . 0.5 OUTLIER -58.19 -69.31 0.18 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 118.421 -0.799 . . . . 54.43 109.593 171.158 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.61 95.22 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 118.36 0.527 . . . . 64.24 112.064 -172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.0 -35.54 78.84 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.287 1.035 . . . . 70.21 111.952 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -101.17 -25.47 14.0 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.602 0.761 . . . . 63.04 111.716 -176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 29.1 ttm -54.39 -38.63 66.38 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 124.47 1.108 . . . . 75.42 112.301 -170.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -64.34 -40.45 95.89 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.62 -1.173 . . . . 73.54 110.884 178.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -55.56 -44.3 76.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.934 0.894 . . . . 75.02 112.131 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -57.83 -50.41 73.38 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.02 0.438 . . . . 72.44 110.649 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -86.28 3.92 41.15 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.972 -1.013 . . . . 72.31 112.188 -175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -125.72 62.22 1.23 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.83 0.852 . . . . 55.45 109.731 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -144.02 160.0 41.63 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.207 1.003 . . . . 71.34 109.097 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.02 -50.44 28.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.542 0.737 . . . . 23.33 111.206 -172.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.37 -102.02 0.78 Allowed Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.368 -0.693 . . . . 43.25 111.368 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.18 155.21 17.27 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.464 0.705 . . . . 53.3 110.35 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . 0.418 ' H ' HG22 ' B' ' 149' ' ' THR . . . 165.7 51.63 0.02 OUTLIER Glycine 0 C--N 1.343 0.921 0 CA-C-N 115.972 -0.558 . . . . 42.52 111.734 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 90.9 m -134.11 122.71 23.29 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.448 -0.575 . . . . 25.33 109.448 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -74.96 81.04 2.17 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.706 0.802 . . . . 61.11 109.069 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -72.35 161.3 31.02 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 114.579 -1.192 . . . . 73.02 111.174 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -142.71 154.7 44.55 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.739 -1.119 . . . . 75.22 108.604 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -76.18 148.13 37.95 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.158 -0.682 . . . . 54.24 109.158 174.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -71.6 90.89 1.05 Allowed 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.242 1.02 . . . . 75.22 109.359 176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.858 -1.065 . . . . 63.21 108.853 -177.306 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 108.653 -0.869 . . . . 74.43 108.653 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -75.39 -96.73 0.13 Allowed Glycine 0 C--N 1.349 1.288 0 N-CA-C 111.217 -0.753 . . . . 71.12 111.217 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -145.26 -72.47 0.25 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.722 0.809 . . . . 73.54 109.3 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 51.6 p -164.7 15.21 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.35 -0.841 . . . . 63.11 110.123 -172.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 68.67 158.5 0.16 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.164 1.386 . . . . 52.32 110.855 -161.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.539 ' H ' HD23 ' E' ' 173' ' ' LEU . 2.3 pt? -85.02 37.13 0.65 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.536 0.734 . . . . 71.41 111.608 -174.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.663 ' HG3' ' H ' ' E' ' 175' ' ' PHE . 12.2 ptt? -152.23 -96.45 0.05 Allowed 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.516 0.932 . . . . 73.31 113.516 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.663 ' H ' ' HG3' ' E' ' 174' ' ' MET . 4.8 t80 54.03 30.84 12.54 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 125.132 1.373 . . . . 74.4 110.463 -155.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -89.04 90.18 8.29 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 115.186 -0.915 . . . . 73.51 109.54 -174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . 0.471 HD12 ' HG ' ' C' ' 98' ' ' LEU . 1.7 tt -159.79 106.64 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.034 -1.469 . . . . 63.53 107.034 178.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -132.18 7.5 4.28 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.491 1.116 . . . . 71.34 109.036 172.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.0 151.27 4.75 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.541 1.537 . . . . 74.15 108.617 -176.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.54 -8.3 22.32 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.091 2.527 . . . . 75.51 113.63 176.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . 0.43 ' CE2' ' HB1' ' C' ' 95' ' ' ALA . 94.7 m-85 66.0 -79.16 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.247 1.419 . . . . 73.12 111.015 -175.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . 0.429 ' HB3' ' CZ ' ' C' ' 133' ' ' PHE . 28.2 t80 -91.4 144.24 25.79 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.969 -1.123 . . . . 64.12 107.969 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 41.3 p -90.41 124.51 35.01 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.34 0.656 . . . . 75.41 111.454 -173.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.421 ' HA ' ' HD3' ' E' ' 185' ' ' PRO . 2.8 p90 -85.93 125.65 67.99 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 122.781 0.432 . . . . 71.22 110.045 169.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' E' ' 184' ' ' TRP . 8.3 Cg_exo -73.45 131.96 16.96 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 123.149 2.566 . . . . 72.24 112.115 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.628 HD13 ' HA ' ' C' ' 43' ' ' ASP . 73.7 mt -110.87 127.35 55.4 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.525 0.73 . . . . 60.23 109.707 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 23.4 pt -97.63 167.56 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.237 1.015 . . . . 71.24 111.971 -174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.24 81.79 2.04 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.066 0.946 . . . . 64.24 109.324 174.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.37 91.99 0.78 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.259 1.024 . . . . 75.12 111.979 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' C' ' 39' ' ' GLU . 6.8 p-10 -66.4 122.68 18.07 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 109.123 -0.695 . . . . 52.44 109.123 174.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.96 131.36 30.82 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-O 119.537 -0.591 . . . . 72.5 111.833 -176.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -72.31 72.74 0.95 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 111.277 -0.729 . . . . 53.44 111.277 175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 63.81 -85.48 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.907 1.683 . . . . 63.52 111.738 -173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 70.51 142.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.061 1.345 . . . . 73.32 111.71 -173.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 66.64 171.76 0.25 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 125.205 1.402 . . . . 74.01 111.849 -173.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -164.48 93.02 0.65 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.618 -0.882 . . . . 72.12 108.618 168.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -86.35 63.86 8.23 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.2 0.6 . . . . 71.44 110.117 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -113.04 5.6 17.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.089 0.556 . . . . 72.23 110.844 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -83.04 15.42 2.8 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.378 0.671 . . . . 62.25 111.633 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 81.39 9.37 85.96 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.362 -0.688 . . . . 45.12 113.18 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' E' ' 201' ' ' LYS . 1.1 tpmt? -170.98 -81.18 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.379 0.672 . . . . 72.35 111.367 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . 0.471 ' HB3' HG12 ' E' ' 204' ' ' ILE . 71.4 t80 -138.36 -169.69 2.65 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 107.681 -1.229 . . . . 71.14 107.681 -167.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -61.41 -24.0 66.21 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.423 0.689 . . . . 73.32 111.113 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' E' ' 202' ' ' TYR . 31.5 pt -81.63 166.54 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-O 121.322 0.582 . . . . 74.5 111.028 172.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -98.14 39.69 1.22 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.085 -0.962 . . . . 65.05 109.736 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.46 -159.76 0.31 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.299 1.04 . . . . 75.14 109.792 -168.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.256 1.445 0 N-CA-C 109.219 -0.66 . . . . 72.52 109.219 176.128 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.365 0.126 . . . . 61.41 110.688 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.45 177.71 31.26 Favored Glycine 0 C--N 1.356 1.651 0 O-C-N 123.852 0.72 . . . . 72.42 113.06 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.07 32.66 4.7 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.585 -0.894 . . . . 64.51 108.585 172.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 45.4 m -70.23 86.8 0.58 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.05 0.94 . . . . 71.03 110.474 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . 0.534 ' HB1' ' SD ' ' B' ' 94' ' ' MET . . . -163.11 113.55 1.4 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.418 -0.956 . . . . 73.23 108.418 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.7 tt -170.14 -64.04 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.155 -1.424 . . . . 72.55 107.155 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 29.5 mmt -108.96 98.94 8.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.964 0.906 . . . . 71.24 110.194 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 20.8 t80 53.59 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 126.124 1.77 . . . . 73.2 113.72 176.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 56.7 t30 179.9 130.87 0.09 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.004 0.922 . . . . 71.31 109.936 171.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.9 mp -99.26 80.19 2.4 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.186 -1.413 . . . . 71.12 107.186 169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -70.8 114.4 8.84 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.969 -1.014 . . . . 75.41 111.131 -174.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 59.99 118.72 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 125.391 1.476 . . . . 62.13 113.184 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.67 83.9 0.66 Allowed 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.169 1.913 . . . . 74.04 110.755 172.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -62.46 -36.34 82.14 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.389 -0.823 . . . . 74.34 110.561 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -131.88 160.54 35.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.251 1.02 . . . . 74.11 110.151 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 40.9 p -138.94 103.28 4.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.181 0.993 . . . . 61.12 109.254 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -72.82 123.92 90.14 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 123.004 0.522 . . . . 72.04 111.501 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -90.35 122.93 0.98 Allowed 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.12 2.547 . . . . 53.43 112.424 176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -98.58 137.46 37.2 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.446 0.699 . . . . 71.13 110.229 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.427 HG12 HG22 ' E' ' 204' ' ' ILE . 2.8 pp -91.51 173.46 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 123.623 0.769 . . . . 73.33 112.979 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.34 165.89 20.59 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.85 1.26 . . . . 40.42 110.399 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.12 130.96 24.32 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.49 0.716 . . . . 35.24 109.906 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -129.45 15.11 6.06 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.433 1.093 . . . . 75.33 109.701 175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.15 124.21 11.09 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.795 -0.639 . . . . 62.44 112.264 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 99.68 145.16 17.58 Favored Glycine 0 C--N 1.343 0.948 0 O-C-N 123.721 0.306 . . . . 52.11 113.415 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -83.41 -43.89 15.39 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.523 0.729 . . . . 72.23 109.644 177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . 52.72 23.76 2.87 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 125.264 1.426 . . . . 73.01 114.633 169.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -147.88 132.03 17.35 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.859 0.864 . . . . 73.22 109.948 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' F' ' 198' ' ' GLU . 10.1 tmtt? -130.77 -21.61 2.73 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.638 1.175 . . . . 51.22 108.342 175.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 35.4 t80 76.91 4.67 3.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.092 1.757 . . . . 74.41 110.388 -169.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' F' ' 205' ' ' LYS . 42.5 mt-10 -142.46 155.54 45.08 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.813 0.845 . . . . 75.41 110.529 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . 0.431 HD22 ' HE2' ' F' ' 201' ' ' LYS . 64.9 t30 74.41 -1.61 3.03 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.161 1.784 . . . . 74.24 112.241 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 76.07 31.61 54.88 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 111.956 -0.458 . . . . 64.3 111.956 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.431 ' HE2' HD22 ' F' ' 199' ' ' ASN . 73.1 mttt -78.85 76.81 5.33 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.327 -0.99 . . . . 65.21 108.327 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 64.68 9.64 5.34 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.197 0.999 . . . . 54.5 110.696 -174.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . 0.427 ' HA ' HH12 ' A' ' 15' ' ' ARG . 3.3 p30 -127.18 -156.74 0.77 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 125.319 1.448 . . . . 74.54 108.763 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 5.8 tt -155.48 121.36 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 123.381 0.672 . . . . 54.42 109.674 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' F' ' 198' ' ' GLU . 14.5 tmtt? -86.51 127.18 34.85 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.102 -1.073 . . . . 71.44 108.102 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -64.19 97.06 0.17 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.969 -0.752 . . . . 70.23 108.969 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.538 HG11 HD11 ' C' ' 136' ' ' LEU . 3.6 p . . . . . 0 CA--C 1.565 1.524 0 C-N-CA 125.264 1.425 . . . . 71.44 113.103 -170.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.066 0.46 . . . . 73.31 110.012 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . 0.473 ' HA2' ' N ' ' G' ' 175' ' ' PHE . . . 90.6 -178.17 42.55 Favored Glycine 0 C--N 1.341 0.853 0 CA-C-N 115.532 -0.758 . . . . 61.21 112.467 -174.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -162.67 -40.48 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.564 0.346 . . . . 72.11 110.531 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . 0.466 ' H ' ' HB2' ' G' ' 175' ' ' PHE . 44.1 t -65.99 -69.29 0.31 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 122.977 0.511 . . . . 72.02 110.346 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . 0.687 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . . . -110.76 -92.17 0.46 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.805 -0.813 . . . . 75.22 108.805 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.605 HD13 ' H ' ' G' ' 173' ' ' LEU . 0.0 OUTLIER -117.92 -8.26 10.79 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.409 1.084 . . . . 71.1 108.783 169.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.428 ' O ' ' HB2' ' G' ' 175' ' ' PHE . 9.3 ptp -126.19 145.37 50.41 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 124.874 1.269 . . . . 72.31 108.973 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.473 ' N ' ' HA2' ' G' ' 169' ' ' GLY . 17.0 t80 170.41 72.73 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.443 1.497 . . . . 75.33 108.039 167.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -165.04 94.19 0.64 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.529 -0.915 . . . . 53.42 108.529 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 6.6 mp -84.54 81.72 8.72 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.349 -0.612 . . . . 72.42 109.349 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -99.22 -168.92 1.69 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.37 -0.832 . . . . 62.14 109.469 172.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -63.33 111.64 5.46 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.283 0.633 . . . . 74.4 109.543 171.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -82.58 -177.08 3.23 Favored 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.88 2.387 . . . . 73.44 112.951 -172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -85.52 164.94 17.5 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.474 -0.785 . . . . 71.04 110.047 173.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 63.51 -165.16 0.24 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.493 1.117 . . . . 65.14 110.729 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.7 t -149.16 141.63 24.29 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.76 0.424 . . . . 71.43 110.461 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -148.73 88.45 5.24 Favored Pre-proline 0 CA--C 1.548 0.888 0 N-CA-C 108.088 -1.079 . . . . 75.24 108.088 178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.75 3.32 7.41 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.116 2.544 . . . . 64.52 114.085 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 79.7 mt 64.82 -168.63 0.21 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.591 1.156 . . . . 74.04 111.426 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.519 HG21 ' HB2' ' H' ' 206' ' ' ASP . 2.3 pp -127.22 163.07 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.558 0.743 . . . . 63.14 110.773 174.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -119.64 164.55 15.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.368 1.067 . . . . 71.13 109.52 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.54 116.96 10.17 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.552 0.741 . . . . 51.11 109.699 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -79.58 169.72 17.6 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.956 0.502 . . . . 72.15 111.162 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -86.4 130.76 10.13 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.765 -0.652 . . . . 64.25 112.592 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -84.02 -129.78 1.78 Allowed Glycine 0 C--N 1.348 1.221 0 N-CA-C 110.547 -1.021 . . . . 71.1 110.547 168.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -166.68 142.14 4.4 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.822 0.849 . . . . 74.32 109.152 173.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . 0.58 ' HB2' ' HA ' ' H' ' 198' ' ' GLU . . . -169.7 -168.64 0.8 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.069 0.948 . . . . 71.23 110.556 -172.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.708 ' H ' ' HB3' ' H' ' 196' ' ' LYS . 2.4 t80 29.37 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 127.665 2.386 . . . . 74.41 113.401 173.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.65 103.2 0.52 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.021 -0.99 . . . . 60.1 109.791 -172.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . 0.751 ' HE1' HH12 ' B' ' 15' ' ' ARG . 54.6 m-85 -87.57 -97.72 0.08 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.537 0.735 . . . . 65.41 109.247 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . 0.509 ' HG2' HD22 ' G' ' 199' ' ' ASN . 35.4 tt0 61.12 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.372 1.579 0 C-N-CA 124.963 1.305 . . . . 65.24 111.794 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . 0.509 HD22 ' HG2' ' G' ' 198' ' ' GLU . 7.4 p30 -150.26 26.55 0.78 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.84 0.856 . . . . 73.54 110.629 175.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -76.31 132.03 12.26 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.078 -0.51 . . . . 73.15 112.453 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -154.31 157.28 38.4 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.794 0.838 . . . . 62.04 110.255 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -70.56 94.56 1.0 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.725 -0.843 . . . . 73.12 108.725 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -67.23 112.67 4.63 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.382 1.073 . . . . 63.42 111.323 -174.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 11.5 tt -171.86 138.13 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 C-N-CA 122.713 0.405 . . . . 74.4 111.61 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -151.05 116.81 5.48 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 107.924 -1.139 . . . . 72.31 107.924 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -128.22 -75.1 0.57 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.22 -1.03 . . . . 61.03 108.22 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.716 -0.659 . . . . 73.04 109.474 176.504 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 110.039 -0.356 . . . . 64.13 110.039 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 125.99 -80.37 0.36 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.126 -0.79 . . . . 52.51 111.126 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -127.62 132.16 49.81 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.813 0.845 . . . . 61.43 111.008 -177.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 47.4 p -79.36 157.14 27.69 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.132 -1.062 . . . . 65.44 108.132 159.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -76.02 -65.37 0.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.386 0.275 . . . . 44.44 110.923 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.621 ' HG ' ' HG2' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -172.73 156.79 3.59 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.319 0.648 . . . . 72.13 110.144 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 14.8 mmt -145.32 -179.45 6.65 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.632 1.173 . . . . 62.54 108.626 166.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -156.32 175.72 13.63 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.459 0.647 . . . . 74.24 111.078 -169.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -128.23 10.37 6.3 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.103 1.361 . . . . 71.1 109.861 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 3.5 tt -65.75 97.67 0.35 Allowed 'General case' 0 C--N 1.363 1.156 0 N-CA-C 108.319 -0.993 . . . . 75.53 108.319 174.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -125.47 30.4 5.79 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.76 1.224 . . . . 72.24 109.539 -177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -114.93 140.62 25.75 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.181 -1.372 . . . . 74.25 109.578 -171.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . 0.428 ' HG3' ' H ' ' D' ' 46' ' ' THR . 12.1 Cg_exo -70.23 77.6 1.23 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.885 2.39 . . . . 45.34 111.239 169.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -101.62 -61.55 1.37 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.231 -0.895 . . . . 62.34 110.032 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -104.08 33.5 3.44 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.37 0.668 . . . . 75.21 109.346 -173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 24.6 p -92.33 165.62 12.99 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.399 1.08 . . . . 74.23 111.241 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . 0.473 ' HH2' ' HB2' ' D' ' 103' ' ' PRO . 44.9 p90 -93.48 160.51 32.88 Favored Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 123.521 0.728 . . . . 73.23 111.821 -176.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.47 139.51 16.36 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.221 1.947 . . . . 75.44 111.588 166.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . 0.448 HD21 HD13 ' D' ' 44' ' ' LEU . 76.3 mt -79.51 164.09 24.19 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.057 0.456 . . . . 64.35 110.674 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.529 HG12 ' HB3' ' D' ' 129' ' ' ALA . 2.5 pp -100.65 176.4 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.092 0.957 . . . . 74.32 111.262 -175.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -159.32 168.65 25.86 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.471 0.708 . . . . 51.43 110.812 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -138.5 167.94 20.85 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.34 1.056 . . . . 64.43 109.177 176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -146.54 -53.03 0.23 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 120.919 0.39 . . . . 61.52 111.51 -170.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.65 33.47 4.16 Favored Glycine 0 C--N 1.343 0.964 0 CA-C-N 116.233 -0.44 . . . . 51.14 114.106 -174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -75.77 -55.16 5.06 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.25 -0.34 . . . . 62.23 112.25 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 60.71 22.45 12.36 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.852 1.261 . . . . 73.33 112.022 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -90.98 75.34 6.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.373 0.669 . . . . 65.22 110.849 -172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -164.28 124.13 2.02 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.04 0.536 . . . . 75.44 109.952 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . 0.708 ' HB3' ' H ' ' G' ' 195' ' ' PHE . 9.2 tppt? -175.03 108.25 0.1 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.775 -1.565 . . . . 64.13 106.775 178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . 0.439 ' CE2' ' HA ' ' D' ' 32' ' ' PHE . 46.1 m-85 -60.1 -68.08 0.33 Allowed 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.674 0.609 . . . . 64.21 111.675 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . 0.58 ' HA ' ' HB2' ' G' ' 194' ' ' ALA . 1.2 tm-20 -172.94 139.95 0.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 106.773 -1.566 . . . . 75.55 106.773 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -123.71 -19.98 5.61 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 118.067 0.394 . . . . 44.22 111.928 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -89.54 16.06 57.23 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-O 119.335 -0.703 . . . . 63.01 114.685 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? 60.03 102.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 125.584 1.553 . . . . 62.42 112.281 -173.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -84.7 54.5 3.07 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 122.396 1.093 . . . . 74.3 108.548 171.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -101.06 93.41 5.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.738 1.215 . . . . 65.31 109.027 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.486 ' H ' ' NE2' ' C' ' 12' ' ' GLN . 46.6 mt -117.64 104.33 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.267 1.027 . . . . 75.53 110.147 -173.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.59 168.41 10.2 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 109.582 -0.525 . . . . 74.43 109.582 170.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . 0.519 ' HB2' HG21 ' G' ' 187' ' ' ILE . 36.0 t70 -149.9 -56.34 0.18 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.764 -1.569 . . . . 52.5 106.764 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.556 HG23 HG23 ' A' ' 131' ' ' VAL . 31.1 t . . . . . 0 C--O 1.254 1.29 0 N-CA-C 106.535 -1.654 . . . . 63.13 106.535 163.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 mmt . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 108.605 -0.887 . . . . 70.33 108.605 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m 52.07 81.57 0.08 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.265 1.026 . . . . 75.12 112.044 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.405 ' HG3' HE21 ' A' ' 142' ' ' GLN . 0.2 OUTLIER -141.59 128.78 20.97 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.625 -1.25 . . . . 64.53 107.625 174.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -162.69 152.94 16.44 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.163 0.585 . . . . 75.4 110.699 -170.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -162.54 107.41 1.16 Allowed 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 107.2 -1.407 . . . . 50.35 107.2 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -157.23 -31.96 0.08 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.001 0.521 . . . . 74.31 111.473 -170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -80.09 77.43 6.79 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.364 0.602 . . . . 75.13 109.862 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -167.92 -73.26 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.43 -0.804 . . . . 70.2 110.154 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.481 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -77.01 161.36 28.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.846 0.684 . . . . 73.3 112.846 -166.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -140.11 126.82 20.49 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.266 0.626 . . . . 60.52 109.328 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 45.3 t80 -127.38 141.68 51.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.204 1.002 . . . . 70.4 108.878 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB3' ' OG ' ' A' ' 85' ' ' SER . 60.0 tp60 -152.66 137.35 16.95 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.999 0.52 . . . . 64.25 110.296 175.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -77.99 117.05 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 107.754 -1.202 . . . . 53.3 107.754 173.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -90.08 -40.73 12.09 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.443 0.297 . . . . 75.13 110.539 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt85 -172.77 125.02 0.46 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.704 0.401 . . . . 51.2 110.693 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.891 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 71.6 mt -106.67 136.34 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 108.504 -0.925 . . . . 63.43 108.504 171.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 31.7 p90 -167.14 171.0 11.32 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.888 0.875 . . . . 72.54 110.101 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -92.38 130.29 38.1 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.498 -0.927 . . . . 75.43 108.498 171.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 38.6 mtpt -92.35 -42.94 9.52 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.61 -0.885 . . . . 65.05 108.61 172.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.4 t70 -135.09 135.03 40.89 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.921 -1.036 . . . . 63.41 110.083 -177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 117' ' ' MET . 82.5 mt -131.65 136.98 56.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.24 -1.393 . . . . 51.24 107.24 173.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -145.66 128.32 16.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.872 -0.418 . . . . 72.32 109.872 174.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 80.8 t80 -134.11 114.86 13.59 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 106.741 -1.578 . . . . 74.23 106.741 175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 46.5 mt-10 -121.61 117.46 26.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.464 -0.569 . . . . 62.25 109.464 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.52 91.95 6.53 Favored Pre-proline 0 C--O 1.245 0.843 0 N-CA-C 109.015 -0.735 . . . . 72.03 109.015 174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 19.0 Cg_exo -67.39 -50.35 0.99 Allowed 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.005 2.47 . . . . 71.4 111.854 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 40.1 m-80 -99.56 42.5 1.1 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.86 0.864 . . . . 73.34 109.86 -178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB1' ' CE2' ' B' ' 17' ' ' TYR . . . -59.19 -48.39 96.45 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 124.76 1.224 . . . . 74.02 114.144 -178.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.88 -17.89 11.92 Favored 'Trans proline' 0 C--N 1.386 2.503 0 CA-C-N 121.168 1.453 . . . . 65.44 111.909 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.3 OUTLIER -74.02 -38.79 63.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.689 0.796 . . . . 74.14 111.546 -173.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.76 -14.15 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.758 0.823 . . . . 74.32 111.747 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.82 -39.63 89.7 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.487 0.715 . . . . 75.44 111.186 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -100.55 -30.28 11.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.604 0.762 . . . . 74.34 110.956 176.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.8 tmtp? -76.49 139.71 40.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.844 0.858 . . . . 73.32 108.95 -173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.43 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 12.1 m-20 -57.78 116.39 3.42 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.881 0.738 . . . . 72.43 109.793 177.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -79.17 80.45 5.52 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 122.191 0.996 . . . . 63.13 109.014 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -114.5 83.86 9.16 Favored Pre-proline 0 C--O 1.245 0.851 0 N-CA-C 107.404 -1.332 . . . . 63.41 107.404 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HB2' HG13 ' A' ' 40' ' ' VAL . 73.2 Cg_endo -73.76 122.16 7.56 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 121.921 1.747 . . . . 72.24 112.125 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -94.93 85.31 4.34 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 105.857 -1.905 . . . . 71.43 105.857 168.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.439 HG13 ' HB2' ' A' ' 38' ' ' PRO . 14.0 m -75.25 93.73 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 113.703 -1.589 . . . . 63.41 110.744 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -77.78 144.7 36.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 113.268 -1.787 . . . . 64.31 108.891 172.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.37 147.7 38.46 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.711 -1.131 . . . . 75.1 108.866 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -146.4 132.04 18.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.425 -0.954 . . . . 63.44 108.425 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.446 HD22 HD21 ' G' ' 186' ' ' LEU . 55.7 tp -99.46 119.24 37.68 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.695 -0.854 . . . . 74.42 108.695 179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -134.78 155.66 50.21 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 109.775 -0.454 . . . . 72.12 109.775 177.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -118.15 162.89 17.47 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.374 0.67 . . . . 73.43 109.443 178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.02 116.12 6.92 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 107.618 -1.253 . . . . 63.23 107.618 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 p -98.88 150.27 22.07 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 110.321 -0.251 . . . . 72.31 110.321 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -159.34 121.07 3.35 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.449 0.7 . . . . 72.42 109.458 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -89.72 131.17 35.82 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.962 -0.755 . . . . 61.52 108.962 174.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -104.45 -38.32 6.85 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.313 0.645 . . . . 51.1 110.454 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.573 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -154.23 -177.61 6.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 124.098 0.959 . . . . 73.22 109.776 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -75.26 128.11 34.7 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.336 -0.987 . . . . 72.31 108.336 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 69.96 2.73 4.02 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.151 0.981 . . . . 72.34 111.935 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 54.5 t -120.31 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.247 0.972 0 N-CA-C 107.01 -1.478 . . . . 73.34 107.01 175.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.401 ' HB2' ' SD ' ' G' ' 174' ' ' MET . 6.6 t80 -128.38 128.67 44.95 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.95 -0.759 . . . . 72.13 108.95 -176.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.25 115.09 28.34 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.861 -1.063 . . . . 52.53 109.168 175.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.42 119.73 53.7 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.047 0 N-CA-C 106.087 -1.82 . . . . 73.54 106.087 169.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.1 t -97.3 132.14 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 123.847 0.859 . . . . 55.33 108.938 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.97 115.37 27.32 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.726 -1.213 . . . . 53.5 107.726 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -105.3 100.74 10.31 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.03 -0.73 . . . . 70.43 109.03 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 114' ' ' ILE . 32.7 t -99.92 127.32 52.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.152 -1.055 . . . . 71.24 108.152 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 m -122.73 132.83 54.42 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.612 -0.514 . . . . 64.45 109.612 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 51.2 t -133.15 126.22 52.71 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 C-N-CA 125.351 1.46 . . . . 61.24 108.569 -174.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.5 m -118.66 137.03 53.58 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.437 -0.579 . . . . 73.44 109.437 174.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.66 111.8 23.49 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.049 -1.093 . . . . 72.31 108.049 171.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.9 m -108.46 131.29 54.94 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.973 0.416 . . . . 62.23 110.323 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 mt -105.14 43.1 1.14 Allowed 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 107.699 -1.223 . . . . 74.04 107.699 173.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.98 -115.01 4.93 Favored Glycine 0 C--N 1.345 1.049 0 N-CA-C 109.946 -1.261 . . . . 63.44 109.946 -168.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -92.41 -25.95 18.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.217 0.607 . . . . 73.44 110.411 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.64 99.6 5.85 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.84 -0.618 . . . . 74.33 110.015 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 92.9 m -68.75 127.45 33.11 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.206 -0.664 . . . . 74.41 109.206 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.83 -52.05 8.87 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.881 0.873 . . . . 64.32 109.101 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -147.46 159.74 43.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.163 -1.38 . . . . 74.33 110.328 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -130.55 132.37 45.53 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.049 -1.463 . . . . 61.45 107.049 173.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.9 m -122.09 135.21 54.78 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 124.145 0.978 . . . . 73.34 108.792 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -148.27 116.49 6.5 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.003 -1.11 . . . . 72.13 108.003 168.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.6 t -123.92 118.71 54.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.87 -0.789 . . . . 71.35 108.87 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.1 mt-30 -97.15 88.23 4.42 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.904 -1.044 . . . . 74.24 108.451 172.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.2 tp-100 -75.7 98.94 4.21 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 114.541 -1.209 . . . . 74.53 107.936 176.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.01 143.74 18.34 Favored Glycine 0 C--N 1.337 0.638 0 N-CA-C 112.042 -0.423 . . . . 64.11 112.042 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.27 120.83 1.96 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.878 -0.889 . . . . 71.45 110.878 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.487 HD11 ' HA ' ' B' ' 29' ' ' PRO . 50.2 mt -81.71 126.73 39.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 107.304 -1.369 . . . . 41.22 107.304 170.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 64.8 m-85 -134.8 128.83 33.54 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.552 -0.536 . . . . 73.33 109.552 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.401 ' OG ' ' HB3' ' A' ' 12' ' ' GLN . 9.3 p -84.08 96.62 8.96 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.58 -0.896 . . . . 72.15 108.58 170.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.03 133.72 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 60.3 109.378 -169.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.45 175.61 4.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.594 0.757 . . . . 64.03 111.161 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 105.46 -22.86 31.54 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.433 -0.803 . . . . 33.42 113.314 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.1 OUTLIER -110.25 150.84 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 53.2 110.152 -176.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.633 ' HA ' ' HB3' ' G' ' 172' ' ' ALA . 53.9 mt-10 -140.88 174.87 10.09 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.596 0.358 . . . . 75.35 110.834 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.6 -134.46 35.54 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-N 116.384 -0.371 . . . . 75.12 113.391 -175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.4 t -68.07 -21.79 64.96 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.814 0.846 . . . . 54.11 111.745 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -65.46 -35.76 81.88 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.676 0.79 . . . . 65.23 110.685 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 62.0 tpp -69.22 -39.89 78.29 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 116.201 -0.454 . . . . 72.2 109.972 174.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.99 -28.59 69.67 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 122.937 0.495 . . . . 74.14 111.31 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -72.36 -61.76 1.68 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.408 0.683 . . . . 63.32 111.017 173.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 9.1 t -68.39 -43.3 77.6 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.87 0.468 . . . . 52.13 110.773 -166.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.5 tt -84.56 -41.2 16.7 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.023 0.929 . . . . 75.25 110.618 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.14 -36.19 28.33 Favored Glycine 0 C--N 1.346 1.136 0 N-CA-C 114.822 0.689 . . . . 75.52 114.822 -171.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.8 -44.44 2.43 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.939 0.496 . . . . 72.04 112.107 -171.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.414 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 83.3 t80 -74.18 -53.62 9.46 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.909 0.883 . . . . 74.31 112.669 -168.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.4 m -67.12 -40.79 30.72 Favored Pre-proline 0 CA--C 1.559 1.301 0 N-CA-C 113.206 0.817 . . . . 73.05 113.206 -177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.8 Cg_endo -66.7 -22.14 50.66 Favored 'Trans proline' 0 C--N 1.379 2.153 0 CA-C-N 121.05 1.411 . . . . 64.11 113.295 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -69.89 -31.17 68.83 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 118.269 0.486 . . . . 71.21 110.461 175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.25 -33.07 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.786 0.803 . . . . 74.52 110.364 173.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 103' ' ' PRO . 86.5 mt -82.67 -23.64 34.1 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.866 1.266 . . . . 65.24 113.123 -174.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -62.3 -40.7 69.08 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.609 1.337 . . . . 71.24 114.609 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -53.52 -38.54 83.57 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 121.982 1.788 . . . . 35.13 112.992 171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -82.56 -34.09 27.89 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.086 0.954 . . . . 74.42 111.515 -175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.09 -46.06 78.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.063 0.545 . . . . 72.52 109.544 175.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.431 ' NH1' HD12 ' C' ' 105' ' ' ILE . 39.6 ttm180 -52.04 -52.7 49.23 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.709 1.256 . . . . 74.23 110.655 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.45 -45.74 92.99 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.403 1.064 . . . . 72.35 111.244 -175.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -58.76 -45.35 89.95 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.771 0.669 . . . . 75.53 111.154 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 118' ' ' VAL . 86.7 mt -62.52 -51.58 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 123.903 0.752 . . . . 73.23 109.793 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.7 m -56.14 -41.28 75.1 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.267 1.027 . . . . 52.03 111.805 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.9 t -66.21 -47.88 72.43 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.345 0.658 . . . . 73.53 110.006 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.416 ' SD ' HG23 ' A' ' 21' ' ' ILE . 13.5 mtp -55.59 -46.77 77.21 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.988 0.915 . . . . 71.41 111.048 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 62.2 t -60.1 -44.15 94.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 124.726 1.21 . . . . 73.11 111.17 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.4 t -68.38 -31.82 71.46 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.816 -0.629 . . . . 64.42 111.322 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.5 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 94.1 mtt-85 -74.16 -20.38 60.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.735 0.814 . . . . 53.21 110.844 178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.04 11.55 57.03 Favored Glycine 0 C--N 1.354 1.535 0 O-C-N 123.511 0.507 . . . . 71.55 112.983 173.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' HH21 ' B' ' 15' ' ' ARG . 17.3 m 66.71 35.51 5.14 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.495 1.14 . . . . 54.44 110.323 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -120.31 149.68 50.11 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.162 -0.926 . . . . 74.53 109.54 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.21 157.78 47.85 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 122.718 2.278 . . . . 64.22 112.564 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -64.83 141.74 58.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.637 -1.165 . . . . 73.53 112.628 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -123.48 107.06 11.16 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.156 -1.424 . . . . 71.43 107.156 171.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -112.55 99.97 8.37 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.148 0.979 . . . . 70.42 109.387 177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.91 148.32 40.21 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.699 0.8 . . . . 71.33 110.421 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.62 147.45 98.69 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.634 0.774 . . . . 63.24 111.817 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' HB3' HH22 ' A' ' 111' ' ' ARG . 71.7 Cg_endo -83.73 165.76 13.66 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.75 2.3 . . . . 75.21 112.801 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.9 t -132.41 114.68 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.744 -0.835 . . . . 72.11 108.744 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -99.98 63.82 1.2 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.948 -1.13 . . . . 71.35 107.948 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -70.27 -33.76 71.98 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.503 -1.226 . . . . 73.15 110.608 -176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -57.36 -44.27 84.24 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.224 1.009 . . . . 52.13 112.043 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.14 -37.85 63.92 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.993 0.517 . . . . 74.44 110.601 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.68 -34.75 78.54 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.637 0.775 . . . . 71.44 110.871 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -67.52 -53.03 32.06 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.854 0.862 . . . . 75.35 109.667 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 59.6 mtp -55.84 -45.62 78.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.967 0.907 . . . . 72.15 110.866 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -52.75 -60.04 3.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.228 1.411 . . . . 62.03 110.908 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -64.43 -35.23 80.24 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.872 0.469 . . . . 75.52 111.57 -176.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.83 -48.78 67.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.712 -0.676 . . . . 74.22 110.257 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.405 HE21 ' HG3' ' A' ' 3' ' ' GLU . 48.6 tp60 -167.18 -14.52 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.684 0.624 . . . . 73.25 112.684 -174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -92.58 20.34 6.44 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 122.585 0.354 . . . . 63.41 111.626 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -82.66 60.37 5.21 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 107.568 -1.271 . . . . 74.31 107.568 166.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.97 136.74 10.26 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.982 -1.008 . . . . 74.34 110.996 -171.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -123.25 -163.91 11.91 Favored Glycine 0 C--O 1.247 0.956 0 N-CA-C 110.346 -1.102 . . . . 53.45 110.346 170.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -156.21 128.1 7.39 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.504 -0.554 . . . . 71.32 109.504 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.49 57.59 0.02 OUTLIER Glycine 0 C--O 1.245 0.806 0 O-C-N 123.22 0.325 . . . . 74.43 112.824 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.7 m -69.01 98.1 0.93 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.163 -0.68 . . . . 74.41 109.163 172.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -111.69 -16.73 13.15 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.593 1.157 . . . . 73.14 110.001 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -77.38 114.63 16.41 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.296 0.638 . . . . 63.11 110.644 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -166.13 112.92 0.88 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.356 1.063 . . . . 73.03 109.256 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -74.42 140.05 44.42 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.821 -0.436 . . . . 71.33 109.821 173.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -157.82 114.8 2.94 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.749 -1.204 . . . . 71.14 107.749 172.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 C-N-CA 123.472 0.709 . . . . 43.34 109.093 -178.101 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 109.041 -0.726 . . . . 64.55 109.041 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 62.3 100.51 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.175 1.39 . . . . 62.12 112.52 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.445 ' HG2' ' HA2' ' B' ' 148' ' ' GLY . 4.5 mp0 -93.34 -164.64 1.2 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.199 0.6 . . . . 73.42 110.627 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -109.03 24.67 12.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.0 0.92 . . . . 63.41 109.286 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.444 ' OD1' ' HB2' ' B' ' 3' ' ' GLU . 2.6 p-10 -77.07 -176.02 3.83 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 122.147 0.975 . . . . 74.03 112.028 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -149.88 175.97 11.17 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.274 -1.33 . . . . 54.24 107.978 173.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -157.81 165.53 35.07 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.941 -0.763 . . . . 61.43 108.941 169.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.444 ' HA ' HE22 ' B' ' 153' ' ' GLN . 1.9 mp0 -77.68 -37.75 49.02 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.544 0.738 . . . . 75.32 109.705 -177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm 50.53 -176.34 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.684 1.994 . . . . 74.21 113.781 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.8 m -146.07 127.05 14.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.424 -1.324 . . . . 74.34 107.424 172.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.9 140.95 38.54 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.813 -0.81 . . . . 71.13 108.813 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.6 140.26 18.93 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.631 0.582 . . . . 74.41 109.906 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 tt -95.09 133.03 37.44 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 123.939 0.896 . . . . 41.0 109.46 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -104.7 -50.55 3.26 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.814 0.446 . . . . 73.41 110.872 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.458 HH21 ' HB ' ' A' ' 122' ' ' THR . 63.3 ttt180 -158.57 140.36 13.69 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.657 0.383 . . . . 75.14 110.8 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.0 mt -117.83 142.42 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.015 -1.105 . . . . 65.44 108.015 169.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.441 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 40.4 p90 -162.86 169.63 19.5 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 123.823 0.702 . . . . 73.02 110.69 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.8 m -99.2 123.23 43.32 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.065 -0.716 . . . . 72.33 109.065 172.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -77.21 -52.7 8.79 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 115.926 -0.579 . . . . 73.42 110.402 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.9 t70 -140.79 140.93 34.82 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.111 0.481 . . . . 71.02 111.919 -165.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.4 mm -132.81 138.14 52.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 124.933 1.293 . . . . 72.31 108.396 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.1 t -143.1 135.98 27.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.063 -0.971 . . . . 62.44 108.509 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -153.35 111.85 3.67 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 107.851 -1.166 . . . . 74.11 107.851 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -119.83 118.66 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.594 -0.891 . . . . 64.22 108.594 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.793 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -115.89 86.88 17.11 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.721 0.808 . . . . 74.04 109.643 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -64.9 -50.57 2.16 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.868 2.379 . . . . 64.25 112.695 -174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.456 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 88.8 m-20 -101.56 20.6 15.79 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.561 0.744 . . . . 72.24 111.435 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.793 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.6 -52.73 42.17 Favored Pre-proline 0 CA--C 1.563 1.472 0 C-N-CA 124.898 1.279 . . . . 54.0 112.932 168.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 83' ' ' ILE . 43.8 Cg_endo -74.62 -12.02 22.31 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 121.692 1.595 . . . . 64.54 113.207 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.456 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 82.8 m-70 -96.01 1.12 52.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.759 0.824 . . . . 72.12 110.915 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.01 -22.92 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 124.817 1.247 . . . . 42.41 112.936 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -56.84 -42.05 78.98 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.915 0.886 . . . . 72.15 110.937 175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -83.46 -12.47 56.3 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.5 1.12 . . . . 74.41 111.136 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -100.54 75.3 1.75 Allowed 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.031 0.932 . . . . 74.24 109.284 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.12 76.04 9.03 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.612 -0.722 . . . . 71.54 110.899 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.48 158.51 1.09 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.89 1.276 . . . . 74.31 109.885 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.471 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 63.8 tt0 -83.93 130.89 53.3 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.007 0.923 . . . . 74.32 108.729 173.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.416 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 50.3 Cg_endo -65.6 153.39 78.4 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.51 2.14 . . . . 64.2 112.746 -176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 42.8 mt-10 -69.76 100.82 1.57 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 108.453 -0.944 . . . . 73.03 108.453 171.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.45 HG11 ' HB2' ' B' ' 126' ' ' LEU . 33.1 t -90.24 121.23 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 107.871 -1.159 . . . . 73.42 107.871 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -148.76 139.78 23.03 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.468 -1.308 . . . . 64.32 107.468 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.464 HD21 HD12 ' B' ' 126' ' ' LEU . 0.8 OUTLIER -128.11 163.03 25.52 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.711 0.767 . . . . 63.23 112.475 -171.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.45 ' HA ' HD13 ' F' ' 186' ' ' LEU . 10.0 m-20 -126.9 154.15 44.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.049 -1.432 . . . . 74.52 108.555 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.463 HD22 ' CZ2' ' F' ' 184' ' ' TRP . 2.5 tt -134.94 116.17 14.4 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.792 -1.559 . . . . 72.24 106.792 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -126.46 155.28 42.51 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.754 0.822 . . . . 74.43 110.044 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 29.2 m -111.4 136.69 50.18 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.298 0.639 . . . . 64.13 110.394 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.583 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.15 154.06 36.7 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.688 1.195 . . . . 71.44 108.177 171.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 43.6 m -141.68 160.69 39.65 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.006 0.431 . . . . 54.34 111.338 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -162.99 163.38 26.13 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.108 1.363 . . . . 65.41 108.332 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.45 ' NE2' ' HG3' ' F' ' 174' ' ' MET . 59.3 tt0 -123.02 137.24 55.0 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.056 0.943 . . . . 74.44 109.193 176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 46.7 mt -101.15 -35.11 9.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.177 0.591 . . . . 73.53 111.117 176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.46 -174.25 2.47 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.346 1.058 . . . . 74.15 110.316 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -71.05 119.09 14.67 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.347 -0.842 . . . . 62.15 109.823 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 67.02 12.46 8.99 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.659 1.184 . . . . 74.34 112.138 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 84.0 t -128.27 110.62 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 107.779 -1.193 . . . . 63.22 107.779 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.453 ' HB3' ' SD ' ' F' ' 174' ' ' MET . 2.8 p90 -122.31 163.96 18.78 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.137 -0.69 . . . . 75.2 109.137 -176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -137.93 110.46 7.51 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.681 -1.229 . . . . 71.31 107.681 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' B' ' 98' ' ' LEU . 24.4 m -107.77 150.66 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 121.211 0.529 . . . . 74.5 110.364 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.583 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 18.0 t -116.61 136.58 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.118 0 CA-C-N 115.272 -0.876 . . . . 64.51 108.648 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.47 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -102.02 116.15 32.07 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.962 -1.125 . . . . 73.21 107.962 178.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -97.44 125.16 41.92 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.016 0.526 . . . . 61.22 109.98 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' B' ' 114' ' ' ILE . 12.7 t -125.7 116.86 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 N-CA-C 108.486 -0.931 . . . . 74.4 108.486 166.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 38.0 m -99.08 152.13 20.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.452 1.101 . . . . 73.14 109.216 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.427 HG22 ' HB3' ' B' ' 42' ' ' LEU . 76.1 t -136.78 111.01 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.936 0.894 . . . . 71.03 109.242 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.2 m -92.31 138.41 31.54 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.514 0.725 . . . . 74.44 109.047 170.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -146.05 142.21 28.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 116.012 -0.54 . . . . 54.23 110.127 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.409 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 35.3 p -140.7 128.65 21.95 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 123.747 0.654 . . . . 73.53 111.824 -178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.8 99.04 11.99 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 107.951 -1.129 . . . . 54.14 107.951 176.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -112.81 3.79 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 115.341 -0.845 . . . . 54.21 111.467 -174.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -108.26 1.32 21.91 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.091 0.956 . . . . 73.3 111.131 -176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -126.0 155.6 41.19 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.481 0.712 . . . . 72.14 110.213 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 32.6 m -66.33 130.72 44.17 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.034 0.534 . . . . 73.53 111.97 -173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.409 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -84.68 -58.85 2.55 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 60.24 108.72 179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -161.55 162.93 30.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 113.536 -1.665 . . . . 63.31 109.352 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.4 mt -136.32 111.63 9.12 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.935 -1.506 . . . . 72.55 106.935 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 51.9 t -117.87 158.17 25.32 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.702 0.801 . . . . 62.14 109.068 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -165.68 146.69 7.0 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.003 -0.74 . . . . 71.34 109.003 178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.15 144.5 37.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.566 -1.197 . . . . 70.42 108.353 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.542 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.1 mt-30 -127.36 93.46 3.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.547 -0.908 . . . . 71.13 108.547 175.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.407 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.2 tp-100 -86.08 102.66 14.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.95 -1.023 . . . . 62.11 109.449 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.57 148.87 20.76 Favored Glycine 0 N--CA 1.471 1.006 0 N-CA-C 111.759 -0.536 . . . . 71.44 111.759 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.25 126.09 2.16 Favored Glycine 0 C--N 1.338 0.651 0 CA-C-N 117.27 0.535 . . . . 64.25 112.416 -175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.98 127.2 40.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 C-N-CA 123.535 0.734 . . . . 63.5 109.079 173.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -139.72 170.18 16.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.32 1.048 . . . . 70.31 109.041 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 51.1 m -133.68 131.72 39.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.947 0.899 . . . . 74.34 108.874 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.691 HD12 ' SG ' ' B' ' 97' ' ' CYS . 7.1 tt -140.32 145.44 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.417 0.287 . . . . 71.1 110.398 176.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.7 163.3 39.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.767 0.827 . . . . 72.24 110.078 177.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.05 -31.6 4.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-N 116.18 -0.464 . . . . 64.22 114.149 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.497 HG12 ' HB2' ' B' ' 94' ' ' MET . 0.1 OUTLIER -71.54 170.18 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.13 0.972 . . . . 75.4 112.679 -177.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.487 ' HA ' ' HB1' ' F' ' 172' ' ' ALA . 13.8 pt-20 -164.12 160.25 21.28 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.326 0.65 . . . . 75.32 110.388 173.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.55 -128.74 47.57 Favored Glycine 0 C--N 1.348 1.209 0 O-C-N 123.469 0.48 . . . . 33.33 113.693 175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 38.0 m -68.47 -21.88 64.59 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.367 0.667 . . . . 63.45 111.382 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' B' ' 90' ' ' GLU . 25.0 mt-30 -64.97 -31.7 73.06 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.907 0.483 . . . . 75.32 110.806 175.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.497 ' HB2' HG12 ' B' ' 89' ' ' ILE . 13.1 tpt -85.86 -46.3 10.75 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.457 -0.338 . . . . 64.32 110.574 174.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.36 -32.67 66.99 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.781 0.833 . . . . 75.31 111.872 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -70.1 -38.67 75.69 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.638 0.775 . . . . 72.43 111.16 173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' B' ' 86' ' ' ILE . 53.4 t -64.98 -68.37 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.882 0.31 . . . . 73.5 111.547 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.77 ' HB2' HG11 ' B' ' 58' ' ' VAL . 2.6 pt? -75.46 -18.02 59.98 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.785 0.266 . . . . 74.23 111.517 -174.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.64 3.64 42.61 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-O 118.984 -0.898 . . . . 74.0 114.373 -175.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.96 -50.88 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 118.076 0.938 . . . . 44.33 112.409 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -72.84 -46.57 52.27 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.557 0.743 . . . . 63.02 111.55 -170.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.0 -44.8 40.91 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-O 118.457 -0.782 . . . . 73.31 110.717 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -47.13 -45.35 21.8 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 122.033 1.822 . . . . 75.31 112.841 163.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -60.74 -36.52 79.08 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.509 0.724 . . . . 73.23 111.782 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.01 -48.37 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.358 0.663 . . . . 71.34 110.77 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.47 ' HB2' HD12 ' B' ' 60' ' ' LEU . 44.2 mt -83.0 -11.48 58.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.911 -1.04 . . . . 71.02 111.575 -173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -62.22 -48.42 87.77 Favored Pre-proline 0 N--CA 1.476 0.865 0 CA-C-O 117.904 -1.046 . . . . 72.43 113.724 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -58.17 -36.07 98.17 Favored 'Trans proline' 0 C--N 1.373 1.851 0 CA-C-N 121.04 1.407 . . . . 44.31 112.267 178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -66.28 -51.37 58.06 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.858 0.863 . . . . 74.15 111.261 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.38 94.71 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.941 0.897 . . . . 63.33 110.832 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -56.58 -50.34 72.24 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.204 1.401 . . . . 75.41 111.292 175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.5 -35.75 81.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.236 0.614 . . . . 71.33 110.374 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.5 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.5 t -72.22 -37.96 69.07 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.152 -0.476 . . . . 61.32 111.065 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' B' ' 62' ' ' VAL . 54.0 mt -60.59 -50.22 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.352 0.661 . . . . 60.23 109.222 172.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 72.5 m -48.2 -46.49 35.05 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 124.842 1.339 . . . . 63.2 110.532 178.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 44.1 t -61.89 -56.51 18.53 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.446 -1.252 . . . . 62.02 110.882 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.483 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 20.0 mmt -67.6 -38.36 83.86 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.752 0.821 . . . . 51.0 112.389 -170.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.91 -44.45 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-O 121.424 0.631 . . . . 75.52 109.944 173.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.485 ' OG ' HG21 ' C' ' 115' ' ' THR . 48.3 t -67.34 -25.16 65.85 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 114.648 -1.16 . . . . 72.0 112.222 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -70.94 -36.4 72.61 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.194 0.597 . . . . 63.35 109.933 177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 6.75 56.59 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 123.662 0.601 . . . . 74.34 112.49 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 34.0 p 57.22 42.01 26.02 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.368 1.867 . . . . 72.11 111.457 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 48.3 m-85 -114.85 159.42 37.49 Favored Pre-proline 0 CA--C 1.554 1.127 0 CA-C-N 114.533 -1.212 . . . . 75.42 110.698 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.573 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 39.6 Cg_exo -60.53 104.56 0.26 Allowed 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 123.58 2.853 . . . . 72.41 114.684 175.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.503 ' HG3' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -65.0 161.53 18.5 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.156 1.382 . . . . 61.21 111.447 171.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.464 HD12 HD21 ' B' ' 42' ' ' LEU . 1.1 tm? -132.29 117.99 18.89 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.395 -0.965 . . . . 72.3 108.395 178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.41 94.85 10.04 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.132 -1.062 . . . . 62.11 108.132 172.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.444 HD23 ' N ' ' B' ' 129' ' ' ALA . 1.8 tt -58.4 138.99 56.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 114.681 -1.145 . . . . 72.12 110.565 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' E' ' 202' ' ' TYR . . . -51.51 148.98 8.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 124.754 1.222 . . . . 70.33 112.228 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.499 ' HG3' HG12 ' D' ' 16' ' ' ILE . 80.1 Cg_endo -72.07 78.81 1.78 Allowed 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 122.331 2.021 . . . . 74.22 111.451 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 8.7 m -74.07 83.28 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 CA-C-O 122.239 1.019 . . . . 74.22 110.691 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -72.58 111.33 7.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.807 -1.088 . . . . 42.04 108.891 175.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -75.45 -20.06 59.06 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.258 0.623 . . . . 74.41 110.91 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.07 -29.25 70.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.368 0.667 . . . . 72.0 110.824 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.63 81.72 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.653 0.596 . . . . 64.11 110.319 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 tp -68.26 -34.29 75.93 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.845 0.458 . . . . 62.35 110.872 178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.588 ' HA ' HD13 ' B' ' 141' ' ' LEU . 60.3 m-85 -71.29 -36.32 71.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.596 0.358 . . . . 72.22 110.776 171.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.41 ' O ' ' HA ' ' B' ' 142' ' ' GLN . 38.0 ttp -69.16 -29.53 67.57 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.318 1.047 . . . . 74.43 111.413 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -105.96 -42.65 5.06 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.642 -0.708 . . . . 54.23 111.028 -166.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -89.5 -37.9 14.42 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.599 0.36 . . . . 61.11 110.618 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.588 HD13 ' HA ' ' B' ' 137' ' ' PHE . 5.0 mp -107.14 -9.63 16.1 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 122.698 0.399 . . . . 75.05 111.565 -178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.41 ' HA ' ' O ' ' B' ' 138' ' ' MET . 90.4 mt-30 67.24 -67.07 0.18 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.844 1.258 . . . . 65.33 111.963 -175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -93.42 172.35 8.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.494 0.718 . . . . 74.23 110.819 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -149.85 127.8 11.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.738 0.815 . . . . 65.2 109.316 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.96 -165.98 0.09 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.734 1.213 . . . . 62.22 109.46 173.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 166.7 87.52 0.07 OUTLIER Glycine 0 C--N 1.35 1.356 0 N-CA-C 111.714 -0.554 . . . . 75.23 111.714 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.405 ' HB3' ' ND2' ' B' ' 5' ' ' ASN . 3.0 tm-20 -155.3 -64.4 0.12 Allowed 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 108.305 -0.998 . . . . 75.14 108.305 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' B' ' 3' ' ' GLU . . . 126.54 -18.54 6.38 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 116.95 1.54 . . . . 43.13 116.95 166.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 46.6 p -105.17 -18.42 14.14 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 119.599 1.7 . . . . 42.23 111.967 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 62.7 90.14 0.08 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.612 1.165 . . . . 63.25 111.138 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -75.45 152.73 37.9 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.15 0.58 . . . . 75.21 111.484 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -98.67 121.64 40.88 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.267 0.627 . . . . 71.42 109.878 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.444 HE22 ' HA ' ' B' ' 8' ' ' GLU . 15.9 mm-40 -84.54 132.19 34.55 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.721 -0.474 . . . . 72.14 109.721 172.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -108.75 -58.26 2.03 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.277 -1.379 . . . . 75.25 107.277 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.815 -1.084 . . . . 74.22 108.719 -178.649 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 48.2 mtt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 109.7 -0.482 . . . . 63.04 109.7 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 33.7 p -162.06 -79.86 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 107.801 -1.185 . . . . 72.14 107.801 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' C' ' 4' ' ' GLN . 19.5 tt0 58.18 -168.83 0.13 Allowed 'General case' 0 CA--C 1.566 1.569 0 C-N-CA 124.81 1.244 . . . . 74.15 111.348 171.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.506 ' H ' ' HG2' ' C' ' 3' ' ' GLU . 34.8 mt-30 69.76 105.45 0.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.763 1.225 . . . . 72.01 110.89 174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -81.91 84.14 7.01 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-O 121.295 0.569 . . . . 70.2 110.428 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -76.06 -14.1 60.21 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 115.222 -0.899 . . . . 72.41 110.636 176.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 19.7 p -68.07 -52.92 29.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.024 0.93 . . . . 70.41 111.077 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.98 155.56 40.13 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.888 0.699 . . . . 75.1 112.888 -171.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.4 ttt 62.62 113.3 0.02 OUTLIER 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.633 1.573 . . . . 74.11 110.916 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m -116.83 114.53 24.04 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.001 -0.74 . . . . 63.41 109.001 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -124.35 119.07 28.19 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.793 -1.188 . . . . 74.03 107.793 170.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -146.66 130.17 16.83 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.459 -0.941 . . . . 72.45 108.459 177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 tp -78.81 137.89 21.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 109.477 -0.564 . . . . 72.44 109.477 172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.503 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.9 mm-40 -98.96 -47.33 5.3 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.273 0.629 . . . . 72.41 109.881 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.411 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 66.4 ttt180 -170.77 124.99 0.68 Allowed 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.581 0.551 . . . . 74.44 110.48 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -109.35 141.9 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 107.665 -1.235 . . . . 74.22 107.665 169.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.455 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 6.8 p90 -179.39 164.94 1.38 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.438 0.695 . . . . 71.35 110.029 -172.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.3 p -88.7 122.87 32.59 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 122.971 0.508 . . . . 71.25 109.913 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.595 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.8 mmtp -74.54 -50.56 17.6 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.069 0.938 . . . . 74.34 108.686 170.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -137.99 141.52 40.45 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.003 -1.453 . . . . 73.34 109.004 -169.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 94.2 mt -137.28 139.58 43.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 106.808 -1.553 . . . . 65.12 106.808 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.6 t -149.85 146.3 27.04 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 109.557 -0.534 . . . . 74.33 109.557 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -152.48 108.84 3.41 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.162 -1.422 . . . . 75.24 107.162 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -116.47 118.68 33.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.91 -0.774 . . . . 61.43 108.91 177.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.49 86.94 5.89 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 106.28 -1.748 . . . . 72.53 106.28 167.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.55 -38.61 61.24 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 122.67 2.247 . . . . 43.42 110.989 -177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -99.9 44.79 1.01 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 114.394 -1.275 . . . . 52.3 109.064 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.462 ' O ' HG12 ' C' ' 31' ' ' VAL . . . -59.26 -64.3 3.13 Favored Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 124.903 1.281 . . . . 61.33 112.694 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 61.3 Cg_endo -74.5 -12.47 22.62 Favored 'Trans proline' 0 C--N 1.382 2.319 0 CA-C-N 121.876 1.706 . . . . 53.42 112.203 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.512 ' CD2' ' HD3' ' C' ' 34' ' ' LYS . 3.5 t-160 -67.7 -30.41 69.92 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.214 1.006 . . . . 73.42 109.907 174.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.824 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 2.9 p -69.51 -26.66 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 111.835 0.309 . . . . 70.33 111.835 -173.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -55.92 -40.15 72.67 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.651 1.18 . . . . 75.32 112.515 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -122.87 39.0 4.05 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.642 0.777 . . . . 65.34 109.889 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.824 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 31.7 ttpt -114.19 153.14 30.11 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.263 0.625 . . . . 71.1 111.463 -175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -70.2 116.56 10.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.246 1.018 . . . . 54.14 110.539 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -87.2 101.7 13.76 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.378 1.071 . . . . 74.24 111.93 -173.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.47 HE22 ' HB3' ' C' ' 68' ' ' LEU . 0.1 OUTLIER -150.38 63.07 5.83 Favored Pre-proline 0 N--CA 1.483 1.203 0 C-N-CA 124.037 0.935 . . . . 75.1 109.683 168.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.26 122.09 6.87 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 123.099 2.532 . . . . 71.24 111.529 -173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -85.07 88.27 7.45 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.62 -1.252 . . . . 75.31 107.62 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 30.3 m -83.82 119.06 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 CA-C-N 114.072 -1.422 . . . . 64.05 110.903 -172.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -130.9 146.54 52.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.716 0.807 . . . . 71.12 110.396 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' C' ' 128' ' ' LEU . 56.1 tp -116.15 124.23 49.8 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.11 0.964 . . . . 70.41 109.201 -176.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.522 ' HA ' HD13 ' E' ' 186' ' ' LEU . 8.9 m-20 -119.21 116.84 27.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.843 0.857 . . . . 74.12 109.664 -173.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.562 ' H ' HD22 ' E' ' 186' ' ' LEU . 5.8 mp -101.2 126.96 47.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.317 -0.994 . . . . 65.52 108.317 176.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -134.4 151.46 51.21 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.294 1.038 . . . . 74.13 108.863 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 24.5 m -112.17 115.83 29.48 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.108 0.563 . . . . 74.01 110.311 -169.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.67 147.76 44.83 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 108.246 -1.02 . . . . 74.45 108.246 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 32.0 t -163.08 145.15 10.11 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.744 0.418 . . . . 55.5 110.649 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.2 t -145.35 125.98 14.2 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.214 1.005 . . . . 52.22 108.413 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -76.01 126.09 30.35 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 109.843 -0.428 . . . . 62.02 109.843 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.636 HD11 HD12 ' C' ' 83' ' ' ILE . 87.3 mt -91.34 -52.2 4.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.401 0.681 . . . . 75.02 110.675 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.83 -170.77 3.66 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.921 0.888 . . . . 72.42 110.646 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -64.13 117.89 7.76 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.184 -0.673 . . . . 71.24 109.184 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 64.76 12.19 7.46 Favored 'General case' 0 CA--C 1.553 1.073 0 O-C-N 124.232 0.958 . . . . 73.42 112.186 177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.4 t -121.74 122.93 68.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 107.621 -1.252 . . . . 72.55 107.621 176.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.42 ' OH ' ' HB3' ' C' ' 98' ' ' LEU . 0.1 OUTLIER -138.99 157.91 45.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.64 -0.874 . . . . 73.05 108.64 175.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -105.02 116.29 31.7 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.575 -1.193 . . . . 73.15 108.563 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.98 132.03 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 107.911 -1.144 . . . . 62.51 107.911 170.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 86.5 t -128.0 111.25 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 107.205 -1.406 . . . . 63.02 107.205 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.76 108.9 18.29 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 106.922 -1.51 . . . . 74.5 106.922 178.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -81.22 104.81 11.94 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.909 -1.145 . . . . 73.1 107.909 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 43.9 t -111.68 107.42 22.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 109.218 -0.66 . . . . 53.32 109.218 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 6.9 m -104.0 145.91 29.47 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.352 0.661 . . . . 72.43 109.285 177.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.612 HG21 HG21 ' C' ' 114' ' ' ILE . 38.9 t -140.54 117.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 124.706 1.202 . . . . 72.45 108.081 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.4 m -111.98 141.62 45.42 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.833 0.349 . . . . 63.14 110.097 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.37 103.17 6.29 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 107.155 -1.424 . . . . 64.42 107.155 173.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.1 m -125.55 137.9 53.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.163 0.506 . . . . 71.34 110.591 -176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.47 ' HB3' HE22 ' C' ' 37' ' ' GLN . 10.9 mt -89.51 37.55 0.87 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.859 1.264 . . . . 72.5 109.308 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.67 -115.47 5.11 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 110.213 -1.155 . . . . 72.34 110.213 -166.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -91.37 -31.48 16.04 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.582 0.753 . . . . 74.14 110.107 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 20.7 tp10 -71.86 105.76 3.93 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.054 0.942 . . . . 62.41 108.922 173.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 11.8 m -78.06 135.61 37.76 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 122.27 -0.269 . . . . 62.24 110.95 -174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.55 -56.46 4.29 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.807 -0.812 . . . . 62.01 108.807 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -161.2 173.4 15.14 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.516 -0.765 . . . . 72.5 111.46 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.3 tm? -136.82 141.16 42.87 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.146 -1.428 . . . . 71.04 107.146 172.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' C' ' 114' ' ' ILE . 35.4 t -141.68 139.57 33.0 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 107.768 -1.197 . . . . 53.11 107.768 177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.49 116.25 3.86 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 109.141 -0.689 . . . . 75.53 109.141 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -120.9 140.11 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.836 0.854 . . . . 71.22 109.623 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -107.7 109.02 20.51 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.941 0.896 . . . . 73.41 109.123 168.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.474 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -89.4 107.74 19.24 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 109.119 -0.697 . . . . 72.04 109.119 175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.32 145.4 22.15 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 123.61 0.569 . . . . 53.03 112.033 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.546 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.43 116.83 0.77 Allowed Glycine 0 CA--C 1.502 -0.747 0 N-CA-C 110.694 -0.962 . . . . 64.5 110.694 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.636 HD12 HD11 ' C' ' 51' ' ' LEU . 13.7 mm -88.7 119.12 35.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.56 -0.904 . . . . 60.32 108.56 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.92 135.65 54.81 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.413 0.685 . . . . 75.0 109.725 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 39.3 t -103.47 99.66 9.49 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.845 -1.168 . . . . 60.34 107.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.82 156.23 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.096 0.558 . . . . 71.43 110.202 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.08 157.36 2.29 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.723 1.209 . . . . 71.23 108.949 171.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.29 -18.27 54.26 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 120.333 -0.148 . . . . 73.44 113.178 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.722 HD12 ' HA ' ' C' ' 94' ' ' MET . 46.1 pt -76.31 165.29 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.126 0.57 . . . . 51.01 111.301 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.612 ' HG3' ' HA ' ' E' ' 171' ' ' SER . 37.5 tt0 -170.96 147.1 2.6 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.041 0.937 . . . . 70.14 108.911 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.72 -108.15 0.48 Allowed Glycine 0 C--N 1.362 1.997 0 O-C-N 124.108 0.88 . . . . 72.14 114.324 170.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.0 p -58.84 -47.61 84.24 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.663 1.185 . . . . 73.54 111.649 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -66.94 -32.33 73.51 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.101 0.56 . . . . 75.15 111.022 178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.741 ' SD ' HD21 ' C' ' 98' ' ' LEU . 25.6 tpp -59.29 -55.37 35.65 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 123.536 0.523 . . . . 75.43 110.101 176.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.96 -34.6 78.47 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.644 -0.707 . . . . 74.41 112.229 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -77.78 -34.08 52.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.671 0.388 . . . . 75.23 111.772 -177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -68.8 -60.66 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.775 0.43 . . . . 62.52 110.755 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.741 HD21 ' SD ' ' C' ' 94' ' ' MET . 1.5 pp -94.43 -19.14 20.85 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.891 0.7 . . . . 75.22 112.891 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.79 6.73 73.76 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.785 -0.453 . . . . 71.5 113.326 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.69 -56.53 0.07 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 122.668 0.387 . . . . 61.01 111.873 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -73.53 -53.82 9.66 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 112.957 0.725 . . . . 71.25 112.957 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.35 -43.41 79.54 Favored Pre-proline 0 N--CA 1.482 1.135 0 C-N-CA 123.685 0.794 . . . . 61.0 112.456 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.04 -30.44 66.25 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 121.308 1.339 . . . . 65.13 112.706 169.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.413 HD21 ' ND2' ' C' ' 132' ' ' ASN . 46.8 t-20 -66.64 -32.7 74.18 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 118.217 0.462 . . . . 72.31 110.315 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.431 HD12 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -60.22 -44.54 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-O 121.291 0.567 . . . . 70.15 109.903 172.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.546 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.8 mt -78.68 -21.12 48.71 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.9 -1.046 . . . . 61.42 111.926 -176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -56.69 -55.36 43.97 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 117.434 -1.27 . . . . 73.21 113.631 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.91 -30.7 84.15 Favored 'Trans proline' 0 C--N 1.377 2.03 0 CA-C-N 121.571 1.597 . . . . 42.32 112.732 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -63.39 -50.85 68.27 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.626 0.77 . . . . 75.01 110.83 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.474 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.42 -42.33 98.73 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.229 1.012 . . . . 70.32 111.225 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 -61.12 -44.17 97.76 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.405 1.882 . . . . 61.1 110.521 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.2 -35.11 63.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.347 0.659 . . . . 64.11 110.3 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.5 t -64.1 -34.43 78.03 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.504 0.722 . . . . 71.35 111.357 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.612 HG21 HG21 ' C' ' 64' ' ' VAL . 97.3 mt -73.28 -45.01 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.805 0.842 . . . . 75.33 111.349 173.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.485 HG21 ' OG ' ' B' ' 119' ' ' SER . 28.4 m -57.83 -35.39 70.83 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.803 0.441 . . . . 75.42 111.787 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.5 p -66.1 -48.66 70.16 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 109.29 -0.633 . . . . 71.43 109.29 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.578 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.34 -39.46 70.03 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.872 1.269 . . . . 71.41 113.144 -179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' C' ' 126' ' ' LEU . 94.2 t -62.09 -48.23 89.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.218 0.532 . . . . 61.1 110.399 176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.9 t -66.52 -28.66 68.73 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.079 -0.964 . . . . 54.42 111.843 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 84.6 mtt-85 -67.16 -40.62 86.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.068 -0.715 . . . . 73.41 109.068 177.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.65 5.04 66.13 Favored Glycine 0 C--N 1.358 1.789 0 O-C-N 124.038 0.836 . . . . 71.34 112.912 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p 56.1 53.66 8.8 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.063 1.745 . . . . 71.31 111.939 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.508 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 56.4 m-85 -113.22 172.57 3.44 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 114.516 -1.22 . . . . 74.22 109.492 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 18.3 Cg_endo -56.59 171.49 0.96 Allowed 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.639 2.226 . . . . 70.14 113.327 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.573 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 9.0 tm0? -60.53 140.7 57.21 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 108.377 -0.972 . . . . 72.54 108.377 173.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.431 ' HB3' HG21 ' C' ' 118' ' ' VAL . 9.5 tp -151.03 83.34 1.33 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.975 0.893 . . . . 73.31 110.363 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -136.99 98.42 3.75 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.812 -1.54 . . . . 73.51 107.092 169.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' C' ' 42' ' ' LEU . 49.8 mt -78.5 149.26 33.17 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 109.636 -0.505 . . . . 63.33 109.636 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.86 155.5 82.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.926 0.89 . . . . 61.1 112.749 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.891 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 76.6 Cg_exo -54.74 132.5 52.09 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 123.926 3.084 . . . . 72.1 113.949 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.407 HG13 ' HB ' ' F' ' 207' ' ' VAL . 61.3 t -111.37 90.16 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.76 0 N-CA-C 107.798 -1.186 . . . . 63.34 107.798 174.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.413 ' ND2' HD21 ' C' ' 104' ' ' ASN . 11.5 m120 -87.59 68.75 9.63 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.543 0.687 . . . . 71.43 110.0 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.402 ' HA ' HG11 ' F' ' 207' ' ' VAL . 71.5 t80 -72.09 -18.93 61.88 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.155 -0.929 . . . . 71.53 110.929 177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.6 -32.27 71.4 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.353 0.661 . . . . 74.32 110.638 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -41.09 91.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.825 0.85 . . . . 73.32 111.356 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.7 tt -68.94 -47.48 65.61 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.824 -0.806 . . . . 70.33 108.824 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -65.55 -24.84 67.2 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.68 1.192 . . . . 64.32 110.821 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -64.4 -59.33 4.48 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.231 1.012 . . . . 73.13 110.438 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -63.13 -35.02 78.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.856 0.862 . . . . 72.01 111.459 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -49.72 -80.58 0.01 OUTLIER 'General case' 0 CA--C 1.559 1.303 0 C-N-CA 125.559 1.544 . . . . 64.32 112.661 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.446 ' H ' HD22 ' C' ' 141' ' ' LEU . 1.7 mm? -72.25 92.25 1.37 Allowed 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.176 -0.675 . . . . 73.45 109.176 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -103.9 -5.6 22.15 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.115 0.783 . . . . 73.22 113.115 -171.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -79.64 140.54 37.06 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 117.915 0.325 . . . . 55.52 111.54 178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -169.7 121.32 0.69 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.334 1.054 . . . . 74.43 108.872 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.34 -178.19 0.18 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.643 1.177 . . . . 60.13 112.858 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.71 37.27 1.85 Allowed Glycine 0 N--CA 1.473 1.131 0 CA-C-N 116.045 -0.525 . . . . 75.23 112.346 -179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.84 148.68 25.58 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.988 0.915 . . . . 71.43 109.065 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -168.37 162.96 36.76 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 121.683 -0.294 . . . . 72.15 113.522 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 12.4 t -86.94 175.08 8.33 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.45 0.7 . . . . 64.42 110.912 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -156.39 17.99 0.34 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.126 0.97 . . . . 74.41 110.067 178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.25 120.97 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.696 0.798 . . . . 74.11 110.911 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -82.03 92.95 6.89 Favored 'General case' 0 CA--C 1.549 0.921 0 N-CA-C 108.645 -0.872 . . . . 70.12 108.645 174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -80.24 82.17 6.34 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.699 -0.852 . . . . 75.21 108.699 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -95.84 154.87 17.0 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.395 -0.821 . . . . 71.44 109.675 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.365 0 C-N-CA 123.588 0.755 . . . . 61.4 108.97 -177.714 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.821 -0.436 . . . . 72.4 109.821 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m -160.3 81.05 0.68 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.549 1.14 . . . . 75.54 108.28 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . 0.432 ' HB3' ' HB2' ' H' ' 172' ' ' ALA . 0.4 OUTLIER -136.8 70.26 1.41 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 122.255 1.026 . . . . 51.02 109.464 -176.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -121.55 74.75 1.14 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.868 -1.06 . . . . 74.33 108.438 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -171.97 -176.76 1.76 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.835 -1.075 . . . . 64.34 108.21 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -66.49 80.56 0.1 Allowed 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 109.009 -0.737 . . . . 71.33 109.009 167.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.6 t -165.2 76.78 0.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.414 1.086 . . . . 71.53 108.532 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -73.11 172.74 10.51 Favored 'General case' 0 C--O 1.246 0.883 0 CA-C-N 115.14 -0.936 . . . . 71.51 109.079 169.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.491 ' SD ' HG23 ' D' ' 89' ' ' ILE . 11.1 tpt -33.43 124.26 0.41 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.416 1.086 . . . . 52.03 112.659 169.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 79.7 m -141.52 137.29 31.93 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 124.141 0.976 . . . . 71.45 109.507 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.7 t80 -156.31 104.72 2.24 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.212 -1.403 . . . . 74.23 107.212 172.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -110.35 112.08 23.78 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.926 -1.138 . . . . 50.23 107.926 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 tt -80.36 98.63 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.102 -1.444 . . . . 72.25 107.102 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -85.66 -50.04 7.51 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.451 -0.795 . . . . 72.42 111.6 -167.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -162.3 119.08 2.03 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.663 -0.495 . . . . 74.55 109.663 -167.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.499 HG12 ' HG3' ' B' ' 130' ' ' PRO . 28.3 mm -111.49 118.21 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 107.897 -1.149 . . . . 74.35 107.897 175.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -148.5 146.59 28.42 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.28 0.632 . . . . 71.21 111.232 -171.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 50.0 p -75.98 113.04 13.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.021 -0.99 . . . . 62.31 109.938 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -80.92 -36.03 31.59 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.415 -0.587 . . . . 62.42 109.415 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.73 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -144.77 137.59 26.56 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.081 -0.963 . . . . 72.54 109.617 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.521 HG21 ' HE2' ' C' ' 117' ' ' MET . 78.2 mt -137.55 139.63 43.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 N-CA-C 107.872 -1.159 . . . . 65.3 107.872 174.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -142.09 140.72 32.61 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.574 -0.899 . . . . 72.32 108.574 174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -151.8 120.95 6.72 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 106.625 -1.621 . . . . 65.1 106.625 173.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.04 112.95 11.61 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.48 0.712 . . . . 64.15 109.778 -175.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.527 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -110.45 84.18 3.75 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.682 0.793 . . . . 64.13 109.581 177.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.51 -26.97 11.44 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 123.051 2.5 . . . . 64.13 113.183 -172.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -114.82 25.35 11.02 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.922 0.889 . . . . 74.51 109.847 -174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -58.72 -57.42 26.86 Favored Pre-proline 0 CA--C 1.564 1.497 0 N-CA-C 115.038 1.496 . . . . 74.12 115.038 -164.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.595 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 86.6 Cg_endo -78.42 -15.07 14.25 Favored 'Trans proline' 0 C--N 1.38 2.217 0 CA-C-N 122.06 1.771 . . . . 75.22 112.799 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.42 -44.24 68.32 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.041 0.936 . . . . 71.2 109.543 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.497 HG23 ' HD2' ' D' ' 34' ' ' LYS . 2.1 p -84.38 0.77 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 123.61 0.764 . . . . 75.35 110.981 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.411 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 84.2 t80 -63.36 -17.33 62.49 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.464 1.106 . . . . 73.4 111.169 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -81.32 -1.31 44.77 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.69 0.796 . . . . 75.21 112.104 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.497 ' HD2' HG23 ' D' ' 31' ' ' VAL . 96.5 mttt -121.8 113.27 19.43 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.877 0.871 . . . . 74.05 112.446 -167.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.98 79.84 2.24 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 122.222 1.011 . . . . 73.13 111.228 173.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.425 ' HB2' HD22 ' D' ' 68' ' ' LEU . 22.3 m95 -127.04 171.38 11.41 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.508 -0.745 . . . . 74.34 110.572 -175.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.566 ' HG2' ' H ' ' H' ' 191' ' ' GLY . 29.4 tp60 -85.04 120.55 73.68 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.605 -1.257 . . . . 75.2 107.605 164.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.476 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 31.8 Cg_exo -57.4 114.5 1.97 Allowed 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 121.977 1.784 . . . . 71.44 110.972 173.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -65.8 112.39 3.71 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 106.71 -1.589 . . . . 73.51 106.71 167.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.699 HG13 HG13 ' D' ' 64' ' ' VAL . 71.2 t -116.34 111.66 36.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 123.188 0.595 . . . . 61.3 109.591 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -87.21 133.67 33.63 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.961 -1.125 . . . . 74.12 107.961 169.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -108.15 127.41 53.79 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.706 -1.22 . . . . 75.43 107.706 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.552 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 35.2 t70 -112.76 125.18 54.05 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.228 -0.656 . . . . 54.53 109.228 174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.643 ' HB2' HD11 ' H' ' 186' ' ' LEU . 62.0 tp -97.05 131.6 43.68 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.114 0.965 . . . . 71.21 109.758 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 33.0 t70 -147.59 155.45 41.84 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.631 -0.877 . . . . 51.24 108.631 168.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.8 t -146.28 151.36 37.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.384 0.674 . . . . 63.14 109.759 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.04 172.6 14.98 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.177 0.991 . . . . 74.14 108.853 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 62.2 p -163.76 163.68 23.97 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.729 0.412 . . . . 44.02 110.73 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 54.9 p -154.04 139.59 17.84 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.401 0.68 . . . . 74.41 109.521 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -76.15 122.98 25.1 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 110.207 -0.294 . . . . 71.23 110.207 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.495 HD11 ' HB2' ' D' ' 57' ' ' GLU . 59.0 mt -94.64 -35.99 11.96 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.631 0.582 . . . . 51.23 109.639 176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.83 -176.6 5.34 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.038 0.935 . . . . 53.21 110.008 175.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -65.76 128.13 34.74 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 115.79 -0.641 . . . . 74.02 109.314 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.44 ' H ' HD11 ' H' ' 173' ' ' LEU . 3.4 m-20 61.08 26.42 16.35 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.933 0.893 . . . . 52.52 110.854 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.6 t -139.68 122.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 C-N-CA 124.105 0.962 . . . . 61.14 109.717 177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.454 ' HE2' HD12 ' H' ' 173' ' ' LEU . 17.0 m-85 -136.07 137.37 41.03 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.464 1.106 . . . . 72.33 108.948 175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.495 ' HB2' HD11 ' D' ' 51' ' ' LEU . 20.5 tt0 -88.29 118.6 28.01 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 108.235 -1.024 . . . . 62.23 108.235 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.44 140.29 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.128 -1.064 . . . . 75.52 108.128 173.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 45.2 t -121.87 143.06 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.437 1.095 . . . . 72.42 108.997 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -119.74 126.83 52.03 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 107.511 -1.292 . . . . 72.13 107.511 174.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.3 ttm-85 -106.66 104.44 14.12 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.339 -0.986 . . . . 73.23 108.339 172.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -97.11 128.19 48.58 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 107.799 -1.186 . . . . 64.02 107.799 167.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.4 m -120.9 129.0 53.31 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.987 -0.375 . . . . 53.41 109.987 178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.699 HG13 HG13 ' D' ' 40' ' ' VAL . 71.7 t -111.95 109.1 27.29 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 125.365 1.466 . . . . 71.11 109.318 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 20.8 m -102.17 93.75 5.38 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.397 -1.334 . . . . 65.12 107.397 169.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.92 144.01 28.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.696 -0.684 . . . . 72.35 110.586 -175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 18.5 m -142.87 135.72 27.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 123.451 0.469 . . . . 75.23 112.196 -174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 52.0 mt -116.65 125.44 51.77 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.87 0.868 . . . . 73.42 109.176 174.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.48 -113.09 4.11 Favored Glycine 0 C--N 1.349 1.257 0 N-CA-C 112.143 -0.383 . . . . 34.42 112.143 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 7.01 10.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.273 0.629 . . . . 65.51 110.865 -176.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -129.42 174.62 9.46 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.37 0.668 . . . . 73.22 110.212 -175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -72.62 132.85 44.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.541 -0.754 . . . . 64.12 110.91 175.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.558 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -82.04 -57.98 3.17 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.62 -0.882 . . . . 72.34 108.62 174.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -164.8 165.53 20.52 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 113.623 -1.626 . . . . 74.11 108.921 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -122.77 153.45 39.49 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.452 -1.314 . . . . 61.41 107.452 177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.571 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 40.1 t -158.7 146.91 18.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 122.742 0.417 . . . . 75.13 110.098 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -155.67 128.92 8.22 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.181 -0.674 . . . . 74.12 109.181 171.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.44 114.18 32.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.214 -0.662 . . . . 64.51 109.214 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.73 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.8 mt-30 -89.46 86.24 6.73 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.55 -0.907 . . . . 75.53 108.55 170.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.422 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.56 104.44 10.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 113.868 -1.515 . . . . 74.32 108.729 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.35 164.74 28.41 Favored Glycine 0 N--CA 1.463 0.475 0 N-CA-C 111.848 -0.501 . . . . 60.12 111.848 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.65 131.82 2.56 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.774 -0.531 . . . . 73.54 111.774 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -87.88 132.24 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.957 -0.757 . . . . 55.14 108.957 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -135.38 145.49 47.4 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.54 0.736 . . . . 72.43 110.075 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 67.0 m -96.34 136.91 36.19 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 109.019 -0.734 . . . . 71.25 109.019 167.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.35 126.49 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.401 1.081 . . . . 70.03 110.134 -176.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -167.93 156.03 8.84 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.733 0.813 . . . . 64.41 110.066 175.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.476 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 88.18 -20.68 28.37 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 120.147 -0.252 . . . . 34.23 112.951 177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.527 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -116.83 157.94 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.12 0.968 . . . . 74.4 109.295 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.756 ' HA ' ' HG2' ' H' ' 174' ' ' MET . 0.3 OUTLIER -160.85 175.0 13.04 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.03 0.381 . . . . 75.23 112.03 -178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.83 -133.45 46.79 Favored Glycine 0 C--N 1.355 1.596 0 O-C-N 124.153 0.908 . . . . 63.13 114.073 170.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.4 m -68.02 -32.49 72.91 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.853 0.861 . . . . 72.23 111.398 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -58.77 -45.28 90.14 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.056 0.943 . . . . 74.11 110.074 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.733 ' SD ' HD23 ' D' ' 98' ' ' LEU . 1.7 tmt? -81.85 -30.74 31.95 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.097 -0.956 . . . . 64.33 110.982 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.27 75.03 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.133 0.573 . . . . 71.03 110.93 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -73.52 -38.42 65.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.92 -0.582 . . . . 74.14 109.957 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.1 t -62.5 -49.2 76.31 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.055 0.542 . . . . 73.54 111.575 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.733 HD23 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -69.03 -29.59 67.79 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.21 0.604 . . . . 72.42 111.973 -175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.19 -18.05 37.97 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.684 0.615 . . . . 63.02 113.342 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -122.44 -65.17 1.13 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.859 0.464 . . . . 73.12 111.396 -175.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -67.66 -49.72 61.42 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 112.556 0.576 . . . . 73.35 112.556 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.494 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.4 m -61.85 -47.42 91.69 Favored Pre-proline 0 CA--C 1.562 1.433 0 C-N-CA 123.521 0.728 . . . . 31.25 111.837 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.562 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.4 Cg_exo -61.25 -34.96 87.21 Favored 'Trans proline' 0 C--N 1.392 2.849 0 C-N-CA 122.48 2.12 . . . . 73.41 112.854 169.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -64.73 -29.54 70.52 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 123.049 0.54 . . . . 62.41 110.718 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 34.0 mm -66.95 -42.81 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.401 0.681 . . . . 73.25 110.388 171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.422 HD13 ' O ' ' D' ' 80' ' ' GLN . 63.9 mt -72.46 -23.74 61.1 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.201 -0.909 . . . . 71.22 111.222 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -64.91 -42.5 63.04 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.609 1.337 . . . . 63.02 114.609 -170.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -51.35 -41.4 59.34 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.115 1.876 . . . . 75.41 113.552 171.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -77.99 -36.83 48.43 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.81 0.844 . . . . 75.41 111.303 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.37 -46.54 82.96 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.312 0.645 . . . . 52.4 109.895 176.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -54.59 -54.64 38.79 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.84 1.256 . . . . 74.41 110.467 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.1 -40.33 94.4 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.301 1.001 . . . . 71.0 111.381 -174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.416 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.4 t -57.41 -44.7 84.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.388 0.43 . . . . 71.14 110.406 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.56 HG21 HG21 ' D' ' 64' ' ' VAL . 86.7 mt -63.09 -55.15 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 115.164 -0.925 . . . . 75.34 110.238 173.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' D' ' 125' ' ' GLN . 95.7 m -50.09 -48.48 53.23 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.306 1.442 . . . . 64.33 111.882 -173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.7 t -65.1 -41.91 94.51 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 114.76 -1.109 . . . . 71.03 109.932 -175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.1 mtm -65.51 -36.84 85.02 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.154 0.581 . . . . 72.23 111.251 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.0 t -62.36 -49.54 83.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.461 -0.791 . . . . 74.15 109.91 176.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.9 p -71.32 -27.63 63.53 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.167 0.587 . . . . 72.04 111.403 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -73.47 -31.07 63.57 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.846 0.859 . . . . 75.42 110.178 174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.42 5.41 68.31 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 123.675 0.61 . . . . 53.31 112.16 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 44.0 p 60.94 27.57 17.42 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 126.554 1.942 . . . . 75.33 112.663 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.402 ' HA ' ' CZ ' ' H' ' 195' ' ' PHE . 66.9 m-85 -93.32 162.47 27.96 Favored Pre-proline 0 CA--C 1.559 1.31 0 C-N-CA 124.826 1.251 . . . . 74.14 109.728 173.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.423 ' HD3' ' CZ ' ' H' ' 195' ' ' PHE . 19.8 Cg_exo -66.56 134.85 36.93 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 122.979 2.453 . . . . 61.42 111.485 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' D' ' 115' ' ' THR . 47.6 tt0 -55.59 134.21 50.85 Favored 'General case' 0 CA--C 1.549 0.913 0 O-C-N 124.314 1.009 . . . . 70.31 111.988 -175.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 27.3 tp -106.58 96.5 6.5 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.129 -0.693 . . . . 74.22 109.129 -172.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -99.55 84.74 3.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.368 -0.604 . . . . 72.31 109.368 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.76 129.24 39.31 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.726 -0.67 . . . . 72.44 110.631 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' G' ' 204' ' ' ILE . . . -68.26 140.46 92.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 123.243 0.617 . . . . 55.33 111.613 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 6.5 Cg_endo -82.38 122.36 3.63 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.25 1.967 . . . . 63.34 109.689 171.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.2 m -107.47 134.82 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.188 0.518 . . . . 73.23 110.088 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -83.96 96.54 8.87 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.892 0.853 . . . . 71.44 109.716 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.528 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 80.8 m-85 -61.6 -21.74 64.6 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 114.943 -1.026 . . . . 73.34 112.033 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -60.85 -49.25 78.23 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.47 1.108 . . . . 73.22 111.587 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.22 74.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.532 -0.758 . . . . 75.43 111.041 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.56 -32.43 73.77 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.926 0.766 . . . . 73.02 110.215 -178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.499 ' HA ' ' HZ ' ' H' ' 182' ' ' PHE . 91.5 t80 -58.8 -56.24 24.71 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.041 0.536 . . . . 64.42 110.146 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 67.6 mtm -64.15 -42.6 96.7 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.279 -0.873 . . . . 63.44 110.691 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -62.92 -42.99 99.98 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.425 1.09 . . . . 74.11 112.096 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -70.73 -39.86 73.12 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.585 0.754 . . . . 73.14 111.53 -173.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 95.2 mt -59.79 -29.48 68.24 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.317 0.647 . . . . 64.11 111.856 -177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.33 0.36 49.5 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.627 0.771 . . . . 63.51 111.936 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -121.32 83.02 2.01 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.636 0.774 . . . . 75.44 109.593 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -164.12 18.2 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.391 0.615 . . . . 43.04 110.795 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.8 112.54 20.19 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.62 0.768 . . . . 41.32 109.896 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.27 153.69 25.49 Favored Glycine 0 C--N 1.351 1.371 0 O-C-N 122.919 0.137 . . . . 75.33 113.214 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -149.49 -162.7 1.61 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.026 0.931 . . . . 73.3 110.13 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.44 157.11 7.12 Favored Glycine 0 C--N 1.353 1.524 0 C-N-CA 122.579 0.133 . . . . 54.12 113.255 172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.4 t -94.26 24.46 4.4 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.508 0.723 . . . . 64.5 109.794 172.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -76.71 134.37 39.24 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.647 0.779 . . . . 71.41 110.694 -175.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.68 102.25 4.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.221 0.608 . . . . 64.54 109.369 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -168.29 161.65 12.24 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.267 1.027 . . . . 75.13 109.515 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -84.76 83.2 8.11 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.41 -0.589 . . . . 74.42 109.41 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.27 95.45 3.75 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.155 0.982 . . . . 73.31 110.074 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.195 0 N-CA-C 109.062 -0.718 . . . . 64.32 109.062 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 63.6 pttt . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.242 -0.281 . . . . 61.45 110.242 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 162.35 66.39 0.02 OUTLIER Glycine 0 C--N 1.346 1.121 0 N-CA-C 111.891 -0.483 . . . . 62.15 111.891 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -64.3 130.94 45.82 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.705 0.402 . . . . 71.22 110.639 176.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . 0.612 ' HA ' ' HG3' ' C' ' 90' ' ' GLU . 52.3 m -65.63 122.17 16.64 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 124.132 0.895 . . . . 70.02 110.716 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -149.98 91.14 1.75 Allowed 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.639 0.775 . . . . 73.1 109.089 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' E' ' 174' ' ' MET . 0.0 OUTLIER -89.05 -28.27 20.25 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.484 0.714 . . . . 64.23 112.749 -171.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.455 ' HB2' HD22 ' E' ' 173' ' ' LEU . 0.0 OUTLIER -117.78 -75.42 0.58 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.908 0.483 . . . . 74.5 109.917 -172.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -165.91 89.78 0.43 Allowed 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 -173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -115.29 35.31 4.43 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 122.031 0.92 . . . . 73.24 109.64 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.19 172.63 16.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.434 0.693 . . . . 75.11 109.703 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -122.89 -54.99 1.81 Allowed 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.067 -0.716 . . . . 70.12 109.067 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -116.46 156.34 47.54 Favored Pre-proline 0 C--O 1.249 1.059 0 CA-C-N 114.986 -1.006 . . . . 72.1 109.254 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.17 164.43 33.99 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.267 1.978 . . . . 72.03 111.37 172.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -56.47 -35.24 67.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.692 0.797 . . . . 75.23 111.445 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -147.21 154.24 40.79 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.262 1.025 . . . . 70.14 108.826 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 13.4 t -80.85 157.25 25.74 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 122.958 0.503 . . . . 64.42 110.215 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -91.04 151.75 43.52 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 123.781 0.832 . . . . 65.15 111.914 -177.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -63.51 136.86 56.74 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.996 2.464 . . . . 65.11 112.175 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.562 HD22 ' H ' ' C' ' 44' ' ' LEU . 67.5 mt -106.32 143.43 34.46 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 74.24 109.784 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 11.6 tt -91.06 146.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 122.999 0.52 . . . . 62.43 110.159 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -148.71 146.36 28.08 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.653 0.781 . . . . 75.22 109.232 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -108.39 128.22 54.58 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.924 -0.769 . . . . 73.12 108.924 174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.04 132.64 51.17 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 123.89 0.744 . . . . 63.2 109.753 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.04 56.31 4.32 Favored Glycine 0 C--N 1.346 1.092 0 O-C-N 123.322 0.389 . . . . 63.31 113.191 -177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -76.0 76.48 1.41 Allowed Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.906 -0.877 . . . . 72.33 110.906 172.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 57.06 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.263 1.425 . . . . 75.25 112.581 -170.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . 0.656 ' HB2' ' HE2' ' F' ' 201' ' ' LYS . . . 60.72 -166.39 0.2 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.564 0.745 . . . . 55.41 110.336 -168.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 9.4 t80 55.92 97.36 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.637 1.175 . . . . 75.44 112.565 169.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -66.82 93.39 0.26 Allowed 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.51 -0.552 . . . . 74.44 109.51 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.83 69.32 7.36 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.054 -1.091 . . . . 74.55 108.054 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -60.94 -49.97 75.31 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.251 1.02 . . . . 72.14 109.774 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . 0.432 ' HB3' ' HA ' ' E' ' 202' ' ' TYR . 56.6 t-20 -169.37 133.8 1.41 Allowed 'General case' 0 C--O 1.244 0.764 0 N-CA-C 106.936 -1.505 . . . . 74.12 106.936 174.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.55 -22.57 66.01 Favored Glycine 0 C--N 1.345 1.04 0 O-C-N 123.512 0.507 . . . . 72.41 113.557 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -112.72 -8.55 13.77 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.384 0.674 . . . . 63.54 111.947 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . 0.548 ' CD2' ' HB2' ' B' ' 129' ' ' ALA . 87.8 m-85 63.92 -159.15 0.31 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.312 1.045 . . . . 64.44 110.371 -167.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.73 82.78 6.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.082 0.553 . . . . 74.11 110.755 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 44.3 mm -124.25 99.24 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 123.696 0.799 . . . . 74.52 109.703 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -158.07 -57.28 0.07 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.413 -0.958 . . . . 63.21 108.413 171.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -81.64 -5.33 57.97 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.667 -1.151 . . . . 75.23 111.266 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.433 HG22 ' HG2' ' F' ' 185' ' ' PRO . 48.3 t . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 118.392 -0.813 . . . . 72.34 108.851 174.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 110.092 -0.336 . . . . 64.32 110.092 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -172.72 -169.56 35.45 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 116.308 -0.405 . . . . 72.21 112.346 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -120.21 -69.2 0.86 Allowed 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.129 0.572 . . . . 55.41 109.885 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 22.8 t -168.05 -151.59 0.11 Allowed 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 107.812 -1.181 . . . . 72.15 107.812 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . 0.487 ' HB1' ' HA ' ' B' ' 90' ' ' GLU . . . -68.65 -12.39 61.31 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.94 0.496 . . . . 73.5 112.011 173.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.2 146.63 24.53 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.725 0.81 . . . . 72.22 110.288 173.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.453 ' SD ' ' HB3' ' B' ' 56' ' ' TYR . 31.8 mmt 66.95 -75.88 0.05 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.386 1.474 . . . . 71.31 111.85 174.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -115.43 91.94 3.76 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.199 -0.667 . . . . 62.42 109.199 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -94.98 -47.25 6.49 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.329 0.652 . . . . 70.21 110.423 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -77.76 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 124.136 0.898 . . . . 71.03 113.217 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 60.82 20.09 10.27 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 124.712 1.205 . . . . 73.23 111.693 -172.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -164.31 148.45 8.14 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.849 0.86 . . . . 73.34 109.102 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.8 97.87 1.03 Allowed 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.677 2.252 . . . . 43.52 111.894 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -71.03 110.76 5.91 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.929 -0.578 . . . . 74.41 110.385 176.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 68.68 -65.62 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.923 1.689 . . . . 74.11 112.904 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 30.8 m 82.04 120.83 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.631 1.972 . . . . 74.54 111.455 178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.463 ' CZ2' HD22 ' B' ' 44' ' ' LEU . 0.6 OUTLIER -50.92 141.79 18.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 125.641 1.577 . . . . 74.51 112.615 175.14 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' F' ' 184' ' ' TRP . 19.9 Cg_exo -66.98 133.91 32.65 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.998 2.465 . . . . 62.24 112.228 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 43' ' ' ASP . 93.3 mt -99.86 115.71 30.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.828 0.851 . . . . 53.41 109.526 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 37.6 pt -81.59 166.35 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.49 0.716 . . . . 43.43 111.469 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.52 139.7 33.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.889 0.876 . . . . 62.14 109.764 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.91 -31.31 20.77 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.376 0.671 . . . . 72.41 111.126 178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 21.3 t70 70.55 158.82 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.795 1.238 . . . . 62.42 111.225 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -70.85 147.24 42.94 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 116.565 -0.289 . . . . 61.21 112.977 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.42 -153.51 6.55 Favored Glycine 0 C--N 1.34 0.784 0 N-CA-C 111.705 -0.558 . . . . 44.05 111.705 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -133.1 8.35 4.03 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.521 0.728 . . . . 74.43 111.228 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -91.92 52.34 1.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.985 0.914 . . . . 61.15 111.205 -178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.465 ' HB3' ' HA ' ' B' ' 37' ' ' GLN . 49.7 t80 -174.37 85.65 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.111 0.964 . . . . 71.13 108.853 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . 0.547 ' HE3' ' HB2' ' F' ' 199' ' ' ASN . 52.0 pttt -175.7 133.88 0.28 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.63 1.172 . . . . 64.44 108.705 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -51.34 -38.57 53.81 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.496 1.119 . . . . 64.11 113.216 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.77 -53.65 54.85 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.523 0.729 . . . . 75.33 110.929 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . 0.547 ' HB2' ' HE3' ' F' ' 196' ' ' LYS . 10.4 t-20 -81.39 -12.39 58.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.196 0.598 . . . . 74.01 110.395 -176.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 92.02 -152.19 21.19 Favored Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.235 -0.893 . . . . 63.02 111.716 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.656 ' HE2' ' HB2' ' E' ' 194' ' ' ALA . 10.8 mptt 68.34 108.45 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.653 1.181 . . . . 71.31 111.695 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' C' ' 125' ' ' GLN . 0.9 OUTLIER 68.49 25.82 6.69 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.354 1.461 . . . . 65.44 111.297 166.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -120.95 -174.15 2.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.694 1.197 . . . . 72.41 109.888 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 21.3 tt -106.19 133.12 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 54.25 110.502 -175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -115.68 -60.97 1.81 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.258 0.623 . . . . 72.33 109.577 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -101.43 122.89 44.59 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.27 -0.877 . . . . 64.12 111.014 -173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' C' ' 131' ' ' VAL . 14.5 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.801 1.64 . . . . 73.33 110.867 176.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 6.5 mptt . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 108.909 -0.774 . . . . 74.23 108.909 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -95.76 0.22 62.76 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 116.611 -0.268 . . . . 61.33 113.32 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -83.44 -14.05 53.41 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.662 -0.496 . . . . 72.5 109.662 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 17.5 m -78.3 157.97 29.01 Favored 'General case' 0 C--N 1.347 0.479 0 C-N-CA 124.491 1.116 . . . . 65.22 112.1 -175.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . 0.633 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . . . -136.88 3.8 2.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.713 0.805 . . . . 73.3 111.485 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.504 HD13 ' HG2' ' G' ' 174' ' ' MET . 0.8 OUTLIER -59.18 109.53 0.87 Allowed 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.432 0.693 . . . . 64.0 109.643 -173.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.504 ' HG2' HD13 ' G' ' 173' ' ' LEU . 29.3 mmt 75.08 89.15 0.09 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.806 1.642 . . . . 73.52 110.8 -174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 19.6 t80 71.96 -108.8 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 73.54 111.608 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 8.4 t30 63.63 7.18 2.96 Favored 'General case' 0 CA--C 1.565 1.551 0 C-N-CA 123.619 0.768 . . . . 72.02 112.599 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 11.2 mp -57.04 -67.47 0.31 Allowed 'General case' 0 C--N 1.364 1.226 0 C-N-CA 123.079 0.552 . . . . 73.13 109.911 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 60.99 115.41 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.638 1.175 . . . . 65.32 111.287 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 68.9 123.64 0.03 OUTLIER Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 125.108 1.363 . . . . 73.22 109.844 -168.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.47 113.52 1.53 Allowed 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.422 2.082 . . . . 50.11 111.206 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -111.7 125.42 53.96 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.251 0.62 . . . . 71.43 109.383 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 66.15 92.97 0.07 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.456 1.502 . . . . 72.52 111.711 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 34.0 p -123.33 127.96 49.26 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.537 -0.912 . . . . 73.14 108.537 171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -100.5 142.78 25.27 Favored Pre-proline 0 C--O 1.244 0.772 0 C-N-CA 123.964 0.906 . . . . 72.1 110.309 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.35 117.99 2.86 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.58 2.187 . . . . 70.14 111.715 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . 0.446 HD21 HD22 ' A' ' 44' ' ' LEU . 3.8 mm? -73.06 151.2 41.79 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.454 -0.794 . . . . 71.53 109.678 173.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.67 175.49 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 123.491 0.716 . . . . 75.13 111.551 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -136.93 145.32 44.12 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.02 0.528 . . . . 51.54 109.581 174.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -104.28 121.87 44.23 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.983 -0.747 . . . . 75.31 108.983 177.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -58.14 -54.23 49.31 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.656 1.182 . . . . 74.34 111.395 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.65 -68.78 0.28 Allowed Glycine 0 C--N 1.342 0.87 0 N-CA-C 110.251 -1.139 . . . . 74.41 110.251 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 94.21 -11.12 70.99 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 115.56 -0.32 . . . . 64.31 113.607 174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -163.19 155.7 18.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.059 0.543 . . . . 71.15 110.533 -176.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -105.85 4.36 29.64 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.255 1.022 . . . . 64.54 110.408 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 68.41 -171.1 0.18 Allowed 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.401 1.48 . . . . 71.34 110.396 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -140.58 90.95 2.39 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.412 -0.588 . . . . 74.01 109.412 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -105.48 -31.91 8.77 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.389 1.076 . . . . 73.33 110.006 171.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -54.47 -54.28 43.09 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.082 0.953 . . . . 71.41 111.051 -179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -119.97 39.15 3.74 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.354 -0.98 . . . . 63.32 108.354 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -141.8 65.25 0.5 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 115.481 -0.781 . . . . 70.14 111.606 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -115.04 148.97 38.19 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.976 0.91 . . . . 74.02 108.849 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -73.09 -33.24 65.49 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.601 0.76 . . . . 71.44 110.476 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 30.5 t70 45.04 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.694 1.998 . . . . 73.35 113.681 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.509 HG21 ' HB2' ' D' ' 129' ' ' ALA . 63.4 mt -90.93 134.29 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.336 -0.847 . . . . 75.12 110.575 -175.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . 0.57 ' HB2' ' HB3' ' H' ' 188' ' ' ALA . 12.2 mptt -93.61 105.52 17.56 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.365 -1.346 . . . . 72.14 107.365 170.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -72.48 162.34 29.61 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.571 0.748 . . . . 73.34 111.291 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 CA--C 1.562 1.433 0 CA-C-O 118.386 -0.816 . . . . 63.21 109.967 175.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.324 -0.621 . . . . 73.44 109.324 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 179.59 -83.23 0.06 OUTLIER Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.606 -0.598 . . . . 52.43 111.606 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -114.2 18.61 16.95 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.149 0.58 . . . . 72.41 110.431 -177.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 61.4 m 62.59 86.53 0.11 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.684 1.194 . . . . 61.33 111.683 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' D' ' 3' ' ' GLU . . . -89.18 23.35 2.49 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 115.69 -0.687 . . . . 65.22 111.238 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.454 HD12 ' HE2' ' D' ' 56' ' ' TYR . 3.7 mm? -61.44 144.63 53.82 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 121.989 0.899 . . . . 70.43 113.214 -166.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.756 ' HG2' ' HA ' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -161.97 168.46 22.81 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 113.057 -1.883 . . . . 61.45 108.492 -172.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -165.28 -68.51 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.297 -1.001 . . . . 74.11 108.297 177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 70.9 -8.05 1.01 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.857 1.263 . . . . 63.52 113.728 172.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 35.8 tp -83.56 73.05 10.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.429 0.633 . . . . 72.25 110.236 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.09 -35.15 10.5 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.243 -1.021 . . . . 72.13 108.243 170.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -108.42 140.59 21.9 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 108.074 -1.084 . . . . 74.22 108.074 174.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.6 -9.18 23.67 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.899 2.399 . . . . 72.33 114.235 -171.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 65.43 -77.03 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 125.284 1.433 . . . . 73.25 109.524 -173.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . 0.499 ' HZ ' ' HA ' ' D' ' 137' ' ' PHE . 45.1 p90 -165.16 152.47 10.9 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.655 1.182 . . . . 73.5 108.83 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 38.6 m -89.17 129.57 35.74 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.523 -0.547 . . . . 70.3 109.523 174.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 30.3 m-90 -73.64 138.08 77.26 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 122.933 0.493 . . . . 75.21 109.933 174.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.86 144.27 82.6 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.992 2.462 . . . . 73.24 111.818 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . 0.643 HD11 ' HB2' ' D' ' 44' ' ' LEU . 89.7 mt -100.13 -164.51 1.13 Allowed 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.573 0.749 . . . . 74.11 111.026 -175.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.522 ' H ' HD12 ' H' ' 187' ' ' ILE . 3.8 mp -73.08 104.31 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 123.831 0.852 . . . . 40.41 109.391 -175.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . 0.57 ' HB3' ' HB2' ' G' ' 205' ' ' LYS . . . -72.08 85.18 1.01 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.21 -1.033 . . . . 65.41 108.21 168.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' H' ' 187' ' ' ILE . . . -105.0 123.61 48.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.029 -0.987 . . . . 45.2 110.187 -174.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -164.46 136.44 4.6 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.422 0.689 . . . . 63.31 109.573 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . 0.566 ' H ' ' HG2' ' D' ' 37' ' ' GLN . . . -131.74 0.18 4.94 Favored Glycine 0 C--N 1.338 0.666 0 O-C-N 124.013 0.82 . . . . 71.21 112.989 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 79.06 -69.81 2.87 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 117.239 0.52 . . . . 73.21 112.874 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -131.17 149.6 52.52 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.86 0.864 . . . . 74.43 110.45 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -154.38 -164.4 1.83 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.721 1.608 . . . . 64.33 107.073 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.423 ' CZ ' ' HD3' ' D' ' 124' ' ' PRO . 0.1 OUTLIER 67.0 177.38 0.24 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 123.287 0.635 . . . . 75.22 111.742 178.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -172.47 85.15 0.07 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.801 -1.09 . . . . 73.33 109.22 161.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -86.35 93.96 9.24 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.451 -0.574 . . . . 74.43 109.451 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -140.3 26.7 2.16 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.663 0.744 . . . . 72.24 110.371 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -79.08 -42.67 25.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.53 -0.759 . . . . 61.34 109.642 172.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 67.15 -83.93 0.12 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.484 -0.78 . . . . 71.32 112.926 178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' H' ' 203' ' ' ASP . 76.6 tttt -142.61 119.96 11.6 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.033 -1.099 . . . . 73.31 108.033 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.23 -32.32 72.98 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.028 0.531 . . . . 71.1 110.848 172.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . 0.414 ' HA ' ' HE2' ' H' ' 201' ' ' LYS . 15.2 t70 69.9 5.31 5.19 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 124.986 1.314 . . . . 73.43 111.76 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 22.1 pt -80.83 140.5 16.55 Favored 'Isoleucine or valine' 0 C--O 1.243 0.718 0 C-N-CA 123.883 0.873 . . . . 74.44 111.466 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -154.42 94.82 1.74 Allowed 'General case' 0 C--O 1.243 0.757 0 N-CA-C 106.254 -1.758 . . . . 72.55 106.254 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.0 -81.88 0.08 Allowed 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 109.057 -0.719 . . . . 72.11 109.057 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 C--O 1.258 1.535 0 N-CA-C 106.944 -1.502 . . . . 72.23 106.944 171.934 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.0 mtp . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 109.168 -0.678 . . . . 74.2 109.168 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.4 m -147.38 123.0 10.48 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.124 -0.489 . . . . 64.22 110.82 -171.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -102.42 113.4 26.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.443 -0.947 . . . . 71.43 108.443 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.81 -46.96 42.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.194 0.598 . . . . 74.31 111.067 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 61.87 91.47 0.06 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.599 1.16 . . . . 62.31 110.744 -176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -128.68 154.23 46.5 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 73.23 109.512 -175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.3 m -68.31 155.73 39.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.159 0.984 . . . . 73.21 110.121 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.93 79.82 0.31 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.649 0.78 . . . . 72.13 109.547 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.631 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 24.4 ptm -77.56 164.8 25.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.539 0.736 . . . . 65.31 111.968 -173.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.4 m -141.58 116.06 9.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.729 0.812 . . . . 51.43 109.365 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.413 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -115.83 126.93 54.63 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.957 -1.497 . . . . 74.35 106.957 165.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.425 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 4.1 tp60 -143.56 124.65 14.46 Favored 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.082 0.239 . . . . 64.54 110.632 -166.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.62 98.61 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.576 -0.898 . . . . 75.05 108.576 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -82.41 -30.64 30.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.915 -0.564 . . . . 73.51 111.535 -177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 179.22 121.93 0.05 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.458 0.703 . . . . 74.12 110.084 170.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.571 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 86.8 mt -105.84 130.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.846 -1.168 . . . . 72.21 107.846 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.813 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 22.6 p90 -171.95 152.44 2.96 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 124.193 0.933 . . . . 71.34 110.561 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -75.64 119.38 19.6 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.215 -0.661 . . . . 74.04 109.215 174.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -78.69 -46.28 19.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 109.136 -0.69 . . . . 60.44 109.136 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -135.46 136.73 41.53 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 114.889 -1.05 . . . . 71.3 109.383 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -129.06 140.72 48.49 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 N-CA-C 107.354 -1.35 . . . . 74.13 107.354 175.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -142.96 128.72 19.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.452 0.701 . . . . 64.11 109.436 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 81.8 t80 -139.19 115.86 10.71 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.841 -1.541 . . . . 72.33 106.841 171.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -115.89 144.97 43.3 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.335 -0.987 . . . . 71.14 108.335 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.34 74.29 11.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 107.248 -1.39 . . . . 50.24 107.248 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -71.09 -23.34 24.93 Favored 'Trans proline' 0 C--N 1.374 1.921 0 C-N-CA 122.543 2.162 . . . . 71.33 111.437 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 80.0 m-20 -110.4 33.54 4.44 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 114.858 -1.065 . . . . 53.4 109.79 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' HB1' ' CE2' ' B' ' 17' ' ' TYR . . . -59.5 -43.42 95.92 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.28 1.032 . . . . 75.22 113.126 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -69.63 -27.83 26.63 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 121.715 1.61 . . . . 72.24 113.023 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.6 m170 -72.6 -37.17 68.2 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.082 0.553 . . . . 72.44 111.077 -174.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.647 HG23 HD11 ' A' ' 68' ' ' LEU . 13.6 p -68.3 -23.11 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.903 0.881 . . . . 63.33 112.317 -172.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.572 ' HD1' HH11 ' B' ' 15' ' ' ARG . 78.5 t80 -70.39 -35.65 73.61 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.882 0.373 . . . . 72.32 110.393 175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -70.73 -46.04 63.76 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.451 -0.795 . . . . 74.54 109.658 174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 3.7 mmmp? -73.17 151.92 41.32 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 114.425 -1.261 . . . . 64.43 111.201 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.72 136.1 47.06 Favored 'General case' 0 C--O 1.245 0.856 0 CA-C-N 115.583 -0.735 . . . . 70.42 109.421 171.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 64.8 t-105 -75.41 84.68 2.53 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.736 0.779 . . . . 71.14 109.261 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -118.23 76.79 12.47 Favored Pre-proline 0 CA--C 1.545 0.761 0 CA-C-N 114.882 -1.053 . . . . 64.31 108.434 174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.17 125.64 9.91 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 121.914 1.742 . . . . 61.41 111.627 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -97.26 89.98 4.95 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 106.706 -1.59 . . . . 75.41 106.706 172.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.452 HG23 ' HA2' ' G' ' 191' ' ' GLY . 62.0 t -70.72 92.4 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-N 115.529 -0.76 . . . . 64.31 110.5 -169.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.39 115.29 20.67 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.452 -0.944 . . . . 51.05 108.452 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.49 151.54 19.9 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 108.771 -0.826 . . . . 61.03 108.771 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.616 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.5 t70 -143.37 147.78 35.2 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.357 -0.979 . . . . 65.03 108.357 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 tp -134.96 126.31 28.35 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.453 -0.943 . . . . 61.44 108.453 -178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -143.47 156.66 44.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.609 -0.886 . . . . 32.45 108.609 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.4 t -140.3 151.56 45.17 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 123.095 0.558 . . . . 61.12 110.149 176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.7 153.58 49.77 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.999 1.32 . . . . 61.23 108.088 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.6 m -131.82 157.43 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 120.867 0.365 . . . . 74.22 110.663 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -148.24 120.69 8.48 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.657 -0.868 . . . . 75.32 108.657 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -81.99 105.22 12.92 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.772 -0.825 . . . . 74.44 108.772 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.18 -33.08 24.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.265 -0.425 . . . . 73.13 110.181 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.35 179.8 8.35 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.028 0.931 . . . . 65.31 109.736 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -70.35 125.03 25.62 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 107.843 -1.169 . . . . 54.11 107.843 172.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 75.11 -8.19 1.61 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 125.688 1.595 . . . . 73.54 112.785 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -107.45 110.6 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 108.683 -0.858 . . . . 71.32 108.683 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -133.65 123.67 25.44 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.271 -0.64 . . . . 71.14 109.271 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.602 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 28.0 tt0 -86.62 116.15 24.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.771 -0.649 . . . . 71.33 109.271 175.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.4 t -100.51 115.6 42.25 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.166 0 N-CA-C 107.233 -1.395 . . . . 55.21 107.233 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.3 t -98.78 136.6 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 C-N-CA 123.694 0.798 . . . . 71.32 109.037 175.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.45 111.67 23.34 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.562 -1.273 . . . . 71.43 107.562 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.01 101.95 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.399 -0.963 . . . . 72.14 108.399 175.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.6 t -99.29 135.8 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 107.601 -1.259 . . . . 75.23 107.601 175.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.616 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 11.8 m -128.73 144.16 51.1 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 109.768 -0.456 . . . . 74.42 109.768 177.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 10.0 t -140.77 125.67 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.672 1.589 . . . . 75.33 107.793 -171.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -129.36 131.92 46.97 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.698 -0.482 . . . . 62.12 109.698 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.34 108.53 18.64 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.663 -0.866 . . . . 51.13 108.663 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.4 m -108.85 139.32 43.86 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.001 0.52 . . . . 74.11 110.17 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.647 HD11 HG23 ' A' ' 31' ' ' VAL . 6.2 mt -113.65 78.48 1.15 Allowed 'General case' 0 C--O 1.246 0.903 0 N-CA-C 108.273 -1.01 . . . . 63.42 108.273 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.54 -86.13 1.24 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.97 -0.852 . . . . 44.32 110.97 -173.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -131.05 -8.09 3.87 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.423 1.089 . . . . 64.32 111.303 177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -99.71 110.35 22.75 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.264 -0.643 . . . . 71.41 109.264 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.0 m -70.76 132.12 44.87 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 110.056 -0.349 . . . . 50.12 110.056 178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.21 -60.53 2.33 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.07 0.948 . . . . 61.21 109.367 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -151.99 172.18 16.67 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 114.613 -1.176 . . . . 74.33 111.075 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.7 tp -132.57 147.43 52.35 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.903 1.281 . . . . 63.32 108.521 172.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.54 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.1 m -135.66 136.15 40.71 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.499 1.12 . . . . 71.23 109.145 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -147.37 129.28 15.34 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.489 -0.93 . . . . 75.54 108.489 169.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.21 109.56 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 108.959 -0.756 . . . . 71.22 108.959 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -85.57 82.84 8.09 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.186 -1.042 . . . . 74.13 108.186 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -75.69 92.26 2.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 114.553 -1.203 . . . . 63.34 108.403 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.68 144.23 21.17 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 111.315 -0.714 . . . . 63.44 111.315 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.89 118.26 1.22 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 110.11 -1.196 . . . . 63.02 110.11 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.602 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 34.4 mt -81.25 124.12 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.581 -1.266 . . . . 44.41 107.581 172.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.413 ' HB3' ' CE2' ' A' ' 11' ' ' PHE . 49.4 m-85 -133.35 121.05 21.78 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 109.411 -0.588 . . . . 73.12 109.411 -178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 22.4 t -79.36 96.67 6.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.026 -1.101 . . . . 65.51 108.026 170.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.53 HG13 ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -121.2 128.07 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 115.067 -0.97 . . . . 64.42 109.418 -171.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -174.15 178.15 2.15 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.535 1.134 . . . . 72.45 110.43 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.631 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 85.69 4.38 85.29 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.928 -0.578 . . . . 65.01 113.951 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.526 HD11 HD11 ' G' ' 173' ' ' LEU . 2.0 pp -114.21 153.45 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 123.983 0.913 . . . . 63.42 109.546 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -144.33 168.94 18.9 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 109.27 -0.641 . . . . 62.53 109.27 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.557 ' HA2' ' H ' ' G' ' 170' ' ' LYS . . . 54.77 -127.29 40.24 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 123.727 0.642 . . . . 61.01 114.688 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 77.6 p -62.25 -26.36 68.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.43 1.092 . . . . 65.21 112.077 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -64.07 -36.41 83.92 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.903 0.881 . . . . 75.32 111.074 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.401 ' CB ' ' HB3' ' G' ' 172' ' ' ALA . 77.7 mtp -67.27 -45.38 76.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.622 0.769 . . . . 65.1 110.2 178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.85 71.98 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.884 -1.053 . . . . 72.53 111.255 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -66.96 -44.32 80.82 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.966 0.906 . . . . 61.41 110.362 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.595 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 14.3 t -71.81 -63.24 1.17 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 123.624 0.577 . . . . 73.33 110.791 -171.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.552 ' HB2' HD23 ' G' ' 173' ' ' LEU . 49.2 tp -68.75 -38.39 80.08 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 120.555 0.217 . . . . 72.43 111.525 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.15 -9.33 84.21 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-O 119.347 -0.696 . . . . 25.33 114.715 -170.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.32 -53.68 0.17 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.904 0.852 . . . . 71.43 112.743 -175.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 89.9 t80 -72.99 -60.97 1.98 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.72 0.808 . . . . 72.41 113.156 -164.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 72.0 m -61.22 -39.72 66.16 Favored Pre-proline 0 CA--C 1.557 1.23 0 N-CA-C 113.761 1.023 . . . . 64.05 113.761 -177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -63.47 -33.56 68.4 Favored 'Trans proline' 0 C--N 1.382 2.341 0 CA-C-N 120.976 1.384 . . . . 62.14 112.87 167.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -72.87 -23.62 60.76 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 117.903 0.319 . . . . 60.44 111.212 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.7 mm -61.12 -42.31 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.952 0.882 . . . . 52.35 109.305 170.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 64.5 mt -80.1 -24.47 40.55 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.143 -1.39 . . . . 64.12 112.348 -174.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -60.39 -41.91 86.15 Favored Pre-proline 0 CA--C 1.562 1.419 0 N-CA-C 113.923 1.082 . . . . 73.21 113.923 -171.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -55.89 -39.33 91.79 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.421 2.081 . . . . 65.24 113.313 172.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -76.27 -41.69 48.07 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.308 -0.86 . . . . 65.23 111.387 -176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.35 -45.86 85.93 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.107 0.563 . . . . 73.0 109.984 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.401 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.8 ttm180 -49.86 -59.08 4.19 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 124.897 1.373 . . . . 70.33 109.683 175.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.412 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 4.4 tm-20 -58.32 -40.97 83.5 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 124.428 1.08 . . . . 71.42 112.251 -174.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.485 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 44.0 t -62.07 -47.6 83.94 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.503 0.502 . . . . 63.21 110.91 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.415 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 96.2 mt -61.47 -43.96 97.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.76 0.824 . . . . 60.13 110.464 175.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.606 HG23 ' HB2' ' A' ' 125' ' ' GLN . 74.0 m -58.26 -42.75 87.12 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.909 1.284 . . . . 54.32 111.586 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -72.93 -41.5 64.44 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.314 -0.857 . . . . 33.11 110.888 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.0 mtm -58.63 -43.38 89.67 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 122.653 0.381 . . . . 60.44 111.324 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.9 -42.99 96.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 O-C-N 123.974 0.796 . . . . 51.32 111.47 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.4 p -67.56 -29.0 68.26 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.106 0.479 . . . . 71.12 110.958 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.8 -31.55 64.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.713 0.805 . . . . 73.13 109.943 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.84 29.53 4.56 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.972 0.796 . . . . 74.32 113.623 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t 60.98 16.8 7.31 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 126.725 2.01 . . . . 70.14 114.994 169.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -122.18 159.36 52.31 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.618 -0.676 . . . . 72.42 111.962 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.18 139.76 90.91 Favored 'Trans proline' 0 C--N 1.393 2.895 0 C-N-CA 122.82 2.346 . . . . 51.23 111.674 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.606 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.0 pt20 -55.44 151.64 9.9 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.576 1.173 . . . . 74.2 112.138 -173.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -120.02 97.46 5.62 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.997 -0.742 . . . . 71.31 108.997 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -124.6 101.82 7.31 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.522 1.129 . . . . 73.24 109.406 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.3 mt -68.78 159.11 32.99 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.882 0.873 . . . . 74.42 112.006 -176.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 152.37 95.98 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 123.895 0.878 . . . . 62.41 111.731 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -91.71 111.26 0.31 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.284 2.656 . . . . 74.42 112.191 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.441 HG13 ' HB ' ' H' ' 207' ' ' VAL . 49.6 t -100.84 111.22 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 107.961 -1.126 . . . . 75.4 107.961 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -96.14 73.06 2.92 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.079 0.942 . . . . 71.04 109.258 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.481 ' HZ ' ' HB2' ' G' ' 182' ' ' PHE . 71.5 t80 -71.21 -25.3 62.45 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.069 -1.423 . . . . 73.43 110.25 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -67.8 -40.23 83.9 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.977 0.911 . . . . 63.24 110.665 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.71 -30.33 67.94 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 115.616 -0.72 . . . . 72.03 110.082 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.08 -35.98 76.39 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 123.81 0.694 . . . . 65.41 111.25 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 74.8 m-85 -59.43 -51.88 67.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 110.227 -0.286 . . . . 73.13 110.227 172.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.5 mmt -58.36 -42.84 87.86 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.872 0.869 . . . . 75.24 111.731 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -76.03 -50.26 15.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.98 -1.009 . . . . 70.12 111.419 -175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -73.8 -31.7 63.38 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 119.132 -0.461 . . . . 62.32 112.205 -172.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.6 OUTLIER -55.71 -52.53 63.58 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.261 0.624 . . . . 72.11 110.782 -170.63 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -152.05 -17.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.647 0.779 . . . . 62.41 111.044 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.603 HE22 ' HA ' ' C' ' 144' ' ' GLN . 0.0 OUTLIER 48.05 81.43 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.697 1.199 . . . . 73.35 111.137 -171.139 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -138.37 156.97 47.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.969 0.507 . . . . 52.55 110.814 -176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.59 175.53 13.53 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.903 -1.044 . . . . 75.1 109.755 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.99 57.22 2.18 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.897 -0.481 . . . . 54.4 111.897 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.48 ' HB2' HE22 ' C' ' 142' ' ' GLN . 10.3 tp10 -76.78 142.63 40.29 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.294 0.638 . . . . 55.31 110.275 176.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.54 2.27 60.16 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 114.435 0.534 . . . . 74.33 114.435 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.1 t -100.64 122.15 42.82 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 117.329 0.564 . . . . 64.31 109.778 173.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.05 -29.4 23.44 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.577 0.751 . . . . 62.44 110.918 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -70.77 98.37 1.53 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.195 0.598 . . . . 73.14 109.585 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -99.45 21.61 11.9 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.877 -0.786 . . . . 73.25 108.877 173.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.1 101.83 0.93 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 108.202 -1.036 . . . . 74.22 108.202 172.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -84.51 128.71 34.74 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.665 -0.698 . . . . 74.31 109.979 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 123.779 0.832 . . . . 71.21 111.402 -176.316 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tmm? . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.577 -0.897 . . . . 74.4 108.577 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.516 ' HA ' HD12 ' F' ' 173' ' ' LEU . 33.4 p -61.32 93.01 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.846 0.858 . . . . 74.22 111.097 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.26 102.01 7.7 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.403 -1.332 . . . . 75.42 107.403 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -80.31 85.94 5.74 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.941 0.497 . . . . 44.54 110.885 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -106.99 147.67 29.61 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.102 -0.703 . . . . 72.04 109.102 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -73.62 83.21 1.55 Allowed 'General case' 0 CA--C 1.551 0.982 0 CA-C-O 122.233 1.016 . . . . 74.02 110.937 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -136.89 144.95 43.78 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 107.633 -1.247 . . . . 73.24 107.633 174.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -84.79 64.67 8.71 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 109.417 -0.586 . . . . 63.23 109.417 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.3 ptm 47.78 177.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 127.033 2.133 . . . . 73.25 114.593 -173.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.9 p -143.21 132.49 23.28 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.432 -1.322 . . . . 75.02 107.432 170.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.43 ' HA ' HG22 ' B' ' 86' ' ' ILE . 16.9 t80 -127.87 139.24 52.74 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -149.66 141.05 23.26 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.23 0.612 . . . . 63.43 109.789 176.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.447 HD11 HG13 ' B' ' 16' ' ' ILE . 7.2 tp -93.18 136.21 25.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 109.018 -0.734 . . . . 62.34 109.018 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.589 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.9 mm100 -104.95 -51.14 3.1 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.33 -0.619 . . . . 63.53 109.33 176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.572 HH11 ' HD1' ' A' ' 32' ' ' PHE . 52.2 ttt180 -173.26 138.83 0.75 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.055 0.542 . . . . 75.23 110.543 -176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.447 HG13 HD11 ' B' ' 13' ' ' ILE . 55.8 mt -114.71 141.45 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 108.075 -1.083 . . . . 72.52 108.075 173.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.433 ' CE2' ' HB1' ' A' ' 28' ' ' ALA . 26.0 p90 -167.5 156.45 9.87 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.112 0.482 . . . . 75.43 111.957 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 91.9 m -81.57 125.83 31.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.31 -0.859 . . . . 74.0 108.685 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.436 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.6 mtpt -98.36 -34.91 10.48 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.159 0.584 . . . . 71.42 111.301 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.662 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 10.6 t70 -153.95 132.82 12.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.743 -0.662 . . . . 65.23 109.942 -165.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 40.9 mm -135.94 138.31 47.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 C-N-CA 124.102 0.961 . . . . 62.53 109.462 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 35.2 m -138.33 121.29 16.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.413 -1.267 . . . . 72.31 108.674 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.529 ' HZ ' ' HD2' ' B' ' 123' ' ' PHE . 83.3 t80 -130.65 108.59 10.02 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.652 -1.61 . . . . 72.24 106.652 163.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -122.45 114.67 21.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.746 -0.835 . . . . 63.4 108.746 -174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.21 87.15 3.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.972 0.909 . . . . 74.14 108.867 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 35.7 Cg_endo -61.75 -41.12 40.52 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.173 2.582 . . . . 72.42 112.901 -173.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -110.52 30.95 6.33 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.109 0.964 . . . . 63.44 109.912 -176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.813 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.66 -50.32 51.87 Favored Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 125.875 1.67 . . . . 62.03 115.057 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.89 -19.21 16.25 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.008 1.805 . . . . 73.41 112.445 -178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -94.04 5.01 53.07 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.923 1.289 . . . . 65.42 110.863 -174.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -57.95 -28.85 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 123.548 0.739 . . . . 72.05 111.698 171.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -73.69 -33.51 64.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.38 0.672 . . . . 70.34 111.314 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.54 -20.38 63.69 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.135 0.974 . . . . 73.43 110.476 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -104.68 112.07 25.01 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.5 1.52 . . . . 64.1 111.379 -173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -93.54 77.97 4.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.229 0.612 . . . . 63.4 111.65 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 170.96 152.48 0.05 Allowed 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 126.384 1.874 . . . . 72.34 109.307 161.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.436 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 0.6 OUTLIER -80.56 128.65 71.61 Favored Pre-proline 0 N--CA 1.48 1.059 0 N-CA-C 108.994 -0.743 . . . . 74.52 108.994 -177.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.519 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 10.6 Cg_endo -52.74 129.7 33.78 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.56 2.84 . . . . 53.1 114.048 -168.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 10.9 pt-20 -53.75 123.02 11.13 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 124.33 1.019 . . . . 52.43 110.358 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.442 HG21 ' HE3' ' E' ' 196' ' ' LYS . 21.8 t -85.41 124.1 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 107.973 -1.121 . . . . 74.31 107.973 -174.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -147.95 142.91 26.93 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.381 0.673 . . . . 75.11 109.598 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -127.55 164.59 21.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.67 0.788 . . . . 51.42 111.012 -171.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 5.0 m-20 -140.25 144.26 36.39 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.166 1.386 . . . . 73.52 108.375 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 tt -129.2 96.28 4.27 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.027 -1.101 . . . . 74.22 108.027 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -129.85 158.3 39.86 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.147 0.979 . . . . 74.42 109.156 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -139.63 137.4 35.26 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.02 0.438 . . . . 74.2 110.901 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.69 161.46 21.38 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.627 1.171 . . . . 62.12 108.377 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.8 p -146.14 167.44 23.43 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.278 0.231 . . . . 53.45 111.107 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.7 p -153.12 135.59 15.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.061 0.944 . . . . 64.23 109.192 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -84.89 132.88 34.33 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.71 0.804 . . . . 71.23 109.408 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.4 mt -99.13 -41.9 7.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.125 0.57 . . . . 61.11 110.262 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.19 -169.34 3.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.266 0.627 . . . . 70.42 110.871 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -76.39 119.05 19.73 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.322 -0.854 . . . . 73.34 110.22 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 59.99 21.98 11.08 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.85 1.26 . . . . 62.21 112.41 -172.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -131.04 117.28 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.477 1.111 . . . . 75.42 108.376 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -125.52 -177.79 4.02 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.339 0.59 . . . . 72.11 109.914 172.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -141.94 117.3 10.18 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.114 -1.81 . . . . 71.44 106.114 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.3 t -105.03 131.41 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 N-CA-C 110.013 -0.366 . . . . 62.11 110.013 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.466 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -103.37 125.82 57.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 124.447 1.099 . . . . 72.53 109.253 176.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.409 HD22 HG23 ' B' ' 62' ' ' VAL . 0.3 OUTLIER -92.17 122.25 34.47 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 107.244 -1.391 . . . . 74.14 107.244 169.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -108.22 106.63 16.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.718 0.807 . . . . 74.03 108.849 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.409 HG23 HD22 ' B' ' 60' ' ' LEU . 31.6 t -106.53 122.39 60.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 108.806 -0.813 . . . . 63.33 108.806 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.2 m -114.59 152.44 31.82 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.354 0.409 . . . . 73.1 109.943 -177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 39.3 t -129.47 126.11 62.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 124.818 1.247 . . . . 73.12 107.947 -176.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.5 m -109.55 136.1 49.47 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.766 -1.198 . . . . 70.13 107.766 170.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.483 -0.932 . . . . 72.12 108.483 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.3 m -138.69 136.2 35.58 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.244 0.545 . . . . 61.23 112.201 -171.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.6 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 46.5 mt -95.05 99.05 11.12 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.742 1.217 . . . . 62.0 108.019 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -129.8 15.58 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-O 120.016 -0.325 . . . . 45.31 112.517 -178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -98.86 36.92 1.59 Allowed 'General case' 0 N--CA 1.481 1.079 0 CA-C-O 121.973 0.892 . . . . 65.13 108.838 177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -153.98 142.95 21.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.656 -0.702 . . . . 72.42 109.396 -172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 34.2 m -66.07 136.91 56.65 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.154 0.582 . . . . 75.34 111.562 -175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.6 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.83 -60.62 1.77 Allowed 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.105 0.962 . . . . 75.05 109.227 177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.435 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 26.3 p90 -157.6 160.58 38.24 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 113.361 -1.745 . . . . 62.52 108.863 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.6 mt -134.56 115.69 14.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.926 -1.509 . . . . 74.1 106.926 176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -115.54 153.78 30.56 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.216 -1.031 . . . . 54.43 108.216 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -164.45 131.66 3.19 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.556 -0.905 . . . . 74.22 108.556 -174.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -122.63 142.66 38.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.485 -0.932 . . . . 74.11 108.485 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.662 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.4 mt-30 -125.29 90.22 3.19 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.462 -0.94 . . . . 62.13 108.462 175.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.499 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -83.79 106.48 15.52 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.151 -1.386 . . . . 63.31 109.12 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.62 164.28 26.55 Favored Glycine 0 C--O 1.24 0.487 0 O-C-N 123.44 0.463 . . . . 64.41 112.838 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.85 126.86 1.6 Allowed Glycine 0 C--N 1.334 0.451 0 N-CA-C 110.828 -0.909 . . . . 62.21 110.828 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 20.1 mt -86.05 129.7 37.72 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 108.607 -0.886 . . . . 75.24 108.607 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 -134.34 141.76 47.0 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.953 0.901 . . . . 62.14 108.9 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.1 m -116.92 114.04 23.28 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.645 0.778 . . . . 50.12 109.227 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.55 HD13 HD11 ' B' ' 89' ' ' ILE . 2.7 pp -135.93 149.49 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.957 0.903 . . . . 71.53 110.645 -172.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.78 172.14 18.84 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.593 0.757 . . . . 70.14 110.119 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.11 -48.69 0.92 Allowed Glycine 0 C--N 1.35 1.317 0 CA-C-O 119.962 -0.354 . . . . 73.41 113.98 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.55 HD11 HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -73.23 162.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 CA-C-N 117.21 0.505 . . . . 73.11 111.679 -177.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -152.3 153.65 34.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.28 0.632 . . . . 73.15 110.163 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.04 -136.56 25.53 Favored Glycine 0 C--N 1.347 1.177 0 C-N-CA 123.888 0.756 . . . . 52.21 113.93 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.0 m -77.87 -16.98 57.85 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.249 1.02 . . . . 62.42 111.508 -176.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -51.84 -39.69 59.25 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 123.682 0.793 . . . . 74.32 111.163 172.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' F' ' 172' ' ' ALA . 14.8 tpt -69.97 -33.66 72.37 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.79 -1.095 . . . . 54.24 111.746 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.423 ' HA ' ' ND2' ' F' ' 176' ' ' ASN . . . -62.5 -29.99 70.95 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.985 0.514 . . . . 71.41 111.527 177.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -73.44 -30.87 63.48 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.769 0.828 . . . . 64.32 111.385 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -79.22 -64.29 1.22 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.2 0.6 . . . . 62.44 110.817 -177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 tt -64.64 -43.67 92.94 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.674 0.79 . . . . 52.1 110.418 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.93 -2.13 86.47 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 118.788 -1.007 . . . . 74.11 114.992 -170.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.79 -52.38 0.29 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.642 1.221 . . . . 62.43 112.299 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -70.76 -44.11 67.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.419 0.287 . . . . 73.4 111.564 -173.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 71.7 m -60.87 -47.89 94.37 Favored Pre-proline 0 CA--C 1.559 1.289 0 CA-C-O 118.765 -0.636 . . . . 74.12 111.593 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_exo -47.48 -50.35 11.54 Favored 'Trans proline' 0 C--N 1.39 2.724 0 C-N-CA 122.442 2.094 . . . . 75.42 113.967 165.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -58.9 -32.21 69.32 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 123.264 0.626 . . . . 71.2 112.507 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.427 HG23 ' NH2' ' D' ' 111' ' ' ARG . 60.6 mt -64.7 -48.1 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.484 0.714 . . . . 74.11 110.881 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 26.6 mt -86.03 -9.32 56.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.044 0.938 . . . . 74.33 111.35 -171.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.467 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 20.5 t80 -60.56 -48.56 93.13 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.255 1.422 . . . . 74.34 113.207 -172.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -38.14 54.79 Favored 'Trans proline' 0 C--N 1.384 2.416 0 C-N-CA 121.732 1.622 . . . . 31.22 113.271 176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.499 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 90.2 m-85 -61.62 -45.83 92.42 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.102 0.561 . . . . 72.01 110.602 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.93 -43.99 94.2 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.095 0.958 . . . . 71.25 111.219 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 32.6 mtp-105 -55.81 -51.35 67.77 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.477 1.111 . . . . 64.13 111.431 176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.27 -37.35 83.3 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.259 -0.882 . . . . 62.42 110.015 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.8 t -66.16 -39.12 89.55 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.811 -0.631 . . . . 55.32 111.279 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.13 -51.98 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 122.738 0.415 . . . . 44.21 110.301 176.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.449 HG23 ' HB2' ' B' ' 125' ' ' GLN . 41.8 m -57.95 -27.36 63.34 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 123.899 0.749 . . . . 64.23 111.269 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -71.24 -62.28 1.46 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.35 0.66 . . . . 70.12 110.462 172.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.9 mmt -61.06 -39.97 91.89 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.488 0.715 . . . . 73.24 112.391 -170.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.425 HG11 ' O ' ' B' ' 124' ' ' PRO . 78.5 t -65.82 -43.04 93.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 115.611 -0.722 . . . . 73.2 111.144 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 63.2 p -69.65 -25.64 64.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.341 0.4 . . . . 73.34 111.394 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.485 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.1 mtt-85 -65.56 -36.89 85.1 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.564 -0.744 . . . . 72.34 110.023 174.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -81.13 7.17 60.84 Favored Glycine 0 C--N 1.356 1.69 0 O-C-N 124.04 0.838 . . . . 74.14 112.897 172.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 20.9 p 54.96 47.64 21.73 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.562 1.945 . . . . 61.32 111.504 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.529 ' HD2' ' HZ ' ' B' ' 23' ' ' PHE . 29.1 m-85 -120.36 166.62 14.77 Favored Pre-proline 0 CA--C 1.568 1.642 0 CA-C-N 114.016 -1.447 . . . . 64.2 110.781 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' B' ' 123' ' ' PHE . 36.7 Cg_endo -61.44 137.03 67.23 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 123.915 3.077 . . . . 73.55 115.334 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.541 ' NE2' ' HA ' ' C' ' 124' ' ' PRO . 13.6 pm0 -59.78 154.56 17.99 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.487 1.115 . . . . 75.1 112.648 177.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 61.6 tp -124.44 95.96 4.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.079 -1.082 . . . . 44.25 108.079 169.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.423 HD22 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -92.58 90.62 7.21 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.973 -1.862 . . . . 64.23 105.973 172.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.467 HD22 ' HZ ' ' B' ' 107' ' ' PHE . 1.2 tt -67.88 133.98 50.06 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.414 -0.958 . . . . 54.24 108.414 -170.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.69 107.55 0.85 Allowed Pre-proline 0 CA--C 1.549 0.941 0 O-C-N 124.602 1.189 . . . . 63.31 111.269 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.411 ' HA ' ' HE2' ' B' ' 107' ' ' PHE . 95.9 Cg_endo -75.14 88.73 1.23 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.946 2.431 . . . . 63.22 112.494 -170.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.74 149.5 12.78 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.981 -1.009 . . . . 61.32 110.425 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.7 t-20 -111.45 116.25 30.59 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 108.009 -1.108 . . . . 64.12 108.009 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -62.2 -28.91 70.01 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.907 0.883 . . . . 64.02 111.975 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' B' ' 138' ' ' MET . 19.6 t70 -56.11 -51.71 66.93 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.23 0.956 . . . . 61.21 111.358 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.72 -35.76 64.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.93 0.892 . . . . 34.32 112.338 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.466 HD13 HG22 ' E' ' 207' ' ' VAL . 54.4 tp -69.94 -48.7 57.38 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.496 -0.774 . . . . 63.04 109.981 177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.475 ' HA ' ' HD2' ' B' ' 140' ' ' TYR . 18.3 m-30 -76.6 -16.07 59.67 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 115.784 -0.644 . . . . 72.32 112.528 -171.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.447 ' HG3' ' O ' ' B' ' 134' ' ' ASP . 94.0 mtp -57.87 -33.97 69.27 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.916 0.886 . . . . 74.41 111.353 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -75.37 -29.54 59.92 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.103 -0.953 . . . . 71.22 110.697 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.475 ' HD2' ' HA ' ' B' ' 137' ' ' PHE . 97.3 m-85 -78.81 -17.0 56.42 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.595 0.758 . . . . 73.45 111.396 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 81.1 mt -93.06 31.44 1.43 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.694 0.798 . . . . 53.52 111.071 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -66.46 -45.73 78.78 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.676 0.791 . . . . 74.14 110.113 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -67.36 -23.86 65.65 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.17 0.588 . . . . 75.51 111.649 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -74.2 101.01 3.84 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.272 -0.64 . . . . 74.11 109.272 176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.01 150.9 24.14 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.305 -0.861 . . . . 73.24 111.084 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -122.27 170.46 15.12 Favored Glycine 0 N--CA 1.471 0.981 0 N-CA-C 110.797 -0.921 . . . . 63.14 110.797 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.78 174.3 12.66 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.244 0.545 . . . . 54.13 111.737 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.62 -156.69 24.53 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 114.656 -1.156 . . . . 75.3 110.551 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.5 t -158.6 149.11 20.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 117.635 0.717 . . . . 31.15 110.824 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -92.65 110.24 21.67 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.644 -1.243 . . . . 72.24 107.644 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -112.92 129.53 56.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.238 -0.653 . . . . 72.04 109.238 176.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -77.28 172.43 13.29 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.352 0.661 . . . . 65.41 111.253 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.22 -52.04 0.05 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.932 -1.507 . . . . 72.52 106.932 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 65.14 -90.97 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.194 1.398 . . . . 61.04 112.089 173.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.017 0 C-N-CA 124.899 1.279 . . . . 52.32 107.883 -174.249 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.307 0.099 . . . . 73.43 110.944 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -115.44 107.74 15.58 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.907 -1.146 . . . . 72.14 107.907 168.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -123.17 148.68 45.51 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.451 0.701 . . . . 75.42 109.632 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.7 159.83 29.96 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.601 -0.889 . . . . 64.13 108.601 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -157.13 159.7 38.09 Favored 'General case' 0 C--O 1.242 0.71 0 N-CA-C 108.714 -0.846 . . . . 70.21 108.714 173.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.547 HD22 ' H ' ' C' ' 149' ' ' THR . 21.3 m-80 -55.99 115.44 2.41 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.913 0.885 . . . . 73.34 109.234 173.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 34.9 p -63.75 93.35 0.08 Allowed 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.164 0.915 . . . . 45.24 111.526 -176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -156.37 127.3 6.87 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.782 0.833 . . . . 74.31 109.117 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 53.8 ttp 59.55 113.96 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.203 1.401 . . . . 73.11 110.93 -171.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -121.12 89.02 3.05 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.538 -0.912 . . . . 64.44 108.538 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.593 ' HB3' ' HB3' ' H' ' 206' ' ' ASP . 2.3 t80 -102.51 127.97 49.34 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.062 -1.426 . . . . 71.55 108.732 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -141.3 131.09 24.26 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.25 -1.389 . . . . 73.35 107.25 167.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.676 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -68.61 117.93 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 N-CA-C 106.621 -1.622 . . . . 65.14 106.621 168.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.543 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.8 mm-40 -83.99 -50.6 7.86 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.149 -0.478 . . . . 65.33 110.007 -176.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -176.13 133.71 0.25 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.77 0.669 . . . . 64.52 110.37 -175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.676 HG13 HD11 ' C' ' 13' ' ' ILE . 96.2 mt -115.48 140.06 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.098 -1.075 . . . . 71.32 108.098 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.5 ' HB3' HG23 ' D' ' 122' ' ' THR . 30.5 p90 -177.91 147.32 0.46 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.703 0.401 . . . . 75.32 110.61 -173.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.495 HG21 ' SG ' ' C' ' 113' ' ' CYS . 77.3 p -72.89 121.67 20.39 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.388 -0.824 . . . . 73.53 109.896 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -76.18 -50.5 14.37 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.949 0.881 . . . . 71.34 108.667 172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -135.0 136.96 42.56 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 113.763 -1.562 . . . . 73.4 108.952 -172.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.8 mt -131.14 142.16 44.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 106.258 -1.756 . . . . 74.45 106.258 174.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 39.0 t -151.65 144.51 24.43 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.643 -0.503 . . . . 64.35 109.643 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -148.69 107.75 3.89 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.34 -1.356 . . . . 71.11 107.34 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.32 110.69 18.38 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.001 -0.74 . . . . 54.43 109.001 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.04 89.82 14.64 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.369 -0.974 . . . . 54.13 108.369 173.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.14 -39.67 22.73 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.554 2.169 . . . . 73.0 110.902 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -93.95 30.66 1.8 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 114.275 -1.33 . . . . 73.35 111.009 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.422 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -57.2 -48.26 97.68 Favored Pre-proline 0 CA--C 1.563 1.46 0 C-N-CA 123.388 0.675 . . . . 71.11 112.461 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.8 Cg_endo -88.42 -22.68 1.23 Allowed 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 122.034 1.823 . . . . 75.2 112.601 171.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -69.63 -25.48 63.95 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.573 1.149 . . . . 71.33 111.682 -175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.15 -13.65 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 123.729 0.811 . . . . 63.43 111.388 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -58.32 -40.55 82.39 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.213 0.605 . . . . 63.52 111.636 -177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -102.14 38.9 1.57 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.114 0.566 . . . . 75.43 110.426 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.479 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -126.65 162.27 26.14 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.563 0.745 . . . . 70.01 109.9 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.19 120.94 18.51 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.694 -0.854 . . . . 73.14 108.694 170.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.415 ' HD1' ' HB1' ' E' ' 194' ' ' ALA . 18.2 p90 -84.37 82.96 8.16 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.806 0.843 . . . . 60.41 110.943 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -139.67 70.48 37.59 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 108.854 -0.795 . . . . 75.05 108.854 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.419 ' HB2' HG13 ' C' ' 40' ' ' VAL . 3.2 Cg_exo -77.37 133.67 13.39 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.978 2.452 . . . . 75.45 112.231 -172.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -86.95 79.54 8.72 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.939 -1.504 . . . . 71.4 106.939 175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.619 HG11 ' HG2' ' C' ' 124' ' ' PRO . 13.8 m -76.02 70.0 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 114.16 -1.382 . . . . 71.3 111.441 -170.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -97.0 136.13 38.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.17 -0.923 . . . . 75.01 110.25 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.592 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -114.43 140.99 48.25 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.656 -0.868 . . . . 61.31 108.656 175.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -120.08 119.65 33.96 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.718 0.807 . . . . 55.02 109.207 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.706 ' HG ' HD21 ' C' ' 60' ' ' LEU . 7.7 tt -85.9 114.14 22.58 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.779 -0.822 . . . . 63.32 108.779 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.456 ' O ' HD23 ' C' ' 60' ' ' LEU . 21.1 t70 -126.65 138.93 53.49 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 108.251 -1.018 . . . . 73.24 108.251 175.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -111.93 143.69 42.48 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.351 0.596 . . . . 72.41 110.541 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.94 150.38 50.38 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.542 1.137 . . . . 53.42 108.743 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -149.24 151.87 34.98 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 122.858 0.463 . . . . 64.53 110.048 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.1 t -160.58 140.42 11.09 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.376 -0.972 . . . . 65.22 108.376 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -86.96 137.55 32.26 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.916 0.388 . . . . 62.21 110.191 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.667 HD11 HD12 ' C' ' 83' ' ' ILE . 76.9 mt -101.38 -58.56 1.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.99 0.916 . . . . 73.51 109.348 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.74 -174.25 3.78 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 114.816 -1.084 . . . . 74.32 110.075 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -69.06 126.25 29.22 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 114.846 -1.07 . . . . 75.01 109.209 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.582 ' HA ' HD23 ' E' ' 173' ' ' LEU . 15.1 m-20 64.15 14.64 8.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.713 1.205 . . . . 75.54 111.898 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -128.77 104.48 11.47 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 C-N-CA 124.447 1.099 . . . . 71.44 108.9 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.57 165.72 10.86 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.011 0.91 . . . . 73.25 110.203 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -126.02 119.22 27.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.844 -1.525 . . . . 75.14 107.416 174.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.02 120.03 57.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.881 -1.155 . . . . 63.42 107.881 172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.404 HG22 ' HA2' ' C' ' 81' ' ' GLY . 90.0 t -106.65 113.49 43.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 108.297 -1.001 . . . . 53.14 108.297 174.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.706 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.4 OUTLIER -84.29 102.79 12.94 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.337 -1.357 . . . . 74.25 107.337 176.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 3.1 tmm_? -84.31 104.53 14.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.337 -0.986 . . . . 74.31 108.337 176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.475 ' HB ' HD11 ' C' ' 114' ' ' ILE . 11.0 t -101.09 130.07 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 108.257 -1.016 . . . . 63.51 108.257 174.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 39.5 m -120.39 126.47 50.56 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.695 -0.854 . . . . 53.31 108.695 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.741 HG21 HG21 ' C' ' 114' ' ' ILE . 40.1 t -99.79 124.28 53.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.333 1.053 . . . . 72.34 109.868 177.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.5 m -100.51 143.97 30.06 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.483 -1.303 . . . . 71.5 107.483 167.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.55 120.93 18.08 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.469 -1.308 . . . . 74.42 107.469 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.7 m -128.47 156.63 42.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.714 0.769 . . . . 44.43 110.627 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' C' ' 34' ' ' LYS . 22.8 mt -116.94 34.18 5.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.206 -1.405 . . . . 71.22 107.206 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 114.38 -82.94 0.32 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.924 -1.271 . . . . 70.52 109.924 -169.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -124.65 -24.77 4.11 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.873 0.869 . . . . 72.24 109.989 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 7.8 tp10 -67.65 120.5 14.13 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.93 0.892 . . . . 71.11 110.103 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.1 m -74.38 123.17 24.15 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.711 -0.478 . . . . 45.43 109.711 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.29 -49.54 22.63 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.502 0.721 . . . . 62.24 109.229 175.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -166.85 173.37 9.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.891 -1.05 . . . . 72.43 110.183 172.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.432 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -130.24 143.11 50.58 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 106.595 -1.631 . . . . 64.24 106.595 170.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.496 ' HB3' ' HB ' ' C' ' 64' ' ' VAL . 43.0 t -144.32 155.28 43.75 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.552 -0.907 . . . . 63.13 108.552 -177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -157.41 129.87 7.37 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.86 0.464 . . . . 74.24 110.165 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.2 t -125.53 115.66 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 169.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 62.8 mt-30 -88.6 91.17 8.7 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.614 -1.254 . . . . 41.31 107.614 171.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -78.07 107.04 10.35 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.546 -0.752 . . . . 62.03 109.725 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -82.04 152.44 31.35 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.874 -0.491 . . . . 42.22 111.874 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.17 118.01 0.81 Allowed Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.601 -0.999 . . . . 72.31 110.601 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.667 HD12 HD11 ' C' ' 51' ' ' LEU . 10.0 mm -84.55 128.91 38.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 108.462 -0.94 . . . . 54.41 108.462 174.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -137.13 128.49 28.18 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 109.443 -0.577 . . . . 70.22 109.443 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 45.3 p -79.38 119.24 22.12 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.573 -0.899 . . . . 71.23 108.573 171.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 8.0 tt -131.66 120.28 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.718 0.807 . . . . 73.11 109.761 -176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.521 ' HB1' ' H ' ' E' ' 172' ' ' ALA . . . -167.32 157.57 11.07 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.004 0.922 . . . . 74.31 110.711 -176.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . 0.557 ' H ' ' HB3' ' E' ' 172' ' ' ALA . . . 104.96 -18.7 42.57 Favored Glycine 0 N--CA 1.479 1.544 0 O-C-N 123.129 0.268 . . . . 52.43 113.709 172.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.594 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -128.86 178.56 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 124.486 1.114 . . . . 74.55 110.625 -175.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -153.55 -172.97 4.4 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.465 -0.789 . . . . 74.33 109.775 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.86 -120.41 9.02 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 115.89 1.116 . . . . 63.13 115.89 168.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 78.7 p -74.3 -30.61 62.16 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.207 1.003 . . . . 71.44 111.459 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.423 ' HG2' ' HB3' ' C' ' 145' ' ' ALA . 1.4 mp0 -68.01 -43.25 79.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.88 -0.6 . . . . 63.42 109.818 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.523 ' HA ' ' HB3' ' C' ' 97' ' ' CYS . 11.2 ptm -78.3 -28.11 47.43 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.173 -0.467 . . . . 74.45 110.979 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.34 73.5 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.202 0.525 . . . . 72.24 110.407 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -77.79 -30.78 51.52 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.426 -0.807 . . . . 75.32 110.681 172.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.523 ' HB3' ' HA ' ' C' ' 94' ' ' MET . 48.7 t -81.53 -21.84 38.3 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.817 1.247 . . . . 73.33 113.521 -169.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.585 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.0 OUTLIER -139.04 -23.73 0.91 Allowed 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 119.064 0.847 . . . . 64.42 111.997 172.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.51 -30.64 53.05 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 120.141 -0.255 . . . . 73.32 112.897 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -118.16 -42.11 2.82 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.017 0.527 . . . . 75.32 110.815 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.524 ' CE1' HG13 ' C' ' 105' ' ' ILE . 10.6 t80 -50.8 -71.34 0.07 Allowed 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.927 0.891 . . . . 75.45 110.87 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 60.3 m -55.34 -45.81 99.8 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 113.558 -1.656 . . . . 74.3 113.71 -168.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.469 ' HB3' HD21 ' C' ' 44' ' ' LEU . 74.2 Cg_exo -55.78 -45.94 35.27 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.446 1.431 . . . . 73.14 113.313 168.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.444 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 81.1 m-20 -66.81 -25.56 66.51 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 123.519 0.728 . . . . 53.55 112.649 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.524 HG13 ' CE1' ' C' ' 101' ' ' TYR . 29.3 mm -85.55 -43.29 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.621 0.768 . . . . 74.51 110.611 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.22 -14.32 57.62 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.935 -0.575 . . . . 55.21 111.032 -176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.446 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 91.8 t80 -56.53 -54.35 54.39 Favored Pre-proline 0 CA--C 1.552 1.045 0 CA-C-O 117.705 -1.14 . . . . 71.44 111.761 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' C' ' 105' ' ' ILE . 32.5 Cg_exo -56.37 -40.33 85.36 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 122.338 2.025 . . . . 55.13 113.054 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.506 ' HE2' HG21 ' A' ' 115' ' ' THR . 84.2 m-85 -63.55 -52.35 61.48 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.045 0.938 . . . . 74.5 111.944 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.63 96.51 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.344 0.658 . . . . 64.22 110.34 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -54.47 -47.85 72.48 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 125.973 1.709 . . . . 71.42 111.403 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.432 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -76.93 -37.58 55.06 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.964 0.505 . . . . 72.11 110.604 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.495 ' SG ' HG21 ' C' ' 18' ' ' THR . 25.6 t -65.85 -32.58 74.18 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.042 0.537 . . . . 72.43 111.494 -177.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.741 HG21 HG21 ' C' ' 64' ' ' VAL . 96.6 mt -72.31 -51.07 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 115.716 -0.675 . . . . 54.45 109.545 172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 16.3 m -51.12 -34.75 32.13 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.614 0.766 . . . . 72.54 111.562 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 46.9 t -59.4 -61.25 2.76 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 114.714 -1.13 . . . . 75.34 109.489 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.506 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -50.28 -45.24 54.27 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 125.514 1.526 . . . . 74.34 113.148 179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.0 t -64.43 -46.71 92.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.248 1.019 . . . . 53.23 110.43 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.2 t -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.988 -1.005 . . . . 62.1 111.43 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -69.1 -37.26 78.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.205 0.602 . . . . 72.13 109.861 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.69 6.7 72.57 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.884 0.74 . . . . 71.31 112.835 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.0 p 65.0 37.89 6.58 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.993 1.717 . . . . 60.43 111.982 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.578 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 60.0 m-85 -107.35 172.65 3.63 Favored Pre-proline 0 CA--C 1.572 1.821 0 C-N-CA 124.897 1.279 . . . . 54.31 109.803 179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.619 ' HG2' HG11 ' C' ' 40' ' ' VAL . 73.8 Cg_endo -70.77 179.64 4.09 Favored 'Trans proline' 0 C--N 1.403 3.429 0 C-N-CA 122.49 2.126 . . . . 60.32 114.368 -171.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.41 ' HB2' ' CE1' ' F' ' 202' ' ' TYR . 28.2 mm-40 -60.37 125.73 24.78 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.609 -0.723 . . . . 74.14 112.025 175.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.41 2.61 36.84 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.408 0.683 . . . . 62.24 110.346 170.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 43.2 t-20 -88.46 82.8 6.89 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 106.719 -1.586 . . . . 72.34 106.719 176.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 73.1 mt -89.86 158.27 17.53 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 112.555 -2.111 . . . . 71.14 110.33 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.597 ' HB2' ' HA ' ' F' ' 204' ' ' ILE . . . -34.62 130.89 0.45 Allowed Pre-proline 0 CA--C 1.555 1.157 0 C-N-CA 125.854 1.661 . . . . 61.14 114.583 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.571 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 74.1 Cg_endo -71.77 109.01 2.55 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.164 2.576 . . . . 73.14 112.664 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -88.88 104.73 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.32 109.123 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -96.64 103.4 15.31 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.41 0.684 . . . . 63.42 109.902 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -79.39 -23.03 43.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.614 0.366 . . . . 63.32 111.349 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.444 ' HB2' ' ND2' ' C' ' 104' ' ' ASN . 3.9 t70 -60.78 -30.14 69.85 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.149 0.499 . . . . 75.44 110.779 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.12 -42.14 96.96 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.139 -0.937 . . . . 75.14 111.563 173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.582 HD11 HG21 ' F' ' 207' ' ' VAL . 74.7 mt -74.58 -34.05 62.79 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.66 0.784 . . . . 75.41 111.139 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -53.13 -32.63 48.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.23 1.012 . . . . 73.41 111.98 -174.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.5 mtm -57.67 -45.08 86.04 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.972 0.909 . . . . 72.33 112.105 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -72.52 -37.7 68.27 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 110.448 -0.205 . . . . 72.21 110.448 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -68.01 -84.78 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.469 0.708 . . . . 75.24 111.597 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 37.8 tp -106.95 120.72 42.81 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.274 -0.639 . . . . 40.21 109.274 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.48 HE22 ' HB2' ' A' ' 147' ' ' GLU . 96.4 mt-30 -82.16 156.9 24.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.29 0.636 . . . . 64.41 111.465 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -117.09 136.26 53.13 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.314 1.045 . . . . 74.14 109.348 -175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.603 ' HA ' HE22 ' A' ' 143' ' ' GLN . 55.0 mt-30 -103.76 -165.09 1.12 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.174 0.59 . . . . 70.43 109.673 170.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.423 ' HB3' ' HG2' ' C' ' 93' ' ' GLN . . . 63.25 -161.97 0.29 Allowed 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.762 0.825 . . . . 60.5 111.782 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.5 30.6 Favored Glycine 0 C--N 1.348 1.221 0 C-N-CA 122.852 0.263 . . . . 75.54 112.837 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -64.09 98.71 0.23 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 74.44 109.509 173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' C' ' 6' ' ' ASN . . . -166.72 124.8 1.26 Allowed Glycine 0 C--O 1.223 -0.562 0 N-CA-C 110.527 -1.029 . . . . 63.11 110.527 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.547 ' H ' HD22 ' C' ' 6' ' ' ASN . 4.1 t -167.66 92.76 0.38 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.48 0.712 . . . . 73.01 109.178 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -147.23 163.37 36.59 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.253 1.021 . . . . 72.41 110.752 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -167.05 121.91 1.06 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 114.959 -1.019 . . . . 64.22 110.0 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 -159.74 26.31 0.18 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.39 1.076 . . . . 73.32 109.689 171.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -47.85 116.84 1.62 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.222 1.409 . . . . 75.45 112.453 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.52 -69.27 0.41 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.213 1.005 . . . . 64.1 108.894 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.351 0 N-CA-C 107.227 -1.397 . . . . 42.44 107.227 -179.207 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.409 ' HA ' ' OE1' ' D' ' 12' ' ' GLN . 27.8 ttt . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 109.807 -0.442 . . . . 62.22 109.807 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 83.1 p -157.66 149.3 21.9 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.81 0.844 . . . . 60.44 109.879 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -32.53 25.15 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.15 0.58 . . . . 64.33 109.981 168.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 63.14 -78.38 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.851 1.661 . . . . 71.21 110.688 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -174.7 179.18 1.75 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.317 0.647 . . . . 72.22 111.04 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.493 HD21 ' HA ' ' H' ' 172' ' ' ALA . 35.4 m-80 -82.57 67.55 8.66 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.776 0.831 . . . . 75.01 109.435 174.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 96.4 m -149.82 -72.29 0.18 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.145 -1.057 . . . . 64.22 108.145 175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -90.3 78.62 6.46 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.157 -1.053 . . . . 55.21 108.157 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.469 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 3.2 ptm -34.34 132.24 0.29 Allowed 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.457 -1.247 . . . . 74.55 112.436 170.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -122.36 141.04 51.99 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.273 -0.64 . . . . 74.32 109.273 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -149.02 100.13 3.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.029 -1.471 . . . . 65.14 107.029 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' D' ' 1' ' ' MET . 1.1 mt-30 -121.58 150.97 40.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.356 -0.979 . . . . 75.43 108.356 -173.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.1 tp -102.81 137.16 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 109.156 -0.683 . . . . 64.53 109.156 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -99.3 -45.47 5.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.549 0.74 . . . . 74.35 109.507 174.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.436 ' HD3' HD12 ' D' ' 83' ' ' ILE . 4.8 ptm180 -168.43 147.26 4.35 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.942 0.497 . . . . 73.12 111.104 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.476 HD12 HD23 ' D' ' 106' ' ' LEU . 48.0 mm -115.81 122.76 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 105.958 -1.867 . . . . 72.53 105.958 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 0.3 OUTLIER -155.69 156.27 34.63 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.098 0.951 . . . . 74.51 111.027 -169.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.403 HG21 HD11 ' D' ' 21' ' ' ILE . 73.3 p -91.86 116.99 29.37 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.945 -1.48 . . . . 72.23 109.152 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -85.84 -29.52 23.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.493 -0.776 . . . . 75.33 109.419 175.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.649 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 18.3 t70 -149.76 135.96 18.92 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.803 -1.09 . . . . 75.31 109.574 -177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.506 HD13 ' HE3' ' C' ' 117' ' ' MET . 60.6 mt -139.37 143.32 31.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.853 -1.165 . . . . 74.32 107.853 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -144.75 144.6 31.27 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.071 0.948 . . . . 52.21 108.861 169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.634 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.4 t80 -145.6 129.63 17.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.53 -2.026 . . . . 73.0 105.53 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.3 mt-10 -133.07 136.03 45.68 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.498 -0.927 . . . . 73.43 108.498 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -131.0 75.27 78.81 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.032 -1.099 . . . . 62.3 108.032 174.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -71.0 -28.89 18.72 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.776 2.317 . . . . 74.23 112.571 -171.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 -114.37 32.76 5.72 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 123.726 0.811 . . . . 73.1 108.959 -178.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -57.65 -58.31 19.23 Favored Pre-proline 0 N--CA 1.483 1.203 0 N-CA-C 114.543 1.312 . . . . 62.44 114.543 -170.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.12 -4.08 13.59 Favored 'Trans proline' 0 C--N 1.381 2.256 0 CA-C-N 121.918 1.721 . . . . 74.14 112.637 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -84.25 -32.36 24.49 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.415 1.486 . . . . 43.32 109.107 172.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.411 HG13 ' CD1' ' D' ' 68' ' ' LEU . 2.1 t -65.57 -27.66 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 125.227 1.411 . . . . 63.41 111.952 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 10.4 m-30 -62.43 -14.71 43.61 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 112.717 0.636 . . . . 74.34 112.717 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -81.21 -29.76 34.45 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.908 0.883 . . . . 72.43 110.932 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -84.26 104.28 14.16 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.715 1.206 . . . . 60.4 109.904 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -102.34 75.33 1.47 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.11 0.564 . . . . 74.35 111.763 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.41 ' HZ2' ' H ' ' D' ' 69' ' ' GLY . 1.6 p-90 -170.05 179.69 3.47 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.006 0.923 . . . . 73.15 109.924 171.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.626 HE21 ' HD2' ' D' ' 38' ' ' PRO . 37.8 tp60 -78.38 123.83 85.68 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.774 0.829 . . . . 72.35 108.787 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.626 ' HD2' HE21 ' D' ' 37' ' ' GLN . 39.7 Cg_exo -56.28 142.13 88.01 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.815 2.343 . . . . 72.22 115.006 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -62.16 112.24 2.3 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.652 -0.87 . . . . 74.34 108.652 167.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 22.5 m -103.33 117.29 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 121.579 0.704 . . . . 64.45 109.983 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -108.41 116.81 32.66 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.118 0.967 . . . . 74.41 108.756 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' D' ' 63' ' ' THR . 6.6 mp -104.64 135.72 45.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 123.283 0.364 . . . . 70.22 110.361 176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -109.48 135.28 50.74 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.411 -0.813 . . . . 71.12 108.87 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.563 HD13 ' H ' ' H' ' 184' ' ' TRP . 5.3 tt -96.55 127.15 42.27 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.893 -1.151 . . . . 60.33 107.893 175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.2 t70 -150.05 155.73 40.41 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.432 -0.951 . . . . 63.02 108.432 172.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.4 t -139.6 160.92 38.77 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-O 121.347 0.594 . . . . 65.0 110.167 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.417 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -148.69 176.74 10.1 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.019 1.328 . . . . 74.3 107.79 179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.461 ' HB2' ' CE1' ' D' ' 56' ' ' TYR . 78.2 p -172.98 165.94 5.05 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.526 0.565 . . . . 74.13 112.526 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 4.4 m -152.11 140.72 20.77 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.017 0.927 . . . . 75.43 109.484 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -83.53 118.24 23.65 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.315 -0.995 . . . . 61.41 108.315 166.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' D' ' 57' ' ' GLU . 22.0 mt -99.79 -29.3 12.7 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.906 0.482 . . . . 64.0 110.177 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -165.13 -172.75 2.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.589 0.756 . . . . 54.32 111.029 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -71.41 120.24 16.71 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.979 -1.009 . . . . 64.1 109.082 177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 62.28 18.08 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.47 1.108 . . . . 71.45 111.276 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 74.0 t -121.22 121.65 65.4 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 107.009 -1.478 . . . . 75.35 107.009 174.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' D' ' 48' ' ' SER . 12.4 t80 -144.64 128.27 17.13 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.909 -0.775 . . . . 73.5 108.909 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.481 ' HB2' HD11 ' D' ' 51' ' ' LEU . 21.4 tt0 -88.11 131.27 34.76 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.625 -0.88 . . . . 63.32 108.625 175.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.6 t -115.06 123.61 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.096 -1.446 . . . . 75.23 107.096 169.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.612 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 27.1 t -100.67 139.61 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 123.622 0.769 . . . . 73.14 109.178 176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.543 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -111.98 126.54 55.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.976 -1.12 . . . . 71.52 107.976 175.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.5 ttm-85 -102.92 101.62 11.65 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 108.715 -0.846 . . . . 70.14 108.715 174.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.9 t -102.91 121.85 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.706 -0.85 . . . . 34.41 108.706 174.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' D' ' 42' ' ' LEU . 23.7 m -125.7 130.92 52.51 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 123.397 0.679 . . . . 73.45 109.636 -171.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.489 HG21 HG21 ' D' ' 114' ' ' ILE . 32.1 t -120.8 103.66 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.677 1.191 . . . . 53.12 109.324 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 41.1 m -100.54 96.52 7.43 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.375 -0.972 . . . . 71.44 108.375 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.38 143.11 27.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.46 -0.791 . . . . 71.2 109.328 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 32.6 p -151.46 130.47 12.59 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 123.403 0.439 . . . . 44.54 111.867 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.411 ' CD1' HG13 ' D' ' 31' ' ' VAL . 21.3 mt -107.06 108.6 20.17 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.037 0.935 . . . . 61.42 110.283 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . 0.41 ' H ' ' HZ2' ' D' ' 36' ' ' TRP . . . 78.12 -115.15 4.14 Favored Glycine 0 C--N 1.343 0.971 0 N-CA-C 111.562 -0.615 . . . . 74.21 111.562 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.29 4.51 15.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.909 0.884 . . . . 64.32 110.598 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -116.14 161.89 18.26 Favored 'General case' 0 C--O 1.245 0.851 0 N-CA-C 109.786 -0.45 . . . . 54.05 109.786 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 35.5 m -71.54 133.86 46.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.537 -0.756 . . . . 63.33 110.572 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -85.88 -64.91 1.07 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.441 -0.948 . . . . 45.13 108.441 173.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -156.15 147.7 22.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.4 -0.818 . . . . 75.41 109.971 171.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.1 mt -100.39 153.94 18.92 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.853 0.861 . . . . 73.33 108.952 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' D' ' 114' ' ' ILE . 44.6 t -159.31 143.72 15.29 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.284 0.633 . . . . 73.13 109.651 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -156.39 128.54 7.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.108 0.563 . . . . 65.14 109.845 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.455 HG22 HG23 ' D' ' 21' ' ' ILE . 88.0 t -127.46 114.66 37.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 123.98 0.912 . . . . 73.33 109.017 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.649 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.6 mt-30 -89.54 86.36 6.73 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.838 0.828 . . . . 70.35 108.879 170.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.433 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.8 tp-100 -79.73 98.9 7.19 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 113.969 -1.468 . . . . 72.42 108.66 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.5 154.91 23.71 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.822 -0.511 . . . . 73.13 111.822 178.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -149.18 131.16 3.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.695 -0.962 . . . . 54.15 110.695 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' D' ' 15' ' ' ARG . 59.3 mt -94.97 109.02 21.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 109.398 -0.594 . . . . 73.55 109.398 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -110.53 126.64 54.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.484 0.714 . . . . 72.2 110.385 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 43.2 m -79.56 97.19 6.37 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 108.735 -0.839 . . . . 75.24 108.735 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.68 130.24 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.224 0.61 . . . . 72.13 110.803 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.76 153.63 14.93 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.779 0.832 . . . . 65.52 109.945 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 84.96 5.39 86.19 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.393 -0.367 . . . . 74.02 113.302 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -119.32 126.33 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.898 0.879 . . . . 70.42 109.465 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.51 174.38 10.68 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 122.046 -0.409 . . . . 73.15 111.215 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -139.79 39.53 Favored Glycine 0 C--N 1.351 1.389 0 O-C-N 123.934 0.772 . . . . 71.23 113.358 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.9 p -69.27 -32.33 71.45 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.641 0.776 . . . . 52.42 111.464 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -61.22 -40.99 96.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.564 0.745 . . . . 71.23 110.619 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.406 ' HG3' HD21 ' H' ' 173' ' ' LEU . 1.2 tmt? -68.6 -55.86 10.18 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 74.53 110.754 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.64 69.52 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.453 0.701 . . . . 53.14 112.089 -175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -85.59 -35.36 21.07 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.466 0.707 . . . . 73.43 110.655 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -66.29 -41.83 89.22 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 120.662 0.268 . . . . 75.05 110.29 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 tt -78.06 -35.18 49.89 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.207 0.603 . . . . 74.43 110.065 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.42 -3.32 81.7 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.353 -0.693 . . . . 50.31 114.448 -176.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.453 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -142.93 -57.28 0.43 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 117.974 0.887 . . . . 73.05 111.818 -176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -72.37 -41.77 66.0 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 112.288 0.477 . . . . 71.44 112.288 -170.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 69.8 m -66.76 -44.97 55.11 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 123.109 0.564 . . . . 51.2 111.088 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.543 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.9 Cg_exo -55.73 -35.55 93.5 Favored 'Trans proline' 0 C--N 1.393 2.9 0 C-N-CA 122.491 2.127 . . . . 55.12 113.402 165.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.48 -29.96 70.2 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.911 0.484 . . . . 54.41 111.161 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mm -68.35 -38.49 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.087 0.555 . . . . 64.32 109.619 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.476 HD23 HD12 ' D' ' 16' ' ' ILE . 94.3 mt -79.14 -22.9 44.44 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.311 1.045 . . . . 62.15 112.589 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -66.21 -40.8 38.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.161 1.171 . . . . 75.4 114.161 -170.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -55.74 -39.23 92.36 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 122.054 1.836 . . . . 50.32 113.296 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -79.44 -33.17 42.72 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.895 0.878 . . . . 74.13 110.799 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.92 -49.85 68.78 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.562 0.745 . . . . 72.25 109.899 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.427 ' NH2' HG23 ' B' ' 105' ' ' ILE . 27.6 ttp180 -52.39 -54.27 34.07 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.226 -1.352 . . . . 74.2 110.553 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.403 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.9 tm-20 -60.34 -45.45 93.4 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 124.472 1.107 . . . . 75.33 111.687 -175.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.439 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 42.7 t -54.82 -44.74 74.13 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 124.016 0.822 . . . . 73.33 110.961 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.489 HG21 HG21 ' D' ' 64' ' ' VAL . 77.0 mt -66.33 -53.03 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 115.203 -0.908 . . . . 50.13 110.885 176.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 54.0 m -53.85 -41.5 67.51 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.67 1.188 . . . . 65.41 111.567 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -67.57 -44.7 77.59 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 114.712 -1.131 . . . . 73.12 110.08 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.5 mtm -66.58 -32.58 74.0 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 122.977 0.511 . . . . 73.43 111.808 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.487 HG23 ' O ' ' D' ' 114' ' ' ILE . 92.4 t -64.14 -46.51 93.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.298 0.639 . . . . 52.43 109.474 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.8 p -73.61 -27.78 61.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.704 -0.68 . . . . 62.44 111.35 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -72.24 -28.79 63.38 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.542 0.737 . . . . 74.04 110.118 174.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.04 10.06 70.0 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 123.83 0.706 . . . . 74.43 112.302 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.5 HG23 ' HB3' ' C' ' 17' ' ' TYR . 71.7 p 58.46 18.87 5.99 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 126.624 1.97 . . . . 71.04 113.691 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -86.58 152.07 54.0 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.889 -0.782 . . . . 54.14 108.889 174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.05 133.02 55.15 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.732 2.288 . . . . 72.01 112.667 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -49.82 139.15 13.73 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.611 1.195 . . . . 65.42 112.376 -176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -120.35 102.4 8.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.756 0.822 . . . . 62.54 108.904 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -99.21 100.83 11.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.777 -0.823 . . . . 73.23 108.777 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 55.4 mt -72.02 136.0 46.55 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 123.616 0.572 . . . . 75.13 110.137 -177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.82 124.01 81.79 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.262 0.625 . . . . 64.24 110.998 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -68.39 96.79 0.49 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.407 2.071 . . . . 51.02 110.259 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 23.5 m -108.15 124.83 64.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 121.279 0.561 . . . . 71.42 110.153 -174.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -79.8 113.7 18.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.375 -0.972 . . . . 73.21 108.375 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.453 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 91.8 m-85 -68.78 -15.77 63.6 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.167 0.587 . . . . 53.54 112.062 -175.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.98 -41.88 90.56 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.55 0.74 . . . . 64.24 110.584 169.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.02 -53.45 49.74 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.635 -0.711 . . . . 73.13 109.174 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 mp -57.3 -28.23 62.86 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.013 0.925 . . . . 71.12 112.116 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.562 ' HA ' ' HE1' ' H' ' 184' ' ' TRP . 66.5 t80 -62.55 -48.45 79.43 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.088 0.955 . . . . 64.22 110.643 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 71.6 mtm -74.22 -34.19 63.61 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.765 0.826 . . . . 74.43 111.066 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.52 HD22 ' NE2' ' D' ' 142' ' ' GLN . 16.5 m120 -78.67 -9.69 59.48 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.924 0.89 . . . . 73.53 111.75 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -69.36 -31.09 69.28 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.045 0.538 . . . . 64.5 110.501 171.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.46 -31.89 72.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.33 0.652 . . . . 71.2 111.297 -176.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.52 ' NE2' HD22 ' D' ' 139' ' ' ASN . 13.8 pt20 -90.99 25.28 2.48 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.448 0.699 . . . . 55.44 111.809 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -116.07 63.77 0.7 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 122.164 0.983 . . . . 75.44 108.804 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -140.66 77.63 1.61 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.818 -1.549 . . . . 72.42 106.818 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.28 93.5 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.531 -0.759 . . . . 60.24 109.907 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.25 -36.84 0.75 Allowed Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.574 -0.739 . . . . 33.23 112.108 -176.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' D' ' 148' ' ' GLY . 15.1 tt0 -163.98 -172.04 2.67 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 122.907 0.483 . . . . 75.42 110.24 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . 0.441 ' H ' ' HG2' ' D' ' 147' ' ' GLU . . . -74.31 -92.58 0.14 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 114.263 0.465 . . . . 65.43 114.263 -173.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.4 t -91.55 163.2 14.22 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.317 0.647 . . . . 74.02 111.324 -173.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.06 123.93 48.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.496 0.718 . . . . 73.12 109.575 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -161.98 13.98 0.08 Allowed 'General case' 0 CA--C 1.551 0.991 0 O-C-N 124.032 0.832 . . . . 62.43 109.643 176.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 40.5 m170 67.94 132.0 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.574 1.549 . . . . 72.41 111.408 -174.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.486 ' H ' HE21 ' D' ' 153' ' ' GLN . 0.0 OUTLIER -56.84 107.67 0.42 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.685 1.194 . . . . 63.55 110.887 -178.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -75.21 82.83 2.37 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.743 0.782 . . . . 74.22 109.934 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.394 0 CA-C-N 114.78 -1.1 . . . . 54.32 108.322 -178.725 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.607 0.241 . . . . 73.22 110.413 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -86.0 -178.46 49.98 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.687 -0.688 . . . . 75.53 112.424 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -139.16 80.53 1.79 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.525 -1.287 . . . . 65.13 107.525 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 23.3 p -66.02 115.28 5.9 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.126 -0.943 . . . . 74.33 110.725 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . 0.557 ' HB3' ' H ' ' C' ' 88' ' ' GLY . . . -164.64 85.62 0.43 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.521 1.128 . . . . 54.21 108.176 -175.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.582 HD23 ' HA ' ' C' ' 54' ' ' ASP . 1.8 tm? -88.54 140.03 29.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.205 -1.035 . . . . 52.14 108.205 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' E' ' 174' ' ' MET . 0.0 OUTLIER -146.66 -52.41 0.22 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.984 0.914 . . . . 74.24 109.986 -170.381 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 52.4 t80 43.58 78.81 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.755 1.622 . . . . 74.33 113.234 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -91.7 85.43 5.65 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 108.439 -0.948 . . . . 71.42 108.439 172.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 3.5 tt -158.92 81.56 0.79 Allowed 'General case' 0 C--O 1.239 0.528 0 N-CA-C 106.312 -1.736 . . . . 72.31 106.312 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.85 -36.21 31.77 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.231 -1.349 . . . . 75.32 109.524 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -154.73 156.67 31.68 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.082 0.953 . . . . 72.24 109.443 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -63.04 97.12 0.18 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.041 1.827 . . . . 73.4 110.965 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -64.85 -28.22 69.4 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.526 0.73 . . . . 71.52 110.428 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -153.29 156.05 37.67 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.67 1.188 . . . . 74.22 108.875 176.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 40.7 m -147.55 147.23 29.89 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.497 -0.927 . . . . 64.25 108.497 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.504 ' HE1' HD13 ' C' ' 44' ' ' LEU . 45.1 p90 -93.97 155.28 40.37 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.52 0.728 . . . . 73.2 111.957 -175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -72.62 160.09 47.28 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.922 2.415 . . . . 75.41 111.562 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.7 -167.75 1.54 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.448 0.699 . . . . 64.14 110.715 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 13.5 tt -72.77 -26.19 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.935 0.494 . . . . 75.24 111.617 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . 59.21 78.46 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.296 1.038 . . . . 63.54 110.793 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.35 152.79 26.08 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.837 -0.62 . . . . 75.43 111.501 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -131.25 163.79 27.01 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.732 0.813 . . . . 73.02 109.585 -174.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -73.62 -100.21 0.08 OUTLIER Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.023 -1.231 . . . . 51.21 110.023 170.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 72.82 -71.96 1.09 Allowed Glycine 0 C--N 1.343 0.932 0 O-C-N 123.843 0.379 . . . . 32.04 114.046 171.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.64 163.47 14.53 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.519 0.728 . . . . 64.13 111.528 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . 0.415 ' HB1' ' HD1' ' C' ' 36' ' ' TRP . . . -101.53 -158.61 0.68 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.265 1.026 . . . . 70.11 110.103 177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . 0.413 ' CE2' ' HB2' ' E' ' 197' ' ' TYR . 6.2 p90 -154.92 -162.76 1.43 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.255 0.622 . . . . 74.35 110.626 175.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . 0.451 ' HE2' ' HE2' ' F' ' 202' ' ' TYR . 3.4 mptp? -81.1 15.58 1.83 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.596 0.758 . . . . 74.32 112.582 -169.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . 0.413 ' HB2' ' CE2' ' E' ' 195' ' ' PHE . 0.2 OUTLIER -96.1 100.44 12.09 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.611 0.641 . . . . 74.02 109.557 172.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . 0.722 ' HB3' ' HD3' ' E' ' 201' ' ' LYS . 3.1 tm-20 -168.24 148.73 4.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 105.387 -2.079 . . . . 70.12 105.387 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -60.58 -29.76 69.39 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.532 0.733 . . . . 63.24 112.657 -169.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -76.57 -16.29 80.86 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 122.96 0.314 . . . . 61.45 113.632 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.722 ' HD3' ' HB3' ' E' ' 198' ' ' GLU . 12.7 mptt -89.85 143.88 26.42 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.29 1.036 . . . . 60.32 109.864 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 54.14 36.74 25.57 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.388 1.075 . . . . 73.04 112.727 174.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -58.95 128.4 37.05 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.766 0.826 . . . . 74.24 112.229 -175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 13.1 pt -131.99 37.83 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.362 1.065 . . . . 70.54 109.896 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -63.32 -13.0 33.96 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.788 -0.642 . . . . 51.42 112.328 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -53.16 -54.96 28.14 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.514 1.126 . . . . 63.14 110.91 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.466 HG22 HD13 ' B' ' 136' ' ' LEU . 37.3 t . . . . . 0 C--O 1.252 1.194 0 C-N-CA 123.795 0.838 . . . . 63.13 109.643 -176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 63.8 mttp . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 120.656 0.265 . . . . 74.21 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 74.7 61.21 3.18 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.533 -0.758 . . . . 73.04 111.643 -175.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -152.31 140.65 20.52 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.888 0.475 . . . . 74.14 110.401 -176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 56.5 m 61.97 83.51 0.15 Allowed 'General case' 0 C--N 1.35 0.618 0 C-N-CA 124.887 1.275 . . . . 70.22 111.509 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' B' ' 94' ' ' MET . . . -66.2 -48.4 70.75 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.415 -0.811 . . . . 53.12 110.673 177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' B' ' 2' ' ' SER . 63.0 mt -56.29 111.07 0.87 Allowed 'General case' 0 C--N 1.356 0.871 0 O-C-N 124.257 0.973 . . . . 71.33 110.133 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 32.1 mmt 77.33 98.65 0.07 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 126.125 1.77 . . . . 71.34 110.993 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 68.37 80.95 0.19 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.107 1.363 . . . . 73.52 112.028 173.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' B' ' 95' ' ' ALA . 3.1 p-10 -86.91 9.58 18.89 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.054 0.941 . . . . 64.34 111.823 177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 6.7 mp -70.58 80.43 0.58 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.327 0.651 . . . . 75.31 109.425 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 177.88 -43.54 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.148 1.379 . . . . 71.34 107.659 -167.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -56.77 138.68 77.7 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.856 -1.066 . . . . 71.53 111.268 173.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.2 113.03 3.15 Favored 'Trans proline' 0 C--N 1.376 2.016 0 C-N-CA 122.338 2.025 . . . . 74.55 111.305 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -130.01 112.52 13.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.199 0.6 . . . . 74.25 109.881 -175.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -66.9 138.2 57.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.456 0.702 . . . . 75.52 110.48 175.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 7.5 m -94.51 155.74 16.78 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.517 0.727 . . . . 72.13 110.537 -173.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.509 ' HB2' ' HG ' ' F' ' 186' ' ' LEU . 28.2 p90 -74.66 127.08 87.85 Favored Pre-proline 0 CA--C 1.559 1.321 0 C-N-CA 124.613 1.165 . . . . 75.42 111.304 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -99.73 24.47 0.19 Allowed 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.672 2.914 . . . . 75.23 112.969 175.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' F' ' 184' ' ' TRP . 0.8 OUTLIER -90.13 170.72 10.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.59 0.756 . . . . 54.45 112.331 -175.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.509 HG13 HD13 ' F' ' 186' ' ' LEU . 57.7 mt 72.97 140.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 C-N-CA 126.125 1.77 . . . . 71.03 113.204 173.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -139.21 -172.52 3.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.264 1.025 . . . . 63.24 109.476 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.3 -156.64 0.74 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.899 0.88 . . . . 75.24 108.671 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -161.91 154.63 20.11 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 118.452 0.569 . . . . 54.34 110.556 -175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -131.98 -174.26 13.58 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.137 -0.483 . . . . 72.12 113.625 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 95.49 -102.68 2.87 Favored Glycine 0 C--N 1.347 1.164 0 N-CA-C 111.452 -0.659 . . . . 55.51 111.452 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 57.6 -169.25 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.497 1.119 . . . . 75.23 112.546 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -164.9 156.68 15.42 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.11 0.564 . . . . 40.54 111.292 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' F' ' 203' ' ' ASP . 97.4 m-85 -91.18 -159.85 0.67 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.856 0.862 . . . . 62.14 109.441 170.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -58.82 -9.76 1.99 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.266 1.026 . . . . 71.43 113.642 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -55.32 -36.95 66.78 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.319 0.647 . . . . 72.23 110.423 173.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.06 31.75 5.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.481 1.112 . . . . 73.21 109.608 176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 42.0 t30 66.22 103.6 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.223 1.409 . . . . 65.33 110.742 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -132.3 -166.34 11.52 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.744 -0.662 . . . . 70.1 112.899 -172.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.65 -35.76 0.88 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.94 0.896 . . . . 63.12 110.73 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . 0.451 ' HE2' ' HE2' ' E' ' 196' ' ' LYS . 14.5 m-30 -89.88 34.03 0.85 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.809 0.844 . . . . 73.41 111.965 -165.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . 0.412 ' HB3' ' CD2' ' F' ' 195' ' ' PHE . 2.9 p30 -125.16 -146.89 0.36 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.013 1.325 . . . . 64.52 108.221 175.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.597 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 2.6 pp -131.66 156.05 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.384 0.611 . . . . 74.02 111.428 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -119.68 113.1 20.15 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.734 -1.21 . . . . 64.35 107.734 166.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -72.72 150.66 42.69 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.295 0.638 . . . . 74.44 109.773 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.582 HG21 HD11 ' C' ' 136' ' ' LEU . 4.3 p . . . . . 0 CA--C 1.565 1.546 0 CA-C-O 118.382 -0.818 . . . . 64.2 110.24 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 108.216 -1.031 . . . . 74.04 108.216 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 163.21 -95.7 0.13 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 111.308 -0.717 . . . . 75.35 111.308 -177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . 0.557 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 3.9 mptp? -116.05 124.78 51.3 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.385 -0.968 . . . . 63.43 108.385 178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 31.6 p -88.21 63.24 7.11 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.78 0.832 . . . . 64.05 110.0 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . 0.401 ' HB3' ' CB ' ' A' ' 94' ' ' MET . . . -87.8 -168.05 2.09 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.248 -0.887 . . . . 64.33 110.176 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 98' ' ' LEU . 77.7 mt 64.1 179.82 0.17 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.023 0.929 . . . . 73.52 111.592 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 7.0 mmt 60.87 10.13 2.59 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.099 1.36 . . . . 73.33 112.587 171.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 57.54 -165.81 0.15 Allowed 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.747 1.219 . . . . 72.25 111.526 -169.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 64.53 18.0 11.14 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 124.057 0.943 . . . . 60.02 110.604 -175.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . 0.412 HD23 HD23 ' A' ' 98' ' ' LEU . 3.5 pp -73.34 159.37 33.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.231 0.612 . . . . 73.52 111.21 -175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -117.29 162.41 17.94 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.606 0.762 . . . . 75.32 110.044 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 69.6 137.31 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 C-N-CA 125.216 1.407 . . . . 75.34 113.103 167.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.33 94.35 0.83 Allowed 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.115 1.877 . . . . 55.12 109.542 170.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -53.8 110.84 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.07 0.948 . . . . 61.23 111.739 -174.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . 0.481 ' HB2' ' HZ ' ' A' ' 133' ' ' PHE . 28.5 m-85 54.49 33.98 20.05 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 125.085 1.354 . . . . 71.32 111.306 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 91.6 m 77.73 -50.08 0.51 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 126.554 1.942 . . . . 74.24 113.626 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 43.3 t-105 69.94 84.05 0.15 Allowed Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 125.414 1.486 . . . . 63.54 109.353 -167.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.67 94.13 1.05 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.695 2.263 . . . . 73.12 110.84 170.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 1.3 tt -84.14 131.69 34.75 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.507 -1.294 . . . . 63.52 107.507 175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -66.84 152.57 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 120.738 0.304 . . . . 75.43 110.84 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -102.14 114.71 29.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.025 -0.732 . . . . 64.44 109.025 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -80.12 102.08 9.15 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.961 -0.755 . . . . 74.14 108.961 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.32 155.72 38.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.532 -0.758 . . . . 72.15 110.751 178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . 0.452 ' HA2' HG23 ' A' ' 40' ' ' VAL . . . -78.69 74.25 2.15 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 116.117 -0.492 . . . . 64.13 113.07 -176.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -63.3 123.14 28.9 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 112.024 -0.431 . . . . 54.41 112.024 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . 0.663 ' HB2' ' HB3' ' H' ' 198' ' ' GLU . 49.3 m-85 -87.66 39.06 0.86 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.198 0.999 . . . . 75.41 110.945 -171.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -70.68 129.88 40.32 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.975 -0.75 . . . . 71.22 108.975 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.497 ' HE1' ' HZ1' ' G' ' 201' ' ' LYS . 62.8 t80 77.3 29.21 0.57 Allowed 'General case' 0 N--CA 1.486 1.325 0 O-C-N 125.169 1.543 . . . . 63.44 110.726 -175.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' G' ' 193' ' ' TYR . 12.1 tmtt? -69.11 80.66 0.33 Allowed 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.637 -0.875 . . . . 65.44 108.637 176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -90.88 149.96 21.72 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 115.283 -0.871 . . . . 74.31 108.989 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -128.42 61.46 1.47 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.941 -0.763 . . . . 75.2 108.941 -177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 71.7 152.04 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 125.034 1.334 . . . . 62.32 111.54 -177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 93.5 119.36 2.89 Favored Glycine 0 C--N 1.353 1.476 0 CA-C-O 119.956 -0.358 . . . . 74.24 112.51 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . 0.497 ' HZ1' ' HE1' ' G' ' 195' ' ' PHE . 35.0 mmtt -147.38 -59.79 0.27 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.382 0.673 . . . . 72.15 111.303 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -123.33 -70.23 0.78 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.776 -1.194 . . . . 73.35 107.776 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 54.85 25.63 6.9 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.303 1.223 . . . . 74.34 114.303 167.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 34.2 pt -89.42 144.48 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-O 120.787 0.327 . . . . 53.25 110.168 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -166.58 104.15 0.6 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.525 -0.916 . . . . 72.44 108.525 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -132.16 -90.62 0.41 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.11 -0.7 . . . . 65.35 109.11 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 33.3 t . . . . . 0 CA--C 1.568 1.673 0 C-N-CA 124.848 1.259 . . . . 73.0 111.156 -177.528 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 119.927 -0.082 . . . . 74.45 111.169 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.55 144.57 4.49 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 112.516 -0.234 . . . . 65.31 112.516 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -111.4 133.24 53.85 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.64 0.776 . . . . 75.1 109.605 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 47.7 m 67.85 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.752 1.221 . . . . 53.33 112.855 174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.493 ' HA ' HD21 ' D' ' 6' ' ' ASN . . . -84.01 -66.56 0.88 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.198 0.599 . . . . 70.44 111.315 -177.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.406 HD21 ' HG3' ' D' ' 94' ' ' MET . 0.0 OUTLIER -169.52 176.34 5.06 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.465 1.106 . . . . 64.31 108.586 -176.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.434 ' HA ' ' CE ' ' H' ' 174' ' ' MET . 1.0 OUTLIER -131.22 -58.65 1.0 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.606 0.965 . . . . 71.14 113.606 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -149.97 147.67 28.15 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 117.853 0.297 . . . . 75.24 111.764 -172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -158.02 119.2 3.51 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.282 1.033 . . . . 42.35 108.705 174.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 15.2 tp -163.34 30.45 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.451 0.7 . . . . 74.45 109.453 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.39 -38.85 72.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.22 1.008 . . . . 73.53 111.599 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -92.18 138.98 24.14 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.589 0.755 . . . . 72.23 109.804 176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.79 114.75 2.71 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.152 2.568 . . . . 51.54 112.721 -176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.96 120.98 34.96 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.588 -0.893 . . . . 75.12 108.588 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -67.47 150.23 49.16 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 122.986 0.515 . . . . 72.21 111.325 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 72.0 p -97.39 -176.72 3.59 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 109.144 -0.687 . . . . 74.23 109.144 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . 0.563 ' H ' HD13 ' D' ' 44' ' ' LEU . 16.3 m-90 -123.05 87.44 51.05 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 122.816 0.447 . . . . 74.21 110.592 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -85.94 122.59 2.26 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.799 2.332 . . . . 65.43 111.855 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -169.06 -26.5 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.405 0.682 . . . . 75.13 111.42 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' D' ' 42' ' ' LEU . 15.6 tt -80.47 89.08 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.164 0 CA-C-O 122.668 1.223 . . . . 74.04 110.447 -175.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -147.23 83.56 1.56 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.238 -1.346 . . . . 55.32 108.263 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.17 133.32 33.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 115.174 -0.921 . . . . 62.4 110.243 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.55 157.34 32.12 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 109.537 -0.542 . . . . 61.44 109.537 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' D' ' 37' ' ' GLN . . . -95.73 154.56 20.97 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.918 -0.583 . . . . 63.01 112.739 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' D' ' 37' ' ' GLN . . . -116.11 177.05 16.79 Favored Glycine 0 C--N 1.346 1.112 0 C-N-CA 122.834 0.254 . . . . 72.44 112.671 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -80.87 89.92 5.87 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.174 0.59 . . . . 74.2 110.052 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -161.17 78.16 0.58 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.461 -0.791 . . . . 65.23 109.884 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.78 -47.43 0.13 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 107.679 -1.23 . . . . 75.03 107.679 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 40.8 tptt 39.84 81.04 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 126.51 1.924 . . . . 74.44 114.0 161.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -76.86 63.05 2.16 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.002 0.921 . . . . 54.35 110.513 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' G' ' 193' ' ' TYR . 2.1 mm-40 -81.5 103.67 11.4 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.099 -0.704 . . . . 74.11 109.099 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 63.94 35.37 10.86 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.282 1.033 . . . . 71.13 110.951 175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -84.09 52.19 4.68 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.795 -0.639 . . . . 64.12 112.531 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -160.18 96.37 1.2 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 106.418 -1.697 . . . . 74.21 106.418 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -64.67 -34.42 78.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.866 0.866 . . . . 74.14 112.983 -172.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 15.5 t70 64.45 28.11 13.53 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.782 0.833 . . . . 74.41 111.048 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 15.5 pt -99.36 159.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.476 0.71 . . . . 63.01 110.94 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -97.89 163.24 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.633 0.773 . . . . 62.21 109.655 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . 0.593 ' HB3' ' HB3' ' C' ' 11' ' ' PHE . 3.3 p-10 -55.85 -59.17 5.25 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.31 1.044 . . . . 52.44 111.24 171.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.441 ' HB ' HG13 ' A' ' 131' ' ' VAL . 2.5 p . . . . . 0 C--O 1.26 1.614 0 N-CA-C 107.681 -1.229 . . . . 72.52 107.681 175.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.6 mtp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 118.803 -0.618 . . . . 75.02 110.41 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t 65.69 164.75 0.17 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 125.137 1.375 . . . . 64.44 113.951 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -102.81 145.74 29.31 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.055 0.942 . . . . 73.13 109.718 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.47 ' HA ' ' HB3' ' A' ' 90' ' ' GLU . 89.7 mt-30 -126.08 135.05 51.27 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.63 0.772 . . . . 63.02 110.099 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.32 -76.75 0.31 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.021 -0.733 . . . . 44.41 109.021 171.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.8 t30 51.1 70.34 0.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.045 1.338 . . . . 72.33 112.096 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 p -125.01 -58.88 1.45 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.321 0.648 . . . . 72.1 109.594 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' C' ' 145' ' ' ALA . 2.2 tm-20 -145.81 127.58 15.31 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 106.618 -1.623 . . . . 74.1 106.618 174.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -136.19 156.77 48.21 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.226 0.536 . . . . 73.42 112.408 -166.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.7 m -144.18 134.81 24.88 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.896 0.878 . . . . 65.01 109.344 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.485 ' HD2' HG22 ' A' ' 86' ' ' ILE . 36.2 t80 -121.32 130.01 53.41 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.767 -1.197 . . . . 72.3 107.767 166.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -144.52 123.39 12.7 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 122.997 0.186 . . . . 63.43 111.37 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.402 HD11 HG13 ' A' ' 16' ' ' ILE . 6.8 tp -68.7 130.95 34.01 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 108.956 -0.757 . . . . 63.55 108.956 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 28.1 mm-40 -110.62 -39.97 4.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.928 -0.578 . . . . 65.04 109.919 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 27.1 ttt180 -173.58 144.29 1.1 Allowed 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 119.871 -0.109 . . . . 74.21 110.755 -173.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.556 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 71.7 mt -123.01 132.31 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.535 -1.283 . . . . 61.02 107.535 170.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 15.4 p90 -156.73 155.45 31.68 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.416 0.686 . . . . 73.5 110.633 -174.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.5 p -88.52 109.39 20.02 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.851 -0.613 . . . . 72.31 109.697 173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -72.4 -32.53 66.46 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.165 0.507 . . . . 74.44 109.985 173.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.72 142.84 27.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.961 -1.018 . . . . 72.23 109.537 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 65.1 mt -132.47 137.88 53.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 106.665 -1.605 . . . . 75.2 106.665 169.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -144.41 136.54 26.27 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.925 -0.769 . . . . 74.14 108.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.601 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.5 t80 -142.32 112.19 6.86 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 106.939 -1.504 . . . . 74.13 106.939 175.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 46.7 mt-10 -118.67 108.45 14.93 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.98 -0.748 . . . . 63.22 108.98 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.95 81.95 2.87 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 107.479 -1.304 . . . . 72.44 107.479 169.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.31 -19.07 20.04 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.153 1.902 . . . . 71.44 111.694 -172.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.572 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 45.7 m-80 -120.65 38.5 4.0 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.014 0.925 . . . . 72.15 109.181 177.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.423 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.66 -44.47 99.5 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.073 -0.967 . . . . 74.11 112.632 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -63.85 -28.96 67.61 Favored 'Trans proline' 0 C--N 1.388 2.642 0 CA-C-N 121.394 1.533 . . . . 73.54 112.856 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.1 m170 -82.19 -26.31 33.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.543 0.737 . . . . 64.41 112.158 -169.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG23 HD11 ' A' ' 68' ' ' LEU . 7.3 p -63.9 -19.2 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-O 121.202 0.525 . . . . 72.43 111.807 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -83.29 -39.78 20.38 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.725 0.81 . . . . 75.03 110.998 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -75.79 -28.22 58.29 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.92 0.488 . . . . 75.21 110.724 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -82.68 160.87 22.31 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.284 0.634 . . . . 74.55 110.099 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.32 144.88 26.58 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.245 -0.65 . . . . 60.1 109.245 169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' CE3' HD21 ' A' ' 68' ' ' LEU . 62.2 t-105 -75.77 89.01 2.83 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.66 0.784 . . . . 64.44 110.557 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' H ' HD22 ' A' ' 68' ' ' LEU . 35.3 tt0 -122.36 77.09 44.31 Favored Pre-proline 0 CA--C 1.551 1.012 0 N-CA-C 107.718 -1.215 . . . . 72.2 107.718 169.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -84.97 145.89 10.09 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 122.486 2.124 . . . . 43.23 113.174 -173.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -98.86 104.61 16.66 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.19 -1.411 . . . . 65.14 107.19 165.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.4 t -80.64 116.14 24.37 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 123.802 0.841 . . . . 74.34 108.881 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 59.2 tttm -120.35 113.99 21.19 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.713 0.805 . . . . 70.04 109.391 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.681 HD21 HD22 ' A' ' 128' ' ' LEU . 10.5 mp -104.87 125.74 51.22 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 108.968 -0.752 . . . . 72.35 108.968 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.646 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.3 m-20 -117.05 128.57 55.29 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.175 -1.046 . . . . 64.41 108.175 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -115.2 121.02 41.67 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.263 0.625 . . . . 71.52 109.69 -176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -138.86 154.57 48.42 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.208 1.003 . . . . 74.43 109.037 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -140.05 153.2 46.72 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.487 0.715 . . . . 52.51 109.484 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.38 113.28 6.77 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.015 -0.735 . . . . 63.13 109.015 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 79.2 p -90.07 165.58 13.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.711 0.404 . . . . 74.45 110.33 -177.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.542 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 47.8 t -166.46 157.34 12.64 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.227 1.011 . . . . 61.32 108.568 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.63 132.8 55.62 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.899 -0.778 . . . . 74.23 108.899 169.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 57' ' ' GLU . 70.3 mt -105.52 -37.45 6.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.885 0.874 . . . . 74.44 110.405 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.49 -175.14 5.28 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.727 0.811 . . . . 52.41 109.82 178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.31 104.71 0.28 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.046 0.538 . . . . 62.31 110.398 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.634 ' H ' HD23 ' G' ' 173' ' ' LEU . 9.2 m-20 70.82 10.11 6.94 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 125.742 1.617 . . . . 65.33 112.432 176.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.07 112.42 32.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.0 -1.482 . . . . 52.04 107.0 170.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -117.74 150.18 39.54 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.502 0.721 . . . . 74.01 109.403 -177.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 33.2 tt0 -111.11 118.31 35.66 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 108.48 -0.933 . . . . 71.13 108.48 171.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -110.8 115.57 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.916 -1.142 . . . . 73.34 107.916 173.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.629 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 53.7 t -98.01 137.52 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 123.387 0.675 . . . . 65.41 109.323 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.96 110.1 21.32 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 107.053 -1.462 . . . . 72.31 107.053 175.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -101.39 101.62 12.28 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 108.806 -0.813 . . . . 72.01 108.806 176.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -94.6 140.1 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 107.746 -1.205 . . . . 74.33 107.746 173.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 21.6 m -128.33 144.49 51.14 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 108.666 -0.864 . . . . 74.43 108.666 171.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 35.1 t -142.06 109.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 124.489 1.116 . . . . 32.21 108.543 -171.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 4.9 m -109.63 137.94 46.73 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.538 -0.541 . . . . 70.22 109.538 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.36 120.48 34.12 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.625 -1.25 . . . . 61.2 107.625 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.4 m -130.52 131.7 45.23 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.384 0.611 . . . . 74.44 110.866 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 31' ' ' VAL . 49.6 mt -87.12 83.64 7.41 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.02 1.328 . . . . 74.21 107.852 177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.93 -89.47 0.77 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.768 -0.651 . . . . 53.51 111.88 -177.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -108.41 -28.67 9.24 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.771 0.828 . . . . 53.31 110.866 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -91.17 117.15 29.38 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.907 0.483 . . . . 74.25 111.144 -171.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 46.3 m -66.95 110.38 3.32 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 121.117 0.484 . . . . 74.33 112.021 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.73 -57.01 14.5 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.796 1.239 . . . . 73.12 110.221 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -157.21 173.6 16.73 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-O 121.732 0.777 . . . . 71.1 111.986 175.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 64.1 tp -141.25 144.04 34.47 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.504 1.522 . . . . 74.45 107.837 174.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.589 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -140.61 125.04 17.74 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.36 1.064 . . . . 63.44 108.769 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -144.99 116.52 8.09 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 122.929 0.491 . . . . 72.25 109.725 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -126.78 111.76 26.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.105 0.962 . . . . 72.23 109.021 -174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -85.05 79.66 9.55 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.027 -1.101 . . . . 73.23 108.027 170.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.44 90.29 3.26 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.931 1.292 . . . . 73.5 108.699 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.55 144.23 19.65 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-N 116.064 -0.516 . . . . 75.43 112.119 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.83 130.26 4.81 Favored Glycine 0 CA--C 1.505 -0.543 0 N-CA-C 111.791 -0.524 . . . . 52.03 111.791 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 39.2 mt -82.14 125.27 39.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 108.53 -0.915 . . . . 74.3 108.53 171.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 21.0 m-85 -131.51 119.45 21.56 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.895 -1.15 . . . . 65.52 107.895 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.3 t -79.03 99.83 7.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 108.977 -0.749 . . . . 72.1 108.977 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.485 HG22 ' HD2' ' A' ' 11' ' ' PHE . 2.7 pp -112.61 153.48 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.354 0.662 . . . . 74.32 110.408 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.88 158.05 7.09 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.85 0.86 . . . . 73.14 110.231 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.1 -10.36 60.93 Favored Glycine 0 C--N 1.353 1.473 0 N-CA-C 114.929 0.732 . . . . 75.41 114.929 173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.32 138.27 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.244 0.618 . . . . 72.5 109.469 -179.003 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 4' ' ' GLN . 12.8 tt0 -148.21 175.7 10.84 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.535 -0.913 . . . . 73.55 108.535 178.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 63.45 -133.61 41.88 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 123.098 0.249 . . . . 64.22 112.953 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -73.43 -21.7 60.4 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.976 0.511 . . . . 53.31 111.113 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -71.14 -41.19 70.81 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.172 0.589 . . . . 74.41 110.169 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.415 ' CE ' ' HA ' ' G' ' 175' ' ' PHE . 26.7 ttt -74.01 -38.8 63.96 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.681 -0.69 . . . . 63.13 109.936 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.71 -28.21 69.73 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.648 -0.705 . . . . 75.52 111.545 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -77.12 -38.51 52.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.408 0.683 . . . . 63.33 109.964 174.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.4 -66.83 0.53 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 123.502 0.502 . . . . 72.02 110.649 -176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -82.24 -10.96 58.94 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.017 0.747 . . . . 72.03 113.017 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.97 2.99 25.69 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-O 118.947 -0.919 . . . . 74.3 114.469 -173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.23 -58.47 0.16 Allowed 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.583 1.191 . . . . 64.35 112.051 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.473 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 68.9 t80 -67.06 -51.51 53.7 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.988 0.915 . . . . 75.5 111.737 -172.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.0 m -71.73 -37.69 5.5 Favored Pre-proline 0 CA--C 1.562 1.407 0 CA-C-O 118.249 -0.882 . . . . 41.22 112.084 -176.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.3 -39.57 72.27 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 121.911 1.741 . . . . 55.34 113.002 161.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -72.06 -24.27 61.49 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.619 0.768 . . . . 62.14 111.132 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 16' ' ' ILE . 47.8 mm -64.79 -43.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 109.149 -0.686 . . . . 53.5 109.149 169.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 82' ' ' GLY . 47.3 mt -75.8 -25.48 56.42 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.988 -1.006 . . . . 64.34 111.769 -174.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -64.41 -40.35 50.23 Favored Pre-proline 0 CA--C 1.566 1.573 0 N-CA-C 114.381 1.252 . . . . 63.12 114.381 -168.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -56.55 -31.57 86.97 Favored 'Trans proline' 0 C--N 1.388 2.654 0 C-N-CA 121.873 1.716 . . . . 73.31 113.502 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -87.64 -29.91 20.83 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.549 0.74 . . . . 72.53 111.001 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.31 -40.9 86.06 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.725 -0.843 . . . . 74.44 108.725 171.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.432 ' NH1' HG23 ' C' ' 105' ' ' ILE . 39.3 ttm180 -62.45 -44.44 96.41 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.362 1.065 . . . . 73.3 110.029 175.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.436 ' HG2' HH12 ' B' ' 120' ' ' ARG . 10.4 tt0 -49.66 -54.28 19.53 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.278 1.031 . . . . 71.04 110.927 176.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 43.3 t -66.14 -42.95 88.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.566 -1.197 . . . . 61.13 111.561 -175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.474 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 97.2 mt -67.01 -62.58 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.911 0.485 . . . . 72.13 110.415 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.453 HG23 ' HG3' ' A' ' 125' ' ' GLN . 57.9 m -48.96 -35.37 14.97 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.004 1.322 . . . . 75.41 111.986 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.5 t -71.13 -49.65 41.92 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 119.027 -0.511 . . . . 42.3 110.875 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.601 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 58.5 mtm -56.33 -42.89 78.41 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.06 0.457 . . . . 71.14 110.847 177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 114' ' ' ILE . 69.3 t -61.12 -49.16 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 124.912 1.285 . . . . 63.41 110.633 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.7 -30.96 68.73 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.615 0.366 . . . . 64.44 111.385 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.488 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.5 mtt-85 -71.08 -30.76 66.96 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.928 0.891 . . . . 72.53 110.532 176.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.0 6.34 49.47 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-N 116.021 -0.536 . . . . 53.12 113.507 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.454 ' HB ' HH21 ' B' ' 15' ' ' ARG . 37.8 m 74.06 7.84 4.76 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 125.413 1.485 . . . . 65.41 111.054 178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.429 ' HE1' HG21 ' A' ' 31' ' ' VAL . 89.0 m-85 -81.71 159.02 67.39 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 123.493 0.717 . . . . 64.53 109.163 175.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.06 161.57 45.3 Favored 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 122.475 2.117 . . . . 65.44 111.614 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.5 tt0 -67.54 132.68 48.03 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.854 0.359 . . . . 74.33 110.551 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -111.69 106.62 15.47 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.93 0.892 . . . . 74.33 109.134 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -98.97 90.79 4.75 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.066 0.546 . . . . 63.51 110.335 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.681 HD22 HD21 ' A' ' 42' ' ' LEU . 48.4 mt -74.57 116.51 15.34 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.586 -0.894 . . . . 74.22 108.586 172.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.36 141.58 97.29 Favored Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 122.068 0.147 . . . . 53.34 111.242 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.12 121.23 8.63 Favored 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.193 1.928 . . . . 45.24 110.341 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.59 HG21 ' HG ' ' G' ' 186' ' ' LEU . 86.5 t -98.14 109.06 23.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.803 -1.184 . . . . 62.22 107.803 -177.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -94.5 91.71 6.76 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.657 -1.156 . . . . 51.31 108.238 -177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -61.34 -28.59 69.33 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 114.945 -1.025 . . . . 71.4 110.814 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.67 -39.24 61.67 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.193 1.397 . . . . 74.34 112.047 176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.31 -58.71 7.36 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.597 0.759 . . . . 64.22 110.945 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.28 -33.75 74.92 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 123.632 0.582 . . . . 72.41 111.537 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.421 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.6 t80 -65.73 -60.51 2.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.569 0.747 . . . . 73.21 110.508 -175.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.72 -41.99 99.43 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.939 0.775 . . . . 73.41 111.02 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 29.7 t30 -55.49 -51.45 66.94 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 124.544 1.153 . . . . 54.31 110.939 176.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -62.76 -39.88 95.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.597 0.759 . . . . 74.42 111.643 -176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 77.5 mt -67.39 -51.28 53.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 123.556 0.535 . . . . 73.23 111.533 -176.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -176.93 22.95 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 123.565 0.541 . . . . 72.44 110.931 -177.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 87.1 mt-30 52.55 48.46 22.51 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.917 0.865 . . . . 75.04 110.979 -173.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -70.02 112.29 6.3 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.171 -1.377 . . . . 72.33 109.443 -175.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.19 84.72 1.04 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.285 0.564 . . . . 63.15 110.124 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.39 164.19 39.85 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 115.316 -0.856 . . . . 62.55 112.914 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -121.38 99.8 6.68 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.371 -0.974 . . . . 75.41 108.371 177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.96 72.3 0.11 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.601 -0.6 . . . . 73.11 111.601 -177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 m -76.19 85.95 3.03 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.303 0.573 . . . . 61.04 109.596 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.59 95.04 7.64 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.53 -0.915 . . . . 72.03 108.53 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -93.24 -36.7 12.46 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.178 0.991 . . . . 73.12 110.118 -177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 79.9 -44.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 126.004 1.722 . . . . 75.03 114.352 167.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -77.03 157.68 31.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.176 0.59 . . . . 74.35 111.584 -170.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -67.65 108.95 3.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.884 0.874 . . . . 75.13 110.255 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.15 0 C-N-CA 123.734 0.813 . . . . 62.23 110.098 -176.505 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.477 ' HB2' ' HG2' ' B' ' 3' ' ' GLU . 15.4 ptp . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.93 0.872 . . . . 65.43 110.244 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -88.21 66.98 8.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.788 -0.819 . . . . 71.44 108.788 173.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.477 ' HG2' ' HB2' ' B' ' 1' ' ' MET . 9.8 mm-40 -94.62 174.94 6.86 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.153 -0.931 . . . . 74.33 110.517 -174.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -117.74 163.98 15.68 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.603 0.761 . . . . 64.42 110.075 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -133.55 144.76 49.55 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.131 0.572 . . . . 73.23 109.985 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -122.0 -143.06 0.33 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.34 -0.985 . . . . 60.15 108.34 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.8 p -63.82 87.91 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.263 0 CA-C-O 121.258 0.551 . . . . 62.11 109.625 169.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.9 -171.12 2.56 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.072 0.949 . . . . 71.24 110.424 -175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.2 ptm 54.67 178.23 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.316 1.846 . . . . 62.51 113.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 4.0 p -150.56 143.0 24.4 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.487 0.715 . . . . 63.01 110.176 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -139.44 134.0 31.75 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.273 -1.01 . . . . 73.21 108.273 171.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -149.62 108.35 3.85 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.251 -0.648 . . . . 74.12 109.251 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.6 tt -78.47 133.97 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.524 0.73 . . . . 65.14 109.309 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -105.6 -50.09 3.28 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.674 0.39 . . . . 63.12 110.925 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.454 HH21 ' HB ' ' A' ' 122' ' ' THR . 45.9 ttt180 -159.99 146.34 15.86 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.456 0.17 . . . . 71.1 110.963 -174.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.1 143.02 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.067 -1.457 . . . . 71.03 107.067 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.405 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.1 p90 -171.29 141.87 1.65 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 118.741 0.701 . . . . 73.13 111.198 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.6 m -74.15 118.55 17.24 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.739 -0.837 . . . . 74.14 108.739 171.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -86.71 -33.05 20.14 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 122.997 0.519 . . . . 74.05 110.524 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -158.21 143.46 16.63 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 111.867 0.321 . . . . 75.05 111.867 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 44.3 mm -131.88 142.35 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.823 1.249 . . . . 75.02 108.977 174.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 39.7 t -141.99 134.86 28.67 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.397 -0.964 . . . . 64.33 108.397 175.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -148.7 127.86 12.87 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 107.047 -1.464 . . . . 75.44 107.047 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -135.7 112.25 9.98 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.081 -1.081 . . . . 55.3 108.081 -175.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -109.75 89.54 7.86 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 123.787 0.835 . . . . 73.43 108.954 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -67.7 -27.56 38.11 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.092 1.861 . . . . 72.45 111.696 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -113.82 29.44 8.0 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.626 0.77 . . . . 64.12 110.463 178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.529 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -47.3 -48.45 55.85 Favored Pre-proline 0 CA--C 1.574 1.896 0 C-N-CA 124.905 1.282 . . . . 74.45 113.008 170.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.42 -25.48 3.8 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.044 1.83 . . . . 71.12 113.396 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -84.54 1.7 44.6 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.411 0.684 . . . . 73.41 111.923 -171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.47 -14.18 15.41 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.567 0 C-N-CA 124.471 1.108 . . . . 44.14 111.237 168.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -60.09 -42.12 93.93 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.916 0.886 . . . . 72.53 110.408 169.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -75.56 -40.67 56.45 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.306 1.042 . . . . 72.33 110.289 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.456 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 32.1 mmtp -108.37 67.96 0.68 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 114.392 -1.276 . . . . 74.04 109.521 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.409 ' HB2' ' N ' ' F' ' 197' ' ' TYR . 8.5 p-10 -89.37 75.64 7.65 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.116 -0.947 . . . . 72.51 111.078 -173.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 4.7 m0 -169.61 170.95 7.82 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 126.098 1.759 . . . . 75.33 109.637 175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.494 ' HG3' ' HG2' ' B' ' 124' ' ' PRO . 54.1 tt0 -67.57 122.06 81.71 Favored Pre-proline 0 N--CA 1.483 1.224 0 C-N-CA 123.318 0.647 . . . . 73.25 110.404 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.31 151.41 80.76 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.92 2.413 . . . . 62.45 113.377 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.41 106.63 6.11 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 108.836 -0.802 . . . . 74.12 108.836 170.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.7 t -108.77 131.94 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.242 1.017 . . . . 73.24 110.803 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -124.43 143.1 50.82 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 108.992 -0.744 . . . . 70.24 108.992 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.602 HD22 HD11 ' B' ' 126' ' ' LEU . 1.0 OUTLIER -129.3 140.99 51.22 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.881 0.372 . . . . 71.53 110.829 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -123.49 145.13 49.08 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.372 1.069 . . . . 75.15 109.558 -168.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.414 HD22 HD21 ' F' ' 186' ' ' LEU . 31.0 tp -93.96 131.82 39.04 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.4 0.68 . . . . 64.44 109.719 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -132.48 124.38 28.43 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.971 0.908 . . . . 75.44 108.695 178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 47.4 m -112.55 113.95 26.36 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.758 0.423 . . . . 32.43 110.169 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -115.95 149.03 39.42 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.774 -1.195 . . . . 74.24 107.774 171.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.1 m -143.15 173.03 11.93 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.84 0.352 . . . . 74.12 110.544 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 69.3 p -157.32 173.99 16.1 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.383 1.073 . . . . 70.31 108.948 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -124.58 121.72 35.57 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.674 0.39 . . . . 73.24 110.566 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.483 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 70.8 mt -80.57 -44.35 19.16 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.158 0.583 . . . . 61.34 111.126 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.51 -173.2 4.38 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.917 0.887 . . . . 74.13 109.746 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -61.72 112.77 2.4 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.433 -0.803 . . . . 74.31 110.277 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.491 ' H ' HD21 ' F' ' 173' ' ' LEU . 4.2 m-20 70.52 0.28 3.19 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.922 1.689 . . . . 63.13 112.745 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 75.8 t -103.66 92.95 2.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.353 0 N-CA-C 107.543 -1.28 . . . . 74.22 107.543 177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -95.26 171.05 8.96 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.29 0.636 . . . . 64.32 109.837 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.483 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 5.0 tm-20 -143.72 101.2 3.72 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 107.281 -1.377 . . . . 74.02 107.281 -177.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.3 122.57 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.5 0.72 . . . . 64.2 110.304 -174.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 41.2 t -102.38 114.52 42.09 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 C-N-CA 123.508 0.723 . . . . 73.54 109.532 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.439 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.5 OUTLIER -92.16 106.87 18.79 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.714 -1.217 . . . . 71.44 107.714 178.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 25.8 ttm180 -95.18 116.41 28.7 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.252 -0.647 . . . . 63.44 109.252 170.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.0 t -105.43 120.88 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.292 -1.374 . . . . 72.14 107.292 164.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 86.8 m -96.51 146.84 24.44 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.0 -0.741 . . . . 52.12 109.0 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.651 HG21 HG21 ' B' ' 114' ' ' ILE . 41.6 t -134.7 128.66 51.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.816 0.846 . . . . 71.21 109.461 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 98.5 m -123.61 138.78 54.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.111 -0.949 . . . . 73.51 108.543 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.71 149.82 37.75 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 123.498 0.719 . . . . 32.45 109.205 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 74.1 p -143.94 137.74 28.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 123.708 0.63 . . . . 64.35 110.25 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 38.8 mt -90.9 98.73 11.95 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.077 -1.823 . . . . 53.14 106.077 170.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.63 -129.68 14.09 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 115.538 -0.755 . . . . 65.15 111.686 -169.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -92.75 2.83 56.53 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.054 0.941 . . . . 74.42 111.021 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -115.65 138.09 51.43 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.244 1.018 . . . . 74.24 109.02 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -65.13 132.7 49.85 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.317 0.58 . . . . 65.33 111.846 -171.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.477 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.87 -58.65 2.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.376 1.071 . . . . 73.24 109.073 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -157.82 157.03 32.53 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 114.275 -1.329 . . . . 74.1 110.544 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 86.3 mt -135.18 110.71 9.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 106.673 -1.603 . . . . 72.55 106.673 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -117.95 157.86 25.95 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.357 -0.608 . . . . 50.44 109.357 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -164.6 135.08 4.05 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.979 -0.749 . . . . 52.55 108.979 -178.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 68.9 t -123.92 139.83 49.21 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 115.546 -0.752 . . . . 71.24 109.086 173.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -122.66 89.13 3.06 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.489 -0.93 . . . . 74.54 108.489 174.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.36 101.23 12.92 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.2 -1.037 . . . . 64.41 108.2 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.5 159.32 28.27 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.24 -0.744 . . . . 61.43 111.24 177.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.92 129.36 2.38 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 112.002 -0.439 . . . . 30.51 112.002 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.405 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.2 mt -85.15 124.13 39.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.578 -0.897 . . . . 74.45 108.578 174.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -136.33 158.11 45.2 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.162 0.985 . . . . 75.32 108.883 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 48.9 m -130.93 114.8 15.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.344 -0.613 . . . . 60.33 109.344 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.501 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.72 143.02 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.384 0.673 . . . . 74.12 110.003 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.03 167.86 29.19 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.98 0.912 . . . . 73.51 109.099 170.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.47 -70.19 1.22 Allowed Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.847 -0.501 . . . . 72.4 111.847 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.431 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -57.62 141.04 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.823 0.449 . . . . 53.11 110.623 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.568 ' HG3' ' HG3' ' F' ' 174' ' ' MET . 31.0 tt0 -151.4 154.24 36.26 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 117.93 0.332 . . . . 75.52 110.593 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.21 -124.33 13.52 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.389 0.431 . . . . 71.34 112.7 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.6 m -65.76 -32.33 73.82 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.61 0.764 . . . . 75.34 110.121 175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -69.38 -36.45 76.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.804 0.842 . . . . 52.41 110.512 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.718 ' SD ' ' HG2' ' F' ' 174' ' ' MET . 18.0 ttt -72.6 -45.6 58.28 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.96 -0.385 . . . . 64.51 109.96 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.16 -20.92 66.68 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.87 0.468 . . . . 54.14 112.057 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -73.36 -33.2 64.94 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.686 0.794 . . . . 75.42 110.806 172.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -86.26 -67.42 0.81 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.196 -0.456 . . . . 72.32 110.284 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 16.8 tp -61.15 -32.36 72.08 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.597 1.159 . . . . 71.1 112.709 -175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.73 1.97 52.56 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.354 -0.692 . . . . 63.12 114.663 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.96 -52.2 0.33 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 117.904 0.852 . . . . 61.32 111.492 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -73.63 -46.8 44.62 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.017 0.527 . . . . 63.02 111.993 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.412 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 78.8 m -63.41 -44.16 81.36 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 118.814 -0.612 . . . . 63.54 111.207 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.7 Cg_exo -59.96 -36.53 89.69 Favored 'Trans proline' 0 C--N 1.392 2.865 0 C-N-CA 121.893 1.729 . . . . 73.34 113.396 164.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.7 -31.04 71.16 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 122.835 0.454 . . . . 72.41 111.432 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.453 HG23 ' NH2' ' D' ' 111' ' ' ARG . 94.7 mt -61.41 -50.76 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.913 0.885 . . . . 75.42 109.964 170.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.439 ' HB2' HD12 ' B' ' 60' ' ' LEU . 46.4 mt -77.58 -11.51 59.87 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.487 1.115 . . . . 72.52 112.135 -175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -69.24 -44.06 26.02 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 124.883 1.273 . . . . 70.12 113.621 -165.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.64 -34.47 51.46 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 121.568 1.512 . . . . 75.21 112.344 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -63.71 -41.67 98.06 Favored 'General case' 0 N--CA 1.481 1.091 0 O-C-N 123.715 0.634 . . . . 75.44 110.136 178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -69.03 -42.76 75.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.447 -0.797 . . . . 73.12 110.325 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -57.24 -54.71 43.7 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.643 1.177 . . . . 52.52 111.776 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -65.08 -38.81 91.98 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.176 0.99 . . . . 73.32 110.395 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.49 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.7 t -67.65 -32.91 73.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.6 -0.727 . . . . 71.54 111.78 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.651 HG21 HG21 ' B' ' 64' ' ' VAL . 74.5 mt -65.52 -55.64 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 109.466 -0.568 . . . . 63.24 109.466 175.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 5.0 m -56.93 -32.17 65.71 Favored 'General case' 0 CA--C 1.55 0.965 0 O-C-N 124.277 0.986 . . . . 62.44 110.983 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.4 t -64.62 -53.2 51.42 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.484 -1.235 . . . . 63.12 110.747 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.1 mmt -67.68 -32.01 72.38 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 122.663 0.385 . . . . 74.51 111.703 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.13 -42.75 95.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 124.237 1.015 . . . . 73.0 110.688 176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.03 -25.32 58.64 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.94 0.496 . . . . 64.31 111.739 -178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' B' ' 116' ' ' SER . 80.8 mtt-85 -66.85 -38.58 86.63 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.799 0.439 . . . . 75.51 109.848 173.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.41 4.21 56.37 Favored Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.263 -0.88 . . . . 73.41 113.148 173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 66.8 p 59.44 50.73 7.25 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 125.921 1.688 . . . . 72.01 112.035 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.534 ' HA ' ' HZ ' ' F' ' 195' ' ' PHE . 59.6 m-85 -120.41 158.53 50.92 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.684 1.194 . . . . 72.25 109.795 176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.494 ' HG2' ' HG3' ' B' ' 37' ' ' GLN . 8.2 Cg_exo -72.37 -174.65 1.49 Allowed 'Trans proline' 0 C--N 1.389 2.696 0 C-N-CA 123.57 2.847 . . . . 63.51 115.435 -166.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -58.85 130.66 48.05 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 113.839 -1.528 . . . . 74.23 112.118 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.602 HD11 HD22 ' B' ' 42' ' ' LEU . 59.0 tp -138.64 83.83 1.98 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.669 -1.234 . . . . 42.11 107.669 171.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.81 132.55 39.48 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.663 -1.236 . . . . 75.44 107.663 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.564 HD11 HD13 ' F' ' 186' ' ' LEU . 2.5 tt -87.0 130.62 34.38 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 108.581 -0.896 . . . . 75.0 108.581 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.36 115.43 34.76 Favored Pre-proline 0 N--CA 1.479 0.985 0 C-N-CA 123.236 0.615 . . . . 73.44 110.466 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.429 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 45.1 Cg_endo -67.06 131.86 26.45 Favored 'Trans proline' 0 C--N 1.371 1.738 0 C-N-CA 122.192 1.928 . . . . 74.33 110.984 175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 p -142.89 143.79 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 122.957 0.503 . . . . 63.45 110.384 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -86.99 111.83 21.24 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.735 0.814 . . . . 62.14 109.24 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -67.28 -27.89 67.57 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.95 0.9 . . . . 72.14 111.43 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.8 -44.69 40.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.261 1.025 . . . . 65.2 111.01 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.98 -34.19 74.39 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.096 -0.502 . . . . 71.01 111.064 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.502 HD22 ' HE1' ' F' ' 184' ' ' TRP . 5.5 tt -56.88 -48.54 77.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.947 0.899 . . . . 74.11 111.139 175.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -65.83 -33.6 76.23 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.794 0.838 . . . . 73.22 110.909 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -72.23 -37.23 69.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.192 0.597 . . . . 64.52 111.856 -176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -74.41 -20.25 60.12 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 120.561 0.219 . . . . 72.12 110.799 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -86.4 -42.83 13.32 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 72.04 109.995 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.94 37.15 2.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.844 0.858 . . . . 71.34 110.062 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.5 147.93 20.69 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.119 0.968 . . . . 62.21 111.698 171.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.12 117.63 10.3 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.602 -0.888 . . . . 74.14 108.602 -173.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.44 ' OE1' ' HB3' ' D' ' 8' ' ' GLU . 22.2 tt0 -148.63 79.69 1.43 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.044 -1.095 . . . . 72.12 108.044 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.57 148.52 48.08 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 115.68 -0.691 . . . . 73.21 112.255 -172.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.14 -45.79 0.06 OUTLIER Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.791 -1.095 . . . . 52.24 110.799 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -168.55 163.56 12.39 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.539 1.136 . . . . 75.25 110.026 176.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.67 141.92 13.1 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 111.286 -0.726 . . . . 72.14 111.286 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 152.22 34.48 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.704 0.801 . . . . 75.15 110.37 -174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -75.62 85.6 2.67 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.738 -0.838 . . . . 54.11 108.738 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.454 ' HG3' ' HG2' ' B' ' 153' ' ' GLN . 13.5 tp10 -164.19 153.68 14.03 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.496 -0.775 . . . . 70.11 109.714 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -133.29 83.29 2.04 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.845 0.858 . . . . 72.33 109.177 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.454 ' HG2' ' HG3' ' B' ' 151' ' ' GLU . 21.0 pt20 -158.63 163.69 36.69 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.749 0.819 . . . . 63.21 110.166 175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -151.73 149.32 28.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.918 0.887 . . . . 74.35 109.321 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.663 0.785 . . . . 75.31 109.497 -177.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.7 mtm . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 110.294 -0.262 . . . . 65.24 110.294 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m 57.8 51.91 8.68 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.339 1.056 . . . . 71.54 112.327 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -66.53 -39.04 88.41 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 114.781 -1.099 . . . . 63.14 109.573 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -157.59 85.71 0.92 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.743 1.217 . . . . 72.33 108.504 168.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 61.98 -92.76 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 125.223 1.409 . . . . 65.34 111.32 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -114.25 97.7 6.5 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.016 -1.105 . . . . 73.13 108.016 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -111.69 -73.88 0.66 Allowed 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.037 -1.098 . . . . 75.33 108.037 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 53.93 83.25 0.08 Allowed 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.639 1.175 . . . . 75.3 112.499 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 64.18 115.4 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.093 1.357 . . . . 73.25 112.217 -172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 90.4 m -115.56 111.71 21.1 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.818 1.247 . . . . 75.3 107.711 175.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.602 ' HA ' HG22 ' C' ' 86' ' ' ILE . 41.5 t80 -125.99 120.1 29.43 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.11 0.564 . . . . 75.23 109.841 -178.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -139.02 128.94 25.01 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.64 0.376 . . . . 61.35 110.066 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.421 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.6 tp -80.99 136.83 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 109.388 -0.597 . . . . 70.55 109.388 170.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -106.65 -49.7 3.27 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.46 0.704 . . . . 73.21 110.17 176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -160.73 136.47 8.16 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 116.144 -0.48 . . . . 74.01 110.313 -173.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -119.83 143.52 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 107.338 -1.356 . . . . 73.54 107.338 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -171.5 162.66 6.62 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.33 0.586 . . . . 72.21 110.754 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 49.9 p -83.8 113.64 21.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.456 -0.793 . . . . 64.32 109.137 170.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -64.76 -46.9 80.23 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.987 -1.116 . . . . 72.22 107.987 167.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -142.8 141.61 31.69 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.42 -1.718 . . . . 71.44 109.791 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.4 mt -140.73 143.43 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 106.388 -1.708 . . . . 53.22 106.388 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -155.69 151.6 27.58 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 122.745 0.418 . . . . 53.43 110.117 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -155.62 121.49 5.04 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.769 -1.197 . . . . 52.31 107.769 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -121.36 136.61 54.94 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.374 0.67 . . . . 61.15 109.804 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.59 77.93 8.56 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.843 -1.169 . . . . 63.04 107.843 176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.53 -9.75 23.09 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.371 2.047 . . . . 61.1 111.943 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -109.38 19.43 19.36 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.716 1.206 . . . . 73.33 110.213 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -51.72 -49.8 81.13 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 124.903 1.281 . . . . 74.43 113.475 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -81.95 -30.12 1.43 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 121.421 1.414 . . . . 73.45 113.31 173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -69.41 -28.06 65.82 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.524 0.729 . . . . 63.05 111.955 -174.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 p -73.87 -12.29 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.47 0 C-N-CA 123.217 0.607 . . . . 74.0 111.411 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.88 -31.67 72.74 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.888 0.875 . . . . 74.25 111.261 178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -104.7 20.83 17.96 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.4 0.68 . . . . 61.02 110.146 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.812 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -100.83 158.27 16.09 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.095 0.558 . . . . 73.34 109.887 177.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -77.44 121.32 23.67 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.281 -1.007 . . . . 71.03 108.281 167.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -85.0 91.15 8.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.598 0.713 . . . . 74.0 110.434 -172.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -131.32 69.66 82.0 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.559 -1.2 . . . . 71.43 108.239 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -80.56 104.65 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.655 2.236 . . . . 63.14 111.933 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -86.99 118.01 26.08 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.753 -0.832 . . . . 61.55 108.753 176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.467 HG11 HD21 ' C' ' 126' ' ' LEU . 48.2 t -80.2 128.29 38.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 C-N-CA 123.819 0.848 . . . . 74.33 111.448 -174.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -127.36 104.31 7.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.688 1.195 . . . . 72.13 107.865 171.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.645 HD13 HD12 ' E' ' 186' ' ' LEU . 0.3 OUTLIER -86.65 165.83 15.83 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 120.838 0.352 . . . . 75.31 110.407 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.692 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -138.35 146.25 42.11 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 107.384 -1.339 . . . . 75.53 107.384 177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.7 tp -138.2 102.26 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 108.921 -0.77 . . . . 72.3 108.921 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 7.1 m-20 -120.09 142.32 48.99 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.427 0.691 . . . . 73.12 109.758 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.9 m -114.88 117.56 31.04 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.137 -0.69 . . . . 63.03 109.137 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.92 153.9 24.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.718 -1.216 . . . . 54.14 107.718 173.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.3 p -164.34 154.17 14.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.934 0.397 . . . . 70.12 111.328 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 15.5 p -170.34 138.92 1.63 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.248 1.019 . . . . 73.24 109.174 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -80.32 135.99 36.32 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.955 0.502 . . . . 44.11 109.817 177.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.444 ' CD1' HD12 ' C' ' 83' ' ' ILE . 63.7 mt -104.57 -26.56 12.3 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.83 0.852 . . . . 73.52 111.591 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.23 -172.99 1.39 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.383 0.673 . . . . 41.05 110.955 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.28 105.92 0.67 Allowed 'General case' 0 N--CA 1.483 1.207 0 O-C-N 123.985 0.803 . . . . 72.33 110.919 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.53 10.04 5.52 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.254 1.422 . . . . 54.33 112.519 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.41 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.545 0 N-CA-C 108.234 -1.024 . . . . 74.34 108.234 172.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -108.31 158.67 17.27 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.124 0.97 . . . . 73.34 108.75 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.437 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.4 tt0 -126.07 127.78 46.36 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.281 -1.007 . . . . 73.14 108.281 172.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 81.1 t -117.93 129.0 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 107.939 -1.134 . . . . 61.32 107.939 170.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 51.0 t -118.09 107.48 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.336 -0.987 . . . . 64.03 108.336 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.472 HD22 HG22 ' C' ' 62' ' ' VAL . 0.9 OUTLIER -86.19 106.21 17.14 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.069 -1.086 . . . . 72.33 108.069 179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 57.4 ttt180 -82.12 105.38 13.16 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.862 -0.792 . . . . 72.33 108.862 176.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.472 HG22 HD22 ' C' ' 60' ' ' LEU . 13.6 t -105.42 130.99 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 108.213 -1.032 . . . . 64.32 108.213 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.692 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 21.9 m -129.7 146.29 51.48 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.02 -0.733 . . . . 74.41 109.02 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.519 HG21 HG21 ' C' ' 114' ' ' ILE . 50.8 t -131.07 127.94 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 123.948 0.899 . . . . 72.5 108.655 174.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.484 HG23 HD23 ' C' ' 75' ' ' LEU . 4.2 m -123.2 109.16 13.64 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.657 -1.238 . . . . 72.42 107.657 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.67 121.14 41.14 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.056 -1.09 . . . . 54.31 108.056 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.8 m -129.8 133.05 46.74 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.282 0.563 . . . . 71.31 110.593 -176.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.812 HD13 ' HG2' ' C' ' 34' ' ' LYS . 12.0 mt -87.1 33.88 0.68 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 125.726 1.61 . . . . 74.14 110.085 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.77 -103.1 2.17 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.176 -0.769 . . . . 60.02 111.176 -172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -89.35 -31.61 17.71 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.427 0.691 . . . . 74.44 110.16 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.401 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 4.0 tp10 -79.21 120.22 23.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.684 1.194 . . . . 75.32 109.2 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 26.6 m -77.56 122.36 25.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 109.15 -0.685 . . . . 64.41 109.15 171.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -71.15 -50.29 34.94 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.353 0.661 . . . . 63.31 109.598 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -160.84 170.66 20.23 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.422 -1.263 . . . . 74.14 110.98 176.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.484 HD23 HG23 ' C' ' 65' ' ' THR . 2.4 tm? -136.35 147.23 47.27 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 106.996 -1.483 . . . . 53.13 106.996 176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.418 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -147.81 149.21 31.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.478 -0.934 . . . . 72.12 108.478 177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -157.61 118.81 3.58 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.848 0.459 . . . . 75.33 109.884 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -121.64 112.47 35.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 123.517 0.727 . . . . 54.52 109.364 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.454 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 49.7 mt-30 -94.82 99.64 11.67 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.704 -0.85 . . . . 73.44 108.704 175.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.62 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.1 tp-100 -85.07 104.93 15.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 71.43 110.542 -176.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.06 145.67 22.54 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 116.47 -0.332 . . . . 42.13 112.326 176.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.92 127.85 2.72 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.057 -0.417 . . . . 54.44 112.057 -177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.444 HD12 ' CD1' ' C' ' 51' ' ' LEU . 12.6 mm -91.19 125.03 43.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.606 0.762 . . . . 64.44 109.124 177.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.421 ' CE2' HD13 ' C' ' 13' ' ' ILE . 58.4 m-85 -133.69 118.31 17.99 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 108.864 -0.791 . . . . 72.01 108.864 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 58.1 p -85.69 97.37 10.09 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.817 -1.179 . . . . 62.44 107.817 171.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.4 pp -125.22 135.48 63.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-O 121.531 0.682 . . . . 43.35 111.235 -174.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.95 -178.54 5.98 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.191 1.396 . . . . 73.4 107.905 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.74 -30.56 4.18 Favored Glycine 0 N--CA 1.477 1.419 0 C-N-CA 121.391 -0.433 . . . . 52.15 113.642 170.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.422 HG13 ' H ' ' C' ' 89' ' ' ILE . 2.4 pp -68.0 140.77 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 124.098 0.959 . . . . 64.11 111.764 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.485 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 41.3 tt0 -155.28 151.51 28.13 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.267 0.627 . . . . 72.21 110.447 -174.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.3 -115.99 6.79 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.063 0.227 . . . . 70.24 112.847 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -71.95 -29.93 64.79 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.242 0.617 . . . . 74.22 110.874 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.485 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 42.4 mt-30 -64.1 -35.17 79.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.862 0.865 . . . . 74.22 111.105 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 5.1 tpt -55.07 -36.93 66.12 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.892 0.877 . . . . 45.35 111.054 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.49 -47.44 11.35 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.636 0.774 . . . . 62.33 111.523 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 m170 -73.7 -34.61 64.93 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.482 0.713 . . . . 72.12 112.656 -167.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -63.6 -55.97 19.54 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.614 0.571 . . . . 75.14 111.233 -175.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.743 HD11 HD11 ' E' ' 177' ' ' LEU . 1.0 OUTLIER -92.83 -16.69 25.01 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.198 0.599 . . . . 60.42 112.528 -175.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.414 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -97.95 -14.87 38.24 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.395 -0.67 . . . . 71.11 113.8 -172.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.08 -46.25 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 117.46 0.63 . . . . 70.35 111.979 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -74.7 -44.25 51.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.119 0.567 . . . . 63.41 111.972 -174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.511 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 73.2 m -67.63 -45.48 45.94 Favored Pre-proline 0 CA--C 1.562 1.437 0 CA-C-O 118.464 -0.779 . . . . 72.21 111.331 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.11 -36.65 96.63 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.249 1.966 . . . . 75.12 112.734 169.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -61.91 -33.44 74.24 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.546 0.738 . . . . 64.43 111.712 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.432 HG23 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -68.37 -39.31 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.165 0.586 . . . . 72.32 110.413 175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.7 mt -80.84 -32.73 34.97 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.274 -0.876 . . . . 74.02 112.483 -171.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -54.19 -48.72 93.49 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-O 117.288 -1.339 . . . . 73.22 113.182 -172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -45.04 -43.19 15.86 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.974 2.449 . . . . 64.11 114.544 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -70.45 -45.32 66.01 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.285 0.634 . . . . 73.23 111.052 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.9 -37.01 81.19 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.117 0.567 . . . . 72.42 110.959 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -54.12 -51.08 65.37 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.341 1.456 . . . . 73.05 110.517 173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -72.24 -32.03 66.33 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.224 -0.898 . . . . 64.53 110.92 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 47.7 t -74.6 -30.84 61.83 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.896 0.478 . . . . 73.51 111.609 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.519 HG21 HG21 ' C' ' 64' ' ' VAL . 94.3 mt -71.7 -46.31 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 109.572 -0.529 . . . . 73.22 109.572 171.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.521 HG23 ' HB2' ' C' ' 125' ' ' GLN . 54.2 m -51.28 -42.54 61.18 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.132 0.973 . . . . 71.35 110.834 176.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 40.6 t -63.68 -52.56 60.13 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.811 -1.541 . . . . 55.44 110.219 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.469 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.93 -40.96 81.7 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.362 1.065 . . . . 73.31 113.162 -176.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -63.44 -46.44 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 123.283 0.633 . . . . 75.21 110.151 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.1 t -64.83 -27.69 69.05 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.001 -1.0 . . . . 71.03 111.648 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 76.6 mtt-85 -70.06 -37.26 75.46 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.616 0.767 . . . . 72.31 110.286 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.92 8.55 56.54 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.172 -0.793 . . . . 55.24 113.135 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 42.8 p 61.28 26.99 16.75 Favored 'General case' 0 C--N 1.363 1.178 0 C-N-CA 125.933 1.693 . . . . 74.14 112.664 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 51.5 m-85 -100.15 167.73 10.52 Favored Pre-proline 0 CA--C 1.562 1.44 0 C-N-CA 124.385 1.074 . . . . 72.44 109.606 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 45.0 Cg_endo -66.06 111.65 2.05 Favored 'Trans proline' 0 C--N 1.389 2.686 0 C-N-CA 122.051 1.834 . . . . 54.32 111.682 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' C' ' 115' ' ' THR . 0.0 OUTLIER -47.47 143.32 3.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 124.569 1.147 . . . . 71.42 112.048 -173.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.467 HD21 HG11 ' C' ' 40' ' ' VAL . 1.2 tm? -111.13 91.25 3.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.21 0.529 . . . . 74.11 110.13 -173.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -129.95 92.33 3.29 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.866 -1.161 . . . . 64.1 107.866 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.535 HD13 ' HB3' ' E' ' 189' ' ' ALA . 61.6 mt -87.36 154.25 20.82 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.104 0.962 . . . . 72.14 111.442 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.72 136.27 13.28 Favored Pre-proline 0 CA--C 1.553 1.083 0 O-C-N 124.42 1.075 . . . . 73.41 112.143 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.556 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 40.8 Cg_endo -63.85 108.4 0.9 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.989 2.46 . . . . 75.24 112.537 -177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 55.8 t -73.33 87.75 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 123.375 0.67 . . . . 71.12 109.492 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.77 101.59 8.55 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.945 -0.761 . . . . 43.31 108.945 175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.88 -43.66 73.39 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.07 0.948 . . . . 72.53 111.096 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.07 -19.37 62.48 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.99 -1.004 . . . . 65.01 111.66 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.42 -48.51 64.43 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.623 0.369 . . . . 52.32 110.746 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.61 -38.37 89.26 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.275 -0.421 . . . . 72.34 110.044 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -64.88 -29.82 70.79 Favored 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 123.767 0.827 . . . . 53.4 110.868 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -69.8 -52.2 27.14 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.761 0.824 . . . . 70.53 110.967 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -69.17 -44.85 71.38 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 120.926 0.393 . . . . 74.44 110.715 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -73.91 -153.16 0.03 OUTLIER 'General case' 0 CA--C 1.563 1.453 0 CA-C-N 115.429 -0.805 . . . . 74.44 110.378 173.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 67.22 -70.62 0.11 Allowed 'General case' 0 C--N 1.365 1.274 0 C-N-CA 125.488 1.515 . . . . 62.01 109.699 -175.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.413 ' OE1' ' HG3' ' C' ' 144' ' ' GLN . 3.2 pp0? -88.32 -177.27 5.62 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.923 0.889 . . . . 72.35 110.92 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -150.44 97.44 2.52 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 107.552 -1.277 . . . . 75.32 107.552 172.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.413 ' HG3' ' OE1' ' C' ' 142' ' ' GLN . 22.2 mt-30 -80.67 -72.13 0.43 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.783 0.433 . . . . 73.32 110.871 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.492 ' HB3' ' HG3' ' A' ' 8' ' ' GLU . . . -155.59 -54.84 0.09 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.338 0.655 . . . . 72.45 109.954 172.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 135.59 -31.8 2.62 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.618 -0.265 . . . . 54.22 112.671 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 162.63 41.09 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 123.659 0.784 . . . . 75.13 110.268 176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.8 -163.0 9.82 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 109.297 -1.521 . . . . 53.41 109.297 169.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 92.0 m -158.16 128.95 6.34 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.691 -0.855 . . . . 75.43 108.691 170.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -109.6 88.27 2.7 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.818 -0.808 . . . . 72.23 108.818 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -79.8 73.35 6.55 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.231 -1.026 . . . . 63.22 108.231 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -154.06 174.79 14.23 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.846 1.258 . . . . 72.14 109.045 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 73.71 -2.09 2.87 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.833 1.253 . . . . 62.21 112.689 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 35.2 t70 51.53 54.17 11.49 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 122.959 1.362 . . . . 73.21 108.211 -166.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . 0.509 ' HB1' HD12 ' G' ' 173' ' ' LEU . . . . . . . . 0 C--O 1.248 1.001 0 CA-C-N 113.428 -1.714 . . . . 65.42 111.323 -168.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.434 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.433 -0.318 . . . . 62.43 110.468 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m 73.65 173.63 0.28 Allowed 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 125.283 1.433 . . . . 71.44 110.554 -164.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -77.52 -89.73 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.805 0.442 . . . . 70.34 110.901 -172.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 167.47 151.64 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.337 1.455 . . . . 75.23 109.087 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -160.02 140.73 12.07 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.755 -0.461 . . . . 33.2 109.755 165.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -103.68 98.29 8.18 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.188 0.995 . . . . 52.02 108.506 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 23.8 p -76.13 -53.56 8.12 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 122.735 0.414 . . . . 55.1 109.92 175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.44 ' HB3' ' OE1' ' B' ' 144' ' ' GLN . 8.8 pt-20 -161.39 45.56 0.18 Allowed 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.263 -0.881 . . . . 55.11 110.165 -177.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -30.61 131.4 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.209 1.559 . . . . 74.03 115.209 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -136.14 143.92 44.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.725 0.81 . . . . 73.1 109.11 168.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -150.47 94.05 2.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.26 -1.385 . . . . 52.52 107.26 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.449 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 80.9 mt-30 -112.11 131.89 55.18 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.644 0.778 . . . . 62.51 108.967 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.449 HG22 HD13 ' E' ' 204' ' ' ILE . 1.6 mp -80.04 138.68 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 108.231 -1.026 . . . . 75.13 108.231 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.579 ' HG2' ' HD3' ' E' ' 205' ' ' LYS . 52.8 mt-30 -106.04 -48.95 3.48 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 110.282 -0.266 . . . . 71.21 110.282 173.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 ttt85 -176.23 130.26 0.22 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 123.071 0.232 . . . . 74.13 111.618 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.429 ' HB ' ' HG3' ' B' ' 130' ' ' PRO . 3.1 mp -117.71 128.83 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.199 -1.037 . . . . 71.24 108.199 176.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -150.21 165.02 34.17 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.396 1.079 . . . . 73.51 110.546 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.6 p -90.85 113.55 25.75 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.289 -0.634 . . . . 74.34 109.289 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 44.3 mtpt -78.95 -31.64 45.16 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.133 0.492 . . . . 72.15 109.964 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -150.37 142.29 23.86 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.053 -0.976 . . . . 73.3 109.3 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.469 HD13 ' HE3' ' C' ' 117' ' ' MET . 63.1 mt -141.34 144.33 26.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.51 -1.293 . . . . 73.44 107.51 174.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.3 t -147.53 142.62 27.1 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.65 -0.87 . . . . 71.31 108.65 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.5 t80 -147.36 125.51 12.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.672 -1.603 . . . . 65.45 106.672 170.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.7 147.01 51.45 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.92 0.888 . . . . 75.44 108.707 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.67 78.43 37.08 Favored Pre-proline 0 C--O 1.24 0.58 0 N-CA-C 107.498 -1.297 . . . . 74.24 107.498 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -66.21 -29.52 47.02 Favored 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.429 2.086 . . . . 52.4 112.275 -174.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -114.4 27.95 9.1 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.892 0.877 . . . . 52.43 110.139 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.12 -57.22 6.5 Favored Pre-proline 0 CA--C 1.576 1.974 0 N-CA-C 116.24 1.941 . . . . 54.21 116.24 -174.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 83' ' ' ILE . 24.1 Cg_endo -87.97 -5.17 6.91 Favored 'Trans proline' 0 C--N 1.384 2.404 0 CA-C-N 122.321 1.865 . . . . 74.24 112.955 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.453 ' HA ' HE21 ' D' ' 33' ' ' GLN . 13.6 t-160 -79.0 -30.95 44.56 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.11 1.364 . . . . 74.45 108.751 171.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' D' ' 123' ' ' PHE . 3.1 t -68.13 -28.59 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.81 1.244 . . . . 61.13 110.82 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -53.65 -23.41 11.18 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.44 0.696 . . . . 74.11 112.605 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' D' ' 30' ' ' HIS . 41.2 mt-30 -86.56 -0.03 55.31 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.644 0.778 . . . . 62.32 112.704 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -126.96 113.12 16.08 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.234 1.013 . . . . 73.43 110.764 -176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.471 ' HA ' ' HB2' ' H' ' 195' ' ' PHE . 7.7 p-10 -98.69 64.62 1.51 Allowed 'General case' 0 CA--C 1.555 1.166 0 CA-C-O 122.189 0.995 . . . . 65.12 110.874 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.507 ' HB2' HD22 ' D' ' 68' ' ' LEU . 14.5 m95 -126.18 173.79 8.99 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.858 0.863 . . . . 75.24 109.508 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' H' ' 194' ' ' ALA . 8.6 tp-100 -89.49 125.62 60.92 Favored Pre-proline 0 N--CA 1.476 0.842 0 N-CA-C 108.259 -1.015 . . . . 65.24 108.259 169.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.06 127.44 21.25 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 121.852 1.701 . . . . 75.1 111.588 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 0.4 OUTLIER -65.41 111.16 2.93 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 107.678 -1.23 . . . . 74.03 107.678 172.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.674 HG13 HG13 ' D' ' 64' ' ' VAL . 59.6 t -104.35 114.42 43.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 122.864 0.465 . . . . 72.13 110.36 -172.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 4.7 tppp? -87.45 120.27 28.58 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.569 -0.741 . . . . 74.24 109.325 169.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.474 HD21 HD22 ' D' ' 128' ' ' LEU . 7.4 mp -96.27 111.72 23.7 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.486 -1.302 . . . . 64.03 107.486 171.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.578 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.6 t70 -109.47 119.6 39.95 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 108.227 -1.027 . . . . 51.22 108.227 175.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.9 tp -96.58 131.12 43.54 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.298 0.639 . . . . 70.55 109.987 -174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.9 t70 -139.42 151.71 46.48 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.096 0.958 . . . . 62.11 108.528 171.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -143.0 155.98 44.76 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.401 0.68 . . . . 75.32 109.598 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.86 163.72 37.28 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.908 0.883 . . . . 62.21 109.096 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.1 p -150.12 153.17 35.91 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.113 0.565 . . . . 75.14 110.006 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.6 p -154.26 123.38 6.41 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.849 0.86 . . . . 55.34 109.005 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -75.99 121.07 22.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 122.891 0.476 . . . . 75.52 110.083 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.2 mt -89.38 -38.63 13.98 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.502 0.668 . . . . 64.4 109.393 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.16 -176.69 5.59 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.38 -1.282 . . . . 40.12 109.504 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -62.4 122.43 15.69 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.799 -0.637 . . . . 75.14 110.918 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 71.04 1.71 3.92 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 125.519 1.528 . . . . 62.43 112.55 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.9 t -110.04 123.08 65.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 124.198 0.999 . . . . 75.04 109.871 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.59 129.94 33.69 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.106 0.563 . . . . 64.45 109.998 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' D' ' 51' ' ' LEU . 9.3 tt0 -95.16 120.38 35.28 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.828 -1.175 . . . . 72.24 107.828 167.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 16.7 m -110.07 134.62 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 109.028 -0.731 . . . . 74.32 109.028 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.9 t -108.92 129.21 63.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.037 0.535 . . . . 73.05 110.029 -175.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.49 123.04 44.88 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 107.562 -1.273 . . . . 70.43 107.562 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.7 ttm-85 -108.8 102.84 11.84 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.876 -0.787 . . . . 74.43 108.876 174.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.82 107.06 19.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.114 -1.069 . . . . 73.3 108.114 172.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.578 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 45.6 m -97.68 136.1 38.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.922 -0.581 . . . . 63.12 109.603 177.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.674 HG13 HG13 ' D' ' 40' ' ' VAL . 53.4 t -126.67 103.61 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.825 1.25 . . . . 62.43 108.742 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 29.2 m -104.62 94.52 5.35 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.917 -1.142 . . . . 73.53 107.917 173.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.06 140.64 30.5 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.851 -0.613 . . . . 34.11 110.115 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.516 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.5 m -148.43 126.12 11.81 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 121.158 0.504 . . . . 65.54 111.577 -175.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' D' ' 36' ' ' TRP . 26.2 mt -94.72 109.25 21.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.704 0.802 . . . . 70.0 109.634 176.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.25 -111.52 3.28 Favored Glycine 0 C--N 1.346 1.139 0 O-C-N 123.366 0.417 . . . . 61.03 112.283 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.57 7.96 12.78 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.367 0.667 . . . . 75.15 110.745 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.12 165.46 18.18 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.835 0.854 . . . . 73.12 109.302 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.3 m -75.8 136.37 40.24 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.278 0.631 . . . . 45.52 111.217 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.516 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -87.88 -65.73 0.99 Allowed 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.93 -1.137 . . . . 71.21 107.93 175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.04 151.3 30.08 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-N 114.984 -1.007 . . . . 71.22 110.333 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.37 146.15 29.24 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 107.929 -1.137 . . . . 71.3 107.929 169.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.1 t -159.36 138.68 11.32 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.568 -0.53 . . . . 61.2 109.568 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -157.35 133.87 9.86 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.027 0.376 . . . . 74.11 110.602 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -131.8 118.13 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.175 0.59 . . . . 73.2 110.071 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.6 mt-30 -90.25 86.03 6.4 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.703 0.801 . . . . 72.24 109.24 170.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.16 95.16 6.81 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.661 1.185 . . . . 75.15 109.604 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.27 143.29 18.63 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 111.88 -0.488 . . . . 73.3 111.88 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.14 130.88 4.16 Favored Glycine 0 C--N 1.337 0.61 0 N-CA-C 111.969 -0.453 . . . . 62.33 111.969 -178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 35.9 mt -90.47 133.6 31.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 C-N-CA 123.693 0.797 . . . . 71.43 109.534 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -136.7 134.61 37.39 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.319 0.648 . . . . 75.2 110.176 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 40.0 m -82.46 104.36 12.69 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.984 -0.747 . . . . 72.45 108.984 166.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.96 134.12 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.282 1.033 . . . . 70.34 109.432 -174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.98 167.11 12.93 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.644 0.778 . . . . 73.01 111.39 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.13 -2.07 77.56 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 115.993 1.157 . . . . 72.41 115.993 166.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.441 HD12 ' HE2' ' D' ' 94' ' ' MET . 2.4 pp -123.18 169.99 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 C-N-CA 124.353 1.061 . . . . 61.31 109.469 174.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.554 ' HB2' ' H ' ' H' ' 172' ' ' ALA . 2.6 pp20? -164.18 -173.37 3.11 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 112.568 0.581 . . . . 75.1 112.568 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.61 -145.14 31.16 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 123.932 0.777 . . . . 62.25 114.171 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.0 m -69.43 -27.19 65.05 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 123.363 0.665 . . . . 75.24 110.251 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -60.79 -43.41 98.16 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 110.223 -0.288 . . . . 74.12 110.223 175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.441 ' HE2' HD12 ' D' ' 89' ' ' ILE . 50.3 ttm -68.08 -49.29 62.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.935 0.494 . . . . 74.32 111.118 176.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.24 -41.22 96.52 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.5 0.72 . . . . 61.4 112.228 -175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -87.63 -25.02 23.76 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.558 -0.746 . . . . 73.14 110.744 -174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.57 -41.26 96.41 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.299 -0.63 . . . . 71.34 109.299 170.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.442 HD21 HD12 ' H' ' 177' ' ' LEU . 27.3 tp -65.51 -42.79 91.67 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.151 -0.931 . . . . 61.21 111.05 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.54 -7.15 76.15 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.753 -0.658 . . . . 64.12 114.615 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.7 -62.75 0.55 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 117.672 0.736 . . . . 64.52 112.077 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -64.88 -47.01 79.4 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.562 0.579 . . . . 74.32 112.562 -167.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -65.25 -45.55 71.24 Favored Pre-proline 0 CA--C 1.557 1.242 0 CA-C-O 118.662 -0.685 . . . . 74.34 110.809 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -52.71 -38.86 77.61 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.266 1.978 . . . . 73.11 113.995 163.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -65.46 -27.73 68.72 Favored 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 122.852 0.461 . . . . 72.41 111.603 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -69.25 -44.88 80.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 172.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' D' ' 82' ' ' GLY . 65.0 mt -76.17 -20.26 57.71 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.829 -1.078 . . . . 65.03 111.732 -174.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -68.25 -40.22 19.89 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-O 117.436 -1.269 . . . . 70.23 113.989 -168.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.95 -42.2 59.49 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 121.722 1.651 . . . . 62.43 112.771 170.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -76.73 -34.94 58.08 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.186 0.994 . . . . 73.41 110.982 -175.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.45 -51.91 51.91 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.465 0.706 . . . . 70.01 110.016 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -56.22 -47.73 77.87 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.818 1.324 . . . . 74.4 110.851 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.74 -46.78 88.16 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 124.236 0.96 . . . . 73.24 111.727 -175.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.6 t -55.73 -41.17 73.49 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.301 1.001 . . . . 75.11 110.349 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.491 HG21 HG21 ' D' ' 64' ' ' VAL . 67.8 mt -66.73 -53.75 31.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 O-C-N 124.347 1.029 . . . . 64.44 110.935 175.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 37.2 m -55.82 -39.2 71.03 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.555 1.142 . . . . 74.52 111.148 -173.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -66.69 -46.23 76.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.573 -1.194 . . . . 52.15 110.261 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.1 mtm -66.23 -30.72 71.23 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 122.811 0.445 . . . . 64.23 112.097 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.474 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.8 t -64.37 -45.06 97.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 64.21 109.394 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.6 p -74.93 -24.32 58.47 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.258 -0.428 . . . . 62.11 111.458 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -74.16 -33.11 63.39 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.449 0.7 . . . . 74.41 109.938 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.11 4.58 85.81 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.976 -0.556 . . . . 63.13 112.531 172.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 68.4 p 61.44 29.6 18.51 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 126.168 1.787 . . . . 62.01 113.349 174.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' D' ' 31' ' ' VAL . 97.3 m-85 -87.91 168.67 16.09 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 125.001 1.32 . . . . 60.32 109.451 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.56 140.1 38.92 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.792 2.328 . . . . 70.11 111.662 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -52.77 130.37 32.61 Favored 'General case' 0 C--O 1.243 0.763 0 O-C-N 124.057 0.848 . . . . 72.43 111.804 -177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 58.7 tp -119.32 96.43 5.21 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.24 1.016 . . . . 64.01 109.401 -175.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.73 98.34 9.18 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.672 -0.862 . . . . 72.41 108.672 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.474 HD22 HD21 ' D' ' 42' ' ' LEU . 75.5 mt -69.23 115.33 8.38 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.213 0.605 . . . . 75.31 109.692 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.84 135.77 87.03 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.264 0.625 . . . . 52.21 111.828 -172.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 11.2 Cg_endo -79.53 101.13 1.37 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 121.972 1.781 . . . . 71.22 110.029 -178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.9 p -107.95 114.27 46.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 124.058 0.943 . . . . 71.01 109.656 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -73.64 107.9 6.17 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.661 0.743 . . . . 60.55 109.588 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -62.64 -13.19 28.99 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.368 1.067 . . . . 71.55 112.101 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -64.39 -50.09 69.03 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 124.717 1.207 . . . . 62.23 111.118 173.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.55 -42.35 96.41 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 123.877 0.736 . . . . 41.33 110.322 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.52 -42.7 99.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.408 -0.815 . . . . 60.14 111.1 178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -65.73 -57.9 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.657 0.783 . . . . 73.25 111.155 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 76.5 mtm -59.37 -47.12 86.64 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.325 1.015 . . . . 64.21 111.005 -173.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.3 -38.12 84.48 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.723 0.639 . . . . 73.34 111.881 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -58.04 -46.53 85.19 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.76 0.824 . . . . 73.21 111.132 -177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.82 -29.77 68.18 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.644 -0.707 . . . . 72.02 111.392 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -78.68 1.29 23.39 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.188 0.595 . . . . 75.22 111.998 177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -122.8 91.39 3.48 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 75.21 109.136 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -144.07 -42.85 0.26 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.853 0.861 . . . . 73.0 110.071 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.93 129.13 37.28 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 123.337 0.655 . . . . 65.2 110.432 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.07 -175.58 39.47 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.627 0.58 . . . . 64.15 112.06 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.33 159.01 38.41 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.978 0.511 . . . . 55.4 110.525 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -135.23 162.77 24.85 Favored Glycine 0 C--N 1.337 0.609 0 CA-C-N 115.653 -0.703 . . . . 74.54 111.67 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -116.79 140.71 49.11 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 121.275 0.559 . . . . 72.45 110.334 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -81.92 147.34 29.32 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.744 -0.836 . . . . 51.12 108.744 168.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -165.53 90.09 0.46 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.433 -0.951 . . . . 61.32 108.433 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -159.59 173.19 16.5 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.356 1.462 . . . . 74.33 108.746 176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -159.02 156.13 28.75 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.62 0.768 . . . . 75.21 109.647 172.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -123.05 21.32 9.79 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.353 0.661 . . . . 75.35 109.345 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 C-N-CA 123.568 0.747 . . . . 37.69 110.147 178.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 N--CA 1.481 1.088 0 N-CA-C 110.263 -0.273 . . . . 73.33 110.263 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.32 26.39 0.04 OUTLIER Glycine 0 C--N 1.347 1.154 0 O-C-N 123.726 0.641 . . . . 62.4 112.382 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -66.92 89.42 0.16 Allowed 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.246 1.018 . . . . 72.11 110.872 -177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 56.8 p -175.88 -58.01 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.085 1.354 . . . . 54.21 108.349 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -159.42 166.17 31.61 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 125.126 1.371 . . . . 73.1 108.725 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.506 ' HB3' ' HE3' ' E' ' 174' ' ' MET . 87.7 mt 62.88 173.51 0.15 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.293 1.037 . . . . 72.41 111.923 -176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.506 ' HE3' ' HB3' ' E' ' 173' ' ' LEU . 29.8 mmt 55.98 30.73 16.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.806 1.642 . . . . 75.11 113.538 171.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 55.2 t80 66.79 105.92 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.995 1.318 . . . . 72.14 111.245 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -108.7 -81.25 0.57 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.434 0.694 . . . . 53.02 110.337 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . 0.743 HD11 HD11 ' C' ' 98' ' ' LEU . 6.1 mp 57.28 -151.73 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.47 1.108 . . . . 74.42 111.775 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 76.62 -62.47 0.41 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.983 1.313 . . . . 74.24 111.004 -178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . 0.43 ' HB3' ' HD3' ' E' ' 180' ' ' PRO . 26.1 tt0 -84.36 -58.37 0.37 Allowed Pre-proline 0 CA--C 1.56 1.353 0 CA-C-O 118.298 -0.858 . . . . 75.43 110.688 174.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' E' ' 179' ' ' GLU . 83.2 Cg_endo -83.16 102.36 1.06 Allowed 'Trans proline' 0 C--N 1.387 2.574 0 CA-C-N 121.778 1.671 . . . . 73.35 111.544 172.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -157.77 113.96 2.85 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.347 -0.842 . . . . 74.31 108.747 176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -91.25 134.83 34.25 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.034 -0.728 . . . . 75.32 109.034 -176.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 19.4 p -76.14 141.11 42.0 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.449 0.7 . . . . 21.42 110.772 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -83.79 125.36 73.44 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.752 0.821 . . . . 73.44 111.442 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -93.81 103.29 0.14 Allowed 'Trans proline' 0 CA--C 1.56 1.782 0 C-N-CA 123.063 2.509 . . . . 73.14 111.846 166.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.645 HD12 HD13 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -120.68 156.59 31.43 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.94 0.896 . . . . 75.41 111.537 -174.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.518 ' O ' HD11 ' C' ' 42' ' ' LEU . 37.4 pt -89.76 142.9 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.025 0.93 . . . . 54.11 111.313 -176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -102.96 74.16 1.29 Allowed 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.124 -1.065 . . . . 62.42 108.124 165.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . 0.535 ' HB3' HD13 ' C' ' 128' ' ' LEU . . . -75.0 88.29 2.37 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.572 -0.74 . . . . 65.04 111.167 -174.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -81.66 -170.42 2.81 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 114.378 -1.283 . . . . 63.53 111.251 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -142.12 98.57 0.22 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.381 -1.088 . . . . 54.3 110.381 175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.9 80.22 0.01 OUTLIER Glycine 0 C--N 1.355 1.639 0 O-C-N 124.513 0.772 . . . . 71.4 113.143 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 44.9 t80 63.86 4.04 1.82 Allowed 'General case' 0 CA--C 1.564 1.492 0 C-N-CA 125.615 1.566 . . . . 72.32 112.458 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.46 80.73 4.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.619 0.768 . . . . 75.24 111.028 -173.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -164.75 146.37 8.07 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.182 1.393 . . . . 71.14 108.719 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -122.71 115.39 21.99 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 72.21 109.777 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -108.61 -57.99 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.602 0.761 . . . . 73.01 109.711 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -80.77 -40.48 25.04 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 115.689 -0.687 . . . . 70.33 110.911 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -85.38 123.07 30.42 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.964 -1.124 . . . . 62.22 107.964 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 115.21 -20.17 14.34 Favored Glycine 0 N--CA 1.469 0.898 0 N-CA-C 110.485 -1.046 . . . . 70.32 110.485 -164.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 9.4 tptp 58.84 48.44 11.22 Favored 'General case' 0 C--N 1.363 1.166 0 C-N-CA 125.443 1.497 . . . . 73.03 111.247 172.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -78.86 78.13 5.31 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 121.853 0.835 . . . . 55.44 109.435 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -176.42 147.24 0.66 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.64 1.576 . . . . 73.25 107.95 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.449 HD13 HG22 ' D' ' 13' ' ' ILE . 3.1 mp -91.21 -87.05 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.912 -0.773 . . . . 75.2 108.912 -176.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' D' ' 14' ' ' GLN . 13.9 mmmm 46.43 41.52 9.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 124.388 1.075 . . . . 75.35 113.776 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -152.7 -61.21 0.15 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.043 -1.095 . . . . 71.12 108.043 -178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . 0.251 10.7 p . . . . . 0 CA--C 1.571 1.773 0 C-N-CA 126.58 1.952 . . . . 72.3 113.915 173.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 8.3 mptt . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.894 -0.409 . . . . 71.5 109.894 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -119.28 53.11 0.68 Allowed Glycine 0 N--CA 1.471 0.968 0 N-CA-C 111.426 -0.67 . . . . 45.24 111.426 177.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -170.77 168.55 7.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.051 0.941 . . . . 74.44 109.348 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 26.8 p -57.15 150.18 18.03 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.39 1.076 . . . . 71.24 111.987 170.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -145.08 114.07 6.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.581 0.753 . . . . 50.44 109.197 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.491 HD21 ' H ' ' B' ' 54' ' ' ASP . 85.6 mt -124.5 111.8 16.13 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.48 0.712 . . . . 72.41 111.519 -173.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.718 ' HG2' ' SD ' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.68 89.74 1.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.1 0.96 . . . . 72.11 109.106 -175.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -81.46 78.11 8.25 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-O 121.598 0.713 . . . . 75.12 109.931 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -95.58 71.48 3.11 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.574 -0.739 . . . . 74.45 109.377 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 40.4 tp -80.47 -29.97 37.46 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.038 -0.983 . . . . 75.33 109.696 176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -67.33 139.34 57.22 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.987 0.915 . . . . 75.55 112.349 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 59.34 83.81 0.21 Allowed Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 125.395 1.478 . . . . 71.14 111.741 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.55 128.55 16.39 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.152 2.568 . . . . 63.1 111.836 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -66.37 107.24 1.95 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.23 0.612 . . . . 75.14 110.105 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 65.92 100.52 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.942 1.297 . . . . 73.11 111.206 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 43.2 p -67.5 107.67 2.56 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.236 0.614 . . . . 73.42 109.646 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.502 ' HE1' HD22 ' B' ' 136' ' ' LEU . 5.3 m-90 -87.69 110.48 35.01 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 123.517 0.727 . . . . 72.31 110.549 -176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -81.74 2.28 8.66 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.492 2.128 . . . . 73.03 112.45 175.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.564 HD13 HD11 ' B' ' 128' ' ' LEU . 58.4 mt 63.69 -92.33 0.03 OUTLIER 'General case' 0 C--N 1.358 0.959 0 C-N-CA 125.523 1.529 . . . . 74.32 111.025 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.496 HD11 ' HA ' ' B' ' 128' ' ' LEU . 1.8 pp -161.85 -178.26 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.176 1.391 . . . . 74.2 109.327 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -155.31 167.06 31.62 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 62.2 109.73 173.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -127.45 120.2 27.83 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.188 0.995 . . . . 62.21 108.51 176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.84 -7.87 38.47 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 113.228 0.825 . . . . 62.42 113.228 -175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.19 -162.43 46.15 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.427 -0.669 . . . . 72.52 111.427 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 146.91 -144.9 13.19 Favored Glycine 0 N--CA 1.467 0.746 0 CA-C-N 117.222 0.511 . . . . 62.43 112.461 177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . 0.48 ' H ' ' HD1' ' F' ' 193' ' ' TYR . 0.4 OUTLIER -81.25 130.56 35.08 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.224 0.61 . . . . 73.23 111.001 -179.064 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -158.61 -83.8 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.532 0.733 . . . . 62.13 110.601 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.534 ' HZ ' ' HA ' ' B' ' 123' ' ' PHE . 96.6 m-85 -54.52 -67.33 0.27 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.84 0.856 . . . . 73.33 112.663 -169.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 17.3 tptm 52.13 29.59 6.63 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 124.525 1.141 . . . . 62.12 111.035 -167.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . 0.409 ' N ' ' HB2' ' B' ' 35' ' ' ASP . 51.5 t80 50.19 -85.78 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.66 1.984 . . . . 72.33 113.191 -176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.22 -13.46 62.19 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.728 0.811 . . . . 63.45 112.339 -169.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' F' ' 195' ' ' PHE . 27.9 t-20 -64.09 -29.52 70.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.725 0.81 . . . . 71.45 110.92 176.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 88.99 13.55 62.08 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 115.244 0.858 . . . . 62.43 115.244 169.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -71.34 92.85 1.08 Allowed 'General case' 0 C--N 1.346 0.415 0 CA-C-N 117.163 0.481 . . . . 74.44 109.774 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 63.13 29.43 16.14 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.13 1.372 . . . . 65.21 109.612 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . 0.442 ' HB2' ' HD2' ' F' ' 195' ' ' PHE . 4.9 t0 -144.92 171.56 14.28 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 113.864 -1.516 . . . . 74.11 107.52 -170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 14.8 tt -67.68 141.16 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 CA-C-O 121.28 0.562 . . . . 72.23 110.294 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -129.61 -77.69 0.55 Allowed 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.428 0.691 . . . . 64.32 109.4 -177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -125.44 149.45 48.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.3 0.64 . . . . 74.2 109.73 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.481 1.103 0 C-N-CA 124.949 1.3 . . . . 73.12 109.176 174.842 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 87.2 tttt . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.224 -0.287 . . . . 72.43 110.224 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 53.59 -99.63 0.05 OUTLIER Glycine 0 C--N 1.361 1.959 0 O-C-N 124.341 1.025 . . . . 63.2 112.81 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' C' ' 155' ' ' ALA . 10.1 mttp -127.09 137.14 52.96 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.501 -0.926 . . . . 73.54 108.501 166.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 9.6 m -103.32 -33.28 9.18 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.161 0.984 . . . . 74.5 109.549 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.67 -78.67 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.063 0.945 . . . . 71.24 109.764 172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.634 HD23 ' H ' ' A' ' 54' ' ' ASP . 0.2 OUTLIER 65.66 104.45 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.794 1.637 . . . . 72.34 110.72 -175.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 33.0 mtm -139.76 -64.46 0.49 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.365 1.066 . . . . 71.42 109.201 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.415 ' HA ' ' CE ' ' A' ' 94' ' ' MET . 44.4 t80 56.8 97.88 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.636 1.574 . . . . 72.45 112.751 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -118.66 119.57 34.85 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.881 -0.785 . . . . 71.32 108.881 175.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 21.9 tp -154.22 37.7 0.44 Allowed 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 107.879 -1.156 . . . . 73.42 107.879 177.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -68.91 -22.17 64.18 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.537 -1.21 . . . . 54.33 112.846 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.37 152.73 69.86 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.158 0.983 . . . . 75.52 109.894 -172.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.76 109.33 2.72 Favored 'Trans proline' 0 C--N 1.369 1.648 0 C-N-CA 122.151 1.901 . . . . 60.21 109.69 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -67.88 -57.42 6.27 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.318 -0.855 . . . . 74.34 111.176 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -141.31 154.11 45.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.699 0.8 . . . . 71.15 109.698 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 17.8 p -80.81 140.29 35.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.416 -0.587 . . . . 61.21 109.416 170.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -145.29 86.01 7.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.326 0.651 . . . . 75.34 109.997 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.45 161.79 39.42 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.113 1.875 . . . . 74.34 112.015 174.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . 0.59 ' HG ' HG21 ' A' ' 131' ' ' VAL . 8.3 tt -135.22 156.15 49.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.852 -1.166 . . . . 73.03 107.852 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.654 HG21 HG23 ' H' ' 204' ' ' ILE . 34.7 pt -57.17 155.11 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 124.123 0.969 . . . . 64.02 112.669 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -112.21 -11.79 13.71 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.37 0.668 . . . . 65.44 111.19 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . 60.62 51.43 5.04 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.969 0.908 . . . . 64.24 111.735 175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -79.73 95.09 5.87 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 115.389 -0.823 . . . . 64.34 110.621 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 152.15 78.95 0.02 OUTLIER Glycine 0 C--N 1.346 1.128 0 C-N-CA 121.461 -0.399 . . . . 71.34 112.812 175.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -136.39 139.52 10.73 Favored Glycine 0 C--N 1.343 0.951 0 N-CA-C 111.149 -0.78 . . . . 73.45 111.149 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -145.25 -18.98 0.49 Allowed 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.451 0.7 . . . . 71.13 110.557 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -67.83 135.18 52.17 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.978 0.511 . . . . 75.5 111.579 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.427 ' HD1' ' N ' ' G' ' 196' ' ' LYS . 5.4 t80 -133.21 -127.18 0.17 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.25 -1.018 . . . . 65.33 108.25 172.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.427 ' N ' ' HD1' ' G' ' 195' ' ' PHE . 95.3 mttt -152.53 8.0 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.794 1.238 . . . . 75.11 109.965 -170.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.94 156.4 48.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.537 0.735 . . . . 73.54 109.521 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' H' ' 193' ' ' TYR . 1.0 OUTLIER -164.34 113.91 1.19 Allowed 'General case' 0 C--O 1.242 0.659 0 N-CA-C 105.839 -1.911 . . . . 61.42 105.839 168.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 61.6 t30 67.79 176.15 0.26 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 124.6 1.188 . . . . 63.44 109.888 -170.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.57 80.51 0.12 Allowed Glycine 0 C--N 1.346 1.135 0 N-CA-C 111.011 -0.836 . . . . 43.21 111.011 168.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 178.34 8.34 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.555 0.742 . . . . 75.41 110.878 -176.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 55.6 t80 63.85 72.09 0.47 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.704 -0.85 . . . . 74.41 108.704 -176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.51 95.6 1.41 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.193 -0.912 . . . . 71.45 109.133 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.81 HG12 ' H ' ' G' ' 206' ' ' ASP . 5.5 tt -73.72 145.38 11.55 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 CA-C-N 114.545 -1.207 . . . . 70.44 110.598 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -72.37 -16.86 61.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.924 0.889 . . . . 54.2 110.521 175.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . 0.81 ' H ' HG12 ' G' ' 204' ' ' ILE . 2.5 m-20 75.43 169.4 0.28 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.239 1.816 . . . . 62.22 110.29 -169.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.564 1.502 0 CA-C-O 118.531 -0.747 . . . . 44.44 110.269 -177.82 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 109.139 -0.689 . . . . 73.11 109.139 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 71.19 -96.21 0.61 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.992 -0.843 . . . . 62.11 110.992 -174.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -137.65 158.72 43.78 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.059 0.943 . . . . 73.42 109.155 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . 0.5 ' HB2' ' HG ' ' H' ' 173' ' ' LEU . 89.9 p -164.98 110.07 0.92 Allowed 'General case' 0 CA--C 1.542 0.656 0 O-C-N 123.653 0.595 . . . . 65.11 110.4 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.554 ' H ' ' HB2' ' D' ' 90' ' ' GLU . . . -51.51 -66.38 0.39 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.099 0.96 . . . . 72.04 109.975 170.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' H' ' 171' ' ' SER . 76.7 mt 42.73 92.05 0.01 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 125.273 1.608 . . . . 71.34 114.082 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.435 ' SD ' ' N ' ' H' ' 174' ' ' MET . 0.0 OUTLIER 72.01 156.6 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.752 1.221 . . . . 75.44 112.103 171.166 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -171.47 -167.56 0.53 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.29 0.636 . . . . 74.45 111.594 -161.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -91.28 -61.33 1.68 Allowed 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.53 -1.285 . . . . 75.23 107.53 161.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . 0.442 HD12 HD21 ' D' ' 98' ' ' LEU . 17.7 tp -142.56 -81.99 0.2 Allowed 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 106.217 -1.772 . . . . 72.43 106.217 173.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . 0.475 ' HA ' HE21 ' H' ' 178' ' ' GLN . 0.0 OUTLIER 162.21 -74.23 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.226 1.811 . . . . 64.13 106.324 178.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -173.67 152.96 2.13 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 113.976 -1.465 . . . . 74.34 108.091 -175.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.92 -14.75 32.61 Favored 'Trans proline' 0 C--N 1.37 1.677 0 C-N-CA 122.262 1.974 . . . . 73.02 113.952 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 62.2 -171.42 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.922 0.889 . . . . 70.41 110.526 -169.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -85.28 0.04 53.22 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.985 -0.447 . . . . 74.32 111.312 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 33.2 p 58.88 172.71 0.07 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.882 1.673 . . . . 72.51 112.099 -171.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 19.6 m-90 -133.56 145.21 55.38 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.556 -0.715 . . . . 75.34 110.593 -172.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.95 122.19 8.25 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.811 2.34 . . . . 62.05 111.925 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.18 -101.48 0.06 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 122.817 0.447 . . . . 70.4 110.277 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 4.6 mp -136.69 152.17 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 N-CA-C 107.622 -1.251 . . . . 43.02 107.622 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -130.17 92.51 3.3 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.838 -0.801 . . . . 44.54 108.838 173.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.55 81.06 5.94 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.285 0.634 . . . . 32.15 109.975 -175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -107.96 -29.14 9.18 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.66 -0.7 . . . . 51.41 111.998 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.73 169.56 37.23 Favored Glycine 0 C--N 1.345 1.062 0 O-C-N 123.499 0.5 . . . . 65.13 113.887 -175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 84.15 178.52 51.6 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.889 0.405 . . . . 44.44 113.005 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.512 ' HB2' ' HB3' ' G' ' 198' ' ' GLU . 96.3 m-85 -130.89 -176.04 3.87 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.215 0.606 . . . . 73.01 110.169 177.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . 0.485 ' HB2' ' NE2' ' D' ' 37' ' ' GLN . . . -168.19 -170.24 1.26 Allowed 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.462 0.705 . . . . 63.33 110.763 -177.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' D' ' 35' ' ' ASP . 53.7 m-85 76.58 -51.76 0.59 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.482 1.513 . . . . 73.52 113.87 169.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp 61.0 40.13 15.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.969 0.907 . . . . 51.52 111.98 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -67.48 93.01 0.32 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.086 0.554 . . . . 74.04 110.988 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -135.91 -65.55 0.58 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.06 -1.459 . . . . 55.31 107.06 174.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -108.02 133.11 52.79 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.338 -0.616 . . . . 74.55 109.338 172.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.79 29.78 0.09 OUTLIER Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.584 -1.006 . . . . 75.45 110.584 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -87.5 -38.59 15.91 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 123.505 0.722 . . . . 74.33 109.873 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 72.49 -11.64 0.8 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.446 1.499 . . . . 73.52 113.503 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 48.15 36.74 7.01 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.77 1.228 . . . . 63.15 113.049 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.654 HG23 HG21 ' G' ' 187' ' ' ILE . 85.6 mt -69.58 -50.32 51.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 CA-C-N 115.121 -0.945 . . . . 73.02 109.857 173.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 65.22 -79.18 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 O-C-N 124.857 1.348 . . . . 64.45 110.016 -170.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -138.95 -77.33 0.35 Allowed 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 121.008 0.432 . . . . 74.31 110.188 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 CA--C 1.557 1.225 0 C-N-CA 124.83 1.252 . . . . 71.52 109.693 -167.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.353 -0.61 . . . . 73.21 109.353 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m 63.71 -79.15 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.878 1.271 . . . . 73.15 111.52 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 63.73 6.38 2.65 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.536 1.534 . . . . 54.42 113.853 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -104.55 92.4 4.28 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.414 -0.958 . . . . 63.22 108.414 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -158.48 136.71 10.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.946 -0.57 . . . . 73.15 110.448 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -74.21 -25.0 59.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.34 1.056 . . . . 50.12 111.309 -174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p -87.37 -11.65 48.68 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.606 0.362 . . . . 72.53 111.625 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -88.34 -15.37 35.82 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.056 0.542 . . . . 70.44 110.488 169.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 95.7 mtp -64.79 131.25 46.27 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.873 -0.788 . . . . 74.12 108.873 171.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 73.4 m -149.63 133.32 16.81 Favored 'General case' 0 C--O 1.217 -0.622 0 N-CA-C 107.921 -1.141 . . . . 74.14 107.921 -177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -136.57 144.0 43.93 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.143 -0.688 . . . . 72.42 109.143 172.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -157.76 137.24 11.98 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.499 0.5 . . . . 74.44 110.999 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.39 119.86 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 N-CA-C 109.374 -0.602 . . . . 73.25 109.374 168.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -97.93 -37.23 9.88 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.401 0.681 . . . . 70.12 110.393 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.5 ttt85 -172.95 141.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.806 0.442 . . . . 74.23 111.3 176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.6 mt -116.61 137.56 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 108.352 -0.981 . . . . 71.22 108.352 171.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -166.24 155.53 11.51 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.713 0.805 . . . . 72.41 111.226 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.0 p -87.04 114.64 23.82 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.973 -0.751 . . . . 74.54 108.973 169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 37.2 mtpt -76.72 -27.03 55.3 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.768 0.427 . . . . 73.33 109.986 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.9 t70 -154.59 140.75 18.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.414 -0.812 . . . . 65.53 109.466 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.8 mt -136.72 140.09 43.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.317 -1.364 . . . . 72.41 107.317 176.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.6 t -145.53 128.99 16.95 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.03 -0.729 . . . . 61.02 109.03 175.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.49 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 91.8 t80 -137.92 112.86 9.06 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.296 -1.742 . . . . 74.04 106.296 171.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -118.22 134.94 54.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.88 78.5 69.8 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 106.045 -1.835 . . . . 55.02 106.045 171.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.5 -24.49 26.21 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.186 1.924 . . . . 64.5 111.177 -177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -110.52 29.33 7.81 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 114.518 -1.219 . . . . 73.21 109.232 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -59.11 -43.64 97.51 Favored Pre-proline 0 CA--C 1.564 1.514 0 C-N-CA 124.283 1.033 . . . . 70.5 112.407 175.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.44 -25.57 70.67 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.231 1.475 . . . . 63.12 113.253 170.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -82.87 -13.77 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.022 0.529 . . . . 62.23 112.188 -174.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.5 p -63.25 -18.17 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 118.468 0.577 . . . . 62.34 111.994 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.67 -40.26 20.93 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.921 0.888 . . . . 65.13 110.521 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -82.98 -25.82 31.9 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.987 0.515 . . . . 72.2 110.751 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.25 146.67 28.44 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.392 0.677 . . . . 73.31 111.184 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -69.65 122.04 18.33 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.547 -1.206 . . . . 54.24 108.602 171.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.592 ' HD1' ' HA ' ' G' ' 194' ' ' ALA . 74.4 t-105 -82.03 86.71 6.52 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 121.494 0.664 . . . . 71.11 110.165 -178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -124.45 83.42 57.64 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 107.487 -1.301 . . . . 74.01 107.487 169.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -76.65 119.29 5.13 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.519 2.146 . . . . 71.05 112.337 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -97.45 112.03 24.04 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.012 -1.107 . . . . 64.4 108.012 175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -89.23 111.29 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.27 1.028 . . . . 71.2 110.729 -172.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -101.82 140.35 36.22 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.836 -0.802 . . . . 74.42 108.836 170.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.54 131.52 55.18 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.425 -0.954 . . . . 73.15 108.425 171.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.662 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -117.9 128.95 55.32 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.047 -1.094 . . . . 72.5 108.047 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 30.8 tp -98.15 128.9 44.9 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.215 -0.661 . . . . 74.24 109.215 176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 25.5 t70 -134.09 151.65 51.49 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.67 -0.863 . . . . 74.32 108.67 172.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.1 m -141.49 147.96 38.68 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.075 0.95 . . . . 73.44 108.493 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.519 ' HA ' HD22 ' G' ' 177' ' ' LEU . . . -132.34 142.95 49.53 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.493 -0.929 . . . . 64.22 108.493 173.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.609 ' H ' ' HB2' ' G' ' 177' ' ' LEU . 18.7 m -132.67 150.15 52.2 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 110.209 -0.293 . . . . 73.41 110.209 176.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -159.79 151.43 20.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.999 0.919 . . . . 65.04 109.128 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -95.53 114.08 25.8 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.838 -0.801 . . . . 53.3 108.838 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 57' ' ' GLU . 83.8 mt -84.09 -43.59 14.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.723 0.409 . . . . 73.31 110.198 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.6 -178.16 6.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.027 0.931 . . . . 60.22 109.277 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -65.98 122.88 18.38 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.967 -0.753 . . . . 63.22 108.967 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 66.67 13.66 9.44 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.81 1.244 . . . . 72.13 112.133 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.33 125.54 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.494 -0.928 . . . . 75.35 108.494 176.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HB3' ' HG3' ' G' ' 174' ' ' MET . 0.1 OUTLIER -130.87 168.32 17.49 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.277 0.56 . . . . 71.41 110.212 176.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 51' ' ' LEU . 31.2 tt0 -127.34 121.78 31.94 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.159 -1.052 . . . . 72.15 108.159 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.5 t -110.51 119.02 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 N-CA-C 107.778 -1.193 . . . . 74.2 107.778 172.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.63 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.5 t -99.16 135.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 123.79 0.836 . . . . 70.43 108.983 176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.37 112.01 23.89 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 106.9 -1.518 . . . . 75.11 106.9 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.508 ' HD3' ' HG2' ' A' ' 79' ' ' GLN . 12.2 ttp180 -108.42 104.33 13.67 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.387 -0.597 . . . . 75.25 109.387 176.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.99 132.42 39.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.237 -1.023 . . . . 64.42 108.237 174.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 9.1 m -114.02 138.2 50.69 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.823 -0.806 . . . . 72.12 108.823 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 39.9 t -133.71 108.58 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 C-N-CA 125.104 1.361 . . . . 75.24 108.382 -175.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 56.7 m -106.02 140.48 38.94 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.568 -0.53 . . . . 74.44 109.568 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.9 117.27 27.67 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.172 -1.047 . . . . 73.34 108.172 170.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 m -113.88 127.56 56.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.189 0.596 . . . . 74.3 110.367 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.4 mt -93.41 53.46 1.9 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.292 1.437 . . . . 72.32 109.642 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.6 -84.93 0.97 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-N 116.119 -0.491 . . . . 74.25 112.147 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -93.04 -28.41 16.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.666 0.786 . . . . 72.31 111.724 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -123.39 133.69 54.07 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.714 0.806 . . . . 73.55 109.893 -169.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.9 m -71.34 136.89 48.04 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 120.916 0.388 . . . . 62.31 110.459 173.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -61.8 1.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.19 0.996 . . . . 61.44 109.214 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -150.83 167.64 26.85 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 114.34 -1.3 . . . . 60.43 110.297 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.5 tp -134.43 140.36 46.2 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.806 1.242 . . . . 64.24 108.178 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.4 m -131.0 135.87 48.0 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.272 1.029 . . . . 53.31 108.973 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -150.17 123.45 8.95 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 122.602 0.361 . . . . 75.44 110.123 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -130.41 113.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.974 0.91 . . . . 74.21 109.749 -174.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.508 ' HG2' ' HD3' ' A' ' 61' ' ' ARG . 65.4 mt-30 -85.6 81.09 8.8 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 123.641 0.776 . . . . 73.51 108.916 172.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.74 90.53 3.43 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.154 0.982 . . . . 64.04 108.572 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.99 144.84 18.28 Favored Glycine 0 C--N 1.338 0.677 0 CA-C-N 116.087 -0.506 . . . . 53.4 112.325 -177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.477 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.12 130.83 5.0 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 111.983 -0.447 . . . . 32.02 111.983 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.8 mt -81.29 131.34 34.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 107.426 -1.324 . . . . 73.44 107.426 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 56' ' ' TYR . 37.7 m-85 -131.79 155.43 47.77 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.725 -0.843 . . . . 72.13 108.725 172.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -111.49 114.22 27.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.603 1.161 . . . . 72.52 108.035 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 tt -139.08 152.92 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 118.086 0.403 . . . . 73.35 111.033 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.82 169.34 13.35 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.374 1.069 . . . . 63.3 110.352 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.45 5.76 86.04 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 123.901 0.751 . . . . 73.21 114.701 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.05 153.67 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.154 0.981 . . . . 72.33 109.606 -177.06 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.23 170.48 22.38 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.165 0.586 . . . . 72.31 109.444 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.73 -125.3 34.59 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 123.701 0.667 . . . . 73.32 113.889 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.422 HG21 ' HG3' ' C' ' 147' ' ' GLU . 64.4 p -75.49 -21.39 58.08 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.731 0.812 . . . . 51.11 111.422 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -65.55 -40.16 92.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.004 0.522 . . . . 70.44 109.797 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.1 -47.44 24.47 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.311 -0.859 . . . . 72.53 109.92 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.42 -34.05 77.09 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.106 -0.952 . . . . 72.52 112.636 -172.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -78.89 -20.81 48.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.194 0.598 . . . . 55.53 110.855 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.532 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 49.4 t -80.42 -64.39 1.2 Allowed 'General case' 0 C--N 1.352 0.715 0 C-N-CA 122.413 0.285 . . . . 53.31 110.242 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.19 -37.12 84.08 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.961 0.504 . . . . 60.33 111.786 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.46 -15.11 64.62 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 114.92 0.728 . . . . 75.22 114.92 -172.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.447 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -140.88 -51.19 0.45 Allowed 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.637 0.718 . . . . 74.54 112.656 -171.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.526 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.5 t80 -77.71 -51.69 10.17 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.216 0.607 . . . . 71.04 112.55 -168.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 67.7 m -70.84 -38.9 8.03 Favored Pre-proline 0 CA--C 1.569 1.688 0 C-N-CA 123.935 0.894 . . . . 74.22 113.112 -176.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.37 -22.01 46.4 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.709 1.606 . . . . 62.23 112.434 169.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -71.42 -30.36 65.99 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.872 0.469 . . . . 73.22 110.492 175.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.1 mm -59.03 -40.08 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 109.375 -0.602 . . . . 61.01 109.375 170.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.477 HD21 ' HA3' ' A' ' 82' ' ' GLY . 36.1 mt -82.1 -21.85 36.54 Favored 'General case' 0 CA--C 1.551 0.982 0 CA-C-N 115.077 -0.965 . . . . 74.3 112.253 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -65.53 -39.31 32.26 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.697 1.369 . . . . 74.33 114.697 -170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -58.65 -34.76 99.11 Favored 'Trans proline' 0 C--N 1.393 2.899 0 CA-C-N 122.153 1.805 . . . . 64.31 112.51 173.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -80.76 -36.66 31.65 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.815 0.846 . . . . 64.31 110.459 -176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -42.87 79.34 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.09 0.556 . . . . 54.44 109.927 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.3 ttm180 -52.0 -57.77 8.49 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 124.593 1.183 . . . . 74.12 109.286 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -60.77 -43.64 97.77 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 124.592 1.183 . . . . 71.31 111.793 -174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.628 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 53.8 t -57.64 -47.64 81.69 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.945 0.898 . . . . 70.33 110.832 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.461 HG21 HG21 ' A' ' 64' ' ' VAL . 89.2 mt -64.34 -53.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 O-C-N 124.041 0.838 . . . . 74.31 110.463 177.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 94.3 m -50.25 -41.83 50.96 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.394 1.478 . . . . 74.01 111.505 -175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -72.78 -42.76 63.61 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 114.825 -1.08 . . . . 72.52 110.926 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' A' ' 113' ' ' CYS . 50.3 mtm -58.35 -42.61 87.25 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.277 0.56 . . . . 74.1 110.86 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 81.8 t -60.12 -49.01 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 114.241 -1.345 . . . . 72.3 111.27 -178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.618 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 80.9 p -66.89 -31.41 71.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.887 0.475 . . . . 74.42 111.507 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.431 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.9 mtt-85 -68.7 -27.12 65.67 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.827 0.851 . . . . 72.21 111.358 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.4 13.06 53.24 Favored Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.628 -0.54 . . . . 71.01 113.545 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.0 m 63.91 27.29 14.41 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.8 1.24 . . . . 72.24 110.871 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -104.36 150.0 37.97 Favored Pre-proline 0 CA--C 1.549 0.925 0 N-CA-C 108.555 -0.905 . . . . 71.11 108.555 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HB2' ' H ' ' G' ' 192' ' ' GLY . 60.8 Cg_endo -70.77 120.56 7.17 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 121.882 1.721 . . . . 73.23 109.674 176.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.618 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 10.8 pt20 -61.69 150.89 35.3 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.338 0.655 . . . . 63.42 111.719 -171.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.42 108.71 20.18 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.746 -0.835 . . . . 60.15 108.746 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -96.69 96.14 8.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.84 -1.17 . . . . 74.23 107.84 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.666 HD23 ' HB2' ' G' ' 189' ' ' ALA . 91.5 mt -65.72 148.63 51.44 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.473 -0.785 . . . . 72.23 110.58 178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB2' HG12 ' H' ' 204' ' ' ILE . . . -79.92 162.84 60.83 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.013 0.525 . . . . 74.4 110.72 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.34 164.0 26.92 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 122.134 1.889 . . . . 64.44 111.924 169.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.01 114.13 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.997 0.919 . . . . 73.02 109.797 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -90.84 85.61 6.06 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.454 0.701 . . . . 72.31 109.476 173.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -57.07 -28.18 62.37 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.544 1.138 . . . . 74.33 111.869 173.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -74.4 -38.8 62.99 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.192 0.997 . . . . 72.14 110.317 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.54 -40.46 80.7 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-N 116.277 -0.42 . . . . 55.22 110.038 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.426 HD22 ' HD3' ' G' ' 185' ' ' PRO . 42.2 tp -60.0 -37.95 81.21 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.314 1.046 . . . . 74.55 111.279 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 87.8 t80 -57.14 -52.12 66.57 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 123.754 0.659 . . . . 62.14 110.378 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.604 ' HB2' HE21 ' C' ' 4' ' ' GLN . 24.8 ptt? -80.63 -21.63 41.32 Favored 'General case' 0 CA--C 1.554 1.107 0 O-C-N 123.771 0.67 . . . . 73.11 111.739 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -77.77 -28.31 50.52 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.094 0.957 . . . . 70.52 110.276 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -85.71 -37.84 18.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.093 -0.503 . . . . 73.14 109.967 173.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -66.42 -43.18 86.42 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.301 0.64 . . . . 73.23 111.475 -177.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -147.7 -5.14 0.48 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 112.538 0.57 . . . . 73.43 112.538 -170.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.66 130.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 124.701 1.2 . . . . 60.5 110.946 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.456 ' HA ' ' HG2' ' C' ' 4' ' ' GLN . 3.3 pp0? -78.32 147.94 34.02 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.808 0.443 . . . . 73.35 111.351 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.54 172.14 16.48 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 123.5 0.72 . . . . 72.22 110.299 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.74 -150.39 17.86 Favored Glycine 0 C--N 1.338 0.643 0 CA-C-N 115.245 -0.888 . . . . 64.0 111.893 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -166.7 42.97 0.05 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.632 1.173 . . . . 72.32 108.636 -175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.62 77.45 0.1 OUTLIER Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.452 -0.795 . . . . 72.13 113.334 -177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.8 t -121.96 140.2 52.74 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.483 1.513 . . . . 71.02 107.966 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -162.5 132.84 4.69 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 109.507 -0.553 . . . . 74.21 109.507 -177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.93 95.11 8.94 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.335 1.054 . . . . 70.54 110.534 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -66.14 96.18 0.32 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 109.735 -0.469 . . . . 73.14 109.735 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -125.45 96.35 4.78 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.349 -0.982 . . . . 71.23 108.349 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -77.6 -39.41 45.62 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.887 -0.783 . . . . 73.35 108.887 171.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 C-N-CA 125.499 1.519 . . . . 75.53 111.513 178.398 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 108.019 -1.104 . . . . 74.41 108.019 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.9 p -79.13 80.49 5.48 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.503 0.721 . . . . 62.11 111.001 -171.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.17 -9.54 58.48 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.233 -0.894 . . . . 72.45 110.99 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -82.8 124.82 30.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.22 1.008 . . . . 64.41 109.475 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -84.06 169.89 14.46 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.288 0.635 . . . . 74.32 111.116 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -121.6 134.25 55.0 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.87 0.868 . . . . 63.22 109.523 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.597 HG21 ' HA ' ' B' ' 89' ' ' ILE . 87.3 m -77.72 120.72 23.04 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.104 0.562 . . . . 61.35 109.646 177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -60.0 -49.63 76.93 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 124.121 0.888 . . . . 64.32 110.907 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 17.2 ptm 45.83 -177.9 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 126.85 2.06 . . . . 74.0 115.208 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.3 t -154.14 142.73 20.79 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.756 -0.831 . . . . 70.11 108.756 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -133.44 144.67 49.64 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.21 0.604 . . . . 74.12 109.826 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -147.77 136.42 21.8 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.962 -1.017 . . . . 73.04 109.114 169.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 tt -95.24 144.06 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.614 -0.884 . . . . 74.05 108.614 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.49 -49.36 2.9 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.412 0.285 . . . . 71.53 110.836 177.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 40.2 ttt180 -162.53 139.49 7.92 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 110.584 -0.154 . . . . 73.34 110.584 -173.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.467 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 93.9 mt -115.28 137.83 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 106.744 -1.576 . . . . 71.24 106.744 170.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.47 ' HE1' HG13 ' B' ' 83' ' ' ILE . 16.2 p90 -165.65 144.91 6.34 Favored 'General case' 0 C--O 1.239 0.507 0 O-C-N 123.66 0.6 . . . . 72.42 111.654 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.6 m -76.31 119.38 20.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.314 -0.857 . . . . 73.41 108.934 172.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -93.8 -26.96 16.73 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.383 0.673 . . . . 74.13 111.238 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 21.9 t70 -160.78 143.13 12.65 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.165 0.291 . . . . 72.0 110.78 -173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 44.3 mm -137.78 138.3 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.991 1.316 . . . . 60.41 108.992 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.658 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 7.9 t -137.91 138.76 39.35 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.22 -1.4 . . . . 35.41 107.22 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.489 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.8 t80 -160.62 114.53 2.11 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 107.753 -1.203 . . . . 73.21 107.753 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -117.8 147.89 42.59 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.811 -1.181 . . . . 74.22 107.811 173.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.469 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -131.85 81.92 61.54 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 106.911 -1.514 . . . . 72.53 106.911 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.55 -21.34 52.85 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.803 2.335 . . . . 73.22 113.094 -171.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -123.33 30.47 6.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.917 0.887 . . . . 60.4 109.938 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.469 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -48.64 -50.54 59.12 Favored Pre-proline 0 CA--C 1.569 1.71 0 C-N-CA 124.752 1.221 . . . . 63.3 114.164 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.3 -16.77 6.9 Favored 'Trans proline' 0 C--N 1.394 2.957 0 C-N-CA 121.87 1.713 . . . . 65.13 112.769 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -87.63 0.86 55.06 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.657 0.783 . . . . 63.11 110.817 -175.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.24 -15.35 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 C-N-CA 124.268 1.027 . . . . 45.24 111.385 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.81 -42.59 89.53 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 123.437 0.695 . . . . 74.03 110.607 173.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.68 -43.41 96.77 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.74 0.816 . . . . 62.22 110.85 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -103.2 76.42 1.44 Allowed 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.631 -1.168 . . . . 71.24 109.989 -171.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' F' ' 196' ' ' LYS . 9.2 p-10 -95.28 76.71 3.42 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 113.557 -1.656 . . . . 74.24 110.368 -174.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' B' ' 68' ' ' LEU . 2.4 p-90 -157.65 176.59 12.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 114.831 -1.077 . . . . 74.32 109.5 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -85.83 99.46 0.99 Allowed Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 123.878 0.871 . . . . 70.53 108.832 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.52 ' HB3' HD23 ' B' ' 68' ' ' LEU . 55.9 Cg_endo -67.15 161.36 43.2 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 122.234 1.956 . . . . 65.15 112.94 -171.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.4 mt-10 -75.18 102.18 4.88 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.903 -1.044 . . . . 74.25 108.964 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.562 HG21 ' HB2' ' B' ' 124' ' ' PRO . 8.0 t -92.21 119.03 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 N-CA-C 107.547 -1.279 . . . . 60.43 107.547 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -146.84 145.77 29.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.032 0.933 . . . . 62.41 108.992 -170.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.568 HD21 HD21 ' B' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 170.01 12.87 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.828 0.851 . . . . 70.43 111.003 -176.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -137.16 139.59 41.25 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.584 1.153 . . . . 62.11 109.335 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 tp -90.44 129.73 36.59 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.794 0.838 . . . . 63.23 109.535 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -139.97 149.51 43.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.741 0.817 . . . . 55.32 109.601 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.525 ' H ' ' HG3' ' F' ' 180' ' ' PRO . 45.2 m -145.22 134.31 22.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.166 0.587 . . . . 61.15 110.02 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.88 149.27 43.2 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.747 1.219 . . . . 64.33 107.738 170.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 37.6 m -143.89 160.97 39.87 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.343 0.657 . . . . 71.15 110.678 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.3 p -163.12 140.15 7.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.694 0.797 . . . . 73.24 109.352 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 61.8 tt0 -82.64 134.43 35.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.944 0.498 . . . . 74.05 109.871 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -92.87 -55.2 3.45 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.297 0.639 . . . . 64.45 110.028 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.59 -165.13 1.97 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.577 -0.738 . . . . 51.52 110.942 -170.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.52 ' HA ' ' HG2' ' F' ' 170' ' ' LYS . 13.7 m-20 -69.06 109.89 4.22 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.547 -0.752 . . . . 51.22 110.206 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 69.53 4.43 4.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 125.028 1.331 . . . . 64.53 111.908 -178.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.2 t -109.94 114.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 C-N-CA 124.734 1.214 . . . . 75.34 109.121 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 15.5 p90 -117.46 174.39 6.17 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.744 0.817 . . . . 75.22 109.224 178.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -145.17 117.66 8.55 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.469 -0.937 . . . . 71.43 108.469 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.13 127.47 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.309 0.644 . . . . 62.11 109.585 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.7 t -101.38 113.77 38.58 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.989 0.915 . . . . 73.1 108.826 174.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.05 110.1 21.58 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 107.005 -1.48 . . . . 73.31 107.005 175.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.92 121.89 42.53 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.906 -0.405 . . . . 55.04 109.906 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' B' ' 114' ' ' ILE . 43.2 t -112.65 126.67 70.07 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 107.541 -1.281 . . . . 51.53 107.541 167.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 77' ' ' GLU . 5.1 m -121.43 127.06 50.76 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 110.062 -0.347 . . . . 61.31 110.062 -177.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' B' ' 42' ' ' LEU . 38.6 t -99.04 127.9 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 124.186 0.995 . . . . 75.14 109.995 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.4 m -107.61 131.87 53.91 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.583 -1.189 . . . . 60.54 108.648 164.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -136.26 152.33 50.61 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.024 -0.732 . . . . 75.14 109.024 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.0 p -145.4 135.39 23.72 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.047 0.758 . . . . 75.32 113.047 -174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.52 HD23 ' HB3' ' B' ' 38' ' ' PRO . 75.9 mt -95.29 97.08 9.59 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 113.752 -1.567 . . . . 74.11 108.003 169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . 0.459 ' H ' ' HZ2' ' B' ' 36' ' ' TRP . . . 71.86 -117.04 6.29 Favored Glycine 0 CA--C 1.53 1.027 0 N-CA-C 111.482 -0.647 . . . . 40.04 111.482 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -105.43 9.33 33.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.494 1.118 . . . . 61.53 110.427 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -114.71 151.09 34.24 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.045 1.338 . . . . 72.55 108.414 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -73.88 133.83 43.17 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 118.164 0.438 . . . . 71.53 110.726 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.434 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.4 -63.3 1.35 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.89 0.876 . . . . 72.51 108.952 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -157.27 160.36 38.52 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.639 -1.164 . . . . 73.3 109.392 176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.87 113.86 16.46 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 107.963 -1.125 . . . . 64.23 107.963 174.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.494 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 52.9 t -115.41 161.11 19.01 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.526 -0.916 . . . . 74.31 108.526 -177.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.658 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.8 tt0 -165.76 135.62 3.45 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.416 -0.587 . . . . 72.13 109.416 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.4 t -126.62 144.04 38.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 108.79 -0.819 . . . . 73.0 108.79 171.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -122.97 91.8 3.57 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.784 -0.821 . . . . 53.5 108.784 174.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.457 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.1 tp-100 -84.61 100.68 11.59 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.419 -0.81 . . . . 74.32 109.161 177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.2 158.41 23.78 Favored Glycine 0 C--O 1.24 0.521 0 N-CA-C 111.459 -0.656 . . . . 52.12 111.459 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.413 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -155.37 128.9 2.38 Favored Glycine 0 C--O 1.237 0.297 0 N-CA-C 112.011 -0.436 . . . . 74.13 112.011 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.47 HG13 ' HE1' ' B' ' 17' ' ' TYR . 55.2 mt -85.32 125.64 40.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.516 -0.92 . . . . 73.24 108.516 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.415 ' HB2' ' CZ ' ' B' ' 56' ' ' TYR . 29.7 m-85 -137.89 170.3 16.29 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.196 0.999 . . . . 54.4 108.574 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 43.5 m -135.14 132.63 38.28 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.93 0.892 . . . . 71.12 110.327 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.451 HD13 HG12 ' B' ' 89' ' ' ILE . 2.8 pp -136.25 146.19 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 123.541 0.736 . . . . 72.33 111.02 174.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.1 167.91 28.24 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.126 1.37 . . . . 73.15 108.245 169.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.76 -27.83 4.69 Favored Glycine 0 N--CA 1.475 1.279 0 CA-C-O 119.931 -0.372 . . . . 62.33 113.811 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.597 ' HA ' HG21 ' B' ' 7' ' ' THR . 1.6 pp -53.24 142.99 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 124.626 1.17 . . . . 72.52 113.057 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -150.57 148.66 28.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.163 0.985 . . . . 73.35 110.434 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.12 -136.09 49.94 Favored Glycine 0 C--N 1.351 1.4 0 O-C-N 124.387 1.054 . . . . 70.15 114.481 173.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.7 m -84.39 -19.21 33.92 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.746 0.818 . . . . 75.02 110.646 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.24 -21.73 63.9 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.101 0.56 . . . . 74.54 110.875 174.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 27.0 ttt -65.3 -42.49 93.04 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.375 0.67 . . . . 65.12 110.515 168.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -21.15 65.58 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.823 0.849 . . . . 72.32 112.367 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -66.11 -42.02 89.76 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.257 0.623 . . . . 53.34 110.483 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.417 ' SG ' HG21 ' B' ' 86' ' ' ILE . 46.4 t -67.52 -57.06 7.17 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.61 -0.723 . . . . 74.5 111.096 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.36 -31.12 66.97 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.766 -0.652 . . . . 72.35 112.542 -175.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.418 ' HA3' ' HD1' ' F' ' 182' ' ' PHE . . . -94.52 -9.59 58.78 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.37 -0.683 . . . . 73.21 114.627 -171.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.68 -48.1 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 117.636 0.718 . . . . 73.03 112.576 -174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -69.49 -48.44 60.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.657 0.383 . . . . 74.45 111.457 -171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 60.4 m -62.18 -48.91 86.8 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 118.216 -0.897 . . . . 74.15 110.793 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 95.7 Cg_exo -50.58 -44.7 38.75 Favored 'Trans proline' 0 C--N 1.405 3.522 0 C-N-CA 122.416 2.077 . . . . 64.43 113.515 166.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -61.13 -34.86 75.66 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.299 1.039 . . . . 61.31 112.178 -173.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 76.5 mt -66.21 -49.28 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.355 0.662 . . . . 61.31 110.176 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.413 HD21 ' HA3' ' B' ' 82' ' ' GLY . 50.0 mt -76.55 -14.77 59.99 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.481 -1.236 . . . . 70.01 111.856 -174.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.425 ' CE1' HD13 ' B' ' 128' ' ' LEU . 27.3 t80 -62.06 -52.64 65.99 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.271 1.428 . . . . 75.11 113.249 -167.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.558 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 36.9 Cg_endo -62.23 -32.55 82.41 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 122.022 1.815 . . . . 50.32 113.17 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.457 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 88.2 m-85 -64.36 -46.29 84.02 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.153 0.581 . . . . 74.23 110.057 177.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.94 -46.2 90.16 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.959 0.903 . . . . 54.3 110.468 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.558 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 31.9 mtp180 -52.3 -56.11 16.98 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 124.586 1.155 . . . . 73.32 111.871 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -73.58 -32.51 64.17 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.284 -0.871 . . . . 74.11 110.676 -173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.467 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.9 t -69.69 -34.6 74.16 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 122.831 0.452 . . . . 70.21 111.008 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.453 HG21 HG21 ' B' ' 64' ' ' VAL . 58.2 mt -62.69 -58.95 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 108.773 -0.825 . . . . 73.33 108.773 172.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.4 m -51.69 -32.65 30.79 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 124.86 1.35 . . . . 75.03 112.263 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.7 t -64.47 -50.33 67.9 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.076 0.95 . . . . 72.21 110.345 176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -71.14 -30.86 67.01 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.105 0.479 . . . . 75.15 111.43 -177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' B' ' 114' ' ' ILE . 89.9 t -70.48 -37.8 71.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.18 0.992 . . . . 72.22 110.978 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.496 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 96.2 p -67.35 -33.04 74.41 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.169 0.509 . . . . 61.24 110.955 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.628 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 58.6 mtt-85 -64.64 -35.26 80.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.399 -0.819 . . . . 71.44 110.292 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.31 10.45 71.26 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.971 -0.905 . . . . 54.42 113.817 177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.468 ' HA ' ' OD1' ' C' ' 127' ' ' ASN . 62.8 p 59.23 34.92 23.32 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.569 1.548 . . . . 65.43 113.213 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.448 ' O ' ' HG3' ' C' ' 125' ' ' GLN . 23.7 m-85 -117.86 164.84 17.97 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 124.211 1.004 . . . . 75.21 110.631 -176.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.562 ' HB2' HG21 ' B' ' 40' ' ' VAL . 7.3 Cg_exo -75.45 137.72 21.11 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 123.693 2.929 . . . . 70.22 115.257 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.636 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.9 OUTLIER -66.81 159.0 29.03 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.517 1.527 . . . . 72.42 113.282 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -126.3 117.47 23.08 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.106 -1.072 . . . . 44.0 108.106 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' C' ' 122' ' ' THR . 3.8 m120 -92.11 97.51 10.97 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 107.042 -1.466 . . . . 72.33 107.042 174.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.63 HD23 ' H ' ' B' ' 129' ' ' ALA . 0.5 OUTLIER -66.18 148.19 52.2 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.258 0.481 . . . . 54.42 110.961 -170.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.63 ' H ' HD23 ' B' ' 128' ' ' LEU . . . -41.11 107.0 0.45 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 127.335 2.254 . . . . 60.0 113.783 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.08 54.33 4.57 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.726 2.284 . . . . 70.23 111.774 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.667 HG22 HD13 ' E' ' 204' ' ' ILE . 67.0 t -87.35 113.63 25.07 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 124.782 1.233 . . . . 71.34 109.034 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -69.8 98.47 1.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.045 -1.095 . . . . 73.23 108.045 169.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -61.33 -25.19 66.97 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.157 -0.929 . . . . 72.0 110.993 -175.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.67 -38.84 61.17 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.744 1.618 . . . . 53.45 111.892 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.52 -30.66 70.38 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.704 0.802 . . . . 73.13 111.563 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.1 tt -68.75 -48.37 63.92 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.957 0.503 . . . . 55.35 109.685 177.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -62.6 -31.54 72.38 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.402 0.681 . . . . 73.41 111.684 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 53.4 ttm -58.71 -36.4 74.2 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.09 0.956 . . . . 75.13 111.496 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 -94.82 -36.65 11.58 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.515 0.726 . . . . 71.15 111.412 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -72.66 -47.69 45.39 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.461 0.705 . . . . 74.4 110.961 -171.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.92 -4.4 59.16 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.515 0.726 . . . . 71.32 112.116 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -149.35 -104.67 0.08 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 119.174 -0.441 . . . . 75.41 110.181 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -147.53 -82.38 0.13 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 118.582 0.628 . . . . 74.53 109.742 -173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -143.66 -67.1 0.35 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.121 -1.066 . . . . 74.13 108.121 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.51 160.18 4.7 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.352 1.061 . . . . 45.43 110.408 177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.13 61.42 0.41 Allowed Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.319 -0.401 . . . . 72.01 112.115 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.87 149.3 28.13 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.737 0.815 . . . . 74.32 110.002 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.72 74.76 1.26 Allowed Glycine 0 C--N 1.347 1.166 0 O-C-N 123.551 0.532 . . . . 75.33 113.562 169.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 5.3 p -150.84 116.43 5.45 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.277 1.031 . . . . 73.13 108.827 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -162.46 159.39 24.99 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.13 0.572 . . . . 71.44 111.079 173.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -166.58 109.05 0.72 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.987 0.915 . . . . 74.14 109.435 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -124.19 77.02 1.51 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.458 -1.312 . . . . 73.1 107.458 169.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.75 163.04 28.01 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.533 -0.758 . . . . 71.51 110.195 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -149.19 101.88 3.18 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.36 -0.607 . . . . 50.04 109.36 -177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.263 0 C-N-CA 123.8 0.84 . . . . 52.44 108.821 -178.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.425 -0.583 . . . . 64.11 109.425 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 59.1 p -157.59 -43.45 0.07 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.508 0.723 . . . . 71.34 110.102 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -94.79 110.43 22.29 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.366 0.667 . . . . 72.25 109.62 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.604 HE21 ' HB2' ' A' ' 138' ' ' MET . 24.2 mp0 -75.08 -63.54 1.24 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.451 0.7 . . . . 75.0 109.373 -177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 64.02 -78.98 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.017 1.327 . . . . 72.11 111.583 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -135.18 72.48 1.45 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.881 -0.785 . . . . 74.24 108.881 175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 46.6 p -133.31 59.62 1.73 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.368 -0.833 . . . . 70.21 109.895 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.423 ' HA ' ' OE1' ' A' ' 144' ' ' GLN . 48.4 mt-10 -68.72 -63.4 1.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.256 -1.016 . . . . 42.54 108.256 172.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.5 ttt 56.08 109.71 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.514 1.925 . . . . 54.03 113.593 174.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 89.2 m -115.76 79.22 1.27 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.017 -1.475 . . . . 60.41 107.017 167.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -95.17 116.64 29.0 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.341 -1.726 . . . . 72.24 106.341 168.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -143.69 141.87 30.71 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.722 -0.844 . . . . 71.32 108.722 -173.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.422 HD11 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -73.0 133.5 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 O-C-N 123.71 0.631 . . . . 62.35 109.435 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -113.29 -28.96 7.41 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.58 0.752 . . . . 71.34 110.107 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.43 ' NH2' ' HB ' ' D' ' 122' ' ' THR . 16.1 ttt85 -179.65 144.39 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 122.976 0.511 . . . . 72.45 110.605 173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.422 HG13 HD11 ' C' ' 13' ' ' ILE . 51.7 mt -124.39 134.17 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 N-CA-C 107.407 -1.331 . . . . 73.32 107.407 168.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.568 ' HB3' HG23 ' D' ' 122' ' ' THR . 21.5 p90 -176.94 155.01 1.17 Allowed 'General case' 0 C--O 1.227 -0.122 0 O-C-N 123.997 0.81 . . . . 62.45 110.421 -174.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.23 120.94 22.19 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 123.629 0.772 . . . . 73.01 109.664 175.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.446 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 28.9 mmtp -70.55 -49.09 51.72 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 107.974 -1.121 . . . . 75.0 107.974 167.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -138.51 142.68 39.34 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 113.803 -1.544 . . . . 75.22 109.498 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.24 144.8 28.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.936 -1.505 . . . . 72.42 106.936 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.2 t -155.21 148.3 24.71 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.254 0.55 . . . . 61.4 110.593 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 86.4 t80 -147.8 125.96 12.18 Favored 'General case' 0 N--CA 1.46 0.064 0 CA-C-N 114.694 -1.139 . . . . 74.52 107.926 172.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -118.36 139.25 51.66 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.361 1.064 . . . . 63.33 108.321 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.6 76.26 36.24 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 105.954 -1.869 . . . . 63.52 105.954 171.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -71.25 -19.68 29.03 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.369 2.046 . . . . 74.53 111.071 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -89.75 11.4 20.13 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.679 -1.146 . . . . 72.2 110.376 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.604 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -49.05 -61.73 3.07 Favored Pre-proline 0 CA--C 1.573 1.85 0 N-CA-C 114.064 1.135 . . . . 63.03 114.064 -165.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.9 Cg_exo -76.05 -23.49 12.09 Favored 'Trans proline' 0 C--N 1.387 2.594 0 CA-C-N 121.746 1.659 . . . . 71.23 112.28 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -71.09 -38.16 72.4 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.797 1.239 . . . . 73.13 111.894 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.36 -10.25 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.377 1.071 . . . . 74.11 111.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.578 ' HA ' ' HE2' ' E' ' 197' ' ' TYR . 73.2 t80 -55.09 -40.52 70.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.759 0.824 . . . . 75.4 111.7 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.548 ' HA ' HE21 ' C' ' 33' ' ' GLN . 0.0 OUTLIER -116.52 38.78 3.33 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.997 0.903 . . . . 72.24 109.811 -178.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.823 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -99.98 152.23 20.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.68 -0.638 . . . . 64.2 110.945 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -70.62 108.57 4.43 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.633 -1.247 . . . . 52.33 107.633 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -70.99 104.58 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.927 0.891 . . . . 74.24 110.68 -171.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -134.47 49.88 4.38 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 124.174 0.99 . . . . 74.31 110.724 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -71.71 112.62 3.42 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.182 1.922 . . . . 73.42 112.302 -169.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -86.0 95.08 9.39 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.579 -1.267 . . . . 63.23 107.579 171.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.734 ' HB ' ' HB3' ' E' ' 189' ' ' ALA . 76.0 t -80.7 89.63 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.095 -0.957 . . . . 74.13 110.118 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.88 139.14 31.24 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.837 -0.801 . . . . 63.25 108.837 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.633 ' HB3' HG22 ' C' ' 64' ' ' VAL . 0.6 OUTLIER -129.12 144.98 51.39 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.379 0.671 . . . . 54.34 109.633 172.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -126.46 139.19 53.44 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.796 1.239 . . . . 55.25 108.836 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.674 ' HG ' HD21 ' C' ' 60' ' ' LEU . 8.9 tt -114.21 135.7 53.76 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.629 0.772 . . . . 73.13 109.16 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -155.63 149.95 25.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.229 1.011 . . . . 74.41 108.835 173.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.0 t -112.16 152.11 28.73 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.466 0.65 . . . . 51.14 109.895 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.0 158.39 41.63 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.5 1.12 . . . . 75.43 108.173 175.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 15.4 t -153.26 148.84 27.3 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.899 0.38 . . . . 64.33 110.675 -178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 30.3 t -157.74 128.09 6.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.62 1.168 . . . . 74.12 108.917 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -81.41 131.22 35.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.312 -0.625 . . . . 73.32 109.312 173.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.632 HD11 HD12 ' C' ' 83' ' ' ILE . 84.2 mt -98.01 -40.1 8.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.542 0.737 . . . . 75.22 110.34 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.36 179.48 9.22 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.221 -0.899 . . . . 65.32 109.526 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.14 126.04 28.27 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.661 -0.866 . . . . 75.42 108.661 173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.434 ' HA ' HG23 ' C' ' 86' ' ' ILE . 3.0 m-20 67.11 13.83 9.58 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.625 1.17 . . . . 64.54 112.606 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -132.68 117.7 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.405 1.082 . . . . 64.4 108.587 174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -132.08 165.76 23.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.66 0.743 . . . . 72.5 109.547 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -126.57 136.63 52.8 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.328 1.051 . . . . 74.24 108.474 -174.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.0 t -123.37 127.43 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 107.179 -1.415 . . . . 73.22 107.179 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.507 HG22 ' HA2' ' C' ' 81' ' ' GLY . 90.2 t -120.44 117.4 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.798 -0.815 . . . . 72.23 108.798 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.674 HD21 ' HG ' ' C' ' 44' ' ' LEU . 0.7 OUTLIER -86.53 113.05 22.13 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 108.786 -0.82 . . . . 64.42 108.786 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tmm_? -90.92 106.76 18.74 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 108.307 -0.998 . . . . 73.33 108.307 174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.438 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.5 t -107.19 135.47 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 108.152 -1.055 . . . . 51.44 108.152 171.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -127.39 124.99 39.85 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.951 -0.388 . . . . 72.23 109.951 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.633 HG22 ' HB3' ' C' ' 42' ' ' LEU . 43.3 t -102.71 115.86 45.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.353 1.061 . . . . 74.31 110.612 175.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.9 m -99.4 134.76 41.79 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.178 -1.045 . . . . 60.55 108.178 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.26 129.92 45.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.32 -0.993 . . . . 52.25 108.32 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 70.2 m -146.88 135.63 22.18 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.626 0.579 . . . . 70.44 111.146 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.823 HD13 ' HG2' ' C' ' 34' ' ' LYS . 5.9 mt -86.83 40.74 0.92 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.319 1.848 . . . . 74.22 109.413 177.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.42 -109.71 3.29 Favored Glycine 0 C--N 1.344 1.028 0 N-CA-C 110.724 -0.95 . . . . 73.33 110.724 -168.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -89.25 -24.47 22.08 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.519 0.728 . . . . 72.2 110.136 176.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.531 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 6.9 tp10 -76.94 120.45 22.08 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 124.389 1.075 . . . . 62.23 110.027 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.1 m -66.65 125.36 25.55 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.958 0.799 . . . . 74.54 109.404 170.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -80.06 -51.9 8.46 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.842 -0.799 . . . . 72.52 108.842 174.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -164.81 175.29 9.77 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.777 -1.101 . . . . 74.12 109.863 177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.406 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -134.33 144.81 48.5 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 106.677 -1.601 . . . . 65.35 106.677 170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.1 t -143.83 148.33 35.36 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.21 -1.033 . . . . 53.32 108.21 177.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -158.62 134.85 9.2 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.922 -0.77 . . . . 55.51 108.922 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 79.5 t -129.73 139.24 52.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 124.364 1.066 . . . . 75.4 108.521 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.468 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -116.4 90.34 3.31 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.116 -1.068 . . . . 75.42 108.116 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -79.56 106.6 11.7 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 114.675 -1.148 . . . . 75.25 109.991 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.507 ' HA2' HG22 ' C' ' 59' ' ' VAL . . . -82.72 148.41 26.05 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.371 0.419 . . . . 64.5 112.166 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.74 116.19 0.77 Allowed Glycine 0 CA--C 1.509 -0.314 0 N-CA-C 110.795 -0.922 . . . . 74.33 110.795 176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.632 HD12 HD11 ' C' ' 51' ' ' LEU . 10.9 mm -87.6 125.23 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.245 -1.02 . . . . 63.0 108.245 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -130.56 156.59 44.58 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.498 -0.927 . . . . 74.02 108.498 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 79.7 p -91.75 137.22 32.54 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.933 -0.766 . . . . 72.34 108.933 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.47 HD12 HD13 ' E' ' 173' ' ' LEU . 0.0 OUTLIER -108.52 134.67 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.655 -0.868 . . . . 71.41 108.655 172.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -178.39 153.56 0.75 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.574 0.75 . . . . 54.11 110.992 173.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.85 -36.53 3.36 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.652 1.021 . . . . 20.15 115.652 163.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' C' ' 94' ' ' MET . 1.6 pp -70.14 167.97 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.99 0.916 . . . . 73.42 112.282 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -168.43 148.57 4.64 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 114.935 -1.029 . . . . 73.35 108.676 173.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.43 -122.58 6.16 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.145 0.278 . . . . 74.03 113.444 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 74.1 p -77.31 -24.96 50.82 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.247 0.619 . . . . 62.11 112.575 -173.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -41.75 98.75 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.79 0.436 . . . . 73.44 110.883 -178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.423 ' HB3' HD13 ' C' ' 89' ' ' ILE . 15.9 ptp -72.47 -27.37 62.25 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.298 -0.41 . . . . 72.13 111.816 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.76 -46.94 76.91 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.491 0.716 . . . . 52.14 111.826 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -72.46 -24.57 61.21 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.063 0.545 . . . . 73.42 111.222 177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 32.3 t -62.96 -63.46 1.2 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 123.537 0.523 . . . . 61.24 111.089 -172.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -77.52 -23.92 50.1 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 118.49 0.586 . . . . 74.14 110.516 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.85 -24.44 76.63 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.486 -0.779 . . . . 64.15 113.521 -172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.401 ' HA ' ' CZ2' ' E' ' 184' ' ' TRP . . . -158.61 -38.01 0.06 Allowed 'General case' 0 C--N 1.358 0.967 0 N-CA-C 113.723 1.009 . . . . 61.12 113.723 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.21 -39.01 82.51 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.517 0.727 . . . . 64.03 112.057 -170.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -74.82 -50.28 4.22 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.46 -0.781 . . . . 72.23 111.301 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.411 ' O ' HD12 ' C' ' 60' ' ' LEU . 34.3 Cg_endo -64.49 -23.16 64.84 Favored 'Trans proline' 0 C--N 1.398 3.183 0 C-N-CA 121.637 1.558 . . . . 75.55 113.306 175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -65.37 -36.13 83.05 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 122.984 0.514 . . . . 71.13 110.394 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -60.27 -41.52 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.895 0.878 . . . . 72.4 110.165 173.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 57.5 mt -86.64 -15.95 38.13 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 114.591 -1.186 . . . . 62.2 112.07 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -59.63 -51.58 80.03 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 117.617 -1.182 . . . . 70.22 113.182 -175.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.94 -34.39 99.1 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 121.927 1.751 . . . . 74.45 112.596 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.64 -46.68 75.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.506 0.722 . . . . 73.3 110.864 177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.59 94.77 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.753 0.821 . . . . 40.14 110.402 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.19 -45.67 93.65 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.421 1.488 . . . . 72.23 110.716 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.59 -30.19 59.53 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 124.004 0.921 . . . . 63.11 110.324 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.1 t -68.67 -39.82 80.43 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.1 0.56 . . . . 44.32 110.481 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.58 HG21 HG21 ' C' ' 64' ' ' VAL . 86.4 mt -68.31 -45.06 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 123.064 0.546 . . . . 64.5 109.932 175.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 18.2 m -55.01 -38.87 68.46 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.634 0.774 . . . . 74.11 111.184 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -59.8 -60.6 3.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.187 -0.915 . . . . 71.42 109.716 175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.524 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -48.2 -47.63 35.26 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.474 1.51 . . . . 73.22 113.349 -179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.622 HG11 HD23 ' C' ' 126' ' ' LEU . 53.5 t -70.69 -43.89 77.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 C-N-CA 124.12 0.968 . . . . 75.24 111.796 -173.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.5 t -64.72 -30.57 71.59 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.889 -0.596 . . . . 64.51 110.793 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 75.2 mtt-85 -66.02 -32.53 74.06 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.816 -0.629 . . . . 73.5 110.564 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.28 12.3 60.9 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.526 0.516 . . . . 73.35 113.557 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.636 HG23 ' HB3' ' D' ' 17' ' ' TYR . 46.5 p 58.79 35.93 24.54 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.793 1.637 . . . . 71.22 112.922 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.418 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 41.5 m-85 -110.21 163.94 16.0 Favored Pre-proline 0 CA--C 1.564 1.505 0 C-N-CA 124.171 0.988 . . . . 71.33 110.504 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 32.7 Cg_endo -59.48 173.35 1.54 Allowed 'Trans proline' 0 C--N 1.402 3.361 0 C-N-CA 123.631 2.888 . . . . 64.41 114.905 -172.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.636 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 5.7 mm-40 -60.68 136.26 58.01 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 115.393 -0.821 . . . . 73.42 111.732 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.622 HD23 HG11 ' C' ' 118' ' ' VAL . 0.2 OUTLIER -112.32 24.81 12.15 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.278 -0.874 . . . . 53.12 111.683 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 7.1 p30 -92.56 84.0 5.01 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-O 123.523 1.63 . . . . 74.22 108.207 171.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' E' ' 187' ' ' ILE . 3.5 mm? -91.91 157.03 17.06 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.915 -1.038 . . . . 74.45 112.63 177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' F' ' 204' ' ' ILE . . . -33.58 135.91 0.31 Allowed Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 126.542 1.937 . . . . 73.22 115.101 -174.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -58.75 109.99 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 122.851 2.367 . . . . 60.23 111.609 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 29.9 m -87.05 30.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.428 0.691 . . . . 74.34 111.381 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -71.2 103.8 2.9 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 108.308 -0.997 . . . . 73.52 108.308 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -67.17 -5.0 11.79 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 115.119 -0.946 . . . . 75.22 111.988 -175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.583 ' HA ' ' HB3' ' C' ' 137' ' ' PHE . 9.9 m-20 -63.46 -19.02 64.38 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.821 1.248 . . . . 65.13 112.999 -173.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.24 89.28 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.468 0.651 . . . . 73.11 109.857 167.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.1 mt -87.9 -25.41 23.25 Favored 'General case' 0 C--O 1.21 -1.003 0 C-N-CA 124.241 1.016 . . . . 71.31 111.739 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.583 ' HB3' ' HA ' ' C' ' 134' ' ' ASP . 77.2 t80 -64.54 -46.96 80.62 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 118.891 0.769 . . . . 74.33 111.278 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -32.89 74.84 Favored 'General case' 0 CA--C 1.551 0.985 0 O-C-N 123.38 0.425 . . . . 63.43 110.324 178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -65.94 -38.57 88.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.135 1.374 . . . . 71.25 110.914 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.496 ' HB3' HD22 ' C' ' 141' ' ' LEU . 8.4 m-85 -71.03 -86.56 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.939 0.896 . . . . 73.23 109.123 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' C' ' 140' ' ' TYR . 2.3 mm? -93.94 111.88 23.65 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.517 0.727 . . . . 75.54 110.034 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -72.24 143.38 48.82 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.419 0.687 . . . . 74.42 109.891 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -72.07 -28.41 63.31 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 74.01 112.121 -174.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 61.6 88.95 0.08 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.961 1.304 . . . . 73.42 110.044 -172.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.05 170.95 15.29 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.344 0.658 . . . . 53.45 111.671 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -129.27 175.79 18.75 Favored Glycine 0 C--O 1.244 0.76 0 N-CA-C 110.219 -1.152 . . . . 45.33 110.219 172.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.422 ' HG3' HG21 ' A' ' 92' ' ' THR . 33.3 tt0 -152.45 109.11 3.45 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.875 -0.417 . . . . 52.21 109.875 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.94 165.11 33.31 Favored Glycine 0 C--O 1.24 0.529 0 N-CA-C 111.423 -0.671 . . . . 71.11 111.423 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 24.3 m 62.29 82.79 0.17 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.496 1.118 . . . . 72.35 111.839 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.58 100.42 13.27 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.499 -1.667 . . . . 60.03 106.499 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -149.14 147.33 28.33 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.986 -0.746 . . . . 61.21 108.986 -167.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -128.49 8.84 5.97 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 113.789 1.033 . . . . 63.55 113.789 -166.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -73.19 -81.34 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.264 0.938 . . . . 71.3 109.834 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -158.09 172.17 18.9 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.406 1.082 . . . . 71.2 109.652 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-N 115.505 -0.77 . . . . 50.33 109.795 171.376 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.734 -0.469 . . . . 60.01 109.734 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.9 p -145.45 88.6 1.87 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.5 0.72 . . . . 60.11 109.686 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -105.88 111.54 24.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.269 -1.011 . . . . 72.12 108.269 170.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -146.69 117.22 7.51 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 123.656 0.782 . . . . 54.2 109.389 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -100.72 140.86 34.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 108.145 -1.057 . . . . 52.32 108.145 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -150.44 -51.33 0.13 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.448 0.699 . . . . 70.02 109.63 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 18.0 m -66.52 141.37 57.9 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.225 -0.898 . . . . 63.21 110.206 175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -64.19 116.54 6.07 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 107.902 -1.147 . . . . 61.14 107.902 171.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.468 ' HG3' HG23 ' D' ' 89' ' ' ILE . 4.4 ttp -31.97 122.86 0.3 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.638 1.211 . . . . 63.54 112.464 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 47.7 m -116.46 141.21 48.47 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.633 -0.877 . . . . 73.35 108.633 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -153.49 99.53 2.34 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.378 -0.971 . . . . 75.22 108.378 -176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -123.58 114.4 19.98 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.77 0.828 . . . . 75.14 108.774 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.417 HG22 ' HD2' ' D' ' 84' ' ' PHE . 1.1 pp -78.75 127.05 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 107.157 -1.424 . . . . 73.25 107.157 175.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 78.3 mt-30 -85.09 -35.37 21.86 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 110.271 -0.27 . . . . 71.41 110.271 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.448 ' HB3' ' HE1' ' D' ' 17' ' ' TYR . 1.6 tpt180 -172.74 157.29 3.71 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.852 0.461 . . . . 64.35 110.514 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 19.7 mt -144.31 124.19 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 C-N-CA 124.514 1.126 . . . . 64.44 108.038 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.636 ' HB3' HG23 ' C' ' 122' ' ' THR . 23.9 p90 -168.96 162.91 11.36 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.758 1.223 . . . . 72.21 109.996 -168.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.8 p -80.94 122.17 26.92 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.314 -0.857 . . . . 62.3 109.912 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 45.7 mtpt -86.09 -44.42 12.27 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 107.98 -1.118 . . . . 74.42 107.98 173.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.765 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.9 t70 -131.59 141.88 49.77 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.963 -1.017 . . . . 75.11 109.848 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.524 HD13 ' HE3' ' C' ' 117' ' ' MET . 55.4 mt -137.7 146.33 27.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.375 1.47 . . . . 74.14 107.778 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -155.1 140.5 17.74 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.498 0.666 . . . . 54.4 111.101 174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.9 t80 -140.8 137.89 33.66 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 106.514 -1.662 . . . . 73.04 106.514 168.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 50.5 mt-10 -138.09 136.94 37.27 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.291 1.036 . . . . 73.15 108.489 -176.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.11 74.17 10.97 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 108.959 -0.756 . . . . 71.23 108.959 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -73.71 -26.72 13.37 Favored 'Trans proline' 0 C--N 1.382 2.302 0 C-N-CA 122.697 2.265 . . . . 73.33 112.407 -176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -99.46 -0.44 40.78 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.05 -0.977 . . . . 73.14 111.508 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.679 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.39 -57.87 4.13 Favored Pre-proline 0 CA--C 1.563 1.464 0 N-CA-C 116.071 1.878 . . . . 63.43 116.071 -163.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 67.1 Cg_endo -77.44 -25.18 8.47 Favored 'Trans proline' 0 C--N 1.387 2.59 0 CA-C-N 121.101 1.429 . . . . 62.45 113.221 -173.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -87.14 -24.17 24.59 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 120.702 0.287 . . . . 74.12 110.585 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -8.93 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.211 0 C-N-CA 123.495 0.718 . . . . 43.41 110.12 175.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -65.98 -38.17 87.85 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.774 0.829 . . . . 72.23 110.614 173.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -75.9 -2.1 28.6 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 120.81 0.338 . . . . 75.34 111.363 176.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -105.68 76.87 1.22 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.635 1.174 . . . . 65.51 107.975 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -83.62 95.19 8.27 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 115.015 -0.993 . . . . 73.12 112.325 -168.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -150.05 176.13 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 109.401 -0.592 . . . . 75.23 109.401 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.2 tp60 -73.3 114.12 28.45 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 124.139 0.976 . . . . 74.44 109.231 172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -59.51 111.16 0.86 Allowed 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 122.111 1.874 . . . . 73.04 110.421 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -63.66 111.17 2.28 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.862 -1.162 . . . . 70.21 107.862 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.3 m -98.35 121.41 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.352 0.661 . . . . 71.33 109.385 -172.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -109.06 114.26 27.83 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.568 -1.271 . . . . 61.43 107.568 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -96.61 116.27 28.82 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.852 0.861 . . . . 74.54 108.968 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.41 125.87 52.24 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.712 -0.847 . . . . 63.1 108.712 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 45.9 tp -95.71 129.82 42.8 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.423 -0.584 . . . . 64.35 109.423 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.5 t70 -144.55 152.82 41.11 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.147 -1.057 . . . . 54.13 108.147 172.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.0 t -145.19 157.31 44.11 Favored 'General case' 0 C--O 1.243 0.749 0 C-N-CA 123.326 0.651 . . . . 62.14 109.506 176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.93 166.85 28.37 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.811 1.245 . . . . 71.23 107.793 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.48 ' OG ' HD11 ' H' ' 177' ' ' LEU . 68.9 p -168.1 166.01 13.15 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.828 0.451 . . . . 55.05 110.813 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.1 p -156.65 132.63 9.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.26 -0.882 . . . . 62.21 109.12 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -70.3 126.99 31.23 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.53 -0.544 . . . . 45.32 109.53 173.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.3 mt -91.45 -40.89 11.16 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 121.263 0.554 . . . . 65.01 109.824 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.22 -173.26 3.94 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.117 -0.947 . . . . 75.55 110.172 -176.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -68.97 123.06 19.99 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.657 -0.701 . . . . 74.34 110.014 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 64.56 17.39 10.85 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.551 1.157 . . . . 75.31 112.242 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 54.9 t -130.12 123.47 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.563 0.745 . . . . 71.52 110.16 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.54 ' HE1' ' HG3' ' H' ' 174' ' ' MET . 12.0 m-85 -125.29 166.33 16.72 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.902 1.281 . . . . 71.14 108.419 173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.483 ' HB2' HD11 ' D' ' 51' ' ' LEU . 8.5 tm-20 -130.6 126.93 37.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.737 -1.949 . . . . 64.31 105.737 168.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.86 133.23 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.189 0.996 . . . . 63.43 108.552 -174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 48.9 t -113.13 135.91 51.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 124.367 1.067 . . . . 65.13 110.079 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -107.46 126.6 52.71 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 107.212 -1.403 . . . . 72.34 107.212 171.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.536 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -104.51 102.95 12.57 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.883 -0.784 . . . . 73.55 108.883 172.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.5 t -95.18 119.39 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 108.373 -0.973 . . . . 63.33 108.373 171.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 32.0 m -115.76 136.92 52.58 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.677 -0.692 . . . . 74.12 110.164 -176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.482 HG21 HG21 ' D' ' 114' ' ' ILE . 76.4 t -126.76 102.3 9.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.897 1.279 . . . . 64.15 108.167 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 35.1 m -97.84 92.53 5.88 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.091 -1.448 . . . . 73.23 107.091 171.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.3 137.35 37.15 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.453 -0.943 . . . . 74.14 108.453 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 13.2 p -148.78 130.26 14.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.321 0.581 . . . . 75.44 111.782 -170.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 59.5 mt -98.31 107.67 20.18 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.694 1.198 . . . . 73.15 108.316 175.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.9 -134.58 22.05 Favored Glycine 0 C--N 1.343 0.932 0 O-C-N 123.536 0.523 . . . . 34.01 112.272 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.32 4.54 38.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.669 0.787 . . . . 43.23 111.943 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -132.08 162.73 30.1 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.836 0.454 . . . . 62.43 110.608 -172.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.0 m -66.83 136.4 55.36 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.148 -0.933 . . . . 71.33 111.552 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -90.12 -56.44 3.22 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.931 -1.137 . . . . 62.24 107.931 169.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -162.62 144.42 10.47 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.201 -1.363 . . . . 54.44 109.802 176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -110.53 111.52 22.82 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.832 0.853 . . . . 74.43 108.785 174.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG23 ' D' ' 114' ' ' ILE . 20.2 t -127.09 127.71 45.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.012 0.525 . . . . 63.11 109.936 -175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -148.38 139.77 23.46 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.431 0.692 . . . . 75.53 109.74 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.493 HG21 ' HB3' ' D' ' 113' ' ' CYS . 99.1 t -132.87 124.67 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.435 0.694 . . . . 64.03 109.678 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.765 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.8 mt-30 -91.74 88.32 6.64 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.751 -0.833 . . . . 74.43 108.751 167.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.405 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.2 tp-100 -80.05 109.71 14.75 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 114.401 -1.272 . . . . 74.23 108.353 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.07 166.8 21.33 Favored Glycine 0 C--O 1.241 0.545 0 N-CA-C 111.946 -0.462 . . . . 53.24 111.946 178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -168.15 140.24 6.11 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.002 -0.839 . . . . 73.22 111.002 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 59.2 mt -88.71 126.25 41.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.81 -0.811 . . . . 71.13 108.81 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.417 ' HD2' HG22 ' D' ' 13' ' ' ILE . 69.3 m-85 -124.61 124.71 42.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.104 0.561 . . . . 72.03 109.965 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 13.7 m -93.28 111.34 22.96 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.052 0.941 . . . . 61.5 108.809 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.412 HD13 HD12 ' D' ' 98' ' ' LEU . 42.2 pt -116.68 142.98 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.237 0.615 . . . . 61.44 111.431 -172.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -157.93 160.64 37.81 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.858 1.263 . . . . 63.4 108.585 173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.75 22.4 78.12 Favored Glycine 0 N--CA 1.476 1.343 0 O-C-N 123.062 0.226 . . . . 52.1 113.404 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.662 HD13 ' HG2' ' D' ' 94' ' ' MET . 1.2 pp -113.1 148.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.311 1.044 . . . . 74.04 109.959 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' H' ' 172' ' ' ALA . 0.0 OUTLIER -144.27 146.41 32.61 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.34 0.656 . . . . 74.34 111.152 -176.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 35.45 -97.65 0.01 OUTLIER Glycine 0 C--N 1.359 1.828 0 N-CA-C 116.494 1.357 . . . . 62.04 116.494 169.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 26.2 m -64.25 -53.82 43.15 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.722 1.209 . . . . 60.24 110.934 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -65.46 -31.06 71.94 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.94 -1.027 . . . . 64.03 110.876 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.662 ' HG2' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -71.96 -54.71 9.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.421 1.088 . . . . 53.04 109.915 -178.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.72 -25.79 68.36 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.835 -1.075 . . . . 65.14 111.563 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -80.67 -44.89 18.08 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.969 0.508 . . . . 65.21 111.01 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.9 -43.27 96.51 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.032 0.533 . . . . 72.55 111.033 -173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.412 HD12 HD13 ' D' ' 86' ' ' ILE . 6.7 tt -92.77 -33.39 14.31 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.152 -0.476 . . . . 72.14 110.682 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -20.73 57.36 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 114.401 0.52 . . . . 34.02 114.401 -174.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.24 -49.86 1.1 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.577 0.689 . . . . 42.12 111.851 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -73.4 -45.01 57.2 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.868 0.467 . . . . 73.0 111.473 -173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 93.2 m -61.5 -48.04 91.64 Favored Pre-proline 0 CA--C 1.567 1.6 0 CA-C-O 118.286 -0.864 . . . . 34.14 111.637 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.58 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.8 Cg_exo -56.9 -38.17 96.55 Favored 'Trans proline' 0 C--N 1.399 3.228 0 C-N-CA 122.353 2.035 . . . . 64.3 113.366 168.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.91 -32.35 73.84 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.365 0.666 . . . . 70.53 111.251 -178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.9 mm -64.65 -41.5 92.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.55 0.74 . . . . 55.41 110.259 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.405 HD13 ' O ' ' D' ' 80' ' ' GLN . 61.7 mt -75.14 -23.52 57.83 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.152 -0.931 . . . . 74.04 111.607 -175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.403 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 66.4 t80 -60.64 -45.39 97.07 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.733 1.382 . . . . 73.33 114.733 -169.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -52.12 -42.63 58.15 Favored 'Trans proline' 0 C--N 1.393 2.902 0 C-N-CA 122.118 1.879 . . . . 62.54 112.816 175.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -76.49 -35.65 58.25 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.921 -1.036 . . . . 71.31 110.724 -176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.96 -43.57 78.74 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.896 0.878 . . . . 62.31 110.905 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -58.87 -55.09 39.65 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 124.448 1.093 . . . . 73.54 109.956 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.56 -40.32 86.9 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.273 0.983 . . . . 74.3 111.895 -173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.493 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -59.28 -42.71 91.86 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.02 0.825 . . . . 53.34 110.333 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.563 HG23 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -63.65 -52.02 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.018 0.927 . . . . 75.42 110.364 172.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 30.8 m -53.66 -43.61 68.96 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.361 1.464 . . . . 65.53 112.099 -172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.8 t -68.48 -43.05 77.77 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.011 -0.995 . . . . 44.4 110.377 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.493 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 76.7 mtm -66.35 -30.92 71.42 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.868 0.467 . . . . 55.54 111.964 -178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.7 t -71.02 -42.39 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 123.391 0.676 . . . . 75.12 110.397 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.3 p -71.06 -29.95 65.97 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 116.553 -0.294 . . . . 74.24 110.442 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.2 mtt-85 -69.74 -28.67 65.99 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.762 0.825 . . . . 75.31 110.148 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.77 11.09 62.91 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.717 0.636 . . . . 74.1 112.922 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.568 HG23 ' HB3' ' C' ' 17' ' ' TYR . 75.1 p 56.06 25.12 8.54 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.292 1.837 . . . . 75.52 113.46 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.441 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 28.2 m-85 -103.34 166.22 12.18 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 125.055 1.342 . . . . 72.41 109.687 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 34.2 Cg_endo -59.23 124.71 16.19 Favored 'Trans proline' 0 C--N 1.394 2.933 0 C-N-CA 123.052 2.501 . . . . 75.23 112.791 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -55.16 119.64 5.8 Favored 'General case' 0 CA--C 1.549 0.915 0 O-C-N 123.883 0.74 . . . . 70.52 109.869 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 62.2 tp -105.01 98.41 8.12 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.327 0.584 . . . . 73.1 109.831 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.467 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 79.6 m-20 -99.13 86.3 3.41 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.006 -1.109 . . . . 74.41 108.006 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.403 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 1.0 OUTLIER -72.59 138.16 46.64 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.934 -1.03 . . . . 61.55 109.896 -173.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 131.5 95.21 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.993 0.517 . . . . 64.13 111.891 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -78.3 119.44 4.58 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 121.906 1.737 . . . . 72.4 110.072 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -106.75 120.22 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.63 0.728 . . . . 72.53 110.031 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -74.34 104.24 5.02 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.316 -0.994 . . . . 52.21 108.316 176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -61.75 -32.87 73.15 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.403 1.081 . . . . 73.13 111.361 -177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.59 -40.55 73.2 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.707 0.803 . . . . 63.14 111.122 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.35 78.38 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.028 0.531 . . . . 65.54 110.729 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.604 HD13 ' HD2' ' H' ' 185' ' ' PRO . 87.0 mt -70.93 -45.18 64.69 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.344 0.658 . . . . 75.33 111.308 177.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.36 -58.18 9.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.051 0.54 . . . . 63.5 110.686 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 62.7 mtm -59.02 -52.86 63.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.892 0.877 . . . . 74.43 111.285 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -59.07 -33.41 70.77 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.583 0.753 . . . . 70.51 111.938 -174.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -64.97 -43.26 93.23 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.972 0.909 . . . . 74.03 110.235 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.59 -39.06 32.56 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.9 0.88 . . . . 71.22 112.239 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.43 35.76 0.88 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.513 0.725 . . . . 72.32 111.351 -173.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -113.32 89.16 3.01 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 122.253 1.025 . . . . 72.13 108.309 -168.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.87 136.9 25.88 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 106.378 -1.712 . . . . 75.51 106.378 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.76 96.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.601 0.76 . . . . 72.41 110.179 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 173.61 51.97 0.05 OUTLIER Glycine 0 C--N 1.336 0.551 0 N-CA-C 110.111 -1.196 . . . . 43.43 110.111 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -63.16 152.63 36.82 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.165 0.986 . . . . 73.22 110.631 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.25 80.7 0.14 Allowed Glycine 0 C--N 1.349 1.303 0 N-CA-C 110.864 -0.894 . . . . 65.43 110.864 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 33.5 p -69.83 -32.26 70.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.15 0.98 . . . . 72.04 109.775 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -58.31 100.75 0.07 Allowed 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.911 -1.04 . . . . 71.52 109.572 171.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -175.85 1.85 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.616 0.767 . . . . 73.42 110.69 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -123.73 154.34 39.61 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 122.004 -0.435 . . . . 74.24 110.92 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -71.49 -175.69 1.36 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.757 0.823 . . . . 75.1 109.996 172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.86 76.51 1.15 Allowed 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.533 0.682 . . . . 71.15 109.854 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 C-N-CA 124.969 1.308 . . . . 72.35 108.22 -172.888 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 110.075 -0.343 . . . . 74.54 110.075 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -69.12 96.93 0.49 Allowed Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.123 -1.191 . . . . 62.4 110.123 175.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -59.64 -19.92 52.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.42 1.088 . . . . 71.24 113.126 -168.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 69.2 m 64.18 39.36 7.59 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.597 0.759 . . . . 74.34 111.084 173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.82 -79.96 0.02 OUTLIER 'General case' 0 C--N 1.363 1.169 0 C-N-CA 124.547 1.139 . . . . 53.54 110.958 -175.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.47 HD13 HD12 ' C' ' 86' ' ' ILE . 3.6 mm? 45.31 41.01 5.79 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 125.102 1.361 . . . . 65.54 114.372 167.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.4 ' HE3' HG12 ' C' ' 86' ' ' ILE . 53.0 mtt 56.69 53.47 8.35 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 123.83 0.852 . . . . 70.4 110.512 -174.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -133.47 -114.89 0.21 Allowed 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.399 -0.963 . . . . 73.4 108.399 173.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 54.98 -103.01 0.16 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.384 1.074 . . . . 74.42 110.776 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.3 mp 53.83 178.7 0.02 OUTLIER 'General case' 0 C--N 1.366 1.291 0 C-N-CA 124.779 1.232 . . . . 74.45 113.434 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -167.39 -49.43 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 106.545 -1.65 . . . . 55.13 106.545 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -132.85 164.39 44.17 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 114.776 -1.102 . . . . 74.11 109.17 174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.71 108.72 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.292 1.995 . . . . 71.23 110.442 164.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -79.65 -4.5 51.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.213 0.605 . . . . 73.13 111.27 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.49 140.92 51.13 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.138 0.975 . . . . 72.52 109.563 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 26.6 m -77.1 111.18 12.42 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.903 0.881 . . . . 74.24 110.148 -175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.401 ' CZ2' ' HA ' ' C' ' 100' ' ' ALA . 74.2 m95 -83.53 113.2 45.29 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 123.46 0.704 . . . . 75.3 109.697 172.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.88 143.97 37.83 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.183 1.922 . . . . 75.1 110.943 172.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 92.1 mt -119.85 110.29 16.57 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.204 -0.665 . . . . 73.14 109.204 177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.584 HG13 ' HB3' ' C' ' 129' ' ' ALA . 0.0 OUTLIER -82.72 143.09 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 108.672 -0.862 . . . . 43.14 108.672 173.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . 0.409 ' N ' HD13 ' E' ' 187' ' ' ILE . . . -141.5 108.13 5.35 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.374 -0.973 . . . . 72.54 108.374 177.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . 0.734 ' HB3' ' HB ' ' C' ' 40' ' ' VAL . . . -65.61 121.11 14.2 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.73 0.812 . . . . 53.03 109.786 173.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.6 163.34 25.58 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.258 0.623 . . . . 64.34 111.235 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.37 160.67 31.69 Favored Glycine 0 C--N 1.352 1.424 0 CA-C-N 115.877 -0.602 . . . . 45.12 113.606 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 179.34 146.4 6.73 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-O 119.782 -0.454 . . . . 72.44 112.466 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -114.9 106.14 13.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.901 0.88 . . . . 74.43 110.702 -173.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -171.69 90.24 0.12 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.037 0.935 . . . . 71.23 110.203 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -147.3 160.38 42.57 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.94 0.896 . . . . 62.45 111.366 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -115.82 106.66 14.09 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.423 -1.325 . . . . 73.2 107.423 169.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . 0.578 ' HE2' ' HA ' ' C' ' 32' ' ' PHE . 44.9 t80 -158.5 3.5 0.1 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.705 0.402 . . . . 75.44 111.827 -170.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -65.81 96.26 0.28 Allowed 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.36 1.064 . . . . 72.14 110.564 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 63.56 -75.34 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 125.641 1.577 . . . . 74.54 111.289 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -127.69 -108.48 1.48 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 109.452 -1.459 . . . . 62.44 109.452 173.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 62.4 tttp 69.12 -59.63 0.47 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.188 1.795 . . . . 74.41 111.672 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . 0.508 ' O ' ' HA ' ' F' ' 187' ' ' ILE . 9.3 t80 -46.61 -49.49 18.9 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.569 1.148 . . . . 62.5 109.55 172.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.49 -167.6 2.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.068 0.547 . . . . 70.13 111.169 173.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.667 HD13 HG22 ' B' ' 131' ' ' VAL . 45.8 mm 73.67 -60.08 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.368 1.403 0 C-N-CA 125.888 1.675 . . . . 63.22 110.566 -171.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 28.8 tptp 71.59 -74.58 0.09 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.127 1.371 . . . . 75.32 110.183 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -165.92 -44.65 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.766 0.826 . . . . 55.42 109.308 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 CA--C 1.561 1.392 0 C-N-CA 124.859 1.263 . . . . 53.24 110.221 -175.296 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 110.155 -0.313 . . . . 64.11 110.155 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 123.76 -51.72 0.8 Allowed Glycine 0 C--N 1.345 1.079 0 N-CA-C 109.362 -1.495 . . . . 74.43 109.362 -173.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . 0.52 ' HG2' ' HA ' ' B' ' 53' ' ' ASP . 50.6 mttp -69.66 88.19 0.51 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.199 -1.038 . . . . 60.22 108.199 167.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 32.3 t -67.7 -45.25 75.64 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.563 1.145 . . . . 74.24 111.817 -165.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.78 134.13 45.99 Favored 'General case' 0 C--O 1.241 0.616 0 O-C-N 123.635 0.585 . . . . 74.44 110.729 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.435 ' H ' HD23 ' F' ' 173' ' ' LEU . 2.4 pt? -62.23 106.17 0.7 Allowed 'General case' 0 CA--C 1.547 0.856 0 O-C-N 124.212 0.945 . . . . 65.32 109.055 172.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.454 ' SD ' ' HB3' ' B' ' 56' ' ' TYR . 0.0 OUTLIER -106.41 -176.23 3.02 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.524 -0.762 . . . . 54.01 109.524 -174.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -142.51 156.23 45.12 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.264 1.025 . . . . 75.34 109.43 -171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -130.8 46.25 2.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.964 0.906 . . . . 71.2 109.493 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 11.2 mp -60.57 119.66 8.5 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.114 0.565 . . . . 74.11 110.076 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.43 -17.63 15.73 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.945 0.498 . . . . 61.13 110.119 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.59 150.1 40.76 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.731 1.212 . . . . 73.03 110.096 -175.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . 0.525 ' HG3' ' H ' ' B' ' 46' ' ' THR . 3.9 Cg_exo -72.75 95.3 0.8 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.647 2.231 . . . . 73.42 110.553 174.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -61.07 -31.67 71.33 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.289 0.635 . . . . 73.34 110.45 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . 0.418 ' HD1' ' HA3' ' B' ' 99' ' ' GLY . 63.0 m-85 -116.33 81.4 1.61 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.517 0.727 . . . . 70.44 109.489 171.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 82.5 m -77.13 110.51 11.86 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 108.933 -0.766 . . . . 71.24 108.933 170.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -111.11 93.09 16.83 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.186 0.595 . . . . 74.14 109.625 174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -88.02 128.82 2.37 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.58 2.187 . . . . 72.41 112.283 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -164.34 177.03 8.57 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.715 0.406 . . . . 74.14 111.76 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.508 ' HA ' ' O ' ' E' ' 202' ' ' TYR . 64.3 mt 81.36 131.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 126.724 2.009 . . . . 75.33 112.534 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.08 87.95 2.13 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.075 -1.083 . . . . 74.23 108.075 169.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -89.72 111.66 22.71 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.649 -0.5 . . . . 70.31 109.649 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -139.11 163.03 33.48 Favored 'General case' 0 C--O 1.247 0.943 0 C-N-CA 123.78 0.832 . . . . 63.32 109.724 176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -158.47 172.2 35.39 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.784 -0.644 . . . . 50.32 111.745 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -76.96 -110.64 0.14 Allowed Glycine 0 C--N 1.343 0.932 0 O-C-N 123.499 0.176 . . . . 72.21 112.755 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -112.96 74.82 0.88 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.636 0.774 . . . . 61.42 109.583 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -107.84 37.42 2.45 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.236 -0.893 . . . . 60.4 109.539 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.494 ' HD1' ' HB2' ' F' ' 202' ' ' TYR . 73.4 t80 -146.16 -81.83 0.14 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.796 -1.093 . . . . 64.34 108.698 -175.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 88.0 tttt 50.73 108.66 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 125.21 1.404 . . . . 73.35 113.177 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . 0.427 ' H ' ' HB2' ' B' ' 35' ' ' ASP . 3.2 t80 -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.436 0.694 . . . . 73.4 111.467 -172.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -56.46 -50.11 72.66 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 72.11 110.283 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -172.32 115.63 0.33 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.591 0.756 . . . . 75.0 109.635 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.9 -91.11 0.08 OUTLIER Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.733 -0.547 . . . . 61.22 111.733 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.404 ' HB3' ' HB1' ' E' ' 189' ' ' ALA . 24.3 pttt -177.08 170.56 2.2 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.904 1.282 . . . . 74.21 111.071 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . 0.494 ' HB2' ' HD1' ' F' ' 195' ' ' PHE . 3.7 m-30 63.29 22.62 13.41 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 124.993 1.317 . . . . 74.44 110.071 -170.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -151.19 174.8 12.81 Favored 'General case' 0 C--O 1.25 1.096 0 CA-C-N 115.148 -0.933 . . . . 75.42 109.172 -164.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.617 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 16.5 mt -93.08 93.19 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 121.295 0.569 . . . . 62.01 109.524 174.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -101.76 -21.11 14.69 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 115.486 -0.779 . . . . 71.32 110.789 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' E' ' 187' ' ' ILE . 18.7 m-20 -138.58 130.1 27.53 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 122.957 0.503 . . . . 72.34 109.758 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.558 1.25 0 C-N-CA 124.663 1.185 . . . . 55.34 109.201 170.766 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt . . . . . 0 C--O 1.238 0.471 0 CA-C-O 120.944 0.402 . . . . 73.23 109.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.68 175.35 43.02 Favored Glycine 0 C--N 1.336 0.563 0 CA-C-N 116.172 -0.467 . . . . 52.45 112.511 -176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . 0.438 ' N ' ' HE2' ' G' ' 170' ' ' LYS . 0.0 OUTLIER -165.23 -158.49 0.39 Allowed 'General case' 0 C--O 1.245 0.837 0 C-N-CA 124.63 1.172 . . . . 64.42 107.86 -179.531 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 31.2 t -56.09 96.98 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 108.994 -0.743 . . . . 70.2 108.994 167.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -174.27 -60.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.377 1.071 . . . . 62.13 109.696 -171.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.642 ' HB2' ' SD ' ' G' ' 174' ' ' MET . 0.6 OUTLIER -132.72 173.37 11.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.25 -1.341 . . . . 64.14 110.737 -170.032 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.642 ' SD ' ' HB2' ' G' ' 173' ' ' LEU . 0.0 OUTLIER 61.92 21.17 12.09 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.438 1.095 . . . . 72.11 113.481 171.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -64.36 157.98 24.84 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.046 0.538 . . . . 63.55 111.74 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -83.98 60.38 5.81 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.966 0.906 . . . . 63.15 109.299 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . 0.609 ' HB2' ' H ' ' A' ' 48' ' ' SER . 55.8 tp 55.45 94.25 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.215 1.406 . . . . 73.44 112.511 -178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . 0.498 ' HG2' ' HG3' ' G' ' 179' ' ' GLU . 48.6 tt0 -84.4 -75.87 0.33 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.602 -0.888 . . . . 63.22 108.602 171.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.498 ' HG3' ' HG2' ' G' ' 178' ' ' GLN . 43.3 mt-10 -146.57 150.2 39.49 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 124.222 1.009 . . . . 74.33 109.513 -172.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.9 -37.66 53.0 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.591 2.194 . . . . 42.32 112.024 169.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 60.5 t80 69.24 133.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.656 1.182 . . . . 74.24 111.746 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 33.4 t80 67.23 161.75 0.17 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.955 1.302 . . . . 63.14 110.859 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 39.2 p -76.48 143.07 40.72 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 122.999 0.52 . . . . 70.42 110.704 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . 0.447 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 29.3 t-105 -124.82 127.21 25.2 Favored Pre-proline 0 N--CA 1.478 0.957 0 N-CA-C 108.14 -1.059 . . . . 73.43 108.14 177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . 0.584 ' HG3' HG23 ' H' ' 207' ' ' VAL . 87.5 Cg_endo -84.63 127.63 3.77 Favored 'Trans proline' 0 C--N 1.368 1.582 0 C-N-CA 122.594 2.196 . . . . 61.41 112.185 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 91.7 mt -89.15 99.71 12.64 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.616 -0.883 . . . . 74.33 108.616 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.408 HD13 ' H ' ' A' ' 129' ' ' ALA . 1.9 pp -71.77 -178.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.13 0.972 . . . . 62.22 112.167 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.35 178.58 4.45 Favored 'General case' 0 C--O 1.243 0.743 0 C-N-CA 123.452 0.701 . . . . 74.33 111.03 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . 0.666 ' HB2' HD23 ' A' ' 128' ' ' LEU . . . -133.78 147.34 51.26 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.387 0.675 . . . . 43.32 111.644 -174.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -86.65 153.09 22.03 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.896 0.878 . . . . 72.34 110.201 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.59 -170.15 23.8 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 115.414 -0.812 . . . . 75.23 111.306 174.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . 0.559 ' H ' ' HB2' ' A' ' 124' ' ' PRO . . . -86.87 3.43 87.01 Favored Glycine 0 N--CA 1.478 1.499 0 O-C-N 122.664 -0.315 . . . . 72.12 112.878 175.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . 0.408 ' HE1' ' HG3' ' H' ' 201' ' ' LYS . 77.5 t80 63.52 -80.69 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.075 1.75 . . . . 73.11 111.27 -172.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . 0.592 ' HA ' ' HD1' ' A' ' 36' ' ' TRP . . . -148.45 155.54 41.34 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.316 0.579 . . . . 74.32 111.452 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -93.9 3.55 55.22 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 114.701 -1.136 . . . . 65.53 110.671 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp 72.11 -59.63 0.55 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.584 1.554 . . . . 74.41 111.531 -169.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 72.21 143.64 0.06 Allowed 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 125.161 1.384 . . . . 64.11 112.208 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . 0.43 ' HB3' ' HE3' ' G' ' 201' ' ' LYS . 5.0 tm-20 -167.5 -77.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 107.173 -1.418 . . . . 74.05 107.173 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 9.0 t30 179.21 -68.76 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.047 1.339 . . . . 64.5 108.269 174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -88.67 61.22 3.85 Favored Glycine 0 C--N 1.35 1.346 0 CA-C-N 115.581 -0.736 . . . . 71.4 112.398 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' G' ' 201' ' ' LYS . 11.4 mmpt? -89.02 -54.33 4.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.697 -0.853 . . . . 73.42 108.697 177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -87.8 113.17 23.21 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 107.258 -1.386 . . . . 72.43 107.258 166.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -65.72 116.17 6.64 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.13 -1.063 . . . . 70.42 108.13 173.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 6.6 tp -126.33 99.65 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.739 0.78 . . . . 74.25 109.193 -176.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.84 160.39 23.51 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.232 -0.895 . . . . 75.52 109.585 174.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -79.12 170.84 16.05 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.464 -0.569 . . . . 72.34 109.464 171.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.567 1.627 0 CA-C-O 118.517 -0.754 . . . . 74.5 111.183 -178.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' H' ' 168' ' ' LYS . 3.2 mptp? . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.201 -1.037 . . . . 72.11 108.201 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.69 85.84 0.04 OUTLIER Glycine 0 C--N 1.349 1.275 0 O-C-N 124.076 0.86 . . . . 31.11 114.427 -169.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -158.84 -67.23 0.08 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.541 0.736 . . . . 60.13 110.313 176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 49.3 m -151.18 141.05 21.94 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.658 0.383 . . . . 73.22 111.076 -171.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' D' ' 90' ' ' GLU . . . -104.25 -76.57 0.59 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.384 0.674 . . . . 54.4 110.509 174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.667 ' HB3' ' SD ' ' H' ' 174' ' ' MET . 87.3 mt -85.09 126.47 33.62 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 114.787 -1.097 . . . . 74.14 110.193 -171.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' H' ' 173' ' ' LEU . 0.7 OUTLIER 69.08 147.43 0.06 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.084 1.354 . . . . 64.42 112.93 172.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.08 174.7 14.35 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.24 0.616 . . . . 73.13 110.835 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -116.46 27.52 9.15 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.643 0.777 . . . . 64.41 109.027 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . 0.48 HD11 ' OG ' ' D' ' 48' ' ' SER . 7.3 mp 64.81 99.22 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.144 1.378 . . . . 72.11 110.645 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.17 -66.08 0.66 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.759 -0.655 . . . . 53.2 111.711 -171.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -163.57 149.41 9.61 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.179 0.592 . . . . 64.01 110.138 -173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -77.76 87.4 1.52 Allowed 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.757 2.305 . . . . 74.24 111.091 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -56.11 -43.61 78.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.881 0.873 . . . . 74.54 111.397 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -134.95 138.69 44.29 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.089 0.956 . . . . 71.13 109.069 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -97.88 -30.69 12.61 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.483 0.713 . . . . 72.53 110.196 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 18.1 m-90 66.59 136.1 0.04 OUTLIER Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 125.545 1.538 . . . . 74.32 112.005 -176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . 0.604 ' HD2' HD13 ' D' ' 136' ' ' LEU . 64.1 Cg_endo -75.79 108.98 2.81 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.02 1.813 . . . . 74.43 112.233 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 6.5 mp -79.37 128.12 32.95 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.021 -0.733 . . . . 73.24 109.021 171.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.58 162.61 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 122.868 0.467 . . . . 75.2 110.917 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -149.58 -167.06 2.72 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.768 0.827 . . . . 73.24 109.5 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -157.26 133.88 9.95 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.104 0.562 . . . . 60.42 110.156 175.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.22 175.97 9.88 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.377 1.071 . . . . 73.0 108.646 175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 68.6 -109.21 2.79 Favored Glycine 0 C--N 1.344 0.994 0 N-CA-C 111.595 -0.602 . . . . 43.2 111.595 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 82.47 -61.85 4.67 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 114.343 0.497 . . . . 63.11 114.343 170.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 90.2 t80 63.32 102.01 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 74.45 110.271 -166.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -159.63 -171.73 3.41 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.699 0.8 . . . . 41.13 108.91 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 71.36 169.22 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.542 1.137 . . . . 55.35 112.14 174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -153.91 -39.1 0.09 Allowed 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.74 -0.664 . . . . 72.42 109.732 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 8.5 m-30 55.57 90.82 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 124.291 0.995 . . . . 65.5 112.31 170.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -129.03 126.1 38.75 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.831 -0.543 . . . . 72.11 111.246 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -85.45 80.19 9.18 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.035 -1.098 . . . . 73.03 108.035 166.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 164.8 -162.06 35.23 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.007 -0.997 . . . . 75.33 111.031 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . 0.408 ' HG3' ' HE1' ' G' ' 193' ' ' TYR . 6.8 tmtt? 61.71 103.57 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 125.179 1.392 . . . . 72.04 108.911 -171.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 64.79 82.52 0.18 Allowed 'General case' 0 C--N 1.355 0.836 0 N-CA-C 106.838 -1.541 . . . . 73.4 106.838 -167.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -109.19 158.75 17.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.14 -0.937 . . . . 74.35 110.517 -167.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.554 HG12 ' HB2' ' A' ' 129' ' ' ALA . 3.8 mp -87.58 140.33 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.322 1.049 . . . . 65.11 109.976 -170.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.81 175.67 5.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.164 0.986 . . . . 72.52 110.708 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -64.67 143.56 57.84 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.481 -0.782 . . . . 71.23 110.053 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' G' ' 185' ' ' PRO . 2.5 p . . . . . 0 CA--C 1.558 1.265 0 CA-C-O 118.224 -0.893 . . . . 74.4 110.69 -172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.664 0.269 . . . . 64.22 110.627 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m -85.41 89.57 7.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.392 0.677 . . . . 71.13 110.52 -173.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -93.37 116.92 29.46 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.79 0.836 . . . . 74.24 110.622 -176.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -172.18 153.25 3.02 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.186 0.994 . . . . 75.41 110.45 -174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.562 ' ND2' ' HB2' ' C' ' 144' ' ' GLN . 6.1 p30 -160.09 121.23 3.09 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.044 -1.095 . . . . 63.31 108.044 175.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -142.04 172.93 12.02 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.597 0.759 . . . . 63.31 109.536 -177.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.1 p -81.12 70.42 7.94 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.999 0.904 . . . . 72.22 108.932 172.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -132.12 174.22 10.42 Favored 'General case' 0 C--O 1.244 0.772 0 C-N-CA 124.398 1.079 . . . . 61.22 109.193 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.489 ' HG2' HG23 ' A' ' 89' ' ' ILE . 52.2 mtm 68.24 134.95 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.749 1.22 . . . . 71.53 111.071 -179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.2 m -146.46 122.0 10.41 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.674 -0.862 . . . . 75.11 108.674 -178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -126.59 116.57 21.24 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.07 -1.085 . . . . 75.51 108.07 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -137.55 110.66 7.79 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.701 0.8 . . . . 64.04 108.997 -176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -65.91 125.29 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 171.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -88.55 -33.4 17.73 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.152 -0.685 . . . . 61.21 109.152 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 17.3 ttt85 -172.61 145.31 1.54 Allowed 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.34 0.4 . . . . 74.42 110.901 -178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.652 HD12 ' HG3' ' C' ' 130' ' ' PRO . 64.7 mt -121.81 129.96 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 N-CA-C 107.912 -1.144 . . . . 74.51 107.912 168.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 38.9 p90 -163.6 159.13 21.44 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.607 0.763 . . . . 74.43 110.751 -177.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -84.92 118.53 24.58 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.354 -0.61 . . . . 74.04 109.354 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HZ1' ' HD3' ' B' ' 29' ' ' PRO . 23.6 mtpp -78.7 -40.64 33.2 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.752 -0.833 . . . . 55.22 108.752 172.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.7 t70 -136.42 142.17 43.65 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.985 -1.007 . . . . 75.01 110.234 -178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.492 HG21 ' SD ' ' B' ' 117' ' ' MET . 74.7 mt -139.84 140.72 35.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.56 1.544 . . . . 73.33 107.271 170.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.4 t -154.05 116.18 4.3 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.289 -0.634 . . . . 62.4 109.289 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 69.8 t80 -111.24 122.62 48.35 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 106.523 -1.658 . . . . 63.33 106.523 166.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -116.58 130.85 56.98 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.645 -0.872 . . . . 72.23 108.645 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.53 79.14 73.86 Favored Pre-proline 0 C--N 1.321 -0.635 0 N-CA-C 106.102 -1.814 . . . . 43.54 106.102 165.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.6 -27.25 45.81 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.439 2.093 . . . . 75.12 111.149 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.1 m-20 -111.33 31.89 5.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.338 -1.301 . . . . 71.33 109.12 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.08 -44.76 99.85 Favored Pre-proline 0 CA--C 1.572 1.825 0 N-CA-C 113.681 0.993 . . . . 71.21 113.681 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -73.52 -22.94 17.77 Favored 'Trans proline' 0 C--N 1.39 2.743 0 C-N-CA 121.905 1.737 . . . . 54.33 113.415 171.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.45 -39.52 70.92 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.188 0.595 . . . . 75.15 111.011 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 73' ' ' ALA . 28.2 m -73.3 -15.64 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.352 0.661 . . . . 72.33 112.045 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' HD1' ' HD2' ' B' ' 15' ' ' ARG . 79.3 t80 -61.94 -38.92 90.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.784 0.834 . . . . 71.13 110.849 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -100.75 -13.26 18.53 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.239 0.616 . . . . 70.41 112.016 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.446 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.7 mmtp -83.29 150.71 25.99 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 117.977 0.353 . . . . 73.02 111.724 175.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -69.49 132.19 45.91 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.099 0.96 . . . . 63.5 109.895 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.537 ' CE3' HD21 ' A' ' 68' ' ' LEU . 77.4 t-105 -77.63 93.44 4.23 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-O 121.216 0.531 . . . . 62.31 110.162 178.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' H ' HD22 ' A' ' 68' ' ' LEU . 8.5 tt0 -125.13 82.82 61.4 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 125.183 1.393 . . . . 75.34 107.745 170.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.4 114.32 3.77 Favored 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 122.537 2.158 . . . . 53.13 112.852 -173.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -94.74 90.5 6.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.238 -1.764 . . . . 74.03 106.238 174.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.39 130.53 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 115.327 -0.851 . . . . 73.2 110.499 -170.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.0 tttm -119.59 115.04 23.18 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.722 -1.214 . . . . 61.21 107.722 178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.31 123.95 45.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.829 0.851 . . . . 73.11 109.222 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.4 m-20 -118.84 109.21 15.76 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.989 0.916 . . . . 71.02 109.569 176.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.6 tp -100.77 120.53 40.23 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.604 -0.887 . . . . 71.53 108.604 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -154.46 162.46 41.14 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.395 -0.594 . . . . 71.41 109.395 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -134.25 164.05 28.26 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.158 0.583 . . . . 72.35 110.842 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.79 108.27 4.29 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.826 -1.176 . . . . 73.24 107.826 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.8 m -109.9 152.44 25.8 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.135 0.574 . . . . 72.2 110.339 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.9 t -157.11 142.86 17.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.48 0.712 . . . . 53.02 110.062 -172.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -90.68 118.96 30.53 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.938 -0.764 . . . . 74.23 108.938 174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 57' ' ' GLU . 71.3 mt -90.14 -39.64 12.73 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.086 0.555 . . . . 73.33 110.569 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -162.96 -174.09 3.74 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.789 0.836 . . . . 75.31 110.415 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -67.04 120.2 13.26 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.34 -0.985 . . . . 74.1 108.34 170.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 69.25 3.48 4.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.59 1.156 . . . . 41.13 112.811 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 21.2 t -115.32 114.59 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.821 -1.177 . . . . 70.35 107.821 176.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -142.58 133.05 25.02 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.488 -0.93 . . . . 74.15 108.488 -173.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' HD11 ' A' ' 51' ' ' LEU . 75.4 tt0 -114.09 120.14 39.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 122.737 0.415 . . . . 73.54 110.55 -178.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.4 t -100.69 121.81 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 106.114 -1.81 . . . . 73.42 106.114 168.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.8 t -106.18 134.97 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.975 -0.75 . . . . 72.2 108.975 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.421 HD11 ' HD1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -96.53 114.89 26.59 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.254 -1.017 . . . . 72.25 108.254 -179.624 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.0 ttp180 -101.77 99.94 10.23 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.824 -0.806 . . . . 74.42 108.824 176.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.84 137.69 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 107.795 -1.187 . . . . 71.24 107.795 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.9 m -129.55 124.63 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.624 -0.88 . . . . 73.11 108.624 171.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 89.5 t -115.37 130.62 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 107.828 -1.175 . . . . 74.53 107.828 176.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 7.3 m -121.98 148.15 45.16 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 106.763 -1.569 . . . . 75.45 106.763 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.07 124.29 14.57 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.967 -1.123 . . . . 72.45 107.967 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 48.5 m -122.4 141.45 51.58 Favored 'General case' 0 C--O 1.217 -0.643 0 C-N-CA 123.205 0.602 . . . . 73.11 110.298 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.537 HD21 ' CE3' ' A' ' 36' ' ' TRP . 51.1 mt -90.68 52.6 2.22 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.335 1.054 . . . . 74.04 109.791 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.14 -85.46 0.91 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.217 -0.901 . . . . 74.12 111.825 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -88.29 -31.09 19.16 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.443 0.697 . . . . 72.15 111.309 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.96 124.49 46.08 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 118.79 -0.624 . . . . 75.23 109.687 -172.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 61.6 m -65.97 132.53 48.82 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.274 0.359 . . . . 65.24 110.797 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -75.51 -53.87 7.93 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.0 0.813 . . . . 44.13 109.697 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -164.06 169.77 17.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 114.583 -1.19 . . . . 74.23 111.304 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 tp -130.21 148.17 52.01 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 113.985 -1.461 . . . . 73.13 107.444 167.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.428 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -142.35 134.55 27.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.127 -1.064 . . . . 70.41 108.127 178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -145.93 119.9 9.38 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.313 -0.995 . . . . 64.14 108.313 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.43 126.76 64.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 124.082 0.953 . . . . 75.32 109.635 -177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.514 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -104.99 90.15 3.36 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.044 -0.98 . . . . 74.01 108.781 172.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.408 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.0 tp-100 -76.83 97.64 4.61 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.929 -1.137 . . . . 64.41 107.929 173.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.82 143.52 20.66 Favored Glycine 0 C--N 1.337 0.608 0 N-CA-C 111.122 -0.791 . . . . 71.25 111.122 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -141.61 120.87 1.74 Allowed Glycine 0 CA--C 1.495 -1.163 0 N-CA-C 110.304 -1.118 . . . . 71.14 110.304 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.0 mt -83.96 125.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 107.791 -1.189 . . . . 75.52 107.791 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -127.57 118.03 23.18 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.197 0.999 . . . . 70.41 108.331 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.0 t -87.5 100.11 12.53 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.161 -1.422 . . . . 75.22 107.161 169.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.629 HG21 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -134.07 118.39 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.706 -0.679 . . . . 72.21 110.128 -168.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.8 177.67 11.01 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.727 1.211 . . . . 73.11 109.85 -172.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.27 10.58 74.09 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 120.883 0.157 . . . . 43.02 112.958 -177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.507 HD13 ' HB2' ' A' ' 94' ' ' MET . 1.1 pp -129.45 161.35 39.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.311 1.444 . . . . 70.33 110.169 -174.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.69 171.18 14.46 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.542 0.737 . . . . 70.44 109.965 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.13 -120.0 2.11 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.387 1.315 . . . . 53.51 116.387 172.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 55.5 p -76.21 -15.97 59.93 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.994 0.918 . . . . 63.32 112.695 -174.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -62.53 -50.86 69.67 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 109.583 -0.525 . . . . 75.2 109.583 177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.507 ' HB2' HD13 ' A' ' 89' ' ' ILE . 14.4 ttt -74.22 -32.71 63.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.114 -0.948 . . . . 65.13 110.756 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.74 92.31 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 121.123 0.487 . . . . 45.21 111.137 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.01 -37.99 78.98 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.778 0.831 . . . . 74.34 110.668 176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 19.4 t -69.82 -63.38 1.09 Allowed 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.514 -0.766 . . . . 72.34 110.198 -176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.629 HD21 HG21 ' A' ' 86' ' ' ILE . 53.8 mt -71.23 -22.78 61.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.251 0.62 . . . . 73.41 111.967 -176.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.6 -28.57 46.89 Favored Glycine 0 C--N 1.346 1.122 0 O-C-N 123.435 0.46 . . . . 71.03 113.887 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.93 -52.38 0.62 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.347 0.573 . . . . 72.24 112.397 -173.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -64.26 -54.42 33.58 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.328 0.651 . . . . 75.54 112.602 -170.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.426 ' SG ' HD23 ' A' ' 98' ' ' LEU . 52.9 m -65.91 -46.45 64.86 Favored Pre-proline 0 CA--C 1.562 1.415 0 C-N-CA 123.839 0.856 . . . . 64.04 112.645 -173.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.32 -24.36 50.53 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 121.587 1.525 . . . . 72.44 112.852 172.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -74.32 -28.76 61.3 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.107 0.412 . . . . 73.34 111.032 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.421 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 19.6 mt -60.75 -43.07 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 CA-C-O 121.369 0.604 . . . . 30.22 109.539 169.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.3 mt -70.53 -19.14 62.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 114.533 -1.212 . . . . 62.12 112.193 -177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.421 ' HD1' HD11 ' A' ' 60' ' ' LEU . 49.4 t80 -70.46 -42.49 15.21 Favored Pre-proline 0 CA--C 1.553 1.074 0 CA-C-O 117.563 -1.208 . . . . 74.44 113.6 -169.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 99.0 Cg_exo -49.43 -35.1 35.06 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.045 1.83 . . . . 55.3 114.022 168.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -84.74 -37.49 20.81 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.296 0.638 . . . . 62.55 111.439 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.33 -42.6 79.09 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 121.158 0.504 . . . . 71.44 109.984 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -53.37 -57.26 11.22 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.497 1.519 . . . . 75.32 109.909 171.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.35 -36.58 84.61 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.393 1.058 . . . . 62.04 111.671 -174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.23 -48.79 80.25 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.183 0.593 . . . . 43.12 110.026 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.89 -44.8 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 115.049 -0.978 . . . . 73.51 110.793 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.493 HG23 ' HB2' ' A' ' 125' ' ' GLN . 60.2 m -57.55 -40.73 79.54 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.924 0.889 . . . . 74.45 111.116 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 47.4 t -69.0 -46.64 67.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.164 -0.925 . . . . 74.21 110.412 177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.6 mtp -56.82 -40.69 76.47 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.764 0.825 . . . . 64.14 111.81 178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 51.5 t -65.19 -46.44 90.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.506 1.123 . . . . 71.22 110.719 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -71.34 -26.49 62.84 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.598 0.359 . . . . 71.01 111.621 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.7 mtt-85 -73.2 -32.57 64.88 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.73 0.812 . . . . 73.24 110.082 175.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 4.4 60.25 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.999 -0.546 . . . . 50.03 112.901 173.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 m 68.07 44.19 1.5 Allowed 'General case' 0 C--N 1.36 1.052 0 CA-C-O 122.721 1.248 . . . . 64.32 110.268 176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.9 149.13 50.22 Favored Pre-proline 0 C--O 1.243 0.73 0 CA-C-N 114.769 -1.105 . . . . 74.14 108.955 174.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -61.29 141.58 93.34 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.087 1.858 . . . . 63.5 110.633 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.493 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -61.41 159.74 12.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.286 1.034 . . . . 61.33 112.448 -168.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.55 102.25 6.29 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 74.33 108.348 174.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -98.17 94.24 6.69 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.173 -0.676 . . . . 72.32 109.173 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.4 mt -59.53 134.99 57.52 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.63 0.772 . . . . 65.54 110.906 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 139.45 91.74 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 123.162 0.585 . . . . 53.04 112.176 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -79.86 97.55 1.08 Allowed 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.461 2.107 . . . . 72.22 109.991 177.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.5 t -101.13 112.76 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.647 -0.872 . . . . 72.02 108.647 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -100.57 87.84 3.47 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.806 -0.634 . . . . 72.43 110.434 -177.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -66.87 -34.27 77.43 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.611 -0.722 . . . . 70.05 109.259 169.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 138' ' ' MET . 4.4 p-10 -55.67 -50.55 69.96 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.256 -0.884 . . . . 73.43 110.89 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.36 -37.69 88.41 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.084 0.553 . . . . 72.5 111.864 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt -60.71 -51.62 68.59 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.006 -0.738 . . . . 75.32 109.006 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 140' ' ' TYR . 61.8 m-85 -76.13 -18.03 59.32 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.625 0.77 . . . . 72.43 112.778 -176.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 88.4 mmm -61.22 -52.63 63.99 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 118.26 0.482 . . . . 73.24 109.919 170.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -73.93 -35.77 64.62 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 116.056 -0.52 . . . . 72.34 111.362 -178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 137' ' ' PHE . 77.1 t80 -63.6 -42.48 98.25 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.389 1.076 . . . . 74.31 110.906 -178.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -68.26 -50.01 56.73 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 116.066 -0.516 . . . . 74.31 110.624 -176.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -165.24 -18.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 112.533 0.568 . . . . 75.04 112.533 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' C' ' 145' ' ' ALA . 0.0 OUTLIER 46.98 84.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 123.636 0.774 . . . . 71.43 109.468 -172.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -169.58 139.86 2.12 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.99 -0.374 . . . . 72.24 109.99 -170.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.18 -178.98 6.11 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.716 0.806 . . . . 71.4 109.85 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.37 144.02 12.26 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 110.748 -0.941 . . . . 63.34 110.748 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.51 93.52 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.027 0.931 . . . . 74.53 110.634 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.66 -73.35 0.58 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 115.256 -0.883 . . . . 72.42 113.012 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -148.67 161.3 42.02 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.332 0.587 . . . . 71.4 111.29 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -123.94 -35.21 2.88 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 125.127 1.371 . . . . 71.2 109.687 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -71.74 162.0 30.11 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.139 0.976 . . . . 73.53 112.684 -170.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -142.3 143.03 32.61 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.837 1.255 . . . . 73.32 108.887 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -72.48 83.1 1.09 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.682 0.753 . . . . 75.52 109.453 178.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -90.14 83.8 6.07 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.401 -1.272 . . . . 72.33 109.92 -171.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.032 0.933 . . . . 74.33 109.214 -177.174 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ttt . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 120.851 0.358 . . . . 55.25 110.948 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 63.6 p -101.16 21.95 13.14 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.227 0.611 . . . . 65.1 110.356 177.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.7 142.69 31.08 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.691 0.797 . . . . 65.31 109.722 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.433 ' HG2' ' HB2' ' D' ' 140' ' ' TYR . 2.9 pp0? -89.91 -3.75 57.89 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.267 0.627 . . . . 74.2 111.745 176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -81.48 78.22 8.26 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 121.778 0.799 . . . . 72.22 109.084 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -143.6 -44.26 0.28 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.162 -0.926 . . . . 71.05 109.545 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.4 m 56.56 69.51 0.73 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.668 1.187 . . . . 75.15 110.911 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.06 178.2 5.01 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 114.701 -1.136 . . . . 73.21 110.765 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.504 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 8.9 ptm 57.58 171.24 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 127.348 2.259 . . . . 45.53 113.699 -174.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 9.1 t -162.24 142.51 10.02 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.294 0.637 . . . . 55.31 110.018 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -131.96 113.58 13.58 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.622 -1.251 . . . . 63.13 107.622 172.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.449 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 21.2 tp60 -127.87 98.66 5.23 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.388 0.613 . . . . 71.22 109.983 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 tt -78.61 119.68 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-N 115.393 -0.821 . . . . 72.23 109.733 176.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.85 -48.35 7.07 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.049 0.54 . . . . 74.45 110.562 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.466 ' HD2' ' HD1' ' A' ' 32' ' ' PHE . 55.2 ttt180 -165.26 142.91 5.99 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.484 -0.325 . . . . 72.14 110.563 -172.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.2 mt -114.5 142.93 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 N-CA-C 107.449 -1.315 . . . . 65.42 107.449 167.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -164.83 158.44 17.4 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.031 0.443 . . . . 71.23 110.567 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.46 HG21 HD11 ' B' ' 21' ' ' ILE . 89.5 m -85.62 123.36 30.94 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 109.158 -0.682 . . . . 55.41 109.158 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.442 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 30.9 mtpt -88.09 -35.87 17.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.453 -0.794 . . . . 54.13 111.183 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -161.92 147.89 13.49 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.999 0.428 . . . . 63.14 111.013 -173.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.7 mm -142.33 145.59 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 126.101 1.76 . . . . 72.14 108.093 -175.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -154.44 148.43 25.69 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.676 0.61 . . . . 73.22 110.217 170.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' B' ' 117' ' ' MET . 88.2 t80 -156.12 107.22 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.166 -1.42 . . . . 74.02 107.166 172.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -122.71 118.58 28.41 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.446 0.699 . . . . 72.41 109.793 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -112.12 87.89 9.57 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.429 1.092 . . . . 70.11 109.821 -175.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.524 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 37.5 Cg_endo -63.67 -41.55 24.42 Favored 'Trans proline' 0 C--N 1.384 2.417 0 C-N-CA 122.65 2.233 . . . . 75.52 113.072 -174.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -106.27 31.51 5.1 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.58 0.752 . . . . 72.12 110.036 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -48.59 -48.11 69.17 Favored Pre-proline 0 CA--C 1.573 1.855 0 C-N-CA 125.217 1.407 . . . . 75.42 114.698 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HZ1' ' A' ' 19' ' ' LYS . 89.9 Cg_endo -92.66 -5.34 3.27 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.086 1.857 . . . . 54.22 113.087 174.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m-70 -98.4 -0.47 43.58 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.689 0.796 . . . . 64.52 110.814 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.5 p -64.99 -28.02 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.39 1.076 . . . . 71.13 111.089 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -71.23 -18.25 62.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.878 0.871 . . . . 74.25 112.519 -174.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -57.33 -41.01 79.18 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.396 0.617 . . . . 74.14 109.887 175.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.519 ' HB2' HD13 ' B' ' 68' ' ' LEU . 81.4 mttt -108.73 106.74 16.91 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.58 -1.191 . . . . 72.42 108.465 178.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -74.44 79.28 1.91 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.74 0.781 . . . . 73.11 110.13 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.584 ' HA ' ' H ' ' F' ' 197' ' ' TYR . 10.0 t-105 -153.52 151.37 29.73 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.996 -1.483 . . . . 71.52 106.996 173.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 37.1 tp60 -90.64 114.93 62.97 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.507 -1.664 . . . . 70.11 106.507 177.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -60.53 131.36 37.72 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.305 2.004 . . . . 63.22 111.978 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 120.41 14.05 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.914 0.759 . . . . 73.53 109.107 -175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.844 HG12 HD22 ' B' ' 126' ' ' LEU . 2.1 t -86.02 118.74 33.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 106.503 -1.666 . . . . 72.24 106.503 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -138.46 134.92 34.64 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.496 -0.557 . . . . 64.55 109.496 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' B' ' 126' ' ' LEU . 0.7 OUTLIER -128.96 156.63 43.47 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.248 0.619 . . . . 73.02 112.393 -169.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -133.19 141.32 48.03 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.932 1.293 . . . . 65.54 108.622 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.458 HD22 HD11 ' F' ' 186' ' ' LEU . 50.2 tp -85.61 136.57 33.33 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.655 0.782 . . . . 72.43 110.99 -175.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.518 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 8.9 m-20 -129.77 144.27 51.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.988 -1.116 . . . . 74.24 107.988 172.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.9 m -130.18 125.64 35.48 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.296 0.638 . . . . 72.32 109.968 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -132.23 159.07 40.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.169 0.988 . . . . 63.11 109.11 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 62.1 m -143.01 168.91 18.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.071 0.549 . . . . 73.01 109.98 174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 36.5 t -151.45 164.35 36.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.515 1.126 . . . . 74.12 108.408 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.547 HE22 HD13 ' F' ' 173' ' ' LEU . 65.3 tt0 -124.05 124.11 41.83 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.082 0.553 . . . . 63.01 109.54 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 85.7 mt -93.41 -28.55 16.08 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.342 0.657 . . . . 64.5 110.783 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -172.93 -171.48 0.75 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.749 0.82 . . . . 62.34 111.223 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -66.48 113.14 4.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.615 -1.175 . . . . 74.21 110.152 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.779 ' H ' HD21 ' F' ' 173' ' ' LEU . 28.3 m-20 75.93 -5.15 2.23 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.773 2.029 . . . . 73.05 112.09 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 51.1 t -104.86 99.73 9.06 Favored 'Isoleucine or valine' 0 C--N 1.345 0.38 0 N-CA-C 108.106 -1.072 . . . . 64.21 108.106 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -102.91 168.48 9.18 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.513 0.673 . . . . 75.34 110.062 175.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -138.41 100.06 4.01 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 106.402 -1.703 . . . . 63.31 106.402 178.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 49.0 t -92.46 128.82 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 123.197 0.599 . . . . 63.05 109.739 -174.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 47.1 t -105.37 145.07 14.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 124.006 0.922 . . . . 73.04 109.815 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.84 112.96 18.99 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.443 -1.688 . . . . 75.04 106.443 173.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 34.0 ttm180 -102.83 130.84 49.97 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.06 -0.718 . . . . 65.45 109.06 172.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.489 HG11 HD12 ' B' ' 42' ' ' LEU . 50.7 t -121.14 108.83 23.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 N-CA-C 107.218 -1.401 . . . . 71.22 107.218 169.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -98.28 136.79 37.96 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.167 0.508 . . . . 74.1 109.93 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 89.8 t -122.97 137.98 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.195 1.398 . . . . 71.14 110.705 -169.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 57.4 m -123.9 151.38 43.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.873 1.269 . . . . 71.31 109.038 173.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.04 146.87 31.11 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.686 0.795 . . . . 41.23 108.913 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 67.3 p -153.68 158.72 41.47 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 75.04 111.554 -171.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' B' ' 34' ' ' LYS . 72.6 mt -128.27 107.0 9.41 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 107.581 -1.266 . . . . 61.02 107.581 169.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.8 -110.6 3.21 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 123.422 0.451 . . . . 73.13 112.322 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -110.0 0.25 18.42 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.54 0.736 . . . . 75.24 111.517 -174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.61 159.19 28.36 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 121.504 -0.747 . . . . 65.24 111.358 -174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 25.6 m -73.9 139.08 44.72 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.434 -0.803 . . . . 51.41 110.488 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -99.96 -53.67 3.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.149 -1.056 . . . . 53.24 108.149 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.524 ' HA ' ' HD2' ' B' ' 26' ' ' PRO . 46.0 p90 -156.44 170.16 22.95 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.724 -1.125 . . . . 70.24 110.415 173.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -138.65 155.14 48.54 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.68 1.592 . . . . 65.22 107.939 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.589 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 54.1 t -152.91 158.67 42.47 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.125 -0.694 . . . . 73.45 109.125 177.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -155.76 137.94 14.69 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.723 -1.214 . . . . 74.01 107.723 171.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.0 146.38 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.303 0.641 . . . . 72.22 109.277 172.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -129.65 99.24 5.08 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.783 0.833 . . . . 64.12 108.969 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -91.42 106.47 18.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.42 -0.809 . . . . 70.43 109.394 175.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.442 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -99.92 168.11 21.15 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.839 -0.505 . . . . 62.24 111.839 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -163.45 129.86 2.11 Favored Glycine 0 C--O 1.236 0.28 0 N-CA-C 111.005 -0.838 . . . . 63.22 111.005 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 45.0 mt -85.15 115.65 27.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.604 -0.887 . . . . 61.55 108.604 177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.89 131.76 52.29 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.526 -0.916 . . . . 75.21 108.526 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 41.9 m -107.71 106.9 17.45 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.329 -0.989 . . . . 51.53 108.329 178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.3 pp -128.35 144.8 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.797 0.839 . . . . 75.42 111.277 -172.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.73 171.92 19.43 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 124.348 1.059 . . . . 74.53 109.183 172.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.68 -48.33 2.06 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 116.368 -0.378 . . . . 73.11 112.733 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.03 163.52 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.533 0.733 . . . . 63.35 110.177 173.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.22 158.11 21.19 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.732 0.413 . . . . 45.04 111.529 177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -113.72 5.45 Favored Glycine 0 C--N 1.352 1.419 0 O-C-N 123.858 0.724 . . . . 63.51 114.298 172.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.4 m -66.08 -38.29 87.92 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.318 1.047 . . . . 64.14 110.471 177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -71.66 -31.32 66.7 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 114.674 -1.148 . . . . 75.12 110.002 -176.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.5 tpt -70.39 -43.19 70.6 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.942 0.897 . . . . 63.45 109.945 172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.2 -26.63 67.48 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.196 -0.911 . . . . 72.32 111.278 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -83.51 -29.19 28.13 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.802 0.841 . . . . 70.43 110.561 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.2 t -68.98 -61.96 1.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.285 0.634 . . . . 54.23 110.789 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.73 -12.66 25.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 112.828 0.677 . . . . 73.23 112.828 -173.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.68 1.42 42.19 Favored Glycine 0 N--CA 1.476 1.329 0 CA-C-O 119.92 -0.378 . . . . 52.12 113.66 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.1 -58.27 0.31 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.173 0.486 . . . . 53.42 111.114 -178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.409 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 52.7 t80 -74.66 -45.32 45.47 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.106 -0.497 . . . . 63.53 111.798 -172.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.558 ' HA ' HD12 ' B' ' 105' ' ' ILE . 99.8 m -63.64 -46.26 82.91 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.422 -0.799 . . . . 71.41 111.734 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.58 -39.19 92.47 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.777 1.651 . . . . 73.53 113.226 168.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -63.22 -30.54 71.66 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 123.014 0.525 . . . . 70.25 111.83 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' B' ' 102' ' ' CYS . 96.7 mt -64.43 -47.46 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.389 1.076 . . . . 73.05 110.41 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.2 mt -81.6 -12.62 58.67 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.345 -1.298 . . . . 60.33 111.384 -174.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.471 ' HE2' ' HA ' ' B' ' 130' ' ' PRO . 26.1 t80 -63.29 -49.94 77.03 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.944 1.298 . . . . 72.2 113.084 -170.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.2 -33.25 95.0 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.867 1.711 . . . . 74.43 113.073 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 81.7 m-85 -66.11 -48.26 71.46 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.023 0.529 . . . . 71.22 110.837 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.37 -40.88 97.89 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.954 0.902 . . . . 72.51 110.961 177.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.452 ' HE ' ' HB2' ' B' ' 127' ' ' ASN . 81.4 mtp180 -55.57 -52.61 63.17 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.317 1.047 . . . . 54.3 110.454 175.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -65.31 -39.83 92.98 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.197 -0.91 . . . . 65.41 111.33 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.6 t -70.74 -43.43 68.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.871 -0.604 . . . . 70.04 111.559 -170.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.474 HD11 ' HB ' ' B' ' 62' ' ' VAL . 95.5 mt -63.11 -46.78 95.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 122.815 0.446 . . . . 74.22 110.474 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.409 HG21 ' CB ' ' C' ' 119' ' ' SER . 22.6 m -52.24 -41.18 62.57 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 123.81 0.693 . . . . 74.24 111.092 176.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.9 t -62.7 -53.92 47.2 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.927 -0.578 . . . . 71.52 110.383 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 21' ' ' ILE . 36.8 mmt -59.49 -44.58 93.04 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 123.208 0.603 . . . . 62.44 111.76 -176.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 56.0 t -69.04 -40.47 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 124.513 1.125 . . . . 70.54 111.235 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 94.3 p -70.52 -31.91 69.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.422 -0.354 . . . . 53.31 110.834 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.1 mtt-85 -63.12 -27.73 69.59 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.321 0.648 . . . . 65.04 111.063 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.457 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -85.13 10.55 63.02 Favored Glycine 0 CA--C 1.539 1.543 0 O-C-N 123.632 0.582 . . . . 52.33 113.059 173.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.2 p 64.62 44.06 4.07 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.749 2.019 . . . . 65.43 112.377 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -119.54 161.87 35.32 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.385 0.674 . . . . 73.34 110.908 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.49 ' HA ' ' OE1' ' C' ' 125' ' ' GLN . 32.1 Cg_exo -62.25 172.89 3.73 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 123.496 2.797 . . . . 65.13 114.326 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.691 ' HB3' ' HG3' ' C' ' 125' ' ' GLN . 12.9 pm0 -64.57 154.99 34.55 Favored 'General case' 0 C--N 1.352 0.692 0 CA-C-N 115.28 -0.873 . . . . 74.53 111.841 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.844 HD22 HG12 ' B' ' 40' ' ' VAL . 23.0 tp -142.48 83.98 1.84 Allowed 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.477 -0.935 . . . . 63.51 108.477 165.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.452 ' HB2' ' HE ' ' B' ' 111' ' ' ARG . 6.2 p30 -115.84 106.31 13.69 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 107.037 -1.468 . . . . 74.24 107.037 170.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.634 ' HB2' HD11 ' B' ' 42' ' ' LEU . 4.0 tt -55.26 136.53 48.77 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.724 -1.125 . . . . 73.51 109.336 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' B' ' 130' ' ' PRO . . . -50.93 140.17 21.07 Favored Pre-proline 0 N--CA 1.478 0.943 0 O-C-N 124.034 0.834 . . . . 52.34 110.985 177.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.521 ' HG2' ' HB ' ' D' ' 16' ' ' ILE . 25.8 Cg_exo -65.13 71.62 0.26 Allowed 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 123.15 2.567 . . . . 74.53 113.242 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.62 85.09 1.23 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 108.298 -1.001 . . . . 63.52 108.298 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.496 ' ND2' HG23 ' D' ' 105' ' ' ILE . 2.1 m-20 -78.38 113.11 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.541 -0.911 . . . . 61.04 108.541 174.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.519 ' HZ ' ' HB2' ' F' ' 182' ' ' PHE . 74.0 t80 -55.64 -32.16 62.93 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.963 0.905 . . . . 75.54 110.709 175.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' B' ' 138' ' ' MET . 6.3 m-20 -56.78 -28.75 61.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.391 1.477 . . . . 74.4 112.155 -179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.04 -49.55 71.93 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.617 0.767 . . . . 74.5 111.16 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.88 -46.34 85.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.248 1.019 . . . . 53.23 109.609 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.57 -32.68 71.75 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.891 -1.504 . . . . 73.43 111.186 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.518 ' O ' ' HG2' ' B' ' 142' ' ' GLN . 94.7 mmm -67.7 -36.29 80.36 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.772 0.429 . . . . 75.03 111.662 177.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -74.78 -38.03 62.26 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.643 0.377 . . . . 72.02 111.413 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -73.21 -41.59 63.61 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.789 -0.641 . . . . 75.01 110.7 -176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.16 19.38 5.88 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.085 0.772 . . . . 75.33 113.085 -172.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' B' ' 138' ' ' MET . 11.6 pt20 -162.32 175.64 11.38 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.101 0.477 . . . . 54.13 111.468 168.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -147.36 -58.16 0.26 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.361 1.064 . . . . 70.44 108.575 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -80.82 -75.31 0.28 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.007 -0.997 . . . . 70.14 109.767 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 51.14 80.3 0.08 Allowed 'General case' 0 C--N 1.358 0.939 0 C-N-CA 124.737 1.215 . . . . 75.2 111.786 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' D' ' 90' ' ' GLU . . . -136.25 -84.68 0.17 Allowed Glycine 0 C--O 1.244 0.732 0 CA-C-N 115.327 -0.851 . . . . 64.32 111.33 -175.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 53.7 39.39 30.16 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.341 1.056 . . . . 72.4 110.809 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -56.99 118.43 12.1 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.946 -1.025 . . . . 31.24 112.088 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 88.2 m -59.39 107.61 0.59 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.568 1.147 . . . . 74.14 110.897 -175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.55 146.93 51.43 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.007 -0.738 . . . . 72.21 109.007 173.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 80.03 137.59 0.06 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 73.33 110.955 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -153.86 130.2 10.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.256 1.022 . . . . 64.23 108.848 176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -129.01 110.09 11.77 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.071 0.948 . . . . 73.21 109.613 -179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -164.38 152.96 12.92 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.321 1.048 . . . . 73.3 109.649 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 C-N-CA 124.937 1.295 . . . . 65.13 110.587 -175.237 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.44 ' HB2' ' HD1' ' G' ' 182' ' ' PHE . 1.2 mpt? . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.236 -0.653 . . . . 73.23 109.236 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 30.7 p -157.23 132.23 8.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.881 0.872 . . . . 74.22 109.402 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -122.53 8.15 9.55 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.244 0.545 . . . . 73.15 110.707 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -148.58 105.43 3.59 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 70.5 109.612 174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -92.39 127.01 37.72 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.639 -1.245 . . . . 54.44 107.639 168.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -94.99 110.65 22.53 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.193 -0.669 . . . . 72.13 109.193 -176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.5 m -92.96 96.95 10.42 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.103 -0.703 . . . . 73.32 109.103 175.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -142.63 115.02 8.45 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.235 -1.024 . . . . 70.41 108.235 170.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.468 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.5 ttp 62.45 111.42 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.407 1.083 . . . . 73.5 110.979 -172.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.7 m -105.37 114.15 28.15 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.875 0.87 . . . . 75.15 109.109 177.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 72.8 t80 -96.36 131.94 42.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.611 -0.885 . . . . 75.11 108.611 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -139.83 124.4 18.19 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.147 0.579 . . . . 63.31 109.878 -175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 mt -93.35 133.24 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.535 0.734 . . . . 73.01 109.262 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -105.17 -45.96 4.37 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.618 0.767 . . . . 71.03 110.371 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -167.81 124.35 1.1 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.999 -0.371 . . . . 73.3 109.999 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.2 mt -110.22 135.45 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 108.552 -0.907 . . . . 75.11 108.552 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' C' ' 19' ' ' LYS . 27.3 p90 -173.45 163.13 4.39 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.176 0.59 . . . . 65.34 109.804 -173.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -85.78 124.28 32.1 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 122.812 0.445 . . . . 71.42 110.374 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.601 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 22.2 mmtp -78.1 -49.95 12.94 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.869 0.842 . . . . 53.01 108.977 170.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.3 t70 -135.41 142.47 45.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.989 -1.459 . . . . 72.51 109.38 -169.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.4 mt -143.99 146.13 21.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.714 -1.587 . . . . 63.14 106.714 176.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -159.7 149.75 18.65 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.266 0.555 . . . . 55.25 110.42 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -142.65 116.5 9.3 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.614 -1.254 . . . . 75.55 107.614 171.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -116.57 126.21 52.97 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.847 0.859 . . . . 75.14 109.725 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 81.32 70.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 107.998 -1.112 . . . . 65.23 107.998 171.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.22 -25.74 42.75 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 123.131 2.554 . . . . 72.13 112.194 -177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -108.25 26.72 10.09 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.985 0.914 . . . . 71.22 110.44 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.479 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -46.16 -53.5 22.09 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.161 1.171 . . . . 44.43 114.161 -173.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 59.9 Cg_endo -81.33 -18.74 8.29 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 121.566 1.511 . . . . 74.52 113.824 177.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -71.57 -49.26 42.24 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.303 0.641 . . . . 64.41 111.472 177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.618 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.5 p -77.83 -13.37 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 124.802 1.241 . . . . 74.32 111.4 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.563 ' HE2' ' HD3' ' D' ' 15' ' ' ARG . 79.3 t80 -53.93 -43.06 69.46 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.322 1.049 . . . . 63.43 112.24 -178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -103.94 27.59 7.47 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.637 0.732 . . . . 71.14 110.046 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -99.11 165.18 11.85 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.404 0.682 . . . . 72.43 109.411 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.35 120.55 24.54 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 108.99 -0.744 . . . . 64.22 108.99 169.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -85.56 88.96 7.59 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.585 0.754 . . . . 71.24 110.688 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.457 ' H ' HD22 ' C' ' 68' ' ' LEU . 35.0 tt0 -128.75 74.32 80.69 Favored Pre-proline 0 CA--C 1.552 1.052 0 N-CA-C 107.768 -1.197 . . . . 75.24 107.768 169.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.82 143.21 4.18 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 123.503 2.802 . . . . 64.41 113.404 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.89 115.38 25.31 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.251 -1.018 . . . . 74.33 108.251 167.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.476 HG11 HD21 ' C' ' 128' ' ' LEU . 26.1 t -83.32 85.42 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 109.05 -0.722 . . . . 73.55 109.05 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -93.87 100.94 13.02 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.746 -1.205 . . . . 70.24 107.746 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.469 HD11 HD12 ' E' ' 186' ' ' LEU . 4.2 pp -90.27 154.53 19.65 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.144 -0.688 . . . . 74.54 109.144 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.477 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 8.1 m-20 -120.9 145.33 47.77 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 124.437 1.095 . . . . 74.44 108.19 178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 18.5 tp -117.73 134.45 54.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.749 0.82 . . . . 70.23 108.861 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -154.15 150.08 27.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.222 -1.029 . . . . 71.33 108.222 172.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 91.6 m -137.95 123.97 20.23 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.096 -0.705 . . . . 75.41 109.096 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.98 23.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.287 1.035 . . . . 54.21 108.497 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 58.9 p -145.27 144.37 30.74 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.748 0.419 . . . . 64.3 110.455 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.4 t -145.1 129.77 18.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.919 0.888 . . . . 72.11 109.109 -176.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -76.95 131.86 38.73 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.527 -0.546 . . . . 64.01 109.527 178.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.594 HD11 HD12 ' C' ' 83' ' ' ILE . 35.4 mt -106.46 -42.71 4.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.404 0.681 . . . . 63.53 109.568 -179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.78 -177.11 5.41 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 114.45 -1.25 . . . . 73.24 109.138 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -72.99 109.08 6.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.053 -0.522 . . . . 73.24 109.935 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 65.86 18.04 11.0 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 125.039 1.336 . . . . 75.21 112.222 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 48.1 t -121.93 114.48 42.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.66 -1.608 . . . . 74.11 106.66 169.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.433 ' HE2' HG12 ' C' ' 86' ' ' ILE . 43.6 p90 -134.64 -178.74 5.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.656 0.741 . . . . 64.34 110.95 -174.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' C' ' 51' ' ' LEU . 23.9 tt0 -126.34 113.24 16.65 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.877 -1.511 . . . . 74.13 108.904 -170.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -96.9 129.52 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.219 -1.03 . . . . 65.04 108.219 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 63.3 t -124.1 106.36 16.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.486 -1.302 . . . . 64.53 107.486 -177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.484 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 0.1 OUTLIER -86.13 103.09 14.46 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.066 -1.087 . . . . 71.01 108.066 -177.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -84.83 106.11 16.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.768 0.827 . . . . 72.24 109.349 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.84 130.73 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.313 -0.995 . . . . 54.53 108.313 173.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 5.8 m -116.8 148.31 41.31 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.041 -1.096 . . . . 64.43 108.041 174.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.702 HG21 HG21 ' C' ' 114' ' ' ILE . 46.1 t -132.91 110.43 15.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 107.872 -1.159 . . . . 62.13 107.872 -176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.5 m -102.57 139.02 38.71 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.0 -0.741 . . . . 74.4 109.0 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.53 112.75 15.91 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.513 -1.291 . . . . 65.1 107.513 175.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 16.5 m -129.82 130.03 44.78 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.346 0.404 . . . . 55.43 110.256 -175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.457 HD22 ' H ' ' C' ' 37' ' ' GLN . 41.7 mt -87.29 27.88 1.01 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.961 1.304 . . . . 74.44 110.906 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.22 -103.1 1.92 Allowed Glycine 0 C--N 1.348 1.228 0 N-CA-C 110.933 -0.867 . . . . 62.53 110.933 -171.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -89.69 -29.37 18.81 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.979 0.512 . . . . 63.03 110.364 179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -76.82 121.12 22.92 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 123.977 0.911 . . . . 72.02 110.146 173.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.2 m -80.81 124.76 29.34 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.789 -0.819 . . . . 74.13 108.789 166.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -80.69 -51.16 9.0 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.405 -0.816 . . . . 73.22 109.973 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -166.53 176.45 7.31 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 115.263 -0.881 . . . . 74.12 110.729 176.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -143.4 141.4 30.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.906 -1.516 . . . . 73.34 106.906 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.506 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -147.4 125.4 12.05 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.864 0.465 . . . . 73.35 109.896 -179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -129.66 133.55 47.17 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.878 0.471 . . . . 64.33 110.122 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -124.51 137.83 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.024 0.93 . . . . 74.42 108.56 168.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -112.15 102.09 10.3 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.294 1.037 . . . . 73.23 108.665 171.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -86.93 108.98 19.04 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.452 -0.794 . . . . 75.02 110.251 -177.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.27 150.21 25.76 Favored Glycine 0 C--N 1.341 0.824 0 O-C-N 123.232 0.332 . . . . 50.4 112.305 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.36 119.33 0.93 Allowed Glycine 0 C--N 1.335 0.51 0 N-CA-C 111.31 -0.716 . . . . 75.2 111.31 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.594 HD12 HD11 ' C' ' 51' ' ' LEU . 11.7 mm -84.82 124.66 40.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 108.52 -0.918 . . . . 64.12 108.52 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -132.12 126.35 33.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.656 0.782 . . . . 75.25 110.014 -175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 48.2 t -96.08 134.98 38.46 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.912 -1.144 . . . . 35.51 107.912 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.452 HD13 HG12 ' C' ' 89' ' ' ILE . 2.7 pp -131.87 162.65 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-O 121.536 0.684 . . . . 43.44 111.911 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.4 149.92 29.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.29 -1.323 . . . . 34.31 108.096 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.48 -17.36 49.17 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.528 -1.151 . . . . 72.41 114.991 173.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.456 ' O ' HG13 ' C' ' 89' ' ' ILE . 36.5 pt -62.1 98.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.321 0 CA-C-N 118.489 1.144 . . . . 70.55 110.753 -176.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.506 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 41.3 mt-10 -145.35 160.17 41.94 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.12 0.968 . . . . 74.41 109.294 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.4 -115.07 7.51 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.844 0.715 . . . . 75.34 112.451 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 60.6 p -75.86 -36.35 59.62 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.376 0.67 . . . . 72.22 110.57 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -58.91 -32.77 69.85 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.92 0.888 . . . . 65.23 112.652 -172.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 5.5 ptm -82.74 5.88 19.94 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.307 0.643 . . . . 71.44 112.149 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -131.15 -21.38 2.64 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 72.32 110.929 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -84.95 -43.06 14.36 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.549 1.14 . . . . 64.04 110.207 -174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.468 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 43.7 t -72.18 -60.46 2.22 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.224 0.61 . . . . 74.25 111.008 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.434 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.3 pp -75.01 -14.47 60.61 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.003 0.521 . . . . 62.01 112.392 -175.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.63 6.96 68.02 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.933 -0.37 . . . . 55.21 113.246 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -156.16 -63.54 0.11 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 117.082 0.441 . . . . 74.34 111.607 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -69.75 -50.79 40.04 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.984 0.913 . . . . 74.31 112.639 -169.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.466 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -59.7 -47.14 98.22 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 118.7 -0.667 . . . . 61.21 112.314 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.484 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 33.2 Cg_exo -63.56 -34.73 63.1 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.858 1.705 . . . . 71.53 113.28 171.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -69.69 -22.07 63.45 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.718 0.407 . . . . 65.43 111.314 -175.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 37.3 mm -69.35 -41.43 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.215 0.606 . . . . 70.13 109.965 170.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' C' ' 82' ' ' GLY . 79.1 mt -78.2 -20.15 52.43 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.911 -1.041 . . . . 73.4 111.366 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -57.79 -51.56 80.84 Favored Pre-proline 0 CA--C 1.558 1.271 0 N-CA-C 113.855 1.057 . . . . 74.44 113.855 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.48 -34.94 99.17 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.851 1.7 . . . . 75.11 112.606 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.45 -43.32 77.3 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.32 0.648 . . . . 73.13 111.243 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.05 -38.65 91.83 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.634 0.773 . . . . 70.45 110.48 176.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -58.22 -58.98 6.09 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.843 1.657 . . . . 75.24 110.615 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -33.2 73.88 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 123.392 0.433 . . . . 71.54 110.65 -176.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 18.5 t -63.05 -33.34 75.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.147 0.579 . . . . 74.5 111.559 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.702 HG21 HG21 ' C' ' 64' ' ' VAL . 91.4 mt -75.04 -47.03 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.407 0.683 . . . . 63.31 109.98 172.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -28.5 67.2 Favored 'General case' 0 CA--C 1.564 1.483 0 CA-C-N 115.252 -0.885 . . . . 31.24 111.183 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 31.1 t -70.74 -50.43 36.27 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.321 -0.854 . . . . 73.11 110.155 170.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.547 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.98 -38.47 73.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.112 0.965 . . . . 71.22 113.323 -175.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 25.6 t -70.92 -36.27 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 CA-C-N 116.337 -0.392 . . . . 72.2 110.604 179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.409 ' CB ' HG21 ' B' ' 115' ' ' THR . 39.6 p -76.36 -22.08 55.29 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.797 0.439 . . . . 71.12 111.298 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.463 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 82.8 mtt-85 -68.39 -36.39 79.09 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.456 -0.793 . . . . 73.05 109.512 171.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.8 3.51 49.84 Favored Glycine 0 C--N 1.354 1.557 0 CA-C-N 115.084 -0.962 . . . . 54.31 112.604 171.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.443 HG23 ' HB3' ' D' ' 17' ' ' TYR . 67.9 p 56.22 21.36 5.22 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 126.765 2.026 . . . . 72.41 112.321 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -97.84 161.24 26.36 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.516 1.126 . . . . 74.22 108.865 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.05 107.99 0.45 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.674 2.25 . . . . 72.42 111.734 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.691 ' HG3' ' HB3' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -60.62 155.97 17.65 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 123.846 0.716 . . . . 72.22 112.067 -179.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -117.11 91.94 3.72 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.394 -0.965 . . . . 62.43 108.394 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -90.73 88.98 7.3 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 106.995 -1.483 . . . . 72.51 106.995 174.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.476 HD21 HG11 ' C' ' 40' ' ' VAL . 48.7 mt -79.55 142.66 35.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.52 -1.218 . . . . 52.32 112.093 -164.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.73 152.43 96.72 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.924 -1.034 . . . . 63.11 111.116 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.652 ' HG3' HD12 ' A' ' 16' ' ' ILE . 86.2 Cg_endo -75.26 -171.9 1.13 Allowed 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 122.81 2.34 . . . . 73.33 113.875 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.456 HG21 ' NE1' ' E' ' 184' ' ' TRP . 2.6 m -140.72 117.15 7.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 CA-C-N 114.185 -1.371 . . . . 44.51 107.412 172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.41 65.72 9.33 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.246 0.546 . . . . 71.41 109.656 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.423 ' CD1' ' HB3' ' E' ' 184' ' ' TRP . 59.4 t80 -66.43 -35.39 80.19 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 108.565 -0.902 . . . . 64.52 108.565 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' C' ' 138' ' ' MET . 4.1 p-10 -51.41 -59.85 3.79 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 124.53 1.144 . . . . 63.31 110.917 173.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.74 76.2 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.766 0.827 . . . . 71.51 112.173 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.9 tt -74.84 -41.17 60.39 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.475 0.71 . . . . 73.34 110.929 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -82.17 -25.64 34.12 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.077 0.951 . . . . 74.32 112.166 -169.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.505 ' HG2' ' O ' ' C' ' 134' ' ' ASP . 23.9 mmt -71.86 -41.88 67.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.582 0.353 . . . . 72.33 110.581 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -71.77 -32.58 67.81 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 122.53 0.332 . . . . 73.25 110.577 177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.446 ' HD2' ' H ' ' C' ' 141' ' ' LEU . 0.3 OUTLIER -67.92 -155.99 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 124.819 1.248 . . . . 60.3 110.941 -179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.446 ' H ' ' HD2' ' C' ' 140' ' ' TYR . 91.7 mt 64.56 -75.1 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.983 1.313 . . . . 72.14 112.718 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -145.65 154.24 41.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.992 0.917 . . . . 75.44 109.083 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -116.01 154.34 30.03 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.633 1.173 . . . . 65.23 108.667 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.562 ' HB2' ' ND2' ' A' ' 5' ' ' ASN . 57.4 tp60 68.04 134.02 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.765 1.226 . . . . 73.44 113.006 173.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -159.08 166.72 30.99 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.334 0.654 . . . . 54.4 110.351 174.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.03 112.98 2.63 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 115.713 -0.676 . . . . 74.2 112.514 -172.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.52 -155.15 0.3 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 106.725 -1.583 . . . . 64.33 106.725 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.9 98.22 2.03 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.722 -0.551 . . . . 73.54 111.722 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 46.1 p -75.92 166.95 22.76 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.514 0.726 . . . . 74.25 110.635 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -136.95 162.06 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.619 0.767 . . . . 60.34 109.883 176.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.13 -101.21 0.07 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 123.853 0.861 . . . . 63.34 109.566 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 m80 58.55 76.51 0.34 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.096 1.358 . . . . 74.5 112.523 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -124.57 111.95 16.26 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.595 -0.891 . . . . 74.1 108.595 172.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -89.39 145.21 25.49 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.515 0.726 . . . . 63.11 110.164 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.078 0 C-N-CA 123.283 0.633 . . . . 71.52 110.479 178.185 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.2 mmt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.535 -0.542 . . . . 53.02 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . 0.557 ' HB2' ' HG2' ' E' ' 201' ' ' LYS . 25.7 t -63.52 101.91 0.38 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.277 0.631 . . . . 71.2 109.966 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -61.64 -62.77 1.57 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.503 0.721 . . . . 75.41 110.605 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -106.32 153.13 22.63 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.909 0.884 . . . . 72.34 110.106 -173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -114.33 -161.09 0.75 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.587 0.755 . . . . 75.04 110.435 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -54.94 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.638 1.175 . . . . 52.14 110.657 174.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -104.51 -56.17 2.23 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 108.994 -0.743 . . . . 72.3 108.994 176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -128.21 -140.64 0.25 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.981 1.312 . . . . 73.11 107.889 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.488 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 11.5 tpt -30.6 125.14 0.18 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.503 1.521 . . . . 74.02 113.568 170.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.1 m -148.62 139.79 23.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.582 1.153 . . . . 74.24 109.685 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.435 ' HD2' HG22 ' D' ' 86' ' ' ILE . 71.1 t80 -158.81 91.11 1.03 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.443 -1.317 . . . . 61.21 107.443 170.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.404 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 47.4 mt-30 -111.89 136.22 51.48 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.263 0.625 . . . . 75.51 109.707 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.49 HG22 HG21 ' E' ' 207' ' ' VAL . 0.0 OUTLIER -91.3 131.92 37.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.02 -1.104 . . . . 71.54 108.02 171.703 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -106.29 -49.0 3.44 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.718 0.407 . . . . 51.41 111.456 178.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.563 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 62.2 ttt180 -178.46 134.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 122.262 0.225 . . . . 53.54 111.282 -174.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.521 ' HB ' ' HG2' ' B' ' 130' ' ' PRO . 3.0 mp -123.23 130.07 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.742 -1.207 . . . . 73.4 107.742 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.443 ' HB3' HG23 ' C' ' 122' ' ' THR . 47.1 p90 -156.31 163.63 39.29 Favored 'General case' 0 C--O 1.238 0.482 0 O-C-N 123.728 0.643 . . . . 75.2 111.842 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -76.02 110.11 10.21 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.736 -1.12 . . . . 74.13 109.634 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.479 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 46.0 mtpt -77.57 -32.81 54.01 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.86 -0.609 . . . . 73.24 109.734 172.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.744 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -146.4 138.41 24.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 114.79 -1.095 . . . . 43.15 109.718 -178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.547 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.2 mt -137.15 147.75 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.528 1.131 . . . . 65.31 108.411 171.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -147.63 143.75 27.92 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.878 0.871 . . . . 63.4 108.668 167.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.3 t80 -147.54 124.98 11.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 105.919 -1.882 . . . . 74.41 105.919 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -132.61 142.01 48.93 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.735 0.814 . . . . 52.13 108.817 177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -135.46 77.65 52.75 Favored Pre-proline 0 CA--C 1.541 0.596 0 N-CA-C 107.431 -1.322 . . . . 71.13 107.431 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.38 -28.89 17.54 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.748 2.299 . . . . 64.21 112.36 -172.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 50.8 m-20 -114.46 28.66 8.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.424 1.089 . . . . 65.13 109.338 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.554 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.25 -47.96 95.32 Favored Pre-proline 0 CA--C 1.561 1.386 0 N-CA-C 115.714 1.746 . . . . 33.42 115.714 -170.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 61.1 Cg_endo -80.94 -15.47 10.54 Favored 'Trans proline' 0 C--N 1.379 2.149 0 CA-C-N 122.021 1.757 . . . . 72.33 112.138 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.425 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.8 t-160 -68.41 -32.07 71.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.93 0.892 . . . . 65.33 108.918 167.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' D' ' 28' ' ' ALA . 12.9 t -68.08 -23.33 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.177 0 C-N-CA 124.265 1.026 . . . . 73.44 111.499 175.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -55.66 -32.92 63.63 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 122.677 0.391 . . . . 74.03 111.67 173.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -73.85 -27.56 61.15 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.572 0.749 . . . . 74.01 111.42 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 66.1 mttt -97.12 111.21 23.54 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.839 0.856 . . . . 70.1 111.704 -174.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.512 ' HB2' ' H ' ' H' ' 197' ' ' TYR . 7.9 p-10 -108.02 52.32 0.72 Allowed 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.947 1.299 . . . . 71.43 111.148 -176.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 8.8 m95 -126.01 165.34 18.98 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.713 0.805 . . . . 62.13 108.94 -173.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.56 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 59.4 tp60 -81.61 122.05 80.27 Favored Pre-proline 0 CA--C 1.549 0.927 0 N-CA-C 109.641 -0.503 . . . . 75.43 109.641 174.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -61.58 126.21 18.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.691 2.261 . . . . 70.32 112.013 176.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -67.85 119.71 12.97 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.411 0.684 . . . . 74.54 109.206 175.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.8 107.19 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.22 0.608 . . . . 61.43 109.669 -168.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 46.9 mmtm -98.82 114.46 27.03 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.425 0.69 . . . . 74.24 109.28 176.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.72 131.59 43.26 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 109.215 -0.661 . . . . 64.21 109.215 177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -120.63 123.18 42.18 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 107.626 -1.25 . . . . 61.34 107.626 171.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -95.42 130.24 42.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.038 0.535 . . . . 61.52 109.893 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.8 t70 -138.35 150.43 46.57 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.433 -1.321 . . . . 55.0 107.433 167.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -145.31 157.11 44.12 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 109.271 -0.64 . . . . 71.03 109.271 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.01 167.57 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.062 0.945 . . . . 70.12 108.835 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 17.2 p -164.92 155.91 14.57 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.058 0.543 . . . . 73.13 110.571 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 19.5 p -164.55 132.29 3.29 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.04 0.936 . . . . 70.21 109.4 -177.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -68.46 131.59 45.54 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.078 0.551 . . . . 73.31 111.309 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' D' ' 57' ' ' GLU . 64.7 mt -103.65 -37.72 7.4 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.632 0.773 . . . . 72.05 110.93 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -158.43 -167.54 2.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.356 0.662 . . . . 21.21 110.929 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -70.87 112.93 7.43 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.25 -0.887 . . . . 53.11 110.271 178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.41 ' HA ' HD23 ' H' ' 173' ' ' LEU . 28.9 m-20 70.76 -2.62 2.21 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.579 1.552 . . . . 64.25 112.313 -176.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 82.5 t -109.88 133.43 55.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 124.204 1.002 . . . . 73.44 109.434 -173.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.03 154.08 36.35 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.458 0.703 . . . . 74.31 109.306 178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.1 tt0 -92.2 134.87 34.47 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 123.801 0.841 . . . . 65.22 109.346 176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 60.2 t -116.86 124.3 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 107.832 -1.173 . . . . 64.21 107.832 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.7 t -105.82 138.55 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 123.201 0.601 . . . . 65.22 109.448 175.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -113.11 123.85 51.22 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 107.948 -1.13 . . . . 54.21 107.948 176.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 23.6 ttm-85 -106.64 103.65 13.15 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.813 -0.81 . . . . 75.4 108.813 175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.02 123.07 52.62 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 108.756 -0.831 . . . . 71.24 108.756 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -114.6 139.14 49.85 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.538 0.735 . . . . 60.11 109.599 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.478 HG21 HG21 ' D' ' 114' ' ' ILE . 50.8 t -131.67 100.6 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.804 1.242 . . . . 60.13 108.376 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 58.7 m -95.02 94.05 7.75 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.16 -1.422 . . . . 73.23 107.16 170.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.06 134.2 40.72 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.577 -0.897 . . . . 51.12 108.577 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.453 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 16.6 p -148.57 129.88 14.69 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.074 0.464 . . . . 62.22 111.524 -170.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 41.5 mt -95.16 104.71 16.6 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 124.569 1.147 . . . . 73.0 110.867 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.15 -110.91 3.6 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.556 0.535 . . . . 74.21 112.523 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -104.22 7.26 35.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 63.42 111.632 178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.38 150.15 48.77 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.212 0.605 . . . . 54.33 110.326 -175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.8 m -73.22 132.55 43.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.27 0.628 . . . . 73.1 110.362 175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -86.98 -57.68 2.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.547 0.739 . . . . 70.14 109.192 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.81 152.89 14.05 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 114.801 -1.091 . . . . 63.03 110.245 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -117.52 120.4 37.96 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.282 1.033 . . . . 63.23 108.788 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.401 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.5 t -133.07 142.0 48.52 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.415 0.686 . . . . 71.51 110.004 -175.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -156.5 129.65 7.99 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 122.916 0.486 . . . . 63.42 110.257 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.49 HG22 HG23 ' D' ' 21' ' ' ILE . 84.8 t -128.37 122.72 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.989 0.916 . . . . 62.31 110.051 -177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.744 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -93.01 87.55 5.8 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-O 121.673 0.749 . . . . 74.51 109.531 169.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.425 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.3 tp-100 -80.27 96.62 6.67 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.19 -1.368 . . . . 61.33 108.954 177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.565 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.92 157.76 29.92 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.812 -0.515 . . . . 63.53 111.812 177.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.31 138.44 5.45 Favored Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.946 -0.462 . . . . 74.23 111.946 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.0 mt -91.85 132.97 34.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.784 0 C-N-CA 123.762 0.825 . . . . 61.03 109.941 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -133.1 150.1 52.09 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.499 0.72 . . . . 72.33 110.602 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 16.7 m -116.55 101.34 8.53 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.315 1.046 . . . . 63.22 109.248 177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.463 ' HB ' HD11 ' D' ' 89' ' ' ILE . 39.2 pt -109.33 132.9 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 CA-C-O 121.031 0.443 . . . . 74.12 110.747 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.98 165.77 26.97 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.971 0.909 . . . . 61.02 109.469 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.738 ' H ' ' HB3' ' H' ' 172' ' ' ALA . . . 81.78 -21.6 6.45 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 114.198 0.439 . . . . 71.45 114.198 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.485 HD13 ' H ' ' D' ' 89' ' ' ILE . 0.2 OUTLIER -107.01 169.37 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.272 1.029 . . . . 75.35 109.308 175.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.509 ' O ' ' HA2' ' B' ' 146' ' ' GLY . 1.1 pp20? -170.78 -168.63 0.69 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.36 0.664 . . . . 71.35 110.895 -179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.65 -141.9 29.2 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 116.243 -0.435 . . . . 35.13 113.837 171.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 29.9 m -82.68 -25.67 32.79 Favored 'General case' 0 C--O 1.248 0.997 0 C-N-CA 123.383 0.673 . . . . 74.44 111.339 -175.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -63.46 -48.88 75.86 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.011 0.524 . . . . 70.42 109.788 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.9 ppp? -66.06 -31.77 72.84 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 123.426 0.454 . . . . 70.24 110.95 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.77 98.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.202 0.601 . . . . 74.15 111.212 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.522 ' HE1' ' HA ' ' D' ' 134' ' ' ASP . 8.9 t-160 -79.22 -37.71 37.43 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.432 -0.349 . . . . 74.45 110.224 177.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.87 -26.29 67.57 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.322 0.649 . . . . 30.0 111.481 -179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.534 HD22 HD13 ' H' ' 177' ' ' LEU . 5.2 tt -75.78 -50.68 14.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.763 0.825 . . . . 74.03 109.042 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.01 14.1 65.08 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 115.868 -0.605 . . . . 61.02 114.398 -170.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -56.67 0.2 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.548 0.674 . . . . 43.12 111.618 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -72.09 -43.24 65.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 112.695 0.628 . . . . 72.53 112.695 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 98.8 m -63.37 -46.41 84.71 Favored Pre-proline 0 CA--C 1.567 1.604 0 CA-C-O 118.747 -0.644 . . . . 51.45 111.084 178.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.557 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.0 Cg_exo -58.82 -31.52 95.39 Favored 'Trans proline' 0 C--N 1.395 2.983 0 C-N-CA 122.608 2.205 . . . . 64.54 114.013 166.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -65.86 -34.94 79.3 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.149 0.58 . . . . 74.21 110.757 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.496 HG23 ' ND2' ' B' ' 132' ' ' ASN . 37.3 mm -63.48 -39.76 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.382 0.673 . . . . 73.53 110.29 172.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.425 HD13 ' O ' ' D' ' 80' ' ' GLN . 84.5 mt -74.24 -21.24 59.86 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 115.374 -0.83 . . . . 74.23 111.672 -175.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -67.9 -40.72 24.64 Favored Pre-proline 0 CA--C 1.559 1.303 0 N-CA-C 114.584 1.327 . . . . 65.22 114.584 -168.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.412 ' HA ' ' NH2' ' D' ' 111' ' ' ARG . 98.2 Cg_exo -49.72 -38.54 46.57 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 121.982 1.788 . . . . 71.25 113.586 170.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -83.87 -29.81 26.93 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.74 -1.118 . . . . 71.13 110.834 -175.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.79 -49.73 64.9 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.31 0.644 . . . . 74.11 110.346 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.1 ttp-105 -50.98 -56.61 11.62 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 124.809 1.318 . . . . 71.52 110.273 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -59.97 -44.39 94.48 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.619 1.2 . . . . 64.04 111.595 -173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.463 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 40.8 t -56.3 -44.03 79.48 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.88 0.738 . . . . 63.42 111.075 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.478 HG21 HG21 ' D' ' 64' ' ' VAL . 74.2 mt -67.85 -53.28 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.883 . . . . 74.14 110.382 176.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 86.1 m -51.56 -43.64 62.46 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.071 1.348 . . . . 60.13 112.265 -173.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 45.9 t -69.71 -41.56 75.2 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.149 -0.932 . . . . 74.5 110.525 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.5 mtm -64.36 -35.1 79.8 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.028 0.531 . . . . 65.23 111.534 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 84.3 t -61.53 -48.15 90.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 115.221 -0.9 . . . . 54.32 110.319 175.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.7 p -73.98 -23.02 59.41 Favored 'General case' 0 CA--C 1.551 1.017 0 CA-C-N 116.079 -0.51 . . . . 70.12 111.604 -178.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 93.1 mtt-85 -73.97 -36.28 64.55 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.726 0.81 . . . . 74.25 110.235 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.41 2.48 71.66 Favored Glycine 0 C--N 1.351 1.396 0 O-C-N 123.714 0.634 . . . . 71.4 112.07 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 62.29 30.76 17.56 Favored 'General case' 0 C--N 1.359 1.003 0 C-N-CA 126.85 2.06 . . . . 71.31 112.45 175.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -88.92 168.64 15.07 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 125.232 1.413 . . . . 75.34 108.077 167.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.36 153.89 27.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 121.706 1.604 . . . . 54.24 110.884 -174.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -66.48 132.31 47.98 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.174 0.19 . . . . 71.41 110.816 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.76 113.03 22.9 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.735 -0.839 . . . . 70.45 108.735 172.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -98.35 88.85 4.26 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.795 -1.187 . . . . 63.55 107.795 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.53 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 75.9 mt -63.56 114.56 4.01 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.568 -0.742 . . . . 55.53 109.425 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.55 137.92 89.45 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 113.215 0.82 . . . . 73.15 113.215 -168.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.409 ' HB2' ' OH ' ' B' ' 101' ' ' TYR . 60.0 Cg_endo -80.3 104.87 1.68 Allowed 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.618 2.212 . . . . 63.4 110.55 176.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' D' ' 133' ' ' PHE . 53.1 t -109.43 111.32 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 114.954 -1.021 . . . . 73.42 110.542 -169.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -95.62 70.89 3.06 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.405 1.098 . . . . 62.13 108.267 177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.401 ' HB2' HG12 ' D' ' 131' ' ' VAL . 18.4 t80 -82.92 -8.87 59.53 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 114.021 -1.445 . . . . 73.43 109.971 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.522 ' HA ' ' HE1' ' D' ' 96' ' ' HIS . 7.9 t0 -66.22 -40.91 90.64 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.921 0.888 . . . . 54.53 109.317 175.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.23 -36.45 66.02 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 123.97 0.908 . . . . 74.22 112.687 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 8.2 tt -59.65 -48.91 79.81 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.54 0.736 . . . . 73.24 109.936 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.409 ' HB2' ' CE1' ' D' ' 96' ' ' HIS . 91.3 m-85 -75.49 -29.13 59.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.549 -0.75 . . . . 72.43 112.34 -177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 56.8 mtm -65.03 -35.96 82.86 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 120.663 0.268 . . . . 73.12 110.927 174.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -75.9 -27.79 57.81 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.108 0.563 . . . . 74.23 110.593 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.433 ' HB2' ' HG2' ' B' ' 4' ' ' GLN . 71.7 t80 -80.5 -25.17 38.91 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 72.11 111.498 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -36.44 84.19 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.196 0.998 . . . . 70.43 110.234 -172.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -90.01 21.54 3.63 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.586 -0.734 . . . . 72.44 111.76 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -117.9 71.7 0.83 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 107.929 -1.137 . . . . 71.43 107.929 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -151.47 156.12 39.95 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.96 -1.473 . . . . 75.31 108.72 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.23 106.77 1.36 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.274 0.629 . . . . 72.51 109.862 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 65.0 -105.47 1.2 Allowed Glycine 0 C--N 1.346 1.137 0 O-C-N 123.943 0.777 . . . . 40.13 113.918 175.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -85.22 147.25 26.67 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.61 0.764 . . . . 74.34 111.122 -175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.62 70.5 2.93 Favored Glycine 0 C--N 1.342 0.898 0 N-CA-C 111.32 -0.712 . . . . 30.25 111.32 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 22.7 p -65.61 93.51 0.17 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.785 0.834 . . . . 73.23 111.278 -177.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 175.41 -35.35 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.871 1.668 . . . . 43.31 108.189 -172.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 55.44 -100.24 0.11 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.526 1.53 . . . . 61.13 111.937 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.1 m80 62.34 155.11 0.04 OUTLIER 'General case' 0 C--N 1.365 1.253 0 C-N-CA 124.739 1.215 . . . . 74.4 111.955 -171.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 57.04 39.49 29.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.863 0.865 . . . . 75.31 110.357 -173.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -61.01 -45.84 93.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 114.677 -1.147 . . . . 72.02 111.389 -177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.596 -0.716 . . . . 73.44 109.11 177.451 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 22.3 ttmm . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.18 -0.674 . . . . 74.12 109.18 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -78.96 67.52 3.22 Favored Glycine 0 C--N 1.349 1.292 0 N-CA-C 112.387 -0.285 . . . . 71.41 112.387 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -132.27 41.1 3.26 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 124.117 0.967 . . . . 71.54 109.673 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 66.9 m -134.98 136.94 42.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.13 -0.941 . . . . 63.22 109.458 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . 0.727 ' HB3' ' HB3' ' E' ' 175' ' ' PHE . . . -80.56 -161.67 0.4 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.815 0.846 . . . . 72.43 110.869 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.81 -26.35 67.24 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 118.336 0.516 . . . . 72.11 110.375 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 17.5 ptt? -144.17 -36.04 0.35 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.812 0.845 . . . . 73.31 110.88 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.727 ' HB3' ' HB3' ' E' ' 172' ' ' ALA . 41.2 t80 -56.52 106.86 0.32 Allowed 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.074 0.549 . . . . 74.33 110.884 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -137.96 99.41 3.89 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 106.84 -1.541 . . . . 74.14 106.84 172.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 52.5 tp -112.08 102.6 10.8 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 108.716 -0.846 . . . . 75.44 108.716 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.05 -64.11 1.25 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.117 -1.438 . . . . 74.13 107.117 174.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -147.16 137.69 12.57 Favored Pre-proline 0 N--CA 1.488 1.442 0 C-N-CA 124.435 1.094 . . . . 64.41 109.396 176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.39 108.48 2.38 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.479 2.119 . . . . 73.43 111.05 171.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -82.01 7.29 13.6 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.348 0.659 . . . . 74.44 112.08 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -118.24 125.7 50.67 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.956 0.902 . . . . 74.33 109.188 170.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 9.6 t -136.84 163.88 29.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.144 0.978 . . . . 75.04 109.006 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.456 ' NE1' HG21 ' C' ' 131' ' ' VAL . 27.3 p90 -108.18 161.56 22.97 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 123.834 0.854 . . . . 74.34 110.141 178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -66.47 108.4 1.39 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.131 1.887 . . . . 75.3 111.753 169.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.469 HD12 HD11 ' C' ' 42' ' ' LEU . 4.0 mm? -73.47 128.57 35.87 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.799 -0.637 . . . . 61.32 109.677 176.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -100.87 154.73 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.283 0.633 . . . . 63.23 111.526 -170.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -111.0 149.43 30.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.843 0.857 . . . . 70.24 109.348 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.24 122.83 25.62 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 109.673 -0.491 . . . . 75.12 109.673 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . 0.486 ' HB2' ' HZ1' ' F' ' 205' ' ' LYS . 18.0 t70 -95.22 160.87 14.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.906 0.882 . . . . 71.22 110.979 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' F' ' 199' ' ' ASN . . . 89.13 101.88 1.03 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 116.111 -0.495 . . . . 65.34 112.866 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -80.13 -177.46 50.84 Favored Glycine 0 C--N 1.344 0.994 0 O-C-N 123.662 0.272 . . . . 72.52 112.781 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -162.11 -172.18 3.13 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.346 1.058 . . . . 72.35 109.535 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.89 -67.6 0.9 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.27 0.628 . . . . 72.32 110.03 177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 19.4 t80 52.41 30.34 8.1 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.923 1.289 . . . . 64.22 112.451 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -71.75 133.08 45.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.485 0.714 . . . . 73.02 109.884 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -90.58 136.38 33.1 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.42 -0.585 . . . . 62.21 109.42 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 -38.0 62.58 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.627 -0.508 . . . . 73.04 109.627 169.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 12.0 t30 64.95 157.3 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.973 1.309 . . . . 74.0 113.227 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 102.53 -103.13 2.39 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 111.014 -0.834 . . . . 42.0 111.014 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.557 ' HG2' ' HB2' ' D' ' 2' ' ' SER . 18.5 tptt -89.82 74.89 7.38 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.769 -1.197 . . . . 54.23 107.769 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -77.11 81.09 3.62 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 114.723 -1.126 . . . . 73.41 109.422 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . 0.501 ' HB2' HG22 ' F' ' 187' ' ' ILE . 12.8 m-20 73.73 -59.42 0.56 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.106 1.762 . . . . 53.54 111.827 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.44 HG22 ' HB2' ' F' ' 185' ' ' PRO . 28.7 pt -60.21 103.94 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.896 0 C-N-CA 124.552 1.141 . . . . 71.13 111.936 -178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -84.94 -33.12 22.73 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.667 -1.151 . . . . 72.04 110.048 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.41 91.14 8.34 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 108.603 -0.888 . . . . 74.5 108.603 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.49 HG21 HG22 ' D' ' 13' ' ' ILE . 7.6 p . . . . . 0 CA--C 1.559 1.32 0 C-N-CA 124.497 1.119 . . . . 71.43 109.557 175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.543 -0.54 . . . . 74.45 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 87.66 82.72 1.21 Allowed Glycine 0 C--N 1.347 1.189 0 N-CA-C 111.643 -0.583 . . . . 74.25 111.643 -174.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -67.24 -69.84 0.29 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.679 0.792 . . . . 65.44 110.917 -177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 55.5 m 64.27 178.67 0.17 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.336 1.055 . . . . 61.13 112.422 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -127.88 78.38 1.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.044 -1.095 . . . . 61.24 108.044 171.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.779 HD21 ' H ' ' B' ' 54' ' ' ASP . 62.4 mt -110.81 80.48 1.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.802 0.811 . . . . 74.01 109.581 -177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.66 52.08 2.1 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.464 -1.244 . . . . 51.12 109.076 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.68 91.45 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.606 -1.179 . . . . 73.0 109.992 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -148.64 104.19 3.46 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.687 0.795 . . . . 62.2 108.978 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.23 -50.01 4.09 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.537 0.735 . . . . 72.54 109.5 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 54.26 80.44 0.12 Allowed 'General case' 0 C--N 1.355 0.837 0 O-C-N 124.802 1.314 . . . . 63.24 111.446 -175.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 66.5 172.71 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 124.171 0.988 . . . . 75.42 111.898 175.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.2 99.21 0.08 OUTLIER 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 121.829 1.686 . . . . 74.4 111.888 165.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -56.57 -32.34 65.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.653 1.181 . . . . 73.23 110.906 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . 0.519 ' HB2' ' HZ ' ' B' ' 133' ' ' PHE . 77.0 m-85 -137.27 155.41 49.51 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 108.224 -1.028 . . . . 72.24 108.224 160.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 79.5 m -70.87 129.7 39.74 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.272 0.629 . . . . 62.42 110.974 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -115.67 92.73 34.71 Favored Pre-proline 0 CA--C 1.548 0.903 0 N-CA-C 107.948 -1.13 . . . . 63.33 107.948 174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . 0.44 ' HB2' HG22 ' E' ' 204' ' ' ILE . 3.6 Cg_exo -75.54 156.98 40.68 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.829 2.352 . . . . 71.34 112.358 -178.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.458 HD11 HD22 ' B' ' 44' ' ' LEU . 3.1 mm? -119.02 178.32 4.54 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.915 0.886 . . . . 71.04 110.306 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' E' ' 203' ' ' ASP . 2.6 pp -110.89 154.4 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.2 0.6 . . . . 74.42 111.26 -175.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -96.51 56.35 1.53 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.922 0.889 . . . . 61.24 111.055 -175.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . 0.412 ' H ' HD12 ' F' ' 187' ' ' ILE . . . 62.38 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.167 1.387 . . . . 65.1 111.748 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -138.55 -29.7 0.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 125.135 1.374 . . . . 64.33 109.325 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 143.89 -21.92 2.14 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.495 -1.042 . . . . 44.13 110.495 -166.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.94 81.56 Favored Glycine 0 C--N 1.356 1.658 0 C-N-CA 123.881 0.753 . . . . 64.52 112.911 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.41 11.02 3.79 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 113.592 0.96 . . . . 74.22 113.592 -166.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.3 -15.97 55.71 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.987 -0.746 . . . . 41.11 108.987 162.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -75.59 138.01 41.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.558 1.543 . . . . 71.44 111.668 176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' F' ' 198' ' ' GLU . 39.3 ttpt 179.51 133.99 0.1 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.491 1.516 . . . . 73.24 108.029 171.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . 0.584 ' H ' ' HA ' ' B' ' 36' ' ' TRP . 1.6 t80 -87.44 77.38 8.87 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 106.803 -1.555 . . . . 41.51 106.803 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . 0.432 ' HB2' ' HE3' ' F' ' 196' ' ' LYS . 40.1 tt0 -69.68 -67.03 0.51 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.729 -1.123 . . . . 74.31 109.958 -177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . 0.438 ' O ' ' HA3' ' E' ' 191' ' ' GLY . 15.5 m120 -145.68 158.35 43.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.176 1.39 . . . . 74.42 107.574 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 58.82 -97.7 0.09 OUTLIER Glycine 0 CA--C 1.532 1.112 0 O-C-N 123.874 0.734 . . . . 53.34 114.684 174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 55.32 76.66 0.25 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.255 1.422 . . . . 65.45 111.55 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 62.0 39.29 13.47 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.798 1.239 . . . . 64.43 110.672 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -83.34 152.72 24.95 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 114.648 -1.16 . . . . 73.3 112.324 -172.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 8.6 tp -79.04 97.72 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 N-CA-C 107.882 -1.155 . . . . 60.43 107.882 168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . 0.486 ' HZ1' ' HB2' ' E' ' 190' ' ' ASP . 0.0 OUTLIER -73.77 -55.34 6.35 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.539 -0.755 . . . . 61.52 112.227 -169.509 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.84 -86.52 0.64 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 119.296 -0.383 . . . . 63.12 111.575 -170.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 C--O 1.255 1.355 0 CA-C-N 118.479 0.581 . . . . 73.35 109.893 -177.182 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 102.65 136.91 9.34 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 111.644 -0.583 . . . . 71.55 111.644 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -75.15 86.53 2.4 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.443 0.697 . . . . 72.53 110.139 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 32.0 t -71.55 117.32 12.96 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.518 -0.764 . . . . 75.2 110.489 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -165.64 -39.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.427 1.091 . . . . 75.23 109.622 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 82.5 mt -65.89 124.66 23.08 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.258 1.023 . . . . 64.04 111.551 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 64.39 47.4 3.08 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.368 1.067 . . . . 65.42 111.617 173.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -62.4 168.88 3.23 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.42 -0.809 . . . . 71.02 112.022 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -68.89 -42.9 76.3 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.672 0.789 . . . . 74.23 111.478 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 5.6 tt 68.3 95.54 0.07 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.714 1.206 . . . . 71.45 109.13 -173.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -153.65 -23.13 0.14 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.071 0.549 . . . . 75.42 110.652 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.5 139.99 94.59 Favored Pre-proline 0 N--CA 1.483 1.218 0 C-N-CA 123.108 0.563 . . . . 73.13 110.619 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 131.71 24.85 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.927 2.418 . . . . 73.34 112.258 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -82.9 -167.98 1.87 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.578 0.751 . . . . 72.15 110.656 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . 0.44 ' HD1' ' HB2' ' C' ' 1' ' ' MET . 74.0 m-85 -56.02 -71.56 0.09 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.027 0.931 . . . . 74.22 111.674 -173.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 14.7 t 177.69 162.59 0.57 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.979 1.312 . . . . 44.23 109.286 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -158.23 89.11 2.3 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.277 0.631 . . . . 73.13 111.344 172.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.22 -36.33 1.39 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.204 2.603 . . . . 62.43 114.063 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 mp 63.88 -172.86 0.17 Allowed 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 124.66 1.184 . . . . 72.43 112.57 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.418 HG21 HG23 ' H' ' 204' ' ' ILE . 39.0 pt -73.83 165.49 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.735 0.814 . . . . 75.32 110.938 175.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -134.93 146.21 48.92 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.584 0.754 . . . . 73.23 109.838 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.54 135.0 20.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.477 0.711 . . . . 50.43 110.35 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -153.14 132.17 12.58 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.932 -0.766 . . . . 74.04 108.932 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 82.46 -170.46 50.51 Favored Glycine 0 C--N 1.336 0.55 0 CA-C-N 116.054 -0.521 . . . . 40.55 113.117 -176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 125.45 84.54 0.56 Allowed Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.581 -1.008 . . . . 64.14 110.581 -176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -76.91 70.84 3.39 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.858 0.837 . . . . 75.33 109.662 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -122.27 176.69 5.72 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.08 1.352 . . . . 31.0 108.343 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 41.3 t80 52.73 31.47 10.44 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 122.467 1.127 . . . . 72.02 109.925 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -67.23 118.86 11.2 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.763 -1.562 . . . . 52.15 110.558 -163.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -71.15 85.06 0.74 Allowed 'General case' 0 CA--C 1.542 0.671 0 O-C-N 124.361 1.038 . . . . 71.33 110.633 -176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -87.28 -53.92 4.58 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.76 -0.83 . . . . 74.41 108.76 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -159.43 161.6 35.57 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.449 -0.796 . . . . 63.24 109.129 174.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -172.14 16.52 0.05 OUTLIER Glycine 0 N--CA 1.471 0.98 0 CA-C-O 120.149 -0.25 . . . . 74.04 113.09 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -78.3 109.58 12.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.537 -0.542 . . . . 60.31 109.537 177.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.42 97.63 0.43 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.437 -0.949 . . . . 64.13 108.437 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -69.65 87.05 0.48 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.92 0.888 . . . . 53.43 111.815 -169.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.775 HG13 HG21 ' H' ' 187' ' ' ILE . 1.7 mp -108.36 132.36 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 124.758 1.223 . . . . 73.51 108.247 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.09 -40.65 4.15 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.903 0.881 . . . . 63.55 110.218 -175.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -99.46 178.53 4.85 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.237 1.015 . . . . 71.12 111.761 -171.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.254 1.313 0 C-N-CA 123.586 0.754 . . . . 73.33 111.095 -179.724 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 86.6 tttt . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 109.2 -0.667 . . . . 64.43 109.2 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.01 112.39 0.05 OUTLIER Glycine 0 CA--C 1.534 1.275 0 CA-C-N 115.833 -0.621 . . . . 62.11 113.858 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -75.91 128.93 36.13 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.473 -0.936 . . . . 73.33 108.473 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.0 m -80.82 -58.61 3.02 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.827 -0.805 . . . . 64.42 108.827 178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.738 ' HB3' ' H ' ' D' ' 88' ' ' GLY . . . -161.66 54.05 0.25 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.204 -0.907 . . . . 73.3 109.761 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' D' ' 54' ' ' ASP . 3.1 tm? -76.31 121.49 23.05 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 107.748 -1.205 . . . . 71.05 107.748 169.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.24 63.18 1.33 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.474 1.11 . . . . 64.11 109.495 -170.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -63.47 86.92 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 123.267 0.627 . . . . 74.21 110.24 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -115.74 84.58 2.13 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.161 0.984 . . . . 74.51 109.555 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . 0.534 HD13 HD22 ' D' ' 98' ' ' LEU . 6.6 tt -156.35 132.54 9.92 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.05 -0.722 . . . . 60.45 109.05 173.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -141.98 93.9 2.6 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.727 1.211 . . . . 52.54 107.761 172.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 64.48 169.46 0.1 OUTLIER Pre-proline 0 CA--C 1.568 1.637 0 C-N-CA 124.615 1.166 . . . . 63.11 112.573 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.91 122.73 11.39 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 121.992 1.794 . . . . 72.05 111.184 168.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.25 -53.05 6.36 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.598 0.759 . . . . 74.41 110.752 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -118.66 14.33 13.49 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.776 0.83 . . . . 71.33 111.97 -172.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . 0.488 HG22 ' HD3' ' H' ' 185' ' ' PRO . 20.2 m 70.05 150.9 0.09 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.046 1.339 . . . . 75.21 112.749 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -147.44 82.91 7.93 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 123.117 0.567 . . . . 74.24 109.484 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . 0.488 ' HD3' HG22 ' H' ' 183' ' ' THR . 74.0 Cg_endo -77.13 144.91 24.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.275 2.65 . . . . 74.13 113.487 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -112.29 -173.53 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.865 0.866 . . . . 74.42 110.52 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.775 HG21 HG13 ' G' ' 204' ' ' ILE . 2.4 pp -73.67 170.54 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.854 0.861 . . . . 71.51 113.107 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -92.75 -22.23 19.49 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.226 -0.897 . . . . 72.42 111.371 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . 62.21 5.36 1.49 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.816 1.246 . . . . 60.02 113.495 178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -94.7 132.96 38.89 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 124.243 1.017 . . . . 72.11 108.57 -175.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 147.99 78.86 0.03 OUTLIER Glycine 0 C--N 1.338 0.654 0 N-CA-C 111.44 -0.664 . . . . 72.42 111.44 -174.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.14 174.98 44.9 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 112.47 -0.252 . . . . 71.44 112.47 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.56 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 21.3 t80 -174.07 91.45 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.141 1.376 . . . . 63.15 107.743 173.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.27 15.65 2.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.537 0.735 . . . . 65.03 110.787 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -103.66 27.51 7.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.955 0.502 . . . . 73.52 109.672 178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -79.59 105.36 10.83 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.108 -0.701 . . . . 53.15 109.108 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . 0.512 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 0.5 OUTLIER -150.15 115.93 5.57 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.197 0.999 . . . . 73.24 109.603 173.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -116.29 58.09 0.76 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.868 0.867 . . . . 75.32 109.054 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 33.1 t30 62.91 88.89 0.09 Allowed 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 107.596 -1.261 . . . . 64.54 107.596 -165.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.9 -61.01 7.93 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.887 0.742 . . . . 30.25 113.542 -168.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -175.1 -44.13 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.182 0.593 . . . . 63.52 110.314 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -59.01 87.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 O-C-N 125.018 1.449 . . . . 73.42 111.742 -166.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -102.8 139.93 37.74 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 107.907 -1.146 . . . . 74.13 107.907 172.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.418 HG23 HG21 ' G' ' 187' ' ' ILE . 91.7 mt -103.89 135.69 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 123.507 0.723 . . . . 74.31 109.405 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.25 112.34 3.53 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.935 -1.505 . . . . 73.32 106.935 177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -162.59 -58.64 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 117.827 0.285 . . . . 73.1 111.306 170.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.255 1.36 0 C-N-CA 123.624 0.77 . . . . 63.32 109.185 -178.403 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 110.436 -0.209 . . . . 72.11 110.436 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.2 m -76.59 105.58 7.73 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.207 0.603 . . . . 74.24 110.024 174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 49.0 mt-10 -146.24 124.47 12.23 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.505 0.722 . . . . 64.42 109.827 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HA ' HE22 ' A' ' 142' ' ' GLN . 76.1 mt-30 -91.95 72.29 5.6 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.729 0.776 . . . . 74.14 110.343 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' MET . 60.6 m-80 -90.1 44.87 1.23 Allowed 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.151 -0.931 . . . . 62.54 110.183 175.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -60.15 -40.36 89.62 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.381 0.672 . . . . 60.33 111.444 -174.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 155' ' ' ALA . 71.1 p -128.59 38.36 3.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.966 0.907 . . . . 45.22 108.661 172.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.96 26.81 6.07 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.687 -0.857 . . . . 74.12 108.687 175.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.486 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -154.8 158.25 39.16 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.672 1.189 . . . . 33.53 108.61 173.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 p -142.17 137.91 31.18 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.631 0.772 . . . . 75.14 109.947 177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 52.4 t80 -135.96 129.17 31.72 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.596 -1.261 . . . . 65.0 107.596 170.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -148.82 123.41 9.78 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.266 0.469 . . . . 62.12 112.266 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 16' ' ' ILE . 3.4 tp -75.19 118.26 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 114.949 -1.023 . . . . 63.52 109.056 168.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -105.9 -20.75 13.34 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.292 0.637 . . . . 71.34 111.048 -177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt85 -178.41 127.16 0.12 Allowed 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 118.249 0.477 . . . . 74.31 111.157 176.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.59 HG13 HD11 ' A' ' 13' ' ' ILE . 48.3 mt -106.48 132.22 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 108.761 -0.829 . . . . 74.15 108.761 169.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -148.45 171.84 15.42 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.27 1.428 . . . . 74.23 109.931 -176.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 53.8 p -102.15 123.49 46.09 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.959 -0.756 . . . . 74.11 108.959 168.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -81.53 -32.19 32.4 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.387 0.675 . . . . 61.25 110.556 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 14.7 t70 -150.1 144.34 25.67 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.13 110.083 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.454 HG23 ' SD ' ' A' ' 117' ' ' MET . 61.6 mt -137.38 130.3 43.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.852 -1.536 . . . . 53.03 106.852 171.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -140.33 116.17 10.3 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.113 -1.069 . . . . 71.14 108.113 -174.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.473 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 80.4 t80 -126.68 109.2 11.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 106.667 -1.605 . . . . 71.22 106.667 173.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.97 108.91 15.85 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.403 -0.962 . . . . 75.54 108.403 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -106.76 89.48 4.31 Favored Pre-proline 0 CA--C 1.547 0.865 0 N-CA-C 108.335 -0.987 . . . . 61.32 108.335 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.59 -43.45 0.93 Allowed 'Trans proline' 0 C--N 1.383 2.388 0 C-N-CA 122.446 2.098 . . . . 63.23 112.794 -172.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' VAL . 43.6 m-80 -101.42 29.27 4.89 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.24 0.616 . . . . 73.25 109.891 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.483 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -50.79 -48.65 82.99 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 124.359 1.064 . . . . 52.41 113.163 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 21.8 Cg_exo -67.84 -26.39 38.37 Favored 'Trans proline' 0 C--N 1.399 3.229 0 C-N-CA 121.688 1.592 . . . . 62.21 112.517 176.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -74.52 -28.4 60.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.625 -0.716 . . . . 73.12 110.857 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.734 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 41.4 t -58.79 -20.34 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 C-N-CA 123.667 0.787 . . . . 62.01 111.645 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.48 ' HE1' ' HB3' ' G' ' 201' ' ' LYS . 66.5 t80 -59.77 -41.4 90.98 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.262 1.025 . . . . 75.24 111.776 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -101.27 -22.21 14.69 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 123.246 0.618 . . . . 70.51 111.436 177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.734 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 26.9 mmmt -69.88 134.72 48.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.269 0.627 . . . . 72.24 110.001 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.42 131.94 44.84 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 115.339 -0.846 . . . . 65.25 109.087 171.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.458 ' HA ' HD22 ' A' ' 68' ' ' LEU . 75.4 t-105 -80.79 90.6 5.86 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.479 0.656 . . . . 75.44 110.006 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -121.22 83.97 39.85 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 106.866 -1.531 . . . . 74.2 106.866 165.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.05 132.24 16.51 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.295 1.996 . . . . 43.43 111.389 -171.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -94.49 91.51 6.66 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.097 -1.446 . . . . 74.13 107.097 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' G' ' 189' ' ' ALA . 5.3 p -65.34 98.59 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 124.612 1.195 . . . . 62.05 111.586 -170.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 20.2 tptm -100.42 130.52 46.52 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 114.428 -1.26 . . . . 72.21 108.763 175.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 48.4 tp -131.67 114.08 14.37 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.41 0.684 . . . . 60.15 109.367 177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -108.08 137.56 45.86 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.394 1.078 . . . . 73.21 108.535 173.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.8 tp -119.0 118.9 32.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.747 -0.835 . . . . 64.42 108.747 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -128.58 149.99 50.39 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.012 0.925 . . . . 60.23 108.953 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -140.63 151.25 44.48 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.378 0.671 . . . . 74.43 109.858 176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -142.53 155.29 45.0 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.226 1.01 . . . . 62.01 109.38 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 36.7 p -125.6 159.81 31.19 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.602 0.761 . . . . 64.24 110.329 176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -159.12 122.43 3.73 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.683 0.793 . . . . 74.01 109.68 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -79.84 111.9 16.6 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 122.755 0.422 . . . . 51.31 109.869 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.5 mt -88.52 -34.16 17.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.124 0.569 . . . . 45.22 110.667 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -161.58 -172.38 3.32 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.437 1.095 . . . . 54.13 109.937 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.19 107.41 1.05 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.109 0.964 . . . . 54.21 109.522 176.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 68.56 3.66 3.94 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 125.219 1.408 . . . . 70.21 112.87 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.5 t -99.64 115.04 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 N-CA-C 107.351 -1.351 . . . . 75.45 107.351 175.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -123.2 167.04 14.23 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.67 0.747 . . . . 74.34 110.745 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' HB2' HD11 ' A' ' 51' ' ' LEU . 19.3 tt0 -128.59 126.26 39.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.043 -1.435 . . . . 65.31 107.143 174.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.7 t -106.48 122.05 59.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.464 -1.31 . . . . 74.0 107.464 170.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.51 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.5 t -97.51 139.71 19.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 124.313 1.045 . . . . 72.52 108.291 174.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.12 112.77 19.1 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.434 -1.321 . . . . 71.3 107.434 173.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -109.75 103.03 11.79 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.658 0.742 . . . . 74.22 109.752 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.49 136.12 28.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 114.703 -1.135 . . . . 75.22 108.414 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.8 m -123.5 128.97 50.53 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.039 0.447 . . . . 73.2 110.276 177.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.685 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 73.5 t -125.33 110.5 24.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.262 1.425 . . . . 74.41 109.394 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 4.6 m -107.73 138.59 43.69 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 118.19 0.45 . . . . 74.24 109.827 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.48 105.85 12.09 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.286 -1.376 . . . . 74.54 107.286 168.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.595 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 47.6 m -106.42 126.52 52.35 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 109.552 -0.536 . . . . 72.31 109.552 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.458 HD22 ' HA ' ' A' ' 36' ' ' TRP . 17.0 mt -93.27 80.84 4.44 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.137 -1.431 . . . . 72.2 107.137 177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.86 -89.24 0.86 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.951 -1.022 . . . . 54.42 111.285 -172.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -121.5 -15.06 8.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.167 0.987 . . . . 71.04 110.477 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.404 ' HB2' ' HE2' ' A' ' 34' ' ' LYS . 4.8 mp0 -97.16 101.74 13.37 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.404 1.082 . . . . 55.42 109.83 -177.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.4 m -66.17 127.19 31.19 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-O 121.263 0.554 . . . . 53.14 111.192 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.4 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -74.28 -55.06 6.47 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.738 1.215 . . . . 62.25 108.986 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -151.22 164.87 35.6 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.749 -1.114 . . . . 64.33 111.125 175.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.21 143.38 50.55 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.3 1.44 . . . . 71.02 107.224 170.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.685 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.8 m -130.11 136.05 48.9 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 123.712 0.805 . . . . 73.41 108.855 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -148.57 115.72 6.13 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.582 -0.896 . . . . 63.3 108.582 173.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.7 t -126.89 112.84 30.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.652 0.781 . . . . 73.23 109.518 -175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -86.67 84.49 7.38 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.751 -0.833 . . . . 64.41 108.751 172.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.53 93.3 3.54 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.588 -0.893 . . . . 74.54 108.588 175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.37 148.44 20.08 Favored Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.413 -0.675 . . . . 73.12 111.413 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.99 131.92 4.03 Favored Glycine 0 CA--C 1.508 -0.386 0 N-CA-C 110.865 -0.894 . . . . 64.13 110.865 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.78 121.33 32.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.662 -0.866 . . . . 64.5 108.662 176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.425 ' CE2' HD13 ' A' ' 13' ' ' ILE . 34.5 m-85 -130.87 117.33 19.14 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 107.723 -1.214 . . . . 74.52 107.723 174.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 p -79.15 115.8 19.03 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.416 -0.957 . . . . 75.43 108.416 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.471 ' HB ' HD11 ' A' ' 89' ' ' ILE . 44.4 pt -118.37 142.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.481 0.712 . . . . 72.4 110.594 -176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.81 155.74 17.04 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.099 0.96 . . . . 54.45 109.628 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 76.17 9.48 85.54 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 114.616 0.606 . . . . 53.52 114.616 173.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.471 HD11 ' HB ' ' A' ' 86' ' ' ILE . 1.3 pp -119.61 132.58 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 CA-C-N 117.409 0.604 . . . . 74.24 110.678 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.592 ' HA ' ' HB3' ' G' ' 172' ' ' ALA . 50.6 mt-10 -151.76 173.39 14.79 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 124.373 1.069 . . . . 64.41 110.217 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.19 -136.26 51.13 Favored Glycine 0 C--N 1.351 1.369 0 O-C-N 123.602 0.564 . . . . 61.12 113.896 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -70.34 -25.95 63.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.759 0.824 . . . . 73.22 111.371 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -65.29 -43.35 91.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.72 0.808 . . . . 62.1 110.492 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.532 ' HE1' ' H ' ' G' ' 175' ' ' PHE . 28.0 ttt -76.11 -38.17 57.21 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.874 -0.603 . . . . 65.21 110.64 177.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.81 -25.26 67.83 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.797 0.439 . . . . 63.22 111.489 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -71.72 -39.44 70.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.949 0.9 . . . . 75.04 110.473 172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.604 ' SG ' ' SG ' ' A' ' 102' ' ' CYS . 48.7 t -77.36 -65.87 0.9 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.65 -0.704 . . . . 65.33 110.222 -175.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 ' HG3' ' A' ' 94' ' ' MET . 3.8 mm? -73.54 -17.95 61.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.745 0.818 . . . . 74.11 112.365 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.29 -16.91 54.73 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.852 -0.416 . . . . 61.23 113.964 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.04 -55.7 0.32 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 117.403 0.601 . . . . 62.22 111.75 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.502 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 92.1 t80 -66.79 -61.05 2.16 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.904 0.882 . . . . 42.31 113.361 -168.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.604 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 79.1 m -62.78 -40.91 68.33 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 118.157 -0.925 . . . . 60.04 113.372 -174.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -63.79 -32.53 67.29 Favored 'Trans proline' 0 C--N 1.396 3.041 0 CA-C-N 121.098 1.428 . . . . 72.12 112.868 168.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -72.02 -24.64 61.59 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 117.945 0.339 . . . . 63.14 111.204 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.4 mm -57.74 -43.26 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.638 0.733 . . . . 73.43 109.406 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 mt -77.49 -21.84 52.15 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.146 -1.388 . . . . 74.44 112.27 -174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -64.61 -41.35 57.04 Favored Pre-proline 0 CA--C 1.562 1.424 0 CA-C-O 117.475 -1.25 . . . . 75.53 114.116 -168.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.69 -31.26 91.54 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.119 1.879 . . . . 74.21 113.26 172.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.95 -41.07 21.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.616 0.766 . . . . 72.03 110.924 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.93 -39.53 87.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.947 0.499 . . . . 73.11 110.061 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.471 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.9 ttm180 -50.51 -58.79 4.95 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.867 1.267 . . . . 54.13 110.154 173.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -64.19 -40.55 96.34 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 124.516 1.135 . . . . 74.52 111.754 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.411 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.6 t -57.59 -48.43 79.42 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 123.854 0.721 . . . . 61.3 110.1 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.46 HG21 HG21 ' A' ' 64' ' ' VAL . 95.1 mt -62.16 -51.16 75.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 O-C-N 124.306 1.004 . . . . 65.3 110.203 175.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.54 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.8 m -53.0 -42.72 65.87 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 124.81 1.244 . . . . 70.4 111.621 -174.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.91 -47.01 66.84 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.969 -1.014 . . . . 61.13 109.985 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.454 ' SD ' HG23 ' A' ' 21' ' ' ILE . 15.6 mtp -53.45 -45.61 69.57 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.856 0.862 . . . . 72.45 111.394 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 114' ' ' ILE . 73.8 t -61.09 -49.11 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.076 1.351 . . . . 74.24 111.046 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.4 p -68.48 -28.84 67.39 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 122.899 0.479 . . . . 70.22 111.454 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.3 -27.59 64.52 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.694 0.798 . . . . 70.22 110.976 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.96 11.96 58.83 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 119.498 -0.612 . . . . 71.41 113.776 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.48 ' HB ' HH21 ' B' ' 15' ' ' ARG . 11.9 m 65.18 32.53 10.04 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 122.351 1.072 . . . . 74.24 110.316 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.424 ' HE1' HG11 ' A' ' 31' ' ' VAL . 65.2 m-85 -109.4 152.69 42.83 Favored Pre-proline 0 N--CA 1.477 0.888 0 CA-C-N 115.106 -0.952 . . . . 74.12 109.101 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.47 149.57 80.23 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.103 1.868 . . . . 65.33 111.319 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.54 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.7 tt0 -56.7 142.29 40.72 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.699 0.8 . . . . 73.33 111.313 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 49.8 tp -133.8 101.79 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.57 0.748 . . . . 71.13 109.434 177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.504 ' ND2' HD21 ' H' ' 199' ' ' ASN . 76.3 m-20 -98.63 100.7 11.95 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.242 -0.651 . . . . 73.13 109.242 176.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 42.4 mt -62.61 117.85 6.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.806 0.842 . . . . 75.14 109.928 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.94 150.36 50.03 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.345 0.658 . . . . 62.43 111.859 -178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -87.71 160.86 7.75 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.378 2.052 . . . . 73.31 112.763 177.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 47.0 t -123.89 114.3 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.806 -1.183 . . . . 72.03 107.806 165.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.54 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 1.6 m120 -98.8 63.41 1.4 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.648 0.737 . . . . 64.24 109.945 176.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -77.08 -32.5 56.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.24 -0.891 . . . . 73.52 109.035 173.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -62.57 -42.23 99.42 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.078 -0.964 . . . . 72.44 110.659 174.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -75.61 -26.43 57.81 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.86 0.725 . . . . 63.21 110.965 178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 60.8 tp -73.07 -44.68 60.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.307 0.643 . . . . 64.15 110.658 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.438 ' HE2' HD23 ' A' ' 141' ' ' LEU . 45.9 t80 -84.66 -23.68 29.34 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.043 -0.526 . . . . 75.43 111.487 -173.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -32.76 72.43 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 118.559 0.618 . . . . 65.12 110.004 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -52.28 -61.22 2.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 124.378 1.049 . . . . 74.55 109.292 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -63.53 -31.59 72.8 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.611 -0.722 . . . . 62.44 112.477 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.438 HD23 ' HE2' ' A' ' 137' ' ' PHE . 2.3 tm? -61.3 -51.11 70.25 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.262 0.625 . . . . 75.24 109.388 -173.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.405 HE22 ' HA ' ' A' ' 4' ' ' GLN . 40.1 tt0 -176.79 -12.54 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.898 0.749 . . . . 61.13 112.378 177.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -68.53 -17.84 64.24 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.168 0.433 . . . . 74.11 112.168 -177.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.458 ' HA ' ' HB2' ' C' ' 143' ' ' GLN . 49.4 tt0 -70.22 -23.42 62.93 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.693 0.797 . . . . 64.23 110.178 174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.582 ' HB2' ' HB2' ' C' ' 147' ' ' GLU . . . -83.68 53.59 2.59 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.543 0.737 . . . . 71.34 109.745 169.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.01 59.62 4.86 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.955 -0.566 . . . . 62.42 112.312 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -78.38 -27.94 46.92 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.127 0.971 . . . . 74.12 109.412 174.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.01 119.59 0.44 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.623 -0.717 . . . . 60.24 111.44 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -136.85 100.02 4.19 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.816 -1.179 . . . . 64.45 107.816 172.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -71.82 127.09 31.44 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.385 -0.825 . . . . 75.23 110.205 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.66 111.28 3.51 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 105.393 -2.077 . . . . 72.3 105.393 173.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -71.48 -97.92 0.01 OUTLIER 'General case' 0 C--N 1.353 0.727 0 CA-C-O 118.255 -0.878 . . . . 60.12 109.817 -175.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 42.5 -89.62 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.927 1.291 . . . . 75.1 112.066 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 168.06 -63.88 0.0 OUTLIER 'General case' 0 C--N 1.351 0.649 0 C-N-CA 126.656 1.983 . . . . 60.31 106.585 -175.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.437 ' HA ' ' HB ' ' A' ' 7' ' ' THR . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-N 114.309 -1.314 . . . . 50.13 108.492 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 108.743 -0.836 . . . . 62.22 108.743 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 27.2 p -163.98 94.72 0.76 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.775 0.83 . . . . 65.51 110.513 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -81.02 155.33 26.42 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.901 -0.778 . . . . 72.31 108.901 169.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 65.57 111.46 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.689 1.196 . . . . 75.24 110.555 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -68.89 -5.75 23.08 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.376 0.67 . . . . 72.51 112.546 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -74.32 73.53 1.84 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.87 0.868 . . . . 74.44 109.799 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 58.6 m -105.68 106.03 16.35 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.351 -1.352 . . . . 64.02 107.351 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -61.03 -50.95 71.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.711 0.805 . . . . 65.34 110.426 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.574 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.0 ptm 50.36 171.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 126.908 2.083 . . . . 72.24 115.071 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.2 p -142.13 134.97 28.57 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.31 1.044 . . . . 63.13 109.089 174.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -139.97 117.17 11.22 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.834 -0.802 . . . . 72.15 108.834 170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.57 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -128.03 103.5 7.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.191 0.596 . . . . 75.43 109.797 176.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' D' ' 129' ' ' ALA . 12.5 tt -67.92 121.63 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 N-CA-C 108.819 -0.808 . . . . 74.41 108.819 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -101.1 -47.38 4.77 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.86 0.464 . . . . 71.32 110.715 -178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.48 HH21 ' HB ' ' A' ' 122' ' ' THR . 66.9 ttt180 -163.25 135.59 5.27 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.158 -0.474 . . . . 74.33 110.098 -171.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.2 mt -114.15 138.25 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 106.805 -1.554 . . . . 64.23 106.805 170.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.507 ' HE1' HG13 ' B' ' 83' ' ' ILE . 15.1 p90 -164.78 146.35 8.02 Favored 'General case' 0 C--O 1.241 0.619 0 O-C-N 123.711 0.632 . . . . 64.32 111.178 -175.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 93.8 m -74.64 116.84 15.8 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.864 -0.791 . . . . 75.4 108.864 173.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -89.48 -30.18 18.46 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.26 0.624 . . . . 73.21 111.158 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.5 t70 -158.25 142.89 16.18 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.091 -0.504 . . . . 60.32 110.376 -171.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 33.9 mm -138.29 141.46 37.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 C-N-CA 125.336 1.455 . . . . 65.23 108.071 176.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 47.2 t -140.49 133.17 28.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 114.73 -1.123 . . . . 75.35 108.073 168.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.1 t80 -142.43 127.43 18.41 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.447 -1.686 . . . . 73.22 106.447 164.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.57 147.05 49.41 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.446 -1.316 . . . . 64.35 107.446 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -141.31 81.74 15.26 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 105.829 -1.915 . . . . 51.42 105.829 172.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.87 -29.08 76.02 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 122.574 2.183 . . . . 72.1 111.13 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -121.25 30.7 6.67 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.66 -1.155 . . . . 42.34 110.435 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.45 -52.45 29.63 Favored Pre-proline 0 CA--C 1.57 1.748 0 C-N-CA 124.734 1.214 . . . . 71.24 111.972 169.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -81.25 -16.84 9.43 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.007 1.804 . . . . 72.32 113.072 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -87.59 3.15 48.72 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.339 0.656 . . . . 71.21 111.419 -172.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.494 HG12 HD11 ' B' ' 68' ' ' LEU . 22.0 m -67.04 -17.12 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.097 0 C-N-CA 123.644 0.778 . . . . 74.1 110.766 166.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -71.33 -31.28 67.21 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.403 1.081 . . . . 74.41 110.123 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -84.18 -42.65 15.74 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.351 0.66 . . . . 72.12 109.383 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -91.45 78.52 5.66 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.076 0.95 . . . . 45.43 109.377 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.682 ' HB3' ' HA ' ' F' ' 196' ' ' LYS . 24.0 m-20 -83.11 74.87 9.95 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.42 -1.264 . . . . 75.44 110.471 -173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -179.46 171.64 1.24 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.199 1.0 . . . . 74.1 109.471 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -71.15 135.57 84.79 Favored Pre-proline 0 N--CA 1.472 0.667 0 C-N-CA 124.181 0.992 . . . . 70.45 111.276 173.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.54 157.41 48.89 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.135 1.89 . . . . 73.0 111.742 170.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 52.5 mt-10 -70.2 102.19 2.04 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 107.826 -1.176 . . . . 61.33 107.826 167.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 15.5 t -87.5 136.6 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 108.436 -0.95 . . . . 71.11 108.436 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -136.68 141.45 43.13 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.62 0.768 . . . . 65.14 109.23 -177.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.552 ' HB3' HD13 ' B' ' 126' ' ' LEU . 2.8 pp -104.83 142.23 35.1 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.475 0.71 . . . . 74.33 109.366 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.543 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 12.2 m-20 -139.6 155.71 47.29 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.687 1.595 . . . . 61.34 106.916 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.89 165.09 36.54 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.944 0.402 . . . . 64.43 110.327 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -159.53 141.51 13.35 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.346 1.058 . . . . 75.22 109.057 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.577 HG21 ' HA2' ' B' ' 99' ' ' GLY . 88.8 m -108.57 120.06 41.34 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 123.251 0.621 . . . . 73.14 109.361 177.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.33 153.82 32.34 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.765 1.226 . . . . 64.14 108.539 173.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.3 m -142.99 163.41 32.86 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.096 0.558 . . . . 75.14 110.889 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 29.7 t -154.03 170.59 20.75 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.05 1.34 . . . . 72.13 109.222 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 64.0 tt0 -125.79 135.36 51.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.786 0.834 . . . . 72.55 109.818 169.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 59.3 mt -100.62 -44.75 5.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.677 0.791 . . . . 71.23 110.767 177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.485 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -147.8 179.23 7.86 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.944 -1.025 . . . . 74.44 109.733 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.11 119.29 10.54 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.526 -0.761 . . . . 65.1 109.851 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' B' ' 85' ' ' SER . 16.6 m-20 70.76 -6.43 1.25 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 126.144 1.778 . . . . 75.12 112.674 -174.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 50.0 t -104.58 94.95 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 108.131 -1.062 . . . . 62.34 108.131 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.464 ' HE2' HD22 ' F' ' 173' ' ' LEU . 8.0 m-85 -94.93 169.39 10.16 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.435 0.694 . . . . 61.32 109.517 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 6.8 tm-20 -142.89 101.72 3.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.518 -1.289 . . . . 71.43 107.518 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.87 125.12 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 109.446 -0.576 . . . . 73.3 109.446 -175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.458 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 31.8 t -102.98 111.58 33.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.569 0.748 . . . . 74.02 109.605 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.37 112.09 23.91 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.381 -0.97 . . . . 74.42 108.381 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -96.44 131.45 43.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.592 -1.186 . . . . 71.02 109.708 173.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.3 t -126.89 120.29 55.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.579 -1.267 . . . . 72.53 107.579 166.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 16.4 m -109.48 153.97 23.31 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.494 1.117 . . . . 51.41 109.805 -174.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 85.1 t -133.33 126.07 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 124.631 1.172 . . . . 72.44 108.766 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 43.2 m -112.8 143.22 44.41 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.679 0.792 . . . . 73.21 109.335 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.7 151.37 34.79 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.56 0.344 . . . . 73.33 110.81 178.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 57.4 p -144.37 133.39 22.74 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.099 0.56 . . . . 75.05 111.203 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.494 HD11 HG12 ' B' ' 31' ' ' VAL . 41.8 mt -100.87 99.67 10.2 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.356 1.062 . . . . 73.21 108.365 171.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.68 -120.01 6.73 Favored Glycine 0 CA--C 1.534 1.277 0 N-CA-C 111.018 -0.833 . . . . 24.33 111.018 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -104.17 6.0 35.37 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.803 0.841 . . . . 75.51 112.191 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 27.0 pt-20 -115.19 165.57 12.78 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.44 0.696 . . . . 64.43 109.793 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 83.6 m -77.82 133.14 38.26 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.121 0.568 . . . . 73.25 111.111 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.442 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -85.46 -60.2 2.1 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.64 0.776 . . . . 74.11 109.291 178.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -158.5 150.98 21.91 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.533 -1.212 . . . . 72.23 110.041 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -129.45 114.22 15.87 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.215 1.006 . . . . 74.41 108.729 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.544 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 51.4 t -115.38 157.94 23.17 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.766 -0.827 . . . . 71.12 108.766 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.88 135.97 2.85 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.451 -0.944 . . . . 71.1 108.451 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -125.74 143.32 39.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.51 -0.922 . . . . 35.31 108.51 172.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -127.15 89.25 2.94 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.68 -0.859 . . . . 73.14 108.68 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -83.45 104.71 13.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.939 -1.028 . . . . 62.21 108.506 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.21 162.52 29.71 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.574 -0.61 . . . . 72.52 111.574 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.09 128.81 2.31 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.519 -0.632 . . . . 64.12 111.519 -177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.507 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.8 mt -85.72 118.39 32.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.748 -0.834 . . . . 71.14 108.748 176.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -133.69 134.71 43.43 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.773 0.829 . . . . 75.13 109.375 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 43.2 m -97.58 113.85 25.65 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.268 0.627 . . . . 62.24 109.993 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 44.6 pt -124.02 137.47 56.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.772 0.829 . . . . 64.44 111.608 -175.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.41 173.09 17.17 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.698 1.199 . . . . 72.52 108.782 165.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 86.53 -44.29 3.32 Favored Glycine 0 N--CA 1.475 1.251 0 CA-C-O 120.279 -0.179 . . . . 75.21 112.771 177.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.91 152.98 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.876 0.87 . . . . 74.44 110.654 169.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 1.1 tm-20 -155.93 144.25 20.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 120.406 0.146 . . . . 64.53 110.64 -174.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.39 -114.36 6.12 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.707 0.67 . . . . 73.15 114.034 173.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.2 m -67.01 -31.13 71.48 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.867 0.867 . . . . 74.13 110.996 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.4 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 92.1 mt-30 -62.85 -43.83 97.75 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.34 0.656 . . . . 73.54 110.475 176.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.575 ' SD ' ' HB2' ' F' ' 174' ' ' MET . 26.2 ttt -73.11 -37.86 66.53 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.767 -0.651 . . . . 64.42 110.681 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.84 -24.85 67.67 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.163 0.585 . . . . 71.01 111.121 175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 m170 -88.75 -23.38 22.92 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.048 0.939 . . . . 73.23 110.985 175.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -75.64 -67.66 0.64 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 122.716 0.406 . . . . 74.21 109.926 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.59 -18.4 58.66 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.034 0.383 . . . . 73.1 112.034 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.577 ' HA2' HG21 ' B' ' 46' ' ' THR . . . -90.11 -20.19 43.49 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.769 -0.462 . . . . 73.42 114.043 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.42 -52.63 0.45 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.766 0.654 . . . . 61.35 112.766 -172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -67.22 -50.17 61.79 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.104 0.561 . . . . 74.34 111.401 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.68 -47.41 82.17 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 118.236 -0.888 . . . . 65.33 110.42 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -48.8 -43.03 36.04 Favored 'Trans proline' 0 C--N 1.404 3.495 0 C-N-CA 122.296 1.998 . . . . 72.44 114.463 165.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.68 -31.42 72.31 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.257 0.623 . . . . 73.21 111.867 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.9 -45.69 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.547 0.739 . . . . 72.43 110.372 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 mt -88.24 -16.38 33.37 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.009 -0.996 . . . . 72.34 111.786 -169.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -60.14 -44.17 95.73 Favored Pre-proline 0 CA--C 1.555 1.166 0 C-N-CA 125.773 1.629 . . . . 61.35 113.757 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.0 Cg_endo -58.59 -40.32 74.93 Favored 'Trans proline' 0 C--N 1.4 3.286 0 C-N-CA 121.873 1.715 . . . . 74.05 112.494 174.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.444 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 87.8 m-85 -63.79 -44.09 94.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.17 0.588 . . . . 74.44 110.33 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.61 89.99 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.445 0.698 . . . . 62.0 111.045 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -60.52 -47.2 87.21 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.966 1.307 . . . . 74.1 111.063 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -69.82 -40.41 75.92 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.643 0.777 . . . . 62.42 110.0 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 11.7 t -67.45 -35.24 78.82 Favored 'General case' 0 C--N 1.356 0.848 0 CA-C-N 115.797 -0.638 . . . . 62.5 111.218 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.485 HG21 HG21 ' B' ' 64' ' ' VAL . 52.1 mt -62.81 -57.76 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.167 0.587 . . . . 74.51 109.548 174.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.406 HG21 ' HB2' ' C' ' 119' ' ' SER . 90.1 m -59.84 -26.43 65.8 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 124.328 1.018 . . . . 70.53 111.183 -176.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 47.6 t -66.03 -58.79 4.71 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.528 0.731 . . . . 75.33 109.852 171.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.2 mmt -62.79 -39.05 93.03 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 122.99 0.516 . . . . 61.25 112.267 -173.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.7 t -67.0 -41.82 87.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 124.498 1.119 . . . . 63.3 110.631 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 79.5 p -72.69 -25.64 61.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.661 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.9 mtt-85 -65.32 -38.63 90.76 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.509 -0.552 . . . . 72.34 109.509 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.95 1.55 62.86 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.908 -0.587 . . . . 73.23 113.191 170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.9 p 63.25 39.99 9.13 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.845 2.058 . . . . 61.12 111.816 177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -112.74 159.26 35.01 Favored Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 124.937 1.295 . . . . 72.22 111.207 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -60.41 141.46 95.64 Favored 'Trans proline' 0 C--N 1.391 2.799 0 C-N-CA 123.745 2.964 . . . . 71.44 115.181 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' C' ' 124' ' ' PRO . 0.9 OUTLIER -65.61 160.39 22.66 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 126.322 1.849 . . . . 64.12 113.701 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.552 HD13 ' HB3' ' B' ' 42' ' ' LEU . 24.3 mt -127.54 102.46 6.87 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.254 -0.885 . . . . 74.01 110.004 163.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -91.05 100.24 13.13 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 107.542 -1.281 . . . . 74.24 107.542 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.87 136.33 33.01 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.112 0.565 . . . . 61.23 112.236 -171.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.54 142.26 74.0 Favored Pre-proline 0 N--CA 1.478 0.946 0 C-N-CA 123.708 0.803 . . . . 72.42 110.324 176.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.419 ' HG2' HG21 ' D' ' 13' ' ' ILE . 29.0 Cg_endo -64.24 100.4 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.156 1.904 . . . . 74.45 111.396 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' F' ' 184' ' ' TRP . 7.5 m -75.5 71.36 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-O 122.024 0.916 . . . . 74.2 109.189 168.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.1 93.2 1.77 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.962 -1.125 . . . . 75.32 107.962 178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.4 -21.88 66.78 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.031 -1.44 . . . . 71.34 111.886 -172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.43 -36.88 65.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.505 0.722 . . . . 74.43 110.642 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.38 -24.81 67.33 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.433 0.693 . . . . 63.22 111.478 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 9.7 tt -58.69 -46.61 86.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.039 0.936 . . . . 64.44 110.353 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -75.88 -17.82 59.65 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 115.702 -0.681 . . . . 72.21 111.879 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 24.6 mmt -67.22 -37.34 83.43 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.82 0.282 . . . . 72.33 111.254 178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -86.56 -32.96 20.39 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 122.876 0.471 . . . . 75.03 111.69 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -89.76 -34.08 16.32 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.731 0.412 . . . . 73.13 112.11 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 72.0 mt -105.95 23.94 13.16 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.031 0.533 . . . . 72.13 110.788 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -58.31 -43.73 88.25 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.405 0.282 . . . . 73.12 110.324 171.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? 56.46 23.91 7.98 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.481 1.112 . . . . 71.43 111.82 171.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -130.83 130.28 43.44 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.035 0.934 . . . . 75.34 109.332 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.412 ' HA ' ' HB2' ' D' ' 5' ' ' ASN . . . -83.29 136.39 34.39 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.428 0.691 . . . . 74.15 109.552 174.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.85 -173.07 49.52 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.261 0.351 . . . . 45.11 112.915 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.2 163.66 39.48 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.679 0.792 . . . . 52.33 109.858 -176.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.29 -54.37 0.25 Allowed Glycine 0 C--N 1.34 0.769 0 CA-C-N 115.727 -0.669 . . . . 74.43 111.805 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 11.3 m 48.82 64.23 1.8 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.682 1.193 . . . . 74.13 110.221 -172.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.15 92.95 1.39 Allowed 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.372 -0.831 . . . . 65.3 109.781 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.07 162.38 16.81 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.006 0.922 . . . . 74.05 109.263 175.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -111.1 163.23 14.09 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.977 0.511 . . . . 75.44 111.117 -174.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -104.99 115.94 31.12 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.039 0.936 . . . . 71.53 108.948 171.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -128.39 140.37 51.88 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.769 0.828 . . . . 72.35 108.975 176.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.903 0.881 . . . . 75.3 109.09 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 40.1 ttp . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 108.791 -0.818 . . . . 70.12 108.791 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -71.74 96.84 1.67 Allowed 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.47 0.708 . . . . 74.12 109.714 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.86 78.2 3.45 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 107.721 -1.214 . . . . 64.3 107.721 171.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.4 tp60 -143.56 49.86 1.4 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.243 -1.344 . . . . 74.12 107.508 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -59.76 -21.78 61.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.64 -1.618 . . . . 75.41 112.89 -173.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -164.25 130.19 2.97 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.077 0.551 . . . . 73.3 110.391 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 29.9 m -136.44 -51.93 0.7 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 106.696 -1.594 . . . . 64.03 106.696 165.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -167.87 100.37 0.47 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 114.404 -1.271 . . . . 64.42 107.739 168.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.793 ' HG3' HG22 ' C' ' 89' ' ' ILE . 24.6 ttt 60.62 111.4 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 125.547 1.539 . . . . 75.21 111.621 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.4 m -122.25 118.84 29.51 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.148 0.979 . . . . 73.33 109.571 -175.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -117.65 125.16 50.23 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.504 1.122 . . . . 73.5 108.159 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.686 ' HG3' HD13 ' H' ' 204' ' ' ILE . 53.7 tt0 -137.14 112.16 9.0 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.054 0.542 . . . . 72.03 109.601 -177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.458 HD11 HG13 ' C' ' 16' ' ' ILE . 6.1 tp -64.47 130.87 30.0 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 CA-C-N 115.862 -0.608 . . . . 73.2 109.926 175.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.551 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.4 mm-40 -103.75 -51.51 3.16 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.085 -0.709 . . . . 74.31 109.085 174.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.421 ' NH2' ' HD1' ' H' ' 197' ' ' TYR . 28.4 ttt85 -166.53 155.96 11.28 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 111.439 0.162 . . . . 71.52 111.439 -174.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.458 HG13 HD11 ' C' ' 13' ' ' ILE . 93.9 mt -138.19 137.48 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.608 1.163 . . . . 63.52 108.128 173.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.569 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.5 p90 -171.84 155.04 3.76 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.524 0.678 . . . . 74.44 111.786 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.8 p -78.72 117.99 20.37 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.67 -1.15 . . . . 74.33 108.461 174.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 17.4 mtmt -92.61 -38.57 11.81 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.903 -0.777 . . . . 74.4 108.903 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 25.9 t70 -133.9 134.89 43.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.683 -1.144 . . . . 74.21 108.729 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -138.82 141.02 37.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.078 -1.453 . . . . 52.15 107.078 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.7 t -151.95 150.22 29.78 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.394 0.616 . . . . 51.41 109.823 177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -150.83 113.33 4.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.889 -1.523 . . . . 64.42 106.889 173.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -115.16 111.15 20.57 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.883 -0.784 . . . . 73.31 108.883 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.02 75.69 53.79 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.09 0.956 . . . . 53.54 108.711 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -69.54 -24.35 30.77 Favored 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.092 1.862 . . . . 72.24 110.465 168.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -92.23 19.12 7.29 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.18 0.992 . . . . 75.21 110.731 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.72 -43.2 94.76 Favored Pre-proline 0 CA--C 1.567 1.615 0 C-N-CA 123.908 0.883 . . . . 75.24 113.353 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -77.63 -25.92 7.52 Favored 'Trans proline' 0 C--N 1.392 2.853 0 C-N-CA 121.46 1.44 . . . . 74.0 112.06 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 -69.48 -32.98 72.21 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.088 1.355 . . . . 72.53 111.29 -175.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.507 HG23 HD11 ' C' ' 68' ' ' LEU . 12.6 p -72.05 -24.24 22.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.809 0.844 . . . . 74.42 111.689 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -63.31 -39.15 93.76 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.199 0.6 . . . . 75.12 111.139 -176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -100.74 39.9 1.33 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.752 0.821 . . . . 62.33 109.858 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.768 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -124.72 173.86 8.27 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.36 0.664 . . . . 72.54 110.459 -176.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -88.27 115.42 25.76 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.041 -1.096 . . . . 74.21 108.041 167.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -86.13 68.02 10.15 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.832 0.853 . . . . 75.11 111.839 -167.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.725 ' HG3' ' HA2' ' E' ' 192' ' ' GLY . 53.8 tt0 -125.73 79.26 68.28 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 108.251 -1.018 . . . . 70.11 108.251 170.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.487 ' HB2' HG13 ' C' ' 40' ' ' VAL . 18.8 Cg_endo -89.42 137.57 3.02 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.472 2.115 . . . . 71.13 111.285 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.25 79.8 9.4 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.37 -1.344 . . . . 72.32 107.37 174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.623 ' HB ' HD11 ' C' ' 126' ' ' LEU . 17.2 m -84.21 111.29 19.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 113.314 -1.766 . . . . 34.4 110.166 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -136.83 140.27 42.31 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.608 0.363 . . . . 74.3 110.104 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.549 HD12 HD11 ' E' ' 186' ' ' LEU . 3.4 pp -88.47 155.36 19.71 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.964 0.506 . . . . 73.51 109.796 168.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -144.31 125.27 14.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.689 -0.486 . . . . 51.52 109.689 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.625 ' HB2' ' HE1' ' E' ' 184' ' ' TRP . 7.4 mp -92.11 120.2 32.5 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.112 0.965 . . . . 73.44 110.229 -175.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.438 ' O ' HD23 ' C' ' 60' ' ' LEU . 30.4 t70 -117.32 146.8 43.12 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.707 1.203 . . . . 54.13 109.27 175.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.8 m -112.83 118.25 34.4 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.393 0.677 . . . . 75.3 110.592 -171.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.87 160.29 29.14 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.88 1.272 . . . . 73.3 108.352 170.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.5 m -161.34 154.13 20.7 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.835 0.854 . . . . 70.32 110.077 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.1 p -147.75 143.45 27.56 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.592 1.157 . . . . 63.43 109.379 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -85.28 136.4 33.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.351 0.66 . . . . 71.52 110.351 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.617 HD11 HD12 ' C' ' 83' ' ' ILE . 85.8 mt -107.24 -39.66 5.63 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.871 0.868 . . . . 74.54 109.731 174.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.1 -178.54 7.06 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 114.587 -1.188 . . . . 73.01 109.752 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -73.33 119.99 18.33 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 114.678 -1.146 . . . . 73.02 108.462 173.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.495 ' H ' ' HB2' ' E' ' 172' ' ' ALA . 14.7 m-20 66.22 19.66 11.08 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.81 1.244 . . . . 75.43 111.256 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 48.4 t -135.14 105.79 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 N-CA-C 107.314 -1.365 . . . . 62.15 107.314 171.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.476 ' CE2' ' SD ' ' E' ' 174' ' ' MET . 93.1 m-85 -123.09 166.57 14.93 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.456 0.703 . . . . 71.33 110.78 -175.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -125.86 110.71 13.98 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 114.261 -1.336 . . . . 72.21 108.537 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.44 HG11 ' HD3' ' C' ' 103' ' ' PRO . 59.9 t -96.08 136.1 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.435 -1.32 . . . . 72.5 107.435 174.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.8 t -128.41 107.01 15.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 124.096 0.959 . . . . 74.35 108.92 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.492 HD12 ' O ' ' C' ' 103' ' ' PRO . 0.4 OUTLIER -87.35 108.09 18.82 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.951 -1.129 . . . . 72.31 107.951 176.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -89.64 104.94 17.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.121 -0.696 . . . . 71.54 109.121 173.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 59.0 t -98.03 107.86 20.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.25 -1.019 . . . . 72.11 108.25 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 3.9 m -103.39 121.91 43.76 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.161 0.584 . . . . 72.43 109.503 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.744 HG21 HG21 ' C' ' 114' ' ' ILE . 88.5 t -102.34 136.44 34.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 124.762 1.225 . . . . 72.43 109.984 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 54.8 m -122.79 140.42 52.93 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.819 0.848 . . . . 74.25 109.044 176.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.41 117.87 17.75 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.036 -1.098 . . . . 64.34 108.036 177.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 49.9 m -135.0 131.78 37.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.481 0.658 . . . . 75.15 110.76 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.768 HD13 ' HG2' ' C' ' 34' ' ' LYS . 14.3 mt -89.61 41.97 1.07 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.423 1.889 . . . . 71.01 109.479 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.26 -109.11 3.29 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.529 -1.028 . . . . 73.3 110.529 -169.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -91.83 -31.4 15.74 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.622 0.769 . . . . 75.44 110.584 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -75.53 119.43 19.57 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.683 1.193 . . . . 61.35 109.074 -177.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -75.79 124.96 28.16 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.772 -0.455 . . . . 71.11 109.772 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.6 -51.99 13.01 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.078 -0.712 . . . . 55.04 109.078 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -166.69 174.87 8.32 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 115.174 -0.921 . . . . 63.11 110.351 173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.6 tm? -133.14 146.79 51.91 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 106.329 -1.73 . . . . 62.24 106.329 171.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.583 ' SG ' HG23 ' C' ' 114' ' ' ILE . 44.7 t -145.53 146.4 31.41 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.447 -0.946 . . . . 53.2 108.447 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.28 130.32 6.06 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.072 0.396 . . . . 72.24 110.698 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 61.7 t -132.87 134.55 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.232 1.013 . . . . 62.43 109.236 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.679 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.6 mt-30 -107.18 97.73 7.46 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.648 1.179 . . . . 70.52 108.361 174.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.8 tp-100 -82.71 101.24 10.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.526 -0.761 . . . . 74.44 109.027 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.02 145.38 20.67 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.948 -0.861 . . . . 64.13 110.948 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.445 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.26 122.65 1.54 Allowed Glycine 0 CA--C 1.505 -0.575 0 N-CA-C 110.508 -1.037 . . . . 54.44 110.508 -177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.617 HD12 HD11 ' C' ' 51' ' ' LEU . 7.7 mm -84.02 128.15 39.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.246 -1.02 . . . . 75.14 108.246 177.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -134.69 120.92 20.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.653 0.781 . . . . 72.42 109.412 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -78.85 116.74 19.37 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 107.631 -1.248 . . . . 65.03 107.631 168.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.573 HG12 HD12 ' C' ' 89' ' ' ILE . 1.5 tt -133.58 114.46 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 C-N-CA 123.937 0.895 . . . . 65.12 109.743 -170.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.53 150.23 41.88 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.582 0.753 . . . . 54.12 110.556 -176.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.7 -19.02 35.28 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 114.217 0.447 . . . . 63.25 114.217 173.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.793 HG22 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -63.39 130.85 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 125.053 1.341 . . . . 65.13 111.283 179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.465 ' HA ' ' HE2' ' C' ' 94' ' ' MET . 44.9 mt-10 -147.29 147.2 30.13 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.809 0.443 . . . . 75.41 110.719 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.63 -136.99 18.2 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.828 -0.624 . . . . 41.01 112.825 175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.449 ' HB ' ' HZ ' ' C' ' 137' ' ' PHE . 37.5 p -66.28 -19.51 65.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.67 0.788 . . . . 75.12 111.357 176.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -64.19 -49.5 71.77 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.609 0.764 . . . . 61.21 110.604 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.465 ' HE2' ' HA ' ' C' ' 90' ' ' GLU . 15.3 ptp -71.38 -32.8 68.9 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 117.776 0.262 . . . . 54.2 110.652 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -42.9 94.97 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.933 0.893 . . . . 54.31 111.705 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -83.4 -30.92 26.98 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.046 -0.525 . . . . 62.5 111.031 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -63.16 -58.16 8.14 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.424 0.289 . . . . 63.45 110.575 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.4 tt -82.31 -38.39 24.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.784 0.434 . . . . 75.14 110.517 -176.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.74 10.23 75.07 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.001 -0.888 . . . . 71.14 115.029 -170.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.92 -49.03 0.06 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.365 1.083 . . . . 60.2 112.452 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.401 ' O ' HG12 ' C' ' 105' ' ' ILE . 82.5 t80 -76.14 -49.26 17.8 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.314 0.646 . . . . 72.52 111.079 -171.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 99.4 m -59.35 -48.03 96.87 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-O 118.218 -0.896 . . . . 52.23 111.639 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.492 ' O ' HD12 ' C' ' 60' ' ' LEU . 39.5 Cg_endo -66.75 -27.29 44.68 Favored 'Trans proline' 0 C--N 1.399 3.234 0 C-N-CA 121.487 1.458 . . . . 73.31 112.781 172.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -63.91 -35.58 81.11 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.224 0.465 . . . . 54.21 110.974 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.471 HD12 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -65.01 -36.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.507 0.723 . . . . 74.04 110.092 174.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.445 HD21 ' HA3' ' C' ' 82' ' ' GLY . 77.6 mt -85.47 -19.68 30.89 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.165 0.986 . . . . 64.32 112.455 -176.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -57.9 -53.0 70.32 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-O 117.256 -1.354 . . . . 62.13 112.68 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.85 -33.85 97.52 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 121.94 1.76 . . . . 72.44 112.273 -176.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.446 ' HE2' HG21 ' A' ' 115' ' ' THR . 89.6 m-85 -67.81 -50.48 56.6 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.005 0.922 . . . . 73.24 111.187 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -62.3 -41.4 98.49 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.777 0.831 . . . . 64.35 110.392 178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -57.76 -48.13 80.51 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.988 1.715 . . . . 73.1 110.902 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -74.89 -33.06 61.98 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.249 0.62 . . . . 73.21 110.581 -178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.1 t -63.85 -33.78 76.46 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.322 0.649 . . . . 63.05 110.824 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.744 HG21 HG21 ' C' ' 64' ' ' VAL . 96.8 mt -75.98 -46.35 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.096 -0.957 . . . . 73.33 110.507 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 85.4 m -55.92 -35.99 67.22 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.524 0.73 . . . . 62.33 110.851 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 44.6 t -60.62 -57.56 12.19 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.26 -1.336 . . . . 75.23 109.89 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.546 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -55.62 -39.39 70.76 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.907 1.283 . . . . 60.44 113.538 -177.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.482 HG13 ' HB2' ' C' ' 123' ' ' PHE . 77.5 t -68.33 -44.1 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.09 0.956 . . . . 62.13 110.439 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.406 ' HB2' HG21 ' B' ' 115' ' ' THR . 40.3 t -63.03 -34.99 78.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-N 115.272 -0.876 . . . . 73.01 111.086 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.546 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 67.0 mtt-85 -64.83 -45.13 87.46 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.07 -0.968 . . . . 74.21 109.925 177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.76 3.47 69.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.402 -0.817 . . . . 63.23 113.447 177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.9 p 65.91 34.46 7.19 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.867 1.667 . . . . 55.25 113.23 170.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.517 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 87.1 m-85 -97.9 169.98 7.75 Favored Pre-proline 0 CA--C 1.565 1.554 0 C-N-CA 124.417 1.087 . . . . 62.13 109.802 175.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.533 ' HA ' HE21 ' B' ' 125' ' ' GLN . 72.1 Cg_endo -70.71 175.32 9.05 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.6 2.2 . . . . 73.42 112.803 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -60.23 130.64 47.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.859 0.464 . . . . 63.3 112.121 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.623 HD11 ' HB ' ' C' ' 40' ' ' VAL . 1.5 mm? -122.81 18.48 10.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.42 1.088 . . . . 72.43 110.857 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -90.44 81.15 6.0 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.001 -1.481 . . . . 63.25 107.001 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 42.7 mt -92.71 101.71 14.11 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 114.196 -1.366 . . . . 71.2 111.088 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.614 ' HB3' HD13 ' E' ' 187' ' ' ILE . . . 54.03 175.63 0.03 OUTLIER Pre-proline 0 CA--C 1.579 2.087 0 N-CA-C 115.399 1.629 . . . . 74.22 115.399 162.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -91.58 -172.33 0.44 Allowed 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.449 2.099 . . . . 72.23 113.334 165.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.48 122.79 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.765 0.826 . . . . 63.13 109.81 171.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -114.9 102.78 10.29 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.937 0.895 . . . . 72.14 109.276 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -82.49 -21.02 35.67 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.819 0.448 . . . . 74.42 111.77 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -59.88 -29.84 68.59 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.795 0.838 . . . . 74.41 111.768 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.47 -41.53 97.37 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.728 0.811 . . . . 63.23 110.926 173.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 68.8 mt -80.01 -28.05 39.45 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.906 0.882 . . . . 64.34 111.495 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.449 ' HZ ' ' HB ' ' C' ' 92' ' ' THR . 84.1 t80 -71.3 -45.68 62.52 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.13 0.572 . . . . 71.42 110.175 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.542 ' HA ' ' HG3' ' C' ' 142' ' ' GLN . 0.0 OUTLIER -68.86 -28.38 66.66 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.518 0.512 . . . . 73.21 110.664 178.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -63.18 -46.05 88.94 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.523 1.129 . . . . 73.35 109.848 174.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -71.73 -85.59 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.761 0.824 . . . . 73.21 110.907 177.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 55.8 tp -148.31 130.67 15.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.055 0.942 . . . . 72.53 108.809 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.542 ' HG3' ' HA ' ' C' ' 138' ' ' MET . 9.3 mp0 -101.99 -77.81 0.55 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.805 0.842 . . . . 74.4 109.449 -174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.458 ' HB2' ' HA ' ' A' ' 144' ' ' GLN . 21.0 mm-40 -145.17 108.41 4.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.683 1.193 . . . . 64.44 107.92 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.54 101.9 13.62 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 107.672 -1.233 . . . . 75.54 107.672 176.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.06 -68.91 0.21 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.742 0.417 . . . . 71.53 110.403 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 154.97 174.71 25.21 Favored Glycine 0 C--N 1.343 0.945 0 CA-C-N 116.664 -0.244 . . . . 65.31 113.497 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.582 ' HB2' ' HB2' ' A' ' 145' ' ' ALA . 2.9 tm-20 -152.36 156.91 40.5 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.69 -1.226 . . . . 74.12 107.69 -177.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.44 -54.53 0.28 Allowed Glycine 0 C--N 1.334 0.435 0 N-CA-C 111.195 -0.762 . . . . 75.14 111.195 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -74.9 86.99 2.27 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.544 0.738 . . . . 73.03 109.876 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -129.06 92.21 3.35 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.011 -1.107 . . . . 74.43 108.011 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -83.14 104.59 13.44 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.454 -0.943 . . . . 61.21 108.454 172.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -90.11 63.76 5.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.742 0.782 . . . . 75.15 110.136 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -95.97 92.6 6.56 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.506 -0.77 . . . . 74.13 109.077 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -136.1 140.81 44.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.217 1.007 . . . . 74.44 108.477 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 N-CA-C 109.326 -0.62 . . . . 73.21 109.326 177.111 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 111.743 0.275 . . . . 71.22 111.743 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.4 m -131.15 88.08 2.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.192 0.597 . . . . 71.23 109.482 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -77.22 8.54 3.92 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.581 0.752 . . . . 74.11 112.308 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -50.87 -60.7 2.79 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 125.038 1.335 . . . . 63.12 109.622 175.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.547 ' HB3' ' HB2' ' D' ' 8' ' ' GLU . 89.7 m-20 -91.74 75.75 5.71 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.665 -0.865 . . . . 64.54 108.665 171.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -75.01 -17.59 60.5 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.084 -0.962 . . . . 70.54 111.203 177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 37.6 p -108.56 26.37 10.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.264 1.025 . . . . 72.04 110.726 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' D' ' 5' ' ' ASN . 10.3 tp10 -70.75 -94.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 123.393 0.677 . . . . 71.51 110.787 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.471 ' HG3' HG13 ' D' ' 89' ' ' ILE . 20.2 ttp -37.97 134.48 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.42 1.088 . . . . 74.13 112.947 171.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 29.4 m -130.46 138.17 50.16 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.783 -0.451 . . . . 63.52 109.783 172.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' D' ' 85' ' ' SER . 73.5 t80 -156.73 93.06 1.34 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.968 1.307 . . . . 64.21 107.651 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -119.82 146.75 45.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.811 -0.631 . . . . 74.54 110.149 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.419 HG21 ' HG2' ' B' ' 130' ' ' PRO . 2.2 mp -83.12 125.83 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.242 1.017 . . . . 71.31 108.688 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -104.0 -46.42 4.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.059 0.544 . . . . 75.11 111.403 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.444 ' NH1' ' HE2' ' E' ' 202' ' ' TYR . 7.9 tpt180 -166.45 122.44 1.23 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 118.919 -0.562 . . . . 42.45 110.938 -169.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.27 124.1 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 107.627 -1.249 . . . . 74.22 107.627 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -158.98 152.77 23.19 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.572 0.749 . . . . 73.12 111.895 -168.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.1 p -86.49 117.8 25.51 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.162 -0.926 . . . . 61.13 109.087 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -88.67 -23.28 23.05 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.759 -0.655 . . . . 60.51 110.183 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.5 t70 -158.53 133.92 8.69 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.258 -0.883 . . . . 62.12 109.416 -175.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.53 HD13 ' HE3' ' C' ' 117' ' ' MET . 76.7 mt -137.61 143.68 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.347 1.059 . . . . 60.44 108.386 175.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.2 t -142.12 143.96 33.28 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.958 1.303 . . . . 74.53 108.023 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.9 t80 -151.49 110.82 3.94 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.511 -2.033 . . . . 64.41 105.511 169.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -128.12 108.22 10.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 109.164 -0.68 . . . . 73.31 109.164 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.46 91.15 4.58 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 106.896 -1.52 . . . . 73.43 106.896 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.24 -24.96 11.95 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.426 2.084 . . . . 51.21 112.24 -172.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 -112.7 36.03 3.62 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 124.186 0.994 . . . . 72.23 108.419 -177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.569 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -59.96 -50.18 87.69 Favored Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.974 1.472 . . . . 44.12 114.974 -166.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.401 ' HB3' HD11 ' C' ' 83' ' ' ILE . 96.8 Cg_endo -83.98 -4.84 10.52 Favored 'Trans proline' 0 C--N 1.392 2.854 0 CA-C-N 121.803 1.68 . . . . 75.14 113.076 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.7 t-160 -83.52 -37.04 23.58 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.288 1.035 . . . . 72.35 109.231 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.716 HG11 ' HA ' ' D' ' 73' ' ' ALA . 33.1 m -83.63 -4.24 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.864 0.865 . . . . 63.45 111.534 178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -60.94 -25.73 67.0 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.671 0.788 . . . . 70.34 109.965 165.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -83.19 0.07 47.03 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.135 0.974 . . . . 52.43 111.447 177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -116.94 86.23 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.536 1.134 . . . . 72.23 109.641 -175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.81 51.53 2.17 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.805 0.812 . . . . 64.41 110.186 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 14.0 m0 -130.15 -175.95 3.79 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.934 0.894 . . . . 73.05 109.222 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.468 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 33.9 tp60 -79.68 116.88 64.09 Favored Pre-proline 0 N--CA 1.472 0.653 0 C-N-CA 122.968 0.507 . . . . 65.11 110.293 -177.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 13.9 Cg_exo -67.52 87.92 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 121.999 1.799 . . . . 74.23 109.375 169.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -67.88 120.66 14.53 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 115.539 -0.755 . . . . 61.24 110.548 -171.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.659 HG13 HG13 ' D' ' 64' ' ' VAL . 84.8 t -95.83 117.65 40.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 114.991 -1.004 . . . . 73.54 110.291 -167.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.525 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.3 mmtt -89.58 115.2 26.81 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.712 -1.218 . . . . 74.31 107.712 171.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.8 mp -93.51 124.53 37.57 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.218 -1.03 . . . . 73.14 108.218 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 27.8 t70 -116.59 125.39 51.76 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.388 -0.967 . . . . 53.2 108.388 174.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 tp -97.61 132.3 43.39 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.749 0.82 . . . . 75.32 109.744 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.57 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.0 t70 -143.04 118.31 10.2 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 107.252 -1.388 . . . . 63.14 107.252 172.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 69.5 m -120.02 145.02 47.22 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.046 0.538 . . . . 63.1 110.27 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.63 158.29 43.94 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.17 0.988 . . . . 72.11 109.087 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.6 m -147.65 156.06 42.41 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.778 0.831 . . . . 65.23 109.521 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 63.4 p -151.77 127.27 10.04 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.329 0.651 . . . . 60.25 109.985 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -69.49 119.58 13.96 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 109.666 -0.494 . . . . 72.25 109.666 175.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' D' ' 57' ' ' GLU . 52.7 mt -92.35 -34.02 14.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.009 0.523 . . . . 75.33 110.348 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.84 -171.68 3.19 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.152 0.981 . . . . 75.22 109.856 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -63.12 109.59 1.56 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.036 0.534 . . . . 62.23 109.837 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.689 ' HA ' HD23 ' H' ' 173' ' ' LEU . 2.5 m-20 64.85 11.16 6.71 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.067 1.347 . . . . 73.12 113.193 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.9 t -111.89 133.27 58.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.259 -1.386 . . . . 51.25 107.259 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.66 174.35 13.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.322 0.582 . . . . 71.14 109.822 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.493 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.8 tt0 -124.86 147.83 48.57 Favored 'General case' 0 C--N 1.314 -0.935 0 C-N-CA 124.251 1.02 . . . . 72.44 108.511 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -120.15 125.57 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.521 -1.289 . . . . 73.15 107.521 167.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.423 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 82.4 t -103.54 126.81 57.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 124.019 0.928 . . . . 64.35 108.691 174.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -110.2 122.08 46.79 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 107.712 -1.218 . . . . 74.43 107.712 178.288 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.57 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.8 ttm-85 -109.47 99.97 9.11 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.298 -1.001 . . . . 53.2 108.298 177.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.08 126.68 44.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 107.19 -1.411 . . . . 33.41 107.19 168.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 16.0 m -120.44 127.22 52.04 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.585 0.707 . . . . 63.21 110.351 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.659 HG13 HG13 ' D' ' 40' ' ' VAL . 17.3 t -112.43 107.29 22.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 126.151 1.78 . . . . 75.2 109.144 -175.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 22.6 m -107.6 93.07 4.34 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 107.7 -1.222 . . . . 61.21 107.7 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.5 137.59 34.34 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 109.151 -0.685 . . . . 64.24 109.151 -175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.514 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 43.4 m -137.68 134.4 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.265 0.555 . . . . 70.5 111.48 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.491 HD12 ' HB ' ' D' ' 31' ' ' VAL . 21.7 mt -108.08 107.05 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.004 1.322 . . . . 75.21 110.397 177.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.55 -112.29 3.67 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 111.936 -0.466 . . . . 74.12 111.936 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.86 6.3 17.87 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.089 0.955 . . . . 74.12 111.002 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -124.17 168.32 13.07 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.659 0.784 . . . . 64.11 110.39 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.4 m -81.31 126.6 31.77 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.312 0.645 . . . . 74.11 110.283 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.716 ' HA ' HG11 ' D' ' 31' ' ' VAL . . . -78.05 -67.17 0.76 Allowed 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.783 0.833 . . . . 53.31 109.243 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -154.08 153.68 32.31 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 115.169 -0.923 . . . . 74.41 110.117 173.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.5 mt -109.66 152.75 25.18 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.623 -1.251 . . . . 61.42 107.623 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.571 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 42.0 t -158.9 146.73 17.86 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.528 0.731 . . . . 70.14 109.095 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -156.1 128.95 7.9 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 109.302 -0.629 . . . . 71.32 109.302 173.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.78 115.58 34.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.03 0.532 . . . . 64.45 109.708 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.537 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.9 mt-30 -90.36 89.1 7.46 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.571 0.749 . . . . 74.24 109.817 170.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -81.31 100.39 9.17 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.684 -1.144 . . . . 75.04 108.838 174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -95.6 144.62 17.35 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.491 -0.644 . . . . 63.32 111.491 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.82 130.52 3.93 Favored Glycine 0 C--N 1.333 0.381 0 N-CA-C 111.317 -0.713 . . . . 62.31 111.317 -178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.6 mt -89.73 124.86 42.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 C-N-CA 124.249 1.02 . . . . 72.43 109.011 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -130.91 168.77 16.76 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.047 1.339 . . . . 71.44 108.973 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 39.6 m -114.07 137.0 52.31 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.765 0.826 . . . . 73.24 109.637 171.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 1.8 pp -129.44 125.44 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.296 0.638 . . . . 60.24 109.939 172.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' H' ' 171' ' ' SER . . . -162.32 164.64 27.34 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.343 0.657 . . . . 71.21 110.602 -176.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.04 -20.63 19.63 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 123.837 0.71 . . . . 73.42 114.788 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.471 HG13 ' HG3' ' D' ' 9' ' ' MET . 2.1 pp -133.49 163.3 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.993 0.917 . . . . 65.33 110.555 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -143.95 -176.12 4.87 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.08 0.952 . . . . 72.02 110.414 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.33 -133.54 20.05 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-N 115.347 -0.842 . . . . 74.2 113.565 171.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.1 m -59.3 -39.7 83.87 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.463 1.105 . . . . 70.33 111.812 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -58.62 -45.29 89.51 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.038 0.935 . . . . 73.11 111.604 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.471 ' SD ' ' N ' ' D' ' 95' ' ' ALA . 3.4 ppp? -81.64 -39.26 24.69 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.547 0.339 . . . . 61.53 111.513 -177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.471 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -65.5 -40.3 92.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.417 0.687 . . . . 73.52 111.272 -174.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -78.96 -26.37 43.48 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.288 -0.869 . . . . 73.13 110.735 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.3 t -68.73 -52.5 30.05 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.437 0.295 . . . . 41.44 110.861 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' D' ' 94' ' ' MET . 1.7 pp -76.82 -18.34 58.45 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.096 0.406 . . . . 70.3 112.096 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.16 0.03 68.49 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.241 -0.755 . . . . 44.03 113.691 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.535 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -151.53 -61.56 0.17 Allowed 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.081 0.94 . . . . 74.32 112.421 -177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -67.05 -48.88 66.95 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.533 0.733 . . . . 75.52 112.631 -171.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 23.4 m -66.05 -42.7 53.19 Favored Pre-proline 0 CA--C 1.563 1.451 0 C-N-CA 123.384 0.674 . . . . 73.22 112.264 -175.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 49.4 Cg_exo -59.15 -35.62 97.39 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.168 1.912 . . . . 70.41 112.762 166.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -65.85 -28.69 69.17 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.126 0.571 . . . . 73.02 111.356 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -65.97 -40.96 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 123.231 0.612 . . . . 75.53 110.011 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.431 HD21 ' HA3' ' D' ' 82' ' ' GLY . 77.1 mt -75.57 -23.01 56.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.021 -0.99 . . . . 73.14 111.762 -174.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -64.14 -40.9 57.5 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-O 117.495 -1.241 . . . . 70.44 113.904 -171.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.46 -41.9 42.85 Favored 'Trans proline' 0 C--N 1.4 3.239 0 C-N-CA 122.224 1.949 . . . . 74.1 113.719 170.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.403 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.2 m-85 -78.09 -38.69 43.59 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.749 0.82 . . . . 73.14 111.422 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -43.04 95.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.152 0.581 . . . . 73.02 109.913 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -57.14 -56.82 16.81 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 124.875 1.27 . . . . 72.54 109.732 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.11 -39.62 90.67 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 124.325 1.016 . . . . 70.53 111.837 -172.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 t -58.36 -45.36 88.35 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 123.743 0.652 . . . . 74.01 110.408 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.553 HG21 HG21 ' D' ' 64' ' ' VAL . 84.2 mt -64.51 -53.66 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.124 0.97 . . . . 50.44 110.155 174.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.0 m -52.4 -41.18 62.96 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.99 1.716 . . . . 71.11 111.546 -172.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -69.7 -44.9 69.46 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 114.685 -1.143 . . . . 61.21 110.105 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -65.72 -30.21 70.85 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.963 0.505 . . . . 72.15 112.007 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.5 t -65.57 -47.37 86.64 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 123.805 0.842 . . . . 73.53 109.75 176.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.7 p -72.18 -29.08 63.66 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 116.047 -0.524 . . . . 44.51 110.744 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -70.18 -30.91 68.15 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.651 0.78 . . . . 55.24 110.166 174.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.38 10.46 63.99 Favored Glycine 0 CA--C 1.539 1.575 0 CA-C-N 115.788 -0.642 . . . . 51.44 112.797 174.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.535 HG23 ' HB3' ' C' ' 17' ' ' TYR . 40.7 p 64.01 18.53 11.27 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.663 1.985 . . . . 74.11 113.841 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.452 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 88.0 m-85 -88.28 164.71 31.93 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.036 0.934 . . . . 74.25 108.875 171.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 59.0 Cg_endo -64.42 140.89 71.89 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.707 2.271 . . . . 72.21 111.012 -177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.5 118.18 7.2 Favored 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 109.521 -0.548 . . . . 72.43 109.521 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 90.0 mt -107.3 101.76 11.11 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.377 0.671 . . . . 64.23 109.689 -171.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -98.8 96.12 7.67 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.508 -0.923 . . . . 63.25 108.508 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.8 mt -63.48 129.63 40.99 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.939 0.896 . . . . 74.23 110.758 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.451 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -57.44 132.07 81.57 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 123.717 0.807 . . . . 75.23 111.121 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.44 114.25 3.87 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 121.962 1.775 . . . . 70.32 110.656 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.8 t -106.03 107.09 21.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.033 -1.099 . . . . 65.35 108.033 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -80.74 106.03 12.43 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.722 -1.214 . . . . 74.53 107.722 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.535 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 51.4 m-85 -66.06 -38.02 87.27 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.038 -0.983 . . . . 73.33 110.546 -175.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.98 -42.34 94.64 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.105 -0.952 . . . . 54.21 110.667 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.55 -53.08 62.37 Favored 'General case' 0 C--N 1.356 0.877 0 O-C-N 124.066 0.854 . . . . 74.22 111.045 178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.584 HD13 ' HD2' ' H' ' 185' ' ' PRO . 77.3 mt -63.66 -33.28 75.27 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.402 0.681 . . . . 52.32 112.257 -177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -62.78 -47.67 82.48 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.65 0.78 . . . . 75.44 110.477 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 71.9 mtm -73.37 -44.22 59.1 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.589 -0.732 . . . . 61.11 111.299 -177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.421 ' HA ' HE21 ' D' ' 142' ' ' GLN . 94.7 m-20 -64.75 -43.11 94.39 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.539 0.736 . . . . 63.34 111.154 -175.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -65.16 -31.54 72.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 123.72 0.638 . . . . 74.2 110.913 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.07 -36.47 82.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.955 0.902 . . . . 72.44 109.725 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.421 HE21 ' HA ' ' D' ' 139' ' ' ASN . 43.4 mt-30 -79.16 5.44 12.07 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.95 0.9 . . . . 73.5 111.86 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -119.52 92.09 3.71 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.279 1.032 . . . . 75.04 108.834 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -141.27 14.99 2.22 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.671 0.788 . . . . 45.51 109.655 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.37 131.63 2.73 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.964 0.905 . . . . 74.4 109.364 174.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.1 124.02 7.71 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.921 -0.872 . . . . 72.52 110.921 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -140.31 148.15 40.95 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.398 0.679 . . . . 74.5 110.481 -174.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.19 39.9 0.1 Allowed Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.901 -0.59 . . . . 70.42 111.925 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 19.5 m -80.81 87.17 5.9 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.603 0.761 . . . . 73.2 110.534 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -163.3 164.22 24.98 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.07 0.948 . . . . 73.33 108.765 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 66.36 144.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.049 1.34 . . . . 73.34 111.908 -171.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -139.29 163.17 33.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.071 0.949 . . . . 73.11 109.351 173.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -135.29 114.87 12.67 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.392 1.077 . . . . 72.41 109.153 -175.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -76.42 102.74 6.1 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.251 0.62 . . . . 65.1 109.624 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 123.831 0.853 . . . . 62.22 110.867 -177.749 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 109.635 -0.506 . . . . 72.42 109.635 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.81 142.88 4.64 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.475 0.484 . . . . 60.42 112.019 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -72.0 121.38 19.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.296 0.638 . . . . 55.2 110.795 178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 51.6 m -84.51 144.73 28.51 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.906 -0.775 . . . . 53.12 108.906 169.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . 0.582 ' HB1' ' SD ' ' E' ' 174' ' ' MET . . . -69.55 154.13 42.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.929 0.492 . . . . 62.11 111.475 -177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.637 HD22 ' HE3' ' E' ' 174' ' ' MET . 0.0 OUTLIER -114.93 7.13 15.55 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.806 0.842 . . . . 63.1 112.75 -169.541 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.637 ' HE3' HD22 ' E' ' 173' ' ' LEU . 1.0 OUTLIER -122.33 -165.92 1.34 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.377 0.671 . . . . 63.41 109.335 -176.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 19.9 t80 72.37 34.02 1.39 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.752 1.221 . . . . 72.22 110.966 171.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -62.67 -47.59 83.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 108.052 -1.092 . . . . 72.14 108.052 169.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 1.6 tt 52.32 70.58 0.55 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.46 1.504 . . . . 72.34 110.821 171.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -93.13 73.74 4.66 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.258 -1.015 . . . . 75.23 108.258 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 67.29 170.17 0.11 Allowed Pre-proline 0 N--CA 1.487 1.395 0 C-N-CA 124.65 1.18 . . . . 71.44 111.621 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -72.63 79.57 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 122.272 1.981 . . . . 74.43 110.564 165.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -70.67 -25.3 62.92 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.23 -0.896 . . . . 72.43 111.581 177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -105.04 118.4 36.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.136 -0.69 . . . . 75.11 109.136 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 49.9 p -131.48 146.17 52.11 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.479 1.112 . . . . 71.23 110.627 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.625 ' HE1' ' HB2' ' C' ' 44' ' ' LEU . 2.8 p90 -101.16 143.51 26.74 Favored Pre-proline 0 N--CA 1.483 1.215 0 C-N-CA 124.944 1.298 . . . . 74.22 109.144 175.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.57 -41.27 26.16 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.795 2.33 . . . . 63.42 111.831 176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.549 HD11 HD12 ' C' ' 42' ' ' LEU . 2.6 tm? 70.54 138.91 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.365 1.466 . . . . 74.42 110.308 176.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' C' ' 129' ' ' ALA . 45.0 pt -55.76 142.23 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 124.116 0.966 . . . . 73.25 112.498 -174.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.76 91.84 4.17 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.86 -1.163 . . . . 74.21 107.86 173.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.28 128.63 36.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 122.896 0.478 . . . . 72.25 110.65 -177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . 0.636 ' HB2' HD22 ' F' ' 199' ' ' ASN . 25.4 t70 -53.17 -45.51 68.52 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 72.21 112.443 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.38 -170.23 54.88 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 115.925 -0.579 . . . . 74.51 112.124 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . 0.725 ' HA2' ' HG3' ' C' ' 37' ' ' GLN . . . 130.98 -161.45 23.49 Favored Glycine 0 N--CA 1.475 1.242 0 CA-C-N 117.314 0.557 . . . . 43.51 113.048 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -82.84 162.42 21.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.921 0.889 . . . . 73.11 111.265 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -164.33 10.02 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.789 0.835 . . . . 75.14 111.432 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -136.96 134.26 36.5 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 123.751 0.821 . . . . 74.32 109.928 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -119.64 82.13 1.83 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.209 -1.404 . . . . 74.12 107.209 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . 0.532 ' HA ' ' HB3' ' E' ' 201' ' ' LYS . 59.1 m-85 -74.46 1.88 10.83 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.317 0.647 . . . . 75.5 112.716 -176.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -108.86 -7.03 15.55 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.47 0.708 . . . . 63.42 110.683 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -134.98 -76.3 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.46 0.704 . . . . 63.14 110.804 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -85.68 24.23 7.85 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 114.333 0.493 . . . . 60.01 114.333 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.532 ' HB3' ' HA ' ' E' ' 197' ' ' TYR . 63.3 pttt -66.42 -179.65 0.85 Allowed 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.822 1.249 . . . . 72.13 112.426 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . 0.444 ' HE2' ' NH1' ' D' ' 15' ' ' ARG . 44.5 m-85 -74.69 77.79 2.04 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.77 -1.196 . . . . 62.34 107.77 167.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -73.51 95.42 2.25 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.829 -0.434 . . . . 75.42 109.829 -174.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 14.0 tt -131.15 137.67 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.274 1.029 . . . . 72.1 109.114 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.17 3.32 1.56 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.856 1.262 . . . . 72.51 109.724 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -130.99 -159.5 0.97 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.701 1.2 . . . . 74.01 109.261 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.484 1.241 0 C-N-CA 124.835 1.254 . . . . 74.3 109.441 -172.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 110.292 -0.262 . . . . 53.21 110.292 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.19 -62.49 3.19 Favored Glycine 0 C--N 1.345 1.067 0 O-C-N 123.74 0.65 . . . . 62.24 113.354 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -91.75 98.63 11.73 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.653 0.781 . . . . 61.22 111.683 -171.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 1.4 m 60.19 -85.26 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.625 1.57 . . . . 75.0 112.227 176.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.02 96.76 0.62 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.133 -1.062 . . . . 63.45 108.133 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.464 HD22 ' HE2' ' B' ' 56' ' ' TYR . 58.2 mt -117.48 96.22 5.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 121.563 0.697 . . . . 71.05 111.108 -175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.575 ' HB2' ' SD ' ' B' ' 94' ' ' MET . 2.8 mpp? -99.09 178.6 4.87 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.749 1.22 . . . . 73.42 108.45 173.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -172.95 89.87 0.09 Allowed 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.528 -0.545 . . . . 71.24 109.528 168.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -138.04 84.97 2.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.756 0.822 . . . . 74.24 109.936 174.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 32.4 tp -88.64 59.52 5.16 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 107.621 -1.252 . . . . 75.03 107.621 167.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -102.82 -73.79 0.65 Allowed 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.88 -1.055 . . . . 73.51 110.146 -176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -94.99 109.18 42.86 Favored Pre-proline 0 C--O 1.243 0.731 0 C-N-CA 123.573 0.749 . . . . 71.15 110.564 -172.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -81.54 94.43 0.94 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.172 1.914 . . . . 53.04 110.244 170.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -62.28 104.26 0.47 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.56 -0.745 . . . . 73.11 109.226 174.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 69.01 163.45 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 125.704 1.601 . . . . 74.42 110.546 -166.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 30.6 p -140.18 151.43 45.22 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.789 -0.57 . . . . 64.24 111.001 176.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.406 ' HB2' ' HB ' ' B' ' 131' ' ' VAL . 38.3 p90 -71.0 152.37 94.94 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.044 1.338 . . . . 62.24 110.864 176.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.52 160.29 41.73 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.738 2.292 . . . . 74.11 112.488 175.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.6 147.42 25.97 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.627 -0.879 . . . . 74.03 108.627 172.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.401 HG22 ' O ' ' F' ' 188' ' ' ALA . 3.9 mp -98.94 154.57 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 N-CA-C 108.674 -0.862 . . . . 72.22 108.674 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . 0.401 ' O ' HG22 ' F' ' 187' ' ' ILE . . . -82.25 -179.23 7.34 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.21 0.604 . . . . 64.34 110.819 172.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -149.22 136.32 19.88 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.395 0.678 . . . . 65.33 109.818 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -92.82 -82.5 0.33 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.525 0.73 . . . . 73.21 111.189 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.96 -105.75 0.6 Allowed Glycine 0 C--N 1.351 1.376 0 N-CA-C 111.631 -0.588 . . . . 50.42 111.631 -177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -144.56 -145.94 4.41 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.795 -0.522 . . . . 50.24 111.795 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -97.9 -84.19 0.39 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 117.039 0.419 . . . . 75.43 109.979 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -134.67 -22.64 1.66 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.724 0.81 . . . . 45.3 110.503 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 63.98 -84.82 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.294 1.438 . . . . 72.33 110.339 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . 0.682 ' HA ' ' HB3' ' B' ' 35' ' ' ASP . 31.2 ttpt 56.43 20.03 4.49 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 124.889 1.275 . . . . 75.01 111.379 -171.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 58.8 t80 68.07 -58.33 0.45 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 126.026 1.731 . . . . 74.35 111.553 -173.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -71.94 -157.03 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.406 1.482 . . . . 73.21 111.746 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . 0.706 HD21 ' HD2' ' F' ' 205' ' ' LYS . 23.6 m120 -57.34 94.9 0.02 OUTLIER 'General case' 0 C--N 1.363 1.164 0 CA-C-O 122.122 0.963 . . . . 64.25 112.358 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -164.7 32.39 0.25 Allowed Glycine 0 C--O 1.244 0.778 0 CA-C-N 113.638 -1.619 . . . . 75.22 109.615 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 75.33 143.34 0.08 Allowed 'General case' 0 C--N 1.363 1.191 0 C-N-CA 126.605 1.962 . . . . 74.32 111.847 -174.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 63.94 37.96 9.08 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 125.568 1.547 . . . . 74.2 109.575 -174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -96.7 -176.68 3.67 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 113.57 -1.65 . . . . 73.12 111.999 -171.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 2.9 tp -132.1 -44.51 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 114.282 -1.326 . . . . 72.45 109.158 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . 0.706 ' HD2' HD21 ' F' ' 199' ' ' ASN . 21.2 ptmt 46.57 -74.0 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 126.414 1.886 . . . . 74.2 113.0 -167.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -168.91 152.22 5.21 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.384 1.074 . . . . 62.54 108.839 175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.564 1.485 0 C-N-CA 124.531 1.133 . . . . 65.23 111.635 -179.54 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' G' ' 168' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.549 0.91 0 CA-C-O 121.407 0.623 . . . . 72.23 109.559 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 97.27 -149.64 19.32 Favored Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.428 -0.669 . . . . 73.54 111.428 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.63 113.64 24.41 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.88 -0.785 . . . . 74.05 108.88 175.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 66.5 p -65.5 142.12 58.24 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.846 0.859 . . . . 74.31 110.972 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . 0.592 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . . . -139.47 -101.58 0.16 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 117.88 -1.057 . . . . 64.24 110.836 -176.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 77.1 mt 66.3 -67.09 0.16 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.822 1.249 . . . . 63.22 113.241 -176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 36.2 mmt -93.16 40.68 1.07 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.33 1.052 . . . . 74.41 112.375 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.532 ' H ' ' HE1' ' A' ' 94' ' ' MET . 53.5 t80 60.59 94.29 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.243 1.417 . . . . 71.33 110.707 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . 0.51 ' OD1' ' HG2' ' G' ' 178' ' ' GLN . 24.4 t-20 -108.65 -77.93 0.59 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.846 0.858 . . . . 74.14 109.702 -178.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp 53.59 65.76 1.42 Allowed 'General case' 0 C--N 1.362 1.132 0 C-N-CA 124.194 0.998 . . . . 75.15 110.805 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . 0.51 ' HG2' ' OD1' ' G' ' 176' ' ' ASN . 25.6 mm-40 -56.42 -40.97 75.62 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.323 0.649 . . . . 72.04 111.518 178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.22 143.83 29.05 Favored Pre-proline 0 C--O 1.245 0.821 0 C-N-CA 124.532 1.133 . . . . 71.44 108.738 -173.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.78 90.36 1.06 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 122.473 2.115 . . . . 63.34 111.404 174.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -62.98 -49.7 73.67 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.513 0.725 . . . . 75.25 110.358 176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -96.07 90.09 5.42 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.742 -1.117 . . . . 64.42 109.979 -174.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 33.6 p -88.14 80.13 7.71 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.103 -0.953 . . . . 74.54 108.786 172.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 20.9 p-90 -102.27 135.66 19.57 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-N 116.021 -0.536 . . . . 63.42 111.003 -174.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -81.02 166.9 18.52 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.674 2.25 . . . . 75.15 112.894 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.86 163.59 14.03 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.951 -1.022 . . . . 61.15 110.413 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.4 ' H ' HG13 ' G' ' 187' ' ' ILE . 2.9 pp -73.64 169.77 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-N 114.799 -1.092 . . . . 70.51 111.241 173.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -131.7 176.15 8.58 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.602 0.761 . . . . 74.14 109.454 171.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . 0.4 ' HB3' HG21 ' A' ' 40' ' ' VAL . . . -113.91 104.74 12.47 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.225 0.61 . . . . 52.43 109.952 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' H' ' 201' ' ' LYS . 25.5 t70 -85.55 -58.31 2.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.559 0.744 . . . . 72.53 110.306 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.62 97.18 1.92 Allowed Glycine 0 C--N 1.347 1.158 0 CA-C-N 116.324 -0.398 . . . . 72.42 112.381 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -171.11 36.05 0.17 Allowed Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.733 0.267 . . . . 70.31 113.361 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -142.03 88.2 2.09 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.169 0.988 . . . . 75.31 109.192 176.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -165.58 -26.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 113.284 0.846 . . . . 73.34 113.284 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -80.39 53.6 1.84 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 122.009 0.909 . . . . 75.45 109.222 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 36' ' ' TRP . 7.0 mtpm? -83.99 30.2 0.52 Allowed 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.29 -0.881 . . . . 74.01 111.562 -170.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 60.01 176.14 0.09 Allowed 'General case' 0 C--N 1.361 1.09 0 C-N-CA 125.466 1.507 . . . . 65.4 111.928 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -160.62 -63.73 0.06 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.603 -0.888 . . . . 74.34 108.603 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -86.16 -56.96 3.21 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.279 -0.873 . . . . 74.2 111.994 -176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 125.18 -67.88 0.52 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.163 -0.775 . . . . 63.02 111.163 -171.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . 0.48 ' HB3' ' HE1' ' A' ' 32' ' ' PHE . 25.0 pttm -146.88 176.99 9.47 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.619 0.723 . . . . 74.24 111.924 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.11 100.9 6.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.468 -1.242 . . . . 74.43 109.312 170.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.26 95.87 6.44 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.954 0.501 . . . . 55.54 110.718 175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.94 -18.07 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 N-CA-C 108.149 -1.056 . . . . 72.22 108.149 162.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt 74.38 -82.93 0.03 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 126.218 1.807 . . . . 71.31 111.137 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -141.55 170.09 16.38 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.881 0.872 . . . . 74.45 110.318 -172.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . 0.581 HG12 HD21 ' D' ' 136' ' ' LEU . 50.0 t . . . . . 0 CA--C 1.557 1.223 0 C-N-CA 124.308 1.043 . . . . 73.12 108.813 177.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 20.6 tptm . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 108.919 -0.771 . . . . 61.13 108.919 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.02 65.07 3.01 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 123.154 0.407 . . . . 61.12 112.697 175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -169.93 102.18 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.648 1.579 . . . . 74.14 108.356 173.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . 0.528 ' HB2' ' HB1' ' D' ' 87' ' ' ALA . 56.7 m -151.74 -59.47 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.43 0.692 . . . . 51.21 111.242 -173.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -143.01 76.99 1.55 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.286 -0.635 . . . . 60.33 109.286 -174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' D' ' 54' ' ' ASP . 2.8 tm? -78.56 129.88 35.32 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.493 -0.928 . . . . 75.34 108.493 176.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.88 29.08 0.6 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 114.521 -1.218 . . . . 74.31 109.739 -168.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -54.18 102.56 0.06 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.423 1.089 . . . . 65.15 111.305 -171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -144.76 96.54 2.88 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.333 1.053 . . . . 61.32 109.348 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 43.9 tp -112.56 93.96 4.69 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 107.853 -1.165 . . . . 72.54 107.853 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -81.1 -69.52 0.6 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.416 -0.811 . . . . 73.35 109.525 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -148.9 147.36 23.97 Favored Pre-proline 0 N--CA 1.479 1.009 0 C-N-CA 124.853 1.261 . . . . 75.15 108.814 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.09 113.87 3.2 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.764 2.31 . . . . 64.21 110.666 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -70.43 130.84 42.98 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.17 0.588 . . . . 72.43 111.358 -176.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 65.6 -176.02 0.18 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 125.237 1.415 . . . . 53.14 111.04 -174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 85.7 m -129.63 125.97 37.33 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.36 0.664 . . . . 72.33 109.638 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . 0.405 ' HA ' ' HD3' ' H' ' 185' ' ' PRO . 5.8 m-90 -98.62 123.63 49.23 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.694 0.798 . . . . 74.12 109.566 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . 0.584 ' HD2' HD13 ' D' ' 136' ' ' LEU . 46.4 Cg_exo -58.09 126.02 20.32 Favored 'Trans proline' 0 C--N 1.38 2.237 0 C-N-CA 123.424 2.749 . . . . 64.23 114.031 -175.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 72.2 mt -85.54 137.61 32.76 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.045 0.938 . . . . 53.14 109.212 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 pt -72.91 148.02 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 123.446 0.698 . . . . 74.22 111.233 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.66 156.41 17.09 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 123.682 0.793 . . . . 70.32 109.882 176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -78.33 127.1 31.72 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.776 0.831 . . . . 61.33 109.81 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -77.76 127.62 32.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.468 0.707 . . . . 75.1 109.439 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.9 95.2 0.19 Allowed Glycine 0 C--N 1.348 1.212 0 O-C-N 123.846 0.716 . . . . 60.22 111.452 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.15 -56.16 15.39 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 124.073 0.514 . . . . 61.4 114.335 -175.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.439 ' H ' ' HE2' ' H' ' 195' ' ' PHE . 47.6 m-85 63.53 8.96 3.89 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.933 1.293 . . . . 75.52 112.464 -175.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.91 81.57 2.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 107.576 -1.268 . . . . 43.22 107.576 174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.439 ' HE2' ' H ' ' H' ' 193' ' ' TYR . 90.2 m-85 -130.88 -92.42 0.42 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.36 0.664 . . . . 74.22 109.461 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 43.37 77.49 0.06 Allowed 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.23 1.012 . . . . 72.3 110.01 -170.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . 0.421 ' HD1' ' NH2' ' C' ' 15' ' ' ARG . 69.9 m-85 -45.18 96.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.388 1.075 . . . . 75.51 113.416 -166.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.23 175.7 2.55 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.894 1.278 . . . . 73.53 110.299 172.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . 0.504 HD21 ' ND2' ' A' ' 127' ' ' ASN . 32.3 t30 70.34 96.44 0.07 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.254 1.022 . . . . 71.23 109.746 -176.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 148.72 169.49 15.54 Favored Glycine 0 C--O 1.24 0.494 0 N-CA-C 110.171 -1.172 . . . . 73.31 110.171 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' G' ' 190' ' ' ASP . 44.1 tttp 61.91 36.24 15.93 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.591 0.756 . . . . 73.15 111.101 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.28 165.84 24.29 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.246 0.618 . . . . 72.22 111.568 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -81.99 102.49 10.98 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.152 0.981 . . . . 74.0 109.511 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.686 HD13 ' HG3' ' C' ' 12' ' ' GLN . 4.2 mp -123.25 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 N-CA-C 108.921 -0.77 . . . . 71.24 108.921 170.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . 0.478 ' HE2' ' H ' ' H' ' 207' ' ' VAL . 5.0 ptmt -62.64 -75.91 0.07 Allowed 'General case' 0 CA--C 1.558 1.277 0 C-N-CA 123.648 0.779 . . . . 73.14 110.162 167.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . 0.468 ' H ' ' HG3' ' H' ' 205' ' ' LYS . 1.6 m-20 -155.21 -73.56 0.11 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 106.319 -1.734 . . . . 75.41 106.319 -174.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.478 ' H ' ' HE2' ' H' ' 205' ' ' LYS . 4.3 m . . . . . 0 CA--C 1.568 1.637 0 C-N-CA 125.019 1.328 . . . . 74.22 108.503 173.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 mmt . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 112.036 0.384 . . . . 64.24 112.036 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -161.28 72.68 0.43 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 122.931 0.492 . . . . 53.04 110.954 -178.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -169.1 -79.52 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.233 1.013 . . . . 71.23 109.197 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -161.02 -162.58 0.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.676 0.791 . . . . 62.01 109.29 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.711 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 14.5 t-20 82.37 -57.64 0.2 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 126.467 1.907 . . . . 74.11 109.932 -172.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.44 ' H ' ' H ' ' C' ' 146' ' ' GLY . 7.7 t-20 67.33 170.63 0.26 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.225 1.41 . . . . 73.34 111.578 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -84.87 -59.3 2.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.818 0.847 . . . . 72.43 109.418 171.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -81.5 -69.17 0.63 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.208 1.003 . . . . 62.12 110.52 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 ppp? 179.93 152.52 0.46 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.296 1.038 . . . . 61.43 109.826 173.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.3 m -144.63 139.82 28.3 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.985 0.914 . . . . 55.42 108.638 171.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.479 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.2 t80 -109.2 149.99 28.58 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 108.748 -0.834 . . . . 72.12 108.748 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 51.0 tp60 -148.68 114.77 5.79 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.289 -0.263 . . . . 75.25 110.289 173.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.45 HD11 HG13 ' A' ' 16' ' ' ILE . 2.3 tp -72.1 90.32 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 106.907 -1.516 . . . . 74.22 106.907 164.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -82.98 -22.69 33.61 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.698 -1.137 . . . . 73.53 110.611 -173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -176.88 145.23 0.49 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 118.07 0.395 . . . . 72.44 111.297 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 HD12 ' HG3' ' C' ' 130' ' ' PRO . 95.3 mt -106.12 139.72 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.606 -1.627 . . . . 73.22 106.606 162.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.561 ' HE1' HG13 ' A' ' 83' ' ' ILE . 27.0 p90 -169.03 135.9 1.8 Allowed 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.951 0.9 . . . . 63.52 109.712 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.7 p -77.71 118.02 19.67 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.141 -0.482 . . . . 61.4 109.799 174.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -84.15 -27.05 28.39 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.764 -0.653 . . . . 75.21 110.114 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -151.8 138.0 18.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.361 -0.836 . . . . 73.45 109.026 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 87.9 mt -132.69 139.23 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.981 -1.489 . . . . 75.1 106.981 174.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.6 t -152.34 110.53 3.7 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.076 0.465 . . . . 75.53 110.501 177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.65 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 72.6 t80 -109.71 120.49 42.64 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 106.397 -1.705 . . . . 73.44 106.397 169.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -119.14 130.71 55.69 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.36 -0.978 . . . . 50.22 108.36 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.65 19.49 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 107.529 -1.286 . . . . 65.1 107.529 172.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.31 -15.94 28.12 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.648 2.232 . . . . 62.41 112.129 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -113.44 28.49 8.74 Favored 'General case' 0 C--O 1.216 -0.674 0 C-N-CA 124.188 0.995 . . . . 73.34 109.544 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.42 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -58.41 -45.68 99.67 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 113.962 1.097 . . . . 61.45 113.962 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -72.79 -32.75 8.85 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 121.538 1.492 . . . . 55.04 112.333 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -74.27 -20.36 60.17 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.75 1.22 . . . . 75.41 111.678 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 28' ' ' ALA . 5.2 p -75.32 -20.53 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.366 0.666 . . . . 75.02 112.097 -170.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -71.65 -29.85 65.08 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 116.019 -0.537 . . . . 71.44 110.224 175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -71.14 -28.83 64.57 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.148 0.979 . . . . 71.4 110.72 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -72.98 142.65 47.76 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 73.23 111.484 -173.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -73.08 115.31 12.25 Favored 'General case' 0 C--O 1.244 0.774 0 N-CA-C 107.489 -1.301 . . . . 71.42 107.489 164.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.59 ' CD1' ' HA ' ' G' ' 196' ' ' LYS . 63.8 t-105 -84.43 96.48 9.1 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.431 0.634 . . . . 74.55 110.867 -170.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' G' ' 192' ' ' GLY . 38.9 tt0 -137.25 80.0 35.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 106.515 -1.661 . . . . 62.24 106.515 168.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.31 148.54 16.63 Favored 'Trans proline' 0 C--N 1.37 1.705 0 C-N-CA 122.393 2.062 . . . . 73.3 112.544 -170.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' HA ' ' HA2' ' G' ' 192' ' ' GLY . 42.5 tt0 -98.37 92.82 5.87 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.25 -1.389 . . . . 75.31 107.25 171.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' G' ' 190' ' ' ASP . 7.1 p -65.32 124.26 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 115.062 -0.972 . . . . 72.55 109.207 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -124.06 117.62 25.11 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.778 0.831 . . . . 74.43 109.321 178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.4 tp -97.21 129.38 44.56 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.753 -0.832 . . . . 72.23 108.753 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.755 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.7 m-20 -115.19 134.35 55.23 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.273 1.029 . . . . 73.1 108.567 172.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.8 tp -113.3 125.23 54.06 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.755 0.822 . . . . 74.01 109.246 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.27 145.52 37.4 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.334 0.653 . . . . 51.03 109.596 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.3 m -135.63 133.11 37.87 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 75.14 109.313 178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 117.04 17.46 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.213 1.005 . . . . 40.32 109.439 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.3 p -118.47 153.27 34.42 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.46 0.704 . . . . 74.44 111.964 -173.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -168.02 153.1 6.73 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.786 1.234 . . . . 73.53 109.523 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.4 138.6 32.16 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 109.887 -0.412 . . . . 70.25 109.887 171.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' HB2' HG12 ' A' ' 55' ' ' VAL . 98.1 mt -107.5 -39.56 5.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.851 0.86 . . . . 75.41 111.134 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -157.95 -170.7 3.25 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.268 0.627 . . . . 64.3 110.305 -174.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.42 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 26.1 t70 -66.96 113.18 4.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.248 1.019 . . . . 75.43 110.444 -177.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 66.87 -4.29 0.81 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.488 1.515 . . . . 53.5 113.571 -171.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 72.6 t -97.59 117.45 42.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.087 0.955 . . . . 65.25 108.439 -172.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' HE2' HD21 ' G' ' 173' ' ' LEU . 26.0 m-85 -119.66 168.76 10.73 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.117 0.967 . . . . 70.11 109.367 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.9 tt0 -130.67 130.84 44.41 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.541 -1.209 . . . . 62.54 108.459 175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 111.94 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 106.477 -1.675 . . . . 65.32 106.477 169.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.538 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 60.2 t -98.35 131.57 45.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.898 -0.778 . . . . 62.14 108.898 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HG ' ' HB3' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -101.28 108.57 20.25 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.073 -1.454 . . . . 73.15 107.073 177.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.02 101.47 12.57 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.356 -0.979 . . . . 74.3 108.356 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' HB1' ' A' ' 110' ' ' ALA . 9.9 t -98.62 145.06 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 114.677 -1.147 . . . . 71.15 108.286 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.755 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 42.5 m -133.11 137.52 46.34 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.735 -0.469 . . . . 72.15 109.735 173.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.1 t -129.12 107.74 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 C-N-CA 124.675 1.19 . . . . 75.23 107.998 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 24.6 m -103.13 138.48 39.9 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.777 -0.823 . . . . 71.44 108.777 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.09 102.81 9.32 Favored 'General case' 0 C--O 1.223 -0.294 0 N-CA-C 106.603 -1.629 . . . . 55.25 106.603 169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 52.5 m -108.45 124.0 49.74 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.339 0.59 . . . . 74.14 109.677 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.443 HD11 ' HB2' ' A' ' 73' ' ' ALA . 14.7 mt -90.02 80.46 6.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.105 -1.443 . . . . 75.42 107.105 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.61 -89.27 0.84 Allowed Glycine 0 C--N 1.345 1.071 0 CA-C-N 115.177 -0.919 . . . . 63.2 111.442 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -114.8 -26.39 7.84 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.451 0.7 . . . . 73.31 110.759 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -99.58 124.48 44.82 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.976 -0.379 . . . . 65.0 109.976 -177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 74.6 m -76.4 137.7 39.91 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.406 0.682 . . . . 43.25 111.437 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.443 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -78.87 -62.56 1.66 Allowed 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.815 1.246 . . . . 70.25 109.615 174.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -144.04 151.68 39.99 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.442 -1.254 . . . . 64.53 109.61 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.8 tp -126.09 115.56 20.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.038 1.335 . . . . 72.51 108.409 175.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.1 m -103.99 139.33 39.27 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.792 0.837 . . . . 63.33 108.94 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -145.1 133.21 21.47 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.887 -1.524 . . . . 74.13 106.887 167.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -135.71 120.92 28.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.781 -0.822 . . . . 61.02 108.781 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -92.34 79.5 5.0 Favored 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.745 -1.205 . . . . 62.21 107.745 171.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.449 ' O ' HD13 ' A' ' 106' ' ' LEU . 7.0 tp-100 -76.65 93.93 3.7 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 106.917 -1.512 . . . . 73.35 106.917 177.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -100.07 160.07 19.39 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 121.746 -0.264 . . . . 72.51 113.0 -174.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.59 138.86 6.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 112.197 -0.361 . . . . 44.52 112.197 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.561 HG13 ' HE1' ' A' ' 17' ' ' TYR . 74.8 mt -81.76 125.47 39.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.892 -1.151 . . . . 73.42 107.892 169.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.479 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 57.3 m-85 -131.26 117.84 19.54 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.897 -1.149 . . . . 63.4 107.897 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 12' ' ' GLN . 18.9 m -81.37 114.34 20.07 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 108.171 -1.048 . . . . 64.24 108.171 174.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -134.7 140.12 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.403 0.681 . . . . 72.23 110.971 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.711 ' HB3' ' HA ' ' A' ' 5' ' ' ASN . . . -178.75 168.53 1.69 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.679 1.592 . . . . 60.44 108.924 172.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.08 -27.51 7.02 Favored Glycine 0 N--CA 1.473 1.152 0 CA-C-N 116.161 -0.472 . . . . 73.41 112.889 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -127.54 179.85 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.907 1.283 . . . . 71.11 110.114 -170.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.63 174.12 15.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.012 0.525 . . . . 73.34 110.068 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.91 -128.12 28.55 Favored Glycine 0 C--N 1.351 1.396 0 CA-C-N 115.819 -0.628 . . . . 62.42 113.753 171.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 59.7 p -67.5 -29.82 69.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.263 1.025 . . . . 64.22 111.516 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.65 -36.64 70.75 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.608 0.568 . . . . 62.43 110.934 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.616 ' SD ' ' HG2' ' G' ' 174' ' ' MET . 23.2 ttt -74.1 -37.31 64.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 110.003 -0.369 . . . . 62.03 110.003 173.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.21 68.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.007 0.523 . . . . 40.15 111.016 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -74.92 -52.19 11.85 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.667 0.787 . . . . 74.45 110.282 176.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 42.1 t -65.21 -62.19 1.69 Allowed 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.957 0.785 . . . . 53.54 110.553 -176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -65.66 -38.77 90.27 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.971 0.908 . . . . 63.13 111.957 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.78 -28.52 38.14 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 115.238 0.855 . . . . 51.35 115.238 -167.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.89 -40.61 0.6 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.165 0.983 . . . . 24.11 112.423 -173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.492 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 56.1 t80 -74.89 -39.44 61.47 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.582 0.753 . . . . 62.13 112.296 -172.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 82.7 m -79.58 -39.8 1.37 Allowed Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 123.235 0.614 . . . . 74.24 111.752 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.513 ' HB3' ' HG ' ' A' ' 60' ' ' LEU . 53.1 Cg_exo -54.91 -30.15 67.36 Favored 'Trans proline' 0 C--N 1.393 2.903 0 C-N-CA 122.372 2.048 . . . . 65.12 112.98 164.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -66.81 -24.26 66.15 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.755 0.822 . . . . 62.32 111.553 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 13' ' ' ILE . 47.3 mm -67.55 -42.5 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.913 0.864 . . . . 73.3 109.757 172.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 80' ' ' GLN . 44.3 mt -86.99 -15.98 37.13 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.272 -1.331 . . . . 71.13 112.25 -173.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -69.36 -41.31 17.15 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-O 118.054 -0.974 . . . . 74.33 113.418 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.78 -35.28 80.02 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 121.81 1.673 . . . . 71.05 112.007 171.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.467 ' CE1' ' HD3' ' C' ' 111' ' ' ARG . 41.6 m-85 -77.0 -29.68 55.57 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.641 0.776 . . . . 72.51 112.213 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -72.36 -47.02 52.8 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.786 -0.82 . . . . 74.11 108.786 176.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.0 ttm180 -49.51 -50.13 42.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 125.048 1.467 . . . . 53.15 110.561 173.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.66 -40.47 73.0 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.36 1.038 . . . . 73.14 111.596 -175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.582 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.5 t -62.83 -41.83 99.49 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 123.483 0.489 . . . . 54.1 110.598 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.3 mt -65.97 -51.01 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.259 -0.882 . . . . 65.22 109.658 174.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 47.1 m -55.36 -39.75 70.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.077 0.951 . . . . 74.22 111.259 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 42.1 t -66.73 -45.22 79.35 Favored 'General case' 0 C--O 1.217 -0.636 0 O-C-N 123.776 0.673 . . . . 73.15 110.342 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.65 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 34.1 mtm -63.13 -40.32 97.24 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.73 0.412 . . . . 70.21 111.146 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.7 t -61.1 -50.29 81.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.499 1.12 . . . . 72.35 110.149 177.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 94.8 p -70.98 -25.92 62.91 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.796 -0.638 . . . . 71.24 111.633 -177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 116' ' ' SER . 37.7 ttm-85 -79.04 -28.9 43.27 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.35 1.06 . . . . 74.55 109.461 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.21 9.77 56.38 Favored Glycine 0 C--N 1.356 1.672 0 CA-C-N 115.196 -0.911 . . . . 61.3 112.825 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.448 HG22 ' NH2' ' B' ' 15' ' ' ARG . 31.1 m 69.22 33.65 3.22 Favored 'General case' 0 C--N 1.363 1.168 0 CA-C-O 123.476 1.607 . . . . 60.22 111.122 173.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 119' ' ' SER . 75.7 m-85 -101.89 158.2 32.23 Favored Pre-proline 0 CA--C 1.551 1.002 0 CA-C-N 113.994 -1.457 . . . . 74.33 107.135 161.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.84 -174.1 0.56 Allowed 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 121.974 1.783 . . . . 72.25 112.004 170.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -76.01 141.59 42.09 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.893 0.477 . . . . 75.43 112.135 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -129.08 94.13 3.75 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 107.455 -1.313 . . . . 63.34 107.455 171.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.11 110.86 22.63 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.331 0.652 . . . . 74.21 110.242 175.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.4 mt -74.15 145.37 44.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.378 -0.828 . . . . 75.14 110.949 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.452 ' HB3' HG21 ' G' ' 187' ' ' ILE . . . -67.12 146.39 98.98 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.096 0.559 . . . . 73.43 111.396 -179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.48 141.0 45.12 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.284 1.989 . . . . 73.15 111.721 178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.23 108.74 22.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 N-CA-C 108.457 -0.942 . . . . 74.02 108.457 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -109.18 74.75 0.92 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.486 -0.779 . . . . 72.31 109.06 -178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -68.03 -27.73 66.79 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.667 -0.697 . . . . 71.24 110.641 177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.83 -33.53 75.43 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.011 0.434 . . . . 65.41 109.952 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.32 -49.82 31.5 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 115.265 -0.88 . . . . 71.32 110.673 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' H' ' 206' ' ' ASP . 9.4 tt -49.71 -45.56 49.16 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.991 0.916 . . . . 70.43 111.721 -177.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 93.3 t80 -57.17 -55.25 37.2 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 124.447 1.092 . . . . 72.22 111.137 -176.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -70.72 -37.38 73.5 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 123.562 0.539 . . . . 71.3 111.156 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -65.57 -33.92 77.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.377 0.671 . . . . 74.53 110.278 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -63.59 -42.76 98.25 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.62 0.768 . . . . 71.31 110.49 174.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 81.6 mt -62.26 -52.06 65.23 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 123.787 0.679 . . . . 52.04 110.875 -174.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 178.61 -5.71 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.909 0.756 . . . . 71.01 112.725 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.13 102.51 0.38 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.437 0.637 . . . . 72.34 110.14 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.789 ' HA ' ' HG2' ' C' ' 8' ' ' GLU . 0.6 OUTLIER -147.92 -43.41 0.16 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.236 1.415 . . . . 74.25 109.079 -175.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.83 77.8 10.01 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.46 -0.791 . . . . 50.15 111.402 -172.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.96 43.91 3.19 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.496 -1.042 . . . . 52.21 110.496 166.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -77.22 86.56 3.66 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.332 1.053 . . . . 75.13 110.523 -170.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.03 -39.21 4.93 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.704 -1.358 . . . . 61.55 109.704 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 65.6 m 71.47 107.08 0.06 Allowed 'General case' 0 C--N 1.364 1.206 0 C-N-CA 125.765 1.626 . . . . 70.11 111.159 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 77.85 59.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.911 1.285 . . . . 72.24 111.102 175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.74 108.44 19.69 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.808 -1.087 . . . . 74.45 109.316 174.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -169.11 167.03 10.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.84 0.856 . . . . 63.41 109.357 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 67.98 107.07 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.603 1.161 . . . . 75.04 109.516 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.81 -62.77 1.57 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.499 0.72 . . . . 55.41 109.992 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 124.035 0.934 . . . . 52.43 109.249 179.151 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 CA--C 1.543 0.707 0 N-CA-C 109.77 -0.455 . . . . 75.4 109.77 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -142.99 26.86 1.66 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.803 0.841 . . . . 55.55 110.312 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.9 131.62 50.33 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.587 0.755 . . . . 73.12 111.031 -178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -161.26 92.11 0.89 Allowed 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.946 0.898 . . . . 52.34 108.843 -177.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -79.31 -6.43 56.7 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.615 0.766 . . . . 74.04 110.796 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -60.29 135.82 57.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.676 1.19 . . . . 73.24 110.222 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -153.26 162.14 41.62 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.998 0.519 . . . . 41.5 110.811 -174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 68.22 -74.19 0.08 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.737 1.615 . . . . 44.55 111.668 -173.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.543 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 9.2 ptm 54.79 171.19 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.849 2.06 . . . . 71.34 113.659 -171.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -167.04 143.5 4.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 115.107 -0.951 . . . . 63.24 109.201 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -148.75 125.21 10.97 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.407 -1.331 . . . . 74.1 107.407 176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -144.96 140.76 28.45 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.312 -0.625 . . . . 71.52 109.312 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.531 HD11 HG13 ' B' ' 16' ' ' ILE . 10.8 tt -90.75 144.07 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.521 0.728 . . . . 72.42 109.459 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -111.66 -44.59 3.47 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.959 0.504 . . . . 74.4 109.772 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.448 ' NH2' HG22 ' A' ' 122' ' ' THR . 19.7 ttt180 -169.6 146.22 3.29 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.3 0.24 . . . . 74.51 110.76 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.531 HG13 HD11 ' B' ' 13' ' ' ILE . 94.2 mt -120.42 144.49 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.378 -1.342 . . . . 61.41 107.378 173.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -169.37 158.98 8.4 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 118.69 0.677 . . . . 74.13 112.176 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 85.8 m -83.54 127.67 33.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.191 -0.913 . . . . 53.55 108.835 171.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtpt -96.37 -36.62 10.79 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.666 0.786 . . . . 72.42 110.885 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -161.74 145.3 12.4 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.352 -0.385 . . . . 73.21 110.375 -171.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.411 HD11 ' SG ' ' B' ' 113' ' ' CYS . 37.3 mm -137.2 138.93 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.682 1.193 . . . . 72.5 109.8 -176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 74.0 m -134.81 125.52 27.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.144 1.378 . . . . 74.43 108.492 176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -142.78 108.2 5.04 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.54 -1.282 . . . . 75.11 107.54 167.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -119.2 122.99 43.24 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.232 1.013 . . . . 45.2 108.462 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.11 89.43 14.05 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.991 0.917 . . . . 61.2 109.278 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.3 -32.04 73.11 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.194 2.596 . . . . 72.21 113.136 -172.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -117.96 32.09 6.34 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.911 0.884 . . . . 34.42 110.122 -179.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.55 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -45.91 -54.76 15.16 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 125.646 1.578 . . . . 41.21 113.829 176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.2 Cg_exo -68.77 -24.36 34.63 Favored 'Trans proline' 0 C--N 1.388 2.621 0 C-N-CA 122.511 2.141 . . . . 74.32 112.881 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -89.19 1.79 55.15 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.777 -1.101 . . . . 63.52 111.786 -169.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.31 -23.88 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 122.927 0.491 . . . . 52.13 110.462 170.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -63.62 -38.85 92.69 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.543 0.737 . . . . 74.53 110.416 175.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -82.88 -41.75 18.58 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.927 0.891 . . . . 74.32 110.296 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -85.38 70.66 10.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.686 1.194 . . . . 73.03 109.032 175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -82.53 74.58 9.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 122.263 1.03 . . . . 61.13 110.798 -174.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -167.08 154.07 8.7 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 107.235 -1.394 . . . . 75.3 107.235 175.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.739 ' HB3' ' HB3' ' F' ' 194' ' ' ALA . 0.0 OUTLIER -64.07 127.74 92.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.049 0.54 . . . . 73.34 110.226 175.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.69 151.79 81.72 Favored 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.257 1.972 . . . . 72.23 112.164 167.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 2.8 pt-20 -61.01 102.5 0.2 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-N 115.035 -0.984 . . . . 62.42 109.303 169.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.0 t -88.46 116.51 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 107.896 -1.15 . . . . 72.11 107.896 -177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -138.96 138.27 37.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.308 0.643 . . . . 72.32 109.275 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.553 HD23 HG13 ' F' ' 187' ' ' ILE . 0.8 OUTLIER -118.71 147.35 43.92 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.655 0.782 . . . . 74.15 110.14 -168.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -131.26 149.5 52.54 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.214 1.406 . . . . 75.4 108.054 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -126.67 135.41 51.13 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.437 -0.579 . . . . 65.42 109.437 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -136.57 154.19 50.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.158 1.383 . . . . 65.41 108.363 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -132.03 139.94 48.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.986 0.514 . . . . 65.25 110.508 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.7 160.8 37.0 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.557 1.543 . . . . 74.24 108.551 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 60.1 m -142.32 162.85 34.43 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.082 0.553 . . . . 72.25 110.588 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -153.35 168.2 26.84 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.821 1.248 . . . . 74.25 108.526 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -123.3 130.73 53.14 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.262 0.625 . . . . 63.01 111.134 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 65.7 mt -97.81 -49.86 4.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.469 0.708 . . . . 70.33 110.183 173.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.51 -170.89 3.67 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.501 -0.772 . . . . 71.02 110.387 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -65.71 116.19 6.66 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.702 -1.136 . . . . 73.33 109.704 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.809 ' H ' HD21 ' F' ' 173' ' ' LEU . 1.9 m-20 72.62 2.78 4.48 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.817 1.647 . . . . 65.04 111.605 177.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.2 t -106.27 95.51 3.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 124.291 1.036 . . . . 64.51 108.33 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.467 ' HB2' HD12 ' B' ' 86' ' ' ILE . 0.1 OUTLIER -94.58 139.02 31.74 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.842 177.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.45 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 4.2 tm-20 -103.65 95.99 6.41 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 106.622 -1.622 . . . . 64.43 106.622 172.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -90.29 123.1 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 109.267 -0.642 . . . . 65.42 109.267 -176.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.6 t -102.31 123.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 123.568 0.747 . . . . 73.03 109.482 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.43 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -93.13 126.67 38.35 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.259 -1.386 . . . . 52.51 107.259 173.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.409 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 29.3 ttt180 -119.41 104.36 10.28 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.19 -0.67 . . . . 74.11 109.19 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.9 t -105.5 120.14 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 N-CA-C 108.571 -0.9 . . . . 61.31 108.571 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 1.3 m -109.39 150.5 27.97 Favored 'General case' 0 C--O 1.218 -0.568 0 N-CA-C 109.065 -0.717 . . . . 63.02 109.065 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.555 HG21 HG21 ' B' ' 114' ' ' ILE . 90.3 t -139.32 122.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 123.865 0.866 . . . . 73.31 109.279 -171.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 79.8 m -113.76 138.78 49.78 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.638 0.775 . . . . 73.5 109.27 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.3 147.03 28.85 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.887 -1.052 . . . . 70.1 109.071 -177.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 9.2 m -143.77 135.27 26.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.497 0.554 . . . . 61.35 112.497 -175.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 50.0 mt -88.47 101.39 13.87 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.69 -1.596 . . . . 62.22 106.69 173.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.92 -111.25 3.22 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.053 -0.819 . . . . 52.23 111.053 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -117.85 4.88 12.18 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.319 1.048 . . . . 72.0 110.734 177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -114.75 139.07 50.0 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.578 1.151 . . . . 75.54 108.098 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 51.5 m -61.98 133.49 55.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.11 0.564 . . . . 71.53 112.141 -173.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.525 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.95 -61.19 1.78 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.5 1.12 . . . . 74.01 109.176 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.02 167.1 28.7 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 113.456 -1.702 . . . . 71.04 109.618 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.69 118.86 11.35 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.661 1.585 . . . . 72.43 106.726 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -119.4 153.42 35.23 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.436 -0.579 . . . . 72.34 109.436 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -160.23 134.85 7.6 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.161 -1.052 . . . . 52.43 108.161 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.6 t -123.39 143.02 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 C-N-CA 123.604 0.762 . . . . 72.22 109.738 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.4 mt-30 -118.15 90.93 3.44 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.653 -0.869 . . . . 70.13 108.653 171.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.446 ' O ' HD13 ' B' ' 106' ' ' LEU . 8.8 tp-100 -89.88 100.8 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.339 -0.985 . . . . 72.24 108.339 175.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.68 163.69 29.85 Favored Glycine 0 C--O 1.242 0.643 0 N-CA-C 111.75 -0.54 . . . . 71.22 111.75 177.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.97 130.8 2.84 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.597 -0.601 . . . . 30.22 111.597 -177.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 42.7 mt -86.39 116.31 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.725 0.81 . . . . 74.11 109.195 176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -133.87 134.59 42.9 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.212 1.005 . . . . 73.2 109.183 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 41.8 m -95.34 110.86 22.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.768 0.827 . . . . 61.4 110.028 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' B' ' 56' ' ' TYR . 0.2 OUTLIER -118.69 138.75 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.146 0.978 . . . . 71.14 110.606 -177.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.98 167.64 27.47 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.598 0.759 . . . . 44.13 109.744 167.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.25 -41.65 3.01 Favored Glycine 0 N--CA 1.478 1.475 0 O-C-N 123.549 0.53 . . . . 51.21 113.045 176.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.409 ' H ' HG13 ' B' ' 89' ' ' ILE . 2.2 pp -63.42 156.14 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.308 1.043 . . . . 74.52 110.872 169.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.06 154.98 7.87 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.146 0.578 . . . . 72.1 109.732 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.59 ' HA2' HD22 ' F' ' 176' ' ' ASN . . . 64.75 -113.33 5.77 Favored Glycine 0 C--N 1.349 1.27 0 C-N-CA 123.25 0.452 . . . . 75.42 113.444 170.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -70.41 -36.94 74.34 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.599 0.76 . . . . 70.42 110.643 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -63.48 -46.39 86.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.782 0.433 . . . . 61.32 110.731 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 21.5 ttt -68.47 -40.87 80.82 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.017 -0.538 . . . . 61.54 110.326 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.55 -30.65 70.34 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.324 0.649 . . . . 64.3 111.434 178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -74.11 -36.33 64.2 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.585 0.754 . . . . 72.11 109.513 175.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.06 -68.53 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.791 -0.64 . . . . 61.23 110.446 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.76 -20.32 61.9 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.138 0.421 . . . . 72.42 112.138 -175.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.46 -6.7 52.78 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-O 119.144 -0.809 . . . . 72.11 114.528 -174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.62 -42.54 0.14 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.255 1.028 . . . . 50.53 112.716 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -79.9 -53.04 7.13 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.932 0.333 . . . . 74.04 111.538 -174.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.405 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 61.7 m -57.69 -45.56 99.82 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.648 0.779 . . . . 62.12 110.991 174.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 79.9 Cg_exo -50.14 -46.93 26.03 Favored 'Trans proline' 0 C--N 1.4 3.288 0 C-N-CA 122.512 2.142 . . . . 74.13 113.582 164.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.4 -35.6 70.24 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 123.624 0.769 . . . . 74.2 112.098 -177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.459 HG23 ' NH2' ' D' ' 111' ' ' ARG . 82.6 mt -65.13 -49.11 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.637 0.775 . . . . 65.43 110.332 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.446 HD13 ' O ' ' B' ' 80' ' ' GLN . 50.8 mt -78.92 -12.65 60.04 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 114.684 -1.144 . . . . 73.21 111.966 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.432 ' HZ ' HD12 ' B' ' 128' ' ' LEU . 22.1 t80 -67.77 -46.11 44.59 Favored Pre-proline 0 N--CA 1.478 0.947 0 C-N-CA 125.06 1.344 . . . . 70.11 113.451 -166.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -62.47 -33.67 78.34 Favored 'Trans proline' 0 C--N 1.384 2.427 0 C-N-CA 121.554 1.503 . . . . 70.1 112.203 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -65.8 -45.2 83.23 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.088 0.555 . . . . 64.13 110.531 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.5 -38.79 77.79 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.318 0.647 . . . . 71.23 110.912 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.0 mtp180 -57.57 -53.41 58.51 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.04 0.936 . . . . 72.02 110.275 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.433 ' HG3' ' NH2' ' C' ' 120' ' ' ARG . 1.7 tm-20 -68.0 -29.79 68.89 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.046 0.842 . . . . 53.32 110.387 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.489 ' O ' ' HG2' ' B' ' 117' ' ' MET . 33.7 t -68.22 -45.63 72.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.158 0.583 . . . . 64.12 111.182 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.555 HG21 HG21 ' B' ' 64' ' ' VAL . 95.0 mt -63.11 -44.25 99.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 64.13 109.847 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.639 ' HA ' ' HG2' ' B' ' 125' ' ' GLN . 32.6 m -66.34 -23.29 66.33 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.829 -1.078 . . . . 74.43 111.534 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.2 t -75.59 -40.87 55.9 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.503 0.721 . . . . 72.1 110.627 170.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.4 mmt -79.29 -38.46 35.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 112.849 0.685 . . . . 74.3 112.849 -172.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.798 ' HB ' ' HG3' ' B' ' 125' ' ' GLN . 95.5 t -75.62 -27.14 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.326 0.65 . . . . 52.12 110.77 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.451 ' HB3' HG21 ' C' ' 115' ' ' THR . 91.9 p -66.72 -37.67 85.14 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.027 0.441 . . . . 63.33 110.248 174.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.582 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 60.5 mtt-85 -63.57 -40.3 96.62 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.147 -0.933 . . . . 65.41 110.508 175.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -73.84 -10.94 80.93 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.716 0.635 . . . . 45.43 113.199 173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p 62.38 33.45 16.32 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 126.548 1.939 . . . . 61.33 112.874 174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.37 -177.17 0.58 Allowed Pre-proline 0 CA--C 1.568 1.635 0 CA-C-N 114.284 -1.325 . . . . 70.14 109.024 172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.542 ' HB2' HG21 ' B' ' 40' ' ' VAL . 3.9 Cg_exo -81.87 116.72 2.86 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.853 2.369 . . . . 73.15 112.964 169.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.798 ' HG3' ' HB ' ' B' ' 118' ' ' VAL . 0.5 OUTLIER -72.02 164.01 26.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.908 0.883 . . . . 71.22 111.324 164.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.436 ' HB3' HD21 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -137.26 127.16 25.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.205 -1.035 . . . . 62.3 108.205 -178.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -91.71 102.81 15.43 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.816 -1.179 . . . . 73.31 107.816 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.752 HD11 HD22 ' F' ' 186' ' ' LEU . 0.3 OUTLIER -66.08 139.34 58.17 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 110.361 -0.237 . . . . 54.55 110.361 -170.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.66 148.23 98.04 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 123.768 0.827 . . . . 70.2 111.118 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.405 ' HG3' ' HB ' ' D' ' 16' ' ' ILE . 93.4 Cg_endo -74.33 97.07 1.0 Allowed 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.22 1.946 . . . . 65.25 111.239 177.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.91 110.95 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 N-CA-C 109.263 -0.643 . . . . 71.54 109.263 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -72.68 97.07 2.1 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.23 0.612 . . . . 74.01 109.452 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -70.82 -13.46 62.05 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.636 0.774 . . . . 70.43 112.17 -175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -76.31 -66.13 0.84 Allowed 'General case' 0 C--O 1.243 0.732 0 C-N-CA 123.882 0.873 . . . . 33.32 111.287 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.65 -11.43 59.87 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.146 0.579 . . . . 61.3 111.673 -175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' F' ' 184' ' ' TRP . 10.5 tt -48.15 -55.27 10.74 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.74 1.216 . . . . 74.24 110.718 176.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -59.21 -41.61 89.01 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.889 0.876 . . . . 73.41 110.667 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.95 -36.18 82.63 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 123.486 0.714 . . . . 71.54 110.651 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -73.79 -32.47 63.78 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 122.991 0.517 . . . . 63.02 110.522 -178.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -67.34 -32.87 74.12 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.978 0.511 . . . . 72.3 110.837 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.83 5.39 28.93 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.689 0.796 . . . . 73.03 111.402 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -118.76 -179.23 3.74 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.29 1.036 . . . . 74.32 110.109 173.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.01 99.96 3.56 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 108.152 -1.055 . . . . 54.4 108.152 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -77.42 115.39 17.15 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.018 0.927 . . . . 74.31 110.306 -178.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.12 156.62 22.19 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.465 1.106 . . . . 72.02 109.449 179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 177.16 -33.13 0.08 OUTLIER Glycine 0 C--N 1.353 1.482 0 CA-C-O 119.595 -0.558 . . . . 42.12 114.011 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 72.7 160.01 0.22 Allowed 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 125.025 1.33 . . . . 73.34 111.384 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.9 -177.87 41.11 Favored Glycine 0 N--CA 1.473 1.13 0 CA-C-N 115.999 -0.546 . . . . 73.23 112.206 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.9 m 60.9 82.78 0.16 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.446 1.098 . . . . 75.23 110.815 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.15 -45.55 5.87 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.275 1.03 . . . . 74.23 110.581 -178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.76 93.04 0.03 OUTLIER 'General case' 0 C--N 1.358 0.955 0 O-C-N 124.3 1.0 . . . . 74.02 111.533 -168.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -83.01 90.54 7.03 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.617 -1.623 . . . . 71.53 106.617 167.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -68.32 119.78 13.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.403 -0.591 . . . . 72.54 109.403 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -69.04 154.87 41.34 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.566 -0.743 . . . . 63.12 109.898 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.866 0 C-N-CA 123.604 0.761 . . . . 72.43 109.07 -179.643 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.473 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.476 0.855 0 N-CA-C 108.929 -0.767 . . . . 75.41 108.929 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 41.4 m -85.9 -64.42 1.16 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.629 0.372 . . . . 64.4 110.767 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 57.82 -80.72 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.209 1.403 . . . . 73.21 111.623 -175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -160.69 -81.38 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 109.012 -0.736 . . . . 74.12 109.012 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -173.04 93.04 0.1 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.531 -0.915 . . . . 72.41 108.531 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -71.15 -25.1 62.41 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.615 0.766 . . . . 62.0 112.039 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -90.95 -146.92 0.2 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.874 1.27 . . . . 61.03 109.833 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.789 ' HG2' ' HA ' ' A' ' 144' ' ' GLN . 15.8 tp10 -150.54 152.42 34.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 118.913 0.779 . . . . 64.25 110.691 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 64.56 111.65 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.772 1.629 . . . . 64.32 109.529 -173.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 75.2 m -107.85 97.22 6.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.012 -0.54 . . . . 75.31 109.596 -174.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.532 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 48.4 t80 -92.84 119.76 32.5 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.676 -1.231 . . . . 72.41 107.676 169.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -137.1 117.95 14.15 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 109.255 -0.646 . . . . 73.31 109.255 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.412 HD11 HG13 ' C' ' 16' ' ' ILE . 6.5 tp -70.53 131.44 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 109.437 -0.579 . . . . 72.41 109.437 173.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.501 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.9 mm-40 -96.15 -48.69 5.55 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.37 -0.832 . . . . 74.24 108.989 175.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.467 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 61.9 ttt180 -176.37 133.95 0.24 Allowed 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 115.387 -0.824 . . . . 72.03 109.787 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.412 HG13 HD11 ' C' ' 13' ' ' ILE . 80.9 mt -108.64 150.32 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.767 -1.197 . . . . 75.32 107.767 170.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.516 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 28.9 p90 -179.62 154.29 0.6 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.74 . . . . 74.2 109.471 -178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.437 HG21 HD11 ' C' ' 21' ' ' ILE . 75.2 p -74.87 118.4 17.79 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.763 -0.828 . . . . 52.24 108.763 173.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.59 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -69.92 -43.3 71.96 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 108.315 -0.994 . . . . 61.25 108.315 176.085 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 14.6 t70 -154.02 138.89 17.15 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.425 -1.716 . . . . 75.04 108.928 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.437 HD11 HG21 ' C' ' 18' ' ' THR . 97.8 mt -129.3 145.72 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.714 -1.217 . . . . 64.11 107.714 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -153.23 150.06 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.527 0.679 . . . . 70.32 110.0 173.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -143.91 127.19 16.71 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 106.815 -1.55 . . . . 73.4 106.815 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 48.5 mt-10 -116.47 125.12 51.52 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 109.118 -0.697 . . . . 61.43 109.118 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.68 74.91 38.27 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.626 1.17 . . . . 74.12 108.189 171.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -65.98 -28.57 49.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.306 2.004 . . . . 74.45 110.452 170.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.427 ' HA ' ' HB3' ' C' ' 30' ' ' HIS . 93.1 m-20 -97.9 24.83 6.51 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 114.768 -1.106 . . . . 74.41 111.094 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HA ' ' HZ ' ' C' ' 123' ' ' PHE . . . -57.09 -48.28 97.68 Favored Pre-proline 0 CA--C 1.568 1.648 0 C-N-CA 123.454 0.701 . . . . 64.2 111.74 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' C' ' 32' ' ' PHE . 56.4 Cg_endo -86.82 -25.46 1.16 Allowed 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 122.164 1.909 . . . . 75.41 113.27 168.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.427 ' HB3' ' HA ' ' C' ' 27' ' ' ASN . 83.0 t60 -70.01 -23.39 63.12 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.64 0.776 . . . . 74.43 112.627 -173.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.616 HG11 ' HE1' ' C' ' 123' ' ' PHE . 9.9 p -78.03 1.3 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.944 0 C-N-CA 124.278 1.031 . . . . 74.04 112.189 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.443 ' HB2' ' O ' ' C' ' 29' ' ' PRO . 36.5 t80 -49.34 -43.45 43.82 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 125.72 1.608 . . . . 72.14 113.913 -171.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -128.65 48.81 2.27 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.364 -0.976 . . . . 72.31 108.364 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.89 155.31 19.46 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.834 -0.621 . . . . 75.52 109.63 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.27 118.39 12.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.639 0.776 . . . . 73.22 109.97 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -78.48 94.57 4.97 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.72 0.808 . . . . 74.03 110.755 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -144.33 54.06 2.55 Favored Pre-proline 0 CA--C 1.559 1.316 0 CA-C-N 114.986 -1.006 . . . . 64.22 110.082 171.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.32 97.88 0.17 Allowed 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 122.09 1.86 . . . . 73.44 111.715 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.636 ' HG2' ' HA ' ' E' ' 190' ' ' ASP . 2.4 tm-20 -84.24 108.83 17.33 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 106.401 -1.703 . . . . 75.43 106.401 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.68 HG11 ' HG ' ' C' ' 126' ' ' LEU . 46.4 t -94.02 102.64 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 113.897 -1.501 . . . . 63.15 110.218 -166.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.87 112.52 24.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.3 0.64 . . . . 70.31 110.442 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.704 HD11 HD12 ' C' ' 128' ' ' LEU . 7.0 mp -91.24 141.01 29.25 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.733 -0.84 . . . . 74.53 108.733 172.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -143.18 138.48 29.76 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.899 0.88 . . . . 63.25 109.476 178.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.504 ' HB3' HD11 ' E' ' 186' ' ' LEU . 0.0 OUTLIER -109.79 127.23 54.52 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.321 -0.622 . . . . 63.43 109.321 177.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -122.73 145.36 48.47 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.353 1.461 . . . . 74.04 108.276 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 8.2 t -123.67 139.45 53.98 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.275 0.559 . . . . 72.33 109.66 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.47 147.61 34.82 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.997 1.319 . . . . 75.31 107.682 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -145.75 155.43 42.95 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.937 0.398 . . . . 74.51 111.346 -175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.0 m -142.62 136.42 29.13 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.266 1.027 . . . . 60.2 108.527 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -84.66 116.76 23.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 108.554 -0.906 . . . . 71.45 108.554 171.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.581 HD11 HD12 ' C' ' 83' ' ' ILE . 76.4 mt -91.0 -34.4 15.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.752 -0.658 . . . . 72.01 109.579 177.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.75 -174.19 2.67 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.101 -0.954 . . . . 52.32 110.004 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.25 122.49 22.04 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.38 -0.827 . . . . 45.33 109.256 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 65.4 11.4 7.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.09 1.356 . . . . 74.3 112.406 -176.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -119.23 110.67 30.4 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 N-CA-C 108.18 -1.044 . . . . 70.33 108.18 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -127.03 129.82 48.8 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 115.631 -0.713 . . . . 75.22 109.623 -177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -82.27 109.92 16.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 114.241 -1.345 . . . . 73.23 108.462 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 64.8 t -97.68 114.7 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.102 -1.073 . . . . 73.21 108.102 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.5 t -109.8 105.34 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 108.676 -0.861 . . . . 63.12 108.676 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -96.7 104.4 16.39 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.754 -1.202 . . . . 65.31 107.754 174.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -85.8 116.48 24.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.627 0.771 . . . . 74.33 109.957 175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.8 t -101.54 127.92 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.71 -1.218 . . . . 64.25 107.71 168.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.8 m -124.61 124.23 41.77 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.087 -0.709 . . . . 71.42 109.087 -178.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.544 HG22 ' HG ' ' C' ' 42' ' ' LEU . 38.3 t -110.58 131.6 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 72.23 109.447 177.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 25.9 m -116.52 149.69 39.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.233 -1.395 . . . . 65.3 107.233 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.52 130.94 41.05 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.768 -1.197 . . . . 75.04 107.768 172.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 39.6 m -133.54 161.64 34.05 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.485 0.66 . . . . 42.4 110.693 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 35.2 mt -128.45 28.5 5.44 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.647 1.579 . . . . 75.54 108.016 -173.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.41 -113.85 2.62 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.349 -1.9 . . . . 75.3 108.349 -165.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.5 -27.12 19.42 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.204 0.601 . . . . 62.43 109.717 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -66.6 117.98 9.54 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 124.658 1.183 . . . . 72.55 110.214 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -79.17 126.43 30.73 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.523 -0.547 . . . . 71.23 109.523 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.03 -52.13 11.85 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.593 0.757 . . . . 54.52 109.011 176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.408 ' HZ ' HD21 ' C' ' 126' ' ' LEU . 43.1 p90 -164.18 172.68 13.33 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.535 -1.211 . . . . 64.14 110.129 174.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -137.72 145.13 42.14 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 106.754 -1.573 . . . . 74.4 106.754 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.469 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.6 t -144.18 144.54 31.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.572 -0.899 . . . . 74.53 108.572 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.05 125.68 9.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.404 -0.591 . . . . 75.21 109.404 -175.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' C' ' 110' ' ' ALA . 75.0 t -126.66 114.66 38.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.263 1.025 . . . . 72.52 108.424 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -96.81 87.51 4.32 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.62 -0.881 . . . . 52.41 108.62 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -85.14 119.81 25.95 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 115.075 -0.966 . . . . 42.51 109.542 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.59 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -114.05 153.77 17.38 Favored Glycine 0 C--N 1.334 0.449 0 O-C-N 123.453 0.471 . . . . 62.54 112.507 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.31 130.98 3.74 Favored Glycine 0 CA--C 1.503 -0.691 0 N-CA-C 109.969 -1.252 . . . . 63.41 109.969 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.581 HD12 HD11 ' C' ' 51' ' ' LEU . 18.6 mm -88.56 119.01 35.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.764 -1.199 . . . . 71.35 107.764 176.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.58 122.88 39.3 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.39 -0.967 . . . . 71.14 108.39 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 17.8 t -90.19 100.4 13.24 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.886 -1.524 . . . . 73.2 106.886 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.57 HD13 ' H ' ' C' ' 86' ' ' ILE . 0.2 OUTLIER -122.72 133.45 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.697 0.799 . . . . 72.34 110.818 -171.057 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.33 177.39 11.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.547 -0.751 . . . . 72.54 110.921 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.08 -63.69 2.07 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.641 -0.709 . . . . 32.53 112.731 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.611 HD11 ' SD ' ' E' ' 174' ' ' MET . 3.0 mp 61.67 123.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 125.161 1.384 . . . . 65.11 112.787 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -162.88 156.76 20.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.253 0.834 . . . . 62.31 113.253 172.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.06 -135.93 48.61 Favored Glycine 0 C--N 1.354 1.561 0 CA-C-N 114.31 -1.314 . . . . 55.31 113.766 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 33.8 p -78.07 -17.82 56.53 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.172 0.989 . . . . 62.13 111.366 176.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -58.69 -31.96 68.71 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.569 0.748 . . . . 65.14 111.944 -178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 11.6 tpt -45.77 -54.13 8.45 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 112.941 0.719 . . . . 43.25 112.941 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.26 -34.32 18.98 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.622 0.369 . . . . 53.52 111.378 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -74.6 -20.05 60.07 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.127 0.788 . . . . 72.21 113.127 -173.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.3 t -68.02 -62.19 1.52 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 118.136 0.425 . . . . 73.35 110.696 -174.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.471 ' H ' HD23 ' C' ' 98' ' ' LEU . 2.7 pt? -79.89 -20.3 46.14 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.239 -0.437 . . . . 54.43 111.294 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.67 -30.22 30.25 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 114.369 0.507 . . . . 54.34 114.369 -174.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.2 -35.29 0.18 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 113.223 0.823 . . . . 52.23 113.223 -173.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -73.38 -56.83 4.54 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.17 0.588 . . . . 73.11 111.169 -169.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.532 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 36.9 m -61.63 -46.36 93.61 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 123.73 0.812 . . . . 61.33 111.226 176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 84.2 Cg_exo -53.44 -34.39 71.45 Favored 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 122.798 2.332 . . . . 60.43 114.61 167.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -68.6 -30.36 69.08 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 123.821 0.849 . . . . 62.15 111.365 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.427 HG23 ' NH1' ' A' ' 111' ' ' ARG . 46.2 mm -68.05 -29.88 46.2 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.135 0 C-N-CA 123.199 0.6 . . . . 44.12 110.206 176.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.9 mt -93.05 -29.71 15.67 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.304 1.042 . . . . 63.43 112.567 -173.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -56.96 -38.32 67.38 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 117.79 -1.1 . . . . 52.34 113.956 -175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -53.17 -50.9 12.37 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 123.079 2.519 . . . . 75.01 113.897 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -62.05 -36.7 82.4 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.989 -1.005 . . . . 75.45 110.873 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.483 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -76.44 -40.0 51.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.459 -0.791 . . . . 54.2 111.2 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' CE1' ' A' ' 109' ' ' TYR . 29.1 ttt180 -58.15 -36.95 73.75 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 123.782 0.833 . . . . 74.22 111.142 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -44.96 25.18 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.197 0.599 . . . . 53.1 110.872 175.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.8 t -65.05 -30.17 71.11 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 123.325 0.65 . . . . 61.31 112.597 -172.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.53 HD13 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -67.33 -49.91 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.339 0.655 . . . . 52.53 109.98 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.46 HG23 ' HB2' ' C' ' 125' ' ' GLN . 90.5 m -54.0 -42.74 69.36 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 124.253 0.971 . . . . 61.11 110.951 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 39.6 t -62.34 -49.26 76.3 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.168 -1.378 . . . . 65.23 110.754 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.554 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -63.19 -39.49 94.8 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.883 0.873 . . . . 72.32 112.373 -177.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -65.03 -41.85 93.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.152 0.581 . . . . 60.35 110.886 176.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.441 ' CB ' HG21 ' B' ' 115' ' ' THR . 28.2 t -59.8 -35.74 75.3 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.439 -1.255 . . . . 73.53 111.851 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.554 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 73.6 mtt-85 -68.91 -38.6 79.67 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.313 -0.858 . . . . 72.44 110.895 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.22 4.66 66.25 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.699 -0.682 . . . . 75.25 112.85 173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.0 p 60.51 38.31 19.11 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 125.829 1.652 . . . . 63.44 112.207 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.616 ' HE1' HG11 ' C' ' 31' ' ' VAL . 43.9 m-85 -106.57 163.53 16.79 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.206 -1.361 . . . . 60.25 109.821 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.475 ' HD3' ' HE2' ' E' ' 195' ' ' PHE . 31.7 Cg_endo -61.34 104.45 0.3 Allowed 'Trans proline' 0 C--N 1.387 2.579 0 C-N-CA 122.263 1.975 . . . . 75.34 111.181 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.792 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -56.07 150.77 13.25 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.237 1.415 . . . . 74.24 112.746 -177.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.68 ' HG ' HG11 ' C' ' 40' ' ' VAL . 1.9 mm? -129.45 99.87 5.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.807 0.443 . . . . 74.24 110.737 -177.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -109.32 84.63 1.96 Allowed 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.37 -1.715 . . . . 71.32 106.37 161.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.704 HD12 HD11 ' C' ' 42' ' ' LEU . 55.4 mt -90.02 156.68 18.24 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.337 -1.301 . . . . 53.52 111.848 -172.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.522 ' HB2' ' HA ' ' F' ' 204' ' ' ILE . . . -34.62 121.98 0.55 Allowed Pre-proline 0 CA--C 1.558 1.253 0 C-N-CA 126.218 1.807 . . . . 54.3 113.65 178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HG3' HD12 ' A' ' 16' ' ' ILE . 74.4 Cg_endo -71.29 110.24 2.79 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.73 2.287 . . . . 63.42 111.559 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' E' ' 186' ' ' LEU . 86.0 t -76.0 94.32 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 108.94 -0.763 . . . . 71.4 108.94 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -71.56 104.67 3.37 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -55.9 -45.41 78.65 Favored 'General case' 0 CA--C 1.549 0.934 0 O-C-N 125.075 1.484 . . . . 74.01 112.761 -170.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -84.76 -29.87 25.13 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.302 -0.408 . . . . 65.33 111.73 -174.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.15 73.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.057 0.143 . . . . 64.21 111.041 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.06 -46.11 90.57 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 122.986 0.514 . . . . 71.44 110.534 175.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -63.6 -39.78 95.26 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.623 0.769 . . . . 73.24 111.391 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt -66.09 -47.6 73.7 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.452 1.101 . . . . 72.41 111.377 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -72.35 -41.77 66.07 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.374 0.67 . . . . 73.02 111.085 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -73.07 -155.04 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.603 0 CA-C-N 115.803 -0.635 . . . . 75.42 109.727 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 18.1 tp 61.72 9.88 3.1 Favored 'General case' 0 CA--C 1.565 1.532 0 C-N-CA 124.662 1.185 . . . . 52.52 111.529 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -172.51 158.69 4.29 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.949 1.3 . . . . 74.03 108.716 -172.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -141.78 74.9 1.47 Allowed 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 122.922 0.489 . . . . 70.21 109.908 -177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -124.16 151.26 44.21 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.715 0.806 . . . . 74.41 109.106 168.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.42 148.23 16.3 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.817 0.847 . . . . 71.42 109.92 174.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.44 ' H ' ' H ' ' A' ' 6' ' ' ASN . . . -96.0 -126.44 5.06 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.636 -0.711 . . . . 75.42 113.273 -172.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -149.04 -23.42 0.3 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.967 0.728 . . . . 74.3 112.967 -158.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.09 -123.72 7.36 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-O 119.995 -0.336 . . . . 74.15 113.184 -175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.3 m 68.34 101.33 0.05 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.04 1.736 . . . . 63.44 111.214 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 29.9 mt-10 -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.584 1.153 . . . . 73.11 112.574 -170.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -168.84 143.9 3.28 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.479 1.112 . . . . 71.42 108.921 172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.592 ' HA ' ' HB3' ' G' ' 175' ' ' PHE . 4.5 p-80 -154.63 122.28 5.79 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.972 0.909 . . . . 74.0 109.738 -176.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 26.1 tp60 -83.79 -39.23 20.27 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.082 0.553 . . . . 74.24 110.071 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 72.41 164.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.165 1.386 . . . . 54.43 112.741 178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.241 0 C-N-CA 124.339 1.056 . . . . 53.41 109.289 -173.908 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.649 ' HG2' HD21 ' E' ' 199' ' ' ASN . 64.7 mtm . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 110.071 -0.344 . . . . 61.51 110.071 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.6 p -157.7 137.71 12.46 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.749 0.419 . . . . 74.33 111.017 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.66 126.61 30.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.702 0.801 . . . . 53.31 109.023 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.403 ' NE2' ' HB1' ' D' ' 52' ' ' ALA . 46.2 mt-30 -76.83 98.59 4.89 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.812 0.845 . . . . 74.12 110.606 -171.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -178.64 167.48 1.76 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.753 1.621 . . . . 54.34 106.844 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -73.45 74.58 1.42 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.661 1.22 . . . . 75.24 108.682 168.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 16.6 m -84.15 169.76 14.5 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 113.773 -1.558 . . . . 23.42 109.303 -175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -60.38 135.25 57.68 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 119.075 -0.488 . . . . 73.34 109.883 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.427 ' HG3' HG22 ' D' ' 89' ' ' ILE . 3.2 ttp -29.4 122.99 0.15 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 125.603 1.814 . . . . 62.1 114.059 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m -134.46 142.61 47.15 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.007 0.432 . . . . 45.42 109.946 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -145.97 94.5 2.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 106.431 -1.692 . . . . 74.01 106.431 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -129.47 139.45 51.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.306 0.642 . . . . 71.34 109.468 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tp -93.48 142.81 12.71 Favored 'Isoleucine or valine' 0 C--O 1.245 0.819 0 C-N-CA 123.152 0.581 . . . . 71.01 109.738 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 56.9 mt-30 -103.36 -43.93 5.29 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.15 0.58 . . . . 70.23 110.683 175.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.542 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 55.6 ttt180 -170.13 148.72 3.4 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 111.784 0.29 . . . . 73.25 111.784 -169.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.405 ' HB ' ' HG3' ' B' ' 130' ' ' PRO . 1.1 mp -120.68 144.2 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 106.205 -1.776 . . . . 74.02 106.205 172.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.542 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 16.3 p90 -165.9 151.07 8.6 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.478 0.656 . . . . 75.43 111.226 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -86.95 113.05 22.39 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.033 -0.985 . . . . 50.22 109.082 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -81.06 -28.84 35.17 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.978 -0.555 . . . . 71.04 110.289 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.611 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -151.82 136.44 17.0 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.788 -1.096 . . . . 71.22 109.131 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' C' ' 117' ' ' MET . 96.7 mt -130.81 138.3 53.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.694 -1.224 . . . . 62.14 107.694 173.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -141.59 137.11 31.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.138 0.975 . . . . 73.2 109.053 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.44 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 83.2 t80 -145.52 114.23 6.82 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 106.263 -1.755 . . . . 60.13 106.263 170.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 38.3 mt-10 -122.26 111.09 16.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.228 0.611 . . . . 75.44 109.707 -177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.91 88.99 5.97 Favored Pre-proline 0 CA--C 1.553 1.063 0 N-CA-C 108.331 -0.989 . . . . 74.41 108.331 174.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.48 -33.94 1.64 Allowed 'Trans proline' 0 C--N 1.386 2.529 0 C-N-CA 122.634 2.223 . . . . 71.52 113.295 -173.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -101.26 28.25 5.55 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.944 0.897 . . . . 73.5 109.317 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -51.58 -55.22 31.43 Favored Pre-proline 0 CA--C 1.574 1.893 0 N-CA-C 116.149 1.907 . . . . 64.32 116.149 -165.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -80.2 -16.24 11.09 Favored 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 122.049 1.768 . . . . 73.25 113.43 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -72.64 -44.78 61.46 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.066 0.946 . . . . 65.35 109.81 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.706 HG21 ' HA ' ' D' ' 73' ' ' ALA . 5.3 p -82.93 -0.27 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.818 -172.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 80.2 t80 -57.82 -29.84 65.26 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.1 0.96 . . . . 74.12 111.098 164.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -78.95 4.36 14.46 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.705 0.802 . . . . 70.13 111.543 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -108.3 110.24 21.77 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.285 1.034 . . . . 62.13 108.717 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.587 ' HB2' ' HA ' ' H' ' 196' ' ' LYS . 5.3 p-10 -112.59 48.83 0.97 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.343 1.057 . . . . 74.24 111.793 -164.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 2.9 p-90 -154.29 -174.55 5.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.533 0.733 . . . . 73.22 110.403 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.418 ' HG2' ' HA3' ' H' ' 191' ' ' GLY . 60.1 tp60 -72.24 126.8 90.97 Favored Pre-proline 0 N--CA 1.481 1.118 0 C-N-CA 123.147 0.579 . . . . 64.14 110.893 -178.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HG2' ' D' ' 124' ' ' PRO . 17.4 Cg_exo -68.06 134.13 30.92 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.548 2.165 . . . . 64.22 111.898 171.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 38.1 mt-10 -60.14 115.08 3.21 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.218 0.949 . . . . 74.31 108.95 170.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.4 HG21 HD13 ' D' ' 126' ' ' LEU . 57.6 t -95.12 107.7 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.099 -1.075 . . . . 75.41 108.099 -176.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' D' ' 65' ' ' THR . 0.2 OUTLIER -88.07 119.23 28.24 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.569 -1.271 . . . . 61.5 107.569 171.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.19 141.86 29.05 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 108.448 -0.945 . . . . 62.33 108.448 179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.6 t70 -144.44 130.43 19.42 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.503 -0.925 . . . . 75.52 108.503 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.3 135.53 52.87 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.511 0.725 . . . . 61.43 109.958 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 25.0 t70 -144.67 156.96 44.36 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.505 1.122 . . . . 64.43 108.894 171.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -139.04 164.53 29.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 53.35 109.55 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.95 174.21 14.94 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.44 1.096 . . . . 73.52 108.594 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 95.8 p -164.14 157.57 18.25 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.006 0.432 . . . . 74.01 110.82 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.3 p -151.29 129.99 12.33 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 115.155 -0.93 . . . . 63.05 108.948 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -74.5 116.81 15.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.635 -0.505 . . . . 75.44 109.635 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' D' ' 57' ' ' GLU . 81.7 mt -92.64 -35.28 13.6 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.359 0.664 . . . . 74.43 109.709 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.99 -177.47 6.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.279 -0.873 . . . . 53.52 110.133 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -74.08 125.16 27.71 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.162 -1.051 . . . . 75.23 108.162 173.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 64.42 16.43 10.19 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.267 1.027 . . . . 75.31 112.271 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 65.2 t -136.72 127.19 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.569 1.147 . . . . 73.15 108.089 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.29 152.62 34.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.194 0.521 . . . . 74.22 110.102 175.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.6 tt0 -88.58 131.48 34.93 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.989 -1.005 . . . . 70.05 109.109 175.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -104.65 131.68 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 107.618 -1.253 . . . . 73.41 107.618 167.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 58.4 t -106.29 133.93 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.953 -0.758 . . . . 71.4 108.953 173.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.2 OUTLIER -104.58 125.34 50.63 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.645 -1.613 . . . . 64.12 106.645 172.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.9 ttm-85 -106.97 100.2 9.72 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.211 -1.033 . . . . 71.14 108.211 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -91.79 121.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 107.298 -1.371 . . . . 62.02 107.298 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.0 m -124.84 128.99 49.54 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.454 0.645 . . . . 64.42 109.965 -175.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.2 t -120.84 132.18 71.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 125.223 1.409 . . . . 75.11 109.171 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' D' ' 41' ' ' LYS . 89.0 m -128.65 98.75 5.11 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 107.649 -1.241 . . . . 74.44 107.649 172.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -96.13 141.95 28.9 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.869 -0.605 . . . . 62.31 109.599 -175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.7 p -143.14 129.13 19.59 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 123.41 0.443 . . . . 74.22 111.227 -177.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 16.4 mt -108.99 99.76 9.05 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.122 0.969 . . . . 73.13 108.751 177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.87 -132.05 10.81 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 123.476 0.485 . . . . 60.03 111.972 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.94 5.03 52.84 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.463 0.705 . . . . 73.22 111.569 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -123.68 167.46 13.96 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.626 0.77 . . . . 71.4 110.557 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 90.9 m -77.68 132.01 37.99 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.2 -0.909 . . . . 72.45 110.293 175.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.706 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.53 -65.8 0.97 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.815 0.846 . . . . 74.52 108.73 176.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -154.75 170.39 21.71 Favored 'General case' 0 C--N 1.346 0.416 0 CA-C-N 115.202 -0.908 . . . . 75.12 110.116 172.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 62.0 mt -128.12 153.46 46.83 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.42 -1.326 . . . . 73.44 107.42 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.508 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 46.0 t -158.58 144.1 16.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.841 0.456 . . . . 71.43 110.253 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.34 124.44 6.22 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.244 -0.65 . . . . 75.11 109.244 170.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.1 t -125.75 116.2 45.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 C-N-CA 123.47 0.708 . . . . 73.32 109.862 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.611 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.4 mt-30 -91.85 86.89 6.04 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.705 0.764 . . . . 74.14 109.809 174.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.421 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.1 tp-100 -80.72 98.36 7.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.112 1.365 . . . . 74.54 109.736 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.99 158.99 26.25 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 112.117 -0.393 . . . . 32.23 112.117 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.65 140.31 6.85 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.842 -0.503 . . . . 52.3 111.842 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.449 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.9 mt -91.55 120.89 41.4 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 123.518 0.727 . . . . 62.42 109.786 -176.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -118.77 126.42 51.83 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.998 0.919 . . . . 72.23 110.407 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 75.2 m -91.31 101.53 14.23 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.487 1.115 . . . . 63.45 109.541 171.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -131.87 141.76 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.072 0.549 . . . . 55.43 110.814 -177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.5 162.74 14.61 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.632 1.173 . . . . 73.22 109.129 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.0 22.79 77.52 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.356 0.41 . . . . 64.42 113.233 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' D' ' 94' ' ' MET . 0.1 OUTLIER -123.26 130.64 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 C-N-CA 124.097 0.959 . . . . 73.15 109.462 179.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.445 ' HA ' ' HB3' ' H' ' 172' ' ' ALA . 47.4 mt-10 -142.89 170.77 15.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.894 0.878 . . . . 74.45 110.357 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.15 -141.98 33.6 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 115.211 -0.904 . . . . 71.42 113.569 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' D' ' 95' ' ' ALA . 16.9 p -75.32 -16.06 60.44 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.716 0.807 . . . . 62.32 111.948 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -60.85 -48.29 82.5 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.345 0.658 . . . . 75.33 109.992 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.672 ' HG3' HD23 ' D' ' 98' ' ' LEU . 11.2 tpt -80.97 -41.16 23.26 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.38 -0.827 . . . . 72.43 110.726 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' D' ' 92' ' ' THR . . . -57.78 -39.92 78.6 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.205 0.602 . . . . 62.23 112.143 -177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 80.4 t60 -76.84 -27.07 54.99 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.625 0.77 . . . . 71.41 110.69 176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.455 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 37.3 t -75.33 -51.51 13.01 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.448 0.299 . . . . 73.51 111.273 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.672 HD23 ' HG3' ' D' ' 94' ' ' MET . 4.1 pp -67.38 -32.72 73.82 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.573 0.749 . . . . 74.41 112.217 -172.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.67 13.56 42.37 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.543 -0.587 . . . . 72.34 113.877 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -156.55 -59.86 0.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.35 0.575 . . . . 71.43 111.946 -178.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.455 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 70.3 t80 -73.69 -42.29 61.46 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 112.888 0.699 . . . . 64.25 112.888 -168.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.411 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 76.0 m -67.04 -44.8 51.56 Favored Pre-proline 0 CA--C 1.559 1.315 0 CA-C-O 118.92 -0.562 . . . . 51.24 111.18 177.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.5 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 78.3 Cg_exo -56.74 -32.62 91.86 Favored 'Trans proline' 0 C--N 1.392 2.844 0 C-N-CA 122.127 1.885 . . . . 65.21 113.663 165.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -64.18 -35.96 82.49 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.435 0.694 . . . . 75.44 111.272 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.87 -41.78 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 123.387 0.675 . . . . 62.51 110.208 173.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.421 HD13 ' O ' ' D' ' 80' ' ' GLN . 86.8 mt -75.06 -21.22 59.13 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.955 -1.021 . . . . 74.23 111.757 -175.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -64.9 -44.61 72.76 Favored Pre-proline 0 CA--C 1.562 1.427 0 N-CA-C 114.784 1.402 . . . . 61.24 114.784 -167.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.37 -39.53 86.89 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 122.244 1.963 . . . . 73.1 113.279 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -78.0 -37.69 46.62 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.014 -0.993 . . . . 71.23 110.932 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.41 90.33 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.62 0.768 . . . . 70.33 110.694 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.459 ' NH2' HG23 ' B' ' 105' ' ' ILE . 40.1 ttp180 -57.47 -49.89 74.81 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.113 1.365 . . . . 64.31 111.009 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -63.17 -41.5 99.23 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 124.277 0.986 . . . . 53.12 111.648 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.464 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 45.0 t -56.58 -40.17 74.76 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.926 0.766 . . . . 75.24 110.896 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.484 HG12 ' SG ' ' D' ' 76' ' ' CYS . 39.8 mt -69.14 -50.36 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 115.088 -0.96 . . . . 72.14 110.087 175.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.442 HG23 ' HG3' ' D' ' 125' ' ' GLN . 20.2 m -52.05 -42.43 63.11 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.678 1.191 . . . . 72.15 111.981 -175.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -70.54 -43.45 69.52 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.894 -1.048 . . . . 73.42 110.948 -178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.7 mtm -64.62 -30.32 71.34 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 122.694 0.398 . . . . 54.21 111.615 178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 114' ' ' ILE . 74.4 t -66.17 -47.9 83.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 123.862 0.726 . . . . 73.44 110.346 175.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.453 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 92.3 p -71.43 -27.67 63.45 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.656 0.383 . . . . 71.04 111.061 -177.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -75.9 -32.77 59.79 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.791 0.837 . . . . 65.44 109.795 173.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.64 -4.88 89.45 Favored Glycine 0 C--N 1.352 1.445 0 CA-C-N 115.718 -0.674 . . . . 61.42 112.119 171.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p 67.88 33.13 4.86 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 126.496 1.918 . . . . 70.52 113.117 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -102.6 166.22 12.37 Favored Pre-proline 0 CA--C 1.566 1.585 0 C-N-CA 124.806 1.242 . . . . 72.15 109.949 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.417 ' HG2' ' HD3' ' D' ' 38' ' ' PRO . 35.4 Cg_exo -60.01 140.15 91.28 Favored 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 123.278 2.652 . . . . 73.32 112.889 177.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.442 ' HG3' HG23 ' D' ' 115' ' ' THR . 29.4 tt0 -52.18 140.06 22.07 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.087 0.867 . . . . 74.01 111.897 -177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.4 HD13 HG21 ' D' ' 40' ' ' VAL . 46.1 tp -128.3 106.12 8.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.634 -0.712 . . . . 73.02 109.519 178.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.433 HD22 ' HB ' ' B' ' 16' ' ' ILE . 8.1 p30 -130.0 106.29 8.54 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.832 0.853 . . . . 74.11 109.021 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.26 151.23 45.56 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.499 -0.773 . . . . 73.3 110.72 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.83 136.63 95.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.462 0.705 . . . . 50.04 111.16 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -69.5 113.11 3.22 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.005 1.804 . . . . 73.13 109.461 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.5 m -104.52 104.43 16.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 122.174 0.987 . . . . 70.1 109.663 -171.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.81 105.62 17.72 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 105.913 -1.884 . . . . 73.54 105.913 174.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -68.15 -27.27 66.29 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.055 0.942 . . . . 65.12 112.106 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.64 -57.16 9.81 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.197 0.999 . . . . 72.01 109.276 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.4 -27.15 67.62 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 114.649 -1.159 . . . . 63.23 111.723 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 64.7 tp -63.65 -44.2 94.53 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.734 1.213 . . . . 65.41 110.894 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -64.8 -51.34 62.74 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.71 0.632 . . . . 73.21 110.365 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 74.3 mtm -65.49 -30.03 70.75 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.47 -0.786 . . . . 40.11 111.521 -177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.413 HD21 ' HA ' ' G' ' 207' ' ' VAL . 7.9 t30 -76.35 -36.89 57.99 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 70.2 110.283 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -58.72 -46.09 88.15 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.706 0.802 . . . . 74.11 111.349 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -70.49 -29.45 65.99 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.33 -0.85 . . . . 61.41 112.118 -177.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -90.65 6.19 44.93 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 122.48 0.312 . . . . 72.11 111.819 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -118.27 84.12 2.12 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.373 0.669 . . . . 73.24 109.685 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -153.09 94.8 1.88 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.664 -1.236 . . . . 72.45 107.664 170.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.12 165.42 15.58 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.918 0.887 . . . . 52.23 109.457 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.96 -174.38 48.67 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 116.053 -0.521 . . . . 72.15 113.391 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.93 147.83 27.67 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.223 1.009 . . . . 62.42 108.896 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.74 63.91 4.38 Favored Glycine 0 C--N 1.344 1.013 0 O-C-N 123.26 0.35 . . . . 44.03 112.988 -174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 53.6 m -80.97 115.0 20.22 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.433 0.693 . . . . 62.2 109.72 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -90.59 177.48 6.34 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.657 0.783 . . . . 74.34 111.183 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -82.52 159.45 22.83 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 116.012 -0.54 . . . . 71.42 110.36 173.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.59 149.16 5.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.589 0.755 . . . . 73.42 110.018 175.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -79.76 167.98 19.9 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.823 -0.626 . . . . 73.21 110.035 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -145.02 -85.21 0.13 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.761 -0.459 . . . . 65.33 109.761 173.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.716 0 N-CA-C 107.836 -1.172 . . . . 71.43 107.836 -176.617 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.485 0.183 . . . . 71.34 110.523 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -123.9 35.08 3.37 Favored Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.224 -0.75 . . . . 51.35 111.224 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.16 104.95 17.03 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.771 0.828 . . . . 73.52 109.442 -177.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 21.3 p -76.85 -174.77 3.2 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.532 0.733 . . . . 64.54 110.866 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -65.84 139.89 58.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.095 0.558 . . . . 61.22 110.308 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -151.03 102.74 2.99 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 108.722 -0.844 . . . . 64.51 108.722 -172.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.611 ' SD ' HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -65.44 76.23 0.06 Allowed 'General case' 0 CA--C 1.559 1.291 0 C-N-CA 124.435 1.094 . . . . 54.45 112.685 178.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.442 ' HA ' HD13 ' C' ' 98' ' ' LEU . 12.9 t80 -165.07 57.69 0.12 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.201 1.001 . . . . 73.51 108.458 176.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -147.85 103.08 3.47 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 114.086 -1.415 . . . . 64.22 108.612 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.61 -168.51 1.58 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.187 -1.042 . . . . 61.05 108.187 168.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -161.37 -66.96 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.351 -1.351 . . . . 71.43 107.351 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -120.24 159.37 47.81 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.781 1.232 . . . . 74.32 107.742 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.09 148.3 89.87 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.596 2.197 . . . . 73.41 112.645 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -74.58 -178.08 3.43 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 108.398 -0.964 . . . . 73.13 108.398 170.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -48.84 108.44 0.18 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.333 0.653 . . . . 73.11 110.337 175.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 44.8 p -58.51 126.26 26.82 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.382 1.073 . . . . 75.1 110.898 -174.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -103.91 96.48 9.36 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.02 0.928 . . . . 74.12 109.877 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.55 112.73 3.0 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.075 1.85 . . . . 62.23 110.998 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' C' ' 44' ' ' LEU . 21.9 mt -67.52 137.8 56.05 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 109.324 -0.621 . . . . 63.32 109.324 175.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.68 147.08 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 O-C-N 123.825 0.703 . . . . 75.44 112.267 -175.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -118.44 100.46 7.48 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.557 0.743 . . . . 64.42 109.536 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' C' ' 40' ' ' VAL . . . -70.84 95.36 1.14 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.395 0.678 . . . . 43.0 110.888 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . 0.636 ' HA ' ' HG2' ' C' ' 39' ' ' GLU . 35.0 t70 -70.27 151.75 44.97 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.846 0.858 . . . . 61.41 111.531 -174.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 52.4 -114.38 3.34 Favored Glycine 0 C--N 1.354 1.555 0 O-C-N 124.021 0.826 . . . . 72.24 113.758 172.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . 0.479 ' HA3' ' HE2' ' F' ' 201' ' ' LYS . . . 67.98 82.2 0.16 Allowed Glycine 0 C--N 1.346 1.1 0 CA-C-O 119.623 -0.543 . . . . 52.32 111.924 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -50.09 -43.15 51.3 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.411 1.084 . . . . 64.42 112.245 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . 69.02 -74.98 0.07 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.914 1.286 . . . . 50.34 111.737 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . 0.475 ' HE2' ' HD3' ' C' ' 124' ' ' PRO . 2.3 p90 -150.92 178.27 9.32 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.316 0.646 . . . . 65.05 110.547 -175.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -119.96 150.76 40.0 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.899 0.88 . . . . 74.41 109.498 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -153.71 112.46 3.68 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.011 0.924 . . . . 74.31 110.041 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -143.18 114.96 8.18 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 107.572 -1.27 . . . . 75.34 107.572 164.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . 0.649 HD21 ' HG2' ' D' ' 1' ' ' MET . 7.3 t30 73.31 159.65 0.22 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.44 1.096 . . . . 71.54 111.524 177.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.7 69.24 1.21 Allowed Glycine 0 C--N 1.351 1.403 0 CA-C-N 116.221 -0.445 . . . . 74.04 112.58 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' E' ' 204' ' ' ILE . 79.6 tttt -139.95 15.75 2.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.165 0.986 . . . . 74.25 109.36 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.47 -36.59 80.87 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.389 1.075 . . . . 73.51 111.337 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . 0.735 ' HB2' ' H ' ' F' ' 187' ' ' ILE . 13.3 p-10 -150.91 -46.51 0.12 Allowed 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.116 -0.947 . . . . 64.2 110.005 -175.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' E' ' 201' ' ' LYS . 0.2 OUTLIER -85.21 167.56 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 109.455 -0.572 . . . . 65.23 109.455 172.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -132.07 -55.8 0.98 Allowed 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.385 -1.339 . . . . 75.23 107.385 172.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -134.35 122.76 23.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 113.844 -1.525 . . . . 61.31 108.187 176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.254 1.318 0 C-N-CA 123.022 0.529 . . . . 45.45 110.409 -172.415 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.594 -0.521 . . . . 75.41 109.594 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.07 -58.16 5.05 Favored Glycine 0 C--N 1.356 1.686 0 CA-C-N 116.216 -0.447 . . . . 72.13 112.072 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -117.16 153.89 32.03 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.937 1.295 . . . . 51.43 109.3 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 41.2 p -171.82 105.06 0.19 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.348 1.059 . . . . 64.2 109.043 175.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -135.67 76.71 1.63 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.805 0.842 . . . . 64.41 109.422 177.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.809 HD21 ' H ' ' B' ' 54' ' ' ASP . 2.3 mm? -122.32 33.34 5.49 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.393 1.077 . . . . 42.11 109.982 -178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -42.99 -51.66 5.55 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.007 1.723 . . . . 53.14 113.275 -178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 50.4 t80 54.58 80.18 0.13 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.45 1.1 . . . . 74.24 111.372 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . 0.59 HD22 ' HA2' ' B' ' 91' ' ' GLY . 73.1 m-20 -78.24 -74.82 0.25 Allowed 'General case' 0 C--O 1.242 0.701 0 N-CA-C 109.339 -0.615 . . . . 45.32 109.339 176.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 23.8 tp 54.64 31.01 14.32 Favored 'General case' 0 CA--C 1.559 1.31 0 O-C-N 124.204 0.94 . . . . 75.4 110.07 -177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -83.97 136.24 34.14 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.187 -0.915 . . . . 75.33 109.866 -172.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 70.5 136.48 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 C-N-CA 125.675 1.59 . . . . 75.33 111.726 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -71.15 102.13 1.2 Allowed 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.575 2.183 . . . . 75.54 110.819 176.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -63.78 170.21 3.54 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.659 0.784 . . . . 65.25 111.543 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -61.3 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.118 0.967 . . . . 74.32 110.86 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 13.0 m -75.76 150.18 37.83 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.171 -0.922 . . . . 74.12 110.207 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.492 ' HB3' HD11 ' B' ' 136' ' ' LEU . 32.6 p90 -96.26 109.78 49.06 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 123.846 0.858 . . . . 63.12 110.549 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.12 137.1 10.59 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.49 2.127 . . . . 71.51 111.197 170.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.752 HD22 HD11 ' B' ' 128' ' ' LEU . 1.0 OUTLIER -150.69 161.56 42.38 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.597 0.713 . . . . 73.41 112.624 -172.506 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.735 ' H ' ' HB2' ' E' ' 203' ' ' ASP . 49.0 mm 77.37 133.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 127.069 2.148 . . . . 72.02 113.288 167.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -145.62 45.17 1.29 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.765 1.226 . . . . 31.24 108.466 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.92 33.47 0.94 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.195 0.998 . . . . 55.32 112.08 -173.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -93.84 130.7 39.77 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.163 0.985 . . . . 41.52 110.038 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 71.96 87.59 0.15 Allowed Glycine 0 C--N 1.353 1.498 0 O-C-N 123.161 0.288 . . . . 72.52 112.882 176.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -130.37 -137.88 4.24 Favored Glycine 0 N--CA 1.472 1.075 0 N-CA-C 111.257 -0.737 . . . . 73.44 111.257 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -136.16 117.01 14.13 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 117.563 0.682 . . . . 72.32 111.465 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . 0.739 ' HB3' ' HB3' ' B' ' 37' ' ' GLN . . . -175.55 178.64 1.57 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.603 1.161 . . . . 52.04 111.621 170.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 64.28 76.57 0.34 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.939 1.695 . . . . 72.45 112.065 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -122.58 102.81 8.29 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.255 -1.387 . . . . 72.15 107.255 169.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -71.54 -4.63 27.91 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.08 0.952 . . . . 74.53 112.713 -170.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.38 5.13 51.8 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.038 0.935 . . . . 53.53 110.839 172.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -139.42 -43.94 0.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.051 0.54 . . . . 51.14 112.37 -169.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 98.07 29.89 7.36 Favored Glycine 0 N--CA 1.476 1.332 0 N-CA-C 114.285 0.474 . . . . 74.24 114.285 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.479 ' HE2' ' HA3' ' E' ' 192' ' ' GLY . 6.9 mmtm -91.53 93.33 8.92 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.123 0.569 . . . . 71.4 109.563 177.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 74.48 15.52 3.4 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 125.109 1.364 . . . . 64.43 111.724 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -136.67 -163.56 1.43 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.479 0.712 . . . . 63.2 111.075 -173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.522 ' HA ' ' HB2' ' C' ' 129' ' ' ALA . 3.8 tp -108.14 110.21 31.09 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 C-N-CA 124.076 0.951 . . . . 74.22 109.506 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -89.44 151.36 22.06 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.796 -0.816 . . . . 74.13 108.796 168.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -56.23 122.49 11.9 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 123.158 0.583 . . . . 64.44 110.152 170.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.561 1.37 0 C-N-CA 123.751 0.821 . . . . 73.0 110.913 -176.934 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.651 -0.5 . . . . 62.14 109.651 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -179.76 109.02 0.25 Allowed Glycine 0 C--N 1.35 1.36 0 C-N-CA 121.474 -0.393 . . . . 53.41 113.534 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -87.74 -51.97 5.57 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.556 0.743 . . . . 72.34 109.601 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 35.5 m 58.26 74.71 0.42 Allowed 'General case' 0 C--N 1.356 0.874 0 O-C-N 124.766 1.291 . . . . 71.22 109.982 -170.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -84.38 17.45 2.6 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.174 -0.921 . . . . 74.44 111.661 -178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.431 HD21 ' HE2' ' A' ' 56' ' ' TYR . 2.5 tm? -83.96 117.15 23.18 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.175 0.99 . . . . 65.41 108.466 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.616 ' HG2' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -137.12 163.45 30.8 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.943 0.897 . . . . 62.14 110.245 -170.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.592 ' HB3' ' HA ' ' C' ' 152' ' ' HIS . 33.7 t80 -170.88 77.81 0.07 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.787 0.835 . . . . 74.3 109.703 175.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -96.07 -65.53 0.96 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.356 -0.609 . . . . 75.31 109.356 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 30.5 tp 54.6 80.41 0.12 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.938 1.295 . . . . 61.31 109.563 -172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -103.72 -81.17 0.52 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.746 0.818 . . . . 60.31 110.619 -173.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.6 153.57 40.54 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 123.789 0.836 . . . . 71.5 110.104 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -73.38 -169.8 0.57 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.935 2.424 . . . . 65.11 111.759 166.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -151.67 142.45 22.86 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.657 -0.497 . . . . 72.13 109.657 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 9.0 t80 59.82 -157.28 0.33 Allowed 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 124.196 0.998 . . . . 63.1 109.993 174.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 9.2 t -132.26 140.14 48.52 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.554 0.742 . . . . 72.03 109.139 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 2.4 p-90 -149.47 124.29 4.8 Favored Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 122.999 0.52 . . . . 73.14 111.203 -178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.91 -179.54 1.85 Allowed 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.684 2.256 . . . . 74.44 110.658 164.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 6.1 mp -114.81 -173.63 2.34 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.842 -0.799 . . . . 41.05 108.842 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 129' ' ' ALA . 45.3 pt -62.78 -23.52 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.59 -0.732 . . . . 55.41 111.425 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . 59.94 69.8 0.68 Allowed 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.59 1.156 . . . . 61.35 110.293 -174.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -81.35 70.5 8.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 114.861 -1.063 . . . . 71.3 108.681 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . 0.544 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 35.9 t70 -147.63 101.88 3.38 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.259 -1.337 . . . . 73.45 107.86 -174.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.0 141.8 6.96 Favored Glycine 0 C--N 1.339 0.71 0 O-C-N 123.617 0.573 . . . . 72.5 111.797 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 39' ' ' GLU . . . -93.49 21.54 40.27 Favored Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.264 -0.742 . . . . 65.24 113.807 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -158.75 84.76 0.82 Allowed 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 122.081 0.944 . . . . 51.33 109.628 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . 0.446 ' HB1' ' HA2' ' H' ' 200' ' ' GLY . . . -168.89 145.49 3.58 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.798 0.839 . . . . 62.45 108.87 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 35.3 t80 70.0 124.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 124.44 1.087 . . . . 75.52 110.319 178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 36' ' ' TRP . 3.9 ttmp? -137.29 138.38 39.98 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 121.646 -0.659 . . . . 65.22 112.203 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.46 166.89 17.95 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 124.004 0.815 . . . . 75.42 111.103 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . 0.768 ' HA ' ' HA ' ' H' ' 195' ' ' PHE . 0.0 OUTLIER -73.85 -179.92 3.93 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.613 -0.721 . . . . 71.21 111.296 174.31 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -130.79 49.33 2.33 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 108.209 -1.034 . . . . 64.24 108.209 177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.78 81.44 0.23 Allowed Glycine 0 C--N 1.354 1.552 0 CA-C-N 114.562 -1.199 . . . . 45.42 112.574 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -77.08 -34.73 56.94 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.105 0.962 . . . . 72.11 110.495 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 62.72 95.62 0.04 OUTLIER 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.623 1.202 . . . . 72.23 109.867 -168.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -87.23 38.16 0.8 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.213 1.005 . . . . 74.45 110.744 -173.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.34 131.54 61.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.26 1.024 . . . . 53.02 109.81 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -155.35 127.24 7.53 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.864 0.866 . . . . 51.25 108.669 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -168.47 -53.41 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 107.488 -1.301 . . . . 64.22 107.488 -172.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . 0.413 ' HA ' HD21 ' D' ' 139' ' ' ASN . 61.7 t . . . . . 0 C--O 1.25 1.082 0 CA-C-N 114.482 -1.235 . . . . 75.43 107.678 170.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 96.9 mttt . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 110.354 -0.239 . . . . 74.12 110.354 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.49 98.72 0.95 Allowed Glycine 0 C--N 1.346 1.095 0 CA-C-N 116.077 -0.51 . . . . 72.44 112.057 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.83 -40.7 79.33 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.815 -0.809 . . . . 62.42 108.815 168.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 34.2 p -131.7 155.44 47.64 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 125.067 1.347 . . . . 71.33 108.621 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' D' ' 90' ' ' GLU . . . -163.7 127.52 2.73 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.365 0.666 . . . . 74.04 110.305 177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 31.9 mt -137.13 -156.33 0.69 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.49 1.116 . . . . 73.02 109.075 175.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' H' ' 174' ' ' MET . 1.0 OUTLIER -61.01 94.97 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.888 1.275 . . . . 63.44 111.562 -171.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 40.1 t80 69.2 104.28 0.06 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.578 1.551 . . . . 71.14 111.609 175.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -153.99 105.39 2.74 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.1 0.96 . . . . 74.44 109.02 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.09 100.73 10.67 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.172 -1.047 . . . . 72.42 108.172 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -104.49 -43.0 5.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 70.25 110.516 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -144.42 115.36 5.34 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.24 1.016 . . . . 65.43 108.988 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.58 95.78 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.777 2.318 . . . . 74.01 112.23 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -81.25 125.18 30.01 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.819 0.848 . . . . 75.21 109.593 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 10.4 t80 68.23 165.58 0.24 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.86 1.264 . . . . 75.13 111.303 178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.6 t -134.66 161.61 34.64 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.722 -0.611 . . . . 41.13 111.216 -177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -107.46 121.41 44.45 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.358 1.063 . . . . 74.13 109.965 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.85 107.09 2.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.208 1.939 . . . . 74.54 111.241 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 95.1 mt -69.01 98.5 0.97 Allowed 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.819 -0.628 . . . . 63.3 109.703 178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.453 HD13 ' H ' ' H' ' 187' ' ' ILE . 0.2 OUTLIER -56.66 110.57 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 C-N-CA 124.694 1.198 . . . . 74.14 113.031 -171.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -103.54 97.48 7.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.447 1.099 . . . . 62.33 109.239 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -85.87 140.43 30.4 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.41 0.684 . . . . 62.34 111.382 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -72.74 -29.44 63.35 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.502 0.721 . . . . 74.24 109.853 171.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . 0.418 ' HA3' ' HG2' ' D' ' 37' ' ' GLN . . . 76.34 -86.07 0.92 Allowed Glycine 0 C--N 1.356 1.656 0 O-C-N 123.8 0.687 . . . . 31.22 111.566 176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -175.09 156.09 21.79 Favored Glycine 0 C--N 1.343 0.933 0 N-CA-C 112.281 -0.328 . . . . 63.22 112.281 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -84.9 -10.23 57.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.5 0.72 . . . . 72.15 111.303 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -112.57 145.69 39.87 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.843 0.857 . . . . 63.14 110.459 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.768 ' HA ' ' HA ' ' G' ' 198' ' ' GLU . 4.7 t80 -164.88 -65.87 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.426 1.09 . . . . 64.11 109.027 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . 0.587 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 74.9 mmtt 62.42 -162.91 0.27 Allowed 'General case' 0 CA--C 1.551 1.013 0 O-C-N 124.224 0.952 . . . . 63.32 110.889 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -149.73 -77.68 0.14 Allowed 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.999 -0.741 . . . . 73.44 108.999 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 55.61 -165.67 0.12 Allowed 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.536 -1.211 . . . . 73.11 111.351 -168.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 24.8 p-10 -163.73 -34.55 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.633 1.173 . . . . 33.54 107.945 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . 0.446 ' HA2' ' HB1' ' G' ' 194' ' ' ALA . . . 120.37 105.79 2.07 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 114.36 -1.291 . . . . 73.51 109.941 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.59 92.0 2.37 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.117 -1.068 . . . . 73.34 108.117 172.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -75.74 164.43 26.27 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 114.178 -1.374 . . . . 73.44 109.164 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -91.93 45.54 1.22 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-O 122.148 0.975 . . . . 72.44 109.277 176.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 6.4 tt -79.25 105.17 8.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 CA-C-N 114.219 -1.355 . . . . 75.2 111.721 -171.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' H' ' 205' ' ' LYS . 1.7 mppt? -133.32 18.62 4.01 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.718 -1.216 . . . . 63.14 107.718 162.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . 0.428 ' HA ' HD12 ' A' ' 136' ' ' LEU . 6.3 p-10 -81.94 14.11 2.94 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.169 0.987 . . . . 55.01 112.687 -172.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 C--O 1.255 1.369 0 C-N-CA 124.561 1.144 . . . . 73.34 108.018 178.783 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.2 ttm . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 109.128 -0.693 . . . . 64.34 109.128 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -84.3 85.57 7.36 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.827 0.851 . . . . 54.2 109.014 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -73.34 93.4 1.91 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.571 0.749 . . . . 72.01 110.216 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -59.44 132.15 53.13 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.348 1.059 . . . . 64.4 110.838 177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.649 HD21 HG23 ' A' ' 7' ' ' THR . 5.9 t30 -139.33 106.89 5.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.483 0.713 . . . . 74.4 109.287 -178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.638 ' HA ' ' HA2' ' C' ' 146' ' ' GLY . 20.4 t-20 -101.37 93.46 5.42 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 122.985 0.514 . . . . 72.23 109.904 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.649 HG23 HD21 ' A' ' 5' ' ' ASN . 16.3 p -80.76 -75.78 0.26 Allowed 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.844 -0.799 . . . . 60.55 108.844 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.56 ' HG3' ' HG3' ' A' ' 9' ' ' MET . 12.0 tp10 -130.38 -83.22 0.54 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.167 -0.679 . . . . 64.4 109.167 -174.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.56 ' HG3' ' HG3' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -176.36 158.54 1.87 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.663 0.785 . . . . 64.34 110.244 -174.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.0 p -152.84 145.02 23.87 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.29 1.036 . . . . 73.01 110.282 172.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -98.54 139.82 33.69 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.098 -0.955 . . . . 72.44 108.513 162.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.658 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -156.39 137.37 13.55 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 112.329 0.492 . . . . 74.1 112.329 174.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 83' ' ' ILE . 7.9 tp -80.02 134.63 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.531 0.732 . . . . 73.24 110.149 169.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' O ' HD13 ' F' ' 204' ' ' ILE . 0.9 OUTLIER -101.77 -40.25 7.04 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.957 -0.757 . . . . 71.04 108.957 174.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.48 ' NH1' ' HA ' ' F' ' 203' ' ' ASP . 20.7 ttt180 -173.75 127.97 0.4 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 118.999 -0.524 . . . . 74.34 110.948 -171.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.8 mt -115.05 133.75 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.614 -0.884 . . . . 72.42 108.614 174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 34.0 p90 -169.04 170.34 8.94 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.899 0.88 . . . . 74.34 110.578 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.8 p -93.39 120.08 33.26 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.32 -0.992 . . . . 73.45 108.32 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.7 mtpt -86.94 -42.94 12.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.204 -0.665 . . . . 75.5 109.204 176.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 12.0 t70 -135.16 128.51 32.21 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.145 -0.934 . . . . 70.54 108.499 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -122.95 143.28 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.952 -1.129 . . . . 64.3 107.952 174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -143.5 125.91 15.73 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.798 -0.816 . . . . 70.03 108.798 172.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 89.9 t80 -131.1 129.87 42.44 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 106.586 -1.635 . . . . 72.52 106.586 171.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -132.91 138.83 47.09 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 109.313 -0.625 . . . . 72.11 109.313 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 76.18 11.39 Favored Pre-proline 0 CA--C 1.54 0.578 0 N-CA-C 107.385 -1.339 . . . . 72.03 107.385 171.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.53 -24.07 16.53 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.296 1.998 . . . . 63.34 111.202 175.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -101.03 25.76 7.74 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.078 0.951 . . . . 73.13 109.104 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -59.2 -47.64 97.93 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 124.389 1.075 . . . . 11.0 112.317 178.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 52.8 Cg_exo -61.17 -27.99 84.68 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 121.982 1.788 . . . . 70.02 113.738 171.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -76.07 -48.79 19.45 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.7 0.8 . . . . 62.22 112.134 -173.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.596 HG23 HD11 ' A' ' 68' ' ' LEU . 7.4 p -57.11 -27.21 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.975 0.91 . . . . 64.2 112.362 -175.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -59.45 -36.32 75.73 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.381 1.072 . . . . 73.44 112.328 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.72 -12.39 20.02 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.063 0.545 . . . . 61.24 111.363 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.706 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 4.6 mmmp? -83.51 143.23 30.34 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.729 0.812 . . . . 55.31 111.972 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -63.47 143.59 57.69 Favored 'General case' 0 C--O 1.245 0.866 0 O-C-N 124.324 1.015 . . . . 74.41 110.578 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.43 ' CE3' HD21 ' A' ' 68' ' ' LEU . 65.9 t-105 -93.0 86.69 5.5 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.758 0.79 . . . . 75.24 110.326 -178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -125.55 79.8 66.88 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 107.058 -1.46 . . . . 62.35 107.058 166.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -82.37 142.38 11.86 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 122.326 2.017 . . . . 72.31 112.928 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -98.55 86.04 3.49 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 106.257 -1.757 . . . . 64.31 106.257 169.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' G' ' 189' ' ' ALA . 19.7 t -76.49 93.76 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.02 -0.991 . . . . 74.31 108.966 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.3 tttt -79.22 124.42 28.35 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.55 -0.75 . . . . 63.53 109.096 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.415 ' HG ' HD21 ' A' ' 128' ' ' LEU . 2.4 mm? -107.38 112.25 24.97 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.01 -1.107 . . . . 71.33 108.01 170.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.497 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 28.9 t70 -105.17 129.86 53.47 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.647 -0.872 . . . . 75.22 108.647 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.675 ' HB2' HD11 ' G' ' 186' ' ' LEU . 31.1 tp -106.04 131.93 52.73 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.174 -0.676 . . . . 73.4 109.174 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -143.0 152.61 42.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.131 -1.063 . . . . 74.32 108.131 176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -138.01 156.59 47.67 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.929 0.892 . . . . 63.41 109.313 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 153.75 34.42 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.139 0.975 . . . . 51.24 108.797 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.0 p -132.46 152.43 51.52 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.896 0.478 . . . . 74.51 110.754 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.5 t -149.94 121.19 7.82 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.998 0.919 . . . . 62.42 109.046 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.37 -0.604 . . . . 74.13 109.37 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -88.58 -43.38 11.42 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.581 -0.736 . . . . 75.01 111.048 -175.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.27 -174.87 4.7 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 115.411 -0.813 . . . . 74.34 110.577 -173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -75.53 123.33 25.28 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.359 -0.837 . . . . 73.13 108.825 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.642 ' HA ' HD21 ' G' ' 173' ' ' LEU . 20.5 m-20 72.33 14.78 5.38 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.304 1.442 . . . . 73.21 111.77 -178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.8 t -126.26 114.13 37.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.771 0.828 . . . . 73.31 110.381 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -124.26 126.14 45.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.742 0.817 . . . . 72.23 108.992 173.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 33.8 tt0 -90.34 120.43 31.46 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.406 1.082 . . . . 60.15 109.152 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.523 HG21 ' HG ' ' A' ' 98' ' ' LEU . 21.5 t -102.61 116.71 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 107.73 -1.211 . . . . 53.2 107.73 175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.0 t -99.23 126.28 52.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 109.038 -0.727 . . . . 73.54 109.038 176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.27 115.67 31.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.349 -1.352 . . . . 75.01 107.349 -176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -108.83 105.38 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.42 0.628 . . . . 74.11 109.742 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.2 t -101.99 133.51 45.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.778 -1.101 . . . . 72.33 108.152 174.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 13.2 m -121.69 118.23 28.61 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.372 0.606 . . . . 73.34 110.528 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.7 t -105.6 107.08 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.701 -1.136 . . . . 62.41 108.931 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 12.4 m -106.51 131.78 53.28 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 108.625 -0.88 . . . . 61.42 108.625 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.78 107.78 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.073 -1.084 . . . . 72.24 108.073 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 44.8 m -115.24 126.98 55.17 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.643 0.377 . . . . 63.1 110.392 178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.596 HD11 HG23 ' A' ' 31' ' ' VAL . 18.9 mt -88.97 58.95 4.8 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 108.093 -1.077 . . . . 75.54 108.093 176.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.36 -89.0 0.71 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-N 114.999 -1.001 . . . . 64.33 112.136 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -92.92 -28.1 16.67 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.049 0.94 . . . . 72.14 110.709 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.706 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -107.54 103.53 12.87 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.592 0.757 . . . . 75.5 109.631 -172.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 91.8 m -66.03 130.34 42.92 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.638 0.654 . . . . 74.4 109.576 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.25 -56.3 4.57 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.806 0.843 . . . . 65.44 109.831 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.5 172.92 16.35 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.83 -1.077 . . . . 64.23 111.36 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -132.09 144.42 50.72 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.138 -1.392 . . . . 71.14 108.276 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.6 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.5 m -136.82 139.82 42.01 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.895 0.878 . . . . 72.14 108.665 174.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.465 ' HG2' ' OE1' ' A' ' 79' ' ' GLN . 43.6 tt0 -149.77 120.22 7.41 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.465 -0.568 . . . . 73.35 109.465 173.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.7 t -127.65 113.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.457 0.703 . . . . 70.02 110.485 -174.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.465 ' OE1' ' HG2' ' A' ' 77' ' ' GLU . 1.7 mp0 -89.0 80.48 7.04 Favored 'General case' 0 C--O 1.241 0.605 0 C-N-CA 125.388 1.475 . . . . 74.24 108.36 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.36 94.27 3.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 114.713 -1.13 . . . . 73.14 108.879 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.88 140.74 19.65 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.409 -0.677 . . . . 52.4 111.409 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.672 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.89 122.22 1.88 Allowed Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 110.417 -1.073 . . . . 73.21 110.417 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 39.0 mt -83.74 125.91 40.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 108.685 -0.857 . . . . 63.21 108.685 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.4 ' CE2' HD13 ' A' ' 13' ' ' ILE . 53.1 m-85 -128.36 120.47 27.06 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 109.079 -0.711 . . . . 64.24 109.079 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.3 t -81.27 102.17 10.22 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.504 0.722 . . . . 54.32 109.295 174.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.86 149.84 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.375 0.67 . . . . 63.53 110.402 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.07 177.06 2.01 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.708 1.203 . . . . 43.32 109.58 172.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.629 ' H ' ' HB3' ' G' ' 172' ' ' ALA . . . 90.36 -34.35 4.19 Favored Glycine 0 N--CA 1.473 1.122 0 CA-C-N 116.126 -0.488 . . . . 73.44 114.076 173.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.55 HG23 ' HG2' ' A' ' 9' ' ' MET . 1.6 pp -110.55 150.85 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.97 0.908 . . . . 71.24 108.772 178.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.626 ' HA ' ' SD ' ' G' ' 174' ' ' MET . 44.8 mt-10 -136.37 176.94 8.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.121 0.568 . . . . 74.51 112.065 -171.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.41 -126.71 40.52 Favored Glycine 0 C--N 1.352 1.447 0 CA-C-N 115.118 -0.947 . . . . 74.25 113.089 172.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.505 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 40.9 p -71.45 -15.06 62.32 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.689 0.796 . . . . 71.35 112.568 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -72.15 -45.65 59.66 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.475 0.71 . . . . 63.4 110.584 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -82.97 -28.99 29.37 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.443 0.697 . . . . 74.43 109.981 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -72.93 -22.99 60.64 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.195 0.598 . . . . 62.11 111.177 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -65.89 -46.55 77.96 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.906 0.882 . . . . 74.43 109.616 169.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.4 m -60.55 -64.72 0.85 Allowed 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 114.711 -1.131 . . . . 63.32 110.318 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.523 ' HG ' HG21 ' A' ' 58' ' ' VAL . 9.7 mp -73.8 -9.91 59.14 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.898 0.703 . . . . 63.21 112.898 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.89 -29.4 13.1 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 119.795 -0.447 . . . . 52.1 113.747 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.504 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -145.33 -44.47 0.22 Allowed 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.876 0.695 . . . . 72.42 112.876 -172.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 81.9 t80 -78.32 -60.44 2.37 Favored 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.246 0.618 . . . . 44.2 112.318 -167.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 97' ' ' CYS . 59.1 m -66.64 -37.9 16.99 Favored Pre-proline 0 CA--C 1.564 1.501 0 N-CA-C 114.325 1.231 . . . . 64.21 114.325 -177.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.51 -27.05 69.97 Favored 'Trans proline' 0 C--N 1.391 2.767 0 CA-C-N 121.391 1.533 . . . . 65.44 112.664 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -73.0 -26.5 61.35 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.974 0.509 . . . . 75.02 110.149 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.3 mm -64.78 -43.44 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-O 121.311 0.576 . . . . 63.13 109.568 171.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.672 HD21 ' HA3' ' A' ' 82' ' ' GLY . 92.4 mt -76.85 -26.45 54.29 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.093 -0.958 . . . . 71.23 112.031 -175.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -64.32 -36.67 20.12 Favored Pre-proline 0 CA--C 1.56 1.339 0 N-CA-C 114.52 1.304 . . . . 62.44 114.52 -168.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.54 -34.37 95.03 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.074 1.849 . . . . 43.55 113.292 170.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -85.65 -36.29 20.39 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.667 0.787 . . . . 73.02 111.149 -174.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.84 -42.89 85.03 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 109.377 -0.601 . . . . 65.42 109.377 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -53.16 -56.48 16.05 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 124.798 1.311 . . . . 63.51 109.492 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -58.8 -41.84 87.72 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.156 0.982 . . . . 74.02 111.8 -174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.476 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 48.3 t -62.5 -50.5 71.14 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.357 0.663 . . . . 74.32 110.674 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.554 HG21 HG21 ' A' ' 64' ' ' VAL . 89.7 mt -61.83 -51.22 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 123.92 0.763 . . . . 61.13 110.451 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.6 m -51.57 -45.16 63.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.923 1.289 . . . . 72.34 111.4 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -73.41 -41.49 63.23 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.841 -1.072 . . . . 50.15 110.833 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 21.5 mtp -55.13 -43.47 74.18 Favored 'General case' 0 N--CA 1.5 2.07 0 C-N-CA 123.652 0.781 . . . . 50.15 111.424 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 54.5 t -65.08 -45.81 93.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-N 114.523 -1.217 . . . . 51.3 111.103 -177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.69 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.2 p -69.18 -32.52 71.88 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.383 0.273 . . . . 42.22 111.595 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -67.54 -28.43 67.79 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.614 0.766 . . . . 74.52 110.829 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.96 67.14 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.475 0.484 . . . . 63.11 113.496 176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.481 ' HB ' HH21 ' B' ' 15' ' ' ARG . 9.5 m 64.07 43.24 5.2 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.74 1.216 . . . . 71.31 110.525 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -118.4 156.63 50.82 Favored Pre-proline 0 N--CA 1.478 0.937 0 CA-C-N 114.908 -1.042 . . . . 73.11 108.918 172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.27 115.56 3.39 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.98 1.787 . . . . 70.0 110.395 173.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.69 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 8.5 pt20 -62.92 143.18 57.92 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 123.422 0.451 . . . . 62.44 110.222 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.84 122.16 46.89 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.88 -0.785 . . . . 73.55 108.88 -169.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -97.11 94.15 6.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.29 -1.374 . . . . 72.23 107.29 178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.415 HD21 ' HG ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -68.05 126.18 28.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.274 -0.875 . . . . 75.41 109.893 -172.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.479 ' HB3' HD13 ' G' ' 187' ' ' ILE . . . -66.08 128.13 93.63 Favored Pre-proline 0 CA--C 1.551 1.0 0 O-C-N 123.466 0.479 . . . . 52.52 110.537 -178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 4.8 Cg_exo -79.19 123.74 5.71 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.615 2.21 . . . . 74.34 111.567 -178.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.9 t -100.4 112.43 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.129 -1.063 . . . . 73.11 108.129 177.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -90.91 72.26 6.51 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.082 -1.081 . . . . 63.22 108.082 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -62.85 -29.66 70.91 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.032 -0.985 . . . . 63.14 111.103 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.95 -29.74 69.68 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.278 1.031 . . . . 75.23 111.933 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.63 -44.31 93.52 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.924 0.489 . . . . 71.11 110.568 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -75.16 -38.55 60.9 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.38 -0.827 . . . . 74.24 110.047 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.445 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t80 -55.55 -50.18 70.7 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.623 1.169 . . . . 62.42 110.951 -176.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 20.7 mmt -61.83 -44.58 96.55 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.726 0.641 . . . . 73.03 111.469 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -65.02 -33.39 75.93 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.261 0.624 . . . . 75.3 111.567 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -74.12 -37.11 64.21 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.437 -0.801 . . . . 65.44 110.634 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 65.0 mt -67.51 -49.73 62.08 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.373 0.42 . . . . 73.14 111.059 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -165.74 -17.04 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.453 0.538 . . . . 75.34 112.453 -177.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 62.15 105.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.603 1.161 . . . . 53.52 110.103 -172.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -72.8 -60.82 2.05 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.965 0.506 . . . . 70.51 111.53 -174.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.86 34.89 16.77 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.362 1.065 . . . . 52.11 111.068 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -91.3 -110.96 1.65 Allowed Glycine 0 C--N 1.351 1.378 0 CA-C-N 115.714 -0.676 . . . . 52.44 112.383 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 53.17 70.88 0.54 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.92 1.288 . . . . 63.04 110.891 -177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.36 72.8 0.08 OUTLIER Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.166 -0.47 . . . . 43.03 112.609 -177.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 61.0 p -94.29 -62.63 1.3 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 108.6 -0.889 . . . . 70.32 108.6 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 73.9 -29.83 0.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 126.03 1.732 . . . . 75.04 112.643 177.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.42 109.64 0.58 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.806 1.242 . . . . 74.21 109.593 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 170.33 103.56 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 126.272 1.829 . . . . 63.32 108.715 166.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -97.16 0.49 48.48 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.679 0.792 . . . . 72.23 110.667 169.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.51 118.66 11.84 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.828 0.851 . . . . 74.3 110.435 -173.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 C-N-CA 123.844 0.857 . . . . 37.78 109.003 175.851 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 75.2 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 108.864 -0.791 . . . . 71.23 108.864 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -74.0 -5.85 43.84 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.744 0.818 . . . . 53.52 111.716 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.566 ' HA ' HD21 ' D' ' 141' ' ' LEU . 9.8 pt-20 -60.87 -17.59 51.19 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.864 0.865 . . . . 75.21 112.099 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.09 166.12 8.16 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.681 0.792 . . . . 74.43 111.376 173.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.407 ' HA ' ' HB3' ' D' ' 138' ' ' MET . 9.6 p30 -137.86 154.7 49.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.87 0.468 . . . . 72.11 110.777 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' D' ' 135' ' ' ALA . 5.8 m-20 -112.26 41.64 1.95 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.584 -0.895 . . . . 62.32 108.584 169.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -84.13 60.78 6.11 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-O 123.101 1.429 . . . . 62.33 107.562 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.559 ' HG2' ' H ' ' B' ' 9' ' ' MET . 23.6 tt0 -161.41 177.18 10.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 112.957 -1.929 . . . . 71.44 106.58 -170.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.663 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 17.9 ptm 56.13 176.45 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.931 1.693 . . . . 73.23 113.285 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 60.2 m -150.96 125.99 9.84 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.423 -1.325 . . . . 74.12 107.423 -177.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -143.18 132.22 22.99 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 108.485 -0.932 . . . . 74.33 108.485 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -154.12 140.93 19.12 Favored 'General case' 0 C--N 1.342 0.267 0 O-C-N 123.396 0.435 . . . . 53.13 111.702 173.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.56 HD13 HD11 ' B' ' 16' ' ' ILE . 58.8 mt -84.66 115.04 25.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.45 -0.944 . . . . 74.33 108.45 168.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -87.9 -35.07 17.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.604 0.565 . . . . 71.15 110.039 174.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.481 HH21 ' HB ' ' A' ' 122' ' ' THR . 70.8 ttt180 -167.27 137.73 2.98 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.139 -0.482 . . . . 72.23 110.045 -177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.56 HD11 HD13 ' B' ' 13' ' ' ILE . 98.0 mt -116.98 135.95 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 106.934 -1.506 . . . . 61.43 106.934 169.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -168.99 152.04 5.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.274 0.559 . . . . 64.23 111.479 -170.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.2 m -83.04 121.48 27.08 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.343 -0.984 . . . . 70.15 108.343 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.4 mtpt -92.24 -32.88 14.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.102 0.561 . . . . 73.34 110.773 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 25.7 t70 -155.95 142.42 18.56 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.981 -0.554 . . . . 75.45 110.851 -168.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 34.4 mm -138.87 142.08 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.721 1.208 . . . . 62.45 108.881 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 41.4 t -141.36 133.76 28.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.451 -1.25 . . . . 52.33 107.856 171.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.519 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 89.0 t80 -147.34 107.54 4.05 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.493 -1.299 . . . . 71.02 107.493 171.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -118.45 120.97 39.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.127 0.971 . . . . 64.41 108.656 -179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -119.23 87.19 34.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.959 0.904 . . . . 62.52 109.857 -174.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.92 -48.83 4.66 Favored 'Trans proline' 0 C--N 1.382 2.326 0 C-N-CA 122.904 2.403 . . . . 64.14 112.672 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.488 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 28.1 m-80 -104.11 28.57 6.65 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.204 0.602 . . . . 73.33 110.66 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -49.99 -51.66 59.58 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.885 1.274 . . . . 70.34 113.411 172.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 97.2 Cg_endo -86.98 -13.06 4.73 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.435 2.09 . . . . 53.44 113.394 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.488 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 88.3 m-70 -89.27 2.97 53.55 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.378 0.671 . . . . 73.24 111.078 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 13.6 p -62.66 -16.48 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 124.973 1.309 . . . . 72.22 111.942 173.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.23 -40.16 73.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.893 0.877 . . . . 75.25 111.532 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.14 -45.91 72.29 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.775 -0.648 . . . . 62.13 110.806 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -109.07 81.61 1.47 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.721 0.809 . . . . 74.03 109.511 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -80.24 74.11 7.07 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.114 0.959 . . . . 70.43 111.41 -174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -159.29 174.28 15.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.997 1.319 . . . . 75.33 109.745 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -75.74 129.97 80.09 Favored Pre-proline 0 CA--C 1.547 0.837 0 CA-C-N 115.284 -0.871 . . . . 75.2 109.757 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -62.15 153.41 69.73 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.341 2.028 . . . . 72.4 111.723 167.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 33.3 mt-10 -65.65 99.79 0.47 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.05 -1.092 . . . . 73.04 108.05 172.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' B' ' 126' ' ' LEU . 21.7 t -87.18 117.43 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.413 -1.328 . . . . 54.21 107.413 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -151.67 132.86 14.43 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.066 -0.716 . . . . 65.45 109.066 -172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' B' ' 64' ' ' VAL . 1.5 pt? -128.92 164.55 22.89 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.032 0.444 . . . . 74.42 111.877 -173.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -149.49 149.93 31.54 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.963 -1.017 . . . . 63.04 109.556 -167.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.425 ' HB2' HD11 ' F' ' 186' ' ' LEU . 7.9 tt -107.14 136.69 46.56 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.584 0.754 . . . . 52.45 111.121 -170.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' B' ' 61' ' ' ARG . 1.2 m-20 -123.61 150.92 43.56 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.223 1.409 . . . . 71.44 107.574 172.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -136.41 134.19 37.5 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.247 -0.649 . . . . 73.11 109.247 175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.77 147.38 27.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.348 1.059 . . . . 72.41 108.237 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -142.65 162.54 35.2 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.843 0.457 . . . . 54.34 110.555 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -154.33 166.4 33.33 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.566 1.146 . . . . 70.44 109.064 -177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -115.05 132.67 56.52 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.858 0.463 . . . . 73.41 110.373 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 71.7 mt -94.93 -48.19 6.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.859 0.864 . . . . 74.25 110.063 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.86 -175.81 5.48 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.797 -1.092 . . . . 53.43 109.779 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -61.43 122.05 14.19 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.241 -0.89 . . . . 74.42 109.455 176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 71.69 -5.29 1.69 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.23 1.412 . . . . 73.3 111.882 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.8 t -109.64 100.21 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.301 1.04 . . . . 75.13 108.715 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -101.49 172.44 6.97 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.623 0.769 . . . . 71.03 110.814 176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -144.04 115.45 8.05 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 106.903 -1.517 . . . . 71.52 106.903 -178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' B' ' 98' ' ' LEU . 43.3 t -117.33 125.6 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.54 0.736 . . . . 53.03 109.805 -173.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 17.6 t -106.29 121.16 58.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.993 0.917 . . . . 65.44 110.319 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -93.81 114.47 26.73 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 107.653 -1.24 . . . . 72.42 107.653 170.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.709 ' HB3' ' HB2' ' B' ' 45' ' ' ASP . 37.0 ttm180 -100.64 112.56 24.96 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.148 -0.686 . . . . 75.42 109.148 171.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.1 t -107.11 118.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.11 -1.071 . . . . 61.45 108.11 170.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 24.2 m -115.9 137.08 52.43 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.616 0.766 . . . . 72.12 109.812 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.64 HG22 ' HB3' ' B' ' 42' ' ' LEU . 94.1 t -111.85 119.99 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.842 1.257 . . . . 74.22 110.453 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 67.5 m -89.67 140.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.896 -1.15 . . . . 63.41 107.896 165.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.54 143.61 26.75 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 110.013 -0.366 . . . . 63.23 110.013 175.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.6 p -156.03 135.2 12.14 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.687 0.625 . . . . 75.33 112.687 -171.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 61.2 mt -92.88 99.1 11.82 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.548 -1.279 . . . . 64.32 107.548 170.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.44 -130.93 41.13 Favored Glycine 0 C--N 1.343 0.969 0 O-C-N 123.65 0.594 . . . . 43.01 112.494 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -90.89 44.92 1.22 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.025 0.93 . . . . 74.22 110.091 178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.06 139.02 13.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.455 0.702 . . . . 72.13 109.42 -178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 64.0 m -72.85 133.12 44.3 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.021 0.529 . . . . 71.43 110.466 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.3 -56.18 3.04 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.839 0.856 . . . . 71.43 109.281 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -152.85 165.93 33.87 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.301 -1.318 . . . . 60.01 109.83 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.2 mt -140.73 121.07 13.98 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.419 -1.697 . . . . 73.3 106.419 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.548 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 49.4 t -116.31 158.96 22.59 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.319 -0.993 . . . . 64.33 108.319 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.433 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 34.3 tt0 -165.88 130.36 2.29 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.131 -0.692 . . . . 74.21 109.131 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -124.33 142.93 39.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.229 -1.026 . . . . 60.33 108.229 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.3 mt-30 -122.05 87.22 2.71 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.126 -1.065 . . . . 72.24 108.126 172.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.8 tp-100 -80.59 101.05 8.94 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.235 -1.348 . . . . 64.23 108.539 176.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.66 171.13 37.53 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.404 -0.678 . . . . 75.33 111.404 177.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.92 131.61 2.46 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.2 -0.76 . . . . 71.53 111.2 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -84.12 122.87 38.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.376 -1.342 . . . . 62.32 107.376 172.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -129.85 129.73 44.34 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.653 -1.24 . . . . 75.22 107.653 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 74.8 m -97.41 102.65 14.47 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 109.216 -0.661 . . . . 64.41 109.216 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -120.36 138.41 50.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.177 0.991 . . . . 71.42 110.901 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.8 172.06 19.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.449 1.099 . . . . 45.35 109.585 172.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 89.64 -43.28 2.99 Favored Glycine 0 N--CA 1.47 0.904 0 CA-C-N 116.173 -0.467 . . . . 62.21 112.859 177.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 163.88 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.934 0.894 . . . . 75.33 111.019 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 9.9 pt-20 -159.37 143.82 15.26 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.005 0.522 . . . . 74.33 110.873 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.11 -104.36 0.45 Allowed Glycine 0 C--N 1.353 1.515 0 O-C-N 124.226 0.954 . . . . 44.12 114.121 169.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 13.3 m -65.88 -41.35 91.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.231 1.012 . . . . 63.11 110.258 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.419 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 72.6 mt-30 -61.33 -40.56 94.7 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.475 -0.784 . . . . 75.3 111.035 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.574 ' SD ' ' SD ' ' F' ' 174' ' ' MET . 20.2 ttt -71.52 -40.7 69.93 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.509 0.505 . . . . 72.11 110.676 -178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.71 -24.3 66.96 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.466 -0.788 . . . . 71.21 111.692 176.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -93.73 -21.22 19.47 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.973 0.909 . . . . 74.33 110.648 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.0 t -79.17 -67.2 0.78 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.563 -0.532 . . . . 75.14 109.563 179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.548 ' HB2' HG21 ' B' ' 58' ' ' VAL . 2.2 pp -95.34 -4.85 44.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.177 0.806 . . . . 70.43 113.177 -176.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.34 -3.21 56.59 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-O 120.04 -0.311 . . . . 73.53 112.665 175.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.05 -56.51 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.013 0.375 . . . . 71.02 112.013 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -74.78 -41.26 60.35 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.106 0.41 . . . . 75.51 112.106 -174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 85.6 m -68.9 -45.72 31.68 Favored Pre-proline 0 CA--C 1.553 1.08 0 CA-C-O 118.698 -0.668 . . . . 73.35 110.532 178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 86.6 Cg_exo -55.69 -31.54 80.28 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.132 1.888 . . . . 73.52 113.895 165.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.455 HD22 ' HE1' ' B' ' 133' ' ' PHE . 54.6 t-20 -66.97 -40.79 87.53 Favored 'General case' 0 N--CA 1.503 2.212 0 C-N-CA 122.886 0.474 . . . . 72.42 110.173 176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.489 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.8 mt -58.57 -49.17 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.66 0.784 . . . . 65.41 109.871 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.71 -9.64 59.67 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.781 -1.1 . . . . 71.22 112.005 -174.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.512 ' HZ ' HD13 ' B' ' 128' ' ' LEU . 76.9 t80 -64.94 -51.06 59.18 Favored Pre-proline 0 N--CA 1.484 1.256 0 CA-C-O 117.991 -1.004 . . . . 74.12 113.402 -172.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -60.79 -35.8 87.14 Favored 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 121.788 1.658 . . . . 74.25 112.174 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.51 ' HE2' HG21 ' D' ' 115' ' ' THR . 88.7 m-85 -64.17 -47.87 78.15 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.745 0.818 . . . . 74.21 110.858 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.61 91.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.379 -0.828 . . . . 54.14 110.467 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -65.1 -45.0 86.99 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.375 1.07 . . . . 64.42 109.948 -175.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -72.08 -37.82 69.52 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.148 -0.933 . . . . 72.11 110.132 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.475 ' O ' ' HG2' ' B' ' 117' ' ' MET . 10.0 t -64.97 -35.69 82.0 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.945 0.498 . . . . 75.3 110.993 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' B' ' 64' ' ' VAL . 73.3 mt -64.7 -53.31 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.22 0.608 . . . . 72.01 109.778 173.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.1 m -56.74 -31.55 64.68 Favored 'General case' 0 CA--C 1.55 0.958 0 O-C-N 124.139 0.899 . . . . 52.01 110.892 -177.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.45 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -64.38 -53.26 51.42 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 114.805 -1.089 . . . . 72.32 110.111 172.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.4 mmt -66.53 -33.84 76.59 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 112.065 0.394 . . . . 72.02 112.065 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.25 -40.86 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.731 0.812 . . . . 44.41 109.906 177.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 91.6 p -73.03 -29.31 62.89 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-N 116.022 -0.535 . . . . 75.35 111.642 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.476 ' NH1' ' HA ' ' A' ' 113' ' ' CYS . 72.5 mtt-85 -65.73 -36.9 84.92 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.46 -0.791 . . . . 72.41 109.484 172.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.98 3.61 69.88 Favored Glycine 0 C--N 1.353 1.477 0 O-C-N 124.024 0.827 . . . . 75.31 113.5 175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 63.4 p 59.56 29.67 19.25 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.824 1.65 . . . . 73.11 112.748 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 63.7 m-85 -102.24 155.51 36.39 Favored Pre-proline 0 N--CA 1.488 1.461 0 C-N-CA 124.206 1.003 . . . . 73.42 111.278 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -62.65 178.85 0.83 Allowed 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 123.731 2.954 . . . . 74.04 115.662 -173.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.619 HE22 ' HB1' ' F' ' 189' ' ' ALA . 1.4 pp0? -64.93 152.85 42.13 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 113.56 -1.655 . . . . 61.11 114.573 -162.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.579 HD21 HD13 ' B' ' 42' ' ' LEU . 26.6 tp -149.32 106.08 3.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.003 -1.453 . . . . 75.22 108.861 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -134.52 92.36 2.9 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.588 -1.264 . . . . 73.24 107.588 170.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.591 HD11 ' HB3' ' F' ' 186' ' ' LEU . 2.4 tt -58.95 141.45 53.68 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 114.745 -1.116 . . . . 64.32 109.649 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.619 ' H ' HD11 ' F' ' 187' ' ' ILE . . . -57.46 106.48 0.69 Allowed Pre-proline 0 N--CA 1.477 0.912 0 O-C-N 124.359 1.037 . . . . 65.33 110.831 173.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.648 ' HB2' ' HB ' ' D' ' 16' ' ' ILE . 6.1 Cg_exo -79.3 123.16 5.42 Favored 'Trans proline' 0 C--N 1.37 1.688 0 C-N-CA 122.662 2.241 . . . . 72.21 109.739 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' D' ' 13' ' ' ILE . 10.0 p -155.44 155.34 5.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 O-C-N 123.694 0.621 . . . . 54.13 109.732 -167.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.536 ' H ' HD12 ' D' ' 13' ' ' ILE . 32.6 t30 -69.09 114.47 7.39 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 107.784 -1.191 . . . . 75.41 107.784 172.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.455 ' HE1' HD22 ' B' ' 104' ' ' ASN . 46.3 p90 -50.12 -35.64 26.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.507 1.123 . . . . 43.22 112.015 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -68.93 -45.45 70.79 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.398 1.079 . . . . 64.41 110.917 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.03 -35.25 80.05 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.792 0.437 . . . . 75.23 110.749 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.2 tt -71.29 -34.67 70.84 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.368 0.667 . . . . 52.45 110.094 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -63.13 -48.38 78.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.203 0.601 . . . . 73.45 110.38 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -37.9 87.61 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.807 0.813 . . . . 64.52 109.387 177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -88.58 1.79 54.27 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.702 -1.136 . . . . 74.25 111.545 -175.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -89.88 -41.71 11.64 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.767 -0.457 . . . . 72.43 109.767 174.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -89.75 9.87 25.61 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.346 0.658 . . . . 43.55 112.037 -176.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.73 177.47 8.88 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.124 0.57 . . . . 61.34 111.155 176.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -143.71 84.01 1.78 Allowed 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.541 -1.281 . . . . 74.04 107.541 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -167.65 105.22 0.52 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.436 -0.802 . . . . 64.54 108.915 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.2 111.37 5.09 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.867 -0.79 . . . . 23.24 108.867 171.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.44 93.33 0.11 Allowed Glycine 0 C--N 1.342 0.913 0 O-C-N 123.701 0.626 . . . . 55.02 111.894 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -78.75 159.59 27.85 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.279 -0.637 . . . . 53.12 109.279 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.68 125.19 3.12 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.558 -1.017 . . . . 42.22 110.558 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 12.7 t -159.65 -178.06 6.82 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.098 -0.705 . . . . 71.42 109.098 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -155.38 145.0 21.25 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.044 -1.095 . . . . 60.13 108.044 177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.5 5.67 1.23 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.161 0.584 . . . . 74.2 111.582 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -87.46 97.98 11.13 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.472 -0.566 . . . . 72.45 109.472 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -87.93 120.41 29.24 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.985 0.514 . . . . 72.41 109.988 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -69.41 -28.77 66.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.779 0.832 . . . . 52.33 111.371 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 124.083 0.953 . . . . 62.24 110.397 -177.6 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtm . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.613 -0.232 . . . . 74.44 110.891 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 34.6 m 66.27 115.9 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.333 1.453 . . . . 74.44 111.524 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -88.92 110.08 20.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.949 0.9 . . . . 70.05 110.003 -175.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -123.3 20.94 9.66 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.585 1.154 . . . . 75.34 109.246 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -150.98 158.82 44.63 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.887 0.875 . . . . 71.12 108.702 -172.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -71.99 70.41 0.77 Allowed 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 122.569 1.176 . . . . 62.42 111.196 177.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.4 m -152.1 86.4 1.3 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.13 1.372 . . . . 72.34 107.847 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -152.01 -56.28 0.14 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.276 -1.379 . . . . 44.13 107.276 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 53.8 ttm 64.53 112.65 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.616 1.566 . . . . 74.44 111.176 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 38.9 m -104.78 103.96 13.66 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.553 -1.277 . . . . 52.24 107.553 167.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -120.94 119.01 31.35 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.133 -1.432 . . . . 71.24 107.133 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -146.13 136.3 23.71 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 109.412 -0.588 . . . . 73.33 109.412 171.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.429 HD12 ' O ' ' C' ' 83' ' ' ILE . 5.5 tp -80.47 132.17 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.369 -0.832 . . . . 72.3 108.79 169.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.445 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 76.2 mm-40 -99.59 -45.61 5.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.263 -0.881 . . . . 61.45 109.866 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -165.41 122.03 1.44 Allowed 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 115.512 -0.767 . . . . 71.01 109.174 -170.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 56.1 mt -112.95 134.53 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.319 -1.363 . . . . 74.04 107.319 172.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.485 ' HB3' HG23 ' D' ' 122' ' ' THR . 18.9 p90 -173.71 168.86 4.32 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 123.816 0.698 . . . . 73.04 110.636 -173.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 65.6 p -91.3 128.29 37.07 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.26 -0.882 . . . . 65.15 109.615 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.469 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 30.0 mmtp -80.01 -52.79 7.39 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.577 0.703 . . . . 71.05 109.413 170.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 28.9 t70 -135.75 115.09 12.54 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 114.6 -1.182 . . . . 75.21 109.267 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 54.8 mt -111.27 139.46 35.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 106.515 -1.661 . . . . 74.32 106.515 170.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.2 t -152.74 142.51 22.01 Favored 'General case' 0 C--O 1.242 0.662 0 CA-C-O 121.276 0.56 . . . . 41.24 109.819 175.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -132.48 133.77 44.23 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.322 -1.362 . . . . 55.35 107.322 172.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -125.89 127.55 46.19 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 107.954 -1.128 . . . . 73.23 107.954 -176.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -145.7 76.61 12.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 107.867 -1.16 . . . . 63.01 107.867 170.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.62 -27.57 22.2 Favored 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.486 2.124 . . . . 63.44 110.785 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -106.56 29.12 7.19 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.484 1.113 . . . . 43.54 109.558 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -58.59 -50.67 86.76 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 114.072 1.138 . . . . 63.54 114.072 -175.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.21 -15.99 4.28 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.367 1.378 . . . . 53.52 112.356 171.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 13.4 t60 -72.12 -29.65 64.28 Favored 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 124.429 1.092 . . . . 73.52 111.548 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.626 HG23 HD11 ' C' ' 68' ' ' LEU . 14.7 p -79.03 -18.15 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 123.69 0.796 . . . . 73.31 111.842 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -53.99 -41.65 68.14 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.487 1.115 . . . . 71.24 112.201 -174.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.61 52.65 0.8 Allowed 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.509 -0.922 . . . . 71.3 108.509 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.521 ' HG2' ' HG2' ' C' ' 71' ' ' GLU . 0.1 OUTLIER -125.56 164.92 19.48 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.816 -0.552 . . . . 63.43 110.337 177.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.34 104.06 1.77 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.542 -0.91 . . . . 63.22 108.542 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -84.93 88.46 7.44 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-O 122.252 1.025 . . . . 62.53 112.616 -171.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -133.1 71.43 77.46 Favored Pre-proline 0 CA--C 1.555 1.164 0 C-N-CA 124.62 1.168 . . . . 73.34 108.611 166.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -72.33 127.26 12.44 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.473 2.115 . . . . 73.13 111.638 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.712 ' HA ' ' HA2' ' E' ' 191' ' ' GLY . 42.1 tt0 -87.09 112.91 22.37 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 108.525 -0.917 . . . . 62.21 108.525 173.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.483 HG21 HD21 ' C' ' 126' ' ' LEU . 21.8 t -79.88 80.49 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 115.141 -0.936 . . . . 44.22 108.691 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.497 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 25.5 tptp -90.95 102.03 14.79 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.585 -0.894 . . . . 65.32 108.585 -175.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -87.91 152.54 22.0 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.605 -0.725 . . . . 72.11 109.817 -179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.56 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 4.6 m-20 -139.75 136.36 34.06 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.075 0.95 . . . . 73.34 109.336 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.58 HD22 HD11 ' E' ' 186' ' ' LEU . 42.0 tp -112.8 108.88 18.04 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.768 0.827 . . . . 71.41 109.283 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 14.4 t70 -113.77 148.05 37.22 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 107.64 -1.245 . . . . 72.31 107.64 173.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 63.2 m -126.97 126.38 43.1 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.934 0.494 . . . . 62.14 109.884 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.13 146.32 45.23 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.11 -1.07 . . . . 75.14 108.11 170.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -149.37 143.66 25.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.77 0.828 . . . . 63.34 109.049 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 34.8 p -154.66 129.28 9.23 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.369 0.667 . . . . 60.33 110.45 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -74.29 133.95 42.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 110.037 -0.357 . . . . 75.13 110.037 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 47.8 mt -98.66 -52.92 3.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.96 0.904 . . . . 71.14 110.417 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.461 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -145.92 -170.78 3.55 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.304 -0.862 . . . . 74.4 110.581 -170.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -67.44 109.64 3.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.135 0.974 . . . . 54.32 110.1 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 67.74 -4.02 1.04 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.911 1.285 . . . . 72.52 112.762 -172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.9 t -92.93 111.96 25.42 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 N-CA-C 108.308 -0.997 . . . . 72.4 108.308 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -119.04 157.88 26.93 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.197 0.999 . . . . 63.03 108.433 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -126.62 139.44 53.18 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.578 -0.897 . . . . 72.3 108.578 177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -123.57 116.84 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.307 -1.368 . . . . 74.12 107.307 169.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.1 t -103.81 105.54 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 108.523 -0.917 . . . . 62.23 108.523 174.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 5.6 tt -86.11 122.16 29.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.841 -1.17 . . . . 74.33 107.841 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 60.0 mtp180 -105.44 114.04 27.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.834 0.854 . . . . 72.25 110.036 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.53 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.9 t -106.91 128.24 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 109.1 -0.704 . . . . 72.45 109.1 172.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 14.3 m -111.59 138.14 48.53 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.473 -0.936 . . . . 50.33 108.473 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.668 HG21 HG21 ' C' ' 114' ' ' ILE . 97.5 t -123.19 112.22 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.957 -1.127 . . . . 63.4 107.957 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.497 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 4.5 m -99.75 142.57 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.86 -0.793 . . . . 53.31 108.86 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.17 102.9 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.758 -1.571 . . . . 74.22 106.758 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.2 m -136.77 142.82 42.99 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.38 0.61 . . . . 44.1 111.275 -175.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.626 HD11 HG23 ' C' ' 31' ' ' VAL . 17.6 mt -94.02 30.62 1.82 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.405 1.482 . . . . 62.44 109.369 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.93 -110.58 2.81 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 109.773 -1.331 . . . . 62.43 109.773 -165.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 -22.45 19.87 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.071 0.548 . . . . 74.42 110.513 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.521 ' HG2' ' HG2' ' C' ' 34' ' ' LYS . 11.4 tp10 -79.58 90.1 5.12 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.03 0.932 . . . . 74.13 109.706 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.3 m -73.04 123.25 23.16 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 120.953 0.406 . . . . 61.13 110.987 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.1 -51.24 26.27 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.68 1.192 . . . . 74.42 109.779 177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.08 168.57 24.11 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.223 -0.899 . . . . 71.35 110.896 172.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -136.44 136.52 39.58 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 106.311 -1.737 . . . . 44.04 106.311 171.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 49.2 t -146.8 113.05 5.87 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.097 0.408 . . . . 61.23 109.989 -177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -118.43 133.21 56.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.546 -0.538 . . . . 54.54 109.546 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.409 HG22 HG23 ' C' ' 21' ' ' ILE . 54.9 t -119.3 143.36 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 108.508 -0.923 . . . . 74.42 108.508 169.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -119.57 94.44 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.246 -1.02 . . . . 63.42 108.246 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -81.77 106.49 13.75 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.783 0.833 . . . . 73.02 110.822 -177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.01 146.8 23.27 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 116.201 -0.454 . . . . 64.11 112.542 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.465 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.16 120.72 1.29 Allowed Glycine 0 C--N 1.339 0.697 0 N-CA-C 111.23 -0.748 . . . . 55.31 111.23 177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 14.8 mm -90.97 115.51 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 N-CA-C 109.18 -0.674 . . . . 64.24 109.18 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -120.9 117.37 27.19 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.642 -0.873 . . . . 55.01 108.642 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.2 t -88.46 104.75 17.09 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.608 -1.256 . . . . 61.11 107.608 172.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' C' ' 10' ' ' THR . 1.8 pp -130.97 138.25 53.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.296 0.638 . . . . 71.23 112.038 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.74 163.02 18.98 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.813 1.245 . . . . 55.14 109.83 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 -26.2 7.88 Favored Glycine 0 N--CA 1.478 1.499 0 CA-C-N 116.293 -0.412 . . . . 63.1 113.287 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.597 HD11 ' SD ' ' E' ' 174' ' ' MET . 0.2 OUTLIER -67.98 145.62 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.443 1.097 . . . . 74.42 110.213 176.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.419 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 0.4 OUTLIER -155.41 146.11 22.22 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.767 -0.457 . . . . 75.12 109.767 -179.078 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.84 -121.61 23.9 Favored Glycine 0 C--N 1.348 1.239 0 O-C-N 123.459 0.475 . . . . 65.05 113.513 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 36.1 p -64.16 -25.9 68.29 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.015 0.926 . . . . 64.24 111.875 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.419 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 47.6 mt-30 -59.54 -56.03 27.06 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 123.263 0.625 . . . . 74.01 109.839 174.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.502 ' HB3' HG12 ' C' ' 89' ' ' ILE . 14.3 ptp -77.58 -28.19 51.58 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.847 0.459 . . . . 64.31 111.897 -175.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.53 -45.48 75.62 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.34 0.656 . . . . 74.34 110.802 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -78.76 -33.98 46.06 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.073 -0.512 . . . . 63.3 110.259 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 38.8 t -63.82 -59.99 3.84 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.96 0.504 . . . . 41.42 111.047 -177.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.9 tt -71.63 -35.84 70.54 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 109.521 -0.548 . . . . 53.14 109.521 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -80.66 -4.68 90.22 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-O 119.163 -0.798 . . . . 53.22 114.882 -174.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -155.08 -60.47 0.11 Allowed 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 118.396 1.098 . . . . 61.52 112.143 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -60.68 -60.54 3.64 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.006 0.923 . . . . 73.43 113.26 -165.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 64.7 m -59.72 -47.71 96.87 Favored Pre-proline 0 CA--C 1.564 1.512 0 N-CA-C 113.181 0.808 . . . . 73.23 113.181 -175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.24 -32.05 42.95 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 120.982 1.386 . . . . 74.52 113.014 173.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -67.78 -27.88 67.13 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.958 0.503 . . . . 62.22 110.625 -178.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -60.83 -42.61 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 123.967 0.907 . . . . 65.12 110.15 170.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.465 HD21 ' HA3' ' C' ' 82' ' ' GLY . 83.2 mt -78.87 -21.63 47.2 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.427 -0.806 . . . . 51.52 112.342 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -55.64 -51.98 75.73 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 117.799 -1.096 . . . . 73.14 113.881 -175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.28 -33.97 92.57 Favored 'Trans proline' 0 C--N 1.387 2.568 0 C-N-CA 122.026 1.817 . . . . 70.44 113.508 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -69.89 -45.92 66.57 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.265 0.626 . . . . 63.23 110.807 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.79 -45.02 90.81 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.446 0.698 . . . . 44.22 110.382 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -54.47 -53.23 57.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.742 1.617 . . . . 72.01 111.127 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -68.4 -34.34 75.85 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.618 0.767 . . . . 72.42 110.65 -175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 35.6 t -70.45 -33.88 71.8 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.381 0.673 . . . . 73.1 112.107 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.668 HG21 HG21 ' C' ' 64' ' ' VAL . 92.5 mt -72.58 -49.08 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.014 0.526 . . . . 72.35 109.742 174.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.567 HG23 ' HB2' ' C' ' 125' ' ' GLN . 99.3 m -57.12 -33.98 67.9 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 124.158 0.911 . . . . 73.42 111.321 -176.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.5 t -58.66 -57.36 13.33 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.57 -1.195 . . . . 63.23 109.743 170.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.413 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.22 -42.53 86.45 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 125.159 1.384 . . . . 75.21 113.914 -175.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 64.7 t -60.19 -47.33 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 O-C-N 123.635 0.584 . . . . 72.24 109.836 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 42.5 t -72.29 -22.56 61.18 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 114.888 -1.051 . . . . 74.25 111.777 -178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 86.0 mtt-85 -71.06 -39.26 72.35 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.118 0.567 . . . . 71.34 109.863 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . 0.431 ' HA2' ' HB2' ' D' ' 17' ' ' TYR . . . -79.95 5.26 62.77 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.893 0.746 . . . . 63.42 112.591 171.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.68 ' HB ' HH21 ' D' ' 15' ' ' ARG . 43.0 p 58.04 38.71 26.7 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.305 1.842 . . . . 74.23 112.143 174.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -102.32 164.15 16.28 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 125.046 1.338 . . . . 74.23 108.792 173.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -65.49 102.54 0.49 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.08 1.853 . . . . 72.45 112.336 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.567 ' HB2' HG23 ' C' ' 115' ' ' THR . 0.0 OUTLIER -60.63 140.87 57.27 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.154 0.582 . . . . 74.13 110.267 177.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.483 HD21 HG21 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -112.2 144.2 41.99 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 123.237 0.615 . . . . 72.1 110.912 -173.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -118.21 93.3 4.08 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 107.948 -1.13 . . . . 62.42 107.948 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.413 ' HB3' HD11 ' E' ' 187' ' ' ILE . 77.9 mt -75.87 133.04 40.67 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 114.684 -1.144 . . . . 74.42 107.95 176.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.29 146.99 77.17 Favored Pre-proline 0 CA--C 1.551 1.005 0 O-C-N 124.293 0.996 . . . . 74.51 111.09 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -59.21 100.63 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 123.117 2.545 . . . . 74.2 112.728 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.2 t -75.28 82.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.378 -0.828 . . . . 63.33 109.635 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -98.86 105.49 17.64 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.49 -1.3 . . . . 64.35 107.49 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -50.86 -41.14 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 123.424 0.69 . . . . 70.21 112.176 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -57.7 -35.53 70.75 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.243 1.017 . . . . 64.33 111.974 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 13' ' ' ILE . . . -62.96 -43.97 97.34 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.556 0.742 . . . . 52.22 111.523 179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.549 HD11 HG11 ' F' ' 207' ' ' VAL . 6.1 mp -77.24 -28.52 53.69 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.52 0.728 . . . . 53.02 110.595 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -64.21 -47.5 79.47 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.245 1.018 . . . . 74.23 109.793 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 97.3 mmm -69.41 -47.8 63.01 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.636 -0.711 . . . . 64.34 110.159 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -53.07 -41.94 65.34 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 124.597 1.159 . . . . 74.03 111.551 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -70.51 -83.28 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 114.873 -1.058 . . . . 70.32 110.667 173.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 31.2 tp -63.54 -19.14 64.54 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.907 1.283 . . . . 71.14 114.111 -160.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -66.23 155.02 38.29 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.932 0.493 . . . . 72.15 110.039 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -83.15 59.71 5.11 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.695 0.798 . . . . 63.03 112.007 -171.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 67.96 152.59 0.09 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.875 1.67 . . . . 72.52 112.607 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.71 153.97 42.64 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.252 -0.886 . . . . 74.41 111.582 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.638 ' HA2' ' HA ' ' A' ' 6' ' ' ASN . . . -128.34 84.16 0.33 Allowed Glycine 0 C--N 1.339 0.695 0 CA-C-N 115.7 -0.682 . . . . 72.23 111.726 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -70.72 165.37 23.15 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 121.787 0.803 . . . . 73.31 112.527 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.07 -153.3 12.19 Favored Glycine 0 C--O 1.24 0.515 0 CA-C-N 114.444 -1.253 . . . . 61.41 109.992 177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.0 t -171.54 129.36 0.68 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.915 -0.772 . . . . 75.35 108.915 173.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.539 ' HB3' ' HB2' ' G' ' 173' ' ' LEU . 43.2 tt0 -177.78 144.12 0.35 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.284 0.634 . . . . 64.22 110.329 -171.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -109.01 175.26 5.52 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 108.332 -0.988 . . . . 61.15 108.332 166.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.528 ' CG ' ' HA ' ' G' ' 174' ' ' MET . 49.8 p-80 -155.27 162.06 40.98 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 122.17 -0.332 . . . . 51.45 111.64 -174.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 25.0 tm0? 58.52 -76.07 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.486 1.741 . . . . 75.13 112.306 164.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.0 t70 69.14 88.98 0.11 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.204 1.402 . . . . 62.41 110.04 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.998 0 CA-C-N 115.19 -0.914 . . . . 72.13 110.814 178.475 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 46.8 ttm . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 108.049 -1.093 . . . . 74.21 108.049 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 22.2 m 67.78 25.96 7.86 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.877 1.271 . . . . 44.42 111.294 -174.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -79.08 125.78 29.86 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.449 -0.575 . . . . 74.21 109.449 174.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -71.52 170.78 12.63 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.584 0.754 . . . . 74.02 109.266 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -71.23 84.0 0.75 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 121.501 0.667 . . . . 45.14 109.604 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -120.53 4.84 10.64 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.552 1.141 . . . . 75.23 109.556 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.552 ' HG1' ' N ' ' H' ' 168' ' ' LYS . 46.5 m -115.64 169.23 9.35 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.064 1.345 . . . . 65.23 108.911 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -76.97 57.32 1.32 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.668 0.787 . . . . 75.35 111.949 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.9 ttp -34.67 125.92 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.421 1.488 . . . . 71.41 112.643 173.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.9 m -135.61 141.54 45.1 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.685 0.794 . . . . 62.04 109.238 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 63.9 t80 -162.58 89.26 0.66 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 105.354 -2.091 . . . . 71.42 105.354 174.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -131.13 144.83 51.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.908 -1.145 . . . . 60.31 107.908 -174.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.593 HD13 HD11 ' D' ' 16' ' ' ILE . 47.8 mt -104.12 120.17 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 CA-C-N 117.676 0.216 . . . . 64.04 111.452 -170.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.34 -28.47 34.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.593 0.757 . . . . 73.13 111.39 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.68 HH21 ' HB ' ' C' ' 122' ' ' THR . 14.1 tpt180 177.89 156.48 0.38 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.691 0.396 . . . . 74.24 110.242 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' B' ' 130' ' ' PRO . 17.8 mt -141.14 127.52 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 106.439 -1.689 . . . . 73.35 106.439 174.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HB2' ' HA2' ' C' ' 121' ' ' GLY . 47.3 p90 -165.71 173.35 10.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 122.053 0.93 . . . . 74.52 110.906 -172.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -96.32 111.95 23.85 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.084 -1.417 . . . . 74.33 109.606 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -82.25 -17.95 44.17 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.104 -0.702 . . . . 74.35 109.104 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.617 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -158.17 135.92 10.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.117 1.367 . . . . 75.43 109.03 -178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.573 HG23 HG22 ' D' ' 78' ' ' VAL . 21.1 mt -137.61 145.27 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 107.877 -1.157 . . . . 63.04 107.877 170.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -144.02 141.29 30.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.391 0.676 . . . . 61.41 110.224 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.1 t80 -147.53 122.61 10.13 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 105.842 -1.91 . . . . 74.11 105.842 169.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -131.16 123.47 28.61 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.118 -1.438 . . . . 64.44 107.118 -174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.561 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -122.04 78.33 41.91 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 108.545 -0.909 . . . . 62.24 108.545 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.24 -41.81 6.54 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.116 2.544 . . . . 73.43 112.963 -165.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.432 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 58.0 m-20 -106.47 17.9 22.7 Favored 'General case' 0 C--O 1.209 -1.054 0 C-N-CA 123.884 0.873 . . . . 75.15 110.231 -175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -42.61 -51.29 11.94 Favored Pre-proline 0 CA--C 1.574 1.866 0 N-CA-C 116.369 1.988 . . . . 32.0 116.369 -164.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.469 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 14.9 Cg_endo -88.05 -14.38 3.45 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 121.807 1.671 . . . . 64.15 113.92 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -75.72 -40.57 55.4 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.417 1.087 . . . . 62.43 109.034 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -85.02 -1.07 6.47 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 114.702 -1.135 . . . . 75.21 110.257 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -57.17 -34.95 68.99 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 124.918 1.287 . . . . 74.11 110.578 164.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -70.95 -12.76 61.72 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.806 1.243 . . . . 72.42 112.156 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -89.94 101.93 14.63 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.097 0.959 . . . . 62.34 109.188 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.545 ' HB2' ' HA ' ' H' ' 196' ' ' LYS . 10.7 p-10 -99.37 52.56 0.95 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.145 0.978 . . . . 71.55 111.234 -175.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.45 -169.46 3.22 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.489 -0.778 . . . . 72.33 109.246 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -78.07 118.27 71.14 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 124.243 1.017 . . . . 73.24 111.528 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' D' ' 68' ' ' LEU . 17.0 Cg_exo -65.47 97.39 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 122.304 2.003 . . . . 65.24 109.682 167.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -63.63 115.51 4.79 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 124.337 1.023 . . . . 74.43 109.847 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.405 HG21 HD11 ' D' ' 126' ' ' LEU . 16.7 m -97.09 113.31 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-O 121.908 0.861 . . . . 45.24 109.555 -174.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.564 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 13.8 tmtt? -88.3 118.56 27.99 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.175 -1.417 . . . . 75.11 107.175 175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.472 HD21 HD22 ' D' ' 128' ' ' LEU . 10.2 mp -94.27 144.33 25.62 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.623 -0.88 . . . . 72.31 108.623 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.6 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 24.6 t70 -145.27 118.66 9.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.142 -0.936 . . . . 64.21 108.839 177.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.514 HD22 HD11 ' H' ' 186' ' ' LEU . 48.5 tp -96.79 130.39 44.05 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.342 0.657 . . . . 73.11 109.869 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -147.09 157.43 43.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.144 -1.058 . . . . 61.21 108.144 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -146.41 166.28 26.86 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.939 0.495 . . . . 72.33 110.479 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.63 166.72 31.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.457 1.103 . . . . 64.45 109.484 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 35.8 m -149.12 153.85 38.35 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.268 0.627 . . . . 61.11 109.743 173.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 77.6 p -152.5 126.83 9.26 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.502 0.721 . . . . 72.22 109.138 172.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' D' ' 55' ' ' VAL . 52.2 tt0 -71.84 119.27 15.78 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.536 -0.542 . . . . 73.43 109.536 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 56.7 mt -91.15 -38.1 12.95 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.2 0.524 . . . . 72.13 110.12 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.08 174.4 11.98 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.803 -1.09 . . . . 55.13 109.561 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -71.67 133.25 45.54 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.245 -0.889 . . . . 74.01 109.534 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.88 15.4 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.797 1.239 . . . . 74.04 112.057 -172.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' D' ' 50' ' ' GLN . 87.6 t -130.54 129.6 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.221 0.608 . . . . 71.12 110.784 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -131.14 129.36 41.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.016 0.926 . . . . 72.5 109.066 171.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -95.48 111.58 23.46 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.709 -0.848 . . . . 71.25 108.709 171.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 41.5 t -100.52 124.37 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.27 -1.011 . . . . 63.22 108.27 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.521 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 46.9 t -101.06 135.27 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 123.754 0.822 . . . . 71.42 109.282 178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.12 121.65 43.66 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 107.897 -1.149 . . . . 72.24 107.897 175.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 41.2 ttm-85 -98.75 108.37 21.04 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 173.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.641 HG21 ' HB1' ' D' ' 110' ' ' ALA . 48.1 t -105.35 116.66 49.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.966 -1.124 . . . . 55.32 107.966 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.6 m -111.81 137.1 50.22 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.156 0.503 . . . . 72.35 109.892 -177.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.48 100.01 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.129 1.372 . . . . 74.23 107.885 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.564 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 40.3 m -96.51 94.59 7.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.409 -1.33 . . . . 71.32 107.409 175.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.83 141.23 30.28 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 109.577 -0.527 . . . . 72.4 109.577 -175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.469 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 63.8 p -150.88 137.46 18.79 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.502 0.501 . . . . 72.53 111.798 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' D' ' 38' ' ' PRO . 12.1 mt -110.53 107.85 17.63 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.919 1.288 . . . . 74.0 109.059 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.52 -143.55 37.27 Favored Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.553 0.533 . . . . 75.2 112.183 -174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.73 8.24 15.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.629 0.772 . . . . 73.05 111.866 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.432 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.7 pt-20 -121.78 157.13 31.7 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.371 0.668 . . . . 62.45 109.894 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.3 m -73.05 141.02 47.63 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.67 -0.695 . . . . 63.02 110.534 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -90.56 -58.36 2.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.873 -1.158 . . . . 73.54 107.873 173.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -160.45 143.19 13.2 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 115.405 -0.816 . . . . 72.14 110.902 172.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 85.7 mt -102.09 111.03 23.14 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.159 0.984 . . . . 74.12 109.209 171.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.556 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.5 t -125.06 133.72 52.81 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.427 0.691 . . . . 73.35 109.509 -176.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -154.99 135.25 13.18 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.275 -0.639 . . . . 75.31 109.275 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.573 HG22 HG23 ' D' ' 21' ' ' ILE . 97.6 t -127.23 142.32 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 123.686 0.795 . . . . 73.51 109.191 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.617 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 16.2 mt-30 -115.25 91.42 3.6 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.757 0.823 . . . . 75.14 109.078 171.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.61 93.04 6.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.899 -1.501 . . . . 61.12 108.861 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.32 141.26 18.94 Favored Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.282 -0.727 . . . . 74.35 111.282 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.53 130.57 4.63 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.558 -1.017 . . . . 51.1 110.558 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.63 121.01 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 108.069 -1.085 . . . . 71.12 108.069 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.5 122.6 35.64 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.584 0.754 . . . . 74.33 109.591 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -75.87 103.1 5.79 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.118 -0.697 . . . . 73.44 109.118 170.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -117.82 136.78 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.406 0.683 . . . . 74.24 110.546 -177.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.88 160.95 12.74 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.215 1.006 . . . . 61.14 109.062 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.5 14.14 74.6 Favored Glycine 0 N--CA 1.472 1.07 0 C-N-CA 121.807 -0.235 . . . . 73.14 113.61 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.602 HD13 ' SD ' ' D' ' 94' ' ' MET . 1.8 pp -114.34 143.17 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 73.12 110.248 -174.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' H' ' 172' ' ' ALA . 0.3 OUTLIER -170.13 177.4 4.25 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.719 0.807 . . . . 64.31 110.084 175.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.84 -137.87 39.29 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.561 0.538 . . . . 75.23 112.709 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.8 m -68.63 -30.73 69.51 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.384 1.074 . . . . 72.44 111.692 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -62.48 -49.3 75.95 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.49 0.716 . . . . 74.31 110.559 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.602 ' SD ' HD13 ' D' ' 89' ' ' ILE . 10.0 tpt -76.5 -33.53 58.64 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.1 0.56 . . . . 73.24 111.245 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.42 -44.48 80.42 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.677 0.751 . . . . 73.32 110.633 176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -80.15 -38.65 30.99 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.382 -1.281 . . . . 71.41 110.738 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 43.5 t -63.4 -45.11 92.55 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.082 0.553 . . . . 52.15 111.486 -173.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.7 tp -79.01 -54.11 6.35 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.743 0.817 . . . . 74.34 110.73 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.11 -4.7 83.94 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 115.005 0.762 . . . . 71.22 115.005 -168.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.44 -49.74 0.41 Allowed 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 117.992 0.896 . . . . 71.14 112.126 -174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.414 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 56.9 t80 -76.04 -37.39 58.38 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.795 0.438 . . . . 70.41 111.582 -171.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 72.1 m -65.06 -50.07 63.66 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-O 118.539 -0.743 . . . . 45.44 110.386 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 88.3 Cg_exo -51.22 -36.02 54.82 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.299 1.999 . . . . 72.02 114.254 167.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -65.37 -40.15 93.18 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.488 0.715 . . . . 55.14 111.022 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.0 mm -66.81 -43.28 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 123.674 0.79 . . . . 74.52 110.348 176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.2 mt -75.2 -20.41 59.3 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.122 -0.944 . . . . 64.13 111.867 -174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -66.34 -41.4 41.69 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.469 1.285 . . . . 74.44 114.469 -169.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -52.44 -45.18 41.52 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.937 1.758 . . . . 54.04 112.846 171.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -75.06 -35.83 61.85 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.892 0.877 . . . . 73.24 111.219 -176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.641 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -64.04 -52.44 59.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.094 0.957 . . . . 65.23 110.243 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.489 ' NH2' HG23 ' B' ' 105' ' ' ILE . 33.9 ttp180 -57.37 -49.84 74.87 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 114.231 -1.35 . . . . 71.03 109.993 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.47 -41.5 89.9 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 124.501 1.126 . . . . 64.43 111.775 -176.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.444 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 36.6 t -57.96 -44.05 86.79 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 123.899 0.749 . . . . 55.24 110.689 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.556 HG23 ' SG ' ' D' ' 76' ' ' CYS . 71.1 mt -67.81 -49.16 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 123.68 0.792 . . . . 71.14 110.498 175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.51 HG21 ' HE2' ' B' ' 109' ' ' TYR . 91.1 m -52.42 -48.11 65.92 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.379 1.472 . . . . 74.32 112.095 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.1 t -67.91 -41.24 82.96 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.369 -1.287 . . . . 73.25 110.533 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -65.15 -34.79 79.23 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.818 0.447 . . . . 73.2 111.964 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 87.3 t -66.4 -44.18 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 123.718 0.637 . . . . 74.42 110.295 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -71.8 -31.59 66.74 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 116.353 -0.385 . . . . 72.12 110.783 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -69.02 -27.65 65.87 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.747 0.819 . . . . 71.24 110.06 173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.24 11.26 68.14 Favored Glycine 0 C--N 1.351 1.404 0 O-C-N 123.873 0.733 . . . . 60.11 112.901 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.485 HG23 ' HB3' ' C' ' 17' ' ' TYR . 42.2 p 56.02 33.8 22.51 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.829 1.651 . . . . 72.13 113.08 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 39.1 m-85 -110.98 166.37 10.89 Favored Pre-proline 0 CA--C 1.561 1.39 0 C-N-CA 125.141 1.376 . . . . 73.41 109.725 175.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 41.5 Cg_endo -61.42 123.46 12.82 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 123.046 2.497 . . . . 72.31 112.167 -176.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -52.06 122.21 8.09 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.051 0.844 . . . . 71.04 110.397 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.405 HD11 HG21 ' D' ' 40' ' ' VAL . 36.8 tp -103.9 93.91 5.13 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.391 0.615 . . . . 51.14 109.658 -166.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 86.9 m-20 -100.53 82.44 2.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.01 -0.996 . . . . 70.53 108.481 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.472 HD22 HD21 ' D' ' 42' ' ' LEU . 95.9 mt -67.4 139.54 57.14 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.16 -0.927 . . . . 73.23 110.669 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.5 143.83 98.58 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.426 0.691 . . . . 52.04 110.779 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.36 142.18 14.74 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.059 1.839 . . . . 73.24 110.233 176.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.43 HG22 HG23 ' H' ' 187' ' ' ILE . 38.7 t -106.76 108.78 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 107.967 -1.124 . . . . 62.11 107.967 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -77.8 88.33 4.03 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.223 -1.399 . . . . 75.54 107.223 174.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -59.01 -33.59 70.9 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.916 -1.038 . . . . 75.33 111.202 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.47 -49.48 76.6 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.48 1.112 . . . . 73.03 110.664 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' B' ' 6' ' ' ASN . . . -57.46 -52.35 65.72 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 124.122 0.889 . . . . 72.43 111.929 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.478 HD23 ' HD2' ' H' ' 185' ' ' PRO . 9.2 mp -70.41 -28.29 64.95 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.767 0.827 . . . . 72.5 111.892 -175.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -68.51 -55.45 11.71 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.132 0.973 . . . . 72.41 110.245 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.407 ' HB3' ' HA ' ' B' ' 5' ' ' ASN . 73.1 mtm -73.38 -20.37 60.77 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.592 -0.731 . . . . 71.52 111.472 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -67.6 -40.24 84.76 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.317 0.647 . . . . 64.21 110.243 172.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.565 ' HB3' ' HB3' ' H' ' 182' ' ' PHE . 45.3 t80 -68.23 -26.99 65.97 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.833 -0.621 . . . . 74.41 110.844 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' B' ' 3' ' ' GLU . 20.3 tp -67.86 -44.16 77.75 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.779 0.832 . . . . 63.42 111.399 175.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.417 HE21 ' HG3' ' D' ' 143' ' ' GLN . 0.9 OUTLIER -82.45 26.67 0.54 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.678 0.391 . . . . 74.22 111.797 -178.075 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.417 ' HG3' HE21 ' D' ' 142' ' ' GLN . 77.9 mt-30 -117.18 46.96 1.58 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.354 -1.35 . . . . 74.44 107.354 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -151.23 -58.37 0.16 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 113.77 -1.559 . . . . 75.21 107.928 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.94 112.29 19.58 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.511 -0.768 . . . . 54.32 109.468 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.35 112.62 0.49 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.055 -0.818 . . . . 30.14 111.055 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.86 93.07 1.66 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.357 0.663 . . . . 74.54 109.673 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -143.71 112.47 0.7 Allowed Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.849 -1.301 . . . . 74.11 109.849 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 18.3 m -85.3 51.97 2.32 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.366 1.079 . . . . 72.1 110.296 -175.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -134.7 162.19 33.04 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.763 1.225 . . . . 73.33 108.481 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.6 88.15 3.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.541 . . . . 61.21 110.83 -177.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -114.05 142.17 46.53 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.302 0.641 . . . . 74.41 110.284 176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.79 -166.7 1.47 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.474 1.11 . . . . 72.53 110.315 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -65.53 -55.91 15.22 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.519 0.728 . . . . 73.43 111.783 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 C-N-CA 123.603 0.761 . . . . 64.34 109.449 -176.742 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 109.697 -0.483 . . . . 63.11 109.697 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -116.48 140.12 15.77 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 116.234 -0.439 . . . . 74.32 112.495 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -86.98 -11.45 50.47 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.97 0.908 . . . . 52.15 110.333 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 56.2 m -67.22 156.24 36.8 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.07 0.948 . . . . 53.31 111.754 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.43 79.22 2.48 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.291 -0.868 . . . . 45.21 109.574 174.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.406 ' HA ' ' HE2' ' E' ' 174' ' ' MET . 81.7 mt -114.5 97.58 6.38 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.542 -0.754 . . . . 75.13 110.028 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.597 ' SD ' HD11 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -57.12 96.34 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.607 -1.179 . . . . 72.11 111.32 172.35 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -162.01 11.54 0.08 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-N 115.312 -0.858 . . . . 65.24 109.7 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -84.03 -67.28 0.81 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.244 1.018 . . . . 72.55 110.29 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.6 mp 60.07 39.0 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.095 0.958 . . . . 72.14 112.731 176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -69.51 -19.86 63.72 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 122.537 0.335 . . . . 52.44 111.652 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.64 116.81 6.41 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.881 0.872 . . . . 74.11 110.685 -176.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -84.73 149.28 11.16 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.697 2.265 . . . . 52.23 111.438 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -101.72 137.63 39.78 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.021 0.528 . . . . 74.11 109.649 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 61.71 -90.95 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.188 1.395 . . . . 71.21 110.686 -170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t 174.86 -23.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 124.3 1.04 . . . . 72.31 111.083 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 2.3 t90 67.3 93.94 0.05 OUTLIER Pre-proline 0 C--N 1.363 1.173 0 C-N-CA 124.836 1.254 . . . . 75.33 108.373 -161.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -74.93 113.23 3.74 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 122.569 2.179 . . . . 73.3 111.835 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.58 HD11 HD22 ' C' ' 44' ' ' LEU . 3.8 mm? -81.87 175.26 10.56 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.508 0.723 . . . . 65.12 111.436 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' C' ' 128' ' ' LEU . 34.1 pt -115.82 -177.06 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.232 -0.895 . . . . 61.54 110.999 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -151.26 126.66 10.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.424 0.69 . . . . 61.31 110.378 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -91.82 1.87 56.89 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.621 0.768 . . . . 75.51 111.88 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 29.2 t70 75.16 162.98 0.26 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.851 1.661 . . . . 72.13 113.097 172.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . 0.712 ' HA2' ' HA ' ' C' ' 39' ' ' GLU . . . -102.53 63.5 0.46 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.372 -0.831 . . . . 63.22 112.243 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -105.62 -165.22 23.48 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 112.696 -0.162 . . . . 71.3 112.696 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -70.39 120.21 15.7 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.562 0.745 . . . . 75.24 109.956 175.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -154.54 76.28 1.02 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.64 0.776 . . . . 51.32 109.957 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -170.52 160.37 7.31 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.02 -0.733 . . . . 73.21 109.02 -176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . 0.408 ' N ' ' HD3' ' E' ' 196' ' ' LYS . 0.0 OUTLIER -156.16 69.44 0.64 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 122.088 0.947 . . . . 65.44 112.153 -168.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -142.63 4.63 1.54 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.464 0.705 . . . . 73.5 111.006 173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.34 -51.73 2.3 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.767 -0.827 . . . . 73.41 108.767 -175.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -52.08 90.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.235 1.414 . . . . 65.4 113.358 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.76 19.53 55.41 Favored Glycine 0 C--N 1.36 1.898 0 CA-C-N 115.316 -0.856 . . . . 52.43 113.768 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 30.9 mtmm 66.91 153.88 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 125.76 1.624 . . . . 72.41 110.884 -167.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -91.66 41.75 1.08 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.609 0.718 . . . . 64.53 109.189 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 55.29 29.71 13.4 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.367 1.067 . . . . 54.43 111.461 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.46 122.33 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 108.974 -0.75 . . . . 72.14 108.974 -175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 46.4 tptt 179.88 -56.12 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.77 0.828 . . . . 73.5 110.371 -175.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -65.41 -15.91 63.08 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.699 1.199 . . . . 70.23 112.586 -168.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.561 1.392 0 C-N-CA 123.908 0.883 . . . . 54.34 109.137 172.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.474 -0.195 . . . . 71.12 110.474 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.1 102.59 0.33 Allowed Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.919 -0.582 . . . . 71.53 112.945 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -78.03 179.88 6.53 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.279 -0.637 . . . . 72.43 109.279 164.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 98.8 p -59.54 154.73 16.76 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 108.903 -0.777 . . . . 72.54 108.903 168.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.19 84.7 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.625 0.726 . . . . 73.14 110.077 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tt -137.61 128.16 26.7 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.532 -1.284 . . . . 72.21 107.532 -167.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.574 ' SD ' ' SD ' ' B' ' 94' ' ' MET . 0.0 OUTLIER -154.14 177.08 11.49 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.362 1.465 . . . . 72.34 108.106 -178.494 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -164.25 -87.77 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.493 -0.558 . . . . 71.24 109.493 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 53.16 23.73 3.24 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.539 1.135 . . . . 74.44 112.867 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 5.4 tt -107.34 116.42 31.9 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.072 0.549 . . . . 74.43 109.741 -173.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -144.52 9.14 1.37 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.544 1.138 . . . . 65.32 109.079 173.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -109.24 128.48 25.36 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.398 1.079 . . . . 74.42 109.787 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.5 102.79 1.53 Allowed 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 121.964 1.776 . . . . 70.22 111.317 171.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -66.66 179.16 1.11 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.534 0.733 . . . . 72.23 110.432 173.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.18 94.45 0.08 Allowed 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.578 0.704 . . . . 72.0 109.651 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 22.2 p -71.96 120.95 18.28 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.113 -1.403 . . . . 54.12 108.238 172.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 26.7 m-90 -68.68 115.97 35.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.807 0.692 . . . . 74.34 109.841 -171.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -59.17 104.57 0.21 Allowed 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 122.965 2.443 . . . . 63.34 112.534 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.591 ' HB3' HD11 ' B' ' 128' ' ' LEU . 73.6 mt -65.86 144.25 56.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.517 -1.219 . . . . 73.52 110.344 178.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.619 HD11 ' H ' ' B' ' 129' ' ' ALA . 2.7 pp -89.11 158.87 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.455 . . . . 75.12 111.522 -175.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.06 178.1 7.35 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.564 0.746 . . . . 62.53 111.211 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . 0.619 ' HB1' HE22 ' B' ' 125' ' ' GLN . . . -120.9 88.35 2.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.676 0.79 . . . . 45.4 110.199 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -100.26 145.15 28.43 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.416 0.687 . . . . 63.51 109.216 172.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 115.68 -158.27 14.5 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.621 -0.718 . . . . 64.51 112.527 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 78.41 -79.78 1.48 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 109.685 -1.366 . . . . 64.45 109.685 -170.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 66.01 29.2 10.24 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.856 1.262 . . . . 72.5 111.004 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' F' ' 199' ' ' ASN . . . -95.36 83.91 3.93 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.684 -1.144 . . . . 41.4 108.754 173.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -162.91 -175.46 4.4 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.899 -1.046 . . . . 75.22 108.601 -177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 48.0 tttp 77.61 42.94 0.11 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.301 1.441 . . . . 64.21 111.637 165.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 59.05 17.27 5.35 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.403 1.081 . . . . 73.32 113.464 167.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -137.98 -55.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.625 -0.88 . . . . 74.42 108.625 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' F' ' 194' ' ' ALA . 4.1 m-20 -93.57 14.06 20.04 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.521 0.728 . . . . 74.25 109.229 168.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -77.68 -126.22 0.34 Allowed Glycine 0 C--N 1.356 1.666 0 N-CA-C 115.348 0.899 . . . . 35.31 115.348 -166.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 81.72 -30.48 0.11 Allowed 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 125.974 1.71 . . . . 63.14 110.48 -165.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . 0.435 ' HE1' HD23 ' C' ' 126' ' ' LEU . 0.8 OUTLIER -61.58 -22.88 65.59 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 124.668 1.187 . . . . 75.54 109.835 163.6 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . 0.48 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -106.76 -89.46 0.44 Allowed 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 125.324 1.449 . . . . 74.4 109.996 174.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.433 HD13 ' O ' ' A' ' 14' ' ' GLN . 7.1 tp -178.32 141.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.765 1.626 . . . . 74.3 108.088 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -159.83 100.93 1.45 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 108.634 -0.876 . . . . 75.5 108.634 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 21.3 t70 66.93 -75.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.94 1.296 . . . . 75.12 108.662 -167.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.549 HG11 HD11 ' C' ' 136' ' ' LEU . 5.2 p . . . . . 0 C--O 1.255 1.384 0 N-CA-C 106.402 -1.703 . . . . 75.11 106.402 162.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 110.434 -0.209 . . . . 74.44 110.434 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 82.17 -44.36 3.15 Favored Glycine 0 C--N 1.355 1.61 0 O-C-N 123.237 0.336 . . . . 72.34 112.405 -177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -61.42 138.42 58.26 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.492 1.517 . . . . 73.24 111.287 173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 30.2 t -74.45 153.92 38.97 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.163 0.585 . . . . 74.4 109.617 174.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . 0.629 ' HB3' ' H ' ' A' ' 88' ' ' GLY . . . -151.11 76.85 1.25 Allowed 'General case' 0 C--O 1.236 0.392 0 N-CA-C 109.304 -0.628 . . . . 75.14 109.304 -174.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.642 HD21 ' HA ' ' A' ' 54' ' ' ASP . 71.4 mt -123.63 95.22 4.5 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.037 -1.097 . . . . 73.0 108.037 175.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.626 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -155.27 162.81 40.79 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.032 -1.44 . . . . 75.32 110.467 -167.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -176.86 112.6 0.09 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.39 -1.337 . . . . 74.44 107.39 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . 0.508 ' HB3' ' HG3' ' G' ' 180' ' ' PRO . 27.3 t-20 -52.46 -51.88 57.03 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 124.48 1.112 . . . . 54.53 111.012 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 tt 76.08 -20.92 0.33 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.018 1.327 . . . . 75.43 112.741 172.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -85.68 46.8 1.35 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.372 1.069 . . . . 74.14 111.1 -174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.4 68.04 3.89 Favored Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.091 1.356 . . . . 73.41 112.794 -174.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' G' ' 176' ' ' ASN . 69.2 Cg_endo -83.83 4.45 6.98 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 122.921 2.414 . . . . 71.31 112.476 172.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -106.11 163.39 12.82 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 124.583 1.153 . . . . 74.22 109.762 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -77.73 167.31 21.77 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.406 0.682 . . . . 54.04 110.894 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 10.9 t -68.75 129.27 39.44 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 115.725 -0.67 . . . . 75.33 111.407 -174.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . 0.504 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 3.2 t-105 -92.39 118.94 68.29 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 123.548 0.739 . . . . 74.23 109.444 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -85.44 113.08 1.38 Allowed 'Trans proline' 0 C--N 1.371 1.736 0 C-N-CA 122.485 2.123 . . . . 63.55 112.428 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 44' ' ' LEU . 96.9 mt -90.2 158.73 17.08 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.239 0.616 . . . . 74.03 110.21 175.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 129' ' ' ALA . 33.6 pt -77.13 89.03 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 121.471 0.653 . . . . 73.14 111.327 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -62.49 98.93 0.13 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 109.437 -0.579 . . . . 55.35 109.437 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 40' ' ' VAL . . . -99.27 94.98 6.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.55 0.74 . . . . 74.54 110.051 -172.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -108.13 105.26 14.91 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.914 -0.772 . . . . 60.05 108.914 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 117.15 -153.55 17.25 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.749 -0.94 . . . . 74.21 110.749 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 103.65 66.13 0.72 Allowed Glycine 0 C--N 1.337 0.613 0 N-CA-C 110.477 -1.049 . . . . 61.31 110.477 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -70.43 107.75 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.078 0.551 . . . . 74.15 111.138 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.8 -179.59 4.74 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.999 0.92 . . . . 51.03 108.545 170.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.405 ' HD1' ' HB1' ' H' ' 194' ' ' ALA . 70.3 m-85 61.74 -84.03 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.39 1.076 . . . . 74.11 111.234 -174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 65.25 31.48 10.65 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 124.037 0.935 . . . . 54.23 110.1 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.29 80.51 7.7 Favored 'General case' 0 CA--C 1.552 1.041 0 CA-C-N 114.742 -1.117 . . . . 64.45 111.016 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -60.71 -27.19 67.7 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.818 0.847 . . . . 65.1 111.568 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -133.09 163.7 28.67 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.777 1.231 . . . . 54.42 108.224 178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -72.44 93.76 0.63 Allowed Glycine 0 C--N 1.348 1.226 0 CA-C-O 120.329 -0.151 . . . . 51.21 113.46 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' H' ' 193' ' ' TYR . 4.0 mptp? -96.31 151.58 19.39 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.156 -0.683 . . . . 52.43 109.156 170.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 24.7 t80 63.54 29.78 15.23 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.539 1.161 . . . . 72.11 109.451 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -80.78 93.14 6.16 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.986 -1.461 . . . . 74.12 108.867 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.79 107.91 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 109.28 -0.637 . . . . 75.1 109.28 -175.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.11 59.77 5.45 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.24 1.016 . . . . 61.42 111.134 -171.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 21.2 t70 71.08 174.56 0.3 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 125.401 1.48 . . . . 73.11 111.885 175.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.567 1.598 0 C-N-CA 123.939 0.896 . . . . 51.35 110.719 179.408 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . 0.552 ' N ' ' HG1' ' D' ' 7' ' ' THR . 59.3 mttm . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.134 -0.321 . . . . 73.35 110.134 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.25 112.09 0.32 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.406 -0.678 . . . . 72.34 111.406 -175.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . 0.435 ' HD2' HD11 ' H' ' 173' ' ' LEU . 57.5 pttt -150.09 156.36 41.51 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.43 1.092 . . . . 64.32 108.418 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 15.9 m -136.22 -29.56 0.98 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.358 0.663 . . . . 63.55 110.408 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' D' ' 90' ' ' GLU . . . -122.08 147.64 45.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.941 0.896 . . . . 65.13 109.384 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.435 HD11 ' HD2' ' H' ' 170' ' ' LYS . 28.9 mt -156.16 -66.52 0.11 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.695 1.198 . . . . 74.03 109.883 176.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.54 99.21 3.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.008 0.923 . . . . 72.43 112.464 -168.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 34.1 t80 59.01 35.05 23.88 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.148 1.379 . . . . 60.43 111.327 172.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -90.07 101.17 13.89 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.008 -0.542 . . . . 71.54 110.104 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.19 -13.42 59.72 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.141 0.576 . . . . 75.32 110.405 177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . 0.509 ' HG3' ' H ' ' H' ' 179' ' ' GLU . 9.6 tp60 63.47 -172.09 0.17 Allowed 'General case' 0 CA--C 1.562 1.437 0 C-N-CA 125.042 1.337 . . . . 72.13 110.808 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . 0.509 ' H ' ' HG3' ' H' ' 178' ' ' GLN . 3.4 mp0 -64.78 148.68 97.03 Favored Pre-proline 0 CA--C 1.558 1.284 0 C-N-CA 123.563 0.745 . . . . 55.13 110.82 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -66.62 96.59 0.36 Allowed 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.61 2.206 . . . . 74.21 111.907 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -78.89 -151.99 0.06 Allowed 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.777 0.831 . . . . 73.1 110.934 178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' D' ' 140' ' ' TYR . 29.4 m-85 -63.68 140.97 58.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.881 0.872 . . . . 74.23 111.479 -173.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 35.6 p -82.84 150.53 26.51 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.218 0.607 . . . . 73.32 111.272 -175.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -137.1 98.76 10.22 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.442 1.097 . . . . 73.2 109.695 -175.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . 0.478 ' HD2' HD23 ' D' ' 136' ' ' LEU . 18.1 Cg_exo -69.45 160.03 51.36 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.551 2.167 . . . . 71.11 112.667 173.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . 0.514 HD11 HD22 ' D' ' 44' ' ' LEU . 3.0 mm? -93.82 169.91 9.95 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.877 0.471 . . . . 71.55 109.826 174.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.43 HG23 HG22 ' D' ' 131' ' ' VAL . 2.7 pp -70.57 171.84 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 123.679 0.792 . . . . 74.24 112.276 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -129.82 150.54 51.07 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.66 0.784 . . . . 63.12 110.456 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -94.73 133.79 38.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.808 0.843 . . . . 62.34 110.082 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -77.44 157.15 30.65 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.37 0.668 . . . . 74.52 110.05 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.62 103.85 0.69 Allowed Glycine 0 C--N 1.348 1.21 0 O-C-N 123.801 0.688 . . . . 42.24 112.654 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.53 152.09 26.05 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 123.021 0.343 . . . . 65.05 113.416 -177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.588 ' HB3' ' HG2' ' G' ' 201' ' ' LYS . 91.2 t80 -168.73 105.32 0.43 Allowed 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.92 1.288 . . . . 75.42 107.866 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . 0.405 ' HB1' ' HD1' ' G' ' 195' ' ' PHE . . . -171.21 56.09 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.624 1.17 . . . . 44.42 109.038 -177.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -142.07 151.53 42.46 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.015 0.526 . . . . 73.23 111.98 -168.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . 0.545 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 1.4 tmtm? -158.45 -46.69 0.06 Allowed 'General case' 0 CA--C 1.551 0.996 0 O-C-N 123.895 0.747 . . . . 72.13 110.506 168.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 68.83 -64.85 0.31 Allowed 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 124.787 1.235 . . . . 72.1 110.882 -171.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.16 165.91 6.68 Favored 'General case' 0 CA--C 1.56 1.359 0 C-N-CA 124.348 1.059 . . . . 74.01 108.614 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 81.79 5.24 1.23 Allowed 'General case' 0 N--CA 1.503 2.187 0 C-N-CA 125.427 1.491 . . . . 70.31 111.327 -173.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -132.84 30.01 3.15 Favored Glycine 0 C--N 1.352 1.419 0 C-N-CA 122.851 0.262 . . . . 75.44 112.925 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -102.35 148.27 25.68 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.65 0.78 . . . . 73.52 109.848 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -97.84 -48.39 5.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.169 0.587 . . . . 72.11 111.951 -173.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 64.48 93.66 0.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.2 1.4 . . . . 74.44 110.822 -176.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 34.2 pt -118.86 136.71 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 123.288 0.635 . . . . 64.23 110.836 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 57.6 mttm -137.69 151.33 48.13 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.43 1.492 . . . . 71.04 109.162 176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 23.6 t70 60.71 110.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 124.646 1.216 . . . . 70.44 112.856 166.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.564 1.5 0 C-N-CA 122.918 0.487 . . . . 72.44 110.591 179.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 109.332 -0.618 . . . . 51.4 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m 65.98 17.53 10.82 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.975 1.31 . . . . 73.23 112.855 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -87.15 156.27 19.77 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 52.45 111.066 -178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.492 ' HB3' ' HA3' ' G' ' 169' ' ' GLY . 12.3 pt20 -157.43 175.32 14.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.112 0.965 . . . . 73.11 109.498 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -98.88 -62.24 1.26 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.176 0.99 . . . . 73.55 108.717 172.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -161.9 171.43 17.71 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.453 -0.794 . . . . 74.45 110.556 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.1 p -104.02 -162.16 0.88 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.054 0.942 . . . . 74.04 109.851 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 65.4 84.17 0.16 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 124.426 1.09 . . . . 74.12 109.815 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.481 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 24.3 ptt? -83.14 139.37 33.23 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.488 0.661 . . . . 73.13 112.348 -175.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.516 HG21 ' H ' ' C' ' 145' ' ' ALA . 72.3 m -145.1 105.75 4.12 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 114.401 -1.272 . . . . 64.12 108.29 173.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 72.1 t80 -95.38 142.39 27.82 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.658 -0.867 . . . . 64.42 108.658 168.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.543 ' NE2' HD21 ' C' ' 139' ' ' ASN . 6.0 tp60 -162.14 137.26 7.15 Favored 'General case' 0 C--N 1.349 0.578 0 O-C-N 123.678 0.611 . . . . 72.01 112.501 170.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.438 HD13 ' CE2' ' A' ' 84' ' ' PHE . 3.8 tp -75.96 121.6 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 C-N-CA 124.516 1.126 . . . . 74.22 109.16 170.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.487 ' O ' HG21 ' F' ' 204' ' ' ILE . 24.3 mm-40 -107.09 -13.8 15.08 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-O 117.781 -1.105 . . . . 65.44 112.163 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 178.38 126.58 0.05 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 119.193 0.906 . . . . 74.1 110.691 173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.483 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 77.2 mt -106.44 131.62 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.015 -1.105 . . . . 61.41 108.015 172.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -158.67 170.06 23.01 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.6 0.714 . . . . 75.11 111.136 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.9 p -99.5 114.31 27.21 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.795 -1.093 . . . . 72.43 108.71 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -77.65 -38.77 47.08 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -140.84 136.13 32.07 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.592 -1.186 . . . . 73.31 109.343 -178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.1 mt -129.95 130.34 66.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.107 -1.442 . . . . 74.32 107.107 171.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -136.32 106.1 6.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.523 -0.917 . . . . 72.15 108.523 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 85.1 t80 -120.65 110.09 16.0 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 106.178 -1.786 . . . . 70.24 106.178 167.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -119.43 127.11 52.79 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.278 0.631 . . . . 73.05 109.379 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.44 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -126.24 79.4 70.07 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.648 -1.241 . . . . 74.42 107.648 174.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.07 -22.07 23.21 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.889 2.393 . . . . 65.13 112.372 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -119.07 33.12 5.78 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.179 0.992 . . . . 61.51 109.048 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' O ' HG12 ' A' ' 31' ' ' VAL . . . -57.16 -44.69 99.83 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.773 1.229 . . . . 63.05 113.331 176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -63.47 -29.68 71.38 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.463 1.442 . . . . 70.34 112.555 173.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -76.62 -28.73 56.21 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.516 -0.766 . . . . 73.11 111.828 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.491 HG12 ' O ' ' A' ' 28' ' ' ALA . 7.6 p -61.74 -23.08 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-N 118.193 0.451 . . . . 73.35 112.143 -173.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -72.61 -39.65 67.12 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.176 0.99 . . . . 75.3 110.869 -176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -88.39 -19.59 26.39 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 71.41 110.744 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -78.38 148.83 33.53 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.419 0.688 . . . . 72.34 110.289 175.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -73.36 127.47 32.78 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.327 -0.99 . . . . 74.24 108.327 169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.484 ' NE1' ' HB3' ' G' ' 195' ' ' PHE . 25.3 t-105 -86.26 84.94 7.35 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.578 0.704 . . . . 73.32 110.182 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -131.22 80.32 68.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 107.283 -1.377 . . . . 71.32 107.283 168.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' G' ' 194' ' ' ALA . 75.9 Cg_endo -81.67 153.26 17.58 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.929 2.419 . . . . 74.42 113.154 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -96.06 90.72 5.64 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.001 -1.111 . . . . 71.1 108.001 170.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.9 m -69.98 93.18 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 122.381 1.086 . . . . 64.01 109.532 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -103.34 121.0 41.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 114.751 -1.113 . . . . 71.14 109.951 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 63.7 tp -97.34 132.33 43.17 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.044 0.937 . . . . 71.51 109.348 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.722 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 7.4 m-20 -126.56 132.45 51.32 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 124.025 0.93 . . . . 73.15 108.754 176.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD22 HD11 ' G' ' 186' ' ' LEU . 54.5 tp -103.18 135.54 44.65 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.746 -0.835 . . . . 74.35 108.746 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -134.29 145.42 49.07 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 109.679 -0.489 . . . . 70.24 109.679 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.2 m -109.42 121.38 45.06 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.865 0.866 . . . . 72.11 108.864 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.97 123.37 27.23 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 107.412 -1.329 . . . . 72.33 107.412 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.6 m -133.16 152.63 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.661 0.384 . . . . 60.54 110.704 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.6 t -149.96 130.84 14.23 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.838 0.855 . . . . 63.05 109.311 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -87.79 117.82 26.89 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 108.866 -0.791 . . . . 74.4 108.866 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' A' ' 57' ' ' GLU . 54.9 mt -84.63 -44.57 13.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.543 0.737 . . . . 73.14 110.696 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.47 -171.94 4.07 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.692 0.797 . . . . 63.13 109.923 -178.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -59.96 102.75 0.17 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.375 0.67 . . . . 74.02 110.39 176.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 65.3 12.11 7.81 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.823 1.249 . . . . 73.12 112.997 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.4 t -99.83 113.82 36.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 106.859 -1.534 . . . . 55.33 106.859 171.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' G' ' 174' ' ' MET . 5.9 m-30 -108.82 165.91 11.21 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 122.199 1.0 . . . . 74.13 111.3 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 51' ' ' LEU . 28.0 tt0 -131.26 118.59 20.6 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 112.574 -2.103 . . . . 74.34 106.862 164.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 87.8 t -100.61 117.8 46.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.344 -1.724 . . . . 63.14 106.344 170.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.4 t -97.9 127.99 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 109.114 -0.698 . . . . 53.21 109.114 174.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.65 109.85 21.14 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.427 -1.323 . . . . 74.14 107.427 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -106.01 106.74 17.4 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.019 -0.991 . . . . 73.2 109.559 -175.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.5 t -96.95 133.47 38.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 114.95 -1.023 . . . . 75.4 108.553 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.722 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.8 m -117.69 131.71 56.59 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.912 -0.773 . . . . 75.14 108.912 173.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 37.1 t -126.21 111.42 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.869 1.268 . . . . 53.34 108.263 -177.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 11.7 m -102.26 145.1 29.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.578 -0.527 . . . . 72.54 109.578 -179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.43 109.94 7.98 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.233 -1.025 . . . . 72.25 108.233 169.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.7 m -126.81 145.69 50.54 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.275 0.559 . . . . 75.15 110.363 176.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.442 HD21 ' CE3' ' A' ' 36' ' ' TRP . 49.1 mt -107.84 51.56 0.74 Allowed 'General case' 0 C--O 1.245 0.818 0 C-N-CA 125.542 1.537 . . . . 73.15 108.031 -175.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.93 -85.44 0.89 Allowed Glycine 0 C--N 1.349 1.282 0 CA-C-N 114.569 -1.196 . . . . 33.15 111.483 -174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -89.92 -24.73 21.25 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.131 0.973 . . . . 75.12 111.846 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -118.15 107.03 13.47 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.086 0.554 . . . . 75.4 110.392 -168.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.2 123.44 20.72 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 118.525 0.602 . . . . 72.54 109.889 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.39 -54.73 6.33 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.852 -1.067 . . . . 70.44 109.648 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -160.5 172.48 17.14 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.467 -1.242 . . . . 74.41 110.912 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.8 tp -141.6 141.31 33.46 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.114 -1.403 . . . . 51.5 107.364 175.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.544 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 54.9 m -140.16 99.78 3.75 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.285 -0.635 . . . . 61.21 109.285 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -121.58 122.86 40.61 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.508 -0.923 . . . . 64.2 108.508 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.5 t -127.47 131.13 70.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 123.511 0.725 . . . . 71.23 109.293 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -104.59 93.44 4.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.931 -1.031 . . . . 64.4 109.434 174.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -81.67 92.88 6.66 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.112 -1.069 . . . . 65.34 108.112 175.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.12 143.7 20.51 Favored Glycine 0 C--N 1.339 0.736 0 N-CA-C 111.242 -0.743 . . . . 54.13 111.242 177.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.82 129.92 4.49 Favored Glycine 0 CA--C 1.506 -0.52 0 N-CA-C 111.491 -0.644 . . . . 72.21 111.491 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -78.53 129.5 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 107.648 -1.242 . . . . 65.22 107.648 173.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.438 ' CE2' HD13 ' A' ' 13' ' ' ILE . 49.5 m-85 -133.49 121.72 22.59 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.134 -0.691 . . . . 62.44 109.134 174.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 33.9 t -74.3 115.27 13.62 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 107.591 -1.262 . . . . 64.51 107.591 169.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -137.78 119.06 17.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.682 0.793 . . . . 71.23 109.729 -170.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.01 161.6 28.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.931 0.893 . . . . 61.23 109.849 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 78.3 5.24 87.48 Favored Glycine 0 C--N 1.351 1.372 0 O-C-N 123.646 0.591 . . . . 63.31 114.399 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.34 166.1 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.584 0.753 . . . . 72.2 108.972 -176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -172.74 175.97 3.27 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.343 -0.614 . . . . 64.25 109.343 -168.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.42 -126.01 38.04 Favored Glycine 0 CA--C 1.523 0.578 0 O-C-N 123.813 0.695 . . . . 74.34 114.437 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 46.3 p -82.47 -20.39 36.97 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.689 0.796 . . . . 73.34 110.98 178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.96 -43.45 98.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.012 0.925 . . . . 71.24 111.006 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.23 -49.48 67.07 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 123.879 0.737 . . . . 74.35 110.352 -179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.95 71.98 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.354 0.662 . . . . 62.13 111.534 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -71.56 -41.8 68.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.732 0.813 . . . . 64.4 110.528 175.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.0 t -72.67 -65.25 0.81 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.029 0.532 . . . . 64.24 110.489 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 tt -67.62 -40.58 84.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.222 0.609 . . . . 74.22 111.046 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.78 -38.81 49.28 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 123.601 0.563 . . . . 51.04 113.793 -168.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.516 ' HB1' ' HB2' ' A' ' 133' ' ' PHE . . . -126.55 -53.53 1.46 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 117.124 0.462 . . . . 40.31 112.149 -171.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.437 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 82.9 t80 -63.7 -42.27 97.99 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.011 0.924 . . . . 74.4 112.862 -171.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' CE2' ' A' ' 11' ' ' PHE . 73.7 m -77.62 -41.43 2.26 Favored Pre-proline 0 CA--C 1.557 1.243 0 N-CA-C 113.048 0.758 . . . . 72.33 113.048 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.76 -23.64 55.53 Favored 'Trans proline' 0 C--N 1.38 2.204 0 CA-C-N 121.139 1.442 . . . . 65.01 112.544 166.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -70.8 -24.92 62.66 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 122.966 0.506 . . . . 73.31 111.463 172.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -64.73 -42.82 96.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.968 0.89 . . . . 70.33 109.299 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.511 HD21 ' HA3' ' A' ' 82' ' ' GLY . 25.1 mt -84.06 -27.72 28.1 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.421 -1.263 . . . . 62.03 112.444 -168.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -61.92 -40.74 71.6 Favored Pre-proline 0 N--CA 1.487 1.417 0 N-CA-C 114.504 1.298 . . . . 73.23 114.504 -171.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -53.89 -36.22 82.57 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.963 1.775 . . . . 71.45 113.057 172.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' C' ' 108' ' ' PRO . 87.5 m-85 -81.56 -35.33 30.39 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.181 -0.918 . . . . 75.42 111.352 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.49 80.92 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.886 0.474 . . . . 62.01 110.566 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HG23 ' C' ' 105' ' ' ILE . 28.0 ttm105 -56.46 -54.83 41.14 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 114.796 -1.093 . . . . 50.12 109.216 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -59.27 -41.33 88.61 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.393 1.058 . . . . 70.21 111.564 -175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.0 t -57.78 -50.98 71.42 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 123.742 0.651 . . . . 73.12 110.102 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.449 HG21 HG21 ' A' ' 64' ' ' VAL . 96.5 mt -63.57 -42.72 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.937 0.895 . . . . 72.25 111.306 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.43 HG21 ' HE2' ' C' ' 109' ' ' TYR . 90.7 m -57.35 -45.19 84.6 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.243 1.017 . . . . 73.4 110.616 -177.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.1 t -70.93 -41.41 71.22 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.702 -1.135 . . . . 73.44 110.054 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 19.4 mtp -57.66 -46.14 84.62 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.864 0.866 . . . . 75.41 111.67 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.05 -44.09 98.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 123.961 0.904 . . . . 73.32 110.67 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.583 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 82.5 p -69.66 -33.07 72.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.406 0.282 . . . . 35.04 111.62 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.598 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.7 mtt-85 -68.65 -27.31 65.89 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.48 0.712 . . . . 63.13 110.789 176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.75 9.88 58.21 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 123.502 0.501 . . . . 61.44 113.2 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 23.8 m 69.31 42.17 1.23 Allowed 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.869 1.319 . . . . 65.54 110.584 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 119' ' ' SER . 90.5 m-85 -120.66 156.48 55.97 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 114.837 -1.074 . . . . 64.22 109.523 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.19 124.65 16.07 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 121.565 1.51 . . . . 72.02 109.789 166.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.583 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 19.7 pt20 -60.69 146.38 45.92 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.827 0.451 . . . . 73.12 111.34 -174.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 52.8 tp -114.22 105.8 13.6 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.008 -0.542 . . . . 62.12 110.19 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -118.28 93.22 4.05 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 74.44 109.742 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.502 ' HB3' HD11 ' G' ' 187' ' ' ILE . 96.8 mt -73.02 160.66 31.72 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 114.697 -1.138 . . . . 71.04 110.824 176.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.485 ' HA ' HG22 ' C' ' 13' ' ' ILE . . . -68.84 145.3 96.71 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 123.279 0.632 . . . . 54.43 112.441 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -72.25 114.5 4.01 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.118 1.879 . . . . 75.02 110.818 168.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.15 109.19 23.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.797 -1.557 . . . . 74.22 106.797 174.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -104.53 92.03 4.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.982 0.913 . . . . 72.53 110.358 -172.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 136' ' ' LEU . 93.2 m-85 -66.5 -21.44 66.17 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 114.988 -1.005 . . . . 74.51 111.67 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.47 -51.18 70.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.308 1.043 . . . . 72.24 110.434 172.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.27 -43.76 49.57 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.517 -0.765 . . . . 53.43 110.629 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 133' ' ' PHE . 46.3 tp -53.45 -39.38 64.4 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.359 1.063 . . . . 74.24 111.852 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 141' ' ' LEU . 86.9 t80 -57.65 -56.78 17.53 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.838 0.711 . . . . 71.34 110.504 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 49.5 mtm -67.63 -36.03 80.02 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.71 0.804 . . . . 74.02 111.352 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -58.61 -58.02 10.42 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.268 1.427 . . . . 74.11 109.509 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -69.01 -30.93 69.43 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.14 -0.936 . . . . 65.3 111.261 -176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 0.2 OUTLIER -61.57 -38.32 87.11 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.972 0.909 . . . . 73.42 110.968 -176.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -148.5 29.98 0.84 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.984 0.735 . . . . 64.11 112.984 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -34.54 71.31 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 118.365 0.53 . . . . 74.31 109.838 175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -59.47 -39.89 85.17 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.856 0.862 . . . . 75.21 111.229 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.89 83.96 1.15 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.088 0.555 . . . . 62.04 110.723 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.24 161.35 19.11 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 115.588 -0.733 . . . . 72.32 111.534 171.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' C' ' 5' ' ' ASN . 11.0 tp10 -166.26 147.77 6.66 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.218 0.607 . . . . 64.23 109.684 176.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.77 153.37 6.2 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 111.933 -0.467 . . . . 62.01 111.933 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -153.26 152.92 31.71 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.541 0.686 . . . . 74.44 110.578 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.702 ' H ' HG21 ' C' ' 92' ' ' THR . 29.9 mt-10 -121.36 -12.23 8.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.408 1.483 . . . . 72.41 109.612 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.444 ' HB2' HG22 ' C' ' 92' ' ' THR . 35.4 tt0 -88.82 94.45 9.93 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 124.09 0.956 . . . . 74.04 111.922 -163.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -179.5 76.14 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.862 0.865 . . . . 74.3 109.677 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.488 ' HB3' ' HG3' ' E' ' 180' ' ' PRO . 40.3 tt0 -176.89 23.0 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 123.192 0.597 . . . . 71.3 109.745 176.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.85 90.47 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.136 0.974 . . . . 73.53 112.314 -167.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.452 0 C-N-CA 125.978 1.711 . . . . 37.83 106.91 175.709 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 110.172 -0.307 . . . . 51.11 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.3 t -141.77 150.13 41.34 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.579 0.752 . . . . 70.15 109.853 -175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -83.5 116.59 22.61 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.182 0.593 . . . . 74.32 111.811 -172.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -77.52 -12.97 60.02 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.226 1.01 . . . . 74.02 110.605 175.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -65.66 131.36 46.15 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.582 0.753 . . . . 65.3 110.061 176.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -143.64 167.17 22.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.719 0.808 . . . . 72.43 110.145 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 21.5 p -133.43 138.43 46.22 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.275 -1.009 . . . . 44.01 108.275 173.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -60.6 -44.78 95.89 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.647 0.779 . . . . 64.11 110.93 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.598 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 19.1 ptm 55.67 168.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.197 2.199 . . . . 73.54 114.589 -178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -176.74 145.05 0.51 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-N 114.224 -1.353 . . . . 50.34 109.017 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.02 156.43 39.96 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.382 -0.372 . . . . 73.04 111.177 162.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.412 HE22 HD13 ' G' ' 204' ' ' ILE . 22.2 tp60 -122.78 111.37 16.62 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.75 -1.204 . . . . 73.4 107.75 176.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 tt -61.34 101.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 CA-C-N 113.914 -1.494 . . . . 72.12 109.318 170.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -78.4 -33.25 48.89 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.677 -0.692 . . . . 71.2 109.672 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -173.19 141.36 0.94 Allowed 'General case' 0 C--N 1.361 1.089 0 O-C-N 123.354 0.409 . . . . 70.04 110.761 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.0 mt -114.36 136.83 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 106.545 -1.65 . . . . 61.14 106.545 166.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -166.04 148.65 7.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.099 0.476 . . . . 73.43 111.069 -176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.616 HG21 HD11 ' B' ' 21' ' ' ILE . 86.3 m -76.92 117.42 18.5 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.712 -0.847 . . . . 73.43 108.712 173.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -88.38 -25.61 22.61 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.152 0.581 . . . . 52.23 110.633 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 15.8 t70 -158.55 143.54 16.24 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-O 121.347 0.594 . . . . 75.43 111.845 -174.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.616 HD11 HG21 ' B' ' 18' ' ' THR . 39.9 mm -134.18 138.59 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 C-N-CA 125.897 1.679 . . . . 72.32 106.867 175.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 30.4 t -146.62 133.4 20.05 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.606 -0.887 . . . . 74.04 108.606 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -148.2 115.59 6.24 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.395 -1.335 . . . . 74.33 107.395 172.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -121.06 127.16 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.831 -1.174 . . . . 74.22 107.831 -178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -122.51 86.95 48.98 Favored Pre-proline 0 C--O 1.243 0.762 0 N-CA-C 108.383 -0.969 . . . . 60.51 108.383 178.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.28 -19.2 50.36 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.916 2.41 . . . . 62.13 111.928 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.491 HD21 ' HB2' ' C' ' 154' ' ' ASP . 33.4 m-80 -126.6 30.58 5.51 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.021 0.928 . . . . 70.41 110.739 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.05 -49.51 50.23 Favored Pre-proline 0 N--CA 1.493 1.722 0 C-N-CA 124.55 1.14 . . . . 72.21 112.894 173.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.64 -24.46 1.86 Allowed 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 121.8 1.666 . . . . 72.44 113.699 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -76.56 -5.36 47.34 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.354 0.662 . . . . 72.32 112.356 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -68.14 -13.74 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.219 0 C-N-CA 123.849 0.86 . . . . 72.43 110.653 170.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.519 ' HZ ' ' HG3' ' C' ' 147' ' ' GLU . 65.3 t80 -57.2 -41.95 80.36 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 124.223 1.009 . . . . 75.41 110.78 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.653 ' NE2' ' HB3' ' C' ' 150' ' ' GLU . 64.2 mm-40 -75.75 -37.99 58.83 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.933 -1.031 . . . . 72.43 110.714 -173.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.406 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 77.5 mttt -107.93 89.03 2.87 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.462 -0.79 . . . . 64.34 109.71 -174.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -84.75 76.21 10.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.846 1.258 . . . . 73.14 112.025 -173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -172.93 156.23 3.3 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.357 0.663 . . . . 73.25 110.468 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -58.29 119.21 33.56 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.537 1.135 . . . . 61.33 111.473 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.576 ' HD2' ' HG2' ' B' ' 124' ' ' PRO . 37.8 Cg_endo -65.92 163.64 30.24 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.906 2.404 . . . . 72.44 112.018 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 -76.08 100.92 5.11 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.724 -1.213 . . . . 73.15 107.724 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.496 HG12 HD13 ' B' ' 126' ' ' LEU . 16.8 t -88.6 120.6 37.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 107.361 -1.348 . . . . 71.2 107.361 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -145.31 144.6 30.83 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.017 0.527 . . . . 64.32 110.276 -174.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.528 HD21 ' HG ' ' B' ' 128' ' ' LEU . 1.9 pt? -115.81 160.24 20.41 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.967 0.907 . . . . 70.35 110.065 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.24 138.18 44.88 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.455 1.102 . . . . 64.33 108.721 -178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 39.7 tp -90.96 134.34 34.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.248 0.619 . . . . 75.12 109.574 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -147.32 150.05 34.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.973 0.909 . . . . 74.31 108.609 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 76.3 m -142.92 113.42 7.37 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.105 -0.702 . . . . 75.01 109.105 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.75 120.81 32.84 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 107.384 -1.339 . . . . 70.11 107.384 173.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.5 p -132.92 172.26 12.85 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.941 0.496 . . . . 63.04 111.368 -171.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.3 p -152.77 179.08 8.96 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.864 0.866 . . . . 74.25 109.999 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -122.13 121.74 37.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.629 0.771 . . . . 71.24 110.083 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 81.4 mt -79.03 -44.8 21.48 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.619 0.767 . . . . 74.05 110.642 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.18 -172.01 3.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.56 -0.745 . . . . 35.32 110.911 -172.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -59.87 111.95 1.66 Allowed 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.767 -1.106 . . . . 75.23 110.265 -177.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 70.43 -5.91 1.28 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 126.047 1.739 . . . . 52.04 112.932 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -100.85 93.17 2.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.054 -1.091 . . . . 65.23 108.054 -171.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -97.13 141.07 30.7 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.898 -1.046 . . . . 73.31 110.005 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.657 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.7 tm-20 -105.2 100.15 9.74 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 106.888 -1.523 . . . . 64.4 106.888 175.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.64 117.68 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.25 0.62 . . . . 73.33 109.822 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.94 121.1 55.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 109.286 -0.635 . . . . 73.14 109.286 178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.06 118.08 30.79 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.05 -1.463 . . . . 72.33 107.05 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -106.45 116.45 31.94 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.494 0.717 . . . . 71.25 109.355 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.514 ' HB ' HD11 ' B' ' 114' ' ' ILE . 21.3 t -109.7 119.04 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 108.145 -1.057 . . . . 74.35 108.145 171.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -116.32 125.82 52.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.988 0.515 . . . . 71.3 110.21 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.666 HG21 HG21 ' B' ' 114' ' ' ILE . 77.8 t -107.72 137.43 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 C-N-CA 124.729 1.212 . . . . 71.13 110.898 -176.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.3 m -124.41 146.85 48.65 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.212 1.005 . . . . 74.21 109.923 172.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.93 156.26 42.49 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.066 0.946 . . . . 73.21 109.402 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.7 p -153.1 142.61 21.77 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 112.655 0.613 . . . . 75.22 112.655 -171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' B' ' 71' ' ' GLU . 62.1 mt -118.56 98.18 6.12 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.629 -0.878 . . . . 73.11 108.629 173.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.87 -110.44 2.62 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 122.954 0.311 . . . . 52.0 113.05 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -88.48 4.97 44.67 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.843 0.857 . . . . 61.1 110.285 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' B' ' 68' ' ' LEU . 1.2 mp0 -114.4 153.07 30.52 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.79 1.236 . . . . 65.41 109.998 -167.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.9 m -87.43 129.24 35.12 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 108.064 -1.088 . . . . 63.11 108.064 162.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.47 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -83.17 -55.8 4.14 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.849 -0.797 . . . . 43.33 108.849 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -159.1 150.29 20.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 114.804 -1.089 . . . . 71.44 110.694 176.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -124.88 113.87 18.44 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 125.505 1.522 . . . . 53.41 107.643 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.521 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 43.7 t -116.29 160.1 20.95 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.407 -0.961 . . . . 72.33 108.407 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -164.02 131.84 3.46 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.628 -0.878 . . . . 73.41 108.628 177.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.52 142.78 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 108.715 -0.846 . . . . 75.21 108.715 172.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.5 mt-30 -120.73 97.91 5.77 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.183 -0.917 . . . . 63.32 109.071 177.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -87.77 101.29 13.55 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.876 -0.787 . . . . 73.11 108.876 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.12 154.49 24.47 Favored Glycine 0 C--O 1.241 0.582 0 N-CA-C 111.16 -0.776 . . . . 71.45 111.16 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.73 126.16 2.01 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 109.673 -1.371 . . . . 55.4 109.673 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.657 HG12 ' HG2' ' B' ' 57' ' ' GLU . 27.9 mt -85.25 115.89 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.114 -1.069 . . . . 73.15 108.114 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -124.93 132.47 53.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 106.798 -1.556 . . . . 74.25 106.798 176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 22.1 m -88.97 88.63 7.66 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.025 -1.102 . . . . 62.43 108.025 175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -94.68 129.83 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.935 0.494 . . . . 65.22 110.626 -168.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.28 170.99 20.67 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 114.966 -1.015 . . . . 53.02 110.249 174.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 92.52 -49.35 2.62 Favored Glycine 0 C--N 1.343 0.927 0 CA-C-N 115.966 -0.561 . . . . 75.21 112.219 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.615 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -72.12 152.28 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.871 0.468 . . . . 74.51 111.316 174.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -160.4 172.48 17.2 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 114.848 -1.069 . . . . 63.01 108.97 172.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.93 -125.42 38.97 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.616 0.572 . . . . 61.12 113.747 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.0 m -74.57 -27.51 60.53 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.744 0.818 . . . . 54.34 111.109 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -68.9 -40.19 79.28 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.682 0.793 . . . . 71.33 109.881 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -74.48 -41.91 59.92 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.045 -0.525 . . . . 54.5 110.116 176.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.64 -36.73 62.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.149 0.98 . . . . 75.11 111.649 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.428 ' CE1' ' HA ' ' B' ' 134' ' ' ASP . 39.0 t-80 -93.34 -13.1 28.52 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.061 -0.972 . . . . 74.44 111.191 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -73.31 -64.32 1.01 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.623 0.369 . . . . 70.24 110.195 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.414 HD21 HD13 ' F' ' 177' ' ' LEU . 0.0 OUTLIER -74.36 -15.83 60.93 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 122.146 0.178 . . . . 50.12 111.167 -176.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.35 -6.08 53.67 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.227 -0.763 . . . . 73.43 114.198 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -149.5 -47.86 0.14 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.399 1.1 . . . . 60.2 112.875 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -73.21 -54.02 9.48 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.052 0.541 . . . . 74.3 111.254 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 68.1 m -63.01 -45.3 86.65 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 123.529 0.732 . . . . 60.23 111.335 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -50.78 -45.0 38.05 Favored 'Trans proline' 0 C--N 1.395 2.995 0 C-N-CA 122.416 2.077 . . . . 73.02 113.893 167.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -56.91 -34.45 67.96 Favored 'General case' 0 N--CA 1.501 2.099 0 C-N-CA 123.176 0.591 . . . . 62.13 112.057 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.525 HG23 ' NH2' ' D' ' 111' ' ' ARG . 79.5 mt -71.57 -47.98 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.659 0.784 . . . . 70.54 110.863 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -80.3 -20.88 43.33 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 115.233 -0.894 . . . . 61.11 112.298 -172.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.423 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 64.5 t80 -64.71 -45.78 75.82 Favored Pre-proline 0 N--CA 1.477 0.876 0 CA-C-O 117.653 -1.165 . . . . 64.24 113.387 -169.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 19.1 Cg_endo -56.72 -37.64 97.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 CA-C-N 121.581 1.6 . . . . 55.02 113.076 176.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -66.81 -49.6 65.29 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.31 0.644 . . . . 75.14 110.973 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.99 -42.39 98.34 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.717 0.807 . . . . 64.24 111.181 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.436 ' NH2' HG22 ' C' ' 122' ' ' THR . 50.1 ttt180 -58.87 -55.22 37.92 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.681 1.593 . . . . 70.41 110.96 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.78 -38.5 90.88 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.487 0.715 . . . . 74.12 109.918 -178.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.598 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.8 t -67.69 -42.08 82.64 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.745 -0.662 . . . . 60.22 112.103 -175.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.666 HG21 HG21 ' B' ' 64' ' ' VAL . 96.8 mt -62.52 -50.61 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.696 -0.483 . . . . 60.13 109.696 174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.523 HG23 HE21 ' C' ' 125' ' ' GLN . 86.7 m -55.59 -31.52 62.3 Favored 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.092 0.87 . . . . 75.53 111.183 -178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.9 t -66.05 -52.56 47.88 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.572 0.749 . . . . 72.21 110.403 172.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.485 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.6 mmt -67.36 -36.14 80.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.55 0.574 . . . . 64.42 112.55 -172.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.94 -42.02 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.639 0.776 . . . . 74.02 110.475 177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.763 ' HB2' ' HB3' ' C' ' 127' ' ' ASN . 90.3 p -71.73 -30.31 65.47 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.469 -0.787 . . . . 63.44 111.872 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -63.44 -33.7 76.13 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 65.15 110.368 173.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.77 9.0 58.05 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.839 0.712 . . . . 71.3 113.329 175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.9 p 56.15 27.97 12.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 125.892 1.677 . . . . 42.24 112.466 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -97.86 158.66 32.54 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-N 115.249 -0.887 . . . . 71.01 110.578 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.576 ' HG2' ' HD2' ' B' ' 38' ' ' PRO . 38.8 Cg_exo -61.98 179.73 0.53 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.484 2.789 . . . . 72.43 115.999 -171.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.63 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 5.1 pp0? -62.84 150.21 42.29 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 113.894 -1.503 . . . . 71.13 114.347 -175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.496 HD13 HG12 ' B' ' 40' ' ' VAL . 53.3 tp -141.61 86.04 1.98 Allowed 'General case' 0 C--O 1.243 0.721 0 N-CA-C 107.008 -1.478 . . . . 63.02 107.008 167.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' C' ' 119' ' ' SER . 7.1 m120 -116.11 90.62 3.38 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.485 -1.302 . . . . 75.04 107.485 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.528 ' HG ' HD21 ' B' ' 42' ' ' LEU . 1.9 tm? -84.88 138.01 32.79 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.512 -0.922 . . . . 73.43 108.512 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.433 ' HB2' ' NH1' ' D' ' 15' ' ' ARG . . . -67.62 107.24 1.64 Allowed Pre-proline 0 CA--C 1.54 0.577 0 O-C-N 124.357 1.035 . . . . 75.13 109.913 178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.01 129.71 25.28 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.09 1.86 . . . . 63.43 110.925 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.516 ' HA ' HD13 ' D' ' 13' ' ' ILE . 30.2 m -118.36 140.52 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.277 0.631 . . . . 71.34 110.522 -177.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.715 ' H ' HG21 ' D' ' 13' ' ' ILE . 15.6 m-20 -69.76 104.97 2.59 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.256 -0.883 . . . . 73.42 109.093 170.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -64.19 -14.37 54.82 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 120.858 0.361 . . . . 72.23 110.427 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.428 ' HA ' ' CE1' ' B' ' 96' ' ' HIS . 29.1 t70 -79.56 -55.12 5.27 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.085 0.954 . . . . 74.44 111.361 172.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.16 77.48 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.225 0.61 . . . . 73.35 111.64 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.98 -44.12 85.83 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.963 0.505 . . . . 73.05 110.266 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.5 -45.21 94.62 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.412 0.685 . . . . 72.23 110.425 176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -58.41 -38.81 78.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.301 1.04 . . . . 74.43 110.088 177.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -77.08 -29.11 54.87 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.407 -1.269 . . . . 73.24 111.05 -174.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -69.5 -23.19 63.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.357 0.663 . . . . 64.14 111.206 176.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.26 -6.47 15.52 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.205 0.602 . . . . 74.11 111.888 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -167.44 101.79 0.51 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.14 0.576 . . . . 70.33 110.907 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -132.02 101.96 5.63 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.918 -1.141 . . . . 75.53 107.918 171.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.695 ' HG2' ' HA ' ' D' ' 8' ' ' GLU . 7.5 tp60 -106.23 -58.5 1.91 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.83 -0.804 . . . . 70.45 108.83 175.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.98 92.88 0.05 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.328 1.451 . . . . 61.24 111.522 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.98 -169.09 23.72 Favored Glycine 0 C--N 1.352 1.463 0 CA-C-N 116.313 -0.403 . . . . 74.41 113.079 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.76 93.37 3.02 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 122.101 0.953 . . . . 74.54 111.747 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -85.3 -166.12 41.37 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-N 114.961 -1.018 . . . . 75.5 111.196 165.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.3 t -163.63 150.58 12.21 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 117.341 0.57 . . . . 72.24 110.564 -176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -173.14 107.0 0.15 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.399 0.68 . . . . 71.54 110.098 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.27 95.51 2.15 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.406 -0.59 . . . . 54.31 109.406 -178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -78.64 100.85 7.18 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 121.437 0.637 . . . . 63.25 109.987 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -87.91 97.23 10.82 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 116.103 -0.499 . . . . 62.51 109.752 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -151.79 168.46 25.01 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.03 0.932 . . . . 71.14 109.846 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.132 -0.937 . . . . 63.24 108.784 176.377 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 108.651 -0.87 . . . . 72.24 108.651 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 88.5 p 53.39 -172.94 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.659 1.584 . . . . 71.43 112.375 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.524 ' HG3' HG22 ' C' ' 7' ' ' THR . 24.9 tt0 -87.58 121.64 30.27 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.804 -1.184 . . . . 73.34 107.804 166.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -87.18 84.96 7.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.632 -0.713 . . . . 73.53 109.13 -174.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 16.4 t-20 76.74 -70.88 0.13 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.634 1.974 . . . . 74.52 111.33 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -156.2 139.15 15.36 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.146 -0.687 . . . . 53.24 109.146 176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.524 HG22 ' HG3' ' C' ' 3' ' ' GLU . 6.5 t -158.33 177.14 11.59 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-O 121.42 0.629 . . . . 73.24 110.995 175.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -160.25 -36.48 0.05 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.754 1.622 . . . . 42.32 107.141 173.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.6 ttt 63.69 112.56 0.03 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 126.294 1.838 . . . . 73.35 111.163 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 30.5 m -114.08 74.57 0.88 Allowed 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.054 -1.091 . . . . 74.35 108.054 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.591 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 8.0 t80 -100.28 119.67 38.75 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.104 -0.702 . . . . 61.1 109.104 -174.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -141.25 119.25 11.93 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 108.948 -0.76 . . . . 64.22 108.948 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.679 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -74.28 127.35 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 108.682 -0.859 . . . . 72.34 108.682 171.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.506 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 77.1 mm-40 -96.36 -49.52 5.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.096 0.558 . . . . 71.25 110.36 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -162.65 123.29 2.44 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.971 -0.381 . . . . 72.23 109.971 -171.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.679 HG13 HD11 ' C' ' 13' ' ' ILE . 76.6 mt -113.69 135.91 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 108.038 -1.097 . . . . 72.11 108.038 175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.9 p90 -174.5 158.29 2.79 Favored 'General case' 0 C--N 1.342 0.264 0 O-C-N 124.132 0.895 . . . . 64.4 110.866 -172.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -80.3 136.71 36.48 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.376 -0.829 . . . . 70.34 109.487 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.7 mmtp -89.55 -51.39 5.56 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 122.27 1.033 . . . . 72.32 108.846 171.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 25.9 t70 -134.91 132.91 39.05 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 113.134 -1.848 . . . . 52.44 108.2 -171.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.4 mt -129.29 140.52 48.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 106.728 -1.582 . . . . 73.11 106.728 172.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.8 t -148.71 145.02 27.48 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.402 -0.592 . . . . 74.43 109.402 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -151.72 111.64 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.032 -1.47 . . . . 75.35 107.032 173.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -115.06 117.87 31.79 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.832 -1.173 . . . . 62.11 107.832 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.36 87.84 8.16 Favored Pre-proline 0 C--O 1.243 0.739 0 N-CA-C 108.112 -1.07 . . . . 71.32 108.112 174.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.3 3.41 7.49 Favored 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 123.05 2.5 . . . . 62.42 111.709 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.3 12.56 8.21 Favored 'General case' 0 C--O 1.215 -0.751 0 C-N-CA 124.246 1.019 . . . . 73.01 109.936 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.39 -49.43 82.18 Favored Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.737 1.014 . . . . 75.25 113.737 -171.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -87.53 -27.87 0.54 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 121.666 1.578 . . . . 54.11 113.449 170.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -70.12 -25.74 63.63 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.205 1.002 . . . . 63.11 112.905 -173.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.57 -6.86 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.328 1.051 . . . . 71.41 111.564 -178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -56.95 -41.7 78.75 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.357 1.063 . . . . 72.4 112.638 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 tm0? -100.42 4.24 43.68 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.702 0.801 . . . . 53.31 110.606 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.496 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.5 OUTLIER -87.68 168.21 13.2 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.058 0.543 . . . . 62.13 111.76 -168.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -73.08 113.53 10.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.008 -0.738 . . . . 63.45 109.008 167.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.3 m-90 -86.78 65.21 8.9 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.497 0.719 . . . . 65.03 110.157 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -135.57 78.98 48.74 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 108.414 -0.958 . . . . 73.21 108.414 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -74.96 167.57 26.77 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.826 2.351 . . . . 53.03 112.448 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -122.83 109.25 13.95 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.971 -1.122 . . . . 73.03 107.971 171.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.568 HG11 HD11 ' C' ' 126' ' ' LEU . 97.6 t -78.45 103.11 5.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.829 -0.804 . . . . 65.22 108.829 177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -91.66 116.33 28.79 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.522 -1.288 . . . . 60.4 107.522 173.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.418 HD12 HG12 ' C' ' 40' ' ' VAL . 9.2 mp -85.93 149.1 25.44 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.974 0.51 . . . . 73.42 109.84 -179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.35 142.29 25.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.847 0.859 . . . . 74.21 108.976 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -135.17 136.02 41.51 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.897 -0.779 . . . . 74.23 108.897 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.468 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 28.0 t70 -141.18 145.9 36.26 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.991 -1.114 . . . . 71.42 107.991 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -114.2 137.5 51.68 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.096 0.558 . . . . 55.41 110.472 -176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.75 157.28 47.13 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.444 1.097 . . . . 35.11 108.589 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 70.2 p -160.22 150.53 18.39 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.741 0.416 . . . . 74.25 110.95 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.3 t -149.43 133.24 16.95 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.554 0.742 . . . . 75.03 109.511 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -77.98 139.03 39.14 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.602 -0.518 . . . . 74.23 109.602 174.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.585 HD11 HD12 ' C' ' 83' ' ' ILE . 53.1 mt -114.65 -30.52 6.47 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.773 0.829 . . . . 73.03 110.893 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.33 -175.07 4.34 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.25 1.02 . . . . 74.34 110.142 -177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.39 100.16 0.34 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.445 -0.798 . . . . 24.33 110.223 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.425 ' HA ' ' SD ' ' E' ' 174' ' ' MET . 0.9 OUTLIER 64.75 9.25 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 125.273 1.429 . . . . 75.31 113.843 -177.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 89.9 t -100.41 117.95 46.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.635 -1.617 . . . . 62.42 106.635 164.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.407 ' HB3' ' SD ' ' E' ' 174' ' ' MET . 1.2 p90 -137.06 -178.1 5.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.852 -0.796 . . . . 73.35 108.852 -176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -128.51 138.9 52.49 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 124.336 1.055 . . . . 63.43 109.829 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 48.3 t -112.69 127.72 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.767 -1.197 . . . . 72.22 107.767 168.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 88.9 t -121.8 111.32 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.913 0.885 . . . . 40.01 109.123 176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' C' ' 103' ' ' PRO . 54.4 mt -87.53 109.06 19.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.077 0.551 . . . . 71.35 110.316 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.468 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 79.6 ttt180 -85.38 102.03 13.08 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.308 -0.997 . . . . 73.42 108.308 172.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.46 124.13 55.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 107.913 -1.143 . . . . 52.23 107.913 177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -124.99 142.34 51.55 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.407 0.622 . . . . 71.14 109.769 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.531 HG11 HD22 ' C' ' 126' ' ' LEU . 70.6 t -135.52 130.22 50.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 124.442 1.097 . . . . 65.53 108.93 -176.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 26.6 m -112.35 141.41 46.1 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.112 -1.07 . . . . 75.03 108.112 172.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.54 125.52 45.9 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 107.475 -1.306 . . . . 74.13 107.475 173.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 21.4 m -135.58 131.31 35.74 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.102 0.477 . . . . 65.32 110.5 -177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.496 HD13 ' HG2' ' C' ' 34' ' ' LYS . 11.7 mt -86.6 35.13 0.66 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 125.602 1.561 . . . . 65.42 109.321 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.57 -112.01 3.57 Favored Glycine 0 C--N 1.353 1.527 0 N-CA-C 110.743 -0.943 . . . . 53.21 110.743 -168.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -88.56 -31.52 18.6 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.632 0.773 . . . . 74.01 109.67 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -70.03 121.98 18.49 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.807 1.243 . . . . 74.41 110.363 175.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.5 m -80.05 131.66 35.82 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.765 0.257 . . . . 72.3 110.33 177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.23 -53.89 4.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.112 0.565 . . . . 64.05 110.005 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -162.28 176.7 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.568 0.747 . . . . 73.01 111.07 176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.482 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.4 tm? -136.73 143.96 43.59 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.656 -1.609 . . . . 63.3 106.656 171.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.482 ' N ' HD13 ' C' ' 75' ' ' LEU . 39.1 t -144.69 141.49 29.35 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.394 -0.965 . . . . 64.44 108.394 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -155.22 131.66 10.41 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.677 -0.49 . . . . 63.33 109.677 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.76 145.09 36.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 124.401 1.08 . . . . 64.21 108.305 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -121.1 96.84 5.26 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.232 1.013 . . . . 72.14 108.335 175.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -85.28 105.13 15.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.272 0.629 . . . . 74.21 110.556 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.45 150.57 25.86 Favored Glycine 0 C--N 1.337 0.625 0 O-C-N 123.668 0.605 . . . . 63.25 112.566 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.54 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -155.72 117.74 0.8 Allowed Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 111.47 -0.652 . . . . 64.21 111.47 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.585 HD12 HD11 ' C' ' 51' ' ' LEU . 9.5 mm -80.99 128.63 38.56 Favored 'Isoleucine or valine' 0 C--O 1.246 0.899 0 N-CA-C 108.733 -0.84 . . . . 52.33 108.733 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -135.11 131.17 36.57 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.193 0.597 . . . . 73.41 110.101 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 t -92.0 122.42 34.49 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.389 -1.337 . . . . 50.53 107.389 164.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 40.8 pt -113.71 -142.42 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.264 0 CA-C-O 118.379 -0.819 . . . . 74.2 109.175 174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 97.78 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.896 2.079 . . . . 72.2 110.596 176.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -39.56 3.1 Favored Glycine 0 CA--C 1.531 1.07 0 N-CA-C 111.316 -0.714 . . . . 64.45 111.316 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.416 HG13 ' H ' ' C' ' 89' ' ' ILE . 2.2 pp -77.65 162.57 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 C-N-CA 124.366 1.066 . . . . 75.32 111.166 169.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -168.77 157.65 8.49 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.133 0.573 . . . . 65.4 110.462 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.07 -119.45 8.01 Favored Glycine 0 C--N 1.357 1.696 0 CA-C-N 116.011 -0.541 . . . . 74.33 112.88 170.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.702 HG21 ' H ' ' A' ' 150' ' ' GLU . 60.3 p -57.64 -44.0 85.27 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.119 0.968 . . . . 72.12 111.036 178.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.13 -46.72 87.75 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.531 -1.213 . . . . 70.33 110.519 -176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 23.1 ttt -69.98 -41.94 73.76 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.676 -0.693 . . . . 74.34 110.957 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.35 -34.1 76.97 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.976 0.51 . . . . 71.2 110.908 179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.456 ' HA ' ' OH ' ' E' ' 181' ' ' TYR . 62.1 m170 -84.31 -21.48 30.99 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.672 0.789 . . . . 72.11 112.148 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.457 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 97.9 m -73.88 -59.75 2.57 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.701 0.401 . . . . 74.42 109.997 172.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.69 -26.3 68.32 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.179 0.991 . . . . 70.11 111.827 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.95 -22.44 42.19 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.375 -0.68 . . . . 75.02 114.295 -177.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.84 -50.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 118.077 0.938 . . . . 64.5 113.428 -171.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.457 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 85.4 t80 -69.87 -55.64 9.21 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 112.482 0.549 . . . . 74.25 112.482 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.591 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 32.0 m -60.9 -45.11 96.64 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.544 0.738 . . . . 52.45 111.277 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' C' ' 60' ' ' LEU . 91.5 Cg_exo -53.08 -40.37 76.96 Favored 'Trans proline' 0 C--N 1.393 2.906 0 C-N-CA 122.591 2.194 . . . . 74.32 114.912 167.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -59.45 -34.38 72.45 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 123.341 0.656 . . . . 72.01 111.511 -176.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.455 HG23 ' NH1' ' A' ' 111' ' ' ARG . 51.4 mm -62.87 -42.4 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 115.471 -0.786 . . . . 72.22 110.554 176.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.54 HD21 ' HA3' ' C' ' 82' ' ' GLY . 73.8 mt -82.79 -25.43 32.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.988 0.915 . . . . 73.32 112.544 -171.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -53.16 -51.49 74.7 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.753 1.02 . . . . 73.11 113.753 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.423 ' HB3' ' CD2' ' A' ' 109' ' ' TYR . 19.5 Cg_endo -58.32 -33.95 98.19 Favored 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 121.837 1.691 . . . . 72.54 113.665 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.43 ' HE2' HG21 ' A' ' 115' ' ' THR . 86.5 m-85 -67.65 -47.73 68.72 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.436 0.694 . . . . 72.25 110.812 177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.97 -41.84 92.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.762 0.825 . . . . 71.02 110.677 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -60.47 -53.26 59.72 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.678 1.591 . . . . 62.22 110.726 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.43 -30.94 70.81 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.699 0.799 . . . . 65.44 110.513 -176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.3 t -65.77 -38.04 87.97 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.845 0.458 . . . . 74.21 110.655 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.458 HG23 ' SG ' ' C' ' 76' ' ' CYS . 61.0 mt -73.24 -42.07 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 116.021 -0.536 . . . . 73.12 110.385 175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.6 m -55.94 -44.24 78.21 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.496 0.719 . . . . 53.42 110.928 -178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 85.6 p -70.58 -47.41 60.36 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 115.248 -0.887 . . . . 70.23 110.462 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.512 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -54.22 -45.77 72.34 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 124.319 1.048 . . . . 74.44 112.768 -177.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.1 t -60.73 -42.86 93.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 O-C-N 123.673 0.608 . . . . 74.13 110.509 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.417 ' HA ' ' ND2' ' B' ' 127' ' ' ASN . 37.6 t -67.82 -27.78 67.01 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.318 -0.855 . . . . 63.14 112.373 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.5 mtt-85 -69.02 -36.08 77.36 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.245 0.618 . . . . 72.53 109.575 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.96 7.96 64.78 Favored Glycine 0 C--N 1.36 1.895 0 O-C-N 123.794 0.684 . . . . 71.13 112.951 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.436 HG22 ' NH2' ' B' ' 111' ' ' ARG . 17.3 p 63.37 16.18 9.31 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 127.369 2.268 . . . . 74.21 113.586 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.91 153.38 63.73 Favored Pre-proline 0 C--O 1.243 0.715 0 N-CA-C 107.894 -1.15 . . . . 71.54 107.894 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.493 ' HB2' ' OH ' ' F' ' 202' ' ' TYR . 17.0 Cg_endo -51.98 118.56 4.63 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.969 2.446 . . . . 63.42 112.088 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.63 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 3.5 pt20 -44.77 146.89 0.7 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 124.906 1.282 . . . . 63.52 112.434 -172.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.568 HD11 HG11 ' C' ' 40' ' ' VAL . 14.7 tp -109.59 79.83 1.25 Allowed 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.71 0.767 . . . . 74.42 112.845 -176.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.763 ' HB3' ' HB2' ' B' ' 119' ' ' SER . 6.9 p-10 -97.47 90.3 5.0 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.572 -1.195 . . . . 72.12 109.564 172.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 66.9 mt -74.83 146.0 42.37 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.478 -1.237 . . . . 72.24 109.465 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.03 130.03 92.83 Favored Pre-proline 0 CA--C 1.548 0.873 0 O-C-N 123.339 0.399 . . . . 52.51 110.334 -177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.483 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 42.6 Cg_endo -65.61 101.31 0.44 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.955 2.437 . . . . 60.2 112.27 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.647 ' HB ' HD11 ' C' ' 136' ' ' LEU . 31.2 m -84.66 130.01 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 115.504 -0.771 . . . . 73.42 111.153 -177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -97.32 105.28 17.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.659 -1.238 . . . . 73.05 107.659 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' C' ' 136' ' ' LEU . 57.3 t80 -48.14 -44.93 32.61 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.575 1.15 . . . . 72.34 113.529 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -65.96 -41.32 91.39 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 123.484 0.49 . . . . 43.11 110.327 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.486 ' HB1' ' OE1' ' A' ' 12' ' ' GLN . . . -62.93 -38.13 89.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.837 0.855 . . . . 73.24 111.951 178.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.647 HD11 ' HB ' ' C' ' 131' ' ' VAL . 65.9 mt -64.57 -38.99 92.92 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.624 0.77 . . . . 73.24 110.646 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -71.58 -42.9 67.22 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.263 -0.88 . . . . 73.22 110.728 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 70.8 mtm -63.74 -50.18 70.11 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.294 0.638 . . . . 74.45 110.678 -178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.543 HD21 ' NE2' ' A' ' 12' ' ' GLN . 95.0 m-20 -57.55 -36.07 71.16 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.896 0.879 . . . . 73.44 112.025 179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -58.61 -80.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.303 0.641 . . . . 64.43 110.011 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.07 -27.96 68.73 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.863 0.865 . . . . 73.25 112.707 -175.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -129.27 116.16 18.71 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.41 -0.959 . . . . 72.53 108.41 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -64.28 154.02 36.45 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.376 0.67 . . . . 71.14 112.525 -175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.414 ' HA ' HG21 ' A' ' 10' ' ' THR . 7.7 tt0 -88.45 151.23 22.7 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.241 -0.436 . . . . 52.24 110.249 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.516 ' H ' HG21 ' A' ' 10' ' ' THR . . . -74.28 157.42 35.85 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.537 0.735 . . . . 60.22 110.216 170.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.63 163.17 53.52 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 114.159 0.424 . . . . 51.53 114.159 -172.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.519 ' HG3' ' HZ ' ' B' ' 32' ' ' PHE . 0.0 OUTLIER -84.44 177.27 8.19 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.644 0.778 . . . . 74.02 110.939 176.485 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -133.96 168.95 23.1 Favored Glycine 0 C--N 1.347 1.146 0 CA-C-N 115.916 -0.584 . . . . 72.01 111.927 177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.7 p -77.2 133.24 38.96 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.635 0.774 . . . . 61.14 111.091 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.653 ' HB3' ' NE2' ' B' ' 33' ' ' GLN . 11.6 tt0 -121.71 149.91 42.56 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.442 1.097 . . . . 71.24 108.676 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.47 ' HG3' HE22 ' C' ' 153' ' ' GLN . 10.6 pt-20 -98.17 142.96 29.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.103 0.561 . . . . 72.22 110.944 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -112.1 139.17 47.84 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.986 0.914 . . . . 74.22 108.594 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.47 HE22 ' HG3' ' C' ' 151' ' ' GLU . 0.0 OUTLIER -149.85 97.27 2.57 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.583 0.706 . . . . 75.54 109.571 -176.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . 0.491 ' HB2' HD21 ' B' ' 27' ' ' ASN . 9.4 t70 -135.77 79.01 1.75 Allowed 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.834 -1.172 . . . . 74.35 107.834 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.046 -0.979 . . . . 37.83 110.117 -179.177 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.826 -0.435 . . . . 34.15 109.826 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.3 m -119.79 144.98 47.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.686 0.794 . . . . 72.31 109.517 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -67.83 158.62 32.13 Favored 'General case' 0 C--O 1.241 0.645 0 O-C-N 123.681 0.613 . . . . 62.42 110.143 170.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.431 HE21 ' HA2' ' H' ' 169' ' ' GLY . 5.3 pp0? -117.57 134.37 54.94 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.497 -0.927 . . . . 71.43 108.497 168.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -126.93 89.87 3.06 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.04 -1.096 . . . . 63.01 108.04 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -93.55 179.82 5.26 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.306 -0.861 . . . . 72.35 109.305 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -65.18 -9.87 26.72 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 123.533 0.733 . . . . 51.25 112.126 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.695 ' HA ' ' HG2' ' B' ' 144' ' ' GLN . 1.2 mp0 -51.81 -43.74 63.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.023 0.529 . . . . 74.24 111.976 169.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.566 ' SD ' HG23 ' D' ' 89' ' ' ILE . 13.3 tpt -33.83 121.29 0.44 Allowed 'General case' 0 C--N 1.36 1.025 0 O-C-N 125.082 1.489 . . . . 72.32 112.878 177.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 83.3 m -151.76 143.18 23.45 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.674 1.19 . . . . 71.44 108.535 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.452 ' CZ ' ' SG ' ' D' ' 102' ' ' CYS . 43.4 t80 -157.31 126.48 5.92 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.658 ' HB3' HG12 ' E' ' 207' ' ' VAL . 47.7 mt-30 -140.08 158.11 44.57 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.143 0.577 . . . . 74.04 110.205 -170.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.715 HG21 ' H ' ' B' ' 132' ' ' ASN . 10.5 tt -104.39 144.18 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.25 1.02 . . . . 74.52 110.191 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -114.44 -45.88 3.0 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.382 0.273 . . . . 73.22 111.624 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.433 ' NH1' ' HB2' ' B' ' 129' ' ' ALA . 12.7 tpt180 -169.79 130.75 1.04 Allowed 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 119.33 -0.367 . . . . 70.31 110.923 -171.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.557 HG12 HD11 ' D' ' 13' ' ' ILE . 32.9 mm -116.73 130.37 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 109.206 -0.664 . . . . 65.04 109.206 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.09 158.79 39.59 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.741 0.817 . . . . 75.25 111.731 -173.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.4 p -88.09 116.35 26.21 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.358 -0.608 . . . . 72.53 109.358 172.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -84.17 -29.13 26.89 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 116.148 -0.478 . . . . 73.52 110.109 175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.2 t70 -149.99 137.58 19.94 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.114 -0.948 . . . . 65.33 109.746 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.512 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.7 mt -133.57 139.54 48.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 107.333 -1.358 . . . . 61.34 107.333 172.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -147.94 112.0 5.17 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.502 0.501 . . . . 44.04 110.012 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.559 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 83.6 t80 -109.73 122.22 46.99 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 105.674 -1.973 . . . . 71.21 105.674 167.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -132.97 109.28 9.46 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.598 -0.89 . . . . 63.41 108.598 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.73 83.45 4.57 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 108.75 -0.834 . . . . 52.5 108.75 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.75 -27.61 31.46 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.494 2.129 . . . . 62.31 112.074 -170.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -114.14 35.59 4.09 Favored 'General case' 0 C--O 1.205 -1.27 0 C-N-CA 124.588 1.155 . . . . 61.41 109.238 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.57 -58.76 16.74 Favored Pre-proline 0 CA--C 1.576 1.963 0 N-CA-C 114.947 1.462 . . . . 75.13 114.947 -164.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.2 Cg_endo -81.68 -14.31 10.24 Favored 'Trans proline' 0 C--N 1.389 2.708 0 CA-C-N 122.384 1.887 . . . . 62.41 113.027 174.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t-160 -68.67 -42.27 78.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.824 0.85 . . . . 62.12 109.934 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.567 HG21 ' HA ' ' D' ' 73' ' ' ALA . 1.0 OUTLIER -85.76 -2.37 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.082 -0.963 . . . . 63.52 110.226 -172.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -56.4 -35.37 67.7 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.022 0.929 . . . . 73.41 111.005 164.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -65.42 -29.06 69.72 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.02 0.928 . . . . 71.5 111.146 174.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.463 ' HB3' ' HB3' ' D' ' 68' ' ' LEU . 23.1 mmtp -91.74 74.19 5.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.228 1.011 . . . . 75.01 110.189 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.499 ' O ' ' HD2' ' H' ' 196' ' ' LYS . 11.9 p-10 -87.42 79.46 8.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.079 0.942 . . . . 65.14 109.001 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 26.1 m95 -134.17 178.16 7.19 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.139 1.376 . . . . 71.24 108.168 -178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 59.0 tp60 -75.68 118.38 70.49 Favored Pre-proline 0 N--CA 1.479 0.984 0 CA-C-N 118.547 0.612 . . . . 73.32 109.446 170.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.26 109.52 0.73 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.225 1.95 . . . . 52.54 111.182 172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.49 113.64 3.81 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.135 -1.061 . . . . 72.4 108.135 173.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.568 HG13 HG13 ' D' ' 64' ' ' VAL . 97.5 t -95.76 106.2 17.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.616 -0.883 . . . . 75.24 108.616 -172.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -87.78 110.35 20.41 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 106.124 -1.806 . . . . 73.51 106.124 169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.669 HD21 ' HA ' ' H' ' 188' ' ' ALA . 3.9 pp -94.66 157.22 16.06 Favored 'General case' 0 C--O 1.246 0.877 0 N-CA-C 108.04 -1.096 . . . . 72.24 108.04 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.51 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 11.4 t70 -146.18 132.37 19.42 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 109.899 -0.408 . . . . 62.13 109.899 177.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' H' ' 186' ' ' LEU . 61.2 tp -102.31 130.5 49.04 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.168 0.987 . . . . 72.43 109.036 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -147.44 150.19 34.16 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.814 0.846 . . . . 53.2 108.914 170.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.6 t -126.42 159.33 33.6 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.256 0.622 . . . . 72.13 110.4 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.607 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.13 161.64 42.34 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.508 1.123 . . . . 75.11 108.958 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 67.5 p -162.31 153.4 17.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.977 0.511 . . . . 64.24 110.936 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -155.47 147.81 23.8 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.717 0.807 . . . . 45.35 109.644 177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -82.35 118.08 22.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.274 -0.639 . . . . 73.52 109.274 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.687 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.0 mt -92.66 -33.49 14.35 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 110.074 -0.343 . . . . 75.24 110.074 176.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.52 -177.96 2.92 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.282 1.033 . . . . 75.24 109.809 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -64.03 124.44 21.6 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.407 0.683 . . . . 53.14 109.977 179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 65.0 14.25 9.22 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.036 1.334 . . . . 74.53 112.487 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 92.6 t -119.22 128.9 75.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 C-N-CA 123.624 0.77 . . . . 72.01 109.404 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.35 149.78 50.37 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.848 0.859 . . . . 75.4 109.733 174.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.687 ' HB2' HD11 ' D' ' 51' ' ' LEU . 27.9 tt0 -109.38 117.47 34.14 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.299 -1.371 . . . . 73.42 107.299 163.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.27 129.75 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 107.528 -1.286 . . . . 73.42 107.528 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.607 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 40.7 t -113.19 132.29 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.67 -0.863 . . . . 62.11 108.67 178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -108.62 126.05 52.53 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.949 -1.13 . . . . 63.15 107.949 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 40.7 ttm-85 -101.01 105.06 16.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.211 -1.033 . . . . 72.02 108.211 170.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -102.13 120.78 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 107.586 -1.264 . . . . 52.44 107.586 169.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.5 m -117.73 147.02 43.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.258 0.623 . . . . 65.11 109.452 -175.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.568 HG13 HG13 ' D' ' 40' ' ' VAL . 69.2 t -133.87 100.57 3.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.014 1.326 . . . . 70.33 107.822 176.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.4 m -91.97 89.96 7.21 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 105.594 -2.002 . . . . 62.55 105.594 167.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' CD1' ' D' ' 74' ' ' PHE . . . -100.0 132.6 45.26 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 114.895 -1.048 . . . . 54.54 108.389 -173.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.502 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 71.5 m -141.15 137.36 32.67 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 122.113 0.959 . . . . 73.15 111.814 -175.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' D' ' 34' ' ' LYS . 54.8 mt -100.19 100.53 11.38 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 113.363 -1.744 . . . . 41.12 109.669 176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.1 -123.6 10.68 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.835 -0.621 . . . . 71.22 111.957 -177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.92 4.21 53.46 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.353 0.661 . . . . 73.43 110.941 177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.71 144.74 46.04 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.195 0.598 . . . . 62.41 110.026 -171.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 57.6 m -72.03 128.94 37.29 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.482 0.488 . . . . 70.33 110.208 177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.567 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -78.33 -61.09 2.12 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.587 -0.894 . . . . 73.23 108.587 177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.574 ' CZ ' HG22 ' D' ' 118' ' ' VAL . 0.5 OUTLIER -159.59 177.62 10.71 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 113.859 -1.519 . . . . 74.12 108.329 171.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -134.34 107.47 7.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 106.447 -1.686 . . . . 73.01 106.447 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.597 ' SG ' HG12 ' D' ' 114' ' ' ILE . 1.9 t -113.77 146.29 40.12 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.836 0.454 . . . . 63.12 111.763 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -157.32 136.53 11.88 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.26 1.024 . . . . 73.24 109.158 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.36 116.26 24.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 108.998 -0.742 . . . . 71.34 108.998 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -91.89 88.21 6.53 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.703 0.764 . . . . 72.14 109.518 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.442 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.7 tp-100 -82.09 104.19 12.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.239 -1.346 . . . . 74.15 109.034 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.95 155.36 23.03 Favored Glycine 0 N--CA 1.465 0.568 0 N-CA-C 111.444 -0.662 . . . . 21.34 111.444 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.419 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -159.08 132.03 2.93 Favored Glycine 0 CA--C 1.504 -0.628 0 N-CA-C 111.574 -0.61 . . . . 50.33 111.574 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 34.3 mt -88.51 134.15 28.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 109.141 -0.689 . . . . 73.23 109.141 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -137.37 148.5 46.29 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.95 0.9 . . . . 72.01 110.06 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.411 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 30.7 m -90.58 135.54 33.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.92 0.888 . . . . 65.2 109.138 170.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 5.0 tt -138.08 117.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 123.87 0.868 . . . . 71.41 110.166 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -167.27 146.29 5.08 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.94 0.896 . . . . 44.31 110.103 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.81 0.27 59.04 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 113.737 0.255 . . . . 63.24 113.737 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.566 HG23 ' SD ' ' D' ' 9' ' ' MET . 1.8 pp -103.06 164.13 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.098 0.959 . . . . 75.54 110.831 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.422 ' HG2' HE21 ' D' ' 4' ' ' GLN . 0.0 OUTLIER -172.54 164.21 5.5 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 124.132 0.895 . . . . 75.51 110.31 173.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.58 -127.09 38.86 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 115.566 -0.743 . . . . 65.45 113.986 173.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.6 p -77.1 -27.31 54.09 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.777 0.831 . . . . 61.35 111.54 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -61.65 -48.01 82.78 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.938 0.895 . . . . 64.25 110.846 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.649 ' SD ' ' HB1' ' H' ' 172' ' ' ALA . 25.3 ptm -68.73 -41.27 79.22 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.0 -0.545 . . . . 73.21 111.714 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.4 -31.15 72.25 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.484 0.714 . . . . 73.21 111.104 -175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -81.16 -37.47 28.72 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.348 -0.842 . . . . 72.0 110.453 177.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.1 t -66.0 -49.79 66.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.166 0.586 . . . . 74.14 111.879 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.821 HD11 HD11 ' H' ' 177' ' ' LEU . 4.5 pp -83.82 -26.32 29.63 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.541 0.336 . . . . 74.03 111.23 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.31 -27.75 29.63 Favored Glycine 0 C--N 1.354 1.566 0 O-C-N 123.304 0.378 . . . . 64.5 113.447 -175.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -115.76 -60.06 1.92 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.155 0.582 . . . . 75.34 110.469 -174.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.419 ' O ' HG12 ' D' ' 105' ' ' ILE . 86.4 t80 -63.54 -49.61 72.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.733 0.413 . . . . 71.12 111.995 -174.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.766 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 60.9 m -58.24 -51.58 80.74 Favored Pre-proline 0 CA--C 1.563 1.474 0 CA-C-O 118.642 -0.694 . . . . 72.23 112.494 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 39.3 Cg_exo -64.91 -32.79 54.26 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 121.66 1.574 . . . . 72.34 112.827 173.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -62.58 -32.17 73.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 122.971 0.508 . . . . 70.41 111.148 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.419 HG12 ' O ' ' D' ' 101' ' ' TYR . 38.2 mm -71.37 -35.68 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.756 0.822 . . . . 72.34 110.997 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' D' ' 80' ' ' GLN . 66.7 mt -75.04 -19.84 59.84 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.399 -0.819 . . . . 64.04 110.827 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -68.32 -42.5 29.35 Favored Pre-proline 0 CA--C 1.558 1.286 0 N-CA-C 114.294 1.22 . . . . 62.44 114.294 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -56.15 -40.42 84.96 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.069 1.846 . . . . 73.05 113.401 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -77.96 -35.0 50.77 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.052 0.941 . . . . 72.44 111.25 -178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.59 -42.87 77.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.467 0.707 . . . . 65.24 109.841 176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.525 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.7 ttp180 -62.43 -46.62 87.7 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.438 -1.255 . . . . 74.14 109.888 177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.92 -46.8 89.23 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 123.963 0.79 . . . . 71.51 110.743 -177.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.426 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.8 t -59.23 -40.98 87.6 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.587 0.555 . . . . 62.32 110.678 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.597 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.8 mt -59.92 -57.29 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 122.915 0.486 . . . . 71.3 109.87 171.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 55.9 m -52.53 -44.49 65.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.36 1.464 . . . . 72.41 111.709 -172.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -67.45 -44.55 78.39 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.528 -1.215 . . . . 44.32 110.07 -177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 66.7 mtm -66.01 -38.47 88.54 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.74 0.416 . . . . 71.32 111.411 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.574 HG22 ' CZ ' ' D' ' 74' ' ' PHE . 98.6 t -62.53 -45.27 99.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 O-C-N 124.141 0.901 . . . . 62.33 109.795 178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.0 p -71.45 -32.8 68.75 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 122.933 0.493 . . . . 74.33 111.03 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 79.9 mtt-85 -70.08 -27.15 64.38 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.577 0.751 . . . . 74.23 109.949 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.17 11.89 70.8 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 123.918 0.761 . . . . 53.32 112.83 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.478 HG23 ' HB3' ' C' ' 17' ' ' TYR . 55.8 p 58.26 32.08 21.61 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 125.863 1.665 . . . . 42.51 113.356 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.431 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 84.9 m-85 -101.92 165.06 14.61 Favored Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 124.233 1.013 . . . . 73.13 108.296 168.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 57.3 Cg_endo -67.41 149.72 80.6 Favored 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.487 2.124 . . . . 61.34 112.423 -178.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -59.19 126.92 29.63 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.294 0.637 . . . . 64.31 111.091 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.472 HD13 HG21 ' D' ' 40' ' ' VAL . 60.4 tp -107.79 96.48 6.42 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.529 0.732 . . . . 72.22 110.458 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -103.89 95.04 5.75 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 109.478 -0.564 . . . . 73.12 109.478 175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.411 HD22 ' HA ' ' D' ' 128' ' ' LEU . 0.8 OUTLIER -73.96 134.28 43.1 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 109.227 -0.657 . . . . 73.31 109.227 179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.86 138.53 87.07 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.812 0.845 . . . . 65.42 111.569 -176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -83.6 103.8 1.1 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.306 2.004 . . . . 53.24 110.889 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 p -107.71 110.92 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-O 121.708 0.766 . . . . 60.1 110.415 -171.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -90.45 116.41 28.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 115.045 -0.98 . . . . 71.53 109.648 175.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.431 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 79.5 m-85 -63.72 -12.38 34.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.269 0.628 . . . . 63.22 111.127 175.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -57.62 -57.23 13.63 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.39 1.076 . . . . 60.33 110.962 170.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.06 85.44 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 123.589 0.555 . . . . 51.54 111.635 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 76.4 mt -70.54 -41.13 72.93 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.612 0.765 . . . . 63.3 111.61 -177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -71.71 -54.51 10.08 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.437 0.695 . . . . 74.22 110.313 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.6 mtm -61.07 -30.49 70.37 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.337 0.655 . . . . 73.13 111.397 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.4 ' HA ' HE21 ' D' ' 142' ' ' GLN . 26.5 t-20 -51.49 -38.02 51.96 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.04 0.936 . . . . 72.42 111.938 175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -77.33 -42.23 37.5 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.597 0.759 . . . . 74.44 110.826 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.39 -29.87 47.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.03 0.752 . . . . 73.32 113.03 -171.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.4 HE21 ' HA ' ' D' ' 139' ' ' ASN . 28.5 pt20 -89.07 30.34 0.96 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.098 0.559 . . . . 64.42 111.677 -172.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -119.72 51.35 1.18 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.192 0.997 . . . . 71.21 108.886 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -163.93 10.8 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 114.957 -1.02 . . . . 71.42 111.093 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -117.72 -54.69 2.33 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.547 0.739 . . . . 74.44 110.379 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.14 -122.08 6.3 Favored Glycine 0 C--O 1.239 0.451 0 CA-C-N 115.001 -1.0 . . . . 74.11 111.558 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -137.48 138.96 40.26 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 108.249 -1.019 . . . . 65.33 108.249 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.32 -124.97 0.21 Allowed Glycine 0 C--N 1.348 1.214 0 O-C-N 123.73 0.644 . . . . 42.42 112.342 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 91.1 m -153.68 145.45 23.43 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.843 0.857 . . . . 52.53 109.246 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -57.33 119.96 7.35 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.665 0.786 . . . . 71.21 110.529 176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -61.69 123.75 18.81 Favored 'General case' 0 C--O 1.241 0.631 0 O-C-N 124.344 1.028 . . . . 53.42 109.317 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -62.55 141.25 58.53 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.856 0.723 . . . . 54.24 110.139 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.92 103.03 0.18 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.417 1.087 . . . . 75.11 109.406 -177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -76.82 151.32 35.95 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.692 0.797 . . . . 74.34 111.065 -175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.389 0 C-N-CA 123.995 0.918 . . . . 61.14 109.393 179.159 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 23.8 pttm . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 122.215 1.007 . . . . 71.01 110.056 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -73.7 -16.12 79.24 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 114.61 -1.177 . . . . 72.23 112.719 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 62.07 -162.45 0.28 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.983 1.313 . . . . 72.42 111.653 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 18.9 m -49.98 104.31 0.07 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.732 1.213 . . . . 75.14 111.896 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . -94.85 -59.3 1.95 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.666 0.787 . . . . 75.4 110.325 -175.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.88 145.57 13.99 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.102 0.561 . . . . 61.45 110.274 -174.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.425 ' SD ' ' HA ' ' C' ' 54' ' ' ASP . 0.1 OUTLIER -122.26 131.82 54.11 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 122.3 -0.25 . . . . 75.22 111.007 -176.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 56.6 108.24 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 126.084 1.754 . . . . 73.33 114.314 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . 0.453 HD21 ' NE2' ' E' ' 178' ' ' GLN . 56.0 t30 -159.72 90.77 0.94 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.085 -1.45 . . . . 74.03 107.085 165.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 5.3 mp -99.02 83.37 2.88 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.166 -0.925 . . . . 75.42 108.662 -178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . 0.453 ' NE2' HD21 ' E' ' 176' ' ' ASN . 48.4 mt-30 -90.25 -158.62 0.54 Allowed 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.81 -1.086 . . . . 73.43 109.166 170.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 73.76 137.67 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.64 1.176 . . . . 63.23 111.341 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . 0.488 ' HG3' ' HB3' ' A' ' 153' ' ' GLN . 29.7 Cg_endo -60.44 -43.54 33.18 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.478 2.119 . . . . 61.34 111.56 177.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' C' ' 96' ' ' HIS . 0.8 OUTLIER 64.55 -169.83 0.2 Allowed 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.557 1.143 . . . . 71.12 111.04 -171.882 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -128.18 168.34 15.57 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.323 -0.992 . . . . 65.44 108.323 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 25.8 m -63.79 -18.94 64.6 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 123.817 0.847 . . . . 74.13 112.622 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 67.84 89.65 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 125.216 1.406 . . . . 71.13 108.746 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' C' ' 136' ' ' LEU . 51.2 Cg_exo -57.25 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.223 2.616 . . . . 71.01 114.085 -178.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.93 125.34 33.98 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.81 -0.811 . . . . 71.52 108.81 172.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 31.5 pt -71.3 167.73 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.517 0.727 . . . . 55.52 111.255 176.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -108.05 128.28 54.53 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.134 -1.062 . . . . 70.22 108.134 169.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -99.58 -19.33 16.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.595 0.358 . . . . 52.52 111.34 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . 0.421 ' O ' HG23 ' C' ' 40' ' ' VAL . 2.6 m-20 59.05 -84.69 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.806 1.242 . . . . 72.42 112.192 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.62 -35.65 2.3 Favored Glycine 0 N--CA 1.464 0.543 0 N-CA-C 110.423 -1.071 . . . . 74.23 110.423 -173.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 68.52 -83.67 0.2 Allowed Glycine 0 C--N 1.35 1.346 0 O-C-N 124.304 0.649 . . . . 52.54 113.826 171.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -166.81 107.05 0.63 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.898 0.879 . . . . 63.24 108.839 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' E' ' 195' ' ' PHE . . . -172.09 123.0 0.49 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 60.1 109.858 174.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . 0.436 ' HB2' ' O ' ' E' ' 194' ' ' ALA . 0.6 OUTLIER 170.36 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.257 -1.386 . . . . 64.35 107.257 171.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . 0.428 ' HG2' ' HB3' ' F' ' 190' ' ' ASP . 3.3 tppp? 67.08 106.03 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.407 1.483 . . . . 71.33 113.634 169.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -123.77 -168.37 1.77 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.919 1.287 . . . . 74.15 108.802 167.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 58.93 83.35 0.13 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.223 1.009 . . . . 72.3 109.519 -175.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . 0.595 ' HA ' ' HA ' ' E' ' 205' ' ' LYS . 38.6 t30 64.01 -73.9 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.012 1.325 . . . . 75.15 110.827 -170.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.4 79.4 Favored Glycine 0 C--N 1.348 1.201 0 CA-C-N 115.517 -0.765 . . . . 64.14 112.722 -179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 60.1 17.82 7.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.236 1.014 . . . . 73.35 111.416 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -90.61 150.54 21.67 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 108.277 -1.009 . . . . 73.52 108.277 177.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.26 -13.24 57.9 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.295 0.638 . . . . 75.14 111.792 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.486 HG23 HG23 ' E' ' 207' ' ' VAL . 9.3 mt -57.37 -61.54 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 124.458 1.103 . . . . 71.24 110.47 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' E' ' 199' ' ' ASN . 77.0 mttt 60.84 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.292 1.037 . . . . 74.0 110.968 -178.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.76 -30.59 1.82 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.596 1.159 . . . . 72.34 109.243 173.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.658 HG12 ' HB3' ' D' ' 12' ' ' GLN . 2.9 t . . . . . 0 C--O 1.254 1.337 0 C-N-CA 126.2 1.8 . . . . 64.43 109.099 -168.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 95.1 mttt . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.52 -0.548 . . . . 61.43 109.52 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -155.85 73.64 0.24 Allowed Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.751 -0.939 . . . . 74.11 110.751 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -105.47 172.67 6.67 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.841 0.856 . . . . 70.32 110.129 176.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 37.5 m -81.06 -159.25 0.24 Allowed 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 108.538 -0.912 . . . . 64.3 108.538 164.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.55 61.97 4.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.622 -0.674 . . . . 64.23 109.698 171.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -132.91 123.83 26.73 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.406 -1.331 . . . . 75.13 107.406 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.99 142.79 6.21 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 114.481 -1.236 . . . . 32.15 108.456 -172.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -156.28 103.09 2.15 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.129 -1.063 . . . . 71.04 108.129 175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.62 -76.3 0.6 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.885 -0.783 . . . . 75.1 108.885 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . 0.414 HD13 HD21 ' B' ' 98' ' ' LEU . 32.1 tp 55.64 27.8 11.06 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.545 1.138 . . . . 74.12 110.796 179.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -104.07 -24.73 13.17 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 114.899 -1.046 . . . . 62.02 110.763 -172.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.62 142.75 28.18 Favored Pre-proline 0 C--O 1.245 0.854 0 C-N-CA 124.867 1.267 . . . . 72.21 109.185 -174.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.06 98.87 0.74 Allowed 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.777 2.318 . . . . 64.0 110.954 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -60.35 -42.73 96.34 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.515 -0.766 . . . . 73.44 110.499 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.55 -51.44 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.341 -0.845 . . . . 73.51 109.826 171.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 26.4 m 60.75 84.87 0.12 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.446 1.098 . . . . 73.53 110.341 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -69.8 121.09 81.49 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.406 0.682 . . . . 70.33 111.02 -174.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -70.44 106.51 1.8 Allowed 'Trans proline' 0 C--N 1.385 2.466 0 C-N-CA 122.795 2.33 . . . . 74.32 111.454 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 76.8 mt -75.81 120.5 21.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.11 -0.495 . . . . 61.3 110.07 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.428 ' H ' HD13 ' F' ' 187' ' ' ILE . 0.2 OUTLIER -64.54 171.39 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 124.474 1.11 . . . . 73.34 111.362 172.065 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.37 -91.72 0.46 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 122.922 0.489 . . . . 73.34 110.874 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -176.44 112.46 0.1 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 107.538 -1.282 . . . . 63.32 107.538 -174.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' E' ' 196' ' ' LYS . 31.7 t70 -74.31 90.91 2.15 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-O 120.803 0.335 . . . . 64.03 110.554 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 70.38 -172.34 41.93 Favored Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.062 -0.972 . . . . 65.44 114.147 177.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 153.33 129.02 1.33 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.522 -0.631 . . . . 31.12 111.522 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -116.68 28.77 8.34 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.928 0.891 . . . . 73.43 109.255 176.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -78.4 -0.28 28.53 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.919 0.888 . . . . 70.04 111.936 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' F' ' 201' ' ' LYS . 42.8 t80 -137.87 135.1 35.83 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.637 0.775 . . . . 74.41 109.215 176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -164.08 115.9 1.35 Allowed 'General case' 0 CA--C 1.536 0.43 0 O-C-N 124.553 1.158 . . . . 74.12 108.462 168.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -64.98 145.03 56.87 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 123.595 0.56 . . . . 73.14 110.533 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 79.46 -45.86 0.34 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.914 1.685 . . . . 73.42 111.057 -177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . 0.517 HD21 ' HE2' ' F' ' 201' ' ' LYS . 4.5 t30 -61.68 -54.53 41.5 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.604 1.162 . . . . 72.33 111.272 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 131.13 -171.96 20.85 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 111.36 -0.696 . . . . 73.22 111.36 -171.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.517 ' HE2' HD21 ' F' ' 199' ' ' ASN . 43.2 mtmt 69.91 106.15 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.983 1.313 . . . . 75.03 110.593 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . 0.493 ' OH ' ' HB2' ' C' ' 124' ' ' PRO . 21.6 m-30 56.11 21.12 4.88 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 124.27 1.028 . . . . 74.51 111.597 -172.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -138.39 151.1 47.19 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.205 -1.361 . . . . 71.43 108.05 -172.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.487 HG21 ' O ' ' A' ' 14' ' ' GLN . 8.2 tp -65.75 -37.02 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.404 -1.271 . . . . 62.32 111.429 -177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 67.11 147.93 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.108 1.363 . . . . 73.0 109.269 -165.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.2 85.71 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.293 0.568 . . . . 72.32 110.465 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.246 0.905 0 C-N-CA 123.658 0.783 . . . . 63.42 109.409 -179.308 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.438 0.161 . . . . 74.05 110.632 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 4' ' ' GLN . . . -87.34 -132.4 3.59 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-N 116.089 -0.505 . . . . 42.41 114.096 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 47.9 tttp -148.09 -88.07 0.09 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.611 0.764 . . . . 74.32 110.002 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 59.3 p -178.4 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.879 0.872 . . . . 71.13 110.091 -167.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -138.96 71.75 1.39 Allowed 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.921 0.888 . . . . 72.54 109.297 -172.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' G' ' 173' ' ' LEU . 10.6 mt -154.72 143.62 20.9 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.944 -1.025 . . . . 74.11 109.196 171.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.492 ' HA ' ' OH ' ' A' ' 56' ' ' TYR . 34.8 mmt 55.62 64.63 1.69 Allowed 'General case' 0 C--O 1.243 0.736 0 O-C-N 124.493 1.121 . . . . 44.51 110.525 -175.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 55.98 -94.05 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 112.584 -2.098 . . . . 55.52 109.679 -166.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 55.89 28.53 12.67 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.7 1.2 . . . . 71.41 112.015 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.67 86.25 0.21 Allowed 'General case' 0 C--N 1.358 0.939 0 N-CA-C 108.699 -0.852 . . . . 63.52 108.699 172.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -64.97 -54.21 34.12 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 109.049 -0.723 . . . . 71.53 109.049 174.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.93 138.1 26.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 114.845 -1.07 . . . . 73.33 108.51 176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -73.66 -6.0 17.98 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.849 2.366 . . . . 74.12 113.274 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 67.78 -75.9 0.06 Allowed 'General case' 0 C--N 1.359 1.007 0 C-N-CA 125.608 1.563 . . . . 73.24 110.439 -178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -85.87 179.95 6.93 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.042 0.937 . . . . 72.44 110.997 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 20.6 m -128.49 159.69 34.65 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.033 0.933 . . . . 64.04 108.544 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -97.99 105.15 25.91 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.498 0.719 . . . . 75.1 110.608 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -81.12 -58.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.332 2.021 . . . . 62.31 112.621 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . 0.596 HD11 HD22 ' A' ' 44' ' ' LEU . 6.7 mp 60.83 176.71 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 125.299 1.44 . . . . 62.31 111.569 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.679 ' HA ' ' HB2' ' H' ' 206' ' ' ASP . 36.0 pt -68.99 150.86 10.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 CA-C-N 116.052 -0.522 . . . . 72.34 110.575 171.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -75.7 -2.14 28.16 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.529 -0.76 . . . . 71.52 112.007 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . 66.61 -76.22 0.05 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.799 1.64 . . . . 64.24 110.986 179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -57.81 131.02 49.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.116 0.966 . . . . 63.32 111.798 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . -119.24 21.19 9.44 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.006 -0.543 . . . . 54.45 111.771 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . 87.51 -50.69 4.07 Favored Glycine 0 C--N 1.347 1.157 0 C-N-CA 123.044 0.354 . . . . 54.24 112.725 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -87.78 46.26 1.36 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.039 0.935 . . . . 75.23 110.125 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . 0.425 ' O ' ' HD2' ' A' ' 38' ' ' PRO . . . -80.3 81.57 6.52 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 115.573 -0.739 . . . . 74.21 110.034 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.484 ' HB3' ' NE1' ' A' ' 36' ' ' TRP . 2.0 m-30 68.32 153.55 0.1 Allowed 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.73 1.212 . . . . 71.25 113.26 170.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 36' ' ' TRP . 0.0 OUTLIER -163.89 139.45 6.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.466 0.706 . . . . 55.45 110.129 170.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . 0.432 ' H ' ' HB3' ' A' ' 36' ' ' TRP . 2.6 m-30 -78.06 155.55 30.56 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 121.306 0.574 . . . . 63.33 110.651 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -114.13 147.21 39.19 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.893 -1.049 . . . . 75.35 108.171 172.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -82.65 24.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.495 0.924 . . . . 71.21 113.495 -168.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -70.7 -42.31 62.38 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-O 119.65 -0.528 . . . . 72.24 113.468 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 74.16 -38.73 0.4 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 125.606 1.563 . . . . 55.44 113.731 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 56.8 t80 68.67 66.76 0.3 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.801 1.241 . . . . 74.12 110.063 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -103.69 138.27 40.57 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 114.679 -1.146 . . . . 72.33 109.001 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.412 HD13 HE22 ' B' ' 12' ' ' GLN . 3.4 mp -97.4 -70.04 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 107.779 -1.193 . . . . 70.43 107.779 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 48.1 tttm 176.11 -71.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.275 1.83 . . . . 74.41 107.187 176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -148.92 -79.92 0.13 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.676 1.19 . . . . 71.15 108.586 178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 2.3 p . . . . . 0 CA--C 1.565 1.55 0 C-N-CA 124.231 1.012 . . . . 70.23 108.646 -173.741 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt . . . . . 0 N--CA 1.476 0.851 0 N-CA-C 109.537 -0.542 . . . . 72.2 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . 0.431 ' HA2' HE21 ' D' ' 4' ' ' GLN . . . 162.83 -152.64 22.9 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.758 -0.937 . . . . 73.01 110.758 -174.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -111.98 -79.64 0.58 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.067 0.547 . . . . 71.42 110.014 175.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 16.8 t -169.47 32.91 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.341 0.656 . . . . 71.54 109.729 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.649 ' HB1' ' SD ' ' D' ' 94' ' ' MET . . . -139.91 114.77 9.53 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 122.993 0.517 . . . . 63.22 111.445 -172.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 32.8 mt -135.56 -49.69 0.72 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.61 1.164 . . . . 63.2 109.21 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.52 166.02 20.66 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.716 -0.674 . . . . 74.04 109.822 173.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -49.57 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 125.807 1.643 . . . . 74.43 111.958 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -89.98 -81.79 0.28 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.955 0.902 . . . . 74.15 109.696 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . 0.821 HD11 HD11 ' D' ' 98' ' ' LEU . 6.0 mp 55.99 34.51 23.82 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.6 1.16 . . . . 64.54 111.579 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -62.18 -48.32 80.59 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.841 0.856 . . . . 64.23 111.21 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -80.02 140.4 53.75 Favored Pre-proline 0 C--O 1.241 0.632 0 CA-C-N 115.846 -0.615 . . . . 73.3 110.297 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.26 99.98 0.25 Allowed 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.528 2.152 . . . . 75.11 110.788 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 45.4 t80 -78.24 81.8 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.069 -0.514 . . . . 75.41 110.069 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 55.88 -99.88 0.1 Allowed 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.718 1.207 . . . . 75.31 111.194 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . 0.588 HG23 ' HD3' ' H' ' 185' ' ' PRO . 15.3 t -178.08 -36.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.627 1.171 . . . . 73.13 109.461 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 36.09 76.17 0.46 Allowed Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 126.443 1.897 . . . . 74.35 114.213 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . 0.588 ' HD3' HG23 ' H' ' 183' ' ' THR . 93.4 Cg_endo -77.27 141.75 20.75 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.464 2.11 . . . . 74.35 112.566 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . 0.437 ' HB2' HD22 ' D' ' 44' ' ' LEU . 5.7 tt -81.86 136.52 35.36 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 107.827 -1.175 . . . . 64.12 107.827 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.9 164.02 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.436 0.695 . . . . 73.1 112.282 -178.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . 0.669 ' HA ' HD21 ' D' ' 42' ' ' LEU . . . -107.61 -178.71 3.7 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.181 0.592 . . . . 71.14 110.952 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -148.26 86.41 1.55 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.464 0.705 . . . . 70.34 109.425 174.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -103.96 105.22 15.34 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.19 -1.041 . . . . 71.33 108.19 171.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.93 -164.98 35.62 Favored Glycine 0 C--N 1.338 0.675 0 O-C-N 123.628 0.58 . . . . 63.1 112.455 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 81.35 171.9 45.88 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 112.024 -0.431 . . . . 65.53 112.024 -175.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.526 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 43.4 t80 -176.87 98.35 0.05 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 107.373 -1.343 . . . . 70.43 107.373 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.91 102.94 0.31 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.115 0.966 . . . . 70.03 109.63 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.425 ' CD1' ' HD3' ' D' ' 124' ' ' PRO . 32.6 t80 -178.28 -13.8 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 123.989 0.916 . . . . 64.35 110.86 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . 0.499 ' HD2' ' O ' ' D' ' 35' ' ' ASP . 2.0 mmmp? -51.27 115.0 1.37 Allowed 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.325 1.05 . . . . 74.1 111.531 -176.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . 0.43 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 36.4 m-85 -84.16 -177.17 6.57 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.425 1.09 . . . . 74.21 110.671 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -138.69 160.16 40.32 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.769 -0.65 . . . . 63.23 109.531 175.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -81.71 143.52 31.8 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.327 -0.851 . . . . 70.05 109.746 175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.79 2.87 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.608 -0.551 . . . . 64.15 113.05 175.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 77.8 tttt 64.84 -82.37 0.03 OUTLIER 'General case' 0 C--N 1.364 1.213 0 C-N-CA 124.861 1.264 . . . . 75.3 109.318 -173.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -142.57 141.13 31.95 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.407 1.483 . . . . 74.12 107.046 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -101.15 100.69 11.28 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.752 -0.462 . . . . 54.52 109.752 -170.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 1.9 mp -82.3 90.35 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 123.525 0.73 . . . . 73.23 109.438 -176.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -94.01 -29.7 15.09 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.791 -1.095 . . . . 75.15 109.521 175.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . 0.679 ' HB2' ' HA ' ' G' ' 187' ' ' ILE . 4.2 m-20 -99.99 129.7 46.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.614 -1.175 . . . . 54.12 111.062 -166.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 C--O 1.251 1.152 0 N-CA-C 106.363 -1.717 . . . . 74.13 106.363 165.453 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 N--CA 1.479 1.017 0 N-CA-C 111.207 0.077 . . . . 75.51 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -126.46 -27.67 3.14 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 112.27 0.47 . . . . 73.11 112.27 -174.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -76.54 113.5 14.22 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.878 0.37 . . . . 74.1 110.959 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -114.83 130.25 56.84 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 61.0 108.636 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -114.44 136.19 53.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.981 0.512 . . . . 61.22 111.16 -174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -169.56 113.09 0.51 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.806 1.242 . . . . 74.24 108.661 170.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -141.67 -52.56 0.43 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 108.149 -1.056 . . . . 74.33 108.149 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -84.43 169.25 14.75 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 114.702 -1.135 . . . . 74.21 108.33 166.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 12.3 tmm? -171.33 134.19 0.87 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.082 0.553 . . . . 72.03 110.348 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -156.69 135.6 11.81 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.255 1.022 . . . . 63.14 109.618 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.543 ' HB3' ' SD ' ' C' ' 138' ' ' MET . 50.5 t80 -136.32 136.96 40.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.84 0.856 . . . . 75.1 108.72 165.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -151.18 125.88 9.63 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.864 -0.153 . . . . 73.4 110.965 -176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -76.26 132.37 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.385 -0.968 . . . . 71.44 108.385 173.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 79.6 mm-40 -103.85 -38.61 6.96 Favored 'General case' 0 C--O 1.242 0.701 0 O-C-N 123.88 0.737 . . . . 72.13 109.906 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -168.94 141.84 2.78 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 112.074 0.398 . . . . 75.01 112.074 -171.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.455 HD13 ' CD2' ' A' ' 109' ' ' TYR . 74.4 mt -106.71 142.47 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 124.932 1.293 . . . . 63.53 107.516 166.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.411 ' HE1' HG13 ' A' ' 83' ' ' ILE . 15.3 p90 -166.21 146.22 6.19 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.723 0.773 . . . . 75.43 111.003 173.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 p -88.46 105.06 17.36 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.845 -1.07 . . . . 73.11 109.321 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.1 mtpt -76.06 -28.21 57.54 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.857 -0.423 . . . . 74.13 109.857 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 21.3 t70 -148.77 130.77 15.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.87 -1.059 . . . . 73.12 109.67 174.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 67.0 mt -122.84 136.36 59.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 N-CA-C 105.983 -1.858 . . . . 65.43 105.983 167.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.82 108.26 3.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.831 0.348 . . . . 72.35 110.649 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.727 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 86.9 t80 -109.83 131.0 55.46 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.035 -1.468 . . . . 64.01 107.035 171.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -132.62 131.6 41.58 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 108.441 -0.948 . . . . 53.13 108.441 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -146.8 72.67 12.51 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.913 -0.773 . . . . 64.2 108.913 177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.44 -13.22 25.2 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.509 2.139 . . . . 73.24 111.853 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -118.04 25.53 10.28 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.762 0.825 . . . . 74.23 109.296 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.37 -46.47 99.8 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.166 0.987 . . . . 72.14 112.898 178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.03 -18.08 18.96 Favored 'Trans proline' 0 C--N 1.391 2.812 0 CA-C-N 120.933 1.369 . . . . 51.33 113.208 175.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.95 -18.99 61.33 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.249 0.62 . . . . 73.42 111.938 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 8.6 p -64.69 -18.39 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 112.783 0.66 . . . . 44.43 112.783 -176.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -71.45 -40.32 70.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.965 0.506 . . . . 65.0 110.604 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -86.68 -19.54 29.06 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.658 -0.701 . . . . 74.3 110.713 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 29.8 mmmt -81.97 151.0 27.37 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.12 0.568 . . . . 74.11 111.29 176.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.717 ' HB3' ' HE1' ' G' ' 193' ' ' TYR . 9.5 m-20 -80.5 124.01 28.57 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 114.931 -1.031 . . . . 54.43 108.714 168.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.477 ' CE3' HD21 ' A' ' 68' ' ' LEU . 75.4 t-105 -76.13 87.42 3.01 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.115 0.483 . . . . 75.15 110.54 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -126.86 80.66 70.63 Favored Pre-proline 0 C--O 1.245 0.837 0 C-N-CA 124.505 1.122 . . . . 74.24 108.035 169.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' O ' ' G' ' 192' ' ' GLY . 94.3 Cg_endo -79.45 129.41 8.47 Favored 'Trans proline' 0 C--N 1.374 1.882 0 C-N-CA 122.269 1.979 . . . . 62.41 111.804 -178.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -95.79 84.17 3.85 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 105.626 -1.99 . . . . 74.35 105.626 172.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -77.19 93.85 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 114.344 -1.298 . . . . 55.04 109.854 -172.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.88 116.11 23.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 113.976 -1.466 . . . . 61.54 110.867 -177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.443 HD23 HD23 ' A' ' 128' ' ' LEU . 6.6 mp -97.38 106.94 19.34 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.45 -1.25 . . . . 70.42 107.882 175.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.522 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.2 t70 -107.47 147.26 30.7 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.793 1.237 . . . . 63.15 109.364 -178.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -129.8 137.61 50.59 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.013 0.925 . . . . 70.4 109.528 -174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -144.41 145.8 32.13 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.31 0.644 . . . . 72.33 109.485 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.8 m -107.19 125.93 51.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.619 0.768 . . . . 72.13 110.032 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.78 138.32 45.65 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.999 0.92 . . . . 55.24 108.825 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -135.65 162.46 32.67 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.434 0.693 . . . . 74.03 110.341 172.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 31.4 t -161.34 123.27 2.97 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.047 0.939 . . . . 72.01 108.661 175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.08 146.26 39.48 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 109.812 -0.44 . . . . 62.2 109.812 178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.537 HD11 ' HB2' ' A' ' 57' ' ' GLU . 49.9 mt -117.35 -34.92 4.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.507 0.723 . . . . 74.31 111.355 -170.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.1 -175.28 5.18 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.987 0.915 . . . . 75.51 109.441 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.09 121.13 17.72 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 108.735 -0.839 . . . . 73.44 108.735 173.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 67.94 9.86 7.42 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.388 1.475 . . . . 70.51 113.013 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.61 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 71.1 t -124.12 122.24 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 108.152 -1.055 . . . . 64.44 108.152 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -140.84 170.47 15.69 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.998 -0.741 . . . . 74.32 108.998 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' HB2' HD11 ' A' ' 51' ' ' LEU . 23.0 tt0 -126.51 140.08 52.73 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 124.174 0.99 . . . . 74.31 108.75 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -117.48 124.86 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 107.138 -1.43 . . . . 74.54 107.138 164.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.508 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -98.29 127.04 51.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.837 -0.801 . . . . 73.43 108.837 172.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.86 109.47 21.81 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.843 -1.54 . . . . 60.13 106.843 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -98.52 100.33 11.56 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.267 -1.012 . . . . 74.34 108.267 -177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.0 t -107.81 117.14 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 114.582 -1.19 . . . . 44.3 108.756 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.522 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 25.1 m -112.74 128.01 56.3 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.55 -0.537 . . . . 71.12 109.55 176.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 25.2 t -120.28 107.54 21.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 107.948 -1.13 . . . . 63.2 107.948 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 32.0 m -102.16 141.35 35.14 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.318 -0.993 . . . . 71.22 108.318 178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.19 106.88 10.22 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.068 -1.086 . . . . 63.21 108.068 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.7 m -108.97 125.96 52.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.049 0.54 . . . . 63.22 110.467 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.477 HD21 ' CE3' ' A' ' 36' ' ' TRP . 46.7 mt -88.46 62.33 6.54 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.47 -1.307 . . . . 73.55 107.47 171.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.87 -102.39 1.32 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 114.57 -1.196 . . . . 43.4 111.371 -175.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -87.01 -20.26 27.47 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.969 0.908 . . . . 75.14 111.161 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -109.2 118.86 37.82 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.351 -0.611 . . . . 75.3 109.351 -171.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 m -73.18 130.17 39.67 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 118.559 0.618 . . . . 73.4 110.129 178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.56 -56.75 4.19 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.78 -0.822 . . . . 53.1 108.78 177.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -157.19 168.6 26.96 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 114.167 -1.379 . . . . 54.23 110.558 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -139.4 116.91 11.36 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.545 1.138 . . . . 73.05 108.733 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.404 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.4 m -104.31 138.82 40.19 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 124.319 1.048 . . . . 75.35 108.893 172.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -148.04 117.33 6.9 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.255 -1.017 . . . . 74.3 108.255 171.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -122.81 111.48 30.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 109.316 -0.624 . . . . 73.14 109.316 178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 51.0 mt-30 -86.42 82.19 8.05 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 114.89 -1.05 . . . . 74.23 108.732 170.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' HG3' HD22 ' A' ' 106' ' ' LEU . 6.2 tp-100 -77.96 95.63 4.85 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.358 -1.292 . . . . 61.15 109.405 -178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.14 154.53 29.02 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 112.057 -0.417 . . . . 51.52 112.057 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.57 131.8 3.0 Favored Glycine 0 C--N 1.334 0.43 0 N-CA-C 112.136 -0.385 . . . . 52.04 112.136 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.499 ' HB ' ' HB2' ' A' ' 14' ' ' GLN . 37.0 mt -81.6 128.28 38.85 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 N-CA-C 108.446 -0.946 . . . . 64.35 108.446 174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -131.38 154.32 48.75 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 174.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 41.2 t -119.26 119.44 34.07 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.649 1.18 . . . . 64.41 108.051 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 89' ' ' ILE . 2.9 pp -122.17 158.79 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.019 0.438 . . . . 73.2 111.098 175.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 151.91 8.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.591 -1.186 . . . . 64.53 109.094 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.23 83.82 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 115.26 0.864 . . . . 73.45 115.26 170.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.481 HD11 HD13 ' A' ' 86' ' ' ILE . 0.1 OUTLIER -115.88 136.58 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 117.538 0.669 . . . . 75.55 110.357 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -144.75 172.37 13.11 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.836 0.455 . . . . 61.31 111.54 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.11 -120.67 23.77 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 115.899 -0.591 . . . . 71.11 113.31 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.7 p -79.58 -16.38 55.99 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.779 0.832 . . . . 71.0 111.832 -174.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.75 -42.43 90.96 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.767 0.827 . . . . 74.21 109.263 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 98' ' ' LEU . 43.5 tpp -67.1 -38.37 85.55 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.976 -1.011 . . . . 75.11 110.509 175.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.44 81.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.704 0.802 . . . . 51.34 111.969 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -84.17 -36.67 22.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.766 0.426 . . . . 63.43 111.095 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 51.9 t -71.95 -64.73 0.88 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.703 0.401 . . . . 65.12 110.669 -175.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.417 ' HB2' ' SD ' ' A' ' 94' ' ' MET . 7.4 tt -68.42 -34.54 76.18 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.38 0.672 . . . . 72.1 110.324 -178.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -5.59 78.19 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 119.077 -0.846 . . . . 44.13 114.968 -172.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.84 -55.22 0.17 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 118.534 1.167 . . . . 63.14 112.742 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.422 ' HE2' ' CD1' ' A' ' 11' ' ' PHE . 81.1 t80 -68.9 -45.74 70.14 Favored 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 112.882 0.697 . . . . 73.41 112.882 -169.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -73.58 -37.42 3.53 Favored Pre-proline 0 CA--C 1.561 1.383 0 C-N-CA 123.05 0.54 . . . . 53.34 112.315 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -48.84 -33.68 26.05 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 122.503 2.136 . . . . 71.15 113.901 162.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -68.19 -16.55 64.03 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 123.576 0.75 . . . . 75.43 111.991 -177.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.409 HG23 HD21 ' C' ' 132' ' ' ASN . 47.7 mm -74.63 -44.3 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 122.002 0.906 . . . . 61.41 109.639 171.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.493 HD22 ' HG3' ' A' ' 80' ' ' GLN . 89.0 mt -85.74 -19.26 31.07 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.164 -1.38 . . . . 73.54 112.33 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -69.44 -44.24 25.04 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 118.215 -0.898 . . . . 73.35 112.483 -173.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.37 -35.26 98.87 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 121.996 1.797 . . . . 63.11 113.062 172.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.455 ' CD2' HD13 ' A' ' 16' ' ' ILE . 27.7 m-85 -82.77 -31.81 28.1 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 113.107 0.78 . . . . 71.5 113.107 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.82 -47.84 61.28 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.515 -0.92 . . . . 72.44 108.515 174.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -46.74 -59.7 2.87 Favored 'General case' 0 C--O 1.214 -0.779 0 O-C-N 125.331 1.644 . . . . 74.24 109.559 172.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' B' ' 120' ' ' ARG . 3.7 tm-20 -64.24 -38.35 90.73 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.433 1.083 . . . . 64.15 111.895 -172.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 117' ' ' MET . 44.8 t -62.12 -46.43 89.09 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.659 0.384 . . . . 71.12 110.471 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 118' ' ' VAL . 34.1 mt -62.33 -47.19 94.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.882 0.873 . . . . 72.24 110.13 173.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.592 HG21 ' HE2' ' C' ' 109' ' ' TYR . 67.5 m -55.68 -42.77 75.61 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.097 1.359 . . . . 61.33 110.71 -174.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -68.87 -39.18 79.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.583 -1.189 . . . . 71.43 110.321 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.727 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -66.79 -35.56 80.36 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 122.425 0.29 . . . . 74.22 111.299 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -66.37 -40.09 85.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 123.478 0.711 . . . . 72.24 110.292 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 78.6 p -73.47 -34.3 65.28 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.36 -0.382 . . . . 62.23 111.259 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -70.12 -23.98 63.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.512 0.725 . . . . 71.22 110.261 173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.3 31.04 3.55 Favored Glycine 0 C--N 1.353 1.512 0 C-N-CA 123.743 0.687 . . . . 61.45 113.522 176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' B' ' 17' ' ' TYR . 14.7 t 58.68 15.96 4.06 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.943 2.097 . . . . 71.21 114.683 173.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 119' ' ' SER . 42.0 m-85 -123.49 159.82 53.5 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.174 0.589 . . . . 74.4 111.066 173.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.61 135.63 57.91 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 122.447 2.098 . . . . 75.32 110.141 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.547 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 12.7 pt20 -57.84 153.27 14.25 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.064 0.946 . . . . 71.24 111.709 -174.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.18 112.17 24.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.162 -1.051 . . . . 61.34 108.162 -175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' C' ' 16' ' ' ILE . 76.6 m-20 -97.31 104.11 16.11 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.316 -0.994 . . . . 64.03 108.316 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.443 HD23 HD23 ' A' ' 42' ' ' LEU . 5.8 mp -69.0 142.12 54.72 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.744 -0.662 . . . . 75.1 109.622 178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.15 134.1 74.55 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 122.704 0.401 . . . . 50.43 110.453 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.455 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 16.8 Cg_exo -68.05 124.78 12.18 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.459 2.106 . . . . 75.23 109.995 170.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.0 m -97.12 111.9 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 122.077 0.942 . . . . 74.25 108.951 -175.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.504 HD22 ' HB3' ' A' ' 135' ' ' ALA . 0.7 OUTLIER -75.91 86.46 2.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.167 -1.378 . . . . 65.24 109.396 177.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -51.78 -37.62 52.23 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.148 1.379 . . . . 73.24 112.951 -171.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.55 -47.51 47.64 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.294 -0.867 . . . . 65.51 110.996 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.504 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -74.27 -20.18 60.23 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 116.034 -0.53 . . . . 63.3 110.972 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.53 -35.47 60.71 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.028 0.931 . . . . 72.21 109.017 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -58.02 -45.36 87.04 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.835 0.854 . . . . 75.41 109.877 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 84.1 mmm -74.52 -29.49 61.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 115.752 -0.658 . . . . 73.43 111.163 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -70.0 -27.13 64.44 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.643 0.777 . . . . 75.54 110.552 174.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -81.27 -38.21 27.23 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.245 -0.65 . . . . 70.1 109.245 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -65.86 -47.43 74.96 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.099 0.959 . . . . 64.23 110.75 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.69 10.85 0.96 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 122.388 0.275 . . . . 54.34 111.043 -171.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 71.19 149.72 0.09 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 124.134 0.973 . . . . 60.24 111.734 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -77.51 171.71 14.48 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.125 0.57 . . . . 70.34 111.24 173.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.85 149.48 21.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.434 0.693 . . . . 64.44 109.906 170.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.97 152.07 6.32 Favored Glycine 0 C--N 1.335 0.484 0 N-CA-C 110.844 -0.903 . . . . 64.3 110.844 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -138.27 114.21 9.98 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.441 0.696 . . . . 71.13 109.331 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -84.0 151.58 27.51 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.375 -0.69 . . . . 75.03 111.375 173.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.9 p -116.23 160.53 20.3 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.842 0.857 . . . . 74.42 109.342 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 -112.28 52.8 0.75 Allowed 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.602 0.715 . . . . 63.51 109.11 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.673 ' HG3' ' HG2' ' E' ' 170' ' ' LYS . 61.0 mm-40 -81.85 85.24 6.69 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.461 -0.79 . . . . 74.12 110.391 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -112.42 113.12 25.14 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.547 -1.279 . . . . 74.15 107.547 173.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -59.44 -43.15 93.2 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.331 0.586 . . . . 74.12 109.863 177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -164.14 -62.02 0.04 OUTLIER 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.577 -1.192 . . . . 74.32 108.329 176.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.777 0 CA-C-N 114.771 -1.104 . . . . 51.5 108.654 -179.912 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.463 ' SD ' ' N ' ' B' ' 1' ' ' MET . 2.7 mpp? . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 109.484 -0.561 . . . . 55.43 109.484 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 58.4 m -169.51 11.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 124.634 1.174 . . . . 73.1 110.974 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.0 168.35 10.32 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 112.316 0.487 . . . . 75.4 112.316 -169.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -83.84 123.48 29.95 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.854 -0.612 . . . . 72.41 111.017 -175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.507 HD21 ' HB3' ' B' ' 90' ' ' GLU . 10.2 p30 -148.37 167.13 26.05 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.182 0.593 . . . . 74.03 110.522 173.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -124.93 148.5 48.32 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.053 0.941 . . . . 73.42 108.748 172.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -162.99 178.4 8.38 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.581 0.752 . . . . 72.0 110.346 -175.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -72.33 -27.69 62.58 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.298 1.039 . . . . 74.24 111.1 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.2 ptm 55.48 -173.61 0.05 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 126.434 1.893 . . . . 72.24 114.158 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 22.8 p -132.45 102.57 5.78 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.534 1.134 . . . . 61.31 107.982 173.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.615 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 31.5 t80 -122.07 134.82 54.77 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.69 -0.855 . . . . 73.32 108.69 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' G' ' 204' ' ' ILE . 2.5 tp60 -165.87 141.45 4.93 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 123.79 0.681 . . . . 72.14 109.248 178.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.616 HD13 HD11 ' B' ' 16' ' ' ILE . 78.4 mt -86.22 121.05 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 122.93 0.492 . . . . 72.51 110.326 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -80.65 -36.72 32.14 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 123.662 0.601 . . . . 73.04 111.249 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -171.32 142.44 1.71 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 122.994 0.518 . . . . 65.23 109.949 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.616 HD11 HD13 ' B' ' 13' ' ' ILE . 90.1 mt -121.26 140.27 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 107.911 -1.144 . . . . 74.33 107.911 172.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 122' ' ' THR . 31.5 p90 -165.53 152.23 10.07 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.896 0.747 . . . . 74.21 111.079 -178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.3 m -75.42 123.98 26.35 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.262 -1.014 . . . . 72.34 108.262 168.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 mtpt -92.54 -37.11 12.67 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.988 0.515 . . . . 74.22 109.679 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.0 t70 -148.84 147.96 29.34 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.531 -0.759 . . . . 75.54 110.712 -170.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.479 HD13 HG13 ' B' ' 78' ' ' VAL . 36.7 mm -143.11 143.41 24.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.677 0 C-N-CA 125.504 1.521 . . . . 72.12 107.79 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 55.6 m -149.09 131.73 15.88 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.203 -0.908 . . . . 63.34 108.706 168.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -140.08 106.95 5.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 106.228 -1.768 . . . . 74.33 106.228 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -122.52 110.6 15.79 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.665 -0.865 . . . . 75.44 108.665 -170.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' B' ' 74' ' ' PHE . . . -108.42 88.56 5.11 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.499 1.12 . . . . 73.41 109.205 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.68 -30.21 59.94 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 123.084 2.523 . . . . 74.13 112.374 -174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -118.45 31.39 6.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.029 0.932 . . . . 71.22 110.22 -177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.63 -52.24 32.11 Favored Pre-proline 0 CA--C 1.572 1.799 0 C-N-CA 125.327 1.451 . . . . 75.14 113.648 173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.501 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 96.0 Cg_endo -77.7 -12.57 16.57 Favored 'Trans proline' 0 C--N 1.386 2.535 0 C-N-CA 121.814 1.676 . . . . 70.4 113.142 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -86.98 1.12 53.85 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.897 0.879 . . . . 74.52 111.803 -175.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 47.2 t -69.13 -14.03 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 123.653 0.781 . . . . 73.34 110.334 169.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -65.76 -41.27 92.28 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.798 0.439 . . . . 73.03 110.266 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -47.27 12.47 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.327 -0.62 . . . . 73.54 109.327 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -87.38 67.82 9.57 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.12 -1.067 . . . . 75.41 108.12 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.21 75.56 9.13 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.432 -1.258 . . . . 63.12 111.442 -168.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 t90 -177.27 172.44 1.89 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.255 -1.339 . . . . 62.22 108.216 176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.627 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 3.9 pt20 -71.05 134.84 85.24 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.322 0.649 . . . . 65.51 111.731 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.88 156.12 60.04 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 122.549 2.166 . . . . 73.35 112.461 169.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 27.2 mt-10 -70.31 98.86 1.45 Allowed 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.372 -0.973 . . . . 63.52 108.372 172.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.606 ' HB ' HD13 ' B' ' 126' ' ' LEU . 16.4 m -87.67 122.55 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 123.177 0.591 . . . . 74.52 109.445 -178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -153.22 130.31 11.11 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.476 1.11 . . . . 70.25 109.645 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.71 HD22 HD11 ' B' ' 126' ' ' LEU . 1.4 pt? -130.81 164.98 23.97 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.993 0.738 . . . . 64.15 112.993 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -138.96 141.19 38.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.188 1.395 . . . . 72.34 109.79 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.7 tt -94.68 124.85 38.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.565 0.746 . . . . 74.23 108.988 178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -124.36 156.14 37.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.862 1.265 . . . . 65.45 108.427 174.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.2 t -129.4 140.85 51.2 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.616 0.722 . . . . 71.54 111.518 -176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.46 161.6 32.15 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.738 1.615 . . . . 64.03 107.981 175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -143.12 165.77 26.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.46 0.648 . . . . 64.35 111.525 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 30.7 t -152.09 157.83 42.15 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.149 1.38 . . . . 55.2 108.379 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -123.66 129.01 50.47 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.286 -1.005 . . . . 64.42 108.286 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.17 -39.48 12.1 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.319 0.648 . . . . 71.01 110.125 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.75 179.96 8.1 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.517 1.127 . . . . 70.25 109.826 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -57.29 121.25 9.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.342 0.657 . . . . 71.45 109.517 173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 66.17 -5.74 0.54 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 126.04 1.736 . . . . 43.14 113.712 -177.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -103.71 86.92 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.468 0 N-CA-C 106.945 -1.502 . . . . 54.23 106.945 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -95.82 168.71 10.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.859 -0.609 . . . . 73.34 110.183 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -145.38 97.64 3.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.833 -1.544 . . . . 64.13 106.833 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.34 130.24 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.946 -0.761 . . . . 73.43 108.946 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.425 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.1 t -106.89 124.03 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.645 0.778 . . . . 72.41 109.734 -176.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 1.0 OUTLIER -93.68 121.41 35.09 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.11 -1.07 . . . . 74.05 108.11 176.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.5 ttt-85 -113.11 113.46 25.44 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.221 0.608 . . . . 71.11 109.821 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.574 ' HB ' HD11 ' B' ' 114' ' ' ILE . 47.9 t -104.93 125.48 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.546 -0.909 . . . . 62.23 108.546 176.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 52.0 m -98.64 137.66 36.95 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.784 -0.821 . . . . 73.13 108.784 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.56 HG21 HG21 ' B' ' 114' ' ' ILE . 50.6 t -128.67 123.76 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 108.774 -0.825 . . . . 50.01 108.774 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.7 m -108.07 139.07 43.26 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.023 0.929 . . . . 74.33 109.637 176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -144.33 143.28 30.9 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 123.438 0.695 . . . . 41.21 109.216 177.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 30.6 p -151.46 134.13 15.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.462 0.541 . . . . 73.34 112.462 -171.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.7 mt -107.41 104.23 13.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.943 1.297 . . . . 62.32 108.758 173.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.96 -113.88 5.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.813 -0.437 . . . . 65.41 112.523 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -97.94 2.76 49.4 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.325 0.65 . . . . 71.34 111.502 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -130.81 157.68 42.21 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.556 0.342 . . . . 70.21 111.864 -170.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.2 m -76.04 133.69 40.29 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.786 -0.643 . . . . 71.42 110.669 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.34 -55.77 3.29 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.533 0.733 . . . . 74.31 109.701 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' B' ' 25' ' ' ALA . 30.8 p90 -154.01 162.34 41.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.26 -0.882 . . . . 73.24 109.956 174.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.7 mt -142.25 116.05 9.24 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.075 1.35 . . . . 72.33 107.453 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.7 t -117.79 120.49 38.09 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.528 -0.545 . . . . 33.43 109.528 -175.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -123.37 124.2 42.4 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.434 -0.95 . . . . 70.24 108.434 176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.479 HG13 HD13 ' B' ' 21' ' ' ILE . 55.3 t -121.47 146.0 27.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.314 -0.995 . . . . 71.2 108.314 178.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 21.8 mt-30 -127.06 99.28 5.64 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.651 -0.704 . . . . 73.14 109.255 174.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.533 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -92.41 104.22 16.58 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.144 -1.389 . . . . 74.44 108.751 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -91.44 159.27 25.99 Favored Glycine 0 C--O 1.243 0.697 0 N-CA-C 112.142 -0.383 . . . . 74.33 112.142 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -156.19 127.98 2.12 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 110.837 -0.905 . . . . 51.34 110.837 -178.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.84 125.0 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 108.608 -0.886 . . . . 73.21 108.608 177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -131.88 136.73 47.65 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.298 1.039 . . . . 63.22 109.979 -173.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 5.7 m -90.22 110.48 21.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.043 -1.095 . . . . 62.44 108.043 172.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 38.3 pt -126.68 109.19 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 121.824 0.821 . . . . 72.43 110.553 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.5 170.71 20.79 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.645 -1.162 . . . . 64.22 109.441 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' F' ' 172' ' ' ALA . . . 99.53 -49.14 1.21 Allowed Glycine 0 N--CA 1.467 0.724 0 N-CA-C 111.413 -0.675 . . . . 65.22 111.413 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 165.76 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.755 0.822 . . . . 71.1 111.387 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.778 ' HA ' ' SD ' ' F' ' 174' ' ' MET . 38.0 tt0 -163.7 144.87 9.03 Favored 'General case' 0 C--O 1.24 0.595 0 O-C-N 123.89 0.744 . . . . 73.22 110.561 169.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.51 -110.44 3.13 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.555 -0.748 . . . . 73.23 113.031 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 20.6 m -65.26 -44.92 86.55 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.824 0.85 . . . . 65.4 112.309 -170.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -71.9 -22.4 61.5 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.573 -0.74 . . . . 72.43 112.126 -167.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.599 ' SD ' ' HB2' ' F' ' 174' ' ' MET . 17.4 ttt -72.15 -38.73 69.13 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 110.405 -0.22 . . . . 75.44 110.405 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.78 -32.53 74.26 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.945 0.498 . . . . 40.01 110.845 175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 59.2 t-80 -74.45 -20.51 60.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.687 0.795 . . . . 74.14 110.848 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -86.92 -67.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.131 0.573 . . . . 61.55 111.289 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.435 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.5 pp -74.19 -24.26 59.33 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.126 0.57 . . . . 64.35 112.301 -172.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.13 3.37 72.94 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.905 -0.386 . . . . 52.24 113.35 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -145.37 -69.92 0.28 Allowed 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.502 0.556 . . . . 72.55 112.502 -173.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -74.03 -39.53 63.49 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.318 0.386 . . . . 63.33 111.562 -168.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.615 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 61.0 m -61.98 -50.33 81.34 Favored Pre-proline 0 CA--C 1.565 1.536 0 CA-C-O 118.865 -0.588 . . . . 53.53 111.522 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -69.64 -25.82 28.76 Favored 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 121.427 1.418 . . . . 64.11 113.415 171.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -63.83 -33.03 74.78 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.281 0.562 . . . . 74.35 110.962 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.442 HD13 HD11 ' B' ' 13' ' ' ILE . 59.6 mt -65.67 -44.9 93.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.257 1.023 . . . . 74.44 110.89 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' B' ' 82' ' ' GLY . 44.9 mt -81.33 -12.9 58.89 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.126 -0.943 . . . . 62.14 111.017 -175.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -60.01 -49.94 88.75 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 117.755 -1.117 . . . . 72.2 112.093 -174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.49 -41.38 77.51 Favored 'Trans proline' 0 C--N 1.385 2.487 0 C-N-CA 121.887 1.725 . . . . 41.01 113.011 174.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.533 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.2 m-85 -65.99 -50.22 65.06 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 123.483 0.713 . . . . 74.11 112.204 -177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.73 81.81 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 123.759 0.824 . . . . 70.12 110.847 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -56.09 -48.6 75.81 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.379 1.472 . . . . 65.15 110.299 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -67.63 -36.36 80.66 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.399 0.68 . . . . 61.35 110.428 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.0 t -68.51 -45.02 73.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.752 0.421 . . . . 72.31 111.82 -174.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.574 HD11 ' HB ' ' B' ' 62' ' ' VAL . 92.1 mt -59.22 -50.77 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 123.955 0.902 . . . . 71.24 110.429 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.436 HG21 ' OG ' ' C' ' 119' ' ' SER . 86.9 m -58.26 -33.06 68.98 Favored 'General case' 0 CA--C 1.563 1.445 0 O-C-N 124.481 1.113 . . . . 65.25 111.175 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.7 t -69.75 -35.18 74.74 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.219 1.008 . . . . 74.44 111.357 174.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -79.24 -33.21 43.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.862 0.465 . . . . 72.04 111.481 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 74.2 t -68.56 -31.9 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.675 0.79 . . . . 74.14 110.748 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.505 ' HB3' HG21 ' C' ' 115' ' ' THR . 80.7 p -68.48 -33.45 74.18 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 116.03 -0.532 . . . . 55.01 112.068 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.454 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 83.7 mtt-85 -65.55 -36.96 85.34 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.011 -0.995 . . . . 72.31 110.96 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.89 9.09 63.9 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 115.508 -0.769 . . . . 71.13 113.85 177.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.2 p 63.84 12.66 6.92 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.436 1.894 . . . . 74.44 113.192 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.498 ' HB3' ' HD2' ' B' ' 124' ' ' PRO . 58.3 m-85 -77.99 170.98 13.74 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 123.915 0.886 . . . . 74.3 110.269 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.627 ' HG3' ' HB2' ' B' ' 37' ' ' GLN . 62.5 Cg_endo -77.18 -169.11 0.67 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 122.101 1.867 . . . . 64.05 114.718 -170.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.429 ' HA ' ' CG ' ' C' ' 125' ' ' GLN . 17.7 pt20 -64.92 142.11 58.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 113.945 -1.48 . . . . 61.23 112.434 177.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.71 HD11 HD22 ' B' ' 42' ' ' LEU . 32.5 tp -151.57 98.34 2.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.334 -0.848 . . . . 72.0 108.895 177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -134.65 126.04 28.34 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.309 0.644 . . . . 75.22 109.769 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.493 HD13 ' HG ' ' F' ' 186' ' ' LEU . 39.0 mt -77.01 151.17 35.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.875 0.87 . . . . 73.34 111.807 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.69 106.54 15.77 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.981 -0.748 . . . . 64.14 108.981 171.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.2 113.47 1.68 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.026 2.484 . . . . 64.32 112.938 -175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.515 HG23 ' HE1' ' F' ' 184' ' ' TRP . 30.7 m -102.23 153.84 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.52 0.728 . . . . 73.55 110.152 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.447 ' HB2' HD12 ' D' ' 13' ' ' ILE . 50.2 t-20 -110.55 115.83 30.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.635 0.774 . . . . 70.22 110.562 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.525 ' HD1' ' HB2' ' F' ' 184' ' ' TRP . 54.4 t80 -66.32 -42.24 88.5 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.973 0.509 . . . . 74.34 111.201 175.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -63.12 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 110.021 -0.363 . . . . 73.33 110.021 -176.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.53 -42.54 98.98 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.875 0.734 . . . . 72.52 110.922 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' B' ' 140' ' ' TYR . 9.4 tt -53.74 -47.73 70.36 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.538 0.735 . . . . 71.2 110.16 173.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -68.77 -37.8 79.6 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.683 1.193 . . . . 64.04 111.208 -177.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 21.7 mmt -69.13 -38.29 78.78 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.278 0.631 . . . . 73.04 110.613 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -92.28 -0.58 57.39 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.839 -0.619 . . . . 74.12 111.188 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' B' ' 136' ' ' LEU . 0.3 OUTLIER -87.7 -37.56 16.6 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.227 0.611 . . . . 74.01 109.352 172.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.01 4.25 49.36 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.225 0.61 . . . . 74.21 111.02 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.625 ' HG3' ' HB3' ' D' ' 8' ' ' GLU . 36.3 tt0 -71.85 148.63 45.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.249 0.62 . . . . 73.44 109.636 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -94.01 -91.98 0.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 108.746 -0.835 . . . . 73.32 108.746 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -153.45 132.51 12.57 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.066 0.947 . . . . 61.33 109.947 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.77 143.01 49.04 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.739 1.216 . . . . 73.24 108.858 174.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -165.51 66.77 0.21 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 111.274 -0.73 . . . . 52.21 111.274 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -161.39 176.47 11.11 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.841 0.857 . . . . 71.34 110.365 -174.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 88.68 31.61 12.68 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 116.257 -0.429 . . . . 63.11 113.098 178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -71.82 88.1 1.01 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.311 -0.626 . . . . 62.13 109.311 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.84 98.67 7.18 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 108.106 -1.072 . . . . 72.33 108.106 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -122.18 39.17 3.96 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.629 0.772 . . . . 73.42 110.305 -177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -118.65 79.39 1.38 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.501 -0.555 . . . . 75.42 109.501 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.22 105.77 2.13 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.543 0.737 . . . . 74.32 109.931 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -74.38 95.27 2.67 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.149 0.58 . . . . 52.31 109.796 176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.243 0 C-N-CA 123.399 0.68 . . . . 74.33 109.354 176.427 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.048 0.451 . . . . 72.03 110.713 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.0 t -138.71 91.05 2.5 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.354 -1.35 . . . . 63.34 107.354 170.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' C' ' 4' ' ' GLN . 6.1 tp10 -82.97 -164.72 0.91 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 123.967 0.907 . . . . 73.5 109.814 -177.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.464 ' H ' ' HG3' ' C' ' 3' ' ' GLU . 2.4 mp0 77.16 76.28 0.08 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.497 1.519 . . . . 44.32 109.444 -174.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 16.7 m120 64.87 25.32 12.82 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 114.337 -1.301 . . . . 51.24 113.074 170.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.514 ' N ' HD22 ' C' ' 6' ' ' ASN . 0.0 OUTLIER -61.66 99.77 0.12 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.081 0.952 . . . . 73.12 112.416 -178.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 25.2 m -110.23 99.37 8.44 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.016 0.926 . . . . 73.51 109.201 177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.37 104.04 4.97 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.987 0.515 . . . . 53.13 110.048 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.2 ttt 64.22 115.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.254 1.422 . . . . 62.12 112.219 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 37.3 m -103.6 111.59 24.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.569 0.748 . . . . 75.53 109.484 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.497 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 64.0 t80 -104.34 140.3 38.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.702 0.801 . . . . 63.54 108.892 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -150.02 140.09 22.05 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.869 0.366 . . . . 74.04 111.305 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -93.34 141.49 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.232 1.013 . . . . 72.42 109.578 172.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.519 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.7 mm-40 -108.49 -49.11 3.22 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.37 0.668 . . . . 74.3 110.087 174.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.555 HH11 ' HD1' ' D' ' 32' ' ' PHE . 63.5 ttt180 -170.57 125.39 0.72 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 122.608 0.363 . . . . 74.25 110.354 -173.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.525 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 73.0 mt -109.6 141.73 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 107.344 -1.354 . . . . 63.1 107.344 176.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.544 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 40.6 p90 -176.94 156.69 1.36 Allowed 'General case' 0 C--O 1.238 0.461 0 O-C-N 124.037 0.836 . . . . 74.52 110.768 -176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.5 p -78.73 123.34 27.07 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.428 -0.806 . . . . 72.34 109.954 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.58 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.1 OUTLIER -81.16 -44.87 17.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.007 -0.738 . . . . 52.14 109.007 -179.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -149.87 134.19 17.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.41 -1.268 . . . . 70.42 109.606 -171.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.0 mt -134.15 145.07 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.519 1.128 . . . . 74.12 108.499 179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -156.24 151.99 27.22 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-O 121.223 0.535 . . . . 73.21 111.154 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -152.94 108.52 3.29 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.152 -1.425 . . . . 71.01 107.152 172.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -116.18 114.88 25.06 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.449 0.7 . . . . 70.03 110.298 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.72 83.44 62.3 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.609 1.163 . . . . 75.54 109.333 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.29 -23.15 24.5 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.412 2.074 . . . . 72.55 111.46 172.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -93.54 15.28 16.43 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.25 1.42 . . . . 70.44 109.535 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' D' ' 17' ' ' TYR . . . -56.95 -49.0 96.48 Favored Pre-proline 0 CA--C 1.567 1.616 0 N-CA-C 113.991 1.108 . . . . 51.21 113.991 -174.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.98 -29.57 6.62 Favored 'Trans proline' 0 C--N 1.388 2.609 0 CA-C-N 121.041 1.407 . . . . 71.44 113.132 175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -70.25 -39.84 74.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.198 0.599 . . . . 75.2 111.739 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.443 HG23 HD11 ' C' ' 68' ' ' LEU . 10.5 p -71.18 -12.68 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 123.672 0.789 . . . . 51.1 111.16 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -56.97 -41.0 77.55 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.186 0.595 . . . . 71.43 110.562 173.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -100.57 48.54 0.91 Allowed 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 122.033 0.92 . . . . 74.32 109.842 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.622 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -125.52 158.75 33.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.803 0.841 . . . . 75.14 110.12 177.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -76.85 107.2 9.0 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 106.766 -1.568 . . . . 54.01 106.766 164.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -77.01 90.01 3.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.824 -0.625 . . . . 74.21 111.962 -164.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -137.75 65.55 46.64 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.969 0.908 . . . . 73.31 109.071 169.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' E' ' 192' ' ' GLY . 28.9 Cg_exo -65.13 133.36 35.15 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.284 1.99 . . . . 75.05 111.727 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' C' ' 66' ' ' ALA . 29.4 tt0 -83.76 86.45 7.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.875 -1.158 . . . . 70.25 107.875 178.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.7 m -74.47 79.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 114.513 -1.221 . . . . 60.52 110.332 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' E' ' 189' ' ' ALA . 41.5 tttp -92.74 134.23 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 114.054 -1.43 . . . . 72.31 110.003 -174.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.424 HD23 HD13 ' C' ' 128' ' ' LEU . 1.4 pp -87.72 167.25 14.01 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.727 0.811 . . . . 73.51 111.867 -176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.97 148.3 18.81 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.709 0.804 . . . . 75.25 109.429 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 tt -123.9 139.02 54.38 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.277 0.631 . . . . 63.35 109.86 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 14.0 m-20 -136.39 150.68 48.91 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.769 1.228 . . . . 53.52 109.156 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -115.0 143.56 44.99 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.572 0.749 . . . . 73.44 109.342 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.23 154.66 41.98 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.187 0.995 . . . . 60.3 108.328 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -163.77 152.96 14.21 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.849 0.357 . . . . 72.52 111.063 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.3 t -151.48 130.92 12.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.28 1.032 . . . . 24.41 109.043 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.549 ' HB2' ' HE2' ' E' ' 175' ' ' PHE . 60.5 tt0 -75.85 129.06 36.41 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.723 -0.473 . . . . 60.11 109.723 175.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.566 HD11 HD12 ' C' ' 83' ' ' ILE . 47.0 mt -104.77 -36.23 7.48 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.504 0.722 . . . . 73.35 110.018 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.55 -173.44 4.58 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.685 -1.143 . . . . 70.14 108.948 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -76.14 124.35 27.3 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 115.43 -0.804 . . . . 63.21 109.798 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.7 ' H ' ' HB2' ' E' ' 172' ' ' ALA . 3.1 m-20 63.34 12.24 6.09 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.416 1.086 . . . . 65.13 112.483 -179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.31 130.28 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.874 1.27 . . . . 50.03 108.36 174.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.2 152.13 36.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.58 0.705 . . . . 74.12 111.458 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.439 ' HB2' HD11 ' C' ' 51' ' ' LEU . 27.6 tt0 -83.61 125.42 31.8 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.234 1.414 . . . . 71.2 109.448 172.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 85.9 t -112.37 130.57 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.99 -1.115 . . . . 75.35 107.99 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.4 107.69 19.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.865 0.866 . . . . 64.21 108.752 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' C' ' 103' ' ' PRO . 3.1 tm? -92.07 108.3 19.83 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.39 -1.337 . . . . 64.34 107.39 173.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.9 ttp180 -89.67 128.65 36.11 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.069 -0.514 . . . . 75.34 109.951 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.577 ' HB ' HD11 ' C' ' 114' ' ' ILE . 21.9 t -117.99 118.94 59.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.734 -1.21 . . . . 72.53 107.734 168.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 32.4 m -110.67 146.49 36.13 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.072 0.949 . . . . 72.55 109.393 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.556 HG21 HG21 ' C' ' 114' ' ' ILE . 63.8 t -129.94 115.26 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.747 1.219 . . . . 65.34 109.131 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 23.1 m -98.67 143.44 29.04 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 108.481 -0.933 . . . . 62.52 108.481 173.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' C' ' 39' ' ' GLU . . . -127.67 121.08 29.49 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.485 -0.561 . . . . 63.45 109.485 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 65.0 m -137.96 131.73 31.28 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.316 0.579 . . . . 73.1 111.38 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.622 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.9 mt -87.79 41.12 0.97 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.192 1.397 . . . . 73.32 109.685 172.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.91 -102.66 2.28 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 110.287 -1.125 . . . . 54.23 110.287 -169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -92.35 -31.87 15.19 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.952 0.501 . . . . 64.32 110.152 174.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.584 ' HB3' ' HB2' ' C' ' 68' ' ' LEU . 3.8 tp10 -66.8 119.0 11.1 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.702 1.201 . . . . 72.51 109.758 -177.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.2 m -73.06 124.63 25.9 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 109.174 -0.676 . . . . 75.22 109.174 173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.64 -47.91 10.03 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.377 -0.601 . . . . 73.32 109.377 175.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -171.44 177.22 3.57 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.864 0.866 . . . . 74.51 110.76 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.426 HD13 ' N ' ' C' ' 76' ' ' CYS . 1.9 tm? -132.43 144.6 50.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.484 -1.672 . . . . 64.21 106.484 167.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.426 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.4 t -140.04 143.02 36.18 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 106.829 -1.545 . . . . 74.1 106.829 176.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -158.72 135.07 9.25 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.146 0.498 . . . . 73.32 110.274 -176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 78.0 t -130.33 135.82 59.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 114.864 -1.062 . . . . 61.12 108.341 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -115.84 94.01 4.5 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.362 -1.348 . . . . 73.41 107.362 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -89.83 115.17 26.96 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.849 -1.068 . . . . 75.13 110.11 -171.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.58 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -108.4 157.4 15.3 Favored Glycine 0 C--N 1.34 0.762 0 CA-C-N 116.014 -0.539 . . . . 63.31 113.28 -174.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.472 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -158.0 133.76 3.62 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.93 -1.268 . . . . 53.32 109.93 177.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.566 HD12 HD11 ' C' ' 51' ' ' LEU . 20.8 mm -91.59 122.81 43.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 107.907 -1.146 . . . . 74.11 107.907 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -125.01 130.74 52.94 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 122.966 0.506 . . . . 75.5 110.052 -173.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.6 t -104.97 119.31 38.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.3 -1.0 . . . . 71.12 108.3 174.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.17 150.56 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.017 0.927 . . . . 65.44 110.24 -178.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.66 149.57 28.56 Favored 'General case' 0 C--O 1.247 0.935 0 C-N-CA 123.813 0.845 . . . . 74.44 109.579 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.58 -16.38 60.22 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.195 -0.457 . . . . 63.2 113.212 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.613 HD11 ' HG3' ' E' ' 174' ' ' MET . 48.0 pt -63.22 139.34 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.849 0.86 . . . . 62.1 112.0 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.636 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 44.7 tt0 -163.97 145.24 8.78 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.145 0.978 . . . . 73.44 108.767 175.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -112.92 3.09 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 124.211 0.944 . . . . 34.32 113.127 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -56.59 -46.25 80.94 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 73.31 111.326 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.636 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 25.7 mt-30 -61.52 -31.13 71.13 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.431 0.693 . . . . 75.1 111.921 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 48.2 ttm -84.74 -44.06 13.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.633 0.373 . . . . 73.13 110.776 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.25 -39.49 65.39 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.418 0.687 . . . . 71.44 111.364 -172.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -69.82 -31.95 70.12 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.756 0.822 . . . . 72.42 110.368 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 45.7 t -80.87 -61.9 1.83 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.886 0.474 . . . . 73.34 110.419 -178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -65.9 -40.36 91.45 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.146 0.978 . . . . 73.3 110.271 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.3 2.97 68.81 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-O 119.074 -0.848 . . . . 54.04 114.622 -172.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -154.06 -59.41 0.12 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.404 1.102 . . . . 72.33 112.768 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 77.0 t80 -71.96 -48.49 44.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 113.062 0.764 . . . . 73.04 113.062 -166.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.56 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 33.2 m -60.35 -48.97 92.54 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.692 0.397 . . . . 75.25 110.57 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 54.2 Cg_exo -59.62 -30.47 92.37 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.277 1.985 . . . . 74.35 114.258 170.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -68.65 -32.96 73.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.648 0.779 . . . . 52.44 110.846 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 23.2 mm -64.48 -36.76 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.246 0.618 . . . . 73.33 110.168 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.472 HD21 ' HA3' ' C' ' 82' ' ' GLY . 82.1 mt -83.44 -25.84 30.87 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.513 -0.767 . . . . 74.41 111.86 -174.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -56.98 -40.15 83.02 Favored Pre-proline 0 CA--C 1.565 1.54 0 C-N-CA 124.324 1.05 . . . . 75.42 113.609 -175.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -50.3 -53.63 6.78 Favored 'Trans proline' 0 C--N 1.387 2.574 0 C-N-CA 122.692 2.262 . . . . 65.25 113.792 170.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.592 ' HE2' HG21 ' A' ' 115' ' ' THR . 53.7 m-85 -63.5 -34.42 77.74 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.58 -1.191 . . . . 73.33 110.793 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.81 -45.24 62.18 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.402 0.681 . . . . 54.3 110.853 178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.83 -37.74 69.11 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.384 1.074 . . . . 72.0 110.647 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.454 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.0 OUTLIER -77.94 -43.15 30.74 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.262 0.625 . . . . 72.04 111.075 179.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.5 t -66.56 -33.28 75.31 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 112.755 0.65 . . . . 73.14 112.755 -170.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' C' ' 62' ' ' VAL . 70.4 mt -67.64 -49.08 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 122.871 0.469 . . . . 60.4 109.821 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.676 HG23 ' HB2' ' C' ' 125' ' ' GLN . 57.4 m -54.8 -37.16 65.74 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.251 -1.341 . . . . 74.11 111.603 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.1 t -57.42 -58.11 9.72 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.906 -1.043 . . . . 62.43 109.98 174.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.591 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -41.68 85.85 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.325 1.05 . . . . 71.12 113.195 -176.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 92.1 t -65.04 -42.82 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 122.594 0.358 . . . . 64.12 110.385 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.436 ' OG ' HG21 ' B' ' 115' ' ' THR . 38.1 t -71.78 -20.15 61.91 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.545 -0.752 . . . . 55.42 111.588 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.5 mtt-85 -73.98 -40.12 63.2 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.108 0.563 . . . . 71.2 110.051 173.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.02 -5.64 71.21 Favored Glycine 0 C--N 1.353 1.507 0 O-C-N 123.53 0.519 . . . . 71.44 111.909 167.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p 65.37 23.05 12.03 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.491 2.316 . . . . 63.33 112.357 173.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -81.85 164.21 49.9 Favored Pre-proline 0 CA--C 1.548 0.865 0 CA-C-N 114.805 -1.089 . . . . 75.52 108.491 173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.17 99.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.775 2.317 . . . . 73.21 113.072 171.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.676 ' HB2' HG23 ' C' ' 115' ' ' THR . 2.6 pt20 -49.78 133.29 21.87 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.806 1.242 . . . . 75.02 111.295 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.405 ' HG ' ' HG ' ' C' ' 128' ' ' LEU . 28.2 tp -90.9 82.33 5.65 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.519 0.676 . . . . 51.43 110.359 -170.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -94.59 85.94 4.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.058 -0.974 . . . . 73.03 108.867 -177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.424 HD13 HD23 ' C' ' 42' ' ' LEU . 93.7 mt -87.85 144.28 26.67 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.416 0.627 . . . . 61.43 111.714 -176.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.18 153.35 90.51 Favored Pre-proline 0 CA--C 1.553 1.089 0 CA-C-N 114.203 -1.362 . . . . 71.45 109.417 171.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.446 ' HB3' HD12 ' A' ' 16' ' ' ILE . 53.5 Cg_endo -64.47 142.19 77.23 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 122.783 2.322 . . . . 71.34 114.737 -168.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.639 HG11 ' HA ' ' E' ' 186' ' ' LEU . 3.0 t -104.08 84.11 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 107.54 -1.282 . . . . 62.33 107.54 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.409 HD21 HG23 ' A' ' 105' ' ' ILE . 8.9 m120 -86.1 99.99 11.88 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.48 0.657 . . . . 74.22 110.456 -178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -68.67 -29.45 67.92 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.421 -1.263 . . . . 74.23 110.873 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -63.86 -37.21 86.53 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.87 0.868 . . . . 71.21 111.076 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.1 -49.4 77.8 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.708 0.803 . . . . 45.12 110.65 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' C' ' 140' ' ' TYR . 7.6 mp -72.94 -22.17 60.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 114.957 -1.019 . . . . 72.02 111.094 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -79.36 -48.32 14.25 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.594 0.758 . . . . 70.44 110.662 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.543 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 4.6 ppp? -76.45 -27.71 56.29 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.28 0.632 . . . . 61.4 111.011 -173.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -70.95 -37.43 72.81 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.877 0.471 . . . . 72.03 110.73 169.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.446 ' HB2' ' O ' ' C' ' 136' ' ' LEU . 4.7 t80 -72.17 -159.42 0.05 Allowed 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 109.818 -0.438 . . . . 74.31 109.818 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 51.17 23.54 1.64 Allowed 'General case' 0 CA--C 1.567 1.602 0 C-N-CA 123.362 0.665 . . . . 55.11 110.797 -171.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -174.97 115.65 0.16 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.354 1.062 . . . . 62.5 108.622 -164.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -76.26 -43.79 40.29 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.98 0.419 . . . . 74.54 110.323 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -81.3 90.95 6.16 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.8 -0.636 . . . . 70.53 110.05 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.3 -68.2 0.44 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 109.478 -0.564 . . . . 55.21 109.478 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 134.54 -26.77 3.3 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.471 -0.627 . . . . 53.35 114.491 170.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 66.0 -178.83 0.19 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.126 0.971 . . . . 74.31 112.11 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.88 139.05 29.24 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 115.568 -0.742 . . . . 75.13 112.187 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.4 m -137.26 12.84 3.04 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.217 0.607 . . . . 71.25 110.612 -174.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 68.1 157.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.222 1.409 . . . . 74.11 112.067 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.434 ' HB3' ' SD ' ' G' ' 174' ' ' MET . 0.0 OUTLIER -123.42 -179.13 4.21 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.219 1.007 . . . . 65.15 109.596 174.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -145.1 68.85 1.24 Allowed 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.002 -1.11 . . . . 70.55 108.002 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -157.22 120.77 4.14 Favored 'General case' 0 C--N 1.348 0.504 0 CA-C-N 115.586 -0.734 . . . . 72.41 110.908 178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -103.34 -49.98 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.836 0.855 . . . . 73.35 110.289 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.636 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 -178.437 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 108.733 -0.84 . . . . 73.52 108.733 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 26.5 p -78.3 84.05 4.51 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.445 0.698 . . . . 72.22 110.61 -176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -82.08 104.51 12.48 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.283 -0.871 . . . . 74.23 109.192 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -74.5 85.21 2.03 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.46 0.704 . . . . 52.41 110.097 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -82.52 58.95 4.4 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 72.1 110.582 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -123.43 86.13 2.53 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.752 0.787 . . . . 73.14 109.828 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.1 t -164.89 157.36 16.13 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 113.927 -1.488 . . . . 74.44 108.216 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.625 ' HB3' ' HG3' ' B' ' 142' ' ' GLN . 32.2 mm-40 -83.14 71.24 10.17 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.1 0.56 . . . . 65.53 111.358 -172.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.563 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm -33.72 137.17 0.1 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.164 1.385 . . . . 73.45 113.575 170.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.4 m -125.6 142.46 51.5 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.115 0.966 . . . . 75.21 108.712 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -144.68 127.12 15.92 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 107.576 -1.268 . . . . 54.4 107.576 177.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.604 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 58.5 mt-30 -132.89 143.63 49.64 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.099 0.96 . . . . 63.44 108.68 177.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.447 HD12 ' HB2' ' B' ' 132' ' ' ASN . 38.5 mt -103.41 115.67 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 108.622 -0.881 . . . . 72.41 108.622 170.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -83.74 -44.33 14.55 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 110.152 -0.314 . . . . 70.34 110.152 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -165.11 141.1 5.51 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 111.52 0.193 . . . . 73.33 111.52 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 38.7 mm -120.47 126.05 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.309 -0.997 . . . . 73.51 108.309 172.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' C' ' 28' ' ' ALA . 2.0 p90 -167.86 154.83 8.09 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.627 0.771 . . . . 72.44 111.534 -174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.44 HG21 HD11 ' D' ' 21' ' ' ILE . 81.3 p -79.55 118.87 21.79 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 115.401 -0.818 . . . . 63.33 110.604 -176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.37 -23.0 30.32 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.515 -0.766 . . . . 65.24 110.862 171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.614 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 35.1 t70 -160.04 132.1 6.25 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.852 0.72 . . . . 65.15 109.696 -175.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.591 HD13 ' HE3' ' C' ' 117' ' ' MET . 96.6 mt -132.48 135.73 57.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.089 -1.449 . . . . 73.22 107.089 175.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 8.3 t -138.61 132.15 30.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.574 -1.269 . . . . 70.14 107.574 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.545 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 82.9 t80 -145.14 112.17 5.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.923 -1.51 . . . . 65.2 106.923 173.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.9 112.19 18.01 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.691 0.796 . . . . 51.13 108.983 -177.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.1 82.47 2.56 Favored Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 107.843 -1.169 . . . . 63.22 107.843 172.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.38 -30.5 5.24 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.424 2.083 . . . . 75.3 112.479 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.43 ' O ' HG23 ' D' ' 31' ' ' VAL . 88.8 m-20 -108.29 38.91 2.09 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.679 1.192 . . . . 72.3 108.962 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.544 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.19 -53.39 65.49 Favored Pre-proline 0 CA--C 1.565 1.536 0 N-CA-C 115.147 1.536 . . . . 70.3 115.147 -169.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.76 -7.21 14.53 Favored 'Trans proline' 0 C--N 1.387 2.553 0 CA-C-N 122.191 1.818 . . . . 70.34 112.364 175.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -84.4 -24.67 29.53 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 125.372 1.469 . . . . 72.32 109.055 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 27' ' ' ASN . 13.4 t -66.25 -29.68 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.946 0.898 . . . . 72.11 110.135 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.555 ' HD1' HH11 ' C' ' 15' ' ' ARG . 91.7 t80 -51.25 -31.75 22.04 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 115.434 -0.803 . . . . 64.12 112.599 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -75.42 -17.51 60.16 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.777 0.831 . . . . 74.21 112.42 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.537 ' NZ ' ' HB2' ' D' ' 71' ' ' GLU . 92.3 mttt -122.55 110.79 16.01 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.337 0.655 . . . . 73.33 110.583 -176.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -110.82 81.75 1.48 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.243 1.017 . . . . 63.32 110.672 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 3.1 p90 -150.81 174.96 12.47 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.203 -0.908 . . . . 73.41 109.143 167.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.545 ' H ' ' HA ' ' H' ' 193' ' ' TYR . 59.9 tp60 -71.73 117.58 58.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 119.494 -0.289 . . . . 73.3 110.278 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.466 ' HG3' HD21 ' D' ' 68' ' ' LEU . 77.6 Cg_exo -55.65 130.5 40.78 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.993 2.462 . . . . 71.15 112.411 175.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.35 122.27 15.27 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.755 -0.831 . . . . 51.12 108.755 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 t -98.45 112.08 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.108 0.563 . . . . 65.32 109.541 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 3.2 mppt? -99.32 120.05 38.94 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.984 -1.117 . . . . 73.44 107.984 170.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -98.06 121.18 39.67 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.092 -1.077 . . . . 75.41 108.092 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.471 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.3 t70 -119.4 135.61 54.66 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.837 -0.801 . . . . 75.34 108.837 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.44 HD11 HD21 ' D' ' 60' ' ' LEU . 29.1 tp -111.97 129.76 56.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.084 0.554 . . . . 74.35 109.852 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -139.12 152.42 47.46 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.335 1.054 . . . . 63.51 108.477 174.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 15.3 t -146.21 162.76 37.33 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.075 0.55 . . . . 73.54 110.295 178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.36 147.66 27.87 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.334 1.054 . . . . 64.51 108.86 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 48.9 m -144.48 152.03 40.03 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 120.878 0.37 . . . . 70.05 111.061 174.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.1 p -163.13 125.99 2.7 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.303 1.041 . . . . 71.31 108.842 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -72.86 123.84 24.21 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.834 0.454 . . . . 63.23 111.106 -175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' D' ' 57' ' ' GLU . 37.8 mt -96.53 -29.41 13.9 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.536 0.734 . . . . 74.04 111.503 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.4 -172.49 3.4 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.507 0.723 . . . . 71.04 110.592 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -64.47 116.62 6.3 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.971 -0.559 . . . . 72.2 110.025 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 69.51 0.43 2.93 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.925 1.29 . . . . 65.33 112.365 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.8 t -110.95 131.56 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.844 0.857 . . . . 64.55 110.117 -175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.47 154.2 42.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.332 0.653 . . . . 65.31 109.734 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.603 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -95.16 118.56 32.15 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.643 0.777 . . . . 75.45 109.39 174.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -103.9 119.21 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.519 -0.919 . . . . 65.34 108.519 169.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.56 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.8 t -98.11 138.04 23.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.949 -1.13 . . . . 75.21 107.949 174.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.561 HD13 HG23 ' D' ' 62' ' ' VAL . 0.3 OUTLIER -125.55 116.19 21.37 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.973 -0.751 . . . . 72.3 108.973 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.1 ttm180 -97.75 110.52 23.07 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 115.613 -0.722 . . . . 74.45 109.244 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.561 HG23 HD13 ' D' ' 60' ' ' LEU . 65.8 t -99.59 123.28 52.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.061 -1.088 . . . . 75.44 108.061 170.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.491 HG23 ' HG3' ' D' ' 77' ' ' GLU . 70.4 m -122.29 130.42 53.14 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.324 -0.853 . . . . 45.25 110.145 -172.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.53 HG21 HG21 ' D' ' 114' ' ' ILE . 37.6 t -120.67 101.58 10.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 113.699 -1.591 . . . . 40.15 107.281 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 11.2 m -94.3 111.36 23.09 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.206 -1.405 . . . . 61.22 107.206 169.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.65 135.09 54.53 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 109.088 -0.708 . . . . 73.43 109.088 -174.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.9 p -139.1 148.92 43.94 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.807 -0.633 . . . . 55.3 110.022 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.466 HD21 ' HG3' ' D' ' 38' ' ' PRO . 85.9 mt -109.96 92.06 3.9 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.376 -0.601 . . . . 74.51 109.376 169.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.27 -121.23 20.4 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.421 -0.809 . . . . 31.41 111.893 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -84.4 27.77 0.68 Allowed 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.957 0.903 . . . . 62.04 112.127 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.537 ' HB2' ' NZ ' ' D' ' 34' ' ' LYS . 5.2 tp10 -135.63 135.64 40.35 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-O 118.889 -0.577 . . . . 61.42 110.048 -170.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.4 m -73.85 113.17 10.7 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.905 -0.776 . . . . 54.42 108.905 167.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -76.23 -61.46 1.94 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.173 -0.677 . . . . 63.33 109.173 -179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.57 154.23 15.99 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.361 -1.29 . . . . 63.11 110.016 175.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 27.5 mt -109.13 149.52 29.21 Favored 'General case' 0 C--O 1.247 0.927 0 N-CA-C 107.111 -1.44 . . . . 63.02 107.111 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.2 t -155.35 103.38 2.33 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.547 -0.538 . . . . 71.11 109.547 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' D' ' 63' ' ' THR . 5.2 mp0 -121.96 121.71 37.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.133 0.973 . . . . 64.14 108.667 -174.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -130.43 114.18 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 109.758 -0.46 . . . . 73.04 109.758 -177.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.614 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.78 91.25 8.55 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.639 0.776 . . . . 70.11 109.268 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -79.17 98.56 6.63 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 114.962 -1.017 . . . . 74.35 108.962 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -85.05 142.92 20.14 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.079 -0.808 . . . . 14.53 111.079 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.16 130.12 3.61 Favored Glycine 0 CA--C 1.504 -0.649 0 N-CA-C 110.689 -0.964 . . . . 62.41 110.689 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.73 128.72 42.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 108.502 -0.925 . . . . 70.1 108.502 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -134.06 148.38 51.04 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.091 0.556 . . . . 73.03 110.489 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.604 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 46.1 m -104.94 105.78 15.98 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.566 -0.902 . . . . 74.42 108.566 170.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 28.1 pt -109.57 145.38 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 118.488 0.585 . . . . 63.14 110.634 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.15 169.3 21.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.697 -1.138 . . . . 62.22 109.43 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 72.67 23.8 77.26 Favored Glycine 0 C--N 1.349 1.256 0 C-N-CA 121.576 -0.345 . . . . 72.1 112.584 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.434 HD13 ' HB2' ' D' ' 94' ' ' MET . 2.2 pp -124.46 146.16 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.749 0.82 . . . . 32.12 110.755 -172.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.29 171.49 17.9 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.961 0.904 . . . . 75.51 110.177 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.98 -134.48 31.69 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 123.941 0.776 . . . . 54.34 114.73 173.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 16.3 m -81.04 -13.25 58.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.269 0.628 . . . . 74.13 110.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -67.9 -36.69 80.65 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.235 0.614 . . . . 70.42 110.468 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.434 ' HB2' HD13 ' D' ' 89' ' ' ILE . 2.0 ppp? -70.45 -35.08 73.12 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.455 -0.572 . . . . 74.1 109.455 175.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.43 -33.85 76.02 Favored 'General case' 0 C--N 1.347 0.478 0 CA-C-N 115.038 -0.983 . . . . 54.32 111.285 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -72.28 -37.68 68.98 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.25 0.62 . . . . 51.41 110.974 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -69.85 -38.96 76.63 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.043 0.537 . . . . 72.03 110.811 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -78.67 -45.86 20.43 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.662 0.785 . . . . 64.21 110.416 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.61 -26.9 40.72 Favored Glycine 0 C--N 1.341 0.84 0 CA-C-N 115.626 -0.715 . . . . 70.23 114.009 -168.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.93 -51.02 2.47 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.142 0.471 . . . . 73.24 111.903 -174.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -73.74 -47.29 40.32 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 112.282 0.475 . . . . 74.22 112.282 -172.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 73.6 m -60.5 -47.84 95.18 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 118.976 -0.535 . . . . 61.4 111.274 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.8 Cg_exo -55.32 -37.0 94.89 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.447 2.098 . . . . 74.21 114.043 169.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.98 -29.61 70.54 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.099 0.56 . . . . 71.01 111.02 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.426 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 44.6 mm -75.34 -46.3 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.351 0.66 . . . . 70.11 110.409 173.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 94.8 mt -75.81 -17.27 59.91 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.202 -0.908 . . . . 71.51 111.822 -172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -67.0 -47.6 52.33 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.256 1.022 . . . . 71.54 112.859 -174.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 83.2 Cg_exo -49.42 -44.98 32.52 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 122.565 2.177 . . . . 73.13 113.945 171.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -73.71 -37.08 65.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.319 0.648 . . . . 74.31 111.918 -177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' D' ' 62' ' ' VAL . . . -64.36 -53.38 49.52 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.212 0.605 . . . . 74.34 110.764 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.602 HH12 ' HB3' ' D' ' 130' ' ' PRO . 8.7 ptt180 -67.13 -30.85 70.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 114.703 -1.135 . . . . 64.54 110.898 -175.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.419 ' CD ' HH12 ' C' ' 120' ' ' ARG . 3.3 tm-20 -67.82 -45.71 73.92 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.09 0.868 . . . . 75.33 110.446 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -58.77 -44.1 90.55 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.696 0.622 . . . . 22.24 110.4 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' D' ' 64' ' ' VAL . 96.5 mt -58.25 -54.83 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-N 114.889 -1.051 . . . . 74.41 110.562 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.611 HG23 ' HG3' ' D' ' 125' ' ' GLN . 27.6 m -51.2 -48.24 62.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.878 1.271 . . . . 73.34 111.145 -176.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -66.93 -44.78 79.79 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 114.464 -1.244 . . . . 62.54 110.176 -173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 72.5 mtm -65.47 -34.03 77.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 122.903 0.481 . . . . 73.14 111.405 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.657 HG13 ' HB2' ' D' ' 123' ' ' PHE . 56.5 t -64.91 -49.63 78.92 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.597 0.759 . . . . 74.33 110.454 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.405 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 90.4 p -69.29 -31.6 70.21 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.959 0.504 . . . . 65.53 111.066 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.6 mtt-85 -70.43 -31.46 68.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.929 0.892 . . . . 75.12 109.945 173.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.96 10.85 64.13 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-N 115.536 -0.756 . . . . 73.31 113.202 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 125' ' ' GLN . 66.8 p 56.92 28.18 14.22 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 125.866 1.667 . . . . 75.35 113.112 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.657 ' HB2' HG13 ' D' ' 118' ' ' VAL . 20.4 m-85 -100.9 164.36 16.25 Favored Pre-proline 0 CA--C 1.561 1.396 0 N-CA-C 108.474 -0.936 . . . . 73.44 108.474 177.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 63.2 Cg_endo -68.77 133.53 27.69 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.311 2.007 . . . . 72.21 112.196 -175.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' D' ' 115' ' ' THR . 57.2 tt0 -56.58 129.91 42.92 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.688 0.795 . . . . 64.23 111.227 -176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -121.99 97.99 5.74 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.031 0.443 . . . . 64.25 110.121 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -99.43 105.05 16.95 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.218 -1.401 . . . . 72.43 107.218 174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.82 115.0 12.75 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 109.888 -0.412 . . . . 70.31 109.888 -175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.81 135.11 86.83 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 123.543 0.737 . . . . 64.31 111.05 -176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.602 ' HB3' HH12 ' D' ' 111' ' ' ARG . 73.1 Cg_endo -79.82 108.72 2.3 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.581 2.187 . . . . 75.04 109.997 -174.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -104.26 113.26 40.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 -174.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -66.3 91.37 0.17 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.731 -1.581 . . . . 52.34 106.731 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -59.68 -24.51 63.99 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-N 115.797 -0.638 . . . . 75.3 110.609 -174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -47.55 -40.51 19.1 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.336 1.054 . . . . 64.01 111.521 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.75 -50.37 72.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.784 0.833 . . . . 64.43 111.142 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 29.4 tp -72.76 -22.53 60.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.535 -0.757 . . . . 72.24 110.846 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' D' ' 141' ' ' LEU . 83.2 t80 -76.58 -44.37 34.84 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.438 1.095 . . . . 70.21 109.188 -177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 74.7 mtm -61.81 -39.89 93.35 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 123.846 0.716 . . . . 71.34 110.305 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -70.62 -27.85 64.39 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.549 -0.751 . . . . 63.33 111.11 176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -76.37 -31.14 57.85 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.052 0.541 . . . . 63.22 110.882 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' D' ' 137' ' ' PHE . 74.4 mt -65.21 -27.12 68.46 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.107 0.563 . . . . 73.51 110.324 176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -76.93 3.87 11.17 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.18 0.992 . . . . 61.43 111.727 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.483 ' HG2' ' H ' ' D' ' 148' ' ' GLY . 47.2 mt-30 -118.17 73.35 0.9 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.196 0.998 . . . . 73.51 108.988 -176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -144.25 6.42 1.31 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.996 -1.002 . . . . 75.14 110.75 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.9 -58.38 0.05 Allowed 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.66 -1.237 . . . . 72.3 107.66 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' D' ' 143' ' ' GLN . . . -110.9 -168.66 19.11 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.099 -0.955 . . . . 42.43 110.886 167.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -101.92 144.1 30.97 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.083 0.553 . . . . 70.31 110.907 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . 0.483 ' H ' ' HG2' ' D' ' 143' ' ' GLN . . . -88.05 158.56 29.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 110.858 -0.897 . . . . 74.25 110.858 172.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -120.09 129.82 54.37 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 117.349 0.575 . . . . 61.31 111.336 -172.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -129.95 127.23 39.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 105.415 -2.068 . . . . 62.21 105.415 168.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -85.04 -77.9 0.27 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 122.985 0.514 . . . . 72.24 110.523 -166.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -175.57 166.54 3.23 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.578 0.751 . . . . 75.14 110.724 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -105.93 124.11 49.06 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 106.474 -1.676 . . . . 60.33 106.474 161.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -62.26 -41.62 98.62 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 123.679 0.792 . . . . 71.15 111.981 -173.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 C-N-CA 124.004 0.922 . . . . 72.41 109.038 179.148 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 22.8 pttp . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.09 -0.707 . . . . 74.22 109.09 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . 72.25 -78.89 0.66 Allowed Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.807 -1.317 . . . . 41.01 109.807 -165.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . 0.673 ' HG2' ' HG3' ' A' ' 151' ' ' GLU . 10.5 mptt -117.16 -166.92 1.23 Allowed 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.163 -1.051 . . . . 64.21 108.163 168.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 20.1 m 61.8 19.77 10.86 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.389 1.076 . . . . 71.24 112.386 176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . 0.7 ' HB2' ' H ' ' C' ' 54' ' ' ASP . . . 61.14 165.04 0.08 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.309 1.444 . . . . 65.41 113.392 -175.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.486 HD22 ' SD ' ' E' ' 174' ' ' MET . 0.0 OUTLIER -124.31 20.07 8.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.552 1.141 . . . . 75.11 109.844 172.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.695 ' SD ' ' HB1' ' E' ' 172' ' ' ALA . 0.1 OUTLIER -84.95 -177.55 6.6 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.48 1.112 . . . . 65.14 111.733 -169.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.549 ' HE2' ' HB2' ' C' ' 50' ' ' GLN . 56.7 m-85 59.46 81.04 0.18 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.731 1.212 . . . . 72.14 110.865 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -146.42 -63.11 0.31 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.538 -0.756 . . . . 73.31 109.186 -176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 7.8 mp 65.89 -2.84 0.84 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.702 1.201 . . . . 63.11 113.096 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . 0.574 ' HG3' ' HG3' ' E' ' 179' ' ' GLU . 55.6 tp60 55.31 -81.94 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.16 1.784 . . . . 74.11 112.16 -173.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . 0.574 ' HG3' ' HG3' ' E' ' 178' ' ' GLN . 49.2 mt-10 -135.99 144.23 47.52 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 124.417 1.087 . . . . 54.25 108.654 -176.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.87 95.13 0.29 Allowed 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.617 2.211 . . . . 72.41 111.833 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -76.35 -173.24 2.39 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.633 0.773 . . . . 74.12 110.466 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 47.9 p90 -56.56 143.73 34.45 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.513 0.725 . . . . 75.52 111.444 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 10.9 t -82.98 -178.14 7.02 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.036 0.535 . . . . 63.25 111.434 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 1.3 p-90 -138.01 84.93 20.12 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 124.186 0.994 . . . . 73.14 109.471 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -84.16 153.59 12.62 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.223 2.615 . . . . 65.33 113.91 -176.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . 0.639 ' HA ' HG11 ' C' ' 131' ' ' VAL . 95.9 mt -84.98 171.01 12.46 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.492 -0.777 . . . . 44.13 110.889 176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.572 HG23 HG22 ' C' ' 131' ' ' VAL . 30.4 pt -68.13 162.02 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 123.616 0.766 . . . . 53.54 111.834 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.41 105.03 10.43 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.912 -0.585 . . . . 51.23 109.644 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' C' ' 41' ' ' LYS . . . -118.54 105.0 11.2 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.965 0.906 . . . . 63.33 108.808 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -142.66 88.27 2.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.428 0.691 . . . . 74.14 109.785 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 140.51 123.6 2.0 Favored Glycine 0 C--N 1.354 1.535 0 C-N-CA 121.277 -0.487 . . . . 72.34 113.71 173.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' C' ' 38' ' ' PRO . . . -125.86 83.99 0.35 Allowed Glycine 0 C--N 1.341 0.829 0 N-CA-C 108.88 -1.688 . . . . 72.31 108.88 173.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -78.96 129.42 34.46 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.34 0.656 . . . . 72.14 111.692 -164.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . 0.426 ' HB2' ' HD2' ' F' ' 193' ' ' TYR . . . 75.14 112.02 0.07 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.753 1.621 . . . . 71.4 113.151 173.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -91.75 150.58 21.03 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.601 -1.259 . . . . 74.14 107.601 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.16 76.53 2.99 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.676 0.79 . . . . 62.25 110.584 177.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -136.05 127.46 28.5 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.61 1.164 . . . . 74.25 109.336 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . 0.523 ' N ' ' HB2' ' E' ' 202' ' ' TYR . 22.6 mt-10 60.85 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.554 1.542 . . . . 71.25 113.608 170.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -56.66 114.49 2.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.737 1.215 . . . . 63.34 110.153 179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 101.51 21.65 11.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-N 115.705 -0.68 . . . . 74.44 112.292 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? 58.48 71.85 0.56 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.371 1.468 . . . . 42.43 111.119 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . 0.523 ' HB2' ' N ' ' E' ' 198' ' ' GLU . 96.3 m-85 -120.58 15.27 11.95 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.796 -1.093 . . . . 73.34 109.791 172.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.54 130.0 38.31 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.646 0.778 . . . . 72.3 108.991 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.452 HG23 HG23 ' E' ' 207' ' ' VAL . 89.0 mt -122.88 99.5 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.964 0.906 . . . . 75.14 109.529 -172.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -121.68 -30.33 4.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.54 0.736 . . . . 64.2 111.146 175.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -75.31 -29.78 60.14 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.525 0.33 . . . . 32.1 111.327 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.452 HG23 HG23 ' E' ' 204' ' ' ILE . 16.6 m . . . . . 0 C--O 1.254 1.314 0 CA-C-O 121.499 0.666 . . . . 70.02 109.968 -175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.604 -0.517 . . . . 52.22 109.604 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -63.97 -39.91 97.74 Favored Glycine 0 C--N 1.348 1.197 0 O-C-N 123.949 0.781 . . . . 32.34 111.873 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.29 99.7 4.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.21 0.604 . . . . 73.12 109.623 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 12.6 m -87.35 130.43 34.64 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 64.54 109.529 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . 0.446 ' HB3' ' H ' ' B' ' 88' ' ' GLY . . . -74.6 79.09 1.99 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.7 0.762 . . . . 73.11 109.594 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -136.2 132.5 35.98 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 106.636 -1.616 . . . . 62.51 106.636 -175.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.778 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 4.1 mtm -142.01 -48.35 0.37 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.052 0.39 . . . . 62.24 112.052 -169.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 14.3 t80 58.79 50.74 8.29 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.925 0.89 . . . . 70.33 108.957 -162.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.91 95.43 0.37 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.593 -1.185 . . . . 54.44 109.523 -177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . 0.643 HD23 ' H ' ' F' ' 178' ' ' GLN . 1.4 tt -153.91 157.66 39.55 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.279 -0.873 . . . . 74.22 108.779 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . 0.643 ' H ' HD23 ' F' ' 177' ' ' LEU . 8.8 mm-40 71.18 86.77 0.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.338 1.455 . . . . 73.14 110.034 -175.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.02 160.67 18.85 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 114.429 -1.259 . . . . 73.43 108.863 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.06 53.82 4.92 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 122.67 2.247 . . . . 73.25 111.377 173.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -66.58 171.69 4.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.057 0.543 . . . . 74.32 110.112 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -59.98 100.33 0.09 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.863 -0.792 . . . . 75.02 108.863 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' F' ' 185' ' ' PRO . 62.9 p -59.34 111.42 1.36 Allowed 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.082 0.553 . . . . 75.44 109.567 -176.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.525 ' HB2' ' HD1' ' B' ' 133' ' ' PHE . 30.2 t90 -109.53 93.9 15.05 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 123.344 0.658 . . . . 74.12 109.521 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' F' ' 183' ' ' THR . 83.1 Cg_endo -98.84 -152.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 123.19 2.593 . . . . 74.44 109.985 170.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.493 ' HG ' HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -131.7 171.8 13.05 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.342 -0.984 . . . . 72.04 108.342 170.629 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . . . . . . . . . 2.8 pp -73.4 164.6 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.858 -0.423 . . . . 62.02 109.858 171.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -79.46 -93.89 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.912 -0.773 . . . . 50.03 108.912 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' B' ' 40' ' ' VAL . . . 176.45 146.39 0.09 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.2 1.0 . . . . 63.11 110.025 175.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -160.66 154.1 22.03 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.214 1.006 . . . . 73.34 109.245 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 106.08 59.51 0.61 Allowed Glycine 0 C--N 1.345 1.041 0 N-CA-C 110.53 -1.028 . . . . 55.45 110.53 -176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.85 97.86 0.77 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-N 115.52 -0.34 . . . . 54.42 112.298 -174.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . 0.426 ' HD2' ' HB2' ' E' ' 194' ' ' ALA . 45.5 m-85 -129.4 21.18 5.65 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.387 0.675 . . . . 73.43 110.013 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.04 -171.34 2.03 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.654 0.782 . . . . 65.51 110.162 -178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 63.5 93.53 0.06 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.844 0.858 . . . . 73.42 109.351 -169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -76.49 -57.6 3.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.359 -0.978 . . . . 64.13 108.359 176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 46.7 t80 62.87 147.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 124.746 1.218 . . . . 71.52 110.139 -171.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 62.57 23.11 13.73 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.11 0.957 . . . . 75.1 109.287 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -167.0 -71.12 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.387 -0.824 . . . . 61.45 110.204 -169.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 169.5 -153.04 21.1 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-O 119.508 -0.607 . . . . 73.54 112.443 -175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.73 95.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.901 1.28 . . . . 75.45 112.304 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 21.4 m-30 69.48 -68.79 0.18 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.552 1.541 . . . . 75.52 110.644 -173.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.48 171.84 14.52 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.667 0.787 . . . . 62.43 109.154 175.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.638 HG13 ' H ' ' F' ' 205' ' ' LYS . 3.5 pt -133.26 -77.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 C-N-CA 123.792 0.837 . . . . 71.33 108.847 170.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . 0.638 ' H ' HG13 ' F' ' 204' ' ' ILE . 87.6 tttt 153.17 -54.4 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 127.045 2.138 . . . . 64.22 107.065 -173.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -143.44 -80.61 0.2 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 114.013 -1.449 . . . . 63.13 108.025 -171.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.598 ' HA ' HD12 ' F' ' 204' ' ' ILE . 61.3 t . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 107.018 -1.475 . . . . 73.41 107.018 166.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 25.8 pttm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.91 -0.404 . . . . 74.12 109.91 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 83.26 -47.19 3.78 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 112.328 -0.309 . . . . 70.02 112.328 -178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . 0.413 ' HD2' ' H ' ' G' ' 170' ' ' LYS . 0.0 OUTLIER -132.18 -179.09 5.21 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.757 1.223 . . . . 74.52 108.755 173.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 49.9 m -65.57 94.48 0.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.721 0.808 . . . . 72.44 111.458 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -176.51 176.61 1.56 Allowed 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.947 0.899 . . . . 43.32 111.606 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 85.5 mt 70.11 102.1 0.06 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.568 1.547 . . . . 70.2 112.34 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' G' ' 174' ' ' MET . 0.9 OUTLIER 78.03 -33.07 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.237 1.815 . . . . 74.33 112.787 171.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -164.81 -167.64 1.28 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.059 0.944 . . . . 74.12 108.573 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 69.88 104.26 0.06 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.067 1.347 . . . . 74.3 110.355 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.63 -17.77 0.69 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.666 0.786 . . . . 64.22 110.166 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 59.76 -82.59 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.72 1.608 . . . . 71.42 112.683 171.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -130.29 85.51 56.57 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.61 -1.255 . . . . 75.11 107.61 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.89 -62.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.806 2.338 . . . . 75.34 112.418 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -170.84 170.07 6.6 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 125.44 1.496 . . . . 75.34 107.562 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -57.87 138.94 55.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.043 0.537 . . . . 74.4 110.814 177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 31.8 m -72.58 131.39 42.4 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 109.216 -0.661 . . . . 74.32 109.216 175.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -63.39 134.46 95.86 Favored Pre-proline 0 CA--C 1.552 1.046 0 O-C-N 123.766 0.666 . . . . 64.13 110.382 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -52.06 113.09 1.03 Allowed 'Trans proline' 0 C--N 1.379 2.143 0 C-N-CA 122.931 2.421 . . . . 62.24 112.413 177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.29 156.55 34.04 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.844 -0.616 . . . . 73.21 111.209 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 79.3 mt -66.54 112.03 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.164 -0.926 . . . . 73.4 109.66 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.23 -58.39 7.32 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 124.206 0.941 . . . . 64.41 110.755 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . 0.677 ' HA ' ' HB3' ' H' ' 203' ' ' ASP . . . 49.55 69.35 0.6 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.496 1.118 . . . . 52.44 112.234 175.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -68.13 -27.19 66.24 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 115.63 -0.714 . . . . 64.03 111.124 -175.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 81.05 -141.3 22.28 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.581 -0.736 . . . . 74.4 112.279 176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . 0.455 ' O ' ' HD2' ' A' ' 38' ' ' PRO . . . 147.83 -164.63 28.85 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 111.535 -0.626 . . . . 64.04 111.535 -179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . 0.717 ' HE1' ' HB3' ' A' ' 35' ' ' ASP . 81.2 m-85 -82.72 148.25 27.99 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 120.998 0.428 . . . . 63.2 112.009 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' H' ' 197' ' ' TYR . . . -151.29 -70.33 0.17 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.641 -1.163 . . . . 71.13 108.321 174.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -87.57 132.43 34.06 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.66 0.784 . . . . 73.45 111.597 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -173.4 112.85 0.21 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 107.192 -1.411 . . . . 73.5 107.192 173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -139.41 108.02 5.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.403 0.681 . . . . 74.12 110.112 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -137.78 -153.57 0.49 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.456 1.102 . . . . 74.24 109.228 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 8.4 t30 76.5 -72.45 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.599 1.56 . . . . 60.02 111.056 175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -176.04 138.15 4.01 Favored Glycine 0 C--O 1.246 0.858 0 N-CA-C 110.167 -1.173 . . . . 43.42 110.167 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? -155.53 -176.59 6.03 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.266 0.533 . . . . 70.32 109.917 -171.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -60.72 94.61 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.847 -1.538 . . . . 73.23 106.847 159.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -72.47 -61.19 1.89 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.876 -1.056 . . . . 74.41 111.116 -165.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.401 ' O ' ' HG2' ' B' ' 12' ' ' GLN . 8.4 tp -174.38 -39.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 114.377 -1.283 . . . . 64.53 108.634 -170.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' G' ' 205' ' ' LYS . 18.7 pttp -79.77 -127.63 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.674 1.59 . . . . 75.2 109.356 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 68.51 29.58 5.56 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 124.032 0.933 . . . . 72.22 111.258 170.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 64.7 t . . . . . 0 C--O 1.25 1.095 0 CA-C-N 114.533 -1.212 . . . . 75.23 109.3 174.707 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 25.9 pttm . . . . . 0 N--CA 1.484 1.271 0 N-CA-C 111.307 0.114 . . . . 73.22 111.307 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . -70.46 -14.39 71.94 Favored Glycine 0 C--N 1.355 1.618 0 C-N-CA 123.124 0.393 . . . . 75.44 113.407 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . 0.449 ' HB2' ' ND2' ' H' ' 176' ' ' ASN . 0.1 OUTLIER -78.05 151.65 33.37 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.728 0.811 . . . . 62.13 110.532 173.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 48.4 t -160.85 -59.64 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.755 0.422 . . . . 64.4 110.114 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -162.26 175.84 11.21 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.271 1.029 . . . . 61.11 109.945 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 1.1 tt 70.14 106.98 0.06 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.859 1.264 . . . . 72.15 109.418 177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 17.2 mmt 65.21 93.55 0.06 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.903 1.281 . . . . 71.54 110.231 -172.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.48 -155.27 0.3 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 124.696 1.198 . . . . 64.41 110.197 -174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' H' ' 170' ' ' LYS . 4.9 m120 69.1 80.33 0.19 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.567 1.147 . . . . 74.31 109.453 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . 0.41 ' H ' ' H ' ' H' ' 178' ' ' GLN . 2.4 pt? -163.51 -12.02 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.598 -0.728 . . . . 73.34 111.448 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' H' ' 177' ' ' LEU . 53.1 tt0 -66.55 -35.97 81.53 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.399 0.68 . . . . 72.13 112.009 -173.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -64.01 -50.48 69.19 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 118.675 -0.679 . . . . 62.55 111.654 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.09 5.67 6.08 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.187 1.924 . . . . 72.11 113.694 173.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -100.85 -179.56 4.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.552 0.741 . . . . 72.02 111.284 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -149.07 174.27 12.49 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.602 1.161 . . . . 75.33 109.789 -178.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 69.1 p -70.3 99.69 1.59 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.852 -0.796 . . . . 75.13 108.852 174.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -66.0 112.06 8.02 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.068 0.947 . . . . 75.15 112.074 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.66 107.31 2.42 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.376 2.051 . . . . 75.52 110.665 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 81.0 mt -64.49 -71.24 0.19 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.527 0.731 . . . . 71.23 110.916 -175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 80.3 mt -140.45 137.0 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.231 1.012 . . . . 45.41 108.569 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -86.75 75.0 9.71 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.768 -0.827 . . . . 72.24 108.768 172.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.9 154.87 31.3 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.317 -0.856 . . . . 53.2 110.542 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -136.64 -77.11 0.42 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.155 0.582 . . . . 71.44 109.511 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.46 -80.03 1.18 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.774 -0.53 . . . . 53.31 111.774 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.73 -65.94 3.11 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.797 0.351 . . . . 72.53 112.626 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.545 ' HA ' ' H ' ' D' ' 37' ' ' GLN . 24.7 p90 -140.03 125.13 18.64 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.495 0.718 . . . . 71.12 109.118 175.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -167.28 -42.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.349 1.059 . . . . 41.43 108.735 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 22.7 t80 -67.44 96.94 0.54 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.574 -1.194 . . . . 73.01 110.22 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -120.32 112.24 18.78 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.002 0.921 . . . . 72.24 109.099 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . 0.512 ' OH ' ' HA ' ' D' ' 32' ' ' PHE . 4.0 p90 -138.23 155.0 49.07 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.691 0.396 . . . . 63.41 110.155 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' H' ' 200' ' ' GLY . 11.6 pt-20 -170.02 -154.26 0.11 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.272 1.029 . . . . 75.25 108.417 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.43 1.59 9.43 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 123.551 0.741 . . . . 70.32 112.138 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . 0.471 ' H ' ' HG3' ' H' ' 198' ' ' GLU . . . -78.44 60.78 3.97 Favored Glycine 0 C--N 1.354 1.545 0 CA-C-O 121.098 0.277 . . . . 71.44 112.489 174.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.47 -19.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.871 1.268 . . . . 75.4 110.293 -175.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -170.5 147.43 2.94 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.925 0.89 . . . . 63.34 109.778 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . 0.677 ' HB3' ' HA ' ' G' ' 189' ' ' ALA . 22.6 t70 -148.83 147.53 28.86 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.939 0.495 . . . . 72.14 111.188 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 1.5 pt -156.17 104.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 C-N-CA 125.379 1.472 . . . . 54.04 108.724 175.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -123.94 32.58 5.52 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.145 0.578 . . . . 74.42 111.019 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -125.71 -53.39 1.56 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.992 -0.744 . . . . 74.33 108.992 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.248 1.012 0 C-N-CA 124.15 0.98 . . . . 73.23 108.692 172.109 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.778 -0.452 . . . . 74.34 109.778 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -152.33 -43.93 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.964 1.306 . . . . 75.41 108.049 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -81.81 169.52 16.79 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.474 -0.784 . . . . 64.22 109.565 171.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -72.12 -45.04 62.13 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.227 -1.027 . . . . 72.42 108.227 171.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -75.89 119.82 20.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.379 -0.828 . . . . 74.1 109.56 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -135.19 91.56 2.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.062 0.945 . . . . 62.43 109.237 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m 62.07 78.41 0.29 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.324 1.05 . . . . 65.31 110.385 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -79.15 95.71 5.67 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.195 -0.912 . . . . 72.32 109.089 -173.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.2 mtt -88.97 175.45 7.41 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.664 -0.698 . . . . 53.14 109.661 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.9 m -140.34 109.16 5.98 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.212 -1.033 . . . . 65.41 108.212 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.508 ' HB3' ' SD ' ' C' ' 138' ' ' MET . 60.3 t80 -135.04 135.91 41.67 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.287 -1.005 . . . . 63.4 108.287 174.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -152.48 135.7 15.79 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 116.134 -0.485 . . . . 61.34 110.2 175.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' C' ' 135' ' ' ALA . 3.7 mp -79.82 117.73 26.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.667 -0.864 . . . . 55.23 108.667 173.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -89.27 -39.65 13.35 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.155 0.582 . . . . 72.34 109.701 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -172.71 123.78 0.45 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 122.307 0.243 . . . . 74.1 111.078 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.82 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 85.6 mt -108.17 132.73 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 123.611 0.764 . . . . 74.31 109.208 173.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.702 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 9.3 p90 -167.73 170.74 10.65 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.047 0.939 . . . . 63.15 110.13 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -88.46 134.86 33.73 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.694 -0.854 . . . . 75.24 108.694 171.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.529 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 46.9 mtpt -94.44 -43.32 8.42 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.927 -0.768 . . . . 62.21 108.927 170.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 28.1 t70 -137.54 129.5 28.91 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.709 -1.132 . . . . 74.21 109.604 -177.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 72.2 mt -124.36 136.15 61.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.416 -1.328 . . . . 61.54 107.416 170.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 30.9 t -145.89 112.75 6.03 Favored 'General case' 0 C--O 1.223 -0.292 0 O-C-N 123.519 0.512 . . . . 62.31 109.725 175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.567 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 77.7 t80 -114.23 111.78 22.08 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 106.609 -1.626 . . . . 65.01 106.609 171.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.76 110.19 16.96 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 108.976 -0.75 . . . . 75.01 108.976 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.47 93.04 7.75 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 107.566 -1.272 . . . . 70.14 107.566 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.46 -41.01 7.02 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.457 2.105 . . . . 65.1 111.182 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 78.0 m-20 -100.56 37.51 1.68 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.651 -1.159 . . . . 75.22 109.303 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.92 -52.34 73.2 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.131 -0.938 . . . . 74.44 113.43 -177.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.33 -27.93 10.92 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 121.541 1.586 . . . . 71.04 112.924 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 14.3 t60 -67.58 -26.26 66.19 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.761 1.224 . . . . 62.34 112.151 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 HD11 ' A' ' 68' ' ' LEU . 12.0 p -55.75 -30.18 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.517 1.127 . . . . 74.14 112.908 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -68.6 -34.46 75.82 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.892 0.877 . . . . 73.23 111.21 -176.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -69.64 -32.03 70.47 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.282 1.033 . . . . 75.21 110.267 177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mmmp? -79.14 162.32 25.88 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.683 -1.144 . . . . 74.45 111.06 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -83.1 143.08 30.79 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 108.316 -0.994 . . . . 74.35 108.316 164.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.547 ' H ' ' HA ' ' G' ' 196' ' ' LYS . 62.8 t-105 -83.68 83.88 7.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.756 0.789 . . . . 75.02 110.038 -177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -120.67 69.77 16.97 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.416 1.086 . . . . 73.42 108.318 176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.27 110.02 0.76 Allowed 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.534 2.156 . . . . 73.25 112.704 -170.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.671 ' HA ' ' HA2' ' G' ' 191' ' ' GLY . 44.8 tt0 -94.11 114.4 26.53 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.634 -1.247 . . . . 74.02 107.634 169.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 65' ' ' THR . 22.8 m -87.63 118.25 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 115.066 -0.97 . . . . 63.03 110.877 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.436 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 64.1 tttm -85.33 116.74 23.84 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.198 -0.91 . . . . 64.13 108.753 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.3 tp -97.34 123.51 41.19 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.863 -0.608 . . . . 51.44 110.206 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.537 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.1 m-20 -115.32 122.92 47.37 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.061 -1.089 . . . . 71.41 108.061 170.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.498 HD23 ' HE2' ' A' ' 133' ' ' PHE . 34.1 tp -124.21 121.23 34.5 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 109.033 -0.729 . . . . 71.43 109.033 178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -142.15 146.06 34.89 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.893 0.877 . . . . 73.34 110.017 -172.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -109.29 150.11 28.46 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.405 0.682 . . . . 73.33 109.811 172.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.28 154.17 49.04 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.767 1.227 . . . . 54.34 108.085 179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.0 p -130.55 152.79 49.55 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.86 0.464 . . . . 70.33 110.454 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.9 t -154.66 119.38 4.87 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.213 1.005 . . . . 62.42 108.537 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -91.47 118.67 30.76 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.183 -1.043 . . . . 62.34 108.183 172.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 57' ' ' GLU . 40.5 mt -93.24 -33.27 14.03 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 123.751 0.82 . . . . 71.52 110.129 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.97 -169.97 1.63 Allowed 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.307 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.68 106.31 0.77 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.898 1.279 . . . . 72.34 109.964 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 67.96 8.18 6.3 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.541 1.136 . . . . 74.44 112.515 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.31 106.36 19.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.736 -1.209 . . . . 71.43 107.736 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.554 ' HE1' ' HB2' ' G' ' 175' ' ' PHE . 9.2 m-85 -122.32 123.32 41.12 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.442 -0.799 . . . . 71.15 109.592 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HB2' HD11 ' A' ' 51' ' ' LEU . 35.9 tt0 -93.64 128.07 39.64 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.878 -1.055 . . . . 64.43 108.796 169.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 80.8 t -101.3 124.86 55.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 106.276 -1.75 . . . . 74.34 106.276 166.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.515 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.9 t -101.83 126.26 55.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.725 -0.843 . . . . 45.02 108.725 174.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 HD21 HD11 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -102.85 107.05 17.76 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 108.127 -1.064 . . . . 63.54 108.127 -175.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -103.68 110.53 22.65 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.952 0.901 . . . . 74.1 109.984 -173.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.01 132.07 66.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.97 -1.013 . . . . 75.23 108.729 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.1 m -121.92 123.22 41.19 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.533 -0.543 . . . . 75.51 109.533 177.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 114' ' ' ILE . 52.4 t -116.69 107.23 21.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 124.727 1.211 . . . . 65.44 108.453 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 21.8 m -102.2 149.81 23.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.132 -1.062 . . . . 44.25 108.132 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.19 122.67 30.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.623 -0.51 . . . . 64.31 109.623 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.5 m -117.74 126.61 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.238 0.615 . . . . 75.1 110.39 178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD11 HG23 ' A' ' 31' ' ' VAL . 28.8 mt -92.92 82.42 4.66 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.791 -1.559 . . . . 65.51 106.791 173.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.53 -83.63 1.0 Allowed Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.177 -1.169 . . . . 50.53 110.177 -167.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -128.93 -18.2 3.82 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.472 1.109 . . . . 75.45 110.321 174.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -78.44 108.86 12.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.41 1.084 . . . . 73.43 110.505 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 58.1 m -66.16 119.15 10.95 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.967 0.348 . . . . 72.43 111.106 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.09 -50.89 17.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.184 0.994 . . . . 64.43 109.336 178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -159.9 173.15 16.36 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 113.607 -1.633 . . . . 71.23 110.174 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 76' ' ' CYS . 19.0 tp -141.1 141.2 34.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.737 1.215 . . . . 60.4 107.811 173.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.567 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 36.2 m -132.25 141.51 49.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.854 0.862 . . . . 71.13 108.877 176.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -146.99 121.39 9.65 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.568 -0.901 . . . . 70.13 108.568 168.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -126.49 112.38 29.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 C-N-CA 123.524 0.73 . . . . 74.43 109.542 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.7 mt-30 -88.73 87.2 7.16 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.536 -1.211 . . . . 71.11 109.086 173.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -77.15 95.55 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.716 -1.129 . . . . 75.25 109.29 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.82 142.95 19.56 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 111.912 -0.475 . . . . 65.43 111.912 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.566 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.43 122.66 2.33 Favored Glycine 0 CA--C 1.503 -0.66 0 N-CA-C 110.865 -0.894 . . . . 72.34 110.865 178.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.3 mt -79.76 131.0 35.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 107.726 -1.212 . . . . 62.02 107.726 176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.454 ' HD2' ' HA ' ' A' ' 13' ' ' ILE . 39.2 m-85 -135.9 138.34 42.32 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.197 0.599 . . . . 75.41 109.577 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.9 m -87.62 121.46 30.08 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.94 -0.763 . . . . 63.51 108.94 171.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.6 tt -129.37 136.09 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.57 0.748 . . . . 72.23 111.26 -170.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.27 174.31 3.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.711 1.204 . . . . 54.5 110.155 174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.41 9.62 86.73 Favored Glycine 0 N--CA 1.475 1.276 0 CA-C-N 116.509 -0.314 . . . . 54.32 113.833 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.519 ' HB ' ' HB3' ' A' ' 94' ' ' MET . 1.8 pp -120.22 149.4 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.311 1.044 . . . . 64.31 111.02 -175.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -144.8 174.55 10.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.597 0.759 . . . . 74.33 110.634 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.43 -140.43 40.12 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 115.683 1.033 . . . . 75.24 115.683 167.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -78.63 -12.04 60.0 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.308 1.043 . . . . 71.53 111.064 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.49 -36.9 79.57 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.752 0.821 . . . . 63.44 110.091 -178.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.519 ' HB3' ' HB ' ' A' ' 89' ' ' ILE . 26.2 ptm -75.69 -20.15 58.61 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 116.397 -0.365 . . . . 74.22 111.191 174.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.412 ' HA ' HD21 ' G' ' 177' ' ' LEU . . . -66.05 -23.8 66.61 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.781 0.432 . . . . 73.0 111.553 177.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' CD2' ' HB2' ' A' ' 134' ' ' ASP . 10.8 t-160 -62.86 -45.0 94.62 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.76 0.824 . . . . 72.22 110.522 169.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 41.9 t -68.85 -64.52 0.85 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.704 0.802 . . . . 72.52 111.601 -173.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -72.58 -26.1 61.59 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.557 0.343 . . . . 74.33 111.688 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.05 -34.15 11.21 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 114.659 0.624 . . . . 52.22 114.659 -170.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.99 -39.25 0.41 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 117.96 0.88 . . . . 74.42 113.067 -171.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 91.1 t80 -69.8 -58.96 3.26 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.844 0.458 . . . . 75.32 111.632 -174.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -67.19 -37.46 13.38 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 123.748 0.819 . . . . 75.42 112.66 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.17 -43.56 47.85 Favored 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.124 1.883 . . . . 75.13 113.309 162.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -71.3 -25.43 62.43 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.17 0.588 . . . . 75.5 111.537 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.0 mm -62.33 -45.96 97.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-O 121.595 0.712 . . . . 74.44 109.176 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.566 HD21 ' HA3' ' A' ' 82' ' ' GLY . 45.5 mt -81.12 -18.74 45.4 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.584 -1.189 . . . . 52.43 112.061 -173.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.481 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 51.4 t80 -63.42 -42.54 74.7 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 113.966 1.098 . . . . 75.21 113.966 -171.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.514 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 73.6 Cg_exo -55.13 -33.19 83.06 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 122.101 1.867 . . . . 73.5 113.785 172.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -80.94 -40.14 24.99 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.265 -0.88 . . . . 73.43 111.317 -175.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.06 -41.14 82.42 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 122.457 0.303 . . . . 63.22 110.586 175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.523 ' NH1' HG23 ' C' ' 105' ' ' ILE . 34.0 ttm180 -51.98 -55.72 18.67 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 124.528 1.142 . . . . 75.33 109.537 176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -62.45 -42.17 99.27 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 124.676 1.235 . . . . 75.35 111.845 -174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.466 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.5 t -57.54 -50.21 73.82 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.967 0.792 . . . . 72.11 110.302 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.1 mt -62.63 -46.5 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 115.141 -0.936 . . . . 64.33 110.667 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.466 HG21 ' HE2' ' C' ' 109' ' ' TYR . 82.0 m -54.41 -44.49 72.41 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.253 1.021 . . . . 64.4 110.902 -176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 41.2 t -72.13 -34.81 68.84 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.547 -1.206 . . . . 73.22 111.035 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.9 mtp -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.516 0.726 . . . . 65.12 111.193 177.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -59.97 -52.08 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 124.008 0.923 . . . . 75.54 110.064 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 71.1 p -68.04 -26.71 66.01 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.17 -0.923 . . . . 75.12 112.151 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 116' ' ' SER . 25.9 ttm-85 -72.81 -25.49 61.16 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.877 0.871 . . . . 60.3 109.985 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.64 22.16 12.03 Favored Glycine 0 C--N 1.358 1.791 0 CA-C-N 116.027 -0.533 . . . . 62.11 113.06 168.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.9 t 55.96 27.86 11.82 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 127.154 2.182 . . . . 74.33 113.664 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.448 ' O ' ' HA ' ' A' ' 119' ' ' SER . 36.1 m-85 -98.48 153.15 38.11 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.398 0.679 . . . . 63.23 110.191 175.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -55.74 118.94 5.78 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.501 2.134 . . . . 74.1 111.14 166.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 119' ' ' SER . 11.9 pt20 -64.23 150.35 46.09 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.391 0.676 . . . . 43.21 112.345 -171.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -109.21 101.24 10.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 109.029 -0.73 . . . . 62.35 109.029 -171.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -98.2 84.7 3.3 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 108.735 -0.839 . . . . 71.14 108.735 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.481 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.5 OUTLIER -59.43 139.95 56.61 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.875 0.87 . . . . 74.11 110.017 -175.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' HD13 ' A' ' 128' ' ' LEU . . . -60.78 132.71 91.74 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 123.316 0.647 . . . . 62.14 111.852 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.456 ' HB3' ' NH2' ' A' ' 111' ' ' ARG . 39.8 Cg_endo -72.07 101.73 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.396 2.064 . . . . 73.21 111.483 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 m -101.03 111.52 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 122.389 1.09 . . . . 73.34 110.711 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.483 HD22 ' HB3' ' A' ' 135' ' ' ALA . 1.7 p-10 -99.16 70.03 1.75 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 113.965 -1.471 . . . . 70.14 108.526 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.498 ' HE2' HD23 ' A' ' 44' ' ' LEU . 21.7 m-85 -57.18 -33.16 67.17 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.726 0.81 . . . . 75.33 112.289 -175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 96' ' ' HIS . 9.8 p-10 -74.98 -36.32 62.03 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.657 0.783 . . . . 61.12 111.001 -177.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.483 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -77.41 -29.37 52.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.454 0.702 . . . . 74.14 110.828 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -69.79 -38.32 76.63 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.709 1.204 . . . . 74.31 108.924 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -85.04 -22.14 29.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.602 -0.727 . . . . 73.43 111.073 177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -61.26 -46.54 89.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.504 0.722 . . . . 71.24 111.067 -177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -68.4 -17.66 64.27 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 115.902 -0.59 . . . . 70.21 111.499 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -91.85 -35.51 14.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.887 0.875 . . . . 73.31 111.289 176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.1 -23.2 67.23 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 125.36 1.464 . . . . 74.04 110.648 -174.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -146.31 33.77 0.98 Allowed 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 108.451 -0.944 . . . . 75.32 108.451 -174.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -43.17 97.54 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 126.02 1.728 . . . . 62.13 114.528 -175.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -174.44 123.05 0.28 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.97 1.308 . . . . 52.12 107.723 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.451 ' HB2' ' ND2' ' C' ' 6' ' ' ASN . . . -72.93 120.17 18.18 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.243 0.617 . . . . 71.15 110.544 -177.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.8 39.47 0.43 Allowed Glycine 0 C--N 1.342 0.892 0 N-CA-C 111.79 -0.524 . . . . 60.34 111.79 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -81.32 141.34 34.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.127 0.571 . . . . 72.32 110.455 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.69 49.87 0.2 Allowed Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.455 -1.058 . . . . 33.55 110.455 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 76.7 p -89.31 109.42 20.32 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.384 0.673 . . . . 63.04 109.232 178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -76.86 78.48 3.45 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.038 0.935 . . . . 73.25 109.478 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -97.21 78.62 2.76 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.441 0.696 . . . . 72.31 109.864 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -88.8 -45.8 9.47 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.225 -1.028 . . . . 74.22 108.225 173.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -71.93 131.55 43.11 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.292 0.637 . . . . 72.12 109.343 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.531 ' HB2' ' HB3' ' C' ' 141' ' ' LEU . 4.1 p-10 -97.38 -26.2 14.95 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.261 0.624 . . . . 70.01 111.095 -175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 O-C-N 124.074 0.859 . . . . 72.14 109.22 -176.023 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 89.8 mtp . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 109.427 -0.583 . . . . 73.3 109.427 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -153.42 117.84 4.92 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.491 0.716 . . . . 62.31 109.57 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.3 103.75 7.12 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.518 0.727 . . . . 71.24 109.284 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.82 88.78 1.2 Allowed 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.014 -1.476 . . . . 63.13 107.014 171.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -64.97 -21.25 66.81 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 114.617 -1.174 . . . . 72.23 112.073 -174.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -87.92 66.81 8.84 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.757 0.789 . . . . 74.32 108.893 172.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -95.03 150.82 19.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.83 -0.623 . . . . 63.31 110.595 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -76.34 -29.45 57.24 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.483 0.713 . . . . 75.25 109.759 173.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.625 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.9 ptm 55.98 172.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 127.272 2.229 . . . . 74.12 114.575 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.4 m -157.37 130.09 7.52 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.681 1.193 . . . . 71.33 107.8 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -137.21 140.48 41.76 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.179 -0.674 . . . . 71.44 109.179 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 23.9 tp60 -142.68 115.46 8.68 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.171 -0.677 . . . . 51.41 109.171 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.409 HD11 HG13 ' B' ' 16' ' ' ILE . 6.8 tp -68.88 127.6 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.953 -0.758 . . . . 63.22 108.953 171.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -113.78 -45.55 3.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.873 0.469 . . . . 63.23 110.332 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -167.09 143.74 4.48 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 123.329 0.393 . . . . 63.13 110.689 -175.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.409 HG13 HD11 ' B' ' 13' ' ' ILE . 92.8 mt -120.04 143.8 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 107.442 -1.318 . . . . 73.5 107.442 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.445 ' HE1' HG13 ' B' ' 83' ' ' ILE . 22.1 p90 -173.19 156.27 3.15 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.167 0.508 . . . . 73.51 111.461 -178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.4 m -84.1 128.98 34.91 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.93 -0.767 . . . . 63.11 108.93 169.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.426 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 39.5 mtpt -90.41 -43.49 10.26 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.496 0.718 . . . . 75.3 109.738 177.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.0 t70 -148.19 142.44 26.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.316 -0.856 . . . . 74.34 111.323 -172.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 41.3 mm -128.27 135.36 62.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 C-N-CA 124.768 1.227 . . . . 63.12 108.878 173.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.8 t -130.39 128.83 42.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.611 -1.177 . . . . 75.11 108.067 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 72.5 t80 -150.08 110.33 4.17 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.793 -1.558 . . . . 75.22 106.793 171.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -125.41 113.93 18.17 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.979 -1.119 . . . . 71.03 107.979 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.07 89.64 5.82 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 123.703 0.801 . . . . 73.24 108.903 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.457 ' HD2' ' HA ' ' B' ' 74' ' ' PHE . 44.7 Cg_endo -63.57 -38.28 42.48 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.25 2.634 . . . . 74.1 112.844 -171.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -111.33 30.69 6.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.302 1.041 . . . . 75.02 109.559 -178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.702 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -47.4 -50.02 51.0 Favored Pre-proline 0 CA--C 1.566 1.57 0 N-CA-C 114.856 1.428 . . . . 32.43 114.856 -173.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.9 Cg_endo -77.68 -23.28 9.8 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.871 1.714 . . . . 43.32 112.738 175.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.464 ' HA ' ' NE2' ' B' ' 33' ' ' GLN . 77.0 m80 -78.38 -8.29 58.29 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.568 0.747 . . . . 75.35 111.437 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 93.6 t -61.01 -24.3 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.074 0.95 . . . . 71.33 111.027 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -66.13 -43.49 86.97 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.665 0.386 . . . . 71.12 110.975 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' B' ' 30' ' ' HIS . 2.1 mp0 -72.54 -36.59 68.32 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.709 0.804 . . . . 62.34 110.049 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.38 76.6 10.08 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.651 0.739 . . . . 72.11 109.786 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -79.79 79.34 6.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.595 -1.184 . . . . 55.52 110.641 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -173.29 156.95 3.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.142 0.977 . . . . 72.02 109.482 170.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -58.54 128.38 83.12 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 123.881 0.872 . . . . 75.25 110.699 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -66.01 152.6 80.91 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.19 1.26 . . . . 73.34 110.281 168.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -71.27 101.66 2.38 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.026 -1.101 . . . . 74.12 108.026 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.594 HG21 ' HB2' ' B' ' 124' ' ' PRO . 4.2 t -84.58 123.21 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.143 -1.428 . . . . 42.34 107.143 -174.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' B' ' 64' ' ' VAL . 1.5 tmtp? -145.83 113.97 6.59 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.629 -0.508 . . . . 61.45 109.629 -174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.71 148.48 23.25 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.646 0.779 . . . . 74.5 109.157 172.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.39 150.33 43.76 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.13 -1.063 . . . . 53.14 108.13 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.401 HD12 HG11 ' B' ' 131' ' ' VAL . 5.5 tt -109.92 125.73 53.14 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.351 0.66 . . . . 74.44 109.257 -172.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -134.46 136.19 43.04 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 107.884 -1.154 . . . . 73.24 107.884 172.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 13.4 t -108.41 146.16 33.49 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.274 0.559 . . . . 62.14 109.957 -177.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.75 159.17 42.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.5 1.12 . . . . 71.4 108.405 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.519 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 81.2 p -143.54 162.35 36.09 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.945 0.402 . . . . 43.22 110.94 -178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -160.48 154.36 22.75 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.781 1.233 . . . . 75.0 108.91 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -121.76 135.07 54.93 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.166 0.587 . . . . 75.15 109.657 175.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.5 mt -100.66 -47.9 4.69 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.474 0.71 . . . . 75.24 109.517 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.06 -175.39 5.13 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.99 -1.005 . . . . 60.21 110.295 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -71.83 130.11 40.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.736 -1.12 . . . . 70.13 109.072 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 66.07 -8.18 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.47 1.508 . . . . 64.32 112.743 -174.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.3 t -110.02 94.18 2.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.87 0 N-CA-C 107.942 -1.133 . . . . 63.43 107.942 -176.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.519 ' HE2' ' HB2' ' B' ' 48' ' ' SER . 2.8 t80 -98.12 165.32 11.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.701 -1.136 . . . . 74.31 109.134 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -141.8 106.01 4.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.548 -1.278 . . . . 70.02 107.548 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 56.7 t -97.94 131.5 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.205 0.602 . . . . 71.24 109.423 -175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 34.7 t -108.92 125.28 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.716 0.806 . . . . 53.14 109.726 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.455 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -94.25 130.95 40.31 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.511 -1.292 . . . . 64.4 107.511 172.167 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -121.26 106.74 11.77 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.401 0.681 . . . . 71.32 109.497 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.1 124.83 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.537 -0.912 . . . . 75.42 108.537 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.1 m -120.35 146.91 45.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.694 0.398 . . . . 63.15 110.931 -174.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 41' ' ' LYS . 55.1 t -116.88 120.1 64.02 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 124.644 1.177 . . . . 75.51 109.577 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.3 m -99.24 127.93 45.29 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.981 -1.488 . . . . 74.31 106.981 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.59 132.43 18.03 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.582 -0.896 . . . . 72.14 108.582 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.6 p -148.55 139.31 22.88 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.587 0.554 . . . . 51.44 111.803 -170.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 51.2 mt -100.24 100.28 11.08 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.054 1.342 . . . . 74.44 109.587 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.66 -111.18 3.61 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 111.801 -0.52 . . . . 73.45 111.801 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -108.16 4.43 24.84 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.566 0.747 . . . . 43.34 111.536 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -121.07 160.31 23.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.693 0.797 . . . . 73.43 109.843 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 41.9 m -78.74 136.99 37.55 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.738 0.415 . . . . 65.33 110.515 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -82.33 -61.42 1.9 Allowed 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.412 1.101 . . . . 65.42 109.024 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.482 ' CE2' ' HB3' ' B' ' 76' ' ' CYS . 1.2 p90 -154.17 171.79 18.61 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 112.892 -1.958 . . . . 72.23 107.623 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.6 mt -136.57 110.17 8.03 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 105.907 -1.886 . . . . 74.04 105.907 167.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.484 ' HB2' ' HD1' ' B' ' 23' ' ' PHE . 1.8 t -113.76 160.22 18.91 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 116.094 -0.503 . . . . 71.31 110.292 174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.2 tt0 -164.98 143.73 6.59 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 107.653 -1.24 . . . . 75.24 107.653 -170.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 73.5 t -128.16 144.01 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 123.786 0.834 . . . . 73.13 108.871 176.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -122.69 92.53 3.73 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 123.748 0.819 . . . . 74.23 108.911 172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -88.54 100.73 13.3 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 114.736 -1.12 . . . . 74.24 108.809 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -94.39 174.52 33.74 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 111.838 -0.505 . . . . 74.02 111.838 177.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -169.29 136.5 4.07 Favored Glycine 0 CA--C 1.509 -0.282 0 N-CA-C 111.729 -0.548 . . . . 74.34 111.729 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.445 HG13 ' HE1' ' B' ' 17' ' ' TYR . 34.5 mt -86.15 124.88 40.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 N-CA-C 108.445 -0.946 . . . . 72.23 108.445 175.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -138.61 131.53 29.56 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.976 -1.12 . . . . 74.01 107.976 -178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 75.1 m -91.03 107.37 19.16 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 109.716 -0.476 . . . . 75.12 109.716 174.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.505 ' HB ' HD11 ' B' ' 89' ' ' ILE . 24.7 pt -106.24 142.85 18.22 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 CA-C-N 115.358 -0.837 . . . . 70.41 110.817 -176.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.38 166.13 33.01 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.313 1.045 . . . . 52.11 108.739 165.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.625 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.63 -53.33 4.84 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.924 -0.375 . . . . 53.3 113.523 177.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.5 pp -51.98 126.07 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.036 0.934 . . . . 73.11 112.474 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.561 ' HB3' ' HG ' ' F' ' 173' ' ' LEU . 10.2 pt-20 -159.36 154.36 24.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.445 0.698 . . . . 73.01 110.768 -177.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.33 -122.93 22.19 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.578 -0.737 . . . . 74.35 112.188 -175.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 19.5 m -68.52 -31.27 70.39 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.66 0.784 . . . . 72.03 110.936 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -72.8 -34.85 67.17 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.642 0.777 . . . . 74.34 110.763 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.447 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 54.1 ttm -62.79 -49.23 75.79 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.527 -0.761 . . . . 75.13 109.36 171.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.0 -28.79 69.81 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.697 0.799 . . . . 65.41 112.071 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 m170 -69.83 -44.73 69.35 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.952 0.501 . . . . 74.33 110.034 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.454 ' HA ' ' HB3' ' B' ' 101' ' ' TYR . 45.5 t -63.91 -59.47 4.47 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.753 0.821 . . . . 62.44 111.535 -176.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.449 HD12 ' N ' ' B' ' 99' ' ' GLY . 4.2 pp -71.12 -28.66 64.46 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.475 0.71 . . . . 75.13 112.486 -175.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.449 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -94.42 -38.41 5.04 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 116.478 -0.328 . . . . 22.12 113.521 -168.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 104' ' ' ASN . . . -125.9 -45.17 1.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 118.984 -0.531 . . . . 52.41 112.223 -171.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.454 ' HB3' ' HA ' ' B' ' 97' ' ' CYS . 93.0 t80 -71.04 -63.86 1.02 Allowed 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 118.17 0.441 . . . . 74.53 111.819 -169.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.46 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 58.1 m -58.32 -45.99 99.67 Favored Pre-proline 0 CA--C 1.557 1.212 0 CA-C-O 118.777 -0.63 . . . . 73.13 111.1 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.3 Cg_exo -54.04 -38.91 87.15 Favored 'Trans proline' 0 C--N 1.398 3.142 0 C-N-CA 122.314 2.009 . . . . 65.22 114.228 167.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' B' ' 100' ' ' ALA . 14.1 t-20 -68.52 -30.14 68.88 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 118.576 0.626 . . . . 64.12 111.49 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.0 mt -62.8 -50.18 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-O 121.528 0.68 . . . . 74.24 109.206 170.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 61.2 mt -77.41 -13.5 59.91 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 113.841 -1.527 . . . . 74.42 111.963 -174.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.424 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 55.2 t80 -67.56 -49.3 41.38 Favored Pre-proline 0 N--CA 1.472 0.635 0 CA-C-O 117.821 -1.085 . . . . 70.5 113.792 -166.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -61.21 -32.42 90.63 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.45 1.433 . . . . 71.45 112.231 177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -65.23 -49.85 68.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.319 0.648 . . . . 71.3 110.531 177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.2 -42.55 99.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.873 0.869 . . . . 73.14 111.15 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -61.28 -49.14 78.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 125.53 1.532 . . . . 73.51 111.265 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.33 -36.85 77.35 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 109.512 -0.551 . . . . 74.42 109.512 179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 37.9 t -62.18 -39.27 92.13 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.326 0.65 . . . . 73.41 112.217 -178.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 28.1 mt -63.51 -51.84 65.45 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.767 0 N-CA-C 109.716 -0.476 . . . . 63.23 109.716 174.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 54.9 m -61.52 -24.42 66.61 Favored 'General case' 0 CA--C 1.561 1.371 0 O-C-N 124.31 1.006 . . . . 74.12 111.438 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.445 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.4 t -69.74 -58.59 3.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.971 0.909 . . . . 64.15 109.884 172.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.483 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 17.4 mmt -65.9 -28.08 68.68 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.309 0.576 . . . . 71.43 111.477 -176.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -52.35 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.726 1.61 . . . . 65.41 109.548 173.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 96.7 p -65.97 -31.6 72.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.015 0.526 . . . . 71.51 111.007 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.483 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 79.8 mtt-85 -62.17 -39.85 94.06 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.406 0.682 . . . . 65.24 110.721 176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 9.21 71.15 Favored Glycine 0 C--N 1.353 1.475 0 O-C-N 123.349 0.406 . . . . 62.04 113.489 174.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 11.3 p 58.95 30.7 20.54 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.406 1.882 . . . . 71.41 112.362 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -90.84 161.53 35.6 Favored Pre-proline 0 CA--C 1.56 1.328 0 C-N-CA 124.749 1.22 . . . . 65.3 110.899 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.594 ' HB2' HG21 ' B' ' 40' ' ' VAL . 14.8 Cg_exo -74.89 145.46 31.94 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 124.157 3.238 . . . . 73.22 115.46 -175.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.485 ' H ' ' HG2' ' C' ' 125' ' ' GLN . 0.4 OUTLIER -67.41 143.13 56.45 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.25 1.42 . . . . 75.23 111.936 177.2 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 43.6 tp -151.28 113.73 4.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.95 -1.13 . . . . 74.13 107.95 163.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -89.01 116.02 26.99 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.147 -1.057 . . . . 65.2 108.147 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.65 ' HA ' HD12 ' F' ' 187' ' ' ILE . 2.3 tt -66.34 137.48 56.94 Favored 'General case' 0 CA--C 1.553 1.066 0 O-C-N 123.853 0.721 . . . . 74.44 110.063 -177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.505 ' HB2' ' HE2' ' E' ' 202' ' ' TYR . . . -55.11 152.89 13.5 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 126.138 1.775 . . . . 70.23 113.539 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.646 ' HG3' HD11 ' D' ' 16' ' ' ILE . 92.6 Cg_endo -69.72 103.98 1.24 Allowed 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.807 2.338 . . . . 72.44 110.701 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.401 HG11 HD12 ' B' ' 44' ' ' LEU . 16.6 m -85.29 52.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-O 122.374 1.083 . . . . 61.24 111.096 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -78.46 71.27 4.92 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 107.402 -1.333 . . . . 73.43 107.402 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -66.47 -31.1 71.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 114.308 -1.315 . . . . 73.5 110.974 -171.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.42 -42.95 88.37 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.212 0.945 . . . . 73.33 111.301 178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.51 -48.76 76.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.457 0.703 . . . . 55.04 111.481 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -65.15 -47.91 75.39 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.756 0.823 . . . . 43.54 110.136 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -62.75 -29.79 70.95 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.399 1.08 . . . . 73.41 111.565 -176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' B' ' 142' ' ' GLN . 1.4 tmt? -67.49 -37.18 82.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.244 0.618 . . . . 72.12 110.931 178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -92.2 -18.21 23.79 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.972 0.509 . . . . 70.12 111.515 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -88.49 -48.38 7.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.666 0.386 . . . . 74.4 110.686 -175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.423 HD13 ' O ' ' B' ' 141' ' ' LEU . 2.0 tm? -90.02 -8.98 50.27 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.5 0.72 . . . . 74.04 109.778 -176.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.458 ' HB3' ' O ' ' B' ' 138' ' ' MET . 6.3 tp-100 -132.88 108.41 8.92 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.872 -0.788 . . . . 70.11 108.872 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -78.23 125.84 29.94 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.143 -1.058 . . . . 73.53 108.143 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -124.54 144.66 50.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.783 0.833 . . . . 72.02 108.936 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.08 152.16 40.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.549 0.74 . . . . 64.22 111.087 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.34 -131.51 2.75 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.958 -0.457 . . . . 70.4 111.958 178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.43 ' HG3' ' HB1' ' D' ' 87' ' ' ALA . 10.5 pt-20 -152.65 162.73 40.85 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.593 1.157 . . . . 71.35 108.756 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 128.71 171.36 12.96 Favored Glycine 0 N--CA 1.473 1.159 0 N-CA-C 112.268 -0.333 . . . . 54.4 112.268 -176.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.2 t -79.54 32.3 0.24 Allowed 'General case' 0 CA--C 1.569 1.674 0 N-CA-C 113.782 1.03 . . . . 71.52 113.782 -168.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -78.55 80.73 4.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 107.767 -1.197 . . . . 75.34 107.767 166.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -69.46 89.9 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.7 0.8 . . . . 75.05 112.528 -166.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . 0.462 ' H ' HG21 ' D' ' 7' ' ' THR . 40.8 m170 -93.64 146.51 23.77 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.219 1.008 . . . . 74.33 109.897 176.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -88.8 5.41 43.73 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.107 0.963 . . . . 54.45 111.177 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -93.23 157.36 16.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.816 0.847 . . . . 64.25 110.646 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 C-N-CA 124.019 0.928 . . . . 62.3 111.041 -174.969 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 108.619 -0.882 . . . . 72.34 108.619 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -161.31 176.68 10.93 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.683 -1.144 . . . . 61.52 109.809 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -131.59 22.39 4.69 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.175 0.99 . . . . 70.12 110.781 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -52.95 140.89 23.5 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.921 0.888 . . . . 74.24 110.883 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.45 66.59 7.07 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 122.085 0.945 . . . . 74.45 110.429 -171.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 145' ' ' ALA . 22.0 m120 -146.73 170.44 16.99 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.209 1.404 . . . . 61.35 107.946 -177.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.7 p -76.8 135.5 38.94 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 122.698 0.399 . . . . 64.41 110.615 174.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.07 -33.28 59.56 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.555 1.142 . . . . 73.01 112.396 -177.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.618 ' HG3' HG22 ' C' ' 89' ' ' ILE . 23.7 ttt 64.81 114.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.817 1.247 . . . . 74.32 111.413 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 18.1 m -96.04 117.41 30.62 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.167 0.587 . . . . 43.23 110.49 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.501 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 44.0 t80 -125.31 118.64 26.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 107.953 -1.128 . . . . 74.55 107.953 170.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.442 ' NE2' ' HG2' ' C' ' 14' ' ' GLN . 11.9 tm0? -136.12 127.57 28.58 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 117.943 0.338 . . . . 75.34 110.235 -175.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 tp -89.15 129.03 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.224 -0.658 . . . . 73.31 109.224 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.442 ' HG2' ' NE2' ' C' ' 12' ' ' GLN . 5.5 mt-30 -99.99 -42.2 6.86 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.413 0.685 . . . . 73.14 110.42 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.498 ' HD2' ' CD1' ' D' ' 32' ' ' PHE . 60.6 ttt180 -174.6 128.19 0.33 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.153 0.581 . . . . 75.33 110.11 -168.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 68.2 mt -112.85 142.1 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 107.961 -1.126 . . . . 64.41 107.961 172.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.556 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 26.2 p90 -177.84 161.37 1.59 Allowed 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.824 0.703 . . . . 72.25 110.909 -175.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.464 HG21 ' SG ' ' C' ' 113' ' ' CYS . 64.9 p -80.41 120.32 24.27 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.609 0.764 . . . . 75.3 109.701 175.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.544 ' HD3' ' HA3' ' C' ' 81' ' ' GLY . 0.2 OUTLIER -74.02 -49.87 22.36 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.862 0.839 . . . . 74.32 108.964 178.177 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' C' ' 79' ' ' GLN . 25.0 m-20 -141.91 122.07 13.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 113.417 -1.72 . . . . 51.01 108.16 -174.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.2 mt -112.63 143.62 21.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 107.412 -1.329 . . . . 73.24 107.412 169.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.9 t -156.19 145.98 21.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.098 0.475 . . . . 53.34 110.214 175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.492 ' HB3' ' HB ' ' D' ' 21' ' ' ILE . 91.8 t80 -148.21 123.99 10.56 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.562 -1.273 . . . . 55.11 107.562 176.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -119.06 115.35 24.11 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 124.14 0.976 . . . . 73.34 109.306 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.32 78.55 27.06 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 108.042 -1.095 . . . . 55.15 108.042 166.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -73.52 -15.34 24.73 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.373 2.049 . . . . 71.43 111.559 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -112.31 25.41 11.55 Favored 'General case' 0 C--O 1.214 -0.784 0 C-N-CA 124.276 1.03 . . . . 51.25 109.945 177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.55 -51.33 77.01 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 114.435 1.272 . . . . 64.11 114.435 -172.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.69 -27.13 9.2 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 121.922 1.748 . . . . 71.21 112.45 173.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -69.84 -33.81 72.79 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.211 1.404 . . . . 71.41 111.395 -174.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.705 HG13 HD11 ' C' ' 68' ' ' LEU . 53.5 t -79.9 -22.78 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 124.78 1.232 . . . . 73.34 111.487 178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.65 -40.87 93.61 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.215 0.606 . . . . 70.34 111.78 -177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -101.97 45.69 0.96 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.415 0.686 . . . . 71.11 109.944 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -125.83 168.33 13.99 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.636 0.775 . . . . 62.12 110.019 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -74.08 115.41 13.52 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 109.032 -0.729 . . . . 72.33 109.032 172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.51 ' HE1' ' HB3' ' E' ' 194' ' ' ALA . 51.7 t-105 -85.25 93.94 8.8 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.659 0.784 . . . . 60.42 111.842 -167.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -142.49 73.39 20.5 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.148 0.979 . . . . 74.31 109.773 169.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.4 120.76 4.97 Favored 'Trans proline' 0 C--N 1.383 2.368 0 C-N-CA 122.999 2.466 . . . . 61.13 112.408 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' C' ' 67' ' ' SER . 8.8 pt-20 -86.49 91.37 8.52 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 122.222 1.01 . . . . 63.42 109.346 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.755 ' HB ' HD13 ' C' ' 126' ' ' LEU . 26.2 m -82.03 89.01 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.155 0 CA-C-O 122.532 1.158 . . . . 65.53 110.449 -173.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -109.61 142.04 41.29 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.691 -1.141 . . . . 73.3 109.507 -176.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.416 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.2 pt? -129.85 160.78 32.47 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.895 0.478 . . . . 74.42 111.17 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -133.41 146.58 51.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.719 1.208 . . . . 62.1 109.053 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.578 ' HG ' HD21 ' C' ' 60' ' ' LEU . 6.0 tt -112.39 109.77 19.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.657 -1.238 . . . . 72.41 107.657 -178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 24.0 t70 -112.97 141.7 46.5 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.039 -1.097 . . . . 74.31 108.039 173.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 43.5 m -113.94 111.63 22.0 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.786 -0.82 . . . . 45.13 108.786 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -111.47 158.86 18.65 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.934 1.294 . . . . 71.12 108.971 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.8 p -165.69 154.48 11.65 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.789 0.436 . . . . 70.25 111.198 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -145.6 160.91 40.97 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.737 0.815 . . . . 52.4 109.172 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.68 121.83 35.51 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.494 -0.558 . . . . 54.34 109.494 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.615 HD11 HD12 ' C' ' 83' ' ' ILE . 61.6 mt -88.3 -53.06 4.88 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.561 -0.903 . . . . 63.21 108.561 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.16 -171.26 3.79 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.852 -1.067 . . . . 71.43 110.328 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.91 118.92 17.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.065 -0.97 . . . . 75.22 108.779 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 69.51 -0.55 2.55 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 124.805 1.242 . . . . 74.44 113.189 -173.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.71 114.64 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 N-CA-C 109.059 -0.719 . . . . 70.31 109.059 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -128.13 140.07 52.14 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.835 0.826 . . . . 75.04 110.839 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -85.24 109.3 18.23 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.373 -1.739 . . . . 64.44 108.138 172.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.32 115.97 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.714 -1.217 . . . . 74.41 107.714 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.6 114.07 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 123.695 0.798 . . . . 62.42 109.973 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.578 HD21 ' HG ' ' C' ' 44' ' ' LEU . 1.3 tt -86.58 106.44 17.56 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 106.97 -1.493 . . . . 73.0 106.97 169.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 45.0 mtp180 -87.61 106.51 18.07 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 74.1 109.738 175.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' C' ' 114' ' ' ILE . 8.2 t -100.19 120.63 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.85 -0.796 . . . . 64.24 108.85 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 86.0 m -104.35 145.42 30.28 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.454 -0.943 . . . . 73.22 108.454 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.545 HG21 HD21 ' C' ' 126' ' ' LEU . 46.8 t -136.88 127.56 40.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.846 0.858 . . . . 65.52 109.637 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 18.1 m -118.17 146.15 44.41 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.39 -0.967 . . . . 72.32 108.39 172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.35 135.67 28.87 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 108.273 -1.01 . . . . 71.15 108.273 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' C' ' 39' ' ' GLU . 70.6 m -143.25 168.18 20.38 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.047 0.939 . . . . 63.54 110.058 176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.705 HD11 HG13 ' C' ' 31' ' ' VAL . 13.2 mt -111.56 37.5 2.88 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.466 -1.309 . . . . 73.13 107.466 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.13 -79.13 0.29 Allowed Glycine 0 C--N 1.345 1.059 0 N-CA-C 109.473 -1.451 . . . . 71.53 109.473 -166.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -128.13 -28.02 2.66 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.153 0.981 . . . . 61.25 110.016 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.93 98.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.986 0.914 . . . . 65.01 109.499 174.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 37.8 m -65.4 117.1 7.44 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.156 0.503 . . . . 62.43 110.43 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.444 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -72.12 -50.33 28.86 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.406 -1.27 . . . . 73.32 109.026 -177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -161.87 166.09 26.79 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.36 -0.836 . . . . 61.12 111.103 171.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -122.65 146.75 47.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.831 -1.915 . . . . 75.3 105.831 167.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.614 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.5 t -152.6 153.35 33.19 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.37 -0.604 . . . . 74.2 109.37 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.25 128.52 6.11 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.834 0.453 . . . . 63.33 110.329 173.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.81 114.06 44.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 108.158 -1.053 . . . . 74.42 108.158 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' C' ' 20' ' ' ASP . 49.6 mt-30 -87.99 90.78 8.52 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.347 -1.353 . . . . 73.13 107.347 169.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.8 tp-100 -79.8 132.48 36.15 Favored 'General case' 0 C--O 1.217 -0.619 0 CA-C-N 115.36 -0.836 . . . . 72.23 109.539 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.544 ' HA3' ' HD3' ' C' ' 19' ' ' LYS . . . -119.72 152.94 16.96 Favored Glycine 0 C--N 1.331 0.301 0 O-C-N 123.376 0.422 . . . . 73.02 112.767 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.12 126.64 2.22 Favored Glycine 0 CA--C 1.501 -0.807 0 N-CA-C 109.321 -1.512 . . . . 71.33 109.321 175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.615 HD12 HD11 ' C' ' 51' ' ' LEU . 19.3 mm -88.26 113.12 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 108.092 -1.077 . . . . 42.23 108.092 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -123.91 119.16 28.81 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.056 -1.09 . . . . 72.43 108.056 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -84.89 108.79 17.71 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 108.944 -0.761 . . . . 62.1 108.944 172.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.408 ' O ' HD12 ' C' ' 86' ' ' ILE . 2.2 pp -112.19 132.41 60.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 123.871 0.869 . . . . 75.41 109.617 -178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.05 135.63 16.14 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.573 0.749 . . . . 42.53 109.962 -176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -19.62 27.87 Favored Glycine 0 C--N 1.346 1.126 0 O-C-N 123.352 0.408 . . . . 63.32 113.078 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.618 HG22 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -60.09 127.85 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.137 0 C-N-CA 124.726 1.21 . . . . 54.43 111.552 -174.766 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -157.99 170.11 23.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.437 0.695 . . . . 70.25 110.451 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.22 -154.09 53.04 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.781 -0.645 . . . . 71.43 113.485 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 75.5 p -69.89 -24.54 63.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.627 0.771 . . . . 51.51 112.151 -176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.17 -53.35 59.26 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 123.516 0.51 . . . . 72.12 109.864 172.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 25.3 ttt -62.42 -42.98 99.85 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.995 0.918 . . . . 74.1 111.773 -177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.55 84.3 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.024 0.827 . . . . 72.53 111.393 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -84.51 -26.59 27.99 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.134 -0.484 . . . . 55.23 110.845 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -70.11 -61.07 1.92 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.009 0.524 . . . . 72.1 111.361 -173.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.482 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 2.6 pp -88.35 -18.6 28.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 111.663 0.245 . . . . 61.41 111.663 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.12 -29.69 27.55 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 123.433 0.458 . . . . 43.34 113.199 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.74 -46.5 0.96 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.72 0.408 . . . . 60.14 112.095 -173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.461 ' O ' HG12 ' C' ' 105' ' ' ILE . 56.5 t80 -76.3 -39.32 54.44 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.542 0.737 . . . . 71.41 112.101 -169.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.501 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 67.7 m -68.74 -46.79 33.81 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.919 -0.563 . . . . 72.52 110.032 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 58.1 Cg_exo -57.4 -34.31 97.73 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 121.884 1.723 . . . . 54.51 113.281 166.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -64.25 -35.87 82.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 123.412 0.685 . . . . 74.52 111.112 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.523 HG23 ' NH1' ' A' ' 111' ' ' ARG . 23.2 mm -62.99 -43.0 98.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 115.629 -0.714 . . . . 72.5 109.777 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.573 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.8 mt -81.49 -21.56 38.6 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 114.672 -1.149 . . . . 71.22 112.582 -173.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -60.75 -48.53 92.79 Favored Pre-proline 0 N--CA 1.478 0.942 0 CA-C-O 117.695 -1.145 . . . . 71.24 113.557 -171.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.05 -33.91 97.83 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 121.704 1.603 . . . . 75.43 112.484 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.466 ' HE2' HG21 ' A' ' 115' ' ' THR . 87.5 m-85 -64.17 -52.78 57.33 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.639 0.775 . . . . 73.45 110.872 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.525 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.09 -38.77 89.08 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.904 0.482 . . . . 72.53 111.218 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -54.68 -47.29 73.81 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.222 1.409 . . . . 72.01 111.126 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -77.57 -36.23 52.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.584 0.754 . . . . 74.51 110.285 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.464 ' SG ' HG21 ' C' ' 18' ' ' THR . 41.6 t -67.02 -37.55 84.36 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.621 0.768 . . . . 70.14 112.046 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.614 HG23 ' SG ' ' C' ' 76' ' ' CYS . 74.7 mt -71.63 -47.4 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.225 -0.657 . . . . 62.31 109.225 175.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 12.6 m -54.82 -33.61 61.81 Favored 'General case' 0 CA--C 1.552 1.045 0 O-C-N 124.036 0.835 . . . . 62.41 111.355 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.8 t -61.64 -57.03 13.63 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.46 -0.791 . . . . 71.12 109.972 172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.77 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -51.97 -43.2 63.44 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 124.817 1.247 . . . . 61.14 112.999 177.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 114' ' ' ILE . 77.2 t -64.56 -47.38 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 124.508 1.123 . . . . 65.52 110.701 -178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.1 t -64.92 -31.96 73.44 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.885 -1.052 . . . . 75.34 111.037 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 79.3 mtt-85 -66.95 -34.48 77.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.401 0.68 . . . . 73.52 110.441 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.17 4.23 81.65 Favored Glycine 0 C--N 1.356 1.64 0 O-C-N 123.644 0.59 . . . . 60.12 113.262 173.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 15.9 p 67.96 29.51 6.47 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.789 2.036 . . . . 71.32 112.819 176.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -100.87 153.23 37.85 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.123 0.969 . . . . 62.4 109.844 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -60.52 173.97 1.81 Allowed 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 123.872 3.048 . . . . 73.44 114.803 -170.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' B' ' 125' ' ' GLN . 38.4 mm-40 -59.31 122.95 15.18 Favored 'General case' 0 C--N 1.36 1.044 0 CA-C-N 115.892 -0.594 . . . . 73.11 111.17 178.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.755 HD13 ' HB ' ' C' ' 40' ' ' VAL . 51.5 tp -107.06 17.21 23.3 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 114.4 -1.273 . . . . 71.35 109.198 174.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -87.37 84.02 7.25 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.111 -1.811 . . . . 74.54 106.111 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 68.5 mt -87.42 153.47 21.42 Favored 'General case' 0 C--O 1.248 1.0 0 CA-C-N 113.437 -1.711 . . . . 61.14 108.91 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -48.83 133.26 14.46 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 124.253 1.021 . . . . 72.31 112.726 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.82 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 54.1 Cg_exo -43.46 129.47 6.61 Favored 'Trans proline' 0 C--N 1.386 2.537 0 C-N-CA 124.525 3.483 . . . . 64.34 114.304 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.06 81.63 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.882 -0.785 . . . . 64.41 108.882 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.502 HD21 ' HB2' ' C' ' 130' ' ' PRO . 46.0 m-80 -83.47 98.38 9.5 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.705 -0.68 . . . . 63.14 109.321 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -70.06 -38.97 75.9 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.182 -0.917 . . . . 74.53 110.872 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -62.11 -27.83 69.21 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.395 0.678 . . . . 72.31 111.459 177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.462 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -67.5 -41.97 83.61 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 123.009 0.524 . . . . 61.12 110.623 174.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.14 -38.84 80.64 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.535 0.522 . . . . 73.1 111.395 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -62.22 -43.55 98.58 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.244 0.617 . . . . 73.1 111.068 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.508 ' SD ' ' HB3' ' A' ' 11' ' ' PHE . 62.8 mtt -75.49 -30.51 59.9 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.715 0.806 . . . . 63.25 111.26 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.437 HD22 HG13 ' F' ' 207' ' ' VAL . 35.6 t30 -70.59 -36.95 73.83 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.534 1.134 . . . . 74.35 110.65 177.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -69.29 -82.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.893 1.277 . . . . 75.54 110.778 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 154' ' ' ASP . 2.2 pp -85.87 172.22 10.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.147 0.579 . . . . 75.33 112.214 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 64.57 -97.01 0.05 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.329 1.451 . . . . 71.45 111.868 -177.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -177.98 148.66 0.53 Allowed 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.48 0.712 . . . . 74.01 110.3 -173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -137.39 98.1 3.63 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.474 1.11 . . . . 70.44 108.328 175.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.6 147.2 25.89 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.371 0.668 . . . . 62.3 110.787 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.16 177.78 50.69 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.793 -0.639 . . . . 61.2 111.906 172.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.66 -36.7 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.844 0.457 . . . . 74.22 111.285 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -79.73 165.4 49.57 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.87 0.15 . . . . 75.32 113.234 -177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 94.5 m -147.19 114.17 6.15 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.708 0.803 . . . . 75.24 109.487 178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -158.55 125.74 4.92 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.587 0.755 . . . . 74.43 110.111 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.2 121.45 20.31 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 109.109 -0.7 . . . . 75.14 109.109 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -162.36 132.21 4.56 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.073 -1.084 . . . . 73.41 108.073 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -122.55 178.4 5.01 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.158 0.983 . . . . 73.4 109.31 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -160.36 -164.86 1.32 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 108.311 -0.996 . . . . 73.15 108.311 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.767 -0.635 . . . . 75.24 109.794 175.777 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.79 0.328 . . . . 72.4 110.461 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.1 m -147.84 102.63 3.43 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.97 0.908 . . . . 74.13 108.97 178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -142.98 147.47 35.23 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.819 0.848 . . . . 73.31 108.946 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.23 177.63 2.69 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.757 0.423 . . . . 63.2 110.942 178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -151.18 -179.47 7.36 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 108.222 -1.029 . . . . 73.35 108.222 178.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -65.21 88.04 0.07 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 109.864 -0.421 . . . . 71.22 109.864 175.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.462 HG21 ' H ' ' B' ' 152' ' ' HIS . 17.5 p 45.68 -139.7 0.44 Allowed 'General case' 0 CA--C 1.563 1.474 0 C-N-CA 125.694 1.598 . . . . 70.23 113.324 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -124.85 171.92 9.77 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 118.819 0.736 . . . . 70.04 112.246 -166.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.2 tpt -29.15 125.72 0.12 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 126.839 2.056 . . . . 74.33 114.299 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.5 m -141.22 143.75 34.34 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.348 0.659 . . . . 73.13 111.022 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -145.03 103.38 3.87 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.527 -1.286 . . . . 64.02 107.527 171.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -129.99 139.88 50.98 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.681 1.192 . . . . 65.11 108.989 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 tt -105.28 135.23 44.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.602 0.761 . . . . 70.42 109.871 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -103.74 -46.64 4.46 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 112.094 0.405 . . . . 74.3 112.094 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -158.27 146.72 18.77 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.214 0.206 . . . . 73.31 110.475 -171.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.646 HD11 ' HG3' ' B' ' 130' ' ' PRO . 1.0 OUTLIER -140.01 134.17 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 107.634 -1.247 . . . . 73.43 107.634 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -159.97 156.74 27.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.515 0.726 . . . . 72.21 110.677 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 55.7 p -85.14 110.07 18.73 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.483 -0.932 . . . . 63.4 108.483 170.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -75.93 -26.6 57.06 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.127 0.489 . . . . 63.31 110.171 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -155.08 133.82 12.07 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.699 -1.137 . . . . 74.04 109.011 -177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.77 HD13 ' HE3' ' C' ' 117' ' ' MET . 92.9 mt -132.68 132.2 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 106.785 -1.561 . . . . 70.15 106.785 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.7 t -137.94 138.22 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.166 -0.679 . . . . 53.22 109.166 171.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.477 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -145.15 109.94 5.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.403 -2.073 . . . . 73.3 105.403 167.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -123.07 113.93 19.67 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.928 -0.767 . . . . 74.03 108.928 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.9 83.71 3.02 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 108.22 -1.03 . . . . 72.43 108.22 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.66 -23.61 22.72 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.377 2.051 . . . . 75.34 112.011 -175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -106.65 20.07 19.56 Favored 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 124.415 1.086 . . . . 74.03 110.256 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.556 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -44.5 -63.93 0.98 Allowed Pre-proline 0 CA--C 1.568 1.648 0 N-CA-C 114.963 1.468 . . . . 63.42 114.963 -172.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.19 -17.8 11.54 Favored 'Trans proline' 0 C--N 1.387 2.572 0 CA-C-N 122.221 1.829 . . . . 61.43 113.331 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -65.79 -52.33 51.7 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.29 1.036 . . . . 45.53 110.319 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 1.8 p -84.15 -1.02 6.0 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.423 0 C-N-CA 124.234 1.014 . . . . 74.23 110.463 -171.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.498 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.8 t80 -54.57 -35.55 63.41 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.117 1.367 . . . . 71.54 111.161 165.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -70.9 -11.8 61.17 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.947 -1.024 . . . . 72.4 111.944 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.597 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 9.6 ttmt -106.78 114.05 27.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.364 0.665 . . . . 71.14 110.715 -173.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -101.56 56.58 0.83 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.147 1.379 . . . . 73.21 112.875 -167.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -125.82 173.97 8.69 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.609 0.764 . . . . 71.33 109.221 -174.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.625 ' HG2' ' HA3' ' H' ' 191' ' ' GLY . 55.3 tp60 -88.07 124.06 67.55 Favored Pre-proline 0 N--CA 1.478 0.928 0 O-C-N 121.59 -0.694 . . . . 51.55 109.322 172.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -56.46 110.58 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.772 2.314 . . . . 73.21 112.896 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -68.82 113.02 5.89 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.193 0.997 . . . . 71.2 109.098 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.628 HG13 HG13 ' D' ' 64' ' ' VAL . 73.9 t -99.27 124.29 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.813 0.845 . . . . 71.25 110.763 -169.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -96.34 108.56 21.09 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 106.499 -1.667 . . . . 72.31 106.499 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.24 113.62 25.25 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.328 -0.99 . . . . 72.31 108.328 -174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.3 t70 -109.17 132.44 54.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.74 -0.837 . . . . 63.13 108.74 174.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tt -108.46 131.88 54.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.776 -1.194 . . . . 65.42 107.776 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 31.3 t70 -145.09 154.26 42.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.943 0.897 . . . . 54.03 108.786 173.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.6 t -126.66 164.6 20.91 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.225 0.61 . . . . 73.22 110.312 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.655 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.21 164.02 39.38 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.036 0.934 . . . . 52.34 109.45 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 72.1 m -154.46 160.39 41.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.041 0.536 . . . . 63.44 110.928 177.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -157.1 120.02 4.02 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.161 0.984 . . . . 74.33 109.373 -176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 41.1 tp60 -79.53 117.61 20.63 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.359 -0.608 . . . . 71.34 109.359 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.9 mt -99.81 -34.39 10.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.744 0.418 . . . . 73.54 110.85 -174.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.6 -171.83 3.45 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.132 0.973 . . . . 75.33 109.773 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -68.04 118.48 11.26 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.754 0.821 . . . . 61.43 110.479 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 61.95 13.32 5.5 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.86 1.264 . . . . 72.22 112.669 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.4 t -122.45 122.64 66.7 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.032 -1.099 . . . . 74.11 108.032 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -151.71 145.88 25.36 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.517 0.675 . . . . 72.23 110.556 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.436 ' HB2' HD11 ' D' ' 51' ' ' LEU . 7.2 tt0 -86.67 125.27 33.75 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 113.887 -1.506 . . . . 71.32 108.744 176.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 99.5 t -107.05 137.78 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.623 -1.251 . . . . 72.12 107.623 171.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.655 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 41.6 t -115.19 145.29 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.366 1.066 . . . . 70.32 109.144 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -117.02 122.33 43.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.116 -1.068 . . . . 55.33 108.116 173.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.507 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 36.2 ttm-85 -96.07 100.38 12.05 Favored 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.46 -0.941 . . . . 72.03 108.46 172.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.51 107.11 18.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.246 -1.02 . . . . 71.31 108.246 171.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -98.65 131.86 44.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.049 0.452 . . . . 70.31 109.884 178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.628 HG13 HG13 ' D' ' 40' ' ' VAL . 54.2 t -127.22 101.42 7.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.857 1.263 . . . . 73.43 108.104 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.7 m -101.92 94.38 5.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.286 -1.375 . . . . 74.32 107.286 173.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.02 143.62 27.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.734 -0.469 . . . . 65.42 109.734 -173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.455 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 38.4 p -146.76 133.3 19.77 Favored 'General case' 0 C--O 1.226 -0.177 0 CA-C-O 121.199 0.523 . . . . 74.4 111.041 -173.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.518 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 55.4 mt -100.2 102.23 13.46 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.522 -1.288 . . . . 73.11 107.522 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.91 -130.56 11.65 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.713 -0.676 . . . . 64.21 112.32 -175.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -94.13 6.52 48.32 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.628 0.771 . . . . 75.54 111.403 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.597 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 8.9 tp10 -121.73 148.16 44.98 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.052 0.941 . . . . 72.44 109.56 -176.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 76.3 m -65.82 131.38 46.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.363 0.665 . . . . 73.05 110.702 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.518 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -86.41 -59.55 2.25 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.483 -0.932 . . . . 62.41 108.483 175.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -160.7 150.39 17.43 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 113.925 -1.489 . . . . 74.13 109.558 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.4 mt -105.33 146.65 29.1 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.781 -1.192 . . . . 74.15 107.781 172.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.586 ' SG ' HG23 ' D' ' 114' ' ' ILE . 45.1 t -158.73 137.94 11.48 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.704 -0.48 . . . . 65.15 109.704 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -156.88 129.36 7.52 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.664 -0.495 . . . . 43.05 109.664 173.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -127.12 116.1 43.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.672 0.789 . . . . 74.11 109.391 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -89.98 90.21 8.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.453 -0.794 . . . . 70.03 108.933 173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.419 ' O ' HD13 ' D' ' 106' ' ' LEU . 8.2 tp-100 -80.28 104.37 10.79 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 114.769 -1.105 . . . . 74.54 109.089 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -100.91 145.03 16.88 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.634 -0.586 . . . . 72.44 111.634 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.1 139.1 7.68 Favored Glycine 0 C--N 1.33 0.235 0 N-CA-C 110.661 -0.975 . . . . 71.0 110.661 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 52.9 mt -88.23 130.77 37.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.709 0.804 . . . . 74.14 109.159 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.15 125.19 34.43 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.72 0.408 . . . . 51.2 110.331 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 24.4 m -84.88 93.23 8.47 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.171 -1.048 . . . . 74.44 108.171 165.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.594 HD11 HD11 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -129.32 134.72 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.521 0.728 . . . . 73.21 109.641 -171.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' B' ' 147' ' ' GLU . . . -163.66 159.55 21.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.502 1.121 . . . . 71.25 109.841 -177.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 115.62 -19.53 14.26 Favored Glycine 0 N--CA 1.48 1.58 0 N-CA-C 115.091 0.797 . . . . 50.11 115.091 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.638 HD13 ' HA ' ' D' ' 94' ' ' MET . 2.2 pp -108.96 161.78 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.397 0.679 . . . . 64.14 111.014 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.405 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 2.6 pt-20 -158.03 -175.44 5.35 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.5 0.72 . . . . 60.21 110.851 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.76 -132.05 47.54 Favored Glycine 0 C--N 1.356 1.663 0 C-N-CA 123.653 0.644 . . . . 74.2 114.014 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -66.35 -28.73 68.89 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.764 0.826 . . . . 74.22 111.254 177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -68.8 -33.31 73.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.464 0.706 . . . . 75.11 111.094 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.638 ' HA ' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -70.34 -47.51 60.71 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 109.567 -0.531 . . . . 72.33 109.567 177.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.3 -33.85 72.94 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.46 -0.791 . . . . 71.13 111.151 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -72.26 -37.81 68.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.063 0.945 . . . . 71.51 111.11 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -72.17 -51.41 21.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.036 0.535 . . . . 71.24 111.394 -177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 8.2 tt -72.9 -36.36 67.3 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.019 0.528 . . . . 62.54 110.168 -177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.23 -23.85 62.46 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 114.304 0.481 . . . . 74.2 114.304 -174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.53 -56.34 1.01 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 117.502 0.651 . . . . 53.43 112.274 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -67.46 -46.46 72.97 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.307 0.854 . . . . 73.33 113.307 -166.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.7 -44.67 43.73 Favored Pre-proline 0 CA--C 1.568 1.658 0 CA-C-O 118.972 -0.537 . . . . 74.31 111.229 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.603 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 85.5 Cg_exo -53.68 -35.78 79.17 Favored 'Trans proline' 0 C--N 1.395 2.975 0 C-N-CA 122.953 2.435 . . . . 50.41 114.119 165.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -61.85 -31.93 72.23 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 123.399 0.68 . . . . 73.21 112.097 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -72.51 -40.08 62.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.376 0.671 . . . . 71.22 110.351 176.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.419 HD13 ' O ' ' D' ' 80' ' ' GLN . 83.8 mt -75.25 -24.93 57.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 114.882 -1.054 . . . . 64.22 111.252 -175.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -61.69 -42.46 83.6 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.876 1.436 . . . . 75.04 114.876 -172.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -51.15 -46.87 28.63 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 122.267 1.978 . . . . 64.41 113.752 171.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.0 -37.21 69.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.511 -0.768 . . . . 72.25 111.226 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.86 -47.78 79.35 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.744 0.818 . . . . 41.45 110.6 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -57.08 -50.67 72.04 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 70.14 110.956 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -67.91 -39.62 83.54 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.039 0.837 . . . . 72.43 111.39 -174.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.4 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 49.0 t -57.64 -40.99 80.5 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 123.732 0.645 . . . . 70.44 110.486 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.586 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -68.45 -52.15 39.71 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-N 114.86 -1.064 . . . . 61.13 110.388 174.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -50.82 -43.46 58.96 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 124.509 1.123 . . . . 70.41 111.673 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -67.45 -45.86 74.76 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.676 -1.147 . . . . 62.14 110.33 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.06 -34.04 77.12 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.005 0.522 . . . . 75.41 111.947 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.57 -46.23 83.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 123.666 0.786 . . . . 73.31 110.252 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.7 p -70.74 -29.13 65.3 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.241 -0.436 . . . . 74.12 110.68 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -70.05 -32.69 70.92 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.6 0.76 . . . . 63.02 109.622 172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 11.1 60.95 Favored Glycine 0 C--N 1.353 1.49 0 O-C-N 123.617 0.573 . . . . 64.42 113.069 174.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.445 HG23 ' HB3' ' C' ' 17' ' ' TYR . 41.4 p 60.27 20.5 9.95 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 126.402 1.881 . . . . 75.05 114.057 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.461 ' HB2' HG13 ' D' ' 118' ' ' VAL . 79.7 m-85 -93.97 159.05 35.22 Favored Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 107.758 -1.201 . . . . 72.55 107.758 171.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' H' ' 195' ' ' PHE . 72.4 Cg_endo -70.91 154.1 63.33 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 121.994 1.796 . . . . 64.15 111.672 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -50.97 120.14 4.59 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.872 0.869 . . . . 72.52 111.438 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.467 HD21 HG21 ' D' ' 40' ' ' VAL . 2.4 tm? -109.57 91.78 3.78 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.446 -1.316 . . . . 72.34 107.446 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -108.85 106.2 16.09 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.077 -0.965 . . . . 72.45 109.62 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.668 ' HB3' HD13 ' H' ' 187' ' ' ILE . 62.5 mt -65.76 134.68 53.67 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.796 -1.093 . . . . 74.11 110.911 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.68 130.98 85.7 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.782 0.833 . . . . 75.3 111.611 -175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -80.85 95.93 0.98 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 C-N-CA 122.497 2.131 . . . . 75.52 110.548 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.52 HG21 HG21 ' G' ' 207' ' ' VAL . 7.6 p -129.66 139.94 50.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 CA-C-N 115.174 -0.921 . . . . 61.23 110.447 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -69.64 116.12 9.67 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.912 -1.144 . . . . 74.15 107.912 166.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.404 ' HD1' HD21 ' H' ' 186' ' ' LEU . 12.6 m-85 -53.17 -33.11 51.18 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.063 0.945 . . . . 74.45 112.542 -177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -67.82 -24.08 65.25 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.575 1.15 . . . . 74.31 112.277 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.71 -30.98 70.29 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.037 0.535 . . . . 61.42 111.523 177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.89 -40.53 72.17 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.29 0.636 . . . . 71.23 110.434 176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.605 ' HB2' ' HE1' ' H' ' 184' ' ' TRP . 63.2 t80 -59.01 -33.16 70.4 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.195 0.998 . . . . 74.32 111.198 178.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.1 mmt -54.64 -52.87 60.93 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.325 0.65 . . . . 72.24 109.87 175.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -65.97 -50.09 65.57 Favored 'General case' 0 C--O 1.217 -0.638 0 CA-C-N 113.968 -1.469 . . . . 72.55 110.924 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -51.6 -34.76 38.7 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.763 1.225 . . . . 74.01 113.848 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.96 -47.74 17.87 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.061 0.545 . . . . 72.2 110.739 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -84.09 13.94 4.65 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.215 0.606 . . . . 72.13 112.503 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -118.92 90.18 3.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.305 0.642 . . . . 73.45 109.272 -171.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -143.51 -19.18 0.61 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.418 1.087 . . . . 74.24 110.195 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -95.91 142.18 28.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.921 0.888 . . . . 61.3 110.439 177.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.4 44.56 1.16 Allowed Glycine 0 N--CA 1.471 0.978 0 N-CA-C 111.269 -0.732 . . . . 72.23 111.269 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -81.5 86.43 6.34 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.036 0.934 . . . . 71.42 110.748 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.33 38.8 0.24 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.021 -0.991 . . . . 33.41 110.998 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 4.3 t -81.57 85.2 6.57 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.917 0.887 . . . . 71.51 110.83 -175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -173.64 141.32 0.84 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.497 1.119 . . . . 64.34 109.824 176.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -163.21 -96.55 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 107.585 -1.265 . . . . 65.43 107.585 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 28.8 m80 -159.3 132.42 7.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.543 1.537 . . . . 74.44 107.012 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -137.21 82.37 1.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.992 -1.114 . . . . 70.33 107.992 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -134.98 101.99 5.07 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.814 0.846 . . . . 72.05 109.012 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 C-N-CA 124.137 0.975 . . . . 71.01 108.686 177.31 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.2 -0.296 . . . . 75.02 110.2 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -92.34 -122.61 3.06 Favored Glycine 0 C--N 1.347 1.191 0 N-CA-C 111.407 -0.677 . . . . 52.32 111.407 174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -131.86 142.84 49.8 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.207 1.003 . . . . 72.14 108.871 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 72.3 m -154.92 114.28 3.68 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.963 1.305 . . . . 72.51 107.763 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 65.15 -170.07 0.2 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.247 1.019 . . . . 72.41 110.904 -170.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 66.55 -76.11 0.05 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.079 1.351 . . . . 63.21 109.53 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 30.8 mmt -86.61 69.91 10.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.378 0.671 . . . . 73.44 110.093 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 53.75 -90.73 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.496 1.518 . . . . 73.51 112.784 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 9.3 t30 54.75 58.18 5.06 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-O 122.229 1.014 . . . . 62.43 110.398 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 10.2 mp -81.19 70.19 7.97 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.206 -0.906 . . . . 62.34 108.973 173.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -66.79 -61.18 2.09 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.384 -0.969 . . . . 64.55 108.384 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.26 154.5 54.45 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 123.913 0.885 . . . . 73.4 110.24 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.92 173.98 11.2 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.679 2.253 . . . . 75.52 112.605 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -112.83 162.31 15.94 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.081 0.952 . . . . 70.24 109.562 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.02 122.71 12.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.22 1.008 . . . . 72.44 108.789 175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 32.7 m -73.66 124.45 26.0 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 123.17 0.588 . . . . 73.12 111.403 -171.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 7.0 p90 -75.66 155.98 85.05 Favored Pre-proline 0 N--CA 1.481 1.077 0 C-N-CA 123.812 0.845 . . . . 74.33 111.528 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.69 169.24 22.7 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.654 2.236 . . . . 62.45 112.26 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -129.23 118.98 23.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.066 -1.087 . . . . 74.44 108.066 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.17 139.28 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 107.912 -1.144 . . . . 74.43 107.912 175.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -150.61 150.38 31.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.807 0.843 . . . . 64.25 109.151 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -107.99 134.39 50.96 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.593 -0.521 . . . . 50.13 109.593 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.44 -169.17 0.78 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.124 0.97 . . . . 45.43 111.61 -174.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.39 -68.31 1.74 Allowed Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.912 -0.585 . . . . 71.45 113.041 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 55.7 -125.33 36.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 124.13 0.547 . . . . 32.41 112.52 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -145.83 -176.13 5.01 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.469 1.108 . . . . 73.43 108.672 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . 0.51 ' HB3' ' HE1' ' C' ' 36' ' ' TRP . . . -165.97 -63.81 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.578 0.751 . . . . 75.5 109.283 176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -113.55 -175.05 2.59 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.083 0.953 . . . . 64.24 110.023 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -150.87 139.91 21.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.646 1.178 . . . . 74.02 108.935 -176.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . 0.655 ' HA ' ' HA ' ' E' ' 201' ' ' LYS . 65.1 m-85 -128.11 -41.41 1.6 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.665 0.617 . . . . 75.21 112.665 -174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -81.54 -14.87 56.35 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.057 0.143 . . . . 62.41 111.211 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -146.26 113.0 6.02 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 107.403 -1.332 . . . . 72.12 107.403 174.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 72.9 49.5 16.92 Favored Glycine 0 C--N 1.352 1.453 0 O-C-N 123.545 0.528 . . . . 71.4 112.618 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' E' ' 197' ' ' TYR . 23.3 ttmm -49.29 -50.11 40.63 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.905 1.282 . . . . 64.33 112.97 -171.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . 0.505 ' HE2' ' HB2' ' B' ' 129' ' ' ALA . 60.1 t80 -173.99 -52.17 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.019 -0.992 . . . . 63.03 108.859 177.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' F' ' 188' ' ' ALA . 18.3 t0 69.32 107.9 0.06 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.342 1.457 . . . . 74.11 112.571 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.57 HD12 ' HB ' ' E' ' 207' ' ' VAL . 17.1 pt -121.31 13.91 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.938 1.295 . . . . 60.41 109.945 172.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 70.27 -73.66 0.09 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.702 1.601 . . . . 73.41 110.382 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -168.45 101.49 0.42 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 108.712 -0.848 . . . . 62.53 108.712 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.57 ' HB ' HD12 ' E' ' 204' ' ' ILE . 57.5 t . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 124.034 0.934 . . . . 73.5 108.539 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 60.4 mttp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.223 -0.658 . . . . 62.31 109.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 81.03 100.48 0.35 Allowed Glycine 0 C--N 1.346 1.123 0 O-C-N 123.503 0.502 . . . . 64.23 112.863 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -80.46 74.37 7.34 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.475 -0.565 . . . . 73.33 109.475 172.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 80.1 p -167.01 -176.05 3.25 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.882 0.873 . . . . 45.42 109.791 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.99 162.59 21.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.157 0.583 . . . . 61.41 110.384 168.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' B' ' 90' ' ' GLU . 0.8 OUTLIER -103.34 89.8 3.5 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.28 0.632 . . . . 71.51 109.3 -171.401 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -78.9 138.3 38.05 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.655 -0.869 . . . . 74.03 108.655 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -130.07 176.3 8.19 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.759 0.824 . . . . 73.11 111.719 -167.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -124.8 108.0 11.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.89 -1.522 . . . . 73.34 106.89 168.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 27.0 tp -69.69 115.89 9.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.907 0.483 . . . . 70.23 112.038 -169.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -165.47 44.13 0.08 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.51 -1.292 . . . . 71.11 107.51 167.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -72.13 149.3 91.95 Favored Pre-proline 0 N--CA 1.483 1.178 0 CA-C-N 115.527 -0.761 . . . . 64.1 111.318 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.14 89.3 0.68 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.612 2.208 . . . . 65.24 111.633 174.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.6 150.66 26.61 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.794 0.837 . . . . 63.53 110.423 176.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -90.56 -173.83 3.89 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.777 0.831 . . . . 53.11 110.749 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 25.5 p -63.09 102.26 0.36 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.758 0.823 . . . . 64.32 112.114 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -69.05 -41.72 19.73 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 123.863 0.865 . . . . 73.32 112.168 172.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.49 81.84 0.73 Allowed 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 121.679 1.586 . . . . 70.42 111.967 170.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' F' ' 186' ' ' LEU . 2.4 pp -96.92 -26.59 15.0 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.122 0.969 . . . . 73.22 110.484 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.65 HD12 ' HA ' ' B' ' 128' ' ' LEU . 6.0 tt -60.71 130.79 25.07 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 124.694 1.197 . . . . 73.33 111.996 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' E' ' 203' ' ' ASP . . . -114.65 161.81 17.61 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.725 0.81 . . . . 71.44 109.552 169.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.02 100.28 2.91 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.586 0.754 . . . . 73.32 109.618 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -102.96 11.03 37.89 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.852 0.861 . . . . 64.25 109.993 179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.81 143.91 42.64 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.609 -0.597 . . . . 55.01 111.609 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -165.84 55.99 0.25 Allowed Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.219 -0.753 . . . . 62.35 111.219 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -138.6 -175.31 4.08 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 74.34 111.264 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . 0.486 ' HB1' ' HB3' ' F' ' 201' ' ' LYS . . . 75.58 -66.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.818 1.647 . . . . 74.24 111.998 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -57.81 104.17 0.17 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.229 1.412 . . . . 61.31 111.935 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -154.78 105.21 2.57 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.68 1.192 . . . . 64.42 109.333 175.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . 0.588 ' HA ' ' HB2' ' F' ' 203' ' ' ASP . 53.8 m-85 -69.26 81.69 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.404 0.682 . . . . 63.23 110.803 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 176.78 -68.27 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.794 1.237 . . . . 74.2 107.956 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -153.04 95.7 1.99 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 114.568 -1.197 . . . . 64.02 108.587 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . 178.14 -106.27 0.21 Allowed Glycine 0 C--N 1.337 0.584 0 CA-C-N 115.881 -0.599 . . . . 75.04 112.023 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.486 ' HB3' ' HB1' ' F' ' 194' ' ' ALA . 34.1 ttmt -163.52 163.64 24.59 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.83 -0.804 . . . . 73.44 108.83 -170.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . 0.442 ' HE2' ' HB3' ' B' ' 124' ' ' PRO . 2.2 m-30 63.0 17.19 9.9 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 124.489 1.116 . . . . 73.35 110.853 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . 0.588 ' HB2' ' HA ' ' F' ' 197' ' ' TYR . 14.2 p-10 -124.39 171.63 9.77 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.591 0.756 . . . . 74.22 112.449 -163.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.425 ' H ' ' HD1' ' F' ' 197' ' ' TYR . 7.2 tp -94.7 135.66 28.21 Favored 'Isoleucine or valine' 0 C--O 1.243 0.75 0 CA-C-N 114.704 -1.135 . . . . 71.33 108.264 167.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -118.28 -178.56 3.54 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.635 -0.876 . . . . 63.32 108.635 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -68.86 161.62 28.25 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.663 0.385 . . . . 75.45 110.25 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.437 HG13 HD22 ' C' ' 139' ' ' ASN . 6.6 p . . . . . 0 C--O 1.251 1.163 0 C-N-CA 123.507 0.723 . . . . 73.11 109.586 -176.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.846 -0.428 . . . . 74.23 109.846 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -169.43 -146.19 4.95 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 111.057 -0.817 . . . . 35.51 111.057 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 61.77 20.69 11.61 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.942 0.897 . . . . 63.41 111.75 176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . . . . . . . . . 66.4 m -141.25 165.59 27.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.51 1.124 . . . . 71.04 109.288 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.43 152.36 45.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.832 0.453 . . . . 53.13 111.655 -176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 2.7 tt -177.0 -48.82 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.114 -1.439 . . . . 64.33 107.114 -177.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 30.2 mmt -76.1 174.98 9.37 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.069 -0.969 . . . . 65.31 110.85 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.554 ' HB2' ' HE1' ' A' ' 56' ' ' TYR . 17.5 t80 -56.74 92.7 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.008 0.923 . . . . 73.22 112.138 -167.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -90.24 0.87 57.0 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.948 -1.024 . . . . 71.24 110.64 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 95' ' ' ALA . 5.1 mp -87.79 165.54 15.25 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.372 -0.603 . . . . 74.43 109.372 172.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -138.84 -64.68 0.51 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.255 -1.387 . . . . 75.13 107.255 169.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -170.47 -51.17 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.489 0 C-N-CA 123.945 0.898 . . . . 71.11 111.41 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -78.35 76.64 4.33 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.51 2.14 . . . . 74.3 111.732 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -138.02 123.07 19.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.539 1.136 . . . . 64.12 108.286 177.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 63.94 -172.9 0.17 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 124.493 1.12 . . . . 71.43 110.974 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 69.3 p -89.81 -32.2 17.03 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.067 -0.396 . . . . 62.34 111.074 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 54.88 80.31 0.3 Allowed Pre-proline 0 N--CA 1.484 1.247 0 C-N-CA 124.942 1.297 . . . . 64.43 110.95 -174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.76 167.26 24.95 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.244 1.963 . . . . 65.31 112.402 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -154.1 135.39 14.09 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.672 -0.862 . . . . 65.04 108.672 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -82.88 131.32 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.415 0.686 . . . . 75.43 110.968 -177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.24 86.37 3.06 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.781 0.832 . . . . 73.13 110.097 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -57.39 130.86 48.15 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.93 0.892 . . . . 62.33 112.349 -173.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.3 174.69 7.72 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.325 1.05 . . . . 73.41 113.278 -172.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . 0.671 ' HA2' ' HA ' ' A' ' 39' ' ' GLU . . . -113.91 123.96 6.3 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-N 114.574 -1.194 . . . . 74.21 112.059 175.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -65.49 153.29 51.15 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 112.057 -0.417 . . . . 73.2 112.057 172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -141.91 14.39 2.09 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.534 0.734 . . . . 72.0 109.818 -177.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' H' ' 196' ' ' LYS . . . -120.14 170.05 9.66 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.01 0.924 . . . . 71.32 110.365 -177.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.422 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 58.5 t80 66.99 21.39 10.3 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.658 1.183 . . . . 64.02 110.582 -178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.547 ' HA ' ' H ' ' A' ' 36' ' ' TRP . 9.7 mtmp? -64.05 128.0 33.89 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.668 0.787 . . . . 70.44 110.711 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -67.19 83.44 0.13 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.134 0.974 . . . . 73.21 110.494 -175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.27 -6.73 4.3 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.938 0.895 . . . . 53.33 111.148 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -141.26 162.52 35.29 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 123.25 0.62 . . . . 73.45 109.828 -174.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -64.42 125.64 31.77 Favored Glycine 0 C--N 1.352 1.472 0 O-C-N 123.782 0.676 . . . . 72.2 112.596 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -90.25 -60.73 1.85 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.589 0.355 . . . . 71.41 110.73 -174.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -109.68 -67.8 0.96 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.481 -0.933 . . . . 74.22 108.481 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 18.3 t70 58.63 106.52 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.412 1.485 . . . . 73.52 112.784 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 3.3 mp -80.65 110.83 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 C-N-CA 123.988 0.915 . . . . 71.52 109.547 -174.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -81.5 97.43 7.79 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.473 -0.936 . . . . 64.12 108.473 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 63.48 -76.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.669 1.188 . . . . 74.41 110.111 -172.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . 0.52 HG21 HG21 ' D' ' 131' ' ' VAL . 1.1 p . . . . . 0 CA--C 1.557 1.24 0 C-N-CA 125.426 1.49 . . . . 63.42 107.751 171.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 56.8 tptt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.14 -0.689 . . . . 62.42 109.14 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.17 178.6 19.55 Favored Glycine 0 C--N 1.35 1.33 0 O-C-N 123.521 0.513 . . . . 51.01 112.949 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 36.4 tptt -86.54 67.76 9.98 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 108.923 -0.769 . . . . 72.53 108.923 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 33.5 t -90.64 60.96 4.7 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.159 0.984 . . . . 62.04 110.164 -174.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . . . . . . . . . . . -174.37 -157.13 0.07 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.959 1.303 . . . . 63.03 109.004 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.497 ' H ' ' HG3' ' D' ' 94' ' ' MET . 49.0 mt 71.94 117.2 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.195 1.398 . . . . 71.01 111.407 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.537 ' SD ' ' N ' ' H' ' 174' ' ' MET . 0.0 OUTLIER 54.86 92.54 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.01 1.324 . . . . 71.53 111.661 170.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 74.0 110.38 0.07 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.897 1.679 . . . . 74.21 110.36 -172.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . 0.504 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 64.8 t30 -153.45 177.28 11.07 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.428 -1.323 . . . . 62.41 107.428 -178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 6.7 tt 77.9 87.06 0.07 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.478 1.111 . . . . 74.23 108.818 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -118.4 -48.15 2.52 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.282 -1.007 . . . . 73.44 108.282 171.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -95.24 -48.46 0.26 Allowed Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.402 1.081 . . . . 74.31 112.449 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.05 159.18 34.01 Favored 'Trans proline' 0 C--N 1.393 2.887 0 CA-C-N 121.511 1.575 . . . . 73.52 112.349 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 63.26 178.05 0.15 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.905 1.282 . . . . 74.53 113.426 174.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -168.23 175.5 6.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.144 1.378 . . . . 73.31 108.54 -177.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 76.8 p -81.57 122.98 28.26 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.075 -0.713 . . . . 73.52 109.075 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . 0.605 ' HE1' ' HB2' ' D' ' 137' ' ' PHE . 16.3 m-90 -83.57 118.33 71.19 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.789 0.835 . . . . 75.34 110.295 -171.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.72 102.24 1.0 Allowed 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.672 2.248 . . . . 43.52 111.796 174.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . 0.404 HD21 ' HD1' ' D' ' 133' ' ' PHE . 1.0 OUTLIER -141.54 173.97 11.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.59 0.756 . . . . 73.32 111.372 -177.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.668 HD13 ' HB3' ' D' ' 128' ' ' LEU . 76.2 mt 70.18 83.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 125.1 1.36 . . . . 73.54 110.46 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -88.11 92.47 9.16 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.874 -1.057 . . . . 62.43 108.921 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -86.37 41.03 0.91 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.697 1.199 . . . . 75.03 111.131 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.01 99.07 5.94 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 123.856 0.863 . . . . 74.21 109.576 178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . 0.625 ' HA3' ' HG2' ' D' ' 37' ' ' GLN . . . -100.63 -169.97 28.93 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 116.251 -0.431 . . . . 71.24 112.05 175.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -120.53 -105.69 2.04 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.611 0.205 . . . . 72.44 113.278 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -123.86 -159.3 0.85 Allowed 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.81 0.844 . . . . 60.45 111.163 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . 67.99 80.2 0.21 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 125.237 1.415 . . . . 35.11 111.073 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . 0.515 ' CE1' ' HD3' ' D' ' 124' ' ' PRO . 40.1 t80 -162.22 33.74 0.12 Allowed 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.884 0.849 . . . . 71.02 109.25 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . 0.532 ' HB2' ' HB1' ' G' ' 194' ' ' ALA . 0.2 OUTLIER -73.83 -0.58 16.32 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 112.493 0.553 . . . . 72.52 112.493 -173.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 61.34 -160.69 0.3 Allowed 'General case' 0 C--N 1.365 1.269 0 C-N-CA 123.671 0.788 . . . . 75.11 111.284 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.87 113.34 3.54 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.009 -1.478 . . . . 72.12 107.009 170.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -72.85 117.93 15.16 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.32 -0.993 . . . . 74.44 108.32 174.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.0 110.17 2.28 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 124.644 1.215 . . . . 51.32 114.827 -168.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -95.95 -72.57 0.63 Allowed 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.006 -0.739 . . . . 74.52 109.006 174.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 60.6 20.06 9.96 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 124.303 1.041 . . . . 71.23 112.707 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 33.5 t70 67.05 66.86 0.42 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.458 1.103 . . . . 72.42 111.542 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.86 112.19 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.345 -0.983 . . . . 73.41 108.345 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -118.94 -38.98 2.99 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.4 0.28 . . . . 73.0 111.569 -166.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -137.55 -52.49 0.65 Allowed 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.563 -0.903 . . . . 63.42 108.563 177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.254 1.299 0 N-CA-C 108.095 -1.076 . . . . 71.13 108.095 172.072 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.887 -0.412 . . . . 54.42 109.887 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.6 p -112.26 110.57 20.88 Favored 'General case' 0 C--O 1.243 0.746 0 N-CA-C 107.803 -1.184 . . . . 63.13 107.803 171.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.61 ' HB3' ' HA3' ' C' ' 146' ' ' GLY . 42.5 mt-10 -76.04 82.9 2.9 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.743 0.782 . . . . 61.24 110.335 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -92.76 166.77 12.28 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.759 -1.109 . . . . 71.13 110.049 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 64.09 66.98 0.62 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.258 1.023 . . . . 73.14 109.888 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -67.31 136.37 54.76 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-N 114.447 -1.251 . . . . 65.35 109.07 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.1 t -159.32 157.29 30.18 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.397 0.679 . . . . 73.44 109.562 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -133.03 146.04 51.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.904 0.881 . . . . 61.23 109.615 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -137.9 166.74 23.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.55 0.74 . . . . 74.43 110.733 -173.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.1 m -141.37 132.5 26.32 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.643 0.777 . . . . 74.35 109.204 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -120.5 136.63 54.71 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.116 0.966 . . . . 62.11 109.76 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' NE2' ' HB ' ' F' ' 207' ' ' VAL . 56.7 tp60 -147.69 136.83 22.27 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 123.375 0.422 . . . . 72.22 111.279 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -77.3 110.29 12.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 124.073 0.949 . . . . 74.44 108.44 175.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.86 -41.04 16.4 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.322 0.649 . . . . 74.2 109.275 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.495 ' HA ' HD13 ' F' ' 204' ' ' ILE . 12.2 ttt180 -161.32 141.08 10.53 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.014 0.526 . . . . 53.1 110.211 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -124.53 135.91 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.003 -1.11 . . . . 71.23 108.003 167.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.678 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 18.3 p90 -170.56 171.88 6.18 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.042 0.839 . . . . 62.24 110.645 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -94.54 124.19 38.42 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.896 -0.779 . . . . 61.41 108.896 170.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.3 mtpt -82.63 -43.54 16.84 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.021 -0.733 . . . . 72.3 109.021 172.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 9.0 t70 -135.79 143.97 45.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.281 -1.327 . . . . 54.41 110.041 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.434 HG23 ' SD ' ' A' ' 117' ' ' MET . 83.3 mt -139.81 141.51 34.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 C-N-CA 125.982 1.713 . . . . 74.13 106.624 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.4 t -151.35 123.24 8.09 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 109.48 -0.563 . . . . 65.25 109.48 173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 85.0 t80 -121.74 126.52 49.08 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 106.823 -1.547 . . . . 74.13 106.823 171.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -123.56 126.57 46.91 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 108.896 -0.779 . . . . 74.14 108.896 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.03 70.98 14.77 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.236 1.014 . . . . 72.34 108.347 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.73 -26.31 27.85 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.053 1.835 . . . . 65.55 110.12 174.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.478 ' O ' HG23 ' A' ' 31' ' ' VAL . 81.9 m-20 -99.8 22.7 10.67 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.734 -1.121 . . . . 71.23 110.767 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.0 -46.42 97.62 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-O 118.594 -0.717 . . . . 51.23 112.425 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.6 -21.38 22.21 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 121.898 1.732 . . . . 70.54 113.495 173.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.0 m170 -71.09 -36.51 72.25 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 122.867 0.467 . . . . 74.01 110.452 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 27' ' ' ASN . 73.4 t -56.34 -35.88 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.174 0.99 . . . . 71.44 112.87 -174.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -65.15 -35.17 80.26 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.322 0.649 . . . . 75.25 110.726 -179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -75.07 -37.9 61.48 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.126 0.97 . . . . 71.52 110.102 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -82.15 156.84 24.27 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.217 -0.901 . . . . 73.52 110.641 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -72.4 125.8 28.29 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.924 -0.769 . . . . 61.44 108.924 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.526 ' HD1' ' H ' ' G' ' 194' ' ' ALA . 77.4 t-105 -78.17 81.07 4.56 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.498 0.666 . . . . 74.21 110.949 -179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -118.09 84.34 21.59 Favored Pre-proline 0 C--O 1.242 0.695 0 N-CA-C 106.822 -1.547 . . . . 64.14 106.822 168.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -71.63 115.3 4.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.255 1.97 . . . . 75.45 111.256 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -95.69 90.87 5.84 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.835 -1.542 . . . . 72.43 106.835 174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 46.9 t -84.47 112.59 21.89 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 114.734 -1.121 . . . . 54.32 111.381 -168.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.455 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 12.6 mptt -80.08 146.07 32.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 124.06 0.944 . . . . 64.33 108.534 167.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.23 114.82 10.52 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.448 0.699 . . . . 70.5 109.539 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 26.0 m-20 -108.8 141.56 40.65 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.402 0.681 . . . . 75.33 109.384 173.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 27.3 tp -133.68 119.44 19.35 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 107.942 -1.132 . . . . 73.14 107.942 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 30.9 t70 -141.81 151.54 42.88 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.432 0.693 . . . . 72.33 110.018 -176.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.2 t -131.35 150.13 52.27 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.894 0.877 . . . . 74.11 109.876 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB2' ' NH2' ' A' ' 61' ' ' ARG . . . -147.34 152.53 38.37 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.73 1.212 . . . . 54.51 108.466 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.686 ' HB2' HD11 ' A' ' 98' ' ' LEU . 8.5 t -133.29 160.47 37.21 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 118.138 0.426 . . . . 73.11 111.345 176.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.3 t -149.57 120.42 7.61 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.212 1.005 . . . . 55.21 108.82 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -74.07 104.13 4.78 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.784 -0.821 . . . . 74.44 108.784 175.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.3 mt -82.75 -32.61 27.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.157 -0.474 . . . . 75.42 110.114 177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.65 -175.69 5.45 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.932 0.893 . . . . 63.43 109.705 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -64.71 125.23 24.12 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.16 -0.681 . . . . 71.44 109.16 174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 70.44 -8.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.622 1.569 . . . . 73.42 112.44 -176.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.78 110.94 28.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.996 -0.742 . . . . 73.15 108.996 -174.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.28 124.47 40.4 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.362 1.065 . . . . 71.25 108.562 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.33 127.19 35.48 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.202 -1.036 . . . . 74.34 108.202 168.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.97 121.86 62.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 108.242 -1.022 . . . . 60.33 108.242 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 52.6 t -103.33 130.21 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 123.199 0.6 . . . . 75.22 109.555 176.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 0.2 OUTLIER -101.38 117.81 35.71 Favored 'General case' 0 CA--C 1.554 1.122 0 C-N-CA 124.213 1.005 . . . . 73.04 108.668 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.405 ' NH2' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -91.9 106.12 18.22 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.071 -0.714 . . . . 74.42 109.071 169.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' HB1' ' A' ' 110' ' ' ALA . 17.7 t -105.92 126.97 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.527 -1.286 . . . . 30.41 107.527 169.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -122.92 134.23 54.36 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.731 -0.47 . . . . 64.53 109.731 177.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.601 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.5 t -130.36 107.31 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.352 1.461 . . . . 72.32 107.791 -177.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 36.3 m -113.2 122.27 46.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.369 -0.604 . . . . 74.01 109.369 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.5 117.96 35.65 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 107.682 -1.229 . . . . 64.32 107.682 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.7 m -117.76 126.77 53.05 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.827 0.451 . . . . 32.01 109.846 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.485 HD21 ' CE3' ' A' ' 36' ' ' TRP . 66.6 mt -89.37 70.3 8.11 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.529 -1.285 . . . . 75.41 107.529 176.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -85.29 0.95 Allowed Glycine 0 C--N 1.344 0.987 0 CA-C-N 114.42 -1.263 . . . . 43.52 110.733 -168.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.04 -25.17 5.39 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.94 0.896 . . . . 72.12 110.961 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -79.83 107.26 12.48 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.26 -0.645 . . . . 63.1 109.26 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 13.4 m -62.1 127.35 30.97 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.903 0.382 . . . . 65.53 110.16 175.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.47 -53.52 6.51 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.125 0.97 . . . . 34.11 108.695 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.14 167.24 30.39 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 113.867 -1.515 . . . . 75.22 110.236 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -129.78 144.12 51.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.33 1.452 . . . . 71.24 107.861 171.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 76.4 m -134.19 138.18 44.95 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.872 0.869 . . . . 74.3 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -147.96 123.69 10.53 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 108.486 -0.931 . . . . 72.13 108.486 168.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -125.89 119.86 55.71 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 108.713 -0.847 . . . . 72.11 108.713 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 73.6 mt-30 -95.3 90.08 5.71 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 114.761 -1.109 . . . . 62.31 108.948 174.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 8.1 tp-100 -81.17 96.66 7.29 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.346 -1.297 . . . . 64.13 107.724 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.54 143.24 17.12 Favored Glycine 0 C--N 1.343 0.948 0 N-CA-C 110.923 -0.871 . . . . 55.53 110.923 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -144.93 121.54 1.57 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.706 -0.958 . . . . 72.11 110.706 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.5 mt -82.91 129.11 37.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.102 -1.073 . . . . 65.32 108.102 177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -137.78 163.91 30.21 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.691 1.197 . . . . 73.14 109.208 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.4 p -110.29 120.18 41.6 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.119 0.568 . . . . 73.1 109.65 172.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 119.6 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.865 0.866 . . . . 75.53 110.327 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.81 160.97 4.55 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.8 1.64 . . . . 61.12 108.711 171.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 100.33 11.83 40.73 Favored Glycine 0 N--CA 1.479 1.529 0 N-CA-C 112.633 -0.187 . . . . 62.12 112.633 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.709 HD11 ' HB3' ' G' ' 173' ' ' LEU . 0.1 OUTLIER -115.79 169.6 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.669 1.188 . . . . 70.41 110.655 -173.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -167.79 173.95 7.95 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.194 -0.669 . . . . 73.04 109.194 167.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.84 -130.97 49.5 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 116.627 -0.26 . . . . 75.32 113.198 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.7 p -79.15 -15.01 58.74 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.693 0.797 . . . . 71.44 112.308 -175.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -56.35 -36.94 69.36 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.047 0.939 . . . . 75.51 111.082 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -40.86 39.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.469 -0.787 . . . . 73.3 110.523 -177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.34 -26.47 67.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.015 0.526 . . . . 72.31 111.319 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -75.19 -44.2 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.82 0.848 . . . . 61.3 110.563 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 49.0 t -74.6 -64.03 1.12 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.913 -0.585 . . . . 42.11 109.938 -177.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 48' ' ' SER . 65.5 tp -64.52 -41.74 96.22 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.674 0.789 . . . . 71.11 112.713 -177.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.12 -36.86 44.62 Favored Glycine 0 C--N 1.343 0.928 0 CA-C-N 116.234 -0.439 . . . . 73.41 113.464 -173.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HA ' ' HZ3' ' G' ' 184' ' ' TRP . . . -119.63 -54.38 2.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.43 0.53 . . . . 71.32 112.43 -170.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.446 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 87.4 t80 -74.27 -55.95 5.45 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 113.38 0.881 . . . . 73.14 113.38 -163.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.445 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 86.2 m -66.61 -38.18 18.3 Favored Pre-proline 0 CA--C 1.563 1.443 0 N-CA-C 113.589 0.959 . . . . 62.41 113.589 -175.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.0 -26.24 43.68 Favored 'Trans proline' 0 C--N 1.387 2.598 0 C-N-CA 121.627 1.551 . . . . 72.33 112.563 167.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.51 -26.61 61.84 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 122.765 0.426 . . . . 71.22 110.849 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 50.3 mm -59.97 -42.3 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.873 0.844 . . . . 73.21 109.685 170.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.518 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.1 mt -78.56 -19.41 52.91 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.116 -1.402 . . . . 65.32 112.167 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 34.0 t80 -64.6 -39.85 44.12 Favored Pre-proline 0 CA--C 1.573 1.857 0 N-CA-C 114.197 1.184 . . . . 70.01 114.197 -169.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -56.58 -40.64 83.05 Favored 'Trans proline' 0 C--N 1.392 2.839 0 C-N-CA 122.318 2.012 . . . . 63.43 113.282 170.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -75.58 -36.76 60.28 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.295 -0.866 . . . . 54.5 111.15 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.48 -48.34 75.58 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.519 0.728 . . . . 72.35 109.747 177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.9 ttm105 -52.89 -50.79 63.16 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 124.706 1.254 . . . . 70.11 110.755 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -60.95 -46.72 89.57 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 124.536 1.148 . . . . 63.3 111.721 -175.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.467 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.3 t -59.04 -43.5 91.64 Favored 'General case' 0 C--N 1.347 0.486 0 O-C-N 124.194 0.934 . . . . 71.22 110.752 -179.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 118' ' ' VAL . 91.1 mt -63.31 -53.89 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 O-C-N 123.963 0.789 . . . . 74.52 110.293 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.641 HG23 ' HB2' ' A' ' 125' ' ' GLN . 61.6 m -51.59 -45.71 63.24 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.697 1.199 . . . . 71.53 111.188 -176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -66.96 -45.54 77.44 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.647 -1.16 . . . . 73.12 110.352 -178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.434 ' SD ' HG23 ' A' ' 21' ' ' ILE . 12.0 mtp -55.22 -44.7 75.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 123.762 0.825 . . . . 73.5 111.719 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 84.6 t -64.07 -46.95 92.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 124.207 1.003 . . . . 73.31 110.817 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.5 p -70.85 -28.59 64.7 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 115.802 -0.635 . . . . 73.03 110.784 -175.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.509 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.8 mtt-85 -72.26 -33.57 67.59 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.022 0.929 . . . . 75.13 110.098 174.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.08 -1.36 68.37 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.485 -0.779 . . . . 54.44 112.763 174.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.0 m 69.28 40.34 1.52 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 124.774 1.229 . . . . 71.42 110.096 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -120.15 145.24 39.64 Favored Pre-proline 0 C--O 1.245 0.852 0 CA-C-N 115.356 -0.838 . . . . 70.41 109.208 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -51.99 114.39 1.6 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.025 2.484 . . . . 73.11 112.096 172.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.641 ' HB2' HG23 ' A' ' 115' ' ' THR . 19.1 pt20 -63.19 156.13 26.17 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.088 -0.96 . . . . 73.14 111.945 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.39 118.68 37.36 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.772 -1.104 . . . . 31.53 108.881 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' C' ' 15' ' ' ARG . 79.0 m-20 -98.72 84.51 3.14 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.315 -1.365 . . . . 73.3 107.315 176.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.478 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -69.35 141.14 54.28 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.262 -0.881 . . . . 73.11 109.453 -174.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' H' ' 204' ' ' ILE . . . -64.9 129.41 94.43 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 122.629 0.372 . . . . 73.13 111.569 -175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -85.66 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 122.559 2.173 . . . . 63.33 110.807 174.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 33.9 m -100.71 114.42 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 114.886 -1.052 . . . . 64.02 109.25 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -87.99 104.9 17.08 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.706 -1.22 . . . . 70.35 107.706 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -59.82 -31.66 69.93 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 124.533 1.145 . . . . 75.21 111.184 -175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.652 ' HA ' ' HE2' ' G' ' 182' ' ' PHE . 27.6 t70 -77.6 -53.45 7.57 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 115.461 -0.79 . . . . 71.23 111.105 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.81 92.49 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.031 0.832 . . . . 64.32 112.523 -169.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' H' ' 207' ' ' VAL . 53.0 tp -62.23 -41.14 98.13 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.07 0.462 . . . . 74.32 111.085 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.433 ' O ' HD13 ' A' ' 141' ' ' LEU . 40.5 t80 -80.57 -32.22 36.64 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.632 -0.713 . . . . 71.03 110.791 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.7 ttt -65.28 -40.41 93.82 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.093 0.957 . . . . 75.23 110.4 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.53 ' HB3' ' HB3' ' C' ' 8' ' ' GLU . 87.0 m-20 -63.13 -31.95 73.21 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.239 -0.891 . . . . 74.22 110.988 177.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -71.19 -40.49 71.17 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.841 -0.618 . . . . 70.3 110.89 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 137' ' ' PHE . 6.1 mp -61.17 -48.94 79.26 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.399 0.679 . . . . 74.41 111.599 -176.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.497 ' HB3' ' NE2' ' A' ' 144' ' ' GLN . 23.6 tm0? -170.98 -18.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 123.729 0.643 . . . . 75.43 110.744 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.425 ' HG3' ' HG3' ' C' ' 8' ' ' GLU . 0.6 OUTLIER 58.89 94.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 123.974 0.91 . . . . 72.21 109.552 -171.508 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.497 ' NE2' ' HB3' ' A' ' 142' ' ' GLN . 24.7 mp0 -87.7 91.81 8.88 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.876 0.471 . . . . 72.04 109.809 -178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.28 136.9 48.16 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.212 -0.662 . . . . 74.32 109.212 172.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.29 90.07 0.27 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.52 -0.632 . . . . 72.25 111.52 -174.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.11 152.29 35.89 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.282 -0.636 . . . . 70.23 109.282 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 151.64 37.55 0.03 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.875 -0.89 . . . . 45.52 110.875 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.1 t -112.33 149.68 32.08 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.292 0.637 . . . . 40.14 110.524 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -152.95 20.94 0.59 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.5 1.12 . . . . 62.21 108.766 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.09 110.14 17.76 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.744 0.783 . . . . 75.02 110.478 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.412 ' CE1' ' HD3' ' E' ' 180' ' ' PRO . 77.0 m-70 -108.35 82.34 1.61 Allowed 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.99 0.916 . . . . 53.03 108.915 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -100.29 137.11 39.16 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.274 0.559 . . . . 75.13 110.329 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -151.95 31.31 0.56 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.486 1.114 . . . . 54.51 108.917 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.194 0 CA-C-N 114.492 -1.231 . . . . 61.5 110.972 -177.759 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 55.0 ttm . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.317 -0.623 . . . . 64.51 109.317 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -77.49 80.2 3.98 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.221 0.609 . . . . 65.23 110.482 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -74.4 106.5 6.04 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.956 0.902 . . . . 75.4 110.18 -171.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.556 ' H ' ' NE2' ' D' ' 143' ' ' GLN . 61.9 mt-30 -122.84 87.83 2.82 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 107.201 -1.407 . . . . 70.33 107.201 178.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 70.15 156.03 0.14 Allowed 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 124.474 1.109 . . . . 75.24 110.882 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.53 147.47 45.95 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 109.628 -0.508 . . . . 73.24 109.628 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -136.54 -34.54 0.76 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.88 1.272 . . . . 75.34 108.785 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.58 98.85 0.28 Allowed 'General case' 0 C--N 1.354 0.789 0 C-N-CA 123.433 0.693 . . . . 73.04 109.769 174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.531 ' HB3' HG23 ' B' ' 89' ' ' ILE . 13.6 ptm 49.49 -179.53 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 126.898 2.079 . . . . 62.24 114.556 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 23.7 p -146.8 137.15 23.66 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 107.983 -1.117 . . . . 71.01 107.983 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -137.28 137.0 38.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.804 -0.813 . . . . 72.45 108.804 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -147.72 126.66 12.77 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.886 0.475 . . . . 74.41 109.975 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 tt -91.47 139.87 17.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 108.918 -0.771 . . . . 70.44 108.918 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -110.79 -44.27 3.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.838 0.455 . . . . 62.43 110.516 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -172.44 139.95 1.04 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.506 0.322 . . . . 72.21 110.219 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.8 mt -115.47 146.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.06 -1.089 . . . . 74.14 108.06 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -167.2 164.87 15.59 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.619 0.723 . . . . 74.4 111.583 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.2 m -90.04 120.01 30.87 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 108.286 -1.005 . . . . 74.03 108.286 170.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.3 mtpt -90.43 -24.88 20.62 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 122.842 0.457 . . . . 72.3 111.301 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.0 t70 -158.62 144.65 16.88 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.94 0.4 . . . . 73.14 111.829 -176.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.476 HD11 ' SG ' ' B' ' 113' ' ' CYS . 42.8 mm -132.96 141.22 45.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.117 1.367 . . . . 75.12 108.755 173.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 38.3 m -137.87 122.25 18.29 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 125.219 1.407 . . . . 71.21 108.388 175.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 65.8 t80 -134.97 110.02 8.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.083 -1.821 . . . . 73.25 106.083 165.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -125.66 111.23 14.71 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.977 -1.12 . . . . 75.12 107.977 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.662 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.06 89.37 5.52 Favored Pre-proline 0 N--CA 1.473 0.682 0 C-N-CA 124.012 0.925 . . . . 50.53 109.162 177.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -71.68 -26.67 19.25 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.416 2.077 . . . . 63.3 111.831 -174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -117.62 24.58 10.99 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.317 1.047 . . . . 74.12 109.313 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.678 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.04 -53.2 13.83 Favored Pre-proline 0 CA--C 1.566 1.576 0 C-N-CA 125.905 1.682 . . . . 64.13 114.498 173.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.0 Cg_exo -74.84 -18.23 19.32 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.541 2.161 . . . . 75.02 112.185 -177.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -89.89 2.53 54.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 114.706 -1.134 . . . . 71.32 111.811 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.3 p -69.04 -18.13 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.172 0.589 . . . . 72.5 110.503 168.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -73.51 -34.48 65.3 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.683 -0.488 . . . . 64.23 109.683 173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -77.11 -45.56 26.51 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.423 0.63 . . . . 75.11 109.4 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.606 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 27.3 mmtp -94.57 68.91 3.48 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.858 1.263 . . . . 64.42 109.191 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -77.16 75.86 3.72 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 114.314 -1.312 . . . . 64.02 110.905 -174.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -162.25 151.95 16.18 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.474 -1.306 . . . . 63.23 107.474 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.458 ' HB2' ' N ' ' F' ' 195' ' ' PHE . 22.7 tt0 -88.08 119.37 70.37 Favored Pre-proline 0 N--CA 1.477 0.922 0 N-CA-C 109.472 -0.566 . . . . 71.5 109.472 -178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.656 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 68.8 Cg_endo -68.63 144.4 60.16 Favored 'Trans proline' 0 C--N 1.367 1.542 0 C-N-CA 121.963 1.776 . . . . 73.3 111.817 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 109.03 2.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 115.075 -0.966 . . . . 71.25 108.71 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.519 HG23 ' HA2' ' F' ' 191' ' ' GLY . 1.1 t -84.79 123.07 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 108.983 -0.747 . . . . 72.33 108.983 -167.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -124.44 147.09 48.54 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.38 1.072 . . . . 75.2 109.659 -173.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.641 ' H ' HD13 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -109.24 167.13 10.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.319 0.648 . . . . 71.24 111.605 179.028 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.9 t70 -153.51 139.98 18.72 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.892 1.277 . . . . 73.53 108.731 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 50.3 tp -124.61 132.98 53.41 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.328 0.651 . . . . 74.33 109.36 -178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -146.81 151.63 37.42 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.551 1.141 . . . . 74.13 109.079 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 84.0 m -139.28 121.84 16.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.835 0.454 . . . . 64.42 110.02 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.91 160.42 19.55 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.64 1.176 . . . . 51.21 108.854 171.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.7 m -144.21 163.95 32.16 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.298 0.639 . . . . 73.21 110.601 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 7.3 p -159.97 137.3 9.58 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.094 0.958 . . . . 73.3 109.853 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -84.12 129.9 34.88 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.535 0.734 . . . . 73.42 110.402 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.53 -42.91 8.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.196 0.598 . . . . 74.2 109.479 176.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.41 -171.23 3.51 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.078 0.951 . . . . 54.42 110.04 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.55 112.93 3.38 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.859 -1.064 . . . . 62.34 110.252 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 69.49 -0.5 2.57 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 125.564 1.546 . . . . 74.45 112.979 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -104.83 104.7 17.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 N-CA-C 107.377 -1.342 . . . . 50.24 107.377 177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -124.09 149.77 45.8 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.395 0.678 . . . . 74.02 109.542 -173.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -116.83 112.59 21.31 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.498 1.119 . . . . 71.41 108.665 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -89.85 118.19 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.429 -0.952 . . . . 73.3 108.429 175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 50.5 t -102.42 109.33 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 108.394 -0.965 . . . . 71.0 108.394 175.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.1 OUTLIER -93.75 117.06 29.6 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.576 -0.898 . . . . 72.44 108.576 -175.077 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -102.04 117.28 34.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.161 0.584 . . . . 73.42 110.128 175.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.51 HG11 HD11 ' B' ' 128' ' ' LEU . 11.8 t -116.19 127.41 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.989 -1.115 . . . . 72.32 107.989 169.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 6.7 m -115.31 150.45 36.24 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.52 0.728 . . . . 44.0 109.567 -178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.442 HG23 HD13 ' B' ' 114' ' ' ILE . 34.8 t -129.43 130.57 67.44 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.637 1.175 . . . . 61.3 109.139 173.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -126.12 140.81 52.27 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.181 0.992 . . . . 75.31 110.351 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.844 ' HB3' ' HE2' ' B' ' 74' ' ' PHE . . . -150.63 161.78 41.94 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 109.045 -0.724 . . . . 64.11 109.045 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 20.9 p -146.91 141.46 26.57 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.45 0.643 . . . . 63.23 112.022 -174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 34.5 mt -91.89 98.85 11.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.831 -1.174 . . . . 70.54 107.831 177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.14 -107.73 2.3 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.44 -1.064 . . . . 71.43 110.44 -171.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.0 8.63 10.45 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.82 0.848 . . . . 73.54 110.376 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -112.39 142.97 44.28 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.192 -0.67 . . . . 72.2 109.192 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.8 m -56.55 126.05 24.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.765 0.826 . . . . 73.14 110.742 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.26 -59.62 2.7 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 122.222 1.011 . . . . 65.23 109.065 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.844 ' HE2' ' HB3' ' B' ' 66' ' ' ALA . 0.2 OUTLIER -154.53 178.66 9.83 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 113.006 -1.906 . . . . 73.41 107.08 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -142.72 136.81 29.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.931 -1.137 . . . . 65.23 107.931 164.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 50.6 t -131.83 147.56 52.49 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 108.589 -0.893 . . . . 71.34 108.589 175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 35.0 tt0 -163.66 134.72 4.62 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.807 -0.812 . . . . 71.43 108.807 -173.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -125.21 146.7 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.325 1.05 . . . . 71.4 109.014 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 27.3 mt-30 -126.05 88.95 2.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.382 -0.969 . . . . 72.05 108.382 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.528 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.7 tp-100 -85.07 100.86 11.98 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.899 -1.046 . . . . 71.4 109.523 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.79 156.46 25.55 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.693 -0.563 . . . . 55.21 111.693 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.83 130.22 2.38 Favored Glycine 0 C--O 1.239 0.456 0 N-CA-C 111.568 -0.613 . . . . 60.21 111.568 -177.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 37.9 mt -84.61 127.26 40.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 123.609 0.764 . . . . 62.21 109.401 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -134.22 158.21 44.28 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.773 1.229 . . . . 75.01 108.665 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 40.5 m -132.51 121.95 24.11 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.407 -0.96 . . . . 63.32 108.407 173.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.623 HG13 ' SG ' ' B' ' 97' ' ' CYS . 0.2 OUTLIER -133.24 141.65 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.568 -0.901 . . . . 74.13 108.568 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.469 ' N ' HD13 ' B' ' 86' ' ' ILE . . . -158.94 174.88 14.29 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.078 0.951 . . . . 71.34 109.487 169.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.14 -54.98 0.53 Allowed Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.27 0.462 . . . . 45.05 112.275 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.531 HG23 ' HB3' ' B' ' 9' ' ' MET . 2.1 pp -78.85 170.75 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 123.506 0.722 . . . . 55.24 112.589 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.7 162.87 40.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.559 0.744 . . . . 73.2 110.634 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.73 -129.38 24.61 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-N 115.473 -0.785 . . . . 44.43 113.771 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 6.8 m -67.61 -28.5 67.79 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 124.355 1.062 . . . . 54.03 111.167 -177.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.68 -18.43 65.37 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.62 0.768 . . . . 65.21 112.09 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 11.4 tpt -68.97 -39.95 79.13 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.991 0.516 . . . . 71.22 110.156 173.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.47 -21.32 66.19 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.295 -0.866 . . . . 62.44 111.587 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -65.14 -40.83 94.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.411 0.685 . . . . 62.44 110.849 173.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.623 ' SG ' HG13 ' B' ' 86' ' ' ILE . 53.9 t -75.23 -69.91 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.852 -0.613 . . . . 74.31 111.128 -172.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.589 HD13 ' H ' ' B' ' 98' ' ' LEU . 0.0 OUTLIER -88.79 -8.33 54.6 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 112.313 0.486 . . . . 73.45 112.313 -171.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.23 3.42 54.82 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-O 119.691 -0.505 . . . . 71.4 112.769 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.09 -67.9 0.18 Allowed 'General case' 0 C--N 1.355 0.807 0 CA-C-N 117.142 0.471 . . . . 72.53 111.424 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -68.05 -50.85 52.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.819 0.674 . . . . 75.54 112.819 -169.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.551 ' HA ' HD12 ' B' ' 105' ' ' ILE . 62.5 m -62.25 -43.4 85.41 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.921 0.888 . . . . 72.35 113.206 -173.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.13 -39.4 49.23 Favored 'Trans proline' 0 C--N 1.391 2.767 0 C-N-CA 121.476 1.451 . . . . 64.54 112.365 169.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -65.73 -18.33 65.25 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 112.761 0.652 . . . . 75.03 112.761 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.592 HG23 ' NH2' ' D' ' 111' ' ' ARG . 96.4 mt -69.83 -44.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.513 0.725 . . . . 75.14 109.988 170.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.483 ' HB2' HD12 ' B' ' 60' ' ' LEU . 30.9 mt -84.85 -18.19 35.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.754 -1.112 . . . . 63.31 111.437 -173.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.427 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 36.0 t80 -61.87 -40.95 73.86 Favored Pre-proline 0 CA--C 1.559 1.327 0 C-N-CA 124.736 1.214 . . . . 71.01 113.197 -171.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.443 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 14.9 Cg_endo -56.71 -45.77 34.46 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.533 2.155 . . . . 61.45 113.479 169.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.528 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 85.1 m-85 -64.82 -42.71 94.76 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.073 0.549 . . . . 74.44 110.42 -177.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -39.99 89.29 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.651 0.78 . . . . 74.52 110.843 178.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' B' ' 128' ' ' LEU . 26.8 ttt180 -58.55 -52.91 63.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.402 1.081 . . . . 63.1 111.486 177.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.53 -38.14 88.76 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.108 -0.951 . . . . 73.15 109.779 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.509 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 5.8 t -68.18 -36.84 80.25 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.477 -0.783 . . . . 74.12 111.474 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.442 HD13 HG23 ' B' ' 64' ' ' VAL . 53.5 mt -62.7 -60.0 3.45 Favored 'Isoleucine or valine' 0 C--N 1.364 1.215 0 N-CA-C 109.351 -0.611 . . . . 65.2 109.351 176.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.8 m -53.55 -38.04 63.46 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 124.724 1.265 . . . . 71.3 110.754 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.7 t -55.88 -54.23 47.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.133 0.973 . . . . 73.04 111.391 174.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.505 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 16.8 mmt -66.29 -37.2 84.88 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 122.902 0.481 . . . . 73.24 111.462 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.498 HG22 ' HE1' ' B' ' 74' ' ' PHE . 91.1 t -63.74 -40.28 88.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.534 1.133 . . . . 71.35 110.577 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.4 m -65.32 -35.88 82.33 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.47 -1.241 . . . . 74.33 111.826 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 75.4 mtt-85 -65.22 -41.73 94.12 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.258 -0.883 . . . . 71.32 110.168 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.59 -1.48 82.87 Favored Glycine 0 C--N 1.353 1.505 0 O-C-N 123.875 0.734 . . . . 44.32 113.895 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 22.6 p 60.0 49.84 7.25 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.74 1.616 . . . . 74.24 111.62 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -118.49 161.36 35.87 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 114.264 -1.335 . . . . 73.52 110.071 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.38 145.6 72.08 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.325 2.683 . . . . 74.44 114.89 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.485 ' OE1' ' HA ' ' C' ' 124' ' ' PRO . 3.9 pt20 -66.63 158.83 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.206 1.403 . . . . 74.42 113.803 -177.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.11 104.27 7.46 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 106.671 -1.603 . . . . 70.42 106.671 162.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -90.05 93.1 9.25 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.371 -0.974 . . . . 65.51 108.371 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' B' ' 111' ' ' ARG . 40.0 mt -57.29 135.27 56.46 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.116 0.967 . . . . 70.25 113.478 -173.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.2 117.51 58.24 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 114.621 -1.172 . . . . 65.22 108.625 173.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' D' ' 16' ' ' ILE . 55.6 Cg_endo -65.67 151.1 85.54 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.399 2.733 . . . . 63.34 112.702 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.07 124.47 64.33 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 CA-C-N 114.67 -1.15 . . . . 71.21 108.117 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -84.34 65.75 9.03 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.669 -0.863 . . . . 64.4 108.669 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -70.81 -26.95 63.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.198 -0.91 . . . . 71.23 109.383 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.31 -39.8 88.26 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.489 1.116 . . . . 74.43 110.136 174.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.2 -44.0 48.81 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.975 0.91 . . . . 51.21 110.982 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.464 ' HB2' HG21 ' E' ' 207' ' ' VAL . 48.3 tp -61.51 -35.41 77.63 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.701 0.8 . . . . 72.44 111.082 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -61.23 -39.86 91.88 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.88 1.272 . . . . 74.2 110.792 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 50.0 mtt -61.88 -42.92 99.64 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.903 0.752 . . . . 74.04 109.985 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -75.97 -29.57 58.3 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.993 -1.003 . . . . 41.54 110.981 -176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -64.65 -36.34 83.96 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.731 0.645 . . . . 75.02 109.95 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt -90.76 35.66 0.89 Allowed 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.807 0.843 . . . . 74.14 111.091 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 62.33 42.25 9.38 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.641 1.176 . . . . 74.31 111.825 175.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 62.61 -157.84 0.33 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.423 1.089 . . . . 74.54 110.918 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.468 ' NE2' ' SD ' ' D' ' 138' ' ' MET . 11.1 pt20 -149.67 -163.63 1.83 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.428 0.691 . . . . 72.23 109.718 -176.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' D' ' 138' ' ' MET . . . -67.46 -3.2 7.83 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.139 0.976 . . . . 61.44 113.487 -176.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.448 ' HA2' ' HE2' ' D' ' 137' ' ' PHE . . . -73.65 62.09 1.97 Allowed Glycine 0 C--N 1.355 1.607 0 C-N-CA 123.273 0.463 . . . . 52.1 112.557 173.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.38 6.67 4.15 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 125.391 1.476 . . . . 73.31 109.495 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.31 71.8 2.92 Favored Glycine 0 C--N 1.358 1.79 0 N-CA-C 110.912 -0.875 . . . . 74.24 110.912 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.722 ' HA ' ' HB2' ' D' ' 93' ' ' GLN . 41.2 p -74.82 -64.87 0.95 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 123.749 0.82 . . . . 64.51 111.123 -172.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 55.23 88.47 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.395 1.078 . . . . 73.23 111.945 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -61.43 117.07 5.2 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.517 0.727 . . . . 72.43 110.38 174.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -165.74 99.89 0.68 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.223 -1.028 . . . . 73.42 108.223 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.602 HE22 ' HB2' ' H' ' 172' ' ' ALA . 42.5 mt-30 -121.17 -62.19 1.46 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.757 0.823 . . . . 62.34 109.217 175.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -74.7 -74.72 0.19 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.646 0.778 . . . . 75.24 110.473 -174.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.965 0 C-N-CA 124.201 1.0 . . . . 45.42 108.742 -177.897 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.854 -0.795 . . . . 54.22 108.854 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.4 m -134.46 169.51 17.14 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.821 0.848 . . . . 74.55 110.386 -175.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.63 96.06 2.96 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.53 -0.915 . . . . 55.51 108.53 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.96 113.27 22.16 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.157 0.583 . . . . 74.23 109.854 -177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -167.04 118.63 0.92 Allowed 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.729 -1.212 . . . . 43.04 107.729 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -160.09 133.92 7.18 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.899 -0.778 . . . . 74.13 108.899 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -84.58 -12.67 53.63 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.728 0.811 . . . . 60.22 112.022 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 139' ' ' ASN . 0.2 OUTLIER -86.2 112.7 21.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.742 -0.836 . . . . 73.41 108.742 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.4 ttp 63.03 115.45 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.385 1.474 . . . . 72.33 112.369 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -116.53 118.95 34.07 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.732 1.213 . . . . 64.22 108.19 170.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -120.83 137.31 54.61 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.054 0.542 . . . . 65.25 109.552 -178.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.459 ' HG3' HG13 ' H' ' 204' ' ' ILE . 54.1 tt0 -148.6 124.16 10.4 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.707 0.803 . . . . 61.42 108.942 173.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 5.9 tp -78.57 133.57 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.037 -0.727 . . . . 72.04 109.037 172.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -103.17 -51.06 3.33 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.583 0.753 . . . . 73.0 110.917 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.513 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 57.4 ttt180 -165.1 123.21 1.64 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.231 -168.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 69.7 mt -112.3 132.02 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 108.522 -0.918 . . . . 72.2 108.522 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.546 ' HB3' HG23 ' D' ' 122' ' ' THR . 22.1 p90 -173.19 148.03 1.63 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.126 0.891 . . . . 73.34 110.597 -174.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -74.42 124.8 27.2 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.718 0.807 . . . . 75.21 110.121 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -74.79 -48.94 22.69 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 122.288 1.042 . . . . 73.22 109.053 170.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 29.1 t70 -139.31 136.02 34.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.923 -1.49 . . . . 51.32 109.284 -167.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.8 mt -137.31 143.7 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 106.902 -1.518 . . . . 72.51 106.902 176.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.1 t -154.21 150.8 28.46 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.335 0.588 . . . . 71.43 109.79 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.427 ' HZ ' ' HD2' ' C' ' 123' ' ' PHE . 79.4 t80 -150.99 110.54 4.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 107.496 -1.298 . . . . 74.12 107.496 173.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -117.07 124.85 50.26 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.597 0.759 . . . . 74.41 109.337 -178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.27 84.0 48.7 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 107.7 -1.222 . . . . 74.12 107.7 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.89 -25.71 38.67 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.471 2.114 . . . . 64.31 111.69 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.3 20.74 17.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.338 1.055 . . . . 71.41 110.412 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.86 -49.96 90.77 Favored Pre-proline 0 CA--C 1.569 1.711 0 N-CA-C 114.723 1.379 . . . . 73.41 114.723 -172.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.83 -30.89 10.87 Favored 'Trans proline' 0 C--N 1.387 2.569 0 CA-C-N 121.58 1.6 . . . . 75.14 112.723 176.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -68.83 -49.57 57.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.976 0.91 . . . . 61.33 111.423 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.45 HG23 HD11 ' C' ' 68' ' ' LEU . 14.3 p -59.51 -18.77 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 125.344 1.458 . . . . 60.24 112.932 -169.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.64 -33.56 71.68 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 124.172 0.989 . . . . 74.2 112.311 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.47 5.34 52.11 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 112.769 0.655 . . . . 72.11 112.769 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -87.6 163.88 16.37 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 109.562 -0.532 . . . . 73.53 109.562 176.136 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.61 107.07 1.3 Allowed 'General case' 0 C--O 1.243 0.749 0 N-CA-C 107.762 -1.199 . . . . 74.13 107.762 164.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -82.15 83.61 7.3 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-O 122.328 1.061 . . . . 72.41 110.348 -171.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -130.56 72.75 81.75 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 115.036 -0.983 . . . . 72.21 108.823 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.06 127.65 15.48 Favored 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 122.416 2.077 . . . . 74.5 111.153 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.46 ' HA ' ' H ' ' E' ' 191' ' ' GLY . 41.8 mt-10 -86.06 76.72 9.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.377 -1.342 . . . . 74.01 107.377 -178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 31.2 m -73.19 85.77 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 123.055 1.407 . . . . 64.22 110.833 -170.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.85 140.47 48.31 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 113.907 -1.497 . . . . 73.21 107.46 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.484 HD12 HD12 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -128.48 155.94 44.03 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.159 0.583 . . . . 74.44 110.767 -178.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -119.21 128.06 53.86 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.695 1.198 . . . . 63.5 108.118 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.589 ' HB3' ' HE1' ' E' ' 184' ' ' TRP . 7.5 tp -106.02 101.26 10.77 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.138 0.575 . . . . 73.54 109.507 -173.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.469 ' O ' HD23 ' C' ' 60' ' ' LEU . 10.3 t70 -113.91 139.03 49.54 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.62 1.168 . . . . 72.42 109.781 -177.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 7.0 t -119.08 131.35 55.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.281 0.632 . . . . 73.11 109.631 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.39 151.72 32.65 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.357 1.063 . . . . 72.32 108.974 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -143.57 143.59 31.58 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.079 0.552 . . . . 72.33 110.404 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -153.21 156.46 38.57 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.569 1.148 . . . . 75.13 108.528 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.573 ' HB2' ' H ' ' E' ' 172' ' ' ALA . 63.5 tt0 -103.79 117.95 35.55 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.342 -0.614 . . . . 75.44 109.342 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.526 HD11 ' HB2' ' C' ' 57' ' ' GLU . 56.7 mt -86.52 -36.63 18.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.369 0.668 . . . . 73.23 110.093 177.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -160.75 -176.37 5.5 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 115.077 -0.965 . . . . 54.1 110.69 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -63.87 102.45 0.47 Allowed 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 114.429 -1.26 . . . . 74.02 110.322 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 13.0 m-20 64.57 13.04 7.95 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 124.968 1.307 . . . . 71.14 113.581 -174.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 98.9 t -106.03 107.74 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 107.973 -1.121 . . . . 74.11 107.973 169.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.418 ' CE2' HD11 ' C' ' 86' ' ' ILE . 7.9 m-30 -114.89 146.05 41.53 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.48 -0.933 . . . . 72.0 108.48 -174.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.6 tt0 -109.08 124.13 50.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.206 1.002 . . . . 71.32 108.557 175.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.809 HG21 ' HB2' ' C' ' 98' ' ' LEU . 92.8 t -119.38 124.55 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 108.189 -1.041 . . . . 31.33 108.189 172.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.3 t -118.9 115.43 47.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 124.581 1.152 . . . . 71.33 108.764 -174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.469 HD23 ' O ' ' C' ' 45' ' ' ASP . 0.9 OUTLIER -86.27 105.25 16.51 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 108.356 -0.979 . . . . 64.12 108.356 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.12 106.45 16.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.242 0.617 . . . . 72.02 109.481 172.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.577 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.9 t -100.7 130.66 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 108.113 -1.069 . . . . 62.44 108.113 170.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 33.9 m -125.25 122.59 37.39 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.48 -0.563 . . . . 72.42 109.48 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.66 HG21 HG21 ' C' ' 114' ' ' ILE . 71.5 t -98.63 113.55 33.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 C-N-CA 124.424 1.09 . . . . 64.12 109.302 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 2.6 m -99.34 134.46 42.17 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.401 -0.963 . . . . 50.12 108.401 171.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.16 124.53 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.676 0.79 . . . . 64.13 108.952 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 30.7 m -133.54 170.98 14.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.944 0.898 . . . . 75.04 110.136 -176.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.652 HD13 ' HG2' ' C' ' 34' ' ' LYS . 27.8 mt -127.89 22.95 6.21 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.666 1.186 . . . . 74.01 108.551 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.24 -96.62 0.99 Allowed Glycine 0 C--N 1.341 0.819 0 N-CA-C 110.027 -1.229 . . . . 50.05 110.027 -167.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -91.48 -30.94 16.17 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.265 0.626 . . . . 74.44 110.744 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -85.69 121.99 29.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.145 0.978 . . . . 74.2 110.87 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -69.62 125.5 26.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.471 -0.566 . . . . 75.44 109.471 168.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.31 -49.09 12.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.247 0.619 . . . . 21.51 109.782 177.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -171.27 177.09 3.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.976 0.91 . . . . 54.31 110.699 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.2 tm? -140.99 139.23 34.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.738 -1.579 . . . . 74.23 106.738 174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.527 ' SG ' HG23 ' C' ' 114' ' ' ILE . 47.2 t -137.24 154.51 50.14 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.643 -0.873 . . . . 71.02 108.643 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -157.09 143.98 18.46 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 122.85 0.46 . . . . 74.03 109.831 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' C' ' 113' ' ' CYS . 19.6 t -142.99 114.28 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.857 1.263 . . . . 74.42 108.171 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.478 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 42.1 mt-30 -93.36 95.53 9.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.546 0.739 . . . . 71.14 109.308 169.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.499 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.4 tp-100 -83.17 104.61 13.48 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 114.779 -1.1 . . . . 45.11 109.829 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.73 146.63 22.41 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.4 0.437 . . . . 52.32 112.327 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.97 124.78 2.64 Favored Glycine 0 C--O 1.24 0.517 0 N-CA-C 110.879 -0.888 . . . . 55.45 110.879 177.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.487 HG12 ' HE1' ' C' ' 17' ' ' TYR . 26.1 mm -93.72 118.04 38.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.3 -1.0 . . . . 63.53 108.3 174.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -122.46 118.55 28.61 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.526 -0.916 . . . . 72.23 108.526 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.7 t -95.75 102.84 14.68 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.183 -1.043 . . . . 74.34 108.183 178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.452 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.7 pp -114.44 -177.76 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 123.744 0.818 . . . . 70.22 110.648 -176.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . 176.91 153.01 0.21 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.584 1.554 . . . . 65.0 108.657 168.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.32 -17.61 46.84 Favored Glycine 0 N--CA 1.477 1.376 0 N-CA-C 114.597 0.599 . . . . 64.14 114.597 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 36.5 pt -57.43 133.09 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 123.833 0.853 . . . . 70.02 111.052 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.582 ' HA ' ' HE3' ' C' ' 94' ' ' MET . 8.8 pt-20 -145.0 -177.9 5.77 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.643 0.777 . . . . 73.53 109.356 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.59 -124.53 23.31 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 124.042 0.839 . . . . 54.31 113.779 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -83.55 -18.48 38.19 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.817 0.847 . . . . 64.32 112.255 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.468 HE22 ' HG3' ' C' ' 90' ' ' GLU . 0.5 OUTLIER -69.23 -40.43 77.92 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.004 0.522 . . . . 63.14 110.501 -172.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.582 ' HE3' ' HA ' ' C' ' 90' ' ' GLU . 11.3 ptp -63.57 -35.4 80.35 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.579 0.352 . . . . 63.41 111.422 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.54 ' HB1' ' HE1' ' E' ' 181' ' ' TYR . . . -76.22 -38.17 56.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.797 0.839 . . . . 74.44 111.245 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -77.96 -37.81 46.68 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.088 0.955 . . . . 61.15 111.23 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.53 -49.98 75.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.118 0.967 . . . . 73.13 111.277 -169.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.809 ' HB2' HG21 ' C' ' 58' ' ' VAL . 3.4 pp -108.88 -11.1 15.05 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.055 0.391 . . . . 51.12 112.055 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.17 -28.98 35.1 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.238 -0.201 . . . . 34.43 112.918 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.09 -45.53 0.71 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.009 0.524 . . . . 75.04 111.481 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -74.43 -47.24 34.94 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.743 0.817 . . . . 74.54 112.364 -172.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.539 ' HB2' ' HA ' ' C' ' 98' ' ' LEU . 97.7 m -65.78 -46.49 66.25 Favored Pre-proline 0 N--CA 1.483 1.189 0 CA-C-O 118.518 -0.753 . . . . 63.2 112.443 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.426 ' O ' HD12 ' C' ' 60' ' ' LEU . 37.8 Cg_endo -66.26 -23.1 52.49 Favored 'Trans proline' 0 C--N 1.385 2.495 0 CA-C-N 121.135 1.441 . . . . 61.22 112.397 172.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.23 -31.72 70.48 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 118.349 0.522 . . . . 75.25 110.191 175.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.446 ' HB ' ' O ' ' C' ' 102' ' ' CYS . 26.8 mm -62.89 -44.11 99.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.63 0.772 . . . . 61.43 109.592 169.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 66.4 mt -82.4 -18.15 42.95 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.766 0.826 . . . . 74.22 112.454 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -62.12 -47.56 90.15 Favored Pre-proline 0 CA--C 1.556 1.181 0 CA-C-O 117.46 -1.257 . . . . 70.35 112.955 -174.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.75 -38.63 92.3 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 122.021 1.814 . . . . 44.54 112.304 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.495 ' HB3' ' NE2' ' C' ' 80' ' ' GLN . 87.9 m-85 -63.46 -50.78 68.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.962 0.905 . . . . 63.15 111.318 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.499 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -67.96 -37.5 81.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.763 -0.653 . . . . 65.13 110.952 -178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 -55.78 -50.41 70.55 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.786 1.234 . . . . 61.44 110.053 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -70.11 -38.22 75.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.86 0.864 . . . . 71.42 110.854 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.422 ' HB3' HG11 ' C' ' 78' ' ' VAL . 9.1 t -64.98 -34.02 77.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.177 0.591 . . . . 73.34 110.89 -177.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.66 HG21 HG21 ' C' ' 64' ' ' VAL . 96.7 mt -70.66 -50.8 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 115.772 -0.649 . . . . 74.42 109.661 173.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.406 HG23 ' H ' ' C' ' 126' ' ' LEU . 27.4 m -58.3 -34.77 70.92 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.957 0.786 . . . . 75.42 111.403 -173.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 79.9 p -67.88 -51.66 45.52 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 115.776 -0.647 . . . . 50.22 109.382 174.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.579 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.1 -41.41 62.41 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.859 1.264 . . . . 61.21 112.664 179.013 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.53 HG11 HD23 ' C' ' 126' ' ' LEU . 88.1 t -72.05 -41.21 67.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.091 -0.959 . . . . 61.14 110.397 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.42 -29.89 70.14 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.396 0.679 . . . . 72.51 111.271 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.48 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 61.5 mtt-85 -67.66 -44.14 78.59 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.634 -0.876 . . . . 73.33 108.634 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.85 -1.94 85.3 Favored Glycine 0 C--N 1.36 1.911 0 O-C-N 124.139 0.9 . . . . 63.33 113.434 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.1 p 66.84 41.84 2.72 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.877 1.671 . . . . 71.05 112.317 169.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HD2' ' HZ ' ' C' ' 23' ' ' PHE . 65.8 m-85 -114.41 163.89 17.93 Favored Pre-proline 0 CA--C 1.565 1.531 0 C-N-CA 124.958 1.303 . . . . 65.03 109.961 176.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.485 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 96.0 Cg_exo -49.41 151.77 6.59 Favored 'Trans proline' 0 C--N 1.399 3.235 0 C-N-CA 124.341 3.36 . . . . 74.42 116.228 -175.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -48.46 132.37 16.92 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.648 1.179 . . . . 75.24 112.011 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.53 HD23 HG11 ' C' ' 118' ' ' VAL . 0.5 OUTLIER -111.47 23.52 13.86 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-N 115.536 -0.756 . . . . 72.13 111.521 177.192 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -90.71 79.5 6.04 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-O 123.788 1.756 . . . . 64.23 106.951 169.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' E' ' 189' ' ' ALA . 82.3 mt -90.12 151.67 21.49 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.648 -1.615 . . . . 72.23 110.185 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.447 ' HB1' HG13 ' F' ' 204' ' ' ILE . . . -35.54 113.19 0.5 Allowed Pre-proline 0 N--CA 1.487 1.389 0 C-N-CA 126.231 1.812 . . . . 63.43 114.319 -173.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -71.37 99.07 0.88 Allowed 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.315 2.01 . . . . 64.03 111.816 -178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.35 97.96 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 115.214 -0.903 . . . . 74.21 110.524 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.51 68.11 10.33 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.593 0.757 . . . . 71.41 109.821 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -51.05 -44.15 61.07 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 113.966 -1.47 . . . . 73.24 111.931 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -68.79 -35.26 76.8 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.253 1.021 . . . . 72.2 111.574 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.36 -36.69 84.53 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.501 -0.772 . . . . 44.15 111.055 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.04 -48.21 82.83 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.869 -0.605 . . . . 65.02 110.234 174.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -68.77 -28.9 67.2 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.975 0.797 . . . . 64.34 111.449 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -70.65 -50.6 35.07 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 123.854 0.721 . . . . 61.45 110.617 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -70.28 -30.9 68.04 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 122.677 0.391 . . . . 63.21 111.121 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -64.29 -149.68 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.722 0 C-N-CA 125.29 1.436 . . . . 73.23 110.919 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 84.9 mt 64.84 95.47 0.05 Allowed 'General case' 0 C--N 1.359 1.02 0 C-N-CA 123.974 0.909 . . . . 52.33 109.874 -176.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -50.25 121.69 5.9 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.585 1.554 . . . . 65.33 111.381 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -140.17 165.84 26.28 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.817 0.847 . . . . 64.32 109.586 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -103.5 -23.33 13.52 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.733 0.813 . . . . 74.31 111.098 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.19 -159.76 0.31 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.389 1.076 . . . . 74.3 111.209 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 3' ' ' GLU . . . 166.45 69.59 0.03 OUTLIER Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.136 -0.786 . . . . 63.0 111.136 174.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -158.48 142.39 15.48 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 122.984 0.514 . . . . 74.32 110.407 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 170.6 141.02 3.17 Favored Glycine 0 C--N 1.341 0.827 0 CA-C-N 115.456 -0.793 . . . . 21.41 111.651 177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 91.6 m -148.82 86.13 1.51 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.224 -1.028 . . . . 71.23 108.224 175.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -86.76 110.9 20.23 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.319 -0.993 . . . . 74.5 108.319 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.16 175.33 13.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.959 0.903 . . . . 64.12 110.084 177.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -169.54 168.78 9.14 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.414 1.086 . . . . 73.35 110.041 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -126.37 102.29 7.08 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.55 0.74 . . . . 64.11 110.144 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -173.69 156.35 2.88 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.789 1.236 . . . . 61.24 109.825 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.988 0.915 . . . . 63.23 108.876 -177.206 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mtp . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.635 0.255 . . . . 73.23 110.769 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 58.8 p -115.18 5.76 14.89 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.651 0.78 . . . . 75.34 109.484 164.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.72 128.06 49.59 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.327 1.051 . . . . 74.41 109.0 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' D' ' 6' ' ' ASN . 9.3 tt0 -77.29 133.12 38.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.771 0.828 . . . . 71.03 110.574 177.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -63.23 -35.05 79.04 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.142 0.977 . . . . 72.41 111.636 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.455 ' H ' ' HG2' ' D' ' 4' ' ' GLN . 28.8 t-20 60.75 -89.53 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.382 1.473 . . . . 62.53 110.551 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 9.7 t -163.12 99.21 0.95 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.563 0.697 . . . . 73.14 109.588 173.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 57.88 -89.93 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.381 1.472 . . . . 75.54 111.025 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 2.8 ttp -36.35 126.35 0.8 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.36 1.064 . . . . 74.44 111.945 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 31.7 m -128.05 138.91 52.75 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.15 -1.055 . . . . 73.24 108.15 171.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.418 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 73.2 t80 -169.74 91.14 0.21 Allowed 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.314 -1.365 . . . . 71.41 107.314 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -126.09 153.37 44.59 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.77 0.828 . . . . 63.0 109.501 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.478 HG23 HD13 ' E' ' 204' ' ' ILE . 10.4 tp -103.53 142.84 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 123.201 0.6 . . . . 73.03 109.559 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -115.2 -45.39 2.94 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.781 0.833 . . . . 72.11 110.633 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -154.58 129.45 9.41 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 120.429 0.157 . . . . 75.01 111.19 -175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.536 HD12 ' N ' ' D' ' 16' ' ' ILE . 0.6 OUTLIER -121.28 112.16 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 106.256 -1.757 . . . . 72.51 106.256 -177.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -159.66 142.07 13.6 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 123.703 0.627 . . . . 72.13 111.704 -164.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.7 p -79.86 115.05 19.23 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.716 -1.129 . . . . 72.22 109.32 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -89.31 -28.83 19.59 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.007 -0.542 . . . . 72.5 110.365 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.5 t70 -147.08 133.49 19.64 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.324 -0.853 . . . . 65.41 109.582 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.579 HD13 ' HE3' ' C' ' 117' ' ' MET . 88.4 mt -133.5 139.5 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 124.688 1.195 . . . . 70.03 108.089 173.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -146.45 118.69 8.34 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.908 0.883 . . . . 71.14 109.289 175.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.7 t80 -124.93 131.96 53.35 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 107.247 -1.39 . . . . 73.05 107.247 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -137.97 118.63 14.01 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.529 1.132 . . . . 75.24 108.803 -173.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.417 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -115.96 89.87 26.02 Favored Pre-proline 0 CA--C 1.548 0.874 0 N-CA-C 108.722 -0.844 . . . . 70.22 108.722 175.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.87 -63.87 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.333 2.688 . . . . 70.25 113.134 -170.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.451 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 10.2 m-80 -98.35 41.07 1.15 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 107.607 -1.257 . . . . 72.15 107.607 -176.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' D' ' 31' ' ' VAL . . . -56.75 -53.0 69.37 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 114.154 1.168 . . . . 62.14 114.154 -168.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.01 -8.45 15.47 Favored 'Trans proline' 0 C--N 1.38 2.232 0 CA-C-N 122.394 1.891 . . . . 71.01 113.072 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.486 ' HA ' HE21 ' D' ' 33' ' ' GLN . 6.3 t-160 -74.27 -34.66 63.64 Favored 'General case' 0 CA--C 1.548 0.865 0 N-CA-C 108.288 -1.004 . . . . 72.33 108.288 168.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.526 HG11 ' HE1' ' D' ' 123' ' ' PHE . 53.2 t -66.99 -26.63 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.512 1.125 . . . . 55.01 111.421 174.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.435 ' CD1' ' HD2' ' C' ' 15' ' ' ARG . 49.6 t80 -60.87 -34.53 74.75 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.032 0.444 . . . . 74.45 110.419 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.486 HE21 ' HA ' ' D' ' 30' ' ' HIS . 40.7 mt-30 -82.74 -33.2 27.54 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.462 -0.79 . . . . 65.03 110.289 176.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -91.94 90.86 7.61 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.737 0.815 . . . . 54.22 109.876 -173.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.85 59.27 3.62 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 124.39 1.076 . . . . 60.1 112.514 -167.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.438 ' HB2' HD22 ' D' ' 68' ' ' LEU . 24.9 m95 -126.47 174.1 8.89 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.858 -0.793 . . . . 73.44 108.858 -177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.822 ' HB2' ' HA ' ' H' ' 193' ' ' TYR . 8.2 tp-100 -85.17 118.13 70.19 Favored Pre-proline 0 N--CA 1.477 0.885 0 O-C-N 122.128 -0.358 . . . . 43.22 110.236 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.74 109.31 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.248 1.966 . . . . 74.45 110.633 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 52.2 mt-10 -62.51 111.85 2.22 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 123.953 0.783 . . . . 74.53 109.037 -179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.516 HG21 HD13 ' D' ' 126' ' ' LEU . 3.7 m -98.06 107.28 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 124.427 1.091 . . . . 60.31 109.267 -172.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -105.33 148.02 27.51 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.571 -0.74 . . . . 72.34 109.878 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -119.43 129.96 55.03 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.708 -0.678 . . . . 72.45 110.362 -172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 28.1 t70 -119.11 128.26 54.14 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.376 -0.972 . . . . 71.01 108.376 173.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 61.8 tp -97.46 132.89 42.73 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.488 0.715 . . . . 73.34 110.03 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.451 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -146.96 156.3 42.95 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.939 -1.134 . . . . 62.14 107.939 169.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -144.57 164.39 31.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.218 0.533 . . . . 40.53 109.873 177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.05 163.86 37.05 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.942 1.297 . . . . 70.12 108.277 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 13.1 p -167.13 153.47 8.17 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.903 0.382 . . . . 63.24 111.772 178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 73.8 p -158.86 141.44 14.21 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.133 0.973 . . . . 71.31 109.716 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -81.75 124.06 29.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.716 0.806 . . . . 74.42 110.856 -178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.454 HD11 ' HB2' ' D' ' 57' ' ' GLU . 28.7 mt -98.22 -35.71 10.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.589 0.756 . . . . 73.5 110.792 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.37 -172.07 4.03 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.226 0.61 . . . . 73.43 111.085 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.53 112.56 4.18 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.288 1.035 . . . . 75.23 110.732 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.68 ' HA ' HD21 ' H' ' 173' ' ' LEU . 27.5 m-20 69.19 3.63 4.19 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 125.944 1.698 . . . . 71.12 112.847 -174.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.2 t -109.14 118.27 56.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.297 0.639 . . . . 52.41 110.438 -173.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -129.81 130.26 45.09 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.092 1.357 . . . . 73.23 108.354 -176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' D' ' 51' ' ' LEU . 14.7 tt0 -87.08 111.87 21.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.702 -1.221 . . . . 75.32 107.702 169.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 75.2 t -100.09 121.01 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 106.961 -1.496 . . . . 72.41 106.961 173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.548 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 44.3 t -99.58 132.55 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.788 0.835 . . . . 75.12 109.231 176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.4 OUTLIER -105.06 128.0 53.13 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 107.646 -1.242 . . . . 73.1 107.646 176.075 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 31.8 ttm-85 -107.49 99.99 9.45 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.572 0.749 . . . . 74.25 109.138 173.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.24 122.49 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.425 -0.954 . . . . 61.11 108.425 170.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 28.8 m -114.9 142.37 46.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.638 -0.71 . . . . 55.14 109.61 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.786 HG21 HG21 ' D' ' 114' ' ' ILE . 81.1 t -130.78 127.45 61.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 C-N-CA 125.127 1.371 . . . . 65.02 108.637 -178.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 4.8 m -123.7 94.76 4.33 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.086 -1.079 . . . . 54.44 108.086 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -98.06 127.37 43.96 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.661 -0.866 . . . . 72.22 108.661 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.484 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.4 m -140.63 139.52 34.87 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.392 0.615 . . . . 73.23 111.298 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' D' ' 36' ' ' TRP . 36.1 mt -110.52 116.98 32.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.284 1.434 . . . . 71.13 109.228 172.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.68 -129.05 44.15 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 120.14 -0.256 . . . . 41.43 112.894 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -89.81 4.06 50.97 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.504 0.721 . . . . 75.01 112.126 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' D' ' 68' ' ' LEU . 11.8 pt-20 -124.15 154.48 39.99 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.129 0.572 . . . . 71.33 110.174 -173.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 33.9 m -74.47 136.13 42.27 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 109.286 -0.635 . . . . 71.13 109.286 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.484 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.46 -57.43 3.15 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.829 -1.175 . . . . 74.34 107.829 175.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' D' ' 118' ' ' VAL . 49.0 p90 -161.3 149.3 15.44 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 114.696 -1.138 . . . . 73.35 110.202 169.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.9 mt -100.75 150.63 22.58 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.505 -0.924 . . . . 74.24 108.505 166.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.695 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.4 t -158.1 132.54 8.23 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 123.34 0.4 . . . . 65.24 109.922 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.87 132.81 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.553 0.741 . . . . 74.21 109.25 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 82.9 t -132.19 119.76 41.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 123.701 0.801 . . . . 72.11 109.687 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.8 mt-30 -89.88 88.2 7.24 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.729 0.812 . . . . 74.23 109.491 171.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.87 102.33 9.99 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 114.466 -1.243 . . . . 63.01 109.153 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.89 145.27 18.59 Favored Glycine 0 N--CA 1.463 0.468 0 N-CA-C 111.438 -0.665 . . . . 70.14 111.438 176.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.569 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.99 130.62 4.75 Favored Glycine 0 C--N 1.335 0.481 0 N-CA-C 110.809 -0.916 . . . . 73.41 110.809 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.41 ' O ' HD12 ' D' ' 13' ' ' ILE . 56.1 mt -90.13 115.78 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 N-CA-C 108.677 -0.86 . . . . 74.44 108.677 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -117.58 152.42 35.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.431 1.092 . . . . 53.45 109.71 -175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.7 m -116.23 95.02 4.88 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.033 -1.099 . . . . 72.14 108.033 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.479 HD12 ' H ' ' D' ' 86' ' ' ILE . 0.1 OUTLIER -110.3 138.71 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.468 0.707 . . . . 72.03 110.038 -171.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.26 169.76 13.89 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.786 1.235 . . . . 53.13 109.157 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.21 21.76 56.18 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-N 116.56 -0.291 . . . . 70.15 112.397 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.459 HD11 HD12 ' H' ' 173' ' ' LEU . 2.4 pp -125.01 161.04 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.485 1.114 . . . . 65.1 110.404 -176.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.561 ' HG3' ' HB ' ' B' ' 149' ' ' THR . 6.6 pt-20 -166.63 165.98 16.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.59 0.756 . . . . 74.53 110.467 175.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' D' ' 94' ' ' MET . . . 60.35 -134.54 50.21 Favored Glycine 0 C--N 1.345 1.072 0 O-C-N 124.026 0.829 . . . . 74.12 114.178 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -79.39 -14.11 59.17 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.012 0.925 . . . . 55.13 112.527 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.722 ' HB2' ' HA ' ' B' ' 149' ' ' THR . 27.3 tp60 -63.89 -34.17 77.36 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.459 0.704 . . . . 72.43 111.564 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' D' ' 91' ' ' GLY . 22.3 ptp -71.38 -28.04 63.76 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 123.521 0.513 . . . . 63.31 111.038 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.36 -35.81 68.62 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.568 0.747 . . . . 42.01 110.002 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 82.1 t60 -72.8 -32.9 65.88 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.058 -0.974 . . . . 63.41 110.542 175.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.82 -50.15 32.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.968 0.507 . . . . 60.14 110.517 -178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' H' ' 174' ' ' MET . 7.8 tt -72.03 -46.02 58.65 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.105 0.562 . . . . 75.35 110.182 -178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.55 84.56 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.378 -0.679 . . . . 54.4 114.344 -172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' D' ' 133' ' ' PHE . . . -148.92 -63.75 0.23 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.881 0.84 . . . . 54.41 112.071 -178.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -68.68 -44.54 73.78 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 113.474 0.916 . . . . 73.14 113.474 -165.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 56.1 m -67.22 -45.26 50.44 Favored Pre-proline 0 CA--C 1.567 1.612 0 CA-C-O 118.971 -0.538 . . . . 61.44 111.772 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 84.7 Cg_exo -53.7 -32.91 67.44 Favored 'Trans proline' 0 C--N 1.394 2.921 0 C-N-CA 122.931 2.421 . . . . 62.32 114.347 168.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -60.64 -28.12 68.31 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 122.786 0.434 . . . . 73.3 112.107 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.22 -42.13 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-O 121.604 0.716 . . . . 65.34 110.041 174.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.569 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.1 mt -76.33 -21.68 55.88 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 114.817 -1.083 . . . . 61.12 111.999 -173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -62.83 -42.98 81.5 Favored Pre-proline 0 CA--C 1.56 1.357 0 CA-C-O 117.693 -1.146 . . . . 74.12 113.623 -171.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.73 -43.85 44.0 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.061 1.841 . . . . 63.35 113.492 169.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.44 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 82.6 m-85 -74.22 -39.06 63.36 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.943 0.897 . . . . 64.12 112.044 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.95 80.54 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.604 0.761 . . . . 42.13 109.95 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.592 ' NH2' HG23 ' B' ' 105' ' ' ILE . 36.9 ttp180 -60.94 -48.82 80.04 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 124.353 1.033 . . . . 71.23 110.055 174.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 5.1 tm-20 -57.62 -48.9 78.15 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.063 0.945 . . . . 62.44 111.956 -173.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.9 t -58.64 -41.3 85.68 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 123.939 0.774 . . . . 75.15 111.147 -177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.786 HG21 HG21 ' D' ' 64' ' ' VAL . 65.1 mt -63.37 -56.28 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.021 0.928 . . . . 74.44 109.701 174.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 82.4 m -51.82 -40.1 59.88 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.095 1.758 . . . . 71.04 111.853 -175.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.3 t -69.64 -45.04 69.35 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 114.531 -1.213 . . . . 72.04 110.226 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.2 mtm -67.0 -31.67 72.39 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.947 0.499 . . . . 71.41 111.847 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.496 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.7 t -62.14 -49.12 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.688 0.795 . . . . 53.13 109.677 175.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -72.79 -28.88 62.85 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 115.733 -0.667 . . . . 62.34 111.139 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -71.74 -25.22 61.97 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.518 0.727 . . . . 74.14 110.056 174.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.9 11.43 70.58 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.791 0.682 . . . . 42.35 112.828 175.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.546 HG23 ' HB3' ' C' ' 17' ' ' TYR . 76.8 p 61.25 14.94 5.99 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 126.331 1.853 . . . . 75.22 113.661 -178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.526 ' HE1' HG11 ' D' ' 31' ' ' VAL . 62.0 m-85 -87.27 159.57 50.36 Favored Pre-proline 0 CA--C 1.56 1.335 0 C-N-CA 123.97 0.908 . . . . 63.32 109.804 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.35 127.53 20.27 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.928 2.419 . . . . 64.53 111.961 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -52.28 132.29 33.8 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.097 0.873 . . . . 73.11 111.318 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.516 HD13 HG21 ' D' ' 40' ' ' VAL . 42.4 tp -108.3 115.52 30.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.521 0.728 . . . . 51.33 110.122 -175.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -113.41 100.78 8.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.364 0.666 . . . . 43.31 109.701 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 68.1 mt -74.49 148.51 40.93 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-N 114.928 -1.033 . . . . 62.44 110.138 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' G' ' 204' ' ' ILE . . . -60.99 125.42 83.57 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 123.787 0.68 . . . . 73.43 110.523 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -68.68 99.07 0.61 Allowed 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 122.44 2.093 . . . . 63.04 109.271 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.8 m -108.07 119.45 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 115.107 -0.951 . . . . 31.24 110.95 -167.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -103.47 107.2 17.94 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.649 -1.241 . . . . 63.31 107.649 167.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.586 ' HB2' ' HB1' ' D' ' 100' ' ' ALA . 13.3 m-85 -67.74 -21.31 65.28 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.48 0.712 . . . . 71.54 111.893 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.67 -23.92 61.75 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 73.34 111.05 178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.67 -33.25 69.91 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.82 0.448 . . . . 74.23 111.873 176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.616 HD13 ' HD2' ' H' ' 185' ' ' PRO . 52.3 mt -84.01 -17.5 40.24 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.9 0.88 . . . . 55.14 111.81 178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.448 ' HE2' ' HA2' ' B' ' 146' ' ' GLY . 82.4 t80 -76.38 -47.26 23.93 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.826 0.85 . . . . 74.53 109.629 173.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.615 ' HG2' ' HB3' ' B' ' 145' ' ' ALA . 78.5 mtm -62.47 -42.44 99.48 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.276 -0.874 . . . . 63.11 110.131 174.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' D' ' 143' ' ' GLN . 18.6 t30 -61.4 -45.34 94.73 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 124.032 0.833 . . . . 65.32 110.436 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -47.54 -48.88 27.49 Favored 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.194 0.934 . . . . 64.34 111.238 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.589 HD12 ' HB1' ' B' ' 145' ' ' ALA . 81.3 mt -71.4 -47.39 56.39 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.081 -0.963 . . . . 71.14 111.79 -176.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -84.4 2.91 38.44 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.669 0.618 . . . . 62.21 112.669 -173.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.556 ' NE2' ' H ' ' B' ' 4' ' ' GLN . 0.0 OUTLIER -115.2 93.1 4.15 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.937 -1.505 . . . . 54.24 106.937 -175.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -158.9 13.84 0.16 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.66 -1.155 . . . . 75.22 110.211 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.23 105.85 3.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.671 0.789 . . . . 71.51 109.65 -177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -163.81 97.46 0.15 Allowed Glycine 0 C--N 1.343 0.962 0 N-CA-C 111.657 -0.577 . . . . 64.02 111.657 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.34 96.65 9.61 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.148 -0.686 . . . . 73.25 109.148 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.61 63.12 4.5 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.325 -0.398 . . . . 70.31 112.352 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 41.1 p -71.58 94.71 1.34 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.898 0.879 . . . . 50.24 109.422 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.06 112.71 7.59 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.786 -0.82 . . . . 73.15 108.786 -176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -84.71 -165.5 1.2 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.311 1.044 . . . . 63.34 111.609 -176.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -137.85 168.16 20.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.068 0.947 . . . . 71.11 109.753 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -78.85 153.95 30.19 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.343 1.057 . . . . 72.43 109.888 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -72.17 78.41 0.96 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.931 -0.766 . . . . 73.35 108.931 170.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 C-N-CA 124.767 1.227 . . . . 74.34 108.652 -178.085 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.207 -0.664 . . . . 74.3 109.207 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.06 82.56 0.75 Allowed Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.552 -0.619 . . . . 63.4 111.552 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -120.16 115.98 24.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.319 1.048 . . . . 74.22 110.574 -172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 30.4 t -113.47 89.94 3.22 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.758 -0.83 . . . . 74.43 108.758 172.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . 0.573 ' H ' ' HB2' ' C' ' 50' ' ' GLN . . . 65.41 178.43 0.2 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.569 1.148 . . . . 30.42 112.301 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.487 HD12 ' HG2' ' E' ' 174' ' ' MET . 2.4 pp -114.96 7.0 15.49 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 122.965 0.506 . . . . 72.1 112.152 178.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.487 ' HG2' HD12 ' E' ' 173' ' ' LEU . 18.2 ptt? -168.56 -4.98 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.504 0.722 . . . . 71.24 111.842 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.423 ' CE2' HD11 ' C' ' 98' ' ' LEU . 55.2 t80 -120.78 151.66 39.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.564 0.746 . . . . 75.32 110.884 -174.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -163.08 147.59 11.3 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.763 1.225 . . . . 71.52 108.404 172.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.15 106.5 2.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.838 0.855 . . . . 61.33 109.771 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -127.12 137.38 52.98 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.199 1.0 . . . . 61.3 110.693 -176.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 67.98 162.57 0.14 Allowed Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 125.129 1.372 . . . . 71.34 113.774 169.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . 0.412 ' HD3' ' CE1' ' A' ' 152' ' ' HIS . 57.0 Cg_endo -70.62 120.58 7.21 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 121.989 1.793 . . . . 71.11 111.117 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . 0.54 ' HE1' ' HB1' ' C' ' 95' ' ' ALA . 99.1 m-85 -76.72 -180.0 5.7 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.583 -0.735 . . . . 74.32 110.031 176.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.96 155.64 30.34 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 122.868 0.467 . . . . 72.42 110.0 -177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 6.9 t -50.46 129.19 21.62 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.95 0.9 . . . . 72.51 111.869 -174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . 0.589 ' HE1' ' HB3' ' C' ' 44' ' ' LEU . 19.4 t-105 -112.4 91.1 15.69 Favored Pre-proline 0 CA--C 1.549 0.916 0 N-CA-C 108.282 -1.007 . . . . 74.33 108.282 -174.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.06 110.33 2.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.737 2.291 . . . . 54.04 111.304 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 94.5 mt -79.07 68.42 5.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.682 0.793 . . . . 73.41 109.652 172.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 2.1 tt 34.18 -71.93 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.666 0 C-N-CA 127.809 2.444 . . . . 74.41 116.614 173.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . 79.28 99.91 0.06 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.275 1.83 . . . . 61.24 110.482 -169.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . 0.566 ' HB3' HD13 ' C' ' 128' ' ' LEU . . . -136.2 36.88 2.76 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.367 1.067 . . . . 74.42 109.807 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.54 145.54 48.29 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.739 1.215 . . . . 71.24 111.645 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . 0.46 ' H ' ' HA ' ' C' ' 39' ' ' GLU . . . 67.86 60.3 5.82 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 123.738 0.649 . . . . 74.32 113.511 177.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.07 76.21 0.59 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 111.445 -0.662 . . . . 73.4 111.445 173.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -88.53 106.44 18.29 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.571 1.148 . . . . 74.33 110.205 -169.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.99 -171.59 3.49 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.139 0.975 . . . . 55.42 110.314 -175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 66.7 173.63 0.25 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.705 1.202 . . . . 71.52 113.468 177.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -151.9 73.9 1.08 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 108.153 -1.055 . . . . 63.35 108.153 -178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -86.18 26.29 1.05 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.874 0.87 . . . . 62.0 111.27 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -61.27 -36.41 79.97 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.184 0.594 . . . . 74.11 110.931 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -136.91 -61.39 0.67 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.599 0.759 . . . . 53.31 109.549 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -167.11 105.97 0.25 Allowed Glycine 0 C--N 1.351 1.382 0 CA-C-N 116.192 -0.458 . . . . 74.02 112.432 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -73.95 111.69 9.36 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 107.239 -1.393 . . . . 74.03 107.239 173.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . 0.431 ' HB3' HG13 ' F' ' 187' ' ' ILE . 42.4 m-85 69.74 92.74 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 125.246 1.418 . . . . 75.14 109.243 -169.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.26 91.19 1.29 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.018 0.527 . . . . 44.01 110.774 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.478 HD13 HG23 ' D' ' 13' ' ' ILE . 47.3 mt -79.63 82.18 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 108.526 -0.916 . . . . 72.54 108.526 175.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 42.2 tttm -78.28 -44.98 23.96 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.633 -1.167 . . . . 72.34 110.548 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -111.31 120.92 43.86 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.197 -0.911 . . . . 73.05 109.329 -176.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' B' ' 136' ' ' LEU . 9.6 m . . . . . 0 CA--C 1.575 1.912 0 C-N-CA 126.477 1.911 . . . . 52.04 114.563 172.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 64.0 mttm . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.1 99.89 0.17 Allowed Glycine 0 C--N 1.348 1.198 0 N-CA-C 110.854 -0.899 . . . . 35.34 110.854 -178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.85 106.69 9.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.721 0.808 . . . . 60.11 110.038 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 49.6 m -143.8 -163.25 1.62 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.958 1.303 . . . . 72.25 108.16 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.69 -70.55 0.25 Allowed 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.051 0.387 . . . . 44.32 110.171 172.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -164.29 40.89 0.09 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.248 0.547 . . . . 63.11 111.763 -177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.496 ' N ' ' SD ' ' F' ' 174' ' ' MET . 0.0 OUTLIER -71.0 87.93 0.75 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.585 0.754 . . . . 54.22 112.181 -173.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 23.6 p90 43.13 -165.34 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 126.84 2.056 . . . . 73.31 115.792 165.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -166.2 -36.0 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.389 1.075 . . . . 74.14 109.826 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp 57.9 67.43 0.96 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.882 1.273 . . . . 72.34 110.329 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -133.89 11.92 3.98 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 114.854 -1.066 . . . . 34.25 109.267 175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -168.81 134.88 1.47 Allowed Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 123.793 0.837 . . . . 54.25 109.939 -170.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.82 89.36 0.76 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.619 2.213 . . . . 63.35 111.393 176.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.3 118.2 29.61 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 109.167 -0.679 . . . . 74.23 109.167 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 68.86 144.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.327 1.451 . . . . 73.33 111.705 -169.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 17.6 p -138.86 103.02 4.7 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.874 0.87 . . . . 74.41 109.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -77.02 130.82 74.41 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 123.754 0.822 . . . . 74.01 111.167 176.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.59 132.19 9.79 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.085 1.857 . . . . 75.44 111.974 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -90.12 -172.12 3.37 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.261 0.624 . . . . 71.31 110.608 176.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.557 ' H ' HD13 ' F' ' 187' ' ' ILE . 0.2 OUTLIER -117.26 154.75 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 124.258 1.023 . . . . 75.12 110.072 -179.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -95.75 169.83 9.74 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 123.694 0.798 . . . . 40.2 109.924 173.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -160.49 143.98 13.63 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.027 -0.533 . . . . 43.24 110.776 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -108.73 165.2 11.73 Favored 'General case' 0 C--O 1.248 1.0 0 C-N-CA 124.455 1.102 . . . . 44.44 108.339 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' B' ' 40' ' ' VAL . . . -65.6 -37.88 94.08 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.395 0.435 . . . . 64.45 112.847 177.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . 104.08 -72.34 0.26 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.57 -0.612 . . . . 71.24 111.57 179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -140.0 140.27 36.22 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.921 0.888 . . . . 71.15 109.299 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -66.46 154.72 39.51 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.553 1.141 . . . . 74.25 113.73 -172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.458 ' N ' ' HB2' ' B' ' 37' ' ' GLN . 17.5 m-85 -53.51 136.54 38.13 Favored 'General case' 0 C--N 1.376 1.748 0 C-N-CA 124.242 1.017 . . . . 74.31 109.722 173.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -127.54 127.2 43.54 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.749 -0.463 . . . . 74.34 109.749 176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -82.54 -3.33 55.78 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.035 1.334 . . . . 70.14 109.758 172.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -81.75 96.72 7.66 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 106.549 -1.649 . . . . 65.13 106.549 167.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 70.42 167.22 0.3 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.969 1.308 . . . . 72.13 110.78 -165.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . 0.487 ' H ' ' HA ' ' E' ' 189' ' ' ALA . . . -81.46 62.77 4.45 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.901 -0.59 . . . . 74.34 112.328 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -79.51 79.74 5.95 Favored 'General case' 0 C--O 1.246 0.915 0 N-CA-C 108.193 -1.04 . . . . 75.21 108.193 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 75.45 -42.62 0.48 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 125.592 1.557 . . . . 74.25 111.499 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -80.59 -174.54 4.74 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 125.122 1.369 . . . . 54.22 109.834 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 15' ' ' ARG . 13.6 tt -122.84 121.19 62.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.048 0.939 . . . . 51.13 109.453 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 -55.31 3.82 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.432 -0.804 . . . . 65.04 110.612 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -151.14 166.07 31.93 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.413 1.085 . . . . 65.3 108.827 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.473 ' HB ' ' NE2' ' A' ' 12' ' ' GLN . 21.3 t . . . . . 0 C--O 1.252 1.232 0 N-CA-C 107.322 -1.362 . . . . 71.34 107.322 171.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 29.0 tptp . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.117 -0.327 . . . . 44.34 110.117 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 149.45 -46.96 0.64 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.548 -1.021 . . . . 53.44 110.548 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . 0.561 ' HB3' ' HB2' ' G' ' 178' ' ' GLN . 26.7 tptp 47.88 68.82 0.6 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.44 1.496 . . . . 74.33 110.521 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' G' ' 177' ' ' LEU . 49.3 p -152.49 157.95 41.88 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.184 -0.916 . . . . 74.44 111.735 -170.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -166.99 -174.33 2.64 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 124.932 1.293 . . . . 75.33 108.06 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.709 ' HB3' HD11 ' A' ' 89' ' ' ILE . 1.3 pt? -58.62 170.55 0.76 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.676 0.79 . . . . 73.21 112.361 174.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 32.1 mmt 74.3 14.61 3.68 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.504 1.522 . . . . 75.13 111.302 -173.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.412 ' CD1' HD21 ' A' ' 98' ' ' LEU . 29.8 t80 63.8 106.41 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.272 1.429 . . . . 70.21 111.075 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -132.73 -87.22 0.44 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.317 -0.623 . . . . 54.31 109.317 174.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . 0.44 ' HA ' ' HB3' ' G' ' 171' ' ' SER . 6.9 mp 57.9 89.94 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.931 1.292 . . . . 73.43 112.194 176.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' G' ' 170' ' ' LYS . 28.5 mm-40 -91.94 -64.25 1.14 Allowed 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.054 0.454 . . . . 73.4 110.374 177.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -94.34 132.56 28.79 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.835 0.854 . . . . 75.34 110.325 -172.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.53 135.92 63.95 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.027 2.485 . . . . 72.1 111.583 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -146.11 167.15 24.12 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.265 0.626 . . . . 74.43 110.518 -176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . 0.652 ' HE2' ' HA ' ' A' ' 134' ' ' ASP . 9.7 t80 72.38 27.81 2.41 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.558 1.543 . . . . 75.13 110.646 174.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 90.8 m 76.91 -49.33 0.55 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.135 1.774 . . . . 74.11 112.598 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . 0.406 ' HZ3' ' HA ' ' A' ' 100' ' ' ALA . 75.7 t-105 58.66 69.11 1.5 Allowed Pre-proline 0 CA--C 1.562 1.43 0 C-N-CA 124.716 1.206 . . . . 74.14 110.703 -177.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -72.55 139.64 31.6 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 123.162 2.575 . . . . 72.32 112.69 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 64.9 mt -142.88 141.47 31.54 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.709 0.804 . . . . 75.23 111.083 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . 0.578 HD13 ' H ' ' G' ' 187' ' ' ILE . 0.2 OUTLIER -84.01 165.05 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 123.726 0.81 . . . . 72.54 110.65 170.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -110.82 128.33 55.73 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.833 0.853 . . . . 35.33 109.284 174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -80.46 149.21 30.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.283 0.633 . . . . 54.24 110.291 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -135.15 -86.75 0.38 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.433 0.693 . . . . 71.25 109.554 -176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 146.2 -173.32 26.53 Favored Glycine 0 C--N 1.35 1.342 0 N-CA-C 112.044 -0.422 . . . . 63.34 112.044 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' H' ' 199' ' ' ASN . . . -152.34 125.86 1.91 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.526 -0.63 . . . . 55.42 111.526 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -74.05 89.44 1.95 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.581 0.705 . . . . 71.12 109.324 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . 0.526 ' H ' ' HD1' ' A' ' 36' ' ' TRP . . . -102.86 -166.01 1.23 Allowed 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.714 1.205 . . . . 75.42 108.782 171.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.4 ' HA ' ' HB1' ' H' ' 194' ' ' ALA . 18.3 m-85 55.79 78.55 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.877 0.871 . . . . 72.11 110.725 -173.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . 0.449 ' H ' ' HA ' ' H' ' 194' ' ' ALA . 33.3 tttp -70.91 93.79 1.01 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.818 -1.179 . . . . 74.02 107.818 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -74.53 75.88 1.97 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.719 0.808 . . . . 72.44 110.787 -176.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -99.72 39.1 1.35 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.389 1.076 . . . . 74.53 109.902 178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 68.06 110.08 0.05 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.95 1.3 . . . . 61.21 109.297 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -69.73 -127.79 0.05 OUTLIER Glycine 0 C--N 1.352 1.427 0 CA-C-O 119.363 -0.687 . . . . 44.41 112.095 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 60.1 114.43 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.236 1.014 . . . . 70.52 111.281 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . 0.637 ' HB3' HG23 ' G' ' 204' ' ' ILE . 24.5 m-85 -59.7 -29.11 67.88 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.498 0.719 . . . . 72.44 112.038 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 14.1 t70 57.54 38.59 28.01 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.773 1.273 . . . . 63.43 110.081 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . 0.637 HG23 ' HB3' ' G' ' 202' ' ' TYR . 4.5 pt -83.44 40.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-N 113.912 -1.494 . . . . 71.43 111.113 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' H' ' 187' ' ' ILE . 45.5 mtpt 59.71 -171.13 0.13 Allowed 'General case' 0 C--N 1.362 1.111 0 C-N-CA 124.493 1.117 . . . . 73.4 111.627 -174.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -92.58 -84.32 0.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.933 -1.136 . . . . 74.43 107.933 164.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . 0.434 HG12 HD11 ' D' ' 136' ' ' LEU . 36.2 t . . . . . 0 C--O 1.259 1.604 0 N-CA-C 107.911 -1.144 . . . . 61.1 107.911 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 110.229 -0.286 . . . . 71.5 110.229 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 69.91 -133.25 24.67 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 124.105 0.878 . . . . 62.31 111.828 -176.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -104.65 -9.41 18.24 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.88 0.872 . . . . 73.24 111.371 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 36.6 m -80.87 78.42 7.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.23 0.612 . . . . 51.51 110.121 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.602 ' HB2' HE22 ' B' ' 153' ' ' GLN . . . -96.45 78.86 3.04 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.023 -0.535 . . . . 72.42 110.222 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.68 HD21 ' HA ' ' D' ' 54' ' ' ASP . 15.8 tp -168.86 86.06 0.17 Allowed 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 105.929 -1.878 . . . . 70.12 105.929 173.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . 0.45 ' HB3' HD12 ' D' ' 98' ' ' LEU . 3.0 mpp? 63.73 176.27 0.17 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 124.086 0.954 . . . . 74.41 112.27 -171.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 69.44 0.41 2.9 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 125.264 1.425 . . . . 65.23 113.3 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -88.83 54.39 3.0 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.995 0.902 . . . . 73.43 109.973 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.48 101.75 14.42 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 107.357 -1.349 . . . . 71.44 107.357 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -79.81 -105.6 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.353 -0.61 . . . . 73.33 109.353 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . 0.458 ' H ' ' HD2' ' H' ' 180' ' ' PRO . 47.6 mt-10 -151.59 -54.75 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.615 1.166 . . . . 63.24 109.428 175.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' H' ' 179' ' ' GLU . 96.3 Cg_endo -79.07 99.19 1.24 Allowed 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 121.437 1.425 . . . . 74.51 112.935 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -155.23 136.85 14.27 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.277 -1.008 . . . . 73.21 108.277 173.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -65.78 126.23 27.81 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.192 0.597 . . . . 71.03 111.074 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.9 t -91.67 -173.25 3.48 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.609 0.764 . . . . 72.34 110.588 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -115.51 152.18 46.83 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 124.192 0.997 . . . . 75.5 109.395 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . 0.616 ' HD2' HD13 ' D' ' 136' ' ' LEU . 72.7 Cg_endo -74.37 138.16 24.31 Favored 'Trans proline' 0 C--N 1.37 1.678 0 C-N-CA 122.377 2.052 . . . . 74.34 111.885 166.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 55.7 mt -83.65 169.34 15.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.404 0.681 . . . . 75.31 110.605 175.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.428 ' HA ' ' HD3' ' G' ' 205' ' ' LYS . 37.5 pt -82.92 179.97 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.9 0.88 . . . . 64.21 111.39 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -98.68 -168.64 1.67 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.807 0.843 . . . . 73.35 109.423 169.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -169.53 125.98 0.88 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.115 0.566 . . . . 73.42 111.26 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -165.25 152.32 10.64 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.201 1.0 . . . . 65.2 109.538 174.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . -110.57 160.13 13.48 Favored Glycine 0 C--N 1.343 0.928 0 N-CA-C 111.313 -0.715 . . . . 73.51 111.313 175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -82.41 31.26 2.96 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 114.292 0.477 . . . . 73.25 114.292 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.822 ' HA ' ' HB2' ' D' ' 37' ' ' GLN . 98.5 m-85 62.88 14.61 7.58 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.397 1.479 . . . . 74.51 113.811 178.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . 0.449 ' HA ' ' H ' ' G' ' 196' ' ' LYS . . . -74.22 103.47 4.65 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.719 0.808 . . . . 74.21 110.994 -178.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -151.79 -83.99 0.08 Allowed 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 109.538 -0.542 . . . . 75.12 109.538 178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . 0.424 ' HG3' ' HB2' ' G' ' 196' ' ' LYS . 22.1 mtpp 72.18 -64.51 0.39 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 126.131 1.772 . . . . 73.0 115.344 170.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 57.8 21.13 7.16 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 123.455 0.702 . . . . 73.21 111.449 -168.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.22 83.54 6.8 Favored 'General case' 0 C--N 1.347 0.469 0 N-CA-C 109.249 -0.649 . . . . 61.34 109.249 -174.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . 0.447 ' HA ' ' HA2' ' G' ' 192' ' ' GLY . 94.5 m-20 -69.57 121.73 17.67 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-N 115.181 -0.918 . . . . 63.34 109.123 175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.93 -60.24 9.39 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.284 0.99 . . . . 74.43 111.532 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -124.71 -74.09 0.62 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.401 -1.703 . . . . 54.01 106.401 167.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 16.6 t80 53.37 24.19 3.74 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.386 1.474 . . . . 64.11 112.07 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.46 80.02 5.87 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 122.58 1.181 . . . . 54.44 109.166 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 129' ' ' ALA . 6.6 pt -74.97 81.46 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 CA-C-N 114.183 -1.371 . . . . 75.24 110.988 -177.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -102.1 142.37 33.47 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 114.489 -1.232 . . . . 71.25 110.441 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -173.41 -60.14 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.875 1.359 . . . . 72.35 108.05 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.42 ' HA ' HD13 ' A' ' 136' ' ' LEU . 46.8 t . . . . . 0 C--O 1.252 1.236 0 CA-C-N 114.297 -1.319 . . . . 71.35 107.953 175.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 108.798 -0.815 . . . . 74.21 108.798 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.2 m -77.27 108.66 10.55 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.954 0.901 . . . . 75.23 110.501 -177.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -142.12 96.81 3.02 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.261 -1.385 . . . . 74.2 107.261 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -104.64 125.1 50.44 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.751 0.821 . . . . 70.21 110.911 -171.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -91.16 87.01 6.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.858 -0.793 . . . . 70.34 108.858 170.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -140.55 106.9 5.26 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.81 -1.181 . . . . 74.4 107.81 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.483 HG22 ' H ' ' C' ' 143' ' ' GLN . 6.6 m -124.02 5.25 8.63 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 109.244 -0.65 . . . . 71.34 109.244 173.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' C' ' 145' ' ' ALA . 6.6 mp0 -92.47 36.28 1.0 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.345 1.058 . . . . 73.0 110.953 -171.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -82.88 177.09 8.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.488 0.715 . . . . 71.23 109.82 174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.429 ' HA ' HE22 ' C' ' 142' ' ' GLN . 32.4 m -147.45 101.27 3.35 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.868 -1.53 . . . . 64.34 106.868 162.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.47 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 32.5 t80 -136.43 128.58 29.77 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.049 0.54 . . . . 72.51 109.845 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -155.6 134.56 12.08 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.481 0.488 . . . . 74.12 110.338 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' C' ' 135' ' ' ALA . 1.8 mp -79.69 116.22 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 107.917 -1.142 . . . . 72.14 107.917 172.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -77.53 -39.36 46.33 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.674 -0.491 . . . . 73.54 109.674 171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.8 ttt85 -169.51 136.89 1.73 Allowed 'General case' 0 N--CA 1.479 1.009 0 O-C-N 123.541 0.526 . . . . 72.33 110.921 -176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.37 130.77 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.809 -1.182 . . . . 62.5 107.809 166.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 3.2 p90 -168.23 151.65 5.77 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.923 0.765 . . . . 73.02 110.77 -173.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -80.71 117.62 21.55 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 108.612 -0.884 . . . . 54.44 108.612 169.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 41.4 mtpt -76.26 -33.47 59.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.446 0.641 . . . . 73.54 109.495 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.2 t70 -150.85 140.78 21.96 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 114.229 -1.35 . . . . 72.35 109.797 -172.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 80.0 mt -137.69 142.7 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.958 1.303 . . . . 65.13 108.022 176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 m -152.34 112.73 4.09 Favored 'General case' 0 C--O 1.219 -0.517 0 C-N-CA 123.621 0.769 . . . . 65.41 110.514 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 73.5 t80 -109.98 127.72 54.96 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 105.843 -1.91 . . . . 53.53 105.843 164.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.9 143.19 51.35 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.787 -0.82 . . . . 74.42 108.787 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -147.86 73.48 11.34 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 106.595 -1.631 . . . . 34.43 106.595 171.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.7 -28.15 44.3 Favored 'Trans proline' 0 C--N 1.382 2.333 0 C-N-CA 122.86 2.373 . . . . 73.35 111.435 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -111.04 32.79 5.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.285 1.034 . . . . 75.21 109.017 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -57.52 -52.4 74.56 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 118.357 -0.83 . . . . 61.45 111.947 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 53.1 Cg_exo -53.52 -33.4 67.86 Favored 'Trans proline' 0 C--N 1.403 3.417 0 C-N-CA 122.119 1.879 . . . . 51.33 113.565 173.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 10.4 m170 -67.61 -35.29 78.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.542 0.737 . . . . 73.25 111.269 -177.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.52 -34.54 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.366 0.666 . . . . 73.21 111.367 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -80.71 -22.21 40.53 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.355 -0.838 . . . . 75.2 111.996 -170.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -92.9 -23.56 18.73 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.808 0.443 . . . . 72.4 109.981 173.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 30' ' ' HIS . 5.3 tmtp? -81.41 163.89 22.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.626 1.17 . . . . 75.42 109.693 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -76.61 138.88 40.38 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.124 -1.065 . . . . 60.33 108.124 166.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.1 t-105 -91.5 79.71 5.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.771 0.796 . . . . 55.45 109.977 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -127.89 82.47 68.33 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 107.114 -1.439 . . . . 70.43 107.114 169.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.53 166.15 12.12 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.866 2.377 . . . . 63.31 112.545 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -112.33 99.96 8.42 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.533 -1.284 . . . . 73.23 107.533 173.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.79 94.32 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.482 1.113 . . . . 70.1 110.1 -171.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.55 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 83.5 tttt -80.33 124.79 29.16 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.357 -0.838 . . . . 73.55 109.555 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.8 tp -103.98 108.75 20.23 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.007 -0.738 . . . . 75.45 109.007 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 16.1 t70 -108.34 117.87 35.28 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.992 0.917 . . . . 73.41 108.617 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -99.79 121.0 40.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.68 -1.23 . . . . 74.14 107.68 171.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -119.09 148.57 42.9 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.084 -1.45 . . . . 52.24 107.084 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -149.77 146.15 27.02 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.818 0.342 . . . . 73.21 110.4 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.38 151.94 46.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.674 1.19 . . . . 54.23 108.959 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -135.1 161.93 33.94 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.971 0.508 . . . . 51.34 111.438 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -168.65 131.87 1.43 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.116 0.966 . . . . 73.31 109.751 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.06 115.69 17.08 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.103 -0.703 . . . . 72.33 109.103 172.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.45 -43.11 17.67 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.142 0.577 . . . . 70.42 110.294 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.64 -173.66 4.24 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.967 -1.015 . . . . 35.03 110.487 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -65.81 114.59 5.17 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.37 0.668 . . . . 72.35 110.882 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.497 ' H ' ' HA ' ' G' ' 171' ' ' SER . 11.9 m-20 68.29 -0.99 1.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 125.508 1.523 . . . . 54.25 111.994 -177.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 58.3 t -105.18 101.86 12.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.568 -1.271 . . . . 41.23 107.568 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -119.03 154.0 33.81 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.375 -1.284 . . . . 72.21 107.756 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -124.24 123.94 41.35 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.694 -0.854 . . . . 42.04 108.694 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.1 t -116.61 116.29 51.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 106.802 -1.555 . . . . 75.42 106.802 168.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 66.0 t -96.72 132.93 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.794 -0.817 . . . . 72.04 108.794 176.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 112.52 24.96 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 106.622 -1.621 . . . . 73.22 106.622 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 23.1 ttp180 -109.63 102.34 11.18 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.277 -0.638 . . . . 73.3 109.277 176.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.75 127.93 45.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 107.976 -1.12 . . . . 74.03 107.976 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.7 m -116.34 122.56 45.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.044 -0.725 . . . . 53.5 109.044 179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 46.5 t -116.51 106.27 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 124.794 1.238 . . . . 64.42 107.896 -178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 20.8 m -104.39 139.71 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.731 -0.84 . . . . 74.03 108.731 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.38 125.21 38.19 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.066 -1.457 . . . . 52.42 107.066 172.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 m -129.99 128.79 42.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.194 0.598 . . . . 63.1 110.066 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 57.0 mt -87.63 75.62 9.01 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.13 -1.063 . . . . 75.33 108.13 176.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.72 -99.66 1.38 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.427 -0.806 . . . . 50.31 112.064 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -100.16 -18.47 16.9 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.77 0.828 . . . . 62.43 111.324 -175.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -112.37 134.51 53.87 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.436 0.694 . . . . 64.32 109.939 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -68.82 136.73 53.18 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.078 0.551 . . . . 74.21 111.42 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -83.01 -59.88 2.34 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.379 1.072 . . . . 64.13 109.334 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -155.97 174.8 14.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.22 -0.9 . . . . 75.23 110.337 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.5 tp -141.32 141.23 33.89 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.283 1.433 . . . . 64.11 107.891 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.3 m -129.62 135.87 49.07 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 107.999 -1.111 . . . . 51.42 107.999 171.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -148.42 116.07 6.3 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.684 -0.858 . . . . 61.53 108.684 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 53.6 t -129.59 112.74 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.651 0.781 . . . . 73.21 109.899 -173.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.621 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 38.3 mt-30 -83.64 87.66 7.04 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.844 -0.799 . . . . 61.24 108.844 168.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD22 ' A' ' 106' ' ' LEU . 8.7 tp-100 -77.11 92.96 3.82 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.264 -1.384 . . . . 73.42 107.264 169.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -83.76 143.38 21.47 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.739 -0.944 . . . . 64.35 110.739 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.17 123.01 2.1 Favored Glycine 0 CA--C 1.496 -1.121 0 N-CA-C 110.677 -0.969 . . . . 74.12 110.677 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 30.6 mt -90.92 121.8 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 108.345 -0.983 . . . . 72.41 108.345 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.47 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 28.6 m-85 -129.73 152.59 49.06 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.518 0.727 . . . . 53.2 109.948 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 66.8 m -91.49 121.71 33.43 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.604 0.762 . . . . 72.12 109.25 174.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.64 HD11 ' HB2' ' A' ' 94' ' ' MET . 5.8 tt -116.96 119.95 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 109.614 -0.513 . . . . 74.33 109.614 173.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.94 172.28 1.67 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.631 1.572 . . . . 75.11 108.895 172.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.44 -32.15 3.97 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 116.79 -0.187 . . . . 55.3 112.784 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.501 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.12 170.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 124.475 1.11 . . . . 73.11 109.206 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 10.0 tt0 -164.29 175.68 9.84 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.493 0.495 . . . . 75.12 110.275 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.45 -130.85 37.9 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.674 -0.694 . . . . 72.13 113.172 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.3 t -62.32 -27.73 69.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.241 1.016 . . . . 54.45 111.772 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -68.16 -48.89 64.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.502 0.721 . . . . 75.35 110.861 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.64 ' HB2' HD11 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -75.59 -30.49 59.63 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 122.893 0.477 . . . . 72.13 111.116 -177.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.4 -34.26 67.76 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.731 0.812 . . . . 41.14 110.612 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.437 ' CE1' ' HA ' ' A' ' 134' ' ' ASP . 11.1 t-80 -76.61 -31.5 57.49 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.028 -0.987 . . . . 72.41 110.178 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.6 m -71.85 -66.13 0.68 Allowed 'General case' 0 C--N 1.36 1.053 0 C-N-CA 123.029 0.532 . . . . 64.21 111.531 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' G' ' 175' ' ' PHE . 7.0 tt -67.74 -29.41 68.63 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.325 0.65 . . . . 53.34 111.044 -172.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.44 -19.97 57.54 Favored Glycine 0 C--N 1.344 1.016 0 CA-C-O 118.682 -1.065 . . . . 45.32 114.721 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.35 -48.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 119.201 1.5 . . . . 70.13 113.911 -173.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 44.9 t80 -66.76 -47.87 70.85 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.123 0.969 . . . . 71.43 111.879 -173.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.6 m -72.33 -41.83 8.45 Favored Pre-proline 0 CA--C 1.565 1.555 0 C-N-CA 123.494 0.717 . . . . 64.55 112.163 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -53.98 -31.78 65.3 Favored 'Trans proline' 0 C--N 1.393 2.876 0 C-N-CA 122.22 1.946 . . . . 24.12 113.919 163.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -68.74 -34.6 75.87 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 123.563 0.745 . . . . 62.14 110.283 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.07 -42.72 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 123.705 0.802 . . . . 75.55 110.172 173.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.5 mt -76.49 -24.77 53.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.553 -1.203 . . . . 71.12 112.462 -174.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -64.13 -40.18 50.95 Favored Pre-proline 0 CA--C 1.563 1.474 0 N-CA-C 114.46 1.281 . . . . 72.23 114.46 -168.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -55.08 -38.78 93.29 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 121.97 1.78 . . . . 72.13 113.344 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -77.65 -38.84 46.88 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.756 0.823 . . . . 72.41 111.644 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.51 -43.19 77.34 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.971 0.509 . . . . 44.44 110.178 176.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HG23 ' C' ' 105' ' ' ILE . 36.1 ttm180 -55.57 -51.19 67.94 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 124.472 1.108 . . . . 70.43 110.025 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' CD ' HH12 ' B' ' 120' ' ' ARG . 4.4 tm-20 -64.0 -41.48 97.48 Favored 'General case' 0 N--CA 1.474 0.764 0 O-C-N 124.125 0.891 . . . . 75.14 111.401 -176.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.481 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.89 -42.02 98.58 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.838 0.712 . . . . 54.11 111.005 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.416 HG21 HG21 ' A' ' 64' ' ' VAL . 91.5 mt -66.74 -51.48 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.384 0.674 . . . . 70.52 110.528 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.694 HG23 ' HB2' ' A' ' 125' ' ' GLN . 52.4 m -52.78 -44.8 66.8 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.624 1.17 . . . . 70.45 110.907 -175.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 37.8 t -64.77 -41.06 96.17 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.403 -1.271 . . . . 65.43 110.907 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.592 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 32.2 mtm -67.87 -41.31 83.04 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.96 0.504 . . . . 75.14 111.541 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.3 t -61.4 -50.34 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 123.792 0.837 . . . . 62.3 110.095 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.594 ' HB3' ' HB3' ' A' ' 125' ' ' GLN . 90.5 p -67.09 -32.05 72.95 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.224 -0.898 . . . . 74.51 111.105 -177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 116' ' ' SER . 26.9 ttm-85 -75.24 -27.44 59.49 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.596 1.159 . . . . 71.45 110.206 -178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.18 8.86 62.43 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 115.62 -0.718 . . . . 74.11 112.86 175.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' D' ' 125' ' ' GLN . 9.4 m 67.07 29.63 7.83 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.794 1.238 . . . . 73.0 110.831 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -108.51 151.09 41.43 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 114.479 -1.237 . . . . 75.0 107.905 171.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.76 121.53 8.43 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.784 1.656 . . . . 75.13 110.104 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.694 ' HB2' HG23 ' A' ' 115' ' ' THR . 18.5 pt20 -60.87 155.4 19.76 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.554 0.741 . . . . 65.45 111.873 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -131.12 122.08 26.05 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.828 -0.805 . . . . 73.42 108.828 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.432 ' ND2' ' HB ' ' C' ' 16' ' ' ILE . 2.3 m-20 -103.54 95.32 5.98 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.758 -1.201 . . . . 74.32 107.758 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 131.86 46.79 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 109.381 -0.6 . . . . 71.45 109.381 -174.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.51 128.02 89.38 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 123.676 0.79 . . . . 54.23 111.886 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -75.01 110.24 3.08 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.025 1.817 . . . . 73.14 110.83 171.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.1 t -99.35 114.79 38.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.773 0 N-CA-C 108.041 -1.096 . . . . 74.13 108.041 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.524 ' OD1' ' HB3' ' A' ' 135' ' ' ALA . 7.6 p30 -76.16 107.03 8.11 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.155 0.502 . . . . 74.24 110.117 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' G' ' 184' ' ' TRP . 65.3 t80 -76.85 -21.81 54.45 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.3 0.571 . . . . 72.44 109.484 171.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.437 ' HA ' ' CE1' ' A' ' 96' ' ' HIS . 2.2 p-10 -66.0 -49.04 69.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.588 1.155 . . . . 74.44 111.724 178.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.524 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . . . -89.06 -26.13 21.56 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 112.276 0.473 . . . . 61.51 112.276 -177.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.507 ' HB2' HG21 ' H' ' 207' ' ' VAL . 6.9 tt -63.12 -32.43 73.81 Favored 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 123.015 0.526 . . . . 64.15 109.865 171.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.439 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 50.2 t80 -58.18 -48.01 81.62 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.632 0.773 . . . . 65.44 111.006 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.456 ' SD ' ' HA ' ' C' ' 5' ' ' ASN . 52.1 mtm -73.65 -38.0 65.14 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.457 0.703 . . . . 72.41 110.658 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 53.7 t-20 -51.62 -38.6 55.4 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.693 1.197 . . . . 72.13 110.311 173.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -70.61 -42.79 70.48 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.493 -0.776 . . . . 62.24 111.45 176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 137' ' ' PHE . 84.2 mt -62.68 -49.59 74.52 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 123.581 0.551 . . . . 61.41 111.529 -172.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -162.75 13.18 0.07 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 111.879 0.326 . . . . 72.13 111.879 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.4 tt0 78.76 -52.26 0.46 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.143 1.377 . . . . 73.24 111.793 178.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.2 mp0 72.88 -77.79 0.05 Allowed 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.117 1.367 . . . . 70.44 112.234 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.98 79.43 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.21 0.604 . . . . 72.52 111.198 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.26 -79.41 0.3 Allowed Glycine 0 C--N 1.345 1.068 0 O-C-N 123.956 0.785 . . . . 63.22 111.186 -177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -156.12 138.74 15.06 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.119 0.967 . . . . 72.13 109.498 172.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.405 ' HA3' ' HB2' ' C' ' 90' ' ' GLU . . . -107.63 -73.4 0.82 Allowed Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.163 -1.175 . . . . 52.32 110.163 171.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 36.9 m 56.17 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 125.961 1.705 . . . . 63.12 114.721 169.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -63.44 96.06 0.11 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 122.982 0.513 . . . . 73.15 111.219 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -176.53 140.44 0.36 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.634 1.174 . . . . 75.14 108.782 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.559 ' HA ' ' HA ' ' E' ' 174' ' ' MET . 25.1 t-80 -156.54 137.37 13.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.297 0.639 . . . . 74.0 110.274 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -112.12 131.24 55.56 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.405 -0.961 . . . . 61.33 108.405 171.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -63.99 -61.94 1.95 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.628 0.771 . . . . 74.42 109.919 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.188 0 N-CA-C 107.747 -1.205 . . . . 71.21 107.747 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 109.854 -0.424 . . . . 74.33 109.854 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -155.75 87.4 1.08 Allowed 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.077 0.951 . . . . 72.04 108.684 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -76.48 170.72 15.85 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 116.116 -0.493 . . . . 75.03 110.744 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 61.06 70.33 0.62 Allowed 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.34 1.056 . . . . 73.54 111.074 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -69.69 126.8 30.81 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.881 -0.6 . . . . 73.44 109.553 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -138.73 106.08 5.53 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.958 -0.756 . . . . 74.42 108.958 -177.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.3 t -160.85 143.81 12.97 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 115.473 -0.785 . . . . 74.33 109.792 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -85.65 -18.35 33.48 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.562 0.745 . . . . 74.11 109.74 173.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.477 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 20.2 ptm 52.69 175.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 127.379 2.272 . . . . 73.3 114.519 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 25.5 p -137.56 128.38 27.16 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.035 0.934 . . . . 65.52 109.304 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -129.67 128.52 42.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.663 0.785 . . . . 71.1 109.565 173.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -135.43 114.63 12.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.568 0.747 . . . . 72.12 109.042 173.136 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.411 HG21 ' HA ' ' D' ' 129' ' ' ALA . 8.7 tt -89.91 107.12 17.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 108.118 -1.067 . . . . 62.33 108.118 171.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -82.58 -40.9 20.25 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 115.774 -0.648 . . . . 74.42 110.61 -178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.436 HH21 HG22 ' A' ' 122' ' ' THR . 16.3 ttt180 -170.33 145.11 2.64 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 123.104 0.253 . . . . 70.24 111.123 -173.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 67.1 mt -116.53 149.83 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 107.492 -1.299 . . . . 74.23 107.492 168.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.455 ' HE1' HG13 ' B' ' 83' ' ' ILE . 23.4 p90 -171.42 150.01 2.8 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.172 0.511 . . . . 73.35 111.208 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -76.0 121.45 22.75 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.552 -0.907 . . . . 62.3 108.552 169.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.51 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.8 mtpt -88.98 -39.7 13.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.352 0.661 . . . . 63.12 109.865 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.05 148.04 27.84 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.08 -0.509 . . . . 74.54 110.62 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.405 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 46.0 mm -142.19 139.42 29.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 125.916 1.686 . . . . 72.42 107.462 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 t -141.22 136.03 31.31 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.182 -1.044 . . . . 60.52 108.182 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -143.72 120.94 11.53 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.009 -1.478 . . . . 71.11 107.009 167.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 23.1 mt-10 -128.76 112.0 13.72 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.447 -0.946 . . . . 73.2 108.447 -176.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.63 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -114.44 88.65 16.1 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 108.7 -0.852 . . . . 73.55 108.7 176.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.08 -29.84 88.18 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.625 2.217 . . . . 61.32 112.059 -177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -119.99 29.41 7.55 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.345 1.058 . . . . 73.23 110.232 -175.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -47.43 -50.07 51.1 Favored Pre-proline 0 CA--C 1.575 1.941 0 C-N-CA 125.236 1.414 . . . . 62.51 114.658 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.453 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 62.6 Cg_endo -81.14 -13.46 11.3 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 121.708 1.605 . . . . 72.11 113.422 176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -94.39 2.9 55.76 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.419 0.687 . . . . 72.0 111.875 -176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.411 HG23 HD11 ' B' ' 68' ' ' LEU . 10.6 p -64.02 -17.81 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.626 0.771 . . . . 74.21 110.896 169.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.44 -37.47 83.67 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.163 0.985 . . . . 64.2 111.065 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -75.45 -45.36 39.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.772 0.829 . . . . 71.11 110.391 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -94.39 67.62 3.47 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.215 1.006 . . . . 73.22 109.513 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -81.44 76.51 8.36 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.122 0.963 . . . . 73.32 110.871 -174.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 2.6 m0 -158.68 167.62 29.03 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.896 1.278 . . . . 65.13 109.897 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -84.41 121.94 75.19 Favored Pre-proline 0 C--O 1.241 0.614 0 CA-C-N 115.89 -0.595 . . . . 65.53 109.476 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -73.02 150.31 48.29 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.213 1.942 . . . . 61.14 110.899 172.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -71.78 114.13 9.55 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.867 -0.79 . . . . 65.32 108.867 175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.548 HG12 HD22 ' B' ' 42' ' ' LEU . 23.5 t -85.15 117.06 29.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.453 0 N-CA-C 107.41 -1.33 . . . . 65.31 107.41 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -140.3 102.1 4.28 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.235 -1.024 . . . . 74.11 108.235 -170.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.582 ' HG ' HD21 ' B' ' 128' ' ' LEU . 1.1 pt? -127.85 138.69 52.78 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 114.197 -1.365 . . . . 72.24 109.652 -170.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -126.51 148.73 49.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.843 0.857 . . . . 70.1 111.067 -170.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.566 ' HG ' HD21 ' B' ' 60' ' ' LEU . 7.6 tt -89.42 131.44 35.47 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.241 1.017 . . . . 73.45 109.016 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -122.89 137.45 54.94 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 106.858 -1.534 . . . . 72.41 106.858 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.472 HG21 ' HA2' ' B' ' 99' ' ' GLY . 85.2 m -107.42 120.37 41.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.08 -0.711 . . . . 74.45 109.08 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.446 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -121.62 153.74 37.69 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.437 1.095 . . . . 61.42 108.129 170.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 49.5 m -143.86 172.0 13.45 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.112 0.482 . . . . 52.02 110.599 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -154.44 167.29 30.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.79 1.236 . . . . 65.2 108.591 177.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -123.43 130.47 52.74 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.054 0.541 . . . . 73.23 109.772 171.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -100.82 -40.4 7.33 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.278 0.631 . . . . 63.23 110.654 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.69 -169.92 3.36 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.063 0.545 . . . . 73.13 111.375 -174.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.401 ' O ' HG23 ' B' ' 55' ' ' VAL . 1.1 m-20 -57.62 111.3 1.08 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 114.754 -1.112 . . . . 60.21 110.967 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.486 ' H ' HD11 ' F' ' 173' ' ' LEU . 10.2 m-20 68.65 0.78 2.76 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.033 1.333 . . . . 73.15 112.186 178.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 53' ' ' ASP . 95.8 t -101.08 101.06 11.57 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.231 -1.025 . . . . 43.45 108.231 -172.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.584 ' HE2' HD21 ' F' ' 173' ' ' LEU . 17.7 m-85 -108.97 136.42 48.53 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.484 -0.78 . . . . 74.55 109.969 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -105.92 96.76 6.71 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 106.97 -1.492 . . . . 64.04 106.97 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 64.4 t -87.08 122.83 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.746 0.818 . . . . 63.32 109.577 -175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -101.68 113.68 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 123.798 0.839 . . . . 51.51 109.263 -178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.566 HD21 ' HG ' ' B' ' 44' ' ' LEU . 0.0 OUTLIER -91.77 105.94 18.1 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.811 -1.181 . . . . 64.14 107.811 177.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -97.8 108.66 21.42 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 115.336 -0.847 . . . . 65.02 109.497 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' B' ' 114' ' ' ILE . 18.3 t -105.41 113.84 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.925 -1.139 . . . . 74.24 107.925 170.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 8.6 m -104.4 150.89 24.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.534 0.733 . . . . 71.43 109.276 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' B' ' 76' ' ' CYS . 26.1 t -134.66 133.77 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.984 0.913 . . . . 61.12 110.341 -167.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 35.9 m -125.15 149.09 48.24 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 123.604 0.762 . . . . 71.14 109.253 170.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.07 147.45 29.56 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.731 0.812 . . . . 70.2 108.972 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 36.0 p -144.64 129.15 18.02 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 123.499 0.499 . . . . 74.35 111.325 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.429 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 37.0 mt -95.61 104.73 16.65 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.752 1.221 . . . . 62.4 108.3 171.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.39 -127.88 21.06 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 123.744 0.652 . . . . 71.45 111.631 -174.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -96.56 17.16 16.88 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.706 0.802 . . . . 62.05 111.485 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -134.84 146.76 49.58 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.51 0.724 . . . . 74.45 109.724 -171.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 58.7 m -63.78 135.65 56.81 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.177 0.591 . . . . 74.34 111.04 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.429 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -92.92 -59.7 1.99 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.931 0.892 . . . . 63.24 108.906 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -156.54 171.35 20.45 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 113.962 -1.472 . . . . 64.41 109.585 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.4 mt -139.94 154.69 47.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.882 1.673 . . . . 75.23 106.99 177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.444 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 53.2 t -159.7 160.42 34.08 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 109.156 -0.683 . . . . 74.53 109.156 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -165.42 136.83 3.98 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 108.233 -1.025 . . . . 75.23 108.233 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 97.1 t -124.18 143.82 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.973 -0.751 . . . . 74.14 108.973 172.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -124.0 102.08 7.57 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 108.531 -0.914 . . . . 74.15 108.531 171.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -92.16 100.11 12.79 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.218 -1.03 . . . . 65.32 108.218 172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.51 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.88 146.64 18.51 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.146 -0.782 . . . . 74.13 111.146 177.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.81 127.75 3.39 Favored Glycine 0 N--CA 1.451 -0.309 0 N-CA-C 110.758 -0.937 . . . . 71.14 110.758 -176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.455 HG13 ' HE1' ' B' ' 17' ' ' TYR . 50.3 mt -84.45 115.7 26.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.25 -1.018 . . . . 63.33 108.25 176.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -124.52 164.39 19.88 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.303 1.041 . . . . 72.23 108.849 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 16.4 m -132.43 103.68 6.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.452 -0.944 . . . . 75.55 108.452 174.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.556 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -115.88 134.71 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 123.214 0.606 . . . . 75.11 110.739 -177.214 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.0 172.76 18.11 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.466 1.106 . . . . 61.15 108.553 172.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.477 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 90.35 -55.01 3.55 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.703 -0.559 . . . . 62.23 111.703 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -60.52 154.45 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 C-N-CA 124.255 1.022 . . . . 74.42 111.996 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -161.75 166.24 26.84 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.501 0.72 . . . . 73.14 110.355 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.61 -127.1 43.84 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 123.737 0.648 . . . . 43.14 113.71 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -65.16 -30.24 71.14 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.106 0.963 . . . . 62.15 111.149 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -74.07 -34.98 64.21 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.513 -0.767 . . . . 74.25 110.71 -172.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.764 ' HG2' ' SD ' ' F' ' 174' ' ' MET . 12.3 tpt -66.56 -47.99 71.09 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.018 -0.537 . . . . 64.21 110.241 172.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.04 77.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.11 0.881 . . . . 63.12 110.844 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -65.78 -34.53 78.38 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.51 0.724 . . . . 64.0 110.666 177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -67.04 -67.9 0.42 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.637 0.375 . . . . 75.44 111.528 -175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' F' ' 177' ' ' LEU . 0.0 OUTLIER -73.39 -17.64 61.25 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 118.106 0.412 . . . . 74.12 112.076 -171.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' HB3' ' F' ' 178' ' ' GLN . . . -108.74 2.27 32.09 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.48 -0.622 . . . . 64.32 114.607 -174.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.87 -49.06 0.17 Allowed 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 117.948 0.874 . . . . 74.12 111.387 178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -72.45 -50.63 24.77 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 122.697 0.399 . . . . 65.01 111.471 -176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 73.7 m -64.24 -46.46 79.23 Favored Pre-proline 0 CA--C 1.555 1.167 0 CA-C-O 118.435 -0.793 . . . . 74.1 111.183 178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -51.58 -41.32 61.43 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.153 1.902 . . . . 71.43 113.835 167.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.84 -36.84 84.54 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 123.478 0.711 . . . . 75.14 111.689 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.44 HG23 ' NH2' ' D' ' 111' ' ' ARG . 64.9 mt -62.35 -47.25 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.625 0.77 . . . . 74.25 110.418 174.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 44.5 mt -86.11 -10.54 54.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.804 -1.089 . . . . 61.41 111.692 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -64.88 -49.76 66.79 Favored Pre-proline 0 N--CA 1.475 0.813 0 CA-C-O 117.411 -1.28 . . . . 73.43 113.312 -171.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -58.73 -34.64 99.08 Favored 'Trans proline' 0 C--N 1.384 2.445 0 C-N-CA 121.944 1.762 . . . . 73.13 112.341 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.422 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.0 m-85 -64.31 -52.56 57.9 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.388 0.675 . . . . 75.41 110.358 177.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.67 -35.86 81.94 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.764 0.825 . . . . 62.33 111.329 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.694 HH22 HG22 ' C' ' 122' ' ' THR . 53.6 ttt180 -67.61 -49.95 60.55 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.223 1.409 . . . . 74.32 110.414 -176.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -34.96 78.99 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.939 0.775 . . . . 74.51 110.191 177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.1 t -67.37 -45.49 76.11 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.066 0.546 . . . . 74.32 111.787 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' B' ' 62' ' ' VAL . 81.5 mt -59.35 -46.36 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.143 0.577 . . . . 55.42 110.196 176.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.626 ' HA ' ' HG3' ' B' ' 125' ' ' GLN . 34.2 m -53.58 -50.15 66.21 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.673 1.233 . . . . 62.2 110.045 176.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.5 t -59.42 -50.72 72.86 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.303 1.041 . . . . 63.21 111.852 -176.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.559 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 20.7 mmt -68.63 -35.18 76.95 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 123.165 0.586 . . . . 73.34 112.494 -170.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -76.91 -32.33 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 C-N-CA 123.089 0.556 . . . . 74.34 110.846 175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 64.5 m -64.22 -30.02 71.1 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.555 0.742 . . . . 54.54 111.276 174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.559 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 80.2 mtt-85 -68.69 -39.78 80.36 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.861 0.864 . . . . 63.45 109.844 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.2 -2.32 66.47 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.838 0.711 . . . . 73.14 113.198 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 27.3 p 60.55 44.95 11.13 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.194 1.797 . . . . 44.21 111.96 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -119.01 144.91 36.81 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 114.718 -1.128 . . . . 75.24 109.785 175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' F' ' 195' ' ' PHE . 20.9 Cg_exo -68.1 94.76 0.41 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.736 2.957 . . . . 74.3 113.718 -177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.626 ' HG3' ' HA ' ' B' ' 115' ' ' THR . 3.3 mm-40 -68.21 160.79 28.5 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.332 1.063 . . . . 72.42 113.163 169.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.416 HD22 HD11 ' F' ' 187' ' ' ILE . 4.5 tt -143.02 124.83 15.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.074 -2.195 . . . . 62.01 105.074 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -87.03 136.19 33.01 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 108.918 -0.771 . . . . 72.3 108.918 -171.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.582 HD21 ' HG ' ' B' ' 42' ' ' LEU . 38.1 mt -58.13 144.78 39.17 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 123.54 0.525 . . . . 54.41 112.296 -178.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.643 ' HB1' HG12 ' E' ' 204' ' ' ILE . . . -66.69 108.56 2.47 Favored Pre-proline 0 CA--C 1.548 0.886 0 O-C-N 124.629 1.206 . . . . 42.23 109.912 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.457 ' HG2' ' H ' ' D' ' 16' ' ' ILE . 73.1 Cg_endo -73.59 113.55 3.81 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.505 2.137 . . . . 73.05 111.185 -176.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 9.3 p -137.08 142.77 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.405 0.682 . . . . 74.41 110.663 -175.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -79.38 118.61 21.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.565 1.146 . . . . 70.1 109.91 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -67.38 -25.8 66.14 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.448 0.699 . . . . 52.31 111.702 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.12 -29.57 65.42 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.461 0.704 . . . . 75.45 111.223 174.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.81 -40.49 95.3 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.139 0.576 . . . . 55.41 110.509 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.0 -40.26 95.04 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.409 -0.814 . . . . 74.04 110.546 173.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -66.45 -39.9 89.13 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.923 . . . . 75.24 110.588 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.0 mtt -65.13 -38.73 91.58 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.568 0.747 . . . . 61.4 111.245 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -88.07 -19.2 27.39 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.546 -0.752 . . . . 74.32 110.636 -172.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -87.01 -35.35 18.83 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.998 0.519 . . . . 74.44 110.658 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.34 1.6 56.99 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.056 0.542 . . . . 60.41 110.662 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -70.37 100.28 1.72 Allowed 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.623 -0.88 . . . . 64.24 108.623 167.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -97.55 -12.55 22.42 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.051 0.94 . . . . 71.11 110.422 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.444 ' HB3' ' HG3' ' D' ' 8' ' ' GLU . 21.5 mp0 -76.46 97.72 4.39 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.517 -0.92 . . . . 70.12 108.517 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.69 121.26 26.16 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.712 0.805 . . . . 72.44 109.391 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 174.05 -168.92 41.88 Favored Glycine 0 C--N 1.339 0.747 0 O-C-N 123.521 0.513 . . . . 72.0 112.169 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -143.27 178.47 7.71 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.276 0.631 . . . . 62.3 110.791 -171.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -164.31 82.63 0.11 Allowed Glycine 0 C--N 1.34 0.788 0 CA-C-N 115.557 -0.747 . . . . 75.03 111.815 179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -112.89 132.68 55.21 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 108.696 -0.853 . . . . 72.14 108.696 178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -140.77 155.15 46.48 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.527 0.731 . . . . 74.15 109.83 -172.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -57.78 108.47 0.58 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.978 0.911 . . . . 64.41 109.55 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -65.28 93.5 0.14 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.842 0.857 . . . . 55.22 109.002 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -55.7 -72.83 0.06 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.93 0.892 . . . . 74.42 111.85 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -92.98 130.93 38.39 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.689 -0.856 . . . . 75.24 108.689 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 O-C-N 123.919 0.762 . . . . 71.21 110.302 178.207 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.272 -0.64 . . . . 75.31 109.272 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 12.0 p -75.3 -169.92 1.08 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.055 0.942 . . . . 63.44 111.795 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -80.79 17.0 1.24 Allowed 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 124.161 0.984 . . . . 71.02 112.448 -167.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -76.34 73.1 3.12 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.94 0.896 . . . . 54.3 108.956 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.456 ' HA ' ' SD ' ' A' ' 138' ' ' MET . 1.0 OUTLIER -123.12 134.17 54.23 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.739 1.215 . . . . 64.44 108.067 176.722 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.6 m120 76.88 -34.48 0.22 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 125.726 1.611 . . . . 71.25 112.979 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -59.37 135.05 57.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.671 1.188 . . . . 53.43 111.69 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -97.78 -61.0 1.45 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.376 -0.972 . . . . 72.51 108.376 166.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 55.5 ttp 64.67 136.26 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.283 1.433 . . . . 72.21 112.311 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 61.4 m -115.67 96.69 5.74 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.595 -1.261 . . . . 75.41 107.595 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HA ' HG22 ' C' ' 86' ' ' ILE . 37.7 t80 -91.02 132.43 36.0 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.442 -1.254 . . . . 71.21 108.27 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.409 ' HG2' ' NE2' ' C' ' 14' ' ' GLN . 25.4 tt0 -136.23 102.08 4.88 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.988 -1.115 . . . . 61.42 107.988 -178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.532 HD11 HG13 ' C' ' 16' ' ' ILE . 7.1 tp -70.44 131.45 34.27 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 115.456 -0.793 . . . . 73.21 109.242 175.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.502 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 22.8 mm-40 -105.21 -49.37 3.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.305 0.642 . . . . 65.44 109.857 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.519 HH11 ' HB2' ' D' ' 32' ' ' PHE . 73.5 ttt180 -173.62 132.25 0.45 Allowed 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.692 -0.685 . . . . 72.43 110.34 -169.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.532 HG13 HD11 ' C' ' 13' ' ' ILE . 84.0 mt -118.93 136.26 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.266 -1.013 . . . . 75.24 108.266 170.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.667 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 8.4 p90 -171.53 172.02 5.22 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 124.355 1.035 . . . . 75.04 110.081 -173.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.2 p -93.17 118.98 31.87 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.521 -0.763 . . . . 74.32 109.384 176.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.414 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 17.4 mmtp -65.83 -47.11 76.09 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 108.124 -1.065 . . . . 74.24 108.124 168.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.5 t70 -141.52 147.09 37.21 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 113.472 -1.694 . . . . 72.33 110.008 -175.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.6 mt -135.1 144.73 33.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 125.767 1.627 . . . . 72.44 106.876 172.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -150.73 146.45 26.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.508 0.671 . . . . 74.22 110.706 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -151.64 118.45 5.79 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 106.566 -1.642 . . . . 65.34 106.566 167.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -115.62 133.08 56.38 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.72 -1.215 . . . . 54.51 107.72 177.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.88 85.22 39.66 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 107.376 -1.342 . . . . 74.12 107.376 173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -71.16 -3.37 12.75 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.619 2.213 . . . . 75.21 112.183 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -124.62 18.24 8.78 Favored 'General case' 0 C--O 1.209 -1.049 0 C-N-CA 123.921 0.889 . . . . 74.34 109.764 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -47.01 -50.85 43.87 Favored Pre-proline 0 CA--C 1.575 1.905 0 N-CA-C 114.309 1.226 . . . . 72.11 114.309 -169.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 85.2 Cg_endo -86.68 -27.88 0.68 Allowed 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.713 1.608 . . . . 75.05 114.107 171.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -71.09 -24.62 62.35 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.474 0.71 . . . . 55.15 112.471 -176.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.444 HG23 HD11 ' C' ' 68' ' ' LEU . 14.4 p -75.28 -18.19 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 124.593 1.157 . . . . 43.44 110.922 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' D' ' 14' ' ' GLN . 42.6 t80 -59.74 -38.48 81.85 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.845 0.858 . . . . 74.22 110.81 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.38 5.48 51.42 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.283 0.633 . . . . 73.42 112.395 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.72 ' HE2' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -98.33 164.55 12.25 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.575 0.35 . . . . 55.32 111.866 -167.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.95 117.37 8.93 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.266 -1.013 . . . . 73.3 108.266 165.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -84.96 67.01 10.03 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.223 1.011 . . . . 73.23 111.242 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -125.07 78.52 66.37 Favored Pre-proline 0 N--CA 1.486 1.344 0 C-N-CA 124.582 1.153 . . . . 71.44 109.261 176.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.5 106.6 1.88 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.542 2.161 . . . . 73.2 111.422 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -84.17 120.36 26.1 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.098 -1.445 . . . . 72.24 107.098 175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.474 HG13 HG13 ' C' ' 64' ' ' VAL . 95.6 t -96.86 148.84 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 114.885 -1.052 . . . . 70.1 110.959 -166.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -133.53 114.98 14.18 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.834 -1.543 . . . . 61.21 106.834 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.419 ' HG ' HD13 ' C' ' 128' ' ' LEU . 5.4 mp -86.44 152.73 22.44 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 108.64 -0.874 . . . . 63.23 108.64 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.2 t70 -154.63 148.6 25.7 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.052 -0.721 . . . . 75.44 109.052 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 10.1 tt -149.78 120.59 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.013 -0.736 . . . . 54.32 109.013 -172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 11.7 m-20 -121.81 144.7 48.67 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.739 1.216 . . . . 75.41 108.656 176.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -113.01 132.8 55.24 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.18 -0.674 . . . . 63.4 109.18 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.17 157.32 38.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.645 0.778 . . . . 64.24 109.044 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.0 p -144.87 150.35 36.93 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.886 -0.597 . . . . 75.22 110.008 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.8 t -156.32 143.16 18.75 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.792 1.237 . . . . 74.22 107.906 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -105.09 132.67 51.02 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.133 0.492 . . . . 71.25 109.692 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.61 HD11 HD12 ' C' ' 83' ' ' ILE . 69.0 mt -104.36 -41.94 5.62 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.453 -0.794 . . . . 73.24 111.252 -175.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.65 -172.89 4.31 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-O 121.204 0.526 . . . . 60.12 111.174 -176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -62.94 112.79 2.73 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.331 -1.304 . . . . 43.54 110.312 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.706 ' HA ' HD21 ' E' ' 173' ' ' LEU . 18.5 m-20 60.87 23.87 13.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.643 1.177 . . . . 74.14 112.782 -178.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -114.91 116.24 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.894 . . . . 62.34 109.284 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -103.09 159.97 15.05 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 122.06 0.933 . . . . 74.42 110.083 173.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -128.05 124.22 36.54 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 113.517 -1.674 . . . . 52.31 107.26 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.7 125.74 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 107.573 -1.269 . . . . 52.31 107.573 171.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.56 105.59 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 108.458 -0.941 . . . . 74.22 108.458 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.412 HD22 ' O ' ' C' ' 45' ' ' ASP . 2.4 tm? -91.33 112.61 24.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.216 -1.031 . . . . 55.14 108.216 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 25.4 ttp180 -91.68 110.76 22.1 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.823 0.849 . . . . 72.21 109.991 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 7.2 t -100.48 124.23 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 108.161 -1.051 . . . . 71.12 108.161 173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 7.5 m -123.44 137.05 54.88 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.491 -0.559 . . . . 75.52 109.491 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.522 HG21 HG21 ' C' ' 114' ' ' ILE . 56.1 t -125.17 115.74 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.861 1.264 . . . . 41.33 108.889 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.4 m -99.48 144.35 28.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.209 -1.034 . . . . 55.24 108.209 171.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.11 136.99 37.28 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.361 -0.607 . . . . 63.21 109.361 -178.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.1 m -137.76 138.4 39.23 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.479 0.487 . . . . 54.02 110.665 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.65 HD13 ' HG2' ' C' ' 34' ' ' LYS . 10.1 mt -86.93 43.82 1.12 Allowed 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.083 1.353 . . . . 62.02 109.356 173.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.96 -113.17 4.37 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 110.517 -1.033 . . . . 73.2 110.517 -170.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.77 -10.03 41.45 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.678 0.791 . . . . 73.45 110.883 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.72 ' HG2' ' HE2' ' C' ' 34' ' ' LYS . 8.3 tp10 -90.11 128.89 36.43 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.308 1.443 . . . . 63.52 110.049 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 16.3 m -64.82 129.34 39.41 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 118.853 0.751 . . . . 75.21 109.908 171.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.534 ' HB2' ' HG ' ' C' ' 68' ' ' LEU . . . -83.36 -54.73 4.77 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.128 -0.694 . . . . 72.31 109.128 171.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -168.57 178.51 4.72 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 114.401 -1.272 . . . . 74.14 110.31 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.8 tm? -141.09 146.22 36.82 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 106.423 -1.695 . . . . 70.43 106.423 175.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.451 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -146.66 145.89 30.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 107.912 -1.144 . . . . 71.4 107.912 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.29 136.85 11.08 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.563 -0.532 . . . . 53.43 109.563 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' C' ' 110' ' ' ALA . 53.6 t -134.87 112.94 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.038 0.935 . . . . 61.23 108.507 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.7 mt-30 -92.71 89.51 6.69 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 108.822 -0.807 . . . . 65.44 108.822 173.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.2 tp-100 -82.59 109.82 17.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.016 -0.993 . . . . 43.34 109.767 -177.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 144.95 17.48 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 123.34 0.4 . . . . 71.11 112.434 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.607 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -143.29 128.29 3.35 Favored Glycine 0 CA--C 1.501 -0.791 0 N-CA-C 110.358 -1.097 . . . . 71.23 110.358 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.61 HD12 HD11 ' C' ' 51' ' ' LEU . 11.8 mm -95.19 118.69 41.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.617 0 N-CA-C 108.032 -1.099 . . . . 75.04 108.032 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -128.47 117.13 20.79 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.502 -0.925 . . . . 55.13 108.502 -174.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.4 t -98.58 107.29 19.7 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.179 -1.045 . . . . 75.21 108.179 176.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.8 pp -131.7 154.31 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.036 0.534 . . . . 73.45 111.065 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.25 177.46 3.59 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.483 -1.235 . . . . 63.02 109.468 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.27 -36.53 3.69 Favored Glycine 0 N--CA 1.477 1.415 0 CA-C-N 116.515 -0.312 . . . . 71.32 112.46 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.409 ' H ' HG13 ' C' ' 89' ' ' ILE . 2.5 pp -75.6 -173.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 124.477 1.111 . . . . 75.15 111.402 176.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.449 ' H ' ' HB2' ' C' ' 93' ' ' GLN . 4.0 tm-20 -168.54 147.11 4.22 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 112.41 0.522 . . . . 50.21 112.41 -174.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.601 ' H ' ' HG2' ' E' ' 174' ' ' MET . . . 54.24 -116.02 5.85 Favored Glycine 0 C--N 1.354 1.564 0 C-N-CA 124.113 0.863 . . . . 53.1 115.001 174.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.2 p -69.07 -24.82 64.2 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.378 0.671 . . . . 54.1 111.914 -178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.449 ' HB2' ' H ' ' C' ' 90' ' ' GLU . 44.4 mt-30 -56.46 -39.38 73.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.274 0.63 . . . . 74.14 110.237 174.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.582 ' HE2' ' SD ' ' E' ' 174' ' ' MET . 54.8 tpp -65.46 -44.4 87.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.558 0.743 . . . . 74.41 110.243 173.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.466 ' HA ' HD11 ' E' ' 177' ' ' LEU . . . -64.62 -26.42 68.39 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.553 0.741 . . . . 65.23 112.431 -177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -88.14 -33.51 18.19 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.518 0.727 . . . . 73.24 111.34 174.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -67.68 -61.58 1.82 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.19 0.596 . . . . 75.4 110.953 -176.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -93.11 -6.64 47.56 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.191 0.441 . . . . 70.0 112.191 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.44 -29.67 21.26 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.919 -0.378 . . . . 70.11 113.527 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.18 -43.47 0.71 Allowed 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 117.154 0.477 . . . . 62.11 111.778 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -72.29 -49.91 31.09 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.228 0.455 . . . . 71.14 112.228 -174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -64.05 -45.66 80.01 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.808 -0.615 . . . . 51.41 112.461 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.15 -23.1 60.65 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 121.877 1.718 . . . . 71.33 113.798 171.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -67.86 -39.74 83.72 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 123.352 0.661 . . . . 73.23 109.602 174.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.46 HG23 ' NH1' ' A' ' 111' ' ' ARG . 48.5 mm -61.61 -40.36 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.738 0.815 . . . . 75.35 110.126 174.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.607 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -76.87 -27.03 54.89 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.129 -0.941 . . . . 74.43 112.288 -176.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.415 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 51.2 t80 -57.67 -47.75 98.4 Favored Pre-proline 0 CA--C 1.559 1.3 0 CA-C-O 117.285 -1.341 . . . . 74.31 114.11 -170.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.78 -39.49 91.03 Favored 'Trans proline' 0 C--N 1.39 2.753 0 C-N-CA 122.032 1.821 . . . . 73.31 112.863 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -63.48 -43.83 96.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.066 0.947 . . . . 75.14 111.3 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -76.04 -35.47 59.47 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.897 -0.592 . . . . 73.32 111.605 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -60.45 -47.39 86.31 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.275 1.43 . . . . 64.41 110.214 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.95 -39.59 87.3 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.365 -0.834 . . . . 61.12 109.959 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 13.7 t -66.02 -27.99 68.53 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.398 0.679 . . . . 60.35 112.329 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.522 HG21 HG21 ' C' ' 64' ' ' VAL . 78.2 mt -73.12 -49.08 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 122.938 0.495 . . . . 64.21 110.113 173.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -58.18 -34.85 70.79 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.028 0.931 . . . . 61.11 111.143 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -62.58 -55.0 31.26 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 113.912 -1.495 . . . . 73.51 109.79 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.503 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -59.48 -36.92 76.94 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.802 1.241 . . . . 73.44 113.443 -176.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.02 -41.37 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 122.848 0.459 . . . . 71.1 110.769 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.9 t -66.6 -30.25 70.49 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.278 -0.873 . . . . 63.05 110.986 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.503 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 89.4 mtt-85 -70.23 -33.46 71.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.535 0.734 . . . . 73.34 110.315 175.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.14 7.38 63.81 Favored Glycine 0 C--N 1.355 1.586 0 CA-C-N 115.668 -0.696 . . . . 53.04 112.966 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.694 HG22 HH22 ' B' ' 111' ' ' ARG . 17.2 p 62.1 21.27 12.28 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 126.897 2.079 . . . . 72.02 113.488 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -94.31 166.4 15.51 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.168 0.987 . . . . 75.33 110.239 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -61.78 105.7 0.39 Allowed 'Trans proline' 0 C--N 1.385 2.463 0 C-N-CA 122.296 1.997 . . . . 71.13 111.236 173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.487 HE22 ' ND2' ' C' ' 127' ' ' ASN . 0.0 OUTLIER -55.34 141.38 36.19 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.863 1.265 . . . . 72.54 111.418 -179.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.76 118.14 36.0 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.631 0.372 . . . . 62.14 111.376 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.487 ' ND2' HE22 ' C' ' 125' ' ' GLN . 12.4 m120 -98.33 85.01 3.32 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.385 -0.969 . . . . 53.3 108.385 169.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.419 HD13 ' HG ' ' C' ' 42' ' ' LEU . 53.5 mt -78.36 142.63 37.52 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 114.882 -1.054 . . . . 43.23 109.15 -175.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 141.4 94.11 Favored Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 123.934 0.894 . . . . 63.33 112.721 -169.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.415 ' HA ' ' HE2' ' C' ' 107' ' ' PHE . 82.6 Cg_endo -75.36 102.37 1.59 Allowed 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.785 2.323 . . . . 73.11 111.521 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 43.2 t -69.19 91.18 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.295 0.638 . . . . 63.41 110.818 -173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -83.83 105.91 15.1 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.084 -0.962 . . . . 74.31 110.134 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -52.22 -44.32 64.74 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.416 0.686 . . . . 72.52 111.229 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.48 -48.27 81.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.582 1.153 . . . . 73.5 111.066 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.683 ' HB2' HD13 ' A' ' 13' ' ' ILE . . . -66.3 -50.22 64.39 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 115.617 -0.72 . . . . 54.51 111.054 -178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.638 HD12 HG21 ' F' ' 207' ' ' VAL . 7.4 tt -58.53 -39.61 80.64 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 124.204 1.002 . . . . 71.34 110.963 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -70.31 -42.74 71.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.393 0.677 . . . . 75.05 110.304 -175.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 18.9 mmt -74.63 -26.68 60.05 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.95 0.9 . . . . 72.03 111.354 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -70.55 -46.92 62.64 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.125 0.97 . . . . 73.24 109.456 178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -73.18 -84.2 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 115.001 -1.0 . . . . 75.51 110.329 177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.603 ' H ' HD23 ' C' ' 141' ' ' LEU . 1.8 pt? -100.53 106.59 18.13 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.834 0.826 . . . . 72.33 110.884 -174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.429 HE22 ' HA ' ' A' ' 10' ' ' THR . 20.6 tt0 -167.61 139.31 3.08 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.728 1.211 . . . . 70.54 108.167 177.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.483 ' H ' HG22 ' A' ' 7' ' ' THR . 6.0 tp-100 -76.2 114.35 14.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.114 -0.699 . . . . 73.01 109.114 175.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.85 96.62 1.02 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.292 -0.632 . . . . 72.14 109.292 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.417 ' HB2' ' HB3' ' A' ' 8' ' ' GLU . . . -75.33 -57.49 3.86 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.14 -0.689 . . . . 53.44 109.14 172.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.42 -143.1 30.06 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.147 -0.933 . . . . 31.24 111.235 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 62.41 130.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.019 1.728 . . . . 74.21 112.752 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.32 144.79 6.88 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.136 -0.786 . . . . 62.43 111.136 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.513 ' H ' HD12 ' G' ' 173' ' ' LEU . 10.0 t -111.37 136.72 50.1 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.824 -1.176 . . . . 61.21 107.824 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' C' ' 151' ' ' GLU . 31.7 tt0 -68.73 125.06 25.38 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.967 0.507 . . . . 72.3 111.027 -174.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' C' ' 150' ' ' GLU . 0.4 OUTLIER -69.94 153.9 42.65 Favored 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 108.573 -0.899 . . . . 72.33 108.573 169.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 66.6 t60 -48.67 -61.35 2.08 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.52 0.728 . . . . 75.35 110.703 172.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 179.68 -41.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.936 1.294 . . . . 72.15 109.652 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 16.7 t70 58.63 83.13 0.13 Allowed 'General case' 0 C--N 1.354 0.799 0 O-C-N 124.945 1.403 . . . . 62.42 109.516 -170.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 C-N-CA 123.917 0.887 . . . . 72.24 108.972 -177.467 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 75.8 mtp . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 109.316 -0.624 . . . . 71.21 109.316 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -158.78 121.85 3.75 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.461 -0.94 . . . . 52.23 108.461 -174.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -121.83 42.94 2.98 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.527 0.731 . . . . 72.03 110.064 -167.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 22.2 tm0? -69.91 -71.52 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.229 0.612 . . . . 65.42 111.069 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -172.44 134.8 0.69 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.759 0.823 . . . . 72.04 109.804 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.482 HD22 HD21 ' H' ' 173' ' ' LEU . 25.0 t30 -171.89 74.78 0.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 106.445 -1.687 . . . . 70.01 106.445 172.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -105.64 -160.88 0.77 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.943 -1.48 . . . . 73.44 109.665 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.444 ' HG3' ' HB3' ' B' ' 144' ' ' GLN . 3.6 mp0 60.84 50.82 5.06 Favored 'General case' 0 C--N 1.366 1.325 0 C-N-CA 123.719 0.808 . . . . 73.43 109.162 -171.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.534 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 6.0 ptm -30.11 131.01 0.08 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.91 2.084 . . . . 63.22 115.707 -171.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.5 m -130.31 139.47 50.71 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.468 -0.938 . . . . 62.41 108.468 174.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -146.83 100.07 3.27 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 106.896 -1.52 . . . . 73.33 106.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.557 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.0 mt-30 -118.31 153.73 33.49 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 108.421 -0.955 . . . . 64.35 108.421 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.1 141.44 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 106.881 -1.525 . . . . 72.54 106.881 172.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.448 ' HB3' ' CZ ' ' C' ' 32' ' ' PHE . 69.8 mt-30 -109.89 -35.2 6.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.84 0.456 . . . . 64.4 110.008 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -173.77 124.06 0.36 Allowed 'General case' 0 C--N 1.367 1.326 0 O-C-N 123.272 0.358 . . . . 74.24 111.028 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.457 ' H ' ' HG2' ' B' ' 130' ' ' PRO . 38.4 mm -110.87 118.92 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 109.075 -0.713 . . . . 72.42 109.075 175.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.45 ' HB3' HG23 ' C' ' 122' ' ' THR . 9.0 p90 -149.6 175.96 11.07 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.909 0.861 . . . . 75.45 111.82 -171.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.44 HG21 HD11 ' D' ' 21' ' ' ILE . 72.2 p -98.99 119.03 37.09 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.238 -1.347 . . . . 62.43 109.733 175.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -84.49 -38.75 19.71 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.902 -0.59 . . . . 74.42 110.207 175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -145.99 136.38 23.96 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.871 -0.788 . . . . 42.01 108.871 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.478 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.9 mt -130.16 132.35 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 106.885 -1.524 . . . . 73.51 106.885 172.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.3 t -145.44 114.96 7.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 123.394 0.434 . . . . 64.54 110.244 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 90.4 t80 -111.39 120.25 41.54 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 106.751 -1.574 . . . . 73.41 106.751 167.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -127.85 119.38 25.53 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.307 -0.627 . . . . 72.43 109.307 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.62 94.57 10.38 Favored Pre-proline 0 CA--C 1.55 0.978 0 N-CA-C 109.114 -0.699 . . . . 70.33 109.114 177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.27 -57.4 0.49 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.15 2.567 . . . . 70.43 112.727 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -92.57 22.09 4.93 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 118.634 -0.698 . . . . 63.44 111.055 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.667 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -28.19 -64.24 0.16 Allowed Pre-proline 0 CA--C 1.577 2.018 0 N-CA-C 117.401 2.371 . . . . 70.03 117.401 -170.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -82.95 -19.62 5.73 Favored 'Trans proline' 0 C--N 1.389 2.661 0 CA-C-N 122.491 1.925 . . . . 74.41 113.57 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -70.01 -40.99 74.92 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.346 1.058 . . . . 73.25 109.727 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.64 HG21 ' HA ' ' D' ' 73' ' ' ALA . 4.9 p -86.09 -0.87 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.25 0 C-N-CA 123.537 0.735 . . . . 74.32 111.249 -175.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.519 ' HB2' HH11 ' C' ' 15' ' ' ARG . 82.3 t80 -62.1 -30.82 71.28 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 122.961 0.504 . . . . 53.33 110.665 164.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -68.44 -15.47 63.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.173 0.989 . . . . 71.35 111.429 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.95 99.95 12.49 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.264 1.026 . . . . 73.42 109.739 177.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -96.88 50.75 1.11 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.33 1.052 . . . . 74.21 110.561 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -127.22 159.55 33.96 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.511 -0.922 . . . . 72.01 108.511 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -63.43 112.61 7.43 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 123.815 0.846 . . . . 60.14 109.96 177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.453 ' HG3' HD11 ' D' ' 68' ' ' LEU . 25.8 Cg_exo -61.47 118.23 5.09 Favored 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 122.652 2.235 . . . . 71.35 111.671 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 51.3 mt-10 -60.38 115.56 3.64 Favored 'General case' 0 C--N 1.347 0.494 0 O-C-N 124.235 0.959 . . . . 75.44 110.243 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.602 HG23 HG13 ' D' ' 64' ' ' VAL . 2.5 p -96.14 110.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 122.12 0.962 . . . . 74.11 109.027 -177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -97.2 107.34 19.84 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 106.668 -1.604 . . . . 72.21 106.668 177.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.584 HD22 HD22 ' D' ' 128' ' ' LEU . 55.3 tp -97.14 113.71 25.32 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.248 -0.649 . . . . 72.51 109.248 -176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 18.8 t70 -113.6 148.74 35.64 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 109.503 -0.554 . . . . 62.11 109.503 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 54.3 tp -119.88 135.05 55.03 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.686 0.794 . . . . 72.4 110.543 -173.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.0 t70 -144.05 142.95 30.94 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 108.155 -1.054 . . . . 74.42 108.155 168.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -120.89 166.54 13.66 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.45 0.7 . . . . 74.04 109.279 175.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.546 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -158.74 169.3 24.7 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.183 0.993 . . . . 62.53 109.015 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' D' ' 57' ' ' GLU . 13.3 p -165.0 155.8 14.28 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 120.947 0.404 . . . . 74.54 111.738 -178.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 91.5 p -152.75 135.7 15.54 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.147 0.979 . . . . 51.11 109.147 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -81.35 118.06 22.34 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.394 -0.595 . . . . 70.01 109.394 174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.49 HD11 ' HB2' ' D' ' 57' ' ' GLU . 34.6 mt -95.19 -34.31 12.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.196 0.598 . . . . 60.31 110.267 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.45 -173.43 4.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.03 0.932 . . . . 70.53 110.357 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -67.58 120.62 14.29 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.316 -0.856 . . . . 75.21 109.519 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 63.46 14.43 7.96 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.742 1.217 . . . . 61.21 112.178 -176.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.87 119.54 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.225 -0.657 . . . . 74.15 109.225 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -133.08 130.48 39.39 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.243 1.017 . . . . 73.5 108.376 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.49 ' HB2' HD11 ' D' ' 51' ' ' LEU . 17.1 tt0 -87.18 112.71 22.24 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.949 -1.13 . . . . 75.52 107.949 169.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 86.7 t -98.32 124.13 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 N-CA-C 107.006 -1.479 . . . . 73.2 107.006 174.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 32.8 t -105.02 135.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.691 0.797 . . . . 70.24 109.024 -177.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.09 121.18 44.6 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.923 -1.14 . . . . 64.41 107.923 178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.4 ttm-85 -103.68 102.28 12.14 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.835 -1.172 . . . . 64.14 107.835 173.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.571 HG21 ' HB1' ' D' ' 110' ' ' ALA . 19.8 t -98.44 120.61 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.664 -0.865 . . . . 71.45 108.664 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.1 m -108.04 137.41 46.09 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.187 0.595 . . . . 72.3 109.931 -177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.602 HG13 HG23 ' D' ' 40' ' ' VAL . 50.7 t -136.89 108.04 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.752 1.221 . . . . 61.24 108.054 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 97.9 m -101.07 126.94 47.8 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.317 -0.994 . . . . 54.21 108.317 171.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -111.94 141.44 45.58 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.323 -0.621 . . . . 53.21 109.323 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 57.5 p -145.13 141.99 29.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 123.708 0.63 . . . . 73.41 111.016 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' D' ' 38' ' ' PRO . 39.9 mt -136.35 112.51 9.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.777 1.231 . . . . 74.21 109.456 -178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.12 -109.72 2.97 Favored Glycine 0 C--N 1.342 0.893 0 N-CA-C 111.368 -0.693 . . . . 72.24 111.368 -175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -122.54 4.09 9.6 Favored 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 123.495 0.718 . . . . 65.43 110.588 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -115.7 153.09 31.98 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.316 0.646 . . . . 72.45 110.601 -174.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.9 m -76.53 116.61 17.37 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 122.774 0.429 . . . . 70.23 110.42 178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -69.5 -56.58 6.96 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.541 -0.754 . . . . 73.44 111.026 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -154.96 174.06 15.69 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.43 -0.804 . . . . 64.43 110.654 170.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 87.1 mt -131.36 145.19 51.73 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 106.88 -1.526 . . . . 73.12 106.88 175.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.523 ' SG ' HG23 ' D' ' 114' ' ' ILE . 53.0 t -157.79 121.21 4.01 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.863 -0.792 . . . . 72.13 108.863 -174.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.83 129.03 10.46 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 109.468 -0.567 . . . . 70.42 109.468 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -128.94 121.2 53.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 C-N-CA 123.875 0.87 . . . . 63.22 109.577 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -87.84 85.01 6.97 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.387 -0.968 . . . . 74.2 108.387 167.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -79.98 97.8 6.91 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.324 -0.991 . . . . 60.12 108.324 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.59 143.72 16.74 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 111.859 -0.496 . . . . 42.14 111.859 -178.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.43 131.48 4.86 Favored Glycine 0 CA--C 1.505 -0.532 0 N-CA-C 111.421 -0.672 . . . . 53.32 111.421 -175.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.2 mt -90.31 125.72 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.574 -0.899 . . . . 71.04 108.574 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -128.5 127.86 43.25 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.942 0.897 . . . . 72.12 109.684 -175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.557 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 49.0 m -81.82 93.18 6.8 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.256 -1.016 . . . . 53.42 108.256 165.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.52 128.36 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.968 1.707 . . . . 64.42 109.751 -172.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.85 164.99 20.85 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.072 0.949 . . . . 72.53 109.958 175.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 83.07 11.54 80.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.092 -0.504 . . . . 71.44 114.182 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 pp -98.17 168.35 1.68 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.912 0 C-N-CA 123.457 0.703 . . . . 74.12 110.571 177.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.521 ' HB2' ' H ' ' H' ' 172' ' ' ALA . 5.7 pt-20 -162.51 146.61 11.81 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 114.894 -1.048 . . . . 73.34 109.815 -176.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.716 ' H ' ' HB3' ' H' ' 172' ' ' ALA . . . 42.88 -107.61 0.12 Allowed Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.307 1.004 . . . . 60.24 114.915 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . 0.436 ' H ' ' HA3' ' H' ' 169' ' ' GLY . 9.7 m -67.27 -38.58 85.33 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.492 0.717 . . . . 62.45 110.937 -177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -63.72 -31.95 73.28 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.77 0.828 . . . . 72.43 110.573 178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 45.1 ttm -67.74 -50.77 55.54 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.682 0.793 . . . . 64.23 110.284 177.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.63 -24.24 62.69 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.829 -0.623 . . . . 63.53 111.303 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -79.51 -32.37 42.33 Favored 'General case' 0 C--O 1.218 -0.599 0 C-N-CA 123.398 0.679 . . . . 72.33 110.31 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.2 t -78.27 -52.75 8.17 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 117.729 0.24 . . . . 55.2 110.356 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 6.9 mp -86.41 -18.52 31.56 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.658 0.383 . . . . 74.31 111.788 -174.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.68 -8.98 29.54 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.266 -0.741 . . . . 61.24 114.254 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.33 -55.21 0.53 Allowed 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 118.027 0.914 . . . . 65.04 112.329 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -76.34 -50.94 12.98 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.096 0.559 . . . . 70.45 111.994 -166.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.401 ' O ' ' HG ' ' D' ' 106' ' ' LEU . 71.0 m -60.96 -46.19 96.69 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-O 118.438 -0.791 . . . . 74.43 110.478 176.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -50.96 -39.57 59.27 Favored 'Trans proline' 0 C--N 1.399 3.22 0 C-N-CA 122.263 1.976 . . . . 65.42 114.019 163.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -69.03 -26.61 65.07 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 123.353 0.661 . . . . 63.15 110.753 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -72.56 -38.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 123.892 0.877 . . . . 74.51 110.387 173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.53 HD21 ' HA3' ' D' ' 82' ' ' GLY . 42.3 mt -79.64 -17.89 52.74 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.032 -0.986 . . . . 55.21 111.209 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -68.69 -38.64 12.46 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 114.18 1.178 . . . . 62.42 114.18 -171.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.34 -46.78 29.93 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.101 1.868 . . . . 74.05 113.095 170.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -71.86 -33.21 68.24 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.158 -0.928 . . . . 65.14 111.123 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.571 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -67.61 -54.24 21.4 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.927 0.891 . . . . 72.21 110.152 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -50.56 -46.5 57.65 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.987 1.43 . . . . 74.0 110.811 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -66.43 -46.07 77.7 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 124.175 0.922 . . . . 72.3 111.732 -176.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -59.95 -41.71 92.44 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 123.737 0.648 . . . . 72.2 110.709 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.523 HG23 ' SG ' ' D' ' 76' ' ' CYS . 81.7 mt -59.45 -56.99 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.365 1.066 . . . . 51.53 110.671 171.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.633 HG23 ' HG3' ' D' ' 125' ' ' GLN . 54.9 m -53.93 -41.37 67.63 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.276 1.43 . . . . 75.31 111.865 -174.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 27.4 t -67.82 -42.59 81.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.923 -1.035 . . . . 73.13 109.958 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.444 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.6 mtm -71.11 -28.07 64.05 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.887 0.475 . . . . 64.34 111.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.2 t -67.42 -42.74 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 123.438 0.695 . . . . 64.41 110.135 174.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -74.38 -26.53 60.17 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.972 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -76.09 -24.16 55.02 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.458 0.703 . . . . 72.23 109.826 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.72 12.24 66.15 Favored Glycine 0 C--N 1.352 1.432 0 O-C-N 123.654 0.596 . . . . 74.33 112.258 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.595 HG23 ' HB3' ' C' ' 17' ' ' TYR . 80.6 p 62.95 9.98 4.09 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 127.385 2.274 . . . . 71.43 114.6 176.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.467 ' HZ ' HG13 ' D' ' 31' ' ' VAL . 41.9 m-85 -89.37 156.42 48.34 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 123.172 0.589 . . . . 74.31 110.65 178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.89 141.37 89.52 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.714 2.276 . . . . 74.21 111.968 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.633 ' HG3' HG23 ' D' ' 115' ' ' THR . 28.2 tt0 -54.51 145.55 18.32 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.686 1.194 . . . . 74.34 112.107 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.85 114.8 15.74 Favored 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 108.065 -1.087 . . . . 71.43 108.065 176.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -100.78 93.24 5.46 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 109.12 -0.696 . . . . 72.32 109.12 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.584 HD22 HD22 ' D' ' 42' ' ' LEU . 89.0 mt -59.0 115.48 3.17 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.25 0.62 . . . . 72.23 110.92 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' B' ' 13' ' ' ILE . . . -65.3 127.84 93.26 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 122.773 0.429 . . . . 74.54 111.867 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -78.28 102.01 1.52 Allowed 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.049 1.833 . . . . 75.05 110.399 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 p -108.01 130.0 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 115.537 -0.756 . . . . 73.2 109.71 -174.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -92.64 116.37 28.95 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 108.4 -0.963 . . . . 75.24 108.4 173.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -63.62 -14.74 54.6 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 119.58 -0.248 . . . . 71.52 111.148 176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -43.56 -50.37 7.25 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.875 1.27 . . . . 74.23 111.127 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.8 -53.76 54.6 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.405 1.066 . . . . 65.23 110.706 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.524 HD21 HG21 ' G' ' 207' ' ' VAL . 2.7 mm? -71.52 -25.01 62.07 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.105 0.562 . . . . 64.35 112.001 -174.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -75.28 -49.71 18.36 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.261 1.024 . . . . 72.43 109.613 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 67.1 mtm -73.46 -46.13 50.11 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.621 0.768 . . . . 72.42 110.731 -178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.429 ' HA ' HE21 ' D' ' 142' ' ' GLN . 3.7 m-20 -62.1 -31.28 71.71 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.603 0.761 . . . . 72.32 112.125 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -55.44 -40.38 71.46 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 123.475 0.484 . . . . 75.04 110.901 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.89 -46.97 10.79 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.14 0.576 . . . . 71.43 112.106 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.429 HE21 ' HA ' ' D' ' 139' ' ' ASN . 5.2 pp0? -85.3 4.97 32.53 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.043 0.757 . . . . 65.44 113.043 -170.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -117.21 90.3 3.3 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 108.509 -0.923 . . . . 63.11 108.509 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.67 17.59 1.82 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.079 -1.419 . . . . 63.02 109.188 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.54 14.73 23.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.993 0.917 . . . . 74.44 111.371 -179.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.77 -16.68 59.49 Favored Glycine 0 C--N 1.357 1.71 0 C-N-CA 123.632 0.634 . . . . 60.5 114.231 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -63.24 91.59 0.05 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.77 0.795 . . . . 74.4 109.978 168.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.47 -128.99 2.88 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-O 119.146 -0.808 . . . . 62.34 111.431 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 30.8 m 59.2 85.51 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.642 1.177 . . . . 40.22 109.496 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 63.2 -167.82 0.21 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.187 0.995 . . . . 73.23 111.316 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -68.66 103.38 1.71 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.121 -0.696 . . . . 64.12 109.121 175.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -113.23 115.94 28.99 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.614 0.766 . . . . 75.04 108.965 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -76.88 94.69 3.95 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.563 -0.532 . . . . 74.1 109.563 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -79.76 136.35 36.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.183 0.593 . . . . 74.04 109.968 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 C-N-CA 123.837 0.855 . . . . 73.12 110.356 -178.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.368 -0.604 . . . . 62.32 109.368 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' E' ' 173' ' ' LEU . . . 163.19 -123.7 1.21 Allowed Glycine 0 C--N 1.341 0.825 0 CA-C-O 119.366 -0.686 . . . . 41.31 111.555 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 10.2 tmtt? 66.75 -76.8 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.233 1.413 . . . . 62.24 109.66 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -78.5 82.15 4.78 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.589 0.756 . . . . 74.03 109.018 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . . . . . . . . . . . 62.57 -128.22 0.62 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 124.276 0.985 . . . . 71.33 110.599 -177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.706 HD21 ' HA ' ' C' ' 54' ' ' ASP . 44.0 mt 61.86 74.83 0.43 Allowed 'General case' 0 C--N 1.368 1.375 0 C-N-CA 124.468 1.107 . . . . 70.22 110.838 172.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . 0.601 ' HG2' ' H ' ' C' ' 91' ' ' GLY . 1.0 OUTLIER -81.01 -42.64 20.82 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.883 -1.508 . . . . 73.22 110.281 -172.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . . . . . . . . . 32.5 t80 56.99 -85.12 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.601 1.16 . . . . 72.12 109.67 -164.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 69.94 25.72 4.84 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.153 0.981 . . . . 72.13 112.774 168.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . 0.466 HD11 ' HA ' ' C' ' 95' ' ' ALA . 6.5 mp -101.26 128.68 47.29 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.785 -0.82 . . . . 74.01 108.785 168.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -145.06 99.38 3.32 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 107.272 -1.381 . . . . 75.34 107.272 169.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 69.48 151.74 0.13 Allowed Pre-proline 0 N--CA 1.487 1.401 0 C-N-CA 125.664 1.585 . . . . 72.13 111.496 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -63.95 103.05 0.39 Allowed 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.319 2.013 . . . . 61.34 110.991 171.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -61.21 -30.43 70.42 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.74 0.816 . . . . 75.02 111.987 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -135.39 114.21 11.95 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.15 -1.056 . . . . 72.14 108.15 173.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . . . . . . . . . 33.6 m -79.93 139.73 36.96 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.558 0.743 . . . . 72.23 109.918 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 4.0 m0 -112.05 94.96 27.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 N-CA-C 109.029 -0.73 . . . . 73.22 109.029 -178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -61.98 124.95 15.41 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.716 2.277 . . . . 74.31 112.824 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 5.2 mp -86.05 165.06 16.96 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.752 0.821 . . . . 74.01 109.863 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . . . . . . . . . 46.2 pt -68.99 148.65 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.027 0.441 . . . . 74.41 111.634 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -77.62 123.52 26.74 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 108.373 -0.973 . . . . 64.13 108.373 167.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.74 -88.21 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.869 0 O-C-N 123.862 0.726 . . . . 60.52 111.707 -173.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 27.6 t70 44.62 -90.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.301 1.44 . . . . 63.53 112.01 -176.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 51.66 -90.7 0.01 OUTLIER Glycine 0 C--N 1.358 1.761 0 C-N-CA 124.992 1.282 . . . . 72.14 115.841 167.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' F' ' 194' ' ' ALA . . . -74.11 96.37 0.88 Allowed Glycine 0 C--N 1.343 0.928 0 CA-C-N 114.704 -0.748 . . . . 74.51 113.153 -174.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -87.08 -24.46 24.56 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.431 0.692 . . . . 65.25 110.174 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' F' ' 193' ' ' TYR . . . -106.94 130.23 54.63 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.049 0.54 . . . . 63.13 111.254 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -144.72 150.18 36.84 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.913 1.285 . . . . 75.04 108.507 175.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -90.71 110.02 21.2 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.221 -0.659 . . . . 63.04 109.221 175.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -142.25 116.5 9.51 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.43 -1.693 . . . . 73.05 106.43 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . 0.558 ' HG2' ' H ' ' E' ' 199' ' ' ASN . 17.5 tt0 67.41 -171.04 0.19 Allowed 'General case' 0 CA--C 1.571 1.777 0 O-C-N 124.139 0.899 . . . . 75.53 110.526 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . 0.558 ' H ' ' HG2' ' E' ' 198' ' ' GLU . 21.5 t-20 69.97 105.89 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 125.384 1.474 . . . . 74.1 111.828 171.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . 86.76 -67.24 3.46 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 111.342 -0.703 . . . . 62.42 111.342 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.94 171.21 19.79 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.277 1.031 . . . . 73.44 108.543 176.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 49.4 t80 76.75 18.07 1.68 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.571 1.548 . . . . 64.31 109.187 -169.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -87.91 -31.34 19.51 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.86 1.664 . . . . 73.34 110.65 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.643 HG12 ' HB1' ' B' ' 129' ' ' ALA . 8.0 mt 71.41 -8.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 C-N-CA 126.142 1.777 . . . . 62.12 112.027 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -77.36 -11.68 59.87 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.235 1.014 . . . . 75.13 110.605 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.59 67.98 6.64 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.45 1.1 . . . . 64.55 110.152 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 75.3 t . . . . . 0 C--O 1.251 1.134 0 C-N-CA 124.638 1.175 . . . . 73.24 108.835 -178.038 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 110.638 -0.134 . . . . 64.24 110.638 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . -156.58 -135.59 1.98 Allowed Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.535 -0.592 . . . . 64.55 111.757 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -66.39 -37.46 85.29 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.61 0.764 . . . . 61.12 110.93 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 39.7 m -75.62 1.19 15.09 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.545 0.738 . . . . 61.32 111.643 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -95.48 15.84 18.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.57 0.748 . . . . 73.41 110.729 171.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.584 HD21 ' HE2' ' B' ' 56' ' ' TYR . 0.3 OUTLIER -63.83 124.51 21.68 Favored 'General case' 0 CA--C 1.552 1.047 0 N-CA-C 109.289 -0.634 . . . . 73.14 109.289 -179.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.764 ' SD ' ' HG2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -153.61 178.83 9.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.146 1.378 . . . . 63.53 109.206 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -149.25 140.65 23.27 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.349 0.659 . . . . 64.44 109.629 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -157.2 109.2 2.41 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.96 -1.126 . . . . 64.53 107.96 174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . 0.459 ' HA ' HD21 ' B' ' 98' ' ' LEU . 38.8 tp -67.06 100.53 0.76 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.785 -0.45 . . . . 74.34 109.785 177.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . 0.581 ' HB3' ' HA3' ' B' ' 99' ' ' GLY . 51.4 tp60 -69.39 116.87 10.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.29 0.636 . . . . 71.3 110.202 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . 0.632 ' H ' ' HD2' ' F' ' 180' ' ' PRO . 34.7 mt-10 -128.73 -50.34 0.03 OUTLIER Pre-proline 0 CA--C 1.563 1.475 0 C-N-CA 124.145 0.978 . . . . 63.02 111.564 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . 0.632 ' HD2' ' H ' ' F' ' 179' ' ' GLU . 85.6 Cg_endo -74.76 -159.86 0.09 OUTLIER 'Trans proline' 0 C--N 1.4 3.246 0 C-N-CA 121.923 1.749 . . . . 73.2 112.687 177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . 0.429 ' HD2' HE22 ' F' ' 178' ' ' GLN . 97.4 m-85 68.5 135.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.237 1.415 . . . . 64.12 112.705 177.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 69.13 -71.48 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.253 1.421 . . . . 72.31 113.118 171.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 15.5 m 69.92 105.21 0.06 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.094 1.358 . . . . 64.1 110.121 -175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.541 ' HE1' ' HB3' ' B' ' 44' ' ' LEU . 4.6 p90 -87.17 110.08 30.4 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 124.221 1.008 . . . . 71.04 111.589 -173.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -81.76 77.13 4.0 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.411 2.074 . . . . 63.13 111.734 176.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.571 HD13 HD22 ' B' ' 128' ' ' LEU . 0.5 OUTLIER -97.16 10.9 38.13 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 113.061 0.763 . . . . 42.45 113.061 -174.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.416 HD11 HD22 ' B' ' 126' ' ' LEU . 7.7 tp -158.87 169.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 N-CA-C 110.052 -0.351 . . . . 74.11 110.052 175.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -154.29 -19.86 0.13 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.101 0.96 . . . . 62.13 111.422 175.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . 61.11 -146.23 0.45 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.903 0.881 . . . . 61.25 109.897 -170.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 34.2 t70 73.78 158.88 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 124.436 1.094 . . . . 75.42 112.109 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . 65.51 11.68 53.85 Favored Glycine 0 N--CA 1.481 1.684 0 N-CA-C 115.549 0.979 . . . . 52.21 115.549 171.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.52 108.54 3.66 Favored Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.733 -0.547 . . . . 61.04 111.733 -176.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . 0.439 ' HB2' ' HB3' ' E' ' 194' ' ' ALA . 64.9 m-85 -138.64 87.8 2.25 Favored 'General case' 0 C--O 1.244 0.809 0 C-N-CA 123.795 0.838 . . . . 62.32 108.946 173.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' E' ' 192' ' ' GLY . . . -130.95 -8.17 3.92 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 114.447 -1.251 . . . . 52.03 111.289 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' B' ' 124' ' ' PRO . 56.8 t80 -91.57 106.69 18.67 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.69 0.796 . . . . 63.43 109.531 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -144.93 136.22 25.11 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.799 -1.185 . . . . 70.01 107.799 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -71.45 -55.01 8.74 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 70.01 108.202 171.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -74.84 112.64 11.27 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.011 -0.737 . . . . 73.01 109.011 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 16.4 m120 60.73 83.09 0.15 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.182 0.993 . . . . 71.3 109.841 -175.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -154.04 127.17 2.07 Favored Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.906 -0.588 . . . . 65.25 112.102 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . 0.422 ' HG3' ' CD1' ' F' ' 202' ' ' TYR . 39.7 pttt -92.93 -6.54 48.31 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.089 0.956 . . . . 71.42 111.002 177.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . 0.422 ' CD1' ' HG3' ' F' ' 201' ' ' LYS . 2.8 m-30 -103.91 1.91 31.88 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.177 0.991 . . . . 74.11 110.975 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -137.47 165.73 25.55 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.016 0.526 . . . . 74.35 109.716 -171.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 10.1 tt -101.69 119.93 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.543 1.137 . . . . 54.04 109.863 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -78.78 -47.77 16.12 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.404 0.621 . . . . 74.22 109.702 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -144.34 -55.48 0.35 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 107.228 -1.397 . . . . 53.13 107.228 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.638 HG21 HD12 ' C' ' 136' ' ' LEU . 28.2 m . . . . . 0 CA--C 1.552 1.043 0 C-N-CA 125.132 1.373 . . . . 74.41 109.157 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 6.4 mptt . . . . . 0 N--CA 1.48 1.064 0 N-CA-C 108.676 -0.861 . . . . 63.34 108.676 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . -66.25 83.88 0.1 OUTLIER Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.691 -0.564 . . . . 51.3 111.691 173.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -126.44 -86.66 0.6 Allowed 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.592 1.157 . . . . 73.23 108.19 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . 0.497 ' HA ' ' H ' ' A' ' 54' ' ' ASP . 16.8 t 66.06 176.8 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.722 1.209 . . . . 60.03 113.581 175.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 86' ' ' ILE . . . -102.97 -175.08 2.7 Favored 'General case' 0 C--O 1.246 0.886 0 N-CA-C 108.81 -0.811 . . . . 65.03 108.81 166.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . 0.513 HD12 ' H ' ' C' ' 149' ' ' THR . 0.0 OUTLIER -133.91 23.08 3.89 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.277 0.631 . . . . 73.51 111.895 -169.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . 0.572 ' SD ' ' HG2' ' A' ' 94' ' ' MET . 7.5 ptt? -159.28 151.85 21.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.864 0.69 . . . . 64.4 112.864 -161.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.562 ' HA ' HD13 ' A' ' 98' ' ' LEU . 57.7 m-85 -137.85 -61.93 0.61 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.246 1.418 . . . . 75.05 108.778 172.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 73.81 -4.1 2.34 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 125.987 1.715 . . . . 74.05 112.038 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 26.3 tp -69.0 -25.03 64.3 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.329 0.652 . . . . 75.53 111.62 -172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . 0.572 ' HG2' ' HG3' ' G' ' 179' ' ' GLU . 27.4 tt0 -49.65 -49.82 45.74 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.237 1.015 . . . . 75.13 110.961 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . 0.572 ' HG3' ' HG2' ' G' ' 178' ' ' GLN . 31.0 mt-10 -134.06 101.31 12.6 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.415 1.086 . . . . 75.31 108.157 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -57.54 106.84 0.26 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.731 2.287 . . . . 55.45 110.746 173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -52.88 -35.87 58.43 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.731 1.212 . . . . 55.31 113.22 -172.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -94.46 -24.12 17.44 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.691 0.796 . . . . 72.24 110.974 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 56.8 m 69.73 126.6 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.715 1.206 . . . . 70.01 112.671 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . 0.449 ' HB3' ' CE1' ' A' ' 133' ' ' PHE . 1.5 p-90 -146.91 91.65 5.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 123.488 0.715 . . . . 63.22 110.622 -176.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -74.24 -19.55 19.71 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.657 2.238 . . . . 65.31 112.946 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 79.2 mt 61.15 -176.43 0.12 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.21 1.404 . . . . 74.15 112.689 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -92.91 172.83 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 115.557 -0.747 . . . . 75.4 110.592 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -136.81 178.8 6.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.061 0.945 . . . . 41.5 109.179 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . . . . . . . . . . . -125.42 171.71 10.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.542 0.737 . . . . 72.02 110.624 -177.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -127.48 -60.48 1.18 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.111 0.564 . . . . 64.4 109.591 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.3 -110.67 0.46 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.047 -0.421 . . . . 53.32 112.047 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' H' ' 200' ' ' GLY . . . 89.85 46.33 4.26 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.753 -0.539 . . . . 73.33 111.753 -176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -111.48 -174.52 2.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.171 0.989 . . . . 72.11 109.424 175.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -157.57 -65.65 0.09 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.443 0.534 . . . . 23.03 112.443 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 64.07 172.21 0.18 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 124.579 1.152 . . . . 71.43 112.127 -168.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -136.91 93.0 2.79 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.603 -0.517 . . . . 71.35 109.603 -177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -115.0 73.4 0.83 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.666 0.786 . . . . 74.25 110.15 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -92.46 -3.38 55.28 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.701 -0.681 . . . . 71.2 109.206 164.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 25.3 p-10 -158.03 -173.16 4.21 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 125.167 1.387 . . . . 75.24 109.596 -167.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . -81.95 -15.56 74.71 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-O 119.634 -0.536 . . . . 41.23 112.91 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.68 -0.55 3.13 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.775 1.23 . . . . 74.24 112.685 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -155.96 22.59 0.38 Allowed 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 107.308 -1.368 . . . . 73.51 107.308 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -71.65 106.45 4.07 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.439 -1.255 . . . . 73.04 111.742 -171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 11.0 pt -129.92 118.69 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.15 -1.426 . . . . 71.03 107.15 169.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -49.19 -34.3 14.35 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 124.459 1.104 . . . . 71.03 113.638 -165.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -164.43 -75.48 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.194 -1.039 . . . . 71.22 108.194 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . 0.524 HG21 HD21 ' D' ' 136' ' ' LEU . 4.2 p . . . . . 0 CA--C 1.556 1.177 0 C-N-CA 123.928 0.891 . . . . 73.01 108.946 174.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 46.7 tptt . . . . . 0 N--CA 1.485 1.277 0 N-CA-C 109.159 -0.682 . . . . 74.11 109.159 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . 0.436 ' HA3' ' H ' ' D' ' 92' ' ' THR . . . -125.29 -152.49 8.25 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 112.282 -0.327 . . . . 62.14 112.282 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -79.89 140.2 36.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.232 -1.025 . . . . 62.21 108.232 174.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 14.8 p -65.66 85.01 0.07 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.833 0.825 . . . . 62.41 110.73 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.716 ' HB3' ' H ' ' D' ' 91' ' ' GLY . . . -115.74 -173.68 2.39 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 125.053 1.341 . . . . 75.43 110.016 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . 0.482 HD21 HD22 ' D' ' 6' ' ' ASN . 1.5 tt -157.77 -74.19 0.09 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 122.841 0.456 . . . . 73.51 109.922 -176.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 27.4 mmt -81.62 159.61 23.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.753 0.421 . . . . 62.22 111.218 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -46.78 103.04 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 O-C-N 125.031 1.457 . . . . 65.34 112.493 -166.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -107.98 -66.6 1.02 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.562 1.145 . . . . 73.1 108.599 178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 21.3 tp 59.93 22.6 11.64 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 124.681 1.192 . . . . 73.43 111.655 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -88.69 6.97 35.98 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.647 0.779 . . . . 75.11 111.381 -174.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -79.11 116.69 62.06 Favored Pre-proline 0 N--CA 1.476 0.826 0 C-N-CA 123.706 0.802 . . . . 64.51 110.438 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -85.11 110.82 1.32 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.4 2.067 . . . . 73.51 111.518 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.636 -0.875 . . . . 72.41 108.636 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -63.82 -71.82 0.16 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.201 0.6 . . . . 75.31 110.861 -172.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 12.1 p -145.64 164.17 32.58 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.216 1.007 . . . . 73.31 108.619 174.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -113.31 92.03 21.39 Favored Pre-proline 0 N--CA 1.473 0.703 0 N-CA-C 107.995 -1.113 . . . . 70.44 107.995 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -83.64 88.08 1.17 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.153 2.569 . . . . 74.15 111.874 -175.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.86 125.94 30.35 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.784 -0.821 . . . . 72.14 108.784 175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . . . . . . . . . 24.4 pt -62.03 138.98 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 124.234 0.959 . . . . 75.53 111.366 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -99.44 1.01 43.77 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.485 -0.779 . . . . 73.12 110.389 175.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . 75.92 -65.67 0.31 Allowed 'General case' 0 C--N 1.363 1.153 0 C-N-CA 126.029 1.732 . . . . 54.14 112.485 176.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 65.15 -172.12 0.18 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.745 1.218 . . . . 74.2 111.186 -173.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . . . . . . . . . . . 76.3 100.43 0.14 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.84 -0.618 . . . . 21.32 112.621 175.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -174.74 100.34 0.15 Allowed Glycine 0 C--N 1.34 0.761 0 N-CA-C 112.245 -0.342 . . . . 72.42 112.245 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -92.63 -54.39 3.8 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.793 -0.817 . . . . 74.4 108.793 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.45 -174.25 2.17 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 114.267 -1.333 . . . . 72.24 109.266 -175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -172.63 -15.38 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 O-C-N 123.931 0.769 . . . . 63.11 111.579 171.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? 68.52 94.51 0.07 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.849 0.86 . . . . 73.23 109.141 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . 0.447 ' HE2' ' HA ' ' D' ' 32' ' ' PHE . 10.3 t80 -80.83 -30.32 35.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.453 1.101 . . . . 74.51 111.869 -170.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -85.47 178.52 7.39 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.226 1.01 . . . . 70.23 111.65 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . 0.411 ' HB3' ' CD2' ' H' ' 202' ' ' TYR . 93.2 m-20 -92.41 -170.8 2.6 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.309 1.043 . . . . 74.24 109.862 172.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . 0.402 ' HA3' ' HA3' ' G' ' 192' ' ' GLY . . . -147.9 -79.03 0.03 OUTLIER Glycine 0 C--N 1.349 1.268 0 N-CA-C 112.296 -0.321 . . . . 55.31 112.296 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -87.11 68.14 9.88 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.651 0.78 . . . . 75.21 109.945 -177.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . 0.411 ' CD2' ' HB3' ' H' ' 199' ' ' ASN . 79.4 m-85 -136.75 92.44 2.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.65 1.18 . . . . 74.02 108.809 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -85.18 82.12 8.53 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.465 -0.789 . . . . 63.12 109.128 177.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . . . . . . . . . 59.1 mt -86.46 73.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 107.883 -1.155 . . . . 53.03 107.883 175.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -122.87 24.91 8.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.221 -1.354 . . . . 73.31 109.864 -171.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.1 -172.07 2.36 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.69 0.796 . . . . 64.23 109.803 -177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.507 HG21 ' HB2' ' A' ' 136' ' ' LEU . 7.0 m . . . . . 0 C--O 1.257 1.456 0 C-N-CA 123.018 0.527 . . . . 64.41 110.594 174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 111.376 0.139 . . . . 73.53 111.376 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 m -132.33 40.17 3.33 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.858 0.863 . . . . 73.02 109.215 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -65.64 120.23 12.56 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.508 0.723 . . . . 74.53 110.879 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -66.26 102.11 0.81 Allowed 'General case' 0 C--O 1.239 0.525 0 O-C-N 124.007 0.817 . . . . 61.14 109.043 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -73.95 72.35 1.6 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.003 0.906 . . . . 72.22 110.583 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -69.71 103.43 2.14 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.987 -1.006 . . . . 62.22 108.301 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -83.9 30.61 0.5 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.444 1.098 . . . . 70.12 111.635 -178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -54.36 -44.58 72.31 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.252 1.421 . . . . 73.05 109.829 169.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.88 167.18 17.25 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.657 -1.156 . . . . 75.12 112.238 -176.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.7 m -149.43 143.88 26.0 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.114 0.965 . . . . 75.3 109.52 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.473 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 65.3 t80 -128.13 147.35 50.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.053 0.941 . . . . 72.2 109.676 173.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -158.93 137.37 10.8 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 120.74 0.305 . . . . 75.25 111.394 173.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' C' ' 132' ' ' ASN . 13.5 mm -74.78 118.73 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 N-CA-C 108.427 -0.953 . . . . 72.52 108.427 166.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -89.25 -38.39 14.26 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 109.685 -0.487 . . . . 74.1 109.685 168.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -169.98 153.24 4.64 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 123.39 0.432 . . . . 74.01 111.259 -174.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.563 ' H ' ' HG3' ' C' ' 130' ' ' PRO . 98.3 mt -137.02 126.68 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 125.731 1.613 . . . . 54.25 106.814 173.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -154.61 157.11 37.71 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.461 1.104 . . . . 70.0 109.598 -170.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.56 HG21 ' SG ' ' A' ' 113' ' ' CYS . 45.3 p -86.99 117.17 25.53 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.881 -0.785 . . . . 71.31 108.881 170.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HA ' ' HB3' ' B' ' 25' ' ' ALA . 42.0 mtpt -83.56 -22.35 32.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.43 0.292 . . . . 71.03 110.284 173.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.4 t70 -153.8 140.02 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.681 -0.691 . . . . 75.22 109.667 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 40.8 mt -136.64 133.18 48.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.953 -1.499 . . . . 73.32 106.953 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.7 t -145.37 107.59 4.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.156 -0.683 . . . . 33.42 109.156 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.2 t80 -119.25 110.32 16.87 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 106.872 -1.529 . . . . 73.13 106.872 169.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' PRO . 40.6 mt-10 -116.95 108.21 15.5 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.756 -1.572 . . . . 70.4 106.756 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.68 83.05 0.72 Allowed Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 106.946 -1.502 . . . . 72.12 106.946 172.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 24' ' ' GLU . 13.7 Cg_exo -68.69 -31.63 25.57 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.726 2.284 . . . . 72.35 111.704 -168.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 27.7 m-80 -118.24 39.99 3.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.059 -0.973 . . . . 61.43 108.807 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.23 -50.0 87.17 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.083 -0.962 . . . . 75.11 113.203 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.42 -24.67 22.33 Favored 'Trans proline' 0 C--N 1.395 2.978 0 C-N-CA 121.775 1.65 . . . . 45.12 113.132 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -69.76 -24.45 63.53 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.408 0.683 . . . . 70.02 111.802 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG11 ' HE1' ' A' ' 123' ' ' PHE . 88.6 t -57.21 -33.26 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.401 0.68 . . . . 43.34 111.465 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -64.05 -32.13 73.57 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.748 0.819 . . . . 72.41 111.224 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -80.49 -27.04 37.87 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.352 1.061 . . . . 64.23 110.255 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -82.67 162.07 21.95 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.379 1.072 . . . . 75.33 112.362 -176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -81.92 129.29 34.72 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 107.363 -1.347 . . . . 71.21 107.363 163.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.45 ' CE3' HD21 ' A' ' 68' ' ' LEU . 68.1 t-105 -77.32 84.17 3.76 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 121.745 0.784 . . . . 72.35 110.329 -179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -132.01 77.11 72.34 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 107.204 -1.406 . . . . 74.14 107.204 171.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.8 146.17 37.59 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.102 1.868 . . . . 64.34 112.077 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -96.34 86.12 4.12 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.39 -1.708 . . . . 75.15 106.39 172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -68.01 102.25 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.54 -1.209 . . . . 62.54 110.823 -175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.0 tttp -111.49 146.18 37.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.918 0.887 . . . . 73.31 110.184 -176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 pp -121.01 153.19 37.68 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.76 0.824 . . . . 62.51 110.659 177.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 19.0 t70 -142.9 113.82 7.62 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.883 0.873 . . . . 54.21 108.66 174.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.8 tp -98.84 119.97 38.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.5 -0.926 . . . . 45.04 108.5 177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -138.3 142.87 39.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.427 0.691 . . . . 74.44 109.952 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -110.03 144.76 38.13 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.817 0.847 . . . . 70.4 108.815 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.34 113.63 12.81 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.077 -1.083 . . . . 23.44 108.077 -176.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.419 ' HB2' ' OH ' ' A' ' 56' ' ' TYR . 35.5 p -88.04 151.02 23.06 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.268 0.627 . . . . 64.32 111.062 -172.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.0 t -163.0 136.72 5.97 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.207 1.003 . . . . 64.11 109.098 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -113.64 124.53 52.55 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.029 0.531 . . . . 72.22 109.75 177.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.5 mt -87.82 -43.16 12.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.33 0.652 . . . . 73.4 110.055 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.28 175.43 13.75 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.638 -1.164 . . . . 73.42 109.676 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -67.06 119.1 11.44 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.609 -0.886 . . . . 74.42 108.609 173.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 78.26 -7.66 1.77 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 125.778 1.631 . . . . 72.21 113.19 -178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -111.83 106.85 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 107.786 -1.19 . . . . 74.21 107.786 174.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' A' ' 48' ' ' SER . 9.3 t80 -117.24 155.33 29.64 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.844 -0.798 . . . . 71.14 108.844 -171.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -127.23 113.77 16.76 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.315 -0.994 . . . . 71.04 108.315 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.09 117.27 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 106.863 -1.532 . . . . 71.14 106.863 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.631 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.6 t -98.36 131.87 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 176.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 106' ' ' LEU . 0.2 OUTLIER -102.12 112.27 24.86 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.261 -1.385 . . . . 72.11 107.261 178.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -101.87 99.98 10.25 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 108.439 -0.948 . . . . 75.24 108.439 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 20.0 t -98.0 132.94 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.991 -1.114 . . . . 74.34 107.991 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 18.7 m -128.77 137.69 51.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.169 0.509 . . . . 72.32 110.096 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.729 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.3 t -130.94 125.57 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 125.354 1.462 . . . . 61.44 108.695 -173.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.1 m -118.58 150.64 39.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.684 0.394 . . . . 71.44 110.097 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.02 112.17 8.02 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.593 -0.892 . . . . 64.23 108.593 172.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.2 m -113.01 126.39 55.45 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.356 0.598 . . . . 64.34 110.411 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 HD21 ' CE3' ' A' ' 36' ' ' TRP . 53.0 mt -89.18 75.6 7.82 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 125.025 1.33 . . . . 71.21 108.652 175.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -82.91 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 111.07 -0.812 . . . . 45.23 111.07 -174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 -19.1 5.59 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.457 1.103 . . . . 71.24 111.742 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -91.68 126.94 36.94 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.031 0.933 . . . . 70.31 109.305 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -77.16 127.59 32.91 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.148 0.885 . . . . 74.44 110.388 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -77.9 -55.74 5.06 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.081 0.952 . . . . 71.33 108.818 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -157.66 169.34 24.88 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.895 -1.502 . . . . 72.12 110.429 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 tp -141.17 138.11 33.16 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.39 -1.277 . . . . 64.44 108.164 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.729 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 66.2 m -128.82 140.6 51.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.038 0.935 . . . . 73.32 109.531 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -149.42 133.53 17.23 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 108.388 -0.967 . . . . 74.24 108.388 167.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.1 t -134.81 110.52 12.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.504 -0.924 . . . . 74.43 108.504 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.2 mt-30 -88.88 79.57 7.33 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.147 -1.057 . . . . 75.53 108.147 173.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -76.06 92.77 3.21 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.032 -0.985 . . . . 75.13 108.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.631 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.47 146.48 20.88 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-N 116.363 -0.38 . . . . 72.11 112.704 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.1 135.89 6.72 Favored Glycine 0 C--N 1.336 0.54 0 CA-C-N 116.789 0.295 . . . . 64.53 112.409 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.7 mt -82.27 126.92 40.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.73 0 N-CA-C 108.332 -0.988 . . . . 74.23 108.332 172.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.464 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 36.1 m-85 -133.18 121.0 21.9 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.876 -0.787 . . . . 71.45 108.876 177.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -78.31 113.36 16.22 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.644 -0.873 . . . . 41.45 108.644 175.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 pp -128.31 133.37 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.559 0.744 . . . . 65.14 110.188 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.04 144.84 14.87 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.804 0.841 . . . . 75.41 109.698 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.37 9.21 86.79 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.783 0.677 . . . . 65.43 113.961 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.635 HD13 ' SD ' ' A' ' 94' ' ' MET . 0.9 OUTLIER -109.89 131.44 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 109.124 -0.695 . . . . 73.13 109.124 -173.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -147.22 176.33 10.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.073 0.949 . . . . 53.24 109.727 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.64 -114.98 3.89 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 124.185 0.928 . . . . 71.13 113.994 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 22.2 p -82.3 -27.29 32.41 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.51 1.124 . . . . 60.34 111.17 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -71.57 -42.55 67.66 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.896 0.879 . . . . 63.32 110.523 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.635 ' SD ' HD13 ' A' ' 89' ' ' ILE . 10.6 tpt -78.52 -34.65 47.15 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.174 176.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.06 -29.18 70.34 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 121.004 0.43 . . . . 52.13 111.313 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -70.71 -56.16 7.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.295 -0.866 . . . . 74.43 109.709 173.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 77.3 m -65.48 -65.53 0.66 Allowed 'General case' 0 CA--C 1.547 0.839 0 O-C-N 123.867 0.729 . . . . 52.32 111.978 -174.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.43 HD21 ' CD1' ' G' ' 175' ' ' PHE . 59.4 tp -63.04 -33.73 76.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.334 1.053 . . . . 73.13 112.114 -177.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.9 -37.26 9.44 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 114.66 0.624 . . . . 50.15 114.66 -170.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.31 -50.38 0.8 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 117.948 0.874 . . . . 64.44 113.348 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 90.1 t80 -68.06 -63.14 1.12 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.435 0.694 . . . . 71.21 111.7 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 58.4 m -61.81 -37.49 40.25 Favored Pre-proline 0 CA--C 1.567 1.617 0 C-N-CA 123.748 0.819 . . . . 63.44 113.209 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.84 -49.82 16.0 Favored 'Trans proline' 0 C--N 1.396 3.065 0 C-N-CA 122.217 1.945 . . . . 62.11 113.081 163.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -73.93 -15.65 61.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.429 0.692 . . . . 73.34 112.007 -172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 13' ' ' ILE . 48.1 mm -62.14 -42.67 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.731 0.777 . . . . 64.33 109.505 169.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 60' ' ' LEU . 52.3 mt -75.31 -21.62 58.3 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.423 -1.262 . . . . 73.12 112.156 -173.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -67.05 -40.65 30.23 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 114.429 1.27 . . . . 74.12 114.429 -166.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.27 -41.31 77.88 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.173 1.915 . . . . 75.34 112.813 170.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -72.95 -36.85 67.25 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.493 0.717 . . . . 71.44 110.976 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.1 -42.46 94.0 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.471 0.708 . . . . 75.4 109.944 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.47 ' NH1' HD12 ' C' ' 105' ' ' ILE . 44.6 ttm105 -55.6 -48.98 73.98 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.618 1.199 . . . . 62.14 110.798 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.66 -45.25 90.99 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.837 0.711 . . . . 64.12 110.301 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.56 ' SG ' HG21 ' A' ' 18' ' ' THR . 42.1 t -61.37 -24.41 66.46 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 115.338 -0.846 . . . . 52.32 112.468 -176.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 64' ' ' VAL . 94.9 mt -85.02 -53.0 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.574 0.749 . . . . 62.24 110.002 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.419 HG23 ' HG3' ' A' ' 125' ' ' GLN . 89.3 m -55.3 -40.95 71.7 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.67 1.188 . . . . 74.01 112.216 -173.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 47.2 t -60.98 -45.55 94.35 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 115.025 -0.989 . . . . 73.02 111.025 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.667 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 61.9 mtm -64.4 -46.03 85.07 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.389 0.675 . . . . 74.25 111.313 -178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.9 t -58.5 -51.02 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 114.572 -1.195 . . . . 75.0 110.846 -178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 123' ' ' PHE . 24.1 t -68.05 -25.86 65.57 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.195 -0.912 . . . . 61.13 111.419 -178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 116' ' ' SER . 45.4 ttm-85 -78.83 -26.0 44.18 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.421 1.088 . . . . 74.55 110.657 -177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.51 13.0 54.14 Favored Glycine 0 C--N 1.356 1.68 0 CA-C-N 115.698 -0.683 . . . . 73.32 112.618 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.512 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 7.0 m 67.98 40.31 2.31 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 124.792 1.237 . . . . 74.33 110.336 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.45 ' HE1' HG11 ' A' ' 31' ' ' VAL . 48.0 m-85 -119.37 157.15 52.14 Favored Pre-proline 0 N--CA 1.477 0.908 0 CA-C-N 114.647 -1.161 . . . . 75.34 108.782 176.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.484 ' HD3' ' HE2' ' G' ' 195' ' ' PHE . 69.3 Cg_endo -70.37 148.47 61.18 Favored 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.155 1.904 . . . . 62.44 111.298 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.6 tt0 -60.01 139.89 57.14 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.525 0.73 . . . . 75.12 111.413 178.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 63.6 tp -131.3 114.75 15.41 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.89 -0.781 . . . . 73.02 108.89 175.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -109.9 105.77 15.08 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 76.3 mt -73.53 128.32 35.16 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 109.082 -0.71 . . . . 51.24 109.082 174.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.32 138.8 97.45 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.516 0.727 . . . . 50.42 111.01 -179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.56 143.99 35.18 Favored 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.237 1.958 . . . . 54.21 110.978 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 46.1 t -99.55 109.68 25.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.042 -1.466 . . . . 64.22 107.042 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.6 t-20 -99.95 74.7 1.82 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.402 -1.332 . . . . 65.41 107.402 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -64.44 -29.62 70.67 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.419 -1.264 . . . . 75.11 110.439 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -55.02 -50.17 69.7 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.54 1.136 . . . . 70.04 110.905 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.94 -52.42 65.12 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 123.49 0.494 . . . . 73.41 110.861 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.8 tp -54.42 -46.37 73.18 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.319 0.648 . . . . 62.53 111.868 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -64.36 -61.79 2.01 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.062 -0.972 . . . . 62.43 110.351 -178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 25.7 mmt -58.97 -50.46 73.99 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.941 0.776 . . . . 65.24 111.685 -172.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 143' ' ' GLN . 91.3 m-20 -53.16 -51.37 62.24 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 124.07 0.856 . . . . 65.34 111.262 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -65.9 -38.25 88.24 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.14 -0.936 . . . . 72.25 111.547 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -66.02 -49.76 66.61 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.934 -0.576 . . . . 75.32 111.403 -176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -176.17 -13.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 113.63 0.974 . . . . 61.21 113.63 -176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 19.9 tp60 -82.44 74.79 9.39 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.074 0.94 . . . . 63.54 110.346 -174.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -78.78 -35.97 43.6 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.547 -1.206 . . . . 63.51 111.478 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.62 103.65 1.38 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.445 0.698 . . . . 70.4 109.738 -176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.43 69.23 3.37 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 111.618 -0.593 . . . . 75.02 111.618 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -54.46 121.81 9.14 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.751 1.22 . . . . 75.41 111.421 -172.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' N ' HG21 ' C' ' 92' ' ' THR . . . -77.15 148.88 35.05 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 115.411 -0.813 . . . . 52.33 113.507 -167.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.5 m -122.11 108.7 13.65 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.881 0.873 . . . . 75.43 109.229 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.446 ' HA ' ' HE1' ' E' ' 182' ' ' PHE . 0.3 OUTLIER -74.77 95.17 2.85 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.679 -1.23 . . . . 73.25 107.679 173.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -119.25 87.62 2.77 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.307 -0.998 . . . . 64.11 108.307 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -74.27 127.17 32.3 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.127 0.971 . . . . 70.1 110.66 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -161.49 144.12 12.14 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.823 0.849 . . . . 72.21 109.198 173.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -84.37 168.21 15.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.01 0.924 . . . . 55.24 110.304 173.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 N-CA-C 108.774 -0.824 . . . . 37.76 108.774 177.182 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtm . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 120.635 0.255 . . . . 71.34 110.686 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 41.3 t -144.35 89.95 2.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.023 0.929 . . . . 71.24 108.661 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.05 -176.99 6.21 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.296 1.038 . . . . 61.5 109.761 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.41 ' HB2' ' HA3' ' B' ' 91' ' ' GLY . 34.7 mm-40 66.44 119.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.18 1.392 . . . . 73.2 111.079 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -138.06 140.69 40.16 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.233 0.613 . . . . 73.2 109.624 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -146.22 89.33 1.86 Allowed 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 107.852 -1.166 . . . . 75.44 107.852 173.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 6.5 m -83.99 76.67 10.03 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.541 -0.754 . . . . 62.33 110.922 -172.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -132.21 -68.72 0.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.737 -1.579 . . . . 61.15 106.737 172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.539 ' HG2' ' N ' ' B' ' 10' ' ' THR . 25.4 ttt 64.52 166.63 0.16 Allowed 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.697 1.599 . . . . 60.23 114.371 166.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.539 ' N ' ' HG2' ' B' ' 9' ' ' MET . 18.9 p -146.8 120.66 9.3 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 125.599 1.559 . . . . 74.22 106.979 169.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -124.5 113.17 17.75 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.997 -0.742 . . . . 73.53 108.997 170.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -135.52 130.45 34.63 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.969 -0.752 . . . . 72.43 108.969 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.543 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -85.36 120.34 35.47 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.633 -1.247 . . . . 73.4 107.633 178.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -90.3 -42.47 10.95 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.567 -0.742 . . . . 75.21 110.451 -177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.512 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 48.3 ttt180 -168.5 137.41 2.28 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 116.041 -0.527 . . . . 64.42 109.728 178.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.543 HG13 HD11 ' B' ' 13' ' ' ILE . 69.4 mt -113.33 133.98 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.468 -1.678 . . . . 71.53 106.468 168.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.458 ' HE1' HG13 ' B' ' 83' ' ' ILE . 29.9 p90 -164.85 146.81 8.11 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 124.013 0.82 . . . . 74.02 110.973 -173.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.4 m -74.9 121.92 22.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.403 -0.817 . . . . 75.14 109.707 172.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -93.99 -31.66 14.16 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.335 0.654 . . . . 73.33 110.907 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 28.6 t70 -153.03 141.16 20.41 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.689 -0.687 . . . . 63.03 110.409 -170.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.483 ' CD1' ' SG ' ' B' ' 113' ' ' CYS . 36.0 mm -136.96 142.92 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.551 1.54 . . . . 61.22 107.831 176.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 36.3 t -148.1 133.62 18.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.222 -1.029 . . . . 34.25 108.222 172.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -150.41 127.73 11.36 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 107.334 -1.358 . . . . 75.25 107.334 169.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.24 155.97 41.03 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 124.523 1.129 . . . . 64.43 108.507 177.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -149.34 79.86 8.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.597 -1.26 . . . . 71.32 107.597 174.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.75 -23.44 30.83 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 122.989 2.459 . . . . 62.23 112.3 -173.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 93.1 m-20 -124.97 31.11 5.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.194 0.998 . . . . 72.31 109.854 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.573 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.6 -47.91 69.67 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 124.967 1.307 . . . . 70.15 113.772 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.47 -23.05 10.29 Favored 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 122.024 1.816 . . . . 72.32 113.551 175.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 69.4 m-70 -78.42 3.45 15.77 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.973 0.909 . . . . 72.4 112.894 -172.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -75.38 -18.88 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 C-N-CA 123.425 0.69 . . . . 73.21 111.192 171.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -83.48 -28.06 29.0 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.894 0.477 . . . . 65.4 110.344 169.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -70.78 -42.48 70.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.12 0.968 . . . . 74.24 109.866 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -103.72 113.07 26.31 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.322 1.049 . . . . 54.21 109.53 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -72.9 80.78 1.17 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 123.166 0.586 . . . . 73.2 110.221 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -170.02 151.35 4.01 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.044 -1.095 . . . . 74.43 108.044 173.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -95.0 127.86 41.26 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-O 118.547 -0.74 . . . . 64.44 109.651 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.518 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 25.1 Cg_endo -60.02 121.97 10.65 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.995 2.463 . . . . 63.23 112.169 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.3 109.25 2.61 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.784 0.677 . . . . 74.42 109.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.717 HG11 ' HA ' ' B' ' 125' ' ' GLN . 6.2 t -85.5 117.16 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 109.054 -0.721 . . . . 75.23 109.054 -168.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 48.6 pttt -136.28 144.22 44.64 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.291 0.636 . . . . 61.13 110.465 -169.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.781 ' HB3' HG13 ' F' ' 187' ' ' ILE . 8.6 tt -126.45 152.49 46.34 Favored 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 124.069 0.948 . . . . 74.13 109.874 -164.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.477 ' N ' HD23 ' B' ' 42' ' ' LEU . 29.5 t70 -137.11 140.85 42.2 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.753 1.221 . . . . 65.33 110.04 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.6 tt -112.16 127.97 56.09 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.058 0.943 . . . . 60.2 109.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -140.62 152.76 45.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.865 1.266 . . . . 70.11 108.984 175.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 88.5 m -145.62 134.4 22.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.007 0.523 . . . . 52.11 110.601 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.66 162.97 30.49 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.071 1.348 . . . . 63.13 108.894 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.1 m -135.62 163.39 30.23 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.922 0.489 . . . . 74.23 110.369 176.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.37 139.21 18.95 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.888 0.875 . . . . 74.22 109.025 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -82.07 132.05 35.25 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.476 0.711 . . . . 71.14 109.408 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 56.0 mt -89.58 -53.08 4.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.792 -0.818 . . . . 64.3 108.792 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.39 -172.36 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.424 -0.807 . . . . 74.35 110.6 -176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -65.39 116.84 7.11 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.319 -0.855 . . . . 72.33 110.078 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.741 ' H ' HD23 ' F' ' 173' ' ' LEU . 12.2 m-20 65.12 13.2 8.55 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.028 1.731 . . . . 75.23 112.602 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.2 t -114.29 100.13 10.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 C-N-CA 124.232 1.013 . . . . 75.13 108.603 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -97.28 165.95 11.79 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.608 0.718 . . . . 75.4 109.847 171.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -144.61 104.63 4.06 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 107.316 -1.364 . . . . 73.44 107.316 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 58.8 t -92.63 123.4 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.711 0.804 . . . . 72.31 109.507 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.41 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 27.2 t -105.54 120.82 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 75.51 109.8 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.3 119.82 34.47 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.909 -1.145 . . . . 75.42 107.909 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -107.9 110.3 22.02 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.294 0.638 . . . . 73.22 110.394 177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -108.2 115.15 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 108.237 -1.023 . . . . 34.02 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -110.68 129.37 55.84 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.941 0.497 . . . . 73.3 109.862 -178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.568 HG21 HG21 ' B' ' 114' ' ' ILE . 54.5 t -119.36 131.24 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.274 1.03 . . . . 74.02 110.317 -176.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 37.7 m -114.7 150.56 35.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.505 1.122 . . . . 74.33 109.726 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -147.28 146.78 29.86 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.232 -1.025 . . . . 71.34 108.232 167.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -148.2 139.48 23.43 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.351 0.596 . . . . 63.41 111.476 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 46.8 mt -113.42 118.4 34.42 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.329 1.051 . . . . 71.52 109.348 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.52 -111.92 3.77 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.864 0.728 . . . . 44.4 112.605 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.1 4.89 21.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.71 0.804 . . . . 75.31 111.712 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -139.21 175.48 9.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.604 0.362 . . . . 72.55 110.84 -175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 36.1 m -69.69 150.0 47.45 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.196 0.998 . . . . 75.32 111.0 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.401 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -105.89 -57.4 2.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 107.987 -1.116 . . . . 71.04 107.987 169.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.447 ' HZ ' HG13 ' B' ' 40' ' ' VAL . 5.5 p90 -147.41 159.66 43.45 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.574 -1.193 . . . . 73.02 109.575 172.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.8 mt -127.55 157.99 38.66 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.163 1.385 . . . . 73.43 108.67 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.699 ' SG ' HG23 ' B' ' 114' ' ' ILE . 16.4 t -156.77 158.05 36.15 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.495 -0.557 . . . . 40.21 109.495 176.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -166.54 132.55 2.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.622 1.169 . . . . 71.24 108.236 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' B' ' 21' ' ' ILE . 56.0 t -128.11 147.36 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 109.036 -0.727 . . . . 75.33 109.036 174.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.587 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 19.5 mt-30 -126.8 93.3 3.74 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.883 0.849 . . . . 75.21 109.291 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.7 tp-100 -86.11 100.25 12.06 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 113.59 -1.641 . . . . 73.34 109.65 -178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.65 164.48 26.64 Favored Glycine 0 C--O 1.244 0.77 0 N-CA-C 111.966 -0.454 . . . . 72.44 111.966 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.25 126.24 1.56 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 111.047 -0.821 . . . . 71.31 111.047 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.458 HG13 ' HE1' ' B' ' 17' ' ' TYR . 37.3 mt -84.56 127.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.369 -0.975 . . . . 74.05 108.369 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -133.66 131.5 39.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.148 -1.427 . . . . 72.33 107.148 177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 67.4 m -96.25 102.53 14.33 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.551 -0.907 . . . . 61.14 108.551 174.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' B' ' 10' ' ' THR . 2.8 pp -122.94 139.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-N 115.669 -0.696 . . . . 75.11 110.584 -175.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.65 173.66 16.51 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.076 1.351 . . . . 51.3 107.852 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.03 -51.12 2.83 Favored Glycine 0 N--CA 1.473 1.119 0 C-N-CA 122.633 0.159 . . . . 74.13 112.893 175.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.532 HD13 ' HG2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -51.28 143.07 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 123.958 0.903 . . . . 71.44 111.178 172.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.96 144.26 24.82 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.644 -0.502 . . . . 74.0 109.644 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' B' ' 4' ' ' GLN . . . 62.25 -110.9 3.54 Favored Glycine 0 C--N 1.356 1.643 0 O-C-N 124.518 1.136 . . . . 73.2 113.335 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -64.13 -47.79 78.57 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.297 0.639 . . . . 75.34 110.046 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.505 ' HB3' HG22 ' B' ' 89' ' ' ILE . 89.1 mt-30 -63.58 -35.3 80.04 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 124.664 1.227 . . . . 75.35 111.484 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.532 ' HG2' HD13 ' B' ' 89' ' ' ILE . 0.0 OUTLIER -67.25 -56.8 8.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.364 -0.835 . . . . 71.11 110.24 -177.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.39 -16.66 61.85 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.169 -0.923 . . . . 71.31 111.673 -177.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -73.05 -39.17 66.13 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.098 0.959 . . . . 73.1 109.795 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -67.6 -63.86 0.98 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.102 -0.953 . . . . 54.32 110.969 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.3 mp -77.82 -15.18 59.27 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 122.126 -0.359 . . . . 75.15 111.736 -175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.89 -29.06 35.81 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.508 0.505 . . . . 61.43 113.711 -177.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.55 -44.01 0.32 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.344 0.572 . . . . 64.43 112.535 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.97 -47.88 70.2 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.435 0.694 . . . . 73.11 112.282 -171.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.8 m -65.28 -50.49 59.11 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 123.583 0.753 . . . . 64.42 111.87 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.73 -24.09 55.2 Favored 'Trans proline' 0 C--N 1.398 3.162 0 C-N-CA 121.568 1.512 . . . . 55.22 113.291 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.06 -36.86 85.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.364 0.602 . . . . 75.43 110.904 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.412 HG23 ' NH2' ' D' ' 111' ' ' ARG . 66.7 mt -61.05 -46.7 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.61 1.164 . . . . 75.33 110.564 173.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 mt -82.52 -10.95 58.78 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.491 -1.231 . . . . 63.52 111.701 -172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -63.28 -52.18 63.27 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.587 1.155 . . . . 71.15 113.153 -170.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -63.9 -31.88 66.8 Favored 'Trans proline' 0 C--N 1.385 2.48 0 C-N-CA 121.772 1.648 . . . . 74.52 112.964 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.472 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.7 m-85 -63.81 -51.11 66.23 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.912 0.485 . . . . 74.24 110.845 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.41 -38.53 91.35 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.288 1.035 . . . . 72.12 111.72 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -58.29 -63.07 1.4 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.197 0.936 . . . . 70.11 109.419 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -58.49 -29.2 66.07 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.207 1.003 . . . . 73.51 111.311 -176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.483 ' SG ' ' CD1' ' B' ' 21' ' ' ILE . 23.9 t -62.87 -60.22 3.77 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 123.473 0.709 . . . . 45.33 112.307 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.699 HG23 ' SG ' ' B' ' 76' ' ' CYS . 85.3 mt -57.82 -44.57 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 124.084 0.954 . . . . 73.52 110.388 176.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.572 HG23 ' HB3' ' B' ' 125' ' ' GLN . 22.8 m -64.61 -25.3 67.9 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 113.463 -1.699 . . . . 54.33 111.435 -175.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.4 t -80.52 -31.38 37.12 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.469 0.708 . . . . 62.33 110.839 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.4 mmt -71.65 -42.71 67.21 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.224 0.609 . . . . 62.42 111.647 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' B' ' 125' ' ' GLN . 96.4 t -73.91 -27.09 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.532 0.733 . . . . 61.04 110.615 178.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.428 ' OG ' HG21 ' C' ' 115' ' ' THR . 34.0 t -56.94 -34.52 68.08 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.8 0.84 . . . . 61.45 111.063 171.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.481 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 53.3 mtt-85 -80.12 -35.54 36.58 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 114.85 -1.068 . . . . 74.12 110.359 178.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.68 1.69 36.19 Favored Glycine 0 C--N 1.36 1.883 0 O-C-N 123.849 0.718 . . . . 60.23 112.597 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.8 p 70.22 25.26 4.63 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 127.115 2.166 . . . . 73.24 113.598 167.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.434 ' O ' HG12 ' B' ' 118' ' ' VAL . 65.2 m-85 -120.32 149.12 48.95 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 123.765 0.826 . . . . 71.11 109.253 171.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.401 ' HA ' HE21 ' C' ' 125' ' ' GLN . 84.4 Cg_endo -82.03 101.73 1.17 Allowed 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.674 2.249 . . . . 75.43 112.303 177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.717 ' HA ' HG11 ' B' ' 40' ' ' VAL . 0.0 OUTLIER -65.15 157.17 29.42 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.047 -0.978 . . . . 74.51 110.096 170.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 44.7 tp -110.11 129.34 55.71 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 126.406 1.882 . . . . 60.12 108.296 -173.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -84.98 125.61 32.84 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 106.548 -1.649 . . . . 73.24 106.548 173.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.647 HD21 ' HB2' ' F' ' 186' ' ' LEU . 0.9 OUTLIER -52.73 134.33 36.38 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 124.877 1.361 . . . . 74.53 109.08 -175.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -38.35 103.02 0.26 Allowed Pre-proline 0 C--N 1.361 1.095 0 O-C-N 125.824 1.953 . . . . 74.34 111.236 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.487 ' HG3' HG21 ' C' ' 122' ' ' THR . 57.1 Cg_endo -67.89 99.76 0.57 Allowed 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.516 2.144 . . . . 65.14 110.843 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -147.94 115.18 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 107.455 -1.313 . . . . 72.43 107.455 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.91 103.1 2.55 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.683 -1.228 . . . . 43.32 107.683 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.539 ' HA ' HD23 ' B' ' 136' ' ' LEU . 64.9 t80 -65.75 -14.95 62.32 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.41 1.084 . . . . 73.5 111.937 -177.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.2 -28.55 69.76 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 124.637 1.175 . . . . 74.3 111.037 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.5 -35.46 77.53 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.562 0.745 . . . . 74.05 111.004 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.539 HD23 ' HA ' ' B' ' 133' ' ' PHE . 4.2 mm? -66.15 -27.58 68.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.566 0.747 . . . . 74.41 111.354 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -62.84 -46.81 86.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.549 0.739 . . . . 72.23 109.959 172.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 17.3 tmm? -67.03 -35.59 80.25 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.644 -1.162 . . . . 50.03 110.555 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -74.64 -35.09 62.88 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.656 0.783 . . . . 71.34 111.148 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -68.93 -43.92 74.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.754 0.822 . . . . 64.4 110.55 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 70.4 mt -93.42 0.0 56.65 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.742 -0.663 . . . . 74.12 112.384 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -77.65 82.98 4.04 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.936 0.494 . . . . 64.14 109.751 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -155.65 120.89 4.85 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.818 1.247 . . . . 63.44 109.799 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -139.79 -87.29 0.21 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.966 0.906 . . . . 71.22 109.387 168.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.79 166.82 13.48 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.576 0.75 . . . . 72.5 109.453 -174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.92 94.81 0.1 OUTLIER Glycine 0 C--N 1.336 0.576 0 N-CA-C 111.359 -0.696 . . . . 53.51 111.359 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -85.56 139.45 31.43 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.106 0.562 . . . . 73.25 109.89 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . 0.572 ' HA3' ' SD ' ' D' ' 1' ' ' MET . . . -118.38 96.09 0.66 Allowed Glycine 0 C--N 1.342 0.896 0 CA-C-N 115.937 -0.574 . . . . 71.24 111.954 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -132.97 137.74 46.65 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.967 0.907 . . . . 75.52 109.947 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -90.45 148.46 22.76 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.774 0.83 . . . . 70.15 109.69 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.71 167.7 10.75 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 123.737 0.648 . . . . 63.22 111.022 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -131.41 143.52 50.52 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.804 0.842 . . . . 72.02 110.656 -177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -113.22 15.2 19.42 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 124.761 1.224 . . . . 75.33 108.975 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -82.88 161.43 21.9 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.167 0.987 . . . . 73.03 111.067 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.315 0 C-N-CA 123.582 0.753 . . . . 75.43 109.771 174.194 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 110.291 -0.262 . . . . 61.05 110.291 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -138.55 -54.11 0.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.619 1.168 . . . . 50.13 108.968 -178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -107.12 89.97 3.16 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.621 0.768 . . . . 73.11 109.384 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.08 170.43 16.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.709 1.204 . . . . 71.14 109.951 177.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 67.12 120.36 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.739 1.216 . . . . 71.43 109.825 -174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -57.82 -49.08 77.84 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.2 0.6 . . . . 72.33 110.52 -174.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.8 m 73.76 -18.22 0.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 124.877 1.271 . . . . 73.23 112.765 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -76.65 148.67 36.74 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.503 0.721 . . . . 75.22 110.689 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.664 ' HG3' HG22 ' C' ' 89' ' ' ILE . 25.3 ttt 60.42 111.69 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.391 1.476 . . . . 72.51 109.482 -164.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.778 ' HB ' ' HG2' ' H' ' 205' ' ' LYS . 73.5 p -123.6 119.47 29.97 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.039 0.536 . . . . 65.12 109.745 -173.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.758 ' HA ' HG22 ' C' ' 86' ' ' ILE . 46.7 t80 -118.69 124.58 47.7 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.38 0.672 . . . . 73.44 109.673 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -139.35 124.94 19.37 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.328 0.651 . . . . 54.44 109.471 175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.578 HD11 HG13 ' C' ' 16' ' ' ILE . 6.0 tp -82.01 134.19 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 N-CA-C 108.945 -0.761 . . . . 75.21 108.945 170.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.554 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.6 mm-40 -97.82 -51.43 4.08 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.281 0.632 . . . . 71.15 109.986 176.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.58 HH11 ' HD1' ' D' ' 32' ' ' PHE . 34.3 ttt180 -176.07 126.83 0.21 Allowed 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.57 -0.741 . . . . 70.04 110.055 -166.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.578 HG13 HD11 ' C' ' 13' ' ' ILE . 97.4 mt -113.32 135.0 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 123.762 0.825 . . . . 71.42 108.847 175.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.754 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.1 p90 -169.74 153.99 5.19 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.24 0.543 . . . . 63.33 110.067 -174.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -74.75 115.08 13.93 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 114.966 -1.016 . . . . 73.24 109.976 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -66.09 -39.32 89.92 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 108.819 -0.808 . . . . 75.14 108.819 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -151.44 147.48 26.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.448 -1.251 . . . . 53.11 110.434 -178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.7 mt -136.34 145.08 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.053 1.741 . . . . 73.43 106.789 172.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -154.7 148.82 25.87 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.987 0.422 . . . . 75.22 110.269 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -153.58 108.61 3.16 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 107.584 -1.265 . . . . 75.0 107.584 174.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -117.57 121.33 40.67 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.571 0.748 . . . . 71.21 109.687 -175.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.82 85.93 56.57 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.472 1.109 . . . . 65.01 108.533 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.68 -16.58 16.54 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.56 2.173 . . . . 71.41 112.006 173.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -99.51 19.64 15.31 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.933 1.293 . . . . 73.5 108.949 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.638 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -54.37 -52.13 71.95 Favored Pre-proline 0 CA--C 1.56 1.353 0 C-N-CA 124.332 1.053 . . . . 74.12 113.487 -172.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 6.2 Cg_exo -80.35 -31.31 1.68 Allowed 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.923 1.749 . . . . 65.52 112.915 178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -70.22 -30.8 67.97 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.425 1.09 . . . . 75.13 112.827 -173.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.26 -17.62 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.253 0 C-N-CA 123.78 0.832 . . . . 73.15 111.796 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -59.79 -32.0 70.21 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 123.621 0.768 . . . . 75.3 111.781 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -87.63 6.48 34.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.613 0.765 . . . . 71.35 111.875 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.841 ' HG2' HD13 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -109.14 143.25 38.77 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.446 0.699 . . . . 73.12 110.205 -176.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 129.65 39.34 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.548 -0.908 . . . . 74.2 108.548 173.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.591 ' HB3' ' HB3' ' E' ' 194' ' ' ALA . 75.6 m95 -84.61 84.41 7.68 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-O 121.736 0.779 . . . . 73.31 111.808 -165.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -132.42 78.64 67.37 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-N 114.44 -1.255 . . . . 74.21 108.082 173.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' C' ' 67' ' ' SER . 5.6 Cg_exo -82.79 146.44 13.16 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.647 2.231 . . . . 54.43 112.455 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -85.79 109.83 18.94 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.403 -1.332 . . . . 70.21 107.403 169.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 33.7 t -78.54 97.4 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 O-C-N 124.378 1.049 . . . . 61.43 109.44 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 92.9 mttt -99.45 104.28 16.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.579 0.752 . . . . 51.1 109.552 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -98.66 129.81 45.15 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.703 -0.851 . . . . 74.4 108.703 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -131.63 137.2 48.27 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.687 0.795 . . . . 73.24 109.201 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.57 113.78 20.27 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.988 -0.745 . . . . 64.12 108.988 173.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -113.54 143.77 43.98 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.195 -0.669 . . . . 62.13 109.195 174.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 26.6 m -114.64 128.3 56.24 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.834 0.453 . . . . 73.02 110.842 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.9 161.93 19.36 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.983 1.313 . . . . 74.25 108.615 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 48.6 p -153.32 150.36 28.84 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.024 0.53 . . . . 75.41 111.137 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -146.0 143.02 29.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.663 1.185 . . . . 63.54 108.981 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -101.16 115.43 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.212 -1.403 . . . . 75.21 107.212 166.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 HD12 ' C' ' 83' ' ' ILE . 32.8 mt -87.43 -28.02 22.37 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.053 0.541 . . . . 72.4 109.944 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.5 -174.95 1.76 Allowed 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.587 1.155 . . . . 62.23 109.442 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 120.73 12.43 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.261 -0.881 . . . . 74.13 109.077 174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 65.76 7.06 4.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.893 1.277 . . . . 64.41 112.822 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 54.5 t -106.26 107.72 23.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 107.568 -1.271 . . . . 72.23 107.568 173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -107.76 148.76 29.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.238 1.015 . . . . 64.23 109.591 -173.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -128.13 110.37 12.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.183 -0.917 . . . . 75.2 108.796 170.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 83.3 t -100.14 125.63 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.654 -1.61 . . . . 60.44 106.654 168.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.5 t -114.54 104.58 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.453 -0.943 . . . . 50.41 108.453 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -91.78 104.54 16.97 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.029 -1.101 . . . . 72.01 108.029 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' C' ' 79' ' ' GLN . 16.4 mtm180 -84.18 137.49 33.48 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.657 -1.156 . . . . 75.25 108.425 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 10.0 t -126.94 132.28 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.873 -1.158 . . . . 74.33 107.873 172.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 10.2 m -121.73 122.51 39.71 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.986 -0.746 . . . . 73.02 108.986 177.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.533 HG23 HD13 ' C' ' 114' ' ' ILE . 71.1 t -110.84 111.48 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.881 -0.785 . . . . 71.34 108.881 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.9 m -100.1 146.12 27.17 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.679 -0.86 . . . . 63.13 108.679 173.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.96 124.72 33.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.101 -1.074 . . . . 64.35 108.101 174.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 38' ' ' PRO . 19.2 m -126.61 168.54 14.17 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.895 0.878 . . . . 51.42 109.255 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.841 HD13 ' HG2' ' C' ' 34' ' ' LYS . 13.9 mt -128.89 26.42 5.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.378 1.071 . . . . 71.21 108.912 -176.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.06 -92.8 0.68 Allowed Glycine 0 C--N 1.34 0.792 0 N-CA-C 109.74 -1.344 . . . . 73.4 109.74 -171.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.49 -13.57 16.55 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.002 0.921 . . . . 75.11 111.12 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -103.25 120.57 40.99 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.984 0.913 . . . . 74.04 109.689 -174.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.6 m -70.65 132.3 45.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 118.017 0.372 . . . . 62.41 110.673 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.42 -51.65 7.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.151 -0.685 . . . . 61.43 109.151 172.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -169.79 177.48 4.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.787 0.835 . . . . 71.52 111.167 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.455 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -134.02 146.89 50.8 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.745 1.218 . . . . 50.54 107.91 170.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.56 ' SG ' HG23 ' C' ' 114' ' ' ILE . 49.2 t -150.67 145.55 25.91 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.789 0.836 . . . . 74.24 109.381 176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -153.09 136.35 15.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.362 0.665 . . . . 62.43 109.529 177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -130.48 114.77 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.027 0.931 . . . . 74.02 108.964 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 15.1 mt-30 -91.63 96.16 10.31 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.688 -0.856 . . . . 65.13 108.688 176.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.596 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.9 tp-100 -87.77 111.93 21.88 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.9 0.48 . . . . 72.54 110.598 -175.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.92 146.93 18.36 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 112.044 -0.422 . . . . 52.44 112.044 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.05 123.8 2.1 Favored Glycine 0 CA--C 1.502 -0.737 0 N-CA-C 110.198 -1.161 . . . . 61.35 110.198 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.7 mm -92.36 125.31 44.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 107.8 -1.185 . . . . 65.33 107.8 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -127.87 119.68 26.13 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.486 -0.931 . . . . 75.2 108.486 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.0 t -89.31 97.48 11.22 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 107.408 -1.33 . . . . 44.13 107.408 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.758 HG22 ' HA ' ' C' ' 11' ' ' PHE . 2.2 pp -135.89 137.1 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 115.753 -0.658 . . . . 70.42 110.151 -170.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.29 166.08 32.9 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.926 0.89 . . . . 54.12 110.605 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.96 -26.27 7.81 Favored Glycine 0 C--N 1.35 1.349 0 CA-C-N 115.812 -0.631 . . . . 52.15 113.103 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.709 HG12 ' HG2' ' C' ' 94' ' ' MET . 0.2 OUTLIER -65.61 134.9 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 C-N-CA 124.401 1.08 . . . . 73.04 110.08 178.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -159.23 157.61 31.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.74 0.416 . . . . 73.3 110.241 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -134.51 40.67 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.826 0.704 . . . . 70.13 111.744 -176.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 148' ' ' GLY . 46.7 p -74.65 -18.68 60.5 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.399 0.68 . . . . 71.33 111.809 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -64.84 -40.89 95.9 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.552 0.741 . . . . 74.55 109.598 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.709 ' HG2' HG12 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -67.18 -50.52 60.76 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 114.583 -1.19 . . . . 73.43 109.026 178.516 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.81 -36.86 77.64 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.162 0.985 . . . . 63.42 112.988 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -73.04 -39.11 66.21 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 63.44 110.494 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.4 t -73.47 -34.75 65.5 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.163 0.585 . . . . 72.04 110.974 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.406 HD22 ' SD ' ' C' ' 94' ' ' MET . 47.0 tp -86.31 -56.93 3.21 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.571 1.148 . . . . 72.13 111.687 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.49 11.39 68.67 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 115.869 -0.605 . . . . 51.23 114.554 -168.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.64 -56.25 0.23 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 117.458 0.629 . . . . 74.11 111.215 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -66.72 -60.06 3.02 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.303 0.641 . . . . 71.01 111.989 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 85.5 m -58.36 -47.8 98.13 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.05 0.94 . . . . 62.43 113.159 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.73 -20.05 35.47 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 121.975 1.783 . . . . 71.23 113.356 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -78.26 -22.68 47.95 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 123.406 0.682 . . . . 61.11 110.467 175.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.47 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.0 mm -69.91 -33.65 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.082 0.553 . . . . 54.12 109.52 169.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' C' ' 82' ' ' GLY . 74.7 mt -89.9 -25.15 21.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.085 0.954 . . . . 72.23 112.613 -174.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -58.45 -45.38 99.69 Favored Pre-proline 0 CA--C 1.558 1.253 0 CA-C-O 117.859 -1.067 . . . . 72.12 113.136 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.41 -43.67 56.58 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 122.112 1.875 . . . . 53.32 112.633 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -63.37 -44.84 93.65 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.051 0.54 . . . . 75.13 111.569 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.596 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -73.21 -37.2 66.52 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.065 -0.516 . . . . 62.14 111.682 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.95 -58.51 7.08 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 124.258 0.974 . . . . 73.22 108.97 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.11 -30.68 66.47 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.222 1.409 . . . . 65.33 112.631 178.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 17.0 t -74.73 -38.71 62.21 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.048 0.539 . . . . 73.32 111.95 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.56 HG23 ' SG ' ' C' ' 76' ' ' CYS . 93.3 mt -67.14 -47.23 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 123.59 0.756 . . . . 73.22 109.737 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.663 HG23 ' HB3' ' C' ' 125' ' ' GLN . 91.8 m -56.61 -37.45 70.7 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 114.435 -1.257 . . . . 74.12 111.359 -179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.1 t -62.84 -49.28 75.51 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 114.91 -1.041 . . . . 61.32 110.251 170.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.624 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.73 -35.67 70.99 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 124.176 0.991 . . . . 73.15 112.96 -178.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 85.7 t -66.78 -45.61 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 123.078 0.551 . . . . 70.34 110.414 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 54.1 p -70.48 -26.44 63.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.661 -0.7 . . . . 74.44 111.02 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 86.9 mtt-85 -66.6 -33.79 76.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 72.34 110.595 174.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.96 11.55 47.54 Favored Glycine 0 C--N 1.357 1.73 0 O-C-N 123.945 0.778 . . . . 42.42 112.826 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.664 HG23 ' HB3' ' D' ' 17' ' ' TYR . 43.9 p 57.93 28.2 15.79 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 126.826 2.05 . . . . 74.02 112.485 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -102.04 150.26 37.29 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 123.826 0.85 . . . . 73.04 108.899 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.729 ' HG3' ' HB1' ' E' ' 194' ' ' ALA . 36.8 Cg_endo -62.5 130.74 31.02 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 123.029 2.486 . . . . 72.14 110.708 175.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.663 ' HB3' HG23 ' C' ' 115' ' ' THR . 31.4 mt-30 -61.01 153.74 24.47 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.167 0.987 . . . . 64.22 113.001 -170.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.43 67.42 0.84 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.348 -0.842 . . . . 53.11 109.704 172.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.527 ' HB3' HG21 ' C' ' 115' ' ' THR . 1.9 p-10 -90.69 80.99 5.86 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.407 -1.331 . . . . 65.43 107.407 167.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.542 ' HB3' HD13 ' E' ' 187' ' ' ILE . 2.0 mm? -95.24 103.89 15.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 113.866 -1.515 . . . . 71.33 110.607 -170.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.497 ' HB3' HD12 ' E' ' 187' ' ' ILE . . . 63.11 155.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.054 0 N-CA-C 115.385 1.624 . . . . 42.24 115.385 166.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.563 ' HG3' ' H ' ' A' ' 16' ' ' ILE . 69.5 Cg_endo -91.29 102.89 0.25 Allowed 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.774 2.316 . . . . 73.02 111.317 161.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 19.7 t -82.45 79.93 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.01 -0.737 . . . . 61.45 109.01 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.518 ' HB3' HG13 ' A' ' 13' ' ' ILE . 28.7 t-20 -82.16 107.19 14.65 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.454 -0.794 . . . . 73.4 109.378 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' E' ' 183' ' ' THR . 29.9 m-85 -68.9 -21.74 64.21 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.195 1.398 . . . . 75.01 112.899 -172.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -77.19 -43.44 33.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.936 0.894 . . . . 62.33 112.386 -169.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.52 96.88 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 112.925 0.713 . . . . 74.04 112.925 -172.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.25 -30.1 64.55 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 116.481 -0.327 . . . . 53.15 111.208 -176.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -70.52 -33.6 71.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.421 0.288 . . . . 74.34 110.528 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.5 mtp -65.76 -34.65 78.66 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.075 0.55 . . . . 73.42 110.489 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -65.95 -36.2 82.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.354 0.662 . . . . 63.03 110.747 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -70.34 -87.47 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 123.211 0.604 . . . . 72.51 110.717 173.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -129.93 139.01 51.19 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.648 0.779 . . . . 65.22 110.404 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -162.9 163.67 26.26 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.055 0.942 . . . . 71.13 110.698 176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -150.57 95.9 2.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.007 0.923 . . . . 70.53 108.991 175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.93 24.01 0.95 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.143 0.977 . . . . 74.32 109.866 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.99 143.14 47.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.615 0.766 . . . . 74.34 110.424 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.12 -68.57 0.01 OUTLIER Glycine 0 C--N 1.342 0.895 0 N-CA-C 110.464 -1.055 . . . . 62.51 110.464 178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -168.53 -70.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.307 0.643 . . . . 52.41 109.416 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 168.79 -135.17 3.49 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.648 -0.581 . . . . 54.2 111.648 -173.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.8 p -134.41 -77.03 0.46 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.847 0.859 . . . . 73.14 110.087 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -172.87 161.98 4.68 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.847 0.859 . . . . 54.42 108.882 -172.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.94 137.92 58.41 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.213 0.605 . . . . 73.51 110.15 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -88.85 169.22 11.78 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 109.457 -0.572 . . . . 74.14 109.457 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -163.1 115.26 1.53 Allowed 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.313 -0.995 . . . . 75.13 108.313 172.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -94.75 96.89 9.67 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.244 -1.021 . . . . 71.31 108.244 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.217 0 N-CA-C 108.647 -0.871 . . . . 75.22 108.647 -178.454 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.572 ' SD ' ' HA3' ' B' ' 148' ' ' GLY . 56.3 mtp . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.251 0.548 . . . . 73.23 109.561 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -153.14 -165.03 2.06 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.649 1.18 . . . . 72.12 108.706 -173.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.53 -42.82 67.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.324 0.65 . . . . 54.25 111.579 177.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 52.06 -90.27 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 125.51 1.524 . . . . 74.55 112.979 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -133.95 -70.99 0.51 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.7 -1.222 . . . . 72.41 107.7 170.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -171.75 87.02 0.09 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.433 1.093 . . . . 72.43 108.434 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 t -162.28 -179.84 7.33 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.488 0.715 . . . . 75.33 109.865 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 77.99 -58.26 0.46 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.566 1.546 . . . . 74.44 112.317 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.432 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 4.0 ttp -30.09 123.68 0.17 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 126.149 1.78 . . . . 63.53 113.187 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 53.9 m -125.79 145.51 50.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.953 0.901 . . . . 64.34 109.425 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.515 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 76.6 t80 -159.39 89.57 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 107.441 -1.318 . . . . 73.44 107.441 171.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -114.8 142.85 45.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.227 1.011 . . . . 70.41 108.468 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 56.4 mt -103.06 110.44 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.085 0.554 . . . . 53.4 110.963 -170.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -79.92 -43.48 22.09 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.81 0.444 . . . . 64.33 111.577 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.429 ' HD2' ' HG2' ' B' ' 130' ' ' PRO . 6.2 tpt180 -166.32 148.61 6.86 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 112.038 0.384 . . . . 62.31 112.038 -165.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.86 128.39 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 107.986 -1.116 . . . . 74.3 107.986 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.664 ' HB3' HG23 ' C' ' 122' ' ' THR . 11.4 p90 -163.32 164.01 24.99 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.584 0.706 . . . . 73.5 111.41 178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -77.93 107.94 10.84 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 114.588 -1.187 . . . . 52.41 109.642 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 46.8 mtpt -77.23 -35.82 55.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.114 -0.494 . . . . 75.21 109.727 173.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.701 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.3 t70 -145.03 136.79 25.52 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.034 -0.984 . . . . 74.23 109.229 -178.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.624 HG21 ' HE2' ' C' ' 117' ' ' MET . 73.1 mt -135.06 145.38 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.427 1.091 . . . . 75.52 108.371 175.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.3 t -149.32 132.43 16.32 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.989 -1.005 . . . . 64.31 108.606 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.3 t80 -137.01 117.49 13.75 Favored 'General case' 0 C--O 1.224 -0.254 0 N-CA-C 106.333 -1.729 . . . . 74.45 106.333 167.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -122.23 133.61 54.71 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.729 -0.841 . . . . 72.21 108.729 178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.54 84.66 19.35 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 107.214 -1.402 . . . . 62.23 107.214 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -61.87 -38.8 56.33 Favored 'Trans proline' 0 C--N 1.383 2.369 0 C-N-CA 122.665 2.243 . . . . 72.1 112.295 -171.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 25.3 m-80 -114.38 31.18 6.78 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.165 0.986 . . . . 74.24 109.275 -177.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.754 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -35.16 -55.64 1.0 Allowed Pre-proline 0 CA--C 1.588 2.411 0 N-CA-C 117.487 2.403 . . . . 64.42 117.487 -172.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.87 -12.88 8.3 Favored 'Trans proline' 0 C--N 1.399 3.198 0 CA-C-N 122.595 1.963 . . . . 64.23 114.512 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -74.42 -35.69 63.4 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.423 1.089 . . . . 75.32 109.762 174.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.647 HG13 HD12 ' D' ' 68' ' ' LEU . 72.3 t -70.43 -34.26 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.527 1.131 . . . . 75.14 110.938 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.58 ' HD1' HH11 ' C' ' 15' ' ' ARG . 3.4 t80 -48.67 -36.68 16.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.446 1.499 . . . . 72.34 112.342 171.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.463 HE21 ' HA ' ' D' ' 30' ' ' HIS . 50.8 mt-30 -81.41 7.83 10.81 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.111 0.964 . . . . 75.44 113.116 -173.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.565 ' NZ ' ' HB3' ' D' ' 71' ' ' GLU . 86.8 mttt -121.66 114.3 20.95 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.534 0.734 . . . . 74.12 110.164 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -95.82 73.62 3.09 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.109 -0.7 . . . . 74.23 109.109 169.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.67 ' HB2' HD22 ' D' ' 68' ' ' LEU . 6.7 m95 -125.8 157.43 37.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 106.05 -1.833 . . . . 73.13 106.05 174.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.424 ' NE2' ' HD2' ' D' ' 38' ' ' PRO . 32.1 tp60 -77.79 113.18 30.19 Favored Pre-proline 0 CA--C 1.556 1.188 0 CA-C-N 118.826 0.739 . . . . 71.12 109.258 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.424 ' HD2' ' NE2' ' D' ' 37' ' ' GLN . 44.6 Cg_exo -58.74 107.1 0.32 Allowed 'Trans proline' 0 C--N 1.391 2.811 0 C-N-CA 122.963 2.442 . . . . 65.34 112.517 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -65.65 112.32 3.6 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.474 1.109 . . . . 71.52 108.736 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.437 HG22 ' OH ' ' G' ' 202' ' ' TYR . 34.5 m -96.8 113.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-O 122.205 1.002 . . . . 70.32 108.527 -179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 71.6 mmtt -92.71 120.48 33.15 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.633 -1.247 . . . . 75.12 107.633 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.549 HD22 ' HB ' ' H' ' 187' ' ' ILE . 7.3 mp -94.58 121.65 36.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.602 -0.518 . . . . 72.32 109.602 -175.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.639 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 6.5 t70 -111.22 135.56 51.57 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.045 -1.465 . . . . 72.32 107.045 169.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 tt -130.77 130.17 43.38 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.532 -0.914 . . . . 74.0 108.532 178.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -134.46 153.72 51.78 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.753 -1.203 . . . . 51.33 107.753 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -143.57 149.19 37.04 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.218 -0.66 . . . . 64.43 109.218 175.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.1 167.54 25.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.095 -0.957 . . . . 41.41 108.458 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -155.13 156.65 36.16 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 120.937 0.399 . . . . 60.23 110.445 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 36.0 p -155.09 139.45 16.73 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.104 0.962 . . . . 64.21 109.143 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -76.84 129.01 35.64 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.672 0.389 . . . . 65.01 110.037 178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 mt -97.69 -39.25 9.16 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.975 0.51 . . . . 75.35 110.102 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.01 -176.03 5.59 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.489 0.716 . . . . 72.54 110.353 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.03 121.64 11.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.043 -0.981 . . . . 71.12 110.309 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 66.85 3.6 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 125.473 1.509 . . . . 70.13 112.036 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 82.1 t -111.74 120.27 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.481 0.712 . . . . 70.33 110.171 -174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' H' ' 175' ' ' PHE . 65.4 m-85 -131.21 129.06 41.19 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.648 1.179 . . . . 72.2 107.933 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -92.75 116.85 29.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.923 0.889 . . . . 52.12 108.887 173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.01 124.71 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 107.781 -1.192 . . . . 72.32 107.781 173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.608 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 26.2 t -101.27 144.21 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.517 1.127 . . . . 45.01 109.331 177.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.615 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.3 OUTLIER -118.05 128.87 55.18 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.196 -1.038 . . . . 64.52 108.196 175.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 28.8 ttm-85 -109.41 106.87 16.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.255 1.022 . . . . 74.01 109.158 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -100.27 128.67 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.567 -1.272 . . . . 53.02 107.567 166.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.3 m -125.42 124.05 40.6 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.264 0.555 . . . . 54.35 109.7 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.442 HG21 HG21 ' D' ' 114' ' ' ILE . 69.0 t -106.59 101.93 13.19 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 125.002 1.321 . . . . 63.23 108.493 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 8.2 m -94.94 93.59 7.51 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 107.647 -1.242 . . . . 70.14 107.647 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.44 138.79 33.5 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.944 -0.762 . . . . 73.15 108.944 -175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.4 p -148.39 138.78 22.68 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.456 0.473 . . . . 73.43 112.128 -176.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' D' ' 36' ' ' TRP . 66.2 mt -107.48 110.58 22.56 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.773 1.229 . . . . 73.2 109.971 172.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.92 -124.51 17.47 Favored Glycine 0 C--N 1.342 0.909 0 O-C-N 123.421 0.451 . . . . 71.21 112.997 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.68 6.25 46.58 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.407 0.683 . . . . 54.41 111.408 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.565 ' HB3' ' NZ ' ' D' ' 34' ' ' LYS . 7.4 tp10 -140.04 149.36 43.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.391 0.676 . . . . 74.0 110.668 -166.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 48.8 m -70.44 138.42 51.18 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.057 0.943 . . . . 73.41 111.512 -174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -87.6 -63.13 1.35 Allowed 'General case' 0 C--N 1.347 0.461 0 C-N-CA 124.561 1.144 . . . . 62.21 108.188 175.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -155.03 161.62 41.29 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-N 115.181 -0.918 . . . . 73.13 110.739 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 76.0 mt -117.59 138.05 52.19 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.271 -1.331 . . . . 72.23 107.498 175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' D' ' 114' ' ' ILE . 47.1 t -149.35 139.42 22.1 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.834 -0.802 . . . . 74.55 108.834 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.434 ' HB2' HG23 ' D' ' 63' ' ' THR . 43.0 tt0 -156.12 131.88 9.71 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.117 -0.697 . . . . 75.11 109.117 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -134.22 118.11 26.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 C-N-CA 123.492 0.717 . . . . 74.32 109.282 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.701 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.0 mt-30 -90.08 85.47 6.31 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.912 0.863 . . . . 52.13 108.871 168.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.92 95.92 6.23 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.685 -1.598 . . . . 70.52 108.901 177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.608 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.28 145.65 18.2 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 112.299 -0.32 . . . . 71.44 112.299 -179.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.99 131.29 4.68 Favored Glycine 0 C--N 1.338 0.693 0 N-CA-C 111.588 -0.605 . . . . 72.41 111.588 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.2 mt -90.88 131.39 38.16 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 108.903 -0.777 . . . . 43.24 108.903 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.26 142.64 48.62 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.94 0.496 . . . . 72.13 110.867 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 49.6 m -89.44 95.9 10.48 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.668 -0.864 . . . . 73.21 108.668 166.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.522 HD11 HG12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -122.04 134.46 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.146 0.978 . . . . 74.31 110.171 -173.193 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.33 171.1 9.47 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.256 1.023 . . . . 53.23 109.951 -175.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.76 22.95 77.68 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 116.237 -0.438 . . . . 32.32 113.881 172.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.522 HG12 HD11 ' D' ' 86' ' ' ILE . 1.8 pp -103.99 158.08 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.201 1.0 . . . . 63.24 110.866 -179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.86 171.68 19.61 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.424 0.69 . . . . 65.03 110.643 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 52.8 -138.06 34.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 124.098 0.874 . . . . 60.24 114.912 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 39.9 p -72.55 -28.69 62.99 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.043 0.937 . . . . 73.14 110.954 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -63.87 -29.11 70.32 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.927 0.891 . . . . 60.04 111.652 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.554 ' SD ' ' HB3' ' H' ' 172' ' ' ALA . 24.2 ttt -59.93 -53.82 53.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.232 0.613 . . . . 73.41 110.525 173.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.18 -29.95 64.5 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.419 -0.81 . . . . 73.33 111.205 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -69.12 -33.35 73.34 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.326 1.05 . . . . 75.11 110.316 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 46.5 t -78.93 -51.41 9.69 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.574 -0.739 . . . . 74.22 110.58 177.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 tt -73.21 -49.48 27.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.284 0.633 . . . . 60.41 110.834 -171.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.34 -26.4 61.62 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.792 -0.64 . . . . 65.41 114.457 -172.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.18 -58.13 1.89 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 117.452 0.626 . . . . 63.44 112.063 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.43 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 76.8 t80 -68.73 -34.08 75.01 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.165 0.802 . . . . 75.4 113.165 -168.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.518 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 43.6 m -72.13 -48.92 10.2 Favored Pre-proline 0 CA--C 1.563 1.476 0 CA-C-O 118.977 -0.535 . . . . 75.15 110.995 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.615 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 71.0 Cg_exo -56.55 -30.97 84.89 Favored 'Trans proline' 0 C--N 1.396 3.05 0 C-N-CA 122.49 2.126 . . . . 71.34 114.431 170.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -61.24 -29.32 69.77 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.039 0.536 . . . . 74.25 111.971 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -68.27 -38.98 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.38 0.672 . . . . 73.42 110.595 174.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 43.1 mt -79.94 -25.37 40.49 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.063 -0.971 . . . . 71.13 111.651 -170.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.65 -41.82 80.22 Favored Pre-proline 0 CA--C 1.558 1.283 0 N-CA-C 114.231 1.197 . . . . 63.21 114.231 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -50.1 -39.99 50.9 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 122.214 1.942 . . . . 75.45 114.19 171.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -82.19 -36.01 27.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.729 0.812 . . . . 71.53 111.109 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.79 -44.19 96.81 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.445 0.698 . . . . 75.41 110.36 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.412 ' NH2' HG23 ' B' ' 105' ' ' ILE . 30.8 ttp180 -55.89 -54.97 38.23 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 124.965 1.415 . . . . 73.42 110.215 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 124.158 0.911 . . . . 72.35 111.837 -173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.427 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 43.0 t -59.7 -42.51 93.17 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.547 0.529 . . . . 74.53 110.96 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.491 HG23 ' SG ' ' D' ' 76' ' ' CYS . 83.4 mt -62.26 -55.16 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 115.123 -0.944 . . . . 73.41 110.338 172.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 97.1 m -53.44 -40.11 64.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.554 1.541 . . . . 74.34 112.4 -171.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.1 t -71.73 -40.77 69.18 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.159 -0.928 . . . . 73.33 110.695 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.3 mtm -69.08 -31.09 69.58 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.864 0.465 . . . . 72.42 111.637 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.0 t -63.23 -46.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 123.622 0.769 . . . . 72.45 109.714 174.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.1 p -74.43 -29.19 61.4 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 116.009 -0.541 . . . . 74.54 111.506 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -74.12 -23.24 59.27 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.83 0.852 . . . . 64.54 110.479 174.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.36 12.19 65.57 Favored Glycine 0 C--N 1.351 1.391 0 CA-C-N 115.725 -0.67 . . . . 60.15 112.43 172.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.9 p 62.26 22.42 13.17 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 126.319 1.848 . . . . 73.34 113.972 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -97.99 161.26 26.16 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.265 1.026 . . . . 72.21 109.551 176.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.25 140.02 47.68 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.106 2.537 . . . . 74.53 111.625 -176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -61.08 119.39 8.26 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.547 0.739 . . . . 72.04 110.618 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.76 103.87 12.76 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.316 -0.994 . . . . 70.22 108.316 -171.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -103.82 99.78 9.56 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.513 0.725 . . . . 54.31 109.328 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.48 HD22 HD21 ' D' ' 42' ' ' LEU . 95.5 mt -71.29 126.88 30.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.29 0.636 . . . . 74.54 110.473 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.37 138.64 96.36 Favored Pre-proline 0 N--CA 1.474 0.737 0 C-N-CA 123.184 0.594 . . . . 54.41 111.064 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 2.1 Cg_endo -74.78 96.59 1.01 Allowed 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 121.946 1.764 . . . . 73.41 109.647 174.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 85.5 t -106.97 109.9 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.014 -1.106 . . . . 72.42 108.014 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -79.44 117.99 20.91 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.588 -0.733 . . . . 71.2 109.137 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -46.89 -33.0 4.17 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.841 1.256 . . . . 65.23 113.136 176.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.78 -36.39 80.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.038 0.935 . . . . 74.35 111.535 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.37 -41.6 98.74 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.159 0.584 . . . . 61.33 111.108 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 mp -67.6 -41.14 84.5 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.236 0.615 . . . . 71.02 110.262 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -63.99 -46.33 85.05 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.925 0.89 . . . . 74.32 110.804 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.436 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 77.8 mtm -65.96 -57.43 7.84 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.637 0.586 . . . . 73.21 110.481 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -57.93 -31.54 66.91 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 123.816 0.846 . . . . 73.43 111.885 -175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -58.59 -53.64 56.11 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.536 0.734 . . . . 72.42 110.38 173.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.94 -32.84 74.58 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.556 0.742 . . . . 65.41 111.502 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' D' ' 138' ' ' MET . 43.9 mt-30 -77.41 3.52 13.08 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.295 0.638 . . . . 75.33 112.309 -176.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -123.82 90.11 3.21 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.702 0.801 . . . . 62.2 109.504 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -161.85 -65.97 0.05 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.413 1.085 . . . . 75.51 108.663 177.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.87 132.52 0.7 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.886 1.275 . . . . 64.23 108.21 -175.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.4 57.03 0.3 Allowed Glycine 0 C--N 1.345 1.028 0 O-C-N 123.209 0.318 . . . . 62.51 112.78 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.9 179.02 7.98 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.998 -0.371 . . . . 71.31 109.998 173.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 122.17 82.32 0.62 Allowed Glycine 0 C--N 1.345 1.071 0 N-CA-C 111.776 -0.53 . . . . 72.34 111.776 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.6 t -133.48 9.94 4.03 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.389 1.076 . . . . 25.41 109.037 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.98 111.2 2.4 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 124.048 0.939 . . . . 73.21 111.315 -170.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -74.81 163.57 27.52 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.892 1.277 . . . . 64.45 111.256 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -147.74 -65.9 0.26 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.239 0.615 . . . . 72.31 110.439 173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -69.98 126.15 28.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.313 0.645 . . . . 74.21 111.158 -176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -112.87 145.38 40.78 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.747 0.819 . . . . 63.43 110.049 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.295 0 C-N-CA 125.806 1.642 . . . . 55.44 110.708 -176.408 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 168' ' ' LYS . . . . . . . . . . . . . 56.0 mttm . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.048 -0.723 . . . . 65.11 109.048 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.36 66.84 3.81 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.459 0.474 . . . . 43.43 112.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.33 8.34 21.33 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.638 1.175 . . . . 71.13 110.847 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 171' ' ' SER . . . . . . . . . . . . . 44.3 p -136.45 -67.83 0.5 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.255 0.622 . . . . 64.15 110.787 -166.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 172' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' E' ' 175' ' ' PHE . . . -169.22 -175.95 2.41 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.583 0.753 . . . . 73.42 111.026 -176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 173' ' ' LEU . . . . . 0.427 HD22 ' H ' ' E' ' 173' ' ' LEU . 1.6 mm? -76.87 -30.63 56.34 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.771 -1.104 . . . . 70.31 109.961 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 174' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 -57.36 1.17 Allowed 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.741 1.216 . . . . 64.13 109.268 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 175' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' E' ' 172' ' ' ALA . 16.0 t80 62.19 86.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.442 1.497 . . . . 73.54 111.422 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 176' ' ' ASN . . . . . 0.473 ' HB2' ' HB3' ' C' ' 94' ' ' MET . 22.1 m-80 -93.49 103.31 15.52 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.451 -0.944 . . . . 73.31 108.451 177.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 177' ' ' LEU . . . . . 0.473 ' HG ' ' H ' ' E' ' 178' ' ' GLN . 11.8 tp -167.42 -169.38 1.21 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.343 -0.984 . . . . 74.05 108.343 -178.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 178' ' ' GLN . . . . . 0.473 ' H ' ' HG ' ' E' ' 177' ' ' LEU . 2.0 mp0 78.23 -41.39 0.32 Allowed 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 125.627 1.571 . . . . 71.13 111.862 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 179' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.29 150.22 43.76 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 125.081 1.352 . . . . 64.12 111.319 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 180' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -67.87 85.12 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.754 2.302 . . . . 51.32 112.536 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 181' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -94.51 96.91 9.78 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.545 -1.28 . . . . 72.52 107.545 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 182' ' ' PHE . . . . . 0.446 ' HE1' ' HA ' ' A' ' 150' ' ' GLU . 10.9 p90 -78.4 65.56 3.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.354 1.062 . . . . 74.51 110.803 -176.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 183' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' C' ' 133' ' ' PHE . 13.5 t -132.11 6.27 4.22 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 114.759 -1.11 . . . . 75.5 109.958 -174.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 184' ' ' TRP . . . . . . . . . . . . . 49.5 t-105 -118.06 87.07 27.51 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 122.954 0.502 . . . . 74.32 110.014 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 185' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.16 154.93 19.32 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.427 2.084 . . . . 65.2 112.371 169.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 186' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.52 151.62 34.51 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 107.923 -1.14 . . . . 64.32 107.923 171.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 187' ' ' ILE . . . . . 0.542 HD13 ' HB3' ' C' ' 128' ' ' LEU . 2.7 tt -80.78 134.73 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 122.663 0.385 . . . . 71.54 110.052 175.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 188' ' ' ALA . . . . . . . . . . . . . . . -107.44 83.62 1.84 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.906 0.882 . . . . 44.34 109.326 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.16 95.73 4.33 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.734 -0.839 . . . . 74.54 108.734 173.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 190' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -68.36 105.96 2.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.903 0.881 . . . . 74.04 110.585 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 191' ' ' GLY . . . . . . . . . . . . . . . 60.39 -124.41 35.77 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 124.1 0.875 . . . . 72.4 111.663 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 192' ' ' GLY . . . . . . . . . . . . . . . 139.53 171.48 12.29 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 111.761 -0.536 . . . . 52.13 111.761 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 193' ' ' TYR . . . . . 0.523 ' HE2' ' HB1' ' F' ' 194' ' ' ALA . 53.7 t80 -146.78 160.52 42.16 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.494 -0.928 . . . . 70.4 108.494 -176.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . 0.729 ' HB1' ' HG3' ' C' ' 124' ' ' PRO . . . -134.45 -78.9 0.46 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.037 0.535 . . . . 74.11 110.4 -176.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 195' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -165.77 178.08 6.8 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.576 0.703 . . . . 74.24 111.894 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 196' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -109.65 121.74 45.9 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.321 1.448 . . . . 61.2 109.06 175.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 197' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.06 104.35 11.49 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.196 -0.668 . . . . 71.02 109.196 174.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 198' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -98.7 171.3 8.19 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.925 0.89 . . . . 61.22 109.702 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 199' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -90.16 8.59 32.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.32 0.648 . . . . 64.14 110.934 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 200' ' ' GLY . . . . . . . . . . . . . . . -151.97 -131.09 1.69 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 109.985 -1.246 . . . . 51.21 109.985 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.84 -74.9 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.198 1.399 . . . . 65.31 110.057 -173.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 202' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -81.95 -172.82 4.13 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.31 1.044 . . . . 74.42 110.645 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -77.18 -145.64 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 106.982 -1.488 . . . . 72.51 106.982 172.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 204' ' ' ILE . . . . . 0.507 ' HA ' HG22 ' E' ' 207' ' ' VAL . 17.4 mm 55.96 32.67 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.241 0 CA-C-O 122.444 1.116 . . . . 73.42 109.15 -170.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 205' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -73.81 -51.62 15.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.276 -1.329 . . . . 72.2 109.119 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 206' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -137.58 64.29 1.52 Allowed 'General case' 0 C--O 1.24 0.571 0 CA-C-N 115.09 -0.959 . . . . 73.13 109.118 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' E' ' 204' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.491 1.583 0 C-N-CA 124.584 1.154 . . . . 74.34 109.808 168.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 168' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.784 0.326 . . . . 72.15 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 169' ' ' GLY . . . . . . . . . . . . . . . 94.51 -61.3 1.77 Allowed Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.812 -0.631 . . . . 24.42 112.124 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 170' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -78.83 124.77 28.55 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.174 0.59 . . . . 71.03 110.142 -178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 171' ' ' SER . . . . . . . . . . . . . 4.3 m -82.53 -63.12 1.44 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.388 1.075 . . . . 70.24 109.178 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 172' ' ' ALA . . . . . . . . . . . . . . . -146.2 68.61 1.19 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.277 1.031 . . . . 45.42 108.551 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 173' ' ' LEU . . . . . 0.741 HD23 ' H ' ' B' ' 54' ' ' ASP . 1.4 tm? -98.63 101.1 12.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 114.21 -1.359 . . . . 52.54 107.791 179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 174' ' ' MET . . . . . 0.409 ' SD ' ' N ' ' F' ' 174' ' ' MET . 0.0 OUTLIER -156.38 108.62 2.54 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.529 0.731 . . . . 73.3 109.174 174.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' F' F ' 175' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -158.83 121.71 3.7 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.019 0.528 . . . . 75.52 110.135 178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 176' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -144.04 130.47 19.93 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 105.994 -1.854 . . . . 62.21 105.994 170.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 177' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.79 -71.27 0.19 Allowed 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.559 0.537 . . . . 74.05 109.614 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 178' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 61.91 -71.66 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 125.096 1.359 . . . . 70.13 111.606 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 179' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -108.82 136.28 20.02 Favored Pre-proline 0 CA--C 1.549 0.912 0 N-CA-C 107.757 -1.201 . . . . 71.11 107.757 171.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 180' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.69 143.11 60.67 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.552 2.168 . . . . 70.0 110.162 176.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 181' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -58.2 -57.81 11.24 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.253 -0.647 . . . . 74.23 109.253 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 182' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -148.01 143.71 27.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.622 1.169 . . . . 73.02 108.606 166.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 183' ' ' THR . . . . . . . . . . . . . 69.5 p -72.14 144.72 48.5 Favored 'General case' 0 C--O 1.243 0.732 0 N-CA-C 109.297 -0.631 . . . . 72.53 109.297 172.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 184' ' ' TRP . . . . . 0.524 ' CD1' HD11 ' F' ' 186' ' ' LEU . 8.3 t90 -142.65 65.02 16.39 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 122.63 0.372 . . . . 72.42 110.026 -176.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 185' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -98.04 132.96 0.3 Allowed 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.762 2.975 . . . . 71.31 112.876 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 186' ' ' LEU . . . . . 0.647 ' HB2' HD21 ' B' ' 128' ' ' LEU . 0.8 OUTLIER -138.92 -165.1 1.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.086 0.555 . . . . 73.41 110.913 -175.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' F' F ' 187' ' ' ILE . . . . . 0.781 HG13 ' HB3' ' B' ' 42' ' ' LEU . 29.8 mm 69.53 134.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 C-N-CA 127.041 2.136 . . . . 75.15 112.985 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 188' ' ' ALA . . . . . . . . . . . . . . . -141.01 35.55 1.74 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.668 -0.696 . . . . 62.14 110.65 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 189' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.88 64.25 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.52 0.728 . . . . 15.4 111.963 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 190' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.08 -49.82 70.71 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 124.808 1.243 . . . . 64.11 110.897 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 191' ' ' GLY . . . . . . . . . . . . . . . -95.59 10.81 68.82 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 115.87 -0.605 . . . . 62.22 112.941 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 192' ' ' GLY . . . . . . . . . . . . . . . -70.22 87.26 0.32 Allowed Glycine 0 C--N 1.35 1.356 0 C-N-CA 123.216 0.436 . . . . 34.41 112.178 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 193' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -72.89 89.83 1.42 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.906 0.882 . . . . 73.35 109.69 -177.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . 0.523 ' HB1' ' HE2' ' E' ' 193' ' ' TYR . . . -170.71 -37.74 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.402 1.081 . . . . 63.31 108.69 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 195' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -71.32 108.01 4.57 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.994 -1.003 . . . . 72.21 110.173 175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 196' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -159.55 155.68 26.77 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.641 1.176 . . . . 71.45 108.91 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 197' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -78.98 -42.48 26.62 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.815 0.446 . . . . 73.24 110.717 -173.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 198' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -80.62 66.4 6.12 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.376 0.671 . . . . 65.51 111.058 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 199' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -166.67 -73.45 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.061 0.544 . . . . 74.21 109.812 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 200' ' ' GLY . . . . . . . . . . . . . . . -136.94 84.52 0.25 Allowed Glycine 0 C--N 1.348 1.229 0 N-CA-C 110.896 -0.882 . . . . 73.24 110.896 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -67.96 117.1 9.37 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.77 0.828 . . . . 71.32 111.409 -174.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 202' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -75.97 -29.0 58.1 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.863 0.84 . . . . 63.24 109.403 167.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.91 130.83 36.04 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 113.943 -1.48 . . . . 61.1 110.099 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 204' ' ' ILE . . . . . . . . . . . . . 23.3 pt -77.38 107.48 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 108.685 -0.857 . . . . 73.12 108.685 167.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 205' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -63.14 -38.97 93.28 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.063 -0.971 . . . . 72.23 109.72 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 206' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -159.85 159.91 33.08 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.251 1.021 . . . . 74.23 108.738 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 C--O 1.258 1.518 0 CA-C-O 118.11 -0.948 . . . . 70.51 109.604 175.124 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' G' G ' 168' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 108.607 -0.886 . . . . 75.41 108.607 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' G' G ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.86 -165.49 15.39 Favored Glycine 0 C--N 1.344 0.991 0 O-C-N 123.587 0.554 . . . . 74.54 113.587 173.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 170' ' ' LYS . . . . . 0.544 ' HG2' ' H ' ' G' ' 171' ' ' SER . 33.5 ttpt -177.07 -170.11 0.28 Allowed 'General case' 0 CA--C 1.563 1.465 0 C-N-CA 125.445 1.498 . . . . 62.25 107.494 -172.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 171' ' ' SER . . . . . 0.544 ' H ' ' HG2' ' G' ' 170' ' ' LYS . 32.3 t 68.41 10.38 7.82 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 123.893 0.877 . . . . 61.44 111.932 172.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 172' ' ' ALA . . . . . . . . . . . . . . . -165.87 -46.95 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.535 0.734 . . . . 53.34 109.353 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 173' ' ' LEU . . . . . . . . . . . . . 73.2 mt -56.47 125.41 21.93 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 124.107 0.88 . . . . 63.14 110.377 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 174' ' ' MET . . . . . . . . . . . . . 30.0 mmt 72.77 -71.41 0.14 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.089 1.756 . . . . 72.55 109.793 -173.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 175' ' ' PHE . . . . . 0.43 ' CD1' HD21 ' A' ' 98' ' ' LEU . 26.7 t80 -148.46 -86.36 0.09 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 108.966 -0.753 . . . . 71.02 108.966 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 176' ' ' ASN . . . . . . . . . . . . . 14.4 m120 49.84 26.41 1.92 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 125.009 1.324 . . . . 53.33 113.282 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 177' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.5 109.78 4.43 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.473 0.709 . . . . 75.41 110.319 -172.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 178' ' ' GLN . . . . . 0.581 ' HA ' HE21 ' G' ' 178' ' ' GLN . 0.0 OUTLIER -139.46 134.98 33.07 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.67 -1.233 . . . . 64.14 107.67 177.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' G' G ' 179' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 84.58 0.18 Allowed Pre-proline 0 CA--C 1.557 1.216 0 O-C-N 124.559 1.162 . . . . 74.04 109.513 -165.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 180' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.42 138.03 53.43 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.409 2.739 . . . . 74.05 112.607 -173.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 181' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -72.19 95.16 1.63 Allowed 'General case' 0 C--O 1.244 0.793 0 C-N-CA 123.694 0.798 . . . . 72.42 109.219 176.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 182' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 68.86 -179.38 0.23 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 125.234 1.414 . . . . 75.12 111.26 -177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 183' ' ' THR . . . . . . . . . . . . . 76.8 p -109.87 -5.9 15.38 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.601 0.76 . . . . 63.45 111.048 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 184' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 67.61 100.91 0.04 OUTLIER Pre-proline 0 C--N 1.366 1.307 0 C-N-CA 125.115 1.366 . . . . 64.3 110.886 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 185' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -80.52 117.08 3.34 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.351 2.034 . . . . 74.02 111.457 168.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 186' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.16 -175.84 5.46 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.401 0.68 . . . . 63.13 110.27 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 187' ' ' ILE . . . . . . . . . . . . . 2.7 pp -93.99 146.59 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 123.489 0.716 . . . . 72.44 109.421 167.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 188' ' ' ALA . . . . . . . . . . . . . . . -100.06 85.08 2.97 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.442 0.697 . . . . 50.53 109.539 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 189' ' ' ALA . . . . . 0.508 ' HB2' HD13 ' H' ' 204' ' ' ILE . . . -86.36 108.02 18.26 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.415 -0.811 . . . . 65.12 109.631 178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 190' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -146.64 174.69 11.21 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.412 0.685 . . . . 71.32 110.002 178.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 191' ' ' GLY . . . . . . . . . . . . . . . 90.1 113.33 1.53 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.469 -1.052 . . . . 71.34 110.469 -169.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 192' ' ' GLY . . . . . . . . . . . . . . . -145.79 116.61 0.91 Allowed Glycine 0 C--N 1.344 1.017 0 CA-C-O 119.58 -0.566 . . . . 60.32 111.941 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 193' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -170.29 130.19 0.91 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.492 1.117 . . . . 65.15 108.849 177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -156.54 171.58 20.05 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.448 0.699 . . . . 60.54 110.231 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 195' ' ' PHE . . . . . 0.484 ' HE2' ' HD3' ' A' ' 124' ' ' PRO . 25.8 m-85 60.65 -166.25 0.2 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.477 1.111 . . . . 64.14 111.269 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 196' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -136.79 92.91 2.79 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.817 0.847 . . . . 75.14 109.439 167.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 197' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -83.5 69.51 10.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.857 0.863 . . . . 73.41 108.875 171.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 198' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.76 -65.47 1.17 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.182 0.993 . . . . 75.52 108.72 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 199' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -169.4 141.58 2.49 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.417 1.087 . . . . 72.31 109.01 174.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 200' ' ' GLY . . . . . . . . . . . . . . . 160.64 141.02 3.02 Favored Glycine 0 C--N 1.346 1.134 0 N-CA-C 111.684 -0.566 . . . . 74.24 111.684 -176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -109.93 -39.55 5.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.448 0.699 . . . . 74.41 111.324 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 202' ' ' TYR . . . . . 0.437 ' OH ' HG22 ' D' ' 40' ' ' VAL . 37.3 t80 63.8 106.55 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.963 1.305 . . . . 74.52 108.396 -167.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -62.12 85.09 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 113.502 0.927 . . . . 74.03 113.502 -161.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 204' ' ' ILE . . . . . . . . . . . . . 9.4 mt -130.88 44.67 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 N-CA-C 106.416 -1.698 . . . . 75.31 106.416 171.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 205' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -67.32 163.31 20.92 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.607 -1.179 . . . . 71.42 112.053 -174.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 206' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -55.06 103.46 0.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.987 0.915 . . . . 60.24 111.471 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.49 1.566 0 C-N-CA 125.797 1.639 . . . . 63.03 111.791 179.824 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' H' H ' 168' ' ' LYS . . . . . . . . . . . . . 55.6 tptt . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 109.79 -0.448 . . . . 73.54 109.79 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' H' H ' 169' ' ' GLY . . . . . . . . . . . . . . . 165.45 35.92 0.02 OUTLIER Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.445 -0.343 . . . . 42.34 113.29 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 170' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -95.16 152.95 17.9 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.685 -0.857 . . . . 71.42 108.685 171.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 171' ' ' SER . . . . . . . . . . . . . 40.2 m -75.19 76.02 2.33 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.932 0.893 . . . . 60.05 109.922 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 172' ' ' ALA . . . . . 0.682 ' HB1' ' HB3' ' H' ' 176' ' ' ASN . . . -74.68 -38.97 62.27 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 114.672 -1.149 . . . . 63.4 110.823 -177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 173' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 72.11 -73.77 0.09 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 125.419 1.488 . . . . 64.43 111.201 175.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 174' ' ' MET . . . . . . . . . . . . . 25.2 mmt -91.51 75.56 5.91 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.602 0.761 . . . . 75.21 111.569 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 175' ' ' PHE . . . . . 0.452 ' HB2' ' CE2' ' D' ' 56' ' ' TYR . 49.8 t80 54.37 94.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.139 1.776 . . . . 73.24 113.779 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 176' ' ' ASN . . . . . 0.682 ' HB3' ' HB1' ' H' ' 172' ' ' ALA . 28.0 t-20 -171.62 98.83 0.19 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.954 0.902 . . . . 72.34 109.113 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -90.3 107.61 19.25 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.074 -1.454 . . . . 73.35 107.074 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 178' ' ' GLN . . . . . . . . . . . . . 17.3 mp0 -66.03 93.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.397 0.679 . . . . 72.34 110.796 -171.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 179' ' ' GLU . . . . . . . . . . . . 0.315 1.2 mp0 34.99 -85.12 0.0 OUTLIER Pre-proline 0 CA--C 1.586 2.346 0 C-N-CA 127.857 2.463 . . . . 73.45 116.015 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 180' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.19 133.19 32.08 Favored 'Trans proline' 0 C--N 1.401 3.322 0 CA-C-N 124.036 2.477 . . . . 53.01 112.138 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 181' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -107.86 -79.19 0.58 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 108.468 -0.938 . . . . 73.14 108.468 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 182' ' ' PHE . . . . . . . . . . . . . 15.4 t80 178.6 153.04 0.35 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.531 1.133 . . . . 61.11 108.312 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 183' ' ' THR . . . . . . . . . . . . . 15.2 t -78.12 148.15 34.31 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.567 0.747 . . . . 72.33 110.996 -177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 184' ' ' TRP . . . . . 0.53 ' HB2' HD13 ' H' ' 186' ' ' LEU . 0.1 OUTLIER -149.27 115.54 3.65 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 122.911 0.484 . . . . 50.45 111.768 -179.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' H' H ' 185' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -78.74 -63.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.219 2.613 . . . . 65.21 111.907 171.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 186' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' H' ' 184' ' ' TRP . 10.2 mp 59.23 86.08 0.09 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 125.384 1.473 . . . . 63.4 112.803 178.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 187' ' ' ILE . . . . . 0.549 ' HB ' HD22 ' D' ' 42' ' ' LEU . 56.8 mt 64.97 108.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 125.767 1.627 . . . . 63.21 112.469 173.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 188' ' ' ALA . . . . . . . . . . . . . . . -112.75 66.48 0.65 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.33 -0.989 . . . . 74.21 108.33 171.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 189' ' ' ALA . . . . . . . . . . . . . . . -71.98 145.57 48.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.877 -1.056 . . . . 74.13 112.84 -168.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 190' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.27 172.57 18.13 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.952 0.901 . . . . 75.45 110.309 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 191' ' ' GLY . . . . . 0.402 ' HA3' ' HG2' ' D' ' 37' ' ' GLN . . . -160.71 -152.3 6.53 Favored Glycine 0 N--CA 1.471 0.994 0 N-CA-C 111.241 -0.744 . . . . 75.1 111.241 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 192' ' ' GLY . . . . . . . . . . . . . . . -135.23 -62.31 0.06 OUTLIER Glycine 0 C--N 1.351 1.388 0 CA-C-N 117.585 0.693 . . . . 55.21 112.73 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 193' ' ' TYR . . . . . 0.444 ' HE1' ' HB2' ' H' ' 196' ' ' LYS . 3.2 t80 -158.89 118.54 3.09 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.464 0.706 . . . . 75.42 109.129 -175.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -168.49 25.75 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.993 0.917 . . . . 75.3 110.338 175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 195' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -122.22 23.57 9.78 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.18 0.992 . . . . 73.21 110.058 -168.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 196' ' ' LYS . . . . . 0.444 ' HB2' ' HE1' ' H' ' 193' ' ' TYR . 6.6 tmtm? -73.84 105.59 5.18 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 115.605 -0.725 . . . . 62.04 110.396 -171.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 197' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -79.2 179.34 7.44 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.048 0.939 . . . . 71.1 111.537 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 198' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.39 137.47 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.109 1.363 . . . . 60.42 111.834 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 199' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -86.85 1.55 52.07 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.136 -0.938 . . . . 74.5 110.433 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 200' ' ' GLY . . . . . . . . . . . . . . . 80.59 -59.45 4.66 Favored Glycine 0 C--N 1.361 1.932 0 O-C-N 123.754 0.659 . . . . 52.22 111.455 -174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -110.19 118.9 37.61 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.919 1.288 . . . . 73.35 107.593 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 202' ' ' TYR . . . . . . . . . . . . . 67.9 t80 179.63 89.29 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.286 -1.376 . . . . 75.55 107.286 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -132.58 96.42 3.83 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.174 0.59 . . . . 72.22 110.562 -169.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 204' ' ' ILE . . . . . 0.508 HD13 ' HB2' ' G' ' 189' ' ' ALA . 15.6 pt -142.9 112.32 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 124.466 1.107 . . . . 73.13 109.27 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 205' ' ' LYS . . . . . 0.778 ' HG2' ' HB ' ' C' ' 10' ' ' THR . 41.3 ttmt -147.16 -61.84 0.28 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.905 0.482 . . . . 73.23 110.906 -173.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 206' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.22 164.43 16.34 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.943 -0.571 . . . . 74.22 110.758 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.559 1.301 0 CA-C-O 117.962 -1.018 . . . . 73.14 109.885 -176.597 . . . . . . . . 0 0 . 1 stop_ save_